subject,predicate,object,pubmed_id,doi,publication_date
Coronavirus Infections,PROCESS_OF,Patients,32634855,10.1111/ggi.13974,2020-07-08
Experience,PROCESS_OF,geriatric patients,32634855,10.1111/ggi.13974,2020-07-08
Pneumonia,PROCESS_OF,Patients,32634855,10.1111/ggi.13974,2020-07-08
Dyspnea,COEXISTS_WITH,One Activity Hour,32634855,10.1111/ggi.13974,2020-07-08
Critical Illness,PROCESS_OF,Patients,32634855,10.1111/ggi.13974,2020-07-08
lung development,PROCESS_OF,Patients,32634855,10.1111/ggi.13974,2020-07-08
Inflammation,PROCESS_OF,geriatric patients,32634855,10.1111/ggi.13974,2020-07-08
Infected,PROCESS_OF,geriatric patients,32634855,10.1111/ggi.13974,2020-07-08
risk factors,PROCESS_OF,Patients,32634830,10.1093/cid/ciaa920,2020-07-08
risk factors,PROCESS_OF,Population Group,32634830,10.1093/cid/ciaa920,2020-07-08
Cessation of life,PROCESS_OF,inpatient,32634830,10.1093/cid/ciaa920,2020-07-08
Woman,ISA,Population Group,32634830,10.1093/cid/ciaa920,2020-07-08
Intervention regimes,TREATS,Survivors,32634828,10.1093/cid/ciaa923,2020-07-08
Males,ASSOCIATED_WITH,Coronavirus Infections,32634827,10.1093/cid/ciaa924,2020-07-08
Males,ASSOCIATED_WITH,Coronavirus Infections,32634827,10.1093/cid/ciaa924,2020-07-08
Atrial Fibrillation,PROCESS_OF,Male population group,32634827,10.1093/cid/ciaa924,2020-07-08
Diagnosis,USES,Ethanol,32634827,10.1093/cid/ciaa924,2020-07-08
Heart failure,PROCESS_OF,Male population group,32634827,10.1093/cid/ciaa924,2020-07-08
Cerebrovascular accident,PROCESS_OF,Male population group,32634827,10.1093/cid/ciaa924,2020-07-08
Hospitals,LOCATION_OF,Cross-Sectional Studies,32634826,10.1093/cid/ciaa905,2020-07-08
Swab specimen,ISA,Entity,32634826,10.1093/cid/ciaa905,2020-07-08
Asymptomatic Infections,PROCESS_OF,Staff,32634823,10.1093/cid/ciaa901,2020-07-08
infection prophylaxis,COEXISTS_WITH,Health Care,32634822,10.1093/cid/ciaa892,2020-07-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32634822,10.1093/cid/ciaa892,2020-07-08
"Infant, Newborn",LOCATION_OF,"CD69 protein, human",32634819,10.1038/s41390-020-1050-z,2020-07-08
Infant,USES,Mobility aid,32634819,10.1038/s41390-020-1050-z,2020-07-08
Infant,USES,Mobility aid,32634819,10.1038/s41390-020-1050-z,2020-07-08
Critical Illness,PROCESS_OF,Child,32634818,10.1038/s41390-020-1053-9,2020-07-08
Severe Acute Respiratory Syndrome,PROCESS_OF,critically ill children,32634818,10.1038/s41390-020-1053-9,2020-07-08
Respiratory distress,PROCESS_OF,Patients,32634818,10.1038/s41390-020-1053-9,2020-07-08
Anti-Inflammatory Agents,ADMINISTERED_TO,Child,32634818,10.1038/s41390-020-1053-9,2020-07-08
Antiviral Agents,ADMINISTERED_TO,Child,32634818,10.1038/s41390-020-1053-9,2020-07-08
Therapeutic procedure,ADMINISTERED_TO,Child,32634818,10.1038/s41390-020-1053-9,2020-07-08
Blood Vessel,LOCATION_OF,risk factors,32634813,10.1159/000509453,2020-07-08
risk factors,PROCESS_OF,Patients,32634813,10.1159/000509453,2020-07-08
Cerebrovascular accident,PROCESS_OF,Patients,32634813,10.1159/000509453,2020-07-08
Arteries,LOCATION_OF,Ischemic foot,32634813,10.1159/000509453,2020-07-08
alteplase,TREATS,Symptoms,32634813,10.1159/000509453,2020-07-08
Neurologic Deficits,PROCESS_OF,Patients,32634813,10.1159/000509453,2020-07-08
Ischemic foot,PROCESS_OF,Patients,32634813,10.1159/000509453,2020-07-08
Endothelial Cells,PRODUCES,Membrane Proteins,32634813,10.1159/000509453,2020-07-08
Cerebrovascular accident,COEXISTS_WITH,risk factors,32634813,10.1159/000509453,2020-07-08
Blood Vessel complications,COEXISTS_WITH,risk factors,32634813,10.1159/000509453,2020-07-08
Immunohistochemistry,AFFECTS,Screening procedure,32634799,10.1159/000509546,2020-07-08
Health Personnel,DIAGNOSES,Malignant Neoplasms,32634799,10.1159/000509546,2020-07-08
Dyspnea,NEG_PROCESS_OF,Patients,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Lung,LOCATION_OF,Stiffness,32634734,10.1016/j.mehy.2020.110022,2020-07-08
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Present,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Blood arterial,LOCATION_OF,Oxygen,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Stiffness,NEG_PROCESS_OF,Patients,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Mixed venous blood,LOCATION_OF,Oxygen,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Cardiac chamber structure,LOCATION_OF,Surgical fistula,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Pulmonary artery structure,LOCATION_OF,Autopsy,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Right cardiac chamber,LOCATION_OF,Autopsy,32634734,10.1016/j.mehy.2020.110022,2020-07-08
Linear,LOCATION_OF,Alveolar Epithelial Cells,32634734,10.1016/j.mehy.2020.110022,2020-07-08
"M Protein, multiple myeloma",PART_OF,Corona,32634734,10.1016/j.mehy.2020.110022,2020-07-08
India,ISA,Country,32634726,10.1016/j.envpol.2020.115080,2020-07-08
Disease,PROCESS_OF,Patients,32634717,10.1016/j.dsx.2020.06.068,2020-07-08
Pharmaceutical Preparations,TREATS,Disease,32634717,10.1016/j.dsx.2020.06.068,2020-07-08
Pharmaceutical Preparations,TREATS,Patients,32634717,10.1016/j.dsx.2020.06.068,2020-07-08
Heart,LOCATION_OF,Vascular Diseases,32634716,10.1016/j.dsx.2020.06.064,2020-07-08
Chronic Kidney Diseases,PROCESS_OF,Patients,32634716,10.1016/j.dsx.2020.06.064,2020-07-08
Cessation of life,PROCESS_OF,Patients,32634716,10.1016/j.dsx.2020.06.064,2020-07-08
IMPACT gene,CAUSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,32634716,10.1016/j.dsx.2020.06.064,2020-07-08
Diabetes Mellitus,PROCESS_OF,Patients,32634716,10.1016/j.dsx.2020.06.064,2020-07-08
Coronavirus Infections,ISA,Disease,32634589,10.1016/j.ijid.2020.06.107,2020-07-08
Coronavirus Infections,ISA,Disease,32634589,10.1016/j.ijid.2020.06.107,2020-07-08
Disease Progression,PRODUCES,Antibodies,32634589,10.1016/j.ijid.2020.06.107,2020-07-08
Coronavirus Infections,ISA,Disease,32634589,10.1016/j.ijid.2020.06.107,2020-07-08
Infected,PROCESS_OF,Persons,32634588,10.1016/j.ijid.2020.06.105,2020-07-08
Decision,PROCESS_OF,Maker (occupation),32634588,10.1016/j.ijid.2020.06.105,2020-07-08
Serologic tests,DIAGNOSES,Non-Ossifying Fibroma,32634587,10.1016/j.ijid.2020.06.106,2020-07-08
Family,ISA,Population Group,32634587,10.1016/j.ijid.2020.06.106,2020-07-08
Severe disorder,PROCESS_OF,Patients,32634585,10.1016/j.ijid.2020.07.003,2020-07-08
CD8A wt Allele,ASSOCIATED_WITH,Disease Progression,32634585,10.1016/j.ijid.2020.07.003,2020-07-08
"T-Cell Surface Glycoprotein CD4, human",ASSOCIATED_WITH,Disease Progression,32634585,10.1016/j.ijid.2020.07.003,2020-07-08
"T-Cell Surface Glycoprotein CD4, human",compared_with,CD8A wt Allele,32634585,10.1016/j.ijid.2020.07.003,2020-07-08
aptamer,DISRUPTS,Coronavirus Infections,32634550,10.1016/j.mcp.2020.101636,2020-07-08
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32634550,10.1016/j.mcp.2020.101636,2020-07-08
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32634459,10.1016/j.jinf.2020.07.002,2020-07-08
Prophylactic treatment,USES,Pharmaceutical Preparations,32634438,10.1016/j.ejphar.2020.173348,2020-07-08
Prophylactic treatment,USES,Vaccines,32634438,10.1016/j.ejphar.2020.173348,2020-07-08
Rest,ISA,Work,32634321,10.1080/08989621.2020.1793675,2020-07-08
Assay,DIAGNOSES,Disease,32634229,10.1093/labmed/lmaa045,2020-07-08
Fever,PROCESS_OF,Patients,32634228,10.1093/jtm/taaa104,2020-07-08
Prolonged menses,PROCESS_OF,Patients,32634228,10.1093/jtm/taaa104,2020-07-08
Antibody Formation,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
intensive care unit,LOCATION_OF,Study,32634129,10.1172/JCI138759,2020-07-08
Ward (environment),LOCATION_OF,Reverse Transcriptase Polymerase Chain Reaction,32634129,10.1172/JCI138759,2020-07-08
Viral Shedding,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
Viral Shedding,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
Cross Reactions,NEG_PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
SARS coronavirus,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
SARS coronavirus,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
Patients,LOCATION_OF,Serum,32634129,10.1172/JCI138759,2020-07-08
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32634129,10.1172/JCI138759,2020-07-08
Plasma,LOCATION_OF,Blood group antibody S,32634129,10.1172/JCI138759,2020-07-08
Immune response,PROCESS_OF,Homo sapiens,32634129,10.1172/JCI138759,2020-07-08
Antibodies,PART_OF,Patients,32634126,10.1172/JCI139760,2020-07-08
Antibodies,AUGMENTS,Antiviral Response,32634126,10.1172/JCI139760,2020-07-08
Patients,LOCATION_OF,Antibodies,32634126,10.1172/JCI139760,2020-07-08
Adolescent (age group),ISA,Persons,32634111,10.1556/2006.2020.00040,2020-07-08
Gaming disorder,PROCESS_OF,Adolescent (age group),32634111,10.1556/2006.2020.00040,2020-07-08
Crisis,PREDISPOSES,Suicide,32634105,10.2196/19867,2020-07-08
Mental disorders,PROCESS_OF,Child,32634105,10.2196/19867,2020-07-08
Telemedicine,ISA,Health Services,32634105,10.2196/19867,2020-07-08
Coronavirus Infections,ISA,Disease,32634080,10.2174/1381612826666200707121636,2020-07-08
Exacerbation,PROCESS_OF,Homo sapiens,32634080,10.2174/1381612826666200707121636,2020-07-08
Chloroquine,ISA,quinoline,32634079,10.2174/1381612826666200707132920,2020-07-08
Hydroxychloroquine,ISA,quinoline,32634079,10.2174/1381612826666200707132920,2020-07-08
quinoline,ISA,Heterocyclic Compounds,32634079,10.2174/1381612826666200707132920,2020-07-08
Rheumatoid Arthritis,ISA,Autoimmune Diseases,32634079,10.2174/1381612826666200707132920,2020-07-08
"Lupus Erythematosus, Systemic",ISA,Autoimmune Diseases,32634079,10.2174/1381612826666200707132920,2020-07-08
Antiphospholipid Syndrome,ISA,Autoimmune Diseases,32634079,10.2174/1381612826666200707132920,2020-07-08
Therapeutic procedure,TREATS,Autoimmune Diseases,32634079,10.2174/1381612826666200707132920,2020-07-08
Therapeutic procedure,TREATS(SPEC),Rheumatoid Arthritis,32634079,10.2174/1381612826666200707132920,2020-07-08
Therapeutic procedure,TREATS(SPEC),"Lupus Erythematosus, Systemic",32634079,10.2174/1381612826666200707132920,2020-07-08
Therapeutic procedure,TREATS(SPEC),Antiphospholipid Syndrome,32634079,10.2174/1381612826666200707132920,2020-07-08
Infected,PROCESS_OF,Patients,32634079,10.2174/1381612826666200707132920,2020-07-08
Perception,PROCESS_OF,Persons,32634067,10.1200/GO.20.00209,2020-07-08
Hip Fractures,PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,ISA,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
"CD69 protein, human",ASSOCIATED_WITH,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Hip Fractures,PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,ISA,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,ISA,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Hip Fractures,PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Disease,PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Hip Fractures,PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,ISA,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Symptoms,NEG_PROCESS_OF,Patients,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
Coronavirus Infections,ISA,Disease,32634029,10.1302/0301-620X.102B9.BJJ-2020-1100.R1,2020-07-08
urgent Operation,TREATS,Hip Fractures,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Patients,LOCATION_OF,IMPACT gene,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Hospitals,LOCATION_OF,Multicenter Study,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
risk factors,PROCESS_OF,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Operative Surgical Procedures,TREATS,Hip Fractures,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Operative Surgical Procedures,TREATS,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
risk factors,PROCESS_OF,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Postoperative Complications,PROCESS_OF,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Hospital admission,TREATS,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
risk factors,PROCESS_OF,Patients,32634023,10.1302/0301-620X.102B9.BJJ-2020-1127.R1,2020-07-08
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Community,32634005,10.4102/phcfm.v12i1.2496,2020-07-08
Scourge,PREDISPOSES,Disease,32634004,10.4102/phcfm.v12i1.2492,2020-07-08
Toxic Epidermal Necrolysis,PROCESS_OF,"Physicians, Family",32634002,10.4102/phcfm.v12i1.2478,2020-07-08
patient condition,COEXISTS_WITH,Coughing,32633997,10.4102/safp.v62i1.5123,2020-07-08
patient condition,COEXISTS_WITH,Dyspnea,32633997,10.4102/safp.v62i1.5123,2020-07-08
patient condition,COEXISTS_WITH,Fever,32633997,10.4102/safp.v62i1.5123,2020-07-08
patient condition,COEXISTS_WITH,Pharyngitis,32633997,10.4102/safp.v62i1.5123,2020-07-08
Disease,PROCESS_OF,Persons,32633997,10.4102/safp.v62i1.5123,2020-07-08
Symptom mild,PROCESS_OF,Persons,32633997,10.4102/safp.v62i1.5123,2020-07-08
Asymptomatic,PROCESS_OF,Patients,32633869,10.1002/jmv.26267,2020-07-08
Disease,PROCESS_OF,Adult,32633869,10.1002/jmv.26267,2020-07-08
Gravidity,PROCESS_OF,Adult,32633869,10.1002/jmv.26267,2020-07-08
Symptoms,PROCESS_OF,Patients,32633869,10.1002/jmv.26267,2020-07-08
Screening procedure,TREATS,early pregnancy,32633869,10.1002/jmv.26267,2020-07-08
Memantine,TREATS,Disease,32633865,10.1002/jmv.26266,2020-07-08
Memantine,TREATS(SPEC),Coronavirus Infections,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,ISA,Disease,32633865,10.1002/jmv.26266,2020-07-08
Disease,PROCESS_OF,Patients,32633865,10.1002/jmv.26266,2020-07-08
Memantine,TREATS,Patients,32633865,10.1002/jmv.26266,2020-07-08
Memantine,TREATS(INFER),Disease,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,ISA,Disease,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32633865,10.1002/jmv.26266,2020-07-08
Disease,PROCESS_OF,Patients,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,ISA,Disease,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32633865,10.1002/jmv.26266,2020-07-08
Vaccines,TREATS,Disease,32633865,10.1002/jmv.26266,2020-07-08
Therapeutic procedure,TREATS,Disease,32633865,10.1002/jmv.26266,2020-07-08
Coronavirus Infections,ISA,Disease,32633865,10.1002/jmv.26266,2020-07-08
Abdominal Pain,COEXISTS_WITH,patient condition,32633863,10.1002/jmv.26265,2020-07-08
Diarrhea,COEXISTS_WITH,patient condition,32633863,10.1002/jmv.26265,2020-07-08
Diarrhea,PROCESS_OF,Patients,32633863,10.1002/jmv.26265,2020-07-08
Parkinson Disease,PROCESS_OF,Persons,32633860,10.1002/mds.28198,2020-07-08
Parkinson Disease,PROCESS_OF,Persons,32633860,10.1002/mds.28198,2020-07-08
Parkinson Disease,PROCESS_OF,Persons,32633860,10.1002/mds.28198,2020-07-08
Infusion procedures,TREATS,Persons,32633860,10.1002/mds.28198,2020-07-08
Infusion procedures,TREATS(INFER),Parkinson Disease,32633860,10.1002/mds.28198,2020-07-08
Parkinson Disease,ISA,Complication,32633860,10.1002/mds.28198,2020-07-08
Parkinson Disease,PROCESS_OF,Persons,32633860,10.1002/mds.28198,2020-07-08
Therapeutic evaluation,DIAGNOSES,Parkinson Disease,32633860,10.1002/mds.28198,2020-07-08
Cessation of life,PROCESS_OF,Elderly (population group),32633856,10.1002/14651858.CD013665,2020-07-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32633856,10.1002/14651858.CD013665,2020-07-08
other medicated shampoos in ATC,CAUSES,Disease,32633856,10.1002/14651858.CD013665,2020-07-08
other medicated shampoos in ATC,CAUSES,Pneumonia,32633856,10.1002/14651858.CD013665,2020-07-08
Coughing,ISA,Symptoms,32633856,10.1002/14651858.CD013665,2020-07-08
Fever,ISA,Symptoms,32633856,10.1002/14651858.CD013665,2020-07-08
Disease,PROCESS_OF,Patients,32633856,10.1002/14651858.CD013665,2020-07-08
Disease,PROCESS_OF,Patients,32633856,10.1002/14651858.CD013665,2020-07-08
Pneumonia,PROCESS_OF,Participant,32633856,10.1002/14651858.CD013665,2020-07-08
Epidemic,OCCURS_IN,World,32633846,10.1002/jmv.26271,2020-07-08
Pharyngitis,ISA,Symptoms,32633846,10.1002/jmv.26271,2020-07-08
Hypertensive disease,PROCESS_OF,Patients,32633846,10.1002/jmv.26271,2020-07-08
Complication,NEG_PROCESS_OF,Patients,32633846,10.1002/jmv.26271,2020-07-08
Diagnosis,AFFECTS,Immunization Programs,32633840,10.1002/jmv.26262,2020-07-08
Heart,LOCATION_OF,Adverse event,32633819,10.1111/ctr.14029,2020-07-08
Heart,LOCATION_OF(SPEC),Primary Graft Dysfunction,32633819,10.1111/ctr.14029,2020-07-08
Primary Graft Dysfunction,ISA,Adverse event,32633819,10.1111/ctr.14029,2020-07-08
Heart,LOCATION_OF,Adverse event,32633819,10.1111/ctr.14029,2020-07-08
Adverse event,NEG_PROCESS_OF,Patients,32633819,10.1111/ctr.14029,2020-07-08
Primary Graft Dysfunction,PROCESS_OF,Patients,32633819,10.1111/ctr.14029,2020-07-08
SARS coronavirus,PROCESS_OF,Homo sapiens,32633815,10.1002/jmv.26261,2020-07-08
Polysaccharides,TREATS,Pholidota,32633815,10.1002/jmv.26261,2020-07-08
Polysaccharides,TREATS(SPEC),Manis javanica,32633815,10.1002/jmv.26261,2020-07-08
Serine,TREATS,Pholidota,32633815,10.1002/jmv.26261,2020-07-08
Manis javanica,ISA,Pholidota,32633815,10.1002/jmv.26261,2020-07-08
Rhinolophus affinis,ISA,Chiroptera,32633815,10.1002/jmv.26261,2020-07-08
Infectious disease prevention / control,TREATS,Sedated state,32633770,10.2344/anpr-67-02-12,2020-07-08
intensive care unit,LOCATION_OF,Services,32633754,10.1001/jamasurg.2020.3107,2020-07-08
Diabetes,COEXISTS_WITH(SPEC),Cerebral Hemorrhage,32633728,10.18632/aging.103511,2020-07-08
Diabetes,ISA,Disease,32633728,10.18632/aging.103511,2020-07-08
Disease,COEXISTS_WITH,Cerebral Hemorrhage,32633728,10.18632/aging.103511,2020-07-08
Hypertensive disease,COEXISTS_WITH(SPEC),Cerebral Hemorrhage,32633728,10.18632/aging.103511,2020-07-08
Hypertensive disease,ISA,Disease,32633728,10.18632/aging.103511,2020-07-08
Senility,COEXISTS_WITH,Cerebral Hemorrhage,32633728,10.18632/aging.103511,2020-07-08
Complication,PROCESS_OF,Patients,32633728,10.18632/aging.103511,2020-07-08
Cerebral Hemorrhage,PROCESS_OF,Patients,32633728,10.18632/aging.103511,2020-07-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32633728,10.18632/aging.103511,2020-07-08
Cerebral Hemorrhage,PROCESS_OF,Patients,32633728,10.18632/aging.103511,2020-07-08
ACE2 gene,PRODUCES,Angiotensins,32633718,10.7554/eLife.59177,2020-07-08
Coronavirus Infections,ISA,Disease,32633713,10.3201/eid2610.202573,2020-07-08
Coronavirus Infections,ISA,Disease,32633713,10.3201/eid2610.202573,2020-07-08
Coronavirus Infections,ISA,Disease,32633713,10.3201/eid2610.202573,2020-07-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32633712,10.3201/eid2609.202144,2020-07-08
Worse,PROCESS_OF,Patients,32633678,10.1148/radiol.2020202504,2020-07-08
Epithelial Cells,PART_OF,Lung,32633594,10.1161/JAHA.120.016948,2020-07-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32633594,10.1161/JAHA.120.016948,2020-07-08
Angiotensin II receptor antagonist,INHIBITS,angiotensin converting enzyme 2,32633594,10.1161/JAHA.120.016948,2020-07-08
Peptidyl-Dipeptidase A,ADMINISTERED_TO,Patients,32633594,10.1161/JAHA.120.016948,2020-07-08
Angiotensin II receptor antagonist therapy,USES,Pharmaceutical Preparations,32633594,10.1161/JAHA.120.016948,2020-07-08
Cessation of life,PROCESS_OF,Patients,32633594,10.1161/JAHA.120.016948,2020-07-08
Department,LOCATION_OF,Multicenter Study,32633594,10.1161/JAHA.120.016948,2020-07-08
hypertensive medication,TREATS,Patients,32633594,10.1161/JAHA.120.016948,2020-07-08
Coronavirus Infections,PROCESS_OF,Patients,32633594,10.1161/JAHA.120.016948,2020-07-08
Antihypertensive therapy,TREATS,Patients,32633594,10.1161/JAHA.120.016948,2020-07-08
Antihypertensive therapy,TREATS(INFER),Coronavirus Infections,32633594,10.1161/JAHA.120.016948,2020-07-08
Anosmia,PROCESS_OF,Patients,32633581,10.1080/02688697.2020.1787342,2020-07-08
headache persistent,ASSOCIATED_WITH,Viral encephalomyelitis NOS,32633581,10.1080/02688697.2020.1787342,2020-07-08
headache persistent,PROCESS_OF,Patients,32633581,10.1080/02688697.2020.1787342,2020-07-08
"CD69 protein, human",AFFECTS,Negative,32633464,10.1002/brb3.1745,2020-07-08
Methyl Group,INTERACTS_WITH,Triazoles,32633433,10.1002/chem.202003192,2020-07-08
fluorophore,COEXISTS_WITH,Methyl Group,32633433,10.1002/chem.202003192,2020-07-08
Polymerase,INTERACTS_WITH,DNA Probes,32633433,10.1002/chem.202003192,2020-07-08
DNA,COEXISTS_WITH,Major Groove,32633433,10.1002/chem.202003192,2020-07-08
Real-Time Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32633433,10.1002/chem.202003192,2020-07-08
contextual factors,PROCESS_OF,nursing home resident,32633418,10.1111/jgs.16664,2020-07-08
Comorbidity,PROCESS_OF,nursing home resident,32633418,10.1111/jgs.16664,2020-07-08
Comorbidity,PROCESS_OF,nursing home resident,32633418,10.1111/jgs.16664,2020-07-08
medication use,PROCESS_OF,nursing home resident,32633418,10.1111/jgs.16664,2020-07-08
Dyspnea,COEXISTS_WITH,Symptoms,32633414,10.26355/eurrev_202006_21713,2020-07-08
Fatigue,COEXISTS_WITH,Symptoms,32633414,10.26355/eurrev_202006_21713,2020-07-08
Fever,COEXISTS_WITH,Symptoms,32633414,10.26355/eurrev_202006_21713,2020-07-08
Infected,PROCESS_OF,Patients,32633414,10.26355/eurrev_202006_21713,2020-07-08
Dry cough,COEXISTS_WITH,Symptoms,32633414,10.26355/eurrev_202006_21713,2020-07-08
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32633414,10.26355/eurrev_202006_21713,2020-07-08
Coronaviridae,PROCESS_OF,Family member,32633414,10.26355/eurrev_202006_21713,2020-07-08
Health Personnel,TREATS,Patients,32633414,10.26355/eurrev_202006_21713,2020-07-08
Interventional procedure,TREATS,Persons,32633414,10.26355/eurrev_202006_21713,2020-07-08
Chest CT,ISA,diagnostic procedure,32633414,10.26355/eurrev_202006_21713,2020-07-08
Emotions,PROCESS_OF,Persons,32633412,10.26355/eurrev_202006_21711,2020-07-08
negative emotionality,PROCESS_OF,Persons,32633412,10.26355/eurrev_202006_21711,2020-07-08
Anger,PROCESS_OF,Population Group,32633412,10.26355/eurrev_202006_21711,2020-07-08
Sad mood,PROCESS_OF,Population Group,32633412,10.26355/eurrev_202006_21711,2020-07-08
Emotions,PROCESS_OF,Persons,32633412,10.26355/eurrev_202006_21711,2020-07-08
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32633327,10.1093/femspd/ftaa033,2020-07-08
Coronavirus Infections,MANIFESTATION_OF,Cytokine release syndrome,32633327,10.1093/femspd/ftaa033,2020-07-08
Cytokine release syndrome,COEXISTS_WITH,Multiple Trauma,32633327,10.1093/femspd/ftaa033,2020-07-08
Severe Acute Respiratory Syndrome,MANIFESTATION_OF,Cytokine release syndrome,32633327,10.1093/femspd/ftaa033,2020-07-08
Middle East Respiratory Syndrome,MANIFESTATION_OF,Cytokine release syndrome,32633327,10.1093/femspd/ftaa033,2020-07-08
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32633236,10.26402/jpp.2020.2.02,2020-07-08
Patients,USES,Preexisting Condition Coverage,32633236,10.26402/jpp.2020.2.02,2020-07-08
Renin-angiotensin system,ASSOCIATED_WITH,Improved,32633235,10.26402/jpp.2020.2.01,2020-07-08
inhibitors,TREATS,Hypertensive disease,32633235,10.26402/jpp.2020.2.01,2020-07-08
Coronary Arteriosclerosis,PROCESS_OF,Old age,32633235,10.26402/jpp.2020.2.01,2020-07-08
Diabetes Mellitus,PROCESS_OF,Old age,32633235,10.26402/jpp.2020.2.01,2020-07-08
Hypertensive disease,PROCESS_OF,Old age,32633235,10.26402/jpp.2020.2.01,2020-07-08
Comorbidity,PROCESS_OF,Patients,32633235,10.26402/jpp.2020.2.01,2020-07-08
Coronavirus Infections,PROCESS_OF,Patients,32633235,10.26402/jpp.2020.2.01,2020-07-08
Plasma membrane,LOCATION_OF,angiotensin converting enzyme 2,32633235,10.26402/jpp.2020.2.01,2020-07-08
angiotensin converting enzyme 2,AUGMENTS,Virus Internalization,32633235,10.26402/jpp.2020.2.01,2020-07-08
Upper respiratory tract,PART_OF,Patients,32633235,10.26402/jpp.2020.2.01,2020-07-08
animal study,LOCATION_OF,ACE2 gene,32633235,10.26402/jpp.2020.2.01,2020-07-08
Illness (finding),PROCESS_OF,Patients,32633215,10.1177/0885066620934801,2020-07-08
Intubation,TREATS,Patients,32633215,10.1177/0885066620934801,2020-07-08
Intubation,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32633215,10.1177/0885066620934801,2020-07-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32633215,10.1177/0885066620934801,2020-07-08
Patient Transfer,TREATS,Crisis,32633215,10.1177/0885066620934801,2020-07-08
Acute hypoxemic respiratory failure,PROCESS_OF,Patients,32633215,10.1177/0885066620934801,2020-07-08
Anxiety,PROCESS_OF,Patients,32633215,10.1177/0885066620934801,2020-07-08
Coronavirus Infections,PROCESS_OF,World,32633185,10.1177/0020764020940741,2020-07-08
mental set,PROCESS_OF,Persons,32633185,10.1177/0020764020940741,2020-07-08
Agitation,PROCESS_OF,Patients,32633175,10.1080/01612840.2020.1773737,2020-07-08
Colchicine,TREATS,Flare,32633162,10.1080/08820139.2020.1789655,2020-07-08
Toes,LOCATION_OF,Pain,32633162,10.1080/08820139.2020.1789655,2020-07-08
oral medication,TREATS,Cytokine release syndrome,32633162,10.1080/08820139.2020.1789655,2020-07-08
Cytokine release syndrome,PROCESS_OF,Patients,32633162,10.1080/08820139.2020.1789655,2020-07-08
Colchicine,PREVENTS,Cytokine release syndrome,32633162,10.1080/08820139.2020.1789655,2020-07-08
Adjunctive Orthodontic Procedure,USES,Antiviral Agents,32633162,10.1080/08820139.2020.1789655,2020-07-08
Microorganism,CAUSES,Small vessel vasculitis,32633104,10.1002/art.41428,2020-07-08
Small vessel vasculitis,ISA,Vasculitis,32633104,10.1002/art.41428,2020-07-08
inhibitors,TREATS,Inflammatory disorder,32633104,10.1002/art.41428,2020-07-08
Inflammatory disorder,PROCESS_OF,Patients,32633104,10.1002/art.41428,2020-07-08
Crohn Disease,PROCESS_OF,Patients,32633104,10.1002/art.41428,2020-07-08
High Level,COEXISTS_WITH,Vasculitis,32633104,10.1002/art.41428,2020-07-08
Interested,PROCESS_OF,"Students, Medical",32633093,10.1002/hed.26251,2020-07-08
Critical Illness,PROCESS_OF,Patients,32633068,10.1111/jth.14992,2020-07-08
Ultrasonography,DIAGNOSES,Deep Vein Thrombosis,32633068,10.1111/jth.14992,2020-07-08
Pulmonary Valve Insufficiency,PROCESS_OF,Patients,32633068,10.1111/jth.14992,2020-07-08
Bed-ridden,ISA,Reduced mobility,32633068,10.1111/jth.14992,2020-07-08
Nasal Therapies,USES,Oxygen,32633068,10.1111/jth.14992,2020-07-08
Prospective Cohort Study,USES,Reverse Transcriptase Polymerase Chain Reaction,32633022,10.1111/1471-0528.16403,2020-07-08
Blood Vessel,LOCATION_OF,Thrombus,32633022,10.1111/1471-0528.16403,2020-07-08
Thrombus,PROCESS_OF,Woman,32633022,10.1111/1471-0528.16403,2020-07-08
Thrombus,AFFECTS,Infection,32633022,10.1111/1471-0528.16403,2020-07-08
Disease,PROCESS_OF,Persons,32632989,10.1111/dme.14360,2020-07-08
Hospital Administration,METHOD_OF,Hospital admission,32632989,10.1111/dme.14360,2020-07-08
Diabetes,PROCESS_OF,Persons,32632989,10.1111/dme.14360,2020-07-08
Vaccines,TREATS,patient condition,32632960,10.1002/ddr.21709,2020-07-08
Pharmaceutical Preparations,TREATS,Seizures,32632917,10.1111/ane.13310,2020-07-08
Epilepsy,PROCESS_OF,Patients,32632917,10.1111/ane.13310,2020-07-08
Epilepsy,PROCESS_OF,Patients,32632917,10.1111/ane.13310,2020-07-08
Diabetes,PROCESS_OF,Patients,32632851,10.1007/s12325-020-01417-8,2020-07-08
Cardiovascular Diseases,PROCESS_OF,Community,32632825,10.1007/s40615-020-00813-8,2020-07-08
Disease,AFFECTS,Old age,32632722,10.1007/s12020-020-02407-0,2020-07-08
Frailty,PROCESS_OF,geriatric patients,32632722,10.1007/s12020-020-02407-0,2020-07-08
activity level,PROCESS_OF,geriatric patients,32632722,10.1007/s12020-020-02407-0,2020-07-08
Predisposition -- attribute,ASSOCIATED_WITH,Rickets,32632722,10.1007/s12020-020-02407-0,2020-07-08
Vitality,PROCESS_OF,Social Networks,32632717,10.1007/s11655-020-3476-x,2020-07-08
ACE2 gene,AFFECTS,Pneumonia,32632717,10.1007/s11655-020-3476-x,2020-07-08
Structure of radial artery,LOCATION_OF,Thrombosis,32632667,10.1007/s10877-020-00555-2,2020-07-08
Lung,LOCATION_OF,Multiple emboli,32632667,10.1007/s10877-020-00555-2,2020-07-08
Arteries,LOCATION_OF,"SUPPLY, NOT OTHERWISE SPECIFIED",32632667,10.1007/s10877-020-00555-2,2020-07-08
Hand,LOCATION_OF,"SUPPLY, NOT OTHERWISE SPECIFIED",32632667,10.1007/s10877-020-00555-2,2020-07-08
Index finger,LOCATION_OF,Pulse oximeter,32632667,10.1007/s10877-020-00555-2,2020-07-08
Wrist,LOCATION_OF,Structure of ulnar artery,32632667,10.1007/s10877-020-00555-2,2020-07-08
"Oximetry, Pulse",MEASURES,Saturated,32632667,10.1007/s10877-020-00555-2,2020-07-08
Tertiary care hospital,LOCATION_OF,Cross-Sectional Studies,32632645,10.1007/s10900-020-00879-9,2020-07-08
Coughing,PROCESS_OF,Persons,32632645,10.1007/s10900-020-00879-9,2020-07-08
Influenza-like symptoms,PROCESS_OF,Persons,32632645,10.1007/s10900-020-00879-9,2020-07-08
Government,LOCATION_OF,Training Programs,32632645,10.1007/s10900-020-00879-9,2020-07-08
Transient Ischemic Attack,PROCESS_OF,Patients,32632635,10.1007/s10072-020-04545-9,2020-07-08
Cerebrovascular accident,PROCESS_OF,Patients,32632635,10.1007/s10072-020-04545-9,2020-07-08
Acute inflammation,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32632558,10.1007/s11239-020-02212-6,2020-07-08
Excessive activity,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32632558,10.1007/s11239-020-02212-6,2020-07-08
Blood Cells,INTERACTS_WITH,Blood Coagulation Factor,32632558,10.1007/s11239-020-02212-6,2020-07-08
Enzyme-Linked Immunosorbent Assay,MEASURES,chemokine,32632558,10.1007/s11239-020-02212-6,2020-07-08
Fibrin,STIMULATES,cytokine,32632558,10.1007/s11239-020-02212-6,2020-07-08
Fibrin,STIMULATES,chemokine,32632558,10.1007/s11239-020-02212-6,2020-07-08
Pain,PROCESS_OF,Program Director,32632454,10.1093/pm/pnaa168,2020-07-08
Pain,PROCESS_OF,Program Director,32632454,10.1093/pm/pnaa168,2020-07-08
Asthma,ISA,Disease,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
Oxygen Therapy Care,TREATS,Patients,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
Invasive mechanical ventilation NOS,TREATS,Patients,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
tocilizumab,TREATS,Patients,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
Birth,PROCESS_OF,Woman,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Woman,32632417,10.1016/j.eclinm.2020.100407,2020-07-08
Present,PROCESS_OF,African race,32632416,10.1016/j.eclinm.2020.100404,2020-07-08
Poor outcome,PROCESS_OF,African race,32632416,10.1016/j.eclinm.2020.100404,2020-07-08
Poor outcome,PROCESS_OF,Patients,32632416,10.1016/j.eclinm.2020.100404,2020-07-08
Dysarthria,PROCESS_OF,Woman,32632380,10.1016/j.ensci.2020.100250,2020-07-08
Hemiplegia,PROCESS_OF,Woman,32632380,10.1016/j.ensci.2020.100250,2020-07-08
Program,AFFECTS,Anxiety,32632379,10.1016/j.ctro.2020.06.006,2020-07-08
Program,AFFECTS,Depressive Symptoms,32632379,10.1016/j.ctro.2020.06.006,2020-07-08
Unemployment,PROCESS_OF,Teacher,32632376,10.1016/j.dib.2020.105913,2020-07-08
Perception,PROCESS_OF,Relative (related person),32632376,10.1016/j.dib.2020.105913,2020-07-08
Evaluation,TREATS,Disease,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
High Level,PROCESS_OF,Elderly (population group),32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Disease,AUGMENTS,Virus Diseases,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Virus Diseases,PROCESS_OF,Population Group,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Oxidative Stress,COEXISTS_WITH,Inflammation,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Cells,LOCATION_OF,multicatalytic endopeptidase complex,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
SCARA3 gene,AFFECTS,Inflammation,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
PARP1 gene,AFFECTS,Equilibrium,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
rosoxacin,AUGMENTS,Lipid Peroxidation,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
rosoxacin,AUGMENTS,interleukin-6 production,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Oxidants,TREATS,Inflammation,32632359,10.1016/j.toxrep.2020.06.003,2020-07-08
Universities,LOCATION_OF,Online Learning,32632357,10.1016/j.imr.2020.100449,2020-07-08
Artificial Intelligence,ISA,Technology,32632356,10.1016/j.imr.2020.100434,2020-07-08
Critical Illness,PROCESS_OF,Patients,32632355,10.1016/j.rmcr.2020.101139,2020-07-08
Infection,PROCESS_OF,Patients,32632355,10.1016/j.rmcr.2020.101139,2020-07-08
Critical Illness,PROCESS_OF,Patients,32632355,10.1016/j.rmcr.2020.101139,2020-07-08
Lung Injury,PROCESS_OF,Patients,32632355,10.1016/j.rmcr.2020.101139,2020-07-08
Disease,PROCESS_OF,"Infant, Newborn",32632198,10.1038/s41372-020-0715-0,2020-07-08
Fever,ISA,Symptoms,32632198,10.1038/s41372-020-0715-0,2020-07-08
Immunoglobulins,COEXISTS_WITH,Antibodies,32632160,10.1038/s41467-020-17317-y,2020-07-08
Pneumonia,AFFECTS,Patients,32632085,10.1038/s41467-020-17292-4,2020-07-08
cytokine production,PROCESS_OF,Patients,32632085,10.1038/s41467-020-17292-4,2020-07-08
Infected,PROCESS_OF,Persons,32632012,10.1073/pnas.2008373117,2020-07-08
Chronic Obstructive Airway Disease,PROCESS_OF,Woman,32631958,10.1136/bmjspcare-2020-002363,2020-07-08
Small cell carcinoma of lung,PROCESS_OF,Woman,32631958,10.1136/bmjspcare-2020-002363,2020-07-08
Severe Acute Respiratory Syndrome,ISA,Disease,32631826,10.1128/AAC.01101-20,2020-07-08
Foot,LOCATION_OF,Edema,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Hand,LOCATION_OF,Edema,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Woman,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Aspirin,TREATS,Symptoms,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
"Immunoglobulins, Intravenous",TREATS,Symptoms,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Mucocutaneous Lymph Node Syndrome,COEXISTS_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Adult,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Adult,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
"Immunoglobulins, Intravenous",TREATS,Physicians,32631771,10.1016/j.ajem.2020.06.053,2020-07-08
Woman,ISA,Adult,32631770,10.1016/j.ajem.2020.06.059,2020-07-08
Parotitis,COEXISTS_WITH,assessment.initial,32631770,10.1016/j.ajem.2020.06.059,2020-07-08
Viral syndrome,COEXISTS_WITH,assessment.initial,32631770,10.1016/j.ajem.2020.06.059,2020-07-08
ciclesonide,NEG_TREATS,Patients,32631736,10.1016/j.jiac.2020.06.022,2020-07-08
Detection,TREATS,Symptoms,32631736,10.1016/j.jiac.2020.06.022,2020-07-08
Program,TREATS,Community,32631735,10.1016/j.jiac.2020.06.018,2020-07-08
Caregiver,TREATS,Patients,32631724,10.1016/j.anorl.2020.06.016,2020-07-08
Disease,PROCESS_OF,Patients,32631724,10.1016/j.anorl.2020.06.016,2020-07-08
Short neck,ISA,Disease,32631724,10.1016/j.anorl.2020.06.016,2020-07-08
Short neck,PROCESS_OF(SPEC),Patients,32631724,10.1016/j.anorl.2020.06.016,2020-07-08
Intubation,USES,Duration,32631724,10.1016/j.anorl.2020.06.016,2020-07-08
Libya,ISA,Country,32631682,10.1016/j.idh.2020.05.008,2020-07-08
Malignant neoplasm of lung,PROCESS_OF,Patients,32631666,10.1053/j.jvca.2020.05.042,2020-07-08
Symptoms,PROCESS_OF,Patients,32631626,10.1016/j.crad.2020.06.005,2020-07-08
Possible,PROCESS_OF,Minority Groups,32631626,10.1016/j.crad.2020.06.005,2020-07-08
Attitude,PROCESS_OF,Persons,32631613,10.1016/j.healthpol.2020.06.009,2020-07-08
Anxiety,PROCESS_OF,Households,32631613,10.1016/j.healthpol.2020.06.009,2020-07-08
Pneumonia,PROCESS_OF,Patients,32631575,10.1016/j.amjms.2020.06.013,2020-07-08
Coronavirus Infections,PROCESS_OF,Patients,32631575,10.1016/j.amjms.2020.06.013,2020-07-08
Frail,PROCESS_OF,Persons,32631469,10.1017/S1478951520000450,2020-07-08
intensive care,TREATS,Not Eligible,32631469,10.1017/S1478951520000450,2020-07-08
"Leukemia, Myelocytic, Acute",PROCESS_OF,Patients,32631469,10.1017/S1478951520000450,2020-07-08
Experience,PROCESS_OF,teams,32631469,10.1017/S1478951520000450,2020-07-08
Dyspnea,PROCESS_OF,Patients,32631469,10.1017/S1478951520000450,2020-07-08
Present,PROCESS_OF,Patients,32631469,10.1017/S1478951520000450,2020-07-08
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32631469,10.1017/S1478951520000450,2020-07-08
Infection,PROCESS_OF,Health Personnel,32631450,10.1186/s13756-020-00763-0,2020-07-08
Surgical face mask,compared_with,Masks,32631450,10.1186/s13756-020-00763-0,2020-07-08
Surgical face mask,same_as,Masks,32631450,10.1186/s13756-020-00763-0,2020-07-08
Clinical Trials,NEG_USES,Masks,32631450,10.1186/s13756-020-00763-0,2020-07-08
Cessation of life,PROCESS_OF,Patients,32631426,10.1186/s40249-020-00709-z,2020-07-08
Infected,PROCESS_OF,Persons,32631426,10.1186/s40249-020-00709-z,2020-07-08
Quarantine,USES,Hoist device,32631426,10.1186/s40249-020-00709-z,2020-07-08
Vitamins,TREATS,Patients,32631405,10.1186/s13063-020-04547-0,2020-07-08
Pharmacotherapy,TREATS,Patients,32631405,10.1186/s13063-020-04547-0,2020-07-08
Placebos,TREATS,Research Personnel,32631405,10.1186/s13063-020-04547-0,2020-07-08
Anxiety,OCCURS_IN,general population,32631403,10.1186/s12992-020-00589-w,2020-07-08
Anxiety,OCCURS_IN,general population,32631403,10.1186/s12992-020-00589-w,2020-07-08
Depressive disorder,OCCURS_IN,general population,32631403,10.1186/s12992-020-00589-w,2020-07-08
"CD69 protein, human",COEXISTS_WITH,GSKIP gene,32631403,10.1186/s12992-020-00589-w,2020-07-08
mental health,PROCESS_OF,Community,32631403,10.1186/s12992-020-00589-w,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
Patients,LOCATION_OF,"CD69 protein, human",32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Survivors,32631393,10.1186/s13054-020-03098-9,2020-07-08
Duration,INTERACTS_WITH,RNA,32631393,10.1186/s13054-020-03098-9,2020-07-08
Duration,TREATS,Survivors,32631393,10.1186/s13054-020-03098-9,2020-07-08
Duration,TREATS(INFER),Critical Illness,32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
"Kidney Failure, Acute",PREDISPOSES,Complication,32631393,10.1186/s13054-020-03098-9,2020-07-08
"Respiratory Distress Syndrome, Adult",PREDISPOSES,Complication,32631393,10.1186/s13054-020-03098-9,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631393,10.1186/s13054-020-03098-9,2020-07-08
Duration,INTERACTS_WITH,RNA,32631393,10.1186/s13054-020-03098-9,2020-07-08
Hospitals,LOCATION_OF,Study,32631365,10.1186/s12931-020-01435-8,2020-07-08
"CD69 protein, human",AFFECTS,Hypertensive disease,32631365,10.1186/s12931-020-01435-8,2020-07-08
"CD69 protein, human",AFFECTS,Hypertensive disease,32631365,10.1186/s12931-020-01435-8,2020-07-08
Hypertensive disease,PROCESS_OF,Patients,32631365,10.1186/s12931-020-01435-8,2020-07-08
Hypertensive disease,PROCESS_OF,Survivors,32631365,10.1186/s12931-020-01435-8,2020-07-08
Hypertensive disease,COEXISTS_WITH,patient condition,32631365,10.1186/s12931-020-01435-8,2020-07-08
Critical Illness,PROCESS_OF,Patients,32631365,10.1186/s12931-020-01435-8,2020-07-08
Cessation of life,PROCESS_OF,Patients,32631365,10.1186/s12931-020-01435-8,2020-07-08
Cessation of life,PROCESS_OF,Patients,32631365,10.1186/s12931-020-01435-8,2020-07-08
Movement,PROCESS_OF,Child,32631350,10.1186/s12966-020-00987-8,2020-07-08
Movement,PROCESS_OF,Child,32631350,10.1186/s12966-020-00987-8,2020-07-08
Engaged to be married,PROCESS_OF,parent,32631350,10.1186/s12966-020-00987-8,2020-07-08
Comorbidity,PROCESS_OF,Participant,32631328,10.1186/s12939-020-01227-y,2020-07-08
Lactate Dehydrogenase,ASSOCIATED_WITH,Pneumonia,32631317,10.1186/s12931-020-01427-8,2020-07-08
Lactate Dehydrogenase,ASSOCIATED_WITH,Pneumonia,32631317,10.1186/s12931-020-01427-8,2020-07-08
Participant,ISA,Persons,32631130,10.1176/appi.ps.202000239,2020-07-08
Serious mental illness,PROCESS_OF,Persons,32631130,10.1176/appi.ps.202000239,2020-07-08
Serious mental illness,PROCESS_OF(SPEC),Participant,32631130,10.1176/appi.ps.202000239,2020-07-08
"Intubation, Intratracheal",ISA,Airway procedure,32631084,10.1089/end.2020.0607,2020-07-08
Chloroquine,TREATS,Malaria,32631083,10.1080/14787210.2020.1792291,2020-07-08
Hydroxychloroquine,TREATS,Malaria,32631083,10.1080/14787210.2020.1792291,2020-07-08
Chloroquine,TREATS,Virus Diseases,32631083,10.1080/14787210.2020.1792291,2020-07-08
Hydroxychloroquine,TREATS,Virus Diseases,32631083,10.1080/14787210.2020.1792291,2020-07-08
Chloroquine,TREATS,HIV,32631083,10.1080/14787210.2020.1792291,2020-07-08
Heart,LOCATION_OF,Adverse reactions,32631083,10.1080/14787210.2020.1792291,2020-07-08
Italy,ISA,European country,32630821,10.3390/ijerph17134779,2020-07-08
Sleep disturbances,PROCESS_OF,Population Group,32630821,10.3390/ijerph17134779,2020-07-08
Sleep disturbances,PROCESS_OF(SPEC),Italians,32630821,10.3390/ijerph17134779,2020-07-08
Depressive Symptoms,PROCESS_OF,Population Group,32630821,10.3390/ijerph17134779,2020-07-08
Depressive Symptoms,PROCESS_OF(SPEC),Italians,32630821,10.3390/ijerph17134779,2020-07-08
Italians,ISA,Population Group,32630821,10.3390/ijerph17134779,2020-07-08
Anxiety symptoms,PROCESS_OF,Population Group,32630821,10.3390/ijerph17134779,2020-07-08
Anxiety symptoms,PROCESS_OF(SPEC),Italians,32630821,10.3390/ijerph17134779,2020-07-08
Sleep disturbances,PROCESS_OF,Participant,32630821,10.3390/ijerph17134779,2020-07-08
Chronic disease,PROCESS_OF,Participant,32630821,10.3390/ijerph17134779,2020-07-08
Family,INTERACTS_WITH,Homo sapiens,32630780,10.3390/microorganisms8070991,2020-07-08
Complication,MANIFESTATION_OF,Virus Diseases,32630746,10.3390/jcm9072084,2020-07-08
Severe Acute Respiratory Syndrome,MANIFESTATION_OF,Virus Diseases,32630746,10.3390/jcm9072084,2020-07-08
Speech,PROCESS_OF,Patients,32630735,10.3390/ijerph17134769,2020-07-08
Advice,TREATS,Dentist,32630735,10.3390/ijerph17134769,2020-07-08
Lung,LOCATION_OF,Ultrasonography,32630707,10.3390/diagnostics10070447,2020-07-08
Ultrasonography,ISA,Evaluation,32630707,10.3390/diagnostics10070447,2020-07-08
Disease,PROCESS_OF,Patients,32630707,10.3390/diagnostics10070447,2020-07-08
intensive care unit,LOCATION_OF,Study,32630707,10.3390/diagnostics10070447,2020-07-08
Lung,LOCATION_OF,Ultrasonography,32630707,10.3390/diagnostics10070447,2020-07-08
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32630707,10.3390/diagnostics10070447,2020-07-08
Lung,LOCATION_OF,Ultrasonography,32630707,10.3390/diagnostics10070447,2020-07-08
Infected,PROCESS_OF,Patients,32630565,10.3390/ijerph17124582,2020-07-08
Confirmation,PROCESS_OF,Patients,32630565,10.3390/ijerph17124582,2020-07-08
"M Protein, multiple myeloma",INTERACTS_WITH,HSPA5 gene,32630514,10.3390/ph13060132,2020-07-08
HSPA5 gene,PART_OF,host cell surface,32630514,10.3390/ph13060132,2020-07-08
Blood,LOCATION_OF,HSPA5 gene,32630514,10.3390/ph13060132,2020-07-08
Pneumonia,PROCESS_OF,Patients,32630514,10.3390/ph13060132,2020-07-08
Pharmaceutical Preparations,INHIBITS,HSPA5 gene,32630514,10.3390/ph13060132,2020-07-08
Pneumonia,PROCESS_OF,Patients,32630514,10.3390/ph13060132,2020-07-08
Blood,LOCATION_OF,HSPA5 gene,32630514,10.3390/ph13060132,2020-07-08
Pneumonia,PROCESS_OF,Patients,32630514,10.3390/ph13060132,2020-07-08
Pharmaceutical Preparations,INTERACTS_WITH,HSPA5 gene,32630514,10.3390/ph13060132,2020-07-08
Physical activity behavior,PROCESS_OF,Population Group,32630367,10.3390/jcm9061986,2020-07-08
Fall prevention,TREATS,Population Group,32630367,10.3390/jcm9061986,2020-07-08
Interventional procedure,METHOD_OF,Fall prevention,32630367,10.3390/jcm9061986,2020-07-08
Wellness promotion,TREATS,Elderly (population group),32630367,10.3390/jcm9061986,2020-07-08
Saudi Arabia,ISA,Country,32630363,10.3390/ijerph17124568,2020-07-08
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,COEXISTS_WITH,Inflammation,32630212,10.3390/children7070069,2020-07-08
Severe Acute Respiratory Syndrome,AFFECTS,Immune dysregulation,32630212,10.3390/children7070069,2020-07-08
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,Patients,32630212,10.3390/children7070069,2020-07-08
Vaccines,ASSOCIATED_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32630212,10.3390/children7070069,2020-07-08
Anxiety,AFFECTS,Compassion Fatigue,32630054,10.3390/ijerph17134720,2020-07-08
Compassion Fatigue,AFFECTS,Anxiety,32630054,10.3390/ijerph17134720,2020-07-08
Compassion Fatigue,AFFECTS,audience,32630054,10.3390/ijerph17134720,2020-07-08
Compassion Fatigue,AFFECTS,Practitioner,32630054,10.3390/ijerph17134720,2020-07-08
Obesity,PREDISPOSES,Malnutrition,32630032,10.3390/ijms21134670,2020-07-08
tomography,ADMINISTERED_TO,Patients,32630032,10.3390/ijms21134670,2020-07-08
Evaluation procedure,USES,Diagnosis,32630032,10.3390/ijms21134670,2020-07-08
Frailty,CAUSES,Complication,32630032,10.3390/ijms21134670,2020-07-08
Immunoregulation,ASSOCIATED_WITH,Virus Diseases,32629995,10.3390/ijms21134662,2020-07-08
Lung,LOCATION_OF,Biopsy,32629995,10.3390/ijms21134662,2020-07-08
Protein-arginine deiminase,PART_OF,A549 Cells,32629995,10.3390/ijms21134662,2020-07-08
Infected,PROCESS_OF,Patients,32629995,10.3390/ijms21134662,2020-07-08
Structure of parenchyma of lung,LOCATION_OF,PADI2 gene,32629995,10.3390/ijms21134662,2020-07-08
Structure of parenchyma of lung,LOCATION_OF,PADI4 gene,32629995,10.3390/ijms21134662,2020-07-08
Organ,LOCATION_OF,Biopsy,32629995,10.3390/ijms21134662,2020-07-08
Skin response,ASSOCIATED_WITH,Symptoms,32629995,10.3390/ijms21134662,2020-07-08
Protein-arginine deiminase,ASSOCIATED_WITH,Virus Diseases,32629995,10.3390/ijms21134662,2020-07-08
Nurses,ISA,Health Personnel,32629963,10.3390/ijerph17134709,2020-07-08
Physicians,ISA,Health Personnel,32629963,10.3390/ijerph17134709,2020-07-08
Noncommunicable Diseases,PROCESS_OF,Community,32629963,10.3390/ijerph17134709,2020-07-08
Health Personnel,USES,Test kit,32629963,10.3390/ijerph17134709,2020-07-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32629963,10.3390/ijerph17134709,2020-07-08
Virus,CAUSES,Infection,32629960,10.3390/pathogens9070529,2020-07-08
Virus,COEXISTS_WITH,Coronaviridae,32629960,10.3390/pathogens9070529,2020-07-08
Infection,PROCESS_OF,Homo sapiens,32629960,10.3390/pathogens9070529,2020-07-08
Virus,PROCESS_OF,Chiroptera,32629960,10.3390/pathogens9070529,2020-07-08
Anxiety,PROCESS_OF,professional occupation status,32629915,10.3390/ijerph17134703,2020-07-08
Confusion,PROCESS_OF,professional occupation status,32629915,10.3390/ijerph17134703,2020-07-08
Blood Coagulation Disorders,CAUSES,Sudden death,32629875,10.3390/cells9071583,2020-07-08
Vascular Diseases,CAUSES,Sudden death,32629875,10.3390/cells9071583,2020-07-08
Angiotensin I,PRODUCES,angiotensin I (1-7),32629875,10.3390/cells9071583,2020-07-08
Alveolar Epithelial Cells,PART_OF,Lung,32629875,10.3390/cells9071583,2020-07-08
Alveolar Epithelial Cells,PRODUCES,Integral Membrane Proteins,32629875,10.3390/cells9071583,2020-07-08
peptide hormone,AFFECTS,Blood Pressure,32629875,10.3390/cells9071583,2020-07-08
peptide hormone,AFFECTS,Vascular constriction (function),32629875,10.3390/cells9071583,2020-07-08
receptor,CAUSES,Biologic Development,32629875,10.3390/cells9071583,2020-07-08
Enterocytes,PRODUCES,Integral Membrane Proteins,32629875,10.3390/cells9071583,2020-07-08
Vascular Endothelial Cells,PRODUCES,Integral Membrane Proteins,32629875,10.3390/cells9071583,2020-07-08
Syndrome,MANIFESTATION_OF,Severe Acute Respiratory Syndrome,32629875,10.3390/cells9071583,2020-07-08
Syndrome,PROCESS_OF,Patients,32629875,10.3390/cells9071583,2020-07-08
Vascular Diseases,MANIFESTATION_OF,Severe Acute Respiratory Syndrome,32629875,10.3390/cells9071583,2020-07-08
Vascular Diseases,PROCESS_OF,Patients,32629875,10.3390/cells9071583,2020-07-08
Attitude,PROCESS_OF,citizen,32629829,10.3390/ijerph17134694,2020-07-08
Present,PROCESS_OF,Research Personnel,32629829,10.3390/ijerph17134694,2020-07-08
Awareness,PROCESS_OF,Persons,32629829,10.3390/ijerph17134694,2020-07-08
Wakefulness,PROCESS_OF,Persons,32629829,10.3390/ijerph17134694,2020-07-08
Anxiety,PROCESS_OF,citizen,32629829,10.3390/ijerph17134694,2020-07-08
Headache,PROCESS_OF,citizen,32629829,10.3390/ijerph17134694,2020-07-08
Mood instability,PROCESS_OF,citizen,32629829,10.3390/ijerph17134694,2020-07-08
Lung,LOCATION_OF,angiotensin converting enzyme 2,32629817,10.3390/ijms21134639,2020-07-08
Syndrome,CAUSES,Septicemia,32629817,10.3390/ijms21134639,2020-07-08
Intestinal cell,LOCATION_OF,angiotensin converting enzyme 2,32629817,10.3390/ijms21134639,2020-07-08
Therapeutic procedure,TREATS,SARS coronavirus,32629804,10.3390/v12070705,2020-07-08
Therapeutic procedure,TREATS,Middle East Respiratory Syndrome Coronavirus,32629804,10.3390/v12070705,2020-07-08
Therapeutic procedure,TREATS,Genus: Coronavirus,32629804,10.3390/v12070705,2020-07-08
camostate-mesilate,ADMINISTERED_TO,Epithelial Cells,32629804,10.3390/v12070705,2020-07-08
Conceptualization,PROCESS_OF,Social Networks,32629791,10.3390/ijerph17134693,2020-07-08
Decreased Immunologic Activity [PE],AFFECTS,Disease,32629788,10.3390/microorganisms8070977,2020-07-08
Pharmaceutical Preparations,ADMINISTERED_TO,Clinician,32629768,10.3390/jcm9072050,2020-07-08
Mental disorders,PROCESS_OF,Patients,32629726,10.1097/MD.0000000000021026,2020-07-08
nursing therapy,AFFECTS,Mental disorders,32629726,10.1097/MD.0000000000021026,2020-07-08
Mental disorders,PROCESS_OF,Patients,32629726,10.1097/MD.0000000000021026,2020-07-08
nursing therapy,AFFECTS,Mental disorders,32629726,10.1097/MD.0000000000021026,2020-07-08
nursing therapy,TREATS,Mental disorders,32629726,10.1097/MD.0000000000021026,2020-07-08
Disease,CAUSES,Atypical pneumonia,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,CAUSES(SPEC),Atypical pneumonia,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,ISA,Disease,32629703,10.1097/MD.0000000000020956,2020-07-08
Disease,PROCESS_OF,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
"Kidney Failure, Chronic",PROCESS_OF,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,ISA,Disease,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Hemodialysis,ADMINISTERED_TO,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
"Kidney Failure, Chronic",PROCESS_OF,Male population group,32629703,10.1097/MD.0000000000020956,2020-07-08
Pneumonia,ISA,Disease,32629703,10.1097/MD.0000000000020956,2020-07-08
Pneumonia,PROCESS_OF,Male population group,32629703,10.1097/MD.0000000000020956,2020-07-08
Pneumonia,PROCESS_OF,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Cardiovascular Diseases,PROCESS_OF,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,History,32629703,10.1097/MD.0000000000020956,2020-07-08
Chest,LOCATION_OF,tomography,32629703,10.1097/MD.0000000000020956,2020-07-08
Continuous renal replacement therapy,ADMINISTERED_TO,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
treatment options,TREATS,Persons,32629703,10.1097/MD.0000000000020956,2020-07-08
Staff,USES,Dialysis units (machines),32629703,10.1097/MD.0000000000020956,2020-07-08
Continuous renal replacement therapy,METHOD_OF,Extraction,32629703,10.1097/MD.0000000000020956,2020-07-08
Disease,PROCESS_OF,Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,ISA,Disease,32629703,10.1097/MD.0000000000020956,2020-07-08
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32629703,10.1097/MD.0000000000020956,2020-07-08
Diabetes,COEXISTS_WITH,Diabetes Mellitus,32629686,10.1097/MD.0000000000020913,2020-07-08
Dyspnea,PROCESS_OF,Patients,32629642,10.1097/MD.0000000000020701,2020-07-08
Acupuncture procedure,AFFECTS,Patients,32629642,10.1097/MD.0000000000020701,2020-07-08
Acupuncture procedure,TREATS,Dyspnea,32629642,10.1097/MD.0000000000020701,2020-07-08
adjunctive treatment,TREATS,Dyspnea,32629642,10.1097/MD.0000000000020701,2020-07-08
Eye,LOCATION_OF,Household composition,32629539,10.1002/jca.21809,2020-07-07
Chronic disease,PROCESS_OF,Patients,32629539,10.1002/jca.21809,2020-07-07
Acute infectious disease,CAUSES,Acute Chest Syndrome,32629539,10.1002/jca.21809,2020-07-07
Acute Chest Syndrome,ISA,"Anemia, Sickle Cell",32629539,10.1002/jca.21809,2020-07-07
"Anemia, Sickle Cell",PROCESS_OF,Patients,32629539,10.1002/jca.21809,2020-07-07
Pneumonia,PROCESS_OF,Patients,32629539,10.1002/jca.21809,2020-07-07
Acute Chest Syndrome,PROCESS_OF,Patients,32629539,10.1002/jca.21809,2020-07-07
Graft-vs-Host Disease,ISA,Complication,32629531,10.1111/tid.13401,2020-07-07
Graft-vs-Host Disease,PROCESS_OF,Patients,32629531,10.1111/tid.13401,2020-07-07
Hemopoietic stem cell transplant,TREATS,Patients,32629531,10.1111/tid.13401,2020-07-07
Hemopoietic stem cell transplant,TREATS(INFER),Chronic graft-versus-host disease,32629531,10.1111/tid.13401,2020-07-07
Chronic graft-versus-host disease,PROCESS_OF,Patients,32629531,10.1111/tid.13401,2020-07-07
Bilateral pneumonia,COMPLICATES,Upper Respiratory Infections,32629518,10.1055/a-1191-8094,2020-07-07
Isolation procedure,TREATS,Persons,32629425,10.2196/21163,2020-07-07
Isolation procedure,TREATS(INFER),Institutionalized,32629425,10.2196/21163,2020-07-07
Institutionalized,PROCESS_OF,Persons,32629425,10.2196/21163,2020-07-07
early identification,TREATS,Persons,32629425,10.2196/21163,2020-07-07
early identification,TREATS(INFER),Institutionalized,32629425,10.2196/21163,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32629425,10.2196/21163,2020-07-07
Polymerase Chain Reaction,METHOD_OF,Diagnosis,32629425,10.2196/21163,2020-07-07
Institutionalized,PROCESS_OF,Persons,32629425,10.2196/21163,2020-07-07
Institutionalized,PROCESS_OF,Persons,32629425,10.2196/21163,2020-07-07
Coronavirus Infections,ISA,Disease,32629280,10.1016/j.bioorg.2020.104027,2020-07-07
Lung,LOCATION_OF,inflammatory response,32629280,10.1016/j.bioorg.2020.104027,2020-07-07
Lung,PART_OF,Patients,32629280,10.1016/j.bioorg.2020.104027,2020-07-07
Coronavirus Infections,ISA,Disease,32629257,10.1016/j.scitotenv.2020.140516,2020-07-07
Hydranencephaly with Renal Aplasia-Dysplasia,CAUSES,Disease,32629257,10.1016/j.scitotenv.2020.140516,2020-07-07
Hydranencephaly with Renal Aplasia-Dysplasia,CAUSES(SPEC),Coronavirus Infections,32629257,10.1016/j.scitotenv.2020.140516,2020-07-07
Nitrogen Dioxide,DISRUPTS,Possible,32629257,10.1016/j.scitotenv.2020.140516,2020-07-07
Nitrogen Oxides,DISRUPTS,Possible,32629257,10.1016/j.scitotenv.2020.140516,2020-07-07
Disease,AFFECTS,Persons,32629204,10.1016/j.mehy.2020.110066,2020-07-07
Virus,CAUSES,Disease,32629204,10.1016/j.mehy.2020.110066,2020-07-07
envelope,LOCATION_OF,Virus,32629204,10.1016/j.mehy.2020.110066,2020-07-07
Lung,LOCATION_OF,angiotensin converting enzyme 2,32629204,10.1016/j.mehy.2020.110066,2020-07-07
Lung,PART_OF,Homo sapiens,32629204,10.1016/j.mehy.2020.110066,2020-07-07
Organ,LOCATION_OF,angiotensin converting enzyme 2,32629204,10.1016/j.mehy.2020.110066,2020-07-07
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32629187,10.1016/j.jcv.2020.104519,2020-07-07
Detection,METHOD_OF,Extraction,32629187,10.1016/j.jcv.2020.104519,2020-07-07
Chloroquine,AFFECTS,Virus Attachment,32629169,10.1016/j.drudis.2020.06.030,2020-07-07
"Condoms, Male",compared_with,Therapeutic procedure,32629169,10.1016/j.drudis.2020.06.030,2020-07-07
"Condoms, Male",same_as,Therapeutic procedure,32629169,10.1016/j.drudis.2020.06.030,2020-07-07
Golgi Apparatus,LOCATION_OF,Chloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Golgi Apparatus,LOCATION_OF,Hydroxychloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Organelles,LOCATION_OF,Chloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Organelles,LOCATION_OF,Hydroxychloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
endolysosome,LOCATION_OF,Chloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
endolysosome,LOCATION_OF,Hydroxychloroquine,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Chloroquine,INTERACTS_WITH,Antimalarials,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Hydroxychloroquine,INTERACTS_WITH,Antimalarials,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
physiological aspects,COEXISTS_WITH,Signal Transduction,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Signal Transduction,COEXISTS_WITH,Cell physiology,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
Pharmaceutical Preparations,AFFECTS,Organelles,32629149,10.1016/j.cellsig.2020.109706,2020-07-07
ENT symptoms,ASSOCIATED_WITH,Disease,32629147,10.1016/j.amjoto.2020.102622,2020-07-07
Chief complaint (finding),PROCESS_OF,Patients,32629147,10.1016/j.amjoto.2020.102622,2020-07-07
Chloroquine,ISA,Pharmaceutical Preparations,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Chloroquine,TREATS,Genus: Coronavirus,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Chloroquine,TREATS(SPEC),Malaria,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Pharmaceutical Preparations,TREATS,Malaria,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Hydroxychloroquine,TREATS(SPEC),Malaria,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Hydroxychloroquine,TREATS,Genus: Coronavirus,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
heparin,PREVENTS,Thrombus,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Cardiotoxicity,PROCESS_OF,Patients,32629115,10.1016/j.ijantimicag.2020.106078,2020-07-07
Pneumonia,PROCESS_OF,Patients,32629100,10.1016/j.resp.2020.103489,2020-07-07
Infected,PROCESS_OF,Patients,32629100,10.1016/j.resp.2020.103489,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32629100,10.1016/j.resp.2020.103489,2020-07-07
Continuous Positive Airway Pressure,TREATS,Neoplasm Metastasis,32629100,10.1016/j.resp.2020.103489,2020-07-07
Evaluation,TREATS,Patients,32629100,10.1016/j.resp.2020.103489,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32629100,10.1016/j.resp.2020.103489,2020-07-07
Ultrasonography,ADMINISTERED_TO,Patients,32629100,10.1016/j.resp.2020.103489,2020-07-07
One Activity Hour,PROCESS_OF,Patients,32629100,10.1016/j.resp.2020.103489,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32629100,10.1016/j.resp.2020.103489,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32629100,10.1016/j.resp.2020.103489,2020-07-07
Intubation,TREATS,Patients,32629085,10.1016/j.virusres.2020.198089,2020-07-07
ciclesonide,TREATS,Patients,32629085,10.1016/j.virusres.2020.198089,2020-07-07
Anosmia,ISA,Symptoms,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Mesocricetus auratus,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Structure of olfactory bulb,LOCATION_OF,Virus,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Olfactory Epithelium,PART_OF,Animals,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Lamina Propria,PART_OF,Animals,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Immune Cell,PART_OF,Animals,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Anosmia,PROCESS_OF,Patients,32629042,10.1016/j.bbi.2020.06.032,2020-07-07
Hematologic Tests,DIAGNOSES,Severe Acute Respiratory Syndrome,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Nucleic Acid Amplification Tests,DIAGNOSES,Infected,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Nucleic Acid Amplification Tests,DIAGNOSES,Severe Acute Respiratory Syndrome,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Chest CT,DIAGNOSES,Severe Acute Respiratory Syndrome,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Antibody studies (procedure),DIAGNOSES,Severe Acute Respiratory Syndrome,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
NNAT gene,NEG_PART_OF,Non-Ossifying Fibroma,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Infected,PROCESS_OF,Patients,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Possible,NEG_PROCESS_OF,Patients,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
hypertensive nephropathy,PROCESS_OF,Patients,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32628990,10.1053/j.ajkd.2020.06.008,2020-07-07
Influenza,ISA,Virus Diseases,32628976,10.1016/j.gene.2020.144944,2020-07-07
receptor,AFFECTS,Reproductive History,32628976,10.1016/j.gene.2020.144944,2020-07-07
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Reproductive History,32628976,10.1016/j.gene.2020.144944,2020-07-07
Severe Acute Respiratory Syndrome,CAUSES,Cessation of life,32628976,10.1016/j.gene.2020.144944,2020-07-07
Respiration Disorders,PROCESS_OF,Animals,32628969,10.1016/j.neures.2020.06.009,2020-07-07
Respiration Disorders,PROCESS_OF,Homo sapiens,32628969,10.1016/j.neures.2020.06.009,2020-07-07
Genus: Coronavirus,ISA,RNA Viruses,32628969,10.1016/j.neures.2020.06.009,2020-07-07
Genus: Coronavirus,ISA,Virus,32628969,10.1016/j.neures.2020.06.009,2020-07-07
Coronavirus Infections,PROCESS_OF,Population Group,32628931,10.1016/j.ajpath.2020.07.001,2020-07-07
Symptoms,PROCESS_OF,Cohort,32628931,10.1016/j.ajpath.2020.07.001,2020-07-07
Symptoms,PROCESS_OF,Patients,32628931,10.1016/j.ajpath.2020.07.001,2020-07-07
Symptoms,PROCESS_OF,hospitalized patients,32628931,10.1016/j.ajpath.2020.07.001,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32628931,10.1016/j.ajpath.2020.07.001,2020-07-07
SARS coronavirus,ISA,Genus: Coronavirus,32628905,10.1016/S1473-3099(20)30484-9,2020-07-07
Integrins,PART_OF,Plasma membrane,32628899,10.1080/07435800.2020.1767127,2020-07-07
Binding Sites,AFFECTS,Virus Attachment,32628899,10.1080/07435800.2020.1767127,2020-07-07
arginyl-glycyl-aspartic acid,AFFECTS,Virus Attachment,32628899,10.1080/07435800.2020.1767127,2020-07-07
arginyl-glycyl-aspartic acid,AFFECTS,Virus Attachment,32628899,10.1080/07435800.2020.1767127,2020-07-07
angiotensin converting enzyme 2,AFFECTS,intracellular signal transduction,32628899,10.1080/07435800.2020.1767127,2020-07-07
Integrins,INTERACTS_WITH,Proteins,32628899,10.1080/07435800.2020.1767127,2020-07-07
Thyronine,ISA,Agent,32628899,10.1080/07435800.2020.1767127,2020-07-07
Eye,LOCATION_OF,SARS coronavirus,32628795,10.1111/joa.13274,2020-07-07
Hospitalization,TREATS,Patients,32628793,10.1111/apt.15996,2020-07-07
Asymptomatic,PROCESS_OF,Health Personnel,32628750,10.1093/cid/ciaa936,2020-07-07
Immune response,PROCESS_OF,Homo sapiens,32628748,10.1093/cid/ciaa935,2020-07-07
South Africa,ISA,Country,32628744,10.1093/cid/ciaa937,2020-07-07
South Africa,ISA,Country,32628744,10.1093/cid/ciaa937,2020-07-07
Abnormal shape,AFFECTS,Participant,32628735,10.1371/journal.pone.0235871,2020-07-07
Quarantine,TREATS,Communicable Diseases,32628716,10.1371/journal.pone.0235731,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Community,32628716,10.1371/journal.pone.0235731,2020-07-07
Secondary Infections,PROCESS_OF,Community,32628716,10.1371/journal.pone.0235731,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Community,32628716,10.1371/journal.pone.0235731,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Community,32628716,10.1371/journal.pone.0235731,2020-07-07
Decision,PROCESS_OF,Community,32628716,10.1371/journal.pone.0235731,2020-07-07
,TREATS,Patients,32628642,10.18632/aging.103417,2020-07-07
Immunoglobulin G,TREATS,Patients,32628642,10.18632/aging.103417,2020-07-07
Serum,LOCATION_OF,Immunoglobulin G,32628642,10.18632/aging.103417,2020-07-07
Serum,LOCATION_OF,Antibodies,32628642,10.18632/aging.103417,2020-07-07
Clinical Services,PREVENTS,Possible,32628638,10.1515/jpm-2020-0218,2020-07-07
Gravidity,PROCESS_OF,Patients,32628638,10.1515/jpm-2020-0218,2020-07-07
Italy,ISA,Geographic Locations,32628637,10.1515/jpm-2020-0208,2020-07-07
Gravidity,PROCESS_OF,Patients,32628637,10.1515/jpm-2020-0208,2020-07-07
Virus,CAUSES,Disease,32628591,10.2174/1574888X15666200705213751,2020-07-07
Etoposide,TREATS,Decreasing,32628591,10.2174/1574888X15666200705213751,2020-07-07
Glycyrrhetinic acid,TREATS,Storm NOS,32628591,10.2174/1574888X15666200705213751,2020-07-07
Pharmaceutical Preparations,NEG_TREATS,Virus,32628591,10.2174/1574888X15666200705213751,2020-07-07
Antiviral Agents,TREATS,Patients,32628591,10.2174/1574888X15666200705213751,2020-07-07
research,USES,Operative Surgical Procedures,32628558,10.1089/lap.2020.0535,2020-07-07
Hospitals,LOCATION_OF,Nasal Swab (procedure),32628534,10.7326/M20-2889,2020-07-07
Immunoglobulin G,AFFECTS,High Level,32628534,10.7326/M20-2889,2020-07-07
Airway Management,TREATS,Patients,32628410,10.1097/ACO.0000000000000892,2020-07-07
Anesthesiologist,TREATS,Patients,32628410,10.1097/ACO.0000000000000892,2020-07-07
Infected,PROCESS_OF,Patients,32628410,10.1097/ACO.0000000000000892,2020-07-07
Evaluation procedure,TREATS,Patients,32628405,10.1097/ACO.0000000000000888,2020-07-07
Evaluation procedure,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32628405,10.1097/ACO.0000000000000888,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32628405,10.1097/ACO.0000000000000888,2020-07-07
Aging,PROCESS_OF,Population Group,32628402,10.1097/ACO.0000000000000895,2020-07-07
Awareness,PROCESS_OF,Anesthesiologist,32628402,10.1097/ACO.0000000000000895,2020-07-07
Skin Manifestations,PROCESS_OF,Patients,32628270,10.1111/bjd.19377,2020-07-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32628270,10.1111/bjd.19377,2020-07-07
Acral Lesion,PROCESS_OF,Patients,32628270,10.1111/bjd.19377,2020-07-07
Blood Coagulation Disorders,PROCESS_OF,hospitalized patients,32628248,10.1093/ajhp/zxaa245,2020-07-07
Venous Thromboembolism,PROCESS_OF,hospitalized patients,32628248,10.1093/ajhp/zxaa245,2020-07-07
Prophylactic treatment,PREDISPOSES,Blood Coagulation Disorders,32628248,10.1093/ajhp/zxaa245,2020-07-07
Angiotensin-Converting Enzyme Inhibitors,ISA,Antihypertensive Agents,32628137,10.14744/AnatolJCardiol.2020.57431,2020-07-07
Angiotensin II receptor antagonist,ISA,Antihypertensive Agents,32628137,10.14744/AnatolJCardiol.2020.57431,2020-07-07
Severe disorder,PROCESS_OF,Participant,32628137,10.14744/AnatolJCardiol.2020.57431,2020-07-07
Angiotensin-Converting Enzyme Inhibitors,INHIBITS,Severe disorder,32628137,10.14744/AnatolJCardiol.2020.57431,2020-07-07
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32628131,10.18632/aging.103525,2020-07-07
Ulcerative Colitis,PROCESS_OF,Patients,32628131,10.18632/aging.103525,2020-07-07
Crohn Disease,PROCESS_OF,Patients,32628131,10.18632/aging.103525,2020-07-07
Exercise,PREDISPOSES,Disease,32628131,10.18632/aging.103525,2020-07-07
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32628131,10.18632/aging.103525,2020-07-07
IMPACT gene,AFFECTS,Traffic,32628131,10.18632/aging.103525,2020-07-07
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32628131,10.18632/aging.103525,2020-07-07
Mediastinal Emphysema,PROCESS_OF,Patients,32628129,10.7861/clinmed.2020-0247,2020-07-07
Mechanical ventilation,NEG_ADMINISTERED_TO,Patients,32628129,10.7861/clinmed.2020-0247,2020-07-07
Diabetes,AFFECTS,Severe (severity modifier),32628128,10.7861/clinmed.2020-0261,2020-07-07
Diabetes,PROCESS_OF,Persons,32628128,10.7861/clinmed.2020-0261,2020-07-07
Patients,LOCATION_OF,IMPACT gene,32628128,10.7861/clinmed.2020-0261,2020-07-07
Skin Manifestations,PROCESS_OF,Male population group,32628082,10.1080/09546634.2020.1791309,2020-07-07
Anagen effluvium,PROCESS_OF,Patients,32628051,10.1080/09546634.2020.1792400,2020-07-07
Chloroquine,ISA,Antimalarials,32628049,10.1080/10408347.2020.1781592,2020-07-07
Pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Community acquired pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Community acquired pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Thrombophilia,COEXISTS_WITH,Pneumonia,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
patient condition,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Community acquired pneumonia,PROCESS_OF,Patients,32628040,10.1161/ATVBAHA.120.314779,2020-07-07
Respiratory distress,PROCESS_OF,Patients,32628003,10.1002/jmv.26191,2020-07-07
tocilizumab,ISA,Interleukin inhibitors,32628003,10.1002/jmv.26191,2020-07-07
tocilizumab,ADMINISTERED_TO,Patients,32628003,10.1002/jmv.26191,2020-07-07
tocilizumab,ADMINISTERED_TO,Patients,32628003,10.1002/jmv.26191,2020-07-07
Glucocorticoids,ADMINISTERED_TO,Patients,32628003,10.1002/jmv.26191,2020-07-07
Hydroxychloroquine,ADMINISTERED_TO,Patients,32628003,10.1002/jmv.26191,2020-07-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32628003,10.1002/jmv.26191,2020-07-07
tocilizumab,INHIBITS,C-reactive protein,32628003,10.1002/jmv.26191,2020-07-07
tocilizumab,ADMINISTERED_TO,Patients,32628003,10.1002/jmv.26191,2020-07-07
Triage,METHOD_OF,Operative Surgical Procedures,32627963,10.1111/1759-7714.13546,2020-07-07
Operative Surgical Procedures,ISA,Interventional procedure,32627963,10.1111/1759-7714.13546,2020-07-07
Decision,PROCESS_OF,teams,32627963,10.1111/1759-7714.13546,2020-07-07
Malignant neoplasm of thorax,PROCESS_OF,Patients,32627963,10.1111/1759-7714.13546,2020-07-07
Decision,PROCESS_OF,Patients,32627907,10.1111/codi.15236,2020-07-07
Decision,PROCESS_OF,Surgeon,32627907,10.1111/codi.15236,2020-07-07
Drug Evaluation,USES,inhibitors,32627689,10.1080/07391102.2020.1786459,2020-07-07
Isolation procedure,TREATS,Infected,32627645,10.1177/1078345820929733,2020-07-07
Complication,PROCESS_OF,Patients,32627622,10.1080/14767058.2020.1786811,2020-07-07
risk factors,PROCESS_OF,Patients,32627622,10.1080/14767058.2020.1786811,2020-07-07
Virus Diseases,COEXISTS_WITH,Disseminated Intravascular Coagulation,32627622,10.1080/14767058.2020.1786811,2020-07-07
Virus Diseases,COEXISTS_WITH,Systemic Inflammatory Response Syndrome,32627622,10.1080/14767058.2020.1786811,2020-07-07
Virus Diseases,COEXISTS_WITH,Thrombotic Microangiopathies,32627622,10.1080/14767058.2020.1786811,2020-07-07
Thrombotic Microangiopathies,COEXISTS_WITH,"Anemia, Hemolytic",32627622,10.1080/14767058.2020.1786811,2020-07-07
Thrombotic Microangiopathies,COEXISTS_WITH,Disease,32627622,10.1080/14767058.2020.1786811,2020-07-07
Thrombotic Microangiopathies,COEXISTS_WITH,Multiple Organ Failure,32627622,10.1080/14767058.2020.1786811,2020-07-07
Thrombotic Microangiopathies,COEXISTS_WITH,Thrombocytopenia,32627622,10.1080/14767058.2020.1786811,2020-07-07
Septicemia,ISA,Disease,32627622,10.1080/14767058.2020.1786811,2020-07-07
Coronavirus Infections,PROCESS_OF,Patients,32627622,10.1080/14767058.2020.1786811,2020-07-07
Thrombotic Microangiopathies,PROCESS_OF,Patients,32627622,10.1080/14767058.2020.1786811,2020-07-07
Post-Traumatic Stress Disorder,PROCESS_OF,Participant,32627606,10.1177/1359105320937057,2020-07-07
psychological distress,PROCESS_OF,Participant,32627606,10.1177/1359105320937057,2020-07-07
psychological distress,AFFECTS,Post-Traumatic Stress Disorder,32627606,10.1177/1359105320937057,2020-07-07
Symptoms,PROCESS_OF,Participant,32627606,10.1177/1359105320937057,2020-07-07
Elective Surgical Procedures,TREATS,Present,32627569,10.1302/0301-620X.102B9.BJJ-2020-1147.R1,2020-07-07
Diagnosis,PRECEDES,Isolation procedure,32627534,10.1021/acssensors.0c01153,2020-07-07
Brain,LOCATION_OF,Present,32627524,10.1021/acschemneuro.0c00373,2020-07-07
Lung,LOCATION_OF,Virus,32627524,10.1021/acschemneuro.0c00373,2020-07-07
"M Protein, multiple myeloma",INTERACTS_WITH,Angiotensin Receptor,32627524,10.1021/acschemneuro.0c00373,2020-07-07
"M Protein, multiple myeloma",PART_OF,SARS coronavirus,32627524,10.1021/acschemneuro.0c00373,2020-07-07
Immunologic Factors,CAUSES,Disease,32627515,10.20452/pamw.15482,2020-07-07
Epithelial Cells,LOCATION_OF,Virus Replication,32627515,10.20452/pamw.15482,2020-07-07
viral transmission,AFFECTS,Virus Replication,32627515,10.20452/pamw.15482,2020-07-07
Disease,COEXISTS_WITH,Immunocompromised Host,32627515,10.20452/pamw.15482,2020-07-07
Infected,PROCESS_OF,Patients,32627515,10.20452/pamw.15482,2020-07-07
Asymptomatic,PROCESS_OF,Patients,32627444,10.3346/jkms.2020.35.e246,2020-07-07
Hemorrhagic Disorders,ISA,Disease,32627443,10.3346/jkms.2020.35.e243,2020-07-07
Comorbidity,PROCESS_OF,Patients,32627330,10.1111/jch.13925,2020-07-07
Hypertensive disease,COEXISTS_WITH,patient condition,32627330,10.1111/jch.13925,2020-07-07
Evaluation procedure,TREATS,Patients,32627330,10.1111/jch.13925,2020-07-07
Comorbidity,PROCESS_OF,Patients,32627330,10.1111/jch.13925,2020-07-07
Conflict (Psychology),PROCESS_OF,Patients,32627330,10.1111/jch.13925,2020-07-07
Hypertensive disease,PROCESS_OF,Patients,32627330,10.1111/jch.13925,2020-07-07
Hypertensive disease,COEXISTS_WITH,patient condition,32627330,10.1111/jch.13925,2020-07-07
Disease,PROCESS_OF,Relative (related person),32627330,10.1111/jch.13925,2020-07-07
risk factors,PROCESS_OF,Relative (related person),32627330,10.1111/jch.13925,2020-07-07
Hypertensive disease,PROCESS_OF,Patients,32627330,10.1111/jch.13925,2020-07-07
"CD69 protein, human",ASSOCIATED_WITH,Hypertensive disease,32627330,10.1111/jch.13925,2020-07-07
"CD69 protein, human",ASSOCIATED_WITH,Coronavirus Infections,32627330,10.1111/jch.13925,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32627319,10.1111/ajt.16176,2020-07-07
clinical aspects,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32627319,10.1111/ajt.16176,2020-07-07
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32627319,10.1111/ajt.16176,2020-07-07
"Kidney Failure, Acute",PROCESS_OF,Patients,32627319,10.1111/ajt.16176,2020-07-07
Dyspnea,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32627319,10.1111/ajt.16176,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32627319,10.1111/ajt.16176,2020-07-07
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32627319,10.1111/ajt.16176,2020-07-07
Interested,PROCESS_OF,General Practitioners,32627299,10.1111/dom.14134,2020-07-07
Experience,PROCESS_OF,General Practitioners,32627299,10.1111/dom.14134,2020-07-07
Clinician,DIAGNOSES,Diabetes,32627299,10.1111/dom.14134,2020-07-07
Clinician,DIAGNOSES,Obesity,32627299,10.1111/dom.14134,2020-07-07
Syndrome,COEXISTS_WITH,Isolated finding,32627255,10.1002/da.23071,2020-07-07
"Smoking, Passive",ISA,Environmental Pollution,32627237,10.1111/apa.15462,2020-07-07
Coronavirus Infections,ISA,Disease,32627216,10.1111/trf.15918,2020-07-07
Coronavirus Infections,ISA,Disease,32627216,10.1111/trf.15918,2020-07-07
Plasma donor,LOCATION_OF,Antibodies,32627216,10.1111/trf.15918,2020-07-07
Symptoms,PROCESS_OF,Plasma donor,32627216,10.1111/trf.15918,2020-07-07
Clinical Enzyme Tests (procedure),MEASURES,CD40LG wt Allele,32627216,10.1111/trf.15918,2020-07-07
Blood Donation,ADMINISTERED_TO,Donor person,32627205,10.1111/trf.15971,2020-07-07
Enabling,PROCESS_OF,Blood donor,32627205,10.1111/trf.15971,2020-07-07
High Level,PREDISPOSES,Coronavirus Infections,32627205,10.1111/trf.15971,2020-07-07
Screening procedure,METHOD_OF,Transfusion medicine service,32627200,10.1111/trf.15973,2020-07-07
Communicable Diseases,ISA,Disease,32627172,10.1111/biom.13325,2020-07-07
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32627127,10.1007/s11845-020-02291-7,2020-07-07
Azithromycin,ISA,Pharmaceutical Preparations,32627127,10.1007/s11845-020-02291-7,2020-07-07
Kaletra,ISA,Pharmaceutical Preparations,32627127,10.1007/s11845-020-02291-7,2020-07-07
"CD69 protein, human",AFFECTS,Corrected Prolonged QT Interval by ECG Finding,32627127,10.1007/s11845-020-02291-7,2020-07-07
Dry cough,ISA,Symptoms,32627126,10.1007/s11239-020-02210-8,2020-07-07
Gastrointestinal symptom,PROCESS_OF,Patients,32627059,10.1007/s00726-020-02870-z,2020-07-07
receptor expression,PROCESS_OF,ACE2 gene,32627059,10.1007/s00726-020-02870-z,2020-07-07
Well adult,PROCESS_OF,Homo sapiens,32627059,10.1007/s00726-020-02870-z,2020-07-07
ACE2 gene,PART_OF,Duodenum,32627059,10.1007/s00726-020-02870-z,2020-07-07
Intestines,LOCATION_OF,Symptoms,32627059,10.1007/s00726-020-02870-z,2020-07-07
Patients,LOCATION_OF,ACE2 gene,32627059,10.1007/s00726-020-02870-z,2020-07-07
ACE2 gene,PART_OF,Intestines,32627059,10.1007/s00726-020-02870-z,2020-07-07
Esthesia,PROCESS_OF,Patients,32626853,10.4193/Rhin20.185,2020-07-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32626853,10.4193/Rhin20.185,2020-07-07
Symptoms,COEXISTS_WITH,Possible,32626853,10.4193/Rhin20.185,2020-07-07
"Kidney Failure, Acute",ISA,Complication,32626733,10.1155/2020/1594726,2020-07-07
Septicemia,PROCESS_OF,Patients,32626733,10.1155/2020/1594726,2020-07-07
Hydroxychloroquine,ADMINISTERED_TO,Patients,32626630,10.7759/cureus.8415,2020-07-07
Hydroxychloroquine,TREATS,Patients,32626630,10.7759/cureus.8415,2020-07-07
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32626626,10.7759/cureus.8411,2020-07-07
dipeptidyl peptidase II,INTERACTS_WITH,AGTR1 gene,32626626,10.7759/cureus.8411,2020-07-07
ACE2 gene,PREVENTS,Lung Injury,32626626,10.7759/cureus.8411,2020-07-07
"Angiotensin II Receptor, Type 2",AFFECTS,Structure of parenchyma of lung,32626626,10.7759/cureus.8411,2020-07-07
PGR-AS1 gene,ASSOCIATED_WITH,Coronavirus Infections,32626626,10.7759/cureus.8411,2020-07-07
PGR-AS1 gene,ASSOCIATED_WITH,pulmonary involvement,32626626,10.7759/cureus.8411,2020-07-07
PGR-AS1 gene,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32626626,10.7759/cureus.8411,2020-07-07
angiotensin II,INTERACTS_WITH,ACE2 gene,32626626,10.7759/cureus.8411,2020-07-07
angiotensin II,INTERACTS_WITH,PGR-AS1 gene,32626626,10.7759/cureus.8411,2020-07-07
Anti-Inflammatory Agents,AFFECTS,Proliferation (morphologic abnormality),32626626,10.7759/cureus.8411,2020-07-07
Coronavirus Infections,PROCESS_OF,Family,32626559,10.34172/jcvtr.2020.27,2020-07-07
Antimalarials,TREATS,Symptoms,32625198,10.3389/fmicb.2020.01476,2020-07-07
Fear (Mental Process),PROCESS_OF,Child,32625198,10.3389/fmicb.2020.01476,2020-07-07
Coronavirus Infections,CAUSES,Respiration Disorders,32625165,10.3389/fneur.2020.00659,2020-07-07
Severe Acute Respiratory Syndrome,PREDISPOSES,Respiratory Failure,32625165,10.3389/fneur.2020.00659,2020-07-07
Symptoms,PROCESS_OF,Participant,32625157,10.3389/fpsyg.2020.01491,2020-07-07
High Level,PROCESS_OF,Male population group,32625157,10.3389/fpsyg.2020.01491,2020-07-07
Chronic disease,PROCESS_OF,Persons,32625157,10.3389/fpsyg.2020.01491,2020-07-07
Chronic disease,PROCESS_OF,Population Group,32625157,10.3389/fpsyg.2020.01491,2020-07-07
Cardiovascular,LOCATION_OF,Toxic effect,32624690,10.7150/ijms.46484,2020-07-07
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
Percutaneous Coronary Intervention,TREATS,Patients,32624690,10.7150/ijms.46484,2020-07-07
Percutaneous Coronary Intervention,TREATS(INFER),ST segment elevation myocardial infarction,32624690,10.7150/ijms.46484,2020-07-07
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
Myocardial Infarction,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
Myocarditis,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
Increased cardiac enzymes,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
Hydroxychloroquine,TREATS,Patients,32624690,10.7150/ijms.46484,2020-07-07
Hydroxychloroquine,TREATS(INFER),Prolonged QT interval,32624690,10.7150/ijms.46484,2020-07-07
Prolonged QT interval,PROCESS_OF,Patients,32624690,10.7150/ijms.46484,2020-07-07
lopinavir / Ritonavir,TREATS,Patients,32624690,10.7150/ijms.46484,2020-07-07
lopinavir / Ritonavir,TREATS(INFER),Prolonged QT interval,32624690,10.7150/ijms.46484,2020-07-07
Gastrointestinal symptom,PROCESS_OF,Patients,32624655,10.20524/aog.2020.0506,2020-07-07
Feces,ASSOCIATED_WITH(INFER),Infected,32624655,10.20524/aog.2020.0506,2020-07-07
Feces,PART_OF,Patients,32624655,10.20524/aog.2020.0506,2020-07-07
Infected,PROCESS_OF,Patients,32624655,10.20524/aog.2020.0506,2020-07-07
Gastrointestinal Diseases,PROCESS_OF,Patients,32624651,10.20524/aog.2020.0498,2020-07-07
Infected,PROCESS_OF,Population Group,32624650,10.1063/5.0015984,2020-07-07
Masks,TREATS,Cross Infection,32624649,10.1063/5.0016018,2020-07-07
Covers (device),USES,Textiles,32624649,10.1063/5.0016018,2020-07-07
medical researcher,ISA,Health Personnel,32624649,10.1063/5.0016018,2020-07-07
Risk Management,TREATS,Health Personnel,32624560,10.23749/mdl.v111i3.9767,2020-07-07
Detection,TREATS,Staff,32624560,10.23749/mdl.v111i3.9767,2020-07-07
Morale,PROCESS_OF,Staff,32624560,10.23749/mdl.v111i3.9767,2020-07-07
Continuous Positive Airway Pressure,TREATS,Respiratory failure without hypercapnia,32624495,10.1136/bmjresp-2020-000639,2020-07-07
Respiratory failure without hypercapnia,PROCESS_OF,Patients,32624495,10.1136/bmjresp-2020-000639,2020-07-07
Respiratory failure without hypercapnia,PROCESS_OF,Patients,32624495,10.1136/bmjresp-2020-000639,2020-07-07
Hypoxia,PROCESS_OF,Patients,32624494,10.1136/bmjresp-2020-000621,2020-07-07
Anoxia,PROCESS_OF,Patients,32624494,10.1136/bmjresp-2020-000621,2020-07-07
Anoxia,PROCESS_OF,Cohort,32624494,10.1136/bmjresp-2020-000621,2020-07-07
treatment options,TREATS,Respiratory Failure,32624494,10.1136/bmjresp-2020-000621,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Critical Illness,PROCESS_OF,Patients,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Ultrasonography,ISA,Evaluation,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Evaluation,USES,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Ultrasonography,DIAGNOSES,patient condition,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Lung,LOCATION_OF,Ultrasonography,32624431,10.1053/j.jvca.2020.06.013,2020-07-07
Disease,PROCESS_OF,Population Group,32624404,10.1016/j.jiph.2020.06.019,2020-07-07
Permanent tracheostomy,TREATS,Severe Acute Respiratory Syndrome,32624392,10.1016/j.anorl.2020.06.002,2020-07-07
"Ear, nose and throat department",LOCATION_OF,Prospective Studies,32624390,10.1016/j.anorl.2020.06.014,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Disease,PROCESS_OF,Patients,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Clinician,TREATS,Patients,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Coronavirus Infections,ISA,Disease,32624376,10.1016/j.jaim.2020.05.011,2020-07-07
Felis catus,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Ferrets,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Monkeys,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Pongo pygmaeus,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Family suidae,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Homo sapiens,ISA,Animals,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
angiotensin converting enzyme 2,PART_OF,Cells,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Diagnostic tests,ADMINISTERED_TO,Homo sapiens,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Infected,PROCESS_OF,Persons,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Insight,PROCESS_OF,Pet Animal,32624360,10.1016/j.jmii.2020.06.006,2020-07-07
Residency,ISA,Knowledge acquisition,32624338,10.1016/j.jagp.2020.06.003,2020-07-07
Residency,ISA,Knowledge acquisition,32624338,10.1016/j.jagp.2020.06.003,2020-07-07
Heart,LOCATION_OF,Medical Valves,32624303,10.1016/j.jtcvs.2020.04.060,2020-07-07
Coronavirus Infections,ISA,Disease,32624303,10.1016/j.jtcvs.2020.04.060,2020-07-07
GSKIP gene,INTERACTS_WITH,Program,32624303,10.1016/j.jtcvs.2020.04.060,2020-07-07
Program,ADMINISTERED_TO,teams,32624303,10.1016/j.jtcvs.2020.04.060,2020-07-07
Virus,CAUSES,Severe Acute Respiratory Syndrome,32624257,10.1016/j.jaci.2020.05.033,2020-07-07
Cell Count,USES,Artificial Airways,32624257,10.1016/j.jaci.2020.05.033,2020-07-07
Lung,LOCATION_OF,angiotensin converting enzyme 2,32624257,10.1016/j.jaci.2020.05.033,2020-07-07
Asymptomatic,PROCESS_OF,Persons,32624257,10.1016/j.jaci.2020.05.033,2020-07-07
Communicable Diseases,PROCESS_OF,Persons,32624237,10.1016/j.outlook.2020.05.009,2020-07-07
Community,LOCATION_OF,"TLR4 protein, human",32624237,10.1016/j.outlook.2020.05.009,2020-07-07
Family,LOCATION_OF,"TLR4 protein, human",32624237,10.1016/j.outlook.2020.05.009,2020-07-07
Health Personnel,LOCATION_OF,"TLR4 protein, human",32624237,10.1016/j.outlook.2020.05.009,2020-07-07
Readiness,PROCESS_OF,Research Personnel,32624237,10.1016/j.outlook.2020.05.009,2020-07-07
Infected,PROCESS_OF,Patients,32624225,10.1016/j.surg.2020.05.030,2020-07-07
Malaise,PROCESS_OF,Patients,32624089,10.1016/j.echo.2020.05.005,2020-07-07
Evaluation procedure,USES,Ultrasonography,32624089,10.1016/j.echo.2020.05.005,2020-07-07
Laboratory,LOCATION_OF,Echocardiography,32624089,10.1016/j.echo.2020.05.005,2020-07-07
Physical Examination,USES,Echocardiography,32624089,10.1016/j.echo.2020.05.005,2020-07-07
Malaise,PROCESS_OF,Child,32624086,10.1017/dmp.2020.198,2020-07-07
Fever,PROCESS_OF,Patients,32624085,10.1017/dmp.2020.199,2020-07-07
Pneumonia,PROCESS_OF,Patients,32624085,10.1017/dmp.2020.199,2020-07-07
Pneumonia,PROCESS_OF,Patients,32624085,10.1017/dmp.2020.199,2020-07-07
Laboratory Procedures,USES,PCR test for SARS,32624085,10.1017/dmp.2020.199,2020-07-07
PCR test for SARS,ISA,Laboratory Procedures,32624085,10.1017/dmp.2020.199,2020-07-07
Mitral Valve,LOCATION_OF,Congenital Disorders,32624054,10.1017/S1047951120002127,2020-07-07
Heart,LOCATION_OF,Comorbidity,32624054,10.1017/S1047951120002127,2020-07-07
Heart,LOCATION_OF,Severe disorder,32624054,10.1017/S1047951120002127,2020-07-07
Italy,ISA,Country,32624052,10.1017/S1047951120002085,2020-07-07
Caring,PROCESS_OF,Health Personnel,32624052,10.1017/S1047951120002085,2020-07-07
Adverse event,PROCESS_OF,Patients,32624052,10.1017/S1047951120002085,2020-07-07
aptamer,compared_with,Antibodies,32623963,10.1080/22221751.2020.1792352,2020-07-07
Assay,USES,Detection,32623963,10.1080/22221751.2020.1792352,2020-07-07
Hospitals,LOCATION_OF,Multicenter Study,32623945,10.1177/1129729820937484,2020-07-07
Vascular Access Complication,ISA,Complication,32623945,10.1177/1129729820937484,2020-07-07
Vascular Access Complication,PROCESS_OF,Patients,32623945,10.1177/1129729820937484,2020-07-07
Catheterization,TREATS,Vascular Access Complication,32623945,10.1177/1129729820937484,2020-07-07
Uremia,PROCESS_OF,Patients,32623945,10.1177/1129729820937484,2020-07-07
Confirmation,PROCESS_OF,Patients,32623945,10.1177/1129729820937484,2020-07-07
Tissue Donors,ISA,Population Group,32623831,10.1111/iji.12505,2020-07-06
Infected,PROCESS_OF,Patients,32623831,10.1111/iji.12505,2020-07-06
Hydranencephaly with Renal Aplasia-Dysplasia,COEXISTS_WITH,Infection,32623774,10.1111/apa.15458,2020-07-06
Coronavirus Infections,ISA,Disease,32623717,10.1002/ijgo.13296,2020-07-06
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32623717,10.1002/ijgo.13296,2020-07-06
Coughing,PROCESS_OF,Patients,32623717,10.1002/ijgo.13296,2020-07-06
Lung,LOCATION_OF,Lesion,32623717,10.1002/ijgo.13296,2020-07-06
Present,COEXISTS_WITH,Disease,32623717,10.1002/ijgo.13296,2020-07-06
Present,COEXISTS_WITH(SPEC),Coronavirus Infections,32623717,10.1002/ijgo.13296,2020-07-06
Coronavirus Infections,ISA,Disease,32623717,10.1002/ijgo.13296,2020-07-06
Coronavirus Infections,ISA,Disease,32623717,10.1002/ijgo.13296,2020-07-06
Lesion,PROCESS_OF,Patients,32623717,10.1002/ijgo.13296,2020-07-06
Obesity,PREDISPOSES,Severe disorder,32623686,10.1007/s11695-020-04826-4,2020-07-06
Obesity,PROCESS_OF,Patients,32623686,10.1007/s11695-020-04826-4,2020-07-06
Coronavirus Infections,ISA,Disease,32623633,10.1007/s12072-020-10071-9,2020-07-06
Severe disorder,PROCESS_OF,Patients,32623633,10.1007/s12072-020-10071-9,2020-07-06
Gamma-glutamyl transferase,STIMULATES,GOT1 gene,32623633,10.1007/s12072-020-10071-9,2020-07-06
Elevation procedure,USES,GOT1 gene,32623633,10.1007/s12072-020-10071-9,2020-07-06
Hypoalbuminemia,COEXISTS_WITH,Severe disorder,32623633,10.1007/s12072-020-10071-9,2020-07-06
Chronic liver disease,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Chronic liver disease,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Chronic liver disease,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Metabolism,ASSOCIATED_WITH,Fatty Liver Disease,32623632,10.1007/s12072-020-10072-8,2020-07-06
Cirrhosis,COEXISTS_WITH,Acute-On-Chronic Liver Failure,32623632,10.1007/s12072-020-10072-8,2020-07-06
Chronic liver disease,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Diabetes,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Obesity,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Chronic liver disease,PROCESS_OF,Patients,32623632,10.1007/s12072-020-10072-8,2020-07-06
Cardiac Surgery procedures,AFFECTS,Hydranencephaly with Renal Aplasia-Dysplasia,32623568,10.1007/s11845-020-02292-6,2020-07-06
Transplantation,AFFECTS,Hydranencephaly with Renal Aplasia-Dysplasia,32623568,10.1007/s11845-020-02292-6,2020-07-06
Lung Transplantation,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32623568,10.1007/s11845-020-02292-6,2020-07-06
Coronavirus Infections,CAUSES,Disease,32623546,10.1007/s10571-020-00915-1,2020-07-06
Coronavirus Infections,ISA,Disease,32623546,10.1007/s10571-020-00915-1,2020-07-06
Possible,PROCESS_OF,Homo sapiens,32623546,10.1007/s10571-020-00915-1,2020-07-06
Neurons,LOCATION_OF,angiotensin converting enzyme 2,32623546,10.1007/s10571-020-00915-1,2020-07-06
Neurons,PART_OF,Homo sapiens,32623546,10.1007/s10571-020-00915-1,2020-07-06
Neoplasms,PROCESS_OF,Patients,32623520,10.1007/s00520-020-05598-4,2020-07-06
pulmonary involvement,COEXISTS_WITH,Pneumonia,32623505,10.1007/s00330-020-07033-y,2020-07-06
Physical Examination,USES,Chest CT,32623505,10.1007/s00330-020-07033-y,2020-07-06
Fibrosis,COEXISTS_WITH,Disease,32623505,10.1007/s00330-020-07033-y,2020-07-06
Abdomen,LOCATION_OF,Chief complaint (finding),32623503,10.1007/s00330-020-07040-z,2020-07-06
CT of lungs,ADMINISTERED_TO,radiologist,32623503,10.1007/s00330-020-07040-z,2020-07-06
Old age,ISA,Population Group,32623503,10.1007/s00330-020-07040-z,2020-07-06
Hypertensive disease,PROCESS_OF,Woman,32623503,10.1007/s00330-020-07040-z,2020-07-06
Senility,PROCESS_OF,Patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
Patient Discharge,TREATS,geriatric patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
Abdominal symptom,PROCESS_OF,Patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
Awareness,PROCESS_OF,geriatric patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
Infected,PROCESS_OF,Patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
Abdominal symptom,PROCESS_OF,Patients,32623503,10.1007/s00330-020-07040-z,2020-07-06
"Oncologic procedure, NOS",TREATS,Neoplasm Metastasis,32623500,10.1007/s00345-020-03333-6,2020-07-06
Infected,PROCESS_OF,Patients,32623491,10.1007/s00392-020-01696-9,2020-07-06
Cell Invasion,PROCESS_OF,Homo sapiens,32623480,10.1007/s00018-020-03580-1,2020-07-06
"CD69 protein, human",COEXISTS_WITH,"M Protein, multiple myeloma",32623480,10.1007/s00018-020-03580-1,2020-07-06
"ACE2 protein, human",INTERACTS_WITH,"M Protein, multiple myeloma",32623480,10.1007/s00018-020-03580-1,2020-07-06
Vaccines,INHIBITS,"M Protein, multiple myeloma",32623480,10.1007/s00018-020-03580-1,2020-07-06
Angiotensin-Converting Enzyme Inhibitors,AFFECTS,Disease Outcome,32623470,10.1093/cid/ciaa677,2020-07-06
Angiotensin Receptor,AFFECTS,Disease Outcome,32623470,10.1093/cid/ciaa677,2020-07-06
Carbonyldiamide,ASSOCIATED_WITH,Acute respiratory failure,32623470,10.1093/cid/ciaa677,2020-07-06
Angiotensin-Converting Enzyme Inhibitors,COEXISTS_WITH,Carbonyldiamide,32623470,10.1093/cid/ciaa677,2020-07-06
Pandemics,ISA,Disease Outbreaks,32623414,10.3233/WOR-203193,2020-07-06
Infertility,PROCESS_OF,Porifera,32623382,10.1515/znc-2020-0105,2020-07-06
Genus: Coronavirus,PROCESS_OF,Family,32623382,10.1515/znc-2020-0105,2020-07-06
"Immunity, Herd",ASSOCIATED_WITH,human plasma,32623350,10.1016/j.jcv.2020.104521,2020-07-06
Coronavirus Infections,ISA,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Therapeutic procedure,TREATS,Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Hospital admission,TREATS,Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,ISA,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,ISA,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Disease,PROCESS_OF,Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,ISA,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,PROCESS_OF(SPEC),Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Infected,PROCESS_OF,Patients,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Pharmacist,DIAGNOSES,Enthesitis-Related Arthritis,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Pharmacist,TREATS,Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,ISA,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Oncologists,DIAGNOSES,Enthesitis-Related Arthritis,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Oncologists,TREATS,Cancer Patient,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Enthesitis-Related Arthritis,COEXISTS_WITH,Disease,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Enthesitis-Related Arthritis,COEXISTS_WITH(SPEC),Coronavirus Infections,32623296,10.1016/j.ctrv.2020.102063,2020-07-06
Coronavirus Infections,ISA,Disease,32623270,10.1016/j.envpol.2020.115099,2020-07-06
Coronavirus Infections,ISA,Disease,32623270,10.1016/j.envpol.2020.115099,2020-07-06
Coronavirus Infections,ISA,Disease,32623270,10.1016/j.envpol.2020.115099,2020-07-06
Disease,PROCESS_OF,Animals,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Disease,PROCESS_OF,Homo sapiens,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Virus,CAUSES,Disease,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Genus: Coronavirus,CAUSES(SPEC),Disease,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Genus: Coronavirus,ISA,Virus,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Genus: Coronavirus,CAUSES,Respiratory Tract Infections,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Virus,CAUSES,Common Cold,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
SARS coronavirus,CAUSES,Respiration Disorders,32623267,10.1016/j.diagmicrobio.2020.115094,2020-07-06
Mental disorders,ISA,Symptoms,32623266,10.1016/j.psychres.2020.113267,2020-07-06
Loneliness,ISA,Mental disorders,32623266,10.1016/j.psychres.2020.113267,2020-07-06
High risk of,PROCESS_OF,Persons,32623266,10.1016/j.psychres.2020.113267,2020-07-06
High risk of,PROCESS_OF,Woman,32623266,10.1016/j.psychres.2020.113267,2020-07-06
mental health,PROCESS_OF,Social Networks,32623263,10.1016/j.psychres.2020.113252,2020-07-06
Spain,ISA,Geographic Locations,32623263,10.1016/j.psychres.2020.113252,2020-07-06
Telemedicine,TREATS,Patients,32623263,10.1016/j.psychres.2020.113252,2020-07-06
Mental disorders,AFFECTS,Patients,32623263,10.1016/j.psychres.2020.113252,2020-07-06
Pharmaceutical Preparations,AUGMENTS,Eye,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Vaccines,AUGMENTS,Eye,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Isopropyl Alcohol,ISA,Ethanol,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Ethanol,CAUSES,Alcohol poisoning,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Cessation of life,AFFECTS,Americas Ethnicity,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Hand,LOCATION_OF,sanitizers,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
sanitizers,TREATS,Child,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Alcohol poisoning,PROCESS_OF,Child,32623176,10.1016/j.scitotenv.2020.140561,2020-07-06
Lung,LOCATION_OF,Abnormal Finding,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
Parenchyma,LOCATION_OF,Congenital anomaly of lung,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
Oxygen saturation below reference range,PROCESS_OF,Patients,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
Comorbidity,PROCESS_OF,Population Group,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
Symptom mild,PROCESS_OF,Population Group,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
CAT scan normal,PROCESS_OF,Patients,32623113,10.1016/j.ejrad.2020.109147,2020-07-06
Asymptomatic,PROCESS_OF,Patients,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
Asymptomatic,PROCESS_OF,Patients,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
viral transmission,PROCESS_OF,Patients,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
Asymptomatic,PROCESS_OF,Patients,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
Infected,PROCESS_OF,Persons,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
Asymptomatic,PROCESS_OF,Patients,32623083,10.1016/j.ijid.2020.06.098,2020-07-06
Torsades de Pointes,NEG_PROCESS_OF,Patients,32623082,10.1016/j.ijid.2020.06.099,2020-07-06
Evaluation procedure,TREATS,risk factors,32623082,10.1016/j.ijid.2020.06.099,2020-07-06
GSKIP gene,compared_with,Hydroxychloroquine,32623082,10.1016/j.ijid.2020.06.099,2020-07-06
Epidemic,ISA,Process,32623081,10.1016/j.ijid.2020.06.101,2020-07-06
Epidemic,ISA,Process,32623081,10.1016/j.ijid.2020.06.101,2020-07-06
Fluctuation,PROCESS_OF,Persons,32623081,10.1016/j.ijid.2020.06.101,2020-07-06
Coronavirus Infections,ISA,Disease,32623042,10.1016/j.diabres.2020.108297,2020-07-06
Introduction procedure,PRECEDES,Quarantine,32623042,10.1016/j.diabres.2020.108297,2020-07-06
Diabetes,PROCESS_OF,Persons,32623041,10.1016/j.diabres.2020.108296,2020-07-06
Diabetes,PROCESS_OF,Health Personnel,32623041,10.1016/j.diabres.2020.108296,2020-07-06
Diabetes,PROCESS_OF,Persons,32623041,10.1016/j.diabres.2020.108296,2020-07-06
Diabetes,PROCESS_OF,Persons,32623041,10.1016/j.diabres.2020.108296,2020-07-06
Persons,LOCATION_OF,IMPACT gene,32623041,10.1016/j.diabres.2020.108296,2020-07-06
Diabetes,PREDISPOSES,Poor outcome,32623040,10.1016/j.diabres.2020.108304,2020-07-06
Diabetes,PROCESS_OF,Persons,32623040,10.1016/j.diabres.2020.108304,2020-07-06
Severe (severity modifier),PREDISPOSES,Fatal Outcome,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Diabetes,PROCESS_OF,Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Hyperglycemia,ISA,Diabetes,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Hyperglycemia,PROCESS_OF(SPEC),Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Human body,LOCATION_OF,receptor,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Diabetes,PROCESS_OF,Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Pharmaceutical Preparations,TREATS,Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Pharmaceutical Preparations,TREATS(INFER),Diabetes,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Diabetes,PROCESS_OF,Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Diabetes,PROCESS_OF,Patients,32623038,10.1016/j.diabres.2020.108303,2020-07-06
Diabetes,PROCESS_OF,Persons,32623037,10.1016/j.diabres.2020.108294,2020-07-06
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32623037,10.1016/j.diabres.2020.108294,2020-07-06
Diagnosis,AFFECTS,Patients,32623037,10.1016/j.diabres.2020.108294,2020-07-06
Diabetes,PROCESS_OF,Persons,32623036,10.1016/j.diabres.2020.108301,2020-07-06
Persons,LOCATION_OF,IMPACT gene,32623036,10.1016/j.diabres.2020.108301,2020-07-06
Cessation of life,PROCESS_OF,Patients,32623035,10.1016/j.diabres.2020.108293,2020-07-06
Cessation of life,PROCESS_OF,Patients,32623035,10.1016/j.diabres.2020.108293,2020-07-06
Diabetes Mellitus,PROCESS_OF,Patients,32623035,10.1016/j.diabres.2020.108293,2020-07-06
Hypertensive disease,PROCESS_OF,Patients,32623035,10.1016/j.diabres.2020.108293,2020-07-06
Hypertensive disease,PROCESS_OF,Patients,32623035,10.1016/j.diabres.2020.108293,2020-07-06
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,parent,32623034,10.1016/j.diabres.2020.108302,2020-07-06
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,School child,32623034,10.1016/j.diabres.2020.108302,2020-07-06
Insulin,compared_with,Tars,32623034,10.1016/j.diabres.2020.108302,2020-07-06
Insulin,TREATS,Child,32623034,10.1016/j.diabres.2020.108302,2020-07-06
bolus infusion,TREATS,Child,32623034,10.1016/j.diabres.2020.108302,2020-07-06
bolus infusion,USES,Insulin,32623034,10.1016/j.diabres.2020.108302,2020-07-06
"CD69 protein, human",ASSOCIATED_WITH,Diabetes,32623032,10.1016/j.diabres.2020.108295,2020-07-06
"CD69 protein, human",ASSOCIATED_WITH,Hypertensive disease,32623032,10.1016/j.diabres.2020.108295,2020-07-06
Diabetes,AFFECTS,Negative,32623032,10.1016/j.diabres.2020.108295,2020-07-06
Hypertensive disease,AFFECTS,Negative,32623032,10.1016/j.diabres.2020.108295,2020-07-06
Diabetes,PROCESS_OF,Patients,32623031,10.1016/j.diabres.2020.108298,2020-07-06
Ambulatory Care Facilities,LOCATION_OF,Services,32623031,10.1016/j.diabres.2020.108298,2020-07-06
Patients,ISA,Persons,32623031,10.1016/j.diabres.2020.108298,2020-07-06
Hospitals,LOCATION_OF,logistic regression analysis,32623030,10.1016/j.diabres.2020.108299,2020-07-06
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32623030,10.1016/j.diabres.2020.108299,2020-07-06
Cessation of life,PROCESS_OF,Patients,32623030,10.1016/j.diabres.2020.108299,2020-07-06
Glucose,PART_OF,Patients,32623030,10.1016/j.diabres.2020.108299,2020-07-06
Poor outcome,COEXISTS_WITH,Diabetes,32623030,10.1016/j.diabres.2020.108299,2020-07-06
"Condoms, Male",PREVENTS,Severe Acute Respiratory Syndrome,32622993,10.1016/j.hrthm.2020.07.001,2020-07-06
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32622993,10.1016/j.hrthm.2020.07.001,2020-07-06
Patients,USES,Preexisting Condition Coverage,32622993,10.1016/j.hrthm.2020.07.001,2020-07-06
Chronic lung disease,PROCESS_OF,Patients,32622963,10.1016/j.jconrel.2020.06.036,2020-07-06
Chronic lung disease,PROCESS_OF,Animal Model,32622963,10.1016/j.jconrel.2020.06.036,2020-07-06
Hospitals,LOCATION_OF,Quantitative Reverse Transcriptase PCR,32622952,10.1016/j.cmi.2020.06.033,2020-07-06
risk factors,PROCESS_OF,Cohort,32622952,10.1016/j.cmi.2020.06.033,2020-07-06
Prognosis bad,PROCESS_OF,Patients,32622952,10.1016/j.cmi.2020.06.033,2020-07-06
Serum,LOCATION_OF,Antibodies,32622905,10.1016/j.jinf.2020.06.076,2020-07-06
Infected,PROCESS_OF,Persons,32622902,10.1016/j.jclinepi.2020.06.037,2020-07-06
Laboratory Procedures,PRODUCES,False Negative,32622902,10.1016/j.jclinepi.2020.06.037,2020-07-06
Symptoms,PROCESS_OF,Patients,32622888,10.1016/j.jaad.2020.06.1016,2020-07-06
Lesion,PROCESS_OF,Patients,32622888,10.1016/j.jaad.2020.06.1016,2020-07-06
Mild disorder,PROCESS_OF,Patients,32622888,10.1016/j.jaad.2020.06.1016,2020-07-06
Coronavirus Infections,ISA,Disease,32622888,10.1016/j.jaad.2020.06.1016,2020-07-06
High Level,PROCESS_OF,Health Personnel,32622882,10.1016/j.rpsm.2020.05.004,2020-07-06
High Level,PROCESS_OF,Woman,32622882,10.1016/j.rpsm.2020.05.004,2020-07-06
High Level,PROCESS_OF,professional occupation status,32622882,10.1016/j.rpsm.2020.05.004,2020-07-06
Contact Dermatitis,PROCESS_OF,Hispanics,32622869,10.1016/j.ad.2020.06.003,2020-07-06
Patch Tests,MEASURES,Increment,32622869,10.1016/j.ad.2020.06.003,2020-07-06
Extravasation,COEXISTS_WITH,Rare Diseases,32622823,10.1016/j.chest.2020.06.049,2020-07-06
endothelial dysfunction,COEXISTS_WITH,Rare Diseases,32622823,10.1016/j.chest.2020.06.049,2020-07-06
inflammatory response,COEXISTS_WITH,Rare Diseases,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Neoplasm Metastasis,ISA,Disease,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Shock,PROCESS_OF,Patients,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Hypoalbuminemia,PROCESS_OF,Patients,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Acute infectious disease,PROCESS_OF,Patients,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Packed cell volume increased,PROCESS_OF,Patients,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Limb structure,LOCATION_OF,Compartment syndromes,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Limb structure,LOCATION_OF,Rhabdomyolysis,32622823,10.1016/j.chest.2020.06.049,2020-07-06
Health Personnel,DIAGNOSES,Symptoms,32622819,10.1016/j.chest.2020.06.051,2020-07-06
Lung,LOCATION_OF,Virus Diseases,32622819,10.1016/j.chest.2020.06.051,2020-07-06
Health Care Systems,LOCATION_OF,Retrospective Studies,32622817,10.1016/j.jacr.2020.06.011,2020-07-06
Image Study,DIAGNOSES,Menstruation Disturbances,32622817,10.1016/j.jacr.2020.06.011,2020-07-06
Hypocalcemia,PROCESS_OF,Patients,32622796,10.1016/j.jiph.2020.05.029,2020-07-06
Hypocalcemia,PROCESS_OF,Patients,32622796,10.1016/j.jiph.2020.05.029,2020-07-06
Poor outcome,PROCESS_OF,Patients,32622796,10.1016/j.jiph.2020.05.029,2020-07-06
Chronic disease,PROCESS_OF,Elderly (population group),32622730,10.1016/j.jagp.2020.05.028,2020-07-06
personality problem,PROCESS_OF,Elderly (population group),32622730,10.1016/j.jagp.2020.05.028,2020-07-06
Laboratory,LOCATION_OF,Administration occupational activities,32622702,10.1016/j.rbmo.2020.05.006,2020-07-06
Lung,LOCATION_OF,Ultrasonography,32622684,10.1016/j.ultrasmedbio.2020.05.006,2020-07-06
Lung,LOCATION_OF,Ultrasonography,32622684,10.1016/j.ultrasmedbio.2020.05.006,2020-07-06
Ultrasonography,ADMINISTERED_TO,Patients,32622684,10.1016/j.ultrasmedbio.2020.05.006,2020-07-06
Community acquired pneumonia,PROCESS_OF,Patients,32622684,10.1016/j.ultrasmedbio.2020.05.006,2020-07-06
Community acquired pneumonia,PROCESS_OF,Patients,32622684,10.1016/j.ultrasmedbio.2020.05.006,2020-07-06
Disease,PROCESS_OF,Patients,32622482,10.1016/j.nefro.2020.05.006,2020-07-06
Lung,LOCATION_OF,Tissue damage,32622469,10.1016/j.amjms.2020.05.044,2020-07-06
Interleukin-6,ISA,Agent,32622469,10.1016/j.amjms.2020.05.044,2020-07-06
Infected,PROCESS_OF,Persons,32622450,10.1016/j.mayocp.2020.05.010,2020-07-06
contextual factors,PROCESS_OF,Outpatients,32622450,10.1016/j.mayocp.2020.05.010,2020-07-06
Cell surface,LOCATION_OF,angiotensin converting enzyme 2,32622449,10.1016/j.mayocp.2020.05.006,2020-07-06
Adipose tissue,LOCATION_OF,angiotensin converting enzyme 2,32622449,10.1016/j.mayocp.2020.05.006,2020-07-06
Structure of parenchyma of lung,LOCATION_OF,angiotensin converting enzyme 2,32622449,10.1016/j.mayocp.2020.05.006,2020-07-06
Obesity,PROCESS_OF,Patients,32622449,10.1016/j.mayocp.2020.05.006,2020-07-06
Coronavirus Infections,PROCESS_OF,Patients,32622449,10.1016/j.mayocp.2020.05.006,2020-07-06
Diploid Cell,PART_OF,ovarian,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Ovarian Tissue,PART_OF,Nonhuman primate,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Ovarian Tissue,PRODUCES,angiotensin converting enzyme 2,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Ovarian Tissue,PRODUCES,TMPRSS2 gene,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
TMPRSS2 gene,LOCATION_OF,"Transcription, Genetic",32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Testis,LOCATION_OF,angiotensin converting enzyme 2,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Testis,LOCATION_OF,TMPRSS2 gene,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
Germ Cells,LOCATION_OF,viral transmission,32622411,10.1016/j.fertnstert.2020.05.001,2020-07-06
brazilian,PROCESS_OF,Caucasoid Race,32622400,10.1016/S2214-109X(20)30285-0,2020-07-06
brazilian,PROCESS_OF,African race,32622400,10.1016/S2214-109X(20)30285-0,2020-07-06
brazilian,PROCESS_OF,African race,32622400,10.1016/S2214-109X(20)30285-0,2020-07-06
brazilian,PROCESS_OF,African race,32622400,10.1016/S2214-109X(20)30285-0,2020-07-06
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32622380,10.1016/S1473-3099(20)30527-2,2020-07-06
Community-Acquired Infections,COEXISTS_WITH,Direct disease transmission,32622380,10.1016/S1473-3099(20)30527-2,2020-07-06
Direct disease transmission,PROCESS_OF,Health Personnel,32622380,10.1016/S1473-3099(20)30527-2,2020-07-06
Direct disease transmission,PROCESS_OF,Patients,32622380,10.1016/S1473-3099(20)30527-2,2020-07-06
Respiratory viruses,CAUSES,Terminal illness,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
"Paris, France",ISA,Geographic Locations,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Mucocutaneous Lymph Node Syndrome,CAUSES,Hospital admission,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Viral Respiratory Tract Infection,CAUSES,Mucocutaneous Lymph Node Syndrome,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Severe disorder,PROCESS_OF,Patients,32622376,10.1016/S2352-4642(20)30175-9,2020-07-06
Neurologic Manifestations,PROCESS_OF,Patients,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Genus: Coronavirus,CAUSES,Middle East Respiratory Syndrome,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Encephalitis,PROCESS_OF,Patients,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Syndrome,PROCESS_OF,Patients,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Cerebrovascular accident,PROCESS_OF,Patients,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
nervous system disorder,PROCESS_OF,Patients,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
Infection,CAUSES,nervous system disorder,32622375,10.1016/S1474-4422(20)30221-0,2020-07-06
ocrelizumab,TREATS,Male population group,32622338,10.1016/j.msard.2020.102341,2020-07-06
ocrelizumab,TREATS,Patients,32622338,10.1016/j.msard.2020.102341,2020-07-06
ocrelizumab,TREATS,Woman,32622338,10.1016/j.msard.2020.102341,2020-07-06
Pharmacologic Substance,TREATS,Illness (finding),32622261,10.1016/j.isci.2020.101303,2020-07-06
paired basic amino acid cleaving enzyme,ISA,Endopeptidases,32622243,10.1016/j.bpc.2020.106420,2020-07-06
"Vitronectin, human",PART_OF,Proteins,32622243,10.1016/j.bpc.2020.106420,2020-07-06
Pandemics,ISA,Disease Outbreaks,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
"Hartmann operation, rectal resection",TREATS,acute diverticulitis,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Laboratory Procedures,DIAGNOSES,Present,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
X-Ray Computed Tomography,DIAGNOSES,Bilateral pneumonia,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
interstitial,LOCATION_OF,Bilateral pneumonia,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Health Personnel,TREATS,Patients,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Health Personnel,TREATS,Patients,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Patient Isolation,PREDISPOSES,Severe Acute Respiratory Syndrome,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Symptoms,PROCESS_OF,Partner,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Pandemics,ISA,Disease Outbreaks,32622186,10.1016/j.ijscr.2020.06.073,2020-07-06
Stress,ISA,Mental disorders,32622172,10.1016/j.psychres.2020.113264,2020-07-06
Mental disorders,PROCESS_OF,Adolescent (age group),32622172,10.1016/j.psychres.2020.113264,2020-07-06
IMPACT gene,NEG_AFFECTS,Crisis,32622172,10.1016/j.psychres.2020.113264,2020-07-06
Anosmia,ISA,Sensory Disorders,32622086,10.1016/j.nbd.2020.105007,2020-07-06
Headache,ISA,Symptoms,32622086,10.1016/j.nbd.2020.105007,2020-07-06
Genus: Coronavirus,CAUSES,Respiratory Tract Infections,32622086,10.1016/j.nbd.2020.105007,2020-07-06
Ageusia,ISA,Sensory Disorders,32622086,10.1016/j.nbd.2020.105007,2020-07-06
Symptoms,PREDISPOSES,Respiratory Failure,32622086,10.1016/j.nbd.2020.105007,2020-07-06
nervous system disorder,PROCESS_OF,Persons,32622086,10.1016/j.nbd.2020.105007,2020-07-06
Infected,PROCESS_OF,Persons,32622086,10.1016/j.nbd.2020.105007,2020-07-06
SARS coronavirus,PROCESS_OF,Relative (related person),32622082,10.1016/j.meegid.2020.104440,2020-07-06
Convergent gaze,PROCESS_OF,Relative (related person),32622082,10.1016/j.meegid.2020.104440,2020-07-06
Genus: Coronavirus,LOCATION_OF,Proteins,32622082,10.1016/j.meegid.2020.104440,2020-07-06
Epitopes,ISA,Antigens,32622082,10.1016/j.meegid.2020.104440,2020-07-06
Epitopes,ISA,Antigens,32622082,10.1016/j.meegid.2020.104440,2020-07-06
Telemedicine,METHOD_OF,Patient Visit,32622075,10.1016/j.jvs.2020.06.051,2020-07-06
Cerebrovascular accident,ISA,Illness (finding),32622075,10.1016/j.jvs.2020.06.051,2020-07-06
Deep Vein Thrombosis,ISA,Illness (finding),32622075,10.1016/j.jvs.2020.06.051,2020-07-06
Problem,COEXISTS_WITH,Enthesitis-Related Arthritis,32622075,10.1016/j.jvs.2020.06.051,2020-07-06
Acquired Immunodeficiency Syndrome,ISA,Disease,32622045,10.1016/j.ymeth.2020.06.013,2020-07-06
Acquired Immunodeficiency Syndrome,PROCESS_OF(SPEC),Homo sapiens,32622045,10.1016/j.ymeth.2020.06.013,2020-07-06
Disease,PROCESS_OF,Homo sapiens,32622045,10.1016/j.ymeth.2020.06.013,2020-07-06
Cardiac Arrhythmia,PROCESS_OF,Child,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Cardiac Arrhythmia,PROCESS_OF,Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Comorbidity,PROCESS_OF,Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Heart,NEG_LOCATION_OF,Comorbidity,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Cardiac Arrhythmia,PROCESS_OF,general population,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Cardiac Arrhythmia,PROCESS_OF,Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Comorbidity,PROCESS_OF,Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Cardiac Arrhythmia,PROCESS_OF,Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Corrected Prolonged QT Interval by ECG Finding,NEG_ISA,Cardiac Arrhythmia,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Corrected Prolonged QT Interval by ECG Finding,NEG_PROCESS_OF(SPEC),Patients,32621881,10.1016/j.hrthm.2020.06.033,2020-07-06
Cells,PRODUCES,Metric,32621869,10.1016/S1473-3099(20)30553-3,2020-07-06
Vaccines,TREATS,Disease,32621869,10.1016/S1473-3099(20)30553-3,2020-07-06
Protection,PROCESS_OF,Pregnant Women,32621859,10.1016/j.ajic.2020.06.206,2020-07-06
Eye,LOCATION_OF,Coronavirus Infections,32621841,10.1016/j.virusres.2020.198082,2020-07-06
"Epitopes, B-Lymphocyte",COEXISTS_WITH,"Vitronectin, human",32621841,10.1016/j.virusres.2020.198082,2020-07-06
SARS coronavirus,LOCATION_OF,Measles Virus Nucleoprotein,32621841,10.1016/j.virusres.2020.198082,2020-07-06
Laboratory,LOCATION_OF,Early Diagnosis,32621814,10.1016/j.cca.2020.06.045,2020-07-06
Basis,TREATS,Confirmation,32621814,10.1016/j.cca.2020.06.045,2020-07-06
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,Meleagris gallopavo,32621774,10.1111/dth.13972,2020-07-06
Isotretinoin,ADMINISTERED_TO,Patients,32621774,10.1111/dth.13972,2020-07-06
Acne,PROCESS_OF,Patients,32621774,10.1111/dth.13972,2020-07-06
Pandemics,CAUSES,Hydranencephaly with Renal Aplasia-Dysplasia,32621761,10.1111/famp.12580,2020-07-06
10 - 19,PREDISPOSES,Venous Thromboembolism,32621757,10.1111/bjh.16993,2020-07-06
risk factors,PROCESS_OF,Patients,32621757,10.1111/bjh.16993,2020-07-06
Venous Thromboembolism,PROCESS_OF,hospitalized patients,32621757,10.1111/bjh.16993,2020-07-06
Laboratory Procedures,DIAGNOSES,Virus,32621728,10.1515/dx-2020-0058,2020-07-06
Coronavirus Infections,ISA,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Coronavirus Infections,ISA,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Radionuclide Imaging,DIAGNOSES,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Radionuclide Imaging,DIAGNOSES(SPEC),Coronavirus Infections,32621728,10.1515/dx-2020-0058,2020-07-06
Plain chest X-ray,DIAGNOSES,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Plain chest X-ray,DIAGNOSES(SPEC),Coronavirus Infections,32621728,10.1515/dx-2020-0058,2020-07-06
Ultrasonography,DIAGNOSES,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Ultrasonography,DIAGNOSES(SPEC),Coronavirus Infections,32621728,10.1515/dx-2020-0058,2020-07-06
Coronavirus Infections,ISA,Disease,32621728,10.1515/dx-2020-0058,2020-07-06
Endopeptidases,TREATS,Possible,32621718,10.2174/1568026620666200704135327,2020-07-06
Autoimmune Diseases,AFFECTS,Old age,32621628,10.1111/dth.13956,2020-07-06
Bullous pemphigoid,AFFECTS(SPEC),Old age,32621628,10.1111/dth.13956,2020-07-06
Bullous pemphigoid,ISA,Autoimmune Diseases,32621628,10.1111/dth.13956,2020-07-06
Bullous pemphigoid,COEXISTS_WITH,Enthesitis-Related Arthritis,32621628,10.1111/dth.13956,2020-07-06
Influenza,ISA,Disease,32621621,10.1002/jmv.26260,2020-07-06
Coronavirus Infections,ISA,Disease,32621621,10.1002/jmv.26260,2020-07-06
Pneumonia,ISA,Disease,32621621,10.1002/jmv.26260,2020-07-06
Pneumonia,ISA,Disease,32621621,10.1002/jmv.26260,2020-07-06
Pneumonia,PROCESS_OF,hospitalized patients,32621621,10.1002/jmv.26260,2020-07-06
Infected,PROCESS_OF,Patients,32621621,10.1002/jmv.26260,2020-07-06
Coinfection,PROCESS_OF,Patients,32621621,10.1002/jmv.26260,2020-07-06
lopinavir / Ritonavir,ADMINISTERED_TO,Patients,32621621,10.1002/jmv.26260,2020-07-06
Infected,PROCESS_OF,Patients,32621621,10.1002/jmv.26260,2020-07-06
lopinavir / Ritonavir,TREATS,Patients,32621621,10.1002/jmv.26260,2020-07-06
lopinavir / Ritonavir,TREATS(INFER),Infected,32621621,10.1002/jmv.26260,2020-07-06
Coronavirus Infections,ISA,Disease,32621621,10.1002/jmv.26260,2020-07-06
Infected,COEXISTS_WITH,Disease,32621621,10.1002/jmv.26260,2020-07-06
Infected,COEXISTS_WITH(SPEC),Coronavirus Infections,32621621,10.1002/jmv.26260,2020-07-06
lopinavir / Ritonavir,TREATS,Pneumonia,32621621,10.1002/jmv.26260,2020-07-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Male population group,32621617,10.1002/jmv.26259,2020-07-06
Serum,LOCATION_OF,Luteinizing Hormone,32621617,10.1002/jmv.26259,2020-07-06
Evaluation,USES,Gonadal Steroid Hormones,32621617,10.1002/jmv.26259,2020-07-06
Abnormal hormone secretion,PROCESS_OF,Patients,32621617,10.1002/jmv.26259,2020-07-06
Coughing,PROCESS_OF,Patients,32621616,10.1002/jmv.26258,2020-07-06
Sneezing,PROCESS_OF,Patients,32621616,10.1002/jmv.26258,2020-07-06
Patients,LOCATION_OF,saliva,32621616,10.1002/jmv.26258,2020-07-06
Patients,LOCATION_OF,Nasopharyngeal swab (specimen),32621616,10.1002/jmv.26258,2020-07-06
saliva,PART_OF,Pharyngeal structure,32621616,10.1002/jmv.26258,2020-07-06
saliva,PART_OF,Pharyngeal structure,32621616,10.1002/jmv.26258,2020-07-06
saliva,PART_OF,Pharyngeal structure,32621616,10.1002/jmv.26258,2020-07-06
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32621616,10.1002/jmv.26258,2020-07-06
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32621523,10.1111/ctr.14032,2020-07-06
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32621523,10.1111/ctr.14032,2020-07-06
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32621523,10.1111/ctr.14032,2020-07-06
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32621523,10.1111/ctr.14032,2020-07-06
Mild disorder,PROCESS_OF,Patients,32621523,10.1111/ctr.14032,2020-07-06
Optimism,PROCESS_OF,Persons,32621498,10.26719/emhj.20.076,2020-07-06
Optimism,PROCESS_OF,Woman,32621498,10.26719/emhj.20.076,2020-07-06
Decision,PROCESS_OF,Maker (occupation),32621497,10.26719/emhj.20.070,2020-07-06
Eye,LOCATION_OF,Acute illness,32621492,10.26719/2020.26.6.626,2020-07-06
Infected,PROCESS_OF,Persons,32621492,10.26719/2020.26.6.626,2020-07-06
Mediterranean countries,ISA,Geographic Locations,32621492,10.26719/2020.26.6.626,2020-07-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32621462,10.17116/jnevro20201200517,2020-07-06
Psychiatric service,TREATS,Patients,32621462,10.17116/jnevro20201200517,2020-07-06
Psychiatric service,TREATS(INFER),Severe Acute Respiratory Syndrome,32621462,10.17116/jnevro20201200517,2020-07-06
Complication,AFFECTS,Respiration,32621462,10.17116/jnevro20201200517,2020-07-06
Syndrome,PROCESS_OF,Patients,32621462,10.17116/jnevro20201200517,2020-07-06
Coronavirus Infections,ISA,Disease,32621392,10.1111/cen.14276,2020-07-06
Vitamin D Deficiency,OCCURS_IN,inpatient,32621392,10.1111/cen.14276,2020-07-06
Vitamin D Deficiency,PROCESS_OF,Patients,32621392,10.1111/cen.14276,2020-07-06
Retrospective audit,TREATS,Vitamin D Deficiency,32621392,10.1111/cen.14276,2020-07-06
Surgical Replantation,ADMINISTERED_TO,Patients,32621392,10.1111/cen.14276,2020-07-06
Surgical Replantation,USES,Cholecalciferol,32621392,10.1111/cen.14276,2020-07-06
Vitamin D Deficiency,PROCESS_OF,Patients,32621392,10.1111/cen.14276,2020-07-06
Ward (environment),LOCATION_OF,Diagnosis,32621392,10.1111/cen.14276,2020-07-06
Disease,COEXISTS_WITH,Lesion,32621358,10.1111/odi.13532,2020-07-06
Acute viral disease,INTERACTS_WITH,Virus,32621352,10.1111/tri.13694,2020-07-06
Reagents,CAUSES,Hypersensitivity,32621339,10.1111/jmp.12483,2020-07-06
Imagery,PROCESS_OF,Social Networks,32621294,10.1111/bjso.12396,2020-07-06
Immunotherapy,TREATS,Dermatologic disorders,32621284,10.1111/ijd.15028,2020-07-06
Immunotherapy,TREATS,Dermatologic disorders,32621284,10.1111/ijd.15028,2020-07-06
congenital deficiency,PART_OF,Homo sapiens,32621284,10.1111/ijd.15028,2020-07-06
Biological Factors,INTERACTS_WITH,,32621284,10.1111/ijd.15028,2020-07-06
Community acquired pneumonia,PROCESS_OF,Patients,32621281,10.1007/s15010-020-01471-y,2020-07-06
Rhinovirus,PROCESS_OF,Patients,32621281,10.1007/s15010-020-01471-y,2020-07-06
Enthesitis-Related Arthritis,PROCESS_OF,Physicians,32621249,10.1007/s00405-020-06177-3,2020-07-06
Face,LOCATION_OF,Protection,32621249,10.1007/s00405-020-06177-3,2020-07-06
Infection,PROCESS_OF,World,32621238,10.1007/s00330-020-07034-x,2020-07-06
Pneumonia,PROCESS_OF,Patients,32621238,10.1007/s00330-020-07034-x,2020-07-06
High sensitivity,DIAGNOSES,Pneumonia,32621238,10.1007/s00330-020-07034-x,2020-07-06
Pneumonia,PROCESS_OF,Patients,32621237,10.1007/s00330-020-07032-z,2020-07-06
Pneumonia,AFFECTS,Patients,32621237,10.1007/s00330-020-07032-z,2020-07-06
Pneumonia,PROCESS_OF,Patients,32621237,10.1007/s00330-020-07032-z,2020-07-06
Performance,PREDISPOSES,Pneumonia,32621237,10.1007/s00330-020-07032-z,2020-07-06
Pleural effusion disorder,NEG_PREDISPOSES,Pneumonia,32621237,10.1007/s00330-020-07032-z,2020-07-06
Mediastinal lymphadenopathy,NEG_PREDISPOSES,Pneumonia,32621237,10.1007/s00330-020-07032-z,2020-07-06
intensive care,TREATS,Virus Diseases,32621206,10.1007/s12664-020-01068-1,2020-07-06
inflammatory response,CAUSES,Virus Diseases,32621206,10.1007/s12664-020-01068-1,2020-07-06
Antihypertensive Agents,TREATS,Patients,32621202,10.1007/s11684-020-0800-y,2020-07-06
Invasive mechanical ventilation NOS,TREATS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32621202,10.1007/s11684-020-0800-y,2020-07-06
Co-morbid conditions,PROCESS_OF,Persons,32621151,10.1007/s11239-020-02206-4,2020-07-06
Co-morbid conditions,PROCESS_OF,Old age,32621151,10.1007/s11239-020-02206-4,2020-07-06
Cardiovascular Diseases,PROCESS_OF,Patients,32621151,10.1007/s11239-020-02206-4,2020-07-06
Hospitals,LOCATION_OF,Services,32621151,10.1007/s11239-020-02206-4,2020-07-06
Negative Regulation of Coagulation,PROCESS_OF,Patients,32621151,10.1007/s11239-020-02206-4,2020-07-06
Peritoneal Dialysis,ISA,Hemodialysis,32621109,10.1007/s40620-020-00794-1,2020-07-06
Italians,ISA,Population Group,32621109,10.1007/s40620-020-00794-1,2020-07-06
Cessation of life,PROCESS_OF,Human Age Group,32621066,10.1007/s00508-020-01707-9,2020-07-06
Extracorporeal Membrane Oxygenation,TREATS,Patients,32621065,10.1007/s00508-020-01708-8,2020-07-06
Heart,PART_OF,Patients,32621065,10.1007/s00508-020-01708-8,2020-07-06
Health care facility,LOCATION_OF,Administration occupational activities,32621013,10.1007/s00247-020-04749-3,2020-07-06
Fever,ISA,Symptoms,32620975,10.1093/jamia/ocaa116,2020-07-06
Basis,TREATS,Disease,32620916,10.1038/s41379-020-0613-1,2020-07-06
Bone marrow biopsy,ADMINISTERED_TO,Patients,32620916,10.1038/s41379-020-0613-1,2020-07-06
Blood capillaries,PART_OF,Alveolar,32620916,10.1038/s41379-020-0613-1,2020-07-06
Microthrombus,COEXISTS_WITH,diffuse alveolar damage,32620916,10.1038/s41379-020-0613-1,2020-07-06
Macrophage Activation Syndrome,PROCESS_OF,Patients,32620916,10.1038/s41379-020-0613-1,2020-07-06
Nurses,DIAGNOSES,Communicable Diseases,32620713,10.18632/aging.103533,2020-07-06
Nurses,DIAGNOSES,Communicable Diseases,32620713,10.18632/aging.103533,2020-07-06
Experience,PROCESS_OF,Nurses,32620713,10.18632/aging.103533,2020-07-06
Experience,PROCESS_OF,Nurses,32620713,10.18632/aging.103533,2020-07-06
Mental problem,PROCESS_OF,Nurses,32620713,10.18632/aging.103533,2020-07-06
Stress,PROCESS_OF,Nurses,32620713,10.18632/aging.103533,2020-07-06
Pneumonia,PROCESS_OF,Patients,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,ASSOCIATED_WITH,Pneumonia,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,INHIBITS,Interleukin-6,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,TREATS,Patients,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,TREATS,Patients,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,TREATS(INFER),Pneumonia,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
sarilumab,TREATS,Patients,32620597,10.1136/annrheumdis-2020-218122,2020-07-06
Patients,ISA,Persons,32620593,10.7861/clinmed.2020-0388,2020-07-06
Decision,PROCESS_OF,Health Personnel,32620592,10.7861/clinmed.2020-0438,2020-07-06
Laboratory Procedures,USES,Buccal smear procedure,32620590,10.7861/clinmed.2020-0373,2020-07-06
Buccal smear procedure,ISA,Laboratory Procedures,32620590,10.7861/clinmed.2020-0373,2020-07-06
Laboratory Procedures,USES,Buccal smear procedure,32620590,10.7861/clinmed.2020-0373,2020-07-06
Buccal smear procedure,ISA,Laboratory Procedures,32620590,10.7861/clinmed.2020-0373,2020-07-06
Laboratory Procedures,USES,Buccal smear procedure,32620590,10.7861/clinmed.2020-0373,2020-07-06
Buccal smear procedure,ISA,Laboratory Procedures,32620590,10.7861/clinmed.2020-0373,2020-07-06
Multimers,AFFECTS,Virus Internalization,32620562,10.1126/sciimmunol.abd4758,2020-07-06
cytokine,DISRUPTS,Maternal Death,32620513,10.1016/j.ejogrb.2020.06.058,2020-07-06
Immune response,COEXISTS_WITH,Pregnancy,32620513,10.1016/j.ejogrb.2020.06.058,2020-07-06
Placenta,LOCATION_OF,ACE2 gene,32620513,10.1016/j.ejogrb.2020.06.058,2020-07-06
Lung,LOCATION_OF,Ultrasonography,32620500,10.1016/j.ejim.2020.06.031,2020-07-06
Acute respiratory failure,CAUSES,Cessation of life,32620500,10.1016/j.ejim.2020.06.031,2020-07-06
Cardiopulmonary Resuscitation,TREATS,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Cardiopulmonary Resuscitation,TREATS(INFER),Disease,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Disease,PROCESS_OF,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Interventional procedure,METHOD_OF,Cardiopulmonary Resuscitation,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Resuscitation procedure,TREATS,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Resuscitation procedure,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
"Central venous catheter, device",TREATS,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
"Central venous catheter, device",TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Cardiopulmonary Resuscitation,PREVENTS,Communicable Diseases,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Comorbidity,PROCESS_OF,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Resuscitation procedure,TREATS,Patients,32620487,10.1053/j.jvca.2020.06.008,2020-07-06
Recurrent Hematologic Malignancy,PROCESS_OF,Patients,32620465,10.1016/j.retram.2020.06.003,2020-07-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32620409,10.1016/j.transci.2020.102867,2020-07-06
GOT1 gene,compared_with,treatment options,32620409,10.1016/j.transci.2020.102867,2020-07-06
disease transmission,COEXISTS_WITH,Encounter due to being a liver donor,32620390,10.1016/j.transproceed.2020.06.004,2020-07-06
Postoperative infection,COEXISTS_WITH,Encounter due to being a liver donor,32620390,10.1016/j.transproceed.2020.06.004,2020-07-06
Coronavirus Infections,PROCESS_OF,Streptococcus pneumoniae,32620371,10.1016/j.vaccine.2020.06.069,2020-07-06
Serine Endopeptidases,PART_OF,integral to membrane,32620366,10.1016/j.purol.2020.05.007,2020-07-06
Antiandrogen therapy,ADMINISTERED_TO,Patients,32620366,10.1016/j.purol.2020.05.007,2020-07-06
Antiandrogen therapy,TREATS,Malignant neoplasm of prostate,32620366,10.1016/j.purol.2020.05.007,2020-07-06
Uncertainty,COEXISTS_WITH,Disease,32620315,10.1016/j.rgmx.2020.06.001,2020-07-06
Gastrointestinal Diseases,PROCESS_OF,Patients,32620315,10.1016/j.rgmx.2020.06.001,2020-07-06
Polymerase Chain Reaction,METHOD_OF,Diagnosis,32620311,10.1016/j.rce.2020.05.013,2020-07-06
Intravenous antibiotic therapy,TREATS,Patients,32620267,10.1016/j.jpedsurg.2020.06.024,2020-07-06
Duration,TREATS,Appendicitis,32620267,10.1016/j.jpedsurg.2020.06.024,2020-07-06
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32620267,10.1016/j.jpedsurg.2020.06.024,2020-07-06
Appendicitis,PROCESS_OF,Child,32620267,10.1016/j.jpedsurg.2020.06.024,2020-07-06
Appendicitis,PROCESS_OF,Patients,32620267,10.1016/j.jpedsurg.2020.06.024,2020-07-06
Upper respiratory sample,PART_OF,Tract,32620182,10.3201/eid2609.201590,2020-07-06
Disease,PROCESS_OF,Woman,32620180,10.3201/eid2610.202328,2020-07-06
Coronavirus Infections,ISA,Disease,32620180,10.3201/eid2610.202328,2020-07-06
Coronavirus Infections,PROCESS_OF(SPEC),Woman,32620180,10.3201/eid2610.202328,2020-07-06
Detection,TREATS,Infant,32620180,10.3201/eid2610.202328,2020-07-06
"Signs and Symptoms, Respiratory",PROCESS_OF,Persons,32620178,10.3201/eid2610.202296,2020-07-06
Coronavirus Infections,ISA,Disease,32620177,10.3201/eid2610.201113,2020-07-06
intensive care unit,LOCATION_OF,Administration occupational activities,32620174,10.1186/s13063-020-04533-6,2020-07-06
Study,USES,Medical Devices,32620174,10.1186/s13063-020-04533-6,2020-07-06
Patient ventilated,PROCESS_OF,Patients,32620174,10.1186/s13063-020-04533-6,2020-07-06
Interventional procedure,PRECEDES,Intermittent Positive-Pressure Ventilation,32620174,10.1186/s13063-020-04533-6,2020-07-06
Study Coordinating Center,LOCATION_OF,Randomization,32620174,10.1186/s13063-020-04533-6,2020-07-06
CT of lungs,DIAGNOSES,Chromosome 2q32-Q33 Deletion Syndrome,32620144,10.1186/s13063-020-04534-5,2020-07-06
Blood Coagulation Disorders,PROCESS_OF,Patients,32620144,10.1186/s13063-020-04534-5,2020-07-06
Hemorrhage,PROCESS_OF,Patients,32620144,10.1186/s13063-020-04534-5,2020-07-06
intensive care unit,LOCATION_OF,Administration occupational activities,32620144,10.1186/s13063-020-04534-5,2020-07-06
Lung,LOCATION_OF,Blood Coagulation Disorders,32620144,10.1186/s13063-020-04534-5,2020-07-06
Lung,LOCATION_OF,Hemorrhage,32620144,10.1186/s13063-020-04534-5,2020-07-06
Multiple Organ Failure,PROCESS_OF,Patients,32620144,10.1186/s13063-020-04534-5,2020-07-06
Patients,USES,Implants,32620144,10.1186/s13063-020-04534-5,2020-07-06
Patients,USES,Pacemakers,32620144,10.1186/s13063-020-04534-5,2020-07-06
Respiratory Failure,PROCESS_OF,Patients,32620144,10.1186/s13063-020-04534-5,2020-07-06
Severe cognitive impairment,PROCESS_OF,Patients,32620144,10.1186/s13063-020-04534-5,2020-07-06
Lactation established in non-human animal,PROCESS_OF,Woman,32620144,10.1186/s13063-020-04534-5,2020-07-06
Hospitals,LOCATION_OF,Study,32620144,10.1186/s13063-020-04534-5,2020-07-06
Hospitals,LOCATION_OF,Retrospective Studies,32620125,10.1186/s12967-020-02423-8,2020-07-06
Coronavirus Infections,ISA,Disease,32620125,10.1186/s12967-020-02423-8,2020-07-06
Coronavirus Infections,PROCESS_OF,Patients,32620125,10.1186/s12967-020-02423-8,2020-07-06
Symptom mild,PROCESS_OF,Patients,32620125,10.1186/s12967-020-02423-8,2020-07-06
risk factors,PREDISPOSES,Disease Progression,32620125,10.1186/s12967-020-02423-8,2020-07-06
Symptoms,PROCESS_OF,Patients,32620118,10.1186/s12931-020-01428-7,2020-07-06
Hospitals,LOCATION_OF,Retrospective Studies,32620118,10.1186/s12931-020-01428-7,2020-07-06
Patients,LOCATION_OF,Fibrin fragment D,32620118,10.1186/s12931-020-01428-7,2020-07-06
Cessation of life,PROCESS_OF,Patients,32620118,10.1186/s12931-020-01428-7,2020-07-06
Cessation of life,PROCESS_OF(SPEC),Survivors,32620118,10.1186/s12931-020-01428-7,2020-07-06
Patients,LOCATION_OF,Fibrin fragment D,32620118,10.1186/s12931-020-01428-7,2020-07-06
Survivors,ISA,Patients,32620118,10.1186/s12931-020-01428-7,2020-07-06
Survivors,LOCATION_OF(SPEC),Fibrin fragment D,32620118,10.1186/s12931-020-01428-7,2020-07-06
Cessation of life,PROCESS_OF,Patients,32620118,10.1186/s12931-020-01428-7,2020-07-06
Hospitalization,TREATS,Patients,32620118,10.1186/s12931-020-01428-7,2020-07-06
Challenge,TREATS,Community,32620062,10.1080/1744666X.2020.1792778,2020-07-06
Mental health problem,PROCESS_OF,Pregnant Women,32620037,10.1002/ijgo.13295,2020-07-04
Mental health problem,PROCESS_OF,Woman,32620037,10.1002/ijgo.13295,2020-07-04
Breast Feeding,PROCESS_OF,Woman,32620037,10.1002/ijgo.13295,2020-07-04
Surgical face mask,USES,disposable,32620033,10.1111/jocn.15401,2020-07-04
Masks,USES,Textiles,32620033,10.1111/jocn.15401,2020-07-04
Chart evaluation by healthcare professional,METHOD_OF,Hospital admission,32620027,10.1111/ane.13307,2020-07-04
Hospital admission,TREATS,Transient Ischemic Attack,32620027,10.1111/ane.13307,2020-07-04
Hospital admission,TREATS,Cerebrovascular accident,32620027,10.1111/ane.13307,2020-07-04
Pandemics,CAUSES,Transient Ischemic Attack,32620027,10.1111/ane.13307,2020-07-04
Pandemics,CAUSES,Cerebrovascular accident,32620027,10.1111/ane.13307,2020-07-04
Birth,PROCESS_OF,Cohort,32620022,10.1055/s-0040-1714060,2020-07-04
Hospitals,LOCATION_OF,Observational Study,32620022,10.1055/s-0040-1714060,2020-07-04
Screening procedure,TREATS,Woman,32620022,10.1055/s-0040-1714060,2020-07-04
Non-Ossifying Fibroma,PROCESS_OF,Woman,32620022,10.1055/s-0040-1714060,2020-07-04
Headache,PROCESS_OF,Woman,32620022,10.1055/s-0040-1714060,2020-07-04
Integrated Health Care Systems,LOCATION_OF,Laboratory Procedures,32620022,10.1055/s-0040-1714060,2020-07-04
Severe Acute Respiratory Syndrome,OCCURS_IN,Cohort,32620022,10.1055/s-0040-1714060,2020-07-04
Detection,NEG_TREATS,Age,32619956,10.1016/j.intimp.2020.106746,2020-07-04
Detection,NEG_TREATS,Gender,32619956,10.1016/j.intimp.2020.106746,2020-07-04
Detection,TREATS,Patients,32619956,10.1016/j.intimp.2020.106746,2020-07-04
Laboratory Procedures,DIAGNOSES,Severe Acute Respiratory Syndrome,32619956,10.1016/j.intimp.2020.106746,2020-07-04
Pandemics,ISA,Disease Outbreaks,32619845,10.1016/j.scitotenv.2020.140563,2020-07-04
Dispenser,USES,sanitizers,32619843,10.1016/j.scitotenv.2020.140540,2020-07-04
Airborne precautions,ISA,Isolation procedure,32619843,10.1016/j.scitotenv.2020.140540,2020-07-04
Coronavirus Infections,ISA,Disease,32619842,10.1016/j.scitotenv.2020.140524,2020-07-04
Laboratory,LOCATION_OF,Quantitative Reverse Transcriptase PCR,32619841,10.1016/j.scitotenv.2020.140370,2020-07-04
Instrument - device,DIAGNOSES,Virus,32619841,10.1016/j.scitotenv.2020.140370,2020-07-04
Mental disorders,AFFECTS,Patients,32619835,10.1016/j.ajp.2020.102270,2020-07-04
Cross Infection,PROCESS_OF,Patients,32619835,10.1016/j.ajp.2020.102270,2020-07-04
Cross Infection,PROCESS_OF,Staff,32619835,10.1016/j.ajp.2020.102270,2020-07-04
flu symptoms,PROCESS_OF,Patients,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Asthma,ISA,Disease,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Asthma,PROCESS_OF(SPEC),Persons,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Asthma,PROCESS_OF(SPEC),Old age,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Disease,PROCESS_OF,Persons,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Disease,PROCESS_OF,Old age,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Lethal,PROCESS_OF,Persons,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Lethal,PROCESS_OF,Old age,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Protein p53,INTERACTS_WITH,Protein Subunits,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Tumor Suppressor Proteins,INTERACTS_WITH,Protein Subunits,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Coronavirus Infections,AFFECTS,Cancer Patient,32619819,10.1016/j.tranon.2020.100814,2020-07-04
Severe disorder,PROCESS_OF,Patients,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Superinfection,COEXISTS_WITH,Pulmonary Infiltrate,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Superinfection,PROCESS_OF,Patients,32619773,10.1016/j.clinimag.2020.06.004,2020-07-04
Patients,LOCATION_OF,Plasma specimen,32619764,10.1016/j.ijid.2020.06.093,2020-07-04
Critical Illness,PROCESS_OF,Patients,32619764,10.1016/j.ijid.2020.06.093,2020-07-04
Respiratory distress,PROCESS_OF,Patients,32619764,10.1016/j.ijid.2020.06.093,2020-07-04
Adrenal Cortex Hormones,TREATS,Diarrhea,32619760,10.1016/j.ijid.2020.06.091,2020-07-04
Diarrhea,PROCESS_OF,Patients,32619760,10.1016/j.ijid.2020.06.091,2020-07-04
Diarrhea,PROCESS_OF,Patients,32619760,10.1016/j.ijid.2020.06.091,2020-07-04
Reverse Transcriptase Polymerase Chain Reaction,USES,Laboratory,32619756,10.1016/j.ijid.2020.06.089,2020-07-04
RNA Viruses,PROCESS_OF,Homo sapiens,32619669,10.1016/j.micpath.2020.104365,2020-07-04
Coagulation procedure,AFFECTS,Inflammation,32619549,10.1016/j.cels.2020.05.012,2020-07-04
Laboratory,LOCATION_OF,Work,32619510,10.1016/j.stem.2020.06.011,2020-07-04
Complication,COEXISTS_WITH,Blood Coagulation Disorders,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Thrombus,COEXISTS_WITH,Blood Coagulation Disorders,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
cell injury,COEXISTS_WITH,Blood Coagulation Disorders,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
P-Selectin,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Thrombomodulin,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
CD40 Ligand,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
von Willebrand factor,compared_with,P-Selectin,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
P-Selectin,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Thrombomodulin,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Thrombomodulin,ASSOCIATED_WITH,Critical Illness,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Thrombomodulin,PART_OF,soluble,32619411,10.1016/S2352-3026(20)30216-7,2020-07-04
Frailty,PROCESS_OF,Persons,32619408,10.1016/S2468-2667(20)30146-8,2020-07-04
Hospitals,LOCATION_OF,Observational Study,32619408,10.1016/S2468-2667(20)30146-8,2020-07-04
Frailty,PROCESS_OF,Patients,32619408,10.1016/S2468-2667(20)30146-8,2020-07-04
medical care,PROCESS_OF,Patients,32619408,10.1016/S2468-2667(20)30146-8,2020-07-04
Virus,INTERACTS_WITH,Severe Acute Respiratory Syndrome,32619390,10.1080/22221751.2020.1791737,2020-07-04
Proteome,PART_OF,Host Cell,32619390,10.1080/22221751.2020.1791737,2020-07-04
intensive care unit,LOCATION_OF,Administration occupational activities,32619360,10.1080/07853890.2020.1791355,2020-07-04
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32619360,10.1080/07853890.2020.1791355,2020-07-04
Hemorrhage,PROCESS_OF,Patients,32619360,10.1080/07853890.2020.1791355,2020-07-04
Interventional procedure,TREATS,Imbalance,32619360,10.1080/07853890.2020.1791355,2020-07-04
Prophylactic treatment,TREATS,Imbalance,32619360,10.1080/07853890.2020.1791355,2020-07-04
American College of Cardiology/American Heart Association Lesion Complexity Score C,PREDISPOSES,Hemorrhage,32619360,10.1080/07853890.2020.1791355,2020-07-04
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32619360,10.1080/07853890.2020.1791355,2020-07-04
Anticoagulants,TREATS,Patients,32619329,10.1111/jth.14988,2020-07-04
Fibrin fragment D,STIMULATES,Plasmin,32619329,10.1111/jth.14988,2020-07-04
Fibrin fragment D,STIMULATES,Thrombin,32619329,10.1111/jth.14988,2020-07-04
Blood Coagulation Disorders,PROCESS_OF,Patients,32619329,10.1111/jth.14988,2020-07-04
Plasmin,TREATS,Patients,32619329,10.1111/jth.14988,2020-07-04
Plasmin,TREATS(INFER),Blood Coagulation Disorders,32619329,10.1111/jth.14988,2020-07-04
Thrombosis,OCCURS_IN,Patients,32619328,10.1111/jth.14994,2020-07-04
Patients,LOCATION_OF,Antiphospholipid Antibodies,32619328,10.1111/jth.14994,2020-07-04
Thrombus,PROCESS_OF,Patients,32619328,10.1111/jth.14994,2020-07-04
Toxic Epidermal Necrolysis,NEG_PROCESS_OF,Patients,32619328,10.1111/jth.14994,2020-07-04
Registration,TREATS,Patients,32619328,10.1111/jth.14994,2020-07-04
Community,LOCATION_OF,IMPACT gene,32619327,10.1111/jpc.15018,2020-07-04
RNA Viruses,INTERACTS_WITH,SARS coronavirus,32619318,10.1111/tbed.13710,2020-07-04
RNA Viruses,INTERACTS_WITH,Middle East Respiratory Syndrome Coronavirus,32619318,10.1111/tbed.13710,2020-07-04
Obesity,PROCESS_OF,Adult,32619294,10.1002/oby.22951,2020-07-04
Obesity,PREDISPOSES,complication of disease,32619294,10.1002/oby.22951,2020-07-04
complication of disease,PROCESS_OF,Young Adult,32619294,10.1002/oby.22951,2020-07-04
Pandemics,ISA,Disease Outbreaks,32619280,10.1111/ced.14365,2020-07-04
Hepatitis B Surface Antigen Vaccine,TREATS,Problem,32619279,10.1002/hep.31445,2020-07-04
Pneumonia,ISA,Communicable Diseases,32619276,10.1002/mp.14367,2020-07-04
Microbicides,TREATS,Coronavirus Infections,32619190,10.1556/030.2020.01199,2020-07-04
Coronavirus Infections,ISA,Disease,32619184,10.2196/20040,2020-07-04
Coronavirus Infections,ISA,Disease,32619184,10.2196/20040,2020-07-04
Complementary therapies,TREATS,Coronavirus Infections,32619167,10.2174/1389201021666200703201458,2020-07-04
novel AODU treatment method,TREATS,Genus: Coronavirus,32619167,10.2174/1389201021666200703201458,2020-07-04
Pharmaceutical Preparations,TREATS,Disease,32619162,10.1080/07391102.2020.1787864,2020-07-04
Vaccines,TREATS,Disease,32619162,10.1080/07391102.2020.1787864,2020-07-04
Hematological Disease,PROCESS_OF,Patients,32619062,10.1002/jmv.26251,2020-07-04
Hematological Disease,PROCESS_OF,Hematologist,32619062,10.1002/jmv.26251,2020-07-04
Liver,LOCATION_OF,diseases and injuries,32619043,10.1002/hep.31447,2020-07-04
Liver,LOCATION_OF,diseases and injuries,32619043,10.1002/hep.31447,2020-07-04
Therapeutic procedure,TREATS,Hematological Disease,32619034,10.1111/cas.14544,2020-07-04
Respiratory physiology,PROCESS_OF,Adult,32619007,10.1093/aje/kwaa126,2020-07-04
Wounds and Injuries,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Wounds and Injuries,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Present,COEXISTS_WITH,Symptoms,32618968,10.1097/TA.0000000000002870,2020-07-04
Present,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Wounds and Injuries,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Infected,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
"Signs and Symptoms, Respiratory",PROCESS_OF,Population Group,32618968,10.1097/TA.0000000000002870,2020-07-04
Wounds and Injuries,PROCESS_OF,Population Group,32618968,10.1097/TA.0000000000002870,2020-07-04
Wounds and Injuries,PROCESS_OF,Patients,32618968,10.1097/TA.0000000000002870,2020-07-04
Viral Shedding,PROCESS_OF,Child,32618932,10.1097/INF.0000000000002814,2020-07-04
Viral Shedding,PROCESS_OF,Patients,32618932,10.1097/INF.0000000000002814,2020-07-04
Coronavirus Infections,PREDISPOSES,Infection,32618918,10.2106/JBJS.20.00715,2020-07-04
Infection,PROCESS_OF,Population Group,32618918,10.2106/JBJS.20.00715,2020-07-04
Infected,PROCESS_OF,Older people,32618917,10.2106/JBJS.20.00686,2020-07-04
Hip Fractures,PROCESS_OF,Patients,32618917,10.2106/JBJS.20.00686,2020-07-04
"CD69 protein, human",ASSOCIATED_WITH,Hip Fractures,32618917,10.2106/JBJS.20.00686,2020-07-04
Femoral Fractures,PROCESS_OF,Cohort,32618917,10.2106/JBJS.20.00686,2020-07-04
Hip Fractures,PROCESS_OF,Patients,32618917,10.2106/JBJS.20.00686,2020-07-04
Operative Surgical Procedures,TREATS,Patients,32618917,10.2106/JBJS.20.00686,2020-07-04
Hip Fractures,PROCESS_OF,Patients,32618917,10.2106/JBJS.20.00686,2020-07-04
Coronavirus Infections,ISA,Disease,32618917,10.2106/JBJS.20.00686,2020-07-04
Health Care Systems,LOCATION_OF,Study,32618916,10.2106/JBJS.20.00602,2020-07-04
Drapes (device),USES,Personal protective equipment,32618914,10.2106/JBJS.20.00567,2020-07-04
Intramedullary Nailing,ADMINISTERED_TO,Surgeon,32618914,10.2106/JBJS.20.00567,2020-07-04
Intramedullary Nailing,TREATS,Patients,32618914,10.2106/JBJS.20.00567,2020-07-04
Occupational Exposure,PROCESS_OF,Surgeon,32618914,10.2106/JBJS.20.00567,2020-07-04
Coronavirus Infections,CAUSES,Disease,32618909,10.2106/JBJS.20.00532,2020-07-04
Fracture,PROCESS_OF,Patients,32618909,10.2106/JBJS.20.00532,2020-07-04
Orthopedic department,LOCATION_OF,Study,32618909,10.2106/JBJS.20.00532,2020-07-04
Ward (environment),LOCATION_OF,Study,32618909,10.2106/JBJS.20.00532,2020-07-04
Infected,PROCESS_OF,Patients,32618909,10.2106/JBJS.20.00532,2020-07-04
Surgical Management,TREATS,Patients,32618909,10.2106/JBJS.20.00532,2020-07-04
Surgical Management,TREATS(INFER),Infected,32618909,10.2106/JBJS.20.00532,2020-07-04
follow-up,TREATS,Patients,32618909,10.2106/JBJS.20.00532,2020-07-04
follow-up,TREATS(INFER),Infected,32618909,10.2106/JBJS.20.00532,2020-07-04
Fracture,PROCESS_OF,Patients,32618909,10.2106/JBJS.20.00532,2020-07-04
Paresthesia,PROCESS_OF,Family,32618839,10.1097/NRL.0000000000000291,2020-07-04
Limb structure,LOCATION_OF,General areflexia,32618839,10.1097/NRL.0000000000000291,2020-07-04
treatment options,TREATS,Pregnant Women,32618794,10.1097/AOG.0000000000004050,2020-07-04
Nasal Swab (procedure),DIAGNOSES,Infiltration,32618794,10.1097/AOG.0000000000004050,2020-07-04
tocilizumab,TREATS,Patients,32618794,10.1097/AOG.0000000000004050,2020-07-04
Disease,PROCESS_OF,Mother (person),32618790,10.1097/MOP.0000000000000931,2020-07-04
Vaccination,TREATS,"Infant, Newborn",32618790,10.1097/MOP.0000000000000931,2020-07-04
Confirmation,PROCESS_OF,Mother (person),32618790,10.1097/MOP.0000000000000931,2020-07-04
Thrombophilia,PROCESS_OF,Patients,32618705,10.1097/DAD.0000000000001733,2020-07-04
Asymptomatic,PROCESS_OF,Patients,32618705,10.1097/DAD.0000000000001733,2020-07-04
Chilblains,PROCESS_OF,Patients,32618705,10.1097/DAD.0000000000001733,2020-07-04
Chilblains,PROCESS_OF,Patients,32618705,10.1097/DAD.0000000000001733,2020-07-04
Pulmonary Embolism,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Pulmonary Embolism,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Venous Thromboembolism,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Pulmonary Embolism,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,NEG_PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
thrombotic occlusion,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Hemorrhage,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Heparin-induced thrombocytopenia,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Critical Illness,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Venous Thromboembolism,PROCESS_OF,Patients,32618700,10.1097/CCM.0000000000004504,2020-07-04
Critical Illness,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Hospitals,LOCATION_OF,Study,32618699,10.1097/CCM.0000000000004472,2020-07-04
Ultrasonography,ISA,Evaluation,32618699,10.1097/CCM.0000000000004472,2020-07-04
Evaluation,USES,Ultrasonography,32618699,10.1097/CCM.0000000000004472,2020-07-04
Venous Thromboembolism,OCCURS_IN,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Patients,LOCATION_OF,Fibrin fragment D,32618699,10.1097/CCM.0000000000004472,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Treatment Protocols,USES,"Condoms, Male",32618699,10.1097/CCM.0000000000004472,2020-07-04
Critical Illness,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Ultrasonography,ISA,Evaluation,32618699,10.1097/CCM.0000000000004472,2020-07-04
Venous Thrombosis,PROCESS_OF,Patients,32618699,10.1097/CCM.0000000000004472,2020-07-04
Evaluation,USES,Ultrasonography,32618699,10.1097/CCM.0000000000004472,2020-07-04
Pandemics,ISA,Disease Outbreaks,32618693,10.1097/CCM.0000000000004473,2020-07-04
lifesaving,TREATS,Respiratory distress,32618693,10.1097/CCM.0000000000004473,2020-07-04
Fatal Outcome,COEXISTS_WITH,risk factors,32618693,10.1097/CCM.0000000000004473,2020-07-04
Fatal Outcome,COEXISTS_WITH,patient condition,32618693,10.1097/CCM.0000000000004473,2020-07-04
Invasive mechanical ventilation NOS,compared_with,Mechanical ventilation,32618693,10.1097/CCM.0000000000004473,2020-07-04
Gastrointestinal symptom,PROCESS_OF,Patients,32618665,10.14309/ajg.0000000000000712,2020-07-04
Digestive symptom,PROCESS_OF,Patients,32618665,10.14309/ajg.0000000000000712,2020-07-04
Elevated liver enzymes level,PROCESS_OF,Patients,32618658,10.14309/ajg.0000000000000717,2020-07-04
Elevated liver enzymes level,PROCESS_OF,Patients,32618658,10.14309/ajg.0000000000000717,2020-07-04
Elevated liver enzymes level,PROCESS_OF,Patients,32618658,10.14309/ajg.0000000000000717,2020-07-04
Musculoskeletal Pain,PROCESS_OF,Patients,32618600,10.1097/JCMA.0000000000000376,2020-07-04
Coronavirus Infections,CAUSES,Malaise,32618547,10.1017/dmp.2020.197,2020-07-04
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,Patients,32618530,10.1017/ice.2020.321,2020-07-04
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,Staff,32618530,10.1017/ice.2020.321,2020-07-04
Multiple interventional procedures,TREATS,Patients,32618530,10.1017/ice.2020.321,2020-07-04
Health Personnel,DIAGNOSES,Secondary Infections,32618530,10.1017/ice.2020.321,2020-07-04
Secondary Infections,PROCESS_OF,Health Personnel,32618530,10.1017/ice.2020.321,2020-07-04
Infected,PROCESS_OF,Patients,32618530,10.1017/ice.2020.321,2020-07-04
Predisposition -- attribute,ASSOCIATED_WITH,Disease,32618498,10.1177/1747493020943815,2020-07-04
Predisposition -- attribute,ASSOCIATED_WITH,Cerebrovascular accident,32618498,10.1177/1747493020943815,2020-07-04
Infected,PROCESS_OF,Persons,32618498,10.1177/1747493020943815,2020-07-04
Antibody Formation,AFFECTS,Disease Progression,32618497,10.1080/22221751.2020.1791738,2020-07-04
High antibody titer,COEXISTS_WITH,Fever,32618497,10.1080/22221751.2020.1791738,2020-07-04
Clinician,TREATS,Patients,32618466,10.1590/S1677-5538.IBJU.2020.S126,2020-07-04
Emergency medical service,ADMINISTERED_TO,Patients,32618465,10.1590/S1677-5538.IBJU.2020.S125,2020-07-04
Health Personnel,TREATS,Patients,32618465,10.1590/S1677-5538.IBJU.2020.S125,2020-07-04
Terminal illness,CAUSES,"Signs and Symptoms, Respiratory",32618463,10.1590/S1677-5538.IBJU.2020.S123,2020-07-04
Telemedicine,METHOD_OF,follow-up,32618463,10.1590/S1677-5538.IBJU.2020.S123,2020-07-04
Clinical Protocols,TREATS,inpatient,32618462,10.1590/S1677-5538.IBJU.2020.S119,2020-07-04
Clinical Protocols,TREATS,Outpatients,32618462,10.1590/S1677-5538.IBJU.2020.S119,2020-07-04
Practice Experience,PROCESS_OF,Hispanics,32618462,10.1590/S1677-5538.IBJU.2020.S119,2020-07-04
Medical dressing,USES,"Condoms, Male",32618418,10.1111/iwj.13435,2020-07-04
Face,LOCATION_OF,Pressure Ulcer,32618418,10.1111/iwj.13435,2020-07-04
Illness (finding),PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Lung Injury,PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Acute respiratory distress,PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Coronavirus Infections,ISA,Disease,32618402,10.1111/dth.13961,2020-07-04
Biological Response Modifier Therapy,USES,Immunosuppressive Agents,32618402,10.1111/dth.13961,2020-07-04
"Arthritis, Psoriatic",PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Psoriasis,PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Infected,PROCESS_OF,Patients,32618402,10.1111/dth.13961,2020-07-04
Infected,PROCESS_OF,spouse,32618402,10.1111/dth.13961,2020-07-04
Cessation of life,PROCESS_OF,Minority Groups,32618332,10.1093/pubmed/fdaa096,2020-07-04
Nance-Horan syndrome,PROCESS_OF,Community,32618332,10.1093/pubmed/fdaa096,2020-07-04
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Personal protective equipment,32618332,10.1093/pubmed/fdaa096,2020-07-04
Cessation of life,PROCESS_OF,Ethnic group,32618332,10.1093/pubmed/fdaa096,2020-07-04
Pneumonia,PROCESS_OF,traveler,32618261,10.4269/ajtmh.20-0597,2020-07-04
Lung,LOCATION_OF,Computed Tomography Angiography,32618261,10.4269/ajtmh.20-0597,2020-07-04
Computed Tomography Angiography,ADMINISTERED_TO,traveler,32618261,10.4269/ajtmh.20-0597,2020-07-04
Pneumonia,PROCESS_OF,traveler,32618261,10.4269/ajtmh.20-0597,2020-07-04
Lung,LOCATION_OF,Computed Tomography Angiography,32618261,10.4269/ajtmh.20-0597,2020-07-04
Pulmonary Embolism,PROCESS_OF,Patients,32618261,10.4269/ajtmh.20-0597,2020-07-04
Pulmonary Embolism,PROCESS_OF,Patients,32618261,10.4269/ajtmh.20-0597,2020-07-04
Deep Vein Thrombosis,PROCESS_OF,Patients,32618261,10.4269/ajtmh.20-0597,2020-07-04
Fever,ISA,Symptoms,32618260,10.4269/ajtmh.20-0564,2020-07-04
Symptoms,COEXISTS_WITH,Coughing,32618260,10.4269/ajtmh.20-0564,2020-07-04
Symptoms,COEXISTS_WITH,Fever,32618260,10.4269/ajtmh.20-0564,2020-07-04
Dipeptidyl-Peptidase IV,INTERACTS_WITH,"M Protein, multiple myeloma",32618198,10.1177/1074248420937868,2020-07-04
Dipeptidyl-Peptidase IV,PART_OF,Homo sapiens,32618198,10.1177/1074248420937868,2020-07-04
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32618198,10.1177/1074248420937868,2020-07-04
Incretins,TREATS,Patients,32618198,10.1177/1074248420937868,2020-07-04
Incretins,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32618198,10.1177/1074248420937868,2020-07-04
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32618198,10.1177/1074248420937868,2020-07-04
Treatment Protocols,TREATS,Patients,32618198,10.1177/1074248420937868,2020-07-04
Treatment Protocols,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32618198,10.1177/1074248420937868,2020-07-04
Treatment Protocols,USES,Antidiabetics,32618198,10.1177/1074248420937868,2020-07-04
Complication,COEXISTS_WITH,Disease,32618041,10.1111/jdv.16801,2020-07-04
Chilblains,PROCESS_OF,Child,32618041,10.1111/jdv.16801,2020-07-04
Retinal Vasculitis,PROCESS_OF,Child,32618041,10.1111/jdv.16801,2020-07-04
Chilblains,ISA,Disease,32618033,10.1111/jdv.16800,2020-07-04
Chilblains,PROCESS_OF,Child,32618033,10.1111/jdv.16800,2020-07-04
Chilblains,PROCESS_OF,Adolescent (age group),32618033,10.1111/jdv.16800,2020-07-04
Health care facility,LOCATION_OF,Study,32617990,10.1002/lary.28957,2020-07-04
Olfaction Disorders,PROCESS_OF,Patients,32617990,10.1002/lary.28957,2020-07-04
arbidol,AFFECTS,Day 7,32617989,10.1002/jmv.26256,2020-07-04
arbidol,TREATS,Patients,32617989,10.1002/jmv.26256,2020-07-04
arbidol,TREATS,Patients,32617989,10.1002/jmv.26256,2020-07-04
Coronavirus Infections,CAUSES,Cessation of life,32617987,10.1002/jmv.26254,2020-07-04
Therapeutic procedure,USES,cytokine,32617987,10.1002/jmv.26254,2020-07-04
Laboratory Procedures,METHOD_OF,Diagnosis,32617987,10.1002/jmv.26254,2020-07-04
Cross Reactions,CAUSES,stem cell factor receptor activity,32617987,10.1002/jmv.26254,2020-07-04
Cessation of life,PROCESS_OF,inpatient,32617986,10.1002/jmv.26252,2020-07-04
Diabetes,PROCESS_OF,hospitalized patients,32617986,10.1002/jmv.26252,2020-07-04
Hypertensive disease,PROCESS_OF,hospitalized patients,32617986,10.1002/jmv.26252,2020-07-04
Cessation of life,PROCESS_OF,inpatient,32617986,10.1002/jmv.26252,2020-07-04
Wounds and Injuries,PROCESS_OF,Patients,32617984,10.1002/jso.26092,2020-07-04
Isolation procedure,PREVENTS,"Infections, Hospital",32617984,10.1002/jso.26092,2020-07-04
Cross-Sectional Studies,USES,Reverse Transcriptase Polymerase Chain Reaction,32617983,10.1002/lary.28964,2020-07-04
Nose,LOCATION_OF,Obstruction,32617983,10.1002/lary.28964,2020-07-04
Depressed mood,COEXISTS_WITH,Ageusia,32617983,10.1002/lary.28964,2020-07-04
Department,LOCATION_OF,Diagnosis,32617968,10.1111/idj.12603,2020-07-04
Maxillofacial Injuries,PROCESS_OF,Patients,32617968,10.1111/idj.12603,2020-07-04
Toothache,PROCESS_OF,Patients,32617968,10.1111/idj.12603,2020-07-04
Infection,PROCESS_OF,Patients,32617968,10.1111/idj.12603,2020-07-04
Medication Management,TREATS,Acute pulpitis,32617968,10.1111/idj.12603,2020-07-04
Accident and Emergency department,LOCATION_OF,Services,32617968,10.1111/idj.12603,2020-07-04
Pharmaceutical Preparations,AFFECTS,Severe (severity modifier),32617864,10.1007/s40199-020-00358-5,2020-07-04
Crisis,COEXISTS_WITH,Enthesitis-Related Arthritis,32617864,10.1007/s40199-020-00358-5,2020-07-04
Viral Genome,LOCATION_OF,"Transcription, Genetic",32617855,10.1007/s12539-020-00381-9,2020-07-04
In prison (finding),PROCESS_OF,Persons,32617825,10.1186/s40352-020-00119-1,2020-07-04
In prison (finding),PROCESS_OF,Persons,32617825,10.1186/s40352-020-00119-1,2020-07-04
Blood Coagulation Disorders,CAUSES,Venous Thromboembolism,32617807,10.1007/s11239-020-02202-8,2020-07-04
Critical Illness,PROCESS_OF,Patients,32617807,10.1007/s11239-020-02202-8,2020-07-04
Negative,PROCESS_OF,Patients,32617807,10.1007/s11239-020-02202-8,2020-07-04
Multiple Sclerosis,PROCESS_OF,Patients,32617741,10.1007/s10072-020-04519-x,2020-07-04
Therapeutic procedure,USES,Cladribine,32617741,10.1007/s10072-020-04519-x,2020-07-04
Creatine Kinase,ASSOCIATED_WITH,Arthralgia,32617738,10.1007/s10072-020-04525-z,2020-07-04
Creatine Kinase,ASSOCIATED_WITH,Headache,32617738,10.1007/s10072-020-04525-z,2020-07-04
Olfaction Disorders,ISA,Symptoms,32617738,10.1007/s10072-020-04525-z,2020-07-04
Arthralgia,COEXISTS_WITH,Symptoms,32617738,10.1007/s10072-020-04525-z,2020-07-04
Myalgia,COEXISTS_WITH,Symptoms,32617738,10.1007/s10072-020-04525-z,2020-07-04
Diagnosis,DIAGNOSES,Lesion,32617690,10.1007/s00330-020-07044-9,2020-07-04
Detection,TREATS,Participant,32617690,10.1007/s00330-020-07044-9,2020-07-04
Pneumonia,PROCESS_OF,Patients,32617690,10.1007/s00330-020-07044-9,2020-07-04
Pneumonia,PROCESS_OF,Patients,32617690,10.1007/s00330-020-07044-9,2020-07-04
lobe,LOCATION_OF,Pneumonia,32617690,10.1007/s00330-020-07044-9,2020-07-04
High sensitivity,DIAGNOSES,Pneumonia,32617690,10.1007/s00330-020-07044-9,2020-07-04
intensive care,PREVENTS,Disorder of eye,32617666,10.1007/s00347-020-01159-6,2020-07-04
intensive care,PREVENTS(SPEC),Lagophthalmos,32617666,10.1007/s00347-020-01159-6,2020-07-04
Lagophthalmos,ISA,Disorder of eye,32617666,10.1007/s00347-020-01159-6,2020-07-04
Subconjunctival hemorrhage,PROCESS_OF,Patients,32617666,10.1007/s00347-020-01159-6,2020-07-04
Eye,LOCATION_OF,Symptoms,32617666,10.1007/s00347-020-01159-6,2020-07-04
Attention,PROCESS_OF,Population Group,32617611,10.1007/s00063-020-00705-z,2020-07-04
Community,LOCATION_OF,IMPACT gene,32617414,10.1186/s41256-020-00159-y,2020-07-04
Persons,LOCATION_OF,IMPACT gene,32617414,10.1186/s41256-020-00159-y,2020-07-04
Anxiety,PROCESS_OF,Health Personnel,32617382,10.1093/ofid/ofaa230,2020-07-04
Health Personnel,LOCATION_OF,"TLR4 protein, human",32617382,10.1093/ofid/ofaa230,2020-07-04
United States,ISA,Country,32617365,10.3934/publichealth.2020033,2020-07-04
Practice Experience,PROCESS_OF,Homo sapiens,32617365,10.3934/publichealth.2020033,2020-07-04
Fever,ISA,Symptoms,32617354,10.3934/publichealth.2020022,2020-07-04
Diarrhea,ISA,Symptoms,32617354,10.3934/publichealth.2020022,2020-07-04
Sore Throat,ISA,Symptoms,32617354,10.3934/publichealth.2020022,2020-07-04
Vaccines,TREATS,Severe Acute Respiratory Syndrome,32617314,10.21037/atm-20-2793,2020-07-04
Drug Delivery Systems,TREATS,Severe Acute Respiratory Syndrome,32617314,10.21037/atm-20-2793,2020-07-04
China,ISA,Country,32617314,10.21037/atm-20-2793,2020-07-04
South Korea,ISA,Country,32617314,10.21037/atm-20-2793,2020-07-04
Incised wound,ISA,Disease,32617313,10.21037/atm-20-3989,2020-07-04
Disease,PROCESS_OF,Phasis,32617313,10.21037/atm-20-3989,2020-07-04
Peptide Hydrolases,PART_OF,Homo sapiens,32617313,10.21037/atm-20-3989,2020-07-04
Coronavirus Infections,ISA,Disease,32617309,10.21037/atm-20-1944,2020-07-04
Coronavirus Infections,ISA,Disease,32617309,10.21037/atm-20-1944,2020-07-04
Coronavirus Infections,ISA,Disease,32617309,10.21037/atm-20-1944,2020-07-04
Chest CT,AFFECTS,Screening procedure,32617299,10.21037/atm-20-2119a,2020-07-04
Evaluation,TREATS,Cohort,32617299,10.21037/atm-20-2119a,2020-07-04
Complication,PROCESS_OF,Patients,32617244,10.7759/cureus.8847,2020-07-04
Critical Illness,PROCESS_OF,Patients,32617244,10.7759/cureus.8847,2020-07-04
Lung,LOCATION_OF,Multiple emboli,32617244,10.7759/cureus.8847,2020-07-04
Complication,PROCESS_OF,Patients,32617244,10.7759/cureus.8847,2020-07-04
Coronavirus Infections,PREDISPOSES,Complication,32617244,10.7759/cureus.8847,2020-07-04
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32617244,10.7759/cureus.8847,2020-07-04
heparin,TREATS,Patients,32617244,10.7759/cureus.8847,2020-07-04
heparin,TREATS(INFER),Coronavirus Infections,32617244,10.7759/cureus.8847,2020-07-04
Warfarin,ISA,Anticoagulants,32617244,10.7759/cureus.8847,2020-07-04
Coronavirus Infections,PROCESS_OF,Patients,32617244,10.7759/cureus.8847,2020-07-04
Coronavirus Infections,CAUSES,Communicable Diseases,32617223,10.7759/cureus.8350,2020-07-04
Infected,PROCESS_OF,Persons,32617223,10.7759/cureus.8350,2020-07-04
Complication,AFFECTS,health and disease,32617223,10.7759/cureus.8350,2020-07-04
"Respiratory Distress Syndrome, Adult",AFFECTS(SPEC),health and disease,32617223,10.7759/cureus.8350,2020-07-04
"Respiratory Distress Syndrome, Adult",ISA,Complication,32617223,10.7759/cureus.8350,2020-07-04
Superinfection,CAUSES,Disease,32617223,10.7759/cureus.8350,2020-07-04
Analysis,USES,Drug Packaging,32617220,10.7759/cureus.8346,2020-07-04
Hydroxychloroquine,ISA,Antimalarials,32617169,10.1093/omcr/omaa042,2020-07-04
Hydroxychloroquine,TREATS,Possible,32617169,10.1093/omcr/omaa042,2020-07-04
Duration,AFFECTS,Pneumonia,32617169,10.1093/omcr/omaa042,2020-07-04
Duration,AFFECTS,Lung finding,32617169,10.1093/omcr/omaa042,2020-07-04
Duration,PREVENTS,Inflammation,32617169,10.1093/omcr/omaa042,2020-07-04
Duration,INHIBITS,Exacerbation,32617169,10.1093/omcr/omaa042,2020-07-04
Hydroxychloroquine,TREATS,patient condition,32617169,10.1093/omcr/omaa042,2020-07-04
Fever,PROCESS_OF,Woman,32617169,10.1093/omcr/omaa042,2020-07-04
Dry cough,PROCESS_OF,Woman,32617169,10.1093/omcr/omaa042,2020-07-04
Cardiovascular Diseases,PREDISPOSES,Poor outcome,32617121,10.15420/ecr.2020.22,2020-07-04
Cardiac complication,PROCESS_OF,Patients,32617121,10.15420/ecr.2020.22,2020-07-04
Author,DIAGNOSES,Severe Acute Respiratory Syndrome,32617121,10.15420/ecr.2020.22,2020-07-04
Virus,PROCESS_OF,World,32617078,10.1186/s12948-020-00127-4,2020-07-04
Lung,LOCATION_OF,Coronavirus Infections,32617050,10.14744/SEMB.2020.93709,2020-07-04
Hospitalization,PREVENTS,Accumulation,32617050,10.14744/SEMB.2020.93709,2020-07-04
Coronavirus Infections,PROCESS_OF,Patients,32617050,10.14744/SEMB.2020.93709,2020-07-04
Pandemics,ISA,Process,32617050,10.14744/SEMB.2020.93709,2020-07-04
Infection,AFFECTS,Patients,32617050,10.14744/SEMB.2020.93709,2020-07-04
Infection,PROCESS_OF,Patients,32617050,10.14744/SEMB.2020.93709,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32617050,10.14744/SEMB.2020.93709,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32617050,10.14744/SEMB.2020.93709,2020-07-04
Operative Surgical Procedures,TREATS,Malignant Neoplasms,32617050,10.14744/SEMB.2020.93709,2020-07-04
Coronavirus Infections,ISA,Disease,32617049,10.14744/SEMB.2020.23326,2020-07-04
Fever,ISA,Symptoms,32617049,10.14744/SEMB.2020.23326,2020-07-04
Coronavirus Infections,ISA,Disease,32617049,10.14744/SEMB.2020.23326,2020-07-04
Patients,USES,Preexisting Condition Coverage,32617049,10.14744/SEMB.2020.23326,2020-07-04
Patients,USES,Preexisting Condition Coverage,32617049,10.14744/SEMB.2020.23326,2020-07-04
Pneumonia,PROCESS_OF,Patients,32617049,10.14744/SEMB.2020.23326,2020-07-04
Pneumonia,PROCESS_OF,Patients,32617049,10.14744/SEMB.2020.23326,2020-07-04
Virus,CAUSES,Respiratory complication,32617049,10.14744/SEMB.2020.23326,2020-07-04
Malignant Neoplasms,PROCESS_OF,Cancer Patient,32617049,10.14744/SEMB.2020.23326,2020-07-04
Coronavirus Infections,ISA,Disease,32617049,10.14744/SEMB.2020.23326,2020-07-04
Malignant neoplasm of breast,PROCESS_OF,Patients,32617049,10.14744/SEMB.2020.23326,2020-07-04
Coronavirus Infections,ISA,Disease,32617049,10.14744/SEMB.2020.23326,2020-07-04
Coronavirus Infections,ISA,Disease,32617048,10.14744/SEMB.2020.65902,2020-07-04
Coronavirus Infections,ISA,Disease,32617048,10.14744/SEMB.2020.65902,2020-07-04
Coronavirus Infections,ISA,Disease,32617048,10.14744/SEMB.2020.65902,2020-07-04
Glycoproteins,INTERACTS_WITH,Vaccines,32616763,10.1038/s41598-020-67749-1,2020-07-04
Vaccines,TREATS,Escherichia coli,32616763,10.1038/s41598-020-67749-1,2020-07-04
Vaccines,AUGMENTS,specific immunity,32616763,10.1038/s41598-020-67749-1,2020-07-04
"Pneumonia, Interstitial",COEXISTS_WITH,Severe Acute Respiratory Syndrome,32616673,10.1126/science.abc5343,2020-07-04
Nasopharyngeal swab (specimen),PART_OF,Patients,32616647,10.1128/MRA.00633-20,2020-07-04
Patients,LOCATION_OF,Genome,32616644,10.1128/MRA.00572-20,2020-07-04
Triage,TREATS,patient condition,32616597,10.1183/13993003.01104-2020,2020-07-04
Performance,PROCESS_OF,Cohort,32616597,10.1183/13993003.01104-2020,2020-07-04
Detection,TREATS,Patients,32616585,10.3174/ajnr.A6674,2020-07-04
Blood Vessel,LOCATION_OF,risk factors,32616585,10.3174/ajnr.A6674,2020-07-04
risk factors,PROCESS_OF,Patients,32616585,10.3174/ajnr.A6674,2020-07-04
Infarction,PROCESS_OF,Patients,32616585,10.3174/ajnr.A6674,2020-07-04
Elevated lactate dehydrogenase,PROCESS_OF,Patients,32616585,10.3174/ajnr.A6674,2020-07-04
D-dimer above reference range,PROCESS_OF,Patients,32616585,10.3174/ajnr.A6674,2020-07-04
"Plaque, Atherosclerotic",CAUSES,Thrombosis,32616585,10.3174/ajnr.A6674,2020-07-04
"Plaque, Atherosclerotic",CAUSES,Acute Cerebrovascular Accidents,32616585,10.3174/ajnr.A6674,2020-07-04
Critical Illness,PROCESS_OF,Patients,32616582,10.3174/ajnr.A6652,2020-07-04
Thrombectomy,TREATS,Patients,32616582,10.3174/ajnr.A6652,2020-07-04
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32616582,10.3174/ajnr.A6652,2020-07-04
Thrombectomy,TREATS,Vascular occlusion,32616582,10.3174/ajnr.A6652,2020-07-04
Vascular occlusion,PROCESS_OF,Patients,32616582,10.3174/ajnr.A6652,2020-07-04
Vascular occlusion,OCCURS_IN,Patients,32616582,10.3174/ajnr.A6652,2020-07-04
Acute cerebrovascular disease,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Cerebral Hemorrhage,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Ischemic stroke,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Cerebrovascular Disorders,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Cerebrovascular Disorders,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
risk factors,PROCESS_OF,Patients,32616524,10.1136/svn-2020-000431,2020-07-04
Coronavirus Infections,ISA,Disease,32616514,10.1128/mBio.01175-20,2020-07-04
Therapeutic immunosuppression,ADMINISTERED_TO,Elderly (population group),32616498,10.1158/1078-0432.CCR-20-2224,2020-07-04
Asymptomatic,PROCESS_OF,Cancer Patient,32616498,10.1158/1078-0432.CCR-20-2224,2020-07-04
Asymptomatic,PROCESS_OF,Cancer Patient,32616498,10.1158/1078-0432.CCR-20-2224,2020-07-04
Telemedicine,ISA,Intervention regimes,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Telemedicine,TREATS(SPEC),Urologic Diseases,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Intervention regimes,TREATS,Urologic Diseases,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Diagnosis,DIAGNOSES,Hematuria,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Diagnosis,PRECEDES,Telemedicine,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Urinary Incontinence,PROCESS_OF,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Urinary tract infection,PROCESS_OF,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
assessment.initial,PROCESS_OF,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Operative Surgical Procedures,PRECEDES,Diagnosis,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
,PART_OF,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Urologic Diseases,PROCESS_OF,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Telemedicine,TREATS,Patients,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Telemedicine,TREATS(INFER),Urologic Diseases,32616405,10.1016/j.eururo.2020.06.025,2020-07-04
Glucocorticoids,ASSOCIATED_WITH,Disease,32616381,10.1016/j.cytogfr.2020.06.012,2020-07-04
Infected,PROCESS_OF,Persons,32616381,10.1016/j.cytogfr.2020.06.012,2020-07-04
Respiration,PROCESS_OF,Patients,32616077,10.1186/s13054-020-03022-1,2020-07-04
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32616077,10.1186/s13054-020-03022-1,2020-07-04
Critical Illness,PROCESS_OF,Patients,32616077,10.1186/s13054-020-03022-1,2020-07-04
Very high,PROCESS_OF,Patients,32616077,10.1186/s13054-020-03022-1,2020-07-04
Hydroxychloroquine,compared_with,Placebos,32616067,10.1186/s13063-020-04543-4,2020-07-04
Hydroxychloroquine,TREATS,Health Personnel,32616067,10.1186/s13063-020-04543-4,2020-07-04
Chemoprevention,USES,Hydroxychloroquine,32616067,10.1186/s13063-020-04543-4,2020-07-04
research study,USES,Interventional procedure,32616067,10.1186/s13063-020-04543-4,2020-07-04
Observational Study,NEG_USES,Interventional procedure,32616067,10.1186/s13063-020-04543-4,2020-07-04
Dose Regimen,TREATS,Alveolar rhabdomyosarcoma,32616067,10.1186/s13063-020-04543-4,2020-07-04
Hydroxychloroquine,AFFECTS,Viral Shedding,32616063,10.1186/s13063-020-04557-y,2020-07-04
Viral Shedding,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Symptom mild,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Infected,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Hydroxychloroquine,PREVENTS,Severe Acute Respiratory Syndrome,32616063,10.1186/s13063-020-04557-y,2020-07-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Disease,AFFECTS,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Infected,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Disease,AFFECTS,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Infected,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Infected,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Hydroxychloroquine,TREATS,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Severe Acute Respiratory Syndrome,AFFECTS,Pregnancy,32616063,10.1186/s13063-020-04557-y,2020-07-04
follow-up,TREATS,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Coughing,ISA,Disease,32616063,10.1186/s13063-020-04557-y,2020-07-04
Negative,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Asymptomatic,NEG_PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Hospitals,LOCATION_OF,Clinical Trials,32616063,10.1186/s13063-020-04557-y,2020-07-04
Infected,PROCESS_OF,Pregnant Women,32616063,10.1186/s13063-020-04557-y,2020-07-04
Malignant Neoplasms,PROCESS_OF,Patients,32616030,10.1186/s40249-020-00707-1,2020-07-04
Virus Diseases,AFFECTS,Patients,32616030,10.1186/s40249-020-00707-1,2020-07-04
Disease,PROCESS_OF,Cancer Patient,32616030,10.1186/s40249-020-00707-1,2020-07-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32616030,10.1186/s40249-020-00707-1,2020-07-04
Complication,AFFECTS,Patients,32615987,10.1186/s13017-020-00320-5,2020-07-04
Acute respiratory failure,AFFECTS,Perforation (observation),32615987,10.1186/s13017-020-00320-5,2020-07-04
Severe Acute Respiratory Syndrome,CAUSES,gangrenous cholecystitis,32615987,10.1186/s13017-020-00320-5,2020-07-04
Gallbladder,LOCATION_OF,Hemorrhagic infarct,32615987,10.1186/s13017-020-00320-5,2020-07-04
Gallbladder,LOCATION_OF,Nerve hypertrophy,32615987,10.1186/s13017-020-00320-5,2020-07-04
Mucous Membrane,PART_OF,Gallbladder,32615987,10.1186/s13017-020-00320-5,2020-07-04
Blood Vessel,PART_OF,Omentum,32615987,10.1186/s13017-020-00320-5,2020-07-04
Blood Vessel,NEG_LOCATION_OF,Immunohistochemistry,32615987,10.1186/s13017-020-00320-5,2020-07-04
Blood Vessel,PART_OF,Gallbladder,32615987,10.1186/s13017-020-00320-5,2020-07-04
Thrombosis,COEXISTS_WITH,Complication,32615987,10.1186/s13017-020-00320-5,2020-07-04
Thrombosis,COEXISTS_WITH(SPEC),Vasculitis,32615987,10.1186/s13017-020-00320-5,2020-07-04
Vasculitis,ISA,Complication,32615987,10.1186/s13017-020-00320-5,2020-07-04
inflammatory response,COEXISTS_WITH,Complication,32615987,10.1186/s13017-020-00320-5,2020-07-04
inflammatory response,COEXISTS_WITH(SPEC),Vasculitis,32615987,10.1186/s13017-020-00320-5,2020-07-04
Coronavirus Infections,ISA,Disease,32615871,10.1177/2050640620930632,2020-07-04
Acute infectious disease,COEXISTS_WITH,Communicable Diseases,32615871,10.1177/2050640620930632,2020-07-04
Advice,PREVENTS,Coronavirus Infections,32615871,10.1177/2050640620930632,2020-07-04
Possible,PROCESS_OF,Patients,32615871,10.1177/2050640620930632,2020-07-04
Serum,LOCATION_OF,C-reactive protein,32615866,10.1177/1753466620937175,2020-07-04
Serum,LOCATION_OF,Ferritin,32615866,10.1177/1753466620937175,2020-07-04
intensive care unit,LOCATION_OF,Study,32615866,10.1177/1753466620937175,2020-07-04
Hospitals,LOCATION_OF,Laboratory Procedures,32615807,10.2217/fca-2020-0082,2020-07-04
Hospitals,LOCATION_OF,Radiographic imaging procedure,32615807,10.2217/fca-2020-0082,2020-07-04
Laboratory Procedures,USES,Nasal Swab (procedure),32615807,10.2217/fca-2020-0082,2020-07-04
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32615807,10.2217/fca-2020-0082,2020-07-04
Sudden Cardiac Death,COEXISTS_WITH,patient condition,32615807,10.2217/fca-2020-0082,2020-07-04
Heart Diseases,PROCESS_OF,Patients,32615807,10.2217/fca-2020-0082,2020-07-04
Pneumonia,PROCESS_OF,Patients,32615802,10.1177/0846537120938328,2020-07-04
radiologist,TREATS,Patients,32615802,10.1177/0846537120938328,2020-07-04
contextual factors,PROCESS_OF,Patients,32615802,10.1177/0846537120938328,2020-07-04
Coronary Arteriosclerosis,ISA,Cardiovascular Diseases,32615796,10.1177/2047487320939671,2020-07-04
Heart failure,ISA,Cardiovascular Diseases,32615796,10.1177/2047487320939671,2020-07-04
Cardiovascular Diseases,PROCESS_OF,Patients,32615796,10.1177/2047487320939671,2020-07-04
Cardiovascular Diseases,PROCESS_OF,Patients,32615796,10.1177/2047487320939671,2020-07-04
Comorbidity,PROCESS_OF,Surgeon,32615695,10.14245/ns.2040336.168,2020-07-04
Heart Diseases,COEXISTS_WITH,Comorbidity,32615695,10.14245/ns.2040336.168,2020-07-04
Comorbidity,COEXISTS_WITH,Hypertensive disease,32615695,10.14245/ns.2040336.168,2020-07-04
Comorbidity,PROCESS_OF,Clinician,32615695,10.14245/ns.2040336.168,2020-07-04
Surgeon,TREATS,Patients,32615695,10.14245/ns.2040336.168,2020-07-04
personal health,PROCESS_OF,Clinician,32615695,10.14245/ns.2040336.168,2020-07-04
Infected,PROCESS_OF,Persons,32615650,10.1111/odi.13529,2020-07-03
Dental Procedures,TREATS,Population Group,32615650,10.1111/odi.13529,2020-07-03
Challenge,TREATS,Pain,32615648,10.1111/odi.13527,2020-07-03
Disease,PROCESS_OF,Patients,32615642,10.1111/odi.13526,2020-07-03
saliva,PART_OF,Patients,32615642,10.1111/odi.13526,2020-07-03
Coronavirus Infections,ISA,Disease,32615642,10.1111/odi.13526,2020-07-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32615642,10.1111/odi.13526,2020-07-03
Diagnosis,DIAGNOSES,Severe Acute Respiratory Syndrome,32615621,10.1055/s-0040-1713851,2020-07-03
Premature Birth,PROCESS_OF,Woman,32615621,10.1055/s-0040-1713851,2020-07-03
Study,MEASURES,Premature Birth,32615621,10.1055/s-0040-1713851,2020-07-03
Premature Birth,PROCESS_OF,Woman,32615621,10.1055/s-0040-1713851,2020-07-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32615621,10.1055/s-0040-1713851,2020-07-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32615621,10.1055/s-0040-1713851,2020-07-03
Spontaneous Preterm Birth,ISA,Premature Birth,32615621,10.1055/s-0040-1713851,2020-07-03
Spontaneous Preterm Birth,NEG_CAUSES,Premature Birth,32615621,10.1055/s-0040-1713851,2020-07-03
Woman,LOCATION_OF,Vaginal secretions,32615620,10.1055/s-0040-1713665,2020-07-03
Tract,PART_OF,Genitalia,32615620,10.1055/s-0040-1713665,2020-07-03
Virus,PROCESS_OF,Woman,32615620,10.1055/s-0040-1713665,2020-07-03
Tract,PART_OF,Genitalia,32615620,10.1055/s-0040-1713665,2020-07-03
Tract,PART_OF,Genitalia,32615620,10.1055/s-0040-1713665,2020-07-03
vulvovaginal,LOCATION_OF,Lesion,32615620,10.1055/s-0040-1713665,2020-07-03
Detection,TREATS,Lesion,32615620,10.1055/s-0040-1713665,2020-07-03
Cesarean section,TREATS,medical care,32615619,10.1055/s-0040-1713602,2020-07-03
Infected,PROCESS_OF,Pregnant Women,32615619,10.1055/s-0040-1713602,2020-07-03
Infected,PROCESS_OF,Pregnant Women,32615619,10.1055/s-0040-1713602,2020-07-03
Medical Devices,TREATS,Patients,32615569,10.1159/000508647,2020-07-03
heparin,DISRUPTS,Blood Circulation,32615569,10.1159/000508647,2020-07-03
Toxin,INTERACTS_WITH,heparin,32615569,10.1159/000508647,2020-07-03
Cell surface,LOCATION_OF,Heparitin Sulfate,32615569,10.1159/000508647,2020-07-03
Extraction,USES,heparin,32615569,10.1159/000508647,2020-07-03
"Antibiotic Resistance, Microbial",ASSOCIATED_WITH,Septicemia,32615569,10.1159/000508647,2020-07-03
"Kidney Failure, Acute",COEXISTS_WITH,patient condition,32615555,10.1159/000509274,2020-07-03
"Kidney Failure, Acute",PROCESS_OF,Patients,32615555,10.1159/000509274,2020-07-03
Cessation of life,PROCESS_OF,Patients,32615555,10.1159/000509274,2020-07-03
"Kidney Failure, Acute",PROCESS_OF,Patients,32615555,10.1159/000509274,2020-07-03
"Kidney Failure, Acute",PROCESS_OF,Patients,32615555,10.1159/000509274,2020-07-03
Continuous renal replacement therapy,TREATS,Patients,32615555,10.1159/000509274,2020-07-03
Continuous renal replacement therapy,TREATS(INFER),"Kidney Failure, Acute",32615555,10.1159/000509274,2020-07-03
Continuous renal replacement therapy,TREATS(INFER),"Kidney Failure, Acute",32615555,10.1159/000509274,2020-07-03
Interventional procedure,TREATS,Patients,32615555,10.1159/000509274,2020-07-03
Brain,LOCATION_OF,Magnetic Resonance Imaging,32615528,10.1016/j.msard.2020.102324,2020-07-03
Magnetic Resonance Imaging,DIAGNOSES,"Myelitis, Transverse",32615528,10.1016/j.msard.2020.102324,2020-07-03
Chest,LOCATION_OF,"Tomography, Spiral Computed",32615528,10.1016/j.msard.2020.102324,2020-07-03
Hypertensive disease,PROCESS_OF,Patients,32615377,10.1016/j.dsx.2020.06.047,2020-07-03
Tinnitus,PROCESS_OF,Patients,32615326,10.1016/j.ijid.2020.06.086,2020-07-03
Hypogeusia,PROCESS_OF,Patients,32615326,10.1016/j.ijid.2020.06.086,2020-07-03
Sense of smell impaired,PROCESS_OF,Patients,32615326,10.1016/j.ijid.2020.06.086,2020-07-03
Severe Acute Respiratory Syndrome,ASSOCIATED_WITH,Biochemical Pathway,32615317,10.1016/j.meegid.2020.104438,2020-07-03
Severe Acute Respiratory Syndrome,AFFECTS,Persons,32615316,10.1016/j.meegid.2020.104445,2020-07-03
Glycoproteins,COEXISTS_WITH,Proteins,32615316,10.1016/j.meegid.2020.104445,2020-07-03
Eye,LOCATION_OF,Membrane Glycoproteins,32615316,10.1016/j.meegid.2020.104445,2020-07-03
Mutation Abnormality,PROCESS_OF,Patients,32615316,10.1016/j.meegid.2020.104445,2020-07-03
Upper respiratory sample,PART_OF,Tract,32615199,10.1016/j.jinf.2020.06.067,2020-07-03
Respiratory sample,PART_OF,Tract,32615199,10.1016/j.jinf.2020.06.067,2020-07-03
Study,MEASURES,Duration,32615199,10.1016/j.jinf.2020.06.067,2020-07-03
Symptoms,PROCESS_OF,general population,32615198,10.1016/j.jinf.2020.06.069,2020-07-03
Chronic metabolic disorder,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Severe course,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Immune,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Pineal gland,PRODUCES,Melatonin,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Diabetes,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Obesity,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Oxidative Stress,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Severe inflammation,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Melatonin,ISA,Agent,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
diabetic,PROCESS_OF,Patients,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Immunologic Adjuvants,TREATS,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Immunologic Adjuvants,TREATS(INFER),Diabetes,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Immunologic Adjuvants,TREATS(INFER),Obesity,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Immunologic Adjuvants,TREATS(INFER),Infected,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Diabetes,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Obesity,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Infected,PROCESS_OF,Persons,32615182,10.1016/j.ejphar.2020.173329,2020-07-03
Uveitis,PROCESS_OF,Patients,32615046,10.1080/1744666X.2020.1791086,2020-07-03
Uveitis,PROCESS_OF,Patients,32615046,10.1080/1744666X.2020.1791086,2020-07-03
Possible,PREDISPOSES,Virus Diseases,32615046,10.1080/1744666X.2020.1791086,2020-07-03
Possible,PROCESS_OF,Patients,32615046,10.1080/1744666X.2020.1791086,2020-07-03
Patients,LOCATION_OF,Throat swab sample,32615038,10.1021/acs.analchem.0c01635,2020-07-03
Serum,LOCATION_OF,CD40LG wt Allele,32615038,10.1021/acs.analchem.0c01635,2020-07-03
Serum,PART_OF,Homo sapiens,32615038,10.1021/acs.analchem.0c01635,2020-07-03
Anxiety,PROCESS_OF,Health Personnel,32614996,10.1002/ijgo.13279,2020-07-03
Depressive disorder,PROCESS_OF,Health Personnel,32614996,10.1002/ijgo.13279,2020-07-03
Attitude,PROCESS_OF,Older people,32614889,10.1371/journal.pone.0235590,2020-07-03
Attitude,PROCESS_OF,Vulnerable Populations,32614889,10.1371/journal.pone.0235590,2020-07-03
Toxic Epidermal Necrolysis,PROCESS_OF,Pregnant Women,32614854,10.1371/journal.pone.0235134,2020-07-03
Symptoms,PROCESS_OF,Patients,32614854,10.1371/journal.pone.0235134,2020-07-03
Patients,LOCATION_OF,C-reactive protein,32614854,10.1371/journal.pone.0235134,2020-07-03
Patients,LOCATION_OF,Fibrin fragment D,32614854,10.1371/journal.pone.0235134,2020-07-03
Lymphadenopathy,PROCESS_OF,Patients,32614854,10.1371/journal.pone.0235134,2020-07-03
Bilateral pleural effusion,PROCESS_OF,Patients,32614854,10.1371/journal.pone.0235134,2020-07-03
Chromosome 2q32-Q33 Deletion Syndrome,ISA,Lesion,32614854,10.1371/journal.pone.0235134,2020-07-03
Bilateral pleural effusion,PROCESS_OF,Patients,32614854,10.1371/journal.pone.0235134,2020-07-03
Radionuclide Imaging,AFFECTS,Evaluation,32614854,10.1371/journal.pone.0235134,2020-07-03
Radionuclide Imaging,AFFECTS,Screening procedure,32614854,10.1371/journal.pone.0235134,2020-07-03
Symptoms,PROCESS_OF,Staff Member,32614816,10.15585/mmwr.mm6926e2,2020-07-03
Mental Health Services,ADMINISTERED_TO,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Confirmation,PROCESS_OF,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Negative Test Result,PROCESS_OF,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Severe Acute Respiratory Syndrome,OCCURS_IN,Health Personnel,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Severe Acute Respiratory Syndrome,OCCURS_IN,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Negative Test Result,PROCESS_OF,Health Personnel,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Negative Test Result,PROCESS_OF,Patients,32614815,10.15585/mmwr.mm6926a4,2020-07-03
Coughing,PROCESS_OF,student,32614814,10.15585/mmwr.mm6926e1,2020-07-03
Academic Medical Centers,LOCATION_OF,Reverse Transcriptase Polymerase Chain Reaction,32614810,10.15585/mmwr.mm6926e3,2020-07-03
Infected,PROCESS_OF,Persons,32614810,10.15585/mmwr.mm6926e3,2020-07-03
Symptoms,PROCESS_OF,Adult,32614778,10.2196/20001,2020-07-03
Pharyngitis,ISA,Symptoms,32614778,10.2196/20001,2020-07-03
skilled nursing facility,LOCATION_OF,Analysis,32614768,10.3201/eid2610.202694,2020-07-03
Infected,PROCESS_OF,Persons,32614767,10.3201/eid2610.202575,2020-07-03
Quarantine,ISA,Isolation procedure,32614740,10.2174/0929867327666200702151018,2020-07-03
Virus,LOCATION_OF,IMPACT gene,32614684,10.1089/vim.2020.0027,2020-07-03
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32614684,10.1089/vim.2020.0027,2020-07-03
Influenza,ISA,Communicable Diseases,32614681,10.1177/0022034520940288,2020-07-03
Measles,AFFECTS,Dental Staff,32614681,10.1177/0022034520940288,2020-07-03
Tuberculosis,AFFECTS,Dental Staff,32614681,10.1177/0022034520940288,2020-07-03
Taiwan,ISA,Country,32614638,10.7326/M20-2927,2020-07-03
Interested,PROCESS_OF,Persons,32614613,10.2105/AJPH.2020.305849,2020-07-03
Oral care,USES,Pharmaceutical Preparations,32614499,10.1111/odi.13520,2020-07-03
Care provision regimes,TREATS,Patients,32614499,10.1111/odi.13520,2020-07-03
Hospitals,LOCATION_OF,case series,32614442,10.1001/jamaoto.2020.1379,2020-07-03
Nasopharynx,LOCATION_OF,IMPACT gene,32614442,10.1001/jamaoto.2020.1379,2020-07-03
Pharyngeal structure,LOCATION_OF,IMPACT gene,32614442,10.1001/jamaoto.2020.1379,2020-07-03
Esthesia,PROCESS_OF,Patients,32614442,10.1001/jamaoto.2020.1379,2020-07-03
Interventional procedure,TREATS,Persons,32614440,10.1093/qjmed/hcaa213,2020-07-03
brief intervention,TREATS,Persons,32614440,10.1093/qjmed/hcaa213,2020-07-03
counselor,PROCESS_OF,teams,32614440,10.1093/qjmed/hcaa213,2020-07-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32614440,10.1093/qjmed/hcaa213,2020-07-03
psychological care,TREATS,Professional Counselor,32614440,10.1093/qjmed/hcaa213,2020-07-03
Virus,NEG_PROCESS_OF,Patients,32614392,10.1093/infdis/jiaa388,2020-07-03
Duration,AFFECTS,Apache II score:Function:Point in time:^Patient:Ordinal,32614392,10.1093/infdis/jiaa388,2020-07-03
Adrenal Cortex Hormones,INTERACTS_WITH,Duration,32614392,10.1093/infdis/jiaa388,2020-07-03
Influenza,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Ischemic stroke,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Cerebrovascular accident,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Influenza,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Blood Vessel,LOCATION_OF,risk factors,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Hospitals,LOCATION_OF,Retrospective Cohort Study,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Influenza,PROCESS_OF,Patients,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Ischemic stroke,PROCESS_OF,Adult,32614385,10.1001/jamaneurol.2020.2730,2020-07-03
Otolaryngologist,ISA,Health Personnel,32614377,10.1001/jamaoto.2020.1423,2020-07-03
Upper respiratory tract,LOCATION_OF,American College of Cardiology/American Heart Association Lesion Complexity Score C,32614377,10.1001/jamaoto.2020.1423,2020-07-03
Diagnosis,DIAGNOSES,Disease,32614284,10.21614/chirurgia.115.3.289,2020-07-03
Population Group,LOCATION_OF,IMPACT gene,32614283,10.1017/S0950268820001314,2020-07-03
Population Group,LOCATION_OF,IMPACT gene,32614283,10.1017/S0950268820001314,2020-07-03
Dysbarism,PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
Pneumonia,PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
Dysbarism,PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
Invasive mechanical ventilation NOS,AFFECTS,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
Invasive mechanical ventilation NOS,TREATS,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32614258,10.1148/radiol.2020202352,2020-07-03
Disease,COEXISTS_WITH,Crisis,32614203,10.1037/apl0000577,2020-07-03
Coronavirus Infections,COEXISTS_WITH(SPEC),Crisis,32614203,10.1037/apl0000577,2020-07-03
Coronavirus Infections,ISA,Disease,32614203,10.1037/apl0000577,2020-07-03
Blood coagulation,PROCESS_OF,Patients,32614178,10.1021/acschemneuro.0c00370,2020-07-03
Inflammation,COEXISTS_WITH,exacerbation acute,32614178,10.1021/acschemneuro.0c00370,2020-07-03
Nucleus solitarius,LOCATION_OF,Inflammation,32614178,10.1021/acschemneuro.0c00370,2020-07-03
Molluscum Contagiosum,PROCESS_OF,Meleagris gallopavo,32614116,10.1111/dth.13949,2020-07-03
Decreasing,COEXISTS_WITH,Enthesitis-Related Arthritis,32614116,10.1111/dth.13949,2020-07-03
Pneumonia,PROCESS_OF,Patients,32614086,10.1111/his.14201,2020-07-03
Structure of parenchyma of lung,LOCATION_OF,Pneumonia,32614086,10.1111/his.14201,2020-07-03
Immunohistochemistry,DIAGNOSES,Alveolar damage,32614086,10.1111/his.14201,2020-07-03
"Antigens, Viral",PART_OF,Protoplasm,32614086,10.1111/his.14201,2020-07-03
Immunohistochemistry,DIAGNOSES,Virus,32614086,10.1111/his.14201,2020-07-03
Nucleoproteins,PART_OF,SARS coronavirus,32614086,10.1111/his.14201,2020-07-03
"Transcription, Genetic",PROCESS_OF,Patients,32614086,10.1111/his.14201,2020-07-03
Immunohistochemistry,DIAGNOSES,Microthrombus,32614086,10.1111/his.14201,2020-07-03
Thrombus,COEXISTS_WITH,Disease Progression,32614086,10.1111/his.14201,2020-07-03
Immune response,PROCESS_OF,Patients,32614086,10.1111/his.14201,2020-07-03
Major change,COEXISTS_WITH,Disease Progression,32614086,10.1111/his.14201,2020-07-03
Masks,TREATS,Protection,32614045,10.1093/cid/ciaa593,2020-07-03
Cellular Immunity,PROCESS_OF,Mus,32613971,10.1039/d0cc03263h,2020-07-03
"Chimeric Proteins, Recombinant",STIMULATES,"Antibodies, Neutralizing",32613971,10.1039/d0cc03263h,2020-07-03
ACE2 gene,PART_OF,soluble,32613971,10.1039/d0cc03263h,2020-07-03
Syndrome,ISA,Disease,32613939,10.2807/1560-7917.ES.2020.25.25.1900562,2020-07-03
Respiratory sample,PART_OF,Homo sapiens,32613937,10.2807/1560-7917.ES.2020.25.25.2001122,2020-07-03
continuous cell line,PRODUCES,Influenza virus vaccine,32613937,10.2807/1560-7917.ES.2020.25.25.2001122,2020-07-03
Blood Circulation,PROCESS_OF,Patients,32613935,10.1017/S1047951120001882,2020-07-03
Circulatory Process,PROCESS_OF,Patients,32613935,10.1017/S1047951120001882,2020-07-03
Cessation of life,PROCESS_OF,Adult,32613934,10.1017/S1047951120001845,2020-07-03
Lung,LOCATION_OF,Severe disorder,32613934,10.1017/S1047951120001845,2020-07-03
Cardiovascular Diseases,PROCESS_OF,Patients,32613934,10.1017/S1047951120001845,2020-07-03
Clinical Trials,MEASURES,year,32613929,10.1017/dmp.2020.195,2020-07-03
Clinician,LOCATION_OF,"CD69 protein, human",32613929,10.1017/dmp.2020.195,2020-07-03
treatment guideline,TREATS,patient condition,32613929,10.1017/dmp.2020.195,2020-07-03
Anxiety symptoms,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
Worried,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
Anxiety symptoms,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
Anxiety symptoms,COEXISTS_WITH,Worried,32613924,10.1017/S1041610220001258,2020-07-03
Worried,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
Anxiety symptoms,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
High Level,PROCESS_OF,Elderly (population group),32613924,10.1017/S1041610220001258,2020-07-03
Nucleic Acid Amplification Tests,METHOD_OF,Detection,32613877,10.1177/0022034520940292,2020-07-03
Disease,AFFECTS,Child,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
Coronavirus Infections,AFFECTS(SPEC),Child,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
Coronavirus Infections,ISA,Disease,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
child abuse behavior,ISA,Domestic Violence,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
"Marriage, life event",PROCESS_OF,Child,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
Coronavirus Infections,ISA,Disease,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
medical care,PROCESS_OF,Child,32613821,10.23736/S0026-4946.20.05887-9,2020-07-03
Diabetes,COEXISTS_WITH,patient condition,32613777,10.4093/dmj.2020.0138,2020-07-03
Diabetes,AFFECTS,Patients,32613777,10.4093/dmj.2020.0138,2020-07-03
Diabetes,PROCESS_OF,Patients,32613777,10.4093/dmj.2020.0138,2020-07-03
Ergocalciferol,ASSOCIATED_WITH,Diabetes,32613681,10.1111/joim.13149,2020-07-03
Ergocalciferol,ASSOCIATED_WITH,Hypertensive disease,32613681,10.1111/joim.13149,2020-07-03
Ergocalciferol,ASSOCIATED_WITH,Obesity,32613681,10.1111/joim.13149,2020-07-03
angiotensin converting enzyme 2,AUGMENTS,Hydrolysis,32613681,10.1111/joim.13149,2020-07-03
angiotensin converting enzyme 2,PREVENTS,inflammatory response,32613681,10.1111/joim.13149,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Score 3,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32613660,10.1002/jpen.1953,2020-07-03
Aggressive Clinical Course,PROCESS_OF,Child,32613638,10.1111/bjd.19349,2020-07-03
Skin Manifestations,PROCESS_OF,Adult,32613638,10.1111/bjd.19349,2020-07-03
Patient in hospital,PROCESS_OF,Adult,32613638,10.1111/bjd.19349,2020-07-03
Antiviral Agents,TREATS,Symptoms,32613637,10.1002/ptr.6781,2020-07-03
naringenin,ISA,Flavonoids,32613637,10.1002/ptr.6781,2020-07-03
Flavonoids,INTERACTS_WITH,naringenin,32613637,10.1002/ptr.6781,2020-07-03
Chymase,INHIBITS,Endopeptidases,32613637,10.1002/ptr.6781,2020-07-03
naringenin,DISRUPTS,angiotensin converting enzyme activity,32613637,10.1002/ptr.6781,2020-07-03
naringenin,ISA,flavanone,32613637,10.1002/ptr.6781,2020-07-03
Chickenpox,COEXISTS_WITH,Vesicular rash,32613623,10.1111/bjd.19350,2020-07-03
Vesicular rash,PROCESS_OF,Patients,32613623,10.1111/bjd.19350,2020-07-03
Vesicular rash,PROCESS_OF,Patients,32613623,10.1111/bjd.19350,2020-07-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32613620,10.1111/bjd.19348,2020-07-03
Author,NEG_DIAGNOSES,Severe Acute Respiratory Syndrome,32613620,10.1111/bjd.19348,2020-07-03
Laboratory Procedures,USES,Buccal smear procedure,32613620,10.1111/bjd.19348,2020-07-03
Buccal smear procedure,ISA,Laboratory Procedures,32613620,10.1111/bjd.19348,2020-07-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Lesion,32613620,10.1111/bjd.19348,2020-07-03
Pandemics,CAUSES,Migraine Disorders,32613542,10.1007/s10072-020-04543-x,2020-07-03
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32613447,10.1007/s00414-020-02354-5,2020-07-03
Complication,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32613385,10.1007/s11239-020-02190-9,2020-07-03
Pandemics,ISA,Disease Outbreaks,32613385,10.1007/s11239-020-02190-9,2020-07-03
Pulmonary angiogram,ADMINISTERED_TO,Patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
Confirmation,PROCESS_OF,Patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
"4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid",ADMINISTERED_TO,Patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
Pulmonary Embolism,PROCESS_OF,Patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
Dyslipidemias,NEG_PROCESS_OF,Patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
Pulmonary Embolism,OCCURS_IN,hospitalized patients,32613385,10.1007/s11239-020-02190-9,2020-07-03
Fibrin fragment D,PREDISPOSES,Pulmonary Embolism,32613385,10.1007/s11239-020-02190-9,2020-07-03
Immune thrombocytopenic purpura,PROCESS_OF,Patients,32613314,10.1007/s12185-020-02931-9,2020-07-03
Serum,LOCATION_OF,Ferritin,32613308,10.1007/s10096-020-03967-9,2020-07-03
Severe Acute Respiratory Syndrome,AFFECTS,Hematopoiesis,32613308,10.1007/s10096-020-03967-9,2020-07-03
Pneumonia,PROCESS_OF,Patients,32613288,10.1007/s40291-020-00481-8,2020-07-03
Urokinase Plasminogen Activator Receptor,PART_OF,soluble,32613288,10.1007/s40291-020-00481-8,2020-07-03
Quick Test for Liver Function,USES,Triage,32613288,10.1007/s40291-020-00481-8,2020-07-03
Emergency medical service,COEXISTS_WITH,Ophthalmology Treatments,32613258,10.1007/s00347-020-01162-x,2020-07-03
Virus,INTERACTS_WITH,Vertebrates,32613257,10.1007/s00347-020-01155-w,2020-07-03
Genus: Coronavirus,INTERACTS_WITH(SPEC),Vertebrates,32613257,10.1007/s00347-020-01155-w,2020-07-03
Genus: Coronavirus,ISA,Virus,32613257,10.1007/s00347-020-01155-w,2020-07-03
Infected,PROCESS_OF,Homo sapiens,32613257,10.1007/s00347-020-01155-w,2020-07-03
Blood,LOCATION_OF,Specific antibody,32613257,10.1007/s00347-020-01155-w,2020-07-03
Specific antibody,PART_OF,Virus,32613257,10.1007/s00347-020-01155-w,2020-07-03
Immunity,PROCESS_OF,Patients,32613257,10.1007/s00347-020-01155-w,2020-07-03
Communicable Diseases,PROCESS_OF,Patients,32613255,10.1007/s00347-020-01156-9,2020-07-03
Protection,PROCESS_OF,Employee,32613255,10.1007/s00347-020-01156-9,2020-07-03
Exercise,PREVENTS,Total physical activity,32613133,10.1016/j.heliyon.2020.e04315,2020-07-03
Patient Discharge,TREATS,Respiratory complication,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
"Pneumonia, Interstitial",PROCESS_OF,Patients,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Low Dose Radiation Therapy,TREATS,"Pneumonia, Interstitial",32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Pharmacotherapy,ADMINISTERED_TO,Control Groups,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Pharmacotherapy,ADMINISTERED_TO,Control Groups,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Low Dose Radiation Therapy,ADMINISTERED_TO,Control Groups,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Pneumonia,PROCESS_OF,Patients,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Low Dose Radiation Therapy,TREATS,Patients,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Low Dose Radiation Therapy,TREATS(INFER),Pneumonia,32613089,10.1016/j.ctro.2020.06.005,2020-07-03
Malaise,PROCESS_OF,Patients,32613024,10.1093/ofid/ofaa220,2020-07-03
Bacterial Infections,PROCESS_OF,Patients,32613024,10.1093/ofid/ofaa220,2020-07-03
Critical Illness,PROCESS_OF,Patients,32613024,10.1093/ofid/ofaa220,2020-07-03
Cardiovascular Diseases,PROCESS_OF,Patients,32613010,10.3389/fcvm.2020.00112,2020-07-03
Diabetes,PROCESS_OF,Patients,32613010,10.3389/fcvm.2020.00112,2020-07-03
Health Services,AFFECTS,Crisis,32613010,10.3389/fcvm.2020.00112,2020-07-03
Disease,PREDISPOSES,Detected (finding),32613004,10.3389/fmed.2020.00294,2020-07-03
China,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
France,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
Germany,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
Iran,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
Italy,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
South Korea,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
Spain,ISA,Country,32612894,10.7717/peerj.9421,2020-07-03
Infected,PROCESS_OF,Child,32612817,10.7189/jogh.10.011101,2020-07-03
Infected,PROCESS_OF,Child,32612817,10.7189/jogh.10.011101,2020-07-03
Pharmaceutical Preparations,TREATS,Symptoms,32612804,10.1177/2045125320935306,2020-07-03
Chloroquine,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
Famotidine,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
Hydroxychloroquine,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
Azithromycin,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
lopinavir / Ritonavir,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
Atazanavir,ISA,Agent,32612804,10.1177/2045125320935306,2020-07-03
consideration,PROCESS_OF,Clinician,32612712,10.1177/1759720X20934276,2020-07-03
treatment options,TREATS,patient symptoms,32612712,10.1177/1759720X20934276,2020-07-03
Conservative Treatment,TREATS,Disease,32612712,10.1177/1759720X20934276,2020-07-03
Conservative Treatment,TREATS,Symptoms,32612712,10.1177/1759720X20934276,2020-07-03
Diabetes,AFFECTS,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Influenza,AFFECTS,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Predisposition -- attribute,ASSOCIATED_WITH,Diabetes,32612666,10.1186/s12979-020-00192-y,2020-07-03
Predisposition -- attribute,ASSOCIATED_WITH,Influenza,32612666,10.1186/s12979-020-00192-y,2020-07-03
Predisposition -- attribute,ASSOCIATED_WITH,Acute respiratory infections,32612666,10.1186/s12979-020-00192-y,2020-07-03
Predisposition -- attribute,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32612666,10.1186/s12979-020-00192-y,2020-07-03
Predisposition -- attribute,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32612666,10.1186/s12979-020-00192-y,2020-07-03
diabetic,PROCESS_OF,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Acute respiratory infections,AFFECTS,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Middle East Respiratory Syndrome,AFFECTS,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Poor outcome,COEXISTS_WITH,Respiratory Tract Infections,32612666,10.1186/s12979-020-00192-y,2020-07-03
diabetic,PROCESS_OF,Patients,32612666,10.1186/s12979-020-00192-y,2020-07-03
Respondents,LOCATION_OF,IMPACT gene,32612645,10.26633/RPSP.2020.81,2020-07-03
Health behavior,PROCESS_OF,Adult,32612645,10.26633/RPSP.2020.81,2020-07-03
Tissue damage,CAUSES,Multiple Organ Failure,32612617,10.3389/fimmu.2020.01446,2020-07-03
cytokine,COMPLICATES,"Respiratory Distress Syndrome, Adult",32612617,10.3389/fimmu.2020.01446,2020-07-03
cytokine,ADMINISTERED_TO,Patients,32612617,10.3389/fimmu.2020.01446,2020-07-03
Pneumonia,AFFECTS,Patient Deceased,32612615,10.3389/fimmu.2020.01441,2020-07-03
Immune response,AFFECTS,Disease Progression,32612615,10.3389/fimmu.2020.01441,2020-07-03
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32612615,10.3389/fimmu.2020.01441,2020-07-03
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32612615,10.3389/fimmu.2020.01441,2020-07-03
Disease,AFFECTS,Immune,32612615,10.3389/fimmu.2020.01441,2020-07-03
Influenza due to Influenza A virus subtype H1N1,PROCESS_OF,Family suidae,32612565,10.3389/fpsyg.2020.01392,2020-07-03
IMPACT gene,PREDISPOSES,Symptoms,32612515,10.3389/fnana.2020.00037,2020-07-03
Coronavirus Infections,ISA,Disease,32612435,10.5152/eurasianjmed.2020.20134,2020-07-03
Coronavirus Infections,ISA,Disease,32612435,10.5152/eurasianjmed.2020.20134,2020-07-03
Disease,PROCESS_OF,Patients,32612435,10.5152/eurasianjmed.2020.20134,2020-07-03
Coronavirus Infections,ISA,Disease,32612435,10.5152/eurasianjmed.2020.20134,2020-07-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32612435,10.5152/eurasianjmed.2020.20134,2020-07-03
Pregnancy,PROCESS_OF,"Infant, Newborn",32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Coughing,PROCESS_OF,Patients,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Fever,PROCESS_OF,Patients,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Pregnant Women,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
lopinavir / Ritonavir,ISA,Protease Inhibitors,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Pneumonia,PROCESS_OF,Health Personnel,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Gravidity,PROCESS_OF,Health Personnel,32612432,10.5152/eurasianjmed.2020.20118,2020-07-03
Pharmaceutical Preparations,TREATS,Patients,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Vaccines,TREATS,Patients,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Isolation procedure,USES,Pharmaceutical Preparations,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Isolation procedure,USES,Vaccines,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Basis,TREATS,Patients,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Orthomyxoviridae,INTERACTS_WITH,Coronavirus Infections,32612431,10.5152/eurasianjmed.2020.20056,2020-07-03
Virus Diseases,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32612430,10.5152/eurasianjmed.2020.20092,2020-07-03
Oxygen,PART_OF,Nose,32612430,10.5152/eurasianjmed.2020.20092,2020-07-03
Hypoxia,PROCESS_OF,Patients,32612430,10.5152/eurasianjmed.2020.20092,2020-07-03
Safety Issues,PROCESS_OF,Patients,32612430,10.5152/eurasianjmed.2020.20092,2020-07-03
Attitude,PROCESS_OF,Patients,32612371,10.2147/IDR.S258736,2020-07-03
Chronic disease,PROCESS_OF,Patients,32612371,10.2147/IDR.S258736,2020-07-03
Hospitals,LOCATION_OF,Cross-Sectional Studies,32612371,10.2147/IDR.S258736,2020-07-03
SARS coronavirus,CAUSES,Disease,32611983,10.7883/yoken.JJID.2020.324,2020-07-03
Assay,USES,Medical Devices,32611983,10.7883/yoken.JJID.2020.324,2020-07-03
Real-Time Polymerase Chain Reaction,USES,Instrument - device,32611983,10.7883/yoken.JJID.2020.324,2020-07-03
Disease,PROCESS_OF,Patients,32611980,10.7883/yoken.JJID.2020.264,2020-07-03
Coronavirus Infections,ISA,Disease,32611980,10.7883/yoken.JJID.2020.264,2020-07-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32611980,10.7883/yoken.JJID.2020.264,2020-07-03
CAT scan normal,PROCESS_OF,Patients,32611980,10.7883/yoken.JJID.2020.264,2020-07-03
Chest,LOCATION_OF,CAT scan normal,32611980,10.7883/yoken.JJID.2020.264,2020-07-03
Disease,CAUSES,Cessation of life,32611979,10.7883/yoken.JJID.2020.227,2020-07-03
Cessation of life,PROCESS_OF,Patients,32611979,10.7883/yoken.JJID.2020.227,2020-07-03
Causative_agents,CAUSES,Infection,32611916,10.4103/ijmr.IJMR_2234_20,2020-07-03
Hydroxychloroquine,ISA,Antimalarials,32611916,10.4103/ijmr.IJMR_2234_20,2020-07-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32611916,10.4103/ijmr.IJMR_2234_20,2020-07-03
"Intubation, Intratracheal",ADMINISTERED_TO,Health Personnel,32611916,10.4103/ijmr.IJMR_2234_20,2020-07-03
Vero Cells,LOCATION_OF,Virus,32611915,10.4103/ijmr.IJMR_2232_20,2020-07-03
Specimen Type - Serum,LOCATION_OF,anti-IgG,32611915,10.4103/ijmr.IJMR_2232_20,2020-07-03
Specimen Type - Serum,LOCATION_OF,anti-IgG,32611915,10.4103/ijmr.IJMR_2232_20,2020-07-03
Specimen Type - Serum,PART_OF,Homo sapiens,32611915,10.4103/ijmr.IJMR_2232_20,2020-07-03
Antibody studies (procedure),USES,Enzyme-Linked Immunosorbent Assay,32611913,10.4103/ijmr.IJMR_1818_20,2020-07-03
Infected,PROCESS_OF,Persons,32611913,10.4103/ijmr.IJMR_1818_20,2020-07-03
Anosmia,ISA,Symptoms,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Dry cough,ISA,Symptoms,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Eye,LOCATION_OF,Shield,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Fever,PROCESS_OF,Patients,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Symptoms,PROCESS_OF,Patients,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Chloroquine,ADMINISTERED_TO,Patients,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Hydroxychloroquine,ADMINISTERED_TO,Patients,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Coronavirus Infections,PROCESS_OF,Patients,32611912,10.4103/ijmr.IJMR_1369_20,2020-07-03
Cardiovascular Diseases,PREDISPOSES,Severe disorder,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Diabetes,PREDISPOSES,Severe disorder,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Hypertensive disease,PREDISPOSES,Severe disorder,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Attention,PROCESS_OF,Patients,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Upper respiratory sample,PART_OF,Tract,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Coronavirus Infections,PROCESS_OF,Patients,32611911,10.4103/ijmr.IJMR_957_20,2020-07-03
Chest CT,ADMINISTERED_TO,Patients,32611906,10.4103/0028-3886.287683,2020-07-03
Feces,PART_OF,Patients,32611796,10.1128/JCM.01369-20,2020-07-03
Assay,METHOD_OF,Detection,32611796,10.1128/JCM.01369-20,2020-07-03
Clinician,DIAGNOSES,Sexually Transmitted Diseases,32611792,10.1128/JCM.01215-20,2020-07-03
Oropharyngeal,LOCATION_OF,Sexually Transmitted Diseases,32611792,10.1128/JCM.01215-20,2020-07-03
Coitus,PROCESS_OF,Male population group,32611792,10.1128/JCM.01215-20,2020-07-03
Gonorrhea,PROCESS_OF,Male population group,32611792,10.1128/JCM.01215-20,2020-07-03
Psychological symptom,PROCESS_OF,Adult,32611746,10.1136/bmjopen-2020-039426,2020-07-03
Psychological symptom,PROCESS_OF,Persons,32611746,10.1136/bmjopen-2020-039426,2020-07-03
IMPACT gene,CAUSES,Psychological symptom,32611746,10.1136/bmjopen-2020-039426,2020-07-03
Virus Diseases,PROCESS_OF,Cancer Patient,32611687,10.1136/jitc-2020-001145,2020-07-03
Vaccines,TREATS,Patients,32611687,10.1136/jitc-2020-001145,2020-07-03
Virulence,AFFECTS,Infection,32611687,10.1136/jitc-2020-001145,2020-07-03
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32611676,10.1136/heartjnl-2020-317336,2020-07-03
Angiotensin II receptor antagonist,TREATS,Patients,32611676,10.1136/heartjnl-2020-317336,2020-07-03
Fever,PROCESS_OF,Patients,32611659,10.1136/bcr-2020-236812,2020-07-03
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32611659,10.1136/bcr-2020-236812,2020-07-03
Possible,PROCESS_OF,Patients,32611659,10.1136/bcr-2020-236812,2020-07-03
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32611659,10.1136/bcr-2020-236812,2020-07-03
Symptoms,ASSOCIATED_WITH,Virus Diseases,32611659,10.1136/bcr-2020-236812,2020-07-03
Inflammation,OCCURS_IN,Child,32611651,10.1136/rmdopen-2020-001333,2020-07-03
Inflammation,OCCURS_IN,Adolescent (age group),32611651,10.1136/rmdopen-2020-001333,2020-07-03
Myocarditis,OCCURS_IN,Child,32611651,10.1136/rmdopen-2020-001333,2020-07-03
Myocarditis,OCCURS_IN,Adolescent (age group),32611651,10.1136/rmdopen-2020-001333,2020-07-03
Shock,OCCURS_IN,Child,32611651,10.1136/rmdopen-2020-001333,2020-07-03
Shock,OCCURS_IN,Adolescent (age group),32611651,10.1136/rmdopen-2020-001333,2020-07-03
Shock,COEXISTS_WITH,Mucocutaneous Lymph Node Syndrome,32611651,10.1136/rmdopen-2020-001333,2020-07-03
Mucocutaneous Lymph Node Syndrome,AFFECTS,Adaptive Immune Response,32611651,10.1136/rmdopen-2020-001333,2020-07-03
Interested,PROCESS_OF,Physicians,32611634,10.1212/WNL.0000000000010015,2020-07-03
Engaged to be married,PROCESS_OF,Physicians,32611634,10.1212/WNL.0000000000010015,2020-07-03
Protection,PROCESS_OF,Community,32611537,10.1016/j.bj.2020.06.003,2020-07-03
Telemedicine,TREATS,Patients,32611509,10.1016/j.jadohealth.2020.05.025,2020-07-03
Mechanical ventilation,CAUSES,Multiple Organ Failure,32611485,10.1016/j.arcmed.2020.06.011,2020-07-03
Atypical pneumonia,PROCESS_OF,Patients,32611485,10.1016/j.arcmed.2020.06.011,2020-07-03
Genes,INTERACTS_WITH,Hyaluronan,32611485,10.1016/j.arcmed.2020.06.011,2020-07-03
GSKIP gene,COEXISTS_WITH,Genes,32611485,10.1016/j.arcmed.2020.06.011,2020-07-03
Caregiver,TREATS,Patients,32611473,10.1017/ipm.2020.86,2020-07-03
early identification,ISA,Prophylactic treatment,32611470,10.1017/ipm.2020.84,2020-07-03
mental health,PROCESS_OF,Persons,32611470,10.1017/ipm.2020.84,2020-07-03
mental health,PROCESS_OF,Persons,32611470,10.1017/ipm.2020.84,2020-07-03
mental health,PROCESS_OF,Persons,32611470,10.1017/ipm.2020.84,2020-07-03
Heart,LOCATION_OF,work up,32611457,10.1017/S1047951120001778,2020-07-03
Heart,LOCATION_OF,work up,32611457,10.1017/S1047951120001778,2020-07-03
School,LOCATION_OF,Educational process of instructing,32611385,10.1186/s40249-020-00695-2,2020-07-03
Coronary Aneurysm,CAUSES,Infarction,32611362,10.1186/s12872-020-01593-z,2020-07-03
Isolation procedure,CAUSES,Thrombophilia,32611362,10.1186/s12872-020-01593-z,2020-07-03
Coronary Aneurysm,CAUSES,Acute myocardial infarction,32611362,10.1186/s12872-020-01593-z,2020-07-03
Chest,LOCATION_OF,Severe pain,32611362,10.1186/s12872-020-01593-z,2020-07-03
Intravascular ultrasound,DIAGNOSES,Coronary Aneurysm,32611362,10.1186/s12872-020-01593-z,2020-07-03
Isolation procedure,CAUSES,Thrombophilia,32611362,10.1186/s12872-020-01593-z,2020-07-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32611362,10.1186/s12872-020-01593-z,2020-07-03
At home,PROCESS_OF,Patients,32611362,10.1186/s12872-020-01593-z,2020-07-03
Proteins,INTERACTS_WITH,Pharmacologic Substance,32611313,10.1186/s12860-020-00294-x,2020-07-03
Pharmacologic Substance,DISRUPTS,Movement,32611313,10.1186/s12860-020-00294-x,2020-07-03
Pharmacologic Substance,TREATS,Homo sapiens,32611313,10.1186/s12860-020-00294-x,2020-07-03
Disease,PROCESS_OF,Patients,32611305,10.2174/1871529X20666200701110045,2020-07-03
Lung,LOCATION_OF,angiotensin converting enzyme 2,32611305,10.2174/1871529X20666200701110045,2020-07-03
Angiotensin II receptor antagonist,STIMULATES,ACE2 gene,32611305,10.2174/1871529X20666200701110045,2020-07-03
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,"Animals, Laboratory",32611305,10.2174/1871529X20666200701110045,2020-07-03
Health behavior,PROCESS_OF,Young Adult,32611226,10.1177/0031512520938178,2020-07-03
"Delirium, Dementia, Amnestic, Cognitive Disorders",PROCESS_OF,Persons,32611226,10.1177/0031512520938178,2020-07-03
Acquired Immunodeficiency Syndrome,NEG_AUGMENTS,Cerebellar decompression injury,32610729,10.34172/ijhpm.2020.63,2020-07-03
Ethanol,ISA,Psychoactive substance,32610613,10.3390/ijerph17134677,2020-07-03
Body tissue,LOCATION_OF,Virus,32610587,10.3390/jcm9072038,2020-07-03
Organ,LOCATION_OF,Virus,32610587,10.3390/jcm9072038,2020-07-03
Challenge:Type:Point in time:^Patient:Nominal,ASSOCIATED_WITH,Respiratory distress,32610549,10.3390/nano10071271,2020-07-03
Assay,USES,magnetic beads,32610549,10.3390/nano10071271,2020-07-03
Hospitals,LOCATION_OF,Cross-Sectional Studies,32610371,10.1002/oby.22947,2020-07-02
Present,PROCESS_OF,Patients,32610371,10.1002/oby.22947,2020-07-02
Finding of body mass index,PROCESS_OF,Patients,32610371,10.1002/oby.22947,2020-07-02
Finding of body mass index,PROCESS_OF,Patients,32610371,10.1002/oby.22947,2020-07-02
Respiration Disorders,COEXISTS_WITH,Pneumonia,32610364,10.1002/oby.22946,2020-07-02
Respiration Disorders,COEXISTS_WITH,Single organ dysfunction,32610364,10.1002/oby.22946,2020-07-02
Diabetes,COEXISTS_WITH,Obesity,32610364,10.1002/oby.22946,2020-07-02
Diabetes,PROCESS_OF,Patients,32610364,10.1002/oby.22946,2020-07-02
Hypertensive disease,COEXISTS_WITH,Obesity,32610364,10.1002/oby.22946,2020-07-02
Hypertensive disease,PROCESS_OF,Patients,32610364,10.1002/oby.22946,2020-07-02
Academic Medical Centers,LOCATION_OF,Quality Improvement,32610350,10.1055/s-0040-1713635,2020-07-02
Telemedicine,METHOD_OF,ambulatory care services,32610350,10.1055/s-0040-1713635,2020-07-02
Telemedicine,TREATS,inpatient,32610350,10.1055/s-0040-1713635,2020-07-02
Blood Vessel,LOCATION_OF,risk factors,32610334,10.1159/000508991,2020-07-02
Comorbidity,PROCESS_OF,Old age,32610334,10.1159/000508991,2020-07-02
Complication,PROCESS_OF,Persons,32610334,10.1159/000508991,2020-07-02
Complication,PROCESS_OF(SPEC),Old age,32610334,10.1159/000508991,2020-07-02
Hypertensive disease,PROCESS_OF,Old age,32610334,10.1159/000508991,2020-07-02
risk factors,PROCESS_OF,Old age,32610334,10.1159/000508991,2020-07-02
Old age,ISA,Persons,32610334,10.1159/000508991,2020-07-02
Sequela of disorder,ASSOCIATED_WITH,EHD1 wt Allele,32610334,10.1159/000508991,2020-07-02
Syndrome,ISA,Disease,32610334,10.1159/000508991,2020-07-02
neurological complication,ASSOCIATED_WITH,EHD1 wt Allele,32610334,10.1159/000508991,2020-07-02
Adrenal Cortex Hormones,TREATS,Patients,32610262,10.1016/j.dsx.2020.06.054,2020-07-02
Oxygen Therapy Care,USES,Dexamethasone,32610262,10.1016/j.dsx.2020.06.054,2020-07-02
Hydroxychloroquine,TREATS,Collagen Diseases,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Hydroxychloroquine,TREATS,Patients,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Atrial Fibrillation,PREDISPOSES,Prolonged QTc,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Heart failure,PREDISPOSES,Prolonged QTc,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Hydroxychloroquine,TREATS,Patients,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Atrial Fibrillation,PREDISPOSES,Prolonged QT interval,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Heart failure,PREDISPOSES,Prolonged QT interval,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Chronic Kidney Diseases,PREDISPOSES,Prolonged QT interval,32610165,10.1016/j.hrthm.2020.06.029,2020-07-02
Disease,AFFECTS,Persons,32610153,10.1016/j.ijcard.2020.06.043,2020-07-02
Coronavirus Infections,AFFECTS(SPEC),Persons,32610153,10.1016/j.ijcard.2020.06.043,2020-07-02
Coronavirus Infections,ISA,Disease,32610153,10.1016/j.ijcard.2020.06.043,2020-07-02
Appendicitis,PROCESS_OF,Patients,32610104,10.1016/j.jacr.2020.06.002,2020-07-02
Sphingomyelins,INHIBITS,Diglycerides,32610096,10.1016/j.cmet.2020.06.016,2020-07-02
Pathologic Processes,COEXISTS_WITH,Disease,32610096,10.1016/j.cmet.2020.06.016,2020-07-02
Pathologic Processes,COEXISTS_WITH(SPEC),Coronavirus Infections,32610096,10.1016/j.cmet.2020.06.016,2020-07-02
Coronavirus Infections,ISA,Disease,32610096,10.1016/j.cmet.2020.06.016,2020-07-02
Severe Acute Respiratory Syndrome,AFFECTS,Protection,32610080,10.1016/j.immuni.2020.06.012,2020-07-02
Epithelial Cells,PART_OF,Lung,32610043,10.1016/j.celrep.2020.107863,2020-07-02
Epithelium,PART_OF,Intestines,32610043,10.1016/j.celrep.2020.107863,2020-07-02
Viremia,PROCESS_OF,Patients,32610043,10.1016/j.celrep.2020.107863,2020-07-02
Coronavirus Infections,ISA,Disease,32610036,10.3201/eid2610.202648,2020-07-02
Disease,PROCESS_OF,Patients,32610036,10.3201/eid2610.202648,2020-07-02
Coronavirus Infections,ISA,Disease,32610036,10.3201/eid2610.202648,2020-07-02
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32610036,10.3201/eid2610.202648,2020-07-02
Clinician,DIAGNOSES,Disease,32610036,10.3201/eid2610.202648,2020-07-02
Decision,PROCESS_OF,Hero,32610022,10.1080/01612840.2020.1773736,2020-07-02
African race,ISA,African American,32610022,10.1080/01612840.2020.1773736,2020-07-02
Disease,PROCESS_OF,Persons,32610022,10.1080/01612840.2020.1773736,2020-07-02
Bipolar Disorder,PROCESS_OF,Patients,32609942,10.1111/bdi.12969,2020-07-02
Telemedicine,METHOD_OF,Challenge,32609942,10.1111/bdi.12969,2020-07-02
Bipolar Disorder,PROCESS_OF,Patients,32609942,10.1111/bdi.12969,2020-07-02
Asthma,ISA,Medical History,32609925,10.1111/bju.15157,2020-07-02
Cessation of life,PROCESS_OF,Recipient,32609908,10.1111/tri.13680,2020-07-02
patient condition,PREDISPOSES,Oral infection,32609906,10.1111/myc.13137,2020-07-02
oropharyngeal candidiasis,AFFECTS,hospitalized patients,32609906,10.1111/myc.13137,2020-07-02
oropharyngeal candidiasis,COEXISTS_WITH,patient condition,32609906,10.1111/myc.13137,2020-07-02
oropharyngeal candidiasis,PROCESS_OF,hospitalized patients,32609906,10.1111/myc.13137,2020-07-02
Diabetes,ISA,Disease,32609906,10.1111/myc.13137,2020-07-02
Antifungal susceptibility test,METHOD_OF,Broth dilution,32609906,10.1111/myc.13137,2020-07-02
Isolate - microorganism,CAUSES,oropharyngeal candidiasis,32609906,10.1111/myc.13137,2020-07-02
oropharyngeal candidiasis,COEXISTS_WITH,patient condition,32609906,10.1111/myc.13137,2020-07-02
oropharyngeal candidiasis,COEXISTS_WITH,patient condition,32609906,10.1111/myc.13137,2020-07-02
"Leukemia, Myelocytic, Acute",PROCESS_OF,Patients,32609881,10.1111/bjh.16985,2020-07-02
Immunocompromised Host,PROCESS_OF,Patients,32609881,10.1111/bjh.16985,2020-07-02
Critical Illness,PROCESS_OF,Patients,32609845,10.1182/bloodadvances.2020001640,2020-07-02
Influenza due to Influenza A virus subtype H1N1,PROCESS_OF,Patients,32609845,10.1182/bloodadvances.2020001640,2020-07-02
Animals,INTERACTS_WITH,Influenza A virus,32609845,10.1182/bloodadvances.2020001640,2020-07-02
virus pathogenesis,PROCESS_OF,Animals,32609845,10.1182/bloodadvances.2020001640,2020-07-02
Neuraminidase,PART_OF,Virus,32609845,10.1182/bloodadvances.2020001640,2020-07-02
Nation,LOCATION_OF,Population Based Study,32609839,10.1093/ntr/ntaa121,2020-07-02
Infected,PROCESS_OF,Patients,32609640,10.1515/cclm-2020-0548,2020-07-02
Immunoassay method,MEASURES,,32609640,10.1515/cclm-2020-0548,2020-07-02
Serum,PART_OF,Homo sapiens,32609640,10.1515/cclm-2020-0548,2020-07-02
Immunoassay method,DIAGNOSES,SARS coronavirus,32609640,10.1515/cclm-2020-0548,2020-07-02
Serum,LOCATION_OF,CD40LG wt Allele,32609640,10.1515/cclm-2020-0548,2020-07-02
Serum,PART_OF,Homo sapiens,32609640,10.1515/cclm-2020-0548,2020-07-02
Hospitals,LOCATION_OF,Services,32609557,10.1177/0218492320940162,2020-07-02
Malignant neoplasm of thorax,PROCESS_OF,Patients,32609557,10.1177/0218492320940162,2020-07-02
Malignant neoplasm of thorax,PROCESS_OF,Patients,32609557,10.1177/0218492320940162,2020-07-02
Confirmation,PROCESS_OF,Patients,32609557,10.1177/0218492320940162,2020-07-02
responsibility,PROCESS_OF,Thoracic surgeon,32609557,10.1177/0218492320940162,2020-07-02
Rehabilitation therapy,TREATS,Male population group,32609464,10.1097/HCR.0000000000000529,2020-07-02
Hypertrophy,PROCESS_OF,Patients,32609464,10.1097/HCR.0000000000000529,2020-07-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32609464,10.1097/HCR.0000000000000529,2020-07-02
Disability,PROCESS_OF,Healthy Volunteers,32609464,10.1097/HCR.0000000000000529,2020-07-02
Complete Recovery,PREDISPOSES,Coronavirus Infections,32609464,10.1097/HCR.0000000000000529,2020-07-02
Assay,USES,"Spectrum Analysis, Raman",32609429,10.1002/jbio.202000189,2020-07-02
Patients,LOCATION_OF,Specimen Type - Stool = Fecal,32609390,10.1002/jmv.26250,2020-07-02
Infected,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Infected,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Upper respiratory tract,LOCATION_OF,risk factors,32609360,10.1093/qjmed/hcaa212,2020-07-02
Upper respiratory tract,LOCATION_OF,Duration,32609360,10.1093/qjmed/hcaa212,2020-07-02
Upper respiratory tract,PART_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Upper respiratory tract,PART_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Laboratory Procedures,DIAGNOSES,Asymptomatic,32609360,10.1093/qjmed/hcaa212,2020-07-02
Infected,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Asymptomatic,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Asymptomatic,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Asymptomatic,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Infected,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Persistence,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Duration,TREATS,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Duration,TREATS(INFER),Infected,32609360,10.1093/qjmed/hcaa212,2020-07-02
Asymptomatic,PROCESS_OF,Persons,32609360,10.1093/qjmed/hcaa212,2020-07-02
Psychiatric symptom,COEXISTS_WITH,risk factors,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Psychiatric symptom,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Anxiety,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Depressive disorder,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
acute stress,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Sleeplessness,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Psychiatric symptom,PROCESS_OF,Respondents,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Confirmation,PROCESS_OF,Participant,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,friend,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Family member,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Occupational Exposure,PROCESS_OF,Persons,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Psychiatric symptom,PROCESS_OF,general population,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Infected,PROCESS_OF,Persons,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Sleeplessness,PROCESS_OF,Persons,32609353,10.1001/jamanetworkopen.2020.14053,2020-07-02
Neurologic Manifestations,PROCESS_OF,Adult,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Neurologic Symptoms,PROCESS_OF,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Neurologic Symptoms,PROCESS_OF,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
GSKIP gene,PART_OF,Child,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Nasal Swab (procedure),METHOD_OF,Assay,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Brain,LOCATION_OF,Magnetic Resonance Imaging,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Electroencephalography,ADMINISTERED_TO,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Patients,LOCATION_OF,Autoantibodies,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Patients,LOCATION_OF,Oligodendrocyte-Myelin Glycoprotein,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Patients,LOCATION_OF,N-Methyl-D-Aspartate Receptors,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Electromyography,ADMINISTERED_TO,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Nerve conduction study,ADMINISTERED_TO,Patients,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Neurologic Symptoms,PROCESS_OF,Child,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Neurologic Symptoms,PROCESS_OF,Child,32609336,10.1001/jamaneurol.2020.2687,2020-07-02
Influenza,ISA,Pneumonia,32609310,10.1001/jamainternmed.2020.3391,2020-07-02
Autoimmune Diseases,PROCESS_OF,Patients,32609290,10.1590/0004-282X20200056,2020-07-02
Neuromyelitis Optica,PROCESS_OF,Patients,32609290,10.1590/0004-282X20200056,2020-07-02
Neuromyelitis Optica,PROCESS_OF,Patients,32609290,10.1590/0004-282X20200056,2020-07-02
Neuromyelitis Optica,PROCESS_OF,Patients,32609290,10.1590/0004-282X20200056,2020-07-02
GSKIP gene,ASSOCIATED_WITH(INFER),Neuromyelitis Optica,32609290,10.1590/0004-282X20200056,2020-07-02
GSKIP gene,PART_OF,Patients,32609290,10.1590/0004-282X20200056,2020-07-02
Brazil,ISA,Country,32609286,10.5935/0103-507X.20200030,2020-07-02
Decision,PROCESS_OF,Maker (occupation),32609286,10.5935/0103-507X.20200030,2020-07-02
Infected,PROCESS_OF,Patients,32609283,10.1590/1518-8345.4493.3346,2020-07-02
Infected,PROCESS_OF,Persons,32609282,10.1590/1518-8345.4501.3345,2020-07-02
Comorbidity,PROCESS_OF,Patients,32609257,10.1590/S1678-9946202062045,2020-07-02
Comorbidity,PROCESS_OF,Patients,32609257,10.1590/S1678-9946202062045,2020-07-02
Comorbidity,PROCESS_OF,Patients,32609257,10.1590/S1678-9946202062045,2020-07-02
Comorbidity,PROCESS_OF,Patients,32609257,10.1590/S1678-9946202062045,2020-07-02
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32609257,10.1590/S1678-9946202062045,2020-07-02
Coronavirus Infections,CAUSES,Communicable Diseases,32609256,10.1590/S1678-9946202062044,2020-07-02
4 times,PROCESS_OF,Relative (related person),32609253,10.1590/0034-7167-2020-0316,2020-07-02
Reading (activity),PREVENTS,Infection,32609252,10.1590/0034-7167-2020-0310,2020-07-02
Coronavirus Infections,AFFECTS,Child,32609250,10.1590/0034-7167-2020-0302,2020-07-02
brazilian,PROCESS_OF,Child,32609250,10.1590/0034-7167-2020-0302,2020-07-02
Isolation procedure,TREATS,Persons,32609235,10.1590/1807-3107bor-2020.vol34.0068,2020-07-02
Isolation procedure,TREATS(INFER),Infected,32609235,10.1590/1807-3107bor-2020.vol34.0068,2020-07-02
Infected,PROCESS_OF,Persons,32609235,10.1590/1807-3107bor-2020.vol34.0068,2020-07-02
Communicable Diseases,AFFECTS,Community,32609168,10.1590/0102-311X00115020,2020-07-02
Communicable Diseases,AFFECTS,Patients,32609168,10.1590/0102-311X00115020,2020-07-02
Interventional procedure,COEXISTS_WITH,Health Promotion,32609168,10.1590/0102-311X00115020,2020-07-02
Dental Procedures,ADMINISTERED_TO,Patients,32609145,10.1590/1807-3107bor-2020.vol34.0084,2020-07-02
Orthodontic procedure,ADMINISTERED_TO(SPEC),Patients,32609145,10.1590/1807-3107bor-2020.vol34.0084,2020-07-02
Orthodontic procedure,ISA,Dental Procedures,32609145,10.1590/1807-3107bor-2020.vol34.0084,2020-07-02
Dental Procedures,TREATS,Patients,32609145,10.1590/1807-3107bor-2020.vol34.0084,2020-07-02
Orthodontic procedure,TREATS,Patients,32609145,10.1590/1807-3107bor-2020.vol34.0084,2020-07-02
Knowledge acquisition,AFFECTS,Has difficulty doing (qualifier value),32609144,10.1590/1807-3107bor-2020.vol34.0083,2020-07-02
Educational process of instructing,AFFECTS,Has difficulty doing (qualifier value),32609144,10.1590/1807-3107bor-2020.vol34.0083,2020-07-02
Fever,ISA,Disease,32609142,10.5123/S1679-49742020000300018,2020-07-02
Wounds and Injuries,PROCESS_OF,Patients,32609085,10.1051/sicotj/2020022,2020-07-02
Emergency operation,TREATS,Patients,32609085,10.1051/sicotj/2020022,2020-07-02
Elective Surgical Procedures,TREATS,Patients,32609085,10.1051/sicotj/2020022,2020-07-02
Coronavirus Infections,ISA,Disease,32609083,10.3201/eid2610.201816,2020-07-02
Post-Exposure Prophylaxis,TREATS,Disease,32609083,10.3201/eid2610.201816,2020-07-02
Post-Exposure Prophylaxis,TREATS,curative treatment,32609083,10.3201/eid2610.201816,2020-07-02
Post-Exposure Prophylaxis,TREATS(SPEC),Coronavirus Infections,32609083,10.3201/eid2610.201816,2020-07-02
Disease,PROCESS_OF,Patients,32609083,10.3201/eid2610.201816,2020-07-02
long-term care,USES,Hydroxychloroquine,32609083,10.3201/eid2610.201816,2020-07-02
Sarcoidosis,PROCESS_OF,Patients,32609083,10.3201/eid2610.201816,2020-07-02
Coronavirus Infections,ISA,Disease,32609083,10.3201/eid2610.201816,2020-07-02
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32609083,10.3201/eid2610.201816,2020-07-02
Infected,PROCESS_OF,Persons,32608513,10.1002/ijgo.13293,2020-07-02
Infected,PROCESS_OF,Persons,32608513,10.1002/ijgo.13293,2020-07-02
Health behavior,AFFECTS,Movement,32608474,10.1093/abm/kaaa049,2020-07-02
Health behavior,AFFECTS,Movement,32608474,10.1093/abm/kaaa049,2020-07-02
Skin lesion,ISA,Symptoms,32608380,10.3390/dermatopathology7010002,2020-07-02
Lesion,PROCESS_OF,Patients,32608380,10.3390/dermatopathology7010002,2020-07-02
Urticaria,ISA,Lesion,32608380,10.3390/dermatopathology7010002,2020-07-02
Chilblains,PROCESS_OF,Child,32608380,10.3390/dermatopathology7010002,2020-07-02
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Child,32608380,10.3390/dermatopathology7010002,2020-07-02
Lesion,PROCESS_OF,Child,32608380,10.3390/dermatopathology7010002,2020-07-02
Vesicular rash,PROCESS_OF,Child,32608380,10.3390/dermatopathology7010002,2020-07-02
Structure of blood vessel of dermis,LOCATION_OF,Lesion,32608380,10.3390/dermatopathology7010002,2020-07-02
Coronavirus Infections,ISA,Disease,32608340,10.1080/01616412.2020.1781455,2020-07-02
Neurosurgical Procedures,TREATS,patient condition,32608340,10.1080/01616412.2020.1781455,2020-07-02
Neurosurgical Procedures,TREATS,Confirmation,32608340,10.1080/01616412.2020.1781455,2020-07-02
Airborne precautions,ADMINISTERED_TO,Health Personnel,32608340,10.1080/01616412.2020.1781455,2020-07-02
Coronavirus Infections,ISA,Disease,32608335,10.1080/22221751.2020.1785952,2020-07-02
Hospitals,LOCATION_OF,Nasal Swab (procedure),32608335,10.1080/22221751.2020.1785952,2020-07-02
Influenza-like symptoms,PROCESS_OF,hospitalized patients,32608335,10.1080/22221751.2020.1785952,2020-07-02
Specimen Type - Serum,LOCATION_OF,CD40LG wt Allele,32608335,10.1080/22221751.2020.1785952,2020-07-02
Possible,PROCESS_OF,Population Group,32608335,10.1080/22221751.2020.1785952,2020-07-02
Influenza,COEXISTS_WITH,Menstruation Disturbances,32608335,10.1080/22221751.2020.1785952,2020-07-02
Influenza-like symptoms,PROCESS_OF,Patients,32608335,10.1080/22221751.2020.1785952,2020-07-02
Coronavirus Infections,ISA,Disease,32608329,10.1080/07391102.2020.1787228,2020-07-02
Pharmaceutical Preparations,CAUSES,Disease,32608329,10.1080/07391102.2020.1787228,2020-07-02
Pharmaceutical Preparations,CAUSES(SPEC),Coronavirus Infections,32608329,10.1080/07391102.2020.1787228,2020-07-02
Vaccines,CAUSES,Disease,32608329,10.1080/07391102.2020.1787228,2020-07-02
Vaccines,CAUSES(SPEC),Coronavirus Infections,32608329,10.1080/07391102.2020.1787228,2020-07-02
Coronavirus Infections,ISA,Disease,32608329,10.1080/07391102.2020.1787228,2020-07-02
Infected,PROCESS_OF,Child,32608325,10.1080/22221751.2020.1787799,2020-07-02
spouse,ISA,Family member,32608325,10.1080/22221751.2020.1787799,2020-07-02
Close Relationship,PROCESS_OF,Persons,32608325,10.1080/22221751.2020.1787799,2020-07-02
Child,ISA,Persons,32608325,10.1080/22221751.2020.1787799,2020-07-02
Infection,ISA,Disease,32608207,10.3349/ymj.2020.61.7.631,2020-07-02
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Infection,32608159,10.1111/jth.14981,2020-07-02
Signaling Protein,AUGMENTS,Storm NOS,32608159,10.1111/jth.14981,2020-07-02
Complement System Proteins,STIMULATES,"SLC6A2 protein, human",32608159,10.1111/jth.14981,2020-07-02
Kidney,LOCATION_OF,Thrombus,32608159,10.1111/jth.14981,2020-07-02
Lung,LOCATION_OF,Thrombus,32608159,10.1111/jth.14981,2020-07-02
Atypical Hemolytic Uremic Syndrome,PROCESS_OF,Patients,32608159,10.1111/jth.14981,2020-07-02
C5 gene,ASSOCIATED_WITH,Virus Diseases,32608159,10.1111/jth.14981,2020-07-02
High Level,PROCESS_OF,Canadian,32608131,10.1111/appy.12400,2020-07-02
Alcohol abuse,ISA,Stress,32608131,10.1111/appy.12400,2020-07-02
Patients,DIAGNOSES,Symptoms,32608131,10.1111/appy.12400,2020-07-02
Clinician,DIAGNOSES,Symptoms,32608131,10.1111/appy.12400,2020-07-02
Present,PROCESS_OF,Patients,32608109,10.1111/jth.14980,2020-07-02
Detection,USES,Antiphospholipid Antibodies,32608109,10.1111/jth.14980,2020-07-02
Vero Cells,LOCATION_OF,Deuterium,32608097,10.1111/jopr.13220,2020-07-02
Curcumin,AFFECTS,Signal Transduction Pathways,32608046,10.1111/ced.14357,2020-07-02
Challenge,METHOD_OF,Screening procedure,32607932,10.1007/s11606-020-05990-0,2020-07-02
risk factors,PROCESS_OF,Patients,32607928,10.1007/s11606-020-05983-z,2020-07-02
risk factors,PROCESS_OF,Cohort,32607928,10.1007/s11606-020-05983-z,2020-07-02
Coronavirus Infections,ISA,Disease,32607866,10.1007/s12250-020-00252-z,2020-07-02
Disease,AFFECTS,Severe acute respiratory infection,32607866,10.1007/s12250-020-00252-z,2020-07-02
Coronavirus Infections,AFFECTS(SPEC),Severe acute respiratory infection,32607866,10.1007/s12250-020-00252-z,2020-07-02
Coronavirus Infections,ISA,Disease,32607866,10.1007/s12250-020-00252-z,2020-07-02
Pancreas,LOCATION_OF,IMPACT gene,32607860,10.1007/s11605-020-04712-5,2020-07-02
Stomach,LOCATION_OF,IMPACT gene,32607860,10.1007/s11605-020-04712-5,2020-07-02
Disease,PROCESS_OF,Corona,32607830,10.1007/s00784-020-03440-z,2020-07-02
Challenge,TREATS,Health Personnel,32607830,10.1007/s00784-020-03440-z,2020-07-02
Respiratory sample,PART_OF,Tract,32607737,10.1007/s10916-020-01597-4,2020-07-02
Hematologic Tests,ISA,Laboratory Procedures,32607737,10.1007/s10916-020-01597-4,2020-07-02
Hematologic Tests,USES,Laboratory Procedures,32607737,10.1007/s10916-020-01597-4,2020-07-02
ST segment elevation myocardial infarction,ISA,Myocardial Infarction,32607704,10.1007/s12471-020-01440-y,2020-07-02
Symptoms,PROCESS_OF,Patients,32607704,10.1007/s12471-020-01440-y,2020-07-02
Structure of medium size blood vessel (organ),PART_OF,Lung,32607684,10.1007/s00428-020-02881-x,2020-07-02
Epithelium,PART_OF,Alveolar,32607684,10.1007/s00428-020-02881-x,2020-07-02
Early-onset,CAUSES,Liver damage,32607684,10.1007/s00428-020-02881-x,2020-07-02
intensive care unit,LOCATION_OF,Study,32607652,10.1007/s11239-020-02181-w,2020-07-02
Ultrasonography,ADMINISTERED_TO,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
Coitus,ASSOCIATED_WITH,Deep Vein Thrombosis,32607652,10.1007/s11239-020-02181-w,2020-07-02
Deep Vein Thrombosis,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
risk factors,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
Deep Vein Thrombosis,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
Deep Vein Thrombosis,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
acute Deep vein thrombosis,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
D-dimer above reference range,PREDISPOSES,Deep Vein Thrombosis,32607652,10.1007/s11239-020-02181-w,2020-07-02
Deep Vein Thrombosis,PROCESS_OF,Patients,32607652,10.1007/s11239-020-02181-w,2020-07-02
Present,PREDISPOSES,Deep Vein Thrombosis,32607652,10.1007/s11239-020-02181-w,2020-07-02
D-dimer above reference range,COEXISTS_WITH,Hypoalbuminemia,32607652,10.1007/s11239-020-02181-w,2020-07-02
patient condition,COEXISTS_WITH,Pneumonia,32607634,10.1007/s00330-020-07022-1,2020-07-02
patient condition,COEXISTS_WITH,Coronavirus Infections,32607634,10.1007/s00330-020-07022-1,2020-07-02
Pneumonia,ISA,Lesion,32607634,10.1007/s00330-020-07022-1,2020-07-02
White Blood Cell Count procedure,DIAGNOSES,patient condition,32607634,10.1007/s00330-020-07022-1,2020-07-02
Hospitalization,ADMINISTERED_TO,Patients,32607633,10.1007/s00330-020-07041-y,2020-07-02
Neoplasms,PROCESS_OF,Patients,32607633,10.1007/s00330-020-07041-y,2020-07-02
Infected,PROCESS_OF,Patients,32607633,10.1007/s00330-020-07041-y,2020-07-02
Infected,PROCESS_OF,Patients,32607633,10.1007/s00330-020-07041-y,2020-07-02
Virus Diseases,COEXISTS_WITH,Domestic Violence,32607631,10.1007/s00330-020-07043-w,2020-07-02
Critical Illness,PROCESS_OF,Patients,32607555,10.1093/jac/dkaa239,2020-07-02
Plasma,LOCATION_OF,"GTP-Binding Protein alpha Subunits, Gs",32607555,10.1093/jac/dkaa239,2020-07-02
Circumferential Supracrestal Fiberotomy,TREATS,Patients,32607555,10.1093/jac/dkaa239,2020-07-02
Circumferential Supracrestal Fiberotomy,TREATS(INFER),Critical Illness,32607555,10.1093/jac/dkaa239,2020-07-02
Day 7,PROCESS_OF,Patients,32607555,10.1093/jac/dkaa239,2020-07-02
Kidney,LOCATION_OF,Mildly Abnormal Ejection Fraction,32607555,10.1093/jac/dkaa239,2020-07-02
Mildly Abnormal Ejection Fraction,PROCESS_OF,Patients,32607555,10.1093/jac/dkaa239,2020-07-02
Disease Progression,NEG_CAUSES,Cessation of life,32607526,10.1101/2020.06.26.20141044,2020-07-02
IMPACT gene,COEXISTS_WITH,Guanosine Diphosphate,32607526,10.1101/2020.06.26.20141044,2020-07-02
IMPACT gene,INTERACTS_WITH,Guanosine Diphosphate,32607526,10.1101/2020.06.26.20141044,2020-07-02
Old age,ISA,Population Group,32607525,10.1101/2020.06.24.20129817,2020-07-02
Old age,ISA,Population Group,32607525,10.1101/2020.06.24.20129817,2020-07-02
Influenza virus vaccine,TREATS,Population Group,32607525,10.1101/2020.06.24.20129817,2020-07-02
Influenza virus vaccine,TREATS(SPEC),Old age,32607525,10.1101/2020.06.24.20129817,2020-07-02
Old age,ISA,Population Group,32607525,10.1101/2020.06.24.20129817,2020-07-02
Phenotype determination,USES,Cytometry,32607524,10.1101/2020.06.26.20141341,2020-07-02
Immune response,PROCESS_OF,Cohort,32607524,10.1101/2020.06.26.20141341,2020-07-02
Cessation of life,PROCESS_OF,Patients,32607523,10.1101/2020.06.17.20134262,2020-07-02
Clinic,LOCATION_OF,Study,32607523,10.1101/2020.06.17.20134262,2020-07-02
Department,LOCATION_OF,Study,32607523,10.1101/2020.06.17.20134262,2020-07-02
Performance,PROCESS_OF,Cohort,32607523,10.1101/2020.06.17.20134262,2020-07-02
Diastolic blood pressure,ISA,Age,32607523,10.1101/2020.06.17.20134262,2020-07-02
contextual factors,PROCESS_OF,Outpatients,32607523,10.1101/2020.06.17.20134262,2020-07-02
Health care facility,LOCATION_OF,Analysis,32607521,10.1101/2020.06.15.20117747,2020-07-02
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32607520,10.1101/2020.06.19.20135095,2020-07-02
Pharmaceutical Preparations,TREATS,Persons,32607520,10.1101/2020.06.19.20135095,2020-07-02
Pharmaceutical Preparations,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32607520,10.1101/2020.06.19.20135095,2020-07-02
Pharmaceutical Preparations,TREATS(INFER),Obesity,32607520,10.1101/2020.06.19.20135095,2020-07-02
Obesity,PROCESS_OF,Persons,32607520,10.1101/2020.06.19.20135095,2020-07-02
Metformin,TREATS,Woman,32607520,10.1101/2020.06.19.20135095,2020-07-02
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Woman,32607520,10.1101/2020.06.19.20135095,2020-07-02
Obesity,PROCESS_OF,Woman,32607520,10.1101/2020.06.19.20135095,2020-07-02
Metformin,INTERACTS_WITH,"TNF protein, human",32607520,10.1101/2020.06.19.20135095,2020-07-02
Antibody Formation,PROCESS_OF,Plasma donor,32607519,10.1101/2020.06.26.20139063,2020-07-02
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32607519,10.1101/2020.06.26.20139063,2020-07-02
"Immunoglobulin A, Human",TREATS,Population Group,32607519,10.1101/2020.06.26.20139063,2020-07-02
Antibody Formation,PROCESS_OF,Plasma donor,32607519,10.1101/2020.06.26.20139063,2020-07-02
Assay,USES,CD40LG wt Allele,32607518,10.1101/2020.06.24.20139006,2020-07-02
Assay,DIAGNOSES,Hypersensitivity,32607518,10.1101/2020.06.24.20139006,2020-07-02
Hypersensitivity,PROCESS_OF,Persons,32607518,10.1101/2020.06.24.20139006,2020-07-02
Immunocompromised Host,PROCESS_OF,Persons,32607518,10.1101/2020.06.24.20139006,2020-07-02
institutionalized population,LOCATION_OF,IMPACT gene,32607517,10.1101/2020.06.24.20139212,2020-07-02
Severe Acute Respiratory Syndrome,AFFECTS,institutionalized population,32607517,10.1101/2020.06.24.20139212,2020-07-02
Disability,PROCESS_OF,Human Age Group,32607517,10.1101/2020.06.24.20139212,2020-07-02
Disability,PROCESS_OF,Population Group,32607517,10.1101/2020.06.24.20139212,2020-07-02
Hearing disability,PROCESS_OF,Population Group,32607517,10.1101/2020.06.24.20139212,2020-07-02
Asymptomatic Infections,INTERACTS_WITH,Virus,32607516,10.1101/2020.06.22.20136309,2020-07-02
High sensitivity,METHOD_OF,Detection,32607516,10.1101/2020.06.22.20136309,2020-07-02
High sensitivity,USES,Laboratory Procedures,32607516,10.1101/2020.06.22.20136309,2020-07-02
"Immunotherapy, Passive",TREATS,Virus,32607514,10.1101/2020.06.19.20135830,2020-07-02
Disease,PROCESS_OF,Patients,32607514,10.1101/2020.06.19.20135830,2020-07-02
Severe disorder,PROCESS_OF,Patients,32607514,10.1101/2020.06.19.20135830,2020-07-02
Disease,PROCESS_OF,Patients,32607514,10.1101/2020.06.19.20135830,2020-07-02
Decreased metabolic requirement,PROCESS_OF,Patients,32607514,10.1101/2020.06.19.20135830,2020-07-02
Coronavirus Infections,ISA,Disease,32607513,10.1101/2020.06.25.20137323,2020-07-02
Coronavirus Infections,ISA,Disease,32607513,10.1101/2020.06.25.20137323,2020-07-02
Hispanics,ISA,Ethnic group,32607513,10.1101/2020.06.25.20137323,2020-07-02
Severe disorder,PROCESS_OF,Patients,32607513,10.1101/2020.06.25.20137323,2020-07-02
Anemia,ISA,Hematological Disease,32607513,10.1101/2020.06.25.20137323,2020-07-02
Anemia,PREDISPOSES,Severe disorder,32607513,10.1101/2020.06.25.20137323,2020-07-02
Blood Coagulation Disorders,ISA,Hematological Disease,32607513,10.1101/2020.06.25.20137323,2020-07-02
Blood Coagulation Disorders,PREDISPOSES,Severe disorder,32607513,10.1101/2020.06.25.20137323,2020-07-02
Thrombocytopenia,ISA,Hematological Disease,32607513,10.1101/2020.06.25.20137323,2020-07-02
Thrombocytopenia,PREDISPOSES,Severe disorder,32607513,10.1101/2020.06.25.20137323,2020-07-02
Serum,PART_OF,Patients,32607511,10.1101/2020.06.22.165712,2020-07-02
ACE2 gene,PART_OF,Homo sapiens,32607511,10.1101/2020.06.22.165712,2020-07-02
A549 Cells,PRODUCES,ACE2 gene,32607511,10.1101/2020.06.22.165712,2020-07-02
A549 Cells,LOCATION_OF,Virus,32607511,10.1101/2020.06.22.165712,2020-07-02
Endometrium,LOCATION_OF,angiotensin converting enzyme 2,32607509,10.1101/2020.06.23.168252,2020-07-02
Endometrium,PART_OF,Homo sapiens,32607509,10.1101/2020.06.23.168252,2020-07-02
Human tissue,LOCATION_OF,Menstrual cycle,32607509,10.1101/2020.06.23.168252,2020-07-02
Stromal cell of endometrium,PART_OF,Homo sapiens,32607509,10.1101/2020.06.23.168252,2020-07-02
Quantitative Reverse Transcriptase PCR,METHOD_OF,Endometrial scraping,32607509,10.1101/2020.06.23.168252,2020-07-02
Stromal cell of endometrium,PART_OF,Homo sapiens,32607509,10.1101/2020.06.23.168252,2020-07-02
Mouse Uterus,LOCATION_OF,receptor,32607509,10.1101/2020.06.23.168252,2020-07-02
Endometrium Specimen,LOCATION_OF,receptor,32607509,10.1101/2020.06.23.168252,2020-07-02
Endometrium Specimen,PART_OF,Homo sapiens,32607509,10.1101/2020.06.23.168252,2020-07-02
ACE2 gene,STIMULATES,Stromal Cells,32607509,10.1101/2020.06.23.168252,2020-07-02
physiological aspects,COEXISTS_WITH,Decidual Cell Reaction,32607509,10.1101/2020.06.23.168252,2020-07-02
physiological aspects,PROCESS_OF,Endometrium,32607509,10.1101/2020.06.23.168252,2020-07-02
Universities,ISA,School,32607509,10.1101/2020.06.23.168252,2020-07-02
Conflict (Psychology),PROCESS_OF,Author,32607509,10.1101/2020.06.23.168252,2020-07-02
Peptide Hydrolases,PART_OF,Cells,32607508,10.1101/2020.06.26.174698,2020-07-02
Supernatant,LOCATION_OF,ethylisopropylamiloride,32607508,10.1101/2020.06.26.174698,2020-07-02
Virus,CAUSES,Infection,32607507,10.1101/2020.06.19.154930,2020-07-02
SARS coronavirus,CAUSES,Disease,32607507,10.1101/2020.06.19.154930,2020-07-02
Proteins,INTERACTS_WITH,Antigens,32607507,10.1101/2020.06.19.154930,2020-07-02
"Antibodies, Neutralizing",INTERACTS_WITH(SPEC),Antigens,32607507,10.1101/2020.06.19.154930,2020-07-02
"Antibodies, Neutralizing",ISA,Proteins,32607507,10.1101/2020.06.19.154930,2020-07-02
Specimen Type - Serum,LOCATION_OF,"Antibodies, Neutralizing",32607507,10.1101/2020.06.19.154930,2020-07-02
Kidney,LOCATION_OF,CLEC4M gene,32607506,10.1101/2020.06.22.165803,2020-07-02
Lung,LOCATION_OF,CLEC4M gene,32607506,10.1101/2020.06.22.165803,2020-07-02
Human tissue,LOCATION_OF,Immunofluorescent stain method,32607506,10.1101/2020.06.22.165803,2020-07-02
Neoplasms,PROCESS_OF,Population Group,32607505,10.33696/Signaling.1.006,2020-07-02
Biological Response Modifiers,DISRUPTS,Storm NOS,32607505,10.33696/Signaling.1.006,2020-07-02
Therapeutic procedure,TREATS,Falls,32607505,10.33696/Signaling.1.006,2020-07-02
Dry cough,ISA,Symptoms,32607499,10.34133/2020/6925296,2020-07-02
Loop-mediated Isothermal Amplification,DIAGNOSES,Disease,32607499,10.34133/2020/6925296,2020-07-02
angiotensin converting enzyme 2,INHIBITS,angiotensin II,32607467,10.1055/s-0040-1713678,2020-07-02
inflammatory response,COEXISTS_WITH,Coronavirus Infections,32607467,10.1055/s-0040-1713678,2020-07-02
angiotensin II,STIMULATES,Thrombin,32607467,10.1055/s-0040-1713678,2020-07-02
Lung Injury,PROCESS_OF,Patients,32607467,10.1055/s-0040-1713678,2020-07-02
angiotensin II,AFFECTS,Blood Coagulation Disorders,32607467,10.1055/s-0040-1713678,2020-07-02
angiotensin II,AFFECTS,Inflammation,32607467,10.1055/s-0040-1713678,2020-07-02
angiotensin II,AFFECTS,Vascular Diseases,32607467,10.1055/s-0040-1713678,2020-07-02
Complication,PROCESS_OF,Patients,32607467,10.1055/s-0040-1713678,2020-07-02
angiotensin II,TREATS,Patients,32607467,10.1055/s-0040-1713678,2020-07-02
Mechanical ventilation,TREATS,Patients,32607454,10.1016/j.cnp.2020.05.004,2020-07-02
frontal lobe,LOCATION_OF,Video EEG,32607454,10.1016/j.cnp.2020.05.004,2020-07-02
Magnetic Resonance Imaging,DIAGNOSES,Microbleeds,32607454,10.1016/j.cnp.2020.05.004,2020-07-02
Non-Convulsive Status Epilepticus,AFFECTS,Patients,32607454,10.1016/j.cnp.2020.05.004,2020-07-02
Attitude,PROCESS_OF,undergraduate student,32607405,10.1016/j.dib.2020.105855,2020-07-02
Iran,ISA,Country,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Hip Fractures,PROCESS_OF,Patients,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Fatigue,ISA,Symptoms,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Weakness,ISA,Symptoms,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Operative Surgical Procedures,TREATS,Patients,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Hip Fractures,PROCESS_OF,geriatric patients,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Disease,CAUSES,Fatigue,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Disease,CAUSES,Weakness,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Hip Fractures,COEXISTS_WITH,Coronavirus Infections,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Hip Fractures,PROCESS_OF,geriatric patients,32607400,10.22038/abjs.2020.47626.2333,2020-07-02
Coronavirus Infections,PROCESS_OF,Family,32607399,10.22038/abjs.2020.47790.2353,2020-07-02
Pharmaceutical Preparations,TREATS,Disease,32607398,10.22038/abjs.2020.47745.2349,2020-07-02
Vaccines,TREATS,Disease,32607398,10.22038/abjs.2020.47745.2349,2020-07-02
Electrons,DISRUPTS,Oxidative Stress,32607398,10.22038/abjs.2020.47745.2349,2020-07-02
Inflammation,AFFECTS,Anoxia,32607398,10.22038/abjs.2020.47745.2349,2020-07-02
Respiratory problem,PROCESS_OF,Patients,32607396,10.22038/abjs.2020.47757.2348,2020-07-02
Disease,OCCURS_IN,manager,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Disease,OCCURS_IN,Employer,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Disease,OCCURS_IN,Owner,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Disease,OCCURS_IN,World,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Coronavirus Infections,ISA,Disease,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Coronavirus Infections,OCCURS_IN(SPEC),manager,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Coronavirus Infections,OCCURS_IN(SPEC),Employer,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Coronavirus Infections,OCCURS_IN(SPEC),Owner,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Coronavirus Infections,OCCURS_IN(SPEC),World,32607395,10.22038/abjs.2020.47410.2323,2020-07-02
Elective Surgical Procedures,COEXISTS_WITH,Morning Report,32607394,10.22038/abjs.2020.47834.2362,2020-07-02
Wounds and Injuries,PROCESS_OF,Patients,32607394,10.22038/abjs.2020.47834.2362,2020-07-02
Elective Surgical Procedures,TREATS,Patients,32607394,10.22038/abjs.2020.47834.2362,2020-07-02
Wounds and Injuries,COEXISTS_WITH,Enthesitis-Related Arthritis,32607394,10.22038/abjs.2020.47834.2362,2020-07-02
Wounds and Injuries,PROCESS_OF,Patients,32607394,10.22038/abjs.2020.47834.2362,2020-07-02
Genus: Coronavirus,ISA,Virus,32607393,10.22038/abjs.2020.47828.2361,2020-07-02
Influenza-like illness,CAUSES,Complication,32607352,10.5455/javar.2020.g412,2020-07-02
Low grade fever,ISA,Symptoms,32607346,10.12998/wjcc.v8.i12.2655,2020-07-02
Low grade fever,PROCESS_OF,Patients,32607346,10.12998/wjcc.v8.i12.2655,2020-07-02
Comorbidity,PROCESS_OF,Patients,32607346,10.12998/wjcc.v8.i12.2655,2020-07-02
Malaise,PROCESS_OF,Patients,32607346,10.12998/wjcc.v8.i12.2655,2020-07-02
Lesion,PROCESS_OF,Patients,32607346,10.12998/wjcc.v8.i12.2655,2020-07-02
Treatment Protocols,TREATS,Pneumonia,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Disease,PROCESS_OF,Patients,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Disease,PROCESS_OF,Patients,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Fever,ISA,Symptoms,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Single organ dysfunction,PROCESS_OF,Patients,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Elevation procedure,TREATS,Females,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Elevation procedure,TREATS,patient is male,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Elevation procedure,TREATS,Patients,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Elevation procedure,TREATS,Males,32607332,10.12998/wjcc.v8.i12.2554,2020-07-02
Virus,CAUSES,Respiratory Failure,32607310,10.1016/j.idcr.2020.e00870,2020-07-02
other medicated shampoos in ATC,CAUSES,Mild disorder,32607305,10.7759/cureus.8815,2020-07-02
Coronavirus Infections,PROCESS_OF,Family,32607305,10.7759/cureus.8815,2020-07-02
Ophthalmologist (occupation),ISA,Health Personnel,32607305,10.7759/cureus.8815,2020-07-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32607304,10.7759/cureus.8808,2020-07-02
Myopericarditis,PROCESS_OF,Patients,32607304,10.7759/cureus.8808,2020-07-02
Hydroxychloroquine,TREATS,Patients,32607304,10.7759/cureus.8808,2020-07-02
Immunodiagnosis,ISA,Laboratory Procedures,32607246,10.1016/j.nmni.2020.100713,2020-07-02
Laboratory Procedures,USES,Immunodiagnosis,32607246,10.1016/j.nmni.2020.100713,2020-07-02
,PART_OF,Persons,32607246,10.1016/j.nmni.2020.100713,2020-07-02
Blood,LOCATION_OF,,32607246,10.1016/j.nmni.2020.100713,2020-07-02
Infected,PROCESS_OF,Persons,32607246,10.1016/j.nmni.2020.100713,2020-07-02
Asymptomatic,PROCESS_OF,Persons,32607242,10.1002/rcr2.604,2020-07-02
Coronavirus Infections,PROCESS_OF,Persons,32607242,10.1002/rcr2.604,2020-07-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32607242,10.1002/rcr2.604,2020-07-02
Pneumonia,CAUSES,Cessation of life,32606886,10.2147/JIR.S259096,2020-07-02
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32606886,10.2147/JIR.S259096,2020-07-02
Single organ dysfunction,CAUSES,Cessation of life,32606886,10.2147/JIR.S259096,2020-07-02
cytokine,AFFECTS,Severe (severity modifier),32606886,10.2147/JIR.S259096,2020-07-02
cytokine,ASSOCIATED_WITH,Disease,32606886,10.2147/JIR.S259096,2020-07-02
cytokine,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32606886,10.2147/JIR.S259096,2020-07-02
Coronavirus Infections,ISA,Disease,32606886,10.2147/JIR.S259096,2020-07-02
chemokine,AFFECTS,Severe (severity modifier),32606886,10.2147/JIR.S259096,2020-07-02
chemokine,ASSOCIATED_WITH,Disease,32606886,10.2147/JIR.S259096,2020-07-02
chemokine,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32606886,10.2147/JIR.S259096,2020-07-02
Genetic Polymorphism,PROCESS_OF,Genes,32606886,10.2147/JIR.S259096,2020-07-02
Antiviral Agents,DISRUPTS,Virus Replication,32606823,10.2147/IDR.S256773,2020-07-02
macrophage,INTERACTS_WITH,scavenger receptor,32606823,10.2147/IDR.S256773,2020-07-02
Cerebrovascular accident,PROCESS_OF,Patients,32606519,10.4103/aian.AIAN_380_20,2020-07-02
inflammatory response,PREDISPOSES,Cerebrovascular accident,32606519,10.4103/aian.AIAN_380_20,2020-07-02
Elevation procedure,USES,Fibrin fragment D,32606519,10.4103/aian.AIAN_380_20,2020-07-02
cytokine activity,PROCESS_OF,Patients,32606519,10.4103/aian.AIAN_380_20,2020-07-02
Heart Injuries,CAUSES,Embolism,32606519,10.4103/aian.AIAN_380_20,2020-07-02
Cerebrovascular accident,PROCESS_OF,Patients,32606519,10.4103/aian.AIAN_380_20,2020-07-02
Cerebral Hemorrhage,PROCESS_OF,Patients,32606509,10.4103/aian.AIAN_362_20,2020-07-02
Cytologist,DIAGNOSES,Enthesitis-Related Arthritis,32606493,10.4103/JOC.JOC_44_20,2020-07-02
Cystic Fibrosis,AFFECTS(SPEC),Caucasoid Race,32606316,10.1038/s41435-020-0103-y,2020-07-02
Cystic Fibrosis,ISA,Disease,32606316,10.1038/s41435-020-0103-y,2020-07-02
Disease,AFFECTS,Caucasoid Race,32606316,10.1038/s41435-020-0103-y,2020-07-02
Myopericarditis,COMPLICATES,Coronavirus Infections,32606285,10.12659/AJCR.925554,2020-07-02
Comorbidity,PROCESS_OF,Woman,32606285,10.12659/AJCR.925554,2020-07-02
Echocardiography,DIAGNOSES,Pericardial effusion,32606285,10.12659/AJCR.925554,2020-07-02
Right ventricular structure,LOCATION_OF,Shock,32606285,10.12659/AJCR.925554,2020-07-02
Lung,LOCATION_OF,Severe disorder,32606285,10.12659/AJCR.925554,2020-07-02
Pericardial effusion,COEXISTS_WITH,Coronavirus Infections,32606285,10.12659/AJCR.925554,2020-07-02
Laboratory,LOCATION_OF,Work,32606253,10.5056/jnm20107,2020-07-02
Protoplasm,LOCATION_OF,Protein Targeting,32606248,10.1073/pnas.2006560117,2020-07-02
Tacrolimus Binding Proteins,INTERACTS_WITH,CEP250 gene,32606248,10.1073/pnas.2006560117,2020-07-02
Tacrolimus Binding Protein 1A,INTERACTS_WITH(SPEC),CEP250 gene,32606248,10.1073/pnas.2006560117,2020-07-02
Tacrolimus Binding Protein 1A,ISA,Tacrolimus Binding Proteins,32606248,10.1073/pnas.2006560117,2020-07-02
Tacrolimus Binding Protein 1A,PART_OF,SARS coronavirus,32606248,10.1073/pnas.2006560117,2020-07-02
SARS coronavirus,CAUSES,Disease,32606248,10.1073/pnas.2006560117,2020-07-02
CEP250 gene,PART_OF,SARS coronavirus,32606248,10.1073/pnas.2006560117,2020-07-02
"Lupus Erythematosus, Systemic",CAUSES,Labor (Childbirth),32606133,10.1136/bcr-2020-235581,2020-07-02
Prehypertension,CAUSES,Labor (Childbirth),32606133,10.1136/bcr-2020-235581,2020-07-02
Coughing,PROCESS_OF,Boys,32606105,10.1136/bcr-2020-236264,2020-07-02
Diarrhea,PROCESS_OF,Boys,32606105,10.1136/bcr-2020-236264,2020-07-02
Nasal congestion (finding),PROCESS_OF,Boys,32606105,10.1136/bcr-2020-236264,2020-07-02
Increased sweating,PROCESS_OF,Boys,32606105,10.1136/bcr-2020-236264,2020-07-02
Hypophagia,PROCESS_OF,Boys,32606105,10.1136/bcr-2020-236264,2020-07-02
Supportive care,TREATS,Patients,32606105,10.1136/bcr-2020-236264,2020-07-02
Coinfection,PROCESS_OF,Child,32606105,10.1136/bcr-2020-236264,2020-07-02
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32606103,10.1136/neurintsurg-2020-016502,2020-07-02
Awake,PROCESS_OF,Patients,32606051,10.3949/ccjm.87a.ccc050,2020-07-02
Drug Repositioning,USES,Pharmaceutical Preparations,32606050,10.3949/ccjm.87a.ccc037,2020-07-02
Melatonin,ISA,Anti-Inflammatory Agents,32606050,10.3949/ccjm.87a.ccc037,2020-07-02
Melatonin,PREVENTS,Virus Diseases,32606050,10.3949/ccjm.87a.ccc037,2020-07-02
Toremifene,PREVENTS,Virus Diseases,32606050,10.3949/ccjm.87a.ccc037,2020-07-02
Physical and emotional exhaustion state,PROCESS_OF,Physicians,32606049,10.3949/ccjm.87a.ccc051,2020-07-02
Telemedicine,ISA,patient care,32605933,10.1136/bjsports-2020-102650,2020-07-02
"CD69 protein, human",COEXISTS_WITH,Pharmaceutical Preparations,32605933,10.1136/bjsports-2020-102650,2020-07-02
"CD69 protein, human",PART_OF,Neoplasm Metastasis,32605933,10.1136/bjsports-2020-102650,2020-07-02
Physiologic Organization,AFFECTS,Athletes,32605933,10.1136/bjsports-2020-102650,2020-07-02
Physiologic Organization,AFFECTS,Athletes,32605933,10.1136/bjsports-2020-102650,2020-07-02
Physiologic Organization,AFFECTS,Clinician,32605933,10.1136/bjsports-2020-102650,2020-07-02
Physiologic Organization,AFFECTS,Coach (occupation),32605933,10.1136/bjsports-2020-102650,2020-07-02
Protection,PROCESS_OF,teams,32605920,10.1136/jclinpath-2020-206710,2020-07-02
Pituitary Apoplexy,PREDISPOSES,Blindness,32605826,10.1016/j.bjan.2020.06.001,2020-07-02
Eye,LOCATION_OF,Blepharoptosis,32605826,10.1016/j.bjan.2020.06.001,2020-07-02
Protection,PROCESS_OF,Patients,32605788,10.1016/j.injury.2020.06.040,2020-07-02
Cross Infection,PROCESS_OF,Patients,32605788,10.1016/j.injury.2020.06.040,2020-07-02
Wounds and Injuries,PROCESS_OF,Patients,32605788,10.1016/j.injury.2020.06.040,2020-07-02
Wounds and Injuries,PROCESS_OF,Patients,32605788,10.1016/j.injury.2020.06.040,2020-07-02
Ergocalciferol,ADMINISTERED_TO,Persons,32605780,10.1016/j.jiph.2020.06.021,2020-07-02
Health care facility,LOCATION_OF,Work,32605730,10.1016/j.jtcvs.2020.05.052,2020-07-02
Health Care,TREATS,Enthesitis-Related Arthritis,32605730,10.1016/j.jtcvs.2020.05.052,2020-07-02
Asthma,ISA,Lung diseases,32605700,10.2500/aap.2020.41.200044,2020-07-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Asthma,32605700,10.2500/aap.2020.41.200044,2020-07-02
Adrenal Cortex Hormones,ISA,Pharmaceutical Preparations,32605700,10.2500/aap.2020.41.200044,2020-07-02
Adrenal Cortex Hormones,TREATS(SPEC),Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Asthma,PROCESS_OF,Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Pharmaceutical Preparations,TREATS,Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Pharmaceutical Preparations,TREATS(INFER),Asthma,32605700,10.2500/aap.2020.41.200044,2020-07-02
Adrenal Cortex Hormones,PREDISPOSES,Coronavirus Infections,32605700,10.2500/aap.2020.41.200044,2020-07-02
Adrenal Cortex Hormones,ISA,Pharmaceutical Preparations,32605700,10.2500/aap.2020.41.200044,2020-07-02
Asthma,PROCESS_OF,Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Health care facility,LOCATION_OF,Pulmonary function tests,32605700,10.2500/aap.2020.41.200044,2020-07-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Cough variant asthma,PROCESS_OF,Patients,32605700,10.2500/aap.2020.41.200044,2020-07-02
Antibody studies (procedure),USES,G Ab,32605700,10.2500/aap.2020.41.200044,2020-07-02
disease detection,TREATS,Asthma,32605700,10.2500/aap.2020.41.200044,2020-07-02
Cardiac Arrhythmia,PROCESS_OF,Cohort,32605683,10.1017/S0950268820001351,2020-07-02
Adverse effects,ASSOCIATED_WITH,tocilizumab,32605683,10.1017/S0950268820001351,2020-07-02
Ferritin,ISA,Iron,32605582,10.1186/s13017-020-00323-2,2020-07-02
intensive care unit,LOCATION_OF,Observational Study,32605582,10.1186/s13017-020-00323-2,2020-07-02
Transferrin Receptor,PART_OF,soluble,32605582,10.1186/s13017-020-00323-2,2020-07-02
Serum,LOCATION_OF,Iron,32605582,10.1186/s13017-020-00323-2,2020-07-02
Serum,LOCATION_OF(SPEC),Ferritin,32605582,10.1186/s13017-020-00323-2,2020-07-02
Immune response,NEG_PROCESS_OF,Patients,32605582,10.1186/s13017-020-00323-2,2020-07-02
iron metabolism,NEG_PROCESS_OF,Patients,32605582,10.1186/s13017-020-00323-2,2020-07-02
iron metabolism,PROCESS_OF,Patients,32605582,10.1186/s13017-020-00323-2,2020-07-02
Respiratory sample,PART_OF,Tract,32605577,10.1186/s12985-020-01359-1,2020-07-02
Transection (procedure),ADMINISTERED_TO,Child,32605549,10.1186/s12889-020-09164-9,2020-07-02
Anxiety,PROCESS_OF,Persons,32605422,10.1177/0020764020938807,2020-07-02
Depressive disorder,PROCESS_OF,Persons,32605422,10.1177/0020764020938807,2020-07-02
Obsessions,PROCESS_OF,Persons,32605422,10.1177/0020764020938807,2020-07-02
Societies,LOCATION_OF,Home Schooling,32605422,10.1177/0020764020938807,2020-07-02
Hospitals,LOCATION_OF,Industry,32605414,10.1177/0020731420937631,2020-07-02
inflammatory response,COEXISTS_WITH,Storm NOS,32605374,10.1021/acschemneuro.0c00346,2020-07-02
Nucleus solitarius,LOCATION_OF,Inflammation,32605374,10.1021/acschemneuro.0c00346,2020-07-02
Norovirus,PROCESS_OF,Mus,32605306,10.3390/v12070699,2020-07-02
Norovirus,PROCESS_OF,Homo sapiens,32605306,10.3390/v12070699,2020-07-02
IMPACT gene,PREVENTS,Complication,32605278,10.3390/jcm9072030,2020-07-02
dapagliflozin,TREATS,patient condition,32605278,10.3390/jcm9072030,2020-07-02
Anxiety,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Depressive disorder,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Stress,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Coronavirus Infections,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Hispanics,ISA,Population Group,32605264,10.3390/healthcare8030190,2020-07-02
Coronavirus Infections,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Coronavirus Infections,ISA,Disease,32605264,10.3390/healthcare8030190,2020-07-02
Self Efficacy,PROCESS_OF,Persons,32605250,10.3390/ijerph17134653,2020-07-02
Serologic tests,USES,CD40LG wt Allele,32605192,10.3390/jcm9072026,2020-07-02
Cartridge device,CAUSES,Acute Lung Injury,32605182,10.3390/toxics8030046,2020-07-02
Constituents,CAUSES,pulmonary toxicity,32605182,10.3390/toxics8030046,2020-07-02
Epithelium,PART_OF,Lung,32605182,10.3390/toxics8030046,2020-07-02
Reactive Oxygen Species,AUGMENTS,inflammatory response,32605182,10.3390/toxics8030046,2020-07-02
Bronchoalveolar Lavage Fluid,LOCATION_OF,Interleukin-6,32605182,10.3390/toxics8030046,2020-07-02
Bronchoalveolar Lavage Fluid,LOCATION_OF,Granulocyte Colony-Stimulating Factor,32605182,10.3390/toxics8030046,2020-07-02
Bronchoalveolar Lavage Fluid,LOCATION_OF,Eotaxin,32605182,10.3390/toxics8030046,2020-07-02
Infiltration,ASSOCIATED_WITH,Interleukin-6,32605182,10.3390/toxics8030046,2020-07-02
Infiltration,ASSOCIATED_WITH,Granulocyte Colony-Stimulating Factor,32605182,10.3390/toxics8030046,2020-07-02
Infiltration,ASSOCIATED_WITH,Eotaxin,32605182,10.3390/toxics8030046,2020-07-02
Leukotrienes,ISA,Eicosanoids,32605182,10.3390/toxics8030046,2020-07-02
user - individual,LOCATION_OF,Plasma,32605182,10.3390/toxics8030046,2020-07-02
Medium chain triglycerides,compared_with,Tocopherol Acetate,32605182,10.3390/toxics8030046,2020-07-02
Cartridge device,CAUSES,cytotoxicity,32605182,10.3390/toxics8030046,2020-07-02
Pharmaceutical Preparations,AFFECTS,Protection,32605097,10.3390/ijerph17134633,2020-07-02
Disease,AFFECTS,Decreasing,32605056,10.3390/ijerph17134624,2020-07-02
Coronavirus Infections,AFFECTS(SPEC),Decreasing,32605056,10.3390/ijerph17134624,2020-07-02
Coronavirus Infections,ISA,Disease,32605056,10.3390/ijerph17134624,2020-07-02
Laboratory Procedures,DIAGNOSES,Asymptomatic,32604919,10.3390/diagnostics10060434,2020-07-02
Serum,LOCATION_OF,"Antibodies, Viral",32604919,10.3390/diagnostics10060434,2020-07-02
Italy,ISA,Country,32604906,10.3390/ijerph17124609,2020-07-02
Disinfection,USES,Ethanol,32604906,10.3390/ijerph17124609,2020-07-02
Aspiration-action,USES,Cannula device,32604906,10.3390/ijerph17124609,2020-07-02
Mechanical Ventilator,compared_with,Surgical face mask,32604906,10.3390/ijerph17124609,2020-07-02
Therapeutic immunosuppression,METHOD_OF,disorder control (procedure),32604895,10.3390/jcm9062011,2020-07-02
Colitis,PROCESS_OF,Patients,32604895,10.3390/jcm9062011,2020-07-02
Gastroenteritis,PROCESS_OF,Patients,32604895,10.3390/jcm9062011,2020-07-02
Eosinophilic esophagitis,PROCESS_OF,Patients,32604895,10.3390/jcm9062011,2020-07-02
Chronic disease,CAUSES,Infection,32604895,10.3390/jcm9062011,2020-07-02
Pneumonia,PROCESS_OF,Patients,32604842,10.3390/plants9060800,2020-07-02
Virus,PROCESS_OF,Family,32604842,10.3390/plants9060800,2020-07-02
Influenza,PROCESS_OF,Hispanics,32604825,10.3390/biology9060141,2020-07-02
Decision,PROCESS_OF,Maker (occupation),32604825,10.3390/biology9060141,2020-07-02
Disease,PROCESS_OF,Persons,32604797,10.3390/molecules25122944,2020-07-02
"Herpesvirus 1, Cercopithecine",CAUSES,Disease,32604797,10.3390/molecules25122944,2020-07-02
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32604797,10.3390/molecules25122944,2020-07-02
N-Acetylneuraminic Acid,ADMINISTERED_TO,Host (organism),32604730,10.3390/ijms21124549,2020-07-02
SAS,INTERACTS_WITH,Glycoproteins,32604730,10.3390/ijms21124549,2020-07-02
Challenge,TREATS,World,32604709,10.3233/SHTI200602,2020-07-02
Body Temperature,ISA,Vital signs,32604593,10.3233/SHTI200486,2020-07-02
sentiments,PROCESS_OF,Community,32604591,10.3233/SHTI200484,2020-07-02
Insight,PROCESS_OF,teams,32604591,10.3233/SHTI200484,2020-07-02
Disease,PROCESS_OF,Population Group,32604590,10.3233/SHTI200483,2020-07-02
Coronavirus Infections,ISA,Disease,32604588,10.3233/SHTI200481,2020-07-02
Diagnosis,ADMINISTERED_TO,Patients,32604588,10.3233/SHTI200481,2020-07-02
Coronavirus Infections,ISA,Disease,32604588,10.3233/SHTI200481,2020-07-02
popularity,ISA,Services,32604587,10.3233/SHTI200480,2020-07-02
Body of uterus,LOCATION_OF,"Analgesics, Opioid",32604586,10.3233/SHTI200479,2020-07-02
Persons,LOCATION_OF,IMPACT gene,32604478,10.31128/AJGP-COVID-28,2020-07-01
Insect Bites,ISA,Animal bite,32604457,10.5603/IMH.2020.0023,2020-07-01
Asymptomatic,PROCESS_OF,traveler,32604457,10.5603/IMH.2020.0023,2020-07-01
Diagnostic tests,DIAGNOSES,Illness (finding),32604457,10.5603/IMH.2020.0023,2020-07-01
Diagnostic tests,DIAGNOSES,Asymptomatic Infections,32604457,10.5603/IMH.2020.0023,2020-07-01
Asymptomatic,PROCESS_OF,traveler,32604457,10.5603/IMH.2020.0023,2020-07-01
Patient in hospital,PROCESS_OF,Woman,32604446,10.1055/s-0040-1713145,2020-07-01
Study,MEASURES,Gestational Age,32604446,10.1055/s-0040-1713145,2020-07-01
Pregnancy,PROCESS_OF,hospitalized patients,32604446,10.1055/s-0040-1713145,2020-07-01
Patient observation,TREATS,Woman,32604446,10.1055/s-0040-1713145,2020-07-01
Respiration Disorders,PROCESS_OF,Human Age Group,32604438,10.1055/s-0040-1713587,2020-07-01
Virus,CAUSES,Respiration Disorders,32604438,10.1055/s-0040-1713587,2020-07-01
brazilian,PROCESS_OF,Obstetrician,32604438,10.1055/s-0040-1713587,2020-07-01
Immune response,CAUSES,Alveolar damage,32604407,10.1093/cid/ciaa904,2020-07-01
Immune response,PROCESS_OF,Patients,32604407,10.1093/cid/ciaa904,2020-07-01
Single organ dysfunction,MANIFESTATION_OF,Wound Healing,32604407,10.1093/cid/ciaa904,2020-07-01
Immunoregulation,PROCESS_OF,Patients,32604407,10.1093/cid/ciaa904,2020-07-01
Critical Illness,PROCESS_OF,Patients,32604407,10.1093/cid/ciaa904,2020-07-01
Immunoregulation,PROCESS_OF,Patients,32604407,10.1093/cid/ciaa904,2020-07-01
other medicated shampoos in ATC,TREATS,Patients,32604407,10.1093/cid/ciaa904,2020-07-01
other medicated shampoos in ATC,TREATS(INFER),Critical Illness,32604407,10.1093/cid/ciaa904,2020-07-01
NSUN2 gene,PART_OF,Patients,32604247,10.1097/WNO.0000000000001038,2020-07-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32604223,10.1097/SHK.0000000000001610,2020-07-01
Interleukin-10,AFFECTS,Storm NOS,32604223,10.1097/SHK.0000000000001610,2020-07-01
"Colony-stimulating factor, granulocyte-monocyte",STIMULATES,CD40LG wt Allele,32604223,10.1097/SHK.0000000000001610,2020-07-01
Symptoms,INTERACTS_WITH,Mood:-:Point in time:^Patient:-,32604203,10.1097/SPV.0000000000000918,2020-07-01
Epithelium,PART_OF,Cornea,32604196,10.1097/ICO.0000000000002479,2020-07-01
Medulla Oblongata,PART_OF,Patients,32604196,10.1097/ICO.0000000000002479,2020-07-01
Body Fluids,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
conjunctiva,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
Endothelium,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
Epithelium,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
Body tissue,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
Body tissue,PART_OF,Cornea,32604196,10.1097/ICO.0000000000002479,2020-07-01
Body tissue,PRODUCES,"RNA, Viral",32604196,10.1097/ICO.0000000000002479,2020-07-01
Stroma,NEG_LOCATION_OF,GSKIP gene,32604196,10.1097/ICO.0000000000002479,2020-07-01
Comorbidity,PROCESS_OF,Persons,32604138,10.1097/QAD.0000000000002607,2020-07-01
HIV,PROCESS_OF,Cohort,32604138,10.1097/QAD.0000000000002607,2020-07-01
risk factors,PROCESS_OF,Cohort,32604138,10.1097/QAD.0000000000002607,2020-07-01
HIV,PROCESS_OF,Cohort,32604138,10.1097/QAD.0000000000002607,2020-07-01
Comorbidity,PROCESS_OF,Cohort,32604138,10.1097/QAD.0000000000002607,2020-07-01
hiv risk factor,PROCESS_OF,Population Group,32604138,10.1097/QAD.0000000000002607,2020-07-01
Disease,PROCESS_OF,Persons,32604133,10.1097/ADM.0000000000000703,2020-07-01
opioid use,ISA,Disease,32604133,10.1097/ADM.0000000000000703,2020-07-01
opioid use,PROCESS_OF(SPEC),Persons,32604133,10.1097/ADM.0000000000000703,2020-07-01
Disease,PROCESS_OF,Patients,32604133,10.1097/ADM.0000000000000703,2020-07-01
opioid use,ISA,Disease,32604133,10.1097/ADM.0000000000000703,2020-07-01
opioid use,PROCESS_OF(SPEC),Patients,32604133,10.1097/ADM.0000000000000703,2020-07-01
Diarrhea,PROCESS_OF,Male population group,32604125,10.1097/RLU.0000000000003196,2020-07-01
Fatigue,PROCESS_OF,Male population group,32604125,10.1097/RLU.0000000000003196,2020-07-01
Intermittent fever,PROCESS_OF,Male population group,32604125,10.1097/RLU.0000000000003196,2020-07-01
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32604085,10.1088/1361-6498/aba16a,2020-07-01
Symptoms,PROCESS_OF,Patients,32604085,10.1088/1361-6498/aba16a,2020-07-01
CT protocol,COEXISTS_WITH,Physical Examination,32604085,10.1088/1361-6498/aba16a,2020-07-01
Performance,PROCESS_OF,Patients,32604085,10.1088/1361-6498/aba16a,2020-07-01
terminal patient care,TREATS,Chronic disease,32604016,10.1016/j.dsx.2020.06.042,2020-07-01
Diabetes,ISA,Disease,32604016,10.1016/j.dsx.2020.06.042,2020-07-01
Hypertensive disease,ISA,Disease,32604016,10.1016/j.dsx.2020.06.042,2020-07-01
Chronic Obstructive Airway Disease,ISA,Disease,32604016,10.1016/j.dsx.2020.06.042,2020-07-01
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32604013,10.1016/j.dsx.2020.06.020,2020-07-01
high-risk group,LOCATION_OF,Anti-Drug Antibody,32604013,10.1016/j.dsx.2020.06.020,2020-07-01
Influenza,AFFECTS,Chronic disease,32604011,10.1016/j.earlhumdev.2020.105116,2020-07-01
Immunotherapy,USES,Biological Response Modifiers,32603991,10.1016/j.jri.2020.103168,2020-07-01
Immunotherapy,USES,Immunosuppressive Agents,32603991,10.1016/j.jri.2020.103168,2020-07-01
Reproductive failure,PROCESS_OF,Woman,32603991,10.1016/j.jri.2020.103168,2020-07-01
Immunotherapy,TREATS,Woman,32603991,10.1016/j.jri.2020.103168,2020-07-01
Immunotherapy,TREATS,Woman,32603991,10.1016/j.jri.2020.103168,2020-07-01
Immunotherapy,TREATS(INFER),Reproductive failure,32603991,10.1016/j.jri.2020.103168,2020-07-01
Reproductive failure,PROCESS_OF,Woman,32603991,10.1016/j.jri.2020.103168,2020-07-01
Psychotic symptom,ASSOCIATED_WITH,Coronavirus Infections,32603930,10.1016/j.psychres.2020.113254,2020-07-01
Psychotic episodes,PROCESS_OF,Patients,32603930,10.1016/j.psychres.2020.113254,2020-07-01
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32603930,10.1016/j.psychres.2020.113254,2020-07-01
Psychotic symptom,PROCESS_OF,Patients,32603930,10.1016/j.psychres.2020.113254,2020-07-01
Asthma,PROCESS_OF,Adult,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Virus Diseases,AFFECTS,Asthma,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Asthma,AFFECTS,Severe asthma,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Asthma,PROCESS_OF,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Pneumonia,COEXISTS_WITH,Asthma,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Pneumonia,COEXISTS_WITH,Asthma,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Pneumonia,COEXISTS_WITH,Radiologic finding,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Exacerbation,PROCESS_OF,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Asthma,PROCESS_OF,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Adrenal Cortex Hormones,TREATS,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Asthma,PROCESS_OF,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Agonist,TREATS,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Exacerbation,PROCESS_OF,Patients,32603901,10.1016/j.jaip.2020.06.032,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32603883,10.1016/j.ridd.2020.103719,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32603883,10.1016/j.ridd.2020.103719,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32603883,10.1016/j.ridd.2020.103719,2020-07-01
Health Personnel,NEG_PRODUCES,BARRIER,32603849,10.1016/j.ajic.2020.06.203,2020-07-01
Coronavirus Infections,ISA,Disease,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Severe Acute Respiratory Syndrome,CAUSES,Disease,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Coronavirus Infections,PROCESS_OF,Family,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Fever,ISA,Symptoms,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Middle East Respiratory Syndrome,ISA,Infection,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Comorbidity,PROCESS_OF,Patients,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Cessation of life,PROCESS_OF,Patients,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Alzheimer's Disease,AFFECTS,CNS disorder,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Alzheimer's Disease,ISA,CNS disorder,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Diabetes Mellitus,AFFECTS,CNS disorder,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Diabetes Mellitus,AFFECTS(SPEC),Alzheimer's Disease,32603829,10.1016/j.bbadis.2020.165889,2020-07-01
Hospitals,LOCATION_OF,Retrospective Studies,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Acute hospital,LOCATION_OF,Polymerase Chain Reaction,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Respiratory Tract Infections,CAUSES,Bacteremia,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Bacteremia,PROCESS_OF,Patients,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Enterococcus,LOCATION_OF,sphingosine 1-phosphate,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Respiratory culture,DIAGNOSES,Coinfection,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Bacterial Infections,NEG_COEXISTS_WITH,Mycoses,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
Coinfection,PROCESS_OF,Control Groups,32603803,10.1016/j.cmi.2020.06.025,2020-07-01
adjuvant therapy,TREATS,"Respiratory Distress Syndrome, Adult",32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS,Influenza,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS,Patients,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS,"Pneumonia, Viral",32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS,Severe Acute Respiratory Syndrome,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS,Middle East Respiratory Syndrome,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Adrenal Cortex Hormones,TREATS(INFER),"Pneumonia, Viral",32603802,10.1016/j.cmi.2020.06.020,2020-07-01
"Pneumonia, Viral",PROCESS_OF,Patients,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,Influenza,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,"Pneumonia, Viral",32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,"Pneumonia, Viral",32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,Severe Acute Respiratory Syndrome,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,Middle East Respiratory Syndrome,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,ADMINISTERED_TO,Patients,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,ADMINISTERED_TO,Patients,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Steroid therapy,TREATS,Symptoms,32603802,10.1016/j.cmi.2020.06.020,2020-07-01
Immunoenzyme Procedure,USES,"Immunoglobulin A, Human",32603801,10.1016/j.cmi.2020.06.024,2020-07-01
Fluorescent Antibody Technique,USES,"M Protein, multiple myeloma",32603801,10.1016/j.cmi.2020.06.024,2020-07-01
Assay,USES,"Immunoglobulin A, Human",32603801,10.1016/j.cmi.2020.06.024,2020-07-01
Performance,PROCESS_OF,Patients,32603801,10.1016/j.cmi.2020.06.024,2020-07-01
Seizures,PROCESS_OF,Population Group,32603801,10.1016/j.cmi.2020.06.024,2020-07-01
Therapeutic procedure,ADMINISTERED_TO,Medical assistant,32603793,10.1016/j.jbi.2020.103483,2020-07-01
Syndrome,PROCESS_OF,Patients,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Neurologic Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Neurologic Symptoms,PROCESS_OF,Patients,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
"Encephalomyelitis, Acute Disseminated",ISA,Disease,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Encephalopathies,ISA,Disease,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Coronavirus Infections,PROCESS_OF,Patients,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Neurological observations,PROCESS_OF,Patients,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Worse,PROCESS_OF,Patients,32603770,10.1016/j.neurad.2020.06.007,2020-07-01
Radiologic finding,PROCESS_OF,Patients,32603707,10.1016/j.athoracsur.2020.06.008,2020-07-01
Superinfection,ISA,Disease,32603707,10.1016/j.athoracsur.2020.06.008,2020-07-01
Lung excision,TREATS,Patients,32603707,10.1016/j.athoracsur.2020.06.008,2020-07-01
Lung excision,TREATS,Air cyst,32603707,10.1016/j.athoracsur.2020.06.008,2020-07-01
Infected,PROCESS_OF,Persons,32603692,10.1016/j.ejphar.2020.173328,2020-07-01
"Heparin, Low-Molecular-Weight",ISA,Agent,32603692,10.1016/j.ejphar.2020.173328,2020-07-01
"Therapies, Investigational",ISA,Therapeutic procedure,32603679,10.1016/j.bjid.2020.06.005,2020-07-01
Experience,PROCESS_OF,Recipient,32603679,10.1016/j.bjid.2020.06.005,2020-07-01
Asymptomatic,PROCESS_OF,Persons,32603652,10.3201/eid2609.201798,2020-07-01
risk factors,PROCESS_OF,Patients,32603535,10.1002/jmv.26244,2020-07-01
chest findings,PROCESS_OF,Outpatients,32603531,10.1111/ijcp.13600,2020-07-01
febuxostat,compared_with,Hydroxychloroquine,32603531,10.1111/ijcp.13600,2020-07-01
Symptoms,PROCESS_OF,Outpatients,32603531,10.1111/ijcp.13600,2020-07-01
"CD69 protein, human",INTERACTS_WITH,Hydroxychloroquine,32603531,10.1111/ijcp.13600,2020-07-01
"CD69 protein, human",INTERACTS_WITH,febuxostat,32603531,10.1111/ijcp.13600,2020-07-01
Hydroxychloroquine,ADMINISTERED_TO,Patients,32603531,10.1111/ijcp.13600,2020-07-01
febuxostat,ADMINISTERED_TO,Patients,32603531,10.1111/ijcp.13600,2020-07-01
pulmonary involvement,PROCESS_OF,Patients,32603531,10.1111/ijcp.13600,2020-07-01
Hydroxychloroquine,TREATS,pulmonary involvement,32603531,10.1111/ijcp.13600,2020-07-01
febuxostat,TREATS,pulmonary involvement,32603531,10.1111/ijcp.13600,2020-07-01
Hydroxychloroquine,TREATS,Patients,32603531,10.1111/ijcp.13600,2020-07-01
lobe,PART_OF,Lung,32603515,10.1002/jmv.26242,2020-07-01
Severe (severity modifier),PREDISPOSES,Severe Acute Respiratory Syndrome,32603509,10.1002/jmv.26243,2020-07-01
Persistence,PROCESS_OF,Homo sapiens,32603505,10.1111/tbed.13707,2020-07-01
Clinical Investigators,DIAGNOSES,Disease,32603497,10.1111/odi.13516,2020-07-01
Clinical Investigators,DIAGNOSES(SPEC),Oral lesion,32603497,10.1111/odi.13516,2020-07-01
Clinical Investigators,DIAGNOSES(SPEC),Coronavirus Infections,32603497,10.1111/odi.13516,2020-07-01
Oral lesion,ISA,Disease,32603497,10.1111/odi.13516,2020-07-01
Coronavirus Infections,ISA,Disease,32603497,10.1111/odi.13516,2020-07-01
Pharmaceutical Preparations,TREATS,inflammatory response,32603493,10.1111/joim.13145,2020-07-01
Respiratory Failure,PROCESS_OF,Patients,32603493,10.1111/joim.13145,2020-07-01
Pharmaceutical Preparations,TREATS,Chronic disease,32603486,10.1111/fcp.12586,2020-07-01
Hospitals,LOCATION_OF,Study,32603484,10.1002/jmv.26235,2020-07-01
Analysis,USES,"Analyzer, device",32603484,10.1002/jmv.26235,2020-07-01
Laboratory Procedures,USES,Matrix Metalloproteinase 3,32603484,10.1002/jmv.26235,2020-07-01
Matrix Metalloproteinase 3,INTERACTS_WITH,TBX4 wt Allele,32603484,10.1002/jmv.26235,2020-07-01
Serum,LOCATION_OF,Matrix Metalloproteinase 3,32603484,10.1002/jmv.26235,2020-07-01
Serum,LOCATION_OF,Matrix Metalloproteinase 3,32603484,10.1002/jmv.26235,2020-07-01
Obesity,PROCESS_OF,Patients,32603481,10.1002/jmv.26237,2020-07-01
Finding of body mass index,PROCESS_OF,Patients,32603481,10.1002/jmv.26237,2020-07-01
Encephalopathies,PROCESS_OF,Patients,32603476,10.1002/jmv.26238,2020-07-01
Hospitals,LOCATION_OF,Retrospective Cohort Study,32603425,10.1093/cid/ciaa851,2020-07-01
Assay,USES,Nasal Swab (procedure),32603425,10.1093/cid/ciaa851,2020-07-01
Intubation,TREATS,Patients,32603425,10.1093/cid/ciaa851,2020-07-01
angiotensin converting enzyme 2,AUGMENTS,Virus Internalization,32603424,10.1210/endocr/bqaa112,2020-07-01
Adipose tissue,LOCATION_OF,angiotensin converting enzyme 2,32603424,10.1210/endocr/bqaa112,2020-07-01
"Endothelium, Vascular",LOCATION_OF,angiotensin converting enzyme 2,32603424,10.1210/endocr/bqaa112,2020-07-01
Islets of Langerhans,LOCATION_OF,angiotensin converting enzyme 2,32603424,10.1210/endocr/bqaa112,2020-07-01
Meta Analysis (statistical procedure),MEASURES,Percent inhibition,32603297,10.1109/TNB.2020.2997257,2020-07-01
Coronavirus Infections,PROCESS_OF,Animal Model,32603297,10.1109/TNB.2020.2997257,2020-07-01
Infected,PROCESS_OF,Child,32603290,10.3201/eid2610.202403,2020-07-01
Malignant Neoplasms,PROCESS_OF,Persons,32603253,10.1200/OP.20.00210,2020-07-01
Virus,PROCESS_OF,Persons,32603253,10.1200/OP.20.00210,2020-07-01
Coronavirus Infections,ISA,Disease,32603253,10.1200/OP.20.00210,2020-07-01
Malignant Neoplasms,PROCESS_OF,Patients,32603253,10.1200/OP.20.00210,2020-07-01
Exercise,TREATS,Persons,32603253,10.1200/OP.20.00210,2020-07-01
Malignant Neoplasms,PROCESS_OF,Woman,32603252,10.1200/OP.20.00364,2020-07-01
Abdomen,LOCATION_OF,Venous Thromboembolism,32603220,10.2214/AJR.20.23617,2020-07-01
Lower Extremity,LOCATION_OF,Venous Thromboembolism,32603220,10.2214/AJR.20.23617,2020-07-01
Pelvis,LOCATION_OF,Venous Thromboembolism,32603220,10.2214/AJR.20.23617,2020-07-01
Solid organ,LOCATION_OF,Infarction,32603220,10.2214/AJR.20.23617,2020-07-01
Arteries,LOCATION_OF,Thrombus,32603220,10.2214/AJR.20.23617,2020-07-01
Veins,LOCATION_OF,Thrombus,32603220,10.2214/AJR.20.23617,2020-07-01
Societies,LOCATION_OF,Knowledge acquisition,32603205,10.1089/omi.2020.0111,2020-07-01
Universities,LOCATION_OF,Knowledge acquisition,32603205,10.1089/omi.2020.0111,2020-07-01
Critical Illness,PROCESS_OF,Patients,32603180,10.20960/nh.03180,2020-07-01
Vitality,PROCESS_OF,Persons,32603180,10.20960/nh.03180,2020-07-01
Critical Illness,PROCESS_OF,Patients,32603180,10.20960/nh.03180,2020-07-01
Poor outcome,PREDISPOSES,Severe Acute Respiratory Syndrome,32603010,10.1111/ctr.14026,2020-07-01
GSKIP gene,AUGMENTS,3/6,32602983,10.1111/jrh.12486,2020-07-01
Operative Surgical Procedures,TREATS,Woman,32602939,10.1002/ijgo.13289,2020-07-01
Distress,PROCESS_OF,Community,32602929,10.3928/02793695-20200616-02,2020-07-01
Patient Monitoring,TREATS,Patients,32602884,10.1093/jamia/ocaa157,2020-07-01
Chiroptera,LOCATION_OF,angiotensin converting enzyme 2,32602823,10.1080/22221751.2020.1787797,2020-07-01
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32602823,10.1080/22221751.2020.1787797,2020-07-01
Interferons,STIMULATES,Integral Membrane Proteins,32602823,10.1080/22221751.2020.1787797,2020-07-01
TMPRSS2 gene,STIMULATES,Membrane Fusion,32602823,10.1080/22221751.2020.1787797,2020-07-01
Mycoses,PROCESS_OF,Patients,32602823,10.1080/22221751.2020.1787797,2020-07-01
Amphotericin B,ADMINISTERED_TO,Patients,32602823,10.1080/22221751.2020.1787797,2020-07-01
patient interview,COEXISTS_WITH,Triage,32602763,10.1080/09546634.2020.1789046,2020-07-01
Genus Betacoronavirus,COEXISTS_WITH,SARS coronavirus,32602627,10.1002/rmv.2122,2020-07-01
angiotensin converting enzyme 2,AFFECTS,Coronavirus Infections,32602627,10.1002/rmv.2122,2020-07-01
Transaminases increased,PROCESS_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
Chest,LOCATION_OF,Distress,32602604,10.1002/hep.31446,2020-07-01
Bilirubin,ASSOCIATED_WITH(INFER),Complication,32602604,10.1002/hep.31446,2020-07-01
Bilirubin,PART_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
Complication,PROCESS_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
GOT1 gene,ASSOCIATED_WITH(INFER),Complication,32602604,10.1002/hep.31446,2020-07-01
GOT1 gene,PART_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
Dyspnea,COEXISTS_WITH,patient condition,32602604,10.1002/hep.31446,2020-07-01
Chest,LOCATION_OF,Distress,32602604,10.1002/hep.31446,2020-07-01
Anoxia,PROCESS_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
Severe inflammation,PROCESS_OF,Patients,32602604,10.1002/hep.31446,2020-07-01
intergroup relations,ISA,Behavior,32602596,10.1111/bjso.12395,2020-07-01
member,INTERACTS_WITH,Corona,32602596,10.1111/bjso.12395,2020-07-01
Hospitals,LOCATION_OF,Work,32602562,10.1002/ijgo.13287,2020-07-01
Coronavirus Infections,ISA,Disease,32602386,10.1080/14767058.2020.1784873,2020-07-01
Adult,ISA,Population Group,32602386,10.1080/14767058.2020.1784873,2020-07-01
Coronavirus Infections,ISA,Disease,32602386,10.1080/14767058.2020.1784873,2020-07-01
Coronavirus Infections,ISA,Disease,32602386,10.1080/14767058.2020.1784873,2020-07-01
"Schools, Secondary",LOCATION_OF,Study,32602316,10.4045/tidsskr.20.0437,2020-07-01
subjective well-being,PROCESS_OF,student,32602316,10.4045/tidsskr.20.0437,2020-07-01
Weakness,PROCESS_OF,Adolescent (age group),32602316,10.4045/tidsskr.20.0437,2020-07-01
Compliance,PROCESS_OF,Woman,32602306,10.4045/tidsskr.20.0449,2020-07-01
Diabetes Mellitus,PROCESS_OF,Patients,32602272,10.4093/dmj.2020.0105,2020-07-01
risk factors,PROCESS_OF,Patients,32602272,10.4093/dmj.2020.0105,2020-07-01
Tertiary Care Centers,LOCATION_OF,Retrospective Cohort Study,32602272,10.4093/dmj.2020.0105,2020-07-01
Confirmation,PROCESS_OF,Patients,32602272,10.4093/dmj.2020.0105,2020-07-01
Diabetes Mellitus,PROCESS_OF,Patients,32602272,10.4093/dmj.2020.0105,2020-07-01
Disease Outcome,PROCESS_OF,geriatric patients,32602272,10.4093/dmj.2020.0105,2020-07-01
Experience,PROCESS_OF,Patients,32602262,10.1002/art.41422,2020-07-01
Suspicion,PROCESS_OF,Patients,32602262,10.1002/art.41422,2020-07-01
anakinra,ADMINISTERED_TO,Patients,32602262,10.1002/art.41422,2020-07-01
anakinra,NEG_ADMINISTERED_TO,Patients,32602262,10.1002/art.41422,2020-07-01
anakinra,TREATS,Patients,32602262,10.1002/art.41422,2020-07-01
anakinra,TREATS,Patients,32602262,10.1002/art.41422,2020-07-01
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Oral lesion,32602230,10.1111/odi.13517,2020-07-01
Coronavirus Infections,COEXISTS_WITH,Oral lesion,32602230,10.1111/odi.13517,2020-07-01
Masks,USES,Textiles,32602208,10.1111/dth.13909,2020-07-01
Masks,USES,Textiles,32602208,10.1111/dth.13909,2020-07-01
Hospitals,LOCATION_OF,Retrospective Cohort Study,32602202,10.1002/oby.22943,2020-07-01
Critical Illness,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Antiphospholipid Antibodies,PREDISPOSES,Blood Coagulation Disorders,32602200,10.1002/art.41425,2020-07-01
Critical Illness,NEG_PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Critical Illness,NEG_PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Critical Illness,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Disease,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Critical Illness,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Cerebral Infarction,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Critical Illness,PROCESS_OF,Patients,32602200,10.1002/art.41425,2020-07-01
Gastrointestinal symptom,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Gastrointestinal symptom,PROCESS_OF(SPEC),hospitalized patients,32602128,10.1111/jgh.15166,2020-07-01
hospitalized patients,ISA,Patients,32602128,10.1111/jgh.15166,2020-07-01
Immune,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Cessation of life,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Diarrhea,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Cessation of life,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Diarrhea,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
Early death,PROCESS_OF,Patients,32602128,10.1111/jgh.15166,2020-07-01
"Kidney Failure, Acute",PROCESS_OF,Patients,32602046,10.1007/s12250-020-00253-y,2020-07-01
Renal epithelial cell,PART_OF,"Kidney Tubules, Proximal",32602046,10.1007/s12250-020-00253-y,2020-07-01
Cell Count,DIAGNOSES,metaplastic cell transformation,32602046,10.1007/s12250-020-00253-y,2020-07-01
Renal epithelial cell,PART_OF,"Kidney Tubules, Proximal",32602046,10.1007/s12250-020-00253-y,2020-07-01
angiotensin converting enzyme 2,ASSOCIATED_WITH,Disease,32602046,10.1007/s12250-020-00253-y,2020-07-01
Cell Count,USES,Tracer,32602046,10.1007/s12250-020-00253-y,2020-07-01
Prostate,LOCATION_OF,Localized Malignant Neoplasm,32602024,10.1007/s11701-020-01115-1,2020-07-01
Cohort,LOCATION_OF,"Discharge, body substance",32602024,10.1007/s11701-020-01115-1,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32602006,10.1007/s40620-020-00790-5,2020-07-01
Abnormal renal function,PROCESS_OF,Patients,32602006,10.1007/s40620-020-00790-5,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32602006,10.1007/s40620-020-00790-5,2020-07-01
Virus,CAUSES,Infectious disease of lung,32601923,10.1007/s11033-020-05621-1,2020-07-01
Malignant Neoplasms,PROCESS_OF,Persons,32601854,10.1007/s00520-020-05588-6,2020-07-01
systemic therapy,TREATS,Malignant Neoplasms,32601854,10.1007/s00520-020-05588-6,2020-07-01
Respiratory Tract Infections,CAUSES,Lymphopenia,32601854,10.1007/s00520-020-05588-6,2020-07-01
systemic therapy,TREATS,Nausea,32601854,10.1007/s00520-020-05588-6,2020-07-01
systemic therapy,TREATS,Vomiting,32601854,10.1007/s00520-020-05588-6,2020-07-01
systemic therapy,TREATS,Solid Neoplasm,32601854,10.1007/s00520-020-05588-6,2020-07-01
Acute Coronary Syndrome,PROCESS_OF,Patients,32601849,10.1007/s11239-020-02201-9,2020-07-01
Myocardial Infarction,PROCESS_OF,Patients,32601849,10.1007/s11239-020-02201-9,2020-07-01
Acute Coronary Syndrome,PROCESS_OF,Patients,32601849,10.1007/s11239-020-02201-9,2020-07-01
Infectious disease prevention / control,COEXISTS_WITH,Dental Procedures,32601787,10.1007/s11282-020-00460-z,2020-07-01
crisis management,TREATS,Ability,32601725,10.1007/s00508-020-01695-w,2020-07-01
Malaise,PROCESS_OF,Patients,32601725,10.1007/s00508-020-01695-w,2020-07-01
Non-Ossifying Fibroma,PART_OF,Patients,32601725,10.1007/s00508-020-01695-w,2020-07-01
Infected,PROCESS_OF,Patients,32601725,10.1007/s00508-020-01695-w,2020-07-01
Critical Illness,PROCESS_OF,Patients,32601708,10.1093/infdis/jiaa387,2020-07-01
Prophylactic treatment,TREATS,Symptoms,32601708,10.1093/infdis/jiaa387,2020-07-01
Cytokine release syndrome,PROCESS_OF,Patients,32601708,10.1093/infdis/jiaa387,2020-07-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32601708,10.1093/infdis/jiaa387,2020-07-01
Critical Illness,PROCESS_OF,Patients,32601708,10.1093/infdis/jiaa387,2020-07-01
Organ,NEG_PART_OF,Lung,32601708,10.1093/infdis/jiaa387,2020-07-01
peripheral blood,LOCATION_OF,Interleukin-6,32601708,10.1093/infdis/jiaa387,2020-07-01
Cytokine release syndrome,PROCESS_OF,Patients,32601708,10.1093/infdis/jiaa387,2020-07-01
Patient in hospital,PROCESS_OF,Persons,32601704,10.1093/infdis/jiaa380,2020-07-01
Risk Assessment,TREATS,Patients,32601682,10.1093/milmed/usaa180,2020-07-01
Coronavirus Infections,PROCESS_OF,Population Group,32601682,10.1093/milmed/usaa180,2020-07-01
disease prevention,COEXISTS_WITH,Hospitalization,32601682,10.1093/milmed/usaa180,2020-07-01
Risk Assessment,TREATS,Population Group,32601682,10.1093/milmed/usaa180,2020-07-01
Risk Assessment,TREATS(INFER),critical limb ischemia,32601682,10.1093/milmed/usaa180,2020-07-01
critical limb ischemia,PROCESS_OF,Population Group,32601682,10.1093/milmed/usaa180,2020-07-01
Amputees,LOCATION_OF,Rheumatoid Factor,32601682,10.1093/milmed/usaa180,2020-07-01
Comorbidity,PROCESS_OF,Patients,32601682,10.1093/milmed/usaa180,2020-07-01
Households,INTERACTS_WITH,Persons,32601677,10.1093/ije/dyaa106,2020-07-01
Anger,PROCESS_OF,Cattle,32601655,10.17061/phrp3022010,2020-07-01
Challenge,TREATS,Practitioner,32601655,10.17061/phrp3022010,2020-07-01
Uptake,PROCESS_OF,Community,32601652,10.17061/phrp3022009,2020-07-01
Anxiety,AFFECTS,Disease,32601651,10.17061/phrp3022008,2020-07-01
Research Personnel,ISA,Persons,32601651,10.17061/phrp3022008,2020-07-01
Disease,PREDISPOSES,Cardiovascular Diseases,32601651,10.17061/phrp3022008,2020-07-01
Disease,PREDISPOSES,Depressive disorder,32601651,10.17061/phrp3022008,2020-07-01
Disease,PREDISPOSES,Mental deterioration,32601651,10.17061/phrp3022008,2020-07-01
Disease,PREDISPOSES,"Mortality, Premature",32601651,10.17061/phrp3022008,2020-07-01
Loneliness,ISA,Disease,32601651,10.17061/phrp3022008,2020-07-01
Loneliness,PREDISPOSES(SPEC),Cardiovascular Diseases,32601651,10.17061/phrp3022008,2020-07-01
Loneliness,PREDISPOSES(SPEC),Depressive disorder,32601651,10.17061/phrp3022008,2020-07-01
Loneliness,PREDISPOSES(SPEC),Mental deterioration,32601651,10.17061/phrp3022008,2020-07-01
Loneliness,PREDISPOSES(SPEC),"Mortality, Premature",32601651,10.17061/phrp3022008,2020-07-01
Loneliness,PROCESS_OF,Persons,32601651,10.17061/phrp3022008,2020-07-01
High Level,PROCESS_OF,parent,32601650,10.17061/phrp3022007,2020-07-01
Fever,ISA,Symptoms,32601577,10.7759/cureus.8790,2020-07-01
Muscle,LOCATION_OF,skeletal injury,32601577,10.7759/cureus.8790,2020-07-01
Dizziness,ISA,Symptoms,32601577,10.7759/cureus.8790,2020-07-01
Headache,ISA,Symptoms,32601577,10.7759/cureus.8790,2020-07-01
Muscle,LOCATION_OF,skeletal injury,32601577,10.7759/cureus.8790,2020-07-01
Myalgia,MANIFESTATION_OF,skeletal injury,32601577,10.7759/cureus.8790,2020-07-01
Cerebrovascular Disorders,COEXISTS_WITH,Comorbidity,32601577,10.7759/cureus.8790,2020-07-01
Encephalitis,COEXISTS_WITH,Comorbidity,32601577,10.7759/cureus.8790,2020-07-01
Encephalitis,ISA,Complication,32601577,10.7759/cureus.8790,2020-07-01
Guillain-Barre Syndrome,COEXISTS_WITH,Comorbidity,32601577,10.7759/cureus.8790,2020-07-01
Guillain-Barre Syndrome,ISA,Complication,32601577,10.7759/cureus.8790,2020-07-01
Myelitis,COEXISTS_WITH,Comorbidity,32601577,10.7759/cureus.8790,2020-07-01
Myelitis,ISA,Complication,32601577,10.7759/cureus.8790,2020-07-01
Genee-Wiedemann syndrome,COEXISTS_WITH,Comorbidity,32601577,10.7759/cureus.8790,2020-07-01
Genee-Wiedemann syndrome,ISA,Complication,32601577,10.7759/cureus.8790,2020-07-01
Neurologists,TREATS,Patients,32601577,10.7759/cureus.8790,2020-07-01
Disease,PROCESS_OF,Homo sapiens,32601278,10.1038/s41598-020-66716-0,2020-07-01
Nose,PART_OF,Homo sapiens,32601278,10.1038/s41598-020-66716-0,2020-07-01
Vaccines,PART_OF,Nose,32601278,10.1038/s41598-020-66716-0,2020-07-01
Respiratory Mucosa,LOCATION_OF,Coronavirus Infections,32601278,10.1038/s41598-020-66716-0,2020-07-01
Coronavirus Infections,ISA,Communicable Diseases,32601125,10.7861/clinmed.2020-0252,2020-07-01
Communicable Diseases,ISA,Disease,32601125,10.7861/clinmed.2020-0252,2020-07-01
Endothelium,LOCATION_OF,Disease,32601125,10.7861/clinmed.2020-0252,2020-07-01
Endothelium,LOCATION_OF(SPEC),Communicable Diseases,32601125,10.7861/clinmed.2020-0252,2020-07-01
Coronavirus Infections,ISA,Communicable Diseases,32601125,10.7861/clinmed.2020-0252,2020-07-01
angiotensin converting enzyme 2,INTERACTS_WITH,Endothelial Cells,32601125,10.7861/clinmed.2020-0252,2020-07-01
angiotensin converting enzyme 2,PRODUCES,Reactive Oxygen Species,32601125,10.7861/clinmed.2020-0252,2020-07-01
Endoscopy (procedure),ADMINISTERED_TO,Patients,32601037,10.1016/j.dld.2020.06.023,2020-07-01
Acute Coronary Syndrome,PROCESS_OF,Patients,32601022,10.1016/j.hlc.2020.05.003,2020-07-01
Coronavirus Infections,ISA,Disease,32601020,10.1016/j.hlc.2020.05.101,2020-07-01
Coronavirus Infections,COEXISTS_WITH,Disease,32601020,10.1016/j.hlc.2020.05.101,2020-07-01
Coronavirus Infections,ISA,Disease,32601020,10.1016/j.hlc.2020.05.101,2020-07-01
Coronavirus Infections,ISA,Disease,32601020,10.1016/j.hlc.2020.05.101,2020-07-01
Analgesics,AUGMENTS,Spitting,32601006,10.1016/j.ajem.2020.04.055,2020-07-01
Hypnotics and Sedatives,AUGMENTS,Spitting,32601006,10.1016/j.ajem.2020.04.055,2020-07-01
intensive care,USES,Artificial Airways,32601006,10.1016/j.ajem.2020.04.055,2020-07-01
Coronavirus Infections,ISA,Disease,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Angiotensin-Converting Enzyme Inhibitors,TREATS,Non-Ossifying Fibroma,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Coronavirus Infections,ISA,Disease,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Coronavirus Infections,PROCESS_OF,Patients,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Angiotensin II receptor antagonist,TREATS,Non-Ossifying Fibroma,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Disease,PROCESS_OF,Patients,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Coronavirus Infections,ISA,Disease,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Coronavirus Infections,ISA,Disease,32600991,10.1016/j.rec.2020.05.018,2020-07-01
Personal protective equipment,ISA,Entity,32600965,10.1016/j.idh.2020.05.005,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Developmental Disabilities,PROCESS_OF,Persons,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Possible,PROCESS_OF,Population Group,32600948,10.1016/j.dhjo.2020.100969,2020-07-01
Coronavirus Infections,PROCESS_OF,Respondents,32600945,10.1016/j.rbmo.2020.05.015,2020-07-01
Institutionalized,PROCESS_OF,Population Group,32600935,10.1016/j.semerg.2020.06.003,2020-07-01
Disease,PROCESS_OF,Old age,32600935,10.1016/j.semerg.2020.06.003,2020-07-01
Malaise,PROCESS_OF,Patients,32600935,10.1016/j.semerg.2020.06.003,2020-07-01
Severe cognitive impairment,PROCESS_OF,Patients,32600935,10.1016/j.semerg.2020.06.003,2020-07-01
Research and Development,USES,Technology Platform,32600908,10.1016/j.vaccine.2020.06.022,2020-07-01
Physical Examination,USES,Boards (medical device),32600881,10.1016/j.surg.2020.06.003,2020-07-01
Physical Examination,USES,Boards (medical device),32600881,10.1016/j.surg.2020.06.003,2020-07-01
Hoarseness,OCCURS_IN,Patients,32600873,10.1016/j.jvoice.2020.05.012,2020-07-01
Symptoms,PROCESS_OF,Patients,32600873,10.1016/j.jvoice.2020.05.012,2020-07-01
Nose,LOCATION_OF,Obstruction,32600873,10.1016/j.jvoice.2020.05.012,2020-07-01
Patients,ISA,Persons,32600873,10.1016/j.jvoice.2020.05.012,2020-07-01
"Stress, Psychological",AFFECTS,Voice,32600872,10.1016/j.jvoice.2020.05.028,2020-07-01
"Stress, Psychological",PROCESS_OF,college teachers,32600872,10.1016/j.jvoice.2020.05.028,2020-07-01
Symptoms,PROCESS_OF,college teachers,32600872,10.1016/j.jvoice.2020.05.028,2020-07-01
"Stress, Psychological",AFFECTS,Voice,32600872,10.1016/j.jvoice.2020.05.028,2020-07-01
Infection,CAUSES,anemia acute,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Hemolytic crisis,PROCESS_OF,Persons,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Glucose-6-phosphate deficiency,COEXISTS_WITH,Virus Diseases,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Pharmaceutical Preparations,CAUSES,Hemolytic crisis,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Hemolytic crisis,PROCESS_OF,Persons,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Glucose-6-phosphate deficiency,PROCESS_OF,Persons,32600868,10.1016/j.arcmed.2020.06.006,2020-07-01
Obesity,PROCESS_OF,Population Group,32600823,10.1016/j.jviscsurg.2020.06.005,2020-07-01
Population Group,LOCATION_OF,IMPACT gene,32600823,10.1016/j.jviscsurg.2020.06.005,2020-07-01
Diabetes,PREDISPOSES,Severe (severity modifier),32600823,10.1016/j.jviscsurg.2020.06.005,2020-07-01
Obesity,PREDISPOSES,Severe (severity modifier),32600823,10.1016/j.jviscsurg.2020.06.005,2020-07-01
Obesity,PROCESS_OF,Patients,32600823,10.1016/j.jviscsurg.2020.06.005,2020-07-01
Disease,PROCESS_OF,Patients,32600800,10.1016/j.bjan.2020.05.002,2020-07-01
"Anesthesia, Conduction",TREATS,pulmonary involvement,32600800,10.1016/j.bjan.2020.05.002,2020-07-01
"Anesthesia, Conduction",TREATS,Adverse effects,32600800,10.1016/j.bjan.2020.05.002,2020-07-01
Protection,PROCESS_OF,Persons,32600800,10.1016/j.bjan.2020.05.002,2020-07-01
"Anesthesia, Conduction",TREATS,Patients,32600800,10.1016/j.bjan.2020.05.002,2020-07-01
Critical Illness,PROCESS_OF,Patients,32600742,10.1016/j.echo.2020.05.022,2020-07-01
Critical Illness,PROCESS_OF,Patients,32600742,10.1016/j.echo.2020.05.022,2020-07-01
"Echocardiography, Transesophageal",ADMINISTERED_TO,Physicians,32600742,10.1016/j.echo.2020.05.022,2020-07-01
Experience,PROCESS_OF,Patients,32600742,10.1016/j.echo.2020.05.022,2020-07-01
Evaluation,ADMINISTERED_TO,Clinician,32600742,10.1016/j.echo.2020.05.022,2020-07-01
Critical Illness,PROCESS_OF,Patients,32600742,10.1016/j.echo.2020.05.022,2020-07-01
Physical Examination,ADMINISTERED_TO,Patients,32600651,10.1016/j.crad.2020.06.010,2020-07-01
Physical Examination,USES,tomography,32600651,10.1016/j.crad.2020.06.010,2020-07-01
Abdominal Pain,PROCESS_OF,Patients,32600651,10.1016/j.crad.2020.06.010,2020-07-01
Elective procedure,TREATS,Patients,32600651,10.1016/j.crad.2020.06.010,2020-07-01
Negative,CAUSES,Hypersensitivity,32600651,10.1016/j.crad.2020.06.010,2020-07-01
Disease,PROCESS_OF,World,32600649,10.1016/j.otorri.2020.05.001,2020-07-01
Coronavirus Infections,ISA,Disease,32600649,10.1016/j.otorri.2020.05.001,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),World,32600649,10.1016/j.otorri.2020.05.001,2020-07-01
medicare/medicaid,LOCATION_OF,Services,32600512,10.4140/TCP.n.2020.331.,2020-07-01
Immunization,COEXISTS_WITH,patient safety,32600512,10.4140/TCP.n.2020.331.,2020-07-01
Cyanosis,PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
Fever,PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
Lung,LOCATION_OF,"Hypertension, severe",32600496,10.1017/S1047951120001857,2020-07-01
Neoplasm Metastasis,PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
"Shock, Cardiogenic",PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
"Heart Failure, Right-Sided",PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
Medical History,PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
"Hypertension, severe",PROCESS_OF,Infant,32600496,10.1017/S1047951120001857,2020-07-01
Infectious disease of lung,PROCESS_OF,Child,32600496,10.1017/S1047951120001857,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Male population group,32600476,10.1017/S1049023X20000837,2020-07-01
Insight,PROCESS_OF,Patients,32600476,10.1017/S1049023X20000837,2020-07-01
Coitus,COEXISTS_WITH,Immune response,32600476,10.1017/S1049023X20000837,2020-07-01
Gonadal Steroid Hormones,AFFECTS,Immune System Processes,32600476,10.1017/S1049023X20000837,2020-07-01
Coronavirus Infections,ISA,Disease,32600460,10.1186/s12909-020-02117-1,2020-07-01
"CD69 protein, human",AFFECTS,Disease,32600460,10.1186/s12909-020-02117-1,2020-07-01
"CD69 protein, human",AFFECTS(SPEC),Coronavirus Infections,32600460,10.1186/s12909-020-02117-1,2020-07-01
Confidence,PROCESS_OF,student,32600460,10.1186/s12909-020-02117-1,2020-07-01
Coronavirus Infections,ISA,Disease,32600460,10.1186/s12909-020-02117-1,2020-07-01
Analysis,MEASURES,Financial cost,32600426,10.1186/s40249-020-00689-0,2020-07-01
Provincial hospital,LOCATION_OF,Cost Analysis,32600426,10.1186/s40249-020-00689-0,2020-07-01
Patients,USES,Preexisting Condition Coverage,32600426,10.1186/s40249-020-00689-0,2020-07-01
Obesity,ISA,Disease,32600411,10.1186/s40249-020-00703-5,2020-07-01
Infected,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Obesity,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Serum,LOCATION_OF,Creatinine,32600411,10.1186/s40249-020-00703-5,2020-07-01
Pneumonia,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Finding of body mass index,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Disease Exacerbation,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Finding of body mass index,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Serum,LOCATION_OF,Creatinine,32600411,10.1186/s40249-020-00703-5,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32600411,10.1186/s40249-020-00703-5,2020-07-01
Immunologic Adjuvants,AFFECTS,cell growth,32600410,10.1186/s12967-020-02433-6,2020-07-01
Lung,LOCATION_OF,Severe disorder,32600410,10.1186/s12967-020-02433-6,2020-07-01
Endosomes,LOCATION_OF,Monomeric GTP-Binding Proteins,32600410,10.1186/s12967-020-02433-6,2020-07-01
Virion,PART_OF,Lysosomes,32600410,10.1186/s12967-020-02433-6,2020-07-01
zoledronic acid,ISA,Diphosphonates,32600410,10.1186/s12967-020-02433-6,2020-07-01
Diphosphonates,AFFECTS,Disease,32600410,10.1186/s12967-020-02433-6,2020-07-01
zoledronic acid,AFFECTS,Disease,32600410,10.1186/s12967-020-02433-6,2020-07-01
zoledronic acid,AFFECTS(SPEC),Disease,32600410,10.1186/s12967-020-02433-6,2020-07-01
zoledronic acid,ISA,Diphosphonates,32600410,10.1186/s12967-020-02433-6,2020-07-01
Home exercise program,ADMINISTERED_TO,Patients,32600378,10.1186/s13063-020-04494-w,2020-07-01
Physical Well-being,PROCESS_OF,Patients,32600378,10.1186/s13063-020-04494-w,2020-07-01
Program,TREATS,Patients,32600378,10.1186/s13063-020-04494-w,2020-07-01
Home exercise program,TREATS,Patients,32600378,10.1186/s13063-020-04494-w,2020-07-01
pantoprazole,ISA,Proton Pump Inhibitors,32600363,10.1186/s13063-020-04476-y,2020-07-01
Plasma,LOCATION_OF,Hydroxychloroquine,32600363,10.1186/s13063-020-04476-y,2020-07-01
Protoplasm,LOCATION_OF,Hydroxychloroquine,32600363,10.1186/s13063-020-04476-y,2020-07-01
peripheral blood,LOCATION_OF,Hydroxychloroquine,32600363,10.1186/s13063-020-04476-y,2020-07-01
Peripheral blood mononuclear cell (cell),LOCATION_OF,Hydroxychloroquine,32600363,10.1186/s13063-020-04476-y,2020-07-01
Hydroxychloroquine,TREATS,Drug Interactions,32600363,10.1186/s13063-020-04476-y,2020-07-01
"cytochrome P450 3A4 protein, human",INTERACTS_WITH,Enzymes,32600363,10.1186/s13063-020-04476-y,2020-07-01
CYP2D6 gene,INTERACTS_WITH,Enzymes,32600363,10.1186/s13063-020-04476-y,2020-07-01
Phenotype determination,USES,Pharmaceutical Preparations,32600363,10.1186/s13063-020-04476-y,2020-07-01
Phenotype determination,USES,Midazolam,32600363,10.1186/s13063-020-04476-y,2020-07-01
Phenotype determination,USES,yohimbine,32600363,10.1186/s13063-020-04476-y,2020-07-01
Phenotype determination,USES,CYP2D6 gene,32600363,10.1186/s13063-020-04476-y,2020-07-01
Neurologic Examination,DIAGNOSES,Weakness,32600350,10.1186/s13000-020-00994-0,2020-07-01
laboratory studies,DIAGNOSES,Agranulocytosis,32600350,10.1186/s13000-020-00994-0,2020-07-01
laboratory studies,DIAGNOSES,Lymphopenia,32600350,10.1186/s13000-020-00994-0,2020-07-01
Anti-Inflammatory Agents,TREATS,Patients,32600350,10.1186/s13000-020-00994-0,2020-07-01
Antiviral Agents,TREATS,Patients,32600350,10.1186/s13000-020-00994-0,2020-07-01
atorvastatin,TREATS,Acute Cerebrovascular Accidents,32600350,10.1186/s13000-020-00994-0,2020-07-01
Communicable Diseases,PROCESS_OF,Physicians,32600350,10.1186/s13000-020-00994-0,2020-07-01
Hospitals,LOCATION_OF,Retrospective Studies,32600344,10.1186/s12931-020-01429-6,2020-07-01
Lung volume,AFFECTS,Respiratory physiology,32600344,10.1186/s12931-020-01429-6,2020-07-01
Abnormal Finding,PROCESS_OF,Patients,32600344,10.1186/s12931-020-01429-6,2020-07-01
HMGB1 gene,PREDISPOSES,Inflammation,32600316,10.1186/s10020-020-00184-0,2020-07-01
HMGB1 gene,CAUSES,Acute Lung Injury,32600316,10.1186/s10020-020-00184-0,2020-07-01
HMGB1 gene,PART_OF,Extracellular,32600316,10.1186/s10020-020-00184-0,2020-07-01
HMGB1 gene,DISRUPTS,Arteries,32600316,10.1186/s10020-020-00184-0,2020-07-01
HMGB1 gene,DISRUPTS,Arteries,32600316,10.1186/s10020-020-00184-0,2020-07-01
Airway structure,LOCATION_OF,HMGB1 gene,32600316,10.1186/s10020-020-00184-0,2020-07-01
Severe disorder,PROCESS_OF,Persons,32600222,10.33321/cdi.2020.44.54,2020-07-01
Disease,PROCESS_OF,Child,32600222,10.33321/cdi.2020.44.54,2020-07-01
Americas,ISA,Geographic Locations,32600222,10.33321/cdi.2020.44.54,2020-07-01
Brazil,ISA,Geographic Locations,32600222,10.33321/cdi.2020.44.54,2020-07-01
Chile,ISA,Geographic Locations,32600222,10.33321/cdi.2020.44.54,2020-07-01
"Asia, Southeastern",ISA,Geographic Locations,32600222,10.33321/cdi.2020.44.54,2020-07-01
Challenge,TREATS,Adult,32600183,10.1176/appi.ps.202000277,2020-07-01
Author,TREATS,Patients,32600183,10.1176/appi.ps.202000277,2020-07-01
Smell Perception,PROCESS_OF,Patients,32600175,10.1177/0194599820939538,2020-07-01
Nose,LOCATION_OF,Congestion,32600175,10.1177/0194599820939538,2020-07-01
Present,PREDISPOSES,Congestion,32600175,10.1177/0194599820939538,2020-07-01
Consultation,ADMINISTERED_TO,Practitioner,32600170,10.1177/0194599820935859,2020-07-01
Consultation,TREATS,Chief complaint (finding),32600170,10.1177/0194599820935859,2020-07-01
Dizziness,PROCESS_OF,Patients,32600170,10.1177/0194599820935859,2020-07-01
Dizziness,PROCESS_OF,Patients,32600170,10.1177/0194599820935859,2020-07-01
Dizziness,PROCESS_OF,Patients,32600170,10.1177/0194599820935859,2020-07-01
thyroid function,PROCESS_OF,Patients,32600165,10.1089/thy.2020.0363,2020-07-01
checkup examination,TREATS,Healthy Volunteers,32600165,10.1089/thy.2020.0363,2020-07-01
Thyroid hormone replacement therapy,NEG_ADMINISTERED_TO,Patients,32600165,10.1089/thy.2020.0363,2020-07-01
Serum,LOCATION_OF,Thyrotropin,32600165,10.1089/thy.2020.0363,2020-07-01
Free triiodothyronine,COEXISTS_WITH,Thyrotropin,32600165,10.1089/thy.2020.0363,2020-07-01
Manipulation procedure,PREVENTS,Inflammation,32600125,10.1177/1753466620937170,2020-07-01
Permanent tracheostomy,ADMINISTERED_TO,Patients,32600107,10.1177/0194599820940655,2020-07-01
Respiratory Failure,PROCESS_OF,Patients,32600107,10.1177/0194599820940655,2020-07-01
IMPACT gene,AFFECTS,Upper aerodigestive tract,32600101,10.1177/0194599820938016,2020-07-01
United States,ISA,Country,32600099,10.1177/0194599820938045,2020-07-01
Otolaryngologist,TREATS,Outpatients,32600099,10.1177/0194599820938045,2020-07-01
Upper aerodigestive tract,LOCATION_OF,Virus,32600099,10.1177/0194599820938045,2020-07-01
risk factors,PROCESS_OF,Patients,32600078,10.1161/JAHA.120.016706,2020-07-01
Cardiovascular Diseases,PROCESS_OF,Patients,32600078,10.1161/JAHA.120.016706,2020-07-01
risk factors,PROCESS_OF,Patients,32600078,10.1161/JAHA.120.016706,2020-07-01
High risk factors,PROCESS_OF,Patients,32600078,10.1161/JAHA.120.016706,2020-07-01
Pneumonia,PROCESS_OF,Patients,32600045,10.1021/acschemneuro.0c00349,2020-07-01
advanced disease,PROCESS_OF,Patients,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Alveolar damage,PROCESS_OF,Patients,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Blood Gas Analysis,DIAGNOSES,patient condition,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Parenchyma,PART_OF,Lung,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Autopsy,CAUSES,Respiratory Failure,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Autopsy,DIAGNOSES,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Autopsy,DIAGNOSES(SPEC),Coronavirus Infections,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Brain Stem,LOCATION_OF,Neurotropism,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Acute respiratory failure,COEXISTS_WITH,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Acute respiratory failure,COEXISTS_WITH(SPEC),Coronavirus Infections,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Neurotropism,CAUSES,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Neurotropism,CAUSES(SPEC),Coronavirus Infections,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Blood Gas Analysis,DIAGNOSES,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Blood Gas Analysis,DIAGNOSES(SPEC),Coronavirus Infections,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Acute respiratory failure,COEXISTS_WITH,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Infection,ASSOCIATED_WITH,EHD1 wt Allele,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Apnea,ASSOCIATED_WITH,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Apnea,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Disease,PROCESS_OF,Patients,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,ISA,Disease,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Respiratory Center,PART_OF,Adrenal Medulla,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Mechanical Ventilator,TREATS,patient condition,32600045,10.1021/acschemneuro.0c00349,2020-07-01
Bone structure of ischium,LOCATION_OF,Degenerative polyarthritis,32600002,10.31128/AJGP-03-20-5286,2020-07-01
Knee,LOCATION_OF,Degenerative polyarthritis,32600002,10.31128/AJGP-03-20-5286,2020-07-01
Degenerative polyarthritis,PROCESS_OF,Patients,32600002,10.31128/AJGP-03-20-5286,2020-07-01
Exercise,TREATS,Patients,32600002,10.31128/AJGP-03-20-5286,2020-07-01
Palliative Care,PREVENTS,Macrophage Activation Syndrome,32600002,10.31128/AJGP-03-20-5286,2020-07-01
Symptom severe,PROCESS_OF,Patients,32600002,10.31128/AJGP-03-20-5286,2020-07-01
"Hospitals, University",LOCATION_OF,Study,32599972,10.3906/sag-2005-385,2020-07-01
Confirmation,PROCESS_OF,hospitalized patients,32599972,10.3906/sag-2005-385,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32599972,10.3906/sag-2005-385,2020-07-01
Hypertensive disease,PREDISPOSES,Pneumonia,32599972,10.3906/sag-2005-385,2020-07-01
Hypertensive disease,PREDISPOSES,Pneumonia,32599972,10.3906/sag-2005-385,2020-07-01
Chest CT,ISA,diagnostic procedure,32599972,10.3906/sag-2005-385,2020-07-01
Dermatologic disorders,COEXISTS_WITH,SARS coronavirus,32599968,10.3906/sag-2005-182,2020-07-01
Agent,CAUSES,Skin lesion,32599968,10.3906/sag-2005-182,2020-07-01
Famotidine,INHIBITS,"ORF74 protein, Human herpesvirus 8",32599963,10.3390/biom10060954,2020-07-01
Famotidine,TREATS,Patients,32599963,10.3390/biom10060954,2020-07-01
Famotidine,INHIBITS,Peptide Hydrolases,32599963,10.3390/biom10060954,2020-07-01
Peptide Hydrolases,AFFECTS,Virus Replication,32599963,10.3390/biom10060954,2020-07-01
Famotidine,INTERACTS_WITH,Peptide Hydrolases,32599963,10.3390/biom10060954,2020-07-01
Buffers,AFFECTS,Social Anxiety,32599911,10.3390/ijerph17124561,2020-07-01
Infected,PROCESS_OF,Population Group,32599867,10.3390/biology9060135,2020-07-01
New Jersey,ISA,Geographic state,32599867,10.3390/biology9060135,2020-07-01
Bronchial Epithelial Cell,PART_OF,Homo sapiens,32599823,10.3390/v12060679,2020-07-01
Bronchial Epithelial Cell,PART_OF,Homo sapiens,32599823,10.3390/v12060679,2020-07-01
Cytoskeleton,LOCATION_OF,TJP1 gene,32599823,10.3390/v12060679,2020-07-01
Cytoskeleton,PART_OF,Cells,32599823,10.3390/v12060679,2020-07-01
Influenza,CAUSES,"Respiratory Distress Syndrome, Adult",32599813,10.3390/jof6020091,2020-07-01
Lung,LOCATION_OF,Epithelial Damage,32599813,10.3390/jof6020091,2020-07-01
Patient Discharge,TREATS,Inflammatory disorder,32599813,10.3390/jof6020091,2020-07-01
Patient Discharge,TREATS,Epithelial Damage,32599813,10.3390/jof6020091,2020-07-01
Patient Discharge,TREATS(SPEC),Pulmonary Aspergillosis,32599813,10.3390/jof6020091,2020-07-01
Pulmonary Aspergillosis,ISA,Inflammatory disorder,32599813,10.3390/jof6020091,2020-07-01
Bronchoscopy,DIAGNOSES,patient condition,32599813,10.3390/jof6020091,2020-07-01
intensive care unit,LOCATION_OF,Diagnostic tests,32599813,10.3390/jof6020091,2020-07-01
Azoles,AFFECTS,Drug Interactions,32599813,10.3390/jof6020091,2020-07-01
Tropism,PROCESS_OF,Kidney,32599813,10.3390/jof6020091,2020-07-01
Reaching,AFFECTS,Persons,32599783,10.3390/ijerph17124548,2020-07-01
World,LOCATION_OF,IMPACT gene,32599783,10.3390/ijerph17124548,2020-07-01
Chronic disease,PROCESS_OF,Persons,32599783,10.3390/ijerph17124548,2020-07-01
Complication,PROCESS_OF,Persons,32599783,10.3390/ijerph17124548,2020-07-01
Cessation of life,AFFECTS,Community,32599783,10.3390/ijerph17124548,2020-07-01
Community,LOCATION_OF,IMPACT gene,32599783,10.3390/ijerph17124548,2020-07-01
HIV,LOCATION_OF,IMPACT gene,32599783,10.3390/ijerph17124548,2020-07-01
HIV,LOCATION_OF,IMPACT gene,32599783,10.3390/ijerph17124548,2020-07-01
Child,LOCATION_OF,IMPACT gene,32599669,10.1111/camh.12398,2020-07-01
Child,LOCATION_OF,IMPACT gene,32599669,10.1111/camh.12398,2020-07-01
Household composition,PROCESS_OF,Child,32599669,10.1111/camh.12398,2020-07-01
Infected,PROCESS_OF,Persons,32599638,10.1055/a-1182-2016,2020-07-01
Symptoms,OCCURS_IN,Patients,32599633,10.1055/a-1190-0247,2020-07-01
Anosmia,PROCESS_OF,Family member,32599633,10.1055/a-1190-0247,2020-07-01
Fever,PROCESS_OF,Persons,32599633,10.1055/a-1190-0247,2020-07-01
Disease,PROCESS_OF,African American,32599614,10.1093/infdis/jiaa372,2020-07-01
African race,ISA,African American,32599614,10.1093/infdis/jiaa372,2020-07-01
History of previous events,PROCESS_OF,African American,32599614,10.1093/infdis/jiaa372,2020-07-01
History of previous events,PROCESS_OF(SPEC),African race,32599614,10.1093/infdis/jiaa372,2020-07-01
Poor outcome,COEXISTS_WITH,Gastrointestinal symptom,32599601,10.1159/000509774,2020-07-01
Gastrointestinal symptom,PROCESS_OF,hospitalized patients,32599601,10.1159/000509774,2020-07-01
patient condition,PROCESS_OF,hospitalized patients,32599601,10.1159/000509774,2020-07-01
Nausea,COEXISTS_WITH,Gastrointestinal symptom,32599601,10.1159/000509774,2020-07-01
Multiple Organ Failure,AFFECTS,Esthesia,32599589,10.1159/000509483,2020-07-01
"Respiratory Distress Syndrome, Adult",AFFECTS,Esthesia,32599589,10.1159/000509483,2020-07-01
Symptom mild,PROCESS_OF,Persons,32599589,10.1159/000509483,2020-07-01
Cytokine release syndrome,CAUSES,Multiple Organ Failure,32599589,10.1159/000509483,2020-07-01
Cytokine release syndrome,CAUSES,"Respiratory Distress Syndrome, Adult",32599589,10.1159/000509483,2020-07-01
Storm NOS,CAUSES,Multiple Organ Failure,32599589,10.1159/000509483,2020-07-01
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32599589,10.1159/000509483,2020-07-01
Anxiety,PROCESS_OF,Patients,32599571,10.1088/1752-7163/aba105,2020-07-01
Disease,PROCESS_OF,Patients,32599571,10.1088/1752-7163/aba105,2020-07-01
Breath Tests,ADMINISTERED_TO,Patients,32599571,10.1088/1752-7163/aba105,2020-07-01
Crisis,PROCESS_OF,Patients,32599534,10.1016/j.dsx.2020.06.032,2020-07-01
Physicians,ISA,Health Personnel,32599534,10.1016/j.dsx.2020.06.032,2020-07-01
Health Personnel,DIAGNOSES,Enthesitis-Related Arthritis,32599534,10.1016/j.dsx.2020.06.032,2020-07-01
patient condition,PROCESS_OF,Health Personnel,32599534,10.1016/j.dsx.2020.06.032,2020-07-01
Squamous cell carcinoma,PROCESS_OF,Patients,32599499,10.1016/j.oraloncology.2020.104849,2020-07-01
Chemoradiotherapy,ISA,Pharmacotherapy,32599499,10.1016/j.oraloncology.2020.104849,2020-07-01
Pharmacotherapy,compared_with,Chemoradiotherapy,32599499,10.1016/j.oraloncology.2020.104849,2020-07-01
Magnetic Resonance Imaging,USES,Gadolinium,32599421,10.1016/j.watres.2020.115966,2020-07-01
Gadolinium,CAUSES,Discrepancy,32599421,10.1016/j.watres.2020.115966,2020-07-01
Gadolinium,CAUSES,High Level,32599421,10.1016/j.watres.2020.115966,2020-07-01
Patients,LOCATION_OF,Urine,32599421,10.1016/j.watres.2020.115966,2020-07-01
Physical Examination,USES,Magnetic Resonance Imaging,32599421,10.1016/j.watres.2020.115966,2020-07-01
Pathogenic organism,CAUSES,Coronavirus Infections,32599395,10.1016/j.scitotenv.2020.140489,2020-07-01
Malignant Neoplasms,PROCESS_OF,Patients,32599375,10.1016/j.critrevonc.2020.103032,2020-07-01
Malignant Neoplasms,OCCURS_IN,Patients,32599375,10.1016/j.critrevonc.2020.103032,2020-07-01
Lung,PART_OF,Patients,32599375,10.1016/j.critrevonc.2020.103032,2020-07-01
Communicable Diseases,ISA,Disease,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Communicable Diseases,NEG_PROCESS_OF(SPEC),Homo sapiens,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Disease,NEG_PROCESS_OF,Homo sapiens,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Virus,CAUSES,Communicable Diseases,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Coronavirus Infections,ISA,Disease,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Coronavirus Infections,NEG_PROCESS_OF(SPEC),Homo sapiens,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Coughing,ISA,Symptoms,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Virus,CAUSES,Respiration Disorders,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Laboratory Procedures,DIAGNOSES,Present,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Virus,PROCESS_OF,Homo sapiens,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Coronavirus Infections,ISA,Disease,32599338,10.1016/j.cmpb.2020.105608,2020-07-01
Disease,CAUSES,Coronavirus Infections,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Syndrome,CAUSES,Asymptomatic Diseases,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Symptoms,PROCESS_OF,Pregnant Women,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Infection,CAUSES,Pregnancy,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Middle East Respiratory Syndrome Coronavirus,CAUSES,Hypertensive disease,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Middle East Respiratory Syndrome Coronavirus,CAUSES,"Kidney Failure, Acute",32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Middle East Respiratory Syndrome Coronavirus,CAUSES,Multiple Organ Failure,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Middle East Respiratory Syndrome Coronavirus,CAUSES,Pneumonia,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Middle East Respiratory Syndrome Coronavirus,CAUSES,Pre-Eclampsia,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Cells,LOCATION_OF,ACE2 gene,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Advanced life support,TREATS,Pregnant Women,32599304,10.1016/j.jogoh.2020.101846,2020-07-01
Coronavirus Infections,ISA,Disease,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Coronavirus Infections,ISA,Disease,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Disease,PROCESS_OF,Patients,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Coronavirus Infections,ISA,Disease,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Warburg Therapy,PREVENTS,Disease,32599285,10.1016/j.ijid.2020.06.080,2020-07-01
Virus,CAUSES,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Virus,CAUSES(SPEC),Coronavirus Infections,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Coronavirus Infections,ISA,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Coronavirus Infections,ISA,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Pharmaceutical Preparations,TREATS,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Coronavirus Infections,ISA,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
imiquimod,STIMULATES,,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Coronavirus Infections,ISA,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
agonists,INTERACTS_WITH,Gamma globulin serum,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Drug Repositioning,TREATS,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Drug Repositioning,TREATS(SPEC),Coronavirus Infections,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Drug Repositioning,USES,agonists,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Coronavirus Infections,ISA,Disease,32599245,10.1016/j.ijbiomac.2020.06.228,2020-07-01
Inferior,LOCATION_OF,Cells,32599237,10.1016/j.ijbiomac.2020.06.213,2020-07-01
Academic Medical Centers,LOCATION_OF,Study,32599201,10.1016/j.wneu.2020.06.176,2020-07-01
Adult,ISA,Persons,32599201,10.1016/j.wneu.2020.06.176,2020-07-01
Telemedicine,ISA,Evaluation procedure,32599201,10.1016/j.wneu.2020.06.176,2020-07-01
Elective Surgical Procedures,COEXISTS_WITH,ambulatory care services,32599184,10.1016/j.wneu.2020.06.167,2020-07-01
Coronavirus Infections,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Heart Injuries,PROCESS_OF,Patients,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Coronavirus Infections,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Coronavirus Infections,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Coronavirus Infections,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Coronavirus Infections,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Therapeutic procedure,TREATS,Myocardial dysfunction,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
Myocardial dysfunction,ISA,Disease,32599178,10.1016/j.hrthm.2020.06.026,2020-07-01
patient condition,PROCESS_OF,Patients,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Symptom mild,PROCESS_OF,Patients,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Feces,LOCATION_OF,Duration,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Duration,TREATS,"Child, Preschool",32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Duration,TREATS,Infant,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Duration,TREATS,Adolescent (age group),32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Duration,TREATS,School child,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Attention,PROCESS_OF,Child,32599159,10.1016/j.cmi.2020.06.015,2020-07-01
Mechanical Ventilator,USES,Hydrogen Peroxide,32599102,10.1016/j.ajic.2020.06.194,2020-07-01
Decontamination,USES,Hydrogen Peroxide,32599102,10.1016/j.ajic.2020.06.194,2020-07-01
Decontamination,USES,Hydrogen Peroxide,32599102,10.1016/j.ajic.2020.06.194,2020-07-01
Decontamination,USES,Mechanical Ventilator,32599102,10.1016/j.ajic.2020.06.194,2020-07-01
Persons,USES,clinical syndromes,32599101,10.1016/j.ajic.2020.06.188,2020-07-01
Prophylactic treatment,TREATS,Persons,32599100,10.1016/j.ajic.2020.06.191,2020-07-01
Contact Transmission,PROCESS_OF,Households,32599100,10.1016/j.ajic.2020.06.191,2020-07-01
Genetic Translation Process,PROCESS_OF,IMPACT gene,32599095,10.1016/j.trsl.2020.06.010,2020-07-01
Enrollment,TREATS,tailor,32599095,10.1016/j.trsl.2020.06.010,2020-07-01
Heart Diseases,PROCESS_OF,Persons,32599060,10.1016/j.apmr.2020.06.004,2020-07-01
"Respiratory Distress Syndrome, Adult",COMPLICATES,Disease,32599018,10.1016/j.cjca.2020.06.014,2020-07-01
"Respiratory Distress Syndrome, Adult",COMPLICATES(SPEC),Coronavirus Infections,32599018,10.1016/j.cjca.2020.06.014,2020-07-01
Coronavirus Infections,ISA,Disease,32599018,10.1016/j.cjca.2020.06.014,2020-07-01
Disease,PROCESS_OF,Patients,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
Coronavirus Infections,ISA,Disease,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
Cardiovascular finding,PROCESS_OF,Patients,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
patient condition,COEXISTS_WITH,Myocardial Infarction,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
patient condition,COEXISTS_WITH,Pulmonary Embolism,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
patient condition,COEXISTS_WITH,Thrombus,32599017,10.1016/j.cjca.2020.06.016,2020-07-01
Sexual sterilization,USES,Autoclave,32599011,10.1016/j.jhin.2020.06.030,2020-07-01
Ethanol,TREATS,Bacteria,32599011,10.1016/j.jhin.2020.06.030,2020-07-01
Sexual sterilization,TREATS,Bacteria,32599011,10.1016/j.jhin.2020.06.030,2020-07-01
ebselen,INTERACTS_WITH,Anti-Inflammatory Agents,32598985,10.1016/j.freeradbiomed.2020.06.032,2020-07-01
ebselen,INTERACTS_WITH,Anti-Bacterial Agents,32598985,10.1016/j.freeradbiomed.2020.06.032,2020-07-01
China,ISA,Country,32598953,10.1016/j.ejphar.2020.173326,2020-07-01
Pharmaceutical Preparations,TREATS,Pneumonia,32598953,10.1016/j.ejphar.2020.173326,2020-07-01
Neoplasms,PROCESS_OF,Community,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Challenge,TREATS,Community,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Malignant Neoplasms,PROCESS_OF,Persons,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Ovarian Carcinoma,PROCESS_OF,Woman,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
cancer surgery,TREATS,Neoplasms,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
cancer therapy,TREATS,Neoplasms,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
cancer surgery,TREATS,Neoplasms,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Ovarian Carcinoma,PROCESS_OF,Patients,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Worried,PREDISPOSES,Anxiety,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Worried,PREDISPOSES,Crisis,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Operative Surgical Procedures,ISA,Therapeutic procedure,32598911,10.1016/j.ajog.2020.06.049,2020-07-01
Patients,LOCATION_OF,Feces,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Analysis,USES,Deep Sequencing,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Fungal Microbiota,ISA,Mycobiome,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Intestines,LOCATION_OF,Fungi,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease Progression,32598884,10.1053/j.gastro.2020.06.048,2020-07-01
Blood,LOCATION_OF,"T-Cell Surface Glycoprotein CD4, human",32598880,10.1016/j.cca.2020.06.040,2020-07-01
Infertility,ISA,Disease,32598835,10.5935/1518-0557.20200054,2020-07-01
compromise,PROCESS_OF,Patients,32598835,10.5935/1518-0557.20200054,2020-07-01
compromise,PROCESS_OF,Staff,32598835,10.5935/1518-0557.20200054,2020-07-01
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,Patients,32598831,10.1056/NEJMoa2021680,2020-07-01
Mechanical ventilation,ADMINISTERED_TO,Patients,32598831,10.1056/NEJMoa2021680,2020-07-01
Coronary Aneurysm,PROCESS_OF,Patients,32598831,10.1056/NEJMoa2021680,2020-07-01
Glucocorticoids,TREATS,Child,32598831,10.1056/NEJMoa2021680,2020-07-01
"Immunoglobulins, Intravenous",TREATS,Well child,32598831,10.1056/NEJMoa2021680,2020-07-01
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,hospitalized patients,32598830,10.1056/NEJMoa2021756,2020-07-01
Myocarditis,PROCESS_OF,hospitalized patients,32598830,10.1056/NEJMoa2021756,2020-07-01
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,hospitalized patients,32598830,10.1056/NEJMoa2021756,2020-07-01
Toxic Shock Syndrome,PROCESS_OF,hospitalized patients,32598830,10.1056/NEJMoa2021756,2020-07-01
personal health,COEXISTS_WITH,Mucocutaneous Lymph Node Syndrome,32598830,10.1056/NEJMoa2021756,2020-07-01
personal health,COEXISTS_WITH,Myocarditis,32598830,10.1056/NEJMoa2021756,2020-07-01
personal health,COEXISTS_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32598830,10.1056/NEJMoa2021756,2020-07-01
personal health,COEXISTS_WITH,Toxic Shock Syndrome,32598830,10.1056/NEJMoa2021756,2020-07-01
Complication,COEXISTS_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32598830,10.1056/NEJMoa2021756,2020-07-01
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,Patients,32598830,10.1056/NEJMoa2021756,2020-07-01
Cardiac dysfunction,COEXISTS_WITH,Syndrome,32598830,10.1056/NEJMoa2021756,2020-07-01
Coronavirus Infections,CAUSES,Pneumonia,32598557,10.1111/andr.12848,2020-07-01
angiotensin converting enzyme 2,AUGMENTS,Spermatogonia,32598557,10.1111/andr.12848,2020-07-01
Virus,PROCESS_OF,Patients,32598557,10.1111/andr.12848,2020-07-01
Seminal fluid specimen,NEG_LOCATION_OF,GSKIP gene,32598557,10.1111/andr.12848,2020-07-01
Detection,PRECEDES,Diagnosis,32598557,10.1111/andr.12848,2020-07-01
Italy,ISA,Country,32598519,10.1111/apa.15454,2020-07-01
Institutes,LOCATION_OF,Study,32598519,10.1111/apa.15454,2020-07-01
Patients,LOCATION_OF,"TLR4 protein, human",32598514,10.1111/ced.14360,2020-07-01
WASF1 gene,PART_OF,Virus,32598499,10.1002/jmv.26233,2020-07-01
Elective procedure,TREATS,Patients,32598480,10.1093/asj/sjaa180,2020-07-01
Patients,LOCATION_OF,GSKIP gene,32598480,10.1093/asj/sjaa180,2020-07-01
Symptoms,NEG_PROCESS_OF,Patients,32598480,10.1093/asj/sjaa180,2020-07-01
Elderly (population group),LOCATION_OF,IMPACT gene,32598450,10.1093/gerona/glaa163,2020-07-01
Elderly (population group),LOCATION_OF,IMPACT gene,32598450,10.1093/gerona/glaa163,2020-07-01
Elderly (population group),ISA,Population Group,32598450,10.1093/gerona/glaa163,2020-07-01
Hospitalization,TREATS,Elderly (population group),32598450,10.1093/gerona/glaa163,2020-07-01
Males,ASSOCIATED_WITH,Pneumonia,32598450,10.1093/gerona/glaa163,2020-07-01
Comorbidity,PROCESS_OF,Elderly (population group),32598450,10.1093/gerona/glaa163,2020-07-01
Health Services,AFFECTS,Severe (severity modifier),32598438,10.1093/ecco-jcc/jjaa137,2020-07-01
Coronavirus Infections,ISA,Respiration Disorders,32598320,10.1515/jpm-2020-0182,2020-07-01
Pregnant Women,LOCATION_OF,"CD69 protein, human",32598320,10.1515/jpm-2020-0182,2020-07-01
Perception,PROCESS_OF,Woman,32598320,10.1515/jpm-2020-0182,2020-07-01
Woman,USES,Subgroup,32598320,10.1515/jpm-2020-0182,2020-07-01
Mutation,AFFECTS,Virulence,32598306,10.1515/cclm-2020-0815,2020-07-01
Nasal Swab (procedure),USES,Interventional procedure,32598306,10.1515/cclm-2020-0815,2020-07-01
Severe disorder,PROCESS_OF,Patients,32598305,10.1515/cclm-2020-0727,2020-07-01
Adipose tissue,LOCATION_OF,Membrane Proteins,32598305,10.1515/cclm-2020-0727,2020-07-01
Heart,LOCATION_OF,Membrane Proteins,32598305,10.1515/cclm-2020-0727,2020-07-01
Kidney,LOCATION_OF,Membrane Proteins,32598305,10.1515/cclm-2020-0727,2020-07-01
Lymphocyte,LOCATION_OF,Membrane Proteins,32598305,10.1515/cclm-2020-0727,2020-07-01
Testis,LOCATION_OF,Membrane Proteins,32598305,10.1515/cclm-2020-0727,2020-07-01
Genetic Polymorphism,PROCESS_OF,ACE gene,32598305,10.1515/cclm-2020-0727,2020-07-01
"M Protein, multiple myeloma",AFFECTS,Lung,32598305,10.1515/cclm-2020-0727,2020-07-01
general population,LOCATION_OF,angiotensin converting enzyme 2,32598305,10.1515/cclm-2020-0727,2020-07-01
Quick Test for Liver Function,METHOD_OF,Detection,32598303,10.1515/cclm-2020-0628,2020-07-01
Laboratory,LOCATION_OF,Polymerase Chain Reaction,32598303,10.1515/cclm-2020-0628,2020-07-01
Laboratory Procedures,DIAGNOSES,Alveolar rhabdomyosarcoma,32598303,10.1515/cclm-2020-0628,2020-07-01
hospitalized patients,LOCATION_OF,Antibodies,32598303,10.1515/cclm-2020-0628,2020-07-01
Hypersensitivity,PROCESS_OF,Outpatients,32598303,10.1515/cclm-2020-0628,2020-07-01
Laboratory Procedures,DIAGNOSES,Hypersensitivity,32598303,10.1515/cclm-2020-0628,2020-07-01
Laboratory Procedures,DIAGNOSES,Presence of infection,32598303,10.1515/cclm-2020-0628,2020-07-01
Presence of infection,PROCESS_OF,primary group,32598303,10.1515/cclm-2020-0628,2020-07-01
Antibodies,COEXISTS_WITH,AKR1A1 wt Allele,32598303,10.1515/cclm-2020-0628,2020-07-01
AKR1A1 wt Allele,PART_OF,Participant,32598303,10.1515/cclm-2020-0628,2020-07-01
Evaluation,ADMINISTERED_TO,Population Group,32598303,10.1515/cclm-2020-0628,2020-07-01
Hypersensitivity,PROCESS_OF,Rattus norvegicus,32598032,10.1002/bmc.4934,2020-07-01
Liquid-Liquid Extraction,USES,ethyl acetate,32598032,10.1002/bmc.4934,2020-07-01
Birth,PROCESS_OF,Rattus norvegicus,32598032,10.1002/bmc.4934,2020-07-01
Therapeutic Drug Monitoring,TREATS,Patients,32598032,10.1002/bmc.4934,2020-07-01
Plasma,LOCATION_OF,Peroxidase,32597954,10.1182/blood.2020007008,2020-07-01
Lung,LOCATION_OF,Autopsy,32597954,10.1182/blood.2020007008,2020-07-01
Autopsy,DIAGNOSES,Microthrombus,32597954,10.1182/blood.2020007008,2020-07-01
Lung,LOCATION_OF,Autopsy,32597954,10.1182/blood.2020007008,2020-07-01
Homo sapiens,ISA,Microorganism,32597948,10.1093/bioinformatics/btaa598,2020-07-01
Homo sapiens,ISA,Microorganism,32597948,10.1093/bioinformatics/btaa598,2020-07-01
Ciprofloxacin,AFFECTS,identifies medication,32597948,10.1093/bioinformatics/btaa598,2020-07-01
Microbicides,AFFECTS,identifies medication,32597948,10.1093/bioinformatics/btaa598,2020-07-01
Symptom severe,PROCESS_OF,Adolescent (age group),32597925,10.1001/jamapediatrics.2020.1876,2020-07-01
Anosmia,ISA,Symptoms,32597823,10.3233/RNN-201042,2020-07-01
Coughing,ISA,Symptoms,32597823,10.3233/RNN-201042,2020-07-01
Fever,ISA,Symptoms,32597823,10.3233/RNN-201042,2020-07-01
Headache,ISA,Symptoms,32597823,10.3233/RNN-201042,2020-07-01
Malaise,ISA,Symptoms,32597823,10.3233/RNN-201042,2020-07-01
AHR Signal Transduction Pathway,AFFECTS,Aryl Hydrocarbon Receptor,32597823,10.3233/RNN-201042,2020-07-01
Aryl Hydrocarbon Receptor,CAUSES,Multiple Trauma,32597823,10.3233/RNN-201042,2020-07-01
Organ,LOCATION_OF,Multiple Trauma,32597823,10.3233/RNN-201042,2020-07-01
Coronavirus Infections,CAUSES,Syndrome,32597823,10.3233/RNN-201042,2020-07-01
Cholecalciferol,INHIBITS,AHR gene,32597823,10.3233/RNN-201042,2020-07-01
Cholecalciferol,INHIBITS,E Vitamin E,32597823,10.3233/RNN-201042,2020-07-01
Dexamethasone,INHIBITS,,32597823,10.3233/RNN-201042,2020-07-01
Dexamethasone,INHIBITS,IDO1 gene,32597823,10.3233/RNN-201042,2020-07-01
Pharmaceutical Preparations,INHIBITS,IDO1 gene,32597823,10.3233/RNN-201042,2020-07-01
E Vitamin E,ISA,Vitamins,32597823,10.3233/RNN-201042,2020-07-01
Dexamethasone,PREVENTS,Virus Diseases,32597823,10.3233/RNN-201042,2020-07-01
Virus Diseases,PROCESS_OF,Corona,32597823,10.3233/RNN-201042,2020-07-01
Exercise,STIMULATES,Quarantine,32597823,10.3233/RNN-201042,2020-07-01
,LOCATION_OF,Gene Expression,32597823,10.3233/RNN-201042,2020-07-01
Therapeutic procedure,TREATS,Homo sapiens,32597823,10.3233/RNN-201042,2020-07-01
IDO1 gene,LOCATION_OF,Gene Expression,32597823,10.3233/RNN-201042,2020-07-01
Basis,ADMINISTERED_TO,Bioethicists,32597738,10.1017/S0963180120000511,2020-07-01
Eye,PART_OF,Research Personnel,32597676,10.1037/tra0000630,2020-07-01
Pandemics,ISA,Disease Outbreaks,32597627,10.1097/MAT.0000000000001198,2020-07-01
Cessation of life,ASSOCIATED_WITH,Viral respiratory infection,32597550,10.1111/tid.13394,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Transplant Recipients,32597550,10.1111/tid.13394,2020-07-01
Fibrosis,PRODUCES,Interleukin-1 beta,32597513,10.1111/odi.13518,2020-07-01
Pneumonia,PRODUCES,Interleukin-1 beta,32597513,10.1111/odi.13518,2020-07-01
"Pneumonia, Interstitial",PRODUCES,Interleukin-6,32597513,10.1111/odi.13518,2020-07-01
Disease,PROCESS_OF,Homo sapiens,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,Arteriosclerosis,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,Malignant Neoplasms,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,Disease,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,Respiration Disorders,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,Infection,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,AFFECTS,neutrophil,32597503,10.1111/jpi.12676,2020-07-01
Glutathione,ISA,Antioxidants,32597503,10.1111/jpi.12676,2020-07-01
Glutathione,INTERACTS_WITH,neutrophil,32597503,10.1111/jpi.12676,2020-07-01
glutathione-disulfide reductase activity,COEXISTS_WITH,Autoimmune Diseases,32597503,10.1111/jpi.12676,2020-07-01
glutathione-disulfide reductase activity,COEXISTS_WITH,Diabetes,32597503,10.1111/jpi.12676,2020-07-01
glutathione-disulfide reductase activity,COEXISTS_WITH,Disease,32597503,10.1111/jpi.12676,2020-07-01
glutathione-disulfide reductase activity,COEXISTS_WITH,nervous system disorder,32597503,10.1111/jpi.12676,2020-07-01
glutathione-disulfide reductase activity,PROCESS_OF,neutrophil,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,COEXISTS_WITH,Glutathione,32597503,10.1111/jpi.12676,2020-07-01
Lipopolysaccharides,CAUSES,Qualitative abnormality of granulocyte,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,TREATS,Qualitative abnormality of granulocyte,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,TREATS,Immune System Diseases,32597503,10.1111/jpi.12676,2020-07-01
Melatonin,TREATS,Infection,32597503,10.1111/jpi.12676,2020-07-01
Hidradenitis Suppurativa,PROCESS_OF,Patients,32597495,10.1111/bjd.19345,2020-07-01
Communicable Diseases,PROCESS_OF,Elderly (population group),32597495,10.1111/bjd.19345,2020-07-01
Single organ dysfunction,COEXISTS_WITH,Communicable Diseases,32597495,10.1111/bjd.19345,2020-07-01
Respiratory Failure,COEXISTS_WITH,Communicable Diseases,32597495,10.1111/bjd.19345,2020-07-01
Malaise,PROCESS_OF,Patients,32597389,10.4269/ajtmh.20-0681,2020-07-01
angiotensin converting enzyme 2,CAUSES,"Respiratory Distress Syndrome, Adult",32597377,10.1080/17843286.2020.1786324,2020-07-01
Patients,LOCATION_OF,IMPACT gene,32597103,10.4081/aiua.2020.2.78,2020-07-01
Pneumonia,PROCESS_OF,Patients,32597102,10.4081/aiua.2020.2.73,2020-07-01
Coronavirus Infections,CAUSES,Communicable Diseases,32597102,10.4081/aiua.2020.2.73,2020-07-01
Coronavirus Infections,PROCESS_OF,Patients,32597102,10.4081/aiua.2020.2.73,2020-07-01
Italy,ISA,European country,32597102,10.4081/aiua.2020.2.73,2020-07-01
Nasal Swab (procedure),DIAGNOSES,RNA Viruses,32597102,10.4081/aiua.2020.2.73,2020-07-01
Symptoms,PROCESS_OF,Patients,32597102,10.4081/aiua.2020.2.73,2020-07-01
Health Services,TREATS,Patients,32597101,10.4081/aiua.2020.2.67,2020-07-01
Operating Room,LOCATION_OF,Administration occupational activities,32597101,10.4081/aiua.2020.2.67,2020-07-01
Operative Surgical Procedures,ADMINISTERED_TO,Surgeon,32597101,10.4081/aiua.2020.2.67,2020-07-01
Operating Room,LOCATION_OF,Work,32597101,10.4081/aiua.2020.2.67,2020-07-01
Pneumonia,CAUSES,Cessation of life,32597100,10.4081/monaldi.2020.1346,2020-07-01
Pneumonia,ISA,Disease,32597100,10.4081/monaldi.2020.1346,2020-07-01
Restrictive lung disease,COEXISTS_WITH,Disease,32597100,10.4081/monaldi.2020.1346,2020-07-01
Restrictive lung disease,COEXISTS_WITH(SPEC),Coronavirus Infections,32597100,10.4081/monaldi.2020.1346,2020-07-01
Coronavirus Infections,ISA,Disease,32597100,10.4081/monaldi.2020.1346,2020-07-01
Coronavirus Infections,CAUSES,Pneumonia,32597076,10.7507/1001-5515.202003045,2020-07-01
Comorbidity,PROCESS_OF,Patients,32597048,10.3346/jkms.2020.35.e237,2020-07-01
Ground Glass Opacity,PROCESS_OF,Patients,32597047,10.3346/jkms.2020.35.e236,2020-07-01
SARS coronavirus,PROCESS_OF,Patients,32597046,10.3346/jkms.2020.35.e234,2020-07-01
Hospital admission,TREATS,Patients,32597046,10.3346/jkms.2020.35.e234,2020-07-01
early/brief intervention/therapy (treatment),TREATS,Patients,32597046,10.3346/jkms.2020.35.e234,2020-07-01
early/brief intervention/therapy (treatment),TREATS,patient condition,32597046,10.3346/jkms.2020.35.e234,2020-07-01
early/brief intervention/therapy (treatment),TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32597046,10.3346/jkms.2020.35.e234,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32597046,10.3346/jkms.2020.35.e234,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,hospitalized patients,32597045,10.3346/jkms.2020.35.e232,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32597045,10.3346/jkms.2020.35.e232,2020-07-01
Acute respiratory failure,AFFECTS,Alveolar ventilation function,32597005,10.1111/acem.14067,2020-07-01
Italy,ISA,Country,32596965,10.1111/tbj.13958,2020-07-01
Pharmaceutical Preparations,ADMINISTERED_TO,Participant,32596936,10.1111/jsr.13119,2020-07-01
Sleep disturbances,COEXISTS_WITH,Crisis,32596936,10.1111/jsr.13119,2020-07-01
Sleep disturbances,PROCESS_OF,Population Group,32596936,10.1111/jsr.13119,2020-07-01
Health Care,ADMINISTERED_TO,Persons,32596914,10.1002/hast.1126,2020-07-01
Decision Making,PROCESS_OF,Persons,32596911,10.1002/hast.1133,2020-07-01
Consultation,TREATS,World,32596910,10.1002/hast.1122,2020-07-01
opioid use,ISA,Disease,32596909,10.1002/hast.1140,2020-07-01
opioid use,ISA,Disease,32596909,10.1002/hast.1140,2020-07-01
"Kidney Failure, Chronic",PROCESS_OF,Patients,32596903,10.1002/hast.1123,2020-07-01
Sexual sterilization,ISA,Operative Surgical Procedures,32596901,10.1002/hast.1130,2020-07-01
Mental disorders,PROCESS_OF,Patients,32596900,10.1002/hast.1139,2020-07-01
Mental disorders,PROCESS_OF,Patients,32596900,10.1002/hast.1139,2020-07-01
Social stigmata,PROCESS_OF,Patients,32596900,10.1002/hast.1139,2020-07-01
Involuntary Treatment,ADMINISTERED_TO,Patients,32596900,10.1002/hast.1139,2020-07-01
Violence,PROCESS_OF,Police,32596896,10.1002/hast.1135,2020-07-01
"Mortality, Premature",PROCESS_OF,African race,32596896,10.1002/hast.1135,2020-07-01
terminal patient care,TREATS,African American,32596896,10.1002/hast.1135,2020-07-01
Household composition,PROCESS_OF,African race,32596896,10.1002/hast.1135,2020-07-01
Intervention regimes,ADMINISTERED_TO,Homo sapiens,32596894,10.1002/hast.1142,2020-07-01
Frustration,PROCESS_OF,Physicians,32596892,10.1002/hast.1120,2020-07-01
Engaged to be married,PROCESS_OF,Community,32596891,10.1002/hast.1129,2020-07-01
Protection,PROCESS_OF,Elderly (population group),32596888,10.1002/hast.1136,2020-07-01
Van der Woude syndrome,PROCESS_OF,Snakes,32596888,10.1002/hast.1136,2020-07-01
Malaise,PROCESS_OF,Persons,32596887,10.1002/hast.1125,2020-07-01
Family,LOCATION_OF,IMPACT gene,32596884,10.1002/hast.1121,2020-07-01
Patients,LOCATION_OF,IMPACT gene,32596884,10.1002/hast.1121,2020-07-01
Family,INTERACTS_WITH,Patients,32596884,10.1002/hast.1121,2020-07-01
Organ Transplantation,TREATS,Patients,32596829,10.1111/xen.12623,2020-07-01
Organ,PART_OF,Sus scrofa,32596829,10.1111/xen.12623,2020-07-01
Xenograft procedure,PREDISPOSES,Zoonoses,32596829,10.1111/xen.12623,2020-07-01
Challenge,ADMINISTERED_TO,Community,32596829,10.1111/xen.12623,2020-07-01
Zoonoses,NEG_PROCESS_OF,Homo sapiens,32596829,10.1111/xen.12623,2020-07-01
Antibodies,PART_OF,Persons,32596697,10.1101/2020.06.22.20137695,2020-07-01
Serum,LOCATION_OF,Antibodies,32596697,10.1101/2020.06.22.20137695,2020-07-01
Serum,LOCATION_OF,Antibodies,32596697,10.1101/2020.06.22.20137695,2020-07-01
Disease,PROCESS_OF,Homo sapiens,32596697,10.1101/2020.06.22.20137695,2020-07-01
Betacoronavirus,CAUSES,Disease,32596697,10.1101/2020.06.22.20137695,2020-07-01
Antibodies,PART_OF,SARS coronavirus,32596697,10.1101/2020.06.22.20137695,2020-07-01
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32596694,10.1101/2020.06.23.167544,2020-07-01
Gabexate,INHIBITS,"KLK11 protein, human",32596694,10.1101/2020.06.23.167544,2020-07-01
camostat,INHIBITS,"KLK11 protein, human",32596694,10.1101/2020.06.23.167544,2020-07-01
nafamostat,INHIBITS,"KLK11 protein, human",32596694,10.1101/2020.06.23.167544,2020-07-01
Hospitals,LOCATION_OF,Intervention Model,32596642,10.1136/gpsych-2020-100292,2020-07-01
Intervention regimes,TREATS,inpatient,32596642,10.1136/gpsych-2020-100292,2020-07-01
Hospitals,LOCATION_OF,Work,32596641,10.1136/gpsych-2020-100260,2020-07-01
Symptoms,PROCESS_OF,member,32596641,10.1136/gpsych-2020-100260,2020-07-01
Sleeplessness,PROCESS_OF,Nursing Staff,32596641,10.1136/gpsych-2020-100260,2020-07-01
Pressure- physical agent,OCCURS_IN,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Mental problem,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Mental problem,PROCESS_OF,Population Group,32596640,10.1136/gpsych-2020-100259,2020-07-01
Anxiety,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Depressive disorder,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Mental problem,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Sleeplessness,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Mental problem,PROCESS_OF,Physicians,32596640,10.1136/gpsych-2020-100259,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Severe (severity modifier),PROCESS_OF,Health Personnel,32596640,10.1136/gpsych-2020-100259,2020-07-01
Attention,PROCESS_OF,Child,32596514,10.1136/bmjpo-2020-000722,2020-07-01
recurrent nasopharyngeal cancer,PROCESS_OF,Patients,32596489,10.1002/lio2.417,2020-07-01
Performance,PROCESS_OF,high-risk group,32596484,10.1002/lio2.389,2020-07-01
RNA Editing,AFFECTS,Deaminase,32596474,10.1126/sciadv.abb5813,2020-07-01
FATE1 gene,PART_OF,Patients,32596474,10.1126/sciadv.abb5813,2020-07-01
FATE1 gene,PART_OF,Virus,32596474,10.1126/sciadv.abb5813,2020-07-01
Coronavirus Infections,ISA,Disease,32596428,10.1016/j.dib.2020.105829,2020-07-01
Base Sequence,PART_OF,Virus,32596428,10.1016/j.dib.2020.105829,2020-07-01
Base Sequence,PART_OF,SARS coronavirus,32596428,10.1016/j.dib.2020.105829,2020-07-01
myocardial injury,PROCESS_OF,Patients,32596365,10.1155/2020/7413673,2020-07-01
myocardial injury,PROCESS_OF,Patients,32596365,10.1155/2020/7413673,2020-07-01
Hospitalization,TREATS,Patients,32596365,10.1155/2020/7413673,2020-07-01
Laboratory,LOCATION_OF,Laboratory Procedures,32596339,10.1155/2020/6159720,2020-07-01
Laboratory,LOCATION_OF,Laboratory Procedures,32596339,10.1155/2020/6159720,2020-07-01
Prothrombin time increased,PROCESS_OF,Patients,32596339,10.1155/2020/6159720,2020-07-01
Critical Illness,PROCESS_OF,Patients,32596339,10.1155/2020/6159720,2020-07-01
Prothrombin time assay,USES,Indicators,32596339,10.1155/2020/6159720,2020-07-01
Membrane Proteins,compared_with,Homologous Protein,32596311,10.1155/2020/4389089,2020-07-01
Virus,LOCATION_OF,Membrane Proteins,32596311,10.1155/2020/4389089,2020-07-01
Virus,LOCATION_OF,Homologous Protein,32596311,10.1155/2020/4389089,2020-07-01
Homo sapiens,LOCATION_OF,Membrane Proteins,32596311,10.1155/2020/4389089,2020-07-01
Homo sapiens,LOCATION_OF,Homologous Protein,32596311,10.1155/2020/4389089,2020-07-01
Isolate - microorganism,PART_OF,Bat coronavirus,32596311,10.1155/2020/4389089,2020-07-01
Dyspnea,PROCESS_OF,Patients,32596131,10.1016/j.idcr.2020.e00868,2020-07-01
Comorbidity,PROCESS_OF,Patients,32596085,10.7759/cureus.8268,2020-07-01
Diabetes Mellitus,COEXISTS_WITH,Septic Shock,32596085,10.7759/cureus.8268,2020-07-01
Diabetes Mellitus,COEXISTS_WITH,Respiratory Failure,32596085,10.7759/cureus.8268,2020-07-01
Hypertensive disease,COEXISTS_WITH,Septic Shock,32596085,10.7759/cureus.8268,2020-07-01
Hypertensive disease,COEXISTS_WITH,Respiratory Failure,32596085,10.7759/cureus.8268,2020-07-01
"Pneumonia, Viral",CAUSES,Acute respiratory failure,32596085,10.7759/cureus.8268,2020-07-01
Cerebrovascular accident,COEXISTS_WITH,Septic Shock,32596085,10.7759/cureus.8268,2020-07-01
Cerebrovascular accident,COEXISTS_WITH,Respiratory Failure,32596085,10.7759/cureus.8268,2020-07-01
Peripheral Vascular Diseases,COEXISTS_WITH,Septic Shock,32596085,10.7759/cureus.8268,2020-07-01
Peripheral Vascular Diseases,COEXISTS_WITH,Respiratory Failure,32596085,10.7759/cureus.8268,2020-07-01
Neurologic Deficits,COEXISTS_WITH,Septic Shock,32596085,10.7759/cureus.8268,2020-07-01
Neurologic Deficits,COEXISTS_WITH,Respiratory Failure,32596085,10.7759/cureus.8268,2020-07-01
Chest,LOCATION_OF,tomography,32596085,10.7759/cureus.8268,2020-07-01
Comorbidity,PROCESS_OF,Patients,32596085,10.7759/cureus.8268,2020-07-01
Hydroxychloroquine,TREATS,Patients,32596085,10.7759/cureus.8268,2020-07-01
Azithromycin,TREATS,Patients,32596085,10.7759/cureus.8268,2020-07-01
Pharmaceutical Preparations,DISRUPTS,Virus Replication,32596078,10.7759/cureus.8260,2020-07-01
Secondary malignant neoplasm of bone,AFFECTS,Malignant neoplasm of prostate,32596073,10.7759/cureus.8254,2020-07-01
Antibiotics,NEG_TREATS,Ulcer,32596073,10.7759/cureus.8254,2020-07-01
Gastrointestinal symptom,PROCESS_OF,Patients,32596069,10.7759/cureus.8249,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32596069,10.7759/cureus.8249,2020-07-01
Pulmonary Embolism,AFFECTS,Patients,32596069,10.7759/cureus.8249,2020-07-01
Symptoms,PROCESS_OF,Patients,32596069,10.7759/cureus.8249,2020-07-01
Prophylactic treatment,NEG_TREATS,Negative Surgical Margin,32596068,10.7759/cureus.8248,2020-07-01
Infected,PROCESS_OF,Persons,32596068,10.7759/cureus.8248,2020-07-01
Confirmation,PROCESS_OF,Patients,32596068,10.7759/cureus.8248,2020-07-01
Serum,LOCATION_OF,Antibodies,32596062,10.7717/peerj.9428,2020-07-01
Assay,DIAGNOSES,Severe Acute Respiratory Syndrome,32596046,10.7717/peerj.9318,2020-07-01
Disease,CAUSES,Multiple Organ Failure,32595974,10.1177/2050313X20933473,2020-07-01
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32595974,10.1177/2050313X20933473,2020-07-01
Disease,CAUSES,Septicemia,32595974,10.1177/2050313X20933473,2020-07-01
Disease,PROCESS_OF,Patients,32595974,10.1177/2050313X20933473,2020-07-01
Microthrombosis,CAUSES(SPEC),Multiple Organ Failure,32595974,10.1177/2050313X20933473,2020-07-01
Microthrombosis,CAUSES(SPEC),"Respiratory Distress Syndrome, Adult",32595974,10.1177/2050313X20933473,2020-07-01
Microthrombosis,CAUSES(SPEC),Septicemia,32595974,10.1177/2050313X20933473,2020-07-01
Microthrombosis,ISA,Disease,32595974,10.1177/2050313X20933473,2020-07-01
Microthrombosis,PROCESS_OF(SPEC),Patients,32595974,10.1177/2050313X20933473,2020-07-01
Comorbidity,PROCESS_OF,Woman,32595974,10.1177/2050313X20933473,2020-07-01
"Dyspnea, progressive",PROCESS_OF,Woman,32595974,10.1177/2050313X20933473,2020-07-01
Dry cough,PROCESS_OF,Woman,32595974,10.1177/2050313X20933473,2020-07-01
Plasma Exchange,TREATS,Multiple Organ Failure,32595974,10.1177/2050313X20933473,2020-07-01
Critical Illness,PROCESS_OF,Patients,32595974,10.1177/2050313X20933473,2020-07-01
Plasma Exchange,AFFECTS,Patients,32595974,10.1177/2050313X20933473,2020-07-01
Coronaviridae,PROCESS_OF,Family,32595947,10.12688/f1000research.24963.1,2020-07-01
Dyspnea,ASSOCIATED_WITH(SPEC),Severe Acute Respiratory Syndrome,32595947,10.12688/f1000research.24963.1,2020-07-01
Dyspnea,COEXISTS_WITH,Lymphopenia,32595947,10.12688/f1000research.24963.1,2020-07-01
Dyspnea,ISA,Symptoms,32595947,10.12688/f1000research.24963.1,2020-07-01
Fever,ASSOCIATED_WITH(SPEC),Severe Acute Respiratory Syndrome,32595947,10.12688/f1000research.24963.1,2020-07-01
Fever,COEXISTS_WITH,Lymphopenia,32595947,10.12688/f1000research.24963.1,2020-07-01
Fever,ISA,Symptoms,32595947,10.12688/f1000research.24963.1,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32595947,10.12688/f1000research.24963.1,2020-07-01
Symptoms,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32595947,10.12688/f1000research.24963.1,2020-07-01
SARS coronavirus,INTERACTS_WITH,Intermediate Host,32595947,10.12688/f1000research.24963.1,2020-07-01
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32595947,10.12688/f1000research.24963.1,2020-07-01
Symptoms,PROCESS_OF,Patients,32595947,10.12688/f1000research.24963.1,2020-07-01
Tracheostomy procedure,ISA,Interventional procedure,32595930,10.1093/jscr/rjaa194,2020-07-01
Tracheotomy procedure,TREATS,Patients,32595930,10.1093/jscr/rjaa194,2020-07-01
Tracheostomy procedure,ADMINISTERED_TO,work teams,32595930,10.1093/jscr/rjaa194,2020-07-01
Tracheostomy procedure,TREATS,patient condition,32595930,10.1093/jscr/rjaa194,2020-07-01
terminal patient care,TREATS,Clinician,32595843,10.4300/JGME-D-20-00290.1,2020-07-01
"Education, Medical, Graduate",ISA,Evaluation procedure,32595843,10.4300/JGME-D-20-00290.1,2020-07-01
Disease,PROCESS_OF,Patients,32595812,10.14740/cr1084,2020-07-01
risk factors,PROCESS_OF,Patients,32595812,10.14740/cr1084,2020-07-01
Health care facility,LOCATION_OF,Analysis,32595811,10.14740/cr1096,2020-07-01
Cardiac Catheterization Procedures,TREATS,Patients,32595811,10.14740/cr1096,2020-07-01
Cardiac Catheterization Procedures,TREATS,Acute Coronary Syndrome,32595811,10.14740/cr1096,2020-07-01
Cardiac Catheterization Procedures,TREATS,Patients,32595811,10.14740/cr1096,2020-07-01
Eye,LOCATION_OF,Acute Coronary Syndrome,32595811,10.14740/cr1096,2020-07-01
Heart Injuries,DISRUPTS,Cardiac Volume,32595811,10.14740/cr1096,2020-07-01
Myocardial Infarction,PROCESS_OF,Patients,32595811,10.14740/cr1096,2020-07-01
Myocardial Infarction,PROCESS_OF,Patients,32595811,10.14740/cr1096,2020-07-01
Coronavirus Infections,ISA,Disease,32595762,10.1177/1756284820934626,2020-07-01
patient condition,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32595762,10.1177/1756284820934626,2020-07-01
Coronavirus Infections,ISA,Disease,32595762,10.1177/1756284820934626,2020-07-01
Infected,PROCESS_OF,Patients,32595762,10.1177/1756284820934626,2020-07-01
gastrointestinal,LOCATION_OF,Epithelial Cells,32595762,10.1177/1756284820934626,2020-07-01
Digestive symptom,PROCESS_OF,Patients,32595762,10.1177/1756284820934626,2020-07-01
Disease,PROCESS_OF,Patients,32595762,10.1177/1756284820934626,2020-07-01
Coronavirus Infections,ISA,Disease,32595762,10.1177/1756284820934626,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32595762,10.1177/1756284820934626,2020-07-01
Digestive symptom,PROCESS_OF,Patients,32595762,10.1177/1756284820934626,2020-07-01
Diagnosis,ADMINISTERED_TO,Patients,32595762,10.1177/1756284820934626,2020-07-01
Disease,PROCESS_OF,Patients,32595762,10.1177/1756284820934626,2020-07-01
Coronavirus Infections,ISA,Disease,32595762,10.1177/1756284820934626,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32595762,10.1177/1756284820934626,2020-07-01
Genes,PART_OF,Transcriptome,32595654,10.3389/fimmu.2020.01372,2020-07-01
Infected,PROCESS_OF,Homo sapiens,32595654,10.3389/fimmu.2020.01372,2020-07-01
Valproic Acid,AUGMENTS,mRNA Expression,32595654,10.3389/fimmu.2020.01372,2020-07-01
Nicotine,ASSOCIATED_WITH,Ulcerative Colitis,32595653,10.3389/fimmu.2020.01359,2020-07-01
Patients,LOCATION_OF,Nicotine,32595653,10.3389/fimmu.2020.01359,2020-07-01
RNA Viruses,PROCESS_OF,Family,32595613,10.3389/fmicb.2020.01105,2020-07-01
Coronavirus Infections,ISA,Disease,32595534,10.3389/fpsyt.2020.00520,2020-07-01
Therapeutic procedure,TREATS,Health Personnel,32595534,10.3389/fpsyt.2020.00520,2020-07-01
Screening procedure,AFFECTS,Negative,32595534,10.3389/fpsyt.2020.00520,2020-07-01
Immunologic Adjuvants,TREATS,Disease,32595362,10.3906/biy-2002-79,2020-07-01
Storm NOS,CAUSES,Pulmonary Pathology,32595362,10.3906/biy-2002-79,2020-07-01
Cells,PART_OF,parent,32595362,10.3906/biy-2002-79,2020-07-01
Membrane,PART_OF,Cells,32595362,10.3906/biy-2002-79,2020-07-01
Cytoplasmic matrix,PART_OF,Cells,32595362,10.3906/biy-2002-79,2020-07-01
Cells,INTERACTS_WITH,Leptocyte,32595362,10.3906/biy-2002-79,2020-07-01
Cells,PART_OF,parent,32595362,10.3906/biy-2002-79,2020-07-01
Therapeutic procedure,USES,,32595362,10.3906/biy-2002-79,2020-07-01
Therapeutic procedure,USES,,32595362,10.3906/biy-2002-79,2020-07-01
Feces,ASSOCIATED_WITH(INFER),Infected,32595361,10.3906/biy-2005-102,2020-07-01
Feces,PART_OF,Patients,32595361,10.3906/biy-2005-102,2020-07-01
Gastrointestinal symptom,PROCESS_OF,Patients,32595361,10.3906/biy-2005-102,2020-07-01
Infected,PROCESS_OF,Patients,32595361,10.3906/biy-2005-102,2020-07-01
Disease,PROCESS_OF,Patients,32595361,10.3906/biy-2005-102,2020-07-01
Intestinal Microbiome,CAUSES,Secondary Infections,32595361,10.3906/biy-2005-102,2020-07-01
Intestinal Microbiome,ASSOCIATED_WITH,Septicemia,32595361,10.3906/biy-2005-102,2020-07-01
Coronavirus Infections,CAUSES,Cessation of life,32595360,10.3906/biy-2005-46,2020-07-01
Peptide Hydrolases,PART_OF,Cells,32595360,10.3906/biy-2005-46,2020-07-01
carvone,NEG_INTERACTS_WITH,P-Glycoproteins,32595360,10.3906/biy-2005-46,2020-07-01
Rattus norvegicus,LOCATION_OF,carvone,32595360,10.3906/biy-2005-46,2020-07-01
carvone,ISA,Agent,32595360,10.3906/biy-2005-46,2020-07-01
Pharmaceutical Preparations,TREATS,Virus,32595359,10.3906/biy-2005-114,2020-07-01
Pharmaceutical Preparations,TREATS,Genus: Coronavirus,32595359,10.3906/biy-2005-114,2020-07-01
Coronavirus Infections,PROCESS_OF,Family,32595358,10.3906/biy-2006-1,2020-07-01
Prophylactic treatment,USES,Vaccines,32595358,10.3906/biy-2006-1,2020-07-01
"Antibodies, Blocking",INTERACTS_WITH,Proteins,32595357,10.3906/biy-2005-91,2020-07-01
angiotensin converting enzyme 2,PART_OF,Host Cell,32595357,10.3906/biy-2005-91,2020-07-01
Pandemics,ISA,Disease Outbreaks,32595356,10.3906/biy-2004-113,2020-07-01
Serine Endopeptidases,PART_OF,integral to membrane,32595355,10.3906/biy-2005-112,2020-07-01
Serine Proteinase Inhibitors,PART_OF,integral to membrane,32595355,10.3906/biy-2005-112,2020-07-01
Serine Proteinase Inhibitors,PART_OF,integral to membrane,32595355,10.3906/biy-2005-112,2020-07-01
Serine Endopeptidases,PART_OF,integral to membrane,32595355,10.3906/biy-2005-112,2020-07-01
Disease,PROCESS_OF,Persons,32595354,10.3906/biy-2005-69,2020-07-01
Mutation,PROCESS_OF,Meleagris gallopavo,32595354,10.3906/biy-2005-69,2020-07-01
Coronavirus Infections,CAUSES,Acute respiratory disease,32595353,10.3906/biy-2005-115,2020-07-01
Transcriptome,PART_OF,Lung,32595353,10.3906/biy-2005-115,2020-07-01
Matrix Metalloproteinase Inhibitors,PREVENTS,Storm NOS,32595353,10.3906/biy-2005-115,2020-07-01
Virus,PROCESS_OF,Meleagris gallopavo,32595351,10.3906/biy-2005-35,2020-07-01
Trees (plant),LOCATION_OF,Viral Genome,32595351,10.3906/biy-2005-35,2020-07-01
Homo sapiens,ISA,Animals,32595350,10.3906/biy-2005-63,2020-07-01
Antimalarials,ADMINISTERED_TO,Patients,32595349,10.3906/biy-2005-29,2020-07-01
Antiviral Agents,TREATS,Virus Diseases,32595349,10.3906/biy-2005-29,2020-07-01
Hydroxychloroquine,ADMINISTERED_TO(SPEC),Patients,32595349,10.3906/biy-2005-29,2020-07-01
Hydroxychloroquine,ISA,Antimalarials,32595349,10.3906/biy-2005-29,2020-07-01
cardiovascular risk factor,AFFECTS,Patients,32595085,10.1016/j.numecd.2020.05.013,2020-07-01
Cessation of life,PROCESS_OF,Patients,32595085,10.1016/j.numecd.2020.05.013,2020-07-01
Heart failure,PROCESS_OF,Patients,32595085,10.1016/j.numecd.2020.05.013,2020-07-01
Chronic Kidney Diseases,PROCESS_OF,Patients,32595085,10.1016/j.numecd.2020.05.013,2020-07-01
Chronic Obstructive Airway Disease,PROCESS_OF,Persons,32595070,10.1016/j.drugpo.2020.102829,2020-07-01
Intervention regimes,PREVENTS,Engaged to be married,32595070,10.1016/j.drugpo.2020.102829,2020-07-01
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Equipment,32595070,10.1016/j.drugpo.2020.102829,2020-07-01
Anxiety,PROCESS_OF,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Persons,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Persons,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF(SPEC),Middle Aged,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF(SPEC),Middle Aged,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Persons,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF,Persons,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF(SPEC),Middle Aged,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Depressive disorder,PROCESS_OF(SPEC),Middle Aged,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Loneliness,PROCESS_OF,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Loneliness,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Loneliness,PROCESS_OF,Persons,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Loneliness,PROCESS_OF(SPEC),Middle Aged,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Middle Aged,ISA,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Middle Aged,ISA,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Middle Aged,ISA,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Middle Aged,ISA,Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Anxiety,PROCESS_OF,Elderly (population group),32595054,10.1016/j.regg.2020.05.005,2020-07-01
Sad mood,PROCESS_OF,Young Adult,32595054,10.1016/j.regg.2020.05.005,2020-07-01
High Level,PROCESS_OF,Participant,32595054,10.1016/j.regg.2020.05.005,2020-07-01
Fever,ISA,Symptoms,32595001,10.1016/j.phymed.2020.153242,2020-07-01
skill,PROCESS_OF,Clinician,32594977,10.1071/HC20030,2020-07-01
Coronavirus Infections,ISA,Disease,32594928,10.1017/S0950268820001338,2020-07-01
Incubation period,PROCESS_OF,Human Age Group,32594928,10.1017/S0950268820001338,2020-07-01
Incubation period,PROCESS_OF,Woman,32594928,10.1017/S0950268820001338,2020-07-01
Cessation of life,PROCESS_OF,World,32594909,10.1186/s12916-020-01646-2,2020-07-01
county,ISA,Geographic Locations,32594909,10.1186/s12916-020-01646-2,2020-07-01
Biological Response Modifier Therapy,TREATS,Psoriasis,32594821,10.1080/09546634.2020.1788704,2020-07-01
Household composition,PROCESS_OF,Homo sapiens,32594816,10.1177/0020764020937736,2020-07-01
"TLR4 protein, human",ADMINISTERED_TO,World,32594816,10.1177/0020764020937736,2020-07-01
Pemphigus Vulgaris,PROCESS_OF,Patients,32594787,10.1080/09546634.2020.1789041,2020-07-01
Associated symptom,PROCESS_OF,Patients,32594787,10.1080/09546634.2020.1789041,2020-07-01
Pemphigus Vulgaris,PROCESS_OF,Patients,32594787,10.1080/09546634.2020.1789041,2020-07-01
rituximab,ADMINISTERED_TO,Patients,32594787,10.1080/09546634.2020.1789041,2020-07-01
Symptoms,PROCESS_OF,Patients,32594787,10.1080/09546634.2020.1789041,2020-07-01
Multiple Trauma,CAUSES,Macrophage Activation Syndrome,32594778,10.1080/14728222.2020.1783243,2020-07-01
Organ,LOCATION_OF,Multiple Trauma,32594778,10.1080/14728222.2020.1783243,2020-07-01
Macrophage Activation Syndrome,CAUSES,Patient Discharge,32594778,10.1080/14728222.2020.1783243,2020-07-01
Increased capillary permeability (finding),CAUSES,Shock,32594778,10.1080/14728222.2020.1783243,2020-07-01
Increased capillary permeability (finding),CAUSES,Shock,32594778,10.1080/14728222.2020.1783243,2020-07-01
Lung,LOCATION_OF,Tissue damage,32594778,10.1080/14728222.2020.1783243,2020-07-01
Septicemia,PROCESS_OF,Animal Model,32594778,10.1080/14728222.2020.1783243,2020-07-01
Cardiovascular,LOCATION_OF,Protection,32594778,10.1080/14728222.2020.1783243,2020-07-01
Testis,PART_OF,Adult,32594644,10.1111/jcmm.15541,2020-07-01
RNA Sequence,ISA,Base Sequence,32594644,10.1111/jcmm.15541,2020-07-01
Germ Cells,LOCATION_OF,mRNA Expression,32594644,10.1111/jcmm.15541,2020-07-01
Diploid Cell,LOCATION_OF,mRNA Expression,32594644,10.1111/jcmm.15541,2020-07-01
ACE2 gene,LOCATION_OF,mRNA Expression,32594644,10.1111/jcmm.15541,2020-07-01
Disease,PROCESS_OF,Male population group,32594644,10.1111/jcmm.15541,2020-07-01
Inferior Colliculus,LOCATION_OF,ACE2 gene,32594644,10.1111/jcmm.15541,2020-07-01
Inferior Colliculus,PART_OF,Male population group,32594644,10.1111/jcmm.15541,2020-07-01
Infertility,PROCESS_OF,Male population group,32594644,10.1111/jcmm.15541,2020-07-01
ACE2 gene,AUGMENTS,Disease,32594644,10.1111/jcmm.15541,2020-07-01
ACE2 gene,CAUSES,Disease,32594644,10.1111/jcmm.15541,2020-07-01
Skin Manifestations,PROCESS_OF,Patients,32594634,10.1111/jdv.16797,2020-07-01
Alopecia,AFFECTS,Persons,32594627,10.1111/dth.13923,2020-07-01
Seborrheic dermatitis,AFFECTS,Persons,32594627,10.1111/dth.13923,2020-07-01
Telogen effluvium,AFFECTS,Persons,32594627,10.1111/dth.13923,2020-07-01
Face,LOCATION_OF,Alopecia,32594627,10.1111/dth.13923,2020-07-01
Chief complaint (finding),PROCESS_OF,Participant,32594627,10.1111/dth.13923,2020-07-01
Telogen effluvium,PROCESS_OF,Woman,32594627,10.1111/dth.13923,2020-07-01
cardiovascular risk factor,PROCESS_OF,Patients,32594619,10.1111/jdv.16798,2020-07-01
Critical Illness,PROCESS_OF,Patients,32594619,10.1111/jdv.16798,2020-07-01
Pharmaceutical Preparations,DISRUPTS,Storm NOS,32594619,10.1111/jdv.16798,2020-07-01
Suction system,USES,Medical irrigating device,32594617,10.1111/ans.16089,2020-07-01
Serum,LOCATION_OF,Antibodies,32594577,10.1002/jcla.23411,2020-07-01
Diarrhea,COEXISTS_WITH(SPEC),Coronavirus Infections,32594575,10.1111/jdv.16779,2020-07-01
Diarrhea,ISA,Disease,32594575,10.1111/jdv.16779,2020-07-01
Disease,COEXISTS_WITH,Coronavirus Infections,32594575,10.1111/jdv.16779,2020-07-01
Skin lesion,PROCESS_OF,Patients,32594575,10.1111/jdv.16779,2020-07-01
Symptom mild,PROCESS_OF,Patients,32594575,10.1111/jdv.16779,2020-07-01
Multiple lesions,COEXISTS_WITH,Disease,32594575,10.1111/jdv.16779,2020-07-01
Multiple lesions,PROCESS_OF,Patients,32594575,10.1111/jdv.16779,2020-07-01
Skin Manifestations,PROCESS_OF,Patients,32594572,10.1111/jdv.16778,2020-07-01
Urticaria,ISA,Lesion,32594572,10.1111/jdv.16778,2020-07-01
keratinocyte,LOCATION_OF,ACE2 gene,32594572,10.1111/jdv.16778,2020-07-01
Triage,PREVENTS,Virus,32594570,10.1111/den.13783,2020-07-01
Interventional procedure,PREVENTS,Virus,32594570,10.1111/den.13783,2020-07-01
Therapeutic immunosuppression,TREATS,Disease,32594549,10.1111/jdv.16771,2020-07-01
Brazil,ISA,Country,32594519,10.1002/ijgo.13283,2020-07-01
IMPACT gene,PART_OF,Respiratory viruses,32594325,10.1007/s10096-020-03959-9,2020-07-01
Influenza,PROCESS_OF,geriatric patients,32594325,10.1007/s10096-020-03959-9,2020-07-01
Respiratory Syncytial Virus Infections,PROCESS_OF,geriatric patients,32594325,10.1007/s10096-020-03959-9,2020-07-01
"Aged, 80 and over",LOCATION_OF,"CD69 protein, human",32594325,10.1007/s10096-020-03959-9,2020-07-01
Tertiary Care Centers,LOCATION_OF,Retrospective Studies,32594325,10.1007/s10096-020-03959-9,2020-07-01
Pneumonia,COEXISTS_WITH,Asthma,32594325,10.1007/s10096-020-03959-9,2020-07-01
Pneumonia,COEXISTS_WITH,Chronic Obstructive Airway Disease,32594325,10.1007/s10096-020-03959-9,2020-07-01
Myocardial Ischemia,COEXISTS_WITH,Chronic Kidney Diseases,32594325,10.1007/s10096-020-03959-9,2020-07-01
Asthma,PREDISPOSES,Pneumonia,32594325,10.1007/s10096-020-03959-9,2020-07-01
Asthma,PREDISPOSES,Myocardial Ischemia,32594325,10.1007/s10096-020-03959-9,2020-07-01
Organ,LOCATION_OF,Chronic failure,32594325,10.1007/s10096-020-03959-9,2020-07-01
Chronic Kidney Diseases,PREDISPOSES,Pneumonia,32594325,10.1007/s10096-020-03959-9,2020-07-01
Chronic Kidney Diseases,PREDISPOSES,Myocardial Ischemia,32594325,10.1007/s10096-020-03959-9,2020-07-01
Berberine,ISA,Plant alkaloid,32594322,10.1007/s00705-020-04706-3,2020-07-01
Berberine,ISA,Phytochemicals,32594322,10.1007/s00705-020-04706-3,2020-07-01
DNA,DISRUPTS,DNA Replication,32594322,10.1007/s00705-020-04706-3,2020-07-01
DNA,DISRUPTS,RNA-directed DNA polymerase activity,32594322,10.1007/s00705-020-04706-3,2020-07-01
Alkaloids,INTERACTS_WITH,Mitogen-Activated Protein Kinase Kinases,32594322,10.1007/s00705-020-04706-3,2020-07-01
Therapeutic procedure,ADMINISTERED_TO,Patients,32594284,10.1007/s10815-020-01821-7,2020-07-01
Malignant neoplasm of breast,PROCESS_OF,Patients,32594281,10.1007/s10549-020-05743-x,2020-07-01
Malignant neoplasm of breast,PROCESS_OF,Patients,32594281,10.1007/s10549-020-05743-x,2020-07-01
Malignant neoplasm of breast,PROCESS_OF,Patients,32594281,10.1007/s10549-020-05743-x,2020-07-01
Epilepsy,AFFECTS,Coronavirus Infections,32594268,10.1007/s10072-020-04549-5,2020-07-01
Epilepsy,PROCESS_OF,Persons,32594268,10.1007/s10072-020-04549-5,2020-07-01
Kidney problem,PROCESS_OF,Patients,32594268,10.1007/s10072-020-04549-5,2020-07-01
Problem,COEXISTS_WITH,Epilepsy,32594268,10.1007/s10072-020-04549-5,2020-07-01
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32594211,10.1007/s00330-020-07018-x,2020-07-01
Lung,LOCATION_OF,Lesion,32594204,10.1007/s00228-020-02947-4,2020-07-01
Complication,COEXISTS_WITH,Virus Diseases,32594204,10.1007/s00228-020-02947-4,2020-07-01
Virus Diseases,CAUSES,Complication,32594204,10.1007/s00228-020-02947-4,2020-07-01
pirfenidone,ISA,Pharmaceutical Preparations,32594204,10.1007/s00228-020-02947-4,2020-07-01
Pulmonary Fibrosis,CAUSES,Inflammation,32594204,10.1007/s00228-020-02947-4,2020-07-01
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32594204,10.1007/s00228-020-02947-4,2020-07-01
DNA,PART_OF,Homo sapiens,32594170,10.1093/infdis/jiaa370,2020-07-01
Disease,INTERACTS_WITH,HIV,32594164,10.1093/cid/ciaa880,2020-07-01
Hospitals,LOCATION_OF,Study,32594164,10.1093/cid/ciaa880,2020-07-01
Mechanical ventilation,COEXISTS_WITH,follow-up,32594164,10.1093/cid/ciaa880,2020-07-01
Cessation of life,ASSOCIATED_WITH,HIV Infections,32594164,10.1093/cid/ciaa880,2020-07-01
Occupational Exposure,PROCESS_OF,Health Personnel,32594160,10.1093/cid/ciaa888,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Health Personnel,32594160,10.1093/cid/ciaa888,2020-07-01
Absenteeism,PROCESS_OF,Health Personnel,32594160,10.1093/cid/ciaa888,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Health Personnel,32594160,10.1093/cid/ciaa888,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Health Personnel,32594160,10.1093/cid/ciaa888,2020-07-01
Coronavirus Infections,ISA,Disease,32594151,10.1093/tropej/fmaa032,2020-07-01
Prophylactic treatment,AFFECTS,Disease,32594151,10.1093/tropej/fmaa032,2020-07-01
Prophylactic treatment,AFFECTS(SPEC),Coronavirus Infections,32594151,10.1093/tropej/fmaa032,2020-07-01
Coronavirus Infections,ISA,Disease,32594151,10.1093/tropej/fmaa032,2020-07-01
Urinary tract infection,PROCESS_OF,Child,32594151,10.1093/tropej/fmaa032,2020-07-01
Urinary tract infection,PROCESS_OF,Citrobacter koseri,32594151,10.1093/tropej/fmaa032,2020-07-01
Pharmacotherapy,TREATS,Adult,32594142,10.1093/cid/ciaa885,2020-07-01
novel AODU treatment method,TREATS,Communicable Diseases,32594142,10.1093/cid/ciaa885,2020-07-01
Pharmacotherapy,TREATS,Child,32594142,10.1093/cid/ciaa885,2020-07-01
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Child,32594142,10.1093/cid/ciaa885,2020-07-01
Eye,LOCATION_OF,Alveolar rhabdomyosarcoma,32594142,10.1093/cid/ciaa885,2020-07-01
Practice Experience,PROCESS_OF,Population Group,32594121,10.1093/cid/ciaa889,2020-07-01
Infection,PROCESS_OF,Cohort,32594121,10.1093/cid/ciaa889,2020-07-01
Disease,PROCESS_OF,Soldiers,32594121,10.1093/cid/ciaa889,2020-07-01
Specific antibody,PART_OF,Virus,32594121,10.1093/cid/ciaa889,2020-07-01
Soldiers,DIAGNOSES,Infection,32594121,10.1093/cid/ciaa889,2020-07-01
Detection,TREATS,Cohort,32594121,10.1093/cid/ciaa889,2020-07-01
Prescription procedure,TREATS,Patients,32594120,10.1093/cid/ciaa883,2020-07-01
Ambulatory Care Facilities,LOCATION_OF,Study,32594116,10.1093/cid/ciaa886,2020-07-01
Oxygen saturation measurement,USES,Oxygen mask,32594085,10.1159/000509107,2020-07-01
emotional dependency,PROCESS_OF,Patients,32594085,10.1159/000509107,2020-07-01
Hemoperfusion,PREVENTS,"Respiratory Distress Syndrome, Adult",32594085,10.1159/000509107,2020-07-01
Hemoperfusion,TREATS,"Respiratory Distress Syndrome, Adult",32594085,10.1159/000509107,2020-07-01
Intubation,PREVENTS,Respiratory distress,32594085,10.1159/000509107,2020-07-01
"Kidney Failure, Acute",ISA,Complication,32594085,10.1159/000509107,2020-07-01
"Kidney Failure, Acute",PROCESS_OF,Patients,32594085,10.1159/000509107,2020-07-01
Oxygen,PREVENTS,Complication,32594085,10.1159/000509107,2020-07-01
Oxygen,PREVENTS(SPEC),"Kidney Failure, Acute",32594085,10.1159/000509107,2020-07-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32594085,10.1159/000509107,2020-07-01
Septic Shock,PROCESS_OF,Patients,32594085,10.1159/000509107,2020-07-01
Continuous renal replacement therapy,PREVENTS,"Respiratory Distress Syndrome, Adult",32594085,10.1159/000509107,2020-07-01
Continuous renal replacement therapy,TREATS,"Respiratory Distress Syndrome, Adult",32594085,10.1159/000509107,2020-07-01
viral transmission,PROCESS_OF,Cohort,32594082,10.1159/000509181,2020-07-01
Therapeutic immunosuppression,TREATS,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
Multiple Sclerosis,PROCESS_OF,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
ocrelizumab,ADMINISTERED_TO,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
Multiple Sclerosis,PROCESS_OF,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
Antibody Formation,PROCESS_OF,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
Mucosa-Associated Lymphoid Tissue Lymphoma,PROCESS_OF,Patients,32593961,10.1016/j.msard.2020.102323,2020-07-01
Oral Glucose Tolerance Test,DIAGNOSES,Gestational Diabetes,32593935,10.1016/j.dsx.2020.06.030,2020-07-01
inpatient,LOCATION_OF,Throat swab sample,32593875,10.1016/j.diagmicrobio.2020.115109,2020-07-01
Confirmation,PROCESS_OF,inpatient,32593875,10.1016/j.diagmicrobio.2020.115109,2020-07-01
Epilepsy,PROCESS_OF,Caregiver,32593874,10.1016/j.yebeh.2020.107238,2020-07-01
Pharmaceutical Preparations,AUGMENTS,Fit frequency,32593874,10.1016/j.yebeh.2020.107238,2020-07-01
Treatment Protocols,TREATS,Patients,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Symptoms,PROCESS_OF,Patients,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Lung,LOCATION_OF,Lesion,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Blood,LOCATION_OF,Zinc,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
C-reactive protein,INHIBITS,Zinc,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Lactate Dehydrogenase,INHIBITS,Zinc,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Phosphotransferases,INHIBITS,Zinc,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Fibrin fragment D,INHIBITS,Zinc,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Corrected Prolonged QT Interval by ECG Finding,PROCESS_OF,Patients,32593867,10.1016/j.tmaid.2020.101791,2020-07-01
Overweight,PROCESS_OF,Male population group,32593832,10.1016/j.mehy.2020.110023,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Male population group,32593832,10.1016/j.mehy.2020.110023,2020-07-01
endothelial dysfunction,CAUSES,Ischemia,32593832,10.1016/j.mehy.2020.110023,2020-07-01
Structure of mesenteric adipose tissue,LOCATION_OF,Cell Count,32593832,10.1016/j.mehy.2020.110023,2020-07-01
Structure of mesenteric adipose tissue,AFFECTS,Inflammation,32593832,10.1016/j.mehy.2020.110023,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Adult disease,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Disease,PREDISPOSES,Deep Vein Thrombosis,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,PREDISPOSES(SPEC),Deep Vein Thrombosis,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Disease,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Radionuclide Imaging,ADMINISTERED_TO,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,COEXISTS_WITH,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,COEXISTS_WITH(SPEC),Coronavirus Infections,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Disease,PREDISPOSES,Deep Vein Thrombosis,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,PREDISPOSES(SPEC),Deep Vein Thrombosis,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Disease,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Fibrinogen,ASSOCIATED_WITH,Deep Vein Thrombosis,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Disease,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Deep Vein Thrombosis,PROCESS_OF,Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,ISA,Disease,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32593770,10.1016/j.jvsv.2020.06.012,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32593743,10.1016/j.cmi.2020.06.017,2020-07-01
Less often,PROCESS_OF,Child,32593743,10.1016/j.cmi.2020.06.017,2020-07-01
Diagnostic tests,DIAGNOSES,Coronavirus Infections,32593741,10.1016/j.cmi.2020.06.019,2020-07-01
Diagnostic tests,DIAGNOSES,Severe Acute Respiratory Syndrome,32593741,10.1016/j.cmi.2020.06.019,2020-07-01
PCR test for SARS,METHOD_OF,Diagnosis,32593741,10.1016/j.cmi.2020.06.019,2020-07-01
Obesity,PROCESS_OF,Patients,32593740,10.1016/j.mce.2020.110917,2020-07-01
angiotensin converting enzyme 2,ASSOCIATED_WITH,Virus Diseases,32593740,10.1016/j.mce.2020.110917,2020-07-01
angiotensin converting enzyme 2,AFFECTS,Virus Replication,32593740,10.1016/j.mce.2020.110917,2020-07-01
Genes,INTERACTS_WITH,Adipocytes,32593740,10.1016/j.mce.2020.110917,2020-07-01
subcutaneous,LOCATION_OF,Adipocytes,32593740,10.1016/j.mce.2020.110917,2020-07-01
paired basic amino acid cleaving enzyme,AUGMENTS,Biological Processes,32593740,10.1016/j.mce.2020.110917,2020-07-01
ADAM10 gene,AUGMENTS,Biological Processes,32593740,10.1016/j.mce.2020.110917,2020-07-01
Adipose tissue,LOCATION_OF,Virus Diseases,32593740,10.1016/j.mce.2020.110917,2020-07-01
"Genes, Regulator",INTERACTS_WITH,FNDC5 gene,32593740,10.1016/j.mce.2020.110917,2020-07-01
FNDC5 gene,ASSOCIATED_WITH,Virus Diseases,32593740,10.1016/j.mce.2020.110917,2020-07-01
IMPACT gene,PART_OF,Recession,32593730,10.1016/j.ypmed.2020.106186,2020-07-01
Recession,COEXISTS_WITH,Domestic Violence,32593730,10.1016/j.ypmed.2020.106186,2020-07-01
Physical abuse,PROCESS_OF,Adult,32593730,10.1016/j.ypmed.2020.106186,2020-07-01
physiological aspects,AFFECTS,Dynamics,32593679,10.1016/j.jtbi.2020.110385,2020-07-01
Abnormal behavior,AFFECTS,Disease,32593679,10.1016/j.jtbi.2020.110385,2020-07-01
Abnormal behavior,PROCESS_OF,Persons,32593679,10.1016/j.jtbi.2020.110385,2020-07-01
Child,LOCATION_OF,IMPACT gene,32593648,10.1016/j.prrv.2020.05.006,2020-07-01
Cessation of life,PROCESS_OF,Human Age Group,32593648,10.1016/j.prrv.2020.05.006,2020-07-01
Fever,PROCESS_OF,Patients,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Unipolar Depression,PROCESS_OF,Participant,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Generalized Anxiety Disorder,PROCESS_OF,Participant,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
"Stress Disorders, Traumatic, Acute",PROCESS_OF,Participant,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Woman,ISA,Persons,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Sleeplessness,PROCESS_OF,Persons,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Sleeplessness,PROCESS_OF(SPEC),Woman,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
poor hygiene,PROCESS_OF,general population,32593614,10.1016/j.sleep.2020.05.018,2020-07-01
Natural Products,ISA,Pharmaceutical Preparations,32593613,10.1016/j.bcp.2020.114123,2020-07-01
angiotensin converting enzyme 2,PART_OF,Epithelial Cells,32593613,10.1016/j.bcp.2020.114123,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Participant,32593608,10.1016/j.jhin.2020.06.028,2020-07-01
Old age,ISA,Population Group,32593567,10.1016/j.anaerobe.2020.102233,2020-07-01
Symptoms,PROCESS_OF,Participant,32593564,10.1016/j.jadohealth.2020.06.009,2020-07-01
Experience,PROCESS_OF,College student,32593564,10.1016/j.jadohealth.2020.06.009,2020-07-01
Ophthalmic antibiotic,TREATS,Acute conjunctivitis,32593563,10.1016/j.jadohealth.2020.06.001,2020-07-01
Conjunctivitis,ISA,Symptoms,32593563,10.1016/j.jadohealth.2020.06.001,2020-07-01
Asymptomatic,PROCESS_OF,Patients,32593563,10.1016/j.jadohealth.2020.06.001,2020-07-01
Coronavirus Infections,ISA,Disease,32593519,10.1016/j.transci.2020.102846,2020-07-01
Pharmaceutical Preparations,PREVENTS,Disease,32593519,10.1016/j.transci.2020.102846,2020-07-01
Pharmaceutical Preparations,PREVENTS(SPEC),Coronavirus Infections,32593519,10.1016/j.transci.2020.102846,2020-07-01
Vaccines,PREVENTS,Disease,32593519,10.1016/j.transci.2020.102846,2020-07-01
Vaccines,PREVENTS(SPEC),Coronavirus Infections,32593519,10.1016/j.transci.2020.102846,2020-07-01
Coronavirus Infections,ISA,Disease,32593519,10.1016/j.transci.2020.102846,2020-07-01
Coronavirus Infections,ISA,Disease,32593519,10.1016/j.transci.2020.102846,2020-07-01
Coronavirus Infections,PROCESS_OF,Patients,32593519,10.1016/j.transci.2020.102846,2020-07-01
"SUPPLY, NOT OTHERWISE SPECIFIED",TREATS,Patients,32593519,10.1016/j.transci.2020.102846,2020-07-01
"SUPPLY, NOT OTHERWISE SPECIFIED",TREATS(INFER),Coronavirus Infections,32593519,10.1016/j.transci.2020.102846,2020-07-01
monitoring systems,USES,Internet,32593519,10.1016/j.transci.2020.102846,2020-07-01
Program,AUGMENTS,Social wellbeing,32593495,10.1016/j.jagp.2020.05.026,2020-07-01
Program,TREATS,Vulnerable Populations,32593495,10.1016/j.jagp.2020.05.026,2020-07-01
Disease,PROCESS_OF,Patients,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Heart,LOCATION_OF,Comorbidity,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Disease,COEXISTS_WITH,Heart Injuries,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Neoplasm Metastasis,MANIFESTATION_OF,Heart Injuries,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Coronavirus Infections,COEXISTS_WITH(SPEC),Heart Injuries,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Coronavirus Infections,ISA,Disease,32593418,10.1016/j.hrtlng.2020.04.019,2020-07-01
Physical Examination,USES,tomography,32593409,10.1016/j.crad.2020.06.006,2020-07-01
Breast normal,PROCESS_OF,Patients,32593409,10.1016/j.crad.2020.06.006,2020-07-01
Surgical Management,COEXISTS_WITH,Emergency operation,32593409,10.1016/j.crad.2020.06.006,2020-07-01
Surgical Management,COEXISTS_WITH,Emergency operation,32593409,10.1016/j.crad.2020.06.006,2020-07-01
Surgical Management,TREATS,Cohort,32593409,10.1016/j.crad.2020.06.006,2020-07-01
Cerebrovascular accident,AFFECTS,Physicians,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Cerebrovascular accident,AFFECTS,Psychiatrist,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Cerebrovascular accident,AFFECTS,Neurologists,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Parenchyma,PART_OF,Brain,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Ischemic stroke,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Encephalitis,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Encephalopathies,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Abnormal mental state,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Abnormal mental state,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Disease,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Psychotic Disorders,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Mood Disorders,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Abnormal mental state,PROCESS_OF,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Encephalitis,OCCURS_IN,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Encephalopathies,OCCURS_IN,Patients,32593341,10.1016/S2215-0366(20)30287-X,2020-07-01
Pediatric Infectious Disorder,PROCESS_OF,Hospital specialist,32593339,10.1016/S2352-4642(20)30177-2,2020-07-01
Body Regions,LOCATION_OF,Severe Acute Respiratory Syndrome,32593339,10.1016/S2352-4642(20)30177-2,2020-07-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32593339,10.1016/S2352-4642(20)30177-2,2020-07-01
Mild disorder,PROCESS_OF,Child,32593339,10.1016/S2352-4642(20)30177-2,2020-07-01
Comorbidity,PROCESS_OF,Patients,32593209,10.1111/ejh.13480,2020-06-28
Severe course,PROCESS_OF,Patients,32593209,10.1111/ejh.13480,2020-06-28
Pneumonia,PROCESS_OF,Patients,32593209,10.1111/ejh.13480,2020-06-28
ruxolitinib,ADMINISTERED_TO,Patients,32593209,10.1111/ejh.13480,2020-06-28
Comorbidity,PROCESS_OF,Patients,32593209,10.1111/ejh.13480,2020-06-28
ruxolitinib,CAUSES,"Respiratory Distress Syndrome, Adult",32593209,10.1111/ejh.13480,2020-06-28
ruxolitinib,CAUSES,Storm NOS,32593209,10.1111/ejh.13480,2020-06-28
ruxolitinib,TREATS,Discontinued,32593209,10.1111/ejh.13480,2020-06-28
Pneumonia,PROCESS_OF,Patients,32593209,10.1111/ejh.13480,2020-06-28
Angiotensin-Converting Enzyme Inhibitors,TREATS,Hypertensive disease,32593202,10.1111/bjh.16978,2020-06-28
Amlodipine,TREATS,Hypertensive disease,32593202,10.1111/bjh.16978,2020-06-28
Elderly (population group),ISA,Population Group,32593196,10.1111/ijcp.13596,2020-06-28
Alzheimer's Disease,PROCESS_OF,Patients,32593196,10.1111/ijcp.13596,2020-06-28
Alzheimer's Disease,PROCESS_OF,Patients,32593196,10.1111/ijcp.13596,2020-06-28
Drug Interactions,PROCESS_OF,Patients,32593196,10.1111/ijcp.13596,2020-06-28
Symptom mild,PROCESS_OF,Patients,32593183,10.1111/bjh.16979,2020-06-28
SARS coronavirus,CAUSES,Syndrome,32593183,10.1111/bjh.16979,2020-06-28
inflammatory response,PROCESS_OF,Patients,32593183,10.1111/bjh.16979,2020-06-28
ruxolitinib,INHIBITS,,32593183,10.1111/bjh.16979,2020-06-28
Immunoassay method,METHOD_OF,Detection,32593133,10.1016/j.jcv.2020.104511,2020-06-28
Laboratory Procedures,USES,Detection,32593133,10.1016/j.jcv.2020.104511,2020-06-28
Symptoms,PROCESS_OF,Patients,32593133,10.1016/j.jcv.2020.104511,2020-06-28
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32593133,10.1016/j.jcv.2020.104511,2020-06-28
HIV Infections,COEXISTS_WITH,Crisis,32593122,10.1016/j.ajp.2020.102254,2020-06-28
Tuberculosis,COEXISTS_WITH,Crisis,32593122,10.1016/j.ajp.2020.102254,2020-06-28
Agony,PROCESS_OF,Health Personnel,32593067,10.1016/j.psychres.2020.113230,2020-06-28
Agony,PROCESS_OF,general population,32593067,10.1016/j.psychres.2020.113230,2020-06-28
Adverse reactions,COEXISTS_WITH,Anxiety,32593067,10.1016/j.psychres.2020.113230,2020-06-28
Adverse reactions,COEXISTS_WITH,Mental disorders,32593067,10.1016/j.psychres.2020.113230,2020-06-28
Adverse reactions,COEXISTS_WITH,Depressive disorder,32593067,10.1016/j.psychres.2020.113230,2020-06-28
Hotlines,PREVENTS,Crisis,32593065,10.1016/j.psychres.2020.113205,2020-06-28
Blood,LOCATION_OF,Antibodies,32593060,10.1016/j.cmpb.2020.105617,2020-06-28
Donor person,USES,Classification,32593060,10.1016/j.cmpb.2020.105617,2020-06-28
Blood arterial,LOCATION_OF,Oxygen,32593060,10.1016/j.cmpb.2020.105617,2020-06-28
Coronavirus Infections,ISA,Disease,32593056,10.1016/j.puhe.2020.06.028,2020-06-28
Proteins,AFFECTS,Virus Replication,32592996,10.1016/j.isci.2020.101258,2020-06-28
Comorbidity,PROCESS_OF,Patients,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Infected,PROCESS_OF,Patients,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Hypertensive disease,PROCESS_OF,Patients,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Cardiovascular Diseases,COEXISTS_WITH,endothelial dysfunction,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Diabetes Mellitus,COEXISTS_WITH,endothelial dysfunction,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Male population group,LOCATION_OF,IMPACT gene,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Gonadal Steroid Hormones,TREATS,Patients,32592919,10.1016/j.mehy.2020.110015,2020-06-28
angiotensin II,AFFECTS,Vascular constriction (function),32592919,10.1016/j.mehy.2020.110015,2020-06-28
Estrogen Receptors,PART_OF,Endothelium,32592919,10.1016/j.mehy.2020.110015,2020-06-28
rosoxacin,STIMULATES,Estrogen Receptors,32592919,10.1016/j.mehy.2020.110015,2020-06-28
Gingival Diseases,COEXISTS_WITH,Comorbidity,32592918,10.1016/j.mehy.2020.109969,2020-06-28
Comorbidity,PREDISPOSES,Complication,32592918,10.1016/j.mehy.2020.109969,2020-06-28
Evaluation procedure,TREATS,patient condition,32592918,10.1016/j.mehy.2020.109969,2020-06-28
Photochemotherapy,TREATS,Bronchiectasis,32592911,10.1016/j.pdpdt.2020.101889,2020-06-28
Photochemotherapy,USES,Artificial Airways,32592911,10.1016/j.pdpdt.2020.101889,2020-06-28
Photosensitizing Agents,TREATS,Respiratory Tract Infections,32592911,10.1016/j.pdpdt.2020.101889,2020-06-28
Vaccines,TREATS,Child,32592908,10.1016/j.ijid.2020.06.072,2020-06-28
Coronavirus Infections,ASSOCIATED_WITH,Host (organism),32592845,10.1016/j.meegid.2020.104432,2020-06-28
Human coronavirus,COEXISTS_WITH,Virus,32592845,10.1016/j.meegid.2020.104432,2020-06-28
DNA Sequence,PART_OF,virus by host,32592845,10.1016/j.meegid.2020.104432,2020-06-28
Diabetic Ketoacidosis,ISA,Complication,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Severe Acute Respiratory Syndrome,PREDISPOSES,Poor outcome,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Hyperosmolar Hyperglycemic State,PROCESS_OF,Patients,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Serum,LOCATION_OF,Bicarbonates,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Acidosis,PROCESS_OF,Patients,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Comorbidity,PROCESS_OF,Patients,32592843,10.1016/j.diabres.2020.108279,2020-06-28
diabetic,PROCESS_OF,Patients,32592843,10.1016/j.diabres.2020.108279,2020-06-28
Cardiovascular Diseases,COEXISTS_WITH,Comorbidity,32592842,10.1016/j.diabres.2020.108278,2020-06-28
Fluctuation,COEXISTS_WITH,Finding of blood glucose level,32592842,10.1016/j.diabres.2020.108278,2020-06-28
Country,ISA,Geographic Locations,32592842,10.1016/j.diabres.2020.108278,2020-06-28
Pharmaceutical Preparations,TREATS,Virus Diseases,32592841,10.1016/j.diabres.2020.108282,2020-06-28
Metformin,INTERACTS_WITH,Sodium-Hydrogen Antiporter,32592841,10.1016/j.diabres.2020.108282,2020-06-28
Metformin,INTERACTS_WITH,vacuolar H+-ATPase,32592841,10.1016/j.diabres.2020.108282,2020-06-28
Sodium-Hydrogen Antiporter,PART_OF,Endosomes,32592841,10.1016/j.diabres.2020.108282,2020-06-28
Agent,TREATS,Pulmonary Fibrosis,32592841,10.1016/j.diabres.2020.108282,2020-06-28
Epidemic,CAUSES,Diabetes,32592837,10.1016/j.diabres.2020.108277,2020-06-28
Diabetes,PROCESS_OF,Patients,32592836,10.1016/j.diabres.2020.108286,2020-06-28
lobe,PART_OF,Lung,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Diabetes,PROCESS_OF,Patients,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Diabetes,PROCESS_OF,Patients,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Diabetes,PROCESS_OF,Patients,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Diabetes,PROCESS_OF,Patients,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Diabetes,PROCESS_OF,Population Group,32592836,10.1016/j.diabres.2020.108286,2020-06-28
Pharmaceutical Preparations,TREATS,Virus Diseases,32592817,10.1016/j.virusres.2020.198073,2020-06-28
Pharmaceutical Preparations,TREATS,Disease,32592817,10.1016/j.virusres.2020.198073,2020-06-28
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32592817,10.1016/j.virusres.2020.198073,2020-06-28
Blood Vessel,LOCATION_OF,risk factors,32592761,10.1016/j.jaapos.2020.06.001,2020-06-28
risk factors,PROCESS_OF,Patients,32592761,10.1016/j.jaapos.2020.06.001,2020-06-28
Nerve palsy,COEXISTS_WITH,Virus Diseases,32592761,10.1016/j.jaapos.2020.06.001,2020-06-28
Pharmaceutical Preparations,TREATS,Liver diseases,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,AFFECTS,Cytoplasm,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,AFFECTS,Membrane,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,ISA,Anti-Inflammatory Agents,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
HMGB1 Protein,INHIBITS,Alarmins,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,AFFECTS,Cytoplasm,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,AFFECTS,Membrane,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Chloroquine,ISA,Pharmaceutical Preparations,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Tenofovir,ISA,Pharmaceutical Preparations,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Glycyrrhizic Acid,TREATS,Patients,32592716,10.1016/j.pharmthera.2020.107618,2020-06-28
Blood Vessel,LOCATION_OF,Thickened,32592709,10.1016/j.chest.2020.06.025,2020-06-28
Hydroxymethylglutaryl-CoA Reductase Inhibitors,AUGMENTS,Virus Internalization,32592657,10.1016/j.cmet.2020.06.015,2020-06-28
Pneumonia,PROCESS_OF,Patients,32592564,10.17116/kurort2020970315,2020-06-28
SARS coronavirus,CAUSES,Pneumonia,32592564,10.17116/kurort2020970315,2020-06-28
Pneumonia,AFFECTS,Patients,32592564,10.17116/kurort2020970315,2020-06-28
Rehabilitation therapy,TREATS,Patients,32592564,10.17116/kurort2020970315,2020-06-28
Coronavirus Infections,AFFECTS,Patients,32592564,10.17116/kurort2020970315,2020-06-28
Program,TREATS,Patients,32592564,10.17116/kurort2020970315,2020-06-28
Syndrome,PROCESS_OF,Neurotics,32592564,10.17116/kurort2020970315,2020-06-28
Rehabilitation therapy,TREATS,Patients,32592564,10.17116/kurort2020970315,2020-06-28
Favorable Clinical Outcome,COEXISTS_WITH,Disease,32592550,10.21101/cejph.a6290,2020-06-28
Blood coagulation,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Performance,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Blood Coagulation Disorders,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Symptom aggravating factors,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Symptom aggravating factors,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Blood Coagulation Disorders,PROCESS_OF,Patients,32592539,10.1111/ijlh.13273,2020-06-28
Serum,LOCATION_OF,CD40LG wt Allele,32592502,10.1002/jmv.26230,2020-06-28
"Diagnosis, clinical",USES,Basis,32592502,10.1002/jmv.26230,2020-06-28
cytokine,AFFECTS,Inflammation,32592496,10.1002/jmv.26229,2020-06-28
cytokine,CAUSES,Multiple Organ Failure,32592496,10.1002/jmv.26229,2020-06-28
Immunocompromised Host,PREDISPOSES,Severe disorder,32592461,10.1093/cid/ciaa863,2020-06-28
HIV,PROCESS_OF,Patients,32592461,10.1093/cid/ciaa863,2020-06-28
Immunomodulation,ADMINISTERED_TO,Patients,32592461,10.1093/cid/ciaa863,2020-06-28
Immunomodulation,TREATS,Autoimmune Diseases,32592461,10.1093/cid/ciaa863,2020-06-28
Malignant Neoplasms,PROCESS_OF,Patients,32592461,10.1093/cid/ciaa863,2020-06-28
Coronavirus Infections,ISA,Disease,32592396,10.1093/femspd/ftaa031,2020-06-28
Coronavirus Infections,ISA,Disease,32592396,10.1093/femspd/ftaa031,2020-06-28
Serum blood tests,USES,CD40LG wt Allele,32592396,10.1093/femspd/ftaa031,2020-06-28
Coronavirus Infections,ISA,Disease,32592396,10.1093/femspd/ftaa031,2020-06-28
Botulinum Toxins,CAUSES,Facial paralysis,32592268,10.1111/jocd.13569,2020-06-28
Muscle,LOCATION_OF,Facial paralysis,32592268,10.1111/jocd.13569,2020-06-28
Disseminated Malignant Neoplasm,PROCESS_OF,Clinician,32592210,10.1111/ejh.13479,2020-06-28
Clinician,TREATS,Patients,32592210,10.1111/ejh.13479,2020-06-28
High Level,PROCESS_OF,Patients,32592160,10.1007/s10900-020-00870-4,2020-06-28
Contacts,ADMINISTERED_TO,Persons,32592160,10.1007/s10900-020-00870-4,2020-06-28
Coronavirus Infections,ISA,Disease,32592145,10.1007/s40268-020-00312-5,2020-06-28
"M Protein, multiple myeloma",INTERACTS_WITH,angiotensin converting enzyme 2,32592145,10.1007/s40268-020-00312-5,2020-06-28
Peptides,DISRUPTS,protein protein interaction,32592145,10.1007/s40268-020-00312-5,2020-06-28
Peptides,ISA,Agent,32592145,10.1007/s40268-020-00312-5,2020-06-28
Peptides,TREATS(SPEC),Severe Acute Respiratory Syndrome,32592145,10.1007/s40268-020-00312-5,2020-06-28
Agent,TREATS,Severe Acute Respiratory Syndrome,32592145,10.1007/s40268-020-00312-5,2020-06-28
Symptoms,PROCESS_OF,Patients,32592118,10.1186/s41747-020-00167-0,2020-06-28
Diabetes Mellitus,PROCESS_OF,Patients,32592113,10.1007/s11739-020-02389-x,2020-06-28
Lung,LOCATION_OF,Dipeptidyl-Peptidase IV,32592113,10.1007/s11739-020-02389-x,2020-06-28
Dipeptidyl-Peptidase IV,AFFECTS,Syndrome,32592113,10.1007/s11739-020-02389-x,2020-06-28
Agent,AFFECTS,Inflammatory disorder,32592113,10.1007/s11739-020-02389-x,2020-06-28
Dipeptidyl-Peptidase IV Inhibitors,AFFECTS,glucose metabolism,32592113,10.1007/s11739-020-02389-x,2020-06-28
Syndrome,COEXISTS_WITH,diabetic,32592113,10.1007/s11739-020-02389-x,2020-06-28
Disease,OCCURS_IN,Community,32592048,10.1007/s11356-020-09733-w,2020-06-28
Genus: Coronavirus,ISA,Virus,32592038,10.1007/s42770-020-00321-1,2020-06-28
SARS gene,PART_OF,SARS coronavirus,32592038,10.1007/s42770-020-00321-1,2020-06-28
Practice Experience,PROCESS_OF,Community,32592023,10.17269/s41997-020-00368-5,2020-06-28
Stress,PROCESS_OF,Health Personnel,32592021,10.1007/s11325-020-02135-9,2020-06-28
Stress,PROCESS_OF,Health Personnel,32592021,10.1007/s11325-020-02135-9,2020-06-28
Inflammatory disorder,PROCESS_OF,Patients,32591970,10.1007/s00296-020-04635-z,2020-06-28
Patients,LOCATION_OF,"CD69 protein, human",32591970,10.1007/s00296-020-04635-z,2020-06-28
Rheumatic Fever,PROCESS_OF,Patients,32591970,10.1007/s00296-020-04635-z,2020-06-28
secukinumab,TREATS,Ankylosing spondylitis,32591970,10.1007/s00296-020-04635-z,2020-06-28
Ankylosing spondylitis,PROCESS_OF,Patients,32591970,10.1007/s00296-020-04635-z,2020-06-28
secukinumab,TREATS,Patients,32591970,10.1007/s00296-020-04635-z,2020-06-28
secukinumab,TREATS(INFER),Ankylosing spondylitis,32591970,10.1007/s00296-020-04635-z,2020-06-28
Lung,LOCATION_OF,nodular density,32591970,10.1007/s00296-020-04635-z,2020-06-28
Lung,LOCATION_OF,Ground Glass Opacity,32591970,10.1007/s00296-020-04635-z,2020-06-28
Lung,LOCATION_OF,Ground Glass Opacity,32591970,10.1007/s00296-020-04635-z,2020-06-28
Interleukin-17,AFFECTS,Hyperinflammatory state,32591970,10.1007/s00296-020-04635-z,2020-06-28
Infected,PROCESS_OF,Persons,32591970,10.1007/s00296-020-04635-z,2020-06-28
angiotensin II,AFFECTS,Organ,32591908,10.1007/s11906-020-01048-y,2020-06-28
angiotensin converting enzyme 2,COEXISTS_WITH,,32591908,10.1007/s11906-020-01048-y,2020-06-28
angiotensin converting enzyme 2,AUGMENTS,Virus Internalization,32591908,10.1007/s11906-020-01048-y,2020-06-28
Agent,INTERACTS_WITH,Renin,32591908,10.1007/s11906-020-01048-y,2020-06-28
Fever,PROCESS_OF,Patients,32591890,10.1007/s00330-020-07007-0,2020-06-28
Chest CT,ADMINISTERED_TO,Patients,32591888,10.1007/s00330-020-07013-2,2020-06-28
Dyspnea,ISA,"Signs and Symptoms, Respiratory",32591888,10.1007/s00330-020-07013-2,2020-06-28
psychological distress,AFFECTS,Surgeon,32591880,10.1007/s00586-020-06517-1,2020-06-28
Senility,PROCESS_OF,Private Sector,32591880,10.1007/s00586-020-06517-1,2020-06-28
Symptoms,PROCESS_OF,Patients,32591839,10.14573/altex.2006111,2020-06-28
Neurons,LOCATION_OF,ACE2 gene,32591839,10.14573/altex.2006111,2020-06-28
Nasopharynx,LOCATION_OF,RNA Sequence,32591762,10.1038/s41587-020-0602-4,2020-06-28
Patients,LOCATION_OF,Bronchial Specimen,32591762,10.1038/s41587-020-0602-4,2020-06-28
RNA Sequence,PART_OF,Cells,32591762,10.1038/s41587-020-0602-4,2020-06-28
Interleukin-1 beta,compared_with,,32591762,10.1038/s41587-020-0602-4,2020-06-28
Immune Cell,PRODUCES,,32591762,10.1038/s41587-020-0602-4,2020-06-28
Household composition,PROCESS_OF,Homo sapiens,32591747,10.1038/s41416-020-0960-1,2020-06-28
corneal surgery,TREATS,Enthesitis-Related Arthritis,32591733,10.1038/s41433-020-1053-3,2020-06-28
Phacoemulsification,USES,HTATIP wt Allele,32591733,10.1038/s41433-020-1053-3,2020-06-28
Cessation of life,PROCESS_OF,Persons,32591714,10.1038/s41415-020-1747-8,2020-06-28
Pneumonia,AFFECTS,Complication,32591714,10.1038/s41415-020-1747-8,2020-06-28
Pneumonia,AFFECTS,Superinfection,32591714,10.1038/s41415-020-1747-8,2020-06-28
"Respiratory Distress Syndrome, Adult",AFFECTS,Complication,32591714,10.1038/s41415-020-1747-8,2020-06-28
"Respiratory Distress Syndrome, Adult",AFFECTS,Superinfection,32591714,10.1038/s41415-020-1747-8,2020-06-28
Septicemia,AFFECTS,Complication,32591714,10.1038/s41415-020-1747-8,2020-06-28
Septicemia,AFFECTS,Superinfection,32591714,10.1038/s41415-020-1747-8,2020-06-28
Gingival Diseases,CAUSES,Imbalance,32591714,10.1038/s41415-020-1747-8,2020-06-28
Imbalance,PREDISPOSES,Gingival Diseases,32591714,10.1038/s41415-020-1747-8,2020-06-28
Oral health,PREVENTS,Complication,32591714,10.1038/s41415-020-1747-8,2020-06-28
Dentist,ISA,professional occupation status,32591703,10.1038/s41415-020-1709-1,2020-06-28
Hypertensive disease,ISA,Cardiovascular Diseases,32591702,10.1038/s41415-020-1781-6,2020-06-28
Minority Groups,ISA,Ethnic group,32591702,10.1038/s41415-020-1781-6,2020-06-28
Coronavirus Infections,AFFECTS,Household composition,32591701,10.1038/s41415-020-1705-5,2020-06-28
Continuous Positive Airway Pressure,TREATS,Patients,32591667,10.1038/s41432-020-0105-7,2020-06-28
Bi-level airway pressure,TREATS,Patients,32591667,10.1038/s41432-020-0105-7,2020-06-28
C-reactive protein measurement,DIAGNOSES,patient condition,32591667,10.1038/s41432-020-0105-7,2020-06-28
"Discharge, body substance",PART_OF,Patients,32591667,10.1038/s41432-020-0105-7,2020-06-28
Salivary Glands,LOCATION_OF,Possible,32591666,10.1038/s41432-020-0104-8,2020-06-28
Leptocyte,PRODUCES,saliva,32591666,10.1038/s41432-020-0104-8,2020-06-28
Proteins,ASSOCIATED_WITH,Disease,32591666,10.1038/s41432-020-0104-8,2020-06-28
paired basic amino acid cleaving enzyme,ASSOCIATED_WITH(SPEC),Disease,32591666,10.1038/s41432-020-0104-8,2020-06-28
paired basic amino acid cleaving enzyme,ISA,Proteins,32591666,10.1038/s41432-020-0104-8,2020-06-28
paired basic amino acid cleaving enzyme,STIMULATES,Up-Regulation (Physiology),32591666,10.1038/s41432-020-0104-8,2020-06-28
Chloroquine,TREATS,Homo sapiens,32591664,10.1038/s41432-020-0098-2,2020-06-28
Hydroxychloroquine,TREATS,Homo sapiens,32591664,10.1038/s41432-020-0098-2,2020-06-28
Prophylactic treatment,USES,Chloroquine,32591664,10.1038/s41432-020-0098-2,2020-06-28
Prophylactic treatment,USES,Hydroxychloroquine,32591664,10.1038/s41432-020-0098-2,2020-06-28
saliva,ASSOCIATED_WITH(INFER),Infected,32591662,10.1038/s41432-020-0101-y,2020-06-28
saliva,PART_OF,Persons,32591662,10.1038/s41432-020-0101-y,2020-06-28
Infected,PROCESS_OF,Persons,32591662,10.1038/s41432-020-0101-y,2020-06-28
Emergency medical service,TREATS,Patients,32591660,10.1038/s41432-020-0095-5,2020-06-28
"TNFSF10 protein, human",PART_OF,Virus,32591660,10.1038/s41432-020-0095-5,2020-06-28
Pennsylvania,ISA,United States,32591659,10.1038/s41432-020-0094-6,2020-06-28
Dental Procedures,ISA,Operative Surgical Procedures,32591659,10.1038/s41432-020-0094-6,2020-06-28
Dental Procedures,TREATS,Enthesitis-Related Arthritis,32591659,10.1038/s41432-020-0094-6,2020-06-28
Aging,PROCESS_OF,Population Group,32591657,10.1038/s41432-020-0091-9,2020-06-28
Cardiopulmonary,LOCATION_OF,Problem,32591657,10.1038/s41432-020-0091-9,2020-06-28
Pharmacotherapy,ISA,Therapeutic procedure,32591657,10.1038/s41432-020-0091-9,2020-06-28
Patients,LOCATION_OF,IMPACT gene,32591657,10.1038/s41432-020-0091-9,2020-06-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32591657,10.1038/s41432-020-0091-9,2020-06-28
Cohort,LOCATION_OF,IMPACT gene,32591657,10.1038/s41432-020-0091-9,2020-06-28
Universities,ISA,School,32591656,10.1038/s41432-020-0092-8,2020-06-28
Patients,LOCATION_OF,Bulla,32591655,10.1038/s41432-020-0100-z,2020-06-28
Confirmation,PROCESS_OF,Patients,32591655,10.1038/s41432-020-0100-z,2020-06-28
Tongue,LOCATION_OF,Pain,32591655,10.1038/s41432-020-0100-z,2020-06-28
Palate,LOCATION_OF,Pain,32591655,10.1038/s41432-020-0100-z,2020-06-28
Simple lobule of cerebellum,LOCATION_OF,herpes lesion,32591655,10.1038/s41432-020-0100-z,2020-06-28
Nasopharynx,LOCATION_OF,Virus,32591654,10.1038/s41432-020-0090-x,2020-06-28
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32591654,10.1038/s41432-020-0090-x,2020-06-28
"Schools, Dental",LOCATION_OF,"Education, Dental",32591653,10.1038/s41432-020-0089-3,2020-06-28
Dentist,USES,Classification,32591653,10.1038/s41432-020-0089-3,2020-06-28
Solutions,ISA,Materials,32591653,10.1038/s41432-020-0089-3,2020-06-28
Drapes (device),PREVENTS,Cross Infection,32591652,10.1038/s41432-020-0088-4,2020-06-28
Internal nose structure,LOCATION_OF,Surgical Endoscopy,32591652,10.1038/s41432-020-0088-4,2020-06-28
Surgical Endoscopy,ADMINISTERED_TO,Patients,32591652,10.1038/s41432-020-0088-4,2020-06-28
Instrument tray,TREATS,Patients,32591652,10.1038/s41432-020-0088-4,2020-06-28
Towelettes,TREATS,Patients,32591652,10.1038/s41432-020-0088-4,2020-06-28
Upper arm,LOCATION_OF,Structure of subregion of abdomen,32591652,10.1038/s41432-020-0088-4,2020-06-28
Operating Room,LOCATION_OF,Research Design,32591652,10.1038/s41432-020-0088-4,2020-06-28
Patients,LOCATION_OF,"Antibodies, Neutralizing",32591466,10.1128/JVI.01083-20,2020-06-28
Vaccines,CAUSES,Immunity,32591466,10.1128/JVI.01083-20,2020-06-28
Recombinant Proteins,NEG_COEXISTS_WITH,Antigens,32591466,10.1128/JVI.01083-20,2020-06-28
Vaccines,PART_OF,Middle East Respiratory Syndrome Coronavirus,32591466,10.1128/JVI.01083-20,2020-06-28
10 - 19,PROCESS_OF,Patients,32591408,10.1126/sciimmunol.abd2071,2020-06-28
Monoclonal Antibodies,PART_OF,Mus,32591393,10.4049/jimmunol.2000583,2020-06-28
Proteome,ISA,Proteins,32591346,10.1074/mcp.RA120.002164,2020-06-28
Open Reading Frames,PART_OF,Cercopithecus aethiops,32591346,10.1074/mcp.RA120.002164,2020-06-28
"Immunity, Innate",ASSOCIATED_WITH,Virus Diseases,32591346,10.1074/mcp.RA120.002164,2020-06-28
Supernatant,PART_OF,Vero Cells,32591346,10.1074/mcp.RA120.002164,2020-06-28
Medical radiographer,TREATS,Patients,32591286,10.1016/j.radi.2020.06.010,2020-06-28
Medical radiographer,USES,Classification,32591286,10.1016/j.radi.2020.06.010,2020-06-28
Chest,LOCATION_OF,X-RAY SENSITIVITY,32591286,10.1016/j.radi.2020.06.010,2020-06-28
favor,INTERACTS_WITH,Angiotensin-Converting Enzyme Inhibitors,32591283,10.1016/j.hipert.2020.06.003,2020-06-28
favor,INTERACTS_WITH,Angiotensin II receptor antagonist,32591283,10.1016/j.hipert.2020.06.003,2020-06-28
Cardiovascular Diseases,PROCESS_OF,Patients,32591283,10.1016/j.hipert.2020.06.003,2020-06-28
Arteries,LOCATION_OF,Thrombosis,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Veins,LOCATION_OF,Thrombosis,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Malaise,PROCESS_OF,Patients,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Pharmaceutical Preparations,AFFECTS,Hemostatic function,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Malaise,PROCESS_OF,Patients,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Thrombophilia,PROCESS_OF,Patients,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Anticoagulants,TREATS,Patients,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Disease,AFFECTS,Hemostatic function,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Thromboembolism of vein,PROCESS_OF,Patients,32591185,10.1016/j.redar.2020.05.007,2020-06-28
Pandemics,CAUSES,Respiratory Tract Infections,32591180,10.1016/j.medcli.2020.05.022,2020-06-28
Pneumococcal Infections,COEXISTS_WITH,Lobar Pneumonia,32591180,10.1016/j.medcli.2020.05.022,2020-06-28
Tertiary Care Centers,LOCATION_OF,Work,32591180,10.1016/j.medcli.2020.05.022,2020-06-28
Screening procedure,TREATS,Bacterial Infections,32591180,10.1016/j.medcli.2020.05.022,2020-06-28
Coinfection,ASSOCIATED_WITH,Streptococcus pneumoniae,32591180,10.1016/j.medcli.2020.05.022,2020-06-28
Respiratory sample,PART_OF,Tract,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
Analysis,USES,Reverse Transcriptase Polymerase Chain Reaction,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
Evaluation,TREATS,Patients,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
High Resolution Computed Tomography,ISA,Evaluation,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
High Resolution Computed Tomography,TREATS(SPEC),Patients,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
Lung,LOCATION_OF,Ultrasonography,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
Lung,LOCATION_OF,Ultrasonography,32591166,10.1016/j.ultrasmedbio.2020.05.012,2020-06-28
exposure history,PROCESS_OF,Child,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
exposure history,PROCESS_OF,geriatric patients,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
Incubation period,PROCESS_OF,Patients,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
Protection,PROCESS_OF,Patients,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
Symptoms,NEG_PROCESS_OF,Persons,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
exposure history,PROCESS_OF,Persons,32591163,10.1016/j.jiph.2020.06.013,2020-06-28
Diagnosis,DIAGNOSES,Multiple Sclerosis,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Pharmaceutical Preparations,TREATS,Patients,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Immunosuppressive Agents,AFFECTS,Severe Acute Respiratory Syndrome,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Symptom mild,PROCESS_OF,Patients,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Therapeutic immunosuppression,ADMINISTERED_TO,Patients,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32591152,10.1016/j.nrl.2020.06.001,2020-06-28
Heart,LOCATION_OF,Medical Valves,32591132,10.1016/j.athoracsur.2020.04.012,2020-06-28
Coronavirus Infections,ISA,Disease,32591132,10.1016/j.athoracsur.2020.04.012,2020-06-28
GSKIP gene,INTERACTS_WITH,Program,32591132,10.1016/j.athoracsur.2020.04.012,2020-06-28
Program,ADMINISTERED_TO,teams,32591132,10.1016/j.athoracsur.2020.04.012,2020-06-28
Pneumonia,CAUSES,Communicable Diseases,32590819,10.1097/MD.0000000000021012,2020-06-27
Critical Illness,PROCESS_OF,Patients,32590819,10.1097/MD.0000000000021012,2020-06-27
Critical Illness,PROCESS_OF,Patients,32590819,10.1097/MD.0000000000021012,2020-06-27
Critical Illness,PROCESS_OF,Patients,32590819,10.1097/MD.0000000000021012,2020-06-27
intensive care unit,LOCATION_OF,case series,32590819,10.1097/MD.0000000000021012,2020-06-27
Plasma Exchange,USES,"Liver, Artificial",32590819,10.1097/MD.0000000000021012,2020-06-27
Mechanical ventilation,ADMINISTERED_TO,Patients,32590819,10.1097/MD.0000000000021012,2020-06-27
Plasma Exchange,USES,"Liver, Artificial",32590819,10.1097/MD.0000000000021012,2020-06-27
Plasma Exchange,USES,"Liver, Artificial",32590819,10.1097/MD.0000000000021012,2020-06-27
Evaluation,ADMINISTERED_TO,civilian,32590808,10.1097/MD.0000000000020965,2020-06-27
Post-Traumatic Stress Disorder,OCCURS_IN,Nurses,32590808,10.1097/MD.0000000000020965,2020-06-27
Diabetes,ISA,Disease,32590779,10.1097/MD.0000000000020844,2020-06-27
Diabetes,PROCESS_OF,Patients,32590779,10.1097/MD.0000000000020844,2020-06-27
Disease,COEXISTS_WITH,Diabetes,32590779,10.1097/MD.0000000000020844,2020-06-27
Diabetes,PROCESS_OF,Patients,32590779,10.1097/MD.0000000000020844,2020-06-27
Diabetic Diet,TREATS,patient condition,32590779,10.1097/MD.0000000000020844,2020-06-27
Multi-disciplinary team,METHOD_OF,psychological care,32590779,10.1097/MD.0000000000020844,2020-06-27
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32590775,10.1097/MD.0000000000020837,2020-06-27
Fever,PROCESS_OF,Patients,32590775,10.1097/MD.0000000000020837,2020-06-27
Ground Glass Opacity,PROCESS_OF,Patients,32590775,10.1097/MD.0000000000020837,2020-06-27
Depressive disorder,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Dyssomnias,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Anxiety symptoms,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Depressive Symptoms,COEXISTS_WITH,Anxiety symptoms,32590755,10.1097/MD.0000000000020769,2020-06-27
Depressive Symptoms,COEXISTS_WITH,Anxiety symptoms,32590755,10.1097/MD.0000000000020769,2020-06-27
Depressive disorder,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Sleep disturbances,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Anxiety symptoms,PROCESS_OF,Nurses,32590755,10.1097/MD.0000000000020769,2020-06-27
Psychosocial problem,PROCESS_OF,Health Personnel,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,general population,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,Health Personnel,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,general population,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,Health Personnel,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,general population,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,Health Personnel,32590751,10.1097/MD.0000000000020751,2020-06-27
Psychosocial problem,PROCESS_OF,general population,32590751,10.1097/MD.0000000000020751,2020-06-27
Mental health.status,PROCESS_OF,Health Personnel,32590751,10.1097/MD.0000000000020751,2020-06-27
Mental health.status,PROCESS_OF,general population,32590751,10.1097/MD.0000000000020751,2020-06-27
Gravidity,PROCESS_OF,Patients,32590725,10.1097/AOG.0000000000004044,2020-06-27
Mechanical ventilation,STIMULATES,Labor (Childbirth),32590725,10.1097/AOG.0000000000004044,2020-06-27
Malaise,PROCESS_OF,Patients,32590725,10.1097/AOG.0000000000004044,2020-06-27
Patients,LOCATION_OF,peripheral blood,32590558,10.1097/TA.0000000000002840,2020-06-27
Acute respiratory disease,MANIFESTATION_OF,Coronavirus Infections,32590533,10.1097/01.JAA.0000669772.78848.8c,2020-06-27
Triage,AFFECTS,Patients,32590335,10.1016/j.dsx.2020.06.027,2020-06-27
Heart Injuries,ISA,Cardiovascular Diseases,32590335,10.1016/j.dsx.2020.06.027,2020-06-27
Heart Injuries,PROCESS_OF,Patients,32590335,10.1016/j.dsx.2020.06.027,2020-06-27
Dyspnea,PROCESS_OF,Patients,32590335,10.1016/j.dsx.2020.06.027,2020-06-27
Present,PREDISPOSES,Cardiovascular Diseases,32590335,10.1016/j.dsx.2020.06.027,2020-06-27
Peptidyl-Dipeptidase A,CAUSES,Pneumonia,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Lung,LOCATION_OF,Alveolar surface tension,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Lung,PART_OF,Mammals,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Pulmonary Surfactants,AFFECTS,Alveolar surface tension,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Cell Count,USES,SLC4A2 gene,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Genus: Coronavirus,CAUSES,Pneumonia,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Cell Count,USES,SLC4A2 gene,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Pulmonary Surfactants,INTERACTS_WITH,Peptidyl-Dipeptidase A,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Structure of parenchyma of lung,LOCATION_OF,Coronavirus Infections,32590326,10.1016/j.mehy.2020.110020,2020-06-27
Purinoceptor,PART_OF,Cell surface,32590324,10.1016/j.mehy.2020.110012,2020-06-27
Adenosine,STIMULATES,"Receptors, Purinergic P1",32590324,10.1016/j.mehy.2020.110012,2020-06-27
Adenosine,TREATS,Immune,32590324,10.1016/j.mehy.2020.110012,2020-06-27
Microorganism,LOCATION_OF,"Receptors, Purinergic P1",32590324,10.1016/j.mehy.2020.110012,2020-06-27
Patients,LOCATION_OF,IMPACT gene,32590314,10.1016/j.msard.2020.102310,2020-06-27
IMPACT gene,PART_OF,Virus,32590314,10.1016/j.msard.2020.102310,2020-06-27
Multiple Sclerosis,PROCESS_OF,Latin American,32590314,10.1016/j.msard.2020.102310,2020-06-27
Possible,PROCESS_OF,Patients,32590314,10.1016/j.msard.2020.102310,2020-06-27
Neuromyelitis Optica,PROCESS_OF,Patients,32590314,10.1016/j.msard.2020.102310,2020-06-27
Tracheotomy procedure,TREATS,Middle East Respiratory Syndrome,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Screening procedure,TREATS,Health Personnel,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Complication,COEXISTS_WITH,Middle East Respiratory Syndrome,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Tracheostomy procedure,TREATS,Middle East Respiratory Syndrome,32590297,10.1016/j.oraloncology.2020.104861,2020-06-27
Health Personnel,LOCATION_OF,"TLR4 protein, human",32590254,10.1016/j.genhosppsych.2020.06.007,2020-06-27
Screening procedure,TREATS,Psychological symptom,32590254,10.1016/j.genhosppsych.2020.06.007,2020-06-27
Medical center,LOCATION_OF,Cross-Sectional Studies,32590254,10.1016/j.genhosppsych.2020.06.007,2020-06-27
psychological distress,PROCESS_OF,therapist,32590254,10.1016/j.genhosppsych.2020.06.007,2020-06-27
"CD69 protein, human",ASSOCIATED_WITH,Tuberculosis,32590235,10.1016/j.puhe.2020.05.042,2020-06-27
Paresthesia,PROCESS_OF,Clinician,32590125,10.1016/j.jneuroim.2020.577294,2020-06-27
Paralysed,PROCESS_OF,Clinician,32590125,10.1016/j.jneuroim.2020.577294,2020-06-27
"Immunoglobulins, Intravenous",TREATS,Syndrome,32590125,10.1016/j.jneuroim.2020.577294,2020-06-27
Evaluation,TREATS,Patients,32590125,10.1016/j.jneuroim.2020.577294,2020-06-27
Nitrogen,COEXISTS_WITH,Smoke,32590117,10.1016/j.niox.2020.06.005,2020-06-27
Coronavirus Infections,ISA,Disease,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Coronavirus Infections,ISA,Disease,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Coronavirus Infections,ISA,Disease,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Asymptomatic,PROCESS_OF,Patients,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Instrument - device,PREVENTS,disease transmission,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Instrument - device,USES,disposable,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
Coronavirus Infections,ISA,Disease,32590073,10.1016/j.ijsu.2020.06.027,2020-06-27
radiologist,DIAGNOSES,Disease,32590015,10.1016/j.jacr.2020.06.006,2020-06-27
Malignant neoplasm of lung,PROCESS_OF,Patients,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
Malignant neoplasm of lung,PROCESS_OF,Patients,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
removal technique,PRECEDES,post surgery radiation therapy,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
Malignant neoplasm of lung,PROCESS_OF,Patients,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
stage I non-small cell lung cancer,ISA,Non-Small Cell Lung Carcinoma,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
Prophylactic Cranial Irradiation,TREATS,limited stage small cell lung cancer,32589990,10.1016/j.ijrobp.2020.05.012,2020-06-27
heparin,NEG_AFFECTS,Limb ischemia,32589931,10.1016/j.avsg.2020.06.046,2020-06-27
Institutes,LOCATION_OF,research,32589931,10.1016/j.avsg.2020.06.046,2020-06-27
Pathogenic,PROCESS_OF,Homo sapiens,32589897,10.1016/j.virusres.2020.198074,2020-06-27
Virus Diseases,COMPLICATES,Severe Acute Respiratory Syndrome,32589897,10.1016/j.virusres.2020.198074,2020-06-27
Interferon-beta,TREATS,Sendai virus,32589897,10.1016/j.virusres.2020.198074,2020-06-27
Order status,PREDISPOSES,Suicide,32589811,10.1111/sltb.12654,2020-06-27
Depressive disorder,NEG_PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Stress,PROCESS_OF,Adult,32589801,10.1111/sltb.12653,2020-06-27
Suicide attempt,NEG_PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Feeling suicidal (finding),NEG_PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Feeling suicidal (finding),PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Suicide attempt,PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Life threatening illness,PROCESS_OF,Participant,32589801,10.1111/sltb.12653,2020-06-27
Inflammatory Bowel Diseases,PREDISPOSES,Coronavirus Infections,32589798,10.1111/jgh.15164,2020-06-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32589798,10.1111/jgh.15164,2020-06-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32589798,10.1111/jgh.15164,2020-06-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32589798,10.1111/jgh.15164,2020-06-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32589798,10.1111/jgh.15164,2020-06-27
Adult,ISA,Population Group,32589788,10.1002/oby.22940,2020-06-27
Obesity,PROCESS_OF,Population Group,32589788,10.1002/oby.22940,2020-06-27
Obesity,PROCESS_OF(SPEC),Adult,32589788,10.1002/oby.22940,2020-06-27
Health food intake,PROCESS_OF,Community,32589788,10.1002/oby.22940,2020-06-27
SARS coronavirus,CAUSES,Obesity,32589784,10.1002/oby.22941,2020-06-27
Finding of body mass index,PROCESS_OF,inpatient,32589784,10.1002/oby.22941,2020-06-27
Obesity,PROCESS_OF,Patients,32589784,10.1002/oby.22941,2020-06-27
Hypoxemia,PROCESS_OF,Patients,32589784,10.1002/oby.22941,2020-06-27
Drug Kinetics,PROCESS_OF,Healthy Volunteers,32589775,10.1111/cts.12840,2020-06-27
risk factors,PROCESS_OF,Vulnerable Populations,32589774,10.1111/ejh.13478,2020-06-27
"Anemia, Sickle Cell",AFFECTS,African American,32589774,10.1111/ejh.13478,2020-06-27
Pneumonia,COEXISTS_WITH,Sickle Cell Trait,32589774,10.1111/ejh.13478,2020-06-27
medical care,COEXISTS_WITH,Enthesitis-Related Arthritis,32589774,10.1111/ejh.13478,2020-06-27
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32589760,10.1111/ctr.14027,2020-06-27
inflammatory response,AFFECTS,Patients,32589760,10.1111/ctr.14027,2020-06-27
Diabetes Mellitus,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Hyperglycemia,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Diabetes Mellitus,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Intubation,TREATS,Patients,32589756,10.1002/jmv.26227,2020-06-27
Intubation,TREATS(INFER),Diabetes Mellitus,32589756,10.1002/jmv.26227,2020-06-27
Obesity,COEXISTS_WITH,glucose metabolism,32589756,10.1002/jmv.26227,2020-06-27
glucose metabolism,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Diabetes Mellitus,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Diabetic Ketoacidosis,PROCESS_OF,Patients,32589756,10.1002/jmv.26227,2020-06-27
Exploration procedure,CAUSES,Disease,32589756,10.1002/jmv.26227,2020-06-27
Universities,ISA,School,32589755,10.1002/jmv.26225,2020-06-27
Interleukin-2,PART_OF,Patients,32589755,10.1002/jmv.26225,2020-06-27
Interleukin-4,PART_OF,Patients,32589755,10.1002/jmv.26225,2020-06-27
Disease,PROCESS_OF,Patients,32589755,10.1002/jmv.26225,2020-06-27
Screening cholesterol level,PROCESS_OF,Patients,32589755,10.1002/jmv.26225,2020-06-27
Initiative,PROCESS_OF,Rural Communities,32589735,10.1093/jamia/ocaa156,2020-06-27
Cardiovascular Diseases,PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
Comorbidity,PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
Hypertensive disease,PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
Obesity,PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
Chronic lung disease,PROCESS_OF,Persons,32589718,10.1093/ptj/pzaa115,2020-06-27
professional occupation status,TREATS,Patients,32589718,10.1093/ptj/pzaa115,2020-06-27
Peer Review,TREATS,Crisis,32589695,10.1016/j.acalib.2020.102187,2020-06-27
Therapeutic procedure,TREATS,Patients,32589691,10.1371/journal.pone.0235459,2020-06-27
Screening procedure,TREATS,Health Personnel,32589687,10.1371/journal.pone.0235460,2020-06-27
Nose,LOCATION_OF,Congestion,32589687,10.1371/journal.pone.0235460,2020-06-27
Congestion,AFFECTS,SARS coronavirus,32589687,10.1371/journal.pone.0235460,2020-06-27
Symptoms,PROCESS_OF,Health Personnel,32589687,10.1371/journal.pone.0235460,2020-06-27
Multiple Organ Failure,CAUSES,Cessation of life,32589600,10.1515/dx-2020-0057,2020-06-27
Disease,PREDISPOSES,Severe disorder,32589600,10.1515/dx-2020-0057,2020-06-27
patient condition,PREDISPOSES,Severe disorder,32589600,10.1515/dx-2020-0057,2020-06-27
Publisher,ISA,Science,32589589,10.2196/21820,2020-06-27
Pharmaceutical Preparations,TREATS,Confirmation,32589546,10.12968/hmed.2020.0312,2020-06-27
Complication,PROCESS_OF,Patients,32589541,10.12968/hmed.2020.0228,2020-06-27
Eye,LOCATION_OF,Complication,32589541,10.12968/hmed.2020.0228,2020-06-27
Eye,LOCATION_OF,Complication,32589541,10.12968/hmed.2020.0228,2020-06-27
Noninvasive Ventilation,TREATS,Patients,32589541,10.12968/hmed.2020.0228,2020-06-27
Eye,LOCATION_OF,Complication,32589541,10.12968/hmed.2020.0228,2020-06-27
Nasogastric tube,TREATS,surgical patients,32589539,10.12968/hmed.2020.0307,2020-06-27
Throat irritation,CAUSES,Coughing,32589539,10.12968/hmed.2020.0307,2020-06-27
Physicians,DIAGNOSES,Nance-Horan syndrome,32589538,10.12968/hmed.2020.0250,2020-06-27
Immunosuppressive Agents,ADMINISTERED_TO,Patients,32589537,10.12968/hmed.2020.0284,2020-06-27
Acute pulmonary embolism,PROCESS_OF,Patients,32589531,10.12968/hmed.2020.0300,2020-06-27
contextual factors,PROCESS_OF,Outpatients,32589531,10.12968/hmed.2020.0300,2020-06-27
treatment options,TREATS,Severe disorder,32589531,10.12968/hmed.2020.0300,2020-06-27
Mild disorder,PROCESS_OF,Patients,32589531,10.12968/hmed.2020.0300,2020-06-27
Engaged to be married,PROCESS_OF,student,32589524,10.1080/14739879.2020.1779616,2020-06-27
professional identity,PROCESS_OF,"Students, Medical",32589524,10.1080/14739879.2020.1779616,2020-06-27
High suicide risk,PROCESS_OF,Population Group,32589519,10.1080/07481187.2020.1784312,2020-06-27
High suicide risk,PROCESS_OF(SPEC),Colombian,32589519,10.1080/07481187.2020.1784312,2020-06-27
Colombian,ISA,Population Group,32589519,10.1080/07481187.2020.1784312,2020-06-27
World,LOCATION_OF,IMPACT gene,32589462,10.1200/GO.20.00227,2020-06-27
Aging,PROCESS_OF,Population Group,32589462,10.1200/GO.20.00227,2020-06-27
Chronic disease,PROCESS_OF,Population Group,32589462,10.1200/GO.20.00227,2020-06-27
"M Protein, multiple myeloma",INTERACTS_WITH,,32589459,10.1080/09273948.2020.1772314,2020-06-27
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
,PRODUCES,Conjunctival specimen,32589459,10.1080/09273948.2020.1772314,2020-06-27
conjunctiva,LOCATION_OF,TMPRSS2 gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
conjunctiva,LOCATION_OF,BSG gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
Cornea,LOCATION_OF,receptor,32589459,10.1080/09273948.2020.1772314,2020-06-27
Cornea,LOCATION_OF,TMPRSS2 gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
Cornea,LOCATION_OF,BSG gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
Conjunctival epithelial cell,LOCATION_OF,receptor,32589459,10.1080/09273948.2020.1772314,2020-06-27
conjunctiva,LOCATION_OF,"Angiotensin II Receptor, Type 2",32589459,10.1080/09273948.2020.1772314,2020-06-27
RNA Editing,AFFECTS,Antiviral Response,32589459,10.1080/09273948.2020.1772314,2020-06-27
Human body,LOCATION_OF,ADAR gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
Human body,LOCATION_OF,APOBEC3A gene,32589459,10.1080/09273948.2020.1772314,2020-06-27
Antiretroviral therapy,ADMINISTERED_TO,Persons,32589451,10.7326/M20-3689,2020-06-27
Nucleoside Reverse Transcriptase Inhibitor,ISA,Reverse Transcriptase Inhibitors,32589451,10.7326/M20-3689,2020-06-27
abacavir / Lamivudine,ISA,Lamivudine,32589451,10.7326/M20-3689,2020-06-27
Antiretroviral therapy,ADMINISTERED_TO,Persons,32589451,10.7326/M20-3689,2020-06-27
Hospitalization,TREATS,Male population group,32589451,10.7326/M20-3689,2020-06-27
Hospitalization,TREATS,Persons,32589451,10.7326/M20-3689,2020-06-27
emtricitabine,ADMINISTERED_TO,Patients,32589451,10.7326/M20-3689,2020-06-27
emtricitabine,NEG_ADMINISTERED_TO,Patients,32589451,10.7326/M20-3689,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32589348,10.1111/jon.12746,2020-06-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32589348,10.1111/jon.12746,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32589348,10.1111/jon.12746,2020-06-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32589348,10.1111/jon.12746,2020-06-27
Eye,LOCATION_OF,Disease,32589296,10.1111/all.14472,2020-06-27
Skin lesion,PROCESS_OF,Patients,32589293,10.1111/jdv.16775,2020-06-27
Skin Manifestations,PROCESS_OF,Patients,32589293,10.1111/jdv.16775,2020-06-27
Challenge,TREATS,therapist,32589265,10.1111/famp.12570,2020-06-27
Hypertensive disease,ISA,Cardiovascular Diseases,32589264,10.1111/eci.13338,2020-06-27
Disease,PROCESS_OF,Patients,32589264,10.1111/eci.13338,2020-06-27
Non-alcoholic Fatty Liver Disease,NEG_PROCESS_OF,Patients,32589264,10.1111/eci.13338,2020-06-27
Non-alcoholic Fatty Liver Disease,PROCESS_OF,Patients,32589264,10.1111/eci.13338,2020-06-27
Non-alcoholic Fatty Liver Disease,NEG_PROCESS_OF,Patients,32589264,10.1111/eci.13338,2020-06-27
Liver,LOCATION_OF,Increased fibrosis,32589264,10.1111/eci.13338,2020-06-27
Increased fibrosis,COEXISTS_WITH,Non-alcoholic Fatty Liver Disease,32589264,10.1111/eci.13338,2020-06-27
Motivation,PROCESS_OF,Persons,32589263,10.1111/famp.12575,2020-06-27
Uncertainty,PROCESS_OF,Persons,32589263,10.1111/famp.12575,2020-06-27
GSKIP gene,PART_OF,Patients,32589258,10.5603/CJ.a2020.0089,2020-06-27
Hospital admission,TREATS,Population at Risk,32589258,10.5603/CJ.a2020.0089,2020-06-27
Growth,COEXISTS_WITH,Cessation of life,32589224,10.1093/intqhc/mzaa069,2020-06-27
Multiple Sclerosis,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
risk factors,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Multiple Sclerosis,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
risk factors,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Coronavirus Infections,COEXISTS_WITH,risk factors,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
"N,N-Dimethyltryptamine",ADMINISTERED_TO,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
"N,N-Dimethyltryptamine",NEG_PART_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Therapeutic procedure,ADMINISTERED_TO,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Multiple Sclerosis,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Multiple Sclerosis,PROCESS_OF,Patients,32589189,10.1001/jamaneurol.2020.2581,2020-06-27
Calcium,TREATS,Patients,32589164,10.18632/aging.103526,2020-06-27
Serum,LOCATION_OF,Calcium,32589164,10.18632/aging.103526,2020-06-27
Hypocalcemia,PROCESS_OF,Patients,32589164,10.18632/aging.103526,2020-06-27
Coronavirus Infections,ISA,Disease,32589145,10.2196/18880,2020-06-27
Coronavirus Infections,ISA,Disease,32589145,10.2196/18880,2020-06-27
Infected,PROCESS_OF,Persons,32589145,10.2196/18880,2020-06-27
Infected,PROCESS_OF,Persons,32589145,10.2196/18880,2020-06-27
Infected,PROCESS_OF,Persons,32589145,10.2196/18880,2020-06-27
Coronavirus Infections,ISA,Disease,32589145,10.2196/18880,2020-06-27
Transference (Psychology),PROCESS_OF,Patients,32589054,10.1177/0003065120938772,2020-06-27
Stress,PROCESS_OF,general population,32588961,10.1002/smi.2969,2020-06-27
Intervention regimes,TREATS,Stress,32588961,10.1002/smi.2969,2020-06-27
Coronavirus Infections,PROCESS_OF,Western society,32588949,10.1111/bjhp.12453,2020-06-27
infection as a complication,AFFECTS,Communicable Diseases,32588943,10.1002/dmrr.3377,2020-06-27
infection as a complication,PREDISPOSES,Infection,32588943,10.1002/dmrr.3377,2020-06-27
Diabetes,AFFECTS,Obesity,32588943,10.1002/dmrr.3377,2020-06-27
Obesity,AFFECTS,Diabetes,32588943,10.1002/dmrr.3377,2020-06-27
Diastasis,AFFECTS,Offspring,32588911,10.1111/apa.15455,2020-06-27
Infected,PROCESS_OF,"Infant, Newborn",32588911,10.1111/apa.15455,2020-06-27
C-reactive protein,ISA,Acute-Phase Proteins,32588812,10.4269/ajtmh.20-0473,2020-06-27
C-reactive protein,STIMULATES,Interleukin-6,32588812,10.4269/ajtmh.20-0473,2020-06-27
Patients,LOCATION_OF,Acute-Phase Proteins,32588812,10.4269/ajtmh.20-0473,2020-06-27
Patients,LOCATION_OF(SPEC),C-reactive protein,32588812,10.4269/ajtmh.20-0473,2020-06-27
Standard chest X-ray abnormal,PREDISPOSES,Severe Acute Respiratory Syndrome,32588801,10.4269/ajtmh.20-0512,2020-06-27
Creatinine,STIMULATES,Phosphotransferases,32588791,10.1177/2050640620931657,2020-06-27
Lactate Dehydrogenase,STIMULATES,Phosphotransferases,32588791,10.1177/2050640620931657,2020-06-27
Liver,LOCATION_OF,Severely Abnormal Ventricular Ejection Fraction,32588791,10.1177/2050640620931657,2020-06-27
cytotoxicity,PROCESS_OF,Patients,32588791,10.1177/2050640620931657,2020-06-27
Intervention regimes,AFFECTS,Negative,32588779,10.1080/16549716.2020.1776526,2020-06-27
prescribed,COEXISTS_WITH,Patient reviewed,32588748,10.1177/0269216320935361,2020-06-27
prescribed,TREATS,Patients,32588748,10.1177/0269216320935361,2020-06-27
prescribed,TREATS,Symptoms,32588748,10.1177/0269216320935361,2020-06-27
Advice,METHOD_OF,Noninvasive Ventilation,32588748,10.1177/0269216320935361,2020-06-27
inhibitors,ASSOCIATED_WITH,Toxic effect,32588674,10.1080/14712598.2020.1789097,2020-06-27
inhibitors,CAUSES,Lung Injury,32588674,10.1080/14712598.2020.1789097,2020-06-27
Immunotherapy,TREATS,Cancer Patient,32588674,10.1080/14712598.2020.1789097,2020-06-27
Clinician,TREATS,Patients,32588674,10.1080/14712598.2020.1789097,2020-06-27
Immunotherapy,TREATS,Virus Diseases,32588674,10.1080/14712598.2020.1789097,2020-06-27
"Signs and Symptoms, Respiratory",PROCESS_OF,Male population group,32588614,10.26444/aaem/123543,2020-06-27
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32588614,10.26444/aaem/123543,2020-06-27
Distal intermedial ridge of tibia,LOCATION_OF,Diastasis,32588593,10.26444/aaem/123801,2020-06-27
Cessation of life,AFFECTS,Population Group,32588589,10.26444/aaem/122137,2020-06-27
Immunity,NEG_PROCESS_OF,Population Group,32588589,10.26444/aaem/122137,2020-06-27
Coronavirus Infections,PROCESS_OF,Population Group,32588589,10.26444/aaem/122137,2020-06-27
"CD69 protein, human",ASSOCIATED_WITH,Laboratory Infection,32588589,10.26444/aaem/122137,2020-06-27
"CD69 protein, human",CAUSES,Pneumonia,32588589,10.26444/aaem/122137,2020-06-27
Critical Illness,AFFECTS,Much worse,32588589,10.26444/aaem/122137,2020-06-27
Chronic disease,PROCESS_OF,Persons,32588589,10.26444/aaem/122137,2020-06-27
Chronic disease,PROCESS_OF,Old age,32588589,10.26444/aaem/122137,2020-06-27
Cessation of life,OCCURS_IN,Persons,32588589,10.26444/aaem/122137,2020-06-27
Cessation of life,OCCURS_IN,Old age,32588589,10.26444/aaem/122137,2020-06-27
Cessation of life,PROCESS_OF,Patients,32588589,10.26444/aaem/122137,2020-06-27
Communicable Diseases,PROCESS_OF,Animals,32588588,10.26444/aaem/122790,2020-06-27
Infected,PROCESS_OF,Persons,32588588,10.26444/aaem/122790,2020-06-27
Asymptomatic,PROCESS_OF,Patients,32588588,10.26444/aaem/122790,2020-06-27
Ocular Tissue,PART_OF,Patients,32588588,10.26444/aaem/122790,2020-06-27
Eye,LOCATION_OF,Symptoms,32588588,10.26444/aaem/122790,2020-06-27
Eye,LOCATION_OF,Symptoms,32588588,10.26444/aaem/122790,2020-06-27
Eye,LOCATION_OF(SPEC),Severe Acute Respiratory Syndrome,32588588,10.26444/aaem/122790,2020-06-27
Severe Acute Respiratory Syndrome,ISA,Symptoms,32588588,10.26444/aaem/122790,2020-06-27
Pneumonia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32588565,10.4070/kcj.2020.0205,2020-06-27
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Severe Acute Respiratory Syndrome,32588565,10.4070/kcj.2020.0205,2020-06-27
Heart,LOCATION_OF,Direct trauma,32588565,10.4070/kcj.2020.0205,2020-06-27
Heart Injuries,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32588565,10.4070/kcj.2020.0205,2020-06-27
angiotensin converting enzyme 2,CAUSES,Direct trauma,32588565,10.4070/kcj.2020.0205,2020-06-27
inflammatory response,MANIFESTATION_OF,Heart Injuries,32588565,10.4070/kcj.2020.0205,2020-06-27
Blood Coagulation Disorders,CAUSES,Acute heart failure,32588565,10.4070/kcj.2020.0205,2020-06-27
Rupture,CAUSES,Disease,32588565,10.4070/kcj.2020.0205,2020-06-27
Rupture,CAUSES,Acute Coronary Syndrome,32588565,10.4070/kcj.2020.0205,2020-06-27
Rupture,CAUSES,Stress induced cardiomyopathy,32588565,10.4070/kcj.2020.0205,2020-06-27
Fibrinogen,ASSOCIATED_WITH,Thrombosis,32588535,10.1111/jth.14942,2020-06-27
Fibrinogen,ISA,Acute-Phase Proteins,32588535,10.1111/jth.14942,2020-06-27
Malaise,PROCESS_OF,Patients,32588493,10.1096/fj.202001451,2020-06-27
Storm NOS,COEXISTS_WITH,Inflammation,32588493,10.1096/fj.202001451,2020-06-27
High Density Lipoproteins,INHIBITS,Anti-Inflammatory Agents,32588493,10.1096/fj.202001451,2020-06-27
High Density Lipoproteins,PREDISPOSES,Pneumonia,32588493,10.1096/fj.202001451,2020-06-27
Anti-Inflammatory Agents,PREVENTS,Complication,32588493,10.1096/fj.202001451,2020-06-27
Anti-Inflammatory Agents,PREVENTS,Inflammation,32588493,10.1096/fj.202001451,2020-06-27
Lipoproteins,INTERACTS_WITH,Omega-3 Fatty Acids,32588493,10.1096/fj.202001451,2020-06-27
Dermatologic disorders,PROCESS_OF,Patients,32588475,10.1111/jdv.16773,2020-06-27
Infected,PROCESS_OF,Patients,32588475,10.1111/jdv.16773,2020-06-27
Lower respiratory tract infection,PROCESS_OF,Patients,32588427,10.1002/cpt.1968,2020-06-27
Evaluation,TREATS,Patients,32588427,10.1002/cpt.1968,2020-06-27
Evaluation,TREATS(INFER),Lower respiratory tract infection,32588427,10.1002/cpt.1968,2020-06-27
Severe Acute Respiratory Syndrome,CAUSES,Lower respiratory tract infection,32588427,10.1002/cpt.1968,2020-06-27
Lower respiratory tract infection,PROCESS_OF,Patients,32588427,10.1002/cpt.1968,2020-06-27
Adverse event,PROCESS_OF,Community,32588404,10.1055/s-0040-1713852,2020-06-27
Epilepsy,AFFECTS,Italians,32588368,10.1007/s10072-020-04546-8,2020-06-27
Electroencephalography,ADMINISTERED_TO,Patients,32588368,10.1007/s10072-020-04546-8,2020-06-27
Electroencephalography,DIAGNOSES,Symptoms,32588368,10.1007/s10072-020-04546-8,2020-06-27
Electroencephalography,ISA,Physical Examination,32588368,10.1007/s10072-020-04546-8,2020-06-27
Physical Examination,USES,Electroencephalography,32588368,10.1007/s10072-020-04546-8,2020-06-27
Screening procedure,TREATS,Patients,32588368,10.1007/s10072-020-04546-8,2020-06-27
Electroencephalography,USES,Masks,32588368,10.1007/s10072-020-04546-8,2020-06-27
Immunologic Memory,PROCESS_OF,Patients,32588367,10.1007/s10072-020-04547-7,2020-06-27
Physical Examination,ADMINISTERED_TO,Neurologists,32588367,10.1007/s10072-020-04547-7,2020-06-27
Evaluation,ADMINISTERED_TO,Neurologists,32588367,10.1007/s10072-020-04547-7,2020-06-27
Headache,ISA,Neurological observations,32588367,10.1007/s10072-020-04547-7,2020-06-27
Neurologic Symptoms,PROCESS_OF,Patients,32588367,10.1007/s10072-020-04547-7,2020-06-27
Headache,PROCESS_OF,Patients,32588367,10.1007/s10072-020-04547-7,2020-06-27
Patients,LOCATION_OF,Interleukin-6,32588367,10.1007/s10072-020-04547-7,2020-06-27
Patients,LOCATION_OF,Creatine Kinase,32588367,10.1007/s10072-020-04547-7,2020-06-27
Myalgia,PROCESS_OF,Patients,32588367,10.1007/s10072-020-04547-7,2020-06-27
Symptoms,PROCESS_OF,Patients,32588367,10.1007/s10072-020-04547-7,2020-06-27
Headache,ASSOCIATED_WITH(SPEC),Disease,32588367,10.1007/s10072-020-04547-7,2020-06-27
Headache,ISA,Neurologic Symptoms,32588367,10.1007/s10072-020-04547-7,2020-06-27
Neurologic Symptoms,ASSOCIATED_WITH,Disease,32588367,10.1007/s10072-020-04547-7,2020-06-27
Dizziness,ISA,Disturbance of consciousness,32588367,10.1007/s10072-020-04547-7,2020-06-27
Diabetes,PROCESS_OF,Patients,32588340,10.1007/s40199-020-00357-6,2020-06-27
Risk Assessment,TREATS,Foundation for the Accreditation of Cellular Therapy,32588340,10.1007/s40199-020-00357-6,2020-06-27
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32588340,10.1007/s40199-020-00357-6,2020-06-27
Antidiabetics,ADMINISTERED_TO,Patients,32588340,10.1007/s40199-020-00357-6,2020-06-27
diabetic,PROCESS_OF,Patients,32588340,10.1007/s40199-020-00357-6,2020-06-27
Coronavirus Infections,ISA,Disease,32588277,10.1007/s11604-020-01010-7,2020-06-27
Pneumonia,ISA,Disease,32588277,10.1007/s11604-020-01010-7,2020-06-27
Plain chest X-ray,ISA,Imaging Techniques,32588200,10.1007/s13246-020-00888-x,2020-06-27
X-Ray Computed Tomography,ISA,Imaging Techniques,32588200,10.1007/s13246-020-00888-x,2020-06-27
Coronavirus Infections,ISA,Disease,32588200,10.1007/s13246-020-00888-x,2020-06-27
Cytopenia,COEXISTS_WITH,"Lymphohistiocytosis, Hemophagocytic",32588191,10.1007/s00296-020-04636-y,2020-06-27
Cytopenia,COEXISTS_WITH,"Lymphohistiocytosis, Hemophagocytic",32588191,10.1007/s00296-020-04636-y,2020-06-27
Storm Syndrome,ISA,Disease,32588191,10.1007/s00296-020-04636-y,2020-06-27
Communicable Diseases,CAUSES,Secondary Hemophagocytic Lymphohistiocytosis,32588191,10.1007/s00296-020-04636-y,2020-06-27
Neoplasm Metastasis,COEXISTS_WITH,Disease,32588191,10.1007/s00296-020-04636-y,2020-06-27
Neoplasm Metastasis,ISA,Disease,32588191,10.1007/s00296-020-04636-y,2020-06-27
Collagen Diseases,CAUSES,"Lymphohistiocytosis, Hemophagocytic",32588191,10.1007/s00296-020-04636-y,2020-06-27
Symptoms,PROCESS_OF,Rheumatologist,32588191,10.1007/s00296-020-04636-y,2020-06-27
Hereditary Diseases,CAUSES,"Lymphohistiocytosis, Hemophagocytic",32588191,10.1007/s00296-020-04636-y,2020-06-27
Infected,PROCESS_OF,Persons,32588166,10.1007/s00417-020-04815-4,2020-06-27
Air,INTERACTS_WITH,other medicated shampoos in ATC,32588166,10.1007/s00417-020-04815-4,2020-06-27
Infected,PROCESS_OF,Persons,32588166,10.1007/s00417-020-04815-4,2020-06-27
Nose,PART_OF,Patients,32588166,10.1007/s00417-020-04815-4,2020-06-27
Respiratory viruses,CAUSES,Acute respiratory infections,32588163,10.1007/s10561-020-09842-3,2020-06-27
Disease,PROCESS_OF,Persons,32588163,10.1007/s10561-020-09842-3,2020-06-27
Coronavirus Infections,ISA,Disease,32588163,10.1007/s10561-020-09842-3,2020-06-27
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32588163,10.1007/s10561-020-09842-3,2020-06-27
Senility,PROCESS_OF,Persons,32588163,10.1007/s10561-020-09842-3,2020-06-27
Coronavirus Infections,CAUSES,Severe acute respiratory infection,32588163,10.1007/s10561-020-09842-3,2020-06-27
Cell Therapy,TREATS,Disease,32588163,10.1007/s10561-020-09842-3,2020-06-27
Coronavirus Infections,CAUSES,Acute respiratory infections,32588163,10.1007/s10561-020-09842-3,2020-06-27
Macaca,ISA,Monkeys,32588125,10.1007/s00347-020-01158-7,2020-06-27
Infected,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infection status,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infection status,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Emergency procedure,TREATS,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Emergency procedure,TREATS,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Emergency procedure,TREATS(INFER),Infected,32588105,10.1007/s00104-020-01229-0,2020-06-27
Emergency procedure,TREATS(INFER),Infection status,32588105,10.1007/s00104-020-01229-0,2020-06-27
Emergency procedure,TREATS(INFER),Infection status,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infection status,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infected,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infection status,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
Infection status,PROCESS_OF,Patients,32588105,10.1007/s00104-020-01229-0,2020-06-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32588067,10.1007/s00134-020-06154-8,2020-06-27
intensive care unit,LOCATION_OF,Assay of volatiles,32588067,10.1007/s00134-020-06154-8,2020-06-27
Coronavirus Infections,ISA,Disease,32588064,10.1007/s00063-020-00704-0,2020-06-27
Comorbidity,PROCESS_OF,Patients,32588061,10.3892/ijmm.2020.4659,2020-06-27
Comorbidity,PROCESS_OF,Old age,32588061,10.3892/ijmm.2020.4659,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32588061,10.3892/ijmm.2020.4659,2020-06-27
Coronavirus Infections,PROCESS_OF,Old age,32588061,10.3892/ijmm.2020.4659,2020-06-27
Infected,PROCESS_OF,Patients,32588061,10.3892/ijmm.2020.4659,2020-06-27
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Coronavirus Infections,32588061,10.3892/ijmm.2020.4659,2020-06-27
Thromboembolism,CAUSES,Disseminated Intravascular Coagulation,32588061,10.3892/ijmm.2020.4659,2020-06-27
Secondary antiphospholipid syndrome,ISA,Blood Coagulation Disorders,32588061,10.3892/ijmm.2020.4659,2020-06-27
multiple pathologies,PROCESS_OF,Patients,32588051,10.1093/ije/dyaa081,2020-06-27
Massively-Parallel Sequencing,USES,Libraries,32588005,10.1101/2020.06.12.20129718,2020-06-27
Diagnosis,DIAGNOSES,One or Two Days,32588005,10.1101/2020.06.12.20129718,2020-06-27
Ecuador,ISA,Country,32588004,10.1101/2020.06.11.20128330,2020-06-27
Chlamydia,ISA,Bacteria,32588004,10.1101/2020.06.11.20128330,2020-06-27
Chlamydia,LOCATION_OF,sphingosine 1-phosphate,32588004,10.1101/2020.06.11.20128330,2020-06-27
Mycobacterium tuberculosis,ISA,Bacteria,32588004,10.1101/2020.06.11.20128330,2020-06-27
Staphylococcus aureus,ISA,Bacteria,32588004,10.1101/2020.06.11.20128330,2020-06-27
Streptococcus pneumoniae,ISA,Bacteria,32588004,10.1101/2020.06.11.20128330,2020-06-27
Mutation,PROCESS_OF,Genome,32588004,10.1101/2020.06.11.20128330,2020-06-27
Child,ISA,Persons,32588003,10.1101/2020.06.16.20126425,2020-06-27
Infected,PROCESS_OF,Persons,32588003,10.1101/2020.06.16.20126425,2020-06-27
Infected,PROCESS_OF,Persons,32588003,10.1101/2020.06.16.20126425,2020-06-27
Infected,PROCESS_OF(SPEC),Child,32588003,10.1101/2020.06.16.20126425,2020-06-27
Antibodies,ASSOCIATED_WITH,Disease,32588002,10.1101/2020.06.16.20133025,2020-06-27
Detection,TREATS,hospitalized patients,32588002,10.1101/2020.06.16.20133025,2020-06-27
Detection,TREATS(INFER),Severe disorder,32588002,10.1101/2020.06.16.20133025,2020-06-27
Severe disorder,PROCESS_OF,hospitalized patients,32588002,10.1101/2020.06.16.20133025,2020-06-27
saliva,PART_OF,Persons,32588002,10.1101/2020.06.16.20133025,2020-06-27
Serum,PART_OF,Persons,32588002,10.1101/2020.06.16.20133025,2020-06-27
Assay,USES,Antibodies,32588002,10.1101/2020.06.16.20133025,2020-06-27
saliva,LOCATION_OF,Nucleocapsid,32588002,10.1101/2020.06.16.20133025,2020-06-27
Asymptomatic,PROCESS_OF,Persons,32588002,10.1101/2020.06.16.20133025,2020-06-27
Blood Coagulation Disorders,CAUSES,Single organ dysfunction,32588001,10.1101/2020.06.17.20134114,2020-06-27
Critical Illness,PROCESS_OF,Patients,32588001,10.1101/2020.06.17.20134114,2020-06-27
Thrombophilia,PROCESS_OF,Patients,32588001,10.1101/2020.06.17.20134114,2020-06-27
Serum,PART_OF,Patients,32588001,10.1101/2020.06.17.20134114,2020-06-27
Cross Infection,PROCESS_OF,Patients,32588000,10.1101/2020.06.16.20132902,2020-06-27
DNA Sequence,PART_OF,Bat coronavirus,32588000,10.1101/2020.06.16.20132902,2020-06-27
RPS6KA1 gene,LOCATION_OF,Mutation,32588000,10.1101/2020.06.16.20132902,2020-06-27
Anosmia,ISA,Symptoms,32587999,10.1101/2020.06.17.20106302,2020-06-27
Odor Detection,MEASURES,Measures,32587999,10.1101/2020.06.17.20106302,2020-06-27
Asymptomatic,PROCESS_OF,student,32587999,10.1101/2020.06.17.20106302,2020-06-27
Sense of smell impaired,PROCESS_OF,Exposed Population,32587999,10.1101/2020.06.17.20106302,2020-06-27
Hypersensitivity,COEXISTS_WITH,Asymptomatic,32587999,10.1101/2020.06.17.20106302,2020-06-27
Normal odor identification,PROCESS_OF,Persons,32587999,10.1101/2020.06.17.20106302,2020-06-27
Virus Diseases,AFFECTS,Immune,32587999,10.1101/2020.06.17.20106302,2020-06-27
United States,ISA,Country,32587997,10.1101/2020.04.18.20070821,2020-06-27
mental health,PROCESS_OF,Persons,32587996,10.1101/2020.06.13.20130120,2020-06-27
Depressive disorder,PROCESS_OF,Adult,32587996,10.1101/2020.06.13.20130120,2020-06-27
Depressive Symptoms,PROCESS_OF,Adult,32587996,10.1101/2020.06.13.20130120,2020-06-27
Depressive Symptoms,PROCESS_OF,Adult,32587996,10.1101/2020.06.13.20130120,2020-06-27
Depressive Symptoms,PROCESS_OF,Adult,32587996,10.1101/2020.06.13.20130120,2020-06-27
Anosmia,ISA,Symptoms,32587994,10.1101/2020.06.14.20131128,2020-06-27
"Receptors, Odorant",DISRUPTS,Olfactory Receptor Cells,32587994,10.1101/2020.06.14.20131128,2020-06-27
"Receptors, Odorant",CAUSES,Anosmia,32587994,10.1101/2020.06.14.20131128,2020-06-27
Taste Buds,LOCATION_OF,Viral Proteins,32587993,10.1101/2020.06.15.20132134,2020-06-27
Viral Proteins,AFFECTS,Severe (severity modifier),32587993,10.1101/2020.06.15.20132134,2020-06-27
Olfactory Epithelium,LOCATION_OF,Viral Proteins,32587993,10.1101/2020.06.15.20132134,2020-06-27
Fibrin,PART_OF,Structure of small blood vessel (organ),32587992,10.1101/2020.06.15.20131607,2020-06-27
Fibrin,TREATS,Patients,32587992,10.1101/2020.06.15.20131607,2020-06-27
Autoantibodies,INHIBITS,Phospholipids,32587992,10.1101/2020.06.15.20131607,2020-06-27
Autoantibodies,INHIBITS,Proteins,32587992,10.1101/2020.06.15.20131607,2020-06-27
Antiphospholipid Syndrome,ISA,Thrombophilia,32587992,10.1101/2020.06.15.20131607,2020-06-27
Antiphospholipid Syndrome,PROCESS_OF(SPEC),Patients,32587992,10.1101/2020.06.15.20131607,2020-06-27
Thrombophilia,PROCESS_OF,Patients,32587992,10.1101/2020.06.15.20131607,2020-06-27
Serum,PART_OF,Patients,32587992,10.1101/2020.06.15.20131607,2020-06-27
Infected,PROCESS_OF,Woman,32587991,10.1101/2020.06.12.20127944,2020-06-27
Woman,LOCATION_OF,Milk (body substance),32587991,10.1101/2020.06.12.20127944,2020-06-27
Infected,PROCESS_OF,Infant,32587991,10.1101/2020.06.12.20127944,2020-06-27
Woman,LOCATION_OF,Milk (body substance),32587991,10.1101/2020.06.12.20127944,2020-06-27
Woman,LOCATION_OF,Milk (body substance),32587991,10.1101/2020.06.12.20127944,2020-06-27
Infected,PROCESS_OF,Woman,32587991,10.1101/2020.06.12.20127944,2020-06-27
Disease,PROCESS_OF,Woman,32587991,10.1101/2020.06.12.20127944,2020-06-27
Laboratory Procedures,USES,PCR test for SARS,32587991,10.1101/2020.06.12.20127944,2020-06-27
PCR test for SARS,ISA,Laboratory Procedures,32587991,10.1101/2020.06.12.20127944,2020-06-27
Woman,LOCATION_OF,Milk (body substance),32587991,10.1101/2020.06.12.20127944,2020-06-27
Infected,PROCESS_OF,Woman,32587991,10.1101/2020.06.12.20127944,2020-06-27
physiological aspects,PROCESS_OF,Persons,32587990,10.1101/2020.06.12.20130021,2020-06-27
Adult,ISA,Persons,32587989,10.1101/2020.06.09.20126946,2020-06-27
Laboratory,LOCATION_OF,Analysis,32587988,10.1101/2020.06.10.20127845,2020-06-27
Screening procedure,TREATS,Patients,32587987,10.1101/2020.06.09.20123836,2020-06-27
Screening procedure,TREATS(INFER),Normal vital signs,32587987,10.1101/2020.06.09.20123836,2020-06-27
Normal vital signs,PROCESS_OF,Patients,32587987,10.1101/2020.06.09.20123836,2020-06-27
Lung,LOCATION_OF,Ultrasonography,32587987,10.1101/2020.06.09.20123836,2020-06-27
Lung,LOCATION_OF,Ultrasonography,32587987,10.1101/2020.06.09.20123836,2020-06-27
Lung,LOCATION_OF,Ultrasonography,32587987,10.1101/2020.06.09.20123836,2020-06-27
Lung,LOCATION_OF,Ultrasonography,32587987,10.1101/2020.06.09.20123836,2020-06-27
Normal vital signs,PROCESS_OF,Patients,32587987,10.1101/2020.06.09.20123836,2020-06-27
Detection,TREATS,Patients,32587987,10.1101/2020.06.09.20123836,2020-06-27
Detection,TREATS(INFER),Normal vital signs,32587987,10.1101/2020.06.09.20123836,2020-06-27
Lung,LOCATION_OF,Ultrasonography,32587987,10.1101/2020.06.09.20123836,2020-06-27
Oncologic,ISA,Medical Specialities,32587986,10.1101/2020.06.11.20128702,2020-06-27
Anxiety,PROCESS_OF,Physicians,32587986,10.1101/2020.06.11.20128702,2020-06-27
Neoplasms,PROCESS_OF,Physicians,32587986,10.1101/2020.06.11.20128702,2020-06-27
Depressive Symptoms,PROCESS_OF,Physicians,32587986,10.1101/2020.06.11.20128702,2020-06-27
Neoplasms,PROCESS_OF,Physicians,32587986,10.1101/2020.06.11.20128702,2020-06-27
Chronic Obstructive Airway Disease,ISA,Chronic lung disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Smoke,AFFECTS,Cell physiology,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,AFFECTS,Gene Expression,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,AFFECTS,Cellular Senescence,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Pulmonary Fibrosis,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Pulmonary Fibrosis,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Human tissue,PART_OF,Lung,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Pulmonary Fibrosis,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Pulmonary Fibrosis,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
NOX4 gene,AUGMENTS,Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
TNKS2 gene,AUGMENTS,Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
RHOT2 gene,ASSOCIATED_WITH,Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
FIS1 gene,ASSOCIATED_WITH,Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
GADD45B gene,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,AFFECTS,Communicable Diseases,32587985,10.1101/2020.06.14.20129957,2020-06-27
Smoker,PROCESS_OF,geriatric patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic lung disease,PROCESS_OF,geriatric patients,32587985,10.1101/2020.06.14.20129957,2020-06-27
Peptide Hydrolases,STIMULATES,ACE2 gene,32587985,10.1101/2020.06.14.20129957,2020-06-27
paired basic amino acid cleaving enzyme,STIMULATES,ACE2 gene,32587985,10.1101/2020.06.14.20129957,2020-06-27
"M Protein, multiple myeloma",STIMULATES,ACE2 gene,32587985,10.1101/2020.06.14.20129957,2020-06-27
TMPRSS2 gene,STIMULATES,ACE2 gene,32587985,10.1101/2020.06.14.20129957,2020-06-27
DPP4 gene,STIMULATES,ACE2 gene,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,ASSOCIATED_WITH,Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,ASSOCIATED_WITH,Chronic lung disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,ASSOCIATED_WITH(SPEC),Chronic Obstructive Airway Disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Aging,ASSOCIATED_WITH(SPEC),Pulmonary Fibrosis,32587985,10.1101/2020.06.14.20129957,2020-06-27
Chronic Obstructive Airway Disease,ISA,Chronic lung disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Pulmonary Fibrosis,ISA,Chronic lung disease,32587985,10.1101/2020.06.14.20129957,2020-06-27
Candidate Disease Gene,AFFECTS,Mitochondria,32587985,10.1101/2020.06.14.20129957,2020-06-27
Assay,DIAGNOSES,SARS coronavirus,32587984,10.1101/2020.06.13.20129841,2020-06-27
Pneumonia,PROCESS_OF,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
risk factors,PROCESS_OF,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
Lenzilumab,TREATS,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
Lenzilumab,ADMINISTERED_TO,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
Inspired fraction of oxygen,PROCESS_OF,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
Pneumonia,PROCESS_OF,Patients,32587983,10.1101/2020.06.08.20125369,2020-06-27
Lenzilumab,NEG_CAUSES,Adverse event,32587983,10.1101/2020.06.08.20125369,2020-06-27
Coronavirus Infections,ISA,Disease,32587982,10.1101/2020.06.11.20125849,2020-06-27
Angiotensin II receptor antagonist,AFFECTS,Disease,32587982,10.1101/2020.06.11.20125849,2020-06-27
Angiotensin II receptor antagonist,AFFECTS(SPEC),Coronavirus Infections,32587982,10.1101/2020.06.11.20125849,2020-06-27
Observational Study,MEASURES,Relative Risk,32587982,10.1101/2020.06.11.20125849,2020-06-27
Coronavirus Infections,ISA,Disease,32587982,10.1101/2020.06.11.20125849,2020-06-27
Patients,LOCATION_OF,cytokine,32587979,10.1101/2020.06.15.20131870,2020-06-27
Patients,LOCATION_OF,tocilizumab,32587979,10.1101/2020.06.15.20131870,2020-06-27
tocilizumab,ISA,Interleukin inhibitors,32587979,10.1101/2020.06.15.20131870,2020-06-27
Transcriptome,PART_OF,Cells,32587977,10.1101/2020.06.16.151555,2020-06-27
Cell Death,PROCESS_OF,Animal Model,32587976,10.1101/2020.06.17.156554,2020-06-27
Patient Discharge,TREATS,Severe Acute Respiratory Syndrome,32587976,10.1101/2020.06.17.156554,2020-06-27
Household composition,PROCESS_OF,Homo sapiens,32587975,10.1101/2020.06.17.153486,2020-06-27
Monoclonal Antibodies,PART_OF,Patients,32587975,10.1101/2020.06.17.153486,2020-06-27
Infected,PROCESS_OF,Patients,32587975,10.1101/2020.06.17.153486,2020-06-27
Enalapril,INHIBITS,Angiotensins,32587974,10.1101/2020.06.08.137331,2020-06-27
Heart,LOCATION_OF,angiotensin converting enzyme 2,32587974,10.1101/2020.06.08.137331,2020-06-27
ileum,LOCATION_OF,angiotensin converting enzyme 2,32587974,10.1101/2020.06.08.137331,2020-06-27
Kidney,LOCATION_OF,angiotensin converting enzyme 2,32587974,10.1101/2020.06.08.137331,2020-06-27
Lung,LOCATION_OF,angiotensin converting enzyme 2,32587974,10.1101/2020.06.08.137331,2020-06-27
ileum,LOCATION_OF,TMPRSS2 gene,32587974,10.1101/2020.06.08.137331,2020-06-27
Lung,LOCATION_OF,TMPRSS2 gene,32587974,10.1101/2020.06.08.137331,2020-06-27
Enalapril,NEG_INTERACTS_WITH,TMPRSS2 gene,32587974,10.1101/2020.06.08.137331,2020-06-27
Losartan,NEG_INTERACTS_WITH,TMPRSS2 gene,32587974,10.1101/2020.06.08.137331,2020-06-27
angiotensin converting enzyme 2,INHIBITS,Angiotensinogen,32587974,10.1101/2020.06.08.137331,2020-06-27
Antisense Oligonucleotides,ADMINISTERED_TO,"Mice, Inbred C57BL",32587974,10.1101/2020.06.08.137331,2020-06-27
Antisense Oligonucleotides,PART_OF,Angiotensinogen,32587974,10.1101/2020.06.08.137331,2020-06-27
TMPRSS2 gene,AFFECTS,Lung,32587974,10.1101/2020.06.08.137331,2020-06-27
"Vitronectin, human",AUGMENTS,viral transmission,32587973,10.1101/2020.06.12.148726,2020-06-27
Proteins,compared_with,Aspartic Acid,32587973,10.1101/2020.06.12.148726,2020-06-27
Pandemics,ISA,Epidemic,32587971,10.1101/2020.03.13.991083,2020-06-27
Stem of Organ,LOCATION_OF,Elements,32587971,10.1101/2020.03.13.991083,2020-06-27
small angle X ray scattering,DIAGNOSES,SARS coronavirus,32587971,10.1101/2020.03.13.991083,2020-06-27
small angle X ray scattering,DIAGNOSES,SARS coronavirus,32587971,10.1101/2020.03.13.991083,2020-06-27
Glycoproteins,AFFECTS,Virus Attachment,32587970,10.1101/2020.06.17.157982,2020-06-27
ACE2 gene,INTERACTS_WITH,"Antibodies, Neutralizing",32587970,10.1101/2020.06.17.157982,2020-06-27
Antibodies,INTERACTS_WITH,ACE2 gene,32587970,10.1101/2020.06.17.157982,2020-06-27
Vaccines,INTERACTS_WITH,ACE2 gene,32587970,10.1101/2020.06.17.157982,2020-06-27
"spike protein, human",LOCATION_OF,"Mutagenesis, Site-Directed",32587969,10.1101/2020.06.14.151357,2020-06-27
"M Protein, multiple myeloma",AUGMENTS,transduction,32587969,10.1101/2020.06.14.151357,2020-06-27
Regulatory DNA sequence,ASSOCIATED_WITH,Coronavirus Infections,32587968,10.1101/2020.06.21.163410,2020-06-27
"Transcription, Genetic",AFFECTS,Viral life cycle,32587966,10.1101/2020.06.17.158121,2020-06-27
Nucleus solitarius,LOCATION_OF,Measles Virus Nucleoprotein,32587965,10.1101/2020.06.11.147199,2020-06-27
Small Molecule,AFFECTS,Mammalian Cell,32587965,10.1101/2020.06.11.147199,2020-06-27
Measles Virus Nucleoprotein,INTERACTS_WITH,Small Molecule,32587965,10.1101/2020.06.11.147199,2020-06-27
ACE2 gene,PART_OF,soluble,32587964,10.1101/2020.06.15.152157,2020-06-27
Mutation,PROCESS_OF,"NR4A2 protein, human",32587964,10.1101/2020.06.15.152157,2020-06-27
Fusion protein,INTERACTS_WITH,Fc Receptor,32587964,10.1101/2020.06.15.152157,2020-06-27
ACE2 gene,DISRUPTS,enzyme activity,32587964,10.1101/2020.06.15.152157,2020-06-27
Cartridge device,CAUSES,Acute Lung Injury,32587960,10.1101/2020.06.14.151381,2020-06-27
Cartridge device,USES,Electronic Cigarettes,32587960,10.1101/2020.06.14.151381,2020-06-27
Constituents,CAUSES,pulmonary toxicity,32587960,10.1101/2020.06.14.151381,2020-06-27
Epithelium,PART_OF,Lung,32587960,10.1101/2020.06.14.151381,2020-06-27
Reactive Oxygen Species,AUGMENTS,inflammatory response,32587960,10.1101/2020.06.14.151381,2020-06-27
Bronchoalveolar Lavage Fluid,LOCATION_OF,Interleukin-6,32587960,10.1101/2020.06.14.151381,2020-06-27
Bronchoalveolar Lavage Fluid,LOCATION_OF,Granulocyte Colony-Stimulating Factor,32587960,10.1101/2020.06.14.151381,2020-06-27
Bronchoalveolar Lavage Fluid,LOCATION_OF,Eotaxin,32587960,10.1101/2020.06.14.151381,2020-06-27
Infiltration,ASSOCIATED_WITH,Interleukin-6,32587960,10.1101/2020.06.14.151381,2020-06-27
Infiltration,ASSOCIATED_WITH,Granulocyte Colony-Stimulating Factor,32587960,10.1101/2020.06.14.151381,2020-06-27
Infiltration,ASSOCIATED_WITH,Eotaxin,32587960,10.1101/2020.06.14.151381,2020-06-27
Leukotrienes,ISA,Eicosanoids,32587960,10.1101/2020.06.14.151381,2020-06-27
user - individual,LOCATION_OF,Plasma,32587960,10.1101/2020.06.14.151381,2020-06-27
Medium chain triglycerides,compared_with,Tocopherol Acetate,32587960,10.1101/2020.06.14.151381,2020-06-27
Cartridge device,CAUSES,cytotoxicity,32587960,10.1101/2020.06.14.151381,2020-06-27
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32587959,10.1101/2020.06.15.153387,2020-06-27
"M Protein, multiple myeloma",INTERACTS_WITH,Integrins,32587959,10.1101/2020.06.15.153387,2020-06-27
ACE2 gene,INTERACTS_WITH,Integrins,32587959,10.1101/2020.06.15.153387,2020-06-27
Blood supply aspects,LOCATION_OF,Virus,32587958,10.1101/2020.06.15.150912,2020-06-27
Headache,ASSOCIATED_WITH(SPEC),Encephalitis,32587958,10.1101/2020.06.15.150912,2020-06-27
Headache,ISA,Neurologic Symptoms,32587958,10.1101/2020.06.15.150912,2020-06-27
Neurologic Symptoms,ASSOCIATED_WITH,Encephalitis,32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,LOCATION_OF,Viral Proteins,32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,PART_OF,Endothelium,32587958,10.1101/2020.06.15.150912,2020-06-27
frontal lobe,LOCATION_OF,angiotensin converting enzyme 2,32587958,10.1101/2020.06.15.150912,2020-06-27
frontal lobe,LOCATION_OF,ACE2 gene,32587958,10.1101/2020.06.15.150912,2020-06-27
Endothelium,LOCATION_OF,ACE2 gene,32587958,10.1101/2020.06.15.150912,2020-06-27
Protein Subunits,STIMULATES,Viral Proteins,32587958,10.1101/2020.06.15.150912,2020-06-27
Blood - brain barrier anatomy,PART_OF,Homo sapiens,32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,LOCATION_OF,Proteins,32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,PART_OF,Endothelium,32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,LOCATION_OF,"M Protein, multiple myeloma",32587958,10.1101/2020.06.15.150912,2020-06-27
brain cell,PART_OF,Endothelium,32587958,10.1101/2020.06.15.150912,2020-06-27
Adult,ISA,Persons,32587937,10.1089/heq.2020.0020,2020-06-27
Intellectual Disability,PROCESS_OF,Adult,32587937,10.1089/heq.2020.0020,2020-06-27
Immune,PROCESS_OF,Population Group,32587932,10.1016/j.idm.2020.04.003,2020-06-27
Coronavirus Infections,ISA,Disease,32587887,10.1002/lio2.384,2020-06-27
Coronavirus Infections,ISA,Disease,32587887,10.1002/lio2.384,2020-06-27
Nose,LOCATION_OF,Obstruction,32587887,10.1002/lio2.384,2020-06-27
Coronavirus Infections,ISA,Disease,32587887,10.1002/lio2.384,2020-06-27
Coronavirus Infections,ISA,Disease,32587887,10.1002/lio2.384,2020-06-27
Nose,LOCATION_OF,Obstruction,32587887,10.1002/lio2.384,2020-06-27
Quarantine,TREATS,Population Group,32587844,10.3389/fpubh.2020.00262,2020-06-27
Infected,PROCESS_OF,Persons,32587844,10.3389/fpubh.2020.00262,2020-06-27
patient condition,PROCESS_OF,Patients,32587806,10.7717/peerj.9392,2020-06-27
Cytokine release syndrome,COEXISTS_WITH,patient condition,32587806,10.7717/peerj.9392,2020-06-27
Lectin,PART_OF,Animals,32587806,10.7717/peerj.9392,2020-06-27
Galectin 3,ISA,Lectin,32587806,10.7717/peerj.9392,2020-06-27
Galectin 3,PART_OF(SPEC),Animals,32587806,10.7717/peerj.9392,2020-06-27
Galectin 3,INHIBITS,,32587806,10.7717/peerj.9392,2020-06-27
Galectin 3,INHIBITS,Interleukin-6,32587806,10.7717/peerj.9392,2020-06-27
"M Protein, multiple myeloma",PART_OF,Coronaviridae,32587806,10.7717/peerj.9392,2020-06-27
Symptoms,PROCESS_OF,Patients,32587651,10.14740/jocmr4200,2020-06-27
Kidney,LOCATION_OF,Virus,32587651,10.14740/jocmr4200,2020-06-27
IMPACT gene,PART_OF,Virus,32587651,10.14740/jocmr4200,2020-06-27
Coronavirus Infections,CAUSES,"Kidney Failure, Acute",32587651,10.14740/jocmr4200,2020-06-27
"Kidney Failure, Acute",CAUSES,inflammatory response,32587651,10.14740/jocmr4200,2020-06-27
"Kidney Failure, Acute",COEXISTS_WITH,Coronavirus Infections,32587651,10.14740/jocmr4200,2020-06-27
"Kidney Failure, Acute",CAUSES,Virus Diseases,32587651,10.14740/jocmr4200,2020-06-27
"Kidney Failure, Acute",PROCESS_OF,Patients,32587651,10.14740/jocmr4200,2020-06-27
Coronavirus Infections,AFFECTS,Chronic Kidney Diseases,32587651,10.14740/jocmr4200,2020-06-27
Infected,PROCESS_OF,Patients,32587649,10.14740/jocmr4201,2020-06-27
Pharmaceutical Preparations,TREATS,Patients,32587649,10.14740/jocmr4201,2020-06-27
Confusion,PROCESS_OF,Health Personnel,32587649,10.14740/jocmr4201,2020-06-27
"Therapies, Investigational",ADMINISTERED_TO,Patients,32587649,10.14740/jocmr4201,2020-06-27
Delirium,PROCESS_OF,Patients,32587625,10.7573/dic.2020-5-1,2020-06-27
Malaise,PROCESS_OF,Patients,32587625,10.7573/dic.2020-5-1,2020-06-27
Sepsis-Associated Encephalopathy,PROCESS_OF,Patients,32587625,10.7573/dic.2020-5-1,2020-06-27
Headache,PROCESS_OF,Persons,32587625,10.7573/dic.2020-5-1,2020-06-27
Myalgia,PROCESS_OF,Patients,32587625,10.7573/dic.2020-5-1,2020-06-27
Ischemic stroke,ISA,Complication,32587625,10.7573/dic.2020-5-1,2020-06-27
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Thrombophilia,32587625,10.7573/dic.2020-5-1,2020-06-27
Problem,PROCESS_OF,Population Group,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Problem,PROCESS_OF(SPEC),Italians,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Italians,ISA,Population Group,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Perception,PROCESS_OF,Persons,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Italians,ISA,Population Group,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Awareness,PROCESS_OF,Persons,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Intervention regimes,TREATS,Distress,32587539,10.3389/fpsyt.2020.00556,2020-06-27
Coronavirus Infections,CAUSES,Lung diseases,32587443,10.3748/wjg.v26.i22.2987,2020-06-27
Liver diseases,PROCESS_OF,Patients,32587443,10.3748/wjg.v26.i22.2987,2020-06-27
Liver diseases,AFFECTS,Patients,32587443,10.3748/wjg.v26.i22.2987,2020-06-27
Vitrectomy,USES,"Camera, device",32587387,10.1038/s41433-020-1052-4,2020-06-27
anatomic valve,LOCATION_OF,Cannula device,32587387,10.1038/s41433-020-1052-4,2020-06-27
anatomic valve,LOCATION_OF,Cannula device,32587387,10.1038/s41433-020-1052-4,2020-06-27
anatomic valve,LOCATION_OF,Cannula device,32587387,10.1038/s41433-020-1052-4,2020-06-27
Cornea,PART_OF,Tissue Donors,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Tertiary Care Centers,LOCATION_OF,Retrospective Cohort Study,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Fresh Tissue,PART_OF,Cornea,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Fresh Tissue,PART_OF,Cornea,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Eye,PART_OF,Patients,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Eye,PART_OF,Patients,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Eye,PART_OF,Patients,32587179,10.4103/ijo.IJO_1198_20,2020-06-27
Masks,USES,Personal protective equipment,32587176,10.4103/ijo.IJO_1221_20,2020-06-27
Disorder of eye,PROCESS_OF,Patients,32587174,10.4103/ijo.IJO_1171_20,2020-06-27
Hospitals,LOCATION_OF,Study,32587174,10.4103/ijo.IJO_1171_20,2020-06-27
Operative Surgical Procedures,ISA,Interventional procedure,32587174,10.4103/ijo.IJO_1171_20,2020-06-27
Strabismus,PROCESS_OF,Patients,32587172,10.4103/ijo.IJO_1675_20,2020-06-27
Department,LOCATION_OF,Teleconsultation,32587172,10.4103/ijo.IJO_1675_20,2020-06-27
Disorder of the optic nerve,PROCESS_OF,Patients,32587172,10.4103/ijo.IJO_1675_20,2020-06-27
Strabismus,PROCESS_OF,Patients,32587172,10.4103/ijo.IJO_1675_20,2020-06-27
Universities,LOCATION_OF,Teleconsultation,32587169,10.4103/ijo.IJO_1658_20,2020-06-27
Teleconsultation,ADMINISTERED_TO,Patients,32587169,10.4103/ijo.IJO_1658_20,2020-06-27
Syndrome,PRECEDES,Conjunctivitis,32587169,10.4103/ijo.IJO_1658_20,2020-06-27
prescribed,TREATS,Uncertain diagnosis,32587169,10.4103/ijo.IJO_1658_20,2020-06-27
Eye,LOCATION_OF,Severe disorder,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Uterine adnexae structure,PART_OF,Eye,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Disease,CAUSES,Pain,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Pain,ISA,Disease,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Organ,LOCATION_OF,"Pain, Referred",32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Disease,CAUSES,Eye pain,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Ambulatory Care Facilities,LOCATION_OF,Teleconsultation,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
hospital visit,TREATS,Enthesitis-Related Arthritis,32587167,10.4103/ijo.IJO_1267_20,2020-06-27
Persons,LOCATION_OF,IMPACT gene,32587166,10.4103/ijo.IJO_1513_20,2020-06-27
Blindness,PROCESS_OF,Persons,32587166,10.4103/ijo.IJO_1513_20,2020-06-27
Disability,PROCESS_OF,Persons,32587166,10.4103/ijo.IJO_1513_20,2020-06-27
Decision,PROCESS_OF,Maker (occupation),32587166,10.4103/ijo.IJO_1513_20,2020-06-27
risk factors,PROCESS_OF,Patients,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Antihistamines,ISA,Pharmaceutical Preparations,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Antihistamines,TREATS,Disease,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Chloroquine,ISA,Pharmaceutical Preparations,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Chloroquine,TREATS,Disease,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Eye,LOCATION_OF,Disease,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Interferons,ISA,Pharmaceutical Preparations,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Interferons,TREATS,Disease,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Trehalose,ISA,Pharmaceutical Preparations,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Trehalose,TREATS,Disease,32587162,10.4103/ijo.IJO_1589_20,2020-06-27
Consultation,ADMINISTERED_TO,Patients,32587157,10.4103/ijo.IJO_1509_20,2020-06-27
Consultation,ADMINISTERED_TO,Physicians,32587157,10.4103/ijo.IJO_1509_20,2020-06-27
telephone call,METHOD_OF,Consultation,32587157,10.4103/ijo.IJO_1509_20,2020-06-27
Screening procedure,NEG_TREATS,Patients,32587157,10.4103/ijo.IJO_1509_20,2020-06-27
Elective Surgical Procedures,TREATS,Enthesitis-Related Arthritis,32587153,10.4103/ijo.IJO_1753_20,2020-06-27
Infantile Neuroaxonal Dystrophy,PROCESS_OF,World,32587153,10.4103/ijo.IJO_1753_20,2020-06-27
Oncology Service,AFFECTS,Severe (severity modifier),32587152,10.4103/ijo.IJO_1669_20,2020-06-27
Eye,LOCATION_OF,Neoplasms,32587152,10.4103/ijo.IJO_1669_20,2020-06-27
Glaucoma,PROCESS_OF,Specialist,32587151,10.4103/ijo.IJO_1724_20,2020-06-27
Eye,LOCATION_OF,Blindness,32587150,10.4103/ijo.IJO_1528_20,2020-06-27
Present,PROCESS_OF,Health Personnel,32587150,10.4103/ijo.IJO_1528_20,2020-06-27
Present,PROCESS_OF,general population,32587150,10.4103/ijo.IJO_1528_20,2020-06-27
Rhabdomyolysis,PROCESS_OF,Patients,32587121,10.1136/bcr-2020-236719,2020-06-27
rituximab,ADMINISTERED_TO,Patients,32587103,10.1212/NXI.0000000000000825,2020-06-27
rituximab,ADMINISTERED_TO,Patients,32587103,10.1212/NXI.0000000000000825,2020-06-27
rituximab,TREATS,Patients,32587103,10.1212/NXI.0000000000000825,2020-06-27
Amino Acids,STIMULATES,protein protein interaction,32587094,10.1074/jbc.RA120.014873,2020-06-27
Missense,PROCESS_OF,Patients,32587094,10.1074/jbc.RA120.014873,2020-06-27
Cultured Cell Line,LOCATION_OF,IFNA1 gene,32587093,10.1074/jbc.AC120.013788,2020-06-27
Angiotensin-Converting Enzyme Inhibitors,ISA,Pharmaceutical Preparations,32587077,10.1136/ejhpharm-2020-002329,2020-06-27
Angiotensin II receptor antagonist,ISA,Pharmaceutical Preparations,32587077,10.1136/ejhpharm-2020-002329,2020-06-27
Viral Proteins,INTERACTS_WITH,ACE2 gene,32587077,10.1136/ejhpharm-2020-002329,2020-06-27
ACE2 gene,AUGMENTS,Cell Invasion,32587077,10.1136/ejhpharm-2020-002329,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,ACE2 gene,32587077,10.1136/ejhpharm-2020-002329,2020-06-27
Health Care Systems,LOCATION_OF,Work,32587063,10.1128/mBio.00997-20,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32586968,10.3174/ajnr.A6650,2020-06-27
Confirmation,COEXISTS_WITH,Coronavirus Infections,32586968,10.3174/ajnr.A6650,2020-06-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32586968,10.3174/ajnr.A6650,2020-06-27
Symptoms,PROCESS_OF,Patients,32586960,10.3174/ajnr.A6675,2020-06-27
headache persistent,PROCESS_OF,Patients,32586960,10.3174/ajnr.A6675,2020-06-27
Critical Illness,PROCESS_OF,Patients,32586959,10.3174/ajnr.A6671,2020-06-27
Coronavirus Infections,PROCESS_OF,Patients,32586959,10.3174/ajnr.A6671,2020-06-27
Spinal Puncture,TREATS,Patients,32586959,10.3174/ajnr.A6671,2020-06-27
Facial Paresis,ASSOCIATED_WITH,Paresthesia,32586958,10.3174/ajnr.A6654,2020-06-27
Diagnosis,ADMINISTERED_TO,Patients,32586958,10.3174/ajnr.A6654,2020-06-27
work up,ADMINISTERED_TO,Patients,32586958,10.3174/ajnr.A6654,2020-06-27
Neurologic Manifestations,COEXISTS_WITH,Disease,32586958,10.3174/ajnr.A6654,2020-06-27
Uveitis,PREDISPOSES,Infection,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunomodulation,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Uveitis,PROCESS_OF,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunomodulation,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunomodulation,TREATS(INFER),Uveitis,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Adrenal Cortex Hormones,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Adrenal Cortex Hormones,TREATS(INFER),Uveitis,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunosuppressive Agents,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunosuppressive Agents,TREATS(INFER),Uveitis,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Uveitis,PROCESS_OF,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Immunomodulation,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Systemic Corticosteroid Therapy,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Scleritis,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Hydroxychloroquine,TREATS,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Hydroxychloroquine,TREATS(INFER),Uveitis,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Uveitis,PROCESS_OF,Patients,32586933,10.1136/bjophthalmol-2020-316776,2020-06-27
Hyperinflammatory state,NEG_PROCESS_OF,Patients,32586897,10.1212/WNL.0000000000010250,2020-06-27
Brain,LOCATION_OF,Magnetic Resonance Imaging,32586897,10.1212/WNL.0000000000010250,2020-06-27
Thalamic structure,LOCATION_OF,Magnetic Resonance Imaging,32586897,10.1212/WNL.0000000000010250,2020-06-27
Cerebrospinal Fluid,LOCATION_OF,Glial Fibrillary Acidic Protein,32586897,10.1212/WNL.0000000000010250,2020-06-27
Plasma Exchange,ADMINISTERED_TO,Patients,32586897,10.1212/WNL.0000000000010250,2020-06-27
"Immunoglobulins, Intravenous",ADMINISTERED_TO,Patients,32586897,10.1212/WNL.0000000000010250,2020-06-27
Spinal Puncture,TREATS,Patients,32586897,10.1212/WNL.0000000000010250,2020-06-27
Neurotropism,PROCESS_OF,Patients,32586897,10.1212/WNL.0000000000010250,2020-06-27
"CD69 protein, human",AFFECTS,Lung,32586885,10.1183/13993003.01727-2020,2020-06-27
"CD69 protein, human",AFFECTS,Virus Diseases,32586885,10.1183/13993003.01727-2020,2020-06-27
Acute miliary tuberculosis,PROCESS_OF,Social Networks,32586885,10.1183/13993003.01727-2020,2020-06-27
Symptoms,PROCESS_OF,Patients,32586872,10.1128/MRA.00573-20,2020-06-27
Cardiac Arrhythmia,PROCESS_OF,Patients,32586839,10.1503/cmaj.200879,2020-06-27
Heart Injuries,PROCESS_OF,Patients,32586839,10.1503/cmaj.200879,2020-06-27
Heart Injuries,PROCESS_OF,Patients,32586839,10.1503/cmaj.200879,2020-06-27
Uncertainty,PROCESS_OF,Physicians,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Structural disorder of heart,PROCESS_OF,Patients,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Percutaneous Coronary Intervention,compared_with,Fibrinolytic Agents,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
ST segment elevation myocardial infarction,ISA,Myocardial Infarction,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Stable angina,PROCESS_OF,Patients,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Acute Coronary Syndrome,PROCESS_OF,Patients,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Structural disorder of heart,PROCESS_OF,Patients,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Percutaneous replacement of aortic valve using fluoroscopic guidance,TREATS,Patients,32586744,10.1016/j.carrev.2020.06.013,2020-06-27
Nose,LOCATION_OF,Congestion,32586739,10.1016/j.anl.2020.06.003,2020-06-27
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
Active Method,TREATS,Cancer Patient,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
Active Method,TREATS(INFER),Severe Acute Respiratory Syndrome,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
Disease,PROCESS_OF,Population Group,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
"Respiratory Distress Syndrome, Adult",ISA,Respiratory distress,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
Respiratory Failure,PROCESS_OF,Patients,32586724,10.1016/j.ejca.2020.06.001,2020-06-27
Study,MEASURES,Delta (difference),32586670,10.1016/j.medcli.2020.05.017,2020-06-27
Platelet Count measurement,DIAGNOSES,Pneumonia,32586670,10.1016/j.medcli.2020.05.017,2020-06-27
C-reactive protein,compared_with,GSKIP gene,32586670,10.1016/j.medcli.2020.05.017,2020-06-27
Infection,PROCESS_OF,Patients,32586669,10.1016/j.medcli.2020.05.012,2020-06-27
Infection,PROCESS_OF,Patients,32586669,10.1016/j.medcli.2020.05.012,2020-06-27
Pandemics,ISA,Disease Outbreaks,32586667,10.1016/j.medcli.2020.05.026,2020-06-27
disease prevention,compared_with,"TLR4 protein, human",32586667,10.1016/j.medcli.2020.05.026,2020-06-27
"TLR4 protein, human",DISRUPTS,Pneumonia,32586667,10.1016/j.medcli.2020.05.026,2020-06-27
Cross Infection,PROCESS_OF,Patients,32586665,10.1016/j.transproceed.2020.05.032,2020-06-27
Transplantation of liver,TREATS,Enthesitis-Related Arthritis,32586665,10.1016/j.transproceed.2020.05.032,2020-06-27
Laboratory,LOCATION_OF,Lead measurement,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Laboratory Procedures,USES,Analysis of arterial blood gases and pH,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Physical Examination,TREATS,Patients,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Analysis of arterial blood gases and pH,ISA,Laboratory Procedures,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Left Ventricular Hypertrophy,PROCESS_OF,Patients,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Electrocardiogram abnormal,PROCESS_OF,Patients,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Lung,LOCATION_OF,Massive embolus,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Electrocardiogram abnormal,PROCESS_OF,Patients,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
"Discharge, body substance",ASSOCIATED_WITH,Electrocardiogram: P-R interval,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Electrocardiogram abnormal,PROCESS_OF,Patients,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Hospitalization,TREATS,Pneumonia,32586646,10.1016/j.ejim.2020.06.015,2020-06-27
Obesity,PREDISPOSES,Severe disorder,32586628,10.1016/j.aprim.2020.05.003,2020-06-27
Obesity,PROCESS_OF,Persons,32586628,10.1016/j.aprim.2020.05.003,2020-06-27
Obesity,AFFECTS,Persons,32586628,10.1016/j.aprim.2020.05.003,2020-06-27
Obesity,PROCESS_OF,Persons,32586628,10.1016/j.aprim.2020.05.003,2020-06-27
Social stigmata,PROCESS_OF,Persons,32586628,10.1016/j.aprim.2020.05.003,2020-06-27
Single organ dysfunction,ASSOCIATED_WITH,Septicemia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Single organ dysfunction,MANIFESTATION_OF,Anoxia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Pharmacotherapy,TREATS,Anoxia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Septicemia,CAUSES,Anoxia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Hypoxia,ISA,Disease,32586399,10.1186/s13063-020-04474-0,2020-06-27
Euthyroid Sick Syndromes,COEXISTS_WITH,Septicemia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Euthyroid Sick Syndromes,COEXISTS_WITH,Wounds and Injuries,32586399,10.1186/s13063-020-04474-0,2020-06-27
Euthyroid Sick Syndromes,COEXISTS_WITH,Acute myocardial infarction,32586399,10.1186/s13063-020-04474-0,2020-06-27
Thyroid Hormones,ASSOCIATED_WITH,Anoxia,32586399,10.1186/s13063-020-04474-0,2020-06-27
Virus Diseases,CAUSES,Critical Illness,32586399,10.1186/s13063-020-04474-0,2020-06-27
liothyronine,ASSOCIATED_WITH(INFER),Infectious disease of lung,32586399,10.1186/s13063-020-04474-0,2020-06-27
liothyronine,PART_OF,Patients,32586399,10.1186/s13063-020-04474-0,2020-06-27
Infected,PROCESS_OF,Patients,32586399,10.1186/s13063-020-04474-0,2020-06-27
body membrane,LOCATION_OF,Alveolar ventilation function,32586399,10.1186/s13063-020-04474-0,2020-06-27
Infectious disease of lung,PROCESS_OF,Patients,32586399,10.1186/s13063-020-04474-0,2020-06-27
Study,MEASURES,Dosage,32586399,10.1186/s13063-020-04474-0,2020-06-27
body membrane,LOCATION_OF,Alveolar ventilation function,32586399,10.1186/s13063-020-04474-0,2020-06-27
,PART_OF,Patients,32586399,10.1186/s13063-020-04474-0,2020-06-27
Critical Illness,PROCESS_OF,Patients,32586399,10.1186/s13063-020-04474-0,2020-06-27
Critical Illness,PROCESS_OF,Patients,32586396,10.1186/s13063-020-04501-0,2020-06-27
Cessation of life,PROCESS_OF,Patients,32586396,10.1186/s13063-020-04501-0,2020-06-27
Vasoconstrictor Agents,TREATS,Patients,32586396,10.1186/s13063-020-04501-0,2020-06-27
cytokine,CAUSES,Shock,32586396,10.1186/s13063-020-04501-0,2020-06-27
Patients,LOCATION_OF,cytokine,32586396,10.1186/s13063-020-04501-0,2020-06-27
Antibiotics,ADMINISTERED_TO,Patients,32586396,10.1186/s13063-020-04501-0,2020-06-27
Antibiotics,TREATS,Shock,32586396,10.1186/s13063-020-04501-0,2020-06-27
Respirator dependence,PROCESS_OF,Patients,32586395,10.1186/s13063-020-04486-w,2020-06-27
cytokine,PREVENTS,Storm NOS,32586395,10.1186/s13063-020-04486-w,2020-06-27
Respiratory distress,PROCESS_OF,Population Group,32586395,10.1186/s13063-020-04486-w,2020-06-27
Study,USES,Interventional procedure,32586395,10.1186/s13063-020-04486-w,2020-06-27
AKR1A1 wt Allele,DISRUPTS,Respiratory distress,32586395,10.1186/s13063-020-04486-w,2020-06-27
Coughing,PROCESS_OF,Patients,32586395,10.1186/s13063-020-04486-w,2020-06-27
"Condoms, Male",TREATS,hospitalized patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
"Heparin, Low-Molecular-Weight",compared_with,"Condoms, Male",32586394,10.1186/s13063-020-04475-z,2020-06-27
"Heparin, Low-Molecular-Weight",TREATS,hospitalized patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Continuous Positive Airway Pressure,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Invasive mechanical ventilation NOS,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Non-invasive mechanical ventilation,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Septicemia,CAUSES,Blood Coagulation Disorders,32586394,10.1186/s13063-020-04475-z,2020-06-27
Hemorrhage,COEXISTS_WITH,Present,32586394,10.1186/s13063-020-04475-z,2020-06-27
Interventional procedure,USES,Enoxaparin,32586394,10.1186/s13063-020-04475-z,2020-06-27
Enoxaparin,ADMINISTERED_TO,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Therapeutic procedure,TREATS,Alveolar rhabdomyosarcoma,32586394,10.1186/s13063-020-04475-z,2020-06-27
Invasive mechanical ventilation NOS,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Standard of Care,USES,Oxygen,32586394,10.1186/s13063-020-04475-z,2020-06-27
Invasive mechanical ventilation NOS,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Invasive mechanical ventilation NOS,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Standard of Care,USES,Oxygen,32586394,10.1186/s13063-020-04475-z,2020-06-27
Invasive mechanical ventilation NOS,TREATS,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
conjunctiva,LOCATION_OF,Hemorrhage,32586394,10.1186/s13063-020-04475-z,2020-06-27
conjunctiva,NEG_LOCATION_OF(SPEC),Eye Hemorrhage,32586394,10.1186/s13063-020-04475-z,2020-06-27
Eye Hemorrhage,NEG_ISA,Hemorrhage,32586394,10.1186/s13063-020-04475-z,2020-06-27
Body of uterus,PART_OF,Eye,32586394,10.1186/s13063-020-04475-z,2020-06-27
Acute hemorrhage,ASSOCIATED_WITH,Hemoglobin,32586394,10.1186/s13063-020-04475-z,2020-06-27
"Heparin, Low-Molecular-Weight",INHIBITS,Worse,32586394,10.1186/s13063-020-04475-z,2020-06-27
Worse,PROCESS_OF,Control Groups,32586394,10.1186/s13063-020-04475-z,2020-06-27
Worse,PROCESS_OF,Patients,32586394,10.1186/s13063-020-04475-z,2020-06-27
Engaged to be married,PROCESS_OF,Community,32586391,10.1186/s12916-020-01624-8,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,TMPRSS2 gene,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,ACE2 gene,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,Angiotensin-Converting Enzyme Inhibitors,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,Antiviral Agents,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,Monobactams,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,fosamprenavir,32586380,10.1186/s12967-020-02430-9,2020-06-27
Pharmaceutical Preparations,INTERACTS_WITH,Emricasan,32586380,10.1186/s12967-020-02430-9,2020-06-27
Bio-Informatics,ISA,Technology,32586380,10.1186/s12967-020-02430-9,2020-06-27
Disease,AFFECTS,human group,32586369,10.1186/s40249-020-00688-1,2020-06-27
IMPACT gene,ASSOCIATED_WITH,Disease,32586369,10.1186/s40249-020-00688-1,2020-06-27
Disease,PROCESS_OF,Cancer Patient,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,ISA,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,PROCESS_OF(SPEC),Cancer Patient,32586363,10.1186/s13063-020-04485-x,2020-06-27
AKR1A1 wt Allele,INTERACTS_WITH,Hydroxychloroquine,32586363,10.1186/s13063-020-04485-x,2020-06-27
Breast,PART_OF,Patients,32586363,10.1186/s13063-020-04485-x,2020-06-27
"Lymphoma, Non-Hodgkin",PROCESS_OF,Patients,32586363,10.1186/s13063-020-04485-x,2020-06-27
Antineoplastic Agents,TREATS,Malignant Neoplasms,32586363,10.1186/s13063-020-04485-x,2020-06-27
Hydroxychloroquine,AFFECTS,Acute respiratory tract infection,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,ISA,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Disease,OCCURS_IN,Patients,32586363,10.1186/s13063-020-04485-x,2020-06-27
Lung,LOCATION_OF,Radionuclide Imaging,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,ISA,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,OCCURS_IN(SPEC),Patients,32586363,10.1186/s13063-020-04485-x,2020-06-27
Hydroxychloroquine,AFFECTS,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Hydroxychloroquine,AFFECTS(SPEC),Coronavirus Infections,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,ISA,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Coronavirus Infections,ISA,Disease,32586363,10.1186/s13063-020-04485-x,2020-06-27
Laboratory Procedures,DIAGNOSES,Infection,32586336,10.1186/s12916-020-01636-4,2020-06-27
Infection,COEXISTS_WITH,Incubation period,32586336,10.1186/s12916-020-01636-4,2020-06-27
Quarantine,ISA,Isolation procedure,32586336,10.1186/s12916-020-01636-4,2020-06-27
Heart,LOCATION_OF,Comorbidity,32586323,10.1186/s12916-020-01665-z,2020-06-27
Cerebrovascular accident,PREDISPOSES,Complication,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Multiple Organ Failure,COEXISTS_WITH,Complication,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Surface,LOCATION_OF,Endothelial Cells,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Endothelial Cells,INTERACTS_WITH,angiotensin converting enzyme 2,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Thrombin,INTERACTS_WITH,Blood Platelets,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Thrombin,INTERACTS_WITH,Leukocytes,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Therapeutic procedure,PREVENTS,Thrombosis,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Diagnosis,DIAGNOSES,Complication,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Pharmaceutical Preparations,TREATS,Complication,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Screening procedure,USES,Diagnosis,32586214,10.1161/CIRCRESAHA.120.317447,2020-06-27
Chronic Insomnia,PROCESS_OF,Patients,32586205,10.1177/0020764020937716,2020-06-27
Chronic Insomnia,PROCESS_OF,Patients,32586205,10.1177/0020764020937716,2020-06-27
Sleep disturbances,ISA,Disease,32586205,10.1177/0020764020937716,2020-06-27
Anxiety,AFFECTS,Patients,32586205,10.1177/0020764020937716,2020-06-27
Chronic Insomnia,PROCESS_OF,Patients,32586205,10.1177/0020764020937716,2020-06-27
montelukast,TREATS,Severe Acute Respiratory Syndrome,32586154,10.1080/02770903.2020.1786112,2020-06-27
Disease,COEXISTS_WITH,RNA Viruses,32585913,10.3390/vaccines8020335,2020-06-27
Disease,COEXISTS_WITH(SPEC),Genus: Coronavirus,32585913,10.3390/vaccines8020335,2020-06-27
Disease,PROCESS_OF,Animals,32585913,10.3390/vaccines8020335,2020-06-27
Disease,PROCESS_OF,Aves,32585913,10.3390/vaccines8020335,2020-06-27
Disease,PROCESS_OF,Homo sapiens,32585913,10.3390/vaccines8020335,2020-06-27
Genus: Coronavirus,ISA,RNA Viruses,32585913,10.3390/vaccines8020335,2020-06-27
"Pneumonia, Viral",PROCESS_OF,Patients,32585913,10.3390/vaccines8020335,2020-06-27
"Respiratory Distress Syndrome, Newborn",PROCESS_OF,Patients,32585913,10.3390/vaccines8020335,2020-06-27
Antiviral Agents,TREATS,Life-threatening infections,32585913,10.3390/vaccines8020335,2020-06-27
Disease Progression,COEXISTS_WITH,risk factors,32585855,10.3390/jcm9061959,2020-06-27
lopinavir / Ritonavir,TREATS,Patients,32585855,10.3390/jcm9061959,2020-06-27
Exercise,TREATS,student,32585830,10.3390/nu12061865,2020-06-27
Reparative closure,TREATS,Females,32585830,10.3390/nu12061865,2020-06-27
Medical History,NEG_PROCESS_OF,Woman,32585767,10.1111/bjd.19338,2020-06-26
Acute diarrhea,PROCESS_OF,Recipient,32585765,10.1111/tid.13388,2020-06-26
Decreased Immunologic Activity [PE],PROCESS_OF,Recipient,32585765,10.1111/tid.13388,2020-06-26
Serum,LOCATION_OF,Interleukin-6,32585765,10.1111/tid.13388,2020-06-26
Tacrolimus,CAUSES,"Kidney Failure, Acute",32585765,10.1111/tid.13388,2020-06-26
alternate pathway,PROCESS_OF,Woman,32585723,10.1111/dme.14346,2020-06-26
Severe (severity modifier),PREDISPOSES,Cardiovascular Diseases,32585699,10.1093/eurheartj/ehaa460,2020-06-26
Severe (severity modifier),PREDISPOSES,Lung diseases,32585699,10.1093/eurheartj/ehaa460,2020-06-26
Smoker,PROCESS_OF,Woman,32585699,10.1093/eurheartj/ehaa460,2020-06-26
Endothelium,LOCATION_OF,IMPACT gene,32585699,10.1093/eurheartj/ehaa460,2020-06-26
Endothelium,LOCATION_OF,IMPACT gene,32585699,10.1093/eurheartj/ehaa460,2020-06-26
Disease,PROCESS_OF,Elderly (population group),32585674,10.1159/000509216,2020-06-26
Comorbidity,PREDISPOSES,Complication,32585674,10.1159/000509216,2020-06-26
Elderly (population group),ISA,Persons,32585674,10.1159/000509216,2020-06-26
Aging,ASSOCIATED_WITH,Chronic disease,32585674,10.1159/000509216,2020-06-26
Interventional procedure,TREATS,Elderly (population group),32585674,10.1159/000509216,2020-06-26
Interventional procedure,TREATS,Persons,32585674,10.1159/000509216,2020-06-26
Interventional procedure,TREATS(SPEC),Elderly (population group),32585674,10.1159/000509216,2020-06-26
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Detection,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Viral culture procedure,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Detection,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Detection,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Detection,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Rapid Antigen Test,USES,Detection,32585619,10.1016/j.jcv.2020.104500,2020-06-26
Multiple Sclerosis,PROCESS_OF,Patients,32585617,10.1016/j.msard.2020.102306,2020-06-26
Immunosuppressive Agents,ASSOCIATED_WITH,Multiple Sclerosis,32585617,10.1016/j.msard.2020.102306,2020-06-26
Multiple Sclerosis,PROCESS_OF,Patients,32585617,10.1016/j.msard.2020.102306,2020-06-26
"Human B-Lymphocyte Antigen CD20, human",COEXISTS_WITH,Antibodies,32585617,10.1016/j.msard.2020.102306,2020-06-26
"Antibodies, Neutralizing",PREVENTS,Virus,32585611,10.1016/j.intimp.2020.106717,2020-06-26
Vaccines,STIMULATES,Antibodies,32585611,10.1016/j.intimp.2020.106717,2020-06-26
Immunologic Adjuvants,COEXISTS_WITH,Vaccines,32585611,10.1016/j.intimp.2020.106717,2020-06-26
Malignant neoplasm of lung,PROCESS_OF,Patients,32585497,10.1016/j.lungcan.2020.05.029,2020-06-26
Malignant neoplasm of lung,PROCESS_OF,Patients,32585497,10.1016/j.lungcan.2020.05.029,2020-06-26
post surgery radiation therapy,TREATS,Non-Small Cell Lung Carcinoma,32585497,10.1016/j.lungcan.2020.05.029,2020-06-26
Malignant neoplasm of lung,PROCESS_OF,Patients,32585497,10.1016/j.lungcan.2020.05.029,2020-06-26
Health Personnel,DIAGNOSES,Anxiety,32585436,10.1016/j.psychres.2020.113174,2020-06-26
Physical Examination,USES,Chest imaging,32585417,10.1016/j.clinimag.2020.06.031,2020-06-26
Nurses,TREATS,Patients,32585417,10.1016/j.clinimag.2020.06.031,2020-06-26
Health Care,PREVENTS,Infected,32585417,10.1016/j.clinimag.2020.06.031,2020-06-26
Diabetes,PROCESS_OF,Persons,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Communicable Diseases,PROCESS_OF,Persons,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Comorbidity,PROCESS_OF,Patients,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Diabetes,AFFECTS,Immune,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Diabetes,PREDISPOSES,Communicable Diseases,32585364,10.1016/j.molmet.2020.101044,2020-06-26
GSKIP gene,PART_OF,Patients,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Diabetes,PREDISPOSES,Communicable Diseases,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Diabetes,PROCESS_OF,Persons,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Diabetes,INTERACTS_WITH,Genus: Coronavirus,32585364,10.1016/j.molmet.2020.101044,2020-06-26
Asymptomatic,PROCESS_OF,Persons,32585353,10.1016/j.cmi.2020.06.009,2020-06-26
Severe disorder,PROCESS_OF,Patients,32585295,10.1016/j.clim.2020.108517,2020-06-26
ruxolitinib,DISRUPTS,Biochemical Pathway,32585295,10.1016/j.clim.2020.108517,2020-06-26
Therapeutic procedure,TREATS,Patients,32585295,10.1016/j.clim.2020.108517,2020-06-26
ruxolitinib,TREATS,Patients,32585295,10.1016/j.clim.2020.108517,2020-06-26
Male population group,ISA,Adult,32585284,10.1016/j.ijid.2020.06.064,2020-06-26
Plasma Exchange,TREATS,Patients,32585284,10.1016/j.ijid.2020.06.064,2020-06-26
cisplatin/etoposide/paclitaxel,TREATS,Male population group,32585284,10.1016/j.ijid.2020.06.064,2020-06-26
cisplatin/etoposide/paclitaxel,TREATS,Pregnant Women,32585284,10.1016/j.ijid.2020.06.064,2020-06-26
cisplatin/etoposide/paclitaxel,TREATS,Patients,32585284,10.1016/j.ijid.2020.06.064,2020-06-26
Atrial Fibrillation,PREDISPOSES,Cardiac Arrhythmia,32585191,10.1016/j.hrthm.2020.06.016,2020-06-26
Bradyarrhythmia (disorder),PREDISPOSES,Cardiac Arrhythmia,32585191,10.1016/j.hrthm.2020.06.016,2020-06-26
Cardiac Arrest,OCCURS_IN,Patients,32585191,10.1016/j.hrthm.2020.06.016,2020-06-26
Systemic disease,CAUSES,Cardiac Arrest,32585191,10.1016/j.hrthm.2020.06.016,2020-06-26
Hepatitis C,PROCESS_OF,Patients,32585136,10.1016/S2468-1253(20)30190-4,2020-06-26
Transplantation,TREATS,Patients,32585136,10.1016/S2468-1253(20)30190-4,2020-06-26
Transplantation,TREATS(INFER),Hepatitis C,32585136,10.1016/S2468-1253(20)30190-4,2020-06-26
Transplantation,TREATS(INFER),"Hepatitis B, Chronic",32585136,10.1016/S2468-1253(20)30190-4,2020-06-26
"Hepatitis B, Chronic",PROCESS_OF,Patients,32585136,10.1016/S2468-1253(20)30190-4,2020-06-26
Epitopes,INTERACTS_WITH,Antibodies,32585135,10.1016/j.chom.2020.06.010,2020-06-26
Assay,MEASURES,Antibodies,32585083,10.1002/cpmc.108,2020-06-26
Influenza,ISA,Pneumonia,32585069,10.1111/myc.13135,2020-06-26
Aspergillosis,COEXISTS_WITH,Pneumonia,32585069,10.1111/myc.13135,2020-06-26
Pneumonia,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
Colonization,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
Colonization,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
Aspergillosis,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
Cessation of life,ASSOCIATED_WITH,Aspergillosis,32585069,10.1111/myc.13135,2020-06-26
Mycoses,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
risk factors,PROCESS_OF,Patients,32585069,10.1111/myc.13135,2020-06-26
Screening procedure,TREATS,Mycoses,32585069,10.1111/myc.13135,2020-06-26
Chronic liver disease,PROCESS_OF,Patients,32585065,10.1111/liv.14583,2020-06-26
Patient in hospital,PROCESS_OF,Adult,32585065,10.1111/liv.14583,2020-06-26
Chronic liver disease,PROCESS_OF,Patients,32585065,10.1111/liv.14583,2020-06-26
Chronic liver disease,PROCESS_OF,Patients,32585065,10.1111/liv.14583,2020-06-26
Critical Illness,COEXISTS_WITH,Chronic liver disease,32585065,10.1111/liv.14583,2020-06-26
Chronic liver disease,PROCESS_OF,hospitalized patients,32585065,10.1111/liv.14583,2020-06-26
Child,LOCATION_OF,IMPACT gene,32585040,10.1111/apa.15450,2020-06-26
Household composition,PROCESS_OF,Child,32585040,10.1111/apa.15450,2020-06-26
Cardiovascular Surgical Procedures,USES,huperzine B,32584978,10.1093/ejcts/ezaa204,2020-06-26
Asymptomatic,PROCESS_OF,Child,32584975,10.1093/cid/ciaa794,2020-06-26
Patients,LOCATION_OF,saliva,32584972,10.1093/cid/ciaa848,2020-06-26
Nasal Swab (procedure),DIAGNOSES,Hypersensitivity,32584972,10.1093/cid/ciaa848,2020-06-26
Social care,TREATS,Older people,32584954,10.1093/ageing/afaa149,2020-06-26
Hostility,ISA,Anger,32584897,10.1371/journal.pone.0235305,2020-06-26
Asymptomatic,PROCESS_OF,Health Personnel,32584894,10.1371/journal.pone.0235417,2020-06-26
Hospital admission,TREATS,Patients,32584868,10.1371/journal.pone.0235107,2020-06-26
emotional dependency,PROCESS_OF,Patients,32584868,10.1371/journal.pone.0235107,2020-06-26
emotional dependency,PROCESS_OF,Patients,32584868,10.1371/journal.pone.0235107,2020-06-26
medicare/medicaid,LOCATION_OF,Services,32584802,10.15585/mmwr.mm6925e2,2020-06-26
Human poliovirus,CAUSES,"Poliomyelitis, paralytic",32584798,10.15585/mmwr.mm6925a4,2020-06-26
Disease,PROCESS_OF,hospitalized patients,32584797,10.15585/mmwr.mm6925e1,2020-06-26
Diabetes Mellitus,PROCESS_OF,Black race,32584797,10.15585/mmwr.mm6925e1,2020-06-26
Cessation of life,COEXISTS_WITH,Pregnancy,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Laboratory Infection,PROCESS_OF,Woman,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Cardiovascular Diseases,PROCESS_OF,Pregnant Women,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Diabetes Mellitus,PROCESS_OF,Pregnant Women,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Chronic lung disease,PROCESS_OF,Pregnant Women,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Mechanical ventilation,ADMINISTERED_TO,Pregnant Women,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Cessation of life,PROCESS_OF,Pregnant Women,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Cessation of life,PROCESS_OF,Woman,32584795,10.15585/mmwr.mm6925a1,2020-06-26
Challenge,TREATS,Health Personnel,32584782,10.1136/rmdopen-2020-001314,2020-06-26
Challenge,TREATS,Patients,32584782,10.1136/rmdopen-2020-001314,2020-06-26
Chronic disease,PROCESS_OF,Patients,32584782,10.1136/rmdopen-2020-001314,2020-06-26
Robotics,ISA,Artificial Intelligence,32584780,10.2196/19104,2020-06-26
Macrophage Activation Syndrome,COEXISTS_WITH,Coronavirus Infections,32584779,10.2196/19982,2020-06-26
Macrophage Activation Syndrome,PROCESS_OF,"Students, Medical",32584779,10.2196/19982,2020-06-26
Macrophage Activation Syndrome,COEXISTS_WITH,Anxiety,32584779,10.2196/19982,2020-06-26
Ventilator - respiratory equipment,TREATS,Patients,32584770,10.1109/MPULS.2020.2995436,2020-06-26
Coronavirus Infections,ISA,Disease,32584605,10.1377/hlthaff.2020.00794,2020-06-26
Coronavirus Infections,ISA,Disease,32584605,10.1377/hlthaff.2020.00794,2020-06-26
Coronavirus Infections,ISA,Disease,32584605,10.1377/hlthaff.2020.00794,2020-06-26
Coronavirus Infections,ISA,Disease,32584605,10.1377/hlthaff.2020.00794,2020-06-26
Coronavirus Infections,ISA,Disease,32584605,10.1377/hlthaff.2020.00794,2020-06-26
Parenchyma,LOCATION_OF,Congenital anomaly of lung,32584604,10.1259/bjr.20200515,2020-06-26
Plasma,LOCATION_OF,Interleukin-1,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Plasma,LOCATION_OF,Interleukin-6,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Plasma,LOCATION_OF,Interleukin-8,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Plasma,LOCATION_OF,Interleukin-10,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Plasma,LOCATION_OF,TNFRSF1A gene,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Community acquired pneumonia,PROCESS_OF,Persons,32584597,10.1164/rccm.202005-1583OC,2020-06-26
TNFRSF1A gene,PART_OF,soluble,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Healthy Volunteers,LOCATION_OF,Plasma,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Acute-Phase Reaction,PROCESS_OF,Patients,32584597,10.1164/rccm.202005-1583OC,2020-06-26
TNFRSF1A gene,PART_OF,soluble,32584597,10.1164/rccm.202005-1583OC,2020-06-26
TNFRSF1A gene,PART_OF,soluble,32584597,10.1164/rccm.202005-1583OC,2020-06-26
PKM gene,PART_OF,Cytoplasmic matrix,32584597,10.1164/rccm.202005-1583OC,2020-06-26
negative regulation of inflammatory response,PROCESS_OF,Patients,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Pneumonia,CAUSES,Single organ dysfunction,32584597,10.1164/rccm.202005-1583OC,2020-06-26
SERPINA1 wt Allele,COEXISTS_WITH,Interleukin-6,32584597,10.1164/rccm.202005-1583OC,2020-06-26
Coronavirus Infections,ISA,Disease,32584487,10.1002/jmv.26224,2020-06-26
Disease,PROCESS_OF,Child,32584487,10.1002/jmv.26224,2020-06-26
Coronavirus Infections,ISA,Disease,32584487,10.1002/jmv.26224,2020-06-26
Coronavirus Infections,PROCESS_OF(SPEC),Child,32584487,10.1002/jmv.26224,2020-06-26
Coronavirus Infections,ISA,Disease,32584487,10.1002/jmv.26224,2020-06-26
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,COEXISTS_WITH,Disease,32584487,10.1002/jmv.26224,2020-06-26
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,COEXISTS_WITH(SPEC),Coronavirus Infections,32584487,10.1002/jmv.26224,2020-06-26
Disease,PROCESS_OF,African American,32584487,10.1002/jmv.26224,2020-06-26
Disease,PROCESS_OF,Latinos,32584487,10.1002/jmv.26224,2020-06-26
Social Distance,ISA,Behavior,32584480,10.1111/bjso.12403,2020-06-26
Vaccines,TREATS,Disease,32584474,10.1002/rmv.2119,2020-06-26
"ACE2 protein, human",INHIBITS,angiotensin converting enzyme 2,32584474,10.1002/rmv.2119,2020-06-26
Ergocalciferol,INHIBITS(SPEC),Renin,32584474,10.1002/rmv.2119,2020-06-26
Ergocalciferol,ISA,Vitamins,32584474,10.1002/rmv.2119,2020-06-26
Vitamins,INHIBITS,Renin,32584474,10.1002/rmv.2119,2020-06-26
Ergocalciferol,INHIBITS,angiotensin converting enzyme 2,32584474,10.1002/rmv.2119,2020-06-26
Ergocalciferol,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32584474,10.1002/rmv.2119,2020-06-26
Challenge,USES,Diagnosis,32584464,10.1002/14651858.CD013652,2020-06-26
Person present,PROCESS_OF,Community,32584464,10.1002/14651858.CD013652,2020-06-26
Iterations,PROCESS_OF,Persons,32584464,10.1002/14651858.CD013652,2020-06-26
Severe Acute Respiratory Syndrome,NEG_PROCESS_OF,Persons,32584464,10.1002/14651858.CD013652,2020-06-26
Assay,USES,Antibodies,32584464,10.1002/14651858.CD013652,2020-06-26
Asymptomatic,PROCESS_OF,Participant,32584464,10.1002/14651858.CD013652,2020-06-26
,INTERACTS_WITH,"Immunoglobulin A, Human",32584464,10.1002/14651858.CD013652,2020-06-26
Total immunoglobulin measurement,DIAGNOSES,Hypersensitivity,32584464,10.1002/14651858.CD013652,2020-06-26
"Signs and Symptoms, Respiratory",PROCESS_OF,Health Personnel,32584464,10.1002/14651858.CD013652,2020-06-26
Possible,PROCESS_OF,Health Personnel,32584464,10.1002/14651858.CD013652,2020-06-26
Possible,PROCESS_OF,Persons,32584464,10.1002/14651858.CD013652,2020-06-26
Too low,PROCESS_OF,Persons,32584464,10.1002/14651858.CD013652,2020-06-26
Antibody studies (procedure),DIAGNOSES,Severe Acute Respiratory Syndrome,32584464,10.1002/14651858.CD013652,2020-06-26
Hypersensitivity,PROCESS_OF,Patients,32584464,10.1002/14651858.CD013652,2020-06-26
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32584447,10.1002/hed.26318,2020-06-26
Practitioner,TREATS,Patients,32584447,10.1002/hed.26318,2020-06-26
Coronavirus Infections,ISA,Disease,32584441,10.1111/all.14462,2020-06-26
Immune System Diseases,COEXISTS_WITH,Severe disorder,32584441,10.1111/all.14462,2020-06-26
Organ,LOCATION_OF,Severe disorder,32584441,10.1111/all.14462,2020-06-26
Immune response,PROCESS_OF,Homo sapiens,32584441,10.1111/all.14462,2020-06-26
Practice Experience,PROCESS_OF,general population,32584437,10.1111/bjso.12399,2020-06-26
Lung,LOCATION_OF,Thrombosis,32584423,10.1111/bjh.16968,2020-06-26
Organ,LOCATION_OF,Thrombosis,32584423,10.1111/bjh.16968,2020-06-26
Structure of small blood vessel (organ),LOCATION_OF,Thrombosis,32584423,10.1111/bjh.16968,2020-06-26
Pulmonary Embolism,OCCURS_IN,Patients,32584423,10.1111/bjh.16968,2020-06-26
Venous Thromboembolism,COEXISTS_WITH,patient condition,32584423,10.1111/bjh.16968,2020-06-26
tocilizumab,ISA,Interleukin inhibitors,32584421,10.1111/bjh.16966,2020-06-26
ruxolitinib,TREATS,Secondary Hemophagocytic Lymphohistiocytosis,32584421,10.1111/bjh.16966,2020-06-26
Patients,LOCATION_OF,Proteins,32584420,10.1002/eji.202048715,2020-06-26
Antigens,PART_OF,Patients,32584420,10.1002/eji.202048715,2020-06-26
Protein Fragment,PART_OF,Patients,32584420,10.1002/eji.202048715,2020-06-26
High sensitivity,USES,Assay,32584420,10.1002/eji.202048715,2020-06-26
Assay,METHOD_OF,Enzyme-Linked Immunosorbent Assay,32584420,10.1002/eji.202048715,2020-06-26
Interleukin-6,AFFECTS,Storm Syndrome,32584416,10.1111/bjh.16961,2020-06-26
Storm Syndrome,PROCESS_OF,Patients,32584416,10.1111/bjh.16961,2020-06-26
Chimeric Antigen Receptor T-Cell Therapy,USES,tocilizumab,32584416,10.1111/bjh.16961,2020-06-26
"Hospitals, University",LOCATION_OF,case series,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Ischemia,PROCESS_OF,Valencia,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Physical findings,PROCESS_OF,Child,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Physical findings,PROCESS_OF,Adolescent (age group),32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Inflammatory lesion,PROCESS_OF,Child,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Inflammatory lesion,PROCESS_OF,Patients,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Inflammatory lesion,PROCESS_OF,Adolescent (age group),32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Biopsy of skin procedure,DIAGNOSES,Non-Ossifying Fibroma,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Biopsy,ADMINISTERED_TO,Patients,32584397,10.1001/jamadermatol.2020.2340,2020-06-26
Department,LOCATION_OF,case series,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Chilblains,PROCESS_OF,Patients,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Skin biopsy sample,LOCATION_OF,Nasal Swab (procedure),32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Patients,LOCATION_OF,Blood specimen,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Physical Examination,ADMINISTERED_TO,Patients,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Vasculitis,PROCESS_OF,Patients,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Structure of small blood vessel (organ),LOCATION_OF,Vasculitis,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Biopsy sample,LOCATION_OF,Nasal Swab (procedure),32584377,10.1001/jamadermatol.2020.2368,2020-06-26
CD40LG wt Allele,NEG_PART_OF,Patients,32584377,10.1001/jamadermatol.2020.2368,2020-06-26
Critical Illness,PROCESS_OF,Woman,32584330,10.24875/RIC.20000207,2020-06-26
Pneumonia,PROCESS_OF,Patients,32584330,10.24875/RIC.20000207,2020-06-26
Comorbidity,PROCESS_OF,Patients,32584330,10.24875/RIC.20000207,2020-06-26
Comorbidity,PROCESS_OF,Patients,32584330,10.24875/RIC.20000207,2020-06-26
Pneumonia,PROCESS_OF,Patients,32584330,10.24875/RIC.20000207,2020-06-26
Tertiary Care Centers,LOCATION_OF,Study,32584326,10.24875/RIC.20000211,2020-06-26
Diabetes,PROCESS_OF,Patients,32584326,10.24875/RIC.20000211,2020-06-26
Patients,LOCATION_OF,Plasma,32584322,10.24875/RIC.20000237,2020-06-26
Patients,LOCATION_OF,Plasma,32584322,10.24875/RIC.20000237,2020-06-26
Therapeutic procedure,ADMINISTERED_TO,Patients,32584322,10.24875/RIC.20000237,2020-06-26
Care of intensive care unit patient,ISA,Evaluation,32584321,10.24875/RIC.20000131,2020-06-26
Disease,PROCESS_OF,Elderly (population group),32584321,10.24875/RIC.20000131,2020-06-26
Geriatric Assessment,ADMINISTERED_TO,Elderly (population group),32584321,10.24875/RIC.20000131,2020-06-26
Geriatricians,ISA,Physicians,32584321,10.24875/RIC.20000131,2020-06-26
Societies,LOCATION_OF,Pulmonary function tests,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,ISA,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,ISA,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Laboratory Procedures,ISA,Evaluation procedure,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Disease,PROCESS_OF,Patients,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Pulmonary function tests,NEG_DIAGNOSES,Confirmation,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,ISA,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,ISA,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Triage,TREATS,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Triage,TREATS(SPEC),Coronavirus Infections,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Coronavirus Infections,ISA,Disease,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Spirometry,ISA,Pulmonary function tests,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Masks,USES,Mechanical Ventilator,32584237,10.5152/TurkThoracJ.2020.20107,2020-06-26
Smoker,ISA,Disease,32584236,10.5152/TurkThoracJ.2020.20052,2020-06-26
Comorbidity,PROCESS_OF,Patients,32584236,10.5152/TurkThoracJ.2020.20052,2020-06-26
Coughing,ISA,Symptoms,32584236,10.5152/TurkThoracJ.2020.20052,2020-06-26
Fever,ISA,Symptoms,32584236,10.5152/TurkThoracJ.2020.20052,2020-06-26
Human coronavirus 229E,CAUSES,Upper Respiratory Infections,32584199,10.1080/20469047.2020.1781356,2020-06-26
Cessation of life,PROCESS_OF,Elderly (population group),32584199,10.1080/20469047.2020.1781356,2020-06-26
Cessation of life,PROCESS_OF,Child,32584199,10.1080/20469047.2020.1781356,2020-06-26
Symptoms,PROCESS_OF,Child,32584199,10.1080/20469047.2020.1781356,2020-06-26
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,CAUSES,Critical Illness,32584199,10.1080/20469047.2020.1781356,2020-06-26
tomography,DIAGNOSES,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32584199,10.1080/20469047.2020.1781356,2020-06-26
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Child,32584199,10.1080/20469047.2020.1781356,2020-06-26
Plain chest X-ray,DIAGNOSES,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32584166,10.1148/radiol.2020202543,2020-06-26
Family,ISA,Population Group,32584112,10.1037/tra0000611,2020-06-26
Mental disorders,PROCESS_OF,Nurses,32584109,10.1037/tra0000810,2020-06-26
Crisis,PROCESS_OF,Health Personnel,32584107,10.1037/tra0000819,2020-06-26
Patients,ISA,Persons,32584106,10.1037/tra0000884,2020-06-26
Dementia,PROCESS_OF,Persons,32584105,10.1037/tra0000793,2020-06-26
Dementia,PROCESS_OF,Caregiver,32584105,10.1037/tra0000793,2020-06-26
Challenge,TREATS,Persons,32584105,10.1037/tra0000793,2020-06-26
Challenge,TREATS,Caregiver,32584105,10.1037/tra0000793,2020-06-26
Safety Issues,COEXISTS_WITH,Violence,32584105,10.1037/tra0000793,2020-06-26
Pandemics,ISA,Disease Outbreaks,32584103,10.1037/tra0000790,2020-06-26
psychological care,TREATS,Vulnerable Populations,32584101,10.1037/tra0000761,2020-06-26
Persons,LOCATION_OF,Whole Care,32584101,10.1037/tra0000761,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
psychology education,ISA,Health Services,32584062,10.1037/amp0000673,2020-06-26
Assay,USES,"Antibodies, Blocking",32583852,10.1093/ajcp/aqaa112,2020-06-26
"Immunoglobulin A, Human",PREDISPOSES,Hypersensitivity,32583852,10.1093/ajcp/aqaa112,2020-06-26
Blood donor,LOCATION_OF,Antibodies,32583766,10.2807/1560-7917.ES.2020.25.24.2001031,2020-06-26
Virus,CAUSES,Disease,32583729,10.1080/07391102.2020.1780944,2020-06-26
Virus,CAUSES(SPEC),Coronavirus Infections,32583729,10.1080/07391102.2020.1780944,2020-06-26
Coronavirus Infections,ISA,Disease,32583729,10.1080/07391102.2020.1780944,2020-06-26
Coronavirus Infections,CAUSES,Communicable Diseases,32583710,10.1177/0020764020934519,2020-06-26
higher education institution,LOCATION_OF,Study,32583710,10.1177/0020764020934519,2020-06-26
Physicians - Internal Medicine - Medical Oncology,TREATS,Cancer Patient,32583680,10.2217/fon-2020-0450,2020-06-26
Airway structure,LOCATION_OF,GSKIP gene,32583671,10.1177/0003489420935500,2020-06-26
Experience,PROCESS_OF,Patients,32583620,10.1111/tid.13382,2020-06-26
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",PROCESS_OF,Patients,32583620,10.1111/tid.13382,2020-06-26
Endomyocardium,LOCATION_OF,Biopsy,32583620,10.1111/tid.13382,2020-06-26
Severe course,PROCESS_OF,Persons,32583537,10.1111/obr.13083,2020-06-26
Exercise,TREATS,Obesity,32583537,10.1111/obr.13083,2020-06-26
Attitude,PROCESS_OF,Woman,32583536,10.1111/1471-0528.16381,2020-06-26
Anxiety,PROCESS_OF,prenatal,32583536,10.1111/1471-0528.16381,2020-06-26
Gravidity,PROCESS_OF,Mother (person),32583536,10.1111/1471-0528.16381,2020-06-26
Possible,PREDISPOSES,Impending shock,32583525,10.1111/hepr.13541,2020-06-26
Impending shock,COEXISTS_WITH,Infection,32583525,10.1111/hepr.13541,2020-06-26
Vaccines,CAUSES,Influenza,32583522,10.1111/1753-6405.13004,2020-06-26
Disease,PROCESS_OF,Persons,32583522,10.1111/1753-6405.13004,2020-06-26
Influenza,ISA,Disease,32583522,10.1111/1753-6405.13004,2020-06-26
Influenza,PROCESS_OF(SPEC),Persons,32583522,10.1111/1753-6405.13004,2020-06-26
Blood Donation,TREATS,patient condition,32583506,10.1111/trf.15947,2020-06-26
Blood Transfusion,TREATS,patient condition,32583506,10.1111/trf.15947,2020-06-26
Prophylactic treatment,TREATS,Patients,32583378,10.1055/a-1193-9315,2020-06-26
Hospitals,LOCATION_OF,Study,32583371,10.1007/s11255-020-02553-4,2020-06-26
Non-Ossifying Fibroma,AFFECTS,Patients,32583371,10.1007/s11255-020-02553-4,2020-06-26
Non-Ossifying Fibroma,AFFECTS,Staff,32583371,10.1007/s11255-020-02553-4,2020-06-26
Operative Surgical Procedures,ISA,Interventional procedure,32583371,10.1007/s11255-020-02553-4,2020-06-26
Outpatient procedure,ISA,Interventional procedure,32583371,10.1007/s11255-020-02553-4,2020-06-26
Postoperative Complications,NEG_PROCESS_OF,Patients,32583371,10.1007/s11255-020-02553-4,2020-06-26
GSKIP gene,NEG_DISRUPTS,Present,32583371,10.1007/s11255-020-02553-4,2020-06-26
Coronavirus Infections,ISA,Disease,32583360,10.1007/s10900-020-00866-0,2020-06-26
Coronavirus Infections,PROCESS_OF,general population,32583360,10.1007/s10900-020-00866-0,2020-06-26
Sumatra,ISA,Geographic Locations,32583360,10.1007/s10900-020-00866-0,2020-06-26
Coronavirus Infections,ISA,Disease,32583360,10.1007/s10900-020-00866-0,2020-06-26
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,general population,32583360,10.1007/s10900-020-00866-0,2020-06-26
Coronavirus Infections,ISA,Disease,32583360,10.1007/s10900-020-00866-0,2020-06-26
Negative attitude,PROCESS_OF,Respondents,32583360,10.1007/s10900-020-00866-0,2020-06-26
Coronavirus Infections,ISA,Disease,32583360,10.1007/s10900-020-00866-0,2020-06-26
Critical Illness,PROCESS_OF,Patients,32583216,10.1007/s13304-020-00832-4,2020-06-26
Activities of Daily Living (activity),TREATS,Crisis,32583216,10.1007/s13304-020-00832-4,2020-06-26
Anosmia,ISA,Symptoms,32583183,10.1007/s00405-020-06131-3,2020-06-26
Laboratory Procedures,MEASURES,Esthesia,32583183,10.1007/s00405-020-06131-3,2020-06-26
Esthesia,PROCESS_OF,Patients,32583183,10.1007/s00405-020-06131-3,2020-06-26
Severe Acute Respiratory Syndrome,PROCESS_OF,Participant,32583183,10.1007/s00405-020-06131-3,2020-06-26
Coughing,PROCESS_OF,Patients,32583169,10.1007/s10072-020-04521-3,2020-06-26
Dyspnea,PROCESS_OF,Patients,32583169,10.1007/s10072-020-04521-3,2020-06-26
Fever,PROCESS_OF,Patients,32583169,10.1007/s10072-020-04521-3,2020-06-26
Myalgia,PROCESS_OF,Patients,32583169,10.1007/s10072-020-04521-3,2020-06-26
Neurologic Symptoms,PROCESS_OF,Patients,32583169,10.1007/s10072-020-04521-3,2020-06-26
Tertiary Care Centers,LOCATION_OF,Diagnosis,32583169,10.1007/s10072-020-04521-3,2020-06-26
Coughing,ISA,Symptoms,32583169,10.1007/s10072-020-04521-3,2020-06-26
Dyspnea,ISA,Symptoms,32583169,10.1007/s10072-020-04521-3,2020-06-26
Myalgia,ISA,Symptoms,32583169,10.1007/s10072-020-04521-3,2020-06-26
Anoxia,CAUSES,endothelial dysfunction,32583086,10.1007/s00277-020-04138-8,2020-06-26
Inflammation,CAUSES,endothelial dysfunction,32583086,10.1007/s00277-020-04138-8,2020-06-26
imatinib,ISA,Pharmaceutical Preparations,32583086,10.1007/s00277-020-04138-8,2020-06-26
eculizumab,ISA,Pharmaceutical Preparations,32583086,10.1007/s00277-020-04138-8,2020-06-26
Cardiovascular Diseases,PREDISPOSES,Severe (severity modifier),32583078,10.1007/s00592-020-01546-0,2020-06-26
Cerebrovascular Disorders,PREDISPOSES,Severe (severity modifier),32583078,10.1007/s00592-020-01546-0,2020-06-26
Diabetes,PREDISPOSES,Severe (severity modifier),32583078,10.1007/s00592-020-01546-0,2020-06-26
Hypertensive disease,ISA,Complication,32583078,10.1007/s00592-020-01546-0,2020-06-26
Hypertensive disease,PREDISPOSES,Severe (severity modifier),32583078,10.1007/s00592-020-01546-0,2020-06-26
Chronic Obstructive Airway Disease,PREDISPOSES,Severe (severity modifier),32583078,10.1007/s00592-020-01546-0,2020-06-26
Diabetes,PROCESS_OF,Patients,32583078,10.1007/s00592-020-01546-0,2020-06-26
Muscle,LOCATION_OF,skeletal injury,32583053,10.1007/s00415-020-10001-7,2020-06-26
Posterior reversible encephalopathy syndrome,PROCESS_OF,Woman,32583053,10.1007/s00415-020-10001-7,2020-06-26
Body tissue,LOCATION_OF,angiotensin converting enzyme 2,32583042,10.1007/s00347-020-01160-z,2020-06-26
Body tissue,LOCATION_OF,TMPRSS2 gene,32583042,10.1007/s00347-020-01160-z,2020-06-26
Disease,PROCESS_OF,Patients,32582946,10.1093/ecco-jcc/jjaa127,2020-06-26
Health Care,TREATS,Patients,32582946,10.1093/ecco-jcc/jjaa127,2020-06-26
Health Care,TREATS(INFER),Disease,32582946,10.1093/ecco-jcc/jjaa127,2020-06-26
Patients,LOCATION_OF,Intercellular adhesion molecule 1,32582936,10.1093/infdis/jiaa349,2020-06-26
Challenge:Type:Point in time:^Patient:Nominal,PREDISPOSES,Tumor Progression,32582818,10.14338/IJPT-20-00022.1,2020-06-26
envelope,PART_OF,Rubella virus,32582766,10.3389/fmolb.2020.00120,2020-06-26
Epitopes,ISA,Antigens,32582766,10.3389/fmolb.2020.00120,2020-06-26
Computational analysis,DIAGNOSES,Measles,32582766,10.3389/fmolb.2020.00120,2020-06-26
Computational analysis,DIAGNOSES,Rubella,32582766,10.3389/fmolb.2020.00120,2020-06-26
Protection,PROCESS_OF,Child,32582766,10.3389/fmolb.2020.00120,2020-06-26
Alarm device,TREATS,World,32582747,10.3389/fmed.2020.00310,2020-06-26
Droplet Transmission,ISA,Contact Transmission,32582747,10.3389/fmed.2020.00310,2020-06-26
Hemoglobinopathies,PROCESS_OF,Patients,32582745,10.3389/fmed.2020.00306,2020-06-26
Thalassemia,ISA,Complication,32582745,10.3389/fmed.2020.00306,2020-06-26
Bacterial Infections,COMPLICATES,Disease,32582745,10.3389/fmed.2020.00306,2020-06-26
Transplantation,TREATS,Enthesitis-Related Arthritis,32582741,10.3389/fmed.2020.00287,2020-06-26
Quarantine,ISA,Isolation procedure,32582718,10.3389/fcell.2020.00468,2020-06-26
DNA Sequence,PART_OF,Virus,32582718,10.3389/fcell.2020.00468,2020-06-26
Assay,USES,Serum Neutralization,32582718,10.3389/fcell.2020.00468,2020-06-26
Severe Acute Respiratory Syndrome,PROCESS_OF,Community,32582620,10.3389/fpubh.2020.00286,2020-06-26
Disease,PROCESS_OF,Persons,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32582617,10.3389/fpubh.2020.00267,2020-06-26
Asymptomatic,PROCESS_OF,Persons,32582617,10.3389/fpubh.2020.00267,2020-06-26
Asymptomatic,PROCESS_OF,Patients,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582617,10.3389/fpubh.2020.00267,2020-06-26
Symptoms,PROCESS_OF,Patients,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582617,10.3389/fpubh.2020.00267,2020-06-26
Symptoms,PROCESS_OF,Patients,32582617,10.3389/fpubh.2020.00267,2020-06-26
Asymptomatic,PROCESS_OF,Persons,32582617,10.3389/fpubh.2020.00267,2020-06-26
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32582617,10.3389/fpubh.2020.00267,2020-06-26
Coronavirus Infections,ISA,Disease,32582614,10.3389/fpubh.2020.00259,2020-06-26
Disease,AFFECTS,human group,32582598,10.3389/fped.2020.00341,2020-06-26
Serum,LOCATION_OF,Antibodies,32582598,10.3389/fped.2020.00341,2020-06-26
Specimen Type - Stool = Fecal,LOCATION_OF,Antibodies,32582598,10.3389/fped.2020.00341,2020-06-26
Serum,LOCATION_OF,Nucleic Acids,32582598,10.3389/fped.2020.00341,2020-06-26
Specimen Type - Stool = Fecal,LOCATION_OF,Nucleic Acids,32582598,10.3389/fped.2020.00341,2020-06-26
Androgens,AFFECTS(SPEC),Body tissue,32582576,10.3389/fcimb.2020.00327,2020-06-26
Androgens,ISA,Gonadal Steroid Hormones,32582576,10.3389/fcimb.2020.00327,2020-06-26
Estrogens,AFFECTS(SPEC),Body tissue,32582576,10.3389/fcimb.2020.00327,2020-06-26
Estrogens,ISA,Gonadal Steroid Hormones,32582576,10.3389/fcimb.2020.00327,2020-06-26
Gonadal Steroid Hormones,AFFECTS,Body tissue,32582576,10.3389/fcimb.2020.00327,2020-06-26
Lung,LOCATION_OF,ACE2 gene,32582576,10.3389/fcimb.2020.00327,2020-06-26
ACE2 gene,ASSOCIATED_WITH,Disease,32582576,10.3389/fcimb.2020.00327,2020-06-26
Supportive care,TREATS,Patients,32582576,10.3389/fcimb.2020.00327,2020-06-26
ACE2 gene,INTERACTS_WITH,Gonadal Steroid Hormones,32582576,10.3389/fcimb.2020.00327,2020-06-26
ACE2 gene,STIMULATES,"ORF74 protein, Human herpesvirus 8",32582574,10.3389/fcimb.2020.00317,2020-06-26
ACE2 gene,INTERACTS_WITH,proto-oncogene proteins c-mas-1,32582574,10.3389/fcimb.2020.00317,2020-06-26
ACE2 gene,INTERACTS_WITH,Alveolar Epithelial Cells,32582574,10.3389/fcimb.2020.00317,2020-06-26
"Kidney Failure, Acute",PROCESS_OF,Patients,32582489,10.7759/cureus.8228,2020-06-26
Laboratory Procedures,DIAGNOSES,Hypoxic Brain Damage,32582489,10.7759/cureus.8228,2020-06-26
Laboratory Procedures,USES,Buccal smear procedure,32582489,10.7759/cureus.8228,2020-06-26
Lethargy,PROCESS_OF,Patients,32582489,10.7759/cureus.8228,2020-06-26
Finding of creatinine level,PROCESS_OF,Patients,32582489,10.7759/cureus.8228,2020-06-26
Buccal smear procedure,DIAGNOSES(SPEC),Hypoxic Brain Damage,32582489,10.7759/cureus.8228,2020-06-26
Buccal smear procedure,ISA,Laboratory Procedures,32582489,10.7759/cureus.8228,2020-06-26
Single organ dysfunction,PROCESS_OF,Patients,32582489,10.7759/cureus.8228,2020-06-26
Storm NOS,CAUSES,Multiple Organ Failure,32582401,10.1186/s41232-020-00121-y,2020-06-26
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32582401,10.1186/s41232-020-00121-y,2020-06-26
Mesenchymal Stem Cells,INTERACTS_WITH,Immune Cell,32582401,10.1186/s41232-020-00121-y,2020-06-26
Influenza,CAUSES,"Respiratory Distress Syndrome, Adult",32582401,10.1186/s41232-020-00121-y,2020-06-26
Ambulatory Care Facilities,LOCATION_OF,Study,32582381,10.1302/1863-2548.14.200099,2020-06-26
Cigarette smoke (substance),CAUSES,Malignant Neoplasms,32582377,10.3332/ecancer.2020.ed102,2020-06-26
Smoking,PROCESS_OF,Mentally Ill Persons,32582377,10.3332/ecancer.2020.ed102,2020-06-26
Smoking,PROCESS_OF,Persons,32582377,10.3332/ecancer.2020.ed102,2020-06-26
Smoking cessation assistance,PREVENTS,Malignant Neoplasms,32582377,10.3332/ecancer.2020.ed102,2020-06-26
Malignant Neoplasms,PROCESS_OF,Patients,32582375,10.3332/ecancer.2020.1060,2020-06-26
Cessation of life,PROCESS_OF,Woman,32582375,10.3332/ecancer.2020.1060,2020-06-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32582374,10.3332/ecancer.2020.1059,2020-06-26
Chronic disease,PROCESS_OF,Patients,32582372,10.3332/ecancer.2020.1057,2020-06-26
Coronavirus Infections,ISA,Disease,32582333,10.12669/pjms.36.COVID19-S4.2751,2020-06-26
Equilibrium,COEXISTS_WITH,Waking,32582333,10.12669/pjms.36.COVID19-S4.2751,2020-06-26
Health Personnel,LOCATION_OF,IMPACT gene,32582331,10.12669/pjms.36.COVID19-S4.2698,2020-06-26
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32582330,10.12669/pjms.36.COVID19-S4.2651,2020-06-26
Liver diseases,AFFECTS,Patients,32582330,10.12669/pjms.36.COVID19-S4.2651,2020-06-26
Immune system,AFFECTS,Dietary intake,32582329,10.12669/pjms.36.COVID19-S4.2776,2020-06-26
Challenge,TREATS,Health Personnel,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Dermatologic disorders,AFFECTS,Health Personnel,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Contact Dermatitis,COMPLICATES,Acne Vulgaris,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Contact Dermatitis,COMPLICATES,Seborrheic dermatitis,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Contact Dermatitis,COMPLICATES,Dermatologic disorders,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Erythema,ISA,Dermatologic disorders,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Advice,PREVENTS,Dermatologic disorders,32582327,10.12669/pjms.36.COVID19-S4.2748,2020-06-26
Infected,PROCESS_OF,Persons,32582326,10.12669/pjms.36.COVID19-S4.2519,2020-06-26
Educational process of instructing,ISA,Evaluation procedure,32582325,10.12669/pjms.36.COVID19-S4.2795,2020-06-26
Tobacco smoking behavior,PROCESS_OF,Community,32582324,10.12669/pjms.36.COVID19-S4.2739,2020-06-26
Infected,PROCESS_OF,Population Group,32582323,10.12669/pjms.36.COVID19-S4.2790,2020-06-26
Severe (severity modifier),PROCESS_OF,Health Personnel,32582323,10.12669/pjms.36.COVID19-S4.2790,2020-06-26
Pakistan,ISA,Country,32582322,10.12669/pjms.36.COVID19-S4.2792,2020-06-26
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32582320,10.12669/pjms.36.COVID19-S4.2784,2020-06-26
Author,ISA,Population Group,32582320,10.12669/pjms.36.COVID19-S4.2784,2020-06-26
Coronavirus Infections,ISA,Disease,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Severe Acute Respiratory Syndrome,PRECEDES,Disease,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Severe Acute Respiratory Syndrome,PRECEDES(SPEC),Coronavirus Infections,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Middle East Respiratory Syndrome,PROCESS_OF,human group,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Virus,PROCESS_OF,Chiroptera,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Coughing,PROCESS_OF,Persons,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Sneezing,PROCESS_OF,Persons,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Infected,PROCESS_OF,Persons,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32582319,10.12669/pjms.36.COVID19-S4.2660,2020-06-26
Stress,PROCESS_OF,parent,32582317,10.12669/pjms.36.COVID19-S4.2759,2020-06-26
Distress,PROCESS_OF,Human Age Group,32582317,10.12669/pjms.36.COVID19-S4.2759,2020-06-26
Self-control as a personality trait,PROCESS_OF,Health Personnel,32582316,10.12669/pjms.36.COVID19-S4.2662,2020-06-26
Uncertainty,PROCESS_OF,professional occupation status,32582316,10.12669/pjms.36.COVID19-S4.2662,2020-06-26
Self-control as a personality trait,PROCESS_OF,professional occupation status,32582316,10.12669/pjms.36.COVID19-S4.2662,2020-06-26
Diamond-Blackfan Anemia 1,PROCESS_OF,student,32582315,10.12669/pjms.36.COVID19-S4.2766,2020-06-26
Perception,PROCESS_OF,student,32582315,10.12669/pjms.36.COVID19-S4.2766,2020-06-26
student,USES,Medical Devices,32582315,10.12669/pjms.36.COVID19-S4.2766,2020-06-26
Hospitals,LOCATION_OF,Cross-Sectional Studies,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Clinic,LOCATION_OF,Cross-Sectional Studies,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Awareness,PROCESS_OF,Health Personnel,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Influenza,ISA,Symptoms,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Universal Precautions,COEXISTS_WITH,Dental surgical procedure,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Universal Precautions,METHOD_OF,Infectious disease prevention / control,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Universal Precautions,USES,Sodium Hypochlorite,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Adequate Knowledge,PROCESS_OF,Health Personnel,32582314,10.12669/pjms.36.COVID19-S4.2704,2020-06-26
Hospitals,LOCATION_OF,Work,32582312,10.12669/pjms.36.COVID19-S4.2643,2020-06-26
Fear (Mental Process),PROCESS_OF,Physicians,32582312,10.12669/pjms.36.COVID19-S4.2643,2020-06-26
Perception,PROCESS_OF,Physicians,32582312,10.12669/pjms.36.COVID19-S4.2643,2020-06-26
Adequate Knowledge,PROCESS_OF,Participant,32582311,10.12669/pjms.36.COVID19-S4.2636,2020-06-26
Knowledge acquisition,AFFECTS,Inefficiency,32582310,10.12669/pjms.36.COVID19-S4.2785,2020-06-26
chest findings,PROCESS_OF,Patients,32582309,10.12669/pjms.36.COVID19-S4.2778,2020-06-26
Lung,LOCATION_OF,Unilateral disease,32582309,10.12669/pjms.36.COVID19-S4.2778,2020-06-26
Unilateral disease,PROCESS_OF,Patients,32582309,10.12669/pjms.36.COVID19-S4.2778,2020-06-26
pulmonary involvement,PROCESS_OF,Patients,32582309,10.12669/pjms.36.COVID19-S4.2778,2020-06-26
Symptoms,COEXISTS_WITH,Physical and emotional exhaustion state,32582308,10.12669/pjms.36.COVID19-S4.2753,2020-06-26
Symptoms,PROCESS_OF,Health Personnel,32582308,10.12669/pjms.36.COVID19-S4.2753,2020-06-26
Virus Diseases,PROCESS_OF,Corona,32582307,10.12669/pjms.36.COVID19-S4.2829,2020-06-26
Symptoms,PROCESS_OF,Persons,32582307,10.12669/pjms.36.COVID19-S4.2829,2020-06-26
Health Personnel,LOCATION_OF,IMPACT gene,32582306,10.12669/pjms.36.COVID19-S4.2779,2020-06-26
Hospitals,LOCATION_OF,Work,32582306,10.12669/pjms.36.COVID19-S4.2779,2020-06-26
Influenza-like symptoms,ISA,Symptoms,32582302,10.3389/fgene.2020.00613,2020-06-26
"Angiotensin-2, Human",INTERACTS_WITH,angiotensin I (1-7),32582222,10.3389/fimmu.2020.01312,2020-06-26
Body tissue,LOCATION_OF,Adoptive Immunotherapy,32582222,10.3389/fimmu.2020.01312,2020-06-26
Dendritic Cells,INTERACTS_WITH,angiotensin converting enzyme 2,32582222,10.3389/fimmu.2020.01312,2020-06-26
macrophage,INTERACTS_WITH,angiotensin converting enzyme 2,32582222,10.3389/fimmu.2020.01312,2020-06-26
Parenchyma,LOCATION_OF,SARS coronavirus,32582222,10.3389/fimmu.2020.01312,2020-06-26
Parenchyma,PART_OF,Lung,32582222,10.3389/fimmu.2020.01312,2020-06-26
macrophage,LOCATION_OF,angiotensin converting enzyme 2,32582222,10.3389/fimmu.2020.01312,2020-06-26
Human coronavirus,CAUSES,Respiratory Tract Infections,32582200,10.3389/fimmu.2020.01120,2020-06-26
Infection,PROCESS_OF,Child,32582200,10.3389/fimmu.2020.01120,2020-06-26
Infection,PROCESS_OF,Patients,32582200,10.3389/fimmu.2020.01120,2020-06-26
Antibodies,PREVENTS,Virus,32582200,10.3389/fimmu.2020.01120,2020-06-26
Antibody-Dependent Enhancement,COEXISTS_WITH,Virus Diseases,32582200,10.3389/fimmu.2020.01120,2020-06-26
Antibody-Dependent Enhancement,CAUSES,Coronavirus Infections,32582200,10.3389/fimmu.2020.01120,2020-06-26
Gastrointestinal symptom,PROCESS_OF,Patients,32582138,10.3389/fmicb.2020.01388,2020-06-26
Intestines,LOCATION_OF,Bacteria,32582134,10.3389/fmicb.2020.01302,2020-06-26
angiotensin converting enzyme 2,INTERACTS_WITH,Antimicrobial Peptide,32582134,10.3389/fmicb.2020.01302,2020-06-26
Intestines,LOCATION_OF,Respiratory viruses,32582134,10.3389/fmicb.2020.01302,2020-06-26
Lung,LOCATION_OF,Respiratory viruses,32582134,10.3389/fmicb.2020.01302,2020-06-26
Coronavirus Infections,ISA,Disease,32581986,10.3389/fpsyg.2020.01431,2020-06-26
Empathy,PROCESS_OF,Health Personnel,32581986,10.3389/fpsyg.2020.01431,2020-06-26
Loneliness,PREDISPOSES,multiple pathologies,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Worried,PREDISPOSES,multiple pathologies,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Italians,ISA,Population Group,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Italians,ISA,Population Group,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Intervention regimes,TREATS,Population Group,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Intervention regimes,TREATS(SPEC),Italians,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Mental disorders,PROCESS_OF,user - individual,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Intervention regimes,TREATS,general population,32581895,10.3389/fpsyt.2020.00533,2020-06-26
Nerve Tissue,PART_OF,Patients,32581854,10.3389/fphys.2020.00671,2020-06-26
Medulla Oblongata,LOCATION_OF,Dysosmia,32581854,10.3389/fphys.2020.00671,2020-06-26
Tissue damage,COEXISTS_WITH,Respiratory Failure,32581854,10.3389/fphys.2020.00671,2020-06-26
Inflammation,COEXISTS_WITH,Respiratory Failure,32581854,10.3389/fphys.2020.00671,2020-06-26
Malaise,PROCESS_OF,Patients,32581816,10.3389/fphar.2020.00870,2020-06-26
Therapeutic procedure,TREATS,"Respiratory Distress Syndrome, Adult",32581816,10.3389/fphar.2020.00870,2020-06-26
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32581816,10.3389/fphar.2020.00870,2020-06-26
Malaise,PROCESS_OF,Patients,32581816,10.3389/fphar.2020.00870,2020-06-26
Virus Diseases,CAUSES,"Respiratory Distress Syndrome, Adult",32581810,10.3389/fphar.2020.00857,2020-06-26
JAK1 Inhibitor,COEXISTS_WITH,ruxolitinib,32581810,10.3389/fphar.2020.00857,2020-06-26
Lung,LOCATION_OF,Lesion,32581810,10.3389/fphar.2020.00857,2020-06-26
eculizumab,TREATS,Severe Acute Respiratory Syndrome,32581810,10.3389/fphar.2020.00857,2020-06-26
ruxolitinib,TREATS,Severe Acute Respiratory Syndrome,32581810,10.3389/fphar.2020.00857,2020-06-26
Interventional procedure,USES,Anti-Inflammatory Agents,32581809,10.3389/fphar.2020.00854,2020-06-26
adjunctive treatment,TREATS,Severe Acute Respiratory Syndrome,32581809,10.3389/fphar.2020.00854,2020-06-26
Eye,LOCATION_OF,Virus,32581799,10.3389/fphar.2020.00836,2020-06-26
Cardiovascular Diseases,PROCESS_OF,Patients,32581799,10.3389/fphar.2020.00836,2020-06-26
Prophylactic treatment,USES,RID,32581612,10.2147/RMHP.S248772,2020-06-26
Tertiary Care Centers,LOCATION_OF,Cross-Sectional Studies,32581612,10.2147/RMHP.S248772,2020-06-26
Symptoms,PROCESS_OF,Patients,32581612,10.2147/RMHP.S248772,2020-06-26
Coughing,PROCESS_OF,Patients,32581612,10.2147/RMHP.S248772,2020-06-26
Coughing,PROCESS_OF,Patients,32581612,10.2147/RMHP.S248772,2020-06-26
Prophylactic treatment,USES,RID,32581612,10.2147/RMHP.S248772,2020-06-26
Prophylactic treatment,USES,RID,32581612,10.2147/RMHP.S248772,2020-06-26
Pharmaceutical Preparations,ISA,Chemicals,32581514,10.2147/DDDT.S254354,2020-06-26
Coronavirus Infections,ISA,Disease,32581514,10.2147/DDDT.S254354,2020-06-26
Coronavirus Infections,ISA,Disease,32581514,10.2147/DDDT.S254354,2020-06-26
Cell Therapy,PREVENTS,Disease,32581514,10.2147/DDDT.S254354,2020-06-26
Cell Therapy,PREVENTS(SPEC),Coronavirus Infections,32581514,10.2147/DDDT.S254354,2020-06-26
Confidence,PROCESS_OF,Patients,32581324,10.1038/s41598-020-66895-w,2020-06-26
Pneumonia,PROCESS_OF,Patients,32581324,10.1038/s41598-020-66895-w,2020-06-26
Disease Progression,PROCESS_OF,Patients,32581324,10.1038/s41598-020-66895-w,2020-06-26
Malignant Neoplasms,PROCESS_OF,Patients,32581323,10.1038/s41591-020-0979-0,2020-06-26
Cessation of life,PROCESS_OF,Persons,32581323,10.1038/s41591-020-0979-0,2020-06-26
Voice,PROCESS_OF,Community,32581299,10.1038/s41562-020-0906-x,2020-06-26
SARS coronavirus,CAUSES,Disease,32581217,10.1038/s41467-020-16954-7,2020-06-26
Laboratory Procedures,USES,Buccal smear procedure,32581183,10.2334/josnusd.20-0267,2020-06-26
Buccal smear procedure,ISA,Laboratory Procedures,32581183,10.2334/josnusd.20-0267,2020-06-26
bony process,PART_OF,Population Group,32581118,10.1073/pnas.2006048117,2020-06-26
intensive care unit,NEG_LOCATION_OF,Training,32581082,10.1136/postgradmedj-2020-138100,2020-06-26
Asymptomatic,PROCESS_OF,Patients,32581071,10.1128/mSphere.00442-20,2020-06-26
Asymptomatic,PROCESS_OF,Patients,32581071,10.1128/mSphere.00442-20,2020-06-26
cancer care,TREATS,Patients,32581069,10.1136/esmoopen-2020-000820,2020-06-26
Malignant Neoplasms,PROCESS_OF,Practitioner,32581069,10.1136/esmoopen-2020-000820,2020-06-26
responsibility,PROCESS_OF,Practitioner,32581069,10.1136/esmoopen-2020-000820,2020-06-26
Malignant Neoplasms,PROCESS_OF,Caregiver,32581069,10.1136/esmoopen-2020-000820,2020-06-26
Human coronavirus,CAUSES,Disease,32580969,10.1128/CMR.00028-20,2020-06-26
Ebola virus,ISA,Virus,32580969,10.1128/CMR.00028-20,2020-06-26
Influenza in Birds,PROCESS_OF,Aves,32580969,10.1128/CMR.00028-20,2020-06-26
Real-Time Polymerase Chain Reaction,METHOD_OF,Early Diagnosis,32580969,10.1128/CMR.00028-20,2020-06-26
Massively-Parallel Sequencing,METHOD_OF,Early Diagnosis,32580969,10.1128/CMR.00028-20,2020-06-26
Assay,MEASURES,Antibodies,32580948,10.1128/JCM.01224-20,2020-06-26
Assay,MEASURES,100%,32580948,10.1128/JCM.01224-20,2020-06-26
Therapeutic procedure,TREATS,Disease,32580925,10.1016/j.bjorl.2020.05.008,2020-06-26
Therapeutic procedure,TREATS,Disease,32580925,10.1016/j.bjorl.2020.05.008,2020-06-26
Interleukin-6,ASSOCIATED_WITH,Cytokine release syndrome,32580895,10.1016/j.tips.2020.06.007,2020-06-26
Cytokine release syndrome,PROCESS_OF,Patients,32580895,10.1016/j.tips.2020.06.007,2020-06-26
Janus kinase,INTERACTS_WITH,cytokine,32580895,10.1016/j.tips.2020.06.007,2020-06-26
Tertiary Care Centers,LOCATION_OF,Study,32580818,10.1017/dmp.2020.221,2020-06-26
Decision,PROCESS_OF,Maker (occupation),32580814,10.1017/dmp.2020.220,2020-06-26
Government,ISA,Organization administrative structures,32580796,10.1017/dmp.2020.175,2020-06-26
Coronavirus Infections,ISA,Disease,32580796,10.1017/dmp.2020.175,2020-06-26
Coronavirus Infections,ISA,Disease,32580796,10.1017/dmp.2020.175,2020-06-26
Intervention regimes,TREATS,Patients,32580792,10.1017/S0950268820001399,2020-06-26
Hospitals,LOCATION_OF,Administration occupational activities,32580774,10.1186/s12992-020-00586-z,2020-06-26
Participant,LOCATION_OF,"CD69 protein, human",32580752,10.1186/s13063-020-04498-6,2020-06-26
Standard of Care,ADMINISTERED_TO,Participant,32580752,10.1186/s13063-020-04498-6,2020-06-26
Adverse event,AFFECTS,Patients,32580752,10.1186/s13063-020-04498-6,2020-06-26
Neoplasms,PROCESS_OF,Patients,32580641,10.1177/1078155220935564,2020-06-26
Possible,PROCESS_OF,student,32580564,10.1177/1010539520931358,2020-06-26
Possible,PROCESS_OF,Teacher,32580564,10.1177/1010539520931358,2020-06-26
Infected,PROCESS_OF,Persons,32580535,10.4178/epih.e2020042,2020-06-26
Movement,PROCESS_OF,Population Group,32580535,10.4178/epih.e2020042,2020-06-26
Infected,PROCESS_OF,Persons,32580532,10.4178/epih.e2020045,2020-06-26
Infected,PROCESS_OF,Persons,32580532,10.4178/epih.e2020045,2020-06-26
Infected,PROCESS_OF,Persons,32580532,10.4178/epih.e2020045,2020-06-26
Infected,PROCESS_OF,Persons,32580532,10.4178/epih.e2020045,2020-06-26
Diagnosis,DIAGNOSES,Infected,32580532,10.4178/epih.e2020045,2020-06-26
Infected,PROCESS_OF,Persons,32580532,10.4178/epih.e2020045,2020-06-26
Asymptomatic,PROCESS_OF,Patients,32580531,10.4178/epih.e2020046,2020-06-26
Asymptomatic,PROCESS_OF,Patients,32580531,10.4178/epih.e2020046,2020-06-26
Early Diagnosis,DIAGNOSES,Confirmation,32580531,10.4178/epih.e2020046,2020-06-26
Symptoms,PROCESS_OF,Patients,32580531,10.4178/epih.e2020046,2020-06-26
Confirmation,PROCESS_OF,Patients,32580531,10.4178/epih.e2020046,2020-06-26
Immunoenzyme Procedure,METHOD_OF,Diagnosis,32580529,10.3390/ijms21124446,2020-06-26
Immunochromatographic Assay,USES,Gold Colloid,32580529,10.3390/ijms21124446,2020-06-26
Cesarean section,TREATS,Woman,32580461,10.3390/medicina56060306,2020-06-26
Cesarean section,TREATS(INFER),Asymptomatic,32580461,10.3390/medicina56060306,2020-06-26
Asymptomatic,PROCESS_OF,Woman,32580461,10.3390/medicina56060306,2020-06-26
Throat swab sample,ASSOCIATED_WITH(INFER),Asymptomatic,32580461,10.3390/medicina56060306,2020-06-26
Throat swab sample,PART_OF,Woman,32580461,10.3390/medicina56060306,2020-06-26
Coronavirus Infections,PROCESS_OF,Family,32580440,10.3390/ijerph17124487,2020-06-26
Particulate Matter,CAUSES,Inflammation,32580440,10.3390/ijerph17124487,2020-06-26
Sleep disturbances,PROCESS_OF,member,32580433,10.3390/ijerph17124479,2020-06-26
Feeling suicidal (finding),PROCESS_OF,member,32580433,10.3390/ijerph17124479,2020-06-26
Sleep disturbances,COEXISTS_WITH,Social Interaction,32580433,10.3390/ijerph17124479,2020-06-26
Sleep disturbances,COEXISTS_WITH,Household composition,32580433,10.3390/ijerph17124479,2020-06-26
Feeling suicidal (finding),PROCESS_OF,Participant,32580433,10.3390/ijerph17124479,2020-06-26
IMPACT gene,ASSOCIATED_WITH,Sleep disturbances,32580433,10.3390/ijerph17124479,2020-06-26
mental health,PROCESS_OF,Homo sapiens,32580396,10.3390/ijerph17124477,2020-06-26
Intervention regimes,TREATS,Enthesitis-Related Arthritis,32580396,10.3390/ijerph17124477,2020-06-26
Human coronavirus,PROCESS_OF,World,32580344,10.3390/jcm9061944,2020-06-26
Respiratory tract structure,LOCATION_OF,Communicable Diseases,32580293,10.3390/biology9060134,2020-06-26
Immune,NEG_PROCESS_OF,Persons,32580293,10.3390/biology9060134,2020-06-26
Lung,LOCATION_OF,Squamous cell carcinoma,32580215,10.4414/smw.2020.20302,2020-06-25
Pneumonectomy,TREATS,Squamous cell carcinoma,32580215,10.4414/smw.2020.20302,2020-06-25
Pneumonectomy,TREATS,Patients,32580215,10.4414/smw.2020.20302,2020-06-25
Lung excision,TREATS,Patients,32580215,10.4414/smw.2020.20302,2020-06-25
Fever,ISA,Symptoms,32580215,10.4414/smw.2020.20302,2020-06-25
Left lung,LOCATION_OF,Lymphopenia,32580215,10.4414/smw.2020.20302,2020-06-25
Left lung,LOCATION_OF,Ground Glass Opacity,32580215,10.4414/smw.2020.20302,2020-06-25
intensive care,USES,Diagnosis,32580215,10.4414/smw.2020.20302,2020-06-25
Lung,LOCATION_OF,Lesion,32580215,10.4414/smw.2020.20302,2020-06-25
Pathology specimen,PART_OF,Patients,32580215,10.4414/smw.2020.20302,2020-06-25
Pneumonia,PROCESS_OF,Patients,32580215,10.4414/smw.2020.20302,2020-06-25
Alveolar wall,LOCATION_OF,Diffuse hypertrophy,32580215,10.4414/smw.2020.20302,2020-06-25
fibroblast proliferation,PROCESS_OF,Patients,32580215,10.4414/smw.2020.20302,2020-06-25
Pneumonia,PROCESS_OF,Patients,32580213,10.4414/smw.2020.20304,2020-06-25
Hypersensitivity,PROCESS_OF,Patients,32580213,10.4414/smw.2020.20304,2020-06-25
Neoplasms,PROCESS_OF,Health Personnel,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Neoplasms,PROCESS_OF,Health Personnel,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Neoplastic disease,PROCESS_OF,Patients,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Neoplasms,PROCESS_OF,Patients,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Infection,PROCESS_OF,Health Personnel,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Infection,PROCESS_OF,Patients,32580131,10.1016/j.ejca.2020.05.029,2020-06-25
Virus,CAUSES,Communicable Diseases,32580130,10.1016/j.ejca.2020.05.015,2020-06-25
Malignant Neoplasms,PROCESS_OF,Patients,32580130,10.1016/j.ejca.2020.05.015,2020-06-25
Chronic disease,PROCESS_OF,Patients,32580130,10.1016/j.ejca.2020.05.015,2020-06-25
Disease,PROCESS_OF,Patients,32579986,10.1016/j.jinf.2020.06.039,2020-06-25
Extracorporeal Membrane Oxygenation,TREATS,Disease,32579986,10.1016/j.jinf.2020.06.039,2020-06-25
Liver Dysfunction,PROCESS_OF,Patients,32579986,10.1016/j.jinf.2020.06.039,2020-06-25
Antiviral Response,PROCESS_OF,Patients,32579983,10.1016/j.jinf.2020.06.051,2020-06-25
Adult,LOCATION_OF,WASF1 gene,32579983,10.1016/j.jinf.2020.06.051,2020-06-25
Coitus,NEG_AFFECTS,Patients,32579983,10.1016/j.jinf.2020.06.051,2020-06-25
Pluripotent Stem Cells,PART_OF,Homo sapiens,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Organoids,PART_OF,Liver,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Endocrine Cells,PART_OF,Pancreas,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Organoids,PART_OF,Liver,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Structure of beta Cell of islet,PART_OF,Homo sapiens,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Hepatocyte,PART_OF,Adult,32579880,10.1016/j.stem.2020.06.015,2020-06-25
Asymptomatic Diseases,PROCESS_OF,Patients,32579877,10.3201/eid2610.202211,2020-06-25
Antibody Formation,PROCESS_OF,Patients,32579877,10.3201/eid2610.202211,2020-06-25
Asymptomatic,PROCESS_OF,Patients,32579877,10.3201/eid2610.202211,2020-06-25
SARS coronavirus,CAUSES,Methemoglobinemia,32579876,10.3201/eid2609.202353,2020-06-25
SARS coronavirus,CAUSES,Intravascular hemolysis,32579876,10.3201/eid2609.202353,2020-06-25
SARS coronavirus,PROCESS_OF,Patients,32579876,10.3201/eid2609.202353,2020-06-25
Glucose-6-phosphate deficiency,PROCESS_OF,Patients,32579876,10.3201/eid2609.202353,2020-06-25
Coronavirus Infections,ISA,Disease,32579876,10.3201/eid2609.202353,2020-06-25
Urticaria,ISA,Lesion,32579756,10.1111/dth.13896,2020-06-25
Scaly rash,ISA,Lesion,32579756,10.1111/dth.13896,2020-06-25
Skin Manifestations,PROCESS_OF,Human Age Group,32579756,10.1111/dth.13896,2020-06-25
Males,NEG_ISA,Gender,32579756,10.1111/dth.13896,2020-06-25
dermatological finding,PROCESS_OF,Patients,32579756,10.1111/dth.13896,2020-06-25
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32579756,10.1111/dth.13896,2020-06-25
Antiviral Agents,TREATS,Complication,32579707,10.1002/jcph.1697,2020-06-25
Therapeutic procedure,TREATS,Complication,32579707,10.1002/jcph.1697,2020-06-25
"Respiratory Distress Syndrome, Adult",ISA,Complication,32579707,10.1002/jcph.1697,2020-06-25
Therapeutic procedure,TREATS,Disease,32579707,10.1002/jcph.1697,2020-06-25
Drug Interactions,PROCESS_OF,Patients,32579707,10.1002/jcph.1697,2020-06-25
Attention,PROCESS_OF,Persons,32579706,10.1111/eci.13336,2020-06-25
Experience,PROCESS_OF,Persons,32579602,10.1371/journal.pone.0235108,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32579597,10.1371/journal.pone.0235248,2020-06-25
Angiotensin-Converting Enzyme Inhibitors,TREATS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32579597,10.1371/journal.pone.0235248,2020-06-25
Therapeutic procedure,USES,Angiotensin-Converting Enzyme Inhibitors,32579597,10.1371/journal.pone.0235248,2020-06-25
Cessation of life,PROCESS_OF,Persons,32579597,10.1371/journal.pone.0235248,2020-06-25
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32579597,10.1371/journal.pone.0235248,2020-06-25
Pharmaceutical Preparations,TREATS,Patients,32579597,10.1371/journal.pone.0235248,2020-06-25
Infected,PROCESS_OF,Population Group,32579590,10.1371/journal.pone.0235307,2020-06-25
Infected,PROCESS_OF,Persons,32579590,10.1371/journal.pone.0235307,2020-06-25
Masks,PREVENTS,Disease,32579379,10.7326/M20-3213,2020-06-25
Masks,TREATS,Community,32579379,10.7326/M20-3213,2020-06-25
Masks,USES,Textiles,32579379,10.7326/M20-3213,2020-06-25
Operative Surgical Procedures,TREATS,Community,32579379,10.7326/M20-3213,2020-06-25
Viral respiratory infection,PREDISPOSES,Coronavirus Infections,32579379,10.7326/M20-3213,2020-06-25
Operative Surgical Procedures,compared_with,Masks,32579379,10.7326/M20-3213,2020-06-25
Compliance,NEG_PREDISPOSES,Influenza,32579379,10.7326/M20-3213,2020-06-25
Mechanical Ventilator,compared_with,Surgical face mask,32579379,10.7326/M20-3213,2020-06-25
Symptoms,COEXISTS_WITH,Severe disorder,32579306,10.18071/isz.73.0171,2020-06-25
Hospitals,LOCATION_OF,Retrospective Studies,32579293,10.1002/ppul.24921,2020-06-25
Fever,PROCESS_OF,Patients,32579293,10.1002/ppul.24921,2020-06-25
Antiviral Therapy,ADMINISTERED_TO,Patients,32579293,10.1002/ppul.24921,2020-06-25
Disease,PROCESS_OF,Child,32579293,10.1002/ppul.24921,2020-06-25
Severe Acute Respiratory Syndrome,ISA,Disease,32579293,10.1002/ppul.24921,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF(SPEC),Child,32579293,10.1002/ppul.24921,2020-06-25
Immune response,PROCESS_OF,Patients,32579268,10.1002/jmv.26213,2020-06-25
"T-Cell Surface Glycoprotein CD4, human",PREVENTS,Severe Acute Respiratory Syndrome,32579268,10.1002/jmv.26213,2020-06-25
Disease,PROCESS_OF,hospitalized patients,32579268,10.1002/jmv.26213,2020-06-25
Flow Cytometry,METHOD_OF,Cytokine assay,32579268,10.1002/jmv.26213,2020-06-25
CD8-Positive T-Lymphocytes,PRODUCES,Interferons,32579268,10.1002/jmv.26213,2020-06-25
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32579268,10.1002/jmv.26213,2020-06-25
intensive care,TREATS,Patients,32579268,10.1002/jmv.26213,2020-06-25
Detection,TREATS,Patients,32579268,10.1002/jmv.26213,2020-06-25
Peritoneal Fluid (body substance),ASSOCIATED_WITH(INFER),Infected,32579264,10.1111/codi.15215,2020-06-25
Peritoneal Fluid (body substance),PART_OF,Patients,32579264,10.1111/codi.15215,2020-06-25
Blood,ASSOCIATED_WITH(INFER),Infected,32579264,10.1111/codi.15215,2020-06-25
Blood,PART_OF,Patients,32579264,10.1111/codi.15215,2020-06-25
Feces,ASSOCIATED_WITH(INFER),Infected,32579264,10.1111/codi.15215,2020-06-25
Feces,PART_OF,Patients,32579264,10.1111/codi.15215,2020-06-25
Infected,PROCESS_OF,Patients,32579264,10.1111/codi.15215,2020-06-25
Particle,INTERACTS_WITH,Gases,32579264,10.1111/codi.15215,2020-06-25
Cell Count,USES,TMPRSS2 gene,32579258,10.1111/1348-0421.12828,2020-06-25
Conjunctivitis,PROCESS_OF,Patients,32579256,10.1002/jmv.26219,2020-06-25
Eye,PART_OF,Patients,32579256,10.1002/jmv.26219,2020-06-25
Conjunctivitis,PROCESS_OF,Patients,32579256,10.1002/jmv.26219,2020-06-25
Eye,LOCATION_OF,Present,32579256,10.1002/jmv.26219,2020-06-25
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32579254,10.1002/jmv.26222,2020-06-25
Blood Vessel,LOCATION_OF,Hypertrophy,32579236,10.1002/jmv.26218,2020-06-25
Hypertrophy,NEG_COEXISTS_WITH,Disease,32579236,10.1002/jmv.26218,2020-06-25
Pneumonia,PROCESS_OF,Patients,32579236,10.1002/jmv.26218,2020-06-25
Critical Illness,PROCESS_OF,Patients,32579222,10.3928/00220124-20200611-02,2020-06-25
Health Personnel,TREATS,Patients,32579222,10.3928/00220124-20200611-02,2020-06-25
Nurses,ISA,Health Personnel,32579222,10.3928/00220124-20200611-02,2020-06-25
Nurses,TREATS,Patients,32579222,10.3928/00220124-20200611-02,2020-06-25
Nurses,TREATS(SPEC),Patients,32579222,10.3928/00220124-20200611-02,2020-06-25
Nurses,ISA,Health Personnel,32579222,10.3928/00220124-20200611-02,2020-06-25
Colchicine,AFFECTS,Heart,32579195,10.1001/jamanetworkopen.2020.13136,2020-06-25
Colchicine,INTERACTS_WITH,Anti-Inflammatory Agents,32579195,10.1001/jamanetworkopen.2020.13136,2020-06-25
Tertiary Care Centers,LOCATION_OF,Study,32579195,10.1001/jamanetworkopen.2020.13136,2020-06-25
Colchicine,ADMINISTERED_TO,Participant,32579195,10.1001/jamanetworkopen.2020.13136,2020-06-25
Troponin,PART_OF,Heart,32579195,10.1001/jamanetworkopen.2020.13136,2020-06-25
Scientific Study,USES,Genome,32579100,10.1099/jgv.0.001458,2020-06-25
Disease,CAUSES,Cessation of life,32579067,10.1080/22221751.2020.1787108,2020-06-25
Infected,PROCESS_OF,Patients,32579061,10.1080/07391102.2020.1782768,2020-06-25
simeprevir,TREATS,Patients,32579061,10.1080/07391102.2020.1782768,2020-06-25
simeprevir,TREATS(INFER),Infected,32579061,10.1080/07391102.2020.1782768,2020-06-25
paritaprevir,ISA,Pharmaceutical Preparations,32579061,10.1080/07391102.2020.1782768,2020-06-25
paritaprevir,TREATS,Patients,32579061,10.1080/07391102.2020.1782768,2020-06-25
Chloroquine,compared_with,Chloroquine,32579059,10.1080/07391102.2020.1782265,2020-06-25
Pneumonia,COEXISTS_WITH,patient condition,32579043,10.1080/09553002.2020.1786609,2020-06-25
Scientific Study,DIAGNOSES,Enthesitis-Related Arthritis,32579043,10.1080/09553002.2020.1786609,2020-06-25
Low Dose Radiation Therapy,TREATS,Pneumonia,32579043,10.1080/09553002.2020.1786609,2020-06-25
Low Dose Radiation Therapy,TREATS,Pneumonia,32579043,10.1080/09553002.2020.1786609,2020-06-25
Complication,PROCESS_OF,Patients,32579014,10.17235/reed.2020.7297/2020,2020-06-25
Complication,PROCESS_OF,Patients,32579014,10.17235/reed.2020.7297/2020,2020-06-25
Coronavirus Infections,CAUSES,inflammatory response,32579012,10.17235/reed.2020.7292/2020,2020-06-25
"Colitis, Ischemic",PROCESS_OF,Patients,32579012,10.17235/reed.2020.7292/2020,2020-06-25
RNA,INTERACTS_WITH,Antiviral Agents,32578982,10.1021/acs.biochem.0c00309,2020-06-25
Endopeptidases,ISA,Proteins,32578982,10.1021/acs.biochem.0c00309,2020-06-25
RNA-Directed RNA Polymerase,ISA,Proteins,32578982,10.1021/acs.biochem.0c00309,2020-06-25
DNA Helicases,ISA,Proteins,32578982,10.1021/acs.biochem.0c00309,2020-06-25
Amino Acids,TREATS,Genus: Coronavirus,32578982,10.1021/acs.biochem.0c00309,2020-06-25
Proteins,INTERACTS_WITH,Adenosine Diphosphate Ribose,32578982,10.1021/acs.biochem.0c00309,2020-06-25
Sunlight,ISA,Light,32578981,10.1021/acsnano.0c03504,2020-06-25
Humoral Immunity,PROCESS_OF,Patients,32578948,10.1111/irv.12783,2020-06-25
Patients,LOCATION_OF,Antibodies,32578948,10.1111/irv.12783,2020-06-25
Improved,PROCESS_OF,Patients,32578948,10.1111/irv.12783,2020-06-25
Serum,LOCATION_OF,Antibodies,32578948,10.1111/irv.12783,2020-06-25
Serum,LOCATION_OF,Antibodies,32578948,10.1111/irv.12783,2020-06-25
Serum,LOCATION_OF,Antibodies,32578948,10.1111/irv.12783,2020-06-25
Anxiety,PROCESS_OF,Study Subject,32578943,10.1002/brb3.1730,2020-06-25
Depressive disorder,PROCESS_OF,Study Subject,32578943,10.1002/brb3.1730,2020-06-25
Anxiety,PROCESS_OF,Study Subject,32578943,10.1002/brb3.1730,2020-06-25
Depressive disorder,PROCESS_OF,Study Subject,32578943,10.1002/brb3.1730,2020-06-25
Pulmonologists,ISA,Health Personnel,32578943,10.1002/brb3.1730,2020-06-25
Fever,OCCURS_IN,Patients,32578926,10.1111/1742-6723.13578,2020-06-25
Health Personnel,TREATS,Patients,32578915,10.1111/1742-6723.13581,2020-06-25
Diagnosis,ADMINISTERED_TO,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
atrial fibrillation new onset,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Ischemic stroke,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Atrial Fibrillation,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Atrial Fibrillation,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Complication,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Poor outcome,PROCESS_OF,Patients,32578859,10.1093/eurheartj/ehaa494,2020-06-25
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Confirmation,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Comorbidity,PROCESS_OF,Male population group,32578843,10.1093/ibd/izaa162,2020-06-25
Crohn Disease,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Hospitalization,TREATS,general population,32578843,10.1093/ibd/izaa162,2020-06-25
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32578843,10.1093/ibd/izaa162,2020-06-25
Safety Issues,PROCESS_OF,Population Group,32578839,10.7416/ai.2020.2368,2020-06-25
Malignant Neoplasms,ISA,Disease,32578829,10.6061/clinics/2020/e2060,2020-06-25
Malignant Neoplasms,PROCESS_OF(SPEC),Patients,32578829,10.6061/clinics/2020/e2060,2020-06-25
Disease,PROCESS_OF,Patients,32578829,10.6061/clinics/2020/e2060,2020-06-25
Malignant neoplasm of lung,PROCESS_OF,Patients,32578829,10.6061/clinics/2020/e2060,2020-06-25
Adapt (substance),TREATS,Decreased Immunologic Activity [PE],32578829,10.6061/clinics/2020/e2060,2020-06-25
Coronavirus Infections,ISA,Disease,32578826,10.6061/clinics/2020/e2027,2020-06-25
Virus,COEXISTS_WITH,Disease,32578826,10.6061/clinics/2020/e2027,2020-06-25
Virus,COEXISTS_WITH(SPEC),Coronavirus Infections,32578826,10.6061/clinics/2020/e2027,2020-06-25
Coronavirus Infections,ISA,Disease,32578826,10.6061/clinics/2020/e2027,2020-06-25
Parenchyma,PART_OF,Lung,32578826,10.6061/clinics/2020/e2027,2020-06-25
Coronavirus Infections,ISA,Disease,32578826,10.6061/clinics/2020/e2027,2020-06-25
Coronavirus Infections,ISA,Disease,32578826,10.6061/clinics/2020/e2027,2020-06-25
Parenchyma,PART_OF,Lung,32578826,10.6061/clinics/2020/e2027,2020-06-25
intensive care unit,LOCATION_OF,Ultrasonography,32578826,10.6061/clinics/2020/e2027,2020-06-25
Lung,LOCATION_OF,Ultrasonography,32578826,10.6061/clinics/2020/e2027,2020-06-25
Present,PROCESS_OF,Patients,32578825,10.6061/clinics/2020/e2017,2020-06-25
Severe Acute Respiratory Syndrome,CAUSES,Single organ dysfunction,32578825,10.6061/clinics/2020/e2017,2020-06-25
Disease,PROCESS_OF,Patients,32578825,10.6061/clinics/2020/e2017,2020-06-25
Coronavirus Infections,ISA,Disease,32578825,10.6061/clinics/2020/e2017,2020-06-25
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32578825,10.6061/clinics/2020/e2017,2020-06-25
Suspicion,PROCESS_OF,Patients,32578820,10.1590/0100-6991e-20202549,2020-06-25
Surgical Management,TREATS,Patients,32578820,10.1590/0100-6991e-20202549,2020-06-25
Cessation of life,AFFECTS,Growth,32578811,10.1590/1980-549720200056,2020-06-25
brazilian,PROCESS_OF,Population Group,32578805,10.1590/0102-311X00115320,2020-06-25
Field Hospitals,ISA,Hospitals,32578805,10.1590/0102-311X00115320,2020-06-25
Cell Count,DIAGNOSES,Complete Response with Incomplete Platelet Recovery,32578794,10.1590/1806-9282.66.4.547,2020-06-25
Coronaviridae,PROCESS_OF,Family,32578794,10.1590/1806-9282.66.4.547,2020-06-25
"TFRC protein, human",PART_OF,Patients,32578794,10.1590/1806-9282.66.4.547,2020-06-25
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32578794,10.1590/1806-9282.66.4.547,2020-06-25
Azithromycin,ISA,Pharmaceutical Preparations,32578794,10.1590/1806-9282.66.4.547,2020-06-25
Severe disorder,PROCESS_OF,Adult,32578790,10.1590/1806-9282.66.4.521,2020-06-25
Antiviral Therapy,COEXISTS_WITH,Hospitalization,32578790,10.1590/1806-9282.66.4.521,2020-06-25
respiratory management,TREATS,Patients,32578785,10.1590/1806-9282.66.4.498,2020-06-25
Study,MEASURES,Numbers,32578784,10.1590/1806-9282.66.4.491,2020-06-25
Physical Therapist,NEG_ISA,Persons,32578784,10.1590/1806-9282.66.4.491,2020-06-25
Coronavirus Infections,CAUSES,Communicable Diseases,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Coronaviridae,CAUSES,Respiration Disorders,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Respiration Disorders,PROCESS_OF,Homo sapiens,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Respiratory Tract Infections,PROCESS_OF,Animals,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Severe Acute Respiratory Syndrome,ISA,Illness (finding),32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Immune dysregulation,PREDISPOSES,Severe Acute Respiratory Syndrome,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Anoxia,AFFECTS,Inflammation,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Oxygen,NEG_PART_OF,Organ,32578747,10.1590/1516-3180.2020.0240.14052020,2020-06-25
Severe Acute Respiratory Syndrome,CAUSES,"Pneumonia, Viral",32578696,10.1590/0100-6991e-20202574,2020-06-25
Tertiary Care Centers,LOCATION_OF,Standardization,32578696,10.1590/0100-6991e-20202574,2020-06-25
Telemedicine,TREATS,speech and language,32578694,10.1590/2317-1782/20192020144,2020-06-25
Hearing therapy,COEXISTS_WITH,Health Services,32578694,10.1590/2317-1782/20192020144,2020-06-25
Hearing therapy,TREATS,Patients,32578694,10.1590/2317-1782/20192020144,2020-06-25
Coronavirus Infections,CAUSES,Disease,32578687,10.31744/einstein_journal/2020RW5741,2020-06-25
Polymerase Chain Reaction,METHOD_OF,Diagnosis,32578687,10.31744/einstein_journal/2020RW5741,2020-06-25
Symptoms,PROCESS_OF,Patients,32578687,10.31744/einstein_journal/2020RW5741,2020-06-25
Present,PREDISPOSES,Comorbidity,32578683,10.1590/S1678-9946202062043,2020-06-25
Comorbidity,PROCESS_OF,Patients,32578683,10.1590/S1678-9946202062043,2020-06-25
Comorbidity,PROCESS_OF,Patients,32578683,10.1590/S1678-9946202062043,2020-06-25
Comorbidity,PROCESS_OF,Patients,32578683,10.1590/S1678-9946202062043,2020-06-25
Comorbidity,PROCESS_OF,Patients,32578683,10.1590/S1678-9946202062043,2020-06-25
Comorbidity,PROCESS_OF,Patients,32578683,10.1590/S1678-9946202062043,2020-06-25
Misdiagnosis,PROCESS_OF,Patients,32578378,10.1002/smll.202002169,2020-06-25
Nucleic acid assay,NEG_DIAGNOSES,Respiratory viruses,32578378,10.1002/smll.202002169,2020-06-25
Infected,PROCESS_OF,Patients,32578378,10.1002/smll.202002169,2020-06-25
Nucleic acid specimen,PART_OF,Patients,32578378,10.1002/smll.202002169,2020-06-25
Disease,PROCESS_OF,Patients,32578324,10.1111/tid.13383,2020-06-25
Anoxia,PROCESS_OF,Patients,32578324,10.1111/tid.13383,2020-06-25
Symptom mild,PROCESS_OF,Patients,32578324,10.1111/tid.13383,2020-06-25
Hospitalization,TREATS,Disease Outcome,32578324,10.1111/tid.13383,2020-06-25
Disease Outcome,PROCESS_OF,Transplant Recipients,32578324,10.1111/tid.13383,2020-06-25
Tertiary care hospital,LOCATION_OF,Study,32578309,10.1111/dth.13883,2020-06-25
Recurrent skin infections,PRECEDES,Inflammatory disorder,32578309,10.1111/dth.13883,2020-06-25
Dermatology consultation and report,TREATS,hospitalized patients,32578309,10.1111/dth.13883,2020-06-25
SARS coronavirus,PROCESS_OF,Transplant Recipients,32578289,10.1111/tid.13381,2020-06-25
Germ Cells,PART_OF,Rat Testis,32578263,10.1111/and.13712,2020-06-25
Germ Cells,PART_OF,Rat Testis,32578263,10.1111/and.13712,2020-06-25
Germ Cells,LOCATION_OF,ACE2 gene,32578263,10.1111/and.13712,2020-06-25
sperm cell,PART_OF,Homo sapiens,32578263,10.1111/and.13712,2020-06-25
Testiculo-,LOCATION_OF,Germ Cells,32578263,10.1111/and.13712,2020-06-25
ACE2 gene,AFFECTS,Inferior Colliculus,32578263,10.1111/and.13712,2020-06-25
IMPACT gene,PART_OF,SARS coronavirus,32578263,10.1111/and.13712,2020-06-25
Vaccination against tuberculosis,TREATS,High Risk Populations,32578215,10.1111/all.14443,2020-06-25
"Pneumonia, Viral",CAUSES,"Respiratory Distress Syndrome, Adult",32578167,10.1007/s40256-020-00420-2,2020-06-25
"Respiratory Distress Syndrome, Adult",CAUSES,Anoxia,32578167,10.1007/s40256-020-00420-2,2020-06-25
Lung Injury,CAUSES,Anoxia,32578167,10.1007/s40256-020-00420-2,2020-06-25
Placebos,ISA,Therapeutic procedure,32578156,10.1007/s40264-020-00966-9,2020-06-25
lopinavir / Ritonavir,DISRUPTS,"Respiratory Distress Syndrome, Adult",32578156,10.1007/s40264-020-00966-9,2020-06-25
Respiratory Tract Infections,CAUSES,Cessation of life,32578131,10.1007/s12024-020-00273-w,2020-06-25
Parenchyma,PART_OF,Lung,32578131,10.1007/s12024-020-00273-w,2020-06-25
Nasal Swab (procedure),DIAGNOSES,Viral Respiratory Tract Infection,32578131,10.1007/s12024-020-00273-w,2020-06-25
Cessation of life,OCCURS_IN,Older people,32578073,10.1007/s11357-020-00218-9,2020-06-25
Immunosenescence,PROCESS_OF,geriatric patients,32578073,10.1007/s11357-020-00218-9,2020-06-25
Deficient Food Intake,PROCESS_OF,geriatric patients,32578073,10.1007/s11357-020-00218-9,2020-06-25
"Oximetry, Pulse",ADMINISTERED_TO,Patients,32578070,10.1007/s10877-020-00550-7,2020-06-25
Acute respiratory failure,PROCESS_OF,Patients,32578070,10.1007/s10877-020-00550-7,2020-06-25
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32578027,10.1007/s13668-020-00325-1,2020-06-25
Immunity,PROCESS_OF,Persons,32578027,10.1007/s13668-020-00325-1,2020-06-25
Virus,INTERACTS_WITH,Disease,32578027,10.1007/s13668-020-00325-1,2020-06-25
Food,AFFECTS,Immunity,32578027,10.1007/s13668-020-00325-1,2020-06-25
Dietary Modification,TREATS,Persons,32578027,10.1007/s13668-020-00325-1,2020-06-25
Dietary Modification,TREATS(INFER),Infected,32578027,10.1007/s13668-020-00325-1,2020-06-25
Infected,PROCESS_OF,Persons,32578027,10.1007/s13668-020-00325-1,2020-06-25
Infected,PROCESS_OF,Patients,32578027,10.1007/s13668-020-00325-1,2020-06-25
Prophylactic treatment,CAUSES,Curb,32578006,10.1007/s10900-020-00863-3,2020-06-25
India,ISA,Country,32577997,10.1007/s10597-020-00664-x,2020-06-25
psychological distress,PROCESS_OF,Persons,32577997,10.1007/s10597-020-00664-x,2020-06-25
Anxiety,PROCESS_OF,Health Personnel,32577997,10.1007/s10597-020-00664-x,2020-06-25
Anxiety,PROCESS_OF,student,32577997,10.1007/s10597-020-00664-x,2020-06-25
Depressive disorder,PROCESS_OF,Health Personnel,32577997,10.1007/s10597-020-00664-x,2020-06-25
Depressive disorder,PROCESS_OF,student,32577997,10.1007/s10597-020-00664-x,2020-06-25
Stress,PROCESS_OF,Health Personnel,32577997,10.1007/s10597-020-00664-x,2020-06-25
Stress,PROCESS_OF,student,32577997,10.1007/s10597-020-00664-x,2020-06-25
consideration,COEXISTS_WITH,Otorhinolaryngologic Diseases,32577905,10.1007/s00405-020-06161-x,2020-06-25
Protection,PROCESS_OF,Staff,32577905,10.1007/s00405-020-06161-x,2020-06-25
Negative,PROCESS_OF,Persons,32577902,10.1007/s00405-020-06155-9,2020-06-25
Chief complaint (finding),PROCESS_OF,Patients,32577902,10.1007/s00405-020-06155-9,2020-06-25
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Dysgeusia,32577902,10.1007/s00405-020-06155-9,2020-06-25
Sense of smell altered,ISA,Symptoms,32577901,10.1007/s00405-020-06165-7,2020-06-25
Mucosal thickening,COEXISTS_WITH,Symptoms,32577901,10.1007/s00405-020-06165-7,2020-06-25
Mucosal thickening,COEXISTS_WITH(SPEC),Sense of smell altered,32577901,10.1007/s00405-020-06165-7,2020-06-25
CAT scan of head,ADMINISTERED_TO,Patients,32577901,10.1007/s00405-020-06165-7,2020-06-25
Head,LOCATION_OF,Recent injury,32577901,10.1007/s00405-020-06165-7,2020-06-25
Mucosal thickening,PROCESS_OF,Patients,32577901,10.1007/s00405-020-06165-7,2020-06-25
Mucosal thickening,PROCESS_OF,Patients,32577901,10.1007/s00405-020-06165-7,2020-06-25
Lung,LOCATION_OF,Lesion,32577901,10.1007/s00405-020-06165-7,2020-06-25
Internal nose structure,LOCATION_OF,Surgical Endoscopy,32577897,10.1007/s00405-020-06149-7,2020-06-25
Diagnosis,USES,Laboratory Procedures,32577869,10.1007/s11604-020-01006-3,2020-06-25
Health care facility,LOCATION_OF,Laboratory Procedures,32577869,10.1007/s11604-020-01006-3,2020-06-25
Asymptomatic,PROCESS_OF,Patients,32577869,10.1007/s11604-020-01006-3,2020-06-25
PET/CT scan,ADMINISTERED_TO,Patients,32577869,10.1007/s11604-020-01006-3,2020-06-25
radiologist,DIAGNOSES,Disease,32577869,10.1007/s11604-020-01006-3,2020-06-25
Nuclear medicine specialist,DIAGNOSES,Disease,32577869,10.1007/s11604-020-01006-3,2020-06-25
Salivary Glands,LOCATION_OF,Peptidyl-Dipeptidase A,32577830,10.1007/s00784-020-03413-2,2020-06-25
Cetylpyridinium Chloride,TREATS,Infected,32577830,10.1007/s00784-020-03413-2,2020-06-25
Cetylpyridinium Chloride,TREATS,Decreasing,32577830,10.1007/s00784-020-03413-2,2020-06-25
Povidone-Iodine,TREATS,Infected,32577830,10.1007/s00784-020-03413-2,2020-06-25
Povidone-Iodine,TREATS,Decreasing,32577830,10.1007/s00784-020-03413-2,2020-06-25
Disease,PROCESS_OF,Persons,32577704,10.1101/2020.06.08.20124990,2020-06-25
simulation,USES,Agent,32577703,10.1101/2020.06.07.20124859,2020-06-25
simulation,USES,Agent,32577703,10.1101/2020.06.07.20124859,2020-06-25
Multiple Myeloma,PROCESS_OF,Population Group,32577702,10.1101/2020.06.04.20122846,2020-06-25
Multiple Myeloma,ISA,Plasma cell dyscrasia,32577702,10.1101/2020.06.04.20122846,2020-06-25
Multiple Myeloma,PROCESS_OF,Patients,32577702,10.1101/2020.06.04.20122846,2020-06-25
Multiple Myeloma,PROCESS_OF(SPEC),Patients,32577702,10.1101/2020.06.04.20122846,2020-06-25
Plasma cell dyscrasia,PROCESS_OF,Patients,32577702,10.1101/2020.06.04.20122846,2020-06-25
Therapeutic procedure,TREATS,At home,32577702,10.1101/2020.06.04.20122846,2020-06-25
Persons,LOCATION_OF,IMPACT gene,32577700,10.1101/2020.06.08.20125989,2020-06-25
Nursing Homes,ISA,skilled nursing facility,32577700,10.1101/2020.06.08.20125989,2020-06-25
Rehabilitation Centers,ISA,skilled nursing facility,32577700,10.1101/2020.06.08.20125989,2020-06-25
Asymptomatic Infections,COEXISTS_WITH,Virus,32577700,10.1101/2020.06.08.20125989,2020-06-25
Asymptomatic,PROCESS_OF,Persons,32577700,10.1101/2020.06.08.20125989,2020-06-25
Donor person,LOCATION_OF,"Antibodies, Neutralizing",32577696,10.1101/2020.05.28.20105692,2020-06-25
Pathology procedure,USES,Therapeutic procedure,32577696,10.1101/2020.05.28.20105692,2020-06-25
lifesaving,TREATS,Plasma donor,32577696,10.1101/2020.05.28.20105692,2020-06-25
Plasma,LOCATION_OF,cytokine,32577695,10.1101/2020.06.06.20123414,2020-06-25
Phenotype determination,DIAGNOSES,patient condition,32577695,10.1101/2020.06.06.20123414,2020-06-25
,STIMULATES,Monocytes,32577695,10.1101/2020.06.06.20123414,2020-06-25
Disease,PROCESS_OF,Patients,32577695,10.1101/2020.06.06.20123414,2020-06-25
Pharmaceutical Preparations,NEG_ADMINISTERED_TO,Patients,32577695,10.1101/2020.06.06.20123414,2020-06-25
Interleukin-8,STIMULATES,Monocytes,32577695,10.1101/2020.06.06.20123414,2020-06-25
"interleukin 18 protein, human",STIMULATES,Monocytes,32577695,10.1101/2020.06.06.20123414,2020-06-25
High Level,PROCESS_OF,Patients,32577695,10.1101/2020.06.06.20123414,2020-06-25
Severe Acute Respiratory Syndrome,AFFECTS,Senility,32577695,10.1101/2020.06.06.20123414,2020-06-25
cytokine,ASSOCIATED_WITH,Disease Progression,32577695,10.1101/2020.06.06.20123414,2020-06-25
Symptoms,PROCESS_OF,Persons,32577694,10.1101/2020.06.04.20109306,2020-06-25
Hypersensitivity,PREDISPOSES,Viral respiratory infection,32577694,10.1101/2020.06.04.20109306,2020-06-25
Viral respiratory infection,ISA,Virus Diseases,32577694,10.1101/2020.06.04.20109306,2020-06-25
Chemokine (C-X-C Motif) Ligand 10 Measurement,DIAGNOSES,Hydranencephaly with Renal Aplasia-Dysplasia,32577694,10.1101/2020.06.04.20109306,2020-06-25
Asymptomatic Infections,PROCESS_OF,Persons,32577692,10.1101/2020.06.02.20120477,2020-06-25
Pharmaceutical Preparations,TREATS,Persons,32577690,10.1101/2020.05.27.20114066,2020-06-25
Pharmaceutical Preparations,TREATS(INFER),Glucose-6-phosphate deficiency,32577690,10.1101/2020.05.27.20114066,2020-06-25
Glucose-6-phosphate deficiency,PROCESS_OF,Persons,32577690,10.1101/2020.05.27.20114066,2020-06-25
Cognition,PROCESS_OF,Relative (related person),32577689,10.1101/2020.05.29.20100735,2020-06-25
simulation,USES,Agent,32577688,10.1101/2020.06.05.20123372,2020-06-25
travel,ISA,Behavior,32577688,10.1101/2020.06.05.20123372,2020-06-25
Pharmacotherapy,ADMINISTERED_TO,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Combined Modality Therapy,ADMINISTERED_TO,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Pharmacotherapy,ADMINISTERED_TO,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Adverse reaction to drug,PROCESS_OF,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Adverse reaction to drug,PROCESS_OF,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Supportive care,TREATS,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
Undifferentiated illness,PROCESS_OF,Patients,32577687,10.1101/2020.06.03.20121558,2020-06-25
"Therapies, Investigational",AFFECTS,Adverse reaction to drug,32577687,10.1101/2020.06.03.20121558,2020-06-25
Point-of-Care Testing,USES,Diagnosis,32577685,10.1101/2020.05.28.20115220,2020-06-25
tocilizumab,INHIBITS,Interleukin-6,32577684,10.1101/2020.05.29.20117358,2020-06-25
tocilizumab,ADMINISTERED_TO,Patients,32577684,10.1101/2020.05.29.20117358,2020-06-25
Chronic lung disease,PROCESS_OF,Patients,32577684,10.1101/2020.05.29.20117358,2020-06-25
Superinfection,PROCESS_OF,Patients,32577684,10.1101/2020.05.29.20117358,2020-06-25
Mechanical ventilation,TREATS,hospitalized patients,32577682,10.1101/2020.05.30.20118109,2020-06-25
patient condition,PROCESS_OF,Patients,32577682,10.1101/2020.05.30.20118109,2020-06-25
Mechanical ventilation,TREATS,hospitalized patients,32577682,10.1101/2020.05.30.20118109,2020-06-25
Cardiovascular Diseases,ISA,Disease,32577681,10.1101/2020.05.31.20118802,2020-06-25
Cardiovascular Diseases,PREDISPOSES,Disease,32577681,10.1101/2020.05.31.20118802,2020-06-25
Cardiovascular Diseases,PREDISPOSES(SPEC),Coronavirus Infections,32577681,10.1101/2020.05.31.20118802,2020-06-25
Coronavirus Infections,ISA,Disease,32577681,10.1101/2020.05.31.20118802,2020-06-25
"Hospitals, Public",LOCATION_OF,case series,32577680,10.1101/2020.05.29.20086645,2020-06-25
Hypertensive disease,ISA,Cardiovascular Diseases,32577680,10.1101/2020.05.29.20086645,2020-06-25
Hypertensive disease,ISA,Cardiovascular Diseases,32577680,10.1101/2020.05.29.20086645,2020-06-25
Community,LOCATION_OF,IMPACT gene,32577679,10.1101/2020.06.02.20120790,2020-06-25
Plasma,LOCATION_OF,Flavoproteins,32577678,10.1101/2020.06.02.20120865,2020-06-25
inflammatory response,COEXISTS_WITH,Severe disorder,32577678,10.1101/2020.06.02.20120865,2020-06-25
inflammatory response,ISA,Disease,32577678,10.1101/2020.06.02.20120865,2020-06-25
Plasma,LOCATION_OF,RNLS gene,32577678,10.1101/2020.06.02.20120865,2020-06-25
RNLS gene,AFFECTS,Patient in hospital,32577678,10.1101/2020.06.02.20120865,2020-06-25
Plasma,LOCATION_OF,RNLS gene,32577678,10.1101/2020.06.02.20120865,2020-06-25
Disease,PROCESS_OF,Patients,32577678,10.1101/2020.06.02.20120865,2020-06-25
Severe disorder,PROCESS_OF,Patients,32577678,10.1101/2020.06.02.20120865,2020-06-25
Plasma,LOCATION_OF,RNLS gene,32577678,10.1101/2020.06.02.20120865,2020-06-25
Virus Diseases,PROCESS_OF,Human Age Group,32577677,10.1101/2020.06.05.20123117,2020-06-25
PIM1 gene,PART_OF,Child,32577677,10.1101/2020.06.05.20123117,2020-06-25
Evaluation procedure,TREATS,Child,32577677,10.1101/2020.06.05.20123117,2020-06-25
Child,NEG_LOCATION_OF,,32577677,10.1101/2020.06.05.20123117,2020-06-25
PIM1 gene,PART_OF,Child,32577677,10.1101/2020.06.05.20123117,2020-06-25
Detection,TREATS,Patients,32577677,10.1101/2020.06.05.20123117,2020-06-25
Infected,PROCESS_OF,Persons,32577676,10.1101/2020.06.01.20118885,2020-06-25
Infection,PROCESS_OF,Community,32577676,10.1101/2020.06.01.20118885,2020-06-25
Infected,PROCESS_OF,Persons,32577676,10.1101/2020.06.01.20118885,2020-06-25
Infected,PROCESS_OF,Persons,32577676,10.1101/2020.06.01.20118885,2020-06-25
Infected,PROCESS_OF,Persons,32577676,10.1101/2020.06.01.20118885,2020-06-25
Immunity,PROCESS_OF,Population Group,32577675,10.1101/2020.06.08.20124792,2020-06-25
Plasma,LOCATION_OF,Antibodies,32577675,10.1101/2020.06.08.20124792,2020-06-25
Plasma,LOCATION_OF(SPEC),"Antibodies, Neutralizing",32577675,10.1101/2020.06.08.20124792,2020-06-25
Serum,PART_OF,Patients,32577675,10.1101/2020.06.08.20124792,2020-06-25
"Antibodies, Neutralizing",ISA,Antibodies,32577675,10.1101/2020.06.08.20124792,2020-06-25
Negative,PROCESS_OF,user - individual,32577674,10.1101/2020.06.09.20126813,2020-06-25
Symptoms,NEG_PROCESS_OF,user - individual,32577674,10.1101/2020.06.09.20126813,2020-06-25
Coronavirus Infections,ISA,Disease,32577673,10.1101/2020.06.09.20127092,2020-06-25
Noncommunicable Diseases,AFFECTS,Immunity,32577673,10.1101/2020.06.09.20127092,2020-06-25
Hypersensitivity,PREDISPOSES,Coronavirus Infections,32577673,10.1101/2020.06.09.20127092,2020-06-25
Coronavirus Infections,ISA,Disease,32577673,10.1101/2020.06.09.20127092,2020-06-25
Coronavirus Infections,ISA,Disease,32577673,10.1101/2020.06.09.20127092,2020-06-25
Coronavirus Infections,ISA,Disease,32577673,10.1101/2020.06.09.20127092,2020-06-25
Masks,USES,Textiles,32577672,10.1101/2020.06.09.20125831,2020-06-25
Masks,USES,Textiles,32577672,10.1101/2020.06.09.20125831,2020-06-25
Masks,USES,Textiles,32577672,10.1101/2020.06.09.20125831,2020-06-25
SARS coronavirus,ISA,Virus,32577670,10.1101/2020.06.09.20125690,2020-06-25
CXCL16 gene,ASSOCIATED_WITH,Thrombus,32577670,10.1101/2020.06.09.20125690,2020-06-25
proteomic profiling,DIAGNOSES,Disease,32577670,10.1101/2020.06.09.20125690,2020-06-25
Plasma,LOCATION_OF,anti-IgG,32577669,10.1101/2020.06.09.20127050,2020-06-25
"M Protein, multiple myeloma",INTERACTS_WITH,angiotensin converting enzyme 2,32577669,10.1101/2020.06.09.20127050,2020-06-25
Assay,USES,Microspheres,32577669,10.1101/2020.06.09.20127050,2020-06-25
anti-IgG,DISRUPTS,enzyme binding,32577669,10.1101/2020.06.09.20127050,2020-06-25
anti-IgG,INTERACTS_WITH,"ACE2 protein, human",32577669,10.1101/2020.06.09.20127050,2020-06-25
High Level,COEXISTS_WITH,Fever,32577669,10.1101/2020.06.09.20127050,2020-06-25
Multiple Myeloma,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
risk factors,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Multiple Myeloma,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Multiple Myeloma,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Multiple Myeloma,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Coronavirus Infections,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Plasma cell dyscrasia,PROCESS_OF,Patients,32577667,10.1101/2020.06.09.20126516,2020-06-25
Laboratory Procedures,USES,PCR test for SARS,32577666,10.1101/2020.06.02.20120774,2020-06-25
PCR test for SARS,ISA,Laboratory Procedures,32577666,10.1101/2020.06.02.20120774,2020-06-25
Viral Shedding,PROCESS_OF,Patients,32577666,10.1101/2020.06.02.20120774,2020-06-25
SARS coronavirus,PROCESS_OF,Patients,32577666,10.1101/2020.06.02.20120774,2020-06-25
"T-Cell Surface Glycoprotein CD4, human",PART_OF,Peptides,32577665,10.1101/2020.06.05.134551,2020-06-25
Immunohistochemistry,MEASURES,receptor expression,32577664,10.1101/2020.04.22.056127,2020-06-25
RNA Sequence,ADMINISTERED_TO,Homo sapiens,32577664,10.1101/2020.04.22.056127,2020-06-25
RNA Sequence,PART_OF,Cells,32577664,10.1101/2020.04.22.056127,2020-06-25
Parenchyma,PART_OF,Lung,32577664,10.1101/2020.04.22.056127,2020-06-25
Lung,LOCATION_OF,risk factors,32577664,10.1101/2020.04.22.056127,2020-06-25
Child,LOCATION_OF,ACE2 gene,32577664,10.1101/2020.04.22.056127,2020-06-25
Severe Acute Respiratory Syndrome,PRECEDES,Immunity,32577663,10.1101/2020.06.08.138826,2020-06-25
"M Protein, multiple myeloma",STIMULATES,Vaccines,32577660,10.1101/2020.05.30.125484,2020-06-25
Assay,MEASURES,Specific antibody,32577658,10.1101/2020.06.08.140871,2020-06-25
Monoclonal Antibodies,PART_OF,Homo sapiens,32577658,10.1101/2020.06.08.140871,2020-06-25
Virus,PROCESS_OF,Surrogate,32577658,10.1101/2020.06.08.140871,2020-06-25
Assay,MEASURES,Monoclonal Antibodies,32577658,10.1101/2020.06.08.140871,2020-06-25
Monoclonal Antibodies,PART_OF,Homo sapiens,32577658,10.1101/2020.06.08.140871,2020-06-25
Laboratory Procedures,MEASURES,"Antibodies, Neutralizing",32577655,10.1101/2020.05.26.117549,2020-06-25
Anti-Antibodies,AFFECTS,Virus Diseases,32577655,10.1101/2020.05.26.117549,2020-06-25
Laboratory Procedures,MEASURES,Capacity,32577655,10.1101/2020.05.26.117549,2020-06-25
Persons,LOCATION_OF,Plasma,32577655,10.1101/2020.05.26.117549,2020-06-25
Persons,LOCATION_OF,Serum,32577655,10.1101/2020.05.26.117549,2020-06-25
Assay,USES,Enzyme-Linked Immunosorbent Assay,32577655,10.1101/2020.05.26.117549,2020-06-25
Host Cell,LOCATION_OF,Genome,32577653,10.1101/2020.06.09.141101,2020-06-25
Host Cell,LOCATION_OF,Measles Virus Nucleoprotein,32577653,10.1101/2020.06.09.141101,2020-06-25
viral factory,LOCATION_OF,Virus,32577653,10.1101/2020.06.09.141101,2020-06-25
Diastasis,ASSOCIATED_WITH,RNA-Binding Proteins,32577653,10.1101/2020.06.09.141101,2020-06-25
RNA-Binding Proteins,PART_OF,Nucleocapsid,32577653,10.1101/2020.06.09.141101,2020-06-25
"Regulatory Sequences, Nucleic Acid",PART_OF,"CISH protein, human",32577650,10.1101/2020.05.27.120105,2020-06-25
Host defense,AFFECTS,SARS coronavirus,32577650,10.1101/2020.05.27.120105,2020-06-25
Virus Internalization,AFFECTS,Immune response,32577649,10.1101/2020.05.27.117184,2020-06-25
RNA,INTERACTS_WITH,Oligonucleotides,32577648,10.1101/2020.06.03.130591,2020-06-25
Nasopharyngeal swab (specimen),PART_OF,Patients,32577648,10.1101/2020.06.03.130591,2020-06-25
Coronavirus Infections,ISA,Disease,32577647,10.1101/2020.05.27.118893,2020-06-25
host cell surface,LOCATION_OF,ACE2 gene,32577646,10.1101/2020.06.09.142794,2020-06-25
Polysaccharides,INTERACTS_WITH,angiotensin converting enzyme 2,32577644,10.1101/2020.06.11.146522,2020-06-25
IGHV3-53 gene,COEXISTS_WITH,"Antibodies, Neutralizing",32577642,10.1101/2020.06.08.141267,2020-06-25
Homo sapiens,LOCATION_OF,Protein coding gene,32577641,10.1101/2020.06.02.130955,2020-06-25
Protein coding gene,COEXISTS_WITH,Proteins,32577641,10.1101/2020.06.02.130955,2020-06-25
Nucleocapsid,INHIBITS,Amino Acids,32577641,10.1101/2020.06.02.130955,2020-06-25
"M Protein, multiple myeloma",COEXISTS_WITH,Isolate - microorganism,32577641,10.1101/2020.06.02.130955,2020-06-25
Infected,PROCESS_OF,Patients,32577640,10.1101/2020.06.02.131144,2020-06-25
Infected,PROCESS_OF,Patients,32577640,10.1101/2020.06.02.131144,2020-06-25
Infected,PROCESS_OF,Patients,32577640,10.1101/2020.06.02.131144,2020-06-25
"ACE2 protein, human",INTERACTS_WITH,Glycosaminoglycans,32577638,10.1101/2020.06.08.140236,2020-06-25
Mammalian Cell,LOCATION_OF,Polysaccharides,32577638,10.1101/2020.06.08.140236,2020-06-25
Enoxaparin,ISA,heparin,32577638,10.1101/2020.06.08.140236,2020-06-25
Glycoproteins,AFFECTS,Virus Internalization,32577637,10.1101/2020.06.08.140244,2020-06-25
Infected,PROCESS_OF,Persons,32577637,10.1101/2020.06.08.140244,2020-06-25
Infected,PROCESS_OF,Persons,32577637,10.1101/2020.06.08.140244,2020-06-25
Overtime,TREATS,Symptoms,32577637,10.1101/2020.06.08.140244,2020-06-25
Orthologous Gene,INTERACTS_WITH,"M Protein, multiple myeloma",32577636,10.1101/2020.06.05.136861,2020-06-25
Epithelium,PART_OF,Lung,32577635,10.1101/2020.06.03.132639,2020-06-25
Vaccines,TREATS,Crisis,32577634,10.1101/2020.06.11.145920,2020-06-25
"M Protein, multiple myeloma",PART_OF,Betacoronavirus,32577634,10.1101/2020.06.11.145920,2020-06-25
Lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32577634,10.1101/2020.06.11.145920,2020-06-25
Lung,PART_OF,Mus,32577634,10.1101/2020.06.11.145920,2020-06-25
Nose,LOCATION_OF,Severe Acute Respiratory Syndrome,32577634,10.1101/2020.06.11.145920,2020-06-25
Nose,PART_OF,Mus,32577634,10.1101/2020.06.11.145920,2020-06-25
"Antibodies, Blocking",PREVENTS,Severe Acute Respiratory Syndrome,32577634,10.1101/2020.06.11.145920,2020-06-25
CD8A wt Allele,PREVENTS,Severe Acute Respiratory Syndrome,32577634,10.1101/2020.06.11.145920,2020-06-25
Interested,PROCESS_OF,Animal Model,32577633,10.1101/2020.06.10.145144,2020-06-25
Hydroxychloroquine,TREATS,Disease,32577633,10.1101/2020.06.10.145144,2020-06-25
Malaria,PROCESS_OF,Homo sapiens,32577633,10.1101/2020.06.10.145144,2020-06-25
Viral Proteins,INTERACTS_WITH,angiotensin converting enzyme 2,32577632,10.1101/2020.06.16.154708,2020-06-25
Betacoronavirus,ISA,Virus,32577631,10.1101/2020.06.12.148692,2020-06-25
Basis,INTERACTS_WITH,ACE2 gene,32577631,10.1101/2020.06.12.148692,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32577428,10.1093/ofid/ofaa210,2020-06-25
Upper respiratory tract,LOCATION_OF,Viral Shedding,32577428,10.1093/ofid/ofaa210,2020-06-25
Dry cough,ISA,Symptoms,32577426,10.1093/ofid/ofaa187,2020-06-25
Severe disorder,PROCESS_OF,Patients,32577426,10.1093/ofid/ofaa187,2020-06-25
Disease,PROCESS_OF,Patients,32577426,10.1093/ofid/ofaa187,2020-06-25
Senility,PROCESS_OF,Patients,32577426,10.1093/ofid/ofaa187,2020-06-25
Short menstrual periods,PROCESS_OF,Patients,32577426,10.1093/ofid/ofaa187,2020-06-25
angiogram,DIAGNOSES,Normal heart,32577331,10.7759/cureus.8685,2020-06-25
Symptoms,PROCESS_OF,Child,32577325,10.7759/cureus.8207,2020-06-25
Complication,PROCESS_OF,Child,32577325,10.7759/cureus.8207,2020-06-25
Symptom mild,PROCESS_OF,Population Group,32577325,10.7759/cureus.8207,2020-06-25
Child,LOCATION_OF,IMPACT gene,32577325,10.7759/cureus.8207,2020-06-25
IMPACT gene,PREVENTS,Complication,32577236,10.1177/2049936120933076,2020-06-25
Viral Matrix Proteins,ADMINISTERED_TO,Epithelial Cells,32577236,10.1177/2049936120933076,2020-06-25
Fasting,PROCESS_OF,Persons,32577190,10.4103/ijpvm.IJPVM_236_20,2020-06-25
Diabetes,ISA,Disease,32577087,10.1186/s41182-020-00241-8,2020-06-25
Diabetes,PROCESS_OF(SPEC),Persons,32577087,10.1186/s41182-020-00241-8,2020-06-25
Disease,PROCESS_OF,Persons,32577087,10.1186/s41182-020-00241-8,2020-06-25
Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32577087,10.1186/s41182-020-00241-8,2020-06-25
Virus Diseases,AFFECTS,Lethal,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
rosoxacin,INTERACTS_WITH,ACE2 gene,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
"pros protein, Drosophila",INTERACTS_WITH,ACE2 gene,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
"Vitronectin, human",PART_OF,Virus,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
Binding Sites,AUGMENTS,Gene Expression,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
TRANSCRIPTION FACTOR,STIMULATES,GA-Binding Protein Transcription Factor,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
dimethyl fumarate,DISRUPTS,Alveolar Epithelial Cells,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
dimethyl fumarate,DISRUPTS,Virus Internalization,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
GA-Binding Protein Transcription Factor,ISA,TRANSCRIPTION FACTOR,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
GA-Binding Protein Transcription Factor,STIMULATES,Enzymes,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
Alveolar Epithelial Cells,PART_OF,Lung,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
Alveolar Epithelial Cells,PART_OF,Lung,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
InFed,STIMULATES,ACE2 gene,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
"DDX58 protein, human",STIMULATES,ACE2 gene,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
Viral Pathogenesis,AFFECTS,Patients,32577056,10.5455/medarh.2020.74.134-138,2020-06-25
Immune System Diseases,AFFECTS,Homeostasis,32576980,10.1038/s41577-020-0357-7,2020-06-25
Pneumonia,AFFECTS,Homeostasis,32576980,10.1038/s41577-020-0357-7,2020-06-25
Pharmaceutical Preparations,INHIBITS,cyclooxygenase 1,32576928,10.1038/s41598-020-67283-0,2020-06-25
Pneumonia,ISA,Disease,32576928,10.1038/s41598-020-67283-0,2020-06-25
lapatinib,TREATS,Disease,32576928,10.1038/s41598-020-67283-0,2020-06-25
Erythema Multiforme,PROCESS_OF,Child,32576730,10.1097/DAD.0000000000001707,2020-06-25
Erythema Multiforme,PROCESS_OF,Young Adult,32576730,10.1097/DAD.0000000000001707,2020-06-25
Erythema,PROCESS_OF,Child,32576730,10.1097/DAD.0000000000001707,2020-06-25
Erythema,PROCESS_OF,Young Adult,32576730,10.1097/DAD.0000000000001707,2020-06-25
Urticaria,PROCESS_OF,Child,32576730,10.1097/DAD.0000000000001707,2020-06-25
Urticaria,PROCESS_OF,Young Adult,32576730,10.1097/DAD.0000000000001707,2020-06-25
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32576730,10.1097/DAD.0000000000001707,2020-06-25
Infiltration,COEXISTS_WITH,Distention of blood vessel,32576730,10.1097/DAD.0000000000001707,2020-06-25
Vascular plexus,LOCATION_OF,Blood Coagulation Disorders,32576730,10.1097/DAD.0000000000001707,2020-06-25
Epidermis,LOCATION_OF,Disease,32576730,10.1097/DAD.0000000000001707,2020-06-25
Chilblains,COEXISTS_WITH,Lesion,32576730,10.1097/DAD.0000000000001707,2020-06-25
Chilblains,COEXISTS_WITH(SPEC),Urticaria,32576730,10.1097/DAD.0000000000001707,2020-06-25
Coughing,PROCESS_OF,Patients,32576730,10.1097/DAD.0000000000001707,2020-06-25
Fever,PROCESS_OF,Patients,32576730,10.1097/DAD.0000000000001707,2020-06-25
Urticaria,ISA,Lesion,32576730,10.1097/DAD.0000000000001707,2020-06-25
Possible,PROCESS_OF,Patients,32576730,10.1097/DAD.0000000000001707,2020-06-25
Negative Regulation of Coagulation,PROCESS_OF,inpatient,32576712,10.18632/aging.103583,2020-06-25
"Psychotherapy, Multiple",USES,Azithromycin,32576712,10.18632/aging.103583,2020-06-25
Cessation of life,PROCESS_OF,Households,32576696,10.1073/pnas.2008764117,2020-06-25
Infection,PROCESS_OF,Old age,32576696,10.1073/pnas.2008764117,2020-06-25
,DISRUPTS,Uptake,32576678,10.1128/mBio.01293-20,2020-06-25
Downstream,LOCATION_OF,Antigen-Presenting Cells,32576678,10.1128/mBio.01293-20,2020-06-25
cytosolic receptor,STIMULATES,,32576678,10.1128/mBio.01293-20,2020-06-25
Dendritic Cells,LOCATION_OF,,32576678,10.1128/mBio.01293-20,2020-06-25
Hepatitis C,PROCESS_OF,Patients,32576678,10.1128/mBio.01293-20,2020-06-25
Plasma,LOCATION_OF,cytokine,32576678,10.1128/mBio.01293-20,2020-06-25
Plasma,PART_OF,Patients,32576678,10.1128/mBio.01293-20,2020-06-25
Infected,PROCESS_OF,Persons,32576605,10.1136/jech-2020-214051,2020-06-25
patient condition,PROCESS_OF,Urologists,32576530,10.1016/j.euf.2020.06.001,2020-06-25
Telemedicine,ADMINISTERED_TO,Participant,32576530,10.1016/j.euf.2020.06.001,2020-06-25
Brain,LOCATION_OF,Magnetic Resonance Imaging,32576457,10.1016/j.jmii.2020.05.017,2020-06-25
Anxiety,PROCESS_OF,Persons,32576424,10.1016/j.jagp.2020.05.022,2020-06-25
Depressive disorder,PROCESS_OF,Persons,32576424,10.1016/j.jagp.2020.05.022,2020-06-25
Stress,PROCESS_OF,Persons,32576424,10.1016/j.jagp.2020.05.022,2020-06-25
Immune response,PROCESS_OF,Persons,32576386,10.1016/j.tips.2020.06.001,2020-06-25
Severe disorder,PROCESS_OF,Patients,32576386,10.1016/j.tips.2020.06.001,2020-06-25
Coronavirus Infections,PROCESS_OF,World,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Patients,LOCATION_OF,Fibrin fragment D,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Fibrin,DISRUPTS,Syndrome,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Plasma,LOCATION_OF,Fibrin,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Fibrin fragment D,ASSOCIATED_WITH,Hyperactive behavior,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Blood coagulation,PROCESS_OF,Patients,32576359,10.3760/cma.j.cn121430-20200303-00124,2020-06-25
Disease,COEXISTS_WITH,"Kidney Failure, Acute",32576358,10.3760/cma.j.cn121430-20200508-00369,2020-06-25
Disease,COEXISTS_WITH,inflammatory response,32576358,10.3760/cma.j.cn121430-20200508-00369,2020-06-25
Fluid Management,TREATS,Communicable Diseases,32576358,10.3760/cma.j.cn121430-20200508-00369,2020-06-25
Organ,LOCATION_OF,Multiple Trauma,32576357,10.3760/cma.j.cn121430-20200312-00159,2020-06-25
Patients,LOCATION_OF,Fibrin fragment D,32576347,10.3760/cma.j.cn121430-20200414-00518,2020-06-25
Patients,LOCATION_OF,Fibrin fragment D,32576347,10.3760/cma.j.cn121430-20200414-00518,2020-06-25
patient condition,COMPLICATES,Disease,32576347,10.3760/cma.j.cn121430-20200414-00518,2020-06-25
D-dimer above reference range,PROCESS_OF,Patients,32576347,10.3760/cma.j.cn121430-20200414-00518,2020-06-25
Interleukin-6,ISA,Interleukins,32576347,10.3760/cma.j.cn121430-20200414-00518,2020-06-25
disorder analysis,ADMINISTERED_TO,Patients,32576346,10.3760/cma.j.cn121430-20200413-00506,2020-06-25
dyspnea acute,COEXISTS_WITH,Nausea,32576346,10.3760/cma.j.cn121430-20200413-00506,2020-06-25
Symptoms,PROCESS_OF,Patients,32576346,10.3760/cma.j.cn121430-20200413-00506,2020-06-25
Basis,TREATS,patient condition,32576346,10.3760/cma.j.cn121430-20200413-00506,2020-06-25
Feels cold,COMPLICATES,Disease,32576345,10.3760/cma.j.cn121430-20200323-00203,2020-06-25
Cessation of life,PROCESS_OF,Patients,32576344,10.3760/cma.j.cn121430-20200507-00364,2020-06-25
Cessation of life,PROCESS_OF,Patients,32576344,10.3760/cma.j.cn121430-20200507-00364,2020-06-25
Cessation of life,PROCESS_OF,Patients,32576344,10.3760/cma.j.cn121430-20200507-00364,2020-06-25
Mechanical ventilation,COEXISTS_WITH,Hospitalization,32576344,10.3760/cma.j.cn121430-20200507-00364,2020-06-25
Cessation of life,AFFECTS,Hypersensitivity,32576344,10.3760/cma.j.cn121430-20200507-00364,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Lung,LOCATION_OF,Syndrome,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Syndrome,PROCESS_OF,Arecaceae,32576343,10.3760/cma.j.cn121430-20200506-00620,2020-06-25
Congenital heart disease,PART_OF,Patients,32576329,10.1017/S1047951120002000,2020-06-25
Interventional procedure,TREATS,Congenital heart disease,32576329,10.1017/S1047951120002000,2020-06-25
Operative Surgical Procedures,TREATS,Congenital heart disease,32576329,10.1017/S1047951120002000,2020-06-25
Diagnosis,DIAGNOSES,Congenital cardiovascular disorder,32576329,10.1017/S1047951120002000,2020-06-25
Palliative procedure,TREATS,Patients,32576329,10.1017/S1047951120002000,2020-06-25
Critical Illness,PROCESS_OF,Patients,32576325,10.1017/S1478951520000498,2020-06-25
Zoonoses,CAUSES,Sequela of disorder,32576317,10.1017/dmp.2020.215,2020-06-25
Anxiety,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
Depressive disorder,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
Stress,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
psychological distress,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
psychological distress,AFFECTS,Persons,32576317,10.1017/dmp.2020.215,2020-06-25
Anxiety,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
Depressive disorder,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
Stress,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
psychological distress,PROCESS_OF,mexican,32576317,10.1017/dmp.2020.215,2020-06-25
Serum,LOCATION_OF,CD40LG wt Allele,32576315,10.1017/dmp.2020.216,2020-06-25
Immune response,PROCESS_OF,Patients,32576315,10.1017/dmp.2020.216,2020-06-25
Awareness,PROCESS_OF,undergraduate student,32576311,10.1017/dmp.2020.204,2020-06-25
Awareness,PROCESS_OF,undergraduate student,32576311,10.1017/dmp.2020.204,2020-06-25
India,ISA,Country,32576311,10.1017/dmp.2020.204,2020-06-25
Awareness,PROCESS_OF,Study Subject,32576311,10.1017/dmp.2020.204,2020-06-25
Initiative,PROCESS_OF,Persons,32576310,10.1017/dmp.2020.207,2020-06-25
Face,LOCATION_OF,Protection,32576310,10.1017/dmp.2020.207,2020-06-25
Foot,LOCATION_OF,Lesion,32576291,10.1186/s13047-020-00408-w,2020-06-25
Lesion,PROCESS_OF,Child,32576291,10.1186/s13047-020-00408-w,2020-06-25
Lesion,PROCESS_OF,Young Adult,32576291,10.1186/s13047-020-00408-w,2020-06-25
Interested,PROCESS_OF,Health Personnel,32576291,10.1186/s13047-020-00408-w,2020-06-25
Decision,PROCESS_OF,Maker (occupation),32576256,10.1186/s40249-020-00685-4,2020-06-25
Complication,PROCESS_OF,Elderly (population group),32576232,10.1186/s13256-020-02432-7,2020-06-25
Pneumonia,AFFECTS,Complication,32576232,10.1186/s13256-020-02432-7,2020-06-25
Aspiration Pneumonia,COEXISTS_WITH,Bed-ridden,32576232,10.1186/s13256-020-02432-7,2020-06-25
Hospitals,LOCATION_OF,Differential Diagnosis,32576232,10.1186/s13256-020-02432-7,2020-06-25
Chest,LOCATION_OF,Radionuclide Imaging,32576232,10.1186/s13256-020-02432-7,2020-06-25
Consequent,PREDISPOSES,Communicable Diseases,32576232,10.1186/s13256-020-02432-7,2020-06-25
Comorbidity,PROCESS_OF,Patients,32576232,10.1186/s13256-020-02432-7,2020-06-25
Pneumonia,PROCESS_OF,Persons,32576232,10.1186/s13256-020-02432-7,2020-06-25
Pneumonia,PROCESS_OF,Nonagenarians,32576232,10.1186/s13256-020-02432-7,2020-06-25
Pneumonia,PROCESS_OF,Patients,32576232,10.1186/s13256-020-02432-7,2020-06-25
chest findings,PROCESS_OF,Patients,32576224,10.1186/s12880-020-00471-6,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32576224,10.1186/s12880-020-00471-6,2020-06-25
Negative Finding,PROCESS_OF,Patients,32576224,10.1186/s12880-020-00471-6,2020-06-25
Positive Finding,PROCESS_OF,Patients,32576224,10.1186/s12880-020-00471-6,2020-06-25
lobe,LOCATION_OF,Lesion,32576224,10.1186/s12880-020-00471-6,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32576224,10.1186/s12880-020-00471-6,2020-06-25
lobe,LOCATION_OF,Pleural effusion disorder,32576224,10.1186/s12880-020-00471-6,2020-06-25
lobe,LOCATION_OF,Thickening of pleura,32576224,10.1186/s12880-020-00471-6,2020-06-25
Coronavirus Infections,ISA,Disease,32576139,10.1186/s12879-020-05144-x,2020-06-25
Disease,PROCESS_OF,Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,ISA,Disease,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,ISA,Disease,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Asymptomatic,COMPLICATES,Symptoms,32576139,10.1186/s12879-020-05144-x,2020-06-25
Symptom severe,PROCESS_OF,Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Chills,COEXISTS_WITH,Diabetes,32576139,10.1186/s12879-020-05144-x,2020-06-25
chest findings,COEXISTS_WITH,Diabetes,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,ISA,Disease,32576139,10.1186/s12879-020-05144-x,2020-06-25
Disease,PROCESS_OF,Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,ISA,Disease,32576139,10.1186/s12879-020-05144-x,2020-06-25
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Symptom mild,PROCESS_OF,Patients,32576139,10.1186/s12879-020-05144-x,2020-06-25
Chilblains,PROCESS_OF,Patients,32576095,10.1080/20477724.2020.1785200,2020-06-25
Symptoms,COEXISTS_WITH,health advice,32576095,10.1080/20477724.2020.1785200,2020-06-25
Hospitals,LOCATION_OF,basic research,32576016,10.21037/apm-20-1113,2020-06-25
Oral cavity,LOCATION_OF,bitter taste,32576016,10.21037/apm-20-1113,2020-06-25
Coronavirus Infections,ISA,Disease,32575957,10.4081/gh.2020.882,2020-06-25
Coronavirus Infections,ISA,Disease,32575957,10.4081/gh.2020.882,2020-06-25
Communicable Diseases,ISA,Disease,32575957,10.4081/gh.2020.882,2020-06-25
Coronavirus Infections,ISA,Disease,32575957,10.4081/gh.2020.882,2020-06-25
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Meleagris gallopavo,32575957,10.4081/gh.2020.882,2020-06-25
Province,ISA,Geographic Locations,32575956,10.4081/gh.2020.867,2020-06-25
Cessation of life,PROCESS_OF,Male population group,32575825,10.3390/ijerph17124450,2020-06-25
Gene Feature,PART_OF,Population Group,32575825,10.3390/ijerph17124450,2020-06-25
Infected,PROCESS_OF,Patients,32575786,10.3390/pathogens9060493,2020-06-25
Stress,PROCESS_OF,general population,32575763,10.3390/ijerph17124441,2020-06-25
Stress,PROCESS_OF,World,32575763,10.3390/ijerph17124441,2020-06-25
Stress,PROCESS_OF,Population Group,32575763,10.3390/ijerph17124441,2020-06-25
Detection,USES,Probes,32575728,10.3390/ijms21124396,2020-06-25
Detection,USES,Probes,32575728,10.3390/ijms21124396,2020-06-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32575728,10.3390/ijms21124396,2020-06-25
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32575554,10.3390/antiox9060540,2020-06-25
Heme,STIMULATES,Cell Adhesion Molecules,32575554,10.3390/antiox9060540,2020-06-25
Anti-Inflammatory Agents,INHIBITS,Heme,32575554,10.3390/antiox9060540,2020-06-25
Carbon Monoxide,INHIBITS,Heme,32575554,10.3390/antiox9060540,2020-06-25
Ferritin,INHIBITS,Heme,32575554,10.3390/antiox9060540,2020-06-25
Heme,STIMULATES,Heme Oxygenase-1,32575554,10.3390/antiox9060540,2020-06-25
Screening procedure,TREATS,Severe Acute Respiratory Syndrome,32575505,10.3390/ijerph17124417,2020-06-25
Academic Medical Centers,LOCATION_OF,Study,32575505,10.3390/ijerph17124417,2020-06-25
Assay,USES,PCR test for SARS,32575505,10.3390/ijerph17124417,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
influenza (epidemic),PROCESS_OF,Family suidae,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
Disease,AFFECTS,Adverse effects,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,AFFECTS(SPEC),Adverse effects,32575492,10.3390/ijerph17124409,2020-06-25
Coronavirus Infections,ISA,Disease,32575492,10.3390/ijerph17124409,2020-06-25
angiotensin converting enzyme 2,AFFECTS,Virus Internalization,32575476,10.3390/plants9060770,2020-06-25
Analysis,USES,Real-Time Polymerase Chain Reaction,32575476,10.3390/plants9060770,2020-06-25
Oils,COEXISTS_WITH,lemon oil,32575476,10.3390/plants9060770,2020-06-25
Geranium,LOCATION_OF,Oils,32575476,10.3390/plants9060770,2020-06-25
geraniol,ISA,Oils,32575476,10.3390/plants9060770,2020-06-25
Geranium,LOCATION_OF,Oils,32575476,10.3390/plants9060770,2020-06-25
Geranium,LOCATION_OF(SPEC),geraniol,32575476,10.3390/plants9060770,2020-06-25
Epithelial Cells,LOCATION_OF,citronellol,32575476,10.3390/plants9060770,2020-06-25
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32575476,10.3390/plants9060770,2020-06-25
Prophylactic treatment,ADMINISTERED_TO,Human body,32575476,10.3390/plants9060770,2020-06-25
Vaccines,TREATS,Disease,32575380,10.3390/jcm9061917,2020-06-25
"Respiratory Distress Syndrome, Adult",COMPLICATES,Respiratory Failure,32575380,10.3390/jcm9061917,2020-06-25
Pulmonary Fibrosis,CAUSES,Dyspnea,32575380,10.3390/jcm9061917,2020-06-25
Pulmonary Fibrosis,MANIFESTATION_OF,Immune response,32575380,10.3390/jcm9061917,2020-06-25
"CD69 protein, human",CAUSES,Possible,32575380,10.3390/jcm9061917,2020-06-25
patient condition,COEXISTS_WITH,Storm Syndrome,32575350,10.3390/vaccines8020320,2020-06-25
Pharmaceutical Preparations,PREVENTS,Inflammation,32575350,10.3390/vaccines8020320,2020-06-25
Ursodiol,ISA,Pharmaceutical Preparations,32575350,10.3390/vaccines8020320,2020-06-25
Ursodiol,PREVENTS(SPEC),Inflammation,32575350,10.3390/vaccines8020320,2020-06-25
Chronic Lymphocytic Leukemia,PROCESS_OF,Patients,32575156,10.1111/ejh.13475,2020-06-24
Virus Diseases,PROCESS_OF,Patients,32575156,10.1111/ejh.13475,2020-06-24
Secondary immune deficiency disorder,PROCESS_OF,Patients,32575156,10.1111/ejh.13475,2020-06-24
Gravidity,PROCESS_OF,Patients,32575140,10.1055/s-0040-1713121,2020-06-24
Critical Illness,PROCESS_OF,Obstetric Patient,32575140,10.1055/s-0040-1713121,2020-06-24
Critical Illness,PROCESS_OF,Patients,32575140,10.1055/s-0040-1713121,2020-06-24
Gravidity,PROCESS_OF,Patients,32575140,10.1055/s-0040-1713121,2020-06-24
Severe disorder,PROCESS_OF,Patients,32575140,10.1055/s-0040-1713121,2020-06-24
Versed,TREATS,Complication,32575140,10.1055/s-0040-1713121,2020-06-24
Malaise,PROCESS_OF,Obstetric Patient,32575140,10.1055/s-0040-1713121,2020-06-24
Patient currently pregnant,PROCESS_OF,Patients,32575140,10.1055/s-0040-1713121,2020-06-24
Critical Illness,PROCESS_OF,Obstetric Patient,32575140,10.1055/s-0040-1713121,2020-06-24
Pneumonia,PROCESS_OF,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,TREATS,Storm NOS,32575124,10.1093/cid/ciaa812,2020-06-24
Pneumonia,PROCESS_OF,hospitalized patients,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,TREATS,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,TREATS,hospitalized patients,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,TREATS(INFER),Pneumonia,32575124,10.1093/cid/ciaa812,2020-06-24
Pneumonia,PROCESS_OF,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
Pneumonia,PROCESS_OF,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
Interleukin-6,ISA,cytokine,32575124,10.1093/cid/ciaa812,2020-06-24
Poor outcome,PROCESS_OF,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
Oxygen,INHIBITS,tocilizumab,32575124,10.1093/cid/ciaa812,2020-06-24
Vasoconstrictor Agents,INHIBITS,tocilizumab,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,PREVENTS,Inflammation,32575124,10.1093/cid/ciaa812,2020-06-24
Detection,TREATS,Pathogenic,32575124,10.1093/cid/ciaa812,2020-06-24
Pathogenic,PROCESS_OF,Patients,32575124,10.1093/cid/ciaa812,2020-06-24
tocilizumab,COEXISTS_WITH,C-reactive protein,32575124,10.1093/cid/ciaa812,2020-06-24
Adult,ISA,Population Group,32575114,10.1093/cid/ciaa828,2020-06-24
Fever,ISA,Symptoms,32575114,10.1093/cid/ciaa828,2020-06-24
Ground Glass Opacity,ISA,Radiologic finding,32575114,10.1093/cid/ciaa828,2020-06-24
Gravidity,NEG_PROCESS_OF,Population Group,32575114,10.1093/cid/ciaa828,2020-06-24
Vaccines,TREATS,Virus,32575078,10.18632/aging.103383,2020-06-24
Therapeutic procedure,TREATS,Virus,32575078,10.18632/aging.103383,2020-06-24
Infection,PROCESS_OF,geriatric patients,32575078,10.18632/aging.103383,2020-06-24
Dyspnea,ISA,Symptoms,32575078,10.18632/aging.103383,2020-06-24
Dyspnea,PROCESS_OF(SPEC),Patients,32575078,10.18632/aging.103383,2020-06-24
Fever,ISA,Symptoms,32575078,10.18632/aging.103383,2020-06-24
Fever,PROCESS_OF(SPEC),Patients,32575078,10.18632/aging.103383,2020-06-24
Symptoms,PROCESS_OF,Patients,32575078,10.18632/aging.103383,2020-06-24
risk factors,PROCESS_OF,Patients,32575078,10.18632/aging.103383,2020-06-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32575073,10.18632/aging.103535,2020-06-24
Coughing,ISA,Symptoms,32575073,10.18632/aging.103535,2020-06-24
Fever,ISA,Symptoms,32575073,10.18632/aging.103535,2020-06-24
Dyspnea,PROCESS_OF,Patients,32575073,10.18632/aging.103535,2020-06-24
Biological Markers,ASSOCIATED_WITH,Dyspnea,32575073,10.18632/aging.103535,2020-06-24
Disease Progression,PROCESS_OF,Patients,32575073,10.18632/aging.103535,2020-06-24
Multiple Organ Failure,PROCESS_OF,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
Storm NOS,PROCESS_OF,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
"Respiratory Distress Syndrome, Adult",DISRUPTS,majority,32575019,10.1016/j.mehy.2020.110005,2020-06-24
Disease,PROCESS_OF,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
pirfenidone,TREATS,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
pirfenidone,TREATS(INFER),Disease,32575019,10.1016/j.mehy.2020.110005,2020-06-24
pirfenidone,DISRUPTS,Apoptosis,32575019,10.1016/j.mehy.2020.110005,2020-06-24
pirfenidone,TREATS,Patients,32575019,10.1016/j.mehy.2020.110005,2020-06-24
Infectious disease prevention / control,TREATS,Persons,32575016,10.1016/j.mehy.2020.109958,2020-06-24
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
Weight Gain,PROCESS_OF,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
Blood Glucose Self-Monitoring,AFFECTS,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
"Stress, Psychological",PROCESS_OF,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
Pharmaceutical Preparations,TREATS,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
Insulin,TREATS,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
"Stress, Psychological",AFFECTS,Hyperglycemia,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
"Stress, Psychological",AFFECTS,Hypertensive disease,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
"Stress, Psychological",PROCESS_OF,Patients,32574982,10.1016/j.dsx.2020.05.044,2020-06-24
Pharmaceutical Preparations,AFFECTS,Immune response,32574958,10.1016/j.ebiom.2020.102836,2020-06-24
Pharmaceutical Preparations,TREATS,Virus Diseases,32574958,10.1016/j.ebiom.2020.102836,2020-06-24
Therapeutic procedure,CAUSES,Critical Illness,32574958,10.1016/j.ebiom.2020.102836,2020-06-24
Therapeutic procedure,CAUSES,Acute respiratory failure,32574958,10.1016/j.ebiom.2020.102836,2020-06-24
Lung,LOCATION_OF,Virus Diseases,32574958,10.1016/j.ebiom.2020.102836,2020-06-24
Autopsy,ADMINISTERED_TO,Human body,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Structure of parenchyma of lung,LOCATION_OF,Fibrin,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Lung,LOCATION_OF,ACE2 gene,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Cell surface,LOCATION_OF,ACE2 gene,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Alveolus,LOCATION_OF,Exudate,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Heart,LOCATION_OF,Tissue damage,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Lung,LOCATION_OF,Tissue damage,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Body tissue,LOCATION_OF,Tissue damage,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Body tissue,PART_OF,Lung,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
"Vitronectin, human",INTERACTS_WITH,macrophage,32574956,10.1016/j.ebiom.2020.102833,2020-06-24
Hospitals,LOCATION_OF,healthcare operations,32574897,10.1016/j.amjoto.2020.102617,2020-06-24
Universities,LOCATION_OF,healthcare operations,32574897,10.1016/j.amjoto.2020.102617,2020-06-24
Laboratory Infection,PROCESS_OF,Patients,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Asthenia,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Coughing,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Fever,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Headache,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Keratoconjunctivitis Sicca,AFFECTS,Esthesia,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
GSKIP gene,ASSOCIATED_WITH,Neurotropism,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Anosmia,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Dysgeusia,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Xerostomia,ISA,Symptoms,32574896,10.1016/j.amjoto.2020.102612,2020-06-24
Povidone-Iodine,TREATS,SARS coronavirus,32574894,10.1016/j.amjoto.2020.102618,2020-06-24
nasal packing,USES,Povidone-Iodine,32574894,10.1016/j.amjoto.2020.102618,2020-06-24
Hypersensitivity,PROCESS_OF,Health Personnel,32574894,10.1016/j.amjoto.2020.102618,2020-06-24
Hypersensitivity,PROCESS_OF,Patients,32574894,10.1016/j.amjoto.2020.102618,2020-06-24
Immunomodulation,TREATS,inflammatory response,32574840,10.1016/j.jaip.2020.06.015,2020-06-24
Virus,PROCESS_OF,Patients,32574840,10.1016/j.jaip.2020.06.015,2020-06-24
Therapeutic procedure,TREATS,Inflammation,32574840,10.1016/j.jaip.2020.06.015,2020-06-24
Virus present,PROCESS_OF,Patients,32574840,10.1016/j.jaip.2020.06.015,2020-06-24
tocilizumab,TREATS,"Respiratory Distress Syndrome, Adult",32574789,10.1016/j.micinf.2020.06.005,2020-06-24
Flow Cytometry,DIAGNOSES,patient condition,32574709,10.1016/j.clim.2020.108516,2020-06-24
Flow Cytometry,DIAGNOSES,patient condition,32574709,10.1016/j.clim.2020.108516,2020-06-24
Flow Cytometry,DIAGNOSES,patient condition,32574709,10.1016/j.clim.2020.108516,2020-06-24
Respiratory Failure,COEXISTS_WITH,Communicable Diseases,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Disease,PROCESS_OF,Patients,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Reactive Oxygen Species,PREDISPOSES,Oxidative Stress,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Extracellular Space,LOCATION_OF,Extracellular Vesicles,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Mitochondrial oxidative stress,PREDISPOSES,Dysbiosis,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Mitochondria,PART_OF,Extracellular,32574708,10.1016/j.mito.2020.06.008,2020-06-24
Infection,PROCESS_OF,Medical Staff,32574702,10.1016/j.jhin.2020.06.023,2020-06-24
Lung volume,PROCESS_OF,Patients,32574694,10.1016/j.ijid.2020.06.059,2020-06-24
Lung volume,PROCESS_OF,Patients,32574694,10.1016/j.ijid.2020.06.059,2020-06-24
Lung,LOCATION_OF,Lesion,32574694,10.1016/j.ijid.2020.06.059,2020-06-24
Lesion,PREDISPOSES,Poor outcome,32574694,10.1016/j.ijid.2020.06.059,2020-06-24
Coronavirus Infections,ISA,Disease,32574691,10.1016/j.ijid.2020.06.061,2020-06-24
Patients,USES,Preexisting Condition Coverage,32574691,10.1016/j.ijid.2020.06.061,2020-06-24
Bacterial Endocarditis,PROCESS_OF,Patients,32574691,10.1016/j.ijid.2020.06.061,2020-06-24
Rheumatic Heart Disease,PROCESS_OF,Patients,32574691,10.1016/j.ijid.2020.06.061,2020-06-24
Reporting,TREATS,Disease,32574691,10.1016/j.ijid.2020.06.061,2020-06-24
Colorectal Carcinoma,PROCESS_OF,Research Personnel,32574570,10.1016/j.gie.2020.06.042,2020-06-24
medical care,PROCESS_OF,"Populations, Underserved",32574570,10.1016/j.gie.2020.06.042,2020-06-24
Persons,NEG_LOCATION_OF,ABCB6 wt Allele,32574453,10.18294/sc.2020.2855,2020-06-24
Cirrhosis,ISA,Disease,32574408,10.1111/tid.13384,2020-06-24
Autoantibodies,NEG_AFFECTS,Immune system,32574379,10.1111/jnc.15098,2020-06-24
Blood,LOCATION_OF,Autoantibodies,32574379,10.1111/jnc.15098,2020-06-24
Antibodies,CAUSES,Neuropathy,32574379,10.1111/jnc.15098,2020-06-24
Pathology procedure,METHOD_OF,Extraction,32574379,10.1111/jnc.15098,2020-06-24
Polysaccharides,DISRUPTS,Tissue Adhesions,32574379,10.1111/jnc.15098,2020-06-24
angiotensin converting enzyme 2,DISRUPTS,Uptake,32574379,10.1111/jnc.15098,2020-06-24
Carbohydrates,COEXISTS_WITH,Vaccines,32574379,10.1111/jnc.15098,2020-06-24
Carbohydrates,COEXISTS_WITH,Pneumococcal vaccine,32574379,10.1111/jnc.15098,2020-06-24
Carbohydrates,COEXISTS_WITH,Meningococcal vaccine,32574379,10.1111/jnc.15098,2020-06-24
Vaccines,INTERACTS_WITH,Carbohydrates,32574379,10.1111/jnc.15098,2020-06-24
Vaccines,PART_OF,Microorganism,32574379,10.1111/jnc.15098,2020-06-24
Complex carbohydrate,PREVENTS,Disease,32574379,10.1111/jnc.15098,2020-06-24
Anxiety,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
Attention,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
Attention,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
Depressive disorder,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
Emotional disorder,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
Emotional disorder,PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
poor health,NEG_PROCESS_OF,Outpatients,32574346,10.1136/gpsych-2020-100231,2020-06-24
"Infant, Premature",PROCESS_OF,"Infant, Newborn",32574345,10.1136/bmjpo-2020-000718,2020-06-24
Premature Birth,PROCESS_OF,"Infant, Newborn",32574345,10.1136/bmjpo-2020-000718,2020-06-24
Speech,PROCESS_OF,Persons,32574342,10.3389/fmed.2020.00260,2020-06-24
Coronavirus Infections,ISA,Disease,32574338,10.3389/fmed.2020.00250,2020-06-24
Coronavirus Infections,ISA,Disease,32574338,10.3389/fmed.2020.00250,2020-06-24
Dyspnea,PROCESS_OF,Patients,32574337,10.3389/fmed.2020.00249,2020-06-24
Blood Glucose control,PREVENTS,Thrombus,32574337,10.3389/fmed.2020.00249,2020-06-24
angiotensin II,AFFECTS,Heart,32574336,10.3389/fmed.2020.00248,2020-06-24
angiotensin II,AFFECTS,Lung,32574336,10.3389/fmed.2020.00248,2020-06-24
Kidney,LOCATION_OF,Cardiac Arrhythmia,32574336,10.3389/fmed.2020.00248,2020-06-24
Kidney,LOCATION_OF,"Respiratory Distress Syndrome, Adult",32574336,10.3389/fmed.2020.00248,2020-06-24
Kidney,LOCATION_OF,Acute myocarditis,32574336,10.3389/fmed.2020.00248,2020-06-24
Heart failure,CAUSES,Cessation of life,32574336,10.3389/fmed.2020.00248,2020-06-24
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32574336,10.3389/fmed.2020.00248,2020-06-24
angiotensin II,PREVENTS,Acute Lung Injury,32574336,10.3389/fmed.2020.00248,2020-06-24
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32574336,10.3389/fmed.2020.00248,2020-06-24
lopinavir / Ritonavir,TREATS,Pneumonia,32574332,10.3389/fmed.2020.00241,2020-06-24
Pneumonia,PROCESS_OF,geriatric patients,32574332,10.3389/fmed.2020.00241,2020-06-24
lopinavir / Ritonavir,TREATS,Pneumonia,32574332,10.3389/fmed.2020.00241,2020-06-24
World,ISA,Population Group,32574327,10.3389/fmed.2020.00226,2020-06-24
Pharmaceutical Preparations,TREATS,Disease,32574327,10.3389/fmed.2020.00226,2020-06-24
Pneumonia,PROCESS_OF,Patients,32574318,10.3389/fcell.2020.00410,2020-06-24
Anti-Inflammatory Agents,TREATS,Disease,32574317,10.3389/fbioe.2020.00554,2020-06-24
Antimalarials,TREATS,Disease,32574317,10.3389/fbioe.2020.00554,2020-06-24
Therapeutic procedure,TREATS,Patients,32574317,10.3389/fbioe.2020.00554,2020-06-24
Therapeutic procedure,TREATS,Inflammation,32574317,10.3389/fbioe.2020.00554,2020-06-24
Secretory Vesicles,PART_OF,Extracellular,32574317,10.3389/fbioe.2020.00554,2020-06-24
Secretory Vesicles,PART_OF,Extracellular,32574317,10.3389/fbioe.2020.00554,2020-06-24
SARS coronavirus,CAUSES,Disease,32574317,10.3389/fbioe.2020.00554,2020-06-24
rapid diagnosis,USES,Biosensors,32574316,10.3389/fchem.2020.00517,2020-06-24
Paper,ISA,Materials,32574316,10.3389/fchem.2020.00517,2020-06-24
Textiles,ISA,Materials,32574316,10.3389/fchem.2020.00517,2020-06-24
Coronavirus Infections,ISA,Disease,32574313,10.3389/fpubh.2020.00253,2020-06-24
"Schools, Medical",LOCATION_OF,Study,32574313,10.3389/fpubh.2020.00253,2020-06-24
Coronavirus Infections,ISA,Disease,32574313,10.3389/fpubh.2020.00253,2020-06-24
Coronavirus Infections,ISA,Disease,32574313,10.3389/fpubh.2020.00253,2020-06-24
Chronic disease,PROCESS_OF,Old age,32574313,10.3389/fpubh.2020.00253,2020-06-24
Coronavirus Infections,ISA,Disease,32574313,10.3389/fpubh.2020.00253,2020-06-24
Chloroquine,TREATS,Autoimmune Diseases,32574312,10.3389/fpubh.2020.00252,2020-06-24
Chloroquine,TREATS,Malaria,32574312,10.3389/fpubh.2020.00252,2020-06-24
Hydroxychloroquine,TREATS,Autoimmune Diseases,32574312,10.3389/fpubh.2020.00252,2020-06-24
Hydroxychloroquine,TREATS,Malaria,32574312,10.3389/fpubh.2020.00252,2020-06-24
Pharmaceutical Preparations,CAUSES,Deafness,32574312,10.3389/fpubh.2020.00252,2020-06-24
Pharmaceutical Preparations,CAUSES(SPEC),Tinnitus,32574312,10.3389/fpubh.2020.00252,2020-06-24
Tinnitus,ISA,Deafness,32574312,10.3389/fpubh.2020.00252,2020-06-24
Chloroquine,TREATS,Congenital Abnormality,32574312,10.3389/fpubh.2020.00252,2020-06-24
Pregnant Women,LOCATION_OF,Congenital Abnormality,32574312,10.3389/fpubh.2020.00252,2020-06-24
Chloroquine,AFFECTS,Ototoxicity,32574312,10.3389/fpubh.2020.00252,2020-06-24
Chloroquine,TREATS,Malaria,32574312,10.3389/fpubh.2020.00252,2020-06-24
Chloroquine,TREATS,Survivors,32574312,10.3389/fpubh.2020.00252,2020-06-24
Hydroxychloroquine,TREATS,Survivors,32574312,10.3389/fpubh.2020.00252,2020-06-24
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Persons,32574304,10.3389/fpubh.2020.00235,2020-06-24
Coronavirus Infections,CAUSES,Epidemic disease,32574303,10.3389/fpubh.2020.00230,2020-06-24
Infected,PROCESS_OF,Population Group,32574303,10.3389/fpubh.2020.00230,2020-06-24
Infected,PROCESS_OF,Persons,32574303,10.3389/fpubh.2020.00230,2020-06-24
Communicable Diseases,PROCESS_OF,Homo sapiens,32574303,10.3389/fpubh.2020.00230,2020-06-24
Cessation of life,PROCESS_OF,Persons,32574303,10.3389/fpubh.2020.00230,2020-06-24
Italy,ISA,European country,32574301,10.3389/fpubh.2020.00222,2020-06-24
Coronavirus Infections,CAUSES,Illness (finding),32574299,10.3389/fpubh.2020.00216,2020-06-24
Anti-HIV Agents,ISA,Antiviral Agents,32574299,10.3389/fpubh.2020.00216,2020-06-24
Fever,ISA,Symptoms,32574296,10.3389/fpubh.2020.00205,2020-06-24
Fever,PROCESS_OF,Patients,32574296,10.3389/fpubh.2020.00205,2020-06-24
Triage,PREVENTS,Cross Infection,32574296,10.3389/fpubh.2020.00205,2020-06-24
Virus,PROCESS_OF,Population Group,32574295,10.3389/fpubh.2020.00202,2020-06-24
Male population group,ISA,Population Group,32574293,10.3389/fpubh.2020.00193,2020-06-24
Woman,ISA,Population Group,32574293,10.3389/fpubh.2020.00193,2020-06-24
Diarrhea,ISA,Symptoms,32574293,10.3389/fpubh.2020.00193,2020-06-24
Diarrhea,PROCESS_OF,Patients,32574293,10.3389/fpubh.2020.00193,2020-06-24
Coronavirus Infections,CAUSES,Acute infectious disease,32574292,10.3389/fpubh.2020.00189,2020-06-24
Protein S,INTERACTS_WITH,angiotensin converting enzyme 2,32574292,10.3389/fpubh.2020.00189,2020-06-24
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32574292,10.3389/fpubh.2020.00189,2020-06-24
Decision,PROCESS_OF,Maker (occupation),32574291,10.3389/fpubh.2020.00188,2020-06-24
Severe disorder,PROCESS_OF,Pregnant Women,32574287,10.3389/fped.2020.00294,2020-06-24
Respiratory secretion precautions,ISA,Isolation procedure,32574287,10.3389/fped.2020.00294,2020-06-24
Symptoms,PROCESS_OF,"Infant, Newborn",32574287,10.3389/fped.2020.00294,2020-06-24
Asymptomatic,PROCESS_OF,Infant,32574287,10.3389/fped.2020.00294,2020-06-24
Stabilization,NEG_TREATS,Infant,32574287,10.3389/fped.2020.00294,2020-06-24
Cessation of life,NEG_PROCESS_OF,Population Group,32574287,10.3389/fped.2020.00294,2020-06-24
Cessation of life,NEG_PROCESS_OF(SPEC),"Infant, Newborn",32574287,10.3389/fped.2020.00294,2020-06-24
"Infant, Newborn",ISA,Population Group,32574287,10.3389/fped.2020.00294,2020-06-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32574286,10.3389/fped.2020.00287,2020-06-24
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32574286,10.3389/fped.2020.00287,2020-06-24
Placenta,LOCATION_OF,Virus,32574285,10.3389/fped.2020.00276,2020-06-24
Serum,LOCATION_OF,Interleukin-6,32574285,10.3389/fped.2020.00276,2020-06-24
Serum,LOCATION_OF,CD40LG wt Allele,32574285,10.3389/fped.2020.00276,2020-06-24
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
exposure history,PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
Hydronephrosis,PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
Left kidney,LOCATION_OF,Calculi,32574284,10.3389/fped.2020.00258,2020-06-24
Fever,PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
Leukopenia,PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
Serum,LOCATION_OF,Ferritin,32574284,10.3389/fped.2020.00258,2020-06-24
Rotavirus Infections,PROCESS_OF,Patients,32574284,10.3389/fped.2020.00258,2020-06-24
"Signs and Symptoms, Respiratory",PROCESS_OF,Child,32574284,10.3389/fped.2020.00258,2020-06-24
Infected,PROCESS_OF,Persons,32574283,10.3389/fcimb.2020.00290,2020-06-24
Intervention regimes,PREVENTS,Disease,32574283,10.3389/fcimb.2020.00290,2020-06-24
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32574277,10.3389/fonc.2020.00862,2020-06-24
Seizures,PROCESS_OF,Patients,32574277,10.3389/fonc.2020.00862,2020-06-24
Airway structure,LOCATION_OF,Virus Diseases,32574274,10.3389/fimmu.2020.01248,2020-06-24
Airway structure,PART_OF,Lung,32574274,10.3389/fimmu.2020.01248,2020-06-24
Thalidomide,ISA,Pharmaceutical Preparations,32574274,10.3389/fimmu.2020.01248,2020-06-24
Thalidomide,TREATS,Respiratory complication,32574274,10.3389/fimmu.2020.01248,2020-06-24
Respiratory complication,COEXISTS_WITH,patient condition,32574274,10.3389/fimmu.2020.01248,2020-06-24
Pharmaceutical Preparations,TREATS,Lung diseases,32574274,10.3389/fimmu.2020.01248,2020-06-24
Thalidomide,TREATS,patient condition,32574274,10.3389/fimmu.2020.01248,2020-06-24
angiotensin converting enzyme 2,AFFECTS,Disease,32574273,10.3389/fimmu.2020.01239,2020-06-24
Plasma,LOCATION_OF,Aldosterone,32574273,10.3389/fimmu.2020.01239,2020-06-24
Glycyrrhizic Acid,TREATS,Infection,32574273,10.3389/fimmu.2020.01239,2020-06-24
Organ,LOCATION_OF,11-beta-Hydroxysteroid Dehydrogenases,32574273,10.3389/fimmu.2020.01239,2020-06-24
Organ,PRODUCES,Enzymes,32574273,10.3389/fimmu.2020.01239,2020-06-24
Glycyrrhizic Acid,INTERACTS_WITH,angiotensin converting enzyme 2,32574273,10.3389/fimmu.2020.01239,2020-06-24
"TLR4 protein, human",INHIBITS,Anti-Inflammatory Agents,32574273,10.3389/fimmu.2020.01239,2020-06-24
Glycyrrhetinic acid,DISRUPTS,viral transmission,32574273,10.3389/fimmu.2020.01239,2020-06-24
Serine Endopeptidases,PART_OF,integral to membrane,32574273,10.3389/fimmu.2020.01239,2020-06-24
Glycyrrhizic Acid,DISRUPTS,viral transmission,32574273,10.3389/fimmu.2020.01239,2020-06-24
Glycyrrhizic Acid,CAUSES,Disease,32574273,10.3389/fimmu.2020.01239,2020-06-24
Viral Proteins,INTERACTS_WITH,"Receptors, Cell Surface",32574272,10.3389/fimmu.2020.01229,2020-06-24
Serine Endopeptidases,PART_OF,integral to membrane,32574272,10.3389/fimmu.2020.01229,2020-06-24
"TMPRSS2 protein, human",AFFECTS,Virus Internalization,32574272,10.3389/fimmu.2020.01229,2020-06-24
Infected,PROCESS_OF,Patients,32574272,10.3389/fimmu.2020.01229,2020-06-24
Storm NOS,DISRUPTS,Antigen-Presenting Cells,32574272,10.3389/fimmu.2020.01229,2020-06-24
Coronavirus Infections,ISA,Disease,32574268,10.3389/fimmu.2020.01201,2020-06-24
"Pneumonia, Interstitial",PROCESS_OF,Persons,32574268,10.3389/fimmu.2020.01201,2020-06-24
Infected,PROCESS_OF,Persons,32574268,10.3389/fimmu.2020.01201,2020-06-24
Alveolar Epithelial Cells,PART_OF,Alveolar,32574268,10.3389/fimmu.2020.01201,2020-06-24
cytokine,STIMULATES,Immune Cell,32574268,10.3389/fimmu.2020.01201,2020-06-24
"Receptors, Pattern Recognition",PART_OF,Immune Cell,32574268,10.3389/fimmu.2020.01201,2020-06-24
Immune Cell,PRODUCES,cytokine,32574268,10.3389/fimmu.2020.01201,2020-06-24
,ASSOCIATED_WITH,Coronavirus Infections,32574268,10.3389/fimmu.2020.01201,2020-06-24
Interleukin-1 beta,ASSOCIATED_WITH,Coronavirus Infections,32574268,10.3389/fimmu.2020.01201,2020-06-24
cytokine,ASSOCIATED_WITH,Coronavirus Infections,32574268,10.3389/fimmu.2020.01201,2020-06-24
"CCL2 protein, human",ASSOCIATED_WITH,Coronavirus Infections,32574268,10.3389/fimmu.2020.01201,2020-06-24
Recombinant Interferon-alpha Inducible Protein 10,ASSOCIATED_WITH,Coronavirus Infections,32574268,10.3389/fimmu.2020.01201,2020-06-24
cytokine,AFFECTS,Immune response,32574268,10.3389/fimmu.2020.01201,2020-06-24
"Pneumonia, Interstitial",ISA,Inflammation,32574268,10.3389/fimmu.2020.01201,2020-06-24
Infected,PROCESS_OF,Patients,32574268,10.3389/fimmu.2020.01201,2020-06-24
"CD69 protein, human",PART_OF,Patients,32574268,10.3389/fimmu.2020.01201,2020-06-24
Complication,PROCESS_OF,Persons,32574265,10.3389/fimmu.2020.01131,2020-06-24
Antiviral Agents,AFFECTS,Antiviral Response,32574265,10.3389/fimmu.2020.01131,2020-06-24
Interventional procedure,USES,Pharmaceutical Preparations,32574265,10.3389/fimmu.2020.01131,2020-06-24
Adult-Onset Still Disease,ISA,Rheumatism,32574264,10.3389/fimmu.2020.01130,2020-06-24
Immunomodulation,TREATS,Hyperactive behavior,32574264,10.3389/fimmu.2020.01130,2020-06-24
Coronavirus Infections,CAUSES,Disease,32574263,10.3389/fimmu.2020.01091,2020-06-24
Mesenchymal Stromal Cells,PART_OF,bony process,32574263,10.3389/fimmu.2020.01091,2020-06-24
Disease,COEXISTS_WITH,patient condition,32574263,10.3389/fimmu.2020.01091,2020-06-24
Therapeutic procedure,TREATS,Inflammation,32574263,10.3389/fimmu.2020.01091,2020-06-24
Therapeutic procedure,TREATS,Pneumonia,32574263,10.3389/fimmu.2020.01091,2020-06-24
Therapeutic procedure,TREATS,Septicemia,32574263,10.3389/fimmu.2020.01091,2020-06-24
Therapeutic procedure,USES,,32574263,10.3389/fimmu.2020.01091,2020-06-24
patient condition,COEXISTS_WITH,Disseminated Intravascular Coagulation,32574263,10.3389/fimmu.2020.01091,2020-06-24
patient condition,COEXISTS_WITH,Multiple Organ Failure,32574263,10.3389/fimmu.2020.01091,2020-06-24
patient condition,COEXISTS_WITH,Thromboembolism,32574263,10.3389/fimmu.2020.01091,2020-06-24
patient condition,COEXISTS_WITH,Thrombophilia,32574263,10.3389/fimmu.2020.01091,2020-06-24
Birth,ASSOCIATED_WITH,Disease,32574263,10.3389/fimmu.2020.01091,2020-06-24
Birth,PRODUCES,Thromboplastin,32574263,10.3389/fimmu.2020.01091,2020-06-24
Thromboplastin,ISA,Procoagulant,32574263,10.3389/fimmu.2020.01091,2020-06-24
,ASSOCIATED_WITH,Disease,32574263,10.3389/fimmu.2020.01091,2020-06-24
Disease,CAUSES,Wound Healing,32574263,10.3389/fimmu.2020.01091,2020-06-24
Organ,LOCATION_OF,Protection,32574263,10.3389/fimmu.2020.01091,2020-06-24
Organ Transplantation,ISA,Therapeutic procedure,32574263,10.3389/fimmu.2020.01091,2020-06-24
Mesenchymal Stromal Cells,PART_OF,bony process,32574263,10.3389/fimmu.2020.01091,2020-06-24
Serum,LOCATION_OF,cytokine,32574262,10.3389/fimmu.2020.01061,2020-06-24
Virus,LOCATION_OF,Duration,32574262,10.3389/fimmu.2020.01061,2020-06-24
arbidol,INHIBITS,Duration,32574262,10.3389/fimmu.2020.01061,2020-06-24
Upper respiratory tract,LOCATION_OF,Virus,32574262,10.3389/fimmu.2020.01061,2020-06-24
Symptoms,ASSOCIATED_WITH,Disease,32574261,10.3389/fimmu.2020.01049,2020-06-24
Humoral Immunity,PROCESS_OF,Patients,32574261,10.3389/fimmu.2020.01049,2020-06-24
Complication,MANIFESTATION_OF,Coronavirus Infections,32574260,10.3389/fimmu.2020.01022,2020-06-24
acute inflammatory response,CAUSES,Pulmonary Fibrosis,32574260,10.3389/fimmu.2020.01022,2020-06-24
acute inflammatory response,CAUSES,"Respiratory Distress Syndrome, Adult",32574260,10.3389/fimmu.2020.01022,2020-06-24
Vaccines,PREVENTS,Coronavirus Infections,32574260,10.3389/fimmu.2020.01022,2020-06-24
Pulmonary Fibrosis,PROCESS_OF,Patients,32574260,10.3389/fimmu.2020.01022,2020-06-24
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32574260,10.3389/fimmu.2020.01022,2020-06-24
Infected,PROCESS_OF,Patients,32574260,10.3389/fimmu.2020.01022,2020-06-24
Combined Modality Therapy,PREVENTS,Complication,32574260,10.3389/fimmu.2020.01022,2020-06-24
Syndrome,PROCESS_OF,Patients,32574260,10.3389/fimmu.2020.01022,2020-06-24
BCG Vaccine,PREVENTS,Tuberculosis,32574258,10.3389/fimmu.2020.00970,2020-06-24
Coronavirus Infections,ISA,Disease,32574257,10.3389/fimmu.2020.00944,2020-06-24
Coronavirus Infections,ISA,Disease,32574257,10.3389/fimmu.2020.00944,2020-06-24
mental health,PROCESS_OF,Persons,32574257,10.3389/fimmu.2020.00944,2020-06-24
Coronavirus Infections,ISA,Disease,32574257,10.3389/fimmu.2020.00944,2020-06-24
Coronavirus Infections,CAUSES,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Middle East Respiratory Syndrome Coronavirus,CAUSES,Communicable Diseases,32574255,10.3389/fmicb.2020.01186,2020-06-24
Respiration Disorders,AFFECTS,Pregnant Women,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Pharmaceutical Preparations,TREATS,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Coronavirus Infections,ISA,Disease,32574255,10.3389/fmicb.2020.01186,2020-06-24
Acute Disease,PROCESS_OF,Patients,32574252,10.3389/fneur.2020.00579,2020-06-24
Health Personnel,TREATS,Patients,32574252,10.3389/fneur.2020.00579,2020-06-24
Thrombectomy,TREATS,patient condition,32574252,10.3389/fneur.2020.00579,2020-06-24
Cerebellar Ataxia,PROCESS_OF,Patients,32574247,10.3389/fneur.2020.00516,2020-06-24
Disease,COEXISTS_WITH,Comorbidity,32574247,10.3389/fneur.2020.00516,2020-06-24
Cerebellar Ataxia,PROCESS_OF,Patients,32574247,10.3389/fneur.2020.00516,2020-06-24
Impaired mobility,PROCESS_OF,Patients,32574247,10.3389/fneur.2020.00516,2020-06-24
Cerebellar Ataxia,PROCESS_OF,Patients,32574247,10.3389/fneur.2020.00516,2020-06-24
Coronavirus Infections,ISA,Disease,32574245,10.3389/fneur.2020.00468,2020-06-24
Symptom severe,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Disease,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
risk factors,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Coronavirus Infections,ISA,Disease,32574245,10.3389/fneur.2020.00468,2020-06-24
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Asymptomatic cerebrovascular disease,PREDISPOSES,Cerebrovascular accident,32574245,10.3389/fneur.2020.00468,2020-06-24
complication of disease,CAUSES,Ischemic stroke,32574245,10.3389/fneur.2020.00468,2020-06-24
Ischemic stroke,PREDISPOSES,Cerebrovascular accident,32574245,10.3389/fneur.2020.00468,2020-06-24
Ischemic stroke,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Vascular occlusion,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Vascular occlusion,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Coronavirus Infections,ISA,Disease,32574245,10.3389/fneur.2020.00468,2020-06-24
Possible,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Vascular occlusion,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Mechanical thrombectomy,TREATS,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Disease,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Coronavirus Infections,ISA,Disease,32574245,10.3389/fneur.2020.00468,2020-06-24
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Ischemic stroke,PROCESS_OF,Patients,32574245,10.3389/fneur.2020.00468,2020-06-24
Anxiety,PROCESS_OF,Persons,32574244,10.3389/fpsyg.2020.01168,2020-06-24
Panic,PROCESS_OF,Persons,32574244,10.3389/fpsyg.2020.01168,2020-06-24
Stress,PROCESS_OF,Persons,32574244,10.3389/fpsyg.2020.01168,2020-06-24
Universities,LOCATION_OF,Study,32574244,10.3389/fpsyg.2020.01168,2020-06-24
Complicated grieving,PROCESS_OF,Persons,32574243,10.3389/fpsyt.2020.00489,2020-06-24
Disease,AFFECTS,Health Personnel,32574242,10.3389/fpsyt.2020.00459,2020-06-24
Disease,AFFECTS,Patients,32574242,10.3389/fpsyt.2020.00459,2020-06-24
Mental health problem,PROCESS_OF,Persons,32574242,10.3389/fpsyt.2020.00459,2020-06-24
Mental health problem,PROCESS_OF,student,32574242,10.3389/fpsyt.2020.00459,2020-06-24
Homo sapiens,LOCATION_OF,TMPRSS2 gene,32574196,10.1371/journal.pone.0235106,2020-06-24
Asians,ISA,Primates,32574196,10.1371/journal.pone.0235106,2020-06-24
sphingosine 1-phosphate,ISA,Agent,32574196,10.1371/journal.pone.0235106,2020-06-24
Homo sapiens,ISA,Primates,32574196,10.1371/journal.pone.0235106,2020-06-24
ACE2 gene,PART_OF,Savannah Monkey,32574196,10.1371/journal.pone.0235106,2020-06-24
consideration,PROCESS_OF,Community,32574196,10.1371/journal.pone.0235106,2020-06-24
Virus,CAUSES,Disease,32574184,10.1371/journal.pone.0235112,2020-06-24
Virus,CAUSES(SPEC),Coronavirus Infections,32574184,10.1371/journal.pone.0235112,2020-06-24
Coronavirus Infections,ISA,Disease,32574184,10.1371/journal.pone.0235112,2020-06-24
Coronavirus Infections,ISA,Disease,32574184,10.1371/journal.pone.0235112,2020-06-24
Coronavirus Infections,ISA,Disease,32574184,10.1371/journal.pone.0235112,2020-06-24
Confidence,PROCESS_OF,Community,32574184,10.1371/journal.pone.0235112,2020-06-24
Infected,PROCESS_OF,traveler,32574177,10.1371/journal.pone.0234955,2020-06-24
Infected,PROCESS_OF,traveler,32574177,10.1371/journal.pone.0234955,2020-06-24
Coronavirus Infections,PROCESS_OF,traveler,32574177,10.1371/journal.pone.0234955,2020-06-24
1 - 3,PROCESS_OF,traveler,32574177,10.1371/journal.pone.0234955,2020-06-24
Fever,ISA,Symptoms,32574165,10.1371/journal.pone.0234765,2020-06-24
body membrane,LOCATION_OF,Alveolar ventilation function,32574165,10.1371/journal.pone.0234765,2020-06-24
Coughing,ISA,Symptoms,32574165,10.1371/journal.pone.0234765,2020-06-24
Fever,ISA,Symptoms,32574165,10.1371/journal.pone.0234765,2020-06-24
Infected,PROCESS_OF,Adult,32574165,10.1371/journal.pone.0234765,2020-06-24
Resident (physician),LOCATION_OF,IMPACT gene,32574154,10.1172/JCI140296,2020-06-24
Protection,PROCESS_OF,Health Personnel,32574154,10.1172/JCI140296,2020-06-24
WASF1 gene,AFFECTS,Readiness,32574154,10.1172/JCI140296,2020-06-24
Coronavirus Infections,ISA,Disease,32574139,10.3201/eid2609.202603,2020-06-24
IMPACT gene,ASSOCIATED_WITH,Neoplasms,32574131,10.1200/OP.20.00297,2020-06-24
Host-Pathogen Interactions,AFFECTS,Homo sapiens,32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
Host-Pathogen Interactions,AFFECTS,Host (organism),32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
inhibitors,ISA,Pharmaceutical Preparations,32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
"PRSS2 protein, human",INHIBITS,Protease Inhibitors,32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
"PRSS2 protein, human",INHIBITS,camostate-mesilate,32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
"PRSS2 protein, human",INHIBITS,nafamostat mesilate,32574109,10.1146/annurev-pharmtox-061220-093932,2020-06-24
Disease,PROCESS_OF,Child,32574107,10.1080/22221751.2020.1785336,2020-06-24
Aspirin,STIMULATES,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Ergocalciferol,STIMULATES,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
"Immunoglobulins, Intravenous",STIMULATES,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Mus,LOCATION_OF,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
TMEM173 gene,INTERACTS_WITH,ACE2 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Aspirin,DISRUPTS,thromboplastin activity,32574107,10.1080/22221751.2020.1785336,2020-06-24
Aspirin,INHIBITS,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Dipyridamole,DISRUPTS,thromboplastin activity,32574107,10.1080/22221751.2020.1785336,2020-06-24
Aspirin,STIMULATES,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Dipyridamole,STIMULATES,TMEM173 gene,32574107,10.1080/22221751.2020.1785336,2020-06-24
Hemorrhage,NEG_PROCESS_OF,Patients,32574107,10.1080/22221751.2020.1785336,2020-06-24
risk factors,PROCESS_OF,Population Group,32574081,10.1080/14787210.2020.1776115,2020-06-24
Vaccines,ISA,Agent,32574081,10.1080/14787210.2020.1776115,2020-06-24
Vaccines,PREVENTS,Virus Diseases,32574081,10.1080/14787210.2020.1776115,2020-06-24
Basis,INHIBITS,IMPACT gene,32574081,10.1080/14787210.2020.1776115,2020-06-24
Serum,LOCATION_OF,Glucose,32573995,10.1515/cclm-2020-0459,2020-06-24
International Normalized Ratio,USES,Prothrombin time assay,32573995,10.1515/cclm-2020-0459,2020-06-24
patient condition,PREDISPOSES,Death in hospital,32573995,10.1515/cclm-2020-0459,2020-06-24
Pneumonia,ISA,Disease,32573990,10.1111/tid.13380,2020-06-24
tocilizumab,TREATS,Symptoms,32573990,10.1111/tid.13380,2020-06-24
Woman,LOCATION_OF,EHD1 wt Allele,32573966,10.1111/jocd.13539,2020-06-24
Virus Diseases,ISA,Communicable Diseases,32573919,10.1111/jocd.13559,2020-06-24
Comorbidity,PROCESS_OF,Persons,32573903,10.1111/dom.14124,2020-06-24
Comorbidity,PROCESS_OF,Patients,32573903,10.1111/dom.14124,2020-06-24
Disease,OCCURS_IN,Persons,32573903,10.1111/dom.14124,2020-06-24
Comorbidity,PROCESS_OF,Patients,32573903,10.1111/dom.14124,2020-06-24
Disease,PROCESS_OF,Patients,32573903,10.1111/dom.14124,2020-06-24
Present,PREDISPOSES,Comorbidity,32573903,10.1111/dom.14124,2020-06-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32573895,10.1111/tid.13377,2020-06-24
Italy,ISA,Geographic Locations,32573895,10.1111/tid.13377,2020-06-24
tocilizumab,ISA,Interleukin inhibitors,32573895,10.1111/tid.13377,2020-06-24
Screening procedure,TREATS,inpatient,32573894,10.1111/tid.13376,2020-06-24
Screening procedure,TREATS,Patients,32573894,10.1111/tid.13376,2020-06-24
World,ISA,Population Group,32573883,10.1111/liv.14575,2020-06-24
Infected,PROCESS_OF,Patients,32573883,10.1111/liv.14575,2020-06-24
Coronavirus Infections,ISA,Disease,32573882,10.1111/tid.13378,2020-06-24
Disease,COEXISTS_WITH,Immunocompromised Host,32573882,10.1111/tid.13378,2020-06-24
Pneumonia,PROCESS_OF,Transplant Recipients,32573882,10.1111/tid.13378,2020-06-24
Immunocompromised Host,PROCESS_OF,Persons,32573882,10.1111/tid.13378,2020-06-24
Immunocompromised Host,PROCESS_OF(SPEC),Transplant Recipients,32573882,10.1111/tid.13378,2020-06-24
Immunocompromised Host,PROCESS_OF(SPEC),Transplant Recipients,32573882,10.1111/tid.13378,2020-06-24
Transplant Recipients,ISA,Persons,32573882,10.1111/tid.13378,2020-06-24
Transplant Recipients,ISA,Persons,32573882,10.1111/tid.13378,2020-06-24
Experience,PROCESS_OF,Transplant Recipients,32573882,10.1111/tid.13378,2020-06-24
Methylprednisolone,ADMINISTERED_TO,Patients,32573882,10.1111/tid.13378,2020-06-24
"Transplantation, Homologous",TREATS,Stable Disease,32573882,10.1111/tid.13378,2020-06-24
"Anemia, Sickle Cell",ISA,Complication,32573838,10.1111/ejh.13476,2020-06-24
"Anemia, Sickle Cell",PREDISPOSES,Complication,32573838,10.1111/ejh.13476,2020-06-24
"Anemia, Sickle Cell",PREDISPOSES(SPEC),Thalassemia,32573838,10.1111/ejh.13476,2020-06-24
Hemoglobinopathies,PROCESS_OF,Patients,32573838,10.1111/ejh.13476,2020-06-24
Thalassemia,ISA,Complication,32573838,10.1111/ejh.13476,2020-06-24
Thalassemia,PREDISPOSES,Complication,32573838,10.1111/ejh.13476,2020-06-24
Thalassemia,PREDISPOSES(SPEC),"Anemia, Sickle Cell",32573838,10.1111/ejh.13476,2020-06-24
Hemoglobinopathies,PROCESS_OF,Patients,32573838,10.1111/ejh.13476,2020-06-24
Coronavirus Infections,PROCESS_OF,Patients,32573838,10.1111/ejh.13476,2020-06-24
Hemoglobinopathies,COEXISTS_WITH,Disease,32573838,10.1111/ejh.13476,2020-06-24
Challenge,USES,"SUPPLY, NOT OTHERWISE SPECIFIED",32573838,10.1111/ejh.13476,2020-06-24
Protein Biosynthesis,PROCESS_OF,Cells,32573788,10.1002/jmv.26212,2020-06-24
Organ,LOCATION_OF,angiotensin converting enzyme 2,32573788,10.1002/jmv.26212,2020-06-24
Organ,PART_OF,Homo sapiens,32573788,10.1002/jmv.26212,2020-06-24
Body tissue,PRODUCES,angiotensin converting enzyme 2,32573788,10.1002/jmv.26212,2020-06-24
Organ,LOCATION_OF,angiotensin converting enzyme 2,32573788,10.1002/jmv.26212,2020-06-24
Organ,PART_OF,Homo sapiens,32573788,10.1002/jmv.26212,2020-06-24
Neurologic Deficits,PROCESS_OF,Patients,32573788,10.1002/jmv.26212,2020-06-24
Peptides,INTERACTS_WITH,Alleles,32573788,10.1002/jmv.26212,2020-06-24
Malignant Neoplasms,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Malignant Neoplasms,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Disease,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Hospitals,LOCATION_OF,Multicenter Study,32573776,10.1002/cncr.33042,2020-06-24
Coronavirus Infections,ISA,Disease,32573776,10.1002/cncr.33042,2020-06-24
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32573776,10.1002/cncr.33042,2020-06-24
Malignant Neoplasms,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Active Method,ADMINISTERED_TO,Patients,32573776,10.1002/cncr.33042,2020-06-24
Malignant Neoplasms,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Infected,PROCESS_OF,Patients,32573776,10.1002/cncr.33042,2020-06-24
Disease,CAUSES,Primary Health Care,32573773,10.1111/eci.13329,2020-06-24
Respiratory Failure,COEXISTS_WITH,Comorbidity,32573773,10.1111/eci.13329,2020-06-24
Heart,LOCATION_OF,Medical Valves,32573737,10.1093/ejcts/ezaa228,2020-06-24
Coronavirus Infections,ISA,Disease,32573737,10.1093/ejcts/ezaa228,2020-06-24
GSKIP gene,INTERACTS_WITH,Program,32573737,10.1093/ejcts/ezaa228,2020-06-24
Program,ADMINISTERED_TO,teams,32573737,10.1093/ejcts/ezaa228,2020-06-24
patient condition,PROCESS_OF,Patients,32573724,10.1182/blood.2020007079,2020-06-24
Symptom severe,PROCESS_OF,Patients,32573724,10.1182/blood.2020007079,2020-06-24
Handling,PROCESS_OF,Patients,32573713,10.1093/jalm/jfaa098,2020-06-24
Complication,PREDISPOSES,Single organ dysfunction,32573711,10.1182/blood.2020007214,2020-06-24
Complication,PROCESS_OF,Patients,32573711,10.1182/blood.2020007214,2020-06-24
Septicemia,COEXISTS_WITH,Disseminated coagulopathy,32573711,10.1182/blood.2020007214,2020-06-24
Present,PROCESS_OF,Patients,32573711,10.1182/blood.2020007214,2020-06-24
Major change,PREDISPOSES,Thrombosis,32573711,10.1182/blood.2020007214,2020-06-24
Coronavirus Infections,ISA,Disease,32573711,10.1182/blood.2020007214,2020-06-24
Severe Acute Respiratory Syndrome,PREDISPOSES,Disease,32573711,10.1182/blood.2020007214,2020-06-24
Severe Acute Respiratory Syndrome,PREDISPOSES(SPEC),Coronavirus Infections,32573711,10.1182/blood.2020007214,2020-06-24
Coronavirus Infections,ISA,Disease,32573538,10.17116/hirurgia202006190,2020-06-24
Chloroquine,ISA,Pharmaceutical Preparations,32573538,10.17116/hirurgia202006190,2020-06-24
Cessation of life,PROCESS_OF,Persons,32573501,10.23750/abm.v91i6-S.10047,2020-06-24
Electron Microscopy,MEASURES,Antibody Formation,32573498,10.1172/JCI139569,2020-06-24
Histological Techniques,DIAGNOSES,Infiltration,32573498,10.1172/JCI139569,2020-06-24
Vascular Diseases,PROCESS_OF,Pregnant Women,32573498,10.1172/JCI139569,2020-06-24
Plasma,LOCATION_OF,Metabolite,32573468,10.1515/cclm-2020-0612,2020-06-24
Ward (environment),LOCATION_OF,Work,32573443,10.1016/S2214-109X(20)30204-7,2020-06-24
Self-Management,ADMINISTERED_TO,Health Personnel,32573443,10.1016/S2214-109X(20)30204-7,2020-06-24
Patients,LOCATION_OF,Plasma,32573433,10.7554/eLife.57877,2020-06-24
Vaccines,PART_OF,Patients,32573433,10.7554/eLife.57877,2020-06-24
Infected,PROCESS_OF,Patients,32573433,10.7554/eLife.57877,2020-06-24
Patients,LOCATION_OF,Antibodies,32573433,10.7554/eLife.57877,2020-06-24
Infected,PROCESS_OF,Patients,32573433,10.7554/eLife.57877,2020-06-24
prednisolone,ISA,Anti-Inflammatory Agents,32573355,10.1080/07391102.2020.1779133,2020-06-24
sinefungin,INHIBITS,"Zinc Finger FYVE Domain-Containing Protein 9, human",32573355,10.1080/07391102.2020.1779133,2020-06-24
Syndrome,PROCESS_OF,Patients,32573351,10.1080/07391102.2020.1778537,2020-06-24
ACE2 gene,PART_OF,Homo sapiens,32573351,10.1080/07391102.2020.1778537,2020-06-24
Peptide Hydrolases,AFFECTS,Virus Replication,32573351,10.1080/07391102.2020.1778537,2020-06-24
Trauma Centers,LOCATION_OF,Observational Study,32573331,10.1080/17453674.2020.1783621,2020-06-24
Hip Fractures,COEXISTS_WITH,extremity injury,32573331,10.1080/17453674.2020.1783621,2020-06-24
Multiple Trauma,COEXISTS_WITH,extremity injury,32573331,10.1080/17453674.2020.1783621,2020-06-24
Diabetes,ISA,Disease,32573311,10.1080/00325481.2020.1786964,2020-06-24
Diabetes,PREDISPOSES(SPEC),Severe disorder,32573311,10.1080/00325481.2020.1786964,2020-06-24
Disease,PREDISPOSES,Severe disorder,32573311,10.1080/00325481.2020.1786964,2020-06-24
Hypertensive disease,ISA,Disease,32573311,10.1080/00325481.2020.1786964,2020-06-24
Hypertensive disease,PREDISPOSES(SPEC),Severe disorder,32573311,10.1080/00325481.2020.1786964,2020-06-24
Respiration Disorders,ISA,Disease,32573311,10.1080/00325481.2020.1786964,2020-06-24
Respiration Disorders,PREDISPOSES(SPEC),Severe disorder,32573311,10.1080/00325481.2020.1786964,2020-06-24
Suspected drug abuse,PROCESS_OF,Child,32573297,10.1080/17453674.2020.1782012,2020-06-24
Protection,PROCESS_OF,teams,32573297,10.1080/17453674.2020.1782012,2020-06-24
Symptom mild,PROCESS_OF,Patients,32573293,10.1080/07420528.2020.1775241,2020-06-24
Symptom severe,PROCESS_OF,Patients,32573293,10.1080/07420528.2020.1775241,2020-06-24
Actigraphy,ISA,Evaluation procedure,32573293,10.1080/07420528.2020.1775241,2020-06-24
Evaluation procedure,USES,Actigraphy,32573293,10.1080/07420528.2020.1775241,2020-06-24
Orthopedic Surgeons,USES,Surgical helmet system,32573285,10.1080/17453674.2020.1771525,2020-06-24
Surgical helmet system,NEG_USES,Respiratory Protective Devices,32573285,10.1080/17453674.2020.1771525,2020-06-24
Anxiety,PROCESS_OF,Pregnant Women,32573258,10.1080/02646838.2020.1786037,2020-06-24
Distress,PROCESS_OF,Pregnant Women,32573258,10.1080/02646838.2020.1786037,2020-06-24
Attention,PROCESS_OF,World,32573207,10.1021/acs.analchem.0c02060,2020-06-24
Molecular Diagnosis,DIAGNOSES,SARS coronavirus,32573207,10.1021/acs.analchem.0c02060,2020-06-24
"Discharge, body substance",PART_OF,Patients,32573175,10.4081/monaldi.2020.1444,2020-06-24
Patients,ISA,Persons,32573175,10.4081/monaldi.2020.1444,2020-06-24
Operative Surgical Procedures,ISA,Interventional procedure,32573106,10.1002/alr.22646,2020-06-24
Nasal Lavage,TREATS,Craniosynostosis,32573106,10.1002/alr.22646,2020-06-24
Craniosynostosis,PROCESS_OF,Patients,32573106,10.1002/alr.22646,2020-06-24
Irrigation,TREATS,Symptoms,32573106,10.1002/alr.22646,2020-06-24
Nasal Lavage,TREATS,Patients,32573106,10.1002/alr.22646,2020-06-24
Craniosynostosis,PROCESS_OF,Patients,32573106,10.1002/alr.22646,2020-06-24
Nasal Lavage,TREATS,Patients,32573106,10.1002/alr.22646,2020-06-24
Operative Surgical Procedures,ISA,Interventional procedure,32573106,10.1002/alr.22646,2020-06-24
Nasal Lavage,TREATS,Craniosynostosis,32573106,10.1002/alr.22646,2020-06-24
Hobbies,ISA,Activities,32573074,10.1111/bjhp.12450,2020-06-24
Curb,AFFECTS,Research Personnel,32572981,10.1111/bjso.12401,2020-06-24
Antibodies,COEXISTS_WITH,GSKIP gene,32572869,10.1055/a-1197-4293,2020-06-24
Enzyme-Linked Immunosorbent Assay,ISA,Laboratory Procedures,32572869,10.1055/a-1197-4293,2020-06-24
Laboratory Procedures,USES,Enzyme-Linked Immunosorbent Assay,32572869,10.1055/a-1197-4293,2020-06-24
Laboratory Procedures,USES,Indirect Immunofluorescence,32572869,10.1055/a-1197-4293,2020-06-24
Serum,NEG_PART_OF,Mother (person),32572869,10.1055/a-1197-4293,2020-06-24
Indirect Immunofluorescence,ISA,Laboratory Procedures,32572869,10.1055/a-1197-4293,2020-06-24
Laboratory Procedures,USES,Indirect Immunofluorescence,32572869,10.1055/a-1197-4293,2020-06-24
Indirect Immunofluorescence,ISA,Laboratory Procedures,32572869,10.1055/a-1197-4293,2020-06-24
teams,LOCATION_OF,IMPACT gene,32572861,10.1055/a-1204-5212,2020-06-24
Acquired Immunodeficiency Syndrome,AFFECTS,Homo sapiens,32572861,10.1055/a-1204-5212,2020-06-24
Patients,ISA,Persons,32572842,10.1007/s40264-020-00965-w,2020-06-24
Pharmaceutical Preparations,AFFECTS,Disease,32572842,10.1007/s40264-020-00965-w,2020-06-24
Critical Illness,PROCESS_OF,Patients,32572835,10.1007/s13365-020-00869-6,2020-06-24
Intracranial Hemorrhages,PROCESS_OF,Patients,32572835,10.1007/s13365-020-00869-6,2020-06-24
Experience,PROCESS_OF,World,32572816,10.1007/s11748-020-01417-z,2020-06-24
Hospitals,LOCATION_OF,Retrospective Studies,32572809,10.1007/s11427-020-1751-3,2020-06-24
Lung,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Lung,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Alveolar,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Alveolar,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Alveolar,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Alveolar,LOCATION_OF,Decreased translucency,32572707,10.1007/s10140-020-01808-y,2020-06-24
Hospitalization,TREATS,Poor outcome,32572707,10.1007/s10140-020-01808-y,2020-06-24
Accident and Emergency department,LOCATION_OF,Retrospective Cohort Study,32572616,10.1007/s00404-020-05655-7,2020-06-24
Medical center,LOCATION_OF,Retrospective Cohort Study,32572616,10.1007/s00404-020-05655-7,2020-06-24
Rheumatism,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Rheumatism,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Rheumatism,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Rheumatism,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Hydroxychloroquine,TREATS,Protection,32572609,10.1007/s00296-020-04626-0,2020-06-24
Anxiety,PROCESS_OF,"Personnel, Hospital",32572609,10.1007/s00296-020-04626-0,2020-06-24
Depressive disorder,PROCESS_OF,Staff,32572609,10.1007/s00296-020-04626-0,2020-06-24
Rheumatism,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Stress,PROCESS_OF,Patients,32572609,10.1007/s00296-020-04626-0,2020-06-24
Psychiatric symptom,COEXISTS_WITH,Co-morbid conditions,32572609,10.1007/s00296-020-04626-0,2020-06-24
Symptoms,PROCESS_OF,Psychiatric inpatient,32572609,10.1007/s00296-020-04626-0,2020-06-24
Patients,LOCATION_OF,GSKIP gene,32572564,10.1007/s00405-020-06138-w,2020-06-24
Malignant Head and Neck Neoplasm,COEXISTS_WITH,Non-Ossifying Fibroma,32572564,10.1007/s00405-020-06138-w,2020-06-24
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32572564,10.1007/s00405-020-06138-w,2020-06-24
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32572564,10.1007/s00405-020-06138-w,2020-06-24
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32572564,10.1007/s00405-020-06138-w,2020-06-24
Universities,LOCATION_OF,Diagnosis,32572561,10.1007/s00259-020-04931-7,2020-06-24
conjunctiva,LOCATION_OF,Smear test,32572552,10.1007/s00347-020-01150-1,2020-06-24
conjunctiva,LOCATION_OF,Can Do Very Little,32572552,10.1007/s00347-020-01150-1,2020-06-24
Smear test,DIAGNOSES,Can Do Very Little,32572552,10.1007/s00347-020-01150-1,2020-06-24
Influenza,PROCESS_OF,Patients,32572532,10.1007/s00134-020-06091-6,2020-06-24
Invasive Pulmonary Aspergillosis,PROCESS_OF,Patients,32572532,10.1007/s00134-020-06091-6,2020-06-24
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32572532,10.1007/s00134-020-06091-6,2020-06-24
Pulmonary Aspergillosis,PROCESS_OF,Patients,32572532,10.1007/s00134-020-06091-6,2020-06-24
Upper respiratory sample,LOCATION_OF,galactomannan,32572532,10.1007/s00134-020-06091-6,2020-06-24
Pulmonary Aspergillosis,PROCESS_OF,Patients,32572532,10.1007/s00134-020-06091-6,2020-06-24
Coronavirus Infections,CAUSES,Challenge,32572378,10.1016/j.dib.2020.105854,2020-06-24
Virus,CAUSES,Respiration Disorders,32572376,10.1016/j.cmrp.2020.05.013,2020-06-24
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32572376,10.1016/j.cmrp.2020.05.013,2020-06-24
Hydroxychloroquine,ISA,Chloroquine,32572376,10.1016/j.cmrp.2020.05.013,2020-06-24
Septicemia,CAUSES,Blood Coagulation Disorders,32572363,10.1016/j.idcr.2020.e00867,2020-06-24
Consultation,ADMINISTERED_TO,Patients,32572350,10.1186/s40545-020-00241-3,2020-06-24
Symptoms,PROCESS_OF,Patients,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Pancreatitis,PROCESS_OF,Child,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Virus,CAUSES,Pancreatitis,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Polymerase Chain Reaction,METHOD_OF,tomography,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Polymerase Chain Reaction,METHOD_OF,Ultrasonography,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Pancreatitis,PROCESS_OF,Child,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Gastrointestinal symptom,PROCESS_OF,Child,32572339,10.1016/j.radcr.2020.06.009,2020-06-24
Decontamination,USES,Hydrogen Peroxide,32572338,10.1186/s13099-020-00367-4,2020-06-24
Fingers,LOCATION_OF,Diarrhea,32572334,10.1186/s12575-020-00124-6,2020-06-24
Fingers,LOCATION_OF,Exanthema,32572334,10.1186/s12575-020-00124-6,2020-06-24
Fingers,LOCATION_OF,Abnormal color,32572334,10.1186/s12575-020-00124-6,2020-06-24
virus pathogenesis,AFFECTS,Human body,32572334,10.1186/s12575-020-00124-6,2020-06-24
Organ,LOCATION_OF,Neprilysin,32572334,10.1186/s12575-020-00124-6,2020-06-24
Fibrosis,CAUSES,Cessation of life,32572334,10.1186/s12575-020-00124-6,2020-06-24
Inflammation,CAUSES,Cessation of life,32572334,10.1186/s12575-020-00124-6,2020-06-24
Lung,LOCATION_OF,Fibrosis,32572334,10.1186/s12575-020-00124-6,2020-06-24
Lung,LOCATION_OF,Inflammation,32572334,10.1186/s12575-020-00124-6,2020-06-24
Evaluation procedure,COEXISTS_WITH,Intubation,32572325,10.1016/j.otot.2020.04.009,2020-06-24
"Loss, Grief, and Bereavement",PROCESS_OF,Author,32572298,10.1111/1467-8322.12575,2020-06-24
Hand,LOCATION_OF,Crisis,32572294,10.1111/1467-8322.12571,2020-06-24
Blood Coagulation Disorders,PROCESS_OF,Patients,32572174,10.1038/s41416-020-0948-x,2020-06-24
Pharmaceutical Preparations,TREATS,Symptoms,32572174,10.1038/s41416-020-0948-x,2020-06-24
Immune System Diseases,PROCESS_OF,Patients,32572174,10.1038/s41416-020-0948-x,2020-06-24
Inflammation,PROCESS_OF,Patients,32572174,10.1038/s41416-020-0948-x,2020-06-24
Neoplasms,PROCESS_OF,Patients,32572174,10.1038/s41416-020-0948-x,2020-06-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32572174,10.1038/s41416-020-0948-x,2020-06-24
Elastance,DIAGNOSES,Patient ventilated,32572155,10.1038/s41379-020-0603-3,2020-06-24
Disease,PROCESS_OF,Patients,32572155,10.1038/s41379-020-0603-3,2020-06-24
Patients,ISA,Persons,32572155,10.1038/s41379-020-0603-3,2020-06-24
Virus,CAUSES,Disease,32572154,10.1038/s41379-020-0601-5,2020-06-24
Medical pathologist,USES,Light microscope,32572154,10.1038/s41379-020-0601-5,2020-06-24
Obesity,PREDISPOSES,disease transmission,32572128,10.1038/s41366-020-0634-3,2020-06-24
Liver damage,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Coronavirus Infections,ISA,Disease,32572128,10.1038/s41366-020-0634-3,2020-06-24
Coronavirus Infections,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Obesity,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Liver Dysfunction,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Coronavirus Infections,ISA,Disease,32572128,10.1038/s41366-020-0634-3,2020-06-24
Obesity,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Liver Dysfunction,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
prolonged hospitalization,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Obesity,NEG_PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Liver Dysfunction,NEG_PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Coronavirus Infections,ISA,Disease,32572128,10.1038/s41366-020-0634-3,2020-06-24
Coronavirus Infections,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
prolonged hospitalization,PROCESS_OF,Patients,32572128,10.1038/s41366-020-0634-3,2020-06-24
Infected,PROCESS_OF,Patients,32571980,10.1126/scitranslmed.abc1126,2020-06-24
Assay,DIAGNOSES,Severe Acute Respiratory Syndrome,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Cardiovascular Diseases,PROCESS_OF,Patients,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Diabetes Mellitus,PROCESS_OF,Patients,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Hypertensive disease,PROCESS_OF,Patients,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Fever,ISA,Symptoms,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Decreased Immunologic Activity [PE],PROCESS_OF,Recipient,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Malignant Neoplasms,PROCESS_OF,Patients,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Poor outcome,PROCESS_OF,Patients,32571972,10.1136/gutjnl-2020-321923,2020-06-24
Multiple Sclerosis,ISA,Disease,32571951,10.1073/pnas.2003432117,2020-06-24
Genes,ASSOCIATED_WITH,inflammatory response,32571951,10.1073/pnas.2003432117,2020-06-24
Histocompatibility Antigens Class I,ASSOCIATED_WITH,inflammatory response,32571951,10.1073/pnas.2003432117,2020-06-24
Oligodendroglia,PRODUCES,Genes,32571951,10.1073/pnas.2003432117,2020-06-24
Oligodendroglia,PRODUCES,Histocompatibility Antigens Class I,32571951,10.1073/pnas.2003432117,2020-06-24
Cell Count,USES,survive,32571951,10.1073/pnas.2003432117,2020-06-24
Immune response,COEXISTS_WITH,Remyelination,32571951,10.1073/pnas.2003432117,2020-06-24
Lung,LOCATION_OF,High Grade Lesion,32571934,10.1073/pnas.2009799117,2020-06-24
Lung,LOCATION_OF,Isolate - microorganism,32571934,10.1073/pnas.2009799117,2020-06-24
Lung,PART_OF,Hamsters,32571934,10.1073/pnas.2009799117,2020-06-24
Lung,PART_OF,Homo sapiens,32571934,10.1073/pnas.2009799117,2020-06-24
Lung,LOCATION_OF,Virus,32571934,10.1073/pnas.2009799117,2020-06-24
Pandemics,ISA,Epidemic,32571880,10.1074/jbc.AC120.013449,2020-06-24
"Frameshifting, Ribosomal",AFFECTS,Proteins,32571880,10.1074/jbc.AC120.013449,2020-06-24
Stem of Organ,LOCATION_OF,Elements,32571880,10.1074/jbc.AC120.013449,2020-06-24
Patients,LOCATION_OF,Monoclonal Antibodies,32571838,10.1126/science.abc6952,2020-06-24
Obesity,PROCESS_OF,Patients,32571783,10.7861/clinmed.2020-0239,2020-06-24
Obesity,AFFECTS,physiological aspects,32571783,10.7861/clinmed.2020-0239,2020-06-24
Obesity,AFFECTS,Respiratory physiology,32571783,10.7861/clinmed.2020-0239,2020-06-24
Obesity,PROCESS_OF,Patients,32571783,10.7861/clinmed.2020-0239,2020-06-24
Obesity,COEXISTS_WITH,Comorbidity,32571783,10.7861/clinmed.2020-0239,2020-06-24
Obesity,PROCESS_OF,Patients,32571783,10.7861/clinmed.2020-0239,2020-06-24
Coronavirus Infections,PROCESS_OF,Patients,32571773,10.3399/bjgp20X711941,2020-06-24
Oseltamivir,TREATS,Coronavirus Infections,32571773,10.3399/bjgp20X711941,2020-06-24
Hospitals,LOCATION_OF,Retrospective Studies,32571747,10.1016/j.diii.2020.05.011,2020-06-24
Physical Examination,USES,tomography,32571747,10.1016/j.diii.2020.05.011,2020-06-24
Physical Examination,USES,tomography,32571747,10.1016/j.diii.2020.05.011,2020-06-24
Pneumonia,PROCESS_OF,Patients,32571747,10.1016/j.diii.2020.05.011,2020-06-24
tomography,DIAGNOSES,Pneumonia,32571747,10.1016/j.diii.2020.05.011,2020-06-24
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32571747,10.1016/j.diii.2020.05.011,2020-06-24
Fatigue,PROCESS_OF,Outpatients,32571747,10.1016/j.diii.2020.05.011,2020-06-24
pulmonary involvement,COEXISTS_WITH,Pneumonia,32571747,10.1016/j.diii.2020.05.011,2020-06-24
tocilizumab,TREATS,Severe acute respiratory infection,32571730,10.1016/j.reuma.2020.06.003,2020-06-24
Respiratory Tract Infections,PROCESS_OF,Male population group,32571730,10.1016/j.reuma.2020.06.003,2020-06-24
Hand,LOCATION_OF,Radionuclide Imaging,32571690,10.1016/j.jsurg.2020.05.027,2020-06-24
envelope,PART_OF,soft tissue,32571690,10.1016/j.jsurg.2020.05.027,2020-06-24
Operative procedure on hand,USES,Kirschner Wires,32571690,10.1016/j.jsurg.2020.05.027,2020-06-24
Primary Health Care,TREATS,Tuberculosis,32571677,10.1016/j.semerg.2020.06.001,2020-06-24
Public health service,TREATS,Tuberculosis,32571677,10.1016/j.semerg.2020.06.001,2020-06-24
Health Personnel,ISA,Population Group,32571661,10.1016/j.enfcli.2020.05.021,2020-06-24
Gown,USES,disposable,32571661,10.1016/j.enfcli.2020.05.021,2020-06-24
Virus,PROCESS_OF,professional occupation status,32571661,10.1016/j.enfcli.2020.05.021,2020-06-24
Chest,LOCATION_OF,Ultrasonography,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
Nursing Homes,LOCATION_OF,Study,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
Abnormal Finding,PROCESS_OF,Patients,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
Pneumonia,PROCESS_OF,Patients,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
"Ultrasonography, Mammary",ADMINISTERED_TO,Patients,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
Early Diagnosis,USES,Diagnostic agents,32571651,10.1016/j.jamda.2020.05.050,2020-06-24
IMPACT gene,AFFECTS,Negative,32571648,10.1016/j.acra.2020.06.002,2020-06-24
Symptom mild,PROCESS_OF,Male population group,32571647,10.1016/j.jiac.2020.06.011,2020-06-24
Diabetes,PROCESS_OF,Asians,32571616,10.1016/j.numecd.2020.05.014,2020-06-24
Diabetes,PREDISPOSES,Critical Illness,32571616,10.1016/j.numecd.2020.05.014,2020-06-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Diabetes,32571616,10.1016/j.numecd.2020.05.014,2020-06-24
Infected,PROCESS_OF,Persons,32571612,10.1016/j.numecd.2020.05.020,2020-06-24
Advice,PREVENTS,Sedentary behavior,32571612,10.1016/j.numecd.2020.05.020,2020-06-24
Pharmaceutical Preparations,AFFECTS,Disease,32571606,10.1016/j.arcmed.2020.06.009,2020-06-24
Vaccines,AFFECTS,Disease,32571606,10.1016/j.arcmed.2020.06.009,2020-06-24
Disease,AFFECTS,Human Age Group,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
C-reactive protein,STIMULATES,procalcitonin,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Leukocytosis,PROCESS_OF,Pregnant Women,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Lymphopenia,PROCESS_OF,Elderly (population group),32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Lymphopenia,PROCESS_OF,Patients,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Neutrophilia (finding),PROCESS_OF,Pregnant Women,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Elevated lactate dehydrogenase,PROCESS_OF,Patients,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Elevation procedure,TREATS,Child,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Elevation procedure,USES,procalcitonin,32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Elevated C-reactive protein,PROCESS_OF,Elderly (population group),32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Symptoms,PROCESS_OF,"Infant, Newborn",32571605,10.1016/j.arcmed.2020.06.007,2020-06-24
Italy,ISA,European country,32571528,10.1016/j.gaceta.2020.05.003,2020-06-24
Spain,ISA,European country,32571528,10.1016/j.gaceta.2020.05.003,2020-06-24
Stress,ISA,Symptoms,32571438,10.1017/S003329172000241X,2020-06-24
GSKIP gene,AFFECTS,Neoplasm Metastasis,32571438,10.1017/S003329172000241X,2020-06-24
Sudden death,PROCESS_OF,Juvenile,32571376,10.1186/s13023-020-01444-2,2020-06-24
Familial disease,CAUSES,Sudden death,32571376,10.1186/s13023-020-01444-2,2020-06-24
Familial disease,CAUSES,Heart failure,32571376,10.1186/s13023-020-01444-2,2020-06-24
Heart,LOCATION_OF,Hereditary Diseases,32571376,10.1186/s13023-020-01444-2,2020-06-24
Hereditary Diseases,AFFECTS,Patients,32571376,10.1186/s13023-020-01444-2,2020-06-24
Diabetes Mellitus,PROCESS_OF,Patients,32571228,10.1186/s12879-020-05154-9,2020-06-24
Hypertensive disease,PROCESS_OF,Patients,32571228,10.1186/s12879-020-05154-9,2020-06-24
Pneumonia,PROCESS_OF,Woman,32571224,10.1186/s12879-020-05164-7,2020-06-24
Constant pain,PROCESS_OF,Woman,32571224,10.1186/s12879-020-05164-7,2020-06-24
Inhalation Drug Administration,USES,Interferons,32571224,10.1186/s12879-020-05164-7,2020-06-24
Percutaneous cholecystostomy,COEXISTS_WITH,Inhalation Drug Administration,32571224,10.1186/s12879-020-05164-7,2020-06-24
Acute Cholecystitis,PROCESS_OF,Patients,32571224,10.1186/s12879-020-05164-7,2020-06-24
Antineoplastic Agents,AFFECTS,Reproduction,32571182,10.1134/S0006297920050016,2020-06-24
Endosomes,PART_OF,Cells,32571182,10.1134/S0006297920050016,2020-06-24
Virus-neutralizing Antibody,STIMULATES,Protein S,32571182,10.1134/S0006297920050016,2020-06-24
Eye,LOCATION_OF,Household composition,32571168,10.1080/07391102.2020.1779819,2020-06-24
"3C-like protease, SARS coronavirus",AFFECTS,Virus Replication,32571168,10.1080/07391102.2020.1779819,2020-06-24
binifibrate,ISA,Pharmaceutical Preparations,32571168,10.1080/07391102.2020.1779819,2020-06-24
IMPACT gene,compared_with,Airway Management,32571147,10.1177/0194599820936615,2020-06-24
IMPACT gene,higher_than,Airway Management,32571147,10.1177/0194599820936615,2020-06-24
Wakefulness,PROCESS_OF,Patients,32571147,10.1177/0194599820936615,2020-06-24
Airway structure,PART_OF,Patients,32571147,10.1177/0194599820936615,2020-06-24
Adverse effects,PROCESS_OF,Health Personnel,32571115,10.1080/09546634.2020.1781041,2020-06-24
Adverse effects,PROCESS_OF,Patients,32571115,10.1080/09546634.2020.1781041,2020-06-24
"Receptors, Cell Surface",PART_OF,viral glycoprotein,32571007,10.1021/acsnano.0c04006,2020-06-24
"Infant, Newborn",LOCATION_OF,IMPACT gene,32570959,10.3390/pathogens9060485,2020-06-24
Pregnant Women,LOCATION_OF,IMPACT gene,32570959,10.3390/pathogens9060485,2020-06-24
Symptoms,PROCESS_OF,Pregnant Women,32570959,10.3390/pathogens9060485,2020-06-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32570959,10.3390/pathogens9060485,2020-06-24
Infected,PROCESS_OF,Woman,32570959,10.3390/pathogens9060485,2020-06-24
Disease,PROCESS_OF,Older Population,32570888,10.3390/ijerph17124392,2020-06-24
Cardiovascular Diseases,PROCESS_OF,Patients,32570882,10.3390/jcm9061909,2020-06-24
Hypertensive disease,PROCESS_OF,Patients,32570882,10.3390/jcm9061909,2020-06-24
Obesity,PROCESS_OF,Patients,32570882,10.3390/jcm9061909,2020-06-24
Severe clinical course,PROCESS_OF,Patients,32570882,10.3390/jcm9061909,2020-06-24
Lipids,COEXISTS_WITH,Hydroxymethylglutaryl-CoA Reductase Inhibitors,32570882,10.3390/jcm9061909,2020-06-24
Plasma membrane,LOCATION_OF,angiotensin converting enzyme 2,32570882,10.3390/jcm9061909,2020-06-24
Therapeutic procedure,PREVENTS,Virus Diseases,32570882,10.3390/jcm9061909,2020-06-24
inhibitors,TREATS,Virus Diseases,32570882,10.3390/jcm9061909,2020-06-24
STMN1 gene,AFFECTS,Immune system,32570850,10.3390/microorganisms8060921,2020-06-24
Butyrates,ISA,"Fatty Acids, Volatile",32570850,10.3390/microorganisms8060921,2020-06-24
Viral Respiratory Tract Infection,CAUSES,"Respiratory Distress Syndrome, Adult",32570850,10.3390/microorganisms8060921,2020-06-24
Awareness,PROCESS_OF,Participant,32570819,10.3390/ijerph17124377,2020-06-24
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32570810,10.3390/genes11060664,2020-06-24
Exudate,PART_OF,Nose,32570810,10.3390/genes11060664,2020-06-24
Respiratory sample,LOCATION_OF,Genes,32570810,10.3390/genes11060664,2020-06-24
Level of anxiety,PROCESS_OF,Adult,32570737,10.3390/ijerph17124360,2020-06-24
SARS coronavirus,PROCESS_OF,Felis catus,32570713,10.3390/pathogens9060480,2020-06-24
Disease,PROCESS_OF,Patients,32570284,10.1111/1471-0528.16369,2020-06-23
Coronavirus Infections,ISA,Disease,32570284,10.1111/1471-0528.16369,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32570284,10.1111/1471-0528.16369,2020-06-23
Gravidity,PROCESS_OF,Patients,32570284,10.1111/1471-0528.16369,2020-06-23
Coronavirus Infections,ISA,Disease,32570284,10.1111/1471-0528.16369,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Ultrasonography,DIAGNOSES,Acute respiratory disease,32570265,10.1159/000509223,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Ultrasonography,ADMINISTERED_TO,Clinician,32570265,10.1159/000509223,2020-06-23
Contrast bronchogram,USES,Air,32570265,10.1159/000509223,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Lung,LOCATION_OF,Ultrasonography,32570265,10.1159/000509223,2020-06-23
Pneumonia,PROCESS_OF,Patients,32570265,10.1159/000509223,2020-06-23
Room air,PROCESS_OF,Patients,32570265,10.1159/000509223,2020-06-23
Malignant neoplasm of prostate,PROCESS_OF,Patients,32570240,10.1159/000509434,2020-06-23
Luteinizing Hormone-releasing Hormone Agonist,TREATS,Patients,32570240,10.1159/000509434,2020-06-23
enzalutamide,ADMINISTERED_TO,Patients,32570240,10.1159/000509434,2020-06-23
Hematologic Tests,DIAGNOSES,Lymphopenia,32570240,10.1159/000509434,2020-06-23
Lymphopenia,ISA,Anemia,32570240,10.1159/000509434,2020-06-23
Hormone Therapy,TREATS,advanced disease,32570240,10.1159/000509434,2020-06-23
Laboratory,LOCATION_OF,Analysis,32570196,10.1016/j.ijmedinf.2020.104224,2020-06-23
Malignant Neoplasms,PROCESS_OF,Persons,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Chronic lung disease,PROCESS_OF,Persons,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Cardiovascular Diseases,PROCESS_OF,Old age,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Old age,ISA,Persons,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Care team,PROCESS_OF,Persons,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Care team,PROCESS_OF(SPEC),Old age,32570168,10.1016/j.mehy.2020.109999,2020-06-23
Adult,LOCATION_OF,Fetal Hemoglobin,32570166,10.1016/j.mehy.2020.109994,2020-06-23
Pharmaceutical Preparations,STIMULATES,Fetal Hemoglobin,32570166,10.1016/j.mehy.2020.109994,2020-06-23
Polymerase Chain Reaction,USES,Nasal Swab (procedure),32570163,10.1016/j.mehy.2020.109980,2020-06-23
Neurologic Manifestations,PROCESS_OF,Patients,32570113,10.1016/j.jns.2020.116969,2020-06-23
Neurologic Manifestations,PROCESS_OF,Patients,32570113,10.1016/j.jns.2020.116969,2020-06-23
World,ISA,Population Group,32570084,10.1016/j.scitotenv.2020.140347,2020-06-23
Gown,USES,Sleeve,32570052,10.1016/j.jcrc.2020.06.005,2020-06-23
Assay,ISA,Laboratory Procedures,32570045,10.1016/j.jcv.2020.104510,2020-06-23
Assay,METHOD_OF,Detection,32570045,10.1016/j.jcv.2020.104510,2020-06-23
Pneumonia,PROCESS_OF,Patients,32570043,10.1016/j.jcv.2020.104444,2020-06-23
Pneumonia,PROCESS_OF,hospitalized patients,32570043,10.1016/j.jcv.2020.104444,2020-06-23
Therapeutic procedure,USES,cytokine,32570043,10.1016/j.jcv.2020.104444,2020-06-23
Therapeutic procedure,TREATS,Raised C-reactive protein,32570043,10.1016/j.jcv.2020.104444,2020-06-23
Therapeutic procedure,USES,cytokine,32570043,10.1016/j.jcv.2020.104444,2020-06-23
outer membrane,PART_OF,Virus,32570023,10.1016/j.envpol.2020.115010,2020-06-23
Negative,PROCESS_OF,Patients,32569892,10.1016/j.ahj.2020.05.009,2020-06-23
Acute Chest Syndrome,NEG_PROCESS_OF,Patients,32569892,10.1016/j.ahj.2020.05.009,2020-06-23
Non-ST Elevation Myocardial Infarction by ECG Finding,PROCESS_OF,Patients,32569892,10.1016/j.ahj.2020.05.009,2020-06-23
Physical findings,COEXISTS_WITH,Complication,32569892,10.1016/j.ahj.2020.05.009,2020-06-23
Complement Activation,PROCESS_OF,Patients,32569879,10.1016/j.thromres.2020.06.027,2020-06-23
Thrombophilia,CAUSES,Complication,32569879,10.1016/j.thromres.2020.06.027,2020-06-23
Complement Activation,COEXISTS_WITH,Coronavirus Infections,32569879,10.1016/j.thromres.2020.06.027,2020-06-23
Complement System Proteins,DISRUPTS,Fibrinolysis,32569879,10.1016/j.thromres.2020.06.027,2020-06-23
Infected,PROCESS_OF,Persons,32569870,10.1016/j.envres.2020.109819,2020-06-23
FBXL15 gene,PART_OF,Persons,32569870,10.1016/j.envres.2020.109819,2020-06-23
Genome,DISRUPTS,Virus Replication,32569833,10.1016/j.drudis.2020.06.014,2020-06-23
Viral Accessory Proteins,DISRUPTS,Virus Replication,32569833,10.1016/j.drudis.2020.06.014,2020-06-23
Influenza A,DISRUPTS,Nuclear Export,32569833,10.1016/j.drudis.2020.06.014,2020-06-23
Immunosuppressive Agents,ISA,Agent,32569797,10.1016/j.jaad.2020.06.051,2020-06-23
Dermatologic disorders,PROCESS_OF,Patients,32569797,10.1016/j.jaad.2020.06.051,2020-06-23
Respiratory sample,PART_OF,Tract,32569635,10.1016/j.chest.2020.06.015,2020-06-23
Respiratory sample,PART_OF,Tract,32569635,10.1016/j.chest.2020.06.015,2020-06-23
Nail-Patella Syndrome,PROCESS_OF,Patients,32569635,10.1016/j.chest.2020.06.015,2020-06-23
Nail-Patella Syndrome,PROCESS_OF,Patients,32569635,10.1016/j.chest.2020.06.015,2020-06-23
Sputum,LOCATION_OF,Steroids,32569635,10.1016/j.chest.2020.06.015,2020-06-23
Serum,LOCATION_OF,IMPACT gene,32569631,10.1016/j.cca.2020.06.032,2020-06-23
Specimen Type - Serum,PART_OF,Patients,32569631,10.1016/j.cca.2020.06.032,2020-06-23
Patients,LOCATION_OF,CD40LG wt Allele,32569631,10.1016/j.cca.2020.06.032,2020-06-23
Serum,LOCATION_OF,Antibodies,32569631,10.1016/j.cca.2020.06.032,2020-06-23
Participant,LOCATION_OF,CD40LG wt Allele,32569631,10.1016/j.cca.2020.06.032,2020-06-23
Inflammation,PROCESS_OF,Patients,32569609,10.1016/j.jhep.2020.06.022,2020-06-23
Hand,PART_OF,Physicians,32569591,10.1016/j.amjmed.2020.05.018,2020-06-23
intensive care,TREATS,Respiratory Failure,32569585,10.1016/S2213-2600(20)30268-X,2020-06-23
Alveolar ventilation function,PROCESS_OF,Patients,32569585,10.1016/S2213-2600(20)30268-X,2020-06-23
Awake,PROCESS_OF,Patients,32569585,10.1016/S2213-2600(20)30268-X,2020-06-23
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32569495,10.1080/09273948.2020.1775261,2020-06-23
Conjunctivitis,PROCESS_OF,Patients,32569495,10.1080/09273948.2020.1775261,2020-06-23
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32569495,10.1080/09273948.2020.1775261,2020-06-23
Negative,NEG_COEXISTS_WITH,Conjunctivitis,32569495,10.1080/09273948.2020.1775261,2020-06-23
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32569495,10.1080/09273948.2020.1775261,2020-06-23
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32569495,10.1080/09273948.2020.1775261,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32569495,10.1080/09273948.2020.1775261,2020-06-23
Globe finding,PROCESS_OF,Patients,32569494,10.1080/09273948.2020.1773868,2020-06-23
Conjunctival hyperemia,PROCESS_OF,Patients,32569494,10.1080/09273948.2020.1773868,2020-06-23
High Level,PROCESS_OF,Patients,32569494,10.1080/09273948.2020.1773868,2020-06-23
Chronic disease,PROCESS_OF,Patients,32569493,10.1080/09546634.2020.1782822,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32569493,10.1080/09546634.2020.1782822,2020-06-23
Psoriasis,PROCESS_OF,Patients,32569493,10.1080/09546634.2020.1782822,2020-06-23
Respiratory Tract Infections,PROCESS_OF,Population Group,32569493,10.1080/09546634.2020.1782822,2020-06-23
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32569491,10.1080/10641963.2020.1783549,2020-06-23
"Intubation, Intratracheal",TREATS,Patients,32569491,10.1080/10641963.2020.1783549,2020-06-23
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32569491,10.1080/10641963.2020.1783549,2020-06-23
Patients,LOCATION_OF,Angiotensinogen,32569491,10.1080/10641963.2020.1783549,2020-06-23
Pneumonia,PROCESS_OF,Patients,32569491,10.1080/10641963.2020.1783549,2020-06-23
Pharmaceutical Preparations,TREATS,Rheumatoid Arthritis,32569446,10.15252/emmm.202012817,2020-06-23
Anti-Inflammatory Agents,TREATS,Patients,32569446,10.15252/emmm.202012817,2020-06-23
Controlled Clinical Trials as Topic,USES,Placebos,32569446,10.15252/emmm.202012817,2020-06-23
Organoids,PART_OF,Liver,32569446,10.15252/emmm.202012817,2020-06-23
Accident and Emergency department,LOCATION_OF,Cross-Sectional Studies,32569419,10.1111/acem.14065,2020-06-23
Anxiety,AFFECTS,Behavior,32569419,10.1111/acem.14065,2020-06-23
Anxiety,PROCESS_OF,Physicians,32569419,10.1111/acem.14065,2020-06-23
Anxiety,PROCESS_OF,Health Personnel,32569374,10.1093/qjmed/hcaa207,2020-06-23
Depressive Symptoms,PROCESS_OF,Health Personnel,32569374,10.1093/qjmed/hcaa207,2020-06-23
Disease,PROCESS_OF,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
tocilizumab,TREATS,Disease,32569363,10.1093/qjmed/hcaa206,2020-06-23
tocilizumab,TREATS,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
tocilizumab,ADMINISTERED_TO,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
tocilizumab,TREATS,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
Bacteremia,PROCESS_OF,Control Groups,32569363,10.1093/qjmed/hcaa206,2020-06-23
Fungemia,PROCESS_OF,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
tocilizumab,ADMINISTERED_TO,Patients,32569363,10.1093/qjmed/hcaa206,2020-06-23
mental health,PROCESS_OF,general population,32569360,10.1093/qjmed/hcaa201,2020-06-23
Quarantine,AFFECTS,Coronavirus Infections,32569360,10.1093/qjmed/hcaa201,2020-06-23
Mental disorders,PROCESS_OF,Persons,32569360,10.1093/qjmed/hcaa201,2020-06-23
developers,USES,Drug Packaging,32569358,10.1093/jamia/ocaa145,2020-06-23
Thromboembolism,PROCESS_OF,Patients,32569013,10.1097/FJC.0000000000000861,2020-06-23
myocardial injury,PROCESS_OF,Patients,32569013,10.1097/FJC.0000000000000861,2020-06-23
Prognosis good,PREDISPOSES,Inflammation,32569013,10.1097/FJC.0000000000000861,2020-06-23
Prognosis good,PROCESS_OF,Patients,32569013,10.1097/FJC.0000000000000861,2020-06-23
alteplase,TREATS,Patient ventilated,32569013,10.1097/FJC.0000000000000861,2020-06-23
alteplase,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32569013,10.1097/FJC.0000000000000861,2020-06-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32569013,10.1097/FJC.0000000000000861,2020-06-23
Negative Regulation of Coagulation,PROCESS_OF,Patients,32569013,10.1097/FJC.0000000000000861,2020-06-23
Coronavirus Infections,PROCESS_OF,Health Personnel,32568806,10.1097/DER.0000000000000639,2020-06-23
Hand Hygiene,PROCESS_OF,Health Personnel,32568806,10.1097/DER.0000000000000639,2020-06-23
Hand eczema,PROCESS_OF,Health Personnel,32568806,10.1097/DER.0000000000000639,2020-06-23
Hand,LOCATION_OF,"Dermatitis, Occupational",32568806,10.1097/DER.0000000000000639,2020-06-23
Hand eczema,AFFECTS,Health Personnel,32568806,10.1097/DER.0000000000000639,2020-06-23
pulmonary complications,AFFECTS,Virus,32568805,10.1097/MEG.0000000000001806,2020-06-23
Liver enzymes abnormal,PROCESS_OF,Patients,32568805,10.1097/MEG.0000000000001806,2020-06-23
Infected,PROCESS_OF,Respondents,32568771,10.1097/QAI.0000000000002424,2020-06-23
Symptom mild,PROCESS_OF,Persons,32568771,10.1097/QAI.0000000000002424,2020-06-23
Male population group,ISA,Persons,32568771,10.1097/QAI.0000000000002424,2020-06-23
Cessation of life,PROCESS_OF,Male population group,32568771,10.1097/QAI.0000000000002424,2020-06-23
Infected,PROCESS_OF,Persons,32568771,10.1097/QAI.0000000000002424,2020-06-23
Infected,PROCESS_OF,Persons,32568771,10.1097/QAI.0000000000002424,2020-06-23
Symptom severe,PROCESS_OF,Male population group,32568771,10.1097/QAI.0000000000002424,2020-06-23
Antiretroviral therapy,TREATS,Coinfection,32568771,10.1097/QAI.0000000000002424,2020-06-23
Mechanical ventilation,TREATS,Patients,32568770,10.1097/QAI.0000000000002423,2020-06-23
"Pneumonia, Bacterial",PROCESS_OF,Patients,32568770,10.1097/QAI.0000000000002423,2020-06-23
Operation on abdominal region,TREATS,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
"Cholecystectomy, Laparoscopic",TREATS,"Empyema, Gallbladder",32568751,10.1097/SLA.0000000000004165,2020-06-23
"Cholecystectomy, Laparoscopic",TREATS,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Crohn Disease,PROCESS_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Laparotomy,TREATS,Crohn Disease,32568751,10.1097/SLA.0000000000004165,2020-06-23
Appendectomy,TREATS,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Laparotomy,TREATS,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Laparotomy,TREATS,Peptic Ulcer Perforation,32568751,10.1097/SLA.0000000000004165,2020-06-23
Feces,PART_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Peptic Ulcer Perforation,PROCESS_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Wall of duodenum,LOCATION_OF,Feces,32568751,10.1097/SLA.0000000000004165,2020-06-23
Wall of duodenum,PART_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
"Subcutaneous Fat, Abdominal",PART_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Experience,PROCESS_OF,Patients,32568751,10.1097/SLA.0000000000004165,2020-06-23
Heart Injuries,PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
Heart Injuries,PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
Heart Injuries,PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
Coronary Arteriosclerosis,COEXISTS_WITH,Heart Injuries,32568741,10.1097/MCA.0000000000000914,2020-06-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32568741,10.1097/MCA.0000000000000914,2020-06-23
Coronavirus Infections,ISA,Disease,32568730,10.2196/19569,2020-06-23
Physicians,DIAGNOSES,Enthesitis-Related Arthritis,32568730,10.2196/19569,2020-06-23
Coronavirus Infections,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Social Networks,USES,Classification,32568730,10.2196/19569,2020-06-23
Disease,PROCESS_OF,Patients,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,PROCESS_OF,Patients,32568730,10.2196/19569,2020-06-23
Pneumonia,PROCESS_OF,Patients,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Pneumonia,ISA,Disease,32568730,10.2196/19569,2020-06-23
Isolation procedure,TREATS,Population Group,32568729,10.2196/18965,2020-06-23
Coronavirus Infections,ISA,Communicable Diseases,32568728,10.2196/19902,2020-06-23
,ASSOCIATED_WITH,Disease,32568728,10.2196/19902,2020-06-23
,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Health center,LOCATION_OF,Data Collection,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Coronavirus Infections,ISA,Disease,32568728,10.2196/19902,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Progressive Neoplastic Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Confirmation,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Telemedicine,ADMINISTERED_TO,Persons,32568727,10.2196/19514,2020-06-23
Telemedicine,TREATS,Persons,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Confirmation,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Confirmation,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Diagnosis,DIAGNOSES,Multiple symptoms,32568727,10.2196/19514,2020-06-23
Disease,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568727,10.2196/19514,2020-06-23
Medical Staff,DIAGNOSES,Disease Progression,32568727,10.2196/19514,2020-06-23
Coronavirus Infections,ISA,Disease,32568727,10.2196/19514,2020-06-23
Cross Infection,PROCESS_OF,Health Personnel,32568727,10.2196/19514,2020-06-23
Cross Infection,PROCESS_OF,Patients,32568727,10.2196/19514,2020-06-23
Minority Groups,ISA,Ethnic group,32568726,10.2196/20472,2020-06-23
African race,ISA,Ethnic group,32568726,10.2196/20472,2020-06-23
Minority Groups,ISA,Ethnic group,32568726,10.2196/20472,2020-06-23
Globalization,CAUSES,Severe Acute Respiratory Syndrome,32568725,10.2196/19866,2020-06-23
Globalization,CAUSES,Middle East Respiratory Syndrome,32568725,10.2196/19866,2020-06-23
Infected,PROCESS_OF,Persons,32568725,10.2196/19866,2020-06-23
regulatory,AFFECTS,Clinic,32568724,10.2196/19745,2020-06-23
Coronavirus Infections,ISA,Disease,32568722,10.2196/19417,2020-06-23
Ambulatory Care Facilities,LOCATION_OF,Study,32568722,10.2196/19417,2020-06-23
Diagnosis,ADMINISTERED_TO,Patients,32568722,10.2196/19417,2020-06-23
Diagnosis,ADMINISTERED_TO,Patients,32568722,10.2196/19417,2020-06-23
Telemedicine,TREATS,Disease,32568722,10.2196/19417,2020-06-23
Telemedicine,TREATS(SPEC),Coronavirus Infections,32568722,10.2196/19417,2020-06-23
Coronavirus Infections,ISA,Disease,32568722,10.2196/19417,2020-06-23
Coronavirus Infections,ISA,Disease,32568722,10.2196/19417,2020-06-23
Symptoms,ASSOCIATED_WITH,Disease,32568722,10.2196/19417,2020-06-23
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32568722,10.2196/19417,2020-06-23
Diagnosis,ADMINISTERED_TO,Patients,32568722,10.2196/19417,2020-06-23
Nose,LOCATION_OF,Obstruction,32568722,10.2196/19417,2020-06-23
Hospitals,LOCATION_OF,Diagnosis,32568722,10.2196/19417,2020-06-23
Coronavirus Infections,ISA,Disease,32568721,10.2196/19322,2020-06-23
Coronavirus Infections,ISA,Disease,32568721,10.2196/19322,2020-06-23
Disease,COEXISTS_WITH,Menstruation Disturbances,32568721,10.2196/19322,2020-06-23
Coronavirus Infections,COEXISTS_WITH(SPEC),Menstruation Disturbances,32568721,10.2196/19322,2020-06-23
Coronavirus Infections,ISA,Disease,32568721,10.2196/19322,2020-06-23
Coronavirus Infections,ISA,Disease,32568721,10.2196/19322,2020-06-23
Avian coronavirus,COEXISTS_WITH,Nidovirales,32568687,10.1016/j.compbiomed.2020.103749,2020-06-23
Lung,LOCATION_OF,11-beta-Hydroxysteroid Dehydrogenase Type 1,32568687,10.1016/j.compbiomed.2020.103749,2020-06-23
Pneumonia,PROCESS_OF,Homo sapiens,32568679,10.1016/j.compbiomed.2020.103805,2020-06-23
Physicians,TREATS,Patients,32568676,10.1016/j.compbiomed.2020.103795,2020-06-23
diagnostic procedure,DIAGNOSES,Disease,32568676,10.1016/j.compbiomed.2020.103795,2020-06-23
Disease,PROCESS_OF,World,32568667,10.1016/j.compbiomed.2020.103827,2020-06-23
Coronavirus Infections,ISA,Disease,32568667,10.1016/j.compbiomed.2020.103827,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),World,32568667,10.1016/j.compbiomed.2020.103827,2020-06-23
Coronavirus Infections,ISA,Disease,32568667,10.1016/j.compbiomed.2020.103827,2020-06-23
Coronavirus Infections,ISA,Disease,32568667,10.1016/j.compbiomed.2020.103827,2020-06-23
Disease,PROCESS_OF,Persons,32568665,10.3201/eid2610.201460,2020-06-23
Coronavirus Infections,ISA,Disease,32568665,10.3201/eid2610.201460,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32568665,10.3201/eid2610.201460,2020-06-23
Asymptomatic,PROCESS_OF,Patients,32568665,10.3201/eid2610.201460,2020-06-23
Disease,PROCESS_OF,Patients,32568665,10.3201/eid2610.201460,2020-06-23
Coronavirus Infections,ISA,Disease,32568665,10.3201/eid2610.201460,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568665,10.3201/eid2610.201460,2020-06-23
Disease,PROCESS_OF,Patients,32568663,10.3201/eid2610.201539,2020-06-23
Coronavirus Infections,ISA,Disease,32568663,10.3201/eid2610.201539,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568663,10.3201/eid2610.201539,2020-06-23
Disease,PROCESS_OF,Patients,32568662,10.3201/eid2610.201620,2020-06-23
Coronavirus Infections,ISA,Disease,32568662,10.3201/eid2610.201620,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32568662,10.3201/eid2610.201620,2020-06-23
Symptoms,PROCESS_OF,Patients,32568662,10.3201/eid2610.201620,2020-06-23
Asymptomatic,PROCESS_OF,Patients,32568662,10.3201/eid2610.201620,2020-06-23
Laboratory,LOCATION_OF,research study,32568661,10.3201/eid2609.201806,2020-06-23
Coronaviridae,PROCESS_OF,Family,32568620,10.1080/07391102.2020.1781694,2020-06-23
Pandemics,ISA,Disease Outbreaks,32568620,10.1080/07391102.2020.1781694,2020-06-23
Coronavirus Infections,ISA,Disease,32568618,10.1080/07391102.2020.1780946,2020-06-23
Severe Acute Respiratory Syndrome,CAUSES,Disease,32568618,10.1080/07391102.2020.1780946,2020-06-23
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32568618,10.1080/07391102.2020.1780946,2020-06-23
epigallocatechin gallate,ISA,polyphenols,32568613,10.1080/07391102.2020.1779818,2020-06-23
Study,USES,inhibitors,32568613,10.1080/07391102.2020.1779818,2020-06-23
Lymphopenia,COEXISTS_WITH,Severe disorder,32568604,10.1080/10408363.2020.1774736,2020-06-23
SARS coronavirus,CAUSES,Disease,32568543,10.1021/acs.jproteome.0c00280,2020-06-23
Clinician,TREATS,Patients,32568500,10.1590/S1677-5538.IBJU.2020.S127,2020-06-23
Pandemics,CAUSES,Disease,32568498,10.1590/S1677-5538.IBJU.2020.S111,2020-06-23
Malignant neoplasm of penis,PROCESS_OF,Patients,32568497,10.1590/S1677-5538.IBJU.2020.S110,2020-06-23
"CD69 protein, human",ASSOCIATED_WITH,Enthesitis-Related Arthritis,32568497,10.1590/S1677-5538.IBJU.2020.S110,2020-06-23
Malignant Neoplasms,ISA,Disease,32568497,10.1590/S1677-5538.IBJU.2020.S110,2020-06-23
lymph nodes,LOCATION_OF,Present,32568497,10.1590/S1677-5538.IBJU.2020.S110,2020-06-23
Malignant neoplasm of testis,PROCESS_OF,Patients,32568496,10.1590/S1677-5538.IBJU.2020.S109,2020-06-23
Operative Surgical Procedures,TREATS,Patients,32568496,10.1590/S1677-5538.IBJU.2020.S109,2020-06-23
follow-up,TREATS,Recurrent disease,32568496,10.1590/S1677-5538.IBJU.2020.S109,2020-06-23
stage I testicular cancer,PROCESS_OF,Patients,32568496,10.1590/S1677-5538.IBJU.2020.S109,2020-06-23
Lithiasis,AFFECTS,Patients,32568495,10.1590/S1677-5538.IBJU.2020.S105,2020-06-23
Lithiasis,AFFECTS,Patients,32568495,10.1590/S1677-5538.IBJU.2020.S105,2020-06-23
follow-up,TREATS,Lithiasis,32568495,10.1590/S1677-5538.IBJU.2020.S105,2020-06-23
Complication,PROCESS_OF,Patients,32568495,10.1590/S1677-5538.IBJU.2020.S105,2020-06-23
Lithiasis,AFFECTS,Patients,32568495,10.1590/S1677-5538.IBJU.2020.S105,2020-06-23
Italy,ISA,Country,32568494,10.1590/S1677-5538.IBJU.2020.S103,2020-06-23
Possible,PROCESS_OF,organ donor,32568471,10.1111/ajt.16157,2020-06-23
Can Do Very Little,PROCESS_OF,Minority Groups,32568434,10.1002/jmv.26206,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Adolescent (age group),32568434,10.1002/jmv.26206,2020-06-23
Enzyme-Linked Immunosorbent Assay,USES,Immunochromatographic Assay,32568413,10.1002/jmv.26211,2020-06-23
Enzyme-Linked Immunosorbent Assay,USES,Chemiluminescence immunoassay,32568413,10.1002/jmv.26211,2020-06-23
Immunochromatographic Assay,USES,Gold,32568413,10.1002/jmv.26211,2020-06-23
Immunochromatographic Assay,USES,Gold,32568413,10.1002/jmv.26211,2020-06-23
contextual factors,PROCESS_OF,Community,32568401,10.1001/jamanetworkopen.2020.12934,2020-06-23
contextual factors,PROCESS_OF,Persons,32568401,10.1001/jamanetworkopen.2020.12934,2020-06-23
Isolation procedure,TREATS,Community,32568401,10.1001/jamanetworkopen.2020.12934,2020-06-23
Health Personnel,ISA,Persons,32568401,10.1001/jamanetworkopen.2020.12934,2020-06-23
"ORAL,SWAB",TREATS,Confirmation,32568341,10.1039/d0an00629g,2020-06-23
Assay,METHOD_OF,Detection,32568341,10.1039/d0an00629g,2020-06-23
anti-IgG,PART_OF,Homo sapiens,32568341,10.1039/d0an00629g,2020-06-23
Assay,DIAGNOSES,Disease,32568341,10.1039/d0an00629g,2020-06-23
Comorbidity,PROCESS_OF,Patients,32568282,10.4997/JRCPE.2020.210,2020-06-23
Alzheimer's Disease,PROCESS_OF,Patients,32568211,10.3233/JAD-200604,2020-06-23
Anxiety,COEXISTS_WITH(SPEC),Crisis,32568211,10.3233/JAD-200604,2020-06-23
Anxiety,ISA,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Depressive disorder,COEXISTS_WITH(SPEC),Crisis,32568211,10.3233/JAD-200604,2020-06-23
Depressive disorder,ISA,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Hallucinations,COEXISTS_WITH(SPEC),Crisis,32568211,10.3233/JAD-200604,2020-06-23
Hallucinations,ISA,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Agitation,ASSOCIATED_WITH,Alzheimer's Disease,32568211,10.3233/JAD-200604,2020-06-23
Agitation,COEXISTS_WITH(SPEC),Crisis,32568211,10.3233/JAD-200604,2020-06-23
Agitation,ISA,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Apathy,COEXISTS_WITH(SPEC),Crisis,32568211,10.3233/JAD-200604,2020-06-23
Apathy,ISA,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Crisis,COEXISTS_WITH,Symptoms,32568211,10.3233/JAD-200604,2020-06-23
Symptoms,COEXISTS_WITH,Crisis,32568211,10.3233/JAD-200604,2020-06-23
Symptoms,PROCESS_OF,Patients,32568211,10.3233/JAD-200604,2020-06-23
Alzheimer's Disease,PROCESS_OF,Patients,32568211,10.3233/JAD-200604,2020-06-23
Cognition,PROCESS_OF,Patients,32568211,10.3233/JAD-200604,2020-06-23
Symptoms,PROCESS_OF,Patients,32568211,10.3233/JAD-200604,2020-06-23
Organ,LOCATION_OF,Functional disorder,32568187,10.3233/CH-209007,2020-06-23
Structure of arteriole,LOCATION_OF,Obstruction,32568187,10.3233/CH-209007,2020-06-23
endothelial dysfunction,PROCESS_OF,Patients,32568187,10.3233/CH-209007,2020-06-23
Infected,PROCESS_OF,Population Group,32568186,10.3233/CH-200895,2020-06-23
Spleen,LOCATION_OF,Tissue damage,32568186,10.3233/CH-200895,2020-06-23
Pneumonia,PROCESS_OF,Patients,32568167,10.3233/XST-200689,2020-06-23
Pneumonia,PROCESS_OF,Patients,32568167,10.3233/XST-200689,2020-06-23
Pneumonia,PROCESS_OF,Patients,32568167,10.3233/XST-200689,2020-06-23
Virus,PROCESS_OF,Patients,32568167,10.3233/XST-200689,2020-06-23
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,Virus,32568167,10.3233/XST-200689,2020-06-23
Differential Diagnosis,DIAGNOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,32568167,10.3233/XST-200689,2020-06-23
Study,MEASURES,Score,32568167,10.3233/XST-200689,2020-06-23
Coronavirus Infections,ISA,Disease,32568157,10.3233/WOR-203182,2020-06-23
burst fracture,PROCESS_OF,Patients,32568102,10.18632/aging.103414,2020-06-23
Severe Acute Respiratory Syndrome,COMPLICATES,burst fracture,32568102,10.18632/aging.103414,2020-06-23
Symptoms,PROCESS_OF,Patients,32568102,10.18632/aging.103414,2020-06-23
Wounds and Injuries,PROCESS_OF,Patients,32568102,10.18632/aging.103414,2020-06-23
Infected,PROCESS_OF,Persons,32568064,10.20344/amp.14108,2020-06-23
Genus: Coronavirus,PROCESS_OF,Tursiops truncatus,32568058,10.3201/eid2607.200093,2020-06-23
Genus: Coronavirus,ISA,Virus,32568058,10.3201/eid2607.200093,2020-06-23
Genus: Coronavirus,PROCESS_OF,Cetacea,32568058,10.3201/eid2607.200093,2020-06-23
Virus Diseases,PROCESS_OF,Offspring,32568027,10.1099/jgv.0.001453,2020-06-23
Measles Virus Nucleoprotein,PART_OF,SARS coronavirus,32568027,10.1099/jgv.0.001453,2020-06-23
Cell Count,USES,pegylated interferon alfa,32568027,10.1099/jgv.0.001453,2020-06-23
Intervention regimes,TREATS,Crisis,32568026,10.2174/1871526520666200622144857,2020-06-23
Exonuclease,ASSOCIATED_WITH(INFER),Coronavirus Infections,32568013,10.1080/07391102.2020.1778536,2020-06-23
Exonuclease,PART_OF,Family,32568013,10.1080/07391102.2020.1778536,2020-06-23
Coronavirus Infections,PROCESS_OF,Family,32568013,10.1080/07391102.2020.1778536,2020-06-23
Pharmaceutical Preparations,TREATS,Virus,32568013,10.1080/07391102.2020.1778536,2020-06-23
Psoriasis,PROCESS_OF,Patients,32568009,10.1080/09546634.2020.1781045,2020-06-23
systemic therapy,TREATS,Patients,32568009,10.1080/09546634.2020.1781045,2020-06-23
systemic therapy,TREATS(INFER),Psoriasis,32568009,10.1080/09546634.2020.1781045,2020-06-23
Psoriasis,PROCESS_OF,Patients,32568009,10.1080/09546634.2020.1781045,2020-06-23
Pharmaceutical Preparations,TREATS,Persons,32567995,10.1080/07391102.2020.1779131,2020-06-23
Pharmaceutical Preparations,TREATS(INFER),Infected,32567995,10.1080/07391102.2020.1779131,2020-06-23
Infected,PROCESS_OF,Persons,32567995,10.1080/07391102.2020.1779131,2020-06-23
Coronavirus Infections,ISA,Disease,32567995,10.1080/07391102.2020.1779131,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32567995,10.1080/07391102.2020.1779131,2020-06-23
Methyltransferase,AFFECTS,capping,32567979,10.1080/07391102.2020.1778535,2020-06-23
Coronavirus Infections,ISA,Disease,32567979,10.1080/07391102.2020.1778535,2020-06-23
Coronavirus Infections,ISA,Disease,32567961,10.1080/13625187.2020.1777398,2020-06-23
"Marriage, life event",PROCESS_OF,Child,32567961,10.1080/13625187.2020.1777398,2020-06-23
Coronavirus Infections,NEG_CAUSES,Reproductive Health Services,32567961,10.1080/13625187.2020.1777398,2020-06-23
Orthodontic procedure,AFFECTS,Patients,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
Orthodontic procedure,PRECEDES,Therapeutic procedure,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
follow-up,NEG_TREATS,Patients,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
follow-up,TREATS,Patients,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
Orthodontic procedure,ADMINISTERED_TO,Patients,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
Fear (Mental Process),PROCESS_OF,Patients,32567949,10.23804/ejpd.2020.21.02.12,2020-06-23
Genus: Coronavirus,CAUSES,Infection,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Airway structure,LOCATION_OF,Infection,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Infected,PROCESS_OF,Persons,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Incubation period,PROCESS_OF,Child,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Virus,PROCESS_OF,Child,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Clinical Observation,TREATS,Child,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Syringes,USES,Air,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Dental caries,PROCESS_OF,Patients,32567938,10.23804/ejpd.2020.21.02.01,2020-06-23
Experience,PROCESS_OF,Pastors,32567874,10.1037/tra0000841,2020-06-23
Mental disorders,PROCESS_OF,Family,32567872,10.1037/tra0000839,2020-06-23
Organ,PART_OF,Homo sapiens,32567823,10.23736/S0026-4806.20.06719-1,2020-06-23
Organ,LOCATION_OF,Multiple congenital anomalies,32567823,10.23736/S0026-4806.20.06719-1,2020-06-23
Infected,PROCESS_OF,Patients,32567656,10.1093/milmed/usaa144,2020-06-23
SARS coronavirus,PROCESS_OF,Patients,32567656,10.1093/milmed/usaa144,2020-06-23
Experience,PROCESS_OF,Staff,32567653,10.1093/pubmed/fdaa092,2020-06-23
Chronic disease,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Indeterminate colitis,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Anxiety,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32567580,10.4103/sjg.SJG_220_20,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32567505,10.1177/0300891620935983,2020-06-23
Protection,PROCESS_OF,Staff,32567505,10.1177/0300891620935983,2020-06-23
Radiopharmaceuticals,TREATS,Tumor-Associated Process,32567505,10.1177/0300891620935983,2020-06-23
Uptake,PROCESS_OF,Lung,32567505,10.1177/0300891620935983,2020-06-23
PET/CT scan,USES,Radiopharmaceuticals,32567505,10.1177/0300891620935983,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32567505,10.1177/0300891620935983,2020-06-23
Pneumonia,PROCESS_OF,Patients,32567505,10.1177/0300891620935983,2020-06-23
Positron-Emission Tomography,CAUSES,Severe Acute Respiratory Syndrome,32567505,10.1177/0300891620935983,2020-06-23
PET/CT scan,ADMINISTERED_TO,Patients,32567505,10.1177/0300891620935983,2020-06-23
Infected,PROCESS_OF,World,32567501,10.1080/07391102.2020.1778538,2020-06-23
Anxiety,PROCESS_OF,Population Group,32567466,10.1177/0020764020934508,2020-06-23
Depressive disorder,PROCESS_OF,Population Group,32567466,10.1177/0020764020934508,2020-06-23
Stress,PROCESS_OF,Population Group,32567466,10.1177/0020764020934508,2020-06-23
Anxiety,PROCESS_OF,Population Group,32567466,10.1177/0020764020934508,2020-06-23
Stress,PROCESS_OF,Population Group,32567466,10.1177/0020764020934508,2020-06-23
Depressive Symptoms,COEXISTS_WITH,Employment status,32567466,10.1177/0020764020934508,2020-06-23
Anxiety symptoms,COEXISTS_WITH,Employment status,32567466,10.1177/0020764020934508,2020-06-23
Hydroxychloroquine,ADMINISTERED_TO,Woman,32567262,10.3346/jkms.2020.35.e231,2020-06-23
Study,MEASURES,per period (qualifier value),32567260,10.3346/jkms.2020.35.e224,2020-06-23
Health Services,ADMINISTERED_TO,Patients,32567260,10.3346/jkms.2020.35.e224,2020-06-23
Coronavirus Infections,ISA,Disease,32567260,10.3346/jkms.2020.35.e224,2020-06-23
Interested,PROCESS_OF,Patients,32567239,10.1002/eahr.500061,2020-06-23
Obesity,PROCESS_OF,Persons,32567171,10.1111/obr.13077,2020-06-23
Renin and aldosterone,DIAGNOSES,Acute Lung Injury,32567171,10.1111/obr.13077,2020-06-23
France,ISA,Country,32567057,10.1111/inr.12604,2020-06-23
Persons,LOCATION_OF,"TLR4 protein, human",32567057,10.1111/inr.12604,2020-06-23
Diagnostic tests,CAUSES,Symptoms,32567041,10.1007/s00417-020-04790-w,2020-06-23
Medical Examination,TREATS,Patients,32567041,10.1007/s00417-020-04790-w,2020-06-23
Coughing,PROCESS_OF,Transient Population Group,32567041,10.1007/s00417-020-04790-w,2020-06-23
Nucleic acid probe with target amplification,USES,RNA-Directed DNA Polymerase,32567006,10.1007/s00259-020-04929-1,2020-06-23
Chest CT,ADMINISTERED_TO,Patients,32567006,10.1007/s00259-020-04929-1,2020-06-23
Hospitals,LOCATION_OF,Retrospective Studies,32567003,10.1007/s11427-020-1733-4,2020-06-23
Critical Illness,PROCESS_OF,Patients,32567003,10.1007/s11427-020-1733-4,2020-06-23
Critical Illness,PROCESS_OF,Survivors,32567003,10.1007/s11427-020-1733-4,2020-06-23
Hospitals,LOCATION_OF,Study,32567003,10.1007/s11427-020-1733-4,2020-06-23
serum LDL,DIAGNOSES,Critical Illness,32567003,10.1007/s11427-020-1733-4,2020-06-23
Critical Illness,PROCESS_OF,Patients,32567003,10.1007/s11427-020-1733-4,2020-06-23
Patients,LOCATION_OF,Serum,32567003,10.1007/s11427-020-1733-4,2020-06-23
Critical Illness,PROCESS_OF,Patients,32567003,10.1007/s11427-020-1733-4,2020-06-23
Disease,CAUSES,Cessation of life,32567003,10.1007/s11427-020-1733-4,2020-06-23
Hypoalbuminemia,AFFECTS,inflammatory response,32567003,10.1007/s11427-020-1733-4,2020-06-23
Exacerbation,COEXISTS_WITH,Hypoalbuminemia,32567003,10.1007/s11427-020-1733-4,2020-06-23
Psychiatric symptom,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Coronavirus Infections,AFFECTS,Immune,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Mental disorders,COEXISTS_WITH,Chronic inflammation,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Mental disorders,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Coronavirus Infections,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Psychiatric symptom,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Infected,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Symptoms,PROCESS_OF,Persons,32566934,10.1016/j.bbih.2020.100096,2020-06-23
Proteins,INTERACTS_WITH,"Antibodies, Neutralizing",32566896,10.1093/abt/tbaa009,2020-06-23
"Antibodies, Neutralizing",ISA,Proteins,32566896,10.1093/abt/tbaa009,2020-06-23
Infection,PROCESS_OF,Corona,32566803,10.1016/j.genrep.2020.100752,2020-06-23
Growth,AFFECTS,Persons,32566795,10.1016/j.heliyon.2020.e04238,2020-06-23
Infected,PROCESS_OF,Persons,32566795,10.1016/j.heliyon.2020.e04238,2020-06-23
Infected,PROCESS_OF,Persons,32566795,10.1016/j.heliyon.2020.e04238,2020-06-23
Infected,PROCESS_OF,Persons,32566795,10.1016/j.heliyon.2020.e04238,2020-06-23
Lung,LOCATION_OF,Lesion,32566621,10.21037/atm-20-3554,2020-06-23
Lung,NEG_LOCATION_OF(SPEC),"Respiratory Distress Syndrome, Adult",32566621,10.21037/atm-20-3554,2020-06-23
"Respiratory Distress Syndrome, Adult",NEG_ISA,Lesion,32566621,10.21037/atm-20-3554,2020-06-23
Lesion,NEG_COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32566621,10.21037/atm-20-3554,2020-06-23
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,patient condition,32566621,10.21037/atm-20-3554,2020-06-23
Lesion,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32566621,10.21037/atm-20-3554,2020-06-23
Coronavirus Infections,CAUSES,Pneumonia,32566620,10.21037/atm-20-3391,2020-06-23
Patients,LOCATION_OF,"CD69 protein, human",32566620,10.21037/atm-20-3391,2020-06-23
Coronavirus Infections,PROCESS_OF,Patients,32566620,10.21037/atm-20-3391,2020-06-23
Fever,ISA,Symptoms,32566620,10.21037/atm-20-3391,2020-06-23
Neutrophil count (procedure),ISA,White Blood Cell Count procedure,32566620,10.21037/atm-20-3391,2020-06-23
Coronavirus Infections,ISA,Disease,32566603,10.21037/atm-20-2124,2020-06-23
Disease,PROCESS_OF,Patients,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,ISA,Disease,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,ISA,Disease,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,ISA,Disease,32566603,10.21037/atm-20-2124,2020-06-23
Disease,PROCESS_OF,Patients,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,ISA,Disease,32566603,10.21037/atm-20-2124,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32566603,10.21037/atm-20-2124,2020-06-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32566603,10.21037/atm-20-2124,2020-06-23
Fever,ISA,Symptoms,32566579,10.21037/atm-20-3422,2020-06-23
Lymphopenia,PROCESS_OF,Patients,32566579,10.21037/atm-20-3422,2020-06-23
Adrenal Cortex Hormones,ADMINISTERED_TO,Patients,32566579,10.21037/atm-20-3422,2020-06-23
Antiviral Therapy,ADMINISTERED_TO,Patients,32566579,10.21037/atm-20-3422,2020-06-23
Psychological counseling,ADMINISTERED_TO,Patients,32566579,10.21037/atm-20-3422,2020-06-23
Confirmation,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Confirmation,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Disease,PROCESS_OF,Male population group,32566574,10.21037/atm-20-2119,2020-06-23
Confirmation,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Confirmation,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Coughing,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Fever,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Sputum production,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Confirmation,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Symptoms,PROCESS_OF,Patients,32566574,10.21037/atm-20-2119,2020-06-23
Incubation period,PROCESS_OF,Cohort,32566574,10.21037/atm-20-2119,2020-06-23
Coughing,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Coughing,MANIFESTATION_OF,Coronavirus Infections,32566574,10.21037/atm-20-2119,2020-06-23
Dyspnea,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Dyspnea,MANIFESTATION_OF,Coronavirus Infections,32566574,10.21037/atm-20-2119,2020-06-23
Fatigue,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Fatigue,MANIFESTATION_OF,Coronavirus Infections,32566574,10.21037/atm-20-2119,2020-06-23
Fever,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Fever,MANIFESTATION_OF,Coronavirus Infections,32566574,10.21037/atm-20-2119,2020-06-23
Coronavirus Infections,ISA,Symptoms,32566574,10.21037/atm-20-2119,2020-06-23
Study,MEASURES,Probability,32566572,10.21037/atm-20-2372,2020-06-23
Pharmaceutical Preparations,ISA,Chemicals,32566569,10.21037/atm-20-2429,2020-06-23
Critical Illness,PROCESS_OF,Patients,32566569,10.21037/atm-20-2429,2020-06-23
Pharmaceutical Preparations,ISA,Chemicals,32566569,10.21037/atm-20-2429,2020-06-23
SARS coronavirus,CAUSES,Disease,32566566,10.21037/atm-20-3324,2020-06-23
Cross Infection,PROCESS_OF,Patients,32566566,10.21037/atm-20-3324,2020-06-23
Confirmation,PROCESS_OF,Patients,32566566,10.21037/atm-20-3324,2020-06-23
Confirmation,PROCESS_OF,Patients,32566566,10.21037/atm-20-3324,2020-06-23
Infected,PROCESS_OF,Medical Staff,32566566,10.21037/atm-20-3324,2020-06-23
Cross Infection,PROCESS_OF,Patients,32566566,10.21037/atm-20-3324,2020-06-23
Public Health Education,AFFECTS,Communicable Diseases,32566565,10.21037/atm-20-3312,2020-06-23
Glucocorticoids,TREATS,Adult,32566564,10.21037/atm-20-3307,2020-06-23
Glucocorticoids,TREATS,Child,32566564,10.21037/atm-20-3307,2020-06-23
Glucocorticoids,INHIBITS,Duration,32566564,10.21037/atm-20-3307,2020-06-23
Glucocorticoids,PREDISPOSES,Adverse reactions,32566564,10.21037/atm-20-3307,2020-06-23
"Glucocorticoids, Systemic",TREATS,Patients,32566564,10.21037/atm-20-3307,2020-06-23
Advice,ADMINISTERED_TO,Persons,32566563,10.21037/atm-20-3315,2020-06-23
Consultation,TREATS,Symptoms,32566563,10.21037/atm-20-3315,2020-06-23
Advice,ADMINISTERED_TO,Patients,32566563,10.21037/atm-20-3315,2020-06-23
Hotlines,TREATS,Disease,32566563,10.21037/atm-20-3315,2020-06-23
Symptoms,PROCESS_OF,Patients,32566563,10.21037/atm-20-3315,2020-06-23
"Immunoglobulins, Intravenous",TREATS,Child,32566562,10.21037/atm-20-3305,2020-06-23
"Immunoglobulins, Intravenous",TREATS,Patients,32566562,10.21037/atm-20-3305,2020-06-23
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32566562,10.21037/atm-20-3305,2020-06-23
"Immunoglobulins, Intravenous",NEG_TREATS,Patients,32566562,10.21037/atm-20-3305,2020-06-23
"Immunoglobulins, Intravenous",NEG_TREATS(INFER),"Respiratory Distress Syndrome, Adult",32566562,10.21037/atm-20-3305,2020-06-23
Patients,LOCATION_OF,"Immunoglobulins, Intravenous",32566562,10.21037/atm-20-3305,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32566562,10.21037/atm-20-3305,2020-06-23
Cross Infection,OCCURS_IN,Adult,32566562,10.21037/atm-20-3305,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32566562,10.21037/atm-20-3305,2020-06-23
Antiviral Agents,TREATS,Child,32566561,10.21037/atm-20-3301,2020-06-23
Intervention regimes,USES,Antiviral Agents,32566561,10.21037/atm-20-3301,2020-06-23
Antiviral Agents,TREATS,Child,32566561,10.21037/atm-20-3301,2020-06-23
Adrenal Cortex Hormones,COEXISTS_WITH,Interferons,32566561,10.21037/atm-20-3301,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32566561,10.21037/atm-20-3301,2020-06-23
Antiviral Agents,TREATS,Child,32566561,10.21037/atm-20-3301,2020-06-23
Ribavirin,COEXISTS_WITH,Interferons,32566561,10.21037/atm-20-3301,2020-06-23
Middle East Respiratory Syndrome,PROCESS_OF,Adult,32566561,10.21037/atm-20-3301,2020-06-23
Antiviral Agents,TREATS,Child,32566561,10.21037/atm-20-3301,2020-06-23
Asymptomatic,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Duration,TREATS,Child,32566560,10.21037/atm-20-3192,2020-06-23
Symptoms,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Asymptomatic Infections,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Symptoms,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Asymptomatic,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Symptoms,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
Symptoms,PROCESS_OF,Child,32566560,10.21037/atm-20-3192,2020-06-23
World,LOCATION_OF,IMPACT gene,32566559,10.21037/atm-20-3311,2020-06-23
tomography,DIAGNOSES,Pneumonia,32566559,10.21037/atm-20-3311,2020-06-23
tomography,METHOD_OF,Diagnosis,32566559,10.21037/atm-20-3311,2020-06-23
Chest CT,METHOD_OF,Diagnosis,32566559,10.21037/atm-20-3311,2020-06-23
Hypersensitivity,PROCESS_OF,Patients,32566559,10.21037/atm-20-3311,2020-06-23
Confirmation,PROCESS_OF,Patients,32566559,10.21037/atm-20-3311,2020-06-23
Disease,PROCESS_OF,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Respiration Disorders,PROCESS_OF,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS(INFER),Respiration Disorders,32566558,10.21037/atm-20-3298,2020-06-23
Respiration Disorders,PROCESS_OF,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Therapeutic procedure,TREATS,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Therapeutic procedure,TREATS(INFER),Respiration Disorders,32566558,10.21037/atm-20-3298,2020-06-23
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Extracorporeal Membrane Oxygenation,NEG_TREATS,Adult,32566558,10.21037/atm-20-3298,2020-06-23
Medical Staff,TREATS,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Respiration Disorders,PROCESS_OF,Patients,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS,Coronavirus Infections,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS,Severe Acute Respiratory Syndrome,32566558,10.21037/atm-20-3298,2020-06-23
Supportive care,TREATS,Middle East Respiratory Syndrome,32566558,10.21037/atm-20-3298,2020-06-23
Symptom mild,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Symptoms,PROCESS_OF,Family,32566557,10.21037/atm-20-3302,2020-06-23
Fever,ISA,Symptoms,32566557,10.21037/atm-20-3302,2020-06-23
Symptom mild,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Abnormal Finding,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Coughing,ISA,Symptoms,32566557,10.21037/atm-20-3302,2020-06-23
Coughing,PROCESS_OF(SPEC),Child,32566557,10.21037/atm-20-3302,2020-06-23
Fever,ISA,Symptoms,32566557,10.21037/atm-20-3302,2020-06-23
Fever,PROCESS_OF(SPEC),Child,32566557,10.21037/atm-20-3302,2020-06-23
Symptoms,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Diarrhea,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Vomiting,PROCESS_OF,Child,32566557,10.21037/atm-20-3302,2020-06-23
Antibiotics,TREATS,Child,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,ADMINISTERED_TO,Patients,32566556,10.21037/atm-20-3300,2020-06-23
Quinolones,ADMINISTERED_TO,Patients,32566556,10.21037/atm-20-3300,2020-06-23
beta-Lactamase,ADMINISTERED_TO,Patients,32566556,10.21037/atm-20-3300,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS,Child,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,COEXISTS_WITH,Macrolide Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,COEXISTS_WITH,Quinolones,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,COEXISTS_WITH,meropenem,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,COEXISTS_WITH,linezolid,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,COEXISTS_WITH,Cephalosporins,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS,Adult,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS,Adult,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS(INFER),Severe Acute Respiratory Syndrome,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS(INFER),Middle East Respiratory Syndrome,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,COEXISTS_WITH(SPEC),Quinolones,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,COEXISTS_WITH(SPEC),meropenem,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,COEXISTS_WITH(SPEC),linezolid,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,COEXISTS_WITH(SPEC),Cephalosporins,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,ISA,Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
Macrolide Antibiotics,TREATS(SPEC),Adult,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,COEXISTS_WITH(SPEC),Macrolide Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,COEXISTS_WITH(SPEC),Quinolones,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,COEXISTS_WITH(SPEC),linezolid,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,COEXISTS_WITH(SPEC),Cephalosporins,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,ISA,Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
meropenem,TREATS(SPEC),Adult,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,COEXISTS_WITH(SPEC),Macrolide Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,COEXISTS_WITH(SPEC),Quinolones,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,COEXISTS_WITH(SPEC),meropenem,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,COEXISTS_WITH(SPEC),Cephalosporins,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,ISA,Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
linezolid,TREATS(SPEC),Adult,32566556,10.21037/atm-20-3300,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,COEXISTS_WITH(SPEC),Macrolide Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,COEXISTS_WITH(SPEC),Quinolones,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,COEXISTS_WITH(SPEC),meropenem,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,COEXISTS_WITH(SPEC),linezolid,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,ISA,Antibiotics,32566556,10.21037/atm-20-3300,2020-06-23
Cephalosporins,TREATS(SPEC),Adult,32566556,10.21037/atm-20-3300,2020-06-23
Middle East Respiratory Syndrome,PROCESS_OF,Adult,32566556,10.21037/atm-20-3300,2020-06-23
Antibiotics,TREATS,Child,32566556,10.21037/atm-20-3300,2020-06-23
Influenza,PROCESS_OF,Mother (person),32566555,10.21037/atm-20-3299,2020-06-23
Mother (person),LOCATION_OF,Milk (body substance),32566555,10.21037/atm-20-3299,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32566555,10.21037/atm-20-3299,2020-06-23
General Anesthesia,PREDISPOSES,Cross Infection,32566494,10.18240/ijo.2020.06.01,2020-06-23
Community,LOCATION_OF,EHD1 wt Allele,32566486,10.5334/aogh.2897,2020-06-23
Migrants,LOCATION_OF,"TLR4 protein, human",32566486,10.5334/aogh.2897,2020-06-23
Health Care,TREATS,Immigrant (person),32566486,10.5334/aogh.2897,2020-06-23
"TLR4 protein, human",PART_OF,Homo sapiens,32566486,10.5334/aogh.2897,2020-06-23
Bronchoalveolar Lavage Fluid,PART_OF,Patients,32566476,10.1016/j.rmcr.2020.101120,2020-06-23
Bronchoalveolar Lavage Fluid,NEG_PART_OF,Nasopharynx,32566476,10.1016/j.rmcr.2020.101120,2020-06-23
Bronchoalveolar Lavage Fluid,PART_OF,Patients,32566476,10.1016/j.rmcr.2020.101120,2020-06-23
"Trauma, Nervous System",CAUSES,"Signs and Symptoms, Respiratory",32566476,10.1016/j.rmcr.2020.101120,2020-06-23
Lower respiratory tract infection,COEXISTS_WITH,Present,32566476,10.1016/j.rmcr.2020.101120,2020-06-23
mental health,PROCESS_OF,Persons,32566473,10.1016/j.mhp.2020.200185,2020-06-23
treatment options,TREATS,Widespread Disease,32566429,10.7759/cureus.8188,2020-06-23
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,patient condition,32566429,10.7759/cureus.8188,2020-06-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32566429,10.7759/cureus.8188,2020-06-23
Membrane,LOCATION_OF,Glycoproteins,32566425,10.7759/cureus.8184,2020-06-23
angiotensin converting enzyme 2,AFFECTS,Virus Attachment,32566425,10.7759/cureus.8184,2020-06-23
Cytoplasm,LOCATION_OF,Virus,32566425,10.7759/cureus.8184,2020-06-23
Type-II Pneumocytes,LOCATION_OF,angiotensin converting enzyme 2,32566425,10.7759/cureus.8184,2020-06-23
Infected,PROCESS_OF,Persons,32566425,10.7759/cureus.8184,2020-06-23
Symptoms,PROCESS_OF,Persons,32566425,10.7759/cureus.8184,2020-06-23
Analysis,USES,Drug Repositioning,32566414,10.7717/peerj.9357,2020-06-23
Vaccines,TREATS,Virus,32566261,10.1038/s41541-020-0204-7,2020-06-23
Therapeutic procedure,TREATS,Virus,32566261,10.1038/s41541-020-0204-7,2020-06-23
Vaccines,TREATS,"Hemorrhagic Fever, Ebola",32566261,10.1038/s41541-020-0204-7,2020-06-23
Coronavirus Infections,ISA,Disease,32566237,10.1002/ams2.521,2020-06-23
Disease,CAUSES,Severe Acute Respiratory Syndrome,32566237,10.1002/ams2.521,2020-06-23
Coronavirus Infections,CAUSES(SPEC),Severe Acute Respiratory Syndrome,32566237,10.1002/ams2.521,2020-06-23
Coronavirus Infections,ISA,Disease,32566237,10.1002/ams2.521,2020-06-23
Respiratory Failure,COEXISTS_WITH,patient condition,32566237,10.1002/ams2.521,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Male population group,32566237,10.1002/ams2.521,2020-06-23
Hypoxemia,PROCESS_OF,Patients,32566237,10.1002/ams2.521,2020-06-23
Assisted breathing,ADMINISTERED_TO,Patients,32566237,10.1002/ams2.521,2020-06-23
Multiple Organ Failure,CAUSES,Respiratory Failure,32566237,10.1002/ams2.521,2020-06-23
Respiratory Failure,PROCESS_OF,Patients,32566237,10.1002/ams2.521,2020-06-23
Critical Illness,PROCESS_OF,Patients,32566237,10.1002/ams2.521,2020-06-23
Disease,PROCESS_OF,Patients,32566237,10.1002/ams2.521,2020-06-23
Coronavirus Infections,ISA,Disease,32566237,10.1002/ams2.521,2020-06-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32566237,10.1002/ams2.521,2020-06-23
Coronavirus Infections,ISA,Disease,32566237,10.1002/ams2.521,2020-06-23
Partnership,LOCATION_OF,Study,32566169,10.7189/jogh.10.011007,2020-06-23
Coronavirus Infections,ISA,Disease,32566168,10.7189/jogh.10.011006,2020-06-23
Coronavirus Infections,ISA,Disease,32566168,10.7189/jogh.10.011006,2020-06-23
Coronavirus Infections,ISA,Disease,32566168,10.7189/jogh.10.011006,2020-06-23
Coronavirus Infections,ISA,Disease,32566168,10.7189/jogh.10.011006,2020-06-23
"Dermatitis, Atopic",AFFECTS,Possible,32566128,10.1186/s13601-020-00333-y,2020-06-23
Chronic urticaria,AFFECTS,Possible,32566128,10.1186/s13601-020-00333-y,2020-06-23
responsibility,PROCESS_OF,Clinical immunologist,32566128,10.1186/s13601-020-00333-y,2020-06-23
Neoplasms,PROCESS_OF,Patients,32565968,10.3892/ol.2020.11599,2020-06-23
Malignant Childhood Neoplasm,COEXISTS_WITH,Enthesitis-Related Arthritis,32565968,10.3892/ol.2020.11599,2020-06-23
Neoplasms,PROCESS_OF,Patients,32565968,10.3892/ol.2020.11599,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32565906,10.3332/ecancer.2020.ed101,2020-06-23
Pharmacotherapy,ISA,Therapeutic procedure,32565906,10.3332/ecancer.2020.ed101,2020-06-23
Fertility,PROCESS_OF,Hospital specialist,32565906,10.3332/ecancer.2020.ed101,2020-06-23
Malignant neoplasm of breast,COEXISTS_WITH,Localized Malignant Neoplasm,32565905,10.3332/ecancer.2020.1052,2020-06-23
Prostate,LOCATION_OF,Localized Malignant Neoplasm,32565905,10.3332/ecancer.2020.1052,2020-06-23
Boards (medical device),TREATS,Patients,32565901,10.3332/ecancer.2020.1048,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32565900,10.3332/ecancer.2020.1047,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32565900,10.3332/ecancer.2020.1047,2020-06-23
Malignant Neoplasms,PROCESS_OF,Patients,32565900,10.3332/ecancer.2020.1047,2020-06-23
Neoplasms,PROCESS_OF,Physician Executives,32565899,10.3332/ecancer.2020.1046,2020-06-23
Awareness,PROCESS_OF,Oncologists,32565899,10.3332/ecancer.2020.1046,2020-06-23
Betacoronavirus,CAUSES,Syndrome,32565897,10.3332/ecancer.2020.1044,2020-06-23
Virus Diseases,AFFECTS,special populations,32565897,10.3332/ecancer.2020.1044,2020-06-23
Mammaplasty,USES,Implants,32565894,10.3332/ecancer.2020.1041,2020-06-23
Experience,PROCESS_OF,Author,32565894,10.3332/ecancer.2020.1041,2020-06-23
Solid Neoplasm,PROCESS_OF,Patients,32565893,10.3332/ecancer.2020.1040,2020-06-23
Physicians - Internal Medicine - Medical Oncology,TREATS,Patients,32565893,10.3332/ecancer.2020.1040,2020-06-23
Coronavirus Infections,ISA,Communicable Diseases,32565882,10.1155/2020/5714714,2020-06-23
IMPACT gene,PREDISPOSES,Disease,32565882,10.1155/2020/5714714,2020-06-23
Cessation of life,PROCESS_OF,Patients,32565882,10.1155/2020/5714714,2020-06-23
Uptake,AFFECTS,Homo sapiens,32565838,10.1155/2020/1646943,2020-06-23
Uptake,AFFECTS,Intestinal Microbiome,32565838,10.1155/2020/1646943,2020-06-23
IMPACT gene,PART_OF,Virus,32565838,10.1155/2020/1646943,2020-06-23
SARS coronavirus,ISA,Virus,32565812,10.1155/2020/8817424,2020-06-23
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32565812,10.1155/2020/8817424,2020-06-23
Very high,PREDISPOSES,Cross Infection,32565812,10.1155/2020/8817424,2020-06-23
Dental Procedures,PREVENTS,Cross Infection,32565812,10.1155/2020/8817424,2020-06-23
"CD69 protein, human",ADMINISTERED_TO,Patients,32565812,10.1155/2020/8817424,2020-06-23
Myomectomy,PREDISPOSES,"Blood Loss, Surgical",32565764,10.1186/s10397-020-01075-2,2020-06-23
Obesity,PROCESS_OF,Patients,32565764,10.1186/s10397-020-01075-2,2020-06-23
Obesity,PROCESS_OF,Patients,32565764,10.1186/s10397-020-01075-2,2020-06-23
Ambulatory surgery center,LOCATION_OF,comparative analysis,32565764,10.1186/s10397-020-01075-2,2020-06-23
Ambulatory surgery center,LOCATION_OF,Study,32565764,10.1186/s10397-020-01075-2,2020-06-23
laparoscopic myomectomy,TREATS,Gravidity,32565764,10.1186/s10397-020-01075-2,2020-06-23
Tourniquets,CAUSES,Complete obstruction,32565764,10.1186/s10397-020-01075-2,2020-06-23
Structure of uterine artery,LOCATION_OF,Complete obstruction,32565764,10.1186/s10397-020-01075-2,2020-06-23
Anterior ramus,PART_OF,Structure of iliac artery,32565764,10.1186/s10397-020-01075-2,2020-06-23
Obesity,PROCESS_OF,Patients,32565764,10.1186/s10397-020-01075-2,2020-06-23
Estimated blood loss,COEXISTS_WITH,Obesity,32565764,10.1186/s10397-020-01075-2,2020-06-23
Obesity,PROCESS_OF,Patients,32565764,10.1186/s10397-020-01075-2,2020-06-23
Coronavirus Infections,PROCESS_OF,Patients,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
macrophage,LOCATION_OF,Virus,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Alveolar Epithelial Cells,LOCATION_OF,Virus,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Alveolar Epithelial Cells,PART_OF,Parenchyma,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Dyspnea,ISA,Symptoms,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Fever,ISA,Symptoms,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Lymphopenia,ISA,Symptoms,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Pneumonia,ISA,Symptoms,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Dry cough,ISA,Symptoms,32565763,10.1016/j.vacun.2020.03.001,2020-06-23
Author,DIAGNOSES,Dermatologic disorders,32565678,10.1177/1178633720928356,2020-06-23
Eye,LOCATION_OF,Coronavirus Infections,32565627,10.1016/j.chaos.2020.110023,2020-06-23
World,ISA,Population Group,32565627,10.1016/j.chaos.2020.110023,2020-06-23
Mutation,PROCESS_OF,Human body,32565626,10.1016/j.chaos.2020.110018,2020-06-23
Pandemics,CAUSES,Infantile Neuroaxonal Dystrophy,32565624,10.1016/j.chaos.2020.110007,2020-06-23
Coughing,ISA,Symptoms,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Fever,ISA,Symptoms,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Headache,ISA,Symptoms,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Nose,LOCATION_OF,Congestion,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Pharyngitis,ISA,Symptoms,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Alarm device,TREATS,Patients,32565599,10.4103/ijp.IJP_310_20,2020-06-23
Intervention regimes,NEG_TREATS,Persons,32565592,10.1016/j.paid.2020.110201,2020-06-23
Decision,PROCESS_OF,Maker (occupation),32565584,10.1016/j.compchemeng.2020.106945,2020-06-23
Clinical Significance,PROCESS_OF,Patients,32565512,10.5582/bst.2020.03197,2020-06-23
Patients,LOCATION_OF,KITLG gene,32565512,10.5582/bst.2020.03197,2020-06-23
Intervention regimes,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32565483,10.1136/bmjopen-2020-039097,2020-06-23
Uptake,PROCESS_OF,Persons,32565483,10.1136/bmjopen-2020-039097,2020-06-23
Amino Acids,AFFECTS,Disease Outcome,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Micronutrients,AFFECTS,Disease Outcome,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Amino Acids,TREATS,Adult,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Amino Acids,TREATS(INFER),Disease,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Amino Acids,TREATS(INFER),Infection,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Disease,PROCESS_OF,Adult,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Glutamine,ISA,Amino Acids,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Glutamine,TREATS(SPEC),Adult,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Micronutrients,TREATS,Adult,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Infection,PROCESS_OF,Adult,32565398,10.1016/j.jand.2020.05.015,2020-06-23
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Target Population,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Ventilator-associated lung injury,PROCESS_OF,Target Population,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Medical Nutrition Therapy,TREATS,Patients,32565398,10.1016/j.jand.2020.05.015,2020-06-23
"Dietitian, Registered",ISA,Nutritionist,32565398,10.1016/j.jand.2020.05.015,2020-06-23
Elderly (population group),ISA,Persons,32565395,10.1016/j.jand.2020.05.012,2020-06-23
Comorbidity,PROCESS_OF,Persons,32565395,10.1016/j.jand.2020.05.012,2020-06-23
Comorbidity,PROCESS_OF(SPEC),Elderly (population group),32565395,10.1016/j.jand.2020.05.012,2020-06-23
Nutrition management,TREATS,Adult,32565395,10.1016/j.jand.2020.05.012,2020-06-23
"Dietitian, Registered",ISA,Nutritionist,32565395,10.1016/j.jand.2020.05.012,2020-06-23
"Dietitian, Registered",ISA,Nutritionist,32565395,10.1016/j.jand.2020.05.012,2020-06-23
special hospital,LOCATION_OF,Study,32565367,10.1016/j.jhin.2020.06.021,2020-06-23
Positron-Emission Tomography,DIAGNOSES,Infection,32565367,10.1016/j.jhin.2020.06.021,2020-06-23
responsibility,PROCESS_OF,Community,32565364,10.1016/j.ijid.2020.06.049,2020-06-23
responsibility,PROCESS_OF,Persons,32565364,10.1016/j.ijid.2020.06.049,2020-06-23
Syndrome,PROCESS_OF,Child,32565364,10.1016/j.ijid.2020.06.049,2020-06-23
Lung,LOCATION_OF,ACE2 gene,32565362,10.1016/j.meegid.2020.104428,2020-06-23
Body tissue,PART_OF,Childhood Solid Neoplasm,32565362,10.1016/j.meegid.2020.104428,2020-06-23
Matched Tissues,LOCATION_OF,ACE2 gene,32565362,10.1016/j.meegid.2020.104428,2020-06-23
Antiviral Agents,TREATS,Comorbidity,32565309,10.1016/j.phrs.2020.105036,2020-06-23
Antiviral Agents,TREATS,Patients,32565309,10.1016/j.phrs.2020.105036,2020-06-23
Combined Modality Therapy,TREATS,Patients,32565309,10.1016/j.phrs.2020.105036,2020-06-23
Triage,TREATS,Patients,32565296,10.1016/j.ijcard.2020.06.023,2020-06-23
Ethanol,INTERACTS_WITH,Hand Sanitizers,32565272,10.1016/j.ajic.2020.06.182,2020-06-23
Hand Sanitizers,compared_with,sanitizers,32565272,10.1016/j.ajic.2020.06.182,2020-06-23
Virus,LOCATION_OF,Water,32565272,10.1016/j.ajic.2020.06.182,2020-06-23
"Respiratory Distress Syndrome, Adult",COMPLICATES,Pneumonia,32565264,10.1016/j.jormas.2020.06.008,2020-06-23
adjuvant therapy,TREATS,Pneumonia,32565264,10.1016/j.jormas.2020.06.008,2020-06-23
Face,LOCATION_OF,Pressure Ulcer,32565264,10.1016/j.jormas.2020.06.008,2020-06-23
Thrombosis,PREDISPOSES,Pressure Ulcer,32565264,10.1016/j.jormas.2020.06.008,2020-06-23
Face,LOCATION_OF,Pressure Ulcer,32565264,10.1016/j.jormas.2020.06.008,2020-06-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32565254,10.1016/j.accpm.2020.06.006,2020-06-23
Critical Illness,PROCESS_OF,Patients,32565254,10.1016/j.accpm.2020.06.006,2020-06-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32565254,10.1016/j.accpm.2020.06.006,2020-06-23
Disease,PROCESS_OF,Patients,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Disease,PROCESS_OF,Surgeon,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Larynx,LOCATION_OF,pathologic fistula,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Nasal cavity,LOCATION_OF,pathologic fistula,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Oral cavity,LOCATION_OF,pathologic fistula,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
"Ear, nose and throat department",LOCATION_OF,"Diagnostic Techniques, Surgical",32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Symptoms,PROCESS_OF,Otorhinolaryngologist,32565242,10.1016/j.anorl.2020.06.007,2020-06-23
Patients,LOCATION_OF,"CD69 protein, human",32565232,10.1016/j.htct.2020.06.001,2020-06-23
Hemostatic function,PROCESS_OF,Committee,32565232,10.1016/j.htct.2020.06.001,2020-06-23
Thrombosis,COEXISTS_WITH,brazilian,32565232,10.1016/j.htct.2020.06.001,2020-06-23
Pneumonia,PROCESS_OF,Patients,32565226,10.1016/j.jaip.2020.06.013,2020-06-23
Serum,LOCATION_OF,Interleukin-6,32565226,10.1016/j.jaip.2020.06.013,2020-06-23
Worse,PROCESS_OF,Patients,32565226,10.1016/j.jaip.2020.06.013,2020-06-23
Smear sample,PART_OF,Nasopharynx,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
Radioisotope scan of lung,DIAGNOSES,Infiltration,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
cefepime,ADMINISTERED_TO,Patients,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
"Pneumonia, Interstitial",COEXISTS_WITH,Immunocompromised Host,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Immunocompromised Host,32565199,10.1016/j.clinre.2020.05.014,2020-06-23
Chloroquine,ISA,Antimalarials,32565195,10.1016/j.ijantimicag.2020.106057,2020-06-23
Chloroquine,TREATS,Disease,32565195,10.1016/j.ijantimicag.2020.106057,2020-06-23
Hydroxychloroquine,TREATS,Disease,32565195,10.1016/j.ijantimicag.2020.106057,2020-06-23
Pharmaceutical Preparations,AFFECTS,Electricity,32565195,10.1016/j.ijantimicag.2020.106057,2020-06-23
Sodium Cation,INTERACTS_WITH,Anti-Arrhythmia Agents,32565195,10.1016/j.ijantimicag.2020.106057,2020-06-23
Health care facility,LOCATION_OF,Diagnostic radiologic examination,32565164,10.1016/j.acra.2020.06.001,2020-06-23
"Schools, Medical",LOCATION_OF,career,32565164,10.1016/j.acra.2020.06.001,2020-06-23
Challenge,TREATS,Educator,32565164,10.1016/j.acra.2020.06.001,2020-06-23
GSKIP gene,AUGMENTS,student enrollment,32565164,10.1016/j.acra.2020.06.001,2020-06-23
Coughing,ISA,Symptoms,32565152,10.1016/j.jiac.2020.06.010,2020-06-23
Fever,ISA,Symptoms,32565152,10.1016/j.jiac.2020.06.010,2020-06-23
Multiple Organ Failure,CAUSES,Cessation of life,32565152,10.1016/j.jiac.2020.06.010,2020-06-23
Lung,LOCATION_OF,Chest CT,32565152,10.1016/j.jiac.2020.06.010,2020-06-23
"Signs and Symptoms, Respiratory",PROCESS_OF,Persons,32565132,10.1016/j.jcyt.2020.04.100,2020-06-23
Immune System Diseases,COEXISTS_WITH,Syndrome,32565132,10.1016/j.jcyt.2020.04.100,2020-06-23
Immune System Diseases,COEXISTS_WITH,Inflammatory disorder,32565132,10.1016/j.jcyt.2020.04.100,2020-06-23
Glycoproteins,AFFECTS,Coronavirus Infections,32565126,10.1016/j.virusres.2020.198068,2020-06-23
Betacoronavirus,PROCESS_OF,Family member,32565126,10.1016/j.virusres.2020.198068,2020-06-23
Fusion inhibitor,ISA,Pharmaceutical Preparations,32565126,10.1016/j.virusres.2020.198068,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Common Cold,ISA,Pharyngitis,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Fever,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Thrombocytopenia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Nasopharyngeal aspirate,ASSOCIATED_WITH,patient condition,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32565097,10.1016/j.jpeds.2020.06.041,2020-06-23
Disorder characterized by fever,PROCESS_OF,Infant,32565095,10.1016/j.jpeds.2020.06.047,2020-06-23
Coronavirus Infections,ISA,Disease,32565094,10.1016/j.jcct.2020.06.003,2020-06-23
Congenital heart disease,PART_OF,Patients,32565094,10.1016/j.jcct.2020.06.003,2020-06-23
Congenital heart disease,PART_OF,Patients,32565094,10.1016/j.jcct.2020.06.003,2020-06-23
intensive care unit,LOCATION_OF,Services,32565047,10.1053/j.jvca.2020.05.028,2020-06-23
Ventilator - respiratory equipment,USES,Procure,32565047,10.1053/j.jvca.2020.05.028,2020-06-23
Personal protective equipment,ISA,Materials,32565047,10.1053/j.jvca.2020.05.028,2020-06-23
Pharmacotherapy,TREATS,Pancreatic carcinoma,32565039,10.1016/j.hpb.2020.05.012,2020-06-23
Pharmacotherapy,TREATS,metastatic colorectal cancer,32565039,10.1016/j.hpb.2020.05.012,2020-06-23
Pharmacotherapy,TREATS,Liver carcinoma,32565039,10.1016/j.hpb.2020.05.012,2020-06-23
Liver,LOCATION_OF,metastatic colorectal cancer,32565039,10.1016/j.hpb.2020.05.012,2020-06-23
cancer surgery,TREATS,World,32565039,10.1016/j.hpb.2020.05.012,2020-06-23
Pharmaceutical Preparations,TREATS,Arthritis,32565030,10.1016/j.reuma.2020.05.006,2020-06-23
Pharmaceutical Preparations,TREATS,Disease,32565030,10.1016/j.reuma.2020.05.006,2020-06-23
Pharmaceutical Preparations,TREATS,Giant Cell Arteritis,32565030,10.1016/j.reuma.2020.05.006,2020-06-23
Challenge,TREATS,Psychogeriatrician,32565007,10.1016/j.jagp.2020.05.019,2020-06-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Storm Syndrome,ISA,Complication,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Chest,LOCATION_OF,tomography,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Pulse taking,ADMINISTERED_TO,Patients,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Pulse taking,USES,tocilizumab,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Pulse taking,ADMINISTERED_TO,Patients,32564984,10.1016/j.regg.2020.05.004,2020-06-23
tocilizumab,ADMINISTERED_TO,Patients,32564984,10.1016/j.regg.2020.05.004,2020-06-23
Emergency medical service,TREATS,Population Group,32564983,10.1016/j.jfo.2020.05.005,2020-06-23
Cornea,LOCATION_OF,Superficial foreign body,32564983,10.1016/j.jfo.2020.05.005,2020-06-23
Disorder of eye,PROCESS_OF,Patients,32564983,10.1016/j.jfo.2020.05.005,2020-06-23
risk factors,PROCESS_OF,Patients,32564974,10.1016/j.amepre.2020.05.002,2020-06-23
Prognosis bad,PROCESS_OF,Patients,32564974,10.1016/j.amepre.2020.05.002,2020-06-23
Coronavirus Infections,ISA,Disease,32564908,10.1016/j.hlc.2020.05.004,2020-06-23
Infected,PROCESS_OF,Patients,32564757,10.2174/1573403X16666200621154842,2020-06-23
other medicated shampoos in ATC,PREDISPOSES,Complication,32564757,10.2174/1573403X16666200621154842,2020-06-23
Hospitals,LOCATION_OF,Administration occupational activities,32564757,10.2174/1573403X16666200621154842,2020-06-23
Kidney,LOCATION_OF,angiotensin converting enzyme 2,32564694,10.1161/HYPERTENSIONAHA.120.15276,2020-06-23
Kidney,LOCATION_OF,Hypertensive disease,32564694,10.1161/HYPERTENSIONAHA.120.15276,2020-06-23
Infusion procedures,TREATS,Mus,32564694,10.1161/HYPERTENSIONAHA.120.15276,2020-06-23
AGTR1 gene,PART_OF,Kidney Glomerulus,32564694,10.1161/HYPERTENSIONAHA.120.15276,2020-06-23
Hypertensive disease,PROCESS_OF,Patients,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Coronary Arteriosclerosis,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Diabetes Mellitus,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Heart failure,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Hypertensive disease,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Chronic Obstructive Airway Disease,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Senility,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Chronic Kidney Diseases,PROCESS_OF,Survivors,32564693,10.1161/HYPERTENSIONAHA.120.15324,2020-06-23
Crisis,PROCESS_OF,World,32564670,10.1080/17441692.2020.1783340,2020-06-23
Study,MEASURES,IMPACT gene,32564637,10.1177/0020764020935489,2020-06-23
Family,INTERACTS_WITH,Participant,32564637,10.1177/0020764020935489,2020-06-23
IMPACT gene,AFFECTS,Mean score,32564637,10.1177/0020764020935489,2020-06-23
Mean score,PROCESS_OF,Participant,32564637,10.1177/0020764020935489,2020-06-23
Mean score,PROCESS_OF,Participant,32564637,10.1177/0020764020935489,2020-06-23
Coronavirus Infections,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Comorbidity,PROCESS_OF,Elderly (population group),32564624,10.5144/0256-4947.2020.273,2020-06-23
Comorbidity,PROCESS_OF,Persons,32564624,10.5144/0256-4947.2020.273,2020-06-23
Chronic liver disease,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Immune System Processes,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Chronic liver disease,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Chronic liver disease,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Chronic liver disease,PROCESS_OF,Patients,32564624,10.5144/0256-4947.2020.273,2020-06-23
Problem,COEXISTS_WITH,Enthesitis-Related Arthritis,32564503,10.1111/codi.15203,2020-06-22
Anoscopy,METHOD_OF,Screening procedure,32564503,10.1111/codi.15203,2020-06-22
Anus,LOCATION_OF,Rectal examination,32564503,10.1111/codi.15203,2020-06-22
Rectal examination,DIAGNOSES,Malignant neoplasm of anus,32564503,10.1111/codi.15203,2020-06-22
Malignant Neoplasms,ISA,Lesion,32564503,10.1111/codi.15203,2020-06-22
Oral Ulcer,PROCESS_OF,Patients,32564476,10.1111/odi.13498,2020-06-22
Cardiac complication,PROCESS_OF,Patients,32564467,10.1002/art.41409,2020-06-22
Antiphospholipid Antibodies,PREDISPOSES,Antiphospholipid Syndrome,32564467,10.1002/art.41409,2020-06-22
Coronavirus Infections,ISA,Disease,32564416,10.1111/odi.13496,2020-06-22
Xerostomia,COEXISTS_WITH,Disease,32564416,10.1111/odi.13496,2020-06-22
Asymptomatic Infections,PROCESS_OF,Patients,32564306,10.1007/s13730-020-00496-4,2020-06-22
Therapeutic procedure,NEG_TREATS,Recipient,32564306,10.1007/s13730-020-00496-4,2020-06-22
Therapeutic procedure,NEG_TREATS(INFER),Severe Acute Respiratory Syndrome,32564306,10.1007/s13730-020-00496-4,2020-06-22
Therapeutic procedure,USES,cytokine,32564306,10.1007/s13730-020-00496-4,2020-06-22
favipiravir,NEG_TREATS,Recipient,32564306,10.1007/s13730-020-00496-4,2020-06-22
favipiravir,NEG_TREATS(INFER),Severe Acute Respiratory Syndrome,32564306,10.1007/s13730-020-00496-4,2020-06-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32564306,10.1007/s13730-020-00496-4,2020-06-22
Fatal Outcome,PROCESS_OF,Recipient,32564306,10.1007/s13730-020-00496-4,2020-06-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32564306,10.1007/s13730-020-00496-4,2020-06-22
Comorbidity,PROCESS_OF,Patients,32564270,10.1007/s10072-020-04522-2,2020-06-22
Immunosuppressive Agents,ISA,Pharmaceutical Preparations,32564270,10.1007/s10072-020-04522-2,2020-06-22
rituximab,ISA,Agent,32564270,10.1007/s10072-020-04522-2,2020-06-22
rituximab,TREATS(SPEC),Multiple Sclerosis,32564270,10.1007/s10072-020-04522-2,2020-06-22
rituximab,TREATS,Patients,32564270,10.1007/s10072-020-04522-2,2020-06-22
Agent,TREATS,Multiple Sclerosis,32564270,10.1007/s10072-020-04522-2,2020-06-22
Attention,PROCESS_OF,Homo sapiens,32564256,10.1007/s12015-020-09994-5,2020-06-22
Coronavirus Infections,ISA,Disease,32564256,10.1007/s12015-020-09994-5,2020-06-22
Coronavirus Infections,ISA,Disease,32564256,10.1007/s12015-020-09994-5,2020-06-22
Coronavirus Infections,ISA,Disease,32564256,10.1007/s12015-020-09994-5,2020-06-22
Quality of Health Care,ADMINISTERED_TO,Population Group,32564248,10.1007/s10995-020-02967-7,2020-06-22
Encephalitis,PROCESS_OF,Patients,32564153,10.1007/s00415-020-09996-w,2020-06-22
Cerebrospinal fluid sample,PART_OF,Patients,32564153,10.1007/s00415-020-09996-w,2020-06-22
Neurologic Manifestations,PROCESS_OF,Patients,32564153,10.1007/s00415-020-09996-w,2020-06-22
Symptom mild,PROCESS_OF,Patients,32564153,10.1007/s00415-020-09996-w,2020-06-22
Cerebrospinal Fluid,LOCATION_OF,Viral Genome,32564153,10.1007/s00415-020-09996-w,2020-06-22
Virus,PROCESS_OF,Patients,32564153,10.1007/s00415-020-09996-w,2020-06-22
Neurologic Symptoms,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32564153,10.1007/s00415-020-09996-w,2020-06-22
skill,AFFECTS,Performance,32564140,10.1007/s00268-020-05648-2,2020-06-22
Perception,PROCESS_OF,Surgeon,32564140,10.1007/s00268-020-05648-2,2020-06-22
Performance,AFFECTS,skill,32564140,10.1007/s00268-020-05648-2,2020-06-22
skill,PROCESS_OF,Patients,32564140,10.1007/s00268-020-05648-2,2020-06-22
Nose,LOCATION_OF,Obstruction,32564071,10.1093/chemse/bjaa041,2020-06-22
Nose,LOCATION_OF,Obstruction,32564071,10.1093/chemse/bjaa041,2020-06-22
Ambulatory Care Facilities,LOCATION_OF,Cross-Sectional Studies,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Adherence To Medication Regime,ISA,Source of information,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Adherence To Medication Regime,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Immunosuppressive Agents,ADMINISTERED_TO,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Immunosuppressive Agents,ADMINISTERED_TO,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
5-Aminosalicylate,INTERACTS_WITH,Pharmaceutical Preparations,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Inflammatory Bowel Diseases,PROCESS_OF,peer,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
High Level,PROCESS_OF,Patients,32564068,10.1093/ecco-jcc/jjaa126,2020-06-22
Acute respiratory failure,PROCESS_OF,Patients,32564028,10.1159/000509104,2020-06-22
Arteries,LOCATION_OF,Acute respiratory failure,32564028,10.1159/000509104,2020-06-22
Blood capillaries,LOCATION_OF,Acute respiratory failure,32564028,10.1159/000509104,2020-06-22
Present,PROCESS_OF,Patients,32564028,10.1159/000509104,2020-06-22
Acute respiratory failure,PROCESS_OF,Patients,32564028,10.1159/000509104,2020-06-22
Critical Illness,PROCESS_OF,Patients,32564002,10.1556/650.2020.31901,2020-06-22
Plasma,PART_OF,Patients,32564002,10.1556/650.2020.31901,2020-06-22
Coronavirus Infections,PROCESS_OF,Patients,32564002,10.1556/650.2020.31901,2020-06-22
Plasma,PART_OF,Donor person,32564002,10.1556/650.2020.31901,2020-06-22
Persons,LOCATION_OF,Plasma,32564002,10.1556/650.2020.31901,2020-06-22
Critical Illness,PROCESS_OF,Patients,32564002,10.1556/650.2020.31901,2020-06-22
Coronavirus Infections,PROCESS_OF,Patients,32564002,10.1556/650.2020.31901,2020-06-22
Vaccines,TREATS,Virus,32563999,10.1136/postgradmedj-2020-138234,2020-06-22
Cell Count,USES,Conveyor,32563970,10.1016/j.mehy.2020.109976,2020-06-22
Pulmonary Surfactants,CAUSES,"Respiratory Distress Syndrome, Adult",32563970,10.1016/j.mehy.2020.109976,2020-06-22
ACE2 gene,PART_OF,protrusion,32563970,10.1016/j.mehy.2020.109976,2020-06-22
Opportunistic Infections,PROCESS_OF,Patients,32563969,10.1016/j.mehy.2020.109903,2020-06-22
Therapeutic immunosuppression,TREATS,Transplant Recipients,32563969,10.1016/j.mehy.2020.109903,2020-06-22
Immunoglobulins,AUGMENTS,Possible,32563969,10.1016/j.mehy.2020.109903,2020-06-22
Malignant neoplasm of thorax,PROCESS_OF,Patients,32563968,10.1016/j.resmer.2020.100769,2020-06-22
Symptoms,PROCESS_OF,Patients,32563968,10.1016/j.resmer.2020.100769,2020-06-22
Coronavirus Infections,CAUSES,Communicable Diseases,32563940,10.1016/j.dsx.2020.06.024,2020-06-22
Pharmaceutical Preparations,TREATS,Disease,32563940,10.1016/j.dsx.2020.06.024,2020-06-22
Vaccines,TREATS,Disease,32563940,10.1016/j.dsx.2020.06.024,2020-06-22
Enzymes,AFFECTS,capping,32563813,10.1016/j.ejmech.2020.112557,2020-06-22
RNA Caps,INHIBITS,Methyltransferase,32563813,10.1016/j.ejmech.2020.112557,2020-06-22
Methyltransferase,PART_OF,Flavivirus,32563813,10.1016/j.ejmech.2020.112557,2020-06-22
Methyltransferase,PART_OF,SARS coronavirus,32563813,10.1016/j.ejmech.2020.112557,2020-06-22
Toxicology,ISA,Pharmacology,32563812,10.1016/j.ejmech.2020.112527,2020-06-22
"Anti-Infective Agents, Local",AFFECTS,exacerbation acute,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Irrigation,AFFECTS,Sinusitis,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Irrigation,TREATS,post operative (finding),32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Mupirocin,AFFECTS,Sinusitis,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Mupirocin,compared_with,Irrigation,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
,compared_with,Salts,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Irrigation,compared_with,Povidone-Iodine,32563787,10.1016/j.amjoto.2020.102604,2020-06-22
Engaged to be married,PROCESS_OF,Old age,32563752,10.1016/j.jamda.2020.05.044,2020-06-22
At risk of disease,PROCESS_OF,Health Personnel,32563745,10.1016/j.psychres.2020.113190,2020-06-22
At risk of disease,PROCESS_OF,Patients,32563745,10.1016/j.psychres.2020.113190,2020-06-22
At risk of disease,PROCESS_OF,general population,32563745,10.1016/j.psychres.2020.113190,2020-06-22
Anxiety,PROCESS_OF,Patients,32563745,10.1016/j.psychres.2020.113190,2020-06-22
Depressive disorder,PROCESS_OF,Patients,32563745,10.1016/j.psychres.2020.113190,2020-06-22
High risk of,PROCESS_OF,Nurses,32563745,10.1016/j.psychres.2020.113190,2020-06-22
psychological distress,PROCESS_OF,High Risk Populations,32563745,10.1016/j.psychres.2020.113190,2020-06-22
Intervention regimes,TREATS,High Risk Populations,32563745,10.1016/j.psychres.2020.113190,2020-06-22
Study,MEASURES,Secondary Infections,32563739,10.1016/j.puhe.2020.05.016,2020-06-22
Coughing,ISA,Symptoms,32563739,10.1016/j.puhe.2020.05.016,2020-06-22
Fever,ISA,Symptoms,32563739,10.1016/j.puhe.2020.05.016,2020-06-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32563739,10.1016/j.puhe.2020.05.016,2020-06-22
Contacts,PREVENTS,Secondary Infections,32563739,10.1016/j.puhe.2020.05.016,2020-06-22
Feline infectious peritonitis,ISA,Coronavirus Infections,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Fluorescent Antibody Technique,METHOD_OF,Detection,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Nucleocapsid Proteins,PART_OF,"Coronavirus OC43, Human",32563698,10.1016/j.bj.2020.05.003,2020-06-22
Feline infectious peritonitis,ISA,Coronavirus Infections,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Feline infectious peritonitis,ISA,Coronavirus Infections,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Adverse reactions,PROCESS_OF,Homo sapiens,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Toxic effect,PROCESS_OF,Homo sapiens,32563698,10.1016/j.bj.2020.05.003,2020-06-22
Cardiovascular Diseases,CAUSES,Cessation of life,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
Hypertensive disease,AFFECTS,African American,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
Hypertensive disease,PROCESS_OF,African American,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
Hypertensive disease,PROCESS_OF,African American,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
inhibitors,TREATS,Hypertensive disease,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
Crisis,PROCESS_OF,African American,32563685,10.1016/j.jnma.2020.05.018,2020-06-22
Inferior Colliculus,LOCATION_OF,Testicular Involvement,32563676,10.1016/j.euf.2020.05.009,2020-06-22
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,Virus,32563676,10.1016/j.euf.2020.05.009,2020-06-22
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,Virus,32563676,10.1016/j.euf.2020.05.009,2020-06-22
Inferior Colliculus,LOCATION_OF,SARS coronavirus,32563676,10.1016/j.euf.2020.05.009,2020-06-22
Inferior Colliculus,NEG_LOCATION_OF,Virus,32563676,10.1016/j.euf.2020.05.009,2020-06-22
Communicable Diseases,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronaviridae,PROCESS_OF,Family,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Saudi Arabia,ISA,Country,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Coronavirus Infections,ISA,Disease,32563674,10.1016/j.jiph.2020.06.015,2020-06-22
Has difficulty doing (qualifier value),PROCESS_OF,Homo sapiens,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
Vaccination,TREATS,Infection,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
Canine coronavirus vaccine,PREVENTS,Disease,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
"Coronavirus, Feline",CAUSES,Feline infectious peritonitis,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
Bovine coronavirus,PROCESS_OF,Cattle,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
Epidemic diarrhea,PROCESS_OF,Family suidae,32563608,10.1016/j.vaccine.2020.06.026,2020-06-22
Invasive mechanical ventilation NOS,TREATS,Persons,32563601,10.1016/j.annemergmed.2020.05.011,2020-06-22
patient characteristics,PREDISPOSES,Disease,32563600,10.1016/j.annemergmed.2020.05.022,2020-06-22
Department,LOCATION_OF,Reverse Transcriptase Polymerase Chain Reaction,32563600,10.1016/j.annemergmed.2020.05.022,2020-06-22
Lung,LOCATION_OF,Ultrasonography,32563600,10.1016/j.annemergmed.2020.05.022,2020-06-22
Lung,LOCATION_OF,Ultrasonography,32563600,10.1016/j.annemergmed.2020.05.022,2020-06-22
Lung,LOCATION_OF,Ultrasonography,32563600,10.1016/j.annemergmed.2020.05.022,2020-06-22
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32563593,10.1016/j.ygyno.2020.06.486,2020-06-22
Brachytherapy,ISA,Therapeutic procedure,32563593,10.1016/j.ygyno.2020.06.486,2020-06-22
Heart Transplantation,TREATS,Male population group,32563584,10.1016/j.transproceed.2020.06.003,2020-06-22
Leukopenia,PROCESS_OF,Transient Population Group,32563584,10.1016/j.transproceed.2020.06.003,2020-06-22
Aging,PROCESS_OF,Population Group,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Eczema,ISA,Disease,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Mycoses,ISA,Disease,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Scabies <infestation>,ISA,Disease,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Diagnosis,DIAGNOSES,Disease,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Alopecia,ISA,Disease,32563581,10.1016/j.jfma.2020.06.007,2020-06-22
Diagnostic tests,AFFECTS,acute care,32563566,10.1016/j.nrl.2020.05.007,2020-06-22
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32563566,10.1016/j.nrl.2020.05.007,2020-06-22
Transient Ischemic Attack,PROCESS_OF,Patients,32563566,10.1016/j.nrl.2020.05.007,2020-06-22
Cerebrovascular accident,PROCESS_OF,Patients,32563566,10.1016/j.nrl.2020.05.007,2020-06-22
Critical Illness,PROCESS_OF,Patients,32563547,10.1016/j.jaut.2020.102506,2020-06-22
Disease,PROCESS_OF,Patients,32563547,10.1016/j.jaut.2020.102506,2020-06-22
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32563547,10.1016/j.jaut.2020.102506,2020-06-22
Syndrome,PROCESS_OF,Patients,32563547,10.1016/j.jaut.2020.102506,2020-06-22
Disease,COEXISTS_WITH,Autoinflammatory condition,32563547,10.1016/j.jaut.2020.102506,2020-06-22
Disease,PROCESS_OF,Patients,32563547,10.1016/j.jaut.2020.102506,2020-06-22
High temperature of physical object,OCCURS_IN,Community,32563533,10.1016/j.gaceta.2020.05.004,2020-06-22
Fracture,PROCESS_OF,Patients,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Fracture,PROCESS_OF,Patients,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Osteoporotic Fractures,ISA,Fracture,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Movement,PROCESS_OF,Persons,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Middle Aged,ISA,Adult,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Old age,ISA,Population Group,32563519,10.1016/j.injury.2020.06.022,2020-06-22
Virus Diseases,ISA,Communicable Diseases,32563494,10.1016/j.jocn.2020.06.006,2020-06-22
Antiviral Agents,TREATS,Genus: Coronavirus,32563494,10.1016/j.jocn.2020.06.006,2020-06-22
Vaccination,TREATS,Genus: Coronavirus,32563494,10.1016/j.jocn.2020.06.006,2020-06-22
Methylprednisolone,ASSOCIATED_WITH,Myopathy,32563494,10.1016/j.jocn.2020.06.006,2020-06-22
Malignant Neoplasms,PROCESS_OF,Patients,32563283,10.1016/S2352-3026(20)30205-2,2020-06-22
Acute leukemia,PROCESS_OF,Patients,32563283,10.1016/S2352-3026(20)30205-2,2020-06-22
Myeloid neoplasm,PROCESS_OF,Patients,32563283,10.1016/S2352-3026(20)30205-2,2020-06-22
Acute leukemia,PROCESS_OF,Patients,32563283,10.1016/S2352-3026(20)30205-2,2020-06-22
Myeloid neoplasm,PROCESS_OF,Patients,32563283,10.1016/S2352-3026(20)30205-2,2020-06-22
Communicable Diseases,NEG_PROCESS_OF,Population Group,32563272,10.4269/ajtmh.20-0642,2020-06-22
Noncommunicable Diseases,NEG_PROCESS_OF,Population Group,32563272,10.4269/ajtmh.20-0642,2020-06-22
Engaged to be married,PROCESS_OF,Community,32563272,10.4269/ajtmh.20-0642,2020-06-22
Coughing,ISA,Disease,32563271,10.4269/ajtmh.20-0583,2020-06-22
Dyspnea,ISA,Disease,32563271,10.4269/ajtmh.20-0583,2020-06-22
Fever,ISA,Disease,32563271,10.4269/ajtmh.20-0583,2020-06-22
Pneumonia,PROCESS_OF,Patients,32563271,10.4269/ajtmh.20-0583,2020-06-22
Diagnosis,AFFECTS,Rhabdomyolysis,32563271,10.4269/ajtmh.20-0583,2020-06-22
Parainfluenza,ISA,Virus Diseases,32563234,10.12932/AP-030520-0826,2020-06-22
Virus,CAUSES,Inflammation,32563234,10.12932/AP-030520-0826,2020-06-22
Infected,PROCESS_OF,Patients,32563234,10.12932/AP-030520-0826,2020-06-22
Ageusia,COEXISTS_WITH,Anosmia,32563234,10.12932/AP-030520-0826,2020-06-22
Pathognomonic symptom,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Virus,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Respiratory viruses,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Acute respiratory infections,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Acute respiratory infections,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Acute respiratory infections,PROCESS_OF,Patients,32563232,10.12932/AP-210520-0853,2020-06-22
Diagnosis,ADMINISTERED_TO,Persons,32563197,10.1111/ijcp.13592,2020-06-21
Infected,PROCESS_OF,Persons,32563197,10.1111/ijcp.13592,2020-06-21
Serum,LOCATION_OF,cytokine,32563194,10.1093/infdis/jiaa363,2020-06-21
chemokine production,PROCESS_OF,Patients,32563194,10.1093/infdis/jiaa363,2020-06-21
Serum,LOCATION_OF,cytokine,32563194,10.1093/infdis/jiaa363,2020-06-21
Critical Illness,PROCESS_OF,Patients,32563190,10.1093/infdis/jiaa355,2020-06-21
Adaptive Immunity,AFFECTS,Severe Acute Respiratory Syndrome,32563187,10.1093/infdis/jiaa356,2020-06-21
Adaptive Immunity,AFFECTS,Middle East Respiratory Syndrome,32563187,10.1093/infdis/jiaa356,2020-06-21
Dendritic Cells,NEG_LOCATION_OF,chemokine,32563187,10.1093/infdis/jiaa356,2020-06-21
chemokine,COEXISTS_WITH,methylene dimethanesulfonate,32563187,10.1093/infdis/jiaa356,2020-06-21
Dendritic Cells,INTERACTS_WITH,STAT1 gene,32563187,10.1093/infdis/jiaa356,2020-06-21
Immunoassay method,METHOD_OF,Detection,32563180,10.1016/j.jcv.2020.104512,2020-06-21
"Immunoglobulin A, Human",compared_with,"Immunoglobulin A, Human",32563180,10.1016/j.jcv.2020.104512,2020-06-21
Antibodies,PART_OF,Respiratory viruses,32563180,10.1016/j.jcv.2020.104512,2020-06-21
Specimen Type - Serum,NEG_PART_OF,Serum,32563180,10.1016/j.jcv.2020.104512,2020-06-21
Traffic accidents,CAUSES,Myocardial Infarction,32563134,10.1016/j.forsciint.2020.110365,2020-06-21
Emergency procedure,USES,Artificial Airways,32563080,10.1016/j.ijporl.2020.110174,2020-06-21
Operating Room,LOCATION_OF,Administration occupational activities,32563080,10.1016/j.ijporl.2020.110174,2020-06-21
Symptoms,COEXISTS_WITH,Anosmia,32563019,10.1016/j.amjoto.2020.102581,2020-06-21
Pathogenic,PROCESS_OF,Patients,32563019,10.1016/j.amjoto.2020.102581,2020-06-21
Anosmia,PROCESS_OF,Outpatients,32563019,10.1016/j.amjoto.2020.102581,2020-06-21
Headache,ISA,Illness (finding),32562988,10.1016/j.scitotenv.2020.140054,2020-06-21
China,ISA,Country,32562988,10.1016/j.scitotenv.2020.140054,2020-06-21
Coronavirus Infections,ISA,Disease,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Coronavirus Infections,ISA,Disease,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Coronavirus Infections,NEG_PROCESS_OF,Homo sapiens,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Cessation of life,PROCESS_OF,World,32562915,10.1016/j.mehy.2020.109876,2020-06-21
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Bronchi,LOCATION_OF,Virus,32562915,10.1016/j.mehy.2020.109876,2020-06-21
"M Protein, multiple myeloma",INTERACTS_WITH,"Receptors, Virus",32562915,10.1016/j.mehy.2020.109876,2020-06-21
Disease,PROCESS_OF,Patients,32562915,10.1016/j.mehy.2020.109876,2020-06-21
"Pneumonia, Interstitial",CAUSES,Storm Syndrome,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Coronavirus Infections,ISA,Disease,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Laser ablation,TREATS,Asymptomatic,32562915,10.1016/j.mehy.2020.109876,2020-06-21
receptor,AFFECTS,Virus Replication,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Respiratory viruses,INTERACTS_WITH,Virus,32562915,10.1016/j.mehy.2020.109876,2020-06-21
Infected,PROCESS_OF,Homo sapiens,32562913,10.1016/j.mehy.2020.109987,2020-06-21
Body tissue,PART_OF,Malignant neoplasm of mouth,32562913,10.1016/j.mehy.2020.109987,2020-06-21
Malignant neoplasm of mouth,PROCESS_OF,Patients,32562913,10.1016/j.mehy.2020.109987,2020-06-21
Malignant neoplasm of mouth,PROCESS_OF,Patients,32562913,10.1016/j.mehy.2020.109987,2020-06-21
paradigm,USES,Current Therapy,32562913,10.1016/j.mehy.2020.109987,2020-06-21
Coronaviridae,CAUSES,Respiration Disorders,32562911,10.1016/j.mehy.2020.109865,2020-06-21
Inflammation,CAUSES,"Respiratory Distress Syndrome, Adult",32562911,10.1016/j.mehy.2020.109865,2020-06-21
cytokine,CAUSES,Inflammation,32562911,10.1016/j.mehy.2020.109865,2020-06-21
Histological Techniques,ISA,Evaluation procedure,32562911,10.1016/j.mehy.2020.109865,2020-06-21
Inflammation,ISA,Signs and Symptoms,32562911,10.1016/j.mehy.2020.109865,2020-06-21
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Signs and Symptoms,32562911,10.1016/j.mehy.2020.109865,2020-06-21
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH(SPEC),Inflammation,32562911,10.1016/j.mehy.2020.109865,2020-06-21
"Respiratory Distress Syndrome, Adult",ISA,Signs and Symptoms,32562911,10.1016/j.mehy.2020.109865,2020-06-21
abnormal xray,PROCESS_OF,Patients,32562846,10.1016/j.ijid.2020.06.052,2020-06-21
Asymptomatic,PROCESS_OF,Patients,32562846,10.1016/j.ijid.2020.06.052,2020-06-21
Heart failure,AFFECTS,Patients,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Coronavirus Infections,PROCESS_OF,Patients,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Inflammation,CAUSES,Cessation of life,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Inflammation,PROCESS_OF,Patients,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Urokinase Plasminogen Activator Receptor,PREDISPOSES,Disease Progression,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Coronavirus Infections,PROCESS_OF,Patients,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
New medications,INTERACTS_WITH,Urokinase Plasminogen Activator Receptor,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
New medications,TREATS,Complication,32562843,10.1016/j.drudis.2020.06.013,2020-06-21
Telemedicine,ADMINISTERED_TO,Patients,32562832,10.1016/j.avsg.2020.06.023,2020-06-21
Telemedicine,METHOD_OF,follow-up,32562832,10.1016/j.avsg.2020.06.023,2020-06-21
Orthomyxoviridae,PROCESS_OF,Persons,32562826,10.1016/j.pharmthera.2020.107613,2020-06-21
Respiratory syncytial virus,CAUSES,Multiple Organ Failure,32562826,10.1016/j.pharmthera.2020.107613,2020-06-21
Respiratory syncytial virus,CAUSES,Pneumonia,32562826,10.1016/j.pharmthera.2020.107613,2020-06-21
Respiratory syncytial virus,CAUSES,"Respiratory Distress Syndrome, Adult",32562826,10.1016/j.pharmthera.2020.107613,2020-06-21
Viral Respiratory Tract Infection,PROCESS_OF,general population,32562826,10.1016/j.pharmthera.2020.107613,2020-06-21
Peptidyl-Dipeptidase A,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32562764,10.1016/j.etap.2020.103436,2020-06-21
Enterocytes,LOCATION_OF,Peptidyl-Dipeptidase A,32562764,10.1016/j.etap.2020.103436,2020-06-21
Sialic Acids,COEXISTS_WITH,Chloroquine,32562764,10.1016/j.etap.2020.103436,2020-06-21
Sialic Acids,COEXISTS_WITH,Hydroxychloroquine,32562764,10.1016/j.etap.2020.103436,2020-06-21
Free Radicals,ASSOCIATED_WITH,Viral respiratory infection,32562746,10.1016/j.niox.2020.06.002,2020-06-21
Respiratory viruses,CAUSES,Pneumonia,32562746,10.1016/j.niox.2020.06.002,2020-06-21
Coronavirus Infections,PROCESS_OF,Family,32562705,10.1016/j.antiviral.2020.104857,2020-06-21
RNA-directed RNA polymerase activity,PROCESS_OF,Polymerase,32562705,10.1016/j.antiviral.2020.104857,2020-06-21
Blood Coagulation Disorders,PROCESS_OF,Patients,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
Lung Injury,PROCESS_OF,Patients,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
AGTR1 gene,PRODUCES,angiotensin II,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
AGTR1 gene,PRODUCES,Peptidyl-Dipeptidase A,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
Pharmaceutical Preparations,TREATS,Cardiac complication,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
Pharmaceutical Preparations,TREATS,Acute Lung Injury,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
angiotensin I (1-7),ASSOCIATED_WITH,Cardiac complication,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
angiotensin I (1-7),ASSOCIATED_WITH,Acute Lung Injury,32562701,10.1016/j.yjmcc.2020.06.007,2020-06-21
Blood group A (finding),PROCESS_OF,Control Groups,32562665,10.1016/j.cca.2020.06.026,2020-06-21
Blood group A (finding),PROCESS_OF,Patients,32562665,10.1016/j.cca.2020.06.026,2020-06-21
Blood group O (finding),PROCESS_OF,Control Groups,32562665,10.1016/j.cca.2020.06.026,2020-06-21
Blood group O (finding),PROCESS_OF,Patients,32562665,10.1016/j.cca.2020.06.026,2020-06-21
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32562665,10.1016/j.cca.2020.06.026,2020-06-21
acute aortic dissection,ISA,Disease,32562625,10.1016/j.athoracsur.2020.06.005,2020-06-21
Dissection of proximal aorta,PROCESS_OF,Patients,32562625,10.1016/j.athoracsur.2020.06.005,2020-06-21
Infected,PROCESS_OF,Persons,32562601,10.1016/S1473-3099(20)30471-0,2020-06-21
Family member,ISA,Persons,32562601,10.1016/S1473-3099(20)30471-0,2020-06-21
Contacts,TREATS,Households,32562601,10.1016/S1473-3099(20)30471-0,2020-06-21
Pregnant Women,ISA,Population Group,32562594,10.1002/eahr.500060,2020-06-21
Pregnant Women,LOCATION_OF,IMPACT gene,32562594,10.1002/eahr.500060,2020-06-21
Chilblains,PROCESS_OF,Child,32562567,10.1111/bjd.19327,2020-06-21
Chilblains,PROCESS_OF,Young Adult,32562567,10.1111/bjd.19327,2020-06-21
Chilblains,PROCESS_OF,Patients,32562567,10.1111/bjd.19327,2020-06-21
Epithelial Cells,LOCATION_OF,Immunohistochemistry,32562567,10.1111/bjd.19327,2020-06-21
Epithelial Cells,PART_OF,Eccrine Glands,32562567,10.1111/bjd.19327,2020-06-21
Endothelial Cells,LOCATION_OF,Immunohistochemistry,32562567,10.1111/bjd.19327,2020-06-21
Endothelial Cells,PART_OF,Eccrine Glands,32562567,10.1111/bjd.19327,2020-06-21
Cytoplasm,PART_OF,Endothelial Cells,32562567,10.1111/bjd.19327,2020-06-21
Endothelium,LOCATION_OF,Chilblains,32562567,10.1111/bjd.19327,2020-06-21
Virus,CAUSES,Chilblains,32562567,10.1111/bjd.19327,2020-06-21
Dyspnea,ISA,Symptoms,32562561,10.1111/tid.13372,2020-06-21
Pneumonia,PROCESS_OF,Patients,32562561,10.1111/tid.13372,2020-06-21
Hydroxychloroquine,TREATS,Patients,32562561,10.1111/tid.13372,2020-06-21
Immunomodulation,TREATS,Patients,32562561,10.1111/tid.13372,2020-06-21
Immunomodulation,USES,tocilizumab,32562561,10.1111/tid.13372,2020-06-21
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32562561,10.1111/tid.13372,2020-06-21
Outpatients,ISA,Patients,32562561,10.1111/tid.13372,2020-06-21
Treatment Protocols,TREATS,Recipient,32562561,10.1111/tid.13372,2020-06-21
Experience,PROCESS_OF,Recipient,32562561,10.1111/tid.13372,2020-06-21
"Hospitals, General",LOCATION_OF,Diagnosis,32562554,10.1111/all.14465,2020-06-21
Pneumonia,PROCESS_OF,Patients,32562554,10.1111/all.14465,2020-06-21
patient condition,PROCESS_OF,Patients,32562554,10.1111/all.14465,2020-06-21
eosinophil,PART_OF,Patients,32562554,10.1111/all.14465,2020-06-21
Fever,PROCESS_OF,Patients,32562554,10.1111/all.14465,2020-06-21
"Kidney Failure, Chronic",PROCESS_OF,Patients,32562553,10.1111/eci.13328,2020-06-21
Coronavirus Infections,ISA,Disease,32562553,10.1111/eci.13328,2020-06-21
"Kidney Failure, Chronic",PROCESS_OF,Patients,32562553,10.1111/eci.13328,2020-06-21
Frail,PROCESS_OF,Patients,32562553,10.1111/eci.13328,2020-06-21
Infected,PROCESS_OF,Patients,32562544,10.1093/cid/ciaa797,2020-06-21
Confirmation,PROCESS_OF,Patients,32562544,10.1093/cid/ciaa797,2020-06-21
Symptoms,PROCESS_OF,Patients,32562541,10.1093/cid/ciaa799,2020-06-21
Leukocyte Trafficking,COEXISTS_WITH,Immune response,32562483,10.1016/j.xcrm.2020.100016,2020-06-21
Adrenal Cortex Hormones,AFFECTS,Neoplasm Metastasis,32562483,10.1016/j.xcrm.2020.100016,2020-06-21
Therapeutic procedure,PREDISPOSES,Secondary Infections,32562483,10.1016/j.xcrm.2020.100016,2020-06-21
Immunotherapy,NEG_PREVENTS,Inflammation,32562483,10.1016/j.xcrm.2020.100016,2020-06-21
Virus,PROCESS_OF,Scientist,32562482,10.1016/j.bsheal.2020.01.003,2020-06-21
Vaccines,PREVENTS,Viremia,32562480,10.1016/j.onehlt.2020.100141,2020-06-21
Pharmaceutical Preparations,PREVENTS,Disease,32562480,10.1016/j.onehlt.2020.100141,2020-06-21
apprehension,PROCESS_OF,Health Personnel,32562478,10.1016/j.jcpo.2020.100234,2020-06-21
Elevation procedure,USES,Troponin I,32562427,10.1002/clc.23384,2020-06-21
Hypotension,PROCESS_OF,Patients,32562427,10.1002/clc.23384,2020-06-21
Cardiac Arrhythmia,PROCESS_OF,Patients,32562427,10.1002/clc.23384,2020-06-21
Cardiac Arrhythmia,PROCESS_OF,Patients,32562427,10.1002/clc.23384,2020-06-21
Sinus Tachycardia,ISA,Cardiac Arrhythmia,32562427,10.1002/clc.23384,2020-06-21
Sinus Tachycardia,PROCESS_OF(SPEC),Patients,32562427,10.1002/clc.23384,2020-06-21
Sinus Tachycardia,PROCESS_OF(SPEC),Patients,32562427,10.1002/clc.23384,2020-06-21
Atrioventricular Block,PROCESS_OF,Patients,32562427,10.1002/clc.23384,2020-06-21
"Tachycardia, Ventricular",PROCESS_OF,Patients,32562427,10.1002/clc.23384,2020-06-21
Intervention regimes,TREATS,Hypotension,32562427,10.1002/clc.23384,2020-06-21
Cessation of life,PROCESS_OF,Community,32562416,10.1093/cid/ciaa815,2020-06-21
Cessation of life,PROCESS_OF,Native Americans,32562416,10.1093/cid/ciaa815,2020-06-21
Minority Groups,ISA,Ethnic group,32562416,10.1093/cid/ciaa815,2020-06-21
Chronic disease,AFFECTS,Minority Groups,32562416,10.1093/cid/ciaa815,2020-06-21
Virus Diseases,PROCESS_OF,Patients,32562351,10.1111/bju.15141,2020-06-21
Operative Surgical Procedures,TREATS,Patients,32562351,10.1111/bju.15141,2020-06-21
Operative Surgical Procedures,TREATS(INFER),Virus Diseases,32562351,10.1111/bju.15141,2020-06-21
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32562325,10.1002/hed.26345,2020-06-21
Vaccines,TREATS,Severe Acute Respiratory Syndrome,32562316,10.1096/fj.202001351,2020-06-21
Therapeutic procedure,TREATS,Severe Acute Respiratory Syndrome,32562316,10.1096/fj.202001351,2020-06-21
Measles Virus Nucleoprotein,PART_OF,SARS coronavirus,32562316,10.1096/fj.202001351,2020-06-21
Nucleocapsid Proteins,AFFECTS,physiological aspects,32562316,10.1096/fj.202001351,2020-06-21
Nucleocapsid Proteins,AFFECTS,intracellular protein transport,32562316,10.1096/fj.202001351,2020-06-21
Nucleocapsid Proteins,PART_OF,Virus,32562316,10.1096/fj.202001351,2020-06-21
Measles Virus Nucleoprotein,AFFECTS,Viral life cycle,32562316,10.1096/fj.202001351,2020-06-21
Catabolism,AFFECTS,Patients,32562276,10.1111/bph.15166,2020-06-21
Hydroxymethylglutaryl-CoA Reductase Inhibitors,AFFECTS,Virus Internalization,32562276,10.1111/bph.15166,2020-06-21
Hydroxymethylglutaryl-CoA Reductase Inhibitors,AFFECTS,Virus Replication,32562276,10.1111/bph.15166,2020-06-21
Hydroxymethylglutaryl-CoA Reductase Inhibitors,AFFECTS,Catabolism,32562276,10.1111/bph.15166,2020-06-21
Hydroxymethylglutaryl-CoA Reductase Inhibitors,AUGMENTS,Autophagy,32562276,10.1111/bph.15166,2020-06-21
Storm NOS,PROCESS_OF,Patients,32562276,10.1111/bph.15166,2020-06-21
Inflammasomes,ASSOCIATED_WITH,Fatal Outcome,32562276,10.1111/bph.15166,2020-06-21
Inflammasomes,PART_OF,NLRP3 gene,32562276,10.1111/bph.15166,2020-06-21
Common Cold,COEXISTS_WITH(SPEC),Genus: Coronavirus,32562214,10.1007/s13760-020-01412-4,2020-06-21
Common Cold,ISA,Upper Respiratory Infections,32562214,10.1007/s13760-020-01412-4,2020-06-21
Upper Respiratory Infections,COEXISTS_WITH,Genus: Coronavirus,32562214,10.1007/s13760-020-01412-4,2020-06-21
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32562214,10.1007/s13760-020-01412-4,2020-06-21
Middle East Respiratory Syndrome Coronavirus,CAUSES,Middle East Respiratory Syndrome,32562214,10.1007/s13760-020-01412-4,2020-06-21
"Pneumonia, Viral",PREDISPOSES,Respiratory Failure,32562214,10.1007/s13760-020-01412-4,2020-06-21
Ward (environment),LOCATION_OF,Observational Study,32562159,10.1007/s40199-020-00353-w,2020-06-21
Drugs regimen,AFFECTS,Patients,32562159,10.1007/s40199-020-00353-w,2020-06-21
Treatment Protocols,COEXISTS_WITH,follow-up,32562159,10.1007/s40199-020-00353-w,2020-06-21
Malignant neoplasm of breast,PROCESS_OF,Patients,32562119,10.1007/s10549-020-05739-7,2020-06-21
cancer surgery,TREATS,Malignant neoplasm of breast,32562119,10.1007/s10549-020-05739-7,2020-06-21
Malignant neoplasm of breast,PROCESS_OF,Patients,32562119,10.1007/s10549-020-05739-7,2020-06-21
Mastectomy,TREATS,Patients,32562119,10.1007/s10549-020-05739-7,2020-06-21
Mastectomy,TREATS(INFER),Malignant neoplasm of breast,32562119,10.1007/s10549-020-05739-7,2020-06-21
Mammaplasty,TREATS,Patients,32562119,10.1007/s10549-020-05739-7,2020-06-21
Mammaplasty,TREATS(INFER),Malignant neoplasm of breast,32562119,10.1007/s10549-020-05739-7,2020-06-21
Hydranencephaly with Renal Aplasia-Dysplasia,COEXISTS_WITH,Crisis,32562119,10.1007/s10549-020-05739-7,2020-06-21
Mammaplasty,USES,Implants,32562119,10.1007/s10549-020-05739-7,2020-06-21
Reconstructive Surgical Procedures,ISA,Interventional procedure,32562119,10.1007/s10549-020-05739-7,2020-06-21
Severe course,PROCESS_OF,Patients,32562109,10.1007/s40477-020-00494-3,2020-06-21
Chest CT,DIAGNOSES,Ground Glass Opacity,32562109,10.1007/s40477-020-00494-3,2020-06-21
Pneumonia,AFFECTS,Patients,32562109,10.1007/s40477-020-00494-3,2020-06-21
Therapeutic procedure,TREATS,Opportunistic Infections,32562070,10.1007/s10067-020-05234-w,2020-06-21
Therapeutic procedure,USES,Antibiotics,32562070,10.1007/s10067-020-05234-w,2020-06-21
Interleukin-6,COEXISTS_WITH,Interleukin 6 Receptor,32562070,10.1007/s10067-020-05234-w,2020-06-21
long-term care,USES,Immunosuppressive Agents,32562070,10.1007/s10067-020-05234-w,2020-06-21
Patients,LOCATION_OF,cytokine,32562070,10.1007/s10067-020-05234-w,2020-06-21
Immune response,AFFECTS,Immunity,32562070,10.1007/s10067-020-05234-w,2020-06-21
consideration,PROCESS_OF,Patients,32562070,10.1007/s10067-020-05234-w,2020-06-21
"Antirheumatic Drugs, Disease-Modifying",TREATS,Disease,32562070,10.1007/s10067-020-05234-w,2020-06-21
Serious mental illness,PROCESS_OF,Clients,32562033,10.1007/s10597-020-00662-z,2020-06-21
Injection,AFFECTS,Infantile Neuroaxonal Dystrophy,32562033,10.1007/s10597-020-00662-z,2020-06-21
Encephalitis,PROCESS_OF,Patients,32561990,10.1007/s00415-020-09990-2,2020-06-21
Neuromuscular Diseases,PROCESS_OF,Patients,32561990,10.1007/s00415-020-09990-2,2020-06-21
Encephalopathies,PROCESS_OF,Patients,32561990,10.1007/s00415-020-09990-2,2020-06-21
,INHIBITS,Janus kinase,32561873,10.1038/s41584-020-0451-z,2020-06-21
Interleukin-1,INHIBITS,Janus kinase,32561873,10.1038/s41584-020-0451-z,2020-06-21
Interleukin-6,INHIBITS,Janus kinase,32561873,10.1038/s41584-020-0451-z,2020-06-21
Zoonoses,NEG_CAUSES,Arthritis,32561873,10.1038/s41584-020-0451-z,2020-06-21
Arthritis,PROCESS_OF,Patients,32561873,10.1038/s41584-020-0451-z,2020-06-21
Arthritis,PROCESS_OF,Patients,32561873,10.1038/s41584-020-0451-z,2020-06-21
Coronavirus Infections,PROCESS_OF,Persons,32561849,10.1038/s41379-020-0595-z,2020-06-21
Disease,PROCESS_OF,Patients,32561849,10.1038/s41379-020-0595-z,2020-06-21
Alveolar Epithelial Cells,PART_OF,Lung,32561849,10.1038/s41379-020-0595-z,2020-06-21
Lung,NEG_LOCATION_OF,Virus,32561849,10.1038/s41379-020-0595-z,2020-06-21
Airway structure,NEG_LOCATION_OF,Virus,32561849,10.1038/s41379-020-0595-z,2020-06-21
Epithelial Cells,PART_OF,Patients,32561849,10.1038/s41379-020-0595-z,2020-06-21
Lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32561849,10.1038/s41379-020-0595-z,2020-06-21
Lung,PART_OF,Patients,32561849,10.1038/s41379-020-0595-z,2020-06-21
Airway structure,LOCATION_OF,Severe Acute Respiratory Syndrome,32561849,10.1038/s41379-020-0595-z,2020-06-21
Airway structure,PART_OF,Patients,32561849,10.1038/s41379-020-0595-z,2020-06-21
Respiratory Failure,PROCESS_OF,Patients,32561849,10.1038/s41379-020-0595-z,2020-06-21
Mental disorders,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Mental disorders,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Mental disorders,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Dementia,ISA,Mental disorders,32561692,10.18632/aging.103371,2020-06-21
Dementia,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Dementia,PROCESS_OF(SPEC),Patients,32561692,10.18632/aging.103371,2020-06-21
Patients,LOCATION_OF,Serum,32561692,10.18632/aging.103371,2020-06-21
Serum,PART_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Dementia,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Mental disorders,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Dementia,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
Dementia,PROCESS_OF,Patients,32561692,10.18632/aging.103371,2020-06-21
AIDS-Associated Nephropathy,PROCESS_OF,Patients,32561682,10.1681/ASN.2020050558,2020-06-21
AIDS-Associated Nephropathy,PROCESS_OF,Patients,32561682,10.1681/ASN.2020050558,2020-06-21
Renal glomerular disease,PROCESS_OF,Patients,32561682,10.1681/ASN.2020050558,2020-06-21
Serum,LOCATION_OF,Creatinine,32561682,10.1681/ASN.2020050558,2020-06-21
Renal glomerular disease,PROCESS_OF,Patients,32561682,10.1681/ASN.2020050558,2020-06-21
Renal glomerular disease,PROCESS_OF,Patients,32561682,10.1681/ASN.2020050558,2020-06-21
Dialysis procedure,ADMINISTERED_TO,Patients,32561681,10.1681/ASN.2020040534,2020-06-21
Dialysis procedure,ADMINISTERED_TO,Patients,32561681,10.1681/ASN.2020040534,2020-06-21
Masks,TREATS,Patients,32561681,10.1681/ASN.2020040534,2020-06-21
Coronavirus Infections,PROCESS_OF,Patients,32561681,10.1681/ASN.2020040534,2020-06-21
Coronavirus Infections,OCCURS_IN,Patients,32561681,10.1681/ASN.2020040534,2020-06-21
intensive care,ADMINISTERED_TO,Patients,32561660,10.1136/medethics-2019-105943,2020-06-21
"Vaccines, Attenuated",INTERACTS_WITH,Vaccines,32561657,10.1128/mBio.00907-20,2020-06-21
Lung,LOCATION_OF,Progressive inflammation,32561657,10.1128/mBio.00907-20,2020-06-21
Vaccination,TREATS,Persons,32561657,10.1128/mBio.00907-20,2020-06-21
Vaccination,USES,MRC1 wt Allele,32561657,10.1128/mBio.00907-20,2020-06-21
Biopsy sample,LOCATION_OF,colonoscopy,32561524,10.1136/jclinpath-2020-206833,2020-06-21
Asthma,PROCESS_OF,Child,32561497,10.1016/j.jaip.2020.06.001,2020-06-21
Allergic asthma,PROCESS_OF,Committee,32561497,10.1016/j.jaip.2020.06.001,2020-06-21
Asthma,PROCESS_OF,Child,32561497,10.1016/j.jaip.2020.06.001,2020-06-21
Coronavirus Infections,PROCESS_OF,Child,32561497,10.1016/j.jaip.2020.06.001,2020-06-21
Fascia,LOCATION_OF,"Transplantation, Autologous",32561491,10.1016/j.wneu.2020.06.065,2020-06-21
Complete excision,COEXISTS_WITH,Evaluation,32561491,10.1016/j.wneu.2020.06.065,2020-06-21
Complete excision,TREATS,"Wounds, Penetrating",32561491,10.1016/j.wneu.2020.06.065,2020-06-21
"Wounds, Penetrating",PROCESS_OF,Patients,32561491,10.1016/j.wneu.2020.06.065,2020-06-21
Craniocervical junction,LOCATION_OF,"Wounds, Penetrating",32561491,10.1016/j.wneu.2020.06.065,2020-06-21
Thrombosis,COEXISTS_WITH,Virus Diseases,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
Blood Coagulation Disorders,COEXISTS_WITH,Virus Diseases,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
Anti-Inflammatory Agents,DISRUPTS,Neutrophil chemotaxis,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
"Heparin, Low-Molecular-Weight",TREATS,Storm NOS,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
"Heparin, Low-Molecular-Weight",TREATS,Lung diseases,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
heparin,TREATS,Patients,32561465,10.1016/j.jvsv.2020.05.018,2020-06-21
skilled nursing facility,LOCATION_OF,Administration occupational activities,32561446,10.1016/j.jamcollsurg.2020.06.006,2020-06-21
Malignant neoplasm of lung,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Malignant neoplasm of lung,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Confirmation,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Malignant neoplasm of lung,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Malignant neoplasm of lung,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Hydroxychloroquine,TREATS,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Hydroxychloroquine,TREATS(INFER),Malignant neoplasm of lung,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Malignant neoplasm of lung,PROCESS_OF,Patients,32561401,10.1016/j.annonc.2020.06.007,2020-06-21
Pharmacotherapy,TREATS,Malignant Neoplasms,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Pharmacotherapy,TREATS,Diabetes Mellitus,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Pharmacotherapy,TREATS,Lung diseases,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Pharmacotherapy,TREATS,Obesity,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Mastocytosis,PROCESS_OF,Patients,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Mastocytosis,PROCESS_OF,Patients,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Patients,LOCATION_OF,IMPACT gene,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Infected,PROCESS_OF,Patients,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
SARS coronavirus,NEG_COEXISTS_WITH,Mastocytosis,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Mastocytosis,PROCESS_OF,Patients,32561389,10.1016/j.jaci.2020.06.009,2020-06-21
Fabry Disease,ISA,Disease,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Kidney,LOCATION_OF,Complication,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Fabry Disease,PROCESS_OF,Patients,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Enzyme Replacement Therapy,AFFECTS,Patients,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Fabry Disease,PROCESS_OF,Patients,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Possible,PROCESS_OF,Patients,32561366,10.1016/j.ymgme.2020.06.002,2020-06-21
Coronavirus Infections,ISA,Disease,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin-Converting Enzyme Inhibitors,TREATS(INFER),Diabetes,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Diabetes,PROCESS_OF,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Pharmaceutical Preparations,AFFECTS,Up-Regulation (Physiology),32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin II receptor antagonist,TREATS,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin II receptor antagonist,TREATS(INFER),Diabetes,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Diabetes,PROCESS_OF,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Diabetes,PROCESS_OF,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Diabetes,PROCESS_OF,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Pharmaceutical Preparations,AFFECTS,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Lung,LOCATION_OF,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Lung,LOCATION_OF,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Adverse reaction to drug,OCCURS_IN,Patients,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Coronavirus Infections,ISA,Disease,32561317,10.1016/j.japh.2020.05.018,2020-06-21
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",COEXISTS_WITH,Acute illness,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Angiotensin-Converting Enzyme Inhibitors,ASSOCIATED_WITH,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Captopril,AFFECTS,Acute Disease,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Captopril,AFFECTS,Infection,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Captopril,ASSOCIATED_WITH,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Captopril,compared_with,Angiotensin-Converting Enzyme Inhibitors,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Lung,LOCATION_OF,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Lung,LOCATION_OF,Adverse reaction to drug,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Adverse reaction to drug,AFFECTS,Pulmonary function,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Coronavirus Infections,ISA,Disease,32561317,10.1016/j.japh.2020.05.018,2020-06-21
Analysis,USES,Deep Sequencing,32561291,10.1016/j.ejphar.2020.173288,2020-06-21
Coronaviridae,PROCESS_OF,Family,32561291,10.1016/j.ejphar.2020.173288,2020-06-21
Viral envelope,LOCATION_OF,Glycoproteins,32561291,10.1016/j.ejphar.2020.173288,2020-06-21
Loneliness,PROCESS_OF,Elderly (population group),32561276,10.1016/j.jagp.2020.05.018,2020-06-21
Psychiatric symptom,COEXISTS_WITH,Symptoms,32561276,10.1016/j.jagp.2020.05.018,2020-06-21
Adverse effects,AFFECTS,Elderly (population group),32561276,10.1016/j.jagp.2020.05.018,2020-06-21
inhibitors,TREATS,Coronavirus Infections,32561274,10.1016/j.jiph.2020.06.016,2020-06-21
Patients,LOCATION_OF,Anti-Antibodies,32561270,10.1016/j.immuni.2020.06.001,2020-06-21
Vaccine Design,USES,Clinical Use Template,32561270,10.1016/j.immuni.2020.06.001,2020-06-21
Philadelphia,ISA,Geographic Locations,32561268,10.1016/j.jvs.2020.05.058,2020-06-21
Hospitals,LOCATION_OF,Work,32561268,10.1016/j.jvs.2020.05.058,2020-06-21
Hospitals,LOCATION_OF,laboratory studies,32561268,10.1016/j.jvs.2020.05.058,2020-06-21
Philadelphia,ISA,Geographic Locations,32561268,10.1016/j.jvs.2020.05.058,2020-06-21
Adult disease,PROCESS_OF,Patients,32561222,10.1016/j.bbi.2020.06.020,2020-06-21
Anxiety,ISA,Disease,32561222,10.1016/j.bbi.2020.06.020,2020-06-21
Feeling suicidal (finding),PROCESS_OF,Patients,32561222,10.1016/j.bbi.2020.06.020,2020-06-21
Cognition,PROCESS_OF,Relative (related person),32561221,10.1016/j.bbi.2020.06.021,2020-06-21
Diagnostic tests,CAUSES,Symptoms,32561220,10.1016/j.bjorl.2020.05.002,2020-06-21
Rhinitis,COEXISTS_WITH,Hypersensitivity,32561220,10.1016/j.bjorl.2020.05.002,2020-06-21
Rhinitis,ISA,Hypersensitivity,32561220,10.1016/j.bjorl.2020.05.002,2020-06-21
Universal Precautions,ADMINISTERED_TO,"Personnel, Hospital",32561172,10.1016/j.jpedsurg.2020.06.001,2020-06-21
tocilizumab,AFFECTS,Anticipated,32561148,10.1016/j.mayocp.2020.04.027,2020-06-21
tocilizumab,ISA,Immunologic Adjuvants,32561148,10.1016/j.mayocp.2020.04.027,2020-06-21
sarilumab,AFFECTS,Anticipated,32561148,10.1016/j.mayocp.2020.04.027,2020-06-21
sarilumab,ISA,Immunologic Adjuvants,32561148,10.1016/j.mayocp.2020.04.027,2020-06-21
Lenzilumab,AFFECTS,Anticipated,32561148,10.1016/j.mayocp.2020.04.027,2020-06-21
Decision,PROCESS_OF,Maker (occupation),32561147,10.1016/j.mayocp.2020.05.009,2020-06-21
Infected,PROCESS_OF,Persons,32561146,10.1016/j.mayocp.2020.05.008,2020-06-21
contextual factors,PROCESS_OF,Community,32561146,10.1016/j.mayocp.2020.05.008,2020-06-21
Challenge,TREATS,patient condition,32561126,10.1016/j.hlc.2020.05.002,2020-06-21
Complication,AFFECTS,Cardiovascular Diseases,32561126,10.1016/j.hlc.2020.05.002,2020-06-21
Coronavirus Infections,ISA,Disease,32561126,10.1016/j.hlc.2020.05.002,2020-06-21
Rehabilitation therapy,TREATS,Patients,32560965,10.1016/j.rh.2020.05.003,2020-06-21
Infected,PROCESS_OF,Persons,32560915,10.1016/j.rce.2020.05.007,2020-06-21
risk factors,PROCESS_OF,Persons,32560875,10.1016/j.msksp.2020.102179,2020-06-21
Lung,LOCATION_OF,Alarmins,32560746,10.1186/s13063-020-04488-8,2020-06-21
Pneumonia,COEXISTS_WITH,patient condition,32560746,10.1186/s13063-020-04488-8,2020-06-21
DNA,PART_OF,Extracellular,32560746,10.1186/s13063-020-04488-8,2020-06-21
Alveolar Epithelial Cells,LOCATION_OF,Dornase Alfa,32560746,10.1186/s13063-020-04488-8,2020-06-21
Alveolar Epithelial Cells,PART_OF,Alveolar,32560746,10.1186/s13063-020-04488-8,2020-06-21
Airway structure,LOCATION_OF,Mucous body substance,32560746,10.1186/s13063-020-04488-8,2020-06-21
Recombinant Human Deoxyribonuclease 1 [EPC],TREATS,Cystic Fibrosis,32560746,10.1186/s13063-020-04488-8,2020-06-21
Cell-Free DNA,PREVENTS,Toxic effect,32560746,10.1186/s13063-020-04488-8,2020-06-21
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,patient condition,32560746,10.1186/s13063-020-04488-8,2020-06-21
Pharmaceutical Preparations,AUGMENTS,Improved,32560746,10.1186/s13063-020-04488-8,2020-06-21
intensive care unit,LOCATION_OF,Open Label Study,32560746,10.1186/s13063-020-04488-8,2020-06-21
Pulmozyme,ISA,Dornase Alfa,32560746,10.1186/s13063-020-04488-8,2020-06-21
Alveolus,LOCATION_OF,Improved,32560746,10.1186/s13063-020-04488-8,2020-06-21
Critical Illness,PROCESS_OF,Patients,32560745,10.1186/s13063-020-04499-5,2020-06-21
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32560745,10.1186/s13063-020-04499-5,2020-06-21
inflammatory response,PROCESS_OF,Patients,32560745,10.1186/s13063-020-04499-5,2020-06-21
Storm NOS,PROCESS_OF,Patients,32560745,10.1186/s13063-020-04499-5,2020-06-21
Adrenal Cortex Hormones,AFFECTS,Storm NOS,32560745,10.1186/s13063-020-04499-5,2020-06-21
Interferon-beta,AFFECTS,Storm NOS,32560745,10.1186/s13063-020-04499-5,2020-06-21
Immunoglobulins,AFFECTS,Storm NOS,32560745,10.1186/s13063-020-04499-5,2020-06-21
Hospitals,LOCATION_OF,Study,32560745,10.1186/s13063-020-04499-5,2020-06-21
Laboratory Infection,PROCESS_OF,Patients,32560744,10.1186/s13063-020-04473-1,2020-06-21
Peripheral oxygen saturation,PROCESS_OF,Patients,32560744,10.1186/s13063-020-04473-1,2020-06-21
Evaluation,ADMINISTERED_TO,Participant,32560744,10.1186/s13063-020-04473-1,2020-06-21
Persons,LOCATION_OF,IMPACT gene,32560716,10.1186/s12889-020-09079-5,2020-06-21
Infectious disease prevention / control,TREATS,Patients,32560694,10.1186/s12879-020-05151-y,2020-06-21
Duration,TREATS,Patients,32560694,10.1186/s12879-020-05151-y,2020-06-21
Coughing,PROCESS_OF,Male population group,32560671,10.1186/s40249-020-00686-3,2020-06-21
Arthralgia,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Arthralgia,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Coughing,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Coughing,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Fatigue,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Fatigue,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Headache,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Headache,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Pharyngitis,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Pharyngitis,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Myalgia,COEXISTS_WITH,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Myalgia,ISA,Symptoms,32560671,10.1186/s40249-020-00686-3,2020-06-21
Brothers,ISA,Family,32560671,10.1186/s40249-020-00686-3,2020-06-21
Province,ISA,Geographic Locations,32560671,10.1186/s40249-020-00686-3,2020-06-21
Younger brother,ISA,Family,32560671,10.1186/s40249-020-00686-3,2020-06-21
Pandemics,ISA,Disease Outbreaks,32560667,10.1186/s40249-020-00694-3,2020-06-21
Acetylcysteine,STIMULATES,Anticoagulants,32560665,10.1186/s13054-020-03060-9,2020-06-21
Acetylcysteine,STIMULATES(SPEC),Tissue factor pathway inhibitor,32560665,10.1186/s13054-020-03060-9,2020-06-21
Dipyridamole,INHIBITS,Complement System Proteins,32560665,10.1186/s13054-020-03060-9,2020-06-21
Tissue factor pathway inhibitor,ISA,Anticoagulants,32560665,10.1186/s13054-020-03060-9,2020-06-21
intensive care unit,LOCATION_OF,Administration occupational activities,32560658,10.1186/s13054-020-03000-7,2020-06-21
SARS coronavirus,CAUSES,"Respiratory Distress Syndrome, Adult",32560658,10.1186/s13054-020-03000-7,2020-06-21
Pulmonary Embolism,ISA,Thrombosis,32560658,10.1186/s13054-020-03000-7,2020-06-21
Inflammation,PROCESS_OF,Patients,32560658,10.1186/s13054-020-03000-7,2020-06-21
Obesity,PROCESS_OF,Patients,32560658,10.1186/s13054-020-03000-7,2020-06-21
Thrombophilia,PROCESS_OF,Patients,32560658,10.1186/s13054-020-03000-7,2020-06-21
Hemostatic function,PROCESS_OF,hospitalized patients,32560658,10.1186/s13054-020-03000-7,2020-06-21
Critical Illness,PROCESS_OF,Patients,32560646,10.1186/s12985-020-01354-6,2020-06-21
Hydroxychloroquine,TREATS,Temporal finding,32560646,10.1186/s12985-020-01354-6,2020-06-21
Communicable Diseases,PROCESS_OF,Patients,32560572,10.3390/biology9060132,2020-06-21
Diabetes,PREDISPOSES,Degenerative disorder,32560550,10.3390/nu12061807,2020-06-21
Adolescent (age group),LOCATION_OF,"CD69 protein, human",32560550,10.3390/nu12061807,2020-06-21
Eating,PROCESS_OF,Adolescent (age group),32560550,10.3390/nu12061807,2020-06-21
Water,ASSOCIATED_WITH,Disease,32560459,10.3390/polym12061362,2020-06-21
Water,AUGMENTS,Stiffness,32560459,10.3390/polym12061362,2020-06-21
Water,AUGMENTS,Stiffness,32560459,10.3390/polym12061362,2020-06-21
Water,STIMULATES,NF-kappa B,32560459,10.3390/polym12061362,2020-06-21
Water,STIMULATES,NF-kappa B,32560459,10.3390/polym12061362,2020-06-21
Water,AFFECTS,Aging,32560459,10.3390/polym12061362,2020-06-21
Water,AFFECTS,Cell physiology,32560459,10.3390/polym12061362,2020-06-21
Vaccines,PART_OF,Human coronavirus,32560340,10.3390/vaccines8020309,2020-06-21
Animal Model,LOCATION_OF,EHD1 wt Allele,32560340,10.3390/vaccines8020309,2020-06-21
Middle East Respiratory Syndrome,PRODUCES,Vaccines,32560340,10.3390/vaccines8020309,2020-06-21
Vaccines,INTERACTS_WITH,WASF1 gene,32560340,10.3390/vaccines8020309,2020-06-21
Symptom severe,PROCESS_OF,Old age,32560227,10.3390/jcm9061885,2020-06-21
Movement,PROCESS_OF,Population Group,32560207,10.3390/microorganisms8060911,2020-06-21
High resolution,USES,TBATA gene,32560207,10.3390/microorganisms8060911,2020-06-21
Spain,ISA,Country,32560180,10.3390/ijerph17124305,2020-06-21
Dyspnea,PROCESS_OF,Patients,32560091,10.3390/diagnostics10060409,2020-06-21
Rheumatoid Arthritis,PROCESS_OF,Patients,32559820,10.1111/bcp.14436,2020-06-20
Hydroxychloroquine,TREATS,Patients,32559820,10.1111/bcp.14436,2020-06-20
Hydroxychloroquine,TREATS,Patients,32559820,10.1111/bcp.14436,2020-06-20
Hydroxychloroquine,TREATS,Patients,32559820,10.1111/bcp.14436,2020-06-20
Hydroxychloroquine,TREATS(INFER),Rheumatoid Arthritis,32559820,10.1111/bcp.14436,2020-06-20
Hydroxychloroquine,TREATS,Patients,32559820,10.1111/bcp.14436,2020-06-20
Coronavirus Infections,AFFECTS,Possible,32559801,10.1055/s-0040-1713408,2020-06-20
Pregnancy,ASSOCIATED_WITH,Enthesitis-Related Arthritis,32559801,10.1055/s-0040-1713408,2020-06-20
Ivermectin,ISA,Anthelmintics,32559771,10.1055/a-1185-8913,2020-06-20
Pharmaceutical Preparations,INTERACTS_WITH,Ion Channel,32559771,10.1055/a-1185-8913,2020-06-20
Ion Channel,ISA,Pharmaceutical Preparations,32559771,10.1055/a-1185-8913,2020-06-20
Pharmaceutical Preparations,TREATS,Dengue Virus,32559771,10.1055/a-1185-8913,2020-06-20
Importins,PART_OF,Membrane Transport Proteins,32559771,10.1055/a-1185-8913,2020-06-20
Ivermectin,ISA,Pharmaceutical Preparations,32559771,10.1055/a-1185-8913,2020-06-20
Microscopic observation,USES,Electrons,32559649,10.1016/j.ejmp.2020.06.011,2020-06-20
Chloroquine,PREDISPOSES,Seizures,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Hydroxychloroquine,PREDISPOSES,Seizures,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Seizures,PROCESS_OF,Persons,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Chloroquine,ISA,Pharmaceutical Preparations,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Pharmaceutical Preparations,CAUSES,Seizures,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Epilepsy,PROCESS_OF,Patients,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Seizures,PROCESS_OF,Patients,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Chloroquine,TREATS,Patients,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Chloroquine,TREATS(INFER),Seizures,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Seizures,PROCESS_OF,Patients,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Pharmaceutical Preparations,AUGMENTS,Seizures,32559589,10.1016/j.eplepsyres.2020.106399,2020-06-20
Immunoregulation,PROCESS_OF,Patients,32559419,10.1016/S2213-2600(20)30267-8,2020-06-20
Therapeutic Intervention,PREVENTS,Disease Progression,32559419,10.1016/S2213-2600(20)30267-8,2020-06-20
Granulocyte-Macrophage Colony-Stimulating Factor,ISA,cytokine,32559419,10.1016/S2213-2600(20)30267-8,2020-06-20
Granulocyte-Macrophage Colony-Stimulating Factor,AFFECTS,Monocytes,32559419,10.1016/S2213-2600(20)30267-8,2020-06-20
Granulocyte-Macrophage Colony-Stimulating Factor,AFFECTS,Homeostasis,32559419,10.1016/S2213-2600(20)30267-8,2020-06-20
Biliary Atresia,CAUSES,End Stage Liver Disease,32559354,10.1111/petr.13778,2020-06-20
Polymerase Chain Reaction,USES,Nasal Swabs,32559354,10.1111/petr.13778,2020-06-20
Hydroxychloroquine,TREATS,Decreased Immunologic Activity [PE],32559354,10.1111/petr.13778,2020-06-20
"Immunoglobulins, Intravenous",ISA,Gamma globulin,32559354,10.1111/petr.13778,2020-06-20
Complement component,STIMULATES,neutrophil,32559343,10.15252/emmm.202012642,2020-06-20
"Respiratory Distress Syndrome, Adult",ASSOCIATED_WITH,Complement Activation,32559343,10.15252/emmm.202012642,2020-06-20
Septicemia,ASSOCIATED_WITH,Complement Activation,32559343,10.15252/emmm.202012642,2020-06-20
Infected,PROCESS_OF,Patients,32559338,10.15252/emmm.202012885,2020-06-20
Cardiac Arrest,ISA,Cardiac Arrhythmia,32559324,10.1111/dth.13859,2020-06-20
Immune complex,CAUSES,Microthrombus,32559324,10.1111/dth.13859,2020-06-20
Brain,LOCATION_OF,Possible injury,32559324,10.1111/dth.13859,2020-06-20
Heart,LOCATION_OF,Possible injury,32559324,10.1111/dth.13859,2020-06-20
Kidney,LOCATION_OF,Possible injury,32559324,10.1111/dth.13859,2020-06-20
Lung,LOCATION_OF,Possible injury,32559324,10.1111/dth.13859,2020-06-20
Organ,LOCATION_OF,Possible injury,32559324,10.1111/dth.13859,2020-06-20
Prophylactic treatment,USES,Antiviral Agents,32559324,10.1111/dth.13859,2020-06-20
manager,USES,Artificial Airways,32559315,10.1111/anae.15188,2020-06-20
Drapes (device),compared_with,Medical Devices,32559315,10.1111/anae.15188,2020-06-20
Coughing,PROCESS_OF,Patients,32559315,10.1111/anae.15188,2020-06-20
"Calorimetry, Indirect",MEASURES,Carbon dioxide production,32559309,10.1002/jpen.1948,2020-06-20
Critical Illness,PROCESS_OF,Patients,32559309,10.1002/jpen.1948,2020-06-20
Energy Metabolism,PROCESS_OF,Patients,32559309,10.1002/jpen.1948,2020-06-20
Alveolar ventilation function,PROCESS_OF,Patients,32559309,10.1002/jpen.1948,2020-06-20
Malaise,PROCESS_OF,Patients,32559309,10.1002/jpen.1948,2020-06-20
Mechanical ventilation,TREATS,Patients,32559309,10.1002/jpen.1948,2020-06-20
Hematologic Neoplasms,PROCESS_OF,Patients,32559308,10.1111/bjh.16956,2020-06-20
Hematologic Neoplasms,PROCESS_OF,Patients,32559308,10.1111/bjh.16956,2020-06-20
Hematologic Neoplasms,PROCESS_OF,Population Group,32559308,10.1111/bjh.16956,2020-06-20
Co-morbid conditions,PROCESS_OF,Patients,32559282,10.1093/jpids/piaa074,2020-06-20
Targeted Therapy,ADMINISTERED_TO,Patients,32559282,10.1093/jpids/piaa074,2020-06-20
Critical Illness,PROCESS_OF,Patients,32559282,10.1093/jpids/piaa074,2020-06-20
Critical Illness,PROCESS_OF,Child,32559282,10.1093/jpids/piaa074,2020-06-20
Health Services,TREATS,Child,32559276,10.1093/ajcn/nqaa171,2020-06-20
Health Services,TREATS,Woman,32559276,10.1093/ajcn/nqaa171,2020-06-20
Water,PREDISPOSES,Shock,32559276,10.1093/ajcn/nqaa171,2020-06-20
Knowledge acquisition,AFFECTS,Nutritional status,32559276,10.1093/ajcn/nqaa171,2020-06-20
IMPACT gene,PREVENTS,Growth Disorders,32559276,10.1093/ajcn/nqaa171,2020-06-20
Intervention regimes,PREVENTS,Food Insecurity,32559276,10.1093/ajcn/nqaa171,2020-06-20
Serum,PART_OF,Patients,32559180,10.1172/jci.insight.140327,2020-06-20
Kynurenine,AFFECTS,Inflammation,32559180,10.1172/jci.insight.140327,2020-06-20
Infected,PROCESS_OF,Patients,32559180,10.1172/jci.insight.140327,2020-06-20
nitrogen metabolism,PROCESS_OF,Patients,32559180,10.1172/jci.insight.140327,2020-06-20
Returned home,PROCESS_OF,student,32559167,10.1109/MPULS.2020.2993665,2020-06-20
Mental disorders,PROCESS_OF,Persons,32559160,10.1109/MPULS.2020.2993657,2020-06-20
Toxic Epidermal Necrolysis,PROCESS_OF,Persons,32559160,10.1109/MPULS.2020.2993657,2020-06-20
viral membrane,LOCATION_OF,"Vitronectin, human",32559081,10.1021/acs.jpcb.0c04553,2020-06-20
viral membrane,LOCATION_OF,Proteins,32559081,10.1021/acs.jpcb.0c04553,2020-06-20
Disease,CAUSES,Fatal Outcome,32558962,10.1002/jmv.26194,2020-06-20
Chronic Morbidities,PROCESS_OF,Patients,32558962,10.1002/jmv.26194,2020-06-20
Virus,CAUSES,Disease,32558961,10.1002/jmv.26197,2020-06-20
Comorbidity,PROCESS_OF,Persons,32558961,10.1002/jmv.26197,2020-06-20
Disease,COEXISTS_WITH,Infected,32558961,10.1002/jmv.26197,2020-06-20
Young Adult,ISA,Adult,32558961,10.1002/jmv.26197,2020-06-20
Life Threatening,PROCESS_OF,Persons,32558961,10.1002/jmv.26197,2020-06-20
Vaccines,PREVENTS,Severe Acute Respiratory Syndrome,32558961,10.1002/jmv.26197,2020-06-20
Physicians,TREATS,Patients,32558961,10.1002/jmv.26197,2020-06-20
Hematologist,TREATS,Patients,32558961,10.1002/jmv.26197,2020-06-20
Encephalitis,ISA,Complication,32558956,10.1002/jmv.26207,2020-06-20
Encephalopathies,ISA,Complication,32558956,10.1002/jmv.26207,2020-06-20
Hypoxia,CAUSES,Encephalopathies,32558956,10.1002/jmv.26207,2020-06-20
Comorbidity,PREDISPOSES,Hypoxia,32558956,10.1002/jmv.26207,2020-06-20
Delirium,ISA,Confusion,32558956,10.1002/jmv.26207,2020-06-20
Encephalopathies,PROCESS_OF,Patients,32558956,10.1002/jmv.26207,2020-06-20
Encephalitis,PROCESS_OF,Patients,32558956,10.1002/jmv.26207,2020-06-20
Encephalopathies,PROCESS_OF,Patients,32558956,10.1002/jmv.26207,2020-06-20
Coronavirus Infections,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Fatigue,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Nose,LOCATION_OF,Congestion,32558955,10.1002/jmv.26208,2020-06-20
Congestion,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Personality Character,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,inpatient,32558955,10.1002/jmv.26208,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32558955,10.1002/jmv.26208,2020-06-20
Pneumonia,AFFECTS,Viral life cycle,32558946,10.1002/jmv.26200,2020-06-20
Trachea,LOCATION_OF,Viral life cycle,32558946,10.1002/jmv.26200,2020-06-20
ACE2 gene,INTERACTS_WITH,"Vitronectin, human",32558946,10.1002/jmv.26200,2020-06-20
host cell membrane,LOCATION_OF,ACE2 gene,32558946,10.1002/jmv.26200,2020-06-20
Virion,PART_OF,Offspring,32558946,10.1002/jmv.26200,2020-06-20
Virus Replication,NEG_AFFECTS,Cytopathic effect,32558946,10.1002/jmv.26200,2020-06-20
,LOCATION_OF,"Transcription, Genetic",32558946,10.1002/jmv.26200,2020-06-20
,LOCATION_OF,"Transcription, Genetic",32558946,10.1002/jmv.26200,2020-06-20
,LOCATION_OF,"Transcription, Genetic",32558946,10.1002/jmv.26200,2020-06-20
Interleukins,AFFECTS,Immune,32558946,10.1002/jmv.26200,2020-06-20
Interleukins,ASSOCIATED_WITH,Inflammation,32558946,10.1002/jmv.26200,2020-06-20
Epithelial Cells,LOCATION_OF,Virus,32558946,10.1002/jmv.26200,2020-06-20
Liver function,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
Chronic liver disease,AFFECTS,Liver function,32558945,10.1002/jmv.26201,2020-06-20
Cirrhosis,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
Increased alanine aminotransferase,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
Liver Cirrhosis,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
elevated sgot,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
Increased alanine aminotransferase,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
Liver Failure,PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
hepatic complications,NEG_PROCESS_OF,Patients,32558945,10.1002/jmv.26201,2020-06-20
COMP wt Allele,PART_OF,Intern,32558931,10.1111/eci.13323,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32558931,10.1111/eci.13323,2020-06-20
Diagnosis,AFFECTS,Patients,32558877,10.1001/jama.2020.11301,2020-06-20
Antihypertensive Agents,TREATS,Cohort,32558877,10.1001/jama.2020.11301,2020-06-20
Hypertensive disease,PROCESS_OF,Patients,32558877,10.1001/jama.2020.11301,2020-06-20
Angiotensin II receptor antagonist,ISA,Antihypertensive Agents,32558877,10.1001/jama.2020.11301,2020-06-20
Angiotensin II receptor antagonist,TREATS,Cohort,32558877,10.1001/jama.2020.11301,2020-06-20
Angiotensin II receptor antagonist,TREATS(SPEC),Cohort,32558877,10.1001/jama.2020.11301,2020-06-20
Angiotensin II receptor antagonist,compared_with,Antihypertensive Agents,32558877,10.1001/jama.2020.11301,2020-06-20
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,user - individual,32558877,10.1001/jama.2020.11301,2020-06-20
Hypertensive disease,PROCESS_OF,Patients,32558877,10.1001/jama.2020.11301,2020-06-20
Angiotensin II receptor antagonist,compared_with,Antihypertensive Agents,32558877,10.1001/jama.2020.11301,2020-06-20
Severe disorder,PROCESS_OF,Patients,32558877,10.1001/jama.2020.11301,2020-06-20
Cessation of life,PROCESS_OF,Patients,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Emergency medical service,METHOD_OF,Resuscitation procedure,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Cardiac Arrest,COEXISTS_WITH,Out-of-Hospital Cardiac Arrest,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Cardiac Arrest,PROCESS_OF,Outpatients,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Out-of-Hospital,COEXISTS_WITH,Menstruation Disturbances,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Resuscitation procedure,TREATS,Out-of-Hospital Cardiac Arrest,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Hypertensive disease,PROCESS_OF,Caucasoid Race,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Out-of-Hospital Cardiac Arrest,PROCESS_OF,Patients,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Cardiac Arrest,COEXISTS_WITH,Menstruation Disturbances,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Menstruation Disturbances,COEXISTS_WITH,Return of spontaneous circulation,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Senility,COEXISTS_WITH,Out-of-Hospital Cardiac Arrest,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Cessation of life,AFFECTS,Reduction (chemical),32558876,10.1001/jamacardio.2020.2488,2020-06-20
contextual factors,PROCESS_OF,Outpatients,32558876,10.1001/jamacardio.2020.2488,2020-06-20
Coronavirus Infections,CAUSES,Disease,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Virus,CAUSES,Disease,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Virus,CAUSES(SPEC),Coronavirus Infections,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Coronavirus Infections,ISA,Disease,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Coronavirus Infections,ISA,Disease,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Negative Test Result,PROCESS_OF,Persons,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Coughing,ISA,Symptoms,32558821,10.14745/ccdr.v46i05a08,2020-06-20
Respiratory viruses,PROCESS_OF,Working Group,32558815,10.14745/ccdr.v46i05a02,2020-06-20
Nucleic Acid Amplification Tests,DIAGNOSES,Acute illness,32558815,10.14745/ccdr.v46i05a02,2020-06-20
Buccal smear procedure,ISA,Laboratory Procedures,32558815,10.14745/ccdr.v46i05a02,2020-06-20
Circulatory Process,ASSOCIATED_WITH,Influenza-like symptoms,32558815,10.14745/ccdr.v46i05a02,2020-06-20
Circulatory Process,COEXISTS_WITH,Immune response,32558815,10.14745/ccdr.v46i05a02,2020-06-20
Human Age Group,ISA,Population Group,32558812,10.14745/ccdr.v46i06a04,2020-06-20
Detection,TREATS,Human Age Group,32558812,10.14745/ccdr.v46i06a04,2020-06-20
Therapeutic procedure,TREATS,Patients,32558790,10.1097/01.NURSE.0000668624.06487.72,2020-06-20
tomography,ADMINISTERED_TO,Patients,32558725,10.1097/RTI.0000000000000542,2020-06-20
tomography,DIAGNOSES,Disease,32558725,10.1097/RTI.0000000000000542,2020-06-20
Fever,ISA,Symptoms,32558725,10.1097/RTI.0000000000000542,2020-06-20
Pneumonia,PROCESS_OF,Patients,32558725,10.1097/RTI.0000000000000542,2020-06-20
Anal canal,LOCATION_OF,Adenocarcinoma,32558722,10.1097/RLU.0000000000003135,2020-06-20
Liver damage,PROCESS_OF,Patients,32558697,10.1097/MEG.0000000000001808,2020-06-20
"Respiratory Distress Syndrome, Newborn",CAUSES,Anoxia,32558697,10.1097/MEG.0000000000001808,2020-06-20
"Respiratory Distress Syndrome, Newborn",CAUSES,Single organ dysfunction,32558697,10.1097/MEG.0000000000001808,2020-06-20
"Respiratory Distress Syndrome, Newborn",CAUSES,inflammatory response,32558697,10.1097/MEG.0000000000001808,2020-06-20
Liver,LOCATION_OF,underdiagnosis,32558697,10.1097/MEG.0000000000001808,2020-06-20
Non-alcoholic Fatty Liver Disease,PREDISPOSES,underdiagnosis,32558697,10.1097/MEG.0000000000001808,2020-06-20
Liver,LOCATION_OF,"CD69 protein, human",32558697,10.1097/MEG.0000000000001808,2020-06-20
Office Visits,PREVENTS,Crisis,32558676,10.1097/BOT.0000000000001861,2020-06-20
Consultation,TREATS,Policy Makers,32558655,10.2196/19659,2020-06-20
Disease,AFFECTS,No incoordination,32558655,10.2196/19659,2020-06-20
Coronavirus Infections,AFFECTS(SPEC),No incoordination,32558655,10.2196/19659,2020-06-20
Coronavirus Infections,ISA,Disease,32558655,10.2196/19659,2020-06-20
Hospitals,LOCATION_OF,tomography,32558645,10.5152/dir.2020.20307,2020-06-20
patient condition,PROCESS_OF,Patients,32558645,10.5152/dir.2020.20307,2020-06-20
Infiltration,PROCESS_OF,Patients,32558645,10.5152/dir.2020.20307,2020-06-20
Parenchyma,LOCATION_OF,Infiltration,32558645,10.5152/dir.2020.20307,2020-06-20
Parenchyma,PART_OF,Lung,32558645,10.5152/dir.2020.20307,2020-06-20
Ground Glass Opacity,PROCESS_OF,Patients,32558645,10.5152/dir.2020.20307,2020-06-20
Blood Vessel,LOCATION_OF,Hypertrophy,32558645,10.5152/dir.2020.20307,2020-06-20
Asymptomatic,PROCESS_OF,Health Personnel,32558644,10.7554/eLife.59391,2020-06-20
Symptoms,PROCESS_OF,Health Personnel,32558644,10.7554/eLife.59391,2020-06-20
Genus: Coronavirus,ISA,Virus,32558641,10.1051/medsci/2020113,2020-06-20
Inferior esophageal sphincter structure,LOCATION_OF,Virus,32558641,10.1051/medsci/2020113,2020-06-20
Inferior esophageal sphincter structure,LOCATION_OF,Coronavirus Infections,32558641,10.1051/medsci/2020113,2020-06-20
Infected,PROCESS_OF,Patients,32558639,10.3201/eid2609.201495,2020-06-20
Virus,LOCATION_OF,Single Nucleotide Polymorphism,32558639,10.3201/eid2609.201495,2020-06-20
Attention,PROCESS_OF,African race,32558631,10.1080/01634372.2020.1779161,2020-06-20
Institutionalized,PROCESS_OF,Elderly (population group),32558631,10.1080/01634372.2020.1779161,2020-06-20
Comorbidity,PROCESS_OF,Elderly (population group),32558630,10.1080/01634372.2020.1766630,2020-06-20
Anxiety,PROCESS_OF,Population at Risk,32558630,10.1080/01634372.2020.1766630,2020-06-20
Emotional support,TREATS,Older people,32558630,10.1080/01634372.2020.1766630,2020-06-20
"Pneumonia, Viral",ISA,Disease,32558620,10.1177/1358863X20932640,2020-06-20
Coronavirus Infections,ISA,Disease,32558620,10.1177/1358863X20932640,2020-06-20
Critical Illness,PROCESS_OF,Patients,32558620,10.1177/1358863X20932640,2020-06-20
Respiratory Failure,PROCESS_OF,Patients,32558620,10.1177/1358863X20932640,2020-06-20
Blood Coagulation Disorders,PROCESS_OF,Patients,32558620,10.1177/1358863X20932640,2020-06-20
Disease,PROCESS_OF,Patients,32558620,10.1177/1358863X20932640,2020-06-20
Fibrin,ASSOCIATED_WITH,Critical Illness,32558620,10.1177/1358863X20932640,2020-06-20
Fibrin fragment D,ASSOCIATED_WITH,Critical Illness,32558620,10.1177/1358863X20932640,2020-06-20
Coronavirus Infections,ISA,Disease,32558620,10.1177/1358863X20932640,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32558620,10.1177/1358863X20932640,2020-06-20
Blood Coagulation Disorders,PROCESS_OF,Patients,32558620,10.1177/1358863X20932640,2020-06-20
Signs and Symptoms,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32558620,10.1177/1358863X20932640,2020-06-20
Signs and Symptoms,ASSOCIATED_WITH,Virus Diseases,32558620,10.1177/1358863X20932640,2020-06-20
Inflammation,CAUSES,Thrombophilia,32558620,10.1177/1358863X20932640,2020-06-20
Complement System Proteins,ASSOCIATED_WITH,Disease,32558620,10.1177/1358863X20932640,2020-06-20
Complement System Proteins,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32558620,10.1177/1358863X20932640,2020-06-20
Coronavirus Infections,ISA,Disease,32558620,10.1177/1358863X20932640,2020-06-20
Coronavirus Infections,ISA,Disease,32558519,10.31053/1853.0605.v77.n2.28336,2020-06-20
Disease,PROCESS_OF,Patients,32558519,10.31053/1853.0605.v77.n2.28336,2020-06-20
Coronavirus Infections,ISA,Disease,32558519,10.31053/1853.0605.v77.n2.28336,2020-06-20
Coronavirus Infections,ISA,Disease,32558519,10.31053/1853.0605.v77.n2.28336,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32558519,10.31053/1853.0605.v77.n2.28336,2020-06-20
Syndrome,PROCESS_OF,traveler,32558518,10.31053/1853.0605.v77.n2.28410,2020-06-20
Seizures,PROCESS_OF,Patients,32558518,10.31053/1853.0605.v77.n2.28410,2020-06-20
Coronavirus Infections,PROCESS_OF,Patients,32558518,10.31053/1853.0605.v77.n2.28410,2020-06-20
Malaise,PROCESS_OF,Patients,32558518,10.31053/1853.0605.v77.n2.28410,2020-06-20
Sirtuins,ASSOCIATED_WITH,Malignant Neoplasms,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
cytotoxicity,PROCESS_OF,Patients,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
Interleukin-4,AUGMENTS,Angiogenic Process,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT2 gene,INTERACTS_WITH,Interleukin-4,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT3 gene,STIMULATES,SIRT2 gene,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
Patients,LOCATION_OF,Tumor Suppressor Genes,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
Tumor Suppressor Genes,CAUSES,Colorectal Carcinoma,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
Tumor Suppressor Genes,COEXISTS_WITH,SIRT5 gene,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT5 gene,AUGMENTS,Cell Proliferation,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT6 gene,ASSOCIATED_WITH,Kaposi Sarcoma,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
compromise,PROCESS_OF,Patients,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
"Tumor cells, malignant",LOCATION_OF,Apoptosis,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT2 gene,ASSOCIATED_WITH,Malignant Neoplasms,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT1 gene,ASSOCIATED_WITH,Malignant Neoplasms,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT4 gene,ASSOCIATED_WITH,Malignant Neoplasms,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT5 gene,AUGMENTS,Apoptosis,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT6 gene,INHIBITS,SIRT1 gene,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT7 gene,AUGMENTS,Apoptosis,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
SIRT7 gene,DISRUPTS,Growth,32558516,10.31053/1853.0605.v77.n2.28196,2020-06-20
acute pneumonia,ISA,Disease,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Disease,PROCESS_OF,Patients,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Hospitals,LOCATION_OF,Administration occupational activities,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Hospitals,LOCATION_OF,Administration occupational activities,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Vaccines,NEG_ASSOCIATED_WITH,Disease,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Telemedicine,TREATS,Outpatients,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Telemedicine,TREATS,Patients,32558514,10.31053/1853.0605.v77.n2.28421,2020-06-20
Hospitals,LOCATION_OF,Genome-Wide Association Study,32558485,10.1056/NEJMoa2020283,2020-06-20
Reproductive History,PROCESS_OF,Hispanics,32558485,10.1056/NEJMoa2020283,2020-06-20
Reproductive History,PROCESS_OF,Italians,32558485,10.1056/NEJMoa2020283,2020-06-20
Patients,LOCATION_OF,Gene Clusters,32558485,10.1056/NEJMoa2020283,2020-06-20
3p21.31,LOCATION_OF,Single Nucleotide Polymorphism,32558485,10.1056/NEJMoa2020283,2020-06-20
Chronic disease,PROCESS_OF,Child,32558360,10.1002/ppul.24909,2020-06-20
Wheezing,PROCESS_OF,Professional Organization or Group,32558360,10.1002/ppul.24909,2020-06-20
Wheezing,PROCESS_OF,Professional Organization or Group,32558360,10.1002/ppul.24909,2020-06-20
At risk of disease,COEXISTS_WITH,Chronic disease,32558360,10.1002/ppul.24909,2020-06-20
Asthma,PROCESS_OF,Adult,32558360,10.1002/ppul.24909,2020-06-20
Asthma,PREDISPOSES,Coronavirus Infections,32558360,10.1002/ppul.24909,2020-06-20
Asthma,PREDISPOSES,Severe Acute Respiratory Syndrome,32558360,10.1002/ppul.24909,2020-06-20
Did not receive therapy or drug for,PROCESS_OF,Patients,32558354,10.1002/psp4.12543,2020-06-20
Virus,PROCESS_OF,Patients,32558354,10.1002/psp4.12543,2020-06-20
"Vitronectin, human",PART_OF,Virus,32558308,10.1002/mgg3.1344,2020-06-20
Disease,PROCESS_OF,Patients,32558285,10.1002/ppul.24895,2020-06-20
Mild inflammation,PROCESS_OF,Infant,32558285,10.1002/ppul.24895,2020-06-20
Cardiovascular,LOCATION_OF,Mild inflammation,32558285,10.1002/ppul.24895,2020-06-20
Chronic metabolic disorder,PROCESS_OF,Persons,32558211,10.1111/jdi.13326,2020-06-20
Prognosis bad,PROCESS_OF,Persons,32558211,10.1111/jdi.13326,2020-06-20
Diabetes Mellitus,PROCESS_OF,Patients,32558211,10.1111/jdi.13326,2020-06-20
Pharmaceutical Preparations,TREATS,patient condition,32558211,10.1111/jdi.13326,2020-06-20
Diabetic Ketoacidosis,COEXISTS_WITH,patient condition,32558211,10.1111/jdi.13326,2020-06-20
Diabetes Mellitus,PROCESS_OF,Patients,32558211,10.1111/jdi.13326,2020-06-20
Vaccination,TREATS,Patients,32558211,10.1111/jdi.13326,2020-06-20
Vaccination,TREATS(INFER),Diabetes Mellitus,32558211,10.1111/jdi.13326,2020-06-20
Suspected coronavirus infection,PROCESS_OF,Patients,32558198,10.1111/jth.14968,2020-06-20
patient condition,COEXISTS_WITH,Fever,32558198,10.1111/jth.14968,2020-06-20
X-Ray Computed Tomography,DIAGNOSES,Increased Drug AUC,32558198,10.1111/jth.14968,2020-06-20
Anticoagulants,TREATS,patient condition,32558198,10.1111/jth.14968,2020-06-20
Dermatologic disorders,PROCESS_OF,Patients,32558193,10.1111/dth.13867,2020-06-20
Coronavirus Infections,AFFECTS,Dermatologic disorders,32558193,10.1111/dth.13867,2020-06-20
systemic therapy,TREATS,Chronic disease of skin,32558193,10.1111/dth.13867,2020-06-20
other medicated shampoos in ATC,TREATS,Symptom mild,32558193,10.1111/dth.13867,2020-06-20
Immunosuppressive Agents,ISA,Immunologic Adjuvants,32558193,10.1111/dth.13867,2020-06-20
Storm NOS,PROCESS_OF,Patients,32558193,10.1111/dth.13867,2020-06-20
Government,LOCATION_OF,research,32558190,10.1002/pbc.28435,2020-06-20
angiotensin converting enzyme 2,ADMINISTERED_TO,Pathogenic organism,32558150,10.1111/acel.13168,2020-06-20
diabetic,PROCESS_OF,Patients,32558150,10.1111/acel.13168,2020-06-20
Asians,LOCATION_OF,angiotensin converting enzyme 2,32558150,10.1111/acel.13168,2020-06-20
Asians,ISA,Ethnic group,32558150,10.1111/acel.13168,2020-06-20
"Regulatory Sequences, Nucleic Acid",PART_OF,angiotensin converting enzyme 2,32558150,10.1111/acel.13168,2020-06-20
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32558150,10.1111/acel.13168,2020-06-20
Patients,LOCATION_OF,angiotensin converting enzyme 2,32558150,10.1111/acel.13168,2020-06-20
Population Group,LOCATION_OF,angiotensin converting enzyme 2,32558150,10.1111/acel.13168,2020-06-20
Performance,PROCESS_OF,Persons,32558102,10.1111/jpm.12666,2020-06-20
Physical and emotional exhaustion state,PROCESS_OF,Caregiver,32558102,10.1111/jpm.12666,2020-06-20
Blood Coagulation Disorders,PROCESS_OF,Patients,32558075,10.1111/jth.14975,2020-06-20
Disseminated Intravascular Coagulation,PROCESS_OF,Patients,32558075,10.1111/jth.14975,2020-06-20
Malaise,PROCESS_OF,Patients,32558075,10.1111/jth.14975,2020-06-20
Laboratory Procedures,USES,Coagulation procedure,32558075,10.1111/jth.14975,2020-06-20
Fibrin,STIMULATES,Fibrin fragment D,32558075,10.1111/jth.14975,2020-06-20
Fibrin,STIMULATES,Fibrin split products,32558075,10.1111/jth.14975,2020-06-20
Fibrin fragment D,ISA,Fibrin,32558075,10.1111/jth.14975,2020-06-20
Fibrin fragment D,STIMULATES(SPEC),Fibrin split products,32558075,10.1111/jth.14975,2020-06-20
Fibrin split products,ISA,Fibrin,32558075,10.1111/jth.14975,2020-06-20
Fibrin split products,STIMULATES(SPEC),Fibrin fragment D,32558075,10.1111/jth.14975,2020-06-20
Lymphocyte,LOCATION_OF,Cell Death,32558075,10.1111/jth.14975,2020-06-20
Organism,ASSOCIATED_WITH,Coronavirus Infections,32558055,10.1111/dth.13871,2020-06-20
Human coronavirus,PROCESS_OF,Family,32558055,10.1111/dth.13871,2020-06-20
Stress,COEXISTS_WITH,Coronavirus Infections,32558055,10.1111/dth.13871,2020-06-20
homocysteine,ASSOCIATED_WITH,Coronavirus Infections,32558055,10.1111/dth.13871,2020-06-20
Folic Acid,DISRUPTS,Complication,32558055,10.1111/dth.13871,2020-06-20
Treatment Protocols,TREATS,Severe Acute Respiratory Syndrome,32558055,10.1111/dth.13871,2020-06-20
Vitamin B 12,DISRUPTS,Complication,32558055,10.1111/dth.13871,2020-06-20
Vitamin B6,DISRUPTS,Complication,32558055,10.1111/dth.13871,2020-06-20
Experience,PROCESS_OF,Italians,32558053,10.1111/bju.15149,2020-06-20
Treatment Adherence,PROCESS_OF,Patients,32558015,10.1111/jdv.16759,2020-06-20
Comorbidity,PROCESS_OF,Patients,32558015,10.1111/jdv.16759,2020-06-20
Psoriasis,PROCESS_OF,Patients,32558015,10.1111/jdv.16759,2020-06-20
Neurologic Symptoms,PROCESS_OF,Patients,32558002,10.1111/ene.14407,2020-06-20
Neoplasms,COEXISTS_WITH,Enthesitis-Related Arthritis,32557972,10.1002/hed.26319,2020-06-20
Head and Neck Carcinoma,COEXISTS_WITH,Neoplasms,32557972,10.1002/hed.26319,2020-06-20
Radiotherapy department,LOCATION_OF,Work,32557972,10.1002/hed.26319,2020-06-20
Health Personnel,TREATS,Patients,32557972,10.1002/hed.26319,2020-06-20
Head and Neck Carcinoma,PROCESS_OF,Patients,32557972,10.1002/hed.26319,2020-06-20
Head and Neck Carcinoma,PROCESS_OF,Patients,32557972,10.1002/hed.26319,2020-06-20
"Africa, Northern",ISA,Geographic Locations,32557820,10.1002/hpm.2982,2020-06-20
Hospitals,LOCATION_OF,Training,32557815,10.1002/hpm.3004,2020-06-20
Child,LOCATION_OF,"CD69 protein, human",32557789,10.1111/apa.15422,2020-06-20
"Infant, Newborn",LOCATION_OF,"CD69 protein, human",32557789,10.1111/apa.15422,2020-06-20
Fever,ISA,Symptoms,32557789,10.1111/apa.15422,2020-06-20
Severe disorder,PROCESS_OF,Infant,32557789,10.1111/apa.15422,2020-06-20
Severe disorder,PROCESS_OF,"Infant, Newborn",32557789,10.1111/apa.15422,2020-06-20
Sahara,ISA,Country,32557761,10.1111/apa.15419,2020-06-20
"TLR4 protein, human",AUGMENTS,Awareness,32557684,10.1111/bjso.12392,2020-06-20
Chronic disease,AFFECTS,Elderly (population group),32557635,10.1111/jgs.16690,2020-06-20
Severe Acute Respiratory Syndrome,CAUSES,Pneumonia,32557623,10.1111/bjh.16896,2020-06-20
Comorbidity,PROCESS_OF,Patients,32557623,10.1111/bjh.16896,2020-06-20
Decreased Immunologic Activity [PE],AFFECTS,Disease Progression,32557623,10.1111/bjh.16896,2020-06-20
Fatal Outcome,PROCESS_OF,Patients,32557623,10.1111/bjh.16896,2020-06-20
Hospitals,LOCATION_OF,Logistics,32557593,10.1111/anae.15185,2020-06-20
Nigeria,ISA,Country,32557562,10.1002/ijgo.13278,2020-06-20
Disease,PROCESS_OF,Persons,32557557,10.1111/bph.15164,2020-06-20
Infected,PROCESS_OF,Persons,32557557,10.1111/bph.15164,2020-06-20
inflammatory response,PREDISPOSES,Disease,32557557,10.1111/bph.15164,2020-06-20
Disease,PROCESS_OF,Patients,32557557,10.1111/bph.15164,2020-06-20
Chronic Lymphocytic Leukemia,PROCESS_OF,Patients,32557555,10.1111/bjh.16954,2020-06-20
Chronic Lymphocytic Leukemia,PROCESS_OF,Patients,32557555,10.1111/bjh.16954,2020-06-20
Prophylactic treatment,TREATS,Patients,32557555,10.1111/bjh.16954,2020-06-20
Prophylactic treatment,TREATS(INFER),Chronic Lymphocytic Leukemia,32557555,10.1111/bjh.16954,2020-06-20
Nursing Homes,LOCATION_OF,Analysis,32557542,10.1111/jgs.16689,2020-06-20
"Respiratory Distress Syndrome, Adult",ISA,Complication,32557541,10.1002/jcph.1693,2020-06-20
Interleukin-6,ASSOCIATED_WITH,Disease,32557541,10.1002/jcph.1693,2020-06-20
Interleukin-6,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32557541,10.1002/jcph.1693,2020-06-20
Coronavirus Infections,ISA,Disease,32557541,10.1002/jcph.1693,2020-06-20
Therapeutic procedure,NEG_TREATS,Disease,32557541,10.1002/jcph.1693,2020-06-20
Disease,PROCESS_OF,Patients,32557541,10.1002/jcph.1693,2020-06-20
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32557541,10.1002/jcph.1693,2020-06-20
Coronavirus Infections,ISA,Disease,32557541,10.1002/jcph.1693,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32557541,10.1002/jcph.1693,2020-06-20
tocilizumab,TREATS,"Respiratory Distress Syndrome, Adult",32557541,10.1002/jcph.1693,2020-06-20
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Disease,32557541,10.1002/jcph.1693,2020-06-20
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH(SPEC),Coronavirus Infections,32557541,10.1002/jcph.1693,2020-06-20
Coronavirus Infections,ISA,Disease,32557541,10.1002/jcph.1693,2020-06-20
tocilizumab,TREATS,"Respiratory Distress Syndrome, Adult",32557541,10.1002/jcph.1693,2020-06-20
"Endoscopy, Gastrointestinal",TREATS,Patients,32557489,10.1055/a-1201-9618,2020-06-20
Malignant neoplasm of gastrointestinal tract,PROCESS_OF,Patients,32557489,10.1055/a-1201-9618,2020-06-20
hesperetin,ISA,Acids,32557405,10.1007/s13659-020-00253-1,2020-06-20
rhein,ISA,Acids,32557405,10.1007/s13659-020-00253-1,2020-06-20
Coronavirus Infections,ISA,Disease,32557405,10.1007/s13659-020-00253-1,2020-06-20
Ethanol,TREATS,Household composition,32557350,10.17269/s41997-020-00360-z,2020-06-20
SYNE2 gene,INTERACTS_WITH,Ethanol,32557350,10.17269/s41997-020-00360-z,2020-06-20
tomography,DIAGNOSES,Ground Glass Opacity,32557347,10.1007/s15010-020-01457-w,2020-06-20
Chest Tubes,TREATS,Right pneumothorax,32557347,10.1007/s15010-020-01457-w,2020-06-20
tomography,DIAGNOSES,Right pneumothorax,32557347,10.1007/s15010-020-01457-w,2020-06-20
pulmonary complications,PROCESS_OF,Physicians,32557347,10.1007/s15010-020-01457-w,2020-06-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32557332,10.1007/s40520-020-01631-y,2020-06-20
Aging,PROCESS_OF,Patients,32557332,10.1007/s40520-020-01631-y,2020-06-20
terminal patient care,TREATS,geriatric patients,32557332,10.1007/s40520-020-01631-y,2020-06-20
Plasma Cells,INTERACTS_WITH,T-Lymphocyte,32557271,10.1007/s40618-020-01327-0,2020-06-20
Ergocalciferol,ASSOCIATED_WITH,Autoimmune Diseases,32557271,10.1007/s40618-020-01327-0,2020-06-20
Ergocalciferol,ASSOCIATED_WITH,Pulmonary Fibrosis,32557271,10.1007/s40618-020-01327-0,2020-06-20
Ergocalciferol,ASSOCIATED_WITH,Respiratory Tract Infections,32557271,10.1007/s40618-020-01327-0,2020-06-20
Virus,PROCESS_OF,Adult,32557271,10.1007/s40618-020-01327-0,2020-06-20
Virus,PROCESS_OF,Population Group,32557271,10.1007/s40618-020-01327-0,2020-06-20
Severe Acute Respiratory Syndrome,ISA,Disease,32557271,10.1007/s40618-020-01327-0,2020-06-20
Interested,PROCESS_OF,Homo sapiens,32557214,10.1007/s40259-020-00430-1,2020-06-20
Drug Repositioning,TREATS,Severe Acute Respiratory Syndrome,32557214,10.1007/s40259-020-00430-1,2020-06-20
Adoptive Immunotherapy,TREATS,patient condition,32557214,10.1007/s40259-020-00430-1,2020-06-20
Adoptive Immunotherapy,USES,Interleukin-6,32557214,10.1007/s40259-020-00430-1,2020-06-20
Interleukin-6,ASSOCIATED_WITH,Storm NOS,32557214,10.1007/s40259-020-00430-1,2020-06-20
Anti-Anxiety Agents,TREATS,patient condition,32557214,10.1007/s40259-020-00430-1,2020-06-20
Pneumonia,PROCESS_OF,Male population group,32557209,10.1007/s13730-020-00495-5,2020-06-20
Membrane,LOCATION_OF,Clotrimazole,32557209,10.1007/s13730-020-00495-5,2020-06-20
Fever,PROCESS_OF,Patients,32557209,10.1007/s13730-020-00495-5,2020-06-20
Fluid Management,AFFECTS,Patients,32557209,10.1007/s13730-020-00495-5,2020-06-20
Clinician,TREATS,Patients,32557209,10.1007/s13730-020-00495-5,2020-06-20
"CD69 protein, human",PREDISPOSES,Virus Diseases,32557183,10.1007/s40368-020-00547-5,2020-06-20
Pharmaceutical Preparations,AFFECTS,Cardiac conduction,32557011,10.1007/s10557-020-07024-7,2020-06-20
Cessation of life,PROCESS_OF,Elderly (population group),32556942,10.1007/s11357-020-00213-0,2020-06-20
Severe Acute Respiratory Syndrome,CAUSES,Aging,32556942,10.1007/s11357-020-00213-0,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Elderly (population group),32556942,10.1007/s11357-020-00213-0,2020-06-20
Therapeutic procedure,TREATS,Older Population,32556942,10.1007/s11357-020-00213-0,2020-06-20
Stress,PROCESS_OF,Adult,32556914,10.1007/s11126-020-09789-4,2020-06-20
"CD69 protein, human",INTERACTS_WITH,Buffers,32556914,10.1007/s11126-020-09789-4,2020-06-20
Intervention regimes,TREATS,Persons,32556914,10.1007/s11126-020-09789-4,2020-06-20
Intervention regimes,TREATS,Persons,32556914,10.1007/s11126-020-09789-4,2020-06-20
Intervention regimes,TREATS,Woman,32556914,10.1007/s11126-020-09789-4,2020-06-20
Intervention regimes,TREATS,Young Adult,32556914,10.1007/s11126-020-09789-4,2020-06-20
Physicians,ISA,Persons,32556893,10.1007/s12687-020-00470-8,2020-06-20
Thrombophilia,PROCESS_OF,Persons,32556892,10.1007/s11886-020-01328-8,2020-06-20
Thrombosis,OCCURS_IN,Persons,32556892,10.1007/s11886-020-01328-8,2020-06-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32556892,10.1007/s11886-020-01328-8,2020-06-20
Septicemia,CAUSES,Blood Coagulation Disorders,32556892,10.1007/s11886-020-01328-8,2020-06-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32556892,10.1007/s11886-020-01328-8,2020-06-20
Negative Regulation of Coagulation,PROCESS_OF,Population Group,32556892,10.1007/s11886-020-01328-8,2020-06-20
Disease,CAUSES,Inflammation,32556875,10.1007/s11606-020-05906-y,2020-06-20
Thromboembolism,PROCESS_OF,hospitalized patients,32556875,10.1007/s11606-020-05906-y,2020-06-20
Therapeutic procedure,ADMINISTERED_TO,Patients,32556875,10.1007/s11606-020-05906-y,2020-06-20
Thromboembolism,PROCESS_OF,hospitalized patients,32556875,10.1007/s11606-020-05906-y,2020-06-20
Imbalance,CAUSES,Actual Discomfort,32556826,10.1186/s13613-020-00702-7,2020-06-20
chest findings,PROCESS_OF,Child,32556807,10.1007/s00247-020-04726-w,2020-06-20
chest findings,PROCESS_OF,Child,32556807,10.1007/s00247-020-04726-w,2020-06-20
follow-up,TREATS,Child,32556807,10.1007/s00247-020-04726-w,2020-06-20
Malignant neoplasm of breast,PROCESS_OF,Patients,32556796,10.1007/s10549-020-05740-0,2020-06-20
Malignant neoplasm of breast,PROCESS_OF,Patients,32556796,10.1007/s10549-020-05740-0,2020-06-20
Malignant neoplasm of breast,PROCESS_OF,Patients,32556796,10.1007/s10549-020-05740-0,2020-06-20
Malignant neoplasm of breast,PROCESS_OF,Patients,32556796,10.1007/s10549-020-05740-0,2020-06-20
Stress,ISA,Disease,32556796,10.1007/s10549-020-05740-0,2020-06-20
Stress,PROCESS_OF,Patients,32556796,10.1007/s10549-020-05740-0,2020-06-20
Racial group,LOCATION_OF,IMPACT gene,32556796,10.1007/s10549-020-05740-0,2020-06-20
Pituitary Diseases,PROCESS_OF,Patients,32556793,10.1007/s11102-020-01059-7,2020-06-20
Pituitary Diseases,PROCESS_OF,Patients,32556793,10.1007/s11102-020-01059-7,2020-06-20
Tracheostomy procedure,COEXISTS_WITH,patient care,32556788,10.1007/s00405-020-06126-0,2020-06-20
Disease,AFFECTS,Esthesia,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,AFFECTS(SPEC),Esthesia,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,ISA,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Infected,PROCESS_OF,Persons,32556781,10.1007/s00405-020-06120-6,2020-06-20
Virus,INTERACTS_WITH,Coronavirus Infections,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,ISA,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,ISA,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Disease,CAUSES,Smell Perception,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,CAUSES(SPEC),Smell Perception,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,ISA,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Coronavirus Infections,ISA,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Anosmia,PROCESS_OF,Patients,32556781,10.1007/s00405-020-06120-6,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32556781,10.1007/s00405-020-06120-6,2020-06-20
Dysgeusia,PROCESS_OF,Patients,32556781,10.1007/s00405-020-06120-6,2020-06-20
Body tissue,PART_OF,Nose,32556781,10.1007/s00405-020-06120-6,2020-06-20
Ageusia,PROCESS_OF,Patients,32556781,10.1007/s00405-020-06120-6,2020-06-20
Prophylactic treatment,AFFECTS,Disease,32556781,10.1007/s00405-020-06120-6,2020-06-20
Steroid therapy,TREATS,Sudden sensorineural hearing loss,32556649,10.1007/s10047-020-01183-y,2020-06-20
Nitric Oxide,TREATS,Abnormal breathing,32556649,10.1007/s10047-020-01183-y,2020-06-20
Norepinephrine,TREATS,Abnormal cardiovascular function,32556649,10.1007/s10047-020-01183-y,2020-06-20
Continuous renal replacement therapy,TREATS,Renal Insufficiency,32556649,10.1007/s10047-020-01183-y,2020-06-20
Human tissue,PART_OF,Cornea,32556553,10.1007/s00347-020-01151-0,2020-06-20
Cornea,PART_OF,Tissue Donors,32556552,10.1007/s00347-020-01152-z,2020-06-20
Risk Assessment,METHOD_OF,Extraction,32556552,10.1007/s00347-020-01152-z,2020-06-20
Cornea,LOCATION_OF,Angiotensin Receptor,32556552,10.1007/s00347-020-01152-z,2020-06-20
Cornea,PART_OF,Tissue Donors,32556552,10.1007/s00347-020-01152-z,2020-06-20
Ear structure,LOCATION_OF,Incised wound,32556449,10.1007/s00266-020-01833-9,2020-06-20
Surgical face mask,USES,loops,32556449,10.1007/s00266-020-01833-9,2020-06-20
Surgical face mask,USES,loops,32556449,10.1007/s00266-020-01833-9,2020-06-20
Cartilage,PART_OF,External Ear,32556449,10.1007/s00266-020-01833-9,2020-06-20
Cartilage,PART_OF,Auricular,32556449,10.1007/s00266-020-01833-9,2020-06-20
Bone structure of ischium,PART_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
Bone structure of ischium,PART_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
mental health,PROCESS_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
Bone structure of ischium,LOCATION_OF,Degenerative polyarthritis,32556438,10.1007/s00167-020-06104-3,2020-06-20
"Osteoarthritis, Knee",PROCESS_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
Bone structure of ischium,PART_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
Physical function,PROCESS_OF,Patients,32556438,10.1007/s00167-020-06104-3,2020-06-20
Patients,LOCATION_OF,"CD69 protein, human",32556400,10.1007/s00259-020-04920-w,2020-06-20
"CD69 protein, human",AUGMENTS,Suspicion,32556400,10.1007/s00259-020-04920-w,2020-06-20
Single Photon Emission Computed Tomography Computed Tomography,ISA,tomography,32556400,10.1007/s00259-020-04920-w,2020-06-20
Nuclear medicine department,LOCATION_OF,Single Photon Emission Computed Tomography Computed Tomography,32556400,10.1007/s00259-020-04920-w,2020-06-20
Chest Pain,PROCESS_OF,Patients,32556400,10.1007/s00259-020-04920-w,2020-06-20
Dyspnea,PROCESS_OF,Patients,32556400,10.1007/s00259-020-04920-w,2020-06-20
Single Photon Emission Computed Tomography Computed Tomography,DIAGNOSES,Pulmonary Embolism,32556400,10.1007/s00259-020-04920-w,2020-06-20
Uptake,COEXISTS_WITH,Respiration,32556400,10.1007/s00259-020-04920-w,2020-06-20
Single Photon Emission Computed Tomography Computed Tomography,ADMINISTERED_TO,Patients,32556400,10.1007/s00259-020-04920-w,2020-06-20
Delirium,PROCESS_OF,Patients,32556328,10.1093/cid/ciaa792,2020-06-20
"Delirium, Dementia, Amnestic, Cognitive Disorders",PROCESS_OF,Patients,32556328,10.1093/cid/ciaa792,2020-06-20
Circulatory Process,PROCESS_OF,Community,32556327,10.1093/jpids/piaa075,2020-06-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Elderly (population group),32556323,10.1093/ptj/pzaa114,2020-06-20
Challenge,TREATS,Patients,32556323,10.1093/ptj/pzaa114,2020-06-20
Physical examination management,TREATS,Patients,32556323,10.1093/ptj/pzaa114,2020-06-20
Symptoms,PROCESS_OF,Patients,32556323,10.1093/ptj/pzaa114,2020-06-20
Physical examination management,TREATS,Patients,32556323,10.1093/ptj/pzaa114,2020-06-20
Breathing Exercises,AFFECTS,Inspiration function,32556323,10.1093/ptj/pzaa114,2020-06-20
Laboratory Procedures,USES,"TNFRSF11A protein, human",32556293,10.1093/cid/ciaa793,2020-06-20
Study,MEASURES,Delta (difference),32556260,10.1001/jamanetworkopen.2020.12403,2020-06-20
Ability to interact with others,ISA,Behavior,32556213,10.1093/pubmed/fdaa095,2020-06-20
Coitus,NEG_AFFECTS,Ethnic group,32556213,10.1093/pubmed/fdaa095,2020-06-20
Patients,LOCATION_OF,Congenital Heart Defects,32556199,10.1093/ehjci/jeaa178,2020-06-20
Patients,LOCATION_OF,GSKIP gene,32556199,10.1093/ehjci/jeaa178,2020-06-20
Echocardiogram abnormal,PROCESS_OF,Patients,32556199,10.1093/ehjci/jeaa178,2020-06-20
Heart,LOCATION_OF,Severe disorder,32556199,10.1093/ehjci/jeaa178,2020-06-20
Heart Ventricle,LOCATION_OF,Severely Abnormal Ventricular Ejection Fraction,32556199,10.1093/ehjci/jeaa178,2020-06-20
Troponin,PART_OF,Heart,32556199,10.1093/ehjci/jeaa178,2020-06-20
Echocardiography,ADMINISTERED_TO,Patients,32556199,10.1093/ehjci/jeaa178,2020-06-20
Respiratory sample,LOCATION_OF,Nucleic Acids,32556191,10.1093/cid/ciaa760,2020-06-20
Respiratory sample,PART_OF,Tract,32556191,10.1093/cid/ciaa760,2020-06-20
Communicable Diseases,PROCESS_OF,Clinician,32556191,10.1093/cid/ciaa760,2020-06-20
patient care,PREVENTS,"Infections, Hospital",32556191,10.1093/cid/ciaa760,2020-06-20
Asymptomatic,PROCESS_OF,Persons,32556191,10.1093/cid/ciaa760,2020-06-20
Asymptomatic,PROCESS_OF,Persons,32556191,10.1093/cid/ciaa760,2020-06-20
Leg,PART_OF,Dental Assistants,32556161,10.2344/anpr-67-03-04,2020-06-20
Leg,PART_OF,Dentist,32556161,10.2344/anpr-67-03-04,2020-06-20
Diabetes,PROCESS_OF,Persons,32556147,10.1210/clinem/dgaa360,2020-06-20
Complication,COEXISTS_WITH,"Diabetes Mellitus, Insulin-Dependent",32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetic Ketoacidosis,COEXISTS_WITH(SPEC),"Diabetes Mellitus, Insulin-Dependent",32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetic Ketoacidosis,ISA,Complication,32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetes,PROCESS_OF,Patients,32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetic Ketoacidosis,ISA,Complication,32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetic Ketoacidosis,PROCESS_OF,Persons,32556147,10.1210/clinem/dgaa360,2020-06-20
Triage,TREATS,Diabetic Ketoacidosis,32556147,10.1210/clinem/dgaa360,2020-06-20
Infected,PROCESS_OF,Patients,32556147,10.1210/clinem/dgaa360,2020-06-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32556147,10.1210/clinem/dgaa360,2020-06-20
Diabetic Ketoacidosis,ISA,Disease,32556147,10.1210/clinem/dgaa360,2020-06-20
"Hospitals, University",LOCATION_OF,Retrospective Cohort Study,32556143,10.1093/cid/ciaa791,2020-06-20
Hydroxychloroquine,ADMINISTERED_TO,Patients,32556143,10.1093/cid/ciaa791,2020-06-20
Hydroxychloroquine,TREATS,Patients,32556143,10.1093/cid/ciaa791,2020-06-20
Patient in hospital,PROCESS_OF,Adult,32556143,10.1093/cid/ciaa791,2020-06-20
Renin-angiotensin system,AFFECTS,Blood Pressure,32556101,10.1084/jem.20201000,2020-06-20
Anosmia,COEXISTS_WITH,Viral upper respiratory tract infection,32556089,10.1093/chemse/bjaa040,2020-06-20
Vaccination,AFFECTS,Viral syndrome,32556089,10.1093/chemse/bjaa040,2020-06-20
Hand,PART_OF,Decedent,32556078,10.1093/ajcp/aqaa106,2020-06-20
Present,PROCESS_OF,Patients,32556070,10.1001/jamaoto.2020.1155,2020-06-20
Present,PROCESS_OF,Patients,32556070,10.1001/jamaoto.2020.1155,2020-06-20
Nose,LOCATION_OF,Obstruction,32556070,10.1001/jamaoto.2020.1155,2020-06-20
Nose,LOCATION_OF,Obstruction,32556070,10.1001/jamaoto.2020.1155,2020-06-20
General Practitioners,TREATS,Patients,32556070,10.1001/jamaoto.2020.1155,2020-06-20
Attention,PROCESS_OF,World,32556034,10.1590/0100-6991e-20202649,2020-06-20
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32556034,10.1590/0100-6991e-20202649,2020-06-20
Operative Surgical Procedures,ADMINISTERED_TO,professional occupation status,32556034,10.1590/0100-6991e-20202649,2020-06-20
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32556033,10.1590/0100-6991e-20202640,2020-06-20
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32556033,10.1590/0100-6991e-20202640,2020-06-20
Hydroxychloroquine,ISA,Chloroquine,32555974,10.1590/1519-6984.238155,2020-06-20
Storm NOS,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32555949,10.6061/clinics/2020/e2022,2020-06-20
glucocorticoid therapy,TREATS,Adrenal gland hypofunction,32555949,10.6061/clinics/2020/e2022,2020-06-20
glucocorticoid therapy,TREATS,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Severe Acute Respiratory Syndrome,CAUSES,Complication,32555949,10.6061/clinics/2020/e2022,2020-06-20
Adrenal gland hypofunction,PROCESS_OF,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Addisonian crisis,PROCESS_OF,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Coronavirus Infections,PROCESS_OF,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Addisonian crisis,CAUSES,Cessation of life,32555949,10.6061/clinics/2020/e2022,2020-06-20
Symptoms,PROCESS_OF,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Hydrocortisone,ADMINISTERED_TO,Patients,32555949,10.6061/clinics/2020/e2022,2020-06-20
Disease,PROCESS_OF,Patients,32555947,10.6061/clinics/2020/e1989,2020-06-20
Coronavirus Infections,ISA,Disease,32555947,10.6061/clinics/2020/e1989,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32555947,10.6061/clinics/2020/e1989,2020-06-20
Health care facility,LOCATION_OF,Study,32555947,10.6061/clinics/2020/e1989,2020-06-20
Screening procedure,TREATS,Outpatients,32555947,10.6061/clinics/2020/e1989,2020-06-20
World,ISA,Population Group,32555723,10.1371/journal.pone.0234956,2020-06-20
Hospital Administration,TREATS,Patients,32555723,10.1371/journal.pone.0234956,2020-06-20
Bone structure of cranium,LOCATION_OF,Disease,32555723,10.1371/journal.pone.0234956,2020-06-20
Coronavirus Infections,ISA,Disease,32555674,10.1371/journal.pone.0234764,2020-06-20
Disease,PROCESS_OF,Patients,32555674,10.1371/journal.pone.0234764,2020-06-20
Coronavirus Infections,ISA,Disease,32555674,10.1371/journal.pone.0234764,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32555674,10.1371/journal.pone.0234764,2020-06-20
Severe disorder,PROCESS_OF,Patients,32555674,10.1371/journal.pone.0234764,2020-06-20
High Level,PROCESS_OF,Patients,32555674,10.1371/journal.pone.0234764,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Disease,NEG_AFFECTS,Physical Well-being,32555642,10.1371/journal.pone.0234850,2020-06-20
Disease,PROCESS_OF,general population,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),general population,32555642,10.1371/journal.pone.0234850,2020-06-20
Aging,PROCESS_OF,Persons,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Malaise,PROCESS_OF,Persons,32555642,10.1371/journal.pone.0234850,2020-06-20
Worried,COEXISTS_WITH,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Worried,COEXISTS_WITH(SPEC),Coronavirus Infections,32555642,10.1371/journal.pone.0234850,2020-06-20
Mixed anxiety and depressive disorder,PROCESS_OF,Persons,32555642,10.1371/journal.pone.0234850,2020-06-20
Chronic disease,COEXISTS_WITH,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Chronic disease,COEXISTS_WITH(SPEC),Coronavirus Infections,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Coronavirus Infections,ISA,Disease,32555642,10.1371/journal.pone.0234850,2020-06-20
Malaise,PROCESS_OF,general population,32555642,10.1371/journal.pone.0234850,2020-06-20
Mixed anxiety and depressive disorder,PROCESS_OF,general population,32555642,10.1371/journal.pone.0234850,2020-06-20
Thrombophilia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32555568,10.1714/3386.33638,2020-06-20
Pneumonia,PROCESS_OF,Patients,32555568,10.1714/3386.33638,2020-06-20
Pulmonary Embolism,PROCESS_OF,Male population group,32555568,10.1714/3386.33638,2020-06-20
Distal aortic dissection,PROCESS_OF,Male population group,32555568,10.1714/3386.33638,2020-06-20
High Resolution Computed Tomography,DIAGNOSES,Pneumonia,32555568,10.1714/3386.33638,2020-06-20
High Resolution Computed Tomography,DIAGNOSES,Pulmonary Embolism,32555568,10.1714/3386.33638,2020-06-20
Pneumonia,PROCESS_OF,Male population group,32555568,10.1714/3386.33638,2020-06-20
Venous Thromboembolism,PROCESS_OF,Male population group,32555568,10.1714/3386.33638,2020-06-20
Possible,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32555568,10.1714/3386.33638,2020-06-20
Sports,TREATS,World,32555567,10.1714/3386.33637,2020-06-20
Hospital admission,TREATS,CARDIAC causes,32555565,10.1714/3386.33635,2020-06-20
Hospital admission,TREATS,cardiac problem,32555565,10.1714/3386.33635,2020-06-20
ST segment elevation myocardial infarction,ISA,Myocardial Infarction,32555565,10.1714/3386.33635,2020-06-20
Disease,PROCESS_OF,Patients,32555565,10.1714/3386.33635,2020-06-20
Cardiologists,TREATS,Patients,32555565,10.1714/3386.33635,2020-06-20
Acute Coronary Syndrome,ISA,Disease,32555565,10.1714/3386.33635,2020-06-20
Adverse event,OCCURS_IN,Patients,32555564,10.1714/3386.33634,2020-06-20
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32555564,10.1714/3386.33634,2020-06-20
inflammatory response,CAUSES,Blood Coagulation Disorders,32555563,10.1714/3386.33633,2020-06-20
inflammatory response,CAUSES,Venous Thromboembolism,32555563,10.1714/3386.33633,2020-06-20
Heart,LOCATION_OF,Problem,32555550,10.1188/20.ONF.371-372,2020-06-20
Radiologic finding,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Radiologic finding,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Symptoms,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Symptoms,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Sign or Symptom,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Sign or Symptom,PROCESS_OF,Child,32555539,10.1038/s41390-020-1015-2,2020-06-20
Asymptomatic,PROCESS_OF,Persons,32555424,10.1038/s41591-020-0965-6,2020-06-20
Asymptomatic,PROCESS_OF,Persons,32555424,10.1038/s41591-020-0965-6,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32555424,10.1038/s41591-020-0965-6,2020-06-20
Asymptomatic,PROCESS_OF,Persons,32555424,10.1038/s41591-020-0965-6,2020-06-20
Deception,PROCESS_OF,Community,32555409,10.1057/s41271-020-00235-0,2020-06-20
Antibody Formation,PROCESS_OF,Homo sapiens,32555388,10.1038/s41586-020-2456-9,2020-06-20
Cessation of life,COEXISTS_WITH,Coitus,32555133,10.15585/mmwr.mm6924a1,2020-06-20
checkup examination,USES,Diagnostic radiologic examination,32555087,10.23750/abm.v91i4-S.9726,2020-06-20
Medical center,LOCATION_OF,Prospective Cohort Study,32555034,10.1097/AOG.0000000000004025,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32555034,10.1097/AOG.0000000000004025,2020-06-20
Premature Birth,PROCESS_OF,Singleton,32555034,10.1097/AOG.0000000000004025,2020-06-20
Laboratory Infection,PROCESS_OF,Woman,32555034,10.1097/AOG.0000000000004025,2020-06-20
Symptoms,NEG_PROCESS_OF,Woman,32555034,10.1097/AOG.0000000000004025,2020-06-20
African American,ISA,Population Group,32554992,10.1097/SHK.0000000000001585,2020-06-20
Day 2,PROCESS_OF,Patients,32554992,10.1097/SHK.0000000000001585,2020-06-20
Poor outcome,PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Proteinuria,PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Microscopic hematuria,PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Kidney panel,USES,"Electrolytes measurement, urine",32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Death in hospital,PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Comorbidity,PROCESS_OF,"Populations, Underserved",32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",COEXISTS_WITH,Heart failure,32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,"Populations, Underserved",32554965,10.1159/000509182,2020-06-20
Heart failure,PREDISPOSES,"Kidney Failure, Acute",32554965,10.1159/000509182,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Patients,32554965,10.1159/000509182,2020-06-20
Electroconvulsive Therapy,ISA,Interventional procedure,32554959,10.1159/000509113,2020-06-20
Electroconvulsive Therapy,TREATS,Patients,32554959,10.1159/000509113,2020-06-20
Finding of body mass index,PROCESS_OF,Patients,32554959,10.1159/000509113,2020-06-20
Complement System Proteins,PART_OF,Genus: Coronavirus,32554923,10.1172/jci.insight.140711,2020-06-20
Critical Illness,PROCESS_OF,Patients,32554879,10.1088/1361-6560/ab9e55,2020-06-20
Coronavirus Infections,CAUSES,Disease,32554879,10.1088/1361-6560/ab9e55,2020-06-20
Infected,PROCESS_OF,Patients,32554861,10.18632/aging.103370,2020-06-20
Hospitals,LOCATION_OF,Study,32554861,10.18632/aging.103370,2020-06-20
Paraganglioma,AFFECTS,Virus Diseases,32554825,10.1530/EJE-20-0424,2020-06-20
Pheochromocytoma,AFFECTS,Virus Diseases,32554825,10.1530/EJE-20-0424,2020-06-20
Medullary carcinoma,AFFECTS,Virus Diseases,32554825,10.1530/EJE-20-0424,2020-06-20
Neuroendocrine Tumors,PROCESS_OF,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Pharmacotherapy,ADMINISTERED_TO,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Radionuclide therapy,ADMINISTERED_TO,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
tumor growth,PROCESS_OF,Show,32554825,10.1530/EJE-20-0424,2020-06-20
Targeted Therapy,ADMINISTERED_TO,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Disease,PROCESS_OF,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Syndrome,PROCESS_OF,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Neuroendocrine Tumors,CAUSES,Syndrome,32554825,10.1530/EJE-20-0424,2020-06-20
Symptoms,PROCESS_OF,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Neuroendocrine Tumors,PROCESS_OF,Patients,32554825,10.1530/EJE-20-0424,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
risk factors,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Department,LOCATION_OF,Study,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
risk factors,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Non-Ossifying Fibroma,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Epilepsy,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
Hypertensive disease,PROCESS_OF,Patients,32554773,10.1212/WNL.0000000000010033,2020-06-20
CAT scan of brain,DIAGNOSES,Sedated state,32554771,10.1212/WNL.0000000000010034,2020-06-20
Health Care,TREATS,Readiness,32554768,10.1212/WNL.0000000000010029,2020-06-20
Nitrogen Oxides,AUGMENTS,Neoplasm Metastasis,32554754,10.1126/science.abb7431,2020-06-20
Gastrointestinal symptom,PROCESS_OF,Patients,32554734,10.3949/ccjm.87a.ccc049,2020-06-20
Virus,PROCESS_OF,Patients,32554734,10.3949/ccjm.87a.ccc049,2020-06-20
Severe disorder,COEXISTS_WITH,Gastrointestinal symptom,32554734,10.3949/ccjm.87a.ccc049,2020-06-20
Digestion,PROCESS_OF,Patients,32554734,10.3949/ccjm.87a.ccc049,2020-06-20
Health Personnel,DIAGNOSES,"Signs and Symptoms, Respiratory",32554734,10.3949/ccjm.87a.ccc049,2020-06-20
Insight,PROCESS_OF,General Practitioners,32554730,10.1136/bmjopen-2020-039674,2020-06-20
Persons,LOCATION_OF,IMPACT gene,32554730,10.1136/bmjopen-2020-039674,2020-06-20
Primary Health Care,TREATS,1/3 meter (distance vision finding),32554730,10.1136/bmjopen-2020-039674,2020-06-20
Livestock,ISA,Animals,32554697,10.1128/JVI.00565-20,2020-06-20
Porcine epidemic diarrhea virus,COEXISTS_WITH,Virus,32554697,10.1128/JVI.00565-20,2020-06-20
Cell Count,USES,PKLR gene,32554697,10.1128/JVI.00565-20,2020-06-20
Faecal swab,USES,Sequence Analysis,32554697,10.1128/JVI.00565-20,2020-06-20
,PREDISPOSES,Diarrhea,32554697,10.1128/JVI.00565-20,2020-06-20
,PREDISPOSES,Diarrhea,32554697,10.1128/JVI.00565-20,2020-06-20
"SH2D3A protein, human",PREDISPOSES,Diarrhea,32554697,10.1128/JVI.00565-20,2020-06-20
Vaccines,PREVENTS,Disease,32554697,10.1128/JVI.00565-20,2020-06-20
Isolation procedure,TREATS,Immune,32554619,10.1136/jitc-2020-000984,2020-06-20
Fragility,PROCESS_OF,Persons,32554604,10.1073/pnas.2007658117,2020-06-20
Universities,ISA,School,32554543,10.1136/postgradmedj-2020-137854,2020-06-20
Adverse reactions,PROCESS_OF,Health Personnel,32554543,10.1136/postgradmedj-2020-137854,2020-06-20
Malaise,PROCESS_OF,Health Personnel,32554543,10.1136/postgradmedj-2020-137854,2020-06-20
Exanthema,PROCESS_OF,Physicians,32554543,10.1136/postgradmedj-2020-137854,2020-06-20
Adverse reactions,AFFECTS,Patients,32554543,10.1136/postgradmedj-2020-137854,2020-06-20
Virus Diseases,PROCESS_OF,Patients,32554425,10.3174/ajnr.A6651,2020-06-20
Lesion,PROCESS_OF,Patients,32554425,10.3174/ajnr.A6651,2020-06-20
neurological complication,PROCESS_OF,Patients,32554425,10.3174/ajnr.A6651,2020-06-20
Present,PROCESS_OF,Patients,32554425,10.3174/ajnr.A6651,2020-06-20
Neurological observations,COEXISTS_WITH,Thrombosis of cerebral veins,32554424,10.3174/ajnr.A6644,2020-06-20
Neurological observations,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Thrombosis,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Thrombosis,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Structure of deep vein,LOCATION_OF,Thrombosis,32554424,10.3174/ajnr.A6644,2020-06-20
Structure of deep vein,PART_OF,Adrenal Medulla,32554424,10.3174/ajnr.A6644,2020-06-20
Veins,LOCATION_OF,Hemorrhagic infarct,32554424,10.3174/ajnr.A6644,2020-06-20
Hemorrhagic infarct,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Diabetic Ketoacidosis,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Hydroxychloroquine,TREATS,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Azithromycin,TREATS,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
Fatal Outcome,PROCESS_OF,Patients,32554424,10.3174/ajnr.A6644,2020-06-20
inflammatory response,CAUSES,Cerebrovascular accident,32554423,10.3174/ajnr.A6642,2020-06-20
Thrombosis,COMPLICATES,Hemorrhagic infarct,32554423,10.3174/ajnr.A6642,2020-06-20
Veins,LOCATION_OF,Hemorrhagic infarct,32554423,10.3174/ajnr.A6642,2020-06-20
Deep cerebral vein,LOCATION_OF,Thrombosis,32554423,10.3174/ajnr.A6642,2020-06-20
Cognitive Therapy,PREVENTS,Symptoms,32554380,10.2196/18595,2020-06-20
Cognitive Therapy,TREATS,Depressive disorder,32554380,10.2196/18595,2020-06-20
Stress,PROCESS_OF,Community,32554380,10.2196/18595,2020-06-20
Unpaid work,PROCESS_OF,Voluntary Workers,32554380,10.2196/18595,2020-06-20
follow-up,TREATS,Depression score,32554380,10.2196/18595,2020-06-20
mental health,PROCESS_OF,secondary group,32554380,10.2196/18595,2020-06-20
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32554346,10.1684/pnv.2020.0869,2020-06-20
Symptoms,PROCESS_OF,Elderly (population group),32554345,10.1684/pnv.2020.0863,2020-06-20
Old age,ISA,Population Group,32554345,10.1684/pnv.2020.0863,2020-06-20
Auditory Perception,PROCESS_OF,Family,32554344,10.1684/pnv.2020.0871,2020-06-20
Patients,LOCATION_OF,"CD69 protein, human",32554337,10.18176/jiaci.0595,2020-06-20
Coronavirus Infections,ISA,Disease,32554337,10.18176/jiaci.0595,2020-06-20
Isolation procedure,TREATS,Multiple Sclerosis,32554288,10.1016/j.msard.2020.102282,2020-06-20
Incubation period,COEXISTS_WITH,Symptoms,32554285,10.1016/j.msard.2020.102199,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32554285,10.1016/j.msard.2020.102199,2020-06-20
rituximab,TREATS,Neuromyelitis Optica,32554285,10.1016/j.msard.2020.102199,2020-06-20
Symptom mild,PROCESS_OF,Woman,32554285,10.1016/j.msard.2020.102199,2020-06-20
Therapeutic procedure,TREATS,Multiple Sclerosis,32554284,10.1016/j.msard.2020.102297,2020-06-20
alemtuzumab,ISA,Pharmaceutical Preparations,32554284,10.1016/j.msard.2020.102297,2020-06-20
alemtuzumab,TREATS,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
alemtuzumab,TREATS,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
"Multiple Sclerosis, Relapsing-Remitting",PROCESS_OF,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
Symptoms,PROCESS_OF,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
Multiple Sclerosis,PROCESS_OF,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
Symptoms,PROCESS_OF,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
alemtuzumab,ADMINISTERED_TO,Patients,32554284,10.1016/j.msard.2020.102297,2020-06-20
Asthma,ISA,Chronic Obstructive Airway Disease,32554251,10.1016/j.biopha.2020.110281,2020-06-20
Chronic inflammatory disorder,ISA,Disease,32554251,10.1016/j.biopha.2020.110281,2020-06-20
protective drug effect,AFFECTS,Social Networks,32554251,10.1016/j.biopha.2020.110281,2020-06-20
Macrolide Antibiotics,AUGMENTS,Immunity,32554149,10.1016/j.mehy.2020.109984,2020-06-20
Azithromycin,AUGMENTS,Immunity,32554149,10.1016/j.mehy.2020.109984,2020-06-20
Clarithromycin,AUGMENTS,Immunity,32554149,10.1016/j.mehy.2020.109984,2020-06-20
Defensins,AUGMENTS,Immunity,32554149,10.1016/j.mehy.2020.109984,2020-06-20
Asthma,PROCESS_OF,Patients,32554082,10.1016/j.jaci.2020.06.010,2020-06-20
Asthma,OCCURS_IN,Patients,32554082,10.1016/j.jaci.2020.06.010,2020-06-20
Pharmaceutical Preparations,TREATS,Asthma,32554082,10.1016/j.jaci.2020.06.010,2020-06-20
Asthma,PROCESS_OF,Patients,32554082,10.1016/j.jaci.2020.06.010,2020-06-20
Asthma,OCCURS_IN,Cohort,32554082,10.1016/j.jaci.2020.06.010,2020-06-20
Serologic tests,USES,Total immunoglobulin measurement,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Laboratory Procedures,USES,Total immunoglobulin measurement,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Total immunoglobulin measurement,ISA,Laboratory Procedures,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Laboratory Procedures,USES,Total immunoglobulin measurement,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Total immunoglobulin measurement,ISA,Laboratory Procedures,32554043,10.1016/j.jviromet.2020.113919,2020-06-20
Quarantine,ISA,Prophylactic treatment,32554034,10.1016/j.jiph.2020.05.023,2020-06-20
North Sea,ISA,Geographic Locations,32554030,10.1016/j.scitotenv.2020.140123,2020-06-20
Traffic,PROCESS_OF,Passenger,32554030,10.1016/j.scitotenv.2020.140123,2020-06-20
SARS coronavirus,PROCESS_OF,Scientist,32554029,10.1016/j.scitotenv.2020.140207,2020-06-20
Biological Factors,COEXISTS_WITH,Air,32554029,10.1016/j.scitotenv.2020.140207,2020-06-20
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32553928,10.1016/j.lfs.2020.117970,2020-06-20
GSKIP gene,INTERACTS_WITH,angiotensin converting enzyme 2,32553928,10.1016/j.lfs.2020.117970,2020-06-20
Confirmation,PROCESS_OF,Pregnant Women,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Confirmation,PROCESS_OF,Pregnant Women,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Premature Birth,COEXISTS_WITH,Obesity,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Maternal morbidity,COEXISTS_WITH,Obesity,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Obesity,PREDISPOSES,Maternal morbidity,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Overweight,PREDISPOSES,Maternal morbidity,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Maternal morbidity,PROCESS_OF,Pregnant Women,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Poor outcome,PROCESS_OF,Woman,32553908,10.1016/j.ajog.2020.06.022,2020-06-20
Liver function,PROCESS_OF,Patients,32553907,10.1016/j.cgh.2020.06.017,2020-06-20
Disease,PROCESS_OF,Patients,32553907,10.1016/j.cgh.2020.06.017,2020-06-20
Infected,PROCESS_OF,Patients,32553907,10.1016/j.cgh.2020.06.017,2020-06-20
Heart Injuries,PROCESS_OF,Patients,32553907,10.1016/j.cgh.2020.06.017,2020-06-20
Shock,PROCESS_OF,Patients,32553907,10.1016/j.cgh.2020.06.017,2020-06-20
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,Child,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Vomiting,ISA,Symptoms,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Patients,LOCATION_OF,C-reactive protein,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Patients,LOCATION_OF,Fibrin fragment D,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Patients,LOCATION_OF,procalcitonin,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Patients,LOCATION_OF,Amino-terminal pro-brain natriuretic peptide,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Malaise,PROCESS_OF,Child,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,Child,32553861,10.1016/j.jpeds.2020.06.045,2020-06-20
Medical center,LOCATION_OF,Retrospective Studies,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Quick Test for Liver Function,USES,CD40LG wt Allele,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Quick Test for Liver Function,USES,CD40LG wt Allele,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Quick Test for Liver Function,USES,CD40LG wt Allele,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Laboratory Procedures,DIAGNOSES,SARS coronavirus,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Quick Test for Liver Function,USES,Detection,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Detection,USES,CD40LG wt Allele,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Laboratory Procedures,USES,Antibodies,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
Point-of-Care Testing,COEXISTS_WITH,Detection,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
patient condition,COMPLICATES,Pneumonia,32553841,10.1016/j.jinf.2020.06.023,2020-06-20
World,ISA,Population Group,32553772,10.1016/j.rgmx.2020.05.002,2020-06-20
Liver,LOCATION_OF,compromise,32553772,10.1016/j.rgmx.2020.05.002,2020-06-20
GOT1 gene,STIMULATES,Bilirubin,32553772,10.1016/j.rgmx.2020.05.002,2020-06-20
Liver,LOCATION_OF,Cirrhosis,32553772,10.1016/j.rgmx.2020.05.002,2020-06-20
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32553772,10.1016/j.rgmx.2020.05.002,2020-06-20
Syndrome,CAUSES,Mucocutaneous Lymph Node Syndrome,32553716,10.1016/j.ijid.2020.06.014,2020-06-20
Hospitals,LOCATION_OF,Retrospective Studies,32553714,10.1016/j.ijid.2020.06.038,2020-06-20
Curb,PROCESS_OF,Patients,32553714,10.1016/j.ijid.2020.06.038,2020-06-20
Celiac Disease,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Celiac Disease,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Comorbidity,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Celiac Disease,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Celiac Disease,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Comorbidity,PROCESS_OF,Patients,32553705,10.1016/j.dld.2020.05.014,2020-06-20
Severe disorder,PROCESS_OF,Patients,32553666,10.1016/j.jhep.2020.06.006,2020-06-20
Chronic liver disease,PROCESS_OF,Patients,32553666,10.1016/j.jhep.2020.06.006,2020-06-20
Type-II Pneumocytes,LOCATION_OF,ACE2 gene,32553666,10.1016/j.jhep.2020.06.006,2020-06-20
"Endothelium, Vascular",PART_OF,Liver,32553666,10.1016/j.jhep.2020.06.006,2020-06-20
Biliary epithelial cell,PART_OF,Liver,32553666,10.1016/j.jhep.2020.06.006,2020-06-20
Steroids,AFFECTS,Smell function,32553562,10.1016/j.anl.2020.05.020,2020-06-20
Steroids,AFFECTS,Smell function,32553562,10.1016/j.anl.2020.05.020,2020-06-20
Virus Diseases,PRECEDES,Smell function,32553562,10.1016/j.anl.2020.05.020,2020-06-20
contextual factors,PROCESS_OF,Patients,32553544,10.1016/j.euf.2020.05.007,2020-06-20
contextual factors,PROCESS_OF,Outpatients,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Elective procedure,TREATS,Benign condition,32553544,10.1016/j.euf.2020.05.007,2020-06-20
contextual factors,PROCESS_OF,inpatient,32553544,10.1016/j.euf.2020.05.007,2020-06-20
contextual factors,PROCESS_OF,Outpatients,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Operative Surgical Procedures,TREATS,Disease,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Operative Surgical Procedures,TREATS,Neoplasms,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Nephrectomy,TREATS,Renal mass,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Complete cystectomy,TREATS,High-Risk Cancer,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Elective procedure,TREATS,Benign condition,32553544,10.1016/j.euf.2020.05.007,2020-06-20
contextual factors,PROCESS_OF,inpatient,32553544,10.1016/j.euf.2020.05.007,2020-06-20
Interleukin-6 Receptor Antagonist [EPC],TREATS,Cytokine release syndrome,32553536,10.1016/j.chest.2020.06.006,2020-06-20
tocilizumab,TREATS,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Disease,PROCESS_OF,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
tocilizumab,ADMINISTERED_TO,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Disease,PROCESS_OF,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Severe disorder,PROCESS_OF,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
High Level,PROCESS_OF,Patients,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Interleukin 2 Receptor,PART_OF,soluble,32553536,10.1016/j.chest.2020.06.006,2020-06-20
"IL2RA protein, human",ISA,Interleukin 2 Receptor,32553536,10.1016/j.chest.2020.06.006,2020-06-20
"IL2RA protein, human",PART_OF(SPEC),soluble,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Laboratory Procedures,USES,"TNFRSF11A protein, human",32553536,10.1016/j.chest.2020.06.006,2020-06-20
tocilizumab,TREATS,Cytokine release syndrome,32553536,10.1016/j.chest.2020.06.006,2020-06-20
Ventilator - respiratory equipment,USES,intensive care unit,32553516,10.1016/j.redar.2020.05.002,2020-06-20
Attention,PROCESS_OF,Patients,32553507,10.1016/j.transproceed.2020.05.031,2020-06-20
Bands,TREATS,Kidney Failure,32553507,10.1016/j.transproceed.2020.05.031,2020-06-20
IMPACT gene,AFFECTS,Renin-angiotensin system,32553503,10.1016/j.therap.2020.05.009,2020-06-20
ACE2 gene,INHIBITS,angiotensin II,32553503,10.1016/j.therap.2020.05.009,2020-06-20
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",NEG_PROCESS_OF,Homo sapiens,32553503,10.1016/j.therap.2020.05.009,2020-06-20
ACE2 gene,PART_OF,soluble,32553503,10.1016/j.therap.2020.05.009,2020-06-20
IMPACT gene,PART_OF,Membrane,32553503,10.1016/j.therap.2020.05.009,2020-06-20
IMPACT gene,PART_OF,student,32553483,10.1016/j.gaceta.2020.05.006,2020-06-20
IMPACT gene,PART_OF,Teacher,32553483,10.1016/j.gaceta.2020.05.006,2020-06-20
Greece,ISA,Country,32553464,10.1016/j.rbmo.2020.05.007,2020-06-20
Italy,ISA,Country,32553464,10.1016/j.rbmo.2020.05.007,2020-06-20
Spain,ISA,Country,32553464,10.1016/j.rbmo.2020.05.007,2020-06-20
Experience,PROCESS_OF,Population Group,32553456,10.1016/j.jpedsurg.2020.05.043,2020-06-20
Decision Making,PROCESS_OF,Population Group,32553456,10.1016/j.jpedsurg.2020.05.043,2020-06-20
Infected,PROCESS_OF,Persons,32553350,10.1016/j.bios.2020.112316,2020-06-20
Infected,PROCESS_OF,Persons,32553350,10.1016/j.bios.2020.112316,2020-06-20
Assay,DIAGNOSES,Hypersensitivity,32553350,10.1016/j.bios.2020.112316,2020-06-20
Laboratory,LOCATION_OF,Assay,32553350,10.1016/j.bios.2020.112316,2020-06-20
Laboratory,LOCATION_OF,Assay,32553350,10.1016/j.bios.2020.112316,2020-06-20
Invalidism,PROCESS_OF,Persons,32553350,10.1016/j.bios.2020.112316,2020-06-20
Indeterminate result,PROCESS_OF,Persons,32553350,10.1016/j.bios.2020.112316,2020-06-20
Assay,DIAGNOSES,Hypersensitivity,32553350,10.1016/j.bios.2020.112316,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Latent Tuberculosis,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Severe disorder,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Intervention regimes,TREATS,Present,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Present,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Intervention regimes,TREATS,Present,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Severe disorder,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Severe disorder,PROCESS_OF,Patients,32553309,10.1016/j.ijtb.2020.05.006,2020-06-20
Infection,PROCESS_OF,Homo sapiens,32553273,10.1016/j.cell.2020.06.011,2020-06-20
Vaccines,DISRUPTS,Severe Acute Respiratory Syndrome,32553273,10.1016/j.cell.2020.06.011,2020-06-20
Evaluation,TREATS,Disease,32553273,10.1016/j.cell.2020.06.011,2020-06-20
"Administration, Intranasal",ADMINISTERED_TO,"Mice, Inbred BALB C",32553273,10.1016/j.cell.2020.06.011,2020-06-20
Structure of parenchyma of lung,LOCATION_OF,"Administration, Intranasal",32553273,10.1016/j.cell.2020.06.011,2020-06-20
Lung,LOCATION_OF,Viral Load result,32553273,10.1016/j.cell.2020.06.011,2020-06-20
"Antibodies, Blocking",DISRUPTS,Viral Load result,32553273,10.1016/j.cell.2020.06.011,2020-06-20
Integrins,STIMULATES,Interferons,32553163,10.1016/j.celrep.2020.107772,2020-06-20
Lymphocyte Function-Associated Antigen-1,ISA,Integrins,32553163,10.1016/j.celrep.2020.107772,2020-06-20
Lymphocyte Function-Associated Antigen-1,STIMULATES(SPEC),Interferons,32553163,10.1016/j.celrep.2020.107772,2020-06-20
ISG15 gene,PART_OF,Extracellular,32553163,10.1016/j.celrep.2020.107772,2020-06-20
Epithelial Cells,PRODUCES,ISG15 gene,32553163,10.1016/j.celrep.2020.107772,2020-06-20
Lymphocyte,PRODUCES,ISG15 gene,32553163,10.1016/j.celrep.2020.107772,2020-06-20
agonists,STIMULATES,ISG15 gene,32553163,10.1016/j.celrep.2020.107772,2020-06-20
Infected,PROCESS_OF,Older people,32553130,10.1016/S2214-109X(20)30264-3,2020-06-20
Possible,PREDISPOSES,Severe disorder,32553130,10.1016/S2214-109X(20)30264-3,2020-06-20
Disease,PROCESS_OF,Population Group,32553130,10.1016/S2214-109X(20)30264-3,2020-06-20
Older Population,ISA,Population Group,32553130,10.1016/S2214-109X(20)30264-3,2020-06-20
Cardiovascular Diseases,PROCESS_OF,Persons,32553130,10.1016/S2214-109X(20)30264-3,2020-06-20
Coronavirus Infections,ISA,Disease,32553064,10.2807/1560-7917.ES.2020.25.23.2000972,2020-06-20
Coronavirus Infections,ISA,Disease,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
Fever,PROCESS_OF,Passenger,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
Fever,PROCESS_OF,member,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
"Signs and Symptoms, Respiratory",PROCESS_OF,Passenger,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
"Signs and Symptoms, Respiratory",PROCESS_OF,member,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
Confirmation,PROCESS_OF,Passenger,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
Confirmation,PROCESS_OF,member,32553062,10.2807/1560-7917.ES.2020.25.23.2000272,2020-06-20
Respiration Disorders,PROCESS_OF,Mink,32553059,10.2807/1560-7917.ES.2020.25.23.2001005,2020-06-20
Organ,LOCATION_OF,"Pneumonia, Interstitial",32553059,10.2807/1560-7917.ES.2020.25.23.2001005,2020-06-20
Clinical Laboratory Services,USES,Diagnosis,32553051,10.1099/mgen.0.000397,2020-06-20
Feeding patient,TREATS,Cohort,32553051,10.1099/mgen.0.000397,2020-06-20
Infection,PROCESS_OF,Cohort,32553051,10.1099/mgen.0.000397,2020-06-20
Diagnostic tests,DIAGNOSES,Malaria,32553046,10.4269/ajtmh.20-0467,2020-06-20
Abnormal renal function,PROCESS_OF,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
Urine screening abnormal,PROCESS_OF,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
Study,MEASURES,"Kidney Failure, Acute",32552872,10.1186/s13054-020-03065-4,2020-06-20
"Kidney Failure, Acute",AFFECTS,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
Proteinuria,PROCESS_OF,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
"Kidney Failure, Acute",OCCURS_IN,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Survivors,32552872,10.1186/s13054-020-03065-4,2020-06-20
"Kidney Failure, Acute",PROCESS_OF,Survivors,32552872,10.1186/s13054-020-03065-4,2020-06-20
Continuous renal replacement therapy,TREATS,6/5,32552872,10.1186/s13054-020-03065-4,2020-06-20
Abnormal renal function,PROCESS_OF,Patients,32552872,10.1186/s13054-020-03065-4,2020-06-20
Bacterial sepsis,CAUSES,Blood Coagulation Disorders,32552865,10.1186/s13054-020-03077-0,2020-06-20
Bacterial sepsis,CAUSES,Disseminated Intravascular Coagulation,32552865,10.1186/s13054-020-03077-0,2020-06-20
Septicemia,CAUSES,Disseminated Intravascular Coagulation,32552865,10.1186/s13054-020-03077-0,2020-06-20
Arterial thrombosis,ASSOCIATED_WITH,,32552865,10.1186/s13054-020-03077-0,2020-06-20
Bronchoalveolar Lavage Fluid,CAUSES,inflammatory response,32552811,10.1186/s12931-020-01396-y,2020-06-20
Bronchoalveolar Lavage Fluid,LOCATION_OF,Nicotine,32552811,10.1186/s12931-020-01396-y,2020-06-20
inflammatory response,ASSOCIATED_WITH,ACE2 gene,32552811,10.1186/s12931-020-01396-y,2020-06-20
ACE2 gene,DISRUPTS,inflammatory response,32552811,10.1186/s12931-020-01396-y,2020-06-20
Woman,LOCATION_OF,Proteins,32552811,10.1186/s12931-020-01396-y,2020-06-20
Matrix Metalloproteinase 9,ISA,Matrix Metalloproteinases,32552811,10.1186/s12931-020-01396-y,2020-06-20
Matrix Metalloproteinase 2,ISA,Matrix Metalloproteinases,32552811,10.1186/s12931-020-01396-y,2020-06-20
"Mice, Knockout",LOCATION_OF,Proteins,32552811,10.1186/s12931-020-01396-y,2020-06-20
Mus,LOCATION_OF,MMP12 gene,32552811,10.1186/s12931-020-01396-y,2020-06-20
Collagen,ISA,Extracellular Matrix Proteins,32552811,10.1186/s12931-020-01396-y,2020-06-20
Fibronectins,ISA,Extracellular Matrix Proteins,32552811,10.1186/s12931-020-01396-y,2020-06-20
Nicotine,AFFECTS,Pneumonia,32552811,10.1186/s12931-020-01396-y,2020-06-20
Abnormal mental state,PROCESS_OF,Woman,32552792,10.1186/s12883-020-01812-2,2020-06-20
Cerebrospinal Fluid,LOCATION_OF,cytokine,32552792,10.1186/s12883-020-01812-2,2020-06-20
Cerebrospinal Fluid,LOCATION_OF,cytokine,32552792,10.1186/s12883-020-01812-2,2020-06-20
Inflammation,COEXISTS_WITH,Neurologic Manifestations,32552792,10.1186/s12883-020-01812-2,2020-06-20
Disease,PROCESS_OF,World,32552751,10.1186/s12879-020-05128-x,2020-06-20
Fatigue,ISA,Symptoms,32552751,10.1186/s12879-020-05128-x,2020-06-20
Experience,PROCESS_OF,Pregnant Women,32552735,10.1186/s12978-020-00949-0,2020-06-20
Storm NOS,PROCESS_OF,World,32552659,10.1186/s12245-020-00294-w,2020-06-20
Challenge,TREATS,tourist,32552659,10.1186/s12245-020-00294-w,2020-06-20
Increased size (finding),PROCESS_OF,Staff,32552659,10.1186/s12245-020-00294-w,2020-06-20
Hospitals,LOCATION_OF,Information Management,32552659,10.1186/s12245-020-00294-w,2020-06-20
Morale,PROCESS_OF,Staff,32552659,10.1186/s12245-020-00294-w,2020-06-20
Severe disorder,PROCESS_OF,Persons,32552623,10.33321/cdi.2020.44.52,2020-06-20
Disease,PROCESS_OF,Child,32552623,10.33321/cdi.2020.44.52,2020-06-20
"Asia, Southeastern",ISA,Geographic Locations,32552623,10.33321/cdi.2020.44.52,2020-06-20
Pandemics,ISA,Disease Outbreaks,32552534,10.1080/07391102.2020.1779130,2020-06-20
Vaccines,TREATS,Disease,32552534,10.1080/07391102.2020.1779130,2020-06-20
Excretory function,ISA,Metabolism,32552534,10.1080/07391102.2020.1779130,2020-06-20
NSUN2 gene,PREDISPOSES,Toxic effect,32552534,10.1080/07391102.2020.1779130,2020-06-20
Motivation,PROCESS_OF,student,32552464,10.1080/10872981.2020.1783784,2020-06-20
IMPACT gene,PART_OF,Virus,32552397,10.1089/omi.2020.0077,2020-06-20
World,LOCATION_OF,IMPACT gene,32552397,10.1089/omi.2020.0077,2020-06-20
Negative Surgical Margin,PROCESS_OF,Actor,32552389,10.1080/17441692.2020.1781914,2020-06-20
Negative,PROCESS_OF,Infant,32552365,10.1080/22221751.2020.1780952,2020-06-20
apprehension,PROCESS_OF,World,32552361,10.1080/07391102.2020.1779128,2020-06-20
Drug Repositioning,AFFECTS,virus maturation,32552361,10.1080/07391102.2020.1779128,2020-06-20
Saquinavir,INHIBITS,HIV Protease,32552361,10.1080/07391102.2020.1779128,2020-06-20
Blood capillaries,LOCATION_OF,Thickened,32552164,10.1161/JAHA.120.017111,2020-06-20
Cooley's anemia,PROCESS_OF,Patients,32552139,10.1080/03630269.2020.1779082,2020-06-20
Comorbidity,PROCESS_OF,Patients,32552139,10.1080/03630269.2020.1779082,2020-06-20
Pneumonia,PROCESS_OF,Patients,32552139,10.1080/03630269.2020.1779082,2020-06-20
Neoplasms,PROCESS_OF,Patients,32552110,10.1200/GO.20.00172,2020-06-20
Breast,LOCATION_OF,Malignant Neoplasms,32552110,10.1200/GO.20.00172,2020-06-20
Neoplasms,PROCESS_OF,Patients,32552110,10.1200/GO.20.00172,2020-06-20
Minocycline,compared_with,Agent,32552044,10.1080/14787210.2020.1782190,2020-06-20
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32552044,10.1080/14787210.2020.1782190,2020-06-20
Coronavirus Infections,PROCESS_OF,Patients,32552044,10.1080/14787210.2020.1782190,2020-06-20
myocardial injury,PROCESS_OF,Patients,32552044,10.1080/14787210.2020.1782190,2020-06-20
Intention - mental process,PROCESS_OF,Participant,32551916,10.1177/0890117120932460,2020-06-20
Betacoronavirus,PROCESS_OF,Homo sapiens,32551877,10.1177/1535370220935409,2020-06-20
Sweat,ASSOCIATED_WITH(INFER),Infected,32551877,10.1177/1535370220935409,2020-06-20
Sweat,PART_OF,Persons,32551877,10.1177/1535370220935409,2020-06-20
Infected,PROCESS_OF,Persons,32551877,10.1177/1535370220935409,2020-06-20
Pneumonia,COEXISTS_WITH,Thickened,32551862,10.1152/ajplung.00195.2020,2020-06-20
Structure of pulmonary blood vessel,LOCATION_OF,Thickened,32551862,10.1152/ajplung.00195.2020,2020-06-20
Anoxia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Anoxia,PREDISPOSES,endothelial dysfunction,32551862,10.1152/ajplung.00195.2020,2020-06-20
Anoxia,PREDISPOSES,Microthrombosis,32551862,10.1152/ajplung.00195.2020,2020-06-20
Blood Coagulation Disorders,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Blood Coagulation Disorders,PREDISPOSES,endothelial dysfunction,32551862,10.1152/ajplung.00195.2020,2020-06-20
Blood Coagulation Disorders,PREDISPOSES,Microthrombosis,32551862,10.1152/ajplung.00195.2020,2020-06-20
DNA Damage,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Inflammation,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Inflammation,PREDISPOSES,endothelial dysfunction,32551862,10.1152/ajplung.00195.2020,2020-06-20
Inflammation,PREDISPOSES,Microthrombosis,32551862,10.1152/ajplung.00195.2020,2020-06-20
Lung,LOCATION_OF,Blood Coagulation Disorders,32551862,10.1152/ajplung.00195.2020,2020-06-20
Oxidative Stress,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Abnormality of mitochondrial metabolism,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551862,10.1152/ajplung.00195.2020,2020-06-20
Abnormality of mitochondrial metabolism,PREDISPOSES,endothelial dysfunction,32551862,10.1152/ajplung.00195.2020,2020-06-20
Abnormality of mitochondrial metabolism,PREDISPOSES,Microthrombosis,32551862,10.1152/ajplung.00195.2020,2020-06-20
Virus,INTERACTS_WITH,Pulmonary Vascular Disorder,32551862,10.1152/ajplung.00195.2020,2020-06-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32551855,10.1177/2515690X20932523,2020-06-20
Betacoronavirus,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32551855,10.1177/2515690X20932523,2020-06-20
Betacoronavirus,INTERACTS_WITH,SARS coronavirus,32551855,10.1177/2515690X20932523,2020-06-20
Diagnostic Services,TREATS,Cohort,32551815,10.5858/arpa.2020-0372-SA,2020-06-20
Microscopy,METHOD_OF,Diagnosis,32551815,10.5858/arpa.2020-0372-SA,2020-06-20
Cessation of life,COEXISTS_WITH,Aging,32551777,10.1037/tra0000695,2020-06-20
Shame,ISA,Guilt,32551775,10.1037/tra0000742,2020-06-20
Clients,LOCATION_OF,IMPACT gene,32551771,10.1037/tra0000857,2020-06-20
Post-Traumatic Stress Disorder,PROCESS_OF,Clients,32551771,10.1037/tra0000857,2020-06-20
Coronavirus Infections,AFFECTS,Child,32551769,10.1037/tra0000754,2020-06-20
Coronavirus Infections,AFFECTS,Adolescent (age group),32551769,10.1037/tra0000754,2020-06-20
Psychological Services,TREATS,Child,32551769,10.1037/tra0000754,2020-06-20
Psychological Services,TREATS,Adolescent (age group),32551769,10.1037/tra0000754,2020-06-20
Psychological Services,TREATS,Distress,32551769,10.1037/tra0000754,2020-06-20
Distress,PROCESS_OF,family system,32551769,10.1037/tra0000754,2020-06-20
mental health,PROCESS_OF,general population,32551768,10.1037/tra0000842,2020-06-20
Insight,PROCESS_OF,general population,32551768,10.1037/tra0000842,2020-06-20
Lebanon,ISA,Country,32551766,10.1037/tra0000757,2020-06-20
mental health,PROCESS_OF,College student,32551764,10.1037/tra0000930,2020-06-20
Wounds and Injuries,PROCESS_OF,Sexual and Gender Minorities,32551761,10.1037/tra0000837,2020-06-20
Mental disorders,PROCESS_OF,student,32551760,10.1037/tra0000786,2020-06-20
Patients,NEG_ISA,Persons,32551760,10.1037/tra0000786,2020-06-20
opioid use,ISA,Disease,32551759,10.1037/tra0000660,2020-06-20
Mental health problem,COEXISTS_WITH,Disease,32551759,10.1037/tra0000660,2020-06-20
Mental health problem,COEXISTS_WITH(SPEC),opioid use,32551759,10.1037/tra0000660,2020-06-20
Coronavirus Infections,ISA,Disease,32551757,10.1037/tra0000721,2020-06-20
Wounds and Injuries,PROCESS_OF,Community,32551756,10.1037/tra0000784,2020-06-20
Wounds and Injuries,PROCESS_OF,African race,32551756,10.1037/tra0000784,2020-06-20
Wounds and Injuries,PROCESS_OF,Racial group,32551756,10.1037/tra0000784,2020-06-20
Wounds and Injuries,PROCESS_OF,Asians,32551756,10.1037/tra0000784,2020-06-20
Wounds and Injuries,PROCESS_OF,Racial group,32551756,10.1037/tra0000784,2020-06-20
Alcohol abuse,ISA,Mental disorders,32551750,10.1037/tra0000753,2020-06-20
macrophage,PART_OF,Homo sapiens,32551679,10.1021/acs.nanolett.0c02278,2020-06-20
century,TREATS,World,32551648,10.1021/acs.jproteome.0c00273,2020-06-20
Biomedicine,ISA,Science,32551648,10.1021/acs.jproteome.0c00273,2020-06-20
"M Protein, multiple myeloma",INTERACTS_WITH,Pharmaceutical Preparations,32551648,10.1021/acs.jproteome.0c00273,2020-06-20
Detection,PREVENTS,Virus Diseases,32551648,10.1021/acs.jproteome.0c00273,2020-06-20
"M Protein, multiple myeloma",PART_OF,SARS coronavirus,32551648,10.1021/acs.jproteome.0c00273,2020-06-20
angiotensin converting enzyme 2,INTERACTS_WITH,"M Protein, multiple myeloma",32551648,10.1021/acs.jproteome.0c00273,2020-06-20
hepcidin,INTERACTS_WITH,"M Protein, multiple myeloma",32551648,10.1021/acs.jproteome.0c00273,2020-06-20
aptamer,INTERACTS_WITH,RNA Recognition Motif,32551560,10.1021/acs.analchem.0c01394,2020-06-20
Macrophage Activation Syndrome,COEXISTS_WITH,Disease,32551559,10.1021/acsnano.0c04421,2020-06-20
Challenge,TREATS,Disease,32551559,10.1021/acsnano.0c04421,2020-06-20
Dexamethasone,ISA,Adrenal Cortex Hormones,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Destructive procedure (surgical),CAUSES,associated disease,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Dexamethasone,ISA,Adrenal Cortex Hormones,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
cytokine,DISRUPTS,B-Lymphocytes,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
cytokine,DISRUPTS,T-Lymphocyte,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Dexamethasone,AFFECTS,macrophage,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Triamcinolone,compared_with,Cortisone,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Triamcinolone,same_as,Cortisone,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Anti-Inflammatory Agents,DISRUPTS,mast cell,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Lung,LOCATION_OF,cytokine,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Luteolin,ISA,Flavonoids,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Disease,PROCESS_OF,Patients,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Physicians,TREATS,Patients,32551464,10.23812/20-EDITORIAL_1-5,2020-06-20
Experience,PROCESS_OF,Meleagris gallopavo,32551453,10.5152/TJAR.2020.607,2020-06-20
Coronavirus Infections,ISA,Disease,32551444,10.5152/TJAR.2020.654,2020-06-20
Emergency operation,TREATS,Patients,32551444,10.5152/TJAR.2020.654,2020-06-20
Emergency operation,TREATS(INFER),Confirmation,32551444,10.5152/TJAR.2020.654,2020-06-20
Emergency operation,TREATS(INFER),Suspected coronavirus infection,32551444,10.5152/TJAR.2020.654,2020-06-20
Confirmation,PROCESS_OF,Patients,32551444,10.5152/TJAR.2020.654,2020-06-20
Suspected coronavirus infection,PROCESS_OF,Patients,32551444,10.5152/TJAR.2020.654,2020-06-20
Disease,PROCESS_OF,Patients,32551444,10.5152/TJAR.2020.654,2020-06-20
Coronavirus Infections,ISA,Disease,32551444,10.5152/TJAR.2020.654,2020-06-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32551444,10.5152/TJAR.2020.654,2020-06-20
Coronavirus Infections,ISA,Disease,32551444,10.5152/TJAR.2020.654,2020-06-20
Anesthesiologist,ISA,Health Personnel,32551444,10.5152/TJAR.2020.654,2020-06-20
General Anesthesia,METHOD_OF,Cesarean section,32551443,10.5152/TJAR.2020.280420,2020-06-20
Chronic disease,PROCESS_OF,Persons,32551437,10.1016/j.medidd.2020.100048,2020-06-20
diabetic,PROCESS_OF,Patients,32551437,10.1016/j.medidd.2020.100048,2020-06-20
How to Prevent Diabetes,PREDISPOSES,Diabetes,32551437,10.1016/j.medidd.2020.100048,2020-06-20
Critical Illness,PROCESS_OF,Patients,32551409,10.1177/2473974X20934770,2020-06-20
"Respiratory Distress Syndrome, Adult",ISA,Symptoms,32551409,10.1177/2473974X20934770,2020-06-20
"Respiratory Distress Syndrome, Adult",PROCESS_OF(SPEC),Patients,32551409,10.1177/2473974X20934770,2020-06-20
Symptoms,PROCESS_OF,Patients,32551409,10.1177/2473974X20934770,2020-06-20
Abnormal coordination,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32551409,10.1177/2473974X20934770,2020-06-20
Oropharyngeal Dysphagia,PROCESS_OF,Patients,32551409,10.1177/2473974X20934770,2020-06-20
Asymptomatic,PROCESS_OF,Patients,32551408,10.1177/2473974X20934734,2020-06-20
Possible,PROCESS_OF,Community,32551408,10.1177/2473974X20934734,2020-06-20
Experience,PROCESS_OF,Patients,32551407,10.1177/2473974X20933573,2020-06-20
Abdominal Pain,PROCESS_OF,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Nausea,PROCESS_OF,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Low grade fever,PROCESS_OF,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Gallbladder,LOCATION_OF,Gangrene,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Gallbladder,LOCATION_OF,Gangrene,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Gangrene,PROCESS_OF,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Percutaneous cholecystostomy,TREATS,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Percutaneous cholecystostomy,TREATS(INFER),Gangrene,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
gangrenous cholecystitis,PROCESS_OF,Patients,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
"Cholecystectomy, Laparoscopic",TREATS,Gangrene of gallbladder,32551214,10.1016/j.ijscr.2020.06.038,2020-06-20
Diagnostic tests,ADMINISTERED_TO,Patients,32551205,10.7717/peerj.9360,2020-06-20
Infected,PROCESS_OF,Patients,32551205,10.7717/peerj.9360,2020-06-20
Family member,INTERACTS_WITH,Patients,32551205,10.7717/peerj.9360,2020-06-20
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,member,32551150,10.5606/tgkdc.dergisi.2020.09293,2020-06-20
Hypoxemia,PROCESS_OF,Patients,32550954,10.5770/cgj.23.445,2020-06-20
Syndrome,PROCESS_OF,Old age,32550954,10.5770/cgj.23.445,2020-06-20
Functional capacity,PROCESS_OF,Elderly (population group),32550953,10.5770/cgj.23.452,2020-06-20
Curb,AFFECTS,Volatility,32550842,10.1016/j.frl.2020.101597,2020-06-20
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32550783,10.29399/npa.26148,2020-06-20
Ataxia,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Confusion,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Dizziness,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Epilepsy,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Headache,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Myopathy,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Neuralgia,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Ischemic stroke,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Poor outcome,COEXISTS_WITH,neurological complication,32550783,10.29399/npa.26148,2020-06-20
Infected,PROCESS_OF,Patients,32550783,10.29399/npa.26148,2020-06-20
Symptoms,COEXISTS_WITH,Carrier of disorder,32550783,10.29399/npa.26148,2020-06-20
Sense of smell impaired,COEXISTS_WITH(SPEC),Carrier of disorder,32550783,10.29399/npa.26148,2020-06-20
Sense of smell impaired,ISA,Symptoms,32550783,10.29399/npa.26148,2020-06-20
Encephalitis,COEXISTS_WITH,Virus,32550783,10.29399/npa.26148,2020-06-20
Genus: Coronavirus,COEXISTS_WITH,SARS coronavirus,32550783,10.29399/npa.26148,2020-06-20
SARS coronavirus,ISA,Human coronavirus,32550783,10.29399/npa.26148,2020-06-20
Attention,PROCESS_OF,Patients,32550707,10.1590/S1677-5538.IBJU.2020.S120,2020-06-19
Attention,PROCESS_OF,Staff,32550707,10.1590/S1677-5538.IBJU.2020.S120,2020-06-19
"CD69 protein, human",AFFECTS,Crisis,32550707,10.1590/S1677-5538.IBJU.2020.S120,2020-06-19
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32550704,10.1590/S1677-5538.IBJU.2020.S117,2020-06-19
Population Group,LOCATION_OF,IMPACT gene,32550703,10.1590/S1677-5538.IBJU.2020.S116,2020-06-19
Experience,PROCESS_OF,Hispanics,32550702,10.1590/S1677-5538.IBJU.2020.S114,2020-06-19
Symptoms,PROCESS_OF,Recipient,32550702,10.1590/S1677-5538.IBJU.2020.S114,2020-06-19
Symptom severe,PROCESS_OF,Patients,32550702,10.1590/S1677-5538.IBJU.2020.S114,2020-06-19
contextual factors,PROCESS_OF,Outpatients,32550702,10.1590/S1677-5538.IBJU.2020.S114,2020-06-19
Elective Surgical Procedures,ISA,Operative Surgical Procedures,32550701,10.1590/S1677-5538.IBJU.2020.S104,2020-06-19
Complication,COEXISTS_WITH,Disease,32550701,10.1590/S1677-5538.IBJU.2020.S104,2020-06-19
Problem,PROCESS_OF,Consultant,32550647,10.7861/fhj.2020-0035,2020-06-19
Problem,PROCESS_OF,"Physicians, Junior",32550647,10.7861/fhj.2020-0035,2020-06-19
Cerebrovascular accident,PROCESS_OF,Patients,32550287,10.7861/fhj.2020-0034,2020-06-19
Intervention regimes,TREATS,Patients,32550287,10.7861/fhj.2020-0034,2020-06-19
Intervention regimes,TREATS(INFER),Cerebrovascular accident,32550287,10.7861/fhj.2020-0034,2020-06-19
Cerebrovascular accident,PROCESS_OF,Clinician,32550287,10.7861/fhj.2020-0034,2020-06-19
unwellness,PROCESS_OF,Patients,32550284,10.7861/fhj.2020-0016,2020-06-19
Patients,LOCATION_OF,IMPACT gene,32550284,10.7861/fhj.2020-0016,2020-06-19
Primary malignant neoplasm of breast,PROCESS_OF,Patients,32550266,10.1038/s41523-020-0168-9,2020-06-19
Endocrine Gland Neoplasms,PROCESS_OF,Patients,32550266,10.1038/s41523-020-0168-9,2020-06-19
Postmenopausal state,PROCESS_OF,Patients,32550266,10.1038/s41523-020-0168-9,2020-06-19
Malignant neoplasm of breast,PROCESS_OF,Patients,32550266,10.1038/s41523-020-0168-9,2020-06-19
"Signs and Symptoms, Respiratory",ASSOCIATED_WITH,Communicable Diseases,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Problem,PROCESS_OF,Patients,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
angiotensin converting enzyme 2,ASSOCIATED_WITH,Direct trauma,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Pharmaceutical Preparations,AFFECTS,patient condition,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Cardiovascular,LOCATION_OF,Toxic effect,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Cardiovascular system,ASSOCIATED_WITH,patient condition,32550259,10.1016/j.ijcha.2020.100557,2020-06-19
Pneumonia,PROCESS_OF,Patients,32550256,10.1016/j.ejro.2020.100239,2020-06-19
Tropism,PROCESS_OF,Lung,32550256,10.1016/j.ejro.2020.100239,2020-06-19
Differential Diagnosis,DIAGNOSES,Disease,32550256,10.1016/j.ejro.2020.100239,2020-06-19
Signs and Symptoms,ASSOCIATED_WITH,Pneumonia,32550256,10.1016/j.ejro.2020.100239,2020-06-19
Disease,PROCESS_OF,Patients,32550223,10.4081/jphr.2020.1786,2020-06-19
Structure of pulmonary blood vessel,LOCATION_OF,Metric,32550141,10.21037/qims-20-546,2020-06-19
Lung,LOCATION_OF,Arterial diameter,32550141,10.21037/qims-20-546,2020-06-19
Lung,LOCATION_OF(SPEC),Aortic diameter,32550141,10.21037/qims-20-546,2020-06-19
Aortic diameter,ISA,Arterial diameter,32550141,10.21037/qims-20-546,2020-06-19
Ground Glass Opacity,PROCESS_OF,Patients,32550141,10.21037/qims-20-546,2020-06-19
Bilateral pneumonia,PROCESS_OF,Patients,32550141,10.21037/qims-20-546,2020-06-19
Lung,LOCATION_OF,Arterial diameter,32550141,10.21037/qims-20-546,2020-06-19
Lung,LOCATION_OF,Arterial diameter,32550141,10.21037/qims-20-546,2020-06-19
Arterial diameter,PROCESS_OF,Patients,32550141,10.21037/qims-20-546,2020-06-19
Pulmonary artery structure,LOCATION_OF,Metric,32550141,10.21037/qims-20-546,2020-06-19
Cessation of life,PROCESS_OF,Patients,32550141,10.21037/qims-20-546,2020-06-19
Lung,LOCATION_OF,Arterial diameter,32550141,10.21037/qims-20-546,2020-06-19
Hospitals,ISA,Health care facility,32550140,10.21037/qims-20-530,2020-06-19
15-19,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Fever,ISA,Symptoms,32550140,10.21037/qims-20-530,2020-06-19
White blood cell count normal,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Elevated C-reactive protein,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Coughing,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Coughing,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Neutrophilia (finding),PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Normal result,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Elevated C-reactive protein,PROCESS_OF,Patients,32550140,10.21037/qims-20-530,2020-06-19
Mediastinum,LOCATION_OF,Lymphadenopathy,32550139,10.21037/qims-20-531,2020-06-19
Disease,AFFECTS,Negative,32550128,10.1016/j.jbef.2020.100349,2020-06-19
Clinical Management,TREATS,high-risk group,32550127,10.1016/j.rmcr.2020.101118,2020-06-19
Hepatitis B Virus,PROCESS_OF,Young Adult,32550096,10.7759/cureus.8645,2020-06-19
Abnormal mental state,PROCESS_OF,Young Adult,32550096,10.7759/cureus.8645,2020-06-19
Hypertransaminasaemia,PROCESS_OF,Young Adult,32550096,10.7759/cureus.8645,2020-06-19
Liver Dysfunction,PROCESS_OF,Patients,32550096,10.7759/cureus.8645,2020-06-19
Liver Dysfunction,PROCESS_OF,Patients,32550096,10.7759/cureus.8645,2020-06-19
Sputum,CAUSES,Airway Obstruction,32550095,10.7759/cureus.8626,2020-06-19
Diabetes,PROCESS_OF,Male population group,32550095,10.7759/cureus.8626,2020-06-19
Hydroxychloroquine,TREATS,Male population group,32550095,10.7759/cureus.8626,2020-06-19
Hydroxychloroquine,TREATS(INFER),Diabetes,32550095,10.7759/cureus.8626,2020-06-19
Hydroxychloroquine,TREATS(INFER),Pneumonia,32550095,10.7759/cureus.8626,2020-06-19
Pneumonia,PROCESS_OF,Male population group,32550095,10.7759/cureus.8626,2020-06-19
Endotracheal aspiration,USES,Suction system,32550095,10.7759/cureus.8626,2020-06-19
Bradycardia,PROCESS_OF,Patients,32550090,10.7759/cureus.8599,2020-06-19
Comorbidity,PROCESS_OF,Patients,32550090,10.7759/cureus.8599,2020-06-19
Cardiovascular,LOCATION_OF,Comorbidity,32550090,10.7759/cureus.8599,2020-06-19
Dexmedetomidine,ADMINISTERED_TO,Patients,32550090,10.7759/cureus.8599,2020-06-19
Patient Admission,TREATS,Bradycardia,32550090,10.7759/cureus.8599,2020-06-19
Sinus bradycardia,PROCESS_OF,Transient Population Group,32550090,10.7759/cureus.8599,2020-06-19
Pharmaceutical Preparations,CAUSES,Possible,32550090,10.7759/cureus.8599,2020-06-19
Pharmaceutical Preparations,AFFECTS,Cardiac Arrhythmia,32550090,10.7759/cureus.8599,2020-06-19
Gynecology,ISA,obstetrics and gynecology (field),32550087,10.7759/cureus.8397,2020-06-19
Dancing,TREATS,teams,32550087,10.7759/cureus.8397,2020-06-19
Chest,LOCATION_OF,ct scan contrast,32550070,10.7759/cureus.8151,2020-06-19
Ground Glass Opacity,PROCESS_OF,Patients,32550070,10.7759/cureus.8151,2020-06-19
Chest CT,DIAGNOSES,Ground Glass Opacity,32550070,10.7759/cureus.8151,2020-06-19
Disease,CAUSES,Non-Neoplastic Disorder,32550070,10.7759/cureus.8151,2020-06-19
radiologist,TREATS,Patients,32550070,10.7759/cureus.8151,2020-06-19
Complication,CAUSES,Blood Coagulation Disorders,32550069,10.7759/cureus.8150,2020-06-19
Disease,CAUSES,Blood Coagulation Disorders,32550069,10.7759/cureus.8150,2020-06-19
Blood Coagulation Disorders,AFFECTS,hospitalized patients,32550069,10.7759/cureus.8150,2020-06-19
"Condoms, Male",NEG_TREATS,High Level,32550069,10.7759/cureus.8150,2020-06-19
Anticoagulants,TREATS,patient condition,32550069,10.7759/cureus.8150,2020-06-19
"Heparin, Low-Molecular-Weight",compared_with,heparin,32550069,10.7759/cureus.8150,2020-06-19
heparin,ISA,Anticoagulants,32550069,10.7759/cureus.8150,2020-06-19
Negative Regulation of Coagulation,PROCESS_OF,Outpatients,32550069,10.7759/cureus.8150,2020-06-19
nafamostat,ISA,Anticoagulants,32550069,10.7759/cureus.8150,2020-06-19
"Respiratory Distress Syndrome, Adult",CAUSES,Diabetes Mellitus,32550066,10.7759/cureus.8147,2020-06-19
Diabetes Mellitus,PROCESS_OF,Middle-aged men,32550066,10.7759/cureus.8147,2020-06-19
Diabetic Ketoacidosis,PROCESS_OF,Middle-aged men,32550066,10.7759/cureus.8147,2020-06-19
Seizures,PROCESS_OF,Middle-aged men,32550066,10.7759/cureus.8147,2020-06-19
Abnormal mental state,PROCESS_OF,Middle-aged men,32550066,10.7759/cureus.8147,2020-06-19
pulmonary involvement,PROCESS_OF,Patients,32550066,10.7759/cureus.8147,2020-06-19
Diabetes Mellitus,PROCESS_OF,Patients,32550066,10.7759/cureus.8147,2020-06-19
Multiple Organ Failure,PROCESS_OF,Patients,32550066,10.7759/cureus.8147,2020-06-19
Persons,LOCATION_OF,IMPACT gene,32550063,10.7759/cureus.8144,2020-06-19
Pharmaceutical Preparations,TREATS,Disease,32550056,10.7759/cureus.8136,2020-06-19
passive immunization procedure,TREATS,Disease,32550056,10.7759/cureus.8136,2020-06-19
Symptom mild,PROCESS_OF,Patients,32550056,10.7759/cureus.8136,2020-06-19
Coronaviridae,PROCESS_OF,Family,32550054,10.7759/cureus.8134,2020-06-19
Asymptomatic Diseases,PROCESS_OF,Homo sapiens,32550054,10.7759/cureus.8134,2020-06-19
Pharmaceutical Preparations,TREATS,Disease,32550054,10.7759/cureus.8134,2020-06-19
Vaccination,TREATS,Disease,32550054,10.7759/cureus.8134,2020-06-19
receptor,ADMINISTERED_TO,Cells,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
angiotensin converting enzyme 2,ASSOCIATED_WITH,Acute Lung Injury,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
angiotensin converting enzyme 2,INTERACTS_WITH,angiotensin II,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
Virus Internalization,AFFECTS,Severe Acute Respiratory Syndrome,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
Cardiovascular Diseases,PROCESS_OF,Patients,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32550040,10.1016/j.cdtm.2020.05.003,2020-06-19
Mechanical ventilation,ADMINISTERED_TO,Patients,32549989,10.1186/s40560-020-00456-1,2020-06-19
Masks,USES,College,32549983,10.4081/mrm.2020.664,2020-06-19
Breath,LOCATION_OF,Nitric Oxide,32549983,10.4081/mrm.2020.664,2020-06-19
Intervention regimes,COEXISTS_WITH,Prophylactic treatment,32549749,10.1186/s41182-020-00236-5,2020-06-19
Hip Fractures,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Hip Fractures,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Operative Surgical Procedures,TREATS,Hip Fractures,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Anoxia,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Anoxia,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Demand (clinical),USES,Oxygen,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Venous Thromboembolism,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Hip Fractures,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Asymptomatic,PROCESS_OF,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
early/brief intervention/therapy (treatment),TREATS,Patients,32549692,10.1016/j.jor.2020.06.003,2020-06-19
early/brief intervention/therapy (treatment),TREATS(INFER),Hip Fractures,32549692,10.1016/j.jor.2020.06.003,2020-06-19
early/brief intervention/therapy (treatment),TREATS(INFER),Asymptomatic,32549692,10.1016/j.jor.2020.06.003,2020-06-19
Patient referral,TREATS,Disease,32549532,10.23736/S0031-0808.20.04000-8,2020-06-19
Virus,INTERACTS_WITH,Pulmonary failure,32549531,10.23736/S0031-0808.20.03999-3,2020-06-19
Prognosis bad,PROCESS_OF,Patients,32549531,10.23736/S0031-0808.20.03999-3,2020-06-19
Pulmonary failure,COEXISTS_WITH,Thrombosis,32549531,10.23736/S0031-0808.20.03999-3,2020-06-19
Hospitalization,TREATS,Severe Acute Respiratory Syndrome,32549531,10.23736/S0031-0808.20.03999-3,2020-06-19
Inflammation,CAUSES,Severe Acute Respiratory Syndrome,32549531,10.23736/S0031-0808.20.03999-3,2020-06-19
Respiratory sample,LOCATION_OF,Duration,32549526,10.3904/kjim.2020.203,2020-06-19
Duration,TREATS,Patients,32549526,10.3904/kjim.2020.203,2020-06-19
Oropharyngeal,LOCATION_OF,Nasal Swab (procedure),32549526,10.3904/kjim.2020.203,2020-06-19
Hospitalization,TREATS,Symptoms,32549526,10.3904/kjim.2020.203,2020-06-19
Long-term Follow-up,TREATS,Symptoms,32549526,10.3904/kjim.2020.203,2020-06-19
Adoption,ISA,Behavior,32549345,10.3390/ijerph17124282,2020-06-19
Perception,ISA,Cognition,32549345,10.3390/ijerph17124282,2020-06-19
Perception,PROCESS_OF,Participant,32549345,10.3390/ijerph17124282,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Government,ISA,Organization administrative structures,32549334,10.3390/ijerph17124279,2020-06-19
Virus,PROCESS_OF,Homo sapiens,32549334,10.3390/ijerph17124279,2020-06-19
Pneumonia,PROCESS_OF,Patients,32549334,10.3390/ijerph17124279,2020-06-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32549334,10.3390/ijerph17124279,2020-06-19
Symptoms,CAUSES,Cessation of life,32549334,10.3390/ijerph17124279,2020-06-19
Intervention regimes,TREATS,Symptoms,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
IMPACT gene,ASSOCIATED_WITH,Disease,32549334,10.3390/ijerph17124279,2020-06-19
IMPACT gene,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32549334,10.3390/ijerph17124279,2020-06-19
Coronavirus Infections,ISA,Disease,32549334,10.3390/ijerph17124279,2020-06-19
Sarcoma,PROCESS_OF,Patients,32549298,10.3390/jcm9061868,2020-06-19
Treatment Protocols,ADMINISTERED_TO,Medical Staff,32549298,10.3390/jcm9061868,2020-06-19
Neoplasms,AFFECTS,Patients,32549297,10.3390/cancers12061581,2020-06-19
ACE2 gene,PART_OF,Virus,32549297,10.3390/cancers12061581,2020-06-19
Thalidomide,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
inhibitors,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
bevacizumab,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
carfilzomib,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
Ibrutinib,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
Selinexor,TREATS,Severe Acute Respiratory Syndrome,32549297,10.3390/cancers12061581,2020-06-19
Infected,PROCESS_OF,Cancer Patient,32549297,10.3390/cancers12061581,2020-06-19
Challenge,USES,Diagnosis,32549297,10.3390/cancers12061581,2020-06-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32549297,10.3390/cancers12061581,2020-06-19
Hydroxychloroquine,TREATS,hospitalized patients,32549293,10.3390/jcm9061867,2020-06-19
Hydroxychloroquine,ADMINISTERED_TO,Patients,32549293,10.3390/jcm9061867,2020-06-19
AES gene,PART_OF,Heart,32549293,10.3390/jcm9061867,2020-06-19
intensive care unit,ISA,Hospitals,32549273,10.3390/ijerph17124267,2020-06-19
Pneumonia,AFFECTS,inflammatory response,32549200,10.3390/v12060646,2020-06-19
SH2D3C gene,CAUSES,Storm NOS,32549200,10.3390/v12060646,2020-06-19
"Cytopathogenic Effect, Viral",COEXISTS_WITH,Severe Acute Respiratory Syndrome,32549125,10.1515/dx-2020-0054,2020-06-19
Lung Injury,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32549125,10.1515/dx-2020-0054,2020-06-19
Hyperinflammatory state,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32549125,10.1515/dx-2020-0054,2020-06-19
Coronavirus Infections,ISA,Disease,32549125,10.1515/dx-2020-0054,2020-06-19
Surgical face mask,USES,Personal protective equipment,32549123,10.1515/cclm-2020-0711,2020-06-19
Laboratory,LOCATION_OF,Biosafety,32549122,10.1515/cclm-2020-0710,2020-06-19
Personal protective equipment,ISA,Equipment,32549122,10.1515/cclm-2020-0710,2020-06-19
Malignant Neoplasms,PROCESS_OF,Patients,32549077,10.1590/S1677-5538.IBJU.2020.S115,2020-06-18
Malignant Neoplasms,PROCESS_OF,Patients,32549077,10.1590/S1677-5538.IBJU.2020.S115,2020-06-18
Coronavirus Infections,ISA,Disease,32549076,10.1590/S1677-5538.IBJU.2020.S113,2020-06-18
Renal Cell Carcinoma,PROCESS_OF,Patients,32549075,10.1590/S1677-5538.IBJU.2020.S108,2020-06-18
Renal Cell Carcinoma,PROCESS_OF,Patients,32549075,10.1590/S1677-5538.IBJU.2020.S108,2020-06-18
Hereditary Renal Cell Carcinoma,ISA,Syndrome,32549075,10.1590/S1677-5538.IBJU.2020.S108,2020-06-18
Malignant Neoplasms,PROCESS_OF,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
Neoplasms,PROCESS_OF,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
Antiandrogen therapy,TREATS,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
Antiandrogen therapy,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
,ASSOCIATED_WITH(INFER),Toxic effect,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
,PART_OF,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
Toxic effect,PROCESS_OF,Patients,32549073,10.1590/S1677-5538.IBJU.2020.S106,2020-06-18
Neoplasms,PROCESS_OF,geriatric patients,32549072,10.1590/S1677-5538.IBJU.2020.S102,2020-06-18
Benign Prostatic Hyperplasia,ISA,Urologic Diseases,32549072,10.1590/S1677-5538.IBJU.2020.S102,2020-06-18
Benign Prostatic Hyperplasia,PROCESS_OF,geriatric patients,32549072,10.1590/S1677-5538.IBJU.2020.S102,2020-06-18
Infection,ISA,Symptoms,32549072,10.1590/S1677-5538.IBJU.2020.S102,2020-06-18
Intermediate Host,ISA,Host (organism),32549071,10.1590/S1677-5538.IBJU.2020.S101,2020-06-18
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32549025,10.4045/tidsskr.20.0356,2020-06-18
Polymerase Chain Reaction,USES,Nasal Swab (procedure),32549025,10.4045/tidsskr.20.0356,2020-06-18
Upper respiratory tract,LOCATION_OF,Severe Acute Respiratory Syndrome,32549025,10.4045/tidsskr.20.0356,2020-06-18
Clinical Laboratory Services,METHOD_OF,Reporting,32549020,10.4045/tidsskr.20.0334,2020-06-18
"CD69 protein, human",ASSOCIATED_WITH,Communicable Diseases,32549020,10.4045/tidsskr.20.0334,2020-06-18
Disease,DISRUPTS,Social Distance,32549020,10.4045/tidsskr.20.0334,2020-06-18
Endocrine System Diseases,AFFECTS,Dynamics,32548995,10.23736/S0391-1977.20.03216-2,2020-06-18
Coronavirus Infections,ISA,Disease,32548995,10.23736/S0391-1977.20.03216-2,2020-06-18
inpatient,LOCATION_OF,IMPACT gene,32548994,10.4081/monaldi.2020.1439,2020-06-18
Outpatients,LOCATION_OF,IMPACT gene,32548994,10.4081/monaldi.2020.1439,2020-06-18
Awareness,PROCESS_OF,Persons,32548832,10.1007/s10943-020-01052-1,2020-06-18
Osteoporosis,AFFECTS,Household composition,32548787,10.1007/s00198-020-05465-2,2020-06-18
Osteoporosis,PROCESS_OF,Outpatients,32548787,10.1007/s00198-020-05465-2,2020-06-18
GSKIP gene,AFFECTS,Possible,32548787,10.1007/s00198-020-05465-2,2020-06-18
Infected,PROCESS_OF,Patients,32548764,10.1007/s00508-020-01688-9,2020-06-18
Early Intervention (Education),TREATS,Communicable Diseases,32548764,10.1007/s00508-020-01688-9,2020-06-18
Early Intervention (Education),TREATS,Easy,32548764,10.1007/s00508-020-01688-9,2020-06-18
Vaccines,PREDISPOSES,Late effect of medical intervention,32548679,10.1007/s00228-020-02933-w,2020-06-18
Pneumonia,CAUSES,Hospitalization,32548652,10.1007/s00108-020-00834-9,2020-06-18
Pneumonia,ISA,Infection,32548652,10.1007/s00108-020-00834-9,2020-06-18
Hypertensive disease,PREDISPOSES,Disease Progression,32548652,10.1007/s00108-020-00834-9,2020-06-18
Infection,PROCESS_OF,Health Personnel,32548652,10.1007/s00108-020-00834-9,2020-06-18
Infected,PROCESS_OF,Persons,32548651,10.1007/s00108-020-00833-w,2020-06-18
Laboratory Procedures,USES,PCR test for SARS,32548636,10.1093/jamia/ocaa076,2020-06-18
PCR test for SARS,ISA,Laboratory Procedures,32548636,10.1093/jamia/ocaa076,2020-06-18
Asymptomatic,PROCESS_OF,Population Group,32548628,10.1093/cid/ciaa763,2020-06-18
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32548628,10.1093/cid/ciaa763,2020-06-18
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32548628,10.1093/cid/ciaa763,2020-06-18
Infectious disease prevention / control,TREATS,High Risk Populations,32548628,10.1093/cid/ciaa763,2020-06-18
Infected,PROCESS_OF,Persons,32548601,10.3290/j.cjdr.a44746,2020-06-18
Hospitals,LOCATION_OF,Diagnosis,32548600,10.3290/j.cjdr.a44745,2020-06-18
Mucous Membrane,LOCATION_OF,Oral Ulcer,32548599,10.3290/j.cjdr.a44744,2020-06-18
Oral Ulcer,PROCESS_OF,Staff,32548599,10.3290/j.cjdr.a44744,2020-06-18
Disorder of oral mucous membrane,PROCESS_OF,Staff,32548599,10.3290/j.cjdr.a44744,2020-06-18
Malaise,PROCESS_OF,Patients,32548599,10.3290/j.cjdr.a44744,2020-06-18
Disorder of oral mucous membrane,PROCESS_OF,Patients,32548599,10.3290/j.cjdr.a44744,2020-06-18
Communicable Diseases,COEXISTS_WITH,Muscle Cramp,32548576,10.1016/j.fsisyn.2020.05.004,2020-06-18
Comorbidity,PROCESS_OF,Patients,32548551,10.1002/rth2.12362,2020-06-18
Malaise,PROCESS_OF,Patients,32548551,10.1002/rth2.12362,2020-06-18
At risk of disease,PROCESS_OF,Patients,32548551,10.1002/rth2.12362,2020-06-18
"Pneumonia, Bacterial",CAUSES,Cessation of life,32548551,10.1002/rth2.12362,2020-06-18
Organ,LOCATION_OF,Thrombin,32548551,10.1002/rth2.12362,2020-06-18
Protein C (activated),DISRUPTS,Cessation of life,32548551,10.1002/rth2.12362,2020-06-18
Anti-Inflammatory Agents,AFFECTS,Negative Regulation of Apoptosis,32548551,10.1002/rth2.12362,2020-06-18
Malaise,PROCESS_OF,Patients,32548551,10.1002/rth2.12362,2020-06-18
Protein C (activated),AFFECTS,Homeostasis,32548551,10.1002/rth2.12362,2020-06-18
head and neck surgery,TREATS,Patients,32548544,10.1177/2473974X20933566,2020-06-18
Extraction,TREATS,Patients,32548544,10.1177/2473974X20933566,2020-06-18
Telemedicine,COEXISTS_WITH,Extraction,32548544,10.1177/2473974X20933566,2020-06-18
Squalene,ISA,Lipids,32548259,10.1126/sciadv.aaz5466,2020-06-18
Adenosine,TREATS,Acute inflammation,32548259,10.1126/sciadv.aaz5466,2020-06-18
Antioxidants,TREATS,Acute inflammation,32548259,10.1126/sciadv.aaz5466,2020-06-18
Duration,TREATS,Participant,32548209,10.1093/ofid/ofaa199,2020-06-18
Biopsy of nose,ADMINISTERED_TO,Patients,32548209,10.1093/ofid/ofaa199,2020-06-18
Symptoms,PROCESS_OF,Patients,32548209,10.1093/ofid/ofaa199,2020-06-18
Symptoms,PROCESS_OF,Patients,32548209,10.1093/ofid/ofaa199,2020-06-18
Coronavirus Infections,CAUSES,Pneumonia,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Diarrhea,PROCESS_OF,Woman,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Pharyngitis,PROCESS_OF,Woman,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Irregular fever,PROCESS_OF,Woman,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
lobe,LOCATION_OF,Lesion,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Diarrhea,PROCESS_OF,Patients,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Antiviral Agents,TREATS,Patients,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Ritonavir,TREATS,Patients,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
lopinavir,TREATS,Patients,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Detection,PREVENTS,Symptoms,32548166,10.12998/wjcc.v8.i11.2345,2020-06-18
Coronavirus Infections,CAUSES,Pneumonia,32548163,10.12998/wjcc.v8.i11.2325,2020-06-18
Fatigue,ISA,Symptoms,32548163,10.12998/wjcc.v8.i11.2325,2020-06-18
Fever,ISA,Symptoms,32548163,10.12998/wjcc.v8.i11.2325,2020-06-18
Dry cough,ISA,Symptoms,32548163,10.12998/wjcc.v8.i11.2325,2020-06-18
Active Method,TREATS,Young Adult,32548163,10.12998/wjcc.v8.i11.2325,2020-06-18
Fever,ISA,Symptoms,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Fever,PROCESS_OF(SPEC),Patients,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Lung,LOCATION_OF,Symptoms,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Lung,LOCATION_OF(SPEC),Fever,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Symptoms,PROCESS_OF,Patients,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Gastrointestinal symptom,PROCESS_OF,Patients,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Coronavirus Infections,ISA,Disease,32547932,10.5501/wjv.v9.i1.1,2020-06-18
Infection,PROCESS_OF,Child,32547911,10.3205/dgkh000346,2020-06-18
Infection,PROCESS_OF,Adolescent (age group),32547911,10.3205/dgkh000346,2020-06-18
Nose,LOCATION_OF,Protection,32547911,10.3205/dgkh000346,2020-06-18
Infection,PROCESS_OF,Child,32547911,10.3205/dgkh000346,2020-06-18
Infection,PROCESS_OF,Persons,32547911,10.3205/dgkh000346,2020-06-18
Infection,PROCESS_OF,student,32547911,10.3205/dgkh000346,2020-06-18
Physical Examination,ISA,Evaluation,32547911,10.3205/dgkh000346,2020-06-18
"Transcription, Genetic",AFFECTS,Gene Expression,32547891,10.7717/peerj.9369,2020-06-18
RNA Viruses,LOCATION_OF,DNA Sequence,32547891,10.7717/peerj.9369,2020-06-18
IMPACT gene,DISRUPTS,Virus Replication,32547891,10.7717/peerj.9369,2020-06-18
Human gene,INTERACTS_WITH,MicroRNAs,32547891,10.7717/peerj.9369,2020-06-18
MicroRNAs,PART_OF,Homo sapiens,32547891,10.7717/peerj.9369,2020-06-18
"Transcription, Genetic",ISA,Metabolism,32547891,10.7717/peerj.9369,2020-06-18
"Genes, Viral",AFFECTS,Transcription Process,32547891,10.7717/peerj.9369,2020-06-18
Mediator of activation protein,PART_OF,Homo sapiens,32547891,10.7717/peerj.9369,2020-06-18
"Genes, Viral",AFFECTS,Viral life cycle,32547891,10.7717/peerj.9369,2020-06-18
MicroRNAs,INTERACTS_WITH,"Genes, Viral",32547891,10.7717/peerj.9369,2020-06-18
MicroRNAs,PART_OF,Homo sapiens,32547891,10.7717/peerj.9369,2020-06-18
Hypersensitivity,ISA,Disease,32547889,10.7717/peerj.9322,2020-06-18
Hypersensitivity,ISA,Disease,32547889,10.7717/peerj.9322,2020-06-18
Assay,METHOD_OF,Detection,32547882,10.7717/peerj.9278,2020-06-18
Loop-mediated Isothermal Amplification,DIAGNOSES,Hypersensitivity,32547882,10.7717/peerj.9278,2020-06-18
X-Ray Computed Tomography,DIAGNOSES,Asymptomatic,32547838,10.25259/JCIS_58_2020,2020-06-18
Asymptomatic,PROCESS_OF,Patients,32547838,10.25259/JCIS_58_2020,2020-06-18
Chest,LOCATION_OF,X-Ray Computed Tomography,32547838,10.25259/JCIS_58_2020,2020-06-18
Community Pharmacy Services,TREATS,World,32547769,10.1186/s40545-020-00240-4,2020-06-18
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32547717,10.4330/wjc.v12.i5.228,2020-06-18
Angiotensin II receptor antagonist,STIMULATES,ACE2 gene,32547717,10.4330/wjc.v12.i5.228,2020-06-18
"M Protein, multiple myeloma",INTERACTS_WITH,WASF1 gene,32547694,10.1021/acsmedchemlett.0c00233,2020-06-18
Comorbidity,PROCESS_OF,Patients,32547383,10.1159/000508378,2020-06-18
Acute respiratory disease,PROCESS_OF,Patients,32547383,10.1159/000508378,2020-06-18
Hematologic Neoplasms,PROCESS_OF,Patients,32547383,10.1159/000508378,2020-06-18
dasatinib,COMPLICATES,"Respiratory Distress Syndrome, Adult",32547383,10.1159/000508378,2020-06-18
China,ISA,Country,32547222,10.2147/CMAR.S254093,2020-06-18
Disease,DISRUPTS,viral transmission,32547222,10.2147/CMAR.S254093,2020-06-18
Coronavirus Infections,ISA,Disease,32547222,10.2147/CMAR.S254093,2020-06-18
viral transmission,PROCESS_OF,Patients,32547222,10.2147/CMAR.S254093,2020-06-18
Coronavirus Infections,ISA,Disease,32547222,10.2147/CMAR.S254093,2020-06-18
Nasopharyngeal carcinoma,PROCESS_OF,Patients,32547222,10.2147/CMAR.S254093,2020-06-18
Coronavirus Infections,ISA,Disease,32547222,10.2147/CMAR.S254093,2020-06-18
Hypertensive disease,PROCESS_OF,Population Group,32547039,10.2147/NDT.S251173,2020-06-18
Hypertensive disease,PROCESS_OF(SPEC),Old age,32547039,10.2147/NDT.S251173,2020-06-18
Old age,ISA,Population Group,32547039,10.2147/NDT.S251173,2020-06-18
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32547039,10.2147/NDT.S251173,2020-06-18
Storm NOS,COMPLICATES,Disease Progression,32547039,10.2147/NDT.S251173,2020-06-18
lopinavir / Ritonavir,COEXISTS_WITH,Interferons,32547039,10.2147/NDT.S251173,2020-06-18
Asymptomatic,PROCESS_OF,Persons,32546849,10.1038/s12276-020-0452-7,2020-06-18
Real-Time Polymerase Chain Reaction,METHOD_OF,Early Diagnosis,32546849,10.1038/s12276-020-0452-7,2020-06-18
Oligonucleotide Primers,AUGMENTS,Possible,32546849,10.1038/s12276-020-0452-7,2020-06-18
Oligonucleotide Primers,CAUSES,False Positive,32546849,10.1038/s12276-020-0452-7,2020-06-18
Candidate Disease Gene,COEXISTS_WITH,Genome,32546849,10.1038/s12276-020-0452-7,2020-06-18
Polymerase Chain Reaction,USES,Multiplex Polymerase Chain Reaction,32546849,10.1038/s12276-020-0452-7,2020-06-18
Asymptomatic,PROCESS_OF,Persons,32546849,10.1038/s12276-020-0452-7,2020-06-18
Lung,LOCATION_OF,Acute Disease,32546764,10.1038/s41422-020-0354-1,2020-06-18
Pharmaceutical Preparations,NEG_TREATS,Fibrosis,32546764,10.1038/s41422-020-0354-1,2020-06-18
Pharmaceutical Preparations,NEG_TREATS,Lung Injury,32546764,10.1038/s41422-020-0354-1,2020-06-18
Immune Cell,INTERACTS_WITH,Human Embryonic Stem Cells,32546764,10.1038/s41422-020-0354-1,2020-06-18
Fibrosis,PROCESS_OF,House mice,32546764,10.1038/s41422-020-0354-1,2020-06-18
Pneumonia,PROCESS_OF,House mice,32546764,10.1038/s41422-020-0354-1,2020-06-18
pirfenidone,ISA,Pharmaceutical Preparations,32546764,10.1038/s41422-020-0354-1,2020-06-18
pirfenidone,TREATS,Monkeys,32546764,10.1038/s41422-020-0354-1,2020-06-18
pirfenidone,TREATS,Mus,32546764,10.1038/s41422-020-0354-1,2020-06-18
Symptoms,COEXISTS_WITH,Comorbidity,32546678,10.12659/MSM.923985,2020-06-18
Persistent cough,ISA,Symptoms,32546678,10.12659/MSM.923985,2020-06-18
Negative Surgical Margin,PROCESS_OF,Health Personnel,32546658,10.1136/medethics-2020-106398,2020-06-18
Disease,PROCESS_OF,Patients,32546655,10.1212/WNL.0000000000010111,2020-06-18
Glial Fibrillary Acidic Protein,compared_with,NEFL gene,32546655,10.1212/WNL.0000000000010111,2020-06-18
Patients,LOCATION_OF,Glial Fibrillary Acidic Protein,32546655,10.1212/WNL.0000000000010111,2020-06-18
Plasma,LOCATION_OF,Glial Fibrillary Acidic Protein,32546655,10.1212/WNL.0000000000010111,2020-06-18
Glial activation,PROCESS_OF,Patients,32546655,10.1212/WNL.0000000000010111,2020-06-18
Plasma,LOCATION_OF,NEFL gene,32546655,10.1212/WNL.0000000000010111,2020-06-18
Hypoxia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32546655,10.1212/WNL.0000000000010111,2020-06-18
Hypoxia,COEXISTS_WITH,Consequent,32546655,10.1212/WNL.0000000000010111,2020-06-18
Brain,LOCATION_OF,Acute Disease,32546654,10.1212/WNL.0000000000010116,2020-06-18
Respiratory distress,PROCESS_OF,Patients,32546654,10.1212/WNL.0000000000010116,2020-06-18
Brain,LOCATION_OF,Lesion,32546654,10.1212/WNL.0000000000010116,2020-06-18
Health care facility,LOCATION_OF,Radionuclide Imaging,32546654,10.1212/WNL.0000000000010116,2020-06-18
Nasopharyngeal swab (specimen),LOCATION_OF,GSKIP gene,32546654,10.1212/WNL.0000000000010116,2020-06-18
Structural brain abnormalities,PROCESS_OF,Survivors,32546654,10.1212/WNL.0000000000010116,2020-06-18
subcortical,LOCATION_OF,Microbiology procedure,32546654,10.1212/WNL.0000000000010116,2020-06-18
Parenchyma,LOCATION_OF,Congenital anomaly of brain,32546654,10.1212/WNL.0000000000010116,2020-06-18
Decedent,LOCATION_OF,Congenital anomaly of brain,32546654,10.1212/WNL.0000000000010116,2020-06-18
Lesion of brain,PROCESS_OF,Survivors,32546654,10.1212/WNL.0000000000010116,2020-06-18
Brain Stem,LOCATION_OF,Magnetic Resonance Imaging,32546654,10.1212/WNL.0000000000010116,2020-06-18
Confirmation,PROCESS_OF,inpatient,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Comorbidity,PROCESS_OF,Patients,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Therapeutic procedure,COEXISTS_WITH,Hospitalization,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
Therapeutic procedure,COEXISTS_WITH,Hospitalization,32546598,10.1136/annrheumdis-2020-217425,2020-06-18
IMPACT gene,ASSOCIATED_WITH,Diabetes,32546593,10.2337/dc20-1192,2020-06-18
Isolation procedure,AFFECTS,viral transmission,32546589,10.1136/bmjgh-2020-002815,2020-06-18
Symptom mild,PROCESS_OF,Patients,32546589,10.1136/bmjgh-2020-002815,2020-06-18
Learning,PROCESS_OF,Staff,32546589,10.1136/bmjgh-2020-002815,2020-06-18
Hospitals,LOCATION_OF,Administration occupational activities,32546589,10.1136/bmjgh-2020-002815,2020-06-18
Physiologic Organization,PROCESS_OF,Community,32546559,10.1136/bmjspcare-2020-002394,2020-06-18
Palliative Care,COEXISTS_WITH,prescribed,32546559,10.1136/bmjspcare-2020-002394,2020-06-18
Abdomen,LOCATION_OF,Severe pain,32546557,10.1136/bcr-2020-236030,2020-06-18
Diarrhea,PROCESS_OF,Male population group,32546557,10.1136/bcr-2020-236030,2020-06-18
Severe pain,PROCESS_OF,Male population group,32546557,10.1136/bcr-2020-236030,2020-06-18
IMPACT gene,AUGMENTS,Domestic Violence,32546463,10.20529/IJME.2020.056,2020-06-18
France,ISA,Country,32546463,10.20529/IJME.2020.056,2020-06-18
Spain,ISA,Country,32546463,10.20529/IJME.2020.056,2020-06-18
Quarantine,ISA,Isolation procedure,32546461,10.20529/IJME.2020.053,2020-06-18
Therapeutic procedure,TREATS,Disease,32546457,10.20529/IJME.2020.058,2020-06-18
Therapeutic procedure,USES,Basis,32546457,10.20529/IJME.2020.058,2020-06-18
Disease,PROCESS_OF,Patients,32546453,10.20529/IJME.2020.064,2020-06-18
Disease,PROCESS_OF,Patients,32546453,10.20529/IJME.2020.064,2020-06-18
Infected,PROCESS_OF,Patients,32546449,10.1016/j.sapharm.2020.05.033,2020-06-18
Home Childbirth,USES,Pharmaceutical Preparations,32546449,10.1016/j.sapharm.2020.05.033,2020-06-18
Fluoroquinolones,ISA,Microbicides,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Microbicides,ISA,Chemicals,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Pharmaceutical Preparations,INTERACTS_WITH,Chloroquine,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Pharmaceutical Preparations,INTERACTS_WITH,Endopeptidases,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Pharmaceutical Preparations,INTERACTS_WITH,Nelfinavir,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Fluoroquinolones,TREATS,inflammatory response,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Levofloxacin,TREATS,Community acquired pneumonia,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
moxifloxacin,TREATS,Community acquired pneumonia,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Fluoroquinolones,TREATS,Community acquired pneumonia,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Antibiotics,TREATS,Respiratory Tract Infections,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Fluoroquinolones,TREATS,Pneumonia,32546446,10.1016/j.arcmed.2020.06.004,2020-06-18
Toxic Epidermal Necrolysis,PROCESS_OF,Child,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
RNA Viruses,PROCESS_OF,Child,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
RNA Viruses,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Assay,DIAGNOSES,RNA Viruses,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Asymptomatic,PROCESS_OF,Child,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Asymptomatic,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Decreasing,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Decreasing,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Respiratory sample,PART_OF,Tract,32546439,10.1016/j.jiph.2020.05.025,2020-06-18
Comorbidity,PROCESS_OF,Patients,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
Fever,ISA,Symptoms,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
Ceftriaxone,ISA,Antibiotics,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
Chloroquine,TREATS,Patients,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
Hydroxychloroquine,TREATS,Patients,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
calcium low,PROCESS_OF,hospitalized patients,32546437,10.1016/j.jiph.2020.06.002,2020-06-18
Infantile Neuroaxonal Dystrophy,COEXISTS_WITH,Coronavirus Infections,32546387,10.1016/j.jsurg.2020.05.026,2020-06-18
Disease,COEXISTS_WITH,Possible,32546368,10.1016/j.rce.2020.06.001,2020-06-18
Vaginal Discharge,PROCESS_OF,Patients,32546368,10.1016/j.rce.2020.06.001,2020-06-18
Chest CT,ADMINISTERED_TO,Patients,32546365,10.1016/j.crad.2020.06.002,2020-06-18
Physical Examination,USES,Chest CT,32546365,10.1016/j.crad.2020.06.002,2020-06-18
Physical Examination,USES,Chest CT,32546365,10.1016/j.crad.2020.06.002,2020-06-18
Chest CT,DIAGNOSES,Pneumonia,32546365,10.1016/j.crad.2020.06.002,2020-06-18
Chest,LOCATION_OF,CT of abdomen,32546365,10.1016/j.crad.2020.06.002,2020-06-18
Disasters,CAUSES,Influenza,32546234,10.1186/s13052-020-00843-2,2020-06-18
Influenza,PROCESS_OF,Hispanics,32546234,10.1186/s13052-020-00843-2,2020-06-18
Frailty,PROCESS_OF,Patients,32546234,10.1186/s13052-020-00843-2,2020-06-18
Asthma,ISA,Chronic disease,32546234,10.1186/s13052-020-00843-2,2020-06-18
Asthma,PROCESS_OF(SPEC),Child,32546234,10.1186/s13052-020-00843-2,2020-06-18
Asthma,PROCESS_OF(SPEC),Adolescent (age group),32546234,10.1186/s13052-020-00843-2,2020-06-18
Chronic disease,PROCESS_OF,Child,32546234,10.1186/s13052-020-00843-2,2020-06-18
Chronic disease,PROCESS_OF,Adolescent (age group),32546234,10.1186/s13052-020-00843-2,2020-06-18
Arteries,LOCATION_OF,Thrombosis,32546188,10.1186/s13054-020-03062-7,2020-06-18
Blood Circulation,PROCESS_OF,Arteries,32546188,10.1186/s13054-020-03062-7,2020-06-18
Veins,LOCATION_OF,Thrombosis,32546188,10.1186/s13054-020-03062-7,2020-06-18
D-dimer above reference range,PROCESS_OF,Patients,32546188,10.1186/s13054-020-03062-7,2020-06-18
Interleukin-6,INTERACTS_WITH,Leukocytes,32546188,10.1186/s13054-020-03062-7,2020-06-18
Interleukin 2 Receptor,INTERACTS_WITH,Leukocytes,32546188,10.1186/s13054-020-03062-7,2020-06-18
Tumor Necrosis Factors,INTERACTS_WITH,Leukocytes,32546188,10.1186/s13054-020-03062-7,2020-06-18
endothelial dysfunction,COEXISTS_WITH,Single organ dysfunction,32546188,10.1186/s13054-020-03062-7,2020-06-18
endothelial dysfunction,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32546188,10.1186/s13054-020-03062-7,2020-06-18
endothelial dysfunction,PROCESS_OF,Patients,32546188,10.1186/s13054-020-03062-7,2020-06-18
Recombinant Erythropoietin,PART_OF,Homo sapiens,32546125,10.1186/s10020-020-00186-y,2020-06-18
,AFFECTS,Respiration,32546125,10.1186/s10020-020-00186-y,2020-06-18
Inflammasomes,CAUSES,Inflammation,32546125,10.1186/s10020-020-00186-y,2020-06-18
Challenge,COEXISTS_WITH,Reparative closure,32546120,10.1177/1942602X20935612,2020-06-18
Vaccines,TREATS,Coronavirus Infections,32546120,10.1177/1942602X20935612,2020-06-18
angiotensin converting enzyme 2,ISA,Pharmaceutical Preparations,32546047,10.1080/19420862.2020.1782600,2020-06-18
angiotensin converting enzyme 2,ISA,Pharmaceutical Preparations,32546047,10.1080/19420862.2020.1782600,2020-06-18
Syndrome,CAUSES,Coronavirus Infections,32546018,10.1080/03602532.2020.1770782,2020-06-18
Human coronavirus,PROCESS_OF,Homo sapiens,32546018,10.1080/03602532.2020.1770782,2020-06-18
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32546018,10.1080/03602532.2020.1770782,2020-06-18
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32546018,10.1080/03602532.2020.1770782,2020-06-18
Kidney Failure,ISA,Symptoms,32546018,10.1080/03602532.2020.1770782,2020-06-18
Septic Shock,ISA,Symptoms,32546018,10.1080/03602532.2020.1770782,2020-06-18
hydroquinone,CAUSES,Apoptosis,32546018,10.1080/03602532.2020.1770782,2020-06-18
Azithromycin,CAUSES,Apoptosis,32546018,10.1080/03602532.2020.1770782,2020-06-18
Nepal,ISA,Country,32545991,10.1177/1010539520932709,2020-06-18
Italy,ISA,Country,32545827,10.3390/ijerph17124233,2020-06-18
Coronavirus Infections,ISA,Disease,32545827,10.3390/ijerph17124233,2020-06-18
"Mortality, Premature",PROCESS_OF,Population Group,32545827,10.3390/ijerph17124233,2020-06-18
Metric,TREATS,Does steer,32545827,10.3390/ijerph17124233,2020-06-18
Pervasive Development Disorder,PROCESS_OF,Child,32545809,10.3390/jcm9061850,2020-06-18
Pervasive Development Disorder,PROCESS_OF,Child,32545809,10.3390/jcm9061850,2020-06-18
Social Skills,ISA,Communication,32545809,10.3390/jcm9061850,2020-06-18
Patients,LOCATION_OF,Serum,32545799,10.3390/v12060642,2020-06-18
Infected,PROCESS_OF,Patients,32545799,10.3390/v12060642,2020-06-18
research,USES,Drug Repositioning,32545714,10.3390/cells9061461,2020-06-18
Biological Processes,AFFECTS,Organism,32545714,10.3390/cells9061461,2020-06-18
Enzymes,AFFECTS,Anabolism,32545714,10.3390/cells9061461,2020-06-18
Attention,PROCESS_OF,Community,32545647,10.3390/healthcare8020168,2020-06-18
Social stigmata,COEXISTS_WITH,Disease,32545647,10.3390/healthcare8020168,2020-06-18
Coronavirus Infections,ISA,Disease,32545630,10.3390/medicina56060294,2020-06-18
Tooth Diseases,AFFECTS,Severe (severity modifier),32545630,10.3390/medicina56060294,2020-06-18
Crisis,PROCESS_OF,Persons,32545630,10.3390/medicina56060294,2020-06-18
Care provision regimes,METHOD_OF,Health Care,32545630,10.3390/medicina56060294,2020-06-18
Learning Disabilities,PROCESS_OF,Persons,32545630,10.3390/medicina56060294,2020-06-18
Learning Disabilities,PROCESS_OF,Persons,32545630,10.3390/medicina56060294,2020-06-18
risk factors,PROCESS_OF,Cohort,32545566,10.3390/jcm9061835,2020-06-18
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Cohort,32545566,10.3390/jcm9061835,2020-06-18
Coronary Arteriosclerosis,PROCESS_OF,Recipient,32545566,10.3390/jcm9061835,2020-06-18
Finding of body mass index,PROCESS_OF,Recipient,32545566,10.3390/jcm9061835,2020-06-18
hypertensive nephropathy,PROCESS_OF,Recipient,32545566,10.3390/jcm9061835,2020-06-18
Success,ISA,Activities,32545556,10.3390/medicina56060289,2020-06-18
Genes,AFFECTS,Immunity,32545518,10.3390/antiox9060518,2020-06-18
TRANSCRIPTION FACTOR,AFFECTS,Equilibrium,32545518,10.3390/antiox9060518,2020-06-18
GA-Binding Protein Transcription Factor,AFFECTS(SPEC),Equilibrium,32545518,10.3390/antiox9060518,2020-06-18
GA-Binding Protein Transcription Factor,ISA,TRANSCRIPTION FACTOR,32545518,10.3390/antiox9060518,2020-06-18
Disease,AFFECTS,Old age,32545518,10.3390/antiox9060518,2020-06-18
Oxidative Stress,AFFECTS,Disease,32545518,10.3390/antiox9060518,2020-06-18
Italy,ISA,European country,32545441,10.3390/ijerph17124182,2020-06-18
Coronavirus Infections,ISA,Disease,32545441,10.3390/ijerph17124182,2020-06-18
Basal cell carcinoma,ISA,Malignant neoplasm of skin,32545409,10.3390/cancers12061543,2020-06-18
Merkel cell carcinoma,ISA,Malignant neoplasm of skin,32545409,10.3390/cancers12061543,2020-06-18
melanoma,ISA,Malignant neoplasm of skin,32545409,10.3390/cancers12061543,2020-06-18
Mucous Membrane,LOCATION_OF,Squamous cell carcinoma,32545409,10.3390/cancers12061543,2020-06-18
Head and neck structure,LOCATION_OF,terminal cancer,32545409,10.3390/cancers12061543,2020-06-18
Squamous cell carcinoma of skin,ISA,Malignant neoplasm of skin,32545409,10.3390/cancers12061543,2020-06-18
Squamous Epithelial Cells,LOCATION_OF,Head and Neck Carcinoma,32545409,10.3390/cancers12061543,2020-06-18
Comorbidity,COEXISTS_WITH,Disease,32545378,10.3390/ijerph17114176,2020-06-18
Interleukin-1,AUGMENTS(SPEC),Maternal-Fetal Infection Transmission,32545268,10.3390/molecules25112707,2020-06-18
Interleukin-1,ISA,cytokine,32545268,10.3390/molecules25112707,2020-06-18
cytokine,AUGMENTS,Maternal-Fetal Infection Transmission,32545268,10.3390/molecules25112707,2020-06-18
Disease,AFFECTS,Severe (severity modifier),32545264,10.3390/jcm9061825,2020-06-18
Health-related behavior,PROCESS_OF,"Students, Medical",32545240,10.3390/ijerph17114164,2020-06-18
Universities,LOCATION_OF,Cross-Sectional Studies,32545240,10.3390/ijerph17114164,2020-06-18
Anatomic Node,PART_OF,Neighbor,32545224,10.3390/diagnostics10060396,2020-06-18
Photochemotherapy,USES,Antibiotics,32545171,10.3390/antibiotics9060320,2020-06-18
Protoporphyrin IX,PREVENTS,Infection,32545171,10.3390/antibiotics9060320,2020-06-18
Pneumonia,CAUSES,Pregnancy,32544963,10.1055/s-0040-1713664,2020-06-17
Respiratory Failure,CAUSES,Pregnancy,32544963,10.1055/s-0040-1713664,2020-06-17
Mechanical ventilation,TREATS,Patients,32544963,10.1055/s-0040-1713664,2020-06-17
Experience,PROCESS_OF,Pregnant Women,32544963,10.1055/s-0040-1713664,2020-06-17
Pneumonia,PROCESS_OF,Pregnant Women,32544963,10.1055/s-0040-1713664,2020-06-17
Respiratory Failure,PROCESS_OF,Pregnant Women,32544963,10.1055/s-0040-1713664,2020-06-17
Mechanical ventilation,TREATS,Pregnant Women,32544963,10.1055/s-0040-1713664,2020-06-17
Coronavirus Infections,PROCESS_OF,Health Personnel,32544961,10.1055/s-0040-1713647,2020-06-17
Screening procedure,PREVENTS,disease transmission,32544961,10.1055/s-0040-1713647,2020-06-17
Vaccines,STIMULATES,"Antibodies, Neutralizing",32544911,10.1159/000509368,2020-06-17
Vaccines,CAUSES,Eosinophilic disorder,32544911,10.1159/000509368,2020-06-17
Obesity,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Anoxia,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Inflammation,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Obesity,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Obesity,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Coronavirus Infections,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Interleukin-6,ISA,cytokine,32544885,10.7570/jomes20056,2020-06-17
Critical Illness,PREDISPOSES,Complication,32544885,10.7570/jomes20056,2020-06-17
risk factors,PREDISPOSES,Complication,32544885,10.7570/jomes20056,2020-06-17
Pharmaceutical Preparations,TREATS,Persons,32544885,10.7570/jomes20056,2020-06-17
Pharmaceutical Preparations,TREATS(INFER),Obesity,32544885,10.7570/jomes20056,2020-06-17
Obesity,PROCESS_OF,Persons,32544885,10.7570/jomes20056,2020-06-17
Malignant neoplasm of breast,PROCESS_OF,Patients,32544879,10.1530/ERC-20-0157,2020-06-17
"CD69 protein, human",COEXISTS_WITH,GSKIP gene,32544867,10.1016/j.intimp.2020.106688,2020-06-17
Conventional Treatment,ADMINISTERED_TO,Patients,32544867,10.1016/j.intimp.2020.106688,2020-06-17
Fever,PROCESS_OF,Patients,32544867,10.1016/j.intimp.2020.106688,2020-06-17
Negative,PROCESS_OF,Patients,32544861,10.1016/j.jcv.2020.104502,2020-06-17
Pharmacotherapy,TREATS,Cancer Patient,32544802,10.1016/j.critrevonc.2020.102991,2020-06-17
Immunotherapy,TREATS,Cancer Patient,32544802,10.1016/j.critrevonc.2020.102991,2020-06-17
Targeted Therapy,TREATS,Cancer Patient,32544802,10.1016/j.critrevonc.2020.102991,2020-06-17
Host (organism),ASSOCIATED_WITH,Disease,32544799,10.1016/j.ejca.2020.05.026,2020-06-17
Middle East Respiratory Syndrome,ISA,Communicable Diseases,32544735,10.1016/j.scitotenv.2020.140112,2020-06-17
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32544725,10.1016/j.envres.2020.109808,2020-06-17
Infected,PROCESS_OF,Patients,32544725,10.1016/j.envres.2020.109808,2020-06-17
Thromboembolism,PREDISPOSES,Thrombophilia,32544670,10.1016/j.ijid.2020.06.039,2020-06-17
Thromboembolism,PROCESS_OF,Patients,32544670,10.1016/j.ijid.2020.06.039,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32544668,10.1016/j.ijid.2020.06.031,2020-06-17
Academic Medical Centers,LOCATION_OF,Services,32544648,10.1016/j.jpainsymman.2020.06.009,2020-06-17
intensive care unit,ISA,Hospitals,32544647,10.1016/j.jpainsymman.2020.06.008,2020-06-17
Telemedicine,METHOD_OF,Consultation,32544647,10.1016/j.jpainsymman.2020.06.008,2020-06-17
Electrocardiogram,PROCESS_OF,Patients,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Electrocardiogram,PROCESS_OF,Patients,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Hypertensive disease,PROCESS_OF,Patients,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Atrial Premature Complexes,ISA,Disease,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Right bundle branch block,ISA,Disease,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Electrocardiogram finding,PROCESS_OF,Patients,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
Sinistrocardia,ISA,Disease,32544622,10.1016/j.cardfail.2020.06.005,2020-06-17
receptor,PART_OF,Exosomes,32544615,10.1016/j.meegid.2020.104422,2020-06-17
Virus Internalization,AFFECTS,Virus,32544615,10.1016/j.meegid.2020.104422,2020-06-17
Severe viral infections,PROCESS_OF,Patients,32544615,10.1016/j.meegid.2020.104422,2020-06-17
Vaccines,TREATS,Virus Diseases,32544615,10.1016/j.meegid.2020.104422,2020-06-17
Exosomes,LOCATION_OF,Origin of Life,32544615,10.1016/j.meegid.2020.104422,2020-06-17
Symptom severe,PROCESS_OF,Adult,32544611,10.1016/j.clim.2020.108510,2020-06-17
Immunity,PROCESS_OF,Child,32544611,10.1016/j.clim.2020.108510,2020-06-17
conjunctiva,LOCATION_OF,ACE2 gene,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
conjunctiva,LOCATION_OF,ACE2 gene,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Cornea,LOCATION_OF,ACE2 gene,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Endopeptidases,AUGMENTS,Virus Internalization,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
TMPRSS2 gene,INTERACTS_WITH,Viral Proteins,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Epithelium,LOCATION_OF,ACE2 gene,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Epithelium of conjunctiva,LOCATION_OF,ACE2 gene,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Epithelium,PART_OF,Cornea,32544566,10.1016/j.jtos.2020.06.007,2020-06-17
Storm NOS,PROCESS_OF,Patients,32544563,10.1016/j.cyto.2020.155151,2020-06-17
angiotensin converting enzyme 2,DISRUPTS,Macrophage Activation Syndrome,32544563,10.1016/j.cyto.2020.155151,2020-06-17
Therapeutic procedure,TREATS,Patients,32544543,10.1016/j.ctrv.2020.102047,2020-06-17
Virus,PROCESS_OF,Pholidota,32544437,10.1016/j.tim.2020.04.001,2020-06-17
diabetic,PROCESS_OF,Persons,32544373,10.1080/17843286.2020.1780390,2020-06-17
diabetic,PROCESS_OF,Persons,32544373,10.1080/17843286.2020.1780390,2020-06-17
Assay,MEASURES,,32544372,10.1080/19420862.2020.1778435,2020-06-17
Pharmaceutical Preparations,TREATS,HIV,32544304,10.1111/hiv.12913,2020-06-17
Hematologic Neoplasms,PROCESS_OF,Patients,32544294,10.1111/ejh.13469,2020-06-17
Hematologic Neoplasms,PROCESS_OF,Social Networks,32544294,10.1111/ejh.13469,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32544294,10.1111/ejh.13469,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Social Networks,32544294,10.1111/ejh.13469,2020-06-17
Hospitals,LOCATION_OF,Diagnosis,32544294,10.1111/ejh.13469,2020-06-17
Hematologic Neoplasms,PROCESS_OF,Patients,32544294,10.1111/ejh.13469,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32544294,10.1111/ejh.13469,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32544294,10.1111/ejh.13469,2020-06-17
Coughing,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Fever,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Negative,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Infection status,PROCESS_OF,Outpatients,32544281,10.1002/jmv.26175,2020-06-17
Fever,COEXISTS_WITH(SPEC),patient condition,32544281,10.1002/jmv.26175,2020-06-17
Fever,ISA,Symptoms,32544281,10.1002/jmv.26175,2020-06-17
Symptoms,COEXISTS_WITH,patient condition,32544281,10.1002/jmv.26175,2020-06-17
Negative,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Negative,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Europe,ISA,Geographic Locations,32544281,10.1002/jmv.26175,2020-06-17
United States,ISA,Geographic Locations,32544281,10.1002/jmv.26175,2020-06-17
Negative,PROCESS_OF,Patients,32544281,10.1002/jmv.26175,2020-06-17
Communicable Diseases,PROCESS_OF,Clinician,32544242,10.1093/cid/ciaa758,2020-06-17
Microbicides,TREATS,Patients,32544232,10.1093/cid/ciaa773,2020-06-17
Pregnancy Outcome,COEXISTS_WITH,Female infertility,32544225,10.1093/humrep/deaa137,2020-06-17
Assisted Reproductive Technologies,TREATS,Female infertility,32544225,10.1093/humrep/deaa137,2020-06-17
Diminished ovarian reserve,PROCESS_OF,Woman,32544225,10.1093/humrep/deaa137,2020-06-17
Infertility,PROCESS_OF,Patients,32544225,10.1093/humrep/deaa137,2020-06-17
Oocyte Retrieval,TREATS,Diminished ovarian reserve,32544225,10.1093/humrep/deaa137,2020-06-17
Oocyte Retrieval,NEG_TREATS,assessment.initial,32544225,10.1093/humrep/deaa137,2020-06-17
Diminished ovarian reserve,PROCESS_OF,Patients,32544225,10.1093/humrep/deaa137,2020-06-17
Pregnancy Outcome,PROCESS_OF,Patients,32544225,10.1093/humrep/deaa137,2020-06-17
Assisted Reproductive Technologies,TREATS,Pregnancy Outcome,32544225,10.1093/humrep/deaa137,2020-06-17
Diminished ovarian reserve,NEG_AFFECTS,Pregnancy Outcome,32544225,10.1093/humrep/deaa137,2020-06-17
Diminished ovarian reserve,PROCESS_OF,Patients,32544225,10.1093/humrep/deaa137,2020-06-17
Chronic disease,PROCESS_OF,Elderly (population group),32544216,10.1093/gerona/glaa149,2020-06-17
Disease,PROCESS_OF,Elderly (population group),32544216,10.1093/gerona/glaa149,2020-06-17
Complication,PROCESS_OF,Homo sapiens,32544216,10.1093/gerona/glaa149,2020-06-17
Disease,PROCESS_OF,Homo sapiens,32544216,10.1093/gerona/glaa149,2020-06-17
Aging,PROCESS_OF,Elderly (population group),32544216,10.1093/gerona/glaa149,2020-06-17
Hospitals,LOCATION_OF,case series,32544155,10.1371/journal.pmed.1003130,2020-06-17
Coinfection,PROCESS_OF,Patients,32544155,10.1371/journal.pmed.1003130,2020-06-17
Comorbidity,PROCESS_OF,Patients,32544155,10.1371/journal.pmed.1003130,2020-06-17
Fever,ISA,Symptoms,32544155,10.1371/journal.pmed.1003130,2020-06-17
C-reactive protein,INHIBITS,Prealbumin,32544155,10.1371/journal.pmed.1003130,2020-06-17
Patients,LOCATION_OF,SAA1 gene,32544155,10.1371/journal.pmed.1003130,2020-06-17
SAA1 gene,COEXISTS_WITH,C-reactive protein,32544155,10.1371/journal.pmed.1003130,2020-06-17
Patients,LOCATION_OF,3-Hydroxybutyrate Dehydrogenase,32544155,10.1371/journal.pmed.1003130,2020-06-17
Radionuclide Imaging,DIAGNOSES,Cutaneous plaque,32544155,10.1371/journal.pmed.1003130,2020-06-17
Cutaneous plaque,PROCESS_OF,Patients,32544155,10.1371/journal.pmed.1003130,2020-06-17
Lobule,LOCATION_OF,Cutaneous plaque,32544155,10.1371/journal.pmed.1003130,2020-06-17
Ground Glass Opacity,PROCESS_OF,Adult,32544155,10.1371/journal.pmed.1003130,2020-06-17
Lobule,LOCATION_OF,Lesion,32544155,10.1371/journal.pmed.1003130,2020-06-17
Lesion,PROCESS_OF,Patients,32544155,10.1371/journal.pmed.1003130,2020-06-17
Lobule,LOCATION_OF,Lesion,32544155,10.1371/journal.pmed.1003130,2020-06-17
Insight,PROCESS_OF,Patients,32544155,10.1371/journal.pmed.1003130,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32544146,10.1097/AOG.0000000000004011,2020-06-17
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Woman,32544146,10.1097/AOG.0000000000004011,2020-06-17
Pandemics,ISA,Process,32544145,10.1097/AOG.0000000000004024,2020-06-17
Maternal Death,AFFECTS,Cessation of life,32544145,10.1097/AOG.0000000000004024,2020-06-17
Telemedicine,TREATS,Vulnerable Populations,32544144,10.1097/AOG.0000000000004026,2020-06-17
Masks,USES,Textiles,32544123,10.2106/JBJS.20.00881,2020-06-17
"Education, Medical",ISA,Health Care,32544103,10.1097/ACM.0000000000003547,2020-06-17
High Level,PROCESS_OF,Patients,32544102,10.1097/ACM.0000000000003548,2020-06-17
Immunologic Tests,ISA,Laboratory Procedures,32544099,10.1172/jci.insight.139024,2020-06-17
Survivors,ISA,Patients,32544099,10.1172/jci.insight.139024,2020-06-17
Comorbidity,PROCESS_OF,Patients,32544099,10.1172/jci.insight.139024,2020-06-17
Coronavirus Infections,ISA,Disease,32544072,10.2196/20586,2020-06-17
"CD69 protein, human",COEXISTS_WITH,GSKIP gene,32544072,10.2196/20586,2020-06-17
Disease Outbreaks,CAUSES,Disease,32544071,10.2196/19636,2020-06-17
Disease Outbreaks,CAUSES(SPEC),Coronavirus Infections,32544071,10.2196/19636,2020-06-17
Coronavirus Infections,ISA,Disease,32544071,10.2196/19636,2020-06-17
Coronavirus Infections,ISA,Disease,32544071,10.2196/19636,2020-06-17
Coronavirus Infections,ISA,Disease,32544071,10.2196/19636,2020-06-17
Chest,LOCATION_OF,Distress,32544071,10.2196/19636,2020-06-17
Infection status,COEXISTS_WITH,Fatigue,32544071,10.2196/19636,2020-06-17
Cardiac complication,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Cohort,LOCATION_OF,Sputum,32544071,10.2196/19636,2020-06-17
Arthralgia,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Chest,LOCATION_OF,Distress,32544071,10.2196/19636,2020-06-17
Dry cough,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Coronavirus Infections,ISA,Disease,32544071,10.2196/19636,2020-06-17
Arthralgia,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Chest,LOCATION_OF,Distress,32544071,10.2196/19636,2020-06-17
Dry cough,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Cardiovascular Diseases,PROCESS_OF,Patients,32544071,10.2196/19636,2020-06-17
Cardiovascular Diseases,PROCESS_OF,Older people,32544071,10.2196/19636,2020-06-17
Patients,LOCATION_OF,Sputum,32544071,10.2196/19636,2020-06-17
Older people,LOCATION_OF,Sputum,32544071,10.2196/19636,2020-06-17
Coronavirus Infections,ISA,Disease,32544053,10.3201/eid2609.201840,2020-06-17
Hospitals,LOCATION_OF,Retrospective Studies,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Infarction,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Infarction,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Thrombosis of cerebral veins,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Thrombosis of cerebral veins,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Lesion,32544034,10.1148/radiol.2020202222,2020-06-17
MRI brain procedure,DIAGNOSES,Lesion,32544034,10.1148/radiol.2020202222,2020-06-17
Temporal Lobe,LOCATION_OF,Magnetic Resonance Imaging,32544034,10.1148/radiol.2020202222,2020-06-17
Lesion,PROCESS_OF,Patients,32544034,10.1148/radiol.2020202222,2020-06-17
Lesion,PROCESS_OF,Patients,32544034,10.1148/radiol.2020202222,2020-06-17
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32544034,10.1148/radiol.2020202222,2020-06-17
Lesion,PROCESS_OF,Patients,32544034,10.1148/radiol.2020202222,2020-06-17
Cerebral Hemorrhage,ISA,Lesion,32544034,10.1148/radiol.2020202222,2020-06-17
Cerebral Hemorrhage,PROCESS_OF(SPEC),Patients,32544034,10.1148/radiol.2020202222,2020-06-17
Magnetic resonance imaging of brain abnormal (finding),COEXISTS_WITH,Infarction,32544034,10.1148/radiol.2020202222,2020-06-17
Coronavirus Infections,CAUSES,Respiration Disorders,32544024,10.1080/07391102.2020.1776158,2020-06-17
Coronavirus Infections,ISA,Disease,32543923,10.1377/hlthaff.2020.00818,2020-06-17
Coronavirus Infections,ISA,Disease,32543923,10.1377/hlthaff.2020.00818,2020-06-17
Oropharyngeal,LOCATION_OF,Nose,32543913,10.1164/rccm.202004-1263PP,2020-06-17
consideration,PROCESS_OF,Cancer Patient,32543802,10.1213/ANE.0000000000004884,2020-06-17
Disease,COEXISTS_WITH,Variable clinical severity,32543757,10.1111/dth.13849,2020-06-17
Coronavirus Infections,COEXISTS_WITH(SPEC),Variable clinical severity,32543757,10.1111/dth.13849,2020-06-17
Coronavirus Infections,ISA,Disease,32543757,10.1111/dth.13849,2020-06-17
Coronavirus Infections,ISA,Disease,32543757,10.1111/dth.13849,2020-06-17
dermatological finding,PROCESS_OF,Patients,32543757,10.1111/dth.13849,2020-06-17
dermatological finding,PROCESS_OF,Population Group,32543757,10.1111/dth.13849,2020-06-17
Physical Examination,TREATS,Patients,32543757,10.1111/dth.13849,2020-06-17
Pruritus,PROCESS_OF,Patients,32543757,10.1111/dth.13849,2020-06-17
Urticaria,ISA,Lesion,32543757,10.1111/dth.13849,2020-06-17
Immunologic Factors,ASSOCIATED_WITH,Pneumonia,32543756,10.1002/ppul.24907,2020-06-17
Pneumonia,PROCESS_OF,Child,32543756,10.1002/ppul.24907,2020-06-17
"Hospitals, Pediatric",LOCATION_OF,Study,32543756,10.1002/ppul.24907,2020-06-17
Pneumonia,PROCESS_OF,Child,32543756,10.1002/ppul.24907,2020-06-17
Patients,LOCATION_OF,cytokine,32543756,10.1002/ppul.24907,2020-06-17
Pneumonia,PROCESS_OF,Patients,32543756,10.1002/ppul.24907,2020-06-17
Disease,PROCESS_OF,Patients,32543753,10.1002/jmv.26187,2020-06-17
Patients,LOCATION_OF,CD40LG wt Allele,32543753,10.1002/jmv.26187,2020-06-17
Coronavirus Infections,ISA,Disease,32543753,10.1002/jmv.26187,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32543753,10.1002/jmv.26187,2020-06-17
Coronavirus Infections,ISA,Disease,32543753,10.1002/jmv.26187,2020-06-17
Cardiac Arrhythmia,PROCESS_OF,Patients,32543745,10.1111/pace.13987,2020-06-17
Cardiac Arrhythmia,PROCESS_OF,Patients,32543745,10.1111/pace.13987,2020-06-17
Disease,PROCESS_OF,Patients,32543740,10.1002/jmv.26181,2020-06-17
Prognosis bad,PROCESS_OF,Patients,32543740,10.1002/jmv.26181,2020-06-17
Adult,ISA,Population Group,32543722,10.1002/jmv.26182,2020-06-17
Coronavirus Infections,PROCESS_OF,Population Group,32543722,10.1002/jmv.26182,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Adult,32543722,10.1002/jmv.26182,2020-06-17
Real-Time Polymerase Chain Reaction,MEASURES,Severe Acute Respiratory Syndrome,32543722,10.1002/jmv.26182,2020-06-17
Negative,PROCESS_OF,Participant,32543722,10.1002/jmv.26182,2020-06-17
Medical History,NEG_PROCESS_OF,Participant,32543722,10.1002/jmv.26182,2020-06-17
infection risk factor,NEG_PROCESS_OF,Participant,32543722,10.1002/jmv.26182,2020-06-17
Asymptomatic,PROCESS_OF,Participant,32543722,10.1002/jmv.26182,2020-06-17
Asymptomatic,PROCESS_OF,Population Group,32543722,10.1002/jmv.26182,2020-06-17
Shock,ISA,Disease Progression,32543710,10.1002/jmv.26183,2020-06-17
Comorbidity,PROCESS_OF,Male population group,32543710,10.1002/jmv.26183,2020-06-17
Hypertensive disease,PRECEDES,Diabetes,32543710,10.1002/jmv.26183,2020-06-17
Homo sapiens,LOCATION_OF,"M Protein, multiple myeloma",32543705,10.1002/prot.25967,2020-06-17
"M Protein, multiple myeloma",COEXISTS_WITH,Proteins,32543705,10.1002/prot.25967,2020-06-17
"M Protein, multiple myeloma",PART_OF,SARS coronavirus,32543705,10.1002/prot.25967,2020-06-17
"M Protein, multiple myeloma",PART_OF,SARS coronavirus,32543705,10.1002/prot.25967,2020-06-17
SARS coronavirus,PROCESS_OF,Chiroptera,32543705,10.1002/prot.25967,2020-06-17
Infected,PROCESS_OF,Patients,32543702,10.1001/jamanetworkopen.2020.12270,2020-06-17
Comorbidity,PROCESS_OF,Patients,32543702,10.1001/jamanetworkopen.2020.12270,2020-06-17
Coughing,ISA,Symptoms,32543702,10.1001/jamanetworkopen.2020.12270,2020-06-17
intensive care unit,LOCATION_OF,Administration occupational activities,32543702,10.1001/jamanetworkopen.2020.12270,2020-06-17
Perception,PROCESS_OF,Sponsor (person),32543384,10.1016/j.jss.2020.05.049,2020-06-17
Personal assessment,AFFECTS,Severe (severity modifier),32543384,10.1016/j.jss.2020.05.049,2020-06-17
Sponsor (person),ISA,Persons,32543384,10.1016/j.jss.2020.05.049,2020-06-17
Gland,LOCATION_OF,paired basic amino acid cleaving enzyme,32543348,10.1080/22221751.2020.1781551,2020-06-17
Symptoms,CAUSES,Influenza-like symptoms,32543348,10.1080/22221751.2020.1781551,2020-06-17
Sexual Health,ISA,Reproduction,32543338,10.1080/26410397.2020.1781583,2020-06-17
Generalized rash,COEXISTS_WITH,Chickenpox,32543328,10.1080/09546634.2020.1782823,2020-06-17
"Ganglia, Spinal",LOCATION_OF,Human herpesvirus 3,32543328,10.1080/09546634.2020.1782823,2020-06-17
Coronavirus Infections,ISA,Communicable Diseases,32543298,10.1080/22221751.2020.1782774,2020-06-17
SARS coronavirus,CAUSES,Communicable Diseases,32543298,10.1080/22221751.2020.1782774,2020-06-17
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32543298,10.1080/22221751.2020.1782774,2020-06-17
Respiratory sample,PART_OF,Tract,32543298,10.1080/22221751.2020.1782774,2020-06-17
Detection,USES,Genes,32543298,10.1080/22221751.2020.1782774,2020-06-17
Detection,USES,Genes,32543298,10.1080/22221751.2020.1782774,2020-06-17
Respiratory System,ASSOCIATED_WITH,Hematogenous spread,32543262,10.1080/09273948.2020.1772313,2020-06-17
Nasolacrimal,LOCATION_OF,Virus,32543262,10.1080/09273948.2020.1772313,2020-06-17
Eye,LOCATION_OF,Virus,32543262,10.1080/09273948.2020.1772313,2020-06-17
Eye,LOCATION_OF,Local disease,32543262,10.1080/09273948.2020.1772313,2020-06-17
Virus,CAUSES,Local disease,32543262,10.1080/09273948.2020.1772313,2020-06-17
Tropism,PROCESS_OF,Eye,32543262,10.1080/09273948.2020.1772313,2020-06-17
Coronavirus Infections,ISA,Communicable Diseases,32543256,10.1080/09603123.2020.1778646,2020-06-17
Lincocin,TREATS,Pneumonia,32543159,10.7748/nm.2020.e1936,2020-06-17
Hospitals,LOCATION_OF,Early Diagnosis,32543119,10.1111/jth.14960,2020-06-17
Pneumonia,PROCESS_OF,Patients,32543119,10.1111/jth.14960,2020-06-17
Lesion,PROCESS_OF,Patients,32543119,10.1111/jth.14960,2020-06-17
Early Diagnosis,USES,Basis,32543119,10.1111/jth.14960,2020-06-17
Bilateral Disease,PROCESS_OF,Patients,32543119,10.1111/jth.14960,2020-06-17
Disease,PROCESS_OF,Patients,32543119,10.1111/jth.14960,2020-06-17
rapid diagnosis,ISA,diagnostic procedure,32543119,10.1111/jth.14960,2020-06-17
Parenchyma,PART_OF,Lung,32543113,10.1002/oby.22935,2020-06-17
Disease,PROCESS_OF,Patients,32543113,10.1002/oby.22935,2020-06-17
Respiratory Failure,PROCESS_OF,Patients,32543113,10.1002/oby.22935,2020-06-17
Genus: Coronavirus,CAUSES,Disease,32542934,10.1111/acem.14048,2020-06-17
Coronavirus Infections,ISA,Disease,32542914,10.1111/petr.13780,2020-06-17
Coronavirus Infections,ISA,Disease,32542914,10.1111/petr.13780,2020-06-17
Asymptomatic,PROCESS_OF,Patients,32542914,10.1111/petr.13780,2020-06-17
Coronavirus Infections,ISA,Disease,32542914,10.1111/petr.13780,2020-06-17
Disease,COEXISTS_WITH,Coronavirus Infections,32542881,10.1002/lt.25821,2020-06-17
Experience,PROCESS_OF,Adult,32542881,10.1002/lt.25821,2020-06-17
Severe disorder,PROCESS_OF,Patients,32542796,10.1111/eje.12555,2020-06-17
Universities,LOCATION_OF,"Education, Dental",32542785,10.1002/phar.2438,2020-06-17
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32542750,10.1002/jmv.26180,2020-06-17
Thromboembolism,PROCESS_OF,Patients,32542750,10.1002/jmv.26180,2020-06-17
Viral Shedding,PROCESS_OF,Patients,32542743,10.1111/his.14180,2020-06-17
Infected,PROCESS_OF,member,32542743,10.1111/his.14180,2020-06-17
Infection,PROCESS_OF,Family,32542743,10.1111/his.14180,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Family,32542743,10.1111/his.14180,2020-06-17
Lung finding,PROCESS_OF,Community,32542735,10.1002/jcp.29868,2020-06-17
Lung finding,PROCESS_OF,inpatient,32542735,10.1002/jcp.29868,2020-06-17
Postmortem Diagnosis,PROCESS_OF,Community,32542735,10.1002/jcp.29868,2020-06-17
Asymptomatic,PROCESS_OF,Community,32542735,10.1002/jcp.29868,2020-06-17
Fibrin blood clot,NEG_COEXISTS_WITH,Hyaline membrane,32542735,10.1002/jcp.29868,2020-06-17
Capillaritis,COEXISTS_WITH,patient condition,32542735,10.1002/jcp.29868,2020-06-17
Hemorrhage,COEXISTS_WITH,patient condition,32542735,10.1002/jcp.29868,2020-06-17
Lung,LOCATION_OF,Severe disorder,32542735,10.1002/jcp.29868,2020-06-17
Fibrinoid necrosis,COEXISTS_WITH,patient condition,32542735,10.1002/jcp.29868,2020-06-17
Disease,PROCESS_OF,Persons,32542723,10.1111/vox.12974,2020-06-17
Infected,PROCESS_OF,Persons,32542723,10.1111/vox.12974,2020-06-17
IMPACT gene,AFFECTS,Mental disorders,32542571,10.1007/s10916-020-01596-5,2020-06-17
Malaise,PROCESS_OF,Patients,32542571,10.1007/s10916-020-01596-5,2020-06-17
Distress,PROCESS_OF,Patients,32542571,10.1007/s10916-020-01596-5,2020-06-17
Health Services,TREATS,Patients,32542552,10.1007/s10900-020-00859-z,2020-06-17
Telemedicine,TREATS,Patients,32542552,10.1007/s10900-020-00859-z,2020-06-17
Cessation of life,PROCESS_OF,Patients,32542549,10.1007/s00246-020-02393-0,2020-06-17
Disease,PROCESS_OF,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,TREATS,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,TREATS(INFER),Disease,32542448,10.1007/s11701-020-01099-y,2020-06-17
Coronavirus Infections,ISA,Disease,32542448,10.1007/s11701-020-01099-y,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Critical Illness,PROCESS_OF,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,TREATS,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,TREATS(INFER),Critical Illness,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,TREATS(INFER),Acute hypoxemic respiratory failure,32542448,10.1007/s11701-020-01099-y,2020-06-17
Nasal Cannula,compared_with,Conventional Treatment,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,TREATS,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,TREATS(INFER),Critical Illness,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,TREATS(INFER),Acute hypoxemic respiratory failure,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,USES,Oxygen,32542448,10.1007/s11701-020-01099-y,2020-06-17
Acute hypoxemic respiratory failure,PROCESS_OF,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Respiration,PROCESS_OF,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Respiratory Failure,PROCESS_OF,Patients,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,TREATS,patient condition,32542448,10.1007/s11701-020-01099-y,2020-06-17
Conventional Treatment,USES,Oxygen,32542448,10.1007/s11701-020-01099-y,2020-06-17
Operative Surgical Procedures,ISA,Interventional procedure,32542429,10.1007/s12020-020-02381-7,2020-06-17
Research Personnel,DIAGNOSES,Disease,32542402,10.1093/pubmed/fdaa082,2020-06-17
Pharmaceutical Preparations,COEXISTS_WITH,Genes,32542402,10.1093/pubmed/fdaa082,2020-06-17
Genes,AFFECTS,Renin-angiotensin system,32542402,10.1093/pubmed/fdaa082,2020-06-17
receptor,AUGMENTS,Uptake,32542349,10.1093/tbm/ibaa055,2020-06-17
Host Cell,LOCATION_OF,receptor,32542349,10.1093/tbm/ibaa055,2020-06-17
"Vitronectin, human",PART_OF,Virus,32542349,10.1093/tbm/ibaa055,2020-06-17
angiotensin converting enzyme 2,PREVENTS,Lung Injury,32542349,10.1093/tbm/ibaa055,2020-06-17
Mesenchymal Stromal Cells,PART_OF,bony process,32542349,10.1093/tbm/ibaa055,2020-06-17
Mesenchymal Stromal Cells,PRODUCES,angiotensin converting enzyme 2,32542349,10.1093/tbm/ibaa055,2020-06-17
Pandemics,ISA,Disease Outbreaks,32542337,10.1093/ehjcvp/pvaa064,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Community,32542337,10.1093/ehjcvp/pvaa064,2020-06-17
Receptor Up-Regulation,PROCESS_OF,Patients,32542238,10.4193/Rhin20.199,2020-06-17
scholar,TREATS,Patients,32542238,10.4193/Rhin20.199,2020-06-17
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32542238,10.4193/Rhin20.199,2020-06-17
Angiotensin-Converting Enzyme Inhibitors,compared_with,Angiotensin II receptor antagonist,32542238,10.4193/Rhin20.199,2020-06-17
Angiotensin II receptor antagonist,TREATS,Patients,32542238,10.4193/Rhin20.199,2020-06-17
Patients,ISA,Persons,32542238,10.4193/Rhin20.199,2020-06-17
Antibiotics,TREATS,Respiratory Failure,32542212,10.1002/rth2.12353,2020-06-17
Antiviral Agents,TREATS,Respiratory Failure,32542212,10.1002/rth2.12353,2020-06-17
anti-cytokine therapy,TREATS,Respiratory Failure,32542212,10.1002/rth2.12353,2020-06-17
Thrombolytic Therapy,TREATS,"Respiratory Distress Syndrome, Adult",32542212,10.1002/rth2.12353,2020-06-17
Pulmonary function,PROCESS_OF,Patients,32542212,10.1002/rth2.12353,2020-06-17
Coagulation procedure,AFFECTS,Pulmonary function,32542212,10.1002/rth2.12353,2020-06-17
"Heparin, Low-Molecular-Weight",TREATS,Patients,32542210,10.1002/rth2.12349,2020-06-17
"Heparin, Low-Molecular-Weight",TREATS(INFER),Coronavirus Infections,32542210,10.1002/rth2.12349,2020-06-17
Coronavirus Infections,PROCESS_OF,Patients,32542210,10.1002/rth2.12349,2020-06-17
heparin,TREATS,patient condition,32542210,10.1002/rth2.12349,2020-06-17
Decompensation,PROCESS_OF,Patients,32542208,10.1021/acsomega.0c01554,2020-06-17
Infected,PROCESS_OF,Patients,32542208,10.1021/acsomega.0c01554,2020-06-17
Intervention regimes,PREVENTS,Decompensation,32542208,10.1021/acsomega.0c01554,2020-06-17
Intervention regimes,PREVENTS,compromise,32542208,10.1021/acsomega.0c01554,2020-06-17
compromise,PROCESS_OF,Patients,32542208,10.1021/acsomega.0c01554,2020-06-17
Up-Regulation (Physiology),PROCESS_OF,Patients,32542208,10.1021/acsomega.0c01554,2020-06-17
Factor XI,PREVENTS,Disseminated Intravascular Coagulation,32542208,10.1021/acsomega.0c01554,2020-06-17
Coronavirus Infections,ISA,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Disease,CAUSES,Acute respiratory disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Coronavirus Infections,CAUSES(SPEC),Acute respiratory disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Coronavirus Infections,ISA,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Coronavirus Infections,ISA,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Nucleic Acid Amplification Tests,DIAGNOSES,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Nucleic Acid Amplification Tests,DIAGNOSES(SPEC),Coronavirus Infections,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Coronavirus Infections,ISA,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Blood,LOCATION_OF,Specific antibody,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Membrane,LOCATION_OF,Nucleoproteins,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
SARS coronavirus,NEG_ISA,Virus,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Severe fever with thrombocytopenia syndrome virus,ISA,Virus,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Hospitals,LOCATION_OF,Diagnosis,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Laboratory,LOCATION_OF,Diagnosis,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Coronavirus Infections,ISA,Disease,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
Assay,METHOD_OF,Diagnosis,32542206,10.1016/j.heliyon.2020.e04175,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,CAUSES,medical complication,32542177,10.1016/j.epsc.2020.101512,2020-06-17
psychological distress,PROCESS_OF,Persons,32542177,10.1016/j.epsc.2020.101512,2020-06-17
Mental disorders,PROCESS_OF,Patients,32542177,10.1016/j.epsc.2020.101512,2020-06-17
Mental disorders,PROCESS_OF,Vulnerable Populations,32542177,10.1016/j.epsc.2020.101512,2020-06-17
Intervention regimes,TREATS,Vulnerable Populations,32542177,10.1016/j.epsc.2020.101512,2020-06-17
X-Ray Computed Tomography,DIAGNOSES,Appendicitis,32542159,10.7759/cureus.8104,2020-06-17
Antibiotics,TREATS,Patients,32542159,10.7759/cureus.8104,2020-06-17
Appendicitis,PROCESS_OF,Patients,32542159,10.7759/cureus.8104,2020-06-17
Discharge to home,TREATS,Patients,32542159,10.7759/cureus.8104,2020-06-17
Appendicitis,PROCESS_OF,Patients,32542159,10.7759/cureus.8104,2020-06-17
"Signs and Symptoms, Respiratory",COEXISTS_WITH,Causative_agents,32542131,10.7759/cureus.8076,2020-06-17
"Signs and Symptoms, Respiratory",NEG_PROCESS_OF,Patients,32542131,10.7759/cureus.8076,2020-06-17
Critical Illness,PROCESS_OF,Patients,32542129,10.7759/cureus.8074,2020-06-17
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32542129,10.7759/cureus.8074,2020-06-17
Clinician,TREATS,Patients,32542129,10.7759/cureus.8074,2020-06-17
Troponin,PART_OF,Heart,32542125,10.7759/cureus.8070,2020-06-17
Seizures,CAUSES,exercise induced,32542125,10.7759/cureus.8070,2020-06-17
"Encephalitis, Acute Necrotizing",ISA,Complication,32542123,10.7759/cureus.8066,2020-06-17
Disease,PROCESS_OF,Population Group,32542123,10.7759/cureus.8066,2020-06-17
Reproductive History,PROCESS_OF,Old age,32542123,10.7759/cureus.8066,2020-06-17
Viral Respiratory Tract Infection,COMPLICATES,"Encephalitis, Acute Necrotizing",32542123,10.7759/cureus.8066,2020-06-17
Viral Respiratory Tract Infection,PROCESS_OF,Patients,32542123,10.7759/cureus.8066,2020-06-17
Comorbidity,PROCESS_OF,Woman,32542123,10.7759/cureus.8066,2020-06-17
Cerebral Infarction,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",32542123,10.7759/cureus.8066,2020-06-17
Cerebral Infarction,AFFECTS,Hypertensive disease,32542123,10.7759/cureus.8066,2020-06-17
Cerebral Infarction,AFFECTS,Chronic heart failure,32542123,10.7759/cureus.8066,2020-06-17
Respiratory Tract Infections,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",32542123,10.7759/cureus.8066,2020-06-17
Respiratory Tract Infections,AFFECTS,Hypertensive disease,32542123,10.7759/cureus.8066,2020-06-17
Respiratory Tract Infections,AFFECTS,Chronic heart failure,32542123,10.7759/cureus.8066,2020-06-17
Sample macroscopy,DIAGNOSES,Petechiae,32542123,10.7759/cureus.8066,2020-06-17
Disease,PROCESS_OF,Patients,32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,ISA,Disease,32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32542111,10.1177/2045125320928167,2020-06-17
Medical History,NEG_PROCESS_OF,Middle-aged men,32542111,10.1177/2045125320928167,2020-06-17
atrial fibrillation new onset,OCCURS_IN,Middle-aged men,32542111,10.1177/2045125320928167,2020-06-17
Atrial Fibrillation,PROCESS_OF,Patients,32542111,10.1177/2045125320928167,2020-06-17
Disease,PROCESS_OF,Patients,32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,ISA,Disease,32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,ISA,Disease,32542111,10.1177/2045125320928167,2020-06-17
Heart,LOCATION_OF,Illness (finding),32542111,10.1177/2045125320928167,2020-06-17
Coronavirus Infections,ISA,Disease,32542111,10.1177/2045125320928167,2020-06-17
Heart,LOCATION_OF,Rhythm,32542111,10.1177/2045125320928167,2020-06-17
Clozapine,TREATS,Schizophrenia,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Clozapine,ADMINISTERED_TO,Patients,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Diabetes,PREDISPOSES,Pneumonia,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Lung diseases,PREDISPOSES,Pneumonia,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Obesity,PREDISPOSES,Pneumonia,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Clozapine,CAUSES,Myocarditis,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Clozapine,CAUSES,Neutropenic sepsis,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Clozapine,ADMINISTERED_TO,Patients,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
neutrophil,LOCATION_OF,Clozapine,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Respiratory Tract Infections,PROCESS_OF,Patients,32542103,10.1016/j.radcr.2020.05.034,2020-06-17
Pulmonary artery structure,LOCATION_OF,Clotrimazole,32542102,10.1016/j.radcr.2020.05.039,2020-06-17
Cerebrovascular accident,PROCESS_OF,Woman,32542102,10.1016/j.radcr.2020.05.039,2020-06-17
Nausea,PROCESS_OF,Patients,32542067,10.1016/j.jclepro.2020.122215,2020-06-17
Generalized abdominal pain,PROCESS_OF,Patients,32542067,10.1016/j.jclepro.2020.122215,2020-06-17
Basal segment of lung,LOCATION_OF,Pneumonia,32542067,10.1016/j.jclepro.2020.122215,2020-06-17
Laboratory Procedures,METHOD_OF,Diagnosis,32542067,10.1016/j.jclepro.2020.122215,2020-06-17
Infected,PROCESS_OF,Persons,32542058,10.1016/j.biocon.2020.108650,2020-06-17
"Analysis, Cohort",MEASURES,Range,32541972,10.19723/j.issn.1671-167X.2020.03.004,2020-06-17
patient condition,COEXISTS_WITH,Coronary Arteriosclerosis,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
patient condition,COEXISTS_WITH,Diabetes,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
patient condition,COEXISTS_WITH,Hypertensive disease,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-6,AUGMENTS,Abnormal,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-6,AUGMENTS,myocardial injury,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-6,AUGMENTS,Oxygen saturation below reference range,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-6,AUGMENTS,Lymphocyte count decreased,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-6,compared_with,Interleukin-10,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-10,AUGMENTS,Abnormal,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-10,AUGMENTS,myocardial injury,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-10,AUGMENTS,Oxygen saturation below reference range,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Interleukin-10,AUGMENTS,Lymphocyte count decreased,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
patient condition,COEXISTS_WITH,Coronary Arteriosclerosis,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
patient condition,COEXISTS_WITH,Diabetes,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
patient condition,COEXISTS_WITH,Hypertensive disease,32541971,10.19723/j.issn.1671-167X.2020.03.003,2020-06-17
Medical Staff,TREATS,Patients,32541865,10.1038/s41422-020-0356-z,2020-06-17
Cross Infection,PROCESS_OF,Patients,32541865,10.1038/s41422-020-0356-z,2020-06-17
Disinfection,TREATS,Patients,32541865,10.1038/s41422-020-0356-z,2020-06-17
Medical Devices,TREATS,Patients,32541865,10.1038/s41422-020-0356-z,2020-06-17
SARS coronavirus,CAUSES,Disease,32541844,10.1038/s41390-020-0976-5,2020-06-17
inhibitors,INTERACTS_WITH,"3C-like protease, SARS coronavirus",32541844,10.1038/s41390-020-0976-5,2020-06-17
Asymptomatic,PROCESS_OF,Infant,32541745,10.1038/s41415-020-1708-2,2020-06-17
Consultation,COEXISTS_WITH,Interventional procedure,32541583,10.1213/ANE.0000000000004834,2020-06-17
Epidemic,ISA,Disease Outbreaks,32541496,10.1097/MD.0000000000020613,2020-06-17
Epidemic,ISA,Disease Outbreaks,32541496,10.1097/MD.0000000000020613,2020-06-17
Iran,ISA,Country,32541496,10.1097/MD.0000000000020613,2020-06-17
Coronavirus Infections,ISA,Disease,32541495,10.1097/MD.0000000000020612,2020-06-17
Pneumonia,PROCESS_OF,Patients,32541495,10.1097/MD.0000000000020612,2020-06-17
Coronavirus Infections,ISA,Disease,32541495,10.1097/MD.0000000000020612,2020-06-17
Coronavirus Infections,ISA,Disease,32541493,10.1097/MD.0000000000020603,2020-06-17
Adverse reactions,PROCESS_OF,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Adverse reactions,OCCURS_IN,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Study,MEASURES,Incidence,32541475,10.1097/MD.0000000000020531,2020-06-17
Adverse reactions,PROCESS_OF,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Adverse reactions,PROCESS_OF,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Adverse reactions,PROCESS_OF,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Adverse reactions,PROCESS_OF,Health Personnel,32541475,10.1097/MD.0000000000020531,2020-06-17
Immunosuppressive Agents,TREATS,Recipient,32541352,10.1097/PHM.0000000000001505,2020-06-17
Immunosuppressive Agents,TREATS(INFER),Symptoms,32541352,10.1097/PHM.0000000000001505,2020-06-17
pulmonary artery and pulmonary artery,LOCATION_OF,Symptoms,32541352,10.1097/PHM.0000000000001505,2020-06-17
Symptoms,PROCESS_OF,Recipient,32541352,10.1097/PHM.0000000000001505,2020-06-17
Serum,LOCATION_OF,Creatinine,32541352,10.1097/PHM.0000000000001505,2020-06-17
Renal function,PROCESS_OF,Transplant Recipients,32541352,10.1097/PHM.0000000000001505,2020-06-17
Disability,PROCESS_OF,Patients,32541273,10.1097/SCS.0000000000006724,2020-06-17
Immunocompromised Host,COEXISTS_WITH,Coronavirus Infections,32541232,10.1097/SLA.0000000000004112,2020-06-17
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Boys,32541232,10.1097/SLA.0000000000004112,2020-06-17
"Hepatitis, Autoimmune",PROCESS_OF,Boys,32541232,10.1097/SLA.0000000000004112,2020-06-17
Boys,LOCATION_OF,Interleukin-6,32541232,10.1097/SLA.0000000000004112,2020-06-17
"T-Cell Surface Glycoprotein CD4, human",INHIBITS,prednisolone,32541232,10.1097/SLA.0000000000004112,2020-06-17
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Child,32541232,10.1097/SLA.0000000000004112,2020-06-17
"Monitoring, Immunologic",TREATS,Child,32541232,10.1097/SLA.0000000000004112,2020-06-17
"Monitoring, Immunologic",TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",32541232,10.1097/SLA.0000000000004112,2020-06-17
"Monitoring, Immunologic",TREATS(INFER),"Hepatitis, Autoimmune",32541232,10.1097/SLA.0000000000004112,2020-06-17
"Hepatitis, Autoimmune",PROCESS_OF,Child,32541232,10.1097/SLA.0000000000004112,2020-06-17
Azathioprine,AUGMENTS,CD8-Positive T-Lymphocytes,32541232,10.1097/SLA.0000000000004112,2020-06-17
Critical Illness,PROCESS_OF,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
"Intubation, Intratracheal",ADMINISTERED_TO,Health Personnel,32541210,10.1097/BOT.0000000000001860,2020-06-17
"Intubation, Intratracheal",TREATS,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
"Intubation, Intratracheal",TREATS(INFER),Critical Illness,32541210,10.1097/BOT.0000000000001860,2020-06-17
Tracheostomy procedure,TREATS,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
Tracheostomy procedure,TREATS,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
Tracheostomy procedure,TREATS,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
Non-Ossifying Fibroma,CAUSES,Acute respiratory failure,32541210,10.1097/BOT.0000000000001860,2020-06-17
Tracheostomy procedure,TREATS,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
Interventional procedure,ADMINISTERED_TO,Health Personnel,32541210,10.1097/BOT.0000000000001860,2020-06-17
Interventional procedure,ADMINISTERED_TO,Patients,32541210,10.1097/BOT.0000000000001860,2020-06-17
Electrocardiographic monitoring,AFFECTS,Patients,32541085,10.1556/650.2020.31899,2020-06-17
Electrocardiography,AFFECTS,Patients,32541085,10.1556/650.2020.31899,2020-06-17
Area striata structure,LOCATION_OF,Old myocardial infarction,32541085,10.1556/650.2020.31899,2020-06-17
Coronavirus Infections,ISA,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Pharmaceutical Preparations,TREATS,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Coronavirus Infections,ISA,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Interleukin-6,AFFECTS,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Interleukin-6,AFFECTS(SPEC),Coronavirus Infections,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Coronavirus Infections,ISA,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
tocilizumab,ISA,Monoclonal Antibodies,32540963,10.1136/bmjgh-2020-002425,2020-06-17
Coronavirus Infections,ISA,Disease,32540963,10.1136/bmjgh-2020-002425,2020-06-17
"Respiratory Distress Syndrome, Adult",PROCESS_OF,hospitalized patients,32540904,10.1126/science.abd0831,2020-06-17
Antibodies,INTERACTS_WITH,"M Protein, multiple myeloma",32540903,10.1126/science.abc7520,2020-06-17
Mutation,PRODUCES,Antibodies,32540903,10.1126/science.abc7520,2020-06-17
human group,LOCATION_OF,Antibodies,32540903,10.1126/science.abc7520,2020-06-17
Antibodies,PART_OF,Persons,32540903,10.1126/science.abc7520,2020-06-17
Disease,PROCESS_OF,Mesocricetus auratus,32540902,10.1126/science.abc5902,2020-06-17
Patients,LOCATION_OF,Monoclonal Antibodies,32540901,10.1126/science.abd0827,2020-06-17
Antibodies,DISRUPTS,Severe Acute Respiratory Syndrome,32540901,10.1126/science.abd0827,2020-06-17
Antibodies,PART_OF,Persons,32540900,10.1126/science.abc7424,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Tissue Donors,32540884,10.1136/bcr-2020-236561,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32540884,10.1136/bcr-2020-236561,2020-06-17
Emotional distress,ISA,Distress,32540883,10.1136/bcr-2020-236182,2020-06-17
Takotsubo Cardiomyopathy,PROCESS_OF,Patients,32540883,10.1136/bcr-2020-236182,2020-06-17
Takotsubo Cardiomyopathy,PROCESS_OF,Patients,32540883,10.1136/bcr-2020-236182,2020-06-17
Storm NOS,CAUSES,Takotsubo Cardiomyopathy,32540883,10.1136/bcr-2020-236182,2020-06-17
Clinician,TREATS,Patients,32540882,10.1136/bcr-2020-236123,2020-06-17
Medical History,NEG_PROCESS_OF,Male population group,32540850,10.1158/1078-0432.CCR-20-1657,2020-06-17
intensive care,METHOD_OF,Mechanical ventilation,32540850,10.1158/1078-0432.CCR-20-1657,2020-06-17
Coronavirus Infections,ISA,Disease,32540844,10.2196/18831,2020-06-17
Engaged to be married,PROCESS_OF,Community,32540844,10.2196/18831,2020-06-17
Health Care,ADMINISTERED_TO,Patients,32540844,10.2196/18831,2020-06-17
Coronavirus Infections,ISA,Disease,32540844,10.2196/18831,2020-06-17
"CD69 protein, human",PART_OF,Patients,32540844,10.2196/18831,2020-06-17
Disease,PREDISPOSES,Risk level,32540844,10.2196/18831,2020-06-17
Disease,PROCESS_OF,Patients,32540844,10.2196/18831,2020-06-17
Risk Assessment,TREATS,Patients,32540844,10.2196/18831,2020-06-17
Risk Assessment,TREATS(INFER),Disease,32540844,10.2196/18831,2020-06-17
Coronavirus Infections,ISA,Disease,32540844,10.2196/18831,2020-06-17
Coronavirus Infections,PREDISPOSES(SPEC),Risk level,32540844,10.2196/18831,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32540844,10.2196/18831,2020-06-17
Pneumonia,ISA,Disease,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,CAUSES,Pneumonia,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
"CD69 protein, human",ASSOCIATED_WITH,Disease,32540841,10.2196/20049,2020-06-17
"CD69 protein, human",ASSOCIATED_WITH,Disease,32540841,10.2196/20049,2020-06-17
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32540841,10.2196/20049,2020-06-17
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
IMPACT gene,ASSOCIATED_WITH,Disease,32540841,10.2196/20049,2020-06-17
IMPACT gene,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
Coronavirus Infections,ISA,Disease,32540841,10.2196/20049,2020-06-17
Delivery of Health Care,TREATS,Enthesitis-Related Arthritis,32540840,10.2196/20493,2020-06-17
Coronavirus Infections,ISA,Disease,32540840,10.2196/20493,2020-06-17
Pediatric care,TREATS,Enthesitis-Related Arthritis,32540840,10.2196/20493,2020-06-17
Problem,PROCESS_OF,Research Personnel,32540840,10.2196/20493,2020-06-17
Telemedicine,ISA,Delivery of Health Care,32540840,10.2196/20493,2020-06-17
Coronavirus Infections,ISA,Disease,32540840,10.2196/20493,2020-06-17
Consultation,TREATS,Chronic disease,32540840,10.2196/20493,2020-06-17
Consultation,TREATS,Acute illness,32540840,10.2196/20493,2020-06-17
Coronavirus Infections,ISA,Disease,32540839,10.2196/20712,2020-06-17
Evaluation,USES,Metric,32540839,10.2196/20712,2020-06-17
HIV,NEG_PROCESS_OF,early adulthood,32540838,10.2196/18415,2020-06-17
HIV,NEG_PROCESS_OF,early adulthood,32540838,10.2196/18415,2020-06-17
Virus,CAUSES,Disease,32540838,10.2196/18415,2020-06-17
Virus,CAUSES(SPEC),Coronavirus Infections,32540838,10.2196/18415,2020-06-17
Coronavirus Infections,ISA,Disease,32540838,10.2196/18415,2020-06-17
Multiple Sclerosis,PROCESS_OF,Persons,32540837,10.2196/20548,2020-06-17
Rehabilitation service,TREATS,Persons,32540837,10.2196/20548,2020-06-17
Rehabilitation service,TREATS(INFER),Multiple Sclerosis,32540837,10.2196/20548,2020-06-17
Multiple Sclerosis,PROCESS_OF,Adult,32540837,10.2196/20548,2020-06-17
Interventional procedure,TREATS,Adult,32540837,10.2196/20548,2020-06-17
Interventional procedure,TREATS(INFER),Multiple Sclerosis,32540837,10.2196/20548,2020-06-17
Hand,LOCATION_OF,Dynamometer,32540837,10.2196/20548,2020-06-17
Training Techniques,AFFECTS,Disease,32540837,10.2196/20548,2020-06-17
Training Techniques,AFFECTS(SPEC),Coronavirus Infections,32540837,10.2196/20548,2020-06-17
Coronavirus Infections,ISA,Disease,32540837,10.2196/20548,2020-06-17
Infantile Neuroaxonal Dystrophy,COEXISTS_WITH,Uncertainty,32540837,10.2196/20548,2020-06-17
Multiple Sclerosis,PROCESS_OF,Participant,32540837,10.2196/20548,2020-06-17
Mechanical ventilation,TREATS,Patients,32540828,10.1684/vir.2020.0830,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32540828,10.1684/vir.2020.0830,2020-06-17
"Infections, Hospital",PROCESS_OF,Patients,32540828,10.1684/vir.2020.0830,2020-06-17
Confirmation,PROCESS_OF,Patients,32540828,10.1684/vir.2020.0830,2020-06-17
Confirmation,PROCESS_OF,Patients,32540828,10.1684/vir.2020.0830,2020-06-17
Hispanics,ISA,Ethnic group,32540828,10.1684/vir.2020.0830,2020-06-17
Serum,LOCATION_OF,procalcitonin,32540828,10.1684/vir.2020.0830,2020-06-17
"Kidney Failure, Acute",COEXISTS_WITH,Comorbidity,32540828,10.1684/vir.2020.0830,2020-06-17
"Kidney Failure, Acute",COEXISTS_WITH,Comorbidity,32540828,10.1684/vir.2020.0830,2020-06-17
Patient Discharge,COEXISTS_WITH,Isolation procedure,32540825,10.1684/vir.2020.0842,2020-06-17
Patient Discharge,COEXISTS_WITH,Isolation procedure,32540814,10.1684/abc.2020.1563,2020-06-17
Secretory Vesicles,PART_OF,neutrophil,32540791,10.18176/jiaci.0625,2020-06-17
Secretory Vesicles,PART_OF,Protoplasm,32540791,10.18176/jiaci.0625,2020-06-17
Helminths,INTERACTS_WITH,Bacteria,32540791,10.18176/jiaci.0625,2020-06-17
Helminths,INTERACTS_WITH,Fungi,32540791,10.18176/jiaci.0625,2020-06-17
Helminths,INTERACTS_WITH,Virus,32540791,10.18176/jiaci.0625,2020-06-17
Cytoplasmic Granules,PRODUCES,Proteins,32540791,10.18176/jiaci.0625,2020-06-17
Cytoplasmic Granules,PRODUCES(SPEC),cytokine,32540791,10.18176/jiaci.0625,2020-06-17
cytokine,ISA,Proteins,32540791,10.18176/jiaci.0625,2020-06-17
Virus Diseases,COEXISTS_WITH,Respiratory viruses,32540791,10.18176/jiaci.0625,2020-06-17
Examination by method,USES,Artificial Airways,32540769,10.1016/j.yebeh.2020.107211,2020-06-17
Respiratory allergy,PROCESS_OF,Patients,32540769,10.1016/j.yebeh.2020.107211,2020-06-17
Cerebrovascular accident,PROCESS_OF,Patients,32540750,10.1016/j.psychres.2020.113100,2020-06-17
Telemedicine,TREATS,Epilepsy,32540750,10.1016/j.psychres.2020.113100,2020-06-17
Telemedicine,TREATS,Epilepsy,32540750,10.1016/j.psychres.2020.113100,2020-06-17
Satisfaction,PROCESS_OF,Physicians,32540750,10.1016/j.psychres.2020.113100,2020-06-17
mental health,PROCESS_OF,Clinician,32540749,10.1016/j.psychres.2020.113096,2020-06-17
Psychometrics,AFFECTS,Population Health,32540749,10.1016/j.psychres.2020.113096,2020-06-17
Disease,PROCESS_OF,Persons,32540744,10.1016/j.scitotenv.2020.140093,2020-06-17
Disease,PROCESS_OF,Drug abuser,32540744,10.1016/j.scitotenv.2020.140093,2020-06-17
Has difficulty doing (qualifier value),COMPLICATES,Disease,32540744,10.1016/j.scitotenv.2020.140093,2020-06-17
Disease,PROCESS_OF,Drug abuser,32540744,10.1016/j.scitotenv.2020.140093,2020-06-17
Disease,PROCESS_OF,Drug abuser,32540744,10.1016/j.scitotenv.2020.140093,2020-06-17
Eye,LOCATION_OF,Feces,32540740,10.1016/j.dsx.2020.06.019,2020-06-17
Hospitals,LOCATION_OF,Services,32540737,10.1016/j.dsx.2020.06.015,2020-06-17
contextual factors,PROCESS_OF,Community,32540737,10.1016/j.dsx.2020.06.015,2020-06-17
Diabetic Foot,PROCESS_OF,Patients,32540737,10.1016/j.dsx.2020.06.015,2020-06-17
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
pioglitazone,TREATS,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
pioglitazone,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32540736,10.1016/j.dsx.2020.06.013,2020-06-17
pioglitazone,STIMULATES,angiotensin converting enzyme 2,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
angiotensin converting enzyme 2,PREVENTS,Acute Lung Injury,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
pioglitazone,STIMULATES,angiotensin converting enzyme 2,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
Alveolar Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
angiotensin converting enzyme 2,AUGMENTS,Body tissue,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
Immune response,PROCESS_OF,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
Diabetes,PROCESS_OF,Persons,32540736,10.1016/j.dsx.2020.06.013,2020-06-17
Alanine Transaminase,COEXISTS_WITH,Alkaline Phosphatase,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Alanine Transaminase,COEXISTS_WITH,Bilirubin,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Aspartate,COEXISTS_WITH,Alkaline Phosphatase,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Aspartate,COEXISTS_WITH,Bilirubin,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Serum,LOCATION_OF,Alkaline Phosphatase,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Serum,LOCATION_OF,Bilirubin,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Malignant Neoplasms,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Cardiovascular Diseases,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Hypertensive disease,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Kidney Diseases,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Obesity,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Senility,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Co-morbid conditions,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Severe disorder,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
associated disease,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
"CD69 protein, human",AFFECTS,associated disease,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Obesity,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
associated disease,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Physicians,TREATS,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Hepatologists,TREATS,Patients,32540735,10.1016/j.dsx.2020.06.008,2020-06-17
Coronavirus Infections,ISA,Disease,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Coronavirus Infections,ISA,Disease,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Coronavirus Infections,ISA,Disease,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Opioids,ASSOCIATED_WITH,Disease,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Opioids,ASSOCIATED_WITH,Addictive Behavior,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Opioids,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Disease,PREDISPOSES,Disease Outcome,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Coronavirus Infections,ISA,Disease,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Coronavirus Infections,PREDISPOSES(SPEC),Disease Outcome,32540734,10.1016/j.dsx.2020.06.018,2020-06-17
Comorbidity,PROCESS_OF,Patients,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Present,PROCESS_OF,Ethnic group,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Disease,PROCESS_OF,Patients,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Pharmaceutical Preparations,TREATS,Patients,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Combined Modality Therapy,AFFECTS,Adverse effects,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Immunization,USES,Vaccines,32540732,10.1016/j.dsx.2020.05.045,2020-06-17
Infected,PROCESS_OF,Population Group,32540668,10.1016/j.scitotenv.2020.140000,2020-06-17
Pharmaceutical Preparations,TREATS,Crisis,32540603,10.1016/j.mehy.2020.109988,2020-06-17
Abnormal inflammatory response,CAUSES,Blood Coagulation Disorders,32540603,10.1016/j.mehy.2020.109988,2020-06-17
Immune response,PROCESS_OF,Patients,32540603,10.1016/j.mehy.2020.109988,2020-06-17
Lecithin,AUGMENTS,Phagocytosis,32540603,10.1016/j.mehy.2020.109988,2020-06-17
Pentoxifylline,DISRUPTS(SPEC),Anabolism,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pentoxifylline,ISA,Phosphodiesterase Inhibitors,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pentoxifylline,STIMULATES(SPEC),Protein Kinases,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Phosphodiesterase Inhibitors,DISRUPTS,Anabolism,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Phosphodiesterase Inhibitors,STIMULATES,Protein Kinases,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
cytokine,PRODUCES,Pentoxifylline,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
receptor expression,PROCESS_OF,Angiotensin I,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pharmaceutical Preparations,TREATS,Patients,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pentoxifylline,PREVENTS,Thrombosis,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Alveolar Epithelial Cells,AFFECTS,Circulatory Process,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pentoxifylline,ISA,Pharmaceutical Preparations,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Pentoxifylline,INHIBITS,,32540495,10.1016/j.ygeno.2020.06.016,2020-06-17
Coronavirus Infections,ASSOCIATED_WITH,Host (organism),32540462,10.1016/j.jhin.2020.06.020,2020-06-17
Genome,PART_OF,Patients,32540462,10.1016/j.jhin.2020.06.020,2020-06-17
Virulence,PROCESS_OF,Patients,32540462,10.1016/j.jhin.2020.06.020,2020-06-17
Glycoproteins,INTERACTS_WITH,angiotensin converting enzyme 2,32540370,10.1016/j.ajic.2020.06.008,2020-06-17
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32540370,10.1016/j.ajic.2020.06.008,2020-06-17
Smoking History,COEXISTS_WITH,Disease,32540369,10.1016/j.ajic.2020.06.006,2020-06-17
Complication,PROCESS_OF,Patients,32540369,10.1016/j.ajic.2020.06.006,2020-06-17
"Immunotherapy, Passive",TREATS,Coronavirus Infections,32540298,10.1016/j.hrthm.2020.06.012,2020-06-17
Passive Method,USES,Antibodies,32540298,10.1016/j.hrthm.2020.06.012,2020-06-17
Coronavirus Infections,PROCESS_OF,Patients,32540298,10.1016/j.hrthm.2020.06.012,2020-06-17
Compassionate Use,TREATS,Patients,32540298,10.1016/j.hrthm.2020.06.012,2020-06-17
Compassionate Use,TREATS(INFER),Coronavirus Infections,32540298,10.1016/j.hrthm.2020.06.012,2020-06-17
Cardiac Arrhythmia,PROCESS_OF,Patients,32540271,10.1016/j.vaccine.2020.06.007,2020-06-17
Infected,PROCESS_OF,Health Personnel,32540271,10.1016/j.vaccine.2020.06.007,2020-06-17
"CD69 protein, human",PART_OF,Health Personnel,32540271,10.1016/j.vaccine.2020.06.007,2020-06-17
Cessation of life,PROCESS_OF,Homo sapiens,32540268,10.1016/j.euf.2020.06.002,2020-06-17
Renal Cell Carcinoma,PROCESS_OF,Patients,32540267,10.1016/j.euf.2020.05.023,2020-06-17
Renal Cell Carcinoma,PROCESS_OF,Patients,32540267,10.1016/j.euf.2020.05.023,2020-06-17
Disease,AFFECTS,Virulence,32540267,10.1016/j.euf.2020.05.023,2020-06-17
Neoplasms,PROCESS_OF,Patients,32540264,10.1016/j.jiph.2020.06.008,2020-06-17
Medical center,ISA,Hospitals,32540223,10.1016/j.pulmoe.2020.05.015,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Cancer Patient,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Nasopharynx,LOCATION_OF,patient symptoms,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Pneumonia,PROCESS_OF,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Hematologic Neoplasms,PROCESS_OF,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Negative,PROCESS_OF,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Cessation of life,OCCURS_IN,Patients,32540201,10.1016/j.cjtee.2020.05.006,2020-06-17
Coronavirus Infections,CAUSES,Pneumonia,32540142,10.1016/j.clinre.2020.04.021,2020-06-17
Traumatic Brain Injury,PROCESS_OF,Patients,32540142,10.1016/j.clinre.2020.04.021,2020-06-17
Protection,PROCESS_OF,Patients,32540142,10.1016/j.clinre.2020.04.021,2020-06-17
Traumatic Brain Injury,PROCESS_OF,Patients,32540142,10.1016/j.clinre.2020.04.021,2020-06-17
Pneumonia,ISA,Disease,32540054,10.1016/j.anl.2020.05.022,2020-06-17
hepatobiliary disease,PROCESS_OF,Patients,32540054,10.1016/j.anl.2020.05.022,2020-06-17
Surgeon,TREATS,Outpatients,32540054,10.1016/j.anl.2020.05.022,2020-06-17
Diagnosis,DIAGNOSES,Stable Disease,32540034,10.1016/j.jcv.2020.104442,2020-06-17
Nasal Swab (procedure),USES,Detection,32540024,10.1016/S2352-4642(20)30186-3,2020-06-17
Oropharyngeal swab,PART_OF,"Nares, entire, anterior or posterior",32540024,10.1016/S2352-4642(20)30186-3,2020-06-17
Nasal Swab (procedure),METHOD_OF,Detection,32540024,10.1016/S2352-4642(20)30186-3,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Study Subject,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Asymptomatic,PROCESS_OF,Persons,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Disease Progression,PROCESS_OF,Patients,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Toxic Epidermal Necrolysis,PROCESS_OF,Participant,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Participant,LOCATION_OF,Hydrogenase,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Lymphopenia,PREDISPOSES,Disease Progression,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Mild disorder,PROCESS_OF,Patients,32539986,10.1016/S1473-3099(20)30364-9,2020-06-17
Antibody Formation,PROCESS_OF,Patients,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Real-Time Polymerase Chain Reaction,METHOD_OF,Quantitative Reverse Transcriptase PCR,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Reverse Transcriptase Polymerase Chain Reaction,USES,Nasal Swab (procedure),32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Chromosome 2q32-Q33 Deletion Syndrome,PROCESS_OF,Patients,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Lung,LOCATION_OF,Asymptomatic Infections,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Asymptomatic Infections,PROCESS_OF,Patients,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Asymptomatic,PROCESS_OF,Patients,32539942,10.1016/S1470-2045(20)30314-4,2020-06-17
Malignant Neoplasms,PROCESS_OF,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Malignant neoplasm of thorax,PROCESS_OF,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Cardiopulmonary,LOCATION_OF,Comorbidity,32539912,10.4269/ajtmh.20-0480,2020-06-17
cancer therapy,ADMINISTERED_TO,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Pharmacotherapy,TREATS,Former smoker,32539912,10.4269/ajtmh.20-0480,2020-06-17
intensive care,TREATS,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Malignant neoplasm of thorax,PROCESS_OF,Patients,32539912,10.4269/ajtmh.20-0480,2020-06-17
Laboratory,LOCATION_OF,Surveillance Program,32539726,10.1186/s12874-020-01024-9,2020-06-17
Rehabilitation Centers,ISA,skilled nursing facility,32539726,10.1186/s12874-020-01024-9,2020-06-17
Tertiary Care Centers,ISA,skilled nursing facility,32539726,10.1186/s12874-020-01024-9,2020-06-17
Interested,PROCESS_OF,Participant,32539692,10.1186/s12880-020-00464-5,2020-06-17
Tertiary Care Centers,LOCATION_OF,Study,32539661,10.1177/0194599820933595,2020-06-17
Chest CT,ADMINISTERED_TO,Patients,32539661,10.1177/0194599820933595,2020-06-17
Chest CT,USES,Microtomy,32539661,10.1177/0194599820933595,2020-06-17
Symptoms,PROCESS_OF,Patients,32539661,10.1177/0194599820933595,2020-06-17
Standard chest X-ray normal,PROCESS_OF,Patients,32539661,10.1177/0194599820933595,2020-06-17
Symptom mild,PROCESS_OF,Patients,32539661,10.1177/0194599820933595,2020-06-17
interstitial,LOCATION_OF,Lesion,32539661,10.1177/0194599820933595,2020-06-17
Lesion,PROCESS_OF,Patients,32539661,10.1177/0194599820933595,2020-06-17
Small Lesion,PROCESS_OF,Patients,32539661,10.1177/0194599820933595,2020-06-17
Chest CT,USES,Microtomy,32539661,10.1177/0194599820933595,2020-06-17
Thickening of pleura,COEXISTS_WITH,Lesion,32539661,10.1177/0194599820933595,2020-06-17
lobe,LOCATION_OF,Lesion,32539661,10.1177/0194599820933595,2020-06-17
Malignant Neoplasms,PROCESS_OF,Patients,32539627,10.1177/1753466620933508,2020-06-17
Malignant Neoplasms,PROCESS_OF,Patients,32539627,10.1177/1753466620933508,2020-06-17
Protoplasm,LOCATION_OF,Cytokine Signaling,32539587,10.1177/0194599820934380,2020-06-17
Coughing,ISA,Symptoms,32539586,10.1177/0194599820934376,2020-06-17
Nose,LOCATION_OF,Congestion,32539586,10.1177/0194599820934376,2020-06-17
Smell Perception,PROCESS_OF,Patients,32539586,10.1177/0194599820934376,2020-06-17
Rhinorrhea,ISA,Symptoms,32539586,10.1177/0194599820934376,2020-06-17
Rhinorrhea,PROCESS_OF(SPEC),Woman,32539586,10.1177/0194599820934376,2020-06-17
Symptoms,PROCESS_OF,Woman,32539586,10.1177/0194599820934376,2020-06-17
Screening procedure,NEG_TREATS,Chief complaint (finding),32539537,10.1164/rccm.202006-2157CP,2020-06-17
Chief complaint (finding),ISA,Symptoms,32539537,10.1164/rccm.202006-2157CP,2020-06-17
Coronavirus Infections,AFFECTS,Idiosyncrasy,32539521,10.7326/ACPJ202006160-062,2020-06-17
receptor,AFFECTS,Chemosensitivity,32539521,10.7326/ACPJ202006160-062,2020-06-17
Anoxia,AFFECTS,Disease,32539521,10.7326/ACPJ202006160-062,2020-06-17
carbon dioxide tension,AFFECTS,Inspiration function,32539521,10.7326/ACPJ202006160-062,2020-06-17
"M Protein, multiple myeloma",AFFECTS,Virus Internalization,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Therapeutic procedure,TREATS,Genus: Coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Therapeutic procedure,TREATS,SARS coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Therapeutic procedure,TREATS,Middle East Respiratory Syndrome Coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Therapeutic procedure,TREATS(SPEC),SARS coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Therapeutic procedure,TREATS(SPEC),Middle East Respiratory Syndrome Coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
SARS coronavirus,ISA,Genus: Coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32539372,10.1021/acs.jcim.0c00283,2020-06-17
Dysgeusia,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32539312,10.23736/S1973-9087.20.06435-7,2020-06-17
Disability,PROCESS_OF,Patients,32539299,10.3343/alm.2020.40.6.439,2020-06-17
Infected,PROCESS_OF,Patients,32539283,10.1213/XAA.0000000000001244,2020-06-17
Airway Management,ISA,Interventional procedure,32539282,10.1213/XAA.0000000000001243,2020-06-17
Endotracheal tube,TREATS,disease transmission,32539282,10.1213/XAA.0000000000001243,2020-06-17
Critical Illness,PROCESS_OF,Patients,32539281,10.1213/XAA.0000000000001247,2020-06-17
Mechanical ventilation,TREATS,Patients,32539281,10.1213/XAA.0000000000001247,2020-06-17
Mechanical ventilation,TREATS(INFER),Critical Illness,32539281,10.1213/XAA.0000000000001247,2020-06-17
Ventilator - respiratory equipment,USES,intensive care unit,32539281,10.1213/XAA.0000000000001247,2020-06-17
Coughing,NEG_PROCESS_OF,Patients,32539273,10.1213/XAA.0000000000001237,2020-06-17
Endotracheal tube,PREVENTS,Coughing,32539273,10.1213/XAA.0000000000001237,2020-06-17
Supraglottic airway,USES,Endotracheal tube,32539273,10.1213/XAA.0000000000001237,2020-06-17
Critical Illness,PROCESS_OF,Patients,32539267,10.1213/XAA.0000000000001235,2020-06-17
Critical Illness,PROCESS_OF,Patients,32539267,10.1213/XAA.0000000000001235,2020-06-17
Factor VIII,TREATS,Patients,32539267,10.1213/XAA.0000000000001235,2020-06-17
Factor VIII,TREATS(INFER),Critical Illness,32539267,10.1213/XAA.0000000000001235,2020-06-17
Critical Illness,PROCESS_OF,Patients,32539267,10.1213/XAA.0000000000001235,2020-06-17
Factor VIII,PREDISPOSES,Thrombophilia,32539267,10.1213/XAA.0000000000001235,2020-06-17
Diagnostic tests,ADMINISTERED_TO,Patients,32539259,10.3760/cma.j.cn112338-20200421-00616,2020-06-17
Asymptomatic,PROCESS_OF,Patients,32539259,10.3760/cma.j.cn112338-20200421-00616,2020-06-17
Asymptomatic,PROCESS_OF,Patients,32539259,10.3760/cma.j.cn112338-20200421-00616,2020-06-17
Acute respiratory infections,PROCESS_OF,Adult,32539257,10.3760/cma.j.cn112138-20200219-00098,2020-06-17
Influenza A,PROCESS_OF,Aves,32539257,10.3760/cma.j.cn112138-20200219-00098,2020-06-17
10 - severe,PROCESS_OF,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Evaluation procedure,TREATS,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Echocardiography,DIAGNOSES,Myocardial dysfunction,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Lung,LOCATION_OF,Ultrasonography,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Oxygen,AUGMENTS,Cardiac function,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Ultrasonography,CAUSES,Respiratory Failure,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Confirmation,PROCESS_OF,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Respiratory Failure,PROCESS_OF,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Evaluation procedure,TREATS,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Telemedicine,TREATS,Patients,32539253,10.1590/S1677-5538.IBJU.2020.99.15,2020-06-17
Life Style,ISA,Behavior,32539247,10.31128/AJGP-COVID-25,2020-06-17
brazilian,PROCESS_OF,Urologists,32539247,10.31128/AJGP-COVID-25,2020-06-17
brazilian,PROCESS_OF,Urologists,32539247,10.31128/AJGP-COVID-25,2020-06-17
Patient Visit,PREVENTS,Severe (severity modifier),32539247,10.31128/AJGP-COVID-25,2020-06-17
Depressive disorder,PROCESS_OF,Health Personnel,32539128,10.1093/ajhp/zxaa211,2020-06-17
Depressive disorder,PROCESS_OF,general population,32539128,10.1093/ajhp/zxaa211,2020-06-17
Sleeplessness,PROCESS_OF,Health Personnel,32539128,10.1093/ajhp/zxaa211,2020-06-17
Sleeplessness,PROCESS_OF,general population,32539128,10.1093/ajhp/zxaa211,2020-06-17
Anxiety,PROCESS_OF,Vulnerable Populations,32539128,10.1093/ajhp/zxaa211,2020-06-17
Mental disorders,PROCESS_OF,Vulnerable Populations,32539128,10.1093/ajhp/zxaa211,2020-06-17
Persons,USES,Preexisting Condition Coverage,32539128,10.1093/ajhp/zxaa211,2020-06-17
Alcohol or Other Drugs use,PROCESS_OF,Vulnerable Populations,32539128,10.1093/ajhp/zxaa211,2020-06-17
contagion,AFFECTS,Anxiety,32539128,10.1093/ajhp/zxaa211,2020-06-17
contagion,AFFECTS,Mental disorders,32539128,10.1093/ajhp/zxaa211,2020-06-17
contagion,AFFECTS,Alcohol or Other Drugs use,32539128,10.1093/ajhp/zxaa211,2020-06-17
Loneliness,PROCESS_OF,general population,32539128,10.1093/ajhp/zxaa211,2020-06-17
Acute respiratory failure,PROCESS_OF,Patients,32539016,10.24875/GMM.M20000377,2020-06-17
Experience,PROCESS_OF,Health Personnel,32539016,10.24875/GMM.M20000377,2020-06-17
Critical Illness,PROCESS_OF,Patients,32538935,10.31729/jnma.4950,2020-06-17
intensive care unit,LOCATION_OF,Administration occupational activities,32538935,10.31729/jnma.4950,2020-06-17
Fatigue,ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Fever,ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Dry cough,ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Diarrhea,ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Diarrhea,PROCESS_OF(SPEC),Patients,32538870,10.3233/JPD-202109,2020-06-17
Nasal congestion (finding),ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Nasal congestion (finding),PROCESS_OF(SPEC),Patients,32538870,10.3233/JPD-202109,2020-06-17
Rhinorrhea,ISA,Symptoms,32538870,10.3233/JPD-202109,2020-06-17
Rhinorrhea,PROCESS_OF(SPEC),Patients,32538870,10.3233/JPD-202109,2020-06-17
Symptoms,PROCESS_OF,Patients,32538870,10.3233/JPD-202109,2020-06-17
High resolution,USES,TBATA gene,32538870,10.3233/JPD-202109,2020-06-17
"Pneumonia, Viral",ISA,Pneumonia,32538870,10.3233/JPD-202109,2020-06-17
Parkinson Disease,PROCESS_OF,Persons,32538857,10.3233/JAD-200581,2020-06-17
mental health,PROCESS_OF,Hospital specialist,32538857,10.3233/JAD-200581,2020-06-17
Parkinson Disease,PROCESS_OF,Persons,32538857,10.3233/JAD-200581,2020-06-17
neurological complication,PROCESS_OF,Patients,32538856,10.3233/JAD-200547,2020-06-17
Blood Vessel,LOCATION_OF,Thrombus,32538856,10.3233/JAD-200547,2020-06-17
Neurologic Manifestations,COEXISTS_WITH,Neurologic Symptoms,32538856,10.3233/JAD-200547,2020-06-17
Neurologic Manifestations,PROCESS_OF,Patients,32538856,10.3233/JAD-200547,2020-06-17
Cognition Disorders,PROCESS_OF,Persons,32538855,10.3233/JAD-200537,2020-06-17
Mild cognitive disorder,PROCESS_OF,Patients,32538855,10.3233/JAD-200537,2020-06-17
Mild dementia,PROCESS_OF,Patients,32538855,10.3233/JAD-200537,2020-06-17
Severe Acute Respiratory Syndrome,PRECEDES,Inflammation,32538831,10.3233/CH-209006,2020-06-17
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32538831,10.3233/CH-209006,2020-06-17
Severe Acute Respiratory Syndrome,PRECEDES,Alzheimer's Disease,32538831,10.3233/CH-209006,2020-06-17
gene therapy,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",32538831,10.3233/CH-209006,2020-06-17
Virus Diseases,COEXISTS_WITH,Alzheimer's Disease,32538831,10.3233/CH-209006,2020-06-17
Old age,ISA,Persons,32538830,10.3233/CH-209005,2020-06-17
Arteries,LOCATION_OF,Pulmonary Embolism,32538780,10.7554/eLife.58807,2020-06-17
Atelectasis,COEXISTS_WITH,Pleural effusion disorder,32538780,10.7554/eLife.58807,2020-06-17
Thrombus,ISA,Embolism,32538780,10.7554/eLife.58807,2020-06-17
ACE2 gene,PART_OF,Homo sapiens,32538665,10.1037/tra0000602,2020-06-17
ACE2 gene,PART_OF,Homo sapiens,32538665,10.1037/tra0000602,2020-06-17
ACE2 gene,PART_OF,Pholidota,32538665,10.1037/tra0000602,2020-06-17
Coronavirus Infections,ISA,Disease,32538661,10.1037/tra0000751,2020-06-17
Coronavirus Infections,ISA,Disease,32538661,10.1037/tra0000751,2020-06-17
Mental health problem,PROCESS_OF,Persons,32538661,10.1037/tra0000751,2020-06-17
Spain,ISA,Country,32538655,10.1037/tra0000775,2020-06-17
Feeling hopeless,PROCESS_OF,general population,32538653,10.1037/tra0000656,2020-06-17
Problem,COEXISTS_WITH,Coronavirus Infections,32538651,10.1037/tra0000732,2020-06-17
Persons,LOCATION_OF,IMPACT gene,32538646,10.1037/tra0000863,2020-06-17
Caring,PROCESS_OF,Community,32538544,10.1111/hir.12319,2020-06-17
Disease,PROCESS_OF,Child,32538491,10.1002/ijgo.13273,2020-06-17
Coronavirus Infections,PROCESS_OF,Child,32538491,10.1002/ijgo.13273,2020-06-17
Confirmation,PROCESS_OF,Child,32538491,10.1002/ijgo.13273,2020-06-17
Symptoms,PROCESS_OF,Child,32538491,10.1002/ijgo.13273,2020-06-17
Pandemics,ISA,Disease Outbreaks,32538353,10.7554/eLife.59285,2020-06-17
Antiviral Agents,TREATS,Patients,32538185,10.1080/17512433.2020.1782738,2020-06-17
Evaluation procedure,METHOD_OF,Coagulation procedure,32538185,10.1080/17512433.2020.1782738,2020-06-17
Coronavirus Infections,ISA,Disease,32538157,10.1080/15402002.2020.1776288,2020-06-17
Sexual Health,ISA,Reproduction,32538157,10.1080/15402002.2020.1776288,2020-06-17
Coronavirus Infections,ISA,Disease,32538157,10.1080/15402002.2020.1776288,2020-06-17
Contraceptive methods,PREDISPOSES,Thromboembolism,32538157,10.1080/15402002.2020.1776288,2020-06-17
Contraceptive methods,PREDISPOSES,Drug Interactions,32538157,10.1080/15402002.2020.1776288,2020-06-17
"Abdomen, Acute",COEXISTS_WITH,Fourth Stage of Labor,32538026,10.2991/jegh.k.200421.001,2020-06-17
pneumatosis intestinalis,PROCESS_OF,Male population group,32538026,10.2991/jegh.k.200421.001,2020-06-17
Infected,PROCESS_OF,Persons,32538025,10.2991/jegh.k.200520.001,2020-06-17
Health Care Systems,LOCATION_OF,Early Diagnosis,32538004,10.13703/j.0255-2930.20200312-k0003,2020-06-17
Moxibustion,TREATS,Patients,32538003,10.13703/j.0255-2930.20200305-k0004,2020-06-17
Moxibustion,TREATS,Symptoms,32538003,10.13703/j.0255-2930.20200305-k0004,2020-06-17
Chest,LOCATION_OF,Distress,32538003,10.13703/j.0255-2930.20200305-k0004,2020-06-17
Moxibustion,TREATS,Epidemic disease,32537961,10.3947/ic.2020.52.2.154,2020-06-17
Acupuncture procedure,TREATS,Epidemic disease,32537961,10.3947/ic.2020.52.2.154,2020-06-17
Moxibustion,ISA,Interventional procedure,32537961,10.3947/ic.2020.52.2.154,2020-06-17
Coronavirus Infections,ISA,Disease,32537957,10.3346/jkms.2020.35.e223,2020-06-17
Coronavirus Infections,ISA,Disease,32537957,10.3346/jkms.2020.35.e223,2020-06-17
Disease,PROCESS_OF,Vulnerable Populations,32537957,10.3346/jkms.2020.35.e223,2020-06-17
Coronavirus Infections,ISA,Disease,32537957,10.3346/jkms.2020.35.e223,2020-06-17
Senility,PROCESS_OF,Patients,32537955,10.3346/jkms.2020.35.e220,2020-06-17
Mechanical ventilation,TREATS,Woman,32537955,10.3346/jkms.2020.35.e220,2020-06-17
Poor outcome,COEXISTS_WITH,Anoxia,32537955,10.3346/jkms.2020.35.e220,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32537955,10.3346/jkms.2020.35.e220,2020-06-17
Social Distance,ISA,Behavior,32537954,10.3346/jkms.2020.35.e209,2020-06-17
Perception,PROCESS_OF,high-risk group,32537954,10.3346/jkms.2020.35.e209,2020-06-17
Tertiary Care Centers,LOCATION_OF,Retrospective Studies,32537930,10.1111/imj.14862,2020-06-17
6/3,PREDISPOSES,Severe disorder,32537930,10.1111/imj.14862,2020-06-17
Severe disorder,PROCESS_OF,hospitalized patients,32537930,10.1111/imj.14862,2020-06-17
Intervention regimes,TREATS,Patients,32537930,10.1111/imj.14862,2020-06-17
Intervention regimes,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32537930,10.1111/imj.14862,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32537930,10.1111/imj.14862,2020-06-17
Poor outcome,PROCESS_OF,Population at Risk,32537852,10.1111/dth.13833,2020-06-17
Hand,LOCATION_OF,Coronavirus Infections,32537839,10.15252/embr.202050946,2020-06-17
Enthesitis-Related Arthritis,PROCESS_OF,Patients,32537839,10.15252/embr.202050946,2020-06-17
Pharmaceutical Preparations,TREATS,Patients,32537839,10.15252/embr.202050946,2020-06-17
Chronic disease,PROCESS_OF,parent,32537771,10.1002/rmv.2132,2020-06-17
Chronic disease,PROCESS_OF,Relative (related person),32537771,10.1002/rmv.2132,2020-06-17
Health Services,TREATS,Protection,32537771,10.1002/rmv.2132,2020-06-17
High Level,PROCESS_OF,student,32537771,10.1002/rmv.2132,2020-06-17
Engaged to be married,PROCESS_OF,audience,32537713,10.1007/s11701-020-01100-8,2020-06-17
hospitalized patients,ISA,Patients,32537704,10.1007/s10620-020-06408-x,2020-06-17
Blood Coagulation Disorders,PROCESS_OF,Patients,32537697,10.1007/s10877-020-00537-4,2020-06-17
"Condoms, Male",PREVENTS,Complication,32537697,10.1007/s10877-020-00537-4,2020-06-17
Hospital Readmissions,TREATS,Gastrointestinal Hemorrhage,32537697,10.1007/s10877-020-00537-4,2020-06-17
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32537697,10.1007/s10877-020-00537-4,2020-06-17
rapid technique,USES,Recombinant Thyroid-Stimulating Hormone,32537662,10.1007/s00392-020-01683-0,2020-06-17
"Hospitals, University",LOCATION_OF,Study,32537615,10.1002/bco2.18,2020-06-17
Prognosis bad,PROCESS_OF,Patients,32537615,10.1002/bco2.18,2020-06-17
Urgent Care,LOCATION_OF,Administration occupational activities,32537614,10.1002/anr3.12052,2020-06-17
Pharmacotherapy,TREATS,Malignant neoplasm of urinary bladder,32537614,10.1002/anr3.12052,2020-06-17
Kidney,LOCATION_OF,advanced cancer,32537614,10.1002/anr3.12052,2020-06-17
Hormone Therapy,ISA,Therapeutic procedure,32537614,10.1002/anr3.12052,2020-06-17
Hormone Therapy,TREATS,Malignant neoplasm of prostate,32537614,10.1002/anr3.12052,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32537610,10.1016/j.medidd.2020.100052,2020-06-17
"Respiratory Distress Syndrome, Adult",AFFECTS,Disability,32537561,10.12688/aasopenres.13059.1,2020-06-17
Aprotinin,ISA,Protease Inhibitors,32537561,10.12688/aasopenres.13059.1,2020-06-17
Aprotinin,INHIBITS,Kininogenase,32537561,10.12688/aasopenres.13059.1,2020-06-17
Aprotinin,INHIBITS,Matrix Metalloproteinases,32537561,10.12688/aasopenres.13059.1,2020-06-17
Point-of-Care Testing,USES,Diagnosis,32537529,10.1002/epi4.12399,2020-06-17
Acute encephalopathy,OCCURS_IN,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Electroencephalography,NEG_DIAGNOSES,Acute encephalopathy,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Encephalopathies,PROCESS_OF,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Body Fluid Discharge,PART_OF,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Body Fluid Discharge,PART_OF,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Seizures,PROCESS_OF,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Encephalopathies,PROCESS_OF,Patients,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Cohort,LOCATION_OF,Body Fluid Discharge,32537527,10.1016/j.idm.2020.05.003,2020-06-17
Chronic disease,PROCESS_OF,Persons,32537482,10.1016/j.imu.2020.100367,2020-06-17
Chronic disease,PROCESS_OF,Old age,32537482,10.1016/j.imu.2020.100367,2020-06-17
Chronic disease,PROCESS_OF,Old age,32537482,10.1016/j.imu.2020.100367,2020-06-17
Cessation of life,PROCESS_OF,Persons,32537482,10.1016/j.imu.2020.100367,2020-06-17
Cessation of life,PROCESS_OF,Old age,32537482,10.1016/j.imu.2020.100367,2020-06-17
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32537481,10.1016/j.eml.2020.100817,2020-06-17
Vaccines,TREATS,Severe Acute Respiratory Syndrome,32537481,10.1016/j.eml.2020.100817,2020-06-17
Mutagens,AFFECTS,Reproduction,32537481,10.1016/j.eml.2020.100817,2020-06-17
Simvastatin,TREATS,Virus Diseases,32537481,10.1016/j.eml.2020.100817,2020-06-17
Mammals,LOCATION_OF,Cholesterol,32537480,10.1016/j.dib.2020.105779,2020-06-17
Tissue membrane,NEG_LOCATION_OF,Cholesterol,32537480,10.1016/j.dib.2020.105779,2020-06-17
Molecular aggregation,CAUSES,pore complex assembly,32537480,10.1016/j.dib.2020.105779,2020-06-17
Lung,LOCATION_OF,Artificial Airways,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Nose,LOCATION_OF,angiotensin converting enzyme 2,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Nose,LOCATION_OF,TMPRSS2 gene,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Airway structure,LOCATION_OF,angiotensin converting enzyme 2,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Airway structure,LOCATION_OF,TMPRSS2 gene,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Airway structure,PART_OF,Bronchial,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Lung,LOCATION_OF,Artificial Airways,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Non-smoker,PROCESS_OF,Patients,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
angiotensin converting enzyme 2,AUGMENTS,Smoker,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
TMPRSS2 gene,AUGMENTS,Smoker,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
diabetic,PROCESS_OF,Patients,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
angiotensin converting enzyme 2,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
TMPRSS2 gene,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Blood,LOCATION_OF,angiotensin converting enzyme 2,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Patients,LOCATION_OF,Genes,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Essential Hypertension,PROCESS_OF,Patients,32537425,10.1016/j.crwh.2020.e00228,2020-06-17
Symptoms,COEXISTS_WITH,Gravidity,32537424,10.1016/j.invent.2020.100327,2020-06-17
Pancreatitis,PROCESS_OF,Homo sapiens,32537424,10.1016/j.invent.2020.100327,2020-06-17
Acute pancreatitis,PROCESS_OF,Patients,32537424,10.1016/j.invent.2020.100327,2020-06-17
Coronavirus Infections,CAUSES,Acute pancreatitis,32537424,10.1016/j.invent.2020.100327,2020-06-17
High Level,PROCESS_OF,Elderly (population group),32537272,10.7759/cureus.8054,2020-06-17
Symptoms,PROCESS_OF,Patients,32537272,10.7759/cureus.8054,2020-06-17
Coronavirus Infections,ISA,Disease,32537248,10.15420/cfr.2020.10,2020-06-17
Disease,PROCESS_OF,Health Personnel,32537248,10.15420/cfr.2020.10,2020-06-17
Coronavirus Infections,ISA,Disease,32537248,10.15420/cfr.2020.10,2020-06-17
Coronavirus Infections,PROCESS_OF(SPEC),Health Personnel,32537248,10.15420/cfr.2020.10,2020-06-17
Covers (device),USES,Hoods,32537248,10.15420/cfr.2020.10,2020-06-17
Hoods,USES,Helmets,32537248,10.15420/cfr.2020.10,2020-06-17
Clip,USES,"Binder, device",32537248,10.15420/cfr.2020.10,2020-06-17
Personal protective equipment,ISA,Entity,32537248,10.15420/cfr.2020.10,2020-06-17
Patients,USES,Preexisting Condition Coverage,32537230,10.1098/rsos.200458,2020-06-17
Myocarditis,PROCESS_OF,Patients,32537230,10.1098/rsos.200458,2020-06-17
Worried,PROCESS_OF,Surgeon,32537120,10.1186/s13570-020-00173-2,2020-06-17
Cessation of life,PROCESS_OF,Persons,32537099,10.1080/20016689.2020.1758390,2020-06-17
Alveolar rhabdomyosarcoma,PROCESS_OF,Population Group,32536989,10.3892/etm.2020.8704,2020-06-17
Antibodies,PART_OF,Mammals,32536988,10.3892/etm.2020.8692,2020-06-17
SARS coronavirus,ISA,Human coronavirus,32536978,10.15420/ecr.2020.17,2020-06-17
Middle East Respiratory Syndrome Coronavirus,ISA,Human coronavirus,32536978,10.15420/ecr.2020.17,2020-06-17
Pharmaceutical Preparations,ADMINISTERED_TO,animal study,32536978,10.15420/ecr.2020.17,2020-06-17
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32536978,10.15420/ecr.2020.17,2020-06-17
Blood,LOCATION_OF,Troponin,32536965,10.1186/s13020-020-00346-6,2020-06-17
Prognosis bad,PROCESS_OF,Patients,32536965,10.1186/s13020-020-00346-6,2020-06-17
Heart,LOCATION_OF,Coronary Occlusion,32536965,10.1186/s13020-020-00346-6,2020-06-17
Inflammation,CAUSES,Myocarditis,32536965,10.1186/s13020-020-00346-6,2020-06-17
Coronary Occlusion,MANIFESTATION_OF,myocardial injury,32536965,10.1186/s13020-020-00346-6,2020-06-17
angiotensin converting enzyme 2,INTERACTS_WITH,receptor,32536965,10.1186/s13020-020-00346-6,2020-06-17
"Cardiomyopathy, Dilated",COEXISTS_WITH,patient condition,32536965,10.1186/s13020-020-00346-6,2020-06-17
Virus Diseases,PREDISPOSES,"Cardiomyopathy, Dilated",32536965,10.1186/s13020-020-00346-6,2020-06-17
Enzyme-Linked Immunosorbent Assay,DIAGNOSES,patient condition,32536953,10.1111/1740-9713.01400,2020-06-17
,ASSOCIATED_WITH,Complications of Diabetes Mellitus,32536953,10.1111/1740-9713.01400,2020-06-17
IL17 Signaling Pathway,ISA,Signal Transduction Pathways,32536953,10.1111/1740-9713.01400,2020-06-17
Quercetin,ISA,kaempferol,32536953,10.1111/1740-9713.01400,2020-06-17
Symptoms,PROCESS_OF,Patients,32536763,10.1016/j.chaos.2020.109988,2020-06-17
Decision,AFFECTS,Phasis,32536762,10.1016/j.chaos.2020.109971,2020-06-17
Infected,PROCESS_OF,Persons,32536761,10.1016/j.chaos.2020.109969,2020-06-17
Coronavirus Infections,ISA,Disease,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Pharmaceutical Preparations,ASSOCIATED_WITH,Disease,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Vaccines,ASSOCIATED_WITH,Disease,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Coronavirus Infections,ISA,Disease,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Communicable Diseases,PROCESS_OF,Homo sapiens,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Cessation of life,PROCESS_OF,Population Group,32536760,10.1016/j.chaos.2020.109968,2020-06-17
Italy,ISA,Geographic Locations,32536738,10.1016/j.physd.2020.132599,2020-06-17
Pandemics,ISA,Disease Outbreaks,32536735,10.1016/j.jbusres.2020.05.059,2020-06-17
Cardiovascular Diseases,COEXISTS_WITH,patient condition,32536670,10.1620/tjem.251.87,2020-06-17
Hypertensive disease,COEXISTS_WITH(SPEC),patient condition,32536670,10.1620/tjem.251.87,2020-06-17
Hypertensive disease,ISA,Cardiovascular Diseases,32536670,10.1620/tjem.251.87,2020-06-17
Chest CT,DIAGNOSES,Ground Glass Opacity,32536670,10.1620/tjem.251.87,2020-06-17
Heart,LOCATION_OF,High troponin I level,32536670,10.1620/tjem.251.87,2020-06-17
hospitalized patients,ISA,Patients,32536670,10.1620/tjem.251.87,2020-06-17
High troponin I level,PROCESS_OF,Patients,32536670,10.1620/tjem.251.87,2020-06-17
High troponin I level,PROCESS_OF,hospitalized patients,32536670,10.1620/tjem.251.87,2020-06-17
High troponin I level,PROCESS_OF(SPEC),hospitalized patients,32536670,10.1620/tjem.251.87,2020-06-17
No incoordination,PROCESS_OF,teams,32536632,10.5582/bst.2020.03106,2020-06-17
Emotional support,TREATS,Medical Staff,32536632,10.5582/bst.2020.03106,2020-06-17
Emotional support,TREATS,Patients,32536632,10.5582/bst.2020.03106,2020-06-17
Current Therapy,TREATS,Storm NOS,32536564,10.1016/j.cytogfr.2020.06.008,2020-06-17
hydrochloride,TREATS,Patients,32536564,10.1016/j.cytogfr.2020.06.008,2020-06-17
Cessation of life,PROCESS_OF,Homo sapiens,32536516,10.1016/j.iccn.2020.102898,2020-06-17
Virus Replication,AFFECTS,Pneumonia,32536516,10.1016/j.iccn.2020.102898,2020-06-17
Storm NOS,PROCESS_OF,Homo sapiens,32536516,10.1016/j.iccn.2020.102898,2020-06-17
Interleukin-15,STIMULATES,Natural killer,32536516,10.1016/j.iccn.2020.102898,2020-06-17
Heart failure,PROCESS_OF,Patients,32536480,10.1016/j.rgmx.2020.05.001,2020-06-17
"Respiratory Distress Syndrome, Newborn",PROCESS_OF,Patients,32536480,10.1016/j.rgmx.2020.05.001,2020-06-17
Nutritional Support,PREVENTS,Communicable Diseases,32536480,10.1016/j.rgmx.2020.05.001,2020-06-17
Fluid Management,PREVENTS,Communicable Diseases,32536480,10.1016/j.rgmx.2020.05.001,2020-06-17
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
Methotrexate,ISA,Pharmaceutical Preparations,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
thiopurine,ISA,Pharmaceutical Preparations,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
opium alkaloids and derivative combination cough suppressants,PREDISPOSES,Infection,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
Anti-Anxiety Agents,TREATS,Patients,32536478,10.1016/j.ajem.2020.05.091,2020-06-17
Asymptomatic,PROCESS_OF,Persons,32536475,10.1016/j.orcp.2020.06.001,2020-06-17
Chronic disease,PROCESS_OF,Persons,32536475,10.1016/j.orcp.2020.06.001,2020-06-17
Coronavirus Infections,ISA,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Obesity,PRECEDES,Diabetes,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Obesity,PRECEDES,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Obesity,PRECEDES(SPEC),Coronavirus Infections,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Coronavirus Infections,ISA,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Coronavirus Infections,ISA,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Comorbidity,PREDISPOSES,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Comorbidity,PREDISPOSES(SPEC),Coronavirus Infections,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
Coronavirus Infections,ISA,Disease,32536457,10.1016/j.arcmed.2020.05.024,2020-06-17
SARS coronavirus,ISA,Genus: Coronavirus,32536436,10.1016/j.joms.2020.05.026,2020-06-17
Experience,PROCESS_OF,Program Director,32536344,10.1186/s12879-020-05147-8,2020-06-17
Masks,USES,Mechanical Ventilator,32536344,10.1186/s12879-020-05147-8,2020-06-17
Chronic disease,PROCESS_OF,Patients,32536162,10.1021/acs.jpclett.0c01097,2020-06-17
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32536150,10.3904/kjim.2020.224,2020-06-17
Virus Diseases,PREDISPOSES,Present,32536150,10.3904/kjim.2020.224,2020-06-17
G-Quadruplexes,AUGMENTS,Host defense,32536150,10.3904/kjim.2020.224,2020-06-17
Hydroxychloroquine,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Clinical Response,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Clinical Response,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,compared_with,lopinavir / Ritonavir,32536002,10.1111/tbed.13684,2020-06-15
Hydroxychloroquine,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
lopinavir / Ritonavir,TREATS,Patients,32536002,10.1111/tbed.13684,2020-06-15
Hydroxychloroquine,TREATS,Hyperbilirubinemia,32536002,10.1111/tbed.13684,2020-06-15
Hydroxychloroquine,TREATS,Lymphopenia,32536002,10.1111/tbed.13684,2020-06-15
Ritonavir,compared_with,Hydroxychloroquine,32536002,10.1111/tbed.13684,2020-06-15
Ritonavir,higher_than,Hydroxychloroquine,32536002,10.1111/tbed.13684,2020-06-15
Ritonavir,TREATS,Hyperbilirubinemia,32536002,10.1111/tbed.13684,2020-06-15
Ritonavir,TREATS,Lymphopenia,32536002,10.1111/tbed.13684,2020-06-15
Virus Diseases,PROCESS_OF,Patients,32535946,10.1111/jdv.16754,2020-06-15
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32535946,10.1111/jdv.16754,2020-06-15
Asthma,PROCESS_OF,Patients,32535946,10.1111/jdv.16754,2020-06-15
Hypersensitivity,PROCESS_OF,Patients,32535946,10.1111/jdv.16754,2020-06-15
Scientist,TREATS,Patients,32535946,10.1111/jdv.16754,2020-06-15
Clinician,TREATS,Patients,32535946,10.1111/jdv.16754,2020-06-15
Critical Illness,PROCESS_OF,Patients,32535890,10.1111/eci.13315,2020-06-15
Infection,OCCURS_IN,Patients,32535890,10.1111/eci.13315,2020-06-15
Critical Illness,PROCESS_OF,Patients,32535890,10.1111/eci.13315,2020-06-15
Infection,PROCESS_OF,Patients,32535890,10.1111/eci.13315,2020-06-15
Anti-Inflammatory Agents,TREATS,patient condition,32535890,10.1111/eci.13315,2020-06-15
Infection,COEXISTS_WITH,patient condition,32535890,10.1111/eci.13315,2020-06-15
Malignant Neoplasms,PROCESS_OF,Patients,32535885,10.1111/eci.13314,2020-06-15
Syndrome,PROCESS_OF,Patients,32535885,10.1111/eci.13314,2020-06-15
Perception,PROCESS_OF,Cancer Patient,32535885,10.1111/eci.13314,2020-06-15
Steroids,TREATS,Toxic effect,32535885,10.1111/eci.13314,2020-06-15
Symptom mild,PROCESS_OF,Patients,32535877,10.1007/s15010-020-01464-x,2020-06-15
Comorbidity,PROCESS_OF,Patients,32535877,10.1007/s15010-020-01464-x,2020-06-15
Hypertensive disease,PRECEDES,Diabetes Mellitus,32535877,10.1007/s15010-020-01464-x,2020-06-15
Respiratory Failure,CAUSES,Hospitalization,32535877,10.1007/s15010-020-01464-x,2020-06-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32535876,10.1007/s15010-020-01458-9,2020-06-15
Respiratory Failure,PROCESS_OF,Patients,32535870,10.1245/s10434-020-08673-6,2020-06-15
Surgical Oncologist,DIAGNOSES,Malignant Neoplasms,32535837,10.1007/s40123-020-00269-3,2020-06-15
Consultation,METHOD_OF,ambulatory care services,32535787,10.1007/s11547-020-01236-5,2020-06-15
Health care facility,LOCATION_OF,Cross-Sectional Studies,32535787,10.1007/s11547-020-01236-5,2020-06-15
Eye,LOCATION_OF,Chief complaint (finding),32535787,10.1007/s11547-020-01236-5,2020-06-15
Consultation,ADMINISTERED_TO,Patients,32535787,10.1007/s11547-020-01236-5,2020-06-15
Lung,LOCATION_OF,Ultrasonography,32535768,10.1007/s00109-020-01931-w,2020-06-15
dyspneic,PROCESS_OF,Patients,32535768,10.1007/s00109-020-01931-w,2020-06-15
Lung,LOCATION_OF,Ultrasonography,32535768,10.1007/s00109-020-01931-w,2020-06-15
follow-up,TREATS,pulmonary involvement,32535768,10.1007/s00109-020-01931-w,2020-06-15
Infection,PROCESS_OF,Patients,32535768,10.1007/s00109-020-01931-w,2020-06-15
Coronavirus Infections,COEXISTS_WITH,SARS coronavirus,32535752,10.1007/s40119-020-00184-5,2020-06-15
Cardiovascular Diseases,CAUSES,Cessation of life,32535732,10.1007/s40290-020-00342-z,2020-06-15
Disease,COEXISTS_WITH,Comorbidity,32535732,10.1007/s40290-020-00342-z,2020-06-15
Heart,LOCATION_OF,Comorbidity,32535732,10.1007/s40290-020-00342-z,2020-06-15
Adverse effects,COEXISTS_WITH,Comorbidity,32535732,10.1007/s40290-020-00342-z,2020-06-15
Myocardium,LOCATION_OF,Direct trauma,32535732,10.1007/s40290-020-00342-z,2020-06-15
Direct trauma,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32535732,10.1007/s40290-020-00342-z,2020-06-15
Coronavirus Infections,ISA,Disease,32535725,10.1007/s11604-020-01003-6,2020-06-15
Agent,NEG_TREATS,Disease,32535725,10.1007/s11604-020-01003-6,2020-06-15
Agent,NEG_TREATS(SPEC),Coronavirus Infections,32535725,10.1007/s11604-020-01003-6,2020-06-15
Coronavirus Infections,ISA,Disease,32535725,10.1007/s11604-020-01003-6,2020-06-15
Pharmaceutical Preparations,INHIBITS,cytokine,32535725,10.1007/s11604-020-01003-6,2020-06-15
Interleukin-6,PART_OF,Lung,32535725,10.1007/s11604-020-01003-6,2020-06-15
tocilizumab,INHIBITS,cytokine,32535725,10.1007/s11604-020-01003-6,2020-06-15
siltuximab,INHIBITS,cytokine,32535725,10.1007/s11604-020-01003-6,2020-06-15
sarilumab,INHIBITS,cytokine,32535725,10.1007/s11604-020-01003-6,2020-06-15
Signal Transduction Pathways,CAUSES,Cell Proliferation,32535725,10.1007/s11604-020-01003-6,2020-06-15
Exudation,PROCESS_OF,Patients,32535725,10.1007/s11604-020-01003-6,2020-06-15
Critical Illness,PROCESS_OF,Patients,32535725,10.1007/s11604-020-01003-6,2020-06-15
Pneumonia,AFFECTS,Patients,32535705,10.1007/s11906-020-01057-x,2020-06-15
Progressive Disease by Computed Tomography,NEG_PROCESS_OF,Patients,32535705,10.1007/s11906-020-01057-x,2020-06-15
Laboratory Procedures,USES,Assay,32535705,10.1007/s11906-020-01057-x,2020-06-15
Assay,ISA,Laboratory Procedures,32535705,10.1007/s11906-020-01057-x,2020-06-15
risk factors,PROCESS_OF,Patients,32535701,10.1007/s00264-020-04644-4,2020-06-15
Hypertensive disease,PROCESS_OF,Patients,32535701,10.1007/s00264-020-04644-4,2020-06-15
Hypertensive disease,PROCESS_OF,Patients,32535701,10.1007/s00264-020-04644-4,2020-06-15
Interested,PROCESS_OF,Adult,32535701,10.1007/s00264-020-04644-4,2020-06-15
Coronavirus Infections,PROCESS_OF,Patients,32535701,10.1007/s00264-020-04644-4,2020-06-15
Complication,COEXISTS_WITH,Hypertensive disease,32535701,10.1007/s00264-020-04644-4,2020-06-15
Hypertensive disease,AFFECTS,Immune response,32535701,10.1007/s00264-020-04644-4,2020-06-15
Severe (severity modifier),PROCESS_OF,Patients,32535701,10.1007/s00264-020-04644-4,2020-06-15
inhibitors,TREATS,Virus Diseases,32535701,10.1007/s00264-020-04644-4,2020-06-15
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32535701,10.1007/s00264-020-04644-4,2020-06-15
Wounds and Injuries,PROCESS_OF,Orthopedic Surgeons,32535674,10.1007/s00128-020-02907-9,2020-06-15
Wounds and Injuries,PROCESS_OF,Orthopedic Surgeons,32535674,10.1007/s00128-020-02907-9,2020-06-15
Wounds and Injuries,PROCESS_OF,Orthopedic Surgeons,32535674,10.1007/s00128-020-02907-9,2020-06-15
Elective Surgical Procedures,ADMINISTERED_TO,Respondents,32535674,10.1007/s00128-020-02907-9,2020-06-15
Hospital specialist,DIAGNOSES,Disease,32535550,10.1136/jech-2020-214401,2020-06-15
Influenza,PROCESS_OF,Hispanics,32535547,10.1016/j.ebiom.2020.102822,2020-06-15
Immunotherapy,TREATS,Patients,32535511,10.1016/j.psychres.2020.113202,2020-06-15
Immunotherapy,TREATS,nervous system disorder,32535511,10.1016/j.psychres.2020.113202,2020-06-15
Tryptophan,CAUSES,Depressive disorder,32535508,10.1016/j.psychres.2020.113213,2020-06-15
Interferons,TREATS,Patients,32535508,10.1016/j.psychres.2020.113213,2020-06-15
Tryptophan,TREATS,Patients,32535508,10.1016/j.psychres.2020.113213,2020-06-15
Population Group,LOCATION_OF,IMPACT gene,32535504,10.1016/j.psychres.2020.113067,2020-06-15
Obsessive-Compulsive Disorder,PROCESS_OF,Patients,32535504,10.1016/j.psychres.2020.113067,2020-06-15
patient condition,PROCESS_OF,Persons,32535456,10.1016/j.mehy.2020.109905,2020-06-15
High Level,PROCESS_OF,Persons,32535456,10.1016/j.mehy.2020.109905,2020-06-15
Particle,PREVENTS,disease transmission,32535398,10.1016/j.jcv.2020.104427,2020-06-15
Pharmacotherapy,TREATS,Virus,32535398,10.1016/j.jcv.2020.104427,2020-06-15
Genes,INTERACTS_WITH,Nucleocapsid,32535397,10.1016/j.jcv.2020.104499,2020-06-15
Genes,compared_with,disease prevention,32535397,10.1016/j.jcv.2020.104499,2020-06-15
Instrument - device,USES,Laboratory,32535304,10.1016/j.ijid.2020.06.024,2020-06-15
Centers for Disease Control and Prevention (U.S.),LOCATION_OF,Quantitative Reverse Transcriptase PCR,32535304,10.1016/j.ijid.2020.06.024,2020-06-15
Laboratory Procedures,METHOD_OF,Assay,32535304,10.1016/j.ijid.2020.06.024,2020-06-15
Detection,USES,fluorophore,32535304,10.1016/j.ijid.2020.06.024,2020-06-15
Algeria,ISA,Country,32535302,10.1016/j.ijid.2020.06.027,2020-06-15
Egypt,ISA,Country,32535302,10.1016/j.ijid.2020.06.027,2020-06-15
Ghana,ISA,Country,32535302,10.1016/j.ijid.2020.06.027,2020-06-15
Nigeria,ISA,Country,32535302,10.1016/j.ijid.2020.06.027,2020-06-15
South Africa,ISA,Country,32535302,10.1016/j.ijid.2020.06.027,2020-06-15
Assay,USES,PCR test for SARS,32535301,10.1016/j.ijid.2020.06.026,2020-06-15
Genome,NEG_AFFECTS,Hypersensitivity,32535301,10.1016/j.ijid.2020.06.026,2020-06-15
Genome,PRODUCES,IMPACT gene,32535301,10.1016/j.ijid.2020.06.026,2020-06-15
Genome,COEXISTS_WITH,Viral Genome,32535301,10.1016/j.ijid.2020.06.026,2020-06-15
Detection,USES,Viral Genome,32535301,10.1016/j.ijid.2020.06.026,2020-06-15
Attention,PROCESS_OF,Patients,32535298,10.1016/j.ijid.2020.06.030,2020-06-15
Influenza A,PROCESS_OF,Patients,32535298,10.1016/j.ijid.2020.06.030,2020-06-15
Gastrointestinal symptom,COEXISTS_WITH,patient condition,32535298,10.1016/j.ijid.2020.06.030,2020-06-15
Influenza A,PROCESS_OF,Patients,32535298,10.1016/j.ijid.2020.06.030,2020-06-15
Influenza A,PROCESS_OF,Child,32535298,10.1016/j.ijid.2020.06.030,2020-06-15
Assay,DIAGNOSES,Viral Shedding,32535294,10.1016/j.ijid.2020.06.023,2020-06-15
Assay,DIAGNOSES,Coronavirus Infections,32535294,10.1016/j.ijid.2020.06.023,2020-06-15
Assay,DIAGNOSES,Asymptomatic,32535294,10.1016/j.ijid.2020.06.023,2020-06-15
Present,PROCESS_OF,Patients,32535232,10.1016/j.thromres.2020.06.008,2020-06-15
Sudden sensorineural hearing loss,PROCESS_OF,Patients,32535232,10.1016/j.thromres.2020.06.008,2020-06-15
Leukopenia,PROCESS_OF,Patients,32535228,10.1016/j.jsb.2020.107548,2020-06-15
Lymphopenia,COEXISTS_WITH,patient condition,32535228,10.1016/j.jsb.2020.107548,2020-06-15
Thrombocytopenia,COEXISTS_WITH,patient condition,32535228,10.1016/j.jsb.2020.107548,2020-06-15
Disease,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Hospital admission,TREATS,"Respiratory Distress Syndrome, Adult",32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Coronavirus Infections,COEXISTS_WITH(SPEC),"Respiratory Distress Syndrome, Adult",32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Coronavirus Infections,ISA,Disease,32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Disease,AFFECTS,European origin,32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Coronavirus Infections,AFFECTS(SPEC),European origin,32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Coronavirus Infections,ISA,Disease,32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Coronavirus Infections,ISA,Disease,32535156,10.1016/j.jinf.2020.06.012,2020-06-15
Specimen Type - Stool = Fecal,PART_OF,Patients,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Specimen Type - Stool = Fecal,PART_OF,Patients,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Specimen Type - Stool = Fecal,PART_OF,Patients,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Intestines,LOCATION_OF,Gastrointestinal symptom,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Severe disorder,PROCESS_OF,Patients,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Community,LOCATION_OF,Feces,32535147,10.1016/j.cmi.2020.06.003,2020-06-15
Ibuprofen,TREATS,Population Group,32535142,10.1016/j.hrthm.2020.06.009,2020-06-15
Acetaminophen,ADMINISTERED_TO,Persons,32535142,10.1016/j.hrthm.2020.06.009,2020-06-15
Fever,PROCESS_OF,Patients,32535142,10.1016/j.hrthm.2020.06.009,2020-06-15
GSKIP gene,compared_with,Acetaminophen,32535142,10.1016/j.hrthm.2020.06.009,2020-06-15
Atrioventricular Block,PROCESS_OF,hospitalized patients,32535088,10.1016/j.pcd.2020.05.014,2020-06-15
Cessation of life,ASSOCIATED_WITH,Signs and Symptoms,32535088,10.1016/j.pcd.2020.05.014,2020-06-15
Diabetes,PROCESS_OF,Community,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Diabetes,PROCESS_OF,Persons,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Diabetes,PROCESS_OF,Persons,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Comprehensive Health Care,TREATS,Complication,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Insulin,ISA,Pharmaceutical Preparations,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Diabetes,PROCESS_OF,Community,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Diabetes,PROCESS_OF,Persons,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Diabetes,PROCESS_OF,Persons,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Insulin,ISA,Pharmaceutical Preparations,32535080,10.1016/j.lfs.2020.117963,2020-06-15
Coronavirus Infections,ISA,Disease,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Coronavirus Infections,ISA,Disease,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Vaccines,AUGMENTS,Severe Acute Respiratory Syndrome,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Genome,PART_OF,RNA Viruses,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Genome,PART_OF,Unmarried person,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Genome,PART_OF(SPEC),SARS coronavirus,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Genome,PART_OF(SPEC),Middle East Respiratory Syndrome Coronavirus,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
SARS coronavirus,ISA,RNA Viruses,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Middle East Respiratory Syndrome Coronavirus,ISA,RNA Viruses,32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
"Condoms, Male",USES,"Tool, device (physical object)",32535032,10.1016/j.jsbmb.2020.105719,2020-06-15
Vitamin D Deficiency,COMPLICATES,"Respiratory Distress Syndrome, Adult",32534982,10.1016/j.bjorl.2020.05.001,2020-06-15
Sense of smell impaired,PROCESS_OF,Persons,32534969,10.1016/j.euf.2020.05.010,2020-06-15
total recovery,PROCESS_OF,Patients,32534969,10.1016/j.euf.2020.05.010,2020-06-15
Sense of smell impaired,PROCESS_OF,Patients,32534969,10.1016/j.euf.2020.05.010,2020-06-15
advanced cancer,PROCESS_OF,Patients,32534946,10.1016/j.jiph.2020.06.005,2020-06-15
Genitourinary,LOCATION_OF,advanced cancer,32534946,10.1016/j.jiph.2020.06.005,2020-06-15
Telemedicine,TREATS,Patients,32534946,10.1016/j.jiph.2020.06.005,2020-06-15
Genitourinary Cancer,PROCESS_OF,Patients,32534946,10.1016/j.jiph.2020.06.005,2020-06-15
Coronavirus Infections,ISA,Disease,32534945,10.1016/j.jiph.2020.05.026,2020-06-15
Coronavirus Infections,ISA,Disease,32534945,10.1016/j.jiph.2020.05.026,2020-06-15
Government,ISA,Organization administrative structures,32534945,10.1016/j.jiph.2020.05.026,2020-06-15
Middle East,ISA,Geographic Locations,32534944,10.1016/j.jiph.2020.06.004,2020-06-15
Comorbidity,PROCESS_OF,Patients,32534944,10.1016/j.jiph.2020.06.004,2020-06-15
Coughing,ISA,Symptoms,32534944,10.1016/j.jiph.2020.06.004,2020-06-15
Coughing,ISA,Symptoms,32534944,10.1016/j.jiph.2020.06.004,2020-06-15
Fever,ISA,Symptoms,32534944,10.1016/j.jiph.2020.06.004,2020-06-15
Cardiac function,COEXISTS_WITH,Pulmonary Gas Exchange,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
deterioration,ISA,Biological Processes,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
telomere,PART_OF,Chromosomes,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
telomere,AFFECTS,Immune System Processes,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
Nicotinamide adenine dinucleotide (NAD),INHIBITS,TIPARP gene,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
Nicotinamide adenine dinucleotide (NAD),AFFECTS,Immune Cell,32534910,10.1016/j.eururo.2020.05.024,2020-06-15
Symptoms,PROCESS_OF,Patients,32534909,10.1016/j.chest.2020.05.583,2020-06-15
Metastatic Urothelial Carcinoma,PROCESS_OF,Patients,32534909,10.1016/j.chest.2020.05.583,2020-06-15
Symptoms,PROCESS_OF,Patients,32534909,10.1016/j.chest.2020.05.583,2020-06-15
risk factors,PROCESS_OF,Patients,32534909,10.1016/j.chest.2020.05.583,2020-06-15
systemic therapy,AFFECTS,Cessation of life,32534909,10.1016/j.chest.2020.05.583,2020-06-15
systemic therapy,TREATS,Malignant Neoplasms,32534909,10.1016/j.chest.2020.05.583,2020-06-15
Evaluation procedure,TREATS,Patients,32534909,10.1016/j.chest.2020.05.583,2020-06-15
Real-Time Polymerase Chain Reaction,METHOD_OF,Diagnosis,32534906,10.1016/j.wombi.2020.05.010,2020-06-15
Thoracentesis,USES,Ultrasonic guidance procedure,32534906,10.1016/j.wombi.2020.05.010,2020-06-15
Pleural effusion disorder,COEXISTS_WITH,Coronavirus Infections,32534906,10.1016/j.wombi.2020.05.010,2020-06-15
Anxiety,PROCESS_OF,member,32534864,10.1016/j.arth.2020.05.051,2020-06-15
Source of information,PROCESS_OF,Woman,32534864,10.1016/j.arth.2020.05.051,2020-06-15
Source of information,PROCESS_OF,prenatal,32534864,10.1016/j.arth.2020.05.051,2020-06-15
Pneumonia,PROCESS_OF,Patients,32534808,10.1016/j.ygyno.2020.06.161,2020-06-15
Obesity,COEXISTS_WITH,Hypertensive disease,32534808,10.1016/j.ygyno.2020.06.161,2020-06-15
Cancer Patient,LOCATION_OF,IMPACT gene,32534807,10.1016/j.jns.2020.116935,2020-06-15
Malignant Neoplasms,AFFECTS,Patients,32534807,10.1016/j.jns.2020.116935,2020-06-15
Pharmacotherapy,TREATS,Patients,32534807,10.1016/j.jns.2020.116935,2020-06-15
Problem,PROCESS_OF,Patients,32534807,10.1016/j.jns.2020.116935,2020-06-15
Pharmacotherapy,TREATS,Cancer Patient,32534807,10.1016/j.jns.2020.116935,2020-06-15
Active Method,TREATS,Malignant Neoplasms,32534807,10.1016/j.jns.2020.116935,2020-06-15
Treatment Protocols,METHOD_OF,Prophylactic treatment,32534739,10.1016/j.jmpt.2020.05.008,2020-06-15
Asymptomatic Diseases,PROCESS_OF,Patients,32534739,10.1016/j.jmpt.2020.05.008,2020-06-15
Treatment Protocols,ISA,Interventional procedure,32534739,10.1016/j.jmpt.2020.05.008,2020-06-15
musculoskeletal problem,PROCESS_OF,Population Group,32534693,10.1016/j.ihj.2020.04.009,2020-06-15
Chiropractic procedure,TREATS,Patients,32534693,10.1016/j.ihj.2020.04.009,2020-06-15
contextual factors,PROCESS_OF,Community,32534693,10.1016/j.ihj.2020.04.009,2020-06-15
Pandemics,CAUSES,Disease,32534633,10.1016/S1470-2045(20)30334-X,2020-06-15
Population Group,LOCATION_OF,Coronavirus antibody,32534600,10.4269/ajtmh.20-0592,2020-06-15
Immunity,PROCESS_OF,Population Group,32534600,10.4269/ajtmh.20-0592,2020-06-15
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32534598,10.4269/ajtmh.20-0596,2020-06-15
Lung,LOCATION_OF,Ultrasonography,32534513,10.18502/ijaai.v19i(s1.r1).2848,2020-06-15
angiotensin II,ISA,Peptides,32534505,10.18502/ijaai.v19i(s1.r1).2849,2020-06-15
angiotensin II,ISA,Peptides,32534505,10.18502/ijaai.v19i(s1.r1).2849,2020-06-15
,STIMULATES,Proteins,32534465,10.1111/anae.15180,2020-06-14
Storm NOS,PROCESS_OF,Patients,32534465,10.1111/anae.15180,2020-06-14
Disease,PROCESS_OF,Patients,32534465,10.1111/anae.15180,2020-06-14
Growth,PROCESS_OF,Clinician,32534458,10.1055/s-0040-1713416,2020-06-14
New Jersey,ISA,Geographic Locations,32534452,10.18632/aging.103493,2020-06-14
IMPACT gene,AFFECTS,Birth,32534452,10.18632/aging.103493,2020-06-14
Diastasis,OCCURS_IN,"Infant, Newborn",32534452,10.18632/aging.103493,2020-06-14
Fasting,PROCESS_OF,Patients,32534451,10.18632/aging.103449,2020-06-14
Growth Factor,CAUSES,Disease,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Growth Factor,PART_OF,Cells,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Metalloproteases,CAUSES,Disease,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
cytokine,CAUSES,Disease,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
chemokine,CAUSES,Disease,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Growth arrest,ASSOCIATED_WITH,Growth Factor,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Growth arrest,ASSOCIATED_WITH,Metalloproteases,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Growth arrest,ASSOCIATED_WITH,cytokine,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Growth arrest,ASSOCIATED_WITH,chemokine,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Pharmaceutical Preparations,DISRUPTS,Virulence,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Lithium,INHIBITS,"TXN protein, human",32534432,10.1016/j.dsx.2020.06.007,2020-06-14
"TXN protein, human",PART_OF,Astrocytes,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Present,PROCESS_OF,Patients,32534432,10.1016/j.dsx.2020.06.007,2020-06-14
Chloroquine,PREDISPOSES,Complication,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Hydroxychloroquine,PREDISPOSES,Complication,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
"Tachycardia, Ventricular",PREDISPOSES,Prolonged QT interval,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Azithromycin,ISA,Antibiotics,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Macrolides,TREATS,hospitalized patients,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Therapeutic procedure,TREATS,Patients,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Contacts,TREATS,Patients,32534344,10.1016/j.cmpb.2020.105581,2020-06-14
Lung,LOCATION_OF,Tissue damage,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Multiple Organ Failure,COEXISTS_WITH,patient condition,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Severe Acute Respiratory Syndrome,COEXISTS_WITH,patient condition,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Myocarditis,PROCESS_OF,Patients,32534336,10.1016/j.mehy.2020.109908,2020-06-14
diacetylrhein,ISA,Anthraquinones,32534336,10.1016/j.mehy.2020.109908,2020-06-14
rhein,ISA,Anthraquinones,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Inflammasomes,PART_OF,NLRP3 gene,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Proto-Oncogene Proteins c-akt,INTERACTS_WITH,TLR4 gene,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Metabolite,ASSOCIATED_WITH,Oxidative Stress,32534336,10.1016/j.mehy.2020.109908,2020-06-14
rhein,TREATS,Severe Acute Respiratory Syndrome,32534336,10.1016/j.mehy.2020.109908,2020-06-14
angiotensin converting enzyme 2,INTERACTS_WITH,"S protein, severe acute respiratory syndrome coronavirus",32534336,10.1016/j.mehy.2020.109908,2020-06-14
Anthraquinones,TREATS,Hyperinflammatory disorder,32534336,10.1016/j.mehy.2020.109908,2020-06-14
Coronavirus Infections,CAUSES,Disease,32534320,10.1016/j.scitotenv.2020.140033,2020-06-14
chemokine,ISA,cytokine,32534320,10.1016/j.scitotenv.2020.140033,2020-06-14
Gingival Diseases,COEXISTS_WITH,Redness,32534320,10.1016/j.scitotenv.2020.140033,2020-06-14
Gingival Diseases,COEXISTS_WITH,Enthesitis-Related Arthritis,32534320,10.1016/j.scitotenv.2020.140033,2020-06-14
Periodontitis,PROCESS_OF,Patients,32534320,10.1016/j.scitotenv.2020.140033,2020-06-14
Coronavirus Infections,ISA,Disease,32534301,10.1016/j.socscimed.2020.113119,2020-06-14
Coronavirus Infections,ISA,Disease,32534301,10.1016/j.socscimed.2020.113119,2020-06-14
Movement,PROCESS_OF,Homo sapiens,32534301,10.1016/j.socscimed.2020.113119,2020-06-14
Coronavirus Infections,ISA,Disease,32534301,10.1016/j.socscimed.2020.113119,2020-06-14
Coronavirus Infections,ISA,Disease,32534301,10.1016/j.socscimed.2020.113119,2020-06-14
Malignant Neoplasms,PROCESS_OF,Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Malignant Neoplasms,PROCESS_OF,Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Respiration Disorders,PROCESS_OF,Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Coronavirus Infections,ISA,Respiration Disorders,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Coronavirus Infections,CAUSES,inflammatory response,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Viral Pathogenesis,PROCESS_OF,Persons,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Malignant Neoplasms,PROCESS_OF,Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Immunotherapy,TREATS,Malignant Neoplasms,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Malignant Neoplasms,PROCESS_OF,Patients,32534228,10.1016/j.srhc.2020.100538,2020-06-14
Patients,LOCATION_OF,"CD69 protein, human",32534228,10.1016/j.srhc.2020.100538,2020-06-14
SARS coronavirus,CAUSES,Disease,32534210,10.1016/j.jse.2020.06.001,2020-06-14
Cross Infection,NEG_PROCESS_OF,Patients,32534189,10.1016/j.ijantimicag.2020.106053,2020-06-14
Cross Infection,NEG_PROCESS_OF,Surgeon,32534189,10.1016/j.ijantimicag.2020.106053,2020-06-14
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32534189,10.1016/j.ijantimicag.2020.106053,2020-06-14
Operative Surgical Procedures,ADMINISTERED_TO,Surgeon,32534189,10.1016/j.ijantimicag.2020.106053,2020-06-14
"Discharge, body substance",PART_OF,Patients,32534189,10.1016/j.ijantimicag.2020.106053,2020-06-14
Azithromycin,PREVENTS,Oxidative Stress,32534188,10.1016/j.ijantimicag.2020.106054,2020-06-14
Azithromycin,AFFECTS,"Respiratory Distress Syndrome, Adult",32534188,10.1016/j.ijantimicag.2020.106054,2020-06-14
Azithromycin,AFFECTS,Middle East Respiratory Syndrome,32534188,10.1016/j.ijantimicag.2020.106054,2020-06-14
Hydroxychloroquine,TREATS,Patients,32534188,10.1016/j.ijantimicag.2020.106054,2020-06-14
Hydroxychloroquine,TREATS,Patients,32534188,10.1016/j.ijantimicag.2020.106054,2020-06-14
Coronavirus Infections,ISA,Disease,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
Dyspnea,ISA,Symptoms,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
Infected,PROCESS_OF,Persons,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
Immunity,PROCESS_OF,Persons,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
"Immunity, Herd",PROCESS_OF,Persons,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
Laboratory Procedures,METHOD_OF,Diagnosis,32534187,10.1016/j.ijantimicag.2020.106055,2020-06-14
SARS coronavirus,CAUSES,Acute respiratory disease,32534186,10.1016/j.ijantimicag.2020.106051,2020-06-14
Middle East Respiratory Syndrome Coronavirus,CAUSES,Acute respiratory disease,32534186,10.1016/j.ijantimicag.2020.106051,2020-06-14
Disease Outbreaks,CAUSES,Disease,32534186,10.1016/j.ijantimicag.2020.106051,2020-06-14
Infected,PROCESS_OF,Patients,32534175,10.1016/j.mehy.2020.109851,2020-06-14
Patients,LOCATION_OF,procalcitonin,32534175,10.1016/j.mehy.2020.109851,2020-06-14
Serum,LOCATION_OF,procalcitonin,32534175,10.1016/j.mehy.2020.109851,2020-06-14
procalcitonin,AUGMENTS,Disease,32534175,10.1016/j.mehy.2020.109851,2020-06-14
Macrophage Activation Syndrome,COEXISTS_WITH,Comorbidity,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Macrophage Activation Syndrome,COEXISTS_WITH,Disseminated Intravascular Coagulation,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Macrophage Activation Syndrome,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Glutathione,PART_OF,Alveolar,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Inflammation,AFFECTS,Satellite Viruses,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Septicemia,CAUSES,Disseminated Intravascular Coagulation,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Anticoagulant therapy,USES,heparin,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
"Clinical Trials, Randomized",USES,Anticoagulant therapy,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
heparin,PREVENTS,Embolism and Thrombosis,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Lung,LOCATION_OF,Embolism and Thrombosis,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
sildenafil,INHIBITS,CARBONATE DEHYDRATASE,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Therapeutic procedure,TREATS,Pneumonia,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Therapeutic procedure,TREATS,"Respiratory Distress Syndrome, Adult",32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Therapeutic procedure,USES,Anti-Inflammatory Agents,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Prophylactic treatment,USES,Ivermectin,32534143,10.1016/j.ijid.2020.06.009,2020-06-14
Infected,PROCESS_OF,Patients,32534129,10.1053/j.ajkd.2020.06.001,2020-06-14
"Discharge, body substance",PART_OF,Patients,32534129,10.1053/j.ajkd.2020.06.001,2020-06-14
Peritoneal Dialysis,ISA,Hemodialysis,32534121,10.1016/j.ajic.2020.06.005,2020-06-14
Peritoneal Dialysis,ISA,Hemodialysis,32534121,10.1016/j.ajic.2020.06.005,2020-06-14
patient care,AFFECTS,Compliance,32534109,10.1016/j.hjc.2020.05.004,2020-06-14
Compliance,PROCESS_OF,Health Personnel,32534109,10.1016/j.hjc.2020.05.004,2020-06-14
Cardiac complication,AFFECTS,Disease Progression,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Coronavirus Infections,ISA,Disease,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Cessation of life,PROCESS_OF,Patients,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Cardiovascular Diseases,PREDISPOSES,Cardiac complication,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Infected,PROCESS_OF,Patients,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Cardiovascular,LOCATION_OF,Comorbidity,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Syndrome,COEXISTS_WITH,Disease Progression,32534094,10.1016/j.ijbiomac.2020.06.031,2020-06-14
Panavir,ISA,Agent,32534053,10.1016/j.gie.2020.06.008,2020-06-14
Coronavirus Infections,PROCESS_OF,Animals,32534053,10.1016/j.gie.2020.06.008,2020-06-14
Panavir,TREATS,Severe Acute Respiratory Syndrome,32534053,10.1016/j.gie.2020.06.008,2020-06-14
GSKIP gene,INTERACTS_WITH,Indicators,32534042,10.1016/j.cgh.2020.06.005,2020-06-14
IMPACT gene,INTERACTS_WITH,Indicators,32534042,10.1016/j.cgh.2020.06.005,2020-06-14
IMPACT gene,INTERACTS_WITH,Metric,32534042,10.1016/j.cgh.2020.06.005,2020-06-14
IMPACT gene,compared_with,GSKIP gene,32534042,10.1016/j.cgh.2020.06.005,2020-06-14
Feces,PART_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Feces,ASSOCIATED_WITH(INFER),Asymptomatic,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Feces,PART_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Asymptomatic,PROCESS_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Patients,LOCATION_OF,Feces,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Quarantine,TREATS,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Quarantine,TREATS(INFER),Virus,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Virus,PROCESS_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Patients,LOCATION_OF,Feces,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Patients,LOCATION_OF,Respiratory sample,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Negative,PROCESS_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Asymptomatic,PROCESS_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Mild disorder,PROCESS_OF,Patients,32534021,10.1016/j.reprotox.2020.06.006,2020-06-14
Coronavirus Infections,ISA,Disease,32533989,10.1016/j.diabres.2020.108266,2020-06-14
angiotensin converting enzyme 2,AFFECTS,Coronavirus Infections,32533989,10.1016/j.diabres.2020.108266,2020-06-14
Coronavirus Infections,ISA,Disease,32533989,10.1016/j.diabres.2020.108266,2020-06-14
Coronavirus Infections,ISA,Disease,32533989,10.1016/j.diabres.2020.108266,2020-06-14
Serum,LOCATION_OF,CD40LG wt Allele,32533989,10.1016/j.diabres.2020.108266,2020-06-14
Coronavirus Infections,ISA,Disease,32533989,10.1016/j.diabres.2020.108266,2020-06-14
Comorbidity,PROCESS_OF,Patients,32533988,10.1016/j.diabres.2020.108267,2020-06-14
Diabetes,PROCESS_OF,Patients,32533988,10.1016/j.diabres.2020.108267,2020-06-14
Antidiabetics,TREATS,Patients,32533988,10.1016/j.diabres.2020.108267,2020-06-14
Diabetes,PROCESS_OF,Patients,32533988,10.1016/j.diabres.2020.108267,2020-06-14
Prophylactic treatment,ISA,Therapeutic procedure,32533988,10.1016/j.diabres.2020.108267,2020-06-14
Peptide Hydrolases,AFFECTS,Virus Internalization,32533986,10.1016/j.cca.2020.06.008,2020-06-14
Peptide Hydrolases,PART_OF,Host Cell,32533986,10.1016/j.cca.2020.06.008,2020-06-14
Genetic Polymorphism,PROCESS_OF,Genes,32533986,10.1016/j.cca.2020.06.008,2020-06-14
Genetic Polymorphism,PROCESS_OF,ACE gene,32533986,10.1016/j.cca.2020.06.008,2020-06-14
Genetic Polymorphism,PROCESS_OF,ACE2 gene,32533986,10.1016/j.cca.2020.06.008,2020-06-14
Vaccination against tuberculosis,TREATS,"Immunity, Innate",32533986,10.1016/j.cca.2020.06.008,2020-06-14
Poor outcome,COEXISTS_WITH,Fever,32533957,10.1016/j.chest.2020.05.580,2020-06-14
Poor outcome,COEXISTS_WITH,Leukocytosis,32533957,10.1016/j.chest.2020.05.580,2020-06-14
Leukocytosis,PREDISPOSES,Poor outcome,32533957,10.1016/j.chest.2020.05.580,2020-06-14
Ambulatory Care Facilities,LOCATION_OF,case series,32533899,10.1111/jdv.16751,2020-06-14
Decision Making,PROCESS_OF,tailor,32533899,10.1111/jdv.16751,2020-06-14
Streptococcus pneumoniae,LOCATION_OF,Polysaccharides,32533899,10.1111/jdv.16751,2020-06-14
Chilblains,PROCESS_OF,Young Adult,32533891,10.1111/andr.12839,2020-06-14
Lesion,PROCESS_OF,Child,32533891,10.1111/andr.12839,2020-06-14
Lesion,PROCESS_OF,Family,32533891,10.1111/andr.12839,2020-06-14
Lesion,PROCESS_OF,Pediatrician (occupation),32533891,10.1111/andr.12839,2020-06-14
Acral Lesion,PROCESS_OF,Child,32533891,10.1111/andr.12839,2020-06-14
risk factors,COEXISTS_WITH,Skin lesion,32533891,10.1111/andr.12839,2020-06-14
Skin lesion,PROCESS_OF,Family member,32533891,10.1111/andr.12839,2020-06-14
Nasal Swab (procedure),USES,Immunoassay method,32533891,10.1111/andr.12839,2020-06-14
Limb structure,LOCATION_OF,Lesion,32533891,10.1111/andr.12839,2020-06-14
Lesion,NEG_PROCESS_OF,Patients,32533891,10.1111/andr.12839,2020-06-14
Biopsy of skin procedure,ADMINISTERED_TO,Patients,32533891,10.1111/andr.12839,2020-06-14
EVA1C gene,PART_OF,Parvovirus,32533891,10.1111/andr.12839,2020-06-14
Cold exposure,CAUSES,Chilblains,32533891,10.1111/andr.12839,2020-06-14
Seminal fluid specimen,PART_OF,Patients,32533876,10.1111/ene.14398,2020-06-14
Male genital infection,PROCESS_OF,Plant seeds,32533876,10.1111/ene.14398,2020-06-14
Tract,LOCATION_OF,Male genital infection,32533876,10.1111/ene.14398,2020-06-14
strategy,PROCESS_OF,Staff,32533844,10.1111/bjd.19311,2020-06-14
Therapeutic procedure,TREATS,Eating Disorders,32533777,10.1002/jmv.26174,2020-06-14
Anorexia Nervosa,PROCESS_OF,Child,32533777,10.1002/jmv.26174,2020-06-14
Anorexia Nervosa,PROCESS_OF,Adolescent (age group),32533777,10.1002/jmv.26174,2020-06-14
Telemedicine,TREATS,Child,32533777,10.1002/jmv.26174,2020-06-14
Telemedicine,TREATS,Adolescent (age group),32533777,10.1002/jmv.26174,2020-06-14
Bulimia Nervosa,PROCESS_OF,Child,32533777,10.1002/jmv.26174,2020-06-14
Bulimia Nervosa,PROCESS_OF,Adolescent (age group),32533777,10.1002/jmv.26174,2020-06-14
"Lung Diseases, Interstitial",ISA,Disease,32533773,10.1002/jmv.26173,2020-06-14
"Lung Diseases, Interstitial",OCCURS_IN,inpatient,32533773,10.1002/jmv.26173,2020-06-14
"Lung Diseases, Interstitial",OCCURS_IN,Cohort,32533773,10.1002/jmv.26173,2020-06-14
Fever,ISA,Symptoms,32533773,10.1002/jmv.26173,2020-06-14
"Lung Diseases, Interstitial",PROCESS_OF,Patients,32533773,10.1002/jmv.26173,2020-06-14
inflammatory response,COEXISTS_WITH,patient condition,32533773,10.1002/jmv.26173,2020-06-14
Coronavirus Infections,ISA,Disease,32533768,10.4193/Rhin20.227,2020-06-14
Coronavirus Infections,ISA,Disease,32533727,10.1002/ana.25814,2020-06-14
SARS coronavirus,CAUSES,Disease,32533727,10.1002/ana.25814,2020-06-14
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32533727,10.1002/ana.25814,2020-06-14
Coronavirus Infections,ISA,Disease,32533727,10.1002/ana.25814,2020-06-14
Coronavirus Infections,ISA,Disease,32533727,10.1002/ana.25814,2020-06-14
Electroencephalography,ADMINISTERED_TO,hospitalized patients,32533676,10.7399/fh.11488,2020-06-14
Infected,PROCESS_OF,hospitalized patients,32533676,10.7399/fh.11488,2020-06-14
Injury of central nervous system,PROCESS_OF,Patients,32533676,10.7399/fh.11488,2020-06-14
Hospital Departments,LOCATION_OF,Educational process of instructing,32533675,10.7399/fh.11494,2020-06-14
Residency,ISA,Training,32533675,10.7399/fh.11494,2020-06-14
Dispense,USES,Pharmaceutical Preparations,32533673,10.7399/fh.11491,2020-06-14
Satisfaction,PROCESS_OF,Patients,32533673,10.7399/fh.11491,2020-06-14
Health care facility,LOCATION_OF,Educational process of instructing,32533672,10.7399/fh.11495,2020-06-14
Patients,ISA,Persons,32533672,10.7399/fh.11495,2020-06-14
treatment need,PROCESS_OF,Patients,32533671,10.7399/fh.11492,2020-06-14
cell transformation,PROCESS_OF,Patients,32533671,10.7399/fh.11492,2020-06-14
Pharmaceutical Preparations,AUGMENTS,Present,32533671,10.7399/fh.11492,2020-06-14
Pharmaceutical Preparations,AUGMENTS,Shift worker,32533671,10.7399/fh.11492,2020-06-14
Nursing Homes,LOCATION_OF,Work,32533669,10.7399/fh.11517,2020-06-14
Experience,PROCESS_OF,Community,32533669,10.7399/fh.11517,2020-06-14
hospital pharmacies,LOCATION_OF,Task,32533668,10.7399/fh.11512,2020-06-14
Anti-Inflammatory Agents,TREATS,Patients,32533668,10.7399/fh.11512,2020-06-14
Antiviral Agents,TREATS,Patients,32533668,10.7399/fh.11512,2020-06-14
Investigational New Drugs,TREATS,teams,32533668,10.7399/fh.11512,2020-06-14
Decision Making,PROCESS_OF,work teams,32533667,10.7399/fh.11510,2020-06-14
Critical Illness,PROCESS_OF,Patients,32533666,10.7399/fh.11513,2020-06-14
Work,ISA,Activities,32533666,10.7399/fh.11513,2020-06-14
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32533662,10.7399/fh.11499,2020-06-14
inpatient,ISA,Patients,32533661,10.7399/fh.11514,2020-06-14
Institutionalized,PROCESS_OF,Patients,32533661,10.7399/fh.11514,2020-06-14
Spain,ISA,Country,32533621,10.1002/hed.26322,2020-06-14
Symptom mild,PROCESS_OF,Patients,32533621,10.1002/hed.26322,2020-06-14
Challenge,TREATS,Community,32533615,10.1111/tid.13367,2020-06-14
Nasopharynx,PART_OF,Patients,32533615,10.1111/tid.13367,2020-06-14
Failure to Thrive,COMPLICATES,Fluid overload,32533613,10.1111/1742-6723.13573,2020-06-14
Opportunistic Infections,COMPLICATES,Fluid overload,32533613,10.1111/1742-6723.13573,2020-06-14
"Wound, non-healed",COMPLICATES,Fluid overload,32533613,10.1111/1742-6723.13573,2020-06-14
cytokine,CAUSES,Multiple Organ Failure,32533613,10.1111/1742-6723.13573,2020-06-14
cytokine,CAUSES,"Respiratory Distress Syndrome, Adult",32533613,10.1111/1742-6723.13573,2020-06-14
Fever,PROCESS_OF,Patients,32533607,10.1111/pde.14269,2020-06-14
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32533607,10.1111/pde.14269,2020-06-14
Chills,PROCESS_OF,Patients,32533607,10.1111/pde.14269,2020-06-14
exposure history,PROCESS_OF,Patients,32533607,10.1111/pde.14269,2020-06-14
Lesion,PROCESS_OF,Patients,32533585,10.1002/clc.23406,2020-06-14
Edema,COEXISTS_WITH,Lateral margin,32533585,10.1002/clc.23406,2020-06-14
Foot,LOCATION_OF,Lateral margin,32533585,10.1002/clc.23406,2020-06-14
Heel,LOCATION_OF,Macule,32533585,10.1002/clc.23406,2020-06-14
Patients,USES,Preexisting Condition Coverage,32533563,10.1002/ca.23636,2020-06-14
Heart,LOCATION_OF,Adverse effects,32533563,10.1002/ca.23636,2020-06-14
Coronaviridae,PROCESS_OF,Family,32533556,10.1111/trf.15927,2020-06-14
Immunity,PROCESS_OF,Research Personnel,32533556,10.1111/trf.15927,2020-06-14
Reverse Transcriptase Polymerase Chain Reaction,USES,Nasal Swabs,32533545,10.17269/s41997-020-00361-y,2020-06-14
Negative,PROCESS_OF,Participant,32533545,10.17269/s41997-020-00361-y,2020-06-14
Community acquired pneumonia,PROCESS_OF,Patients,32533391,10.1007/s11604-020-00997-3,2020-06-14
Chronic lung disease,PROCESS_OF,Patients,32533391,10.1007/s11604-020-00997-3,2020-06-14
CD8A wt Allele,INHIBITS,"ERBB2 protein, human",32533346,10.1007/s00455-020-10140-z,2020-06-14
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32533346,10.1007/s00455-020-10140-z,2020-06-14
"T-Cell Surface Glycoprotein CD4, human",INHIBITS,"ERBB2 protein, human",32533346,10.1007/s00455-020-10140-z,2020-06-14
Signs and Symptoms,PROCESS_OF,Patients,32533263,10.1208/s12248-020-00465-w,2020-06-14
Pandemics,ISA,Disease Outbreaks,32533263,10.1208/s12248-020-00465-w,2020-06-14
Abnormality of the cranial nerves,ISA,Signs and Symptoms,32533263,10.1208/s12248-020-00465-w,2020-06-14
Abnormality of the cranial nerves,PROCESS_OF(SPEC),Patients,32533263,10.1208/s12248-020-00465-w,2020-06-14
Manometry,USES,High resolution,32533263,10.1208/s12248-020-00465-w,2020-06-14
Deglutition Disorders,COEXISTS_WITH,Respiratory Tract Infections,32533263,10.1208/s12248-020-00465-w,2020-06-14
Aspiration Pneumonia,COEXISTS_WITH,Respiratory Tract Infections,32533263,10.1208/s12248-020-00465-w,2020-06-14
Azithromycin,INTERACTS_WITH,,32533223,10.1007/s00167-020-06093-3,2020-06-14
Cytoplasmic matrix,PART_OF,Cells,32533223,10.1007/s00167-020-06093-3,2020-06-14
Azithromycin,AUGMENTS,Diffusion,32533223,10.1007/s00167-020-06093-3,2020-06-14
Hydroxychloroquine,compared_with,Hydroxychloroquine,32533223,10.1007/s00167-020-06093-3,2020-06-14
Critical Illness,PROCESS_OF,Patients,32533174,10.1093/pubmed/fdaa086,2020-06-14
"Kidney Failure, Acute",COEXISTS_WITH,Comorbidity,32533174,10.1093/pubmed/fdaa086,2020-06-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32533174,10.1093/pubmed/fdaa086,2020-06-14
Kidney,LOCATION_OF,receptor,32533174,10.1093/pubmed/fdaa086,2020-06-14
Virus Diseases,AUGMENTS,"Kidney Failure, Acute",32533174,10.1093/pubmed/fdaa086,2020-06-14
Positive End-Expiratory Pressure,AFFECTS,Patients,32533174,10.1093/pubmed/fdaa086,2020-06-14
INVESTIGATIONAL AGENTS,AFFECTS,"Kidney Failure, Acute",32533174,10.1093/pubmed/fdaa086,2020-06-14
Septicemia,PROCESS_OF,Patients,32533174,10.1093/pubmed/fdaa086,2020-06-14
"Kidney Failure, Acute",MANIFESTATION_OF,Injury of kidney,32533174,10.1093/pubmed/fdaa086,2020-06-14
"Kidney Failure, Acute",PROCESS_OF,Patients,32533174,10.1093/pubmed/fdaa086,2020-06-14
mental health,PROCESS_OF,Persons,32533166,10.1093/annweh/wxaa057,2020-06-14
Reaching,PROCESS_OF,Health Personnel,32533108,10.1038/s41577-020-0366-6,2020-06-14
Yellow Fever,INTERACTS_WITH,RNA Viruses,32533062,10.1038/s41392-020-0190-2,2020-06-14
Influenza A,PROCESS_OF,Aves,32533062,10.1038/s41392-020-0190-2,2020-06-14
SARS coronavirus,LOCATION_OF,"TLR4 protein, human",32532826,10.1136/medethics-2020-106516,2020-06-14
Complication,COEXISTS_WITH,Virus Diseases,32532802,10.1126/science.abc0035,2020-06-14
Vascular Endothelial Cells,PRODUCES,ACE2 gene,32532802,10.1126/science.abc0035,2020-06-14
Thromboplastin,INTERACTS_WITH,factor VII,32532802,10.1126/science.abc0035,2020-06-14
NADPH Oxidase,STIMULATES,NF-kappa B p50 Subunit,32532802,10.1126/science.abc0035,2020-06-14
NF-kappa B p50 Subunit,STIMULATES,F3 wt Allele,32532802,10.1126/science.abc0035,2020-06-14
Endosomes,LOCATION_OF,Virus,32532802,10.1126/science.abc0035,2020-06-14
Endosomes,PART_OF,Cells,32532802,10.1126/science.abc0035,2020-06-14
complex (molecular entity),INTERACTS_WITH,"TLR7 protein, human",32532802,10.1126/science.abc0035,2020-06-14
Thromboplastin,STIMULATES,NADPH Oxidase,32532802,10.1126/science.abc0035,2020-06-14
Glycine,PREDISPOSES,Thrombus,32532802,10.1126/science.abc0035,2020-06-14
Pharmaceutical Preparations,TREATS,Patients,32532755,10.2337/dc20-1176,2020-06-14
risk factors,PROCESS_OF,Patients,32532755,10.2337/dc20-1176,2020-06-14
Steroid therapy,TREATS,Patients,32532755,10.2337/dc20-1176,2020-06-14
Steroid therapy,TREATS(INFER),risk factors,32532755,10.2337/dc20-1176,2020-06-14
Diabetic Foot,ISA,Disease,32532753,10.1136/annrheumdis-2020-217763,2020-06-14
Rheumatism,PROCESS_OF,Patients,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Rheumatology department,LOCATION_OF,Retrospective Studies,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Hospitals,LOCATION_OF,Laboratory Procedures,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Arthritis,PROCESS_OF,Patients,32532703,10.1016/j.euf.2020.05.020,2020-06-14
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Senility,PROCESS_OF,reference group,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Arthritis,PROCESS_OF,Patients,32532703,10.1016/j.euf.2020.05.020,2020-06-14
Pandemics,ISA,Disease Outbreaks,32532691,10.1016/j.transci.2020.102817,2020-06-14
Prostate,LOCATION_OF,High-Risk Cancer,32532691,10.1016/j.transci.2020.102817,2020-06-14
Radical prostatectomy,TREATS,Low Grade Malignant Neoplasm,32532691,10.1016/j.transci.2020.102817,2020-06-14
Extraction,USES,"Stent, device",32532691,10.1016/j.transci.2020.102817,2020-06-14
"Immunotherapy, Passive",TREATS,Patients,32532623,10.1016/j.bj.2020.05.021,2020-06-14
Donor person,LOCATION_OF,Plasma,32532623,10.1016/j.bj.2020.05.021,2020-06-14
Evaluation,TREATS,Muscle Rigidity,32532623,10.1016/j.bj.2020.05.021,2020-06-14
Coronavirus Infections,CAUSES,Cessation of life,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Diagnosis,DIAGNOSES,Severe Acute Respiratory Syndrome,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Serologic tests,USES,Antibodies,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Protease Inhibitors,INHIBITS,Interleukin-6,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Viral Proteins,ASSOCIATED_WITH,Virus Diseases,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Vaccines,TREATS,Homo sapiens,32532619,10.1016/j.ajem.2020.05.117,2020-06-14
Disease,AFFECTS,Infant,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Disease,AFFECTS,Patients,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Organ,LOCATION_OF,Multiple Trauma,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Exanthema,PROCESS_OF,Woman,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Fever,PROCESS_OF,Woman,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Pharyngitis,PROCESS_OF,Woman,32532596,10.1016/j.radi.2020.05.012,2020-06-14
Critical Illness,PROCESS_OF,Patients,32532586,10.1016/j.remn.2020.04.004,2020-06-14
Critical Illness,PROCESS_OF,Patients,32532586,10.1016/j.remn.2020.04.004,2020-06-14
X-Ray Departments,LOCATION_OF,Diagnostic Imaging,32532586,10.1016/j.remn.2020.04.004,2020-06-14
Pneumonia,PROCESS_OF,Patients,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Asymptomatic,PROCESS_OF,Patients,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Asymptomatic,PROCESS_OF,Patients,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Lung,LOCATION_OF,INFECTIOUS PROCESS,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Lung,LOCATION_OF,INFECTIOUS PROCESS,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Asymptomatic,PROCESS_OF,Patients,32532524,10.1016/j.arcmed.2020.05.020,2020-06-14
Coronavirus Infections,ISA,Disease,32532523,10.1016/j.arcmed.2020.05.021,2020-06-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32532523,10.1016/j.arcmed.2020.05.021,2020-06-14
Coronavirus Infections,COEXISTS_WITH,compromise,32532523,10.1016/j.arcmed.2020.05.021,2020-06-14
Lung,PART_OF,Patients,32532523,10.1016/j.arcmed.2020.05.021,2020-06-14
Physicians,ISA,professional occupation status,32532461,10.1016/j.medcli.2020.04.018,2020-06-14
social worker,ISA,professional occupation status,32532461,10.1016/j.medcli.2020.04.018,2020-06-14
Storm Syndrome,ISA,Complication,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,ADMINISTERED_TO,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,ADMINISTERED_TO,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,ASSOCIATED_WITH,Storm Syndrome,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
tocilizumab,ADMINISTERED_TO,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
tocilizumab,ADMINISTERED_TO,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Storm Syndrome,PROCESS_OF,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,PART_OF,Patients,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,COEXISTS_WITH,tocilizumab,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Glucocorticoids,INTERACTS_WITH,CCL21 gene,32532460,10.1016/j.ygyno.2020.06.001,2020-06-14
Operative Surgical Procedures,TREATS,Patients,32532449,10.1016/j.jns.2020.116936,2020-06-14
Hemoglobin,PART_OF,Erythrocytes,32532430,10.1016/j.redar.2020.05.001,2020-06-14
Syndrome,ISA,Disease,32532430,10.1016/j.redar.2020.05.001,2020-06-14
Immune response,AFFECTS,Shock,32532430,10.1016/j.redar.2020.05.001,2020-06-14
Puncture procedure,METHOD_OF,Tracheotomy procedure,32532356,10.1186/s13063-020-04380-5,2020-06-14
Hospitals,LOCATION_OF,Clinical Trials,32532348,10.1186/s13054-020-03064-5,2020-06-14
Dental pulp cell,PART_OF,bony process,32532348,10.1186/s13054-020-03064-5,2020-06-14
Liver,LOCATION_OF,Severe disorder,32532348,10.1186/s13054-020-03064-5,2020-06-14
Severe disorder,PROCESS_OF,Patients,32532348,10.1186/s13054-020-03064-5,2020-06-14
Kidney Failure,PROCESS_OF,Patients,32532348,10.1186/s13054-020-03064-5,2020-06-14
Infusion procedures,COEXISTS_WITH,Hospitalization,32532348,10.1186/s13054-020-03064-5,2020-06-14
Serum amyloid A protein,ISA,Amyloid,32532348,10.1186/s13054-020-03064-5,2020-06-14
Serum,LOCATION_OF,Amyloid,32532348,10.1186/s13054-020-03064-5,2020-06-14
Serum,LOCATION_OF(SPEC),Serum amyloid A protein,32532348,10.1186/s13054-020-03064-5,2020-06-14
Genomic Profile,USES,Single-Cell Analysis,32532348,10.1186/s13054-020-03064-5,2020-06-14
Interleukin-1,ISA,cytokine,32532348,10.1186/s13054-020-03064-5,2020-06-14
Interleukin-4,ISA,cytokine,32532348,10.1186/s13054-020-03064-5,2020-06-14
Occult blood screen,ISA,Chemical method,32532348,10.1186/s13054-020-03064-5,2020-06-14
Pneumonia,ISA,Disease,32532085,10.3390/v12060628,2020-06-14
Pharmaceutical Preparations,TREATS,Disseminated Intravascular Coagulation,32532085,10.3390/v12060628,2020-06-14
nafamostat mesilate,INHIBITS,"PRSS2 protein, human",32532085,10.3390/v12060628,2020-06-14
Genus: Coronavirus,ISA,Virus,32532077,10.3390/ijerph17114151,2020-06-14
Betaferon,COEXISTS_WITH,"Antigens, Viral",32532077,10.3390/ijerph17114151,2020-06-14
Therapeutic procedure,TREATS,Coronavirus Infections,32532029,10.3390/ijerph17114148,2020-06-14
Intestines,LOCATION_OF,Purines,32532029,10.3390/ijerph17114148,2020-06-14
Voluntary,PROCESS_OF,citizen,32532013,10.3390/ijerph17114144,2020-06-14
Health-related behavior,PROCESS_OF,citizen,32532013,10.3390/ijerph17114144,2020-06-14
Exercise,TREATS,Sedentary behavior,32532012,10.3390/ijerph17114140,2020-06-14
Coronavirus Infections,ISA,Disease,32531955,10.3390/vaccines8020293,2020-06-14
Coronavirus Infections,ISA,Disease,32531955,10.3390/vaccines8020293,2020-06-14
Coronavirus Infections,ISA,Disease,32531955,10.3390/vaccines8020293,2020-06-14
Vaccines,NEG_TREATS,Genus: Coronavirus,32531948,10.3390/cancers12061513,2020-06-14
Multi-disciplinary team,USES,huperzine B,32531935,10.3390/ijerph17114135,2020-06-14
Symptoms,PROCESS_OF,Patients,32531935,10.3390/ijerph17114135,2020-06-14
Clinician,TREATS,Patients,32531935,10.3390/ijerph17114135,2020-06-14
IMPACT gene,PREDISPOSES,Metabolic Diseases,32531892,10.3390/nu12061730,2020-06-14
IkappaB kinase,ISA,Phosphotransferases,32531892,10.3390/nu12061730,2020-06-14
Metabolic Diseases,PROCESS_OF,Persons,32531892,10.3390/nu12061730,2020-06-14
Moving,AFFECTS,Persons,32531892,10.3390/nu12061730,2020-06-14
Adult,ISA,Population Group,32531884,10.3390/jcm9061802,2020-06-14
olive oil,ISA,Food,32531884,10.3390/jcm9061802,2020-06-14
Anxiety,ISA,Symptoms,32531837,10.1111/medu.14270,2020-06-13
Uncertainty,PROCESS_OF,Persons,32531837,10.1111/medu.14270,2020-06-13
Hypersensitivity,AFFECTS,Patients,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lung,LOCATION_OF,Chloroquine,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lung,LOCATION_OF,Hydroxychloroquine,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lung,LOCATION_OF,Azithromycin,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lung,LOCATION_OF,Respiration Disorders,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Structure of parenchyma of lung,LOCATION_OF,Chloroquine,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Structure of parenchyma of lung,LOCATION_OF,Hydroxychloroquine,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Kidney Failure,PROCESS_OF,Patients,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lung,LOCATION_OF,Renal Insufficiency,32531777,10.1088/1752-7163/ab9c32,2020-06-13
Lipids,PREDISPOSES,Virus Diseases,32531754,10.1016/j.msard.2020.102250,2020-06-13
Proteins,PREDISPOSES,Virus Diseases,32531754,10.1016/j.msard.2020.102250,2020-06-13
Host Cell,LOCATION_OF,Glycolysis,32531754,10.1016/j.msard.2020.102250,2020-06-13
Therapeutic procedure,USES,Integrins,32531713,10.1016/j.intimp.2020.106683,2020-06-13
natalizumab,TREATS,Multiple Sclerosis,32531713,10.1016/j.intimp.2020.106683,2020-06-13
Multiple Sclerosis,PROCESS_OF,Patients,32531713,10.1016/j.intimp.2020.106683,2020-06-13
natalizumab,TREATS,Patients,32531713,10.1016/j.intimp.2020.106683,2020-06-13
natalizumab,TREATS(INFER),Multiple Sclerosis,32531713,10.1016/j.intimp.2020.106683,2020-06-13
natalizumab,STIMULATES,Integrins,32531713,10.1016/j.intimp.2020.106683,2020-06-13
Senility,PROCESS_OF,Patients,32531684,10.1016/j.scitotenv.2020.140101,2020-06-13
Performance,PROCESS_OF,Patients,32531684,10.1016/j.scitotenv.2020.140101,2020-06-13
Disease Progression,PROCESS_OF,Patients,32531684,10.1016/j.scitotenv.2020.140101,2020-06-13
Epidemic disease,PROCESS_OF,World,32531620,10.1016/j.amjoto.2020.102573,2020-06-13
Pandemics,ISA,Disease Outbreaks,32531620,10.1016/j.amjoto.2020.102573,2020-06-13
Vaccines,NEG_TREATS,Virus,32531620,10.1016/j.amjoto.2020.102573,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Cessation of life,PROCESS_OF,Child,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Pneumonia,CAUSES,Cessation of life,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Comorbidity,PROCESS_OF,Patients,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Coughing,PROCESS_OF,Patients,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Child,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Therapeutic procedure,USES,Hydroxychloroquine,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Population Group,LOCATION_OF,Antiviral Agents,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Population Group,LOCATION_OF,Interferons,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Infected,PROCESS_OF,Child,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Comorbidity,PROCESS_OF,Child,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Unilateral clinical finding,PROCESS_OF,Patients,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Coughing,PROCESS_OF,Patients,32531548,10.1016/j.thromres.2020.06.010,2020-06-13
Pneumonia,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Pulmonary Embolism,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Thrombus,ISA,Lesion,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Thrombus,PROCESS_OF(SPEC),Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Lesion,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Acute pulmonary embolism,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Thrombus,ISA,Lesion,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Thrombus,PROCESS_OF(SPEC),Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Lesion,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Parenchyma,LOCATION_OF,Lesion,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Parenchyma,LOCATION_OF(SPEC),Thrombus,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Parenchyma,PART_OF,Lung,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Pulmonary Trunk,LOCATION_OF,Pulmonary Embolism,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Pulmonary Embolism,PROCESS_OF,Patients,32531540,10.1016/j.mehy.2020.109972,2020-06-13
Residency,ISA,Training,32531539,10.1016/j.mehy.2020.109954,2020-06-13
IMPACT gene,DISRUPTS,Syndrome,32531539,10.1016/j.mehy.2020.109954,2020-06-13
Microcirculation,AFFECTS,Respiration,32531538,10.1016/j.mehy.2020.109957,2020-06-13
Hesperidin,ISA,Antioxidants,32531475,10.1016/j.cmi.2020.05.036,2020-06-13
Hesperidin,AFFECTS,Coronavirus Infections,32531475,10.1016/j.cmi.2020.05.036,2020-06-13
heparin,PREVENTS,Venous Thromboembolism,32531475,10.1016/j.cmi.2020.05.036,2020-06-13
Hesperidin,ISA,Agent,32531475,10.1016/j.cmi.2020.05.036,2020-06-13
treatment options,USES,Immunologic Adjuvants,32531475,10.1016/j.cmi.2020.05.036,2020-06-13
Patients,LOCATION_OF,Serum,32531372,10.1016/j.jaci.2020.05.051,2020-06-13
Asthma,PROCESS_OF,Cohort,32531352,10.1016/j.mvr.2020.104028,2020-06-13
Intrinsic factor,ASSOCIATED_WITH,Asthma,32531352,10.1016/j.mvr.2020.104028,2020-06-13
Intrinsic factor,PART_OF,Patients,32531352,10.1016/j.mvr.2020.104028,2020-06-13
Epithelium of bronchus,LOCATION_OF,ACE2 gene,32531352,10.1016/j.mvr.2020.104028,2020-06-13
Cell Count,USES,Bronchial Lavage,32531352,10.1016/j.mvr.2020.104028,2020-06-13
Hypertensive disease,ASSOCIATED_WITH,Up-Regulation (Physiology),32531352,10.1016/j.mvr.2020.104028,2020-06-13
Coronavirus Infections,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Gastrointestinal symptom,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Viral Conjunctivitis,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Negative,PROCESS_OF,Adult,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Negative,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Positive Finding,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
conjunctiva,LOCATION_OF,Virus present,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Possible,PROCESS_OF,Patients,32531325,10.1016/j.diabres.2020.108263,2020-06-13
Duration,TREATS,Diabetes,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetes,PROCESS_OF,Patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetic Ketoacidosis,PROCESS_OF,Patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetes,PROCESS_OF,hospitalized patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetes,PROCESS_OF,geriatric patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetic Ketoacidosis,PROCESS_OF,Patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Diabetic Ketoacidosis,PROCESS_OF,Patients,32531308,10.1016/j.ijsu.2020.06.015,2020-06-13
Laboratory Procedures,DIAGNOSES,Tissue damage,32531256,10.1016/j.cca.2020.06.017,2020-06-13
Oxygen,PART_OF,Arteries,32531256,10.1016/j.cca.2020.06.017,2020-06-13
C-reactive protein,AFFECTS,Respiration,32531256,10.1016/j.cca.2020.06.017,2020-06-13
Respiratory Failure,PROCESS_OF,Patients,32531256,10.1016/j.cca.2020.06.017,2020-06-13
Laboratory Procedures,METHOD_OF,early identification,32531256,10.1016/j.cca.2020.06.017,2020-06-13
Malaise,PROCESS_OF,Patients,32531236,10.1016/j.virusres.2020.198057,2020-06-13
Storm NOS,PROCESS_OF,Patients,32531236,10.1016/j.virusres.2020.198057,2020-06-13
Storm NOS,COEXISTS_WITH,Disease Progression,32531236,10.1016/j.virusres.2020.198057,2020-06-13
Pharmaceutical Preparations,DISRUPTS,Immune response,32531236,10.1016/j.virusres.2020.198057,2020-06-13
Pharmaceutical Preparations,INHIBITS,cytokine,32531236,10.1016/j.virusres.2020.198057,2020-06-13
Pharmaceutical Preparations,ISA,Chemicals,32531235,10.1016/j.virusres.2020.198058,2020-06-13
Coronavirus Infections,ISA,Disease,32531208,10.1016/j.celrep.2020.107774,2020-06-13
Structural protein,PART_OF,Virus,32531208,10.1016/j.celrep.2020.107774,2020-06-13
Virus,PROCESS_OF,Engineer,32531208,10.1016/j.celrep.2020.107774,2020-06-13
Cessation of life,PROCESS_OF,Homo sapiens,32531181,10.1080/17843286.2020.1778348,2020-06-13
Protein Subunits,PART_OF,Persons,32531181,10.1080/17843286.2020.1778348,2020-06-13
"Hypothermia, natural",PROCESS_OF,Homo sapiens,32531181,10.1080/17843286.2020.1778348,2020-06-13
Disease,PROCESS_OF,Patients,32531154,10.1021/acs.est.0c02178,2020-06-13
Coronavirus Infections,ISA,Disease,32531154,10.1021/acs.est.0c02178,2020-06-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32531154,10.1021/acs.est.0c02178,2020-06-13
Disease,COEXISTS_WITH,study.total,32531154,10.1021/acs.est.0c02178,2020-06-13
Coronavirus Infections,COEXISTS_WITH(SPEC),study.total,32531154,10.1021/acs.est.0c02178,2020-06-13
Coronavirus Infections,ISA,Disease,32531154,10.1021/acs.est.0c02178,2020-06-13
Influenza-like symptoms,PROCESS_OF,Patients,32531154,10.1021/acs.est.0c02178,2020-06-13
Isolation procedure,TREATS,"Infant, Newborn",32531138,10.1111/tbed.13674,2020-06-13
Infection status,PROCESS_OF,Infant,32531138,10.1111/tbed.13674,2020-06-13
Infection status,PROCESS_OF,Infant,32531138,10.1111/tbed.13674,2020-06-13
"Infant, Newborn",LOCATION_OF,Expressed breast milk,32531138,10.1111/tbed.13674,2020-06-13
Hospitals,LOCATION_OF,Retrospective Studies,32531129,10.1111/jocs.14641,2020-06-13
Duration,TREATS,Subgroup A Nepoviruses,32531129,10.1111/jocs.14641,2020-06-13
intensive care unit,LOCATION_OF,Administration occupational activities,32531129,10.1111/jocs.14641,2020-06-13
Current Therapy,USES,Antiviral Agents,32531129,10.1111/jocs.14641,2020-06-13
Epidemic,ISA,Disease Outbreaks,32531129,10.1111/jocs.14641,2020-06-13
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32531128,10.1111/jocs.14657,2020-06-13
Patient Transport,COEXISTS_WITH,Disinfection,32531128,10.1111/jocs.14657,2020-06-13
Cannulation,PRECEDES,Disinfection,32531128,10.1111/jocs.14657,2020-06-13
Decision,PROCESS_OF,Patients,32531124,10.1111/jocs.14648,2020-06-13
urgent Operation,TREATS,Patients,32531124,10.1111/jocs.14648,2020-06-13
Clinical immunologist,ISA,Health Personnel,32531085,10.1111/bjh.16938,2020-06-13
Diagnosis,AFFECTS,Asthma,32531085,10.1111/bjh.16938,2020-06-13
World Health Organization,ISA,Organization administrative structures,32531085,10.1111/bjh.16938,2020-06-13
Allergy clinic,LOCATION_OF,Administration occupational activities,32531085,10.1111/bjh.16938,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32531083,10.1111/ene.14388,2020-06-13
Health Personnel,DIAGNOSES,Symptoms,32531046,10.1093/ntr/ntaa105,2020-06-13
Decision,PROCESS_OF,Staff,32531046,10.1093/ntr/ntaa105,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32531046,10.1093/ntr/ntaa105,2020-06-13
Pandemics,ISA,health and disease,32531040,10.1093/ehjcvp/pvaa062,2020-06-13
Coronary Arteriosclerosis,PROCESS_OF,Patients,32530994,10.15403/jgld-2440,2020-06-13
1 time,PROCESS_OF,Patients,32530994,10.15403/jgld-2440,2020-06-13
Liver Cirrhosis,PROCESS_OF,Patients,32530989,10.15403/jgld-2513,2020-06-13
Coronavirus Infections,PROCESS_OF,Patients,32530989,10.15403/jgld-2513,2020-06-13
Bilirubin,ASSOCIATED_WITH,Liver damage,32530929,10.1371/journal.pone.0234682,2020-06-13
Virus,CAUSES,Disease,32530911,10.1371/journal.pone.0234232,2020-06-13
Patients,LOCATION_OF,"LAMP2 protein, human",32530911,10.1371/journal.pone.0234232,2020-06-13
Program,TREATS,Woman,32530870,10.1097/MCG.0000000000001371,2020-06-13
Infection status,PROCESS_OF,Staff,32530870,10.1097/MCG.0000000000001371,2020-06-13
Program,TREATS,Woman,32530870,10.1097/MCG.0000000000001371,2020-06-13
Ibuprofen,ISA,"Anti-Inflammatory Agents, Non-Steroidal",32530862,10.1097/QAI.0000000000002414,2020-06-13
Infected,PROCESS_OF,Patients,32530862,10.1097/QAI.0000000000002414,2020-06-13
mesalamine,ISA,aminosalicylate,32530862,10.1097/QAI.0000000000002414,2020-06-13
Aspirin,TREATS,Inflammatory Bowel Diseases,32530862,10.1097/QAI.0000000000002414,2020-06-13
medication use,PROCESS_OF,Patients,32530862,10.1097/QAI.0000000000002414,2020-06-13
HIV,LOCATION_OF,IMPACT gene,32530822,10.1097/01.ASW.0000669920.94084.c1,2020-06-13
Face,LOCATION_OF,Protection,32530817,10.2196/20156,2020-06-13
Health Campaigns,TREATS,Population Group,32530816,10.2196/19611,2020-06-13
Coronavirus Infections,ISA,Disease,32530814,10.2196/19236,2020-06-13
Adequate Knowledge,PROCESS_OF,student,32530814,10.2196/19236,2020-06-13
Anxiety,AFFECTS,Population Group,32530813,10.2196/20469,2020-06-13
Disease,COEXISTS_WITH,Worried,32530813,10.2196/20469,2020-06-13
Coronavirus Infections,COEXISTS_WITH(SPEC),Worried,32530813,10.2196/20469,2020-06-13
Coronavirus Infections,ISA,Disease,32530813,10.2196/20469,2020-06-13
Nurses,ISA,Health Personnel,32530808,10.1016/j.virol.2020.05.006,2020-06-13
Physicians,ISA,Health Personnel,32530808,10.1016/j.virol.2020.05.006,2020-06-13
"Immunoglobulins, Intravenous",TREATS,Patients,32530776,10.12968/jowc.2020.29.6.312,2020-06-13
Lung,LOCATION_OF,Lesion,32530776,10.12968/jowc.2020.29.6.312,2020-06-13
"Immunoglobulins, Intravenous",TREATS,Disease,32530776,10.12968/jowc.2020.29.6.312,2020-06-13
Lesion,PROCESS_OF,Patients,32530776,10.12968/jowc.2020.29.6.312,2020-06-13
Symptom severe,PROCESS_OF,Patients,32530776,10.12968/jowc.2020.29.6.312,2020-06-13
Pressure- physical agent,CAUSES,Pressure Ulcer,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Force,CAUSES,Pressure Ulcer,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Skin,LOCATION_OF,Destructive procedure (surgical),32530738,10.1161/STROKEAHA.120.030481,2020-06-13
IMPACT gene,AUGMENTS,Respiration,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
IMPACT gene,AUGMENTS,Alveolar ventilation function,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Respiration,PROCESS_OF,Patients,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Prophylactic treatment,TREATS,Patients,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Hydrocolloids,TREATS,Cohort,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Prophylactic treatment,USES,Medical dressing,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Transparent film,TREATS,Cohort,32530738,10.1161/STROKEAHA.120.030481,2020-06-13
Nose,LOCATION_OF,Obstruction,32530587,10.3906/sag-2005-378,2020-06-13
Obstruction,ISA,Signs and Symptoms,32530587,10.3906/sag-2005-378,2020-06-13
Rhinitis,ISA,Signs and Symptoms,32530587,10.3906/sag-2005-378,2020-06-13
Disease,AFFECTS,Inflammation,32530587,10.3906/sag-2005-378,2020-06-13
Nucleus solitarius,LOCATION_OF,Inflammation,32530587,10.3906/sag-2005-378,2020-06-13
Hypoxemia,PROCESS_OF,Patients,32530587,10.3906/sag-2005-378,2020-06-13
Projection Defense Mechanism,PROCESS_OF,Meleagris gallopavo,32530552,10.1002/ppul.24900,2020-06-13
Anxiety,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Patients,32530531,10.1002/jmv.26167,2020-06-13
Teleconference,METHOD_OF,State-trait anger expression inventory,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Anxiety score,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Chronic infectious disease,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Chronic infectious disease,PROCESS_OF,Pseudomonas,32530531,10.1002/jmv.26167,2020-06-13
Anxiety,PROCESS_OF,Mother (person),32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Cystic Fibrosis,PROCESS_OF,Child,32530531,10.1002/jmv.26167,2020-06-13
Coinfection,PROCESS_OF,Community,32530509,10.1002/jmv.26166,2020-06-13
Coughing,ISA,Symptoms,32530509,10.1002/jmv.26166,2020-06-13
Fever,ISA,Symptoms,32530509,10.1002/jmv.26166,2020-06-13
"Pneumonia, Viral",PROCESS_OF,Patients,32530509,10.1002/jmv.26166,2020-06-13
Complication,PROCESS_OF,Patients,32530509,10.1002/jmv.26166,2020-06-13
Complication,PROCESS_OF,Patients,32530509,10.1002/jmv.26166,2020-06-13
"Respiratory Distress Syndrome, Adult",ISA,Complication,32530509,10.1002/jmv.26166,2020-06-13
"Respiratory Distress Syndrome, Adult",PROCESS_OF(SPEC),Patients,32530509,10.1002/jmv.26166,2020-06-13
Influenza,AFFECTS,Coinfection,32530509,10.1002/jmv.26166,2020-06-13
Cardiac troponin I,PART_OF,Patients,32530507,10.1002/jmv.26165,2020-06-13
Evaluation procedure,AFFECTS,Improved,32530507,10.1002/jmv.26165,2020-06-13
Evaluation procedure,TREATS,Patients,32530507,10.1002/jmv.26165,2020-06-13
Coronavirus Infections,ISA,Disease,32530505,10.1002/jmv.26170,2020-06-13
Storm NOS,COEXISTS_WITH,Disease,32530505,10.1002/jmv.26170,2020-06-13
Storm NOS,COEXISTS_WITH(SPEC),Coronavirus Infections,32530505,10.1002/jmv.26170,2020-06-13
Adrenal Cortex Hormones,ASSOCIATED_WITH,Pneumonia,32530505,10.1002/jmv.26170,2020-06-13
Adrenal Cortex Hormones,ASSOCIATED_WITH,Syndrome,32530505,10.1002/jmv.26170,2020-06-13
Pneumonia,PROCESS_OF,Patients,32530505,10.1002/jmv.26170,2020-06-13
Complement System Proteins,ISA,Agent,32530503,10.1111/dth.13804,2020-06-13
Mucous Membrane,LOCATION_OF,"Skin Diseases, Bacterial",32530499,10.1002/jmv.26163,2020-06-13
Common wart,ISA,Disease,32530499,10.1002/jmv.26163,2020-06-13
Infected,PROCESS_OF,Patients,32530494,10.1002/jmv.26168,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32530494,10.1002/jmv.26168,2020-06-13
Confirmation,PROCESS_OF,Patients,32530490,10.1002/jmv.26171,2020-06-13
Coitus,PROCESS_OF,Human Age Group,32530490,10.1002/jmv.26171,2020-06-13
Acute respiratory disease,COEXISTS_WITH,Coronavirus Infections,32530453,10.1001/jamasurg.2020.2713,2020-06-13
Epidemic,ISA,Disease Outbreaks,32530453,10.1001/jamasurg.2020.2713,2020-06-13
Blood Vessel,LOCATION_OF,Complication,32530438,10.1172/jci.insight.140971,2020-06-13
Complication,PROCESS_OF,Patients,32530438,10.1172/jci.insight.140971,2020-06-13
Operative Surgical Procedures,TREATS,Patients,32530438,10.1172/jci.insight.140971,2020-06-13
Complication,PROCESS_OF,Patients,32530438,10.1172/jci.insight.140971,2020-06-13
urgent Operation,TREATS,surgical patients,32530438,10.1172/jci.insight.140971,2020-06-13
Complication,PROCESS_OF,Patients,32530438,10.1172/jci.insight.140971,2020-06-13
Neurologic Symptoms,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Comatose,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Seizures,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Cerebrovascular accident,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Paraparesis,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Weakness,PROCESS_OF,Patients,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Severe Acute Respiratory Syndrome,CAUSES,Syndrome,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Neurological observations,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32530369,10.1080/1120009X.2020.1775424,2020-06-13
Coronavirus Infections,ISA,Disease,32530367,10.1177/0025817220935752,2020-06-13
Symptom severe,PROCESS_OF,Patients,32530367,10.1177/0025817220935752,2020-06-13
treatment options,TREATS,Community,32530367,10.1177/0025817220935752,2020-06-13
treatment options,TREATS,Patients,32530367,10.1177/0025817220935752,2020-06-13
treatment options,TREATS(INFER),Symptom severe,32530367,10.1177/0025817220935752,2020-06-13
Disease,PROCESS_OF,Patients,32530367,10.1177/0025817220935752,2020-06-13
Coronavirus Infections,ISA,Disease,32530367,10.1177/0025817220935752,2020-06-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32530367,10.1177/0025817220935752,2020-06-13
Department,LOCATION_OF,Retrospective Studies,32530367,10.1177/0025817220935752,2020-06-13
lopinavir / Ritonavir,TREATS,Short menstrual periods,32530367,10.1177/0025817220935752,2020-06-13
lopinavir / Ritonavir,TREATS,Patients,32530367,10.1177/0025817220935752,2020-06-13
lopinavir / Ritonavir,TREATS(INFER),Severe Acute Respiratory Syndrome,32530367,10.1177/0025817220935752,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32530367,10.1177/0025817220935752,2020-06-13
Partnership,LOCATION_OF,Clinical Decision-Making,32530326,10.1080/14992027.2020.1776406,2020-06-13
Cardiac Arrhythmia,PROCESS_OF,Patients,32530284,10.1021/acs.jcim.0c00501,2020-06-13
Infected,PROCESS_OF,Health Personnel,32530284,10.1021/acs.jcim.0c00501,2020-06-13
"CD69 protein, human",PART_OF,Health Personnel,32530284,10.1021/acs.jcim.0c00501,2020-06-13
Pharmaceutical Preparations,TREATS,Virus,32530163,10.12116/j.issn.1004-5619.2020.02.006,2020-06-13
darunavir,INTERACTS_WITH,"3C-like protease, SARS coronavirus",32530163,10.12116/j.issn.1004-5619.2020.02.006,2020-06-13
darunavir,ISA,HIV Protease Inhibitors,32530163,10.12116/j.issn.1004-5619.2020.02.006,2020-06-13
"Pneumonia, Viral",PROCESS_OF,Child,32530131,10.1002/hed.26317,2020-06-13
"Pneumonia, Viral",PROCESS_OF,Child,32530131,10.1002/hed.26317,2020-06-13
Coronavirus Infections,CAUSES,"Pneumonia, Viral",32530131,10.1002/hed.26317,2020-06-13
Lung,LOCATION_OF,Edema,32530131,10.1002/hed.26317,2020-06-13
Lung,LOCATION_OF(SPEC),Pleural effusion disorder,32530131,10.1002/hed.26317,2020-06-13
Pleural effusion disorder,ISA,Edema,32530131,10.1002/hed.26317,2020-06-13
Respiratory Mucosa,LOCATION_OF,Hyperemia,32530131,10.1002/hed.26317,2020-06-13
Alveolus,LOCATION_OF,Edema,32530131,10.1002/hed.26317,2020-06-13
Alveolus,LOCATION_OF,Edema,32530131,10.1002/hed.26317,2020-06-13
Immunity,PROCESS_OF,Child,32530131,10.1002/hed.26317,2020-06-13
"Pneumonia, Viral",PROCESS_OF,Child,32530131,10.1002/hed.26317,2020-06-13
Coronavirus Infections,PROCESS_OF,Patients,32530033,10.1093/pubmed/fdaa078,2020-06-13
Chest,LOCATION_OF,tomography,32530033,10.1093/pubmed/fdaa078,2020-06-13
Severe Acute Respiratory Syndrome,PREDISPOSES,Viral Pathogenesis,32529918,10.1080/08959420.2020.1772003,2020-06-13
antagonists,compared_with,antagonists,32529918,10.1080/08959420.2020.1772003,2020-06-13
Aging,COEXISTS_WITH,Waking,32529906,10.1080/22221751.2020.1780951,2020-06-13
Diagnostic tests,DIAGNOSES,Acute Disease,32529889,10.1080/08880018.2020.1767740,2020-06-13
Malignant Neoplasms,PROCESS_OF,Child,32529866,10.1080/17476348.2020.1782198,2020-06-13
Infection,PROCESS_OF,Child,32529866,10.1080/17476348.2020.1782198,2020-06-13
Pharmacotherapy,PREVENTS,Severe Acute Respiratory Syndrome,32529866,10.1080/17476348.2020.1782198,2020-06-13
Elective Surgical Procedures,PREVENTS,Severe Acute Respiratory Syndrome,32529866,10.1080/17476348.2020.1782198,2020-06-13
Solid Neoplasm,PROCESS_OF,Patients,32529866,10.1080/17476348.2020.1782198,2020-06-13
SARS coronavirus,LOCATION_OF,Vaccines,32529815,10.3348/kjr.2020.0423,2020-06-13
Disease,PROCESS_OF,Patients,32529795,10.1002/ehf2.12805,2020-06-13
Coronavirus Infections,ISA,Disease,32529795,10.1002/ehf2.12805,2020-06-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32529795,10.1002/ehf2.12805,2020-06-13
Coronavirus Infections,ISA,Disease,32529795,10.1002/ehf2.12805,2020-06-13
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32529774,10.1111/joim.13126,2020-06-13
Ethambutol,CAUSES,myocardial injury,32529774,10.1111/joim.13126,2020-06-13
Cyclosporine,TREATS,Transplant Recipients,32529703,10.1111/maq.12587,2020-06-13
Blood,LOCATION_OF,CD40LG wt Allele,32529595,10.1007/s40520-020-01616-x,2020-06-13
Blood,PART_OF,"Infant, Newborn",32529595,10.1007/s40520-020-01616-x,2020-06-13
Optimism,PROCESS_OF,general population,32529575,10.1007/s00415-020-09974-2,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Old age,32529575,10.1007/s00415-020-09974-2,2020-06-13
Brain,LOCATION_OF,Syndrome,32529545,10.1007/s13659-020-00250-4,2020-06-13
Brain,LOCATION_OF,Acute inflammation,32529545,10.1007/s13659-020-00250-4,2020-06-13
Meninges,LOCATION_OF,Syndrome,32529545,10.1007/s13659-020-00250-4,2020-06-13
Meninges,LOCATION_OF,Acute inflammation,32529545,10.1007/s13659-020-00250-4,2020-06-13
Spinal Cord,LOCATION_OF,Syndrome,32529545,10.1007/s13659-020-00250-4,2020-06-13
Spinal Cord,LOCATION_OF,Acute inflammation,32529545,10.1007/s13659-020-00250-4,2020-06-13
Neurologic Manifestations,COEXISTS_WITH,Disease Progression,32529545,10.1007/s13659-020-00250-4,2020-06-13
Antiviral Agents,TREATS,Severe Acute Respiratory Syndrome,32529517,10.1007/s11886-020-01327-9,2020-06-13
Antiviral Agents,TREATS,Middle East Respiratory Syndrome,32529517,10.1007/s11886-020-01327-9,2020-06-13
Prophylactic treatment,TREATS,Patients,32529516,10.1007/s13365-020-00858-9,2020-06-13
vinyltriethoxysilane,COEXISTS_WITH,GSKIP gene,32529516,10.1007/s13365-020-00858-9,2020-06-13
Clinician,DIAGNOSES,Disease,32529516,10.1007/s13365-020-00858-9,2020-06-13
Pneumonia,PROCESS_OF,Woman,32529477,10.1007/s00011-020-01372-8,2020-06-13
Neurologic Examination,DIAGNOSES,Miller Fisher Syndrome,32529477,10.1007/s00011-020-01372-8,2020-06-13
Lower Extremity,LOCATION_OF,"Signs and Symptoms, Respiratory",32529477,10.1007/s00011-020-01372-8,2020-06-13
Lower Extremity,LOCATION_OF,Hyporeflexia,32529477,10.1007/s00011-020-01372-8,2020-06-13
Old age,ISA,Adult,32529424,10.1007/s00347-020-01142-1,2020-06-13
Coronavirus Infections,PROCESS_OF,Adult,32529424,10.1007/s00347-020-01142-1,2020-06-13
Multiple Organ Failure,PROCESS_OF,Patients,32529424,10.1007/s00347-020-01142-1,2020-06-13
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32529424,10.1007/s00347-020-01142-1,2020-06-13
Storm NOS,PROCESS_OF,geriatric patients,32529424,10.1007/s00347-020-01142-1,2020-06-13
ACE2 gene,PREDISPOSES,Storm NOS,32529424,10.1007/s00347-020-01142-1,2020-06-13
Storm NOS,PROCESS_OF,geriatric patients,32529424,10.1007/s00347-020-01142-1,2020-06-13
Adult,LOCATION_OF,"CD69 protein, human",32529424,10.1007/s00347-020-01142-1,2020-06-13
Coronavirus Infections,PROCESS_OF,Adult,32529424,10.1007/s00347-020-01142-1,2020-06-13
Coronavirus Infections,PROCESS_OF(SPEC),Old age,32529424,10.1007/s00347-020-01142-1,2020-06-13
Old age,ISA,Adult,32529424,10.1007/s00347-020-01142-1,2020-06-13
Old age,LOCATION_OF(SPEC),"CD69 protein, human",32529424,10.1007/s00347-020-01142-1,2020-06-13
Triage,TREATS,At risk of disease,32529409,10.1007/s10549-020-05724-0,2020-06-13
Standard precautions,PREVENTS,Infection,32529409,10.1007/s10549-020-05724-0,2020-06-13
Cryosurgery,TREATS,Malignant neoplasm of breast,32529405,10.1007/s10286-020-00702-4,2020-06-13
Cryosurgery,TREATS,Malignant neoplasm of breast,32529405,10.1007/s10286-020-00702-4,2020-06-13
Cryosurgery,NEG_AFFECTS,viral transmission,32529405,10.1007/s10286-020-00702-4,2020-06-13
Cardiac finding,PROCESS_OF,Child,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
PIM1 gene,PART_OF,Child,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
PIM1 gene,PART_OF,Child,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
Valvular regurgitation,PROCESS_OF,Transient Population Group,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
Present,PROCESS_OF,Patients,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
PIM1 gene,PART_OF,Cohort,32529116,10.1016/j.chempr.2020.04.023,2020-06-13
Coronavirus Infections,PROCESS_OF,Family member,32529094,10.4081/hpr.2020.9124,2020-06-13
"Thinking, function",PROCESS_OF,Participant,32529041,10.12688/wellcomeopenres.15873.1,2020-06-13
Symptoms,ASSOCIATED_WITH,Respiratory Tract Infections,32528815,10.24171/j.phrp.2020.11.3.05,2020-06-13
Supernatant,PART_OF,Cells,32528815,10.24171/j.phrp.2020.11.3.05,2020-06-13
Sequence Alignment,USES,Molecular Analysis,32528785,10.7759/cureus.8464,2020-06-13
Phylogenetic Analysis,USES,Sequence Alignment,32528785,10.7759/cureus.8464,2020-06-13
Missense Mutation,PROCESS_OF,Genes,32528785,10.7759/cureus.8464,2020-06-13
"Tuberculosis, Pulmonary",PROCESS_OF,Population Group,32528783,10.7759/cureus.8460,2020-06-13
Opportunistic Infections,PROCESS_OF,Patients,32528770,10.7759/cureus.8034,2020-06-13
Comorbidity,PROCESS_OF,Patients,32528770,10.7759/cureus.8034,2020-06-13
Myocardium,LOCATION_OF,Disease,32528760,10.7759/cureus.8021,2020-06-13
Myocardium,LOCATION_OF(SPEC),Cardiomyopathies,32528760,10.7759/cureus.8021,2020-06-13
Cardiomyopathies,ISA,Disease,32528760,10.7759/cureus.8021,2020-06-13
Cardiac complication,COEXISTS_WITH,patient condition,32528760,10.7759/cureus.8021,2020-06-13
inflammatory response,CAUSES,Cardiomyopathies,32528760,10.7759/cureus.8021,2020-06-13
Heart,LOCATION_OF,Respiratory System Finding,32528732,10.1038/s41541-020-0198-1,2020-06-13
myocardial injury,PROCESS_OF,Persons,32528732,10.1038/s41541-020-0198-1,2020-06-13
Asymptomatic,PROCESS_OF,Patients,32528624,10.11604/pamj.2020.35.2.23059,2020-06-13
Asymptomatic,PROCESS_OF,Patients,32528624,10.11604/pamj.2020.35.2.23059,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32528624,10.11604/pamj.2020.35.2.23059,2020-06-13
Asymptomatic,PROCESS_OF,Patients,32528624,10.11604/pamj.2020.35.2.23059,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32528624,10.11604/pamj.2020.35.2.23059,2020-06-13
Cessation of life,PROCESS_OF,Patients,32528621,10.11604/pamj.2020.35.2.22945,2020-06-13
Thromboembolism,CAUSES,Cessation of life,32528621,10.11604/pamj.2020.35.2.22945,2020-06-13
Critical Illness,PROCESS_OF,Patients,32528621,10.11604/pamj.2020.35.2.22945,2020-06-13
Disease,PROCESS_OF,Patients,32528621,10.11604/pamj.2020.35.2.22945,2020-06-13
Thromboembolism,OCCURS_IN,Patients,32528621,10.11604/pamj.2020.35.2.22945,2020-06-13
Cessation of life,PROCESS_OF,Patients,32528613,10.11604/pamj.supp.2020.35.2.22606,2020-06-13
Thromboembolism,CAUSES,Cessation of life,32528613,10.11604/pamj.supp.2020.35.2.22606,2020-06-13
Critical Illness,PROCESS_OF,Patients,32528613,10.11604/pamj.supp.2020.35.2.22606,2020-06-13
Disease,PROCESS_OF,Patients,32528613,10.11604/pamj.supp.2020.35.2.22606,2020-06-13
Thromboembolism,OCCURS_IN,Patients,32528613,10.11604/pamj.supp.2020.35.2.22606,2020-06-13
Government,LOCATION_OF,Analysis,32528612,10.11604/pamj.supp.2020.35.2.22665,2020-06-13
Agencies,LOCATION_OF,Analysis,32528612,10.11604/pamj.supp.2020.35.2.22665,2020-06-13
Congolese,ISA,Population Group,32528612,10.11604/pamj.supp.2020.35.2.22665,2020-06-13
Hispanics,ISA,Population Group,32528234,10.1155/2020/8923036,2020-06-13
Coronavirus Infections,NEG_AFFECTS,Possible,32528233,10.1186/s12950-020-00250-8,2020-06-13
Smoking History,PROCESS_OF,Persons,32528209,10.1016/j.jenvp.2020.101444,2020-06-13
Rapid Antigen Test,DIAGNOSES,"Meningitis, Bacterial",32528195,10.24911/SJP.106-1585398078,2020-06-13
Sesame Oil,PREVENTS,Coronavirus Infections,32528194,10.24911/SJP.106-1587122398,2020-06-13
Agencies,LOCATION_OF,Analysis,32528139,10.1038/s41575-020-0319-3,2020-06-13
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32528136,10.1038/s41577-020-0348-8,2020-06-13
Surgical Endoscopy,ADMINISTERED_TO,Patients,32528136,10.1038/s41577-020-0348-8,2020-06-13
Inflammatory Bowel Diseases,PROCESS_OF,Health Personnel,32528136,10.1038/s41577-020-0348-8,2020-06-13
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32528136,10.1038/s41577-020-0348-8,2020-06-13
Pandemics,CAUSES,Virus Diseases,32528128,10.1038/s41579-020-0394-z,2020-06-13
Animal - origin,PROCESS_OF,Homo sapiens,32528042,10.1038/s41375-020-0910-1,2020-06-13
Cessation of life,PROCESS_OF,Persons,32527990,10.12659/AJCR.925512,2020-06-13
Cross Infection,PROCESS_OF,Medical Staff,32527987,10.18632/aging.103335,2020-06-13
Cesarean section,TREATS,Pregnant Women,32527987,10.18632/aging.103335,2020-06-13
Communicable Diseases,PROCESS_OF,Homo sapiens,32527948,10.1136/emermed-2020-209829,2020-06-13
Coughing,ISA,Symptoms,32527948,10.1136/emermed-2020-209829,2020-06-13
Fever,ISA,Symptoms,32527948,10.1136/emermed-2020-209829,2020-06-13
Respiratory distress,ISA,Symptoms,32527948,10.1136/emermed-2020-209829,2020-06-13
Brain hemorrhage,PROCESS_OF,Old age,32527948,10.1136/emermed-2020-209829,2020-06-13
Diabetes,PREDISPOSES,Brain hemorrhage,32527948,10.1136/emermed-2020-209829,2020-06-13
Hypertensive disease,PREDISPOSES,Brain hemorrhage,32527948,10.1136/emermed-2020-209829,2020-06-13
Glycoproteins,PART_OF,host cell surface,32527948,10.1136/emermed-2020-209829,2020-06-13
angiotensin converting enzyme 2,ASSOCIATED_WITH,Brain hemorrhage,32527948,10.1136/emermed-2020-209829,2020-06-13
Anxiety,CAUSES,Immune System Diseases,32527948,10.1136/emermed-2020-209829,2020-06-13
Evaluation procedure,TREATS,patient condition,32527948,10.1136/emermed-2020-209829,2020-06-13
Interferons,ISA,cytokine,32527925,10.1126/science.abc3545,2020-06-13
Epithelium,LOCATION_OF,,32527925,10.1126/science.abc3545,2020-06-13
,DISRUPTS,Wound Healing,32527925,10.1126/science.abc3545,2020-06-13
,STIMULATES,TP53 gene,32527925,10.1126/science.abc3545,2020-06-13
,COMPLICATES,Virus Diseases,32527925,10.1126/science.abc3545,2020-06-13
Duration,INTERACTS_WITH,,32527925,10.1126/science.abc3545,2020-06-13
Dendritic Cells,PART_OF,Lung,32527868,10.1136/annrheumdis-2020-217960,2020-06-13
Dendritic Cells,PRODUCES,,32527868,10.1136/annrheumdis-2020-217960,2020-06-13
Orthomyxoviridae,ISA,Virus,32527868,10.1136/annrheumdis-2020-217960,2020-06-13
Less often,PROCESS_OF,Child,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
"Paris, France",ISA,Geographic Locations,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
"Paris, France",ISA,Geographic Locations,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
Detection,AFFECTS,Mucocutaneous Lymph Node Syndrome,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
Severe Acute Respiratory Syndrome,COEXISTS_WITH,> 2 years,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32527863,10.1136/annrheumdis-2020-217697,2020-06-13
Musculoskeletal Diseases,PROCESS_OF,Community,32527856,10.1073/pnas.2009637117,2020-06-13
Empowered,PROCESS_OF,Patients,32527856,10.1073/pnas.2009637117,2020-06-13
Complication,PROCESS_OF,hospitalized patients,32527843,10.3174/ajnr.A6630,2020-06-13
Coronavirus Infections,PROCESS_OF,hospitalized patients,32527843,10.3174/ajnr.A6630,2020-06-13
Thrombosis,PROCESS_OF,Patients,32527842,10.3174/ajnr.A6627,2020-06-13
Thrombotic Microangiopathies,ISA,Thrombosis,32527842,10.3174/ajnr.A6627,2020-06-13
Thrombotic Microangiopathies,PROCESS_OF(SPEC),Patients,32527842,10.3174/ajnr.A6627,2020-06-13
Neuroimaging,ADMINISTERED_TO,Patients,32527802,10.1126/sciimmunol.abc8413,2020-06-13
Physical Examination,USES,Neuroimaging,32527802,10.1126/sciimmunol.abc8413,2020-06-13
Blood Vessel,LOCATION_OF,risk factors,32527802,10.1126/sciimmunol.abc8413,2020-06-13
Virus Diseases,PROCESS_OF,Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Virus Diseases,PROCESS_OF,Population Group,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Infected,PROCESS_OF,Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Human coronavirus,PROCESS_OF,Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
SARS coronavirus,ISA,Human coronavirus,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
SARS coronavirus,PROCESS_OF,Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
SARS coronavirus,PROCESS_OF(SPEC),Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Serum,PART_OF,Homo sapiens,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Patients,LOCATION_OF,Antibodies,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Patients,LOCATION_OF,"Antibodies, Neutralizing",32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Antibody Formation,PROCESS_OF,Persons,32527790,10.1136/bmjspcare-2020-002364,2020-06-13
Disease,CAUSES,intensive care,32527780,10.1128/MRA.00568-20,2020-06-13
Zoonoses,ISA,Infection,32527756,10.1136/postgradmedj-2020-137934,2020-06-13
Awareness,PROCESS_OF,World,32527756,10.1136/postgradmedj-2020-137934,2020-06-13
Symptoms,OCCURS_IN,Patients,32527730,10.1136/esmoopen-2020-000810,2020-06-13
Malignant Neoplasms,PROCESS_OF,Patients,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
contextual factors,PROCESS_OF,Outpatients,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
National Academy of Sciences (U.S.),LOCATION_OF,Real-Time Polymerase Chain Reaction,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
Neoplasms,PROCESS_OF,Patients,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
Screening procedure,COEXISTS_WITH,Active Method,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
Malignant Neoplasms,PROCESS_OF,Patients,32527713,10.1016/j.jaim.2020.05.009,2020-06-13
Pharmaceutical Preparations,TREATS,Communicable Diseases,32527700,10.1016/j.jmii.2020.05.005,2020-06-13
Pharmaceutical Preparations,TREATS,Viral fever,32527700,10.1016/j.jmii.2020.05.005,2020-06-13
Pneumonia,PROCESS_OF,Patients,32527699,10.1016/j.hipert.2020.05.005,2020-06-13
Influenza,PROCESS_OF,Patients,32527699,10.1016/j.hipert.2020.05.005,2020-06-13
Autoimmune Diseases,PROCESS_OF,Patients,32527624,10.1016/j.euf.2020.05.021,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32527624,10.1016/j.euf.2020.05.021,2020-06-13
Autoimmune Diseases,PROCESS_OF,Patients,32527624,10.1016/j.euf.2020.05.021,2020-06-13
Symptoms,PROCESS_OF,Patients,32527624,10.1016/j.euf.2020.05.021,2020-06-13
Critical Illness,PROCESS_OF,Patients,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
intensive care unit,LOCATION_OF,Retrospective Studies,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PREDISPOSES,Nutritional status,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
"Respiratory Distress Syndrome, Adult",PROCESS_OF,high-risk group,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32527573,10.1016/j.jadohealth.2020.05.021,2020-06-13
Coronavirus Infections,ISA,Disease,32527471,10.1016/j.medin.2020.04.016,2020-06-13
Acute respiratory failure,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32527379,10.3238/arztebl.2020.0336,2020-06-13
intensive care unit,LOCATION_OF,Ultrasonography,32527379,10.3238/arztebl.2020.0336,2020-06-13
Lung,LOCATION_OF,Ultrasonography,32527379,10.3238/arztebl.2020.0336,2020-06-13
Ultrasonography,DIAGNOSES(SPEC),Dysbarism,32527379,10.3238/arztebl.2020.0336,2020-06-13
Ultrasonography,DIAGNOSES(SPEC),Pleural effusion disorder,32527379,10.3238/arztebl.2020.0336,2020-06-13
Ultrasonography,ISA,Diagnostic tests,32527379,10.3238/arztebl.2020.0336,2020-06-13
Diagnostic tests,DIAGNOSES,Dysbarism,32527379,10.3238/arztebl.2020.0336,2020-06-13
Diagnostic tests,DIAGNOSES,Pleural effusion disorder,32527379,10.3238/arztebl.2020.0336,2020-06-13
Parenchyma,PART_OF,Lung,32527379,10.3238/arztebl.2020.0336,2020-06-13
Echocardiography,DIAGNOSES,Cor pulmonale,32527379,10.3238/arztebl.2020.0336,2020-06-13
Echocardiography,DIAGNOSES,Shock,32527379,10.3238/arztebl.2020.0336,2020-06-13
Disease,PROCESS_OF,Population Group,32527378,10.3238/arztebl.2020.0329,2020-06-13
Population Group,LOCATION_OF,IMPACT gene,32527378,10.3238/arztebl.2020.0329,2020-06-13
VePesid-Ifosfamide-Platinol Regimen,TREATS,Severe Acute Respiratory Syndrome,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Immunoglobulins,ADMINISTERED_TO,Patients,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Immunoglobulins,AFFECTS,Symptoms,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Therapeutic procedure,NEG_ADMINISTERED_TO,Patients,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32527347,10.3760/cma.j.cn121430-20200309-00413,2020-06-13
Pneumonia,PROCESS_OF,Patients,32527346,10.3760/cma.j.cn121430-20200406-00386,2020-06-13
Pneumonia,PROCESS_OF,Patients,32527346,10.3760/cma.j.cn121430-20200406-00386,2020-06-13
Pneumonia,PROCESS_OF,Patients,32527346,10.3760/cma.j.cn121430-20200406-00386,2020-06-13
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Patients,32527346,10.3760/cma.j.cn121430-20200406-00386,2020-06-13
Extracorporeal Membrane Oxygenation,TREATS,patient condition,32527346,10.3760/cma.j.cn121430-20200406-00386,2020-06-13
Disease,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Diarrhea,ISA,Symptoms,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Hematologic Tests,DIAGNOSES,Leukopenia,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Leukocytosis,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Leukopenia,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Lymphopenia,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
White blood cell count normal,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
4 - severe,PROCESS_OF,Patients,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Diagnosis,USES,Basis,32527344,10.3760/cma.j.cn121430-20200312-00412,2020-06-13
Diagnosis,DIAGNOSES,Communicable Diseases,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Gastrointestinal symptom,PROCESS_OF,Patients,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
patient condition,COEXISTS_WITH,Decrease in appetite,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Decrease in appetite,NEG_ISA,Symptoms,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Decrease in appetite,PROCESS_OF,Patients,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Gastrointestinal symptom,PROCESS_OF,Patients,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Pharmaceutical Preparations,CAUSES,Symptoms,32527342,10.3760/cma.j.cn121430-20200302-00198,2020-06-13
Hospitals,LOCATION_OF,Retrospective Cohort Study,32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
"Kidney Failure, Acute",PROCESS_OF,Patients,32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
"Kidney Failure, Acute",PROCESS_OF,Patients,32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
Serum,LOCATION_OF,Creatinine,32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
"Kidney Failure, Acute",PROCESS_OF,Patients,32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
early/brief intervention/therapy (treatment),PREVENTS,"Kidney Failure, Acute",32527341,10.3760/cma.j.cn121430-20200325-00410,2020-06-13
Clinical Treatment,ADMINISTERED_TO,Medical Staff,32527327,10.1186/s13256-020-02396-8,2020-06-13
Critical Illness,PROCESS_OF,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
Critical Illness,PROCESS_OF,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
Critical Illness,PROCESS_OF,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
Respiration,PROCESS_OF,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
Respiration,PROCESS_OF,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
Deep Sedation,ADMINISTERED_TO,Physicians,32527327,10.1186/s13256-020-02396-8,2020-06-13
Deep Sedation,TREATS,Patients,32527327,10.1186/s13256-020-02396-8,2020-06-13
1 - 3,PROCESS_OF,Staff,32527327,10.1186/s13256-020-02396-8,2020-06-13
Coronavirus Infections,PROCESS_OF,Woman,32527304,10.1186/s13054-020-03020-3,2020-06-13
Leukopenia,PROCESS_OF,Transient Population Group,32527304,10.1186/s13054-020-03020-3,2020-06-13
work up,DIAGNOSES,Disease,32527304,10.1186/s13054-020-03020-3,2020-06-13
Storm NOS,COEXISTS_WITH,Pneumonia,32527300,10.1186/s13756-020-00746-1,2020-06-13
Storm NOS,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32527300,10.1186/s13756-020-00746-1,2020-06-13
Pandemics,ISA,Disease Outbreaks,32527257,10.1186/s12933-020-01047-y,2020-06-13
Tertiary Care Centers,LOCATION_OF,Cross-Sectional Studies,32527257,10.1186/s12933-020-01047-y,2020-06-13
Compliance,PROCESS_OF,Patients,32527257,10.1186/s12933-020-01047-y,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
Disease,COEXISTS_WITH,Coronavirus Infections,32527255,10.1186/s12931-020-01411-2,2020-06-13
Diabetes,PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
Severe disorder,PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
Capillary plexus,PART_OF,Lung,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Signs and Symptoms, Respiratory",PREDISPOSES,Lung diseases,32527255,10.1186/s12931-020-01411-2,2020-06-13
Interleukin-6,PREDISPOSES,Lung diseases,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",COEXISTS_WITH,Coronavirus Infections,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
Lung,LOCATION_OF,Severe disorder,32527255,10.1186/s12931-020-01411-2,2020-06-13
Patients,LOCATION_OF,Interleukin 6 Receptor,32527255,10.1186/s12931-020-01411-2,2020-06-13
Interleukin 6 Receptor,AFFECTS,Severe disorder,32527255,10.1186/s12931-020-01411-2,2020-06-13
Coronavirus Infections,PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32527255,10.1186/s12931-020-01411-2,2020-06-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32527161,10.1177/1090198120935073,2020-06-13
Confirmation,PROCESS_OF,Patients,32527161,10.1177/1090198120935073,2020-06-13
Lymphocyte count decreased,PROCESS_OF,Survivors,32527161,10.1177/1090198120935073,2020-06-13
Elevated lactate dehydrogenase,PROCESS_OF,Adult,32527161,10.1177/1090198120935073,2020-06-13
Prognosis bad,PROCESS_OF,Patients,32527161,10.1177/1090198120935073,2020-06-13
Health Personnel,DIAGNOSES,Communication impairment,32527141,10.1177/1945892420930954,2020-06-13
Smell Perception,OCCURS_IN,Patients,32527136,10.21037/apm-20-452,2020-06-13
10 - 19,COEXISTS_WITH,Multiple symptoms,32527136,10.21037/apm-20-452,2020-06-13
Smell Perception,PROCESS_OF,Patients,32527136,10.21037/apm-20-452,2020-06-13
Nose,LOCATION_OF,Obstruction,32527136,10.21037/apm-20-452,2020-06-13
Woman,ISA,Population Group,32527136,10.21037/apm-20-452,2020-06-13
Lung,LOCATION_OF,Lesion,32527073,10.4081/monaldi.2020.1341,2020-06-13
Lung,LOCATION_OF(SPEC),"Pneumonia, Viral",32527073,10.4081/monaldi.2020.1341,2020-06-13
"Pneumonia, Viral",ISA,Lesion,32527073,10.4081/monaldi.2020.1341,2020-06-13
interstitial,LOCATION_OF,Pneumonia,32527073,10.4081/monaldi.2020.1341,2020-06-13
Fatigue,ISA,Symptoms,32527073,10.4081/monaldi.2020.1341,2020-06-13
Fever,ISA,Symptoms,32527073,10.4081/monaldi.2020.1341,2020-06-13
Decrease in appetite,ISA,Symptoms,32527073,10.4081/monaldi.2020.1341,2020-06-13
Dry cough,ISA,Symptoms,32527073,10.4081/monaldi.2020.1341,2020-06-13
Antiviral Therapy,ADMINISTERED_TO,Patients,32527073,10.4081/monaldi.2020.1341,2020-06-13
Cavitation of lung,PROCESS_OF,Patients,32527073,10.4081/monaldi.2020.1341,2020-06-13
lobe,LOCATION_OF,Cavitation of lung,32527073,10.4081/monaldi.2020.1341,2020-06-13
lobe,PART_OF,Right lung,32527073,10.4081/monaldi.2020.1341,2020-06-13
Neurologic Manifestations,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Present,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Depressed Level of Consciousness,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Comorbidity,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Comorbidity,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Comorbidity,PROCESS_OF,Old age,32527056,10.3390/ijerph17114124,2020-06-13
Critical Illness,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
Brain,LOCATION_OF,tomography,32527056,10.3390/ijerph17114124,2020-06-13
Comorbidity,PROCESS_OF,Patients,32527056,10.3390/ijerph17114124,2020-06-13
disease transmission,PROCESS_OF,Community,32526996,10.3390/ijerph17114119,2020-06-13
IMPACT gene,PART_OF,Virus,32526996,10.3390/ijerph17114119,2020-06-13
Pharmaceutical Preparations,INHIBITS,IMPACT gene,32526996,10.3390/ijerph17114119,2020-06-13
Vaccines,INHIBITS,IMPACT gene,32526996,10.3390/ijerph17114119,2020-06-13
Coronavirus Infections,ISA,Disease,32526996,10.3390/ijerph17114119,2020-06-13
Readiness,PROCESS_OF,citizen,32526996,10.3390/ijerph17114119,2020-06-13
Epitopes,PART_OF,SARS coronavirus,32526937,10.3390/genes11060637,2020-06-13
Major Histocompatibility Complex,PART_OF,Homo sapiens,32526937,10.3390/genes11060637,2020-06-13
Immunotherapy,USES,"Vaccines, Peptide",32526937,10.3390/genes11060637,2020-06-13
Disease,CAUSES,Coronavirus Infections,32526774,10.1055/s-0040-1712157,2020-06-12
Lithium,TREATS,Bipolar Disorder,32526774,10.1055/s-0040-1712157,2020-06-12
Infected,PROCESS_OF,Patients,32526763,10.1159/000508638,2020-06-12
Severe Acute Respiratory Syndrome,CAUSES,Middle East Respiratory Syndrome,32526763,10.1159/000508638,2020-06-12
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32526763,10.1159/000508638,2020-06-12
Response process,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32526763,10.1159/000508638,2020-06-12
Response process,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32526763,10.1159/000508638,2020-06-12
heparin,TREATS,Patients,32526759,10.1159/000509143,2020-06-12
Anosmia,ISA,Symptoms,32526746,10.1159/000508062,2020-06-12
Anosmia,PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Anosmia,PROCESS_OF,Population Group,32526746,10.1159/000508062,2020-06-12
Symptoms,PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Anosmia,PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Anosmia,PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Negative,PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Airflow,NEG_PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Airflow,PROCESS_OF,Nose,32526746,10.1159/000508062,2020-06-12
Chief complaint (finding),PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Anosmia,PROCESS_OF,hospitalized patients,32526746,10.1159/000508062,2020-06-12
Nasal congestion (finding),PROCESS_OF,Patients,32526746,10.1159/000508062,2020-06-12
Sense of smell altered,ISA,Symptoms,32526746,10.1159/000508062,2020-06-12
Nasal congestion (finding),COEXISTS_WITH,Anosmia,32526746,10.1159/000508062,2020-06-12
"Kidney Failure, Acute",PROCESS_OF,Patients,32526721,10.1088/1478-3975/ab9bf5,2020-06-12
Critical Illness,PROCESS_OF,Patients,32526721,10.1088/1478-3975/ab9bf5,2020-06-12
"Kidney Failure, Acute",COEXISTS_WITH,patient condition,32526721,10.1088/1478-3975/ab9bf5,2020-06-12
Unstable status,PROCESS_OF,Patients,32526721,10.1088/1478-3975/ab9bf5,2020-06-12
Neuromyelitis Optica,AFFECTS,Immobile,32526661,10.1016/j.clinimag.2020.05.026,2020-06-12
Neuromyelitis Optica,AFFECTS,Bulbar weakness,32526661,10.1016/j.clinimag.2020.05.026,2020-06-12
Agent,TREATS,Neuromyelitis Optica,32526661,10.1016/j.clinimag.2020.05.026,2020-06-12
Tracheostomy procedure,ISA,Operative Surgical Procedures,32526627,10.1016/j.dsx.2020.05.035,2020-06-12
Tracheostomy procedure,TREATS,Patients,32526627,10.1016/j.dsx.2020.05.035,2020-06-12
Tracheostomy procedure,TREATS(INFER),Infected,32526627,10.1016/j.dsx.2020.05.035,2020-06-12
Infected,PROCESS_OF,Patients,32526627,10.1016/j.dsx.2020.05.035,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
mass hysteria,CAUSES,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
mass hysteria,CAUSES(SPEC),Coronavirus Infections,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Panic,ISA,Anxiety,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Quarantine,TREATS,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Quarantine,TREATS(SPEC),Coronavirus Infections,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
IMPACT gene,CAUSES,Panic,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Disease,DISRUPTS,Life Style,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,DISRUPTS(SPEC),Life Style,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526560,10.1016/j.puhe.2020.05.043,2020-06-12
Coronavirus Infections,ISA,Disease,32526559,10.1016/j.puhe.2020.04.016,2020-06-12
Symptom mild,PROCESS_OF,Persons,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Infected,PROCESS_OF,Persons,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Infected,PROCESS_OF,Persons,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Abnormality of coagulation,PROCESS_OF,Persons,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Critical Illness,PROCESS_OF,Patients,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Disease,PROCESS_OF,Patients,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Pulmonary Embolism,PROCESS_OF,Patients,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
risk factors,PROCESS_OF,Patients,32526541,10.1016/j.ijporl.2020.110169,2020-06-12
Coronavirus Infections,ISA,Disease,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Mental problem,PROCESS_OF,Participant,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Mental problem,PROCESS_OF,Participant,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Coronavirus Infections,ISA,Disease,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Mental problem,PROCESS_OF,Woman,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Mental problem,PROCESS_OF,Woman,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Mental problem,PROCESS_OF,general population,32526511,10.1016/j.mehy.2020.109850,2020-06-12
Coronavirus Infections,ISA,Disease,32526511,10.1016/j.mehy.2020.109850,2020-06-12
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32526507,10.1016/j.mehy.2020.109802,2020-06-12
Biomedicine,ISA,Science,32526492,10.1016/j.envres.2020.109754,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32526460,10.1016/j.jclinepi.2020.06.005,2020-06-12
Interventional procedure,CAUSES,Adverse effects,32526460,10.1016/j.jclinepi.2020.06.005,2020-06-12
Oral Manifestations,PROCESS_OF,Patients,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
Neoplasm Metastasis,ISA,Lesion,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
Coronavirus Infections,ISA,Lesion,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
Mouth Diseases,PROCESS_OF,Patients,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
deterioration,CAUSES,Mouth Diseases,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
Oral health,TREATS,Patients,32526372,10.1016/j.tmaid.2020.101782,2020-06-12
Cessation of life,PROCESS_OF,Patients,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Cessation of life,PROCESS_OF,Patients,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Patients,LOCATION_OF,Albumins,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Cessation of life,PROCESS_OF,Patients,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Cessation of life,PROCESS_OF,Patients,32526370,10.1016/j.meegid.2020.104417,2020-06-12
Pharmaceutical Preparations,TREATS,Virus,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
Vaccines,TREATS,Virus,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
Single-Stranded RNA,AFFECTS,Gene Expression,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
MicroRNAs,AUGMENTS,Immune Cell,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
"RNA, Viral",INTERACTS_WITH,SARS gene,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
MicroRNAs,INTERACTS_WITH,SARS gene,32526365,10.1016/j.wneu.2020.06.016,2020-06-12
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,World,32526275,10.1016/j.cmi.2020.05.041,2020-06-12
Biopsy,ADMINISTERED_TO,Patients,32526275,10.1016/j.cmi.2020.05.041,2020-06-12
Department,LOCATION_OF,Biopsy,32526275,10.1016/j.cmi.2020.05.041,2020-06-12
Negative Surgical Margin,NEG_CAUSES,Postoperative Complications,32526275,10.1016/j.cmi.2020.05.041,2020-06-12
Acute hemorrhage,PROCESS_OF,Patients,32526275,10.1016/j.cmi.2020.05.041,2020-06-12
Disease Progression,PROCESS_OF,Persons,32526265,10.1016/j.ijsu.2020.06.004,2020-06-12
Coronary Arteriosclerosis,PREDISPOSES,Disease Progression,32526265,10.1016/j.ijsu.2020.06.004,2020-06-12
Fibrin fragment D,PREDISPOSES,Disease Progression,32526265,10.1016/j.ijsu.2020.06.004,2020-06-12
Disease Progression,PROCESS_OF,Persons,32526265,10.1016/j.ijsu.2020.06.004,2020-06-12
Knowledge acquisition,AFFECTS,Physical and emotional exhaustion state,32526252,10.1016/j.jhep.2020.06.001,2020-06-12
Comorbidity,PROCESS_OF,Patients,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Coronavirus Infections,ISA,Disease,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Cirrhosis,AFFECTS,Patients,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Coronavirus Infections,ISA,Disease,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Prothrombin time assay,DIAGNOSES,Disease,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Disease,PROCESS_OF,Patients,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Coronavirus Infections,ISA,Disease,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32526224,10.1016/j.yjmcc.2020.06.002,2020-06-12
Cardiovascular,LOCATION_OF,Symptom severe,32526218,10.1016/j.cca.2020.05.047,2020-06-12
Immunoassay method,METHOD_OF,Detection,32526208,10.1016/j.cell.2020.05.034,2020-06-12
Detection,TREATS,Patients,32526208,10.1016/j.cell.2020.05.034,2020-06-12
Nucleic Acids,compared_with,Oligonucleotide Primers,32526206,10.1016/j.cell.2020.05.042,2020-06-12
Nose,LOCATION_OF,angiotensin converting enzyme 2,32526193,10.1016/S1473-3099(20)30434-5,2020-06-12
modulation by virus of host morphology or physiology,COEXISTS_WITH,Immunity,32526193,10.1016/S1473-3099(20)30434-5,2020-06-12
Hospitals,LOCATION_OF,Analysis,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Structure of parenchyma of lung,PART_OF,Patients,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Blood capillaries,LOCATION_OF,Congestion,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Proliferation (morphologic abnormality),PROCESS_OF,Phasis,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Alveolar,LOCATION_OF,Edema,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Interstitium,LOCATION_OF,Inflammatory infiltrate,32526180,10.1016/j.chom.2020.05.017,2020-06-12
diffuse alveolar damage,PROCESS_OF,Patients,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Blood Coagulation Disorders,PROCESS_OF,Patients,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Structure of small artery,LOCATION_OF,Fibrin blood clot,32526180,10.1016/j.chom.2020.05.017,2020-06-12
Clinical Trials,USES,manifold,32526092,10.1111/jth.14954,2020-06-12
heparin,TREATS,Patients,32526088,10.1002/nau.24429,2020-06-12
Factor VIIIa,ASSOCIATED_WITH,Hemophilia A,32526088,10.1002/nau.24429,2020-06-12
Factor VIII inhibitor by-passing fraction,ADMINISTERED_TO,Patients,32526088,10.1002/nau.24429,2020-06-12
emicizumab,TREATS,Patients,32526088,10.1002/nau.24429,2020-06-12
,AUGMENTS,Thrombus,32526088,10.1002/nau.24429,2020-06-12
Thrombus,PROCESS_OF,Patients,32526088,10.1002/nau.24429,2020-06-12
Prophylactic treatment,USES,emicizumab,32526088,10.1002/nau.24429,2020-06-12
Severe hereditary factor VIII deficiency disease,PROCESS_OF,Patients,32526088,10.1002/nau.24429,2020-06-12
Neurogenesis,PROCESS_OF,Patients,32526083,10.1111/liv.14565,2020-06-12
Abnormality,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
Critical Illness,PROCESS_OF,hospitalized patients,32526079,10.1002/sctm.20-0186,2020-06-12
hospitalized patients,LOCATION_OF,IMPACT gene,32526079,10.1002/sctm.20-0186,2020-06-12
GSKIP gene,ASSOCIATED_WITH(INFER),Critical Illness,32526079,10.1002/sctm.20-0186,2020-06-12
GSKIP gene,PART_OF,hospitalized patients,32526079,10.1002/sctm.20-0186,2020-06-12
Abnormality,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
Severe inflammation,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
Acetaminophen,ASSOCIATED_WITH,Inflammation,32526079,10.1002/sctm.20-0186,2020-06-12
lopinavir / Ritonavir,ASSOCIATED_WITH,Inflammation,32526079,10.1002/sctm.20-0186,2020-06-12
tocilizumab,ASSOCIATED_WITH,Inflammation,32526079,10.1002/sctm.20-0186,2020-06-12
Abnormality,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
Abnormality,PROCESS_OF,Patients,32526079,10.1002/sctm.20-0186,2020-06-12
Mesenchymal Stem Cells,PART_OF,Homo sapiens,32526077,10.1111/cts.12834,2020-06-12
Immune System Diseases,AFFECTS,Immunoregulation,32526077,10.1111/cts.12834,2020-06-12
Lung,LOCATION_OF,Communicable Diseases,32526077,10.1111/cts.12834,2020-06-12
Coronavirus Infections,ISA,Disease,32526068,10.1002/acr.24347,2020-06-12
France,ISA,European country,32526068,10.1002/acr.24347,2020-06-12
Italy,ISA,European country,32526068,10.1002/acr.24347,2020-06-12
Spain,ISA,European country,32526068,10.1002/acr.24347,2020-06-12
Coronavirus Infections,ISA,Disease,32526068,10.1002/acr.24347,2020-06-12
Rheumatism,PROCESS_OF,Patients,32526061,10.1111/andr.12837,2020-06-12
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32526061,10.1111/andr.12837,2020-06-12
High Level,PROCESS_OF,Patients,32526061,10.1111/andr.12837,2020-06-12
Pandemics,ISA,Disease Outbreaks,32526060,10.1111/ene.14395,2020-06-12
Diabetes,PROCESS_OF,Male population group,32526060,10.1111/ene.14395,2020-06-12
Respiratory Tract Infections,PROCESS_OF,Male population group,32526060,10.1111/ene.14395,2020-06-12
Renal Insufficiency,PROCESS_OF,Male population group,32526060,10.1111/ene.14395,2020-06-12
cytokine,CAUSES,Complication,32526060,10.1111/ene.14395,2020-06-12
Inflammation,PROCESS_OF,Patients,32526060,10.1111/ene.14395,2020-06-12
Metabolic Diseases,PROCESS_OF,Patients,32526060,10.1111/ene.14395,2020-06-12
Cardiovascular,LOCATION_OF,Protection,32526060,10.1111/ene.14395,2020-06-12
Complication,COEXISTS_WITH,diabetic,32526060,10.1111/ene.14395,2020-06-12
Lung,LOCATION_OF,"Cyclic Nucleotide Phosphodiesterases, Type 5",32526060,10.1111/ene.14395,2020-06-12
Disinfection,ISA,Therapeutic procedure,32526044,10.1002/ijgo.13272,2020-06-12
Sexual sterilization,USES,century,32526044,10.1002/ijgo.13272,2020-06-12
Retina,PART_OF,Mammals,32526044,10.1002/ijgo.13272,2020-06-12
Disease,COEXISTS_WITH,Malignant Neoplasms,32526039,10.1111/bjh.16935,2020-06-12
Disease,PROCESS_OF,Woman,32526039,10.1111/bjh.16935,2020-06-12
Malignant Female Reproductive System Neoplasm,COEXISTS_WITH,Malignant Neoplasms,32526039,10.1111/bjh.16935,2020-06-12
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Woman,32526039,10.1111/bjh.16935,2020-06-12
Immunologic Adjuvants,TREATS,Respondents,32526039,10.1111/bjh.16935,2020-06-12
Teleconsultation,DIAGNOSES,Epithelial ovarian cancer,32526039,10.1111/bjh.16935,2020-06-12
Disease,PROCESS_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Lung,LOCATION_OF,angiotensin converting enzyme 2,32525979,10.1093/infdis/jiaa334,2020-06-12
Lung,PART_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Comorbidity,PROCESS_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Patients,LOCATION_OF,angiotensin converting enzyme 2,32525979,10.1093/infdis/jiaa334,2020-06-12
Transcriptome,PART_OF,Lung,32525979,10.1093/infdis/jiaa334,2020-06-12
Transcriptome,PART_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Comorbidity,PROCESS_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Genes,AFFECTS,histone modification,32525979,10.1093/infdis/jiaa334,2020-06-12
Lung,LOCATION_OF,angiotensin converting enzyme 2,32525979,10.1093/infdis/jiaa334,2020-06-12
Lung,PART_OF,Homo sapiens,32525979,10.1093/infdis/jiaa334,2020-06-12
Comorbidity,PROCESS_OF,Patients,32525979,10.1093/infdis/jiaa334,2020-06-12
Matrix,AFFECTS,Sunlight,32525973,10.1210/clinem/dgaa373,2020-06-12
Thyrotoxicosis,PROCESS_OF,Patients,32525881,10.1371/journal.pone.0234292,2020-06-12
Telemedicine,METHOD_OF,Evaluation,32525881,10.1371/journal.pone.0234292,2020-06-12
Evaluation,TREATS,Patients,32525881,10.1371/journal.pone.0234292,2020-06-12
Evaluation,TREATS(INFER),Thyrotoxicosis,32525881,10.1371/journal.pone.0234292,2020-06-12
Coronavirus Infections,CAUSES,Pneumonia,32525856,10.15585/mmwr.mm6923e1,2020-06-12
emergency visit,TREATS,Persons,32525853,10.15585/mmwr.mm6923e3,2020-06-12
Myocardial Infarction,ISA,Disease,32525853,10.15585/mmwr.mm6923e3,2020-06-12
Confirmation,PROCESS_OF,Homo sapiens,32525852,10.15585/mmwr.mm6923e2,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Animals,32525852,10.15585/mmwr.mm6923e2,2020-06-12
SPEN gene,AUGMENTS,Decision,32525850,10.15585/mmwr.mm6923e4,2020-06-12
SUCO gene,AUGMENTS,Decision,32525850,10.15585/mmwr.mm6923e4,2020-06-12
Respondents,USES,Cleaning Device,32525850,10.15585/mmwr.mm6923e4,2020-06-12
Plasma,ASSOCIATED_WITH,Serious Adverse Event,32525829,10.3855/jidc.12792,2020-06-12
human plasma,TREATS,Adult,32525829,10.3855/jidc.12792,2020-06-12
human plasma,TREATS(INFER),Patient in hospital,32525829,10.3855/jidc.12792,2020-06-12
Patient in hospital,PROCESS_OF,Adult,32525829,10.3855/jidc.12792,2020-06-12
Critical Illness,PROCESS_OF,Patients,32525829,10.3855/jidc.12792,2020-06-12
hospitalized patients,LOCATION_OF,Plasma,32525829,10.3855/jidc.12792,2020-06-12
Disease,PROCESS_OF,Family member,32525828,10.3855/jidc.12678,2020-06-12
Disease,PROCESS_OF,Patients,32525826,10.3855/jidc.12814,2020-06-12
Fever,ISA,Symptoms,32525826,10.3855/jidc.12814,2020-06-12
ESR raised,PROCESS_OF,Patients,32525826,10.3855/jidc.12814,2020-06-12
Serum,LOCATION_OF,Ferritin,32525826,10.3855/jidc.12814,2020-06-12
Quarantine,ISA,Interventional procedure,32525826,10.3855/jidc.12814,2020-06-12
Isolation procedure,ISA,Interventional procedure,32525826,10.3855/jidc.12814,2020-06-12
Disease,CAUSES,Coronavirus Infections,32525825,10.3855/jidc.13003,2020-06-12
Italy,ISA,European country,32525825,10.3855/jidc.13003,2020-06-12
Italy,ISA,Country,32525825,10.3855/jidc.13003,2020-06-12
Italy,ISA,European country,32525825,10.3855/jidc.13003,2020-06-12
Critical Illness,PROCESS_OF,Patients,32525825,10.3855/jidc.13003,2020-06-12
Protection,PROCESS_OF,Health Personnel,32525825,10.3855/jidc.13003,2020-06-12
Disease,AFFECTS,Vulnerable Populations,32525707,10.1377/hlthaff.2020.00902,2020-06-12
Hotlines,TREATS,Crisis,32525705,10.1377/hlthaff.2020.00903,2020-06-12
Palliative Care,TREATS,patient condition,32525704,10.1377/hlthaff.2020.00904,2020-06-12
Pivot,AFFECTS,"Transformation, function",32525704,10.1377/hlthaff.2020.00904,2020-06-12
Coronavirus Infections,ISA,Disease,32525695,10.1044/2020_AJSLP-20-00089,2020-06-12
Coronavirus Infections,ISA,Disease,32525695,10.1044/2020_AJSLP-20-00089,2020-06-12
speech and language,PROCESS_OF,Medical pathologist,32525657,10.1021/acschemneuro.0c00249,2020-06-12
speech and language,PROCESS_OF,Medical pathologist,32525657,10.1021/acschemneuro.0c00249,2020-06-12
speech and language,PROCESS_OF,Medical pathologist,32525657,10.1021/acschemneuro.0c00249,2020-06-12
Gown,TREATS,Patients,32525657,10.1021/acschemneuro.0c00249,2020-06-12
Dysosmia,PROCESS_OF,Patients,32525650,10.1021/acschemneuro.0c00312,2020-06-12
Olfactory Epithelium,LOCATION_OF,Biopsy,32525650,10.1021/acschemneuro.0c00312,2020-06-12
,AUGMENTS,Olfactory Epithelium,32525650,10.1021/acschemneuro.0c00312,2020-06-12
Olfactory Epithelium,PART_OF,Coronaviridae,32525650,10.1021/acschemneuro.0c00312,2020-06-12
Physical findings,PROCESS_OF,Community,32525600,10.1096/fj.202001115R,2020-06-12
ACE gene,AFFECTS,Dynamics,32525587,10.1002/jmv.26162,2020-06-12
Histocompatibility Antigens Class I,AFFECTS,Immunity,32525587,10.1002/jmv.26162,2020-06-12
Genes,INTERACTS_WITH,Toll-like receptors,32525587,10.1002/jmv.26162,2020-06-12
Host-Pathogen Interactions,AFFECTS,Dynamics,32525587,10.1002/jmv.26162,2020-06-12
"Influenza A Virus, Avian",PROCESS_OF,"Fowls, Domestic",32525575,10.1002/jmv.26158,2020-06-12
"Avian influenza virus, highly pathogenic",PROCESS_OF,"Fowls, Domestic",32525575,10.1002/jmv.26158,2020-06-12
Mass Vaccination,USES,Vaccines,32525575,10.1002/jmv.26158,2020-06-12
Lung,LOCATION_OF,Virus Diseases,32525568,10.1002/jmv.26159,2020-06-12
Virus Diseases,PROCESS_OF,Patients,32525568,10.1002/jmv.26159,2020-06-12
Brain Stem,LOCATION_OF,Virus,32525568,10.1002/jmv.26159,2020-06-12
C Fibers,LOCATION_OF,Virus,32525568,10.1002/jmv.26159,2020-06-12
C Fibers,PART_OF,Bronchus and lung,32525568,10.1002/jmv.26159,2020-06-12
C Fibers,PART_OF,Bronchus and lung,32525568,10.1002/jmv.26159,2020-06-12
"Influenza A Virus, H5N1 Subtype",CAUSES,"Reflex, Tendon",32525568,10.1002/jmv.26159,2020-06-12
Gastrointestinal symptom,PROCESS_OF,Patients,32525548,10.1001/jamanetworkopen.2020.11122,2020-06-12
Gastrointestinal symptom,PROCESS_OF,Patients,32525548,10.1001/jamanetworkopen.2020.11122,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32525548,10.1001/jamanetworkopen.2020.11122,2020-06-12
Feces,LOCATION_OF,"CISH protein, human",32525548,10.1001/jamanetworkopen.2020.11122,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32525548,10.1001/jamanetworkopen.2020.11122,2020-06-12
Renin-angiotensin system,ASSOCIATED_WITH,Possible,32525485,10.2196/20157,2020-06-12
Diagnosis,ADMINISTERED_TO,Patients,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Potassium supplement,TREATS,Patients,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Increased creatine kinase level,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
High Level,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Critical Illness,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Potassium,ADMINISTERED_TO,Patients,32525485,10.2196/20157,2020-06-12
Potassium,CAUSES,Hypokalemia,32525485,10.2196/20157,2020-06-12
Potassium,PART_OF,Kidney,32525485,10.2196/20157,2020-06-12
angiotensin converting enzyme 2,INHIBITS,Potassium supplement,32525485,10.2196/20157,2020-06-12
Hypokalemia,PROCESS_OF,Patients,32525485,10.2196/20157,2020-06-12
Religious Missions,LOCATION_OF,Analysis,32525469,10.1017/S0950268820001235,2020-06-12
Infection,ISA,Disease,32525468,10.1177/1747493020938301,2020-06-12
Asymptomatic Infections,ISA,Disease,32525468,10.1177/1747493020938301,2020-06-12
Spain,ISA,Country,32525402,10.1177/2324709620931238,2020-06-12
Cerebrovascular accident,PROCESS_OF,Patients,32525402,10.1177/2324709620931238,2020-06-12
Awareness,NEG_PROCESS_OF,traveler,32525394,10.1177/1062860620933587,2020-06-12
Disease,COEXISTS_WITH,Chronic disease,32525394,10.1177/1062860620933587,2020-06-12
Disease,COEXISTS_WITH(SPEC),"Kidney Failure, Chronic",32525394,10.1177/1062860620933587,2020-06-12
"Kidney Failure, Chronic",ISA,Chronic disease,32525394,10.1177/1062860620933587,2020-06-12
"Kidney Failure, Chronic",COEXISTS_WITH,Nausea,32525394,10.1177/1062860620933587,2020-06-12
Pain,ASSOCIATED_WITH,Disease,32525392,10.1037/tra0000803,2020-06-12
Infected,PROCESS_OF,Patients,32525390,10.1037/tra0000821,2020-06-12
Post-Traumatic Stress Disorder,PROCESS_OF,Persons,32525387,10.1037/tra0000687,2020-06-12
Substance Use Disorders,PROCESS_OF,Persons,32525387,10.1037/tra0000687,2020-06-12
Italy,ISA,European country,32525386,10.1037/tra0000764,2020-06-12
Depressive disorder,PROCESS_OF,Elderly (population group),32525380,10.1037/tra0000840,2020-06-12
Suicide,PROCESS_OF,Elderly (population group),32525380,10.1037/tra0000840,2020-06-12
Subgroup A Nepoviruses,PROCESS_OF,Young Adult,32525379,10.1037/tra0000845,2020-06-12
Intervention regimes,TREATS,Emotional distress,32525379,10.1037/tra0000845,2020-06-12
Males,ISA,Gender,32525379,10.1037/tra0000845,2020-06-12
Anxiety,PRECEDES,Mental disorders,32525379,10.1037/tra0000845,2020-06-12
Anxiety,PRECEDES,Depressive disorder,32525379,10.1037/tra0000845,2020-06-12
Mental disorders,ISA,Disease,32525379,10.1037/tra0000845,2020-06-12
Depressive disorder,ISA,Disease,32525379,10.1037/tra0000845,2020-06-12
Depressive disorder,PRECEDES,Mental disorders,32525379,10.1037/tra0000845,2020-06-12
Elderly (population group),ISA,Persons,32525378,10.1037/tra0000918,2020-06-12
Initiative,PROCESS_OF,World,32525377,10.1037/tra0000878,2020-06-12
Indonesians,ISA,Population Group,32525376,10.1037/tra0000694,2020-06-12
Readiness,NEG_PROCESS_OF,Population Group,32525376,10.1037/tra0000694,2020-06-12
Violence,PROCESS_OF,Persons,32525376,10.1037/tra0000694,2020-06-12
Acclimatization,AFFECTS,Child,32525374,10.1037/tra0000815,2020-06-12
Eye,LOCATION_OF,Virus,32525373,10.1037/tra0000756,2020-06-12
Nation,LOCATION_OF,Population Based Study,32525371,10.1037/tra0000881,2020-06-12
Disease,AFFECTS,African American,32525370,10.1037/tra0000796,2020-06-12
Pandemics,CAUSES,Disease,32525370,10.1037/tra0000796,2020-06-12
mental health,PROCESS_OF,Clinician,32525369,10.1037/tra0000879,2020-06-12
Wounds and Injuries,PROCESS_OF,Racial group,32525369,10.1037/tra0000879,2020-06-12
"Loss, Grief, and Bereavement",PROCESS_OF,Persons,32525366,10.1037/tra0000861,2020-06-12
Coronavirus Infections,ISA,Disease,32525366,10.1037/tra0000861,2020-06-12
Neurosurgical Procedures,TREATS,Enthesitis-Related Arthritis,32525290,10.23736/S0390-5616.20.05018-3,2020-06-12
Neurosurgical department,LOCATION_OF,Study,32525249,10.1111/nmo.13930,2020-06-12
Neoplasms,PROCESS_OF,Patients,32525249,10.1111/nmo.13930,2020-06-12
Base of skull structure,LOCATION_OF,Surgical Endoscopy,32525249,10.1111/nmo.13930,2020-06-12
Telemedicine,ISA,Evaluation,32525249,10.1111/nmo.13930,2020-06-12
Gastrointestinal Motility,PROCESS_OF,Patients,32525098,10.1016/j.jshs.2020.06.005,2020-06-12
Breath Tests,AFFECTS,Evaluation,32525098,10.1016/j.jshs.2020.06.005,2020-06-12
Interventional procedure,PREDISPOSES,Communicable Diseases,32525098,10.1016/j.jshs.2020.06.005,2020-06-12
Sleep,PROCESS_OF,Child,32525082,10.1016/j.jpainsymman.2020.06.002,2020-06-12
Operating microscope,USES,Hoses,32525022,10.1016/j.resuscitation.2020.06.001,2020-06-12
IMPACT gene,ASSOCIATED_WITH,Cardiac Arrest,32525005,10.1016/j.ejphar.2020.173237,2020-06-12
Birth,PROCESS_OF,Adult,32525005,10.1016/j.ejphar.2020.173237,2020-06-12
Birth,PROCESS_OF,Child,32525005,10.1016/j.ejphar.2020.173237,2020-06-12
pirfenidone,ISA,Pyridones,32524964,10.4269/ajtmh.20-0563,2020-06-12
Agent,TREATS,Hamman-Rich syndrome,32524964,10.4269/ajtmh.20-0563,2020-06-12
Coronavirus Infections,ISA,Disease,32524964,10.4269/ajtmh.20-0563,2020-06-12
pirfenidone,TREATS,Disease,32524964,10.4269/ajtmh.20-0563,2020-06-12
pirfenidone,TREATS(SPEC),Coronavirus Infections,32524964,10.4269/ajtmh.20-0563,2020-06-12
Abdomen,LOCATION_OF,Mild pain,32524961,10.4269/ajtmh.20-0561,2020-06-12
Andorra,ISA,Country,32524957,10.2807/1560-7917.ES.2020.25.22.2001010,2020-06-12
Coronavirus Infections,ISA,Disease,32524956,10.2807/1560-7917.ES.2020.25.22.2000921,2020-06-12
Coronavirus Infections,ISA,Disease,32524953,10.4269/ajtmh.20-0462,2020-06-12
Negative,CAUSES,disease transmission,32524953,10.4269/ajtmh.20-0462,2020-06-12
Risk Assessment,TREATS,Population at Risk,32524953,10.4269/ajtmh.20-0462,2020-06-12
Cessation of life,PROCESS_OF,nursing home resident,32524946,10.2807/1560-7917.ES.2020.25.22.2000746,2020-06-12
Coronavirus Infections,ISA,Disease,32524946,10.2807/1560-7917.ES.2020.25.22.2000746,2020-06-12
Genetic Structures,ASSOCIATED_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,32524893,10.1080/17441692.2020.1779331,2020-06-12
Chronic disease,COEXISTS_WITH,risk factors,32524835,10.1161/CIRCOUTCOMES.120.006938,2020-06-12
Cardiologists,ISA,Health Personnel,32524835,10.1161/CIRCOUTCOMES.120.006938,2020-06-12
Myocardial Infarction,ISA,nervous system disorder,32524832,10.1089/ars.2020.8142,2020-06-12
Cerebrovascular accident,ISA,nervous system disorder,32524832,10.1089/ars.2020.8142,2020-06-12
Antioxidants,TREATS,Patients,32524792,10.3348/kjr.2020.0231,2020-06-12
C-reactive protein,compared_with,Troponin,32524792,10.3348/kjr.2020.0231,2020-06-12
Hospitals,LOCATION_OF,Radionuclide Imaging,32524786,10.3348/kjr.2020.0293,2020-06-12
Abnormal Finding,NEG_PROCESS_OF,Patients,32524786,10.3348/kjr.2020.0293,2020-06-12
Abnormal Finding,NEG_PROCESS_OF,Patients,32524786,10.3348/kjr.2020.0293,2020-06-12
pulmonary involvement,PROCESS_OF,Patients,32524786,10.3348/kjr.2020.0293,2020-06-12
pulmonary involvement,PROCESS_OF,Patients,32524786,10.3348/kjr.2020.0293,2020-06-12
Cross Infection,PROCESS_OF,Patients,32524743,10.1111/ajt.16138,2020-06-12
Cross Infection,PROCESS_OF,Medical radiographer,32524743,10.1111/ajt.16138,2020-06-12
Infected,PROCESS_OF,Patients,32524743,10.1111/ajt.16138,2020-06-12
Infected,PROCESS_OF,Medical radiographer,32524743,10.1111/ajt.16138,2020-06-12
Confirmation,PROCESS_OF,Medical radiographer,32524743,10.1111/ajt.16138,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Donor person,32524732,10.1111/andr.12836,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32524732,10.1111/andr.12836,2020-06-12
Infected,PROCESS_OF,Male population group,32524712,10.1111/hae.14089,2020-06-12
SARS coronavirus,PROCESS_OF,Male population group,32524712,10.1111/hae.14089,2020-06-12
Testosterone,ISA,Androgens,32524712,10.1111/hae.14089,2020-06-12
Critical Illness,PROCESS_OF,Male population group,32524712,10.1111/hae.14089,2020-06-12
angiotensin converting enzyme 2,AUGMENTS,internalization,32524712,10.1111/hae.14089,2020-06-12
Obesity,PROCESS_OF,Patients,32524712,10.1111/hae.14089,2020-06-12
Infected,PROCESS_OF,Patients,32524712,10.1111/hae.14089,2020-06-12
Malaise,PROCESS_OF,Persons,32524712,10.1111/hae.14089,2020-06-12
Congenital bleeding disorders,PROCESS_OF,Patients,32524707,10.1002/hed.26288,2020-06-12
Disability,COEXISTS_WITH,"Hemophilia, NOS",32524707,10.1002/hed.26288,2020-06-12
Evaluation procedure,AFFECTS,Severe (severity modifier),32524707,10.1002/hed.26288,2020-06-12
Evaluation procedure,TREATS,"Hemophilia, NOS",32524707,10.1002/hed.26288,2020-06-12
smell and taste disorder,PROCESS_OF,Patients,32524646,10.1002/ddr.21701,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32524646,10.1002/ddr.21701,2020-06-12
Symptoms,OCCURS_IN,Patients,32524646,10.1002/ddr.21701,2020-06-12
Lithium,TREATS,Mood Disorders,32524645,10.1111/jcpt.13199,2020-06-12
Respiration Disorders,PROCESS_OF,Animals,32524645,10.1111/jcpt.13199,2020-06-12
Upper Respiratory Infections,PROCESS_OF,Patients,32524645,10.1111/jcpt.13199,2020-06-12
Influenza-like symptoms,PROCESS_OF,Patients,32524645,10.1111/jcpt.13199,2020-06-12
Disease,PROCESS_OF,Homo sapiens,32524645,10.1111/jcpt.13199,2020-06-12
Lithium,ADMINISTERED_TO,Patients,32524645,10.1111/jcpt.13199,2020-06-12
Patient Monitoring,TREATS,Adverse reactions,32524630,10.1111/pde.14257,2020-06-12
Patient Monitoring,TREATS,Drug Interactions,32524630,10.1111/pde.14257,2020-06-12
Antimalarials,ISA,Pharmaceutical Preparations,32524630,10.1111/pde.14257,2020-06-12
Antiviral Agents,ISA,Pharmaceutical Preparations,32524630,10.1111/pde.14257,2020-06-12
Hydroxychloroquine,ISA,Chloroquine,32524630,10.1111/pde.14257,2020-06-12
Skin Manifestations,PROCESS_OF,Adult,32524611,10.1111/all.14452,2020-06-12
Cutaneous Involvement,PROCESS_OF,Child,32524611,10.1111/all.14452,2020-06-12
Skin finding,PROCESS_OF,Boys,32524611,10.1111/all.14452,2020-06-12
Dry cough,ISA,Symptoms,32524537,10.1007/s13760-020-01401-7,2020-06-12
Asymptomatic Infections,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Infected,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Alkaline Phosphatase,compared_with,,32524537,10.1007/s13760-020-01401-7,2020-06-12
Pneumonia,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Serum,LOCATION_OF,procalcitonin,32524537,10.1007/s13760-020-01401-7,2020-06-12
Symptoms,COEXISTS_WITH,Coughing,32524537,10.1007/s13760-020-01401-7,2020-06-12
Symptoms,COEXISTS_WITH,Fever,32524537,10.1007/s13760-020-01401-7,2020-06-12
Pneumonia,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Pneumonia,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Intussusception,CAUSES,Cessation of life,32524537,10.1007/s13760-020-01401-7,2020-06-12
Septicemia,CAUSES,Cessation of life,32524537,10.1007/s13760-020-01401-7,2020-06-12
Serum,LOCATION_OF,cytokine,32524537,10.1007/s13760-020-01401-7,2020-06-12
Pneumonia,PROCESS_OF,Patients,32524537,10.1007/s13760-020-01401-7,2020-06-12
risk factors,PROCESS_OF,Child,32524537,10.1007/s13760-020-01401-7,2020-06-12
Severe Acute Respiratory Syndrome,AFFECTS,Disease Progression,32524537,10.1007/s13760-020-01401-7,2020-06-12
Symptoms,PROCESS_OF,Elderly (population group),32524516,10.1007/s11239-020-02171-y,2020-06-12
Agitation,PROCESS_OF,Patients,32524516,10.1007/s11239-020-02171-y,2020-06-12
Coronavirus Infections,PREDISPOSES,Hemorrhage,32524515,10.1007/s15010-020-01461-0,2020-06-12
Coronavirus Infections,PREDISPOSES,Thrombosis,32524515,10.1007/s15010-020-01461-0,2020-06-12
Pneumonia,PROCESS_OF,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Community acquired pneumonia,PROCESS_OF,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Patients,LOCATION_OF,Fibrin fragment D,32524515,10.1007/s15010-020-01461-0,2020-06-12
Community acquired pneumonia,PROCESS_OF,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Community acquired pneumonia,PROCESS_OF,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Fibrin fragment D,PREDISPOSES,Inflammation,32524515,10.1007/s15010-020-01461-0,2020-06-12
Fibrin fragment D,PREDISPOSES,Thrombosis,32524515,10.1007/s15010-020-01461-0,2020-06-12
Aftercare,TREATS,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Aftercare,TREATS(INFER),Prognosis good,32524515,10.1007/s15010-020-01461-0,2020-06-12
Prognosis good,PROCESS_OF,Patients,32524515,10.1007/s15010-020-01461-0,2020-06-12
Inflammation,COEXISTS_WITH,D-dimer above reference range,32524515,10.1007/s15010-020-01461-0,2020-06-12
"Hospitals, University",LOCATION_OF,Study,32524513,10.1007/s11096-020-01078-1,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Study Subject,32524513,10.1007/s11096-020-01078-1,2020-06-12
Coronavirus Infections,CAUSES,Communicable Diseases,32524445,10.1007/s13246-020-00865-4,2020-06-12
"Pneumonia, Bacterial",ISA,Disease,32524333,10.1007/s12026-020-09137-5,2020-06-12
"Pneumonia, Bacterial",PROCESS_OF,Patients,32524333,10.1007/s12026-020-09137-5,2020-06-12
Diagnostic radiologic examination,DIAGNOSES,Disease,32524333,10.1007/s12026-020-09137-5,2020-06-12
"Pneumonia, Interstitial",AFFECTS,Patient Deceased,32524296,10.1007/s10140-020-01806-0,2020-06-12
Disease Outbreaks,CAUSES,Atypical pneumonia,32524266,10.1007/s11883-020-00849-5,2020-06-12
Intervention regimes,TREATS,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Intervention regimes,TREATS,Structural disorder of heart,32524227,10.1007/s00402-020-03516-1,2020-06-12
Disease,PROCESS_OF,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Elective Surgical Procedures,TREATS,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Elective Surgical Procedures,TREATS(INFER),Acute Coronary Syndrome,32524227,10.1007/s00402-020-03516-1,2020-06-12
Elective procedure,TREATS,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Elective procedure,TREATS(INFER),Acute Coronary Syndrome,32524227,10.1007/s00402-020-03516-1,2020-06-12
Acute Coronary Syndrome,PROCESS_OF,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Illness (finding),PROCESS_OF,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
Heart failure,PROCESS_OF,Patients,32524227,10.1007/s00402-020-03516-1,2020-06-12
"Infections, Hospital",ISA,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Coronavirus Infections,CAUSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Coronavirus Infections,CAUSES(SPEC),"Infections, Hospital",32524223,10.1007/s00330-020-06976-6,2020-06-12
Removal of implant (procedure),TREATS,Patients,32524223,10.1007/s00330-020-06976-6,2020-06-12
Nurses,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Nurses,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
"Students, Nursing",DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Orthopedic Surgeons,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Anesthesiologist,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Medical assistant,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Service worker,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Certified registered nurse anesthetist,DIAGNOSES,Disease,32524223,10.1007/s00330-020-06976-6,2020-06-12
Health Personnel,DIAGNOSES,Symptoms,32524223,10.1007/s00330-020-06976-6,2020-06-12
Nose,LOCATION_OF,Congestion,32524223,10.1007/s00330-020-06976-6,2020-06-12
Physical Examination,USES,Chest CT,32524220,10.1007/s00330-020-06969-5,2020-06-12
Cessation of life,PROCESS_OF,Patients,32524194,10.1007/s00347-020-01143-0,2020-06-12
Introduction procedure,COEXISTS_WITH,Challenge,32524171,10.1007/s00134-020-06148-6,2020-06-12
Anterior eyeball segment structure,LOCATION_OF,Symptoms,32524171,10.1007/s00134-020-06148-6,2020-06-12
Eye,LOCATION_OF,Disease,32524171,10.1007/s00134-020-06148-6,2020-06-12
infection prophylaxis,TREATS,Disease,32524171,10.1007/s00134-020-06148-6,2020-06-12
Fracture,ISA,Wounds and Injuries,32524147,10.1093/jamia/ocaa062,2020-06-12
Ward (environment),LOCATION_OF,Training,32524147,10.1093/jamia/ocaa062,2020-06-12
Protection,PREDISPOSES,Cross Infection,32524147,10.1093/jamia/ocaa062,2020-06-12
Health Personnel,TREATS,Patients,32524147,10.1093/jamia/ocaa062,2020-06-12
other medicated shampoos in ATC,TREATS,Patients,32524147,10.1093/jamia/ocaa062,2020-06-12
Ambulatory Care Facilities,LOCATION_OF,research data,32523979,10.1055/a-1167-1703,2020-06-12
Tertiary Care Centers,LOCATION_OF,research data,32523979,10.1055/a-1167-1703,2020-06-12
research data,USES,Extraction,32523979,10.1055/a-1167-1703,2020-06-12
Symptoms,COEXISTS_WITH,Fever,32523932,10.12890/2020_001736,2020-06-12
Symptoms,COEXISTS_WITH,Dry cough,32523932,10.12890/2020_001736,2020-06-12
Lung,LOCATION_OF,Ultrasonography,32523932,10.12890/2020_001736,2020-06-12
lobe,LOCATION_OF,Pleural effusion disorder,32523932,10.12890/2020_001736,2020-06-12
Abdomen,LOCATION_OF,X-Ray Computed Tomography,32523932,10.12890/2020_001736,2020-06-12
X-Ray Computed Tomography,DIAGNOSES,Atelectasis,32523932,10.12890/2020_001736,2020-06-12
X-Ray Computed Tomography,DIAGNOSES,Perforation of stomach,32523932,10.12890/2020_001736,2020-06-12
X-Ray Computed Tomography,DIAGNOSES,Rupture of diaphragm,32523932,10.12890/2020_001736,2020-06-12
lobe,LOCATION_OF,Atelectasis,32523932,10.12890/2020_001736,2020-06-12
lobe,LOCATION_OF,Perforation of stomach,32523932,10.12890/2020_001736,2020-06-12
lobe,LOCATION_OF,Rupture of diaphragm,32523932,10.12890/2020_001736,2020-06-12
lobe,LOCATION_OF,Ground Glass Opacity,32523932,10.12890/2020_001736,2020-06-12
lobe,PART_OF,Left lung,32523932,10.12890/2020_001736,2020-06-12
Diagnosis,DIAGNOSES,Pneumonia,32523932,10.12890/2020_001736,2020-06-12
Disease,CAUSES,Coughing,32523932,10.12890/2020_001736,2020-06-12
Disease,CAUSES,Fever,32523932,10.12890/2020_001736,2020-06-12
Disease,CAUSES,Dry cough,32523932,10.12890/2020_001736,2020-06-12
Antibiotic therapy,CAUSES,Complication,32523932,10.12890/2020_001736,2020-06-12
Cerebrovascular accident,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
Atrial Fibrillation,CAUSES,Severe Acute Respiratory Syndrome,32523931,10.12890/2020_001732,2020-06-12
Cerebrovascular accident,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
Embolic stroke,CAUSES,Severe Acute Respiratory Syndrome,32523931,10.12890/2020_001732,2020-06-12
Receptive aphasia (finding),ISA,Symptoms,32523931,10.12890/2020_001732,2020-06-12
Right hemiparesis,ISA,Symptoms,32523931,10.12890/2020_001732,2020-06-12
Cardioembolic stroke,PROCESS_OF,geriatric patients,32523931,10.12890/2020_001732,2020-06-12
Atrial Fibrillation,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
Infarction,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
Cerebrovascular accident,PROCESS_OF,Patients,32523931,10.12890/2020_001732,2020-06-12
Cerebrovascular accident,PROCESS_OF,geriatric patients,32523931,10.12890/2020_001732,2020-06-12
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32523930,10.12890/2020_001731,2020-06-12
Deep Sedation,AFFECTS,Thrombotic stroke,32523930,10.12890/2020_001731,2020-06-12
inflammatory response,ASSOCIATED_WITH,Fibrinogen,32523930,10.12890/2020_001731,2020-06-12
inflammatory response,ASSOCIATED_WITH,Fibrin fragment D,32523930,10.12890/2020_001731,2020-06-12
Cytokine release syndrome,PROCESS_OF,Patients,32523929,10.12890/2020_001728,2020-06-12
tocilizumab,ISA,Interleukin inhibitors,32523929,10.12890/2020_001728,2020-06-12
tocilizumab,TREATS(SPEC),Cytokine release syndrome,32523929,10.12890/2020_001728,2020-06-12
Interleukin inhibitors,TREATS,Cytokine release syndrome,32523929,10.12890/2020_001728,2020-06-12
Coronavirus Infections,CAUSES,Cytokine release syndrome,32523929,10.12890/2020_001728,2020-06-12
Cytokine release syndrome,CAUSES,inflammatory response,32523929,10.12890/2020_001728,2020-06-12
Cytokine release syndrome,ISA,Syndrome,32523929,10.12890/2020_001728,2020-06-12
Cytokine release syndrome,AFFECTS,Patients,32523929,10.12890/2020_001728,2020-06-12
Respiratory distress,PROCESS_OF,Patients,32523928,10.12890/2020_001725,2020-06-12
Inspiration function,PROCESS_OF,Patients,32523928,10.12890/2020_001725,2020-06-12
Nerve palsy,CAUSES,neurological complication,32523928,10.12890/2020_001725,2020-06-12
Nerve palsy,ISA,Neurologic Manifestations,32523928,10.12890/2020_001725,2020-06-12
Pulmonary Embolism,PROCESS_OF,Patients,32523927,10.12890/2020_001724,2020-06-12
Biological Markers,PREDISPOSES,Pulmonary Embolism,32523927,10.12890/2020_001724,2020-06-12
Diagnosis,DIAGNOSES,Disease,32523927,10.12890/2020_001724,2020-06-12
Pulmonary Embolism,ISA,Symptoms,32523927,10.12890/2020_001724,2020-06-12
Pulmonary Embolism,PROCESS_OF,Patients,32523927,10.12890/2020_001724,2020-06-12
Pulmonary Embolism,PROCESS_OF,Patients,32523927,10.12890/2020_001724,2020-06-12
C-reactive protein measurement,DIAGNOSES,Pulmonary Embolism,32523927,10.12890/2020_001724,2020-06-12
Diabetic Ketoacidosis,PROCESS_OF,Male population group,32523926,10.12890/2020_001718,2020-06-12
Dyspnea,PROCESS_OF,Male population group,32523926,10.12890/2020_001718,2020-06-12
Acute onset pain,PROCESS_OF,Male population group,32523926,10.12890/2020_001718,2020-06-12
Right lower extremity,LOCATION_OF,Dyspnea,32523926,10.12890/2020_001718,2020-06-12
Right lower extremity,LOCATION_OF,Acute onset pain,32523926,10.12890/2020_001718,2020-06-12
Medical History,PROCESS_OF,Male population group,32523926,10.12890/2020_001718,2020-06-12
Limb ischemia,PROCESS_OF,Male population group,32523926,10.12890/2020_001718,2020-06-12
Arterial thrombosis,COEXISTS_WITH,Thrombosis,32523926,10.12890/2020_001718,2020-06-12
Pneumonia,AFFECTS,Patients,32523925,10.12890/2020_001710,2020-06-12
Takotsubo Cardiomyopathy,COEXISTS_WITH,Disease,32523925,10.12890/2020_001710,2020-06-12
Takotsubo Cardiomyopathy,PROCESS_OF,Patients,32523925,10.12890/2020_001710,2020-06-12
acute stress,CAUSES,Takotsubo Cardiomyopathy,32523925,10.12890/2020_001710,2020-06-12
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32523924,10.12890/2020_001707,2020-06-12
Acute pancreatitis,OCCURS_IN,Population Group,32523924,10.12890/2020_001707,2020-06-12
Pancreatic enzyme,TREATS,Patients,32523924,10.12890/2020_001707,2020-06-12
Acute pancreatitis,COEXISTS_WITH,Pancreatitis,32523924,10.12890/2020_001707,2020-06-12
IMPACT gene,AFFECTS,patient condition,32523924,10.12890/2020_001707,2020-06-12
Infected,PROCESS_OF,Patients,32523923,10.12890/2020_001703,2020-06-12
Pericardial effusion,PROCESS_OF,Woman,32523922,10.12890/2020_001702,2020-06-12
Purpura,COEXISTS_WITH,Thrombocytopenia,32523921,10.12890/2020_001701,2020-06-12
Mucosal bleeding,COEXISTS_WITH,Thrombocytopenia,32523921,10.12890/2020_001701,2020-06-12
"Immunoglobulins, Intravenous",TREATS,Patients,32523921,10.12890/2020_001701,2020-06-12
eltrombopag,TREATS,Patients,32523921,10.12890/2020_001701,2020-06-12
Thrombocytopenia,PROCESS_OF,Patients,32523921,10.12890/2020_001701,2020-06-12
Thrombocytopenia,PROCESS_OF,Patients,32523921,10.12890/2020_001701,2020-06-12
Cardiac Tamponade,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Acute viral pericarditis,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Cardiac Tamponade,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Complication,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Pericardial effusion,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Pericardial effusion,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Acute pericarditis,PROCESS_OF,Patients,32523920,10.12890/2020_001692,2020-06-12
Virus,CAUSES,Disease,32523874,10.1016/j.crwh.2020.e00212,2020-06-12
Inflammation,CAUSES,Blood Coagulation Disorders,32523874,10.1016/j.crwh.2020.e00212,2020-06-12
Abnormality,PROCESS_OF,Patients,32523874,10.1016/j.crwh.2020.e00212,2020-06-12
Pulmonary Thromboembolisms,ISA,Thromboembolism,32523874,10.1016/j.crwh.2020.e00212,2020-06-12
Gravidity,PROCESS_OF,Mother (person),32523872,10.1016/j.idcr.2020.e00860,2020-06-12
Cesarean section,TREATS,Woman,32523872,10.1016/j.idcr.2020.e00860,2020-06-12
Respiratory Tract Infections,COEXISTS_WITH,Fever,32523871,10.1016/j.idcr.2020.e00859,2020-06-12
Respiratory Tract Infections,COEXISTS_WITH,Dry cough,32523871,10.1016/j.idcr.2020.e00859,2020-06-12
Disease,COEXISTS_WITH,Symptoms,32523871,10.1016/j.idcr.2020.e00859,2020-06-12
Nausea,PROCESS_OF,Woman,32523871,10.1016/j.idcr.2020.e00859,2020-06-12
Hyponatremia,ISA,Syndrome,32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Hyponatremia,PROCESS_OF,hospitalized patients,32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Inappropriate ADH Syndrome,CAUSES,Hyponatremia,32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Hyponatremia,COEXISTS_WITH,Detected (finding),32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Vasopressins,ASSOCIATED_WITH,Hyponatremia,32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Acute hyponatremia,PROCESS_OF,Patients,32523870,10.1016/j.rmcr.2020.101113,2020-06-12
Coronavirus Infections,ISA,Disease,32523858,10.7759/cureus.8440,2020-06-12
Extracorporeal Membrane Oxygenation,TREATS,Pneumonia,32523858,10.7759/cureus.8440,2020-06-12
Pneumonia,ISA,Disease,32523858,10.7759/cureus.8440,2020-06-12
Pharmacotherapy,TREATS,Discrepancy,32523858,10.7759/cureus.8440,2020-06-12
Extracorporeal Membrane Oxygenation,TREATS,Discrepancy,32523858,10.7759/cureus.8440,2020-06-12
Analysis,MEASURES,Future,32523709,10.1177/2054358120928153,2020-06-12
"Hemodialysis, Home",TREATS,Patients,32523686,10.1177/2045894020924566,2020-06-12
"Hemodialysis, Home",TREATS(INFER),"Kidney Failure, Chronic",32523686,10.1177/2045894020924566,2020-06-12
"Kidney Failure, Chronic",PROCESS_OF,Patients,32523686,10.1177/2045894020924566,2020-06-12
Peritoneal Dialysis,TREATS,Community,32523686,10.1177/2045894020924566,2020-06-12
Pulmonary Hypertension,PROCESS_OF,Patients,32523681,10.1186/s12998-020-00319-4,2020-06-12
Pulmonary Hypertension,PROCESS_OF,Patients,32523681,10.1186/s12998-020-00319-4,2020-06-12
Pulmonary Hypertension,PROCESS_OF,Patients,32523681,10.1186/s12998-020-00319-4,2020-06-12
Pulmonary Hypertension,PROCESS_OF,Patients,32523681,10.1186/s12998-020-00319-4,2020-06-12
Pulmonary Hypertension,PROCESS_OF,Patients,32523681,10.1186/s12998-020-00319-4,2020-06-12
Manipulation of spine,TREATS,user - individual,32523611,10.7573/dic.2020-5-2,2020-06-12
Manipulation of spine,TREATS,activity level,32523611,10.7573/dic.2020-5-2,2020-06-12
Manipulation of spine,TREATS,Policy Makers,32523611,10.7573/dic.2020-5-2,2020-06-12
Challenge,TREATS,Health Personnel,32523258,10.1016/j.jor.2020.06.001,2020-06-12
Wounds and Injuries,PROCESS_OF,Adult,32523257,10.1016/j.chaos.2020.109932,2020-06-12
Challenge,TREATS,Osteoporosis,32523257,10.1016/j.chaos.2020.109932,2020-06-12
Fragility,PROCESS_OF,Elderly (population group),32523257,10.1016/j.chaos.2020.109932,2020-06-12
Hip Fractures,ISA,Fracture,32523257,10.1016/j.chaos.2020.109932,2020-06-12
Community,LOCATION_OF,IMPACT gene,32523151,10.24875/ACM.M20000074,2020-06-12
Virus,PROCESS_OF,Persons,32523151,10.24875/ACM.M20000074,2020-06-12
Infected,PROCESS_OF,Persons,32523151,10.24875/ACM.M20000074,2020-06-12
Infected,PROCESS_OF,Persons,32523151,10.24875/ACM.M20000074,2020-06-12
Diabetes Mellitus,PROCESS_OF,Patients,32523150,10.24875/ACM.M20000061,2020-06-12
parenteral administration,COEXISTS_WITH,Hospitalization,32523150,10.24875/ACM.M20000061,2020-06-12
parenteral administration,TREATS,Outpatients,32523150,10.24875/ACM.M20000061,2020-06-12
Pharmaceutical Preparations,STIMULATES,receptor,32523143,10.24875/ACM.M20000058,2020-06-12
Pharmaceutical Preparations,TREATS,Disease,32523143,10.24875/ACM.M20000058,2020-06-12
Medicament,TREATS,Complication,32523143,10.24875/ACM.M20000058,2020-06-12
Medicament,TREATS,Disease,32523143,10.24875/ACM.M20000058,2020-06-12
Lung,LOCATION_OF,Ultrasonography,32523141,10.24875/ACM.M20000068,2020-06-12
Patient Monitoring,TREATS,Patients,32523141,10.24875/ACM.M20000068,2020-06-12
Critical Illness,PROCESS_OF,Patients,32523141,10.24875/ACM.M20000068,2020-06-12
Heart failure,PROCESS_OF,Patients,32523141,10.24875/ACM.M20000068,2020-06-12
Pleura,LOCATION_OF,Pulmonary Pathology,32523141,10.24875/ACM.M20000068,2020-06-12
Pulmonary Pathology,PROCESS_OF,Patients,32523141,10.24875/ACM.M20000068,2020-06-12
Coronary Arteriosclerosis,PROCESS_OF,Patients,32523140,10.24875/ACM.M20000065,2020-06-12
Hyperglycemia,PROCESS_OF,Patients,32523140,10.24875/ACM.M20000065,2020-06-12
Diabetes,COEXISTS_WITH,Comorbidity,32523140,10.24875/ACM.M20000065,2020-06-12
Peripheral Vascular Diseases,PROCESS_OF,Patients,32523140,10.24875/ACM.M20000065,2020-06-12
Genus: Coronavirus,COEXISTS_WITH,Diabetes,32523140,10.24875/ACM.M20000065,2020-06-12
Diabetes,PROCESS_OF,Patients,32523140,10.24875/ACM.M20000065,2020-06-12
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,general population,32523140,10.24875/ACM.M20000065,2020-06-12
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Population Group,32523140,10.24875/ACM.M20000065,2020-06-12
Hospital Administration,TREATS,Patients,32523140,10.24875/ACM.M20000065,2020-06-12
Hospital Administration,TREATS(INFER),Diabetes,32523140,10.24875/ACM.M20000065,2020-06-12
Symptoms,PROCESS_OF,Patients,32523138,10.24875/ACM.M20000057,2020-06-12
Cardiovascular,LOCATION_OF,Chronic disease,32523138,10.24875/ACM.M20000057,2020-06-12
Heart failure,PROCESS_OF,Patients,32523138,10.24875/ACM.M20000057,2020-06-12
Cardiovascular Diseases,PROCESS_OF,Patients,32523137,10.24875/ACM.M20000064,2020-06-12
Disease,CAUSES,Cessation of life,32523136,10.24875/ACM.M20000069,2020-06-12
Atypical pneumonia,CAUSES,Inflammation,32523136,10.24875/ACM.M20000069,2020-06-12
Present,PREDISPOSES,Cardiovascular Diseases,32523136,10.24875/ACM.M20000069,2020-06-12
Present,PREDISPOSES,Diabetes,32523136,10.24875/ACM.M20000069,2020-06-12
Present,PREDISPOSES,Hypertensive disease,32523136,10.24875/ACM.M20000069,2020-06-12
IMPACT gene,ASSOCIATED_WITH,Coronavirus Infections,32523136,10.24875/ACM.M20000069,2020-06-12
Myocardial Infarction,PROCESS_OF,Patients,32523135,10.24875/ACM.M20000062,2020-06-12
Reperfusion Therapy,TREATS,Patients,32523135,10.24875/ACM.M20000062,2020-06-12
Reperfusion Therapy,TREATS(INFER),Myocardial Infarction,32523135,10.24875/ACM.M20000062,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32523135,10.24875/ACM.M20000062,2020-06-12
Percutaneous Coronary Intervention,TREATS,Patients,32523135,10.24875/ACM.M20000062,2020-06-12
Percutaneous Coronary Intervention,TREATS(INFER),Severe Acute Respiratory Syndrome,32523135,10.24875/ACM.M20000062,2020-06-12
Coronavirus Infections,ISA,Disease,32523135,10.24875/ACM.M20000062,2020-06-12
Acute Coronary Syndrome,PROCESS_OF,Patients,32523080,10.1038/s41598-020-66368-0,2020-06-12
Acute myocardial infarction,PROCESS_OF,Patients,32523080,10.1038/s41598-020-66368-0,2020-06-12
Italy,ISA,Geographic Locations,32522874,10.1073/pnas.2008176117,2020-06-12
Measles Virus Nucleoprotein,COEXISTS_WITH,Glycoproteins,32522870,10.1073/pnas.2008025117,2020-06-12
ACE2 gene,PREVENTS,Lung Injury,32522845,10.1136/postgradmedj-2020-137735,2020-06-12
"Respiratory Distress Syndrome, Adult",ISA,Disease,32522845,10.1136/postgradmedj-2020-137735,2020-06-12
ACE2 gene,AFFECTS,"Respiratory Distress Syndrome, Adult",32522845,10.1136/postgradmedj-2020-137735,2020-06-12
Pharmaceutical Preparations,STIMULATES,ACE2 gene,32522845,10.1136/postgradmedj-2020-137735,2020-06-12
ACE2 gene,AFFECTS,"Respiratory Distress Syndrome, Adult",32522845,10.1136/postgradmedj-2020-137735,2020-06-12
Lung,LOCATION_OF,AKR1A1 wt Allele,32522845,10.1136/postgradmedj-2020-137735,2020-06-12
Pandemics,ISA,Process,32522844,10.1136/postgradmedj-2020-137979,2020-06-12
Hospitals,LOCATION_OF,Services,32522844,10.1136/postgradmedj-2020-137979,2020-06-12
Disease,PROCESS_OF,Homo sapiens,32522822,10.1136/heartjnl-2020-317258,2020-06-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32522822,10.1136/heartjnl-2020-317258,2020-06-12
Dry cough,ASSOCIATED_WITH,Atypical pneumonia,32522822,10.1136/heartjnl-2020-317258,2020-06-12
Tropism,PROCESS_OF,Dual,32522822,10.1136/heartjnl-2020-317258,2020-06-12
SARS coronavirus,PROCESS_OF,Homo sapiens,32522822,10.1136/heartjnl-2020-317258,2020-06-12
SARS coronavirus,PROCESS_OF,Homo sapiens,32522822,10.1136/heartjnl-2020-317258,2020-06-12
tissue tropism,PROCESS_OF,Lung,32522822,10.1136/heartjnl-2020-317258,2020-06-12
Disease,PROCESS_OF,Patients,32522814,10.1136/medethics-2020-106489,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32522814,10.1136/medethics-2020-106489,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32522814,10.1136/medethics-2020-106489,2020-06-12
Heart Diseases,PROCESS_OF,Patients,32522814,10.1136/medethics-2020-106489,2020-06-12
Cardiac dilatation,PROCESS_OF,Patients,32522814,10.1136/medethics-2020-106489,2020-06-12
Challenge,TREATS,Health Personnel,32522812,10.1136/medethics-2020-106402,2020-06-12
Patient Problem,PROCESS_OF,Patients,32522754,10.1136/bmjgast-2020-000434,2020-06-12
Therapeutic procedure,ADMINISTERED_TO,Patients,32522754,10.1136/bmjgast-2020-000434,2020-06-12
Patients,ISA,Persons,32522754,10.1136/bmjgast-2020-000434,2020-06-12
Antibiotics,TREATS,General symptom,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Hydroxychloroquine,TREATS,General symptom,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Teicoplanin,ISA,Antibiotics,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Teicoplanin,TREATS(SPEC),General symptom,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Metronidazole,CAUSES,pneumatosis intestinalis,32522738,10.1136/bmjgh-2020-002769,2020-06-12
pneumatosis intestinalis,AFFECTS,Possible,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Severe Acute Respiratory Syndrome,CAUSES,pneumatosis intestinalis,32522738,10.1136/bmjgh-2020-002769,2020-06-12
Coronavirus Infections,ISA,Disease,32522737,10.1136/bmj.m2195,2020-06-12
Awareness,PROCESS_OF,Community,32522737,10.1136/bmj.m2195,2020-06-12
Isolation procedure,TREATS,Community,32522737,10.1136/bmj.m2195,2020-06-12
Coronavirus Infections,ISA,Disease,32522737,10.1136/bmj.m2195,2020-06-12
exposure history,NEG_PROCESS_OF,Health Personnel,32522674,10.1016/j.ijantimicag.2020.106044,2020-06-12
Interventional procedure,ADMINISTERED_TO,Patients,32522674,10.1016/j.ijantimicag.2020.106044,2020-06-12
Immunity,PROCESS_OF,Study Subject,32522674,10.1016/j.ijantimicag.2020.106044,2020-06-12
Chloroquine,TREATS,Patients,32522671,10.1016/j.jhin.2020.06.003,2020-06-12
Chloroquine,TREATS,Patients,32522671,10.1016/j.jhin.2020.06.003,2020-06-12
Interventional procedure,PREVENTS,Communicable Diseases,32522666,10.1016/j.imlet.2020.06.002,2020-06-12
Symptom severe,PROCESS_OF,Persons,32522632,10.1016/j.athoracsur.2020.06.001,2020-06-12
Lung,LOCATION_OF,inflammatory response,32522632,10.1016/j.athoracsur.2020.06.001,2020-06-12
Nicotine,AFFECTS,inflammatory response,32522632,10.1016/j.athoracsur.2020.06.001,2020-06-12
SARS coronavirus,CAUSES,Virus Diseases,32522617,10.1016/j.hjc.2020.05.007,2020-06-12
Organ,LOCATION_OF,ACE2 gene,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
ACE2 gene,INHIBITS,angiotensin II,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
Heart,LOCATION_OF,ACE2 gene,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
"Respiratory Distress Syndrome, Adult",CAUSES,Anoxia,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32522610,10.1016/j.ajic.2020.05.043,2020-06-12
Study,MEASURES,Percent (qualifier value),32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Hand Hygiene,ISA,Behavior,32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Hand Hygiene,ISA,Behavior,32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Protection,PROCESS_OF,Patients,32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Hand Hygiene,ISA,Behavior,32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Protection,PROCESS_OF,Patients,32522608,10.1016/j.ajic.2020.06.002,2020-06-12
Decontamination,TREATS,Phage MS2,32522606,10.1016/j.ajic.2020.06.003,2020-06-12
Phage MS2,ISA,Virus,32522606,10.1016/j.ajic.2020.06.003,2020-06-12
Pulmonary Gas Exchange,AFFECTS,Respiration,32522523,10.1016/j.cjca.2020.06.005,2020-06-12
Carotid Body,LOCATION_OF,IMPACT gene,32522523,10.1016/j.cjca.2020.06.005,2020-06-12
Severe Acute Respiratory Syndrome,AFFECTS,Esthesia,32522523,10.1016/j.cjca.2020.06.005,2020-06-12
Pharmacotherapy,USES,Erythropoietin,32522523,10.1016/j.cjca.2020.06.005,2020-06-12
vascular bed,LOCATION_OF,Inflammation,32522523,10.1016/j.cjca.2020.06.005,2020-06-12
myocardial injury,PROCESS_OF,Patients,32522513,10.1016/j.ajog.2020.06.006,2020-06-12
follow-up,TREATS,Unspecified Abortion,32522473,10.1016/j.transci.2020.102836,2020-06-12
Symptoms,PROCESS_OF,Patients,32522473,10.1016/j.transci.2020.102836,2020-06-12
lifesaving,TREATS,Disease,32522412,10.1016/j.euf.2020.05.022,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32522406,10.1016/j.soard.2020.04.038,2020-06-12
Worse,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
General wellbeing,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Symptoms,COEXISTS_WITH,Learning difficulties,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32522406,10.1016/j.soard.2020.04.038,2020-06-12
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32522406,10.1016/j.soard.2020.04.038,2020-06-12
"CD69 protein, human",ASSOCIATED_WITH,Obesity,32522369,10.1016/j.jss.2020.05.014,2020-06-12
Obesity,PROCESS_OF,Ethnic group,32522369,10.1016/j.jss.2020.05.014,2020-06-12
Obesity,PROCESS_OF,Ethnic group,32522369,10.1016/j.jss.2020.05.014,2020-06-12
Obesity,OCCURS_IN,Ethnic group,32522369,10.1016/j.jss.2020.05.014,2020-06-12
Therapeutic procedure,TREATS,Coronavirus Infections,32522307,10.1017/S1047951120001821,2020-06-12
INVESTIGATIONAL VACCINES,TREATS,Coronavirus Infections,32522307,10.1017/S1047951120001821,2020-06-12
Complication,PROCESS_OF,high-risk group,32522306,10.1017/S1047951120001638,2020-06-12
altretamine/cisplatin/cyclophosphamide protocol,TREATS,Patients,32522306,10.1017/S1047951120001638,2020-06-12
Disease,PROCESS_OF,Patients,32522282,10.1186/s13063-020-04409-9,2020-06-12
Obesity,PROCESS_OF,Patients,32522282,10.1186/s13063-020-04409-9,2020-06-12
diabetic,PROCESS_OF,Patients,32522282,10.1186/s13063-020-04409-9,2020-06-12
Severe clinical course,PROCESS_OF,Patients,32522282,10.1186/s13063-020-04409-9,2020-06-12
intensive care unit,LOCATION_OF,Controlled Clinical Trials as Topic,32522278,10.1186/s13045-020-00907-0,2020-06-12
Azithromycin,ISA,Antibiotics,32522278,10.1186/s13045-020-00907-0,2020-06-12
Respiratory medicine department,LOCATION_OF,Clinical Trials,32522278,10.1186/s13045-020-00907-0,2020-06-12
Duration,TREATS,Patients,32522278,10.1186/s13045-020-00907-0,2020-06-12
Fertility,NEG_PROCESS_OF,Woman,32522278,10.1186/s13045-020-00907-0,2020-06-12
Fertility,PROCESS_OF,Woman,32522278,10.1186/s13045-020-00907-0,2020-06-12
Liver,LOCATION_OF,Severe disorder,32522278,10.1186/s13045-020-00907-0,2020-06-12
Digoxin,NEG_TREATS,Patients,32522278,10.1186/s13045-020-00907-0,2020-06-12
Myasthenia gravis treatment,USES,Digoxin,32522278,10.1186/s13045-020-00907-0,2020-06-12
Placebos,ADMINISTERED_TO,Control Groups,32522278,10.1186/s13045-020-00907-0,2020-06-12
Pharmaceutical Preparations,NEG_ADMINISTERED_TO,Patients,32522278,10.1186/s13045-020-00907-0,2020-06-12
Nasogastric tube,USES,Pharmaceutical Preparations,32522278,10.1186/s13045-020-00907-0,2020-06-12
Hydroxychloroquine,TREATS,Patients,32522278,10.1186/s13045-020-00907-0,2020-06-12
Asthma,ISA,Chronic Obstructive Airway Disease,32522278,10.1186/s13045-020-00907-0,2020-06-12
Hospitals,LOCATION_OF,Retrospective Studies,32522223,10.1186/s13046-020-01614-x,2020-06-12
GSKIP gene,PART_OF,Patients,32522223,10.1186/s13046-020-01614-x,2020-06-12
Coitus,AFFECTS,Age,32522223,10.1186/s13046-020-01614-x,2020-06-12
risk factors,PROCESS_OF,hospitalized patients,32522223,10.1186/s13046-020-01614-x,2020-06-12
Solid Neoplasm,PROCESS_OF,Patients,32522223,10.1186/s13046-020-01614-x,2020-06-12
Hematologic Neoplasms,PROCESS_OF,Patients,32522223,10.1186/s13046-020-01614-x,2020-06-12
Complication,PROCESS_OF,Cancer Patient,32522223,10.1186/s13046-020-01614-x,2020-06-12
Poor outcome,PROCESS_OF,Cancer Patient,32522223,10.1186/s13046-020-01614-x,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Cancer Patient,32522223,10.1186/s13046-020-01614-x,2020-06-12
C-reactive protein,STIMULATES,Ferritin,32522223,10.1186/s13046-020-01614-x,2020-06-12
Inflammation,COEXISTS_WITH,patient condition,32522223,10.1186/s13046-020-01614-x,2020-06-12
Today,TREATS,Cancer Patient,32522216,10.1186/s12911-020-01145-7,2020-06-12
Physicians,TREATS,Patients,32522207,10.1186/s12967-020-02405-w,2020-06-12
Telemedicine,METHOD_OF,Risk Assessment,32522207,10.1186/s12967-020-02405-w,2020-06-12
Human coronavirus,INTERACTS_WITH,Human coronavirus 229E,32522191,10.1186/s12939-020-01208-1,2020-06-12
Glycoproteins,PART_OF,SARS coronavirus,32522191,10.1186/s12939-020-01208-1,2020-06-12
Glycoproteins,PART_OF,Middle East Respiratory Syndrome Coronavirus,32522191,10.1186/s12939-020-01208-1,2020-06-12
Human coronavirus,LOCATION_OF,cytokine,32522191,10.1186/s12939-020-01208-1,2020-06-12
Human coronavirus,LOCATION_OF,Toll-like receptors,32522191,10.1186/s12939-020-01208-1,2020-06-12
Human coronavirus,LOCATION_OF,GSKIP gene,32522191,10.1186/s12939-020-01208-1,2020-06-12
"CD69 protein, human",PART_OF,Social Networks,32522191,10.1186/s12939-020-01208-1,2020-06-12
"Hospitals, Urban",LOCATION_OF,Study,32522141,10.33321/cdi.2020.44.45,2020-06-12
Serum,LOCATION_OF,Hemoglobin,32522141,10.33321/cdi.2020.44.45,2020-06-12
Experience,PROCESS_OF,"Populations, Underserved",32522141,10.33321/cdi.2020.44.45,2020-06-12
Disease,PROCESS_OF,Community,32522074,10.1089/hs.2020.0021,2020-06-12
Virus,PROCESS_OF,high-risk group,32522074,10.1089/hs.2020.0021,2020-06-12
Cessation of life,NEG_OCCURS_IN,year,32522074,10.1089/hs.2020.0021,2020-06-12
Cessation of life,OCCURS_IN,Old age,32522074,10.1089/hs.2020.0021,2020-06-12
Disease,PROCESS_OF,Child,32522074,10.1089/hs.2020.0021,2020-06-12
Hydroxychloroquine,TREATS,Patients,32522037,10.1177/2324709620934674,2020-06-12
Hydroxychloroquine,TREATS,Severe Acute Respiratory Syndrome,32522037,10.1177/2324709620934674,2020-06-12
Coinfection,PROCESS_OF,Patients,32522031,10.1089/dia.2020.0240,2020-06-12
Residency,ISA,Training,32521987,10.3760/cma.j.cn.441530-20200603-00334,2020-06-12
Department,LOCATION_OF,Educational process of instructing,32521953,10.3760/cma.j.cn112138-20200228-00151,2020-06-12
Department,LOCATION_OF,Training,32521953,10.3760/cma.j.cn112138-20200228-00151,2020-06-12
Prophylactic treatment,TREATS,Old age,32521811,10.3390/ijerph17114098,2020-06-12
Prophylactic treatment,TREATS,Old age,32521811,10.3390/ijerph17114098,2020-06-12
Decision,PROCESS_OF,Maker (occupation),32521776,10.3390/ijerph17114095,2020-06-12
Adaptive Immunity,PROCESS_OF,Health Personnel,32521776,10.3390/ijerph17114095,2020-06-12
Dietary Supplements,PREDISPOSES,Severe Acute Respiratory Syndrome,32521726,10.3390/dj8020057,2020-06-12
Blood Coagulation Disorders,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Disseminated Intravascular Coagulation,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Respiratory distress,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Disseminated Intravascular Coagulation,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Complication,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Complication,PROCESS_OF,Patients,32521706,10.3390/v12060624,2020-06-12
Cardiovascular morbidity,COEXISTS_WITH,American College of Cardiology/American Heart Association Lesion Complexity Score C,32521641,10.3390/ijerph17114076,2020-06-12
Congenital heart disease,PART_OF,Patients,32521641,10.3390/ijerph17114076,2020-06-12
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32521641,10.3390/ijerph17114076,2020-06-12
Congenital heart disease,PART_OF,Patients,32521641,10.3390/ijerph17114076,2020-06-12
Diabetes,PROCESS_OF,Child,32521641,10.3390/ijerph17114076,2020-06-12
Cardiovascular,LOCATION_OF,Comorbidity,32521641,10.3390/ijerph17114076,2020-06-12
Cardiac complication,PROCESS_OF,Patients,32521641,10.3390/ijerph17114076,2020-06-12
Cardiovascular morbidity,PROCESS_OF,Patients,32521641,10.3390/ijerph17114076,2020-06-12
Mild disease course,PROCESS_OF,Cohort,32521641,10.3390/ijerph17114076,2020-06-12
Genome,PRODUCES,Viral Proteins,32510035,10.12688/hrbopenres.13030.2,2020-06-12
Enzymes,AFFECTS,Cell physiology,32510035,10.12688/hrbopenres.13030.2,2020-06-12
Enzymes,AFFECTS,Cell physiology,32510035,10.12688/hrbopenres.13030.2,2020-06-12
Virus,CAUSES,Oxidative Stress,32510035,10.12688/hrbopenres.13030.2,2020-06-12
Therapeutic procedure,CAUSES,Inflammation,32510035,10.12688/hrbopenres.13030.2,2020-06-12
GA-Binding Protein Transcription Factor,ISA,TRANSCRIPTION FACTOR,32510035,10.12688/hrbopenres.13030.2,2020-06-12
GA-Binding Protein Transcription Factor,PART_OF,TRANSCRIPTION FACTOR,32510035,10.12688/hrbopenres.13030.2,2020-06-12
inflammatory response,COEXISTS_WITH,Acute respiratory infections,32510035,10.12688/hrbopenres.13030.2,2020-06-12
Dementia,PROCESS_OF,Persons,32521580,10.3760/cma.j.cn112138-20200306-00202,2020-06-11
Dementia,PROCESS_OF,Persons,32521580,10.3760/cma.j.cn112138-20200306-00202,2020-06-11
Dementia,PROCESS_OF,Persons,32521580,10.3760/cma.j.cn112138-20200306-00202,2020-06-11
Storm Syndrome,AFFECTS,patient condition,32521564,10.1111/odi.13473,2020-06-11
Hemofiltration,TREATS,Patients,32521564,10.1111/odi.13473,2020-06-11
Hemofiltration,TREATS(INFER),Storm Syndrome,32521564,10.1111/odi.13473,2020-06-11
Storm Syndrome,PROCESS_OF,Patients,32521564,10.1111/odi.13473,2020-06-11
Skin lesion,COEXISTS_WITH,Virus Diseases,32521557,10.1055/a-1183-4835,2020-06-11
Taste Disorders,PROCESS_OF,Patients,32521463,10.1016/j.dsx.2020.05.050,2020-06-11
Ziziphus mauritiana,LOCATION_OF,amsonic acid,32521463,10.1016/j.dsx.2020.05.050,2020-06-11
Coronavirus Infections,ISA,Disease,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Diabetes Mellitus,ISA,Disease,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Ergocalciferol,TREATS,Diabetes Mellitus,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Coronavirus Infections,ISA,Disease,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Endocrine System Diseases,PROCESS_OF,general population,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Coronavirus Infections,ISA,Disease,32521411,10.1016/j.socscimed.2020.113101,2020-06-11
Infected,PROCESS_OF,Persons,32521222,10.3201/eid2609.202272,2020-06-11
Disinfection,USES,Air,32521222,10.3201/eid2609.202272,2020-06-11
Kindergartens (organization),ISA,School,32521222,10.3201/eid2609.202272,2020-06-11
Coronavirus Infections,ISA,Disease,32521191,10.1080/15548627.2020.1779531,2020-06-11
Chloroquine,TREATS,Patients,32521167,10.1513/AnnalsATS.202005-418FR,2020-06-11
Chloroquine,INTERACTS_WITH,Safe-Guard,32521167,10.1513/AnnalsATS.202005-418FR,2020-06-11
Hypoxemia,PROCESS_OF,Patients,32521159,10.1021/acs.jpcb.0c04198,2020-06-11
Complication,PROCESS_OF,Patients,32521159,10.1021/acs.jpcb.0c04198,2020-06-11
Present,PREDISPOSES,Complication,32521159,10.1021/acs.jpcb.0c04198,2020-06-11
At home,PREDISPOSES,Complication,32521159,10.1021/acs.jpcb.0c04198,2020-06-11
RNA-Directed RNA Polymerase,PART_OF,SARS coronavirus,32521120,10.1111/jdi.13320,2020-06-11
,compared_with,"ATP8A2 protein, human",32521120,10.1111/jdi.13320,2020-06-11
,higher_than,"ATP8A2 protein, human",32521120,10.1111/jdi.13320,2020-06-11
Multiple Organ Failure,CAUSES,Cessation of life,32521074,10.1111/tid.13364,2020-06-11
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32521074,10.1111/tid.13364,2020-06-11
Septic Shock,CAUSES,Cessation of life,32521074,10.1111/tid.13364,2020-06-11
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32521064,10.1002/jclp.23005,2020-06-11
Uncertainty,PROCESS_OF,Patients,32521064,10.1002/jclp.23005,2020-06-11
Migraine Disorders,PROCESS_OF,Patients,32521039,10.1111/head.13884,2020-06-11
Headache,PROCESS_OF,Patients,32520981,10.1590/1678-4685-gmb-2020-0104,2020-06-11
Headache Disorders,AFFECTS,Patients,32520981,10.1590/1678-4685-gmb-2020-0104,2020-06-11
Headache,PROCESS_OF,Patients,32520981,10.1590/1678-4685-gmb-2020-0104,2020-06-11
Headache Disorders,PROCESS_OF,Patients,32520981,10.1590/1678-4685-gmb-2020-0104,2020-06-11
Headache,ASSOCIATED_WITH,Enthesitis-Related Arthritis,32520981,10.1590/1678-4685-gmb-2020-0104,2020-06-11
human group,NEG_LOCATION_OF,ACE2 gene,32520930,10.1371/journal.pntd.0008305,2020-06-11
Infected,PROCESS_OF,Homo sapiens,32520930,10.1371/journal.pntd.0008305,2020-06-11
Coronavirus Infections,PROCESS_OF,Specialist,32520930,10.1371/journal.pntd.0008305,2020-06-11
Coronavirus Infections,PROCESS_OF,Child,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Coughing,ISA,Symptoms,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Interferons,TREATS,Patients,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Ribavirin,COEXISTS_WITH,Ritonavir,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Ribavirin,COEXISTS_WITH,lopinavir,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Ritonavir,TREATS,Negative,32520878,10.1097/OLQ.0000000000001198,2020-06-11
lopinavir,TREATS,Negative,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Laboratory Procedures,ISA,diagnostic procedure,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Asymptomatic,PROCESS_OF,Patients,32520878,10.1097/OLQ.0000000000001198,2020-06-11
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32520770,10.1097/JCMA.0000000000000367,2020-06-11
Diagnosis,DIAGNOSES,Confirmation,32520770,10.1097/JCMA.0000000000000367,2020-06-11
Virus,CAUSES,Communicable Diseases,32520751,10.1097/ACM.0000000000003540,2020-06-11
Disease,PROCESS_OF,Patients,32520751,10.1097/ACM.0000000000003540,2020-06-11
Vaccines,TREATS,Virus,32520751,10.1097/ACM.0000000000003540,2020-06-11
Prophylactic treatment,COEXISTS_WITH,Challenge,32520751,10.1097/ACM.0000000000003540,2020-06-11
Academic Medical Centers,LOCATION_OF,Graduation,32520750,10.1097/ACM.0000000000003542,2020-06-11
Supportive care,TREATS,Patients,32520743,10.1097/SLA.0000000000004116,2020-06-11
Supportive care,TREATS(INFER),"Mental Disorders, Severe",32520743,10.1097/SLA.0000000000004116,2020-06-11
"Mental Disorders, Severe",PROCESS_OF,Patients,32520743,10.1097/SLA.0000000000004116,2020-06-11
major surgery,PRECEDES,Operative Surgical Procedures,32520742,10.1097/SLA.0000000000004125,2020-06-11
Telemedicine,METHOD_OF,Consultation,32520728,10.1213/ANE.0000000000005056,2020-06-11
Telemedicine,METHOD_OF,Consultation,32520728,10.1213/ANE.0000000000005056,2020-06-11
Operative Surgical Procedures,ISA,Interventional procedure,32520728,10.1213/ANE.0000000000005056,2020-06-11
Intubation,PREDISPOSES,Respiratory Tract Infections,32520683,10.2174/1389200221666200610172929,2020-06-11
Respiratory Tract Infections,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32520683,10.2174/1389200221666200610172929,2020-06-11
Hospitals,LOCATION_OF,Study,32520683,10.2174/1389200221666200610172929,2020-06-11
Work related exposure,PROCESS_OF,Physicians,32520683,10.2174/1389200221666200610172929,2020-06-11
Infected,PROCESS_OF,Persons,32520599,10.1177/0145561320932318,2020-06-11
Hydroxychloroquine,TREATS,Patients,32520599,10.1177/0145561320932318,2020-06-11
Decontamination,USES,Povidone-Iodine,32520580,10.2214/AJR.20.23167,2020-06-11
Oral cavity,LOCATION_OF,Nasal cavity,32520580,10.2214/AJR.20.23167,2020-06-11
Mucous Membrane,LOCATION_OF,Cell Count,32520580,10.2214/AJR.20.23167,2020-06-11
ciliated epithelium,PART_OF,Nose,32520580,10.2214/AJR.20.23167,2020-06-11
Conscious,PROCESS_OF,Adult,32520580,10.2214/AJR.20.23167,2020-06-11
Adverse event,NEG_PROCESS_OF,Adult,32520580,10.2214/AJR.20.23167,2020-06-11
Adverse event,NEG_PROCESS_OF,Child,32520580,10.2214/AJR.20.23167,2020-06-11
Nose,LOCATION_OF,Iodides,32520580,10.2214/AJR.20.23167,2020-06-11
PET/CT scan,ADMINISTERED_TO,Patients,32520513,10.1097/RLU.0000000000003175,2020-06-11
PET/CT scan,DIAGNOSES,Bilateral pneumonia,32520513,10.1097/RLU.0000000000003175,2020-06-11
PET/CT scan,USES,fluorocholine,32520513,10.1097/RLU.0000000000003175,2020-06-11
PET/CT scan,USES,fluorocholine,32520513,10.1097/RLU.0000000000003175,2020-06-11
Lung,LOCATION_OF,Incidental Findings,32520512,10.1097/RLU.0000000000003174,2020-06-11
Neoplasms,PROCESS_OF,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Incidental Findings,PROCESS_OF,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Lymphoma,PROCESS_OF,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Lung consolidation,PROCESS_OF,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Asymptomatic,PROCESS_OF,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Nuclear medicine specialist,TREATS,Patients,32520512,10.1097/RLU.0000000000003174,2020-06-11
Malignant Neoplasms,PROCESS_OF,Male population group,32520509,10.1097/RLU.0000000000003150,2020-06-11
Chronic Obstructive Airway Disease,PROCESS_OF,Male population group,32520509,10.1097/RLU.0000000000003150,2020-06-11
Radionuclide Imaging,DIAGNOSES,primary tumor,32520509,10.1097/RLU.0000000000003150,2020-06-11
Department,LOCATION_OF,FDG-Positron Emission Tomography and Computed Tomography Scan,32520508,10.1097/RLU.0000000000003152,2020-06-11
FDG-Positron Emission Tomography and Computed Tomography Scan,ADMINISTERED_TO,Patients,32520508,10.1097/RLU.0000000000003152,2020-06-11
Structure of lobe of lung,LOCATION_OF,Lung consolidation,32520508,10.1097/RLU.0000000000003152,2020-06-11
lobe,LOCATION_OF,Disease,32520508,10.1097/RLU.0000000000003152,2020-06-11
Lung,LOCATION_OF,Lesion,32520508,10.1097/RLU.0000000000003152,2020-06-11
Uptake,AFFECTS,Mediastinal lymph node group,32520508,10.1097/RLU.0000000000003152,2020-06-11
Severe Acute Respiratory Syndrome,PROCESS_OF,Male population group,32520507,10.1097/RLU.0000000000003143,2020-06-11
PET/CT scan,USES,Fluorodeoxyglucose F18,32520507,10.1097/RLU.0000000000003143,2020-06-11
nivolumab,TREATS,Severe Acute Respiratory Syndrome,32520507,10.1097/RLU.0000000000003143,2020-06-11
FDG-Positron Emission Tomography and Computed Tomography Scan,ADMINISTERED_TO,Woman,32520475,10.20452/pamw.15430,2020-06-11
Left lung,LOCATION_OF,Lesion,32520475,10.20452/pamw.15430,2020-06-11
Left lung,LOCATION_OF,Chromosome 2q32-Q33 Deletion Syndrome,32520475,10.20452/pamw.15430,2020-06-11
"CD69 protein, human",CAUSES,Communicable Diseases,32520406,10.1111/anae.15175,2020-06-11
Lung,LOCATION_OF,Ultrasonography,32520401,10.1002/jmv.26157,2020-06-11
Lung,LOCATION_OF,Ultrasonography,32520401,10.1002/jmv.26157,2020-06-11
Virus,CAUSES,Disease,32520340,10.1093/ajcp/aqaa099,2020-06-11
Awareness,NEG_PROCESS_OF,Patients,32520340,10.1093/ajcp/aqaa099,2020-06-11
Awareness,NEG_PROCESS_OF,Physicians,32520340,10.1093/ajcp/aqaa099,2020-06-11
Attention,PROCESS_OF,Population Group,32520312,10.1093/ecco-jcc/jjaa120,2020-06-11
Attention,PROCESS_OF,Population Group,32520312,10.1093/ecco-jcc/jjaa120,2020-06-11
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32520311,10.1093/ecco-jcc/jjaa119,2020-06-11
Biological Response Modifier Therapy,TREATS,Patients,32520311,10.1093/ecco-jcc/jjaa119,2020-06-11
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32520294,10.1590/1413-81232020256.1.11492020,2020-06-11
Challenge,TREATS,Patients,32520294,10.1590/1413-81232020256.1.11492020,2020-06-11
Challenge,TREATS(INFER),Inflammatory Bowel Diseases,32520294,10.1590/1413-81232020256.1.11492020,2020-06-11
Pharmaceutical Preparations,TREATS,Symptoms,32520294,10.1590/1413-81232020256.1.11492020,2020-06-11
Challenge,TREATS,Severe Acute Respiratory Syndrome,32520292,10.1590/1413-81232020256.1.11472020,2020-06-11
Mental disorders,PROCESS_OF,Persons,32520288,10.1590/1413-81232020256.1.10472020,2020-06-11
Eminent,CAUSES,Stress,32520288,10.1590/1413-81232020256.1.10472020,2020-06-11
Emotions,PROCESS_OF,Persons,32520287,10.1590/1413-81232020256.1.10502020,2020-06-11
Social Interaction,PROCESS_OF,Persons,32520285,10.1590/1413-81232020256.1.11112020,2020-06-11
Financial problem,PROCESS_OF,Persons,32520285,10.1590/1413-81232020256.1.11112020,2020-06-11
Symptoms,PROCESS_OF,Persons,32520235,10.1590/0037-8682-0283-2020,2020-06-11
Infected,PROCESS_OF,Persons,32520235,10.1590/0037-8682-0283-2020,2020-06-11
Infected,PROCESS_OF,Persons,32520235,10.1590/0037-8682-0283-2020,2020-06-11
Quick Test for Liver Function,METHOD_OF,Detection,32520235,10.1590/0037-8682-0283-2020,2020-06-11
Coronavirus Infections,ISA,Disease,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,ISA,Disease,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,PROCESS_OF,Patients,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,ISA,Disease,32520223,10.6061/clinics/2020/e1962,2020-06-11
Cessation of life,NEG_PROCESS_OF,Child,32520223,10.6061/clinics/2020/e1962,2020-06-11
Disease,PROCESS_OF,Patients,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,ISA,Disease,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32520223,10.6061/clinics/2020/e1962,2020-06-11
Disease,PROCESS_OF,Solid Organ Transplantation Recipient,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,ISA,Disease,32520223,10.6061/clinics/2020/e1962,2020-06-11
Coronavirus Infections,PROCESS_OF(SPEC),Solid Organ Transplantation Recipient,32520223,10.6061/clinics/2020/e1962,2020-06-11
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32520223,10.6061/clinics/2020/e1962,2020-06-11
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32520160,10.1590/1806-9282.66.3.370,2020-06-11
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32520160,10.1590/1806-9282.66.3.370,2020-06-11
Coronavirus Infections,ISA,Disease,32520160,10.1590/1806-9282.66.3.370,2020-06-11
Pediatric gastroenterologist,TREATS,Patients,32520160,10.1590/1806-9282.66.3.370,2020-06-11
Laboratory Diagnosis,AFFECTS,Infection,32520155,10.1590/1806-9282.66.3.338,2020-06-11
Laboratory Procedures,DIAGNOSES,Severe Acute Respiratory Syndrome,32520155,10.1590/1806-9282.66.3.338,2020-06-11
Malignant Neoplasms,PROCESS_OF,Outpatients,32520135,10.1590/0100-6991e-20202597,2020-06-11
Water,TREATS,Problem,32520108,10.5123/S1679-49742020000300008,2020-06-11
Attitude,PROCESS_OF,parent,32520073,10.1590/0102-311X00099920,2020-06-11
Toothache,PROCESS_OF,Child,32520073,10.1590/0102-311X00099920,2020-06-11
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Child,32520073,10.1590/0102-311X00099920,2020-06-11
Severe pain,PROCESS_OF,Child,32520073,10.1590/0102-311X00099920,2020-06-11
Social Networks,NEG_ISA,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Infected,PROCESS_OF,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Anatomic Node,NEG_PART_OF,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Infected,PROCESS_OF,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Anatomic Node,PART_OF,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Infected,PROCESS_OF,Persons,32520071,10.31744/einstein_journal/2020AE5793,2020-06-11
Pneumonia,PROCESS_OF,Patients,32520031,10.1039/d0fo00530d,2020-06-11
Therapeutic procedure,TREATS,Patients,32520031,10.1039/d0fo00530d,2020-06-11
Fish Proteins,PART_OF,Marines,32519994,10.14639/0392-100X-N0820,2020-06-11
Interventional procedure,USES,MIA2 gene,32519978,10.5543/tkda.2020.03374,2020-06-11
"CD69 protein, human",AFFECTS,Cardiovascular system,32519964,10.2196/19771,2020-06-11
"CD69 protein, human",COEXISTS_WITH,Traditional Chinese Medicine Formulation,32519964,10.2196/19771,2020-06-11
Telemedicine,ADMINISTERED_TO,Patients,32519963,10.2196/20185,2020-06-11
Heart Diseases,PROCESS_OF,Patients,32519963,10.2196/20185,2020-06-11
Coronavirus Infections,ISA,Disease,32519963,10.2196/20185,2020-06-11
Disease,AFFECTS,Persons,32519953,10.5152/tjg.2020.20413,2020-06-11
Coronavirus Infections,AFFECTS(SPEC),Persons,32519953,10.5152/tjg.2020.20413,2020-06-11
Coronavirus Infections,ISA,Disease,32519953,10.5152/tjg.2020.20413,2020-06-11
Esthesia,PROCESS_OF,College student,32519953,10.5152/tjg.2020.20413,2020-06-11
Coronavirus Infections,ISA,Disease,32519953,10.5152/tjg.2020.20413,2020-06-11
mental health,PROCESS_OF,Cohort,32519953,10.5152/tjg.2020.20413,2020-06-11
Coronavirus Infections,ISA,Disease,32519953,10.5152/tjg.2020.20413,2020-06-11
Disease,AFFECTS,Patients,32519944,10.3238/arztebl.2020.0271,2020-06-11
Chronic liver disease,PROCESS_OF,Patients,32519944,10.3238/arztebl.2020.0271,2020-06-11
Liver transplant recipient,PROCESS_OF,Patients,32519944,10.3238/arztebl.2020.0271,2020-06-11
Coronavirus Infections,CAUSES,Pneumonia,32519921,10.1080/02770903.2020.1781165,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519921,10.1080/02770903.2020.1781165,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519921,10.1080/02770903.2020.1781165,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519921,10.1080/02770903.2020.1781165,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519921,10.1080/02770903.2020.1781165,2020-06-11
Thrombophilia,COEXISTS_WITH,patient condition,32519842,10.1021/acsnano.0c03697,2020-06-11
Anticoagulants,TREATS,Severe Acute Respiratory Syndrome,32519842,10.1021/acsnano.0c03697,2020-06-11
Anticoagulants,TREATS,Critical Illness,32519842,10.1021/acsnano.0c03697,2020-06-11
Awareness,PROCESS_OF,Dentist,32519809,10.1002/ppul.24869,2020-06-11
Practice Experience,PROCESS_OF,Dentist,32519809,10.1002/ppul.24869,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Disease,PROCESS_OF,Child,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,PROCESS_OF(SPEC),Child,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Fever,ISA,Symptoms,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Symptom mild,PROCESS_OF,Patients,32519768,10.1002/jmv.26154,2020-06-11
Disease,PROCESS_OF,Child,32519768,10.1002/jmv.26154,2020-06-11
Disease,PROCESS_OF,Child,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,ISA,Disease,32519768,10.1002/jmv.26154,2020-06-11
Coronavirus Infections,PROCESS_OF(SPEC),Child,32519768,10.1002/jmv.26154,2020-06-11
Prognosis bad,PROCESS_OF,Child,32519768,10.1002/jmv.26154,2020-06-11
Severe disorder,PROCESS_OF,Child,32519768,10.1002/jmv.26154,2020-06-11
Hyperpyrexia,PROCESS_OF,Patients,32519760,10.1002/jmv.26153,2020-06-11
Hyperpyrexia,PROCESS_OF,Patients,32519760,10.1002/jmv.26153,2020-06-11
Hyperpyrexia,PROCESS_OF,Patients,32519760,10.1002/jmv.26153,2020-06-11
Coronavirus Infections,ISA,Disease,32519760,10.1002/jmv.26153,2020-06-11
Respiratory sample,PART_OF,Tract,32519753,10.1111/bph.15157,2020-06-11
Chest CT,DIAGNOSES,Severe Acute Respiratory Syndrome,32519753,10.1111/bph.15157,2020-06-11
Chest CT,DIAGNOSES,Slight change,32519753,10.1111/bph.15157,2020-06-11
Chest CT,DIAGNOSES,Radiologic finding,32519753,10.1111/bph.15157,2020-06-11
Pneumonia,PROCESS_OF,Patients,32519753,10.1111/bph.15157,2020-06-11
Cannabidiol,TREATS,Injury 3,32519743,10.1093/jtm/taaa095,2020-06-11
Respiratory physiology,PROCESS_OF,Patients,32519743,10.1093/jtm/taaa095,2020-06-11
Myofibroblasts,LOCATION_OF,fibroblast activation,32519743,10.1093/jtm/taaa095,2020-06-11
agonists,AFFECTS,fibroblast activation,32519743,10.1093/jtm/taaa095,2020-06-11
Old age,ISA,Population Group,32519618,10.6002/ect.2020.0194,2020-06-11
Hypertensive disease,ISA,Cardiovascular Diseases,32519618,10.6002/ect.2020.0194,2020-06-11
Hypertensive disease,PREDISPOSES,Cardiovascular Diseases,32519618,10.6002/ect.2020.0194,2020-06-11
Hypertensive disease,OCCURS_IN,Population Group,32519618,10.6002/ect.2020.0194,2020-06-11
Obesity,OCCURS_IN,Population Group,32519618,10.6002/ect.2020.0194,2020-06-11
Old age,ISA,Population Group,32519618,10.6002/ect.2020.0194,2020-06-11
"Kidney Failure, Chronic",PROCESS_OF,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
Hemodialysis,ADMINISTERED_TO,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
Normal renal function,PROCESS_OF,Persons,32519617,10.6002/ect.2020.0193,2020-06-11
Normal renal function,PROCESS_OF,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
Normal renal function,PROCESS_OF,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
Cessation of life,OCCURS_IN,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
Patients,LOCATION_OF,Killer-Cell Immunoglobulin-Like Receptor,32519617,10.6002/ect.2020.0193,2020-06-11
Immunocompromised Host,PROCESS_OF,Patients,32519617,10.6002/ect.2020.0193,2020-06-11
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Recipient,32519594,10.1080/13854046.2020.1769192,2020-06-11
Ambulatory Care Facilities,LOCATION_OF,Diagnosis,32519594,10.1080/13854046.2020.1769192,2020-06-11
Accident and Emergency department,LOCATION_OF,Diagnosis,32519594,10.1080/13854046.2020.1769192,2020-06-11
Coughing,PROCESS_OF,Patients,32519594,10.1080/13854046.2020.1769192,2020-06-11
Fever,PROCESS_OF,Patients,32519594,10.1080/13854046.2020.1769192,2020-06-11
Therapeutic procedure,TREATS,Patients,32519568,10.1177/0025817220926925,2020-06-11
"CD69 protein, human",AFFECTS,Severe Acute Respiratory Syndrome,32519568,10.1177/0025817220926925,2020-06-11
"CD69 protein, human",ASSOCIATED_WITH,Enthesitis-Related Arthritis,32519568,10.1177/0025817220926925,2020-06-11
Decreased Immunologic Activity [PE],AFFECTS,Patients,32519383,10.1111/medu.14268,2020-06-11
Viral Shedding,PROCESS_OF,Recipient,32519383,10.1111/medu.14268,2020-06-11
Treatment Protocols,TREATS,Transplant Recipients,32519383,10.1111/medu.14268,2020-06-11
Treatment Protocols,TREATS(INFER),Associated symptom,32519383,10.1111/medu.14268,2020-06-11
Associated symptom,PROCESS_OF,Transplant Recipients,32519383,10.1111/medu.14268,2020-06-11
Uncertainty,CAUSES,Sequela of disorder,32519364,10.1111/bjhp.12438,2020-06-11
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32519302,10.1007/s13238-020-00738-2,2020-06-11
Human coronavirus,CAUSES,Respiratory Tract Infections,32519302,10.1007/s13238-020-00738-2,2020-06-11
Coronavirus Infections,ISA,Disease,32519294,10.1007/s10140-020-01801-5,2020-06-11
Pneumonia,PROCESS_OF,Patients,32519294,10.1007/s10140-020-01801-5,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519294,10.1007/s10140-020-01801-5,2020-06-11
Infected,PROCESS_OF,Patients,32519294,10.1007/s10140-020-01801-5,2020-06-11
Body Fluids,PART_OF,Alveolar,32519294,10.1007/s10140-020-01801-5,2020-06-11
Endothelium,PART_OF,Lung,32519294,10.1007/s10140-020-01801-5,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32519294,10.1007/s10140-020-01801-5,2020-06-11
Graft acceptance,PROCESS_OF,Lung,32519294,10.1007/s10140-020-01801-5,2020-06-11
Graft acceptance,PROCESS_OF,Lung,32519294,10.1007/s10140-020-01801-5,2020-06-11
BARRIER,TREATS,patient condition,32519294,10.1007/s10140-020-01801-5,2020-06-11
Evaluation,USES,tomography,32519293,10.1007/s10140-020-01802-4,2020-06-11
Infectious disease prevention / control,TREATS,Patients,32519293,10.1007/s10140-020-01802-4,2020-06-11
Infected,PROCESS_OF,Patients,32519293,10.1007/s10140-020-01802-4,2020-06-11
Computed Tomography Scanning Systems,TREATS,Patients,32519293,10.1007/s10140-020-01802-4,2020-06-11
angiogram,ISA,Evaluation,32519281,10.1007/s11481-020-09930-x,2020-06-11
Physical Examination,TREATS,Patients,32519281,10.1007/s11481-020-09930-x,2020-06-11
Early Diagnosis,ADMINISTERED_TO,Patients,32519281,10.1007/s11481-020-09930-x,2020-06-11
Hydroxychloroquine,TREATS,Patients,32519256,10.1007/s11547-020-01232-9,2020-06-11
Department,LOCATION_OF,Retrospective Studies,32519205,10.1007/s00406-020-01151-w,2020-06-11
Department,LOCATION_OF,Buccal smear procedure,32519205,10.1007/s00406-020-01151-w,2020-06-11
Lung consolidation,PROCESS_OF,Patients,32519205,10.1007/s00406-020-01151-w,2020-06-11
Psychiatric hospital,LOCATION_OF,Study,32519165,10.1007/s11239-020-02176-7,2020-06-11
Pulmonary Embolism,PROCESS_OF,Patients,32519164,10.1007/s11239-020-02172-x,2020-06-11
Deep Vein Thrombosis,PROCESS_OF,Patients,32519164,10.1007/s11239-020-02172-x,2020-06-11
Acute Coronary Syndrome,PROCESS_OF,Patients,32519164,10.1007/s11239-020-02172-x,2020-06-11
"Plaque, Atherosclerotic",PART_OF,Arteries,32519164,10.1007/s11239-020-02172-x,2020-06-11
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32519150,10.1007/s00455-020-10144-9,2020-06-11
,STIMULATES,Down-Regulation,32519150,10.1007/s00455-020-10144-9,2020-06-11
Interleukin-6,STIMULATES,Down-Regulation,32519150,10.1007/s00455-020-10144-9,2020-06-11
Antiphospholipid Antibodies,COEXISTS_WITH,Thromboplastin,32519150,10.1007/s00455-020-10144-9,2020-06-11
Deglutition Disorders,PROCESS_OF,Patients,32519138,10.1007/s10620-020-06401-4,2020-06-11
Deglutition Disorders,PROCESS_OF,Clinician,32519138,10.1007/s10620-020-06401-4,2020-06-11
Deglutition Disorders,COEXISTS_WITH,Enthesitis-Related Arthritis,32519138,10.1007/s10620-020-06401-4,2020-06-11
Physical and emotional exhaustion state,PROCESS_OF,Gastroenterologist,32519136,10.1007/s11739-020-02395-z,2020-06-11
Chronic disease,PROCESS_OF,Patients,32519117,10.1007/s00347-020-01148-9,2020-06-11
Hospital admission,TREATS,Disease,32519117,10.1007/s00347-020-01148-9,2020-06-11
Emergency room admission,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32519117,10.1007/s00347-020-01148-9,2020-06-11
Chronic disease,PROCESS_OF,Patients,32519117,10.1007/s00347-020-01148-9,2020-06-11
Mild disorder,PROCESS_OF,Patients,32519117,10.1007/s00347-020-01148-9,2020-06-11
Screening procedure,USES,Chloroquine,32519085,10.17269/s41997-020-00343-0,2020-06-11
Screening procedure,USES,Hydroxychloroquine,32519085,10.17269/s41997-020-00343-0,2020-06-11
Eye,LOCATION_OF,Coronavirus Infections,32519081,10.1007/s00405-020-06113-5,2020-06-11
Health care facility,LOCATION_OF,Training Techniques,32519035,10.1007/s00428-020-02861-1,2020-06-11
Malaise,PROCESS_OF,Patients,32519035,10.1007/s00428-020-02861-1,2020-06-11
Cessation of life,PROCESS_OF,Patients,32518989,10.1007/s00330-020-06977-5,2020-06-11
Health Personnel,TREATS,Patients,32518989,10.1007/s00330-020-06977-5,2020-06-11
Autopsy,CAUSES,Disease,32518989,10.1007/s00330-020-06977-5,2020-06-11
Lung,LOCATION_OF,Computed Tomography Angiography,32518987,10.1007/s00330-020-06978-4,2020-06-11
Lung,LOCATION_OF,Computed Tomography Angiography,32518987,10.1007/s00330-020-06978-4,2020-06-11
Acute pulmonary embolism,OCCURS_IN,hospitalized patients,32518987,10.1007/s00330-020-06978-4,2020-06-11
Fibrin fragment D,PART_OF,Patients,32518987,10.1007/s00330-020-06978-4,2020-06-11
pulmonary artery and pulmonary artery,LOCATION_OF,Lesion,32518987,10.1007/s00330-020-06978-4,2020-06-11
Lung,LOCATION_OF,Computed Tomography Angiography,32518987,10.1007/s00330-020-06978-4,2020-06-11
Pneumonia,PROCESS_OF,hospitalized patients,32518987,10.1007/s00330-020-06978-4,2020-06-11
Lung,LOCATION_OF,Computed Tomography Angiography,32518987,10.1007/s00330-020-06978-4,2020-06-11
Acute pulmonary embolism,PROCESS_OF,Patients,32518987,10.1007/s00330-020-06978-4,2020-06-11
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Real-Time Polymerase Chain Reaction,32518941,10.1093/glycob/cwaa052,2020-06-11
Cell Count,PRODUCES,Human cells,32518935,10.15537/smj.2020.6.25101,2020-06-11
Tandem Mass Spectrometry,USES,Spectrometry,32518935,10.15537/smj.2020.6.25101,2020-06-11
"Binding Sites, Antibody",INTERACTS_WITH,Carbohydrates,32518935,10.15537/smj.2020.6.25101,2020-06-11
"Binding Sites, Antibody",ISA,Antibodies,32518935,10.15537/smj.2020.6.25101,2020-06-11
Peptides,INTERACTS_WITH,"Binding Sites, Antibody",32518935,10.15537/smj.2020.6.25101,2020-06-11
Peptides,INTERACTS_WITH,Carbohydrates,32518935,10.15537/smj.2020.6.25101,2020-06-11
Readiness,PROCESS_OF,Health Personnel,32518902,10.1016/j.ajogmf.2020.100111,2020-06-11
Symptoms,PROCESS_OF,Patients,32518901,10.1016/j.ajogmf.2020.100110,2020-06-11
Gravidity,PROCESS_OF,Patients,32518893,10.12688/hrbopenres.13063.1,2020-06-11
Disease,CAUSES,Cessation of life,32518882,10.1016/j.idm.2020.03.004,2020-06-11
Dementia,ISA,Disease,32518882,10.1016/j.idm.2020.03.004,2020-06-11
Dementia,PROCESS_OF,Community,32518882,10.1016/j.idm.2020.03.004,2020-06-11
Cessation of life,PROCESS_OF,Population Group,32518832,10.1186/s41256-020-00151-6,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Interventional procedure,AFFECTS,Disease,32518817,10.1002/slct.202001123,2020-06-11
Interventional procedure,AFFECTS(SPEC),Coronavirus Infections,32518817,10.1002/slct.202001123,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Coronavirus Infections,ISA,Disease,32518817,10.1002/slct.202001123,2020-06-11
Chest CT,ADMINISTERED_TO,Patients,32518785,10.12998/wjcc.v8.i10.1944,2020-06-11
Performance,PROCESS_OF,Patients,32518785,10.12998/wjcc.v8.i10.1944,2020-06-11
Fever,PROCESS_OF,Patients,32518785,10.12998/wjcc.v8.i10.1944,2020-06-11
Fever,COEXISTS_WITH,Initial screen,32518785,10.12998/wjcc.v8.i10.1944,2020-06-11
Fever,PROCESS_OF,Patients,32518785,10.12998/wjcc.v8.i10.1944,2020-06-11
Emergency operation,TREATS,Patients,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Appendicitis,PROCESS_OF,Male population group,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Lung,PART_OF,Patients,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Chest CT,DIAGNOSES,Ground Glass Opacity,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
lobe,LOCATION_OF,Ground Glass Opacity,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
lobe,PART_OF,Lung,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Disease,PROCESS_OF,Patients,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Emergency procedure,TREATS,Patients,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Respiratory sample,PART_OF,Tract,32518768,10.12998/wjcc.v8.i10.1763,2020-06-11
Experience,PROCESS_OF,manager,32518767,10.12998/wjcc.v8.i10.1756,2020-06-11
Stress,PROCESS_OF,Patients,32518767,10.12998/wjcc.v8.i10.1756,2020-06-11
"Management, Nursing Care",TREATS,Stress,32518767,10.12998/wjcc.v8.i10.1756,2020-06-11
Population Group,LOCATION_OF,IMPACT gene,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
IMPACT gene,PART_OF,Virus,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
Physicians,DIAGNOSES,Infantile Neuroaxonal Dystrophy,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
Procedure on spinal cord (procedure),TREATS,Spinal Diseases,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
Spinal Diseases,PROCESS_OF,Patients,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
Surgeon,TREATS,Patients,32518738,10.1109/JTEHM.2020.2993531,2020-06-11
GSKIP gene,compared_with,BARRIER,32518636,10.12688/f1000research.23843.1,2020-06-11
Epidemic,ISA,Disease Outbreaks,32518475,10.1016/j.chaos.2020.109964,2020-06-11
Acupuncture and Oriental Medicine,TREATS,Symptoms,32518475,10.1016/j.chaos.2020.109964,2020-06-11
Acupuncture and Oriental Medicine,TREATS,Pneumonia,32518475,10.1016/j.chaos.2020.109964,2020-06-11
viral transmission,PROCESS_OF,Persons,32518469,10.1016/j.buildenv.2020.107022,2020-06-11
Microbiologist,ISA,Scientist,32518463,10.1016/S0262-4079(20)30635-7,2020-06-11
Depressive disorder,PROCESS_OF,Participant,32518419,10.1038/s41375-020-0891-0,2020-06-11
Post-Traumatic Stress Disorder,PROCESS_OF,Participant,32518419,10.1038/s41375-020-0891-0,2020-06-11
Evaluation,AFFECTS,Possible,32518419,10.1038/s41375-020-0891-0,2020-06-11
other medicated shampoos in ATC,TREATS,Mental health problem,32518419,10.1038/s41375-020-0891-0,2020-06-11
Emotions,PROCESS_OF,Persons,32518419,10.1038/s41375-020-0891-0,2020-06-11
Mental health problem,PROCESS_OF,Persons,32518419,10.1038/s41375-020-0891-0,2020-06-11
ruxolitinib,DISRUPTS,Cytokine Signaling Process,32518317,10.1038/s41598-020-66440-9,2020-06-11
Today,NEG_TREATS,Severe Acute Respiratory Syndrome,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Polymerase,INTERACTS_WITH,Pharmaceutical Preparations,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Polymerase,INTERACTS_WITH,Nucleoside Analogs,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Polymerase,PART_OF,Hepatitis C virus,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Polymerase,PART_OF,SARS coronavirus,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Polymerase,PART_OF,Middle East Respiratory Syndrome Coronavirus,32518212,10.1136/bmjopen-2020-039978,2020-06-11
Antimalarials,TREATS,Neoplasms,32518172,10.1212/NXI.0000000000000781,2020-06-11
Antiviral Agents,TREATS,Neoplasms,32518172,10.1212/NXI.0000000000000781,2020-06-11
Immunosuppressive Agents,TREATS,Neoplasms,32518172,10.1212/NXI.0000000000000781,2020-06-11
Clinical Trials,MEASURES,Alveolar ventilation function,32518172,10.1212/NXI.0000000000000781,2020-06-11
Glycolipids,PART_OF,Nerve,32518152,10.1212/WNL.0000000000010010,2020-06-11
Glycolipids,PART_OF,"M Protein, multiple myeloma",32518152,10.1212/WNL.0000000000010010,2020-06-11
Guillain-Barre Syndrome,ISA,Autoimmune Diseases,32518152,10.1212/WNL.0000000000010010,2020-06-11
Glycolipids,PART_OF,Peripheral Nerves,32518152,10.1212/WNL.0000000000010010,2020-06-11
"M Protein, multiple myeloma",INTERACTS_WITH,Glycoproteins,32518152,10.1212/WNL.0000000000010010,2020-06-11
Anti-Antibodies,CAUSES,Neuropathy,32518152,10.1212/WNL.0000000000010010,2020-06-11
Paresis,PROCESS_OF,Patients,32518152,10.1212/WNL.0000000000010010,2020-06-11
Brain Stem,LOCATION_OF,"Encephalitis, Acute Necrotizing",32518152,10.1212/WNL.0000000000010010,2020-06-11
Complement System Proteins,CAUSES,Guillain-Barre Syndrome,32518152,10.1212/WNL.0000000000010010,2020-06-11
Guillain-Barre Syndrome,ISA,Autoimmune Diseases of the Nervous System,32518152,10.1212/WNL.0000000000010010,2020-06-11
Autoimmune Diseases,PROCESS_OF,Patients,32518152,10.1212/WNL.0000000000010010,2020-06-11
Autoimmune Diseases of the Nervous System,NEG_ISA,Autoimmune Diseases,32518152,10.1212/WNL.0000000000010010,2020-06-11
Autoimmune Diseases of the Nervous System,NEG_PROCESS_OF(SPEC),Patients,32518152,10.1212/WNL.0000000000010010,2020-06-11
Autoimmune Diseases of the Nervous System,PROCESS_OF,Patients,32518152,10.1212/WNL.0000000000010010,2020-06-11
Less often,PROCESS_OF,Minority Groups,32518134,10.3949/ccjm.87a.ccc047,2020-06-11
Less often,PROCESS_OF,Patients,32518134,10.3949/ccjm.87a.ccc047,2020-06-11
Less often,PROCESS_OF,Racial group,32518134,10.3949/ccjm.87a.ccc047,2020-06-11
Mobility aid,TREATS,Patients,32518132,10.3949/ccjm.87a.ccc048,2020-06-11
Screening procedure,TREATS,Patients,32518103,10.7861/clinmed.2020-0213,2020-06-11
Screening procedure,TREATS,Symptoms,32518103,10.7861/clinmed.2020-0213,2020-06-11
Hand,LOCATION_OF,Paresthesia,32518102,10.7861/clinmed.2020-0207,2020-06-11
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32518102,10.7861/clinmed.2020-0207,2020-06-11
Lower Extremity,LOCATION_OF,Low Back Pain,32518102,10.7861/clinmed.2020-0207,2020-06-11
Lower Extremity,LOCATION_OF,Weakness,32518102,10.7861/clinmed.2020-0207,2020-06-11
Nerve,LOCATION_OF,Bilateral facial muscle weakness,32518102,10.7861/clinmed.2020-0207,2020-06-11
Vertebral column,LOCATION_OF,Magnetic Resonance Imaging,32518102,10.7861/clinmed.2020-0207,2020-06-11
"Immunoglobulins, Intravenous",ASSOCIATED_WITH,Syndrome,32518102,10.7861/clinmed.2020-0207,2020-06-11
"Immunoglobulins, Intravenous",ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32518102,10.7861/clinmed.2020-0207,2020-06-11
pretesting,TREATS,Readiness,32518072,10.1128/JCM.01068-20,2020-06-11
Real-Time Polymerase Chain Reaction,DIAGNOSES,Virus,32518071,10.1128/JCM.01233-20,2020-06-11
Immunity,PROCESS_OF,Population Group,32518047,10.1016/j.morpho.2020.05.003,2020-06-11
Hypersensitivity,ISA,Symptoms,32518047,10.1016/j.morpho.2020.05.003,2020-06-11
Educational process of instructing,ISA,Knowledge acquisition,32518045,10.1016/j.arcped.2020.05.010,2020-06-11
Genetic Carriers,PROCESS_OF,Tissue Donors,32518045,10.1016/j.arcped.2020.05.010,2020-06-11
Child,LOCATION_OF,"CD69 protein, human",32518044,10.1016/j.tig.2020.05.010,2020-06-11
Pediatric intensive care unit,LOCATION_OF,Observational Study,32518044,10.1016/j.tig.2020.05.010,2020-06-11
Comorbidity,PROCESS_OF,Patients,32518044,10.1016/j.tig.2020.05.010,2020-06-11
Life Threatening,PROCESS_OF,Patients,32518044,10.1016/j.tig.2020.05.010,2020-06-11
Additional assessment,TREATS,Child,32518044,10.1016/j.tig.2020.05.010,2020-06-11
Masks,USES,Personal protective equipment,32517998,10.1016/j.encep.2020.05.012,2020-06-11
Face shield,USES,Personal protective equipment,32517998,10.1016/j.encep.2020.05.012,2020-06-11
Headlights,USES,ADAPTER,32517998,10.1016/j.encep.2020.05.012,2020-06-11
ADAPTER,USES,Face shield,32517998,10.1016/j.encep.2020.05.012,2020-06-11
Plain chest X-ray,ADMINISTERED_TO,teams,32517963,10.1016/j.jacc.2020.06.007,2020-06-11
Plain chest X-ray,USES,Laboratory Procedures,32517963,10.1016/j.jacc.2020.06.007,2020-06-11
Ward (environment),LOCATION_OF,Plain chest X-ray,32517963,10.1016/j.jacc.2020.06.007,2020-06-11
Problem,NEG_PROCESS_OF,Patients,32517963,10.1016/j.jacc.2020.06.007,2020-06-11
Elevation procedure,USES,Troponin,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Patient in hospital,PROCESS_OF,Cohort,32517882,10.1016/j.imbio.2020.151955,2020-06-11
myocardial injury,PROCESS_OF,Cohort,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Atrial Fibrillation,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Coronary Arteriosclerosis,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Heart failure,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Troponin,ASSOCIATED_WITH(INFER),Atrial Fibrillation,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Troponin,ASSOCIATED_WITH(INFER),Coronary Arteriosclerosis,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Troponin,ASSOCIATED_WITH(INFER),Heart failure,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Troponin,PART_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Cardiovascular Diseases,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
myocardial injury,ISA,Cardiovascular Diseases,32517882,10.1016/j.imbio.2020.151955,2020-06-11
myocardial injury,PROCESS_OF,Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
myocardial injury,PROCESS_OF(SPEC),Patients,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Elevation procedure,USES,Troponin,32517882,10.1016/j.imbio.2020.151955,2020-06-11
Macrophage Activation Syndrome,PRODUCES,Vaccines,32517845,10.1017/S0950268820001247,2020-06-11
Duration,COEXISTS_WITH,WASF1 gene,32517815,10.1186/s13052-020-00844-1,2020-06-11
Comorbidity,PROCESS_OF,Persons,32517815,10.1186/s13052-020-00844-1,2020-06-11
Disease,PROCESS_OF,Persons,32517815,10.1186/s13052-020-00844-1,2020-06-11
Malaise,PROCESS_OF,Patients,32517815,10.1186/s13052-020-00844-1,2020-06-11
Asymptomatic,PROCESS_OF,Child,32517803,10.1186/s12998-020-00319-4,2020-06-11
Mild disorder,PROCESS_OF,Child,32517803,10.1186/s12998-020-00319-4,2020-06-11
Manipulation of spine,TREATS,user - individual,32517786,10.1186/s42358-020-00134-8,2020-06-11
Manipulation of spine,TREATS,activity level,32517786,10.1186/s42358-020-00134-8,2020-06-11
Manipulation of spine,TREATS,Policy Makers,32517786,10.1186/s42358-020-00134-8,2020-06-11
Antimalarials,TREATS,Rheumatism,32517769,10.1186/s13000-020-00990-4,2020-06-11
Antimalarials,ADMINISTERED_TO,Rheumatologist,32517769,10.1186/s13000-020-00990-4,2020-06-11
Chronic disease of immune system,PROCESS_OF,Patients,32517769,10.1186/s13000-020-00990-4,2020-06-11
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32517769,10.1186/s13000-020-00990-4,2020-06-11
Pharmaceutical Preparations,TREATS,Adverse effects,32517769,10.1186/s13000-020-00990-4,2020-06-11
Malignant neoplasm of lung,PROCESS_OF,Patients,32517645,10.33321/cdi.2020.44.51,2020-06-11
Symptoms,MANIFESTATION_OF,Cessation of life,32517645,10.33321/cdi.2020.44.51,2020-06-11
Disease,PROCESS_OF,Child,32517639,10.1176/appi.ps.202000219,2020-06-11
Severe disorder,PROCESS_OF,Persons,32517639,10.1176/appi.ps.202000219,2020-06-11
"Asia, Southeastern",ISA,Geographic Locations,32517639,10.1176/appi.ps.202000219,2020-06-11
Ebola virus,COEXISTS_WITH,Communicable Diseases,32517519,10.1177/1090198120933281,2020-06-11
Severe Acute Respiratory Syndrome,ISA,Communicable Diseases,32517519,10.1177/1090198120933281,2020-06-11
Macrophage Activation Syndrome,PROCESS_OF,Homo sapiens,32517463,10.37201/req/053.2020,2020-06-11
silybin,INTERACTS_WITH,Monoclonal Antibodies,32517322,10.3390/ijerph17114066,2020-06-11
silybin,INTERACTS_WITH,JAK1 Inhibitor,32517322,10.3390/ijerph17114066,2020-06-11
silybin,TREATS,Storm NOS,32517322,10.3390/ijerph17114066,2020-06-11
Institutes,LOCATION_OF,Phase 2 Clinical Trials,32517322,10.3390/ijerph17114066,2020-06-11
Neoplasms,PROCESS_OF,Catalonian,32517322,10.3390/ijerph17114066,2020-06-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32517322,10.3390/ijerph17114066,2020-06-11
silybin,PREVENTS,"Respiratory Distress Syndrome, Adult",32517322,10.3390/ijerph17114066,2020-06-11
Reading Frames (Nucleotide Sequence),PART_OF,Population Group,32517294,10.3390/ijerph17114065,2020-06-11
psychological distress,AFFECTS,Choice Behavior,32517266,10.3390/v12060622,2020-06-11
Anxiety,AFFECTS,Alcohol consumption,32517266,10.3390/v12060622,2020-06-11
Depressive disorder,AFFECTS,Alcohol consumption,32517266,10.3390/v12060622,2020-06-11
Sepharose,ADMINISTERED_TO,Cultured Cell Line,32517210,10.3390/nu12061699,2020-06-11
microcrystalline cellulose,ADMINISTERED_TO,Cultured Cell Line,32517210,10.3390/nu12061699,2020-06-11
Infected,PROCESS_OF,Persons,32517125,10.3390/ijerph17114047,2020-06-11
Coronavirus Infections,PROCESS_OF,Persons,32516940,10.3390/jcm9061753,2020-06-11
travel,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32516940,10.3390/jcm9061753,2020-06-11
Virus Diseases,AFFECTS,Human Age Group,32516880,10.3390/ijerph17114013,2020-06-11
Chest Pain,ISA,Symptoms,32516880,10.3390/ijerph17114013,2020-06-11
Fever,ISA,Symptoms,32516880,10.3390/ijerph17114013,2020-06-11
Paresis,ISA,Symptoms,32516880,10.3390/ijerph17114013,2020-06-11
Dry cough,ISA,Symptoms,32516880,10.3390/ijerph17114013,2020-06-11
Symptoms,PROCESS_OF,Patients,32516880,10.3390/ijerph17114013,2020-06-11
Gambling,AFFECTS,Alcohol consumption,32516868,10.21149/11606,2020-06-11
Decision,PROCESS_OF,Persons,32516868,10.21149/11606,2020-06-11
VIDAS,USES,LIAS gene,32516861,10.1111/ggi.13960,2020-06-10
Seizures,PROCESS_OF,Cohort,32516847,10.1111/tid.13363,2020-06-10
Cessation of life,PROCESS_OF,Patients,32516847,10.1111/tid.13363,2020-06-10
risk factors,PROCESS_OF,Population Group,32516847,10.1111/tid.13363,2020-06-10
Cessation of life,PROCESS_OF,Patients,32516847,10.1111/tid.13363,2020-06-10
Virus,PROCESS_OF,Patients,32516839,10.1111/vox.12968,2020-06-10
Severe Acute Respiratory Syndrome,NEG_COEXISTS_WITH,Chief complaint (finding),32516839,10.1111/vox.12968,2020-06-10
contextual factors,PROCESS_OF,Outpatients,32516839,10.1111/vox.12968,2020-06-10
Comorbidity,PROCESS_OF,Patients,32516839,10.1111/vox.12968,2020-06-10
Medication Management,TREATS,Disease,32516836,10.1111/his.14174,2020-06-10
Medication Management,TREATS(SPEC),Coronavirus Infections,32516836,10.1111/his.14174,2020-06-10
Coronavirus Infections,ISA,Disease,32516836,10.1111/his.14174,2020-06-10
Hospitals,LOCATION_OF,Clinical Research,32516836,10.1111/his.14174,2020-06-10
Hospitals,LOCATION_OF,research data,32516836,10.1111/his.14174,2020-06-10
Coronavirus Infections,ISA,Disease,32516836,10.1111/his.14174,2020-06-10
Coronavirus Infections,ISA,Disease,32516836,10.1111/his.14174,2020-06-10
Reporting,METHOD_OF,"Intubation, Intratracheal",32516817,10.1055/s-0040-1713120,2020-06-10
"Intubation, Intratracheal",PRECEDES,Isolation procedure,32516817,10.1055/s-0040-1713120,2020-06-10
Severe disorder,PROCESS_OF,Population Group,32516816,10.1055/s-0040-1712939,2020-06-10
Academic Medical Centers,LOCATION_OF,Study,32516797,10.1038/s41586-020-2423-5,2020-06-10
Telemedicine,METHOD_OF,Prenatal care,32516797,10.1038/s41586-020-2423-5,2020-06-10
Asthma,PROCESS_OF,Adult,32516772,10.1159/000509065,2020-06-10
Asthma,PROCESS_OF,Child,32516772,10.1159/000509065,2020-06-10
Asthma,PROCESS_OF,Patients,32516772,10.1159/000509065,2020-06-10
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32516772,10.1159/000509065,2020-06-10
Asthma,PROCESS_OF,Patients,32516772,10.1159/000509065,2020-06-10
Coronavirus Infections,AFFECTS,Child,32516772,10.1159/000509065,2020-06-10
Asthma,AFFECTS,allergic inflammation,32516772,10.1159/000509065,2020-06-10
Asthma,AFFECTS(SPEC),allergic inflammation,32516772,10.1159/000509065,2020-06-10
Asthma,ISA,Hypersensitivity,32516772,10.1159/000509065,2020-06-10
Hypersensitivity,AFFECTS,Asthma,32516772,10.1159/000509065,2020-06-10
Hypersensitivity,AFFECTS,allergic inflammation,32516772,10.1159/000509065,2020-06-10
Asthma,PROCESS_OF,Patients,32516772,10.1159/000509065,2020-06-10
Malignant neoplasm of urinary bladder,ISA,Disease,32516766,10.1159/000509103,2020-06-10
Disease,AFFECTS,Symptom mild,32516766,10.1159/000509103,2020-06-10
Recurrence,CAUSES,Pneumonia,32516766,10.1159/000509103,2020-06-10
Coronavirus Infections,AFFECTS(SPEC),Symptom mild,32516766,10.1159/000509103,2020-06-10
Coronavirus Infections,ISA,Disease,32516766,10.1159/000509103,2020-06-10
risk factors,PROCESS_OF,Patients,32516766,10.1159/000509103,2020-06-10
"Carcinoma of urinary bladder, invasive",OCCURS_IN,Patients,32516766,10.1159/000509103,2020-06-10
Lymphocyte,INTERACTS_WITH,neutrophil,32516766,10.1159/000509103,2020-06-10
Therapeutic procedure,AFFECTS,cytokine production,32516766,10.1159/000509103,2020-06-10
Symptom severe,PROCESS_OF,Persons,32516739,10.1016/j.jcv.2020.104476,2020-06-10
Assay,METHOD_OF,Detection,32516733,10.1016/j.mehy.2020.109948,2020-06-10
Severe Acute Respiratory Syndrome,PROCESS_OF,Modulus,32516733,10.1016/j.mehy.2020.109948,2020-06-10
Assay,METHOD_OF,Detection,32516733,10.1016/j.mehy.2020.109948,2020-06-10
Assay,METHOD_OF,Detection,32516733,10.1016/j.mehy.2020.109948,2020-06-10
Vaccines,TREATS,Genus: Coronavirus,32516704,10.1016/j.ctrv.2020.102041,2020-06-10
Complication,PROCESS_OF,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Confirmation,PROCESS_OF,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Malignant Neoplasms,PROCESS_OF,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Disease,COEXISTS_WITH,Malignant neoplasm of lung,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Lung,LOCATION_OF,compromise,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Hematologic Neoplasms,PROCESS_OF,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Active Method,ADMINISTERED_TO,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Malignant Neoplasms,AFFECTS,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Diagnosis,AFFECTS,Patients,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
IMPACT gene,CAUSES,Symptoms,32516658,10.1016/j.amjoto.2020.102583,2020-06-10
Interventional procedure,TREATS,Medical Staff,32516655,10.1016/j.mehy.2020.109858,2020-06-10
Antibiotics,TREATS,Malignant Neoplasms,32516636,10.1016/j.envres.2020.109748,2020-06-10
Antibiotics,TREATS,Virus Diseases,32516636,10.1016/j.envres.2020.109748,2020-06-10
salinomycin,ISA,Antibiotics,32516636,10.1016/j.envres.2020.109748,2020-06-10
salinomycin,TREATS(SPEC),Malignant Neoplasms,32516636,10.1016/j.envres.2020.109748,2020-06-10
salinomycin,TREATS(SPEC),Virus Diseases,32516636,10.1016/j.envres.2020.109748,2020-06-10
Coronavirus Infections,ISA,Disease,32516621,10.1016/j.puhe.2020.05.015,2020-06-10
Coronavirus Infections,ISA,Disease,32516621,10.1016/j.puhe.2020.05.015,2020-06-10
Coronavirus Infections,ISA,Disease,32516621,10.1016/j.puhe.2020.05.015,2020-06-10
Mus,LOCATION_OF,"ACE2 protein, human",32516506,10.1111/aor.13748,2020-06-10
Lung,LOCATION_OF,Severe (severity modifier),32516506,10.1111/aor.13748,2020-06-10
Extracorporeal Membrane Oxygenation,NEG_TREATS,Disease,32516482,10.1111/hae.14087,2020-06-10
Decision Making,PROCESS_OF,Patients,32516482,10.1111/hae.14087,2020-06-10
Coagulation procedure,AFFECTS,Disease Progression,32516482,10.1111/hae.14087,2020-06-10
Telemedicine,TREATS,Patients,32516462,10.1111/bjh.16932,2020-06-10
Telemedicine,TREATS(INFER),Severe hereditary factor VIII deficiency disease,32516462,10.1111/bjh.16932,2020-06-10
Severe hereditary factor VIII deficiency disease,PROCESS_OF,Patients,32516462,10.1111/bjh.16932,2020-06-10
major surgery,TREATS,Severe hereditary factor VIII deficiency disease,32516462,10.1111/bjh.16932,2020-06-10
Telemedicine,TREATS,"Hemophilia, NOS",32516462,10.1111/bjh.16932,2020-06-10
Disability,PROCESS_OF,Patients,32516281,10.1097/INF.0000000000002718,2020-06-10
Infected,PROCESS_OF,Patients,32516281,10.1097/INF.0000000000002718,2020-06-10
Hospitals,LOCATION_OF,Study,32516281,10.1097/INF.0000000000002718,2020-06-10
Symptoms,PROCESS_OF,Patients,32516279,10.2106/JBJS.20.01053,2020-06-10
Anosmia,PROCESS_OF,Patients,32516279,10.2106/JBJS.20.01053,2020-06-10
Coronavirus Infections,PROCESS_OF,Patients,32516279,10.2106/JBJS.20.01053,2020-06-10
Infected,PROCESS_OF,Persons,32516274,10.1097/AOG.0000000000004012,2020-06-10
Asymptomatic,PROCESS_OF,Patients,32516274,10.1097/AOG.0000000000004012,2020-06-10
Anoxia,PROCESS_OF,Patients,32516274,10.1097/AOG.0000000000004012,2020-06-10
Asymptomatic,PROCESS_OF,Patients,32516274,10.1097/AOG.0000000000004012,2020-06-10
Disease,PREDISPOSES,Negative Test Result,32516274,10.1097/AOG.0000000000004012,2020-06-10
Hypoxemia,PROCESS_OF,Pregnant Women,32516273,10.1097/AOG.0000000000004010,2020-06-10
"Respiratory Distress Syndrome, Adult",COMPLICATES,Pneumonia,32516273,10.1097/AOG.0000000000004010,2020-06-10
Hypoxemia,COMPLICATES,Pneumonia,32516273,10.1097/AOG.0000000000004010,2020-06-10
Respiratory distress,PROCESS_OF,Pregnant Women,32516273,10.1097/AOG.0000000000004010,2020-06-10
Gravidity,PROCESS_OF,Patients,32516204,10.14309/ajg.0000000000000719,2020-06-10
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32516204,10.14309/ajg.0000000000000719,2020-06-10
Severe Acute Respiratory Syndrome,COMPLICATES,Non-Ossifying Fibroma,32516204,10.14309/ajg.0000000000000719,2020-06-10
Gastrointestinal Hemorrhage,COEXISTS_WITH,patient condition,32516161,10.1097/MEJ.0000000000000723,2020-06-10
Gastrointestinal Hemorrhage,COEXISTS_WITH,Respiratory Failure,32516161,10.1097/MEJ.0000000000000723,2020-06-10
American College of Cardiology/American Heart Association Lesion Complexity Score C,CAUSES,Gastrointestinal Hemorrhage,32516161,10.1097/MEJ.0000000000000723,2020-06-10
Gastrointestinal Hemorrhage,COEXISTS_WITH,patient condition,32516161,10.1097/MEJ.0000000000000723,2020-06-10
Coronavirus Infections,CAUSES,Septicemia,32516119,10.1556/650.2020.31871,2020-06-10
Coronavirus Infections,CAUSES,Acute respiratory failure,32516119,10.1556/650.2020.31871,2020-06-10
Multiple Chronic Conditions,PROCESS_OF,Patients,32516119,10.1556/650.2020.31871,2020-06-10
Adenocarcinoma,PROCESS_OF,Patients,32516119,10.1556/650.2020.31871,2020-06-10
Ascending colon,LOCATION_OF,Adenocarcinoma,32516119,10.1556/650.2020.31871,2020-06-10
Arterial hemorrhage,PROCESS_OF,Patients,32516119,10.1556/650.2020.31871,2020-06-10
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32516115,10.2196/20173,2020-06-10
Severe viral infections,AFFECTS,Patients,32516115,10.2196/20173,2020-06-10
Epidemic,CAUSES,Respiration Disorders,32516115,10.2196/20173,2020-06-10
Coronavirus Infections,CAUSES,Infectious disease of lung,32516115,10.2196/20173,2020-06-10
Comorbidity,NEG_PROCESS_OF,Patients,32516115,10.2196/20173,2020-06-10
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32516115,10.2196/20173,2020-06-10
Flare-up,PROCESS_OF,high-risk group,32516115,10.2196/20173,2020-06-10
Malignant neoplasm of lung,PROCESS_OF,Patients,32516070,10.1089/tmj.2020.0145,2020-06-10
Chief complaint (finding),PROCESS_OF,Patients,32516070,10.1089/tmj.2020.0145,2020-06-10
Thoracic cavity structure,LOCATION_OF,Respiratory distress,32516070,10.1089/tmj.2020.0145,2020-06-10
Pleural fluid,NEG_PART_OF,"Tumor cells, malignant",32516070,10.1089/tmj.2020.0145,2020-06-10
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32516070,10.1089/tmj.2020.0145,2020-06-10
Transient Ischemic Attack,CAUSES,Hospital admission,32516047,10.12968/bjon.2020.29.11.632,2020-06-10
Acute Cerebrovascular Accidents,CAUSES,Hospital admission,32516047,10.12968/bjon.2020.29.11.632,2020-06-10
Hospital admission,TREATS,Transient Ischemic Attack,32516047,10.12968/bjon.2020.29.11.632,2020-06-10
Homelessness,PROCESS_OF,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Disease,PROCESS_OF,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Acclimatization,PROCESS_OF,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Homelessness,PROCESS_OF,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Isolation procedure,TREATS,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Asymptomatic,PROCESS_OF,Population Group,32516020,10.1080/07420528.2020.1772810,2020-06-10
Infection,PROCESS_OF,Population Group,32516020,10.1080/07420528.2020.1772810,2020-06-10
Adult,ISA,Population Group,32516020,10.1080/07420528.2020.1772810,2020-06-10
Homelessness,PROCESS_OF,Persons,32516020,10.1080/07420528.2020.1772810,2020-06-10
Coronavirus Infections,CAUSES,Pneumonia,32515974,10.1021/acs.nanolett.0c01723,2020-06-10
Virion,PART_OF,Influenza A virus,32515882,10.1002/1348-9585.12128,2020-06-10
Glycoproteins,PART_OF,Virion,32515882,10.1002/1348-9585.12128,2020-06-10
Virion,PART_OF,Influenza A virus,32515882,10.1002/1348-9585.12128,2020-06-10
membrane layer,PART_OF,Cells,32515882,10.1002/1348-9585.12128,2020-06-10
Coronavirus Infections,CAUSES,Illness (finding),32515729,10.5414/CP203824,2020-06-10
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32515729,10.5414/CP203824,2020-06-10
Communicable Diseases,AFFECTS,Disease,32515729,10.5414/CP203824,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Communicable Diseases,PROCESS_OF,Persons,32515699,10.18087/cardio.2020.5.n1132,2020-06-10
Thromboembolism,PROCESS_OF,Patients,32515698,10.18087/cardio.2020.5.n1130,2020-06-10
Thrombosis,PROCESS_OF,Patients,32515698,10.18087/cardio.2020.5.n1130,2020-06-10
Vascular Hemostatic Disorders,PROCESS_OF,Patients,32515698,10.18087/cardio.2020.5.n1130,2020-06-10
Hemoglobin,COMPLICATES,Anoxia,32515698,10.18087/cardio.2020.5.n1130,2020-06-10
Cardiac rhythm type,PROCESS_OF,Patients,32515685,10.1080/22221751.2020.1772677,2020-06-10
Cardiac rhythm type,PROCESS_OF,Patients,32515685,10.1080/22221751.2020.1772677,2020-06-10
Cardiovascular surgeon,ISA,Physicians,32515685,10.1080/22221751.2020.1772677,2020-06-10
Vaccines,TREATS,Child,32515682,10.1177/0194599820934370,2020-06-10
DNA Sequence,NEG_STIMULATES,Gadolinium,32515642,10.1177/0194599820933599,2020-06-10
Magnetic Resonance Imaging (MRI) of Heart,DIAGNOSES,Edema,32515642,10.1177/0194599820933599,2020-06-10
Myocarditis due to infectious agent,PROCESS_OF,Child,32515642,10.1177/0194599820933599,2020-06-10
Myocarditis due to infectious agent,PROCESS_OF,Adolescent (age group),32515642,10.1177/0194599820933599,2020-06-10
Negative Regulation of Coagulation,PROCESS_OF,Patients,32515561,10.36233/0507-4088-2020-65-2-62-70,2020-06-10
Death of unknown cause,PROCESS_OF,Patients,32515561,10.36233/0507-4088-2020-65-2-62-70,2020-06-10
parenteral therapy,USES,"Heparin, Low-Molecular-Weight",32515561,10.36233/0507-4088-2020-65-2-62-70,2020-06-10
Betacoronavirus,ISA,Genus: Coronavirus,32515555,10.1111/cob.12386,2020-06-10
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32515555,10.1111/cob.12386,2020-06-10
Ability,MANIFESTATION_OF,Acclimatization,32515555,10.1111/cob.12386,2020-06-10
receptor,PART_OF,Epithelial Cells,32515555,10.1111/cob.12386,2020-06-10
Circulatory Process,PROCESS_OF,Chiroptera,32515555,10.1111/cob.12386,2020-06-10
Obesity,PROCESS_OF,Patients,32515544,10.1111/ajt.16117,2020-06-10
Hispanics,ISA,Ethnic group,32515544,10.1111/ajt.16117,2020-06-10
Obesity,AFFECTS,Patients,32515544,10.1111/ajt.16117,2020-06-10
Disease,PROCESS_OF,Patients,32515499,10.1002/jmv.26149,2020-06-10
Coronavirus Infections,ISA,Disease,32515499,10.1002/jmv.26149,2020-06-10
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32515499,10.1002/jmv.26149,2020-06-10
Cessation of life,PROCESS_OF,Italians,32515499,10.1002/jmv.26149,2020-06-10
Experience,PROCESS_OF,Italians,32515499,10.1002/jmv.26149,2020-06-10
Coronavirus Infections,ISA,Disease,32515499,10.1002/jmv.26149,2020-06-10
Coronavirus Infections,ISA,Disease,32515499,10.1002/jmv.26149,2020-06-10
Pneumonia,ISA,Disease,32515499,10.1002/jmv.26149,2020-06-10
Pneumonia,PROCESS_OF,Patients,32515499,10.1002/jmv.26149,2020-06-10
Pneumonia,AFFECTS,Patients,32515406,10.5455/JPMA.40,2020-06-10
Survivors,LOCATION_OF,Interleukin-6,32515406,10.5455/JPMA.40,2020-06-10
Interleukin-6,ASSOCIATED_WITH,Pneumonia,32515406,10.5455/JPMA.40,2020-06-10
tocilizumab,INHIBITS,Interleukin-6,32515406,10.5455/JPMA.40,2020-06-10
Awareness,PROCESS_OF,general population,32515404,10.5455/JPMA.37,2020-06-10
Evaluation procedure,ADMINISTERED_TO,Persons,32515404,10.5455/JPMA.37,2020-06-10
Virus,PROCESS_OF,World,32515404,10.5455/JPMA.37,2020-06-10
Coronavirus Infections,PROCESS_OF,Young Adult,32515404,10.5455/JPMA.37,2020-06-10
Coronavirus Infections,ISA,Disease,32515402,10.5455/JPMA.39,2020-06-10
Challenge,TREATS,World,32515402,10.5455/JPMA.39,2020-06-10
Patients,ISA,Persons,32515399,10.5455/JPMA.34,2020-06-10
Coronavirus Infections,ISA,Disease,32515398,10.5455/JPMA.35,2020-06-10
World,ISA,Population Group,32515398,10.5455/JPMA.35,2020-06-10
Performance,PROCESS_OF,Congregational,32515398,10.5455/JPMA.35,2020-06-10
Coronavirus Infections,ISA,Disease,32515398,10.5455/JPMA.35,2020-06-10
Coronavirus Infections,ISA,Disease,32515398,10.5455/JPMA.35,2020-06-10
Critical Illness,PROCESS_OF,Patients,32515396,10.5455/JPMA.33,2020-06-10
Triage,TREATS,Patients,32515396,10.5455/JPMA.33,2020-06-10
Symptoms,PROCESS_OF,Patients,32515396,10.5455/JPMA.33,2020-06-10
Coronavirus Infections,ISA,Disease,32515394,10.5455/JPMA.30,2020-06-10
Cessation of life,PROCESS_OF,Persons,32515394,10.5455/JPMA.30,2020-06-10
Disease,PROCESS_OF,Patients,32515394,10.5455/JPMA.30,2020-06-10
Coronavirus Infections,ISA,Disease,32515394,10.5455/JPMA.30,2020-06-10
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32515394,10.5455/JPMA.30,2020-06-10
Coronavirus Infections,PROCESS_OF,Family,32515392,10.5455/JPMA.18,2020-06-10
EHD1 wt Allele,AFFECTS,Complication,32515392,10.5455/JPMA.18,2020-06-10
Infection,PRECEDES,Complication,32515392,10.5455/JPMA.18,2020-06-10
Conjunctivitis,PROCESS_OF,Patients,32515391,10.5455/JPMA.26,2020-06-10
RNA Viruses,PROCESS_OF,World,32515389,10.5455/JPMA.25,2020-06-10
Coronavirus Infections,ISA,Disease,32515389,10.5455/JPMA.25,2020-06-10
Coronavirus Infections,ISA,Disease,32515388,10.5455/JPMA.13,2020-06-10
Mild disorder,PROCESS_OF,Child,32515388,10.5455/JPMA.13,2020-06-10
Pharmaceutical Preparations,TREATS,Child,32515388,10.5455/JPMA.13,2020-06-10
Coronavirus Infections,ISA,Disease,32515387,10.5455/JPMA.21,2020-06-10
Confirmation,PROCESS_OF,Patients,32515387,10.5455/JPMA.21,2020-06-10
Disease,PROCESS_OF,Patients,32515387,10.5455/JPMA.21,2020-06-10
Coronavirus Infections,ISA,Disease,32515387,10.5455/JPMA.21,2020-06-10
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32515387,10.5455/JPMA.21,2020-06-10
Coronavirus Infections,ISA,Disease,32515386,10.5455/JPMA.15,2020-06-10
Pneumonia,ISA,Disease,32515386,10.5455/JPMA.15,2020-06-10
Screening procedure,TREATS,Pneumonia,32515386,10.5455/JPMA.15,2020-06-10
Lung,LOCATION_OF,Nodule,32515386,10.5455/JPMA.15,2020-06-10
Lung,LOCATION_OF,Ultrasonography,32515386,10.5455/JPMA.15,2020-06-10
Comorbidity,PROCESS_OF,Persons,32515385,10.5455/JPMA.17,2020-06-10
Diabetes,PROCESS_OF,Persons,32515385,10.5455/JPMA.17,2020-06-10
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32515385,10.5455/JPMA.17,2020-06-10
Middle East Respiratory Syndrome Coronavirus,CAUSES,Middle East Respiratory Syndrome,32515385,10.5455/JPMA.17,2020-06-10
Coronavirus Infections,ISA,Disease,32515385,10.5455/JPMA.17,2020-06-10
Coronavirus Infections,ISA,Disease,32515385,10.5455/JPMA.17,2020-06-10
Coronavirus Infections,ISA,Disease,32515385,10.5455/JPMA.17,2020-06-10
Coronavirus Infections,ISA,Disease,32515384,10.5455/JPMA.23,2020-06-10
Virus,ISA,Organism,32515383,10.5455/JPMA.22,2020-06-10
Coughing,PROCESS_OF,Patients,32515383,10.5455/JPMA.22,2020-06-10
Fever,PROCESS_OF,Patients,32515383,10.5455/JPMA.22,2020-06-10
Pneumonia,COEXISTS_WITH,Immunocompromised Host,32515383,10.5455/JPMA.22,2020-06-10
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Immunocompromised Host,32515383,10.5455/JPMA.22,2020-06-10
Rhinitis,PROCESS_OF,Patients,32515383,10.5455/JPMA.22,2020-06-10
Influenza-like symptoms,PROCESS_OF,Patients,32515383,10.5455/JPMA.22,2020-06-10
Symptom severe,PROCESS_OF,Patients,32515383,10.5455/JPMA.22,2020-06-10
Acute illness,COEXISTS_WITH,Immunocompromised Host,32515383,10.5455/JPMA.22,2020-06-10
Coronavirus Infections,ISA,Disease,32515382,10.5455/JPMA.14,2020-06-10
Glucocorticoids,INHIBITS,Interleukins,32515382,10.5455/JPMA.14,2020-06-10
urinastatin,ISA,antagonists,32515382,10.5455/JPMA.14,2020-06-10
Antiviral Agents,COEXISTS_WITH,Biological Response Modifiers,32515382,10.5455/JPMA.14,2020-06-10
"Psychotherapy, Multiple",USES,Pharmaceutical Preparations,32515382,10.5455/JPMA.14,2020-06-10
Coronavirus Infections,ISA,Disease,32515381,10.5455/JPMA.19,2020-06-10
Fever,MANIFESTATION_OF,Disease,32515380,10.5455/JPMA.16,2020-06-10
Fever,MANIFESTATION_OF(SPEC),Coronavirus Infections,32515380,10.5455/JPMA.16,2020-06-10
Coronavirus Infections,ISA,Disease,32515380,10.5455/JPMA.16,2020-06-10
Associated symptom,PROCESS_OF,Patients,32515380,10.5455/JPMA.16,2020-06-10
Coronavirus Infections,ISA,Disease,32515380,10.5455/JPMA.16,2020-06-10
Digestive symptom,ASSOCIATED_WITH,Disease,32515380,10.5455/JPMA.16,2020-06-10
Digestive symptom,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32515380,10.5455/JPMA.16,2020-06-10
Endocrine Glands,LOCATION_OF,IMPACT gene,32515379,10.5455/JPMA.20,2020-06-10
Infected,PROCESS_OF,Persons,32515379,10.5455/JPMA.20,2020-06-10
Coronavirus Infections,ISA,Disease,32515378,10.5455/JPMA.12,2020-06-10
Neurologic Manifestations,PROCESS_OF,Patients,32515378,10.5455/JPMA.12,2020-06-10
Coronavirus Infections,ISA,Disease,32515378,10.5455/JPMA.12,2020-06-10
Coronavirus Infections,ISA,Disease,32515378,10.5455/JPMA.12,2020-06-10
Neurologic Deficits,COEXISTS_WITH,Disease,32515378,10.5455/JPMA.12,2020-06-10
Neurologic Deficits,COEXISTS_WITH(SPEC),Coronavirus Infections,32515378,10.5455/JPMA.12,2020-06-10
Anosmia,ASSOCIATED_WITH(SPEC),Disease,32515378,10.5455/JPMA.12,2020-06-10
Anosmia,ISA,Symptoms,32515378,10.5455/JPMA.12,2020-06-10
Coronavirus Infections,ISA,Disease,32515378,10.5455/JPMA.12,2020-06-10
Symptoms,ASSOCIATED_WITH,Disease,32515378,10.5455/JPMA.12,2020-06-10
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32515378,10.5455/JPMA.12,2020-06-10
Ageusia,ASSOCIATED_WITH(SPEC),Disease,32515378,10.5455/JPMA.12,2020-06-10
Ageusia,ISA,Symptoms,32515378,10.5455/JPMA.12,2020-06-10
Coronavirus Infections,ISA,Disease,32515378,10.5455/JPMA.12,2020-06-10
Neurologic Deficits,COEXISTS_WITH,Disease,32515378,10.5455/JPMA.12,2020-06-10
Neurologic Deficits,COEXISTS_WITH(SPEC),Coronavirus Infections,32515378,10.5455/JPMA.12,2020-06-10
Communicable Diseases,PREDISPOSES,Coronavirus Infections,32515377,10.5455/JPMA.27,2020-06-10
Coronavirus Infections,ISA,Disease,32515377,10.5455/JPMA.27,2020-06-10
patient condition,PROCESS_OF,Patients,32515377,10.5455/JPMA.27,2020-06-10
Cardiovascular finding,PROCESS_OF,Patients,32515376,10.5455/JPMA.09,2020-06-10
Eye,LOCATION_OF,Disease,32515372,10.5455/JPMA.28,2020-06-10
Eye,LOCATION_OF(SPEC),Coronavirus Infections,32515372,10.5455/JPMA.28,2020-06-10
Coronavirus Infections,ISA,Disease,32515372,10.5455/JPMA.28,2020-06-10
Coronavirus Infections,ISA,Disease,32515372,10.5455/JPMA.28,2020-06-10
Pharmaceutical Preparations,TREATS,Disease,32515370,10.5455/JPMA.04,2020-06-10
"Immunity, Herd",PROCESS_OF,Community,32515370,10.5455/JPMA.04,2020-06-10
"Immunity, Herd",PROCESS_OF,Population Group,32515370,10.5455/JPMA.04,2020-06-10
Pandemics,ISA,Disease Outbreaks,32515369,10.5455/JPMA.07,2020-06-10
Eye,LOCATION_OF,Virus Diseases,32515369,10.5455/JPMA.07,2020-06-10
Coronavirus Infections,ISA,Disease,32515368,10.5455/JPMA.06,2020-06-10
Coronavirus Infections,ISA,Disease,32515297,10.1080/08959420.2020.1774313,2020-06-10
Aging,PROCESS_OF,Community,32515260,10.1177/0020731420931431,2020-06-10
Aging,PROCESS_OF,Social Networks,32515260,10.1177/0020731420931431,2020-06-10
Infected,PROCESS_OF,Persons,32515258,10.1177/0025817220923692,2020-06-10
Illness (finding),PROCESS_OF,Patients,32515254,10.1161/JAHA.120.017175,2020-06-10
"CD69 protein, human",INHIBITS,"TLR4 protein, human",32515254,10.1161/JAHA.120.017175,2020-06-10
mental health,PROCESS_OF,Households,32515254,10.1161/JAHA.120.017175,2020-06-10
mental health,PROCESS_OF,parent,32515254,10.1161/JAHA.120.017175,2020-06-10
mental health,PROCESS_OF,Partner in relationship,32515254,10.1161/JAHA.120.017175,2020-06-10
Influenza,PROCESS_OF,Hispanics,32515254,10.1161/JAHA.120.017175,2020-06-10
Atrial Fibrillation,PROCESS_OF,hospitalized patients,32515231,10.1177/0018720820932699,2020-06-10
Pharmaceutical Preparations,TREATS,Atrial Fibrillation,32515231,10.1177/0018720820932699,2020-06-10
Cytochrome P450,INHIBITS,Potassium Channel,32515231,10.1177/0018720820932699,2020-06-10
Drug Interactions,AFFECTS,Hemorrhage,32515231,10.1177/0018720820932699,2020-06-10
Drug Interactions,AFFECTS,Ventricular arrhythmia,32515231,10.1177/0018720820932699,2020-06-10
Drug Interactions,AFFECTS,Bradycardia,32515231,10.1177/0018720820932699,2020-06-10
Drug Interactions,PROCESS_OF,Patients,32515231,10.1177/0018720820932699,2020-06-10
Anti-Arrhythmia Agents,TREATS,patient condition,32515231,10.1177/0018720820932699,2020-06-10
Anticoagulants,TREATS,patient condition,32515231,10.1177/0018720820932699,2020-06-10
patient condition,COEXISTS_WITH,Atrial Fibrillation,32515231,10.1177/0018720820932699,2020-06-10
Administration occupational activities,ISA,Health systems,32515209,10.1177/0844562120931623,2020-06-10
Clone,LOCATION_OF,Hematopoiesis,32515125,10.1111/ajt.16118,2020-06-10
Chronic liver disease,PROCESS_OF,Patients,32515085,10.1111/ajt.16120,2020-06-10
Attitude,PROCESS_OF,Solid Organ Transplantation Recipient,32515085,10.1111/ajt.16120,2020-06-10
High Level,PROCESS_OF,Solid Organ Transplantation Recipient,32515085,10.1111/ajt.16120,2020-06-10
Steroid therapy,TREATS,Solid Organ Transplantation Recipient,32515085,10.1111/ajt.16120,2020-06-10
Transplantation,TREATS,Households,32515085,10.1111/ajt.16120,2020-06-10
Comorbidity,PROCESS_OF,Recipient,32515084,10.1111/jsr.13096,2020-06-10
Dyssomnias,PROCESS_OF,Population Group,32515076,10.1111/tid.13359,2020-06-10
Sleeplessness,PROCESS_OF,"Personnel, Hospital",32515076,10.1111/tid.13359,2020-06-10
Disease,AFFECTS,Immune response,32515076,10.1111/tid.13359,2020-06-10
Counseling,TREATS,Health Personnel,32515076,10.1111/tid.13359,2020-06-10
Advice,TREATS,Sleep Deprivation,32515076,10.1111/tid.13359,2020-06-10
Advice,TREATS,Shift worker,32515076,10.1111/tid.13359,2020-06-10
Advice,TREATS,Dyssomnias,32515076,10.1111/tid.13359,2020-06-10
Advice,TREATS,Sleeplessness,32515076,10.1111/tid.13359,2020-06-10
Advice,TREATS,Sleeplessness,32515076,10.1111/tid.13359,2020-06-10
Coronavirus Infections,OCCURS_IN,Transplant Recipients,32515039,10.1111/ajt.16125,2020-06-10
Cessation of life,PROCESS_OF,Donor person,32515033,10.1111/dth.13778,2020-06-10
France,ISA,Country,32515033,10.1111/dth.13778,2020-06-10
Pharmacotherapy,ADMINISTERED_TO,Patients,32514935,10.1007/s12471-020-01439-5,2020-06-10
Prescribed medications,TREATS,Heart failure,32514856,10.1007/s10072-020-04517-z,2020-06-10
Prescribed medications,TREATS,Hypertensive disease,32514856,10.1007/s10072-020-04517-z,2020-06-10
Prescribed medications,TREATS,Chronic Kidney Diseases,32514856,10.1007/s10072-020-04517-z,2020-06-10
Pharmaceutical Preparations,STIMULATES,angiotensin converting enzyme 2,32514856,10.1007/s10072-020-04517-z,2020-06-10
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",COEXISTS_WITH,patient condition,32514856,10.1007/s10072-020-04517-z,2020-06-10
Infected,PROCESS_OF,Family member,32514763,10.1007/s11239-020-02177-6,2020-06-10
Disease,PROCESS_OF,member,32514763,10.1007/s11239-020-02177-6,2020-06-10
Complication,CAUSES,Deep Vein Thrombosis,32514743,10.1007/s13304-020-00821-7,2020-06-10
Hospitals,LOCATION_OF,Study,32514743,10.1007/s13304-020-00821-7,2020-06-10
Coronavirus Infections,PROCESS_OF,Pregnant Women,32514743,10.1007/s13304-020-00821-7,2020-06-10
Coronavirus Infections,ISA,Disease,32514743,10.1007/s13304-020-00821-7,2020-06-10
Obesity,PROCESS_OF,Patients,32514696,10.1007/s13181-020-00790-8,2020-06-10
personal experience,PROCESS_OF,Patients,32514696,10.1007/s13181-020-00790-8,2020-06-10
Chloroquine,TREATS,Disease,32514689,10.1007/s00705-020-04693-5,2020-06-10
Hydroxychloroquine,TREATS,Disease,32514689,10.1007/s00705-020-04693-5,2020-06-10
Toxic effect,PROCESS_OF,Male population group,32514689,10.1007/s00705-020-04693-5,2020-06-10
Poisoning,PROCESS_OF,Patients,32514689,10.1007/s00705-020-04693-5,2020-06-10
Chloroquine,ISA,Pharmacologic Substance,32514683,10.1007/s11739-020-02396-y,2020-06-10
Smoker,PROCESS_OF,hospitalized patients,32514682,10.1007/s11739-020-02391-3,2020-06-10
Anticoagulants,TREATS,Patients,32514674,10.1007/s10067-020-05193-2,2020-06-10
Virus,PROCESS_OF,Patients,32514674,10.1007/s10067-020-05193-2,2020-06-10
Systemic Scleroderma,ISA,Autoimmune Diseases,32514623,10.1007/s00508-020-01685-y,2020-06-10
Systemic Scleroderma,PROCESS_OF,Patients,32514623,10.1007/s00508-020-01685-y,2020-06-10
"Lung Diseases, Interstitial",COEXISTS_WITH,Systemic Scleroderma,32514623,10.1007/s00508-020-01685-y,2020-06-10
Systemic Scleroderma,PROCESS_OF,Patients,32514623,10.1007/s00508-020-01685-y,2020-06-10
Systemic Scleroderma,PROCESS_OF,Patients,32514623,10.1007/s00508-020-01685-y,2020-06-10
Systemic Scleroderma,PROCESS_OF,Patients,32514623,10.1007/s00508-020-01685-y,2020-06-10
Infection,COEXISTS_WITH,Unemployment,32514620,10.1007/s00701-020-04437-z,2020-06-10
Intervention regimes,TREATS,Influenza,32514620,10.1007/s00701-020-04437-z,2020-06-10
Disease,PROCESS_OF,Patients,32514616,10.1007/s00520-020-05563-1,2020-06-10
"Hematoma, Subdural, Chronic",PROCESS_OF,Patients,32514616,10.1007/s00520-020-05563-1,2020-06-10
"Subarachnoid Hemorrhage, Aneurysmal",PROCESS_OF,Patients,32514616,10.1007/s00520-020-05563-1,2020-06-10
Blood Vessel,LOCATION_OF,Disease,32514616,10.1007/s00520-020-05563-1,2020-06-10
Symptom severe,PROCESS_OF,geriatric patients,32514616,10.1007/s00520-020-05563-1,2020-06-10
"Hematoma, Subdural, Chronic",PROCESS_OF,geriatric patients,32514616,10.1007/s00520-020-05563-1,2020-06-10
Neoplasms,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Chemotherapy Regimen,AFFECTS,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Neoplasms,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Pruritus,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Xerosis,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Inflammatory disease of mucous membrane,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Neoplasms,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Neoplasms,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Neoplasms,PROCESS_OF,Patients,32514605,10.1007/s00106-020-00892-3,2020-06-10
Infection,PROCESS_OF,Health Personnel,32514598,10.1007/s00134-020-06092-5,2020-06-10
Tracheotomy procedure,TREATS,Weaning,32514598,10.1007/s00134-020-06092-5,2020-06-10
Patient ventilated,COEXISTS_WITH,Disease,32514598,10.1007/s00134-020-06092-5,2020-06-10
Tracheostomy care,ADMINISTERED_TO,Health Personnel,32514598,10.1007/s00134-020-06092-5,2020-06-10
Protection,PROCESS_OF,Health Personnel,32514598,10.1007/s00134-020-06092-5,2020-06-10
intensive care unit,LOCATION_OF,organizational management,32514587,10.1007/s00059-020-04951-x,2020-06-10
Malignant Neoplasms,PROCESS_OF,Patients,32514473,10.1016/j.tipsro.2020.05.003,2020-06-10
Therapeutic procedure,TREATS,Long-Term Cancer Survivors,32514473,10.1016/j.tipsro.2020.05.003,2020-06-10
Malignant Neoplasms,COEXISTS_WITH,Cardiovascular Diseases,32514473,10.1016/j.tipsro.2020.05.003,2020-06-10
Lung,LOCATION_OF,Symptoms,32514431,10.1002/jgh3.12362,2020-06-10
Coronavirus Infections,AFFECTS,Nutritional status,32514431,10.1002/jgh3.12362,2020-06-10
Post-Traumatic Stress Disorder,ISA,Mental disorders,32514427,10.1186/s41256-020-00154-3,2020-06-10
Prophylactic treatment,TREATS,Post-Traumatic Stress Disorder,32514427,10.1186/s41256-020-00154-3,2020-06-10
early/brief intervention/therapy (treatment),TREATS,Post-Traumatic Stress Disorder,32514427,10.1186/s41256-020-00154-3,2020-06-10
Pneumonia,PROCESS_OF,Patients,32514386,10.1186/s41077-020-00127-z,2020-06-10
Polyneuropathy,PROCESS_OF,Patients,32514386,10.1186/s41077-020-00127-z,2020-06-10
Coronavirus Infections,ISA,Disease,32514386,10.1186/s41077-020-00127-z,2020-06-10
Anxiety,PROCESS_OF,Participant,32514385,10.1186/s41077-020-00128-y,2020-06-10
Health care facility,LOCATION_OF,simulation,32514385,10.1186/s41077-020-00128-y,2020-06-10
Health Care Systems,LOCATION_OF,simulation,32514354,10.1002/rcr2.596,2020-06-10
Program,STIMULATES,IMPACT gene,32514354,10.1002/rcr2.596,2020-06-10
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32514348,10.1186/s13690-020-00432-z,2020-06-10
Coronavirus Infections,CAUSES(SPEC),"Respiratory Distress Syndrome, Adult",32514348,10.1186/s13690-020-00432-z,2020-06-10
Coronavirus Infections,ISA,Disease,32514348,10.1186/s13690-020-00432-z,2020-06-10
Coronavirus Infections,ISA,Disease,32514348,10.1186/s13690-020-00432-z,2020-06-10
Ultrasonography,DIAGNOSES,Crisis,32514319,10.1002/ajum.12210,2020-06-10
Cardiopulmonary,LOCATION_OF,Ultrasonography,32514319,10.1002/ajum.12210,2020-06-10
Waking,AFFECTS,Persons,32514291,10.1186/s13020-020-00337-7,2020-06-10
Disability,PROCESS_OF,Adult,32514291,10.1186/s13020-020-00337-7,2020-06-10
Disability,PROCESS_OF,World,32514291,10.1186/s13020-020-00337-7,2020-06-10
Infected,PROCESS_OF,Persons,32514291,10.1186/s13020-020-00337-7,2020-06-10
Occupational Exposure,PROCESS_OF,Medical Staff,32514287,10.1186/s13020-020-00336-8,2020-06-10
Author,TREATS,Patients,32514230,10.1186/s41182-020-00228-5,2020-06-10
artesunate,ISA,Antimalarials,32514230,10.1186/s41182-020-00228-5,2020-06-10
Diabetes,PROCESS_OF,Patients,32514210,10.2471/BLT.20.020620,2020-06-10
Hypertensive disease,PROCESS_OF,Patients,32514210,10.2471/BLT.20.020620,2020-06-10
Liver diseases,PROCESS_OF,Patients,32514210,10.2471/BLT.20.020620,2020-06-10
Obesity,PROCESS_OF,Patients,32514210,10.2471/BLT.20.020620,2020-06-10
Predisposition -- attribute,ASSOCIATED_WITH,Coronavirus Infections,32514210,10.2471/BLT.20.020620,2020-06-10
Hydroxychloroquine,ISA,Chloroquine,32514210,10.2471/BLT.20.020620,2020-06-10
Oxytocin,ISA,Neuropeptides,32514047,10.1038/s41418-020-0572-6,2020-06-10
Oxytocin,TREATS,Mental disorders,32514047,10.1038/s41418-020-0572-6,2020-06-10
Brain,LOCATION_OF,Oxytocin,32514047,10.1038/s41418-020-0572-6,2020-06-10
Oxytocin,INTERACTS_WITH,Cells,32514047,10.1038/s41418-020-0572-6,2020-06-10
Severe disorder,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Inflammation,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Immune,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Severe disorder,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Patients,LOCATION_OF,peripheral blood,32513989,10.1038/s41419-020-2636-4,2020-06-10
Infected,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Interleukin-6,STIMULATES,Effector T-Lymphocyte,32513989,10.1038/s41419-020-2636-4,2020-06-10
T-Lymphocyte,LOCATION_OF,,32513989,10.1038/s41419-020-2636-4,2020-06-10
Transforming Growth Factors,STIMULATES,Effector T-Lymphocyte,32513989,10.1038/s41419-020-2636-4,2020-06-10
Severe disorder,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Mild disorder,PROCESS_OF,Patients,32513989,10.1038/s41419-020-2636-4,2020-06-10
Plasma specimen,LOCATION_OF,Transforming Growth Factors,32513989,10.1038/s41419-020-2636-4,2020-06-10
Inflammation,AFFECTS,Disease Progression,32513989,10.1038/s41419-020-2636-4,2020-06-10
Pneumonia,PROCESS_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Prognosis good,PROCESS_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Immune response,PROCESS_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Plasma,LOCATION_OF,cytokine,32513951,10.1038/s41419-020-2603-0,2020-06-10
Plasma,PART_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Peripheral blood mononuclear cell (cell),LOCATION_OF,IL2 Signaling Pathway,32513951,10.1038/s41419-020-2603-0,2020-06-10
Peripheral blood mononuclear cell (cell),PART_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Pneumonia,PROCESS_OF,Patients,32513951,10.1038/s41419-020-2603-0,2020-06-10
Prophylactic treatment,TREATS,Disease,32513867,10.1126/scitranslmed.abc3539,2020-06-10
Cytoplasm,NEG_PART_OF,Old World rabbit,32513865,10.1126/science.abb9263,2020-06-10
"M Protein, multiple myeloma",AUGMENTS,Antibody Formation,32513865,10.1126/science.abb9263,2020-06-10
Protein antigen,PART_OF,Old World rabbit,32513865,10.1126/science.abb9263,2020-06-10
Antigens,compared_with,Antigens,32513865,10.1126/science.abb9263,2020-06-10
Introduction procedure,USES,CFC1 gene,32513860,10.1128/JCM.01110-20,2020-06-10
Serologic tests,METHOD_OF,Detection,32513858,10.1128/JCM.00995-20,2020-06-10
Abbott Laboratories,LOCATION_OF,Assay,32513858,10.1128/JCM.00995-20,2020-06-10
Assay,USES,anti-IgG,32513858,10.1128/JCM.00995-20,2020-06-10
Assay,USES,anti-IgG,32513858,10.1128/JCM.00995-20,2020-06-10
Negative,PROCESS_OF,Patients,32513850,10.4049/jimmunol.2000526,2020-06-10
Severe disorder,PROCESS_OF,Patients,32513850,10.4049/jimmunol.2000526,2020-06-10
Suspicion,PROCESS_OF,Patients,32513850,10.4049/jimmunol.2000526,2020-06-10
Performance,PROCESS_OF,Patients,32513850,10.4049/jimmunol.2000526,2020-06-10
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Disease,32513832,10.1136/oemed-2020-106626,2020-06-10
Accommodation,PROCESS_OF,Migrant Workers,32513808,10.3949/ccjm.87a.ccc043,2020-06-10
"Suicide, Assisted",ISA,Services,32513807,10.3949/ccjm.87a.ccc046,2020-06-10
Intervention regimes,USES,Anti-Anxiety Agents,32513807,10.3949/ccjm.87a.ccc046,2020-06-10
Antiviral Agents,PREVENTS,Severe Acute Respiratory Syndrome,32513791,10.3899/jrheum.200740,2020-06-10
Suramin,ISA,Antiparasitic Agents,32513791,10.3899/jrheum.200740,2020-06-10
Challenge,TREATS,Health Personnel,32513768,10.1136/bcr-2020-235456,2020-06-10
Abdominal Pain,PROCESS_OF,Male population group,32513678,10.1136/bmjspcare-2020-002446,2020-06-10
Diarrhea,PROCESS_OF,Male population group,32513678,10.1136/bmjspcare-2020-002446,2020-06-10
Hyponatremia,PROCESS_OF,Male population group,32513678,10.1136/bmjspcare-2020-002446,2020-06-10
Cardiopulmonary Resuscitation,COEXISTS_WITH,Health Care,32513664,10.1136/ijgc-2020-001585,2020-06-10
Cardiopulmonary Resuscitation,ISA,Interventional procedure,32513664,10.1136/ijgc-2020-001585,2020-06-10
Cardiopulmonary Resuscitation,TREATS(SPEC),Persons,32513664,10.1136/ijgc-2020-001585,2020-06-10
Interventional procedure,TREATS,Persons,32513664,10.1136/ijgc-2020-001585,2020-06-10
Interventional procedure,TREATS(INFER),multiple pathologies,32513664,10.1136/ijgc-2020-001585,2020-06-10
multiple pathologies,PROCESS_OF,Persons,32513664,10.1136/ijgc-2020-001585,2020-06-10
Negative,PROCESS_OF,Patients,32513659,10.1136/bmj.m2107,2020-06-10
Neck,LOCATION_OF,Locally Advanced Malignant Neoplasm,32513659,10.1136/bmj.m2107,2020-06-10
Operative Surgical Procedures,TREATS,Patients,32513659,10.1136/bmj.m2107,2020-06-10
Pharmacotherapy,TREATS,Patients,32513659,10.1136/bmj.m2107,2020-06-10
Pharmacotherapy,TREATS,advanced cancer,32513659,10.1136/bmj.m2107,2020-06-10
Pharmacotherapy,TREATS(INFER),Malignant Female Reproductive System Neoplasm,32513659,10.1136/bmj.m2107,2020-06-10
ovarian,LOCATION_OF,advanced cancer,32513659,10.1136/bmj.m2107,2020-06-10
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32513659,10.1136/bmj.m2107,2020-06-10
Comorbidity,PROCESS_OF,Ethnic group,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Comorbidity,PROCESS_OF,African race,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Comorbidity,PROCESS_OF(SPEC),Minority Groups,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Comorbidity,PROCESS_OF(SPEC),African race,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Minority Groups,ISA,Ethnic group,32513653,10.1136/gutjnl-2020-321927,2020-06-10
African race,ISA,Ethnic group,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Unspecified Abortion,PROCESS_OF,Woman,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Severe Acute Respiratory Syndrome,COEXISTS_WITH,late pregnancy,32513653,10.1136/gutjnl-2020-321927,2020-06-10
Hydrocortisone,TREATS,Patients,32513617,10.1016/j.jmii.2020.05.016,2020-06-10
Hydrocortisone,TREATS(INFER),Pneumonia,32513617,10.1016/j.jmii.2020.05.016,2020-06-10
Pneumonia,PROCESS_OF,Patients,32513617,10.1016/j.jmii.2020.05.016,2020-06-10
Acclimatization,PROCESS_OF,Patients,32513617,10.1016/j.jmii.2020.05.016,2020-06-10
Negative Regulation of Coagulation,PROCESS_OF,Patients,32513617,10.1016/j.jmii.2020.05.016,2020-06-10
Laboratory,LOCATION_OF,Diagnosis,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
Serologic tests,DIAGNOSES,SARS coronavirus,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
RNA-Directed RNA Polymerase,INTERACTS_WITH,Genes,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
Health Care Systems,LOCATION_OF,Laboratory Procedures,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
Early Diagnosis,DIAGNOSES,Disease,32513593,10.1016/j.clcc.2020.05.004,2020-06-10
Malignant Neoplasms,PROCESS_OF,Patients,32513566,10.1016/j.cytogfr.2020.06.001,2020-06-10
Emergency medical service,ISA,Evaluation procedure,32513566,10.1016/j.cytogfr.2020.06.001,2020-06-10
Malignant neoplasm of gastrointestinal tract,PROCESS_OF,Patients,32513566,10.1016/j.cytogfr.2020.06.001,2020-06-10
Pandemics,ISA,Disease Outbreaks,32513566,10.1016/j.cytogfr.2020.06.001,2020-06-10
Interleukin-1,ISA,cytokine,32513532,10.1016/j.bbrc.2020.05.203,2020-06-10
Interleukin-6,ISA,cytokine,32513532,10.1016/j.bbrc.2020.05.203,2020-06-10
Interleukin-12,ISA,cytokine,32513532,10.1016/j.bbrc.2020.05.203,2020-06-10
Patients,LOCATION_OF,cytokine,32513532,10.1016/j.bbrc.2020.05.203,2020-06-10
cytokine,ASSOCIATED_WITH,Disease,32513532,10.1016/j.bbrc.2020.05.203,2020-06-10
Cerebrovascular accident,PREDISPOSES,Cerebrovascular Disorders,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
Cerebrovascular accident,PROCESS_OF,Patients,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
Blood Vessel,LOCATION_OF,angiotensin converting enzyme 2,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
Brain,LOCATION_OF,angiotensin converting enzyme 2,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
angiotensin converting enzyme 2,STIMULATES,TSPAN33 gene,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
Bark - plant part,LOCATION_OF,TSPAN33 gene,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
angiotensin converting enzyme 2,AUGMENTS,Blood Vessel,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
angiotensin converting enzyme 2,AUGMENTS,Blood Vessel,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
angiotensin converting enzyme 2,AUGMENTS,Brain,32513529,10.1016/j.scitotenv.2020.139853,2020-06-10
Lung,LOCATION_OF,Chronic inflammation,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Chronic Obstructive Airway Disease,CAUSES,Obstruction,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Comprehensive Health Care,TREATS,Patients,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Comprehensive Health Care,TREATS(INFER),Chronic Obstructive Airway Disease,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Comprehensive Health Care,USES,Spirometry,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Therapeutic procedure,USES,Inhaler,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
terminal patient care,ADMINISTERED_TO,Patients,32513514,10.1016/j.vaccine.2020.04.070,2020-06-10
Vaccines,NEG_TREATS,World,32513502,10.1016/j.semerg.2020.05.011,2020-06-10
Epitopes,PART_OF,Cells,32513502,10.1016/j.semerg.2020.05.011,2020-06-10
Basques,ISA,Population Group,32513456,10.1016/j.otorri.2020.04.002,2020-06-10
Puncture procedure,METHOD_OF,Tracheotomy procedure,32513452,10.1016/j.ajem.2020.05.054,2020-06-10
Thromboembolism,OCCURS_IN,Patients,32513429,10.1016/j.bjoms.2020.05.021,2020-06-10
Arteries,LOCATION_OF,Thromboembolism,32513429,10.1016/j.bjoms.2020.05.021,2020-06-10
Arteries,PART_OF,Woman,32513429,10.1016/j.bjoms.2020.05.021,2020-06-10
Veins,PART_OF,Woman,32513429,10.1016/j.bjoms.2020.05.021,2020-06-10
Asymptomatic,PROCESS_OF,Patients,32513393,10.1016/j.ad.2020.05.001,2020-06-10
Operative Surgical Procedures,AFFECTS,Disease,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Squamous cell carcinoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
melanoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
tumor growth,AFFECTS,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Squamous cell carcinoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
melanoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Head and neck structure,LOCATION_OF,Squamous cell carcinoma,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Squamous cell carcinoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Patients,LOCATION_OF,LIN7B gene,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
melanoma,PROCESS_OF,Patients,32513349,10.29271/jcpsp.2020.04.349,2020-06-10
Infected,PROCESS_OF,traveler,32513320,10.1017/S003329172000224X,2020-06-10
human plasma,TREATS,Adult,32513299,10.1186/s13063-020-04399-8,2020-06-10
human plasma,TREATS(INFER),Patient in hospital,32513299,10.1186/s13063-020-04399-8,2020-06-10
Patient in hospital,PROCESS_OF,Adult,32513299,10.1186/s13063-020-04399-8,2020-06-10
Academic Medical Centers,LOCATION_OF,Study,32513299,10.1186/s13063-020-04399-8,2020-06-10
Symptoms,PROCESS_OF,Donor person,32513299,10.1186/s13063-020-04399-8,2020-06-10
Cessation of life,PROCESS_OF,hospitalized patients,32513299,10.1186/s13063-020-04399-8,2020-06-10
lopinavir / Ritonavir,TREATS,Patients,32513299,10.1186/s13063-020-04399-8,2020-06-10
Plasma,ASSOCIATED_WITH,Serious Adverse Event,32513299,10.1186/s13063-020-04399-8,2020-06-10
Pulmonary Fibrosis,PROCESS_OF,Patients,32513292,10.1186/s13012-020-01006-x,2020-06-10
Pulmonary Fibrosis,PROCESS_OF,Patients,32513292,10.1186/s13012-020-01006-x,2020-06-10
Asthma,ISA,Chronic Obstructive Airway Disease,32513292,10.1186/s13012-020-01006-x,2020-06-10
Lactation established in non-human animal,PROCESS_OF,Woman,32513292,10.1186/s13012-020-01006-x,2020-06-10
"Contraceptives, Oral",ISA,Pharmaceutical Preparations,32513292,10.1186/s13012-020-01006-x,2020-06-10
Lung,LOCATION_OF,tomography,32513292,10.1186/s13012-020-01006-x,2020-06-10
Intervention regimes,TREATS,Patients,32513290,10.1186/s13063-020-04454-4,2020-06-10
Plasma Exchange,TREATS,Patients,32513289,10.1186/s13063-020-04421-z,2020-06-10
Palliative Care,ADMINISTERED_TO,dying patients,32513289,10.1186/s13063-020-04421-z,2020-06-10
Plasma Exchange,ADMINISTERED_TO,Intervention Group,32513289,10.1186/s13063-020-04421-z,2020-06-10
Plasma Exchange,USES,Apheresis system,32513289,10.1186/s13063-020-04421-z,2020-06-10
acid citrate dextrose,ISA,Anticoagulants,32513289,10.1186/s13063-020-04421-z,2020-06-10
Blood Coagulation Disorders,PROCESS_OF,Patients,32513289,10.1186/s13063-020-04421-z,2020-06-10
Patients,LOCATION_OF,Fresh frozen plasma,32513289,10.1186/s13063-020-04421-z,2020-06-10
Serum,LOCATION_OF,C-reactive protein,32513289,10.1186/s13063-020-04421-z,2020-06-10
Nasal Swab (procedure),MEASURES,Degree or extent,32513287,10.1186/s13017-020-00317-0,2020-06-10
Ivermectin,ADMINISTERED_TO,Participant,32513287,10.1186/s13017-020-00317-0,2020-06-10
Placebos,ADMINISTERED_TO,Participant,32513287,10.1186/s13017-020-00317-0,2020-06-10
follow-up,COEXISTS_WITH,Isolation procedure,32513287,10.1186/s13017-020-00317-0,2020-06-10
Eye,LOCATION_OF,Disease,32513287,10.1186/s13017-020-00317-0,2020-06-10
Amiodarone,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Cyclosporine,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Diltiazem,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Erythromycin,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Ketoconazole,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Quinidine,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Spironolactone,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Verapamil,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Clarithromycin,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Itraconazole,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Tacrolimus,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Ritonavir,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Indinavir,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
cobicistat,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
P-glycoprotein Inhibitor,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Warfarin,ISA,Pharmaceutical Preparations,32513287,10.1186/s13017-020-00317-0,2020-06-10
Contraceptive methods,ADMINISTERED_TO,Woman,32513287,10.1186/s13017-020-00317-0,2020-06-10
Sexual sterilization,ISA,Operative Surgical Procedures,32513287,10.1186/s13017-020-00317-0,2020-06-10
Institutes,LOCATION_OF,Clinical Trials,32513287,10.1186/s13017-020-00317-0,2020-06-10
Mild disorder,PROCESS_OF,Patients,32513287,10.1186/s13017-020-00317-0,2020-06-10
"Nursing, Team",METHOD_OF,Follow-up visit,32513287,10.1186/s13017-020-00317-0,2020-06-10
Placebos,ADMINISTERED_TO,Control Groups,32513287,10.1186/s13017-020-00317-0,2020-06-10
Placebos,TREATS,Control Groups,32513287,10.1186/s13017-020-00317-0,2020-06-10
Coughing,PROCESS_OF,Patients,32513287,10.1186/s13017-020-00317-0,2020-06-10
Fever,PROCESS_OF,Patients,32513287,10.1186/s13017-020-00317-0,2020-06-10
Cell Count,MEASURES,Flow Cytometry,32513287,10.1186/s13017-020-00317-0,2020-06-10
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32513287,10.1186/s13017-020-00317-0,2020-06-10
Placebos,ADMINISTERED_TO,Staff,32513287,10.1186/s13017-020-00317-0,2020-06-10
"Cholecystectomy, Laparoscopic",TREATS,Acute Cholecystitis,32513261,10.1186/s12939-020-01207-2,2020-06-10
Surgeon,DIAGNOSES,Enthesitis-Related Arthritis,32513261,10.1186/s12939-020-01207-2,2020-06-10
Present,PREDISPOSES,Complication,32513202,10.1186/s12961-020-00571-3,2020-06-10
Medical contraindication,PROCESS_OF,Patients,32513202,10.1186/s12961-020-00571-3,2020-06-10
follow-up,NEG_COEXISTS_WITH,Interventional procedure,32513202,10.1186/s12961-020-00571-3,2020-06-10
Placebos,ADMINISTERED_TO,Patients,32513202,10.1186/s12961-020-00571-3,2020-06-10
Disease,PROCESS_OF,World,32513197,10.1186/s12967-020-02399-5,2020-06-10
research,MEASURES,STMN1 gene,32513197,10.1186/s12967-020-02399-5,2020-06-10
Matrix,TREATS,Homo sapiens,32513197,10.1186/s12967-020-02399-5,2020-06-10
Coronavirus Infections,ISA,Disease,32513197,10.1186/s12967-020-02399-5,2020-06-10
Coronavirus vaccination,USES,Matrix,32513197,10.1186/s12967-020-02399-5,2020-06-10
Syndrome,PROCESS_OF,Homo sapiens,32513096,10.1177/0194599820931820,2020-06-10
Cessation of life,PROCESS_OF,World,32513096,10.1177/0194599820931820,2020-06-10
Old age,ISA,Population Group,32513096,10.1177/0194599820931820,2020-06-10
Health care facility,LOCATION_OF,Cross-Sectional Studies,32513064,10.1177/0194599820933179,2020-06-10
Anosmia,PROCESS_OF,Patients,32513064,10.1177/0194599820933179,2020-06-10
Otolaryngologist,ISA,Persons,32513062,10.1177/0194599820935419,2020-06-10
Heart,LOCATION_OF,Household composition,32513062,10.1177/0194599820935419,2020-06-10
Halls,TREATS,Family,32513060,10.1177/0194599820934776,2020-06-10
Membrane,PART_OF,Tympanic membrane structure,32513054,10.1177/0194599820934775,2020-06-10
Otoscopes,USES,Smartphone,32513054,10.1177/0194599820934775,2020-06-10
Membrane,PART_OF,Tympanic membrane structure,32513054,10.1177/0194599820934775,2020-06-10
Otoscopes,USES,"Drugs, Non-Prescription",32513054,10.1177/0194599820934775,2020-06-10
Oral cavity,LOCATION_OF,Coughing,32512988,10.4081/monaldi.2020.1323,2020-06-10
Pulmonary Valve Insufficiency,PROCESS_OF,Patients,32512950,10.3390/microorganisms8060850,2020-06-10
Nasal Cannula,TREATS,Disease,32512950,10.3390/microorganisms8060850,2020-06-10
Nasal Cannula,TREATS(SPEC),Coronavirus Infections,32512950,10.3390/microorganisms8060850,2020-06-10
Continuous Positive Airway Pressure,TREATS,Disease,32512950,10.3390/microorganisms8060850,2020-06-10
Continuous Positive Airway Pressure,TREATS(SPEC),Coronavirus Infections,32512950,10.3390/microorganisms8060850,2020-06-10
Coronavirus Infections,ISA,Disease,32512950,10.3390/microorganisms8060850,2020-06-10
Noninvasive Ventilation,TREATS,Disease,32512950,10.3390/microorganisms8060850,2020-06-10
Noninvasive Ventilation,TREATS(SPEC),Coronavirus Infections,32512950,10.3390/microorganisms8060850,2020-06-10
Warburg Therapy,TREATS,Respiratory Failure,32512950,10.3390/microorganisms8060850,2020-06-10
Warburg Therapy,USES,Nasal Cannula,32512950,10.3390/microorganisms8060850,2020-06-10
Clinician,DIAGNOSES,Respiratory Failure,32512950,10.3390/microorganisms8060850,2020-06-10
Human coronavirus,CAUSES,Respiratory Tract Infections,32512929,10.3390/v12060614,2020-06-10
Chloroquine,ISA,Antiparasitic Agents,32512929,10.3390/v12060614,2020-06-10
Asymptomatic,PROCESS_OF,Persons,32512929,10.3390/v12060614,2020-06-10
Virus,PROCESS_OF,general population,32512826,10.3390/ijerph17113986,2020-06-10
Respiratory viruses,PROCESS_OF,Health Personnel,32512826,10.3390/ijerph17113986,2020-06-10
Virus,PROCESS_OF,World,32512702,10.3390/brainsci10060345,2020-06-10
Health Authority,LOCATION_OF,Observation in research,32512702,10.3390/brainsci10060345,2020-06-10
Neurologists,LOCATION_OF,Reading Frames (Nucleotide Sequence),32512688,10.3390/jcm9061733,2020-06-10
Patient Care Management,PREVENTS,Severe Acute Respiratory Syndrome,32512688,10.3390/jcm9061733,2020-06-10
Multiple Sclerosis,ISA,Autoimmune Diseases,32512688,10.3390/jcm9061733,2020-06-10
Multiple Sclerosis,PROCESS_OF,Persons,32512688,10.3390/jcm9061733,2020-06-10
Fever,ISA,Symptoms,32512673,10.3906/sag-2005-287,2020-06-10
Comorbidity,PROCESS_OF,Patients,32512673,10.3906/sag-2005-287,2020-06-10
Abnormal,PROCESS_OF,Patients,32512673,10.3906/sag-2005-287,2020-06-10
Fatal Outcome,PROCESS_OF,Patients,32512673,10.3906/sag-2005-287,2020-06-10
Body tissue,LOCATION_OF,ACE2 gene,32512670,10.4178/epih.e2020028,2020-06-10
Severe course,PROCESS_OF,Patients,32512670,10.4178/epih.e2020028,2020-06-10
Fever,ISA,Symptoms,32512670,10.4178/epih.e2020028,2020-06-10
Quarantine,PREVENTS,Communicable Diseases,32512635,10.1111/tbed.13662,2020-06-09
Isolation procedure,PREVENTS,Communicable Diseases,32512635,10.1111/tbed.13662,2020-06-09
Quarantine,PREVENTS,Communicable Diseases,32512635,10.1111/tbed.13662,2020-06-09
Isolation procedure,PREVENTS,Communicable Diseases,32512635,10.1111/tbed.13662,2020-06-09
Quarantine,AFFECTS,Health Personnel,32512635,10.1111/tbed.13662,2020-06-09
Quarantine,AFFECTS,Patients,32512635,10.1111/tbed.13662,2020-06-09
Quarantine,AFFECTS,Informal carer,32512635,10.1111/tbed.13662,2020-06-09
Isolation procedure,AFFECTS,Health Personnel,32512635,10.1111/tbed.13662,2020-06-09
Isolation procedure,AFFECTS,Patients,32512635,10.1111/tbed.13662,2020-06-09
Isolation procedure,AFFECTS,Informal carer,32512635,10.1111/tbed.13662,2020-06-09
Mental health problem,PROCESS_OF,Health Personnel,32512635,10.1111/tbed.13662,2020-06-09
Mental health problem,PROCESS_OF,Patients,32512635,10.1111/tbed.13662,2020-06-09
Mental health problem,PROCESS_OF,Informal carer,32512635,10.1111/tbed.13662,2020-06-09
Anxiety,ISA,Mood Disorders,32512635,10.1111/tbed.13662,2020-06-09
Mental health problem,PROCESS_OF,Persons,32512635,10.1111/tbed.13662,2020-06-09
Mental health problem,PROCESS_OF,Persons,32512635,10.1111/tbed.13662,2020-06-09
Iran,ISA,Country,32512611,10.1055/a-1172-1352,2020-06-09
Level of anxiety,PROCESS_OF,general population,32512611,10.1055/a-1172-1352,2020-06-09
Masks,PREVENTS,Severe Acute Respiratory Syndrome,32512611,10.1055/a-1172-1352,2020-06-09
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Social stigmata,32512611,10.1055/a-1172-1352,2020-06-09
Euphoric mood,PROCESS_OF,Respondents,32512611,10.1055/a-1172-1352,2020-06-09
Endocrine System Diseases,PROCESS_OF,Persons,32512579,10.1038/s41586-020-2405-7,2020-06-09
Endocrine System Diseases,PROCESS_OF,Persons,32512579,10.1038/s41586-020-2405-7,2020-06-09
Symptom mild,PROCESS_OF,Patients,32512530,10.1016/j.ajp.2020.102188,2020-06-09
Coronavirus Infections,ISA,Disease,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Coronavirus Infections,ISA,Disease,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Coughing,ISA,Symptoms,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Coughing,PROCESS_OF(SPEC),Persons,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Fever,ISA,Symptoms,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Fever,PROCESS_OF(SPEC),Persons,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Headache,NEG_PROCESS_OF,general population,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Sleep disturbances,NEG_PROCESS_OF,general population,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Infected,PROCESS_OF,Persons,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Symptoms,PROCESS_OF,Persons,32512494,10.1016/j.mehy.2020.109946,2020-06-09
Influenzal respiratory infection,PROCESS_OF,hospitalized patients,32512493,10.1016/j.mehy.2020.109934,2020-06-09
Nutritional status,PROCESS_OF,Old age,32512493,10.1016/j.mehy.2020.109934,2020-06-09
cytokine,DISRUPTS,Abnormality of the immune system,32512491,10.1016/j.mehy.2020.109918,2020-06-09
Coronavirus Infections,PROCESS_OF,Patients,32512491,10.1016/j.mehy.2020.109918,2020-06-09
Phosphoric Acid Esters,STIMULATES,Protein Kinases,32512491,10.1016/j.mehy.2020.109918,2020-06-09
leptin,INTERACTS_WITH,cytokine,32512491,10.1016/j.mehy.2020.109918,2020-06-09
Symptoms,COEXISTS_WITH,Coronavirus Infections,32512491,10.1016/j.mehy.2020.109918,2020-06-09
Erythrocyte Membrane,LOCATION_OF,"Receptor, Angiotensin II",32512490,10.1016/j.mehy.2020.109848,2020-06-09
complement pathway,COEXISTS_WITH,Decompression Sickness,32512490,10.1016/j.mehy.2020.109848,2020-06-09
Zinc supplement,AUGMENTS,Immunity,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Immune System Processes,AFFECTS,Cell physiology,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Hepatitis C,PROCESS_OF,Patients,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Standard of Care,TREATS,Patients,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Standard of Care,TREATS(INFER),Hepatitis C,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Zinc,AFFECTS,Virus Internalization,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Orthomyxoviridae,LOCATION_OF,Polyproteins,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Orthomyxoviridae,LOCATION_OF,RNA-Directed RNA Polymerase,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Polyproteins,PART_OF,replicase,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Rhinovirus,LOCATION_OF,Polyproteins,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Rhinovirus,LOCATION_OF,RNA-Directed RNA Polymerase,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Zinc,DISRUPTS,Virus Replication,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Hepatitis C virus,LOCATION_OF,Polyproteins,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Hepatitis C virus,LOCATION_OF,RNA-Directed RNA Polymerase,32512479,10.1016/j.clinimag.2020.05.032,2020-06-09
Epilepsy,PROCESS_OF,Adult,32512463,10.1016/j.legalmed.2020.101718,2020-06-09
Epilepsy,PROCESS_OF,Child,32512463,10.1016/j.legalmed.2020.101718,2020-06-09
Hospitalization,NEG_TREATS,Patients,32512463,10.1016/j.legalmed.2020.101718,2020-06-09
Sharing (Social Behavior),ISA,Behavior,32512386,10.1016/j.isci.2020.101212,2020-06-09
SARS coronavirus,ISA,Betacoronavirus,32512383,10.1016/j.isci.2020.101215,2020-06-09
SARS coronavirus,PROCESS_OF,Chiroptera,32512383,10.1016/j.isci.2020.101215,2020-06-09
SARS coronavirus,PROCESS_OF,Chiroptera,32512383,10.1016/j.isci.2020.101215,2020-06-09
Clinical act of insertion,USES,Amino Acids,32512383,10.1016/j.isci.2020.101215,2020-06-09
paired basic amino acid cleaving enzyme,ISA,Endopeptidases,32512383,10.1016/j.isci.2020.101215,2020-06-09
Lung,LOCATION_OF,Storm NOS,32512381,10.1016/j.scitotenv.2020.139864,2020-06-09
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32512381,10.1016/j.scitotenv.2020.139864,2020-06-09
Storm NOS,DISRUPTS,Immune Cell,32512381,10.1016/j.scitotenv.2020.139864,2020-06-09
Virus,INTERACTS_WITH,"Respiratory Distress Syndrome, Adult",32512381,10.1016/j.scitotenv.2020.139864,2020-06-09
Test kit,USES,"Lights, manufactured",32512362,10.1016/j.scitotenv.2020.139825,2020-06-09
Nasal Swab (procedure),DIAGNOSES,Hypersensitivity,32512362,10.1016/j.scitotenv.2020.139825,2020-06-09
Coronavirus Infections,ISA,Disease,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Invasive Streptococcus pneumoniae disease,ISA,Disease,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Coronavirus Infections,ISA,Disease,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Coronavirus Infections,COEXISTS_WITH,Disease,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Coronavirus Infections,ISA,Disease,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Proteins,ASSOCIATED_WITH,disease transmission,32512357,10.1016/j.psychres.2020.113172,2020-06-09
Anxiety,PROCESS_OF,Young Adult,32512349,10.1016/j.jcrc.2020.05.017,2020-06-09
Depressive disorder,PROCESS_OF,Young Adult,32512349,10.1016/j.jcrc.2020.05.017,2020-06-09
Post-Traumatic Stress Disorder,PROCESS_OF,Young Adult,32512349,10.1016/j.jcrc.2020.05.017,2020-06-09
High Level,PROCESS_OF,Respondents,32512349,10.1016/j.jcrc.2020.05.017,2020-06-09
Clinical Management,TREATS,Mental health problem,32512349,10.1016/j.jcrc.2020.05.017,2020-06-09
Critical Illness,PROCESS_OF,Patients,32512291,10.1016/j.ahj.2020.05.010,2020-06-09
Infected,PROCESS_OF,Patients,32512290,10.1016/j.mehy.2020.109893,2020-06-09
angiotensin II,AFFECTS,Permeability,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Angiotensin II receptor antagonist,PREVENTS,Acute Lung Injury,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Angiotensin II receptor antagonist,TREATS,Patients,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Infected,PROCESS_OF,Patients,32512290,10.1016/j.mehy.2020.109893,2020-06-09
valsartan,compared_with,Placebos,32512290,10.1016/j.mehy.2020.109893,2020-06-09
"CD69 protein, human",INTERACTS_WITH,valsartan,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Cessation of life,AFFECTS,hospitalized patients,32512290,10.1016/j.mehy.2020.109893,2020-06-09
valsartan,compared_with,Placebos,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Infected,PROCESS_OF,hospitalized patients,32512290,10.1016/j.mehy.2020.109893,2020-06-09
Coronavirus Infections,ISA,Disease,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Proteins,PREDISPOSES,Communicable Diseases,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Proteins,PREDISPOSES,Noncommunicable Diseases,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Communicable Diseases,ISA,Disease,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Coronavirus Infections,ISA,Disease,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Acute respiratory infections,ISA,Communicable Diseases,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Proprotein,AFFECTS,Biologic Development,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Proprotein,PART_OF,Family,32512289,10.1016/j.mehy.2020.109884,2020-06-09
paired basic amino acid cleaving enzyme,STIMULATES,Glycoproteins,32512289,10.1016/j.mehy.2020.109884,2020-06-09
paired basic amino acid cleaving enzyme,ADMINISTERED_TO,Cells,32512289,10.1016/j.mehy.2020.109884,2020-06-09
Infected,PROCESS_OF,Homo sapiens,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Disease,COMPLICATES,Septicemia,32512271,10.1016/j.intimp.2020.106654,2020-06-09
"M Protein, multiple myeloma",AUGMENTS,Virus Diseases,32512271,10.1016/j.intimp.2020.106654,2020-06-09
immunoglobulin complex,PART_OF,Virus,32512271,10.1016/j.intimp.2020.106654,2020-06-09
DNA Sequence,PART_OF,Virus,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Disease,PROCESS_OF,Child,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Vaccines,STIMULATES,Virus-neutralizing Antibody,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Evaluation,TREATS,Patients,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Vaccines,AUGMENTS,Humoral Immunity,32512271,10.1016/j.intimp.2020.106654,2020-06-09
Vaccines,PREVENTS,Severe Acute Respiratory Syndrome,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,PART_OF,Mammals,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,PART_OF,yolk,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,ISA,Antibodies,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,PART_OF(SPEC),yolk,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
yolk,PART_OF,Ovum,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Virus Diseases,PROCESS_OF,Animals,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Virus Diseases,PROCESS_OF,Homo sapiens,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,ISA,Antibodies,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,INTERACTS_WITH,IgY,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,INTERACTS_WITH,Specific antigen,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,PART_OF,Mammals,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Antibodies,PART_OF,yolk,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,INTERACTS_WITH(SPEC),Specific antigen,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,ISA,Antibodies,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,PART_OF(SPEC),yolk,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
IgY,compared_with,Specific antigen,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Monoclonal Antibodies,PART_OF,yolk,32512263,10.1016/j.semarthrit.2020.05.010,2020-06-09
Rheumatism,PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Rheumatism,PROCESS_OF,inpatient,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
"Pneumonia, Viral",PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Respiratory complication,PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Exacerbation,PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Rheumatism,PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Hydroxychloroquine,INHIBITS,,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Virus Diseases,PROCESS_OF,Patients,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
tocilizumab,INHIBITS,,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
rituximab,COMPLICATES,Virus Diseases,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
secukinumab,COMPLICATES,Virus Diseases,32512244,10.1016/j.wneu.2020.05.263,2020-06-09
Mixed anxiety and depressive disorder,PROCESS_OF,Neurosurgeon,32512241,10.1016/j.wneu.2020.05.251,2020-06-09
Depressive disorder,PROCESS_OF,Neurosurgeon,32512241,10.1016/j.wneu.2020.05.251,2020-06-09
Headache,PROCESS_OF,Neurosurgeon,32512241,10.1016/j.wneu.2020.05.251,2020-06-09
Depressive disorder,PROCESS_OF,Neurosurgeon,32512241,10.1016/j.wneu.2020.05.251,2020-06-09
Depressive disorder,PROCESS_OF,Neurosurgeon,32512241,10.1016/j.wneu.2020.05.251,2020-06-09
Telemedicine,METHOD_OF,Outpatient visits,32512240,10.1016/j.ijnurstu.2020.103629,2020-06-09
Masks,TREATS,Health Personnel,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Masks,TREATS,Patients,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Masks,TREATS,general population,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Masks,TREATS(INFER),Illness (finding),32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Mechanical Ventilator,TREATS,Health Personnel,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Mechanical Ventilator,TREATS,Patients,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Mechanical Ventilator,TREATS,general population,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Mechanical Ventilator,TREATS(INFER),Illness (finding),32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Illness (finding),PROCESS_OF,Patients,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Illness (finding),PROCESS_OF,Patients,32512197,10.1016/j.accpm.2020.05.012,2020-06-09
Fever,PROCESS_OF,Patients,32512133,10.1016/j.bbi.2020.05.075,2020-06-09
Post-Traumatic Stress Disorder,PROCESS_OF,Male population group,32512133,10.1016/j.bbi.2020.05.075,2020-06-09
Depressive Symptoms,PROCESS_OF,Male population group,32512133,10.1016/j.bbi.2020.05.075,2020-06-09
Mental problem,PROCESS_OF,Medical Staff,32512133,10.1016/j.bbi.2020.05.075,2020-06-09
Sleep,AFFECTS,Immune System Processes,32512122,10.1016/j.pcad.2020.05.013,2020-06-09
Lymphopenia,PROCESS_OF,hospitalized patients,32512122,10.1016/j.pcad.2020.05.013,2020-06-09
Hospitalization,TREATS,Patients,32512122,10.1016/j.pcad.2020.05.013,2020-06-09
Hospitalization,TREATS(INFER),Lymphopenia,32512122,10.1016/j.pcad.2020.05.013,2020-06-09
Lymphopenia,PROCESS_OF,Patients,32512122,10.1016/j.pcad.2020.05.013,2020-06-09
Coronavirus Infections,PROCESS_OF,Patients,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Elevation procedure,TREATS,Patients,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Elevation procedure,TREATS(INFER),Coronavirus Infections,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Inflammation,CAUSES,Myocardial rupture,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Signal Transduction Pathways,PROCESS_OF,"Myocytes, Cardiac",32512110,10.1016/j.urology.2020.05.051,2020-06-09
Storm NOS,CAUSES,Myocarditis,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Troponin,PART_OF,Patients,32512110,10.1016/j.urology.2020.05.051,2020-06-09
myocardial injury,PROCESS_OF,Patients,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Myocardium,LOCATION_OF,diseases and injuries,32512110,10.1016/j.urology.2020.05.051,2020-06-09
Residency,ISA,Training,32512089,10.1016/j.ijbiomac.2020.06.007,2020-06-09
Respondents,USES,Medical Devices,32512073,10.1016/j.radonc.2020.05.044,2020-06-09
Disinfection,PREVENTS,Cross Infection,32512073,10.1016/j.radonc.2020.05.044,2020-06-09
Health Personnel,USES,Medical Devices,32512073,10.1016/j.radonc.2020.05.044,2020-06-09
Experience,PROCESS_OF,Indonesians,32512054,10.1016/j.acap.2020.06.001,2020-06-09
Tracheostomy procedure,TREATS,Patients,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Tracheostomy procedure,TREATS(INFER),Respiratory Failure,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Respiratory Failure,PROCESS_OF,Patients,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Tracheostomy procedure,TREATS,Patients,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Additional comments,PROCESS_OF,Patients,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Interventional procedure,ADMINISTERED_TO,Health Personnel,32511989,10.1016/j.athoracsur.2020.05.017,2020-06-09
Coronavirus Infections,CAUSES,Cessation of life,32511971,10.1016/j.cca.2020.06.009,2020-06-09
Patients,LOCATION_OF,C-reactive protein,32511971,10.1016/j.cca.2020.06.009,2020-06-09
Creatine,compared_with,Fibrin fragment D,32511951,10.1016/S2468-1253(20)30182-5,2020-06-09
Coronavirus Infections,ISA,Disease,32511951,10.1016/S2468-1253(20)30182-5,2020-06-09
Pharmaceutical Preparations,TREATS,Severe disorder,32511867,10.1002/psp4.12537,2020-06-09
Vaccines,TREATS,Severe disorder,32511867,10.1002/psp4.12537,2020-06-09
New medications,TREATS,Disease,32511867,10.1002/psp4.12537,2020-06-09
Proteins,AFFECTS,Virus Replication,32511867,10.1002/psp4.12537,2020-06-09
Macrolide Antibiotics,TREATS,Patients,32511851,10.1111/jopr.13209,2020-06-09
Azithromycin,ISA,Macrolide Antibiotics,32511851,10.1111/jopr.13209,2020-06-09
Azithromycin,TREATS(SPEC),Patients,32511851,10.1111/jopr.13209,2020-06-09
,compared_with,EC90,32511851,10.1111/jopr.13209,2020-06-09
Clinical Trials,USES,Dose Regimen,32511851,10.1111/jopr.13209,2020-06-09
Control Groups,USES,Ethanol 70%,32511834,10.1111/ijcp.13578,2020-06-09
Mechanical Ventilator,compared_with,Masks,32511791,10.1111/jgh.15133,2020-06-09
Mechanical Ventilator,higher_than,Masks,32511791,10.1111/jgh.15133,2020-06-09
Gastrointestinal Diseases,PROCESS_OF,Patients,32511784,10.1111/all.14439,2020-06-09
Gastrointestinal Diseases,PROCESS_OF,Patients,32511784,10.1111/all.14439,2020-06-09
Patients,INTERACTS_WITH,Phasis,32511784,10.1111/all.14439,2020-06-09
Gastrointestinal Diseases,PROCESS_OF,Patients,32511784,10.1111/all.14439,2020-06-09
Birth,COEXISTS_WITH,Acclimatization,32511784,10.1111/all.14439,2020-06-09
Human coronavirus,CAUSES,Respiratory Tract Infections,32511724,10.1093/eurheartj/ehaa462,2020-06-09
Drug Allergy,COEXISTS_WITH,Disease,32511724,10.1093/eurheartj/ehaa462,2020-06-09
Syndrome,PROCESS_OF,Child,32511679,10.1093/cid/ciaa742,2020-06-09
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32511679,10.1093/cid/ciaa742,2020-06-09
Fever,PROCESS_OF,Child,32511679,10.1093/cid/ciaa742,2020-06-09
Symptoms,PROCESS_OF,Child,32511679,10.1093/cid/ciaa742,2020-06-09
Shock,PROCESS_OF,Child,32511679,10.1093/cid/ciaa742,2020-06-09
Coronary Aneurysm,PROCESS_OF,Patients,32511679,10.1093/cid/ciaa742,2020-06-09
PIM1 gene,compared_with,Elevation procedure,32511679,10.1093/cid/ciaa742,2020-06-09
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32511679,10.1093/cid/ciaa742,2020-06-09
Shock,PROCESS_OF,Patients,32511679,10.1093/cid/ciaa742,2020-06-09
Patients,ISA,Persons,32511678,10.1093/ajh/hpaa096,2020-06-09
Immunity,PROCESS_OF,Community,32511678,10.1093/ajh/hpaa096,2020-06-09
Immunity,PROCESS_OF,Persons,32511678,10.1093/ajh/hpaa096,2020-06-09
Hypertensive disease,PROCESS_OF,Patients,32511661,10.1101/2020.04.30.20086652,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,ISA,Antihypertensive Agents,32511661,10.1101/2020.04.30.20086652,2020-06-09
cancer therapy,TREATS,Persons,32511660,10.1101/2020.04.09.20059204,2020-06-09
Pandemics,CAUSES,Coronavirus Infections,32511660,10.1101/2020.04.09.20059204,2020-06-09
Active Method,ADMINISTERED_TO,Participant,32511660,10.1101/2020.04.09.20059204,2020-06-09
Neoplasm Metastasis,PROCESS_OF,Patients,32511660,10.1101/2020.04.09.20059204,2020-06-09
Active Method,TREATS,Malignant Neoplasms,32511660,10.1101/2020.04.09.20059204,2020-06-09
Viral Matrix Proteins,INTERACTS_WITH,"ACE2 protein, human",32511659,10.1101/2020.04.10.20060863,2020-06-09
Myocardial specimen,PART_OF,Homo sapiens,32511659,10.1101/2020.04.10.20060863,2020-06-09
Infected,PROCESS_OF,Persons,32511658,10.1101/2020.04.20.20072702,2020-06-09
Disease,PROCESS_OF,hospitalized patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Coronavirus Infections,ISA,Disease,32511657,10.1101/2020.04.28.20083691,2020-06-09
Coronavirus Infections,ISA,Disease,32511657,10.1101/2020.04.28.20083691,2020-06-09
Coronavirus Infections,PROCESS_OF(SPEC),hospitalized patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Elevation procedure,USES,Troponin,32511657,10.1101/2020.04.28.20083691,2020-06-09
Patient in hospital,PROCESS_OF,Cohort,32511657,10.1101/2020.04.28.20083691,2020-06-09
myocardial injury,PROCESS_OF,Cohort,32511657,10.1101/2020.04.28.20083691,2020-06-09
myocardial injury,PROCESS_OF,hospitalized patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Atrial Fibrillation,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Coronary Arteriosclerosis,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Heart failure,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Troponin,ASSOCIATED_WITH(INFER),Atrial Fibrillation,32511657,10.1101/2020.04.28.20083691,2020-06-09
Troponin,ASSOCIATED_WITH(INFER),Coronary Arteriosclerosis,32511657,10.1101/2020.04.28.20083691,2020-06-09
Troponin,ASSOCIATED_WITH(INFER),Heart failure,32511657,10.1101/2020.04.28.20083691,2020-06-09
Troponin,PART_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Cessation of life,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Coronavirus Infections,ISA,Disease,32511657,10.1101/2020.04.28.20083691,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Disease,32511657,10.1101/2020.04.28.20083691,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH(SPEC),Coronavirus Infections,32511657,10.1101/2020.04.28.20083691,2020-06-09
Cardiovascular Diseases,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
myocardial injury,ISA,Cardiovascular Diseases,32511657,10.1101/2020.04.28.20083691,2020-06-09
myocardial injury,PROCESS_OF,Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
myocardial injury,PROCESS_OF(SPEC),Patients,32511657,10.1101/2020.04.28.20083691,2020-06-09
Elevation procedure,USES,Troponin,32511657,10.1101/2020.04.28.20083691,2020-06-09
Infected,PROCESS_OF,Persons,32511656,10.1101/2020.05.02.20084673,2020-06-09
Inflammation,PROCESS_OF,Runaways,32511655,10.1101/2020.04.19.20062117,2020-06-09
Severe (severity modifier),PROCESS_OF,Drivers of Vehicles,32511655,10.1101/2020.04.19.20062117,2020-06-09
Inflammation,COEXISTS_WITH,Severe disorder,32511655,10.1101/2020.04.19.20062117,2020-06-09
Therapeutic procedure,TREATS,Inflammation,32511655,10.1101/2020.04.19.20062117,2020-06-09
,INHIBITS,CD8A wt Allele,32511655,10.1101/2020.04.19.20062117,2020-06-09
Interleukin-6,INHIBITS,CD8A wt Allele,32511655,10.1101/2020.04.19.20062117,2020-06-09
Plasma,LOCATION_OF,Interleukin-6,32511655,10.1101/2020.04.19.20062117,2020-06-09
Plasma,LOCATION_OF,Interleukin-6,32511655,10.1101/2020.04.19.20062117,2020-06-09
CD4/CD8 ratio procedure,DIAGNOSES,Viremia,32511655,10.1101/2020.04.19.20062117,2020-06-09
Plasma,LOCATION_OF,Interleukin-6,32511655,10.1101/2020.04.19.20062117,2020-06-09
Cell cluster,LOCATION_OF,Interleukin-6,32511655,10.1101/2020.04.19.20062117,2020-06-09
Cell cluster,PRODUCES,Interferons,32511655,10.1101/2020.04.19.20062117,2020-06-09
Cell cluster,PRODUCES,Interleukin-6,32511655,10.1101/2020.04.19.20062117,2020-06-09
ACE2 gene,PART_OF,X Chromosome,32511653,10.1101/2020.04.24.20078204,2020-06-09
Hypomethylation,PROCESS_OF,ACE2 gene,32511653,10.1101/2020.04.24.20078204,2020-06-09
Demethylation,PROCESS_OF,Patients,32511653,10.1101/2020.04.24.20078204,2020-06-09
Disease remission,PROCESS_OF,Patients,32511653,10.1101/2020.04.24.20078204,2020-06-09
Coronavirus Infections,CAUSES,Growth,32511651,10.1101/2020.04.05.20054502,2020-06-09
Resident (physician),LOCATION_OF,IMPACT gene,32511651,10.1101/2020.04.05.20054502,2020-06-09
Mechanical ventilation,COEXISTS_WITH,Hospitalization,32511649,10.1101/2020.04.03.20050195,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32511649,10.1101/2020.04.03.20050195,2020-06-09
Assay,USES,PCR test for SARS,32511648,10.1101/2020.03.23.20041814,2020-06-09
South Korea,ISA,Country,32511647,10.1101/2020.04.26.20079756,2020-06-09
African American,ISA,Ethnic group,32511646,10.1101/2020.04.19.20071944,2020-06-09
Disease,PROCESS_OF,Patients,32511643,10.1101/2020.04.08.20057067,2020-06-09
Infected,PROCESS_OF,Patients,32511643,10.1101/2020.04.08.20057067,2020-06-09
Middle Aged,ISA,Persons,32511642,10.1101/2020.04.27.20082107,2020-06-09
Did not receive therapy or drug for,PROCESS_OF,Patients,32511640,10.1101/2020.04.22.20075416,2020-06-09
Virus,PROCESS_OF,Patients,32511640,10.1101/2020.04.22.20075416,2020-06-09
Serum,LOCATION_OF,Sodium,32511639,10.1101/2020.04.17.20069930,2020-06-09
RNA Sequence,ISA,Base Sequence,32511638,10.1101/2020.04.15.20067157,2020-06-09
RNA Sequence,PART_OF,Cells,32511638,10.1101/2020.04.15.20067157,2020-06-09
Peripheral blood mononuclear cell (cell),PART_OF,Patients,32511638,10.1101/2020.04.15.20067157,2020-06-09
Down-Regulation,PROCESS_OF,Patients,32511638,10.1101/2020.04.15.20067157,2020-06-09
Peripheral,LOCATION_OF,Immune Cell,32511638,10.1101/2020.04.15.20067157,2020-06-09
Acute respiratory failure,PROCESS_OF,Patients,32511638,10.1101/2020.04.15.20067157,2020-06-09
Critical Illness,PROCESS_OF,Adult,32511637,10.1101/2020.04.29.20085233,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511637,10.1101/2020.04.29.20085233,2020-06-09
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32511637,10.1101/2020.04.29.20085233,2020-06-09
Organ,LOCATION_OF,Pulmonary Dysfunction,32511637,10.1101/2020.04.29.20085233,2020-06-09
Chronic lung disease,PROCESS_OF,Patients,32511637,10.1101/2020.04.29.20085233,2020-06-09
Comorbidity,NEG_PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Negative,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Anoxia,NEG_PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Negative,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Cardiovascular Diseases,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
"Diabetes Mellitus, Non-Insulin-Dependent",NEG_PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Negative,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Negative,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Cessation of life,NEG_PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
Symptom severe,PROCESS_OF,Patients,32511636,10.1101/2020.04.29.20085738,2020-06-09
inhibitors,TREATS,Multiple malignancy,32511635,10.1101/2020.04.29.20083717,2020-06-09
Malignant neoplasm of lung,PROCESS_OF,Patients,32511635,10.1101/2020.04.29.20083717,2020-06-09
Acute Lung Injury,PROCESS_OF,Patients,32511635,10.1101/2020.04.29.20083717,2020-06-09
Antibody-Secreting Cells,PRODUCES,Autoantibodies,32511634,10.1101/2020.04.23.20076935,2020-06-09
CXCR5 gene,NEG_PART_OF,Antibody-Secreting Cells,32511634,10.1101/2020.04.23.20076935,2020-06-09
CR2 gene,NEG_PART_OF,Antibody-Secreting Cells,32511634,10.1101/2020.04.23.20076935,2020-06-09
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32511634,10.1101/2020.04.23.20076935,2020-06-09
B-Cell Activation,PROCESS_OF,Patients,32511634,10.1101/2020.04.23.20076935,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511634,10.1101/2020.04.23.20076935,2020-06-09
Targeted Therapy,TREATS,Patients,32511634,10.1101/2020.04.23.20076935,2020-06-09
Health care facility,LOCATION_OF,Data Collection,32511633,10.1101/2020.04.09.20059626,2020-06-09
Hospitalization,TREATS,Patients,32511633,10.1101/2020.04.09.20059626,2020-06-09
Hospitalization,TREATS(INFER),Gastrointestinal symptom,32511633,10.1101/2020.04.09.20059626,2020-06-09
Gastrointestinal symptom,PROCESS_OF,Patients,32511633,10.1101/2020.04.09.20059626,2020-06-09
Nausea,COEXISTS_WITH,Digestive symptom,32511633,10.1101/2020.04.09.20059626,2020-06-09
Vomiting,COEXISTS_WITH,Digestive symptom,32511633,10.1101/2020.04.09.20059626,2020-06-09
Symptom mild,PROCESS_OF,Patients,32511633,10.1101/2020.04.09.20059626,2020-06-09
Digestive symptom,COEXISTS_WITH,assessment.initial,32511633,10.1101/2020.04.09.20059626,2020-06-09
neutrophil,PRODUCES,Chromatin,32511632,10.1101/2020.04.17.20057125,2020-06-09
Lung,LOCATION_OF,Inflammation,32511632,10.1101/2020.04.17.20057125,2020-06-09
Lung,LOCATION_OF,Thrombosis,32511632,10.1101/2020.04.17.20057125,2020-06-09
Lung,PART_OF,Patients,32511632,10.1101/2020.04.17.20057125,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511632,10.1101/2020.04.17.20057125,2020-06-09
Patients,LOCATION_OF,Serum,32511632,10.1101/2020.04.17.20057125,2020-06-09
Cell-Free DNA,COEXISTS_WITH,DNA,32511632,10.1101/2020.04.17.20057125,2020-06-09
Mechanical ventilation,ADMINISTERED_TO,hospitalized patients,32511632,10.1101/2020.04.17.20057125,2020-06-09
Persons,LOCATION_OF,Serum,32511632,10.1101/2020.04.17.20057125,2020-06-09
High Level,PROCESS_OF,Patients,32511632,10.1101/2020.04.17.20057125,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
Severe disorder,PROCESS_OF,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
alteplase,ADMINISTERED_TO,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
Pneumonia,PROCESS_OF,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
Shock,PROCESS_OF,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
Respiratory Failure,PROCESS_OF,Patients,32511631,10.1101/2020.02.04.20020479,2020-06-09
Lung,LOCATION_OF,Microthrombus,32511631,10.1101/2020.02.04.20020479,2020-06-09
Pneumonia,CAUSES,endothelial dysfunction,32511631,10.1101/2020.02.04.20020479,2020-06-09
Pneumonia,CAUSES,Respiratory Failure,32511631,10.1101/2020.02.04.20020479,2020-06-09
Country,ISA,Geographic Locations,32511630,10.1101/2020.03.25.20043828,2020-06-09
Pacific Northwest,ISA,Geographic Locations,32511629,10.1101/2020.05.30.20117788,2020-06-09
Reproductive History,COEXISTS_WITH,Coronavirus Infections,32511628,10.1101/2020.06.04.20122044,2020-06-09
Reproductive History,COEXISTS_WITH,Coronavirus Infections,32511628,10.1101/2020.06.04.20122044,2020-06-09
Homo sapiens,ISA,Animals,32511628,10.1101/2020.06.04.20122044,2020-06-09
Reproductive History,COEXISTS_WITH,Coronavirus Infections,32511628,10.1101/2020.06.04.20122044,2020-06-09
Reproductive History,COEXISTS_WITH,Coronavirus Infections,32511628,10.1101/2020.06.04.20122044,2020-06-09
Reproductive History,COEXISTS_WITH,Coronavirus Infections,32511628,10.1101/2020.06.04.20122044,2020-06-09
Evaluation,COEXISTS_WITH,gene therapy,32511628,10.1101/2020.06.04.20122044,2020-06-09
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32511627,10.1101/2020.03.21.20040261,2020-06-09
Obesity,PROCESS_OF,Persons,32511627,10.1101/2020.03.21.20040261,2020-06-09
Serum,ASSOCIATED_WITH,High Level,32511627,10.1101/2020.03.21.20040261,2020-06-09
Serum,LOCATION_OF,ACE2 gene,32511627,10.1101/2020.03.21.20040261,2020-06-09
Smoker,PROCESS_OF,Patients,32511627,10.1101/2020.03.21.20040261,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Disease,PROCESS_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Lung,LOCATION_OF,angiotensin converting enzyme 2,32511626,10.1101/2020.04.04.20052696,2020-06-09
Lung,PART_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Patients,LOCATION_OF,angiotensin converting enzyme 2,32511626,10.1101/2020.04.04.20052696,2020-06-09
Transcriptome,PART_OF,Lung,32511626,10.1101/2020.04.04.20052696,2020-06-09
Transcriptome,PART_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32511626,10.1101/2020.04.04.20052696,2020-06-09
RAB1A gene,AFFECTS,Severe Acute Respiratory Syndrome,32511626,10.1101/2020.04.04.20052696,2020-06-09
Genes,AFFECTS,histone modification,32511626,10.1101/2020.04.04.20052696,2020-06-09
Lung,LOCATION_OF,angiotensin converting enzyme 2,32511626,10.1101/2020.04.04.20052696,2020-06-09
Lung,PART_OF,Homo sapiens,32511626,10.1101/2020.04.04.20052696,2020-06-09
KDM5B gene,STIMULATES,angiotensin converting enzyme 2,32511626,10.1101/2020.04.04.20052696,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511626,10.1101/2020.04.04.20052696,2020-06-09
Pandemics,CAUSES,Toxic Epidermal Necrolysis,32511625,10.1101/2020.04.19.20070995,2020-06-09
Masks,TREATS,general population,32511625,10.1101/2020.04.19.20070995,2020-06-09
Disease,PROCESS_OF,general population,32511625,10.1101/2020.04.19.20070995,2020-06-09
Masks,PREVENTS,Infection,32511625,10.1101/2020.04.19.20070995,2020-06-09
Coronavirus Infections,ISA,Disease,32511625,10.1101/2020.04.19.20070995,2020-06-09
Coronavirus Infections,PROCESS_OF(SPEC),general population,32511625,10.1101/2020.04.19.20070995,2020-06-09
Masks,PREVENTS,Infection,32511625,10.1101/2020.04.19.20070995,2020-06-09
Masks,TREATS,Population Group,32511625,10.1101/2020.04.19.20070995,2020-06-09
Physicians,USES,License,32511622,10.1101/2020.04.16.20065920,2020-06-09
Physicians,USES,License,32511622,10.1101/2020.04.16.20065920,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Physicians,32511622,10.1101/2020.04.16.20065920,2020-06-09
Physicians,USES,License,32511622,10.1101/2020.04.16.20065920,2020-06-09
Physicians,USES,License,32511622,10.1101/2020.04.16.20065920,2020-06-09
Hydroxychloroquine,TREATS,Patients,32511621,10.1101/2020.04.19.20065219,2020-06-09
Medical center,LOCATION_OF,Analysis,32511621,10.1101/2020.04.19.20065219,2020-06-09
Respiration,PROCESS_OF,Patients,32511621,10.1101/2020.04.19.20065219,2020-06-09
Coronavirus Infections,ISA,Disease,32511620,10.1101/2020.03.22.20041145,2020-06-09
Symptoms,PROCESS_OF,Persons,32511620,10.1101/2020.03.22.20041145,2020-06-09
Adult,ISA,Population Group,32511620,10.1101/2020.03.22.20041145,2020-06-09
Fever,ISA,Symptoms,32511620,10.1101/2020.03.22.20041145,2020-06-09
Coughing,PROCESS_OF,Persons,32511620,10.1101/2020.03.22.20041145,2020-06-09
Fever,PROCESS_OF,Persons,32511620,10.1101/2020.03.22.20041145,2020-06-09
Movement,PROCESS_OF,Persons,32511619,10.1101/2020.04.04.20050427,2020-06-09
Infected,PROCESS_OF,Persons,32511619,10.1101/2020.04.04.20050427,2020-06-09
Mutation,PROCESS_OF,Viral Genome,32511619,10.1101/2020.04.04.20050427,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Community,32511617,10.1101/2020.04.04.20053629,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32511617,10.1101/2020.04.04.20053629,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32511617,10.1101/2020.04.04.20053629,2020-06-09
Virus Diseases,PROCESS_OF,Community,32511616,10.1101/2020.04.23.20075796,2020-06-09
High risk of,PROCESS_OF,Older people,32511614,10.1101/2020.04.29.20066506,2020-06-09
Infection,PROCESS_OF,Households,32511614,10.1101/2020.04.29.20066506,2020-06-09
Hospital Administrators,ISA,Health Personnel,32511611,10.1101/2020.04.15.20066746,2020-06-09
Community,LOCATION_OF,Feces,32511610,10.1101/2020.04.08.20058248,2020-06-09
High Level,PROCESS_OF,Population at Risk,32511609,10.1101/2020.04.14.20059501,2020-06-09
Antibodies,PART_OF,Persons,32511608,10.1101/2020.04.19.20069948,2020-06-09
Serum,LOCATION_OF,Antibodies,32511608,10.1101/2020.04.19.20069948,2020-06-09
Serum,PART_OF,Homo sapiens,32511608,10.1101/2020.04.19.20069948,2020-06-09
Bead Dosage Form,INTERACTS_WITH,Streptavidin,32511608,10.1101/2020.04.19.20069948,2020-06-09
Bead Dosage Form,INTERACTS_WITH,Anti-Antibodies,32511608,10.1101/2020.04.19.20069948,2020-06-09
Serum,PART_OF,Persons,32511608,10.1101/2020.04.19.20069948,2020-06-09
Virus,CAUSES,Disease,32511606,10.1101/2020.04.28.20083279,2020-06-09
Virus,CAUSES(SPEC),Coronavirus Infections,32511606,10.1101/2020.04.28.20083279,2020-06-09
Coronavirus Infections,ISA,Disease,32511606,10.1101/2020.04.28.20083279,2020-06-09
Amino-terminal pro-brain natriuretic peptide,ISA,pro-brain natriuretic peptide (1-76),32511606,10.1101/2020.04.28.20083279,2020-06-09
Disease,PROCESS_OF,hospitalized patients,32511606,10.1101/2020.04.28.20083279,2020-06-09
Coronavirus Infections,ISA,Disease,32511606,10.1101/2020.04.28.20083279,2020-06-09
Household composition,PROCESS_OF,Patients,32511606,10.1101/2020.04.28.20083279,2020-06-09
Immunity,PROCESS_OF,Persons,32511604,10.1101/2020.04.15.20064485,2020-06-09
Uncertainty,PROCESS_OF,Human Age Group,32511602,10.1101/2020.03.26.20044750,2020-06-09
medical care,PROCESS_OF,Human Age Group,32511602,10.1101/2020.03.26.20044750,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,german race,32511602,10.1101/2020.03.26.20044750,2020-06-09
Influenza,ISA,Respiratory Tract Infections,32511601,10.1101/2020.03.03.20029843,2020-06-09
Influenza,ISA,Symptoms,32511601,10.1101/2020.03.03.20029843,2020-06-09
Isolation procedure,PREVENTS,Infection,32511600,10.1101/2020.04.20.20072470,2020-06-09
Infected,PROCESS_OF,Patients,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,NEG_OCCURS_IN,Cohort,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,NEG_PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,NEG_PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,OCCURS_IN,Cohort,32511599,10.1101/2020.04.23.20076737,2020-06-09
Undiagnosed,PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Infected,PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Hospitals,LOCATION_OF,Laboratory Procedures,32511599,10.1101/2020.04.23.20076737,2020-06-09
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Crisis,32511599,10.1101/2020.04.23.20076737,2020-06-09
risk factors,PROCESS_OF,Health Personnel,32511599,10.1101/2020.04.23.20076737,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511598,10.1101/2020.04.26.20075937,2020-06-09
Critical Illness,PROCESS_OF,Cohort,32511598,10.1101/2020.04.26.20075937,2020-06-09
Critical Illness,PROCESS_OF,Adult,32511598,10.1101/2020.04.26.20075937,2020-06-09
Infection,PROCESS_OF,Adult,32511597,10.1101/2020.04.29.20082065,2020-06-09
SARS coronavirus,PROCESS_OF,Target Population,32511596,10.1101/2020.04.02.20051417,2020-06-09
Infected,PROCESS_OF,Patients,32511595,10.1101/2020.04.09.20059964,2020-06-09
"Transport Media, Viral",USES,Assay,32511592,10.1101/2020.04.29.20085456,2020-06-09
"Transport Media, Viral",AFFECTS,Challenge,32511592,10.1101/2020.04.29.20085456,2020-06-09
Coronavirus Infections,ISA,Disease,32511591,10.1101/2020.04.17.20069641,2020-06-09
Coronavirus Infections,ISA,Disease,32511591,10.1101/2020.04.17.20069641,2020-06-09
Decontamination,USES,Mechanical Ventilator,32511591,10.1101/2020.04.17.20069641,2020-06-09
Decontamination,USES,VPS51 gene,32511591,10.1101/2020.04.17.20069641,2020-06-09
Orthologous Gene,DISRUPTS,Immune,32511590,10.1101/2020.04.11.20056010,2020-06-09
contextual factors,PROCESS_OF,Households,32511589,10.1101/2020.05.05.20075507,2020-06-09
Communicable Diseases,COEXISTS_WITH,Incubation period,32511589,10.1101/2020.05.05.20075507,2020-06-09
Movement,PROCESS_OF,Homo sapiens,32511589,10.1101/2020.05.05.20075507,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32511588,10.1101/2020.04.23.20077545,2020-06-09
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32511588,10.1101/2020.04.23.20077545,2020-06-09
Cameroon,ISA,Geographic Locations,32511587,10.1101/2020.04.15.20064931,2020-06-09
Cessation of life,PROCESS_OF,Patients,32511585,10.1101/2020.03.13.20035568,2020-06-09
Perception,PROCESS_OF,general population,32511584,10.1101/2020.04.01.20050492,2020-06-09
Perception,PROCESS_OF,general population,32511584,10.1101/2020.04.01.20050492,2020-06-09
Household income,PROCESS_OF,Participant,32511584,10.1101/2020.04.01.20050492,2020-06-09
Household income,PROCESS_OF,Participant,32511584,10.1101/2020.04.01.20050492,2020-06-09
care seeking,ISA,Behavior,32511584,10.1101/2020.04.01.20050492,2020-06-09
WASF1 gene,compared_with,WASF1 gene,32511581,10.1101/2020.04.03.20051706,2020-06-09
WASF1 gene,higher_than,WASF1 gene,32511581,10.1101/2020.04.03.20051706,2020-06-09
Analysis,USES,Interventional procedure,32511581,10.1101/2020.04.03.20051706,2020-06-09
Passenger,LOCATION_OF,Viral Genome,32511578,10.1101/2020.04.21.20073890,2020-06-09
California,ISA,Geographic Locations,32511578,10.1101/2020.04.21.20073890,2020-06-09
Health Care Systems,LOCATION_OF,Work,32511576,10.1101/2020.03.20.20039602,2020-06-09
modeling,MEASURES,Ratio,32511574,10.1101/2020.05.08.20095471,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Donor person,32511573,10.1101/2020.05.13.20100925,2020-06-09
Supportive care,ADMINISTERED_TO,Patients,32511573,10.1101/2020.05.13.20100925,2020-06-09
treatment options,TREATS,Severe disorder,32511573,10.1101/2020.05.13.20100925,2020-06-09
Symptom mild,PROCESS_OF,Persons,32511572,10.1101/2020.05.06.20093377,2020-06-09
Infected,PROCESS_OF,Persons,32511572,10.1101/2020.05.06.20093377,2020-06-09
Inflammation,OCCURS_IN,Patients,32511572,10.1101/2020.05.06.20093377,2020-06-09
Severe course,PROCESS_OF,Patients,32511572,10.1101/2020.05.06.20093377,2020-06-09
Lung,PART_OF,Patients,32511572,10.1101/2020.05.06.20093377,2020-06-09
Blood,PART_OF,Patients,32511572,10.1101/2020.05.06.20093377,2020-06-09
"CD69 protein, human",STIMULATES,Dendritic Cells,32511572,10.1101/2020.05.06.20093377,2020-06-09
"CD69 protein, human",STIMULATES,Monocytes,32511572,10.1101/2020.05.06.20093377,2020-06-09
Patients,LOCATION_OF,Blood,32511572,10.1101/2020.05.06.20093377,2020-06-09
Lung,LOCATION_OF,Blood,32511572,10.1101/2020.05.06.20093377,2020-06-09
Patients,ISA,Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
Present,PROCESS_OF,Patients,32511571,10.1101/2020.05.14.20102491,2020-06-09
Present,PROCESS_OF,Population Group,32511571,10.1101/2020.05.14.20102491,2020-06-09
Infected,PROCESS_OF,Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
Human coronavirus,PROCESS_OF,Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
SARS coronavirus,ISA,Human coronavirus,32511571,10.1101/2020.05.14.20102491,2020-06-09
SARS coronavirus,PROCESS_OF,Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
SARS coronavirus,PROCESS_OF(SPEC),Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
Serum,PART_OF,Homo sapiens,32511571,10.1101/2020.05.14.20102491,2020-06-09
Patients,LOCATION_OF,Antibodies,32511571,10.1101/2020.05.14.20102491,2020-06-09
Patients,LOCATION_OF,"Antibodies, Neutralizing",32511571,10.1101/2020.05.14.20102491,2020-06-09
Antibody Formation,PROCESS_OF,Persons,32511571,10.1101/2020.05.14.20102491,2020-06-09
Serum,PART_OF,Patients,32511570,10.1101/2020.05.20.20108159,2020-06-09
Inflammation,AFFECTS,Metabolism,32511570,10.1101/2020.05.20.20108159,2020-06-09
Infected,PROCESS_OF,Patients,32511570,10.1101/2020.05.20.20108159,2020-06-09
nitrogen metabolism,PROCESS_OF,Patients,32511570,10.1101/2020.05.20.20108159,2020-06-09
Tryptophan Metabolite,COEXISTS_WITH,Kynurenine,32511570,10.1101/2020.05.20.20108159,2020-06-09
Homeostasis,PROCESS_OF,Patients,32511570,10.1101/2020.05.20.20108159,2020-06-09
Biological Neural Networks,PROCESS_OF,Siamese,32511569,10.1101/2020.05.29.20117184,2020-06-09
Biological Neural Networks,PROCESS_OF,Siamese,32511569,10.1101/2020.05.29.20117184,2020-06-09
Plasma,ASSOCIATED_WITH,Serious Adverse Event,32511565,10.1101/2020.05.03.20084442,2020-06-09
human plasma,TREATS,Adult,32511565,10.1101/2020.05.03.20084442,2020-06-09
human plasma,TREATS(INFER),Patient in hospital,32511565,10.1101/2020.05.03.20084442,2020-06-09
Patient in hospital,PROCESS_OF,Adult,32511565,10.1101/2020.05.03.20084442,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511565,10.1101/2020.05.03.20084442,2020-06-09
hospitalized patients,LOCATION_OF,Plasma,32511565,10.1101/2020.05.03.20084442,2020-06-09
Antibody Formation,PROCESS_OF,Patients,32511564,10.1101/2020.05.04.20090944,2020-06-09
"Kidney Failure, Acute",COEXISTS_WITH,patient condition,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",AFFECTS,hospitalized patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,hospitalized patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
Coronavirus Infections,ISA,Disease,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
intensive care,ADMINISTERED_TO,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
Dialysis procedure,TREATS,Patients,32511563,10.1101/2020.05.07.20083386,2020-06-09
"Hospitals, Community",LOCATION_OF,Analysis,32511562,10.1101/2020.05.28.20115758,2020-06-09
Academia (organization),LOCATION_OF,Analysis,32511562,10.1101/2020.05.28.20115758,2020-06-09
Percutaneous Coronary Intervention,TREATS,Acute Coronary Syndrome,32511562,10.1101/2020.05.28.20115758,2020-06-09
Cerebrovascular accident,PROCESS_OF,Patients,32511562,10.1101/2020.05.28.20115758,2020-06-09
Acute Coronary Syndrome,PROCESS_OF,Patients,32511562,10.1101/2020.05.28.20115758,2020-06-09
Cessation of life,PROCESS_OF,Patients,32511561,10.1101/2020.05.14.20102038,2020-06-09
Infected,PROCESS_OF,Patients,32511561,10.1101/2020.05.14.20102038,2020-06-09
Serum,LOCATION_OF,Interleukin-6,32511561,10.1101/2020.05.14.20102038,2020-06-09
hospitalized patients,LOCATION_OF,,32511561,10.1101/2020.05.14.20102038,2020-06-09
hospitalized patients,LOCATION_OF,Interleukin-1,32511561,10.1101/2020.05.14.20102038,2020-06-09
hospitalized patients,LOCATION_OF,Interleukin-6,32511561,10.1101/2020.05.14.20102038,2020-06-09
hospitalized patients,LOCATION_OF,Interleukin-8,32511561,10.1101/2020.05.14.20102038,2020-06-09
Serum,LOCATION_OF,Interleukin-6,32511561,10.1101/2020.05.14.20102038,2020-06-09
Serum,LOCATION_OF,Interleukin-6,32511561,10.1101/2020.05.14.20102038,2020-06-09
,PART_OF,Patients,32511561,10.1101/2020.05.14.20102038,2020-06-09
Inflammation,COEXISTS_WITH,Disease,32511561,10.1101/2020.05.14.20102038,2020-06-09
Interleukin-6,PART_OF,Patients,32511561,10.1101/2020.05.14.20102038,2020-06-09
Respiratory sample,PART_OF,Tract,32511560,10.1101/2020.05.05.20092379,2020-06-09
Vaping,ISA,Electronic Cigarette Use,32511559,10.1101/2020.04.12.20062661,2020-06-09
Chest CT,ISA,Evaluation,32511558,10.1101/2020.05.19.20107144,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32511558,10.1101/2020.05.19.20107144,2020-06-09
Radiologic finding,PROCESS_OF,Patients,32511558,10.1101/2020.05.19.20107144,2020-06-09
Reverse Transcriptase Polymerase Chain Reaction,USES,Massively-Parallel Sequencing,32511558,10.1101/2020.05.19.20107144,2020-06-09
Hypersensitivity,PROCESS_OF,Patients,32511558,10.1101/2020.05.19.20107144,2020-06-09
Chicago,ISA,Geographic Locations,32511557,10.1101/2020.05.21.20109116,2020-06-09
Airway structure,PART_OF,Patients,32511557,10.1101/2020.05.21.20109116,2020-06-09
Symptoms,PROCESS_OF,inpatient,32511555,10.1101/2020.05.28.20116301,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Persons,32511555,10.1101/2020.05.28.20116301,2020-06-09
Wells syndrome,PROCESS_OF,inpatient,32511555,10.1101/2020.05.28.20116301,2020-06-09
Symptoms,PROCESS_OF,Outpatients,32511555,10.1101/2020.05.28.20116301,2020-06-09
Eating Disorders,AFFECTS,Persons,32511554,10.1101/2020.05.20.20104398,2020-06-09
Anorexia Nervosa,PROCESS_OF,Participant,32511554,10.1101/2020.05.20.20104398,2020-06-09
Binge eating disorder,PROCESS_OF,Persons,32511554,10.1101/2020.05.20.20104398,2020-06-09
Bulimia Nervosa,PROCESS_OF,Persons,32511554,10.1101/2020.05.20.20104398,2020-06-09
Telemedicine,TREATS,Population Group,32511554,10.1101/2020.05.20.20104398,2020-06-09
Cardiac Arrhythmia,COEXISTS_WITH,Multiple Organ Failure,32511553,10.1101/2020.04.30.20086736,2020-06-09
Complication,COEXISTS_WITH,Multiple Organ Failure,32511553,10.1101/2020.04.30.20086736,2020-06-09
Pulmonary Valve Insufficiency,COEXISTS_WITH,Multiple Organ Failure,32511553,10.1101/2020.04.30.20086736,2020-06-09
Shock,COEXISTS_WITH,Multiple Organ Failure,32511553,10.1101/2020.04.30.20086736,2020-06-09
SARS coronavirus,CAUSES,Disease,32511553,10.1101/2020.04.30.20086736,2020-06-09
Red Blood Cell Count measurement,USES,Flow Cytometry,32511553,10.1101/2020.04.30.20086736,2020-06-09
Complement Activation,PROCESS_OF,Patients,32511553,10.1101/2020.04.30.20086736,2020-06-09
Erythrocytes,LOCATION_OF,Diagnosis,32511553,10.1101/2020.04.30.20086736,2020-06-09
Arteries,LOCATION_OF,American College of Cardiology/American Heart Association Lesion Complexity Score C,32511552,10.1101/2020.05.12.20073577,2020-06-09
Veins,LOCATION_OF,American College of Cardiology/American Heart Association Lesion Complexity Score C,32511552,10.1101/2020.05.12.20073577,2020-06-09
Thrombosis,PROCESS_OF,Patients,32511552,10.1101/2020.05.12.20073577,2020-06-09
Heparinoids,ADMINISTERED_TO,Patients,32511552,10.1101/2020.05.12.20073577,2020-06-09
Serum,PART_OF,Patients,32511552,10.1101/2020.05.12.20073577,2020-06-09
Thrombosis,PROCESS_OF,Patients,32511552,10.1101/2020.05.12.20073577,2020-06-09
Neutrophil Activation,PROCESS_OF,Patients,32511552,10.1101/2020.05.12.20073577,2020-06-09
Patient in hospital,PROCESS_OF,Persons,32511551,10.1101/2020.05.11.20098228,2020-06-09
Placenta,PART_OF,Woman,32511549,10.1101/2020.05.08.20095893,2020-06-09
Stillbirth,PROCESS_OF,Patients,32511549,10.1101/2020.05.08.20095893,2020-06-09
Thrombophilia,AFFECTS,Placental function,32511549,10.1101/2020.05.08.20095893,2020-06-09
Viral Respiratory Tract Infection,COEXISTS_WITH,Vitamin D Deficiency,32511548,10.1101/2020.05.01.20087130,2020-06-09
Lung,LOCATION_OF,tizoxanide,32511547,10.1101/2020.05.17.20104604,2020-06-09
Screening procedure,NEG_TREATS,Chief complaint (finding),32511545,10.1101/2020.05.16.20103408,2020-06-09
Chief complaint (finding),ISA,Symptoms,32511545,10.1101/2020.05.16.20103408,2020-06-09
Asymptomatic,PROCESS_OF,Patients,32511543,10.1101/2020.05.28.20115667,2020-06-09
Influenza,ISA,Disease,32511542,10.1101/2020.05.03.20089151,2020-06-09
Coronavirus Infections,ISA,Disease,32511542,10.1101/2020.05.03.20089151,2020-06-09
Coronavirus Infections,ISA,Disease,32511542,10.1101/2020.05.03.20089151,2020-06-09
Interleukin-6,compared_with,Interleukin-8,32511542,10.1101/2020.05.03.20089151,2020-06-09
Coronavirus Infections,ISA,Disease,32511542,10.1101/2020.05.03.20089151,2020-06-09
Coronavirus Infections,ISA,Disease,32511542,10.1101/2020.05.03.20089151,2020-06-09
Interleukin-6,ASSOCIATED_WITH,Influenza,32511542,10.1101/2020.05.03.20089151,2020-06-09
Interleukin-6,ASSOCIATED_WITH,Coronavirus Infections,32511542,10.1101/2020.05.03.20089151,2020-06-09
anakinra,ASSOCIATED_WITH,Influenza,32511542,10.1101/2020.05.03.20089151,2020-06-09
anakinra,ASSOCIATED_WITH,Coronavirus Infections,32511542,10.1101/2020.05.03.20089151,2020-06-09
Respiratory Failure,COEXISTS_WITH,patient condition,32511542,10.1101/2020.05.03.20089151,2020-06-09
Influenza,PROCESS_OF,Patients,32511542,10.1101/2020.05.03.20089151,2020-06-09
Influenza,PROCESS_OF,Patients,32511542,10.1101/2020.05.03.20089151,2020-06-09
Interleukin-6,PREDISPOSES,Acute respiratory failure,32511542,10.1101/2020.05.03.20089151,2020-06-09
PCR test for SARS,USES,Laboratory Procedures,32511541,10.1101/2020.05.04.20086322,2020-06-09
PCR test for SARS,USES,Assay,32511541,10.1101/2020.05.04.20086322,2020-06-09
Laboratory Procedures,USES,PCR test for SARS,32511541,10.1101/2020.05.04.20086322,2020-06-09
Negative,PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
PCR test for SARS,ISA,Laboratory Procedures,32511541,10.1101/2020.05.04.20086322,2020-06-09
Additional day,NEG_PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
Additional day,PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
Negative,NEG_PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
Negative,NEG_PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
Negative,PROCESS_OF,Patients,32511541,10.1101/2020.05.04.20086322,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511540,10.1101/2020.05.06.20093070,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511540,10.1101/2020.05.06.20093070,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511540,10.1101/2020.05.06.20093070,2020-06-09
Hospitalization,TREATS,Patients,32511540,10.1101/2020.05.06.20093070,2020-06-09
Hospitalization,TREATS,Patients,32511539,10.1101/2020.05.02.20088872,2020-06-09
Serum,LOCATION_OF,Leukocyte L1 Antigen Complex,32511539,10.1101/2020.05.02.20088872,2020-06-09
Chloroquine,TREATS,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Chloroquine,TREATS(SPEC),Coronavirus Infections,32511538,10.1101/2020.05.27.20114090,2020-06-09
Coronavirus Infections,ISA,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Hydroxychloroquine,compared_with,Placebos,32511538,10.1101/2020.05.27.20114090,2020-06-09
Chloroquine,TREATS,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Hydroxychloroquine,TREATS,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Chloroquine,ADMINISTERED_TO,Participant,32511538,10.1101/2020.05.27.20114090,2020-06-09
Chloroquine,compared_with,Placebos,32511538,10.1101/2020.05.27.20114090,2020-06-09
Placebos,ADMINISTERED_TO,Participant,32511538,10.1101/2020.05.27.20114090,2020-06-09
Participant,LOCATION_OF,AES gene,32511538,10.1101/2020.05.27.20114090,2020-06-09
AES gene,PART_OF,Eye,32511538,10.1101/2020.05.27.20114090,2020-06-09
Chloroquine,ADMINISTERED_TO,Participant,32511538,10.1101/2020.05.27.20114090,2020-06-09
Hydroxychloroquine,ADMINISTERED_TO,Participant,32511538,10.1101/2020.05.27.20114090,2020-06-09
Placebos,ADMINISTERED_TO,Participant,32511538,10.1101/2020.05.27.20114090,2020-06-09
Pharmaceutical Preparations,TREATS,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32511538,10.1101/2020.05.27.20114090,2020-06-09
Coronavirus Infections,ISA,Disease,32511538,10.1101/2020.05.27.20114090,2020-06-09
Pneumonia,PROCESS_OF,Patients,32511537,10.1101/2020.05.24.20112300,2020-06-09
Assisted breathing,TREATS,Patients,32511537,10.1101/2020.05.24.20112300,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511537,10.1101/2020.05.24.20112300,2020-06-09
Standard of Care,ADMINISTERED_TO,Patients,32511537,10.1101/2020.05.24.20112300,2020-06-09
Standard of Care,TREATS,"Respiratory Distress Syndrome, Adult",32511537,10.1101/2020.05.24.20112300,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511537,10.1101/2020.05.24.20112300,2020-06-09
Immunity,PROCESS_OF,Population Group,32511536,10.1101/2020.05.06.20092841,2020-06-09
saliva,NEG_PART_OF,Specimen Type - Serum,32511536,10.1101/2020.05.06.20092841,2020-06-09
Participant,LOCATION_OF,saliva,32511536,10.1101/2020.05.06.20092841,2020-06-09
Participant,LOCATION_OF,Specimen Type - Serum,32511536,10.1101/2020.05.06.20092841,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Participant,32511536,10.1101/2020.05.06.20092841,2020-06-09
Specimen Type - Serum,NEG_PART_OF,saliva,32511536,10.1101/2020.05.06.20092841,2020-06-09
Immunoenzyme Procedure,USES,Antibodies,32511536,10.1101/2020.05.06.20092841,2020-06-09
Detection,USES,Immunoglobulin Isotypes,32511536,10.1101/2020.05.06.20092841,2020-06-09
High sensitivity,DIAGNOSES,Severe Acute Respiratory Syndrome,32511536,10.1101/2020.05.06.20092841,2020-06-09
saliva,LOCATION_OF,,32511536,10.1101/2020.05.06.20092841,2020-06-09
Serum,LOCATION_OF,,32511536,10.1101/2020.05.06.20092841,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32511536,10.1101/2020.05.06.20092841,2020-06-09
Cross Reactions,PROCESS_OF,B-Lymphocytes,32511536,10.1101/2020.05.06.20092841,2020-06-09
saliva,LOCATION_OF,,32511536,10.1101/2020.05.06.20092841,2020-06-09
Serum,LOCATION_OF,,32511536,10.1101/2020.05.06.20092841,2020-06-09
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32511533,10.1101/2020.05.01.20088054,2020-06-09
Severe Acute Respiratory Syndrome,AFFECTS,Hypoxemia,32511533,10.1101/2020.05.01.20088054,2020-06-09
Nitric Oxide,ISA,Gases,32511533,10.1101/2020.05.01.20088054,2020-06-09
Nitric Oxide,TREATS,Hypoxemia,32511533,10.1101/2020.05.01.20088054,2020-06-09
Alveolar ventilation function,PROCESS_OF,Patients,32511533,10.1101/2020.05.01.20088054,2020-06-09
"CD69 protein, human",AFFECTS,Alveolar ventilation function,32511533,10.1101/2020.05.01.20088054,2020-06-09
Laboratory Procedures,USES,PCR test for SARS,32511533,10.1101/2020.05.01.20088054,2020-06-09
PCR test for SARS,ISA,Laboratory Procedures,32511533,10.1101/2020.05.01.20088054,2020-06-09
Virus,PROCESS_OF,Cohort,32511532,10.1101/2020.05.03.20086819,2020-06-09
Family,LOCATION_OF,Alleles,32511532,10.1101/2020.05.03.20086819,2020-06-09
Infected,PROCESS_OF,Persons,32511529,10.1101/2020.05.29.20116004,2020-06-09
Pharmaceutical Preparations,CAUSES,cardiac event,32511527,10.1101/2020.05.18.20105494,2020-06-09
Chloroquine,INTERACTS_WITH,Pharmaceutical Preparations,32511527,10.1101/2020.05.18.20105494,2020-06-09
Azithromycin,INTERACTS_WITH,Pharmaceutical Preparations,32511527,10.1101/2020.05.18.20105494,2020-06-09
Ritonavir,INTERACTS_WITH,Pharmaceutical Preparations,32511527,10.1101/2020.05.18.20105494,2020-06-09
lopinavir,INTERACTS_WITH,Pharmaceutical Preparations,32511527,10.1101/2020.05.18.20105494,2020-06-09
Heart,LOCATION_OF,Adverse event,32511527,10.1101/2020.05.18.20105494,2020-06-09
Therapeutic procedure,CAUSES,Adverse event,32511527,10.1101/2020.05.18.20105494,2020-06-09
Muscle Cells,PART_OF,Heart Ventricle,32511527,10.1101/2020.05.18.20105494,2020-06-09
Drug Combinations,compared_with,Pharmaceutical Preparations,32511527,10.1101/2020.05.18.20105494,2020-06-09
Influenza,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Ischemic stroke,32511526,10.1101/2020.05.15.20103655,2020-06-09
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Ischemic stroke,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Cerebrovascular accident,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Influenza,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Influenza,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Ischemic stroke,PROCESS_OF,Patients,32511526,10.1101/2020.05.15.20103655,2020-06-09
Drug Overdose,CAUSES,hiv-infection/aids,32511524,10.1101/2020.05.12.20099135,2020-06-09
IMPACT gene,AUGMENTS,Cessation of life,32511524,10.1101/2020.05.12.20099135,2020-06-09
African race,ISA,Ethnic group,32511523,10.1101/2020.04.30.20087015,2020-06-09
Complication,AFFECTS,health and disease,32511521,10.1101/2020.05.04.20091231,2020-06-09
Hypertensive disease,PREDISPOSES,Complication,32511521,10.1101/2020.05.04.20091231,2020-06-09
Negative,PROCESS_OF,Patients,32511520,10.1101/2020.05.19.20103036,2020-06-09
Disease,AFFECTS,Patients,32511519,10.1101/2020.04.24.20078576,2020-06-09
avoidance,PROCESS_OF,Patients,32511517,10.1101/2020.04.30.20077594,2020-06-09
Emergency medical service,TREATS,Hypoxemia,32511517,10.1101/2020.04.30.20077594,2020-06-09
Hypoxemia,PROCESS_OF,Patients,32511517,10.1101/2020.04.30.20077594,2020-06-09
Respiratory tract structure,PART_OF,Donor person,32511515,10.1101/2020.05.21.20051300,2020-06-09
Organelles,LOCATION_OF,angiotensin converting enzyme 2,32511515,10.1101/2020.05.21.20051300,2020-06-09
Organelles,PART_OF,Cilia,32511515,10.1101/2020.05.21.20051300,2020-06-09
Organelles,PART_OF,Ciliated epithelial cell,32511515,10.1101/2020.05.21.20051300,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,angiotensin converting enzyme 2,32511515,10.1101/2020.05.21.20051300,2020-06-09
Cilia,LOCATION_OF,angiotensin converting enzyme 2,32511515,10.1101/2020.05.21.20051300,2020-06-09
Angiotensin II receptor antagonist,STIMULATES,angiotensin converting enzyme 2,32511515,10.1101/2020.05.21.20051300,2020-06-09
Complication,CAUSES,Cessation of life,32511514,10.1101/2020.05.13.20087734,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511514,10.1101/2020.05.13.20087734,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511514,10.1101/2020.05.13.20087734,2020-06-09
Blood,PART_OF,Patients,32511514,10.1101/2020.05.13.20087734,2020-06-09
Immunity,PROCESS_OF,Lung,32511514,10.1101/2020.05.13.20087734,2020-06-09
Cessation of life,ISA,contextual factors,32511514,10.1101/2020.05.13.20087734,2020-06-09
DNA,ASSOCIATED_WITH,Mucoid sputum,32511513,10.1101/2020.05.04.20090092,2020-06-09
Dornase Alfa,TREATS,Cystic Fibrosis,32511513,10.1101/2020.05.04.20090092,2020-06-09
DNA,AFFECTS,Viscosity,32511513,10.1101/2020.05.04.20090092,2020-06-09
Serum,PART_OF,Patients,32511513,10.1101/2020.05.04.20090092,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511513,10.1101/2020.05.04.20090092,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511513,10.1101/2020.05.04.20090092,2020-06-09
Intervention regimes,TREATS,Disease,32511512,10.1101/2020.04.16.20067306,2020-06-09
Disinfection,USES,Oxygen,32511510,10.1101/2020.05.09.20096560,2020-06-09
Ozone,ISA,Gases,32511510,10.1101/2020.05.09.20096560,2020-06-09
Mechanical Ventilator,USES,Hospitals,32511510,10.1101/2020.05.09.20096560,2020-06-09
Pneumonia,ISA,Infection,32511509,10.1101/2020.05.03.20089920,2020-06-09
Infection,CAUSES,Pneumonia,32511509,10.1101/2020.05.03.20089920,2020-06-09
Overprotected,PROCESS_OF,Vulnerable Populations,32511508,10.1101/2020.05.07.20093542,2020-06-09
saliva,PART_OF,Homo sapiens,32511507,10.1101/2020.04.20.20072116,2020-06-09
Assay,USES,Colorimetry,32511507,10.1101/2020.04.20.20072116,2020-06-09
Assay,USES,Loop-mediated Isothermal Amplification,32511507,10.1101/2020.04.20.20072116,2020-06-09
Academic Medical Centers,LOCATION_OF,Laboratory Procedures,32511506,10.1101/2020.05.27.20114652,2020-06-09
Academic Medical Centers,LOCATION_OF(SPEC),PCR test for SARS,32511506,10.1101/2020.05.27.20114652,2020-06-09
Laboratory Procedures,USES,PCR test for SARS,32511506,10.1101/2020.05.27.20114652,2020-06-09
PCR test for SARS,ISA,Laboratory Procedures,32511506,10.1101/2020.05.27.20114652,2020-06-09
Coughing,ISA,Symptoms,32511506,10.1101/2020.05.27.20114652,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511506,10.1101/2020.05.27.20114652,2020-06-09
Comorbidity,PROCESS_OF,hospitalized patients,32511506,10.1101/2020.05.27.20114652,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511506,10.1101/2020.05.27.20114652,2020-06-09
Patient in hospital,PROCESS_OF,inpatient,32511506,10.1101/2020.05.27.20114652,2020-06-09
"Antigens, Viral",INTERACTS_WITH,Biotin,32511505,10.1101/2020.05.29.20116376,2020-06-09
Antibodies,compared_with,angiotensin converting enzyme 2,32511505,10.1101/2020.05.29.20116376,2020-06-09
receptor binding,PROCESS_OF,Patients,32511505,10.1101/2020.05.29.20116376,2020-06-09
Anti-Antibodies,INTERACTS_WITH,Epitopes,32511505,10.1101/2020.05.29.20116376,2020-06-09
Serum,PART_OF,Patients,32511505,10.1101/2020.05.29.20116376,2020-06-09
Patients,LOCATION_OF,Viral Genome,32511504,10.1101/2020.05.15.20103226,2020-06-09
Hospitals,LOCATION_OF,Study,32511504,10.1101/2020.05.15.20103226,2020-06-09
Clinic,LOCATION_OF,Prospective Studies,32511503,10.1101/2020.05.19.20106344,2020-06-09
Health Care,TREATS,Child,32511503,10.1101/2020.05.19.20106344,2020-06-09
Male population group,ISA,Adult,32511503,10.1101/2020.05.19.20106344,2020-06-09
Noncommunicable Diseases,PROCESS_OF,Male population group,32511503,10.1101/2020.05.19.20106344,2020-06-09
Noncommunicable Diseases,PROCESS_OF,Woman,32511503,10.1101/2020.05.19.20106344,2020-06-09
long-term care,TREATS,High Risk Populations,32511503,10.1101/2020.05.19.20106344,2020-06-09
Hospitalization,AFFECTS,Physical Well-being,32511502,10.1101/2020.05.08.20031666,2020-06-09
Fatigue,PROCESS_OF,Patients,32511501,10.1101/2020.05.17.20101915,2020-06-09
Impaired health,PROCESS_OF,Patients,32511501,10.1101/2020.05.17.20101915,2020-06-09
Fatigue,COEXISTS_WITH,patient condition,32511501,10.1101/2020.05.17.20101915,2020-06-09
Symptoms,PREDISPOSES,Anxiety,32511501,10.1101/2020.05.17.20101915,2020-06-09
Self-Assessment,PROCESS_OF,Health Personnel,32511500,10.1101/2020.05.25.20112433,2020-06-09
Physical and emotional exhaustion state,PROCESS_OF,Health Personnel,32511500,10.1101/2020.05.25.20112433,2020-06-09
Physical and emotional exhaustion state,PROCESS_OF,Health Personnel,32511500,10.1101/2020.05.25.20112433,2020-06-09
Disease,PROCESS_OF,Patients,32511498,10.1101/2020.05.09.20096438,2020-06-09
Coronavirus Infections,ISA,Disease,32511498,10.1101/2020.05.09.20096438,2020-06-09
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32511498,10.1101/2020.05.09.20096438,2020-06-09
e protein,PART_OF,SARS coronavirus,32511498,10.1101/2020.05.09.20096438,2020-06-09
,COEXISTS_WITH,CD40LG wt Allele,32511498,10.1101/2020.05.09.20096438,2020-06-09
Hypersensitivity,ASSOCIATED_WITH,CD40LG wt Allele,32511498,10.1101/2020.05.09.20096438,2020-06-09
Body mass index procedure,USES,Indicators,32511497,10.1101/2020.04.25.20074856,2020-06-09
risk factors,PREDISPOSES,Noncommunicable Diseases,32511497,10.1101/2020.04.25.20074856,2020-06-09
Serologic tests,ISA,Evaluation procedure,32511496,10.1101/2020.04.28.20083865,2020-06-09
Persons,LOCATION_OF,Plasma,32511496,10.1101/2020.04.28.20083865,2020-06-09
Persons,LOCATION_OF,Specimen Type - Serum,32511496,10.1101/2020.04.28.20083865,2020-06-09
Detection,USES,CD40LG wt Allele,32511496,10.1101/2020.04.28.20083865,2020-06-09
Immunity,AFFECTS,Infection,32511494,10.1101/2020.05.05.20092452,2020-06-09
Complement System Proteins,INTERACTS_WITH,Proteome,32511493,10.1101/2020.05.04.20090746,2020-06-09
Analysis,USES,protein structure function,32511493,10.1101/2020.05.04.20090746,2020-06-09
Complement System Proteins,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32511493,10.1101/2020.05.04.20090746,2020-06-09
Complement System Proteins,AFFECTS,Variation (Genetics),32511493,10.1101/2020.05.04.20090746,2020-06-09
,COEXISTS_WITH,COMPLEMENT FACTOR H,32511493,10.1101/2020.05.04.20090746,2020-06-09
,COEXISTS_WITH,Single Nucleotide Polymorphism,32511493,10.1101/2020.05.04.20090746,2020-06-09
,COEXISTS_WITH,C4BPA gene,32511493,10.1101/2020.05.04.20090746,2020-06-09
"Immunity, Innate",ASSOCIATED_WITH,Age related macular degeneration,32511493,10.1101/2020.05.04.20090746,2020-06-09
Analysis,USES,protein structure function,32511493,10.1101/2020.05.04.20090746,2020-06-09
Coronavirus Infections,ISA,Disease,32511492,10.1101/2020.05.05.20083436,2020-06-09
Decision,PROCESS_OF,Maker (occupation),32511488,10.1101/2020.05.02.20082461,2020-06-09
Pneumonia,PROCESS_OF,Patients,32511488,10.1101/2020.05.02.20082461,2020-06-09
Asthma,ISA,Cardiovascular Diseases,32511488,10.1101/2020.05.02.20082461,2020-06-09
Lymphopenia,PROCESS_OF,Patients,32511487,10.1101/2020.05.01.20086801,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511487,10.1101/2020.05.01.20086801,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32511487,10.1101/2020.05.01.20086801,2020-06-09
Severe Acute Respiratory Syndrome,PRECEDES,Immunity,32511484,10.1101/2020.05.10.20096073,2020-06-09
Health care facility,LOCATION_OF,Knowledge acquisition,32511483,10.1101/2020.05.26.20114124,2020-06-09
1/3 meter (distance vision finding),PROCESS_OF,radiologist,32511483,10.1101/2020.05.26.20114124,2020-06-09
Infected,PROCESS_OF,Child,32511482,10.1101/2020.05.29.20116426,2020-06-09
Mild disorder,PROCESS_OF,Child,32511482,10.1101/2020.05.29.20116426,2020-06-09
medical care,COEXISTS_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,32511482,10.1101/2020.05.29.20116426,2020-06-09
Serum,PART_OF,Child,32511482,10.1101/2020.05.29.20116426,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,AFFECTS,Severe Acute Respiratory Syndrome,32511480,10.1101/2020.04.19.20069997,2020-06-09
Angiotensin II receptor antagonist,AFFECTS,Severe Acute Respiratory Syndrome,32511480,10.1101/2020.04.19.20069997,2020-06-09
Antihypertensive Agents,COEXISTS_WITH,Angiotensin-Converting Enzyme Inhibitors,32511480,10.1101/2020.04.19.20069997,2020-06-09
Hypertensive disease,PROCESS_OF,Persons,32511480,10.1101/2020.04.19.20069997,2020-06-09
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Persons,32511480,10.1101/2020.04.19.20069997,2020-06-09
Hypertensive disease,PROCESS_OF,Persons,32511480,10.1101/2020.04.19.20069997,2020-06-09
Evaluation procedure,TREATS,Persons,32511480,10.1101/2020.04.19.20069997,2020-06-09
Evaluation procedure,TREATS,Outpatients,32511480,10.1101/2020.04.19.20069997,2020-06-09
Evaluation procedure,TREATS,Cohort,32511480,10.1101/2020.04.19.20069997,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Population Group,32511480,10.1101/2020.04.19.20069997,2020-06-09
Signs and Symptoms,PROCESS_OF,Older people,32511480,10.1101/2020.04.19.20069997,2020-06-09
Sexual sterilization,USES,Hydrogen Peroxide,32511479,10.1101/2020.05.03.20089524,2020-06-09
Immunoglobulin G,TREATS,Patients,32511476,10.1101/2020.05.18.20105171,2020-06-09
Immune response,PROCESS_OF,Patients,32511475,10.1101/2020.05.05.20092361,2020-06-09
Genes,INTERACTS_WITH,Toll-like receptors,32511475,10.1101/2020.05.05.20092361,2020-06-09
"Immunity, Innate",ASSOCIATED_WITH,Virus Diseases,32511475,10.1101/2020.05.05.20092361,2020-06-09
risk factors,PROCESS_OF,Population Group,32511473,10.1101/2020.05.21.20108738,2020-06-09
Wheezing,PROCESS_OF,Professional Organization or Group,32511473,10.1101/2020.05.21.20108738,2020-06-09
Wheezing,PROCESS_OF,Professional Organization or Group,32511473,10.1101/2020.05.21.20108738,2020-06-09
Asthma,PROCESS_OF,Adult,32511473,10.1101/2020.05.21.20108738,2020-06-09
Pharmaceutical Preparations,STIMULATES,ACE2 gene,32511472,10.1101/2020.05.21.20109280,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,NEG_STIMULATES,ACE2 gene,32511472,10.1101/2020.05.21.20109280,2020-06-09
Angiotensin-Converting Enzyme Inhibitors,TREATS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32511472,10.1101/2020.05.21.20109280,2020-06-09
Serum,LOCATION_OF,Renin,32511472,10.1101/2020.05.21.20109280,2020-06-09
Serum,LOCATION_OF,ACE2 gene,32511472,10.1101/2020.05.21.20109280,2020-06-09
Serum,PART_OF,Persons,32511472,10.1101/2020.05.21.20109280,2020-06-09
ACE2 gene,compared_with,Angiotensin-Converting Enzyme Inhibitors,32511472,10.1101/2020.05.21.20109280,2020-06-09
Discontinued,PROCESS_OF,Patients,32511472,10.1101/2020.05.21.20109280,2020-06-09
Disease,PROCESS_OF,Cancer Patient,32511469,10.1101/2020.04.30.20086264,2020-06-09
Cessation of life,PROCESS_OF,Patients,32511469,10.1101/2020.04.30.20086264,2020-06-09
Hematologic Neoplasms,PRECEDES,Malignant neoplasm of lung,32511469,10.1101/2020.04.30.20086264,2020-06-09
directive therapy,TREATS,Cancer Patient,32511469,10.1101/2020.04.30.20086264,2020-06-09
Disease,PROCESS_OF,Patients,32511469,10.1101/2020.04.30.20086264,2020-06-09
Immunity,PROCESS_OF,Population Group,32511468,10.1101/2020.05.05.20091553,2020-06-09
"Immunity, Herd",PROCESS_OF,Vulnerable Populations,32511468,10.1101/2020.05.05.20091553,2020-06-09
Acute respiratory infections,PROCESS_OF,Persons,32511467,10.1101/2020.04.23.20076885,2020-06-09
Coronavirus Infections,CAUSES,Disease,32511464,10.1101/2020.03.13.20035618,2020-06-09
Fever,ISA,Symptoms,32511464,10.1101/2020.03.13.20035618,2020-06-09
Diarrhea,PROCESS_OF,Patients,32511464,10.1101/2020.03.13.20035618,2020-06-09
Ground Glass Opacity,ISA,Radiologic finding,32511464,10.1101/2020.03.13.20035618,2020-06-09
Fever,ISA,Symptoms,32511464,10.1101/2020.03.13.20035618,2020-06-09
Dyspnea,ASSOCIATED_WITH,Disease,32511464,10.1101/2020.03.13.20035618,2020-06-09
Clinical Trials,USES,Vaccination against tuberculosis,32511461,10.1101/2020.05.09.20096511,2020-06-09
Diabetes,PROCESS_OF,Patients,32511460,10.1101/2020.04.30.20081257,2020-06-09
Kidney Diseases,PROCESS_OF,Patients,32511460,10.1101/2020.04.30.20081257,2020-06-09
Leptocyte,LOCATION_OF,angiotensin converting enzyme 2,32511460,10.1101/2020.04.30.20081257,2020-06-09
Diabetic Nephropathy,COEXISTS_WITH,Virus Diseases,32511460,10.1101/2020.04.30.20081257,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32511460,10.1101/2020.04.30.20081257,2020-06-09
Patients,LOCATION_OF,Urine - SpecimenType,32511460,10.1101/2020.04.30.20081257,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511459,10.1101/2020.03.10.20033761,2020-06-09
Poor outcome,COEXISTS_WITH,Hypertensive heart failure,32511459,10.1101/2020.03.10.20033761,2020-06-09
Organ,LOCATION_OF,Severe Acute Respiratory Syndrome,32511459,10.1101/2020.03.10.20033761,2020-06-09
Cells,LOCATION_OF,RNA Sequence,32511459,10.1101/2020.03.10.20033761,2020-06-09
Cells,LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Cells,PART_OF,Unmarried person,32511459,10.1101/2020.03.10.20033761,2020-06-09
Fibroblasts,LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Heart,LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Heart,LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Heart,PART_OF,Homo sapiens,32511459,10.1101/2020.03.10.20033761,2020-06-09
RNA Sequence,ISA,Base Sequence,32511459,10.1101/2020.03.10.20033761,2020-06-09
RNA Sequence,PART_OF,Cells,32511459,10.1101/2020.03.10.20033761,2020-06-09
Endothelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
"Myocytes, Cardiac",LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
"Myocytes, Cardiac",LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
"Myocytes, Cardiac",LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
angiotensin converting enzyme 2,AUGMENTS,Heart,32511459,10.1101/2020.03.10.20033761,2020-06-09
"Myocytes, Smooth Muscle",LOCATION_OF,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Microarray Analysis,USES,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Atrial Natriuretic Factor,STIMULATES,"Myocytes, Cardiac",32511459,10.1101/2020.03.10.20033761,2020-06-09
Nesiritide,STIMULATES,"Myocytes, Cardiac",32511459,10.1101/2020.03.10.20033761,2020-06-09
Genes,ASSOCIATED_WITH,Heart failure,32511459,10.1101/2020.03.10.20033761,2020-06-09
Genes,AFFECTS,Virus Internalization,32511459,10.1101/2020.03.10.20033761,2020-06-09
"Myocytes, Cardiac",LOCATION_OF,Virus Replication,32511459,10.1101/2020.03.10.20033761,2020-06-09
Atrial Natriuretic Factor,STIMULATES,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
Plasma,LOCATION_OF,Nesiritide,32511459,10.1101/2020.03.10.20033761,2020-06-09
Nesiritide,PART_OF,Patients,32511459,10.1101/2020.03.10.20033761,2020-06-09
Nesiritide,STIMULATES,angiotensin converting enzyme 2,32511459,10.1101/2020.03.10.20033761,2020-06-09
procalcitonin,AUGMENTS,Virus Internalization,32511459,10.1101/2020.03.10.20033761,2020-06-09
GSKIP gene,AUGMENTS,Virus Internalization,32511459,10.1101/2020.03.10.20033761,2020-06-09
Cessation of life,PROCESS_OF,Population Group,32511458,10.1101/2020.02.04.20020495,2020-06-09
Coronavirus Infections,CAUSES,Atypical pneumonia,32511457,10.1101/2020.01.28.20019299,2020-06-09
Absenteeism,PROCESS_OF,Health Personnel,32511454,10.1101/2020.02.19.20025452,2020-06-09
dependent children,PROCESS_OF,Health Personnel,32511454,10.1101/2020.02.19.20025452,2020-06-09
Absenteeism,PROCESS_OF,Health Personnel,32511454,10.1101/2020.02.19.20025452,2020-06-09
Coronavirus Infections,PROCESS_OF,World,32511452,10.1101/2020.03.02.20026708,2020-06-09
Infected,PROCESS_OF,Persons,32511452,10.1101/2020.03.02.20026708,2020-06-09
Symptom mild,PROCESS_OF,Persons,32511452,10.1101/2020.03.02.20026708,2020-06-09
Infected,PROCESS_OF,Persons,32511452,10.1101/2020.03.02.20026708,2020-06-09
Infected,PROCESS_OF,Persons,32511452,10.1101/2020.03.02.20026708,2020-06-09
Virus,PROCESS_OF,human group,32511451,10.1101/2020.04.27.20081893,2020-06-09
Infected,PROCESS_OF,Patients,32511449,10.1101/2020.03.06.20032334,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511449,10.1101/2020.03.06.20032334,2020-06-09
Comorbidity,PROCESS_OF,Old age,32511449,10.1101/2020.03.06.20032334,2020-06-09
3/4,PROCESS_OF,Patients,32511449,10.1101/2020.03.06.20032334,2020-06-09
3/4,PROCESS_OF,Old age,32511449,10.1101/2020.03.06.20032334,2020-06-09
Nitric Oxide,TREATS,Syndrome,32511449,10.1101/2020.03.06.20032334,2020-06-09
Coronavirus Infections,AFFECTS,Syndrome,32511449,10.1101/2020.03.06.20032334,2020-06-09
Spontaneous respiration,PROCESS_OF,Patients,32511449,10.1101/2020.03.06.20032334,2020-06-09
Nitric Oxide,ADMINISTERED_TO,Patients,32511449,10.1101/2020.03.06.20032334,2020-06-09
hospital care,ADMINISTERED_TO,Control Groups,32511449,10.1101/2020.03.06.20032334,2020-06-09
Assay,METHOD_OF,Detection,32511448,10.1101/2020.05.04.20090803,2020-06-09
Assay,USES,PCR test for SARS,32511448,10.1101/2020.05.04.20090803,2020-06-09
Infected,PROCESS_OF,Persons,32511447,10.1101/2020.03.09.20033241,2020-06-09
Virus,CAUSES,Respiration Disorders,32511447,10.1101/2020.03.09.20033241,2020-06-09
3 - serious,PROCESS_OF,inpatient,32511445,10.1101/2020.04.20.20071423,2020-06-09
Serum,LOCATION_OF,Antibodies,32511444,10.1101/2020.03.13.20035238,2020-06-09
Infected,PROCESS_OF,Patients,32511444,10.1101/2020.03.13.20035238,2020-06-09
Specific antibody,PART_OF,Virus,32511444,10.1101/2020.03.13.20035238,2020-06-09
Assay,USES,Immunoprecipitation,32511444,10.1101/2020.03.13.20035238,2020-06-09
Measles Virus Nucleoprotein,compared_with,Protein antibody,32511444,10.1101/2020.03.13.20035238,2020-06-09
Measles Virus Nucleoprotein,higher_than,Protein antibody,32511444,10.1101/2020.03.13.20035238,2020-06-09
Assay,DIAGNOSES,SARS coronavirus,32511444,10.1101/2020.03.13.20035238,2020-06-09
Assay,USES,Immunoprecipitation,32511444,10.1101/2020.03.13.20035238,2020-06-09
Comorbidity,PROCESS_OF,Persons,32511442,10.1101/2020.02.13.20022707,2020-06-09
Comorbidity,PROCESS_OF,Patients,32511442,10.1101/2020.02.13.20022707,2020-06-09
medication use,PROCESS_OF,Persons,32511442,10.1101/2020.02.13.20022707,2020-06-09
Detection,TREATS,traveler,32511441,10.1101/2020.03.17.20037713,2020-06-09
Assay,DIAGNOSES,Acute infectious disease,32511440,10.1101/2020.03.05.20031088,2020-06-09
"M Protein, multiple myeloma",CONVERTS_TO,Antigens,32511440,10.1101/2020.03.05.20031088,2020-06-09
Immunity,PROCESS_OF,general population,32511440,10.1101/2020.03.05.20031088,2020-06-09
Infected,PROCESS_OF,Patients,32511440,10.1101/2020.03.05.20031088,2020-06-09
Coronavirus Infections,COEXISTS_WITH,Infection,32511438,10.1101/2020.04.11.20060749,2020-06-09
Infection,AFFECTS,viral transmission,32511438,10.1101/2020.04.11.20060749,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Poor outcome,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Poor outcome,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Cardiac Arrest,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Cardiopulmonary Resuscitation,TREATS,Cohort,32511437,10.1101/2020.04.10.20060962,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Pneumonia,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Septicemia,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Mechanical ventilation,ADMINISTERED_TO,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Vasoconstrictor Agents,ADMINISTERED_TO,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
neurological disability,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Rhythm,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Subgroup A Nepoviruses,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Rhythm,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Rhythm,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511437,10.1101/2020.04.10.20060962,2020-06-09
Resuscitation procedure,PRECEDES,Mechanical ventilation,32511437,10.1101/2020.04.10.20060962,2020-06-09
IMPACT gene,PART_OF,Pathogenic organism,32511431,10.1101/2020.04.07.20056812,2020-06-09
Immunity,PROCESS_OF,Persons,32511431,10.1101/2020.04.07.20056812,2020-06-09
Infected,PROCESS_OF,Mother (person),32511429,10.1101/2020.03.27.20045815,2020-06-09
Human coronavirus 229E,COEXISTS_WITH,SARS coronavirus,32511429,10.1101/2020.03.27.20045815,2020-06-09
Intervention regimes,TREATS,Coronavirus Infections,32511426,10.1101/2020.03.06.20032417,2020-06-09
Asymptomatic,PROCESS_OF,Persons,32511425,10.1101/2020.03.04.20031005,2020-06-09
Symptoms,NEG_PROCESS_OF,Patients,32511425,10.1101/2020.03.04.20031005,2020-06-09
Severe Acute Respiratory Syndrome,PREDISPOSES,Influenza,32511424,10.1101/2020.02.21.20026328,2020-06-09
Middle East Respiratory Syndrome,PREDISPOSES,Influenza,32511424,10.1101/2020.02.21.20026328,2020-06-09
prohibition,ISA,Implementation,32511422,10.1101/2020.01.28.20019224,2020-06-09
Decrease in height,PROCESS_OF,Community,32511422,10.1101/2020.01.28.20019224,2020-06-09
Coronavirus Infections,CAUSES,Cessation of life,32511418,10.1101/2020.05.27.120204,2020-06-09
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32511418,10.1101/2020.05.27.120204,2020-06-09
SARS coronavirus,LOCATION_OF,Proteins,32511418,10.1101/2020.05.27.120204,2020-06-09
Proteins,compared_with,Binding Proteins,32511418,10.1101/2020.05.27.120204,2020-06-09
SARS coronavirus,LOCATION_OF,Proteins,32511418,10.1101/2020.05.27.120204,2020-06-09
SARS coronavirus,LOCATION_OF,Binding Proteins,32511418,10.1101/2020.05.27.120204,2020-06-09
receptor,CAUSES,Incubation period,32511418,10.1101/2020.05.27.120204,2020-06-09
High Level,PROCESS_OF,Human body,32511418,10.1101/2020.05.27.120204,2020-06-09
Mus,LOCATION_OF,Immunoglobulin Isotypes,32511416,10.1101/2020.05.21.109322,2020-06-09
"Condoms, Male",PREVENTS,Severe Acute Respiratory Syndrome,32511416,10.1101/2020.05.21.109322,2020-06-09
Monoclonal Antibodies,PART_OF,Homo sapiens,32511412,10.1101/2020.05.11.089375,2020-06-09
Assay,MEASURES,Monoclonal Antibodies,32511412,10.1101/2020.05.11.089375,2020-06-09
inhibitors,compared_with,Peptide Hydrolases,32511410,10.1101/2020.04.20.051656,2020-06-09
Chiroptera,LOCATION_OF,ACE gene,32511409,10.1101/2020.05.22.111005,2020-06-09
Chiroptera,ISA,Mammals,32511409,10.1101/2020.05.22.111005,2020-06-09
Chiroptera,LOCATION_OF,angiotensin converting enzyme 2,32511409,10.1101/2020.05.22.111005,2020-06-09
Genus: Coronavirus,INTERACTS_WITH,SARS coronavirus,32511409,10.1101/2020.05.22.111005,2020-06-09
Syndrome,PROCESS_OF,Patients,32511406,10.1101/2020.05.06.081497,2020-06-09
Severe Acute Respiratory Syndrome,CAUSES,Syndrome,32511406,10.1101/2020.05.06.081497,2020-06-09
Orthologous Gene,PART_OF,Mus,32511405,10.1101/2020.05.16.099317,2020-06-09
Orthologous Gene,PART_OF,Homo sapiens,32511405,10.1101/2020.05.16.099317,2020-06-09
"Vitronectin, human",PART_OF,Homo sapiens,32511405,10.1101/2020.05.16.099317,2020-06-09
Airway structure,PART_OF,"Mice, Inbred BALB C",32511405,10.1101/2020.05.16.099317,2020-06-09
Airway structure,PART_OF,Young Adult,32511405,10.1101/2020.05.16.099317,2020-06-09
Disease,PROCESS_OF,Mus,32511405,10.1101/2020.05.16.099317,2020-06-09
Interventional procedure,TREATS,Crisis,32511404,10.1101/2020.05.10.087288,2020-06-09
"Vitronectin, human",PART_OF,Virus,32511404,10.1101/2020.05.10.087288,2020-06-09
Polysaccharides,AFFECTS,Possible,32511404,10.1101/2020.05.10.087288,2020-06-09
"M Protein, multiple myeloma",INTERACTS_WITH,heparin,32511403,10.1101/2020.05.05.079095,2020-06-09
Pluripotent Stem Cells,PART_OF,Homo sapiens,32511402,10.1101/2020.04.21.051912,2020-06-09
Organoids,PART_OF,Lung,32511402,10.1101/2020.04.21.051912,2020-06-09
Organoids,PRODUCES,ACE2 gene,32511402,10.1101/2020.04.21.051912,2020-06-09
Pharmaceutical Preparations,PREVENTS,Severe Acute Respiratory Syndrome,32511402,10.1101/2020.04.21.051912,2020-06-09
Organoids,LOCATION_OF,Severe Acute Respiratory Syndrome,32511402,10.1101/2020.04.21.051912,2020-06-09
"Myocytes, Cardiac",LOCATION_OF,IMPACT gene,32511401,10.1101/2020.05.18.102038,2020-06-09
"Myocytes, Cardiac",PART_OF,Homo sapiens,32511401,10.1101/2020.05.18.102038,2020-06-09
inflammatory response,AFFECTS,Cardiac function,32511401,10.1101/2020.05.18.102038,2020-06-09
Location,LOCATION_OF,"Myocytes, Cardiac",32511401,10.1101/2020.05.18.102038,2020-06-09
Clone,PART_OF,Vesicular stomatitis virus,32511400,10.1101/2020.05.14.096016,2020-06-09
Virus Diseases,INTERACTS_WITH,Virus,32511399,10.1101/2020.05.21.108035,2020-06-09
Olfactory Epithelium,LOCATION_OF,Virus Diseases,32511399,10.1101/2020.05.21.108035,2020-06-09
Epithelium,PART_OF,Intestines,32511399,10.1101/2020.05.21.108035,2020-06-09
Specialized epithelial cell,PRODUCES,"TRPM5 protein, human",32511399,10.1101/2020.05.21.108035,2020-06-09
Olfactory epithelial cell,INTERACTS_WITH,Olfactory Receptor Cells,32511399,10.1101/2020.05.21.108035,2020-06-09
Transcript,AFFECTS,Inflammation,32511399,10.1101/2020.05.21.108035,2020-06-09
Laboratory,LOCATION_OF,research,32511398,10.1101/2020.04.21.053058,2020-06-09
Virus Internalization,ISA,Process,32511397,10.1101/2020.05.15.098616,2020-06-09
"Gene Products, env",PART_OF,Ebolavirus,32511397,10.1101/2020.05.15.098616,2020-06-09
vacuolin-1,STIMULATES,"Gene Products, env",32511397,10.1101/2020.05.15.098616,2020-06-09
Apilimod,STIMULATES,"Gene Products, env",32511397,10.1101/2020.05.15.098616,2020-06-09
Amino Acids,STIMULATES,protein protein interaction,32511396,10.1101/2020.05.15.096719,2020-06-09
Missense,PROCESS_OF,Patients,32511396,10.1101/2020.05.15.096719,2020-06-09
Intervention regimes,METHOD_OF,Prophylactic treatment,32511395,10.1101/2020.05.18.103184,2020-06-09
Vaccines,AFFECTS,"Immunity, Mucosal",32511395,10.1101/2020.05.18.103184,2020-06-09
Proteins,AFFECTS,receptor binding,32511395,10.1101/2020.05.18.103184,2020-06-09
conjunctiva,LOCATION_OF,ACE2 gene,32511392,10.1101/2020.04.27.064279,2020-06-09
conjunctiva,LOCATION_OF,ACE2 gene,32511392,10.1101/2020.04.27.064279,2020-06-09
Cornea,LOCATION_OF,ACE2 gene,32511392,10.1101/2020.04.27.064279,2020-06-09
Endopeptidases,AUGMENTS,Virus Internalization,32511392,10.1101/2020.04.27.064279,2020-06-09
TMPRSS2 gene,INTERACTS_WITH,Viral Proteins,32511392,10.1101/2020.04.27.064279,2020-06-09
Epithelium,LOCATION_OF,ACE2 gene,32511392,10.1101/2020.04.27.064279,2020-06-09
Epithelium of conjunctiva,LOCATION_OF,ACE2 gene,32511392,10.1101/2020.04.27.064279,2020-06-09
Epithelium,PART_OF,Cornea,32511392,10.1101/2020.04.27.064279,2020-06-09
Cells,LOCATION_OF,receptor,32511389,10.1101/2020.05.20.103325,2020-06-09
Epithelial Cells,PART_OF,Trachea,32511389,10.1101/2020.05.20.103325,2020-06-09
Neuroepithelium,LOCATION_OF,Structure of upper respiratory tract cavity,32511389,10.1101/2020.05.20.103325,2020-06-09
viral membrane,LOCATION_OF,"Vitronectin, human",32511388,10.1101/2020.04.21.053017,2020-06-09
viral membrane,LOCATION_OF,Proteins,32511388,10.1101/2020.04.21.053017,2020-06-09
Coronavirus Infections,CAUSES,Cessation of life,32511387,10.1101/2020.05.11.088674,2020-06-09
Influenza A virus,LOCATION_OF,Vaccines,32511387,10.1101/2020.05.11.088674,2020-06-09
Polymerase,INTERACTS_WITH,"RNA, Viral",32511387,10.1101/2020.05.11.088674,2020-06-09
Mesocricetus auratus,LOCATION_OF,"Antibodies, Neutralizing",32511386,10.1101/2020.05.21.109546,2020-06-09
Alhydrogel,STIMULATES,"Antibodies, Neutralizing",32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,compared_with,"Vitronectin, human",32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,TREATS,Mus,32511384,10.1101/2020.05.13.092619,2020-06-09
Lung,LOCATION_OF,Cellular infiltrate,32511384,10.1101/2020.05.13.092619,2020-06-09
Specific antibody,PREVENTS,Cellular infiltrate,32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,compared_with,Proteins,32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,compared_with(SPEC),RNA Recognition Motif,32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,higher_than,Proteins,32511384,10.1101/2020.05.13.092619,2020-06-09
Alhydrogel,higher_than(SPEC),RNA Recognition Motif,32511384,10.1101/2020.05.13.092619,2020-06-09
RNA Recognition Motif,ISA,Proteins,32511384,10.1101/2020.05.13.092619,2020-06-09
Antibody Formation,PROCESS_OF,Homo sapiens,32511383,10.1101/2020.04.26.061705,2020-06-09
Causative_agents,CAUSES,Infection,32511382,10.1101/2020.05.06.081695,2020-06-09
Ribose,ISA,Carbohydrates,32511382,10.1101/2020.05.06.081695,2020-06-09
RNA Sequence,PART_OF,Cells,32511381,10.1101/2020.04.17.045161,2020-06-09
RNA Sequence,PART_OF,Bronchial Epithelial Cell,32511381,10.1101/2020.04.17.045161,2020-06-09
Bronchial Epithelial Cell,PART_OF,Homo sapiens,32511381,10.1101/2020.04.17.045161,2020-06-09
Pharmaceutical Preparations,INTERACTS_WITH,Small Molecule,32511380,10.1101/2020.05.15.098731,2020-06-09
inhibitors,TREATS,Virus Diseases,32511379,10.1101/2020.04.24.059527,2020-06-09
favipiravir,DISRUPTS,RNA biosynthesis,32511379,10.1101/2020.04.24.059527,2020-06-09
Coronavirus Infections,AFFECTS,Cellular signal transduction,32511378,10.1101/2020.04.20.051581,2020-06-09
Response process,ASSOCIATED_WITH,Coronavirus Infections,32511378,10.1101/2020.04.20.051581,2020-06-09
Cellular signal transduction,PROCESS_OF,Homo sapiens,32511378,10.1101/2020.04.20.051581,2020-06-09
Imbrication (procedure),AFFECTS,Coronavirus Infections,32511378,10.1101/2020.04.20.051581,2020-06-09
SARS coronavirus,CAUSES,Disease,32511377,10.1101/2020.05.17.100289,2020-06-09
inhibitors,INTERACTS_WITH,"3C-like protease, SARS coronavirus",32511377,10.1101/2020.05.17.100289,2020-06-09
Disease,PROCESS_OF,Homo sapiens,32511376,10.1101/2020.04.17.047498,2020-06-09
Respiration Disorders,PROCESS_OF,Cercopithecus aethiops,32511376,10.1101/2020.04.17.047498,2020-06-09
Mucous Membrane,PART_OF,Animals,32511376,10.1101/2020.04.17.047498,2020-06-09
Respiration Disorders,PROCESS_OF,Cercopithecus aethiops,32511376,10.1101/2020.04.17.047498,2020-06-09
Virus Replication,PROCESS_OF,Nonhuman primate,32511376,10.1101/2020.04.17.047498,2020-06-09
Coronaviridae,PROCESS_OF,Family,32511375,10.1101/2020.05.08.084806,2020-06-09
S-Adenosylmethionine,PART_OF,methyltransferase complex,32511375,10.1101/2020.05.08.084806,2020-06-09
Organ,PART_OF,Adult,32511374,10.1101/2020.05.21.109272,2020-06-09
Organ,PART_OF,"Intestines, Small",32511374,10.1101/2020.05.21.109272,2020-06-09
Goblet Cells,PART_OF,"Intestines, Small",32511374,10.1101/2020.05.21.109272,2020-06-09
Epithelial cell of renal tubule,PART_OF,"Kidney Tubules, Proximal",32511374,10.1101/2020.05.21.109272,2020-06-09
Basal Cell,PART_OF,Gallbladder,32511374,10.1101/2020.05.21.109272,2020-06-09
Enterocytes,PART_OF,"Intestines, Small",32511374,10.1101/2020.05.21.109272,2020-06-09
Heart,LOCATION_OF,Severe Acute Respiratory Syndrome,32511374,10.1101/2020.05.21.109272,2020-06-09
Lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32511374,10.1101/2020.05.21.109272,2020-06-09
Endocrine Cells,PART_OF,Prostate,32511374,10.1101/2020.05.21.109272,2020-06-09
Organ,PART_OF,Macaca,32511374,10.1101/2020.05.21.109272,2020-06-09
Disease,PROCESS_OF,Child,32511373,10.1101/2020.04.28.065201,2020-06-09
Present,PROCESS_OF,Child,32511373,10.1101/2020.04.28.065201,2020-06-09
Cell Adhesion Molecules,PART_OF,Protoplasm,32511373,10.1101/2020.04.28.065201,2020-06-09
Superantigens,ASSOCIATED_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32511373,10.1101/2020.04.28.065201,2020-06-09
Storm NOS,PROCESS_OF,Patients,32511373,10.1101/2020.04.28.065201,2020-06-09
"RNA, Viral",AFFECTS,Virus Replication,32511372,10.1101/2020.05.16.099788,2020-06-09
Transcriptome,PART_OF,Homo sapiens,32511372,10.1101/2020.05.16.099788,2020-06-09
RNA,AUGMENTS,Mitochondrial matrix,32511372,10.1101/2020.05.16.099788,2020-06-09
Genes,AFFECTS,Immunity,32511371,10.1101/2020.05.20.106401,2020-06-09
TRANSCRIPTION FACTOR,AFFECTS,Equilibrium,32511371,10.1101/2020.05.20.106401,2020-06-09
GA-Binding Protein Transcription Factor,AFFECTS(SPEC),Equilibrium,32511371,10.1101/2020.05.20.106401,2020-06-09
GA-Binding Protein Transcription Factor,ISA,TRANSCRIPTION FACTOR,32511371,10.1101/2020.05.20.106401,2020-06-09
Disease,AFFECTS,Old age,32511371,10.1101/2020.05.20.106401,2020-06-09
Oxidative Stress,AFFECTS,Disease,32511371,10.1101/2020.05.20.106401,2020-06-09
Hep G2 Cells,LOCATION_OF,TMPRSS2 gene,32511371,10.1101/2020.05.20.106401,2020-06-09
Hep G2 Cells,LOCATION_OF,ACE2 gene,32511371,10.1101/2020.05.20.106401,2020-06-09
TMPRSS2 gene,STIMULATES,"M Protein, multiple myeloma",32511371,10.1101/2020.05.20.106401,2020-06-09
Endotoxins,AUGMENTS,Endothelium,32511371,10.1101/2020.05.20.106401,2020-06-09
Intercellular adhesion molecule 1,ISA,Cell Adhesion Molecules,32511371,10.1101/2020.05.20.106401,2020-06-09
cytokine,ASSOCIATED_WITH,Storm NOS,32511371,10.1101/2020.05.20.106401,2020-06-09
Immune,PROCESS_OF,Patients,32511370,10.1101/2020.05.23.112235,2020-06-09
T-Cell Activation,PROCESS_OF,Patients,32511370,10.1101/2020.05.23.112235,2020-06-09
Pharmaceutical Preparations,INHIBITS,"3C-like protease, SARS coronavirus",32511369,10.1101/2020.05.22.111518,2020-06-09
Blood,LOCATION_OF,Antibodies,32511368,10.1101/2020.04.22.056283,2020-06-09
JTB gene,compared_with,Imaging Device,32511368,10.1101/2020.04.22.056283,2020-06-09
JTB gene,higher_than,Imaging Device,32511368,10.1101/2020.04.22.056283,2020-06-09
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32511367,10.1101/2020.04.27.064139,2020-06-09
Virus Diseases,COEXISTS_WITH,Cytopathic effect,32511366,10.1101/2020.05.09.086249,2020-06-09
production,ISA,Action,32511366,10.1101/2020.05.09.086249,2020-06-09
"RNA, Viral",DISRUPTS,Virus Replication,32511366,10.1101/2020.05.09.086249,2020-06-09
Lung,LOCATION_OF,Plaque (lesion),32511366,10.1101/2020.05.09.086249,2020-06-09
Disease,PROCESS_OF,Old age,32511365,10.1101/2020.05.20.105247,2020-06-09
Serum,LOCATION_OF,Cholesterol,32511365,10.1101/2020.05.20.105247,2020-06-09
Cholesterol,ADMINISTERED_TO,Cells,32511365,10.1101/2020.05.20.105247,2020-06-09
Blood,LOCATION_OF,Cholesterol,32511365,10.1101/2020.05.20.105247,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511365,10.1101/2020.05.20.105247,2020-06-09
Specific antibody,COEXISTS_WITH,Immune Sera,32511364,10.1101/2020.05.22.111187,2020-06-09
high throughput screening,USES,Tracer,32511364,10.1101/2020.05.22.111187,2020-06-09
Coronavirus Infections,CAUSES,Disease,32511362,10.1101/2020.05.12.091090,2020-06-09
Protomers,INTERACTS_WITH,PSMD2 gene,32511361,10.1101/2020.05.12.091256,2020-06-09
Antiviral Agents,INTERACTS_WITH,Viral Proteins,32511360,10.1101/2020.05.12.091082,2020-06-09
Adenocarcinoma Cell,PART_OF,Lung,32511360,10.1101/2020.05.12.091082,2020-06-09
Viral Proteins,INTERACTS_WITH,angiotensin converting enzyme 2,32511359,10.1101/2020.05.17.100685,2020-06-09
host cell membrane,LOCATION_OF,angiotensin converting enzyme 2,32511359,10.1101/2020.05.17.100685,2020-06-09
high throughput screening,USES,Pharmaceutical Preparations,32511359,10.1101/2020.05.17.100685,2020-06-09
Human Embryonic Stem Cells,LOCATION_OF,high throughput screening,32511359,10.1101/2020.05.17.100685,2020-06-09
Analysis,USES,Drug Delivery Systems,32511359,10.1101/2020.05.17.100685,2020-06-09
Alveolar Epithelial Cells,PART_OF,Homo sapiens,32511359,10.1101/2020.05.17.100685,2020-06-09
Complication,COEXISTS_WITH,patient condition,32511359,10.1101/2020.05.17.100685,2020-06-09
Measles Virus Nucleoprotein,INTERACTS_WITH,"RNA, Viral",32511358,10.1101/2020.05.21.108381,2020-06-09
SARS coronavirus,ISA,Genus: Coronavirus,32511358,10.1101/2020.05.21.108381,2020-06-09
Amino Acid Substitution,PROCESS_OF,Persons,32511358,10.1101/2020.05.21.108381,2020-06-09
Amino Acid Substitution,PROCESS_OF,Measles Virus Nucleoprotein,32511358,10.1101/2020.05.21.108381,2020-06-09
performance tests,DIAGNOSES,SARS coronavirus,32511357,10.1101/2020.04.16.044016,2020-06-09
Registration,USES,Pharmaceutical Preparations,32511356,10.1101/2020.04.16.045302,2020-06-09
Pharmaceutical Preparations,DISRUPTS,Virus Replication,32511356,10.1101/2020.04.16.045302,2020-06-09
Mental concentration,PROCESS_OF,Patients,32511356,10.1101/2020.04.16.045302,2020-06-09
N-benzyloxycarbonyl-leucyl-valyl-glycine diazomethane,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
MDL 28170,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
MLN gene,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
Apilimod,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
ONO-5334,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
VBY-825,INHIBITS,CCR1 gene,32511356,10.1101/2020.04.16.045302,2020-06-09
Chloroquine,AFFECTS,Cells,32511354,10.1101/2020.04.07.023903,2020-06-09
Hydroxychloroquine,AFFECTS,Cells,32511354,10.1101/2020.04.07.023903,2020-06-09
Toxic effect,PROCESS_OF,Patients,32511354,10.1101/2020.04.07.023903,2020-06-09
Coronavirus Infections,ISA,Disease,32511352,10.1101/2020.04.20.048066,2020-06-09
Oropharyngeal swab,PART_OF,Nose,32511351,10.1101/2020.05.16.088989,2020-06-09
Histocompatibility Antigens Class II,compared_with,Vaccines,32511350,10.1101/2020.04.21.042911,2020-06-09
Does hit (finding),PROCESS_OF,Persons,32511350,10.1101/2020.04.21.042911,2020-06-09
Peptides,PART_OF,Persons,32511350,10.1101/2020.04.21.042911,2020-06-09
Does hit (finding),PROCESS_OF,Persons,32511350,10.1101/2020.04.21.042911,2020-06-09
Assay,METHOD_OF,Detection,32511349,10.1101/2020.05.01.073387,2020-06-09
Detection,USES,"Antibodies, Anti-Idiotypic",32511349,10.1101/2020.05.01.073387,2020-06-09
Detection,USES,"Antibodies, Anti-Idiotypic",32511349,10.1101/2020.05.01.073387,2020-06-09
Surface,LOCATION_OF,Immune Cell,32511348,10.1101/2020.03.20.000885,2020-06-09
P-selectin ligand protein,AFFECTS,Virus Attachment,32511348,10.1101/2020.03.20.000885,2020-06-09
SARS coronavirus,LOCATION_OF,P-selectin ligand protein,32511348,10.1101/2020.03.20.000885,2020-06-09
SARS coronavirus,LOCATION_OF,P-selectin ligand protein,32511348,10.1101/2020.03.20.000885,2020-06-09
"Vitronectin, human",AFFECTS,Virus Attachment,32511348,10.1101/2020.03.20.000885,2020-06-09
"Vaccines, Attenuated",TREATS,Severe Acute Respiratory Syndrome,32511348,10.1101/2020.03.20.000885,2020-06-09
Host Specificity,AFFECTS,"Recombination, Genetic",32511347,10.1101/2020.03.31.018978,2020-06-09
Proteome,PART_OF,Homo sapiens,32511346,10.1101/2020.03.03.972133,2020-06-09
Vaccines,COEXISTS_WITH,DNA,32511346,10.1101/2020.03.03.972133,2020-06-09
Vaccines,COEXISTS_WITH,"RNA, Messenger",32511346,10.1101/2020.03.03.972133,2020-06-09
Vaccines,COEXISTS_WITH,synthetic construct,32511346,10.1101/2020.03.03.972133,2020-06-09
Epitopes,AUGMENTS,Membrane Fusion,32511346,10.1101/2020.03.03.972133,2020-06-09
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32511346,10.1101/2020.03.03.972133,2020-06-09
Infected,PROCESS_OF,Patients,32511345,10.1101/2020.03.05.979260,2020-06-09
"Spike Glycoprotein, Coronavirus",PART_OF,Engineer,32511342,10.1101/2020.05.12.091298,2020-06-09
Vaccine Design,USES,Clinical Use Template,32511341,10.1101/2020.05.13.092536,2020-06-09
Virus,INTERACTS_WITH,Virus Diseases,32511340,10.1101/2020.05.13.093195,2020-06-09
Genes,ASSOCIATED_WITH,Inflammation,32511340,10.1101/2020.05.13.093195,2020-06-09
Cells,PART_OF,Lung,32511340,10.1101/2020.05.13.093195,2020-06-09
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32511338,10.1101/2020.05.14.096727,2020-06-09
Histocompatibility Antigens Class I,ADMINISTERED_TO,Pathogenic organism,32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,ASSOCIATED_WITH,HIV Infections,32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,INTERACTS_WITH,Histocompatibility Antigens Class I,32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,COEXISTS_WITH,"M Protein, multiple myeloma",32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32511338,10.1101/2020.05.14.096727,2020-06-09
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32511338,10.1101/2020.05.14.096727,2020-06-09
Genus: Coronavirus,LOCATION_OF,Epitopes,32511338,10.1101/2020.05.14.096727,2020-06-09
Present,PROCESS_OF,Persons,32511338,10.1101/2020.05.14.096727,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Tissue Donors,32511336,10.1101/2020.03.26.010322,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32511336,10.1101/2020.03.26.010322,2020-06-09
Protomers,AFFECTS,Immune Evasion,32511335,10.1101/2020.03.07.982264,2020-06-09
Genus: Coronavirus,PROCESS_OF,Chiroptera,32511334,10.1101/2020.03.25.008904,2020-06-09
Interferons,TREATS,Hypersensitivity,32511334,10.1101/2020.03.25.008904,2020-06-09
Vero Cells,LOCATION_OF,SARS coronavirus,32511334,10.1101/2020.03.25.008904,2020-06-09
,STIMULATES,Phosphorylation,32511334,10.1101/2020.03.25.008904,2020-06-09
"Gene Products, Protein",AUGMENTS,Present,32511334,10.1101/2020.03.25.008904,2020-06-09
Cell Count,USES,CD244 gene,32511334,10.1101/2020.03.25.008904,2020-06-09
Homologous Gene,COEXISTS_WITH,Viral Proteins,32511334,10.1101/2020.03.25.008904,2020-06-09
Homologous Gene,INHIBITS,Interferons,32511334,10.1101/2020.03.25.008904,2020-06-09
Proteome,PART_OF,Virus,32511333,10.1101/2020.03.20.000141,2020-06-09
SARS coronavirus,CAUSES,Communicable Diseases,32511332,10.1101/2020.04.24.057323,2020-06-09
Measles Virus Nucleoprotein,CAUSES,Symptom mild,32511332,10.1101/2020.04.24.057323,2020-06-09
Homo sapiens,ISA,Animals,32511332,10.1101/2020.04.24.057323,2020-06-09
Persons,LOCATION_OF,Immune Sera,32511331,10.1101/2020.03.29.008631,2020-06-09
Azithromycin,ISA,Pharmaceutical Preparations,32511330,10.1101/2020.04.09.034967,2020-06-09
intracellular organelle,LOCATION_OF,Ciprofloxacin,32511330,10.1101/2020.04.09.034967,2020-06-09
intracellular organelle,LOCATION_OF,Azithromycin,32511330,10.1101/2020.04.09.034967,2020-06-09
Hydroxychloroquine,INTERACTS_WITH,Azithromycin,32511330,10.1101/2020.04.09.034967,2020-06-09
Azithromycin,INTERACTS_WITH,Hydroxychloroquine,32511330,10.1101/2020.04.09.034967,2020-06-09
Toxic Epidermal Necrolysis,PROCESS_OF,Homo sapiens,32511329,10.1101/2020.03.22.002386,2020-06-09
Catarrhine,ISA,Monkeys,32511329,10.1101/2020.03.22.002386,2020-06-09
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,disease prevention,32511327,10.1101/2020.04.02.022764,2020-06-09
Real-Time Polymerase Chain Reaction,NEG_USES,Ribonucleic acid extraction technique,32511327,10.1101/2020.04.02.022764,2020-06-09
Suspicion,PROCESS_OF,Persons,32511327,10.1101/2020.04.02.022764,2020-06-09
Coronavirus Infections,CAUSES,Disease,32511326,10.1101/2020.04.09.034454,2020-06-09
Recombinant Interferon,PART_OF,Homo sapiens,32511326,10.1101/2020.04.09.034454,2020-06-09
Vero Cells,LOCATION_OF,,32511326,10.1101/2020.04.09.034454,2020-06-09
Vero Cells,LOCATION_OF,,32511326,10.1101/2020.04.09.034454,2020-06-09
Antiviral Response,PRODUCES,Epitopes,32511324,10.1101/2020.03.24.006544,2020-06-09
SARS coronavirus,ISA,Betacoronavirus,32511324,10.1101/2020.03.24.006544,2020-06-09
SARS coronavirus,LOCATION_OF(SPEC),Epitopes,32511324,10.1101/2020.03.24.006544,2020-06-09
Betacoronavirus,LOCATION_OF,Epitopes,32511324,10.1101/2020.03.24.006544,2020-06-09
Alleles,INTERACTS_WITH,Peptides,32511324,10.1101/2020.03.24.006544,2020-06-09
Proteins,CONVERTS_TO,Peptides,32511324,10.1101/2020.03.24.006544,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32511323,10.1101/2020.03.19.998724,2020-06-09
Serum,PART_OF,Homo sapiens,32511323,10.1101/2020.03.19.998724,2020-06-09
Severe Acute Respiratory Syndrome,AFFECTS,Disease Progression,32511323,10.1101/2020.03.19.998724,2020-06-09
HIV,CAUSES(SPEC),Acquired Immunodeficiency Syndrome,32511322,10.1101/2020.04.02.019075,2020-06-09
HIV,ISA,Virus,32511322,10.1101/2020.04.02.019075,2020-06-09
Virus,CAUSES,Acquired Immunodeficiency Syndrome,32511322,10.1101/2020.04.02.019075,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Human Age Group,32511321,10.1101/2020.03.16.994236,2020-06-09
Protein S,INTERACTS_WITH,ACE2 gene,32511320,10.1101/2020.03.18.997585,2020-06-09
Host Cell,LOCATION_OF,ACE2 gene,32511320,10.1101/2020.03.18.997585,2020-06-09
Host Cell,PRODUCES,Viral Genome,32511320,10.1101/2020.03.18.997585,2020-06-09
ACE2 gene,PART_OF,soluble,32511320,10.1101/2020.03.18.997585,2020-06-09
Peptides,INHIBITS,receptor binding sites,32511320,10.1101/2020.03.18.997585,2020-06-09
Coronavirus Infections,PROCESS_OF,Family,32511319,10.1101/2020.04.15.043166,2020-06-09
RNA-Directed RNA Polymerase,PART_OF,SARS coronavirus,32511319,10.1101/2020.04.15.043166,2020-06-09
Virus inhibitors,INHIBITS,RNA-Directed RNA Polymerase,32511319,10.1101/2020.04.15.043166,2020-06-09
Epclusa,ISA,Pharmaceutical Preparations,32511319,10.1101/2020.04.15.043166,2020-06-09
Pharmaceutical Preparations,TREATS,HIV,32511319,10.1101/2020.04.15.043166,2020-06-09
alovudine,ISA,Antiviral Agents,32511319,10.1101/2020.04.15.043166,2020-06-09
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disorder of lower respiratory system,32511318,10.1101/2020.03.24.005900,2020-06-09
Disorder of lower respiratory system,PROCESS_OF,Transient Population Group,32511318,10.1101/2020.03.24.005900,2020-06-09
Vaccination,PRECEDES,Autopsy,32511318,10.1101/2020.03.24.005900,2020-06-09
Topoisomerase,PART_OF,Homo sapiens,32511317,10.1101/2020.03.15.993097,2020-06-09
Pharmaceutical Preparations,INHIBITS,Topoisomerase,32511317,10.1101/2020.03.15.993097,2020-06-09
Patients,LOCATION_OF,Plasma,32511316,10.1101/2020.03.02.972935,2020-06-09
Nasopharynx,LOCATION_OF,Virus,32511315,10.1101/2020.05.11.089045,2020-06-09
Vero Cells,LOCATION_OF,Virus,32511315,10.1101/2020.05.11.089045,2020-06-09
Vero Cells,LOCATION_OF,Virus,32511315,10.1101/2020.05.11.089045,2020-06-09
3' Untranslated Regions,compared_with,Untranslated Regions,32511312,10.1101/2020.02.29.971101,2020-06-09
3' Untranslated Regions,higher_than,Untranslated Regions,32511312,10.1101/2020.02.29.971101,2020-06-09
SARS coronavirus,PROCESS_OF,Chiroptera,32511311,10.1101/2020.02.10.942185,2020-06-09
Implantation procedure,USES,Amino Acids,32511311,10.1101/2020.02.10.942185,2020-06-09
"M Protein, multiple myeloma",PRODUCES,paired basic amino acid cleaving enzyme,32511311,10.1101/2020.02.10.942185,2020-06-09
"M Protein, multiple myeloma",PRODUCES,TMPRSS2 gene,32511311,10.1101/2020.02.10.942185,2020-06-09
"Amino Acids, Basic",PART_OF,SARS coronavirus,32511310,10.1101/2020.02.07.939207,2020-06-09
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32511310,10.1101/2020.02.07.939207,2020-06-09
HEK293 Cells,LOCATION_OF,Proteins,32511306,10.1101/2020.03.27.012906,2020-06-09
Virus,LOCATION_OF,Antigens,32511306,10.1101/2020.03.27.012906,2020-06-09
Peptides,COEXISTS_WITH,Glycoproteins,32511306,10.1101/2020.03.27.012906,2020-06-09
Protein Glycosylation,AFFECTS,Adaptive Immune Response,32511306,10.1101/2020.03.27.012906,2020-06-09
Human leukocyte antigen complex,LOCATION_OF,Peptides,32511306,10.1101/2020.03.27.012906,2020-06-09
Polysaccharides,INTERACTS_WITH,Antibodies,32511306,10.1101/2020.03.27.012906,2020-06-09
Antiviral Agents,INTERACTS_WITH,RNA,32511305,10.1101/2020.04.07.030734,2020-06-09
Virus,PROCESS_OF,Homo sapiens,32511303,10.1101/2020.04.17.047480,2020-06-09
ACE2 gene,PART_OF,Homo sapiens,32511303,10.1101/2020.04.17.047480,2020-06-09
SARS coronavirus,PROCESS_OF,Chiroptera,32511303,10.1101/2020.04.17.047480,2020-06-09
Gene Feature,PART_OF,SARS coronavirus,32511303,10.1101/2020.04.17.047480,2020-06-09
Lethal,PROCESS_OF,Older people,32511302,10.1101/2020.04.15.043364,2020-06-09
Interferons,DISRUPTS,Virus Replication,32511302,10.1101/2020.04.15.043364,2020-06-09
Nicotinamide adenine dinucleotide (NAD),PART_OF,Host Cell,32511302,10.1101/2020.04.15.043364,2020-06-09
Patients,LOCATION_OF,Respiratory sample,32511301,10.1101/2020.04.05.026450,2020-06-09
Measles Virus Nucleoprotein,COEXISTS_WITH,Glycoproteins,32511300,10.1101/2020.03.30.016832,2020-06-09
Coronavirus Infections,CAUSES,Respiration Disorders,32511298,10.1101/2020.03.15.992883,2020-06-09
Disease,PROCESS_OF,Homo sapiens,32511298,10.1101/2020.03.15.992883,2020-06-09
Disease,PROCESS_OF,Animal Model,32511298,10.1101/2020.03.15.992883,2020-06-09
Disease,PROCESS_OF,Macaca mulatta,32511298,10.1101/2020.03.15.992883,2020-06-09
Respiration Disorders,PROCESS_OF,Macaca mulatta,32511298,10.1101/2020.03.15.992883,2020-06-09
Disease,PROCESS_OF,Homo sapiens,32511298,10.1101/2020.03.15.992883,2020-06-09
Nose,PART_OF,Animals,32511298,10.1101/2020.03.15.992883,2020-06-09
Pharyngeal structure,PART_OF,Animals,32511298,10.1101/2020.03.15.992883,2020-06-09
Antibodies,INTERACTS_WITH,Binding Sites,32511297,10.1101/2020.03.04.977736,2020-06-09
Betacoronavirus,LOCATION_OF,Epitopes,32511297,10.1101/2020.03.04.977736,2020-06-09
Epitopes,PART_OF,Betacoronavirus,32511297,10.1101/2020.03.04.977736,2020-06-09
Severe disorder,PROCESS_OF,Homo sapiens,32511296,10.1101/2020.03.02.968818,2020-06-09
Virus,LOCATION_OF,Immunoglobulins,32511296,10.1101/2020.03.02.968818,2020-06-09
Glycoproteins,INTERACTS_WITH,Vaccines,32511294,10.1101/2020.01.22.915660,2020-06-09
Coronavirus Infections,PROCESS_OF,Animals,32511293,10.1101/2020.04.15.20066431,2020-06-09
SARS coronavirus,ISA,Betacoronavirus,32511293,10.1101/2020.04.15.20066431,2020-06-09
ACE2 gene,PART_OF,Homo sapiens,32511293,10.1101/2020.04.15.20066431,2020-06-09
STMN1 gene,AFFECTS,Coronavirus Infections,32511291,10.26434/chemrxiv.12153615,2020-06-09
Pneumonia and influenza,CAUSES,Cessation of life,32511291,10.26434/chemrxiv.12153615,2020-06-09
Pneumonia and influenza,CAUSES,Cessation of life,32511291,10.26434/chemrxiv.12153615,2020-06-09
Pneumonia and influenza,CAUSES,Cessation of life,32511291,10.26434/chemrxiv.12153615,2020-06-09
Antiviral Agents,TREATS,Persons,32511290,10.26434/chemrxiv.12084822,2020-06-09
Antiviral Agents,TREATS(INFER),Infected,32511290,10.26434/chemrxiv.12084822,2020-06-09
Infected,PROCESS_OF,Persons,32511290,10.26434/chemrxiv.12084822,2020-06-09
Pharmaceutical Preparations,TREATS,Homo sapiens,32511290,10.26434/chemrxiv.12084822,2020-06-09
Pharmaceutical Preparations,NEG_TREATS,Disease,32511289,10.26434/chemrxiv.12275705,2020-06-09
Severe Acute Respiratory Syndrome,ISA,Virus Diseases,32511289,10.26434/chemrxiv.12275705,2020-06-09
Protease Inhibitors,TREATS,HIV,32511289,10.26434/chemrxiv.12275705,2020-06-09
Antiviral Agents,INTERACTS_WITH,Proteins,32511289,10.26434/chemrxiv.12275705,2020-06-09
Investigational New Drugs,INTERACTS_WITH,Proteins,32511289,10.26434/chemrxiv.12275705,2020-06-09
grazoprevir,ISA,Pharmaceutical Preparations,32511289,10.26434/chemrxiv.12275705,2020-06-09
Pharmaceutical Preparations,TREATS,Virus,32511288,10.26434/chemrxiv.12009582,2020-06-09
Serine Proteinase Inhibitors,ISA,Pharmaceutical Preparations,32511287,10.26434/chemrxiv.12153594,2020-06-09
Pharmaceutical Preparations,ISA,Chemicals,32511287,10.26434/chemrxiv.12153594,2020-06-09
TMPRSS2 gene,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32511287,10.26434/chemrxiv.12153594,2020-06-09
Endopeptidases,PART_OF,SARS coronavirus,32511285,10.26434/chemrxiv.11728983,2020-06-09
Coronavirus Infections,NEG_PROCESS_OF,Homo sapiens,32511260,10.1371/journal.pone.0234023,2020-06-09
Reverse Transcriptase Polymerase Chain Reaction,USES,Laboratory,32511260,10.1371/journal.pone.0234023,2020-06-09
Infected,PROCESS_OF,Persons,32511260,10.1371/journal.pone.0234023,2020-06-09
Ambulatory Care Facilities,LOCATION_OF,Laboratory Procedures,32511260,10.1371/journal.pone.0234023,2020-06-09
Nucleic Acids,PART_OF,IFNG-AS1 gene,32511260,10.1371/journal.pone.0234023,2020-06-09
Disease,PROCESS_OF,Population Group,32511245,10.1371/journal.pbio.3000715,2020-06-09
Quantitative Autoradiography,USES,Electron Microscopy,32511190,10.1097/JXX.0000000000000448,2020-06-09
huperzine B,INTERACTS_WITH,"RNA, Viral",32511190,10.1097/JXX.0000000000000448,2020-06-09
Vesicle (morphologic abnormality),COEXISTS_WITH,Coronavirus Infections,32511190,10.1097/JXX.0000000000000448,2020-06-09
Aging,PROCESS_OF,Population Group,32511171,10.1097/NJH.0000000000000665,2020-06-09
Critical Illness,PROCESS_OF,Patients,32511171,10.1097/NJH.0000000000000665,2020-06-09
Chronic disease,PROCESS_OF,Patients,32511100,10.2196/19606,2020-06-09
Collagen Diseases,PROCESS_OF,Patients,32511100,10.2196/19606,2020-06-09
Complication,PROCESS_OF,Patients,32511100,10.2196/19606,2020-06-09
Comprehensive Health Care,PREVENTS,Complication,32511100,10.2196/19606,2020-06-09
Comprehensive Health Care,PREVENTS,Infection,32511100,10.2196/19606,2020-06-09
Infection,PROCESS_OF,Patients,32511100,10.2196/19606,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
"CD69 protein, human",PART_OF,Patients,32511099,10.2196/19947,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32511099,10.2196/19947,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
Coronavirus Infections,ISA,Disease,32511099,10.2196/19947,2020-06-09
Disease,PROCESS_OF,Patients,32511089,10.3201/eid2609.202267,2020-06-09
Coronavirus Infections,ISA,Disease,32511089,10.3201/eid2609.202267,2020-06-09
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32511089,10.3201/eid2609.202267,2020-06-09
High Level,COEXISTS_WITH,Malaise,32511089,10.3201/eid2609.202267,2020-06-09
Disease,PROCESS_OF,Patients,32511089,10.3201/eid2609.202267,2020-06-09
Coronavirus Infections,ISA,Disease,32511089,10.3201/eid2609.202267,2020-06-09
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32511089,10.3201/eid2609.202267,2020-06-09
Introduction procedure,STIMULATES,Vision,32511089,10.3201/eid2609.202267,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511054,10.1089/omi.2020.0089,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511054,10.1089/omi.2020.0089,2020-06-09
Malignant Neoplasms,PROCESS_OF,Patients,32511054,10.1089/omi.2020.0089,2020-06-09
Malignant Neoplasms,PROCESS_OF,geriatric patients,32511054,10.1089/omi.2020.0089,2020-06-09
Oral health,TREATS,Older people,32511033,10.1080/17446651.2020.1774360,2020-06-09
Neglected Diseases,CAUSES,Infection,32511033,10.1080/17446651.2020.1774360,2020-06-09
Oral care,TREATS,World,32511033,10.1080/17446651.2020.1774360,2020-06-09
Diabetes Mellitus,PROCESS_OF,Patients,32510978,10.1161/ATVBAHA.120.314558,2020-06-09
IMPACT gene,INTERACTS_WITH,Blood Glucose,32510978,10.1161/ATVBAHA.120.314558,2020-06-09
Hospital admission,TREATS,Supplemental oxygen,32510973,10.1152/ajpcell.00224.2020,2020-06-09
cytokine,AUGMENTS,Acute Lung Injury,32510973,10.1152/ajpcell.00224.2020,2020-06-09
Endothelium,AFFECTS,Cardiac complication,32510973,10.1152/ajpcell.00224.2020,2020-06-09
Disease Progression,AFFECTS,endothelial dysfunction,32510973,10.1152/ajpcell.00224.2020,2020-06-09
Disease Progression,PROCESS_OF,Persons,32510973,10.1152/ajpcell.00224.2020,2020-06-09
Therapeutic procedure,TREATS,Response process,32510973,10.1152/ajpcell.00224.2020,2020-06-09
Mitochondria,LOCATION_OF,SARS coronavirus,32510901,10.5935/1518-0557.20200047,2020-06-09
Mitochondria,PART_OF,Host Cell,32510901,10.5935/1518-0557.20200047,2020-06-09
Open Reading Frames,AUGMENTS,Virus Replication,32510901,10.5935/1518-0557.20200047,2020-06-09
Open Reading Frames,INTERACTS_WITH,ACE2 gene,32510901,10.5935/1518-0557.20200047,2020-06-09
"DNA, Mitochondrial",STIMULATES,Inflammasomes,32510901,10.5935/1518-0557.20200047,2020-06-09
Open Reading Frames,PRODUCES,"DNA, Mitochondrial",32510901,10.5935/1518-0557.20200047,2020-06-09
Elderly (population group),LOCATION_OF,ACE2 gene,32510901,10.5935/1518-0557.20200047,2020-06-09
Mitochondria,LOCATION_OF,ACE2 gene,32510901,10.5935/1518-0557.20200047,2020-06-09
ACE2 gene,CAUSES,Malignant Neoplasms,32510901,10.5935/1518-0557.20200047,2020-06-09
ACE2 gene,CAUSES,Diabetes,32510901,10.5935/1518-0557.20200047,2020-06-09
ACE2 gene,CAUSES,Chronic metabolic disorder,32510901,10.5935/1518-0557.20200047,2020-06-09
Mitochondria,LOCATION_OF,Proteins,32510901,10.5935/1518-0557.20200047,2020-06-09
Symptoms,PROCESS_OF,hospitalized patients,32510799,10.1111/1744-9987.13536,2020-06-09
Skin Manifestations,PROCESS_OF,Patients,32510799,10.1111/1744-9987.13536,2020-06-09
Pneumonia,CAUSES,Cessation of life,32510771,10.1111/tid.13356,2020-06-09
Pneumonia,PROCESS_OF,Transplant Recipients,32510756,10.1111/tid.13355,2020-06-09
"Signs and Symptoms, Respiratory",PROCESS_OF,Transplant Recipients,32510748,10.1111/1462-2920.15118,2020-06-09
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32510748,10.1111/1462-2920.15118,2020-06-09
Vasopressins,CAUSES,Hyponatremia,32510748,10.1111/1462-2920.15118,2020-06-09
Hyponatremia,PROCESS_OF,Population Group,32510748,10.1111/1462-2920.15118,2020-06-09
Syndrome,CAUSES,Hyponatremia,32510748,10.1111/1462-2920.15118,2020-06-09
Hyponatremia,OCCURS_IN,Transplant Recipients,32510748,10.1111/1462-2920.15118,2020-06-09
Coronavirus Infections,CAUSES,Influenza-like illness,32510716,10.1002/hed.26320,2020-06-09
San Francisco,ISA,California,32510716,10.1002/hed.26320,2020-06-09
Azithromycin,TREATS,Adult,32510716,10.1002/hed.26320,2020-06-09
Azithromycin,TREATS,Child,32510716,10.1002/hed.26320,2020-06-09
Operative Surgical Procedures,TREATS,pathologic fistula,32510697,10.15252/embr.202050883,2020-06-09
Pandemics,CAUSES,Toxic Epidermal Necrolysis,32510581,10.1002/ijgo.13265,2020-06-09
Heart,PART_OF,Adult,32510581,10.1002/ijgo.13265,2020-06-09
ACE2 gene,ASSOCIATED_WITH,Pulmonary Fibrosis,32510581,10.1002/ijgo.13265,2020-06-09
Blood Circulation,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
Heart,PART_OF,Homo sapiens,32510581,10.1002/ijgo.13265,2020-06-09
Heart failure,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
ACE2 gene,INTERACTS_WITH,"Myocytes, Cardiac",32510581,10.1002/ijgo.13265,2020-06-09
Respiratory syncytial virus,PROCESS_OF,Mus,32510581,10.1002/ijgo.13265,2020-06-09
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Mus,32510581,10.1002/ijgo.13265,2020-06-09
Heart failure,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
Pulmonary Fibrosis,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
Virus Diseases,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32510581,10.1002/ijgo.13265,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32510581,10.1002/ijgo.13265,2020-06-09
Pneumonia,NEG_PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Asymptomatic Infections,PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Gravidity,PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Patients,LOCATION_OF,C-reactive protein,32510576,10.1002/ijgo.13264,2020-06-09
Patients,LOCATION_OF,Fibrin fragment D,32510576,10.1002/ijgo.13264,2020-06-09
Patients,LOCATION_OF,procalcitonin,32510576,10.1002/ijgo.13264,2020-06-09
Pregnant Women,LOCATION_OF,Fibrin fragment D,32510576,10.1002/ijgo.13264,2020-06-09
Pregnant Women,LOCATION_OF,GSKIP gene,32510576,10.1002/ijgo.13264,2020-06-09
Fibrin fragment D,compared_with,GSKIP gene,32510576,10.1002/ijgo.13264,2020-06-09
Gravidity,PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Gravidity,PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Gravidity,PROCESS_OF,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Medical counseling,TREATS,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Active Method,TREATS,Patients,32510576,10.1002/ijgo.13264,2020-06-09
Perception,PROCESS_OF,Participant,32510562,10.1093/femspd/ftaa025,2020-06-09
Immune,PROCESS_OF,Population Group,32510525,10.1101/2020.04.29.20083485,2020-06-09
Immune,PROCESS_OF,Persons,32510525,10.1101/2020.04.29.20083485,2020-06-09
Immune response,NEG_PROCESS_OF,Patients,32510525,10.1101/2020.04.29.20083485,2020-06-09
Infected,PROCESS_OF,Persons,32510524,10.1101/2020.04.24.056259,2020-06-09
Country,ISA,Geographic Locations,32510524,10.1101/2020.04.24.056259,2020-06-09
Antibody Formation,PROCESS_OF,Patients,32510339,10.1016/j.bios.2020.112356,2020-06-09
saliva,PART_OF,Pharyngeal structure,32510339,10.1016/j.bios.2020.112356,2020-06-09
Ligation,USES,Probes,32510329,10.7554/eLife.58989,2020-06-09
Experience,PROCESS_OF,Cohort,32510232,10.1037/tra0000619,2020-06-09
Wounds and Injuries,PROCESS_OF,Homo sapiens,32510173,10.1002/jmv.26146,2020-06-09
Gastrointestinal symptom,COEXISTS_WITH,patient condition,32510169,10.1002/jmv.26142,2020-06-09
Gastrointestinal symptom,OCCURS_IN,Patients,32510169,10.1002/jmv.26142,2020-06-09
Gastrointestinal symptom,PROCESS_OF,Patients,32510169,10.1002/jmv.26142,2020-06-09
Gastrointestinal symptom,COEXISTS_WITH,patient condition,32510169,10.1002/jmv.26142,2020-06-09
arbidol,ADMINISTERED_TO,Control Groups,32510168,10.1002/jmv.26145,2020-06-09
Nose,LOCATION_OF,Obstruction,32510168,10.1002/jmv.26145,2020-06-09
Nucleic Acids,PART_OF,Virus,32510168,10.1002/jmv.26145,2020-06-09
procalcitonin,NEG_PART_OF,Virus,32510168,10.1002/jmv.26145,2020-06-09
C-reactive protein,PART_OF,Patients,32510168,10.1002/jmv.26145,2020-06-09
Fasting,PROCESS_OF,Control Groups,32510168,10.1002/jmv.26145,2020-06-09
adjuvant therapy,TREATS,Fever,32510168,10.1002/jmv.26145,2020-06-09
Enzyme-Linked Immunosorbent Assay,USES,Assay,32510164,10.1002/jmv.26143,2020-06-09
Specimen Type - Serum,PART_OF,Plasma,32510164,10.1002/jmv.26143,2020-06-09
other medicated shampoos in ATC,COEXISTS_WITH,FATE1 gene,32510155,10.1093/ejcts/ezaa193,2020-06-09
Aortic Valve Insufficiency,PROCESS_OF,Patients,32510142,10.1042/BST20200505,2020-06-09
Surgical Replantation,TREATS,Patients,32510142,10.1042/BST20200505,2020-06-09
Surgical Replantation,TREATS(INFER),Aortic Valve Insufficiency,32510142,10.1042/BST20200505,2020-06-09
Radionuclide Imaging,ADMINISTERED_TO,Patients,32510142,10.1042/BST20200505,2020-06-09
Radionuclide Imaging,DIAGNOSES,Infiltration,32510142,10.1042/BST20200505,2020-06-09
Left lung,LOCATION_OF,Infiltration,32510142,10.1042/BST20200505,2020-06-09
Surgical Replantation,USES,Medical Valves,32510142,10.1042/BST20200505,2020-06-09
Duration,PREDISPOSES,pulmonary complications,32510142,10.1042/BST20200505,2020-06-09
Ambulatory Care Facilities,LOCATION_OF,Pathology procedure,32510106,10.1007/s12603-020-1389-1,2020-06-09
Pharmaceutical Preparations,DISRUPTS,Biochemical Pathway,32510106,10.1007/s12603-020-1389-1,2020-06-09
miglitol,ISA,Pharmaceutical Preparations,32510106,10.1007/s12603-020-1389-1,2020-06-09
risk factors,PROCESS_OF,Patients,32510105,10.1007/s12603-020-1385-5,2020-06-09
Hospitals,LOCATION_OF,Diagnosis,32510105,10.1007/s12603-020-1385-5,2020-06-09
Dementia,AFFECTS,Patients,32510105,10.1007/s12603-020-1385-5,2020-06-09
Diagnosis,DIAGNOSES,Dementia,32510105,10.1007/s12603-020-1385-5,2020-06-09
risk factors,PROCESS_OF,Patients,32510105,10.1007/s12603-020-1385-5,2020-06-09
Dementia,PROCESS_OF,Patients,32510105,10.1007/s12603-020-1385-5,2020-06-09
Dementia,ISA,Symptoms,32510105,10.1007/s12603-020-1385-5,2020-06-09
Hypertensive disease,ISA,Cardiovascular Diseases,32510102,10.1007/s12603-020-1401-9,2020-06-09
Heart failure,COEXISTS_WITH,diabetic,32510102,10.1007/s12603-020-1401-9,2020-06-09
Cardiovascular,NEG_LOCATION_OF,Comorbidity,32510102,10.1007/s12603-020-1401-9,2020-06-09
Nitrogen trichloride poisoning,PROCESS_OF,Population Group,32510102,10.1007/s12603-020-1401-9,2020-06-09
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32510102,10.1007/s12603-020-1401-9,2020-06-09
Psyche structure,PROCESS_OF,Physicians,32510102,10.1007/s12603-020-1401-9,2020-06-09
Coronavirus Infections,ISA,Disease,32510042,10.1002/hbe2.191,2020-06-09
Universities,LOCATION_OF,Online Learning,32510005,10.1016/j.genrep.2020.100740,2020-06-09
Virus,INTERACTS_WITH,Disease,32509977,10.1093/hropen/hoaa028,2020-06-09
Virus,INTERACTS_WITH(SPEC),Coronavirus Infections,32509977,10.1093/hropen/hoaa028,2020-06-09
Coronavirus Infections,ISA,Disease,32509977,10.1093/hropen/hoaa028,2020-06-09
Endometriosis,PROCESS_OF,Patients,32509960,10.1055/a-1180-8527,2020-06-09
Disease,PREDISPOSES,Coronavirus Infections,32509960,10.1055/a-1180-8527,2020-06-09
Endometriosis,ISA,Disease,32509960,10.1055/a-1180-8527,2020-06-09
Endometriosis,PREDISPOSES(SPEC),Coronavirus Infections,32509960,10.1055/a-1180-8527,2020-06-09
Endometriosis,PROCESS_OF,Patients,32509960,10.1055/a-1180-8527,2020-06-09
Self-Management,TREATS,Symptoms,32509960,10.1055/a-1180-8527,2020-06-09
Self-Management,TREATS,Pain,32509960,10.1055/a-1180-8527,2020-06-09
Pregnant Women,LOCATION_OF,GSKIP gene,32509860,10.1155/2020/4892382,2020-06-09
Spontaneous abortion,ISA,Pregnancy Outcome,32509860,10.1155/2020/4892382,2020-06-09
Fever,PROCESS_OF,Woman,32509860,10.1155/2020/4892382,2020-06-09
Stillbirth,ISA,Pregnancy Outcome,32509860,10.1155/2020/4892382,2020-06-09
Viral Respiratory Tract Infection,AFFECTS,Spontaneous abortion,32509860,10.1155/2020/4892382,2020-06-09
Viral Respiratory Tract Infection,AFFECTS,Premature Obstetric Labor,32509860,10.1155/2020/4892382,2020-06-09
Viral Respiratory Tract Infection,AFFECTS,Low Birth Weights,32509860,10.1155/2020/4892382,2020-06-09
Viral Respiratory Tract Infection,AFFECTS,Stillbirth,32509860,10.1155/2020/4892382,2020-06-09
Hand,PART_OF,Persons,32509860,10.1155/2020/4892382,2020-06-09
Infected,PROCESS_OF,Persons,32509860,10.1155/2020/4892382,2020-06-09
Frail,PROCESS_OF,Population Group,32509535,10.1016/j.omsc.2020.100160,2020-06-09
School,LOCATION_OF,educational programs,32509535,10.1016/j.omsc.2020.100160,2020-06-09
BARRIER,USES,Equipment,32509485,10.7759/cureus.8408,2020-06-09
Blood Coagulation Disorders,COEXISTS_WITH,Coronavirus Infections,32509479,10.7759/cureus.7954,2020-06-09
Limb structure,LOCATION_OF,Deep Vein Thrombosis,32509479,10.7759/cureus.7954,2020-06-09
Pneumonia,PROCESS_OF,Patients,32509479,10.7759/cureus.7954,2020-06-09
Deep Vein Thrombosis,PROCESS_OF,Patients,32509479,10.7759/cureus.7954,2020-06-09
Virus Diseases,AFFECTS,Thrombosis,32509479,10.7759/cureus.7954,2020-06-09
Box,ISA,Materials,32509472,10.7717/peerj.9255,2020-06-09
Cesarean section,METHOD_OF,Intubation,32509415,10.1055/s-0040-1712926,2020-06-09
mother and fetus,LOCATION_OF,consideration,32509415,10.1055/s-0040-1712926,2020-06-09
Heart failure,CAUSES,Pulmonary Edema,32509338,10.1038/s41541-020-0193-6,2020-06-09
Hypertensive emergency,CAUSES,Heart failure,32509338,10.1038/s41541-020-0193-6,2020-06-09
Chest,LOCATION_OF,tomography,32509338,10.1038/s41541-020-0193-6,2020-06-09
Vaccines,TREATS,Homo sapiens,32509312,10.1186/s40545-020-00216-4,2020-06-09
Vaccines,TREATS,Viral Pathogenesis,32509312,10.1186/s40545-020-00216-4,2020-06-09
Eating Disorders,PROCESS_OF,Woman,32509294,10.7189/jogh.10.011005,2020-06-09
Persons,LOCATION_OF,IMPACT gene,32509294,10.7189/jogh.10.011005,2020-06-09
Eating Disorders,PROCESS_OF,Persons,32509294,10.7189/jogh.10.011005,2020-06-09
Eating Disorders,PROCESS_OF,Persons,32509294,10.7189/jogh.10.011005,2020-06-09
National Academy of Sciences (U.S.),LOCATION_OF,Diagnosis,32509258,10.4081/cp.2020.1271,2020-06-09
Elderly (population group),ISA,Persons,32509258,10.4081/cp.2020.1271,2020-06-09
Toxic Epidermal Necrolysis,PROCESS_OF,Foundation for the Accreditation of Cellular Therapy,32509258,10.4081/cp.2020.1271,2020-06-09
Hygiene,ISA,Technology,32509258,10.4081/cp.2020.1271,2020-06-09
,PART_OF,Erythrocytes,32509006,10.3892/etm.2020.8671,2020-06-09
Hemoglobin,PART_OF,Erythrocytes,32509006,10.3892/etm.2020.8671,2020-06-09
receptor,PART_OF,Erythrocytes,32509006,10.3892/etm.2020.8671,2020-06-09
"DPP4 protein, human",PART_OF,Erythrocytes,32509006,10.3892/etm.2020.8671,2020-06-09
Blood capillaries,LOCATION_OF,BARRIER,32509006,10.3892/etm.2020.8671,2020-06-09
Hematological Disease,COEXISTS_WITH,consideration,32509006,10.3892/etm.2020.8671,2020-06-09
Intervention regimes,USES,Immunologic Adjuvants,32509006,10.3892/etm.2020.8671,2020-06-09
Neoplasms,AFFECTS,Anxiety,32508399,10.1016/j.chaos.2020.109945,2020-06-09
India,ISA,Country,32508398,10.1016/j.chaos.2020.109891,2020-06-09
Evaluation,USES,Metric,32508398,10.1016/j.chaos.2020.109891,2020-06-09
Possible,COEXISTS_WITH,Symptoms,32508374,10.1016/j.landusepol.2020.104805,2020-06-09
Myasthenia Gravis,PROCESS_OF,Patients,32508313,10.1530/EJE-20-0377,2020-06-09
Complication,NEG_AFFECTS,Myasthenias,32508313,10.1530/EJE-20-0377,2020-06-09
Patients,ISA,Persons,32508313,10.1530/EJE-20-0377,2020-06-09
Delivery care,USES,SYNE2 gene,32508311,10.1530/ERC-20-0165,2020-06-09
Diabetes,PROCESS_OF,Persons,32508311,10.1530/ERC-20-0165,2020-06-09
Diabetes,PROCESS_OF,Persons,32508311,10.1530/ERC-20-0165,2020-06-09
Complication,CAUSES,Diabetes Mellitus,32508311,10.1530/ERC-20-0165,2020-06-09
angiotensin converting enzyme 2,AUGMENTS,Virus Internalization,32508257,10.1177/0300891620933672,2020-06-09
Human tissue,LOCATION_OF,angiotensin converting enzyme 2,32508257,10.1177/0300891620933672,2020-06-09
Human tissue,LOCATION_OF,TMPRSS2 gene,32508257,10.1177/0300891620933672,2020-06-09
TMPRSS2 gene,AFFECTS,Malignant neoplasm of prostate,32508257,10.1177/0300891620933672,2020-06-09
Antiandrogen therapy,METHOD_OF,androgen suppression,32508257,10.1177/0300891620933672,2020-06-09
androgen suppression,TREATS,Malignant neoplasm of prostate,32508257,10.1177/0300891620933672,2020-06-09
Androgens,INHIBITS,TMPRSS2 gene,32508257,10.1177/0300891620933672,2020-06-09
Androgens,INTERACTS_WITH,angiotensin converting enzyme 2,32508257,10.1177/0300891620933672,2020-06-09
Androgens,INTERACTS_WITH,TMPRSS2 gene,32508257,10.1177/0300891620933672,2020-06-09
Androgens,TREATS,Malignant neoplasm of prostate,32508257,10.1177/0300891620933672,2020-06-09
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32508193,10.1080/13685538.2020.1774748,2020-06-09
Shock,PROCESS_OF,Woman,32508062,10.1002/ctm2.44,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32508062,10.1002/ctm2.44,2020-06-09
Storm Syndrome,CAUSES,Hyperpyrexia,32508062,10.1002/ctm2.44,2020-06-09
Extracorporeal Membrane Oxygenation,TREATS,Hyperpyrexia,32508062,10.1002/ctm2.44,2020-06-09
Hyperpyrexia,PROCESS_OF,Patients,32508062,10.1002/ctm2.44,2020-06-09
Storm Syndrome,PROCESS_OF,Patients,32508062,10.1002/ctm2.44,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32508041,10.1002/ctm2.17,2020-06-09
Severe disorder,PROCESS_OF,Patients,32508041,10.1002/ctm2.17,2020-06-09
alteplase,ADMINISTERED_TO,Patients,32508041,10.1002/ctm2.17,2020-06-09
Pneumonia,PROCESS_OF,Patients,32508041,10.1002/ctm2.17,2020-06-09
Shock,PROCESS_OF,Patients,32508041,10.1002/ctm2.17,2020-06-09
Respiratory Failure,PROCESS_OF,Patients,32508041,10.1002/ctm2.17,2020-06-09
Lung,LOCATION_OF,Microthrombus,32508041,10.1002/ctm2.17,2020-06-09
Pneumonia,CAUSES,endothelial dysfunction,32508041,10.1002/ctm2.17,2020-06-09
Pneumonia,CAUSES,Respiratory Failure,32508041,10.1002/ctm2.17,2020-06-09
Severe Acute Respiratory Syndrome,ISA,Respiratory Tract Infections,32508038,10.1002/ctm2.23,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32508038,10.1002/ctm2.23,2020-06-09
Dyspnea,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32508038,10.1002/ctm2.23,2020-06-09
Diagnosis,AFFECTS,Physician service,32508038,10.1002/ctm2.23,2020-06-09
Pneumonia,CAUSES,Community acquired pneumonia,32508026,10.1002/ctm2.90,2020-06-09
Community acquired pneumonia,PROCESS_OF,Patients,32508026,10.1002/ctm2.90,2020-06-09
Community acquired pneumonia,PROCESS_OF,Patients,32508026,10.1002/ctm2.90,2020-06-09
Disorder characterized by fever,PROCESS_OF,Patients,32508026,10.1002/ctm2.90,2020-06-09
Immunochromatographic Assay,USES,Gold Colloid,32508022,10.1002/ctm2.16,2020-06-09
Antibodies,AFFECTS(SPEC),Membrane,32508022,10.1002/ctm2.16,2020-06-09
Antibodies,ISA,Antigens,32508022,10.1002/ctm2.16,2020-06-09
Antibodies,PART_OF,Lactobacillus rhamnosus GG,32508022,10.1002/ctm2.16,2020-06-09
Antigens,AFFECTS,Membrane,32508022,10.1002/ctm2.16,2020-06-09
Immunochromatographic Assay,USES,Gold Colloid,32508022,10.1002/ctm2.16,2020-06-09
Specimen Type - Serum,PART_OF,Plasma,32508022,10.1002/ctm2.16,2020-06-09
Infected,PROCESS_OF,Patients,32508021,10.1002/ctm2.7,2020-06-09
Acute Lung Injury,ISA,Pulmonary Edema,32508021,10.1002/ctm2.7,2020-06-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32508021,10.1002/ctm2.7,2020-06-09
Glucocorticoids,TREATS,Edema,32508021,10.1002/ctm2.7,2020-06-09
Glucocorticoids,TREATS,Pneumonia,32508021,10.1002/ctm2.7,2020-06-09
Pneumonia,PROCESS_OF,Patients,32507963,10.1007/s12020-020-02364-8,2020-06-09
Comorbidity,PROCESS_OF,Persons,32507926,10.1007/s11739-020-02390-4,2020-06-09
Comorbidity,PROCESS_OF,Pregnant Women,32507926,10.1007/s11739-020-02390-4,2020-06-09
Comorbidity,PROCESS_OF,Old age,32507926,10.1007/s11739-020-02390-4,2020-06-09
Problem,NEG_PROCESS_OF,Patients,32507926,10.1007/s11739-020-02390-4,2020-06-09
Thyroid dysfunction,PROCESS_OF,Patients,32507926,10.1007/s11739-020-02390-4,2020-06-09
Coronaviridae,CAUSES,Severe Acute Respiratory Syndrome,32507926,10.1007/s11739-020-02390-4,2020-06-09
Severe Acute Respiratory Syndrome,CAUSES,Thyroid Diseases,32507926,10.1007/s11739-020-02390-4,2020-06-09
Epidemic,ISA,Disease Outbreaks,32507883,10.1042/CS20200492,2020-06-09
drug response,PROCESS_OF,Social Networks,32507883,10.1042/CS20200492,2020-06-09
angiotensin converting enzyme 2,PART_OF,integral to membrane,32507746,10.1016/j.mbs.2020.108378,2020-06-09
Care setting,LOCATION_OF,Study,32507697,10.1016/j.jsurg.2020.05.018,2020-06-09
Dizziness,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Fatigue,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Fever,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Myalgia,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Pneumonia,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Gastrointestinal symptom,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Pneumonia,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Coronavirus Infections,ISA,Disease,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Gastrointestinal symptom,PROCESS_OF,Patients,32507686,10.1016/j.jagp.2020.05.016,2020-06-09
Alzheimer's Disease,ISA,"Delirium, Dementia, Amnestic, Cognitive Disorders",32507662,10.1016/j.idh.2020.05.003,2020-06-09
"Delirium, Dementia, Amnestic, Cognitive Disorders",AFFECTS,Persons,32507662,10.1016/j.idh.2020.05.003,2020-06-09
Coronavirus Infections,PROCESS_OF,member,32507619,10.1016/j.dld.2020.05.023,2020-06-09
Lanugo,LOCATION_OF,IMPACT gene,32507619,10.1016/j.dld.2020.05.023,2020-06-09
Coronavirus Infections,ISA,Disease,32507619,10.1016/j.dld.2020.05.023,2020-06-09
Coronavirus Infections,ISA,Disease,32507619,10.1016/j.dld.2020.05.023,2020-06-09
Liver problem,PROCESS_OF,Patients,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
Liver Dysfunction,PROCESS_OF,Male population group,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
Liver Dysfunction,PROCESS_OF,Woman,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
Liver Dysfunction,PROCESS_OF,Old age,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
"Respiratory Distress Syndrome, Newborn",CAUSES,Anoxia,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
"Respiratory Distress Syndrome, Newborn",CAUSES,Septicemia,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
"Respiratory Distress Syndrome, Newborn",CAUSES,Single organ dysfunction,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
"Respiratory Distress Syndrome, Newborn",CAUSES,inflammatory response,32507575,10.1016/j.sapharm.2020.05.030,2020-06-09
Diabetes,PROCESS_OF,Patients,32507572,10.1016/j.ajem.2020.05.080,2020-06-09
Challenge,COEXISTS_WITH,Cardiopulmonary Resuscitation,32507570,10.1016/j.ajem.2020.05.100,2020-06-09
Challenge,TREATS,Health Personnel,32507570,10.1016/j.ajem.2020.05.100,2020-06-09
Magnetic Resonance Imaging (MRI) of Heart,DIAGNOSES,Edema,32507557,10.1016/j.encep.2020.05.008,2020-06-09
Mental disorders,PROCESS_OF,Patients,32507556,10.1016/j.encep.2020.05.010,2020-06-09
Obsessive-Compulsive Disorder,COMPLICATES,Mental disorders,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Post-Traumatic Stress Disorder,COMPLICATES,Mental disorders,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Generalized Anxiety Disorder,COMPLICATES,Mental disorders,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Hypervigilance,COMPLICATES,Panic Disorder,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Coughing,ISA,"Signs and Symptoms, Respiratory",32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Dyspnea,ISA,"Signs and Symptoms, Respiratory",32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Prognosis bad,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Hypervigilance,PROCESS_OF,Persons,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Abnormal breathing,PREDISPOSES,Panic Attacks,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Comorbidity,PROCESS_OF,Persons,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Panic Disorder,PROCESS_OF,Persons,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Panic Attacks,PROCESS_OF,Persons,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Albuterol,TREATS,Patients,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Albuterol,TREATS(INFER),Anxiety Disorders,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Anxiety Disorders,PROCESS_OF,Patients,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Diarrhea,PROCESS_OF,Patients,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Vomiting,PROCESS_OF,Patients,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Citalopram,ISA,Antidepressive Agents,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Citalopram,ISA,Psychotropic Drugs,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Citalopram,PREDISPOSES(SPEC),Torsades de Pointes,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Psychotropic Drugs,PREDISPOSES,Torsades de Pointes,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Escitalopram,ISA,Psychotropic Drugs,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Escitalopram,PREDISPOSES(SPEC),Torsades de Pointes,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
First line treatment,TREATS,Panic Disorder,32507546,10.1016/j.urolonc.2020.05.017,2020-06-09
Coronavirus Infections,CAUSES,Disease,32507536,10.1016/j.medcli.2020.05.005,2020-06-09
Therapeutic procedure,TREATS,Cancer Patient,32507520,10.1016/j.revmed.2020.05.003,2020-06-09
Detection,TREATS,Virus,32507409,10.1016/j.vaccine.2020.05.064,2020-06-09
developers,USES,Vaccines,32507401,10.1016/j.jiph.2020.05.020,2020-06-09
Vaccines,PART_OF,Respiratory syncytial virus,32507401,10.1016/j.jiph.2020.05.020,2020-06-09
Vaccines,AUGMENTS,Disease,32507401,10.1016/j.jiph.2020.05.020,2020-06-09
Middle East Respiratory Syndrome,PROCESS_OF,Animal Model,32507401,10.1016/j.jiph.2020.05.020,2020-06-09
Assessment centres,LOCATION_OF,Laboratory Procedures,32507122,10.1017/S1049023X20000783,2020-06-09
Symptoms,PROCESS_OF,Adult,32507122,10.1017/S1049023X20000783,2020-06-09
Sense of smell impaired,ISA,Symptoms,32507122,10.1017/S1049023X20000783,2020-06-09
Ageusia,ISA,Symptoms,32507122,10.1017/S1049023X20000783,2020-06-09
Negative,PROCESS_OF,Patients,32507122,10.1017/S1049023X20000783,2020-06-09
Negative,PROCESS_OF,Patients,32507122,10.1017/S1049023X20000783,2020-06-09
Ageusia,ISA,Symptoms,32507122,10.1017/S1049023X20000783,2020-06-09
Drivers of Vehicles,USES,Ambulances,32507119,10.1017/ipm.2020.75,2020-06-09
Disease,PROCESS_OF,Patients,32507119,10.1017/ipm.2020.75,2020-06-09
Emergency medical service,TREATS,Patients,32507119,10.1017/ipm.2020.75,2020-06-09
Functional disorder,PROCESS_OF,Patients,32507119,10.1017/ipm.2020.75,2020-06-09
Anxiety Disorders,PROCESS_OF,Patients,32507114,10.1017/ice.2020.282,2020-06-09
Diagnosis,MEASURES,IMPACT gene,32507114,10.1017/ice.2020.282,2020-06-09
Mental Health Services,USES,Diagnosis,32507114,10.1017/ice.2020.282,2020-06-09
IMPACT gene,AFFECTS,Anxiety,32507114,10.1017/ice.2020.282,2020-06-09
IMPACT gene,AFFECTS,Symptoms,32507114,10.1017/ice.2020.282,2020-06-09
IMPACT gene,AFFECTS,Anxiety symptoms,32507114,10.1017/ice.2020.282,2020-06-09
IMPACT gene,AFFECTS,Anxiety symptoms,32507114,10.1017/ice.2020.282,2020-06-09
Nitric Oxide,ASSOCIATED_WITH,Disease,32507114,10.1017/ice.2020.282,2020-06-09
Persons,LOCATION_OF,IMPACT gene,32507114,10.1017/ice.2020.282,2020-06-09
Persons,USES,Preexisting Condition Coverage,32507114,10.1017/ice.2020.282,2020-06-09
Surgical face mask,USES,Filters,32507113,10.1017/ice.2020.281,2020-06-09
Negative,PROCESS_OF,Patients,32507113,10.1017/ice.2020.281,2020-06-09
"Hospitals, University",ISA,Hospitals,32507110,10.1186/s40779-020-00256-6,2020-06-09
Atypical Lipoma,COEXISTS_WITH,Disease Progression,32507105,10.1186/s12929-020-00665-8,2020-06-09
Atypical Lipoma,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Coronavirus Infections,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Atypical Lipoma,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Atypical Lipoma,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Atypical Lipoma,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Abnormality,PROCESS_OF,Patients,32507105,10.1186/s12929-020-00665-8,2020-06-09
Malignant Neoplasms,ISA,Disease,32507061,10.1080/08959420.2020.1771237,2020-06-09
High Level,PROCESS_OF,Patients,32507061,10.1080/08959420.2020.1771237,2020-06-09
Antineoplastic Agents,AUGMENTS,Decreased Immunologic Activity [PE],32507061,10.1080/08959420.2020.1771237,2020-06-09
Disease,PROCESS_OF,Elderly (population group),32507060,10.1080/08959420.2020.1772002,2020-06-09
Chronic disease,PROCESS_OF,Persons,32507006,10.1080/17453674.2020.1774138,2020-06-09
Chronic disease,PROCESS_OF,Old age,32507006,10.1080/17453674.2020.1774138,2020-06-09
Frail,PROCESS_OF,Population Group,32507006,10.1080/17453674.2020.1774138,2020-06-09
Victim of neglect (finding),PROCESS_OF,Community,32506866,10.3904/kjim.2020.122,2020-06-09
Common Cold,ISA,Symptoms,32506865,10.19852/j.cnki.jtcm.2020.03.019,2020-06-09
Chills,ISA,Symptoms,32506865,10.19852/j.cnki.jtcm.2020.03.019,2020-06-09
Virus,PROCESS_OF,Community,32506865,10.19852/j.cnki.jtcm.2020.03.019,2020-06-09
Pneumonia,PROCESS_OF,Patients,32506792,10.1111/ajt.16116,2020-06-09
Experience,PROCESS_OF,Transplant Recipients,32506785,10.1111/dth.13788,2020-06-09
Anxiety,PROCESS_OF,Patients,32506785,10.1111/dth.13788,2020-06-09
Anxiety,PROCESS_OF,Practitioner,32506785,10.1111/dth.13788,2020-06-09
Stress,PREDISPOSES,Possible,32506780,10.1111/dth.13777,2020-06-09
Unmarried,PROCESS_OF,Persons,32506780,10.1111/dth.13777,2020-06-09
Stress,PROCESS_OF,Physicians,32506780,10.1111/dth.13777,2020-06-09
Stress,PROCESS_OF,Dermatologist,32506780,10.1111/dth.13777,2020-06-09
Mucous Membrane,PART_OF,Upper respiratory tract,32506768,10.1111/ijcp.13574,2020-06-09
Colonization,PREDISPOSES,Viral Shedding,32506768,10.1111/ijcp.13574,2020-06-09
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32506762,10.1111/1744-9987.13531,2020-06-09
Benign Prostatic Hyperplasia,PROCESS_OF,Patients,32506762,10.1111/1744-9987.13531,2020-06-09
Benign Prostatic Hyperplasia,PROCESS_OF,Patients,32506762,10.1111/1744-9987.13531,2020-06-09
Laboratory Procedures,METHOD_OF,Diagnosis,32506762,10.1111/1744-9987.13531,2020-06-09
Comorbidity,PROCESS_OF,Patients,32506762,10.1111/1744-9987.13531,2020-06-09
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF,Patients,32506757,10.1111/odi.13460,2020-06-09
Symptom severe,PROCESS_OF,Patients,32506757,10.1111/odi.13460,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32506757,10.1111/odi.13460,2020-06-09
Hospitalization,PREVENTS,Cross Infection,32506757,10.1111/odi.13460,2020-06-09
Face,LOCATION_OF,Protection,32506743,10.1111/ijcp.13576,2020-06-09
Face,LOCATION_OF,Protection,32506743,10.1111/ijcp.13576,2020-06-09
Masks,PREVENTS,Disease,32506743,10.1111/ijcp.13576,2020-06-09
Region of face,LOCATION_OF,Protection,32506743,10.1111/ijcp.13576,2020-06-09
Face,LOCATION_OF,Protection,32506743,10.1111/ijcp.13576,2020-06-09
Peptidyl-Dipeptidase A,ASSOCIATED_WITH,Acute respiratory disease,32506730,10.1111/odi.13463,2020-06-09
Ibuprofen,CAUSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,32506730,10.1111/odi.13463,2020-06-09
Ibuprofen,STIMULATES,Peptidyl-Dipeptidase A,32506730,10.1111/odi.13463,2020-06-09
"Anti-Inflammatory Agents, Non-Steroidal",COMPLICATES,Severe Acute Respiratory Syndrome,32506730,10.1111/odi.13463,2020-06-09
Community acquired pneumonia,PROCESS_OF,Child,32506730,10.1111/odi.13463,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Human Age Group,32506730,10.1111/odi.13463,2020-06-09
Oral Manifestations,PROCESS_OF,Patients,32506726,10.1002/jcla.23392,2020-06-09
Mucous Membrane,LOCATION_OF,Ulcer,32506726,10.1002/jcla.23392,2020-06-09
Mucous Membrane,PART_OF,Palate,32506726,10.1002/jcla.23392,2020-06-09
Palate,LOCATION_OF,Erythema,32506726,10.1002/jcla.23392,2020-06-09
Medical center,LOCATION_OF,Outcome Studies,32506725,10.1002/cyto.a.24047,2020-06-09
Confirmation,PROCESS_OF,Patients,32506725,10.1002/cyto.a.24047,2020-06-09
Hospitalization,COEXISTS_WITH,Quarantine,32506725,10.1002/cyto.a.24047,2020-06-09
tomography,NEG_DIAGNOSES,Pulmonary sign AND/OR symptom,32506725,10.1002/cyto.a.24047,2020-06-09
follow-up,TREATS,Patients,32506725,10.1002/cyto.a.24047,2020-06-09
Secondary Infections,ISA,Infection,32506699,10.1002/art.41388,2020-06-09
Fc Receptor,AFFECTS,Uptake,32506699,10.1002/art.41388,2020-06-09
Complication,PROCESS_OF,Patients,32506549,10.1002/ana.25807,2020-06-09
Encephalitis,ISA,Encephalopathies,32506541,10.1111/jocd.13530,2020-06-09
"Encephalomyelitis, Acute Disseminated",ISA,Encephalitis,32506541,10.1111/jocd.13530,2020-06-09
Coronavirus Infections,ISA,Disease,32506258,10.1186/s13613-020-00689-1,2020-06-09
Postmortem Diagnosis,PROCESS_OF,Patients,32506258,10.1186/s13613-020-00689-1,2020-06-09
Echocardiography,DIAGNOSES,Spontaneous echo contrast,32506258,10.1186/s13613-020-00689-1,2020-06-09
Right cardiac chamber,LOCATION_OF,Spontaneous echo contrast,32506258,10.1186/s13613-020-00689-1,2020-06-09
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32506258,10.1186/s13613-020-00689-1,2020-06-09
Discussion (procedure),TREATS,Patients,32506222,10.1007/s13300-020-00847-5,2020-06-09
Voting,PROCESS_OF,Participant,32506222,10.1007/s13300-020-00847-5,2020-06-09
Targeted Therapy,NEG_TREATS,Patients,32506222,10.1007/s13300-020-00847-5,2020-06-09
Coronavirus Infections,PRECEDES,Diabetes,32506198,10.1007/s00392-020-01682-1,2020-06-09
Hyperglycemia,AFFECTS,Birth,32506198,10.1007/s00392-020-01682-1,2020-06-09
Cardiology department,LOCATION_OF,Study,32506195,10.1007/s00592-020-01539-z,2020-06-09
"CD69 protein, human",NEG_PART_OF,Patients,32506195,10.1007/s00592-020-01539-z,2020-06-09
Complication,AFFECTS,Physiological Processes,32506184,10.1007/s11882-020-00927-3,2020-06-09
Disease,PRODUCES,Endothelium,32506184,10.1007/s11882-020-00927-3,2020-06-09
Disease,PRODUCES,Epithelium,32506184,10.1007/s11882-020-00927-3,2020-06-09
Human coronavirus,INTERACTS_WITH,Coronavirus Infections,32506184,10.1007/s11882-020-00927-3,2020-06-09
Inflammation,PROCESS_OF,Patients,32506184,10.1007/s11882-020-00927-3,2020-06-09
Lung,LOCATION_OF,Inflammation,32506184,10.1007/s11882-020-00927-3,2020-06-09
Lung,LOCATION_OF,Storm NOS,32506184,10.1007/s11882-020-00927-3,2020-06-09
Storm NOS,PROCESS_OF,Patients,32506184,10.1007/s11882-020-00927-3,2020-06-09
Storm NOS,PROCESS_OF,Patients,32506184,10.1007/s11882-020-00927-3,2020-06-09
Metric,TREATS,Household composition,32506145,10.1007/s00405-020-06112-6,2020-06-09
Symptoms,PROCESS_OF,Patients,32506142,10.1007/s00264-020-04651-5,2020-06-09
Laryngotracheal stenosis,PROCESS_OF,Committee,32506142,10.1007/s00264-020-04651-5,2020-06-09
Chest CT,ADMINISTERED_TO,Patients,32506141,10.1007/s00264-020-04635-5,2020-06-09
Bone structure of lumbar vertebra,LOCATION_OF,Chest CT,32506141,10.1007/s00264-020-04635-5,2020-06-09
Chest,LOCATION_OF,Chest CT,32506141,10.1007/s00264-020-04635-5,2020-06-09
Parenchyma,PART_OF,Lung,32506141,10.1007/s00264-020-04635-5,2020-06-09
Chest CT,AFFECTS,Patients,32506141,10.1007/s00264-020-04635-5,2020-06-09
Polymerase Chain Reaction,METHOD_OF,Diagnosis,32506141,10.1007/s00264-020-04635-5,2020-06-09
Orthopedic Surgeons,ISA,Surgeon,32506141,10.1007/s00264-020-04635-5,2020-06-09
Positive Finding,PROCESS_OF,Patients,32506141,10.1007/s00264-020-04635-5,2020-06-09
Wounds and Injuries,PROCESS_OF,Patients,32506141,10.1007/s00264-020-04635-5,2020-06-09
Severe Acute Respiratory Syndrome,ISA,Wounds and Injuries,32506122,10.1093/gerona/glaa146,2020-06-09
hospital care,AFFECTS,Shift worker,32506122,10.1093/gerona/glaa146,2020-06-09
hospital care,TREATS,consideration,32506122,10.1093/gerona/glaa146,2020-06-09
Nurses,TREATS,Patients,32506122,10.1093/gerona/glaa146,2020-06-09
Anesthesiologist,TREATS,Patients,32506122,10.1093/gerona/glaa146,2020-06-09
Complication,AFFECTS,Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Cessation of life,OCCURS_IN,Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Atrial Fibrillation,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Comorbidity,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Coronary Arteriosclerosis,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Heart failure,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
HIV Infections,PROCESS_OF,Young Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Hypertensive disease,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
"Kidney Failure, Chronic",PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Obesity,PROCESS_OF,Young Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Cerebrovascular accident,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Chronic liver disease,PROCESS_OF,Young Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Dementia,PROCESS_OF,Patients,32506118,10.1093/cid/ciaa722,2020-06-09
Superinfection,COEXISTS_WITH,Well adult,32506118,10.1093/cid/ciaa722,2020-06-09
Respiratory complication,PROCESS_OF,Young Adult,32506118,10.1093/cid/ciaa722,2020-06-09
Respiration Disorders,AFFECTS,Respiratory complication,32506118,10.1093/cid/ciaa722,2020-06-09
Diabetes,COEXISTS_WITH,Cardiovascular Diseases,32505994,10.1016/j.amjoto.2020.102570,2020-06-09
elective care,TREATS,Patients,32505993,10.1016/j.amjoto.2020.102578,2020-06-09
Gaseous anesthetic agent,DISRUPTS,Coughing,32505993,10.1016/j.amjoto.2020.102578,2020-06-09
Critical Illness,PROCESS_OF,Patients,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Tracheostomy procedure,ADMINISTERED_TO,Surgeon,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Tracheostomy procedure,TREATS,Patients,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Tracheostomy procedure,TREATS,Patients,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Intention - mental process,PROCESS_OF,Pulmonologists,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Tracheostomy procedure,TREATS,Patients,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Percutaneous dilational tracheostomy,TREATS,Patients,32505992,10.1016/j.amjoto.2020.102574,2020-06-09
Laboratory,LOCATION_OF,Simulation Training,32505980,10.1016/j.dsx.2020.05.047,2020-06-09
Health care facility,LOCATION_OF,Simulation Training,32505980,10.1016/j.dsx.2020.05.047,2020-06-09
Confidence,PROCESS_OF,Physicians,32505980,10.1016/j.dsx.2020.05.047,2020-06-09
Influenza-like symptoms,PROCESS_OF,Persons,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Infected,PROCESS_OF,Persons,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
envelope,LOCATION_OF,Virus,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Interleukin-1,compared_with,Wild Type,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Pulmonary Edema,AFFECTS,Transmembrane Transport,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
macrophage,PRODUCES,Interleukin-1,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
NLRP3 gene,PART_OF,Protoplasm,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
NLRP3 gene,PART_OF,NLRP3 inflammasome complex,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
"SLC6A2 protein, human",CAUSES,Acute Lung Injury,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Interleukin-1,INTERACTS_WITH,Inflammasomes,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Inflammasomes,PART_OF,NLRP3 gene,32505908,10.1016/j.jneuroim.2020.577282,2020-06-09
Multiple Sclerosis,PROCESS_OF,Patients,32505878,10.1016/j.ijid.2020.05.123,2020-06-09
fingolimod,TREATS,Patients,32505878,10.1016/j.ijid.2020.05.123,2020-06-09
fingolimod,TREATS(INFER),Multiple Sclerosis,32505878,10.1016/j.ijid.2020.05.123,2020-06-09
Fever,ISA,Symptoms,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Acetaminophen,ADMINISTERED_TO,Persons,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Acetaminophen,ISA,Antipyretics,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Acetaminophen,PREVENTS(SPEC),Malaise,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Antipyretics,PREVENTS,Malaise,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,ADMINISTERED_TO,Persons,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,ISA,Antipyretics,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,PREVENTS(SPEC),Malaise,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,TREATS,Patients,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Symptoms,PROCESS_OF,Young Adult,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Acetaminophen,PREVENTS,Fever,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,compared_with,Acetaminophen,32505821,10.1016/j.biopha.2020.110316,2020-06-09
Ibuprofen,PREVENTS,Fever,32505821,10.1016/j.biopha.2020.110316,2020-06-09
"Kidney Failure, Acute",PROCESS_OF,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Kidney Failure,PROCESS_OF,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Continuous renal replacement therapy,TREATS,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Continuous renal replacement therapy,TREATS(INFER),"Kidney Failure, Acute",32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Continuous renal replacement therapy,TREATS(INFER),Kidney Failure,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Dialysis Solutions,TREATS,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Peritoneal Dialysis,TREATS,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Intermittent hemodialysis,TREATS,Patients,32505805,10.1016/j.jogoh.2020.101826,2020-06-09
Respiratory complication,PROCESS_OF,Woman,32505792,10.1016/j.ajic.2020.05.036,2020-06-09
Radionuclide Imaging,DIAGNOSES,Severe Acute Respiratory Syndrome,32505792,10.1016/j.ajic.2020.05.036,2020-06-09
Age,ASSOCIATED_WITH,Disease,32505792,10.1016/j.ajic.2020.05.036,2020-06-09
Premature Birth,PROCESS_OF,Woman,32505792,10.1016/j.ajic.2020.05.036,2020-06-09
Prophylactic treatment,TREATS,Comorbidity,32505792,10.1016/j.ajic.2020.05.036,2020-06-09
Asymptomatic Infections,PROCESS_OF,Patients,32505778,10.1016/j.jcv.2020.104477,2020-06-09
Laboratory Procedures,USES,PCR test for SARS,32505777,10.1016/j.jcv.2020.104480,2020-06-09
PCR test for SARS,ISA,Laboratory Procedures,32505777,10.1016/j.jcv.2020.104480,2020-06-09
Measles Virus Nucleoprotein,NEG_INTERACTS_WITH,"Immunoglobulin A, Human",32505774,10.1016/j.cca.2020.06.004,2020-06-09
Specimen Type - Serum,PART_OF,Plasma,32505774,10.1016/j.cca.2020.06.004,2020-06-09
Assay,METHOD_OF,High sensitivity,32505774,10.1016/j.cca.2020.06.004,2020-06-09
Hypersensitivity,ASSOCIATED_WITH,Proteins,32505774,10.1016/j.cca.2020.06.004,2020-06-09
Assay,USES,Measles Virus Nucleoprotein,32505774,10.1016/j.cca.2020.06.004,2020-06-09
Assay,USES,Measles Virus Nucleoprotein,32505774,10.1016/j.cca.2020.06.004,2020-06-09
follow-up,COEXISTS_WITH,Detection,32505774,10.1016/j.cca.2020.06.004,2020-06-09
Assay,MEASURES,Total immunoglobulin measurement,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Immunoenzyme Procedure,MEASURES,Total immunoglobulin measurement,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Immunoenzyme Procedure,USES,Microspheres,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Immunoenzyme Procedure,USES,Microspheres,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Immunoenzyme Procedure,USES,Microspheres,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Assay,DIAGNOSES,Patient in hospital,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Assay,DIAGNOSES,Patient in hospital,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Assay,USES,Immunoenzyme Procedure,32505730,10.1016/j.clinre.2020.05.001,2020-06-09
Abdominal Pain,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32505692,10.1016/j.meegid.2020.104390,2020-06-09
Nausea,ISA,Digestive symptom,32505692,10.1016/j.meegid.2020.104390,2020-06-09
Chest,LOCATION_OF,CAT scan normal,32505692,10.1016/j.meegid.2020.104390,2020-06-09
Mutation,PROCESS_OF,Genome,32505678,10.1016/j.avsg.2020.06.001,2020-06-09
SARS coronavirus,PROCESS_OF,Colombian,32505678,10.1016/j.avsg.2020.06.001,2020-06-09
Disease Outbreaks,CAUSES,Disease,32505658,10.1016/j.wneu.2020.05.246,2020-06-09
Tertiary Care Centers,LOCATION_OF,Observational Study,32505658,10.1016/j.wneu.2020.05.246,2020-06-09
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32505658,10.1016/j.wneu.2020.05.246,2020-06-09
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32505562,10.1016/j.jacr.2020.05.026,2020-06-09
Coughing,PROCESS_OF,Patients,32505562,10.1016/j.jacr.2020.05.026,2020-06-09
Diarrhea,ISA,Symptoms,32505562,10.1016/j.jacr.2020.05.026,2020-06-09
Fever,ASSOCIATED_WITH,Disease,32505562,10.1016/j.jacr.2020.05.026,2020-06-09
Poisoning,PROCESS_OF,Persons,32505492,10.1016/j.healun.2020.04.019,2020-06-09
Coronavirus Infections,ISA,Disease,32505492,10.1016/j.healun.2020.04.019,2020-06-09
Coronavirus Infections,ISA,Disease,32505492,10.1016/j.healun.2020.04.019,2020-06-09
Methyl alcohol poisoning,ISA,Disease,32505492,10.1016/j.healun.2020.04.019,2020-06-09
Coronavirus Infections,ISA,Disease,32505492,10.1016/j.healun.2020.04.019,2020-06-09
Challenge,METHOD_OF,Transplantation,32505489,10.1016/j.apmr.2020.05.015,2020-06-09
Challenge,METHOD_OF,Mechanical Circulatory Support,32505489,10.1016/j.apmr.2020.05.015,2020-06-09
Symptoms,COEXISTS_WITH,immobilization prolonged,32505462,10.1016/j.jiph.2020.05.018,2020-06-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32505461,10.1016/j.jiph.2020.05.021,2020-06-09
Confirmation,PROCESS_OF,Patients,32505461,10.1016/j.jiph.2020.05.021,2020-06-09
Infected,PROCESS_OF,Patients,32505456,10.1016/j.jtcvs.2020.05.016,2020-06-09
other medicated shampoos in ATC,TREATS,Anxiety,32505456,10.1016/j.jtcvs.2020.05.016,2020-06-09
other medicated shampoos in ATC,TREATS,"Stress, Psychological",32505456,10.1016/j.jtcvs.2020.05.016,2020-06-09
Cardiac Surgery procedures,TREATS,Patients,32505438,10.1016/j.jnma.2020.05.015,2020-06-09
Hospital admission,METHOD_OF,Cardiac Surgery procedures,32505438,10.1016/j.jnma.2020.05.015,2020-06-09
Chest,LOCATION_OF,tomography,32505438,10.1016/j.jnma.2020.05.015,2020-06-09
Multi-disciplinary team,TREATS,Patients,32505438,10.1016/j.jnma.2020.05.015,2020-06-09
Time of symptom onset,PROCESS_OF,Patients,32505251,10.1016/S0140-6736(20)30122-7,2020-06-09
Malignant neoplasm of lung,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Malignant neoplasm of lung,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Prognosis bad,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Malignant neoplasm of lung,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Survivors,ISA,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Malignant neoplasm of lung,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Malignant neoplasm of lung,PROCESS_OF(SPEC),Survivors,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Combined Modality Therapy,TREATS,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Combined Modality Therapy,TREATS(INFER),Malignant neoplasm of lung,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Hydroxychloroquine,TREATS,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Hydroxychloroquine,TREATS(INFER),Malignant neoplasm of lung,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Azithromycin,TREATS,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Azithromycin,TREATS(INFER),Malignant neoplasm of lung,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Malignant neoplasm of lung,PROCESS_OF,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
other medicated shampoos in ATC,TREATS,Patients,32505072,10.1016/j.mehy.2020.109917,2020-06-07
Coronavirus Infections,ISA,Disease,32505070,10.1016/j.mehy.2020.109947,2020-06-07
Pandemics,ISA,Disease Outbreaks,32505069,10.1016/j.mehy.2020.109910,2020-06-07
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Persons,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Acute Lung Injury,PROCESS_OF,Persons,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Infected,PROCESS_OF,Persons,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Analgesics,PREVENTS,Coughing,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Anti-Arrhythmia Agents,PREVENTS,Coughing,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Asthma,PROCESS_OF,Patients,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Lidocaine,PREVENTS,Coughing,32505069,10.1016/j.mehy.2020.109910,2020-06-07
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Lidocaine,TREATS,patient condition,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Symptom severe,PROCESS_OF,Patients,32505069,10.1016/j.mehy.2020.109910,2020-06-07
adjunctive treatment,TREATS,Coronavirus Infections,32505069,10.1016/j.mehy.2020.109910,2020-06-07
adjunctive treatment,TREATS,Symptom severe,32505069,10.1016/j.mehy.2020.109910,2020-06-07
Oral,LOCATION_OF,Epithelial Cells,32505067,10.1016/j.mehy.2020.109899,2020-06-07
Cardiovascular Diseases,ISA,Disease,32505066,10.1016/j.mehy.2020.109861,2020-06-07
Diabetes,ISA,Disease,32505066,10.1016/j.mehy.2020.109861,2020-06-07
Obesity,ISA,Disease,32505066,10.1016/j.mehy.2020.109861,2020-06-07
Atrial Septal Defects,ISA,Disease,32505066,10.1016/j.mehy.2020.109861,2020-06-07
Suicide,PROCESS_OF,Vulnerable Populations,32504992,10.1016/j.dsx.2020.05.041,2020-06-07
Intervention regimes,PREVENTS,Suicide,32504992,10.1016/j.dsx.2020.05.041,2020-06-07
Centers for Disease Control and Prevention (U.S.),LOCATION_OF,Laboratory Procedures,32504945,10.1016/j.jcv.2020.104473,2020-06-07
High sensitivity,DIAGNOSES,SARS coronavirus,32504945,10.1016/j.jcv.2020.104473,2020-06-07
Negative,PROCESS_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Specimen Type - Serum,NEG_PART_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
etiology unknown,NEG_PROCESS_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Patients,LOCATION_OF,CD40LG wt Allele,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Pneumonia,PROCESS_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Negative,PROCESS_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Symptoms,PROCESS_OF,Patients,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Immunoenzyme Procedure,DIAGNOSES,Severe Acute Respiratory Syndrome,32504944,10.1016/j.jcv.2020.104472,2020-06-07
Molecular Diagnosis,METHOD_OF,Laboratory Procedures,32504927,10.1016/j.mehy.2020.109907,2020-06-07
Laboratory,LOCATION_OF,Quantitative Reverse Transcriptase PCR,32504927,10.1016/j.mehy.2020.109907,2020-06-07
Negative,CAUSES,Hypersensitivity,32504927,10.1016/j.mehy.2020.109907,2020-06-07
Quantitative Reverse Transcriptase PCR,METHOD_OF,Smear test,32504927,10.1016/j.mehy.2020.109907,2020-06-07
Laboratory Procedures,USES,Triage,32504927,10.1016/j.mehy.2020.109907,2020-06-07
Adult,ISA,Population Group,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Periodontal Pocket,ISA,Periodontitis,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Chronic inflammatory disorder,PROCESS_OF,Population Group,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Chronic inflammatory disorder,PROCESS_OF(SPEC),Adult,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Eye,PART_OF,Persons,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Infected,PROCESS_OF,Persons,32504925,10.1016/j.mehy.2020.109886,2020-06-07
Lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32504923,10.1016/j.mehy.2020.109862,2020-06-07
SARS coronavirus,CAUSES,Communicable Diseases,32504923,10.1016/j.mehy.2020.109862,2020-06-07
SARS coronavirus,PROCESS_OF,ancestors,32504923,10.1016/j.mehy.2020.109862,2020-06-07
Patients,LOCATION_OF,angiotensin converting enzyme 2,32504923,10.1016/j.mehy.2020.109862,2020-06-07
angiotensin converting enzyme 2,DISRUPTS,Structure of parenchyma of lung,32504923,10.1016/j.mehy.2020.109862,2020-06-07
Eye,LOCATION_OF,Respiration Disorders,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
,AFFECTS,Oxidation-Reduction,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Oxidation-Reduction,PROCESS_OF,Cells,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Acetylcysteine,INHIBITS,Interleukin-1,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Acetylcysteine,INHIBITS,Interleukin-18,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Acetylcysteine,INHIBITS,Inflammasomes,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Plasma,LOCATION_OF,,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Inflammasomes,PART_OF,NLRP3 gene,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Oxidation-Reduction,PROCESS_OF,Cells,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
Acetylcysteine,STIMULATES,Glutathione,32504808,10.1016/j.jaac.2020.05.009,2020-06-07
mental health,PROCESS_OF,Child,32504802,10.1016/j.pep.2020.105686,2020-06-07
mental health,PROCESS_OF,Adolescent (age group),32504802,10.1016/j.pep.2020.105686,2020-06-07
Observation - diagnostic procedure,DIAGNOSES,Well child,32504802,10.1016/j.pep.2020.105686,2020-06-07
Loneliness,PREDISPOSES,Anxiety,32504802,10.1016/j.pep.2020.105686,2020-06-07
Loneliness,PREDISPOSES,Depressive disorder,32504802,10.1016/j.pep.2020.105686,2020-06-07
Loneliness,ISA,Psychiatric symptom,32504802,10.1016/j.pep.2020.105686,2020-06-07
early/brief intervention/therapy (treatment),TREATS,Mental health problem,32504802,10.1016/j.pep.2020.105686,2020-06-07
Hospitals,LOCATION_OF,Administration occupational activities,32504757,10.1016/j.lfs.2020.117905,2020-06-07
Coronavirus Infections,ISA,Disease,32504751,10.1016/j.lfs.2020.117907,2020-06-07
angiotensin II,TREATS,Patients,32504751,10.1016/j.lfs.2020.117907,2020-06-07
"M Protein, multiple myeloma",INHIBITS,ACE2 gene,32504751,10.1016/j.lfs.2020.117907,2020-06-07
angiotensin II,ASSOCIATED_WITH,Disease,32504751,10.1016/j.lfs.2020.117907,2020-06-07
angiotensin II,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32504751,10.1016/j.lfs.2020.117907,2020-06-07
Coronavirus Infections,ISA,Disease,32504751,10.1016/j.lfs.2020.117907,2020-06-07
Antidiarrheals,TREATS,Myocarditis,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Antidiarrheals,TREATS,Acute Lung Injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Lipopolysaccharides,CAUSES,Myocarditis,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Lipopolysaccharides,CAUSES,Acute Lung Injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Lipopolysaccharides,CAUSES,Leucocytic infiltrate,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
nifuroxazide,DISRUPTS,Heart,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
nifuroxazide,DISRUPTS,Lung,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Lipopolysaccharides,CAUSES,Acute Lung Injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Lipopolysaccharides,CAUSES,myocardial injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
nifuroxazide,TREATS,Acute Lung Injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
nifuroxazide,TREATS,myocardial injury,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Critical Illness,PROCESS_OF,Patients,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Septicemia,PROCESS_OF,Patients,32504745,10.1016/j.jinf.2020.05.067,2020-06-07
Severe Acute Respiratory Syndrome,CAUSES,Disease,32504743,10.1016/j.jinf.2020.05.073,2020-06-07
Asymptomatic,PROCESS_OF,Staff,32504741,10.1016/j.jinf.2020.05.075,2020-06-07
Obesity,AFFECTS,Prognosis bad,32504735,10.1016/j.jinf.2020.05.077,2020-06-07
Hematologic Neoplasms,PROCESS_OF,Patients,32504735,10.1016/j.jinf.2020.05.077,2020-06-07
Poor outcome,PROCESS_OF,Patients,32504735,10.1016/j.jinf.2020.05.077,2020-06-07
Assay,USES,Antibodies,32504637,10.1016/j.cca.2020.06.002,2020-06-07
Enzyme-Linked Immunosorbent Assay,METHOD_OF,Diagnosis,32504637,10.1016/j.cca.2020.06.002,2020-06-07
Laboratory Procedures,USES,POMC gene,32504637,10.1016/j.cca.2020.06.002,2020-06-07
Performance,PROCESS_OF,hospitalized patients,32504637,10.1016/j.cca.2020.06.002,2020-06-07
Laboratory Procedures,USES,POMC gene,32504637,10.1016/j.cca.2020.06.002,2020-06-07
Hospitals,LOCATION_OF,Observational Study,32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
Patients,LOCATION_OF,"CD69 protein, human",32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
whole blood specimen,PART_OF,Veins,32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
Nasal Swab (procedure),METHOD_OF,Detection,32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
Hypersensitivity,PROCESS_OF,Patients,32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
Symptoms,ASSOCIATED_WITH,Disease,32504604,10.1016/j.athoracsur.2020.05.016,2020-06-07
Insufflation,USES,cobaltous cation,32504552,10.1016/j.bjid.2020.05.004,2020-06-07
Arteries,LOCATION_OF,"ACE2 protein, human",32504363,10.1007/s13187-020-01786-2,2020-06-07
Endothelial Cells,LOCATION_OF,"ACE2 protein, human",32504363,10.1007/s13187-020-01786-2,2020-06-07
Endothelial Cells,PART_OF,Veins,32504363,10.1007/s13187-020-01786-2,2020-06-07
"Myocytes, Smooth Muscle",LOCATION_OF,"ACE2 protein, human",32504363,10.1007/s13187-020-01786-2,2020-06-07
"Myocytes, Smooth Muscle",PART_OF,Arteries,32504363,10.1007/s13187-020-01786-2,2020-06-07
angiotensin converting enzyme 2,AUGMENTS,Abnormal,32504363,10.1007/s13187-020-01786-2,2020-06-07
Cessation of life,PROCESS_OF,Patients,32504363,10.1007/s13187-020-01786-2,2020-06-07
Health care facility,LOCATION_OF,Training,32504360,10.1007/s12519-020-00368-y,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Infected,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Chest CT,DIAGNOSES,Pneumonia,32504280,10.1007/s10140-020-01797-y,2020-06-07
Chest CT,DIAGNOSES,Bilateral pneumonia,32504280,10.1007/s10140-020-01797-y,2020-06-07
Complication,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
High Level,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
"T-Cell Surface Glycoprotein CD4, human",STIMULATES,CD8A wt Allele,32504280,10.1007/s10140-020-01797-y,2020-06-07
Malaise,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Alanine Transaminase,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
C-reactive protein,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Creatine Kinase,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Creatinine,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Interleukin-6,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Fibrin fragment D,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Interleukin-10,STIMULATES,GSKIP gene,32504280,10.1007/s10140-020-01797-y,2020-06-07
Coinfection,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Prognosis good,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Symptom mild,PROCESS_OF,Infant,32504280,10.1007/s10140-020-01797-y,2020-06-07
Infected,PROCESS_OF,Patients,32504252,10.1007/s11524-020-00456-4,2020-06-07
Coronavirus Infections,ISA,Disease,32504135,10.1007/s00431-020-03706-4,2020-06-07
Mild disease course,PROCESS_OF,Patients,32504135,10.1007/s00431-020-03706-4,2020-06-07
Autopsy,DIAGNOSES,Severe Acute Respiratory Syndrome,32504135,10.1007/s00431-020-03706-4,2020-06-07
Virus,CAUSES,Disease,32504106,10.1007/s00104-020-01222-7,2020-06-07
Pneumonia,PROCESS_OF,Adult,32504106,10.1007/s00104-020-01222-7,2020-06-07
Pneumonia,PROCESS_OF,Child,32504106,10.1007/s00104-020-01222-7,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32504106,10.1007/s00104-020-01222-7,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32504106,10.1007/s00104-020-01222-7,2020-06-07
Lung finding,PROCESS_OF,"Infant, Newborn",32504106,10.1007/s00104-020-01222-7,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32504106,10.1007/s00104-020-01222-7,2020-06-07
Deep Vein Thrombosis,OCCURS_IN,Patients,32504100,10.1007/s00417-020-04777-7,2020-06-07
Deep Vein Thrombosis,OCCURS_IN,Patients,32504100,10.1007/s00417-020-04777-7,2020-06-07
Patients,LOCATION_OF,"CD69 protein, human",32504100,10.1007/s00417-020-04777-7,2020-06-07
Deep Vein Thrombosis,PROCESS_OF,Patients,32504100,10.1007/s00417-020-04777-7,2020-06-07
Structure of deep vein,LOCATION_OF,Ultrasonography,32504100,10.1007/s00417-020-04777-7,2020-06-07
Structure of deep vein,PART_OF,Lower Extremity,32504100,10.1007/s00417-020-04777-7,2020-06-07
Anticoagulant prophylaxis,ADMINISTERED_TO,Patients,32504100,10.1007/s00417-020-04777-7,2020-06-07
Anticoagulant prophylaxis,USES,"Heparin, Low-Molecular-Weight",32504100,10.1007/s00417-020-04777-7,2020-06-07
Eye,LOCATION_OF,Symptoms,32504052,10.1038/s41591-020-0949-6,2020-06-07
Symptoms,ISA,Signs and Symptoms,32504052,10.1038/s41591-020-0949-6,2020-06-07
Eye,LOCATION_OF,Abnormality,32504052,10.1038/s41591-020-0949-6,2020-06-07
Abnormality,PROCESS_OF,Patients,32504052,10.1038/s41591-020-0949-6,2020-06-07
Photophobia,ISA,Symptoms,32504052,10.1038/s41591-020-0949-6,2020-06-07
Neutrophilia (finding),PROCESS_OF,Patients,32504052,10.1038/s41591-020-0949-6,2020-06-07
Acute-Phase Proteins,AFFECTS,Eye,32504052,10.1038/s41591-020-0949-6,2020-06-07
Fever,PROCESS_OF,Patients,32504052,10.1038/s41591-020-0949-6,2020-06-07
Immune response,PROCESS_OF,Persons,32503959,10.4103/jmas.JMAS_92_20,2020-06-07
Endometriosis,PROCESS_OF,Gastrointestinal surgeon,32503958,10.4103/jmas.JMAS_93_20,2020-06-07
Interested,PROCESS_OF,Child,32503918,10.1073/pnas.2008209117,2020-06-07
Discrepancy,COEXISTS_WITH,Adverse event,32503889,10.1136/bmjgh-2020-002550,2020-06-07
Immune response,PROCESS_OF,Patients,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Agammaglobulinaemia tyrosine kinase,INTERACTS_WITH,macrophage,32503874,10.1136/bmjopen-2020-039159,2020-06-07
acalabrutinib,STIMULATES,Oxygen,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Toxic effect,PROCESS_OF,Patients,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Patients,LOCATION_OF,C-reactive protein,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Patients,LOCATION_OF,Interleukin-6,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Room air,PROCESS_OF,Cohort,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Supplemental oxygen,PROCESS_OF,Cohort,32503874,10.1136/bmjopen-2020-039159,2020-06-07
autophosphorylation,PROCESS_OF,Monocytes,32503874,10.1136/bmjopen-2020-039159,2020-06-07
Musculoskeletal Diseases,PROCESS_OF,Patients,32503847,10.1128/JCM.01288-20,2020-06-07
Musculoskeletal Diseases,PROCESS_OF,Patients,32503847,10.1128/JCM.01288-20,2020-06-07
,AFFECTS,Psychosocial well-being,32503829,10.21873/invivo.11961,2020-06-07
amsonic acid,AFFECTS,Psychosocial well-being,32503829,10.21873/invivo.11961,2020-06-07
Emotional support,TREATS,Health Personnel,32503829,10.21873/invivo.11961,2020-06-07
Emotional support,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score A,32503829,10.21873/invivo.11961,2020-06-07
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Health Personnel,32503829,10.21873/invivo.11961,2020-06-07
Malignant Neoplasms,PROCESS_OF,Patients,32503828,10.21873/invivo.11960,2020-06-07
Disease,PROCESS_OF,Patients,32503828,10.21873/invivo.11960,2020-06-07
Assay,METHOD_OF,Nasal Swab (procedure),32503828,10.21873/invivo.11960,2020-06-07
Screening procedure,ISA,Evaluation procedure,32503828,10.21873/invivo.11960,2020-06-07
Prophylactic treatment,TREATS,Patients,32503827,10.21873/invivo.11959,2020-06-07
Fever,PROCESS_OF,Patients,32503827,10.21873/invivo.11959,2020-06-07
Malignant neoplasm of breast,PROCESS_OF,Patients,32503826,10.21873/invivo.11958,2020-06-07
invasive cancer,PROCESS_OF,Patients,32503826,10.21873/invivo.11958,2020-06-07
Breast-Conserving Surgery,TREATS,invasive cancer,32503826,10.21873/invivo.11958,2020-06-07
Postoperative Complications,NEG_PROCESS_OF,Health Personnel,32503826,10.21873/invivo.11958,2020-06-07
Postoperative Complications,NEG_PROCESS_OF,Patients,32503826,10.21873/invivo.11958,2020-06-07
Italy,ISA,European country,32503825,10.21873/invivo.11957,2020-06-07
Malignant neoplasm of breast,PROCESS_OF,Patients,32503825,10.21873/invivo.11957,2020-06-07
Patients,LOCATION_OF,"CD69 protein, human",32503825,10.21873/invivo.11957,2020-06-07
"CD69 protein, human",INHIBITS,IMPACT gene,32503825,10.21873/invivo.11957,2020-06-07
Malignant neoplasm of breast,PROCESS_OF,Patients,32503825,10.21873/invivo.11957,2020-06-07
Pandemics,ISA,Disease Outbreaks,32503824,10.21873/invivo.11956,2020-06-07
Malignant neoplasm of breast,PROCESS_OF,Patients,32503824,10.21873/invivo.11956,2020-06-07
Anxiety,PROCESS_OF,Patients,32503824,10.21873/invivo.11956,2020-06-07
Breast,LOCATION_OF,Lesion,32503824,10.21873/invivo.11956,2020-06-07
Breast,LOCATION_OF,Lesion,32503824,10.21873/invivo.11956,2020-06-07
Breast,LOCATION_OF,Lesion,32503824,10.21873/invivo.11956,2020-06-07
Lesion,PROCESS_OF,Patients,32503824,10.21873/invivo.11956,2020-06-07
Malignant neoplasm of breast,PROCESS_OF,Patients,32503824,10.21873/invivo.11956,2020-06-07
Breast,LOCATION_OF,Lesion,32503824,10.21873/invivo.11956,2020-06-07
Pneumonia,PROCESS_OF,Patients,32503823,10.21873/invivo.11955,2020-06-07
Endoplasmic Reticulum Stress,PROCESS_OF,Patients,32503823,10.21873/invivo.11955,2020-06-07
Pneumonia,PROCESS_OF,Patients,32503823,10.21873/invivo.11955,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32503823,10.21873/invivo.11955,2020-06-07
Clinical Enzyme Tests (procedure),MEASURES,Extracellular Signal Regulated Kinases,32503823,10.21873/invivo.11955,2020-06-07
Clinical Enzyme Tests (procedure),MEASURES,"EBP protein, human",32503823,10.21873/invivo.11955,2020-06-07
Clinical Enzyme Tests (procedure),USES,,32503823,10.21873/invivo.11955,2020-06-07
"EBP protein, human",PART_OF,Homologous Gene,32503823,10.21873/invivo.11955,2020-06-07
Serum,LOCATION_OF,HSPA5 gene,32503823,10.21873/invivo.11955,2020-06-07
Masks,USES,Gauzes,32503822,10.21873/invivo.11954,2020-06-07
Masks,USES,Gauzes,32503822,10.21873/invivo.11954,2020-06-07
Surgical face mask,ISA,Masks,32503822,10.21873/invivo.11954,2020-06-07
Surgical face mask,USES(SPEC),Gauzes,32503822,10.21873/invivo.11954,2020-06-07
"Genome, Human",compared_with,Viral Genome,32503821,10.21873/invivo.11953,2020-06-07
Base Sequence,COEXISTS_WITH,Open Reading Frames,32503821,10.21873/invivo.11953,2020-06-07
Open Reading Frames,ISA,Base Sequence,32503821,10.21873/invivo.11953,2020-06-07
"Chromosomes, Human, Pair 3",LOCATION_OF,SARS coronavirus,32503821,10.21873/invivo.11953,2020-06-07
SARS coronavirus,ISA,Genus: Coronavirus,32503821,10.21873/invivo.11953,2020-06-07
Base Sequence,PART_OF,Homo sapiens,32503821,10.21873/invivo.11953,2020-06-07
Base Sequence,COEXISTS_WITH,"Genome, Human",32503820,10.21873/invivo.11952,2020-06-07
Haloperidol,TREATS,Schizophrenia,32503820,10.21873/invivo.11952,2020-06-07
SARS gene,COEXISTS_WITH,NTNG1 gene,32503820,10.21873/invivo.11952,2020-06-07
NTNG1 gene,AFFECTS,Schizophrenia,32503820,10.21873/invivo.11952,2020-06-07
NTNG1 gene,PART_OF,Homo sapiens,32503820,10.21873/invivo.11952,2020-06-07
Myalgia,ISA,Complication,32503819,10.21873/invivo.11951,2020-06-07
Coronavirus Infections,ISA,Disease,32503818,10.21873/invivo.11950,2020-06-07
Coronavirus Infections,ISA,Disease,32503818,10.21873/invivo.11950,2020-06-07
disorder analysis,TREATS,Disease,32503818,10.21873/invivo.11950,2020-06-07
disorder analysis,TREATS(SPEC),Coronavirus Infections,32503818,10.21873/invivo.11950,2020-06-07
SARS coronavirus,ISA,Virus,32503816,10.21873/invivo.11948,2020-06-07
Antiviral Agents,TREATS,Virus Diseases,32503816,10.21873/invivo.11948,2020-06-07
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32503816,10.21873/invivo.11948,2020-06-07
Antiviral Agents,TREATS,Disease,32503816,10.21873/invivo.11948,2020-06-07
Methionine gamma-lyase,PART_OF,Patients,32503815,10.21873/invivo.11947,2020-06-07
Cell Count,USES,Methionine,32503815,10.21873/invivo.11947,2020-06-07
macrophage,INTERACTS_WITH,cytokine,32503815,10.21873/invivo.11947,2020-06-07
Methionine,DISRUPTS,Cessation of life,32503815,10.21873/invivo.11947,2020-06-07
T-Lymphocyte,INTERACTS_WITH,cytokine,32503815,10.21873/invivo.11947,2020-06-07
Coronavirus Infections,PROCESS_OF,Patients,32503815,10.21873/invivo.11947,2020-06-07
Comorbidity,PROCESS_OF,Persons,32503814,10.21873/invivo.11946,2020-06-07
Comorbidity,PROCESS_OF,Old age,32503814,10.21873/invivo.11946,2020-06-07
pulmonary complications,PROCESS_OF,Persons,32503814,10.21873/invivo.11946,2020-06-07
pulmonary complications,PROCESS_OF,Old age,32503814,10.21873/invivo.11946,2020-06-07
Interleukin-6,DISRUPTS,Interleukin Signaling Process,32503814,10.21873/invivo.11946,2020-06-07
Coronavirus Infections,ISA,Disease,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Pharmaceutical Preparations,TREATS,Disease,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Coronavirus Infections,ISA,Disease,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Acetylcysteine,COEXISTS_WITH,Colchicine,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Acetylcysteine,COEXISTS_WITH,Copper,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Acetylcysteine,COEXISTS_WITH,Nitric Oxide,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Antiviral Agents,COEXISTS_WITH,Copper,32503812,10.1136/bmjdrc-2020-001476,2020-06-07
Critical Illness,PROCESS_OF,Patients,32503806,10.1158/1078-0432.CCR-20-1914,2020-06-07
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Pneumonia,32503800,10.7861/clinmed.2020-0179,2020-06-07
Vitamin supplementation,AUGMENTS,CD4+ CD25+ Regulatory T Cells,32503800,10.7861/clinmed.2020-0179,2020-06-07
Vitamin D Deficiency,COEXISTS_WITH,Thrombotic episodes,32503800,10.7861/clinmed.2020-0179,2020-06-07
Diabetes,PROCESS_OF,Patients,32503800,10.7861/clinmed.2020-0179,2020-06-07
Obesity,PROCESS_OF,Patients,32503800,10.7861/clinmed.2020-0179,2020-06-07
Vitamin D Deficiency,OCCURS_IN,Patients,32503800,10.7861/clinmed.2020-0179,2020-06-07
Ergocalciferol,INHIBITS,IMPACT gene,32503800,10.7861/clinmed.2020-0179,2020-06-07
Cardiomyopathies,PROCESS_OF,Patients,32503706,10.1016/j.echo.2020.04.004,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32503706,10.1016/j.echo.2020.04.004,2020-06-07
Lung,LOCATION_OF,Ultrasonography,32503706,10.1016/j.echo.2020.04.004,2020-06-07
Echocardiography,ADMINISTERED_TO,Patients,32503701,10.1016/j.echo.2020.04.014,2020-06-07
Echocardiography,ADMINISTERED_TO,Patients,32503701,10.1016/j.echo.2020.04.014,2020-06-07
cardiac ultrasound,ADMINISTERED_TO,Patients,32503701,10.1016/j.echo.2020.04.014,2020-06-07
Structure of right hand,LOCATION_OF,Radionuclide Imaging,32503668,10.1186/s13054-020-03007-0,2020-06-07
Lung,LOCATION_OF,Homeostasis,32503662,10.1186/s13063-020-04420-0,2020-06-07
Wound Healing,AFFECTS,Immunity,32503662,10.1186/s13063-020-04420-0,2020-06-07
Lithium therapy,USES,Carbonates,32503662,10.1186/s13063-020-04420-0,2020-06-07
Hydroxychloroquine Sulfate,TREATS,Patients,32503657,10.1186/s13063-020-04430-y,2020-06-07
Troponin,PART_OF,Heart,32503657,10.1186/s13063-020-04430-y,2020-06-07
Hydroxychloroquine Sulfate,TREATS,Symptoms,32503657,10.1186/s13063-020-04430-y,2020-06-07
Hydroxychloroquine Sulfate,TREATS,Score 2,32503657,10.1186/s13063-020-04430-y,2020-06-07
"Hospitals, University",LOCATION_OF,Randomization,32503657,10.1186/s13063-020-04430-y,2020-06-07
Department,LOCATION_OF,Laboratory reporting,32503657,10.1186/s13063-020-04430-y,2020-06-07
Troponin,PART_OF,Heart,32503657,10.1186/s13063-020-04430-y,2020-06-07
Antiviral Agents,INHIBITS,RNA-Directed RNA Polymerase,32503620,10.1186/s13063-020-04455-3,2020-06-07
favipiravir,INHIBITS(SPEC),RNA-Directed RNA Polymerase,32503620,10.1186/s13063-020-04455-3,2020-06-07
favipiravir,ISA,Antiviral Agents,32503620,10.1186/s13063-020-04455-3,2020-06-07
favipiravir,TREATS,Life-threatening infections,32503620,10.1186/s13063-020-04455-3,2020-06-07
Taking medication (activity),TREATS,Adverse event,32503620,10.1186/s13063-020-04455-3,2020-06-07
Pharmaceutical Preparations,TREATS,Coughing,32503620,10.1186/s13063-020-04455-3,2020-06-07
Coronavirus Infections,PROCESS_OF,Patients,32503620,10.1186/s13063-020-04455-3,2020-06-07
Sputum,LOCATION_OF,Nucleic Acids,32503620,10.1186/s13063-020-04455-3,2020-06-07
Respiratory sample,NEG_PART_OF,Control Groups,32503620,10.1186/s13063-020-04455-3,2020-06-07
Colchicine,ISA,Pharmaceutical Preparations,32503613,10.1186/s12939-020-01210-7,2020-06-07
Antibiotics,ADMINISTERED_TO,Patients,32503613,10.1186/s12939-020-01210-7,2020-06-07
Antioxidants,ADMINISTERED_TO,Patients,32503613,10.1186/s12939-020-01210-7,2020-06-07
Minerals,ADMINISTERED_TO,Patients,32503613,10.1186/s12939-020-01210-7,2020-06-07
Vitamins,ADMINISTERED_TO,Patients,32503613,10.1186/s12939-020-01210-7,2020-06-07
Antibiotics,COEXISTS_WITH,Colchicine,32503613,10.1186/s12939-020-01210-7,2020-06-07
Antioxidants,COEXISTS_WITH,Colchicine,32503613,10.1186/s12939-020-01210-7,2020-06-07
Trace Elements,COEXISTS_WITH,Colchicine,32503613,10.1186/s12939-020-01210-7,2020-06-07
lopinavir / Ritonavir,COEXISTS_WITH,Colchicine,32503613,10.1186/s12939-020-01210-7,2020-06-07
Participant,LOCATION_OF,Interleukin-6,32503613,10.1186/s12939-020-01210-7,2020-06-07
Absenteeism,PROCESS_OF,Health Personnel,32503600,10.1186/s13054-020-03018-x,2020-06-07
Hospitals,LOCATION_OF,Work,32503600,10.1186/s13054-020-03018-x,2020-06-07
Hospitals,LOCATION_OF,Clinical Trials,32503600,10.1186/s13054-020-03018-x,2020-06-07
Physiologic Organization,PROCESS_OF,Elderly (population group),32503600,10.1186/s13054-020-03018-x,2020-06-07
Absenteeism,PROCESS_OF,Health Personnel,32503600,10.1186/s13054-020-03018-x,2020-06-07
Pharmaceutical Preparations,ADMINISTERED_TO,Research Personnel,32503600,10.1186/s13054-020-03018-x,2020-06-07
Hospital Administration,TREATS,Patients,32503593,10.1186/s13054-020-03021-2,2020-06-07
Hospital Administration,USES,Artificial Airways,32503593,10.1186/s13054-020-03021-2,2020-06-07
Complication,PROCESS_OF,Patients,32503352,10.3390/v12060611,2020-06-07
Multiple Organ Failure,PROCESS_OF,Patients,32503352,10.3390/v12060611,2020-06-07
cytokine,ASSOCIATED_WITH,Blood Coagulation Disorders,32503352,10.3390/v12060611,2020-06-07
Interleukin-6,ASSOCIATED_WITH,Disseminated Intravascular Coagulation,32503352,10.3390/v12060611,2020-06-07
Interleukin-6,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32503352,10.3390/v12060611,2020-06-07
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32503333,10.3390/ijerph17113973,2020-06-07
Epitopes,PART_OF,Middle East Respiratory Syndrome Coronavirus,32503333,10.3390/ijerph17113973,2020-06-07
Camels,LOCATION_OF,DNA Sequence,32503333,10.3390/ijerph17113973,2020-06-07
Homo sapiens,LOCATION_OF,DNA Sequence,32503333,10.3390/ijerph17113973,2020-06-07
"M Protein, multiple myeloma",PART_OF,Middle East Respiratory Syndrome Coronavirus,32503333,10.3390/ijerph17113973,2020-06-07
Genus: Coronavirus,PROCESS_OF,World,32503305,10.3390/jcm9061730,2020-06-07
Coronavirus Infections,PROCESS_OF,Family,32503305,10.3390/jcm9061730,2020-06-07
Coronavirus Infections,ISA,Disease,32503304,10.3390/healthcare8020155,2020-06-07
contextual factors,PROCESS_OF,Public Sector,32503304,10.3390/healthcare8020155,2020-06-07
Consultation,COEXISTS_WITH,Emergency operation,32503304,10.3390/healthcare8020155,2020-06-07
Coronavirus Infections,ISA,Disease,32503304,10.3390/healthcare8020155,2020-06-07
Coronavirus Infections,ISA,Disease,32503304,10.3390/healthcare8020155,2020-06-07
Asymptomatic,PROCESS_OF,Patients,32503205,10.3390/ijerph17113956,2020-06-07
Safety procedure,METHOD_OF,Prophylactic treatment,32503205,10.3390/ijerph17113956,2020-06-07
Severe Acute Respiratory Syndrome,PROCESS_OF,General Practitioners,32503205,10.3390/ijerph17113956,2020-06-07
Coronavirus Infections,ISA,Disease,32503192,10.3390/ijerph17113955,2020-06-07
Severe Acute Respiratory Syndrome,CAUSES,Disease,32503192,10.3390/ijerph17113955,2020-06-07
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32503192,10.3390/ijerph17113955,2020-06-07
Pandemics,ISA,Epidemic,32503192,10.3390/ijerph17113955,2020-06-07
Infected,PROCESS_OF,Persons,32503180,10.3390/jcm9061718,2020-06-07
"Kidney Failure, Acute",PROCESS_OF,Social Networks,32503173,10.3390/nu12061657,2020-06-07
"Kidney Failure, Acute",PROCESS_OF,Patients,32503173,10.3390/nu12061657,2020-06-07
"Kidney Failure, Acute",PROCESS_OF,Patients,32503173,10.3390/nu12061657,2020-06-07
Coronavirus Infections,ISA,Disease,32503172,10.3390/brainsci10060341,2020-06-07
Child,ISA,Persons,32503172,10.3390/brainsci10060341,2020-06-07
psychological distress,PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Autism Spectrum Disorders,PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Persons,LOCATION_OF,IMPACT gene,32503169,10.3390/ijerph17113953,2020-06-07
Coronavirus Infections,ISA,Disease,32503169,10.3390/ijerph17113953,2020-06-07
Autism Spectrum Disorders,PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Autism Spectrum Disorders,PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Autism Spectrum Disorders,PROCESS_OF,Child,32503169,10.3390/ijerph17113953,2020-06-07
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Autism Spectrum Disorders,PROCESS_OF,Persons,32503169,10.3390/ijerph17113953,2020-06-07
Vaccines,PREVENTS,Disease,32503092,10.1212/NXI.0000000000000787,2020-06-07
Therapeutic procedure,PREVENTS,Disease,32503092,10.1212/NXI.0000000000000787,2020-06-07
Viral life cycle,AFFECTS,Disease,32503092,10.1212/NXI.0000000000000787,2020-06-07
Pharmaceutical Preparations,AFFECTS,Immunity,32503088,10.1111/ene.14382,2020-06-06
Neuromyelitis Optica,PROCESS_OF,Patients,32503088,10.1111/ene.14382,2020-06-06
Treatment Protocols,USES,,32503088,10.1111/ene.14382,2020-06-06
Pneumonia,PROCESS_OF,Patients,32503088,10.1111/ene.14382,2020-06-06
Neuromyelitis Optica,PREDISPOSES,Coronavirus Infections,32503088,10.1111/ene.14382,2020-06-06
Pneumonia,PREDISPOSES,Severe Acute Respiratory Syndrome,32503088,10.1111/ene.14382,2020-06-06
Coronavirus Infections,PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score A,32503088,10.1111/ene.14382,2020-06-06
Coronavirus Infections,PROCESS_OF,Patients,32503088,10.1111/ene.14382,2020-06-06
Symptoms,PROCESS_OF,Patients,32503084,10.1111/ene.14383,2020-06-06
Neurologic Symptoms,PROCESS_OF,Cohort,32503084,10.1111/ene.14383,2020-06-06
Marfan Syndrome,PROCESS_OF,Patients,32503062,10.1055/s-0040-1713082,2020-06-06
Communicable Diseases,ASSOCIATED_WITH,Pathogenic organism,32503061,10.1055/s-0040-1710545,2020-06-06
Disease,COEXISTS_WITH,Symptoms,32502958,10.1016/j.dsx.2020.05.039,2020-06-06
Diabetes,COEXISTS_WITH,Severe (severity modifier),32502901,10.1016/j.mehy.2020.109904,2020-06-06
Hyperglycemia,PROCESS_OF,Persons,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Coronavirus Infections,PROCESS_OF,hospitalized patients,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Evaluation procedure,TREATS,hospitalized patients,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Evaluation procedure,TREATS(INFER),Coronavirus Infections,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Evaluation procedure,USES,Glucose,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Blood capillaries,LOCATION_OF,Monitors blood glucose,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Hyperglycemia,PROCESS_OF,Persons,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Screening procedure,NEG_TREATS,Coronavirus Infections,32502901,10.1016/j.mehy.2020.109904,2020-06-06
Coronavirus Infections,ISA,Disease,32502882,10.1016/j.ahj.2020.05.002,2020-06-06
Severe Acute Respiratory Syndrome,CAUSES,Disease,32502882,10.1016/j.ahj.2020.05.002,2020-06-06
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32502882,10.1016/j.ahj.2020.05.002,2020-06-06
Proteins,AFFECTS,Virus Replication,32502882,10.1016/j.ahj.2020.05.002,2020-06-06
Antiviral Therapy,AFFECTS,Virus Diseases,32502882,10.1016/j.ahj.2020.05.002,2020-06-06
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Up-Regulation (Physiology),PROCESS_OF,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
angiotensin converting enzyme 2,STIMULATES,Up-Regulation (Physiology),32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Angiotensin II receptor antagonist,TREATS,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Transient Ischemic Attack,ISA,Cerebrovascular accident,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Discontinued,PROCESS_OF,Patients,32502844,10.1016/j.sleep.2020.05.023,2020-06-06
Genome,PART_OF,World,32502693,10.1016/j.diabres.2020.108246,2020-06-06
Clinical act of insertion,USES,Amino Acids,32502693,10.1016/j.diabres.2020.108246,2020-06-06
"Vitronectin, human",INTERACTS_WITH,"Protein, Organized by Structure",32502693,10.1016/j.diabres.2020.108246,2020-06-06
World,LOCATION_OF,IMPACT gene,32502664,10.1016/j.ijid.2020.05.076,2020-06-06
Physiologic Organization,PROCESS_OF,Consumer,32502664,10.1016/j.ijid.2020.05.076,2020-06-06
Thrombus,PROCESS_OF,Patients,32502646,10.1016/j.cmi.2020.05.028,2020-06-06
Cardiac complication,PROCESS_OF,Patients,32502646,10.1016/j.cmi.2020.05.028,2020-06-06
Inflammation,PROCESS_OF,Patients,32502646,10.1016/j.cmi.2020.05.028,2020-06-06
endothelial dysfunction,PROCESS_OF,Patients,32502646,10.1016/j.cmi.2020.05.028,2020-06-06
"Signs and Symptoms, Respiratory",PROCESS_OF,Persons,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Performance,PROCESS_OF,Persons,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hypersensitivity,PROCESS_OF,Cohort,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hypersensitivity,PROCESS_OF,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Symptoms,PROCESS_OF,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hypersensitivity,PROCESS_OF,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hypersensitivity,PROCESS_OF,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hypersensitivity,AFFECTS,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Symptoms,PROCESS_OF,Patients,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Hospitals,LOCATION_OF,Logistics,32502645,10.1016/j.cmi.2020.05.026,2020-06-06
Anosmia,PROCESS_OF,Community,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Anosmia,PROCESS_OF,Households,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Anosmia,PROCESS_OF,Patients,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Ageusia,PROCESS_OF,Community,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Ageusia,PROCESS_OF,Households,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Ageusia,PROCESS_OF,Patients,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Symptoms,PROCESS_OF,Patients,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Symptoms,PROCESS_OF,Patients,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Symptoms,PROCESS_OF,Households,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Symptoms,PROCESS_OF,Patients,32502616,10.1016/j.jtos.2020.05.013,2020-06-06
Epithelium,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,PART_OF,Cornea,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Conjunctival ring,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Conjunctival ring,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
embryo and fetus,LOCATION_OF,Base Sequence,32502594,10.1016/j.chest.2020.05.559,2020-06-06
embryo and fetus,LOCATION_OF,"XCL1 protein, human",32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,LOCATION_OF,Chromatin,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium,PART_OF,Cornea,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Conjunctival ring,LOCATION_OF,Chromatin,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Conjunctival ring,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Conjunctival ring,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Limbus Corneae,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Limbus Corneae,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Surface,LOCATION_OF,Leptocyte,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium of conjunctiva,LOCATION_OF,TMPRSS2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Epithelium of conjunctiva,LOCATION_OF,ACE2 gene,32502594,10.1016/j.chest.2020.05.559,2020-06-06
Recombinant Interferon-gamma,STIMULATES,Up-Regulation (Physiology),32502594,10.1016/j.chest.2020.05.559,2020-06-06
Prophylactic treatment,TREATS,Patients,32502585,10.1016/j.jaad.2020.05.145,2020-06-06
Acral Lesion,PROCESS_OF,Patients,32502551,10.1016/j.virusres.2020.198043,2020-06-06
Blood Vessel,LOCATION_OF,Fibrin deposition,32502551,10.1016/j.virusres.2020.198043,2020-06-06
Disease,OCCURS_IN,Family,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Coronavirus Infections,ISA,Disease,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Coronavirus Infections,OCCURS_IN(SPEC),Family,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Disease,PROCESS_OF,Elderly (population group),32502542,10.1016/j.lfs.2020.117900,2020-06-06
Disease,PROCESS_OF,Family,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Coronavirus Infections,ISA,Disease,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Coronavirus Infections,PROCESS_OF(SPEC),Elderly (population group),32502542,10.1016/j.lfs.2020.117900,2020-06-06
Coronavirus Infections,PROCESS_OF(SPEC),Family,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Cessation of life,PROCESS_OF,Patients,32502542,10.1016/j.lfs.2020.117900,2020-06-06
SARS coronavirus,PROCESS_OF,Family,32502542,10.1016/j.lfs.2020.117900,2020-06-06
SARS coronavirus,PROCESS_OF,Patients,32502542,10.1016/j.lfs.2020.117900,2020-06-06
Critical Illness,PROCESS_OF,Patients,32502389,10.1016/S2468-2667(20)30133-X,2020-06-06
inflammatory response,CAUSES,"Respiratory Distress Syndrome, Adult",32502389,10.1016/S2468-2667(20)30133-X,2020-06-06
inflammatory response,PROCESS_OF,Patients,32502389,10.1016/S2468-2667(20)30133-X,2020-06-06
Coronavirus Infections,AFFECTS,Crisis,32502331,10.1002/rmv.2112,2020-06-06
Therapeutic procedure,TREATS,Virus,32502331,10.1002/rmv.2112,2020-06-06
Confirmation,PROCESS_OF,Patients,32502327,10.1111/php.13293,2020-06-06
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32502327,10.1111/php.13293,2020-06-06
Fever,ISA,Symptoms,32502327,10.1111/php.13293,2020-06-06
Standard chest X-ray abnormal,PROCESS_OF,Patients,32502327,10.1111/php.13293,2020-06-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32502327,10.1111/php.13293,2020-06-06
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32502327,10.1111/php.13293,2020-06-06
,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32502327,10.1111/php.13293,2020-06-06
,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32502327,10.1111/php.13293,2020-06-06
Infected,PROCESS_OF,Patients,32502319,10.1111/ijcp.13580,2020-06-06
Pharmaceutical Preparations,COMPLICATES,Rheumatism,32502288,10.1111/ced.14324,2020-06-06
Glucocorticoids,COMPLICATES,Rheumatism,32502288,10.1111/ced.14324,2020-06-06
Rheumatism,PROCESS_OF,Patients,32502288,10.1111/ced.14324,2020-06-06
Rheumatism,PROCESS_OF,Physicians,32502288,10.1111/ced.14324,2020-06-06
Rheumatism,PROCESS_OF,Pregnant Women,32502288,10.1111/ced.14324,2020-06-06
Rheumatism,PROCESS_OF,Rheumatologist,32502288,10.1111/ced.14324,2020-06-06
Coronavirus Infections,PROCESS_OF,Patients,32502288,10.1111/ced.14324,2020-06-06
Coronavirus Infections,PROCESS_OF,Physicians,32502288,10.1111/ced.14324,2020-06-06
Passenger,LOCATION_OF,Air,32502263,10.1093/cid/ciaa725,2020-06-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,traveler,32502263,10.1093/cid/ciaa725,2020-06-06
China,ISA,Geographic Locations,32502263,10.1093/cid/ciaa725,2020-06-06
Europe,ISA,Geographic Locations,32502263,10.1093/cid/ciaa725,2020-06-06
United States,ISA,Geographic Locations,32502263,10.1093/cid/ciaa725,2020-06-06
Coronavirus Infections,ISA,Disease,32502135,10.1213/ANE.0000000000005044,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
Decreased Immunologic Activity [PE],ASSOCIATED_WITH,GSKIP gene,32502132,10.1213/ANE.0000000000005043,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
Cell positive for CD14 antigen,LOCATION_OF,HLA-DR Antigens,32502132,10.1213/ANE.0000000000005043,2020-06-06
Critical Illness,PROCESS_OF,Patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
Critical Illness,PROCESS_OF,hospitalized patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
Acute respiratory failure,PROCESS_OF,Patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
hospitalized patients,LOCATION_OF,HLA-DR Antigens,32502132,10.1213/ANE.0000000000005043,2020-06-06
Critical Illness,PROCESS_OF,Patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
HLA-DR Antigens,PART_OF,Monocytes,32502132,10.1213/ANE.0000000000005043,2020-06-06
Critical Illness,PROCESS_OF,Patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
Interventional procedure,ADMINISTERED_TO,Patients,32502132,10.1213/ANE.0000000000005043,2020-06-06
Immunoregulation,PROCESS_OF,Population Group,32502132,10.1213/ANE.0000000000005043,2020-06-06
Coronavirus Infections,ISA,Communicable Diseases,32502117,10.1097/JCMA.0000000000000323,2020-06-06
Study,METHOD_OF,Occupations,32502117,10.1097/JCMA.0000000000000323,2020-06-06
Symptoms,PROCESS_OF,Child,32502116,10.1097/JCMA.0000000000000332,2020-06-06
Malaise,PROCESS_OF,Child,32502116,10.1097/JCMA.0000000000000332,2020-06-06
Asymptomatic,PROCESS_OF,Child,32502116,10.1097/JCMA.0000000000000332,2020-06-06
Old age,ISA,Population Group,32502107,10.1097/SCS.0000000000006696,2020-06-06
Coronavirus Infections,CAUSES,Disease,32502091,10.1097/RLU.0000000000003100,2020-06-06
Coronavirus Infections,ISA,Disease,32502091,10.1097/RLU.0000000000003100,2020-06-06
Coronavirus Infections,ISA,Disease,32502091,10.1097/RLU.0000000000003100,2020-06-06
Coronavirus Infections,ISA,Disease,32502091,10.1097/RLU.0000000000003100,2020-06-06
Masks,TREATS,Health Personnel,32502091,10.1097/RLU.0000000000003100,2020-06-06
Author,PRODUCES,Masks,32502091,10.1097/RLU.0000000000003100,2020-06-06
Physical Examination,ADMINISTERED_TO,Patients,32502054,10.1097/MD.0000000000020661,2020-06-06
Physical Examination,USES,PET/CT scan,32502054,10.1097/MD.0000000000020661,2020-06-06
Single Photon Emission Computed Tomography Computed Tomography,ADMINISTERED_TO,Patients,32502054,10.1097/MD.0000000000020661,2020-06-06
skill,PROCESS_OF,Nuclear medicine specialist,32502054,10.1097/MD.0000000000020661,2020-06-06
Disease,PROCESS_OF,Child,32502034,10.1097/MD.0000000000020605,2020-06-06
Coughing,PROCESS_OF,Infant,32502034,10.1097/MD.0000000000020605,2020-06-06
Rhinorrhea,PROCESS_OF,Infant,32502034,10.1097/MD.0000000000020605,2020-06-06
Awareness,PROCESS_OF,Adult,32502034,10.1097/MD.0000000000020605,2020-06-06
Awareness,PROCESS_OF,Child,32502034,10.1097/MD.0000000000020605,2020-06-06
Chronic disease,PROCESS_OF,Male population group,32502008,10.1097/MD.0000000000020529,2020-06-06
Masks,PREVENTS,Infection,32502008,10.1097/MD.0000000000020529,2020-06-06
Masks,PREVENTS,Infection,32502008,10.1097/MD.0000000000020529,2020-06-06
Massage,ISA,Interventional procedure,32502005,10.1097/MD.0000000000020525,2020-06-06
Chest,LOCATION_OF,Distress,32502005,10.1097/MD.0000000000020525,2020-06-06
Symptoms,PROCESS_OF,Patients,32502005,10.1097/MD.0000000000020525,2020-06-06
Influenza,PROCESS_OF,Community,32501972,10.1097/MD.0000000000020203,2020-06-06
Masks,TREATS,Influenza,32501972,10.1097/MD.0000000000020203,2020-06-06
Masks,TREATS,Influenza,32501972,10.1097/MD.0000000000020203,2020-06-06
Disease,CAUSES,Cessation of life,32501877,10.1097/MEG.0000000000001792,2020-06-06
Hospitalization,TREATS,Patients,32501876,10.1097/MEG.0000000000001811,2020-06-06
Gastrointestinal Diseases,PROCESS_OF,Patients,32501839,10.1097/SAP.0000000000002459,2020-06-06
Therapeutic immunosuppression,TREATS,Patients,32501839,10.1097/SAP.0000000000002459,2020-06-06
Therapeutic immunosuppression,TREATS(INFER),Gastrointestinal Diseases,32501839,10.1097/SAP.0000000000002459,2020-06-06
Acclimatization,PROCESS_OF,Patients,32501839,10.1097/SAP.0000000000002459,2020-06-06
S-Adenosylhomocysteine,ASSOCIATED_WITH,Hand Injuries,32501820,10.2106/JBJS.20.00773,2020-06-06
S-Adenosylhomocysteine,compared_with,S-Adenosylhomocysteine,32501820,10.2106/JBJS.20.00773,2020-06-06
Domestic Violence,COEXISTS_WITH,Traffic accidents,32501820,10.2106/JBJS.20.00773,2020-06-06
Transection (procedure),METHOD_OF,Interventional procedure,32501820,10.2106/JBJS.20.00773,2020-06-06
Transection (procedure),METHOD_OF(SPEC),Operative Surgical Procedures,32501820,10.2106/JBJS.20.00773,2020-06-06
Operative Surgical Procedures,ISA,Interventional procedure,32501820,10.2106/JBJS.20.00773,2020-06-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32501809,10.2196/19725,2020-06-06
Disease,AFFECTS,Negative,32501807,10.2196/19691,2020-06-06
Coronavirus Infections,AFFECTS(SPEC),Negative,32501807,10.2196/19691,2020-06-06
Coronavirus Infections,ISA,Disease,32501807,10.2196/19691,2020-06-06
Coronavirus Infections,ISA,Disease,32501807,10.2196/19691,2020-06-06
Government,ISA,Organization administrative structures,32501807,10.2196/19691,2020-06-06
Malignant Neoplasms,COEXISTS_WITH,Disease,32501806,10.2196/19969,2020-06-06
Malignant Neoplasms,COEXISTS_WITH(SPEC),Coronavirus Infections,32501806,10.2196/19969,2020-06-06
Malignant Neoplasms,PROCESS_OF,Patients,32501806,10.2196/19969,2020-06-06
Therapeutic procedure,TREATS,Patients,32501806,10.2196/19969,2020-06-06
Therapeutic procedure,TREATS(INFER),Malignant Neoplasms,32501806,10.2196/19969,2020-06-06
Coronavirus Infections,ISA,Disease,32501806,10.2196/19969,2020-06-06
Oncologists,TREATS,Patients,32501806,10.2196/19969,2020-06-06
High Level,PROCESS_OF,Patients,32501806,10.2196/19969,2020-06-06
Coronavirus Infections,ISA,Disease,32501806,10.2196/19969,2020-06-06
Malignant Neoplasms,PROCESS_OF,Patients,32501806,10.2196/19969,2020-06-06
Challenge,TREATS,Patients,32501806,10.2196/19969,2020-06-06
Intervention regimes,TREATS,disease transmission,32501805,10.2196/19292,2020-06-06
Negative Surgical Margin,PROCESS_OF,Policy Makers,32501805,10.2196/19292,2020-06-06
Coronavirus Infections,ISA,Disease,32501804,10.2196/19284,2020-06-06
IMPACT gene,PART_OF,Virus,32501804,10.2196/19284,2020-06-06
Program,AFFECTS,Crisis,32501804,10.2196/19284,2020-06-06
Program,INHIBITS,Distress,32501804,10.2196/19284,2020-06-06
Coronavirus Infections,ISA,Disease,32501803,10.2196/19787,2020-06-06
Persons,LOCATION_OF,IMPACT gene,32501802,10.2196/20369,2020-06-06
France,ISA,Country,32501802,10.2196/20369,2020-06-06
Spain,ISA,Country,32501802,10.2196/20369,2020-06-06
Coronavirus Infections,ISA,Disease,32501801,10.2196/19782,2020-06-06
Coronavirus Infections,ISA,Disease,32501801,10.2196/19782,2020-06-06
Coronavirus Infections,ISA,Disease,32501754,10.7326/M20-2223,2020-06-06
Engaged to be married,COEXISTS_WITH,Disease,32501754,10.7326/M20-2223,2020-06-06
Engaged to be married,COEXISTS_WITH(SPEC),Coronavirus Infections,32501754,10.7326/M20-2223,2020-06-06
Coronavirus Infections,ISA,Disease,32501754,10.7326/M20-2223,2020-06-06
Coronavirus Infections,ISA,Disease,32501754,10.7326/M20-2223,2020-06-06
Coronavirus Infections,ISA,Disease,32501754,10.7326/M20-2223,2020-06-06
Analysis,USES,Medical Devices,32501753,10.1080/08959420.2020.1771240,2020-06-06
Elderly (population group),LOCATION_OF,"TLR4 protein, human",32501751,10.1177/1747493020937189,2020-06-06
Minority Groups,ISA,Persons,32501751,10.1177/1747493020937189,2020-06-06
Minority Groups,LOCATION_OF(SPEC),"TLR4 protein, human",32501751,10.1177/1747493020937189,2020-06-06
Persons,LOCATION_OF,"TLR4 protein, human",32501751,10.1177/1747493020937189,2020-06-06
"TLR4 protein, human",ADMINISTERED_TO,Population Group,32501751,10.1177/1747493020937189,2020-06-06
Cessation of life,PROCESS_OF,Community,32501751,10.1177/1747493020937189,2020-06-06
Infection,COEXISTS_WITH,Crisis,32501751,10.1177/1747493020937189,2020-06-06
Malaise,COEXISTS_WITH,Crisis,32501751,10.1177/1747493020937189,2020-06-06
Aging,PROCESS_OF,Community,32501751,10.1177/1747493020937189,2020-06-06
Acute cerebrovascular disease,PROCESS_OF,Patients,32501747,10.1089/tmj.2020.0144,2020-06-06
"Sinus Thrombosis, Intracranial",PROCESS_OF,Patients,32501747,10.1089/tmj.2020.0144,2020-06-06
Interventional procedure,TREATS,Patients,32501747,10.1089/tmj.2020.0144,2020-06-06
Mechanical thrombectomy,TREATS,Patients,32501747,10.1089/tmj.2020.0144,2020-06-06
Functional Status,PROCESS_OF,Patients,32501747,10.1089/tmj.2020.0144,2020-06-06
"Discharge, body substance",ASSOCIATED_WITH,patient condition,32501747,10.1089/tmj.2020.0144,2020-06-06
Blood supply aspects,PART_OF,Veins,32501747,10.1089/tmj.2020.0144,2020-06-06
Coronavirus Infections,ISA,Disease,32501645,10.1111/jocd.13531,2020-06-06
Coronavirus Infections,ISA,Disease,32501645,10.1111/jocd.13531,2020-06-06
Blood Coagulation Disorders,COEXISTS_WITH,Disease,32501645,10.1111/jocd.13531,2020-06-06
Blood Coagulation Disorders,COEXISTS_WITH(SPEC),Coronavirus Infections,32501645,10.1111/jocd.13531,2020-06-06
Coronavirus Infections,ISA,Disease,32501645,10.1111/jocd.13531,2020-06-06
Disease,PROCESS_OF,Patients,32501645,10.1111/jocd.13531,2020-06-06
Coronavirus Infections,ISA,Disease,32501645,10.1111/jocd.13531,2020-06-06
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32501645,10.1111/jocd.13531,2020-06-06
Dyslipidemias,PROCESS_OF,Patients,32501645,10.1111/jocd.13531,2020-06-06
Coronavirus Infections,ISA,Disease,32501645,10.1111/jocd.13531,2020-06-06
Face,LOCATION_OF,Mimetic Muscles,32501640,10.1002/pon.5418,2020-06-06
Set of muscles,PART_OF,Mimetic Muscles,32501640,10.1002/pon.5418,2020-06-06
Face,LOCATION_OF,anatomical layer,32501640,10.1002/pon.5418,2020-06-06
Complication,PROCESS_OF,Patients,32501600,10.1002/hed.26274,2020-06-06
Complication,PROCESS_OF,Old age,32501600,10.1002/hed.26274,2020-06-06
Diabetic Foot,ISA,Complication,32501600,10.1002/hed.26274,2020-06-06
Complication,OCCURS_IN,Health Personnel,32501600,10.1002/hed.26274,2020-06-06
Complication,OCCURS_IN,Patients,32501600,10.1002/hed.26274,2020-06-06
Evaluation,TREATS,Patients,32501600,10.1002/hed.26274,2020-06-06
Screening procedure,TREATS,Patients,32501600,10.1002/hed.26274,2020-06-06
Screening procedure,USES,Chest CT,32501600,10.1002/hed.26274,2020-06-06
Detection,TREATS,Patients,32501600,10.1002/hed.26274,2020-06-06
Tracheostomy procedure,TREATS,Patients,32501565,10.1111/medu.14267,2020-06-06
Tracheostomy procedure,TREATS,Patients,32501565,10.1111/medu.14267,2020-06-06
Hospitals,LOCATION_OF,Study,32501535,10.1002/jmv.26140,2020-06-06
lopinavir / Ritonavir,TREATS,patient condition,32501535,10.1002/jmv.26140,2020-06-06
danoprevir,TREATS,patient condition,32501535,10.1002/jmv.26140,2020-06-06
danoprevir,TREATS,Patients,32501535,10.1002/jmv.26140,2020-06-06
Detection,TREATS,Patients,32501511,10.1001/jamapediatrics.2020.2422,2020-06-06
Mutation,AFFECTS,Hypersensitivity,32501511,10.1001/jamapediatrics.2020.2422,2020-06-06
Nasopharynx,LOCATION_OF,Non structural gene,32501511,10.1001/jamapediatrics.2020.2422,2020-06-06
Saliva specimen,LOCATION_OF,Non structural gene,32501511,10.1001/jamapediatrics.2020.2422,2020-06-06
Detection,USES,Synapsin I,32501511,10.1001/jamapediatrics.2020.2422,2020-06-06
Plasma,LOCATION_OF,Hydroxychloroquine,32501455,10.1016/j.xcrm.2020.100019,2020-06-06
Interstitial Fluid,LOCATION_OF,Hydroxychloroquine,32501455,10.1016/j.xcrm.2020.100019,2020-06-06
Interstitial Fluid,PART_OF,Lung,32501455,10.1016/j.xcrm.2020.100019,2020-06-06
Autoimmune Diseases,COEXISTS_WITH,Respiratory viruses,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Down Syndrome,PROCESS_OF,Persons,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Inflammatory disorder,PROCESS_OF,general population,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Down Syndrome,PROCESS_OF,Persons,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Down Syndrome,CAUSES,Cytokine release syndrome,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Immune dysregulation,PROCESS_OF,Population Group,32501454,10.1016/S2665-9913(20)30127-2,2020-06-06
Pandemics,ISA,Disease Outbreaks,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Noninvasive Ventilation,ADMINISTERED_TO,Persons,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Hospitals,LOCATION_OF,Retrospective Cohort Study,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Noninvasive Ventilation,TREATS,Severe Acute Respiratory Syndrome,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
C-reactive protein,compared_with,anakinra,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Respiration,PROCESS_OF,Cohort,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,NEG_ADMINISTERED_TO,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,ADMINISTERED_TO,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Noninvasive Ventilation,ADMINISTERED_TO,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Serum,LOCATION_OF,C-reactive protein,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,INTERACTS_WITH,C-reactive protein,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,ADMINISTERED_TO,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Serum,LOCATION_OF,C-reactive protein,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,INHIBITS,C-reactive protein,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,ADMINISTERED_TO,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
anakinra,TREATS,Patients,32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Noninvasive Ventilation,TREATS,"Respiratory Distress Syndrome, Adult",32501440,10.1016/S2589-7500(20)30109-6,2020-06-06
Clinic,LOCATION_OF,Observational Study,32501429,10.1016/j.coesh.2020.05.003,2020-06-06
Disinfection,USES,huperzine B,32501424,10.1016/j.imu.2020.100360,2020-06-06
Disease,PROCESS_OF,victim,32501420,10.1016/j.jth.2020.100877,2020-06-06
Stress,PROCESS_OF,Drivers of Vehicles,32501416,10.1186/s13362-020-00083-3,2020-06-06
Stress,PROCESS_OF,Drivers of Vehicles,32501416,10.1186/s13362-020-00083-3,2020-06-06
Disease,CAUSES,Growth,32501410,10.1186/s40545-020-00229-z,2020-06-06
Coronavirus Infections,CAUSES(SPEC),Growth,32501410,10.1186/s40545-020-00229-z,2020-06-06
Coronavirus Infections,ISA,Disease,32501410,10.1186/s40545-020-00229-z,2020-06-06
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32501410,10.1186/s40545-020-00229-z,2020-06-06
Real-Time Polymerase Chain Reaction,USES,Nasal Swab (procedure),32501410,10.1186/s40545-020-00229-z,2020-06-06
Vaccines,NEG_PART_OF,Persons,32501410,10.1186/s40545-020-00229-z,2020-06-06
Real-Time Polymerase Chain Reaction,USES,Nasal Swab (procedure),32501410,10.1186/s40545-020-00229-z,2020-06-06
Decision,PROCESS_OF,Pharmacist,32501409,10.1186/s13690-020-00433-y,2020-06-06
Clinical Response,PROCESS_OF,Patients,32501392,10.1016/j.envsci.2020.05.017,2020-06-06
Herpesviridae Infections,AFFECTS,Immune System Processes,32501392,10.1016/j.envsci.2020.05.017,2020-06-06
Zoonoses,AFFECTS,Disease,32501384,10.1186/s42269-020-00337-5,2020-06-06
Epidemic,ISA,Disease Outbreaks,32501380,10.1016/j.tranpol.2020.05.012,2020-06-06
Household composition,PROCESS_OF,Homo sapiens,32501377,10.1016/j.chaos.2020.109926,2020-06-06
Vaccines,TREATS,Community,32501377,10.1016/j.chaos.2020.109926,2020-06-06
Communicable Diseases,PROCESS_OF,Population Group,32501377,10.1016/j.chaos.2020.109926,2020-06-06
Communicable Diseases,PROCESS_OF,traveler,32501374,10.1016/j.chaos.2020.109930,2020-06-06
Household composition,PROCESS_OF,Homo sapiens,32501370,10.1016/j.chaos.2020.109853,2020-06-06
Cessation of life,PROCESS_OF,Human body,32501370,10.1016/j.chaos.2020.109853,2020-06-06
Autopsy procedure,ADMINISTERED_TO,Medical Staff,32501370,10.1016/j.chaos.2020.109853,2020-06-06
Cessation of life,PROCESS_OF,Human body,32501370,10.1016/j.chaos.2020.109853,2020-06-06
Coronavirus Infections,ISA,Disease,32501369,10.1016/j.chaos.2020.109841,2020-06-06
Epidemic,ISA,Process,32501368,10.1016/j.psep.2020.05.029,2020-06-06
Infection,PROCESS_OF,Homo sapiens,32501367,10.1016/j.ssci.2020.104842,2020-06-06
Decision,PROCESS_OF,Maker (occupation),32501367,10.1016/j.ssci.2020.104842,2020-06-06
Chloroquine,TREATS,Pneumonia,32501363,10.1016/j.cie.2020.106517,2020-06-06
Chloroquine,CAUSES,Adverse effects,32501363,10.1016/j.cie.2020.106517,2020-06-06
Pharmaceutical Preparations,TREATS,Patients,32501363,10.1016/j.cie.2020.106517,2020-06-06
Azithromycin,AUGMENTS,Prolonged QT interval,32501363,10.1016/j.cie.2020.106517,2020-06-06
Azithromycin,AUGMENTS,Cardiomyopathies,32501363,10.1016/j.cie.2020.106517,2020-06-06
Study,USES,Dose Regimen,32501363,10.1016/j.cie.2020.106517,2020-06-06
Symptom mild,PROCESS_OF,Patients,32501362,10.1016/j.buildenv.2020.106991,2020-06-06
Laboratory Infection,ISA,Infection,32501355,10.1016/j.cities.2020.102759,2020-06-06
Respiration,PROCESS_OF,Persons,32501321,10.1016/S0262-4079(20)30862-9,2020-06-06
Coronavirus Infections,PROCESS_OF,Persons,32501313,10.1016/j.cose.2020.101833,2020-06-06
Breath Analyzer,USES,Nanotubes,32501313,10.1016/j.cose.2020.101833,2020-06-06
Company (organization),LOCATION_OF,Knowledge acquisition,32501308,10.1016/j.jbusres.2020.05.029,2020-06-06
School,LOCATION_OF,Online Learning,32501308,10.1016/j.jbusres.2020.05.029,2020-06-06
Masks,USES,Manual Cytometers,32501293,10.1172/jci.insight.139834,2020-06-06
Screening procedure,ISA,Evaluation,32501293,10.1172/jci.insight.139834,2020-06-06
Analysis,MEASURES,Percent (qualifier value),32501293,10.1172/jci.insight.139834,2020-06-06
Blood,LOCATION_OF,Biological Response Modifiers,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Blood,LOCATION_OF,cytokine,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Blood,LOCATION_OF,chemokine,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Blood,PART_OF,Patients,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
peripheral blood,LOCATION_OF,Biological Response Modifiers,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
peripheral blood,LOCATION_OF,cytokine,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
peripheral blood,LOCATION_OF,chemokine,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Patients,LOCATION_OF,RANTES,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
RANTES,ISA,chemokine,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Interleukin-10,COEXISTS_WITH,,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Interleukin-10,COEXISTS_WITH,anakinra,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
anakinra,COEXISTS_WITH,,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
anakinra,COEXISTS_WITH,Interleukin-10,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
cytokine,ASSOCIATED_WITH,Storm NOS,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Storm NOS,COEXISTS_WITH,Virus Diseases,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Blood,LOCATION_OF,Interleukin-10,32501218,10.1016/j.placenta.2020.05.012,2020-06-06
Coronavirus Infections,COEXISTS_WITH,Vertical Disease Transmission,32501190,10.2217/pgs-2020-0048,2020-06-06
Organ,LOCATION_OF,BARRIER,32501190,10.2217/pgs-2020-0048,2020-06-06
Blood capillaries,LOCATION_OF,BARRIER,32501190,10.2217/pgs-2020-0048,2020-06-06
Caveolae,PART_OF,Plasma membrane,32501190,10.2217/pgs-2020-0048,2020-06-06
Binding Sites,ASSOCIATED_WITH,Lung Injury,32501190,10.2217/pgs-2020-0048,2020-06-06
Cell Count,USES,BARRIER,32501190,10.2217/pgs-2020-0048,2020-06-06
Syncytiotrophoblasts,NEG_LOCATION_OF,Caveolins,32501190,10.2217/pgs-2020-0048,2020-06-06
BARRIER,PREVENTS,Vertical Disease Transmission,32501190,10.2217/pgs-2020-0048,2020-06-06
Gravidity,NEG_PROCESS_OF,Population Group,32501190,10.2217/pgs-2020-0048,2020-06-06
Population Group,LOCATION_OF,CACNA1S gene,32501190,10.2217/pgs-2020-0048,2020-06-06
hypertensive medication,INTERACTS_WITH,angiotensin I (1-7),32501175,10.1177/0025817220930553,2020-06-06
hypertensive medication,INTERACTS_WITH,angiotensin converting enzyme 2,32501175,10.1177/0025817220930553,2020-06-06
Violence,PROCESS_OF,Family,32501174,10.1080/01634372.2020.1772934,2020-06-06
disappointment,ISA,Emotions,32501174,10.1080/01634372.2020.1772934,2020-06-06
Coronavirus Infections,ISA,Disease,32501146,10.1080/01634372.2020.1773596,2020-06-06
Old age,ISA,Population Group,32501146,10.1080/01634372.2020.1773596,2020-06-06
Disease,PROCESS_OF,Elderly (population group),32501146,10.1080/01634372.2020.1773596,2020-06-06
Coronavirus Infections,ISA,Disease,32501146,10.1080/01634372.2020.1773596,2020-06-06
Coronavirus Infections,PROCESS_OF(SPEC),Elderly (population group),32501146,10.1080/01634372.2020.1773596,2020-06-06
Coronavirus Infections,ISA,Disease,32501146,10.1080/01634372.2020.1773596,2020-06-06
Government,ISA,Organization administrative structures,32501145,10.1024/0301-1526/a000885,2020-06-06
Cessation of life,PROCESS_OF,Human body,32501133,10.1080/21645515.2020.1773141,2020-06-06
Coronavirus Infections,ISA,Disease,32501130,10.1080/21645515.2020.1766939,2020-06-06
Infected,PROCESS_OF,Persons,32501130,10.1080/21645515.2020.1766939,2020-06-06
Interferons,TREATS,Population Group,32501130,10.1080/21645515.2020.1766939,2020-06-06
Vaccination,USES,Measles-Mumps-Rubella Vaccine,32501130,10.1080/21645515.2020.1766939,2020-06-06
Coronavirus Infections,ISA,Disease,32501130,10.1080/21645515.2020.1766939,2020-06-06
Chronic disease,PROCESS_OF,Patients,32501021,10.4102/phcfm.v12i1.2499,2020-06-06
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32501021,10.4102/phcfm.v12i1.2499,2020-06-06
Comorbidity,PROCESS_OF,Persons,32501021,10.4102/phcfm.v12i1.2499,2020-06-06
Primary Health Care,TREATS,Community,32501020,10.4102/phcfm.v12i1.2455,2020-06-06
Early Intervention (Education),TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32501020,10.4102/phcfm.v12i1.2455,2020-06-06
Program,TREATS,Community,32501020,10.4102/phcfm.v12i1.2455,2020-06-06
Pharmaceutical Preparations,TREATS,Enthesitis-Related Arthritis,32501019,10.4102/phcfm.v12i1.2445,2020-06-06
Epistaxis,PROCESS_OF,Patients,32501018,10.4102/phcfm.v12i1.2457,2020-06-06
Headache,PROCESS_OF,Patients,32501018,10.4102/phcfm.v12i1.2457,2020-06-06
Laboratory Procedures,USES,Immunoenzyme Procedure,32500951,10.1111/ijcp.13573,2020-06-06
Immunoenzyme Procedure,ISA,Laboratory Procedures,32500951,10.1111/ijcp.13573,2020-06-06
Pandemics,ISA,Disease Outbreaks,32500944,10.1111/tbed.13659,2020-06-06
Chronic disease,PROCESS_OF,Patients,32500944,10.1111/tbed.13659,2020-06-06
contextual factors,PROCESS_OF,Outpatients,32500944,10.1111/tbed.13659,2020-06-06
Specimen Type - Serum,LOCATION_OF,Antibodies,32500942,10.1111/tid.13353,2020-06-06
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Liver transplant recipient,32500936,10.1111/tid.13348,2020-06-06
interstitial,LOCATION_OF,Bilateral pneumonia,32500936,10.1111/tid.13348,2020-06-06
Bilateral pneumonia,CAUSES,Respiratory Insufficiency,32500936,10.1111/tid.13348,2020-06-06
Asymptomatic,PROCESS_OF,Patients,32500936,10.1111/tid.13348,2020-06-06
tocilizumab,TREATS,Patients,32500928,10.1111/febs.15442,2020-06-06
Cardiovascular,LOCATION_OF,Comorbidity,32500928,10.1111/febs.15442,2020-06-06
Evaluation,TREATS,Population Group,32500928,10.1111/febs.15442,2020-06-06
tocilizumab,AFFECTS,Pneumonia,32500928,10.1111/febs.15442,2020-06-06
Coronavirus Infections,ISA,Disease,32500854,10.4269/ajtmh.20-0498,2020-06-06
Coronavirus Infections,ISA,Disease,32500854,10.4269/ajtmh.20-0498,2020-06-06
Ergocalciferol,ASSOCIATED_WITH,Disease,32500854,10.4269/ajtmh.20-0498,2020-06-06
Ergocalciferol,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32500854,10.4269/ajtmh.20-0498,2020-06-06
Coronavirus Infections,ISA,Disease,32500854,10.4269/ajtmh.20-0498,2020-06-06
Severe Acute Respiratory Syndrome,AFFECTS,Child,32500854,10.4269/ajtmh.20-0498,2020-06-06
Pathogenic,PROCESS_OF,Cohort,32500854,10.4269/ajtmh.20-0498,2020-06-06
Coinfection,PROCESS_OF,Patients,32500853,10.4269/ajtmh.20-0536,2020-06-06
Hand Hygiene,PROCESS_OF,general population,32500851,10.4269/ajtmh.20-0470,2020-06-06
Lung,LOCATION_OF,Ultrasonography,32500793,10.1177/2472555220934421,2020-06-06
Lung,LOCATION_OF,Ultrasonography,32500793,10.1177/2472555220934421,2020-06-06
Ultrasonography,DIAGNOSES,Congenital anomaly of lung,32500793,10.1177/2472555220934421,2020-06-06
Lung,LOCATION_OF,Ultrasonography,32500793,10.1177/2472555220934421,2020-06-06
Ultrasonography,AFFECTS,Patients,32500793,10.1177/2472555220934421,2020-06-06
Lung,LOCATION_OF,Ultrasonography,32500793,10.1177/2472555220934421,2020-06-06
Leptocyte,LOCATION_OF,angiotensin converting enzyme 2,32500773,10.1177/2324709620933438,2020-06-06
"NR4A2 protein, human",PART_OF,Membrane,32500773,10.1177/2324709620933438,2020-06-06
Membrane Transport Proteins,PART_OF,Plasma membrane,32500773,10.1177/2324709620933438,2020-06-06
,COEXISTS_WITH,angiotensin converting enzyme 2,32500773,10.1177/2324709620933438,2020-06-06
,INTERACTS_WITH,Viral Proteins,32500773,10.1177/2324709620933438,2020-06-06
nimesulide,INHIBITS,,32500773,10.1177/2324709620933438,2020-06-06
Intravenous steroid injection,TREATS,Flare,32500721,10.1161/CIRCHEARTFAILURE.120.007220,2020-06-06
Flare,PROCESS_OF,Patients,32500721,10.1161/CIRCHEARTFAILURE.120.007220,2020-06-06
Cardiac complication,PROCESS_OF,Patients,32500700,10.20452/pamw.15422,2020-06-06
risk factors,PROCESS_OF,Patients,32500666,10.1111/tid.13351,2020-06-06
Coronavirus Infections,PROCESS_OF,Patients,32500666,10.1111/tid.13351,2020-06-06
lobe,PART_OF,Lung,32500666,10.1111/tid.13351,2020-06-06
lobe,PART_OF,Lung,32500666,10.1111/tid.13351,2020-06-06
Parenchyma,LOCATION_OF,Diffuse Pattern,32500666,10.1111/tid.13351,2020-06-06
lobe,PART_OF,Lung,32500666,10.1111/tid.13351,2020-06-06
Parenchyma,LOCATION_OF,Diffuse Pattern,32500666,10.1111/tid.13351,2020-06-06
inflammatory response,CAUSES,"Respiratory Distress Syndrome, Adult",32500648,10.1111/dth.13767,2020-06-06
Crisis,PREDISPOSES,Substance Use Disorders,32500586,10.1002/jdd.12236,2020-06-06
Crisis,PREDISPOSES,Addictive Behavior,32500586,10.1002/jdd.12236,2020-06-06
Pharmacologic Substance,TREATS,Disease,32500526,10.1111/all.14407,2020-06-06
Disease,PROCESS_OF,Woman,32500526,10.1111/all.14407,2020-06-06
Disease,PROCESS_OF,Woman,32500526,10.1111/all.14407,2020-06-06
Mild disorder,PROCESS_OF,Woman,32500526,10.1111/all.14407,2020-06-06
Fever,ISA,Symptoms,32500526,10.1111/all.14407,2020-06-06
Severe disorder,PROCESS_OF,Patients,32500518,10.1007/s12020-020-02357-7,2020-06-06
Storm NOS,PROCESS_OF,Patients,32500518,10.1007/s12020-020-02357-7,2020-06-06
cytokine,DISRUPTS,inflammatory response,32500518,10.1007/s12020-020-02357-7,2020-06-06
Hypersensitivity,PROCESS_OF,Patients,32500518,10.1007/s12020-020-02357-7,2020-06-06
Inflammation,PROCESS_OF,Patients,32500518,10.1007/s12020-020-02357-7,2020-06-06
Hypersensitivity,PROCESS_OF,Patients,32500518,10.1007/s12020-020-02357-7,2020-06-06
Community,LOCATION_OF,Body Fluids,32500510,10.1007/s11547-020-01231-w,2020-06-06
Endocrine System Diseases,PROCESS_OF,Patients,32500510,10.1007/s11547-020-01231-w,2020-06-06
Malignant neoplasm of thyroid,PROCESS_OF,Patients,32500510,10.1007/s11547-020-01231-w,2020-06-06
Operative Surgical Procedures,TREATS,Patients,32500510,10.1007/s11547-020-01231-w,2020-06-06
Operative Surgical Procedures,TREATS(INFER),Malignant neoplasm of thyroid,32500510,10.1007/s11547-020-01231-w,2020-06-06
Infected,PROCESS_OF,Patients,32500509,10.1007/s11547-020-01237-4,2020-06-06
Early Diagnosis,AFFECTS,Disease,32500504,10.1007/s12250-020-00242-1,2020-06-06
Blood Vessel,LOCATION_OF,Hypertrophy,32500504,10.1007/s12250-020-00242-1,2020-06-06
Patients,LOCATION_OF,"CD69 protein, human",32500504,10.1007/s12250-020-00242-1,2020-06-06
nucleoside triphosphatase,ISA,Hydrolase,32500438,10.1007/s10900-020-00854-4,2020-06-06
Bismuth salt,INHIBITS,nucleoside triphosphatase,32500438,10.1007/s10900-020-00854-4,2020-06-06
nucleoside triphosphatase,INTERACTS_WITH,Antiviral Agents,32500438,10.1007/s10900-020-00854-4,2020-06-06
county,ISA,Geographic Locations,32500432,10.1007/s00384-020-03635-6,2020-06-06
Health systems,ISA,Activities,32500431,10.1007/s13304-020-00825-3,2020-06-06
Neoplasm Metastasis,PROCESS_OF,Patients,32500431,10.1007/s13304-020-00825-3,2020-06-06
Tertiary Care Centers,LOCATION_OF,Study,32500416,10.1007/s11605-020-04673-9,2020-06-06
Comorbidity,PROCESS_OF,Patients,32500416,10.1007/s11605-020-04673-9,2020-06-06
Liver Cirrhosis,PROCESS_OF,Patients,32500416,10.1007/s11605-020-04673-9,2020-06-06
Transplantation,ADMINISTERED_TO,Patients,32500416,10.1007/s11605-020-04673-9,2020-06-06
major surgery,ADMINISTERED_TO,Patients,32500416,10.1007/s11605-020-04673-9,2020-06-06
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32500388,10.1007/s40615-020-00775-x,2020-06-06
Mild disorder,PROCESS_OF,Child,32500388,10.1007/s40615-020-00775-x,2020-06-06
Biological Response Modifiers,ISA,Pharmaceutical Preparations,32500388,10.1007/s40615-020-00775-x,2020-06-06
Immunosuppressive Agents,ISA,Pharmaceutical Preparations,32500388,10.1007/s40615-020-00775-x,2020-06-06
Rheumatologist,TREATS,Patients,32500388,10.1007/s40615-020-00775-x,2020-06-06
Rheumatism,PROCESS_OF,Patients,32500388,10.1007/s40615-020-00775-x,2020-06-06
Rheumatism,PROCESS_OF,Patients,32500388,10.1007/s40615-020-00775-x,2020-06-06
Rheumatism,PROCESS_OF,Patients,32500388,10.1007/s40615-020-00775-x,2020-06-06
Experience,PROCESS_OF,Americas Ethnicity,32500379,10.1007/s12192-020-01126-9,2020-06-06
Heat shock proteins,COEXISTS_WITH,Oxygenases,32500339,10.1007/s12024-020-00270-z,2020-06-06
risk factors,COEXISTS_WITH,Inflammation,32500339,10.1007/s12024-020-00270-z,2020-06-06
Non-smoker,PROCESS_OF,general population,32500339,10.1007/s12024-020-00270-z,2020-06-06
Smoke,STIMULATES,HMOX1 gene,32500339,10.1007/s12024-020-00270-z,2020-06-06
Autopsy,ADMINISTERED_TO,teams,32500327,10.1007/s00405-020-06093-6,2020-06-06
Buccal smear procedure,DIAGNOSES,Present,32500327,10.1007/s00405-020-06093-6,2020-06-06
Ambulatory Care Facilities,LOCATION_OF,Nasopharyngoscopy,32500326,10.1007/s00405-020-06102-8,2020-06-06
Interventional procedure,USES,Pivot,32500326,10.1007/s00405-020-06102-8,2020-06-06
Nasopharyngoscopy,ISA,Endoscopy (procedure),32500326,10.1007/s00405-020-06102-8,2020-06-06
Nasopharyngoscopy,ISA,Endoscopy (procedure),32500326,10.1007/s00405-020-06102-8,2020-06-06
Nasopharyngoscopy,ISA,Endoscopy (procedure),32500326,10.1007/s00405-020-06102-8,2020-06-06
Nasopharyngoscopy,ISA,Endoscopy (procedure),32500326,10.1007/s00405-020-06102-8,2020-06-06
Population Group,LOCATION_OF,"CD69 protein, human",32500322,10.1007/s00266-020-01805-z,2020-06-06
Asymptomatic,PROCESS_OF,Patients,32500322,10.1007/s00266-020-01805-z,2020-06-06
Virus,CAUSES,Macrophage Activation Syndrome,32500199,10.1007/s00414-020-02317-w,2020-06-06
Communicable Diseases,COEXISTS_WITH,Unemployment,32500199,10.1007/s00414-020-02317-w,2020-06-06
Laboratory Procedures,METHOD_OF,Autopsy,32500177,10.1007/s00586-020-06477-6,2020-06-06
Nasopharynx,LOCATION_OF,Autopsy,32500177,10.1007/s00586-020-06477-6,2020-06-06
Structure of parenchyma of lung,LOCATION_OF,Autopsy,32500177,10.1007/s00586-020-06477-6,2020-06-06
Structure of parenchyma of lung,LOCATION_OF,Buccal smear procedure,32500177,10.1007/s00586-020-06477-6,2020-06-06
Comorbidity,NEG_PROCESS_OF,Woman,32500177,10.1007/s00586-020-06477-6,2020-06-06
Pneumonia,COEXISTS_WITH,Pulmonary Embolism,32500177,10.1007/s00586-020-06477-6,2020-06-06
Infected,PROCESS_OF,Patients,32500177,10.1007/s00586-020-06477-6,2020-06-06
Epidemic disease,AFFECTS,Readiness,32500134,10.1093/dote/doaa054,2020-06-06
Epidemic disease,PROCESS_OF,Community,32500134,10.1093/dote/doaa054,2020-06-06
Experience,PROCESS_OF,Respondents,32500134,10.1093/dote/doaa054,2020-06-06
cancer resection,TREATS,Patients,32500116,10.12688/aasopenres.13052.1,2020-06-06
Malignant Neoplasms,PROCESS_OF,Patients,32500116,10.12688/aasopenres.13052.1,2020-06-06
Esophagogastric,LOCATION_OF,Malignant Neoplasms,32500116,10.12688/aasopenres.13052.1,2020-06-06
Malignant Neoplasms,PROCESS_OF,Patients,32500116,10.12688/aasopenres.13052.1,2020-06-06
Esophagogastric,LOCATION_OF,Malignant Neoplasms,32500116,10.12688/aasopenres.13052.1,2020-06-06
Disability,PROCESS_OF,Persons,32499988,10.7759/cureus.8399,2020-06-06
Disability,PROCESS_OF,Persons,32499988,10.7759/cureus.8399,2020-06-06
Dementia,PROCESS_OF,Persons,32499988,10.7759/cureus.8399,2020-06-06
Dry cough,COEXISTS_WITH,Mild disorder,32499983,10.7759/cureus.7943,2020-06-06
Mild disorder,PROCESS_OF,Persons,32499983,10.7759/cureus.7943,2020-06-06
Vaccines,CAUSES,Protection,32499983,10.7759/cureus.7943,2020-06-06
Infected,PROCESS_OF,Persons,32499974,10.7759/cureus.7930,2020-06-06
Possible,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32499974,10.7759/cureus.7930,2020-06-06
Encephalopathies,PROCESS_OF,Patients,32499970,10.7759/cureus.7923,2020-06-06
Coronavirus Infections,PROCESS_OF,Patients,32499970,10.7759/cureus.7923,2020-06-06
IMPACT gene,CAUSES,Abnormal behavior,32499919,10.1186/s40560-020-00454-3,2020-06-06
Crisis,PROCESS_OF,Population Group,32499919,10.1186/s40560-020-00454-3,2020-06-06
Fear (Mental Process),PROCESS_OF,Target Population,32499919,10.1186/s40560-020-00454-3,2020-06-06
Anxiety,PROCESS_OF,Persons,32499919,10.1186/s40560-020-00454-3,2020-06-06
Disease,PROCESS_OF,World,32499909,10.1186/s13601-020-00323-0,2020-06-06
Disease,PROCESS_OF,Social Networks,32499909,10.1186/s13601-020-00323-0,2020-06-06
Gray Platelet Syndrome,PROCESS_OF,Social Networks,32499909,10.1186/s13601-020-00323-0,2020-06-06
Germany,ISA,European country,32499903,10.4081/ejtm.2019.8966,2020-06-06
Coronavirus Infections,CAUSES,Disease,32499650,10.1038/s41586-020-2281-1,2020-06-06
Coronavirus Infections,ISA,Disease,32499650,10.1038/s41586-020-2281-1,2020-06-06
Coronavirus Infections,ISA,Disease,32499650,10.1038/s41586-020-2281-1,2020-06-06
Therapeutic procedure,TREATS,Disease,32499650,10.1038/s41586-020-2281-1,2020-06-06
Therapeutic procedure,TREATS(SPEC),Coronavirus Infections,32499650,10.1038/s41586-020-2281-1,2020-06-06
Coronavirus Infections,ISA,Disease,32499650,10.1038/s41586-020-2281-1,2020-06-06
Adrenal Cortex Hormones,TREATS,Patients,32499650,10.1038/s41586-020-2281-1,2020-06-06
tocilizumab,TREATS,Patients,32499650,10.1038/s41586-020-2281-1,2020-06-06
Compliance,PROCESS_OF,World,32499448,10.18632/aging.103298,2020-06-06
strategy,PROCESS_OF,Social Networks,32499448,10.18632/aging.103298,2020-06-06
Dyspnea,PROCESS_OF,Older Population,32499385,10.1136/rapm-2020-101584,2020-06-06
Fever,PROCESS_OF,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Myalgia,PROCESS_OF,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Disease,PROCESS_OF,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Immunoglobulin Therapy,ADMINISTERED_TO,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Mechanical ventilation,ADMINISTERED_TO,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Critical Illness,PROCESS_OF,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Multiple Trauma,PROCESS_OF,Patients,32499385,10.1136/rapm-2020-101584,2020-06-06
Organ,LOCATION_OF,Multiple Trauma,32499385,10.1136/rapm-2020-101584,2020-06-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Older Population,32499385,10.1136/rapm-2020-101584,2020-06-06
Cerebrovascular Disorders,ISA,Symptoms,32499385,10.1136/rapm-2020-101584,2020-06-06
Heart Injuries,ISA,Symptoms,32499385,10.1136/rapm-2020-101584,2020-06-06
Hypertensive disease,ISA,Symptoms,32499385,10.1136/rapm-2020-101584,2020-06-06
Immune System Diseases,COEXISTS_WITH,Critical Illness,32499385,10.1136/rapm-2020-101584,2020-06-06
Shock,ISA,Symptoms,32499385,10.1136/rapm-2020-101584,2020-06-06
Secondary Infections,ISA,Symptoms,32499385,10.1136/rapm-2020-101584,2020-06-06
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Critical Illness,32499385,10.1136/rapm-2020-101584,2020-06-06
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Pain,32499358,10.1128/MRA.00520-20,2020-06-06
Present,COMPLICATES,Symptoms,32499358,10.1128/MRA.00520-20,2020-06-06
Patients,LOCATION_OF,Oropharyngeal swab,32499314,10.1136/ejhpharm-2020-002322,2020-06-06
Interleukin-6,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32499303,10.1136/gutjnl-2020-321852,2020-06-06
siltuximab,ISA,Pharmaceutical Preparations,32499303,10.1136/gutjnl-2020-321852,2020-06-06
"CD69 protein, human",INTERACTS_WITH,Interleukin-6,32499303,10.1136/gutjnl-2020-321852,2020-06-06
Monoclonal Antibodies,ASSOCIATED_WITH,Angiolymphoid hyperplasia,32499303,10.1136/gutjnl-2020-321852,2020-06-06
siltuximab,ASSOCIATED_WITH(SPEC),Angiolymphoid hyperplasia,32499303,10.1136/gutjnl-2020-321852,2020-06-06
siltuximab,ISA,Monoclonal Antibodies,32499303,10.1136/gutjnl-2020-321852,2020-06-06
Famotidine,ISA,Histamine H2 Antagonists,32499236,10.1136/heartjnl-2020-317186,2020-06-06
Coughing,ISA,Symptoms,32499236,10.1136/heartjnl-2020-317186,2020-06-06
Experience,PROCESS_OF,Patients,32499236,10.1136/heartjnl-2020-317186,2020-06-06
Treatment Protocols,USES,Famotidine,32499236,10.1136/heartjnl-2020-317186,2020-06-06
Lung,LOCATION_OF,ACE2 gene,32499212,10.2196/19457,2020-06-06
Blood Vessel,PRODUCES,ACE2 gene,32499212,10.2196/19457,2020-06-06
Heart,PRODUCES,ACE2 gene,32499212,10.2196/19457,2020-06-06
Patients,LOCATION_OF,Troponin,32499212,10.2196/19457,2020-06-06
Troponin,PART_OF,Heart,32499212,10.2196/19457,2020-06-06
Infection,PROCESS_OF,Patients,32499212,10.2196/19457,2020-06-06
Anoxia,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Anoxia,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Embolism,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Embolism,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Inflammation,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Inflammation,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Respiratory Tract Infections,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Respiratory Tract Infections,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Septicemia,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Septicemia,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Pulmonary thrombosis,COEXISTS_WITH,Myocarditis,32499212,10.2196/19457,2020-06-06
Pulmonary thrombosis,COEXISTS_WITH,Storm Syndrome,32499212,10.2196/19457,2020-06-06
Myocarditis,PROCESS_OF,Homo sapiens,32499212,10.2196/19457,2020-06-06
Myocardium,LOCATION_OF,Virus,32499212,10.2196/19457,2020-06-06
Myocardium,LOCATION_OF,Direct Contact Transmission Infection,32499212,10.2196/19457,2020-06-06
Coronavirus Infections,ISA,Disease,32499187,10.1016/j.bjps.2020.05.002,2020-06-06
Coronavirus Infections,ISA,Disease,32499187,10.1016/j.bjps.2020.05.002,2020-06-06
Symptom mild,PROCESS_OF,Persons,32499187,10.1016/j.bjps.2020.05.002,2020-06-06
Program,AFFECTS,Protection,32499187,10.1016/j.bjps.2020.05.002,2020-06-06
Plastic surgeon,TREATS,Patients,32499176,10.1016/j.ajem.2020.05.072,2020-06-06
Telemedicine,COEXISTS_WITH,Therapeutic tactile stimulation,32499176,10.1016/j.ajem.2020.05.072,2020-06-06
Evaluation,ADMINISTERED_TO,Patients,32499176,10.1016/j.ajem.2020.05.072,2020-06-06
Lung,LOCATION_OF,Symptoms,32499169,10.1016/j.ejvs.2020.05.024,2020-06-06
Thrombophilia,COEXISTS_WITH,"Colitis, Ischemic",32499169,10.1016/j.ejvs.2020.05.024,2020-06-06
"Colitis, Ischemic",PROCESS_OF,Patients,32499169,10.1016/j.ejvs.2020.05.024,2020-06-06
Thrombophilia,PROCESS_OF,Patients,32499169,10.1016/j.ejvs.2020.05.024,2020-06-06
Symptoms,PROCESS_OF,Patients,32499161,10.1016/j.sapharm.2020.05.025,2020-06-06
Symptoms,PROCESS_OF,Physicians,32499161,10.1016/j.sapharm.2020.05.025,2020-06-06
Old age,ISA,Population Group,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Polypharmacy,TREATS,Population Group,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Polypharmacy,TREATS(SPEC),Old age,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Communicable Diseases,AFFECTS,Household composition,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Communicable Diseases,ISA,Disease,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Coronavirus Infections,ISA,Disease,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Prophylactic treatment,TREATS,Actual Lack Of Knowledge,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Actual Lack Of Knowledge,PROCESS_OF,Patients,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Deprescribing,TREATS,Disease,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Old age,ISA,Population Group,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Deprescribing,TREATS,Population Group,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Deprescribing,TREATS(SPEC),Old age,32499160,10.1016/j.sapharm.2020.05.027,2020-06-06
Practitioner,ISA,Persons,32499159,10.1016/j.sapharm.2020.05.020,2020-06-06
Symptoms,PROCESS_OF,Pharmacist,32499157,10.1016/j.acra.2020.05.017,2020-06-06
Chest CT,DIAGNOSES,Enthesitis-Related Arthritis,32499154,10.1016/j.arcmed.2020.05.007,2020-06-06
X-Ray Departments,LOCATION_OF,containment,32499154,10.1016/j.arcmed.2020.05.007,2020-06-06
Middle East Respiratory Syndrome Coronavirus,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32499132,10.1016/j.dhjo.2020.100943,2020-06-06
daily activities,NEG_TREATS,Child,32498972,10.1016/j.pan.2020.05.016,2020-06-06
Complication,PROCESS_OF,Patients,32498938,10.1016/j.maturitas.2020.04.019,2020-06-06
inflammatory response,PROCESS_OF,Patients,32498762,10.20344/amp.13957,2020-06-06
"Heparin, Low-Molecular-Weight",AUGMENTS,risk factors,32498762,10.20344/amp.13957,2020-06-06
Postmenopausal state,PROCESS_OF,Woman,32498762,10.20344/amp.13957,2020-06-06
estrogen therapy,ADMINISTERED_TO,Woman,32498762,10.20344/amp.13957,2020-06-06
Menopause,PROCESS_OF,Woman,32498762,10.20344/amp.13957,2020-06-06
Hormone replacement therapy,ADMINISTERED_TO,Woman,32498762,10.20344/amp.13957,2020-06-06
Hormonal Contraception,ADMINISTERED_TO,Woman,32498762,10.20344/amp.13957,2020-06-06
Coronavirus Infections,CAUSES,Pneumonia,32498752,10.1017/dmp.2020.189,2020-06-06
treatment options,PREVENTS,Coronavirus Infections,32498752,10.1017/dmp.2020.189,2020-06-06
Coughing,ISA,Symptoms,32498752,10.1017/dmp.2020.189,2020-06-06
Dyspnea,ISA,Symptoms,32498752,10.1017/dmp.2020.189,2020-06-06
Fever,ISA,Symptoms,32498752,10.1017/dmp.2020.189,2020-06-06
Coronavirus Infections,ISA,Disease,32498752,10.1017/dmp.2020.189,2020-06-06
Hand,LOCATION_OF,sanitizers,32498749,10.1017/dmp.2020.186,2020-06-06
"CD69 protein, human",AFFECTS,Possible,32498742,10.1017/S096318012000047X,2020-06-06
Perception,PROCESS_OF,Pharmacist,32498742,10.1017/S096318012000047X,2020-06-06
Dentist,ISA,Health Personnel,32498735,10.1017/dmp.2020.187,2020-06-06
Nurses,ISA,Health Personnel,32498735,10.1017/dmp.2020.187,2020-06-06
Physicians,ISA,Health Personnel,32498735,10.1017/dmp.2020.187,2020-06-06
mental health,PROCESS_OF,Dentist,32498735,10.1017/dmp.2020.187,2020-06-06
teams,USES,Classification,32498731,10.1017/S0950268820001193,2020-06-06
Virus,CAUSES,Pneumonia,32498696,10.1186/s40246-020-00272-6,2020-06-06
angiotensin converting enzyme 2,ADMINISTERED_TO,Human body,32498691,10.1186/s13195-020-00640-3,2020-06-06
Disease,PROCESS_OF,Homo sapiens,32498691,10.1186/s13195-020-00640-3,2020-06-06
Cognition Disorders,CAUSES,Neurodegenerative Disorders,32498686,10.1186/s12929-020-00663-w,2020-06-06
Lung,LOCATION_OF,Storm NOS,32498655,10.1080/17513758.2020.1773000,2020-06-06
Virus,PROCESS_OF,Persons,32498655,10.1080/17513758.2020.1773000,2020-06-06
Vaccination,TREATS,Disease,32498655,10.1080/17513758.2020.1773000,2020-06-06
Coronavirus Infections,ISA,Disease,32498653,10.1089/lap.2020.0371,2020-06-06
Isolation procedure,TREATS,Disease,32498653,10.1089/lap.2020.0371,2020-06-06
Minimally Invasive Surgical Procedures,ADMINISTERED_TO,Child,32498581,10.1080/14767058.2020.1771692,2020-06-06
Screening procedure,ADMINISTERED_TO,Health Personnel,32498581,10.1080/14767058.2020.1771692,2020-06-06
Screening procedure,TREATS,Patients,32498581,10.1080/14767058.2020.1771692,2020-06-06
Protection,PROCESS_OF,Health Personnel,32498581,10.1080/14767058.2020.1771692,2020-06-06
Protection,PROCESS_OF,Persons,32498581,10.1080/14767058.2020.1771692,2020-06-06
Percutaneous replacement of aortic valve using fluoroscopic guidance,TREATS,Persons,32498549,10.1089/cyber.2020.0250,2020-06-06
Coronavirus Infections,ISA,Disease,32498535,10.21037/apm-20-1084,2020-06-06
Coronavirus Infections,ISA,Disease,32498535,10.21037/apm-20-1084,2020-06-06
intensive care unit,LOCATION_OF,Study,32498503,10.4081/monaldi.2020.1298,2020-06-06
intensive care unit,LOCATION_OF,Administration occupational activities,32498503,10.4081/monaldi.2020.1298,2020-06-06
Epidemic,ISA,Disease Outbreaks,32498502,10.4081/monaldi.2020.1405,2020-06-06
Genus: Coronavirus,COEXISTS_WITH,Coronaviridae,32498502,10.4081/monaldi.2020.1405,2020-06-06
Virus,PROCESS_OF,Chiroptera,32498502,10.4081/monaldi.2020.1405,2020-06-06
Confirmation,PROCESS_OF,Homo sapiens,32498502,10.4081/monaldi.2020.1405,2020-06-06
Pneumonia,CAUSES,Cessation of life,32498502,10.4081/monaldi.2020.1405,2020-06-06
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32498502,10.4081/monaldi.2020.1405,2020-06-06
Single organ dysfunction,CAUSES,Cessation of life,32498502,10.4081/monaldi.2020.1405,2020-06-06
Government,ISA,Organization administrative structures,32498493,10.3760/cma.j.cn112338-20200304-00247,2020-06-06
Reporting,ADMINISTERED_TO,Community,32498490,10.4097/kja.20204,2020-06-06
Clinical Treatment,TREATS,Virus Diseases,32498490,10.4097/kja.20204,2020-06-06
disease prevention,AFFECTS,Anabolism,32498490,10.4097/kja.20204,2020-06-06
Clinical Treatment,AFFECTS,Anabolism,32498490,10.4097/kja.20204,2020-06-06
Infectious disease prevention / control,COEXISTS_WITH,Cesarean section,32498413,10.3390/antibiotics9060298,2020-06-06
Pharmaceutical Preparations,TREATS,Infection,32498401,10.3390/ijerph17113947,2020-06-06
Primary Health Care,USES,Pharmaceutical Preparations,32498401,10.3390/ijerph17113947,2020-06-06
psychological distress,PROCESS_OF,Persons,32498376,10.3390/cells9061383,2020-06-06
psychological distress,PROCESS_OF,Woman,32498376,10.3390/cells9061383,2020-06-06
Inflammation,PROCESS_OF,Patients,32498323,10.3390/nu12061648,2020-06-06
Heart,LOCATION_OF,Infectious pneumonias,32498262,10.3390/jcm9061688,2020-06-06
Coronavirus Infections,ISA,Disease,32498230,10.3390/jcm9061683,2020-06-06
Chronic Kidney Diseases,PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Disease,PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Hospitals,LOCATION_OF,Study,32498230,10.3390/jcm9061683,2020-06-06
Coronavirus Infections,ISA,Disease,32498230,10.3390/jcm9061683,2020-06-06
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32498230,10.3390/jcm9061683,2020-06-06
Coronavirus Infections,ISA,Disease,32498230,10.3390/jcm9061683,2020-06-06
Coughing,ISA,Symptoms,32498230,10.3390/jcm9061683,2020-06-06
Lymphopenia,PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Elevated inflammatory markers,PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Pulmonary Infiltrate,PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Hemodialysis,TREATS,Patients,32498230,10.3390/jcm9061683,2020-06-06
Mechanical ventilation,ADMINISTERED_TO,Patients,32498230,10.3390/jcm9061683,2020-06-06
Continuous renal replacement therapy,ADMINISTERED_TO,Patients,32498230,10.3390/jcm9061683,2020-06-06
Extracorporeal Membrane Oxygenation,TREATS,Patients,32498230,10.3390/jcm9061683,2020-06-06
Early Diagnosis,CAUSES,Disease,32498230,10.3390/jcm9061683,2020-06-06
Disease Outcome,NEG_PROCESS_OF,Patients,32498230,10.3390/jcm9061683,2020-06-06
Acute myocardial infarction,NEG_COEXISTS_WITH,Disease,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Acute myocardial infarction,NEG_COEXISTS_WITH(SPEC),Coronavirus Infections,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Coronavirus Infections,ISA,Disease,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Disease,COEXISTS_WITH,Acute Coronary Syndrome,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Myocardial Infarction,COEXISTS_WITH,Acute Coronary Syndrome,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Respiratory Tract Infections,COEXISTS_WITH,Acute Coronary Syndrome,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Coronavirus Infections,COEXISTS_WITH(SPEC),Acute Coronary Syndrome,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Coronavirus Infections,ISA,Disease,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Coronavirus Infections,ISA,Disease,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Confirmation,PROCESS_OF,Patients,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Acute Coronary Syndrome,PROCESS_OF,Patients,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32498207,10.1016/j.scitotenv.2020.138543,2020-06-06
Infected,PROCESS_OF,Persons,32498141,10.3961/jpmph.20.105,2020-06-06
Virus,PROCESS_OF,Persons,32498139,10.3961/jpmph.20.072,2020-06-06
Poor outcome,PROCESS_OF,Patients,32498131,10.1002/cpt.1932,2020-06-05
"Kidney Failure, Acute",PROCESS_OF,Patients,32498131,10.1002/cpt.1932,2020-06-05
Vaccines,INTERACTS_WITH,Pharmaceutical Preparations,32498128,10.1111/jdv.16720,2020-06-05
Skin lesion,PROCESS_OF,Patients,32498097,10.1055/a-1178-3551,2020-06-05
Equipment in use,PROCESS_OF,Health Personnel,32498097,10.1055/a-1178-3551,2020-06-05
Coronavirus Infections,ISA,Disease,32498096,10.1055/s-0040-1713107,2020-06-05
Venous Thromboembolism,PROCESS_OF,Patients,32498096,10.1055/s-0040-1713107,2020-06-05
Blood Coagulation Disorders,PROCESS_OF,Patients,32498096,10.1055/s-0040-1713107,2020-06-05
Hemorrhage,NEG_COEXISTS_WITH,Disseminated Intravascular Coagulation,32498096,10.1055/s-0040-1713107,2020-06-05
Inflammation,CAUSES,Thrombophilia,32498096,10.1055/s-0040-1713107,2020-06-05
Communicable Diseases,AFFECTS,Patient Deceased,32498092,10.1055/s-0040-1712513,2020-06-05
Lung,LOCATION_OF,Obstruction,32498092,10.1055/s-0040-1712513,2020-06-05
Aorta,LOCATION_OF,Syndrome,32498092,10.1055/s-0040-1712513,2020-06-05
Aorta,LOCATION_OF,Intramural hematoma,32498092,10.1055/s-0040-1712513,2020-06-05
Syndrome,PROCESS_OF,Patients,32498092,10.1055/s-0040-1712513,2020-06-05
Coronavirus Infections,PROCESS_OF,Patients,32498092,10.1055/s-0040-1712513,2020-06-05
Gravidity,PROCESS_OF,Persons,32498085,10.1210/clinem/dgaa342,2020-06-05
High-Risk Pregnancy,PROCESS_OF,Persons,32498085,10.1210/clinem/dgaa342,2020-06-05
Gravidity,PROCESS_OF,Persons,32498085,10.1210/clinem/dgaa342,2020-06-05
Critical Illness,PROCESS_OF,Patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Diabetes,PROCESS_OF,Patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
hospital care,TREATS,Patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
hospital care,TREATS(INFER),Diabetes,32498081,10.1093/eurheartj/ehaa461,2020-06-05
hospital care,TREATS(INFER),Infected,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Infected,PROCESS_OF,Patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Blood glucose management,TREATS,Acute illness,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Diabetes,PROCESS_OF,hospitalized patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Infected,PROCESS_OF,hospitalized patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Glucocorticoids,ISA,Pharmaceutical Preparations,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Problem,PROCESS_OF,hospitalized patients,32498081,10.1093/eurheartj/ehaa461,2020-06-05
Caring,PROCESS_OF,Staff,32498076,10.1093/eurheartj/ehaa433,2020-06-05
Heart failure,PROCESS_OF,Patients,32498076,10.1093/eurheartj/ehaa433,2020-06-05
Challenge,TREATS,Heart failure,32498076,10.1093/eurheartj/ehaa433,2020-06-05
Hypertensive disease,PROCESS_OF,Patients,32498065,10.1159/000508962,2020-06-05
Antihypertensive Agents,NEG_TREATS,Hypertensive disease,32498065,10.1159/000508962,2020-06-05
Therapeutic procedure,USES,Antihypertensive Agents,32498065,10.1159/000508962,2020-06-05
Antihypertensive Agents,TREATS,Hypertensive disease,32498065,10.1159/000508962,2020-06-05
Antihypertensive Agents,TREATS,Discontinued,32498065,10.1159/000508962,2020-06-05
Hypertensive disease,PROCESS_OF,Patients,32498065,10.1159/000508962,2020-06-05
Discontinued,PROCESS_OF,Patients,32498065,10.1159/000508962,2020-06-05
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32498065,10.1159/000508962,2020-06-05
Older child,LOCATION_OF,IMPACT gene,32497969,10.1016/j.psychres.2020.113130,2020-06-05
"Infant, Newborn",LOCATION_OF,IMPACT gene,32497969,10.1016/j.psychres.2020.113130,2020-06-05
Meningitis,PROCESS_OF,Patients,32497969,10.1016/j.psychres.2020.113130,2020-06-05
Multiple Organ Failure,PROCESS_OF,Patients,32497969,10.1016/j.psychres.2020.113130,2020-06-05
Symptoms,PROCESS_OF,Participant,32497963,10.1016/j.dsx.2020.05.033,2020-06-05
Heart,LOCATION_OF,High troponin I level,32497913,10.1016/j.ahj.2020.04.025,2020-06-05
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32497913,10.1016/j.ahj.2020.04.025,2020-06-05
High troponin I level,PROCESS_OF,Patients,32497913,10.1016/j.ahj.2020.04.025,2020-06-05
Chronic disease,PROCESS_OF,Patients,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
cardiovascular risk factor,PROCESS_OF,Patients,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Cardiovascular,LOCATION_OF,Chronic disease,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Troponin,PART_OF,Heart,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Acute Coronary Syndrome,CAUSES,Thrombus,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
"SUPPLY, NOT OTHERWISE SPECIFIED",CAUSES,Myocardial Infarction,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Thrombosis,PROCESS_OF,Patients,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Troponin,PART_OF,Heart,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Fibrin fragment D,ISA,Fibrinogen,32497852,10.1016/j.wneu.2020.05.236,2020-06-05
Epistaxis,PROCESS_OF,Male population group,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Base of skull structure,LOCATION_OF,"Wounds, Penetrating",32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Serous nasal discharge,PROCESS_OF,Male population group,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
tomography,DIAGNOSES,Pneumocephalus,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Left frontal lobe structure,LOCATION_OF,Cerebral Contusion,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Wall of anterior cranial fossa,LOCATION_OF,"Wounds, Penetrating",32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Wall of anterior cranial fossa,LOCATION_OF,Cerebrospinal fluid leak,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Detection,TREATS,Cerebrospinal fluid leak,32497812,10.1016/j.ijid.2020.05.091,2020-06-05
Disease Progression,CAUSES,Disease,32497810,10.1016/j.ijid.2020.05.092,2020-06-05
Illness (finding),PROCESS_OF,Patients,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Coronavirus Infections,NEG_PROCESS_OF,Households,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Coronavirus Infections,PROCESS_OF,Child,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Coronavirus Infections,PROCESS_OF,Patients,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Illness (finding),PROCESS_OF,Patients,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Masks,compared_with,Mechanical Ventilator,32497809,10.1016/j.ijid.2020.05.098,2020-06-05
Immunochromatographic test,USES,Transport medium,32497808,10.1016/j.ijid.2020.05.093,2020-06-05
Rapid Antigen Test,USES,Detection,32497808,10.1016/j.ijid.2020.05.093,2020-06-05
Rapid Antigen Test,USES,Detection,32497808,10.1016/j.ijid.2020.05.093,2020-06-05
WASF1 gene,AFFECTS,Movement,32497806,10.1016/j.ijid.2020.05.086,2020-06-05
Delivery of Health Care,TREATS,Communicable Diseases,32497796,10.1016/j.ijid.2020.05.118,2020-06-05
Complication,NEG_ASSOCIATED_WITH,alteplase,32497794,10.1016/j.ijid.2020.05.104,2020-06-05
Complication,NEG_ASSOCIATED_WITH,tocilizumab,32497794,10.1016/j.ijid.2020.05.104,2020-06-05
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32497778,10.1016/j.bbi.2020.05.078,2020-06-05
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32497778,10.1016/j.bbi.2020.05.078,2020-06-05
SARS coronavirus,PROCESS_OF,Homo sapiens,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Coughing,ASSOCIATED_WITH,Disease,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Breath,CAUSES,Pneumonia,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Breath,CAUSES,"Respiratory Distress Syndrome, Adult",32497776,10.1016/j.bbi.2020.05.074,2020-06-05
RNA Sequence,PART_OF,Cells,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Immunologic Factors,INTERACTS_WITH,receptor,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
nerve supply,PRODUCES,receptor,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Neurons,PART_OF,"Ganglia, Spinal",32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Neurogenic Inflammation,COEXISTS_WITH,Lung diseases,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
Pharmaceutical Preparations,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32497776,10.1016/j.bbi.2020.05.074,2020-06-05
mental health,PROCESS_OF,Community,32497751,10.1016/j.ijsu.2020.05.072,2020-06-05
mental health,PROCESS_OF,Male population group,32497751,10.1016/j.ijsu.2020.05.072,2020-06-05
mental health,PROCESS_OF,Woman,32497751,10.1016/j.ijsu.2020.05.072,2020-06-05
Elective Surgical Procedures,TREATS,Persons,32497747,10.1016/j.jvs.2020.05.048,2020-06-05
Thoracic Outlet Syndrome,PROCESS_OF,Patients,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Operative Surgical Procedures,AFFECTS,Disease,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
"Upper Extremity Deep Vein Thrombosis, Primary",ISA,Upper Extremity Deep Vein Thrombosis,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Intervention regimes,TREATS,Venous Thoracic Outlet Syndrome,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Obstruction,PROCESS_OF,Patients,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
central vein,LOCATION_OF,Obstruction,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Upper limb ischemia,PROCESS_OF,Phasis,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Operative Surgical Procedures,TREATS,Arterial Thoracic Outlet Syndrome,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Definitive Treatment,AFFECTS,Disease,32497746,10.1016/j.jvs.2020.05.049,2020-06-05
Clinician,TREATS,Patients,32497745,10.1016/j.diabres.2020.108245,2020-06-05
Infection,PROCESS_OF,Medical Staff,32497745,10.1016/j.diabres.2020.108245,2020-06-05
Operating Room,LOCATION_OF,Prevention Protocol,32497745,10.1016/j.diabres.2020.108245,2020-06-05
Diabetes,PROCESS_OF,Persons,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Foot Ulcer,PROCESS_OF,Persons,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Triage,TREATS,Participant,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Comorbidity,PROCESS_OF,Patients,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Operative Surgical Procedures,ISA,Interventional procedure,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Telemedicine,TREATS,Patients,32497662,10.1016/j.jaip.2020.05.027,2020-06-05
Asthma,ISA,Chronic disease,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Asthma,PROCESS_OF,Child,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Asthma,ISA,Chronic disease,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Asthma,PROCESS_OF(SPEC),Child,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Chronic disease,PROCESS_OF,Child,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Delivery of Health Care,TREATS,Asthma,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Exercise,TREATS,Child,32497651,10.1016/j.jhin.2020.05.037,2020-06-05
Perception,PROCESS_OF,Persons,32497623,10.1016/j.mbs.2020.108391,2020-06-05
Cyclic AMP,AFFECTS,Equilibrium,32497522,10.1016/j.immuni.2020.05.004,2020-06-05
Cyclic AMP,ASSOCIATED_WITH,inflammatory response,32497522,10.1016/j.immuni.2020.05.004,2020-06-05
Cyclic AMP,INHIBITS,Phosphodiesterase 4 Inhibitors,32497522,10.1016/j.immuni.2020.05.004,2020-06-05
Cyclic AMP,TREATS,Storm NOS,32497522,10.1016/j.immuni.2020.05.004,2020-06-05
Virus,PROCESS_OF,Family,32497510,10.1016/S0140-6736(20)31142-9,2020-06-05
Betacoronavirus,CAUSES,Severe Acute Respiratory Syndrome,32497467,10.1080/08959420.2020.1773190,2020-06-05
Betacoronavirus,CAUSES,Middle East Respiratory Syndrome,32497467,10.1080/08959420.2020.1773190,2020-06-05
Quarantine,TREATS,Staffing level,32497459,10.1080/21548331.2020.1778908,2020-06-05
Health Personnel,TREATS,Patients,32497451,10.1080/01612840.2020.1752865,2020-06-05
Nursing Diagnoses,PROCESS_OF,Community,32497341,10.1111/jocs.14678,2020-06-05
Decision,PROCESS_OF,Community,32497341,10.1111/jocs.14678,2020-06-05
Marfan Syndrome,PROCESS_OF,Woman,32497323,10.1002/jmv.26139,2020-06-05
Distal aortic dissection,PROCESS_OF,Woman,32497323,10.1002/jmv.26139,2020-06-05
Disease,PROCESS_OF,Homo sapiens,32497318,10.1002/jso.26050,2020-06-05
Coronavirus Infections,ISA,Disease,32497318,10.1002/jso.26050,2020-06-05
Coronavirus Infections,PROCESS_OF(SPEC),Homo sapiens,32497318,10.1002/jso.26050,2020-06-05
"S protein, severe acute respiratory syndrome coronavirus",INTERACTS_WITH,angiotensin converting enzyme 2,32497318,10.1002/jso.26050,2020-06-05
Disease,PREDISPOSES,Severe Acute Respiratory Syndrome,32497318,10.1002/jso.26050,2020-06-05
Coronavirus Infections,ISA,Disease,32497318,10.1002/jso.26050,2020-06-05
Coronavirus Infections,PREDISPOSES(SPEC),Severe Acute Respiratory Syndrome,32497318,10.1002/jso.26050,2020-06-05
Pharmaceutical Preparations,INTERACTS_WITH,angiotensin converting enzyme 2,32497318,10.1002/jso.26050,2020-06-05
Core needle biopsy,DIAGNOSES,Early-Stage Breast Carcinoma,32497297,10.1002/jmv.26137,2020-06-05
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Biopsy,32497297,10.1002/jmv.26137,2020-06-05
Coitus,AFFECTS,Inflammation,32497283,10.1002/jmv.26125,2020-06-05
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32497283,10.1002/jmv.26125,2020-06-05
Influenza,CAUSES,Respiratory Tract Infections,32497257,10.1111/bph.15154,2020-06-05
Diagnosis,DIAGNOSES,Influenza,32497257,10.1111/bph.15154,2020-06-05
Chest,LOCATION_OF,Diagnostic radiologic examination,32497257,10.1111/bph.15154,2020-06-05
Coinfection,PROCESS_OF,Patients,32497257,10.1111/bph.15154,2020-06-05
Chest,LOCATION_OF,Radiologic finding,32497257,10.1111/bph.15154,2020-06-05
Plain chest X-ray,DIAGNOSES,Virus,32497257,10.1111/bph.15154,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32497196,10.1093/cid/ciaa721,2020-06-05
Asymptomatic,PROCESS_OF,Persons,32497196,10.1093/cid/ciaa721,2020-06-05
Asymptomatic,PROCESS_OF,Participant,32497196,10.1093/cid/ciaa721,2020-06-05
Asymptomatic,PROCESS_OF,Persons,32497196,10.1093/cid/ciaa721,2020-06-05
Fasting,PROCESS_OF,Persons,32497196,10.1093/cid/ciaa721,2020-06-05
Asymptomatic,PROCESS_OF,Persons,32497196,10.1093/cid/ciaa721,2020-06-05
Patients,LOCATION_OF,"Antibodies, Neutralizing",32497194,10.1093/ajhp/zxaa206,2020-06-05
Enzyme-Linked Immunosorbent Assay,METHOD_OF,Assay,32497194,10.1093/ajhp/zxaa206,2020-06-05
High Level,PROCESS_OF,Patients,32497194,10.1093/ajhp/zxaa206,2020-06-05
Disease,PROCESS_OF,Patients,32497194,10.1093/ajhp/zxaa206,2020-06-05
High antibody titer,PROCESS_OF,Patients,32497194,10.1093/ajhp/zxaa206,2020-06-05
Gastrointestinal symptom,COEXISTS_WITH,patient condition,32497168,10.1093/cid/ciaa726,2020-06-05
Disease,ASSOCIATED_WITH,Intestinal Microbiome,32497168,10.1093/cid/ciaa726,2020-06-05
Vaccines,compared_with,Vaccines,32497090,10.1371/journal.pone.0234187,2020-06-05
Vaccines,higher_than,Vaccines,32497090,10.1371/journal.pone.0234187,2020-06-05
Low Birth Weights,PROCESS_OF,"Infant, Newborn",32497031,10.15585/mmwr.mm6922e2,2020-06-05
Symptoms,PROCESS_OF,Pregnant Women,32497031,10.15585/mmwr.mm6922e2,2020-06-05
Patients,ISA,Persons,32497028,10.15585/mmwr.mm6922e1,2020-06-05
Isolation procedure,TREATS,Symptoms,32497028,10.15585/mmwr.mm6922e1,2020-06-05
Department,LOCATION_OF,Sentinel Surveillance,32497001,10.3201/eid2610.202449,2020-06-05
Asymptomatic,PROCESS_OF,Child,32496988,10.2174/1573405616666200604163954,2020-06-05
Lung,PART_OF,Patients,32496967,10.1080/22221751.2020.1777906,2020-06-05
Maximal Inspiratory Pressure Test,DIAGNOSES,chest disorders,32496967,10.1080/22221751.2020.1777906,2020-06-05
Hydroxychloroquine,TREATS,Patients,32496926,10.1080/00325481.2020.1778982,2020-06-05
Kidney Failure,PROCESS_OF,Patients,32496926,10.1080/00325481.2020.1778982,2020-06-05
Glucose-6-phosphate deficiency,PROCESS_OF,Patients,32496926,10.1080/00325481.2020.1778982,2020-06-05
Hydroxychloroquine,DISRUPTS,Membrane Fusion,32496919,10.7326/M20-2854,2020-06-05
Molecular Genetic Technique,METHOD_OF,Diagnosis,32496899,10.1080/08959420.2020.1770037,2020-06-05
Laboratory Procedures,USES,Procedure to identify antibody,32496899,10.1080/08959420.2020.1770037,2020-06-05
Procedure to identify antibody,ISA,Laboratory Procedures,32496899,10.1080/08959420.2020.1770037,2020-06-05
Eye,LOCATION_OF,Disease,32496864,10.1377/hlthaff.2020.00652,2020-06-05
Thrombosis,COMPLICATES,"Respiratory Distress Syndrome, Adult",32496864,10.1377/hlthaff.2020.00652,2020-06-05
Thrombosis,COMPLICATES,"Pneumonia, Interstitial",32496864,10.1377/hlthaff.2020.00652,2020-06-05
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Offenders,32496858,10.12968/bjcn.2020.25.6.266,2020-06-05
Infection,PROCESS_OF,Community,32496858,10.12968/bjcn.2020.25.6.266,2020-06-05
skill,PROCESS_OF,Dentist,32496851,10.12968/bjcn.2020.25.6.294,2020-06-05
contextual factors,PROCESS_OF,Community,32496851,10.12968/bjcn.2020.25.6.294,2020-06-05
prescribed,ADMINISTERED_TO,Health Personnel,32496749,10.1097/PRA.0000000000000476,2020-06-05
Isolation procedure,AFFECTS,Obstruction,32496734,10.3906/sag-2005-395,2020-06-05
Isolation procedure,AFFECTS,Moral Injury,32496734,10.3906/sag-2005-395,2020-06-05
Coronavirus Infections,ISA,Disease,32496715,10.36233/0507-4088-2020-65-1-6-15,2020-06-05
"CD69 protein, human",PREDISPOSES,Severe Acute Respiratory Syndrome,32496715,10.36233/0507-4088-2020-65-1-6-15,2020-06-05
SARS coronavirus,ISA,Virus,32496637,10.1002/hed.26292,2020-06-05
Coronaviridae,PROCESS_OF,Family,32496637,10.1002/hed.26292,2020-06-05
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32496637,10.1002/hed.26292,2020-06-05
Genus: Coronavirus,PROCESS_OF,Chiroptera,32496637,10.1002/hed.26292,2020-06-05
Anxiety,PROCESS_OF,Otolaryngologist,32496602,10.1002/ajim.23144,2020-06-05
Distress,PROCESS_OF,Physicians,32496602,10.1002/ajim.23144,2020-06-05
Distress,PROCESS_OF,Otolaryngologist,32496602,10.1002/ajim.23144,2020-06-05
Physical and emotional exhaustion state,PROCESS_OF,Otolaryngologist,32496602,10.1002/ajim.23144,2020-06-05
Comorbidity,PROCESS_OF,Patients,32496430,10.1213/XAA.0000000000001253,2020-06-05
Epithelium,LOCATION_OF,"DPP4 protein, human",32496430,10.1213/XAA.0000000000001253,2020-06-05
risk factors,PROCESS_OF,Patients,32496430,10.1213/XAA.0000000000001253,2020-06-05
RNA Sequence,ADMINISTERED_TO,Patients,32496430,10.1213/XAA.0000000000001253,2020-06-05
Site,LOCATION_OF,Natural Killer Cells,32496430,10.1213/XAA.0000000000001253,2020-06-05
Bronchial Epithelial Cell,LOCATION_OF,"DPP4 protein, human",32496430,10.1213/XAA.0000000000001253,2020-06-05
Bronchial Epithelial Cell,PART_OF,Homo sapiens,32496430,10.1213/XAA.0000000000001253,2020-06-05
Immune Cell,LOCATION_OF,"DPP4 protein, human",32496430,10.1213/XAA.0000000000001253,2020-06-05
T-Lymphocyte,LOCATION_OF,Genes,32496430,10.1213/XAA.0000000000001253,2020-06-05
Peripheral blood mononuclear cell (cell),LOCATION_OF,Genes,32496430,10.1213/XAA.0000000000001253,2020-06-05
Asthma,ISA,Chronic Obstructive Airway Disease,32496430,10.1213/XAA.0000000000001253,2020-06-05
,ASSOCIATED_WITH,Skin lesion,32496430,10.1213/XAA.0000000000001253,2020-06-05
Skin lesion,AFFECTS,Severe Acute Respiratory Syndrome,32496430,10.1213/XAA.0000000000001253,2020-06-05
ACE2 gene,ASSOCIATED_WITH,Skin lesion,32496430,10.1213/XAA.0000000000001253,2020-06-05
Reporting,USES,Lung simulator,32496429,10.1213/XAA.0000000000001252,2020-06-05
Present,PROCESS_OF,Health Personnel,32496422,10.1097/SHK.0000000000001574,2020-06-05
Infected,PROCESS_OF,Patients,32496422,10.1097/SHK.0000000000001574,2020-06-05
BARRIER,USES,enclosure,32496422,10.1097/SHK.0000000000001574,2020-06-05
Adrenal Cortex Hormones,ISA,Immunologic Adjuvants,32496407,10.1097/INF.0000000000002783,2020-06-05
Patients,LOCATION_OF,Adrenal Cortex Hormones,32496407,10.1097/INF.0000000000002783,2020-06-05
IMPACT gene,INTERACTS_WITH,Adrenal Cortex Hormones,32496407,10.1097/INF.0000000000002783,2020-06-05
Evaluation,TREATS,Child,32496369,10.1097/PRS.0000000000007221,2020-06-05
Consultation,TREATS,Enthesitis-Related Arthritis,32496364,10.1097/CRD.0000000000000319,2020-06-05
Reconstructive Surgical Procedures,COEXISTS_WITH,patient care,32496364,10.1097/CRD.0000000000000319,2020-06-05
Cessation of life,PROCESS_OF,Patients,32496357,10.1097/TP.0000000000003339,2020-06-05
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32496357,10.1097/TP.0000000000003339,2020-06-05
Angiotensin II receptor antagonist,STIMULATES,ACE2 gene,32496357,10.1097/TP.0000000000003339,2020-06-05
Heart,LOCATION_OF,Enzymes,32496357,10.1097/TP.0000000000003339,2020-06-05
Angiotensin-Converting Enzyme Inhibitors,INHIBITS,ACE2 gene,32496357,10.1097/TP.0000000000003339,2020-06-05
ACE2 gene,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32496357,10.1097/TP.0000000000003339,2020-06-05
Discontinued,PROCESS_OF,Patients,32496357,10.1097/TP.0000000000003339,2020-06-05
Challenge,TREATS,Immunocompromised Host,32496339,10.14309/ajg.0000000000000732,2020-06-05
intensive care unit,LOCATION_OF,Administration occupational activities,32496339,10.14309/ajg.0000000000000732,2020-06-05
Pancreas,LOCATION_OF,Disease,32496292,10.1097/ACM.0000000000003535,2020-06-05
Pancreas,LOCATION_OF(SPEC),Coronavirus Infections,32496292,10.1097/ACM.0000000000003535,2020-06-05
Coronavirus Infections,ISA,Disease,32496292,10.1097/ACM.0000000000003535,2020-06-05
Hyperlipasaemia,PROCESS_OF,Patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Hyperlipasaemia,PROCESS_OF,hospitalized patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Acute pancreatitis,NEG_PROCESS_OF,Patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Disease,PROCESS_OF,Patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Lipase,TREATS,Patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Lipase,TREATS(INFER),Disease,32496292,10.1097/ACM.0000000000003535,2020-06-05
Coronavirus Infections,ISA,Disease,32496292,10.1097/ACM.0000000000003535,2020-06-05
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32496292,10.1097/ACM.0000000000003535,2020-06-05
Serum,LOCATION_OF,Lipase,32496292,10.1097/ACM.0000000000003535,2020-06-05
Symptoms,NEG_COEXISTS_WITH,Hyperlipasaemia,32496292,10.1097/ACM.0000000000003535,2020-06-05
Poor outcome,NEG_COEXISTS_WITH,Hyperlipasaemia,32496292,10.1097/ACM.0000000000003535,2020-06-05
Institutes,LOCATION_OF,Reverse Transcriptase Polymerase Chain Reaction,32496264,10.4103/ijph.IJPH_472_20,2020-06-05
Coronavirus Infections,ISA,Disease,32496262,10.4103/ijph.IJPH_524_20,2020-06-05
Coronavirus Infections,ISA,Disease,32496262,10.4103/ijph.IJPH_524_20,2020-06-05
Coronavirus Infections,ISA,Disease,32496262,10.4103/ijph.IJPH_524_20,2020-06-05
Masks,PREVENTS,Respiratory Tract Infections,32496259,10.4103/ijph.IJPH_486_20,2020-06-05
Health Personnel,USES,Masks,32496259,10.4103/ijph.IJPH_486_20,2020-06-05
Anxiety,PROCESS_OF,Population Group,32496254,10.4103/ijph.IJPH_470_20,2020-06-05
Educational Status,PROCESS_OF,Persons,32496254,10.4103/ijph.IJPH_470_20,2020-06-05
mental health,PROCESS_OF,Persons,32496254,10.4103/ijph.IJPH_470_20,2020-06-05
Pandemics,ISA,Disease Outbreaks,32496252,10.4103/ijph.IJPH_522_20,2020-06-05
Rapid response team,METHOD_OF,Take,32496250,10.4103/ijph.IJPH_465_20,2020-06-05
game,ISA,Behavior,32496249,10.4103/ijph.IJPH_508_20,2020-06-05
game,ISA,Behavior,32496249,10.4103/ijph.IJPH_508_20,2020-06-05
game,ISA,Behavior,32496249,10.4103/ijph.IJPH_508_20,2020-06-05
game,ISA,Behavior,32496249,10.4103/ijph.IJPH_508_20,2020-06-05
game,ISA,Behavior,32496249,10.4103/ijph.IJPH_508_20,2020-06-05
Ward (environment),LOCATION_OF,Analysis,32496248,10.4103/ijph.IJPH_464_20,2020-06-05
Intervention regimes,PREVENTS,Disease,32496247,10.4103/ijph.IJPH_506_20,2020-06-05
Insight,PROCESS_OF,Patients,32496246,10.4103/ijph.IJPH_510_20,2020-06-05
Open Reading Frames,PART_OF,Persons,32496246,10.4103/ijph.IJPH_510_20,2020-06-05
DNA Sequence,COEXISTS_WITH,Isolate - microorganism,32496246,10.4103/ijph.IJPH_510_20,2020-06-05
DNA Sequence,PART_OF,World,32496246,10.4103/ijph.IJPH_510_20,2020-06-05
Mutation,PROCESS_OF,Open Reading Frames,32496246,10.4103/ijph.IJPH_510_20,2020-06-05
ADAMTS2 gene,AFFECTS,Dynamics,32496245,10.4103/ijph.IJPH_495_20,2020-06-05
Spreader,compared_with,century,32496244,10.4103/ijph.IJPH_488_20,2020-06-05
Spreader,higher_than,century,32496244,10.4103/ijph.IJPH_488_20,2020-06-05
Homo sapiens,ISA,Animals,32496243,10.4103/ijph.IJPH_466_20,2020-06-05
Antimalarials,TREATS,Possible,32496240,10.4103/ijph.IJPH_457_20,2020-06-05
Asymptomatic,PROCESS_OF,Households,32496240,10.4103/ijph.IJPH_457_20,2020-06-05
Confirmation,PROCESS_OF,Patients,32496240,10.4103/ijph.IJPH_457_20,2020-06-05
Hydroxychloroquine,TREATS,Adult,32496240,10.4103/ijph.IJPH_457_20,2020-06-05
Hydroxychloroquine,TREATS,Adolescent (age group),32496240,10.4103/ijph.IJPH_457_20,2020-06-05
Chemoprevention,PREVENTS,Coronavirus Infections,32496238,10.4103/ijph.IJPH_520_20,2020-06-05
Pharmacologic Substance,TREATS,patient condition,32496238,10.4103/ijph.IJPH_520_20,2020-06-05
Symptoms,PROCESS_OF,Community,32496235,10.4103/ijph.IJPH_459_20,2020-06-05
China,ISA,Country,32496232,10.4103/ijph.IJPH_507_20,2020-06-05
Quarantine,TREATS,citizen,32496232,10.4103/ijph.IJPH_507_20,2020-06-05
Community Health Care,AFFECTS,Readiness,32496231,10.4103/ijph.IJPH_530_20,2020-06-05
Possible,PREDISPOSES,Mental disorders,32496210,10.3851/IMP3362,2020-06-05
Coronavirus Infections,ISA,Disease,32496207,10.2196/20239,2020-06-05
Communicable Diseases,ISA,Disease,32496207,10.2196/20239,2020-06-05
Coronavirus Infections,ISA,Disease,32496207,10.2196/20239,2020-06-05
Pandemics,ISA,Disease Outbreaks,32496207,10.2196/20239,2020-06-05
Treatment Protocols,TREATS,Disease,32496207,10.2196/20239,2020-06-05
Treatment Protocols,USES,lopinavir / Ritonavir,32496207,10.2196/20239,2020-06-05
lopinavir / Ritonavir,TREATS,Patients,32496207,10.2196/20239,2020-06-05
lopinavir / Ritonavir,TREATS(INFER),Severe Acute Respiratory Syndrome,32496207,10.2196/20239,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32496207,10.2196/20239,2020-06-05
Coronavirus Infections,ISA,Disease,32496206,10.2196/19855,2020-06-05
Coronavirus Infections,ISA,Disease,32496206,10.2196/19855,2020-06-05
Diagnosis,DIAGNOSES,Disease,32496206,10.2196/19855,2020-06-05
Coronavirus Infections,ISA,Disease,32496206,10.2196/19855,2020-06-05
Coronavirus Infections,ISA,Disease,32496206,10.2196/19855,2020-06-05
Coronavirus Infections,ISA,Disease,32496205,10.2196/19934,2020-06-05
Symptoms,PROCESS_OF,user - individual,32496205,10.2196/19934,2020-06-05
Anosmia,PROCESS_OF,Participant,32496205,10.2196/19934,2020-06-05
Anosmia,ISA,Disease,32496205,10.2196/19934,2020-06-05
Coughing,ASSOCIATED_WITH,Disease,32496205,10.2196/19934,2020-06-05
Coughing,ASSOCIATED_WITH(SPEC),Anosmia,32496205,10.2196/19934,2020-06-05
Coughing,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32496205,10.2196/19934,2020-06-05
Hospitalization,TREATS,Disease,32496205,10.2196/19934,2020-06-05
Hospitalization,TREATS(SPEC),Coronavirus Infections,32496205,10.2196/19934,2020-06-05
Coronavirus Infections,ISA,Disease,32496205,10.2196/19934,2020-06-05
Coronavirus Infections,ISA,Disease,32496205,10.2196/19934,2020-06-05
Comorbidity,PROCESS_OF,Community,32496123,10.17235/reed.2020.7188/2020,2020-06-05
IMPACT gene,PART_OF,Racial group,32496123,10.17235/reed.2020.7188/2020,2020-06-05
Coronavirus Infections,ISA,Disease,32496123,10.17235/reed.2020.7188/2020,2020-06-05
Ulcerative Colitis,COEXISTS_WITH,Crohn Disease,32496122,10.17235/reed.2020.7156/2020,2020-06-05
extracurricular activity,TREATS,Child,32496103,10.1037/tra0000627,2020-06-05
Psychologist,ISA,Health Personnel,32496102,10.1037/tra0000622,2020-06-05
Wounds and Injuries,PROCESS_OF,general population,32496102,10.1037/tra0000622,2020-06-05
Moral Injury,PROCESS_OF,Health Personnel,32496100,10.1037/tra0000924,2020-06-05
Intention - mental process,PROCESS_OF,Adult,32496099,10.1037/tra0000720,2020-06-05
Suicide attempt,PROCESS_OF,Persons,32496094,10.1037/tra0000725,2020-06-05
Obsessive-Compulsive Disorder,ISA,Mental disorders,32496074,10.1037/amp0000662,2020-06-05
Challenge,TREATS,Persons,32496074,10.1037/amp0000662,2020-06-05
Illness anxiety disorder,ISA,Mental disorders,32496074,10.1037/amp0000662,2020-06-05
mental health,PROCESS_OF,Practitioner,32496074,10.1037/amp0000662,2020-06-05
Diabetes Mellitus,COEXISTS_WITH,patient condition,32495985,10.1111/jth.14941,2020-06-05
diabetic,PROCESS_OF,hospitalized patients,32495985,10.1111/jth.14941,2020-06-05
diabetic,PROCESS_OF,Patients,32495985,10.1111/jth.14941,2020-06-05
diabetic,PROCESS_OF,Patients,32495985,10.1111/jth.14941,2020-06-05
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Diabetes Mellitus,32495985,10.1111/jth.14941,2020-06-05
diabetic,PROCESS_OF,Patients,32495985,10.1111/jth.14941,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32495985,10.1111/jth.14941,2020-06-05
Easy,PROCESS_OF,Patients,32495979,10.1002/rmv.2116,2020-06-05
"Hospitals, University",LOCATION_OF,Observation - diagnostic procedure,32495979,10.1002/rmv.2116,2020-06-05
Coronavirus Infections,PROCESS_OF,Patients,32495952,10.1111/dth.13757,2020-06-05
Psoriasis,PROCESS_OF,Patients,32495940,10.1111/lam.13334,2020-06-05
Biological Factors,AUGMENTS,Infection,32495940,10.1111/lam.13334,2020-06-05
Biological Factors,compared_with,Placebos,32495940,10.1111/lam.13334,2020-06-05
Physicians,TREATS,Patients,32495940,10.1111/lam.13334,2020-06-05
Psoriasis,PROCESS_OF,Patients,32495940,10.1111/lam.13334,2020-06-05
Coronavirus Infections,PROCESS_OF,Family member,32495921,10.26355/eurrev_202005_21377,2020-06-05
Coughing,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Dyspnea,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Fatigue,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Fever,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Headache,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Pharyngitis,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Myalgia,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Chronic disease,PROCESS_OF,Elderly (population group),32495921,10.26355/eurrev_202005_21377,2020-06-05
Chronic disease,PROCESS_OF,Patients,32495921,10.26355/eurrev_202005_21377,2020-06-05
Eye,LOCATION_OF,Malignant Neoplasms,32495921,10.26355/eurrev_202005_21377,2020-06-05
Coronavirus Infections,ISA,Disease,32495920,10.26355/eurrev_202005_21376,2020-06-05
Coughing,COEXISTS_WITH,Incubation period,32495920,10.26355/eurrev_202005_21376,2020-06-05
Symptoms,PROCESS_OF,communes,32495920,10.26355/eurrev_202005_21376,2020-06-05
Infected,PROCESS_OF,Persons,32495920,10.26355/eurrev_202005_21376,2020-06-05
Infected,PROCESS_OF,Homo sapiens,32495920,10.26355/eurrev_202005_21376,2020-06-05
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32495920,10.26355/eurrev_202005_21376,2020-06-05
Coronavirus Infections,ISA,Disease,32495920,10.26355/eurrev_202005_21376,2020-06-05
rapid technique,DIAGNOSES,Disease,32495920,10.26355/eurrev_202005_21376,2020-06-05
rapid technique,DIAGNOSES(SPEC),Coronavirus Infections,32495920,10.26355/eurrev_202005_21376,2020-06-05
Natural Childbirth assistance,USES,Pharmaceutical Preparations,32495920,10.26355/eurrev_202005_21376,2020-06-05
Myalgia,ISA,Complication,32495917,10.26355/eurrev_202005_21373,2020-06-05
Generalized muscle weakness,ISA,Complication,32495917,10.26355/eurrev_202005_21373,2020-06-05
"Respiratory Distress Syndrome, Adult",ISA,Complication,32495917,10.26355/eurrev_202005_21373,2020-06-05
"CD69 protein, human",COEXISTS_WITH,lopinavir / Ritonavir,32495916,10.26355/eurrev_202005_21372,2020-06-05
Immunologic Adjuvants,TREATS,Patients,32495916,10.26355/eurrev_202005_21372,2020-06-05
Immunologic Adjuvants,TREATS(INFER),Lymphocyte count decreased,32495916,10.26355/eurrev_202005_21372,2020-06-05
Lymphocyte count decreased,PROCESS_OF,Patients,32495916,10.26355/eurrev_202005_21372,2020-06-05
Storm NOS,PROCESS_OF,Patients,32495915,10.26355/eurrev_202005_21371,2020-06-05
Interleukin-6,AFFECTS,Storm NOS,32495915,10.26355/eurrev_202005_21371,2020-06-05
Pharmaceutical Preparations,INHIBITS,Interleukin 6 Receptor,32495915,10.26355/eurrev_202005_21371,2020-06-05
Pharmaceutical Preparations,TREATS,Patients,32495915,10.26355/eurrev_202005_21371,2020-06-05
China,ISA,Geographic Locations,32495914,10.26355/eurrev_202005_21370,2020-06-05
Immunologic Deficiency Syndromes,PROCESS_OF,Elderly (population group),32495914,10.26355/eurrev_202005_21370,2020-06-05
Immunologic Deficiency Syndromes,PROCESS_OF,Woman,32495914,10.26355/eurrev_202005_21370,2020-06-05
Osteoporosis,PROCESS_OF,Patients,32495914,10.26355/eurrev_202005_21370,2020-06-05
Postmenopausal state,PROCESS_OF,Woman,32495914,10.26355/eurrev_202005_21370,2020-06-05
Osteoporosis,PROCESS_OF,Patients,32495914,10.26355/eurrev_202005_21370,2020-06-05
Osteoporosis,PROCESS_OF,Patients,32495914,10.26355/eurrev_202005_21370,2020-06-05
Osteoporosis,PROCESS_OF,Patients,32495914,10.26355/eurrev_202005_21370,2020-06-05
Therapeutic procedure,COEXISTS_WITH,ambulatory care services,32495914,10.26355/eurrev_202005_21370,2020-06-05
Therapeutic procedure,TREATS,Patients,32495914,10.26355/eurrev_202005_21370,2020-06-05
Therapeutic procedure,TREATS(INFER),Osteoporosis,32495914,10.26355/eurrev_202005_21370,2020-06-05
Evaluation,PREVENTS,Osteoporosis,32495914,10.26355/eurrev_202005_21370,2020-06-05
follow-up,PREVENTS,Osteoporosis,32495914,10.26355/eurrev_202005_21370,2020-06-05
Feces,LOCATION_OF,Nucleic Acids,32495913,10.26355/eurrev_202005_21369,2020-06-05
Feces,LOCATION_OF,Nucleic Acids,32495913,10.26355/eurrev_202005_21369,2020-06-05
Nucleic Acids,PART_OF,Patients,32495913,10.26355/eurrev_202005_21369,2020-06-05
Nucleic Acids,PART_OF,Patients,32495913,10.26355/eurrev_202005_21369,2020-06-05
Diarrhea,ISA,Symptoms,32495913,10.26355/eurrev_202005_21369,2020-06-05
Nucleic Acids,PART_OF,Respiratory viruses,32495913,10.26355/eurrev_202005_21369,2020-06-05
Symptoms,PROCESS_OF,Patients,32495913,10.26355/eurrev_202005_21369,2020-06-05
Feces,LOCATION_OF,Nucleic Acids,32495913,10.26355/eurrev_202005_21369,2020-06-05
"Discharge, body substance",LOCATION_OF,CD40LG wt Allele,32495913,10.26355/eurrev_202005_21369,2020-06-05
Limb structure,LOCATION_OF,Cyanosis,32495830,10.1093/jamia/ocaa077,2020-06-05
Limb structure,LOCATION_OF,"Signs and Symptoms, Respiratory",32495830,10.1093/jamia/ocaa077,2020-06-05
Fingers,PART_OF,Foot,32495830,10.1093/jamia/ocaa077,2020-06-05
Laboratory Procedures,DIAGNOSES,Disseminated Intravascular Coagulation,32495830,10.1093/jamia/ocaa077,2020-06-05
Fingers,LOCATION_OF,Cyanosis,32495830,10.1093/jamia/ocaa077,2020-06-05
Nose,LOCATION_OF,Cyanosis,32495830,10.1093/jamia/ocaa077,2020-06-05
Toes,LOCATION_OF,Cyanosis,32495830,10.1093/jamia/ocaa077,2020-06-05
Multiple Organ Failure,COMPLICATES,Comatose,32495830,10.1093/jamia/ocaa077,2020-06-05
Septic Shock,COMPLICATES,Comatose,32495830,10.1093/jamia/ocaa077,2020-06-05
Syndrome,COMPLICATES,Comatose,32495830,10.1093/jamia/ocaa077,2020-06-05
Blood Coagulation Disorders,CAUSES,Gangrene,32495830,10.1093/jamia/ocaa077,2020-06-05
Disseminated Intravascular Coagulation,CAUSES,Gangrene,32495830,10.1093/jamia/ocaa077,2020-06-05
Prognosis bad,COEXISTS_WITH,Blood Coagulation Disorders,32495830,10.1093/jamia/ocaa077,2020-06-05
Engaged to be married,PROCESS_OF,Vendors,32495826,10.1093/ibd/izaa142,2020-06-05
Disease,PROCESS_OF,member,32495582,10.19540/j.cnki.cjcmm.20200318.501,2020-06-05
Symptoms,PROCESS_OF,Patients,32495582,10.19540/j.cnki.cjcmm.20200318.501,2020-06-05
Coronavirus Infections,PROCESS_OF,World,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Acupuncture and Oriental Medicine,TREATS,Symptoms,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Interventional procedure,METHOD_OF,Epidemiology,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Interventional procedure,METHOD_OF,Evidence-Based Medicine,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Acupuncture and Oriental Medicine,ISA,Interventional procedure,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Acupuncture and Oriental Medicine,METHOD_OF(SPEC),Epidemiology,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Acupuncture and Oriental Medicine,METHOD_OF(SPEC),Evidence-Based Medicine,32495581,10.19540/j.cnki.cjcmm.20200318.502,2020-06-05
Pharmaceutical Preparations,TREATS,Heart Injuries,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Heart,LOCATION_OF,Adverse reactions,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Traditional Chinese Medicine,ISA,Biomedicine,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Adverse reactions,MANIFESTATION_OF,Toxic effect,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Study,METHOD_OF,Bio-Informatics,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Notifications,USES,Pharmaceutical Preparations,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Procedure findings:Finding:Point in time:^Patient:Narrative,PREDISPOSES,Drug usage,32495579,10.19540/j.cnki.cjcmm.20200316.408,2020-06-05
Disease,PROCESS_OF,Social Networks,32495577,10.19540/j.cnki.cjcmm.20200325.401,2020-06-05
protein protein interaction,PROCESS_OF,Mouse Lung,32495577,10.19540/j.cnki.cjcmm.20200325.401,2020-06-05
Acupuncture and Oriental Medicine,ADMINISTERED_TO,Clinician,32495577,10.19540/j.cnki.cjcmm.20200325.401,2020-06-05
energy balance,AFFECTS,Immunity,32495576,10.19540/j.cnki.cjcmm.20200320.501,2020-06-05
Hospitals,LOCATION_OF,Study,32495574,10.19540/j.cnki.cjcmm.20200323.501,2020-06-05
Diagnosis,USES,sodium chloride injection,32495496,10.1111/liv.14557,2020-06-05
Gastrointestinal symptom,PROCESS_OF,Patients,32495496,10.1111/liv.14557,2020-06-05
Lung,LOCATION_OF,Lesion,32495496,10.1111/liv.14557,2020-06-05
Nucleic Acids,compared_with,matrine,32495496,10.1111/liv.14557,2020-06-05
Liver Dysfunction,PROCESS_OF,hospitalized patients,32495493,10.1002/oby.22924,2020-06-05
Liver Dysfunction,PROCESS_OF,Patients,32495493,10.1002/oby.22924,2020-06-05
Hospitals,LOCATION_OF,Retrospective Cohort Study,32495493,10.1002/oby.22924,2020-06-05
liver test abnormal,PREDISPOSES,Severe course,32495493,10.1002/oby.22924,2020-06-05
Disease,AFFECTS,Patients,32495390,10.1002/ajp.23158,2020-06-05
Obesity,NEG_AFFECTS(SPEC),Patients,32495390,10.1002/ajp.23158,2020-06-05
Obesity,NEG_ISA,Disease,32495390,10.1002/ajp.23158,2020-06-05
Obesity,PROCESS_OF,Persons,32495390,10.1002/ajp.23158,2020-06-05
Disease,AFFECTS,Animals,32495368,10.1111/jdv.16707,2020-06-05
Symptoms,PROCESS_OF,Community,32495368,10.1111/jdv.16707,2020-06-05
Breath,PART_OF,Patients,32495336,10.6224/JN.202006_67(3).14,2020-06-05
Author,USES,Physiologic monitoring system,32495336,10.6224/JN.202006_67(3).14,2020-06-05
Anxiety,PROCESS_OF,Patients,32495336,10.6224/JN.202006_67(3).14,2020-06-05
Coronavirus Infections,ISA,Disease,32495334,10.6224/JN.202006_67(3).12,2020-06-05
Coronavirus Infections,ISA,Disease,32495334,10.6224/JN.202006_67(3).12,2020-06-05
Chronic infectious disease,PROCESS_OF,Persons,32495333,10.6224/JN.202006_67(3).11,2020-06-05
Nurses,DIAGNOSES,Fever,32495332,10.6224/JN.202006_67(3).10,2020-06-05
Coronavirus Infections,ISA,Disease,32495323,10.6224/JN.202006_67(3).01,2020-06-05
Stress,PROCESS_OF,Nurses,32495323,10.6224/JN.202006_67(3).01,2020-06-05
Infected,PROCESS_OF,Family member,32495323,10.6224/JN.202006_67(3).01,2020-06-05
Experience,PROCESS_OF,Voluntary Workers,32495323,10.6224/JN.202006_67(3).01,2020-06-05
Coronavirus Infections,PRECEDES,Severe Acute Respiratory Syndrome,32495299,10.1007/s40618-020-01318-1,2020-06-05
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32495299,10.1007/s40618-020-01318-1,2020-06-05
Critical Illness,PROCESS_OF,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Pharmaceutical Preparations,TREATS,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Pharmaceutical Preparations,TREATS(INFER),Critical Illness,32495299,10.1007/s40618-020-01318-1,2020-06-05
Complication,PROCESS_OF,Survivors,32495299,10.1007/s40618-020-01318-1,2020-06-05
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Impaired cognition,PROCESS_OF,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Weakness,PROCESS_OF,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Anxiety,ISA,Symptoms,32495299,10.1007/s40618-020-01318-1,2020-06-05
Depressive disorder,ISA,Symptoms,32495299,10.1007/s40618-020-01318-1,2020-06-05
Post-Traumatic Stress Disorder,ISA,Symptoms,32495299,10.1007/s40618-020-01318-1,2020-06-05
Punctate inner choroidopathy,AFFECTS,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Mechanical ventilation,ADMINISTERED_TO,Survivors,32495299,10.1007/s40618-020-01318-1,2020-06-05
Disease,PROCESS_OF,Patients,32495299,10.1007/s40618-020-01318-1,2020-06-05
Multi-disciplinary team,METHOD_OF,Intervention regimes,32495299,10.1007/s40618-020-01318-1,2020-06-05
Cardiovascular Diseases,ISA,Disease,32495288,10.1007/s11684-020-0788-3,2020-06-05
Diabetes,ISA,Disease,32495288,10.1007/s11684-020-0788-3,2020-06-05
Pneumonia,PROCESS_OF,Patients,32495288,10.1007/s11684-020-0788-3,2020-06-05
Pneumonia,PROCESS_OF,Old age,32495288,10.1007/s11684-020-0788-3,2020-06-05
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,angiotensin converting enzyme 2,32495288,10.1007/s11684-020-0788-3,2020-06-05
Carboxypeptidase,PART_OF,Membrane,32495288,10.1007/s11684-020-0788-3,2020-06-05
Cells,LOCATION_OF,angiotensin converting enzyme 2,32495288,10.1007/s11684-020-0788-3,2020-06-05
Diabetes,AFFECTS,Patients,32495288,10.1007/s11684-020-0788-3,2020-06-05
Angiotensin II receptor antagonist,STIMULATES,angiotensin converting enzyme 2,32495288,10.1007/s11684-020-0788-3,2020-06-05
angiotensin converting enzyme 2,ISA,Carboxypeptidase,32495288,10.1007/s11684-020-0788-3,2020-06-05
angiotensin converting enzyme 2,PART_OF(SPEC),Membrane,32495288,10.1007/s11684-020-0788-3,2020-06-05
Hydroxymethylglutaryl-CoA Reductase Inhibitors,STIMULATES,agonists,32495288,10.1007/s11684-020-0788-3,2020-06-05
Pharmacologic Substance,STIMULATES,angiotensin converting enzyme 2,32495288,10.1007/s11684-020-0788-3,2020-06-05
Lung,LOCATION_OF,angiotensin converting enzyme 2,32495288,10.1007/s11684-020-0788-3,2020-06-05
Elective Surgical Procedures,COEXISTS_WITH,discipline,32495231,10.1007/s40620-020-00755-8,2020-06-05
Italy,ISA,Country,32495226,10.1007/s10067-020-05202-4,2020-06-05
Experience,PROCESS_OF,Italians,32495226,10.1007/s10067-020-05202-4,2020-06-05
Chloroquine,ISA,Pharmaceutical Preparations,32495148,10.1007/s40264-020-00955-y,2020-06-05
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32495148,10.1007/s40264-020-00955-y,2020-06-05
Hydroxychloroquine,TREATS,Patients,32495147,10.1007/s00431-020-03683-8,2020-06-05
Metformin,INTERACTS_WITH,Hydroxychloroquine,32495147,10.1007/s00431-020-03683-8,2020-06-05
Hospitals,LOCATION_OF,case series,32495141,10.1007/s11605-020-04665-9,2020-06-05
Hospitals,LOCATION_OF,case series,32495141,10.1007/s11605-020-04665-9,2020-06-05
Elective Surgical Procedures,TREATS,Patients,32495123,10.1007/s00128-020-02895-w,2020-06-05
colon cancer resection,TREATS,Patients,32495123,10.1007/s00128-020-02895-w,2020-06-05
Infected,PROCESS_OF,Persons,32495030,10.1007/s00520-020-05557-z,2020-06-05
Introduction procedure,PRECEDES,internal-external locus of control scale,32495030,10.1007/s00520-020-05557-z,2020-06-05
Toxic effect,COEXISTS_WITH,Malnutrition,32495027,10.1007/s00277-020-04103-5,2020-06-05
Communicable Diseases,PROCESS_OF,Homo sapiens,32494931,10.1007/s00109-020-01927-6,2020-06-05
Lung,LOCATION_OF,Severe disorder,32494931,10.1007/s00109-020-01927-6,2020-06-05
Severe disorder,PROCESS_OF,Patients,32494931,10.1007/s00109-020-01927-6,2020-06-05
Lung,LOCATION_OF,Diminished productivity,32494931,10.1007/s00109-020-01927-6,2020-06-05
Inflammation,PRECEDES,"Respiratory Distress Syndrome, Adult",32494921,10.1007/s00392-020-01681-2,2020-06-05
Lymphopenia,PRECEDES,"Respiratory Distress Syndrome, Adult",32494921,10.1007/s00392-020-01681-2,2020-06-05
"Respiratory Distress Syndrome, Adult",ISA,Disease,32494921,10.1007/s00392-020-01681-2,2020-06-05
cardiac event,CAUSES,Hospital admission,32494896,10.1007/s10840-020-00789-9,2020-06-05
Hospital admission,TREATS,cardiac event,32494896,10.1007/s10840-020-00789-9,2020-06-05
cardiac event,PROCESS_OF,Patients,32494896,10.1007/s10840-020-00789-9,2020-06-05
cardiac event,CAUSES,Hospital admission,32494896,10.1007/s10840-020-00789-9,2020-06-05
Troponin T,DISRUPTS,cardiac event,32494896,10.1007/s10840-020-00789-9,2020-06-05
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32494896,10.1007/s10840-020-00789-9,2020-06-05
Atrial Fibrillation,ISA,Tachyarrhythmia,32494856,10.1007/s00415-020-09944-8,2020-06-05
Severe sinus bradycardia,ISA,Bradyarrhythmia (disorder),32494856,10.1007/s00415-020-09944-8,2020-06-05
Anticoagulation Therapy,ADMINISTERED_TO,Respondents,32494856,10.1007/s00415-020-09944-8,2020-06-05
Anticoagulation Therapy,TREATS,Patients,32494856,10.1007/s00415-020-09944-8,2020-06-05
Hydroxychloroquine,ISA,Chloroquine,32494856,10.1007/s00415-020-09944-8,2020-06-05
Torsades de Pointes,PROCESS_OF,Patients,32494856,10.1007/s00415-020-09944-8,2020-06-05
Amiodarone,ISA,Anti-Arrhythmia Agents,32494856,10.1007/s00415-020-09944-8,2020-06-05
Amiodarone,TREATS(SPEC),Ventricular arrhythmia,32494856,10.1007/s00415-020-09944-8,2020-06-05
Anti-Arrhythmia Agents,TREATS,Ventricular arrhythmia,32494856,10.1007/s00415-020-09944-8,2020-06-05
Multiple Sclerosis,PROCESS_OF,Patients,32494854,10.1007/s00415-020-09950-w,2020-06-05
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32494854,10.1007/s00415-020-09950-w,2020-06-05
Multiple Sclerosis,PROCESS_OF,Patients,32494854,10.1007/s00415-020-09950-w,2020-06-05
Disease,AFFECTS,Homo sapiens,32494800,10.5830-CVJA-2020-016,2020-06-05
Fever,PROCESS_OF,Patients,32494800,10.5830-CVJA-2020-016,2020-06-05
ST segment elevation myocardial infarction,ISA,Disease,32494576,10.1183/23120541.00198-2020,2020-06-05
Diabetes Mellitus,PROCESS_OF,Patients,32494576,10.1183/23120541.00198-2020,2020-06-05
Hypertensive disease,PROCESS_OF,Patients,32494576,10.1183/23120541.00198-2020,2020-06-05
"Pneumonia, Viral",ISA,Symptoms,32494576,10.1183/23120541.00198-2020,2020-06-05
Chest Pain,PROCESS_OF,Patients,32494576,10.1183/23120541.00198-2020,2020-06-05
Stress,PROCESS_OF,Patients,32494576,10.1183/23120541.00198-2020,2020-06-05
Coronary artery,LOCATION_OF,Thrombosis,32494576,10.1183/23120541.00198-2020,2020-06-05
High Level,CAUSES,Thrombosis,32494576,10.1183/23120541.00198-2020,2020-06-05
High Level,COEXISTS_WITH,ST segment elevation myocardial infarction,32494576,10.1183/23120541.00198-2020,2020-06-05
Epidemic,ISA,Disease Outbreaks,32494546,10.7759/cureus.8342,2020-06-05
Trigeminal Neuralgia,CAUSES,Headache,32494330,10.14740/cr1074,2020-06-05
Coughing,PROCESS_OF,Male population group,32494062,10.1038/s41591-020-0948-7,2020-06-05
Dyspnea,PROCESS_OF,Male population group,32494062,10.1038/s41591-020-0948-7,2020-06-05
Fever,PROCESS_OF,Male population group,32494062,10.1038/s41591-020-0948-7,2020-06-05
Heart failure,PROCESS_OF,Male population group,32494062,10.1038/s41591-020-0948-7,2020-06-05
Disability,PROCESS_OF,Persons,32493814,10.4049/jimmunol.2000513,2020-06-05
Disability,PROCESS_OF,Immigrant (person),32493814,10.4049/jimmunol.2000513,2020-06-05
Homelessness,PROCESS_OF,Persons,32493814,10.4049/jimmunol.2000513,2020-06-05
Cells,LOCATION_OF,Pyroptosis,32493812,10.4049/jimmunol.2000380,2020-06-05
cytokine,STIMULATES,Inflammasomes,32493812,10.4049/jimmunol.2000380,2020-06-05
Aging,AFFECTS,Immunity,32493791,10.1126/scitranslmed.abc1931,2020-06-05
Aging,AFFECTS,Respiratory viruses,32493791,10.1126/scitranslmed.abc1931,2020-06-05
Antiviral Agents,ADMINISTERED_TO,Patients,32493739,10.1136/bmj.m2094,2020-06-05
Hydroxychloroquine,ISA,Chloroquine,32493739,10.1136/bmj.m2094,2020-06-05
lopinavir / Ritonavir,TREATS,Diarrhea,32493739,10.1136/bmj.m2094,2020-06-05
lopinavir / Ritonavir,TREATS,Nausea,32493739,10.1136/bmj.m2094,2020-06-05
lopinavir / Ritonavir,TREATS,Vomiting,32493739,10.1136/bmj.m2094,2020-06-05
Gastrointestinal symptom,PROCESS_OF,Patients,32493738,10.3949/ccjm.87a.ccc040,2020-06-05
"Immunoglobulins, Intravenous",ADMINISTERED_TO,Patients,32493738,10.3949/ccjm.87a.ccc040,2020-06-05
"Paris, France",ISA,Geographic Locations,32493738,10.3949/ccjm.87a.ccc040,2020-06-05
Gastrointestinal symptom,PROCESS_OF,Child,32493738,10.3949/ccjm.87a.ccc040,2020-06-05
Gastrointestinal symptom,PROCESS_OF,Adolescent (age group),32493738,10.3949/ccjm.87a.ccc040,2020-06-05
Manipulation procedure,USES,Artificial Airways,32493737,10.3949/ccjm.87a.ccc038,2020-06-05
Cardiopulmonary Resuscitation,ADMINISTERED_TO,Health Personnel,32493737,10.3949/ccjm.87a.ccc038,2020-06-05
Cardiopulmonary Resuscitation,TREATS,Patients,32493737,10.3949/ccjm.87a.ccc038,2020-06-05
Severe disorder,PREDISPOSES,Cerebrovascular accident,32493735,10.3949/ccjm.87a.ccc041,2020-06-05
Ambulatory Care Facilities,LOCATION_OF,Quality Improvement,32493734,10.3949/ccjm.87a.ccc039,2020-06-05
Syndrome,PROCESS_OF,Child,32493713,10.1136/medethics-2020-106353,2020-06-05
risk factors,COEXISTS_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32493713,10.1136/medethics-2020-106353,2020-06-05
Stress,PROCESS_OF,general population,32493712,10.1136/medethics-2020-106467,2020-06-05
Coronavirus Infections,ISA,Disease,32493669,10.1016/j.jiph.2020.05.014,2020-06-05
Coronavirus Infections,ISA,Disease,32493669,10.1016/j.jiph.2020.05.014,2020-06-05
Infected,PROCESS_OF,Patients,32493669,10.1016/j.jiph.2020.05.014,2020-06-05
Coronavirus Infections,ISA,Disease,32493669,10.1016/j.jiph.2020.05.014,2020-06-05
Infection status,PROCESS_OF,Health Personnel,32493669,10.1016/j.jiph.2020.05.014,2020-06-05
disorder control (procedure),TREATS,World,32493648,10.1016/j.anorl.2020.05.006,2020-06-05
Coronavirus Infections,ISA,Disease,32493648,10.1016/j.anorl.2020.05.006,2020-06-05
Communicable Diseases,PROCESS_OF,Persons,32493648,10.1016/j.anorl.2020.05.006,2020-06-05
Coronavirus Infections,ISA,Disease,32493648,10.1016/j.anorl.2020.05.006,2020-06-05
Heart failure,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Comorbidity,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Heart failure,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Cardiovascular,LOCATION_OF,Comorbidity,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Myocarditis,COEXISTS_WITH,Cardiomyopathies,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Heart failure,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Heart failure,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Heart failure,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Coronavirus Infections,CAUSES,Heart failure,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Coronavirus Infections,PROCESS_OF,Patients,32493627,10.1016/j.arcmed.2020.05.012,2020-06-05
Coronaviridae,PROCESS_OF,Family,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Protein Subunits,STIMULATES,Membrane Fusion,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
ACE2 gene,AFFECTS,Virus Attachment,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
"Vitronectin, human",STIMULATES,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Amino Acids,INTERACTS_WITH,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Amino Acids,PART_OF,Serine,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Asparagine,INTERACTS_WITH,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Glutamine,INTERACTS_WITH,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Leucine,INTERACTS_WITH,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Phenylalanine,INTERACTS_WITH,ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Serine,INTERACTS_WITH(SPEC),ACE2 gene,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Serine,ISA,Amino Acids,32493626,10.1016/j.arcmed.2020.05.013,2020-06-05
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
Leptocyte,LOCATION_OF,Virus,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
Peptide Hydrolases,PART_OF,Host Cell,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
angiotensin converting enzyme 2,ADMINISTERED_TO,Leptocyte,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
angiotensin converting enzyme 2,INTERACTS_WITH,Peptide Hydrolases,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
angiotensin converting enzyme 2,INTERACTS_WITH,receptor,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
angiotensin converting enzyme 2,INTERACTS_WITH,Protein Subunits,32493604,10.1016/j.anpedi.2020.04.022,2020-06-05
Appendectomy,TREATS,World,32493597,10.1016/j.nrl.2020.04.015,2020-06-05
Severe Acute Respiratory Syndrome,OCCURS_IN,Patients,32493516,10.1192/bjp.2020.125,2020-06-05
Cerebrovascular accident,PROCESS_OF,Patients,32493516,10.1192/bjp.2020.125,2020-06-05
IMPACT gene,PART_OF,Population Group,32493514,10.1186/s13063-020-04447-3,2020-06-05
Inflammation,CAUSES,Pulmonary failure,32493510,10.1186/s12967-020-02392-y,2020-06-05
tocilizumab,TREATS,Patients,32493510,10.1186/s12967-020-02392-y,2020-06-05
tocilizumab,TREATS,Inflammation,32493510,10.1186/s12967-020-02392-y,2020-06-05
tocilizumab,TREATS,Pneumonia,32493510,10.1186/s12967-020-02392-y,2020-06-05
tocilizumab,TREATS,Patients,32493510,10.1186/s12967-020-02392-y,2020-06-05
Hydroxychloroquine,DISRUPTS,Coronavirus Infections,32493489,10.1186/s40463-020-00429-2,2020-06-05
"Hospitals, University",LOCATION_OF,Study,32493489,10.1186/s40463-020-00429-2,2020-06-05
Health Personnel,DIAGNOSES,Alveolar rhabdomyosarcoma,32493489,10.1186/s40463-020-00429-2,2020-06-05
Health Personnel,DIAGNOSES,Alveolar rhabdomyosarcoma,32493489,10.1186/s40463-020-00429-2,2020-06-05
Negative,PROCESS_OF,Patients,32493478,10.1186/s13063-020-04446-4,2020-06-05
Asymptomatic,PROCESS_OF,Patients,32493478,10.1186/s13063-020-04446-4,2020-06-05
Ascorbic Acid,PREVENTS,Severe Acute Respiratory Syndrome,32493475,10.1186/s13063-020-04436-6,2020-06-05
Hydroxychloroquine,PREVENTS,Severe Acute Respiratory Syndrome,32493475,10.1186/s13063-020-04436-6,2020-06-05
Hydroxychloroquine,PREVENTS,Severe Acute Respiratory Syndrome,32493475,10.1186/s13063-020-04436-6,2020-06-05
Hydroxychloroquine,compared_with,Ascorbic Acid,32493475,10.1186/s13063-020-04436-6,2020-06-05
Hydroxychloroquine,compared_with,Ascorbic Acid,32493475,10.1186/s13063-020-04436-6,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32493475,10.1186/s13063-020-04436-6,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32493475,10.1186/s13063-020-04436-6,2020-06-05
Post-Exposure Prophylaxis,TREATS,Adult,32493475,10.1186/s13063-020-04436-6,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32493475,10.1186/s13063-020-04436-6,2020-06-05
Ascorbic Acid,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32493475,10.1186/s13063-020-04436-6,2020-06-05
Hydroxychloroquine,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32493475,10.1186/s13063-020-04436-6,2020-06-05
Interventional procedure,ADMINISTERED_TO,Households,32493475,10.1186/s13063-020-04436-6,2020-06-05
Prophylactic treatment,PREVENTS,Severe Acute Respiratory Syndrome,32493473,10.1186/s13063-020-04416-w,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32493473,10.1186/s13063-020-04416-w,2020-06-05
Melatonin,ADMINISTERED_TO,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Melatonin,TREATS,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Melatonin,TREATS(INFER),Severe Acute Respiratory Syndrome,32493473,10.1186/s13063-020-04416-w,2020-06-05
Prophylactic treatment,PREVENTS,Severe Acute Respiratory Syndrome,32493473,10.1186/s13063-020-04416-w,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Symptoms,PROCESS_OF,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Melatonin,AFFECTS,Sleep,32493473,10.1186/s13063-020-04416-w,2020-06-05
Melatonin,compared_with,Placebos,32493473,10.1186/s13063-020-04416-w,2020-06-05
Placebos,AFFECTS,Sleep,32493473,10.1186/s13063-020-04416-w,2020-06-05
Disease,PROCESS_OF,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Hematological Disease,PROCESS_OF,Participant,32493473,10.1186/s13063-020-04416-w,2020-06-05
Lactase,PART_OF,Lapps,32493473,10.1186/s13063-020-04416-w,2020-06-05
Circadin,ISA,Melatonin,32493473,10.1186/s13063-020-04416-w,2020-06-05
Laboratory Procedures,DIAGNOSES,Infection,32493473,10.1186/s13063-020-04416-w,2020-06-05
Serologic tests,DIAGNOSES,Infection,32493473,10.1186/s13063-020-04416-w,2020-06-05
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32493468,10.1186/s13063-020-04382-3,2020-06-05
intensive care unit,LOCATION_OF,placebo controlled study,32493468,10.1186/s13063-020-04382-3,2020-06-05
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32493468,10.1186/s13063-020-04382-3,2020-06-05
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Patients,32493468,10.1186/s13063-020-04382-3,2020-06-05
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Malignant Neoplasms,32493468,10.1186/s13063-020-04382-3,2020-06-05
SDC2 gene,PART_OF,Tissue Donors,32493468,10.1186/s13063-020-04382-3,2020-06-05
Non-English speaking,NEG_PROCESS_OF,Patients,32493468,10.1186/s13063-020-04382-3,2020-06-05
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32493468,10.1186/s13063-020-04382-3,2020-06-05
interferon beta-1b,TREATS,Patients,32493466,10.1186/s12916-020-01615-9,2020-06-05
Interferon beta-1a,compared_with,interferon beta-1b,32493466,10.1186/s12916-020-01615-9,2020-06-05
Medical center,LOCATION_OF,Clinical Trials,32493466,10.1186/s12916-020-01615-9,2020-06-05
Confirmation,PROCESS_OF,Patients,32493466,10.1186/s12916-020-01615-9,2020-06-05
Therapeutic regimen,TREATS,Patients,32493466,10.1186/s12916-020-01615-9,2020-06-05
lopinavir / Ritonavir,ADMINISTERED_TO,secondary group,32493466,10.1186/s12916-020-01615-9,2020-06-05
lopinavir / Ritonavir,TREATS,Control Groups,32493466,10.1186/s12916-020-01615-9,2020-06-05
Coronavirus Infections,ISA,Disease,32493466,10.1186/s12916-020-01615-9,2020-06-05
Hospitalization,USES,"Oximetry, Pulse",32493466,10.1186/s12916-020-01615-9,2020-06-05
Laboratory Procedures,USES,"TNFRSF11A protein, human",32493466,10.1186/s12916-020-01615-9,2020-06-05
Interferon beta-1a,ADMINISTERED_TO,Patients,32493466,10.1186/s12916-020-01615-9,2020-06-05
Rest,TREATS,Patients,32493466,10.1186/s12916-020-01615-9,2020-06-05
United States National Institutes of Health,LOCATION_OF,Clinical Trials,32493466,10.1186/s12916-020-01615-9,2020-06-05
Interested,PROCESS_OF,Persons,32493459,10.1186/s13063-020-04387-y,2020-06-05
Current residence,PROCESS_OF,Participant,32493459,10.1186/s13063-020-04387-y,2020-06-05
Anti-Inflammatory Agents,CAUSES,Pneumonia,32493447,10.1186/s13063-020-04439-3,2020-06-05
Pneumonia,PROCESS_OF,Patients,32493447,10.1186/s13063-020-04439-3,2020-06-05
Pneumonia,PROCESS_OF,Patients,32493447,10.1186/s13063-020-04439-3,2020-06-05
Cell Therapy,TREATS,Patients,32493447,10.1186/s13063-020-04439-3,2020-06-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32493447,10.1186/s13063-020-04439-3,2020-06-05
Hospitals,LOCATION_OF,Double-Blind Method,32493443,10.1186/s13014-020-01579-3,2020-06-05
Hydroxychloroquine,compared_with,Placebos,32493443,10.1186/s13014-020-01579-3,2020-06-05
AKR1A1 wt Allele,INTERACTS_WITH,Hydroxychloroquine,32493443,10.1186/s13014-020-01579-3,2020-06-05
Dyspnea,ISA,Symptoms,32493443,10.1186/s13014-020-01579-3,2020-06-05
Fever,ISA,Symptoms,32493443,10.1186/s13014-020-01579-3,2020-06-05
Nausea,ISA,Symptoms,32493443,10.1186/s13014-020-01579-3,2020-06-05
Myalgia,ISA,Symptoms,32493443,10.1186/s13014-020-01579-3,2020-06-05
Drug Packaging,TREATS,Participant,32493443,10.1186/s13014-020-01579-3,2020-06-05
Malignant neoplasm of breast,PROCESS_OF,geriatric patients,32493441,10.1186/s13063-020-04453-5,2020-06-05
Hodgkin Disease,PROCESS_OF,geriatric patients,32493441,10.1186/s13063-020-04453-5,2020-06-05
Omission,PROCESS_OF,geriatric patients,32493441,10.1186/s13063-020-04453-5,2020-06-05
Coronavirus Infections,PROCESS_OF,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
Acute respiratory failure,PROCESS_OF,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
Cytokine release syndrome,PROCESS_OF,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
Ward (environment),LOCATION_OF,Study,32493409,10.1186/s12939-020-01199-z,2020-06-05
Medical Devices,USES,Oxygen,32493409,10.1186/s12939-020-01199-z,2020-06-05
Increased ferritin,COEXISTS_WITH,Cytokine release syndrome,32493409,10.1186/s12939-020-01199-z,2020-06-05
"Antibodies, Anti-Idiotypic",PART_OF,Chimera organism,32493409,10.1186/s12939-020-01199-z,2020-06-05
tocilizumab,COEXISTS_WITH,anakinra,32493409,10.1186/s12939-020-01199-z,2020-06-05
tocilizumab,COEXISTS_WITH,anakinra,32493409,10.1186/s12939-020-01199-z,2020-06-05
tocilizumab,COEXISTS_WITH,siltuximab,32493409,10.1186/s12939-020-01199-z,2020-06-05
anakinra,TREATS,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
anakinra,ADMINISTERED_TO,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
anakinra,ADMINISTERED_TO,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
tocilizumab,ADMINISTERED_TO,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
siltuximab,ADMINISTERED_TO,Patients,32493409,10.1186/s12939-020-01199-z,2020-06-05
Hospitals,LOCATION_OF,Nested Case-Control Studies,32493339,10.1186/s12961-020-00576-y,2020-06-05
Dyspnea,PROCESS_OF,Patients,32493339,10.1186/s12961-020-00576-y,2020-06-05
Hypertensive disease,PROCESS_OF,Patients,32493339,10.1186/s12961-020-00576-y,2020-06-05
Oxidoreductase,compared_with,C-reactive protein,32493339,10.1186/s12961-020-00576-y,2020-06-05
High Level,PROCESS_OF,Patients,32493339,10.1186/s12961-020-00576-y,2020-06-05
Exacerbation,PROCESS_OF,Patients,32493339,10.1186/s12961-020-00576-y,2020-06-05
High Level,PREDISPOSES,Exacerbation,32493339,10.1186/s12961-020-00576-y,2020-06-05
Anosmia,PROCESS_OF,Patients,32493174,10.1080/10872981.2020.1772014,2020-06-05
Sense of smell impaired,PROCESS_OF,Patients,32493174,10.1080/10872981.2020.1772014,2020-06-05
Coughing,PROCESS_OF,Patients,32493073,10.1177/2324709620931239,2020-06-05
Fever,PROCESS_OF,Patients,32493073,10.1177/2324709620931239,2020-06-05
Lung,LOCATION_OF,Coccidioidomycosis,32493073,10.1177/2324709620931239,2020-06-05
Virus,CAUSES,Pneumonia,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
heparin,TREATS,Erythema,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Lower Extremity,LOCATION_OF,Erythema,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Symptoms,NEG_PREDISPOSES,Deep Vein Thrombosis,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Iliac Vein,LOCATION_OF,Aneurysm,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Iliac Vein,LOCATION_OF,Thrombosis,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Bone structure of ilium,LOCATION_OF,Aneurysm,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Bone structure of ilium,LOCATION_OF,Thrombosis,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Structure of vein of lower extremity,LOCATION_OF,Color doppler ultrasound,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Color doppler ultrasound,DIAGNOSES,Aneurysm,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Color doppler ultrasound,DIAGNOSES,Thrombosis,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Awareness,PROCESS_OF,Medical Staff,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Symptoms,PROCESS_OF,Patients,32493070,10.1161/HYPERTENSIONAHA.120.15622,2020-06-05
Pseudostratified Epithelium,PART_OF,Airway structure,32493004,10.31616/asj.2020.0248,2020-06-05
Bronchioles,LOCATION_OF,Severe disorder,32493004,10.31616/asj.2020.0248,2020-06-05
ACE2 gene,INTERACTS_WITH,Type-II Pneumocytes,32493004,10.31616/asj.2020.0248,2020-06-05
Body Fluids,PART_OF,Alveolar,32493004,10.31616/asj.2020.0248,2020-06-05
Lung,LOCATION_OF,Residual Tumor,32493004,10.31616/asj.2020.0248,2020-06-05
Intervention regimes,AFFECTS,Neurologic Deficits,32492995,10.23736/S1121-421X.20.02713-0,2020-06-05
Coronavirus Infections,AFFECTS,Surgeon,32492995,10.23736/S1121-421X.20.02713-0,2020-06-05
Neurosurgical Procedures,AFFECTS,Coronavirus Infections,32492995,10.23736/S1121-421X.20.02713-0,2020-06-05
Surgeon,LOCATION_OF,IMPACT gene,32492995,10.23736/S1121-421X.20.02713-0,2020-06-05
Procedure on spinal cord (procedure),AFFECTS,Coronavirus Infections,32492995,10.23736/S1121-421X.20.02713-0,2020-06-05
Liver diseases,PROCESS_OF,Patients,32492991,10.37201/req/052.2020,2020-06-05
Patients,LOCATION_OF,CD40LG wt Allele,32492874,10.3390/jcm9061668,2020-06-05
Negative,PROCESS_OF,Persons,32492874,10.3390/jcm9061668,2020-06-05
Detection,USES,CD40LG wt Allele,32492874,10.3390/jcm9061668,2020-06-05
Vitamin supplementation,DISRUPTS,Influenza,32492787,10.3390/nu12061620,2020-06-05
Ergocalciferol,TREATS,Persons,32492787,10.3390/nu12061620,2020-06-05
Coronavirus Infections,AFFECTS,Reduced physical activity levels,32492764,10.1111/ene.14375,2020-06-04
Reduced physical activity levels,PROCESS_OF,general population,32492764,10.1111/ene.14375,2020-06-04
Cerebrovascular accident,PROCESS_OF,Neurologists,32492760,10.1111/acem.14039,2020-06-04
Transient Ischemic Attack,PROCESS_OF,Patients,32492760,10.1111/acem.14039,2020-06-04
Cerebrovascular accident,PROCESS_OF,Patients,32492760,10.1111/acem.14039,2020-06-04
Cerebrovascular accident,PROCESS_OF,Patients,32492760,10.1111/acem.14039,2020-06-04
Cerebrovascular accident,PROCESS_OF,Neurologists,32492760,10.1111/acem.14039,2020-06-04
Cerebrovascular accident,PROCESS_OF,Community,32492760,10.1111/acem.14039,2020-06-04
Health Personnel,ISA,Persons,32492745,10.1055/a-1158-5756,2020-06-04
Stress,COEXISTS_WITH,Pneumonia,32492743,10.1055/a-1114-3699,2020-06-04
Troponin,PART_OF,Heart,32492743,10.1055/a-1114-3699,2020-06-04
myocardial injury,COEXISTS_WITH,Pneumonia,32492743,10.1055/a-1114-3699,2020-06-04
Stress,COEXISTS_WITH,Pneumonia,32492743,10.1055/a-1114-3699,2020-06-04
Cardiovascular,LOCATION_OF,Comorbidity,32492743,10.1055/a-1114-3699,2020-06-04
China,ISA,Geographic Locations,32492721,10.1055/s-0040-1713020,2020-06-04
Excretory function,PROCESS_OF,Persons,32492721,10.1055/s-0040-1713020,2020-06-04
Asymptomatic,PROCESS_OF,Persons,32492721,10.1055/s-0040-1713020,2020-06-04
Oropharyngeal,LOCATION_OF,Nasal Swab (procedure),32492712,10.1182/blood.2020006520,2020-06-04
Infected,PROCESS_OF,Persons,32492712,10.1182/blood.2020006520,2020-06-04
saliva,LOCATION_OF,angiotensin converting enzyme 2,32492712,10.1182/blood.2020006520,2020-06-04
D-dimer above reference range,PROCESS_OF,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
D-dimer above reference range,PREDISPOSES,Complication,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
C-reactive protein,TREATS,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Complication,PROCESS_OF,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Ferritin,TREATS,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Ferritin,TREATS(INFER),Complication,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Fibrinogen,TREATS,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
procalcitonin,TREATS,Patients,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Hemorrhage,COEXISTS_WITH,patient condition,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
"Clinical Trials, Randomized",MEASURES,benefit,32492613,10.1016/j.scitotenv.2020.139658,2020-06-04
Obesity,PROCESS_OF,Persons,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Organ,LOCATION_OF,Chronic inflammatory disorder,32492560,10.1016/j.mehy.2020.109843,2020-06-04
SARS coronavirus,CAUSES,Immune response,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Pharmaceutical Preparations,INHIBITS,Behavior showing increased motor activity,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Severe (severity modifier),PREDISPOSES,Prognosis bad,32492560,10.1016/j.mehy.2020.109843,2020-06-04
montelukast,ISA,Leukotriene Antagonists,32492560,10.1016/j.mehy.2020.109843,2020-06-04
montelukast,TREATS(SPEC),Asthma,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Leukotriene Antagonists,TREATS,Asthma,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Inflammatory cell,LOCATION_OF,"IL5 protein, human",32492560,10.1016/j.mehy.2020.109843,2020-06-04
Homo sapiens,LOCATION_OF,Interleukin-1,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Homo sapiens,LOCATION_OF,Interleukin-8,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Viral upper respiratory tract infection,PROCESS_OF,Homo sapiens,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Patient Discharge,TREATS,Patients,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Patient Discharge,TREATS(INFER),Syndrome,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Patient Discharge,TREATS(INFER),"Obesity, Abdominal",32492560,10.1016/j.mehy.2020.109843,2020-06-04
Syndrome,PROCESS_OF,Patients,32492560,10.1016/j.mehy.2020.109843,2020-06-04
montelukast,PREVENTS,multiorgan damage,32492560,10.1016/j.mehy.2020.109843,2020-06-04
"Obesity, Abdominal",PROCESS_OF,Patients,32492560,10.1016/j.mehy.2020.109843,2020-06-04
Diethylcarbamazine,DISRUPTS,arachidonic acid metabolic process,32492559,10.1016/j.mehy.2020.109853,2020-06-04
Retroviridae,LOCATION_OF,Prostaglandins,32492559,10.1016/j.mehy.2020.109853,2020-06-04
arachidonic acid metabolic process,PROCESS_OF,Animal Model,32492559,10.1016/j.mehy.2020.109853,2020-06-04
Isolation procedure,ADMINISTERED_TO,World,32492557,10.1016/j.clinimag.2020.05.021,2020-06-04
Intervention regimes,TREATS,Psoriasis,32492557,10.1016/j.clinimag.2020.05.021,2020-06-04
Exercise,CAUSES,Worse,32492557,10.1016/j.clinimag.2020.05.021,2020-06-04
Isolation procedure,TREATS,Dermatologist,32492557,10.1016/j.clinimag.2020.05.021,2020-06-04
Quarantine,AFFECTS,Dermatologic disorders,32492557,10.1016/j.clinimag.2020.05.021,2020-06-04
Coronavirus Infections,ISA,Disease,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Abdominal symptom,PROCESS_OF,Patients,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Coronavirus Infections,ISA,Disease,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Basal segment of lung,LOCATION_OF,Incidental Findings,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Abdominal symptom,PROCESS_OF,Patients,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Parenchyma,LOCATION_OF,Incidental Findings,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Abdomen,LOCATION_OF,Chief complaint (finding),32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Lung,LOCATION_OF,Widespread Disease,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Widespread Disease,PROCESS_OF,Patients,32492533,10.1016/j.ijid.2020.05.107,2020-06-04
Coronavirus Infections,ISA,Disease,32492531,10.1016/j.ijid.2020.05.099,2020-06-04
Coronavirus Infections,ISA,Disease,32492531,10.1016/j.ijid.2020.05.099,2020-06-04
disease transmission,PRECEDES,Disease,32492531,10.1016/j.ijid.2020.05.099,2020-06-04
disease transmission,PRECEDES(SPEC),Coronavirus Infections,32492531,10.1016/j.ijid.2020.05.099,2020-06-04
Coronavirus Infections,ISA,Disease,32492531,10.1016/j.ijid.2020.05.099,2020-06-04
Diagnosis,DIAGNOSES,SARS coronavirus,32492530,10.1016/j.ijid.2020.05.106,2020-06-04
Infection,COEXISTS_WITH,Crisis,32492485,10.1016/j.tmaid.2020.101754,2020-06-04
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Asymptomatic,32492407,10.1016/j.cell.2020.05.041,2020-06-04
Asymptomatic,PROCESS_OF,Persons,32492407,10.1016/j.cell.2020.05.041,2020-06-04
Asymptomatic Infections,PROCESS_OF,Elderly (population group),32492407,10.1016/j.cell.2020.05.041,2020-06-04
Symptom severe,PROCESS_OF,Elderly (population group),32492407,10.1016/j.cell.2020.05.041,2020-06-04
Pandemics,CAUSES,Syndrome,32492406,10.1016/j.cell.2020.05.032,2020-06-04
Serum,PART_OF,Patients,32492354,10.1513/AnnalsATS.202005-478SD,2020-06-04
Serum,LOCATION_OF,Metabolite,32492354,10.1513/AnnalsATS.202005-478SD,2020-06-04
Serum,PART_OF,Patients,32492354,10.1513/AnnalsATS.202005-478SD,2020-06-04
Disease,PROCESS_OF,Patients,32492293,10.1056/NEJMoa2016638,2020-06-04
Hydroxychloroquine,compared_with,Placebos,32492293,10.1056/NEJMoa2016638,2020-06-04
Hydroxychloroquine,TREATS,Adult,32492293,10.1056/NEJMoa2016638,2020-06-04
Placebos,TREATS,Adult,32492293,10.1056/NEJMoa2016638,2020-06-04
Hydroxychloroquine,TREATS,Adult,32492293,10.1056/NEJMoa2016638,2020-06-04
Hydroxychloroquine,TREATS(INFER),Patient in hospital,32492293,10.1056/NEJMoa2016638,2020-06-04
Patient in hospital,PROCESS_OF,Adult,32492293,10.1056/NEJMoa2016638,2020-06-04
Hydroxychloroquine,ADMINISTERED_TO,Participant,32492292,10.1002/kjm2.12237,2020-06-04
Placebos,ADMINISTERED_TO,Participant,32492292,10.1002/kjm2.12237,2020-06-04
Asymptomatic,PROCESS_OF,Participant,32492292,10.1002/kjm2.12237,2020-06-04
Hydroxychloroquine,ADMINISTERED_TO,Participant,32492292,10.1002/kjm2.12237,2020-06-04
Hydroxychloroquine,compared_with,Placebos,32492292,10.1002/kjm2.12237,2020-06-04
Hydroxychloroquine,higher_than,Placebos,32492292,10.1002/kjm2.12237,2020-06-04
angiotensin converting enzyme 2,AFFECTS,Down-Regulation,32492290,10.1002/kjm2.12239,2020-06-04
Comorbidity,PROCESS_OF,Patients,32492290,10.1002/kjm2.12239,2020-06-04
Does hit (finding),PROCESS_OF,Patients,32492290,10.1002/kjm2.12239,2020-06-04
Fever,ISA,Symptoms,32492212,10.1002/jmv.26114,2020-06-04
Pneumonia,PROCESS_OF,Child,32492212,10.1002/jmv.26114,2020-06-04
Fever,PROCESS_OF,Child,32492212,10.1002/jmv.26114,2020-06-04
"Signs and Symptoms, Respiratory",PROCESS_OF,Child,32492212,10.1002/jmv.26114,2020-06-04
Hospitals,LOCATION_OF,Cross-Sectional Studies,32492209,10.1002/jmv.26106,2020-06-04
Detection,COEXISTS_WITH,Hospitalization,32492209,10.1002/jmv.26106,2020-06-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32492206,10.1002/jmv.26115,2020-06-04
Pneumonia,PROCESS_OF,Patients,32492206,10.1002/jmv.26115,2020-06-04
Pneumonia,PROCESS_OF,Patients,32492206,10.1002/jmv.26115,2020-06-04
United Kingdom,ISA,European country,32492205,10.1002/jmv.26129,2020-06-04
Antiviral Agents,TREATS,Patients,32492203,10.1002/jmv.26107,2020-06-04
Antiviral Agents,TREATS,Patients,32492203,10.1002/jmv.26107,2020-06-04
GSKIP gene,INTERACTS_WITH(INFER),Antiviral Agents,32492203,10.1002/jmv.26107,2020-06-04
GSKIP gene,PART_OF,Patients,32492203,10.1002/jmv.26107,2020-06-04
Virus,PROCESS_OF,Patients,32492203,10.1002/jmv.26107,2020-06-04
"Psychotherapy, Multiple",ADMINISTERED_TO,Patients,32492203,10.1002/jmv.26107,2020-06-04
"Genes, Viral",ASSOCIATED_WITH,Malignant neoplasm of lung,32492197,10.1002/jmv.26123,2020-06-04
Enzymes,ASSOCIATED_WITH,Adenocarcinoma,32492197,10.1002/jmv.26123,2020-06-04
Enzymes,ASSOCIATED_WITH,Squamous cell carcinoma,32492197,10.1002/jmv.26123,2020-06-04
Lung,LOCATION_OF,Adenocarcinoma,32492197,10.1002/jmv.26123,2020-06-04
Lung,LOCATION_OF,Squamous cell carcinoma,32492197,10.1002/jmv.26123,2020-06-04
Lung,LOCATION_OF,Adenocarcinoma,32492197,10.1002/jmv.26123,2020-06-04
Angiotensin converting enzyme measurement,DIAGNOSES,Adenocarcinoma,32492197,10.1002/jmv.26123,2020-06-04
Genome,ASSOCIATED_WITH,Malignant neoplasm of lung,32492197,10.1002/jmv.26123,2020-06-04
Laboratory,LOCATION_OF,research study,32492197,10.1002/jmv.26123,2020-06-04
Coronavirus Infections,ISA,Disease,32492196,10.1002/jmv.26116,2020-06-04
Coronavirus Infections,ISA,Disease,32492196,10.1002/jmv.26116,2020-06-04
World,ISA,Population Group,32492196,10.1002/jmv.26116,2020-06-04
Coronavirus Infections,ISA,Disease,32492196,10.1002/jmv.26116,2020-06-04
Symptoms,PROCESS_OF,Patients,32492188,10.1002/jmv.26102,2020-06-04
pulmonary involvement,PROCESS_OF,Patients,32492188,10.1002/jmv.26102,2020-06-04
Body tissue,PART_OF,Lung,32492188,10.1002/jmv.26102,2020-06-04
Organ,PART_OF,Homo sapiens,32492188,10.1002/jmv.26102,2020-06-04
HIV viral load,DIAGNOSES,Fourth Stage of Labor,32492183,10.1002/jmv.26104,2020-06-04
Detection,PRECEDES,Antiretroviral therapy,32492183,10.1002/jmv.26104,2020-06-04
HIV,PROCESS_OF,Patients,32492183,10.1002/jmv.26104,2020-06-04
HIV,PROCESS_OF,Patients,32492183,10.1002/jmv.26104,2020-06-04
Italy,ISA,Country,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Glycoproteins,COEXISTS_WITH,Isolate - microorganism,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Glycoproteins,LOCATION_OF,Mutation,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Mutation,AFFECTS,viral transmission,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Nucleocapsid,COEXISTS_WITH,Isolate - microorganism,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Nucleocapsid,LOCATION_OF,Mutation,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Isolate - microorganism,PART_OF,Italians,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Virus,PROCESS_OF,Patients,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Viral Proteins,COEXISTS_WITH,Isolate - microorganism,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Isolate - microorganism,PART_OF,Italians,32492165,10.1001/jamanetworkopen.2020.10895,2020-06-04
Tumor Necrosis Factors,compared_with,Interferons,32492144,10.1093/infdis/jiaa303,2020-06-04
Inflammation,OCCURS_IN,Patients,32492144,10.1093/infdis/jiaa303,2020-06-04
Lymphopenia,PROCESS_OF,Adult,32492144,10.1093/infdis/jiaa303,2020-06-04
inflammatory response,PROCESS_OF,Adult,32492144,10.1093/infdis/jiaa303,2020-06-04
Health Care,TREATS,Child,32492117,10.1093/cid/ciaa710,2020-06-04
Symptom mild,PROCESS_OF,Child,32492117,10.1093/cid/ciaa710,2020-06-04
Vaccines,TREATS,Child,32492117,10.1093/cid/ciaa710,2020-06-04
Protection,PROCESS_OF,Community,32492117,10.1093/cid/ciaa710,2020-06-04
Common Cold,ISA,Gastroenteritis,32492092,10.1001/jamapediatrics.2020.2430,2020-06-04
emergency visit,TREATS,Communicable Diseases,32492092,10.1001/jamapediatrics.2020.2430,2020-06-04
Fever,PROCESS_OF,Patients,32492084,10.1001/jama.2020.10044,2020-06-04
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32492084,10.1001/jama.2020.10044,2020-06-04
Severe disorder,PROCESS_OF,Infant,32492084,10.1001/jama.2020.10044,2020-06-04
Mechanical ventilation,AFFECTS,Obesity,32492084,10.1001/jama.2020.10044,2020-06-04
Hydroxychloroquine,ADMINISTERED_TO,Patients,32492084,10.1001/jama.2020.10044,2020-06-04
Immunocompromised Host,NEG_PREDISPOSES,Severe disorder,32492084,10.1001/jama.2020.10044,2020-06-04
Medical center,LOCATION_OF,"Clinical Trials, Randomized",32492045,10.1371/journal.pone.0234025,2020-06-04
Adverse event,AFFECTS,Patients,32492045,10.1371/journal.pone.0234025,2020-06-04
Adverse event,PROCESS_OF,Patients,32492045,10.1371/journal.pone.0234025,2020-06-04
Respiratory Tract Infections,PROCESS_OF,Health Personnel,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,compared_with,Surgical face mask,32491984,10.3201/eid2609.202059,2020-06-04
Prophylactic treatment,USES,Mechanical Ventilator,32491984,10.3201/eid2609.202059,2020-06-04
Prophylactic treatment,USES,Surgical face mask,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,PREVENTS,Clinical infection,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,compared_with,Surgical face mask,32491984,10.3201/eid2609.202059,2020-06-04
Surgical face mask,PREVENTS,Clinical infection,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,TREATS,Protection,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,compared_with,Surgical face mask,32491984,10.3201/eid2609.202059,2020-06-04
Mechanical Ventilator,higher_than,Surgical face mask,32491984,10.3201/eid2609.202059,2020-06-04
Surgical face mask,TREATS,Protection,32491984,10.3201/eid2609.202059,2020-06-04
Protection,PROCESS_OF,Health Personnel,32491984,10.3201/eid2609.202059,2020-06-04
Parotitis,ISA,Inflammation,32491983,10.3201/eid2609.201524,2020-06-04
Parotitis,PROCESS_OF,Patients,32491983,10.3201/eid2609.201524,2020-06-04
Coronavirus Infections,ISA,Disease,32491983,10.3201/eid2609.201524,2020-06-04
Parotid salivary apparatus,LOCATION_OF,Inflammation,32491983,10.3201/eid2609.201524,2020-06-04
Parotid salivary apparatus,LOCATION_OF(SPEC),Parotitis,32491983,10.3201/eid2609.201524,2020-06-04
Lymphadenitis,CAUSES,Parotitis,32491983,10.3201/eid2609.201524,2020-06-04
Symptom mild,PROCESS_OF,Adult,32491919,10.7326/M20-3012,2020-06-04
Lung Injury,PROCESS_OF,Child,32491919,10.7326/M20-3012,2020-06-04
Virus Internalization,PROCESS_OF,Child,32491919,10.7326/M20-3012,2020-06-04
Infected,PROCESS_OF,Persons,32491888,10.1063/5.0008834,2020-06-04
Asymptomatic,PROCESS_OF,Persons,32491888,10.1063/5.0008834,2020-06-04
Congenital anomaly of lung,COEXISTS_WITH,Asymptomatic Infections,32491888,10.1063/5.0008834,2020-06-04
Asymptomatic,PROCESS_OF,Persons,32491888,10.1063/5.0008834,2020-06-04
Detected (finding),PROCESS_OF,Patients,32491829,10.1021/acschemneuro.0c00251,2020-06-04
Fever,ISA,Symptoms,32491306,10.5935/1518-0557.20200046,2020-06-04
acute pneumonia,ISA,Symptoms,32491306,10.5935/1518-0557.20200046,2020-06-04
Dry cough,ISA,Symptoms,32491306,10.5935/1518-0557.20200046,2020-06-04
Epithelial Cells,PRODUCES,angiotensin converting enzyme 2,32491306,10.5935/1518-0557.20200046,2020-06-04
Organ,LOCATION_OF,Respiratory viruses,32491306,10.5935/1518-0557.20200046,2020-06-04
Coronavirus Infections,PROCESS_OF,Family,32491298,10.20452/pamw.15414,2020-06-04
"Pneumonia, Viral",AFFECTS,Poor outcome,32491298,10.20452/pamw.15414,2020-06-04
"Pneumonia, Viral",COEXISTS_WITH,Coughing,32491298,10.20452/pamw.15414,2020-06-04
"Pneumonia, Viral",COEXISTS_WITH,Fever,32491298,10.20452/pamw.15414,2020-06-04
Supportive care,TREATS,Patients,32491298,10.20452/pamw.15414,2020-06-04
brazilian,PROCESS_OF,Population Group,32491298,10.20452/pamw.15414,2020-06-04
Taste Disorders,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Taste Disorders,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Patient Self-Report,MEASURES,Communicable Diseases,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Chronic disease,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Diabetes,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Hypertensive disease,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Taste Disorders,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Taste Disorders,PROCESS_OF,Woman,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Taste Disorders,PROCESS_OF,Patients,32491297,10.23736/S0026-4806.20.06702-6,2020-06-04
Evaluation,USES,Magnetic Resonance Imaging,32491254,10.1111/ced.14319,2020-06-04
Evaluation,USES,Chest CT,32491254,10.1111/ced.14319,2020-06-04
Household composition,PROCESS_OF,Persons,32491199,10.1111/trf.15921,2020-06-04
Laboratory Procedures,USES,Nasal Swab (procedure),32491178,10.1093/infdis/jiaa301,2020-06-04
Fever,PROCESS_OF,Plasma donor,32491178,10.1093/infdis/jiaa301,2020-06-04
Plasmapheresis,METHOD_OF,Routine procedure,32491178,10.1093/infdis/jiaa301,2020-06-04
Ergocalciferol,PREVENTS,Acute respiratory infections,32491104,10.1590/0037-8682-0227-2020,2020-06-04
Plasma,LOCATION_OF,Ergocalciferol,32491104,10.1590/0037-8682-0227-2020,2020-06-04
Serum,LOCATION_OF,Ergocalciferol,32491104,10.1590/0037-8682-0227-2020,2020-06-04
Rickets,PROCESS_OF,Woman,32491104,10.1590/0037-8682-0227-2020,2020-06-04
Ergocalciferol,TREATS,Communicable Diseases,32491104,10.1590/0037-8682-0227-2020,2020-06-04
Thrombophilia,PROCESS_OF,Patients,32491098,10.1590/0037-8682-0287-2020,2020-06-04
Acute pulmonary embolism,PROCESS_OF,Patients,32491098,10.1590/0037-8682-0287-2020,2020-06-04
Lung,LOCATION_OF,Computed Tomography Angiography,32491098,10.1590/0037-8682-0287-2020,2020-06-04
Anchoring procedure,COEXISTS_WITH,Health belief model,32491091,10.11606/s1518-8787.2020054002596,2020-06-04
Anchoring procedure,TREATS,Coronavirus Infections,32491091,10.11606/s1518-8787.2020054002596,2020-06-04
Subgroup A Nepoviruses,PROCESS_OF,Adult,32491075,10.36660/abc.20200243,2020-06-04
Complication,ISA,Disease,32491073,10.36660/abc.20200273,2020-06-04
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Disease,32491073,10.36660/abc.20200273,2020-06-04
Cardiovascular,LOCATION_OF,Comorbidity,32491053,10.11606/s1518-8787.2020054002577,2020-06-04
Angiotensin-Converting Enzyme Inhibitors,TREATS,Heart failure,32491053,10.11606/s1518-8787.2020054002577,2020-06-04
Angiotensin-Converting Enzyme Inhibitors,TREATS,Hypertensive disease,32491053,10.11606/s1518-8787.2020054002577,2020-06-04
Angiotensin II receptor antagonist,TREATS,Heart failure,32491053,10.11606/s1518-8787.2020054002577,2020-06-04
Angiotensin II receptor antagonist,TREATS,Hypertensive disease,32491053,10.11606/s1518-8787.2020054002577,2020-06-04
Non-communicable Chronic Diseases,COEXISTS_WITH,Disease,32491028,10.1590/0100-6991e-20202576,2020-06-04
Disease,PROCESS_OF,Patients,32490972,10.5935/0004-2749.20200067,2020-06-04
Cerebrovascular Disorders,ISA,Disease,32490931,10.6061/clinics/2020/e1980,2020-06-04
Myalgia,ISA,Symptoms,32490931,10.6061/clinics/2020/e1980,2020-06-04
Sense of smell impaired,ISA,Symptoms,32490931,10.6061/clinics/2020/e1980,2020-06-04
Estradiol,TREATS,Patients,32490918,10.1590/0102-311x00090520,2020-06-04
Hypoxemia,PROCESS_OF,Patients,32490918,10.1590/0102-311x00090520,2020-06-04
Structure of arteriole,LOCATION_OF,Fibrin blood clot,32490918,10.1590/0102-311x00090520,2020-06-04
Structure of arteriole,PART_OF,Lung,32490918,10.1590/0102-311x00090520,2020-06-04
Lung,LOCATION_OF,Virus Diseases,32490918,10.1590/0102-311x00090520,2020-06-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32490918,10.1590/0102-311x00090520,2020-06-04
Estradiol,AFFECTS,Immune response,32490918,10.1590/0102-311x00090520,2020-06-04
Endothelium,LOCATION_OF,Estradiol,32490918,10.1590/0102-311x00090520,2020-06-04
Nitric Oxide,INTERACTS_WITH,"NOS3 protein, human",32490918,10.1590/0102-311x00090520,2020-06-04
Estrogens,AUGMENTS,Vasodilation,32490918,10.1590/0102-311x00090520,2020-06-04
Response process,ASSOCIATED_WITH,Lung diseases,32490918,10.1590/0102-311x00090520,2020-06-04
Immunologic Adjuvants,TREATS,Patients,32490918,10.1590/0102-311x00090520,2020-06-04
Coronavirus Infections,AFFECTS,Patients,32490918,10.1590/0102-311x00090520,2020-06-04
Pneumonia,PROCESS_OF,Patients,32490892,10.1590/0100-6991e-20202568,2020-06-04
29+,PROCESS_OF,Health Personnel,32490891,10.1590/0100-6991e-20202595,2020-06-04
Chest Tubes,TREATS,Patients,32490891,10.1590/0100-6991e-20202595,2020-06-04
Infected,PROCESS_OF,Persons,32490890,10.5935/0103-507x.20200028,2020-06-04
Thrombus,PROCESS_OF,Cohort,32490890,10.5935/0103-507x.20200028,2020-06-04
Dental Clinics,LOCATION_OF,Study,32490854,10.1039/d0an00538j,2020-06-04
MicroRNAs,ISA,"RNA, Small Untranslated",32490853,10.1039/d0lc00373e,2020-06-04
Liquid Biopsy,METHOD_OF,Screening for cancer,32490853,10.1039/d0lc00373e,2020-06-04
Malignant neoplasm of urinary bladder,PROCESS_OF,Patients,32490853,10.1039/d0lc00373e,2020-06-04
Plasma,PART_OF,Patients,32490853,10.1039/d0lc00373e,2020-06-04
Virus,CAUSES,Disease,32490846,10.2196/19509,2020-06-04
Virus,CAUSES(SPEC),Coronavirus Infections,32490846,10.2196/19509,2020-06-04
Coronavirus Infections,ISA,Disease,32490846,10.2196/19509,2020-06-04
Amino-terminal pro-brain natriuretic peptide,ISA,pro-brain natriuretic peptide (1-76),32490846,10.2196/19509,2020-06-04
Disease,PROCESS_OF,hospitalized patients,32490846,10.2196/19509,2020-06-04
Comorbidity,PROCESS_OF,Patients,32490846,10.2196/19509,2020-06-04
Heart,LOCATION_OF,Comorbidity,32490846,10.2196/19509,2020-06-04
Coronavirus Infections,ISA,Disease,32490846,10.2196/19509,2020-06-04
Coronavirus Infections,ISA,Disease,32490846,10.2196/19509,2020-06-04
Household composition,PROCESS_OF,Patients,32490846,10.2196/19509,2020-06-04
Problem,COEXISTS_WITH,Symptoms,32490845,10.2196/20696,2020-06-04
Symptoms,COEXISTS_WITH,Problem,32490845,10.2196/20696,2020-06-04
Coronavirus Infections,ISA,Disease,32490845,10.2196/20696,2020-06-04
Coronavirus Infections,ISA,Disease,32490845,10.2196/20696,2020-06-04
Symptoms,ASSOCIATED_WITH,Disease,32490845,10.2196/20696,2020-06-04
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32490845,10.2196/20696,2020-06-04
Coronavirus Infections,ISA,Disease,32490845,10.2196/20696,2020-06-04
Symptoms,ASSOCIATED_WITH,Disease,32490845,10.2196/20696,2020-06-04
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32490845,10.2196/20696,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
mental health,PROCESS_OF,Cohort,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
Study,MEASURES,Disease,32490843,10.2196/19938,2020-06-04
Study,MEASURES(SPEC),Coronavirus Infections,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490843,10.2196/19938,2020-06-04
Coronavirus Infections,ISA,Disease,32490842,10.2196/19825,2020-06-04
Coronavirus Infections,ISA,Disease,32490839,10.2196/20021,2020-06-04
Perception,PROCESS_OF,citizen,32490839,10.2196/20021,2020-06-04
Coronavirus Infections,ISA,Disease,32490839,10.2196/20021,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Coronavirus Infections,ISA,Disease,32490829,10.5152/dir.2020.20144,2020-06-04
Self Confidence,PROCESS_OF,Health Personnel,32490829,10.5152/dir.2020.20144,2020-06-04
tomography,DIAGNOSES,Disease,32490743,10.1177/0025817220926943,2020-06-04
Laboratory Procedures,METHOD_OF,tomography,32490743,10.1177/0025817220926943,2020-06-04
tomography,DIAGNOSES,Disease,32490743,10.1177/0025817220926943,2020-06-04
tomography,DIAGNOSES,Ground Glass Opacity,32490743,10.1177/0025817220926943,2020-06-04
Physical findings,PROCESS_OF,Patients,32490743,10.1177/0025817220926943,2020-06-04
Non-Ossifying Fibroma,PROCESS_OF,Patients,32490743,10.1177/0025817220926943,2020-06-04
tomography,DIAGNOSES,Disease,32490743,10.1177/0025817220926943,2020-06-04
High sensitivity,DIAGNOSES,Disease,32490743,10.1177/0025817220926943,2020-06-04
tomography,ISA,Evaluation,32490743,10.1177/0025817220926943,2020-06-04
Adverse reactions,PROCESS_OF,Employer,32490731,10.1080/22221751.2020.1776161,2020-06-04
Severe Acute Respiratory Syndrome,CAUSES,Patient Discharge,32490723,10.1080/21505594.2020.1771980,2020-06-04
Severe Acute Respiratory Syndrome,COMPLICATES,"Pneumonia, Interstitial",32490723,10.1080/21505594.2020.1771980,2020-06-04
Early Therapy,USES,Immunologic Adjuvants,32490723,10.1080/21505594.2020.1771980,2020-06-04
Diarrhea,ISA,Gastrointestinal Diseases,32490720,10.1177/0025817220926926,2020-06-04
Palliative Care,TREATS,Patients,32490715,10.1177/1470320320928872,2020-06-04
Telemedicine,TREATS,Legal investigation,32490715,10.1177/1470320320928872,2020-06-04
Coronavirus Infections,PROCESS_OF,Family member,32490713,10.1177/0025817220926942,2020-06-04
Body tissue,PART_OF,Lung,32490713,10.1177/0025817220926942,2020-06-04
Epithelial Cells,LOCATION_OF,"CD69 protein, human",32490713,10.1177/0025817220926942,2020-06-04
Epithelial Cells,PART_OF,Lung,32490713,10.1177/0025817220926942,2020-06-04
Epithelial Cells,PART_OF,Lung,32490713,10.1177/0025817220926942,2020-06-04
Coronavirus Infections,PROCESS_OF,Family member,32490713,10.1177/0025817220926942,2020-06-04
"CD69 protein, human",COEXISTS_WITH,NRAS gene,32490713,10.1177/0025817220926942,2020-06-04
Italy,ISA,Country,32490689,10.1080/13548506.2020.1776891,2020-06-04
Smartphone,ISA,Telephone,32490689,10.1080/13548506.2020.1776891,2020-06-04
Coronavirus Infections,PROCESS_OF,Patients,32490640,10.3906/sag-2004-332,2020-06-04
Tachycardia,PROCESS_OF,Patients,32490640,10.3906/sag-2004-332,2020-06-04
Fibrin fragment D,ISA,Fibrinogen,32490640,10.3906/sag-2004-332,2020-06-04
Pneumonia,COEXISTS_WITH,Problem,32490639,10.3906/sag-2005-230,2020-06-04
Pneumonia,ISA,Disease,32490639,10.3906/sag-2005-230,2020-06-04
Pneumonia,ISA,Disease,32490639,10.3906/sag-2005-230,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Health Care Organization,LOCATION_OF,Study,32490556,10.1002/hpm.2991,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Developmental Disabilities,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Chronically Ill,PROCESS_OF,Persons,32490556,10.1002/hpm.2991,2020-06-04
Coronavirus Infections,ISA,Disease,32490519,10.1093/pubmed/fdaa069,2020-06-04
Asymptomatic,PROCESS_OF,Health Personnel,32490519,10.1093/pubmed/fdaa069,2020-06-04
Adverse event,PROCESS_OF,Participant,32490519,10.1093/pubmed/fdaa069,2020-06-04
Hydroxychloroquine,TREATS,Cardiovascular Diseases,32490519,10.1093/pubmed/fdaa069,2020-06-04
Adverse event,AFFECTS,Patients,32490519,10.1093/pubmed/fdaa069,2020-06-04
ST segment elevation myocardial infarction,ISA,Disease,32490453,10.1039/d0fd90009e,2020-06-04
Diabetes Mellitus,PROCESS_OF,Patients,32490453,10.1039/d0fd90009e,2020-06-04
Hypertensive disease,PROCESS_OF,Patients,32490453,10.1039/d0fd90009e,2020-06-04
"Pneumonia, Viral",ISA,Symptoms,32490453,10.1039/d0fd90009e,2020-06-04
Chest Pain,PROCESS_OF,Patients,32490453,10.1039/d0fd90009e,2020-06-04
Stress,PROCESS_OF,Patients,32490453,10.1039/d0fd90009e,2020-06-04
Coronary artery,LOCATION_OF,Thrombosis,32490453,10.1039/d0fd90009e,2020-06-04
High Level,CAUSES,Thrombosis,32490453,10.1039/d0fd90009e,2020-06-04
High Level,COEXISTS_WITH,ST segment elevation myocardial infarction,32490453,10.1039/d0fd90009e,2020-06-04
Coronavirus Infections,ISA,Disease,32489929,10.21037/qims-20-564,2020-06-04
Coronavirus Infections,ISA,Disease,32489929,10.21037/qims-20-564,2020-06-04
Coronavirus Infections,ISA,Disease,32489929,10.21037/qims-20-564,2020-06-04
Coronavirus Infections,ISA,Disease,32489929,10.21037/qims-20-564,2020-06-04
Coronavirus Infections,ISA,Disease,32489929,10.21037/qims-20-564,2020-06-04
Lung,LOCATION_OF,Abnormal,32489928,10.21037/qims.2020.04.11,2020-06-04
Chest CT,DIAGNOSES,Disease,32489928,10.21037/qims.2020.04.11,2020-06-04
Chest CT,DIAGNOSES,Detected (finding),32489928,10.21037/qims.2020.04.11,2020-06-04
Lung,LOCATION_OF,Lesion,32489928,10.21037/qims.2020.04.11,2020-06-04
Chest,LOCATION_OF,CAT scan normal,32489928,10.21037/qims.2020.04.11,2020-06-04
Chest CT,DIAGNOSES,patient condition,32489928,10.21037/qims.2020.04.11,2020-06-04
Challenge,TREATS,Disease,32489804,10.5334/gh.778,2020-06-04
Ligation,TREATS,Patients,32489743,10.7759/cureus.7889,2020-06-04
Ligation,TREATS(INFER),Cirrhosis,32489743,10.7759/cureus.7889,2020-06-04
Ligation,USES,Bands,32489743,10.7759/cureus.7889,2020-06-04
Cirrhosis,COEXISTS_WITH,Acute hemorrhage,32489743,10.7759/cureus.7889,2020-06-04
Cirrhosis,PROCESS_OF,Patients,32489743,10.7759/cureus.7889,2020-06-04
neurological complication,PROCESS_OF,Patients,32489730,10.7759/cureus.7876,2020-06-04
Neurological morbidity,PROCESS_OF,Patients,32489730,10.7759/cureus.7876,2020-06-04
Muscle,LOCATION_OF,skeletal injury,32489730,10.7759/cureus.7876,2020-06-04
Virus Diseases,PROCESS_OF,Patients,32489730,10.7759/cureus.7876,2020-06-04
Encephalopathies,ISA,Symptoms,32489711,10.14336/AD.2020.0502,2020-06-04
Abnormal mental state,PROCESS_OF,Patients,32489711,10.14336/AD.2020.0502,2020-06-04
Hypertensive disease,ISA,Cardiovascular Diseases,32489708,10.14336/AD.2020.0317,2020-06-04
patient condition,COEXISTS_WITH,Cardiovascular Diseases,32489708,10.14336/AD.2020.0317,2020-06-04
patient condition,COEXISTS_WITH,Diabetes,32489708,10.14336/AD.2020.0317,2020-06-04
patient condition,COEXISTS_WITH,Hypertensive disease,32489708,10.14336/AD.2020.0317,2020-06-04
patient condition,COEXISTS_WITH,Chronic lung disease,32489708,10.14336/AD.2020.0317,2020-06-04
Diabetes,ISA,Metabolic Diseases,32489708,10.14336/AD.2020.0317,2020-06-04
Heart,LOCATION_OF,Metabolic Diseases,32489708,10.14336/AD.2020.0317,2020-06-04
Heart,LOCATION_OF(SPEC),Diabetes,32489708,10.14336/AD.2020.0317,2020-06-04
Chronic lung disease,COEXISTS_WITH,patient condition,32489708,10.14336/AD.2020.0317,2020-06-04
Patients,USES,Preexisting Condition Coverage,32489708,10.14336/AD.2020.0317,2020-06-04
Active Method,TREATS,Patients,32489708,10.14336/AD.2020.0317,2020-06-04
MicroRNAs,INTERACTS_WITH,Open Reading Frames,32489696,10.14336/AD.2020.0506,2020-06-04
MicroRNAs,INTERACTS_WITH,Untranslated Regions,32489696,10.14336/AD.2020.0506,2020-06-04
MicroRNAs,PART_OF,Host Cell,32489696,10.14336/AD.2020.0506,2020-06-04
Storm NOS,CAUSES,Pneumonia,32489695,10.14336/AD.2020.0402,2020-06-04
Interleukin-6,CAUSES,Pneumonia,32489695,10.14336/AD.2020.0402,2020-06-04
Infected,PROCESS_OF,Patients,32489695,10.14336/AD.2020.0402,2020-06-04
EHD1 wt Allele,PART_OF,Patients,32489695,10.14336/AD.2020.0402,2020-06-04
Elderly (population group),NEG_ISA,Population Group,32489695,10.14336/AD.2020.0402,2020-06-04
Patients,LOCATION_OF,,32489692,10.14336/AD.2020.0422,2020-06-04
Pneumonia,PROCESS_OF,Patients,32489692,10.14336/AD.2020.0422,2020-06-04
Additional comments,COEXISTS_WITH,Coronavirus Infections,32489692,10.14336/AD.2020.0422,2020-06-04
Adipocytes,PART_OF,bony process,32489666,10.1002/rcr2.591,2020-06-04
Diabetes,COEXISTS_WITH,Coughing,32489523,10.1080/20008198.2020.1752504,2020-06-04
Insufflation,METHOD_OF,Warburg Therapy,32489523,10.1080/20008198.2020.1752504,2020-06-04
Obesity,COEXISTS_WITH,Coughing,32489523,10.1080/20008198.2020.1752504,2020-06-04
"Sleep Apnea, Obstructive",COEXISTS_WITH,Coughing,32489523,10.1080/20008198.2020.1752504,2020-06-04
patient condition,COEXISTS_WITH,Coughing,32489523,10.1080/20008198.2020.1752504,2020-06-04
Coughing,ISA,Symptoms,32489437,10.4103/atm.ATM_99_20,2020-06-04
"Kidney Failure, Acute",OCCURS_IN,Patients,32489437,10.4103/atm.ATM_99_20,2020-06-04
Coronavirus Infections,PROCESS_OF,Patients,32489437,10.4103/atm.ATM_99_20,2020-06-04
"Kidney Failure, Acute",COEXISTS_WITH,patient condition,32489437,10.4103/atm.ATM_99_20,2020-06-04
"Kidney Failure, Chronic",PROCESS_OF,Patients,32489437,10.4103/atm.ATM_99_20,2020-06-04
contextual factors,PROCESS_OF,inpatient,32489437,10.4103/atm.ATM_99_20,2020-06-04
contextual factors,PROCESS_OF,inpatient,32489437,10.4103/atm.ATM_99_20,2020-06-04
contextual factors,PROCESS_OF,Outpatients,32489437,10.4103/atm.ATM_99_20,2020-06-04
audience,USES,Health Policy,32489248,10.3747/co.27.6643,2020-06-04
Neoplasms,PROCESS_OF,Community,32489191,10.1708/3382.33570,2020-06-04
Challenge,TREATS,Community,32489191,10.1708/3382.33570,2020-06-04
Community,LOCATION_OF,IMPACT gene,32489191,10.1708/3382.33570,2020-06-04
Neoplasms,PROCESS_OF,Community,32489191,10.1708/3382.33570,2020-06-04
Emotions,PROCESS_OF,Respondents,32489191,10.1708/3382.33570,2020-06-04
IMPACT gene,PREDISPOSES,Toxic effect,32489191,10.1708/3382.33570,2020-06-04
Distress,PREDISPOSES,Post-Traumatic Stress Disorder,32489190,10.1708/3382.33569,2020-06-04
Validation,USES,Interventional procedure,32489190,10.1708/3382.33569,2020-06-04
Stress,PROCESS_OF,Psychologist,32489190,10.1708/3382.33569,2020-06-04
Wounds and Injuries,PROCESS_OF,Psychologist,32489190,10.1708/3382.33569,2020-06-04
Symptoms,PROCESS_OF,Persons,32489190,10.1708/3382.33569,2020-06-04
Psychometrics,AFFECTS,Emotional support,32489190,10.1708/3382.33569,2020-06-04
Disease,PROCESS_OF,World,32489188,10.1708/3382.33567,2020-06-04
Stress,ISA,Disease,32489188,10.1708/3382.33567,2020-06-04
Disease,PROCESS_OF,World,32489179,10.2807/1560-7917.ES.2020.25.21.2000903,2020-06-04
Stress,ISA,Disease,32489179,10.2807/1560-7917.ES.2020.25.21.2000903,2020-06-04
Infected,PROCESS_OF,Patients,32489162,10.1017/ice.2020.268,2020-06-04
Fear (Mental Process),PROCESS_OF,Health Personnel,32489144,10.1080/08959420.2020.1770031,2020-06-04
Quarantine,METHOD_OF,Economics,32489144,10.1080/08959420.2020.1770031,2020-06-04
Social stigmata,PROCESS_OF,Health Personnel,32489144,10.1080/08959420.2020.1770031,2020-06-04
Quarantine,TREATS,general population,32489031,10.19540/j.cnki.cjcmm.20200306.501,2020-06-04
Coronavirus Infections,OCCURS_IN,citizen,32489031,10.19540/j.cnki.cjcmm.20200306.501,2020-06-04
directive therapy,PREVENTS,Inflammation,32489028,10.19540/j.cnki.cjcmm.20200305.501,2020-06-04
Therapeutic procedure,TREATS,Asthma,32489028,10.19540/j.cnki.cjcmm.20200305.501,2020-06-04
Adverse reactions,NEG_ISA,Disease,32489027,10.19540/j.cnki.cjcmm.20200312.502,2020-06-04
Respiratory viruses,CAUSES,Infectious disease of lung,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Virus Diseases,CAUSES,Pneumonia,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Fatigue,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Fever,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Headache,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Rhinitis,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Myalgia,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Dry cough,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Storm NOS,CAUSES,Rhinorrhea,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Organ,LOCATION_OF,Tissue damage,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Symptom severe,PROCESS_OF,Patients,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
inflammatory response,AFFECTS,Equilibrium,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Clinical Treatment,TREATS,Symptoms,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Equilibrium,AFFECTS,Pulmonary Fibrosis,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
inflammatory response,AFFECTS,Equilibrium,32489025,10.19540/j.cnki.cjcmm.20200229.401,2020-06-04
Energy Metabolism,ISA,Metabolism,32489024,10.19540/j.cnki.cjcmm.20200315.401,2020-06-04
Biochemical Pathway,AFFECTS,Equilibrium,32489024,10.19540/j.cnki.cjcmm.20200315.401,2020-06-04
Fibroblast Growth Factor Receptors,AFFECTS,Signal Transduction Pathways,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
"FLT1 protein, human",ISA,Vascular Endothelial Growth Factor Receptor,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
Interventional procedure,AFFECTS,Pulmonary Fibrosis,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
Rhizome,ISA,Plant Roots,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
Acupuncture and Oriental Medicine,TREATS,Pulmonary Fibrosis,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
Lung,LOCATION_OF,Symptoms,32489023,10.19540/j.cnki.cjcmm.20200303.402,2020-06-04
Lung,LOCATION_OF,Syndrome,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Syndrome,ISA,Disease,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Syndrome,INTERACTS_WITH,Virus,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Upper Respiratory Infections,INTERACTS_WITH,Virus,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Nucleic Acids,PART_OF,Structure of parenchyma of lung,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Lung,LOCATION_OF,Syndrome,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
,compared_with,,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Lung,LOCATION_OF,,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Lung,LOCATION_OF,,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
motilin,INHIBITS,,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
motilin,INHIBITS,,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
motilin,INHIBITS,Interleukin-6,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
motilin,INHIBITS,Interleukin-10,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Serum,LOCATION_OF,motilin,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Disease,AFFECTS,Mouse Model,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Lung,LOCATION_OF,Syndrome,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Syndrome,DISRUPTS,Virus Replication,32489022,10.19540/j.cnki.cjcmm.20200303.401,2020-06-04
Lung,LOCATION_OF,Syndrome,32488958,10.1002/jcla.23415,2020-06-04
Lung,LOCATION_OF,Syndrome,32488958,10.1002/jcla.23415,2020-06-04
Serum,LOCATION_OF,Gastrins,32488958,10.1002/jcla.23415,2020-06-04
Serum,LOCATION_OF,motilin,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,LOCATION_OF,Interleukin-10,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,LOCATION_OF,Viral load measurement,32488958,10.1002/jcla.23415,2020-06-04
Pneumonia,PROCESS_OF,Mus,32488958,10.1002/jcla.23415,2020-06-04
Interleukin-10,INHIBITS,motilin,32488958,10.1002/jcla.23415,2020-06-04
Serum,LOCATION_OF,motilin,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,LOCATION_OF,Interleukin-10,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,LOCATION_OF,Viral load measurement,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,PART_OF,Mus,32488958,10.1002/jcla.23415,2020-06-04
Structure of parenchyma of lung,PART_OF,Mus,32488958,10.1002/jcla.23415,2020-06-04
Pneumonia,PROCESS_OF,Mus,32488958,10.1002/jcla.23415,2020-06-04
Lung,LOCATION_OF,Lesion,32488958,10.1002/jcla.23415,2020-06-04
Complication,PRECEDES,Disorder of electrolytes,32488957,10.1002/cyto.a.24040,2020-06-04
"Respiratory Distress Syndrome, Adult",ISA,Complication,32488957,10.1002/cyto.a.24040,2020-06-04
"Respiratory Distress Syndrome, Adult",PRECEDES(SPEC),Disorder of electrolytes,32488957,10.1002/cyto.a.24040,2020-06-04
Abnormal result,PROCESS_OF,Patients,32488866,10.1002/jso.26056,2020-06-04
Liver diseases,NEG_COEXISTS_WITH,Abnormal,32488866,10.1002/jso.26056,2020-06-04
Abnormal,PROCESS_OF,Patients,32488866,10.1002/jso.26056,2020-06-04
Liver Function Tests,DIAGNOSES,patient condition,32488866,10.1002/jso.26056,2020-06-04
Malignant Neoplasms,PROCESS_OF,Patients,32488861,10.1002/cpt.1931,2020-06-04
tumor removal,TREATS,Patients,32488861,10.1002/cpt.1931,2020-06-04
tumor removal,TREATS(INFER),Malignant Neoplasms,32488861,10.1002/cpt.1931,2020-06-04
Evaluation,TREATS,Coronavirus Infections,32488861,10.1002/cpt.1931,2020-06-04
Pharmaceutical Preparations,TREATS,Household composition,32488828,10.1007/s10943-020-01047-y,2020-06-04
Sequence Analysis,USES,Homology Modeling,32488828,10.1007/s10943-020-01047-y,2020-06-04
Pharmaceutical Preparations,TREATS,Virus,32488828,10.1007/s10943-020-01047-y,2020-06-04
Meglumine,ISA,Chemicals,32488828,10.1007/s10943-020-01047-y,2020-06-04
Peptides,ISA,Pharmaceutical Preparations,32488828,10.1007/s10943-020-01047-y,2020-06-04
Peptides,TREATS(SPEC),Virus,32488828,10.1007/s10943-020-01047-y,2020-06-04
Vidarabine,ISA,Adenosine,32488828,10.1007/s10943-020-01047-y,2020-06-04
Clergy,ISA,Persons,32488763,10.1007/s11524-020-00450-w,2020-06-04
Hypertensive disease,AFFECTS,geriatric patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Disease,PROCESS_OF,Patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Hemodialysis,TREATS,"Kidney Failure, Chronic",32488665,10.1007/s00268-020-05627-7,2020-06-04
"Kidney Failure, Chronic",PROCESS_OF,Patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Lung,LOCATION_OF,Ultrasonography,32488665,10.1007/s00268-020-05627-7,2020-06-04
Echocardiography,ADMINISTERED_TO,Patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Lung,LOCATION_OF,Ultrasonography,32488665,10.1007/s00268-020-05627-7,2020-06-04
Ultrasonography,ADMINISTERED_TO,Patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Ultrasonography,ADMINISTERED_TO,Patients,32488665,10.1007/s00268-020-05627-7,2020-06-04
Genus: Coronavirus,PROCESS_OF,Rodent,32488564,10.1007/s00264-020-04654-2,2020-06-04
Arm Injuries,PROCESS_OF,Patients,32488505,10.1186/s13613-020-00690-8,2020-06-04
Hospitals,LOCATION_OF,Study,32488505,10.1186/s13613-020-00690-8,2020-06-04
soft tissue,LOCATION_OF,Laceration,32488505,10.1186/s13613-020-00690-8,2020-06-04
Shock,AFFECTS,Severe Acute Respiratory Syndrome,32488493,10.1007/s12630-020-01729-x,2020-06-04
Acute myocarditis,PROCESS_OF,critically ill children,32488493,10.1007/s12630-020-01729-x,2020-06-04
Tertiary Care Centers,LOCATION_OF,case series,32488493,10.1007/s12630-020-01729-x,2020-06-04
Abdominal Pain,ISA,Symptoms,32488493,10.1007/s12630-020-01729-x,2020-06-04
Fever,ISA,Symptoms,32488493,10.1007/s12630-020-01729-x,2020-06-04
Elevated C-reactive protein,PROCESS_OF,Child,32488493,10.1007/s12630-020-01729-x,2020-06-04
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Child,32488493,10.1007/s12630-020-01729-x,2020-06-04
Adrenal Cortex Hormones,DISRUPTS,interleukin receptor activity,32488493,10.1007/s12630-020-01729-x,2020-06-04
Adrenal Cortex Hormones,ISA,Immunologic Adjuvants,32488493,10.1007/s12630-020-01729-x,2020-06-04
"Immunoglobulins, Intravenous",ADMINISTERED_TO,Child,32488493,10.1007/s12630-020-01729-x,2020-06-04
Severe Acute Respiratory Syndrome,PRECEDES,Inflammation,32488493,10.1007/s12630-020-01729-x,2020-06-04
Severe Acute Respiratory Syndrome,PRECEDES,Mucocutaneous Lymph Node Syndrome,32488493,10.1007/s12630-020-01729-x,2020-06-04
Severe Acute Respiratory Syndrome,PRECEDES,Myocarditis,32488493,10.1007/s12630-020-01729-x,2020-06-04
Health Personnel,TREATS,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Disease,OCCURS_IN,Population Group,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Coronavirus Infections,ISA,Disease,32488448,10.1007/s00068-020-01413-1,2020-06-04
Asymptomatic,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
Symptoms,PROCESS_OF,Patients,32488448,10.1007/s00068-020-01413-1,2020-06-04
"Surgical Procedures, Laparoscopic",CAUSES,Dissecting hemorrhage,32488422,10.1007/s00482-020-00483-9,2020-06-04
"Surgical Procedures, Laparoscopic",TREATS,Patients,32488422,10.1007/s00482-020-00483-9,2020-06-04
Intervention regimes,TREATS,Patients,32488413,10.1007/s00115-020-00939-4,2020-06-04
telephone call,COEXISTS_WITH,Isolation procedure,32488413,10.1007/s00115-020-00939-4,2020-06-04
Undifferentiated illness,COEXISTS_WITH,Acute infectious disease,32488319,10.1007/s00113-020-00830-6,2020-06-04
Infection,PROCESS_OF,Patients,32488318,10.1007/s00011-020-01370-w,2020-06-04
Operative Surgical Procedures,TREATS,Patients,32488318,10.1007/s00011-020-01370-w,2020-06-04
Operative Surgical Procedures,TREATS(INFER),Infection,32488318,10.1007/s00011-020-01370-w,2020-06-04
Infection,PROCESS_OF,Patients,32488318,10.1007/s00011-020-01370-w,2020-06-04
Operative Surgical Procedures,ISA,Interventional procedure,32488318,10.1007/s00011-020-01370-w,2020-06-04
Betacoronavirus,ISA,Virus,32488203,10.1038/s41577-020-0353-y,2020-06-04
Macrophage Activation Syndrome,AFFECTS,Worse,32488203,10.1038/s41577-020-0353-y,2020-06-04
Skin lesion,COEXISTS_WITH,Systemic disease,32488203,10.1038/s41577-020-0353-y,2020-06-04
angiotensin converting enzyme 2,CAUSES,Lesion,32488203,10.1038/s41577-020-0353-y,2020-06-04
integral to membrane,LOCATION_OF,serine protease activity,32488203,10.1038/s41577-020-0353-y,2020-06-04
Exanthema,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32488203,10.1038/s41577-020-0353-y,2020-06-04
Urticaria,ISA,Eruptions,32488203,10.1038/s41577-020-0353-y,2020-06-04
Spinal Cord Injuries,PROCESS_OF,Patients,32487927,10.1097/PHH.0000000000001215,2020-06-04
Coronavirus Infections,PROCESS_OF,Patients,32487927,10.1097/PHH.0000000000001215,2020-06-04
Neck,LOCATION_OF,acute spinal cord injury,32487927,10.1097/PHH.0000000000001215,2020-06-04
Acute respiratory infections,COEXISTS_WITH,Spinal Injuries,32487927,10.1097/PHH.0000000000001215,2020-06-04
Therapeutic procedure,ADMINISTERED_TO,Patients,32487927,10.1097/PHH.0000000000001215,2020-06-04
acute spinal cord injury,PROCESS_OF,Patients,32487927,10.1097/PHH.0000000000001215,2020-06-04
IMPACT gene,PART_OF,World,32487868,10.2459/JCM.0000000000000990,2020-06-04
Infected,PROCESS_OF,Persons,32487868,10.2459/JCM.0000000000000990,2020-06-04
Cardiac Imaging,AFFECTS,Patients,32487856,10.1097/SLE.0000000000000811,2020-06-04
Comorbidity,PROCESS_OF,high-risk group,32487491,10.1016/j.jadohealth.2020.05.004,2020-06-04
Antiviral Agents,TREATS,Syndrome,32487491,10.1016/j.jadohealth.2020.05.004,2020-06-04
Comorbidity,PROCESS_OF,Patients,32487491,10.1016/j.jadohealth.2020.05.004,2020-06-04
Experience,PROCESS_OF,Patients,32487491,10.1016/j.jadohealth.2020.05.004,2020-06-04
Nutritional status,PROCESS_OF,Patients,32487432,10.1016/j.hlc.2020.05.001,2020-06-04
Chronic intestinal failure,PROCESS_OF,Patients,32487432,10.1016/j.hlc.2020.05.001,2020-06-04
Cardiovascular Diseases,PROCESS_OF,Persons,32487347,10.1016/j.tree.2020.05.004,2020-06-04
Disease,COEXISTS_WITH,Asymptomatic,32487283,10.3201/eid2610.201886,2020-06-04
Detection,TREATS,Patients,32487283,10.3201/eid2610.201886,2020-06-04
Nasal Swab (procedure),DIAGNOSES,Disease,32487283,10.3201/eid2610.201886,2020-06-04
Coronavirus Infections,ISA,Disease,32487282,10.3201/eid2609.202122,2020-06-04
Disease,PROCESS_OF,Patients,32487272,10.1017/S1744133120000171,2020-06-04
Coronavirus Infections,ISA,Disease,32487272,10.1017/S1744133120000171,2020-06-04
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32487272,10.1017/S1744133120000171,2020-06-04
Cerebrospinal fluid sample,NEG_LOCATION_OF,Interleukin-6,32487272,10.1017/S1744133120000171,2020-06-04
Cerebrospinal fluid sample,NEG_LOCATION_OF,Interleukin-8,32487272,10.1017/S1744133120000171,2020-06-04
Cerebrospinal fluid sample,NEG_LOCATION_OF,Interleukin-10,32487272,10.1017/S1744133120000171,2020-06-04
Coronavirus Infections,ISA,Disease,32487272,10.1017/S1744133120000171,2020-06-04
Nance-Horan syndrome,PROCESS_OF,Staff,32487271,10.1017/S0950268820001181,2020-06-04
Symptoms,PROCESS_OF,Patients,32487159,10.1186/s12943-020-01218-1,2020-06-04
Isolation procedure,TREATS,patient condition,32487159,10.1186/s12943-020-01218-1,2020-06-04
Infected,PROCESS_OF,Persons,32487103,10.1186/s12961-020-00573-1,2020-06-04
Infected,PROCESS_OF,Persons,32487103,10.1186/s12961-020-00573-1,2020-06-04
Virus,COEXISTS_WITH,Pyotraumatic dermatitis,32487009,10.1176/appi.ps.202000244,2020-06-04
New York City,ISA,Geographic Locations,32487009,10.1176/appi.ps.202000244,2020-06-04
Serious mental illness,PROCESS_OF,Persons,32487005,10.1089/tmj.2020.0114,2020-06-04
Pandemics,ISA,Epidemic,32486811,10.1121/10.0001271,2020-06-04
Bands,USES,Ships,32486563,10.3760/cma.j.cn112144-20200311-00143,2020-06-04
Oral health,AFFECTS,General health,32486557,10.3760/cma.j.cn112147-20200214-00094,2020-06-04
Infected,PROCESS_OF,Persons,32486469,10.3390/jcm9061651,2020-06-04
Plasma membrane,PART_OF,Mammals,32486469,10.3390/jcm9061651,2020-06-04
Mass Screening,TREATS,Coronavirus Infections,32486469,10.3390/jcm9061651,2020-06-04
Eye,LOCATION_OF,Household composition,32486380,10.3390/ijerph17113899,2020-06-04
Household composition,PROCESS_OF,Persons,32486380,10.3390/ijerph17113899,2020-06-04
Physical activity behavior,PROCESS_OF,Participant,32486364,10.3390/nano10061072,2020-06-04
Nanotechnology Techniques,USES,Detection,32486283,10.3390/v12060598,2020-06-04
Prophylactic treatment,TREATS,Virus Diseases,32486283,10.3390/v12060598,2020-06-04
Replicon,PART_OF,ssRNA viruses,32486229,10.3390/ijms21113922,2020-06-04
Respiration Disorders,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Ischemic stroke,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Pathogenic,PROCESS_OF,Research Personnel,32486188,10.3390/pathogens9060430,2020-06-04
risk factors,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Smoking,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Smoking,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Vaping,PROCESS_OF,Patients,32486188,10.3390/pathogens9060430,2020-06-04
Liver,LOCATION_OF,Direct trauma,32486140,10.3390/diagnostics10060358,2020-06-04
Biliary epithelial cell,LOCATION_OF,receptor,32486140,10.3390/diagnostics10060358,2020-06-04
Patients,LOCATION_OF,Liver enzyme,32486140,10.3390/diagnostics10060358,2020-06-04
Patients,USES,Preexisting Condition Coverage,32486140,10.3390/diagnostics10060358,2020-06-04
Infected,PROCESS_OF,Patients,32486140,10.3390/diagnostics10060358,2020-06-04
Infected,PROCESS_OF,Persons,32486074,10.3390/jcm9061643,2020-06-04
Respiration Disorders,COEXISTS_WITH,Pneumonia,32486074,10.3390/jcm9061643,2020-06-04
Camels,ISA,Mammals,32486011,10.3390/ijerph17113872,2020-06-04
Felis catus,ISA,Mammals,32486011,10.3390/ijerph17113872,2020-06-04
Cattle,ISA,Mammals,32486011,10.3390/ijerph17113872,2020-06-04
Chiroptera,ISA,Mammals,32486011,10.3390/ijerph17113872,2020-06-04
Coronavirus Infections,PROCESS_OF,Persons,32486011,10.3390/ijerph17113872,2020-06-04
responsibility,PROCESS_OF,Persons,32485970,10.3390/pathogens9060426,2020-06-04
Adequate Knowledge,PROCESS_OF,Respondents,32485970,10.3390/pathogens9060426,2020-06-04
Infected,PROCESS_OF,Patients,32485894,10.3390/molecules25112529,2020-06-04
Coronavirus Infections,ISA,Disease,32485875,10.3390/healthcare8020148,2020-06-04
Pandemics,CAUSES,Disease,32485875,10.3390/healthcare8020148,2020-06-04
Pandemics,CAUSES(SPEC),Coronavirus Infections,32485875,10.3390/healthcare8020148,2020-06-04
Drug Delivery Systems,compared_with,Protease Inhibitors,32485875,10.3390/healthcare8020148,2020-06-04
Endopeptidases,PART_OF,Hepatitis C virus,32485875,10.3390/healthcare8020148,2020-06-04
Endopeptidases,PART_OF,Hepatitis C virus,32485875,10.3390/healthcare8020148,2020-06-04
Diabetes,PROCESS_OF,Patients,32485875,10.3390/healthcare8020148,2020-06-04
Infected,PROCESS_OF,Patients,32485875,10.3390/healthcare8020148,2020-06-04
on anti-coagulants,TREATS,Patients,32485875,10.3390/healthcare8020148,2020-06-04
on anti-coagulants,TREATS(INFER),Diabetes,32485875,10.3390/healthcare8020148,2020-06-04
on anti-coagulants,TREATS(INFER),Infected,32485875,10.3390/healthcare8020148,2020-06-04
Dipeptidyl Peptidase 4 Inhibitors [MoA],COEXISTS_WITH,Pneumonia,32485875,10.3390/healthcare8020148,2020-06-04
Camels,ISA,Animals,32485871,10.3390/jcm9061641,2020-06-04
Felis catus,ISA,Animals,32485871,10.3390/jcm9061641,2020-06-04
Cattle,ISA,Animals,32485871,10.3390/jcm9061641,2020-06-04
Chiroptera,ISA,Animals,32485871,10.3390/jcm9061641,2020-06-04
Virus,PROCESS_OF,Homo sapiens,32485871,10.3390/jcm9061641,2020-06-04
Coronavirus Infections,AFFECTS,Animals,32485871,10.3390/jcm9061641,2020-06-04
Coronavirus Infections,AFFECTS(SPEC),Camels,32485871,10.3390/jcm9061641,2020-06-04
Coronavirus Infections,AFFECTS(SPEC),Felis catus,32485871,10.3390/jcm9061641,2020-06-04
Coronavirus Infections,AFFECTS(SPEC),Cattle,32485871,10.3390/jcm9061641,2020-06-04
Coronavirus Infections,AFFECTS(SPEC),Chiroptera,32485871,10.3390/jcm9061641,2020-06-04
Eye,LOCATION_OF,Disease,32485871,10.3390/jcm9061641,2020-06-04
Depressive disorder,PROCESS_OF,general population,32485858,10.3390/biomedicines8060138,2020-06-04
Dyssomnias,PROCESS_OF,general population,32485858,10.3390/biomedicines8060138,2020-06-04
Symptoms,PROCESS_OF,general population,32485858,10.3390/biomedicines8060138,2020-06-04
"CD69 protein, human",INHIBITS,Interleukin-1 beta,32485854,10.3390/ijerph17113856,2020-06-04
"CD69 protein, human",INHIBITS,Interleukin-6,32485854,10.3390/ijerph17113856,2020-06-04
"CD69 protein, human",INHIBITS,"TNF protein, human",32485854,10.3390/ijerph17113856,2020-06-04
Interleukin-1 beta,INTERACTS_WITH,Interleukin-6,32485854,10.3390/ijerph17113856,2020-06-04
Western Blot,USES,Cell Count,32485854,10.3390/ijerph17113856,2020-06-04
Imbrication (procedure),USES,TBATA gene,32485652,10.1016/j.compbiolchem.2020.107292,2020-06-03
Enzyme-Linked Immunosorbent Assay,METHOD_OF,Detection,32485619,10.1016/j.jcv.2020.104475,2020-06-03
Polymerase Chain Reaction,METHOD_OF,Diagnosis,32485619,10.1016/j.jcv.2020.104475,2020-06-03
Human coronavirus,PROCESS_OF,Patients,32485619,10.1016/j.jcv.2020.104475,2020-06-03
Lymphopenia,PROCESS_OF,Patients,32485618,10.1016/j.jcv.2020.104455,2020-06-03
Adrenal Cortex Hormones,ADMINISTERED_TO,Patients,32485618,10.1016/j.jcv.2020.104455,2020-06-03
Antibiotics,ADMINISTERED_TO,Patients,32485618,10.1016/j.jcv.2020.104455,2020-06-03
Coronavirus Infections,PROCESS_OF,Patients,32485618,10.1016/j.jcv.2020.104455,2020-06-03
skill,PROCESS_OF,Staff,32485610,10.1016/j.phrs.2020.104917,2020-06-03
Immunochromatographic test,METHOD_OF,Detection,32485610,10.1016/j.phrs.2020.104917,2020-06-03
Rapid Antigen Test,USES,Detection,32485610,10.1016/j.phrs.2020.104917,2020-06-03
Dietary Supplements,CAUSES,Toxic effect,32485487,10.1016/j.psychres.2020.113129,2020-06-03
NSUN2 gene,PART_OF,Patients,32485487,10.1016/j.psychres.2020.113129,2020-06-03
Emotional distress,PREDISPOSES,Post-Traumatic Stress Disorder,32485483,10.1016/j.psychres.2020.113137,2020-06-03
Schizophrenia,PROCESS_OF,Male population group,32485473,10.1016/j.jcv.2020.104454,2020-06-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Coronavirus Infections,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Blood Coagulation Disorders,PROCESS_OF,Patients,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Thrombosis,PROCESS_OF,Patients,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Present,PROCESS_OF,Patients,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Malaise,PROCESS_OF,Patients,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Problem,PROCESS_OF,Patients,32485335,10.1016/j.ejrad.2020.109092,2020-06-03
Alveolar,LOCATION_OF,Decreased translucency,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Negative,PROCESS_OF,Patients,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Pneumonia,PROCESS_OF,Patients,32485332,10.1016/j.meegid.2020.104387,2020-06-03
interstitial,LOCATION_OF,Decreased translucency,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Hypersensitivity,PROCESS_OF,Patients,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Chest,LOCATION_OF,X-RAY SENSITIVITY,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Hypersensitivity,ISA,Symptoms,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Hypersensitivity,PROCESS_OF(SPEC),Patients,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Symptoms,PROCESS_OF,Patients,32485332,10.1016/j.meegid.2020.104387,2020-06-03
Genes,COEXISTS_WITH,Isolate - microorganism,32485315,10.1016/j.mehy.2020.109923,2020-06-03
Diabetes Mellitus,AFFECTS,Immunity,32485314,10.1016/j.mehy.2020.109882,2020-06-03
Carcinogen effect,CAUSES,Persistent infection,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Persistent infection,COEXISTS_WITH,Malignant Neoplasms,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Persistent infection,PROCESS_OF,Persons,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Coronaviridae,CAUSES,Persistent infection,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Coronaviridae,ISA,RNA Viruses,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Retroviridae,ISA,RNA Viruses,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Persistent infection,ASSOCIATED_WITH,Host (organism),32485299,10.1016/j.amjoto.2020.102550,2020-06-03
TP53 gene,ISA,Tumor Suppressor Genes,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
TP53 gene,PART_OF(SPEC),Pyronia tithonus,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Tumor Suppressor Genes,PART_OF,Pyronia tithonus,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Homologous Gene,INHIBITS,TP53 gene,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Homologous Gene,INHIBITS,Retinoblastoma Protein,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Infected,PROCESS_OF,Patients,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Additional assessment,PREVENTS,Complication,32485299,10.1016/j.amjoto.2020.102550,2020-06-03
Cities,ISA,Geographic Locations,32485289,10.1016/j.bbi.2020.05.048,2020-06-03
Psychiatric symptom,PROCESS_OF,Patients,32485273,10.1016/j.ajic.2020.05.027,2020-06-03
General health,PROCESS_OF,Psychiatric inpatient,32485273,10.1016/j.ajic.2020.05.027,2020-06-03
Infected,PROCESS_OF,Patients,32485273,10.1016/j.ajic.2020.05.027,2020-06-03
Patients,USES,Preexisting Condition Coverage,32485273,10.1016/j.ajic.2020.05.027,2020-06-03
Patients,USES,Preexisting Condition Coverage,32485273,10.1016/j.ajic.2020.05.027,2020-06-03
Pneumonia,PROCESS_OF,Patients,32485251,10.1016/j.ijbiomac.2020.05.239,2020-06-03
Asymptomatic,PROCESS_OF,Patients,32485251,10.1016/j.ijbiomac.2020.05.239,2020-06-03
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32485251,10.1016/j.ijbiomac.2020.05.239,2020-06-03
Disinfection,TREATS,patient condition,32485251,10.1016/j.ijbiomac.2020.05.239,2020-06-03
Respiration Disorders,PROCESS_OF,Homo sapiens,32485205,10.1016/j.biochi.2020.05.013,2020-06-03
Pandemics,CAUSES,Respiration Disorders,32485205,10.1016/j.biochi.2020.05.013,2020-06-03
Lactobacillus plantarum,PRODUCES,"M Protein, multiple myeloma",32485205,10.1016/j.biochi.2020.05.013,2020-06-03
Chloroquine,ISA,Antimalarials,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Lysosomes,LOCATION_OF,Chloroquine,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
food vacuole,LOCATION_OF,Chloroquine,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
food vacuole,PART_OF,Plasmodium falciparum,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Chloroquine,TREATS,Malaria,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Peptide Hydrolases,AFFECTS,Biologic Development,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Cells,LOCATION_OF,Chloroquine,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Accumulation,COEXISTS_WITH,Lysosomal Storage Diseases,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Lipids,AUGMENTS,nonselective vesicle assembly,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
late endosome,LOCATION_OF,Lipids,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Pharmaceutical Preparations,CAUSES,Accumulation,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Progesterone,CAUSES,Accumulation,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
U 18666A,CAUSES,Accumulation,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Phosphonates,CAUSES,Accumulation,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Virion,PART_OF,HIV,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Pharmaceutical Preparations,CAUSES,Virus Diseases,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Bone Morphogenetic Proteins,AFFECTS,Virus Diseases,32485198,10.1016/j.jhin.2020.05.038,2020-06-03
Isolation procedure,USES,"Condoms, Male",32485197,10.1016/j.jhin.2020.05.035,2020-06-03
At risk of disease,PROCESS_OF,Patients,32485164,10.1016/j.chom.2020.05.020,2020-06-03
Diagnosis,ADMINISTERED_TO,Patients,32485164,10.1016/j.chom.2020.05.020,2020-06-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32485164,10.1016/j.chom.2020.05.020,2020-06-03
"Infections, Hospital",PREDISPOSES,Severe disorder,32485164,10.1016/j.chom.2020.05.020,2020-06-03
Decision,PROCESS_OF,Cohort,32485164,10.1016/j.chom.2020.05.020,2020-06-03
dipeptidyl peptidase II,PART_OF,Homo sapiens,32485157,10.1016/j.cca.2020.05.050,2020-06-03
ACE2 gene,PART_OF,Homo sapiens,32485157,10.1016/j.cca.2020.05.050,2020-06-03
Vaccination,CAUSES,Pulmonary Pathology,32485157,10.1016/j.cca.2020.05.050,2020-06-03
Pulmonary Pathology,PROCESS_OF,Mus,32485157,10.1016/j.cca.2020.05.050,2020-06-03
Virus,PROCESS_OF,Community,32485155,10.1016/j.cca.2020.05.049,2020-06-03
Assay,USES,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",32485155,10.1016/j.cca.2020.05.049,2020-06-03
Assay,USES,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",32485155,10.1016/j.cca.2020.05.049,2020-06-03
Immunoenzyme Procedure,MEASURES,Assay,32485147,10.1016/j.jacr.2020.04.024,2020-06-03
Immunoenzyme Procedure,USES,Antibodies,32485147,10.1016/j.jacr.2020.04.024,2020-06-03
small mass of the lung,PROCESS_OF,Patients,32485131,10.1080/15265161.2020.1764145,2020-06-03
Screening for malignant neoplasm of lung,AFFECTS,Evaluation,32485131,10.1080/15265161.2020.1764145,2020-06-03
Coronavirus Infections,ISA,Disease,32485101,10.1021/acschemneuro.0c00294,2020-06-03
SARS coronavirus,CAUSES,Disease,32485101,10.1021/acschemneuro.0c00294,2020-06-03
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32485101,10.1021/acschemneuro.0c00294,2020-06-03
Neurologic Symptoms,PROCESS_OF,Patients,32485082,10.1002/ejhf.1924,2020-06-03
Brain,LOCATION_OF,vascular factor,32485082,10.1002/ejhf.1924,2020-06-03
Inflammation,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32485082,10.1002/ejhf.1924,2020-06-03
vascular factor,DISRUPTS,Inflammation,32485082,10.1002/ejhf.1924,2020-06-03
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin-Converting Enzyme Inhibitors,TREATS(INFER),Diabetes,32485048,10.1111/ced.14323,2020-06-03
Angiotensin-Converting Enzyme Inhibitors,TREATS(INFER),Hypertensive disease,32485048,10.1111/ced.14323,2020-06-03
Diabetes,PROCESS_OF,Patients,32485048,10.1111/ced.14323,2020-06-03
Hospitals,LOCATION_OF,Angiotensin converting enzyme measurement,32485048,10.1111/ced.14323,2020-06-03
Hypertensive disease,PROCESS_OF,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin II receptor antagonist,TREATS,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin II receptor antagonist,TREATS(INFER),Diabetes,32485048,10.1111/ced.14323,2020-06-03
Angiotensin II receptor antagonist,TREATS(INFER),Hypertensive disease,32485048,10.1111/ced.14323,2020-06-03
Comorbidity,PROCESS_OF,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32485048,10.1111/ced.14323,2020-06-03
Comorbidity,PROCESS_OF,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32485048,10.1111/ced.14323,2020-06-03
Comorbidity,PROCESS_OF,Patients,32485048,10.1111/ced.14323,2020-06-03
Angiotensin II receptor antagonist,TREATS,Patients,32485048,10.1111/ced.14323,2020-06-03
"Epilepsies, Partial",PROCESS_OF,Patients,32484966,10.1111/apa.15382,2020-06-03
Coughing,PROCESS_OF,Patients,32484966,10.1111/apa.15382,2020-06-03
Fever,PROCESS_OF,Patients,32484966,10.1111/apa.15382,2020-06-03
ITSN2 gene,PART_OF,Nasopharynx,32484966,10.1111/apa.15382,2020-06-03
Blood Vessel,LOCATION_OF,Nitric Oxide,32484958,10.1002/jmv.26103,2020-06-03
Pulmonary vessels,LOCATION_OF,Nitric Oxide,32484958,10.1002/jmv.26103,2020-06-03
Upper respiratory sample,PART_OF,Tract,32484930,10.1002/jmv.26111,2020-06-03
Immune response,CAUSES,Severe disorder,32484930,10.1002/jmv.26111,2020-06-03
Pneumonia,PROCESS_OF,Patients,32484915,10.1002/jmv.26110,2020-06-03
tocilizumab,ADMINISTERED_TO,Patients,32484915,10.1002/jmv.26110,2020-06-03
Pneumonia,PROCESS_OF,Patients,32484915,10.1002/jmv.26110,2020-06-03
Room air,PROCESS_OF,Patients,32484915,10.1002/jmv.26110,2020-06-03
tocilizumab,TREATS,Fever,32484915,10.1002/jmv.26110,2020-06-03
Pneumonia,PROCESS_OF,Patients,32484915,10.1002/jmv.26110,2020-06-03
tocilizumab,TREATS,Patients,32484912,10.1111/jgs.16661,2020-06-03
tocilizumab,TREATS,Patients,32484912,10.1111/jgs.16661,2020-06-03
Coronavirus Infections,ISA,Disease,32484783,10.2196/19246,2020-06-03
Coronavirus Infections,ISA,Disease,32484782,10.2196/19773,2020-06-03
Practice Experience,PROCESS_OF,member,32484737,10.1177/1039856220930675,2020-06-03
Practice Experience,PROCESS_OF,Social Networks,32484737,10.1177/1039856220930675,2020-06-03
Disease,PROCESS_OF,Older people,32484737,10.1177/1039856220930675,2020-06-03
Coronavirus Infections,ISA,Disease,32484737,10.1177/1039856220930675,2020-06-03
Coronavirus Infections,PROCESS_OF(SPEC),Older people,32484737,10.1177/1039856220930675,2020-06-03
mental health,PROCESS_OF,Consumer,32484731,10.1177/0194599820932167,2020-06-03
mental health,PROCESS_OF,Consumer,32484731,10.1177/0194599820932167,2020-06-03
Voice,PROCESS_OF,Patients,32484728,10.1177/0194599820933169,2020-06-03
Structure of upper respiratory tract cavity,LOCATION_OF,Disease,32484728,10.1177/0194599820933169,2020-06-03
Nose,LOCATION_OF,Obstruction,32484683,10.1021/acs.nanolett.0c02211,2020-06-03
Textiles,ISA,Materials,32484584,10.1002/mds.28176,2020-06-03
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32484511,10.1093/jee/toaa102,2020-06-03
Apis mellifera,ISA,Hymenoptera,32484453,10.18632/aging.103255,2020-06-03
Fibrin fragment D,ADMINISTERED_TO,Clinician,32484443,10.2196/19930,2020-06-03
Patients,LOCATION_OF,cytokine,32484443,10.2196/19930,2020-06-03
Lymphopenia,PROCESS_OF,Patients,32484443,10.2196/19930,2020-06-03
Storm NOS,PROCESS_OF,Patients,32484443,10.2196/19930,2020-06-03
Immunoassay method,METHOD_OF,Flow Cytometry,32484443,10.2196/19930,2020-06-03
Coronavirus Infections,ISA,Disease,32484425,10.1177/0194599820932128,2020-06-03
cancer therapy,TREATS,Malignant Neoplasms,32484307,10.1111/1742-6723.13566,2020-06-03
Invasive mechanical ventilation NOS,TREATS,Patients,32484225,10.1093/milmed/usaa112,2020-06-03
Easy,PROCESS_OF,inpatient,32484225,10.1093/milmed/usaa112,2020-06-03
Invasive mechanical ventilation NOS,AFFECTS,Diabetes,32484225,10.1093/milmed/usaa112,2020-06-03
Invasive mechanical ventilation NOS,AFFECTS,Hypertensive disease,32484225,10.1093/milmed/usaa112,2020-06-03
Invasive mechanical ventilation NOS,AFFECTS,Chronic Obstructive Airway Disease,32484225,10.1093/milmed/usaa112,2020-06-03
Eminent,ADMINISTERED_TO,teams,32484220,10.1093/bib/bbaa114,2020-06-03
DNA Sequence,COEXISTS_WITH,Open Reading Frames,32484159,10.1016/j.jcin.2020.05.045,2020-06-03
Coronaviridae,PROCESS_OF,Family,32484159,10.1016/j.jcin.2020.05.045,2020-06-03
Assay,USES,Spectrum Analysis,32484159,10.1016/j.jcin.2020.05.045,2020-06-03
Aortic Valve Stenosis,PROCESS_OF,Patients,32484156,10.4269/ajtmh.20-0474,2020-06-03
Aortic Valve Stenosis,COEXISTS_WITH,Enthesitis-Related Arthritis,32484156,10.4269/ajtmh.20-0474,2020-06-03
Aortic Valve Stenosis,PROCESS_OF,Patients,32484156,10.4269/ajtmh.20-0474,2020-06-03
Coronavirus Infections,CAUSES,Pneumonia,32483909,10.1111/ajt.16089,2020-06-03
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32483909,10.1111/ajt.16089,2020-06-03
Viral syndrome,CAUSES,Coronavirus Infections,32483909,10.1111/ajt.16089,2020-06-03
Duration,PREDISPOSES,Thrombophilia,32483811,10.1055/s-0040-1712942,2020-06-03
Renal infarction,PROCESS_OF,Recipient,32483811,10.1055/s-0040-1712942,2020-06-03
Duration,TREATS,Recipient,32483811,10.1055/s-0040-1712942,2020-06-03
Complication,PROCESS_OF,Pregnant Women,32483768,10.1055/a-1180-3692,2020-06-03
Male population group,ISA,Population Group,32483768,10.1055/a-1180-3692,2020-06-03
Old age,ISA,Population Group,32483768,10.1055/a-1180-3692,2020-06-03
Infected,PROCESS_OF,Mother (person),32483768,10.1055/a-1180-3692,2020-06-03
Infected,PROCESS_OF,Woman,32483768,10.1055/a-1180-3692,2020-06-03
Gravidity,PROCESS_OF,Health Personnel,32483768,10.1055/a-1180-3692,2020-06-03
skill,AFFECTS,Performance,32483687,10.1007/s10072-020-04486-3,2020-06-03
Training,NEG_AFFECTS,Body Composition,32483687,10.1007/s10072-020-04486-3,2020-06-03
Isolation procedure,COEXISTS_WITH,Challenge,32483687,10.1007/s10072-020-04486-3,2020-06-03
Challenge,ADMINISTERED_TO,Athletes,32483687,10.1007/s10072-020-04486-3,2020-06-03
Athletes,ISA,Persons,32483687,10.1007/s10072-020-04486-3,2020-06-03
Dizziness,ISA,Disturbance of consciousness,32483586,10.1093/jalm/jfaa089,2020-06-03
Anosmia,ISA,Neurologic Manifestations,32483586,10.1093/jalm/jfaa089,2020-06-03
Confusion,ISA,Neurologic Manifestations,32483586,10.1093/jalm/jfaa089,2020-06-03
Ageusia,ISA,Neurologic Manifestations,32483586,10.1093/jalm/jfaa089,2020-06-03
Extraction,compared_with,RNA,32483554,10.1021/acscentsci.0c00489,2020-06-03
Extraction,TREATS,Coronavirus Infections,32483554,10.1021/acscentsci.0c00489,2020-06-03
peginterferon alfa-2a,TREATS,Patients,32483525,10.1016/j.idcr.2020.e00829,2020-06-03
Respiratory Failure,CAUSES,Cessation of life,32483524,10.1016/j.idcr.2020.e00820,2020-06-03
pulmonary involvement,PROCESS_OF,Patients,32483523,10.1016/j.imr.2020.100426,2020-06-03
Lymphopenia,COEXISTS_WITH,Thrombocytopenia,32483523,10.1016/j.imr.2020.100426,2020-06-03
Chest imaging,DIAGNOSES,Thrombocytopenia,32483523,10.1016/j.imr.2020.100426,2020-06-03
Fever,PROCESS_OF,Patients,32483523,10.1016/j.imr.2020.100426,2020-06-03
Lung,LOCATION_OF,Symptoms,32483523,10.1016/j.imr.2020.100426,2020-06-03
Symptoms,PROCESS_OF,Patients,32483523,10.1016/j.imr.2020.100426,2020-06-03
Deep Vein Thrombosis,ISA,Thrombosis,32483500,10.7759/cureus.7849,2020-06-03
Virus Diseases,PROCESS_OF,Patients,32483500,10.7759/cureus.7849,2020-06-03
Chest,LOCATION_OF,Virus Diseases,32483500,10.7759/cureus.7849,2020-06-03
Symptoms,PROCESS_OF,Patients,32483500,10.7759/cureus.7849,2020-06-03
"Sleep Apnea, Obstructive",ISA,Disease,32483497,10.7759/cureus.7846,2020-06-03
Invasive positive pressure ventilation,TREATS,Disease,32483497,10.7759/cureus.7846,2020-06-03
Invasive positive pressure ventilation,TREATS(SPEC),"Sleep Apnea, Obstructive",32483497,10.7759/cureus.7846,2020-06-03
Hypertensive disease,COEXISTS_WITH,Respiratory Failure,32483497,10.7759/cureus.7846,2020-06-03
Pulmonary Hypertension,COEXISTS_WITH,Respiratory Failure,32483497,10.7759/cureus.7846,2020-06-03
Respiratory Failure,PROCESS_OF,Patients,32483497,10.7759/cureus.7846,2020-06-03
Subarachnoid Hemorrhage,PROCESS_OF,Patients,32483490,10.1016/j.nmni.2020.100697,2020-06-03
Virus Diseases,PROCESS_OF,Homo sapiens,32483488,10.1186/s40560-020-00453-4,2020-06-03
Heart,LOCATION_OF,Comorbidity,32483487,10.1016/j.amsu.2020.05.025,2020-06-03
Poor outcome,COEXISTS_WITH,Lymphopenia,32483487,10.1016/j.amsu.2020.05.025,2020-06-03
Poor outcome,PROCESS_OF,Patients,32483487,10.1016/j.amsu.2020.05.025,2020-06-03
Poor outcome,PROCESS_OF,Patients,32483487,10.1016/j.amsu.2020.05.025,2020-06-03
Hypertensive disease,AFFECTS,Disease Progression,32483300,10.1038/s41375-020-0887-9,2020-06-03
Hypertensive disease,PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Cerebrovascular Disorders,PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Diabetes,PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Hypertensive disease,PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Fibrinogen,TREATS,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Lactate Dehydrogenase,TREATS,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Fibrin fragment D,TREATS,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Pneumonia,ISA,Inflammation,32483300,10.1038/s41375-020-0887-9,2020-06-03
Pneumonia,NEG_PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
Hypertensive disease,PROCESS_OF,Patients,32483300,10.1038/s41375-020-0887-9,2020-06-03
receptor,CAUSES,Storm NOS,32483236,10.1038/s41467-020-16638-2,2020-06-03
Hematopoietic stem cells,PART_OF,bony process,32483236,10.1038/s41467-020-16638-2,2020-06-03
Patients,LOCATION_OF,Serum,32483035,10.1097/YCT.0000000000000705,2020-06-03
Peptides,PART_OF,B-Lymphocytes,32483035,10.1097/YCT.0000000000000705,2020-06-03
Antibodies,INTERACTS_WITH,Immunodominant Epitopes,32483035,10.1097/YCT.0000000000000705,2020-06-03
Elevated liver enzymes level,PROCESS_OF,Patients,32482985,10.5435/JAAOS-D-20-00557,2020-06-03
Elevated liver enzymes level,PROCESS_OF,Patients,32482985,10.5435/JAAOS-D-20-00557,2020-06-03
Elevated liver enzymes level,PROCESS_OF,Patients,32482985,10.5435/JAAOS-D-20-00557,2020-06-03
Hip Fractures,PROCESS_OF,Patients,32482976,10.1097/BOT.0000000000001845,2020-06-03
contextual factors,PROCESS_OF,Participant,32482976,10.1097/BOT.0000000000001845,2020-06-03
Fracture,PROCESS_OF,Patients,32482976,10.1097/BOT.0000000000001845,2020-06-03
Hip Fractures,PROCESS_OF,Population Group,32482971,10.1097/BSD.0000000000001017,2020-06-03
Complication,PROCESS_OF,inpatient,32482971,10.1097/BSD.0000000000001017,2020-06-03
Hip Fractures,PROCESS_OF,Patients,32482971,10.1097/BSD.0000000000001017,2020-06-03
Virus,PROCESS_OF,Patients,32482971,10.1097/BSD.0000000000001017,2020-06-03
Hip Fractures,PROCESS_OF,Patients,32482971,10.1097/BSD.0000000000001017,2020-06-03
Hip Fractures,PROCESS_OF,Patients,32482971,10.1097/BSD.0000000000001017,2020-06-03
Physicians,TREATS,Patients,32482971,10.1097/BSD.0000000000001017,2020-06-03
Health Care Systems,LOCATION_OF,Study,32482888,10.1136/jclinpath-2020-206789,2020-06-03
Pandemics,CAUSES,"Respiratory Distress Syndrome, Adult",32482862,10.1073/pnas.1922686117,2020-06-03
Laboratory Procedures,DIAGNOSES,Enthesitis-Related Arthritis,32482862,10.1073/pnas.1922686117,2020-06-03
UGT1A7 wt Allele,PART_OF,Vertebrates,32482845,10.1212/WNL.0000000000009937,2020-06-03
IMPACT gene,PART_OF,Homo sapiens,32482845,10.1212/WNL.0000000000009937,2020-06-03
Neurologic Manifestations,PROCESS_OF,hospitalized patients,32482844,10.1212/WNL.0000000000009936,2020-06-03
Hispanics,ISA,Population Group,32482844,10.1212/WNL.0000000000009936,2020-06-03
Myalgia,ISA,Symptoms,32482844,10.1212/WNL.0000000000009936,2020-06-03
Conscious,PROCESS_OF,Patients,32482844,10.1212/WNL.0000000000009936,2020-06-03
neurological complication,CAUSES,Cessation of life,32482844,10.1212/WNL.0000000000009936,2020-06-03
Malaise,PROCESS_OF,Patients,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,AFFECTS,Child,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,AFFECTS,Young Adult,32482785,10.1183/13993003.01483-2020,2020-06-03
Prognosis good,PROCESS_OF,Family,32482785,10.1183/13993003.01483-2020,2020-06-03
Prognosis good,PROCESS_OF,Patients,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,PROCESS_OF,Child,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,PROCESS_OF,Young Adult,32482785,10.1183/13993003.01483-2020,2020-06-03
Supportive care,TREATS,Disease Progression,32482785,10.1183/13993003.01483-2020,2020-06-03
novel AODU treatment method,TREATS,Disease Progression,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,PROCESS_OF,Child,32482785,10.1183/13993003.01483-2020,2020-06-03
Neuromuscular Diseases,PROCESS_OF,Young Adult,32482785,10.1183/13993003.01483-2020,2020-06-03
Acute illness,PROCESS_OF,Population Group,32482785,10.1183/13993003.01483-2020,2020-06-03
Intubation,TREATS,Protection,32482688,10.1681/ASN.2020040461,2020-06-03
Medical procedure,COEXISTS_WITH,Intubation,32482688,10.1681/ASN.2020040461,2020-06-03
BARRIER,USES,Box,32482688,10.1681/ASN.2020040461,2020-06-03
BARRIER,USES,Box,32482688,10.1681/ASN.2020040461,2020-06-03
BARRIER,USES,Box,32482688,10.1681/ASN.2020040461,2020-06-03
BARRIER,USES,Box,32482688,10.1681/ASN.2020040461,2020-06-03
Foot,PART_OF,Patients,32482688,10.1681/ASN.2020040461,2020-06-03
Cross Infection,AFFECTS,Severe Acute Respiratory Syndrome,32482654,10.3899/jrheum.200723,2020-06-03
Cross Infection,AFFECTS,Middle East Respiratory Syndrome,32482654,10.3899/jrheum.200723,2020-06-03
Hemodialysis unit,LOCATION_OF,Multicenter Study,32482654,10.3899/jrheum.200723,2020-06-03
screening tests,ADMINISTERED_TO,Persons,32482654,10.3899/jrheum.200723,2020-06-03
patient condition,PROCESS_OF,Community,32482597,10.1016/j.ejim.2020.05.021,2020-06-03
high throughput screening,USES,molecular diagnostics (lab procedure),32482597,10.1016/j.ejim.2020.05.021,2020-06-03
Diagnosis,METHOD_OF,high throughput screening,32482597,10.1016/j.ejim.2020.05.021,2020-06-03
Hyperactive behavior,PROCESS_OF,Patients,32482591,10.1016/j.virusres.2020.198024,2020-06-03
tocilizumab,TREATS,Patients,32482591,10.1016/j.virusres.2020.198024,2020-06-03
"Antibodies, Monoclonal, Humanized",INTERACTS_WITH,Interleukin 6 Receptor,32482591,10.1016/j.virusres.2020.198024,2020-06-03
tocilizumab,TREATS,Patients,32482591,10.1016/j.virusres.2020.198024,2020-06-03
Pulmonary thrombosis,PROCESS_OF,Cohort,32482591,10.1016/j.virusres.2020.198024,2020-06-03
Alphacoronavirus,ISA,Virus,32482587,10.1016/j.sapharm.2020.05.024,2020-06-03
"CD69 protein, human",COEXISTS_WITH,IMPACT gene,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
Acetaminophen,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
Ascorbic Acid,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
Metformin,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
formoterol,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
ezetimibe,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
dapagliflozin,ISA,Pharmaceutical Preparations,32482571,10.1016/j.anorl.2020.04.014,2020-06-03
Local Therapy,USES,Adrenal Cortex Hormones,32482542,10.1016/j.clinre.2020.05.003,2020-06-03
Local Therapy,NEG_TREATS,Bacterial Infections,32482542,10.1016/j.clinre.2020.05.003,2020-06-03
Local Therapy,USES,Adrenal Cortex Hormones,32482542,10.1016/j.clinre.2020.05.003,2020-06-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32482538,10.1016/j.reuma.2020.04.009,2020-06-03
Acute obstructive cholangitis,PROCESS_OF,Patients,32482538,10.1016/j.reuma.2020.04.009,2020-06-03
Symptoms,PROCESS_OF,Patients,32482538,10.1016/j.reuma.2020.04.009,2020-06-03
Diagnosis,DIAGNOSES,Acute obstructive cholangitis,32482538,10.1016/j.reuma.2020.04.009,2020-06-03
Storm NOS,DISRUPTS,Alveolar,32482485,10.1016/j.sleep.2020.05.021,2020-06-03
anakinra,ISA,Biological Factors,32482485,10.1016/j.sleep.2020.05.021,2020-06-03
Disease,PROCESS_OF,line worker,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Coronavirus Infections,ISA,Disease,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Coronavirus Infections,PROCESS_OF(SPEC),line worker,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Stress,COEXISTS_WITH,Disease,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Stress,COEXISTS_WITH(SPEC),Coronavirus Infections,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Coronavirus Infections,ISA,Disease,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Stress,COEXISTS_WITH,Disease,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Stress,COEXISTS_WITH(SPEC),Coronavirus Infections,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Coronavirus Infections,ISA,Disease,32482483,10.1016/j.ajem.2020.05.079,2020-06-03
Symptom mild,PROCESS_OF,Patients,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
intensive care unit,LOCATION_OF,Ultrasonography,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
Lung,LOCATION_OF,Ultrasonography,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
Pulmonary Pathology,PROCESS_OF,Patients,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
Department,LOCATION_OF,Ultrasonography,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
Lung finding,PROCESS_OF,Patients,32482373,10.1016/j.arcmed.2020.05.009,2020-06-03
High Level,COEXISTS_WITH,Disease,32482366,10.1016/j.jmii.2020.05.013,2020-06-03
High Level,PROCESS_OF,Patients,32482366,10.1016/j.jmii.2020.05.013,2020-06-03
Patients,LOCATION_OF,Interleukin-6,32482366,10.1016/j.jmii.2020.05.013,2020-06-03
tocilizumab,INHIBITS(SPEC),Janus kinase,32482366,10.1016/j.jmii.2020.05.013,2020-06-03
tocilizumab,ISA,"Antibodies, Monoclonal, Humanized",32482366,10.1016/j.jmii.2020.05.013,2020-06-03
"Antibodies, Monoclonal, Humanized",INHIBITS,Janus kinase,32482366,10.1016/j.jmii.2020.05.013,2020-06-03
Coinfection,PROCESS_OF,Patients,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Coinfection,PROCESS_OF,Patients,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
patient condition,PROCESS_OF,Survivors,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Streptococcus pneumoniae,ISA,Bacteria,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Severe Acute Respiratory Syndrome,ASSOCIATED_WITH,Respiratory pathogens,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Clinician,DIAGNOSES,Severe Acute Respiratory Syndrome,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Respiratory pathogens,CAUSES,Coinfection,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Pathogenic organism,CAUSES,Coinfection,32482348,10.1016/j.bjoms.2020.05.020,2020-06-03
Coronavirus Infections,ISA,Disease,32482336,10.1016/j.ygyno.2020.05.028,2020-06-03
Movement,PROCESS_OF,Population Group,32482336,10.1016/j.ygyno.2020.05.028,2020-06-03
Remote Consultation,ADMINISTERED_TO,Patients,32482336,10.1016/j.ygyno.2020.05.028,2020-06-03
Ovarian Carcinoma,ISA,Malignant Neoplasms,32482306,10.1016/j.ijlp.2020.101564,2020-06-03
Psychiatrist,NEG_TREATS,Patients,32482298,10.1016/j.ijlp.2020.101560,2020-06-03
Ovum,INTERACTS_WITH,Germ Cells,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Body tissue,LOCATION_OF,receptor,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Orchitis,DISRUPTS,Germ Cells,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Destructive procedure (surgical),TREATS,Males,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Ovary,LOCATION_OF,angiotensin converting enzyme 2,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Ovary,PART_OF,Homo sapiens,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
"Signs and Symptoms, Respiratory",PROCESS_OF,Woman,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Asymptomatic,PROCESS_OF,Woman,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Premature Birth,COEXISTS_WITH,Coronavirus Infections,32482249,10.1016/j.fertnstert.2020.04.024,2020-06-03
Seminal fluid,PART_OF,Patients,32482155,10.1177/0194599820933168,2020-06-03
Scrotum,LOCATION_OF,Malaise,32482155,10.1177/0194599820933168,2020-06-03
Testis,LOCATION_OF,angiotensin converting enzyme 2,32482155,10.1177/0194599820933168,2020-06-03
Testis,LOCATION_OF,TMPRSS2 gene,32482155,10.1177/0194599820933168,2020-06-03
Testis,PART_OF,Homo sapiens,32482155,10.1177/0194599820933168,2020-06-03
Plant seeds,NEG_LOCATION_OF,angiotensin converting enzyme 2,32482155,10.1177/0194599820933168,2020-06-03
Plant seeds,NEG_LOCATION_OF,TMPRSS2 gene,32482155,10.1177/0194599820933168,2020-06-03
Testis,LOCATION_OF,Unlikely,32482155,10.1177/0194599820933168,2020-06-03
Testis,PART_OF,Homo sapiens,32482155,10.1177/0194599820933168,2020-06-03
angiotensin converting enzyme 2,AFFECTS,Virus Internalization,32482155,10.1177/0194599820933168,2020-06-03
Laryngectomy,PREDISPOSES,Disease,32482142,10.1177/0194599820933597,2020-06-03
Residency,ISA,Knowledge acquisition,32482134,10.1080/08820139.2020.1773850,2020-06-03
head and neck surgery,COEXISTS_WITH,Operative Surgical Procedures,32482124,10.1177/0194599820933253,2020-06-03
medicare/medicaid,LOCATION_OF,Services,32482124,10.1177/0194599820933253,2020-06-03
"CD69 protein, human",AFFECTS,risk factors,32482087,10.1161/CIRCHEARTFAILURE.120.007274,2020-06-03
Heart failure,PROCESS_OF,Patients,32482077,10.1021/acssensors.0c00979,2020-06-03
Heart failure,PROCESS_OF,Patients,32482077,10.1021/acssensors.0c00979,2020-06-03
Therapeutic procedure,USES,Anti-Inflammatory Agents,32481719,10.3390/ijms21113848,2020-06-03
Septicemia,COEXISTS_WITH,Immunocompromised Host,32481719,10.3390/ijms21113848,2020-06-03
Coinfection,COEXISTS_WITH,Immunocompromised Host,32481719,10.3390/ijms21113848,2020-06-03
"RNA, Untranslated",AFFECTS,Gene Expression,32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,AFFECTS(SPEC),Gene Expression,32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,ISA,"RNA, Untranslated",32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,INTERACTS_WITH,Ion Channel,32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,INTERACTS_WITH,Membrane Transport Proteins,32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,AFFECTS,Host defense,32481690,10.3390/ijms21113843,2020-06-03
MicroRNAs,AFFECTS,Homeostasis,32481690,10.3390/ijms21113843,2020-06-03
Pathogenic organism,ASSOCIATED_WITH,Communicable Diseases,32481672,10.3390/ijerph17113835,2020-06-03
Awareness,PROCESS_OF,Dentist,32481629,10.3390/ijerph17113827,2020-06-03
Perception,PROCESS_OF,Dentist,32481629,10.3390/ijerph17113827,2020-06-03
Life Style,ISA,Behavior,32481547,10.3390/ijerph17113819,2020-06-03
Life Style,ISA,Behavior,32481547,10.3390/ijerph17113819,2020-06-03
Acupuncture procedure,ISA,Interventional procedure,32481381,10.1097/MD.0000000000020166,2020-06-03
World,LOCATION_OF,IMPACT gene,32481380,10.1097/MD.0000000000020157,2020-06-03
Smoking History,PROCESS_OF,Patients,32481380,10.1097/MD.0000000000020157,2020-06-03
Right lung,LOCATION_OF,Squamous cell carcinoma,32481380,10.1097/MD.0000000000020157,2020-06-03
Right lung,LOCATION_OF,Nodule,32481380,10.1097/MD.0000000000020157,2020-06-03
Complication,PROCESS_OF,Patients,32481333,10.1097/MD.0000000000020370,2020-06-03
intensive care unit,LOCATION_OF,Study,32481333,10.1097/MD.0000000000020370,2020-06-03
Oxygen Therapy Care,USES,Nasal Cannula,32481333,10.1097/MD.0000000000020370,2020-06-03
Mechanical ventilation,PRECEDES,Oxygen Therapy Care,32481333,10.1097/MD.0000000000020370,2020-06-03
Prognosis bad,PROCESS_OF,Patients,32481333,10.1097/MD.0000000000020370,2020-06-03
"Pneumonia, Ventilator-Associated",ISA,Complication,32481333,10.1097/MD.0000000000020370,2020-06-03
"Pneumonia, Ventilator-Associated",PROCESS_OF(SPEC),Patients,32481333,10.1097/MD.0000000000020370,2020-06-03
Intubation,TREATS,Patients,32481333,10.1097/MD.0000000000020370,2020-06-03
Discrepancy,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
Abnormal Finding,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
Abnormal Finding,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
Ground Glass Opacity,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
CAT scan normal,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
Ground Glass Opacity,PROCESS_OF,Patients,32481322,10.1097/MD.0000000000020335,2020-06-03
Pharmacotherapy,ADMINISTERED_TO,Patients,32480419,10.1111/bjh.16905,2020-06-02
Primary amyloidosis,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Hypotension,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Nephrotic Syndrome,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Primary amyloidosis,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Gastrointestinal symptom,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Neuropathy,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Cardiac dysfunction,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Primary amyloidosis,PROCESS_OF,Patients,32480419,10.1111/bjh.16905,2020-06-02
Medical procedure,TREATS,Disease,32480326,10.1016/j.msard.2020.102196,2020-06-02
Comorbidity,PROCESS_OF,Patients,32480226,10.1016/j.biopha.2020.110296,2020-06-02
Interferon Type I,TREATS,Multiple Sclerosis,32480226,10.1016/j.biopha.2020.110296,2020-06-02
Interferon Type I,TREATS,Patients,32480226,10.1016/j.biopha.2020.110296,2020-06-02
Quarantine,USES,Interferon Type I,32480226,10.1016/j.biopha.2020.110296,2020-06-02
Crisis,PREDISPOSES,Disease,32480215,10.1016/j.jcv.2020.104470,2020-06-02
Severe Acute Respiratory Syndrome,AFFECTS,Ethnic group,32480215,10.1016/j.jcv.2020.104470,2020-06-02
Laboratory Procedures,DIAGNOSES,Disease Progression,32480215,10.1016/j.jcv.2020.104470,2020-06-02
Present,PREDISPOSES,Respiration Disorders,32480215,10.1016/j.jcv.2020.104470,2020-06-02
Respiratory Tract Infections,PROCESS_OF,Patients,32480215,10.1016/j.jcv.2020.104470,2020-06-02
Respiratory Tract Infections,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32480215,10.1016/j.jcv.2020.104470,2020-06-02
Rome,ISA,Geographic Locations,32480154,10.1016/j.scitotenv.2020.139510,2020-06-02
Laboratory,LOCATION_OF,Real-Time Polymerase Chain Reaction,32480154,10.1016/j.scitotenv.2020.139510,2020-06-02
Influenza,ISA,Illness (finding),32480154,10.1016/j.scitotenv.2020.139510,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32480154,10.1016/j.scitotenv.2020.139510,2020-06-02
Respiratory Tract Infections,PROCESS_OF,Persons,32480136,10.1016/j.ijporl.2020.110092,2020-06-02
Influenza,PROCESS_OF,Voluntary Workers,32480136,10.1016/j.ijporl.2020.110092,2020-06-02
Disease,COEXISTS_WITH,Asymptomatic,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Infant,ISA,Child,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Foreign body in nose,PROCESS_OF,Child,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Asymptomatic,PROCESS_OF,Child,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Asymptomatic Infections,COEXISTS_WITH,Enthesitis-Related Arthritis,32480121,10.1016/j.psychres.2020.113117,2020-06-02
Depressive disorder,AFFECTS,Respondents,32480061,10.1016/j.scitotenv.2020.139765,2020-06-02
Immune Complex Diseases,ISA,Hypersensitivity,32479985,10.1016/j.clim.2020.108486,2020-06-02
"Myocytes, Smooth Muscle",PART_OF,Blood Vessel,32479985,10.1016/j.clim.2020.108486,2020-06-02
Wall of blood vessel,LOCATION_OF,Immune complex,32479985,10.1016/j.clim.2020.108486,2020-06-02
Lymphopenia,PROCESS_OF,Patients,32479979,10.1016/j.jaad.2020.05.109,2020-06-02
Pneumonia,PROCESS_OF,hospitalized patients,32479979,10.1016/j.jaad.2020.05.109,2020-06-02
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,hospitalized patients,32479979,10.1016/j.jaad.2020.05.109,2020-06-02
Lymphopenia,PREDISPOSES,Prognosis bad,32479979,10.1016/j.jaad.2020.05.109,2020-06-02
Prognosis bad,PROCESS_OF,Patients,32479979,10.1016/j.jaad.2020.05.109,2020-06-02
Chilblains,COEXISTS_WITH,Confirmation,32479958,10.1016/j.scitotenv.2020.139487,2020-06-02
Chilblains,PROCESS_OF,Patients,32479958,10.1016/j.scitotenv.2020.139487,2020-06-02
Chilblains,ISA,Symptoms,32479958,10.1016/j.scitotenv.2020.139487,2020-06-02
Symptoms,PROCESS_OF,Patients,32479958,10.1016/j.scitotenv.2020.139487,2020-06-02
"Kidney Failure, Acute",COEXISTS_WITH,Coronavirus Infections,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Body Fluids,CAUSES,Ischemia of kidney,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Kidney,LOCATION_OF,Virus,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
"Kidney Failure, Acute",COEXISTS_WITH,Coronavirus Infections,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Coronavirus Infections,PROCESS_OF,Patients,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Atrial Fibrillation,NEG_PROCESS_OF,Patients,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Differential Diagnosis,DIAGNOSES,patient condition,32479915,10.1016/j.ijsu.2020.05.076,2020-06-02
Headache,PROCESS_OF,Woman,32479908,10.1016/j.wneu.2020.05.237,2020-06-02
Seizures,PROCESS_OF,Woman,32479908,10.1016/j.wneu.2020.05.237,2020-06-02
Histological Techniques,DIAGNOSES,Encephalitis,32479908,10.1016/j.wneu.2020.05.237,2020-06-02
Clinician,TREATS,Patients,32479908,10.1016/j.wneu.2020.05.237,2020-06-02
Skull Base Operation,TREATS,Patients,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Radical excision,TREATS,Males,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Cerebrospinal fluid leak,PROCESS_OF,Patients,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Meningitis,PROCESS_OF,Patients,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Respiratory Failure,COMPLICATES,"Respiratory Distress Syndrome, Adult",32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Flap necrosis,PROCESS_OF,Patients,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Complication,AFFECTS,Thrombosis of blood vessel,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Complication,AFFECTS,Flap necrosis,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Pedicle,LOCATION_OF,Thrombosis of blood vessel,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Body tissue,PART_OF,Nose,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Skull Base Operation,TREATS,Enthesitis-Related Arthritis,32479900,10.1016/j.hrthm.2020.05.030,2020-06-02
Prescribed medications,TREATS,patient condition,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
Fluorescent Dyes,INTERACTS_WITH,Hydroxychloroquine,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
Heart,PART_OF,Rabbits,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
Cardiac complication,PROCESS_OF,Cavia,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
Cardiac complication,PROCESS_OF,Rabbits,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
alternan,INTERACTS_WITH,Hydroxychloroquine,32479893,10.1016/j.ijantimicag.2020.106037,2020-06-02
Ivermectin,ISA,Antiparasitic Agents,32479865,10.1016/j.ijid.2020.05.085,2020-06-02
Pharmaceutical Preparations,TREATS,Filarial Elephantiases,32479865,10.1016/j.ijid.2020.05.085,2020-06-02
Pharmaceutical Preparations,TREATS,Onchocerciasis,32479865,10.1016/j.ijid.2020.05.085,2020-06-02
disease transmission,PROCESS_OF,Helminths,32479865,10.1016/j.ijid.2020.05.085,2020-06-02
Anti-Retroviral Agents,TREATS,HIV Infections,32479861,10.1016/j.jpainsymman.2020.05.026,2020-06-02
Infection,PROCESS_OF,human group,32479844,10.1016/j.ajic.2020.05.026,2020-06-02
Mechanical Ventilator,USES,Aerosols,32479829,10.1016/S0140-6736(20)31182-X,2020-06-02
Hospitals,LOCATION_OF,Study,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
pulmonary complications,PROCESS_OF,Patients,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
pulmonary complications,PROCESS_OF,Patients,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
Elective Surgical Procedures,compared_with,Minor Surgical Procedures,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
Neoplasms,AFFECTS,Upper gastrointestinal surgeon,32479816,10.1016/j.tmaid.2020.101755,2020-06-02
compromise,PROCESS_OF,Patients,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Inflammation,COEXISTS_WITH,Storm Syndrome,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Severe Acute Respiratory Syndrome,COEXISTS_WITH,patient condition,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Lymphopenia,ISA,Leukopenia,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32479811,10.1016/j.joms.2020.05.027,2020-06-02
SARS coronavirus,ISA,Genus: Coronavirus,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Oncolytic Virotherapy,TREATS,Community,32479811,10.1016/j.joms.2020.05.027,2020-06-02
Screening procedure,PREVENTS,Disease,32479798,10.1016/j.jacr.2020.05.021,2020-06-02
Screening procedure,TREATS,Symptoms,32479798,10.1016/j.jacr.2020.05.021,2020-06-02
Physical and emotional exhaustion state,PROCESS_OF,Physicians,32479790,10.1016/S1470-2045(20)30309-0,2020-06-02
Visual Accommodation,AFFECTS,Health Personnel,32479790,10.1016/S1470-2045(20)30309-0,2020-06-02
Physicians,LOCATION_OF,IMPACT gene,32479790,10.1016/S1470-2045(20)30309-0,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,NEG_PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
follow-up,TREATS,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Lymphopenia,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
risk factors,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
risk factors,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Disease Progression,PROCESS_OF,Patients,32479787,10.1016/S1470-2045(20)30310-7,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Malignant Neoplasms,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Therapeutic procedure,ADMINISTERED_TO,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Prognosis bad,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Solid Neoplasm,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Hematologic Neoplasms,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Hematologic Neoplasms,PROCESS_OF,Patients,32479777,10.1016/j.radonc.2020.05.041,2020-06-02
Cessation of life,PROCESS_OF,Persons,32479766,10.1016/j.diabres.2020.108239,2020-06-02
Laboratory Diagnosis,DIAGNOSES,Handling,32479747,10.1016/S1473-3099(20)30438-2,2020-06-02
Infected,PROCESS_OF,Patients,32479747,10.1016/S1473-3099(20)30438-2,2020-06-02
Malaise,PROCESS_OF,Patients,32479747,10.1016/S1473-3099(20)30438-2,2020-06-02
RNA Sequence,ISA,Base Sequence,32479682,10.1111/1471-0528.16339,2020-06-02
RNA Sequence,PART_OF,Cells,32479682,10.1111/1471-0528.16339,2020-06-02
Immune system,LOCATION_OF,Irrigation,32479682,10.1111/1471-0528.16339,2020-06-02
IMPACT gene,PART_OF,Virus,32479682,10.1111/1471-0528.16339,2020-06-02
Monocytes,LOCATION_OF,Human Metapneumovirus,32479682,10.1111/1471-0528.16339,2020-06-02
Pregnancy,AFFECTS,Pre-Eclampsia,32479680,10.1111/bjd.19264,2020-06-02
Pregnancy,AFFECTS,Pre-Eclampsia,32479680,10.1111/bjd.19264,2020-06-02
Pre-Eclampsia,ISA,Hypertensive disease,32479680,10.1111/bjd.19264,2020-06-02
Structure of uterine artery,LOCATION_OF,"Pulsatility index, arterial velocity waveform",32479680,10.1111/bjd.19264,2020-06-02
Structure of uterine artery,LOCATION_OF,"Pulsatility index, arterial velocity waveform",32479680,10.1111/bjd.19264,2020-06-02
"Pulsatility index, arterial velocity waveform",PROCESS_OF,Woman,32479680,10.1111/bjd.19264,2020-06-02
Structure of uterine artery,LOCATION_OF,"Pulsatility index, arterial velocity waveform",32479680,10.1111/bjd.19264,2020-06-02
Syndrome,PROCESS_OF,Woman,32479680,10.1111/bjd.19264,2020-06-02
Skin Manifestations,PROCESS_OF,Patients,32479657,10.1111/gcb.15197,2020-06-02
Vascular Diseases,COEXISTS_WITH,Skin finding,32479657,10.1111/gcb.15197,2020-06-02
Vasculitis,ISA,Lesion,32479657,10.1111/gcb.15197,2020-06-02
Discrepancy,COEXISTS_WITH,Communicable Diseases,32479632,10.1093/jpids/piaa070,2020-06-02
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32479413,10.2196/19045,2020-06-02
Dyspnea,PROCESS_OF,hospitalized patients,32479413,10.2196/19045,2020-06-02
Fever,PROCESS_OF,hospitalized patients,32479413,10.2196/19045,2020-06-02
Comorbidity,PROCESS_OF,hospitalized patients,32479413,10.2196/19045,2020-06-02
Coinfection,PROCESS_OF,hospitalized patients,32479413,10.2196/19045,2020-06-02
Laboratory Infection,PROCESS_OF,Households,32479413,10.2196/19045,2020-06-02
Infected,PROCESS_OF,Adult,32479413,10.2196/19045,2020-06-02
Comorbidity,PREDISPOSES,Severe disorder,32479413,10.2196/19045,2020-06-02
Coinfection,PREDISPOSES,Severe disorder,32479413,10.2196/19045,2020-06-02
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32479411,10.2196/19515,2020-06-02
Nucleic Acids,PART_OF,observers,32479411,10.2196/19515,2020-06-02
Coronavirus Infections,ISA,Disease,32479246,10.2174/1574888X15666200601152832,2020-06-02
Coronavirus Infections,ISA,Disease,32479246,10.2174/1574888X15666200601152832,2020-06-02
"CD69 protein, human",ADMINISTERED_TO,Community,32479246,10.2174/1574888X15666200601152832,2020-06-02
Coronavirus Infections,ISA,Disease,32479246,10.2174/1574888X15666200601152832,2020-06-02
Infected,PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
Single organ dysfunction,PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
Infected,PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
Storm NOS,PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32479239,10.1377/hlthaff.2019.00743,2020-06-02
Attention,PROCESS_OF,Participant,32478971,10.1111/dth.13743,2020-06-02
Immune System Diseases,PROCESS_OF,Patients,32478961,10.1002/ccd.28997,2020-06-02
"Arthritis, Psoriatic",PROCESS_OF,Patients,32478961,10.1002/ccd.28997,2020-06-02
IMPACT gene,PREDISPOSES,Pulmonary Fibrosis,32478961,10.1002/ccd.28997,2020-06-02
Pharmaceutical Preparations,COEXISTS_WITH,PSAT1 wt Allele,32478961,10.1002/ccd.28997,2020-06-02
Tract,LOCATION_OF,Upper airway infection,32478961,10.1002/ccd.28997,2020-06-02
Myocardial Infarction,PROCESS_OF,Patients,32478959,10.1111/dth.13745,2020-06-02
Ear structure,LOCATION_OF,Pressure Ulcer,32478957,10.1002/ccd.28993,2020-06-02
Structure of dorsum of nose,LOCATION_OF,Pressure Ulcer,32478957,10.1002/ccd.28993,2020-06-02
Recombinant Fibroblast Growth Factor 1,PART_OF,Homo sapiens,32478957,10.1002/ccd.28993,2020-06-02
Recombinant Fibroblast Growth Factor 1,TREATS,Pressure Ulcer,32478957,10.1002/ccd.28993,2020-06-02
Recombinant Fibroblast Growth Factor 1,DISRUPTS,Pressure Ulcer,32478957,10.1002/ccd.28993,2020-06-02
Recombinant Fibroblast Growth Factor 1,PART_OF,Homo sapiens,32478957,10.1002/ccd.28993,2020-06-02
Recombinant Fibroblast Growth Factor 1,PART_OF,Homo sapiens,32478957,10.1002/ccd.28993,2020-06-02
Myocardial Infarction,PROCESS_OF,Patients,32478951,10.1002/ejhf.1925,2020-06-02
Myocardial Infarction,PROCESS_OF,Patients,32478951,10.1002/ejhf.1925,2020-06-02
Myocardial Infarction,PROCESS_OF,Patients,32478951,10.1002/ejhf.1925,2020-06-02
Symptom severe,PROCESS_OF,hospitalized patients,32478949,10.1111/dth.13738,2020-06-02
"Dermatitis, Atopic",ISA,Eczema,32478936,10.1111/ene.14368,2020-06-02
Dermatitis,PROCESS_OF,Patients,32478936,10.1111/ene.14368,2020-06-02
Substance,CAUSES,Dermatitis,32478936,10.1111/ene.14368,2020-06-02
Tract,LOCATION_OF,SARS coronavirus,32478897,10.1002/jmv.26093,2020-06-02
gastrointestinal Tests,USES,catheter device,32478897,10.1002/jmv.26093,2020-06-02
Motility,ASSOCIATED_WITH,Enthesitis-Related Arthritis,32478897,10.1002/jmv.26093,2020-06-02
Cell surface,LOCATION_OF,Human virus,32478895,10.1002/cncr.32968,2020-06-02
Squamous Epithelial Cells,LOCATION_OF,Head and Neck Carcinoma,32478867,10.1002/cncr.32969,2020-06-02
Head and Neck Carcinoma,PROCESS_OF,Patients,32478867,10.1002/cncr.32969,2020-06-02
Concurrent Chemoradiotherapy,compared_with,Concurrent Chemoradiotherapy,32478867,10.1002/cncr.32969,2020-06-02
Agenesis of corpus callosum,PART_OF,Patients,32478867,10.1002/cncr.32969,2020-06-02
Concurrent Chemoradiotherapy,compared_with,Concurrent Chemoradiotherapy,32478867,10.1002/cncr.32969,2020-06-02
Concurrent Chemoradiotherapy,compared_with,Concurrent Chemoradiotherapy,32478867,10.1002/cncr.32969,2020-06-02
Concurrent Chemoradiotherapy,TREATS,N2c,32478867,10.1002/cncr.32969,2020-06-02
Merkel cell carcinoma,PROCESS_OF,Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
Disease,PROCESS_OF,Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
complication of disease,ISA,Disease,32478853,10.1093/pubmed/fdaa077,2020-06-02
complication of disease,PROCESS_OF(SPEC),Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
melanoma,PROCESS_OF,Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
Squamous cell carcinoma of skin,PROCESS_OF,Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
Squamous cell carcinoma,PROCESS_OF,Patients,32478853,10.1093/pubmed/fdaa077,2020-06-02
Materials,CAUSES,Compassion Fatigue,32478558,10.1037/tra0000866,2020-06-02
Moderate Level,PROCESS_OF,therapist,32478558,10.1037/tra0000866,2020-06-02
Wounds and Injuries,PROCESS_OF,Survivors,32478554,10.1037/tra0000808,2020-06-02
Wounds and Injuries,PROCESS_OF,Family,32478551,10.1037/tra0000723,2020-06-02
Engaged to be married,PROCESS_OF,Family,32478551,10.1037/tra0000723,2020-06-02
Internet,ISA,Computers,32478551,10.1037/tra0000723,2020-06-02
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Readiness,32478547,10.1037/tra0000632,2020-06-02
Hallucinations,PROCESS_OF,Population Group,32478546,10.1037/tra0000925,2020-06-02
Paranoia,PROCESS_OF,Population Group,32478546,10.1037/tra0000925,2020-06-02
Grief reaction,PROCESS_OF,Research Personnel,32478542,10.1037/tra0000729,2020-06-02
Cessation of life,PROCESS_OF,World,32478540,10.1037/tra0000853,2020-06-02
Challenge,TREATS,Rural Communities,32478540,10.1037/tra0000853,2020-06-02
Pain,COEXISTS_WITH,Stress,32478538,10.1037/tra0000684,2020-06-02
Pain,COEXISTS_WITH,Present,32478538,10.1037/tra0000684,2020-06-02
Infected,PROCESS_OF,Persons,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
Proteins,PART_OF,SARS coronavirus,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
Proteins,PART_OF,SARS coronavirus,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
Proteins,compared_with,ACE2 gene,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
ACE2 gene,PART_OF,SARS coronavirus,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
ACE2 gene,PART_OF,SARS coronavirus,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
Membrane Proteins,PART_OF,ACE2 gene,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
ACE2 gene,AFFECTS,Electrostatics,32478500,10.1021/acsinfecdis.0c00291,2020-06-02
Pharmaceutical Preparations,AFFECTS,Physical Barriers,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Vaccines,AFFECTS,Physical Barriers,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Oral cavity,LOCATION_OF,Protection,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Basis,PREVENTS,Respiratory Tract Infections,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Oral cavity,LOCATION_OF,Protection,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
anatomic valve,NEG_LOCATION_OF,Mechanical Ventilator,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Plague,PROCESS_OF,Physicians,32478496,10.1922/CDH_RavaghiJune20editorial02,2020-06-02
Interventional procedure,PRECEDES,Cardiovascular procedures,32478465,10.1111/liv.14516,2020-06-02
Interleukin-6,AFFECTS,Storm NOS,32478445,10.1002/jum.15367,2020-06-02
Liver,LOCATION_OF,Serious Injury,32478445,10.1002/jum.15367,2020-06-02
Drug-Induced Liver Disease,PROCESS_OF,Patients,32478445,10.1002/jum.15367,2020-06-02
Storm NOS,PROCESS_OF,Patients,32478445,10.1002/jum.15367,2020-06-02
Lung,LOCATION_OF,Ultrasonography,32478302,10.14744/nci.2020.90277,2020-06-02
Coronavirus Infections,ISA,Disease,32478302,10.14744/nci.2020.90277,2020-06-02
Lung,LOCATION_OF,Ultrasonography,32478302,10.14744/nci.2020.90277,2020-06-02
Lung,LOCATION_OF,Ultrasound examination,32478302,10.14744/nci.2020.90277,2020-06-02
Coronavirus Infections,ISA,Disease,32478302,10.14744/nci.2020.90277,2020-06-02
Ultrasound examination,ADMINISTERED_TO,Pregnant Women,32478302,10.14744/nci.2020.90277,2020-06-02
Lung,LOCATION_OF,Ultrasound examination,32478302,10.14744/nci.2020.90277,2020-06-02
Chest CT,AFFECTS,Reverse Transcription,32478302,10.14744/nci.2020.90277,2020-06-02
Ultrasound examination,DIAGNOSES,pulmonary involvement,32478302,10.14744/nci.2020.90277,2020-06-02
Coronavirus Infections,ISA,Disease,32478302,10.14744/nci.2020.90277,2020-06-02
Abnormal Finding,PROCESS_OF,Patients,32478302,10.14744/nci.2020.90277,2020-06-02
Lung,LOCATION_OF,Ultrasonography,32478302,10.14744/nci.2020.90277,2020-06-02
Chest,LOCATION_OF,tomography,32478290,10.14744/nci.2020.62443,2020-06-02
Coughing,ISA,Symptoms,32478290,10.14744/nci.2020.62443,2020-06-02
Dyspnea,ISA,Symptoms,32478290,10.14744/nci.2020.62443,2020-06-02
Fever,ISA,Symptoms,32478290,10.14744/nci.2020.62443,2020-06-02
Rhinorrhea,PROCESS_OF,Patients,32478290,10.14744/nci.2020.62443,2020-06-02
Radionuclide Imaging,DIAGNOSES,Disease,32478290,10.14744/nci.2020.62443,2020-06-02
Bacterial Infections,NEG_PROCESS_OF,Patients,32478290,10.14744/nci.2020.62443,2020-06-02
Gender,ASSOCIATED_WITH,Respiratory Tract Infections,32478289,10.14744/nci.2020.90532,2020-06-02
Disease,PROCESS_OF,Meleagris gallopavo,32477912,10.21037/tp.2020.03.08,2020-06-02
DNA Sequence,PART_OF,Virus,32477912,10.21037/tp.2020.03.08,2020-06-02
Asymptomatic,PROCESS_OF,Patients,32477912,10.21037/tp.2020.03.08,2020-06-02
Pulmonary Infiltrate,PROCESS_OF,Patients,32477912,10.21037/tp.2020.03.08,2020-06-02
Mild disorder,PROCESS_OF,Patients,32477912,10.21037/tp.2020.03.08,2020-06-02
Symptoms,PROCESS_OF,Child,32477887,10.5334/aogh.2894,2020-06-02
Symptoms,PROCESS_OF,Child,32477887,10.5334/aogh.2894,2020-06-02
Coughing,PROCESS_OF,Hospital specialist,32477887,10.5334/aogh.2894,2020-06-02
Fever,PROCESS_OF,Child,32477887,10.5334/aogh.2894,2020-06-02
Fever,PROCESS_OF,Child,32477887,10.5334/aogh.2894,2020-06-02
Hospitals,LOCATION_OF,screening questionnaire,32477887,10.5334/aogh.2894,2020-06-02
screening questionnaire,USES,Triage,32477887,10.5334/aogh.2894,2020-06-02
Psoriasis,AFFECTS,Patients,32477373,10.3389/fimmu.2020.01059,2020-06-02
Biological Factors,PART_OF,Patients,32477373,10.3389/fimmu.2020.01059,2020-06-02
Therapeutic immunosuppression,TREATS,Virus,32477373,10.3389/fimmu.2020.01059,2020-06-02
Infected,PROCESS_OF,Patients,32477373,10.3389/fimmu.2020.01059,2020-06-02
Multiple Sclerosis,ISA,Disease,32477021,10.1177/1559827620918808,2020-06-02
Therapeutic procedure,TREATS,Disease,32477021,10.1177/1559827620918808,2020-06-02
Therapeutic procedure,TREATS(SPEC),Multiple Sclerosis,32477021,10.1177/1559827620918808,2020-06-02
Severe Acute Respiratory Syndrome,NEG_AFFECTS,Severe (severity modifier),32477021,10.1177/1559827620918808,2020-06-02
Middle East Respiratory Syndrome,NEG_AFFECTS,Severe (severity modifier),32477021,10.1177/1559827620918808,2020-06-02
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32477021,10.1177/1559827620918808,2020-06-02
Therapeutic procedure,CAUSES,Lymphopenia,32477021,10.1177/1559827620918808,2020-06-02
Severe course,COEXISTS_WITH,Lymphopenia,32477021,10.1177/1559827620918808,2020-06-02
tositumomab,ISA,Pharmaceutical Preparations,32477021,10.1177/1559827620918808,2020-06-02
Severe disorder,PROCESS_OF,Patients,32477021,10.1177/1559827620918808,2020-06-02
Infected,PROCESS_OF,Persons,32476796,10.3748/wjg.v26.i19.2323,2020-06-02
Coughing,PROCESS_OF,Patients,32476793,10.3748/wjg.v26.i19.2286,2020-06-02
Dyspnea,PROCESS_OF,Patients,32476793,10.3748/wjg.v26.i19.2286,2020-06-02
Fever,PROCESS_OF,Patients,32476793,10.3748/wjg.v26.i19.2286,2020-06-02
Disease,CAUSES,Coronavirus Infections,32476778,10.1016/j.jor.2020.05.014,2020-06-02
Liver damage,PROCESS_OF,Patients,32476778,10.1016/j.jor.2020.05.014,2020-06-02
Swab specimen,ISA,Specimen,32476600,10.1177/0049475520928217,2020-06-02
Immunochromatographic Assay,USES,Gold Colloid,32476600,10.1177/0049475520928217,2020-06-02
Negative,PROCESS_OF,Patients,32476600,10.1177/0049475520928217,2020-06-02
Immunochromatographic Assay,USES,Gold,32476600,10.1177/0049475520928217,2020-06-02
Severe disorder,PROCESS_OF,Patients,32476600,10.1177/0049475520928217,2020-06-02
Antibody Formation,PROCESS_OF,Patients,32476600,10.1177/0049475520928217,2020-06-02
Severe course,PROCESS_OF,Patients,32476600,10.1177/0049475520928217,2020-06-02
Immunochromatographic Assay,USES,Gold,32476600,10.1177/0049475520928217,2020-06-02
contextual factors,PROCESS_OF,Community,32476597,10.1080/08959420.2020.1773192,2020-06-02
Infected,PROCESS_OF,Persons,32476594,10.1080/10799893.2020.1772298,2020-06-02
Behavioral change,PROCESS_OF,Population Group,32476594,10.1080/10799893.2020.1772298,2020-06-02
Coronavirus Infections,CAUSES,Pneumonia,32476586,10.1080/08959420.2020.1773189,2020-06-02
Methyltransferase,INTERACTS_WITH,Pharmaceutical Preparations,32476586,10.1080/08959420.2020.1773189,2020-06-02
Endopeptidases,INTERACTS_WITH,Pharmaceutical Preparations,32476586,10.1080/08959420.2020.1773189,2020-06-02
Severe Acute Respiratory Syndrome,ISA,Disease,32476586,10.1080/08959420.2020.1773189,2020-06-02
Fungi,LOCATION_OF,Metabolite,32476547,10.1161/JAHA.120.017443,2020-06-02
Metabolite,AFFECTS,Virus Attachment,32476547,10.1161/JAHA.120.017443,2020-06-02
Training,ISA,patient care,32476472,10.1161/HYPERTENSIONAHA.120.15353,2020-06-02
Pneumonia,ISA,Disease,32476394,10.17116/otorino20208502163,2020-06-02
Thrombosis,ISA,Disease,32476394,10.17116/otorino20208502163,2020-06-02
angiotensin II,CAUSES,Adverse reactions,32476394,10.17116/otorino20208502163,2020-06-02
Angiotensins,DISRUPTS,reminiscence,32476394,10.17116/otorino20208502163,2020-06-02
Attention,PROCESS_OF,World,32476380,10.23812/EDITORIAL-RONCONI-E-59,2020-06-02
Organ,LOCATION_OF,Symptoms,32476380,10.23812/EDITORIAL-RONCONI-E-59,2020-06-02
Anosmia,PROCESS_OF,Population Group,32476380,10.23812/EDITORIAL-RONCONI-E-59,2020-06-02
Thrombosis,COEXISTS_WITH,Fibrin deposition,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Vascular Diseases,COEXISTS_WITH,Fibrin deposition,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Thrombus,COEXISTS_WITH,Fibrin deposition,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Severe Acute Respiratory Syndrome,CAUSES,"Respiratory Distress Syndrome, Adult",32476324,10.4142/jvs.2020.21.e51,2020-06-02
Alveolar,LOCATION_OF,Fibrin deposition,32476324,10.4142/jvs.2020.21.e51,2020-06-02
cytokine,AFFECTS,Sign or Symptom,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Acute inflammatory disease,AFFECTS,Child,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Immunologic Deficiency Syndromes,CAUSES,Fever,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Virus Diseases,COMPLICATES,Disease,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Immunosuppressive Agents,TREATS,Immunologic Deficiency Syndromes,32476324,10.4142/jvs.2020.21.e51,2020-06-02
Coronavirus Infections,PROCESS_OF,human group,32476308,10.3947/ic.2020.52.2.142,2020-06-02
Infected,PROCESS_OF,Homo sapiens,32476308,10.3947/ic.2020.52.2.142,2020-06-02
Common Cold,COEXISTS_WITH,Communicable Diseases,32476306,10.3346/jkms.2020.35.e201,2020-06-02
Anticoagulants,INHIBITS,C5 gene,32476306,10.3346/jkms.2020.35.e201,2020-06-02
Biological Response Modifiers,COEXISTS_WITH,Antiviral Agents,32476306,10.3346/jkms.2020.35.e201,2020-06-02
heparin,INHIBITS(SPEC),C5 gene,32476306,10.3346/jkms.2020.35.e201,2020-06-02
heparin,ISA,Anticoagulants,32476306,10.3346/jkms.2020.35.e201,2020-06-02
prednisolone,COEXISTS_WITH(SPEC),Antiviral Agents,32476306,10.3346/jkms.2020.35.e201,2020-06-02
prednisolone,INHIBITS,C5 gene,32476306,10.3346/jkms.2020.35.e201,2020-06-02
prednisolone,ISA,Biological Response Modifiers,32476306,10.3346/jkms.2020.35.e201,2020-06-02
Immunity,PROCESS_OF,Population Group,32476306,10.3346/jkms.2020.35.e201,2020-06-02
Anosmia,ISA,Neurologic Symptoms,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Ageusia,ISA,Neurologic Symptoms,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Immunosuppressive Agents,NEG_AFFECTS,Symptoms,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Smell Perception,PROCESS_OF,Patients,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Ankylosing spondylitis,PROCESS_OF,Patients,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Etanercept,TREATS,Ankylosing spondylitis,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Neurologic Examination,DIAGNOSES,Hypogeusia,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Neurologic Examination,DIAGNOSES,Sense of smell impaired,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Etanercept,AFFECTS,Smell Perception,32476305,10.3346/jkms.2020.35.e199,2020-06-02
Korea,ISA,Country,32476285,10.1111/ajt.16081,2020-06-02
Study,MEASURES,Adjusted Life Years,32476285,10.1111/ajt.16081,2020-06-02
Decision,PROCESS_OF,Maker (occupation),32476285,10.1111/ajt.16081,2020-06-02
Respiratory sample,PART_OF,Tissue Donors,32476261,10.1111/ajt.16080,2020-06-02
Elevated C-reactive protein,COEXISTS_WITH,Influenza-like illness,32476258,10.1111/ajt.16079,2020-06-02
Elevated C-reactive protein,COEXISTS_WITH,inflammatory response,32476258,10.1111/ajt.16079,2020-06-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Recipient,32476258,10.1111/ajt.16079,2020-06-02
Experience,PROCESS_OF,Recipient,32476258,10.1111/ajt.16079,2020-06-02
tocilizumab,ISA,Interleukin inhibitors,32476258,10.1111/ajt.16079,2020-06-02
Chimeric Antigen Receptor T-Cell Therapy,CAUSES,Collagen Diseases,32476258,10.1111/ajt.16079,2020-06-02
Chimeric Antigen Receptor T-Cell Therapy,CAUSES,Cytokine release syndrome,32476258,10.1111/ajt.16079,2020-06-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Recipient,32476258,10.1111/ajt.16079,2020-06-02
Duration,INHIBITS,C-reactive protein,32476258,10.1111/ajt.16079,2020-06-02
Immunocompromised Host,PREDISPOSES,Severe disorder,32476233,10.1111/ajt.16082,2020-06-02
Experience,PROCESS_OF,Patients,32476233,10.1111/ajt.16082,2020-06-02
Malignant Head and Neck Neoplasm,AFFECTS,Patients,32476175,10.1002/eat.23318,2020-06-02
Malignant Head and Neck Neoplasm,AFFECTS,Patients,32476175,10.1002/eat.23318,2020-06-02
Clinical Management,TREATS,Patients,32476175,10.1002/eat.23318,2020-06-02
Neoplasms,PROCESS_OF,Patients,32476175,10.1002/eat.23318,2020-06-02
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32476175,10.1002/eat.23318,2020-06-02
Challenge,TREATS,Patients,32476175,10.1002/eat.23318,2020-06-02
Challenge,TREATS,"Ear, nose and throat surgeon",32476175,10.1002/eat.23318,2020-06-02
Severe Acute Respiratory Syndrome,CAUSES,Hospitalization,32476175,10.1002/eat.23318,2020-06-02
Sleep behavior finding,PREDISPOSES,Eating Disorders,32476163,10.1002/eat.23317,2020-06-02
Protective Factors,PREDISPOSES,Eating Disorders,32476163,10.1002/eat.23317,2020-06-02
IMPACT gene,PREDISPOSES,Eating Disorders,32476163,10.1002/eat.23317,2020-06-02
Exercise,ISA,Behavior,32476158,10.1002/hpm.2986,2020-06-02
Eating,PROCESS_OF,australian,32476158,10.1002/hpm.2986,2020-06-02
Eating Disorders,PROCESS_OF,Persons,32476158,10.1002/hpm.2986,2020-06-02
Exercise,ISA,Behavior,32476158,10.1002/hpm.2986,2020-06-02
Exercise,ISA,Behavior,32476158,10.1002/hpm.2986,2020-06-02
Exercise,ISA,Behavior,32476158,10.1002/hpm.2986,2020-06-02
Eating Disorders,PROCESS_OF,Patients,32476158,10.1002/hpm.2986,2020-06-02
Eating,PROCESS_OF,general population,32476158,10.1002/hpm.2986,2020-06-02
Exercise,ISA,Behavior,32476158,10.1002/hpm.2986,2020-06-02
Birth,AFFECTS,Persons,32476155,10.1002/jso.26057,2020-06-02
Ovarian Carcinoma,PROCESS_OF,Patients,32476080,10.1007/s11239-020-02162-z,2020-06-02
Ovarian Carcinoma,AFFECTS,Patients,32476080,10.1007/s11239-020-02162-z,2020-06-02
heparin,TREATS,Patients,32476041,10.1007/s00392-020-01676-z,2020-06-02
Oxygen Therapy Care,USES,heparin,32476041,10.1007/s00392-020-01676-z,2020-06-02
tocilizumab,COEXISTS_WITH,Ritonavir,32476041,10.1007/s00392-020-01676-z,2020-06-02
tocilizumab,COEXISTS_WITH,lopinavir,32476041,10.1007/s00392-020-01676-z,2020-06-02
tocilizumab,COEXISTS_WITH,Oseltamivir,32476041,10.1007/s00392-020-01676-z,2020-06-02
heparin,TREATS,Patients,32476041,10.1007/s00392-020-01676-z,2020-06-02
heparin,TREATS,Community,32476041,10.1007/s00392-020-01676-z,2020-06-02
Hospitals,LOCATION_OF,Study,32476041,10.1007/s00392-020-01676-z,2020-06-02
Chest Pain,PROCESS_OF,Patients,32476001,10.1093/ibd/izaa143,2020-06-02
Disease,AFFECTS,Persons,32475884,10.2188/jea.JE20200150,2020-06-02
Experience,PROCESS_OF,Greeks,32475884,10.2188/jea.JE20200150,2020-06-02
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32475884,10.2188/jea.JE20200150,2020-06-02
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32475884,10.2188/jea.JE20200150,2020-06-02
Therapeutic procedure,TREATS,Patients,32475884,10.2188/jea.JE20200150,2020-06-02
Therapeutic procedure,TREATS(INFER),Inflammatory Bowel Diseases,32475884,10.2188/jea.JE20200150,2020-06-02
Inflammatory Bowel Diseases,PROCESS_OF,Community,32475884,10.2188/jea.JE20200150,2020-06-02
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32475884,10.2188/jea.JE20200150,2020-06-02
Pandemics,ISA,Disease Outbreaks,32475881,10.7883/yoken.JJID.2020.240,2020-06-02
traveler,LOCATION_OF,Throat swab sample,32475880,10.7883/yoken.JJID.2020.194,2020-06-02
Patients,LOCATION_OF,Blood,32475878,10.7883/yoken.JJID.2020.181,2020-06-02
risk factors,PROCESS_OF,Patients,32475878,10.7883/yoken.JJID.2020.181,2020-06-02
Critical Illness,PROCESS_OF,Patients,32475878,10.7883/yoken.JJID.2020.181,2020-06-02
Coronavirus Infections,CAUSES,Communicable Diseases,32475877,10.7883/yoken.JJID.2020.165,2020-06-02
Influenza,PROCESS_OF,Child,32475877,10.7883/yoken.JJID.2020.165,2020-06-02
Human metapneumovirus infection,PROCESS_OF,Child,32475877,10.7883/yoken.JJID.2020.165,2020-06-02
Cross Infection,PROCESS_OF,Health Personnel,32475876,10.7883/yoken.JJID.2020.098,2020-06-02
Severe Acute Respiratory Syndrome,PREDISPOSES,Cross Infection,32475876,10.7883/yoken.JJID.2020.098,2020-06-02
Fever,PROCESS_OF,Patients,32475873,10.7883/yoken.JJID.2020.067,2020-06-02
Lung,PART_OF,Patients,32475873,10.7883/yoken.JJID.2020.067,2020-06-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32475841,10.12809/hkmj208606,2020-06-02
Readiness,PROCESS_OF,member,32475827,10.1136/rapm-2020-101640,2020-06-02
Physicians,TREATS,Patients,32475827,10.1136/rapm-2020-101640,2020-06-02
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Personal protective equipment,32475827,10.1136/rapm-2020-101640,2020-06-02
Infantile Neuroaxonal Dystrophy,COEXISTS_WITH,medical care,32475821,10.1136/bjsports-2020-102596,2020-06-02
MULTISYSTEM DISORDER,CAUSES,Cessation of life,32475810,10.1016/j.lfs.2020.117788,2020-06-02
Pain,PROCESS_OF,Specialist,32475810,10.1016/j.lfs.2020.117788,2020-06-02
Confirmation,PROCESS_OF,Persons,32475807,10.1016/j.jiph.2020.05.010,2020-06-02
Troponin,PART_OF,Heart,32475807,10.1016/j.jiph.2020.05.010,2020-06-02
Complication,PROCESS_OF,Patients,32475807,10.1016/j.jiph.2020.05.010,2020-06-02
High Level,PROCESS_OF,Patients,32475807,10.1016/j.jiph.2020.05.010,2020-06-02
X-Ray Computed Tomography,DIAGNOSES,assessment.initial,32475761,10.1016/j.ajem.2020.05.066,2020-06-02
Pneumothorax,PROCESS_OF,Patients,32475761,10.1016/j.ajem.2020.05.066,2020-06-02
Subcutaneous Emphysema,PROCESS_OF,Patients,32475761,10.1016/j.ajem.2020.05.066,2020-06-02
Pharmaceutical Preparations,AFFECTS,Delirium,32475759,10.1016/j.cytogfr.2020.05.009,2020-06-02
Dexmedetomidine,TREATS,Compliance,32475759,10.1016/j.cytogfr.2020.05.009,2020-06-02
Pneumonia,CAUSES,Multiple Organ Failure,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
Pneumonia,CAUSES,Cytokine release syndrome,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
"Respiratory Distress Syndrome, Adult",CAUSES,Multiple Organ Failure,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
"Respiratory Distress Syndrome, Adult",CAUSES,Cytokine release syndrome,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
Adverse effects,PROCESS_OF,Patients,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
Interleukin-6,AFFECTS,Disease Exacerbation,32475747,10.1016/j.eururo.2020.05.013,2020-06-02
Awareness,PROCESS_OF,Urologists,32475734,10.1016/j.bjps.2020.05.037,2020-06-02
Increased frequency of micturition,PROCESS_OF,Patients,32475734,10.1016/j.bjps.2020.05.037,2020-06-02
Symptoms,PROCESS_OF,Patients,32475734,10.1016/j.bjps.2020.05.037,2020-06-02
Persons,LOCATION_OF,IMPACT gene,32475692,10.1016/j.encep.2020.05.003,2020-06-02
mental health,PROCESS_OF,Health Personnel,32475692,10.1016/j.encep.2020.05.003,2020-06-02
Population Group,LOCATION_OF,IMPACT gene,32475692,10.1016/j.encep.2020.05.003,2020-06-02
Decompensation,PROCESS_OF,Patients,32475692,10.1016/j.encep.2020.05.003,2020-06-02
Severe disorder,PROCESS_OF,Patients,32475692,10.1016/j.encep.2020.05.003,2020-06-02
Psychiatric therapeutic procedure,TREATS,general population,32475692,10.1016/j.encep.2020.05.003,2020-06-02
Quarantine,AFFECTS,Circadian Rhythms,32475597,10.1016/j.carbpol.2020.116346,2020-06-02
Quarantine,AFFECTS,Sleep,32475597,10.1016/j.carbpol.2020.116346,2020-06-02
Quarantine,TREATS,Sleep behavior finding,32475597,10.1016/j.carbpol.2020.116346,2020-06-02
Extraction,METHOD_OF,Pharmacology,32475376,10.1192/bjb.2020.61,2020-06-02
"CD69 protein, human",ADMINISTERED_TO,World,32475347,10.1186/s13075-020-02211-1,2020-06-02
Mental disorders,PROCESS_OF,Persons,32475347,10.1186/s13075-020-02211-1,2020-06-02
Emotions,PROCESS_OF,Persons,32475347,10.1186/s13075-020-02211-1,2020-06-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Homeless persons,32475347,10.1186/s13075-020-02211-1,2020-06-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Migrants,32475347,10.1186/s13075-020-02211-1,2020-06-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Minority Groups,32475347,10.1186/s13075-020-02211-1,2020-06-02
Mental disorders,PROCESS_OF,Persons,32475347,10.1186/s13075-020-02211-1,2020-06-02
Hydroxychloroquine,TREATS,Rheumatoid Arthritis,32475257,10.1080/08959420.2020.1774312,2020-06-02
Hydroxychloroquine,TREATS,"Lupus Erythematosus, Systemic",32475257,10.1080/08959420.2020.1774312,2020-06-02
Hydroxychloroquine,TREATS,Rheumatic Fever,32475257,10.1080/08959420.2020.1774312,2020-06-02
Plasma,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
peripheral blood,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Serum,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Therapeutic Drug Monitoring,USES,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Hydroxychloroquine,TREATS,Patients,32475257,10.1080/08959420.2020.1774312,2020-06-02
Hydroxychloroquine,TREATS(INFER),"Lupus Erythematosus, Systemic",32475257,10.1080/08959420.2020.1774312,2020-06-02
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,PART_OF,Homo sapiens,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,PART_OF,Homo sapiens,32475257,10.1080/08959420.2020.1774312,2020-06-02
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32475257,10.1080/08959420.2020.1774312,2020-06-02
Patients,LOCATION_OF,Plasma,32475257,10.1080/08959420.2020.1774312,2020-06-02
Patients,LOCATION_OF,peripheral blood,32475257,10.1080/08959420.2020.1774312,2020-06-02
Patients,LOCATION_OF,Serum,32475257,10.1080/08959420.2020.1774312,2020-06-02
Plasma,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
peripheral blood,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Serum,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Liquid Chromatography Mass Spectrometry,USES,High resolution,32475257,10.1080/08959420.2020.1774312,2020-06-02
Liquid Chromatography Mass Spectrometry,USES,High resolution,32475257,10.1080/08959420.2020.1774312,2020-06-02
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,LOCATION_OF,Hydroxychloroquine,32475257,10.1080/08959420.2020.1774312,2020-06-02
Blood,PART_OF,Homo sapiens,32475257,10.1080/08959420.2020.1774312,2020-06-02
Hydroxychloroquine,TREATS,Patients,32475257,10.1080/08959420.2020.1774312,2020-06-02
Critical Illness,PROCESS_OF,Patients,32475223,10.1080/07391102.2020.1775123,2020-06-02
Serum,LOCATION_OF,Interleukin-6,32475223,10.1080/07391102.2020.1775123,2020-06-02
Host Cell,LOCATION_OF,receptor,32475183,10.1080/13543784.2020.1777277,2020-06-02
RNA Recognition Motif,PART_OF,"M Protein, multiple myeloma",32475183,10.1080/13543784.2020.1777277,2020-06-02
RNA Recognition Motif,PART_OF,"ACE2 protein, human",32475183,10.1080/13543784.2020.1777277,2020-06-02
Evaluation,TREATS,Patient in hospital,32475157,10.1177/2047487320930596,2020-06-02
Ritonavir,TREATS,HIV,32475157,10.1177/2047487320930596,2020-06-02
Respiratory sample,LOCATION_OF,Ritonavir,32475157,10.1177/2047487320930596,2020-06-02
Respiratory sample,LOCATION_OF,lopinavir,32475157,10.1177/2047487320930596,2020-06-02
lopinavir,TREATS,HIV,32475157,10.1177/2047487320930596,2020-06-02
Exercise,TREATS,Infection,32475144,10.1177/1010539520931326,2020-06-02
Heart,LOCATION_OF,SARS coronavirus,32475144,10.1177/1010539520931326,2020-06-02
Uncertainty,PROCESS_OF,Athletes,32475144,10.1177/1010539520931326,2020-06-02
IMPACT gene,CAUSES,Anxiety,32475144,10.1177/1010539520931326,2020-06-02
IMPACT gene,PART_OF,SARS coronavirus,32475144,10.1177/1010539520931326,2020-06-02
Coronavirus Infections,CAUSES,Communicable Diseases,32475091,10.31128/AJGP-COVID-22,2020-06-02
Fever,ISA,Symptoms,32475091,10.31128/AJGP-COVID-22,2020-06-02
Conjunctivitis,PROCESS_OF,Woman,32475091,10.31128/AJGP-COVID-22,2020-06-02
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32475066,10.1002/cpmc.105,2020-06-01
Performance,PROCESS_OF,Patients,32475066,10.1002/cpmc.105,2020-06-01
"CD69 protein, human",ASSOCIATED_WITH,Inflammatory Bowel Diseases,32475066,10.1002/cpmc.105,2020-06-01
Disease,PROCESS_OF,Patients,32475066,10.1002/cpmc.105,2020-06-01
Disease,COEXISTS_WITH,Liver transplant recipient,32475052,10.1111/tan.13956,2020-06-01
Proteome,PART_OF,Human virus,32475036,10.1111/dth.13722,2020-06-01
apremilast,ISA,Pharmaceutical Preparations,32475035,10.1111/dth.13713,2020-06-01
Therapeutic procedure,NEG_TREATS,Comorbidity,32475035,10.1111/dth.13713,2020-06-01
favipiravir,ISA,Pharmaceutical Preparations,32475018,10.1111/jocd.13517,2020-06-01
Critical Illness,PROCESS_OF,Patients,32475018,10.1111/jocd.13517,2020-06-01
Drug Kinetics,PROCESS_OF,Patients,32475018,10.1111/jocd.13517,2020-06-01
Critical Illness,PROCESS_OF,Patients,32475018,10.1111/jocd.13517,2020-06-01
Nucleic Acid Amplification Tests,METHOD_OF,Detection,32475006,10.1111/odi.13447,2020-06-01
Diagnosis,DIAGNOSES,Infection,32475006,10.1111/odi.13447,2020-06-01
Coronaviridae,ISA,Virus,32475003,10.1111/dth.13730,2020-06-01
EHD1 wt Allele,CAUSES,Upper Respiratory Infections,32475003,10.1111/dth.13730,2020-06-01
Coronavirus Infections,PROCESS_OF,Family,32474966,10.1111/bjso.12391,2020-06-01
Skin symptom,ASSOCIATED_WITH,Disease,32474966,10.1111/bjso.12391,2020-06-01
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Patients,32474966,10.1111/bjso.12391,2020-06-01
Pityriasis Rosea,PROCESS_OF,Patients,32474966,10.1111/bjso.12391,2020-06-01
herpes,PROCESS_OF,Homo sapiens,32474966,10.1111/bjso.12391,2020-06-01
Chilblains,PROCESS_OF,Patients,32474941,10.1111/jcpp.13278,2020-06-01
Fingers,LOCATION_OF,Videocapillaroscopy,32474941,10.1111/jcpp.13278,2020-06-01
Hematologic Tests,DIAGNOSES,Autoimmune Diseases,32474941,10.1111/jcpp.13278,2020-06-01
Hematologic Tests,DIAGNOSES,Abnormality of coagulation,32474941,10.1111/jcpp.13278,2020-06-01
Toes,LOCATION_OF,Videocapillaroscopy,32474941,10.1111/jcpp.13278,2020-06-01
Videocapillaroscopy,DIAGNOSES,Edema,32474941,10.1111/jcpp.13278,2020-06-01
Structure of blood vessel of dermis,LOCATION_OF,Thrombus,32474941,10.1111/jcpp.13278,2020-06-01
Patients,LOCATION_OF,"M Protein, multiple myeloma",32474941,10.1111/jcpp.13278,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32474941,10.1111/jcpp.13278,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32474941,10.1111/jcpp.13278,2020-06-01
Biologic Development,AFFECTS,Sleep,32474910,10.1002/ijgo.13249,2020-06-01
Initiative,PROCESS_OF,Child,32474910,10.1002/ijgo.13249,2020-06-01
Initiative,PROCESS_OF,Adolescent (age group),32474910,10.1002/ijgo.13249,2020-06-01
Disease,AFFECTS,Symptom aggravating factors,32474891,10.1007/s40121-020-00306-5,2020-06-01
Health Personnel,USES,Ambulances,32474891,10.1007/s40121-020-00306-5,2020-06-01
Fear (Mental Process),PROCESS_OF,general population,32474891,10.1007/s40121-020-00306-5,2020-06-01
"Pneumonia, Ventilator-Associated",PROCESS_OF,inpatient,32474885,10.1007/s10067-020-05190-5,2020-06-01
Coinfection,COMPLICATES,Disease,32474885,10.1007/s10067-020-05190-5,2020-06-01
"Pneumonia, Ventilator-Associated",PROCESS_OF,Patients,32474885,10.1007/s10067-020-05190-5,2020-06-01
Macrophage Activation Syndrome,ISA,Complication,32474883,10.1007/s10067-020-05200-6,2020-06-01
Macrophage Activation Syndrome,OCCURS_IN,Patients,32474883,10.1007/s10067-020-05200-6,2020-06-01
Secondary Hemophagocytic Lymphohistiocytosis,CAUSES,Syndrome,32474883,10.1007/s10067-020-05200-6,2020-06-01
Secondary Hemophagocytic Lymphohistiocytosis,CAUSES,Storm Syndrome,32474883,10.1007/s10067-020-05200-6,2020-06-01
Post-Exposure Prophylaxis,USES,arbidol,32474850,10.1007/s11739-020-02379-z,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32474850,10.1007/s11739-020-02379-z,2020-06-01
arbidol,PREVENTS,Coronavirus Infections,32474850,10.1007/s11739-020-02379-z,2020-06-01
contextual factors,PROCESS_OF,Outpatients,32474836,10.1007/s10943-020-01049-w,2020-06-01
"Paris, France",ISA,Geographic Locations,32474836,10.1007/s10943-020-01049-w,2020-06-01
General symptom,ISA,Symptoms,32474836,10.1007/s10943-020-01049-w,2020-06-01
General symptom,OCCURS_IN,Patients,32474836,10.1007/s10943-020-01049-w,2020-06-01
ENT symptoms,OCCURS_IN,Patients,32474836,10.1007/s10943-020-01049-w,2020-06-01
Heart,NEG_PART_OF,Patients,32474757,10.1007/s11239-020-02160-1,2020-06-01
Infected,PROCESS_OF,Patients,32474757,10.1007/s11239-020-02160-1,2020-06-01
myocardial injury,PROCESS_OF,Patients,32474757,10.1007/s11239-020-02160-1,2020-06-01
Pneumonia,CAUSES,Respiratory Failure,32474751,10.1007/s00432-020-03275-x,2020-06-01
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32474751,10.1007/s00432-020-03275-x,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32474751,10.1007/s00432-020-03275-x,2020-06-01
Pneumonia,AFFECTS,Male population group,32474751,10.1007/s00432-020-03275-x,2020-06-01
Acute pulmonary embolism,PROCESS_OF,Male population group,32474751,10.1007/s00432-020-03275-x,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32474718,10.1007/s00264-020-04647-1,2020-06-01
Wounds and Injuries,PROCESS_OF,Patients,32474676,10.1007/s10554-020-01861-1,2020-06-01
Elective Surgical Procedures,ISA,Operative Surgical Procedures,32474676,10.1007/s10554-020-01861-1,2020-06-01
Wounds and Injuries,PROCESS_OF,Patients,32474676,10.1007/s10554-020-01861-1,2020-06-01
Comatose,PROCESS_OF,Woman,32474632,10.1007/s00330-020-06975-7,2020-06-01
Brain,LOCATION_OF,Magnetic Resonance Imaging,32474632,10.1007/s00330-020-06975-7,2020-06-01
Magnetic Resonance Imaging,DIAGNOSES,Multifocal Lesion,32474632,10.1007/s00330-020-06975-7,2020-06-01
cerebrospinal fluid test,NEG_DIAGNOSES,Direct Contact Transmission Infection,32474632,10.1007/s00330-020-06975-7,2020-06-01
"Encephalomyelitis, Acute Disseminated",CAUSES,Encephalopathies,32474632,10.1007/s00330-020-06975-7,2020-06-01
Bronchi,LOCATION_OF,Abnormal shape,32474631,10.1007/s00330-020-06973-9,2020-06-01
Contrast bronchogram,USES,Air,32474631,10.1007/s00330-020-06973-9,2020-06-01
Structure of pulmonary blood vessel,LOCATION_OF,Hypertrophy,32474631,10.1007/s00330-020-06973-9,2020-06-01
Ground Glass Opacity,PROCESS_OF,Young Adult,32474631,10.1007/s00330-020-06973-9,2020-06-01
chest findings,PROCESS_OF,Patients,32474631,10.1007/s00330-020-06973-9,2020-06-01
Ground Glass Opacity,PROCESS_OF,Persons,32474631,10.1007/s00330-020-06973-9,2020-06-01
Pneumonia,PROCESS_OF,Patients,32474630,10.1007/s00330-020-06967-7,2020-06-01
Pneumonia,PROCESS_OF,Patients,32474630,10.1007/s00330-020-06967-7,2020-06-01
Blood Vessel,LOCATION_OF,Aneurysm,32474630,10.1007/s00330-020-06967-7,2020-06-01
Present,COEXISTS_WITH,Fever,32474630,10.1007/s00330-020-06967-7,2020-06-01
Lymphocyte count decreased,COEXISTS_WITH,Hypertensive disease,32474630,10.1007/s00330-020-06967-7,2020-06-01
Severe disorder,PROCESS_OF,Patients,32474630,10.1007/s00330-020-06967-7,2020-06-01
Present,COEXISTS_WITH,Fever,32474630,10.1007/s00330-020-06967-7,2020-06-01
Lymphocyte count decreased,COEXISTS_WITH,Hypertensive disease,32474630,10.1007/s00330-020-06967-7,2020-06-01
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32474629,10.1007/s00330-020-06955-x,2020-06-01
Ground Glass Opacity,PROCESS_OF,Patients,32474629,10.1007/s00330-020-06955-x,2020-06-01
Plain chest X-ray,DIAGNOSES,Congenital anomaly of lung,32474629,10.1007/s00330-020-06955-x,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32474629,10.1007/s00330-020-06955-x,2020-06-01
Critical Illness,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Critical Illness,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Cessation of life,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Lung,LOCATION_OF,Lesion,32474608,10.1093/infdis/jiaa311,2020-06-01
Cessation of life,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Comorbidity,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Cessation of life,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Diabetes,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Diabetes,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Pathological accumulation of air in tissues,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Pathological accumulation of air in tissues,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
lobe,PART_OF,Lung,32474608,10.1093/infdis/jiaa311,2020-06-01
Cessation of life,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
pulmonary involvement,PROCESS_OF,Patients,32474608,10.1093/infdis/jiaa311,2020-06-01
Serum,LOCATION_OF,C-reactive protein,32474608,10.1093/infdis/jiaa311,2020-06-01
Cells,PART_OF,Patients,32474598,10.1210/clinem/dgaa346,2020-06-01
Complication,PROCESS_OF,Patients,32474594,10.1093/cid/ciaa695,2020-06-01
Disease,PROCESS_OF,Patients,32474594,10.1093/cid/ciaa695,2020-06-01
Diabetes,PREDISPOSES,Negative,32474594,10.1093/cid/ciaa695,2020-06-01
Diabetes,PREDISPOSES,Confirmation,32474594,10.1093/cid/ciaa695,2020-06-01
Obesity,PREDISPOSES,Negative,32474594,10.1093/cid/ciaa695,2020-06-01
Obesity,PREDISPOSES,Confirmation,32474594,10.1093/cid/ciaa695,2020-06-01
Obesity,AFFECTS,Diabetes,32474594,10.1093/cid/ciaa695,2020-06-01
Diabetes,PREDISPOSES,Complication,32474594,10.1093/cid/ciaa695,2020-06-01
Obesity,PREDISPOSES,Complication,32474594,10.1093/cid/ciaa695,2020-06-01
Comorbidity,PROCESS_OF,geriatric patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
Disease,PROCESS_OF,geriatric patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
High Level,PROCESS_OF,geriatric patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
Chronic disease,PROCESS_OF,hospitalized patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
Complication,PROCESS_OF,Patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
Very Important,PROCESS_OF,geriatric patients,32474558,10.4103/ijmr.IJMR_1722_20,2020-06-01
Severe Acute Respiratory Syndrome,OCCURS_IN,tourist,32474557,10.4103/ijmr.IJMR_1200_20,2020-06-01
Coronavirus Infections,ISA,Disease,32474553,10.4103/ijmr.IJMR_1125_20,2020-06-01
Infected,PROCESS_OF,Patients,32474523,10.4103/jcrt.JCRT_480_20,2020-06-01
Country,ISA,Geographic Locations,32474523,10.4103/jcrt.JCRT_480_20,2020-06-01
TBATA gene,PART_OF,Virus,32474523,10.4103/jcrt.JCRT_480_20,2020-06-01
Disease,PROCESS_OF,Patients,32474476,10.3233/JRS-200024,2020-06-01
Coronavirus Infections,ISA,Disease,32474476,10.3233/JRS-200024,2020-06-01
Coronavirus Infections,ISA,Disease,32474476,10.3233/JRS-200024,2020-06-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32474476,10.3233/JRS-200024,2020-06-01
Parenchyma,LOCATION_OF,Bands,32474476,10.3233/JRS-200024,2020-06-01
Parenchyma,LOCATION_OF,Abnormality,32474476,10.3233/JRS-200024,2020-06-01
Fibrosis,PROCESS_OF,Patients,32474476,10.3233/JRS-200024,2020-06-01
Disease,PROCESS_OF,Patients,32474476,10.3233/JRS-200024,2020-06-01
Fibrosis,PROCESS_OF,Patients,32474476,10.3233/JRS-200024,2020-06-01
Coronavirus Infections,ISA,Disease,32474476,10.3233/JRS-200024,2020-06-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32474476,10.3233/JRS-200024,2020-06-01
Fibrosis,PROCESS_OF,Patients,32474476,10.3233/JRS-200024,2020-06-01
Hydroxychloroquine,ISA,Antimalarials,32474399,10.1016/j.ebiom.2020.102799,2020-06-01
Vaccines,TREATS,Disease,32474399,10.1016/j.ebiom.2020.102799,2020-06-01
Antiviral Therapy,TREATS,Disease,32474399,10.1016/j.ebiom.2020.102799,2020-06-01
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32474399,10.1016/j.ebiom.2020.102799,2020-06-01
Neurologic Symptoms,ISA,Symptoms,32474389,10.1016/j.oraloncology.2020.104821,2020-06-01
Brain,LOCATION_OF,Present,32474389,10.1016/j.oraloncology.2020.104821,2020-06-01
medical care,PROCESS_OF,professional occupation status,32474381,10.1016/j.mehy.2020.109881,2020-06-01
World,LOCATION_OF,saliva,32474381,10.1016/j.mehy.2020.109881,2020-06-01
Host defense,AFFECTS,Apoptosis,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Olfactory Receptor Cells,LOCATION_OF,Apoptosis,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Smell Perception,PROCESS_OF,Adult,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Neurons,LOCATION_OF,Apoptosis,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Apoptosis,PROCESS_OF,Mus,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Neurodegenerative Disorders,COEXISTS_WITH,Coronavirus Infections,32474371,10.1016/j.jcv.2020.104469,2020-06-01
Major change,PROCESS_OF,Persons,32474280,10.1016/j.scitotenv.2020.139631,2020-06-01
Infected,PROCESS_OF,Persons,32474145,10.1016/j.avsg.2020.05.031,2020-06-01
Stress,PROCESS_OF,Homo sapiens,32474145,10.1016/j.avsg.2020.05.031,2020-06-01
10 - 19,PREDISPOSES,Complication,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
Pulmonary Embolism,ISA,Complication,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
Arterial thrombosis,PROCESS_OF,Patients,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
Complication,PROCESS_OF,Patients,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
aortic thrombosis,PROCESS_OF,Patients,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32474140,10.1016/j.jpsychires.2020.05.019,2020-06-01
disorder control (procedure),AFFECTS,inflammatory response,32474135,10.1016/j.tcm.2020.05.004,2020-06-01
Plasma,LOCATION_OF,Choline,32474135,10.1016/j.tcm.2020.05.004,2020-06-01
Respiratory viruses,PROCESS_OF,Mother (person),32474135,10.1016/j.tcm.2020.05.004,2020-06-01
Weeks pregnant,PROCESS_OF,Mother (person),32474135,10.1016/j.tcm.2020.05.004,2020-06-01
High Level,PROCESS_OF,Mother (person),32474135,10.1016/j.tcm.2020.05.004,2020-06-01
Virus Diseases,COEXISTS_WITH,early pregnancy,32474135,10.1016/j.tcm.2020.05.004,2020-06-01
Patients,USES,Preexisting Condition Coverage,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Cardiac Arrhythmia,PROCESS_OF,Patients,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Heart failure,PROCESS_OF,Patients,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Myocarditis,PROCESS_OF,Patients,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Immune response,CAUSES,risk factors,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Cardiovascular,LOCATION_OF,Problem,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Cardiovascular,LOCATION_OF,Problem,32474129,10.1016/j.radonc.2020.05.037,2020-06-01
Initiative,PROCESS_OF,Cancer Patient,32474128,10.1016/j.radonc.2020.05.032,2020-06-01
Neoplasms,PROCESS_OF,Patients,32474128,10.1016/j.radonc.2020.05.032,2020-06-01
Cohort,DIAGNOSES,Severe Acute Respiratory Syndrome,32474128,10.1016/j.radonc.2020.05.032,2020-06-01
Employee,DIAGNOSES,Severe Acute Respiratory Syndrome,32474128,10.1016/j.radonc.2020.05.032,2020-06-01
Care team,PROCESS_OF,member,32474128,10.1016/j.radonc.2020.05.032,2020-06-01
Malignant tumor of cervix,ISA,Disease,32474126,10.1016/j.radonc.2020.05.034,2020-06-01
IMPACT gene,ASSOCIATED_WITH,Malignant tumor of cervix,32474126,10.1016/j.radonc.2020.05.034,2020-06-01
Malignant tumor of cervix,PROCESS_OF,Patients,32474126,10.1016/j.radonc.2020.05.034,2020-06-01
Pneumonia,PROCESS_OF,Patients,32474104,10.1016/j.wneu.2020.05.191,2020-06-01
Disease Screening,ADMINISTERED_TO,Patients,32474093,10.1016/j.wneu.2020.05.193,2020-06-01
Emergency operation,COEXISTS_WITH,Screening procedure,32474093,10.1016/j.wneu.2020.05.193,2020-06-01
Screening procedure,TREATS,Patients,32474093,10.1016/j.wneu.2020.05.193,2020-06-01
Communicable Diseases,CAUSES,Severe Acute Respiratory Syndrome,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Infected,PROCESS_OF,Homo sapiens,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Virus,PROCESS_OF,Homo sapiens,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
nervous system disorder,AFFECTS,Neurological observations,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Headache,ISA,Symptoms,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Myalgia,ISA,Symptoms,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Sense of smell impaired,ISA,Symptoms,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
risk factors,PROCESS_OF,Patients,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Acute cerebrovascular disease,OCCURS_IN,Minority Groups,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
Laboratory,LOCATION_OF,Neurologic Examination,32474092,10.1016/j.wneu.2020.05.192,2020-06-01
nervous system disorder,PROCESS_OF,Patients,32474087,10.1016/j.phrs.2020.104965,2020-06-01
Ischemic stroke,PROCESS_OF,Patients,32474087,10.1016/j.phrs.2020.104965,2020-06-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,hospitalized patients,32474064,10.1016/j.yexcr.2020.112101,2020-06-01
Patients,LOCATION_OF,"CD69 protein, human",32474064,10.1016/j.yexcr.2020.112101,2020-06-01
Cessation of life,PROCESS_OF,Patients,32474064,10.1016/j.yexcr.2020.112101,2020-06-01
Anticoagulants,NEG_PREDISPOSES,"Respiratory Distress Syndrome, Adult",32474064,10.1016/j.yexcr.2020.112101,2020-06-01
Acute Lung Injury,ISA,Lung diseases,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Critical Illness,PROCESS_OF,Patients,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Lipopolysaccharides,AUGMENTS,neutrophil,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Lipopolysaccharides,AUGMENTS,Neutrophil Extracellular Traps,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Protein Component,PART_OF,Neutrophil Extracellular Traps,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Pneumonia,PROCESS_OF,Patients,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Neutrophil Extracellular Traps,LOCATION_OF,Acetaminophen,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Neutrophil Extracellular Traps,LOCATION_OF,Aspirin,32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Therapeutic procedure,TREATS,"Respiratory Distress Syndrome, Adult",32474043,10.1016/j.jinf.2020.05.052,2020-06-01
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32474026,10.1016/j.jmii.2020.05.014,2020-06-01
Hypertensive disease,PROCESS_OF,Patients,32474026,10.1016/j.jmii.2020.05.014,2020-06-01
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",AFFECTS,Patients,32474026,10.1016/j.jmii.2020.05.014,2020-06-01
Death in hospital,PROCESS_OF,Patients,32474026,10.1016/j.jmii.2020.05.014,2020-06-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,NEG_COEXISTS_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32474026,10.1016/j.jmii.2020.05.014,2020-06-01
lopinavir / Ritonavir,compared_with,lopinavir / Ritonavir,32474025,10.1016/j.jmii.2020.05.011,2020-06-01
Coronavirus Infections,ISA,Disease,32473977,10.1016/j.meegid.2020.104386,2020-06-01
Coronavirus Infections,ISA,Disease,32473977,10.1016/j.meegid.2020.104386,2020-06-01
Viral Genome,AFFECTS,Gene Expression,32473976,10.1016/j.meegid.2020.104384,2020-06-01
CpG Islands,COEXISTS_WITH,Genome,32473976,10.1016/j.meegid.2020.104384,2020-06-01
Open Reading Frames,PART_OF,SARS coronavirus,32473976,10.1016/j.meegid.2020.104384,2020-06-01
TRANSCRIPTION FACTOR,PART_OF,Unmarried person,32473976,10.1016/j.meegid.2020.104384,2020-06-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32473953,10.1016/j.cmi.2020.05.023,2020-06-01
Evaluation procedure,TREATS,Patients,32473953,10.1016/j.cmi.2020.05.023,2020-06-01
Quick Test for Liver Function,USES,CD40LG wt Allele,32473952,10.1016/j.idh.2020.05.002,2020-06-01
Viral Shedding,PROCESS_OF,Persons,32473912,10.1016/j.carrev.2020.05.030,2020-06-01
Mitral Valve Insufficiency,PROCESS_OF,Patients,32473905,10.1016/j.dsx.2020.05.012,2020-06-01
"Shock, Cardiogenic",PROCESS_OF,Patients,32473905,10.1016/j.dsx.2020.05.012,2020-06-01
Cessation of life,PROCESS_OF,Patients,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Diabetes Mellitus,PREDISPOSES,Complication,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
diabetic,PROCESS_OF,Patients,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Challenge,TREATS,Patients,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Challenge,TREATS(INFER),diabetic,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Diabetic care,TREATS,Patients,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Diabetic care,TREATS(INFER),diabetic,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
diabetic,PROCESS_OF,Patients,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Challenge,COEXISTS_WITH,diabetes mellitus management,32473903,10.1016/j.dsx.2020.05.037,2020-06-01
Diabetes,PROCESS_OF,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Diabetes,PROCESS_OF,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Diabetes,PROCESS_OF,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Hyperglycemia,PROCESS_OF,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Hyperglycemia,ISA,Stress,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Hyperglycemia,PROCESS_OF,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Treating Physician,TREATS,Patients,32473875,10.1016/j.dhjo.2020.100942,2020-06-01
Developmental Disabilities,PROCESS_OF,Persons,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
Cessation of life,PROCESS_OF,Patients,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
Developmental Disabilities,PROCESS_OF,Persons,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
Developmental Disabilities,PROCESS_OF,Persons,32473864,10.1016/j.anorl.2020.05.013,2020-06-01
Laboratory Procedures,DIAGNOSES,Parasitic Diseases,32473812,10.1016/j.therap.2020.05.010,2020-06-01
Chloroquine,ISA,Pharmaceutical Preparations,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Pharmaceutical Preparations,TREATS,Possible,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Coronavirus Infections,ISA,Disease,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Disease,PROCESS_OF,Patients,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Pharmaceutical Preparations,TREATS,Patients,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Pharmaceutical Preparations,TREATS(INFER),Disease,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Coronavirus Infections,ISA,Disease,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Weakness,CAUSES,Disease,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Weakness,CAUSES(SPEC),Coronavirus Infections,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Coronavirus Infections,ISA,Disease,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Adverse reaction to drug,PROCESS_OF,Patients,32473781,10.1016/j.hlc.2020.04.007,2020-06-01
Atherosclerosis,PROCESS_OF,Patients,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Secondary Prevention,TREATS,Patients,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Secondary Prevention,TREATS(INFER),Atherosclerosis,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Pharmaceutical Preparations,AFFECTS,Birth,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Cardiovascular Diseases,PROCESS_OF,Persons,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Prophylactic treatment,TREATS,Persons,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
Prophylactic treatment,TREATS(INFER),Cardiovascular Diseases,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
treatment guideline,METHOD_OF,Prophylactic treatment,32473756,10.1016/j.ajem.2020.05.042,2020-06-01
"Respiratory Distress Syndrome, Adult",CAUSES,Coronavirus Infections,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Male population group,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
favipiravir,ADMINISTERED_TO,Male population group,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
"Respiratory Distress Syndrome, Adult",CAUSES,Coronavirus Infections,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Male population group,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
favipiravir,TREATS,Male population group,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
favipiravir,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
Neuroleptic Malignant Syndrome,PROCESS_OF,Patients,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
Coronavirus Infections,PROCESS_OF,Patients,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
Neuroleptic Malignant Syndrome,COEXISTS_WITH,patient condition,32473682,10.1016/S0140-6736(20)31173-9,2020-06-01
Malignant Neoplasms,PROCESS_OF,Persons,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
systemic administration,ADMINISTERED_TO,Persons,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
GSKIP gene,PART_OF,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Malignant Neoplasms,AFFECTS,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Mild disease course,PROCESS_OF,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Present,PREDISPOSES,Comorbidity,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Pharmacotherapy,NEG_ADMINISTERED_TO,Patients,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Targeted Therapy,TREATS,Cancer Patient,32473681,10.1016/S0140-6736(20)31187-9,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Patients,LOCATION_OF,GSKIP gene,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
risk factors,COEXISTS_WITH,Obesity,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
risk factors,COEXISTS_WITH,Obesity,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Malignant Neoplasms,PROCESS_OF,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
follow-up,TREATS,Patients,32473657,10.1016/S2352-3018(20)30164-8,2020-06-01
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Adult,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
GSKIP gene,PART_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Comorbidity,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Comorbidity,PROCESS_OF(SPEC),Patients,32473607,10.1002/hep.31404,2020-05-31
Diabetes,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Diabetes,PROCESS_OF(SPEC),Patients,32473607,10.1002/hep.31404,2020-05-31
Hypertensive disease,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Hypertensive disease,PROCESS_OF(SPEC),Patients,32473607,10.1002/hep.31404,2020-05-31
Patients,ISA,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF(SPEC),Patients,32473607,10.1002/hep.31404,2020-05-31
Infected,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Severe disorder,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Persons,32473607,10.1002/hep.31404,2020-05-31
Hospitals,LOCATION_OF,Retrospective Cohort Study,32473600,10.15252/emmm.202012697,2020-05-31
Liver,LOCATION_OF,diseases and injuries,32473600,10.15252/emmm.202012697,2020-05-31
Social Networks,LOCATION_OF,GSKIP gene,32473600,10.15252/emmm.202012697,2020-05-31
diseases and injuries,OCCURS_IN,Cohort,32473600,10.15252/emmm.202012697,2020-05-31
Severe clinical course,PROCESS_OF,Patients,32473600,10.15252/emmm.202012697,2020-05-31
Cessation of life,AFFECTS,Atypical Lipoma,32473600,10.15252/emmm.202012697,2020-05-31
Liver,LOCATION_OF,Injury of kidney,32473600,10.15252/emmm.202012697,2020-05-31
Injury of kidney,PROCESS_OF,Patients,32473600,10.15252/emmm.202012697,2020-05-31
"Genes, Viral",PART_OF,Host Cell,32473596,10.1055/s-0040-1713152,2020-05-31
baricitinib,INTERACTS_WITH,cytokine,32473596,10.1055/s-0040-1713152,2020-05-31
JAK1 Inhibitor,TREATS,Rheumatoid Arthritis,32473596,10.1055/s-0040-1713152,2020-05-31
baricitinib,INHIBITS,cytokine,32473596,10.1055/s-0040-1713152,2020-05-31
GAK gene,INHIBITS,baricitinib,32473596,10.1055/s-0040-1713152,2020-05-31
Liver,LOCATION_OF,Spheroids,32473596,10.1055/s-0040-1713152,2020-05-31
TBK1 gene,CAUSES,Virus Diseases,32473596,10.1055/s-0040-1713152,2020-05-31
Bilateral pneumonia,PROCESS_OF,Patients,32473596,10.1055/s-0040-1713152,2020-05-31
baricitinib,TREATS,Patients,32473596,10.1055/s-0040-1713152,2020-05-31
baricitinib,TREATS(INFER),Bilateral pneumonia,32473596,10.1055/s-0040-1713152,2020-05-31
Evaluation procedure,TREATS,hospitalized patients,32473596,10.1055/s-0040-1713152,2020-05-31
heparin,ISA,Antithrombotic Agents,32473537,10.1016/j.ajp.2020.102147,2020-05-31
Coagulation panel for thrombosis,USES,Antithrombotic Agents,32473537,10.1016/j.ajp.2020.102147,2020-05-31
Coagulation panel for thrombosis,USES(SPEC),heparin,32473537,10.1016/j.ajp.2020.102147,2020-05-31
Quarantine,TREATS,Persons,32473509,10.1016/j.mehy.2020.109866,2020-05-31
Infected,PROCESS_OF,Patients,32473497,10.1016/j.nedt.2020.104479,2020-05-31
zinc iodide,ISA,"Anti-Infective Agents, Local",32473497,10.1016/j.nedt.2020.104479,2020-05-31
Training,ISA,Health Care,32473458,10.1016/j.scitotenv.2020.139611,2020-05-31
Masks,TREATS,Readiness,32473418,10.1016/j.jbspin.2020.05.006,2020-05-31
Biopolymers,PART_OF,Wheat gluten,32473418,10.1016/j.jbspin.2020.05.006,2020-05-31
Gluten,PART_OF,Filamentous fungus,32473418,10.1016/j.jbspin.2020.05.006,2020-05-31
Anti-Inflammatory Agents,TREATS,Patients,32473390,10.1016/j.micpath.2020.104277,2020-05-31
"Antirheumatic Drugs, Disease-Modifying",TREATS,Patients,32473390,10.1016/j.micpath.2020.104277,2020-05-31
Steroid therapy,ADMINISTERED_TO,Persons,32473390,10.1016/j.micpath.2020.104277,2020-05-31
Rheumatism,PROCESS_OF,Patients,32473390,10.1016/j.micpath.2020.104277,2020-05-31
Communicable Diseases,ISA,Disease,32473352,10.1016/j.meegid.2020.104382,2020-05-31
Coronavirus Infections,ISA,Communicable Diseases,32473352,10.1016/j.meegid.2020.104382,2020-05-31
Epidemic,ISA,Disease Outbreaks,32473352,10.1016/j.meegid.2020.104382,2020-05-31
Coronavirus Infections,ISA,Communicable Diseases,32473352,10.1016/j.meegid.2020.104382,2020-05-31
Pharmaceutical Preparations,ISA,Chemicals,32473352,10.1016/j.meegid.2020.104382,2020-05-31
Immunodominant Epitopes,COEXISTS_WITH,Membrane Proteins,32473312,10.1016/j.tmaid.2020.101751,2020-05-31
Masks,PREVENTS,Viral respiratory infection,32473310,10.1016/j.phrs.2020.104960,2020-05-31
Lung,LOCATION_OF,Massive embolus,32473235,10.1016/j.jinf.2020.05.046,2020-05-31
Vena Cava Filters,PREVENTS,Massive embolus,32473235,10.1016/j.jinf.2020.05.046,2020-05-31
Coinfection,PROCESS_OF,Patients,32473197,10.1016/j.jamcollsurg.2020.05.015,2020-05-31
Bacterial Infections,PROCESS_OF,Patients,32473197,10.1016/j.jamcollsurg.2020.05.015,2020-05-31
Bacterial Infections,PROCESS_OF,Patients,32473197,10.1016/j.jamcollsurg.2020.05.015,2020-05-31
Hydranencephaly with Renal Aplasia-Dysplasia,AFFECTS,Obstruction,32473179,10.1016/j.jhin.2020.05.032,2020-05-31
Health Personnel,TREATS,Patients,32473161,10.1016/j.mbs.2020.108389,2020-05-31
Decontamination,USES,Mechanical Ventilator,32473161,10.1016/j.mbs.2020.108389,2020-05-31
Decontamination,USES,VPS51 gene,32473161,10.1016/j.mbs.2020.108389,2020-05-31
Decontamination,USES,VPS51 gene,32473161,10.1016/j.mbs.2020.108389,2020-05-31
Mechanical Ventilator,TREATS,Health Personnel,32473161,10.1016/j.mbs.2020.108389,2020-05-31
Physicians,TREATS,"Child, Hospitalized",32473127,10.1016/j.cell.2020.05.015,2020-05-31
Heart,LOCATION_OF,Possible injury,32473127,10.1016/j.cell.2020.05.015,2020-05-31
Troponin,PART_OF,Heart,32473127,10.1016/j.cell.2020.05.015,2020-05-31
Coronavirus Infections,ISA,Disease,32473124,10.1016/S2213-2600(20)30243-5,2020-05-31
Hemorrhage,AFFECTS,Cessation of life,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Structure of small blood vessel (organ),LOCATION_OF,Thrombosis,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Structure of small blood vessel (organ),LOCATION_OF,Disease of capillaries,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Structure of small blood vessel (organ),PART_OF,Lung,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Capillary vessel,LOCATION_OF,Thrombosis,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Capillary vessel,LOCATION_OF,Disease of capillaries,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Capillary vessel,PART_OF,Lung,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
inflammatory response,COEXISTS_WITH,Thrombosis,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
inflammatory response,COEXISTS_WITH,Disease of capillaries,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Present,PROCESS_OF,Patients,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Necrosis,PROCESS_OF,Persons,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Cessation of life,PROCESS_OF,Patients,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Lung,LOCATION_OF,Thrombus,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Lung,LOCATION_OF,Disease of capillaries,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Lung,LOCATION_OF,Secondary Infections,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Thrombus,AFFECTS,Cessation of life,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Disease of capillaries,AFFECTS,Cessation of life,32473113,10.1016/S2468-2667(20)30117-1,2020-05-31
Cardiopulmonary Resuscitation,compared_with,Interventional procedure,32473109,10.1016/j.ajpath.2020.05.014,2020-05-31
Out-of-Hospital Cardiac Arrest,PROCESS_OF,Patients,32473109,10.1016/j.ajpath.2020.05.014,2020-05-31
SARS coronavirus,PROCESS_OF,Donor person,32473108,10.1016/j.jacr.2020.05.010,2020-05-31
Chart evaluation by healthcare professional,ADMINISTERED_TO,radiologist,32473085,10.1002/ccd.28974,2020-05-31
Cardiac Catheterization Laboratory,ISA,Health care facility,32473082,10.1111/tbed.13653,2020-05-31
Laboratory Procedures,METHOD_OF,Diagnosis,32473082,10.1111/tbed.13653,2020-05-31
Zoonoses,COEXISTS_WITH,Bat coronavirus,32473070,10.1111/dth.13733,2020-05-31
Rhinolophus ferrumequinum,ISA,Chiroptera,32473070,10.1111/dth.13733,2020-05-31
Betacoronavirus,PROCESS_OF,Rhinolophus ferrumequinum,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Miniopterus schreibersii,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Rhinolophus ferrumequinum,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Miniopterus fuliginosus,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Myotis macrodactylus,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Myotis bombinus,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Myotis petax,32473070,10.1111/dth.13733,2020-05-31
Alphacoronavirus,PROCESS_OF,Hypsugo alaschanicus,32473070,10.1111/dth.13733,2020-05-31
Genus: Coronavirus,PROCESS_OF,Chiroptera,32473070,10.1111/dth.13733,2020-05-31
Genus: Coronavirus,PROCESS_OF,Chiroptera,32473070,10.1111/dth.13733,2020-05-31
Pentoxifylline,INHIBITS(SPEC),"Cyclic Nucleotide Phosphodiesterases, Type 4",32473051,10.1002/ccd.29050,2020-05-31
Pentoxifylline,ISA,methylxanthine,32473051,10.1002/ccd.29050,2020-05-31
methylxanthine,INHIBITS,"Cyclic Nucleotide Phosphodiesterases, Type 4",32473051,10.1002/ccd.29050,2020-05-31
Pharmaceutical Preparations,AFFECTS,Single organ dysfunction,32473051,10.1002/ccd.29050,2020-05-31
ST segment elevation myocardial infarction,ISA,Disease,32473049,10.1111/tbed.13656,2020-05-31
Inflammation,CAUSES,Blood Coagulation Disorders,32473049,10.1111/tbed.13656,2020-05-31
Inflammation,CAUSES,Coronary Thrombosis,32473049,10.1111/tbed.13656,2020-05-31
Thrombosis,CAUSES,Blood Coagulation Disorders,32473049,10.1111/tbed.13656,2020-05-31
Thrombosis,CAUSES,Coronary Thrombosis,32473049,10.1111/tbed.13656,2020-05-31
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32473049,10.1111/tbed.13656,2020-05-31
Hospitals,LOCATION_OF,Data Collection,32473021,10.1093/infdis/jiaa305,2020-05-31
Screening procedure,METHOD_OF,Disinfection,32473021,10.1093/infdis/jiaa305,2020-05-31
SARS coronavirus,PROCESS_OF,Patients,32473020,10.1093/jac/dkaa191,2020-05-31
Enzyme-Linked Immunosorbent Assay,USES,Total immunoglobulin measurement,32473020,10.1093/jac/dkaa191,2020-05-31
"Immunoglobulin A, Human",AUGMENTS,Hypersensitivity,32473020,10.1093/jac/dkaa191,2020-05-31
Hydroxychloroquine,AFFECTS,Virus Replication,32473015,10.1093/jbcr/iraa086,2020-05-31
Dose Regimen,USES,Hydroxychloroquine Sulfate,32473015,10.1093/jbcr/iraa086,2020-05-31
Sex Characteristics,ASSOCIATED_WITH,Communicable Diseases,32473007,10.1093/cid/ciaa682,2020-05-31
Woman,ISA,Population Group,32473007,10.1093/cid/ciaa682,2020-05-31
Myocarditis,ISA,Cardiovascular finding,32472990,10.23736/S0026-4725.20.05298-6,2020-05-31
Myocardium,LOCATION_OF,Direct trauma,32472990,10.23736/S0026-4725.20.05298-6,2020-05-31
Comorbidity,PROCESS_OF,Persons,32472989,10.23736/S0026-4725.20.05271-8,2020-05-31
Angiotensin-Converting Enzyme Inhibitors,TREATS,Confusion,32472974,10.1111/odi.13444,2020-05-31
Infected,PROCESS_OF,Patients,32472974,10.1111/odi.13444,2020-05-31
Angiotensin II receptor antagonist,TREATS,Critical Illness,32472974,10.1111/odi.13444,2020-05-31
Angiotensin II receptor antagonist,TREATS,Patients,32472974,10.1111/odi.13444,2020-05-31
Angiotensin II receptor antagonist,TREATS(INFER),Infected,32472974,10.1111/odi.13444,2020-05-31
Health Care Systems,LOCATION_OF,Services,32472939,10.4414/smw.2020.20295,2020-05-31
Hospitals,LOCATION_OF,Services,32472939,10.4414/smw.2020.20295,2020-05-31
Urgent Care,LOCATION_OF,Services,32472939,10.4414/smw.2020.20295,2020-05-31
Patients,LOCATION_OF,IMPACT gene,32472939,10.4414/smw.2020.20295,2020-05-31
IMPACT gene,PREDISPOSES,disease transmission,32472939,10.4414/smw.2020.20295,2020-05-31
Swiss,ISA,Population Group,32472936,10.1093/cid/ciaa681,2020-05-31
Otologic Surgical Procedures,USES,Instrument - device,32472897,10.1097/SCS.0000000000006658,2020-05-31
"Respirators, Air-Purifying",compared_with,Masks,32472897,10.1097/SCS.0000000000006658,2020-05-31
"Respirators, Air-Purifying",higher_than,Masks,32472897,10.1097/SCS.0000000000006658,2020-05-31
Fever,ISA,Symptoms,32472827,10.1097/MAT.0000000000001178,2020-05-31
Mucous Membrane,PART_OF,Eye,32472827,10.1097/MAT.0000000000001178,2020-05-31
Critical Illness,PROCESS_OF,Patients,32472811,10.1097/NMD.0000000000001200,2020-05-31
ERAS gene,ASSOCIATED_WITH,Plague,32472775,10.1097/ADM.0000000000000698,2020-05-31
Psychiatrist,ISA,Health Personnel,32472775,10.1097/ADM.0000000000000698,2020-05-31
Sleep Apnea Syndromes,PROCESS_OF,Patients,32472745,10.1111/mcn.13032,2020-05-31
Infected,PROCESS_OF,Mother (person),32472706,10.1002/jmv.26100,2020-05-31
Asymptomatic,PROCESS_OF,Patients,32472687,10.1093/cid/ciaa672,2020-05-31
Intervention regimes,COEXISTS_WITH,Prophylactic treatment,32472685,10.1093/ons/opaa168,2020-05-31
Instrument - device,USES,Harbor,32472683,10.1093/cid/ciaa673,2020-05-31
Skull Base Operation,TREATS,Enthesitis-Related Arthritis,32472683,10.1093/cid/ciaa673,2020-05-31
Nose,LOCATION_OF,Trocar,32472683,10.1093/cid/ciaa673,2020-05-31
Infected,PROCESS_OF,Persons,32472676,10.1093/cid/ciaa674,2020-05-31
Coronavirus Infections,CAUSES,Disease,32472675,10.1093/cid/ciaa678,2020-05-31
Supportive care,TREATS,risk factors,32472675,10.1093/cid/ciaa678,2020-05-31
early/brief intervention/therapy (treatment),TREATS,risk factors,32472675,10.1093/cid/ciaa678,2020-05-31
Diabetes,PROCESS_OF,Patients,32472675,10.1093/cid/ciaa678,2020-05-31
White blood cell count increased (lab result),PROCESS_OF,Patients,32472675,10.1093/cid/ciaa678,2020-05-31
C-reactive protein,AUGMENTS,Severe disorder,32472675,10.1093/cid/ciaa678,2020-05-31
Comorbidity,PROCESS_OF,Patients,32472655,10.1002/ptr.6776,2020-05-31
risk factors,PROCESS_OF,Patients,32472655,10.1002/ptr.6776,2020-05-31
Diabetes,PROCESS_OF,Patients,32472655,10.1002/ptr.6776,2020-05-31
Predisposition -- attribute,ASSOCIATED_WITH,Diabetes,32472655,10.1002/ptr.6776,2020-05-31
Patients,LOCATION_OF,"CD69 protein, human",32472655,10.1002/ptr.6776,2020-05-31
"CD69 protein, human",ASSOCIATED_WITH,Diabetes,32472655,10.1002/ptr.6776,2020-05-31
Pneumonia,PROCESS_OF,Patients,32472653,10.1002/sctm.20-0146,2020-05-31
Interleukin-6,AFFECTS,Storm NOS,32472653,10.1002/sctm.20-0146,2020-05-31
Patients,LOCATION_OF,cytokine,32472653,10.1002/sctm.20-0146,2020-05-31
Comorbidity,PROCESS_OF,Patients,32472653,10.1002/sctm.20-0146,2020-05-31
Interleukin-6,ASSOCIATED_WITH,Cardiovascular Diseases,32472653,10.1002/sctm.20-0146,2020-05-31
Interleukin-6,ASSOCIATED_WITH,Diabetes Mellitus,32472653,10.1002/sctm.20-0146,2020-05-31
Interleukin-6,ASSOCIATED_WITH,Storm NOS,32472653,10.1002/sctm.20-0146,2020-05-31
feverfew extract,INHIBITS,Interleukin-1,32472653,10.1002/sctm.20-0146,2020-05-31
human cell line,LOCATION_OF,Interleukin-8,32472653,10.1002/sctm.20-0146,2020-05-31
Cessation of life,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32472516,10.1007/s10072-020-04487-2,2020-05-31
Blood capillaries,LOCATION_OF,BARRIER,32472516,10.1007/s10072-020-04487-2,2020-05-31
Cell Therapy,TREATS,"Respiratory Distress Syndrome, Adult",32472516,10.1007/s10072-020-04487-2,2020-05-31
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32472516,10.1007/s10072-020-04487-2,2020-05-31
Author,TREATS,Patients,32472516,10.1007/s10072-020-04487-2,2020-05-31
Lung Compliance,ISA,Pulmonary function,32472516,10.1007/s10072-020-04487-2,2020-05-31
Pneumonia,PROCESS_OF,Patients,32472486,10.1007/s11606-020-05898-9,2020-05-31
Evaluation procedure,TREATS,Patients,32472486,10.1007/s11606-020-05898-9,2020-05-31
Intervention regimes,AFFECTS,Stress,32472464,10.1007/s10029-020-02227-1,2020-05-31
Stress,PROCESS_OF,Male population group,32472464,10.1007/s10029-020-02227-1,2020-05-31
Stress,PROCESS_OF,Young Adult,32472464,10.1007/s10029-020-02227-1,2020-05-31
Hernia,COEXISTS_WITH,"Hernia, Inguinal",32472461,10.1007/s10067-020-05189-y,2020-05-31
Rheumatic Fever,PROCESS_OF,Patients,32472459,10.1007/s10067-020-05179-0,2020-05-31
Current Therapy,TREATS,Patients,32472454,10.1007/s12094-020-02399-3,2020-05-31
Anticoagulants,ISA,Pharmaceutical Preparations,32472454,10.1007/s12094-020-02399-3,2020-05-31
Malignant Childhood Neoplasm,AFFECTS,Staff,32472408,10.1245/s10434-020-08563-x,2020-05-31
Malignant Neoplasms,PROCESS_OF,Child,32472408,10.1245/s10434-020-08563-x,2020-05-31
Pandemics,CAUSES,Respiration Disorders,32472403,10.1007/s13304-020-00815-5,2020-05-31
Italy,ISA,Country,32472347,10.1007/s12098-020-03347-3,2020-05-31
psychological distress,PROCESS_OF,Child,32472325,10.1007/s11096-020-01067-4,2020-05-31
psychological distress,PROCESS_OF,Adolescent (age group),32472325,10.1007/s11096-020-01067-4,2020-05-31
Pharmacist,ISA,Health Personnel,32472231,10.1007/s10552-020-01310-3,2020-05-31
Infected,PROCESS_OF,Patients,32472231,10.1007/s10552-020-01310-3,2020-05-31
Diabetes,COEXISTS_WITH,Severe (severity modifier),32472138,10.1093/cid/ciaa635,2020-05-31
Diabetes,COEXISTS_WITH,patient condition,32472138,10.1093/cid/ciaa635,2020-05-31
Diabetes,PROCESS_OF,Persons,32472138,10.1093/cid/ciaa635,2020-05-31
Diabetes,PROCESS_OF,Persons,32472138,10.1093/cid/ciaa635,2020-05-31
"Intubation, Intratracheal",METHOD_OF,Mechanical ventilation,32472138,10.1093/cid/ciaa635,2020-05-31
Diabetes,PROCESS_OF,Persons,32472138,10.1093/cid/ciaa635,2020-05-31
Patient in hospital,PROCESS_OF,Cohort,32472043,10.1038/s41467-020-16670-2,2020-05-31
Italy,ISA,Country,32471930,10.1136/rapm-2020-101541,2020-05-31
Decision,PROCESS_OF,Maker (occupation),32471930,10.1136/rapm-2020-101541,2020-05-31
Population Group,USES,Masks,32471930,10.1136/rapm-2020-101541,2020-05-31
Manipulation procedure,USES,Artificial Airways,32471903,10.1136/annrheumdis-2020-217871,2020-05-31
Oxygen,PART_OF,Hemoglobin,32471903,10.1136/annrheumdis-2020-217871,2020-05-31
Operating Room,LOCATION_OF,Administration occupational activities,32471903,10.1136/annrheumdis-2020-217871,2020-05-31
Rheumatism,PROCESS_OF,Persons,32471894,10.1128/JCM.01136-20,2020-05-31
Collagen Diseases,PROCESS_OF,Persons,32471894,10.1128/JCM.01136-20,2020-05-31
Hospitalization,TREATS,Persons,32471894,10.1128/JCM.01136-20,2020-05-31
Collagen Diseases,PROCESS_OF,Patients,32471894,10.1128/JCM.01136-20,2020-05-31
Hospitalization,TREATS,Patients,32471894,10.1128/JCM.01136-20,2020-05-31
Hospitalization,TREATS(INFER),Collagen Diseases,32471894,10.1128/JCM.01136-20,2020-05-31
Challenge,METHOD_OF,Clinical Laboratory Services,32471884,10.1136/bmj.m1996,2020-05-31
Assay,USES,molecular diagnostics (lab procedure),32471884,10.1136/bmj.m1996,2020-05-31
"Transport Media, Viral",USES,Nasal Swab (procedure),32471884,10.1136/bmj.m1996,2020-05-31
"Transport Media, Viral",USES,Nasal Swabs,32471884,10.1136/bmj.m1996,2020-05-31
Coughing,ISA,Symptoms,32471876,10.1158/2159-8290.CD-NB2020-050,2020-05-31
Comorbidity,PROCESS_OF,Patients,32471876,10.1158/2159-8290.CD-NB2020-050,2020-05-31
"Kidney Failure, Acute",PROCESS_OF,Patients,32471876,10.1158/2159-8290.CD-NB2020-050,2020-05-31
Malignant Neoplasms,PROCESS_OF,Patients,32471856,10.1126/science.abc1917,2020-05-31
Pharmacotherapy,TREATS,Age,32471856,10.1126/science.abc1917,2020-05-31
Virus,PROCESS_OF,Patients,32471830,10.1128/mBio.00812-20,2020-05-31
Virus,PROCESS_OF,Patients,32471830,10.1128/mBio.00812-20,2020-05-31
Virulence Factors,AFFECTS,Immunity,32471812,10.3949/ccjm.87a.ccc036,2020-05-31
Alveolar rhabdomyosarcoma,PROCESS_OF,Racial group,32471812,10.3949/ccjm.87a.ccc036,2020-05-31
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32471783,10.1016/j.ajem.2020.05.044,2020-05-31
Asymptomatic,ISA,Symptoms,32471782,10.1016/j.ajem.2020.05.058,2020-05-31
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32471782,10.1016/j.ajem.2020.05.058,2020-05-31
Disease,NEG_AFFECTS,Child,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Coronavirus Infections,ISA,Disease,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Coronavirus Infections,NEG_AFFECTS(SPEC),Child,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Prolonged fever,PROCESS_OF,Child,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Coronavirus Infections,ISA,Disease,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Antibody studies (procedure),DIAGNOSES,Coronavirus Infections,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Child,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Coronavirus Infections,ISA,Disease,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Toxic Shock Syndrome,PROCESS_OF,Child,32471712,10.1016/j.carrev.2020.05.027,2020-05-31
Coronavirus Infections,CAUSES,Disease,32471707,10.1016/j.encep.2020.05.001,2020-05-31
Pain,PROCESS_OF,Persons,32471705,10.1016/j.encep.2020.05.004,2020-05-31
Crisis,PREDISPOSES,Suicide,32471705,10.1016/j.encep.2020.05.004,2020-05-31
Psychiatric hospital,LOCATION_OF,Observation - diagnostic procedure,32471703,10.1016/j.arcmed.2020.05.011,2020-05-31
psychiatric hospitalization,AFFECTS,Disease,32471703,10.1016/j.arcmed.2020.05.011,2020-05-31
Health Care Systems,LOCATION_OF,Teleconsultation,32471703,10.1016/j.arcmed.2020.05.011,2020-05-31
Mental Recall,PROCESS_OF,Patients,32471703,10.1016/j.arcmed.2020.05.011,2020-05-31
Societies,LOCATION_OF,Teleconsultation,32471703,10.1016/j.arcmed.2020.05.011,2020-05-31
Demand (clinical),TREATS,Ability,32471650,10.1016/j.ijcard.2020.04.028,2020-05-31
intensive care unit,ISA,Hospital Units,32471650,10.1016/j.ijcard.2020.04.028,2020-05-31
Pneumonia,PREDISPOSES,Pulmonary Embolism,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Pneumonia,PREDISPOSES,Deep Vein Thrombosis,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Pneumonia,PREDISPOSES,Venous Thromboembolism,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Pneumonia,PROCESS_OF,Patients,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Computed Tomography Angiography,DIAGNOSES,Pulmonary Embolism,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Pulmonary Embolism,PROCESS_OF,Patients,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Males,PREDISPOSES,Venous Thromboembolism,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Pulmonary Embolism,PROCESS_OF,Patients,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Segmental pulmonary artery,LOCATION_OF,Thrombosis,32471628,10.1016/j.transproceed.2020.05.002,2020-05-31
Health care facility,LOCATION_OF,Services,32471513,10.1186/s40249-020-00678-3,2020-05-31
Transplantation,TREATS,Enthesitis-Related Arthritis,32471513,10.1186/s40249-020-00678-3,2020-05-31
Anxiety state,PROCESS_OF,Respondents,32471334,10.1080/22221751.2020.1760735,2020-05-31
Phobic anxiety disorder,PROCESS_OF,Respondents,32471334,10.1080/22221751.2020.1760735,2020-05-31
Anxiety,AFFECTS,Hand Hygiene,32471334,10.1080/22221751.2020.1760735,2020-05-31
"Stress, Psychological",PROCESS_OF,Persons,32471334,10.1080/22221751.2020.1760735,2020-05-31
Virus Replication,AFFECTS,Antibody Formation,32471311,10.22605/RRH6045,2020-05-31
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Old World rabbit,32471311,10.22605/RRH6045,2020-05-31
Symptoms,PROCESS_OF,Patients,32471295,10.3390/ijerph17113815,2020-05-31
Infected,PROCESS_OF,Persons,32471295,10.3390/ijerph17113815,2020-05-31
Coronavirus Infections,ISA,Disease,32471278,10.3390/ijms21113812,2020-05-31
Coronavirus Infections,ISA,Disease,32471278,10.3390/ijms21113812,2020-05-31
Lung,LOCATION_OF,inflammatory response,32471274,10.3390/tropicalmed5020086,2020-05-31
Vaccines,CAUSES,inflammatory response,32471274,10.3390/tropicalmed5020086,2020-05-31
inflammatory response,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32471274,10.3390/tropicalmed5020086,2020-05-31
Cessation of life,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32471274,10.3390/tropicalmed5020086,2020-05-31
Pneumonia,CAUSES,Cessation of life,32471274,10.3390/tropicalmed5020086,2020-05-31
Therapeutic procedure,USES,Anti-Inflammatory Agents,32471274,10.3390/tropicalmed5020086,2020-05-31
Combined Modality Therapy,TREATS,"Respiratory Distress Syndrome, Adult",32471274,10.3390/tropicalmed5020086,2020-05-31
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,patient condition,32471274,10.3390/tropicalmed5020086,2020-05-31
Pulmonary vessels,LOCATION_OF,Thrombosis,32471251,10.3390/nu12061562,2020-05-31
Severe Acute Respiratory Syndrome,PRODUCES,Estrogens,32471251,10.3390/nu12061562,2020-05-31
CNR2 gene,ASSOCIATED_WITH,Inflammation,32471251,10.3390/nu12061562,2020-05-31
Inflammation,ASSOCIATED_WITH,receptor,32471251,10.3390/nu12061562,2020-05-31
"Receptor, Cannabinoid, CB2",STIMULATES,Mesenchymal Stromal Cells,32471251,10.3390/nu12061562,2020-05-31
Challenge,TREATS,general population,32471205,10.3390/ijms21113793,2020-05-31
NF-kappa B,COEXISTS_WITH,Anti-Inflammatory Agents,32471205,10.3390/ijms21113793,2020-05-31
NF-kappa B,ISA,TRANSCRIPTION FACTOR,32471205,10.3390/ijms21113793,2020-05-31
GA-Binding Protein Transcription Factor,COEXISTS_WITH,Anti-Inflammatory Agents,32471205,10.3390/ijms21113793,2020-05-31
GA-Binding Protein Transcription Factor,ISA,TRANSCRIPTION FACTOR,32471205,10.3390/ijms21113793,2020-05-31
Inflammation,COEXISTS_WITH,Crisis,32471205,10.3390/ijms21113793,2020-05-31
Pharmaceutical Preparations,AFFECTS,Virus Replication,32471203,10.3390/medicina56060261,2020-05-31
Pharmaceutical Preparations,INHIBITS,Endopeptidases,32471203,10.3390/medicina56060261,2020-05-31
Pharmaceutical Preparations,INTERACTS_WITH,Antiviral Agents,32471203,10.3390/medicina56060261,2020-05-31
Endopeptidases,PART_OF,Virus,32471203,10.3390/medicina56060261,2020-05-31
Operative Surgical Procedures,TREATS,Patients,32471171,10.3390/ph13060107,2020-05-31
Spectrum Analysis,USES,Visceral manipulation,32471115,10.3390/cells9061336,2020-05-31
Ascorbate,INHIBITS,Albumins,32471115,10.3390/cells9061336,2020-05-31
Ascorbate,INHIBITS,Hemoglobin,32471115,10.3390/cells9061336,2020-05-31
Blood,LOCATION_OF,Hemoglobin,32471115,10.3390/cells9061336,2020-05-31
Ascorbate,ISA,Biological Factors,32471115,10.3390/cells9061336,2020-05-31
integral to membrane,PRODUCES,G-Protein-Coupled Receptors,32471083,10.3390/ijerph17113793,2020-05-31
Breast,LOCATION_OF,Malignant Neoplasms,32471083,10.3390/ijerph17113793,2020-05-31
Losartan,TREATS,Malignant neoplasm of breast,32471083,10.3390/ijerph17113793,2020-05-31
candesartan,TREATS,Malignant neoplasm of breast,32471083,10.3390/ijerph17113793,2020-05-31
Interventional procedure,ADMINISTERED_TO,Dentist,32471066,10.3390/ijerph17113792,2020-05-31
Author,DIAGNOSES,Infection of tooth,32471066,10.3390/ijerph17113792,2020-05-31
Financial resources,PREDISPOSES,Infection,32471066,10.3390/ijerph17113792,2020-05-31
Hospitals,LOCATION_OF,Administration occupational activities,32471016,10.1111/bjd.19255,2020-05-30
Health Services,TREATS,Problem,32471013,10.1111/liv.14552,2020-05-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Cohort,32471012,10.1002/ijgo.13248,2020-05-30
Decreased Immunologic Activity [PE],AFFECTS,Immune response,32471012,10.1002/ijgo.13248,2020-05-30
Body cavities,LOCATION_OF,Present,32471009,10.1111/bjd.19258,2020-05-30
Infected,PROCESS_OF,Patients,32471009,10.1111/bjd.19258,2020-05-30
Patient History,METHOD_OF,Health Risk Assessment,32471009,10.1111/bjd.19258,2020-05-30
Severe Acute Respiratory Syndrome,ISA,Disease,32470974,10.1093/jamia/ocaa122,2020-05-30
Cessation of life,PROCESS_OF,Adult,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
patient condition,COEXISTS_WITH,Coughing,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
patient condition,COEXISTS_WITH,Dyspnea,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
patient condition,COEXISTS_WITH,Fever,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
Genetic screening method,DIAGNOSES,Disease,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
Therapeutic procedure,AFFECTS,Immune response,32470851,10.1016/j.dsx.2020.05.007,2020-05-30
Cardiovascular Diseases,PROCESS_OF,Elderly (population group),32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
Cardiovascular Diseases,PROCESS_OF,Persons,32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
oxidized low density lipoprotein,AFFECTS,Severe (severity modifier),32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
Immunity,PROCESS_OF,Lung,32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
"CD69 protein, human",CAUSES,cytokine secretion,32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
"CD69 protein, human",CAUSES,Alveolar damage,32470824,10.1016/j.genhosppsych.2020.05.008,2020-05-30
Delirium,OCCURS_IN,Patients,32470789,10.1016/j.mehy.2020.109871,2020-05-30
Encephalopathies,COEXISTS_WITH,inflammatory response,32470789,10.1016/j.mehy.2020.109871,2020-05-30
Disease,PROCESS_OF,Transient Population Group,32470687,10.1016/j.scitotenv.2020.139115,2020-05-30
Coronavirus Infections,ISA,Disease,32470606,10.1016/j.ijid.2020.05.068,2020-05-30
GSKIP gene,PART_OF,Patients,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Influenza,PROCESS_OF,Patients,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Influenza,PROCESS_OF,Survivors,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Tumor Necrosis Factors,PART_OF,Survivors,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Tumor Necrosis Factors,PART_OF,Survivors,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Creatinine increased,PROCESS_OF,Survivors,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Neutrophil count (procedure),ISA,White Blood Cell Count procedure,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Influenza,PROCESS_OF,Patients,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Severe inflammation,PROCESS_OF,Patients,32470605,10.1016/j.ijid.2020.05.066,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32470604,10.1016/j.ijid.2020.05.070,2020-05-30
Upper respiratory tract,LOCATION_OF,Colonization,32470603,10.1016/j.ijid.2020.05.049,2020-05-30
Colonization,PROCESS_OF,Transient Population Group,32470603,10.1016/j.ijid.2020.05.049,2020-05-30
Decision,PROCESS_OF,Maker (occupation),32470602,10.1016/j.ijid.2020.05.072,2020-05-30
nafamostat,TREATS,Pneumonia,32470601,10.1016/j.ijid.2020.05.065,2020-05-30
Pneumonia,PROCESS_OF,geriatric patients,32470601,10.1016/j.ijid.2020.05.065,2020-05-30
Possible,PROCESS_OF,geriatric patients,32470601,10.1016/j.ijid.2020.05.065,2020-05-30
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32470577,10.1016/j.ijbiomac.2020.05.184,2020-05-30
Prescribed medications,TREATS,Virus,32470568,10.1016/j.cmi.2020.05.016,2020-05-30
Chloroquine,ADMINISTERED_TO,Homo sapiens,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Hydroxychloroquine,ADMINISTERED_TO,Homo sapiens,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Virus Diseases,PROCESS_OF,Adult,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Virus Diseases,PROCESS_OF,Child,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Pharmaceutical Preparations,TREATS,HIV,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Chloroquine,TREATS,HIV Infections,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Hydroxychloroquine,TREATS,HIV Infections,32470547,10.1016/j.bcp.2020.114057,2020-05-30
Pneumonia,PROCESS_OF,Homo sapiens,32470516,10.1016/j.jacc.2020.05.038,2020-05-30
Virus Diseases,CAUSES,Pneumonia,32470516,10.1016/j.jacc.2020.05.038,2020-05-30
Hospitalization,AFFECTS,cardiovascular disorder risk,32470515,10.1016/j.jacc.2020.05.040,2020-05-30
Hospitalization,TREATS,Acute Disease,32470515,10.1016/j.jacc.2020.05.040,2020-05-30
cardiovascular disorder risk,PROCESS_OF,Patients,32470515,10.1016/j.jacc.2020.05.040,2020-05-30
Cardiovascular,LOCATION_OF,Acute Disease,32470515,10.1016/j.jacc.2020.05.040,2020-05-30
risk factors,PROCESS_OF,Patients,32470486,10.1016/j.jaci.2020.05.019,2020-05-30
Cardiovascular Diseases,AFFECTS,At risk of disease,32470486,10.1016/j.jaci.2020.05.019,2020-05-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32470486,10.1016/j.jaci.2020.05.019,2020-05-30
ruxolitinib,ADMINISTERED_TO,Patients,32470470,10.1016/j.pharmthera.2020.107587,2020-05-30
"TLR4 protein, human",PART_OF,Persons,32470381,10.1016/j.molmed.2020.03.008,2020-05-30
Hydroxychloroquine,ISA,Antimalarials,32470381,10.1016/j.molmed.2020.03.008,2020-05-30
caspase-5,PART_OF,Endosomes,32470381,10.1016/j.molmed.2020.03.008,2020-05-30
inhibitors,AFFECTS,Severe Acute Respiratory Syndrome,32470381,10.1016/j.molmed.2020.03.008,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32470381,10.1016/j.molmed.2020.03.008,2020-05-30
Disease,AFFECTS,Communicable Diseases,32470316,10.3201/eid2608.201423,2020-05-30
Coronavirus Infections,ISA,Disease,32470229,10.1111/jebm.12395,2020-05-30
Disease,PROCESS_OF,Patients,32470207,10.1111/jth.14937,2020-05-30
Coronavirus Infections,ISA,Disease,32470207,10.1111/jth.14937,2020-05-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32470207,10.1111/jth.14937,2020-05-30
Fever,PROCESS_OF,Patients,32470207,10.1111/jth.14937,2020-05-30
Obesity,PROCESS_OF,Patients,32470207,10.1111/jth.14937,2020-05-30
Critical Illness,PROCESS_OF,Racial group,32470207,10.1111/jth.14937,2020-05-30
Normal weight,PROCESS_OF,Persons,32470207,10.1111/jth.14937,2020-05-30
Obesity,PREDISPOSES,Severe (severity modifier),32470207,10.1111/jth.14937,2020-05-30
Present,PROCESS_OF,Patients,32470186,10.1002/jmv.26082,2020-05-30
Disease,PROCESS_OF,Patients,32470178,10.1002/ijgo.13240,2020-05-30
Disease,PROCESS_OF,Patients,32470178,10.1002/ijgo.13240,2020-05-30
Isolate - microorganism,PART_OF,Chiroptera,32470171,10.1111/den.13757,2020-05-30
Coronavirus Infections,PROCESS_OF,Pholidota,32470171,10.1111/den.13757,2020-05-30
Proteins,AUGMENTS,Tropism,32470171,10.1111/den.13757,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32470171,10.1111/den.13757,2020-05-30
Acclimatization,PROCESS_OF,Homo sapiens,32470171,10.1111/den.13757,2020-05-30
Infected,PROCESS_OF,Patients,32470167,10.1002/jmv.26071,2020-05-30
Pneumonia,PREDISPOSES,Exacerbation,32470164,10.1002/jmv.26041,2020-05-30
Hypertensive disease,PROCESS_OF,Patients,32470164,10.1002/jmv.26041,2020-05-30
Cardiovascular Diseases,PROCESS_OF,Patients,32470161,10.1002/lary.28847,2020-05-30
Infected,PROCESS_OF,Patients,32470161,10.1002/lary.28847,2020-05-30
Acute myocardial infarction,PROCESS_OF,Woman,32470161,10.1002/lary.28847,2020-05-30
Coronavirus Infections,PROCESS_OF,Woman,32470161,10.1002/lary.28847,2020-05-30
Percutaneous Coronary Intervention,TREATS,Acute myocardial infarction,32470161,10.1002/lary.28847,2020-05-30
Pulmonary Embolism,PROCESS_OF,Patients,32470153,10.1002/jmv.26070,2020-05-30
Dyspnea,ISA,Symptoms,32470153,10.1002/jmv.26070,2020-05-30
Dyspnea,ISA,Symptoms,32470153,10.1002/jmv.26070,2020-05-30
Dyspnea,PROCESS_OF(SPEC),Patients,32470153,10.1002/jmv.26070,2020-05-30
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32470153,10.1002/jmv.26070,2020-05-30
Symptoms,PROCESS_OF,Patients,32470153,10.1002/jmv.26070,2020-05-30
Disease,CAUSES,Pulmonary Embolism,32470153,10.1002/jmv.26070,2020-05-30
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32470153,10.1002/jmv.26070,2020-05-30
Hypoxemia,COEXISTS_WITH,Pulmonary Embolism,32470153,10.1002/jmv.26070,2020-05-30
Parenchyma,LOCATION_OF,Disease,32470153,10.1002/jmv.26070,2020-05-30
severe Breathlessness,COEXISTS_WITH,Pulmonary Embolism,32470153,10.1002/jmv.26070,2020-05-30
Serum,LOCATION_OF,Ferritin,32470151,10.1002/jmv.26083,2020-05-30
Serum,LOCATION_OF,Ferritin,32470151,10.1002/jmv.26083,2020-05-30
Ferritin,TREATS,Patients,32470151,10.1002/jmv.26083,2020-05-30
Serum,LOCATION_OF,Ferritin,32470151,10.1002/jmv.26083,2020-05-30
Patients,LOCATION_OF,Interleukin-1,32470151,10.1002/jmv.26083,2020-05-30
Lymphopenia,PROCESS_OF,Patients,32470151,10.1002/jmv.26083,2020-05-30
Immunity,AFFECTS,"Immunity, Innate",32470148,10.1002/jmv.26087,2020-05-30
Type-II Pneumocytes,PART_OF,Alveolar,32470146,10.1002/jmv.26085,2020-05-30
Disease,PROCESS_OF,Patients,32470146,10.1002/jmv.26085,2020-05-30
Patients,LOCATION_OF,KITLG gene,32470146,10.1002/jmv.26085,2020-05-30
Coronavirus Infections,ISA,Disease,32470146,10.1002/jmv.26085,2020-05-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32470146,10.1002/jmv.26085,2020-05-30
Coronavirus Infections,ISA,Disease,32470146,10.1002/jmv.26085,2020-05-30
Patients,LOCATION_OF,KITLG gene,32470146,10.1002/jmv.26085,2020-05-30
Serum,LOCATION_OF,KITLG gene,32470146,10.1002/jmv.26085,2020-05-30
Severe disorder,PROCESS_OF,Patients,32470146,10.1002/jmv.26085,2020-05-30
Patients,LOCATION_OF,KITLG gene,32470146,10.1002/jmv.26085,2020-05-30
"Pulmonary involvement, severe",PROCESS_OF,Patients,32470146,10.1002/jmv.26085,2020-05-30
Inflammation,PROCESS_OF,Patients,32470131,10.1093/ageing/afaa118,2020-05-30
Mild disorder,PROCESS_OF,Patients,32470131,10.1093/ageing/afaa118,2020-05-30
Attitude,PROCESS_OF,Adult,32470119,10.1093/bioinformatics/btaa550,2020-05-30
mental health,PROCESS_OF,Adult,32470119,10.1093/bioinformatics/btaa550,2020-05-30
SARS coronavirus,LOCATION_OF,Proteins,32470088,10.1371/journal.pone.0233874,2020-05-30
Intervention regimes,TREATS,Persons,32470046,10.1371/journal.pone.0233947,2020-05-30
plaque assay,MEASURES,Titer,32470007,10.1371/journal.pone.0233831,2020-05-30
Critical Illness,PROCESS_OF,Patients,32470007,10.1371/journal.pone.0233831,2020-05-30
mental health,PROCESS_OF,Health Personnel,32469989,10.1371/journal.pone.0233875,2020-05-30
mental health,PROCESS_OF,Health Personnel,32469989,10.1371/journal.pone.0233875,2020-05-30
Mental Health Services,TREATS,Health Personnel,32469989,10.1371/journal.pone.0233875,2020-05-30
Patient in hospital,PROCESS_OF,Persons,32469854,10.5867/medwave.2020.04.7902,2020-05-30
Coronavirus Infections,CAUSES,"Respiratory Distress Syndrome, Newborn",32469853,10.5867/medwave.2020.04.7898,2020-05-30
Ambulatory Care Facilities,LOCATION_OF,Work,32469853,10.5867/medwave.2020.04.7898,2020-05-30
Cessation of life,OCCURS_IN,day,32469844,10.1556/650.2020.31873,2020-05-30
Infected,PROCESS_OF,Persons,32469844,10.1556/650.2020.31873,2020-05-30
Pandemics,ISA,Disease Outbreaks,32469732,10.1016/j.rmed.2020.106036,2020-05-30
Telemedicine,AFFECTS,Severe (severity modifier),32469732,10.1016/j.rmed.2020.106036,2020-05-30
Infected,PROCESS_OF,Persons,32469732,10.1016/j.rmed.2020.106036,2020-05-30
Infected,PROCESS_OF,Patients,32469732,10.1016/j.rmed.2020.106036,2020-05-30
early identification,TREATS,Persons,32469732,10.1016/j.rmed.2020.106036,2020-05-30
early identification,TREATS(INFER),Infected,32469732,10.1016/j.rmed.2020.106036,2020-05-30
Chronic disease,PROCESS_OF,Patients,32469732,10.1016/j.rmed.2020.106036,2020-05-30
interstitial,LOCATION_OF,Decreased translucency,32469731,10.1016/j.rmed.2020.106038,2020-05-30
Alveolar,LOCATION_OF,Decreased translucency,32469731,10.1016/j.rmed.2020.106038,2020-05-30
Alveolar,LOCATION_OF,Decreased translucency,32469731,10.1016/j.rmed.2020.106038,2020-05-30
interstitial,LOCATION_OF,Decreased translucency,32469731,10.1016/j.rmed.2020.106038,2020-05-30
Lung,LOCATION_OF,Lesion,32469731,10.1016/j.rmed.2020.106038,2020-05-30
Alveolar,LOCATION_OF,Decreased translucency,32469731,10.1016/j.rmed.2020.106038,2020-05-30
Interventional procedure,TREATS,Patients,32469633,10.1089/vbz.2020.2652,2020-05-30
Interventional procedure,TREATS,Staff,32469633,10.1089/vbz.2020.2652,2020-05-30
patient condition,PROCESS_OF,Staff,32469633,10.1089/vbz.2020.2652,2020-05-30
portable biomedical equipment,USES,Hoods,32469633,10.1089/vbz.2020.2652,2020-05-30
portable biomedical equipment,USES,Hoods,32469633,10.1089/vbz.2020.2652,2020-05-30
Critical Illness,PROCESS_OF,Patients,32469632,10.1080/14739879.2020.1772123,2020-05-30
IMPACT gene,PART_OF,Virus,32469632,10.1080/14739879.2020.1772123,2020-05-30
Present,PROCESS_OF,Teacher,32469627,10.1080/07481187.2020.1773026,2020-05-30
Research Personnel,LOCATION_OF,IMPACT gene,32469618,10.1177/1942602X20928352,2020-05-30
Coughing,PROCESS_OF,Patients,32469610,10.1200/GO.20.00156,2020-05-30
Diarrhea,PROCESS_OF,Patients,32469610,10.1200/GO.20.00156,2020-05-30
cardiac symptom,PROCESS_OF,Patients,32469610,10.1200/GO.20.00156,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Cessation of life,PROCESS_OF,Patients,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Intervention regimes,TREATS,Infection,32469504,10.1021/acschemneuro.0c00286,2020-05-30
Lung,LOCATION_OF,Symptoms,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,ISA,Disease,32469464,10.1111/dom.14099,2020-05-30
Brain,LOCATION_OF,Cerebrospinal Fluid,32469464,10.1111/dom.14099,2020-05-30
Disease,PROCESS_OF,Patients,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,ISA,Disease,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32469464,10.1111/dom.14099,2020-05-30
Acute respiratory failure,PROCESS_OF,Patients,32469464,10.1111/dom.14099,2020-05-30
Disease,PROCESS_OF,Patients,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,ISA,Disease,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32469464,10.1111/dom.14099,2020-05-30
Health Personnel,DIAGNOSES,Disease,32469464,10.1111/dom.14099,2020-05-30
Health Personnel,DIAGNOSES(SPEC),Coronavirus Infections,32469464,10.1111/dom.14099,2020-05-30
Coronavirus Infections,ISA,Disease,32469464,10.1111/dom.14099,2020-05-30
Hyperglycemia,PROCESS_OF,hospitalized patients,32469437,10.1002/jcph.1673,2020-05-30
GSKIP gene,ASSOCIATED_WITH(INFER),Hyperglycemia,32469437,10.1002/jcph.1673,2020-05-30
GSKIP gene,PART_OF,hospitalized patients,32469437,10.1002/jcph.1673,2020-05-30
Diabetes,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Hyperglycemia,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
glucose normal,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Diabetes,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Diabetes,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Hyperglycemia,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Hyperglycemia,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
glucose normal,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
glucose normal,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Newly diagnosed diabetes,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Newly diagnosed diabetes,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32469437,10.1002/jcph.1673,2020-05-30
Blood Screening,USES,Glucose,32469437,10.1002/jcph.1673,2020-05-30
Buffers,INHIBITS,Possible,32469387,10.1001/jamaneurol.2020.2065,2020-05-30
Severe Acute Respiratory Syndrome,CAUSES,Disease,32469301,10.1099/jmm.0.001203,2020-05-30
Anosmia,ISA,Disease,32469301,10.1099/jmm.0.001203,2020-05-30
Anosmia,ISA,Neurologic Symptoms,32469301,10.1099/jmm.0.001203,2020-05-30
Headache,ISA,Disease,32469301,10.1099/jmm.0.001203,2020-05-30
Headache,ISA,Neurologic Symptoms,32469301,10.1099/jmm.0.001203,2020-05-30
Cerebrovascular accident,ISA,Disease,32469301,10.1099/jmm.0.001203,2020-05-30
Ageusia,ISA,Disease,32469301,10.1099/jmm.0.001203,2020-05-30
Ageusia,ISA,Neurologic Symptoms,32469301,10.1099/jmm.0.001203,2020-05-30
Patient Monitoring,TREATS,neurologic sequelae,32469301,10.1099/jmm.0.001203,2020-05-30
Decision,PROCESS_OF,World,32469265,10.1080/07391102.2020.1775703,2020-05-30
MCF-7 Cells,LOCATION_OF,TMPRSS2 gene,32469265,10.1080/07391102.2020.1775703,2020-05-30
withanone,INTERACTS_WITH,TMPRSS2 gene,32469265,10.1080/07391102.2020.1775703,2020-05-30
Coronavirus Infections,ISA,Disease,32469263,10.1024/1661-8157/a003526,2020-05-30
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32469263,10.1024/1661-8157/a003526,2020-05-30
Severe Acute Respiratory Syndrome,COEXISTS_WITH(SPEC),Coronavirus Infections,32469263,10.1024/1661-8157/a003526,2020-05-30
"N protein, Severe acute respiratory syndrome virus",INTERACTS_WITH,Viral Genome,32469263,10.1024/1661-8157/a003526,2020-05-30
Disease,PROCESS_OF,Homo sapiens,32469263,10.1024/1661-8157/a003526,2020-05-30
Phosphoproteins,PART_OF,Nucleocapsid,32469263,10.1024/1661-8157/a003526,2020-05-30
RNA Recognition Motif,PART_OF,Phosphoproteins,32469263,10.1024/1661-8157/a003526,2020-05-30
Cessation of life,PROCESS_OF,Patients,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Cessation of life,PROCESS_OF,Patients,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Disorder of eye,PROCESS_OF,Patients,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,LOCATION_OF,Present,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,PART_OF,Homo sapiens,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Present,PROCESS_OF,Patients,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,PART_OF,Homo sapiens,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,LOCATION_OF,DNA Sequence,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,LOCATION_OF,DNA Sequence,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Retina,PART_OF,Homo sapiens,32469255,10.1152/ajpendo.00219.2020,2020-05-30
Comorbidity,PROCESS_OF,Elderly (population group),32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Comorbidity,PROCESS_OF,Persons,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
angiotensin converting enzyme 2,ADMINISTERED_TO,Foundation for the Accreditation of Cellular Therapy,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Diabetes Mellitus,PROCESS_OF,Persons,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Energy Metabolism,PROCESS_OF,Persons,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Obesity,PROCESS_OF,Persons,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Diabetes Mellitus,PROCESS_OF,Patients,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Obesity,PROCESS_OF,Patients,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Infection,PROCESS_OF,Patients,32469253,10.1161/CIRCULATIONAHA.120.047971,2020-05-30
Anosmia,PROCESS_OF,Patients,32469194,10.1097/JOM.0000000000001877,2020-05-30
Anosmia,PROCESS_OF,Patients,32469194,10.1097/JOM.0000000000001877,2020-05-30
Reverse Transcriptase Polymerase Chain Reaction,USES,Nasal Swab (procedure),32469194,10.1097/JOM.0000000000001877,2020-05-30
Evaluation,ADMINISTERED_TO,Patients,32469194,10.1097/JOM.0000000000001877,2020-05-30
Reverse Transcriptase Polymerase Chain Reaction,MEASURES,day,32469194,10.1097/JOM.0000000000001877,2020-05-30
Duration,compared_with,Duration,32469194,10.1097/JOM.0000000000001877,2020-05-30
Anosmia,PROCESS_OF,Patients,32469194,10.1097/JOM.0000000000001877,2020-05-30
Anosmia,ISA,Symptoms,32469194,10.1097/JOM.0000000000001877,2020-05-30
Quarantine,TREATS,Patients,32469164,10.1111/1759-7714.13498,2020-05-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Malignant Neoplasms,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS,Patients,32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS(INFER),Malignant neoplasm of lung,32469137,10.1111/tbed.13651,2020-05-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Clinical Management,TREATS,Patients,32469137,10.1111/tbed.13651,2020-05-30
Fever,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS,Patients,32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS(INFER),Fever,32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS(INFER),"Signs and Symptoms, Respiratory",32469137,10.1111/tbed.13651,2020-05-30
early identification,TREATS(INFER),Malignant neoplasm of lung,32469137,10.1111/tbed.13651,2020-05-30
Coronavirus Infections,CAUSES,Pneumonia,32469114,10.1111/apha.13513,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32469114,10.1111/apha.13513,2020-05-30
Fibrinogen,INHIBITS,risk factors,32469114,10.1111/apha.13513,2020-05-30
Fibrin fragment D,INHIBITS(SPEC),risk factors,32469114,10.1111/apha.13513,2020-05-30
Fibrin fragment D,ISA,Fibrinogen,32469114,10.1111/apha.13513,2020-05-30
angiotensin II,ISA,Peptides,32469096,10.1111/bju.15119,2020-05-30
Peptides,INTERACTS_WITH,angiotensin II,32469096,10.1111/bju.15119,2020-05-30
Carboxypeptidase,INHIBITS,angiotensin II,32469096,10.1111/bju.15119,2020-05-30
Demand (clinical),AFFECTS,Nance-Horan syndrome,32469074,10.1093/infdis/jiaa284,2020-05-30
Satisfaction,PROCESS_OF,Clinician,32469074,10.1093/infdis/jiaa284,2020-05-30
Consultation,TREATS,Patients,32469074,10.1093/infdis/jiaa284,2020-05-30
"Hospitals, Community",LOCATION_OF,Analysis,32468998,10.12659/MSM.925669,2020-05-30
inpatient pharmacy,LOCATION_OF,Analysis,32468998,10.12659/MSM.925669,2020-05-30
Hypnotics and Sedatives,ISA,Pharmaceutical Preparations,32468998,10.12659/MSM.925669,2020-05-30
Acclimatization,PROCESS_OF,Persons,32468988,10.1192/j.eurpsy.2020.58,2020-05-30
Intervention regimes,TREATS,Medical Staff,32468988,10.1192/j.eurpsy.2020.58,2020-05-30
Psychiatric therapeutic procedure,AFFECTS,Patients,32468944,10.12968/hmed.2020.0241,2020-05-30
Psychiatric therapeutic procedure,AFFECTS,Caregiver,32468944,10.12968/hmed.2020.0241,2020-05-30
SARS coronavirus,CAUSES,Disease,32468890,10.1080/0142159X.2020.1770713,2020-05-30
Immunotherapy,TREATS,Multiple malignancy,32468845,10.1177/0846537120930344,2020-05-30
Immune system,LOCATION_OF,Therapeutic procedure,32468845,10.1177/0846537120930344,2020-05-30
Immune system,LOCATION_OF(SPEC),Immunotherapy,32468845,10.1177/0846537120930344,2020-05-30
Immunotherapy,ISA,Therapeutic procedure,32468845,10.1177/0846537120930344,2020-05-30
Laboratory,LOCATION_OF,Analysis,32468845,10.1177/0846537120930344,2020-05-30
Immunotherapy,ISA,Therapeutic procedure,32468845,10.1177/0846537120930344,2020-05-30
Coronavirus Infections,CAUSES,Disease,32468695,10.1111/jan.14438,2020-05-30
Coronavirus Infections,ISA,Disease,32468631,10.1002/hast.1113,2020-05-30
Coronavirus Infections,ISA,Disease,32468631,10.1002/hast.1113,2020-05-30
Unemployment,PREDISPOSES,child abuse behavior,32468607,10.1002/hed.26287,2020-05-30
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32468509,10.1007/s11739-020-02382-4,2020-05-30
Protection,PROCESS_OF,Health Personnel,32468508,10.1007/s11739-020-02384-2,2020-05-30
Contacts,USES,Masks,32468508,10.1007/s11739-020-02384-2,2020-05-30
Infusion procedures,TREATS,Patients,32468425,10.1007/s40261-020-00927-1,2020-05-30
Critical Illness,PROCESS_OF,Patients,32468425,10.1007/s40261-020-00927-1,2020-05-30
Definitive Treatment,NEG_USES,Pharmaceutical Preparations,32468414,10.1007/s11845-020-02269-5,2020-05-30
Hydroxychloroquine,TREATS,patient condition,32468414,10.1007/s11845-020-02269-5,2020-05-30
Physicians,ISA,Population Group,32468411,10.1007/s12016-020-08797-3,2020-05-30
Asthma,PROCESS_OF,Patients,32468357,10.1007/s10140-020-01799-w,2020-05-30
Asthma,PROCESS_OF,Persons,32468357,10.1007/s10140-020-01799-w,2020-05-30
Interleukin-4,ISA,cytokine,32468357,10.1007/s10140-020-01799-w,2020-05-30
Adrenal Cortex Hormones,PREVENTS,Asthma,32468357,10.1007/s10140-020-01799-w,2020-05-30
Allergen Immunotherapy,PREVENTS,Asthma,32468357,10.1007/s10140-020-01799-w,2020-05-30
Anti-IgE [EPC],PREVENTS,Asthma,32468357,10.1007/s10140-020-01799-w,2020-05-30
Complication,COEXISTS_WITH,patient condition,32468343,10.1007/s11684-020-0787-4,2020-05-30
Neurologic Symptoms,PROCESS_OF,Patients,32468343,10.1007/s11684-020-0787-4,2020-05-30
Severe disorder,PROCESS_OF,Patients,32468343,10.1007/s11684-020-0787-4,2020-05-30
Psoriasis,PROCESS_OF,Patients,32468229,10.1007/s13555-020-00402-x,2020-05-30
Biological Response Modifier Therapy,TREATS,Psoriasis,32468229,10.1007/s13555-020-00402-x,2020-05-30
Psoriasis,PROCESS_OF,Patients,32468229,10.1007/s13555-020-00402-x,2020-05-30
Biological Factors,ISA,Pharmaceutical Preparations,32468229,10.1007/s13555-020-00402-x,2020-05-30
Biological Factors,TREATS(SPEC),Psoriasis,32468229,10.1007/s13555-020-00402-x,2020-05-30
Pharmaceutical Preparations,TREATS,Psoriasis,32468229,10.1007/s13555-020-00402-x,2020-05-30
Fever,PROCESS_OF,Patients,32468229,10.1007/s13555-020-00402-x,2020-05-30
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32468229,10.1007/s13555-020-00402-x,2020-05-30
Biological Response Modifier Therapy,TREATS,Psoriasis,32468229,10.1007/s13555-020-00402-x,2020-05-30
Possible,PROCESS_OF,Patients,32468229,10.1007/s13555-020-00402-x,2020-05-30
melanoma,ISA,Malignant Neoplasms,32468203,10.1007/s00264-020-04622-w,2020-05-30
Experience,PROCESS_OF,Patients,32468201,10.1007/s00264-020-04626-6,2020-05-30
traumatic fracture,PROCESS_OF,Patients,32468201,10.1007/s00264-020-04626-6,2020-05-30
Fracture,PROCESS_OF,Patients,32468201,10.1007/s00264-020-04626-6,2020-05-30
traumatic fracture,PROCESS_OF,Patients,32468201,10.1007/s00264-020-04626-6,2020-05-30
Postoperative fever,PROCESS_OF,Patients,32468201,10.1007/s00264-020-04626-6,2020-05-30
"Infections, Hospital",PROCESS_OF,Medical Staff,32468196,10.1007/s40264-020-00952-1,2020-05-30
Hospitals,LOCATION_OF,Administration occupational activities,32468196,10.1007/s40264-020-00952-1,2020-05-30
Medical procedure,PREVENTS,"Infections, Hospital",32468196,10.1007/s40264-020-00952-1,2020-05-30
Orthopedic department,LOCATION_OF,Administration occupational activities,32468196,10.1007/s40264-020-00952-1,2020-05-30
Coronavirus Infections,ISA,Disease,32468193,10.1007/s00455-020-10139-6,2020-05-30
Placebos,ISA,Therapeutic procedure,32468193,10.1007/s00455-020-10139-6,2020-05-30
Placebos,ISA,Therapeutic procedure,32468193,10.1007/s00455-020-10139-6,2020-05-30
scholar,TREATS,Patients,32468193,10.1007/s00455-020-10139-6,2020-05-30
Active Method,compared_with,Placebos,32468193,10.1007/s00455-020-10139-6,2020-05-30
Placebos,ADMINISTERED_TO,Patients,32468193,10.1007/s00455-020-10139-6,2020-05-30
Placebos,ADMINISTERED_TO,Patients,32468193,10.1007/s00455-020-10139-6,2020-05-30
Placebos,compared_with,Placebos,32468193,10.1007/s00455-020-10139-6,2020-05-30
Serious Adverse Event,PROCESS_OF,Patients,32468193,10.1007/s00455-020-10139-6,2020-05-30
Aspiration-action,PREDISPOSES,Deglutition Disorders,32468155,10.1007/s10900-020-00853-5,2020-05-30
Deglutition Disorders,PROCESS_OF,Patients,32468155,10.1007/s10900-020-00853-5,2020-05-30
Deglutition Disorders,PROCESS_OF,Patients,32468155,10.1007/s10900-020-00853-5,2020-05-30
Emotions,PROCESS_OF,Persons,32468151,10.1007/s00011-020-01366-6,2020-05-30
mental health,PROCESS_OF,Adult,32468151,10.1007/s00011-020-01366-6,2020-05-30
intensive care,TREATS,Respiratory complication,32468103,10.1007/s00384-020-03622-x,2020-05-30
Intervention regimes,TREATS,Pneumonia,32468103,10.1007/s00384-020-03622-x,2020-05-30
inflammatory response,AFFECTS,Septicemia,32468103,10.1007/s00384-020-03622-x,2020-05-30
Crisis,COEXISTS_WITH,Enthesitis-Related Arthritis,32468052,10.3892/ijo.2020.5071,2020-05-30
Severe Acute Respiratory Syndrome,CAUSES,Disease,32468014,10.3892/ijmm.2020.4608,2020-05-30
Peptide Hydrolases,PART_OF,Host Cell,32468014,10.3892/ijmm.2020.4608,2020-05-30
Adenocarcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Adenocarcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Adenocarcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Prostate,LOCATION_OF,Adenocarcinoma,32468014,10.3892/ijmm.2020.4608,2020-05-30
Prostate,LOCATION_OF,Adenocarcinoma,32468014,10.3892/ijmm.2020.4608,2020-05-30
Adenocarcinoma of rectum,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Adenocarcinoma of rectum,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Cervical Squamous Cell Carcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Uterine Carcinosarcoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Endocervical adenocarcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Endometrial Endometrioid Adenocarcinoma,MANIFESTATION_OF,Malignant Neoplasms,32468014,10.3892/ijmm.2020.4608,2020-05-30
Squamous Epithelial Cells,LOCATION_OF,Head and Neck Carcinoma,32468014,10.3892/ijmm.2020.4608,2020-05-30
Genes,LOCATION_OF,Hypomethylation,32468014,10.3892/ijmm.2020.4608,2020-05-30
Attention,PROCESS_OF,Research Personnel,32467968,10.1093/ehjqcco/qcaa046,2020-05-30
Therapeutic procedure,TREATS,Disease,32467968,10.1093/ehjqcco/qcaa046,2020-05-30
Infected,PROCESS_OF,Cancer Patient,32467809,10.7759/cureus.7834,2020-05-30
primary disorders,CAUSES,Complication,32467809,10.7759/cureus.7834,2020-05-30
Appendectomy,TREATS,Appendicitis,32467792,10.7759/cureus.7816,2020-05-30
Conservative Treatment,TREATS,Patients,32467792,10.7759/cureus.7816,2020-05-30
Conservative Treatment,USES,Antibiotics,32467792,10.7759/cureus.7816,2020-05-30
Appendectomy,TREATS,Patients,32467792,10.7759/cureus.7816,2020-05-30
Appendectomy,TREATS(INFER),Appendicitis,32467792,10.7759/cureus.7816,2020-05-30
Appendectomy,TREATS(INFER),Disease,32467792,10.7759/cureus.7816,2020-05-30
Appendicitis,PROCESS_OF,Patients,32467792,10.7759/cureus.7816,2020-05-30
Disease,PROCESS_OF,Patients,32467792,10.7759/cureus.7816,2020-05-30
Coronavirus Infections,ISA,Disease,32467792,10.7759/cureus.7816,2020-05-30
Coronavirus Infections,ISA,Disease,32467792,10.7759/cureus.7816,2020-05-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32467792,10.7759/cureus.7816,2020-05-30
Appendicitis,PREDISPOSES,treatment failure,32467792,10.7759/cureus.7816,2020-05-30
Disease,PREDISPOSES,treatment failure,32467792,10.7759/cureus.7816,2020-05-30
Coronavirus Infections,ISA,Disease,32467792,10.7759/cureus.7816,2020-05-30
Coronavirus Infections,PREDISPOSES(SPEC),treatment failure,32467792,10.7759/cureus.7816,2020-05-30
Multiple Chronic Conditions,PROCESS_OF,Middle-aged men,32467792,10.7759/cureus.7816,2020-05-30
Antibiotics,ADMINISTERED_TO,Patients,32467792,10.7759/cureus.7816,2020-05-30
Antibiotics,TREATS,Symptoms,32467792,10.7759/cureus.7816,2020-05-30
Appendicitis,COEXISTS_WITH,patient condition,32467792,10.7759/cureus.7816,2020-05-30
Signal Transduction Pathways,COEXISTS_WITH,Virus Diseases,32467492,10.1097/PHM.0000000000001479,2020-05-30
Biological Processes,AFFECTS,Virus Diseases,32467492,10.1097/PHM.0000000000001479,2020-05-30
pulmonary involvement,PROCESS_OF,Survivors,32467457,10.1097/INF.0000000000002777,2020-05-30
Lung,NEG_LOCATION_OF,consideration,32467457,10.1097/INF.0000000000002777,2020-05-30
"Abdomen, Acute",PROCESS_OF,Child,32467452,10.1097/INF.0000000000002769,2020-05-30
Hemodynamic instability,PROCESS_OF,Child,32467452,10.1097/INF.0000000000002769,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32467452,10.1097/INF.0000000000002769,2020-05-30
Symptoms,PROCESS_OF,Child,32467443,10.1097/CCM.0000000000004458,2020-05-30
"Heparin, Low-Molecular-Weight",ADMINISTERED_TO,hospitalized patients,32467432,10.1097/JAC.0000000000000339,2020-05-30
Blood Coagulation Disorders,CAUSES,Complication,32467432,10.1097/JAC.0000000000000339,2020-05-30
Blood Coagulation Disorders,CAUSES,Thrombosis,32467432,10.1097/JAC.0000000000000339,2020-05-30
Critical Illness,PROCESS_OF,hospitalized patients,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disseminated Intravascular Coagulation,CAUSES,Blood Coagulation Disorders,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disseminated Intravascular Coagulation,CAUSES,Thrombus,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disseminated Intravascular Coagulation,CAUSES,Disease of capillaries,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disseminated Intravascular Coagulation,CAUSES,Thrombophilia,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disseminated Intravascular Coagulation,ISA,Blood Coagulation Disorders,32467432,10.1097/JAC.0000000000000339,2020-05-30
Pulmonary Embolism,PROCESS_OF,hospitalized patients,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disease of capillaries,CAUSES,Complication,32467432,10.1097/JAC.0000000000000339,2020-05-30
Disease of capillaries,CAUSES,Thrombosis,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombophilia,CAUSES,Complication,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombophilia,CAUSES,Thrombosis,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombotic Microangiopathies,CAUSES,Blood Coagulation Disorders,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombotic Microangiopathies,CAUSES,Thrombus,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombotic Microangiopathies,CAUSES,Disease of capillaries,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombotic Microangiopathies,CAUSES,Thrombophilia,32467432,10.1097/JAC.0000000000000339,2020-05-30
Thrombotic Microangiopathies,ISA,Blood Coagulation Disorders,32467432,10.1097/JAC.0000000000000339,2020-05-30
Anticoagulant prophylaxis,TREATS,hospitalized patients,32467432,10.1097/JAC.0000000000000339,2020-05-30
Heart Injuries,PROCESS_OF,Patients,32467422,10.1097/HPC.0000000000000228,2020-05-30
Inflammation,MANIFESTATION_OF,Heart Injuries,32467422,10.1097/HPC.0000000000000228,2020-05-30
Troponin T,PREDISPOSES,Heart Injuries,32467422,10.1097/HPC.0000000000000228,2020-05-30
Troponin T,PREDISPOSES,Inflammation,32467422,10.1097/HPC.0000000000000228,2020-05-30
Plasma C-reactive protein measurement,USES,High sensitivity,32467422,10.1097/HPC.0000000000000228,2020-05-30
Heart Injuries,PROCESS_OF,Patients,32467422,10.1097/HPC.0000000000000228,2020-05-30
Inflammation,PROCESS_OF,Patients,32467422,10.1097/HPC.0000000000000228,2020-05-30
cytokine secretion,CAUSES,cardiac muscle cell apoptotic process,32467422,10.1097/HPC.0000000000000228,2020-05-30
Pandemics,ISA,Disease Outbreaks,32467422,10.1097/HPC.0000000000000228,2020-05-30
"Recombination, Genetic",CAUSES,Acute infectious disease,32467422,10.1097/HPC.0000000000000228,2020-05-30
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32467359,10.1128/JCM.00958-20,2020-05-30
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32467359,10.1128/JCM.00958-20,2020-05-30
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32467359,10.1128/JCM.00958-20,2020-05-30
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32467359,10.1128/JCM.00958-20,2020-05-30
Assay,MEASURES,Copy Number,32467290,10.1136/medethics-2020-106389,2020-05-30
"RNA, Viral",CAUSES,False Negative,32467290,10.1136/medethics-2020-106389,2020-05-30
Infection,PROCESS_OF,Family,32467284,10.1128/MRA.00489-20,2020-05-30
Alveolar rhabdomyosarcoma,PROCESS_OF,Service Personnel,32467284,10.1128/MRA.00489-20,2020-05-30
Awareness,PROCESS_OF,Patients,32467191,10.3174/ajnr.A6610,2020-05-30
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32467191,10.3174/ajnr.A6610,2020-05-30
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32467191,10.3174/ajnr.A6610,2020-05-30
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32467191,10.3174/ajnr.A6610,2020-05-30
Brain,LOCATION_OF,Magnetic Resonance Imaging,32467190,10.3174/ajnr.A6609,2020-05-30
White matter,LOCATION_OF,Disease of capillaries,32467190,10.3174/ajnr.A6609,2020-05-30
White matter,LOCATION_OF,Disease of capillaries,32467190,10.3174/ajnr.A6609,2020-05-30
Coughing,PROCESS_OF,Patients,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Dyspnea,PROCESS_OF,Patients,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Fever,PROCESS_OF,Patients,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Disease,PROCESS_OF,Patients,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Diagnosis,DIAGNOSES,Incidental Findings,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Lung,LOCATION_OF,Incidental Findings,32467176,10.5731/pdajpst.2020.012021,2020-05-30
Possible,PROCESS_OF,Staff,32467124,10.1136/bcr-2020-236069,2020-05-30
Virus,CAUSES,Virus Diseases,32467113,10.1681/ASN.2020040470,2020-05-30
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32467113,10.1681/ASN.2020040470,2020-05-30
Chest CT,AFFECTS,Communicable Diseases,32467113,10.1681/ASN.2020040470,2020-05-30
Comorbidity,PROCESS_OF,Patients,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Comorbidity,PROCESS_OF,Patients,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Comorbidity,PROCESS_OF,Patients,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Peritoneal Dialysis,ISA,Hemodialysis,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Fever,ISA,Symptoms,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Dialysis procedure,TREATS,Vulnerable Populations,32467101,10.1136/bmjspcare-2020-002368,2020-05-30
Symptoms,PROCESS_OF,Patients,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Coughing,ISA,Symptoms,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Coughing,PROCESS_OF(SPEC),Persons,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Dyspnea,ISA,Symptoms,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Dyspnea,PROCESS_OF(SPEC),Persons,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Fatigue,ISA,Symptoms,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Fatigue,PROCESS_OF(SPEC),Persons,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Myalgia,ISA,Symptoms,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Myalgia,PROCESS_OF(SPEC),Persons,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Symptoms,PROCESS_OF,Persons,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Dyspnea,ISA,Symptoms,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Decision,PROCESS_OF,Patients,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
Cessation of life,AFFECTS,Clinician,32467031,10.1016/j.hlc.2020.04.003,2020-05-30
contextual factors,PROCESS_OF,Patients,32467007,10.1016/j.transci.2020.102820,2020-05-30
Coughing,PROCESS_OF,Centenarians,32466995,10.1016/j.rbmo.2020.05.001,2020-05-30
Dyspnea,PROCESS_OF,Centenarians,32466995,10.1016/j.rbmo.2020.05.001,2020-05-30
Antiviral Therapy,TREATS,Old age,32466995,10.1016/j.rbmo.2020.05.001,2020-05-30
"Societies, Scientific",ISA,Societies,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Therapeutic procedure,TREATS,Patients,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Assisted Reproductive Technologies,ISA,Therapeutic procedure,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Assisted Reproductive Technologies,TREATS(SPEC),Patients,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Embryo,LOCATION_OF,Virus,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Germ Cells,LOCATION_OF,Virus,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Embryo,LOCATION_OF,Virus,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Germ Cells,LOCATION_OF,Virus,32466994,10.1016/j.rbmo.2020.04.018,2020-05-30
Coronavirus Infections,ISA,Disease,32466990,10.1016/j.medin.2020.05.002,2020-05-30
Medication Management,AFFECTS,Panic,32466990,10.1016/j.medin.2020.05.002,2020-05-30
Puncture procedure,METHOD_OF,Tracheotomy procedure,32466867,10.1016/j.ejogrb.2020.05.031,2020-05-30
Birth,NEG_PROCESS_OF,Woman,32466862,10.1016/j.otorri.2020.04.003,2020-05-30
Negative,PROCESS_OF,Woman,32466862,10.1016/j.otorri.2020.04.003,2020-05-30
Olfaction Disorders,COEXISTS_WITH,Respiratory Tract Diseases,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Edema,CAUSES,Olfaction Disorders,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Obstruction,CAUSES,Olfaction Disorders,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Olfaction Disorders,COEXISTS_WITH,Upper Respiratory Infections,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Anosmia,PROCESS_OF,Patients,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Isolation procedure,TREATS,Patients,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Isolation procedure,TREATS(INFER),Olfaction Disorders,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Olfaction Disorders,PROCESS_OF,Patients,32466830,10.1016/j.rgmx.2020.04.003,2020-05-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32466822,10.1017/dmp.2020.173,2020-05-30
Severe disorder,PROCESS_OF,Patients,32466822,10.1017/dmp.2020.173,2020-05-30
Endoscopes,TREATS,Patients,32466822,10.1017/dmp.2020.173,2020-05-30
Coronavirus Infections,CAUSES,Lung diseases,32466820,10.1192/j.eurpsy.2020.56,2020-05-30
"SPRR2A protein, human",PART_OF,Population Group,32466816,10.1017/dmp.2020.179,2020-05-30
Minority Groups,ISA,Population Group,32466757,10.1186/s12916-020-01640-8,2020-05-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32466757,10.1186/s12916-020-01640-8,2020-05-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),Minority Groups,32466757,10.1186/s12916-020-01640-8,2020-05-30
Treatment Protocols,TREATS,Minority Groups,32466757,10.1186/s12916-020-01640-8,2020-05-30
Treatment Protocols,USES,IMPACT gene,32466757,10.1186/s12916-020-01640-8,2020-05-30
Health Care,TREATS,Physicians,32466757,10.1186/s12916-020-01640-8,2020-05-30
Hospitals,LOCATION_OF,Laboratory Procedures,32466738,10.1161/STROKEAHA.120.030106,2020-05-30
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32466738,10.1161/STROKEAHA.120.030106,2020-05-30
Acute Disease,PROCESS_OF,Patients,32466736,10.1161/STROKEAHA.120.030574,2020-05-30
Cerebrovascular accident,PROCESS_OF,Social Networks,32466736,10.1161/STROKEAHA.120.030574,2020-05-30
Cerebrovascular accident,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Acute Cerebrovascular Accidents,AFFECTS,patient condition,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Vascular occlusion,CAUSES,Acute Cerebrovascular Accidents,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
patient condition,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Vascular occlusion,CAUSES,Acute Cerebrovascular Accidents,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Vascular occlusion,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Vascular occlusion,CAUSES,Acute Cerebrovascular Accidents,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Vascular occlusion,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
reocclusion,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Poor outcome,PROCESS_OF,Patients,32466735,10.1161/STROKEAHA.120.030365,2020-05-30
Cerebrovascular accident,PROCESS_OF,Survivors,32466654,10.22605/RRH6038,2020-05-30
Hospitals,LOCATION_OF,Study,32466654,10.22605/RRH6038,2020-05-30
Patients,LOCATION_OF,Interleukin-6,32466654,10.22605/RRH6038,2020-05-30
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Survivors,32466654,10.22605/RRH6038,2020-05-30
Cerebrovascular accident,PROCESS_OF,Survivors,32466654,10.22605/RRH6038,2020-05-30
Symptom severe,PROCESS_OF,Patients,32466654,10.22605/RRH6038,2020-05-30
Poor outcome,PROCESS_OF,Patients,32466654,10.22605/RRH6038,2020-05-30
IMPACT gene,AFFECTS,energy balance,32466581,10.3390/ijerph17113780,2020-05-30
Malaise,PROCESS_OF,Patients,32466581,10.3390/ijerph17113780,2020-05-30
rapid diagnosis,DIAGNOSES,Virus Diseases,32466523,10.3390/healthcare8020145,2020-05-30
Laboratory Procedures,USES,Specimen Collection,32466477,10.3390/ijerph17113766,2020-05-30
Asymptomatic,PROCESS_OF,Persons,32466477,10.3390/ijerph17113766,2020-05-30
Patients,ISA,Persons,32466392,10.3390/ijerph17113751,2020-05-30
Viral Shedding,COEXISTS_WITH,Convalescence,32466392,10.3390/ijerph17113751,2020-05-30
Asymptomatic,PROCESS_OF,Persons,32466392,10.3390/ijerph17113751,2020-05-30
Asymptomatic,PROCESS_OF(SPEC),Patients,32466392,10.3390/ijerph17113751,2020-05-30
Disease,AFFECTS,"Child, Preschool",32466326,10.3390/ijerph17103747,2020-05-30
Toothache,ISA,Complication,32466326,10.3390/ijerph17103747,2020-05-30
Therapeutic procedure,AFFECTS,Early childhood caries,32466326,10.3390/ijerph17103747,2020-05-30
Satisfaction,PROCESS_OF,tourist,32466251,10.3390/ijerph17103740,2020-05-30
Satisfaction,PROCESS_OF,tourist,32466251,10.3390/ijerph17103740,2020-05-30
Depressive disorder,PROCESS_OF,Respondents,32466199,10.3390/ijerph17103730,2020-05-30
Communicable Diseases,CAUSES,Challenge,32466164,10.3390/ijerph17103723,2020-05-30
Coronavirus Infections,ISA,Disease,32466163,10.3390/ijerph17103722,2020-05-30
Anxiety,PROCESS_OF,Respondents,32466163,10.3390/ijerph17103722,2020-05-30
Depressive disorder,PROCESS_OF,Respondents,32466163,10.3390/ijerph17103722,2020-05-30
Symptoms,PROCESS_OF,Physical Therapist,32466163,10.3390/ijerph17103722,2020-05-30
IMPACT gene,AUGMENTS,mental health,32466136,10.3390/ijerph17103715,2020-05-30
Health Personnel,ISA,Persons,32464707,10.1111/jth.14938,2020-05-29
Advice,TREATS,Health Personnel,32464707,10.1111/jth.14938,2020-05-29
Blood Coagulation Disorders,PROCESS_OF,Patients,32464695,10.1111/pan.13934,2020-05-29
Thrombophilia,PROCESS_OF,Patients,32464695,10.1111/pan.13934,2020-05-29
Mild disorder,PROCESS_OF,Patients,32464695,10.1111/pan.13934,2020-05-29
Thrombosis,CAUSES,Cerebrovascular accident,32464695,10.1111/pan.13934,2020-05-29
Venous Thrombosis,PROCESS_OF,Patients,32464695,10.1111/pan.13934,2020-05-29
Disease of capillaries,PROCESS_OF,Patients,32464695,10.1111/pan.13934,2020-05-29
Severe disorder,PREDISPOSES,Thrombus,32464695,10.1111/pan.13934,2020-05-29
Secondary Prevention,TREATS,Patients,32464695,10.1111/pan.13934,2020-05-29
Infection,PROCESS_OF,Health Personnel,32464685,10.1111/aor.13744,2020-05-29
Cardiovascular Diseases,AFFECTS,Patients,32464670,10.1055/a-1174-0234,2020-05-29
Patients,USES,Left ventricular assist device,32464670,10.1055/a-1174-0234,2020-05-29
Patients,USES,Left ventricular assist device,32464670,10.1055/a-1174-0234,2020-05-29
Communicable Diseases,PROCESS_OF,Patients,32464668,10.1215/03616878-8641542,2020-05-29
Protection,PROCESS_OF,Employee,32464668,10.1215/03616878-8641542,2020-05-29
Pandemics,ISA,Process,32464668,10.1215/03616878-8641542,2020-05-29
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Community,32464665,10.1215/03616878-8641530,2020-05-29
Critical Illness,PROCESS_OF,Patients,32464658,10.1215/03616878-8641506,2020-05-29
Virus,CAUSES,Disease,32464651,10.1215/03616878-8641518,2020-05-29
Homelessness,PROCESS_OF,Community,32464651,10.1215/03616878-8641518,2020-05-29
In prison (finding),PROCESS_OF,Community,32464651,10.1215/03616878-8641518,2020-05-29
Engaged to be married,PROCESS_OF,Community,32464651,10.1215/03616878-8641518,2020-05-29
Health Insurance,TREATS,parent,32464639,10.1215/03616878-8641457,2020-05-29
Cells,INTERACTS_WITH,angiotensin converting enzyme 2,32464624,10.1159/000508278,2020-05-29
Cells,INTERACTS_WITH,angiotensin converting enzyme 2,32464624,10.1159/000508278,2020-05-29
"Receptor, Angiotensin, Type 1",CAUSES,Endocytosis,32464624,10.1159/000508278,2020-05-29
"Receptor, Angiotensin, Type 1",ADMINISTERED_TO,Cells,32464624,10.1159/000508278,2020-05-29
angiotensin converting enzyme 2,ADMINISTERED_TO,Cells,32464624,10.1159/000508278,2020-05-29
Therapeutic procedure,AFFECTS,Biological Processes,32464624,10.1159/000508278,2020-05-29
angiotensin converting enzyme 2,NEG_DISRUPTS,Functional capacity,32464624,10.1159/000508278,2020-05-29
Angiotensin II Type 1 Receptor Blockers,TREATS,Severe Acute Respiratory Syndrome,32464624,10.1159/000508278,2020-05-29
Angiotensin II Type 1 Receptor Blockers,NEG_INHIBITS,angiotensin converting enzyme 2,32464624,10.1159/000508278,2020-05-29
Complication,PROCESS_OF,Patients,32464585,10.1016/j.msard.2020.102216,2020-05-29
Infectious Encephalitis,PROCESS_OF,Patients,32464584,10.1016/j.msard.2020.102174,2020-05-29
Virus,COEXISTS_WITH,Encephalitis,32464584,10.1016/j.msard.2020.102174,2020-05-29
Multiple Sclerosis,ISA,Disease,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Therapeutic procedure,TREATS,Disease,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Therapeutic procedure,TREATS,Multiple Sclerosis,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Therapeutic procedure,TREATS(SPEC),Multiple Sclerosis,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Severe Acute Respiratory Syndrome,MANIFESTATION_OF,Immunity,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Leukocytes,INTERACTS_WITH,CD8-Positive T-Lymphocytes,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Lymphopenia,COEXISTS_WITH,Storm NOS,32464579,10.1016/j.clinimag.2020.04.042,2020-05-29
Diagnosis,ADMINISTERED_TO,Patients,32464491,10.1016/j.mehy.2020.109878,2020-05-29
Fatigue,PROCESS_OF,Patients,32464491,10.1016/j.mehy.2020.109878,2020-05-29
Decrease in appetite,PROCESS_OF,Patients,32464491,10.1016/j.mehy.2020.109878,2020-05-29
Contrast bronchogram,USES,Air,32464491,10.1016/j.mehy.2020.109878,2020-05-29
Both lungs,LOCATION_OF,Diffuse Lesion,32464491,10.1016/j.mehy.2020.109878,2020-05-29
Patients,LOCATION_OF,"Discharge, body substance",32464491,10.1016/j.mehy.2020.109878,2020-05-29
Selenium,ASSOCIATED_WITH,Malignant Neoplasms,32464409,10.1016/j.scitotenv.2020.139560,2020-05-29
Selenium,ASSOCIATED_WITH,Heart Diseases,32464409,10.1016/j.scitotenv.2020.139560,2020-05-29
evaporation,AFFECTS,Climate,32464367,10.1016/j.jns.2020.116884,2020-05-29
Respiratory Center,PART_OF,Brain Stem,32464333,10.1016/j.scitotenv.2020.139652,2020-05-29
Endothelium,LOCATION_OF,ACE2 gene,32464333,10.1016/j.scitotenv.2020.139652,2020-05-29
Virus,PROCESS_OF,Community,32464298,10.1016/j.ajic.2020.05.020,2020-05-29
Patients,LOCATION_OF,Feces,32464298,10.1016/j.ajic.2020.05.020,2020-05-29
Italy,ISA,Country,32464298,10.1016/j.ajic.2020.05.020,2020-05-29
Circulatory Process,PROCESS_OF,Population Group,32464298,10.1016/j.ajic.2020.05.020,2020-05-29
Infected,PROCESS_OF,Health Personnel,32464297,10.1016/j.ajic.2020.05.022,2020-05-29
Practice Experience,PROCESS_OF,Child,32464294,10.1016/j.ajic.2020.05.024,2020-05-29
Asymptomatic,PROCESS_OF,Child,32464294,10.1016/j.ajic.2020.05.024,2020-05-29
Severe disorder,PROCESS_OF,Child,32464294,10.1016/j.ajic.2020.05.024,2020-05-29
Ambulatory Care Facilities,LOCATION_OF,"Education, Continuing",32464294,10.1016/j.ajic.2020.05.024,2020-05-29
Accident and Emergency department,LOCATION_OF,"Education, Continuing",32464294,10.1016/j.ajic.2020.05.024,2020-05-29
Masks,USES,Household Products,32464271,10.1016/j.ijid.2020.05.071,2020-05-29
Depressive disorder,PROCESS_OF,Patients,32464098,10.1016/j.chom.2020.05.009,2020-05-29
Immune response,PROCESS_OF,Patients,32464098,10.1016/j.chom.2020.05.009,2020-05-29
Depressive disorder,AFFECTS,Immune System Processes,32464098,10.1016/j.chom.2020.05.009,2020-05-29
Coronavirus Infections,ISA,Disease,32464097,10.1016/j.chom.2020.05.008,2020-05-29
Laboratory,LOCATION_OF,Work,32464084,10.17305/bjbms.2020.4838,2020-05-29
Immune response,AFFECTS,"Respiratory Distress Syndrome, Adult",32463802,10.1172/JCI139587,2020-05-29
Antiviral Response,PROCESS_OF,Patients,32463802,10.1172/JCI139587,2020-05-29
Granzymes,INTERACTS_WITH,Natural Killer Cells,32463802,10.1172/JCI139587,2020-05-29
Coronavirus Infections,CAUSES,Growth,32463794,10.18632/aging.103347,2020-05-29
Malignant Neoplasms,PROCESS_OF,Patients,32463752,10.12968/bjon.2020.29.10.582,2020-05-29
Telemedicine,TREATS,Patients,32463752,10.12968/bjon.2020.29.10.582,2020-05-29
Malignant Neoplasms,PROCESS_OF,Patients,32463752,10.12968/bjon.2020.29.10.582,2020-05-29
Malignant Neoplasms,PROCESS_OF,Patients,32463752,10.12968/bjon.2020.29.10.582,2020-05-29
Telemedicine,TREATS,Patients,32463752,10.12968/bjon.2020.29.10.582,2020-05-29
Residency,ISA,Training,32463704,10.2105/AJPH.2020.305751,2020-05-29
Coronavirus Infections,ISA,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Residency,AFFECTS,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Residency,AFFECTS(SPEC),Coronavirus Infections,32463704,10.2105/AJPH.2020.305751,2020-05-29
Coronavirus Infections,ISA,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Coronavirus Infections,ISA,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Coronavirus Infections,ISA,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Coronavirus Infections,ISA,Disease,32463704,10.2105/AJPH.2020.305751,2020-05-29
Negative,CAUSES,Adverse effects,32463545,10.1002/oby.22918,2020-05-29
Obesity,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Overweight,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Obesity,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Intention - mental process,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Dementia,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Overweight,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
advanced cancer,PROCESS_OF,Patients,32463543,10.1002/ejhf.1915,2020-05-29
Heart failure,PROCESS_OF,Patients,32463530,10.1002/oby.22917,2020-05-29
Heart failure,PROCESS_OF,Patients,32463530,10.1002/oby.22917,2020-05-29
Heart failure,PROCESS_OF,Hospital specialist,32463530,10.1002/oby.22917,2020-05-29
Challenge,TREATS,Clinician,32463530,10.1002/oby.22917,2020-05-29
Critical Illness,PROCESS_OF,Patients,32463478,10.1002/cncr.32962,2020-05-29
Emulsions,INTERACTS_WITH,,32463478,10.1002/cncr.32962,2020-05-29
Emulsions,INTERACTS_WITH,sodium dehydroacetate,32463478,10.1002/cncr.32962,2020-05-29
Emulsions,INTERACTS_WITH,Resolvin,32463478,10.1002/cncr.32962,2020-05-29
Malignant Neoplasms,PROCESS_OF,Patients,32463434,10.1093/cid/ciaa663,2020-05-29
Malignant Neoplasms,PROCESS_OF,Patients,32463434,10.1093/cid/ciaa663,2020-05-29
Central Nervous System Involvement,COEXISTS_WITH,Disease,32463377,10.2196/19264,2020-05-29
Disease,PROCESS_OF,Older people,32463375,10.2196/19494,2020-05-29
Telemedicine,TREATS,Persons,32463375,10.2196/19494,2020-05-29
Severe (severity modifier),PROCESS_OF,user - individual,32463375,10.2196/19494,2020-05-29
Coronavirus Infections,ISA,Disease,32463375,10.2196/19494,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Older people,32463375,10.2196/19494,2020-05-29
Coronavirus Infections,ISA,Disease,32463375,10.2196/19494,2020-05-29
Health Services,ADMINISTERED_TO,Older people,32463375,10.2196/19494,2020-05-29
Smoking,ISA,Services,32463367,10.2196/19455,2020-05-29
Current Some Day Smoker,PROCESS_OF,Adult,32463367,10.2196/19455,2020-05-29
Coronavirus Infections,ISA,Disease,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,COEXISTS_WITH,Disease,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,COEXISTS_WITH(SPEC),Coronavirus Infections,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,PROCESS_OF,Persons,32463365,10.7554/eLife.58040,2020-05-29
Coronavirus Infections,ISA,Disease,32463365,10.7554/eLife.58040,2020-05-29
Coronavirus Infections,ISA,Disease,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,PROCESS_OF,Persons,32463365,10.7554/eLife.58040,2020-05-29
Coronavirus Infections,ISA,Disease,32463365,10.7554/eLife.58040,2020-05-29
Confirmation,PROCESS_OF,Patients,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,PROCESS_OF,Persons,32463365,10.7554/eLife.58040,2020-05-29
Worried,COEXISTS_WITH,physical symptom,32463365,10.7554/eLife.58040,2020-05-29
Anxiety,PROCESS_OF,Persons,32463365,10.7554/eLife.58040,2020-05-29
Coronavirus Infections,ISA,Disease,32463365,10.7554/eLife.58040,2020-05-29
keratinocyte,PART_OF,Tongue,32463348,10.1161/JAHA.120.017144,2020-05-29
Enterocytes,PART_OF,"Intestines, Small",32463348,10.1161/JAHA.120.017144,2020-05-29
Hydroxychloroquine,ADMINISTERED_TO,Patients,32463289,10.1037/tra0000718,2020-05-29
Azithromycin,ADMINISTERED_TO,Patients,32463289,10.1037/tra0000718,2020-05-29
Pharmaceutical Preparations,AUGMENTS,Cardiac Arrhythmia,32463289,10.1037/tra0000718,2020-05-29
Hydroxychloroquine,COEXISTS_WITH,Pharmaceutical Preparations,32463289,10.1037/tra0000718,2020-05-29
Post-Traumatic Stress Disorder,PROCESS_OF,Veterans,32463288,10.1037/tra0000773,2020-05-29
Disability,PROCESS_OF,Community,32463285,10.1037/tra0000715,2020-05-29
Disability,PROCESS_OF,Community,32463285,10.1037/tra0000715,2020-05-29
Disability,PROCESS_OF,Persons,32463285,10.1037/tra0000715,2020-05-29
Moral Injury,PROCESS_OF,Health Personnel,32463284,10.1037/tra0000716,2020-05-29
Demand (clinical),AFFECTS,Moral Injury,32463284,10.1037/tra0000716,2020-05-29
Glycoproteins,AFFECTS,Virus Attachment,32463221,10.1021/acsinfecdis.0c00288,2020-05-29
Viral envelope,LOCATION_OF,Glycoproteins,32463221,10.1021/acsinfecdis.0c00288,2020-05-29
angiotensin converting enzyme 2,ADMINISTERED_TO,Human body,32463221,10.1021/acsinfecdis.0c00288,2020-05-29
Comorbidity,PROCESS_OF,Older people,32463212,10.23736/S0375-9393.20.14691-1,2020-05-29
Cessation of life,PROCESS_OF,Older people,32463212,10.23736/S0375-9393.20.14691-1,2020-05-29
Oxidative Stress,AFFECTS,Persons,32463212,10.23736/S0375-9393.20.14691-1,2020-05-29
Cessation of life,PROCESS_OF,Patients,32463212,10.23736/S0375-9393.20.14691-1,2020-05-29
Suspected infectious disease,PROCESS_OF,Patients,32463186,10.4045/tidsskr.20.0366,2020-05-29
Disease,PROCESS_OF,Patients,32463186,10.4045/tidsskr.20.0366,2020-05-29
Venous Thromboembolism,OCCURS_IN,Patients,32463179,10.1111/dom.14097,2020-05-29
Thrombophilia,PROCESS_OF,Transient Population Group,32463179,10.1111/dom.14097,2020-05-29
inflammatory response,PROCESS_OF,Patients,32463179,10.1111/dom.14097,2020-05-29
Pulmonary Embolism,CAUSES,Respiratory distress,32463179,10.1111/dom.14097,2020-05-29
Venous Thromboembolism,COEXISTS_WITH,Disease,32463179,10.1111/dom.14097,2020-05-29
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,hospitalized patients,32463092,10.1093/jpids/piaa069,2020-05-29
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
Pneumonia,PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
Disease Outcome,PROCESS_OF,Patients,32463092,10.1093/jpids/piaa069,2020-05-29
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,PROCESS_OF,critically ill children,32463088,10.1093/jtm/taaa084,2020-05-29
Conjunctivitis,COEXISTS_WITH,Exanthema,32463088,10.1093/jtm/taaa084,2020-05-29
Antibiotics,ADMINISTERED_TO,Patients,32463076,10.1093/cid/ciaa654,2020-05-29
Hospitals,ISA,skilled nursing facility,32463076,10.1093/cid/ciaa654,2020-05-29
Asymptomatic,PROCESS_OF,Persons,32463026,10.12659/MSM.926016,2020-05-29
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Symptom severe,32462996,10.1080/07391102.2020.1775129,2020-05-29
Rabies (disorder),INTERACTS_WITH,Virus,32462996,10.1080/07391102.2020.1775129,2020-05-29
DNA Sequence,PART_OF,Hepatitis C virus,32462996,10.1080/07391102.2020.1775129,2020-05-29
Fusion protein,PART_OF,Capsid,32462996,10.1080/07391102.2020.1775129,2020-05-29
Particle,INTERACTS_WITH,Fusion protein,32462996,10.1080/07391102.2020.1775129,2020-05-29
Basis,STIMULATES,"TLR4 protein, human",32462984,10.1177/0300891620931568,2020-05-29
Neoplasms,PROCESS_OF,Patients,32462970,10.1080/07391102.2020.1775127,2020-05-29
Prophylactic treatment,TREATS,Coronavirus Infections,32462858,10.23812/20-250-E-56,2020-05-29
Disease,PROCESS_OF,Patients,32462783,10.1002/hed.26291,2020-05-29
Patients,LOCATION_OF,"CD69 protein, human",32462783,10.1002/hed.26291,2020-05-29
"CD69 protein, human",INTERACTS_WITH,Ozone,32462783,10.1002/hed.26291,2020-05-29
systemic administration,AFFECTS,Disease,32462783,10.1002/hed.26291,2020-05-29
Genus: Coronavirus,CAUSES,Pneumonia,32462756,10.1111/ans.16057,2020-05-29
Colon and Rectal Surgery (procedure),ADMINISTERED_TO,Patients,32462744,10.1002/pmic.202000107,2020-05-29
Virus,LOCATION_OF,Proteins,32462732,10.1111/1742-6723.13558,2020-05-29
Enteral Nutrition,USES,Standard formula,32462717,10.1002/jmv.26078,2020-05-29
Storm NOS,PROCESS_OF,Patients,32462708,10.1111/acem.14035,2020-05-29
tocilizumab,ISA,"Antibodies, Monoclonal, Humanized",32462708,10.1111/acem.14035,2020-05-29
sarilumab,ISA,"Antibodies, Monoclonal, Humanized",32462708,10.1111/acem.14035,2020-05-29
Infected,PROCESS_OF,Persons,32462708,10.1111/acem.14035,2020-05-29
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32462705,10.1002/jmv.26075,2020-05-29
Pneumonia,AFFECTS,Viral Shedding,32462701,10.1111/bph.15143,2020-05-29
Pneumonia,PROCESS_OF,Old age,32462701,10.1111/bph.15143,2020-05-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Animal Model,32462695,10.1002/jmv.26073,2020-05-29
Severe Acute Respiratory Syndrome,PRODUCES,"ACE2 protein, human",32462695,10.1002/jmv.26073,2020-05-29
Disease,COEXISTS_WITH,Sequela of disorder,32462695,10.1002/jmv.26073,2020-05-29
Coronavirus Infections,ISA,Disease,32462695,10.1002/jmv.26073,2020-05-29
Coronavirus Infections,PROCESS_OF,Animal Model,32462695,10.1002/jmv.26073,2020-05-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Animal Model,32462695,10.1002/jmv.26073,2020-05-29
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32462675,10.1002/mus.26990,2020-05-29
Asymptomatic,PROCESS_OF,Patients,32462675,10.1002/mus.26990,2020-05-29
Performance,PROCESS_OF,inpatient,32462545,10.1007/s40121-020-00303-8,2020-05-29
Performance,PROCESS_OF,Outpatients,32462545,10.1007/s40121-020-00303-8,2020-05-29
Therapeutic procedure,ADMINISTERED_TO,Patients,32462501,10.1007/s10096-020-03930-8,2020-05-29
Therapeutic procedure,ADMINISTERED_TO,Patients,32462501,10.1007/s10096-020-03930-8,2020-05-29
Therapeutic procedure,TREATS,Patients,32462501,10.1007/s10096-020-03930-8,2020-05-29
Assay,METHOD_OF,PCR test for SARS,32462497,10.1186/s43044-020-00061-5,2020-05-29
Cardiovascular Diseases,PROCESS_OF,Patients,32462468,10.1007/s00595-020-02033-3,2020-05-29
contextual factors,PROCESS_OF,Outpatients,32462468,10.1007/s00595-020-02033-3,2020-05-29
Evaluation procedure,TREATS,Patients,32462468,10.1007/s00595-020-02033-3,2020-05-29
Medical Examination,USES,Chest CT,32462423,10.1007/s10067-020-05191-4,2020-05-29
Community acquired pneumonia,PROCESS_OF,Patients,32462423,10.1007/s10067-020-05191-4,2020-05-29
Community acquired pneumonia,PROCESS_OF,Patients,32462423,10.1007/s10067-020-05191-4,2020-05-29
Systemic Scleroderma,AFFECTS,Patients,32462412,10.1007/s12028-020-01006-1,2020-05-29
Systemic Scleroderma,PROCESS_OF,Patients,32462412,10.1007/s12028-020-01006-1,2020-05-29
Systemic Scleroderma,PROCESS_OF,Patients,32462412,10.1007/s12028-020-01006-1,2020-05-29
Epilepsy,PROCESS_OF,Patients,32462399,10.1007/s00259-020-04884-x,2020-05-29
Brain Injuries,PROCESS_OF,Patients,32462399,10.1007/s00259-020-04884-x,2020-05-29
Seizures,NEG_PROCESS_OF,Population Group,32462399,10.1007/s00259-020-04884-x,2020-05-29
Multifactorial,PREDISPOSES,Acute encephalopathy,32462399,10.1007/s00259-020-04884-x,2020-05-29
Multiple symptoms,PROCESS_OF,Patients,32462399,10.1007/s00259-020-04884-x,2020-05-29
Possible,PROCESS_OF,Patients,32462399,10.1007/s00259-020-04884-x,2020-05-29
cytokine,CAUSES,Multifactorial,32462399,10.1007/s00259-020-04884-x,2020-05-29
Electroencephalographic monitoring regime,TREATS,Seizures,32462399,10.1007/s00259-020-04884-x,2020-05-29
Electroencephalographic monitoring regime,TREATS,Encephalopathies,32462399,10.1007/s00259-020-04884-x,2020-05-29
Sign or Symptom,PROCESS_OF,Patients,32462399,10.1007/s00259-020-04884-x,2020-05-29
Seizures,PROCESS_OF,Population Group,32462399,10.1007/s00259-020-04884-x,2020-05-29
professional occupation status,LOCATION_OF,"CD69 protein, human",32462378,10.1007/s10157-020-01904-w,2020-05-29
Department,LOCATION_OF,Diagnosis,32462378,10.1007/s10157-020-01904-w,2020-05-29
Nuclear medicine department,LOCATION_OF,Work,32462378,10.1007/s10157-020-01904-w,2020-05-29
Diabetic Nephropathy,PROCESS_OF,Patients,32462354,10.1007/s12098-020-03357-1,2020-05-29
Glomerulonephritis,PROCESS_OF,Patients,32462354,10.1007/s12098-020-03357-1,2020-05-29
Kidney,LOCATION_OF,patient condition,32462354,10.1007/s12098-020-03357-1,2020-05-29
Diabetes,PROCESS_OF,Patients,32462354,10.1007/s12098-020-03357-1,2020-05-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32462354,10.1007/s12098-020-03357-1,2020-05-29
Fever,PROCESS_OF,Patients,32462354,10.1007/s12098-020-03357-1,2020-05-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32462354,10.1007/s12098-020-03357-1,2020-05-29
Acute illness,PRECEDES,Shock,32462316,10.1007/s40618-020-01290-w,2020-05-29
Episcleritis,PROCESS_OF,Child,32462316,10.1007/s40618-020-01290-w,2020-05-29
Peripheral edema,PROCESS_OF,Child,32462316,10.1007/s40618-020-01290-w,2020-05-29
Echocardiography,DIAGNOSES,Normal heart,32462316,10.1007/s40618-020-01290-w,2020-05-29
Echocardiography,DIAGNOSES,Moderately Abnormal Ejection Fraction,32462316,10.1007/s40618-020-01290-w,2020-05-29
Testis,LOCATION_OF,Virus,32462314,10.1007/s00264-020-04609-7,2020-05-29
Orchitis,ISA,Complication,32462314,10.1007/s00264-020-04609-7,2020-05-29
Pathologic Neovascularization,CAUSES,Orchitis,32462314,10.1007/s00264-020-04609-7,2020-05-29
Testis,LOCATION_OF,Pathologic Neovascularization,32462314,10.1007/s00264-020-04609-7,2020-05-29
Vasculitis,CAUSES,Orchitis,32462314,10.1007/s00264-020-04609-7,2020-05-29
Seminal fluid,PART_OF,Patients,32462314,10.1007/s00264-020-04609-7,2020-05-29
Seminal fluid,PART_OF,Plasma,32462314,10.1007/s00264-020-04609-7,2020-05-29
consideration,COEXISTS_WITH,Urologic Diseases,32462289,10.1007/s11912-020-00945-4,2020-05-29
"Kidney Failure, Acute",PROCESS_OF,Patients,32462289,10.1007/s11912-020-00945-4,2020-05-29
Urine,LOCATION_OF,Duration,32462289,10.1007/s11912-020-00945-4,2020-05-29
Malignant Neoplasms,PROCESS_OF,geriatric patients,32462282,10.1007/s00210-020-01902-5,2020-05-29
cancer therapy,TREATS,geriatric patients,32462282,10.1007/s00210-020-01902-5,2020-05-29
cancer therapy,TREATS(INFER),Malignant Neoplasms,32462282,10.1007/s00210-020-01902-5,2020-05-29
cancer therapy,PREDISPOSES,Cardiovascular Diseases,32462282,10.1007/s00210-020-01902-5,2020-05-29
Immunomodulation,TREATS,Cytokine release syndrome,32462282,10.1007/s00210-020-01902-5,2020-05-29
Coronavirus Infections,PROCESS_OF,Patients,32462282,10.1007/s00210-020-01902-5,2020-05-29
cancer therapy,TREATS,Patients,32462282,10.1007/s00210-020-01902-5,2020-05-29
cancer therapy,TREATS(INFER),Coronavirus Infections,32462282,10.1007/s00210-020-01902-5,2020-05-29
Malignant Neoplasms,ISA,Disease,32462282,10.1007/s00210-020-01902-5,2020-05-29
Malignant Neoplasms,PROCESS_OF(SPEC),Vulnerable Populations,32462282,10.1007/s00210-020-01902-5,2020-05-29
Disease,PROCESS_OF,Vulnerable Populations,32462282,10.1007/s00210-020-01902-5,2020-05-29
Ivermectin,ISA,Antiparasitic Agents,32462267,10.1007/s00392-020-01656-3,2020-05-29
Dyspnea,PROCESS_OF,Patients,32462195,10.1093/ajcp/aqaa097,2020-05-29
Fatigue,PROCESS_OF,Patients,32462195,10.1093/ajcp/aqaa097,2020-05-29
Prophylactic treatment,TREATS,Patients,32462195,10.1093/ajcp/aqaa097,2020-05-29
Cardiovascular,LOCATION_OF,Co-morbid conditions,32462195,10.1093/ajcp/aqaa097,2020-05-29
Cardiovascular Agents,STIMULATES,"Receptors, Virus",32462195,10.1093/ajcp/aqaa097,2020-05-29
Cardiovascular Agents,TREATS,Protection,32462195,10.1093/ajcp/aqaa097,2020-05-29
Lung,LOCATION_OF,Protection,32462195,10.1093/ajcp/aqaa097,2020-05-29
"Receptors, Virus",INHIBITS,Enzymes,32462195,10.1093/ajcp/aqaa097,2020-05-29
Cardiovascular,LOCATION_OF,Comorbidity,32462195,10.1093/ajcp/aqaa097,2020-05-29
abbott,LOCATION_OF,Assay,32462098,10.1016/j.heliyon.2020.e04063,2020-05-29
Stress,PROCESS_OF,Homo sapiens,32461981,10.1155/2020/3842470,2020-05-29
Pneumonia,PROCESS_OF,Patients,32461973,10.1155/2020/2683286,2020-05-29
Coronavirus Infections,ISA,Disease,32461911,10.1016/j.idcr.2020.e00834,2020-05-29
Study,MEASURES,Peptides,32461911,10.1016/j.idcr.2020.e00834,2020-05-29
Oxygen,PART_OF,Nose,32461867,10.7759/cureus.7800,2020-05-29
Pneumonia,CAUSES,Anoxia,32461867,10.7759/cureus.7800,2020-05-29
Vaccines,AFFECTS,Disease,32461554,10.1038/s41366-020-0598-3,2020-05-29
Vaccines,AFFECTS,Infection,32461554,10.1038/s41366-020-0598-3,2020-05-29
Colchicine,TREATS,Patients,32461511,10.5582/bst.2020.03133,2020-05-29
Obesity,PROCESS_OF,Adult,32461511,10.5582/bst.2020.03133,2020-05-29
Obesity,PROCESS_OF,Adult,32461511,10.5582/bst.2020.03133,2020-05-29
Obesity,PROCESS_OF,Adult,32461511,10.5582/bst.2020.03133,2020-05-29
Proteins,AFFECTS,Immune system,32461511,10.5582/bst.2020.03133,2020-05-29
Coronavirus Infections,ISA,Disease,32461502,10.1620/tjem.251.47,2020-05-29
Epidemic,ISA,Process,32461502,10.1620/tjem.251.47,2020-05-29
Advice,ADMINISTERED_TO,Patients,32461413,10.4103/ijo.IJO_1067_20,2020-05-29
Ophthalmologist (occupation),LOCATION_OF,"CD69 protein, human",32461412,10.4103/ijo.IJO_1458_20,2020-05-29
Hand,LOCATION_OF,Virus,32461408,10.4103/ijo.IJO_1415_20,2020-05-29
Emergency operation,TREATS,Communicable Diseases,32461407,10.4103/ijo.IJO_1404_20,2020-05-29
Emergency operation,TREATS,Trauma,32461407,10.4103/ijo.IJO_1404_20,2020-05-29
Comorbidity,PROCESS_OF,Patients,32461326,10.1503/cmaj.200794,2020-05-29
Cardiovascular,LOCATION_OF,Comorbidity,32461326,10.1503/cmaj.200794,2020-05-29
Cardiovascular Diseases,AFFECTS,Comorbidity,32461326,10.1503/cmaj.200794,2020-05-29
Hypertensive disease,AFFECTS,Comorbidity,32461326,10.1503/cmaj.200794,2020-05-29
Fatal Outcome,PROCESS_OF,Patients,32461326,10.1503/cmaj.200794,2020-05-29
Cardiovascular,LOCATION_OF,Comorbidity,32461326,10.1503/cmaj.200794,2020-05-29
Cardiovascular Diseases,PREDISPOSES,Fatal Outcome,32461326,10.1503/cmaj.200794,2020-05-29
Hypertensive disease,PREDISPOSES,Fatal Outcome,32461326,10.1503/cmaj.200794,2020-05-29
Cardiovascular,LOCATION_OF,Comorbidity,32461326,10.1503/cmaj.200794,2020-05-29
Critical Illness,PROCESS_OF,Patients,32461325,10.1503/cmaj.200869,2020-05-29
Critical Illness,PROCESS_OF,Patients,32461325,10.1503/cmaj.200869,2020-05-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32461325,10.1503/cmaj.200869,2020-05-29
tocilizumab,ADMINISTERED_TO,Patients,32461325,10.1503/cmaj.200869,2020-05-29
Critical Illness,PROCESS_OF,Patients,32461325,10.1503/cmaj.200869,2020-05-29
intensive care unit,ISA,Hospitals,32461325,10.1503/cmaj.200869,2020-05-29
contextual factors,PROCESS_OF,Patients,32461325,10.1503/cmaj.200869,2020-05-29
Anosmia,ISA,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Dysgeusia,ISA,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Anosmia,ISA,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Dysgeusia,ISA,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Anosmia,COEXISTS_WITH,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Dysgeusia,COEXISTS_WITH,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Anosmia,COEXISTS_WITH,Myalgia,32461321,10.1128/JVI.00447-20,2020-05-29
Dysgeusia,COEXISTS_WITH,Myalgia,32461321,10.1128/JVI.00447-20,2020-05-29
Smell Perception,ASSOCIATED_WITH,Symptoms,32461321,10.1128/JVI.00447-20,2020-05-29
Cytospin-B,INHIBITS,Interferons,32461288,10.1128/JCM.01029-20,2020-05-29
Respiratory Failure,PROCESS_OF,Patients,32461251,10.1136/emermed-2020-209788,2020-05-29
Challenge,TREATS,Caregiver,32461251,10.1136/emermed-2020-209788,2020-05-29
Infected,PROCESS_OF,Participant,32461231,10.1136/thoraxjnl-2020-215091,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Cardiovascular Diseases,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Hypertensive disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,AFFECTS,Comorbidity,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Comorbidity,COEXISTS_WITH,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Comorbidity,COEXISTS_WITH(SPEC),Coronavirus Infections,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Evaluation,TREATS,Comorbidity,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Cardiovascular Diseases,COEXISTS_WITH,patient condition,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Hypertensive disease,COEXISTS_WITH,patient condition,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Complication,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Hypertensive disease,CAUSES,Complication,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Cardiovascular Diseases,COEXISTS_WITH,patient condition,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Cardiovascular Diseases,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Hypertensive disease,COEXISTS_WITH,patient condition,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Hypertensive disease,PROCESS_OF,Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,ISA,Disease,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32461194,10.1016/j.ijpharm.2020.119431,2020-05-29
Health care facility,LOCATION_OF,Study,32461141,10.1016/j.kint.2020.05.013,2020-05-29
Academic Medical Centers,LOCATION_OF,Knowledge acquisition,32461141,10.1016/j.kint.2020.05.013,2020-05-29
Parenchymal cell,PART_OF,Lung,32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Immune system,ASSOCIATED_WITH,Severe (severity modifier),32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Lung,LOCATION_OF,Virus,32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Virus,CAUSES,Severe Acute Respiratory Syndrome,32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Organ,LOCATION_OF,Virus,32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Coagulation procedure,PREDISPOSES,Multiple Organ Failure,32461068,10.1016/j.ajic.2020.05.018,2020-05-29
Coronavirus Infections,ISA,Disease,32461066,10.1016/j.ajic.2020.05.017,2020-05-29
Patient observation,TREATS,Outpatients,32461066,10.1016/j.ajic.2020.05.017,2020-05-29
Patient observation,TREATS,hospitalized patients,32461066,10.1016/j.ajic.2020.05.017,2020-05-29
PER1 gene,PART_OF,SARS coronavirus,32461066,10.1016/j.ajic.2020.05.017,2020-05-29
Older Population,USES,Shield,32460966,10.1016/j.orcp.2020.05.004,2020-05-29
Possible,PROCESS_OF,Participant,32460953,10.1017/ipm.2020.70,2020-05-29
Snacking,NEG_AFFECTS,Behavior,32460953,10.1017/ipm.2020.70,2020-05-29
Comorbidity,PROCESS_OF,Patients,32460926,10.1017/ipm.2020.71,2020-05-29
Hypertensive disease,AFFECTS,Severe Acute Respiratory Syndrome,32460926,10.1017/ipm.2020.71,2020-05-29
Delirium,PROCESS_OF,Patients,32460839,10.1186/s13287-020-01725-4,2020-05-29
Much worse,PROCESS_OF,Patients,32460839,10.1186/s13287-020-01725-4,2020-05-29
Pharmaceutical Preparations,TREATS,Delirium,32460839,10.1186/s13287-020-01725-4,2020-05-29
Problem,PREDISPOSES,Communicable Diseases,32460839,10.1186/s13287-020-01725-4,2020-05-29
Delirium,PROCESS_OF,Patients,32460839,10.1186/s13287-020-01725-4,2020-05-29
Pharmaceutical Preparations,TREATS,Patients,32460829,10.1186/s13058-020-01293-8,2020-05-29
Pharmaceutical Preparations,TREATS(INFER),Coronavirus Infections,32460829,10.1186/s13058-020-01293-8,2020-05-29
Vaccines,TREATS,Patients,32460829,10.1186/s13058-020-01293-8,2020-05-29
Vaccines,TREATS(INFER),Coronavirus Infections,32460829,10.1186/s13058-020-01293-8,2020-05-29
Coronavirus Infections,PROCESS_OF,Patients,32460829,10.1186/s13058-020-01293-8,2020-05-29
Coronavirus Infections,ISA,Disease,32460829,10.1186/s13058-020-01293-8,2020-05-29
Wharton Jelly Cells,PART_OF,bony process,32460829,10.1186/s13058-020-01293-8,2020-05-29
Pneumonia,PROCESS_OF,Patients,32460829,10.1186/s13058-020-01293-8,2020-05-29
Malignant neoplasm of breast,PROCESS_OF,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
"Paris, France",ISA,Geographic Locations,32460766,10.1186/s12939-020-01192-6,2020-05-29
Symptoms,PROCESS_OF,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
Adrenal Cortex Hormones,ADMINISTERED_TO,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
Lung,LOCATION_OF,Lesion,32460766,10.1186/s12939-020-01192-6,2020-05-29
Comorbidity,PROCESS_OF,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
Malignant neoplasm of breast,PROCESS_OF,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
Malignant neoplasm of breast,PROCESS_OF,Patients,32460766,10.1186/s12939-020-01192-6,2020-05-29
Old age,ISA,Population Group,32460683,10.1176/appi.ps.202000230,2020-05-29
Coronavirus Infections,ISA,Disease,32460566,10.1177/1090198120931420,2020-05-29
Symptom mild,PROCESS_OF,Patients,32460566,10.1177/1090198120931420,2020-05-29
Biological Response Modifiers,CAUSES,Storm NOS,32460566,10.1177/1090198120931420,2020-05-29
Lung,LOCATION_OF,Epithelial Damage,32460566,10.1177/1090198120931420,2020-05-29
Cytokine release syndrome,CAUSES,Lysis,32460566,10.1177/1090198120931420,2020-05-29
Secondary Hemophagocytic Lymphohistiocytosis,CAUSES,Multiple Organ Failure,32460566,10.1177/1090198120931420,2020-05-29
innovativeness,PROCESS_OF,student,32460458,10.3904/kjim.2020.157,2020-05-29
Hydroxychloroquine,TREATS,Patients,32460457,10.3904/kjim.2020.159,2020-05-29
lopinavir / Ritonavir,TREATS,Patients,32460457,10.3904/kjim.2020.159,2020-05-29
Real-Time Polymerase Chain Reaction,METHOD_OF,Therapeutic procedure,32460457,10.3904/kjim.2020.159,2020-05-29
Hydroxychloroquine,TREATS,Homo sapiens,32460457,10.3904/kjim.2020.159,2020-05-29
Antipyretics,ADMINISTERED_TO,Patients,32460453,10.11622/smedj.2020082,2020-05-29
Symptoms,PROCESS_OF,Patients,32460453,10.11622/smedj.2020082,2020-05-29
Coronavirus Infections,ISA,Disease,32460433,10.1111/ijcp.13559,2020-05-28
Chloroquine,TREATS,Patients,32460385,10.1111/tri.13661,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Viral Respiratory Tract Infection,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Viral Respiratory Tract Infection,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Viral Respiratory Tract Infection,32460364,10.1111/apa.15376,2020-05-28
Middle East Respiratory Syndrome,ISA,Infection,32460364,10.1111/apa.15376,2020-05-28
Ibuprofen,NEG_AFFECTS,cold symptoms,32460364,10.1111/apa.15376,2020-05-28
Naproxen,NEG_AFFECTS,cold symptoms,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",ADMINISTERED_TO,Patients,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",COEXISTS_WITH,Naproxen,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",COEXISTS_WITH,Clarithromycin,32460364,10.1111/apa.15376,2020-05-28
"Anti-Inflammatory Agents, Non-Steroidal",COEXISTS_WITH,Oseltamivir,32460364,10.1111/apa.15376,2020-05-28
Hospitalization,TREATS,Patients,32460364,10.1111/apa.15376,2020-05-28
Hospitalization,TREATS(INFER),Pneumonia,32460364,10.1111/apa.15376,2020-05-28
Influenza,CAUSES,Respiratory Tract Infections,32460364,10.1111/apa.15376,2020-05-28
Pneumonia,PROCESS_OF,Patients,32460364,10.1111/apa.15376,2020-05-28
Appendicitis,PROCESS_OF,Patients,32460358,10.1111/imm.13222,2020-05-28
Complicated appendicitis,COEXISTS_WITH,Enthesitis-Related Arthritis,32460358,10.1111/imm.13222,2020-05-28
Complicated appendicitis,PROCESS_OF,Child,32460358,10.1111/imm.13222,2020-05-28
Complication,COEXISTS_WITH,Pediatric Disorder,32460358,10.1111/imm.13222,2020-05-28
Complication,COEXISTS_WITH,Enthesitis-Related Arthritis,32460358,10.1111/imm.13222,2020-05-28
World,LOCATION_OF,paired basic amino acid cleaving enzyme,32460357,10.1111/imm.13223,2020-05-28
Patients,LOCATION_OF,C-reactive protein,32460302,10.1159/000508544,2020-05-28
Patients,LOCATION_OF,Interleukin-6,32460302,10.1159/000508544,2020-05-28
Patients,LOCATION_OF,Interleukin-10,32460302,10.1159/000508544,2020-05-28
Lung,LOCATION_OF,Lesion,32460229,10.1016/j.ijheh.2020.113555,2020-05-28
Critical Illness,PROCESS_OF,Patients,32460229,10.1016/j.ijheh.2020.113555,2020-05-28
Evaluation,TREATS,Patients,32460229,10.1016/j.ijheh.2020.113555,2020-05-28
Evaluation,TREATS(INFER),Critical Illness,32460229,10.1016/j.ijheh.2020.113555,2020-05-28
China,ISA,Geographic Locations,32460210,10.1016/j.mehy.2020.109855,2020-05-28
Respiratory Tract Infections,CAUSES,Cessation of life,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Virus Diseases,AFFECTS,Inflammation,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Chromo,DIAGNOSES,Infectious disease of lung,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Amides,AFFECTS,Chronic inflammation,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Amides,AFFECTS,Pain,32460185,10.1016/j.psychres.2020.113112,2020-05-28
palmidrol,AFFECTS,Homeostasis,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Lung,PART_OF,Patients,32460185,10.1016/j.psychres.2020.113112,2020-05-28
Assay,ISA,Laboratory Procedures,32460144,10.1016/j.cyto.2020.155143,2020-05-28
Assay,METHOD_OF,Detection,32460144,10.1016/j.cyto.2020.155143,2020-05-28
Severe (severity modifier),PREDISPOSES,Drug Interactions,32460086,10.1016/j.msard.2020.102195,2020-05-28
Drug Interactions,PROCESS_OF,Patients,32460086,10.1016/j.msard.2020.102195,2020-05-28
Demyelinating Diseases,PROCESS_OF,Patients,32460041,10.1016/j.jns.2020.116930,2020-05-28
Coughing,PROCESS_OF,Patients,32460041,10.1016/j.jns.2020.116930,2020-05-28
Fever,PROCESS_OF,Patients,32460041,10.1016/j.jns.2020.116930,2020-05-28
Chronic nervous system disorder,PROCESS_OF,Patients,32459984,10.3201/eid2608.201525,2020-05-28
Universities,ISA,School,32459984,10.3201/eid2608.201525,2020-05-28
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32459916,10.1056/NEJMsa2011686,2020-05-28
Adverse event,COMPLICATES,Respiratory Failure,32459916,10.1056/NEJMsa2011686,2020-05-28
Integrated Delivery Systems,LOCATION_OF,Retrospective Cohort Study,32459857,10.4414/smw.2020.20293,2020-05-28
Hispanics,ISA,Racial group,32459857,10.4414/smw.2020.20293,2020-05-28
Veins,LOCATION_OF,Lactates,32459857,10.4414/smw.2020.20293,2020-05-28
consideration,PROCESS_OF,Patients,32459832,10.1093/cid/ciaa656,2020-05-28
pulmonary complications,PROCESS_OF,Patients,32459832,10.1093/cid/ciaa656,2020-05-28
Factor VIII,INTERACTS_WITH,Endothelial Cells,32459832,10.1093/cid/ciaa656,2020-05-28
von Willebrand factor,INTERACTS_WITH,Endothelial Cells,32459832,10.1093/cid/ciaa656,2020-05-28
Chemoprevention,TREATS,inpatient,32459832,10.1093/cid/ciaa656,2020-05-28
Health care facility,LOCATION_OF,Therapeutic Clinical Trial,32459790,10.1097/PCC.0000000000002475,2020-05-28
Spain,ISA,Country,32459701,10.1097/AOG.0000000000003996,2020-05-28
Chest radiograph,DIAGNOSES,Pneumonia,32459701,10.1097/AOG.0000000000003996,2020-05-28
Lymphopenia,PROCESS_OF,Patients,32459701,10.1097/AOG.0000000000003996,2020-05-28
Mechanical ventilation,TREATS,Patients,32459701,10.1097/AOG.0000000000003996,2020-05-28
tocilizumab,TREATS,Child,32459701,10.1097/AOG.0000000000003996,2020-05-28
heparin,ADMINISTERED_TO,Child,32459701,10.1097/AOG.0000000000003996,2020-05-28
Coronavirus Infections,PROCESS_OF,Pregnant Women,32459675,10.1097/ACM.0000000000003520,2020-05-28
Coronavirus Infections,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Symptoms,PROCESS_OF,Pregnant Women,32459675,10.1097/ACM.0000000000003520,2020-05-28
Coronavirus Infections,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Coronavirus Infections,PROCESS_OF,Pregnant Women,32459675,10.1097/ACM.0000000000003520,2020-05-28
Patient in hospital,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Comorbidity,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Leukopenia,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Transaminases increased,PROCESS_OF,Woman,32459675,10.1097/ACM.0000000000003520,2020-05-28
Premature Birth,PROCESS_OF,Pregnant Women,32459675,10.1097/ACM.0000000000003520,2020-05-28
Challenge,TREATS,"Students, Medical",32459672,10.1097/CCM.0000000000004466,2020-05-28
Venous Thromboembolism,COEXISTS_WITH,patient condition,32459668,10.1213/ANE.0000000000005009,2020-05-28
Study,MEASURES,Frequencies (time pattern),32459668,10.1213/ANE.0000000000005009,2020-05-28
SARS coronavirus,PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
patient condition,PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,COEXISTS_WITH,prevention outcome,32459668,10.1213/ANE.0000000000005009,2020-05-28
Study,MEASURES,Frequencies (time pattern),32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,NEG_PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,PROCESS_OF,Patients,32459668,10.1213/ANE.0000000000005009,2020-05-28
Venous Thromboembolism,COEXISTS_WITH,D-dimer above reference range,32459668,10.1213/ANE.0000000000005009,2020-05-28
Fibrin fragment D,PREDISPOSES,Venous Thromboembolism,32459668,10.1213/ANE.0000000000005009,2020-05-28
Disease Outcome,COEXISTS_WITH,Thrombophilia,32459668,10.1213/ANE.0000000000005009,2020-05-28
paired basic amino acid cleaving enzyme,PART_OF,Bulla,32459664,10.1097/CEJ.0000000000000604,2020-05-28
paired basic amino acid cleaving enzyme,CAUSES,Crisis,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Respiratory Failure,ISA,Disease,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Severe Acute Respiratory Syndrome,CAUSES,Disease,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Respiratory Failure,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Tracheostomy procedure,TREATS,Patients,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Tracheostomy procedure,TREATS(INFER),Infected,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Infected,PROCESS_OF,Patients,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Severe Acute Respiratory Syndrome,AFFECTS,teams,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Movement,PROCESS_OF,Patients,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Tracheostomy procedure,TREATS,Patients,32459664,10.1097/CEJ.0000000000000604,2020-05-28
Coronavirus Infections,ISA,Disease,32459647,10.2196/16018,2020-05-28
intensive care unit,LOCATION_OF,Study,32459647,10.2196/16018,2020-05-28
Tongue,LOCATION_OF,Diagnosis,32459621,10.3201/eid2609.201761,2020-05-28
Diagnosis,DIAGNOSES,Furred tongue,32459621,10.3201/eid2609.201761,2020-05-28
Tongue,LOCATION_OF,Diagnosis,32459621,10.3201/eid2609.201761,2020-05-28
Tongue,LOCATION_OF,Diagnosis,32459621,10.3201/eid2609.201761,2020-05-28
Telemedicine,TREATS,Furred tongue,32459621,10.3201/eid2609.201761,2020-05-28
Telemedicine,TREATS,Detected (finding),32459621,10.3201/eid2609.201761,2020-05-28
Ethanol,TREATS,Macrophage Activation Syndrome,32459578,10.1080/17441692.2020.1770831,2020-05-28
Pharmaceutical Preparations,TREATS,Rare Diseases,32459571,10.1080/17441692.2020.1771396,2020-05-28
Health Care,TREATS,permanent resident,32459567,10.1080/09546634.2020.1775774,2020-05-28
Human body,USES,regulatory,32459529,10.7326/M20-2496,2020-05-28
systemic administration,PREDISPOSES,Psoriasis,32459529,10.7326/M20-2496,2020-05-28
risk factors,PROCESS_OF,Patients,32459529,10.7326/M20-2496,2020-05-28
Chloroquine,TREATS,Adult,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Chloroquine,TREATS,Child,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Hydroxychloroquine,TREATS,Adult,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Hydroxychloroquine,TREATS,Child,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Hydroxychloroquine,ADMINISTERED_TO,Patients,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Signs and Symptoms,PROCESS_OF,Patients,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Adult,USES,chloroquine phosphate 500 MG,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Chloroquine,NEG_ADMINISTERED_TO,Patients,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Chloroquine,TREATS,Fever,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Hydroxychloroquine,TREATS,Fever,32459524,10.1152/ajpendo.00198.2020,2020-05-28
Chronic inflammation,COEXISTS_WITH,Obesity,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Immune dysregulation,COEXISTS_WITH,Obesity,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
,CAUSES,Oxidative Stress,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Interleukin-1,CAUSES,Oxidative Stress,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Interleukin-6,CAUSES,Oxidative Stress,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Monocyte Chemoattractant Proteins,CAUSES,Oxidative Stress,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Arterial Stiffness,PROCESS_OF,Heart,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
endothelial dysfunction,COEXISTS_WITH,Obesity,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Cardiovascular event,PROCESS_OF,Patients,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Rheumatoid Arthritis,PROCESS_OF,Patients,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Disease,PROCESS_OF,Patients,32459409,10.5435/JAAOS-D-20-00339,2020-05-28
Pharmaceutical Preparations,STIMULATES,angiotensin converting enzyme 2,32459192,10.1515/cclm-2020-0722,2020-05-28
Adoptive Immunotherapy,USES,angiotensin converting enzyme 2,32459192,10.1515/cclm-2020-0722,2020-05-28
receptor,AUGMENTS,Problem,32459192,10.1515/cclm-2020-0722,2020-05-28
Coronavirus Infections,PROCESS_OF,Patients,32459192,10.1515/cclm-2020-0722,2020-05-28
SARS coronavirus,PROCESS_OF,Patients,32459192,10.1515/cclm-2020-0722,2020-05-28
Challenge,METHOD_OF,Clinical Laboratory Services,32459186,10.2196/19347,2020-05-28
biochemical test,DIAGNOSES,Disease,32459186,10.2196/19347,2020-05-28
Disease,COEXISTS_WITH,Household composition,32459175,10.7554/eLife.59147,2020-05-28
Coronavirus Infections,COEXISTS_WITH(SPEC),Household composition,32459175,10.7554/eLife.59147,2020-05-28
Coronavirus Infections,ISA,Disease,32459175,10.7554/eLife.59147,2020-05-28
Coronavirus Infections,ISA,Disease,32459175,10.7554/eLife.59147,2020-05-28
IMPACT gene,ASSOCIATED_WITH,Psychiatric symptom,32459175,10.7554/eLife.59147,2020-05-28
Participant,ISA,Persons,32459175,10.7554/eLife.59147,2020-05-28
Coronavirus Infections,ISA,Disease,32459175,10.7554/eLife.59147,2020-05-28
Feeling suicidal (finding),COEXISTS_WITH,Sleep disturbances,32459175,10.7554/eLife.59147,2020-05-28
IMPACT gene,PART_OF,Research Personnel,32459144,10.2144/btn-2020-0038,2020-05-28
Endopeptidases,TREATS,Disease,32459137,10.1080/22221751.2020.1775133,2020-05-28
Molecular Genetic Technique,USES,Boat dock,32459137,10.1080/22221751.2020.1775133,2020-05-28
alliin,compared_with,other medicated shampoos in ATC,32459137,10.1080/22221751.2020.1775133,2020-05-28
alliin,higher_than,other medicated shampoos in ATC,32459137,10.1080/22221751.2020.1775133,2020-05-28
Severe disorder,PROCESS_OF,Patients,32459061,10.1002/hed.26202,2020-05-28
Lung,LOCATION_OF,Accumulation,32459061,10.1002/hed.26202,2020-05-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32459046,10.1111/jth.14929,2020-05-28
Cardiovascular Diseases,COEXISTS_WITH,Venous Thromboembolism,32459003,10.1111/1440-1681.13354,2020-05-28
Critical Illness,PROCESS_OF,Patients,32459003,10.1111/1440-1681.13354,2020-05-28
Challenge,TREATS,Patients,32459003,10.1111/1440-1681.13354,2020-05-28
Challenge,TREATS(INFER),Critical Illness,32459003,10.1111/1440-1681.13354,2020-05-28
"Pneumonia, Viral",PROCESS_OF,Patients,32459003,10.1111/1440-1681.13354,2020-05-28
Severe Acute Respiratory Syndrome,OCCURS_IN,hospitalized patients,32459003,10.1111/1440-1681.13354,2020-05-28
Interferon Type I,ISA,cytokine,32458969,10.1093/aje/kwaa093,2020-05-28
Interferon Type I,PART_OF(SPEC),Family,32458969,10.1093/aje/kwaa093,2020-05-28
cytokine,PART_OF,Family,32458969,10.1093/aje/kwaa093,2020-05-28
Retinoids,COEXISTS_WITH,Vitamin A,32458969,10.1093/aje/kwaa093,2020-05-28
Vitamin A,ISA,Retinoids,32458969,10.1093/aje/kwaa093,2020-05-28
Immunologic Adjuvants,COEXISTS_WITH,opium alkaloids and derivative combination cough suppressants,32458969,10.1093/aje/kwaa093,2020-05-28
Retinoids,STIMULATES,,32458969,10.1093/aje/kwaa093,2020-05-28
Antibodies,PART_OF,Americas Ethnicity,32458963,10.1093/jamia/ocaa117,2020-05-28
Disease,PROCESS_OF,Patients,32458963,10.1093/jamia/ocaa117,2020-05-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32458963,10.1093/jamia/ocaa117,2020-05-28
Patient in hospital,PROCESS_OF,inpatient,32458963,10.1093/jamia/ocaa117,2020-05-28
Azithromycin,TREATS,inpatient,32458963,10.1093/jamia/ocaa117,2020-05-28
Cardiac Arrhythmia,PROCESS_OF,Elderly (population group),32458963,10.1093/jamia/ocaa117,2020-05-28
Embedding,USES,Operative Surgical Procedures,32458795,10.4269/ajtmh.20-0295,2020-05-28
Coronavirus Infections,ISA,Communicable Diseases,32458795,10.4269/ajtmh.20-0295,2020-05-28
Coronavirus Infections,ISA,Communicable Diseases,32458795,10.4269/ajtmh.20-0295,2020-05-28
Virus,PROCESS_OF,Community,32458770,10.1080/01634372.2020.1769792,2020-05-28
Disease,PROCESS_OF,Community,32458770,10.1080/01634372.2020.1769792,2020-05-28
Negative,PROCESS_OF,Community,32458770,10.1080/01634372.2020.1769792,2020-05-28
Household composition,PROCESS_OF,member,32458760,10.1080/22221751.2020.1775132,2020-05-28
Elderly (population group),LOCATION_OF,IMPACT gene,32458760,10.1080/22221751.2020.1775132,2020-05-28
Coronavirus Infections,CAUSES,Communicable Diseases,32458742,10.1080/22221751.2020.1775131,2020-05-28
Mild thrombocytopenia,PROCESS_OF,Patients,32458694,10.1161/HYPERTENSIONAHA.120.15572,2020-05-28
Angiotensin-Converting Enzyme Inhibitors,TREATS,patient condition,32458599,10.16250/j.32.1374.2020092,2020-05-28
Angiotensin II receptor antagonist,TREATS,patient condition,32458599,10.16250/j.32.1374.2020092,2020-05-28
Hypertensive disease,PROCESS_OF,Patients,32458599,10.16250/j.32.1374.2020092,2020-05-28
Coronavirus Infections,PROCESS_OF,Patients,32458599,10.16250/j.32.1374.2020092,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Vaccines,TREATS,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Vaccines,TREATS(SPEC),Coronavirus Infections,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Antiviral Agents,TREATS,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Antiviral Agents,TREATS,Patients,32458598,10.16250/j.32.1374.2020063,2020-05-28
Antiviral Agents,TREATS(INFER),Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Antiviral Agents,TREATS(SPEC),Coronavirus Infections,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,ISA,Antimalarials,32458598,10.16250/j.32.1374.2020063,2020-05-28
Disease,PROCESS_OF,Patients,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,TREATS,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,TREATS(SPEC),Coronavirus Infections,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
chloroquine phosphate,ISA,Chloroquine,32458598,10.16250/j.32.1374.2020063,2020-05-28
Hydroxychloroquine Sulfate,ISA,Chloroquine,32458598,10.16250/j.32.1374.2020063,2020-05-28
Adverse reactions,MANIFESTATION_OF,Drug effect disorder,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,ISA,Pharmaceutical Preparations,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,ISA,Agent,32458598,10.16250/j.32.1374.2020063,2020-05-28
Chloroquine,TREATS(SPEC),Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Coronavirus Infections,ISA,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Agent,TREATS,Disease,32458598,10.16250/j.32.1374.2020063,2020-05-28
Agent,TREATS(SPEC),Coronavirus Infections,32458598,10.16250/j.32.1374.2020063,2020-05-28
Clinical Treatment,TREATS,Malaria,32458598,10.16250/j.32.1374.2020063,2020-05-28
Pandemics,ISA,Disease Outbreaks,32458596,10.3802/jgo.2020.31.e68,2020-05-28
Complication,PROCESS_OF,Cancer Patient,32458588,10.1111/dth.13695,2020-05-28
Malignant Neoplasms,PROCESS_OF,Patients,32458588,10.1111/dth.13695,2020-05-28
Triage,TREATS,Symptoms,32458574,10.1111/mcn.13036,2020-05-28
Lactation established in non-human animal,PROCESS_OF,Woman,32458565,10.1111/jir.12739,2020-05-28
Intellectual Disability,PROCESS_OF,Persons,32458561,10.1002/cbin.11403,2020-05-28
Cessation of life,OCCURS_IN,Human Age Group,32458561,10.1002/cbin.11403,2020-05-28
Endocrine System Diseases,PROCESS_OF,Persons,32458561,10.1002/cbin.11403,2020-05-28
Disease,CAUSES,Lymphopenia,32458558,10.1111/mcn.13033,2020-05-28
Disease,PROCESS_OF,Child,32458551,10.1111/dth.13684,2020-05-28
Communicable Diseases,AFFECTS,Infant,32458551,10.1111/dth.13684,2020-05-28
Hypogalactia,PROCESS_OF,Community,32458551,10.1111/dth.13684,2020-05-28
Cessation of life,PROCESS_OF,Infant,32458551,10.1111/dth.13684,2020-05-28
Cessation of life,PROCESS_OF,Woman,32458551,10.1111/dth.13684,2020-05-28
Virus,CAUSES,Severe Acute Respiratory Syndrome,32458550,10.1111/bjhp.12430,2020-05-28
Adult,ISA,Population Group,32458546,10.1111/dth.13696,2020-05-28
General symptom,COEXISTS_WITH,High Level,32458546,10.1111/dth.13696,2020-05-28
Somatization,AFFECTS,Generalized Anxiety Disorder,32458546,10.1111/dth.13696,2020-05-28
Therapeutic procedure,TREATS,Patients,32458534,10.1002/art.41380,2020-05-28
Therapeutic procedure,TREATS(INFER),Infected,32458534,10.1002/art.41380,2020-05-28
Infected,PROCESS_OF,Patients,32458534,10.1002/art.41380,2020-05-28
Pharmaceutical Preparations,TREATS,"Dermatitis, Atopic",32458534,10.1002/art.41380,2020-05-28
Pharmaceutical Preparations,TREATS,Psoriasis,32458534,10.1002/art.41380,2020-05-28
tofacitinib,ISA,Janus kinase inhibitor,32458534,10.1002/art.41380,2020-05-28
Interleukin-17,compared_with,Tumor Necrosis Factor Blocker [EPC],32458534,10.1002/art.41380,2020-05-28
Interleukin-17,higher_than,Tumor Necrosis Factor Blocker [EPC],32458534,10.1002/art.41380,2020-05-28
Acitretin,TREATS,Patients,32458534,10.1002/art.41380,2020-05-28
apremilast,TREATS,Patients,32458534,10.1002/art.41380,2020-05-28
dupilumab,TREATS,Patients,32458534,10.1002/art.41380,2020-05-28
"Dermatitis, Atopic",PROCESS_OF,Patients,32458534,10.1002/art.41380,2020-05-28
Predisposition -- attribute,PREDISPOSES,Hypertensive disease,32458502,10.1002/jmv.26064,2020-05-28
Biological treatment,PREVENTS,Storm NOS,32458502,10.1002/jmv.26064,2020-05-28
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32458479,10.1002/jmv.26060,2020-05-28
Prescription procedure,TREATS,Symptoms,32458479,10.1002/jmv.26060,2020-05-28
Diammonium Glycyrrhizinate,TREATS,Symptoms,32458479,10.1002/jmv.26060,2020-05-28
Serum,PART_OF,Homo sapiens,32458459,10.1002/jmv.26061,2020-05-28
Quick Test for Liver Function,USES,Immunochromatography,32458459,10.1002/jmv.26061,2020-05-28
Serum,PART_OF,Population Group,32458459,10.1002/jmv.26061,2020-05-28
Immunoglobulin G,ISA,Antibodies,32458459,10.1002/jmv.26061,2020-05-28
Immunoglobulin G,ISA,Antibodies,32458459,10.1002/jmv.26061,2020-05-28
Immunoglobulin G,ISA,Antibodies,32458459,10.1002/jmv.26061,2020-05-28
Quick Test for Liver Function,USES,Immunochromatography,32458459,10.1002/jmv.26061,2020-05-28
Assay,DIAGNOSES,Present,32458459,10.1002/jmv.26061,2020-05-28
Assay,METHOD_OF,Detection,32458459,10.1002/jmv.26061,2020-05-28
Hematologic Neoplasms,PROCESS_OF,Patients,32458400,10.1007/s12265-020-10031-6,2020-05-28
Critical Illness,PROCESS_OF,Patients,32458400,10.1007/s12265-020-10031-6,2020-05-28
Respiration Disorders,PROCESS_OF,Patients,32458395,10.1007/s00384-020-03627-6,2020-05-28
Syndrome,PROCESS_OF,Patients,32458395,10.1007/s00384-020-03627-6,2020-05-28
Cytokine release syndrome,ISA,Syndrome,32458395,10.1007/s00384-020-03627-6,2020-05-28
Cytokine release syndrome,PROCESS_OF(SPEC),Patients,32458395,10.1007/s00384-020-03627-6,2020-05-28
Gastrointestinal symptom,PROCESS_OF,Patients,32458382,10.1007/s40037-020-00592-2,2020-05-28
Infected,PROCESS_OF,Patients,32458382,10.1007/s40037-020-00592-2,2020-05-28
Passion,PROCESS_OF,Clinician,32458370,10.1007/s40256-020-00415-z,2020-05-28
Severe (severity modifier),PREDISPOSES,Severe course,32458356,10.1007/s40520-020-01601-4,2020-05-28
Noncommunicable Diseases,PROCESS_OF,Persons,32458289,10.1007/s00464-020-07652-y,2020-05-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Survivors,32458289,10.1007/s00464-020-07652-y,2020-05-28
Exercise,PREDISPOSES,Noncommunicable Diseases,32458289,10.1007/s00464-020-07652-y,2020-05-28
Outpatient visits,TREATS,Patients,32458289,10.1007/s00464-020-07652-y,2020-05-28
Noncommunicable Diseases,NEG_PROCESS_OF,Patients,32458289,10.1007/s00464-020-07652-y,2020-05-28
Frail,PROCESS_OF,Persons,32458289,10.1007/s00464-020-07652-y,2020-05-28
Noncommunicable Diseases,NEG_PROCESS_OF,Patients,32458289,10.1007/s00464-020-07652-y,2020-05-28
Frail,PROCESS_OF,Persons,32458289,10.1007/s00464-020-07652-y,2020-05-28
Compassionate Use,TREATS,Patients,32458267,10.1007/s12630-020-01713-5,2020-05-28
Lung,LOCATION_OF,Unlikely,32458267,10.1007/s12630-020-01713-5,2020-05-28
Coronavirus Infections,ISA,Disease,32458206,10.1007/s11739-020-02383-3,2020-05-28
Critical Illness,PROCESS_OF,Patients,32458206,10.1007/s11739-020-02383-3,2020-05-28
Chloroquine,TREATS,Patients,32458197,10.1007/s00415-020-09939-5,2020-05-28
Bromhexine,DISRUPTS,Virus Internalization,32458197,10.1007/s00415-020-09939-5,2020-05-28
Bromhexine,INHIBITS,TMPRSS2 gene,32458197,10.1007/s00415-020-09939-5,2020-05-28
Betacoronavirus,CAUSES,Disease,32458182,10.1007/s10840-020-00782-2,2020-05-28
Dizziness,ISA,Neurologic Symptoms,32458182,10.1007/s10840-020-00782-2,2020-05-28
Headache,ISA,Neurologic Symptoms,32458182,10.1007/s10840-020-00782-2,2020-05-28
Hypogeusia,ISA,Neurologic Symptoms,32458182,10.1007/s10840-020-00782-2,2020-05-28
Sense of smell impaired,ISA,Neurologic Symptoms,32458182,10.1007/s10840-020-00782-2,2020-05-28
Cerebrospinal fluid sample,PART_OF,Patients,32458182,10.1007/s10840-020-00782-2,2020-05-28
Acute care hospital,LOCATION_OF,Services,32458174,10.1007/s00330-020-06961-z,2020-05-28
Carpal Tunnel Syndrome,PROCESS_OF,Patients,32458150,10.1186/s40634-020-00255-5,2020-05-28
Disease,AFFECTS,Health Personnel,32458149,10.1007/s12011-020-02194-9,2020-05-28
Disease,AFFECTS,Patients,32458149,10.1007/s12011-020-02194-9,2020-05-28
patient condition,PROCESS_OF,Health Personnel,32458149,10.1007/s12011-020-02194-9,2020-05-28
patient condition,PROCESS_OF,Patients,32458149,10.1007/s12011-020-02194-9,2020-05-28
Elective Surgical Procedures,ISA,Therapeutic procedure,32458149,10.1007/s12011-020-02194-9,2020-05-28
Doxycycline,ISA,Antibiotics,32458125,10.1007/s11604-020-00988-4,2020-05-28
Ribavirin,ISA,Antiviral Agents,32458125,10.1007/s11604-020-00988-4,2020-05-28
Azithromycin,ISA,Antibiotics,32458125,10.1007/s11604-020-00988-4,2020-05-28
Cells,LOCATION_OF,Chloroquine,32458125,10.1007/s11604-020-00988-4,2020-05-28
prescribed,TREATS,consideration,32458125,10.1007/s11604-020-00988-4,2020-05-28
Family,INTERACTS_WITH,Patients,32458121,10.1007/s00405-020-06068-7,2020-05-28
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32458121,10.1007/s00405-020-06068-7,2020-05-28
Fatigue,ISA,Symptoms,32458121,10.1007/s00405-020-06068-7,2020-05-28
Ground Glass Opacity,ISA,Radiologic finding,32458121,10.1007/s00405-020-06068-7,2020-05-28
Problem,PROCESS_OF,Patients,32458111,10.1007/s10456-020-09730-0,2020-05-28
Trachea,LOCATION_OF,Tissue damage,32458111,10.1007/s10456-020-09730-0,2020-05-28
Tracheostomy procedure,TREATS,Patients,32458111,10.1007/s10456-020-09730-0,2020-05-28
Tracheostomy procedure,TREATS,inpatient,32458111,10.1007/s10456-020-09730-0,2020-05-28
Experience,PROCESS_OF,inpatient,32458111,10.1007/s10456-020-09730-0,2020-05-28
Disease,PREDISPOSES,Possible,32458111,10.1007/s10456-020-09730-0,2020-05-28
Tracheostomy procedure,TREATS,Patients,32458111,10.1007/s10456-020-09730-0,2020-05-28
Orotracheal intubation,PRECEDES,Tracheostomy procedure,32458111,10.1007/s10456-020-09730-0,2020-05-28
Blood Coagulation Disorders,COEXISTS_WITH,patient condition,32458044,10.1007/s00414-020-02318-9,2020-05-28
Complication,COEXISTS_WITH,Respiration Disorders,32458044,10.1007/s00414-020-02318-9,2020-05-28
Patients,LOCATION_OF,Plasma,32458044,10.1007/s00414-020-02318-9,2020-05-28
Lymphopenia,PROCESS_OF,Patients,32458044,10.1007/s00414-020-02318-9,2020-05-28
E-Selectin,PART_OF,soluble,32458044,10.1007/s00414-020-02318-9,2020-05-28
Cohort,LOCATION_OF,SELE gene,32458044,10.1007/s00414-020-02318-9,2020-05-28
Autopsy,DIAGNOSES,Edema,32458042,10.1007/s00266-020-01789-w,2020-05-28
Autopsy,DIAGNOSES,"Pneumonia, Interstitial",32458042,10.1007/s00266-020-01789-w,2020-05-28
Autopsy,DIAGNOSES,diffuse alveolar damage,32458042,10.1007/s00266-020-01789-w,2020-05-28
Critical Illness,PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
"Kidney Failure, Acute",PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
"Kidney Failure, Acute",PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Clinical act of insertion,USES,Peritoneal dialysis catheter,32458019,10.1007/s00268-020-05599-8,2020-05-28
"Kidney Failure, Acute",PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Chronic Kidney Diseases,PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
catheter device,TREATS,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Abdomen,LOCATION_OF,H/O: surgery,32458019,10.1007/s00268-020-05599-8,2020-05-28
H/O: surgery,PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Hemoperitoneum,PROCESS_OF,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Peritoneal Dialysis,TREATS,Patients,32458019,10.1007/s00268-020-05599-8,2020-05-28
Appendicitis,PROCESS_OF,Patients,32457932,10.1080/24734306.2020.1757967,2020-05-28
Chloroquine,ISA,Antimalarials,32457924,10.1093/ofid/ofaa152,2020-05-28
Chloroquine,TREATS,Coronavirus Infections,32457924,10.1093/ofid/ofaa152,2020-05-28
Hydroxychloroquine,TREATS,Coronavirus Infections,32457924,10.1093/ofid/ofaa152,2020-05-28
Toxic effect,PROCESS_OF,Homo sapiens,32457924,10.1093/ofid/ofaa152,2020-05-28
Poisoning,CAUSES,Myocardial dysfunction,32457924,10.1093/ofid/ofaa152,2020-05-28
Vasodilation,CAUSES,Hypotension,32457924,10.1093/ofid/ofaa152,2020-05-28
Potassium Channel,CAUSES,Ventricular escape rhythm,32457924,10.1093/ofid/ofaa152,2020-05-28
Potassium Channel,CAUSES,Bradycardia,32457924,10.1093/ofid/ofaa152,2020-05-28
Sodium,CAUSES,Ventricular escape rhythm,32457924,10.1093/ofid/ofaa152,2020-05-28
Sodium,CAUSES,Bradycardia,32457924,10.1093/ofid/ofaa152,2020-05-28
Chloroquine,CAUSES,Seizures,32457924,10.1093/ofid/ofaa152,2020-05-28
Chloroquine,COEXISTS_WITH,APELA gene,32457924,10.1093/ofid/ofaa152,2020-05-28
Hydroxychloroquine,COEXISTS_WITH,APELA gene,32457924,10.1093/ofid/ofaa152,2020-05-28
Diazepam,INTERACTS_WITH,Chloroquine,32457924,10.1093/ofid/ofaa152,2020-05-28
Epinephrine,TREATS,Hypotension,32457924,10.1093/ofid/ofaa152,2020-05-28
Potassium,TREATS,Hypokalemia,32457924,10.1093/ofid/ofaa152,2020-05-28
Agent,NEG_TREATS,Disease,32457924,10.1093/ofid/ofaa152,2020-05-28
Coronavirus Infections,ISA,Disease,32457811,10.1186/s12979-020-00183-z,2020-05-28
Laboratory Procedures,DIAGNOSES,Lymphopenia,32457811,10.1186/s12979-020-00183-z,2020-05-28
Lymphopenia,PROCESS_OF,Patients,32457811,10.1186/s12979-020-00183-z,2020-05-28
Interleukin-6,ISA,cytokine,32457811,10.1186/s12979-020-00183-z,2020-05-28
High Level,PROCESS_OF,Patients,32457811,10.1186/s12979-020-00183-z,2020-05-28
High Level,PROCESS_OF,Cohort,32457811,10.1186/s12979-020-00183-z,2020-05-28
Eye,LOCATION_OF,Household composition,32457556,10.1016/j.jbusres.2020.05.030,2020-05-28
Immune system,AFFECTS,Aging,32457556,10.1016/j.jbusres.2020.05.030,2020-05-28
Aplastic Anemia,ISA,Symptoms,32457134,10.7861/clinmed.2020-0246,2020-05-28
Aplastic Anemia,PROCESS_OF,Patients,32457134,10.7861/clinmed.2020-0246,2020-05-28
Seizures,PROCESS_OF,Woman,32457134,10.7861/clinmed.2020-0246,2020-05-28
Acute necrotizing encephalopathy,PROCESS_OF,Patients,32457134,10.7861/clinmed.2020-0246,2020-05-28
Brain Stem,LOCATION_OF,Edema,32457134,10.7861/clinmed.2020-0246,2020-05-28
Intubation,TREATS,Protection,32457134,10.7861/clinmed.2020-0246,2020-05-28
Mechanical ventilation,TREATS,Protection,32457134,10.7861/clinmed.2020-0246,2020-05-28
Brain Stem,LOCATION_OF,Edema,32457134,10.7861/clinmed.2020-0246,2020-05-28
Brain Stem,LOCATION_OF,Lesion,32457134,10.7861/clinmed.2020-0246,2020-05-28
Acute encephalopathy,AFFECTS,Patients,32457134,10.7861/clinmed.2020-0246,2020-05-28
Pleural effusion disorder,ISA,Complication,32457133,10.7861/clinmed.2020-0183,2020-05-28
Implantation procedure,TREATS,Pneumothorax,32457133,10.7861/clinmed.2020-0183,2020-05-28
Pneumothorax,PROCESS_OF,Patients,32457133,10.7861/clinmed.2020-0183,2020-05-28
Population Group,LOCATION_OF,Blood,32457086,10.1136/bmjspcare-2020-002326,2020-05-28
Consultation,TREATS,Community,32457048,10.1136/annrheumdis-2020-217888,2020-05-28
Collagen Diseases,PROCESS_OF,Patients,32457038,10.1194/jlr.R120000851,2020-05-28
Health Care Systems,LOCATION_OF,Diagnosis,32457038,10.1194/jlr.R120000851,2020-05-28
Coronavirus Infections,PROCESS_OF,Patients,32457038,10.1194/jlr.R120000851,2020-05-28
Collagen Diseases,PROCESS_OF,Patients,32457038,10.1194/jlr.R120000851,2020-05-28
Symptoms,PROCESS_OF,Patients,32457038,10.1194/jlr.R120000851,2020-05-28
Collagen Diseases,AFFECTS,Patients,32457038,10.1194/jlr.R120000851,2020-05-28
Molecular Target,TREATS,Disease Progression,32457036,10.1136/esmoopen-2020-000826,2020-05-28
Lysosomes,LOCATION_OF,Lipids,32457036,10.1136/esmoopen-2020-000826,2020-05-28
"Niemann-Pick Disease, Type C",ISA,Rare Diseases,32457036,10.1136/esmoopen-2020-000826,2020-05-28
Genes,CAUSES,"Niemann-Pick Disease, Type C",32457036,10.1136/esmoopen-2020-000826,2020-05-28
NPC1 gene,DISRUPTS,Severe Acute Respiratory Syndrome,32457036,10.1136/esmoopen-2020-000826,2020-05-28
Gastrointestinal symptom,PROCESS_OF,Patients,32457027,10.1136/bmj.m1936,2020-05-28
Abdominal Pain,PROCESS_OF,Patients,32457027,10.1136/bmj.m1936,2020-05-28
Severe disorder,PROCESS_OF,Patients,32457027,10.1136/bmj.m1936,2020-05-28
Severe disorder,PROCESS_OF,Patients,32457027,10.1136/bmj.m1936,2020-05-28
Victim of neglect (finding),PROCESS_OF,Child,32456959,10.1016/j.jemermed.2020.04.060,2020-05-28
Weakness,PROCESS_OF,Child,32456959,10.1016/j.jemermed.2020.04.060,2020-05-28
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32456948,10.1016/j.numecd.2020.04.013,2020-05-28
Eye,LOCATION_OF,Symptoms,32456948,10.1016/j.numecd.2020.04.013,2020-05-28
Mucous Membrane,PART_OF,Eye,32456948,10.1016/j.numecd.2020.04.013,2020-05-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32456948,10.1016/j.numecd.2020.04.013,2020-05-28
Cardiovascular Diseases,PREDISPOSES,Rapidly progressive,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
3-Hydroxybutyrate Dehydrogenase,ISA,Oxidoreductase,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
Lung,LOCATION_OF,Cardiovascular Diseases,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
Serum,LOCATION_OF,Ferritin,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
Serum,LOCATION_OF,Fibrinogen,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
Cardiovascular Diseases,PROCESS_OF,Patients,32456944,10.1016/j.nefro.2020.04.005,2020-05-28
Cessation of life,PROCESS_OF,Community,32456846,10.1016/j.jdiacomp.2020.107637,2020-05-28
Toxic Epidermal Necrolysis,CAUSES,Pneumonia,32456846,10.1016/j.jdiacomp.2020.107637,2020-05-28
Diabetes,PROCESS_OF,Population Group,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Complication,PROCESS_OF,Persons,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Diabetes,ASSOCIATED_WITH,enzyme pathway,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Diabetes,PROCESS_OF,Persons,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Diabetes,PROCESS_OF,Persons,32456758,10.4140/TCP.n.2020.283.,2020-05-28
"CD69 protein, human",AUGMENTS,Complication,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Urine,LOCATION_OF,Blood Glucose,32456758,10.4140/TCP.n.2020.283.,2020-05-28
Urine,LOCATION_OF,Ketone Bodies,32456758,10.4140/TCP.n.2020.283.,2020-05-28
attribution,PROCESS_OF,Patients,32456715,10.1017/ipm.2020.68,2020-05-28
Challenge,METHOD_OF,Health Services,32456689,10.1186/s12916-020-01619-5,2020-05-28
Coronavirus Infections,ISA,Disease,32456650,10.1186/s12978-020-00926-7,2020-05-28
Early Diagnosis,PRECEDES,Intervention regimes,32456650,10.1186/s12978-020-00926-7,2020-05-28
Symptoms,PROCESS_OF,Persons,32456650,10.1186/s12978-020-00926-7,2020-05-28
Disseminated Intravascular Coagulation,ISA,Blood Coagulation Disorders,32456489,10.1080/10641955.2020.1769645,2020-05-28
Septicemia,CAUSES,Blood Coagulation Disorders,32456489,10.1080/10641955.2020.1769645,2020-05-28
Septicemia,CAUSES(SPEC),Disseminated Intravascular Coagulation,32456489,10.1080/10641955.2020.1769645,2020-05-28
Gravidity,PROCESS_OF,Patients,32456461,10.2217/fon-2020-0300,2020-05-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32456461,10.2217/fon-2020-0300,2020-05-28
Malignant Neoplasms,PROCESS_OF,Patients,32456441,10.22605/RRH6000,2020-05-28
Mutagens,CAUSES,Neoplasms,32456441,10.22605/RRH6000,2020-05-28
Obesity,PROCESS_OF,Persons,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Immune response,PROCESS_OF,Patients,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Obesity,PROCESS_OF,Patients,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
"RNA, Viral",INTERACTS_WITH,,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Obesity,PROCESS_OF,Patients,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Pharmaceutical Preparations,TREATS,Flare,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Treatment Protocols,TREATS,Flare,32456404,10.23736/S0031-0808.20.03958-0,2020-05-28
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32456367,10.3760/cma.j.cn501120-20200416-00229,2020-05-28
Basis,TREATS,Clinician,32456367,10.3760/cma.j.cn501120-20200416-00229,2020-05-28
Feline infectious peritonitis,ISA,Virus Diseases,32456123,10.3390/jcm9051583,2020-05-28
Antiviral Agents,COEXISTS_WITH,Pharmaceutical Preparations,32456123,10.3390/jcm9051583,2020-05-28
Antiviral Agents,TREATS,Feline infectious peritonitis,32456123,10.3390/jcm9051583,2020-05-28
Pharmaceutical Preparations,TREATS,Immune System Diseases,32456123,10.3390/jcm9051583,2020-05-28
Pharmaceutical Preparations,TREATS,Malaria,32456123,10.3390/jcm9051583,2020-05-28
Hydroxychloroquine,AFFECTS,Virus Diseases,32456123,10.3390/jcm9051583,2020-05-28
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32456123,10.3390/jcm9051583,2020-05-28
Hydroxychloroquine,TREATS(SPEC),Immune System Diseases,32456123,10.3390/jcm9051583,2020-05-28
Hydroxychloroquine,TREATS(SPEC),Malaria,32456123,10.3390/jcm9051583,2020-05-28
Immune System Diseases,PROCESS_OF,Homo sapiens,32456123,10.3390/jcm9051583,2020-05-28
Malaria,PROCESS_OF,Homo sapiens,32456123,10.3390/jcm9051583,2020-05-28
Diabetes,PROCESS_OF,Patients,32455961,10.3390/ijerph17103650,2020-05-28
Diabetes,AFFECTS,Persons,32455961,10.3390/ijerph17103650,2020-05-28
Disease,COEXISTS_WITH,Comorbidity,32455961,10.3390/ijerph17103650,2020-05-28
IMPACT gene,AFFECTS,Virus Internalization,32455961,10.3390/ijerph17103650,2020-05-28
Decompensation,PROCESS_OF,Patients,32455961,10.3390/ijerph17103650,2020-05-28
Severe malnutrition,PROCESS_OF,Patients,32455961,10.3390/ijerph17103650,2020-05-28
Communicable Diseases,CAUSES,Disease,32455894,10.3390/jcm9051574,2020-05-28
Interventional procedure,TREATS,Disease,32455894,10.3390/jcm9051574,2020-05-28
Interventional procedure,TREATS,Persons,32455894,10.3390/jcm9051574,2020-05-28
Interventional procedure,TREATS(INFER),Infected,32455894,10.3390/jcm9051574,2020-05-28
Infected,PROCESS_OF,Persons,32455894,10.3390/jcm9051574,2020-05-28
Malignant neoplasm of urinary bladder,PROCESS_OF,Community,32455859,10.3390/ijerph17103642,2020-05-28
Malignant neoplasm of urinary bladder,PROCESS_OF,Patients,32455859,10.3390/ijerph17103642,2020-05-28
Localized Malignant Neoplasm,PROCESS_OF,Patients,32455859,10.3390/ijerph17103642,2020-05-28
Metastatic Urothelial Carcinoma,PROCESS_OF,Patients,32455859,10.3390/ijerph17103642,2020-05-28
Communicable Diseases,AFFECTS,Severe (severity modifier),32455807,10.3390/jcm9051564,2020-05-28
dental emergency,AFFECTS,Patients,32455807,10.3390/jcm9051564,2020-05-28
Human body,LOCATION_OF,paired basic amino acid cleaving enzyme,32455617,10.3390/biology9050107,2020-05-28
Human body,LOCATION_OF,ACE2 gene,32455617,10.3390/biology9050107,2020-05-28
Coronavirus Infections,AFFECTS,professional occupation status,32455550,10.3390/ijerph17103604,2020-05-28
IMPACT gene,PART_OF,Virus,32455539,10.3390/ijms21103627,2020-05-28
Endopeptidases,PART_OF,integral to membrane,32455534,10.3390/ijms21103626,2020-05-28
ACE2 gene,STIMULATES,Androgens,32455534,10.3390/ijms21103626,2020-05-28
Androgens,STIMULATES,ACE2 gene,32455534,10.3390/ijms21103626,2020-05-28
Smoking,PROCESS_OF,Patients,32455534,10.3390/ijms21103626,2020-05-28
Tobacco,STIMULATES,ACE2 gene,32455534,10.3390/ijms21103626,2020-05-28
Spinal Diseases,PROCESS_OF,Patients,32455515,10.3760/cma.j.cn112148-20200304-00155,2020-05-27
Operative Surgical Procedures,TREATS,Patients,32455515,10.3760/cma.j.cn112148-20200304-00155,2020-05-27
Symptom aggravating factors,PROCESS_OF,Patients,32455111,10.1016/j.epsc.2020.101495,2020-05-27
High Level,PROCESS_OF,Patients,32455111,10.1016/j.epsc.2020.101495,2020-05-27
Severe disorder,PROCESS_OF,Patients,32455107,10.1016/j.rmcr.2020.101096,2020-05-27
Pneumonia,PROCESS_OF,Patients,32455094,10.1186/s40163-020-00117-6,2020-05-27
Acute respiratory distress,PROCESS_OF,Persons,32455089,10.7759/cureus.8192,2020-05-27
Cardiovascular,LOCATION_OF,compromise,32455089,10.7759/cureus.8192,2020-05-27
Virus,PROCESS_OF,Patients,32455089,10.7759/cureus.8192,2020-05-27
Hospitals,LOCATION_OF,Laboratory Procedures,32455089,10.7759/cureus.8192,2020-05-27
Overlap syndrome,AFFECTS,Confirmation,32455089,10.7759/cureus.8192,2020-05-27
imatinib,TREATS,Gout,32455089,10.7759/cureus.8192,2020-05-27
Laboratory,LOCATION_OF,Laboratory Procedures,32455089,10.7759/cureus.8192,2020-05-27
simulation,USES,Operative Surgical Procedures,32455057,10.7759/cureus.7737,2020-05-27
Bone structure of lumbar vertebra,LOCATION_OF,X-Ray Computed Tomography,32455057,10.7759/cureus.7737,2020-05-27
simulation,USES,Operative Surgical Procedures,32455057,10.7759/cureus.7737,2020-05-27
Masks,TREATS,Infantile Neuroaxonal Dystrophy,32454984,10.1186/s40794-020-00107-1,2020-05-27
Introduction procedure,USES,Masks,32454984,10.1186/s40794-020-00107-1,2020-05-27
Optimism,PROCESS_OF,Health Personnel,32454984,10.1186/s40794-020-00107-1,2020-05-27
Asthma,PROCESS_OF,Patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Asthma,PROCESS_OF,Patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Respiratory distress,PROCESS_OF,Patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Metered Dose Inhaler,ISA,Inhaler,32454982,10.1186/s40545-020-00219-1,2020-05-27
Metered Dose Inhaler,USES,Inhaler,32454982,10.1186/s40545-020-00219-1,2020-05-27
Asthma,PROCESS_OF,Patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Respiratory distress,PROCESS_OF,Patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Chronic Obstructive Airway Disease,PROCESS_OF,geriatric patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Respiratory syncytial virus,PROCESS_OF,geriatric patients,32454982,10.1186/s40545-020-00219-1,2020-05-27
Metered Dose Inhaler,USES,Ventolin,32454982,10.1186/s40545-020-00219-1,2020-05-27
Clinician,USES,License,32454891,10.1017/S1754470X20000148,2020-05-27
Emotional support,TREATS,Staff,32454888,10.1186/s13020-020-00332-y,2020-05-27
Nance-Horan syndrome,PROCESS_OF,Staff,32454888,10.1186/s13020-020-00332-y,2020-05-27
Clinical Treatment,TREATS,Complication,32454808,10.26633/RPSP.2020.59,2020-05-27
Pregnant Women,LOCATION_OF,Milk (body substance),32454807,10.26633/RPSP.2020.54,2020-05-27
Milk (body substance),PART_OF,Pregnant Women,32454807,10.26633/RPSP.2020.54,2020-05-27
Fever,PROCESS_OF,Patients,32454807,10.26633/RPSP.2020.54,2020-05-27
Low Birth Weights,PROCESS_OF,"Infant, Newborn",32454807,10.26633/RPSP.2020.54,2020-05-27
Milk (body substance),PART_OF,Pregnant Women,32454807,10.26633/RPSP.2020.54,2020-05-27
Knowledge acquisition,AFFECTS,Possible,32454545,10.1007/s10273-020-2655-x,2020-05-27
Societies,LOCATION_OF,Knowledge acquisition,32454545,10.1007/s10273-020-2655-x,2020-05-27
Mycobacterium avium Complex,LOCATION_OF,"cholest-8(14)-ene-3,26-diol-15-one",32454545,10.1007/s10273-020-2655-x,2020-05-27
Virus Diseases,ASSOCIATED_WITH,nitric oxide mediated signal transduction,32454500,10.1159/000508125,2020-05-27
nitric oxide mediated signal transduction,PROCESS_OF,Cells,32454500,10.1159/000508125,2020-05-27
Nitric Oxide,INTERACTS_WITH,TONICS,32454500,10.1159/000508125,2020-05-27
Behavior Therapy,TREATS,Disease,32454500,10.1159/000508125,2020-05-27
Therapeutic procedure,PREVENTS,Single organ dysfunction,32454456,10.1530/EJE-20-0401,2020-05-27
Gestational Diabetes,PROCESS_OF,Woman,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Gestational Diabetes,PREDISPOSES,Direct disease transmission,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Gestational Diabetes,PROCESS_OF,Woman,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Care provision regimes,TREATS,Woman,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Care provision regimes,TREATS,high-risk group,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Care provision regimes,TREATS(INFER),Gestational Diabetes,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Gestational Diabetes,PROCESS_OF,Woman,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Screening procedure,TREATS,Woman,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Screening procedure,TREATS(INFER),Gestational Diabetes,32454398,10.1016/j.carpath.2020.107232,2020-05-27
Health Personnel,DIAGNOSES,ST segment elevation myocardial infarction,32454268,10.1016/j.rmed.2020.106023,2020-05-27
Pulmonary Embolism,PROCESS_OF,Patients,32454253,10.1016/j.ijsu.2020.05.061,2020-05-27
Pulmonary Embolism,PROCESS_OF,Patients,32454253,10.1016/j.ijsu.2020.05.061,2020-05-27
General surgical department,LOCATION_OF,Administration occupational activities,32454250,10.1016/j.ijsu.2020.05.060,2020-05-27
Equilibrium,PROCESS_OF,Clinician,32454250,10.1016/j.ijsu.2020.05.060,2020-05-27
Evaluation,METHOD_OF,"Surgical Procedures, Laparoscopic",32454250,10.1016/j.ijsu.2020.05.060,2020-05-27
China,ISA,Country,32454233,10.1016/j.jvs.2020.05.032,2020-05-27
Interventional procedure,TREATS,critical limb ischemia,32454232,10.1016/j.jvs.2020.05.026,2020-05-27
Singapore,ISA,Country,32454187,10.1016/j.cmi.2020.05.019,2020-05-27
European Union,LOCATION_OF,Clinical Trials,32454186,10.1016/j.jpainsymman.2020.05.022,2020-05-27
Scientific Study,USES,treatments and procedures,32454186,10.1016/j.jpainsymman.2020.05.022,2020-05-27
Assay,METHOD_OF,Palliative Care,32454184,10.1016/j.jpainsymman.2020.05.021,2020-05-27
Comorbidity,PROCESS_OF,Patients,32454184,10.1016/j.jpainsymman.2020.05.021,2020-05-27
Senility,PROCESS_OF,Patients,32454184,10.1016/j.jpainsymman.2020.05.021,2020-05-27
Infected,PROCESS_OF,Patients,32454174,10.1016/j.jshs.2020.05.006,2020-05-27
Engaged to be married,PROCESS_OF,Child,32454157,10.1016/j.lfs.2020.117842,2020-05-27
IMPACT gene,AFFECTS,Weight Gain,32454157,10.1016/j.lfs.2020.117842,2020-05-27
IMPACT gene,AFFECTS,Pediatric Obesity,32454157,10.1016/j.lfs.2020.117842,2020-05-27
IMPACT gene,AFFECTS,Pediatric Obesity,32454157,10.1016/j.lfs.2020.117842,2020-05-27
Reactive Oxygen Species,ASSOCIATED_WITH,Virus Diseases,32454138,10.1016/j.bbi.2020.05.059,2020-05-27
Body mass index procedure,USES,Indicators,32454128,10.1016/j.ejps.2020.105387,2020-05-27
risk factors,PREDISPOSES,Noncommunicable Diseases,32454128,10.1016/j.ejps.2020.105387,2020-05-27
Coronavirus Infections,ISA,Disease,32454103,10.1016/j.yexmp.2020.104474,2020-05-27
Coronavirus Infections,ISA,Disease,32454103,10.1016/j.yexmp.2020.104474,2020-05-27
Betacoronavirus,LOCATION_OF,Epitopes,32454103,10.1016/j.yexmp.2020.104474,2020-05-27
Virus Diseases,AFFECTS,Immune response,32454092,10.1016/j.trsl.2020.05.006,2020-05-27
cytokine,AFFECTS,Organ,32454092,10.1016/j.trsl.2020.05.006,2020-05-27
cytokine secretion,AFFECTS,Murine hepatitis virus,32454092,10.1016/j.trsl.2020.05.006,2020-05-27
Brain,PRODUCES,cytokine,32454092,10.1016/j.trsl.2020.05.006,2020-05-27
Disease,PROCESS_OF,Homo sapiens,32454090,10.1016/j.arr.2020.101091,2020-05-27
Disseminated Intravascular Coagulation,ISA,Disease,32454090,10.1016/j.arr.2020.101091,2020-05-27
Disseminated Intravascular Coagulation,PROCESS_OF(SPEC),Homo sapiens,32454090,10.1016/j.arr.2020.101091,2020-05-27
Thrombotic Microangiopathies,ISA,Disseminated Intravascular Coagulation,32454090,10.1016/j.arr.2020.101091,2020-05-27
Thrombosis,PROCESS_OF,Patients,32454090,10.1016/j.arr.2020.101091,2020-05-27
Inflammation,COEXISTS_WITH,Thrombosis,32454090,10.1016/j.arr.2020.101091,2020-05-27
Thrombosis,COEXISTS_WITH,Disease,32454090,10.1016/j.arr.2020.101091,2020-05-27
Thrombosis,COEXISTS_WITH,Thrombus,32454090,10.1016/j.arr.2020.101091,2020-05-27
Disease,PROCESS_OF,Patients,32454090,10.1016/j.arr.2020.101091,2020-05-27
Thrombosis,COEXISTS_WITH,Disease,32454090,10.1016/j.arr.2020.101091,2020-05-27
Frail,PROCESS_OF,Persons,32454041,10.1016/j.jhep.2020.05.023,2020-05-27
Degenerative polyarthritis,PROCESS_OF,Patients,32454041,10.1016/j.jhep.2020.05.023,2020-05-27
Chronic inflammation,AFFECTS,Old age,32454041,10.1016/j.jhep.2020.05.023,2020-05-27
End Stage Liver Disease,PROCESS_OF,Patients,32454025,10.1016/j.ccell.2020.04.018,2020-05-27
Hospitals,LOCATION_OF,Study,32453702,10.1556/650.2020.31870,2020-05-27
Thrombocytopenia,PROCESS_OF,Patients,32453702,10.1556/650.2020.31870,2020-05-27
Thrombocytopenia,PROCESS_OF,geriatric patients,32453702,10.1556/650.2020.31870,2020-05-27
Lymphocyte count decreased,PROCESS_OF,Patients,32453702,10.1556/650.2020.31870,2020-05-27
Lymphocyte count decreased,PROCESS_OF,geriatric patients,32453702,10.1556/650.2020.31870,2020-05-27
Thrombocytopenia,PROCESS_OF,Patients,32453702,10.1556/650.2020.31870,2020-05-27
Platelet destruction,CAUSES,Thrombocytopenia,32453702,10.1556/650.2020.31870,2020-05-27
High Level,COEXISTS_WITH,Disease,32453695,10.1556/650.2020.31848,2020-05-27
Laboratory Procedures,USES,Coagulation procedure,32453695,10.1556/650.2020.31848,2020-05-27
Thromboembolism,PROCESS_OF,Patients,32453695,10.1556/650.2020.31848,2020-05-27
Radiologic finding,PROCESS_OF,Patients,32453687,10.2450/2020.0124-20,2020-05-27
Symptoms,PROCESS_OF,Patients,32453687,10.2450/2020.0124-20,2020-05-27
Symptom mild,PROCESS_OF,Patients,32453687,10.2450/2020.0124-20,2020-05-27
Awareness,PROCESS_OF,Patients,32453687,10.2450/2020.0124-20,2020-05-27
Frail,PROCESS_OF,Patients,32453687,10.2450/2020.0124-20,2020-05-27
"CD69 protein, human",AUGMENTS,Awareness,32453687,10.2450/2020.0124-20,2020-05-27
"Immunotherapy, Passive",TREATS,Patients,32453686,10.3201/eid2608.201142,2020-05-27
Donor person,LOCATION_OF,Plasma,32453686,10.3201/eid2608.201142,2020-05-27
Evaluation,TREATS,Muscle Rigidity,32453686,10.3201/eid2608.201142,2020-05-27
Coronavirus Infections,ISA,Disease,32453685,10.3201/eid2609.201791,2020-05-27
Coronavirus Infections,ISA,Disease,32453685,10.3201/eid2609.201791,2020-05-27
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32453685,10.3201/eid2609.201791,2020-05-27
Infection,PROCESS_OF,Persons,32453685,10.3201/eid2609.201791,2020-05-27
Anticoagulation Therapy,METHOD_OF,Stroke prophylaxis,32453656,10.1200/OP.20.00286,2020-05-27
Malignant neoplasm of lung,PROCESS_OF,Patients,32453494,10.1111/andr.12825,2020-05-27
Health Care Systems,LOCATION_OF,Administration occupational activities,32453494,10.1111/andr.12825,2020-05-27
Neoplasms,PROCESS_OF,Community,32453494,10.1111/andr.12825,2020-05-27
Malignant neoplasm of lung,PROCESS_OF,Patients,32453494,10.1111/andr.12825,2020-05-27
Seminal fluid,LOCATION_OF,IMPACT gene,32453483,10.1111/tid.13338,2020-05-27
Testis,LOCATION_OF,TMPRSS2 gene,32453483,10.1111/tid.13338,2020-05-27
Testis,LOCATION_OF,ACE2 gene,32453483,10.1111/tid.13338,2020-05-27
Fetal Distress,PROCESS_OF,"Infant, Newborn",32453436,10.3928/00989134-20200515-01,2020-05-27
"Infant, Premature",PROCESS_OF,"Infant, Newborn",32453436,10.3928/00989134-20200515-01,2020-05-27
Stillbirth,PROCESS_OF,"Infant, Newborn",32453436,10.3928/00989134-20200515-01,2020-05-27
Medical History,NEG_PROCESS_OF,Woman,32453074,10.1097/FJC.0000000000000854,2020-05-27
Chest CT,DIAGNOSES,Physical findings,32453074,10.1097/FJC.0000000000000854,2020-05-27
Atrial Fibrillation,ISA,Cardiovascular Diseases,32453053,10.14309/ajg.0000000000000691,2020-05-27
"CD69 protein, human",INTERACTS_WITH,Cardiovascular Agents,32453053,10.14309/ajg.0000000000000691,2020-05-27
Pediatric Crohn's disease,PROCESS_OF,Patients,32452978,10.1097/MPG.0000000000002798,2020-05-27
Face,LOCATION_OF,Maculopapular eruption,32452978,10.1097/MPG.0000000000002798,2020-05-27
,ASSOCIATED_WITH,Inflammatory Bowel Diseases,32452978,10.1097/MPG.0000000000002798,2020-05-27
,ASSOCIATED_WITH,Coronavirus Infections,32452978,10.1097/MPG.0000000000002798,2020-05-27
Interleukin-6,ASSOCIATED_WITH,Inflammatory Bowel Diseases,32452978,10.1097/MPG.0000000000002798,2020-05-27
Interleukin-6,ASSOCIATED_WITH,Coronavirus Infections,32452978,10.1097/MPG.0000000000002798,2020-05-27
Interleukin-8,ASSOCIATED_WITH,Inflammatory Bowel Diseases,32452978,10.1097/MPG.0000000000002798,2020-05-27
Interleukin-8,ASSOCIATED_WITH,Coronavirus Infections,32452978,10.1097/MPG.0000000000002798,2020-05-27
infliximab,ASSOCIATED_WITH,Crohn Disease,32452978,10.1097/MPG.0000000000002798,2020-05-27
infliximab,ASSOCIATED_WITH,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,32452978,10.1097/MPG.0000000000002798,2020-05-27
infliximab,TREATS,Patients,32452978,10.1097/MPG.0000000000002798,2020-05-27
,COEXISTS_WITH,Interleukin-6,32452978,10.1097/MPG.0000000000002798,2020-05-27
,COEXISTS_WITH,Interleukin-8,32452978,10.1097/MPG.0000000000002798,2020-05-27
Coronavirus Infections,ISA,Disease,32452978,10.1097/MPG.0000000000002798,2020-05-27
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,AFFECTS,Patients,32452978,10.1097/MPG.0000000000002798,2020-05-27
Child,LOCATION_OF,Feces,32452954,10.1097/SLA.0000000000004081,2020-05-27
Viral Shedding,PROCESS_OF,Child,32452954,10.1097/SLA.0000000000004081,2020-05-27
Elective Surgical Procedures,TREATS,Disease,32452949,10.1097/SLA.0000000000004029,2020-05-27
Sarcoma,ISA,Neoplasms,32452949,10.1097/SLA.0000000000004029,2020-05-27
Interventional procedure,TREATS,Colorectal Carcinoma,32452947,10.1097/SLA.0000000000004084,2020-05-27
Operative Surgical Procedures,ISA,Interventional procedure,32452947,10.1097/SLA.0000000000004084,2020-05-27
Operative Surgical Procedures,TREATS(SPEC),Colorectal Carcinoma,32452947,10.1097/SLA.0000000000004084,2020-05-27
Respiratory Failure,PROCESS_OF,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Extracorporeal Membrane Oxygenation,TREATS,Respiratory failure without hypercapnia,32452941,10.1097/NCM.0000000000000454,2020-05-27
Therapeutic procedure,TREATS,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Illness (finding),PROCESS_OF,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Therapeutic procedure,TREATS,"Respiratory Distress Syndrome, Adult",32452941,10.1097/NCM.0000000000000454,2020-05-27
Cannulation,TREATS,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Extracorporeal Membrane Oxygenation,TREATS,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Duration,TREATS,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Extracorporeal Membrane Oxygenation,TREATS,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Extracorporeal Membrane Oxygenation,TREATS(INFER),Respiratory Failure,32452941,10.1097/NCM.0000000000000454,2020-05-27
Respiratory Failure,PROCESS_OF,Patients,32452941,10.1097/NCM.0000000000000454,2020-05-27
Crisis,PROCESS_OF,Case Manager,32452908,10.1097/JCMA.0000000000000348,2020-05-27
Case Manager,ISA,Health Personnel,32452908,10.1097/JCMA.0000000000000348,2020-05-27
Case Manager,ISA,Health Personnel,32452908,10.1097/JCMA.0000000000000348,2020-05-27
Coronavirus Infections,AFFECTS,Patients,32452905,10.1213/ANE.0000000000005000,2020-05-27
Opioids,ISA,Pharmaceutical Preparations,32452902,10.1097/JAC.0000000000000341,2020-05-27
IMPACT gene,INHIBITS,Pharmaceutical Preparations,32452902,10.1097/JAC.0000000000000341,2020-05-27
IMPACT gene,INHIBITS(SPEC),Opioids,32452902,10.1097/JAC.0000000000000341,2020-05-27
Pain,PROCESS_OF,Patients,32452902,10.1097/JAC.0000000000000341,2020-05-27
Vertebral column,LOCATION_OF,Pain,32452902,10.1097/JAC.0000000000000341,2020-05-27
Elective procedure,TREATS,Patients,32452902,10.1097/JAC.0000000000000341,2020-05-27
Elective procedure,TREATS(INFER),Pain,32452902,10.1097/JAC.0000000000000341,2020-05-27
Critical Illness,PROCESS_OF,Adult,32452879,10.1097/PHM.0000000000001477,2020-05-27
Critical Illness,PROCESS_OF,Patients,32452879,10.1097/PHM.0000000000001477,2020-05-27
Critical Illness,PROCESS_OF,Atlanta,32452879,10.1097/PHM.0000000000001477,2020-05-27
Critical Illness,PROCESS_OF,Cohort,32452879,10.1097/PHM.0000000000001477,2020-05-27
Critical Illness,PROCESS_OF,Adult,32452879,10.1097/PHM.0000000000001477,2020-05-27
"Kidney Failure, Chronic",PROCESS_OF,Adult,32452879,10.1097/PHM.0000000000001477,2020-05-27
Coronavirus Infections,ISA,Disease,32452839,10.1097/ACM.0000000000003517,2020-05-27
Disease,PROCESS_OF,Survivors,32452839,10.1097/ACM.0000000000003517,2020-05-27
student,USES,Rules of conduct,32452819,10.2196/19927,2020-05-27
Coronavirus Infections,ISA,Disease,32452816,10.2196/19361,2020-05-27
Readiness,COEXISTS_WITH,Disease,32452816,10.2196/19361,2020-05-27
Readiness,COEXISTS_WITH(SPEC),Coronavirus Infections,32452816,10.2196/19361,2020-05-27
Medical colleges,LOCATION_OF,Cross-Sectional Studies,32452816,10.2196/19361,2020-05-27
Wellness Centers,LOCATION_OF,Administration occupational activities,32452816,10.2196/19361,2020-05-27
Wellness Centers,LOCATION_OF,Management procedure,32452816,10.2196/19361,2020-05-27
Coronavirus Infections,ISA,Disease,32452816,10.2196/19361,2020-05-27
Maker (occupation),USES,Health Policy,32452816,10.2196/19361,2020-05-27
Coronavirus Infections,ISA,Disease,32452804,10.2196/19421,2020-05-27
Coronavirus Infections,ISA,Disease,32452762,10.7554/eLife.58603,2020-05-27
Coronavirus Infections,ISA,Disease,32452762,10.7554/eLife.58603,2020-05-27
"CD69 protein, human",ASSOCIATED_WITH,Disease,32452762,10.7554/eLife.58603,2020-05-27
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32452762,10.7554/eLife.58603,2020-05-27
Coronavirus Infections,ISA,Disease,32452762,10.7554/eLife.58603,2020-05-27
Symptoms,ASSOCIATED_WITH,Disease,32452762,10.7554/eLife.58603,2020-05-27
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32452762,10.7554/eLife.58603,2020-05-27
Coronavirus Infections,ISA,Disease,32452762,10.7554/eLife.58603,2020-05-27
Coronavirus Infections,ISA,Disease,32452762,10.7554/eLife.58603,2020-05-27
Mutation,PROCESS_OF,Patients,32452746,10.1177/0194599820931041,2020-05-27
Respiration Disorders,COEXISTS_WITH,Mimicry,32452746,10.1177/0194599820931041,2020-05-27
Tertiary Care Centers,LOCATION_OF,Retrospective Cohort Study,32452739,10.1177/0194599820931805,2020-05-27
Hand,LOCATION_OF,Instrument - device,32452731,10.2214/AJR.20.23214,2020-05-27
Evaluation,COEXISTS_WITH,Operative Surgical Procedures,32452731,10.2214/AJR.20.23214,2020-05-27
pathologic fistula,PART_OF,Patients,32452701,10.1080/17460441.2020.1767063,2020-05-27
Postoperative Care,TREATS,Patients,32452701,10.1080/17460441.2020.1767063,2020-05-27
Base of skull structure,LOCATION_OF,Chief complaint (finding),32452701,10.1080/17460441.2020.1767063,2020-05-27
Coronavirus Infections,ISA,Disease,32452701,10.1080/17460441.2020.1767063,2020-05-27
Evaluation procedure,ADMINISTERED_TO,Patients,32452701,10.1080/17460441.2020.1767063,2020-05-27
Spices,AFFECTS,Immunity,32452661,10.7748/ns.2020.e11561,2020-05-27
Immunity,AFFECTS,Ability,32452661,10.7748/ns.2020.e11561,2020-05-27
Coronavirus Infections,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Coronavirus Infections,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Coronavirus Infections,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Coronavirus Infections,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Severe Acute Respiratory Syndrome,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Severe Acute Respiratory Syndrome,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Middle East Respiratory Syndrome,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Middle East Respiratory Syndrome,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Coronavirus Infections,ISA,Disease,32452644,10.1111/andr.12829,2020-05-27
Sex Characteristics,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32452598,10.1002/dmrr.3331,2020-05-27
Coronavirus Infections,ISA,Disease,32452539,10.1002/jcp.29735,2020-05-27
Coronavirus Infections,ISA,Disease,32452539,10.1002/jcp.29735,2020-05-27
Coronavirus Infections,ISA,Disease,32452455,10.1016/j.jflm.2020.101965,2020-05-27
Physicians,USES,License,32452417,10.1016/j.virol.2020.03.007,2020-05-27
"Genes, Overlapping",COEXISTS_WITH,Reading Frames (Nucleotide Sequence),32452410,10.1016/j.virol.2020.04.011,2020-05-27
"Genes, Overlapping",COEXISTS_WITH,Genome,32452410,10.1016/j.virol.2020.04.011,2020-05-27
Serum,LOCATION_OF,Serum amyloid A protein,32452282,10.1080/07391102.2020.1771424,2020-05-27
Serum,PART_OF,Patients,32452282,10.1080/07391102.2020.1771424,2020-05-27
CD40LG wt Allele,NEG_PART_OF,Patients,32452282,10.1080/07391102.2020.1771424,2020-05-27
Tissue membrane,LOCATION_OF,Rupture,32452050,10.1002/jcp.29804,2020-05-27
Birth,AFFECTS,Alveolar ventilation function,32452050,10.1002/jcp.29804,2020-05-27
Lung Injury,COEXISTS_WITH,Common Cold,32452036,10.1111/cod.13618,2020-05-27
Hand eczema,PROCESS_OF,Health Personnel,32451923,10.1007/s40265-020-01321-z,2020-05-27
Hand,LOCATION_OF,"Dermatitis, Occupational",32451923,10.1007/s40265-020-01321-z,2020-05-27
Symptoms,ASSOCIATED_WITH,Acute hand eczema,32451923,10.1007/s40265-020-01321-z,2020-05-27
SARS coronavirus,ISA,Genus: Coronavirus,32451906,10.1007/s40123-020-00262-w,2020-05-27
DNA Helicases,DISRUPTS,Virus Replication,32451906,10.1007/s40123-020-00262-w,2020-05-27
Ambulatory Care Facilities,LOCATION_OF,Visual acuity testing,32451877,10.1007/s10554-020-01892-8,2020-05-27
Health Care,TREATS,Patients,32451846,10.1007/s11357-020-00207-y,2020-05-27
Cardiopulmonary,LOCATION_OF,Diagnostic radiologic examination,32451846,10.1007/s11357-020-00207-y,2020-05-27
Cardiovascular symptoms,PROCESS_OF,Patients,32451846,10.1007/s11357-020-00207-y,2020-05-27
Inflammation,CAUSES,Acute respiratory infections,32451823,10.1007/s11239-020-02146-z,2020-05-27
Nerve Degeneration,CAUSES,Acute respiratory infections,32451823,10.1007/s11239-020-02146-z,2020-05-27
Venous Thromboembolism,PROCESS_OF,inpatient,32451808,10.1007/s10916-020-01582-x,2020-05-27
intensive care unit,LOCATION_OF,Retrospective Cohort Study,32451808,10.1007/s10916-020-01582-x,2020-05-27
Veins,LOCATION_OF,Duplex ultrasonography,32451808,10.1007/s10916-020-01582-x,2020-05-27
Patients,LOCATION_OF,Fibrin fragment D,32451808,10.1007/s10916-020-01582-x,2020-05-27
Deep Vein Thrombosis,PROCESS_OF,Patients,32451808,10.1007/s10916-020-01582-x,2020-05-27
Comorbidity,PROCESS_OF,Patients,32451808,10.1007/s10916-020-01582-x,2020-05-27
Veins,LOCATION_OF,Duplex ultrasonography,32451808,10.1007/s10916-020-01582-x,2020-05-27
Genus: Coronavirus,ISA,Virus,32451736,10.1007/s11095-020-02842-8,2020-05-27
Virus,PROCESS_OF,Homo sapiens,32451736,10.1007/s11095-020-02842-8,2020-05-27
SARS coronavirus,PROCESS_OF,Homo sapiens,32451736,10.1007/s11095-020-02842-8,2020-05-27
Ammonium Chloride,ISA,Quaternary Ammonium Compounds,32451729,10.1007/s10067-020-05172-7,2020-05-27
Cetylpyridinium,ISA,Quaternary Ammonium Compounds,32451729,10.1007/s10067-020-05172-7,2020-05-27
miramistin,ISA,Quaternary Ammonium Compounds,32451729,10.1007/s10067-020-05172-7,2020-05-27
Critical Illness,PROCESS_OF,Patients,32451657,10.1007/s00264-020-04636-4,2020-05-27
Pneumonia,PROCESS_OF,Patients,32451657,10.1007/s00264-020-04636-4,2020-05-27
Adrenal Cortex Hormones,ADMINISTERED_TO,Patients,32451657,10.1007/s00264-020-04636-4,2020-05-27
Malaise,PROCESS_OF,Patients,32451657,10.1007/s00264-020-04636-4,2020-05-27
Coronavirus Infections,ISA,Disease,32451655,10.1007/s00264-020-04619-5,2020-05-27
"CD69 protein, human",AFFECTS,Disease,32451655,10.1007/s00264-020-04619-5,2020-05-27
"CD69 protein, human",AFFECTS(SPEC),Coronavirus Infections,32451655,10.1007/s00264-020-04619-5,2020-05-27
Coronavirus Infections,ISA,Disease,32451655,10.1007/s00264-020-04619-5,2020-05-27
Malignant Neoplasms,AFFECTS,Infiltration,32451655,10.1007/s00264-020-04619-5,2020-05-27
Neurovascular bundle,LOCATION_OF,Infiltration,32451655,10.1007/s00264-020-04619-5,2020-05-27
Coronavirus Infections,ISA,Disease,32451655,10.1007/s00264-020-04619-5,2020-05-27
Fracture,PROCESS_OF,Cohort,32451626,10.1007/s00540-020-02801-y,2020-05-27
Sprain,ISA,Wounds and Injuries,32451626,10.1007/s00540-020-02801-y,2020-05-27
Sprain,PROCESS_OF(SPEC),Cohort,32451626,10.1007/s00540-020-02801-y,2020-05-27
Wounds and Injuries,PROCESS_OF,Cohort,32451626,10.1007/s00540-020-02801-y,2020-05-27
Operative Surgical Procedures,TREATS,Patients,32451626,10.1007/s00540-020-02801-y,2020-05-27
Critical Illness,PROCESS_OF,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Fluid Management,TREATS,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Fluid Management,TREATS(INFER),Critical Illness,32451597,10.1007/s00210-020-01911-4,2020-05-27
Poor outcome,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32451597,10.1007/s00210-020-01911-4,2020-05-27
Fluid Management,TREATS,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Easy,PROCESS_OF,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Evaluation procedure,TREATS,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Evaluation procedure,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32451597,10.1007/s00210-020-01911-4,2020-05-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Procedure on heart,TREATS,Patients,32451597,10.1007/s00210-020-01911-4,2020-05-27
Procedure on heart,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32451597,10.1007/s00210-020-01911-4,2020-05-27
Pulmonary Edema,ISA,Fluid overload,32451597,10.1007/s00210-020-01911-4,2020-05-27
Edema of lower extremity,ISA,Fluid overload,32451597,10.1007/s00210-020-01911-4,2020-05-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32451564,10.1007/s00106-020-00891-4,2020-05-27
Infected,PROCESS_OF,Patients,32451564,10.1007/s00106-020-00891-4,2020-05-27
Symptoms,ASSOCIATED_WITH,Storm Syndrome,32451564,10.1007/s00106-020-00891-4,2020-05-27
Symptoms,PROCESS_OF,Patients,32451563,10.1007/s00038-020-01390-7,2020-05-27
Sense of smell impaired,PROCESS_OF,Patients,32451563,10.1007/s00038-020-01390-7,2020-05-27
Present,PROCESS_OF,Patients,32451563,10.1007/s00038-020-01390-7,2020-05-27
Sense of smell impaired,ISA,Symptoms,32451563,10.1007/s00038-020-01390-7,2020-05-27
Nose,LOCATION_OF,Obstruction,32451563,10.1007/s00038-020-01390-7,2020-05-27
Sense of smell impaired,PROCESS_OF,Cohort,32451563,10.1007/s00038-020-01390-7,2020-05-27
Comorbidity,PROCESS_OF,geriatric patients,32451562,10.1007/s00048-020-00255-7,2020-05-27
Dyspnea,ISA,Symptoms,32451562,10.1007/s00048-020-00255-7,2020-05-27
Cardiovascular Diseases,ISA,Symptoms,32451562,10.1007/s00048-020-00255-7,2020-05-27
Hypertensive disease,ISA,Symptoms,32451562,10.1007/s00048-020-00255-7,2020-05-27
Chronic Obstructive Airway Disease,PREDISPOSES,Comorbidity,32451562,10.1007/s00048-020-00255-7,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451562,10.1007/s00048-020-00255-7,2020-05-27
Hypertensive disease,PROCESS_OF,Patients,32451562,10.1007/s00048-020-00255-7,2020-05-27
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32451562,10.1007/s00048-020-00255-7,2020-05-27
Beak,LOCATION_OF,Masks,32451533,10.1093/ajcp/aqaa091,2020-05-27
Physicians,USES,Masks,32451533,10.1093/ajcp/aqaa091,2020-05-27
Plague,PROCESS_OF,Physicians,32451533,10.1093/ajcp/aqaa091,2020-05-27
Plague,PROCESS_OF,Physicians,32451533,10.1093/ajcp/aqaa091,2020-05-27
Beak,LOCATION_OF,Masks,32451533,10.1093/ajcp/aqaa091,2020-05-27
Symptom severe,PROCESS_OF,Persons,32451366,10.1136/bmjgh-2020-002647,2020-05-27
primary care facility,LOCATION_OF,Services,32451362,10.1136/heartjnl-2020-316909,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,ISA,Symptoms,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Sputum production,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Critical Illness,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Coronary Arteriosclerosis,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Disease,COEXISTS_WITH,Cardiovascular Diseases,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451359,10.1136/neurintsurg-2020-016220,2020-05-27
Thrombectomy,ADMINISTERED_TO,Patients,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Vascular occlusion,PROCESS_OF,Patients,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Abnormality of coagulation,PROCESS_OF,Patients,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Carotid artery occlusion,PROCESS_OF,Patients,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Structure of carotid sinus,LOCATION_OF,Complete obstruction,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Structure of carotid sinus,LOCATION_OF,Thrombus,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Abnormality of coagulation,PROCESS_OF,Patients,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Mechanical thrombectomy,TREATS,Vascular occlusion,32451358,10.1136/neurintsurg-2020-016177,2020-05-27
Complete obstruction,PART_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Arteries,LOCATION_OF,Complete obstruction,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,TREATS,Complete obstruction,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,TREATS,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,TREATS(INFER),Acute Cerebrovascular Accidents,32451354,10.3899/jrheum.200679,2020-05-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,ADMINISTERED_TO,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,TREATS,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Thrombectomy,TREATS(INFER),Acute Cerebrovascular Accidents,32451354,10.3899/jrheum.200679,2020-05-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32451354,10.3899/jrheum.200679,2020-05-27
Disease Screening,AFFECTS,Disease,32451354,10.3899/jrheum.200679,2020-05-27
Malaise,PROCESS_OF,Patients,32451353,10.3899/jrheum.200638,2020-05-27
Collagen Diseases,PROCESS_OF,Patients,32451352,10.3899/jrheum.200657,2020-05-27
Abstract thinking ability,PROCESS_OF,Patients,32451352,10.3899/jrheum.200657,2020-05-27
Ventilator - respiratory equipment,TREATS,Patients,32451317,10.1016/j.diabres.2020.108217,2020-05-27
Minority Groups,ISA,Ethnic group,32451301,10.1016/j.rbmo.2020.04.015,2020-05-27
Severe (severity modifier),PROCESS_OF,Population at Risk,32451301,10.1016/j.rbmo.2020.04.015,2020-05-27
Hyperglycemia,CAUSES,Disease of capillaries,32451301,10.1016/j.rbmo.2020.04.015,2020-05-27
Minority Groups,ISA,Ethnic group,32451301,10.1016/j.rbmo.2020.04.015,2020-05-27
Disease of capillaries,COEXISTS_WITH,Diabetes,32451301,10.1016/j.rbmo.2020.04.015,2020-05-27
Cessation of life,NEG_PROCESS_OF,Pregnant Women,32451271,10.1053/j.jvca.2020.04.041,2020-05-27
Pneumonia,PROCESS_OF,Pregnant Women,32451271,10.1053/j.jvca.2020.04.041,2020-05-27
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Cardiac complication,PROCESS_OF,Patients,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Poor outcome,PROCESS_OF,Patients,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Cardiovascular Diseases,PROCESS_OF,Patients,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Cardiac complication,ISA,Cardiovascular Diseases,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Cardiac complication,PROCESS_OF(SPEC),Patients,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Cardiac complication,PROCESS_OF,Patients,32451268,10.1016/j.jsams.2020.05.004,2020-05-27
Physicians,ISA,Health Personnel,32451257,10.1016/j.jiph.2020.04.015,2020-05-27
Pneumonia,PROCESS_OF,World,32451239,10.1016/j.tics.2020.05.003,2020-05-27
Cardiac Arrhythmia,PROCESS_OF,Patients,32451194,10.1016/j.ultrasmedbio.2020.04.033,2020-05-27
Lung,LOCATION_OF,Ultrasonography,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Acute respiratory failure,PROCESS_OF,Patients,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Evaluation procedure,USES,Imaging Techniques,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Diagnostic radiologic examination,METHOD_OF,Radionuclide Imaging,32451162,10.1016/j.surg.2020.04.036,2020-05-27
tomography,ADMINISTERED_TO,Physicians,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Acute respiratory failure,PROCESS_OF,Patients,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Radionuclide Imaging,ADMINISTERED_TO,Patients,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Acute respiratory failure,PROCESS_OF,Patients,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Plain chest X-ray,DIAGNOSES,patient condition,32451162,10.1016/j.surg.2020.04.036,2020-05-27
tomography,DIAGNOSES,patient condition,32451162,10.1016/j.surg.2020.04.036,2020-05-27
Acute respiratory failure,PROCESS_OF,Patients,32451162,10.1016/j.surg.2020.04.036,2020-05-27
IMPACT gene,AUGMENTS,Cerebrovascular accident,32450906,10.1186/s13293-020-00304-9,2020-05-27
Woman,LOCATION_OF,UGT1A7 wt Allele,32450877,10.1186/s13049-020-00736-7,2020-05-27
Infected,PROCESS_OF,Male population group,32450877,10.1186/s13049-020-00736-7,2020-05-27
Coitus,PROCESS_OF,Male population group,32450877,10.1186/s13049-020-00736-7,2020-05-27
IMPACT gene,AFFECTS,Coitus,32450877,10.1186/s13049-020-00736-7,2020-05-27
Illness (finding),PROCESS_OF,Patients,32450787,10.1177/2050640620924157,2020-05-27
Infected,PROCESS_OF,Patients,32450787,10.1177/2050640620924157,2020-05-27
Liver diseases,INTERACTS_WITH,Virus,32450770,10.1177/0194599820930244,2020-05-27
Physical Examination,USES,Laryngoscopy,32450761,10.1177/0194599820931801,2020-05-27
Nasopharynx,PART_OF,Patients,32450761,10.1177/0194599820931801,2020-05-27
Intubation,TREATS,Patients,32450756,10.1177/0194599820931819,2020-05-27
Percutaneous techniques,TREATS,Surgeon,32450756,10.1177/0194599820931819,2020-05-27
Creativity,PROCESS_OF,Community,32450754,10.1177/0194599820931793,2020-05-27
Disease,PROCESS_OF,Patients,32450752,10.1177/0194599820931082,2020-05-27
Nasal Swab (procedure),DIAGNOSES,Disease,32450752,10.1177/0194599820931082,2020-05-27
Nose,LOCATION_OF,Obstruction,32450752,10.1177/0194599820931082,2020-05-27
Nose,LOCATION_OF,Obstruction,32450752,10.1177/0194599820931082,2020-05-27
Negative,PROCESS_OF,Patients,32450718,10.1177/1120672120929961,2020-05-27
Negative,PROCESS_OF,Patients,32450718,10.1177/1120672120929961,2020-05-27
Negative,PROCESS_OF,Patients,32450718,10.1177/1120672120929961,2020-05-27
Ground Glass Opacity,NEG_PROCESS_OF,Patients,32450718,10.1177/1120672120929961,2020-05-27
Attention,PROCESS_OF,Persons,32450712,10.1177/1010539520928180,2020-05-27
Asymptomatic,PROCESS_OF,Persons,32450712,10.1177/1010539520928180,2020-05-27
Italy,ISA,Country,32450712,10.1177/1010539520928180,2020-05-27
China,ISA,Country,32450631,10.3760/cma.j.cn112147-20200219-00121,2020-05-27
Treatment Protocols,TREATS,Pneumonia,32450629,10.3760/cma.j.cn112147-20200304-00237,2020-05-27
Donor person,LOCATION_OF,Plasma,32450416,10.1016/j.psychres.2020.113111,2020-05-26
Plasma,ASSOCIATED_WITH(INFER),Infected,32450416,10.1016/j.psychres.2020.113111,2020-05-26
Plasma,PART_OF,Persons,32450416,10.1016/j.psychres.2020.113111,2020-05-26
Infected,PROCESS_OF,Persons,32450416,10.1016/j.psychres.2020.113111,2020-05-26
World,LOCATION_OF,"TLR4 protein, human",32450409,10.1016/j.psychres.2020.113108,2020-05-26
IMPACT gene,CAUSES,Cessation of life,32450409,10.1016/j.psychres.2020.113108,2020-05-26
Community,LOCATION_OF,"CD69 protein, human",32450346,10.1016/j.phrs.2020.104946,2020-05-26
Secondary Hemophagocytic Lymphohistiocytosis,CAUSES,Inflammation,32450344,10.1016/j.phrs.2020.104950,2020-05-26
Secondary Hemophagocytic Lymphohistiocytosis,CAUSES,Lymphopenia,32450344,10.1016/j.phrs.2020.104950,2020-05-26
Secondary Infections,PREDISPOSES,Exacerbation,32450344,10.1016/j.phrs.2020.104950,2020-05-26
Pulmonary capillary,LOCATION_OF,Thrombus,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Hypoxemia,PROCESS_OF,Patients,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
endothelial dysfunction,AFFECTS,Anabolism,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Respiratory Care Units,LOCATION_OF,Study,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Alveolar ventilation function,PROCESS_OF,Patients,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
tirofiban,ADMINISTERED_TO,Patients,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Continuous infusion,ADMINISTERED_TO,Patients,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
bolus infusion,ADMINISTERED_TO,Patients,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
antiplatelet therapy,CAUSES,Respiratory Failure,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Modulated,LOCATION_OF,Megakaryocytes,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Pulmonary capillary,LOCATION_OF,Blood Clot,32450314,10.1016/j.wneu.2020.05.150,2020-05-26
Coronavirus Infections,ISA,Disease,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Coronavirus Infections,ISA,Disease,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Neurosurgical Procedures,TREATS,Patients,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Tertiary Care Centers,LOCATION_OF,Study,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Disease,COEXISTS_WITH,patient condition,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Coronavirus Infections,COEXISTS_WITH(SPEC),patient condition,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Coronavirus Infections,ISA,Disease,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Operative Surgical Procedures,compared_with,Neurosurgical Procedures,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Neurosurgical department,LOCATION_OF,Knowledge acquisition,32450310,10.1016/j.wneu.2020.05.136,2020-05-26
Hospital admission,TREATS,Population Group,32450309,10.1016/j.wneu.2020.05.140,2020-05-26
Masks,USES,Mechanical Ventilator,32450255,10.1016/j.cmi.2020.05.009,2020-05-26
Face shield,USES,"Lights, manufactured",32450255,10.1016/j.cmi.2020.05.009,2020-05-26
Screening procedure,TREATS,Persons,32450255,10.1016/j.cmi.2020.05.009,2020-05-26
Cell Count,DIAGNOSES,Disease,32450246,10.1016/j.meegid.2020.104374,2020-05-26
Risk level,PROCESS_OF,Community,32450198,10.1016/j.ijantimicag.2020.106028,2020-05-26
Malaria,PROCESS_OF,Homo sapiens,32450197,10.1016/j.ijantimicag.2020.106024,2020-05-26
Hydroxychloroquine,TREATS,Severe Acute Respiratory Syndrome,32450197,10.1016/j.ijantimicag.2020.106024,2020-05-26
Lysosomes,LOCATION_OF,Hydroxychloroquine,32450197,10.1016/j.ijantimicag.2020.106024,2020-05-26
late endosome,LOCATION_OF,Hydroxychloroquine,32450197,10.1016/j.ijantimicag.2020.106024,2020-05-26
Fever,PROCESS_OF,Patients,32450171,10.1016/j.lfs.2020.117836,2020-05-26
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32450171,10.1016/j.lfs.2020.117836,2020-05-26
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32450171,10.1016/j.lfs.2020.117836,2020-05-26
Severe Acute Respiratory Syndrome,AFFECTS,Clinician,32450171,10.1016/j.lfs.2020.117836,2020-05-26
Prognosis bad,COEXISTS_WITH,Blood Coagulation Disorders,32450171,10.1016/j.lfs.2020.117836,2020-05-26
Prognosis bad,COEXISTS_WITH,Complication,32450171,10.1016/j.lfs.2020.117836,2020-05-26
Prognosis bad,COEXISTS_WITH,"Kidney Failure, Acute",32450171,10.1016/j.lfs.2020.117836,2020-05-26
SARS coronavirus,ISA,Genus: Coronavirus,32450166,10.1016/j.lfs.2020.117831,2020-05-26
Organ,LOCATION_OF,Comorbidity,32450107,10.1016/S0140-6736(20)31180-6,2020-05-26
Gastrointestinal dysfunction,PREDISPOSES,Hypertensive disease,32450107,10.1016/S0140-6736(20)31180-6,2020-05-26
SARS coronavirus,LOCATION_OF,Alkalies,32450107,10.1016/S0140-6736(20)31180-6,2020-05-26
Middle East Respiratory Syndrome Coronavirus,LOCATION_OF,Alkalies,32450107,10.1016/S0140-6736(20)31180-6,2020-05-26
Diagnosis,PRECEDES,Therapeutic procedure,32450106,10.1016/S0140-6736(20)31208-3,2020-05-26
Hydroxychloroquine,compared_with,Macrolides,32450106,10.1016/S0140-6736(20)31208-3,2020-05-26
Chloroquine,PREDISPOSES,Ventricular arrhythmia,32450106,10.1016/S0140-6736(20)31208-3,2020-05-26
Hydroxychloroquine,PREDISPOSES,Ventricular arrhythmia,32450106,10.1016/S0140-6736(20)31208-3,2020-05-26
Hydroxychloroquine,compared_with,Macrolides,32450106,10.1016/S0140-6736(20)31208-3,2020-05-26
"Vaccines, Recombinant",PRODUCES,Glycoproteins,32450049,10.1080/0142159X.2020.1766669,2020-05-26
Vaccination,TREATS,Well adult,32450049,10.1080/0142159X.2020.1766669,2020-05-26
Anxiety,AFFECTS,Coronavirus Infections,32449972,10.1002/jmv.26026,2020-05-26
Orthodontic procedure,TREATS,Patients,32449972,10.1002/jmv.26026,2020-05-26
Coinfection,PROCESS_OF,Patients,32449939,10.1002/1873-3468.13845,2020-05-26
Coughing,PROCESS_OF,Patients,32449939,10.1002/1873-3468.13845,2020-05-26
Myalgia,ISA,Symptoms,32449939,10.1002/1873-3468.13845,2020-05-26
Serum,LOCATION_OF,Ferritin,32449939,10.1002/1873-3468.13845,2020-05-26
Virus,PROCESS_OF,Population Group,32449876,10.1080/00325481.2020.1774179,2020-05-26
"Vitronectin, human",ISA,Glycoproteins,32449876,10.1080/00325481.2020.1774179,2020-05-26
Bacteria,PRODUCES,Binding Proteins,32449876,10.1080/00325481.2020.1774179,2020-05-26
Upper Respiratory Infections,PROCESS_OF,Population Group,32449876,10.1080/00325481.2020.1774179,2020-05-26
Upper respiratory tract,LOCATION_OF,Bacteria,32449876,10.1080/00325481.2020.1774179,2020-05-26
health hazards,INTERACTS_WITH,Smoke,32449850,10.1503/cjs.006120,2020-05-26
Carcinogens,COEXISTS_WITH,Smoke,32449850,10.1503/cjs.006120,2020-05-26
Alzheimer's Disease,PROCESS_OF,Persons,32449789,10.1002/jmv.26056,2020-05-26
Alzheimer's Disease,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Mild cognitive disorder,PROCESS_OF,Persons,32449789,10.1002/jmv.26056,2020-05-26
Mild cognitive disorder,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Diagnosis,AFFECTS,Mild cognitive disorder,32449789,10.1002/jmv.26056,2020-05-26
Evaluation,TREATS,Patients,32449789,10.1002/jmv.26056,2020-05-26
Symptoms,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Symptoms,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Alzheimer's Disease,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Anxiety,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Agitation,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Apathy,ISA,Symptoms,32449789,10.1002/jmv.26056,2020-05-26
Apathy,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Mild cognitive disorder,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Alzheimer's Disease,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Agitation,ISA,Symptoms,32449789,10.1002/jmv.26056,2020-05-26
Mild cognitive disorder,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Symptoms,PROCESS_OF,Patients,32449789,10.1002/jmv.26056,2020-05-26
Viral Shedding,PROCESS_OF,Patients,32449782,10.2340/16501977-2694,2020-05-26
Asymptomatic,PROCESS_OF,Patients,32449782,10.2340/16501977-2694,2020-05-26
Problem,PROCESS_OF,Patients,32449782,10.2340/16501977-2694,2020-05-26
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32449781,10.2340/00015555-3536,2020-05-26
Decreased exercise capacity,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32449781,10.2340/00015555-3536,2020-05-26
Decreased exercise capacity,COEXISTS_WITH,Middle East Respiratory Syndrome,32449781,10.2340/00015555-3536,2020-05-26
Middle East Respiratory Syndrome,PROCESS_OF,Survivors,32449781,10.2340/00015555-3536,2020-05-26
Clinician,TREATS,Survivors,32449781,10.2340/00015555-3536,2020-05-26
Pruritus,PROCESS_OF,Participant,32449770,10.1093/occmed/kqaa101,2020-05-26
Respondents,USES,Masks,32449770,10.1093/occmed/kqaa101,2020-05-26
Masks,TREATS,Pruritus,32449770,10.1093/occmed/kqaa101,2020-05-26
Coitus,ASSOCIATED_WITH,Symptoms,32449766,10.1093/jamia/ocaa105,2020-05-26
Perception,PROCESS_OF,Persons,32449766,10.1093/jamia/ocaa105,2020-05-26
Post-Traumatic Stress Disorder,ISA,Mental disorders,32449766,10.1093/jamia/ocaa105,2020-05-26
Screening procedure,TREATS,patient symptoms,32449757,10.1093/jnci/djaa079,2020-05-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32449754,10.1093/occmed/kqaa095,2020-05-26
Aging,PROCESS_OF,Patients,32449754,10.1093/occmed/kqaa095,2020-05-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32449754,10.1093/occmed/kqaa095,2020-05-26
Coronavirus Infections,ISA,Disease,32449663,10.1001/amajethics.2020.441,2020-05-26
Coronavirus Infections,ISA,Disease,32449663,10.1001/amajethics.2020.441,2020-05-26
Coronavirus Infections,ISA,Disease,32449614,10.4081/monaldi.2020.1389,2020-05-26
Coronavirus Infections,ISA,Disease,32449614,10.4081/monaldi.2020.1389,2020-05-26
China,ISA,Country,32449555,10.1002/eat.23303,2020-05-26
Pandemics,ISA,Disease Outbreaks,32449555,10.1002/eat.23303,2020-05-26
Infected,PROCESS_OF,Persons,32449555,10.1002/eat.23303,2020-05-26
Cessation of life,PROCESS_OF,Patients,32449555,10.1002/eat.23303,2020-05-26
Persons,LOCATION_OF,IMPACT gene,32449528,10.1002/mds.28170,2020-05-26
Eating Disorders,PROCESS_OF,Research Personnel,32449528,10.1002/mds.28170,2020-05-26
Telemedicine,ADMINISTERED_TO,therapist,32449420,10.1080/13685538.2020.1769058,2020-05-26
Coronavirus Infections,ISA,Disease,32449333,10.20452/pamw.15388,2020-05-26
Disease,PROCESS_OF,Patients,32449333,10.20452/pamw.15388,2020-05-26
Coronavirus Infections,ISA,Disease,32449333,10.20452/pamw.15388,2020-05-26
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32449333,10.20452/pamw.15388,2020-05-26
Attention,PROCESS_OF,Patients,32449333,10.20452/pamw.15388,2020-05-26
Disease,PROCESS_OF,Patients,32449333,10.20452/pamw.15388,2020-05-26
Coronavirus Infections,ISA,Disease,32449333,10.20452/pamw.15388,2020-05-26
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32449333,10.20452/pamw.15388,2020-05-26
Cell Count,USES,gamma-delta T-Cell Receptor,32449329,10.3346/jkms.2020.35.e195,2020-05-26
Lung,LOCATION_OF,Anti-Antibodies,32449329,10.3346/jkms.2020.35.e195,2020-05-26
High Level,PROCESS_OF,Patients,32449329,10.3346/jkms.2020.35.e195,2020-05-26
saliva,PART_OF,Patients,32449297,10.1002/adbi.202000105,2020-05-26
Sputum,PART_OF,Patients,32449297,10.1002/adbi.202000105,2020-05-26
Urine - SpecimenType,PART_OF,Patients,32449297,10.1002/adbi.202000105,2020-05-26
Oropharyngeal swab,PART_OF,Patients,32449297,10.1002/adbi.202000105,2020-05-26
Neurons,LOCATION_OF,Human virus,32449247,10.1111/ene.14359,2020-05-26
Neurons,PART_OF,Ganglia,32449247,10.1111/ene.14359,2020-05-26
Face,LOCATION_OF,Herpes zoster disease,32449247,10.1111/ene.14359,2020-05-26
Human herpesvirus 3,PROCESS_OF,Patients,32449247,10.1111/ene.14359,2020-05-26
latent infection,COEXISTS_WITH,inflammatory response,32449247,10.1111/ene.14359,2020-05-26
New medications,TREATS,Patients,32449224,10.1111/jcpt.13170,2020-05-26
Hydroxychloroquine,TREATS,Patients,32449224,10.1111/jcpt.13170,2020-05-26
Steroids,TREATS,Patients,32449224,10.1111/jcpt.13170,2020-05-26
lopinavir / Ritonavir,TREATS,Patients,32449224,10.1111/jcpt.13170,2020-05-26
tocilizumab,TREATS,Patients,32449224,10.1111/jcpt.13170,2020-05-26
Hospitals,LOCATION_OF,case series,32449188,10.1111/ajt.16074,2020-05-26
Myoglobin,compared_with,Troponin I,32449188,10.1111/ajt.16074,2020-05-26
Glucocorticoids,ISA,Immunologic Adjuvants,32449188,10.1111/ajt.16074,2020-05-26
Chronic disease,PROCESS_OF,dying patients,32449188,10.1111/ajt.16074,2020-05-26
Anti-Bacterial Agents,PREDISPOSES,Drug-Induced Liver Disease,32449188,10.1111/ajt.16074,2020-05-26
Psychological counseling,ADMINISTERED_TO,Patients,32449188,10.1111/ajt.16074,2020-05-26
France,ISA,Geographic Locations,32449187,10.1111/jan.14434,2020-05-26
Attitude,PROCESS_OF,Family,32449178,10.1111/aogs.13925,2020-05-26
Decision,PROCESS_OF,Maker (occupation),32449178,10.1111/aogs.13925,2020-05-26
Maternal distress,PROCESS_OF,prenatal,32449169,10.1111/trf.15910,2020-05-26
Distress,PROCESS_OF,prenatal,32449169,10.1111/trf.15910,2020-05-26
Antenatal clinic,LOCATION_OF,Study,32449169,10.1111/trf.15910,2020-05-26
Pregnant Women,ISA,Woman,32449169,10.1111/trf.15910,2020-05-26
Distress,PROCESS_OF,prenatal,32449169,10.1111/trf.15910,2020-05-26
Distress,PROCESS_OF,prenatal,32449169,10.1111/trf.15910,2020-05-26
Symptoms,PROCESS_OF,Pregnant Women,32449169,10.1111/trf.15910,2020-05-26
Partner in relationship,INTERACTS_WITH,Tissue Donors,32449141,10.1007/s40279-020-01295-8,2020-05-26
Hydroxychloroquine,AUGMENTS,Complication,32449100,10.1007/s10140-020-01792-3,2020-05-26
Azithromycin,AUGMENTS,Complication,32449100,10.1007/s10140-020-01792-3,2020-05-26
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32449099,10.1007/s10140-020-01787-0,2020-05-26
Disease,OCCURS_IN,Population Group,32449099,10.1007/s10140-020-01787-0,2020-05-26
interstitial,LOCATION_OF,Decreased translucency,32449057,10.1007/s00401-020-02166-2,2020-05-26
Central nervous system complication,PROCESS_OF,Patients,32449044,10.1007/s00264-020-04608-8,2020-05-26
Has difficulty doing (qualifier value),COEXISTS_WITH,Critical Illness,32449044,10.1007/s00264-020-04608-8,2020-05-26
Italy,ISA,Geographic Locations,32449034,10.1007/s13304-020-00818-2,2020-05-26
Coronavirus Infections,CAUSES,Influenza,32449021,10.1007/s00405-020-06066-9,2020-05-26
Hydroxychloroquine,INTERACTS_WITH,Acetic Acid,32449021,10.1007/s00405-020-06066-9,2020-05-26
Hydroxychloroquine,TREATS,Patients,32449021,10.1007/s00405-020-06066-9,2020-05-26
lopinavir / Ritonavir,INTERACTS_WITH,Acetic Acid,32449021,10.1007/s00405-020-06066-9,2020-05-26
Acetic Acid,TREATS,Patients,32449021,10.1007/s00405-020-06066-9,2020-05-26
Disinfection,USES,Acetic Acid,32449021,10.1007/s00405-020-06066-9,2020-05-26
Symptoms,PROCESS_OF,Persons,32449021,10.1007/s00405-020-06066-9,2020-05-26
Dysgeusia,PROCESS_OF,Households,32449007,10.1208/s12249-020-01718-9,2020-05-26
Symptoms,PROCESS_OF,Households,32449007,10.1208/s12249-020-01718-9,2020-05-26
Dysgeusia,PROCESS_OF,Patients,32449007,10.1208/s12249-020-01718-9,2020-05-26
Italy,ISA,Country,32448878,10.1701/3366.33409,2020-05-26
Homelessness,PROCESS_OF,Persons,32448878,10.1701/3366.33409,2020-05-26
Italy,ISA,Country,32448876,10.1701/3366.33407,2020-05-26
Homelessness,PROCESS_OF,Persons,32448876,10.1701/3366.33407,2020-05-26
Infection,PROCESS_OF,Prisoners,32448818,10.1620/tjem.251.27,2020-05-26
receptor,PART_OF,SARS coronavirus,32448805,10.1136/ijgc-2020-001523,2020-05-26
Endopeptidases,PART_OF,integral to membrane,32448805,10.1136/ijgc-2020-001523,2020-05-26
SARS coronavirus,CAUSES,Common Cold,32448805,10.1136/ijgc-2020-001523,2020-05-26
camostat,INTERACTS_WITH,Protease Inhibitors,32448805,10.1136/ijgc-2020-001523,2020-05-26
nafamostat,INTERACTS_WITH,Protease Inhibitors,32448805,10.1136/ijgc-2020-001523,2020-05-26
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32448805,10.1136/ijgc-2020-001523,2020-05-26
Interferons,ISA,Pharmaceutical Preparations,32448805,10.1136/ijgc-2020-001523,2020-05-26
Interferons,TREATS(SPEC),Severe Acute Respiratory Syndrome,32448805,10.1136/ijgc-2020-001523,2020-05-26
Ritonavir,INTERACTS_WITH,Interferons,32448805,10.1136/ijgc-2020-001523,2020-05-26
lopinavir,INTERACTS_WITH,Interferons,32448805,10.1136/ijgc-2020-001523,2020-05-26
favipiravir,INTERACTS_WITH,Interferons,32448805,10.1136/ijgc-2020-001523,2020-05-26
Protease Inhibitors,COEXISTS_WITH,Pharmaceutical Preparations,32448805,10.1136/ijgc-2020-001523,2020-05-26
Screening procedure,ADMINISTERED_TO,Nurses,32448770,10.1016/j.ejim.2020.05.011,2020-05-26
Screening procedure,ADMINISTERED_TO,Patients,32448770,10.1016/j.ejim.2020.05.011,2020-05-26
Interleukin 6 Receptor,INHIBITS,Interleukin-6,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
tocilizumab,INTERACTS_WITH(SPEC),Interleukin 6 Receptor,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
tocilizumab,ISA,"Antibodies, Monoclonal, Humanized",32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
"Antibodies, Monoclonal, Humanized",INTERACTS_WITH,Interleukin 6 Receptor,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
GSKIP gene,PART_OF,Patients,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
tocilizumab,TREATS,Pneumonia,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
tocilizumab,TREATS,Confirmation,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
IMPACT gene,AFFECTS,Fever,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
Critical Illness,PROCESS_OF,Patients,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32448761,10.1016/j.jviscsurg.2020.04.018,2020-05-26
Coronavirus Infections,ISA,Disease,32448757,10.1016/j.cpcardiol.2020.100620,2020-05-26
Minority Groups,ISA,Ethnic group,32448757,10.1016/j.cpcardiol.2020.100620,2020-05-26
Comorbidity,PROCESS_OF,Patients,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Cardiovascular,LOCATION_OF,Comorbidity,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Cardiovascular,LOCATION_OF,Diagnostic assessment,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Ambulatory Care Facilities,LOCATION_OF,Echocardiography,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Coronavirus Infections,ISA,Disease,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Echocardiography lab,LOCATION_OF,Echocardiography,32448749,10.1016/j.jsams.2020.05.016,2020-05-26
Exercise,ISA,Activities,32448674,10.1016/j.nrl.2020.05.002,2020-05-26
Ischemic stroke,PROCESS_OF,Patients,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Ischemic stroke,PROCESS_OF,Patients,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Adrenal Cortex,LOCATION_OF,Infarction,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Laboratory,LOCATION_OF,Analysis,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Cerebrovascular accident,PROCESS_OF,Patients,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Inflammation,CAUSES,Ischemic stroke,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Virus,CAUSES,endothelial dysfunction,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
endothelial dysfunction,CAUSES,Thrombophilia,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Cerebrovascular accident,PROCESS_OF,Patients,32448633,10.1016/j.semerg.2020.05.005,2020-05-26
Blood Vessel,LOCATION_OF,Lesion,32448590,10.1016/j.mayocp.2020.04.028,2020-05-26
Lesion,PROCESS_OF,Patients,32448590,10.1016/j.mayocp.2020.04.028,2020-05-26
Kidney,LOCATION_OF,Complication,32448590,10.1016/j.mayocp.2020.04.028,2020-05-26
Kidney Diseases,PROCESS_OF,Patients,32448590,10.1016/j.mayocp.2020.04.028,2020-05-26
Cardiovascular Diseases,PROCESS_OF,Population Group,32448590,10.1016/j.mayocp.2020.04.028,2020-05-26
Hypertrophic Cardiomyopathy,PROCESS_OF,Patients,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Hypertrophic Cardiomyopathy,PROCESS_OF,Patients,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Heart,PART_OF,Tissue Donors,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Heart tissue,LOCATION_OF,Flash,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
NUCLEAR RIBONUCLEIC ACID,PROCESS_OF,Patients,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Septal myectomy,TREATS,Patients,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Septal myectomy,TREATS(INFER),Hypertrophic Cardiomyopathy,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Hypertrophic Cardiomyopathy,PROCESS_OF,Patients,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Bioanalytical Validation Method,USES,Western Blotting,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Bioanalytical Validation Method,USES,Real-Time Polymerase Chain Reaction,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Genes,ASSOCIATED_WITH,Hypertrophic Cardiomyopathy,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
ACE2 gene,INTERACTS_WITH,Angiotensins,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Genes,ASSOCIATED_WITH,Hypertrophic Cardiomyopathy,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
ACE2 gene,STIMULATES,Genes,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Heart,LOCATION_OF,ACE2 gene,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Patients,LOCATION_OF,ACE2 gene,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
ACE2 gene,STIMULATES,Proteins,32448589,10.1016/j.mayocp.2020.04.030,2020-05-26
Masks,USES,Cardiopulmonary resuscitation mask,32448490,10.1016/j.arcmed.2020.04.022,2020-05-26
Disease Outbreaks,ISA,Process,32448391,10.1186/s12931-020-01385-1,2020-05-26
Fever,ISA,Symptoms,32448391,10.1186/s12931-020-01385-1,2020-05-26
Dry cough,ISA,Symptoms,32448391,10.1186/s12931-020-01385-1,2020-05-26
nitazoxanide,ISA,Pharmaceutical Preparations,32448391,10.1186/s12931-020-01385-1,2020-05-26
Pneumonia,PROCESS_OF,Patients,32448345,10.1186/s13063-020-04352-9,2020-05-26
Chest CT,ADMINISTERED_TO,Patients,32448345,10.1186/s13063-020-04352-9,2020-05-26
distilled alcoholic beverage,ISA,Entity,32448333,10.1186/s13017-020-00314-3,2020-05-26
Infected,PROCESS_OF,Surgeon,32448323,10.1186/s13052-020-00833-4,2020-05-26
Asymptomatic,PROCESS_OF,Physicians,32448323,10.1186/s13052-020-00833-4,2020-05-26
Chronic lung disease,PROCESS_OF,Child,32448136,10.1186/s12880-020-00456-5,2020-05-26
Coronavirus Infections,CAUSES,Communicable Diseases,32448124,10.1186/s12859-020-3537-3,2020-05-26
Lymphopenia,PROCESS_OF,Patients,32448124,10.1186/s12859-020-3537-3,2020-05-26
low white blood cell count,PROCESS_OF,Patients,32448124,10.1186/s12859-020-3537-3,2020-05-26
Peripheral Blood Lymphocyte,LOCATION_OF,Apoptosis,32448124,10.1186/s12859-020-3537-3,2020-05-26
Pandemics,ISA,Disease Outbreaks,32448085,10.1080/07391102.2020.1772885,2020-05-26
Vaccines,NEG_TREATS,Disease,32448084,10.1080/22221751.2020.1772679,2020-05-26
"Vitronectin, human",COEXISTS_WITH,Water,32448084,10.1080/22221751.2020.1772679,2020-05-26
Pharmaceutical Preparations,AFFECTS,Virus Replication,32448084,10.1080/22221751.2020.1772679,2020-05-26
Ivermectin,AFFECTS(SPEC),Virus Replication,32448084,10.1080/22221751.2020.1772679,2020-05-26
Ivermectin,ISA,Pharmaceutical Preparations,32448084,10.1080/22221751.2020.1772679,2020-05-26
Real-Time Polymerase Chain Reaction,METHOD_OF,Prophylactic treatment,32448041,10.1080/07391102.2020.1772110,2020-05-26
Secondary Infections,AFFECTS,Enthesitis-Related Arthritis,32448039,10.1080/07391102.2020.1772111,2020-05-26
Bacterial Infections,PROCESS_OF,Patients,32448039,10.1080/07391102.2020.1772111,2020-05-26
"CD69 protein, human",PREDISPOSES,Bacterial Infections,32448039,10.1080/07391102.2020.1772111,2020-05-26
Pharmaceutical Preparations,NEG_TREATS,Disease,32448036,10.1177/1048291120929763,2020-05-26
Chloroquine,TREATS,Disease,32448036,10.1177/1048291120929763,2020-05-26
Coronavirus Infections,ISA,Disease,32447949,10.4081/monaldi.2020.1325,2020-05-26
Vulnerable Populations,ISA,Persons,32447949,10.4081/monaldi.2020.1325,2020-05-26
compromise,PROCESS_OF,Persons,32447949,10.4081/monaldi.2020.1325,2020-05-26
Tuberculosis,PROCESS_OF,Persons,32447949,10.4081/monaldi.2020.1325,2020-05-26
Disease,PROCESS_OF,Homo sapiens,32447949,10.4081/monaldi.2020.1325,2020-05-26
Tuberculosis,ISA,Disease,32447949,10.4081/monaldi.2020.1325,2020-05-26
Tuberculosis,PROCESS_OF(SPEC),Homo sapiens,32447949,10.4081/monaldi.2020.1325,2020-05-26
Pneumonia,PROCESS_OF,Patients,32447801,10.1111/dth.13666,2020-05-25
Coronavirus Infections,ISA,Disease,32447801,10.1111/dth.13666,2020-05-25
Antimalarials,TREATS,Disease,32447801,10.1111/dth.13666,2020-05-25
Antimalarials,TREATS(SPEC),Coronavirus Infections,32447801,10.1111/dth.13666,2020-05-25
Coronavirus Infections,ISA,Disease,32447801,10.1111/dth.13666,2020-05-25
Coronavirus Infections,ISA,Disease,32447801,10.1111/dth.13666,2020-05-25
Skin Manifestations,PROCESS_OF,Patients,32447777,10.1111/scd.12472,2020-05-25
Chickenpox,PRECEDES,Dormancy,32447777,10.1111/scd.12472,2020-05-25
"Ganglia, Spinal",PART_OF,Nerve,32447777,10.1111/scd.12472,2020-05-25
Dormancy,PROCESS_OF,"Ganglia, Spinal",32447777,10.1111/scd.12472,2020-05-25
varicella zoster,CAUSES,"Skin Diseases, Viral",32447777,10.1111/scd.12472,2020-05-25
Movement,PROCESS_OF,Population Group,32447746,10.1007/s11481-020-09924-9,2020-05-25
Ataxia,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Cerebrovascular Disorders,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Confusion,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Dizziness,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Respiration Disorders,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Seizures,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Myalgia,PROCESS_OF,Persons,32447742,10.1007/s10620-020-06362-8,2020-05-25
Symptoms,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32447742,10.1007/s10620-020-06362-8,2020-05-25
Neurologic Symptoms,PROCESS_OF,Patients,32447742,10.1007/s10620-020-06362-8,2020-05-25
Infected,PROCESS_OF,Homo sapiens,32447721,10.1007/s12072-020-10054-w,2020-05-25
EHD1 wt Allele,PART_OF,Homo sapiens,32447721,10.1007/s12072-020-10054-w,2020-05-25
Fever,ISA,Symptoms,32447721,10.1007/s12072-020-10054-w,2020-05-25
Lung,LOCATION_OF,Symptoms,32447721,10.1007/s12072-020-10054-w,2020-05-25
Gastrointestinal symptom,PROCESS_OF,Patients,32447721,10.1007/s12072-020-10054-w,2020-05-25
patient condition,COEXISTS_WITH,Gastrointestinal symptom,32447721,10.1007/s12072-020-10054-w,2020-05-25
"M Protein, multiple myeloma",PART_OF,Virus,32447629,10.1007/s40122-020-00173-5,2020-05-25
Headache,ISA,nervous system disorder,32447629,10.1007/s40122-020-00173-5,2020-05-25
Myalgia,ISA,nervous system disorder,32447629,10.1007/s40122-020-00173-5,2020-05-25
Critical Illness,CAUSES,Complication,32447629,10.1007/s40122-020-00173-5,2020-05-25
Ibuprofen,ISA,"Anti-Inflammatory Agents, Non-Steroidal",32447603,10.1007/s10067-020-05176-3,2020-05-25
Symptoms,ASSOCIATED_WITH,Disease,32447603,10.1007/s10067-020-05176-3,2020-05-25
"Drugs, Non-Prescription",ISA,Pharmaceutical Preparations,32447603,10.1007/s10067-020-05176-3,2020-05-25
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32447603,10.1007/s10067-020-05176-3,2020-05-25
Collagen Diseases,PROCESS_OF,Patients,32447571,10.1007/s10930-020-09901-4,2020-05-25
High Level,PROCESS_OF,Patients,32447571,10.1007/s10930-020-09901-4,2020-05-25
Universities,ISA,Academia (organization),32447571,10.1007/s10930-020-09901-4,2020-05-25
Epitopes,PART_OF,Virus,32447505,10.1007/s00467-020-04617-0,2020-05-25
Immune Globulin (Human),INTERACTS_WITH,Epitopes,32447505,10.1007/s00467-020-04617-0,2020-05-25
Myalgia,PROCESS_OF,Adult,32447496,10.1007/s00405-020-06069-6,2020-05-25
Symptoms,PROCESS_OF,Child,32447496,10.1007/s00405-020-06069-6,2020-05-25
Rhabdomyolysis,PROCESS_OF,Adult,32447496,10.1007/s00405-020-06069-6,2020-05-25
Fever,PROCESS_OF,Boys,32447496,10.1007/s00405-020-06069-6,2020-05-25
Serum,LOCATION_OF,Creatinine,32447496,10.1007/s00405-020-06069-6,2020-05-25
Serum,LOCATION_OF,Creatinine,32447496,10.1007/s00405-020-06069-6,2020-05-25
Creatinine concentration in urine above normal,PROCESS_OF,Patients,32447496,10.1007/s00405-020-06069-6,2020-05-25
Rhabdomyolysis,ISA,Complication,32447496,10.1007/s00405-020-06069-6,2020-05-25
Ageusia,ISA,Symptoms,32447443,10.1007/s00345-020-03264-2,2020-05-25
Anosmia,PROCESS_OF,Patients,32447443,10.1007/s00345-020-03264-2,2020-05-25
Anosmia,PROCESS_OF,Patients,32447443,10.1007/s00345-020-03264-2,2020-05-25
Virus Diseases,PROCESS_OF,Patients,32447443,10.1007/s00345-020-03264-2,2020-05-25
Anosmia,PROCESS_OF,Patients,32447443,10.1007/s00345-020-03264-2,2020-05-25
Respiratory Tract Infections,PROCESS_OF,Patients,32447443,10.1007/s00345-020-03264-2,2020-05-25
Italy,ISA,Country,32447441,10.1007/s00345-020-03262-4,2020-05-25
Therapeutic procedure,TREATS,Patients,32447373,10.1093/jamia/ocaa045,2020-05-25
Symptom mild,PROCESS_OF,Patients,32447328,10.1515/cclm-2020-0594,2020-05-25
Social Networks,USES,Bone Wires,32447328,10.1515/cclm-2020-0594,2020-05-25
Enzyme-Linked Immunosorbent Assay,ISA,Laboratory Procedures,32447292,10.1136/rapm-2020-101653,2020-05-25
Laboratory Procedures,USES,Enzyme-Linked Immunosorbent Assay,32447292,10.1136/rapm-2020-101653,2020-05-25
Serum,PART_OF,Patients,32447292,10.1136/rapm-2020-101653,2020-05-25
Peripheral block anesthesia,TREATS,Patients,32447283,10.9778/cmajo.20200069,2020-05-25
Program,TREATS,Patients,32447256,10.1016/j.jcv.2020.104436,2020-05-25
Evaluation procedure,TREATS,Outpatients,32447256,10.1016/j.jcv.2020.104436,2020-05-25
Respiratory viruses,CAUSES,Coinfection,32447232,10.1016/j.mehy.2020.109827,2020-05-25
"Signs and Symptoms, Respiratory",PROCESS_OF,inpatient,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Patient in hospital,PROCESS_OF,inpatient,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Viral respiratory infection,PROCESS_OF,inpatient,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Coinfection,PROCESS_OF,Patients,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Mild disorder,PROCESS_OF,Patients,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Respiratory viruses,PROCESS_OF,Patients,32447232,10.1016/j.mehy.2020.109827,2020-05-25
Pneumonia,ISA,Communicable Diseases,32447193,10.1016/j.jns.2020.116923,2020-05-25
Coronavirus Infections,PROCESS_OF,Family,32447193,10.1016/j.jns.2020.116923,2020-05-25
Acute respiratory infections,ISA,Communicable Diseases,32447193,10.1016/j.jns.2020.116923,2020-05-25
Confirmation,PROCESS_OF,Patients,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
Confirmation,PROCESS_OF(SPEC),hospitalized patients,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
hospitalized patients,ISA,Patients,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
Scientific Study,METHOD_OF,Neuroimaging,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
Acute Cerebrovascular Accidents,PROCESS_OF,hospitalized patients,32447172,10.1016/j.drugalcdep.2020.108047,2020-05-25
Overdose,PROCESS_OF,Persons,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Overdose,PROCESS_OF,Persons,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Overdose,PROCESS_OF,Cohort,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Chronic disease,PROCESS_OF,Persons,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Overdose,PROCESS_OF,Persons,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Reflecting,PROCESS_OF,Persons,32447153,10.1016/j.prevetmed.2020.105030,2020-05-25
Animal Diseases,AFFECTS,Disease,32447121,10.1016/j.ijid.2020.05.060,2020-05-25
Coronavirus Infections,PROCESS_OF,Animals,32447121,10.1016/j.ijid.2020.05.060,2020-05-25
Thromboembolism,PROCESS_OF,Patients,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
Lower limb ischemia,PROCESS_OF,Patients,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
Intravenous infusion procedures,USES,heparin,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
Embolectomy,ISA,Operative Surgical Procedures,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
Embolectomy,METHOD_OF,Recanalization,32447102,10.1016/j.diabet.2020.05.005,2020-05-25
tocilizumab,INHIBITS,Interleukin 6 Receptor,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Disease Progression,NEG_PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Communicable Diseases,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Diabetes,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Blood glucose normal,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Diabetes,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Blood glucose normal,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Blood glucose normal,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
High Level,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Blood glucose normal,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS(INFER),Blood glucose normal,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS,Hyperglycemia,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS,diabetic,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
tocilizumab,TREATS,diabetic,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Interested,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Interested,PROCESS_OF,Patients,32447101,10.1016/j.diabet.2020.05.008,2020-05-25
Diabetes,PROCESS_OF,Patients,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Diabetes,PROCESS_OF,Population Group,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Increased body mass index,PREDISPOSES,Severe (severity modifier),32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Present,PREDISPOSES,Comorbidity,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Present,PREDISPOSES,inflammatory response,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Cessation of life,PROCESS_OF,hospitalized patients,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Diabetes,PROCESS_OF,hospitalized patients,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Poor outcome,COEXISTS_WITH,Hyperglycemia,32447070,10.1016/j.scitotenv.2020.139542,2020-05-25
Rome,ISA,Cities,32447060,10.1016/j.cjca.2020.05.023,2020-05-25
Coronavirus Infections,ISA,Disease,32447060,10.1016/j.cjca.2020.05.023,2020-05-25
Italians,ISA,Population Group,32447059,10.1016/j.cjca.2020.05.024,2020-05-25
Acute Chest Syndrome,PROCESS_OF,Patients,32447059,10.1016/j.cjca.2020.05.024,2020-05-25
Acute Coronary Syndrome,PROCESS_OF,Patients,32447059,10.1016/j.cjca.2020.05.024,2020-05-25
Hospitalization,TREATS,Acute Chest Syndrome,32447059,10.1016/j.cjca.2020.05.024,2020-05-25
Acute Chest Syndrome,AFFECTS,Patients,32447059,10.1016/j.cjca.2020.05.024,2020-05-25
anticipation,PROCESS_OF,Patients,32447019,10.1016/j.cgh.2020.05.030,2020-05-25
Heart,LOCATION_OF,Scheduled surgical procedure,32447019,10.1016/j.cgh.2020.05.030,2020-05-25
Cardiovascular Diseases,PROCESS_OF,Patients,32447019,10.1016/j.cgh.2020.05.030,2020-05-25
Coronary Arteriosclerosis,AFFECTS,Growth,32447019,10.1016/j.cgh.2020.05.030,2020-05-25
Heart valve disease,AFFECTS,Growth,32447019,10.1016/j.cgh.2020.05.030,2020-05-25
Lung,LOCATION_OF,Heparin-induced thrombocytopenia,32447002,10.1016/j.ijsu.2020.05.042,2020-05-25
Readiness,PROCESS_OF,Health Personnel,32447001,10.1016/j.ijsu.2020.05.051,2020-05-25
Elective procedure,TREATS,Patients,32446982,10.1016/j.wneu.2020.05.126,2020-05-25
Cessation of life,PROCESS_OF,Patients,32446902,10.1016/j.micinf.2020.05.013,2020-05-25
Cessation of life,ASSOCIATED_WITH,Disease,32446902,10.1016/j.micinf.2020.05.013,2020-05-25
Cessation of life,ASSOCIATED_WITH,Obesity,32446902,10.1016/j.micinf.2020.05.013,2020-05-25
Cessation of life,ASSOCIATED_WITH,Obesity,32446902,10.1016/j.micinf.2020.05.013,2020-05-25
Cessation of life,PROCESS_OF,Patients,32446902,10.1016/j.micinf.2020.05.013,2020-05-25
"Gene Products, env",PART_OF,Genus: Coronavirus,32446866,10.1016/j.jtos.2020.05.011,2020-05-25
Homologous Protein,PART_OF,Genus: Coronavirus,32446866,10.1016/j.jtos.2020.05.011,2020-05-25
Epitopes,COEXISTS_WITH,"Gene Products, env",32446866,10.1016/j.jtos.2020.05.011,2020-05-25
Genus: Coronavirus,INTERACTS_WITH,Severe Acute Respiratory Syndrome,32446866,10.1016/j.jtos.2020.05.011,2020-05-25
Tropism,PROCESS_OF,Eye,32446813,10.1016/j.joim.2020.04.001,2020-05-25
disease transmission,COEXISTS_WITH,Influenza,32446813,10.1016/j.joim.2020.04.001,2020-05-25
disease transmission,COEXISTS_WITH,Crisis,32446813,10.1016/j.joim.2020.04.001,2020-05-25
angiotensin converting enzyme 2,PART_OF,conjunctiva,32446813,10.1016/j.joim.2020.04.001,2020-05-25
Tropism,PROCESS_OF,Eye,32446813,10.1016/j.joim.2020.04.001,2020-05-25
systemic administration,AFFECTS,Virus Attachment,32446813,10.1016/j.joim.2020.04.001,2020-05-25
Eye,LOCATION_OF,Hydroxychloroquine,32446813,10.1016/j.joim.2020.04.001,2020-05-25
Eye,LOCATION_OF,Zinc,32446813,10.1016/j.joim.2020.04.001,2020-05-25
Eye,LOCATION_OF,Azithromycin,32446813,10.1016/j.joim.2020.04.001,2020-05-25
Disease,PROCESS_OF,Patients,32446798,10.1016/j.diabres.2020.108229,2020-05-25
Pandemics,CAUSES,Diabetes,32446798,10.1016/j.diabres.2020.108229,2020-05-25
Pandemics,CAUSES,Hypertensive disease,32446798,10.1016/j.diabres.2020.108229,2020-05-25
Pandemics,CAUSES,Obesity,32446798,10.1016/j.diabres.2020.108229,2020-05-25
diabetic,PROCESS_OF,Patients,32446798,10.1016/j.diabres.2020.108229,2020-05-25
Diabetes,PROCESS_OF,Patients,32446798,10.1016/j.diabres.2020.108229,2020-05-25
Diabetes,PROCESS_OF,Patients,32446795,10.1016/j.diabres.2020.108227,2020-05-25
Diabetes,PROCESS_OF,Patients,32446795,10.1016/j.diabres.2020.108227,2020-05-25
Hospitalization,TREATS,Patients,32446795,10.1016/j.diabres.2020.108227,2020-05-25
Hospitalization,TREATS,Patients,32446795,10.1016/j.diabres.2020.108227,2020-05-25
Hospitalization,TREATS(INFER),Diabetes,32446795,10.1016/j.diabres.2020.108227,2020-05-25
Coronavirus Infections,ISA,Disease,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Disease,PROCESS_OF,hospitalized patients,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,ISA,Disease,32446793,10.1016/j.rec.2020.05.001,2020-05-25
GSKIP gene,ASSOCIATED_WITH,Diabetes,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Poor outcome,COEXISTS_WITH,Diabetes,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,ISA,Disease,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Diabetes,PROCESS_OF,Patients,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Serum,LOCATION_OF,Creatinine,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Disease,CAUSES,Diabetes,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Disease,PROCESS_OF,Patients,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,CAUSES(SPEC),Diabetes,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,ISA,Disease,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,ISA,Disease,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32446793,10.1016/j.rec.2020.05.001,2020-05-25
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32446793,10.1016/j.rec.2020.05.001,2020-05-25
Cessation of life,PROCESS_OF,Old age,32446778,10.1016/j.cytogfr.2020.05.003,2020-05-25
Cardiovascular Diseases,AFFECTS,Immune response,32446778,10.1016/j.cytogfr.2020.05.003,2020-05-25
Inflammation,AFFECTS,inflammatory response,32446722,10.1016/j.jhin.2020.05.025,2020-05-25
chemokine,INTERACTS_WITH,Immune Cell,32446722,10.1016/j.jhin.2020.05.025,2020-05-25
chemokine receptor,AFFECTS,Storm NOS,32446722,10.1016/j.jhin.2020.05.025,2020-05-25
Storm NOS,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32446722,10.1016/j.jhin.2020.05.025,2020-05-25
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32446721,10.1016/j.jhin.2020.05.027,2020-05-25
Household composition,PROCESS_OF,Persons,32446652,10.1016/j.sapharm.2020.05.017,2020-05-25
Mental disorders,AFFECTS,Patients,32446652,10.1016/j.sapharm.2020.05.017,2020-05-25
Pharyngitis,CAUSES,"Respiratory Distress Syndrome, Adult",32446595,10.1016/j.gaceta.2020.04.009,2020-05-25
SARS coronavirus,PROCESS_OF,Community,32446594,10.1016/j.gaceta.2020.04.008,2020-05-25
Disease,AFFECTS,Cessation of life,32446594,10.1016/j.gaceta.2020.04.008,2020-05-25
Infection,PROCESS_OF,Woman,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Cessation of life,ASSOCIATED_WITH,Signs and Symptoms,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Cessation of life,PROCESS_OF,Male population group,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Cessation of life,PROCESS_OF,Woman,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Cessation of life,PROCESS_OF,hospitalized patients,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Coitus,AFFECTS,Woman,32446559,10.1016/j.bbrc.2020.05.008,2020-05-25
Therapeutic procedure,TREATS,Virus Diseases,32446312,10.4269/ajtmh.20-0375,2020-05-25
Diabetes,PROCESS_OF,hospitalized patients,32446311,10.1186/s13063-020-04383-2,2020-05-25
diabetic,PROCESS_OF,hospitalized patients,32446311,10.1186/s13063-020-04383-2,2020-05-25
Therapeutic procedure,TREATS,Patients,32446311,10.1186/s13063-020-04383-2,2020-05-25
Conventional Treatment,TREATS,Patients,32446305,10.1186/s12941-020-00363-1,2020-05-25
Tuberculosis,CAUSES,Cessation of life,32446287,10.1002/phar.2429,2020-05-24
Tuberculosis,PROCESS_OF,Patients,32446287,10.1002/phar.2429,2020-05-24
Comorbidity,PROCESS_OF,Patients,32446287,10.1002/phar.2429,2020-05-24
Tuberculosis,PROCESS_OF,Patients,32446287,10.1002/phar.2429,2020-05-24
Tuberculosis,PROCESS_OF,Patients,32446287,10.1002/phar.2429,2020-05-24
Tuberculosis,PROCESS_OF,Child,32446287,10.1002/phar.2429,2020-05-24
triphosphate,INTERACTS_WITH,"RNA, Viral",32446285,10.1111/febs.15375,2020-05-24
Fever,PROCESS_OF,Persons,32446267,10.1111/ctr.13991,2020-05-24
Pneumonia,PROCESS_OF,Persons,32446267,10.1111/ctr.13991,2020-05-24
Virus,CAUSES,Severe Acute Respiratory Syndrome,32446267,10.1111/ctr.13991,2020-05-24
Severe Acute Respiratory Syndrome,ISA,Disease,32446267,10.1111/ctr.13991,2020-05-24
Pharmaceutical Preparations,TREATS,Possible,32446267,10.1111/ctr.13991,2020-05-24
Vaccines,TREATS,Virus,32446267,10.1111/ctr.13991,2020-05-24
angiotensin converting enzyme 2,ADMINISTERED_TO,Leptocyte,32446187,10.1016/j.epidem.2020.100392,2020-05-24
Discontinued,PROCESS_OF,Recipient,32446187,10.1016/j.epidem.2020.100392,2020-05-24
"Hospitals, Pediatric",LOCATION_OF,Study,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
"Hospitals, Pediatric",ISA,Hospitals,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
Pneumonia,PROCESS_OF,Child,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
Pneumonia,PROCESS_OF,Patients,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
arbidol,ADMINISTERED_TO,Patients,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
Antiviral Therapy,TREATS,Child,32446037,10.1016/j.cmpb.2020.105532,2020-05-24
Health Care Systems,LOCATION_OF,Early Diagnosis,32445956,10.1016/j.phrs.2020.104939,2020-05-24
Diagnosis,DIAGNOSES,Pneumonia,32445956,10.1016/j.phrs.2020.104939,2020-05-24
Pathogenic organism,CAUSES,Pneumonia,32445956,10.1016/j.phrs.2020.104939,2020-05-24
Pathogenic organism,CAUSES,Pneumonia,32445956,10.1016/j.phrs.2020.104939,2020-05-24
Organ,LOCATION_OF,Protection,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
Quercetin,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
3-methylquercetin,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
baicalein,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
kaempferol,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
Luteolin,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
naringenin,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
wogonin,AFFECTS,Immunity,32445935,10.1016/j.jbspin.2020.05.003,2020-05-24
Laboratory Procedures,USES,Buccal smear procedure,32445924,10.1016/j.gene.2020.144792,2020-05-24
Buccal smear procedure,ISA,Laboratory Procedures,32445924,10.1016/j.gene.2020.144792,2020-05-24
Therapeutic procedure,USES,Antibodies,32445881,10.1016/j.micinf.2020.05.012,2020-05-24
Viral Proteins,PART_OF,Glycoproteins,32445881,10.1016/j.micinf.2020.05.012,2020-05-24
Pneumonia,PROCESS_OF,Patients,32445875,10.1016/j.jviromet.2020.113888,2020-05-24
arbidol,ADMINISTERED_TO,Patients,32445875,10.1016/j.jviromet.2020.113888,2020-05-24
Leukocytes,PART_OF,Patients,32445875,10.1016/j.jviromet.2020.113888,2020-05-24
Lymphopenia,PROCESS_OF,Patients,32445875,10.1016/j.jviromet.2020.113888,2020-05-24
Ribosomal RNA,PART_OF,Homo sapiens,32445872,10.1016/j.virusres.2020.198034,2020-05-24
Epithelial Cells,PART_OF,Body tissue,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
angiotensin converting enzyme 2,INTERACTS_WITH,Epithelial Cells,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Renal Insufficiency,PROCESS_OF,hospitalized patients,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Renal Insufficiency,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Down-Regulation,PROCESS_OF,Renal Tissue,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
receptor expression,PROCESS_OF,angiotensin converting enzyme 2,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Membrane receptor,AFFECTS,Kidney,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Diabetes,PROCESS_OF,Patients,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Hypertensive disease,PROCESS_OF,Patients,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Kidney Diseases,PROCESS_OF,Patients,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Dietary sodium intake,PROCESS_OF,Patients,32445839,10.1016/j.jaci.2020.05.012,2020-05-24
Laboratory Procedures,DIAGNOSES,Present,32445829,10.1016/j.scitotenv.2020.139541,2020-05-24
Serologic tests,USES,Basis,32445829,10.1016/j.scitotenv.2020.139541,2020-05-24
"Hospitals, University",LOCATION_OF,Study,32445773,10.1016/j.jhin.2020.05.023,2020-05-24
Possible,PROCESS_OF,Patients,32445710,10.1016/S1473-3099(20)30361-3,2020-05-24
Confirmation,PROCESS_OF,Patients,32445710,10.1016/S1473-3099(20)30361-3,2020-05-24
Health Personnel,USES,Mechanical Ventilator,32445710,10.1016/S1473-3099(20)30361-3,2020-05-24
Hospitals,LOCATION_OF,Laboratory Procedures,32445710,10.1016/S1473-3099(20)30361-3,2020-05-24
Quarantine,compared_with,Active monitoring,32445697,10.1016/j.ijid.2020.05.059,2020-05-24
Chilblains,PROCESS_OF,Child,32445581,10.1111/anae.15147,2020-05-24
Chilblains,PROCESS_OF,Adolescent (age group),32445581,10.1111/anae.15147,2020-05-24
Epithelial Cells,LOCATION_OF,Immunohistochemistry,32445581,10.1111/anae.15147,2020-05-24
Epithelial Cells,PART_OF,Eccrine Glands,32445581,10.1111/anae.15147,2020-05-24
Endothelial Cells,LOCATION_OF,Immunohistochemistry,32445581,10.1111/anae.15147,2020-05-24
Endothelial Cells,PART_OF,Eccrine Glands,32445581,10.1111/anae.15147,2020-05-24
Disease,COEXISTS_WITH,Virus,32445581,10.1111/anae.15147,2020-05-24
Clinician,USES,regulatory,32445580,10.1093/cid/ciaa631,2020-05-24
Challenge,TREATS,Clinician,32445580,10.1093/cid/ciaa631,2020-05-24
Respiratory sample,PART_OF,Tract,32445579,10.1093/cid/ciaa641,2020-05-24
Elevated C-reactive protein level,PROCESS_OF,Patients,32445573,10.1093/ndt/gfaa112,2020-05-24
Patients,LOCATION_OF,C-reactive protein,32445573,10.1093/ndt/gfaa112,2020-05-24
procalcitonin,compared_with,Fibrin fragment D,32445573,10.1093/ndt/gfaa112,2020-05-24
Forecast of outcome,TREATS,Patients,32445573,10.1093/ndt/gfaa112,2020-05-24
Kidney Diseases,PROCESS_OF,Patients,32445512,10.1002/oby.22913,2020-05-24
Infected,PROCESS_OF,Patients,32445512,10.1002/oby.22913,2020-05-24
Dialysis procedure,TREATS,Patients,32445512,10.1002/oby.22913,2020-05-24
Dialysis procedure,TREATS(INFER),Kidney Diseases,32445512,10.1002/oby.22913,2020-05-24
Kidney Diseases,PROCESS_OF,Patients,32445512,10.1002/oby.22913,2020-05-24
Transplantation,TREATS,Patients,32445512,10.1002/oby.22913,2020-05-24
Transplantation,TREATS(INFER),Kidney Diseases,32445512,10.1002/oby.22913,2020-05-24
Complication,PROCESS_OF,Patients,32445512,10.1002/oby.22913,2020-05-24
Kidney Diseases,PROCESS_OF,Patients,32445512,10.1002/oby.22913,2020-05-24
risk factors,PROCESS_OF,hospitalized patients,32445496,10.1002/oby.22914,2020-05-24
Obesity,COEXISTS_WITH,Complication,32445489,10.1002/jmv.26055,2020-05-24
High Level,PROCESS_OF,Patients,32445484,10.1002/cpt.1922,2020-05-24
Therapeutic procedure,TREATS,Toxic Epidermal Necrolysis,32445440,10.1056/NEJMoa2007764,2020-05-24
Subgroup A Nepoviruses,PROCESS_OF,Patients,32445440,10.1056/NEJMoa2007764,2020-05-24
developers,USES,Pharmaceutical Preparations,32445440,10.1056/NEJMoa2007764,2020-05-24
Placebos,ADMINISTERED_TO,Patients,32445421,10.1111/jce.14579,2020-05-24
Serious Adverse Event,PROCESS_OF,Adult,32445421,10.1111/jce.14579,2020-05-24
Communicable Diseases,PROCESS_OF,Patients,32445417,10.1111/trf.15869,2020-05-24
cytokine,AUGMENTS,patient condition,32445330,10.4103/ijc.IJC_343_20,2020-05-24
Proteins,INTERACTS_WITH,"Receptors, Pattern Recognition",32445330,10.4103/ijc.IJC_343_20,2020-05-24
RNA,INTERACTS_WITH,"Receptors, Pattern Recognition",32445330,10.4103/ijc.IJC_343_20,2020-05-24
Immune response,AFFECTS,Virus Replication,32445330,10.4103/ijc.IJC_343_20,2020-05-24
Prophylactic treatment,USES,BARRIER,32445315,10.4103/ijc.IJC_356_20,2020-05-24
Has difficulty doing (qualifier value),PROCESS_OF,World,32445315,10.4103/ijc.IJC_356_20,2020-05-24
Renal Cell Carcinoma,PROCESS_OF,Patients,32445288,10.1111/jebm.12388,2020-05-24
Muscle,LOCATION_OF,"Carcinoma of urinary bladder, invasive",32445288,10.1111/jebm.12388,2020-05-24
Muscle,NEG_LOCATION_OF,"Carcinoma of urinary bladder, invasive",32445288,10.1111/jebm.12388,2020-05-24
Muscle,NEG_LOCATION_OF,"Carcinoma of urinary bladder, invasive",32445288,10.1111/jebm.12388,2020-05-24
High-Risk Cancer,PROCESS_OF,Patients,32445288,10.1111/jebm.12388,2020-05-24
Testicular Neoplasms,PROCESS_OF,Patients,32445288,10.1111/jebm.12388,2020-05-24
Inguinal Orchiectomy,TREATS,Patients,32445288,10.1111/jebm.12388,2020-05-24
Inguinal Orchiectomy,TREATS(INFER),Testicular Neoplasms,32445288,10.1111/jebm.12388,2020-05-24
Amputation of penis,TREATS,Malignant neoplasm of penis,32445288,10.1111/jebm.12388,2020-05-24
Participant,ISA,Persons,32445287,10.1111/jebm.12387,2020-05-24
Engaged to be married,PROCESS_OF,Community,32445276,10.1111/jocs.14643,2020-05-24
Coronavirus Infections,ISA,Disease,32445276,10.1111/jocs.14643,2020-05-24
Challenge,COEXISTS_WITH,Prophylactic treatment,32445276,10.1111/jocs.14643,2020-05-24
Joints,LOCATION_OF,Engaged to be married,32445276,10.1111/jocs.14643,2020-05-24
Engaged to be married,PROCESS_OF,Community,32445276,10.1111/jocs.14643,2020-05-24
Aorta,LOCATION_OF,Prosthetic valve,32445249,10.1002/hed.26275,2020-05-24
Prosthetic valve,TREATS,consideration,32445249,10.1002/hed.26275,2020-05-24
skill,PROCESS_OF,Internist,32445134,10.1007/s40123-020-00260-y,2020-05-24
Fever,PROCESS_OF,Patients,32445134,10.1007/s40123-020-00260-y,2020-05-24
Influenza-like symptoms,PROCESS_OF,Patients,32445134,10.1007/s40123-020-00260-y,2020-05-24
Disease,PROCESS_OF,Animals,32445105,10.1007/s12028-020-00995-3,2020-05-24
Disease,PROCESS_OF,Homo sapiens,32445105,10.1007/s12028-020-00995-3,2020-05-24
Coronavirus Infections,ISA,Disease,32445105,10.1007/s12028-020-00995-3,2020-05-24
Coronavirus Infections,PROCESS_OF(SPEC),Animals,32445105,10.1007/s12028-020-00995-3,2020-05-24
Coronavirus Infections,PROCESS_OF(SPEC),Homo sapiens,32445105,10.1007/s12028-020-00995-3,2020-05-24
"CD69 protein, human",ASSOCIATED_WITH(INFER),Disease,32445105,10.1007/s12028-020-00995-3,2020-05-24
"CD69 protein, human",PART_OF,Animals,32445105,10.1007/s12028-020-00995-3,2020-05-24
"CD69 protein, human",PART_OF,Homo sapiens,32445105,10.1007/s12028-020-00995-3,2020-05-24
Eye,LOCATION_OF,Symptoms,32445105,10.1007/s12028-020-00995-3,2020-05-24
Pneumonia,PROCESS_OF,Patients,32445105,10.1007/s12028-020-00995-3,2020-05-24
Conjunctival sac,LOCATION_OF,Virus,32445105,10.1007/s12028-020-00995-3,2020-05-24
Conjunctival sac,PART_OF,Patients,32445105,10.1007/s12028-020-00995-3,2020-05-24
Symptoms,PROCESS_OF,Patients,32445105,10.1007/s12028-020-00995-3,2020-05-24
Conjunctivitis,ISA,Disease,32445105,10.1007/s12028-020-00995-3,2020-05-24
Ophthalmology clinic,LOCATION_OF,Administration occupational activities,32445105,10.1007/s12028-020-00995-3,2020-05-24
Coronavirus Infections,ISA,Disease,32445105,10.1007/s12028-020-00995-3,2020-05-24
Ethical Review,USES,Boards (medical device),32445083,10.1007/s11523-020-00721-1,2020-05-24
neurological complication,OCCURS_IN,hospitalized patients,32445083,10.1007/s11523-020-00721-1,2020-05-24
Malignant Neoplasms,PROCESS_OF,Patients,32445064,10.1007/s11239-020-02145-0,2020-05-24
Malignant Neoplasms,PROCESS_OF,Patients,32445064,10.1007/s11239-020-02145-0,2020-05-24
Infected,PROCESS_OF,Patients,32445064,10.1007/s11239-020-02145-0,2020-05-24
Malignant Neoplasms,PROCESS_OF,Patients,32445064,10.1007/s11239-020-02145-0,2020-05-24
Blood Coagulation Disorders,PROCESS_OF,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
heparin,NEG_TREATS,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
Negative Regulation of Coagulation,PROCESS_OF,Cohort,32445031,10.1007/s00264-020-04615-9,2020-05-24
Anticoagulants,ADMINISTERED_TO,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
heparin,NEG_TREATS,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
Patients,LOCATION_OF,Plasma,32445031,10.1007/s00264-020-04615-9,2020-05-24
heparin,TREATS,Patients,32445031,10.1007/s00264-020-04615-9,2020-05-24
Pain management,AFFECTS,Patients,32444993,10.1007/s12178-020-09642-y,2020-05-24
Acetaminophen,ISA,Antipyretics,32444993,10.1007/s12178-020-09642-y,2020-05-24
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32444993,10.1007/s12178-020-09642-y,2020-05-24
Respiratory Depression,PROCESS_OF,Patients,32444993,10.1007/s12178-020-09642-y,2020-05-24
Steroids,ADMINISTERED_TO,Patients,32444993,10.1007/s12178-020-09642-y,2020-05-24
Steroids,ADMINISTERED_TO,Patients,32444993,10.1007/s12178-020-09642-y,2020-05-24
heparin,PART_OF,parent,32444993,10.1007/s12178-020-09642-y,2020-05-24
Elective procedure,compared_with,Urgent Procedure,32444942,10.1007/s13760-020-01373-8,2020-05-24
Author,TREATS,Patients,32444942,10.1007/s13760-020-01373-8,2020-05-24
Pandemics,ISA,Process,32444942,10.1007/s13760-020-01373-8,2020-05-24
Down Syndrome,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Down Syndrome,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Down Syndrome,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Fatal Outcome,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Fatal Outcome,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Disease Progression,PROCESS_OF,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Supportive care,ADMINISTERED_TO,Patients,32444880,10.1093/cid/ciaa632,2020-05-24
Down Syndrome,PREDISPOSES,Disease Progression,32444880,10.1093/cid/ciaa632,2020-05-24
risk factors,PROCESS_OF,Adult,32444876,10.1093/infdis/jiaa281,2020-05-24
Hypertensive disease,PROCESS_OF,Patients,32444876,10.1093/infdis/jiaa281,2020-05-24
Lymphopenia,PROCESS_OF,Patients,32444876,10.1093/infdis/jiaa281,2020-05-24
Comorbidity,PROCESS_OF,geriatric patients,32444876,10.1093/infdis/jiaa281,2020-05-24
Disease,AFFECTS,geriatric patients,32444876,10.1093/infdis/jiaa281,2020-05-24
Severe disorder,PROCESS_OF,hospitalized patients,32444876,10.1093/infdis/jiaa281,2020-05-24
Mus,LOCATION_OF,Antibodies,32444874,10.1093/jpids/piaa065,2020-05-24
Infected,PROCESS_OF,Child,32444866,10.1038/s41375-020-0876-z,2020-05-24
Buccal smear procedure,DIAGNOSES,Infected,32444866,10.1038/s41375-020-0876-z,2020-05-24
Multiple Myeloma,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
Knowledge acquisition,METHOD_OF,Hygiene,32444797,10.1038/s41431-020-0634-8,2020-05-24
Multiple Myeloma,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
Patients,LOCATION_OF,Dexamethasone,32444797,10.1038/s41431-020-0634-8,2020-05-24
Patients,LOCATION_OF,bortezomib,32444797,10.1038/s41431-020-0634-8,2020-05-24
Patients,LOCATION_OF,carfilzomib,32444797,10.1038/s41431-020-0634-8,2020-05-24
Patients,LOCATION_OF,daratumumab,32444797,10.1038/s41431-020-0634-8,2020-05-24
Frail,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
end organ damage,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
Disease,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
Multiple Myeloma,PROCESS_OF,Patients,32444797,10.1038/s41431-020-0634-8,2020-05-24
Polypharmacy,CAUSES,Drug Interactions,32444797,10.1038/s41431-020-0634-8,2020-05-24
follow-up,TREATS,dyads,32444504,10.1136/heartjnl-2020-317011,2020-05-24
"Angina, Unstable",CAUSES,Cessation of life,32444493,10.1212/WNL.0000000000009848,2020-05-24
Coronary Arteriosclerosis,COEXISTS_WITH,Acute Coronary Syndrome,32444493,10.1212/WNL.0000000000009848,2020-05-24
Myocardial Infarction,CAUSES,Cessation of life,32444493,10.1212/WNL.0000000000009848,2020-05-24
Non ST elevation myocardial infarction,CAUSES,Cessation of life,32444493,10.1212/WNL.0000000000009848,2020-05-24
Heart Diseases,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Comorbidity,COEXISTS_WITH,Cardiovascular Diseases,32444493,10.1212/WNL.0000000000009848,2020-05-24
Comorbidity,COEXISTS_WITH,Coronary Arteriosclerosis,32444493,10.1212/WNL.0000000000009848,2020-05-24
Comorbidity,COEXISTS_WITH,Diabetes,32444493,10.1212/WNL.0000000000009848,2020-05-24
Comorbidity,COEXISTS_WITH,Hypertensive disease,32444493,10.1212/WNL.0000000000009848,2020-05-24
Comorbidity,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Acute Coronary Syndrome,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Acute Coronary Syndrome,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Disease,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Acute Coronary Syndrome,PROCESS_OF,Patients,32444493,10.1212/WNL.0000000000009848,2020-05-24
Influenza,PROCESS_OF,Patients,32444481,10.1503/cmaj.200711,2020-05-24
Coronavirus Infections,PROCESS_OF,Patients,32444481,10.1503/cmaj.200711,2020-05-24
"Hemorrhagic Fever, Ebola",PROCESS_OF,Patients,32444481,10.1503/cmaj.200711,2020-05-24
Malignant Neoplasms,PROCESS_OF,Biologist (general),32444460,10.1136/bmj.m1985,2020-05-24
Hospitals,LOCATION_OF,Diagnosis,32444415,10.1136/annrheumdis-2020-217627,2020-05-24
Asthma,ISA,Chronic lung disease,32444415,10.1136/annrheumdis-2020-217627,2020-05-24
Chronic Kidney Diseases,NEG_COEXISTS_WITH,Severe (severity modifier),32444415,10.1136/annrheumdis-2020-217627,2020-05-24
Asthma,ISA,Chronic lung disease,32444415,10.1136/annrheumdis-2020-217627,2020-05-24
Hospitals,LOCATION_OF,Prospective Cohort Study,32444415,10.1136/annrheumdis-2020-217627,2020-05-24
Present,COEXISTS_WITH,Respiratory Failure,32444412,10.1183/13993003.00775-2020,2020-05-24
Flare,PROCESS_OF,Patients,32444412,10.1183/13993003.00775-2020,2020-05-24
Leukopenia,PROCESS_OF,Patients,32444412,10.1183/13993003.00775-2020,2020-05-24
"Lung Diseases, Interstitial",PROCESS_OF,Patients,32444412,10.1183/13993003.00775-2020,2020-05-24
Hydroxychloroquine,TREATS,Patients,32444412,10.1183/13993003.00775-2020,2020-05-24
Hospitals,LOCATION_OF,Study,32444382,10.1128/mBio.01114-20,2020-05-24
Coughing,PROCESS_OF,Patients,32444382,10.1128/mBio.01114-20,2020-05-24
Fever,PROCESS_OF,Patients,32444382,10.1128/mBio.01114-20,2020-05-24
Hydroxychloroquine Sulfate,TREATS,SARS coronavirus,32444366,10.1136/bmj.m1966,2020-05-24
lopinavir / Ritonavir,TREATS,SARS coronavirus,32444366,10.1136/bmj.m1966,2020-05-24
Emtricitabine + tenofovir,TREATS,SARS coronavirus,32444366,10.1136/bmj.m1966,2020-05-24
Azathioprine,TREATS,Ferrets,32444366,10.1136/bmj.m1966,2020-05-24
Therapeutic immunosuppression,AFFECTS,Virus Diseases,32444366,10.1136/bmj.m1966,2020-05-24
Antibody titer measurement,USES,Serum Neutralization,32444366,10.1136/bmj.m1966,2020-05-24
Age,ASSOCIATED_WITH,Heart failure,32444358,10.1136/bmj.m1923,2020-05-24
Fibrin fragment D,ASSOCIATED_WITH,Critical Illness,32444358,10.1136/bmj.m1923,2020-05-24
Comorbidity,PREDISPOSES,Inflammation,32444358,10.1136/bmj.m1923,2020-05-24
Critical Illness,PROCESS_OF,Persons,32444358,10.1136/bmj.m1923,2020-05-24
Cerebrovascular accident,PROCESS_OF,Patients,32444223,10.1016/j.jpeds.2020.04.026,2020-05-24
Disease,PROCESS_OF,Patients,32444200,10.1016/j.tics.2020.05.001,2020-05-24
Patients,LOCATION_OF,Plasma,32443899,10.3390/jcm9051548,2020-05-24
cellular homeostasis,AFFECTS,viral process,32443899,10.3390/jcm9051548,2020-05-24
Chemicals,INTERACTS_WITH,RNA,32443899,10.3390/jcm9051548,2020-05-24
MG 132,ADMINISTERED_TO,Cells,32443899,10.3390/jcm9051548,2020-05-24
MG 132,INTERACTS_WITH(SPEC),RNA,32443899,10.3390/jcm9051548,2020-05-24
MG 132,ISA,Chemicals,32443899,10.3390/jcm9051548,2020-05-24
bortezomib,DISRUPTS,Virus Internalization,32443899,10.3390/jcm9051548,2020-05-24
Ubiquitin,PREVENTS,Storm NOS,32443899,10.3390/jcm9051548,2020-05-24
Inflammatory disorder,COEXISTS_WITH,Storm NOS,32443899,10.3390/jcm9051548,2020-05-24
Coughing,ISA,Symptoms,32443871,10.3390/jcm9051547,2020-05-24
Serum,LOCATION_OF,Ferritin,32443871,10.3390/jcm9051547,2020-05-24
Supportive care,TREATS,Patients,32443871,10.3390/jcm9051547,2020-05-24
Infected,PROCESS_OF,Persons,32443856,10.3390/diagnostics10050327,2020-05-24
Signs and Symptoms,ASSOCIATED_WITH,Disease,32443856,10.3390/diagnostics10050327,2020-05-24
Infected,PROCESS_OF,Population Group,32443856,10.3390/diagnostics10050327,2020-05-24
Clients,ISA,Persons,32443834,10.3390/jcm9051545,2020-05-24
Encephalopathies,PROCESS_OF,Patients,32443828,10.3390/medicina56050250,2020-05-24
Encephalopathies,PROCESS_OF,Patients,32443828,10.3390/medicina56050250,2020-05-24
"Encephalopathy, Toxic",PROCESS_OF,Patients,32443828,10.3390/medicina56050250,2020-05-24
Encephalopathies,PROCESS_OF,Patients,32443828,10.3390/medicina56050250,2020-05-24
Cardiopulmonary Arrest,PROCESS_OF,Patients,32443828,10.3390/medicina56050250,2020-05-24
rapid diagnosis,ADMINISTERED_TO,Community,32443810,10.3390/cells9051267,2020-05-24
Medical offices,LOCATION_OF,Administration occupational activities,32443810,10.3390/cells9051267,2020-05-24
Frail Elderly,ISA,Persons,32443640,10.3390/ijerph17103535,2020-05-24
Gravidity,PROCESS_OF,Patients,32443476,10.3390/ijerph17103520,2020-05-24
Journal,ISA,Publications,32443476,10.3390/ijerph17103520,2020-05-24
Infected,PROCESS_OF,Persons,32443459,10.3390/jcm9051515,2020-05-24
Infected,PROCESS_OF,Persons,32443459,10.3390/jcm9051515,2020-05-24
Infected,PROCESS_OF,Persons,32443459,10.3390/jcm9051515,2020-05-24
Health care facility,LOCATION_OF,diagnostic procedure,32443442,10.3390/jcm9051514,2020-05-24
Laboratory,LOCATION_OF,diagnostic procedure,32443442,10.3390/jcm9051514,2020-05-24
Coronavirus Infections,PROCESS_OF,Patients,32443430,10.3390/ijerph17103514,2020-05-24
Parenchyma,PART_OF,Lung,32443430,10.3390/ijerph17103514,2020-05-24
Severe course,PROCESS_OF,Patients,32443430,10.3390/ijerph17103514,2020-05-24
Neck,LOCATION_OF,Pneumonia,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Scrotum,PART_OF,Male population group,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Echocardiography,DIAGNOSES,Left Ventricular Hypertrophy,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Pathological accumulation of air in tissues,OCCURS_IN,Patients,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Pneumonia,PROCESS_OF,Patients,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Pneumothorax,OCCURS_IN,Patients,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Chronic lung disease,PROCESS_OF,Patients,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Severe Acute Respiratory Syndrome,COMPLICATES,Chronic heart disease,32443202,10.1016/j.envpol.2020.114665,2020-05-24
Disinfection,USES,Sodium Hypochlorite,32443177,10.1111/his.14160,2020-05-23
Disinfection,USES,chlorine dioxide,32443177,10.1111/his.14160,2020-05-23
Disinfection,USES,Liquid chlorine,32443177,10.1111/his.14160,2020-05-23
Autopsy,DIAGNOSES,Disease,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Autopsy,METHOD_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Brain,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Heart,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Kidney,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Liver,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Lung,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Spleen,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Testis,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Skeletal muscle structure,LOCATION_OF,Tissue sampling,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Structure of arteriole,LOCATION_OF,Fibrin blood clot,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Structure of arteriole,PART_OF,Alveolar,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Megakaryocytes,PART_OF,Alveolar,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Present,PROCESS_OF,Patients,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Present,PROCESS_OF,Patients,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Virus Diseases,CAUSES,Septicemia,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Lung,LOCATION_OF,Systemic disease,32443133,10.1097/01.NAJ.0000668776.90290.76,2020-05-23
Symptoms,PROCESS_OF,Patients,32443022,10.1097/MPG.0000000000002750,2020-05-23
Birth,AFFECTS,Enthesitis-Related Arthritis,32443020,10.1097/MPG.0000000000002729,2020-05-23
"CD69 protein, human",PART_OF,Patients,32443020,10.1097/MPG.0000000000002729,2020-05-23
Face,LOCATION_OF,Protection,32443020,10.1097/MPG.0000000000002729,2020-05-23
Inflammatory Bowel Diseases,PROCESS_OF,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Inflammatory Bowel Diseases,COEXISTS_WITH,Enthesitis-Related Arthritis,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Inflammatory Bowel Diseases,PROCESS_OF,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Immunologic Adjuvants,NEG_TREATS,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Exacerbation,PROCESS_OF,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Hand,LOCATION_OF,Severe course,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Present,PROCESS_OF,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Severe course,PROCESS_OF,Child,32442894,10.1016/j.ajp.2020.102159,2020-05-23
Anxiety,AFFECTS,Participant,32442842,10.1016/j.puhe.2020.05.001,2020-05-23
Anxiety,AFFECTS,Hypersensitivity,32442842,10.1016/j.puhe.2020.05.001,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Coronavirus Infections,ISA,Disease,32442756,10.1016/j.jcv.2020.104431,2020-05-23
Symptoms,COEXISTS_WITH,Symptom severe,32442732,10.1016/j.wneu.2020.05.124,2020-05-23
Coronavirus Infections,CAUSES,Pneumonia,32442699,10.1016/j.jaad.2020.05.074,2020-05-23
Isolation procedure,TREATS,Disease,32442699,10.1016/j.jaad.2020.05.074,2020-05-23
Pharmaceutical Preparations,TREATS,Human coronavirus,32442699,10.1016/j.jaad.2020.05.074,2020-05-23
Vaccines,TREATS,Human coronavirus,32442699,10.1016/j.jaad.2020.05.074,2020-05-23
Hydroxychloroquine,TREATS,Patients,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Hydroxychloroquine,TREATS,Exacerbation,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Hydroxychloroquine,ADMINISTERED_TO,Patients,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Psoriasis,PROCESS_OF,Patients,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Relapse,CAUSES,Psoriasis,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Hydroxychloroquine,TREATS,Adverse effects,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Adverse effects,PROCESS_OF,Patients,32442684,10.1016/j.ijsu.2020.05.040,2020-05-23
Coronavirus Infections,ISA,Disease,32442581,10.1016/j.annonc.2020.05.009,2020-05-23
Disease,PROCESS_OF,Meleagris gallopavo,32442581,10.1016/j.annonc.2020.05.009,2020-05-23
Coronavirus Infections,ISA,Disease,32442581,10.1016/j.annonc.2020.05.009,2020-05-23
Coronavirus Infections,PROCESS_OF(SPEC),Meleagris gallopavo,32442581,10.1016/j.annonc.2020.05.009,2020-05-23
Ambulatory Care Facilities,LOCATION_OF,Diagnosis,32442581,10.1016/j.annonc.2020.05.009,2020-05-23
removal technique,TREATS,Malignant Neoplasms,32442562,10.1053/j.gastro.2020.05.048,2020-05-23
Patients,LOCATION_OF,Feces,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Analysis,USES,Shotgun Sequencing,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Feces,LOCATION_OF,ACE2 gene,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Bacteroides ovatus,INTERACTS_WITH,Microbiome,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Bacteroides thetaiotaomicron,INTERACTS_WITH,Microbiome,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Bacteroides massiliensis,INTERACTS_WITH,Microbiome,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Bacteroides dorei,INTERACTS_WITH,Microbiome,32442528,10.1016/S0140-6736(20)31189-2,2020-05-23
Critical Illness,PROCESS_OF,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Hospitals,LOCATION_OF,Prospective Cohort Study,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
One chronic disease,PROCESS_OF,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Obesity,PROCESS_OF,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Vasoconstrictor Agents,ADMINISTERED_TO,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Chronic lung disease,PROCESS_OF,Patients,32442437,10.1016/j.pharmthera.2020.107579,2020-05-23
Proteostasis,PROCESS_OF,Social Networks,32442427,10.1016/j.jacr.2020.05.001,2020-05-23
Disease,PROCESS_OF,Homo sapiens,32442427,10.1016/j.jacr.2020.05.001,2020-05-23
bortezomib,TREATS,refractory plasma cell neoplasm,32442427,10.1016/j.jacr.2020.05.001,2020-05-23
multicatalytic endopeptidase complex,CAUSES,Accumulation,32442427,10.1016/j.jacr.2020.05.001,2020-05-23
risk factors,PROCESS_OF,Health Personnel,32442404,10.1016/j.cell.2020.05.014,2020-05-23
Experience,PROCESS_OF,Patients,32442333,10.1111/trf.15858,2020-05-23
Storm NOS,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32442315,10.1042/CS20200419,2020-05-23
Immune system,ASSOCIATED_WITH,patient condition,32442315,10.1042/CS20200419,2020-05-23
Chronotherapy,TREATS,"Respiratory Distress Syndrome, Adult",32442315,10.1042/CS20200419,2020-05-23
Transcript,ADMINISTERED_TO,Cells,32442308,10.1093/qjmed/hcaa178,2020-05-23
Alternative Splicing,PRODUCES,angiotensin converting enzyme 2,32442308,10.1093/qjmed/hcaa178,2020-05-23
angiotensin converting enzyme 2,PART_OF,soluble,32442308,10.1093/qjmed/hcaa178,2020-05-23
Antisense Oligonucleotides,ASSOCIATED_WITH,Disease,32442308,10.1093/qjmed/hcaa178,2020-05-23
ACE gene,LOCATION_OF,Alternative Splicing,32442308,10.1093/qjmed/hcaa178,2020-05-23
Coughing,PROCESS_OF,Patients,32442294,10.1093/cid/ciaa634,2020-05-23
Fever,PROCESS_OF,Transient Population Group,32442294,10.1093/cid/ciaa634,2020-05-23
Chest CT,ADMINISTERED_TO,Patients,32442294,10.1093/cid/ciaa634,2020-05-23
Exanthema,PROCESS_OF,Community,32442294,10.1093/cid/ciaa634,2020-05-23
Cardiovascular Diseases,PROCESS_OF,Patients,32442287,10.1093/cid/ciaa630,2020-05-23
Cardiovascular Diseases,PROCESS_OF,Patients,32442287,10.1093/cid/ciaa630,2020-05-23
Diabetes,PROCESS_OF,Patients,32442287,10.1093/cid/ciaa630,2020-05-23
Diabetes,PROCESS_OF,Patients,32442287,10.1093/cid/ciaa630,2020-05-23
Lymphopenia,PROCESS_OF,Patients,32442285,10.1093/cid/ciaa624,2020-05-23
Exhaustion,PROCESS_OF,Patients,32442285,10.1093/cid/ciaa624,2020-05-23
thymalfasin,TREATS,Virus Diseases,32442285,10.1093/cid/ciaa624,2020-05-23
CD8-Positive T-Lymphocytes,LOCATION_OF,PDCD1 gene,32442285,10.1093/cid/ciaa624,2020-05-23
CD8-Positive T-Lymphocytes,LOCATION_OF,HAVCR2 gene,32442285,10.1093/cid/ciaa624,2020-05-23
Lymphopenia,PROCESS_OF,Patients,32442285,10.1093/cid/ciaa624,2020-05-23
Disease,PROCESS_OF,Patients,32442285,10.1093/cid/ciaa624,2020-05-23
CD8-Positive T-Lymphocytes,LOCATION_OF,PDCD1 gene,32442285,10.1093/cid/ciaa624,2020-05-23
CD8-Positive T-Lymphocytes,LOCATION_OF,HAVCR2 gene,32442285,10.1093/cid/ciaa624,2020-05-23
Exhaustion,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32442285,10.1093/cid/ciaa624,2020-05-23
health review,ADMINISTERED_TO,Patients,32442266,10.1093/jamia/ocaa112,2020-05-23
Evaluation procedure,ADMINISTERED_TO,Patients,32442266,10.1093/jamia/ocaa112,2020-05-23
Comorbidity,PROCESS_OF,user - individual,32442266,10.1093/jamia/ocaa112,2020-05-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,NEG_COEXISTS_WITH,Decreased Immunologic Activity [PE],32442266,10.1093/jamia/ocaa112,2020-05-23
Extracorporeal Membrane Oxygenation,ISA,Renal Replacement Therapy,32442266,10.1093/jamia/ocaa112,2020-05-23
Respiration,PROCESS_OF,Patients,32442266,10.1093/jamia/ocaa112,2020-05-23
Chest,LOCATION_OF,CAT scan normal,32442256,10.1093/cid/ciaa638,2020-05-23
Comorbidity,PROCESS_OF,Cohort,32442256,10.1093/cid/ciaa638,2020-05-23
other medicated shampoos in ATC,TREATS,Abnormal,32442256,10.1093/cid/ciaa638,2020-05-23
other medicated shampoos in ATC,TREATS,CAT scan normal,32442256,10.1093/cid/ciaa638,2020-05-23
Negative,PROCESS_OF,Patients,32442256,10.1093/cid/ciaa638,2020-05-23
Asymptomatic,PROCESS_OF,Persons,32442256,10.1093/cid/ciaa638,2020-05-23
Chest,LOCATION_OF,CAT scan normal,32442256,10.1093/cid/ciaa638,2020-05-23
Persons,LOCATION_OF,IMPACT gene,32442256,10.1093/cid/ciaa638,2020-05-23
Reverse Transcriptase Polymerase Chain Reaction,MEASURES,Duration,32442210,10.1371/journal.ppat.1008536,2020-05-23
Vero Cells,LOCATION_OF,GSKIP gene,32442210,10.1371/journal.ppat.1008536,2020-05-23
PCR test for SARS,MEASURES,Ability,32442210,10.1371/journal.ppat.1008536,2020-05-23
Pharmaceutical Preparations,TREATS,Zoonoses,32442131,10.2196/19464,2020-05-23
Coronavirus Infections,ISA,Disease,32442130,10.2196/18707,2020-05-23
Attention,PROCESS_OF,Patients,32442130,10.2196/18707,2020-05-23
Asymptomatic,PROCESS_OF,Patients,32442130,10.2196/18707,2020-05-23
Asymptomatic,PROCESS_OF,Patients,32442130,10.2196/18707,2020-05-23
Asymptomatic,PROCESS_OF,Patients,32442130,10.2196/18707,2020-05-23
Asymptomatic,PROCESS_OF,Patients,32442130,10.2196/18707,2020-05-23
Respiratory Tract Infections,PROCESS_OF,Patients,32442105,10.1016/j.virol.2020.05.002,2020-05-23
Auranofin,ISA,Pharmaceutical Preparations,32442082,10.2174/1567202617666200522220509,2020-05-23
Cell Count,USES,Auranofin,32442082,10.2174/1567202617666200522220509,2020-05-23
Anti-Inflammatory Agents,CAUSES,Lung Injury,32442082,10.2174/1567202617666200522220509,2020-05-23
Anti-Inflammatory Agents,CAUSES,Severe Acute Respiratory Syndrome,32442082,10.2174/1567202617666200522220509,2020-05-23
Reactive Oxygen Species,CAUSES,Lung Injury,32442082,10.2174/1567202617666200522220509,2020-05-23
Reactive Oxygen Species,CAUSES,Severe Acute Respiratory Syndrome,32442082,10.2174/1567202617666200522220509,2020-05-23
Auranofin,TREATS,associated disease,32442082,10.2174/1567202617666200522220509,2020-05-23
Disease,CAUSES,Cessation of life,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Neurological observations,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Symptoms,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Symptoms,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Seizures,ISA,Disease,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Seizures,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Cerebrovascular accident,ISA,Disease,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Cerebrovascular accident,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Neuroglia,PRODUCES,angiotensin converting enzyme 2,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Neurons,PRODUCES,angiotensin converting enzyme 2,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Brain tissue,LOCATION_OF,SARS coronavirus,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Alzheimer's Disease,AFFECTS,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Symptom severe,PROCESS_OF,Persons,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Dementia,PROCESS_OF,Research Personnel,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Alzheimer's Disease,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Depressive disorder,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Depressive disorder,PROCESS_OF,Caregiver,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Alzheimer's Disease,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Alzheimer's Disease,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Dementia,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Dementia,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Dementia,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Dementia,PROCESS_OF,Patients,32442052,10.1080/0142159X.2020.1767769,2020-05-23
Disease,CAUSES,Coronavirus Infections,32442030,10.2214/AJR.20.23145,2020-05-23
Mechanical ventilation,TREATS,Respiratory Failure,32442030,10.2214/AJR.20.23145,2020-05-23
Coronavirus Infections,PROCESS_OF,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Alveolar ventilation function,PROCESS_OF,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Invasive mechanical ventilation NOS,TREATS,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Invasive mechanical ventilation NOS,TREATS(INFER),Middle East Respiratory Syndrome,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,TREATS,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,TREATS(INFER),Middle East Respiratory Syndrome,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,compared_with,Invasive mechanical ventilation NOS,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,higher_than,Invasive mechanical ventilation NOS,32442030,10.2214/AJR.20.23145,2020-05-23
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,compared_with,Mechanical ventilation,32442030,10.2214/AJR.20.23145,2020-05-23
Noninvasive Ventilation,compared_with,Conventional Treatment,32442030,10.2214/AJR.20.23145,2020-05-23
Conventional Treatment,USES,Oxygen,32442030,10.2214/AJR.20.23145,2020-05-23
Coronavirus Infections,PROCESS_OF,Patients,32441894,10.1002/eahr.500056,2020-05-23
Acute respiratory disease,PROCESS_OF,Patients,32441894,10.1002/eahr.500056,2020-05-23
Healthy Volunteers,ISA,Persons,32441869,10.1002/oby.22910,2020-05-23
Salivary Glands,LOCATION_OF,Present,32441805,10.1002/jcph.1644,2020-05-23
Body tissue,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Salivary Gland Tissue,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Salivary Glands,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Salivary Glands,LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Body organ structure,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Body organ structure,LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Population Group,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Population Group,LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Salivary Glands,LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Salivary Glands,LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Male population group,NEG_LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Male population group,NEG_LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Human Age Group,NEG_LOCATION_OF,angiotensin converting enzyme 2,32441805,10.1002/jcph.1644,2020-05-23
Human Age Group,NEG_LOCATION_OF,TMPRSS2 gene,32441805,10.1002/jcph.1644,2020-05-23
Salivary,LOCATION_OF,Glandular Epithelial Cells,32441805,10.1002/jcph.1644,2020-05-23
TMPRSS2 gene,INTERACTS_WITH,Glandular Epithelial Cells,32441805,10.1002/jcph.1644,2020-05-23
Adrenal Cortex Hormones,TREATS,Edema,32441789,10.1002/jmv.26050,2020-05-23
Monoclonal Antibodies,TREATS,Edema,32441789,10.1002/jmv.26050,2020-05-23
Pharmaceutical Preparations,PREVENTS,Inflammation,32441789,10.1002/jmv.26050,2020-05-23
Interferons,TREATS,Edema,32441789,10.1002/jmv.26050,2020-05-23
Escin,TREATS,Acute Lung Injury,32441789,10.1002/jmv.26050,2020-05-23
Acute Lung Injury,COEXISTS_WITH,Coronavirus Infections,32441789,10.1002/jmv.26050,2020-05-23
Agent,AFFECTS,Lung Injury,32441789,10.1002/jmv.26050,2020-05-23
Cessation of life,ASSOCIATED_WITH,Diabetes,32441786,10.1002/jmv.26052,2020-05-23
Creatinine,compared_with,Alanine Transaminase,32441786,10.1002/jmv.26052,2020-05-23
Troponin,PART_OF,Heart,32441786,10.1002/jmv.26052,2020-05-23
Coronavirus Infections,CAUSES,end organ damage,32441786,10.1002/jmv.26052,2020-05-23
Adrenal Cortex Hormones,ASSOCIATED_WITH,"Pneumonia, Viral",32441783,10.1111/bph.15138,2020-05-23
Methylprednisolone,PREVENTS,Disease Progression,32441783,10.1111/bph.15138,2020-05-23
Methylprednisolone,TREATS,Symptoms,32441783,10.1111/bph.15138,2020-05-23
"Pneumonia, Viral",PROCESS_OF,Patients,32441783,10.1111/bph.15138,2020-05-23
Dyspnea,ISA,Symptoms,32441783,10.1111/bph.15138,2020-05-23
Steroid therapy,PREVENTS,Disease Progression,32441783,10.1111/bph.15138,2020-05-23
persistent fever,AFFECTS,Alveolar ventilation function,32441783,10.1111/bph.15138,2020-05-23
persistent fever,ISA,Symptoms,32441783,10.1111/bph.15138,2020-05-23
receptor,ASSOCIATED_WITH,Pneumonia,32441771,10.1111/jgs.16623,2020-05-23
Chronic disease,PROCESS_OF,Elderly (population group),32441770,10.1111/jgs.16625,2020-05-23
Hydroxychloroquine,ISA,Antimalarials,32441770,10.1111/jgs.16625,2020-05-23
Hydroxychloroquine,TREATS,Acute infectious disease,32441770,10.1111/jgs.16625,2020-05-23
Hydroxychloroquine,PREDISPOSES,Drug Interactions,32441770,10.1111/jgs.16625,2020-05-23
Polypharmacy,TREATS,Population Group,32441770,10.1111/jgs.16625,2020-05-23
Patient in hospital,PROCESS_OF,Elderly (population group),32441770,10.1111/jgs.16625,2020-05-23
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32441770,10.1111/jgs.16625,2020-05-23
Pharmaceutical Preparations,INTERACTS_WITH,Hydroxychloroquine,32441770,10.1111/jgs.16625,2020-05-23
Antipsychotic Agents,TREATS,Elderly (population group),32441770,10.1111/jgs.16625,2020-05-23
Cardiac agent,TREATS,Elderly (population group),32441770,10.1111/jgs.16625,2020-05-23
Antidiabetics,TREATS,Elderly (population group),32441770,10.1111/jgs.16625,2020-05-23
Coronavirus Infections,ISA,Disease,32441770,10.1111/jgs.16625,2020-05-23
Polypharmacy,PREVENTS,Disease,32441770,10.1111/jgs.16625,2020-05-23
Polypharmacy,PREVENTS(SPEC),Coronavirus Infections,32441770,10.1111/jgs.16625,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,TREATS,Sequela of disorder,32441753,10.1093/jpids/piaa060,2020-05-23
Interleukins,ASSOCIATED_WITH,Storm NOS,32441753,10.1093/jpids/piaa060,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,INHIBITS,,32441753,10.1093/jpids/piaa060,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,INHIBITS,Interleukin-1,32441753,10.1093/jpids/piaa060,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,INHIBITS,Interleukin-6,32441753,10.1093/jpids/piaa060,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,CAUSES,Cell Death,32441753,10.1093/jpids/piaa060,2020-05-23
Poly(ADP-ribose) Polymerase Inhibitors,CAUSES,Cell Survival,32441753,10.1093/jpids/piaa060,2020-05-23
Animal Model,LOCATION_OF,Poly(ADP-ribose) Polymerase Inhibitors,32441753,10.1093/jpids/piaa060,2020-05-23
Nasopharynx,LOCATION_OF,Virus,32441744,10.1093/chemse/bjaa034,2020-05-23
Upper respiratory tract,LOCATION_OF,Virus,32441744,10.1093/chemse/bjaa034,2020-05-23
Feces,PART_OF,Child,32441744,10.1093/chemse/bjaa034,2020-05-23
Disease,PROCESS_OF,general population,32441710,10.4193/Rhin20.119,2020-05-23
Swedish,ISA,Population Group,32441710,10.4193/Rhin20.119,2020-05-23
Disease,PROCESS_OF,general population,32441710,10.4193/Rhin20.119,2020-05-23
Emergency procedure,TREATS,Patients,32441700,10.1188/20.CJON.S1.3,2020-05-23
Cardiovascular Diseases,PROCESS_OF,Patients,32441574,10.1080/21505594.2020.1767357,2020-05-23
Care team,PROCESS_OF,member,32441574,10.1080/21505594.2020.1767357,2020-05-23
Congenital heart disease,AFFECTS,Visual Accommodation,32441574,10.1080/21505594.2020.1767357,2020-05-23
Congenital heart disease,AFFECTS,Patients,32441574,10.1080/21505594.2020.1767357,2020-05-23
Young Adult,ISA,Population Group,32441574,10.1080/21505594.2020.1767357,2020-05-23
White blood cell count normal,PROCESS_OF,Patients,32441573,10.1080/08959420.2020.1771238,2020-05-23
Chest CT,ADMINISTERED_TO,Patients,32441573,10.1080/08959420.2020.1771238,2020-05-23
Pneumonia,PROCESS_OF,geriatric patients,32441573,10.1080/08959420.2020.1771238,2020-05-23
Virus,LOCATION_OF,Today,32441572,10.1080/08959420.2020.1771239,2020-05-23
Hospital admission,TREATS,Severe disorder,32441462,10.1111/cts.12824,2020-05-23
Tertiary Care Centers,LOCATION_OF,Study,32441462,10.1111/cts.12824,2020-05-23
Cardiovascular,LOCATION_OF,Severe disorder,32441462,10.1111/cts.12824,2020-05-23
Cardiovascular,LOCATION_OF,Severe disorder,32441462,10.1111/cts.12824,2020-05-23
Benzene,ISA,Hydrocarbons,32441380,10.1002/hed.26270,2020-05-23
scalpel,TREATS,Patients,32441380,10.1002/hed.26270,2020-05-23
scalpel,USES,Smoke Evacuator,32441380,10.1002/hed.26270,2020-05-23
Nasopharynx,LOCATION_OF,Severe acute respiratory infection,32441373,10.1111/dth.13643,2020-05-23
Nasal Swab (procedure),METHOD_OF,Diagnosis,32441373,10.1111/dth.13643,2020-05-23
HTATIP wt Allele,PART_OF,Nose,32441373,10.1111/dth.13643,2020-05-23
Nasal Swab (procedure),METHOD_OF,Diagnosis,32441373,10.1111/dth.13643,2020-05-23
Coronavirus Infections,ISA,Disease,32441360,10.1111/dth.13642,2020-05-23
Consultation,TREATS,Disease,32441360,10.1111/dth.13642,2020-05-23
Adjunctive Orthodontic Procedure,AFFECTS,Enthesitis-Related Arthritis,32441360,10.1111/dth.13642,2020-05-23
Suspicion,PROCESS_OF,Patients,32441351,10.1002/hed.26280,2020-05-23
Skin lesion,PROCESS_OF,Patients,32441351,10.1002/hed.26280,2020-05-23
Urticaria,ISA,Lesion,32441351,10.1002/hed.26280,2020-05-23
Tracheotomy procedure,TREATS,Patients,32441332,10.1111/aogs.13921,2020-05-23
Disease,PROCESS_OF,Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,ISA,Disease,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,PROCESS_OF(SPEC),Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
"CD69 protein, human",ADMINISTERED_TO,Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Disease,PROCESS_OF,Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,ISA,Disease,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,PROCESS_OF(SPEC),Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Coughing,ISA,Symptoms,32441330,10.1002/14651858.CD013632,2020-05-23
Fever,ISA,Symptoms,32441330,10.1002/14651858.CD013632,2020-05-23
Pharmacotherapy,TREATS,Woman,32441330,10.1002/14651858.CD013632,2020-05-23
C-reactive protein,ASSOCIATED_WITH,Pneumonia,32441330,10.1002/14651858.CD013632,2020-05-23
Fibrin fragment D,ASSOCIATED_WITH,Pneumonia,32441330,10.1002/14651858.CD013632,2020-05-23
Disease,PROCESS_OF,Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,ISA,Disease,32441330,10.1002/14651858.CD013632,2020-05-23
Coronavirus Infections,PROCESS_OF(SPEC),Pregnant Women,32441330,10.1002/14651858.CD013632,2020-05-23
Pneumonia,AFFECTS,Patients,32441330,10.1002/14651858.CD013632,2020-05-23
"Infectious Disease Transmission, Horizontal",PROCESS_OF,"Infant, Newborn",32441330,10.1002/14651858.CD013632,2020-05-23
Loneliness,PROCESS_OF,Older people,32441303,10.1093/ajcp/aqaa089,2020-05-23
Physical Well-being,PROCESS_OF,Older people,32441303,10.1093/ajcp/aqaa089,2020-05-23
Loneliness,PROCESS_OF,Elderly (population group),32441303,10.1093/ajcp/aqaa089,2020-05-23
Loneliness,PROCESS_OF,Elderly (population group),32441303,10.1093/ajcp/aqaa089,2020-05-23
Symptoms,PROCESS_OF,Participant,32441303,10.1093/ajcp/aqaa089,2020-05-23
Loneliness,PROCESS_OF,Elderly (population group),32441303,10.1093/ajcp/aqaa089,2020-05-23
Intervention regimes,PREVENTS,Loneliness,32441303,10.1093/ajcp/aqaa089,2020-05-23
Intervention regimes,TREATS,Elderly (population group),32441303,10.1093/ajcp/aqaa089,2020-05-23
Loneliness,PROCESS_OF,Population Group,32441303,10.1093/ajcp/aqaa089,2020-05-23
Placenta,PART_OF,Woman,32441299,10.1042/BSR20201256,2020-05-23
Decidua,LOCATION_OF,Arteriopathic disease,32441299,10.1042/BSR20201256,2020-05-23
Stillbirth,PROCESS_OF,Patients,32441299,10.1042/BSR20201256,2020-05-23
Thrombophilia,AFFECTS,Placental function,32441299,10.1042/BSR20201256,2020-05-23
Coronavirus Infections,ISA,Disease,32441243,10.3201/eid2609.202126,2020-05-23
Coronavirus Infections,ISA,Disease,32441243,10.3201/eid2609.202126,2020-05-23
maraviroc,TREATS,Disease,32441243,10.3201/eid2609.202126,2020-05-23
maraviroc,TREATS(SPEC),Coronavirus Infections,32441243,10.3201/eid2609.202126,2020-05-23
glecaprevir,TREATS,Disease,32441243,10.3201/eid2609.202126,2020-05-23
glecaprevir,TREATS(SPEC),Coronavirus Infections,32441243,10.3201/eid2609.202126,2020-05-23
Diarrhea,COEXISTS_WITH,Disease,32441240,10.1192/j.eurpsy.2020.53,2020-05-23
Diarrhea,COEXISTS_WITH(SPEC),Coronavirus Infections,32441240,10.1192/j.eurpsy.2020.53,2020-05-23
Diarrhea,PROCESS_OF,Patients,32441240,10.1192/j.eurpsy.2020.53,2020-05-23
Coronavirus Infections,ISA,Disease,32441240,10.1192/j.eurpsy.2020.53,2020-05-23
Psychotic Disorders,PROCESS_OF,Patients,32441232,10.1017/dmp.2020.166,2020-05-23
Sedentary lifestyle,PROCESS_OF,Patients,32441232,10.1017/dmp.2020.166,2020-05-23
Psychotic Disorders,PROCESS_OF,Persons,32441232,10.1017/dmp.2020.166,2020-05-23
Coronavirus Infections,ISA,Disease,32441209,10.1080/08959420.2020.1765684,2020-05-23
Virus,PROCESS_OF,Health Personnel,32440979,10.1007/s10072-020-04470-x,2020-05-23
Pharmaceutical Preparations,CAUSES,Disability,32440918,10.1007/s15010-020-01446-z,2020-05-23
Multiple Sclerosis,PROCESS_OF,Persons,32440918,10.1007/s15010-020-01446-z,2020-05-23
Multiple Sclerosis,PROCESS_OF,Hospital specialist,32440918,10.1007/s15010-020-01446-z,2020-05-23
Neurologic Examination,DIAGNOSES,Multiple Sclerosis,32440918,10.1007/s15010-020-01446-z,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32440906,10.1007/s12630-020-01704-6,2020-05-23
Severe Acute Respiratory Syndrome,PRECEDES,Hypersensitivity,32440906,10.1007/s12630-020-01704-6,2020-05-23
Coronavirus Infections,ISA,Disease,32440887,10.1007/s00431-020-03690-9,2020-05-23
pulmonary complications,ISA,Disease,32440887,10.1007/s00431-020-03690-9,2020-05-23
Lung,LOCATION_OF,Ultrasound examination,32440887,10.1007/s00431-020-03690-9,2020-05-23
Severe Acute Respiratory Syndrome,CAUSES,Disease,32440883,10.1007/s11239-020-02138-z,2020-05-23
Virus Diseases,COEXISTS_WITH,Blood Coagulation Disorders,32440857,10.1007/s12072-020-10051-z,2020-05-23
Virus Diseases,COEXISTS_WITH,inflammatory response,32440857,10.1007/s12072-020-10051-z,2020-05-23
Virus Diseases,COEXISTS_WITH,Storm NOS,32440857,10.1007/s12072-020-10051-z,2020-05-23
Critical Illness,PROCESS_OF,Patients,32440857,10.1007/s12072-020-10051-z,2020-05-23
Arterial Thromboembolic disease,PROCESS_OF,Patients,32440857,10.1007/s12072-020-10051-z,2020-05-23
Anticoagulants,TREATS,Patients,32440857,10.1007/s12072-020-10051-z,2020-05-23
Anticoagulant therapy,TREATS,Patients,32440857,10.1007/s12072-020-10051-z,2020-05-23
Ascites,PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
"Hypertension, Portal",PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
Disease Progression,PROCESS_OF,Patients,32440817,10.1007/s00264-020-04617-7,2020-05-23
Cirrhosis,PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
Cirrhosis,PROCESS_OF,Patients,32440817,10.1007/s00264-020-04617-7,2020-05-23
"Hypertension, Portal",PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
"Liver Cirrhosis, Alcoholic",PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
Esophageal bleeding,PROCESS_OF,Male population group,32440817,10.1007/s00264-020-04617-7,2020-05-23
Cirrhosis,PREDISPOSES,Poor outcome,32440817,10.1007/s00264-020-04617-7,2020-05-23
Poor outcome,PROCESS_OF,Patients,32440817,10.1007/s00264-020-04617-7,2020-05-23
Italy,ISA,Country,32440724,10.1007/s10900-020-00845-5,2020-05-23
Italy,ISA,European country,32440692,10.1093/ibd/izaa131,2020-05-23
Health Personnel,LOCATION_OF,IMPACT gene,32440692,10.1093/ibd/izaa131,2020-05-23
Physicians,ISA,Health Personnel,32440692,10.1093/ibd/izaa131,2020-05-23
Interested,PROCESS_OF,Anesthesiologist,32440386,10.7759/cureus.8190,2020-05-23
Malignant Neoplasms,PROCESS_OF,Patients,32440384,10.7759/cureus.7914,2020-05-23
Therapeutic procedure,NEG_ADMINISTERED_TO,Patients,32440384,10.7759/cureus.7914,2020-05-23
Confirmation,PROCESS_OF,"Infant, Newborn",32439821,10.1212/WNL.0000000000009829,2020-05-23
Practice Experience,PROCESS_OF,Clinician,32439821,10.1212/WNL.0000000000009829,2020-05-23
Confirmation,PROCESS_OF,Woman,32439821,10.1212/WNL.0000000000009829,2020-05-23
Telemedicine,METHOD_OF,Phototherapy,32439821,10.1212/WNL.0000000000009829,2020-05-23
Myoclonus,PROCESS_OF,Male population group,32439820,10.1212/WNL.0000000000009844,2020-05-23
Myoclonus,PROCESS_OF,Patients,32439820,10.1212/WNL.0000000000009844,2020-05-23
Myoclonus,PROCESS_OF,Woman,32439820,10.1212/WNL.0000000000009844,2020-05-23
Hypersomnia,PROCESS_OF,Male population group,32439820,10.1212/WNL.0000000000009844,2020-05-23
Hypersomnia,PROCESS_OF,Patients,32439820,10.1212/WNL.0000000000009844,2020-05-23
Hypersomnia,PROCESS_OF,Woman,32439820,10.1212/WNL.0000000000009844,2020-05-23
Apnea,PROCESS_OF,Patients,32439820,10.1212/WNL.0000000000009844,2020-05-23
Significant hypoxia,PROCESS_OF,Patients,32439820,10.1212/WNL.0000000000009844,2020-05-23
Take,TREATS,Readiness,32439740,10.1136/bmjoq-2020-000985,2020-05-23
Mild disorder,PROCESS_OF,Patients,32439716,10.1136/esmoopen-2020-000793,2020-05-23
Primary Health Care,ISA,Health Services,32439651,10.3174/ajnr.A6607,2020-05-23
Telemedicine,COEXISTS_WITH,cancer care,32439651,10.3174/ajnr.A6607,2020-05-23
CAT scan of head,ADMINISTERED_TO,Patients,32439650,10.3174/ajnr.A6606,2020-05-23
CAT scan of head,ADMINISTERED_TO,Patients,32439650,10.3174/ajnr.A6606,2020-05-23
Detection,TREATS,Patients,32439650,10.3174/ajnr.A6606,2020-05-23
Cerebrovascular accident,ISA,Vascular occlusion,32439646,10.3174/ajnr.A6595,2020-05-23
Thrombectomy,TREATS,Cerebrovascular accident,32439646,10.3174/ajnr.A6595,2020-05-23
IMPACT gene,PART_OF,Eye,32439646,10.3174/ajnr.A6595,2020-05-23
Cerebrovascular accident,ISA,Vascular occlusion,32439646,10.3174/ajnr.A6595,2020-05-23
Cerebrovascular accident,ISA,Vascular occlusion,32439646,10.3174/ajnr.A6595,2020-05-23
Cerebrovascular accident,PROCESS_OF,Patients,32439646,10.3174/ajnr.A6595,2020-05-23
Brain,LOCATION_OF,Coronavirus Infections,32439516,10.1016/j.jpainsymman.2020.05.014,2020-05-23
Coronavirus Infections,PROCESS_OF,hospitalized patients,32439516,10.1016/j.jpainsymman.2020.05.014,2020-05-23
Pregnant Women,LOCATION_OF,IMPACT gene,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Gravidity,PROCESS_OF,Patients,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Gravidity,PROCESS_OF,Patients,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Gravidity,PROCESS_OF,Persons,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Premature Birth,PROCESS_OF,Woman,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Class III obesity,PROCESS_OF,Woman,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Obesity,PROCESS_OF,Woman,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Gravidity,PROCESS_OF,Patients,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Lung,LOCATION_OF,Maternal status,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Obesity,PREDISPOSES,Indicated Preterm Birth,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Coronavirus Infections,PREDISPOSES,Indicated Preterm Birth,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Maternal status,COEXISTS_WITH,late pregnancy,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Gravidity,PROCESS_OF,Patients,32439366,10.1016/j.ijcard.2020.05.036,2020-05-23
Combined Modality Therapy,USES,Azithromycin,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Electrocardiogram,PROCESS_OF,Patients,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Hydroxychloroquine,TREATS,Electrocardiogram,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Coitus,AFFECTS,Patients,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Hydroxychloroquine,AFFECTS,qtc interval,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Azithromycin,AFFECTS,qtc interval,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
patient condition,PROCESS_OF,Patients,32439309,10.1016/j.anpedi.2020.04.016,2020-05-23
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32439306,10.1016/j.cjca.2020.04.010,2020-05-23
Infected,PROCESS_OF,Persons,32439272,10.1016/j.anl.2020.05.003,2020-05-23
Infected,PROCESS_OF,Persons,32439272,10.1016/j.anl.2020.05.003,2020-05-23
Medical Devices,USES,enclosure,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Tracheotomy procedure,ISA,Operative Surgical Procedures,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Tracheotomy procedure,TREATS,Patients,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Tracheotomy procedure,USES(SPEC),Artificial Airways,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Operative Surgical Procedures,USES,Artificial Airways,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Medical Devices,TREATS,Patients,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
Medical Devices,USES,enclosure,32439237,10.1016/j.ajg.2020.04.019,2020-05-23
"Liver Failure, Acute",PROCESS_OF,Patients,32439209,10.1016/j.jaut.2020.102473,2020-05-23
End Stage Liver Disease,PROCESS_OF,Patients,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Therapeutic immunosuppression,ADMINISTERED_TO,Patients,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Infection,COEXISTS_WITH,Liver transplant recipient,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Coronavirus Infections,PROCESS_OF,Family,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Elective Surgical Procedures,TREATS,Patients,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Telemedicine,COEXISTS_WITH,Triage,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Therapeutic immunosuppression,TREATS,underlying infection,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Drug Interactions,COEXISTS_WITH,Liver transplant recipient,32439209,10.1016/j.jaut.2020.102473,2020-05-23
Critical Illness,PROCESS_OF,Patients,32439198,10.1016/j.arcmed.2020.05.001,2020-05-23
Severe disorder,PROCESS_OF,Patients,32439198,10.1016/j.arcmed.2020.05.001,2020-05-23
Antiviral Agents,TREATS,Disease,32439197,10.1016/j.cpcardiol.2020.100618,2020-05-23
angiotensin converting enzyme 2,AFFECTS,Body organ structure,32439139,10.1016/j.ciresp.2020.04.031,2020-05-23
Decision,PROCESS_OF,Maker (occupation),32438948,10.1017/cem.2020.403,2020-05-23
Challenge,USES,Diagnosis,32438943,10.1017/dmp.2020.169,2020-05-23
Disease,PROCESS_OF,Persons,32438941,10.1017/dmp.2020.168,2020-05-23
Coronavirus Infections,ISA,Disease,32438941,10.1017/dmp.2020.168,2020-05-23
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32438941,10.1017/dmp.2020.168,2020-05-23
Coronavirus Infections,ISA,Disease,32438941,10.1017/dmp.2020.168,2020-05-23
Coronavirus Infections,ISA,Disease,32438940,10.1017/dmp.2020.148,2020-05-23
Communicable Diseases,NEG_ISA,Disease,32438940,10.1017/dmp.2020.148,2020-05-23
Coronavirus Infections,ISA,Disease,32438940,10.1017/dmp.2020.148,2020-05-23
WASF1 gene,PART_OF,Patients,32438938,10.1017/S1049023X20000746,2020-05-23
Disease,PROCESS_OF,Community,32438895,10.1161/STROKEAHA.120.030329,2020-05-23
Virus,PROCESS_OF,high-risk group,32438895,10.1161/STROKEAHA.120.030329,2020-05-23
Cessation of life,NEG_OCCURS_IN,year,32438895,10.1161/STROKEAHA.120.030329,2020-05-23
Cessation of life,OCCURS_IN,Old age,32438895,10.1161/STROKEAHA.120.030329,2020-05-23
Disease,PROCESS_OF,Child,32438895,10.1161/STROKEAHA.120.030329,2020-05-23
Hospital clinic,LOCATION_OF,Study,32438878,10.1177/2050640620929133,2020-05-23
Cerebrovascular accident,PROCESS_OF,teams,32438878,10.1177/2050640620929133,2020-05-23
Decision,PROCESS_OF,geriatric patients,32438878,10.1177/2050640620929133,2020-05-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32438876,10.1177/0284185120924806,2020-05-23
Critical Illness,PROCESS_OF,Patients,32438824,10.1289/EHP7200,2020-05-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32438824,10.1289/EHP7200,2020-05-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32438824,10.1289/EHP7200,2020-05-23
Septicemia,PROCESS_OF,Patients,32438824,10.1289/EHP7200,2020-05-23
Continuous renal replacement therapy,TREATS,Patients,32438824,10.1289/EHP7200,2020-05-23
Continuous renal replacement therapy,TREATS(INFER),"Kidney Failure, Acute",32438824,10.1289/EHP7200,2020-05-23
Continuous renal replacement therapy,TREATS(INFER),Septicemia,32438824,10.1289/EHP7200,2020-05-23
Laboratory,LOCATION_OF,Laboratory Procedures,32438799,10.1021/acsnano.0c03972,2020-05-23
Assay,METHOD_OF,Detection,32438799,10.1021/acsnano.0c03972,2020-05-23
Pore,LOCATION_OF,Floods,32438763,10.3390/jcm9051536,2020-05-23
Anemia,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
Intestines,LOCATION_OF,Chronic inflammatory disorder,32438729,10.3390/s20102885,2020-05-23
Chronic inflammatory disorder,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
"Anemia, severe",ISA,Disease,32438729,10.3390/s20102885,2020-05-23
Iron,TREATS,Patients,32438729,10.3390/s20102885,2020-05-23
Iron,TREATS(INFER),Disease remission,32438729,10.3390/s20102885,2020-05-23
Iron,TREATS(INFER),Mild anemia,32438729,10.3390/s20102885,2020-05-23
Disease remission,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
Mild anemia,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
Iron,TREATS,Anemia,32438729,10.3390/s20102885,2020-05-23
complex (molecular entity),TREATS,Anemia,32438729,10.3390/s20102885,2020-05-23
Anemia,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32438729,10.3390/s20102885,2020-05-23
Persons,USES,Tympanic infrared thermometer,32438703,10.3390/cancers12051287,2020-05-23
Coronavirus Infections,PROCESS_OF,Adult,32438687,10.3390/pathogens9050389,2020-05-23
Coronavirus Infections,PROCESS_OF,Cancer Patient,32438687,10.3390/pathogens9050389,2020-05-23
systemic therapy,TREATS,Cancer Patient,32438687,10.3390/pathogens9050389,2020-05-23
Communicable Diseases,PROCESS_OF,Patients,32438677,10.3390/diagnostics10050319,2020-05-23
Diabetes,PROCESS_OF,Patients,32438677,10.3390/diagnostics10050319,2020-05-23
Diabetes,PROCESS_OF,Patients,32438677,10.3390/diagnostics10050319,2020-05-23
Hyperglycemia,PROCESS_OF,Patients,32438677,10.3390/diagnostics10050319,2020-05-23
Inflammation,PROCESS_OF,Patients,32438677,10.3390/diagnostics10050319,2020-05-23
diabetic,CAUSES,Multiple Organ Failure,32438677,10.3390/diagnostics10050319,2020-05-23
Antigen test,ISA,Laboratory Procedures,32438622,10.3390/vaccines8020236,2020-05-23
Laboratory Procedures,DIAGNOSES,Hypersensitivity,32438622,10.3390/vaccines8020236,2020-05-23
Laboratory Procedures,USES,CD40LG wt Allele,32438622,10.3390/vaccines8020236,2020-05-23
Fluorescent Antibody Technique,METHOD_OF,Enzyme-Linked Immunosorbent Assay,32438622,10.3390/vaccines8020236,2020-05-23
Immunoassay method,METHOD_OF,Enzyme-Linked Immunosorbent Assay,32438622,10.3390/vaccines8020236,2020-05-23
Enzyme-Linked Immunosorbent Assay,ISA,Laboratory Procedures,32438622,10.3390/vaccines8020236,2020-05-23
Laboratory Procedures,USES,Enzyme-Linked Immunosorbent Assay,32438622,10.3390/vaccines8020236,2020-05-23
Immunoassay method,DIAGNOSES,Hypersensitivity,32438622,10.3390/vaccines8020236,2020-05-23
Therapeutic procedure,TREATS,Symptoms,32438620,10.3390/nu12051466,2020-05-23
Basis,AUGMENTS,specific immunity,32438620,10.3390/nu12051466,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
Chronic lung disease,COEXISTS_WITH,Malnutrition,32438617,10.3390/jcm9051529,2020-05-23
Inflammation,COEXISTS_WITH,Disease,32438617,10.3390/jcm9051529,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
Therapeutic procedure,USES,Anti-Inflammatory Agents,32438617,10.3390/jcm9051529,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
Nutritional status,COEXISTS_WITH,Infection,32438617,10.3390/jcm9051529,2020-05-23
Coronavirus Infections,ISA,Disease,32438617,10.3390/jcm9051529,2020-05-23
"Kidney Failure, Acute",COMPLICATES,"Respiratory Distress Syndrome, Adult",32438579,10.3390/jcm9051527,2020-05-23
Renal Replacement Therapy,TREATS,"Kidney Failure, Acute",32438579,10.3390/jcm9051527,2020-05-23
Renal Replacement Therapy,TREATS,Patients,32438579,10.3390/jcm9051527,2020-05-23
Pandemics,ISA,Disease Outbreaks,32438579,10.3390/jcm9051527,2020-05-23
Can Do Very Little,PROCESS_OF,Cohort,32438579,10.3390/jcm9051527,2020-05-23
Infection,PROCESS_OF,Family,32438527,10.1111/pan.13924,2020-05-22
Infection,PROCESS_OF,Family,32438527,10.1111/pan.13924,2020-05-22
Infection,PROCESS_OF,Family,32438527,10.1111/pan.13924,2020-05-22
Infection,PROCESS_OF,Couples (persons),32438527,10.1111/pan.13924,2020-05-22
Infection,PROCESS_OF,Family,32438527,10.1111/pan.13924,2020-05-22
Anesthetics,TREATS,Patients,32438520,10.1111/tbed.13631,2020-05-22
Anesthetics,TREATS,Population Group,32438520,10.1111/tbed.13631,2020-05-22
Bronchitis,ISA,Illness (finding),32438454,10.1002/cpt.1910,2020-05-22
Pneumonia,ISA,Illness (finding),32438454,10.1002/cpt.1910,2020-05-22
Coronavirus Infections,CAUSES,Illness (finding),32438454,10.1002/cpt.1910,2020-05-22
Coronavirus Infections,CAUSES(SPEC),Bronchitis,32438454,10.1002/cpt.1910,2020-05-22
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32438454,10.1002/cpt.1910,2020-05-22
Patients,ISA,Persons,32438454,10.1002/cpt.1910,2020-05-22
Vaccines,AUGMENTS,Antiviral Response,32438454,10.1002/cpt.1910,2020-05-22
"CD69 protein, human",PREVENTS,Coronavirus Infections,32438454,10.1002/cpt.1910,2020-05-22
Degenerative polyarthritis,ISA,Disease,32438453,10.1111/medu.14254,2020-05-22
Therapeutic procedure,METHOD_OF,Pathology,32438453,10.1111/medu.14254,2020-05-22
Therapeutic procedure,TREATS,Disease,32438453,10.1111/medu.14254,2020-05-22
Therapeutic procedure,TREATS(SPEC),Degenerative polyarthritis,32438453,10.1111/medu.14254,2020-05-22
Degenerative polyarthritis,COEXISTS_WITH,patient condition,32438453,10.1111/medu.14254,2020-05-22
Degenerative polyarthritis,PROCESS_OF,Patients,32438453,10.1111/medu.14254,2020-05-22
Acetaminophen,ISA,"Anti-Inflammatory Agents, Non-Steroidal",32438453,10.1111/medu.14254,2020-05-22
Acetaminophen,TREATS,Degenerative polyarthritis,32438453,10.1111/medu.14254,2020-05-22
Pharmaceutical Preparations,TREATS,Degenerative polyarthritis,32438453,10.1111/medu.14254,2020-05-22
Degenerative polyarthritis,PROCESS_OF,Patients,32438453,10.1111/medu.14254,2020-05-22
Physicians,TREATS,Patients,32438453,10.1111/medu.14254,2020-05-22
Pharmacologist,TREATS,Patients,32438453,10.1111/medu.14254,2020-05-22
Clinician,TREATS,Patients,32438453,10.1111/medu.14254,2020-05-22
Pharmaceutical Preparations,TREATS,Homo sapiens,32438425,10.1055/s-0040-1712529,2020-05-22
Fever,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Suspected coronavirus infection,PROCESS_OF,Patients,32438371,10.1038/s41586-020-2368-8,2020-05-22
Disease,CAUSES,Hospital admission,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,CAUSES(SPEC),Hospital admission,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Oxygen,ADMINISTERED_TO,Woman,32438371,10.1038/s41586-020-2368-8,2020-05-22
Fetal Death,PROCESS_OF,Woman,32438371,10.1038/s41586-020-2368-8,2020-05-22
Disease,PROCESS_OF,Woman,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,PROCESS_OF(SPEC),Woman,32438371,10.1038/s41586-020-2368-8,2020-05-22
Confirmation,PROCESS_OF,Woman,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Disease,PROCESS_OF,Pregnant Women,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,PROCESS_OF(SPEC),Pregnant Women,32438371,10.1038/s41586-020-2368-8,2020-05-22
Coronavirus Infections,ISA,Disease,32438371,10.1038/s41586-020-2368-8,2020-05-22
Genes,LOCATION_OF,"Transcription, Genetic",32438345,10.1530/EJE-20-0269,2020-05-22
Malignant neoplasm of thyroid,PROCESS_OF,Patients,32438340,10.1530/EJE-20-0445,2020-05-22
Thyroid Nodule,PROCESS_OF,Patients,32438340,10.1530/EJE-20-0445,2020-05-22
Thyroid Nodule,ISA,Malignant Neoplasms,32438340,10.1530/EJE-20-0445,2020-05-22
Thyrotoxicosis,CAUSES,Complication,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Treatment Protocols,TREATS,Patients,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Conjunctivitis,PROCESS_OF,Patients,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Thyroid Hormones,TREATS,Patients,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Thyroid dysfunction,PROCESS_OF,Patients,32438333,10.1016/j.dsx.2020.05.021,2020-05-22
Diabetes,OCCURS_IN,Patients,32438331,10.1016/j.dsx.2020.05.013,2020-05-22
Diabetes,OCCURS_IN,Patients,32438331,10.1016/j.dsx.2020.05.013,2020-05-22
Antidiabetics,TREATS,Comorbidity,32438331,10.1016/j.dsx.2020.05.013,2020-05-22
Cardiovascular,LOCATION_OF,Comorbidity,32438331,10.1016/j.dsx.2020.05.013,2020-05-22
Diabetes,PROCESS_OF,Patients,32438330,10.1016/j.dsx.2020.05.023,2020-05-22
Natural Birth,ASSOCIATED_WITH,Diabetes,32438330,10.1016/j.dsx.2020.05.023,2020-05-22
Natural Birth,ASSOCIATED_WITH,Coronavirus Infections,32438330,10.1016/j.dsx.2020.05.023,2020-05-22
Infected,PROCESS_OF,Patients,32438330,10.1016/j.dsx.2020.05.023,2020-05-22
Diabetes,PROCESS_OF,Patients,32438330,10.1016/j.dsx.2020.05.023,2020-05-22
Eye,LOCATION_OF,Virus Diseases,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Diabetes,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Diabetes,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Disease,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Liver diseases,PREDISPOSES,Severe Acute Respiratory Syndrome,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Liver Dysfunction,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Severe Acute Respiratory Syndrome,ISA,Disease,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Severe Acute Respiratory Syndrome,PROCESS_OF(SPEC),Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Diabetes,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Liver Dysfunction,PROCESS_OF,Patients,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Infected,PROCESS_OF,Persons,32438329,10.1016/j.dsx.2020.05.011,2020-05-22
Invasive mechanical ventilation NOS,TREATS,Patients,32438256,10.1016/j.jcv.2020.104396,2020-05-22
Aggressive behavior,PROCESS_OF,Population Group,32438256,10.1016/j.jcv.2020.104396,2020-05-22
Mainstreaming (Education),ISA,diagnostic procedure,32438240,10.1016/j.mehy.2020.109754,2020-05-22
Genus: Coronavirus,CAUSES,Pneumonia,32438240,10.1016/j.mehy.2020.109754,2020-05-22
Cessation of life,PROCESS_OF,Homo sapiens,32438037,10.1016/j.phrs.2020.104896,2020-05-22
Infected,PROCESS_OF,Patients,32438037,10.1016/j.phrs.2020.104896,2020-05-22
Antiviral Agents,TREATS,Human virus,32438037,10.1016/j.phrs.2020.104896,2020-05-22
New medications,TREATS,Virus,32438037,10.1016/j.phrs.2020.104896,2020-05-22
Extraction,TREATS,Genus: Coronavirus,32438037,10.1016/j.phrs.2020.104896,2020-05-22
Coronavirus Infections,ISA,Disease,32438018,10.1016/j.hrthm.2020.05.008,2020-05-22
Coronavirus Infections,ISA,Disease,32438018,10.1016/j.hrthm.2020.05.008,2020-05-22
Coronavirus Infections,ISA,Disease,32438018,10.1016/j.hrthm.2020.05.008,2020-05-22
Coronavirus Infections,ISA,Disease,32438018,10.1016/j.hrthm.2020.05.008,2020-05-22
QT interval:Time:Point in time:Heart:Quantitative:EKG,PREDISPOSES,Torsades de Pointes,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Ventricular arrhythmia,PREDISPOSES,Prolonged QT interval,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Pharmaceutical Preparations,TREATS,Patients,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Chloroquine,TREATS,Patients,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Chloroquine,TREATS(INFER),Ventricular arrhythmia,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Ventricular arrhythmia,PROCESS_OF,Patients,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Chloroquine,CAUSES,Prolonged QT interval,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Hydroxychloroquine,CAUSES,Prolonged QT interval,32438005,10.1016/j.wneu.2020.05.019,2020-05-22
Coronavirus Infections,ISA,Disease,32437982,10.1016/j.wneu.2020.05.022,2020-05-22
Coronavirus Infections,ISA,Disease,32437982,10.1016/j.wneu.2020.05.022,2020-05-22
Experience,PROCESS_OF,World,32437946,10.1016/j.jpainsymman.2020.04.155,2020-05-22
Engaged to be married,PROCESS_OF,Family,32437944,10.1016/j.jpainsymman.2020.05.005,2020-05-22
Critical Illness,PROCESS_OF,Patients,32437942,10.1016/j.jpainsymman.2020.04.151,2020-05-22
Critical Illness,PROCESS_OF,Patients,32437942,10.1016/j.jpainsymman.2020.04.151,2020-05-22
Reflecting,PROCESS_OF,Clinician,32437942,10.1016/j.jpainsymman.2020.04.151,2020-05-22
Patients,ISA,Persons,32437935,10.1016/j.ijid.2020.05.024,2020-05-22
Viral exanthem,PROCESS_OF,Persons,32437935,10.1016/j.ijid.2020.05.024,2020-05-22
Viral exanthem,PROCESS_OF(SPEC),Patients,32437935,10.1016/j.ijid.2020.05.024,2020-05-22
Chronic disease,PROCESS_OF,Survivors,32437934,10.1016/j.ijid.2020.05.026,2020-05-22
Lymphopenia,PROCESS_OF,Survivors,32437934,10.1016/j.ijid.2020.05.026,2020-05-22
Troponin I,PART_OF,Patients,32437934,10.1016/j.ijid.2020.05.026,2020-05-22
Asymptomatic,PROCESS_OF,Patients,32437932,10.1016/j.ijid.2020.05.027,2020-05-22
Asymptomatic,PROCESS_OF,Patients,32437932,10.1016/j.ijid.2020.05.027,2020-05-22
Asymptomatic,PROCESS_OF,Patients,32437932,10.1016/j.ijid.2020.05.027,2020-05-22
Symptoms,COEXISTS_WITH,Incubation period,32437932,10.1016/j.ijid.2020.05.027,2020-05-22
Upper respiratory sample,PART_OF,Tract,32437931,10.1016/j.ijid.2020.05.023,2020-05-22
Nasal Swab (procedure),DIAGNOSES,Pneumonia,32437931,10.1016/j.ijid.2020.05.023,2020-05-22
Terminal illness,AFFECTS,Disease,32437929,10.1016/j.ijid.2020.05.011,2020-05-22
Italy,ISA,Country,32437929,10.1016/j.ijid.2020.05.011,2020-05-22
Vaccines,AFFECTS,Cells,32437919,10.1016/j.avsg.2020.04.041,2020-05-22
Vaccines,PART_OF,SARS coronavirus,32437919,10.1016/j.avsg.2020.04.041,2020-05-22
Coronavirus vaccination,METHOD_OF,Prophylactic treatment,32437919,10.1016/j.avsg.2020.04.041,2020-05-22
Acute abdominal pain,PROCESS_OF,Patients,32437915,10.1016/j.bbi.2020.05.026,2020-05-22
Anxiety,PROCESS_OF,Health Personnel,32437912,10.1016/j.ijoa.2020.04.006,2020-05-22
Depressive disorder,PROCESS_OF,Health Personnel,32437912,10.1016/j.ijoa.2020.04.006,2020-05-22
Sleeplessness,PROCESS_OF,Health Personnel,32437912,10.1016/j.ijoa.2020.04.006,2020-05-22
Clinician,TREATS,Patients,32437891,10.1016/j.fct.2020.111418,2020-05-22
Anesthetics,TREATS,Pregnant Women,32437891,10.1016/j.fct.2020.111418,2020-05-22
Pharmaceutical Preparations,CAUSES,Immunotoxicity,32437881,10.1016/j.acap.2020.05.004,2020-05-22
Chemicals,CAUSES,Immunotoxicity,32437881,10.1016/j.acap.2020.05.004,2020-05-22
Cells,LOCATION_OF,Xenobiotics,32437881,10.1016/j.acap.2020.05.004,2020-05-22
Metals,PREDISPOSES,Immunologic Deficiency Syndromes,32437881,10.1016/j.acap.2020.05.004,2020-05-22
Telemedicine,TREATS,Patients,32437877,10.1016/j.resp.2020.103455,2020-05-22
Mechanical ventilation,PRECEDES,respiratory management,32437830,10.1016/j.jhep.2020.05.002,2020-05-22
Therapeutic procedure,TREATS,Phenotype,32437830,10.1016/j.jhep.2020.05.002,2020-05-22
Severe Acute Respiratory Syndrome,NEG_CAUSES,Liver damage,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Transaminases increased,PROCESS_OF,Patients,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Cytoplasm,PART_OF,Hepatocyte,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Cholestasis,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Granuloma,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Hepatitis,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Chronic eosinophilic inflammation,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Massive necrosis,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Liver,LOCATION_OF,Fibrin deposition,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Hepatic impairment,COEXISTS_WITH,patient condition,32437822,10.1016/j.jhin.2020.05.007,2020-05-22
Coronaviridae,PROCESS_OF,Family,32437770,10.1016/j.kint.2020.04.031,2020-05-22
Coronavirus Infections,PROCESS_OF,Pholidota,32437770,10.1016/j.kint.2020.04.031,2020-05-22
Maintenance therapy,TREATS,general population,32437768,10.1016/j.kint.2020.04.030,2020-05-22
Real-Time Polymerase Chain Reaction,METHOD_OF,Observation - diagnostic procedure,32437768,10.1016/j.kint.2020.04.030,2020-05-22
Worse,PROCESS_OF,Patients,32437768,10.1016/j.kint.2020.04.030,2020-05-22
cardiovascular risk factor,PROCESS_OF,general population,32437768,10.1016/j.kint.2020.04.030,2020-05-22
Elevated lactate dehydrogenase,PROCESS_OF,Survivors,32437768,10.1016/j.kint.2020.04.030,2020-05-22
Cessation of life,ASSOCIATED_WITH,Coughing,32437754,10.1016/j.ajic.2020.05.007,2020-05-22
Dyspnea,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32437754,10.1016/j.ajic.2020.05.007,2020-05-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32437754,10.1016/j.ajic.2020.05.007,2020-05-22
Necrotizing Enterocolitis,PROCESS_OF,Infant,32437706,10.1016/j.humpath.2020.04.015,2020-05-22
Elevated IL6,PROCESS_OF,Infant,32437706,10.1016/j.humpath.2020.04.015,2020-05-22
Radionuclide Imaging,DIAGNOSES,Chromosome 2q32-Q33 Deletion Syndrome,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Both lungs,PART_OF,Patients,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Hypercapnic respiratory failure,COEXISTS_WITH,Multiple Organ Failure,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Lung,LOCATION_OF,Biopsy,32437696,10.1016/j.chest.2020.05.515,2020-05-22
neutrophil,PART_OF,Alveolar,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Alveolitis,COEXISTS_WITH,diffuse alveolar damage,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Lung,LOCATION_OF,Dilated capillaries,32437696,10.1016/j.chest.2020.05.515,2020-05-22
Symptom mild,PROCESS_OF,Patients,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Symptom severe,PROCESS_OF,Patients,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Fever,ISA,Symptoms,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Lung,LOCATION_OF,Lesion,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Severe disorder,PROCESS_OF,Patients,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Negative,PROCESS_OF,Patients,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Symptom mild,PROCESS_OF,Patients,32437681,10.1016/j.cels.2020.04.008,2020-05-22
Quarantine,AFFECTS,Coronavirus Infections,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Isolation procedure,AFFECTS,Coronavirus Infections,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Symptoms,PROCESS_OF,Patients,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Delirium,ISA,Confusion,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Dysexecutive syndrome,PROCESS_OF,Patients,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Universities,LOCATION_OF,research,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
nhs trust,LOCATION_OF,research,32437675,10.1016/j.athoracsur.2020.05.001,2020-05-22
Antibiotics,TREATS,"Pneumonia, Viral",32437665,10.1016/j.ajog.2020.05.009,2020-05-22
Hydroxychloroquine,TREATS,"Pneumonia, Viral",32437665,10.1016/j.ajog.2020.05.009,2020-05-22
Acute Disease,PROCESS_OF,Patients,32437665,10.1016/j.ajog.2020.05.009,2020-05-22
Aorta,LOCATION_OF,Acute Disease,32437665,10.1016/j.ajog.2020.05.009,2020-05-22
risk factors,PROCESS_OF,Pregnant Women,32437659,10.1016/j.cell.2020.04.042,2020-05-22
Anxiety symptoms,PROCESS_OF,Pregnant Women,32437659,10.1016/j.cell.2020.04.042,2020-05-22
Depressive Symptoms,PROCESS_OF,Woman,32437659,10.1016/j.cell.2020.04.042,2020-05-22
Mental disorders,PROCESS_OF,Pregnant Women,32437659,10.1016/j.cell.2020.04.042,2020-05-22
Anxiety symptoms,PREDISPOSES,Mental disorders,32437659,10.1016/j.cell.2020.04.042,2020-05-22
Comorbidity,PROCESS_OF,Persons,32437596,10.1056/NEJMoa2015432,2020-05-22
Comorbidity,PROCESS_OF,Old age,32437596,10.1056/NEJMoa2015432,2020-05-22
Severe disorder,PROCESS_OF,Persons,32437596,10.1056/NEJMoa2015432,2020-05-22
Severe disorder,PROCESS_OF,Old age,32437596,10.1056/NEJMoa2015432,2020-05-22
"Vaccines, Attenuated",CAUSES,Protection,32437596,10.1056/NEJMoa2015432,2020-05-22
Vaccines,CAUSES,Immunity,32437596,10.1056/NEJMoa2015432,2020-05-22
Respiratory Insufficiency,CAUSES,Cessation of life,32437587,10.1002/eji.202048663,2020-05-22
Lung,LOCATION_OF,Disease,32437587,10.1002/eji.202048663,2020-05-22
Lung,PART_OF,Patients,32437587,10.1002/eji.202048663,2020-05-22
Lung,LOCATION_OF,Respiratory Failure,32437587,10.1002/eji.202048663,2020-05-22
Protoplasm,LOCATION_OF,Virus,32437587,10.1002/eji.202048663,2020-05-22
Blood capillaries,LOCATION_OF,Microthrombus,32437587,10.1002/eji.202048663,2020-05-22
Influenza,PROCESS_OF,Patients,32437587,10.1002/eji.202048663,2020-05-22
Microthrombus,PROCESS_OF,Patients,32437587,10.1002/eji.202048663,2020-05-22
Influenza,PROCESS_OF,Patients,32437587,10.1002/eji.202048663,2020-05-22
Lung,LOCATION_OF,2 times,32437587,10.1002/eji.202048663,2020-05-22
Neoplasms,MANIFESTATION_OF,intussusceptive angiogenesis,32437587,10.1002/eji.202048663,2020-05-22
Diagnosis,ADMINISTERED_TO,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Fever,PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Teaching Hospitals,LOCATION_OF,Cross-Sectional Studies,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
"Signs and Symptoms, Respiratory",PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Circulatory Process,PROCESS_OF,Community,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Circulatory Process,PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Fever,PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
"Signs and Symptoms, Respiratory",PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Mild disorder,PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Fever,PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
"Signs and Symptoms, Respiratory",PROCESS_OF,Health Personnel,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
Virus,PROCESS_OF,Community,32437575,10.1001/jamanetworkopen.2020.9666,2020-05-22
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Health Personnel,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Hospitals,LOCATION_OF,research,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Asymptomatic,PROCESS_OF,Population Group,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Asymptomatic Infections,OCCURS_IN,Population Group,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Asymptomatic Infections,PROCESS_OF,Health Personnel,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Disease,PROCESS_OF,Health Personnel,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Fever,ISA,Symptoms,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Infection,PROCESS_OF,Health Personnel,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Asymptomatic,PROCESS_OF,Staff,32437547,10.1001/jamainternmed.2020.2233,2020-05-22
Coughing,ISA,Symptoms,32437513,10.1093/clinchem/hvaa122,2020-05-22
Fever,ISA,Symptoms,32437513,10.1093/clinchem/hvaa122,2020-05-22
Asymptomatic,PROCESS_OF,Persons,32437513,10.1093/clinchem/hvaa122,2020-05-22
Laboratory,LOCATION_OF,Assay,32437434,10.1371/journal.pone.0233668,2020-05-22
Hand Hygiene,AFFECTS,Movement,32437432,10.1371/journal.pone.0233744,2020-05-22
Chronic disease,PROCESS_OF,Older people,32437381,10.1371/journal.pone.0233330,2020-05-22
Infected,PROCESS_OF,Persons,32437381,10.1371/journal.pone.0233330,2020-05-22
Did not attend,PROCESS_OF,Patients,32437377,10.1371/journal.pone.0233329,2020-05-22
Italy,ISA,European country,32437340,10.15585/mmwr.mm6920e1,2020-05-22
Infected,PROCESS_OF,Persons,32437340,10.15585/mmwr.mm6920e1,2020-05-22
Possible,PROCESS_OF,Elderly (population group),32437340,10.15585/mmwr.mm6920e1,2020-05-22
Infected,PROCESS_OF,Patients,32437340,10.15585/mmwr.mm6920e1,2020-05-22
abnormal fragmented structure,PART_OF,Family,32437340,10.15585/mmwr.mm6920e1,2020-05-22
Fever,PROCESS_OF,Couples (persons),32437329,10.2196/19369,2020-05-22
"Signs and Symptoms, Respiratory",PROCESS_OF,Couples (persons),32437329,10.2196/19369,2020-05-22
Coronavirus Infections,ISA,Disease,32437316,10.3201/eid2609.202095,2020-05-22
Coronavirus Infections,ISA,Disease,32437316,10.3201/eid2609.202095,2020-05-22
Coronavirus Infections,ISA,Disease,32437316,10.3201/eid2609.202095,2020-05-22
Coronavirus Infections,ISA,Disease,32437316,10.3201/eid2609.202095,2020-05-22
Coronavirus Infections,ISA,Disease,32437316,10.3201/eid2609.202095,2020-05-22
Coronavirus Infections,ISA,Disease,32437314,10.1148/radiol.2020202040,2020-05-22
Disease,PROCESS_OF,Patients,32437314,10.1148/radiol.2020202040,2020-05-22
Body tissue,PART_OF,Patients,32437314,10.1148/radiol.2020202040,2020-05-22
Coronavirus Infections,ISA,Disease,32437314,10.1148/radiol.2020202040,2020-05-22
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32437314,10.1148/radiol.2020202040,2020-05-22
Body tissue,LOCATION_OF,Electron Microscopy,32437314,10.1148/radiol.2020202040,2020-05-22
Immunohistochemistry,DIAGNOSES,Anatomical dead space,32437314,10.1148/radiol.2020202040,2020-05-22
Electron Microscopy,DIAGNOSES,Anatomical dead space,32437314,10.1148/radiol.2020202040,2020-05-22
Body tissue,NEG_LOCATION_OF,Immunohistochemistry,32437314,10.1148/radiol.2020202040,2020-05-22
Body tissue,NEG_LOCATION_OF,Electron Microscopy,32437314,10.1148/radiol.2020202040,2020-05-22
Hemorrhage,COEXISTS_WITH,Finding of brain,32437283,10.2105/AJPH.2020.305732,2020-05-22
Infarction,COEXISTS_WITH,Finding of brain,32437283,10.2105/AJPH.2020.305732,2020-05-22
Acute necrotizing encephalopathy,COEXISTS_WITH,Finding of brain,32437283,10.2105/AJPH.2020.305732,2020-05-22
Health care facility,LOCATION_OF,Magnetic Resonance Imaging,32437283,10.2105/AJPH.2020.305732,2020-05-22
White matter,PART_OF,Corpus Callosum,32437283,10.2105/AJPH.2020.305732,2020-05-22
Virus,PROCESS_OF,Male population group,32437242,10.2217/fon-2020-0358,2020-05-22
Coitus,AFFECTS,Immune response,32437242,10.2217/fon-2020-0358,2020-05-22
Adoptive Immunotherapy,USES,angiotensin converting enzyme 2,32437242,10.2217/fon-2020-0358,2020-05-22
Gonadal Steroid Hormones,INTERACTS_WITH,angiotensin converting enzyme 2,32437242,10.2217/fon-2020-0358,2020-05-22
Multiple Organ Failure,PROCESS_OF,Patients,32437228,10.1177/0025817220923693,2020-05-22
Patients,LOCATION_OF,peripheral blood,32437228,10.1177/0025817220923693,2020-05-22
Insight,PROCESS_OF,Patients,32437228,10.1177/0025817220923693,2020-05-22
Translational Research,USES,Precision Medicine,32437228,10.1177/0025817220923693,2020-05-22
Coronavirus Infections,ISA,Disease,32437181,10.1037/amp0000660,2020-05-22
Coronavirus Infections,ISA,Disease,32437181,10.1037/amp0000660,2020-05-22
2 times,PROCESS_OF,Patients,32437181,10.1037/amp0000660,2020-05-22
BARRIER,TREATS,Patients,32437181,10.1037/amp0000660,2020-05-22
Coronavirus Infections,ISA,Disease,32437181,10.1037/amp0000660,2020-05-22
Phosphoproteins,PART_OF,Nucleocapsid,32437080,10.1002/jmv.26048,2020-05-22
Assay,DIAGNOSES,Disease,32437080,10.1002/jmv.26048,2020-05-22
Assay,USES,Colorimetry,32437080,10.1002/jmv.26048,2020-05-22
Assay,DIAGNOSES,Present,32437080,10.1002/jmv.26048,2020-05-22
Lower respiratory tract infection,PROCESS_OF,Child,32437066,10.1002/hed.26276,2020-05-22
Aggressive Clinical Course,PROCESS_OF,Younger child,32437066,10.1002/hed.26276,2020-05-22
Symptoms,PROCESS_OF,Child,32437066,10.1002/hed.26276,2020-05-22
Disease,PROCESS_OF,Patients,32437052,10.1002/jmv.26035,2020-05-22
Permanent tracheostomy,TREATS,Patients,32437052,10.1002/jmv.26035,2020-05-22
Permanent tracheostomy,TREATS(INFER),Disease,32437052,10.1002/jmv.26035,2020-05-22
Coronavirus Infections,ISA,Disease,32437052,10.1002/jmv.26035,2020-05-22
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32437052,10.1002/jmv.26035,2020-05-22
Critical Illness,PROCESS_OF,Patients,32437052,10.1002/jmv.26035,2020-05-22
patient condition,PROCESS_OF,Patients,32437052,10.1002/jmv.26035,2020-05-22
"CD69 protein, human",ADMINISTERED_TO,Patients,32437052,10.1002/jmv.26035,2020-05-22
Keel structure,LOCATION_OF,Endotracheal tube,32437052,10.1002/jmv.26035,2020-05-22
Keel structure,LOCATION_OF,Endotracheal tube,32437052,10.1002/jmv.26035,2020-05-22
Coronavirus Infections,AFFECTS,World,32437033,10.1002/hed.26279,2020-05-22
Belgium,ISA,Country,32437033,10.1002/hed.26279,2020-05-22
Netherlands,ISA,Country,32437033,10.1002/hed.26279,2020-05-22
Russia,ISA,Country,32437033,10.1002/hed.26279,2020-05-22
Sweden,ISA,Country,32437033,10.1002/hed.26279,2020-05-22
United Kingdom,ISA,Country,32437033,10.1002/hed.26279,2020-05-22
Nose,LOCATION_OF,Chief complaint (finding),32437032,10.1002/hed.26272,2020-05-22
Fatigue,ISA,Symptoms,32437032,10.1002/hed.26272,2020-05-22
Nose,LOCATION_OF,Obstruction,32437032,10.1002/hed.26272,2020-05-22
Nose,LOCATION_OF,Obstruction,32437032,10.1002/hed.26272,2020-05-22
Head and neck structure,LOCATION_OF,Neoplasms,32437031,10.1002/hed.26169,2020-05-22
Head and neck structure,LOCATION_OF,Neoplasms,32437031,10.1002/hed.26169,2020-05-22
Malignant Neoplasms,PROCESS_OF,Patients,32437031,10.1002/hed.26169,2020-05-22
Asymptomatic,PROCESS_OF,Patients,32437017,10.1002/jmv.26032,2020-05-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
Comorbidity,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
Malaise,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
Atypical Lipoma,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
Non-invasive mechanical ventilation,TREATS,Patients,32437016,10.1002/jmv.26039,2020-05-22
Non-invasive mechanical ventilation,TREATS(INFER),3 - severe,32437016,10.1002/jmv.26039,2020-05-22
3 - severe,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
Comorbidity,PROCESS_OF,Patients,32437016,10.1002/jmv.26039,2020-05-22
risk factors,PROCESS_OF,Patients,32437014,10.1002/jmv.26040,2020-05-22
Cessation of life,PROCESS_OF,Patients,32437014,10.1002/jmv.26040,2020-05-22
risk factors,PROCESS_OF,Patients,32437014,10.1002/jmv.26040,2020-05-22
Duration,TREATS,Viral Shedding,32437004,10.1002/jmv.26036,2020-05-22
Hepatocyte,INTERACTS_WITH,angiotensin converting enzyme 2,32436996,10.1002/jmv.26031,2020-05-22
Disease,CAUSES,Liver Failure,32436996,10.1002/jmv.26031,2020-05-22
Severe disorder,PROCESS_OF,Patients,32436996,10.1002/jmv.26031,2020-05-22
Mild disorder,PROCESS_OF,Patients,32436996,10.1002/jmv.26031,2020-05-22
risk factors,PROCESS_OF,Patients,32436996,10.1002/jmv.26031,2020-05-22
Heart Diseases,PROCESS_OF,Patients,32436994,10.1002/jmv.26038,2020-05-22
tocilizumab,INHIBITS,Interleukin-6,32436948,10.1210/clinem/dgaa276,2020-05-22
Disease,PROCESS_OF,Patients,32436948,10.1210/clinem/dgaa276,2020-05-22
"Respiratory Distress Syndrome, Adult",ISA,Complication,32436948,10.1210/clinem/dgaa276,2020-05-22
tocilizumab,TREATS,patient condition,32436948,10.1210/clinem/dgaa276,2020-05-22
C-reactive protein measurement,DIAGNOSES,Hyperinflammatory state,32436948,10.1210/clinem/dgaa276,2020-05-22
Subacute thyroiditis,ISA,Thyroid Diseases,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Goiter,PROCESS_OF,Patients,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Pain,PROCESS_OF,Patients,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Tachycardia,PROCESS_OF,Patients,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Neck,LOCATION_OF,Ultrasonography,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Severe Acute Respiratory Syndrome,PRECEDES,Subacute thyroiditis,32436867,10.4103/ijmm.IJMM_20_54,2020-05-22
Homologous Gene,ASSOCIATED_WITH,Coronavirus Infections,32436847,10.5152/dir.2019.20176,2020-05-22
Pharmaceutical Preparations,TREATS,Patients,32436847,10.5152/dir.2019.20176,2020-05-22
Endopeptidases,ISA,Pharmaceutical Preparations,32436847,10.5152/dir.2019.20176,2020-05-22
Endopeptidases,TREATS(SPEC),Patients,32436847,10.5152/dir.2019.20176,2020-05-22
inhibitors,ISA,Pharmaceutical Preparations,32436847,10.5152/dir.2019.20176,2020-05-22
inhibitors,TREATS(SPEC),Patients,32436847,10.5152/dir.2019.20176,2020-05-22
lobe,PART_OF,Lung,32436845,10.5152/dir.2019.20294,2020-05-22
lobe,PART_OF,Left lung,32436845,10.5152/dir.2019.20294,2020-05-22
Lung,PART_OF,Patients,32436829,10.2174/1566524020666200521075848,2020-05-22
Hypersensitivity,PREDISPOSES,Pneumonia,32436829,10.2174/1566524020666200521075848,2020-05-22
Coitus,PROCESS_OF,Patients,32436617,10.1111/dth.13639,2020-05-22
associated disease,PROCESS_OF,Patients,32436617,10.1111/dth.13639,2020-05-22
,INTERACTS_WITH,Pharmaceutical Preparations,32436581,10.7556/jaoa.2020.064,2020-05-22
Immunosuppressive Agents,TREATS,Dermatologic disorders,32436581,10.7556/jaoa.2020.064,2020-05-22
IMPACT gene,ASSOCIATED_WITH,Infection,32436581,10.7556/jaoa.2020.064,2020-05-22
Lung,LOCATION_OF,Symptoms,32436578,10.1093/pubmed/fdaa068,2020-05-22
Engaged to be married,PROCESS_OF,Community,32436571,10.1093/cid/ciaa599,2020-05-22
India,ISA,Country,32436481,10.1017/cem.2020.399,2020-05-22
Medical transport,PROCESS_OF,Administrators,32436460,10.1177/1753466620926800,2020-05-22
Alveolar Epithelial Cells,LOCATION_OF,Apoptosis,32436446,10.1080/08959420.2020.1765685,2020-05-22
Rapidly progressive,PROCESS_OF,Patients,32436446,10.1080/08959420.2020.1765685,2020-05-22
Disease Progression,PROCESS_OF,Patients,32436446,10.1080/08959420.2020.1765685,2020-05-22
Etanercept,TREATS,Disease Progression,32436446,10.1080/08959420.2020.1765685,2020-05-22
Adrenal Cortex Hormones,ASSOCIATED_WITH,Pneumonia,32436441,10.1177/0145561320925191,2020-05-22
Nose,LOCATION_OF,Obstruction,32436422,10.1080/17441692.2020.1769702,2020-05-22
Engaged to be married,PROCESS_OF,Male population group,32436405,10.1177/1090198120929677,2020-05-22
Pneumonia,AFFECTS,Patients,32436262,10.1111/dth.13627,2020-05-22
IMPACT gene,PART_OF,Male population group,32436262,10.1111/dth.13627,2020-05-22
IMPACT gene,PART_OF,Woman,32436262,10.1111/dth.13627,2020-05-22
IMPACT gene,PART_OF,SARS coronavirus,32436262,10.1111/dth.13627,2020-05-22
Testosterone,TREATS,Stable Disease,32436262,10.1111/dth.13627,2020-05-22
Fibrin fragment D,ISA,Fibrinogen,32436262,10.1111/dth.13627,2020-05-22
C-reactive protein,COEXISTS_WITH,Testosterone,32436262,10.1111/dth.13627,2020-05-22
Testosterone,PART_OF,Male population group,32436262,10.1111/dth.13627,2020-05-22
Prognosis bad,PROCESS_OF,Male population group,32436262,10.1111/dth.13627,2020-05-22
Infected,PROCESS_OF,Male population group,32436262,10.1111/dth.13627,2020-05-22
sanitizers,USES,Ethanol,32436251,10.1111/bjh.16736,2020-05-22
Ethanol,TREATS,Crisis,32436251,10.1111/bjh.16736,2020-05-22
Hemorrhage,PROCESS_OF,Patients,32436229,10.1111/and.13654,2020-05-22
Massive hemorrhage,PROCESS_OF,Patients,32436229,10.1111/and.13654,2020-05-22
Lung,LOCATION_OF,Macrophage Activation Syndrome,32436105,10.1007/s00415-020-09885-2,2020-05-22
Italy,ISA,Country,32436101,10.1007/s00415-020-09896-z,2020-05-22
case series,USES,Reverse Transcriptase Polymerase Chain Reaction,32436101,10.1007/s00415-020-09896-z,2020-05-22
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Blood Vessel,LOCATION_OF,risk factors,32436101,10.1007/s00415-020-09896-z,2020-05-22
risk factors,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Cerebrovascular accident,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Encephalopathies,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Abnormal behavior,COEXISTS_WITH,Cerebrovascular accident,32436101,10.1007/s00415-020-09896-z,2020-05-22
Abnormal behavior,COEXISTS_WITH,Encephalopathies,32436101,10.1007/s00415-020-09896-z,2020-05-22
"Seizures, Focal",COEXISTS_WITH,Cerebrovascular accident,32436101,10.1007/s00415-020-09896-z,2020-05-22
"Seizures, Focal",COEXISTS_WITH,Encephalopathies,32436101,10.1007/s00415-020-09896-z,2020-05-22
Elevation procedure,USES,Lactate Dehydrogenase,32436101,10.1007/s00415-020-09896-z,2020-05-22
Multiple Organ Failure,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Pneumonia,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Cerebrovascular accident,PROCESS_OF,Patients,32436101,10.1007/s00415-020-09896-z,2020-05-22
Present,COEXISTS_WITH,Coronavirus Infections,32436038,10.1007/s00132-020-03926-4,2020-05-22
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32436005,10.1007/s00240-020-01193-8,2020-05-22
Extracorporeal Membrane Oxygenation,TREATS,"Respiratory Distress Syndrome, Adult",32436005,10.1007/s00240-020-01193-8,2020-05-22
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32436005,10.1007/s00240-020-01193-8,2020-05-22
Terminal illness,CAUSES,Disease,32435987,10.1007/s40258-020-00595-4,2020-05-22
Intervention regimes,TREATS,Patients,32435987,10.1007/s40258-020-00595-4,2020-05-22
General Anesthesia,METHOD_OF,Anesthesia procedures,32435987,10.1007/s40258-020-00595-4,2020-05-22
Coronavirus Infections,ISA,Disease,32435961,10.1007/s00464-020-07631-3,2020-05-22
Coronavirus Infections,ISA,Disease,32435961,10.1007/s00464-020-07631-3,2020-05-22
Coronavirus Infections,ISA,Disease,32435961,10.1007/s00464-020-07631-3,2020-05-22
Coronavirus Infections,ISA,Disease,32435961,10.1007/s00464-020-07631-3,2020-05-22
Illness (finding),PROCESS_OF,Patients,32435934,10.1007/s11739-020-02370-8,2020-05-22
Physicians,ISA,Health Personnel,32435934,10.1007/s11739-020-02370-8,2020-05-22
Disease,PROCESS_OF,Patients,32435934,10.1007/s11739-020-02370-8,2020-05-22
Clinician,LOCATION_OF,"TLR4 protein, human",32435934,10.1007/s11739-020-02370-8,2020-05-22
Respiratory failure without hypercapnia,PROCESS_OF,Patients,32435925,10.1007/s00330-020-06920-8,2020-05-22
Chest CT,ADMINISTERED_TO,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
lobe,PART_OF,Lung,32435920,10.1186/s40345-020-00191-4,2020-05-22
Lung,LOCATION_OF,Decreased translucency,32435920,10.1186/s40345-020-00191-4,2020-05-22
Decreased translucency,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Chromosome 2q32-Q33 Deletion Syndrome,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Ground Glass Opacity,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Lung,PART_OF,Caucasoid Race,32435920,10.1186/s40345-020-00191-4,2020-05-22
Mild disease course,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Severe course,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Symptom aggravating factors,PROCESS_OF,Patients,32435920,10.1186/s40345-020-00191-4,2020-05-22
Chest,LOCATION_OF,"Tomography, X-Ray",32435920,10.1186/s40345-020-00191-4,2020-05-22
Chest CT,DIAGNOSES,Rapidly progressive,32435920,10.1186/s40345-020-00191-4,2020-05-22
Pneumonia,NEG_ISA,Symptoms,32435920,10.1186/s40345-020-00191-4,2020-05-22
First line treatment,TREATS,Disease,32435890,10.1007/s00381-020-04671-x,2020-05-22
Lithium,PREVENTS,Toxic effect,32435890,10.1007/s00381-020-04671-x,2020-05-22
Body tissue,LOCATION_OF,Lithium,32435890,10.1007/s00381-020-04671-x,2020-05-22
Challenge,TREATS,Community,32435882,10.1007/s10928-020-09690-4,2020-05-22
Fracture,ISA,Wounds and Injuries,32435882,10.1007/s10928-020-09690-4,2020-05-22
Indomethacin,ISA,Anti-Inflammatory Agents,32435879,10.1007/s00467-020-04597-1,2020-05-22
Indomethacin,TREATS,Canis familiaris,32435879,10.1007/s00467-020-04597-1,2020-05-22
Indomethacin,TREATS,Homo sapiens,32435879,10.1007/s00467-020-04597-1,2020-05-22
physiological aspects,PROCESS_OF,Homo sapiens,32435879,10.1007/s00467-020-04597-1,2020-05-22
In complete remission,PROCESS_OF,Patients,32435879,10.1007/s00467-020-04597-1,2020-05-22
Sustained-Release Preparations,TREATS,In complete remission,32435879,10.1007/s00467-020-04597-1,2020-05-22
Clinical Trials,MEASURES,Indomethacin,32435879,10.1007/s00467-020-04597-1,2020-05-22
Glomerular filtration,PROCESS_OF,Patients,32435872,10.1007/10_2020_127,2020-05-22
Dose Adjustment,USES,Pharmaceutical Preparations,32435872,10.1007/10_2020_127,2020-05-22
Steroid-dependent nephrotic syndrome,PROCESS_OF,Patients,32435872,10.1007/10_2020_127,2020-05-22
Dose Adjustment,USES,Pharmaceutical Preparations,32435872,10.1007/10_2020_127,2020-05-22
Warburg Therapy,TREATS,Disease,32435872,10.1007/10_2020_127,2020-05-22
Infected,PROCESS_OF,Patients,32435867,10.1007/s00508-020-01672-3,2020-05-22
Diabetes,PROCESS_OF,Patients,32435829,10.1007/s00270-020-02493-7,2020-05-22
Diabetes Mellitus,PREDISPOSES,Severe course,32435829,10.1007/s00270-020-02493-7,2020-05-22
Comorbidity,PROCESS_OF,Patients,32435829,10.1007/s00270-020-02493-7,2020-05-22
Diabetes,PROCESS_OF,Patients,32435829,10.1007/s00270-020-02493-7,2020-05-22
Insulin,INTERACTS_WITH,Blood Glucose,32435829,10.1007/s00270-020-02493-7,2020-05-22
Antidiabetics,INTERACTS_WITH,Blood Glucose,32435829,10.1007/s00270-020-02493-7,2020-05-22
Diabetes,PROCESS_OF,Patients,32435829,10.1007/s00270-020-02493-7,2020-05-22
Diabetes,PROCESS_OF,Patients,32435829,10.1007/s00270-020-02493-7,2020-05-22
X-Ray Departments,LOCATION_OF,Administration occupational activities,32435809,10.1093/pubmed/fdaa070,2020-05-22
Minority Groups,ISA,Racial group,32435791,10.1093/cid/ciaa623,2020-05-22
African American,ISA,Racial group,32435791,10.1093/cid/ciaa623,2020-05-22
Hydroxychloroquine,compared_with,Hydroxychloroquine,32435695,10.1186/s41256-020-00152-5,2020-05-22
Infected,PROCESS_OF,Persons,32435645,10.3389/fmed.2020.00169,2020-05-22
angiotensin converting enzyme 2,NEG_AFFECTS,Virus Internalization,32435500,10.1186/s40545-020-00215-5,2020-05-22
angiotensin II,AUGMENTS,protective drug effect,32435500,10.1186/s40545-020-00215-5,2020-05-22
angiotensin converting enzyme 2,INTERACTS_WITH,angiotensin II,32435500,10.1186/s40545-020-00215-5,2020-05-22
angiotensin converting enzyme 2,AFFECTS,Very Important,32435500,10.1186/s40545-020-00215-5,2020-05-22
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32435268,10.7573/dic.2020-4-12,2020-05-22
"Psychotherapy, Multiple",ADMINISTERED_TO,Patients,32435268,10.7573/dic.2020-4-12,2020-05-22
intensive care unit,LOCATION_OF,Study,32435268,10.7573/dic.2020-4-12,2020-05-22
Chest CT,ISA,tomography,32435268,10.7573/dic.2020-4-12,2020-05-22
Malignant Neoplasms,PROCESS_OF,Child,32435173,10.1186/s10397-020-01070-7,2020-05-22
Malignant Neoplasms,PROCESS_OF,Child,32435173,10.1186/s10397-020-01070-7,2020-05-22
Infection,AFFECTS,Diffusion,32435065,10.1055/a-1156-3991,2020-05-22
Minimally Invasive Surgical Procedures,ISA,Interventional procedure,32435065,10.1055/a-1156-3991,2020-05-22
Virus Diseases,CAUSES,Challenge,32434946,10.1126/science.abc4776,2020-05-22
intensive care,TREATS,Patients,32434946,10.1126/science.abc4776,2020-05-22
Acute Lung Injury,PROCESS_OF,Patients,32434946,10.1126/science.abc4776,2020-05-22
Assisted breathing,TREATS,Single organ dysfunction,32434946,10.1126/science.abc4776,2020-05-22
Macaca mulatta,LOCATION_OF,"Vitronectin, human",32434891,10.1136/bmj.m1997,2020-05-22
Cellular Immune Response,PROCESS_OF,Macaca,32434891,10.1136/bmj.m1997,2020-05-22
Cellular Immune Response,PROCESS_OF,Homo sapiens,32434891,10.1136/bmj.m1997,2020-05-22
Respiratory Tract Diseases,COEXISTS_WITH,Genus: Coronavirus,32434874,10.1136/postgradmedj-2020-137884,2020-05-22
Respiratory Tract Diseases,PROCESS_OF,Homo sapiens,32434874,10.1136/postgradmedj-2020-137884,2020-05-22
Virus,PROCESS_OF,Homo sapiens,32434874,10.1136/postgradmedj-2020-137884,2020-05-22
ciliated cell,LOCATION_OF,Virus,32434874,10.1136/postgradmedj-2020-137884,2020-05-22
Pneumonia,PROCESS_OF,Patients,32434806,10.3949/ccjm.87a.ccc034,2020-05-22
pro-brain natriuretic peptide (1-76),ASSOCIATED_WITH,Pneumonia,32434806,10.3949/ccjm.87a.ccc034,2020-05-22
Adrenal Medulla,LOCATION_OF,renal hypoxia,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Kidney,LOCATION_OF,Hypoperfusion,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Viral myocarditis,CAUSES,Rhabdomyolysis,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Viral myocarditis,CAUSES,renal hypoxia,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Viral myocarditis,CAUSES,Cardio-Renal Syndrome,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Hypoperfusion,CAUSES,Septicemia,32434805,10.3949/ccjm.87a.ccc035,2020-05-22
Confirmation,PROCESS_OF,Patients,32434798,10.1136/neurintsurg-2020-016161,2020-05-22
Challenge,TREATS,teams,32434798,10.1136/neurintsurg-2020-016161,2020-05-22
Patients,USES,Mobility aid,32434798,10.1136/neurintsurg-2020-016161,2020-05-22
Caregiver,USES,Mobility aid,32434798,10.1136/neurintsurg-2020-016161,2020-05-22
Practitioner,DIAGNOSES,Pyotraumatic dermatitis,32434790,10.1136/jitc-2020-000933,2020-05-22
Neurosurgical Procedures,TREATS,Patients,32434790,10.1136/jitc-2020-000933,2020-05-22
Inflammation,COEXISTS_WITH,Infection,32434789,10.1136/jitc-2020-000898,2020-05-22
Lung,LOCATION_OF,Inflammation,32434789,10.1136/jitc-2020-000898,2020-05-22
Organ,LOCATION_OF,Inflammation,32434789,10.1136/jitc-2020-000898,2020-05-22
Cardiopulmonary,LOCATION_OF,Comorbidity,32434789,10.1136/jitc-2020-000898,2020-05-22
Infected,PROCESS_OF,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
Decision,PROCESS_OF,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
Symptoms,PROCESS_OF,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
IMPACT gene,PART_OF,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
Malignant Neoplasms,PROCESS_OF,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
Clinician,TREATS,Patients,32434789,10.1136/jitc-2020-000898,2020-05-22
inhibitors,CAUSES,Adverse event,32434788,10.1136/jitc-2020-000892,2020-05-22
Immunotherapy,USES,ipilimumab,32434788,10.1136/jitc-2020-000892,2020-05-22
"stage, melanoma",PROCESS_OF,Male population group,32434788,10.1136/jitc-2020-000892,2020-05-22
Immunotherapy,TREATS,Pneumonia,32434788,10.1136/jitc-2020-000892,2020-05-22
Immunotherapy,USES,ipilimumab,32434788,10.1136/jitc-2020-000892,2020-05-22
melanoma,PROCESS_OF,Patients,32434788,10.1136/jitc-2020-000892,2020-05-22
nivolumab,TREATS,Pneumonia,32434788,10.1136/jitc-2020-000892,2020-05-22
Patients,LOCATION_OF,IMPACT gene,32434788,10.1136/jitc-2020-000892,2020-05-22
Pneumonia,PROCESS_OF,Patients,32434788,10.1136/jitc-2020-000892,2020-05-22
Critical Illness,PROCESS_OF,Patients,32434770,10.1136/jclinpath-2020-206711,2020-05-22
intensive care,TREATS,Patients,32434770,10.1136/jclinpath-2020-206711,2020-05-22
intensive care,TREATS(INFER),Critical Illness,32434770,10.1136/jclinpath-2020-206711,2020-05-22
Malignant Neoplasms,PROCESS_OF,Patients,32434770,10.1136/jclinpath-2020-206711,2020-05-22
Patients,ISA,Persons,32434770,10.1136/jclinpath-2020-206711,2020-05-22
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32434770,10.1136/jclinpath-2020-206711,2020-05-22
Epithelium,LOCATION_OF,Acute Lung Injury,32434770,10.1136/jclinpath-2020-206711,2020-05-22
cytokine,AFFECTS,Pneumonia,32434770,10.1136/jclinpath-2020-206711,2020-05-22
Neoplasms,PROCESS_OF,Patients,32434728,10.1016/j.jstrokecerebrovasdis.2020.104927,2020-05-22
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32434708,10.1016/j.jcv.2020.104437,2020-05-22
Evaluation procedure,TREATS,Acute Cerebrovascular Accidents,32434708,10.1016/j.jcv.2020.104437,2020-05-22
Cerebrovascular accident,PROCESS_OF,Patients,32434708,10.1016/j.jcv.2020.104437,2020-05-22
Health Personnel,TREATS,Patients,32434708,10.1016/j.jcv.2020.104437,2020-05-22
Evaluation,COEXISTS_WITH,CODE protocol,32434708,10.1016/j.jcv.2020.104437,2020-05-22
Health Personnel,ISA,Cohort,32434707,10.1016/j.jcv.2020.104434,2020-05-22
Lassa virus,CAUSES,"Hemorrhagic Fevers, Viral",32434706,10.1016/j.jcv.2020.104428,2020-05-22
Coronavirus Infections,ISA,Disease,32434620,10.1017/ipm.2020.59,2020-05-22
Pandemics,CAUSES,Disease,32434620,10.1017/ipm.2020.59,2020-05-22
General wellbeing,PROCESS_OF,Health Personnel,32434615,10.1017/ipm.2020.60,2020-05-22
Mental concentration,PROCESS_OF,Clinician,32434615,10.1017/ipm.2020.60,2020-05-22
Anorexia Nervosa,COEXISTS_WITH,Complication,32434611,10.1017/ipm.2020.56,2020-05-22
Psychotic Disorders,AFFECTS,Persons,32434610,10.1017/ipm.2020.58,2020-05-22
Confusion,PROCESS_OF,Policy Makers,32434606,10.1017/ipm.2020.53,2020-05-22
Schizophrenia,PROCESS_OF,Patients,32434606,10.1017/ipm.2020.53,2020-05-22
Recovery of Function,PREDISPOSES,Violence,32434606,10.1017/ipm.2020.53,2020-05-22
Mental Health Services,TREATS,Persons,32434605,10.1017/ipm.2020.61,2020-05-22
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32434605,10.1017/ipm.2020.61,2020-05-22
Attention deficit hyperactivity disorder,PROCESS_OF,Persons,32434605,10.1017/ipm.2020.61,2020-05-22
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32434605,10.1017/ipm.2020.61,2020-05-22
Evaluation procedure,COEXISTS_WITH,Pharmacotherapy Initiation,32434605,10.1017/ipm.2020.61,2020-05-22
Transection (procedure),TREATS,Attention deficit hyperactivity disorder,32434605,10.1017/ipm.2020.61,2020-05-22
Attention deficit hyperactivity disorder,PROCESS_OF,Child,32434605,10.1017/ipm.2020.61,2020-05-22
Attention deficit hyperactivity disorder,PROCESS_OF,Adolescent (age group),32434605,10.1017/ipm.2020.61,2020-05-22
Obsessive-Compulsive Disorder,PROCESS_OF,Patients,32434603,10.1017/ipm.2020.52,2020-05-22
Obsessive-Compulsive Disorder,PROCESS_OF,Patients,32434603,10.1017/ipm.2020.52,2020-05-22
Mental disorders,PROCESS_OF,Persons,32434603,10.1017/ipm.2020.52,2020-05-22
Mental disorders,PROCESS_OF,Patients,32434602,10.1017/ipm.2020.55,2020-05-22
Mental disorders,PROCESS_OF,Vulnerable Populations,32434602,10.1017/ipm.2020.55,2020-05-22
Mental Health Services,AFFECTS,Has difficulty doing (qualifier value),32434599,10.1017/ipm.2020.62,2020-05-22
Insight,PROCESS_OF,Child,32434599,10.1017/ipm.2020.62,2020-05-22
Addictive Behavior,PROCESS_OF,Patients,32434596,10.1017/ipm.2020.54,2020-05-22
Critical Illness,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,ISA,Disease,32434416,10.1080/21505594.2020.1763637,2020-05-22
Critical Illness,AFFECTS,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,ISA,Disease,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Critical Illness,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,ISA,Disease,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Critical Illness,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Critical Illness,PROCESS_OF,Patients,32434416,10.1080/21505594.2020.1763637,2020-05-22
Coronavirus Infections,ISA,Disease,32434416,10.1080/21505594.2020.1763637,2020-05-22
Pluripotent Stem Cells,PART_OF,Homo sapiens,32434403,10.1080/14767058.2020.1765334,2020-05-22
Coronavirus Infections,ISA,Disease,32434402,10.1177/0020764020925835,2020-05-22
Tract,LOCATION_OF,Severe Acute Respiratory Syndrome,32434402,10.1177/0020764020925835,2020-05-22
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,Virus,32434402,10.1177/0020764020925835,2020-05-22
Disease,AFFECTS,Pregnancy,32434402,10.1177/0020764020925835,2020-05-22
Coronavirus Infections,AFFECTS(SPEC),Pregnancy,32434402,10.1177/0020764020925835,2020-05-22
Coronavirus Infections,ISA,Disease,32434402,10.1177/0020764020925835,2020-05-22
Coronavirus Infections,ISA,Disease,32434314,10.23736/S1973-9087.20.06317-0,2020-05-22
Coronavirus Infections,ISA,Disease,32434314,10.23736/S1973-9087.20.06317-0,2020-05-22
Sequela of disorder,PROCESS_OF,Survivors,32434310,10.21053/ceo.2020.00570,2020-05-22
acute care,PREVENTS,Disability,32434310,10.21053/ceo.2020.00570,2020-05-22
Fever,COEXISTS_WITH,patient condition,32434289,10.4097/kja.20182,2020-05-21
Respiratory Tract Infections,PROCESS_OF,Patients,32434289,10.4097/kja.20182,2020-05-21
Less often,PROCESS_OF,Patients,32434289,10.4097/kja.20182,2020-05-21
Less often,PROCESS_OF,Patients,32434289,10.4097/kja.20182,2020-05-21
Dyspnea,PROCESS_OF,Patients,32434289,10.4097/kja.20182,2020-05-21
Fever,PROCESS_OF,Patients,32434289,10.4097/kja.20182,2020-05-21
Intubation,ADMINISTERED_TO,Anesthetist,32434272,10.1111/all.14409,2020-05-21
Anesthetist,USES,Videolaryngoscope,32434272,10.1111/all.14409,2020-05-21
Community,LOCATION_OF,Enzymes,32434254,10.1055/a-1177-4396,2020-05-21
Natural Products,DISRUPTS,Infection,32434211,10.1038/s41586-020-2355-0,2020-05-21
Host Cell,PART_OF,Virus,32434211,10.1038/s41586-020-2355-0,2020-05-21
"Oils, Volatile",PREVENTS,inflammatory response,32434211,10.1038/s41586-020-2355-0,2020-05-21
Disease,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Urologic Diseases,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Urologic Diseases,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Hematuria,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Urinary tract infection,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Wounds and Injuries,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Urinary Retention,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Renal Colic,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Pain in scrotum,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Disease,PROCESS_OF,Patients,32434145,10.2196/19862,2020-05-21
Coronavirus Infections,ISA,Disease,32434133,10.1016/j.carpath.2020.107233,2020-05-21
Coronavirus Infections,ISA,Disease,32434133,10.1016/j.carpath.2020.107233,2020-05-21
Coronavirus Infections,ISA,Disease,32434133,10.1016/j.carpath.2020.107233,2020-05-21
Systemic disease,AFFECTS,Severe (severity modifier),32434108,10.1016/j.ejca.2020.04.034,2020-05-21
Structure of arteriole,LOCATION_OF,Fibrin deposition,32434108,10.1016/j.ejca.2020.04.034,2020-05-21
Glomerular capillaries structure,LOCATION_OF,Thrombosis,32434108,10.1016/j.ejca.2020.04.034,2020-05-21
Malignant Neoplasms,PROCESS_OF,Patients,32434093,10.1016/j.psychres.2020.113076,2020-05-21
Active Method,TREATS,Neoplasms,32434093,10.1016/j.psychres.2020.113076,2020-05-21
Malignant Neoplasms,PROCESS_OF,Patients,32434093,10.1016/j.psychres.2020.113076,2020-05-21
Coronavirus Infections,PROCESS_OF,Patients,32434093,10.1016/j.psychres.2020.113076,2020-05-21
Malignant Neoplasms,PROCESS_OF,Patients,32434093,10.1016/j.psychres.2020.113076,2020-05-21
Sleeplessness,COEXISTS_WITH,Crisis,32434092,10.1016/j.psychres.2020.113098,2020-05-21
Difficulty sleeping,PROCESS_OF,Population Group,32434092,10.1016/j.psychres.2020.113098,2020-05-21
Difficulty sleeping,PROCESS_OF(SPEC),Greeks,32434092,10.1016/j.psychres.2020.113098,2020-05-21
Greeks,ISA,Population Group,32434092,10.1016/j.psychres.2020.113098,2020-05-21
Difficulty sleeping,PROCESS_OF,Persons,32434092,10.1016/j.psychres.2020.113098,2020-05-21
Adult,LOCATION_OF,IMPACT gene,32434058,10.1016/j.scitotenv.2020.139278,2020-05-21
IMPACT gene,ASSOCIATED_WITH,Anxiety,32434058,10.1016/j.scitotenv.2020.139278,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Disease,AFFECTS,viral transmission,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,AFFECTS(SPEC),viral transmission,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Chloroquine,TREATS,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Chloroquine,TREATS(SPEC),Coronavirus Infections,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Hydroxychloroquine,TREATS,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Hydroxychloroquine,TREATS(SPEC),Coronavirus Infections,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Hydroxychloroquine,compared_with,Chloroquine,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Hydroxychloroquine,higher_than,Chloroquine,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Coronavirus Infections,ISA,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
nafamostat mesilate,DISRUPTS,Membrane Fusion,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Body organ structure,LOCATION_OF,Disease,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
Body organ structure,LOCATION_OF(SPEC),Coronavirus Infections,32433946,10.1016/j.immuni.2020.04.012,2020-05-21
associated disease,AFFECTS,Population Group,32433907,10.3201/eid2609.201469,2020-05-21
IMPACT gene,PART_OF,Pathogenic organism,32433907,10.3201/eid2609.201469,2020-05-21
Coronavirus Infections,ISA,Disease,32433817,10.1002/acn3.51067,2020-05-21
Coronavirus Infections,ISA,Disease,32433817,10.1002/acn3.51067,2020-05-21
Disease,COEXISTS_WITH,Mass gathering,32433817,10.1002/acn3.51067,2020-05-21
Coronavirus Infections,COEXISTS_WITH(SPEC),Mass gathering,32433817,10.1002/acn3.51067,2020-05-21
Coronavirus Infections,ISA,Disease,32433817,10.1002/acn3.51067,2020-05-21
Basal segment of lung,LOCATION_OF,Normal limits,32433796,10.1002/ccd.28982,2020-05-21
Neurologic Manifestations,PROCESS_OF,Patients,32433796,10.1002/ccd.28982,2020-05-21
Acute confusional state,ISA,Symptoms,32433796,10.1002/ccd.28982,2020-05-21
Pathogenic organism,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32433465,10.1038/s41467-020-16505-0,2020-05-21
Genus: Coronavirus,COEXISTS_WITH,SARS coronavirus,32433465,10.1038/s41467-020-16505-0,2020-05-21
Genotype,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32433465,10.1038/s41467-020-16505-0,2020-05-21
Coronavirus Infections,PROCESS_OF,Family member,32433453,10.1097/AOG.0000000000003979,2020-05-21
Agent,TREATS,Virus Diseases,32433453,10.1097/AOG.0000000000003979,2020-05-21
Surface Antigens,PART_OF,Genus: Coronavirus,32433453,10.1097/AOG.0000000000003979,2020-05-21
ACE2 gene,INHIBITS,Antibodies,32433453,10.1097/AOG.0000000000003979,2020-05-21
Patient in hospital,PROCESS_OF,Pregnant Women,32433448,10.1097/AOG.0000000000003985,2020-05-21
Severe disorder,PROCESS_OF,Patients,32433448,10.1097/AOG.0000000000003985,2020-05-21
Severe disorder,PROCESS_OF,Patients,32433448,10.1097/AOG.0000000000003985,2020-05-21
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Woman,32433448,10.1097/AOG.0000000000003985,2020-05-21
Disease,PROCESS_OF,Woman,32433448,10.1097/AOG.0000000000003985,2020-05-21
Dyspnea,PROCESS_OF,Woman,32433448,10.1097/AOG.0000000000003985,2020-05-21
Fever,PROCESS_OF,Woman,32433448,10.1097/AOG.0000000000003985,2020-05-21
Birth,PROCESS_OF,Persons,32433389,10.1097/PHH.0000000000001206,2020-05-21
Screening procedure,ADMINISTERED_TO,Persons,32433389,10.1097/PHH.0000000000001206,2020-05-21
Screening procedure,ADMINISTERED_TO,Patients,32433389,10.1097/PHH.0000000000001206,2020-05-21
Coronavirus Infections,PROCESS_OF,Persons,32433389,10.1097/PHH.0000000000001206,2020-05-21
Coronavirus Infections,PROCESS_OF,Patients,32433389,10.1097/PHH.0000000000001206,2020-05-21
Negative,PROCESS_OF,Patients,32433389,10.1097/PHH.0000000000001206,2020-05-21
Coronavirus Infections,PROCESS_OF,Patients,32433389,10.1097/PHH.0000000000001206,2020-05-21
Negative,PROCESS_OF,Woman,32433389,10.1097/PHH.0000000000001206,2020-05-21
Mental health problem,PROCESS_OF,general population,32433364,10.1097/ADM.0000000000000682,2020-05-21
Gambling,ISA,Behavior,32433364,10.1097/ADM.0000000000000682,2020-05-21
Homelessness,PROCESS_OF,Patients,32433363,10.1097/ADM.0000000000000679,2020-05-21
"Opioid use disorder, severe",PROCESS_OF,Male population group,32433363,10.1097/ADM.0000000000000679,2020-05-21
Addictive Behavior,PROCESS_OF,Specialist,32433363,10.1097/ADM.0000000000000679,2020-05-21
Addictive Behavior,PROCESS_OF,Specialist,32433363,10.1097/ADM.0000000000000679,2020-05-21
"Opioid use disorder, severe",PROCESS_OF,Male population group,32433363,10.1097/ADM.0000000000000679,2020-05-21
Buprenorphine / Naloxone,PREVENTS,opioid use,32433363,10.1097/ADM.0000000000000679,2020-05-21
Homelessness,PROCESS_OF,Patients,32433363,10.1097/ADM.0000000000000679,2020-05-21
opioid use,ISA,Disease,32433363,10.1097/ADM.0000000000000679,2020-05-21
Disease,PROCESS_OF,Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,ISA,Disease,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,PROCESS_OF(SPEC),Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
Disease,PROCESS_OF,Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
Disease,PROCESS_OF,Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,ISA,Disease,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,ISA,Disease,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,PROCESS_OF(SPEC),Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,PROCESS_OF(SPEC),Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
Disease,PROCESS_OF,Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,ISA,Disease,32433356,10.2106/JBJS.20.00756,2020-05-21
opioid use,PROCESS_OF(SPEC),Persons,32433356,10.2106/JBJS.20.00756,2020-05-21
"Hospitals, University",LOCATION_OF,Study,32433345,10.1097/JCMA.0000000000000353,2020-05-21
"Hospitals, University",LOCATION_OF,Study,32433345,10.1097/JCMA.0000000000000353,2020-05-21
"Hospitals, University",LOCATION_OF,Study,32433345,10.1097/JCMA.0000000000000353,2020-05-21
Antibodies,ISA,Agent,32433344,10.1097/JCMA.0000000000000354,2020-05-21
Vaccines,INTERACTS_WITH,RNA,32433344,10.1097/JCMA.0000000000000354,2020-05-21
Neuraminidase inhibitor,DISRUPTS,Virus Internalization,32433344,10.1097/JCMA.0000000000000354,2020-05-21
Diabetes,PROCESS_OF,Persons,32433343,10.1097/JCMA.0000000000000356,2020-05-21
"Kidney Tubules, Proximal",LOCATION_OF,Glucose,32433343,10.1097/JCMA.0000000000000356,2020-05-21
"Kidney Tubules, Proximal",PART_OF,Kidney,32433343,10.1097/JCMA.0000000000000356,2020-05-21
"Kidney Failure, Acute",COEXISTS_WITH,Sepsis,32433343,10.1097/JCMA.0000000000000356,2020-05-21
Diabetes,PROCESS_OF,Persons,32433343,10.1097/JCMA.0000000000000356,2020-05-21
Immunity,PROCESS_OF,Patients,32433342,10.1097/JCMA.0000000000000352,2020-05-21
"Kidney Failure, Chronic",PROCESS_OF,Patients,32433342,10.1097/JCMA.0000000000000352,2020-05-21
disease transmission,PROCESS_OF,Patients,32433342,10.1097/JCMA.0000000000000352,2020-05-21
"Kidney Failure, Chronic",PROCESS_OF,Patients,32433342,10.1097/JCMA.0000000000000352,2020-05-21
Infected,PROCESS_OF,Persons,32433329,10.1097/PHM.0000000000001451,2020-05-21
risk factors,PROCESS_OF,Patients,32433329,10.1097/PHM.0000000000001451,2020-05-21
Birth,PROCESS_OF,teams,32433293,10.1097/SLA.0000000000004087,2020-05-21
Elective Surgical Procedures,TREATS,Patients,32433291,10.1097/SLA.0000000000004031,2020-05-21
Elective Surgical Procedures,TREATS(INFER),Possible,32433291,10.1097/SLA.0000000000004031,2020-05-21
Possible,PROCESS_OF,Patients,32433291,10.1097/SLA.0000000000004031,2020-05-21
Critical Illness,PROCESS_OF,Patients,32433285,10.1097/SLA.0000000000004010,2020-05-21
Parenchyma,PART_OF,Lung,32433285,10.1097/SLA.0000000000004010,2020-05-21
Respiration,PROCESS_OF,Patients,32433285,10.1097/SLA.0000000000004010,2020-05-21
Practice Experience,PROCESS_OF,Outpatients,32433260,10.1097/BPO.0000000000001600,2020-05-21
Health care facility,LOCATION_OF,Retrospective Cohort Study,32433251,10.1097/RCT.0000000000001040,2020-05-21
IMPACT gene,ASSOCIATED_WITH,Fracture,32433251,10.1097/RCT.0000000000001040,2020-05-21
Fracture,PROCESS_OF,Patients,32433251,10.1097/RCT.0000000000001040,2020-05-21
Fracture,PROCESS_OF,Adolescent (age group),32433251,10.1097/RCT.0000000000001040,2020-05-21
radius fracture distal,PROCESS_OF,Patients,32433251,10.1097/RCT.0000000000001040,2020-05-21
Splint Device,TREATS,radius fracture distal,32433251,10.1097/RCT.0000000000001040,2020-05-21
Splint Device,USES,Velcro,32433251,10.1097/RCT.0000000000001040,2020-05-21
Hypoxemia,ISA,Disease,32433243,10.1097/PHM.0000000000001470,2020-05-21
Severe Acute Respiratory Syndrome,ISA,Disease,32433243,10.1097/PHM.0000000000001470,2020-05-21
Intubation,ADMINISTERED_TO,Anesthetist,32433243,10.1097/PHM.0000000000001470,2020-05-21
Laryngoscopes,PREVENTS,Virus Diseases,32433243,10.1097/PHM.0000000000001470,2020-05-21
Laryngoscopes,USES,videocassette,32433243,10.1097/PHM.0000000000001470,2020-05-21
Diagnosis,ADMINISTERED_TO,Patients,32433243,10.1097/PHM.0000000000001470,2020-05-21
Diagnosis,ADMINISTERED_TO,Staff,32433243,10.1097/PHM.0000000000001470,2020-05-21
Patients,DIAGNOSES,Coronavirus Infections,32433243,10.1097/PHM.0000000000001470,2020-05-21
Staff,DIAGNOSES,Coronavirus Infections,32433243,10.1097/PHM.0000000000001470,2020-05-21
Necrotizing Enterocolitis,PROCESS_OF,Child,32433225,10.1097/INF.0000000000002750,2020-05-21
Pathogenic organism,ASSOCIATED_WITH,Acute gastroenteritis,32433225,10.1097/INF.0000000000002750,2020-05-21
Acute gastroenteritis,PROCESS_OF,Child,32433225,10.1097/INF.0000000000002750,2020-05-21
Gastrointestinal symptom,PROCESS_OF,Child,32433225,10.1097/INF.0000000000002750,2020-05-21
Diarrhea,PROCESS_OF,Infant,32433225,10.1097/INF.0000000000002750,2020-05-21
Diarrhea,PROCESS_OF,"Infant, Newborn",32433225,10.1097/INF.0000000000002750,2020-05-21
Vomiting,PROCESS_OF,Infant,32433225,10.1097/INF.0000000000002750,2020-05-21
Vomiting,PROCESS_OF,"Infant, Newborn",32433225,10.1097/INF.0000000000002750,2020-05-21
Infected,PROCESS_OF,Child,32433225,10.1097/INF.0000000000002750,2020-05-21
SARS coronavirus,PROCESS_OF,Child,32433217,10.1097/SHK.0000000000001565,2020-05-21
Inflammation,PROCESS_OF,Adult,32433217,10.1097/SHK.0000000000001565,2020-05-21
Myocarditis,PROCESS_OF,Infant,32433217,10.1097/SHK.0000000000001565,2020-05-21
Hypersensitivity,PROCESS_OF,Survivors,32433168,10.1097/RLU.0000000000003084,2020-05-21
Lung,LOCATION_OF,Ground Glass Opacity,32433162,10.1097/RLU.0000000000003137,2020-05-21
Woman,ISA,Adult,32433161,10.1097/RLU.0000000000003141,2020-05-21
"Carcinoma, Small Cell",PROCESS_OF,Woman,32433161,10.1097/RLU.0000000000003141,2020-05-21
Low grade fever,PROCESS_OF,Patients,32433161,10.1097/RLU.0000000000003141,2020-05-21
Secondary malignant neoplasm of liver,PROCESS_OF,Male population group,32433160,10.1097/RLU.0000000000003145,2020-05-21
Salivary duct carcinoma,PROCESS_OF,Male population group,32433160,10.1097/RLU.0000000000003145,2020-05-21
Lung,LOCATION_OF,Thickened,32433160,10.1097/RLU.0000000000003145,2020-05-21
FDG-Positron Emission Tomography and Computed Tomography Scan,DIAGNOSES,Ground Glass Opacity,32433160,10.1097/RLU.0000000000003145,2020-05-21
Asymptomatic,PROCESS_OF,Outpatients,32433160,10.1097/RLU.0000000000003145,2020-05-21
PET/CT scan,ADMINISTERED_TO,Outpatients,32433160,10.1097/RLU.0000000000003145,2020-05-21
Infected,PROCESS_OF,Patients,32433100,10.1097/JOM.0000000000001916,2020-05-21
Asymptomatic,PROCESS_OF,Patients,32433100,10.1097/JOM.0000000000001916,2020-05-21
Infected,PROCESS_OF,Persons,32433015,10.3201/eid2608.201843,2020-05-21
Transient Ischemic Attack,PROCESS_OF,Patients,32432997,10.1161/STROKEAHA.120.030225,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32432997,10.1161/STROKEAHA.120.030225,2020-05-21
Cerebrovascular accident,PROCESS_OF,inpatient,32432997,10.1161/STROKEAHA.120.030225,2020-05-21
Blood Vessel,LOCATION_OF,risk factors,32432997,10.1161/STROKEAHA.120.030225,2020-05-21
Blood Coagulation Disorders,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Coronavirus Infections,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Ischemic stroke,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Ischemic stroke,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Ischemic stroke,PROCESS_OF,hospitalized patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Cerebrovascular accident,COEXISTS_WITH,Acquired thrombophilia,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Thrombus,PROCESS_OF,Patients,32432995,10.1161/STROKEAHA.120.030091,2020-05-21
Communicable Disease Control,TREATS,Acute Cerebrovascular Accidents,32432994,10.1161/STROKEAHA.120.030373,2020-05-21
Cerebrovascular accident,AFFECTS,Uncertainty,32432994,10.1161/STROKEAHA.120.030373,2020-05-21
Uncertainty,PROCESS_OF,Nurses,32432994,10.1161/STROKEAHA.120.030373,2020-05-21
Uncertainty,PROCESS_OF,Physicians,32432994,10.1161/STROKEAHA.120.030373,2020-05-21
Uncertainty,PROCESS_OF,Technician,32432994,10.1161/STROKEAHA.120.030373,2020-05-21
Ischemic stroke,AFFECTS,Patients,32432977,10.1080/22221751.2020.1772676,2020-05-21
Mechanical thrombectomy,TREATS,Patients,32432977,10.1080/22221751.2020.1772676,2020-05-21
Mechanical thrombectomy,ADMINISTERED_TO,Patients,32432977,10.1080/22221751.2020.1772676,2020-05-21
Antiviral Therapy,NEG_TREATS,Virus Diseases,32432953,10.1080/0142159X.2020.1766668,2020-05-21
Vero Cells,LOCATION_OF,Virus Replication,32432953,10.1080/0142159X.2020.1766668,2020-05-21
Cytidine,ISA,Nucleosides,32432953,10.1080/0142159X.2020.1766668,2020-05-21
oxysophoridine,COEXISTS_WITH,gemcitabine,32432953,10.1080/0142159X.2020.1766668,2020-05-21
Screening procedure,TREATS,Virus Diseases,32432953,10.1080/0142159X.2020.1766668,2020-05-21
Estrogens,INTERACTS_WITH,angiotensin converting enzyme 2,32432912,10.2214/AJR.20.23495,2020-05-21
Gonadal Steroid Hormones,AFFECTS,Severe Acute Respiratory Syndrome,32432912,10.2214/AJR.20.23495,2020-05-21
Scanning Electron Microscopy,USES,"CD69 protein, human",32432785,10.26355/eurrev_202005_21215,2020-05-21
Coronavirus Infections,ISA,Disease,32432783,10.26355/eurrev_202005_21213,2020-05-21
Coronavirus Infections,ISA,Disease,32432783,10.26355/eurrev_202005_21213,2020-05-21
Fragility,PROCESS_OF,Patients,32432780,10.26355/eurrev_202005_21210,2020-05-21
Fragility,PROCESS_OF,Patients,32432780,10.26355/eurrev_202005_21210,2020-05-21
Coronavirus Infections,CAUSES,Communicable Diseases,32432672,10.1093/infdis/jiaa274,2020-05-21
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32432672,10.1093/infdis/jiaa274,2020-05-21
Coronavirus Infections,ISA,Disease,32432527,10.5152/eurjrheum.2020.2064,2020-05-21
Assay,USES,Fibrin fragment D,32432527,10.5152/eurjrheum.2020.2064,2020-05-21
Assay,USES,Fibrin fragment D,32432527,10.5152/eurjrheum.2020.2064,2020-05-21
Critical Illness,PROCESS_OF,Patients,32432519,10.1080/07420528.2020.1756841,2020-05-21
treatment empiric,PROCESS_OF,Persons,32432519,10.1080/07420528.2020.1756841,2020-05-21
Sleep,AFFECTS,Circadian Rhythms,32432483,10.1164/rccm.202003-0541OC,2020-05-21
Sleep,AFFECTS,Immune System Processes,32432483,10.1164/rccm.202003-0541OC,2020-05-21
Coronavirus Infections,ISA,Disease,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Epithelium,LOCATION_OF,receptor,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Epithelium,LOCATION_OF,Single-Cell Analysis,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Epithelium,LOCATION_OF,angiotensin converting enzyme 2,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Genes,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Trachea,LOCATION_OF,Fiberoptic bronchoscopy,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Trachea,LOCATION_OF,angiotensin converting enzyme 2,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Basal Cell,PART_OF,ancestors,32432466,10.1021/acschemneuro.0c00288,2020-05-21
angiotensin converting enzyme 2,AUGMENTS,Epithelium,32432466,10.1021/acschemneuro.0c00288,2020-05-21
Severe Acute Respiratory Syndrome,INTERACTS_WITH,Virus,32432466,10.1021/acschemneuro.0c00288,2020-05-21
cytokine,AFFECTS,Cellular Immunity,32432433,10.4081/monaldi.2020.1372,2020-05-21
Cytopathic effect,AFFECTS,Disease,32432433,10.4081/monaldi.2020.1372,2020-05-21
Cessation of life,PROCESS_OF,Child,32432433,10.4081/monaldi.2020.1372,2020-05-21
Dialysis procedure,TREATS,"Kidney Failure, Chronic",32432433,10.4081/monaldi.2020.1372,2020-05-21
"Kidney Failure, Chronic",PROCESS_OF,Child,32432433,10.4081/monaldi.2020.1372,2020-05-21
Infection,CAUSES,Cessation of life,32432433,10.4081/monaldi.2020.1372,2020-05-21
Pandemics,CAUSES,Disease,32432169,10.1136/bmjophth-2020-000487,2020-05-21
Brachytherapy,ISA,Therapeutic procedure,32432169,10.1136/bmjophth-2020-000487,2020-05-21
Problem,CAUSES,Infection,32432169,10.1136/bmjophth-2020-000487,2020-05-21
Screening procedure,TREATS,Enthesitis-Related Arthritis,32432167,10.1186/s41256-020-00149-0,2020-05-21
Critical Illness,PREDISPOSES,Cardiac Arrhythmia,32432121,10.3389/fmed.2020.00168,2020-05-21
Critical Illness,PREDISPOSES,Torsades de Pointes,32432121,10.3389/fmed.2020.00168,2020-05-21
Disease,AFFECTS,Child,32431992,10.7759/cureus.7714,2020-05-21
Disease,AFFECTS,Infant,32431992,10.7759/cureus.7714,2020-05-21
Disease,AFFECTS,Human Age Group,32431992,10.7759/cureus.7714,2020-05-21
Fever,PROCESS_OF,Infant,32431992,10.7759/cureus.7714,2020-05-21
treatment options,TREATS,Population Group,32431961,10.21106/ijma.378,2020-05-21
Medical History,NEG_PROCESS_OF,Woman,32431961,10.21106/ijma.378,2020-05-21
Extracorporeal Membrane Oxygenation,TREATS,Patients,32431961,10.21106/ijma.378,2020-05-21
Extracorporeal Membrane Oxygenation,TREATS(INFER),Infected,32431961,10.21106/ijma.378,2020-05-21
Infected,PROCESS_OF,Patients,32431961,10.21106/ijma.378,2020-05-21
Health Personnel,NEG_TREATS,Patients,32431961,10.21106/ijma.378,2020-05-21
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32431961,10.21106/ijma.378,2020-05-21
Coronavirus Infections,CAUSES,Cessation of life,32431949,10.1093/ve/veaa032,2020-05-21
Acute respiratory distress,PROCESS_OF,Patients,32431755,10.1186/s13037-020-00248-4,2020-05-21
Intubation,USES,Medical Tent,32431755,10.1186/s13037-020-00248-4,2020-05-21
Intubation,ADMINISTERED_TO,Staff,32431755,10.1186/s13037-020-00248-4,2020-05-21
Lung,LOCATION_OF,Virus Diseases,32431550,10.2147/CLEP.S259005,2020-05-21
Inflammation,COEXISTS_WITH,Storm NOS,32431550,10.2147/CLEP.S259005,2020-05-21
Inflammation,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32431550,10.2147/CLEP.S259005,2020-05-21
Storm NOS,PROCESS_OF,Patients,32431550,10.2147/CLEP.S259005,2020-05-21
Coronavirus Infections,ISA,Disease,32431289,10.2807/1560-7917.ES.2020.25.19.2000620,2020-05-21
Coronavirus Infections,ISA,Disease,32431287,10.4269/ajtmh.20-0442,2020-05-21
Climate Change,AFFECTS,Communicable Diseases,32431285,10.4269/ajtmh.20-0256,2020-05-21
Movement,PROCESS_OF,Persons,32431255,10.1192/j.eurpsy.2020.54,2020-05-21
Persons,USES,Preexisting Condition Coverage,32431217,10.1080/07391102.2020.1772108,2020-05-21
Mental disorders,PROCESS_OF,Patients,32431217,10.1080/07391102.2020.1772108,2020-05-21
Diabetes,PREDISPOSES,Complication,32431217,10.1080/07391102.2020.1772108,2020-05-21
Mental health problem,PROCESS_OF,Persons,32431217,10.1080/07391102.2020.1772108,2020-05-21
Withania somnifera (plant),LOCATION_OF,Withanolides,32431134,10.4081/monaldi.2020.1085,2020-05-21
Pronation,AFFECTS,Alveolar ventilation function,32431085,10.1002/rmv.2111,2020-05-21
Exercise,TREATS,Patients,32431085,10.1002/rmv.2111,2020-05-21
Disease,PROCESS_OF,World,32431052,10.1111/jcmm.15275,2020-05-21
Coronavirus Infections,ISA,Disease,32431052,10.1111/jcmm.15275,2020-05-21
Coronavirus Infections,PROCESS_OF(SPEC),World,32431052,10.1111/jcmm.15275,2020-05-21
Coronavirus Infections,CAUSES,"Pneumonia, Viral",32430996,10.1002/ptr.6738,2020-05-21
Nucleic acid assay,DIAGNOSES,Pathogenic,32430996,10.1002/ptr.6738,2020-05-21
Nucleic acid assay,METHOD_OF,Detection,32430996,10.1002/ptr.6738,2020-05-21
Pandemics,ISA,Disease Outbreaks,32430964,10.1111/apa.15371,2020-05-21
Kidney,LOCATION_OF,Complication,32430964,10.1111/apa.15371,2020-05-21
Virus,CAUSES,Complication,32430964,10.1111/apa.15371,2020-05-21
Disease,PROCESS_OF,Patients,32430964,10.1111/apa.15371,2020-05-21
Coronavirus Infections,ISA,Disease,32430964,10.1111/apa.15371,2020-05-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32430964,10.1111/apa.15371,2020-05-21
treatment options,TREATS,Patients,32430964,10.1111/apa.15371,2020-05-21
treatment options,TREATS(INFER),Disease,32430964,10.1111/apa.15371,2020-05-21
Endopeptidases,INTERACTS_WITH,Curcumin,32430964,10.1111/apa.15371,2020-05-21
Symptoms,PROCESS_OF,Adult,32430957,10.1002/uog.22088,2020-05-21
Asymptomatic,PROCESS_OF,Child,32430957,10.1002/uog.22088,2020-05-21
Unlikely,PROCESS_OF,Older people,32430957,10.1002/uog.22088,2020-05-21
Maternal-Fetal Infection Transmission,ISA,Vertical Disease Transmission,32430840,10.1007/s10654-020-00649-w,2020-05-21
Gravidity,PROCESS_OF,Patients,32430840,10.1007/s10654-020-00649-w,2020-05-21
Fever,ISA,Symptoms,32430840,10.1007/s10654-020-00649-w,2020-05-21
Nucleic Acid Amplification Tests,DIAGNOSES,Vaginal mucositis,32430840,10.1007/s10654-020-00649-w,2020-05-21
Complication,PROCESS_OF,Pregnant Women,32430840,10.1007/s10654-020-00649-w,2020-05-21
Disease,PROCESS_OF,Pregnant Women,32430840,10.1007/s10654-020-00649-w,2020-05-21
Maternal Death,COEXISTS_WITH,Pregnancy,32430840,10.1007/s10654-020-00649-w,2020-05-21
Pregnant Women,LOCATION_OF,IMPACT gene,32430840,10.1007/s10654-020-00649-w,2020-05-21
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32430840,10.1007/s10654-020-00649-w,2020-05-21
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32430840,10.1007/s10654-020-00649-w,2020-05-21
Cells,PART_OF,Lung,32430637,10.1007/s00701-020-04402-w,2020-05-21
Hypertensive disease,ISA,Cardiovascular Diseases,32430637,10.1007/s00701-020-04402-w,2020-05-21
Angiotensin II receptor antagonist,TREATS,Cardiovascular Diseases,32430637,10.1007/s00701-020-04402-w,2020-05-21
Angiotensin II receptor antagonist,TREATS,Hypertensive disease,32430637,10.1007/s00701-020-04402-w,2020-05-21
Angiotensin II receptor antagonist,TREATS(SPEC),Hypertensive disease,32430637,10.1007/s00701-020-04402-w,2020-05-21
Peptidyl-Dipeptidase A,STIMULATES,angiotensin converting enzyme 2,32430637,10.1007/s00701-020-04402-w,2020-05-21
Kidney,LOCATION_OF,"RNA, Messenger",32430637,10.1007/s00701-020-04402-w,2020-05-21
angiotensin converting enzyme 2,ISA,Peptidyl-Dipeptidase A,32430637,10.1007/s00701-020-04402-w,2020-05-21
Infected,PROCESS_OF,Patients,32430637,10.1007/s00701-020-04402-w,2020-05-21
Comorbidity,PROCESS_OF,Patients,32430637,10.1007/s00701-020-04402-w,2020-05-21
Cessation of life,PROCESS_OF,Patients,32430637,10.1007/s00701-020-04402-w,2020-05-21
Cardiovascular,LOCATION_OF,Comorbidity,32430637,10.1007/s00701-020-04402-w,2020-05-21
Cigarette smoke (substance),STIMULATES,angiotensin converting enzyme 2,32430637,10.1007/s00701-020-04402-w,2020-05-21
Antihypertensive Agents,TREATS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32430637,10.1007/s00701-020-04402-w,2020-05-21
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32430637,10.1007/s00701-020-04402-w,2020-05-21
"Hematoma, Subdural",COMPLICATES,Meningoencephalitis,32430627,10.1007/s11357-020-00198-w,2020-05-21
Intracerebral hematoma,COMPLICATES,Meningoencephalitis,32430627,10.1007/s11357-020-00198-w,2020-05-21
Physicians,TREATS,Patients,32430627,10.1007/s11357-020-00198-w,2020-05-21
Cardiac Arrhythmia,PROCESS_OF,geriatric patients,32430621,10.1007/s10072-020-04450-1,2020-05-21
Cardiovascular,LOCATION_OF,Comorbidity,32430621,10.1007/s10072-020-04450-1,2020-05-21
Pandemics,OCCURS_IN,Patients,32430621,10.1007/s10072-020-04450-1,2020-05-21
Heart,LOCATION_OF,Protection,32430621,10.1007/s10072-020-04450-1,2020-05-21
Coronavirus Infections,ISA,Disease,32430621,10.1007/s10072-020-04450-1,2020-05-21
Frail,PROCESS_OF,Patients,32430621,10.1007/s10072-020-04450-1,2020-05-21
Neurologic Symptoms,PROCESS_OF,Patients,32430617,10.1007/s00210-020-01901-6,2020-05-21
Sign or Symptom,PROCESS_OF,Outpatients,32430617,10.1007/s00210-020-01901-6,2020-05-21
Central Nervous System,ASSOCIATED_WITH,Neurologic Manifestations,32430617,10.1007/s00210-020-01901-6,2020-05-21
Hospitals,LOCATION_OF,Computed Tomography Angiography,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Head and neck structure,LOCATION_OF,Computed Tomography Angiography,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Lung diseases,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Lung diseases,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Lung diseases,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,Patients,32430459,10.2337/dc20-0643,2020-05-21
Cerebrovascular accident,PROCESS_OF,teams,32430459,10.2337/dc20-0643,2020-05-21
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32430441,10.1542/peds.2020-000786,2020-05-21
Hyperglycemia,NEG_AFFECTS,Patients,32430441,10.1542/peds.2020-000786,2020-05-21
Hyperglycemia,AFFECTS,Patients,32430441,10.1542/peds.2020-000786,2020-05-21
Hyperglycemia,AFFECTS,Patients,32430441,10.1542/peds.2020-000786,2020-05-21
Diabetes,PROCESS_OF,Patients,32430441,10.1542/peds.2020-000786,2020-05-21
grandparent,ISA,Family member,32430429,10.1183/13993003.00763-2020,2020-05-21
Hospitals,LOCATION_OF,Laboratory Procedures,32430428,10.1183/13993003.00799-2020,2020-05-21
Serum,PART_OF,Patients,32430428,10.1183/13993003.00799-2020,2020-05-21
Antibodies,compared_with,CD40LG wt Allele,32430428,10.1183/13993003.00799-2020,2020-05-21
,INTERACTS_WITH,Antibodies,32430428,10.1183/13993003.00799-2020,2020-05-21
Infected,PROCESS_OF,Patients,32430344,10.7861/clinmed.2020-0142,2020-05-21
lopinavir / Ritonavir,TREATS,risk factors,32430344,10.7861/clinmed.2020-0142,2020-05-21
lopinavir / Ritonavir,TREATS,Patients,32430344,10.7861/clinmed.2020-0142,2020-05-21
lopinavir / Ritonavir,TREATS,Senility,32430344,10.7861/clinmed.2020-0142,2020-05-21
lopinavir / Ritonavir,NEG_TREATS,Patients,32430344,10.7861/clinmed.2020-0142,2020-05-21
Medical emergencies,PROCESS_OF,Patients,32430309,10.1126/sciimmunol.abc6347,2020-05-21
Staff,TREATS,Patients,32430309,10.1126/sciimmunol.abc6347,2020-05-21
Confidence,PROCESS_OF,Patients,32430309,10.1126/sciimmunol.abc6347,2020-05-21
Chloroquine,ISA,Antimalarials,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Hydroxychloroquine,TREATS,Autoimmune Diseases,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Duration,ADMINISTERED_TO,Patients,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Anti-Inflammatory Agents,INTERACTS_WITH,Hydroxychloroquine,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Chloroquine,INTERACTS_WITH,Hydroxychloroquine,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Pharmaceutical Preparations,INTERACTS_WITH,Hydroxychloroquine,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Hydroxychloroquine,TREATS,patient condition,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Chloroquine,AFFECTS,iron ion homeostasis,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Hydroxychloroquine,AFFECTS,iron ion homeostasis,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Disease Progression,AFFECTS,Human virus,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Severe Acute Respiratory Syndrome,AFFECTS,Human virus,32430279,10.1016/j.virusres.2020.198018,2020-05-21
Feces,ASSOCIATED_WITH(INFER),Infected,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Feces,PART_OF,Patients,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
RNA,INTERACTS_WITH,ACE2 gene,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Infected,PROCESS_OF,Patients,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Epithelial Cells,PART_OF,Intestines,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Enterocytes,PART_OF,"Intestines, Small",32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Enterocytes,PRODUCES,ACE2 gene,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Lung diseases,ASSOCIATED_WITH,Intestinal Microbiome,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Viral respiratory infection,ASSOCIATED_WITH,Intestinal Microbiome,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Diet,AFFECTS,Immunity,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Senility,PROCESS_OF,geriatric patients,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Intestinal Microbiome,ASSOCIATED_WITH,Disease,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Immunity,AFFECTS,Disease,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Nutritional status,PROCESS_OF,Persons,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Nutritional status,PROCESS_OF,Patients,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
compromise,PROCESS_OF,Patients,32430154,10.1016/j.jacl.2020.04.008,2020-05-21
Single organ dysfunction,PROCESS_OF,Patients,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Cholesterol measurement test,DIAGNOSES,patient condition,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Dyslipidemias,PROCESS_OF,Patients,32430140,10.1016/j.purol.2020.05.001,2020-05-21
GSKIP gene,INTERACTS_WITH,LDL Cholesterol Lipoproteins,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Serum total cholesterol measurement,DIAGNOSES,patient condition,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Hypolipidemia,PROCESS_OF,Patients,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Symptom mild,PROCESS_OF,Patients,32430140,10.1016/j.purol.2020.05.001,2020-05-21
Department,LOCATION_OF,Study,32430111,10.1016/j.jagp.2020.04.025,2020-05-21
Severe (severity modifier),PROCESS_OF,Family,32430111,10.1016/j.jagp.2020.04.025,2020-05-21
Intervention regimes,ADMINISTERED_TO,Family,32430111,10.1016/j.jagp.2020.04.025,2020-05-21
Genital Procedures,ISA,Operative Surgical Procedures,32430111,10.1016/j.jagp.2020.04.025,2020-05-21
Dementia,PROCESS_OF,nursing home resident,32430094,10.1099/jgv.0.001439,2020-05-21
Dementia,PROCESS_OF,Persons,32430094,10.1099/jgv.0.001439,2020-05-21
Dementia,PROCESS_OF,Persons,32430094,10.1099/jgv.0.001439,2020-05-21
Dementia,PROCESS_OF,Persons,32430094,10.1099/jgv.0.001439,2020-05-21
Human coronavirus,CAUSES,Common Cold,32430088,10.1017/S0950268820001107,2020-05-21
Humoral Immunity,PROCESS_OF,Homo sapiens,32430088,10.1017/S0950268820001107,2020-05-21
Homo sapiens,ISA,Primates,32430088,10.1017/S0950268820001107,2020-05-21
Anxiety,OCCURS_IN,Medical Staff,32430086,10.1017/S0950268820001090,2020-05-21
Infected,PROCESS_OF,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Medical Staff,TREATS,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Infected,PROCESS_OF,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Medical Staff,TREATS,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Infected,PROCESS_OF,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Anxiety score,PROCESS_OF,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Infected,PROCESS_OF,Patients,32430086,10.1017/S0950268820001090,2020-05-21
Anxiety symptoms,PROCESS_OF,Study Subject,32430086,10.1017/S0950268820001090,2020-05-21
Minority Groups,ISA,Population Group,32429991,10.1186/s13052-020-00826-3,2020-05-21
arab ethnic group,ISA,Population Group,32429991,10.1186/s13052-020-00826-3,2020-05-21
Critical Illness,PROCESS_OF,Patients,32429769,10.1089/tmj.2020.0150,2020-05-21
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32429769,10.1089/tmj.2020.0150,2020-05-21
antiplatelet therapy,TREATS,Patients,32429769,10.1089/tmj.2020.0150,2020-05-21
Coronavirus Infections,ISA,Disease,32429681,10.1177/1010539520927261,2020-05-21
Therapeutic procedure,TREATS,Severe Acute Respiratory Syndrome,32429681,10.1177/1010539520927261,2020-05-21
Quarantine,ISA,Operative Surgical Procedures,32429580,10.3390/molecules25102343,2020-05-21
Prodrugs,INTERACTS_WITH,RNA-Directed RNA Polymerase,32429572,10.3390/ijms21103544,2020-05-21
Virus Diseases,ASSOCIATED_WITH,Lipid Metabolism,32429536,10.3390/ijerph17103497,2020-05-21
Coronavirus Infections,PROCESS_OF,Foundation for the Accreditation of Cellular Therapy,32429517,10.3390/ijerph17103493,2020-05-21
Hypertensive disease,PROCESS_OF,Patients,32429235,10.3390/ijms21103518,2020-05-21
Coronavirus Infections,ISA,Disease,32429235,10.3390/ijms21103518,2020-05-21
"Diabetes Mellitus, Non-Insulin-Dependent",ISA,Metabolic Diseases,32429193,10.3390/ijerph17103459,2020-05-21
Obesity,ISA,Metabolic Diseases,32429193,10.3390/ijerph17103459,2020-05-21
"Respiratory Distress Syndrome, Adult",ISA,Metabolic Diseases,32429193,10.3390/ijerph17103459,2020-05-21
Eye,LOCATION_OF,Disease,32429121,10.3390/jcm9051492,2020-05-21
Eye,LOCATION_OF(SPEC),Coronavirus Infections,32429121,10.3390/jcm9051492,2020-05-21
Coronavirus Infections,ISA,Disease,32429121,10.3390/jcm9051492,2020-05-21
Infected,PROCESS_OF,Population Group,32429101,10.3390/jcm9051491,2020-05-21
Laboratory,LOCATION_OF,Analysis,32429099,10.3390/ijms21103492,2020-05-21
saliva,LOCATION_OF,Proteome,32429099,10.3390/ijms21103492,2020-05-21
Proteome,ASSOCIATED_WITH,Disease,32429099,10.3390/ijms21103492,2020-05-21
Proteome,ASSOCIATED_WITH,Disease,32429099,10.3390/ijms21103492,2020-05-21
Specimen Collection,METHOD_OF,Diagnosis,32429099,10.3390/ijms21103492,2020-05-21
Pharmaceutical Preparations,NEG_TREATS,"Pneumonia, Viral",32429041,10.3390/geriatrics5020031,2020-05-21
Endopeptidases,PRODUCES,replicase,32429041,10.3390/geriatrics5020031,2020-05-21
Pyridoxal Phosphate,ASSOCIATED_WITH,Coronavirus Infections,32429041,10.3390/geriatrics5020031,2020-05-21
Suspicion,PROCESS_OF,Older people,32429038,10.3390/tropicalmed5020080,2020-05-21
Comorbidity,PROCESS_OF,Patients,32419926,10.12688/f1000research.22149.3,2020-05-21
Patients,LOCATION_OF,"CD69 protein, human",32419926,10.12688/f1000research.22149.3,2020-05-21
Liver diseases,PROCESS_OF,Patients,32419926,10.12688/f1000research.22149.3,2020-05-21
Chronic Kidney Diseases,PROCESS_OF,Patients,32419926,10.12688/f1000research.22149.3,2020-05-21
Liver diseases,PROCESS_OF,Patients,32419926,10.12688/f1000research.22149.3,2020-05-21
Chronic Kidney Diseases,PROCESS_OF,Patients,32419926,10.12688/f1000research.22149.3,2020-05-21
Coronavirus Infections,AFFECTS,Homo sapiens,32428990,10.15252/emmm.202012421,2020-05-20
Severe disorder,PROCESS_OF,Patients,32428965,10.1055/s-0040-1712103,2020-05-20
Ferritin,STIMULATES,Interleukin-6,32428965,10.1055/s-0040-1712103,2020-05-20
Fibrin fragment D,STIMULATES,Interleukin-6,32428965,10.1055/s-0040-1712103,2020-05-20
Patients,LOCATION_OF,Interleukin-6,32428965,10.1055/s-0040-1712103,2020-05-20
Patients,LOCATION_OF,Interleukin-6,32428965,10.1055/s-0040-1712103,2020-05-20
Chest CT,ISA,Evaluation procedure,32428965,10.1055/s-0040-1712103,2020-05-20
Symptom aggravating factors,PROCESS_OF,Patients,32428965,10.1055/s-0040-1712103,2020-05-20
Evaluation procedure,USES,Chest CT,32428965,10.1055/s-0040-1712103,2020-05-20
Patients,LOCATION_OF,Interleukin-6,32428965,10.1055/s-0040-1712103,2020-05-20
Asymptomatic,PROCESS_OF,Pregnant Women,32428957,10.1055/a-1163-1335,2020-05-20
Screening procedure,ADMINISTERED_TO,Woman,32428957,10.1055/a-1163-1335,2020-05-20
Premature Birth,PROCESS_OF,Woman,32428957,10.1055/a-1163-1335,2020-05-20
Asymptomatic,PROCESS_OF,Pregnant Women,32428957,10.1055/a-1163-1335,2020-05-20
Symptoms,PROCESS_OF,Woman,32428957,10.1055/a-1163-1335,2020-05-20
Infected,PROCESS_OF,Pregnant Women,32428957,10.1055/a-1163-1335,2020-05-20
Symptoms,PROCESS_OF,Woman,32428957,10.1055/a-1163-1335,2020-05-20
Severe disorder,PROCESS_OF,Woman,32428957,10.1055/a-1163-1335,2020-05-20
Severe course,PROCESS_OF,Patients,32428909,10.1159/000508399,2020-05-20
GS-5734,TREATS,Patients,32428864,10.1016/j.dsx.2020.05.022,2020-05-20
angiotensin converting enzyme 2,PREVENTS,Lung Injury,32428835,10.1016/j.biopha.2020.110230,2020-05-20
"ACE2 protein, human",ISA,angiotensin converting enzyme 2,32428835,10.1016/j.biopha.2020.110230,2020-05-20
Coronavirus Infections,PREDISPOSES,Prognosis bad,32428392,10.1021/acsinfecdis.0c00168,2020-05-20
Betacoronavirus,PROCESS_OF,Homo sapiens,32428385,10.1111/bjhp.12428,2020-05-20
Endopeptidases,DISRUPTS,Ubiquitination,32428385,10.1111/bjhp.12428,2020-05-20
Endopeptidases,INTERACTS_WITH,Ubiquitin,32428385,10.1111/bjhp.12428,2020-05-20
Endopeptidases,TREATS,SARS coronavirus,32428385,10.1111/bjhp.12428,2020-05-20
Middle East Respiratory Syndrome Coronavirus,LOCATION_OF,Endopeptidases,32428385,10.1111/bjhp.12428,2020-05-20
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32428379,10.1111/febs.15369,2020-05-20
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32428379,10.1111/febs.15369,2020-05-20
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32428379,10.1111/febs.15369,2020-05-20
Patients,LOCATION_OF,angiotensin converting enzyme 2,32428379,10.1111/febs.15369,2020-05-20
Overweight,PROCESS_OF,Patients,32428379,10.1111/febs.15369,2020-05-20
angiotensin converting enzyme 2,CAUSES,Severe Acute Respiratory Syndrome,32428379,10.1111/febs.15369,2020-05-20
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32428379,10.1111/febs.15369,2020-05-20
Severe Acute Respiratory Syndrome,CAUSES,Pneumonia,32428372,10.1111/odi.13431,2020-05-20
Epithelium,LOCATION_OF,Severe Acute Respiratory Syndrome,32428372,10.1111/odi.13431,2020-05-20
Epithelium,PART_OF,Lung,32428372,10.1111/odi.13431,2020-05-20
Coronavirus Infections,ISA,Disease,32428295,10.1002/oby.22904,2020-05-20
SARS coronavirus,CAUSES,Disease,32428295,10.1002/oby.22904,2020-05-20
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32428295,10.1002/oby.22904,2020-05-20
Asymptomatic,PROCESS_OF,Persons,32428295,10.1002/oby.22904,2020-05-20
Staff,TREATS,Patients,32428295,10.1002/oby.22904,2020-05-20
Disease,COEXISTS_WITH,Enthesitis-Related Arthritis,32428295,10.1002/oby.22904,2020-05-20
Coronavirus Infections,COEXISTS_WITH(SPEC),Enthesitis-Related Arthritis,32428295,10.1002/oby.22904,2020-05-20
Coronavirus Infections,ISA,Disease,32428295,10.1002/oby.22904,2020-05-20
Weight maintenance regimen,TREATS,Adult,32428286,10.1111/den.13728,2020-05-20
Obesity,PROCESS_OF,Adult,32428286,10.1111/den.13728,2020-05-20
Challenge,ADMINISTERED_TO,Patients,32428207,10.1093/jalm/jfaa079,2020-05-20
Patients,LOCATION_OF,CD40LG wt Allele,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Assay,MEASURES,Specificity,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Patients,LOCATION_OF,,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Assay,DIAGNOSES,SARS coronavirus,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Malaise,PROCESS_OF,Patients,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Cohort,LOCATION_OF,,32428144,10.1590/1806-9282.66.2.116,2020-05-20
Coronaviridae,PROCESS_OF,Family,32428115,10.6061/clinics/2020/e1923,2020-05-20
Small intestine mucous membrane,LOCATION_OF,Cell Count,32428115,10.6061/clinics/2020/e1923,2020-05-20
"TFRC protein, human",PART_OF,Patients,32428115,10.6061/clinics/2020/e1923,2020-05-20
Suspicion,PROCESS_OF,Patients,32428115,10.6061/clinics/2020/e1923,2020-05-20
Detection,TREATS,Complete Response with Incomplete Platelet Recovery,32428115,10.6061/clinics/2020/e1923,2020-05-20
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32428115,10.6061/clinics/2020/e1923,2020-05-20
Azithromycin,ISA,Pharmaceutical Preparations,32428115,10.6061/clinics/2020/e1923,2020-05-20
Operating Room,LOCATION_OF,Administration occupational activities,32428113,10.6061/clinics/2020/e1912,2020-05-20
Coronavirus Infections,ISA,Disease,32428113,10.6061/clinics/2020/e1912,2020-05-20
American Samoa,ISA,Country,32428112,10.6061/clinics/2020/e1932,2020-05-20
Disease,CAUSES,Influenza-like symptoms,32428112,10.6061/clinics/2020/e1932,2020-05-20
Coronavirus Infections,CAUSES(SPEC),Influenza-like symptoms,32428112,10.6061/clinics/2020/e1932,2020-05-20
Coronavirus Infections,ISA,Disease,32428112,10.6061/clinics/2020/e1932,2020-05-20
Comorbidity,PROCESS_OF,Persons,32428112,10.6061/clinics/2020/e1932,2020-05-20
"Hospitals, University",LOCATION_OF,Work,32428087,10.1590/0001-3765202020200560,2020-05-20
Hospital specialist,DIAGNOSES,Disease,32428087,10.1590/0001-3765202020200560,2020-05-20
Gravidity,PROCESS_OF,Mother (person),32428087,10.1590/0001-3765202020200560,2020-05-20
viral transmission,AFFECTS,"Infant, Newborn",32428087,10.1590/0001-3765202020200560,2020-05-20
viral transmission,AFFECTS,Pregnant Women,32428087,10.1590/0001-3765202020200560,2020-05-20
viral transmission,PROCESS_OF,Mother (person),32428087,10.1590/0001-3765202020200560,2020-05-20
Immunity,PROCESS_OF,Persons,32428080,10.1590/0102-311x00075720,2020-05-20
Elective procedure,NEG_ADMINISTERED_TO,Persons,32428080,10.1590/0102-311x00075720,2020-05-20
Symptoms,NEG_PROCESS_OF,Persons,32428080,10.1590/0102-311x00075720,2020-05-20
exposure history,NEG_PROCESS_OF,Persons,32428080,10.1590/0102-311x00075720,2020-05-20
Disease,PROCESS_OF,Patients,32428041,10.1371/journal.pone.0233145,2020-05-20
Chest CT,ISA,Evaluation,32427809,10.1097/BOT.0000000000001842,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32427809,10.1097/BOT.0000000000001842,2020-05-20
Radiologic finding,PROCESS_OF,Patients,32427809,10.1097/BOT.0000000000001842,2020-05-20
Reverse Transcriptase Polymerase Chain Reaction,USES,Massively-Parallel Sequencing,32427809,10.1097/BOT.0000000000001842,2020-05-20
Hypersensitivity,PROCESS_OF,Patients,32427809,10.1097/BOT.0000000000001842,2020-05-20
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32427809,10.1097/BOT.0000000000001842,2020-05-20
Radionuclide Imaging,DIAGNOSES,patient condition,32427809,10.1097/BOT.0000000000001842,2020-05-20
diseases and injuries,PROCESS_OF,Patients,32427774,10.1097/TA.0000000000002787,2020-05-20
Operative Surgical Procedures,ISA,Interventional procedure,32427774,10.1097/TA.0000000000002787,2020-05-20
Coronavirus Infections,PROCESS_OF,Patients,32427773,10.1097/TA.0000000000002786,2020-05-20
alteplase,TREATS,Patients,32427773,10.1097/TA.0000000000002786,2020-05-20
Fibrinolytic Agents,COEXISTS_WITH,Oxygen,32427773,10.1097/TA.0000000000002786,2020-05-20
Blood Coagulation Disorders,PROCESS_OF,Patients,32427651,10.1097/RTI.0000000000000527,2020-05-20
Critical Illness,PROCESS_OF,Patients,32427651,10.1097/RTI.0000000000000527,2020-05-20
Thrombolytic Therapy,TREATS,Respiratory Failure,32427651,10.1097/RTI.0000000000000527,2020-05-20
Thrombolytic Therapy,USES,alteplase,32427651,10.1097/RTI.0000000000000527,2020-05-20
Respiratory Failure,PROCESS_OF,Patients,32427651,10.1097/RTI.0000000000000527,2020-05-20
TPA Administration,TREATS,Transient Population Group,32427651,10.1097/RTI.0000000000000527,2020-05-20
Respiratory Status,PROCESS_OF,Patients,32427651,10.1097/RTI.0000000000000527,2020-05-20
Predictability,PROCESS_OF,Patients,32427645,10.1097/INF.0000000000002744,2020-05-20
Disease,PROCESS_OF,Child,32427637,10.1097/CRD.0000000000000317,2020-05-20
IMPACT gene,PART_OF,Cardiovascular,32427632,10.1097/MOU.0000000000000786,2020-05-20
contextual factors,PROCESS_OF,Outpatients,32427613,10.1097/CCM.0000000000004447,2020-05-20
Extracorporeal Membrane Oxygenation,TREATS,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Extracorporeal Membrane Oxygenation,TREATS(INFER),Pneumonia,32427582,10.1172/jci.insight.138070,2020-05-20
Pneumonia,PROCESS_OF,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Mechanical ventilation,ADMINISTERED_TO,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Hospital-ICU,LOCATION_OF,Study,32427582,10.1172/jci.insight.138070,2020-05-20
Critical Illness,PROCESS_OF,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Pneumonia,PROCESS_OF,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Mechanical ventilation,ADMINISTERED_TO,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Extracorporeal Membrane Oxygenation,TREATS,Survivors,32427582,10.1172/jci.insight.138070,2020-05-20
Survivors,ISA,Patients,32427582,10.1172/jci.insight.138070,2020-05-20
Blood,LOCATION_OF,cytokine,32427569,10.1556/650.2020.31862,2020-05-20
,TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
Interleukin-6,TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
RANTES,TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
Interleukin-8,TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
"CCL2 protein, human",TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
Recombinant Interferon-alpha Inducible Protein 10,TREATS,Patients,32427569,10.1556/650.2020.31862,2020-05-20
Interleukin-6,ASSOCIATED_WITH,Disease Progression,32427569,10.1556/650.2020.31862,2020-05-20
Interleukin-8,ASSOCIATED_WITH,Disease Progression,32427569,10.1556/650.2020.31862,2020-05-20
Cells,LOCATION_OF,Pyroptosis,32427569,10.1556/650.2020.31862,2020-05-20
Blood,LOCATION_OF,"T-Cell Surface Glycoprotein CD4, human",32427569,10.1556/650.2020.31862,2020-05-20
Infected,PROCESS_OF,Persons,32427529,10.1089/tmj.2020.0158,2020-05-20
Child,LOCATION_OF,Blood,32427529,10.1089/tmj.2020.0158,2020-05-20
Quick Test for Liver Function,USES,Antibodies,32427529,10.1089/tmj.2020.0158,2020-05-20
Coronary Thrombosis,COMPLICATES,Acute myocardial infarction,32427410,10.1002/hed.26262,2020-05-20
"Shock, Cardiogenic",COMPLICATES,Acute myocardial infarction,32427410,10.1002/hed.26262,2020-05-20
Acute myocardial infarction,PROCESS_OF,Patients,32427410,10.1002/hed.26262,2020-05-20
Tracheostomy procedure,TREATS,Patients,32427393,10.1096/fj.202001025,2020-05-20
Tracheostomy procedure,TREATS,hospitalized patients,32427393,10.1096/fj.202001025,2020-05-20
Tracheostomy procedure,AFFECTS,Cross Infection,32427393,10.1096/fj.202001025,2020-05-20
Tracheostomy procedure,NEG_AFFECTS,Postoperative Complications,32427393,10.1096/fj.202001025,2020-05-20
Tracheostomy procedure,TREATS,Patients,32427393,10.1096/fj.202001025,2020-05-20
Evaluation,COEXISTS_WITH,Tracheostomy procedure,32427393,10.1096/fj.202001025,2020-05-20
Lymphopoiesis,PROCESS_OF,Persons,32427357,10.1002/jmv.26027,2020-05-20
Short telomere length,PART_OF,Persons,32427357,10.1002/jmv.26027,2020-05-20
Immunoprecipitation,USES,Luciferases,32427279,10.1093/cid/ciaa601,2020-05-20
Serum,LOCATION_OF,Antibodies,32427279,10.1093/cid/ciaa601,2020-05-20
Specific antibody,PART_OF,Virus,32427279,10.1093/cid/ciaa601,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32427279,10.1093/cid/ciaa601,2020-05-20
Assay,USES,Immunoprecipitation,32427279,10.1093/cid/ciaa601,2020-05-20
"M Protein, multiple myeloma",ISA,Antibodies,32427279,10.1093/cid/ciaa601,2020-05-20
Measles Virus Nucleoprotein,compared_with,Protein antibody,32427279,10.1093/cid/ciaa601,2020-05-20
Measles Virus Nucleoprotein,higher_than,Protein antibody,32427279,10.1093/cid/ciaa601,2020-05-20
Immunoprecipitation,DIAGNOSES,SARS coronavirus,32427279,10.1093/cid/ciaa601,2020-05-20
Immunoprecipitation,USES,Luciferases,32427279,10.1093/cid/ciaa601,2020-05-20
Health center,LOCATION_OF,Non-Randomized Controlled Trials as Topic,32427227,10.1016/j.jaerosci.2020.105585,2020-05-20
Early Therapy,AFFECTS,Patients,32427227,10.1016/j.jaerosci.2020.105585,2020-05-20
Early Therapy,USES,Adrenal Cortex Hormones,32427227,10.1016/j.jaerosci.2020.105585,2020-05-20
Methylprednisolone,TREATS,Patients,32427227,10.1016/j.jaerosci.2020.105585,2020-05-20
Coughing,PROCESS_OF,Homo sapiens,32427226,10.1016/j.chemolab.2020.104054,2020-05-20
Disease,PROCESS_OF,Homo sapiens,32427226,10.1016/j.chemolab.2020.104054,2020-05-20
Disease,AFFECTS,Convection,32427226,10.1016/j.chemolab.2020.104054,2020-05-20
Virus,CAUSES,Disease,32427219,10.1007/s41649-020-00119-1,2020-05-20
Coronavirus Infections,COEXISTS_WITH,living situation,32427215,10.1016/j.jbef.2020.100341,2020-05-20
Hospitalization,ADMINISTERED_TO,Patients,32427215,10.1016/j.jbef.2020.100341,2020-05-20
Hospitalization,USES,Psychotropic Drugs,32427215,10.1016/j.jbef.2020.100341,2020-05-20
Coronavirus Infections,ISA,Disease,32427206,10.1007/s11071-020-05680-w,2020-05-20
Infected,PROCESS_OF,Persons,32427205,10.1016/j.chaos.2020.109883,2020-05-20
Infected,PROCESS_OF,Persons,32427202,10.1007/s41649-020-00118-2,2020-05-20
Infected,PROCESS_OF,Persons,32427202,10.1007/s41649-020-00118-2,2020-05-20
Infected,PROCESS_OF,Persons,32427197,10.1002/hbe2.192,2020-05-20
Social Interaction,PROCESS_OF,Homo sapiens,32427192,10.1007/s00740-020-00350-4,2020-05-20
Community acquired pneumonia,PROCESS_OF,Patients,32427189,10.1002/asi.24357,2020-05-20
Chronic lung disease,PROCESS_OF,Patients,32427189,10.1002/asi.24357,2020-05-20
Coronavirus Infections,CAUSES,Acute illness,32427171,10.1002/emp2.12071,2020-05-20
Oxygen,PART_OF,Nose,32427170,10.1007/s10669-020-09772-1,2020-05-20
Coronavirus Infections,ISA,Disease,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
Texas,ISA,Geographic Locations,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
United States,ISA,Country,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
IMPACT gene,AUGMENTS,exposure (to) disease,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
Coronavirus Infections,ISA,Disease,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
Coronavirus Infections,ISA,Disease,32427167,10.1016/j.hlpt.2020.04.009,2020-05-20
Serologic tests,USES,Antibodies,32427165,10.1007/s11469-020-00305-0,2020-05-20
Pharmaceutical Preparations,AFFECTS,Contraindicated,32427165,10.1007/s11469-020-00305-0,2020-05-20
Quarantine,AFFECTS,"Stress Disorders, Traumatic",32427140,10.1016/j.matt.2020.04.026,2020-05-20
Brain,LOCATION_OF,Genus: Coronavirus,32427106,10.2196/19273,2020-05-20
Neurologic Symptoms,PROCESS_OF,Patients,32427106,10.2196/19273,2020-05-20
Parenchyma,PART_OF,Brain,32427106,10.2196/19273,2020-05-20
SARS coronavirus,CAUSES,Demyelination,32427106,10.2196/19273,2020-05-20
SARS coronavirus,CAUSES,Degenerative brain disorder,32427106,10.2196/19273,2020-05-20
neurologic sequelae,PROCESS_OF,Patients,32427106,10.2196/19273,2020-05-20
Multiple Sclerosis,PROCESS_OF,Patients,32427106,10.2196/19273,2020-05-20
Pandemics,ISA,Disease Outbreaks,32427104,10.2196/19353,2020-05-20
Epidemic,ISA,Disease Outbreaks,32427104,10.2196/19353,2020-05-20
Coronavirus Infections,ISA,Disease,32427103,10.2196/19501,2020-05-20
Interventional procedure,PREVENTS,Disease,32427103,10.2196/19501,2020-05-20
Coronavirus Infections,ISA,Disease,32427103,10.2196/19501,2020-05-20
Acclimatization,AFFECTS,Local disease,32427103,10.2196/19501,2020-05-20
Empowered,PROCESS_OF,Policy Makers,32427103,10.2196/19501,2020-05-20
Masks,TREATS,member,32427056,10.1177/0194599820930668,2020-05-20
Coronavirus Infections,ISA,Disease,32427056,10.1177/0194599820930668,2020-05-20
Masks,USES,Textiles,32427056,10.1177/0194599820930668,2020-05-20
Disease,PROCESS_OF,general population,32427056,10.1177/0194599820930668,2020-05-20
Masks,PREVENTS,Disease,32427056,10.1177/0194599820930668,2020-05-20
Masks,PREVENTS(SPEC),Coronavirus Infections,32427056,10.1177/0194599820930668,2020-05-20
Coronavirus Infections,ISA,Disease,32427056,10.1177/0194599820930668,2020-05-20
Coronavirus Infections,PROCESS_OF(SPEC),general population,32427056,10.1177/0194599820930668,2020-05-20
Coronavirus Infections,ISA,Disease,32427056,10.1177/0194599820930668,2020-05-20
Intubation,ADMINISTERED_TO,Author,32427004,10.1080/17425247.2020.1772229,2020-05-20
Disease,PROCESS_OF,Patients,32426897,10.1111/jth.14898,2020-05-20
Patients,USES,Preexisting Condition Coverage,32426897,10.1111/jth.14898,2020-05-20
Symptoms,ASSOCIATED_WITH,Rheumatism,32426897,10.1111/jth.14898,2020-05-20
Blood Coagulation Disorders,COEXISTS_WITH,Respiratory Failure,32426890,10.1111/ene.14334,2020-05-20
Lung,LOCATION_OF,Blood Coagulation Disorders,32426890,10.1111/ene.14334,2020-05-20
Critical Illness,PROCESS_OF,Patients,32426890,10.1111/ene.14334,2020-05-20
Hemostatic function,PROCESS_OF,Patients,32426890,10.1111/ene.14334,2020-05-20
Septicemia,CAUSES,Thrombophilia,32426890,10.1111/ene.14334,2020-05-20
heparin,CAUSES,Virus Diseases,32426890,10.1111/ene.14334,2020-05-20
Polysaccharides,COEXISTS_WITH,heparin,32426890,10.1111/ene.14334,2020-05-20
Proteins,INTERACTS_WITH,Heparitin Sulfate,32426890,10.1111/ene.14334,2020-05-20
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32426864,10.1111/jdv.16631,2020-05-20
Ultrasonography,ISA,Evaluation procedure,32426864,10.1111/jdv.16631,2020-05-20
Ultrasonography,TREATS(SPEC),Acute Cerebrovascular Accidents,32426864,10.1111/jdv.16631,2020-05-20
Acute Cerebrovascular Accidents,PROCESS_OF,Working Group,32426864,10.1111/jdv.16631,2020-05-20
Acute Cerebrovascular Accidents,PROCESS_OF,Working Group,32426864,10.1111/jdv.16631,2020-05-20
Evaluation procedure,TREATS,Acute Cerebrovascular Accidents,32426864,10.1111/jdv.16631,2020-05-20
Evaluation procedure,USES,Ultrasonography,32426864,10.1111/jdv.16631,2020-05-20
Attention,PROCESS_OF,Patients,32426864,10.1111/jdv.16631,2020-05-20
Hospitals,LOCATION_OF,Knowledge acquisition,32426864,10.1111/jdv.16631,2020-05-20
Cerebrovascular accident,PROCESS_OF,Patients,32426864,10.1111/jdv.16631,2020-05-20
Ultrasonography,ISA,Evaluation procedure,32426864,10.1111/jdv.16631,2020-05-20
Ultrasonography,TREATS(SPEC),Acute Cerebrovascular Accidents,32426864,10.1111/jdv.16631,2020-05-20
Evaluation procedure,TREATS,Acute Cerebrovascular Accidents,32426864,10.1111/jdv.16631,2020-05-20
Evaluation procedure,USES,Ultrasonography,32426864,10.1111/jdv.16631,2020-05-20
Coronavirus Infections,COEXISTS_WITH,Disease,32426805,10.1093/cid/ciaa575,2020-05-20
Alarmins,STIMULATES,Genome,32426749,10.1097/CCE.0000000000000107,2020-05-20
Alarmins,STIMULATES,cytokine,32426749,10.1097/CCE.0000000000000107,2020-05-20
Seizures,ASSOCIATED_WITH,Severe viral infections,32426693,10.1007/s11357-020-00195-z,2020-05-20
Comorbidity,PROCESS_OF,Social Networks,32426653,10.5811/cpcem.2020.4.47524,2020-05-20
Ultrasonography,ISA,Evaluation,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Evaluation,USES,Ultrasonography,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Medical Examination,USES,Ultrasonography,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Lung,LOCATION_OF,Ultrasonography,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Respiratory distress,PROCESS_OF,Patients,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Medical Examination,PREVENTS,Uncertainty,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Medical Examination,USES,Ultrasonography,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Evaluation procedure,TREATS,Patients,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Evaluation procedure,TREATS(INFER),Respiratory distress,32426652,10.5811/cpcem.2020.4.47443,2020-05-20
Medical Devices,USES,Piperine Extract (Standardized),32426576,10.1016/j.jogoh.2020.101813,2020-05-20
SARS coronavirus,PROCESS_OF,Patients,32426576,10.1016/j.jogoh.2020.101813,2020-05-20
Uterine adnexae structure,LOCATION_OF,Laparoscopy,32426575,10.1016/j.case.2020.05.007,2020-05-20
Spinal Anesthesia,compared_with,General Anesthesia,32426575,10.1016/j.case.2020.05.007,2020-05-20
Laparoscopy,PRECEDES,Anesthesia procedures,32426575,10.1016/j.case.2020.05.007,2020-05-20
General Anesthesia,ADMINISTERED_TO,Woman,32426575,10.1016/j.case.2020.05.007,2020-05-20
Spinal Anesthesia,ADMINISTERED_TO,Woman,32426575,10.1016/j.case.2020.05.007,2020-05-20
"Surgical Procedures, Laparoscopic",TREATS,Benign condition,32426575,10.1016/j.case.2020.05.007,2020-05-20
SLC33A1 gene,COEXISTS_WITH,AKR1A1 wt Allele,32426575,10.1016/j.case.2020.05.007,2020-05-20
Spinal Anesthesia,ADMINISTERED_TO,Patients,32426575,10.1016/j.case.2020.05.007,2020-05-20
drug management,USES,Opioids,32426575,10.1016/j.case.2020.05.007,2020-05-20
Spinal Anesthesia,TREATS,Woman,32426575,10.1016/j.case.2020.05.007,2020-05-20
Respiratory System,LOCATION_OF,Spinal Anesthesia,32426575,10.1016/j.case.2020.05.007,2020-05-20
Thromboembolism,ISA,Embolism,32426560,10.1016/j.jvscit.2020.05.001,2020-05-20
Lower Extremity,LOCATION_OF,Pain,32426559,10.1016/j.idh.2020.05.001,2020-05-20
Fever,PROCESS_OF,Patients,32426559,10.1016/j.idh.2020.05.001,2020-05-20
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32426559,10.1016/j.idh.2020.05.001,2020-05-20
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32426529,10.1136/tsaco-2020-000505,2020-05-20
IMPACT gene,AUGMENTS,Wounds and Injuries,32426441,10.1016/j.accpm.2020.05.008,2020-05-20
Critical Illness,PROCESS_OF,Patients,32426388,10.1016/j.bj.2020.05.002,2020-05-20
Health Care,TREATS,Household composition,32426388,10.1016/j.bj.2020.05.002,2020-05-20
NCKIPSD gene,PART_OF,Patients,32426388,10.1016/j.bj.2020.05.002,2020-05-20
Proteins,PART_OF,Virus,32426387,10.1016/j.bj.2020.05.001,2020-05-20
Disease,PROCESS_OF,Patients,32426374,10.3389/fcvm.2020.00078,2020-05-20
Artificial Intelligence,ISA,Technology,32426374,10.3389/fcvm.2020.00078,2020-05-20
Storm NOS,COMPLICATES,Cardiovascular Diseases,32426363,10.3389/fmed.2020.00190,2020-05-20
Conventional Treatment,TREATS,Multiple Organ Failure,32426363,10.3389/fmed.2020.00190,2020-05-20
Cardiovascular,LOCATION_OF,Protection,32426363,10.3389/fmed.2020.00190,2020-05-20
Cardiovascular therapy,USES,Anti-Inflammatory Agents,32426363,10.3389/fmed.2020.00190,2020-05-20
Anti-Inflammatory Agents,TREATS,patient condition,32426363,10.3389/fmed.2020.00190,2020-05-20
Cardiovascular therapy,TREATS,patient condition,32426363,10.3389/fmed.2020.00190,2020-05-20
Cardiovascular therapy,USES,Anti-Inflammatory Agents,32426363,10.3389/fmed.2020.00190,2020-05-20
Cardiovascular therapy,USES,Anti-Inflammatory Agents,32426363,10.3389/fmed.2020.00190,2020-05-20
Infected,PROCESS_OF,Patients,32426362,10.3389/fmed.2020.00185,2020-05-20
Italy,ISA,Country,32426320,10.3389/fpubh.2020.00181,2020-05-20
Virus,PROCESS_OF,Child,32426303,10.1016/j.remn.2020.04.004,2020-05-20
Pneumonia,PROCESS_OF,Patients,32426292,10.3389/fonc.2020.00793,2020-05-20
Asymptomatic,PROCESS_OF,Patients,32426292,10.3389/fonc.2020.00793,2020-05-20
Asymptomatic,PROCESS_OF,Patients,32426292,10.3389/fonc.2020.00793,2020-05-20
Lung,LOCATION_OF,INFECTIOUS PROCESS,32426292,10.3389/fonc.2020.00793,2020-05-20
Lung,LOCATION_OF,INFECTIOUS PROCESS,32426292,10.3389/fonc.2020.00793,2020-05-20
Asymptomatic,PROCESS_OF,Patients,32426292,10.3389/fonc.2020.00793,2020-05-20
Lung,LOCATION_OF,advanced cancer,32426285,10.3389/fonc.2020.00648,2020-05-20
advanced cancer,PROCESS_OF,Patients,32426285,10.3389/fonc.2020.00648,2020-05-20
Lung,LOCATION_OF,advanced cancer,32426285,10.3389/fonc.2020.00648,2020-05-20
advanced cancer,PROCESS_OF,Patients,32426285,10.3389/fonc.2020.00648,2020-05-20
Italy,ISA,European country,32426243,10.1016/j.crwh.2020.e00221,2020-05-20
Cessation of life,PROCESS_OF,Patients,32426243,10.1016/j.crwh.2020.e00221,2020-05-20
viral transmission,AFFECTS,Oncologists,32426243,10.1016/j.crwh.2020.e00221,2020-05-20
Malignant Neoplasms,PROCESS_OF,geriatric patients,32426243,10.1016/j.crwh.2020.e00221,2020-05-20
Therapeutic procedure,TREATS,Patients,32426242,10.1016/j.crwh.2020.e00220,2020-05-20
Critical Illness,PROCESS_OF,Obstetric Patient,32426242,10.1016/j.crwh.2020.e00220,2020-05-20
Nose,LOCATION_OF,Congestion,32426231,10.1016/j.idcr.2020.e00828,2020-05-20
X-Ray Computed Tomography,DIAGNOSES,Ground Glass Opacity,32426231,10.1016/j.idcr.2020.e00828,2020-05-20
Chest,LOCATION_OF,X-Ray Computed Tomography,32426231,10.1016/j.idcr.2020.e00828,2020-05-20
truck driver,DIAGNOSES,Septicemia,32426230,10.1016/j.idcr.2020.e00814,2020-05-20
Hydroxychloroquine,TREATS,Mental state,32426229,10.1016/j.idcr.2020.e00794,2020-05-20
Azithromycin,TREATS,Mental state,32426229,10.1016/j.idcr.2020.e00794,2020-05-20
Infusion procedures,TREATS,Respiratory Failure,32426220,10.1016/j.jvsv.2020.05.002,2020-05-20
Diversion procedure,TREATS,Patients,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Veins,PART_OF,Patients,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Operative Surgical Procedures,ISA,Interventional procedure,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Veins,LOCATION_OF,Chronic disease,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Disease,PROCESS_OF,Persons,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Lung,LOCATION_OF,Massive embolus,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Veins,LOCATION_OF,Chronic disease,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Veins,PART_OF,Patients,32426212,10.1016/j.celrep.2020.107725,2020-05-20
Patients,LOCATION_OF,Plasma,32426202,10.7759/cureus.8126,2020-05-20
Antibody Formation,AFFECTS,Antibody-Dependent Enhancement,32426202,10.7759/cureus.8126,2020-05-20
Adrenal Cortex,LOCATION_OF,Cerebrovascular accident,32426144,10.1186/s40545-020-00214-6,2020-05-20
Cerebrovascular accident,PROCESS_OF,Woman,32426144,10.1186/s40545-020-00214-6,2020-05-20
Sequela of disorder,PROCESS_OF,Patients,32426144,10.1186/s40545-020-00214-6,2020-05-20
American College of Cardiology/American Heart Association Lesion Complexity Score A,NEG_PREDISPOSES,Cerebrovascular accident,32426144,10.1186/s40545-020-00214-6,2020-05-20
Critical Illness,PROCESS_OF,Patients,32426144,10.1186/s40545-020-00214-6,2020-05-20
acute care,TREATS,Patients,32426144,10.1186/s40545-020-00214-6,2020-05-20
acute care,TREATS(INFER),Critical Illness,32426144,10.1186/s40545-020-00214-6,2020-05-20
Pulmonary Hypertension,PROCESS_OF,Patients,32426099,10.1007/s40617-020-00429-8,2020-05-20
Pulmonary arterial hypertension,PROCESS_OF,Patients,32426099,10.1007/s40617-020-00429-8,2020-05-20
Pulmonary arterial hypertension,PROCESS_OF,Patients,32426099,10.1007/s40617-020-00429-8,2020-05-20
Therapeutic procedure,TREATS,Patients,32426099,10.1007/s40617-020-00429-8,2020-05-20
Hypertensive disease,PROCESS_OF,Patients,32426099,10.1007/s40617-020-00429-8,2020-05-20
Pulmonary arterial hypertension,PROCESS_OF,Community,32426099,10.1007/s40617-020-00429-8,2020-05-20
Telemedicine,METHOD_OF,Telehealth service,32426090,10.1016/j.waojou.2020.100126,2020-05-20
Autism Spectrum Disorders,PROCESS_OF,Vulnerable Populations,32426090,10.1016/j.waojou.2020.100126,2020-05-20
Severe asthma,PROCESS_OF,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Asthma,PROCESS_OF,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Pharmaceutical Preparations,TREATS,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Pharmaceutical Preparations,TREATS(INFER),Asthma,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Asthma,PROCESS_OF,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Severe asthma,PROCESS_OF,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Multi-disciplinary team,METHOD_OF,Biological Response Modifier Therapy,32426089,10.1016/j.waojou.2020.100124,2020-05-20
Severe asthma,PROCESS_OF,Patients,32426089,10.1016/j.waojou.2020.100124,2020-05-20
IL13 gene,ASSOCIATED_WITH,Enthesitis-Related Arthritis,32426070,10.1016/j.wneu.2020.05.108,2020-05-20
Health Care,AFFECTS,Negative,32426066,10.1016/j.wneu.2020.05.090,2020-05-20
Patients,ISA,Persons,32426066,10.1016/j.wneu.2020.05.090,2020-05-20
Uncertainty,PREDISPOSES,Moral Injury,32426066,10.1016/j.wneu.2020.05.090,2020-05-20
Patients,ISA,Persons,32426066,10.1016/j.wneu.2020.05.090,2020-05-20
Telemedicine,COEXISTS_WITH,Neurosurgical Procedures,32426064,10.1016/j.wneu.2020.05.087,2020-05-20
Problem,PROCESS_OF,Patients,32426064,10.1016/j.wneu.2020.05.087,2020-05-20
Telemedicine,COEXISTS_WITH,Neurosurgical Procedures,32426064,10.1016/j.wneu.2020.05.087,2020-05-20
Coronavirus Infections,ISA,Disease,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Coronavirus Infections,ISA,Disease,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
IMPACT gene,PART_OF,Virus,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Disease,PROCESS_OF,Patients,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Coronavirus Infections,ISA,Disease,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Hospitals,LOCATION_OF,Training,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Coronavirus Infections,ISA,Disease,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Hospitals,LOCATION_OF,Training,32426062,10.1016/j.dsx.2020.05.026,2020-05-20
Singapore,ISA,Country,32426019,10.1016/j.ijsu.2020.05.037,2020-05-20
Hospital Units,LOCATION_OF,Knowledge acquisition,32426019,10.1016/j.ijsu.2020.05.037,2020-05-20
Infectious disease prevention / control,TREATS,Patients,32426019,10.1016/j.ijsu.2020.05.037,2020-05-20
Physical and emotional exhaustion state,PROCESS_OF,Surgeon,32426019,10.1016/j.ijsu.2020.05.037,2020-05-20
Operative Surgical Procedures,TREATS,Tissue damage,32426002,10.1016/j.reuma.2020.05.002,2020-05-20
Empowered,PROCESS_OF,Community,32426002,10.1016/j.reuma.2020.05.002,2020-05-20
Critical Illness,PROCESS_OF,Patients,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Cessation of life,PROCESS_OF,Patients,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Cytokine release syndrome,AFFECTS,Severe (severity modifier),32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Critical Illness,PROCESS_OF,Patients,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Pharmaceutical Preparations,TREATS,Disease,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Pharmaceutical Preparations,TREATS,Patients,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
Pharmaceutical Preparations,TREATS(INFER),Critical Illness,32426001,10.1016/j.reuma.2020.05.001,2020-05-20
colchicine treatment,TREATS,Crisis,32425996,10.1016/j.jmii.2020.05.001,2020-05-20
Inflammasomes,STIMULATES,macrophage,32425996,10.1016/j.jmii.2020.05.001,2020-05-20
Colchicine,PREVENTS,"Respiratory Distress Syndrome, Adult",32425996,10.1016/j.jmii.2020.05.001,2020-05-20
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32425996,10.1016/j.jmii.2020.05.001,2020-05-20
Symptom mild,PROCESS_OF,Patients,32425995,10.1016/j.jmii.2020.05.002,2020-05-20
Screening procedure,TREATS,Asymptomatic Infections,32425995,10.1016/j.jmii.2020.05.002,2020-05-20
consideration,PROCESS_OF,Patients,32425955,10.3389/fimmu.2020.00932,2020-05-20
Peptides,COEXISTS_WITH,Proteins,32425950,10.3389/fimmu.2020.00827,2020-05-20
Peptides,COEXISTS_WITH,"M Protein, multiple myeloma",32425950,10.3389/fimmu.2020.00827,2020-05-20
Peptides,PART_OF,SARS coronavirus,32425950,10.3389/fimmu.2020.00827,2020-05-20
Infected,PROCESS_OF,Patients,32425733,10.1016/j.dld.2020.05.017,2020-05-20
member,LOCATION_OF,IMPACT gene,32425732,10.1016/j.dld.2020.05.015,2020-05-20
Endoscopy (procedure),DIAGNOSES,Colorectal Carcinoma,32425732,10.1016/j.dld.2020.05.015,2020-05-20
Ultrasonography,DIAGNOSES,Colorectal Carcinoma,32425732,10.1016/j.dld.2020.05.015,2020-05-20
Disease,PROCESS_OF,Patients,32425731,10.1016/j.dld.2020.05.014,2020-05-20
Physical Examination,USES,Upper gastrointestinal tract series,32425731,10.1016/j.dld.2020.05.014,2020-05-20
Celiac Disease,PROCESS_OF,Patients,32425713,10.1016/j.sapharm.2020.05.016,2020-05-20
Celiac Disease,PROCESS_OF,Patients,32425713,10.1016/j.sapharm.2020.05.016,2020-05-20
Comorbidity,PROCESS_OF,Patients,32425713,10.1016/j.sapharm.2020.05.016,2020-05-20
Eye,LOCATION_OF,Crisis,32425710,10.1016/j.jacr.2020.05.004,2020-05-20
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Staff,32425710,10.1016/j.jacr.2020.05.004,2020-05-20
Health Care Systems,LOCATION_OF,Study,32425708,10.1016/j.jacr.2020.05.006,2020-05-20
Malignant neoplasm of thorax,PROCESS_OF,Patients,32425701,10.1016/j.devcel.2020.05.012,2020-05-20
Cardiopulmonary,LOCATION_OF,Comorbidity,32425701,10.1016/j.devcel.2020.05.012,2020-05-20
Malignant neoplasm of thorax,AFFECTS,Patients,32425701,10.1016/j.devcel.2020.05.012,2020-05-20
Lung,PART_OF,Homo sapiens,32425663,10.1016/j.jcv.2020.104447,2020-05-20
Up-Regulation (Physiology),PROCESS_OF,Rodent,32425663,10.1016/j.jcv.2020.104447,2020-05-20
Up-Regulation (Physiology),PROCESS_OF,Homo sapiens,32425663,10.1016/j.jcv.2020.104447,2020-05-20
angiotensin converting enzyme 2,INTERACTS_WITH,Secretory cell,32425663,10.1016/j.jcv.2020.104447,2020-05-20
Smoke,COEXISTS_WITH,angiotensin converting enzyme 2,32425663,10.1016/j.jcv.2020.104447,2020-05-20
angiotensin converting enzyme 2,AFFECTS,Virus Diseases,32425663,10.1016/j.jcv.2020.104447,2020-05-20
Severe Acute Respiratory Syndrome,AFFECTS,Smoker,32425663,10.1016/j.jcv.2020.104447,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32425662,10.1016/j.jcv.2020.104444,2020-05-20
Prospective Cohort Study,MEASURES,Incidence,32425662,10.1016/j.jcv.2020.104444,2020-05-20
Pneumonia,PROCESS_OF,Patients,32425660,10.1016/j.jcv.2020.104442,2020-05-20
Pneumonia,PROCESS_OF,hospitalized patients,32425660,10.1016/j.jcv.2020.104442,2020-05-20
Therapeutic procedure,USES,cytokine,32425660,10.1016/j.jcv.2020.104442,2020-05-20
Therapeutic procedure,TREATS,Raised C-reactive protein,32425660,10.1016/j.jcv.2020.104442,2020-05-20
Therapeutic procedure,USES,cytokine,32425660,10.1016/j.jcv.2020.104442,2020-05-20
Nasal Swab (procedure),USES,Detection,32425659,10.1016/j.jcv.2020.104441,2020-05-20
Oropharyngeal swab,PART_OF,"Nares, entire, anterior or posterior",32425659,10.1016/j.jcv.2020.104441,2020-05-20
Nasal Swab (procedure),METHOD_OF,Detection,32425659,10.1016/j.jcv.2020.104441,2020-05-20
Amino Acids,COEXISTS_WITH,Viral Proteins,32425658,10.1016/j.jcv.2020.104440,2020-05-20
Mutation,PROCESS_OF,Viral Genome,32425658,10.1016/j.jcv.2020.104440,2020-05-20
Laboratory,LOCATION_OF,"Transport Media, Viral",32425656,10.1007/s10840-020-00761-7,2020-05-20
Medical Devices,DIAGNOSES,SARS coronavirus,32425656,10.1007/s10840-020-00761-7,2020-05-20
Suspicion,PROCESS_OF,Patients,32425656,10.1007/s10840-020-00761-7,2020-05-20
Pandemics,ISA,Disease Outbreaks,32425655,10.1038/s41391-020-0240-4,2020-05-20
Hospitals,ISA,Health care facility,32425655,10.1038/s41391-020-0240-4,2020-05-20
Elective Surgical Procedures,ISA,Therapeutic procedure,32425653,10.1186/s41182-020-00219-6,2020-05-20
Italy,ISA,Country,32425653,10.1186/s41182-020-00219-6,2020-05-20
Africa,ISA,Geographic Locations,32425651,10.1016/j.sjbs.2020.05.024,2020-05-20
Malaria,PROCESS_OF,Child,32425651,10.1016/j.sjbs.2020.05.024,2020-05-20
Malaria,PROCESS_OF,Pregnant Women,32425651,10.1016/j.sjbs.2020.05.024,2020-05-20
Prophylactic treatment,TREATS,Malaria,32425651,10.1016/j.sjbs.2020.05.024,2020-05-20
Has difficulty doing (qualifier value),PROCESS_OF,Persons,32425651,10.1016/j.sjbs.2020.05.024,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Adult,32425649,10.1016/j.micinf.2020.05.007,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Human Age Group,32425649,10.1016/j.micinf.2020.05.007,2020-05-20
Confirmation,PROCESS_OF,Patients,32425643,10.1016/j.ijid.2020.05.055,2020-05-20
Laboratory Procedures,DIAGNOSES,Virus Diseases,32425643,10.1016/j.ijid.2020.05.055,2020-05-20
Virus Diseases,ISA,Symptoms,32425643,10.1016/j.ijid.2020.05.055,2020-05-20
Serum,LOCATION_OF,Ferritin,32425638,10.1016/j.ijid.2020.05.040,2020-05-20
directive therapy,ISA,Therapeutic procedure,32425637,10.1016/j.ijid.2020.05.039,2020-05-20
Male population group,ISA,Persons,32425636,10.1016/j.ijid.2020.05.045,2020-05-20
Viral Shedding,PROCESS_OF,Patients,32425635,10.1016/j.ijid.2020.05.047,2020-05-20
Viral Shedding,PROCESS_OF,Patients,32425635,10.1016/j.ijid.2020.05.047,2020-05-20
Infected,PROCESS_OF,Patients,32425635,10.1016/j.ijid.2020.05.047,2020-05-20
Coronavirus Infections,CAUSES,Atypical pneumonia,32425631,10.1016/j.ijid.2020.05.043,2020-05-20
Movement,PROCESS_OF,Homo sapiens,32425631,10.1016/j.ijid.2020.05.043,2020-05-20
Movement,PROCESS_OF,Homo sapiens,32425631,10.1016/j.ijid.2020.05.043,2020-05-20
Movement,PROCESS_OF,Homo sapiens,32425631,10.1016/j.ijid.2020.05.043,2020-05-20
Quarantine,ISA,Isolation procedure,32425491,10.1016/j.semerg.2020.05.010,2020-05-20
Intervention regimes,COEXISTS_WITH,Isolation procedure,32425491,10.1016/j.semerg.2020.05.010,2020-05-20
Intervention regimes,COEXISTS_WITH(SPEC),Quarantine,32425491,10.1016/j.semerg.2020.05.010,2020-05-20
Prophylactic treatment,TREATS,Disease,32425489,10.1016/j.enfcli.2020.05.009,2020-05-20
Birth,ISA,Pregnancy,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Labor (Childbirth),PROCESS_OF,Woman,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Health Personnel,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Pregnant Women,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Pregnant Women,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Pregnant Women,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Pregnant Women,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Prophylactic treatment,TREATS,Pregnant Women,32425488,10.1016/j.enfcli.2020.05.005,2020-05-20
Child,ISA,Population Group,32425487,10.1016/j.enfcli.2020.05.006,2020-05-20
Disease,COEXISTS_WITH,Incubation period,32425487,10.1016/j.enfcli.2020.05.006,2020-05-20
Households,INTERACTS_WITH,Family,32425487,10.1016/j.enfcli.2020.05.006,2020-05-20
Households,ISA,Family,32425487,10.1016/j.enfcli.2020.05.006,2020-05-20
Tension,PROCESS_OF,Health Personnel,32425486,10.1016/j.enfcli.2020.05.008,2020-05-20
Tension,AFFECTS,Health Personnel,32425486,10.1016/j.enfcli.2020.05.008,2020-05-20
Complication,PROCESS_OF,Patients,32425485,10.1016/j.enfcli.2020.05.004,2020-05-20
Critical Illness,PROCESS_OF,Patients,32425485,10.1016/j.enfcli.2020.05.004,2020-05-20
Decision,PROCESS_OF,Population Group,32425484,10.1016/j.enfcli.2020.05.007,2020-05-20
Physician service,TREATS,Confirmation,32425474,10.1016/j.jagp.2020.05.009,2020-05-20
mental health,PROCESS_OF,Old age,32425473,10.1016/j.jagp.2020.05.004,2020-05-20
Old age,ISA,Population Group,32425473,10.1016/j.jagp.2020.05.004,2020-05-20
Old age,ISA,Population Group,32425473,10.1016/j.jagp.2020.05.004,2020-05-20
Older Population,LOCATION_OF,IMPACT gene,32425471,10.1016/j.jagp.2020.05.012,2020-05-20
Complication,PREDISPOSES,Coronavirus Infections,32425471,10.1016/j.jagp.2020.05.012,2020-05-20
Loneliness,PROCESS_OF,Patients,32425471,10.1016/j.jagp.2020.05.012,2020-05-20
Infantile Neuroaxonal Dystrophy,PREDISPOSES,Suicide,32425471,10.1016/j.jagp.2020.05.012,2020-05-20
Coronavirus Infections,ISA,Disease,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
Virus,PROCESS_OF,Old age,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
Fever,PROCESS_OF,geriatric patients,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
"Signs and Symptoms, Respiratory",PROCESS_OF,geriatric patients,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
Abnormal mental state,PROCESS_OF,geriatric patients,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
Symptoms,PROCESS_OF,geriatric patients,32425430,10.1016/j.jcot.2020.05.009,2020-05-20
Fixation - action,TREATS,Patients,32425428,10.1016/j.jcot.2020.05.011,2020-05-20
orthopedic disorders,AFFECTS,Community,32425415,10.1016/j.jor.2020.05.013,2020-05-20
Smoke,ASSOCIATED_WITH,Communicable Diseases,32425361,10.1016/j.phymed.2020.153242,2020-05-20
Fever,ISA,Symptoms,32425360,10.1016/j.numecd.2020.05.007,2020-05-20
Fingers,LOCATION_OF,endothelial dysfunction,32425356,10.1016/j.jdermsci.2020.05.002,2020-05-20
Fingers,PART_OF,Patients,32425356,10.1016/j.jdermsci.2020.05.002,2020-05-20
Obesity,PROCESS_OF,Patients,32425356,10.1016/j.jdermsci.2020.05.002,2020-05-20
Pneumonia,PROCESS_OF,Patients,32425337,10.1016/j.clinimag.2020.05.016,2020-05-20
Study,USES,Real-Time Polymerase Chain Reaction,32425334,10.1016/j.mcp.2020.101599,2020-05-20
Lung,LOCATION_OF,X-Ray Computed Tomography,32425334,10.1016/j.mcp.2020.101599,2020-05-20
X-Ray Computed Tomography,USES,Microtomy,32425334,10.1016/j.mcp.2020.101599,2020-05-20
Screening procedure,METHOD_OF,Contacts,32425334,10.1016/j.mcp.2020.101599,2020-05-20
Pleural effusion disorder,PROCESS_OF,Patients,32425334,10.1016/j.mcp.2020.101599,2020-05-20
Both lungs,LOCATION_OF,Ground Glass Opacity,32425334,10.1016/j.mcp.2020.101599,2020-05-20
follow-up,TREATS,Patients,32425334,10.1016/j.mcp.2020.101599,2020-05-20
Myocardium,LOCATION_OF,Direct Contact Transmission Infection,32425326,10.1016/j.jvs.2020.04.503,2020-05-20
Respiratory Failure,CAUSES,Anoxia,32425326,10.1016/j.jvs.2020.04.503,2020-05-20
Health Services,TREATS,Acute Disease,32425326,10.1016/j.jvs.2020.04.503,2020-05-20
Heart,LOCATION_OF,Acute Disease,32425326,10.1016/j.jvs.2020.04.503,2020-05-20
Coronavirus Infections,PREDISPOSES,Complication,32425320,10.1016/j.ajem.2020.05.023,2020-05-20
Dispensing medication,TREATS,patient condition,32425320,10.1016/j.ajem.2020.05.023,2020-05-20
Lung,LOCATION_OF,Leriche Syndrome,32425317,10.1016/j.anl.2020.05.006,2020-05-20
Hospitals,ISA,Health care facility,32425315,10.1016/j.maturitas.2020.05.009,2020-05-20
Complication,PROCESS_OF,Male population group,32425307,10.1016/j.mehy.2020.109845,2020-05-20
Severe disorder,PROCESS_OF,Patients,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Old age,ISA,Human Age Group,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Multiple Chronic Conditions,PROCESS_OF,Human Age Group,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Multiple Chronic Conditions,PROCESS_OF(SPEC),Old age,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Virus,CAUSES,Immune response,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Adaptive Immunity,PROCESS_OF,Patients,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Lung Injury,CAUSES,"Respiratory Distress Syndrome, Adult",32425304,10.1016/j.mehy.2020.109842,2020-05-20
Storm NOS,PROCESS_OF,Patients,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Symptom severe,PROCESS_OF,Patients,32425304,10.1016/j.mehy.2020.109842,2020-05-20
Symptom mild,PROCESS_OF,Child,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Cross Protection,PROCESS_OF,Child,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Vaccines,TREATS,Influenza,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Vaccines,TREATS,Pneumonia,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Vaccines,TREATS,Tuberculosis,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Diabetes,AFFECTS,Immunity,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Diabetes,ISA,Disease,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Diabetes,PROCESS_OF(SPEC),Old age,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Disease,PROCESS_OF,Old age,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Hypertensive disease,AFFECTS,Immunity,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Hypertensive disease,ISA,Disease,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Hypertensive disease,PROCESS_OF(SPEC),Old age,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Immunity,AFFECTS,Ability,32425295,10.1016/j.socscimed.2020.113036,2020-05-20
Movement,PROCESS_OF,Population Group,32425294,10.1016/j.blre.2020.100707,2020-05-20
Movement,PROCESS_OF,Population Group,32425294,10.1016/j.blre.2020.100707,2020-05-20
Inflammation,PROCESS_OF,Patients,32425292,10.1016/j.clnu.2020.05.006,2020-05-20
Single organ dysfunction,PROCESS_OF,Patients,32425292,10.1016/j.clnu.2020.05.006,2020-05-20
Diagnosis,CAUSES,Storm Syndrome,32425292,10.1016/j.clnu.2020.05.006,2020-05-20
cytokine,ASSOCIATED_WITH,Storm Syndrome,32425292,10.1016/j.clnu.2020.05.006,2020-05-20
Dietary Modification,TREATS,"Physicians, Family",32425289,10.1016/j.medin.2020.05.004,2020-05-20
Pharmaceutical Preparations,COEXISTS_WITH,Program,32425283,10.1016/j.cmpb.2020.105537,2020-05-20
Abdomen,LOCATION_OF,Tract,32425282,10.1016/j.healthpol.2020.05.010,2020-05-20
Tract,PART_OF,Aorta,32425282,10.1016/j.healthpol.2020.05.010,2020-05-20
mental health,PROCESS_OF,Clinician,32425275,10.1016/j.jad.2020.05.061,2020-05-20
Psychometrics,AFFECTS,Population Health,32425275,10.1016/j.jad.2020.05.061,2020-05-20
"Psychosis, Brief Reactive",PROCESS_OF,General Practitioners,32425272,10.1016/j.hrtlng.2020.05.005,2020-05-20
Delusions,AFFECTS,Behavior,32425272,10.1016/j.hrtlng.2020.05.005,2020-05-20
Mental disorders,PROCESS_OF,Health Personnel,32425272,10.1016/j.hrtlng.2020.05.005,2020-05-20
Psychotic illness,PROCESS_OF,Patients,32425272,10.1016/j.hrtlng.2020.05.005,2020-05-20
Fever,PROCESS_OF,Male population group,32425270,10.1016/j.cell.2020.05.025,2020-05-20
Tracheobronchomegaly,PROCESS_OF,Patients,32425270,10.1016/j.cell.2020.05.025,2020-05-20
Respiratory Failure,COEXISTS_WITH,Disease,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Creatinine,PREDISPOSES,Respiratory Failure,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Lactate Dehydrogenase,PREDISPOSES,Respiratory Failure,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
assessment.initial,PROCESS_OF,Cohort,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Respiratory Failure,PROCESS_OF,Cohort,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Cohort,LOCATION_OF,Interleukin-6,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Syndrome,PROCESS_OF,Patients,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32425268,10.1016/j.ygyno.2020.05.019,2020-05-20
Hysterectomy,TREATS,Woman,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Hysterectomy,TREATS,Stage IIA Cervical Carcinoma,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Cervicectomy,TREATS,Woman,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Cervicectomy,TREATS,Stage IIA Cervical Carcinoma,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Biopsy,DIAGNOSES,Infiltrating Cervical Carcinoma,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Woman,USES,Limited stage (cancer stage),32425267,10.1016/j.urology.2020.05.011,2020-05-20
disease recurrence,PROCESS_OF,Woman,32425267,10.1016/j.urology.2020.05.011,2020-05-20
Rheumatism,PROCESS_OF,Adult,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Rheumatism,PROCESS_OF,Adult,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Rheumatism,PROCESS_OF,Patients,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Rheumatism,PROCESS_OF,Patients,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
"Antirheumatic Drugs, Disease-Modifying",ADMINISTERED_TO,Adult,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
"Antirheumatic Drugs, Disease-Modifying",ADMINISTERED_TO,Patients,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Laboratory Procedures,USES,PCR test for SARS,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
PCR test for SARS,ISA,Laboratory Procedures,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Rheumatism,PROCESS_OF,Patients,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Rheumatism,PROCESS_OF,Patients,32425259,10.1016/j.semarthrit.2020.04.015,2020-05-20
Disease,PROCESS_OF,Patients,32425251,10.1016/j.watres.2020.115942,2020-05-20
Coughing,ISA,Symptoms,32425251,10.1016/j.watres.2020.115942,2020-05-20
Fever,ISA,Symptoms,32425251,10.1016/j.watres.2020.115942,2020-05-20
Coronavirus Infections,PROCESS_OF,Family suidae,32425247,10.1016/j.surg.2020.05.006,2020-05-20
Nucleocapsid,PART_OF,Virus,32425247,10.1016/j.surg.2020.05.006,2020-05-20
Adrenal Cortex Hormones,AFFECTS,body system,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Ascorbic Acid,AFFECTS,body system,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Colchicine,AFFECTS,body system,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Interferons,AFFECTS,body system,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Pharmaceutical Preparations,TREATS,Patients,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Pharmaceutical Preparations,TREATS,Disease,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
psychiatric issue,PROCESS_OF,Population Group,32425239,10.1016/j.ijnurstu.2020.103635,2020-05-20
Disease,AFFECTS,Persons,32425237,10.1007/s43465-020-00135-1,2020-05-20
Coronavirus Infections,AFFECTS(SPEC),Persons,32425237,10.1007/s43465-020-00135-1,2020-05-20
Coronavirus Infections,ISA,Disease,32425237,10.1007/s43465-020-00135-1,2020-05-20
Inflammatory Bowel Diseases,AFFECTS,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Immunosuppressive Agents,TREATS,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Immunosuppressive Agents,TREATS(INFER),Inflammatory Bowel Diseases,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Therapeutic procedure,USES,Immunosuppressive Agents,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
risk factors,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Comorbidity,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32425224,10.1016/j.rce.2020.05.003,2020-05-20
Chlorpromazine,DISRUPTS(SPEC),clathrin-dependent endocytosis,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Chlorpromazine,ISA,Phenothiazine derivatives,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Phenothiazine derivatives,DISRUPTS,clathrin-dependent endocytosis,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Brain,LOCATION_OF,Chlorpromazine,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Lung,LOCATION_OF,Chlorpromazine,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
saliva,LOCATION_OF,Chlorpromazine,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Chlorpromazine,DISRUPTS,contagion,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
Chlorpromazine,TREATS,Infection status,32425210,10.1016/j.bulcan.2020.05.001,2020-05-20
IMPACT gene,PART_OF,mediterranean,32425203,10.1016/j.athoracsur.2020.05.007,2020-05-20
Tumor board,LOCATION_OF,Study,32425203,10.1016/j.athoracsur.2020.05.007,2020-05-20
Prenatal care,ADMINISTERED_TO,Patients,32425199,10.1016/j.amjcard.2020.04.054,2020-05-20
Gravidity,PROCESS_OF,Patients,32425199,10.1016/j.amjcard.2020.04.054,2020-05-20
Screening procedure,TREATS,Gestational Diabetes,32425199,10.1016/j.amjcard.2020.04.054,2020-05-20
Delivery care,TREATS,Patients,32425199,10.1016/j.amjcard.2020.04.054,2020-05-20
Cardiovascular Diseases,PROCESS_OF,Patients,32425198,10.1016/j.ahj.2020.05.006,2020-05-20
Disease,PROCESS_OF,Patients,32425198,10.1016/j.ahj.2020.05.006,2020-05-20
Cardiovascular Diseases,PROCESS_OF,Patients,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
cardiovascular risk factor,PROCESS_OF,Patients,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
Myocardial Infarction,PROCESS_OF,hospitalized patients,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
Intervention regimes,TREATS,patient condition,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
ST segment elevation myocardial infarction,AFFECTS,Canadian,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
History of previous events,PROCESS_OF,Control Groups,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
Elevation procedure,TREATS,patient condition,32425197,10.1016/j.ahj.2020.05.005,2020-05-20
Cardiovascular,LOCATION_OF,Comorbidity,32425184,10.1714/3359.33323,2020-05-20
Cardiovascular,LOCATION_OF,Comorbidity,32425184,10.1714/3359.33323,2020-05-20
Takotsubo Cardiomyopathy,CAUSES,Myocardial Infarction,32425183,10.1714/3359.33322,2020-05-20
Complication,PROCESS_OF,hospitalized patients,32425183,10.1714/3359.33322,2020-05-20
Health Personnel,DIAGNOSES,Enthesitis-Related Arthritis,32425182,10.1714/3359.33321,2020-05-20
Patients,DIAGNOSES,Enthesitis-Related Arthritis,32425182,10.1714/3359.33321,2020-05-20
Physical Examination,USES,Diagnosis,32425182,10.1714/3359.33321,2020-05-20
Cardiovascular Diseases,NEG_ISA,Illness (finding),32425152,10.20344/amp.13908,2020-05-20
Heart,LOCATION_OF,Illness (finding),32425152,10.20344/amp.13908,2020-05-20
Heart,NEG_LOCATION_OF(SPEC),Cardiovascular Diseases,32425152,10.20344/amp.13908,2020-05-20
Cardiovascular,LOCATION_OF,Disease,32425152,10.20344/amp.13908,2020-05-20
Investigational New Drugs,TREATS,Patients,32425051,10.1513/AnnalsATS.202004-309SD,2020-05-20
Hydroxychloroquine,compared_with,Azithromycin,32425014,10.4081/monaldi.2020.1358,2020-05-20
Patient Transport,TREATS,Disease,32425013,10.4081/monaldi.2020.1300,2020-05-20
Screening procedure,TREATS,Complication,32425013,10.4081/monaldi.2020.1300,2020-05-20
heart study,AFFECTS,Screening procedure,32425013,10.4081/monaldi.2020.1300,2020-05-20
Cessation of life,PROCESS_OF,Patients,32425010,10.1631/jzus.B2000109,2020-05-20
Prognosis bad,PROCESS_OF,Patients,32425010,10.1631/jzus.B2000109,2020-05-20
Inflammation,COEXISTS_WITH,Virus Diseases,32425010,10.1631/jzus.B2000109,2020-05-20
Blood Coagulation Disorders,ISA,Disease,32425010,10.1631/jzus.B2000109,2020-05-20
Signs and Symptoms,MANIFESTATION_OF,Thromboembolism,32425010,10.1631/jzus.B2000109,2020-05-20
"Heparin, Low-Molecular-Weight",ISA,Anticoagulants,32425010,10.1631/jzus.B2000109,2020-05-20
"Heparin, Low-Molecular-Weight",TREATS,Patients,32425010,10.1631/jzus.B2000109,2020-05-20
Diagnosis,DIAGNOSES,Handling,32425009,10.1631/jzus.B2000182,2020-05-20
Percutaneous Coronary Intervention,TREATS,Acute myocardial infarction,32425008,10.1631/jzus.B2000117,2020-05-20
Infectious disorder of the fetus,PROCESS_OF,Pregnant Women,32425006,10.1631/jzus.B2010013,2020-05-20
Birth,PRECEDES,Breast Feeding,32425006,10.1631/jzus.B2010013,2020-05-20
Milk (body substance),PART_OF,Patients,32425006,10.1631/jzus.B2010013,2020-05-20
Infected,PROCESS_OF,Patients,32425005,10.1631/jzus.B2010012,2020-05-20
Anxiety symptoms,PROCESS_OF,Patients,32425005,10.1631/jzus.B2010012,2020-05-20
Anxiety,AFFECTS,Medical Staff,32425004,10.1631/jzus.B2010011,2020-05-20
Anxiety,AFFECTS,Patients,32425004,10.1631/jzus.B2010011,2020-05-20
Anxiety,AFFECTS,general population,32425004,10.1631/jzus.B2010011,2020-05-20
Anxiety,AFFECTS,Population Group,32425004,10.1631/jzus.B2010011,2020-05-20
Depressive disorder,AFFECTS,Medical Staff,32425004,10.1631/jzus.B2010011,2020-05-20
Depressive disorder,AFFECTS,Patients,32425004,10.1631/jzus.B2010011,2020-05-20
Depressive disorder,AFFECTS,general population,32425004,10.1631/jzus.B2010011,2020-05-20
Depressive disorder,AFFECTS,Population Group,32425004,10.1631/jzus.B2010011,2020-05-20
psychological distress,AFFECTS,Medical Staff,32425004,10.1631/jzus.B2010011,2020-05-20
psychological distress,AFFECTS,Patients,32425004,10.1631/jzus.B2010011,2020-05-20
psychological distress,AFFECTS,general population,32425004,10.1631/jzus.B2010011,2020-05-20
psychological distress,AFFECTS,Population Group,32425004,10.1631/jzus.B2010011,2020-05-20
Loneliness,PREDISPOSES,Depressed mood,32425004,10.1631/jzus.B2010011,2020-05-20
Ward (environment),LOCATION_OF,research,32425004,10.1631/jzus.B2010011,2020-05-20
Hospitals,LOCATION_OF,Study,32425002,10.1631/jzus.B2000112,2020-05-20
Extracorporeal Membrane Oxygenation,TREATS,Patients,32425002,10.1631/jzus.B2000112,2020-05-20
Kidney,LOCATION_OF,Complication,32425002,10.1631/jzus.B2000112,2020-05-20
Lymphopenia,PROCESS_OF,Patients,32425002,10.1631/jzus.B2000112,2020-05-20
Patients,LOCATION_OF,Interleukin-6,32425002,10.1631/jzus.B2000112,2020-05-20
Plasma,LOCATION_OF,Interleukin-6,32425002,10.1631/jzus.B2000112,2020-05-20
Interleukin-6,AFFECTS,Blood Platelets,32425002,10.1631/jzus.B2000112,2020-05-20
Lactate Dehydrogenase,AFFECTS,Blood Platelets,32425002,10.1631/jzus.B2000112,2020-05-20
Lactate Dehydrogenase,compared_with,Interleukin-6,32425002,10.1631/jzus.B2000112,2020-05-20
Patients,LOCATION_OF,Interleukin-6,32425002,10.1631/jzus.B2000112,2020-05-20
Patients,LOCATION_OF,Lactate Dehydrogenase,32425002,10.1631/jzus.B2000112,2020-05-20
Fibrin fragment D,AFFECTS,Blood Platelets,32425002,10.1631/jzus.B2000112,2020-05-20
Headache,PROCESS_OF,Control Groups,32425001,10.1631/jzus.B2010010,2020-05-20
Headache,PROCESS_OF,Exposed Population,32425001,10.1631/jzus.B2010010,2020-05-20
Pharyngitis,PROCESS_OF,Control Groups,32425001,10.1631/jzus.B2010010,2020-05-20
Pharyngitis,PROCESS_OF,Patients,32425001,10.1631/jzus.B2010010,2020-05-20
Pharyngitis,PROCESS_OF,Exposed Population,32425001,10.1631/jzus.B2010010,2020-05-20
Control Groups,LOCATION_OF,Aspartate Transaminase,32425001,10.1631/jzus.B2010010,2020-05-20
Control Groups,LOCATION_OF,Lactate Dehydrogenase,32425001,10.1631/jzus.B2010010,2020-05-20
Dental Procedures,PREDISPOSES,disease transmission,32425000,10.1631/jzus.B2000083,2020-05-20
Infected,PROCESS_OF,Patients,32424990,10.1111/bju.15115,2020-05-20
Pharmaceutical Preparations,TREATS,Physiatry department,32424945,10.1111/tan.13941,2020-05-20
Satisfaction,PROCESS_OF,Physicians,32424945,10.1111/tan.13941,2020-05-20
Experience,PROCESS_OF,Physicians,32424945,10.1111/tan.13941,2020-05-20
Telemedicine,ADMINISTERED_TO,Physicians,32424945,10.1111/tan.13941,2020-05-20
Coronavirus Infections,CAUSES,Respiration Disorders,32424845,10.1002/ptr.6733,2020-05-20
Pivot,AFFECTS,Immune response,32424845,10.1002/ptr.6733,2020-05-20
Patients,LOCATION_OF,Alleles,32424845,10.1002/ptr.6733,2020-05-20
Fever,ISA,Symptoms,32424660,10.1007/s10943-020-01036-1,2020-05-20
Chest CT,ADMINISTERED_TO,Child,32424660,10.1007/s10943-020-01036-1,2020-05-20
Disease,PROCESS_OF,Child,32424660,10.1007/s10943-020-01036-1,2020-05-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32424660,10.1007/s10943-020-01036-1,2020-05-20
Radiologic finding,PROCESS_OF,Child,32424660,10.1007/s10943-020-01036-1,2020-05-20
Coronavirus Infections,ISA,Disease,32424603,10.1007/s11845-020-02252-0,2020-05-20
Coronavirus Infections,ISA,Disease,32424603,10.1007/s11845-020-02252-0,2020-05-20
Olfaction Disorders,ISA,Symptoms,32424603,10.1007/s11845-020-02252-0,2020-05-20
Clinical Protocols,COEXISTS_WITH,Evaluation procedure,32424589,10.1245/s10434-020-08623-2,2020-05-20
Genus: Coronavirus,ISA,Virus,32424489,10.1007/5584_2020_540,2020-05-20
Symptoms,CAUSES,Respiratory distress,32424489,10.1007/5584_2020_540,2020-05-20
Fever,PROCESS_OF,Persons,32424489,10.1007/5584_2020_540,2020-05-20
Coronavirus Infections,PROCESS_OF,Persons,32424489,10.1007/5584_2020_540,2020-05-20
Dry cough,PROCESS_OF,Persons,32424489,10.1007/5584_2020_540,2020-05-20
IMPACT gene,PART_OF,Genus: Coronavirus,32424489,10.1007/5584_2020_540,2020-05-20
Current Therapy,PREVENTS,Severe Acute Respiratory Syndrome,32424429,10.1093/neuros/nyaa198,2020-05-20
Anoxia,PROCESS_OF,Patients,32424417,10.1093/ptj/pzaa096,2020-05-20
Extracorporeal Membrane Oxygenation,TREATS,patient condition,32424417,10.1093/ptj/pzaa096,2020-05-20
Intracranial Hemorrhages,PROCESS_OF,Patients,32424417,10.1093/ptj/pzaa096,2020-05-20
Complication,PROCESS_OF,Cohort,32424417,10.1093/ptj/pzaa096,2020-05-20
CAT scan of head,DIAGNOSES,neurological complication,32424417,10.1093/ptj/pzaa096,2020-05-20
Structural modification,COEXISTS_WITH,Health Care,32424329,10.1038/s41433-020-0965-2,2020-05-20
GSKIP gene,PART_OF,Patients,32424327,10.1038/s41433-020-0926-9,2020-05-20
Fever,PROCESS_OF,Patients,32424327,10.1038/s41433-020-0926-9,2020-05-20
Conjunctivitis,PROCESS_OF,Patients,32424327,10.1038/s41433-020-0926-9,2020-05-20
Conjunctivitis,PROCESS_OF,Patients,32424327,10.1038/s41433-020-0926-9,2020-05-20
Patients,LOCATION_OF,Tears - SpecimenType,32424327,10.1038/s41433-020-0926-9,2020-05-20
Tropism,PROCESS_OF,Eye,32424293,10.1038/s41375-020-0853-6,2020-05-20
Cornea,LOCATION_OF,Present,32424293,10.1038/s41375-020-0853-6,2020-05-20
Infected,PROCESS_OF,Patients,32424293,10.1038/s41375-020-0853-6,2020-05-20
Eye,LOCATION_OF,Conjunctivitis,32424293,10.1038/s41375-020-0853-6,2020-05-20
Conjunctivitis,PROCESS_OF,Patients,32424293,10.1038/s41375-020-0853-6,2020-05-20
Conjunctivitis,PROCESS_OF,Patients,32424293,10.1038/s41375-020-0853-6,2020-05-20
Eye,LOCATION_OF,Colonization,32424293,10.1038/s41375-020-0853-6,2020-05-20
Hematologic Neoplasms,PROCESS_OF,Persons,32424085,10.1073/pnas.2006706117,2020-05-20
"Myeloid Leukemia, Chronic",PROCESS_OF,Persons,32424085,10.1073/pnas.2006706117,2020-05-20
risk factors,PROCESS_OF,Persons,32424085,10.1073/pnas.2006706117,2020-05-20
Health Personnel,TREATS,Patients,32423996,10.1126/science.abc2535,2020-05-20
Nurses,ISA,Health Personnel,32423996,10.1126/science.abc2535,2020-05-20
Nurses,TREATS,Patients,32423996,10.1126/science.abc2535,2020-05-20
Nurses,TREATS(SPEC),Patients,32423996,10.1126/science.abc2535,2020-05-20
Physicians,ISA,Health Personnel,32423996,10.1126/science.abc2535,2020-05-20
Physicians,TREATS,Patients,32423996,10.1126/science.abc2535,2020-05-20
Physicians,TREATS(SPEC),Patients,32423996,10.1126/science.abc2535,2020-05-20
Problem,COEXISTS_WITH,Influenza,32423996,10.1126/science.abc2535,2020-05-20
American Medical Association,LOCATION_OF,Coding,32423996,10.1126/science.abc2535,2020-05-20
Weather,AFFECTS,Infection,32423974,10.3899/jrheum.200527,2020-05-20
Disease,PROCESS_OF,Patients,32423954,10.1128/AAC.00857-20,2020-05-20
Secondary Hemophagocytic Lymphohistiocytosis,PROCESS_OF,Patients,32423954,10.1128/AAC.00857-20,2020-05-20
Disease,CAUSES,Secondary Hemophagocytic Lymphohistiocytosis,32423954,10.1128/AAC.00857-20,2020-05-20
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Child,32423954,10.1128/AAC.00857-20,2020-05-20
Toxic Shock Syndrome,PROCESS_OF,Child,32423954,10.1128/AAC.00857-20,2020-05-20
Infected,PROCESS_OF,Persons,32423911,10.1136/bcr-2020-235861,2020-05-20
Symptoms,PROCESS_OF,Persons,32423911,10.1136/bcr-2020-235861,2020-05-20
Therapeutic procedure,TREATS,Patients,32423911,10.1136/bcr-2020-235861,2020-05-20
Therapeutic procedure,TREATS(INFER),Symptom severe,32423911,10.1136/bcr-2020-235861,2020-05-20
Symptom severe,PROCESS_OF,Patients,32423911,10.1136/bcr-2020-235861,2020-05-20
Therapeutic procedure,AFFECTS,Inflammation,32423911,10.1136/bcr-2020-235861,2020-05-20
Dyspnea,PROCESS_OF,Patients,32423903,10.7861/clinmed.2020-0228,2020-05-20
Virus,CAUSES,Thrombosis,32423899,10.1136/esmoopen-2020-000804,2020-05-20
heparin,TREATS,Thromboembolism,32423899,10.1136/esmoopen-2020-000804,2020-05-20
Venous Thromboembolism,OCCURS_IN,Cohort,32423899,10.1136/esmoopen-2020-000804,2020-05-20
High Level,PROCESS_OF,Patients,32423899,10.1136/esmoopen-2020-000804,2020-05-20
Pneumonia,PROCESS_OF,Patients,32423842,10.1016/j.radi.2020.04.017,2020-05-20
Coughing,ISA,Symptoms,32423842,10.1016/j.radi.2020.04.017,2020-05-20
lobe,PART_OF,Lung,32423842,10.1016/j.radi.2020.04.017,2020-05-20
Pneumonia,PROCESS_OF,Patients,32423833,10.1016/j.soncn.2020.151028,2020-05-20
Real-Time Polymerase Chain Reaction,METHOD_OF,Plain chest X-ray,32423833,10.1016/j.soncn.2020.151028,2020-05-20
Malignant Neoplasms,AFFECTS,Persons,32423791,10.1016/j.carrev.2020.05.009,2020-05-20
Challenge,METHOD_OF,Oncology Service,32423791,10.1016/j.carrev.2020.05.009,2020-05-20
Critical Illness,PROCESS_OF,Patients,32423724,10.1016/j.tibtech.2020.04.016,2020-05-20
Decision,PROCESS_OF,Patients,32423724,10.1016/j.tibtech.2020.04.016,2020-05-20
Isolation procedure,TREATS,Community,32423664,10.1016/j.numecd.2020.04.001,2020-05-20
Symptoms,PROCESS_OF,Community,32423664,10.1016/j.numecd.2020.04.001,2020-05-20
Lung,LOCATION_OF,Coronavirus Infections,32423584,10.1016/S0140-6736(20)31022-9,2020-05-20
Cardiovascular,LOCATION_OF,Coronavirus Infections,32423584,10.1016/S0140-6736(20)31022-9,2020-05-20
Antiviral Agents,TREATS,Patients,32423553,10.1016/j.vph.2020.106680,2020-05-20
Hospitals,LOCATION_OF,Multicenter Trials,32423553,10.1016/j.vph.2020.106680,2020-05-20
Middle East Respiratory Syndrome Coronavirus,INTERACTS_WITH,Animals,32423553,10.1016/j.vph.2020.106680,2020-05-20
Middle East Respiratory Syndrome Coronavirus,INTERACTS_WITH,Human coronavirus,32423553,10.1016/j.vph.2020.106680,2020-05-20
Placebos,ADMINISTERED_TO,Patients,32423553,10.1016/j.vph.2020.106680,2020-05-20
ACE2 gene,ASSOCIATED_WITH,Hypertensive disease,32423523,10.1192/bjp.2020.109,2020-05-20
Mechanical Ventilator,TREATS,Injury due to exposure to external cause,32423513,10.1017/S1049023X20000692,2020-05-20
Coronavirus Infections,ISA,Disease,32423513,10.1017/S1049023X20000692,2020-05-20
Protection,COEXISTS_WITH,Disease,32423513,10.1017/S1049023X20000692,2020-05-20
Protection,COEXISTS_WITH(SPEC),Coronavirus Infections,32423513,10.1017/S1049023X20000692,2020-05-20
Infantile Neuroaxonal Dystrophy,CAUSES,Disease,32423504,10.1017/S0950268820001119,2020-05-20
Microbial agent,CAUSES,Atypical pneumonia,32423499,10.1017/dmp.2020.159,2020-05-20
Movement,PROCESS_OF,Population Group,32423499,10.1017/dmp.2020.159,2020-05-20
"CD69 protein, human",AFFECTS,Movement,32423499,10.1017/dmp.2020.159,2020-05-20
Radioisotope scan of lung,ISA,Evaluation procedure,32423497,10.1017/S0714980820000215,2020-05-20
Evaluation procedure,USES,Radioisotope scan of lung,32423497,10.1017/S0714980820000215,2020-05-20
Comorbidity,PREDISPOSES,Severe disorder,32423435,10.1186/s12887-020-02140-7,2020-05-20
Pulmonary Edema,CAUSES,Anoxia,32423435,10.1186/s12887-020-02140-7,2020-05-20
Mesenchymal Stromal Cells,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
Body Fluids,PART_OF,Alveolar,32423435,10.1186/s12887-020-02140-7,2020-05-20
Antibiotics,DISRUPTS,Pain,32423435,10.1186/s12887-020-02140-7,2020-05-20
Mesenchymal Stromal Cells,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
Mesenchymal Stromal Cells,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
Virus Diseases,AFFECTS,Pulmonary function,32423435,10.1186/s12887-020-02140-7,2020-05-20
Mesenchymal Stromal Cells,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
Adipocytes,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
Adipocytes,PART_OF,bony process,32423435,10.1186/s12887-020-02140-7,2020-05-20
lobe,LOCATION_OF,Bronchopneumonia,32423368,10.1177/0194599820929640,2020-05-20
chest findings,PROCESS_OF,"Child, Preschool",32423368,10.1177/0194599820929640,2020-05-20
Both lungs,LOCATION_OF,Bronchopneumonia,32423368,10.1177/0194599820929640,2020-05-20
risk factors,PROCESS_OF,hospitalized patients,32423359,10.1177/0194599820929957,2020-05-20
Intubation,TREATS,Acute respiratory failure,32423359,10.1177/0194599820929957,2020-05-20
Intubation,TREATS,Acute respiratory failure,32423359,10.1177/0194599820929957,2020-05-20
Obesity,PROCESS_OF,Patients,32423359,10.1177/0194599820929957,2020-05-20
Symptoms,PROCESS_OF,Patients,32423357,10.1177/0194599820929185,2020-05-20
Symptoms,PROCESS_OF,Patients,32423357,10.1177/0194599820929185,2020-05-20
Symptoms,PROCESS_OF,Patients,32423357,10.1177/0194599820929185,2020-05-20
Symptoms,PROCESS_OF,Respondents,32423357,10.1177/0194599820929185,2020-05-20
Anosmia,ISA,Symptoms,32423338,10.1177/0194599820929275,2020-05-20
Coronavirus Infections,CAUSES,Symptoms,32423338,10.1177/0194599820929275,2020-05-20
Coronavirus Infections,CAUSES(SPEC),Anosmia,32423338,10.1177/0194599820929275,2020-05-20
Coronavirus Infections,CAUSES(SPEC),Sense of smell impaired,32423338,10.1177/0194599820929275,2020-05-20
Sense of smell impaired,ISA,Symptoms,32423338,10.1177/0194599820929275,2020-05-20
Coronavirus Infections,ISA,Disease,32423338,10.1177/0194599820929275,2020-05-20
Nose,LOCATION_OF,Obstruction,32423338,10.1177/0194599820929275,2020-05-20
Clinical Trials,NEG_USES,Masks,32423324,10.1177/1078155220924084,2020-05-20
Clinical Trials,NEG_USES,Negative-Pressure Ventilators,32423324,10.1177/1078155220924084,2020-05-20
Clinical Trials,NEG_USES,Surgical face mask,32423324,10.1177/1078155220924084,2020-05-20
Negative-Pressure Ventilators,USES,Artificial Airways,32423324,10.1177/1078155220924084,2020-05-20
Negative-Pressure Ventilators,USES,Artificial Airways,32423324,10.1177/1078155220924084,2020-05-20
Negative-Pressure Ventilators,USES,Artificial Airways,32423324,10.1177/1078155220924084,2020-05-20
Multiple Chronic Conditions,PROCESS_OF,Patients,32423323,10.1177/0194599820929641,2020-05-20
nivolumab,ADMINISTERED_TO,Patients,32423323,10.1177/0194599820929641,2020-05-20
nivolumab,TREATS,"Malignant melanoma, metastatic",32423323,10.1177/0194599820929641,2020-05-20
cancer diagnosis,DIAGNOSES,Disease,32423323,10.1177/0194599820929641,2020-05-20
Challenge,AFFECTS,Severe (severity modifier),32423299,10.1177/0194599820928977,2020-05-20
Physical Examination,ADMINISTERED_TO,Rural Population,32423299,10.1177/0194599820928977,2020-05-20
Interventional procedure,TREATS,Patients,32423298,10.1177/0194599820928970,2020-05-20
Interventional procedure,TREATS,Otolaryngologist,32423298,10.1177/0194599820928970,2020-05-20
Diagnostic endoscopic examination of larynx,ADMINISTERED_TO,Patients,32423298,10.1177/0194599820928970,2020-05-20
contextual factors,PROCESS_OF,Outpatients,32423298,10.1177/0194599820928970,2020-05-20
Head and neck structure,LOCATION_OF,Abscess,32423297,10.1177/0194599820930239,2020-05-20
Head and neck structure,LOCATION_OF,Malignant Neoplasms,32423297,10.1177/0194599820930239,2020-05-20
Upper airway obstruction,PROCESS_OF,Adult,32423297,10.1177/0194599820930239,2020-05-20
Upper airway obstruction,PROCESS_OF,Child,32423297,10.1177/0194599820930239,2020-05-20
"Oncologic procedure, NOS",PREVENTS,Abscess,32423297,10.1177/0194599820930239,2020-05-20
"Oncologic procedure, NOS",PREVENTS,Fractured nasal bones,32423297,10.1177/0194599820930239,2020-05-20
Head and neck structure,LOCATION_OF,Abscess,32423297,10.1177/0194599820930239,2020-05-20
Clinician,TREATS,Patients,32423293,10.1177/0194599820931011,2020-05-20
Neck,LOCATION_OF,Macrophage Activation Syndrome,32423293,10.1177/0194599820931011,2020-05-20
Operative Surgical Procedures,ISA,Interventional procedure,32423293,10.1177/0194599820931011,2020-05-20
Religious Missions,LOCATION_OF,Study,32423291,10.1177/0194599820930238,2020-05-20
middle ear,LOCATION_OF,Present,32423285,10.1177/0194599820929278,2020-05-20
Microscopy,METHOD_OF,Burr hole procedure,32423285,10.1177/0194599820929278,2020-05-20
Implantation procedure,PRECEDES,Mastoidectomy,32423285,10.1177/0194599820929278,2020-05-20
Tympanostomy,PRECEDES,Mastoidectomy,32423285,10.1177/0194599820929278,2020-05-20
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32423283,10.1177/0194599820929274,2020-05-20
Ageusia,PROCESS_OF,Patients,32423283,10.1177/0194599820929274,2020-05-20
Rhinitis,COEXISTS_WITH,Genus: Coronavirus,32423283,10.1177/0194599820929274,2020-05-20
Internal nose structure,LOCATION_OF,Surgical Endoscopy,32423262,10.1080/14767058.2020.1763949,2020-05-20
Functional endoscopic sinus surgery,USES,"ASPIRATOR, ULTRASONIC",32423262,10.1080/14767058.2020.1763949,2020-05-20
Disease,AFFECTS,Old age,32423059,10.3390/vaccines8020224,2020-05-20
UGT1A7 wt Allele,PART_OF,Woman,32423059,10.3390/vaccines8020224,2020-05-20
ACE2 gene,PART_OF,Homo sapiens,32423059,10.3390/vaccines8020224,2020-05-20
Coronavirus Infections,CAUSES,Disease,32423027,10.3390/ph13050098,2020-05-20
Coronavirus Infections,PREDISPOSES,Disease Progression,32423027,10.3390/ph13050098,2020-05-20
Severe disorder,PROCESS_OF,Patients,32423027,10.3390/ph13050098,2020-05-20
Pharmaceutical Preparations,TREATS,Patients,32423027,10.3390/ph13050098,2020-05-20
Small Molecule,COEXISTS_WITH,Chloroquine,32423024,10.3390/ph13050096,2020-05-20
Small Molecule,COEXISTS_WITH,Hydroxychloroquine,32423024,10.3390/ph13050096,2020-05-20
Small Molecule,COEXISTS_WITH,lopinavir / Ritonavir,32423024,10.3390/ph13050096,2020-05-20
Coronavirus Infections,ISA,Disease,32422996,10.3390/jcm9051473,2020-05-20
Human coronavirus,CAUSES,Disease,32422996,10.3390/jcm9051473,2020-05-20
Human coronavirus,CAUSES(SPEC),Coronavirus Infections,32422996,10.3390/jcm9051473,2020-05-20
Coronavirus Infections,ISA,Disease,32422996,10.3390/jcm9051473,2020-05-20
Coronavirus Infections,ISA,Disease,32422996,10.3390/jcm9051473,2020-05-20
Viral Genome,CONVERTS_TO,Pharmaceutical Preparations,32422983,10.3390/jcm9051472,2020-05-20
Show,LOCATION_OF,"M Protein, multiple myeloma",32422983,10.3390/jcm9051472,2020-05-20
Screening procedure,USES,Drug Delivery Systems,32422983,10.3390/jcm9051472,2020-05-20
Coronavirus Infections,PROCESS_OF,Family,32422983,10.3390/jcm9051472,2020-05-20
Cessation of life,PROCESS_OF,Patients,32422948,10.3390/ijerph17103417,2020-05-20
Chronic Obstructive Airway Disease,ISA,Respiration Disorders,32422948,10.3390/ijerph17103417,2020-05-20
"Kidney Failure, Acute",ISA,Complication,32422948,10.3390/ijerph17103417,2020-05-20
"Respiratory Distress Syndrome, Adult",ISA,Complication,32422948,10.3390/ijerph17103417,2020-05-20
Thromboembolism,PROCESS_OF,Patients,32422948,10.3390/ijerph17103417,2020-05-20
Back,LOCATION_OF,Memory observations,32422894,10.3390/vaccines8020220,2020-05-20
Moscow,ISA,Cities,32422894,10.3390/vaccines8020220,2020-05-20
Labor (Childbirth),PROCESS_OF,Voluntary Workers,32422894,10.3390/vaccines8020220,2020-05-20
Glycoproteins,AFFECTS,Virus Internalization,32422664,10.1055/a-1175-4169,2020-05-19
Glycoproteins,PART_OF,Genus: Coronavirus,32422664,10.1055/a-1175-4169,2020-05-19
"Epitopes, B-Lymphocyte",INHIBITS,Antigens,32422664,10.1055/a-1175-4169,2020-05-19
assessment.initial,PROCESS_OF,Patients,32422645,10.1038/s41586-020-2349-y,2020-05-19
Suspicion,PROCESS_OF,Patients,32422645,10.1038/s41586-020-2349-y,2020-05-19
intensive care,TREATS,Outpatients,32422645,10.1038/s41586-020-2349-y,2020-05-19
Lung,LOCATION_OF,Computed Tomography Angiography,32422645,10.1038/s41586-020-2349-y,2020-05-19
Outpatients,ISA,Patients,32422645,10.1038/s41586-020-2349-y,2020-05-19
Laboratory,LOCATION_OF,Assay,32422545,10.1016/j.clineuro.2020.105921,2020-05-19
Introduction procedure,USES,BARRIER,32422545,10.1016/j.clineuro.2020.105921,2020-05-19
Homologous Gene,AFFECTS,Neurological observations,32422501,10.1016/j.psychres.2020.113070,2020-05-19
Cerebrovascular Disorders,COEXISTS_WITH,Neurologic Manifestations,32422501,10.1016/j.psychres.2020.113070,2020-05-19
"Encephalomyelitis, Acute Disseminated",COEXISTS_WITH,Neurologic Manifestations,32422501,10.1016/j.psychres.2020.113070,2020-05-19
Multiple Sclerosis,COEXISTS_WITH,Neurologic Manifestations,32422501,10.1016/j.psychres.2020.113070,2020-05-19
Polyneuropathy,COEXISTS_WITH,Neurologic Manifestations,32422501,10.1016/j.psychres.2020.113070,2020-05-19
nervous system disorder,PROCESS_OF,Patients,32422501,10.1016/j.psychres.2020.113070,2020-05-19
Medically Unexplained Symptoms,PROCESS_OF,College student,32422482,10.1016/j.envres.2020.109668,2020-05-19
Medically Unexplained Symptoms,PROCESS_OF,student,32422482,10.1016/j.envres.2020.109668,2020-05-19
Medically Unexplained Symptoms,PROCESS_OF,College student,32422482,10.1016/j.envres.2020.109668,2020-05-19
Mental disorders,ISA,Disease,32422482,10.1016/j.envres.2020.109668,2020-05-19
Hand,LOCATION_OF,regional difference,32422427,10.1016/j.comppsych.2020.152180,2020-05-19
Anxiety,PROCESS_OF,Persons,32422426,10.1016/j.comppsych.2020.152184,2020-05-19
Depressive disorder,PROCESS_OF,Persons,32422426,10.1016/j.comppsych.2020.152184,2020-05-19
Stress,PROCESS_OF,Persons,32422426,10.1016/j.comppsych.2020.152184,2020-05-19
Psychoactive substance,INHIBITS,Stress,32422426,10.1016/j.comppsych.2020.152184,2020-05-19
Chief complaint (finding),PROCESS_OF,Patients,32422410,10.1016/j.cmi.2020.05.007,2020-05-19
Clinical Observation,TREATS,Disease,32422410,10.1016/j.cmi.2020.05.007,2020-05-19
Assay,USES,Detection,32422408,10.1016/j.cmi.2020.05.001,2020-05-19
Persons,LOCATION_OF,saliva,32422384,10.1016/j.ijsu.2020.05.018,2020-05-19
Specimen Collection,DIAGNOSES,Hydranencephaly with Renal Aplasia-Dysplasia,32422384,10.1016/j.ijsu.2020.05.018,2020-05-19
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32422384,10.1016/j.ijsu.2020.05.018,2020-05-19
Reverse Transcriptase Polymerase Chain Reaction,USES,Buccal smear procedure,32422384,10.1016/j.ijsu.2020.05.018,2020-05-19
anakinra,TREATS,Respiratory Failure,32422375,10.1016/j.ijid.2020.05.025,2020-05-19
Respiratory Failure,COEXISTS_WITH,Macrophage Activation Syndrome,32422375,10.1016/j.ijid.2020.05.025,2020-05-19
Malignant Neoplasms,PROCESS_OF,Patients,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
immunocompromised condition,PROCESS_OF,Patients,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
Malignant Neoplasms,PROCESS_OF,Patients,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
Malignant neoplasm of lung,PROCESS_OF,Patients,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
Cardiopulmonary,LOCATION_OF,Comorbidity,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
Malignant neoplasm of lung,PROCESS_OF,Patients,32422349,10.1016/j.jamcollsurg.2020.05.007,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Assay,USES,Coagulation procedure,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Critical Illness,PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Lysis,NEG_PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Lysis,PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
risk factors,NEG_PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Thrombelastography,DIAGNOSES,Thromboembolism,32422341,10.1016/j.phrs.2020.104927,2020-05-19
Venous Thromboembolism,PROCESS_OF,Patients,32422341,10.1016/j.phrs.2020.104927,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,NEG_COEXISTS_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32422331,10.1016/j.wneu.2020.05.093,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,NEG_COEXISTS_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32422331,10.1016/j.wneu.2020.05.093,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score A,COEXISTS_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32422331,10.1016/j.wneu.2020.05.093,2020-05-19
Discontinued,PROCESS_OF,Patients,32422331,10.1016/j.wneu.2020.05.093,2020-05-19
Challenge,ADMINISTERED_TO,Neurosurgeon,32422330,10.1016/j.wneu.2020.05.092,2020-05-19
Heart,LOCATION_OF,SARS coronavirus,32422305,10.1016/j.lfs.2020.117808,2020-05-19
Lung,LOCATION_OF,SARS coronavirus,32422305,10.1016/j.lfs.2020.117808,2020-05-19
Interleukin-6,AFFECTS,Acute Lung Injury,32422305,10.1016/j.lfs.2020.117808,2020-05-19
Interleukin-6,AFFECTS,Myocardial dysfunction,32422305,10.1016/j.lfs.2020.117808,2020-05-19
,CAUSES,inflammatory response,32422305,10.1016/j.lfs.2020.117808,2020-05-19
Heart,LOCATION_OF,angiotensin converting enzyme 2,32422305,10.1016/j.lfs.2020.117808,2020-05-19
Lung,LOCATION_OF,angiotensin converting enzyme 2,32422305,10.1016/j.lfs.2020.117808,2020-05-19
angiotensin II,STIMULATES,mitogen-activated protein kinase p38,32422305,10.1016/j.lfs.2020.117808,2020-05-19
angiotensin I (1-7),INHIBITS,,32422305,10.1016/j.lfs.2020.117808,2020-05-19
,INTERACTS_WITH,Viral Proteins,32422305,10.1016/j.lfs.2020.117808,2020-05-19
World,ISA,Population Group,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Lung,LOCATION_OF,Inflammation,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Oxidative Stress,COEXISTS_WITH,inflammatory response,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
inflammatory response,CAUSES,Severe Acute Respiratory Syndrome,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
World,ISA,Population Group,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Definitive Treatment,METHOD_OF,Pathology,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Ergocalciferol,TREATS,Immune,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Melatonin,TREATS,Immune,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Ergocalciferol,AFFECTS,Organ,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Melatonin,AFFECTS,Organ,32422288,10.1016/j.avsg.2020.05.011,2020-05-19
Aortic Diseases,PROCESS_OF,Patients,32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Pneumonia,AFFECTS,Patients,32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Aorta,LOCATION_OF,"Aneurysm, Ruptured",32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Arteries,LOCATION_OF,"Stent, device",32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Arteries,LOCATION_OF,"Stent, device",32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Arteries,PART_OF,Right kidney,32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Superior mesenteric,LOCATION_OF,Arteries,32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Negative Regulation of Coagulation,PROCESS_OF,Patients,32422287,10.1016/j.avsg.2020.05.012,2020-05-19
Operative Surgical Procedures,COMPLICATES,"Respiratory Distress Syndrome, Adult",32422280,10.1016/j.etap.2020.103411,2020-05-19
Ruptured popliteal artery aneurysm,PROCESS_OF,Male population group,32422280,10.1016/j.etap.2020.103411,2020-05-19
Comorbidity,PROCESS_OF,Patients,32422280,10.1016/j.etap.2020.103411,2020-05-19
Alveolar Epithelial Cells,PART_OF,Lung,32422233,10.1016/j.metabol.2020.154262,2020-05-19
angiotensin converting enzyme 2,STIMULATES,Alveolar Epithelial Cells,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Obesity,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Smoker,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Co-morbid conditions,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Accumulation,32422233,10.1016/j.metabol.2020.154262,2020-05-19
risk factors,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Severe Acute Respiratory Syndrome,CAUSES,Cessation of life,32422233,10.1016/j.metabol.2020.154262,2020-05-19
Age,ASSOCIATED_WITH,Obesity,32422204,10.1016/S1473-3099(20)30371-6,2020-05-19
Finding of body mass index,PROCESS_OF,Minority Groups,32422204,10.1016/S1473-3099(20)30371-6,2020-05-19
risk factors,PROCESS_OF,General Practitioners,32422201,10.1016/S1473-3099(20)30314-5,2020-05-19
Chronic Kidney Diseases,PROCESS_OF,Persons,32422201,10.1016/S1473-3099(20)30314-5,2020-05-19
Obesity,PROCESS_OF,Persons,32422201,10.1016/S1473-3099(20)30314-5,2020-05-19
Normal weight,PROCESS_OF,Persons,32422201,10.1016/S1473-3099(20)30314-5,2020-05-19
Smoking,PROCESS_OF,Cohort,32422201,10.1016/S1473-3099(20)30314-5,2020-05-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Body Fluids,PART_OF,Patients,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Contacts,COEXISTS_WITH,Quarantine,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Coughing,COEXISTS_WITH,Symptoms,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Fever,COEXISTS_WITH,Symptoms,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Symptom mild,PROCESS_OF,Patients,32422192,10.1016/j.joms.2020.05.003,2020-05-19
Critical Illness,PROCESS_OF,Patients,32422178,10.1016/S2213-2600(20)30225-3,2020-05-19
Tracheostomy procedure,TREATS,Patients,32422178,10.1016/S2213-2600(20)30225-3,2020-05-19
Challenge,METHOD_OF,Tracheostomy care,32422178,10.1016/S2213-2600(20)30225-3,2020-05-19
Tracheostomy procedure,TREATS,Patients,32422178,10.1016/S2213-2600(20)30225-3,2020-05-19
Upper respiratory tract,LOCATION_OF,Symptom mild,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Comorbidity,PREDISPOSES,Severe (severity modifier),32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Hamman-Rich syndrome,AFFECTS,Patients,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Severe Acute Respiratory Syndrome,PRECEDES,Middle East Respiratory Syndrome,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Hamman-Rich syndrome,AFFECTS,Fibrosis,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Hamman-Rich syndrome,PROCESS_OF,Patients,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Therapeutic procedure,TREATS,Patients,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Therapeutic procedure,TREATS(INFER),Hamman-Rich syndrome,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Severe Acute Respiratory Syndrome,PRECEDES,Fibrosis,32422146,10.1016/j.jaci.2020.05.004,2020-05-19
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Epithelial Cells,LOCATION_OF,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Hypersensitivity,ASSOCIATED_WITH,"CD69 protein, human",32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Endopeptidases,INTERACTS_WITH,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Endopeptidases,INTERACTS_WITH,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Endopeptidases,PART_OF,integral to membrane,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
angiotensin converting enzyme 2,INTERACTS_WITH,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Asthma,PROCESS_OF,Adult,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Asthma,PROCESS_OF,Child,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Epithelial Cells,LOCATION_OF,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
angiotensin converting enzyme 2,INHIBITS,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
TMPRSS2 gene,INHIBITS,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
angiotensin converting enzyme 2,ASSOCIATED_WITH,Asthma,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
TMPRSS2 gene,AUGMENTS,Epithelial Cells,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
TMPRSS2 gene,AUGMENTS,Nose,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Epithelial Cells,LOCATION_OF,TMPRSS2 gene,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
cytokine,COEXISTS_WITH,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
TMPRSS2 gene,INTERACTS_WITH,angiotensin converting enzyme 2,32422124,10.1016/S0140-6736(20)31104-1,2020-05-19
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Amazona,32422121,10.1016/j.athoracsur.2020.05.004,2020-05-19
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Community,32422121,10.1016/j.athoracsur.2020.05.004,2020-05-19
Cardiac Surgery procedures,TREATS,inpatient,32422081,10.5858/arpa.2020-0217-SA,2020-05-19
Cardiac Surgery procedures,TREATS,Outpatients,32422081,10.5858/arpa.2020-0217-SA,2020-05-19
Cardiovascular care,METHOD_OF,Cardiac Surgery procedures,32422081,10.5858/arpa.2020-0217-SA,2020-05-19
Virus,INTERACTS_WITH,Disease,32422078,10.5858/arpa.2020-0232-SA,2020-05-19
Lung,LOCATION_OF,Severe pre-eclampsia,32422078,10.5858/arpa.2020-0232-SA,2020-05-19
diffuse alveolar damage,COEXISTS_WITH,"Pneumonia, Viral",32422078,10.5858/arpa.2020-0232-SA,2020-05-19
Cardiovascular Pathology,COEXISTS_WITH,Viral myocarditis,32422078,10.5858/arpa.2020-0232-SA,2020-05-19
Clinical impression,COEXISTS_WITH,Viral myocarditis,32422078,10.5858/arpa.2020-0232-SA,2020-05-19
Body tissue,LOCATION_OF,Autopsy,32422078,10.5858/arpa.2020-0232-SA,2020-05-19
Cessation of life,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
Bronchopneumonia,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
Infarction,COEXISTS_WITH,Thrombosis,32422062,10.7326/M20-1515,2020-05-19
Infarction,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
Thrombosis,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
Chronic congestion,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
Cell Proliferation,PROCESS_OF,Patients,32422062,10.7326/M20-1515,2020-05-19
central vein,LOCATION_OF,Thrombosis,32422062,10.7326/M20-1515,2020-05-19
Specimen Type - Bile fluid,CAUSES,Acute respiratory insufficiency,32422062,10.7326/M20-1515,2020-05-19
Thrombosis,CAUSES,Cessation of life,32422062,10.7326/M20-1515,2020-05-19
Early Therapy,TREATS,Thromboembolism,32422062,10.7326/M20-1515,2020-05-19
Early Therapy,TREATS,Pulmonary artery thrombosis,32422062,10.7326/M20-1515,2020-05-19
Early Therapy,USES,Anticoagulants,32422062,10.7326/M20-1515,2020-05-19
Angiotensin-Converting Enzyme Inhibitors,TREATS,Community,32422057,10.7326/M20-1495,2020-05-19
Test Result,PREDISPOSES,Severe Acute Respiratory Syndrome,32422057,10.7326/M20-1495,2020-05-19
Angiotensin II receptor antagonist,TREATS,Community,32422057,10.7326/M20-1495,2020-05-19
Severe disorder,PROCESS_OF,Patients,32422057,10.7326/M20-1495,2020-05-19
Health Personnel,ISA,Persons,32421857,10.1111/ced.14294,2020-05-19
inpatient,ISA,Persons,32421857,10.1111/ced.14294,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32421857,10.1111/ced.14294,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),Health Personnel,32421857,10.1111/ced.14294,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),inpatient,32421857,10.1111/ced.14294,2020-05-19
Infected,PROCESS_OF,Persons,32421857,10.1111/ced.14294,2020-05-19
Coughing,PROCESS_OF,Patients,32421686,10.2196/19276,2020-05-19
Dyspnea,PROCESS_OF,Patients,32421686,10.2196/19276,2020-05-19
Fever,PROCESS_OF,Patients,32421686,10.2196/19276,2020-05-19
Virus,PROCESS_OF,Persons,32421627,10.1016/j.bios.2020.112274,2020-05-19
Coronavirus Infections,ISA,Disease,32421627,10.1016/j.bios.2020.112274,2020-05-19
Symptoms,ASSOCIATED_WITH,Disease,32421627,10.1016/j.bios.2020.112274,2020-05-19
Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32421627,10.1016/j.bios.2020.112274,2020-05-19
Pandemics,ISA,Disease Outbreaks,32421541,10.1016/j.rmed.2020.105987,2020-05-19
Coronavirus Infections,CAUSES,Disease,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Coughing,CAUSES,Contacts,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Coughing,PROCESS_OF,Persons,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Sneezing,CAUSES,Contacts,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Infected,PROCESS_OF,Patients,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Interventional procedure,TREATS,Lung diseases,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Aerosol therapy,ISA,Interventional procedure,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Aerosol therapy,TREATS(SPEC),Lung diseases,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Inspiration function,AFFECTS,Health Personnel,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Inspiration function,AFFECTS,Caregiver,32421539,10.1016/j.rmed.2020.105951,2020-05-19
Lung,LOCATION_OF,Lesion,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Dyspnea,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Distress,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Chest,LOCATION_OF,Distress,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Dyspnea,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Lung,LOCATION_OF,Lesion,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Distress,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Chest,LOCATION_OF,Distress,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Dyspnea,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Inflammation,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Site,LOCATION_OF,T-Lymphocyte,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Distress,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Chest,LOCATION_OF,Distress,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Adrenal Cortex Hormones,TREATS,Dyspnea,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Adrenal Cortex Hormones,TREATS,Chest tightness,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Dyspnea,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Chest tightness,PROCESS_OF,Patients,32421497,10.5811/westjem.2020.4.47596,2020-05-19
Infected,PROCESS_OF,Patients,32421495,10.3201/eid2609.201435,2020-05-19
Disease,PROCESS_OF,Persons,32421494,10.3201/eid2608.200681,2020-05-19
Coronavirus Infections,ISA,Disease,32421494,10.3201/eid2608.200681,2020-05-19
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32421494,10.3201/eid2608.200681,2020-05-19
Covers (device),USES,Pillow,32421494,10.3201/eid2608.200681,2020-05-19
Feces,PART_OF,Patients,32421479,10.12968/jowc.2020.29.5.245,2020-05-19
Coronavirus Infections,ISA,Disease,32421479,10.12968/jowc.2020.29.5.245,2020-05-19
Wakefulness,ISA,Attention,32421381,10.1161/CIRCULATIONAHA.120.046702,2020-05-19
angiotensin converting enzyme 2,AFFECTS,Spermatogenesis,32421355,10.1089/dia.2020.0169,2020-05-19
angiotensin converting enzyme 2,AFFECTS,Steroid biosynthesis,32421355,10.1089/dia.2020.0169,2020-05-19
angiotensin converting enzyme 2,AFFECTS,Male Reproductive System,32421355,10.1089/dia.2020.0169,2020-05-19
Infected,PROCESS_OF,Persons,32421281,10.3906/sag-2004-336,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32421281,10.3906/sag-2004-336,2020-05-19
Infected,PROCESS_OF,Persons,32421281,10.3906/sag-2004-336,2020-05-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32421281,10.3906/sag-2004-336,2020-05-19
Immunity,PROCESS_OF,Community,32421281,10.3906/sag-2004-336,2020-05-19
Immunity,PROCESS_OF,Community,32421281,10.3906/sag-2004-336,2020-05-19
Coronavirus Infections,ISA,Disease,32421258,10.1111/aos.14472,2020-05-19
Eye,LOCATION_OF,Chronic disease,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Eye,LOCATION_OF,Symptoms,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Eye,LOCATION_OF,Symptoms,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Patients,LOCATION_OF,Tears body substance,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Photophobia,ISA,Eye pain,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Chronic disease,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Eye,LOCATION_OF,Chronic disease,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Coughing,ISA,Symptoms,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Fatigue,ISA,Symptoms,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Fever,ISA,Symptoms,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Detection,TREATS,Congestion,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
Conjunctival congestion,PROCESS_OF,Patients,32421108,10.1016/j.chaos.2020.109896,2020-05-19
receptor,INTERACTS_WITH,Ligands,32421098,10.1007/s10669-020-09774-z,2020-05-19
"Vitronectin, human",COEXISTS_WITH,ACE2 gene,32421098,10.1007/s10669-020-09774-z,2020-05-19
Chlorogenic acid,COEXISTS_WITH,ACE2 gene,32421098,10.1007/s10669-020-09774-z,2020-05-19
phillyrin,COEXISTS_WITH,ACE2 gene,32421098,10.1007/s10669-020-09774-z,2020-05-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32421089,10.1007/s10479-020-03635-3,2020-05-19
tocilizumab,TREATS,Patients,32421089,10.1007/s10479-020-03635-3,2020-05-19
tocilizumab,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32421089,10.1007/s10479-020-03635-3,2020-05-19
Interleukin-6,ISA,cytokine,32421089,10.1007/s10479-020-03635-3,2020-05-19
Passenger,LOCATION_OF,Air,32421076,10.1007/s11069-020-04045-1,2020-05-19
Complication,PROCESS_OF,Population Group,32420960,10.23750/abm.v91i2.9625,2020-05-19
Infected,PROCESS_OF,Population Group,32420960,10.23750/abm.v91i2.9625,2020-05-19
Birth,ASSOCIATED_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,32420960,10.23750/abm.v91i2.9625,2020-05-19
Laboratory Procedures,NEG_DIAGNOSES,Disease,32420960,10.23750/abm.v91i2.9625,2020-05-19
Adverse effects,NEG_COEXISTS_WITH,late pregnancy,32420960,10.23750/abm.v91i2.9625,2020-05-19
Influenza,PROCESS_OF,Hispanics,32420959,10.23750/abm.v91i2.9699,2020-05-19
Parenchymal cell,PART_OF,Lung,32420957,10.23750/abm.v91i2.9605,2020-05-19
sofosbuvir,TREATS,Patients,32420957,10.23750/abm.v91i2.9605,2020-05-19
Heart Diseases,COEXISTS_WITH,Comorbidity,32420948,10.23750/abm.v91i2.9563,2020-05-19
Pulmonary Hypertension,COEXISTS_WITH(SPEC),Comorbidity,32420948,10.23750/abm.v91i2.9563,2020-05-19
Pulmonary Hypertension,ISA,Heart Diseases,32420948,10.23750/abm.v91i2.9563,2020-05-19
Prophylactic treatment,USES,BCG Vaccine,32420946,10.23750/abm.v91i2.9614,2020-05-19
Food Allergy,PROCESS_OF,Child,32420944,10.23750/abm.v91i2.9534,2020-05-19
Coronavirus Infections,AFFECTS,Homo sapiens,32420943,10.23750/abm.v91i2.9543,2020-05-19
"Transcription, Genetic",AFFECTS,Virus Diseases,32420943,10.23750/abm.v91i2.9543,2020-05-19
Genome,INTERACTS_WITH,MicroRNAs,32420943,10.23750/abm.v91i2.9543,2020-05-19
Coughing,CAUSES,Respiratory distress,32420942,10.23750/abm.v91i2.9655,2020-05-19
Diarrhea,PROCESS_OF,Patients,32420942,10.23750/abm.v91i2.9655,2020-05-19
Nausea,PROCESS_OF,Patients,32420942,10.23750/abm.v91i2.9655,2020-05-19
Vomiting,PROCESS_OF,Patients,32420942,10.23750/abm.v91i2.9655,2020-05-19
Adult,ISA,Population Group,32420941,10.23750/abm.v91i2.9586,2020-05-19
Complication,PROCESS_OF,Patients,32420941,10.23750/abm.v91i2.9586,2020-05-19
Present,PROCESS_OF,Patients,32420941,10.23750/abm.v91i2.9586,2020-05-19
Disease,PROCESS_OF,Child,32420941,10.23750/abm.v91i2.9586,2020-05-19
Cardiovascular,LOCATION_OF,Problem,32420941,10.23750/abm.v91i2.9586,2020-05-19
Congenital heart disease,PART_OF,Child,32420941,10.23750/abm.v91i2.9586,2020-05-19
Congenital heart disease,PART_OF,Patients,32420941,10.23750/abm.v91i2.9586,2020-05-19
Child,LOCATION_OF,"CD69 protein, human",32420940,10.23750/abm.v91i2.9564,2020-05-19
Spreader,TREATS,Community,32420940,10.23750/abm.v91i2.9564,2020-05-19
MULTISYSTEM DISORDER,PROCESS_OF,Older people,32420938,10.23750/abm.v91i2.9574,2020-05-19
Frail,PROCESS_OF,Population Group,32420938,10.23750/abm.v91i2.9574,2020-05-19
Disease,PROCESS_OF,Patients,32420938,10.23750/abm.v91i2.9574,2020-05-19
Pharmacotherapy,TREATS,Nutritional status,32420938,10.23750/abm.v91i2.9574,2020-05-19
Thrombosis,ISA,Disease,32420938,10.23750/abm.v91i2.9574,2020-05-19
Interventional procedure,TREATS,Population Group,32420938,10.23750/abm.v91i2.9574,2020-05-19
Respiratory sample,PART_OF,Tract,32420936,10.23750/abm.v91i2.9639,2020-05-19
Persons,LOCATION_OF,Antibodies,32420936,10.23750/abm.v91i2.9639,2020-05-19
Pharmacotherapy,TREATS,Virus Diseases,32420935,10.23750/abm.v91i2.9626,2020-05-19
Very high,PREDISPOSES,Prognosis bad,32420933,10.23750/abm.v91i2.9635,2020-05-19
Very high,PROCESS_OF,Male population group,32420933,10.23750/abm.v91i2.9635,2020-05-19
Disease,PROCESS_OF,Patients,32420933,10.23750/abm.v91i2.9635,2020-05-19
Smoking History,PROCESS_OF,Patients,32420933,10.23750/abm.v91i2.9635,2020-05-19
Smoking History,PROCESS_OF,Patients,32420933,10.23750/abm.v91i2.9635,2020-05-19
Infected,PROCESS_OF,Patients,32420932,10.23750/abm.v91i2.9636,2020-05-19
Italy,ISA,Geographic Locations,32420932,10.23750/abm.v91i2.9636,2020-05-19
Coronavirus Infections,ISA,Disease,32420931,10.23750/abm.v91i2.9619,2020-05-19
Cessation of life,OCCURS_IN,Patients,32420931,10.23750/abm.v91i2.9619,2020-05-19
Cessation of life,PROCESS_OF,geriatric patients,32420931,10.23750/abm.v91i2.9619,2020-05-19
Hospitals,LOCATION_OF,Study,32420931,10.23750/abm.v91i2.9619,2020-05-19
Suspected coronavirus infection,PROCESS_OF,Patients,32420930,10.23750/abm.v91i2.9624,2020-05-19
Coronavirus Infections,ISA,Disease,32420930,10.23750/abm.v91i2.9624,2020-05-19
Infected,PROCESS_OF,Patients,32420930,10.23750/abm.v91i2.9624,2020-05-19
Infected,PROCESS_OF,Child,32420928,10.23750/abm.v91i2.9569,2020-05-19
Fever,ISA,Symptoms,32420928,10.23750/abm.v91i2.9569,2020-05-19
Experience,PROCESS_OF,Occupational physician,32420925,10.23750/abm.v91i2.9592,2020-05-19
Thalassemia,AFFECTS,Severe Acute Respiratory Syndrome,32420924,10.23750/abm.v91i2.9565,2020-05-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32420924,10.23750/abm.v91i2.9565,2020-05-19
Supportive care,TREATS,Patients,32420924,10.23750/abm.v91i2.9565,2020-05-19
Growth,PROCESS_OF,Patients,32420923,10.23750/abm.v91i2.9557,2020-05-19
Population Group,LOCATION_OF,IMPACT gene,32420921,10.23750/abm.v91i2.9579,2020-05-19
Italy,ISA,Country,32420920,10.23750/abm.v91i2.9600,2020-05-19
France,ISA,Geographic Locations,32420919,10.23750/abm.v91i2.9615,2020-05-19
county,ISA,Geographic Locations,32420919,10.23750/abm.v91i2.9615,2020-05-19
Infection,PROCESS_OF,World,32420918,10.23750/abm.v91i2.9582,2020-05-19
cardiovascular risk factor,PROCESS_OF,Patients,32420863,10.5152/tud.2020.140520,2020-05-19
Cardiovascular Diseases,COMPLICATES,Secondary Infections,32420863,10.5152/tud.2020.140520,2020-05-19
angiotensin II,ASSOCIATED_WITH,Cardiac complication,32420863,10.5152/tud.2020.140520,2020-05-19
Cardiovascular,LOCATION_OF,consideration,32420863,10.5152/tud.2020.140520,2020-05-19
Pandemics,ISA,Disease Outbreaks,32420831,10.1080/01634372.2020.1766628,2020-05-19
Coronavirus Infections,PROCESS_OF,Pet Animal,32420831,10.1080/01634372.2020.1766628,2020-05-19
Patients,ISA,Persons,32420788,10.1080/09546634.2020.1771261,2020-05-19
Disability,PROCESS_OF,Persons,32420788,10.1080/09546634.2020.1771261,2020-05-19
Lung,LOCATION_OF,Lesion,32420777,10.1080/23744235.2020.1766105,2020-05-19
Coronavirus Infections,ISA,Disease,32420777,10.1080/23744235.2020.1766105,2020-05-19
Lesion,COEXISTS_WITH,Disease,32420777,10.1080/23744235.2020.1766105,2020-05-19
Lesion,COEXISTS_WITH(SPEC),Coronavirus Infections,32420777,10.1080/23744235.2020.1766105,2020-05-19
Autoimmune Diseases,PROCESS_OF,Patients,32420777,10.1080/23744235.2020.1766105,2020-05-19
Autoimmune Diseases,PROCESS_OF,Patients,32420777,10.1080/23744235.2020.1766105,2020-05-19
Autoimmune Diseases,PROCESS_OF,Patients,32420777,10.1080/23744235.2020.1766105,2020-05-19
Confirmation,PROCESS_OF,Patients,32420720,10.1097/PCC.0000000000002429,2020-05-19
Supportive care,ADMINISTERED_TO,Patients,32420720,10.1097/PCC.0000000000002429,2020-05-19
Coughing,ISA,Symptoms,32420720,10.1097/PCC.0000000000002429,2020-05-19
Diarrhea,ISA,Symptoms,32420720,10.1097/PCC.0000000000002429,2020-05-19
Fever,ISA,Symptoms,32420720,10.1097/PCC.0000000000002429,2020-05-19
Specimen Type - Stool = Fecal,PART_OF,Patients,32420720,10.1097/PCC.0000000000002429,2020-05-19
Fever,PROCESS_OF,Control Groups,32420720,10.1097/PCC.0000000000002429,2020-05-19
Diarrhea,PROCESS_OF,Control Groups,32420720,10.1097/PCC.0000000000002429,2020-05-19
Critical Illness,PROCESS_OF,Patients,32420710,10.20452/pamw.15361,2020-05-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Physicians,32420710,10.20452/pamw.15361,2020-05-19
Critical Illness,OCCURS_IN,Adult,32420710,10.20452/pamw.15361,2020-05-19
Comorbidity,PROCESS_OF,Patients,32420674,10.1002/rmv.2113,2020-05-19
Fever,ISA,Symptoms,32420674,10.1002/rmv.2113,2020-05-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32420674,10.1002/rmv.2113,2020-05-19
Infected,PROCESS_OF,Persons,32420631,10.1002/hed.26256,2020-05-19
EHD1 wt Allele,PART_OF,Persons,32420631,10.1002/hed.26256,2020-05-19
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32420527,10.1136/gpsych-2020-100213corr1,2020-05-19
Schizophrenia,PROCESS_OF,Patients,32420521,10.1136/gpsych-2019-100183,2020-05-19
Schizophrenia,PROCESS_OF,Patients,32420521,10.1136/gpsych-2019-100183,2020-05-19
Schizophrenia,PROCESS_OF,Patients,32420521,10.1136/gpsych-2019-100183,2020-05-19
Schizophrenia,PROCESS_OF,Patients,32420521,10.1136/gpsych-2019-100183,2020-05-19
Symptoms,PROCESS_OF,Psychiatric inpatient,32420521,10.1136/gpsych-2019-100183,2020-05-19
Schizophrenia,PROCESS_OF,Patients,32420521,10.1136/gpsych-2019-100183,2020-05-19
Clozapine,CAUSES,Inflammation,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Clozapine,PREDISPOSES,Pneumonia,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Pneumonia,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Pneumonia,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Pneumonia,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Clozapine,PREDISPOSES,Pneumonia,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Pneumonia,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Infected,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Infection,PROCESS_OF,Patients,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Pneumonia,AFFECTS,Intoxication,32420305,10.12998/wjcc.v8.i9.1705,2020-05-19
Fever,PROCESS_OF,Woman,32420073,10.21037/tlcr.2020.02.10,2020-05-19
Treatment Protocols,TREATS,Population Group,32420073,10.21037/tlcr.2020.02.10,2020-05-19
Coronavirus Infections,ISA,Disease,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Coronavirus Infections,ISA,Disease,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Lung,LOCATION_OF,Ground Glass Opacity,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Radiation Pneumonitis,ISA,Disease,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Radiation Pneumonitis,ISA,Pneumonia,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Coronavirus Infections,ISA,Disease,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Coronavirus Infections,ISA,Disease,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Operative Surgical Procedures,TREATS,Patients,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32420049,10.1016/j.btre.2020.e00467,2020-05-19
Infected,PROCESS_OF,Cancer Patient,32420049,10.1016/j.btre.2020.e00467,2020-05-19
RNA Viruses,CAUSES,Disease,32419998,10.7759/cureus.7671,2020-05-19
Epithelial Cells,PART_OF,Lung,32419998,10.7759/cureus.7671,2020-05-19
Membrane Proteins,INTERACTS_WITH,ACE2 gene,32419998,10.7759/cureus.7671,2020-05-19
health hazards,CAUSES,Multiple Organ Failure,32419998,10.7759/cureus.7671,2020-05-19
Delirium,AFFECTS,Patients,32419998,10.7759/cureus.7671,2020-05-19
Tissue damage,PROCESS_OF,Patients,32419998,10.7759/cureus.7671,2020-05-19
Academic Medical Centers,LOCATION_OF,Work,32419887,10.5114/pjr.2020.95022,2020-05-19
Asymptomatic,PROCESS_OF,Patients,32419876,10.1007/s13167-020-00208-z,2020-05-19
Indicators,AFFECTS,health and disease,32419875,10.1016/j.zefq.2020.05.005,2020-05-19
Virus Diseases,AFFECTS,Patients,32419875,10.1016/j.zefq.2020.05.005,2020-05-19
Patients,LOCATION_OF,GSKIP gene,32419875,10.1016/j.zefq.2020.05.005,2020-05-19
Specific antibody,PART_OF,Virus,32419854,10.26574/maedica.2020.15.1.6,2020-05-19
Antibodies,CAUSES,consideration,32419854,10.26574/maedica.2020.15.1.6,2020-05-19
Virus,CAUSES,Common Cold,32419848,10.1186/s13040-020-00213-y,2020-05-19
Genus: Coronavirus,CAUSES(SPEC),Common Cold,32419848,10.1186/s13040-020-00213-y,2020-05-19
Genus: Coronavirus,ISA,Virus,32419848,10.1186/s13040-020-00213-y,2020-05-19
Severe Acute Respiratory Syndrome,ISA,Infection,32419848,10.1186/s13040-020-00213-y,2020-05-19
Severe Acute Respiratory Syndrome,ISA,Infection,32419848,10.1186/s13040-020-00213-y,2020-05-19
Gravidity,PROCESS_OF,Patients,32419848,10.1186/s13040-020-00213-y,2020-05-19
Health Care,TREATS,patient condition,32419840,10.1186/s13034-020-00329-3,2020-05-19
Mental disorders,PROCESS_OF,parent,32419838,10.1186/s13027-020-00302-x,2020-05-19
Human coronavirus,ISA,RNA Viruses,32419772,10.1016/j.enfcli.2020.05.003,2020-05-19
Infected,PROCESS_OF,Persons,32419771,10.1016/j.enfcli.2020.05.001,2020-05-19
Health Personnel,LOCATION_OF,SLC25A3 gene,32419771,10.1016/j.enfcli.2020.05.001,2020-05-19
Terminal illness,PROCESS_OF,Persons,32419771,10.1016/j.enfcli.2020.05.001,2020-05-19
Health Services,TREATS,Persons,32419771,10.1016/j.enfcli.2020.05.001,2020-05-19
Coronavirus Infections,PROCESS_OF,Family,32419770,10.1016/j.enfcli.2020.05.002,2020-05-19
Infected,PROCESS_OF,Persons,32419770,10.1016/j.enfcli.2020.05.002,2020-05-19
Multiple Organ Failure,ISA,Complication,32419770,10.1016/j.enfcli.2020.05.002,2020-05-19
Infected,PROCESS_OF,Persons,32419770,10.1016/j.enfcli.2020.05.002,2020-05-19
Coronavirus Infections,ISA,Disease,32419767,10.1016/j.jdiacomp.2020.107622,2020-05-19
Coronavirus Infections,ISA,Disease,32419767,10.1016/j.jdiacomp.2020.107622,2020-05-19
Diabetic Foot,ISA,Complication,32419766,10.1016/j.annepidem.2020.05.003,2020-05-19
Cessation of life,ASSOCIATED_WITH,Disease,32419765,10.1016/j.annepidem.2020.05.004,2020-05-19
Cessation of life,PROCESS_OF,Community,32419765,10.1016/j.annepidem.2020.05.004,2020-05-19
Chronic nervous system disorder,PROCESS_OF,World,32419751,10.4103/aian.AIAN_210_20,2020-05-19
Migraine Disorders,PROCESS_OF,Patients,32419751,10.4103/aian.AIAN_210_20,2020-05-19
Patient in hospital,PROCESS_OF,Persons,32419750,10.4103/aian.AIAN_295_20,2020-05-19
Cerebrovascular accident,PROCESS_OF,Persons,32419750,10.4103/aian.AIAN_295_20,2020-05-19
Infected,PROCESS_OF,Persons,32419750,10.4103/aian.AIAN_295_20,2020-05-19
Febrile Convulsions,PROCESS_OF,Human Age Group,32419750,10.4103/aian.AIAN_295_20,2020-05-19
Multiple Sclerosis,PROCESS_OF,Persons,32419750,10.4103/aian.AIAN_295_20,2020-05-19
Eye,LOCATION_OF,Coronavirus Infections,32419749,10.4103/aian.AIAN_302_20,2020-05-19
Cerebrovascular accident,AFFECTS,Level of consciousness,32419749,10.4103/aian.AIAN_302_20,2020-05-19
Cerebrovascular accident,AFFECTS,Leukoencephalopathies,32419749,10.4103/aian.AIAN_302_20,2020-05-19
Parkinson Disease,PROCESS_OF,Persons,32419749,10.4103/aian.AIAN_302_20,2020-05-19
Challenge,TREATS,Medical emergencies,32419748,10.4103/0972-2327.282442,2020-05-19
Acute Cerebrovascular Accidents,ISA,Disability,32419748,10.4103/0972-2327.282442,2020-05-19
Coronavirus Infections,PROCESS_OF,Patients,32419721,10.1016/j.clindermatol.2020.05.003,2020-05-19
Uncertainty,PROCESS_OF,Patients,32419720,10.1016/j.earlhumdev.2020.105074,2020-05-19
Uncertainty,PROCESS_OF,Physicians,32419720,10.1016/j.earlhumdev.2020.105074,2020-05-19
Virus,LOCATION_OF,Immunosuppressive Agents,32419720,10.1016/j.earlhumdev.2020.105074,2020-05-19
Therapeutic procedure,TREATS,Discontinued,32419720,10.1016/j.earlhumdev.2020.105074,2020-05-19
Discontinued,PROCESS_OF,Patients,32419720,10.1016/j.earlhumdev.2020.105074,2020-05-19
Therapeutic procedure,AFFECTS,Disease Progression,32419713,10.1016/j.annemergmed.2020.05.018,2020-05-19
Simulation Training,AFFECTS,Readiness,32419705,10.1016/j.redar.2020.05.002,2020-05-19
Ventilator - respiratory equipment,USES,intensive care unit,32419694,10.4269/ajtmh.20-0440,2020-05-19
Wakefulness,ISA,Awareness,32419693,10.4269/ajtmh.20-0433,2020-05-19
"Loss, Grief, and Bereavement",PROCESS_OF,Survivors,32419658,10.1080/08959420.2020.1764319,2020-05-19
Performance,PROCESS_OF,Patients,32419599,10.1177/0025817220923698,2020-05-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32419599,10.1177/0025817220923698,2020-05-19
Sinusitis,PROCESS_OF,Adolescent (age group),32419564,10.1080/09593985.2020.1766181,2020-05-19
Orbital Cellulitis,PROCESS_OF,Adolescent (age group),32419564,10.1080/09593985.2020.1766181,2020-05-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Adolescent (age group),32419564,10.1080/09593985.2020.1766181,2020-05-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32419558,10.1080/14767058.2020.1763946,2020-05-19
Weakness,COEXISTS_WITH,Poor outcome,32419558,10.1080/14767058.2020.1763946,2020-05-19
Poor outcome,PROCESS_OF,Patients,32419558,10.1080/14767058.2020.1763946,2020-05-19
intensive care unit,LOCATION_OF,Administration occupational activities,32419558,10.1080/14767058.2020.1763946,2020-05-19
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32419558,10.1080/14767058.2020.1763946,2020-05-19
early/brief intervention/therapy (treatment),TREATS,Patients,32419558,10.1080/14767058.2020.1763946,2020-05-19
early/brief intervention/therapy (treatment),TREATS(INFER),"Respiratory Distress Syndrome, Adult",32419558,10.1080/14767058.2020.1763946,2020-05-19
Illness (finding),PROCESS_OF,Infant,32419544,10.1080/14767058.2020.1759542,2020-05-19
Illness (finding),PROCESS_OF,Pregnant Women,32419544,10.1080/14767058.2020.1759542,2020-05-19
tocilizumab,TREATS,patient condition,32419495,10.1177/0145561320926291,2020-05-19
Treatment Protocols,TREATS,Patients,32419495,10.1177/0145561320926291,2020-05-19
Coronavirus Infections,ISA,Disease,32419438,10.5114/ait.2020.95164,2020-05-19
Residency,ISA,Training,32419438,10.5114/ait.2020.95164,2020-05-19
Critical Illness,PROCESS_OF,Patients,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Delirium,OCCURS_IN,Patients,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Prodromal Symptoms,ASSOCIATED_WITH,Respiratory Failure,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Delirium,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Delirium,ISA,Symptoms,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Delirium,PROCESS_OF,Patients,32419401,10.3346/jkms.2020.35.e189,2020-05-19
early identification,TREATS,Patients,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,risk factors,32419401,10.3346/jkms.2020.35.e189,2020-05-19
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Has difficulty doing (qualifier value),32419401,10.3346/jkms.2020.35.e189,2020-05-19
Communicable Diseases,PROCESS_OF,Patients,32419400,10.3346/jkms.2020.35.e182,2020-05-19
Tertiary Care Centers,LOCATION_OF,Study,32419400,10.3346/jkms.2020.35.e182,2020-05-19
Eligibility Determination,COEXISTS_WITH,Isolation procedure,32419400,10.3346/jkms.2020.35.e182,2020-05-19
Intervention regimes,AFFECTS,Severe (severity modifier),32419272,10.1002/biot.202000152,2020-05-19
Academia (organization),LOCATION_OF,research,32419218,10.1111/jocs.14631,2020-05-19
IMPACT gene,PART_OF,Virus,32419218,10.1111/jocs.14631,2020-05-19
Infected,PROCESS_OF,Patients,32419177,10.1111/jocs.14638,2020-05-19
Hospitals,LOCATION_OF,research,32419177,10.1111/jocs.14638,2020-05-19
General observation,TREATS,Problem,32419128,10.5603/CJ.a2020.0068,2020-05-19
Patients,LOCATION_OF,"CD69 protein, human",32419053,10.1007/s11033-020-05511-6,2020-05-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32419053,10.1007/s11033-020-05511-6,2020-05-19
Manis tricuspis,ISA,Pholidota,32419024,10.1093/jtm/taaa077,2020-05-19
Cell Differentiation process,PROCESS_OF,Source Population,32419024,10.1093/jtm/taaa077,2020-05-19
Cerebrospinal Fluid,PART_OF,Patients,32418917,10.1016/j.clim.2020.108459,2020-05-19
"Immunoglobulins, Intravenous",compared_with,Globulins,32418894,10.1016/j.lfs.2020.117775,2020-05-19
Inflammation,COEXISTS_WITH,Virus Diseases,32418875,10.1016/j.hlc.2020.04.005,2020-05-19
Agent,TREATS,"Respiratory Distress Syndrome, Adult",32418875,10.1016/j.hlc.2020.04.005,2020-05-19
Cardiomyopathies,PROCESS_OF,Patients,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Cessation of life,ASSOCIATED_WITH,Acute heart failure,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Cessation of life,PROCESS_OF,Patients,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Multiple Organ Failure,COMPLICATES,"Respiratory Distress Syndrome, Adult",32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Serum,LOCATION_OF,Troponin,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Acute heart failure,PROCESS_OF,Patients,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
patient assessment,TREATS,Acute heart failure,32418874,10.1016/j.hlc.2020.04.006,2020-05-19
Heart,LOCATION_OF,Hereditary Diseases,32418852,10.1016/j.clinre.2020.04.012,2020-05-19
Liver Dysfunction,PROCESS_OF,Patients,32418832,10.1053/j.jvca.2020.04.002,2020-05-19
Abdominal Pain,OCCURS_IN,Patients,32418832,10.1053/j.jvca.2020.04.002,2020-05-19
Diarrhea,OCCURS_IN,Patients,32418832,10.1053/j.jvca.2020.04.002,2020-05-19
Nausea and vomiting,OCCURS_IN,Patients,32418832,10.1053/j.jvca.2020.04.002,2020-05-19
Gastrointestinal symptom,OCCURS_IN,Patients,32418832,10.1053/j.jvca.2020.04.002,2020-05-19
primary disorders,AFFECTS,Patients,32418804,10.1016/j.jsams.2020.05.005,2020-05-19
Lung,LOCATION_OF,Ultrasonography,32418804,10.1016/j.jsams.2020.05.005,2020-05-19
Patients,ISA,Persons,32418794,10.1016/j.vaccine.2020.05.007,2020-05-19
Epidemic,ISA,Disease Outbreaks,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Ataxia Telangiectasia Mutated Proteins,PART_OF,Ebolavirus,32418773,10.1016/j.dld.2020.03.031,2020-05-19
specific immunity,PROCESS_OF,Survivors,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Measles Virus Nucleoprotein,PART_OF,Ebolavirus,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Vaccines,PART_OF,T-Lymphocyte,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Measles Virus Nucleoprotein,PART_OF,Ebolavirus,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Measles Virus Nucleoprotein,PART_OF,Ebolavirus,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Immunity,PROCESS_OF,Mus,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Immunity,PROCESS_OF,Survivors,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Ebolavirus,PROCESS_OF,Survivors,32418773,10.1016/j.dld.2020.03.031,2020-05-19
Therapeutic procedure,TREATS,Malignant neoplasm of gastrointestinal tract,32418751,10.1016/j.jsxm.2020.04.380,2020-05-19
Malignant neoplasm of gastrointestinal tract,PROCESS_OF,Patients,32418751,10.1016/j.jsxm.2020.04.380,2020-05-19
Experience,PROCESS_OF,Persons,32418734,10.1016/j.purol.2020.04.007,2020-05-19
Exploration procedure,ADMINISTERED_TO,Persons,32418734,10.1016/j.purol.2020.04.007,2020-05-19
Risk Behavior,PROCESS_OF,Male population group,32418734,10.1016/j.purol.2020.04.007,2020-05-19
Risk Behavior,PROCESS_OF,Woman,32418734,10.1016/j.purol.2020.04.007,2020-05-19
Cystectomy,TREATS,Urinary Fistula,32418730,10.1016/j.therap.2020.05.002,2020-05-19
Laboratory Procedures,DIAGNOSES,Pressure Ulcer,32418730,10.1016/j.therap.2020.05.002,2020-05-19
Anogenital region,LOCATION_OF,Pressure Ulcer,32418730,10.1016/j.therap.2020.05.002,2020-05-19
Ileal conduit procedure,TREATS,Urinary Fistula,32418730,10.1016/j.therap.2020.05.002,2020-05-19
Cardiac Arrhythmia,CAUSES,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Pharmaceutical Preparations,INTERACTS_WITH,Hydroxychloroquine,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Pharmaceutical Preparations,INTERACTS_WITH,Azithromycin,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Pharmaceutical Preparations,INTERACTS_WITH,lopinavir / Ritonavir,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Electrocardiogram,CAUSES,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Heart,LOCATION_OF,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Undifferentiated illness,CAUSES,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Corrected Prolonged QT Interval by ECG Finding,CAUSES,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Heart,LOCATION_OF,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Heart,LOCATION_OF,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Hydroxychloroquine,AFFECTS,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Azithromycin,AFFECTS,Adverse reaction to drug,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Heart,LOCATION_OF,Undifferentiated illness,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Pharmaceutical Preparations,TREATS,Patients,32418728,10.1016/j.therap.2020.05.003,2020-05-19
Pharmaceutical Preparations,TREATS(INFER),risk factors,32418728,10.1016/j.therap.2020.05.003,2020-05-19
risk factors,PROCESS_OF,Patients,32418728,10.1016/j.therap.2020.05.003,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Fever,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Musculoskeletal Pain,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",PREDISPOSES,Complication,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
Antibiotics,COEXISTS_WITH,"Anti-Inflammatory Agents, Non-Steroidal",32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",PREDISPOSES,Complication,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Fever,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Pain,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Myalgia,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Symptom severe,32418724,10.1016/j.molmed.2020.04.007,2020-05-19
interferon production,ASSOCIATED_WITH,Pneumonia,32418711,10.1016/j.ejogrb.2020.04.065,2020-05-19
Vaccines,TREATS,patient condition,32418711,10.1016/j.ejogrb.2020.04.065,2020-05-19
Vertical Disease Transmission,PROCESS_OF,Patients,32418663,10.1016/j.tibtech.2020.04.003,2020-05-19
Gravidity,PROCESS_OF,Patients,32418663,10.1016/j.tibtech.2020.04.003,2020-05-19
Italy,ISA,Country,32418550,10.1017/dmp.2020.156,2020-05-19
intensive care unit,ISA,Hospitals,32418550,10.1017/dmp.2020.156,2020-05-19
Lung,LOCATION_OF,receptor,32418549,10.1017/dmp.2020.155,2020-05-19
Mustard Gas,CAUSES,Oxidative Stress,32418549,10.1017/dmp.2020.155,2020-05-19
Coronavirus Infections,PROCESS_OF,Survivors,32418549,10.1017/dmp.2020.155,2020-05-19
Mustard Gas,CAUSES,Lung Injury,32418549,10.1017/dmp.2020.155,2020-05-19
Epidemic,ISA,Process,32418532,10.2174/1871526520666200518073329,2020-05-19
Immune System Processes,AFFECTS,Homo sapiens,32418508,10.33321/cdi.2020.44.44,2020-05-19
Rickets,PROCESS_OF,Patients,32418508,10.33321/cdi.2020.44.44,2020-05-19
Neurons,LOCATION_OF,angiotensin converting enzyme 2,32418508,10.33321/cdi.2020.44.44,2020-05-19
angiotensin converting enzyme 2,ISA,Metalloproteases,32418508,10.33321/cdi.2020.44.44,2020-05-19
Monocytes+Macrophages,LOCATION_OF,angiotensin converting enzyme 2,32418508,10.33321/cdi.2020.44.44,2020-05-19
Disease,PROCESS_OF,Persons,32418508,10.33321/cdi.2020.44.44,2020-05-19
Infected,PROCESS_OF,Persons,32418508,10.33321/cdi.2020.44.44,2020-05-19
Renin-angiotensin system,ASSOCIATED_WITH,Symptoms & diseases,32418508,10.33321/cdi.2020.44.44,2020-05-19
Peptidyl-Dipeptidase A,PRODUCES,angiotensin II,32418508,10.33321/cdi.2020.44.44,2020-05-19
Cells,INTERACTS_WITH,angiotensin II,32418508,10.33321/cdi.2020.44.44,2020-05-19
angiotensin I (1-7),INTERACTS_WITH,"MAS1 protein, human",32418508,10.33321/cdi.2020.44.44,2020-05-19
angiotensin I (1-7),INTERACTS_WITH,alamandine,32418508,10.33321/cdi.2020.44.44,2020-05-19
alamandine,STIMULATES,angiotensin I (1-7),32418508,10.33321/cdi.2020.44.44,2020-05-19
"angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-",INTERACTS_WITH,AGTR1 gene,32418508,10.33321/cdi.2020.44.44,2020-05-19
angiotensin I (1-7),TREATS,Macrophage Activation Syndrome,32418508,10.33321/cdi.2020.44.44,2020-05-19
Infected,PROCESS_OF,Homo sapiens,32418508,10.33321/cdi.2020.44.44,2020-05-19
Angiotensin-Converting Enzyme Inhibitors,INHIBITS,AGTR1 gene,32418508,10.33321/cdi.2020.44.44,2020-05-19
Peptides,ISA,Pharmaceutical Preparations,32418508,10.33321/cdi.2020.44.44,2020-05-19
angiotensin I (1-7),TREATS,Disease,32418508,10.33321/cdi.2020.44.44,2020-05-19
Cardiovascular Diseases,OCCURS_IN,general population,32418481,10.1177/1120672120927865,2020-05-19
Hospital admission,TREATS,Cardiovascular event,32418481,10.1177/1120672120927865,2020-05-19
Interventional procedure,TREATS,Confirmation,32418481,10.1177/1120672120927865,2020-05-19
Infected,PROCESS_OF,Persons,32418475,10.1080/08959420.2020.1764310,2020-05-19
Italy,ISA,Country,32418475,10.1080/08959420.2020.1764310,2020-05-19
patient care,COEXISTS_WITH,Ophthalmic examination and evaluation,32418475,10.1080/08959420.2020.1764310,2020-05-19
Population Group,LOCATION_OF,"TLR4 protein, human",32418463,10.1161/JAHA.120.016997,2020-05-19
Life Style,ISA,Behavior,32418460,10.1161/JAHA.120.017042,2020-05-19
Cardiac Surgery procedures,TREATS,Patients,32418446,10.1161/CIRCULATIONAHA.120.048360,2020-05-19
Coronavirus Infections,CAUSES,Acute respiratory failure,32411359,10.12688/f1000research.23275.2,2020-05-19
Heart failure,PROCESS_OF,Patients,32411359,10.12688/f1000research.23275.2,2020-05-19
Respiration Disorders,ISA,Disease,32411358,10.12688/f1000research.22942.2,2020-05-19
Coronavirus Infections,ISA,Disease,32411358,10.12688/f1000research.22942.2,2020-05-19
Gilles de la Tourette syndrome,ISA,Neurodevelopmental Disorders,32411358,10.12688/f1000research.22942.2,2020-05-19
Comorbidity,PROCESS_OF,Patients,32411358,10.12688/f1000research.22942.2,2020-05-19
Gilles de la Tourette syndrome,PROCESS_OF,Patients,32411358,10.12688/f1000research.22942.2,2020-05-19
Gilles de la Tourette syndrome,PROCESS_OF,Patients,32411358,10.12688/f1000research.22942.2,2020-05-19
Coronavirus Infections,ISA,Disease,32411358,10.12688/f1000research.22942.2,2020-05-19
Dry cough,ISA,Disease,32411358,10.12688/f1000research.22942.2,2020-05-19
Gilles de la Tourette syndrome,PROCESS_OF,Patients,32411358,10.12688/f1000research.22942.2,2020-05-19
"Signs and Symptoms, Respiratory",COEXISTS_WITH,Chief complaint (finding),32418288,10.1002/ana.25783,2020-05-18
Patients,LOCATION_OF,Feces,32418288,10.1002/ana.25783,2020-05-18
Feces,PART_OF,Patients,32418288,10.1002/ana.25783,2020-05-18
Multiple symptoms,PROCESS_OF,Patients,32418237,10.1002/jmv.26020,2020-05-18
Respiratory distress,PROCESS_OF,Patients,32418237,10.1002/jmv.26020,2020-05-18
Akinetic Mutism,PROCESS_OF,Patients,32418237,10.1002/jmv.26020,2020-05-18
Electroencephalography,DIAGNOSES,Generalized slowing,32418237,10.1002/jmv.26020,2020-05-18
Lymphopenia,PROCESS_OF,Adult,32418199,10.1002/path.5471,2020-05-18
Child,LOCATION_OF,Creatine Kinase MB Isoenzyme,32418199,10.1002/path.5471,2020-05-18
Heart Injuries,OCCURS_IN,Patients,32418199,10.1002/path.5471,2020-05-18
Disease,AFFECTS,disease transmission,32418199,10.1002/path.5471,2020-05-18
Disease,PROCESS_OF,Child,32418199,10.1002/path.5471,2020-05-18
Organ,PART_OF,Homo sapiens,32418194,10.4414/smw.2020.20282,2020-05-18
angiotensin II,INTERACTS_WITH,angiotensin converting enzyme 2,32418194,10.4414/smw.2020.20282,2020-05-18
Coronavirus Infections,ISA,Disease,32418194,10.4414/smw.2020.20282,2020-05-18
Human tissue,LOCATION_OF,angiotensin converting enzyme 2,32418194,10.4414/smw.2020.20282,2020-05-18
angiotensin converting enzyme 2,CAUSES,Disease,32418194,10.4414/smw.2020.20282,2020-05-18
Coronavirus Infections,ISA,Disease,32418194,10.4414/smw.2020.20282,2020-05-18
Severe Acute Respiratory Syndrome,AFFECTS,Disease,32418194,10.4414/smw.2020.20282,2020-05-18
Severe Acute Respiratory Syndrome,AFFECTS(SPEC),Coronavirus Infections,32418194,10.4414/smw.2020.20282,2020-05-18
Coronavirus Infections,ISA,Disease,32418194,10.4414/smw.2020.20282,2020-05-18
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32418194,10.4414/smw.2020.20282,2020-05-18
Antiviral Agents,TREATS,Patients,32418181,10.1007/s10840-020-00765-3,2020-05-18
Torsades de Pointes,PROCESS_OF,Patients,32418181,10.1007/s10840-020-00765-3,2020-05-18
Chloroquine,ISA,Antimalarials,32418146,10.1007/s00467-020-04584-6,2020-05-18
Chloroquine,ISA,Pharmaceutical Preparations,32418146,10.1007/s00467-020-04584-6,2020-05-18
Hydroxychloroquine,ISA,Antimalarials,32418146,10.1007/s00467-020-04584-6,2020-05-18
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32418146,10.1007/s00467-020-04584-6,2020-05-18
Pharmaceutical Preparations,CAUSES,Ventricular arrhythmia,32418146,10.1007/s00467-020-04584-6,2020-05-18
Chronic Kidney Diseases,PROCESS_OF,Child,32418114,10.1007/s11427-020-1732-2,2020-05-18
Exercise,TREATS,Social Networks,32418114,10.1007/s11427-020-1732-2,2020-05-18
Health Care Systems,LOCATION_OF,Administration occupational activities,32418114,10.1007/s11427-020-1732-2,2020-05-18
Hospitals,LOCATION_OF,Retrospective Studies,32418066,10.1007/s11239-020-02139-y,2020-05-18
"Administration, Oral",USES,Hydroxychloroquine,32418066,10.1007/s11239-020-02139-y,2020-05-18
Therapeutic procedure,ADMINISTERED_TO,Patients,32418066,10.1007/s11239-020-02139-y,2020-05-18
Hydroxychloroquine,compared_with,Therapeutic procedure,32418066,10.1007/s11239-020-02139-y,2020-05-18
Hydroxychloroquine,TREATS,Patients,32418066,10.1007/s11239-020-02139-y,2020-05-18
heparin use,PROCESS_OF,Patients,32418055,10.1007/s13365-020-00851-2,2020-05-18
Venous Thromboembolism,PROCESS_OF,Patients,32418055,10.1007/s13365-020-00851-2,2020-05-18
neurological complication,PROCESS_OF,Patients,32418029,10.1007/s00268-020-05595-y,2020-05-18
Genus: Coronavirus,COEXISTS_WITH,Central Nervous System Infection,32418029,10.1007/s00268-020-05595-y,2020-05-18
Experience,PROCESS_OF,Italians,32418028,10.1007/s00268-020-05575-2,2020-05-18
Operative Surgical Procedures,TREATS,patient condition,32417996,10.1007/s00345-020-03251-7,2020-05-18
Asymptomatic,PROCESS_OF,Patients,32417996,10.1007/s00345-020-03251-7,2020-05-18
Virus,PROCESS_OF,Staff,32417872,10.31729/jnma.4974,2020-05-18
Pandemics,ISA,Disease Outbreaks,32417862,10.31729/jnma.4941,2020-05-18
Hospitals,LOCATION_OF,Services,32417802,10.3233/NPM-200460,2020-05-18
Hospitals,LOCATION_OF,Polymerase Chain Reaction,32417802,10.3233/NPM-200460,2020-05-18
Disease,PROCESS_OF,Infant,32417768,10.3233/HAB-200413,2020-05-18
Disease,PROCESS_OF,Patients,32417768,10.3233/HAB-200413,2020-05-18
Gravidity,PROCESS_OF,Patients,32417768,10.3233/HAB-200413,2020-05-18
Gravidity,NEG_PROCESS_OF,Adult,32417768,10.3233/HAB-200413,2020-05-18
Gravidity,PROCESS_OF,Patients,32417768,10.3233/HAB-200413,2020-05-18
Gravidity,PROCESS_OF,Mother (person),32417768,10.3233/HAB-200413,2020-05-18
Lung,PART_OF,Patients,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Airway structure,PART_OF,Patients,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Associated symptom,PROCESS_OF,Patients,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Comorbidity,PROCESS_OF,geriatric patients,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Cessation of life,PROCESS_OF,geriatric patients,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Fever,ISA,Symptoms,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Fever,PROCESS_OF(SPEC),Persons,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Secondary Infections,PROCESS_OF,Health Personnel,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Symptoms,PROCESS_OF,Persons,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Contacts,PREVENTS,Secondary Infections,32417744,10.1016/j.ijid.2020.04.036,2020-05-18
Coronavirus Infections,ISA,Disease,32417709,10.1016/j.dsx.2020.05.025,2020-05-18
Persons,USES,Preexisting Condition Coverage,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Coronavirus Infections,CAUSES,Respiration Disorders,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Angiotensin-Converting Enzyme Inhibitors,TREATS,Coronavirus Infections,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Obesity,PROCESS_OF,Persons,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Infection,PROCESS_OF,Persons,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
"Receptors, C-Type Lectin",INTERACTS_WITH,Glucose,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Pharmaceutical Preparations,TREATS,Disease,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Disease,PROCESS_OF,Persons,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Antiviral Therapy,PREVENTS,Complication,32417708,10.1016/j.dsx.2020.05.017,2020-05-18
Reverse Transcriptase Polymerase Chain Reaction,MEASURES,Hydroxychloroquine,32417701,10.1016/j.clinph.2020.04.011,2020-05-18
Hydroxychloroquine,TREATS,Patients,32417701,10.1016/j.clinph.2020.04.011,2020-05-18
Prognosis good,PROCESS_OF,Patients,32417674,10.1016/j.jcv.2020.104426,2020-05-18
Confirmation,PROCESS_OF,Mother (person),32417674,10.1016/j.jcv.2020.104426,2020-05-18
Medical Laboratory,LOCATION_OF,Assay,32417555,10.1016/j.scitotenv.2020.139298,2020-05-18
Detection,TREATS,Confirmation,32417554,10.1016/j.scitotenv.2020.139281,2020-05-18
Transection (procedure),TREATS,Complication,32417446,10.1016/j.jaip.2020.05.007,2020-05-18
contextual factors,PROCESS_OF,Patients,32417398,10.1016/j.ejps.2020.105375,2020-05-18
Self Administration,TREATS,Patients,32417398,10.1016/j.ejps.2020.105375,2020-05-18
HEBP2 gene,PART_OF,Homo sapiens,32417380,10.1016/j.cardfail.2020.05.008,2020-05-18
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32417380,10.1016/j.cardfail.2020.05.008,2020-05-18
Vaccines,AUGMENTS,Immune response,32417380,10.1016/j.cardfail.2020.05.008,2020-05-18
Vaccines,PART_OF,Engineer,32417380,10.1016/j.cardfail.2020.05.008,2020-05-18
Vaccines,PART_OF,Engineer,32417380,10.1016/j.cardfail.2020.05.008,2020-05-18
Heart,LOCATION_OF,Orthotopic graft (qualifier value),32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Heart,LOCATION_OF,Orthotopic graft (qualifier value),32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Heart,LOCATION_OF,Orthotopic graft (qualifier value),32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Heart,LOCATION_OF,Orthotopic graft (qualifier value),32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Orthotopic graft (qualifier value),PROCESS_OF,Patients,32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Symptoms,PROCESS_OF,Cohort,32417304,10.1016/j.jvs.2020.05.015,2020-05-18
Obesity,ISA,Malignant Neoplasms,32417248,10.1016/j.ijid.2020.05.035,2020-05-18
Thrombosis,PROCESS_OF,Patients,32417248,10.1016/j.ijid.2020.05.035,2020-05-18
Assay,USES,molecular diagnostics (lab procedure),32417247,10.1016/j.ijid.2020.05.031,2020-05-18
Nose,LOCATION_OF,Bacteria,32417247,10.1016/j.ijid.2020.05.031,2020-05-18
Fluorescent Antibody Technique,NEG_DIAGNOSES,Virus,32417247,10.1016/j.ijid.2020.05.031,2020-05-18
Nucleic acid assay,NEG_DIAGNOSES,Virus,32417247,10.1016/j.ijid.2020.05.031,2020-05-18
diagnostic procedure,DIAGNOSES,Virus,32417247,10.1016/j.ijid.2020.05.031,2020-05-18
risk factors,PROCESS_OF,Patients,32417195,10.1016/j.athoracsur.2020.05.003,2020-05-18
Disease Progression,PROCESS_OF,Patients,32417195,10.1016/j.athoracsur.2020.05.003,2020-05-18
Coronavirus Infections,CAUSES,Disease,32417164,10.1016/j.anorl.2020.05.001,2020-05-18
Sleep disturbances,ASSOCIATED_WITH,Disease,32417124,10.1016/j.jocn.2020.04.124,2020-05-18
Teleconsultation,METHOD_OF,Polysomnography,32417124,10.1016/j.jocn.2020.04.124,2020-05-18
Muscle,LOCATION_OF,skeletal injury,32417123,10.1016/j.transci.2020.102792,2020-05-18
Acute cerebrovascular disease,COEXISTS_WITH,Severe disorder,32417123,10.1016/j.transci.2020.102792,2020-05-18
Coronavirus Infections,AFFECTS,Neurological observations,32417123,10.1016/j.transci.2020.102792,2020-05-18
Neurological observations,PROCESS_OF,Homo sapiens,32417123,10.1016/j.transci.2020.102792,2020-05-18
Plasma,LOCATION_OF,Antibodies,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Plasmapheresis,ISA,Interventional procedure,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Plasmapheresis,TREATS(SPEC),Donor person,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Interventional procedure,TREATS,Donor person,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Citrates,AFFECTS,Deep Vein Thrombosis,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Extraction,AFFECTS,Deep Vein Thrombosis,32417117,10.1016/j.gaceta.2020.04.002,2020-05-18
Community Pharmacies,LOCATION_OF,Cross-Sectional Studies,32416984,10.1016/j.burns.2020.04.003,2020-05-18
Pharmaceutical Preparations,compared_with,Ethanol,32416984,10.1016/j.burns.2020.04.003,2020-05-18
Pharmaceutical Preparations,higher_than,Ethanol,32416984,10.1016/j.burns.2020.04.003,2020-05-18
Eye,LOCATION_OF,Coronavirus Infections,32416961,10.1016/j.bbrc.2020.04.136,2020-05-18
Measles Virus Nucleoprotein,AFFECTS,Coronavirus Infections,32416956,10.1016/j.arth.2020.04.048,2020-05-18
,COEXISTS_WITH,"Immunoglobulin A, Human",32416956,10.1016/j.arth.2020.04.048,2020-05-18
Immunoblotting,DIAGNOSES,Present,32416956,10.1016/j.arth.2020.04.048,2020-05-18
Author,TREATS,Patients,32416785,10.1016/S0140-6736(20)31030-8,2020-05-18
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32416769,10.1016/S2213-2600(20)30229-0,2020-05-18
Cardiovascular,LOCATION_OF,Comorbidity,32416769,10.1016/S2213-2600(20)30229-0,2020-05-18
Coitus,PROCESS_OF,Patients,32416769,10.1016/S2213-2600(20)30229-0,2020-05-18
Diabetes,PROCESS_OF,Patients,32416769,10.1016/S2213-2600(20)30229-0,2020-05-18
Symptom mild,PROCESS_OF,Patients,32416679,10.2174/1568026620999200517043137,2020-05-18
RNA-Directed RNA Polymerase,INTERACTS_WITH,ACE2 gene,32416647,10.31128/AJGP-COVID-20,2020-05-18
Disease,AFFECTS,Americas Ethnicity,32416600,10.1016/j.jcv.2020.104412,2020-05-18
Liver diseases,PROCESS_OF,Patients,32416600,10.1016/j.jcv.2020.104412,2020-05-18
IMPACT gene,ASSOCIATED_WITH,Adult Liver Carcinoma,32416600,10.1016/j.jcv.2020.104412,2020-05-18
Challenge,TREATS,Chronic liver disease,32416600,10.1016/j.jcv.2020.104412,2020-05-18
Coronavirus Infections,PROCESS_OF,human group,32416599,10.1016/j.jcv.2020.104394,2020-05-18
Infected,PROCESS_OF,Persons,32416599,10.1016/j.jcv.2020.104394,2020-05-18
Patients,LOCATION_OF,Serum,32416598,10.1016/j.jcv.2020.104423,2020-05-18
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32416598,10.1016/j.jcv.2020.104423,2020-05-18
PCR test for SARS,METHOD_OF,Assay,32416598,10.1016/j.jcv.2020.104423,2020-05-18
Study,USES,Polymerase Chain Reaction,32416567,10.1016/j.seizure.2020.05.005,2020-05-18
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Febrile Convulsions,ISA,Seizures,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Coronavirus Infections,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Nervous system problem,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Coronavirus Infections,ISA,Disease,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Heart Injuries,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Pneumonia,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Coronavirus Infections,ISA,Disease,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Subclinical Seizure,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Seizures,PROCESS_OF,Patients,32416536,10.1016/j.scitotenv.2020.139357,2020-05-18
Disease,AFFECTS,Community,32416535,10.1016/j.scitotenv.2020.139358,2020-05-18
risk factors,PROCESS_OF,Indigenous Population (Natives),32416535,10.1016/j.scitotenv.2020.139358,2020-05-18
Clinical act of insertion,TREATS,Community,32416535,10.1016/j.scitotenv.2020.139358,2020-05-18
risk factors,PROCESS_OF,Community,32416535,10.1016/j.scitotenv.2020.139358,2020-05-18
Infected,PROCESS_OF,Homo sapiens,32416534,10.1016/j.scitotenv.2020.139356,2020-05-18
Feces,PART_OF,Homo sapiens,32416534,10.1016/j.scitotenv.2020.139356,2020-05-18
Disinfection,PREVENTS,Severe Acute Respiratory Syndrome,32416527,10.1016/j.dsx.2020.04.053,2020-05-18
Diabetes,PROCESS_OF,Persons,32416433,10.1016/j.lungcan.2020.05.001,2020-05-18
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Participant,32416433,10.1016/j.lungcan.2020.05.001,2020-05-18
Anxiety,PROCESS_OF,Patients,32416433,10.1016/j.lungcan.2020.05.001,2020-05-18
Diabetes,PROCESS_OF,Patients,32416433,10.1016/j.lungcan.2020.05.001,2020-05-18
Insulin,TREATS,Anxiety,32416433,10.1016/j.lungcan.2020.05.001,2020-05-18
Neoplasms,PROCESS_OF,Patients,32416415,10.1016/j.mehy.2020.109826,2020-05-18
Therapeutic procedure,PREVENTS,Disease Progression,32416415,10.1016/j.mehy.2020.109826,2020-05-18
Lung,LOCATION_OF,advanced cancer,32416415,10.1016/j.mehy.2020.109826,2020-05-18
advanced cancer,PROCESS_OF,Patients,32416415,10.1016/j.mehy.2020.109826,2020-05-18
Experience,PROCESS_OF,Patients,32416415,10.1016/j.mehy.2020.109826,2020-05-18
Epstein-Barr Virus,CAUSES,Hypoplastic Left Heart Syndrome,32416412,10.1016/j.mehy.2020.109812,2020-05-18
Cytotoxic Chemotherapy,TREATS,"Lymphohistiocytosis, Hemophagocytic",32416412,10.1016/j.mehy.2020.109812,2020-05-18
Immune response,PROCESS_OF,Chiroptera,32416411,10.1016/j.mehy.2020.109797,2020-05-18
Severe inflammation,PROCESS_OF,Homo sapiens,32416411,10.1016/j.mehy.2020.109797,2020-05-18
Insulin-Like Growth Factor I Deficiency,PROCESS_OF,"Infant, Newborn",32416410,10.1016/j.mehy.2020.109795,2020-05-18
Patients,LOCATION_OF,Insulin-Like Growth Factor I,32416410,10.1016/j.mehy.2020.109795,2020-05-18
Autistic Disorder,PROCESS_OF,Offspring,32416410,10.1016/j.mehy.2020.109795,2020-05-18
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Patients,32416408,10.1016/j.mehy.2020.109828,2020-05-18
Fragility,PROCESS_OF,Population Group,32416408,10.1016/j.mehy.2020.109828,2020-05-18
montelukast,AFFECTS(SPEC),cytokine production,32416374,10.1016/j.envint.2020.105794,2020-05-18
montelukast,DISRUPTS(SPEC),Oxidative Stress,32416374,10.1016/j.envint.2020.105794,2020-05-18
montelukast,INTERACTS_WITH(SPEC),Anti-Inflammatory Agents,32416374,10.1016/j.envint.2020.105794,2020-05-18
montelukast,ISA,Leukotriene Antagonists,32416374,10.1016/j.envint.2020.105794,2020-05-18
Leukotriene Antagonists,AFFECTS,cytokine production,32416374,10.1016/j.envint.2020.105794,2020-05-18
Leukotriene Antagonists,DISRUPTS,Oxidative Stress,32416374,10.1016/j.envint.2020.105794,2020-05-18
Leukotriene Antagonists,INTERACTS_WITH,Anti-Inflammatory Agents,32416374,10.1016/j.envint.2020.105794,2020-05-18
Reporting,TREATS,Symptoms,32416359,10.1016/j.envres.2020.109634,2020-05-18
Awareness,PROCESS_OF,Population Group,32416359,10.1016/j.envres.2020.109634,2020-05-18
Air Pollutants,AFFECTS,Disease,32416330,10.1016/j.msard.2020.102182,2020-05-18
Disease,CAUSES,Adverse effects,32416330,10.1016/j.msard.2020.102182,2020-05-18
Adverse effects,PROCESS_OF,Homo sapiens,32416330,10.1016/j.msard.2020.102182,2020-05-18
Respiratory viruses,CAUSES,Respiratory Tract Infections,32416330,10.1016/j.msard.2020.102182,2020-05-18
Multiple Sclerosis,PROCESS_OF,Patients,32416318,10.1016/j.cjca.2020.05.008,2020-05-18
Decision,PROCESS_OF,Patients,32416318,10.1016/j.cjca.2020.05.008,2020-05-18
Pharmaceutical Preparations,AFFECTS,Disease Outcome,32416318,10.1016/j.cjca.2020.05.008,2020-05-18
Pharmaceutical Preparations,AFFECTS,At risk of disease,32416318,10.1016/j.cjca.2020.05.008,2020-05-18
tocilizumab,NEG_COMPLICATES,Multiple Sclerosis,32416318,10.1016/j.cjca.2020.05.008,2020-05-18
Lung,LOCATION_OF,Ultrasonography,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Lung,LOCATION_OF,Auscultation,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Lung,LOCATION_OF,Ultrasonography,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Lung,LOCATION_OF,Ultrasonography,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Lung,LOCATION_OF,Ultrasonography,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Lung,LOCATION_OF,Ultrasonography,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
Cor pulmonale,PROCESS_OF,Patients,32416290,10.1016/j.bbi.2020.05.038,2020-05-18
psychological distress,PROCESS_OF,hospitalized patients,32416289,10.1016/j.bbi.2020.05.037,2020-05-18
Depressive disorder,ISA,Psychiatric symptom,32416289,10.1016/j.bbi.2020.05.037,2020-05-18
Pneumonia,CAUSES,Severe Acute Respiratory Syndrome,32416259,10.1016/j.virusres.2020.198021,2020-05-18
,ASSOCIATED_WITH,Symptoms,32416259,10.1016/j.virusres.2020.198021,2020-05-18
Patients,LOCATION_OF,"CD69 protein, human",32416259,10.1016/j.virusres.2020.198021,2020-05-18
angiotensin converting enzyme 2,compared_with,Antibodies,32416233,10.1016/j.jpainsymman.2020.05.012,2020-05-18
angiotensin converting enzyme 2,higher_than,Antibodies,32416233,10.1016/j.jpainsymman.2020.05.012,2020-05-18
Communicable Diseases,AFFECTS,Diabetes,32416121,10.1016/j.diabres.2020.108214,2020-05-18
Noncommunicable Diseases,PROCESS_OF,Persons,32416121,10.1016/j.diabres.2020.108214,2020-05-18
Coronavirus Infections,ISA,Disease,32416120,10.1016/j.diabres.2020.108216,2020-05-18
Coronavirus Infections,ISA,Disease,32416120,10.1016/j.diabres.2020.108216,2020-05-18
Co-morbid conditions,PROCESS_OF,Patients,32416116,10.1016/j.kint.2020.05.006,2020-05-18
Hyperglycemia,PREDISPOSES,Poor outcome,32416116,10.1016/j.kint.2020.05.006,2020-05-18
Poor outcome,PROCESS_OF,Patients,32416116,10.1016/j.kint.2020.05.006,2020-05-18
Dipeptidyl-Peptidase IV Inhibitors,TREATS,Patients,32416116,10.1016/j.kint.2020.05.006,2020-05-18
"Kidney Failure, Acute",PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
"Kidney Failure, Acute",PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
"Kidney Failure, Acute",PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
Respiratory Failure,PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
"Kidney Failure, Acute",PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
Diabetes Mellitus,PREDISPOSES,"Kidney Failure, Acute",32416074,10.1016/j.cub.2020.05.023,2020-05-18
"Kidney Failure, Acute",PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
Disease,PROCESS_OF,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
"Kidney Failure, Acute",OCCURS_IN,Patients,32416074,10.1016/j.cub.2020.05.023,2020-05-18
Prognosis bad,COEXISTS_WITH,Respiratory Failure,32416074,10.1016/j.cub.2020.05.023,2020-05-18
Coronavirus Infections,CAUSES,Pneumonia,32416070,10.1016/j.cell.2020.04.026,2020-05-18
Pneumonia,PROCESS_OF,Patients,32416028,10.1111/ene.14329,2020-05-18
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32416028,10.1111/ene.14329,2020-05-18
Neurologic Manifestations,PROCESS_OF,Patients,32416014,10.1111/ced.14289,2020-05-18
Syndrome,PROCESS_OF,Patients,32416014,10.1111/ced.14289,2020-05-18
Cranial Nerves,LOCATION_OF,Symptoms,32416014,10.1111/ced.14289,2020-05-18
Neurologic Manifestations,PROCESS_OF,Patients,32416014,10.1111/ced.14289,2020-05-18
Nose,LOCATION_OF,Associated symptom,32416014,10.1111/ced.14289,2020-05-18
Smell Perception,PROCESS_OF,Patients,32416014,10.1111/ced.14289,2020-05-18
Neurologic Symptoms,PROCESS_OF,Patients,32416014,10.1111/ced.14289,2020-05-18
Direct trauma,CAUSES,Neurologic Symptoms,32416014,10.1111/ced.14289,2020-05-18
Prophylactic treatment,USES,Vaccines,32416014,10.1111/ced.14289,2020-05-18
Family Planning,ISA,Health Services,32415961,10.1093/ajhp/zxaa181,2020-05-18
Congenital Abnormality,ISA,Disease,32415914,10.1111/bjhp.12427,2020-05-18
IMPACT gene,AFFECTS,Possible,32415914,10.1111/bjhp.12427,2020-05-18
Depressive Symptoms,ASSOCIATED_WITH,Disease,32415905,10.1111/tid.13329,2020-05-18
Depressive Symptoms,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32415905,10.1111/tid.13329,2020-05-18
Coronavirus Infections,ISA,Disease,32415905,10.1111/tid.13329,2020-05-18
Coronavirus Infections,ISA,Disease,32415905,10.1111/tid.13329,2020-05-18
Pulmonary Embolism,ISA,Complication,32415893,10.1002/hed.26259,2020-05-18
"Heparin, Low-Molecular-Weight",TREATS,Patients,32415893,10.1002/hed.26259,2020-05-18
Infection,PROCESS_OF,Cancer Patient,32415891,10.1002/hed.26258,2020-05-18
Experience,PROCESS_OF,Patients,32415891,10.1002/hed.26258,2020-05-18
Challenge,TREATS,Practitioner,32415888,10.1111/ene.14327,2020-05-18
Mouth Diseases,AFFECTS,Patients,32415888,10.1111/ene.14327,2020-05-18
Health care facility,LOCATION_OF,Administration occupational activities,32415888,10.1111/ene.14327,2020-05-18
Telemedicine,ISA,Evaluation procedure,32415888,10.1111/ene.14327,2020-05-18
Mouth Diseases,PROCESS_OF,Patients,32415888,10.1111/ene.14327,2020-05-18
Epidemic,ISA,Disease Outbreaks,32415882,10.1002/hed.26257,2020-05-18
Ischemic stroke,PROCESS_OF,Patients,32415882,10.1002/hed.26257,2020-05-18
Malignant Neoplasms,PROCESS_OF,Hospital specialist,32415876,10.1002/mus.26921,2020-05-18
Wall of anterior cranial fossa,LOCATION_OF,Malignant Neoplasms,32415876,10.1002/mus.26921,2020-05-18
Amyotrophic Lateral Sclerosis,PROCESS_OF,Patients,32415869,10.1002/hed.26260,2020-05-18
Amyotrophic Lateral Sclerosis,PROCESS_OF,Patients,32415869,10.1002/hed.26260,2020-05-18
Reduced mobility,PROCESS_OF,Patients,32415869,10.1002/hed.26260,2020-05-18
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32415860,10.1002/hep.31326,2020-05-18
Head and Neck Carcinoma,PROCESS_OF,Patients,32415860,10.1002/hep.31326,2020-05-18
Malignant Neoplasms,PROCESS_OF,teams,32415860,10.1002/hep.31326,2020-05-18
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32415860,10.1002/hep.31326,2020-05-18
GOT1 gene,compared_with,Alanine Transaminase,32415815,10.17305/bjbms.2020.4847,2020-05-18
GOT1 gene,higher_than,Alanine Transaminase,32415815,10.17305/bjbms.2020.4847,2020-05-18
Transaminases,STIMULATES,Alkaline Phosphatase,32415815,10.17305/bjbms.2020.4847,2020-05-18
Transaminases,STIMULATES,Bilirubin,32415815,10.17305/bjbms.2020.4847,2020-05-18
GOT1 gene,PREDISPOSES,Inflammation,32415815,10.17305/bjbms.2020.4847,2020-05-18
GOT1 gene,PREDISPOSES,muscle injury,32415815,10.17305/bjbms.2020.4847,2020-05-18
Atypical Lipoma,PROCESS_OF,Patients,32415815,10.17305/bjbms.2020.4847,2020-05-18
Italy,ISA,Country,32415767,10.33963/KP.15358,2020-05-18
Chronic disease,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
Infected,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
Cardiovascular,LOCATION_OF,Chronic disease,32415753,10.1111/dth.13597,2020-05-18
Protection,PROCESS_OF,Health Personnel,32415753,10.1111/dth.13597,2020-05-18
Aortic Valve Stenosis,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
Mitral Valve Insufficiency,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
Prognosis bad,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
advanced disease,PROCESS_OF,Patients,32415753,10.1111/dth.13597,2020-05-18
Cardiovascular,LOCATION_OF,Chronic disease,32415753,10.1111/dth.13597,2020-05-18
Elective Surgical Procedures,TREATS,Heart valve disease,32415753,10.1111/dth.13597,2020-05-18
Symptoms,PROCESS_OF,Health Personnel,32415727,10.1111/dth.13508,2020-05-18
Hematologic Neoplasms,PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
Malignant Neoplasms,PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
Lymphoma,PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
"Pneumonia, Viral",PREDISPOSES,Severe disorder,32415690,10.1111/bph.15101,2020-05-18
Severe disorder,PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
Hematologic Neoplasms,PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32415690,10.1111/bph.15101,2020-05-18
Diazepam,AFFECTS,Heart tissue,32415658,10.1007/s11605-020-04645-z,2020-05-18
"CD69 protein, human",INTERACTS_WITH,Diazepam,32415658,10.1007/s11605-020-04645-z,2020-05-18
Chloroquine,ADMINISTERED_TO,Rattus norvegicus,32415658,10.1007/s11605-020-04645-z,2020-05-18
Chloroquine,ADMINISTERED_TO,Old World rabbit,32415658,10.1007/s11605-020-04645-z,2020-05-18
Clonazepam,TREATS,Rattus norvegicus,32415658,10.1007/s11605-020-04645-z,2020-05-18
Diazepam,TREATS,Rattus norvegicus,32415658,10.1007/s11605-020-04645-z,2020-05-18
Ro 5-4864,TREATS,Rattus norvegicus,32415658,10.1007/s11605-020-04645-z,2020-05-18
Tension,AFFECTS,refractory period,32415658,10.1007/s11605-020-04645-z,2020-05-18
Clonazepam,AFFECTS,qtc interval,32415658,10.1007/s11605-020-04645-z,2020-05-18
Diazepam,AFFECTS,Heart Contractility,32415658,10.1007/s11605-020-04645-z,2020-05-18
Diazepam,TREATS,Cardiotoxicity,32415658,10.1007/s11605-020-04645-z,2020-05-18
Epinephrine,AFFECTS,Heart Contractility,32415658,10.1007/s11605-020-04645-z,2020-05-18
Diazepam,PREVENTS,Cardiotoxicity,32415658,10.1007/s11605-020-04645-z,2020-05-18
Poor outcome,PROCESS_OF,Cancer Patient,32415585,10.1007/s00330-020-06934-2,2020-05-18
Rectal Carcinoma,PROCESS_OF,Patients,32415585,10.1007/s00330-020-06934-2,2020-05-18
Chest CT,DIAGNOSES,Disease,32415548,10.1186/s13568-020-01028-0,2020-05-18
disease detection,USES,Chest CT,32415548,10.1186/s13568-020-01028-0,2020-05-18
High sensitivity,DIAGNOSES,Disease,32415548,10.1186/s13568-020-01028-0,2020-05-18
Symptoms,PROCESS_OF,Persons,32415519,10.1007/s10900-020-00841-9,2020-05-18
Air,ASSOCIATED_WITH,disease transmission,32415519,10.1007/s10900-020-00841-9,2020-05-18
Food,NEG_PREDISPOSES,Disease,32415519,10.1007/s10900-020-00841-9,2020-05-18
Culicidae,ISA,Arthropods,32415519,10.1007/s10900-020-00841-9,2020-05-18
Ibuprofen,ISA,Pharmaceutical Preparations,32415481,10.1007/s11883-020-00842-y,2020-05-18
Pharmaceutical Preparations,TREATS,Fever,32415481,10.1007/s11883-020-00842-y,2020-05-18
Pharmaceutical Preparations,TREATS,Pain,32415481,10.1007/s11883-020-00842-y,2020-05-18
Pneumonia,MANIFESTATION_OF,Heart Injuries,32415473,10.1007/s11547-020-01217-8,2020-05-18
angiotensin converting enzyme 2,ASSOCIATED_WITH,myocardial injury,32415473,10.1007/s11547-020-01217-8,2020-05-18
Malignant Neoplasms,PROCESS_OF,inpatient,32415472,10.1007/s11547-020-01216-9,2020-05-18
Surgical face mask,USES,disposable,32415472,10.1007/s11547-020-01216-9,2020-05-18
Malignant neoplasm of prostate,PROCESS_OF,Patients,32415426,10.1007/s10943-020-01041-4,2020-05-18
Malignant neoplasm of prostate,PROCESS_OF,Patients,32415426,10.1007/s10943-020-01041-4,2020-05-18
Stereotactic Body Radiotherapy,TREATS,Patients,32415426,10.1007/s10943-020-01041-4,2020-05-18
Stereotactic Body Radiotherapy,TREATS(INFER),Malignant neoplasm of prostate,32415426,10.1007/s10943-020-01041-4,2020-05-18
Genitourinary,LOCATION_OF,Toxic effect,32415426,10.1007/s10943-020-01041-4,2020-05-18
Genitourinary,LOCATION_OF,Toxic effect,32415426,10.1007/s10943-020-01041-4,2020-05-18
Pharmaceutical Preparations,TREATS,Malaria,32415348,10.1007/s00405-020-06037-0,2020-05-18
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32415348,10.1007/s00405-020-06037-0,2020-05-18
Hydroxychloroquine,TREATS(SPEC),Malaria,32415348,10.1007/s00405-020-06037-0,2020-05-18
Cholesteatoma,CAUSES,Complication,32415341,10.1007/s00432-020-03249-z,2020-05-18
Surgical Management,TREATS,Cholesteatoma,32415341,10.1007/s00432-020-03249-z,2020-05-18
Cholesteatoma,PROCESS_OF,Patients,32415341,10.1007/s00432-020-03249-z,2020-05-18
Malignant Neoplasms,PROCESS_OF,Patients,32415305,10.1093/jjco/hyaa077,2020-05-18
Chronic disease,PROCESS_OF,Patients,32415305,10.1093/jjco/hyaa077,2020-05-18
Health Services,TREATS,Patients,32415305,10.1093/jjco/hyaa077,2020-05-18
Health Services,TREATS(INFER),Chronic disease,32415305,10.1093/jjco/hyaa077,2020-05-18
Coronavirus Infections,ISA,Disease,32415272,10.1038/s41431-020-0637-5,2020-05-18
Exhaustion,COEXISTS_WITH,Affected Area,32415272,10.1038/s41431-020-0637-5,2020-05-18
Coronavirus Infections,ISA,Disease,32415272,10.1038/s41431-020-0637-5,2020-05-18
Coronavirus Infections,ISA,Disease,32415272,10.1038/s41431-020-0637-5,2020-05-18
Malignant Neoplasms,PROCESS_OF,Patients,32415272,10.1038/s41431-020-0637-5,2020-05-18
Malignant Neoplasms,PROCESS_OF,Patients,32415272,10.1038/s41431-020-0637-5,2020-05-18
Coronavirus Infections,ISA,Disease,32415272,10.1038/s41431-020-0637-5,2020-05-18
Initiative,PROCESS_OF,Community,32415260,10.1038/s41423-020-0458-z,2020-05-18
Initiative,PROCESS_OF,Partner,32415260,10.1038/s41423-020-0458-z,2020-05-18
Viral Proteins,AFFECTS,Virus Internalization,32415045,10.4103/sjg.SJG_175_20,2020-05-18
Immunization,TREATS,Mus,32415045,10.4103/sjg.SJG_175_20,2020-05-18
RNA Recognition Motif,PART_OF,Virus,32415045,10.4103/sjg.SJG_175_20,2020-05-18
Antibodies,ISA,Pharmaceutical Preparations,32415045,10.4103/sjg.SJG_175_20,2020-05-18
Inflammatory Bowel Diseases,ISA,Disability,32414996,10.4103/0028-3886.283130,2020-05-18
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32414996,10.4103/0028-3886.283130,2020-05-18
Tertiary Care Centers,LOCATION_OF,Cross-Sectional Studies,32414996,10.4103/0028-3886.283130,2020-05-18
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32414996,10.4103/0028-3886.283130,2020-05-18
Biological Response Modifiers,ISA,Biological Factors,32414996,10.4103/0028-3886.283130,2020-05-18
Body Image,ISA,Perception,32414996,10.4103/0028-3886.283130,2020-05-18
Ulcerative Colitis,PROCESS_OF,Patients,32414996,10.4103/0028-3886.283130,2020-05-18
Crohn Disease,PROCESS_OF,Patients,32414996,10.4103/0028-3886.283130,2020-05-18
Disability,PROCESS_OF,Cohort,32414996,10.4103/0028-3886.283130,2020-05-18
Persons,LOCATION_OF,"TLR4 protein, human",32414880,10.1212/WNL.0000000000009744,2020-05-18
World,LOCATION_OF,"TLR4 protein, human",32414880,10.1212/WNL.0000000000009744,2020-05-18
Patients,ISA,Persons,32414839,10.1128/JCM.01094-20,2020-05-18
Epidemic disease,AFFECTS,Research Subject,32414755,10.1212/NXI.0000000000000761,2020-05-18
Therapeutic procedure,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32414716,10.7861/clinmed.2020-0160,2020-05-18
Therapeutic procedure,AFFECTS,Immune response,32414716,10.7861/clinmed.2020-0160,2020-05-18
Insight,PROCESS_OF,Population Group,32414716,10.7861/clinmed.2020-0160,2020-05-18
Coughing,ASSOCIATED_WITH,Disease,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
Fatigue,ASSOCIATED_WITH,Disease,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
Fever,ASSOCIATED_WITH,Disease,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
Cells,INTERACTS_WITH,ACE2 gene,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
Antihypertensive Agents,STIMULATES,ACE2 gene,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
ACE2 gene,PREVENTS,Lung Injury,32414708,10.3949/ccjm.87a.ccc033,2020-05-18
Pharmaceutical Preparations,PREDISPOSES,disease transmission,32414678,10.1016/j.ijom.2020.04.015,2020-05-18
Present,PROCESS_OF,Homo sapiens,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
"M Protein, multiple myeloma",INTERACTS_WITH,"ACE2 protein, human",32414626,10.1016/j.eururo.2020.04.063,2020-05-18
Epithelial Cells,PART_OF,Lung,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
Peptide Hydrolases,AFFECTS,Renin-Angiotensin-Aldosterone System,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
Genetic Polymorphism,PROCESS_OF,human group,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
angiotensin II,PART_OF,Patients,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
Infected,PROCESS_OF,Patients,32414626,10.1016/j.eururo.2020.04.063,2020-05-18
Muscle,LOCATION_OF,"Carcinoma of urinary bladder, invasive",32414623,10.1016/j.wasman.2020.05.006,2020-05-18
"Carcinoma of urinary bladder, invasive",PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
renal cancer metastatic,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Tract,LOCATION_OF,"Carcinoma, Transitional Cell",32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Disease,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Cancer of Urinary Tract,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Clinician,TREATS,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Cancer Intervention,TREATS,Health Personnel,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
"Carcinoma, Transitional Cell",PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Kidney,LOCATION_OF,advanced cancer,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Malignant neoplasm of testis,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Malignant neoplasm of penis,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
advanced cancer,PROCESS_OF,Patients,32414623,10.1016/j.wasman.2020.05.006,2020-05-18
Respiratory Tract Infections,CAUSES,Acute myocardial infarction,32414594,10.1016/j.jtcvs.2020.04.005,2020-05-18
Respiratory Tract Infections,CAUSES,Acute Cerebrovascular Accidents,32414594,10.1016/j.jtcvs.2020.04.005,2020-05-18
alteplase,TREATS,Patients,32414594,10.1016/j.jtcvs.2020.04.005,2020-05-18
Ischemic stroke,PROCESS_OF,Patients,32414594,10.1016/j.jtcvs.2020.04.005,2020-05-18
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32414544,10.1053/j.jvca.2020.03.059,2020-05-18
Leukocytosis,PROCESS_OF,Patients,32414544,10.1053/j.jvca.2020.03.059,2020-05-18
Eosinopenia,PROCESS_OF,Patients,32414544,10.1053/j.jvca.2020.03.059,2020-05-18
Serum,LOCATION_OF,Antibodies,32414544,10.1053/j.jvca.2020.03.059,2020-05-18
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32414544,10.1053/j.jvca.2020.03.059,2020-05-18
Thoracic Surgical Procedures,TREATS,Coronavirus Infections,32414539,10.1016/j.bjoms.2020.04.035,2020-05-18
Infected,PROCESS_OF,Patients,32414539,10.1016/j.bjoms.2020.04.035,2020-05-18
Oral and Maxillofacial Surgeons,ISA,Surgeon,32414522,10.1016/j.ajem.2020.05.015,2020-05-18
Infected,PROCESS_OF,Surgeon,32414522,10.1016/j.ajem.2020.05.015,2020-05-18
Infected,PROCESS_OF(SPEC),Oral and Maxillofacial Surgeons,32414522,10.1016/j.ajem.2020.05.015,2020-05-18
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32414407,10.1186/s40463-020-00427-4,2020-05-18
Rhabdomyolysis,PROCESS_OF,Patients,32414407,10.1186/s40463-020-00427-4,2020-05-18
Coronavirus Infections,ISA,Disease,32414390,10.1186/s13017-020-00312-5,2020-05-18
Disease,PROCESS_OF,member,32414390,10.1186/s13017-020-00312-5,2020-05-18
Coronavirus Infections,ISA,Disease,32414390,10.1186/s13017-020-00312-5,2020-05-18
Infected,PROCESS_OF,Patients,32414390,10.1186/s13017-020-00312-5,2020-05-18
Coronavirus Infections,ISA,Disease,32414390,10.1186/s13017-020-00312-5,2020-05-18
Otolaryngologist,ISA,Health Personnel,32414390,10.1186/s13017-020-00312-5,2020-05-18
Coronavirus Infections,ISA,Disease,32414390,10.1186/s13017-020-00312-5,2020-05-18
Coronavirus Infections,ISA,Disease,32414390,10.1186/s13017-020-00312-5,2020-05-18
Coronavirus Infections,NEG_PROCESS_OF,Homo sapiens,32414384,10.1186/s12939-020-01190-8,2020-05-18
Wounds and Injuries,PROCESS_OF,Patients,32414384,10.1186/s12939-020-01190-8,2020-05-18
Wounds and Injuries,PROCESS_OF,Patients,32414384,10.1186/s12939-020-01190-8,2020-05-18
Wounds and Injuries,PROCESS_OF,Patients,32414384,10.1186/s12939-020-01190-8,2020-05-18
Emergency operation,COEXISTS_WITH,Emergency medical service,32414384,10.1186/s12939-020-01190-8,2020-05-18
Biological Markers,PREDISPOSES,Disease,32414379,10.1186/s12992-020-00574-3,2020-05-18
Caring,PROCESS_OF,Medical Staff,32414291,10.1089/AID.2020.0095,2020-05-18
Coughing,PROCESS_OF,Patients,32414291,10.1089/AID.2020.0095,2020-05-18
Malaise,PROCESS_OF,Health Personnel,32414291,10.1089/AID.2020.0095,2020-05-18
Protection,PROCESS_OF,Family,32414291,10.1089/AID.2020.0095,2020-05-18
Protection,PROCESS_OF,Health Personnel,32414291,10.1089/AID.2020.0095,2020-05-18
HIV,PROCESS_OF,Professional Counselor,32414291,10.1089/AID.2020.0095,2020-05-18
Screening procedure,ADMINISTERED_TO,Health Personnel,32414291,10.1089/AID.2020.0095,2020-05-18
Contacts,ADMINISTERED_TO,Health Personnel,32414291,10.1089/AID.2020.0095,2020-05-18
Motivation,PROCESS_OF,Staff,32414291,10.1089/AID.2020.0095,2020-05-18
Clinical Trials,USES,Immunization,32414230,10.23736/S0031-0808.20.03938-5,2020-05-18
Cognition,PROCESS_OF,Homo sapiens,32414126,10.3390/ijerph17103399,2020-05-18
Decision,PROCESS_OF,Maker (occupation),32414126,10.3390/ijerph17103399,2020-05-18
Disease,PROCESS_OF,Patients,32414013,10.3390/ijerph17103387,2020-05-18
Oral Surgical Procedures,COEXISTS_WITH,follow-up,32414013,10.3390/ijerph17103387,2020-05-18
Autism Spectrum Disorders,NEG_ISA,Disease,32413914,10.1055/a-1164-6611,2020-05-16
Autism Spectrum Disorders,PROCESS_OF,Persons,32413914,10.1055/a-1164-6611,2020-05-16
Autism Spectrum Disorders,PROCESS_OF,Persons,32413914,10.1055/a-1164-6611,2020-05-16
Self-Perception,PROCESS_OF,Persons,32413914,10.1055/a-1164-6611,2020-05-16
Decision,PROCESS_OF,Maker (occupation),32413821,10.1016/j.dsx.2020.05.008,2020-05-16
Household composition,PROCESS_OF,Persons,32413819,10.1016/j.dsx.2020.04.050,2020-05-16
Calcifediol,TREATS,African race,32413736,10.1016/j.intimp.2020.106560,2020-05-16
Calcifediol,TREATS,South Asian,32413736,10.1016/j.intimp.2020.106560,2020-05-16
Coronavirus Infections,CAUSES,Disease,32413707,10.1016/j.psychres.2020.113069,2020-05-16
Antibodies,PART_OF,Patients,32413707,10.1016/j.psychres.2020.113069,2020-05-16
Patients,LOCATION_OF,Antibodies,32413707,10.1016/j.psychres.2020.113069,2020-05-16
Patients,LOCATION_OF,Plasma,32413707,10.1016/j.psychres.2020.113069,2020-05-16
Adrenal Cortex Hormones,DISRUPTS,Cessation of life,32413707,10.1016/j.psychres.2020.113069,2020-05-16
tocilizumab,TREATS,Patients,32413707,10.1016/j.psychres.2020.113069,2020-05-16
tocilizumab,TREATS(INFER),High Level,32413707,10.1016/j.psychres.2020.113069,2020-05-16
High Level,PROCESS_OF,Patients,32413707,10.1016/j.psychres.2020.113069,2020-05-16
Comorbidity,PROCESS_OF,Patients,32413655,10.1016/j.scitotenv.2020.139052,2020-05-16
SARS coronavirus,CAUSES,Disease,32413655,10.1016/j.scitotenv.2020.139052,2020-05-16
mental health,PROCESS_OF,Clinician,32413655,10.1016/j.scitotenv.2020.139052,2020-05-16
Maker (occupation),USES,Health Policy,32413655,10.1016/j.scitotenv.2020.139052,2020-05-16
Interleukin-1,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32413617,10.1016/j.ajp.2020.102156,2020-05-16
Interleukin-6,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32413617,10.1016/j.ajp.2020.102156,2020-05-16
Lentinula edodes,ISA,Agaricales,32413617,10.1016/j.ajp.2020.102156,2020-05-16
macrophage,LOCATION_OF,Phagocytosis,32413617,10.1016/j.ajp.2020.102156,2020-05-16
Lentinan,DISRUPTS,Cytokine Signaling Process,32413617,10.1016/j.ajp.2020.102156,2020-05-16
Coronavirus Infections,ISA,Disease,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Psychosocial problem,COEXISTS_WITH,Disease,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Psychosocial problem,COEXISTS_WITH(SPEC),Coronavirus Infections,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Disease,COEXISTS_WITH,Anxiety,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Disease,COEXISTS_WITH,Social stigmata,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Coronavirus Infections,COEXISTS_WITH(SPEC),Anxiety,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Coronavirus Infections,COEXISTS_WITH(SPEC),Social stigmata,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Coronavirus Infections,ISA,Disease,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Substance Use Disorders,PROCESS_OF,Persons,32413616,10.1016/j.ajp.2020.102085,2020-05-16
Coronavirus Infections,ISA,Disease,32413608,10.1016/j.ijid.2020.05.013,2020-05-16
Detection,PREVENTS,Severe Acute Respiratory Syndrome,32413608,10.1016/j.ijid.2020.05.013,2020-05-16
HIV,LOCATION_OF,IMPACT gene,32413554,10.1016/j.brs.2020.05.010,2020-05-16
HIV,LOCATION_OF,IMPACT gene,32413554,10.1016/j.brs.2020.05.010,2020-05-16
consideration,COEXISTS_WITH,Enthesitis-Related Arthritis,32413527,10.1016/j.radonc.2020.04.061,2020-05-16
Comorbidity,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
diabetic,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
diabetic,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Obesity,PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Ketosis,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
diabetic,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Metformin,PREDISPOSES,"Acidosis, Lactic",32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Metformin,PREDISPOSES,Ketosis,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Sodium-Glucose Transporter 2 Inhibitors [MoA],PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Diabetes,PROCESS_OF,Patients,32413330,10.1016/j.immuni.2020.04.023,2020-05-16
Cellular Immunity,PROCESS_OF,Patients,32413319,10.1016/j.cell.2020.04.035,2020-05-16
Patients,LOCATION_OF,Blood,32413319,10.1016/j.cell.2020.04.035,2020-05-16
Immunoglobulin G,ISA,Antibodies,32413319,10.1016/j.cell.2020.04.035,2020-05-16
"Vitronectin, human",INTERACTS_WITH,angiotensin converting enzyme 2,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Cells,INTERACTS_WITH,angiotensin converting enzyme 2,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Homo sapiens,ISA,Primates,32413300,10.1016/j.cell.2020.04.013,2020-05-16
RNA Sequence,ISA,Base Sequence,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Type-II Pneumocytes,LOCATION_OF,angiotensin converting enzyme 2,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Type-II Pneumocytes,LOCATION_OF,TMPRSS2 gene,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Type-II Pneumocytes,PART_OF,Lung,32413300,10.1016/j.cell.2020.04.013,2020-05-16
angiotensin converting enzyme 2,STIMULATES,Epithelial Cells,32413300,10.1016/j.cell.2020.04.013,2020-05-16
Interferons,STIMULATES,Up-Regulation (Physiology),32413300,10.1016/j.cell.2020.04.013,2020-05-16
Single-Domain Antibodies,INTERACTS_WITH,Epitopes,32413270,10.1177/1942602X20925031,2020-05-16
Single-Domain Antibodies,PART_OF,Homo sapiens,32413270,10.1177/1942602X20925031,2020-05-16
Isolation procedure,USES,Antibodies,32413270,10.1177/1942602X20925031,2020-05-16
Coronavirus Infections,ISA,Disease,32413201,10.1111/pai.13278,2020-05-16
Rules of conduct,AFFECTS,School,32413201,10.1111/pai.13278,2020-05-16
Serologic tests,USES,Immunoglobulins,32413158,10.1111/head.13841,2020-05-16
Asymptomatic,PROCESS_OF,Persons,32413158,10.1111/head.13841,2020-05-16
Antibody Formation,PROCESS_OF,Staff Member,32413158,10.1111/head.13841,2020-05-16
Enzyme-Linked Immunosorbent Assay,METHOD_OF,Laboratory Procedures,32413158,10.1111/head.13841,2020-05-16
Symptoms,PROCESS_OF,Study Subject,32413158,10.1111/head.13841,2020-05-16
Asymptomatic,PROCESS_OF,contact person,32413158,10.1111/head.13841,2020-05-16
Immune response,NEG_ISA,contextual factors,32413158,10.1111/head.13841,2020-05-16
Intracranial,LOCATION_OF,Noncommunicable Diseases,32413112,10.1001/jamanetworkopen.2020.11102,2020-05-16
Group Psychotherapy,TREATS,Enthesitis-Related Arthritis,32412909,10.2196/20110,2020-05-16
Coronavirus Infections,ISA,Disease,32412897,10.3201/eid2609.201353,2020-05-16
medicare/medicaid,LOCATION_OF,Services,32412897,10.3201/eid2609.201353,2020-05-16
Dementia,PROCESS_OF,Persons,32412897,10.3201/eid2609.201353,2020-05-16
Coronavirus Infections,ISA,Disease,32412896,10.3201/eid2608.200633,2020-05-16
Coronavirus Infections,ISA,Disease,32412896,10.3201/eid2608.200633,2020-05-16
Direct trauma,COEXISTS_WITH,Disorder of lower respiratory system,32412896,10.3201/eid2608.200633,2020-05-16
Disorder of lower respiratory system,ISA,Disease,32412896,10.3201/eid2608.200633,2020-05-16
Entire eye,LOCATION_OF,SARS coronavirus,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Coronavirus Infections,CAUSES,Cessation of life,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Present,PROCESS_OF,Patients,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Older people,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Anti-Anxiety Agents,PREVENTS,Storm NOS,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Hyperbaric oxygenation therapy,ADMINISTERED_TO,Patients,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Tachypnea,PROCESS_OF,Patients,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Oxygen saturation below reference range,PROCESS_OF,Patients,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Hyperbaric oxygenation therapy,TREATS,Disease,32412815,10.1080/0142159X.2020.1762851,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412790,10.2214/AJR.20.23418,2020-05-16
Therapeutic procedure,TREATS,Patients,32412790,10.2214/AJR.20.23418,2020-05-16
follow-up,COEXISTS_WITH,Pharmacotherapy,32412790,10.2214/AJR.20.23418,2020-05-16
follow-up,COEXISTS_WITH,Immunotherapy,32412790,10.2214/AJR.20.23418,2020-05-16
Prostate,PART_OF,Patients,32412790,10.2214/AJR.20.23418,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412790,10.2214/AJR.20.23418,2020-05-16
Italy,ISA,Geographic Locations,32412679,10.1111/dth.13591,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412679,10.1111/dth.13591,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412679,10.1111/dth.13591,2020-05-16
cancer care,TREATS,Patients,32412679,10.1111/dth.13591,2020-05-16
Malignant neoplasm of breast,PROCESS_OF,Patients,32412679,10.1111/dth.13591,2020-05-16
Patients,ISA,Persons,32412679,10.1111/dth.13591,2020-05-16
Malignant neoplasm of breast,PROCESS_OF,Patients,32412679,10.1111/dth.13591,2020-05-16
Triage,TREATS,teams,32412679,10.1111/dth.13591,2020-05-16
Virus,CAUSES,Infection,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Infection,PROCESS_OF,Camels,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Infection,PROCESS_OF,Chiroptera,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Infection,PROCESS_OF,Homo sapiens,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Direct trauma,CAUSES,Symptoms,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Systemic disease,CAUSES,Neurologic Symptoms,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Neurological observations,PROCESS_OF,Homo sapiens,32412631,10.1093/eurheartj/ehaa409,2020-05-16
Observation - diagnostic procedure,AFFECTS,Patient Admission,32412556,10.1016/j.chaos.2020.109888,2020-05-16
Hospital admission,TREATS,Acute myocardial infarction,32412556,10.1016/j.chaos.2020.109888,2020-05-16
receptor,INHIBITS,Peptide Hydrolases,32412538,10.1007/s41870-020-00466-0,2020-05-16
Coronavirus Infections,CAUSES,Communicable Diseases,32412532,10.1007/s10049-020-00709-4,2020-05-16
Influenza,PROCESS_OF,Hispanics,32412532,10.1007/s10049-020-00709-4,2020-05-16
Clinic,LOCATION_OF,Training,32412522,10.1007/s10669-020-09773-0,2020-05-16
Diagnostic tests,USES,Quick Test for Liver Function,32412422,10.2196/19367,2020-05-16
Old age,ISA,Population Group,32412422,10.2196/19367,2020-05-16
Interleukin-6,ISA,Agent,32412422,10.2196/19367,2020-05-16
tocilizumab,ISA,Agent,32412422,10.2196/19367,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Disease,PROCESS_OF,Patients,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412418,10.2196/19447,2020-05-16
Coronavirus Infections,ISA,Disease,32412416,10.2196/19437,2020-05-16
Coronavirus Infections,ISA,Disease,32412416,10.2196/19437,2020-05-16
Household composition,PROCESS_OF,Homo sapiens,32412416,10.2196/19437,2020-05-16
Coronavirus Infections,ISA,Disease,32412415,10.2196/19170,2020-05-16
Disease,PROCESS_OF,Patients,32412415,10.2196/19170,2020-05-16
Disease,PROCESS_OF,Patients,32412415,10.2196/19170,2020-05-16
Coronavirus Infections,ISA,Disease,32412415,10.2196/19170,2020-05-16
Coronavirus Infections,ISA,Disease,32412415,10.2196/19170,2020-05-16
Coronavirus Infections,ISA,Disease,32412415,10.2196/19170,2020-05-16
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32412415,10.2196/19170,2020-05-16
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32412415,10.2196/19170,2020-05-16
Disease,COEXISTS_WITH,Enthesitis-Related Arthritis,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,COEXISTS_WITH(SPEC),Enthesitis-Related Arthritis,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,ISA,Disease,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,ISA,Disease,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,ISA,Disease,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,ISA,Disease,32412403,10.1017/ice.2020.238,2020-05-16
Coronavirus Infections,ISA,Disease,32412403,10.1017/ice.2020.238,2020-05-16
Engaged to be married,PROCESS_OF,user - individual,32412403,10.1017/ice.2020.238,2020-05-16
Disease,AFFECTS,Persons,32412403,10.1017/ice.2020.238,2020-05-16
Conjunctivitis,PROCESS_OF,Patients,32412401,10.1192/bjp.2020.106,2020-05-16
Serious mental illness,PROCESS_OF,Elderly (population group),32412313,10.1302/0301-620X.102B7.BJJ-2020-0808,2020-05-16
self-management skills,PROCESS_OF,Clients,32412313,10.1302/0301-620X.102B7.BJJ-2020-0808,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412308,10.1080/01459740.2020.1761352,2020-05-16
Malignant Neoplasms,PROCESS_OF,Male population group,32412308,10.1080/01459740.2020.1761352,2020-05-16
Malignant neoplasm of prostate,ISA,Malignant Neoplasms,32412308,10.1080/01459740.2020.1761352,2020-05-16
Malignant neoplasm of prostate,PROCESS_OF(SPEC),Male population group,32412308,10.1080/01459740.2020.1761352,2020-05-16
Pharmacotherapy,ADMINISTERED_TO,Patients,32412308,10.1080/01459740.2020.1761352,2020-05-16
Metastatic Prostate Carcinoma,PROCESS_OF,Patients,32412308,10.1080/01459740.2020.1761352,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32412308,10.1080/01459740.2020.1761352,2020-05-16
Metastatic Prostate Carcinoma,PROCESS_OF,Patients,32412308,10.1080/01459740.2020.1761352,2020-05-16
Noncommunicable Diseases,PREDISPOSES,Complication,32412303,10.1152/ajprenal.00160.2020,2020-05-16
Coronavirus Infections,ISA,Disease,32412303,10.1152/ajprenal.00160.2020,2020-05-16
"ACE2 protein, human",DISRUPTS,Homeostasis,32412231,10.1021/acsinfecdis.0c00265,2020-05-16
Benzalkonium Chloride,ISA,Quaternary Ammonium Compounds,32412159,10.1111/ajt.16062,2020-05-16
Immunocompromised Host,PREDISPOSES,Complication,32412158,10.1111/ijcp.13535,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32412158,10.1111/ijcp.13535,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32412158,10.1111/ijcp.13535,2020-05-16
Fever,ISA,Symptoms,32412158,10.1111/ijcp.13535,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32412158,10.1111/ijcp.13535,2020-05-16
Inflammation,COEXISTS_WITH,Severe disorder,32412156,10.1002/ejhf.1871,2020-05-16
Interleukin-6,CAUSES(SPEC),Inflammation,32412156,10.1002/ejhf.1871,2020-05-16
Interleukin-6,ISA,cytokine,32412156,10.1002/ejhf.1871,2020-05-16
Tumor Necrosis Factors,CAUSES(SPEC),Inflammation,32412156,10.1002/ejhf.1871,2020-05-16
Tumor Necrosis Factors,ISA,cytokine,32412156,10.1002/ejhf.1871,2020-05-16
cytokine,CAUSES,Inflammation,32412156,10.1002/ejhf.1871,2020-05-16
Virus Replication,AFFECTS,inflammatory response,32412156,10.1002/ejhf.1871,2020-05-16
Indomethacin,PREVENTS,"Coronavirus, Canine",32412156,10.1002/ejhf.1871,2020-05-16
"Coronavirus, Canine",PROCESS_OF,Canis familiaris,32412156,10.1002/ejhf.1871,2020-05-16
Cardiovascular Diseases,PROCESS_OF,Patients,32412125,10.1002/ddr.21688,2020-05-16
Severe clinical course,PROCESS_OF,Patients,32412125,10.1002/ddr.21688,2020-05-16
Heart,LOCATION_OF,concomitant disease,32412125,10.1002/ddr.21688,2020-05-16
Fever,ISA,Infection,32412125,10.1002/ddr.21688,2020-05-16
Myocarditis,PROCESS_OF,Patients,32412125,10.1002/ddr.21688,2020-05-16
angiotensin converting enzyme 2,STIMULATES,angiotensin II,32412125,10.1002/ddr.21688,2020-05-16
Heart Diseases,PROCESS_OF,Patients,32412125,10.1002/ddr.21688,2020-05-16
Patients,LOCATION_OF,angiotensin converting enzyme 2,32412125,10.1002/ddr.21688,2020-05-16
angiotensin II,AFFECTS,Vascular constriction (function),32412125,10.1002/ddr.21688,2020-05-16
Angiotensin-Converting Enzyme Inhibitors,TREATS,Coronavirus Infections,32412125,10.1002/ddr.21688,2020-05-16
Angiotensin II receptor antagonist,TREATS,Coronavirus Infections,32412125,10.1002/ddr.21688,2020-05-16
Endopeptidases,PART_OF,integral to membrane,32412101,10.1111/head.13856,2020-05-16
Androgen Receptor,INTERACTS_WITH,Endopeptidases,32412101,10.1111/head.13856,2020-05-16
"M Protein, multiple myeloma",PART_OF,Virus,32412101,10.1111/head.13856,2020-05-16
Polycystic Ovary Syndrome,AFFECTS,Variation (Genetics),32412101,10.1111/head.13856,2020-05-16
Androgenetic Alopecia,AFFECTS,Variation (Genetics),32412101,10.1111/head.13856,2020-05-16
Malignant neoplasm of prostate,AFFECTS,Variation (Genetics),32412101,10.1111/head.13856,2020-05-16
Benign Prostatic Hyperplasia,AFFECTS,Variation (Genetics),32412101,10.1111/head.13856,2020-05-16
Coughing,ASSOCIATED_WITH,Coronavirus Infections,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Dyspnea,ASSOCIATED_WITH,Coronavirus Infections,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Fever,ASSOCIATED_WITH,Coronavirus Infections,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Headache,ISA,Neurological observations,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Forehead,LOCATION_OF,new onset,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Periorbital region,LOCATION_OF,new onset,32412096,10.1002/14651858.CD011621.pub5,2020-05-16
Diazooxonorleucine,AUGMENTS,Compliance,32412088,10.1111/ane.13266,2020-05-16
Diazooxonorleucine,ADMINISTERED_TO,Health Personnel,32412088,10.1111/ane.13266,2020-05-16
"Respirators, Air-Purifying",compared_with,Masks,32412088,10.1111/ane.13266,2020-05-16
"Respirators, Air-Purifying",higher_than,Masks,32412088,10.1111/ane.13266,2020-05-16
Gown,compared_with,Apron,32412088,10.1111/ane.13266,2020-05-16
Gown,higher_than,Apron,32412088,10.1111/ane.13266,2020-05-16
Covers (device),compared_with,RAB3IL1 gene,32412088,10.1111/ane.13266,2020-05-16
Hand,LOCATION_OF,Isopropyl Alcohol,32412088,10.1111/ane.13266,2020-05-16
Extraction,USES,Gown,32412088,10.1111/ane.13266,2020-05-16
Anosmia,ISA,Neurologic Manifestations,32412064,10.1093/jtm/taaa076,2020-05-16
Headache,ISA,Neurologic Manifestations,32412064,10.1093/jtm/taaa076,2020-05-16
Sequela of disorder,PROCESS_OF,Patients,32412064,10.1093/jtm/taaa076,2020-05-16
Laser ablation,USES,Hydrogen Peroxide,32412013,10.1016/j.fsisyn.2020.03.007,2020-05-16
Communicable Diseases,CAUSES,Cessation of life,32411943,10.1016/j.pulmoe.2020.05.002,2020-05-16
Disease,PROCESS_OF,Cohort,32411941,10.31138/mjr.31.1.94,2020-05-16
Tuberculosis,PROCESS_OF,Cohort,32411941,10.31138/mjr.31.1.94,2020-05-16
Sequela of disorder,PROCESS_OF,Cohort,32411941,10.31138/mjr.31.1.94,2020-05-16
Tuberculosis,PROCESS_OF,hospitalized patients,32411941,10.31138/mjr.31.1.94,2020-05-16
Comorbidity,PROCESS_OF,geriatric patients,32411941,10.31138/mjr.31.1.94,2020-05-16
Tuberculosis,NEG_PREDISPOSES,Severe (severity modifier),32411941,10.31138/mjr.31.1.94,2020-05-16
Pharmaceutical Preparations,TREATS,Autoimmune Diseases,32411822,10.1136/tsaco-2020-000498,2020-05-16
Hydroxychloroquine,TREATS,Severe Acute Respiratory Syndrome,32411822,10.1136/tsaco-2020-000498,2020-05-16
Pneumonia,PROCESS_OF,Patients,32411822,10.1136/tsaco-2020-000498,2020-05-16
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32411822,10.1136/tsaco-2020-000498,2020-05-16
Hydroxychloroquine,TREATS,Pneumonia,32411822,10.1136/tsaco-2020-000498,2020-05-16
bony process,PART_OF,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Pneumonia,PROCESS_OF,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Pneumonia,PROCESS_OF,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Combined Modality Therapy,ADMINISTERED_TO,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Gamma globulin,ADMINISTERED_TO,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Hormone Therapy,ADMINISTERED_TO,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Severe disorder,PROCESS_OF,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Pneumonia,PROCESS_OF,Patients,32411751,10.21037/atm.2020.04.26,2020-05-16
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Genus: Coronavirus,32411652,10.3389/fpubh.2020.00152,2020-05-16
Middle East Respiratory Syndrome,COEXISTS_WITH,Genus: Coronavirus,32411652,10.3389/fpubh.2020.00152,2020-05-16
treatment options,TREATS,Respiratory Tract Infections,32411575,10.1016/j.jand.2020.05.012,2020-05-16
Polyomavirus,PROCESS_OF,Homo sapiens,32411575,10.1016/j.jand.2020.05.012,2020-05-16
Human coronavirus HKU1,ISA,Human coronavirus,32411575,10.1016/j.jand.2020.05.012,2020-05-16
Point-of-Care Testing,TREATS,Respiratory Tract Infections,32411575,10.1016/j.jand.2020.05.012,2020-05-16
Elderly (population group),ISA,Persons,32411566,10.7759/cureus.8069,2020-05-16
Comorbidity,PROCESS_OF,Persons,32411566,10.7759/cureus.8069,2020-05-16
Comorbidity,PROCESS_OF(SPEC),Elderly (population group),32411566,10.7759/cureus.8069,2020-05-16
Nutrition management,TREATS,Adult,32411566,10.7759/cureus.8069,2020-05-16
"Dietitian, Registered",ISA,Nutritionist,32411566,10.7759/cureus.8069,2020-05-16
"Dietitian, Registered",ISA,Nutritionist,32411566,10.7759/cureus.8069,2020-05-16
Calcium Channel Blockers,ISA,Agent,32411552,10.7759/cureus.7651,2020-05-16
Clinical Management,USES,Calcium Channel Blockers,32411552,10.7759/cureus.7651,2020-05-16
Calcium Channel Blockers,TREATS,hospitalized patients,32411552,10.7759/cureus.7651,2020-05-16
Virus Diseases,CAUSES,Cessation of life,32411552,10.7759/cureus.7651,2020-05-16
Nifedipine,ADMINISTERED_TO,Patients,32411552,10.7759/cureus.7651,2020-05-16
Amlodipine,ADMINISTERED_TO,Patients,32411552,10.7759/cureus.7651,2020-05-16
Calcium Channel Blockers,TREATS,Patients,32411552,10.7759/cureus.7651,2020-05-16
Intubation,TREATS,Patients,32411552,10.7759/cureus.7651,2020-05-16
Mechanical ventilation,TREATS,Patients,32411552,10.7759/cureus.7651,2020-05-16
Intubation,TREATS,geriatric patients,32411552,10.7759/cureus.7651,2020-05-16
Mechanical ventilation,TREATS,geriatric patients,32411552,10.7759/cureus.7651,2020-05-16
Hypertensive disease,PROCESS_OF,geriatric patients,32411552,10.7759/cureus.7651,2020-05-16
Eye,LOCATION_OF,Coronavirus Infections,32411496,10.1016/j.cdtm.2020.05.002,2020-05-16
Mental disorders,PROCESS_OF,Patients,32411396,10.15420/cfr.2020.07,2020-05-16
Complication,PROCESS_OF,Patients,32411396,10.15420/cfr.2020.07,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32411396,10.15420/cfr.2020.07,2020-05-16
new therapy,PROCESS_OF,Patients,32411315,10.1016/j.waojou.2020.100125,2020-05-16
new therapy,PROCESS_OF,Research Personnel,32411315,10.1016/j.waojou.2020.100125,2020-05-16
new therapy,PROCESS_OF,Clinician,32411315,10.1016/j.waojou.2020.100125,2020-05-16
Vision,PROCESS_OF,Patients,32411313,10.1016/j.chom.2020.05.007,2020-05-16
Metered Dose Inhaler,USES,Bronchodilator Agents,32411313,10.1016/j.chom.2020.05.007,2020-05-16
Nebulizers,TREATS,disease transmission,32411313,10.1016/j.chom.2020.05.007,2020-05-16
Metered dose inhaler therapy,TREATS,Patients,32411313,10.1016/j.chom.2020.05.007,2020-05-16
Interleukin-6,AFFECTS,Complication,32411310,10.1016/j.jiph.2020.05.003,2020-05-16
Pneumonia,PROCESS_OF,Patients,32411310,10.1016/j.jiph.2020.05.003,2020-05-16
Vasoconstrictor Agents,AFFECTS,Respiration,32411310,10.1016/j.jiph.2020.05.003,2020-05-16
anakinra,TREATS,Patients,32411310,10.1016/j.jiph.2020.05.003,2020-05-16
Provincial hospital,LOCATION_OF,Retrospective Studies,32411271,10.1016/j.jsxm.2020.05.001,2020-05-16
Isolation procedure,AFFECTS,Chronic mental disorder,32411034,10.3389/fpsyt.2020.00386,2020-05-16
Anxiety,PROCESS_OF,Medical Staff,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Depressive Symptoms,PROCESS_OF,Medical Staff,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Anxiety,PROCESS_OF,Physicians,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Depressive Symptoms,PROCESS_OF,Physicians,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Anxiety symptoms,PROCESS_OF,Physicians,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Anxiety,PROCESS_OF,Nurses,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Depressive Symptoms,PROCESS_OF,Nurses,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Anxiety,ISA,Anxiety symptoms,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Depressive Symptoms,PROCESS_OF,Nurses,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Anxiety,PROCESS_OF,Medical Staff,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Depressive Symptoms,PROCESS_OF,Medical Staff,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Personal status - Adopted,PROCESS_OF,Medical Staff,32410913,10.1016/j.cppeds.2020.100795,2020-05-16
Comorbidity,PROCESS_OF,Older people,32410896,10.5455/msm.2020.32.71-76,2020-05-16
Disease,PROCESS_OF,Adult,32410896,10.5455/msm.2020.32.71-76,2020-05-16
Cardiovascular Diseases,PROCESS_OF,World,32410816,10.1016/j.radi.2020.05.003,2020-05-16
Chronic disease,PROCESS_OF,World,32410816,10.1016/j.radi.2020.05.003,2020-05-16
Cardiovascular Diseases,PROCESS_OF,World,32410816,10.1016/j.radi.2020.05.003,2020-05-16
Vaccines,ASSOCIATED_WITH,Ataxia Telangiectasia,32410816,10.1016/j.radi.2020.05.003,2020-05-16
Complication,PROCESS_OF,Patients,32410807,10.1016/j.jstrokecerebrovasdis.2020.104949,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32410807,10.1016/j.jstrokecerebrovasdis.2020.104949,2020-05-16
Tertiary Care Centers,LOCATION_OF,New Diagnosis Procedure,32410807,10.1016/j.jstrokecerebrovasdis.2020.104949,2020-05-16
Health Services,TREATS,Symptom mild,32410807,10.1016/j.jstrokecerebrovasdis.2020.104949,2020-05-16
Vascular occlusion,CAUSES,Cerebrovascular accident,32410807,10.1016/j.jstrokecerebrovasdis.2020.104949,2020-05-16
Cerebrovascular Disorders,PROCESS_OF,Patients,32410788,10.1016/j.jocn.2020.05.016,2020-05-16
Pneumonia,PROCESS_OF,Patients,32410788,10.1016/j.jocn.2020.05.016,2020-05-16
Poor outcome,PROCESS_OF,Patients,32410788,10.1016/j.jocn.2020.05.016,2020-05-16
Cardiovascular,LOCATION_OF,Cerebrovascular Disorders,32410788,10.1016/j.jocn.2020.05.016,2020-05-16
Poor outcome,COEXISTS_WITH,Cerebrovascular Disorders,32410788,10.1016/j.jocn.2020.05.016,2020-05-16
Symptoms,PROCESS_OF,Patients,32410773,10.1016/j.rmr.2020.05.001,2020-05-16
Pneumonia,PROCESS_OF,Patients,32410772,10.1016/j.biopha.2020.110267,2020-05-16
Lesion,PROCESS_OF,Patients,32410772,10.1016/j.biopha.2020.110267,2020-05-16
other medicated shampoos in ATC,CAUSES,Dyspnea,32410772,10.1016/j.biopha.2020.110267,2020-05-16
Vaccines,TREATS,Virus,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
Antimalarials,ISA,Pharmaceutical Preparations,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
chloroquine phosphate,ISA,Pharmaceutical Preparations,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
Anti-HIV Agents,COEXISTS_WITH,lopinavir / Ritonavir,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
Storm NOS,PROCESS_OF,Persons,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
cytokine,ISA,Pharmaceutical Preparations,32410765,10.1016/j.nrl.2020.05.004,2020-05-16
Headache,PROCESS_OF,Patients,32410760,10.1016/S0140-6736(20)31103-X,2020-05-16
Neuralgia,PROCESS_OF,Patients,32410760,10.1016/S0140-6736(20)31103-X,2020-05-16
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32410751,10.1007/s12088-020-00882-7,2020-05-16
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32410751,10.1007/s12088-020-00882-7,2020-05-16
IMPACT gene,INTERACTS_WITH,angiotensin converting enzyme 2,32410723,10.4269/ajtmh.20-0405,2020-05-16
Ground Glass Opacity,COEXISTS_WITH,Pneumonia,32410714,10.1186/s13054-020-02939-x,2020-05-16
Critical Illness,PROCESS_OF,Patients,32410706,10.1186/s13049-020-00734-9,2020-05-16
intensive care unit,LOCATION_OF,Multicenter Study,32410706,10.1186/s13049-020-00734-9,2020-05-16
multiple pathologies,PROCESS_OF,Patients,32410706,10.1186/s13049-020-00734-9,2020-05-16
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32410706,10.1186/s13049-020-00734-9,2020-05-16
Therapeutic procedure,ADMINISTERED_TO,inpatient,32410706,10.1186/s13049-020-00734-9,2020-05-16
Malaise,PROCESS_OF,inpatient,32410706,10.1186/s13049-020-00734-9,2020-05-16
Communicable Diseases,PROCESS_OF,Patients,32410517,10.1177/0025817220923691,2020-05-16
Communicable Diseases,PROCESS_OF,Patients,32410517,10.1177/0025817220923691,2020-05-16
Natural Products,INTERACTS_WITH,"3C-like protease, SARS coronavirus",32410502,10.1080/07391102.2020.1767690,2020-05-16
Natural Products,PART_OF,Marines,32410502,10.1080/07391102.2020.1767690,2020-05-16
Pulmonary Fibrosis,AFFECTS,Patients,32410412,10.3348/kjr.2020.0171,2020-05-16
Pulmonary Fibrosis,PROCESS_OF,Patients,32410412,10.3348/kjr.2020.0171,2020-05-16
Fibrosis,NEG_PROCESS_OF,Patients,32410412,10.3348/kjr.2020.0171,2020-05-16
Fibrosis,PROCESS_OF,Patients,32410412,10.3348/kjr.2020.0171,2020-05-16
Severe disorder,PROCESS_OF,Patients,32410412,10.3348/kjr.2020.0171,2020-05-16
Disease,PREDISPOSES,Pulmonary Fibrosis,32410412,10.3348/kjr.2020.0171,2020-05-16
Pulmonary Fibrosis,ISA,Disease,32410412,10.3348/kjr.2020.0171,2020-05-16
Parenchyma,LOCATION_OF,Bands,32410412,10.3348/kjr.2020.0171,2020-05-16
Parenchyma,LOCATION_OF,Bands,32410412,10.3348/kjr.2020.0171,2020-05-16
lobe,PART_OF,Lung,32410386,10.1002/alr.22610,2020-05-16
assessment.initial,PROCESS_OF,Patients,32410386,10.1002/alr.22610,2020-05-16
"CD69 protein, human",PART_OF,Patients,32410347,10.1002/eahr.500055,2020-05-16
Enrollment,TREATS,High risk environment,32410333,10.1111/bju.15110,2020-05-16
Lung,LOCATION_OF,Fatigue,32410319,10.1002/jmv.26021,2020-05-16
Lung,LOCATION_OF,Fever,32410319,10.1002/jmv.26021,2020-05-16
Lung,LOCATION_OF,Dry cough,32410319,10.1002/jmv.26021,2020-05-16
Multiple Organ Failure,PROCESS_OF,Patients,32410319,10.1002/jmv.26021,2020-05-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32410319,10.1002/jmv.26021,2020-05-16
Infected,PROCESS_OF,Persons,32410319,10.1002/jmv.26021,2020-05-16
Critical Illness,PROCESS_OF,Patients,32410245,10.1002/jmv.26017,2020-05-16
Storm NOS,CAUSES,Critical Illness,32410245,10.1002/jmv.26017,2020-05-16
Antibodies,CAUSES,Storm NOS,32410245,10.1002/jmv.26017,2020-05-16
Vaccines,TREATS,Human coronavirus,32410245,10.1002/jmv.26017,2020-05-16
memory b cell,PRODUCES,Antibodies,32410245,10.1002/jmv.26017,2020-05-16
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32410245,10.1002/jmv.26017,2020-05-16
White blood cell count normal,PROCESS_OF,Patients,32410236,10.1002/jmv.26010,2020-05-16
Awareness,PROCESS_OF,general population,32410234,10.1002/jmv.26016,2020-05-16
Pneumonia,PROCESS_OF,Patients,32410229,10.1002/jmv.26018,2020-05-16
tocilizumab,TREATS,Pneumonia,32410229,10.1002/jmv.26018,2020-05-16
Betacoronavirus,CAUSES,Atypical pneumonia,32410225,10.1002/hast.1110,2020-05-16
Nurses,ISA,Health Personnel,32410206,10.1007/s11096-020-01031-2,2020-05-16
exposure history,ISA,Medical History,32410196,10.1007/s00266-020-01752-9,2020-05-16
Fatigue,PROCESS_OF,Patients,32410196,10.1007/s00266-020-01752-9,2020-05-16
Fever,ISA,Symptoms,32410196,10.1007/s00266-020-01752-9,2020-05-16
Administration of antibiotic,TREATS,Population Group,32410196,10.1007/s00266-020-01752-9,2020-05-16
Novaferon,TREATS,Population Group,32410196,10.1007/s00266-020-01752-9,2020-05-16
Coronavirus Infections,ISA,Disease,32410141,10.1007/s11033-020-05478-4,2020-05-16
Coronavirus Infections,ISA,Disease,32410141,10.1007/s11033-020-05478-4,2020-05-16
Coronavirus Infections,ISA,Disease,32410141,10.1007/s11033-020-05478-4,2020-05-16
Elective Surgical Procedures,TREATS,Patients,32410141,10.1007/s11033-020-05478-4,2020-05-16
Challenge,TREATS,Crisis,32410141,10.1007/s11033-020-05478-4,2020-05-16
Acclimatization,COEXISTS_WITH,Waking,32410141,10.1007/s11033-020-05478-4,2020-05-16
Elective procedure,TREATS,patient condition,32410141,10.1007/s11033-020-05478-4,2020-05-16
Coronavirus Infections,ISA,Disease,32410141,10.1007/s11033-020-05478-4,2020-05-16
patient safety,COEXISTS_WITH,Elective Surgical Procedures,32410141,10.1007/s11033-020-05478-4,2020-05-16
Body tissue,PART_OF,House mice,32410125,10.1007/s11606-020-05875-2,2020-05-16
Clinical Significance,PROCESS_OF,Homo sapiens,32410125,10.1007/s11606-020-05875-2,2020-05-16
Kidney,LOCATION_OF,Immunohistochemistry,32410125,10.1007/s11606-020-05875-2,2020-05-16
Body tissue,LOCATION_OF,Immunohistochemistry,32410125,10.1007/s11606-020-05875-2,2020-05-16
Body tissue,LOCATION_OF,Immunohistochemistry,32410125,10.1007/s11606-020-05875-2,2020-05-16
Body tissue,PART_OF,Malignant Neoplasms,32410125,10.1007/s11606-020-05875-2,2020-05-16
Kidney,LOCATION_OF,ACE2 gene,32410125,10.1007/s11606-020-05875-2,2020-05-16
Testis,LOCATION_OF,ACE2 gene,32410125,10.1007/s11606-020-05875-2,2020-05-16
Female breast,LOCATION_OF,ACE2 gene,32410125,10.1007/s11606-020-05875-2,2020-05-16
Testis,LOCATION_OF,High Level,32410125,10.1007/s11606-020-05875-2,2020-05-16
Cardiovascular,LOCATION_OF,High Level,32410125,10.1007/s11606-020-05875-2,2020-05-16
High Level,CAUSES,Infertility,32410125,10.1007/s11606-020-05875-2,2020-05-16
Kidney,LOCATION_OF,ACE2 gene,32410125,10.1007/s11606-020-05875-2,2020-05-16
ACE2 gene,ASSOCIATED_WITH,Adult Liver Carcinoma,32410125,10.1007/s11606-020-05875-2,2020-05-16
ACE2 gene,ASSOCIATED_WITH,Malignant neoplasm of kidney,32410125,10.1007/s11606-020-05875-2,2020-05-16
ACE2 gene,ASSOCIATED_WITH,Neoplasms,32410125,10.1007/s11606-020-05875-2,2020-05-16
ACE2 gene,ASSOCIATED_WITH,Malignant Neoplasms,32410125,10.1007/s11606-020-05875-2,2020-05-16
Masks,USES,Diazooxonorleucine,32410003,10.1007/s12098-020-03322-y,2020-05-16
Severe disorder,PROCESS_OF,Child,32409989,10.1007/s10943-020-01035-2,2020-05-16
Insight,PROCESS_OF,Child,32409989,10.1007/s10943-020-01035-2,2020-05-16
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Adult,32409989,10.1007/s10943-020-01035-2,2020-05-16
pulmonary effects,AFFECTS,Pulmonary capillary,32409989,10.1007/s10943-020-01035-2,2020-05-16
Infection,NEG_PROCESS_OF,Child,32409989,10.1007/s10943-020-01035-2,2020-05-16
Senility,PROCESS_OF,Old age,32409989,10.1007/s10943-020-01035-2,2020-05-16
Epithelium,PART_OF,Alveolar,32409989,10.1007/s10943-020-01035-2,2020-05-16
risk factors,PROCESS_OF,Child,32409989,10.1007/s10943-020-01035-2,2020-05-16
Child,USES,Preexisting Condition Coverage,32409989,10.1007/s10943-020-01035-2,2020-05-16
Infant,USES,Preexisting Condition Coverage,32409989,10.1007/s10943-020-01035-2,2020-05-16
Immune,PROCESS_OF,Child,32409989,10.1007/s10943-020-01035-2,2020-05-16
Coronavirus Infections,CAUSES,Disease,32409911,10.1007/s00264-020-04606-w,2020-05-16
Lesion,COEXISTS_WITH,Prodromal Period,32409911,10.1007/s00264-020-04606-w,2020-05-16
Exanthema,ISA,Skin lesion,32409911,10.1007/s00264-020-04606-w,2020-05-16
Skin lesion,CAUSES,Exanthema,32409911,10.1007/s00264-020-04606-w,2020-05-16
Evaluation,TREATS,Acute urticaria,32409911,10.1007/s00264-020-04606-w,2020-05-16
Evaluation,TREATS,Edema disease,32409911,10.1007/s00264-020-04606-w,2020-05-16
Ambulatory Surgical Procedures,TREATS,Spinal instability,32409839,10.1093/occmed/kqaa088,2020-05-16
Spinal instability,PREDISPOSES,Complication,32409839,10.1093/occmed/kqaa088,2020-05-16
Cessation of life,PROCESS_OF,Physicians,32409832,10.1093/cid/ciaa587,2020-05-16
Cessation of life,PROCESS_OF,Physicians,32409832,10.1093/cid/ciaa587,2020-05-16
Italy,ISA,Country,32409832,10.1093/cid/ciaa587,2020-05-16
Coronavirus Infections,CAUSES,Pneumonia,32409826,10.1093/cid/ciaa578,2020-05-16
Cyclosporine,INHIBITS,Peptidylprolyl Isomerase,32409826,10.1093/cid/ciaa578,2020-05-16
Patients,LOCATION_OF,alisporivir,32409826,10.1093/cid/ciaa578,2020-05-16
Cessation of life,PROCESS_OF,Patients,32409825,10.1093/cid/ciaa588,2020-05-16
Influenza,PROCESS_OF,hospitalized patients,32409825,10.1093/cid/ciaa588,2020-05-16
Cessation of life,PROCESS_OF,Health Personnel,32409818,10.1093/cid/ciaa580,2020-05-16
Nurses,ISA,Persons,32409818,10.1093/cid/ciaa580,2020-05-16
Infected,PROCESS_OF,Persons,32409818,10.1093/cid/ciaa580,2020-05-16
Infected,PROCESS_OF(SPEC),Nurses,32409818,10.1093/cid/ciaa580,2020-05-16
Infected,PROCESS_OF,Health Personnel,32409818,10.1093/cid/ciaa580,2020-05-16
Chronic inflammation,PROCESS_OF,Persons,32409625,10.1136/medethics-2020-106284,2020-05-16
Obesity,PROCESS_OF,Persons,32409625,10.1136/medethics-2020-106284,2020-05-16
Complication,PROCESS_OF,Patients,32409625,10.1136/medethics-2020-106284,2020-05-16
Coronavirus Infections,PROCESS_OF,Patients,32409625,10.1136/medethics-2020-106284,2020-05-16
Awareness,PROCESS_OF,Patients,32409625,10.1136/medethics-2020-106284,2020-05-16
Coronavirus Infections,PROCESS_OF,Patients,32409625,10.1136/medethics-2020-106284,2020-05-16
Disease,PROCESS_OF,Recipient,32409547,10.1128/MRA.00383-20,2020-05-16
Hydroxychloroquine,ADMINISTERED_TO,Participant,32409547,10.1128/MRA.00383-20,2020-05-16
Hydroxychloroquine,ADMINISTERED_TO,Participant,32409547,10.1128/MRA.00383-20,2020-05-16
Adverse event,PROCESS_OF,Population Group,32409547,10.1128/MRA.00383-20,2020-05-16
Severe disorder,PROCESS_OF,Participant,32409547,10.1128/MRA.00383-20,2020-05-16
Adverse event,PROCESS_OF,Recipient,32409547,10.1128/MRA.00383-20,2020-05-16
Hydroxychloroquine,TREATS,Patients,32409547,10.1128/MRA.00383-20,2020-05-16
Adverse event,PROCESS_OF,Recipient,32409547,10.1128/MRA.00383-20,2020-05-16
Genome,COEXISTS_WITH,WASF1 gene,32409522,10.1503/cmaj.200645,2020-05-16
Adrenal Cortex Hormones,TREATS,Patients,32409519,10.1503/cmaj.200715,2020-05-16
Adrenal Cortex Hormones,NEG_TREATS,Patients,32409519,10.1503/cmaj.200715,2020-05-16
Adrenal Cortex Hormones,NEG_TREATS,Patients,32409519,10.1503/cmaj.200715,2020-05-16
Adrenal Cortex Hormones,compared_with,Adrenal Cortex Hormones,32409519,10.1503/cmaj.200715,2020-05-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32409519,10.1503/cmaj.200715,2020-05-16
Diabetes,PROCESS_OF,Patients,32409502,10.2337/dc20-0576,2020-05-16
Tertiary Care Centers,LOCATION_OF,Retrospective Studies,32409502,10.2337/dc20-0576,2020-05-16
Diabetes,PROCESS_OF,Patients,32409502,10.2337/dc20-0576,2020-05-16
Diabetes,PROCESS_OF,Patients,32409502,10.2337/dc20-0576,2020-05-16
Diabetes,PROCESS_OF,Patients,32409502,10.2337/dc20-0576,2020-05-16
Diabetes,PROCESS_OF,Patients,32409502,10.2337/dc20-0576,2020-05-16
Obesity,PROCESS_OF,Patients,32409501,10.2337/dc20-0941,2020-05-16
Obesity,ISA,Overweight,32409501,10.2337/dc20-0941,2020-05-16
Obesity,PROCESS_OF,Patients,32409501,10.2337/dc20-0941,2020-05-16
Obesity,PROCESS_OF,Patients,32409501,10.2337/dc20-0941,2020-05-16
Symptoms,PROCESS_OF,Patients,32409501,10.2337/dc20-0941,2020-05-16
Obesity,PROCESS_OF,Patients,32409501,10.2337/dc20-0941,2020-05-16
Diabetes,PROCESS_OF,Persons,32409498,10.2337/dc20-0660,2020-05-16
Diabetes,PROCESS_OF,Persons,32409498,10.2337/dc20-0660,2020-05-16
Diabetes,PROCESS_OF,Persons,32409498,10.2337/dc20-0660,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32409498,10.2337/dc20-0660,2020-05-16
Diabetes,PROCESS_OF,Persons,32409498,10.2337/dc20-0660,2020-05-16
Diabetes,PROCESS_OF,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Diabetes,PROCESS_OF,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Diabetes,PROCESS_OF,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Diabetes,PROCESS_OF,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Diabetes,PROCESS_OF,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Insulin,ADMINISTERED_TO,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Diabetes,NEG_AFFECTS,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Hypertensive disease,NEG_AFFECTS,Patients,32409488,10.1136/bmj.m1835,2020-05-16
Cessation of life,PROCESS_OF,Older people,32409486,10.1136/bmj.m1844,2020-05-16
Hydroxychloroquine,TREATS,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Pneumonia,PROCESS_OF,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Hydroxychloroquine,ADMINISTERED_TO,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Hydroxychloroquine,NEG_ADMINISTERED_TO,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Hydroxychloroquine,ADMINISTERED_TO,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Control Groups,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Oxygen,TREATS,Control Groups,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
Attention,PROCESS_OF,Patients,32409443,10.3949/ccjm.87a.ccc025,2020-05-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32409442,10.3949/ccjm.87a.ccc031,2020-05-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32409442,10.3949/ccjm.87a.ccc031,2020-05-16
Disease,PROCESS_OF,Patients,32409441,10.3949/ccjm.87a.ccc027,2020-05-16
Virus Diseases,PROCESS_OF,Patients,32409441,10.3949/ccjm.87a.ccc027,2020-05-16
Skin Manifestations,PROCESS_OF,Patients,32409441,10.3949/ccjm.87a.ccc027,2020-05-16
Infected,PROCESS_OF,Patients,32409441,10.3949/ccjm.87a.ccc027,2020-05-16
Immune System Diseases,PROCESS_OF,Patients,32409440,10.3949/ccjm.87a.ccc020,2020-05-16
Esthesia,PROCESS_OF,Community,32409440,10.3949/ccjm.87a.ccc020,2020-05-16
Immune System Diseases,PROCESS_OF,Patients,32409440,10.3949/ccjm.87a.ccc020,2020-05-16
Immune System Diseases,PROCESS_OF,Patients,32409440,10.3949/ccjm.87a.ccc020,2020-05-16
Vulnerable Populations,LOCATION_OF,IMPACT gene,32409440,10.3949/ccjm.87a.ccc020,2020-05-16
Troponin,PART_OF,Patients,32409439,10.3949/ccjm.87a.ccc018,2020-05-16
follow-up,TREATS,Patients,32409439,10.3949/ccjm.87a.ccc018,2020-05-16
"Therapies, Investigational",TREATS,Hyperinflammatory state,32409438,10.3949/ccjm.87a.ccc016,2020-05-16
Monoclonal Antibodies,INTERACTS_WITH,Interleukin-6,32409438,10.3949/ccjm.87a.ccc016,2020-05-16
Monoclonal Antibodies,INTERACTS_WITH,Interleukin 6 Receptor,32409438,10.3949/ccjm.87a.ccc016,2020-05-16
Pharmaceutical Preparations,TREATS,Patients,32409438,10.3949/ccjm.87a.ccc016,2020-05-16
Anxiety,PROCESS_OF,Patients,32409437,10.3949/ccjm.87a.ccc017,2020-05-16
Malaise,PROCESS_OF,Patients,32409437,10.3949/ccjm.87a.ccc017,2020-05-16
Relaxation Techniques,ISA,Psychotherapy,32409437,10.3949/ccjm.87a.ccc017,2020-05-16
Medication Management,TREATS,Patients,32409435,10.3949/ccjm.87a.ccc024,2020-05-16
Mechanical ventilation,TREATS,exacerbation acute,32409435,10.3949/ccjm.87a.ccc024,2020-05-16
Blood Coagulation Disorders,PROCESS_OF,Patients,32409434,10.3949/ccjm.87a.ccc009,2020-05-16
Fibrin fragment D,PREDISPOSES,Thrombosis,32409434,10.3949/ccjm.87a.ccc009,2020-05-16
Thrombosis,PROCESS_OF,Patients,32409434,10.3949/ccjm.87a.ccc009,2020-05-16
angiotensin converting enzyme 2,PREDISPOSES,Severe Acute Respiratory Syndrome,32409433,10.3949/ccjm.87a.ccc030,2020-05-16
Virus Internalization,PROCESS_OF,Patients,32409433,10.3949/ccjm.87a.ccc030,2020-05-16
Pharmaceutical Preparations,TREATS,RNA Viruses,32409432,10.3949/ccjm.87a.ccc028,2020-05-16
Antiviral Agents,TREATS,Influenza,32409432,10.3949/ccjm.87a.ccc028,2020-05-16
Infected,PROCESS_OF,Persons,32409431,10.3949/ccjm.87a.ccc019,2020-05-16
Ultrasonography,ADMINISTERED_TO,Patients,32409430,10.3949/ccjm.87a.ccc029,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409430,10.3949/ccjm.87a.ccc029,2020-05-16
Ultrasonography,ADMINISTERED_TO,Patients,32409430,10.3949/ccjm.87a.ccc029,2020-05-16
Chronic lung disease,PREDISPOSES,Severe course,32409328,10.1136/bmjgh-2020-002650,2020-05-16
Cessation of life,PROCESS_OF,Persons,32409327,10.1136/bmjgh-2020-002604,2020-05-16
Cessation of life,PROCESS_OF,Persons,32409327,10.1136/bmjgh-2020-002604,2020-05-16
Coronavirus Infections,ISA,Disease,32409327,10.1136/bmjgh-2020-002604,2020-05-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32409327,10.1136/bmjgh-2020-002604,2020-05-16
Cessation of life,PROCESS_OF,Human body,32409327,10.1136/bmjgh-2020-002604,2020-05-16
Diagnostic Imaging,METHOD_OF,Diagnosis,32409298,10.1136/esmoopen-2020-000789,2020-05-16
Asymptomatic,PROCESS_OF,Patients,32409298,10.1136/esmoopen-2020-000789,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
Comorbidity,PREDISPOSES,Severe (severity modifier),32409243,10.1016/j.oftal.2020.04.002,2020-05-16
Lung,LOCATION_OF,Comorbidity,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
Neoplasms,NEG_PROCESS_OF,Population Group,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
metaplastic cell transformation,ISA,Neoplasms,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
metaplastic cell transformation,NEG_PROCESS_OF(SPEC),Population Group,32409243,10.1016/j.oftal.2020.04.002,2020-05-16
Disorder of eye,COEXISTS_WITH,Disease,32409232,10.1016/j.ultrasmedbio.2020.04.026,2020-05-16
Disorder of eye,COEXISTS_WITH(SPEC),Coronavirus Infections,32409232,10.1016/j.ultrasmedbio.2020.04.026,2020-05-16
Disorder of eye,PROCESS_OF,Patients,32409232,10.1016/j.ultrasmedbio.2020.04.026,2020-05-16
Health Personnel,TREATS,Patients,32409232,10.1016/j.ultrasmedbio.2020.04.026,2020-05-16
Coronavirus Infections,ISA,Disease,32409232,10.1016/j.ultrasmedbio.2020.04.026,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Ultrasonography,DIAGNOSES,Pneumonia,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Pneumonia,PROCESS_OF,Child,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
pulmonary involvement,COEXISTS_WITH,Coronavirus Infections,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Lung,PART_OF,Caucasoid Race,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Lung,LOCATION_OF,Ultrasonography,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Evaluation,ADMINISTERED_TO,Clinician,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Evaluation,PREVENTS,Sedated state,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Sedated state,PROCESS_OF,Child,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
Experience,PROCESS_OF,Clinician,32409230,10.1016/j.cytogfr.2020.05.001,2020-05-16
risk factors,PROCESS_OF,Patients,32409215,10.1016/j.jocn.2020.05.017,2020-05-16
ACE2 gene,INTERACTS_WITH,"Antibodies, Neutralizing",32409215,10.1016/j.jocn.2020.05.017,2020-05-16
Comorbidity,PROCESS_OF,Patients,32409215,10.1016/j.jocn.2020.05.017,2020-05-16
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32409215,10.1016/j.jocn.2020.05.017,2020-05-16
Coronavirus Infections,ISA,Disease,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Encephalitis,ISA,Complication,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Cerebrovascular accident,ISA,Complication,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
"Myelitis, Acute Transverse",ISA,Complication,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Coughing,PROCESS_OF,Patients,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Fever,PROCESS_OF,Patients,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Ward (environment),LOCATION_OF,Diagnosis,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Virus Diseases,CAUSES,neurological complication,32409210,10.1016/j.jocn.2020.05.018,2020-05-16
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
Symptoms,PROCESS_OF,Patients,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
D-dimer above reference range,PROCESS_OF,Patients,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
C-reactive protein,PREDISPOSES,Inflammation,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
Fibrin fragment D,PREDISPOSES,Inflammation,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
risk factors,PROCESS_OF,Patients,32409192,10.1016/j.jagp.2020.04.027,2020-05-16
Screening procedure,TREATS,Elderly (population group),32409163,10.1016/j.amjoto.2020.102533,2020-05-16
Screening procedure,TREATS,Elderly (population group),32409163,10.1016/j.amjoto.2020.102533,2020-05-16
Disease,AFFECTS,Patients,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Caring,PROCESS_OF,Nursing Staff,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Tracheotomy procedure,ISA,Operative Surgical Procedures,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Tracheotomy procedure,TREATS,Patients,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Tracheotomy procedure,ADMINISTERED_TO,Patients,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Tracheotomy procedure,ISA,Operative Surgical Procedures,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Tracheotomy procedure,TREATS,Patients,32409150,10.1016/j.sapharm.2020.04.031,2020-05-16
Hydroxychloroquine,ISA,Chloroquine,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Chloroquine,compared_with,Azithromycin,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Corrected Prolonged QT Interval by ECG Finding,PREDISPOSES,cardiac event,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Autoimmune Diseases,PROCESS_OF,Patients,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Chloroquine,TREATS,Patients,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Chloroquine,TREATS(INFER),Autoimmune Diseases,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Cessation of life,PROCESS_OF,inpatient,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Cardiac Arrhythmia,PROCESS_OF,Population Group,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Cardiac Arrhythmia,PROCESS_OF(SPEC),World,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
cardiac symptom,COEXISTS_WITH,Cardiac Arrhythmia,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
World,ISA,Population Group,32409144,10.1016/j.arcmed.2020.04.020,2020-05-16
Comorbidity,PROCESS_OF,Elderly (population group),32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Comorbidity,PROCESS_OF,Patients,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Disease,PROCESS_OF,Elderly (population group),32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Disease,PROCESS_OF,Patients,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Symptoms,CAUSES,Cessation of life,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Coughing,ISA,Symptoms,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Dyspnea,ISA,Symptoms,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Fever,ISA,Symptoms,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
White blood cell count normal,PROCESS_OF,Patients,32409107,10.1016/j.gastrohep.2020.04.001,2020-05-16
Operative Surgical Procedures,TREATS,Patients,32408926,10.1017/ipm.2020.40,2020-05-16
Neoplastic disease,PROCESS_OF,Patients,32408926,10.1017/ipm.2020.40,2020-05-16
World Health Organization,ISA,Organization administrative structures,32408910,10.1017/S0714980820000203,2020-05-16
China,ISA,Country,32408910,10.1017/S0714980820000203,2020-05-16
Surgical face mask,TREATS,Health Personnel,32408910,10.1017/S0714980820000203,2020-05-16
Masks,USES,Textiles,32408910,10.1017/S0714980820000203,2020-05-16
Multi-disciplinary team,METHOD_OF,Evaluation,32408845,10.1080/17453674.2020.1764234,2020-05-16
Malignant Neoplasms,PROCESS_OF,Patients,32408808,10.1177/1010539520927265,2020-05-16
Challenge,AFFECTS,Handling,32408808,10.1177/1010539520927265,2020-05-16
Hypertensive disease,PROCESS_OF,Patients,32408776,10.1080/14767058.2020.1759540,2020-05-16
Disease Progression,PROCESS_OF,Patients,32408776,10.1080/14767058.2020.1759540,2020-05-16
Poor outcome,COEXISTS_WITH,Hypertensive disease,32408776,10.1080/14767058.2020.1759540,2020-05-16
Pregnancy,COEXISTS_WITH,Birth,32408770,10.1177/1090198120929985,2020-05-16
Community,LOCATION_OF,IMPACT gene,32408757,10.1177/1010539520927266,2020-05-16
African American,LOCATION_OF,IMPACT gene,32408757,10.1177/1010539520927266,2020-05-16
Decision,PROCESS_OF,Maker (occupation),32408757,10.1177/1010539520927266,2020-05-16
Disease,PROCESS_OF,Community,32408753,10.1177/1945892420927178,2020-05-16
Coronavirus Infections,ISA,Disease,32408753,10.1177/1945892420927178,2020-05-16
Coronavirus Infections,PROCESS_OF(SPEC),Community,32408753,10.1177/1945892420927178,2020-05-16
Immunoglobulin M,COEXISTS_WITH,Duration,32408730,10.23876/j.krcp.20.046,2020-05-16
Hemodialysis,ADMINISTERED_TO,Patients,32408729,10.23736/S1973-9087.20.06378-9,2020-05-16
Dialysis procedure,TREATS,Confirmation,32408729,10.23736/S1973-9087.20.06378-9,2020-05-16
Isolation procedure,TREATS,Patients,32408729,10.23736/S1973-9087.20.06378-9,2020-05-16
Sequela of disorder,OCCURS_IN,Patients,32408699,10.3390/ijms21103426,2020-05-16
Household composition,PROCESS_OF,Persons,32408602,10.3390/ijerph17103356,2020-05-16
Pharmaceutical Preparations,NEG_TREATS,Disease,32408528,10.3390/ijerph17103347,2020-05-16
Enzymes,AUGMENTS,Virus Internalization,32408528,10.3390/ijerph17103347,2020-05-16
Excretory function,ISA,Metabolism,32408528,10.3390/ijerph17103347,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Disease,COEXISTS_WITH,Crisis,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,COEXISTS_WITH(SPEC),Crisis,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Prophylactic treatment,TREATS,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Prophylactic treatment,TREATS(SPEC),Coronavirus Infections,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Coronavirus Infections,ISA,Disease,32408508,10.3390/ijerph17103344,2020-05-16
Italy,ISA,Country,32408453,10.1016/j.scitotenv.2020.138226,2020-05-16
Decision,PROCESS_OF,Maker (occupation),32408453,10.1016/j.scitotenv.2020.138226,2020-05-16
Severe Acute Respiratory Syndrome,ISA,Communicable Diseases,32408450,10.1016/j.scitotenv.2020.138201,2020-05-16
D-dimer above reference range,PROCESS_OF,Patients,32408388,10.1111/ijcp.13524,2020-05-15
Storm NOS,CAUSES,Thrombosis,32408388,10.1111/ijcp.13524,2020-05-15
Organ,LOCATION_OF,"SUPPLY, NOT OTHERWISE SPECIFIED",32408388,10.1111/ijcp.13524,2020-05-15
Severe Sepsis,CAUSES,Single organ dysfunction,32408388,10.1111/ijcp.13524,2020-05-15
Endoscopy (procedure),ADMINISTERED_TO,Patients,32408338,10.1038/s41586-020-2342-5,2020-05-15
SARS coronavirus,PROCESS_OF,Rhinolophus,32408337,10.1038/s41586-020-2334-5,2020-05-15
SARS coronavirus,PROCESS_OF,Rhinolophus,32408337,10.1038/s41586-020-2334-5,2020-05-15
Hand,LOCATION_OF,EHD1 wt Allele,32408222,10.1016/j.ejrad.2020.109041,2020-05-15
Coronavirus Infections,ISA,Disease,32408222,10.1016/j.ejrad.2020.109041,2020-05-15
Coronavirus Infections,ISA,Disease,32408222,10.1016/j.ejrad.2020.109041,2020-05-15
Coronavirus Infections,ISA,Disease,32408222,10.1016/j.ejrad.2020.109041,2020-05-15
Coinfection,PROCESS_OF,Homo sapiens,32408155,10.1016/j.msard.2020.102180,2020-05-15
Bacterial Infections,PROCESS_OF,Patients,32408155,10.1016/j.msard.2020.102180,2020-05-15
Coinfection,PROCESS_OF,Patients,32408155,10.1016/j.msard.2020.102180,2020-05-15
Multiple Sclerosis,PROCESS_OF,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS,Immune,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
Coronavirus Infections,PROCESS_OF,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
"Multiple Sclerosis, Relapsing-Remitting",PROCESS_OF,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS(INFER),Coronavirus Infections,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS(INFER),"Multiple Sclerosis, Relapsing-Remitting",32408119,10.1016/j.dsx.2020.04.047,2020-05-15
interstitial,LOCATION_OF,Bilateral pneumonia,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
Bilateral pneumonia,PROCESS_OF,Patients,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS,Peripheral lymphopenia,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,ISA,Pharmaceutical Preparations,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
fingolimod,TREATS,patient condition,32408119,10.1016/j.dsx.2020.04.047,2020-05-15
Fever,ISA,Symptoms,32408118,10.1016/j.dsx.2020.04.044,2020-05-15
Severe disorder,COEXISTS_WITH,Diabetes,32408070,10.1016/j.mehy.2020.109815,2020-05-15
Diabetes,OCCURS_IN,Patients,32408070,10.1016/j.mehy.2020.109815,2020-05-15
Diabetes,PROCESS_OF,Patients,32408070,10.1016/j.mehy.2020.109815,2020-05-15
Diabetes,OCCURS_IN,Patients,32408070,10.1016/j.mehy.2020.109815,2020-05-15
Diabetes,OCCURS_IN,Patients,32408070,10.1016/j.mehy.2020.109815,2020-05-15
Drug Repositioning,TREATS,Patients,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Chloroquine,ISA,Antimalarials,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
intracellular vesicle,LOCATION_OF,Chloroquine,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
intracellular vesicle,LOCATION_OF,Hydroxychloroquine,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Hydroxychloroquine,INTERACTS_WITH,Zinc,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Lysosomes,PART_OF,Protoplasm,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Zinc,DISRUPTS,RNA-directed RNA polymerase activity,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Zinc,PART_OF,Extracellular,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Zinc deficiency,OCCURS_IN,geriatric patients,32408047,10.1016/j.janxdis.2020.102232,2020-05-15
Anxiety,PROCESS_OF,Persons,32408043,10.1016/j.archger.2020.104096,2020-05-15
Stress,PROCESS_OF,Persons,32408043,10.1016/j.archger.2020.104096,2020-05-15
Analysis,MEASURES,Age,32408041,10.1016/j.scitotenv.2020.139297,2020-05-15
Hospitals,LOCATION_OF,Open Label Study,32407937,10.1016/j.thromres.2020.05.006,2020-05-15
Oxygen,TREATS,Pneumonia,32407937,10.1016/j.thromres.2020.05.006,2020-05-15
Mechanical ventilation,TREATS,Pneumonia,32407937,10.1016/j.thromres.2020.05.006,2020-05-15
Pneumonia,PROCESS_OF,Patients,32407937,10.1016/j.thromres.2020.05.006,2020-05-15
Laboratory Procedures,USES,receptor operated channel,32407898,10.1016/j.jogoh.2020.101805,2020-05-15
follow-up,TREATS,"Infant, Newborn",32407897,10.1016/j.jogoh.2020.101804,2020-05-15
follow-up,TREATS,Woman,32407897,10.1016/j.jogoh.2020.101804,2020-05-15
Infected,PROCESS_OF,Cohort,32407884,10.1016/j.hrthm.2020.05.014,2020-05-15
Infected,PROCESS_OF,Patients,32407884,10.1016/j.hrthm.2020.05.014,2020-05-15
Azithromycin,TREATS,Patients,32407853,10.1016/j.athoracsur.2020.05.002,2020-05-15
"Ventricular tachycardia, polymorphic",PROCESS_OF,Patients,32407853,10.1016/j.athoracsur.2020.05.002,2020-05-15
Azithromycin,AFFECTS,qtc interval,32407853,10.1016/j.athoracsur.2020.05.002,2020-05-15
Corrected Prolonged QT Interval by ECG Finding,PROCESS_OF,Patients,32407853,10.1016/j.athoracsur.2020.05.002,2020-05-15
Hospitalization,TREATS,Survivors,32407826,10.1016/j.ajic.2020.05.003,2020-05-15
High Level,PROCESS_OF,Survivors,32407826,10.1016/j.ajic.2020.05.003,2020-05-15
Liver enzymes abnormal,PROCESS_OF,Patients,32407799,10.1016/j.ijsu.2020.05.022,2020-05-15
Pharmaceutical Preparations,TREATS,Symptoms,32407799,10.1016/j.ijsu.2020.05.022,2020-05-15
Liver,LOCATION_OF,Adverse effects,32407799,10.1016/j.ijsu.2020.05.022,2020-05-15
Problem,PROCESS_OF,Staff,32407772,10.1016/j.jacc.2020.05.006,2020-05-15
Diabetes Mellitus,OCCURS_IN,Patients,32407719,10.1016/j.jpeds.2020.05.006,2020-05-15
Critical Illness,PROCESS_OF,"Child, Hospitalized",32407708,10.1016/j.chom.2020.04.021,2020-05-15
Critical Illness,PROCESS_OF,Adolescent (age group),32407708,10.1016/j.chom.2020.04.021,2020-05-15
Severe disorder,PROCESS_OF,Patients,32407708,10.1016/j.chom.2020.04.021,2020-05-15
Visual Accommodation,PROCESS_OF,Homo sapiens,32407669,10.1016/j.chom.2020.04.017,2020-05-15
Coronavirus Infections,ISA,Disease,32407609,10.1002/acn3.51071,2020-05-15
Severe Acute Respiratory Syndrome,CAUSES,Disease,32407609,10.1002/acn3.51071,2020-05-15
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32407609,10.1002/acn3.51071,2020-05-15
Community acquired pneumonia,PROCESS_OF,Patients,32407609,10.1002/acn3.51071,2020-05-15
Genes,ASSOCIATED_WITH,Inflammation,32407609,10.1002/acn3.51071,2020-05-15
Severe Acute Respiratory Syndrome,CAUSES,Disease,32407609,10.1002/acn3.51071,2020-05-15
Status Epilepticus,PROCESS_OF,Woman,32407600,10.1111/jth.14899,2020-05-15
Virus,PROCESS_OF,Woman,32407600,10.1111/jth.14899,2020-05-15
Status Epilepticus,PROCESS_OF,Persons,32407600,10.1111/jth.14899,2020-05-15
Asymptomatic,PROCESS_OF,Persons,32407600,10.1111/jth.14899,2020-05-15
Comorbidity,PROCESS_OF,Patients,32407600,10.1111/jth.14899,2020-05-15
Senility,PROCESS_OF,Patients,32407600,10.1111/jth.14899,2020-05-15
Easy,PROCESS_OF,Patients,32407539,10.1002/cpt.1891,2020-05-15
Homo sapiens,ISA,Animals,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Amino Acids,COEXISTS_WITH,"M Protein, multiple myeloma",32407491,10.1093/bioinformatics/btaa496,2020-05-15
Protein Subunits,AFFECTS,Membrane Fusion,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Protein Subunits,INTERACTS_WITH,carbohydrate receptor,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Virus,PROCESS_OF,Homo sapiens,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Severe (severity modifier),PROCESS_OF,Homo sapiens,32407491,10.1093/bioinformatics/btaa496,2020-05-15
Coronavirus Infections,ASSOCIATED_WITH,"Recombination, Genetic",32407491,10.1093/bioinformatics/btaa496,2020-05-15
Coronavirus Infections,PROCESS_OF,Family suidae,32407491,10.1093/bioinformatics/btaa496,2020-05-15
HIV,PROCESS_OF,Patients,32407466,10.1093/cid/ciaa577,2020-05-15
Smell Perception,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32407459,10.1093/cid/ciaa576,2020-05-15
Present,PREDISPOSES,Severe disorder,32407411,10.1371/journal.pone.0233255,2020-05-15
Elevated lactate dehydrogenase,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32407411,10.1371/journal.pone.0233255,2020-05-15
Adrenal Cortex Hormones,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32407411,10.1371/journal.pone.0233255,2020-05-15
Infected,PROCESS_OF,Health Personnel,32407409,10.1371/journal.pone.0233410,2020-05-15
Infected,PROCESS_OF,Health Personnel,32407409,10.1371/journal.pone.0233410,2020-05-15
Infected,PROCESS_OF,Persons,32407409,10.1371/journal.pone.0233410,2020-05-15
Infected,PROCESS_OF,Patients,32407409,10.1371/journal.pone.0233410,2020-05-15
Infected,PROCESS_OF,Health Personnel,32407409,10.1371/journal.pone.0233410,2020-05-15
Epidemic,ISA,Disease Outbreaks,32407364,10.1371/journal.ppat.1008421,2020-05-15
Coronavirus Infections,ISA,Disease,32407364,10.1371/journal.ppat.1008421,2020-05-15
psychological distress,PROCESS_OF,general population,32407364,10.1371/journal.ppat.1008421,2020-05-15
psychological distress,PROCESS_OF,general population,32407364,10.1371/journal.ppat.1008421,2020-05-15
Epidemic,ISA,Disease Outbreaks,32407364,10.1371/journal.ppat.1008421,2020-05-15
psychological distress,PROCESS_OF,general population,32407364,10.1371/journal.ppat.1008421,2020-05-15
Epidemic,ISA,Disease Outbreaks,32407364,10.1371/journal.ppat.1008421,2020-05-15
Epidemic,OCCURS_IN,Community,32407364,10.1371/journal.ppat.1008421,2020-05-15
High Level,PROCESS_OF,Population Group,32407364,10.1371/journal.ppat.1008421,2020-05-15
Coronavirus Infections,ISA,Disease,32407364,10.1371/journal.ppat.1008421,2020-05-15
Coronavirus Infections,ISA,Disease,32407364,10.1371/journal.ppat.1008421,2020-05-15
High Level,PROCESS_OF,general population,32407364,10.1371/journal.ppat.1008421,2020-05-15
Coronavirus Infections,PROCESS_OF,Subgenus Paramanis,32407329,10.1371/journal.pone.0232652,2020-05-15
Coronavirus Infections,PROCESS_OF,Pholidota,32407329,10.1371/journal.pone.0232652,2020-05-15
Genus: Coronavirus,PROCESS_OF,Pholidota,32407329,10.1371/journal.pone.0232652,2020-05-15
Genus: Coronavirus,PROCESS_OF,Pholidota,32407329,10.1371/journal.pone.0232652,2020-05-15
Cessation of life,PROCESS_OF,Persons,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Cessation of life,NEG_PROCESS_OF,Health Personnel,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Cessation of life,PROCESS_OF,Persons,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Cessation of life,NEG_ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32407303,10.15585/mmwr.mm6919e6,2020-05-15
Symptoms,PROCESS_OF,Persons,32407301,10.15585/mmwr.mm6919e3,2020-05-15
Challenge,TREATS,Communicable Diseases,32407300,10.15585/mmwr.mm6919e1,2020-05-15
Hospital admission,ADMINISTERED_TO,Community,32407300,10.15585/mmwr.mm6919e1,2020-05-15
Cessation of life,PROCESS_OF,Staff Member,32407300,10.15585/mmwr.mm6919e1,2020-05-15
Awareness,PROCESS_OF,Administrators,32407300,10.15585/mmwr.mm6919e1,2020-05-15
Contacts,PREVENTS,patient condition,32407300,10.15585/mmwr.mm6919e1,2020-05-15
California,ISA,Geographic Locations,32407255,10.1148/radiol.2020201754,2020-05-15
Coronavirus Infections,ISA,Disease,32407255,10.1148/radiol.2020201754,2020-05-15
Disease,PROCESS_OF,hospitalized patients,32407255,10.1148/radiol.2020201754,2020-05-15
Cardiovascular Diseases,PROCESS_OF,Patients,32407255,10.1148/radiol.2020201754,2020-05-15
Hypersensitivity,ISA,Disease,32407171,10.1377/hlthaff.2020.00608,2020-05-15
Infection,PROCESS_OF,Health Personnel,32407171,10.1377/hlthaff.2020.00608,2020-05-15
Coronavirus Infections,ISA,Disease,32407155,10.2105/AJPH.2020.305686,2020-05-15
Coronavirus Infections,ISA,Disease,32407155,10.2105/AJPH.2020.305686,2020-05-15
Influenza,COEXISTS_WITH,Family illness,32407151,10.1089/fpsam.2020.0258,2020-05-15
Eye,LOCATION_OF,IMPACT gene,32407062,10.23736/S0026-4970.20.04372-1,2020-05-15
Pandemics,CAUSES,Respiratory Tract Infections,32407051,10.23736/S0026-4806.20.06616-1,2020-05-15
Virus,CAUSES,Shock,32407051,10.23736/S0026-4806.20.06616-1,2020-05-15
Dentistry,ISA,Occupations,32407051,10.23736/S0026-4806.20.06616-1,2020-05-15
Antiviral Agents,NEG_TREATS,Disease,32407003,10.1111/tid.13327,2020-05-15
Antiviral Agents,NEG_TREATS(SPEC),Coronavirus Infections,32407003,10.1111/tid.13327,2020-05-15
Coronavirus Infections,ISA,Disease,32407003,10.1111/tid.13327,2020-05-15
Compliance,PREDISPOSES,"Infections, Hospital",32406952,10.1002/jmv.26003,2020-05-15
Hospitals,LOCATION_OF,Administration occupational activities,32406952,10.1002/jmv.26003,2020-05-15
Albumins,COEXISTS_WITH,Alanine Transaminase,32406927,10.1002/14651858.CD013600,2020-05-15
Cessation of life,ASSOCIATED_WITH,Hypoalbuminemia,32406927,10.1002/14651858.CD013600,2020-05-15
Comorbidity,PROCESS_OF,Patients,32406927,10.1002/14651858.CD013600,2020-05-15
Patients,LOCATION_OF,Immunoglobulins,32406905,10.1093/ajhp/zxaa147,2020-05-15
Respiratory viruses,PROCESS_OF,Patients,32406905,10.1093/ajhp/zxaa147,2020-05-15
Coronavirus Infections,ISA,Disease,32406905,10.1093/ajhp/zxaa147,2020-05-15
Severe Acute Respiratory Syndrome,ISA,Disease,32406905,10.1093/ajhp/zxaa147,2020-05-15
Single Group Study,USES,Interventional procedure,32406905,10.1093/ajhp/zxaa147,2020-05-15
Disease,PROCESS_OF,Participant,32406905,10.1093/ajhp/zxaa147,2020-05-15
intensive care unit,LOCATION_OF,Study,32406905,10.1093/ajhp/zxaa147,2020-05-15
Fever,PROCESS_OF,Participant,32406905,10.1093/ajhp/zxaa147,2020-05-15
Shock,PROCESS_OF,Persons,32406905,10.1093/ajhp/zxaa147,2020-05-15
Single Group Study,USES,Interventional procedure,32406905,10.1093/ajhp/zxaa147,2020-05-15
Virus,PROCESS_OF,Patients,32406855,10.2196/19033,2020-05-15
Communicable Diseases,PROCESS_OF,Patients,32406855,10.2196/19033,2020-05-15
Cardiovascular Diseases,PROCESS_OF,geriatric patients,32406855,10.2196/19033,2020-05-15
"CD69 protein, human",ADMINISTERED_TO,Patients,32406855,10.2196/19033,2020-05-15
Coronavirus Infections,ISA,Disease,32406853,10.2196/18928,2020-05-15
Chronic disease,PROCESS_OF,Patients,32406853,10.2196/18928,2020-05-15
Infected,PROCESS_OF,Physicians,32406853,10.2196/18928,2020-05-15
Coronavirus Infections,ISA,Disease,32406853,10.2196/18928,2020-05-15
Coronavirus Infections,ISA,Disease,32406852,10.2196/19047,2020-05-15
Disease,PROCESS_OF,Patients,32406852,10.2196/19047,2020-05-15
Coronavirus Infections,ISA,Disease,32406852,10.2196/19047,2020-05-15
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32406852,10.2196/19047,2020-05-15
"Surgical Procedures, Laparoscopic",TREATS,Patients,32406852,10.2196/19047,2020-05-15
Coronavirus Infections,ISA,Disease,32406852,10.2196/19047,2020-05-15
Coronavirus Infections,ISA,Disease,32406852,10.2196/19047,2020-05-15
Intubation,TREATS,Health Personnel,32406852,10.2196/19047,2020-05-15
Intubation,TREATS,SARS coronavirus,32406852,10.2196/19047,2020-05-15
Intubation,ISA,Interventional procedure,32406852,10.2196/19047,2020-05-15
Intubation,PREDISPOSES,Pneumoperitoneum,32406852,10.2196/19047,2020-05-15
Communicable Diseases,COEXISTS_WITH,Crisis,32406829,10.1109/TMI.2020.2994459,2020-05-15
Mediterranean countries,ISA,Geographic Locations,32406829,10.1109/TMI.2020.2994459,2020-05-15
Experience,PROCESS_OF,member,32406829,10.1109/TMI.2020.2994459,2020-05-15
Diagnostic Imaging,DIAGNOSES,Lung diseases,32406778,10.1080/09593985.2020.1757264,2020-05-15
Intervention regimes,TREATS,Pneumonia,32406755,10.1080/01459740.2020.1761804,2020-05-15
Short wave diathermy,TREATS,Lung diseases,32406755,10.1080/01459740.2020.1761804,2020-05-15
Short wave diathermy,TREATS,Patients,32406755,10.1080/01459740.2020.1761804,2020-05-15
Chronic disease,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Disability,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Chronic disease,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Chronic disease,PROCESS_OF(SPEC),Participant,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Disability,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Disability,PROCESS_OF(SPEC),Participant,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Participant,ISA,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Chronic disease,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Chronic disease,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Stress,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Disability,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
Disability,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
research results,PROCESS_OF,Persons,32406687,10.1021/acs.jpclett.0c00994,2020-05-15
SARS coronavirus,COEXISTS_WITH,Virus,32406606,10.1111/aos.14456,2020-05-15
Endopeptidases,PART_OF,SARS coronavirus,32406606,10.1111/aos.14456,2020-05-15
Infected,PROCESS_OF,Patients,32406594,10.1111/dom.14086,2020-05-15
Nucleic Acids,PART_OF,Virus,32406594,10.1111/dom.14086,2020-05-15
Obstruction,PROCESS_OF,Patients,32406594,10.1111/dom.14086,2020-05-15
Assay,MEASURES,Buccal smear procedure,32406594,10.1111/dom.14086,2020-05-15
Eye Specimen,PART_OF,Patients,32406594,10.1111/dom.14086,2020-05-15
Nucleic Acids,PART_OF,Virus,32406594,10.1111/dom.14086,2020-05-15
Flow Cytometry,DIAGNOSES,Obstruction,32406594,10.1111/dom.14086,2020-05-15
Common Duct,LOCATION_OF,Obstruction,32406594,10.1111/dom.14086,2020-05-15
Eye,LOCATION_OF,Disease,32406594,10.1111/dom.14086,2020-05-15
Diabetes,PROCESS_OF,Patients,32406551,10.1111/bju.15109,2020-05-15
Ferritin,compared_with,Fibrin fragment D,32406551,10.1111/bju.15109,2020-05-15
Leukocytosis,PROCESS_OF,Patients,32406551,10.1111/bju.15109,2020-05-15
High Level,PROCESS_OF,Patients,32406551,10.1111/bju.15109,2020-05-15
Hyperglycemia,PROCESS_OF,Patients,32406551,10.1111/bju.15109,2020-05-15
Hyperglycemia,PROCESS_OF,Patients,32406551,10.1111/bju.15109,2020-05-15
Clinician,NEG_DIAGNOSES,Diabetes,32406551,10.1111/bju.15109,2020-05-15
Chronic disease,COEXISTS_WITH,Weakness,32406522,10.1111/eci.13276,2020-05-15
compromise,PREDISPOSES,Osteopenia,32406522,10.1111/eci.13276,2020-05-15
Osteoporosis,COEXISTS_WITH,Enthesitis-Related Arthritis,32406522,10.1111/eci.13276,2020-05-15
Osteoporosis,PROCESS_OF,Patients,32406522,10.1111/eci.13276,2020-05-15
Osteoporosis,PROCESS_OF,Patients,32406522,10.1111/eci.13276,2020-05-15
"Respiratory Distress Syndrome, Adult",CAUSES,Symptoms,32406513,10.1093/occmed/kqaa085,2020-05-15
Infected,PROCESS_OF,Persons,32406513,10.1093/occmed/kqaa085,2020-05-15
Abdominal Pain,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Nausea,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Infected,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Feces,ASSOCIATED_WITH(INFER),Infected,32406513,10.1093/occmed/kqaa085,2020-05-15
Feces,LOCATION_OF,Nucleic Acids,32406513,10.1093/occmed/kqaa085,2020-05-15
Feces,PART_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Infected,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Infected,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Symptoms,PROCESS_OF,Patients,32406513,10.1093/occmed/kqaa085,2020-05-15
Occupational Health Services,LOCATION_OF,business career,32406512,10.1093/jtm/taaa069,2020-05-15
Severe Acute Respiratory Syndrome,NEG_AFFECTS,Persons,32406420,10.1016/j.jrid.2020.05.001,2020-05-15
Chest,LOCATION_OF,High Resolution Computed Tomography,32406406,10.1016/j.ssci.2020.104830,2020-05-15
Disease,PROCESS_OF,Patients,32406406,10.1016/j.ssci.2020.104830,2020-05-15
Masks,TREATS,general population,32406404,10.1007/s11469-020-00283-3,2020-05-15
Masks,USES,disposable,32406404,10.1007/s11469-020-00283-3,2020-05-15
Ozone,ISA,Gases,32406404,10.1007/s11469-020-00283-3,2020-05-15
Quarantine,TREATS,Disease,32406381,10.1515/cclm-2020-0502,2020-05-15
Interventional procedure,TREATS,disease transmission,32406381,10.1515/cclm-2020-0502,2020-05-15
Infected,PROCESS_OF,Persons,32406381,10.1515/cclm-2020-0502,2020-05-15
Disease,CAUSES,Severe Acute Respiratory Syndrome,32406369,10.4269/ajtmh.20-0279,2020-05-15
Possible,PROCESS_OF,Patients,32406369,10.4269/ajtmh.20-0279,2020-05-15
"Signs and Symptoms, Respiratory",PROCESS_OF,Persons,32406361,10.1017/ipm.2020.39,2020-05-15
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32406361,10.1017/ipm.2020.39,2020-05-15
Asymptomatic,PROCESS_OF,Persons,32406361,10.1017/ipm.2020.39,2020-05-15
Viral Shedding,PROCESS_OF,Persons,32406361,10.1017/ipm.2020.39,2020-05-15
Eye,PART_OF,Practice nurse,32406360,10.1017/ipm.2020.35,2020-05-15
Brain,PART_OF,Persons,32406317,10.1080/07391102.2020.1768902,2020-05-15
Functional modification,TREATS,Persons,32406317,10.1080/07391102.2020.1768902,2020-05-15
Endopeptidases,PART_OF,Virus,32406305,10.1177/2309499020923499,2020-05-15
Viomycin,compared_with,Pharmaceutical Preparations,32406305,10.1177/2309499020923499,2020-05-15
Coronavirus Infections,AFFECTS,Community,32406269,10.1177/1010539520927283,2020-05-15
disabling disease,PROCESS_OF,Persons,32406211,10.3947/ic.2020.52.2.133,2020-05-15
Disability,PROCESS_OF,Persons,32406211,10.3947/ic.2020.52.2.133,2020-05-15
Functional Limitation,COEXISTS_WITH,Chronic disease,32406211,10.3947/ic.2020.52.2.133,2020-05-15
Persons,LOCATION_OF,IMPACT gene,32406211,10.3947/ic.2020.52.2.133,2020-05-15
Disability,PROCESS_OF,Persons,32406211,10.3947/ic.2020.52.2.133,2020-05-15
disabling disease,AFFECTS,Persons,32406211,10.3947/ic.2020.52.2.133,2020-05-15
Cessation of life,PROCESS_OF,Patients,32406181,10.1111/ajt.16003,2020-05-15
Malaise,PROCESS_OF,Patients,32406181,10.1111/ajt.16003,2020-05-15
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32406181,10.1111/ajt.16003,2020-05-15
BARRIER,TREATS,Readiness,32406181,10.1111/ajt.16003,2020-05-15
Disease,NEG_AFFECTS,Child,32406140,10.1111/cxo.13088,2020-05-15
Immunocompromised Host,PROCESS_OF,Child,32406140,10.1111/cxo.13088,2020-05-15
Comorbidity,PROCESS_OF,Child,32406140,10.1111/cxo.13088,2020-05-15
Serum,LOCATION_OF,Creatinine,32406140,10.1111/cxo.13088,2020-05-15
Immunocompromised Host,PROCESS_OF,Child,32406140,10.1111/cxo.13088,2020-05-15
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32406084,10.1111/jgs.16562,2020-05-15
conjunctiva,LOCATION_OF,angiotensin converting enzyme 2,32406084,10.1111/jgs.16562,2020-05-15
Cornea,LOCATION_OF,angiotensin converting enzyme 2,32406084,10.1111/jgs.16562,2020-05-15
Epithelium,LOCATION_OF,Genus: Coronavirus,32406084,10.1111/jgs.16562,2020-05-15
Conjunctivitis,COEXISTS_WITH,Coronavirus Infections,32406084,10.1111/jgs.16562,2020-05-15
Conjunctivitis,PROCESS_OF,Patients,32406084,10.1111/jgs.16562,2020-05-15
Capillary vessel,PART_OF,conjunctiva,32406084,10.1111/jgs.16562,2020-05-15
Virus,PROCESS_OF,Patients,32406084,10.1111/jgs.16562,2020-05-15
Fragility,PROCESS_OF,citizen,32406081,10.1111/1467-9566.13104,2020-05-15
medicare/medicaid,LOCATION_OF,Services,32406081,10.1111/1467-9566.13104,2020-05-15
Cystic Fibrosis,PROCESS_OF,Persons,32406064,10.1111/cod.13601,2020-05-15
Air,TREATS,Persons,32406064,10.1111/cod.13601,2020-05-15
Air,TREATS(INFER),Cystic Fibrosis,32406064,10.1111/cod.13601,2020-05-15
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32406001,10.1007/s10067-020-05160-x,2020-05-15
Elevated IL6,PROCESS_OF,Patients,32406001,10.1007/s10067-020-05160-x,2020-05-15
Rheumatism,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Collagen Diseases,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Present,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Rheumatoid Arthritis,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Fatigue,ISA,Symptoms,32405974,10.1007/s11684-020-0774-9,2020-05-15
Leukopenia,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Lymphopenia,PROCESS_OF,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Lung,LOCATION_OF,Ground Glass Opacity,32405974,10.1007/s11684-020-0774-9,2020-05-15
Chest CT,DIAGNOSES,Ground Glass Opacity,32405974,10.1007/s11684-020-0774-9,2020-05-15
Antibiotics,TREATS,Secondary Infections,32405974,10.1007/s11684-020-0774-9,2020-05-15
Antiviral Agents,TREATS,Patients,32405974,10.1007/s11684-020-0774-9,2020-05-15
Biological Response Modifiers,TREATS,Rheumatism,32405974,10.1007/s11684-020-0774-9,2020-05-15
Infected,PROCESS_OF,Patients,32405955,10.1007/s12311-020-01139-1,2020-05-15
Hoover technique,AFFECTS,Patients,32405955,10.1007/s12311-020-01139-1,2020-05-15
Experience,PROCESS_OF,Patients,32405955,10.1007/s12311-020-01139-1,2020-05-15
Ataxia,ISA,Complication,32405913,10.1007/s11886-020-01302-4,2020-05-15
Cerebellar Ataxia,PROCESS_OF,Patients,32405913,10.1007/s11886-020-01302-4,2020-05-15
Disease,COEXISTS_WITH,Ataxia,32405913,10.1007/s11886-020-01302-4,2020-05-15
Illness (finding),COEXISTS_WITH,Ataxia,32405913,10.1007/s11886-020-01302-4,2020-05-15
Cerebellar Ataxia,PROCESS_OF,Patients,32405913,10.1007/s11886-020-01302-4,2020-05-15
Consultation,AFFECTS,Negative,32405913,10.1007/s11886-020-01302-4,2020-05-15
Ataxia,PROCESS_OF,Patients,32405913,10.1007/s11886-020-01302-4,2020-05-15
Therapeutic procedure,TREATS,Severe Acute Respiratory Syndrome,32405905,10.1007/s10900-020-00839-3,2020-05-15
Perception,PROCESS_OF,Population Group,32405882,10.1007/s10072-020-04461-y,2020-05-15
Perception,PROCESS_OF,Population Group,32405882,10.1007/s10072-020-04461-y,2020-05-15
Herpes Simplex Virus 1 encephalitis,PROCESS_OF,Woman,32405877,10.1007/s41030-020-00118-5,2020-05-15
Storm NOS,CAUSES,Edema,32405872,10.1186/s40634-020-00248-4,2020-05-15
Complement System Proteins,PREVENTS,Virus,32405872,10.1186/s40634-020-00248-4,2020-05-15
Complement System Proteins,AFFECTS,Coronavirus Infections,32405872,10.1186/s40634-020-00248-4,2020-05-15
Lung diseases,PROCESS_OF,"Mice, Knockout",32405872,10.1186/s40634-020-00248-4,2020-05-15
Pulmonary Edema,CAUSES,Intervention regimes,32405872,10.1186/s40634-020-00248-4,2020-05-15
Intervention regimes,TREATS,Edema,32405872,10.1186/s40634-020-00248-4,2020-05-15
Bradykinin,AFFECTS,Pulmonary Edema,32405872,10.1186/s40634-020-00248-4,2020-05-15
Infected,PROCESS_OF,Nursing Staff,32405783,10.1007/s00125-020-05164-x,2020-05-15
Comorbidity,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Hyperglycemia,PREDISPOSES,Poor outcome,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Antiviral Therapy,TREATS,Mild disorder,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
consideration,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Patients,32405780,10.1208/s12249-020-01679-z,2020-05-15
Diabetes,PROCESS_OF,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Challenge,METHOD_OF,Prophylactic treatment,32405780,10.1208/s12249-020-01679-z,2020-05-15
Challenge,TREATS,Persons,32405780,10.1208/s12249-020-01679-z,2020-05-15
Challenge,TREATS(INFER),Diabetes,32405780,10.1208/s12249-020-01679-z,2020-05-15
Choice Behavior,PROCESS_OF,Neurosurgeon,32405641,10.1093/eurheartj/ehaa381,2020-05-15
Triage,TREATS,Patients,32405641,10.1093/eurheartj/ehaa381,2020-05-15
Disease,PROCESS_OF,Patients,32405622,10.1016/j.isci.2020.101160,2020-05-15
Cardiologists,TREATS,Patients,32405622,10.1016/j.isci.2020.101160,2020-05-15
Acute Coronary Syndrome,PROCESS_OF,Patients,32405622,10.1016/j.isci.2020.101160,2020-05-15
Cardiovascular procedures,COEXISTS_WITH,acute care,32405622,10.1016/j.isci.2020.101160,2020-05-15
"Receptors, Cell Surface",PART_OF,Virus,32405620,10.1016/j.htct.2020.05.001,2020-05-15
Dipeptidyl-Peptidase IV,PART_OF,Homo sapiens,32405620,10.1016/j.htct.2020.05.001,2020-05-15
Multiple Myeloma,PROCESS_OF,Patients,32405603,10.1016/S2468-1253(20)30126-6,2020-05-15
Communicable Diseases,PROCESS_OF,Patients,32405603,10.1016/S2468-1253(20)30126-6,2020-05-15
Multiple Myeloma,PROCESS_OF,Patients,32405603,10.1016/S2468-1253(20)30126-6,2020-05-15
Gastrointestinal symptom,PROCESS_OF,Patients,32405544,10.1016/j.euf.2020.05.001,2020-05-15
Infected,PROCESS_OF,Patients,32405544,10.1016/j.euf.2020.05.001,2020-05-15
Gastrointestinal tract finding,PROCESS_OF,Patients,32405544,10.1016/j.euf.2020.05.001,2020-05-15
Gastrointestinal symptom,PROCESS_OF,Patients,32405544,10.1016/j.euf.2020.05.001,2020-05-15
Digestive symptom,PROCESS_OF,Patients,32405544,10.1016/j.euf.2020.05.001,2020-05-15
WASF1 gene,PART_OF,Patients,32405515,10.1016/j.dib.2020.105698,2020-05-15
Child health care,ISA,Intervention regimes,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Cessation of life,COEXISTS_WITH,Maternal Death,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Antibiotics,TREATS,Pneumonia,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Antibiotics,TREATS,Sepsis of the newborn,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Oral rehydration solution,TREATS,Diarrhea,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Health Care,TREATS,Child,32405454,10.1016/j.rmcr.2020.101090,2020-05-15
Influenza-like symptoms,PROCESS_OF,Patients,32405418,10.1016/j.nmni.2020.100694,2020-05-15
lobe,LOCATION_OF,Ground Glass Opacity,32405418,10.1016/j.nmni.2020.100694,2020-05-15
meropenem,ISA,Pharmaceutical Preparations,32405418,10.1016/j.nmni.2020.100694,2020-05-15
meropenem,TREATS,Pneumonia,32405418,10.1016/j.nmni.2020.100694,2020-05-15
Kidney Failure,PROCESS_OF,Patients,32405418,10.1016/j.nmni.2020.100694,2020-05-15
Hospitals,LOCATION_OF,Study,32405411,10.1016/j.amsu.2020.05.014,2020-05-15
Infected,PROCESS_OF,Nurses,32405411,10.1016/j.amsu.2020.05.014,2020-05-15
Coughing,PROCESS_OF,Patients,32405330,10.1016/j.ajp.2020.102165,2020-05-15
Fever,PROCESS_OF,Patients,32405330,10.1016/j.ajp.2020.102165,2020-05-15
Infected,PROCESS_OF,Patients,32405330,10.1016/j.ajp.2020.102165,2020-05-15
Pandemics,ISA,Disease Outbreaks,32405288,10.1016/j.hemonc.2020.05.001,2020-05-15
Patients,LOCATION_OF,Serum,32405288,10.1016/j.hemonc.2020.05.001,2020-05-15
Male population group,ISA,Adult,32405288,10.1016/j.hemonc.2020.05.001,2020-05-15
Platelet Transfusion,ADMINISTERED_TO,Male population group,32405288,10.1016/j.hemonc.2020.05.001,2020-05-15
Severe Aplastic Anemia,PROCESS_OF,Male population group,32405288,10.1016/j.hemonc.2020.05.001,2020-05-15
"Signs and Symptoms, Respiratory",ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32405285,10.1016/j.dld.2020.05.002,2020-05-15
"Signs and Symptoms, Respiratory",ASSOCIATED_WITH,Storm Syndrome,32405285,10.1016/j.dld.2020.05.002,2020-05-15
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32405285,10.1016/j.dld.2020.05.002,2020-05-15
Arteries,LOCATION_OF,Thromboembolism,32405285,10.1016/j.dld.2020.05.002,2020-05-15
Arterial thrombosis,PROCESS_OF,Patients,32405285,10.1016/j.dld.2020.05.002,2020-05-15
Coronavirus Infections,ISA,Disease,32405277,10.1016/j.sapharm.2020.05.011,2020-05-15
Coronaviridae,PROCESS_OF,Family,32405259,10.1016/j.clinph.2020.05.006,2020-05-15
Genus: Coronavirus,ISA,RNA Viruses,32405259,10.1016/j.clinph.2020.05.006,2020-05-15
Decision,PROCESS_OF,World,32405259,10.1016/j.clinph.2020.05.006,2020-05-15
neurological complication,PROCESS_OF,Patients,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Electroencephalography,ISA,Evaluation,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Technologist,TREATS,Patients,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Comatose,COEXISTS_WITH,Hypoxic Brain Damage,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Stupor,COEXISTS_WITH,Hypoxic Brain Damage,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Chronic lung disease,PROCESS_OF,Patients,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Symptomatic seizures,ASSOCIATED_WITH,Acute respiratory failure,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Clinician,DIAGNOSES,Anoxia,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Clinician,DIAGNOSES,Hypoxia,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Comatose,PROCESS_OF,Patients,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Communicable Diseases,PROCESS_OF,Patients,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Unmarried person,USES,Subdermal needle electrode,32405257,10.1016/j.jcv.2020.104438,2020-05-15
Assay,DIAGNOSES,Virus,32405254,10.1016/j.jcv.2020.104433,2020-05-15
Bronchial Lavage,compared_with,Hanks Balanced Salt Solution,32405254,10.1016/j.jcv.2020.104433,2020-05-15
Quantitative Reverse Transcriptase PCR,METHOD_OF,Detection,32405254,10.1016/j.jcv.2020.104433,2020-05-15
Viral Transport medium,INTERACTS_WITH,Matrix,32405254,10.1016/j.jcv.2020.104433,2020-05-15
Laboratory Procedures,DIAGNOSES,Hypersensitivity,32405254,10.1016/j.jcv.2020.104433,2020-05-15
Hospitals,LOCATION_OF,Study,32405247,10.1016/j.cytogfr.2020.05.005,2020-05-15
Laboratory,LOCATION_OF,Study,32405247,10.1016/j.cytogfr.2020.05.005,2020-05-15
Laboratory Procedures,USES,Detection,32405247,10.1016/j.cytogfr.2020.05.005,2020-05-15
Disease,PROCESS_OF,Persons,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,ISA,Disease,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Pneumonia,PROCESS_OF,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Fever,ISA,Symptoms,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Pneumonia,PROCESS_OF,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Present,COEXISTS_WITH,Fever,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Pneumonia,PROCESS_OF,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
"Neuraminidase inhibitors, direct acting antivirals",ADMINISTERED_TO,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Disease,PROCESS_OF,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,ISA,Disease,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Severe disorder,PROCESS_OF,Patients,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Disease,COEXISTS_WITH,Pneumonia,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,COEXISTS_WITH(SPEC),Pneumonia,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,ISA,Disease,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Serum,LOCATION_OF,Lactate Dehydrogenase,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Serum albumin low result,PREDISPOSES,Pneumonia,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,ISA,Disease,32405236,10.1016/j.micinf.2020.05.005,2020-05-15
Coronavirus Infections,ISA,Disease,32405226,10.1016/j.phrs.2020.104901,2020-05-15
SARS coronavirus,ISA,Virus,32405226,10.1016/j.phrs.2020.104901,2020-05-15
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32405226,10.1016/j.phrs.2020.104901,2020-05-15
Influenza A virus,CAUSES,Respiration Disorders,32405226,10.1016/j.phrs.2020.104901,2020-05-15
century,TREATS,Fever,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
century,TREATS,Malaria,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
century,TREATS,Chills,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
NF-kappa B,STIMULATES,BAX gene,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
NF-kappa B,STIMULATES,BAK1 gene,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
Matrix Metalloproteinases,STIMULATES,Reactive Oxygen Species,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
Artemisinins,AUGMENTS,Apoptosis,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
Vascular Endothelial Growth Factors,AUGMENTS,Cell Cycle Arrest,32405183,10.1016/j.jceh.2020.03.001,2020-05-15
Liver enzymes abnormal,PROCESS_OF,Patients,32405164,10.6026/97320630016139,2020-05-15
Chief complaint (finding),PROCESS_OF,Patients,32405164,10.6026/97320630016139,2020-05-15
Nausea,ISA,Digestive symptom,32405164,10.6026/97320630016139,2020-05-15
Illness (finding),PROCESS_OF,Patients,32405164,10.6026/97320630016139,2020-05-15
Anti-Bacterial Agents,TREATS,Patients,32405164,10.6026/97320630016139,2020-05-15
Anti-Bacterial Agents,TREATS(INFER),Illness (finding),32405164,10.6026/97320630016139,2020-05-15
Coronavirus Infections,PROCESS_OF,Family,32405160,10.1016/j.ejim.2020.05.009,2020-05-15
Vaccines,NEG_TREATS,Patients,32405160,10.1016/j.ejim.2020.05.009,2020-05-15
Prophylactic treatment,TREATS,Patients,32405160,10.1016/j.ejim.2020.05.009,2020-05-15
tocilizumab,ADMINISTERED_TO,Patients,32405158,10.1016/j.clon.2020.05.001,2020-05-15
Respiration,PROCESS_OF,Patients,32405158,10.1016/j.clon.2020.05.001,2020-05-15
Infection,COEXISTS_WITH,Pneumonia,32405158,10.1016/j.clon.2020.05.001,2020-05-15
Stage III Lung Cancer,PROCESS_OF,Patients,32405156,10.1016/j.ijantimicag.2020.106020,2020-05-15
stage III non-small cell lung cancer,ISA,Non-Small Cell Lung Carcinoma,32405156,10.1016/j.ijantimicag.2020.106020,2020-05-15
Lung,PART_OF,Structure of right thigh,32405156,10.1016/j.ijantimicag.2020.106020,2020-05-15
Combined Modality Therapy,USES,Azithromycin,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
Plasma membrane,PART_OF,Host Cell,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
lipid raft,LOCATION_OF,Gangliosides,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
chemical cofactor,PART_OF,Cell-Matrix Junction,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
Combined Modality Therapy,AFFECTS,Patients,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
Combined Modality Therapy,USES,Azithromycin,32405152,10.1016/j.ajodo.2020.04.016,2020-05-15
SARS coronavirus,CAUSES,Communicable Diseases,32405150,10.1016/j.bbi.2020.05.040,2020-05-15
Infectious disease prevention / control,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32405150,10.1016/j.bbi.2020.05.040,2020-05-15
Hispanics,ISA,Population Group,32405146,10.1016/j.cjca.2020.05.009,2020-05-15
Virus,COEXISTS_WITH,nervous system disorder,32405146,10.1016/j.cjca.2020.05.009,2020-05-15
Loneliness,PREDISPOSES,Anxiety,32405146,10.1016/j.cjca.2020.05.009,2020-05-15
Loneliness,PREDISPOSES,Depressive disorder,32405146,10.1016/j.cjca.2020.05.009,2020-05-15
Loneliness,PREDISPOSES,Post-Traumatic Stress Disorder,32405146,10.1016/j.cjca.2020.05.009,2020-05-15
Heart failure,PROCESS_OF,Health Personnel,32405117,10.1016/j.antiviral.2020.104820,2020-05-15
Heart failure,PROCESS_OF,Community,32405117,10.1016/j.antiviral.2020.104820,2020-05-15
SARS coronavirus,LOCATION_OF,Epitopes,32405115,10.1016/j.psychres.2020.113096,2020-05-15
SARS coronavirus,LOCATION_OF,Epitopes,32405115,10.1016/j.psychres.2020.113096,2020-05-15
Binding Sites,INTERACTS_WITH,angiotensin converting enzyme 2,32405115,10.1016/j.psychres.2020.113096,2020-05-15
Disease,PROCESS_OF,Persons,32405114,10.1016/j.psychres.2020.113094,2020-05-15
Disease,PROCESS_OF,Drug abuser,32405114,10.1016/j.psychres.2020.113094,2020-05-15
Has difficulty doing (qualifier value),COMPLICATES,Disease,32405114,10.1016/j.psychres.2020.113094,2020-05-15
Disease,PROCESS_OF,Drug abuser,32405114,10.1016/j.psychres.2020.113094,2020-05-15
Disease,PROCESS_OF,Drug abuser,32405114,10.1016/j.psychres.2020.113094,2020-05-15
Post-Traumatic Stress Disorder,PROCESS_OF,Participant,32405103,10.1016/S0140-6736(20)30854-0,2020-05-15
Depressive Symptoms,PROCESS_OF,Participant,32405103,10.1016/S0140-6736(20)30854-0,2020-05-15
Cessation of life,PROCESS_OF,Persons,32405102,10.1016/j.cell.2020.05.016,2020-05-15
Disease,PROCESS_OF,Persons,32405102,10.1016/j.cell.2020.05.016,2020-05-15
Infected,PROCESS_OF,Persons,32405102,10.1016/j.cell.2020.05.016,2020-05-15
Disease,PROCESS_OF,Persons,32405102,10.1016/j.cell.2020.05.016,2020-05-15
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32405102,10.1016/j.cell.2020.05.016,2020-05-15
Clinical variability,PROCESS_OF,Persons,32405101,10.1016/j.thromres.2020.05.018,2020-05-15
Pneumonia,PREDISPOSES,Venous Thromboembolism,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Diagnosis,DIAGNOSES,Deep Vein Thrombosis,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Deep Vein Thrombosis,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
D-dimer above reference range,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Deep Vein Thrombosis,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Deep Vein Thrombosis,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Deep Vein Thrombosis,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Fibrin fragment D,ASSOCIATED_WITH,Deep Vein Thrombosis,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Fibrin fragment D,ASSOCIATED_WITH,Deep Vein Thrombosis,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Deep Vein Thrombosis,PROCESS_OF,Patients,32405095,10.1016/j.puhe.2020.05.004,2020-05-15
Tertiary Care Centers,LOCATION_OF,Observational Study,32405084,10.1016/j.envres.2020.109652,2020-05-15
Bone structure of ischium,LOCATION_OF,Osteoporotic Fractures,32405084,10.1016/j.envres.2020.109652,2020-05-15
Bone structure of ischium,LOCATION_OF,Osteoporotic Fractures,32405084,10.1016/j.envres.2020.109652,2020-05-15
Hospital admission,TREATS,Osteoporotic Fractures,32405084,10.1016/j.envres.2020.109652,2020-05-15
Bone structure of ischium,LOCATION_OF,Osteoporotic Fractures,32405084,10.1016/j.envres.2020.109652,2020-05-15
Organ,LOCATION_OF,Disease,32405081,10.1016/j.crad.2020.05.001,2020-05-15
Disease,PROCESS_OF,Child,32405081,10.1016/j.crad.2020.05.001,2020-05-15
Disease,PROCESS_OF,Adolescent (age group),32405081,10.1016/j.crad.2020.05.001,2020-05-15
Autistic Disorder,PROCESS_OF,Persons,32405081,10.1016/j.crad.2020.05.001,2020-05-15
discipline,COEXISTS_WITH,Quarantine,32405081,10.1016/j.crad.2020.05.001,2020-05-15
Challenging behavior,PROCESS_OF,Persons,32405081,10.1016/j.crad.2020.05.001,2020-05-15
intensive care unit,LOCATION_OF,Ultrasonography,32405080,10.1016/j.cca.2020.05.019,2020-05-15
Lung,LOCATION_OF,Ultrasonography,32405080,10.1016/j.cca.2020.05.019,2020-05-15
Assay,USES,Flow Cytometry,32405079,10.1016/j.cca.2020.04.034,2020-05-15
Coronavirus Infections,ISA,Communicable Diseases,32405073,10.1016/j.ajog.2020.05.022,2020-05-15
Severe disorder,PROCESS_OF,Patients,32405073,10.1016/j.ajog.2020.05.022,2020-05-15
Severe disorder,PROCESS_OF,Patients,32405073,10.1016/j.ajog.2020.05.022,2020-05-15
Age,PREDISPOSES,Disease,32404899,10.1038/s41430-020-0659-7,2020-05-15
Age,PREDISPOSES(SPEC),Malignant Neoplasms,32404899,10.1038/s41430-020-0659-7,2020-05-15
Malignant Neoplasms,ISA,Disease,32404899,10.1038/s41430-020-0659-7,2020-05-15
Problem,PROCESS_OF,Tissue Donors,32404899,10.1038/s41430-020-0659-7,2020-05-15
Hospitals,LOCATION_OF,Study,32404898,10.1038/s41430-020-0652-1,2020-05-15
Screening procedure,TREATS,Patients,32404898,10.1038/s41430-020-0652-1,2020-05-15
Diabetes,PROCESS_OF,Patients,32404896,10.1038/s41394-020-0288-3,2020-05-15
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32404896,10.1038/s41394-020-0288-3,2020-05-15
Angiotensin II receptor antagonist,TREATS,Patients,32404896,10.1038/s41394-020-0288-3,2020-05-15
angiotensin converting enzyme 2,ASSOCIATED_WITH,Lung Injury,32404896,10.1038/s41394-020-0288-3,2020-05-15
Diabetes,PROCESS_OF,Patients,32404896,10.1038/s41394-020-0288-3,2020-05-15
Diabetes,PROCESS_OF,Patients,32404896,10.1038/s41394-020-0288-3,2020-05-15
Hospitals,LOCATION_OF,Diagnosis,32404799,10.1097/RTI.0000000000000531,2020-05-15
Spinal Cord Injuries,PROCESS_OF,Patients,32404799,10.1097/RTI.0000000000000531,2020-05-15
Spinal Cord Injuries,PROCESS_OF,Cohort,32404799,10.1097/RTI.0000000000000531,2020-05-15
Infected,PROCESS_OF,Cohort,32404799,10.1097/RTI.0000000000000531,2020-05-15
Exudate,PART_OF,Nose,32404799,10.1097/RTI.0000000000000531,2020-05-15
Asthenia,ISA,Symptoms,32404799,10.1097/RTI.0000000000000531,2020-05-15
Spinal Cord Injuries,PROCESS_OF,Patients,32404799,10.1097/RTI.0000000000000531,2020-05-15
Coronavirus Infections,PROCESS_OF,Patients,32404799,10.1097/RTI.0000000000000531,2020-05-15
Symptoms,PROCESS_OF,Patients,32404799,10.1097/RTI.0000000000000531,2020-05-15
Spinal Cord Injuries,PROCESS_OF,Population Group,32404799,10.1097/RTI.0000000000000531,2020-05-15
tomography,DIAGNOSES,pulmonary involvement,32404797,10.1097/RTI.0000000000000533,2020-05-15
Complication,ISA,Disease,32404797,10.1097/RTI.0000000000000533,2020-05-15
Performance,PROCESS_OF,Patients,32404786,10.1097/INF.0000000000002740,2020-05-15
Negative,PROCESS_OF,Patients,32404786,10.1097/INF.0000000000002740,2020-05-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32404786,10.1097/INF.0000000000002740,2020-05-15
Coronavirus Infections,PROCESS_OF,Child,32404780,10.1097/INF.0000000000002742,2020-05-15
Coughing,ISA,Symptoms,32404780,10.1097/INF.0000000000002742,2020-05-15
Interferons,TREATS,Patients,32404780,10.1097/INF.0000000000002742,2020-05-15
Ribavirin,COEXISTS_WITH,Ritonavir,32404780,10.1097/INF.0000000000002742,2020-05-15
Ribavirin,COEXISTS_WITH,lopinavir,32404780,10.1097/INF.0000000000002742,2020-05-15
Ritonavir,TREATS,Negative,32404780,10.1097/INF.0000000000002742,2020-05-15
lopinavir,TREATS,Negative,32404780,10.1097/INF.0000000000002742,2020-05-15
Laboratory Procedures,ISA,diagnostic procedure,32404780,10.1097/INF.0000000000002742,2020-05-15
Asymptomatic,PROCESS_OF,Patients,32404780,10.1097/INF.0000000000002742,2020-05-15
leukemia,PROCESS_OF,Patients,32404721,10.2106/JBJS.20.00602,2020-05-15
Health Care Systems,LOCATION_OF,Study,32404718,10.2106/JBJS.20.00599,2020-05-15
Asymptomatic,PROCESS_OF,Patients,32404711,10.1097/RLU.0000000000003077,2020-05-15
Orthopedic Procedures,ADMINISTERED_TO,Orthopedic Surgeons,32404711,10.1097/RLU.0000000000003077,2020-05-15
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32404711,10.1097/RLU.0000000000003077,2020-05-15
Disease,PREDISPOSES,Severe disorder,32404668,10.1097/SLA.0000000000003991,2020-05-15
Infected,PROCESS_OF,Patients,32404668,10.1097/SLA.0000000000003991,2020-05-15
SUCO gene,PART_OF,Patients,32404668,10.1097/SLA.0000000000003991,2020-05-15
Surgeon,ISA,Health Personnel,32404668,10.1097/SLA.0000000000003991,2020-05-15
SARS coronavirus,ISA,Virus,32404652,10.1097/ADM.0000000000000685,2020-05-15
Substance Use Disorders,PROCESS_OF,Persons,32404651,10.1097/ADM.0000000000000684,2020-05-15
Hotlines,USES,Buprenorphine,32404651,10.1097/ADM.0000000000000684,2020-05-15
Disease,PROCESS_OF,Patients,32404630,10.1097/TA.0000000000002780,2020-05-15
Pharmaceutical Preparations,TREATS,Crisis,32404630,10.1097/TA.0000000000002780,2020-05-15
opioid use,ISA,Disease,32404630,10.1097/TA.0000000000002780,2020-05-15
opioid use,PROCESS_OF(SPEC),Patients,32404630,10.1097/TA.0000000000002780,2020-05-15
Challenge,TREATS,Patients,32404630,10.1097/TA.0000000000002780,2020-05-15
Challenge,TREATS(INFER),Disease,32404630,10.1097/TA.0000000000002780,2020-05-15
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32404630,10.1097/TA.0000000000002780,2020-05-15
Operating Room,LOCATION_OF,case series,32404623,10.1097/SCS.0000000000006654,2020-05-15
Tracheostomy procedure,TREATS,Patients,32404623,10.1097/SCS.0000000000006654,2020-05-15
Tracheostomy procedure,TREATS,Patients,32404623,10.1097/SCS.0000000000006654,2020-05-15
Surgeon,ISA,Health Personnel,32404529,10.1128/JVI.00831-20,2020-05-15
Animals,LOCATION_OF,ACE2 gene,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Homo sapiens,32404514,10.1128/mSphere.00317-20,2020-05-15
Amino Acids,COEXISTS_WITH,ACE2 gene,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Chiroptera,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Raccoons,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Homo sapiens,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Pholidota,32404514,10.1128/mSphere.00317-20,2020-05-15
ACE2 gene,PART_OF,Civets,32404514,10.1128/mSphere.00317-20,2020-05-15
Pharmaceutical Preparations,TREATS,Patients,32404512,10.1128/mSphere.00288-20,2020-05-15
Pharmaceutical Preparations,TREATS(INFER),Malaise,32404512,10.1128/mSphere.00288-20,2020-05-15
Malaise,PROCESS_OF,Patients,32404512,10.1128/mSphere.00288-20,2020-05-15
Pharmaceutical Preparations,TREATS,patient condition,32404512,10.1128/mSphere.00288-20,2020-05-15
Anti-Inflammatory Agents,DISRUPTS,Symptoms,32404498,10.1136/postgradmedj-2020-137840,2020-05-15
"Transport Media, Viral",USES,Assay,32404480,10.1128/JCM.00977-20,2020-05-15
"Transport Media, Viral",AFFECTS,Challenge,32404480,10.1128/JCM.00977-20,2020-05-15
Monoclonal Antibodies,PART_OF,Homo sapiens,32404476,10.1126/science.abc3517,2020-05-15
Patients,LOCATION_OF,Monoclonal Antibodies,32404476,10.1126/science.abc3517,2020-05-15
Antibodies,PART_OF,Lung,32404476,10.1126/science.abc3517,2020-05-15
Immunity,PROCESS_OF,Population Group,32404473,10.1136/jclinpath-2020-206685,2020-05-15
Infected,PROCESS_OF,Persons,32404473,10.1136/jclinpath-2020-206685,2020-05-15
Immunity,PROCESS_OF,Population Group,32404473,10.1136/jclinpath-2020-206685,2020-05-15
Assay,USES,molecular diagnostics (lab procedure),32404436,10.1126/sciimmunol.abc3582,2020-05-15
Laboratory Procedures,METHOD_OF,Diagnosis,32404436,10.1126/sciimmunol.abc3582,2020-05-15
Reverse Transcriptase Polymerase Chain Reaction,USES,Laboratory,32404436,10.1126/sciimmunol.abc3582,2020-05-15
Immune,PROCESS_OF,Persons,32404436,10.1126/sciimmunol.abc3582,2020-05-15
Gastrointestinal symptom,PROCESS_OF,Patients,32404431,10.1542/peds.2020-1056,2020-05-15
Intestines,PART_OF,Homo sapiens,32404431,10.1542/peds.2020-1056,2020-05-15
Fever,PROCESS_OF,Infant,32404416,10.1073/pnas.2006874117,2020-05-15
Fever,PROCESS_OF,Patients,32404416,10.1073/pnas.2006874117,2020-05-15
Leukopenia,PROCESS_OF,Patients,32404416,10.1073/pnas.2006874117,2020-05-15
Coronavirus Infections,CAUSES,Disease,32404307,10.1158/2159-8290.CD-20-0657,2020-05-15
Asymptomatic,PROCESS_OF,Patients,32404307,10.1158/2159-8290.CD-20-0657,2020-05-15
Ambulatory Care Facilities,LOCATION_OF,Commerce,32404302,10.4244/EIJY20M05_01,2020-05-15
Laboratory,LOCATION_OF,Commerce,32404302,10.4244/EIJY20M05_01,2020-05-15
Malignant Neoplasms,PROCESS_OF,Research Personnel,32404302,10.4244/EIJY20M05_01,2020-05-15
Research Personnel,TREATS,Patients,32404302,10.4244/EIJY20M05_01,2020-05-15
Infected,PROCESS_OF,Patients,32404302,10.4244/EIJY20M05_01,2020-05-15
Disease,PROCESS_OF,Patients,32404258,10.1016/j.schres.2020.05.009,2020-05-15
Cardiologists,TREATS,Patients,32404258,10.1016/j.schres.2020.05.009,2020-05-15
Acute Coronary Syndrome,PROCESS_OF,Patients,32404258,10.1016/j.schres.2020.05.009,2020-05-15
Cardiovascular procedures,COEXISTS_WITH,acute care,32404258,10.1016/j.schres.2020.05.009,2020-05-15
Mental disorders,PROCESS_OF,Patients,32404257,10.1016/j.gaceta.2020.04.005,2020-05-15
Bipolar Disorder,PROCESS_OF,Woman,32404257,10.1016/j.gaceta.2020.04.005,2020-05-15
Quarantine,AFFECTS,Violence,32404232,10.1017/ipm.2020.45,2020-05-15
Infantile Neuroaxonal Dystrophy,COEXISTS_WITH,Crisis,32404232,10.1017/ipm.2020.45,2020-05-15
Intellectual Disability,PROCESS_OF,Persons,32404230,10.1017/ipm.2020.25,2020-05-15
Intellectual Disability,PROCESS_OF,Persons,32404230,10.1017/ipm.2020.25,2020-05-15
Intellectual Disability,PROCESS_OF,Persons,32404230,10.1017/ipm.2020.25,2020-05-15
Intellectual Disability,PROCESS_OF,Persons,32404230,10.1017/ipm.2020.25,2020-05-15
Anxiety,CAUSES,Influenza,32404229,10.1192/bjb.2020.54,2020-05-15
Influenza,PROCESS_OF,Hispanics,32404229,10.1192/bjb.2020.54,2020-05-15
Influenza,PROCESS_OF,Hispanics,32404229,10.1192/bjb.2020.54,2020-05-15
Mental disorders,PROCESS_OF,Persons,32404229,10.1192/bjb.2020.54,2020-05-15
Mental disorders,PROCESS_OF,Spanish Person,32404229,10.1192/bjb.2020.54,2020-05-15
Influenza,PREDISPOSES,poor physical health,32404229,10.1192/bjb.2020.54,2020-05-15
Influenza,PROCESS_OF,Hispanics,32404229,10.1192/bjb.2020.54,2020-05-15
Poor outcome,PROCESS_OF,Persons,32404229,10.1192/bjb.2020.54,2020-05-15
Mental disorders,PROCESS_OF,Persons,32404229,10.1192/bjb.2020.54,2020-05-15
Mental disorders,PROCESS_OF,Persons,32404219,10.1017/ipm.2020.43,2020-05-15
Universities,LOCATION_OF,Educational process of instructing,32404189,10.1186/s40001-020-00414-5,2020-05-15
Protection,PROCESS_OF,Child,32404189,10.1186/s40001-020-00414-5,2020-05-15
Critical Illness,PROCESS_OF,Patients,32404178,10.1186/s12939-020-01186-4,2020-05-15
Violence,PROCESS_OF,Community,32404170,10.1186/s12958-020-00605-z,2020-05-15
Infertility,PROCESS_OF,Patients,32404141,10.1186/s13049-020-00735-8,2020-05-15
Therapeutic procedure,ADMINISTERED_TO,Infant,32404141,10.1186/s13049-020-00735-8,2020-05-15
Assisted Reproductive Technologies,ADMINISTERED_TO(SPEC),Infant,32404141,10.1186/s13049-020-00735-8,2020-05-15
Assisted Reproductive Technologies,ISA,Therapeutic procedure,32404141,10.1186/s13049-020-00735-8,2020-05-15
"Crossing Over, Genetic",PROCESS_OF,Adolescent (age group),32404050,10.1186/s12874-020-01011-0,2020-05-15
Hospitals,LOCATION_OF,Study,32403995,10.1080/22221751.2020.1768806,2020-05-15
Genus: Coronavirus,CAUSES,Severe viral infections,32403983,10.1080/09297049.2020.1763938,2020-05-15
Severe viral infections,PROCESS_OF,Homo sapiens,32403983,10.1080/09297049.2020.1763938,2020-05-15
Proteins,AUGMENTS,Virus Internalization,32403983,10.1080/09297049.2020.1763938,2020-05-15
host cell membrane,LOCATION_OF,ACE2 gene,32403983,10.1080/09297049.2020.1763938,2020-05-15
Antibodies,ISA,Agent,32403983,10.1080/09297049.2020.1763938,2020-05-15
Genome,AFFECTS,Complication,32403946,10.2217/fon-2020-0369,2020-05-15
Child,LOCATION_OF,IMPACT gene,32403946,10.2217/fon-2020-0369,2020-05-15
Respiratory Tract Infections,PROCESS_OF,Persons,32403895,10.31616/asj.2020.0193,2020-05-15
Bronchus and lung,LOCATION_OF,Infiltration,32403895,10.31616/asj.2020.0193,2020-05-15
Respiratory Failure,CAUSES,Cessation of life,32403895,10.31616/asj.2020.0193,2020-05-15
Elective Surgical Procedures,ISA,Therapeutic procedure,32403895,10.31616/asj.2020.0193,2020-05-15
Coronavirus Infections,AFFECTS,Birth,32403895,10.31616/asj.2020.0193,2020-05-15
Coronavirus Infections,AFFECTS,Pregnancy,32403895,10.31616/asj.2020.0193,2020-05-15
Disease,PROCESS_OF,Patients,32403894,10.31616/asj.2020.0224,2020-05-15
Experience,PROCESS_OF,Patients,32403894,10.31616/asj.2020.0224,2020-05-15
Back Pain,PROCESS_OF,Patients,32403894,10.31616/asj.2020.0224,2020-05-15
Viral hepatitis,CAUSES,inflammatory response,32403248,10.3390/ijerph17093325,2020-05-15
Liver diseases,OCCURS_IN,Patients,32403248,10.3390/ijerph17093325,2020-05-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32403248,10.3390/ijerph17093325,2020-05-15
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32403248,10.3390/ijerph17093325,2020-05-15
Hepatic impairment,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32403248,10.3390/ijerph17093325,2020-05-15
Hepatic impairment,COEXISTS_WITH,Middle East Respiratory Syndrome,32403248,10.3390/ijerph17093325,2020-05-15
Dentist,DIAGNOSES,Enthesitis-Related Arthritis,32403242,10.3390/v12050527,2020-05-15
Risk level,PROCESS_OF,Patients,32403242,10.3390/v12050527,2020-05-15
Coronavirus Infections,ISA,Disease,32403217,10.3390/jcm9051417,2020-05-15
Disease,AFFECTS,cardiovascular risk factor,32403217,10.3390/jcm9051417,2020-05-15
Coronavirus Infections,AFFECTS(SPEC),cardiovascular risk factor,32403217,10.3390/jcm9051417,2020-05-15
Coronavirus Infections,ISA,Disease,32403217,10.3390/jcm9051417,2020-05-15
Cardiovascular Diseases,COEXISTS_WITH,Disease,32403217,10.3390/jcm9051417,2020-05-15
Cardiovascular Diseases,COEXISTS_WITH(SPEC),Coronavirus Infections,32403217,10.3390/jcm9051417,2020-05-15
Comorbidity,PROCESS_OF,Patients,32403217,10.3390/jcm9051417,2020-05-15
risk factors,PROCESS_OF,Patients,32403217,10.3390/jcm9051417,2020-05-15
Coronavirus Infections,ISA,Disease,32403217,10.3390/jcm9051417,2020-05-15
Cardiovascular,LOCATION_OF,Comorbidity,32403217,10.3390/jcm9051417,2020-05-15
Laboratory Procedures,DIAGNOSES,Disease,32403217,10.3390/jcm9051417,2020-05-15
Laboratory Procedures,DIAGNOSES(SPEC),Coronavirus Infections,32403217,10.3390/jcm9051417,2020-05-15
Coronavirus Infections,ISA,Disease,32403217,10.3390/jcm9051417,2020-05-15
Coronavirus Infections,ISA,Disease,32403217,10.3390/jcm9051417,2020-05-15
"CD69 protein, human",ASSOCIATED_WITH,Disease,32403217,10.3390/jcm9051417,2020-05-15
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32403217,10.3390/jcm9051417,2020-05-15
Disease,AFFECTS,Patients,32403209,10.30773/pi.2020.0127,2020-05-15
Coronavirus Infections,AFFECTS(SPEC),Patients,32403209,10.30773/pi.2020.0127,2020-05-15
Coronavirus Infections,ISA,Disease,32403209,10.30773/pi.2020.0127,2020-05-15
Virus,PROCESS_OF,Human body,32403209,10.30773/pi.2020.0127,2020-05-15
Coronavirus Infections,ISA,Disease,32403209,10.30773/pi.2020.0127,2020-05-15
Evaluation,TREATS,Disease,32403209,10.30773/pi.2020.0127,2020-05-15
Evaluation,TREATS(SPEC),Coronavirus Infections,32403209,10.30773/pi.2020.0127,2020-05-15
Suspected lung cancer,PROCESS_OF,Patients,32403190,10.1111/codi.15134,2020-05-14
Performance,PROCESS_OF,Patients,32403190,10.1111/codi.15134,2020-05-14
Challenge,METHOD_OF,Delivery of Health Care,32403182,10.1002/acr2.11152,2020-05-14
Endoscopy (procedure),DIAGNOSES,Colorectal Carcinoma,32403182,10.1002/acr2.11152,2020-05-14
Abdomen,LOCATION_OF,Endoscopy (procedure),32403182,10.1002/acr2.11152,2020-05-14
Pelvis,LOCATION_OF,Endoscopy (procedure),32403182,10.1002/acr2.11152,2020-05-14
Chronic disease,NEG_AFFECTS,No incoordination,32403155,10.1111/vox.12944,2020-05-14
"Administration, Oral",USES,sultamicillin,32403141,10.1055/s-0040-1712161,2020-05-14
General Practitioners,TREATS,Patients,32403141,10.1055/s-0040-1712161,2020-05-14
Hypertensive disease,CAUSES,Physical Examination,32403141,10.1055/s-0040-1712161,2020-05-14
Lung,LOCATION_OF,Auscultation,32403141,10.1055/s-0040-1712161,2020-05-14
Chest,LOCATION_OF,Radiographic imaging procedure,32403141,10.1055/s-0040-1712161,2020-05-14
Radiographic imaging procedure,DIAGNOSES,Infiltration,32403141,10.1055/s-0040-1712161,2020-05-14
Chest,LOCATION_OF,X-Ray Computed Tomography,32403141,10.1055/s-0040-1712161,2020-05-14
Real-Time Polymerase Chain Reaction,USES,Nasal Swab (procedure),32403010,10.1016/j.jcv.2020.104413,2020-05-14
Cesarean section,compared_with,Vaginal delivery procedure,32403010,10.1016/j.jcv.2020.104413,2020-05-14
Cesarean section,higher_than,Vaginal delivery procedure,32403010,10.1016/j.jcv.2020.104413,2020-05-14
Immunoassay method,METHOD_OF,Detection,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Assay,USES,"Immunoglobulin A, Human",32403008,10.1016/j.jcv.2020.104391,2020-05-14
Patients,LOCATION_OF,Serum,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Healthy Volunteers,LOCATION_OF,Serum,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Laboratory Procedures,DIAGNOSES,Hypersensitivity,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Laboratory Procedures,USES,CD40LG wt Allele,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Laboratory Procedures,USES,"Immunoglobulin A, Human",32403008,10.1016/j.jcv.2020.104391,2020-05-14
Assay,DIAGNOSES,SARS coronavirus,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Assay,USES,Antibodies,32403008,10.1016/j.jcv.2020.104391,2020-05-14
Respiratory viruses,PROCESS_OF,Patients,32402928,10.1016/j.scitotenv.2020.139280,2020-05-14
Movement,PROCESS_OF,Persons,32402910,10.1016/j.scitotenv.2020.139211,2020-05-14
Virus,PROCESS_OF,Family,32402905,10.1016/j.scitotenv.2020.139133,2020-05-14
IMPACT gene,ASSOCIATED_WITH,Disease,32402905,10.1016/j.scitotenv.2020.139133,2020-05-14
Coronavirus Infections,CAUSES,Disease,32402856,10.1016/j.ceca.2020.102212,2020-05-14
"Plumbum metallicum, homeopathic preparation",ADMINISTERED_TO,Nurses,32402766,10.1016/j.mehy.2020.109783,2020-05-14
Coronavirus Infections,ISA,Disease,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Alveolar Epithelial Cells,PART_OF,Lung,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
chloroquine phosphate,ISA,Antimalarials,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
ACE2 gene,PART_OF,Cell surface,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Disease,AFFECTS,Pneumonia,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Pneumonia,AFFECTS,Lung finding,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Hydroxychloroquine,TREATS,Patients,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Hydroxychloroquine,TREATS,Pneumonia,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
"Administration, Oral",USES,Pharmaceutical Preparations,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Pharmaceutical Preparations,AUGMENTS,Resorption,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Liver,LOCATION_OF,Accumulation,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Lung,LOCATION_OF,Accumulation,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Spleen,LOCATION_OF,Accumulation,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Alveolar Epithelial Cells,LOCATION_OF,Hydroxychloroquine,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Infected,PROCESS_OF,Persons,32402764,10.1016/j.jgo.2020.05.001,2020-05-14
Elderly (population group),ISA,Population Group,32402693,10.1016/j.amjoto.2020.102535,2020-05-14
Malignant Neoplasms,PROCESS_OF,Elderly (population group),32402693,10.1016/j.amjoto.2020.102535,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32402693,10.1016/j.amjoto.2020.102535,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),Elderly (population group),32402693,10.1016/j.amjoto.2020.102535,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32402693,10.1016/j.amjoto.2020.102535,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32402693,10.1016/j.amjoto.2020.102535,2020-05-14
Surgeon,LOCATION_OF,IMPACT gene,32402576,10.1016/j.arcmed.2020.04.019,2020-05-14
cytokine production,AFFECTS,Respiratory viruses,32402532,10.1016/j.medin.2020.04.006,2020-05-14
Age,ASSOCIATED_WITH,Disease,32402532,10.1016/j.medin.2020.04.006,2020-05-14
Age,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32402532,10.1016/j.medin.2020.04.006,2020-05-14
Patients,LOCATION_OF,"CD69 protein, human",32402532,10.1016/j.medin.2020.04.006,2020-05-14
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32402532,10.1016/j.medin.2020.04.006,2020-05-14
Cardiovascular Diseases,PROCESS_OF,Patients,32402477,10.1016/j.aprim.2020.04.003,2020-05-14
Cardiovascular Diseases,PROCESS_OF,Patients,32402477,10.1016/j.aprim.2020.04.003,2020-05-14
Cells,LOCATION_OF,Virus,32402433,10.1016/j.arcped.2020.05.004,2020-05-14
Coronavirus Infections,PROCESS_OF,Patients,32402329,10.1016/j.vetmic.2020.108693,2020-05-14
Coronavirus Infections,PROCESS_OF,Animals,32402186,10.1021/acscombsci.0c00058,2020-05-14
SARS coronavirus,PROCESS_OF,Homo sapiens,32402186,10.1021/acscombsci.0c00058,2020-05-14
Italy,ISA,European country,32402090,10.1111/apt.15813,2020-05-14
Patients,LOCATION_OF,IMPACT gene,32402088,10.1093/ageing/afaa113,2020-05-14
Hepatic impairment,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32402088,10.1093/ageing/afaa113,2020-05-14
Clinical Significance,PROCESS_OF,Patients,32402088,10.1093/ageing/afaa113,2020-05-14
Severe Acute Respiratory Syndrome,CAUSES,Evaluation,32402088,10.1093/ageing/afaa113,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32402088,10.1093/ageing/afaa113,2020-05-14
Chronic liver disease,PROCESS_OF,Patients,32402088,10.1093/ageing/afaa113,2020-05-14
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Personal protective equipment,32402061,10.1093/clinchem/hvaa120,2020-05-14
Health Care,METHOD_OF,Challenge,32402061,10.1093/clinchem/hvaa120,2020-05-14
Polymerase Chain Reaction,USES,Assay,32402056,10.1001/jamacardio.2020.2159,2020-05-14
Laboratory,LOCATION_OF,Analysis,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Diabetes,PROCESS_OF,Patients,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Hypertensive disease,PROCESS_OF,Patients,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Cardiac allograft vasculopathy,PROCESS_OF,Patients,32402018,10.1590/1413-81232020255.07192020,2020-05-14
mycophenolate mofetil,TREATS,Patients,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Adrenal Cortex Hormones,INHIBITS,Interleukin 6 Receptor,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Coronavirus Infections,PROCESS_OF,Recipient,32402018,10.1590/1413-81232020255.07192020,2020-05-14
Coronavirus Infections,PROCESS_OF,Population Group,32402018,10.1590/1413-81232020255.07192020,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Participant,32401989,10.5935/0103-507x.20200002,2020-05-14
High Level,PROCESS_OF,Participant,32401989,10.5935/0103-507x.20200002,2020-05-14
Symptom mild,PROCESS_OF,Patients,32401959,10.1590/s1678-9946202062030,2020-05-14
Infected,PROCESS_OF,Patients,32401959,10.1590/s1678-9946202062030,2020-05-14
Adult,ISA,Population Group,32401931,10.1590/1807-3107bor-2020.vol34.0041,2020-05-14
Cross Infection,PROCESS_OF,Dentist,32401907,10.1590/0102-311x00088120,2020-05-14
Cross Infection,PROCESS_OF,Health Personnel,32401907,10.1590/0102-311x00088120,2020-05-14
Cross Infection,PROCESS_OF,Patients,32401907,10.1590/0102-311x00088120,2020-05-14
cardiovascular risk factor,PROCESS_OF,Patients,32401844,10.36660/abc.20200215,2020-05-14
Cardiac complication,PROCESS_OF,Patients,32401844,10.36660/abc.20200215,2020-05-14
diabetic,PROCESS_OF,Patients,32401828,10.1590/1807-3107bor-2020.vol34.0047,2020-05-14
Immune System Diseases,COEXISTS_WITH,Disease Progression,32401828,10.1590/1807-3107bor-2020.vol34.0047,2020-05-14
inflammatory response,COEXISTS_WITH,Disease Progression,32401828,10.1590/1807-3107bor-2020.vol34.0047,2020-05-14
Peptidyl-Dipeptidase A,ADMINISTERED_TO,Cells,32401828,10.1590/1807-3107bor-2020.vol34.0047,2020-05-14
ACE2 gene,STIMULATES,receptor,32401828,10.1590/1807-3107bor-2020.vol34.0047,2020-05-14
Brazil,ISA,Country,32401715,10.1016/S0140-6736(20)31042-4,2020-05-14
Ribavirin,TREATS,Adult,32401686,10.1200/OP.20.00229,2020-05-14
interferon beta-1b,TREATS,Adult,32401686,10.1200/OP.20.00229,2020-05-14
lopinavir / Ritonavir,TREATS,Adult,32401686,10.1200/OP.20.00229,2020-05-14
Negative,PROCESS_OF,Population Group,32401686,10.1200/OP.20.00229,2020-05-14
Viral Shedding,PROCESS_OF,Patients,32401686,10.1200/OP.20.00229,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401680,10.1161/STROKEAHA.120.030340,2020-05-14
paradigm,USES,Conventional Treatment,32401680,10.1161/STROKEAHA.120.030340,2020-05-14
Blood capillaries,LOCATION_OF,BARRIER,32401670,10.1152/ajplung.00144.2020,2020-05-14
Lung,LOCATION_OF,BARRIER,32401670,10.1152/ajplung.00144.2020,2020-05-14
Coronavirus Infections,ISA,Disease,32401670,10.1152/ajplung.00144.2020,2020-05-14
BARRIER,CAUSES,Pulmonary Edema,32401670,10.1152/ajplung.00144.2020,2020-05-14
Blood capillaries,LOCATION_OF,BARRIER,32401670,10.1152/ajplung.00144.2020,2020-05-14
BARRIER,TREATS,patient condition,32401670,10.1152/ajplung.00144.2020,2020-05-14
Acute cardiac pulmonary edema,PROCESS_OF,Patients,32401670,10.1152/ajplung.00144.2020,2020-05-14
Acute cardiac pulmonary edema,PROCESS_OF,Healthy Volunteers,32401670,10.1152/ajplung.00144.2020,2020-05-14
Blood capillaries,LOCATION_OF,BARRIER,32401670,10.1152/ajplung.00144.2020,2020-05-14
Coronavirus Infections,ISA,Disease,32401670,10.1152/ajplung.00144.2020,2020-05-14
Blood capillaries,LOCATION_OF,BARRIER,32401670,10.1152/ajplung.00144.2020,2020-05-14
Adrenal Cortex Hormones,TREATS,Exacerbation of asthma,32401630,10.1089/sur.2020.169,2020-05-14
Inflammation,COEXISTS_WITH,Syndrome,32401630,10.1089/sur.2020.169,2020-05-14
Syndrome,AFFECTS,Asthma,32401630,10.1089/sur.2020.169,2020-05-14
Immunity,AFFECTS,Asthma,32401630,10.1089/sur.2020.169,2020-05-14
Hydroxychloroquine,ISA,Antimalarials,32401401,10.1111/dth.13581,2020-05-14
"Antirheumatic Drugs, Disease-Modifying",TREATS,Rheumatic Fever,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,AFFECTS,glucose homeostasis,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,INTERACTS_WITH,Glucose,32401401,10.1111/dth.13581,2020-05-14
Insulin,PREVENTS,Inflammation,32401401,10.1111/dth.13581,2020-05-14
Insulin,PART_OF,Hepatic,32401401,10.1111/dth.13581,2020-05-14
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32401401,10.1111/dth.13581,2020-05-14
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32401401,10.1111/dth.13581,2020-05-14
Hypoglycemic Agents,TREATS,Patients,32401401,10.1111/dth.13581,2020-05-14
Hypoglycemic Agents,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32401401,10.1111/dth.13581,2020-05-14
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32401401,10.1111/dth.13581,2020-05-14
Diabetes,PROCESS_OF,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS,Patients,32401401,10.1111/dth.13581,2020-05-14
Hydroxychloroquine,TREATS(INFER),Diabetes,32401401,10.1111/dth.13581,2020-05-14
Clinic Visits,COEXISTS_WITH,Quarantine,32401374,10.1002/jmv.26007,2020-05-14
Psoriasis,ISA,Disease,32401374,10.1002/jmv.26007,2020-05-14
Asteatosis cutis,ISA,Disease,32401374,10.1002/jmv.26007,2020-05-14
Serum,LOCATION_OF,Antibodies,32401360,10.5694/mja2.50607,2020-05-14
Serum,LOCATION_OF,Antibodies,32401360,10.5694/mja2.50607,2020-05-14
Coughing,ISA,Symptoms,32401360,10.5694/mja2.50607,2020-05-14
C-reactive protein,compared_with,SAA1 gene,32401360,10.5694/mja2.50607,2020-05-14
Decreasing,COEXISTS_WITH,Gastrointestinal symptom,32401360,10.5694/mja2.50607,2020-05-14
Chest CT,DIAGNOSES,Lesion,32401360,10.5694/mja2.50607,2020-05-14
Immunoglobulin G,TREATS,Patients,32401360,10.5694/mja2.50607,2020-05-14
Symptom mild,PROCESS_OF,Patients,32401360,10.5694/mja2.50607,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Immunity,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Advice,TREATS,Clinician,32401348,10.1002/ijgo.13198,2020-05-14
Clinician,TREATS,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Clinician,TREATS,Patients,32401348,10.1002/ijgo.13198,2020-05-14
Lymphoma panel,DIAGNOSES,Malignant Neoplasms,32401348,10.1002/ijgo.13198,2020-05-14
Population Health,TREATS,World,32401345,10.1002/jmv.26001,2020-05-14
Complication,AFFECTS,Malnutrition,32401345,10.1002/jmv.26001,2020-05-14
Intervention regimes,TREATS,Pregnancy Outcome,32401345,10.1002/jmv.26001,2020-05-14
Isolate - microorganism,PART_OF,Asians,32401343,10.1002/jmv.26005,2020-05-14
Isolate - microorganism,PART_OF,Chilean,32401343,10.1002/jmv.26005,2020-05-14
Labor (Childbirth),COEXISTS_WITH,Birth,32401227,10.1515/jpm-2020-0183,2020-05-14
Labor (Childbirth),ISA,Birth,32401227,10.1515/jpm-2020-0183,2020-05-14
Asymptomatic,PROCESS_OF,Woman,32401227,10.1515/jpm-2020-0183,2020-05-14
Pregnancy,AFFECTS,Family,32401227,10.1515/jpm-2020-0183,2020-05-14
Pregnancy,AFFECTS,Infant,32401227,10.1515/jpm-2020-0183,2020-05-14
Pregnancy,AFFECTS,Mother (person),32401227,10.1515/jpm-2020-0183,2020-05-14
Gravidity,PROCESS_OF,Patients,32401226,10.1515/jpm-2020-0181,2020-05-14
Maternal morbidity,COEXISTS_WITH,Coronavirus Infections,32401219,10.2196/19334,2020-05-14
Coronavirus Infections,ISA,Disease,32401218,10.2196/18995,2020-05-14
Coronavirus Infections,ISA,Disease,32401218,10.2196/18995,2020-05-14
Decision,PROCESS_OF,Maker (occupation),32401215,10.2196/19434,2020-05-14
Coronavirus Infections,ISA,Disease,32401211,10.2196/19702,2020-05-14
Mild cognitive disorder,PROCESS_OF,Elderly (population group),32401211,10.2196/19702,2020-05-14
Mild dementia,PROCESS_OF,Elderly (population group),32401211,10.2196/19702,2020-05-14
Self-Help Devices,USES,Television,32401211,10.2196/19702,2020-05-14
Telemedicine,ISA,Health Care,32401211,10.2196/19702,2020-05-14
Mild cognitive disorder,PROCESS_OF,Elderly (population group),32401211,10.2196/19702,2020-05-14
Mild dementia,PROCESS_OF,Elderly (population group),32401211,10.2196/19702,2020-05-14
Leisure Activities,PREDISPOSES,Disease,32401211,10.2196/19702,2020-05-14
Leisure Activities,PREDISPOSES(SPEC),Coronavirus Infections,32401211,10.2196/19702,2020-05-14
Coronavirus Infections,ISA,Disease,32401211,10.2196/19702,2020-05-14
Coronavirus Infections,ISA,Disease,32401210,10.2196/19087,2020-05-14
Coronavirus Infections,ISA,Disease,32401210,10.2196/19087,2020-05-14
Coronavirus Infections,ISA,Disease,32401210,10.2196/19087,2020-05-14
Coronavirus Infections,ISA,Disease,32401210,10.2196/19087,2020-05-14
Nose,LOCATION_OF,Obstruction,32401210,10.2196/19087,2020-05-14
Coronavirus Infections,ISA,Disease,32401210,10.2196/19087,2020-05-14
STMN1 gene,compared_with,STMN1 gene,32401210,10.2196/19087,2020-05-14
Coronavirus Infections,ISA,Disease,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Coronavirus Infections,ISA,Disease,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Symptoms,PROCESS_OF,Patients,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Fever,ISA,Symptoms,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Symptoms,PROCESS_OF,Patients,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Ground Glass Opacity,PROCESS_OF,Patients,32401085,10.1080/0142159X.2020.1757634,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32401085,10.1080/0142159X.2020.1757634,2020-05-14
Coronavirus Infections,CAUSES,Pneumonia,32401043,10.1089/cmb.2020.0193,2020-05-14
Diagnostic tests,DIAGNOSES,Pneumonia,32401043,10.1089/cmb.2020.0193,2020-05-14
Malignant Neoplasms,PROCESS_OF,Child,32400911,10.1002/jts.22544,2020-05-14
Malignant Neoplasms,PROCESS_OF,Child,32400911,10.1002/jts.22544,2020-05-14
Malignant Neoplasms,COEXISTS_WITH,Malignant Childhood Neoplasm,32400911,10.1002/jts.22544,2020-05-14
Malignant Neoplasms,PROCESS_OF,Child,32400911,10.1002/jts.22544,2020-05-14
Treatment Protocols,TREATS,Child,32400911,10.1002/jts.22544,2020-05-14
Treatment Protocols,TREATS(INFER),Malignant Neoplasms,32400911,10.1002/jts.22544,2020-05-14
Telemedicine,METHOD_OF,Cognitive Therapy,32400879,10.1093/intqhc/mzaa049,2020-05-14
Telemedicine,METHOD_OF,Cognitive Therapy,32400879,10.1093/intqhc/mzaa049,2020-05-14
Telemedicine,METHOD_OF,Cognitive Therapy,32400879,10.1093/intqhc/mzaa049,2020-05-14
Alcohol Use Disorder,PROCESS_OF,Patients,32400852,10.1093/alcalc/agaa045,2020-05-14
Patients,LOCATION_OF,IMPACT gene,32400852,10.1093/alcalc/agaa045,2020-05-14
Ethanol,CAUSES,Derivative Chromosome,32400364,10.2807/1560-7917.ES.2020.25.18.2000603,2020-05-14
Disulfiram,ISA,Ethanol,32400364,10.2807/1560-7917.ES.2020.25.18.2000603,2020-05-14
Disulfiram,TREATS,Patients,32400364,10.2807/1560-7917.ES.2020.25.18.2000603,2020-05-14
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32400362,10.2807/1560-7917.ES.2020.25.18.2000600,2020-05-14
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32400362,10.2807/1560-7917.ES.2020.25.18.2000600,2020-05-14
Fever,ISA,Symptoms,32400361,10.2807/1560-7917.ES.2020.25.18.2000543,2020-05-14
Seizures,PROCESS_OF,Child,32400361,10.2807/1560-7917.ES.2020.25.18.2000543,2020-05-14
Pneumonia,CAUSES,Coronavirus Infections,32400298,10.1080/10872981.2020.1764740,2020-05-14
in vitro study,USES,Therapeutic procedure,32400298,10.1080/10872981.2020.1764740,2020-05-14
Disability,PROCESS_OF,Persons,32400142,10.7748/nm.2020.e1933,2020-05-14
Health Care Systems,LOCATION_OF,research,32400099,10.1111/ajt.15999,2020-05-14
Disease,PROCESS_OF,Patients,32400087,10.1111/ajt.16000,2020-05-14
Coughing,PROCESS_OF,Recipient,32400087,10.1111/ajt.16000,2020-05-14
Dyspnea,PROCESS_OF,Recipient,32400087,10.1111/ajt.16000,2020-05-14
Pneumonia,PROCESS_OF,Recipient,32400087,10.1111/ajt.16000,2020-05-14
Cessation of life,PROCESS_OF,Donor person,32400084,10.1111/ajt.15998,2020-05-14
SARS coronavirus,ISA,Genus: Coronavirus,32400084,10.1111/ajt.15998,2020-05-14
Organ,LOCATION_OF,SARS coronavirus,32400084,10.1111/ajt.15998,2020-05-14
Cessation of life,PROCESS_OF,Donor person,32400084,10.1111/ajt.15998,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Donor person,32400084,10.1111/ajt.15998,2020-05-14
Screening procedure,TREATS,Patients,32400074,10.1111/ajt.15993,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32400074,10.1111/ajt.15993,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Transplant Recipients,32400074,10.1111/ajt.15993,2020-05-14
Pneumonia,PROCESS_OF,Transplant Recipients,32400049,10.1002/ccd.28959,2020-05-14
Calcineurin inhibitor,TREATS,Patients,32400049,10.1002/ccd.28959,2020-05-14
Fatal Outcome,PROCESS_OF,Patients,32400049,10.1002/ccd.28959,2020-05-14
Pneumonia,AFFECTS,Transplant Recipients,32400049,10.1002/ccd.28959,2020-05-14
Isolation procedure,TREATS,Patients,32400044,10.1111/jocs.14604,2020-05-14
Isolation procedure,TREATS,Patients,32400044,10.1111/jocs.14604,2020-05-14
Isolation procedure,TREATS(INFER),Infected,32400044,10.1111/jocs.14604,2020-05-14
Isolation procedure,TREATS(INFER),Acute Coronary Syndrome,32400044,10.1111/jocs.14604,2020-05-14
Infected,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Acute Coronary Syndrome,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Acute Coronary Syndrome,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Disease,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Coronary angiography,ADMINISTERED_TO,Patients,32400044,10.1111/jocs.14604,2020-05-14
Infected,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Hypoxemia,PROCESS_OF,Patients,32400044,10.1111/jocs.14604,2020-05-14
Heart,LOCATION_OF,Severe disorder,32400044,10.1111/jocs.14604,2020-05-14
Percutaneous Coronary Intervention,TREATS,Patients,32400044,10.1111/jocs.14604,2020-05-14
"Intubation, Intratracheal",TREATS,Patients,32400044,10.1111/jocs.14604,2020-05-14
Percutaneous Coronary Intervention,TREATS,Patients,32400044,10.1111/jocs.14604,2020-05-14
Percutaneous Coronary Intervention,TREATS,Acute Coronary Syndrome,32400044,10.1111/jocs.14604,2020-05-14
Elective Surgical Procedures,PREVENTS,disease transmission,32400017,10.1111/ajt.16001,2020-05-14
Coronary Artery Bypass Surgery,TREATS,Woman,32400017,10.1111/ajt.16001,2020-05-14
Discharge location,COEXISTS_WITH,Enthesitis-Related Arthritis,32400017,10.1111/ajt.16001,2020-05-14
Transplantation,TREATS,Patients,32399995,10.1111/ene.14316,2020-05-14
Stroke unit,LOCATION_OF,Study,32399954,10.1007/s11739-020-02348-6,2020-05-14
Symptoms,ASSOCIATED_WITH,Cerebrovascular accident,32399954,10.1007/s11739-020-02348-6,2020-05-14
Elevation procedure,USES,Troponin,32399950,10.1007/s10072-020-04449-8,2020-05-14
Severe disorder,PROCESS_OF,Patients,32399950,10.1007/s10072-020-04449-8,2020-05-14
Elevation procedure,USES,Troponin,32399950,10.1007/s10072-020-04449-8,2020-05-14
CYBB gene,AUGMENTS,Pneumonia,32399950,10.1007/s10072-020-04449-8,2020-05-14
rosoxacin,INTERACTS_WITH,CYBB gene,32399950,10.1007/s10072-020-04449-8,2020-05-14
Polyradiculoneuropathy,COEXISTS_WITH,Communicable Diseases,32399942,10.1007/s00464-020-07629-x,2020-05-14
Flaccid paralysis,PROCESS_OF,Woman,32399942,10.1007/s00464-020-07629-x,2020-05-14
Dissociation,NEG_COEXISTS_WITH,Syndrome,32399942,10.1007/s00464-020-07629-x,2020-05-14
Nasal Swab (procedure),DIAGNOSES,Coronavirus Infections,32399942,10.1007/s00464-020-07629-x,2020-05-14
Early complication,PROCESS_OF,Patients,32399942,10.1007/s00464-020-07629-x,2020-05-14
Surgeon,ISA,Health Personnel,32399908,10.1007/s00266-020-01751-w,2020-05-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32399806,10.1007/s12015-020-09987-4,2020-05-14
Respiratory Failure,PROCESS_OF,Patients,32399806,10.1007/s12015-020-09987-4,2020-05-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32399806,10.1007/s12015-020-09987-4,2020-05-14
SARS coronavirus,ISA,Virus,32399798,10.1007/s10461-020-02908-z,2020-05-14
IMPACT gene,CAUSES,Cardiac complication,32399798,10.1007/s10461-020-02908-z,2020-05-14
Hematological Disease,ISA,Disease,32399798,10.1007/s10461-020-02908-z,2020-05-14
Coronavirus Infections,ISA,Disease,32399798,10.1007/s10461-020-02908-z,2020-05-14
Eye,LOCATION_OF,Household composition,32399755,10.1007/s12024-020-00258-9,2020-05-14
Eye,LOCATION_OF,Pneumonia,32399719,10.1007/s12640-020-00219-8,2020-05-14
Autopsy,ADMINISTERED_TO,Medical pathologist,32399719,10.1007/s12640-020-00219-8,2020-05-14
Central Nervous System,ASSOCIATED_WITH,Prognosis bad,32399710,10.1007/s00330-020-06928-0,2020-05-14
Central Nervous System,ASSOCIATED_WITH,Worse,32399710,10.1007/s00330-020-06928-0,2020-05-14
Severe Acute Respiratory Syndrome,CAUSES,Symptoms,32399710,10.1007/s00330-020-06928-0,2020-05-14
Fever,ISA,Symptoms,32399655,10.1007/s00395-020-0795-1,2020-05-14
Pneumonia,PROCESS_OF,Patients,32399655,10.1007/s00395-020-0795-1,2020-05-14
Pneumonia,PROCESS_OF,Patients,32399655,10.1007/s00395-020-0795-1,2020-05-14
Wall of bronchiole,LOCATION_OF,Thickened,32399655,10.1007/s00395-020-0795-1,2020-05-14
Wall of bronchiole,LOCATION_OF,Thickened,32399655,10.1007/s00395-020-0795-1,2020-05-14
Definitive Treatment,NEG_TREATS,Patients,32399620,10.1007/s00259-020-04854-3,2020-05-14
Severe disorder,PROCESS_OF,Patients,32399620,10.1007/s00259-020-04854-3,2020-05-14
Critical Illness,PROCESS_OF,Patients,32399620,10.1007/s00259-020-04854-3,2020-05-14
Coronavirus Infections,ISA,Disease,32399522,10.11152/mu-2612,2020-05-14
Coronavirus Infections,ISA,Disease,32399522,10.11152/mu-2612,2020-05-14
Intervention regimes,TREATS,disease transmission,32399501,10.12688/wellcomeopenres.15795.1,2020-05-14
Wounds and Injuries,PROCESS_OF,teams,32399481,10.1016/j.jrid.2020.05.002,2020-05-14
Wounds and Injuries,PROCESS_OF,Patients,32399481,10.1016/j.jrid.2020.05.002,2020-05-14
Quarantine,COEXISTS_WITH,Evaluation,32399479,10.1007/s13337-020-00594-y,2020-05-14
Lung,LOCATION_OF,Ground Glass Opacity,32399479,10.1007/s13337-020-00594-y,2020-05-14
Chest CT,DIAGNOSES,Ground Glass Opacity,32399479,10.1007/s13337-020-00594-y,2020-05-14
SARS coronavirus,PROCESS_OF,Homo sapiens,32399457,10.12890/2020_001691,2020-05-14
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32399457,10.12890/2020_001691,2020-05-14
Fever,ISA,Symptoms,32399456,10.12890/2020_001690,2020-05-14
Headache,PROCESS_OF,Male population group,32399456,10.12890/2020_001690,2020-05-14
tomography,DIAGNOSES,Cerebral venous sinus thrombosis,32399456,10.12890/2020_001690,2020-05-14
Cerebral venous sinus thrombosis,ISA,Symptoms,32399456,10.12890/2020_001690,2020-05-14
"Pneumonia, Interstitial",PROCESS_OF,Patients,32399455,10.12890/2020_001675,2020-05-14
Blood Vessel,LOCATION_OF,Arterial thrombosis,32399455,10.12890/2020_001675,2020-05-14
Intestines,LOCATION_OF,Pathological Dilatation,32399455,10.12890/2020_001675,2020-05-14
abdomen scan,DIAGNOSES,Arterial thrombosis,32399455,10.12890/2020_001675,2020-05-14
Superior mesenteric,LOCATION_OF,Arteries,32399455,10.12890/2020_001675,2020-05-14
Arteries,LOCATION_OF,Thromboembolism,32399455,10.12890/2020_001675,2020-05-14
Thromboembolism,AFFECTS,Patients,32399455,10.12890/2020_001675,2020-05-14
Thromboembolism,PROCESS_OF,Patients,32399455,10.12890/2020_001675,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32399455,10.12890/2020_001675,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32399455,10.12890/2020_001675,2020-05-14
Antithrombotic Agents,TREATS,Thrombus,32399455,10.12890/2020_001675,2020-05-14
Immune response,PROCESS_OF,Patients,32399454,10.12890/2020_001672,2020-05-14
Antiviral Therapy,TREATS,Cytokine release syndrome,32399454,10.12890/2020_001672,2020-05-14
Therapeutic immunosuppression,USES,tocilizumab,32399454,10.12890/2020_001672,2020-05-14
Immunotherapy,TREATS,Clinical Deterioration,32399454,10.12890/2020_001672,2020-05-14
Clinical Deterioration,ASSOCIATED_WITH,Pneumonia,32399454,10.12890/2020_001672,2020-05-14
Therapeutic immunosuppression,TREATS,Patients,32399454,10.12890/2020_001672,2020-05-14
Cytokine release syndrome,PROCESS_OF,Patients,32399454,10.12890/2020_001672,2020-05-14
tocilizumab,TREATS,Patients,32399454,10.12890/2020_001672,2020-05-14
tocilizumab,TREATS(INFER),Cytokine release syndrome,32399454,10.12890/2020_001672,2020-05-14
Myocarditis,PROCESS_OF,Patients,32399453,10.12890/2020_001665,2020-05-14
Acute Coronary Syndrome,PROCESS_OF,Patients,32399453,10.12890/2020_001665,2020-05-14
Elevation procedure,NEG_TREATS,Patients,32399453,10.12890/2020_001665,2020-05-14
health information,METHOD_OF,Supportive care,32399452,10.12890/2020_001656,2020-05-14
Nasal Swab (procedure),DIAGNOSES,Pneumonia,32399452,10.12890/2020_001656,2020-05-14
Tachycardia,PROCESS_OF,Patients,32399452,10.12890/2020_001656,2020-05-14
Cardiac complication,COEXISTS_WITH,Takotsubo Cardiomyopathy,32399452,10.12890/2020_001656,2020-05-14
Influenza A,PROCESS_OF,Woman,32399451,10.12890/2020_001652,2020-05-14
urgent Operation,TREATS,Patients,32399449,10.12890/2020_001646,2020-05-14
Mental disorders,COMPLICATES,Disease,32399449,10.12890/2020_001646,2020-05-14
Psychiatric symptom,PROCESS_OF,Persons,32399449,10.12890/2020_001646,2020-05-14
Distress,PROCESS_OF,Patients,32399449,10.12890/2020_001646,2020-05-14
Coughing,ISA,Symptoms,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Fever,ISA,Symptoms,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,risk factors,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Blood Coagulation Disorders,AFFECTS,Cessation of life,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Disseminated Intravascular Coagulation,AFFECTS,Cessation of life,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Pneumonia,COEXISTS_WITH,Sign or Symptom,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Pneumonia,PROCESS_OF,Patients,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Pulmonary Embolism,PROCESS_OF,Patients,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Venous Thrombosis,PROCESS_OF,Patients,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
disease prevention,NEG_PREVENTS,Venous Thromboembolism,32399393,10.1016/j.rmcr.2020.101087,2020-05-14
disease prevention,USES,"Heparin, Low-Molecular-Weight",32399393,10.1016/j.rmcr.2020.101087,2020-05-14
Eye,LOCATION_OF,Virus,32399342,10.7759/cureus.7608,2020-05-14
Infected,PROCESS_OF,Patients,32399342,10.7759/cureus.7608,2020-05-14
Health Personnel,TREATS,Patients,32399342,10.7759/cureus.7608,2020-05-14
Peripheral,LOCATION_OF,Immune Cell,32399192,10.12688/f1000research.22611.1,2020-05-14
Peripheral,LOCATION_OF,Immune Cell,32399192,10.12688/f1000research.22611.1,2020-05-14
Response process,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32399192,10.12688/f1000research.22611.1,2020-05-14
Immune Cell,LOCATION_OF,KIR2DL4 gene,32399192,10.12688/f1000research.22611.1,2020-05-14
Immune Cell,LOCATION_OF,LILRB2 gene,32399192,10.12688/f1000research.22611.1,2020-05-14
Immunologic Adjuvants,TREATS,Elderly (population group),32399096,10.5114/aoms.2020.94567,2020-05-14
Vaccines,TREATS,Elderly (population group),32399096,10.5114/aoms.2020.94567,2020-05-14
Vaccines,AUGMENTS,Cells,32399096,10.5114/aoms.2020.94567,2020-05-14
Vaccines,TREATS,Old age,32399096,10.5114/aoms.2020.94567,2020-05-14
Economic problem,PROCESS_OF,World,32399095,10.5114/aoms.2020.94046,2020-05-14
Protease Inhibitors,ISA,Pharmaceutical Preparations,32399095,10.5114/aoms.2020.94046,2020-05-14
Protease Inhibitors,TREATS,HIV Infections,32399095,10.5114/aoms.2020.94046,2020-05-14
vapreotide,ISA,Pharmaceutical Preparations,32399095,10.5114/aoms.2020.94046,2020-05-14
DNA Helicases,ISA,Pharmaceutical Preparations,32399095,10.5114/aoms.2020.94046,2020-05-14
Nucleoside Reverse Transcriptase Inhibitor,ISA,Pharmaceutical Preparations,32399095,10.5114/aoms.2020.94046,2020-05-14
Nucleoside Reverse Transcriptase Inhibitor,TREATS,HIV Infections,32399095,10.5114/aoms.2020.94046,2020-05-14
Non-nucleoside reverse transcriptase inhibitors,TREATS,HIV Infections,32399095,10.5114/aoms.2020.94046,2020-05-14
Ligands,INTERACTS_WITH,receptor,32399094,10.5114/aoms.2020.94655,2020-05-14
Phosphoproteins,PART_OF,Nucleocapsid,32399094,10.5114/aoms.2020.94655,2020-05-14
Phosphoproteins,PART_OF,Nucleocapsid,32399094,10.5114/aoms.2020.94655,2020-05-14
Vitality,PROCESS_OF,Foundation for the Accreditation of Cellular Therapy,32399092,10.1016/j.eujim.2020.101136,2020-05-14
pitavastatin,INTERACTS_WITH,Hydroxymethylglutaryl-CoA Reductase Inhibitors,32399092,10.1016/j.eujim.2020.101136,2020-05-14
pitavastatin,ISA,Hydroxymethylglutaryl-CoA Reductase Inhibitors,32399092,10.1016/j.eujim.2020.101136,2020-05-14
Cessation of life,PROCESS_OF,Homo sapiens,32398918,10.1016/j.jcot.2020.05.007,2020-05-14
N18,PROCESS_OF,Patients,32398902,10.1016/j.ssci.2020.104811,2020-05-14
Infected,PROCESS_OF,industrial worker,32398901,10.1016/j.ssci.2020.104810,2020-05-14
Disease,PROCESS_OF,industrial worker,32398901,10.1016/j.ssci.2020.104810,2020-05-14
Vaccines,AFFECTS,reception,32398890,10.1016/j.chb.2020.106424,2020-05-14
Therapeutic procedure,AFFECTS,reception,32398890,10.1016/j.chb.2020.106424,2020-05-14
RNA Sequence,ADMINISTERED_TO,Patients,32398625,10.1097/SCS.0000000000006601,2020-05-14
RNA Sequence,PART_OF,Cells,32398625,10.1097/SCS.0000000000006601,2020-05-14
Patients,LOCATION_OF,Bronchoalveolar Lavage Fluid,32398625,10.1097/SCS.0000000000006601,2020-05-14
Nose,PART_OF,Entire ear,32398624,10.1097/SCS.0000000000006574,2020-05-14
angiotensin converting enzyme 2,AFFECTS,Possible,32398624,10.1097/SCS.0000000000006574,2020-05-14
Head and neck structure,LOCATION_OF,Respiratory Tract Infections,32398607,10.1097/HCO.0000000000000759,2020-05-14
Surgeon,ISA,Health Personnel,32398607,10.1097/HCO.0000000000000759,2020-05-14
Antihypertensive therapy,AFFECTS,Blood Pressure,32398569,10.1097/INF.0000000000002700,2020-05-14
Cardiovascular,LOCATION_OF,Disease Outcome,32398569,10.1097/INF.0000000000002700,2020-05-14
Symptoms,PROCESS_OF,Adult,32398567,10.1097/MOG.0000000000000646,2020-05-14
Severe disorder,PROCESS_OF,Adult,32398567,10.1097/MOG.0000000000000646,2020-05-14
Coughing,ISA,Symptoms,32398567,10.1097/MOG.0000000000000646,2020-05-14
Nose,LOCATION_OF,Congestion,32398567,10.1097/MOG.0000000000000646,2020-05-14
Rhinorrhea,ISA,Symptoms,32398567,10.1097/MOG.0000000000000646,2020-05-14
Cessation of life,PROCESS_OF,Child,32398567,10.1097/MOG.0000000000000646,2020-05-14
Pregnancy,PROCESS_OF,"Infant, Newborn",32398567,10.1097/MOG.0000000000000646,2020-05-14
Pregnancy,PROCESS_OF,Woman,32398567,10.1097/MOG.0000000000000646,2020-05-14
Pharmaceutical Preparations,AUGMENTS,Peeling of skin,32398410,10.2106/JBJS.20.00709,2020-05-14
Elective procedure,PREDISPOSES,Communicable Diseases,32398383,10.5604/01.3001.0014.1320,2020-05-14
Disability,PROCESS_OF,Patients,32398383,10.5604/01.3001.0014.1320,2020-05-14
Persistence,PROCESS_OF,Population Group,32398343,10.3399/bjgpopen20X101094,2020-05-14
Azithromycin,ISA,Pharmaceutical Preparations,32398322,10.1136/archdischild-2020-319261,2020-05-14
Azithromycin,COEXISTS_WITH,Hydroxychloroquine,32398322,10.1136/archdischild-2020-319261,2020-05-14
Hydroxychloroquine,TREATS,Patients,32398322,10.1136/archdischild-2020-319261,2020-05-14
Azithromycin,TREATS,Bacterial Infections,32398322,10.1136/archdischild-2020-319261,2020-05-14
Azithromycin,TREATS,Patients,32398322,10.1136/archdischild-2020-319261,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32398322,10.1136/archdischild-2020-319261,2020-05-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32398322,10.1136/archdischild-2020-319261,2020-05-14
Hydroxychloroquine,INTERACTS_WITH,Azithromycin,32398322,10.1136/archdischild-2020-319261,2020-05-14
Infected,PROCESS_OF,Adult,32398273,10.1261/rna.076141.120,2020-05-14
Disease,PROCESS_OF,Child,32398273,10.1261/rna.076141.120,2020-05-14
Infected,PROCESS_OF,Child,32398273,10.1261/rna.076141.120,2020-05-14
Gastrointestinal symptom,PROCESS_OF,Child,32398273,10.1261/rna.076141.120,2020-05-14
Asymptomatic Infections,PROCESS_OF,Older child,32398273,10.1261/rna.076141.120,2020-05-14
Cessation of life,PROCESS_OF,Human Age Group,32398273,10.1261/rna.076141.120,2020-05-14
Asymptomatic,PROCESS_OF,Child,32398273,10.1261/rna.076141.120,2020-05-14
Asymptomatic,PROCESS_OF,Adolescent (age group),32398273,10.1261/rna.076141.120,2020-05-14
Infected,PROCESS_OF,Child,32398273,10.1261/rna.076141.120,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32398273,10.1261/rna.076141.120,2020-05-14
Antiviral Agents,INTERACTS_WITH,RNA,32398268,10.7861/clinmed.2020-0123,2020-05-14
"Respiratory Distress Syndrome, Adult",ISA,Complication,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Pandemics,ISA,Disease Outbreaks,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Lung,LOCATION_OF,Ultrasonography,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Coronavirus Infections,PROCESS_OF,Male population group,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Lung,LOCATION_OF,Ultrasonography,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Ultrasonography,METHOD_OF,Diagnosis,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Lung,LOCATION_OF,Ultrasonography,32398243,10.1158/2159-8290.CD-20-0596,2020-05-14
Malignant Neoplasms,PROCESS_OF,Patients,32398188,10.1017/S1049023X20000643,2020-05-14
Malignant neoplasm of lung,PROCESS_OF,Patients,32398188,10.1017/S1049023X20000643,2020-05-14
Malignant neoplasm of lung,PROCESS_OF,Patients,32398188,10.1017/S1049023X20000643,2020-05-14
Patients,LOCATION_OF,IMPACT gene,32398188,10.1017/S1049023X20000643,2020-05-14
Malignant neoplasm of lung,PROCESS_OF,Patients,32398188,10.1017/S1049023X20000643,2020-05-14
Coughing,PROCESS_OF,Woman,32398170,10.1017/cem.2020.400,2020-05-14
Disease,PROCESS_OF,Family member,32398170,10.1017/cem.2020.400,2020-05-14
Dyspnea,PROCESS_OF,Woman,32398170,10.1017/cem.2020.400,2020-05-14
Fever,PROCESS_OF,Woman,32398170,10.1017/cem.2020.400,2020-05-14
Coronavirus Infections,ISA,Disease,32398170,10.1017/cem.2020.400,2020-05-14
Coronavirus Infections,PROCESS_OF(SPEC),Family member,32398170,10.1017/cem.2020.400,2020-05-14
Myalgia,PROCESS_OF,Woman,32398170,10.1017/cem.2020.400,2020-05-14
Phase 3 Clinical Trials,USES,cancer therapy,32398162,10.1186/s40246-020-00267-3,2020-05-14
Toxic effect,PROCESS_OF,Homo sapiens,32398162,10.1186/s40246-020-00267-3,2020-05-14
Proteins,INTERACTS_WITH,Nucleic Acids,32398162,10.1186/s40246-020-00267-3,2020-05-14
Lipogenesis,AFFECTS,Energy Metabolism,32398162,10.1186/s40246-020-00267-3,2020-05-14
Pharmaceutical Preparations,DISRUPTS,"Tumor cells, malignant",32398162,10.1186/s40246-020-00267-3,2020-05-14
Disease,INTERACTS_WITH,SARS coronavirus,32398137,10.1186/s12992-020-00575-2,2020-05-14
Disease,INTERACTS_WITH,Middle East Respiratory Syndrome Coronavirus,32398137,10.1186/s12992-020-00575-2,2020-05-14
Coronavirus Infections,INTERACTS_WITH(SPEC),SARS coronavirus,32398137,10.1186/s12992-020-00575-2,2020-05-14
Coronavirus Infections,INTERACTS_WITH(SPEC),Middle East Respiratory Syndrome Coronavirus,32398137,10.1186/s12992-020-00575-2,2020-05-14
Coronavirus Infections,ISA,Disease,32398137,10.1186/s12992-020-00575-2,2020-05-14
gene therapy,PREDISPOSES,Disease,32398137,10.1186/s12992-020-00575-2,2020-05-14
gene therapy,PREDISPOSES(SPEC),Coronavirus Infections,32398137,10.1186/s12992-020-00575-2,2020-05-14
Coronavirus Infections,ISA,Disease,32398137,10.1186/s12992-020-00575-2,2020-05-14
Coronavirus Infections,AFFECTS,Persons,32398026,10.1186/s12967-020-02363-3,2020-05-14
India,ISA,Country,32398026,10.1186/s12967-020-02363-3,2020-05-14
SPEN gene,AUGMENTS,Infected,32398026,10.1186/s12967-020-02363-3,2020-05-14
huperzine B,TREATS,Passenger,32398026,10.1186/s12967-020-02363-3,2020-05-14
Viral Vaccines,DISRUPTS,Immunosenescence,32397951,10.1080/07391102.2020.1767211,2020-05-14
Well adult,PROCESS_OF,Old age,32397951,10.1080/07391102.2020.1767211,2020-05-14
Antiviral Agents,TREATS,Patients,32397940,10.1080/07391102.2020.1766572,2020-05-14
Body tissue,LOCATION_OF,angiotensin converting enzyme 2,32397940,10.1080/07391102.2020.1766572,2020-05-14
Lung,LOCATION_OF,angiotensin converting enzyme 2,32397940,10.1080/07391102.2020.1766572,2020-05-14
Body tissue,LOCATION_OF,receptor,32397940,10.1080/07391102.2020.1766572,2020-05-14
Molecular Dynamics Simulation,METHOD_OF,Exploration procedure,32397915,10.1080/09537104.2020.1762852,2020-05-14
Lung,LOCATION_OF,Microthrombosis,32397911,10.4155/tde-2020-0035,2020-05-14
Present,PREDISPOSES,Microthrombosis,32397911,10.4155/tde-2020-0035,2020-05-14
Present,PROCESS_OF,Patients,32397911,10.4155/tde-2020-0035,2020-05-14
Organ,LOCATION_OF,Present,32397911,10.4155/tde-2020-0035,2020-05-14
patient condition,PROCESS_OF,Cohort,32397911,10.4155/tde-2020-0035,2020-05-14
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32397906,10.1080/07391102.2020.1767210,2020-05-14
Infection,PROCESS_OF,Homo sapiens,32397896,10.1177/1093526620925569,2020-05-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Animal Model,32397896,10.1177/1093526620925569,2020-05-14
Middle East Respiratory Syndrome,PROCESS_OF,Animal Model,32397896,10.1177/1093526620925569,2020-05-14
Coronavirus Infections,CAUSES,Cessation of life,32397762,10.1177/1535370220925768,2020-05-14
Coronavirus Infections,ISA,Disease,32397762,10.1177/1535370220925768,2020-05-14
Crisis Intervention,PREVENTS,Anxiety,32397688,10.3390/v12050526,2020-05-14
Crisis Intervention,PREVENTS,Depressive disorder,32397688,10.3390/v12050526,2020-05-14
Crisis Intervention,PREVENTS,Post-Traumatic Stress Disorder,32397688,10.3390/v12050526,2020-05-14
Symptoms,ASSOCIATED_WITH,Pneumonia,32397684,10.3390/ijms21093377,2020-05-14
Gene Expression Profiling,USES,Map,32397684,10.3390/ijms21093377,2020-05-14
intensive care,TREATS,Patients,32397643,10.3390/v12050525,2020-05-14
Antiviral Agents,CAUSES,"Respiratory Distress Syndrome, Adult",32397643,10.3390/v12050525,2020-05-14
Vaccines,TREATS,Patients,32397643,10.3390/v12050525,2020-05-14
Drug Repositioning,USES,Basis,32397558,10.3390/jcm9051407,2020-05-14
Comorbidity,PROCESS_OF,Patients,32397530,10.3390/jcm9051403,2020-05-14
Cardiovascular,LOCATION_OF,Comorbidity,32397530,10.3390/jcm9051403,2020-05-14
Comprehensive Health Care,TREATS,Patients,32397530,10.3390/jcm9051403,2020-05-14
Comprehensive Health Care,TREATS(INFER),Critical Illness,32397530,10.3390/jcm9051403,2020-05-14
Critical Illness,PROCESS_OF,Patients,32397530,10.3390/jcm9051403,2020-05-14
Cardiovascular,LOCATION_OF,consideration,32397530,10.3390/jcm9051403,2020-05-14
Medical procedure,TREATS,World,32397515,10.3390/ijerph17093311,2020-05-14
SPEN gene,DISRUPTS,Eye,32397515,10.3390/ijerph17093311,2020-05-14
Protection,COEXISTS_WITH,Enthesitis-Related Arthritis,32397515,10.3390/ijerph17093311,2020-05-14
Challenge,TREATS,Arbovirus Infections,32397511,10.3390/nu12051359,2020-05-14
Symptom severe,PROCESS_OF,Patients,32397499,10.3390/dj8020046,2020-05-14
Plasma,LOCATION_OF,Ergocalciferol,32397499,10.3390/dj8020046,2020-05-14
World,LOCATION_OF,IMPACT gene,32397487,10.3390/diagnostics10050290,2020-05-14
Asymptomatic,PROCESS_OF,Patients,32397399,10.3390/microorganisms8050695,2020-05-14
screening tests,TREATS,Patients,32397275,10.3390/brainsci10050284,2020-05-14
Infected,PROCESS_OF,Patients,32397182,10.3390/v12050518,2020-05-14
Introduction procedure,ADMINISTERED_TO,human group,32397174,10.3390/ijms21093330,2020-05-14
Introduction procedure,CAUSES,Infection,32397174,10.3390/ijms21093330,2020-05-14
Infection,PROCESS_OF,Homo sapiens,32397174,10.3390/ijms21093330,2020-05-14
Cells,PART_OF,Insecta,32397174,10.3390/ijms21093330,2020-05-14
Pneumonia,PROCESS_OF,Patients,32397138,10.3390/pathogens9050355,2020-05-14
"Pneumonia, Interstitial",CAUSES,Disease,32397138,10.3390/pathogens9050355,2020-05-14
Antiviral Agents,TREATS,underlying infection,32397138,10.3390/pathogens9050355,2020-05-14
Immunosuppressive Agents,ASSOCIATED_WITH,Rheumatism,32397138,10.3390/pathogens9050355,2020-05-14
Immunosuppressive Agents,ADMINISTERED_TO,Patients,32397138,10.3390/pathogens9050355,2020-05-14
Patient observation,TREATS,Zoonoses,32397011,10.1111/irv.12758,2020-05-13
logistic regression analysis,METHOD_OF,Demography,32397008,10.1111/anae.15115,2020-05-13
Present,PROCESS_OF,Family,32397008,10.1111/anae.15115,2020-05-13
Coronavirus Infections,ISA,Disease,32397008,10.1111/anae.15115,2020-05-13
Coughing,ISA,Symptoms,32397008,10.1111/anae.15115,2020-05-13
Fever,ISA,Symptoms,32397008,10.1111/anae.15115,2020-05-13
Amino Acids,PART_OF,Unmarried person,32397008,10.1111/anae.15115,2020-05-13
Intubation,TREATS,Patients,32397000,10.1111/hae.14044,2020-05-13
Intubation,ADMINISTERED_TO,Specialist,32397000,10.1111/hae.14044,2020-05-13
Intubation,ADMINISTERED_TO,Anesthetist,32397000,10.1111/hae.14044,2020-05-13
Blood Coagulation Disorders,PROCESS_OF,Community,32396999,10.1111/pde.14227,2020-05-13
Acral Lesion,PROCESS_OF,Patients,32396996,10.1111/all.14364,2020-05-13
Symptom mild,PROCESS_OF,Patients,32396996,10.1111/all.14364,2020-05-13
Prophylactic treatment,USES,Pharmaceutical Preparations,32396986,10.1111/anae.15120,2020-05-13
Prophylactic treatment,USES,Vaccines,32396986,10.1111/anae.15120,2020-05-13
Immune response,PROCESS_OF,Patients,32396986,10.1111/anae.15120,2020-05-13
Immunity,PROCESS_OF,Population Group,32396986,10.1111/anae.15120,2020-05-13
"Immunoglobulin A, Human",PREVENTS,Disease,32396986,10.1111/anae.15120,2020-05-13
Virus,PROCESS_OF,Health Personnel,32396986,10.1111/anae.15120,2020-05-13
Storm NOS,CAUSES,Multiple Organ Failure,32396986,10.1111/anae.15120,2020-05-13
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32396986,10.1111/anae.15120,2020-05-13
Immune,PREDISPOSES,Prognosis bad,32396986,10.1111/anae.15120,2020-05-13
Pharmaceutical Preparations,TREATS,Patients,32396986,10.1111/anae.15120,2020-05-13
Patients,ISA,Persons,32396986,10.1111/anae.15120,2020-05-13
Vaccines,TREATS,Patients,32396986,10.1111/anae.15120,2020-05-13
Invasive mechanical ventilation NOS,TREATS,Patients,32396948,10.1055/s-0040-1712121,2020-05-13
Tracheostomy procedure,ISA,Implantation procedure,32396948,10.1055/s-0040-1712121,2020-05-13
Experience,PROCESS_OF,Staff,32396948,10.1055/s-0040-1712121,2020-05-13
Congenital Abnormality,ISA,Fetal Diseases,32396947,10.1055/s-0040-1710538,2020-05-13
Fetal Growth Retardation,ISA,Fetal Diseases,32396947,10.1055/s-0040-1710538,2020-05-13
Prenatal care,TREATS,Patients,32396947,10.1055/s-0040-1710538,2020-05-13
Prenatal care,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32396947,10.1055/s-0040-1710538,2020-05-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32396947,10.1055/s-0040-1710538,2020-05-13
Telemedicine,METHOD_OF,Prenatal care,32396947,10.1055/s-0040-1710538,2020-05-13
Telemedicine,PREVENTS,Coronavirus Infections,32396947,10.1055/s-0040-1710538,2020-05-13
Transaminases,PART_OF,Liver,32396922,10.1038/s41586-020-2324-7,2020-05-13
Hypertensive disease,PROCESS_OF,Pregnant Women,32396922,10.1038/s41586-020-2324-7,2020-05-13
Pharmaceutical Preparations,TREATS,Pre-Eclampsia,32396922,10.1038/s41586-020-2324-7,2020-05-13
Coronavirus Infections,CAUSES,Respiration Disorders,32396903,10.1159/000508233,2020-05-13
Coronavirus Infections,ISA,Disease,32396877,10.1088/1752-7163/ab924a,2020-05-13
Respiratory complication,PROCESS_OF,hospitalized patients,32396877,10.1088/1752-7163/ab924a,2020-05-13
Disease,PROCESS_OF,hospitalized patients,32396877,10.1088/1752-7163/ab924a,2020-05-13
Anticoagulants,TREATS,Disease,32396877,10.1088/1752-7163/ab924a,2020-05-13
Anticoagulants,TREATS(SPEC),Coronavirus Infections,32396877,10.1088/1752-7163/ab924a,2020-05-13
Coronavirus Infections,ISA,Disease,32396877,10.1088/1752-7163/ab924a,2020-05-13
Disease,AFFECTS,Patients,32396877,10.1088/1752-7163/ab924a,2020-05-13
Coronavirus Infections,AFFECTS(SPEC),Patients,32396877,10.1088/1752-7163/ab924a,2020-05-13
Coronavirus Infections,ISA,Disease,32396877,10.1088/1752-7163/ab924a,2020-05-13
Blushing,ASSOCIATED_WITH,Neuropathy,32396683,10.1111/nyas.14379,2020-05-13
Eye,LOCATION_OF,Neuropathy,32396683,10.1111/nyas.14379,2020-05-13
Pandemics,CAUSES,Cerebrovascular accident,32396670,10.1111/acem.14009,2020-05-13
Hypersensitivity,ISA,Symptoms,32396655,10.1111/dth.13561,2020-05-13
Fever,ISA,Symptoms,32396655,10.1111/dth.13561,2020-05-13
Fever,ISA,Symptoms,32396655,10.1111/dth.13561,2020-05-13
Fever,ISA,Symptoms,32396655,10.1111/dth.13561,2020-05-13
Infected,PROCESS_OF,Persons,32396542,10.1371/journal.pone.0233074,2020-05-13
Coronavirus Infections,ISA,Disease,32396516,10.2196/18718,2020-05-13
Coronavirus Infections,ISA,Disease,32396516,10.2196/18718,2020-05-13
Coronavirus Infections,ISA,Disease,32396516,10.2196/18718,2020-05-13
GSKIP gene,INTERACTS_WITH,Duration,32396516,10.2196/18718,2020-05-13
Duration,PREDISPOSES,Hydranencephaly with Renal Aplasia-Dysplasia,32396516,10.2196/18718,2020-05-13
Coronavirus Infections,ISA,Disease,32396516,10.2196/18718,2020-05-13
Coronavirus Infections,ISA,Disease,32396506,10.3201/eid2608.201383,2020-05-13
Coronavirus Infections,ISA,Disease,32396506,10.3201/eid2608.201383,2020-05-13
Coronavirus Infections,ISA,Disease,32396505,10.3201/eid2608.201246,2020-05-13
Disease,PROCESS_OF,Postpartum Women,32396505,10.3201/eid2608.201246,2020-05-13
Coronavirus Infections,ISA,Disease,32396504,10.3201/eid2608.201161,2020-05-13
Assay,DIAGNOSES,Severe Acute Respiratory Syndrome,32396504,10.3201/eid2608.201161,2020-05-13
Disease,PROCESS_OF,Patients,32396491,10.1200/OP.20.00275,2020-05-13
Coronavirus Infections,ISA,Disease,32396491,10.1200/OP.20.00275,2020-05-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32396491,10.1200/OP.20.00275,2020-05-13
Infarction,PROCESS_OF,Patients,32396491,10.1200/OP.20.00275,2020-05-13
tomography,DIAGNOSES,Infarction,32396491,10.1200/OP.20.00275,2020-05-13
Coronavirus Infections,ISA,Disease,32396491,10.1200/OP.20.00275,2020-05-13
Tracheostomy procedure,TREATS,Patients,32396451,10.1177/0194599820927335,2020-05-13
"Respirators, Air-Purifying",compared_with,"Respirators, Air-Purifying",32396447,10.1080/17441692.2020.1764076,2020-05-13
Pharmaceutical Preparations,TREATS,consideration,32396445,10.1177/0194599820926144,2020-05-13
Quinine,CONVERTS_TO,Pharmaceutical Preparations,32396445,10.1177/0194599820926144,2020-05-13
"Diabetes Mellitus, Insulin-Dependent",AFFECTS,Persons,32396397,10.1089/dia.2020.0223,2020-05-13
Adult,LOCATION_OF,"CD69 protein, human",32396397,10.1089/dia.2020.0223,2020-05-13
"CD69 protein, human",INTERACTS_WITH,Blood Glucose,32396397,10.1089/dia.2020.0223,2020-05-13
Thoracic Diseases,PROCESS_OF,Patients,32396382,10.1177/1060028020928052,2020-05-13
Crushing injury,OCCURS_IN,Medical Staff,32396261,10.1002/dc.24453,2020-05-13
Crushing injury,PROCESS_OF,Medical Staff,32396261,10.1002/dc.24453,2020-05-13
Crushing injury,PROCESS_OF,Medical Staff,32396261,10.1002/dc.24453,2020-05-13
Disease,AFFECTS,hospitalized patients,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,AFFECTS(SPEC),hospitalized patients,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,ISA,Disease,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Study,MEASURES,IMPACT gene,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,ISA,Disease,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,ISA,Disease,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Symptoms score,PROCESS_OF,Patients,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Critical Illness,PROCESS_OF,Patients,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Disease,PROCESS_OF,Patients,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,ISA,Disease,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Disease,COMPLICATES,Reflux,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,COMPLICATES(SPEC),Reflux,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Laryngopharyngeal Reflux,ISA,Disease,32396163,10.1001/jamainternmed.2020.2033,2020-05-13
Critical Illness,PROCESS_OF,Patients,32396143,10.2478/rjim-2020-0013,2020-05-13
Critical Illness,PROCESS_OF,Patients,32396143,10.2478/rjim-2020-0013,2020-05-13
Critical Illness,PROCESS_OF,hospitalized patients,32396143,10.2478/rjim-2020-0013,2020-05-13
Respiration,PROCESS_OF,Cohort,32396143,10.2478/rjim-2020-0013,2020-05-13
patient condition,PREDISPOSES,Critical Illness,32396143,10.2478/rjim-2020-0013,2020-05-13
Confirmation,PROCESS_OF,Patients,32396137,10.1515/cclm-2020-0633,2020-05-13
Comorbidity,PROCESS_OF,Old age,32396137,10.1515/cclm-2020-0633,2020-05-13
Cessation of life,ASSOCIATED_WITH,Lymphopenia,32396137,10.1515/cclm-2020-0633,2020-05-13
Disease,PROCESS_OF,Homo sapiens,32396134,10.1530/EJE-20-0385,2020-05-13
Intravenous infusion procedures,USES,zoledronic acid,32396132,10.2196/18638,2020-05-13
denosumab,CAUSES,Fracture,32396132,10.2196/18638,2020-05-13
Coronavirus Infections,ISA,Disease,32396126,10.1109/TCYB.2020.2990162,2020-05-13
Coronavirus Infections,ISA,Disease,32396126,10.1109/TCYB.2020.2990162,2020-05-13
Evaluation,COEXISTS_WITH,Prophylactic treatment,32396126,10.1109/TCYB.2020.2990162,2020-05-13
Evaluation,COEXISTS_WITH,disorder control (procedure),32396126,10.1109/TCYB.2020.2990162,2020-05-13
Coronavirus Infections,PROCESS_OF,Persons,32396101,10.1109/RBME.2020.2992838,2020-05-13
"Memory, Long-Term",PROCESS_OF,Social Networks,32396101,10.1109/RBME.2020.2992838,2020-05-13
Coronavirus Infections,PROCESS_OF,Persons,32396101,10.1109/RBME.2020.2992838,2020-05-13
Immune response,CAUSES,Lesion,32395909,10.1002/bjs5.50304,2020-05-13
Alcohol or Other Drugs use,PROCESS_OF,Clients,32395848,10.1002/bjs.11746,2020-05-13
Ethanol,TREATS,Participant,32395848,10.1002/bjs.11746,2020-05-13
Alcohol or Other Drugs use,PROCESS_OF,Clients,32395848,10.1002/bjs.11746,2020-05-13
Surgeon,TREATS,Patients,32395829,10.1002/bjs.11747,2020-05-13
Operating Room,LOCATION_OF,Standardization,32395720,10.1007/s42843-020-00013-2,2020-05-13
Decontamination,compared_with,"Surgical Procedures, Laparoscopic",32395720,10.1007/s42843-020-00013-2,2020-05-13
Response process,ASSOCIATED_WITH,Gall Bladder Diseases,32395720,10.1007/s42843-020-00013-2,2020-05-13
Cell surface,LOCATION_OF,Growth Factor Receptors,32395696,10.1007/s42058-020-00034-2,2020-05-13
Pharmaceutical Preparations,INTERACTS_WITH,Growth Factor Receptors,32395696,10.1007/s42058-020-00034-2,2020-05-13
Signal Transduction,PROCESS_OF,Malignant Neoplasms,32395696,10.1007/s42058-020-00034-2,2020-05-13
tomography,ADMINISTERED_TO,Patients,32395673,10.1016/j.adro.2020.04.020,2020-05-13
pulmonary involvement,PROCESS_OF,Patients,32395673,10.1016/j.adro.2020.04.020,2020-05-13
Eye,LOCATION_OF,Disease,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Eye,LOCATION_OF(SPEC),Coronavirus Infections,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Coronavirus Infections,ISA,Disease,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Malignant Neoplasms,PROCESS_OF,Patients,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Coronavirus Infections,ISA,Disease,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32395672,10.1016/j.adro.2020.04.021,2020-05-13
Neoplasms,PROCESS_OF,Patients,32395606,10.1016/j.imu.2020.100345,2020-05-13
Pelvis,LOCATION_OF,Neoplasms,32395606,10.1016/j.imu.2020.100345,2020-05-13
Toxic effect,PROCESS_OF,Patients,32395606,10.1016/j.imu.2020.100345,2020-05-13
Tract,LOCATION_OF,Neoplasms,32395606,10.1016/j.imu.2020.100345,2020-05-13
Pharmaceutical Preparations,TREATS,Virus,32395572,10.1016/j.dib.2020.105682,2020-05-13
Suspicion,PROCESS_OF,Patients,32395550,10.21037/atm.2020.03.89,2020-05-13
Coughing,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Fever,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Head,LOCATION_OF,Magnetic Resonance Imaging,32395544,10.21037/atm.2020.03.130,2020-05-13
Headache,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Pharyngeal dryness,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Abnormality,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Abnormality,COEXISTS_WITH,Dizziness,32395544,10.21037/atm.2020.03.130,2020-05-13
Radionuclide Imaging,DIAGNOSES,multiple skin Eruption,32395544,10.21037/atm.2020.03.130,2020-05-13
Lung,LOCATION_OF,Chromosome 2q32-Q33 Deletion Syndrome,32395544,10.21037/atm.2020.03.130,2020-05-13
Lung,LOCATION_OF,Chest CT,32395544,10.21037/atm.2020.03.130,2020-05-13
Colorectal Carcinoma,PROCESS_OF,Patients,32395541,10.21037/atm.2020.03.157,2020-05-13
Coughing,ISA,Symptoms,32395541,10.21037/atm.2020.03.157,2020-05-13
Fever,ISA,Symptoms,32395541,10.21037/atm.2020.03.157,2020-05-13
Colorectal Carcinoma,PROCESS_OF,Patients,32395541,10.21037/atm.2020.03.157,2020-05-13
Colorectal Carcinoma,PROCESS_OF,Patients,32395541,10.21037/atm.2020.03.157,2020-05-13
Respiratory distress,CAUSES,Challenge,32395525,10.21037/atm.2020.03.61,2020-05-13
dipeptidyl peptidase II,PART_OF,Homo sapiens,32395494,10.21037/atm.2020.03.132,2020-05-13
Infected,PROCESS_OF,Persons,32395494,10.21037/atm.2020.03.132,2020-05-13
Digestion,PROCESS_OF,Persons,32395494,10.21037/atm.2020.03.132,2020-05-13
Organ,LOCATION_OF,ACE2 gene,32395494,10.21037/atm.2020.03.132,2020-05-13
Neoplasms,PROCESS_OF,Patients,32395494,10.21037/atm.2020.03.132,2020-05-13
Organ,LOCATION_OF,ACE2 gene,32395494,10.21037/atm.2020.03.132,2020-05-13
Human tissue,LOCATION_OF,ACE2 gene,32395494,10.21037/atm.2020.03.132,2020-05-13
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32395494,10.21037/atm.2020.03.132,2020-05-13
ACE2 gene,ASSOCIATED_WITH,Malignant Neoplasms,32395494,10.21037/atm.2020.03.132,2020-05-13
ACE2 gene,ASSOCIATED_WITH,Liver carcinoma,32395494,10.21037/atm.2020.03.132,2020-05-13
ACE2 gene,ASSOCIATED_WITH,Liver carcinoma,32395494,10.21037/atm.2020.03.132,2020-05-13
Liver carcinoma,PROCESS_OF,Patients,32395494,10.21037/atm.2020.03.132,2020-05-13
Atypical pneumonia,PROCESS_OF,Patients,32395487,10.21037/atm.2020.03.147,2020-05-13
Interested,PROCESS_OF,Persons,32395487,10.21037/atm.2020.03.147,2020-05-13
Tertiary care hospital,LOCATION_OF,Study,32395474,10.21037/atm.2020.03.229,2020-05-13
Disease,PROCESS_OF,hospitalized patients,32395473,10.21037/atm.2020.03.60,2020-05-13
Hypertensive disease,PREDISPOSES,Disease,32395473,10.21037/atm.2020.03.60,2020-05-13
Hypertensive disease,PROCESS_OF,hospitalized patients,32395473,10.21037/atm.2020.03.60,2020-05-13
Antihypertensive Agents,ADMINISTERED_TO,Patients,32395473,10.21037/atm.2020.03.60,2020-05-13
Participant,USES,Group B,32395473,10.21037/atm.2020.03.60,2020-05-13
Serum,LOCATION_OF,Cardiac troponin I,32395473,10.21037/atm.2020.03.60,2020-05-13
Neonatal Screening,PREVENTS,Mental Retardation,32395425,10.1016/j.idcr.2020.e00806,2020-05-13
Mediastinal Emphysema,COEXISTS_WITH,Pneumonia,32395424,10.1016/j.idcr.2020.e00805,2020-05-13
Respiration,PROCESS_OF,Patients,32395423,10.1016/j.mmcr.2020.05.001,2020-05-13
Invasive Pulmonary Aspergillosis,OCCURS_IN,Patients,32395420,10.1016/j.ijscr.2020.04.088,2020-05-13
Acute obstruction,PROCESS_OF,Male population group,32395419,10.1007/s40495-020-00215-8,2020-05-13
Colon structure (body structure),LOCATION_OF,Open Resection,32395419,10.1007/s40495-020-00215-8,2020-05-13
Open Resection,ADMINISTERED_TO,Patients,32395419,10.1007/s40495-020-00215-8,2020-05-13
Operative Surgical Procedures,TREATS,Patients,32395419,10.1007/s40495-020-00215-8,2020-05-13
Challenge,TREATS,surgical patients,32395419,10.1007/s40495-020-00215-8,2020-05-13
Pandemics,ISA,Disease Outbreaks,32395418,10.1007/s40495-020-00216-7,2020-05-13
Pharmaceutical Preparations,TREATS,patient condition,32395417,10.1007/s10389-020-01294-z,2020-05-13
Ascorbic Acid,ISA,Agent,32395417,10.1007/s10389-020-01294-z,2020-05-13
Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32395391,10.1007/s42242-020-00075-7,2020-05-13
skill,PROCESS_OF,Technician,32395258,10.1038/s41578-020-0205-1,2020-05-13
Operative Surgical Procedures,TREATS,Disease,32395187,10.1007/s13300-020-00829-7,2020-05-13
Coronavirus Infections,ISA,Disease,32395179,10.1186/s13037-020-00245-7,2020-05-13
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Persons,32395179,10.1186/s13037-020-00245-7,2020-05-13
Persons,LOCATION_OF,IMPACT gene,32395179,10.1186/s13037-020-00245-7,2020-05-13
Glucose,ASSOCIATED_WITH,Hypoglycemia,32395179,10.1186/s13037-020-00245-7,2020-05-13
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Patients,32395179,10.1186/s13037-020-00245-7,2020-05-13
"Stress, Psychological",AFFECTS,Patients,32395179,10.1186/s13037-020-00245-7,2020-05-13
daily activities,TREATS,"Diabetes Mellitus, Insulin-Dependent",32395179,10.1186/s13037-020-00245-7,2020-05-13
Extracorporeal Membrane Oxygenation,TREATS,Patients,32395096,10.1007/s11469-020-00289-x,2020-05-13
Extracorporeal Membrane Oxygenation,TREATS,Respiratory Failure,32395096,10.1007/s11469-020-00289-x,2020-05-13
Extracorporeal Membrane Oxygenation,TREATS,Patients,32395096,10.1007/s11469-020-00289-x,2020-05-13
Attention,PROCESS_OF,World,32395092,10.1016/j.nurpra.2020.05.003,2020-05-13
Coronavirus Infections,AFFECTS,Physical Well-being,32395092,10.1016/j.nurpra.2020.05.003,2020-05-13
Attitude,PROCESS_OF,student,32395064,10.1007/s13193-020-01086-7,2020-05-13
Practice Experience,PROCESS_OF,student,32395064,10.1007/s13193-020-01086-7,2020-05-13
Optimism,PROCESS_OF,Persons,32395064,10.1007/s13193-020-01086-7,2020-05-13
Practice Experience,PROCESS_OF,Participant,32395064,10.1007/s13193-020-01086-7,2020-05-13
IMPACT gene,ASSOCIATED_WITH,Malignant Neoplasms,32395038,10.1016/j.chaos.2020.109866,2020-05-13
Organ,LOCATION_OF,Solid Neoplasm,32395038,10.1016/j.chaos.2020.109866,2020-05-13
Disease Progression,PROCESS_OF,Cancer Patient,32395038,10.1016/j.chaos.2020.109866,2020-05-13
Coronavirus Infections,ISA,Disease,32395017,10.1007/s00148-020-00778-2,2020-05-13
Disease,CAUSES,Cessation of life,32395017,10.1007/s00148-020-00778-2,2020-05-13
Coronavirus Infections,CAUSES(SPEC),Cessation of life,32395017,10.1007/s00148-020-00778-2,2020-05-13
Coronavirus Infections,ISA,Disease,32395017,10.1007/s00148-020-00778-2,2020-05-13
Coronavirus Infections,ISA,Disease,32395017,10.1007/s00148-020-00778-2,2020-05-13
Quarantine,AFFECTS,viral transmission,32394997,10.1016/j.ijinfomgt.2020.102143,2020-05-13
Challenge,TREATS,Persons,32394993,10.1016/j.paid.2020.110108,2020-05-13
Chronic disease,PROCESS_OF,Epidemiologists,32394850,10.18087/cardio.2020.4.n1122,2020-05-13
Arts,ISA,Humanities,32394850,10.18087/cardio.2020.4.n1122,2020-05-13
Severe Acute Respiratory Syndrome,ISA,Disease,32394816,10.1080/17461391.2020.1761076,2020-05-13
Human body,LOCATION_OF,IMPACT gene,32394721,10.1177/0890117120924531,2020-05-13
Denervation,USES,Fiber,32394721,10.1177/0890117120924531,2020-05-13
Bed rest,PREVENTS,Insulin Sensitivity,32394721,10.1177/0890117120924531,2020-05-13
Psyche structure,PROCESS_OF,Community,32394687,10.3906/sag-2004-331,2020-05-13
Coronavirus Infections,CAUSES,Pneumonia,32394650,10.13703/j.0255-2930.20200224-k0004,2020-05-13
Chest CT,DIAGNOSES,"Pneumonia, Viral",32394650,10.13703/j.0255-2930.20200224-k0004,2020-05-13
Disease,PROCESS_OF,Patients,32394650,10.13703/j.0255-2930.20200224-k0004,2020-05-13
Severe disorder,PROCESS_OF,Patients,32394650,10.13703/j.0255-2930.20200224-k0004,2020-05-13
Moxibustion,ISA,Interventional procedure,32394639,10.1111/1753-0407.13052,2020-05-13
Moxibustion,ISA,Interventional procedure,32394639,10.1111/1753-0407.13052,2020-05-13
Moxibustion,ISA,Interventional procedure,32394639,10.1111/1753-0407.13052,2020-05-13
Moxibustion,ISA,Interventional procedure,32394639,10.1111/1753-0407.13052,2020-05-13
Middle East Respiratory Syndrome,CAUSES,"Respiratory Distress Syndrome, Adult",32394605,10.1111/eje.12542,2020-05-13
Comorbidity,PROCESS_OF,Patients,32394605,10.1111/eje.12542,2020-05-13
Obesity,PROCESS_OF,Patients,32394605,10.1111/eje.12542,2020-05-13
Glycoproteins,INTERACTS_WITH,Dipeptidyl-Peptidase IV,32394605,10.1111/eje.12542,2020-05-13
Membrane Glycoproteins,INTERACTS_WITH,angiotensin converting enzyme 2,32394605,10.1111/eje.12542,2020-05-13
Dipeptidyl-Peptidase IV,PART_OF,Homo sapiens,32394605,10.1111/eje.12542,2020-05-13
Dipeptidyl-Peptidase IV,INTERACTS_WITH,Cells,32394605,10.1111/eje.12542,2020-05-13
angiotensin converting enzyme 2,ISA,Metalloproteases,32394605,10.1111/eje.12542,2020-05-13
SARS coronavirus,ISA,Betacoronavirus,32394605,10.1111/eje.12542,2020-05-13
Endocrine system,ASSOCIATED_WITH,Nutritional status,32394605,10.1111/eje.12542,2020-05-13
Plasma,LOCATION_OF,Aminopeptidase,32394605,10.1111/eje.12542,2020-05-13
Dipeptidyl-Peptidase IV Inhibitors,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",32394605,10.1111/eje.12542,2020-05-13
Dipeptidyl-Peptidase IV Inhibitors,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",32394605,10.1111/eje.12542,2020-05-13
Plasma,LOCATION_OF,Dipeptidyl-Peptidase IV,32394605,10.1111/eje.12542,2020-05-13
dipeptidyl peptidase IV activity,PROCESS_OF,Older people,32394605,10.1111/eje.12542,2020-05-13
novel AODU treatment method,AFFECTS,Virus Internalization,32394605,10.1111/eje.12542,2020-05-13
"Pneumonia, Viral",PROCESS_OF,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
Therapeutic procedure,NEG_TREATS,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
SARS coronavirus,ISA,Virus,32394416,10.14744/tjtes.2020.79954,2020-05-13
Cathepsin L,ADMINISTERED_TO,Cells,32394416,10.14744/tjtes.2020.79954,2020-05-13
Teicoplanin,DISRUPTS,Virus Replication,32394416,10.14744/tjtes.2020.79954,2020-05-13
Hydroxychloroquine,PREVENTS,inflammatory response,32394416,10.14744/tjtes.2020.79954,2020-05-13
Hydroxychloroquine,PREVENTS,Storm NOS,32394416,10.14744/tjtes.2020.79954,2020-05-13
Zanamivir,ISA,"Neuraminidase inhibitors, direct acting antivirals",32394416,10.14744/tjtes.2020.79954,2020-05-13
Oseltamivir,ISA,"Neuraminidase inhibitors, direct acting antivirals",32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,DISRUPTS,Disease,32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,ISA,Protease Inhibitors,32394416,10.14744/tjtes.2020.79954,2020-05-13
Ribavirin,TREATS,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
Ribavirin,INTERACTS_WITH,Adrenal Cortex Hormones,32394416,10.14744/tjtes.2020.79954,2020-05-13
Ribavirin,PREVENTS,"Respiratory Distress Syndrome, Adult",32394416,10.14744/tjtes.2020.79954,2020-05-13
Ribavirin,TREATS,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
Ribavirin,TREATS(INFER),SARS coronavirus,32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,INTERACTS_WITH,Adrenal Cortex Hormones,32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,PREVENTS,"Respiratory Distress Syndrome, Adult",32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,TREATS,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
lopinavir / Ritonavir,TREATS(INFER),SARS coronavirus,32394416,10.14744/tjtes.2020.79954,2020-05-13
SARS coronavirus,PROCESS_OF,Patients,32394416,10.14744/tjtes.2020.79954,2020-05-13
favipiravir,INHIBITS,Respiratory problem,32394416,10.14744/tjtes.2020.79954,2020-05-13
Severe disorder,PROCESS_OF,Elderly (population group),32394344,10.1007/s15010-020-01438-z,2020-05-13
Severe disorder,PROCESS_OF,Persons,32394344,10.1007/s15010-020-01438-z,2020-05-13
Disease,PROCESS_OF,Patients,32394279,10.1007/s00330-020-06925-3,2020-05-13
Coronavirus Infections,ISA,Disease,32394279,10.1007/s00330-020-06925-3,2020-05-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32394279,10.1007/s00330-020-06925-3,2020-05-13
Pneumonia,PROCESS_OF,Patients,32394237,10.1007/s11239-020-02132-5,2020-05-13
Pneumonia,PROCESS_OF,Patients,32394237,10.1007/s11239-020-02132-5,2020-05-13
Pleural effusion disorder,NEG_PREDISPOSES,Pneumonia,32394237,10.1007/s11239-020-02132-5,2020-05-13
Communicable Diseases,CAUSES,Cardiac complication,32394236,10.1007/s11239-020-02130-7,2020-05-13
Pulmonary Embolism,PROCESS_OF,Patients,32394236,10.1007/s11239-020-02130-7,2020-05-13
Coronavirus Infections,PROCESS_OF,Patients,32394236,10.1007/s11239-020-02130-7,2020-05-13
Acute massive pulmonary embolism,CAUSES,Sudden death,32394236,10.1007/s11239-020-02130-7,2020-05-13
Lung,LOCATION_OF,Computed Tomography Angiography,32394236,10.1007/s11239-020-02130-7,2020-05-13
Symptoms,PROCESS_OF,Patients,32394236,10.1007/s11239-020-02130-7,2020-05-13
Coronavirus Infections,CAUSES,Venous Thromboembolism,32394236,10.1007/s11239-020-02130-7,2020-05-13
Critical Illness,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Pneumonia,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Thrombus,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Bleeding risk,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Critical Illness,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Thromboelastometry,ADMINISTERED_TO,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Cyclophosphamide/Fluorouracil/Tamoxifen,TREATS,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
CD38 wt Allele,compared_with,CD38 wt Allele,32394175,10.1007/s00464-020-07618-0,2020-05-13
CD38 wt Allele,compared_with,CD38 wt Allele,32394175,10.1007/s00464-020-07618-0,2020-05-13
CD38 wt Allele,higher_than,CD38 wt Allele,32394175,10.1007/s00464-020-07618-0,2020-05-13
Deep Vein Thrombosis,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Pneumonia,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
Thrombophilia,PROCESS_OF,Patients,32394175,10.1007/s00464-020-07618-0,2020-05-13
major surgery,PRECEDES,"Surgical Procedures, Laparoscopic",32394153,10.1007/s11845-020-02241-3,2020-05-13
"Surgical Procedures, Laparoscopic",TREATS,Patients,32394153,10.1007/s11845-020-02241-3,2020-05-13
Masks,USES,Textiles,32394052,10.1007/s00128-020-02877-y,2020-05-13
Ascorbic Acid,TREATS,Septicemia,32393973,10.1093/ibd/izaa109,2020-05-13
huperzine B,INTERACTS_WITH,Ascorbic Acid,32393973,10.1093/ibd/izaa109,2020-05-13
Immune System Diseases,PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
early pregnancy,COEXISTS_WITH,Enthesitis-Related Arthritis,32393966,10.1093/pubmed/fdaa060,2020-05-13
Acute ulcerative colitis,PROCESS_OF,Patients,32393966,10.1093/pubmed/fdaa060,2020-05-13
Fear (Mental Process),PROCESS_OF,Persons,32393804,10.1038/s41591-020-0916-2,2020-05-13
Anxiety,PROCESS_OF,german race,32393804,10.1038/s41591-020-0916-2,2020-05-13
Depressive disorder,PROCESS_OF,german race,32393804,10.1038/s41591-020-0916-2,2020-05-13
Laboratory Procedures,DIAGNOSES,Negative Test Result,32393767,10.1038/s41394-020-0284-7,2020-05-13
Coronavirus Infections,ISA,Disease,32393664,10.3899/jrheum.200493,2020-05-13
Disease,PROCESS_OF,Patients,32393664,10.3899/jrheum.200493,2020-05-13
Coronavirus Infections,ISA,Disease,32393664,10.3899/jrheum.200493,2020-05-13
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32393664,10.3899/jrheum.200493,2020-05-13
Spinal Cord Injuries,PROCESS_OF,Persons,32393664,10.3899/jrheum.200493,2020-05-13
Coronavirus Infections,ISA,Disease,32393664,10.3899/jrheum.200493,2020-05-13
Symptoms,NEG_PROCESS_OF,Persons,32393664,10.3899/jrheum.200493,2020-05-13
Challenge,TREATS,Vulnerable Populations,32393664,10.3899/jrheum.200493,2020-05-13
Hydroxychloroquine,TREATS,Patients,32393597,10.3949/ccjm.87a.ccc023,2020-05-13
Plasma,LOCATION_OF,Hydroxychloroquine,32393597,10.3949/ccjm.87a.ccc023,2020-05-13
Serum,LOCATION_OF,Hydroxychloroquine,32393597,10.3949/ccjm.87a.ccc023,2020-05-13
Hydroxychloroquine,TREATS,Rheumatism,32393597,10.3949/ccjm.87a.ccc023,2020-05-13
"Lupus Erythematosus, Systemic",PROCESS_OF,Patients,32393596,10.3949/ccjm.87a.ccc021,2020-05-13
"Drugs, Essential",ADMINISTERED_TO,Patients,32393596,10.3949/ccjm.87a.ccc021,2020-05-13
Hydroxychloroquine,TREATS,"Lupus Erythematosus, Systemic",32393596,10.3949/ccjm.87a.ccc021,2020-05-13
Treatment Protocols,USES,Hydroxychloroquine,32393596,10.3949/ccjm.87a.ccc021,2020-05-13
Treatment Protocols,USES,Hydroxychloroquine,32393596,10.3949/ccjm.87a.ccc021,2020-05-13
Pulmonary Hypertension,ISA,Pulmonary Vascular Disorder,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Vascular constriction (function),CAUSES,Elevated pulmonary artery pressure,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Pulmonary Arterial Remodeling,CAUSES,Elevated pulmonary artery pressure,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Disease,PROCESS_OF,Patients,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Pulmonary Hypertension,PROCESS_OF,Patients,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Chronic disease,PROCESS_OF,Patients,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Pharmaceutical Preparations,TREATS,Pulmonary Hypertension,32393595,10.3949/ccjm.87a.ccc022,2020-05-13
Disease Progression,PROCESS_OF,Child,32393594,10.3949/ccjm.87a.ccc007,2020-05-13
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
copd exacerbation,CAUSES,Dyspnea,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
Adrenal Cortex Hormones,TREATS,Chronic Obstructive Airway Disease,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
Steroids,PREDISPOSES,Viral Shedding,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
Microbicides,TREATS,Chronic Obstructive Airway Disease,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32393593,10.3949/ccjm.87a.ccc015,2020-05-13
Respiratory Tract Infections,CAUSES,Viral Pathogenesis,32393592,10.3949/ccjm.87a.ccc008,2020-05-13
Viral respiratory infection,COEXISTS_WITH,Fourth Stage of Labor,32393592,10.3949/ccjm.87a.ccc008,2020-05-13
Immunotherapy,ISA,Therapeutic procedure,32393591,10.3949/ccjm.87a.ccc004,2020-05-13
Hydroxychloroquine,TREATS,Health Personnel,32393447,10.20529/IJME.2020.041,2020-05-13
Hydroxychloroquine,TREATS(INFER),Asymptomatic,32393447,10.20529/IJME.2020.041,2020-05-13
Asymptomatic,PROCESS_OF,Health Personnel,32393447,10.20529/IJME.2020.041,2020-05-13
Confirmation,PROCESS_OF,Patients,32393447,10.20529/IJME.2020.041,2020-05-13
Confirmation,PROCESS_OF,Patients,32393447,10.20529/IJME.2020.041,2020-05-13
Retinal Diseases,ISA,Disease,32393447,10.20529/IJME.2020.041,2020-05-13
Retinal Diseases,PROCESS_OF,Vulnerable Populations,32393447,10.20529/IJME.2020.041,2020-05-13
Disorder of macula of retina,ISA,Disease,32393447,10.20529/IJME.2020.041,2020-05-13
Disorder of macula of retina,PROCESS_OF,Vulnerable Populations,32393447,10.20529/IJME.2020.041,2020-05-13
Corrected Prolonged QT Interval by ECG Finding,ISA,Disease,32393447,10.20529/IJME.2020.041,2020-05-13
Corrected Prolonged QT Interval by ECG Finding,PROCESS_OF,Vulnerable Populations,32393447,10.20529/IJME.2020.041,2020-05-13
Hydroxychloroquine,ISA,Chloroquine,32393447,10.20529/IJME.2020.041,2020-05-13
Heart Diseases,PROCESS_OF,Old age,32393446,10.20529/IJME.2020.042,2020-05-13
Noncommunicable Diseases,NEG_PROCESS_OF,Patients,32393446,10.20529/IJME.2020.042,2020-05-13
Noncommunicable Diseases,NEG_PROCESS_OF,Patients,32393446,10.20529/IJME.2020.042,2020-05-13
Hemostatic function,AFFECTS,Thrombosis,32393419,10.1691/ph.2020.0431,2020-05-13
Hemorrhage,MANIFESTATION_OF,Platelet aggregation,32393419,10.1691/ph.2020.0431,2020-05-13
Clotrimazole,AFFECTS,Blood flow,32393419,10.1691/ph.2020.0431,2020-05-13
Blood coagulation,PROCESS_OF,Patients,32393419,10.1691/ph.2020.0431,2020-05-13
Thrombus,COEXISTS_WITH,Inflammation,32393419,10.1691/ph.2020.0431,2020-05-13
Blood,PART_OF,Homo sapiens,32393419,10.1691/ph.2020.0431,2020-05-13
Specimen Type - Thrombocyte (platelet),PART_OF,Homo sapiens,32393419,10.1691/ph.2020.0431,2020-05-13
Myocardial Infarction,PROCESS_OF,Patients,32393419,10.1691/ph.2020.0431,2020-05-13
Chemicals,CAUSES,Myocardial Infarction,32393419,10.1691/ph.2020.0431,2020-05-13
Chemicals,CAUSES,Cerebrovascular accident,32393419,10.1691/ph.2020.0431,2020-05-13
Pandemics,ISA,Disease Outbreaks,32393394,10.1186/s12998-020-00314-9,2020-05-13
Coronavirus Infections,ISA,Disease,32393394,10.1186/s12998-020-00314-9,2020-05-13
Coronavirus Infections,ISA,Disease,32393394,10.1186/s12998-020-00314-9,2020-05-13
Coronavirus Infections,ISA,Disease,32393394,10.1186/s12998-020-00314-9,2020-05-13
Compliance,PROCESS_OF,Practitioner,32393381,10.1186/s40779-020-00254-8,2020-05-13
Fever,ISA,Symptoms,32393351,10.1186/s12933-020-01035-2,2020-05-13
"Stress, Psychological",PROCESS_OF,Staff,32393351,10.1186/s12933-020-01035-2,2020-05-13
Change in Emotional State,PROCESS_OF,Staff,32393351,10.1186/s12933-020-01035-2,2020-05-13
Tertiary Care Centers,LOCATION_OF,Study,32393346,10.1186/s40463-020-00424-7,2020-05-13
Diabetes,PROCESS_OF,Patients,32393346,10.1186/s40463-020-00424-7,2020-05-13
patient condition,PREDISPOSES,Poor outcome,32393346,10.1186/s40463-020-00424-7,2020-05-13
Tracheotomy procedure,ADMINISTERED_TO,Health Personnel,32393325,10.1186/s13054-020-02916-4,2020-05-13
Tracheotomy procedure,NEG_ADMINISTERED_TO,Health Personnel,32393325,10.1186/s13054-020-02916-4,2020-05-13
Infected,PROCESS_OF,Patients,32393325,10.1186/s13054-020-02916-4,2020-05-13
Upper aerodigestive tract,PART_OF,Patients,32393325,10.1186/s13054-020-02916-4,2020-05-13
Symptoms,NEG_PROCESS_OF,Persons,32393325,10.1186/s13054-020-02916-4,2020-05-13
Protection,PROCESS_OF,Health Personnel,32393325,10.1186/s13054-020-02916-4,2020-05-13
"Respirators, Air-Purifying",compared_with,Masks,32393325,10.1186/s13054-020-02916-4,2020-05-13
"Respirators, Air-Purifying",higher_than,Masks,32393325,10.1186/s13054-020-02916-4,2020-05-13
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32393325,10.1186/s13054-020-02916-4,2020-05-13
intensive care unit,LOCATION_OF,Services,32393161,10.33321/cdi.2020.44.42,2020-05-13
United States,ISA,Country,32393147,10.1177/0194599820927710,2020-05-13
SARS coronavirus,ISA,Genus: Coronavirus,32393105,10.1177/0194599820927002,2020-05-13
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32393105,10.1177/0194599820927002,2020-05-13
EHD1 wt Allele,PART_OF,SARS coronavirus,32393105,10.1177/0194599820927002,2020-05-13
EHD1 wt Allele,PART_OF,Middle East Respiratory Syndrome Coronavirus,32393105,10.1177/0194599820927002,2020-05-13
Challenge,METHOD_OF,Surgical Management,32393101,10.1177/0194599820928987,2020-05-13
Surgeon,USES,Artificial Airways,32393101,10.1177/0194599820928987,2020-05-13
Airway Obstruction,PROCESS_OF,Patients,32393101,10.1177/0194599820928987,2020-05-13
Symptoms,PROCESS_OF,Patients,32393101,10.1177/0194599820928987,2020-05-13
Neoplasms,PROCESS_OF,Otolaryngologist,32392948,10.3760/cma.j.cn112140-20200228-00154,2020-05-13
Not true,PROCESS_OF,Elderly (population group),32392948,10.3760/cma.j.cn112140-20200228-00154,2020-05-13
Coronavirus Infections,CAUSES,Communicable Diseases,32392859,10.3390/diagnostics10050283,2020-05-13
Virus Diseases,CAUSES,Cessation of life,32392759,10.3390/antiox9050392,2020-05-13
Radiologic finding,PROCESS_OF,Patients,32392759,10.3390/antiox9050392,2020-05-13
Infection,PROCESS_OF,Unmarried person,32392741,10.3390/jcm9051371,2020-05-13
Microalgae,ISA,Organism,32392741,10.3390/jcm9051371,2020-05-13
Human coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32392624,10.1111/jgs.16554,2020-05-12
Acute illness,PROCESS_OF,Patients,32392624,10.1111/jgs.16554,2020-05-12
Old age,ISA,Adult,32392587,10.1055/a-1169-4443,2020-05-12
Coinfection,PROCESS_OF,Infant,32392587,10.1055/a-1169-4443,2020-05-12
dipeptidyl peptidase II,ASSOCIATED_WITH,Disease,32392559,10.1159/000508199,2020-05-12
Peptides,DISRUPTS,Heart,32392559,10.1159/000508199,2020-05-12
Signal Pathways,PROCESS_OF,Patients,32392559,10.1159/000508199,2020-05-12
Signal Pathways,PROCESS_OF,Patients,32392559,10.1159/000508199,2020-05-12
ACE2 gene,AFFECTS,Signal Pathways,32392559,10.1159/000508199,2020-05-12
ACE2 gene,COEXISTS_WITH,Anti-Inflammatory Agents,32392559,10.1159/000508199,2020-05-12
leukemia,PROCESS_OF,Patients,32392473,10.2196/19581,2020-05-12
Challenge,TREATS,Patients,32392473,10.2196/19581,2020-05-12
leukemia,COEXISTS_WITH,Menstruation Disturbances,32392473,10.2196/19581,2020-05-12
Communicable Diseases,COEXISTS_WITH,leukemia,32392473,10.2196/19581,2020-05-12
Malignant Neoplasms,PROCESS_OF,Patients,32392473,10.2196/19581,2020-05-12
Disease,AFFECTS,Persons,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Coronavirus Infections,AFFECTS(SPEC),Persons,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Coronavirus Infections,ISA,Disease,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Pharmaceutical Preparations,INTERACTS_WITH,Blood Glucose,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Insulin,INTERACTS_WITH,Blood Glucose,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Coronavirus Infections,ISA,Disease,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Diabetes,PROCESS_OF,Community,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Diabetes,PROCESS_OF,Community,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Persons,LOCATION_OF,IMPACT gene,32392464,10.1016/j.immuni.2020.04.016,2020-05-12
Severe disorder,PROCESS_OF,Homo sapiens,32392461,10.5152/eurjrheum.2020.2063,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Lung diseases,PROCESS_OF,Patients,32392431,10.1089/dia.2020.0219,2020-05-12
Lung finding,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32392431,10.1089/dia.2020.0219,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Ultrasonography,AFFECTS,Screening procedure,32392431,10.1089/dia.2020.0219,2020-05-12
"Lung Diseases, Interstitial",COEXISTS_WITH,Connective Tissue Diseases,32392431,10.1089/dia.2020.0219,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Pneumonia,PROCESS_OF,Phasis,32392431,10.1089/dia.2020.0219,2020-05-12
Ultrasonography,ADMINISTERED_TO,Patients,32392431,10.1089/dia.2020.0219,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Lung,LOCATION_OF,Ultrasonography,32392431,10.1089/dia.2020.0219,2020-05-12
Ultrasonography,AFFECTS,Pneumonia,32392431,10.1089/dia.2020.0219,2020-05-12
Today,TREATS,Symptoms,32392400,10.1002/ijgo.13193,2020-05-12
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Patients,32392400,10.1002/ijgo.13193,2020-05-12
Female sexual finding,PROCESS_OF,Woman,32392389,10.1002/mus.26918,2020-05-12
Menstrual abnormalities,PROCESS_OF,Woman,32392389,10.1002/mus.26918,2020-05-12
Intubation,TREATS,Respiratory failure without hypercapnia,32392380,10.1111/dme.14319,2020-05-12
Myasthenia Gravis,PROCESS_OF,hospitalized patients,32392380,10.1111/dme.14319,2020-05-12
Patients,LOCATION_OF,IMPACT gene,32392380,10.1111/dme.14319,2020-05-12
hospitalized patients,LOCATION_OF,IMPACT gene,32392380,10.1111/dme.14319,2020-05-12
Myasthenia Gravis,PROCESS_OF,Patients,32392380,10.1111/dme.14319,2020-05-12
Exacerbation,PROCESS_OF,Patients,32392380,10.1111/dme.14319,2020-05-12
tocilizumab,TREATS,Patients,32392380,10.1111/dme.14319,2020-05-12
Myasthenia Gravis,PROCESS_OF,Patients,32392380,10.1111/dme.14319,2020-05-12
Myasthenia Gravis,PROCESS_OF,Patients,32392380,10.1111/dme.14319,2020-05-12
Coronavirus Infections,PROCESS_OF,Patients,32392380,10.1111/dme.14319,2020-05-12
Diabetes,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
Diabetes,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
Diabetes,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
Worried,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
High Level,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
Worried,COEXISTS_WITH,Diabetes,32392377,10.1111/ijcp.13533,2020-05-12
Response process,ASSOCIATED_WITH,Diabetes,32392377,10.1111/ijcp.13533,2020-05-12
Complication,PROCESS_OF,Woman,32392377,10.1111/ijcp.13533,2020-05-12
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Woman,32392377,10.1111/ijcp.13533,2020-05-12
Distress,PROCESS_OF,Woman,32392377,10.1111/ijcp.13533,2020-05-12
Worried,COEXISTS_WITH,Diabetes,32392377,10.1111/ijcp.13533,2020-05-12
poor health,COEXISTS_WITH,Diabetes,32392377,10.1111/ijcp.13533,2020-05-12
Diabetes,PROCESS_OF,Persons,32392377,10.1111/ijcp.13533,2020-05-12
Virus,COEXISTS_WITH,Disease,32392337,10.1093/cid/ciaa556,2020-05-12
Disease,PROCESS_OF,Child,32392334,10.1093/cid/ciaa560,2020-05-12
Clinician,TREATS,Patients,32392333,10.1093/cid/ciaa552,2020-05-12
prevention service,TREATS,Disease,32392332,10.1093/cid/ciaa558,2020-05-12
Hydroxychloroquine,TREATS,Patients,32392331,10.1093/cid/ciaa557,2020-05-12
Drug Kinetics,PROCESS_OF,Population Group,32392331,10.1093/cid/ciaa557,2020-05-12
Secondary Infections,PROCESS_OF,Households,32392288,10.1001/jamapediatrics.2020.1948,2020-05-12
Isolation procedure,PRECEDES,Active monitoring,32392288,10.1001/jamapediatrics.2020.1948,2020-05-12
Adult,LOCATION_OF,"TLR4 protein, human",32392282,10.1001/jama.2020.8630,2020-05-12
Coronavirus Infections,COEXISTS_WITH,Comorbidity,32392282,10.1001/jama.2020.8630,2020-05-12
Coronavirus Infections,PROCESS_OF,"Child, Hospitalized",32392282,10.1001/jama.2020.8630,2020-05-12
Comorbidity,PROCESS_OF,Patients,32392282,10.1001/jama.2020.8630,2020-05-12
Hydroxychloroquine,ISA,Agent,32392282,10.1001/jama.2020.8630,2020-05-12
Targeted Therapy,TREATS,Patients,32392282,10.1001/jama.2020.8630,2020-05-12
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Patients,32392282,10.1001/jama.2020.8630,2020-05-12
Coronavirus Infections,PROCESS_OF,Adult,32392282,10.1001/jama.2020.8630,2020-05-12
Coronavirus Infections,PROCESS_OF,Child,32392282,10.1001/jama.2020.8630,2020-05-12
Comorbidity,PROCESS_OF,Child,32392282,10.1001/jama.2020.8630,2020-05-12
Coronavirus Infections,PROCESS_OF,Child,32392282,10.1001/jama.2020.8630,2020-05-12
Hospitals,LOCATION_OF,Random Sampling,32392280,10.1093/jamia/ocaa097,2020-05-12
Diabetes,PROCESS_OF,hospitalized patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Pharmaceutical Preparations,NEG_ADMINISTERED_TO,hospitalized patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Cardiac Arrest,ISA,Cardiac Arrhythmia,32392280,10.1093/jamia/ocaa097,2020-05-12
Hydroxychloroquine,ADMINISTERED_TO,hospitalized patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Electrocardiogram abnormal,ISA,Cardiac Arrhythmia,32392280,10.1093/jamia/ocaa097,2020-05-12
Azithromycin,ADMINISTERED_TO,Patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Azithromycin,ADMINISTERED_TO,Patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Cardiac Arrest,NEG_PROCESS_OF,Patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Azithromycin,ADMINISTERED_TO,Patients,32392280,10.1093/jamia/ocaa097,2020-05-12
Hydroxychloroquine,TREATS,Electrocardiogram abnormal,32392280,10.1093/jamia/ocaa097,2020-05-12
Symptoms,PROCESS_OF,Patients,32392262,10.1371/journal.pone.0233147,2020-05-12
Symptoms,PROCESS_OF,Patients,32392262,10.1371/journal.pone.0233147,2020-05-12
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32392172,10.2196/19370,2020-05-12
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32392172,10.2196/19370,2020-05-12
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32392172,10.2196/19370,2020-05-12
Coronavirus Infections,COEXISTS_WITH,Chronic Obstructive Airway Disease,32392172,10.2196/19370,2020-05-12
Never smoked tobacco,ISA,Complication,32392172,10.2196/19370,2020-05-12
Never smoked tobacco,PREDISPOSES,Complication,32392172,10.2196/19370,2020-05-12
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32392172,10.2196/19370,2020-05-12
At risk of disease,PROCESS_OF,Patients,32392172,10.2196/19370,2020-05-12
Coronavirus Infections,ISA,Disease,32392129,10.7554/eLife.58728,2020-05-12
crisis management,TREATS,Crisis,32392129,10.7554/eLife.58728,2020-05-12
crisis management,compared_with,crisis management,32392129,10.7554/eLife.58728,2020-05-12
Asymptomatic,PROCESS_OF,Staff,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,PROCESS_OF,Nurses,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,PROCESS_OF,Physicians,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,PROCESS_OF,Physical Therapist,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,NEG_PROCESS_OF,Persons,32392125,10.3201/eid2608.201235,2020-05-12
Infected,PROCESS_OF,Persons,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,PROCESS_OF,Persons,32392125,10.3201/eid2608.201235,2020-05-12
Symptoms,PROCESS_OF,Health Personnel,32392125,10.3201/eid2608.201235,2020-05-12
Virus,PROCESS_OF,Staff,32392125,10.3201/eid2608.201235,2020-05-12
Disease,PROCESS_OF,Participant,32392093,10.1377/hlthaff.2020.00693,2020-05-12
Coronavirus Infections,ISA,Disease,32392093,10.1377/hlthaff.2020.00693,2020-05-12
Coronavirus Infections,PROCESS_OF(SPEC),Participant,32392093,10.1377/hlthaff.2020.00693,2020-05-12
Attention,PROCESS_OF,World,32391912,10.1093/ehjci/jeaa136,2020-05-12
Pandemics,ISA,Disease Outbreaks,32391912,10.1093/ehjci/jeaa136,2020-05-12
RNA-directed RNA polymerase activity,PROCESS_OF,"M Protein, multiple myeloma",32391912,10.1093/ehjci/jeaa136,2020-05-12
Patients,LOCATION_OF,Troponin,32391877,10.1093/eurheartj/ehaa408,2020-05-12
Elevation procedure,TREATS,Patients,32391877,10.1093/eurheartj/ehaa408,2020-05-12
Elevation procedure,USES,Troponin,32391877,10.1093/eurheartj/ehaa408,2020-05-12
myocardial injury,PROCESS_OF,Patients,32391801,10.2196/19115,2020-05-12
myocardial injury,PROCESS_OF,Patients,32391801,10.2196/19115,2020-05-12
High Level,PREDISPOSES,Death in hospital,32391801,10.2196/19115,2020-05-12
Comorbidity,PREDISPOSES,Death in hospital,32391801,10.2196/19115,2020-05-12
Death in hospital,PROCESS_OF,Patients,32391801,10.2196/19115,2020-05-12
Cardiovascular,LOCATION_OF,Comorbidity,32391801,10.2196/19115,2020-05-12
Coronavirus Infections,ISA,Disease,32391746,10.1017/ice.2020.219,2020-05-12
Coronavirus Infections,ISA,Disease,32391746,10.1017/ice.2020.219,2020-05-12
Coronavirus Infections,ISA,Disease,32391746,10.1017/ice.2020.219,2020-05-12
Coronavirus Infections,ISA,Disease,32391746,10.1017/ice.2020.219,2020-05-12
Morale,PROCESS_OF,Staff,32391742,10.1148/radiol.2020201908,2020-05-12
Symptoms,PROCESS_OF,Health Personnel,32391742,10.1148/radiol.2020201908,2020-05-12
Acute illness,PROCESS_OF,Health Personnel,32391742,10.1148/radiol.2020201908,2020-05-12
responsibility,PROCESS_OF,Health Personnel,32391742,10.1148/radiol.2020201908,2020-05-12
responsibility,PROCESS_OF,Persons,32391742,10.1148/radiol.2020201908,2020-05-12
Symptom mild,PROCESS_OF,Persons,32391742,10.1148/radiol.2020201908,2020-05-12
Blood supply aspects,LOCATION_OF,angiotensin converting enzyme 2,32391741,10.1148/radiol.2020201743,2020-05-12
"Intestines, Small",LOCATION_OF,angiotensin converting enzyme 2,32391741,10.1148/radiol.2020201743,2020-05-12
Lung,LOCATION_OF,angiotensin converting enzyme 2,32391741,10.1148/radiol.2020201743,2020-05-12
Abdomen,LOCATION_OF,Image Study,32391741,10.1148/radiol.2020201743,2020-05-12
Image Study,ADMINISTERED_TO,Patients,32391741,10.1148/radiol.2020201743,2020-05-12
Abdomen,LOCATION_OF,Image Study,32391741,10.1148/radiol.2020201743,2020-05-12
Image Study,ADMINISTERED_TO,Patients,32391741,10.1148/radiol.2020201743,2020-05-12
Intestines,LOCATION_OF,Yellow discoloration,32391741,10.1148/radiol.2020201743,2020-05-12
Structure of arteriole,LOCATION_OF,Fibrin blood clot,32391741,10.1148/radiol.2020201743,2020-05-12
Ultrasonography,DIAGNOSES,Cholestasis,32391741,10.1148/radiol.2020201743,2020-05-12
Abdomen,LOCATION_OF,Cholestasis,32391741,10.1148/radiol.2020201743,2020-05-12
Ischemia,PROCESS_OF,Patients,32391741,10.1148/radiol.2020201743,2020-05-12
Neck,LOCATION_OF,Computed tomography of cervical spine,32391719,10.1177/2047487320924501,2020-05-12
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32391719,10.1177/2047487320924501,2020-05-12
Accident and Emergency department,LOCATION_OF,Chest CT,32391719,10.1177/2047487320924501,2020-05-12
Lung finding,PROCESS_OF,Patients,32391719,10.1177/2047487320924501,2020-05-12
Parenchyma,LOCATION_OF,Lung finding,32391719,10.1177/2047487320924501,2020-05-12
Coughing,NEG_COEXISTS_WITH,Symptoms,32391719,10.1177/2047487320924501,2020-05-12
Fever,NEG_COEXISTS_WITH,Symptoms,32391719,10.1177/2047487320924501,2020-05-12
Neck,LOCATION_OF,Carpal Tunnel Syndrome,32391719,10.1177/2047487320924501,2020-05-12
Neck,LOCATION_OF,Computed tomography of cervical spine,32391719,10.1177/2047487320924501,2020-05-12
Computed tomography of cervical spine,ADMINISTERED_TO,Patients,32391719,10.1177/2047487320924501,2020-05-12
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32391719,10.1177/2047487320924501,2020-05-12
Chest CT,ADMINISTERED_TO,Patients,32391719,10.1177/2047487320924501,2020-05-12
Cardiovascular Diseases,PROCESS_OF,Patients,32391651,10.1111/odi.13408,2020-05-12
cardiovascular risk factor,PROCESS_OF,Patients,32391651,10.1111/odi.13408,2020-05-12
Infected,PROCESS_OF,Patients,32391651,10.1111/odi.13408,2020-05-12
Influenza,PROCESS_OF,Hispanics,32391519,10.1016/j.ajogmf.2020.100134,2020-05-12
Pandemics,ISA,Epidemic,32391519,10.1016/j.ajogmf.2020.100134,2020-05-12
Pregnancy,PROCESS_OF,Pregnant Women,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Patient in hospital,PROCESS_OF,Pregnant Women,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Oxygen,PART_OF,Arteries,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Chest,LOCATION_OF,Lung,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Critical Illness,PROCESS_OF,Woman,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Woman,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Perinatal death,NEG_PROCESS_OF,Cohort,32391518,10.1016/j.ajogmf.2020.100133,2020-05-12
Virus,PROCESS_OF,Pregnant Women,32391444,10.1016/j.adro.2020.04.018,2020-05-12
Gravidity,PROCESS_OF,Patients,32391444,10.1016/j.adro.2020.04.018,2020-05-12
Gravidity,PROCESS_OF,Patients,32391444,10.1016/j.adro.2020.04.018,2020-05-12
Birth,PROCESS_OF,Woman,32391444,10.1016/j.adro.2020.04.018,2020-05-12
Clinical Services,TREATS,World,32391441,10.1186/s41256-020-00150-7,2020-05-12
Telemedicine,METHOD_OF,Patient Visit,32391441,10.1186/s41256-020-00150-7,2020-05-12
Long-term Follow-up,TREATS,Patients,32391441,10.1186/s41256-020-00150-7,2020-05-12
Hospitalization,TREATS,Traffic,32391413,10.1007/s41207-020-00163-1,2020-05-12
Infected,PROCESS_OF,Persons,32391413,10.1007/s41207-020-00163-1,2020-05-12
Challenge,METHOD_OF,Medical service,32391413,10.1007/s41207-020-00163-1,2020-05-12
disorder control (procedure),TREATS,Genetic Carriers,32391413,10.1007/s41207-020-00163-1,2020-05-12
Health behavior,PROCESS_OF,Nigerian race,32391410,10.1016/j.dib.2020.105684,2020-05-12
Social network analysis,ADMINISTERED_TO,user - individual,32391409,10.1016/j.dib.2020.105683,2020-05-12
Social Sciences,ISA,Science,32391409,10.1016/j.dib.2020.105683,2020-05-12
Social Sciences,ISA,Science,32391409,10.1016/j.dib.2020.105683,2020-05-12
Coronavirus Infections,ISA,Disease,32391407,10.1016/j.cmrp.2020.05.003,2020-05-12
Coronavirus Infections,ISA,Disease,32391407,10.1016/j.cmrp.2020.05.003,2020-05-12
Coronavirus Infections,ISA,Disease,32391407,10.1016/j.cmrp.2020.05.003,2020-05-12
Autophagy,AFFECTS,cellular homeostasis,32391369,10.3389/fmed.2020.00170,2020-05-12
"Antigens, Viral",DISRUPTS,Inflammation,32391369,10.3389/fmed.2020.00170,2020-05-12
Autophagy,AFFECTS,Immunity,32391369,10.3389/fmed.2020.00170,2020-05-12
glucocorticoid therapy,TREATS,Patients,32391309,10.3389/fpubh.2020.00155,2020-05-12
Diagnosis,USES,Adrenal Cortex Hormones,32391309,10.3389/fpubh.2020.00155,2020-05-12
Negative Finding,PROCESS_OF,Patients,32391309,10.3389/fpubh.2020.00155,2020-05-12
Methylprednisolone,DISRUPTS,Cessation of life,32391309,10.3389/fpubh.2020.00155,2020-05-12
Conjunctivitis,PROCESS_OF,Patients,32391308,10.3389/fpubh.2020.00153,2020-05-12
Lacrimal Apparatus,PART_OF,Body Parts - Canal,32391308,10.3389/fpubh.2020.00153,2020-05-12
Mucous Membrane,PART_OF,Nasopharynx,32391308,10.3389/fpubh.2020.00153,2020-05-12
Pathogenic organism,CAUSES,Respiratory Tract Infections,32391308,10.3389/fpubh.2020.00153,2020-05-12
Infected,PROCESS_OF,Persons,32391282,10.3389/fonc.2020.00665,2020-05-12
Cessation of life,PROCESS_OF,Persons,32391282,10.3389/fonc.2020.00665,2020-05-12
Italy,ISA,Geographic Locations,32391282,10.3389/fonc.2020.00665,2020-05-12
Sardinia,ISA,Geographic Locations,32391282,10.3389/fonc.2020.00665,2020-05-12
"CD69 protein, human",PART_OF,Persons,32391282,10.3389/fonc.2020.00665,2020-05-12
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32391243,10.1016/j.rmcr.2020.101078,2020-05-12
Malignant neoplasm of lung,PROCESS_OF,Patients,32391243,10.1016/j.rmcr.2020.101078,2020-05-12
Therapeutic procedure,ADMINISTERED_TO,Patients,32391243,10.1016/j.rmcr.2020.101078,2020-05-12
Institutes,LOCATION_OF,Study,32391243,10.1016/j.rmcr.2020.101078,2020-05-12
Malignant neoplasm of lung,PROCESS_OF,Patients,32391243,10.1016/j.rmcr.2020.101078,2020-05-12
Antibiotics,TREATS,Coughing,32391242,10.1007/s40521-020-00258-8,2020-05-12
Antibiotics,TREATS,Fever,32391242,10.1007/s40521-020-00258-8,2020-05-12
Antibiotics,TREATS,Pneumonia,32391242,10.1007/s40521-020-00258-8,2020-05-12
lobe,LOCATION_OF,Pneumonia,32391242,10.1007/s40521-020-00258-8,2020-05-12
Plain chest X-ray,DIAGNOSES,Bilateral pneumonia,32391242,10.1007/s40521-020-00258-8,2020-05-12
Bronchi,LOCATION_OF,Sputum,32391242,10.1007/s40521-020-00258-8,2020-05-12
Coronavirus Infections,AFFECTS,Florid red complexion (finding),32391241,10.1186/s13717-020-00231-y,2020-05-12
Lung,PART_OF,Homo sapiens,32391241,10.1186/s13717-020-00231-y,2020-05-12
Ciliated epithelial cell,LOCATION_OF,angiotensin converting enzyme 2,32391241,10.1186/s13717-020-00231-y,2020-05-12
Ciliated epithelial cell,PART_OF,Lung,32391241,10.1186/s13717-020-00231-y,2020-05-12
Patients,LOCATION_OF,"M Protein, multiple myeloma",32391241,10.1186/s13717-020-00231-y,2020-05-12
anakinra,TREATS,Patients,32391241,10.1186/s13717-020-00231-y,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32391241,10.1186/s13717-020-00231-y,2020-05-12
Symptoms,PROCESS_OF,Patients,32391241,10.1186/s13717-020-00231-y,2020-05-12
Coronavirus Infections,CAUSES,Communicable Diseases,32391169,10.1186/s40885-020-00144-0,2020-05-12
Disease,PROCESS_OF,Patients,32391169,10.1186/s40885-020-00144-0,2020-05-12
Coronavirus Infections,AFFECTS,Patients,32391169,10.1186/s40885-020-00144-0,2020-05-12
Pharmacologic Substance,TREATS,Old age,32391113,10.1007/s12671-020-01382-x,2020-05-12
Pharmacologic Substance,TREATS,World,32391113,10.1007/s12671-020-01382-x,2020-05-12
Pneumonia,CAUSES,Cessation of life,32391113,10.1007/s12671-020-01382-x,2020-05-12
Antihypertensive Agents,AFFECTS,Hypotension,32391113,10.1007/s12671-020-01382-x,2020-05-12
Antihypertensive therapy,TREATS,Septicemia,32391113,10.1007/s12671-020-01382-x,2020-05-12
Plasma membrane,LOCATION_OF,angiotensin converting enzyme 2,32391113,10.1007/s12671-020-01382-x,2020-05-12
angiotensin converting enzyme 2,AUGMENTS,Virus Internalization,32391113,10.1007/s12671-020-01382-x,2020-05-12
Psyche structure,PROCESS_OF,"Buddhist, follower of religion",32391022,10.3389/fimmu.2020.00879,2020-05-12
Infected,PROCESS_OF,Persons,32390971,10.3389/fmicb.2020.00658,2020-05-12
Genetic Materials,PART_OF,Persons,32390971,10.3389/fmicb.2020.00658,2020-05-12
Assay,DIAGNOSES,Present,32390971,10.3389/fmicb.2020.00658,2020-05-12
Medical procedure,TREATS,Homo sapiens,32390931,10.3389/fneur.2020.00296,2020-05-12
Antiviral Agents,TREATS,Crisis,32390931,10.3389/fneur.2020.00296,2020-05-12
Infected,PROCESS_OF,Persons,32390757,10.1186/s41182-020-00218-7,2020-05-12
"CD69 protein, human",PART_OF,Animals,32390757,10.1186/s41182-020-00218-7,2020-05-12
"CD69 protein, human",PART_OF,Persons,32390757,10.1186/s41182-020-00218-7,2020-05-12
Infected,PROCESS_OF,Persons,32390757,10.1186/s41182-020-00218-7,2020-05-12
Nerve,PART_OF,Health Personnel,32390694,10.1007/s12262-020-02283-y,2020-05-12
follow-up,ISA,Evaluation,32390694,10.1007/s12262-020-02283-y,2020-05-12
Comfort,PROCESS_OF,user - individual,32390694,10.1007/s12262-020-02283-y,2020-05-12
Symptoms,PROCESS_OF,Patients,32390692,10.1016/j.chaos.2020.109867,2020-05-12
Societies,LOCATION_OF,simulation,32390691,10.1016/j.chaos.2020.109864,2020-05-12
Perception,PROCESS_OF,World,32390659,10.1016/j.jvb.2020.103440,2020-05-12
Minority Groups,ISA,Ethnic group,32390657,10.1016/j.jvb.2020.103437,2020-05-12
Unemployment,PROCESS_OF,Persons,32390655,10.1016/j.jvb.2020.103434,2020-05-12
South Korea,ISA,Asian country,32390523,10.1177/0391560320927106,2020-05-12
Taiwan,ISA,Asian country,32390523,10.1177/0391560320927106,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32390495,10.1177/1129729820926860,2020-05-12
Severe Acute Respiratory Syndrome,OCCURS_IN,Patients,32390495,10.1177/1129729820926860,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32390495,10.1177/1129729820926860,2020-05-12
In prison (finding),PROCESS_OF,Persons,32390368,10.3349/ymj.2020.61.5.438,2020-05-12
Behavior Disorders,PROCESS_OF,Persons,32390368,10.3349/ymj.2020.61.5.438,2020-05-12
Academic Medical Centers,LOCATION_OF,Retrospective Studies,32390285,10.1111/1742-6723.13550,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32390285,10.1111/1742-6723.13550,2020-05-12
Diabetes Mellitus,PROCESS_OF,Patients,32390285,10.1111/1742-6723.13550,2020-05-12
"Kidney Failure, Acute",PROCESS_OF,Patients,32390285,10.1111/1742-6723.13550,2020-05-12
Antibiotic therapy,ADMINISTERED_TO,Patients,32390285,10.1111/1742-6723.13550,2020-05-12
Hydroxychloroquine,TREATS,Patients,32390285,10.1111/1742-6723.13550,2020-05-12
glucocorticoid therapy,TREATS,Patients,32390285,10.1111/1742-6723.13550,2020-05-12
"Hospitals, Pediatric",LOCATION_OF,Retrospective Cohort Study,32390279,10.1111/dth.13549,2020-05-12
Comorbidity,PROCESS_OF,Patients,32390279,10.1111/dth.13549,2020-05-12
Comorbidity,PROCESS_OF,Patients,32390279,10.1111/dth.13549,2020-05-12
Negative,PROCESS_OF,Patients,32390279,10.1111/dth.13549,2020-05-12
risk factors,PROCESS_OF,Patients,32390279,10.1111/dth.13549,2020-05-12
Comorbidity,PROCESS_OF,Patients,32390279,10.1111/dth.13549,2020-05-12
Epithelium,PART_OF,Airway structure,32390132,10.33588/rn.7010.2020204,2020-05-12
Coronavirus Infections,ISA,Disease,32390132,10.33588/rn.7010.2020204,2020-05-12
Skin symptom,ASSOCIATED_WITH,Disease,32390132,10.33588/rn.7010.2020204,2020-05-12
Skin symptom,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32390132,10.33588/rn.7010.2020204,2020-05-12
Body tissue,LOCATION_OF,Disease,32390132,10.33588/rn.7010.2020204,2020-05-12
Symptoms,ISA,Sign or Symptom,32390132,10.33588/rn.7010.2020204,2020-05-12
Coronavirus Infections,ISA,Disease,32390132,10.33588/rn.7010.2020204,2020-05-12
Critical Illness,PROCESS_OF,Patients,32390064,10.1007/s40520-020-01581-5,2020-05-12
Coughing,ISA,Symptoms,32390064,10.1007/s40520-020-01581-5,2020-05-12
Fever,ISA,Symptoms,32390064,10.1007/s40520-020-01581-5,2020-05-12
Pharyngitis,ISA,Symptoms,32390064,10.1007/s40520-020-01581-5,2020-05-12
Parenchyma,NEG_LOCATION_OF,Abnormality,32390064,10.1007/s40520-020-01581-5,2020-05-12
Parenchyma,PART_OF,Lung,32390064,10.1007/s40520-020-01581-5,2020-05-12
Abnormality,PROCESS_OF,Patients,32390064,10.1007/s40520-020-01581-5,2020-05-12
exercise intervention,TREATS,"Stress, Psychological",32389941,10.5582/bst.2020.03094,2020-05-12
"CD69 protein, human",AFFECTS,Sleep,32389941,10.5582/bst.2020.03094,2020-05-12
Anxiety,PROCESS_OF,Medical Staff,32389941,10.5582/bst.2020.03094,2020-05-12
Sleeplessness,PROCESS_OF,Participant,32389941,10.5582/bst.2020.03094,2020-05-12
Sleeplessness,PROCESS_OF,Participant,32389941,10.5582/bst.2020.03094,2020-05-12
Psychological symptom,PROCESS_OF,Medical Staff,32389941,10.5582/bst.2020.03094,2020-05-12
Symptoms,PROCESS_OF,Medical Staff,32389941,10.5582/bst.2020.03094,2020-05-12
Psychological counseling,TREATS,Medical Staff,32389941,10.5582/bst.2020.03094,2020-05-12
Malaise,PROCESS_OF,Patients,32389893,10.1016/j.clineuro.2020.105866,2020-05-12
medical supplies,TREATS,Patients,32389893,10.1016/j.clineuro.2020.105866,2020-05-12
medical supplies,TREATS(INFER),Malaise,32389893,10.1016/j.clineuro.2020.105866,2020-05-12
FATE1 gene,PART_OF,Virus,32389882,10.1016/j.jshs.2020.05.001,2020-05-12
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32389878,10.1016/j.wneu.2020.04.226,2020-05-12
Aging,AFFECTS,Adaptive Immunity,32389878,10.1016/j.wneu.2020.04.226,2020-05-12
Obesity,CAUSES,Inflammation,32389878,10.1016/j.wneu.2020.04.226,2020-05-12
World,ISA,Population Group,32389878,10.1016/j.wneu.2020.04.226,2020-05-12
"Hypercholesterolemia, Familial",PROCESS_OF,Persons,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
Poor outcome,COEXISTS_WITH,Cardiovascular Diseases,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
"Hypercholesterolemia, Familial",PROCESS_OF,Patients,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
"Hypercholesterolemia, Familial",PROCESS_OF,Patients,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
Infection,AFFECTS,Patients,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
Hydroxymethylglutaryl-CoA Reductase Inhibitors,ISA,Hypolipidemic Agents,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
responsibility,PROCESS_OF,Persons,32389851,10.1016/j.ijid.2020.05.007,2020-05-12
Fever,ISA,Symptoms,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Fever,PROCESS_OF(SPEC),Patients,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Symptoms,PROCESS_OF,Patients,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Fever,ASSOCIATED_WITH,Influenza,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Fever,COEXISTS_WITH,patient condition,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Virus Diseases,PROCESS_OF,Patients,32389849,10.1016/j.ijid.2020.04.090,2020-05-12
Asymptomatic,PROCESS_OF,Child,32389848,10.1016/j.ijid.2020.05.001,2020-05-12
Complication,PROCESS_OF,Child,32389848,10.1016/j.ijid.2020.05.001,2020-05-12
"Hospitals, Public",LOCATION_OF,Diagnosis,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Cessation of life,OCCURS_IN,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Influenza A virus,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Respiratory syncytial virus,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Respiratory viruses,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Cessation of life,OCCURS_IN,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Influenza A virus,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Respiratory syncytial virus,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Respiratory viruses,PROCESS_OF,Patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Cessation of life,PROCESS_OF,hospitalized patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Respiratory viruses,COEXISTS_WITH,Influenza A virus,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Cessation of life,PROCESS_OF,hospitalized patients,32389847,10.1016/j.ijid.2020.05.002,2020-05-12
Shock,PROCESS_OF,Patients,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Acute respiratory distress,PROCESS_OF,Patients,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Cardiomyopathies,PROCESS_OF,Patients,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Interstitial lung fibrosis,PROCESS_OF,Patients,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Angiotensin II Type 1 Receptor Blockers,TREATS,Severe Acute Respiratory Syndrome,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Evaluation,TREATS,Patients,32389846,10.1016/j.ijid.2020.04.080,2020-05-12
Water,CAUSES,Disease,32389803,10.1016/j.bbmt.2020.04.027,2020-05-12
Transplantation,TREATS,Severe Aplastic Anemia,32389784,10.1016/j.jinf.2020.04.033,2020-05-12
Possible,PROCESS_OF,Patients,32389784,10.1016/j.jinf.2020.04.033,2020-05-12
Severe Aplastic Anemia,PROCESS_OF,Patients,32389784,10.1016/j.jinf.2020.04.033,2020-05-12
Immunochromatographic test,METHOD_OF,Detection,32389755,10.1016/j.radonc.2020.04.031,2020-05-12
Laboratory Procedures,DIAGNOSES,Hypersensitivity,32389755,10.1016/j.radonc.2020.04.031,2020-05-12
Immunochromatographic test,METHOD_OF,Detection,32389755,10.1016/j.radonc.2020.04.031,2020-05-12
China,ISA,Country,32389723,10.1016/j.ijantimicag.2020.106012,2020-05-12
Ribavirin,ISA,Antiviral Agents,32389720,10.1016/j.ijantimicag.2020.106007,2020-05-12
Lonicera,LOCATION_OF,Flavonoids,32389720,10.1016/j.ijantimicag.2020.106007,2020-05-12
Chloroquine,INTERACTS_WITH,Endopeptidases,32389720,10.1016/j.ijantimicag.2020.106007,2020-05-12
Hydroxychloroquine,ADMINISTERED_TO,Patients,32389697,10.1016/j.bbi.2020.05.022,2020-05-12
Azithromycin,ADMINISTERED_TO,Patients,32389697,10.1016/j.bbi.2020.05.022,2020-05-12
Lysosomes,LOCATION_OF,Hydroxychloroquine,32389697,10.1016/j.bbi.2020.05.022,2020-05-12
Lysosomes,LOCATION_OF,Azithromycin,32389697,10.1016/j.bbi.2020.05.022,2020-05-12
Lysosomes,LOCATION_OF,Observation - diagnostic procedure,32389697,10.1016/j.bbi.2020.05.022,2020-05-12
Meningoencephalitis,PROCESS_OF,Patients,32389695,10.1016/j.jaac.2020.05.001,2020-05-12
Malaise,PROCESS_OF,Patients,32389695,10.1016/j.jaac.2020.05.001,2020-05-12
CAT scan normal,PROCESS_OF,Infant,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Chest,LOCATION_OF,CAT scan normal,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Dry cough,PROCESS_OF,Infant,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Inhalation Therapy,USES,recombinant interferon alpha-1b,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Nose,LOCATION_OF,Pharyngeal Swabs,32389615,10.1016/j.schres.2020.05.005,2020-05-12
Psychotic Disorders,PROCESS_OF,Persons,32389604,10.1016/j.jpainsymman.2020.04.152,2020-05-12
Psychotic symptom,PROCESS_OF,Patients,32389604,10.1016/j.jpainsymman.2020.04.152,2020-05-12
Engaged to be married,PROCESS_OF,Patients,32389604,10.1016/j.jpainsymman.2020.04.152,2020-05-12
Virus,PROCESS_OF,Survivors,32389592,10.1016/j.jamda.2020.04.001,2020-05-12
Challenge,TREATS,Nursing Home Administrator,32389590,10.1016/j.jaci.2020.05.001,2020-05-12
Immune response,AFFECTS,Virus Internalization,32389541,10.1016/j.joms.2020.04.034,2020-05-12
Immunity,AFFECTS,Virus,32389541,10.1016/j.joms.2020.04.034,2020-05-12
Immune Evasion,PROCESS_OF,Patients,32389541,10.1016/j.joms.2020.04.034,2020-05-12
Basis,TREATS,Asymptomatic,32389541,10.1016/j.joms.2020.04.034,2020-05-12
Residency,ISA,Knowledge acquisition,32389538,10.1016/j.oraloncology.2020.104767,2020-05-12
Permanent tracheostomy,ISA,Operative Surgical Procedures,32389518,10.1016/j.nefro.2020.04.002,2020-05-12
Experience,PROCESS_OF,Cohort,32389518,10.1016/j.nefro.2020.04.002,2020-05-12
Challenge,TREATS,Patients,32389518,10.1016/j.nefro.2020.04.002,2020-05-12
general population,LOCATION_OF,IMPACT gene,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Virus,PROCESS_OF,Patients,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Symptoms,PROCESS_OF,Patients,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Cessation of life,PROCESS_OF,Patients,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Pneumonia,PROCESS_OF,Patients,32389516,10.1016/j.rpsm.2020.04.009,2020-05-12
Reactive psychoses,PROCESS_OF,Patients,32389499,10.1016/j.cytogfr.2020.04.005,2020-05-12
Comorbidity,PROCESS_OF,Elderly man,32389492,10.1016/j.purol.2020.04.021,2020-05-12
Aging,PROCESS_OF,Elderly man,32389492,10.1016/j.purol.2020.04.021,2020-05-12
Chronic inflammation,CAUSES,Disease,32389492,10.1016/j.purol.2020.04.021,2020-05-12
Severe Acute Respiratory Syndrome,MANIFESTATION_OF,Aging,32389492,10.1016/j.purol.2020.04.021,2020-05-12
Emergency medical service,TREATS,Patients,32389410,10.1016/j.arth.2020.04.049,2020-05-12
Urolithiasis,PROCESS_OF,Committee,32389410,10.1016/j.arth.2020.04.049,2020-05-12
Operating Room,LOCATION_OF,air filtration,32389408,10.1016/j.arth.2020.04.053,2020-05-12
Persons,LOCATION_OF,Antibodies,32389373,10.1016/j.crad.2020.04.010,2020-05-12
Coughing,PROCESS_OF,Child,32389318,10.1016/j.clon.2020.04.005,2020-05-12
Fever,PROCESS_OF,Child,32389318,10.1016/j.clon.2020.04.005,2020-05-12
Nasal congestion (finding),PROCESS_OF,Child,32389318,10.1016/j.clon.2020.04.005,2020-05-12
Parenchyma,LOCATION_OF,Bands,32389318,10.1016/j.clon.2020.04.005,2020-05-12
Urothelium,PART_OF,Patients,32389195,10.1016/S2214-109X(20)30222-9,2020-05-12
Health center,LOCATION_OF,Analysis,32389163,10.1017/dmp.2020.140,2020-05-12
dispensaries,LOCATION_OF,Analysis,32389163,10.1017/dmp.2020.140,2020-05-12
Hospitals,LOCATION_OF,Management procedure,32389148,10.1017/S0033291720001555,2020-05-12
Universities,LOCATION_OF,Prospective Cohort Study,32389144,10.1017/dmp.2020.151,2020-05-12
"Stress Disorders, Traumatic, Acute",PROCESS_OF,student,32389144,10.1017/dmp.2020.151,2020-05-12
"Stress Disorders, Traumatic, Acute",PROCESS_OF,student,32389144,10.1017/dmp.2020.151,2020-05-12
School,LOCATION_OF,Graduate Education,32389117,10.2174/1871526520666200511005546,2020-05-12
Diabetes,PROCESS_OF,hospitalized patients,32389025,10.1177/1060028020925558,2020-05-12
Acute hyperglycemia,PROCESS_OF,hospitalized patients,32389025,10.1177/1060028020925558,2020-05-12
Diabetes,PROCESS_OF,Patients,32389025,10.1177/1060028020925558,2020-05-12
Hyperglycemia,PROCESS_OF,Patients,32389025,10.1177/1060028020925558,2020-05-12
Diabetes,PROCESS_OF,Patients,32389025,10.1177/1060028020925558,2020-05-12
Hyperglycemia,PROCESS_OF,Patients,32389025,10.1177/1060028020925558,2020-05-12
Hyperglycemia,PROCESS_OF,inpatient,32389025,10.1177/1060028020925558,2020-05-12
Respiration Disorders,PROCESS_OF,World,32388976,10.1021/acsinfecdis.0c00224,2020-05-12
Coronavirus Infections,CAUSES,Respiration Disorders,32388976,10.1021/acsinfecdis.0c00224,2020-05-12
Immunity,PROCESS_OF,general population,32388948,10.3760/cma.j.cn112150-20200227-00201,2020-05-12
Retirement,PROCESS_OF,Staff,32388947,10.3760/cma.j.cn112150-20200204-00065,2020-05-12
Asymptomatic,PROCESS_OF,Patients,32388946,10.3760/cma.j.cn112150-20200229-00220,2020-05-12
Lung,LOCATION_OF,Lesion,32388946,10.3760/cma.j.cn112150-20200229-00220,2020-05-12
Screening procedure,AFFECTS,Lesion,32388946,10.3760/cma.j.cn112150-20200229-00220,2020-05-12
Screening procedure,TREATS,Patients,32388946,10.3760/cma.j.cn112150-20200229-00220,2020-05-12
Limb structure,LOCATION_OF,Paresthesia,32388805,10.1007/s00066-020-01635-7,2020-05-11
Cerebrospinal fluid examination,DIAGNOSES,Dissociation,32388805,10.1007/s00066-020-01635-7,2020-05-11
Syndrome,PROCESS_OF,Patients,32388805,10.1007/s00066-020-01635-7,2020-05-11
Pneumonia,PROCESS_OF,Patients,32388722,10.1007/s00431-020-03674-9,2020-05-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32388722,10.1007/s00431-020-03674-9,2020-05-11
Low Dose Radiation Therapy,TREATS,Patients,32388722,10.1007/s00431-020-03674-9,2020-05-11
Low Dose Radiation Therapy,TREATS,Pneumonia,32388722,10.1007/s00431-020-03674-9,2020-05-11
Asymptomatic,PROCESS_OF,Persons,32388698,10.1007/s11033-020-05479-3,2020-05-11
Signs and Symptoms,COEXISTS_WITH,Household composition,32388698,10.1007/s11033-020-05479-3,2020-05-11
Mammographic difference in size (finding),PROCESS_OF,Child,32388698,10.1007/s11033-020-05479-3,2020-05-11
Asymptomatic,PROCESS_OF,Persons,32388698,10.1007/s11033-020-05479-3,2020-05-11
Masks,TREATS,Household composition,32388698,10.1007/s11033-020-05479-3,2020-05-11
Mammographic difference in size (finding),PROCESS_OF,Child,32388698,10.1007/s11033-020-05479-3,2020-05-11
Gynecologist,ISA,Physicians,32388643,10.1007/s00403-020-02086-x,2020-05-11
Oncologists,ISA,Physicians,32388643,10.1007/s00403-020-02086-x,2020-05-11
Dermatologist,DIAGNOSES,Adverse reactions,32388565,10.1093/eurheartj/ehaa373,2020-05-11
Skin irritation,PROCESS_OF,Caucasoid Race,32388565,10.1093/eurheartj/ehaa373,2020-05-11
Practice Experience,PROCESS_OF,Dermatologist,32388565,10.1093/eurheartj/ehaa373,2020-05-11
Heart failure,PROCESS_OF,Male population group,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Heart failure,PROCESS_OF,Woman,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Male population group,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Patients,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Woman,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Cohort,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Plasma,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Angiotensin-Converting Enzyme Inhibitors,TREATS,Male population group,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Heart failure,PROCESS_OF,Patients,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Plasma,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
Plasma,LOCATION_OF,angiotensin converting enzyme 2,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
angiotensin converting enzyme 2,ASSOCIATED_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
angiotensin converting enzyme 2,ASSOCIATED_WITH(INFER),Heart failure,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
angiotensin converting enzyme 2,PART_OF,Patients,32388486,10.1016/j.jphotobiol.2020.111891,2020-05-11
"TLR4 protein, human",PART_OF,Community,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Phototherapy,AFFECTS,Disease,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Phototherapy,AFFECTS(SPEC),Coronavirus Infections,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Coronavirus Infections,ISA,Disease,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Antibiotics,TREATS,Tuberculosis,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Coronavirus Infections,COEXISTS_WITH,Complication,32388476,10.1016/j.mehy.2020.109814,2020-05-11
Coronavirus Infections,PROCESS_OF,"Animals, Laboratory",32388476,10.1016/j.mehy.2020.109814,2020-05-11
Copper,ISA,Trace Elements,32388472,10.1016/j.jcv.2020.104397,2020-05-11
Blood Cells,PRODUCES,Specific antibody,32388472,10.1016/j.jcv.2020.104397,2020-05-11
Human poliovirus,ISA,Virus,32388472,10.1016/j.jcv.2020.104397,2020-05-11
Adaptive Immunity,PROCESS_OF,Persons,32388472,10.1016/j.jcv.2020.104397,2020-05-11
Fever,ISA,Symptoms,32388471,10.1016/j.jcv.2020.104390,2020-05-11
patient condition,COEXISTS_WITH,Diarrhea,32388471,10.1016/j.jcv.2020.104390,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32388471,10.1016/j.jcv.2020.104390,2020-05-11
Diagnosis,USES,Immunologic Adjuvants,32388471,10.1016/j.jcv.2020.104390,2020-05-11
Nasal Swab (procedure),MEASURES,Direct assay,32388469,10.1016/j.jcv.2020.104386,2020-05-11
Extraction,METHOD_OF,Detection,32388469,10.1016/j.jcv.2020.104386,2020-05-11
Infected,PROCESS_OF,Patients,32388469,10.1016/j.jcv.2020.104386,2020-05-11
Persons,USES,Test kit,32388458,10.1016/j.msard.2020.102163,2020-05-11
Multiple Sclerosis,PROCESS_OF,Patients,32388451,10.1016/j.msard.2020.102165,2020-05-11
Organ,LOCATION_OF,Present,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Organ,PART_OF,Homo sapiens,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Parenchyma,PART_OF,Lung,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Immunosuppressive Agents,AUGMENTS,Infection,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Therapeutic procedure,ADMINISTERED_TO,Patients,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Therapeutic procedure,USES,Immunosuppressive Agents,32388418,10.1016/j.psychres.2020.113045,2020-05-11
natalizumab,TREATS,Patients,32388418,10.1016/j.psychres.2020.113045,2020-05-11
natalizumab,TREATS,Worse,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Discontinued,PROCESS_OF,Patients,32388418,10.1016/j.psychres.2020.113045,2020-05-11
Pandemics,ISA,Disease Outbreaks,32388417,10.1016/j.psychres.2020.113041,2020-05-11
Depressive disorder,PROCESS_OF,general population,32388390,10.1016/j.mehy.2020.109762,2020-05-11
Depressive disorder,PROCESS_OF,Practitioner,32388390,10.1016/j.mehy.2020.109762,2020-05-11
Panic,PROCESS_OF,general population,32388390,10.1016/j.mehy.2020.109762,2020-05-11
Panic,PROCESS_OF,Practitioner,32388390,10.1016/j.mehy.2020.109762,2020-05-11
Adenosine Triphosphate,PART_OF,Cells,32388333,10.1016/j.dsx.2020.04.041,2020-05-11
Infected,PROCESS_OF,Patients,32388332,10.1016/j.dsx.2020.04.045,2020-05-11
Scientist,DIAGNOSES,Symptoms,32388332,10.1016/j.dsx.2020.04.045,2020-05-11
Infected,PROCESS_OF,Patients,32388332,10.1016/j.dsx.2020.04.045,2020-05-11
IMPACT gene,INTERACTS_WITH,Blood Glucose,32388331,10.1016/j.dsx.2020.04.049,2020-05-11
insulin secretion,COEXISTS_WITH,Pregnancy,32388331,10.1016/j.dsx.2020.04.049,2020-05-11
Coronaviridae,PROCESS_OF,Pregnant Women,32388331,10.1016/j.dsx.2020.04.049,2020-05-11
Premature Birth,PROCESS_OF,Pregnant Women,32388331,10.1016/j.dsx.2020.04.049,2020-05-11
Prognosis bad,COEXISTS_WITH,Diabetes Mellitus,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Prognosis bad,PROCESS_OF,Patients,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Hyperglycemia,ISA,Stress,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Dysglycemia,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,ISA,Diabetes,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,PREDISPOSES,Prognosis bad,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,AFFECTS,Worse,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Hypokalemia,PREDISPOSES,Worse,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Worse,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Diabetes Mellitus,PROCESS_OF,Persons,32388330,10.1016/j.dsx.2020.04.040,2020-05-11
Hyperglycemia,AFFECTS,glucose homeostasis,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Hypoglycemic Agents,ISA,Pharmaceutical Preparations,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
angiotensin II,AFFECTS,Lung Injury,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Hypoglycemic Agents,ISA,Pharmaceutical Preparations,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Hypoglycemic Agents,ISA,Pharmaceutical Preparations,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Hypoglycemic Agents,ISA,Pharmaceutical Preparations,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Early Therapy,USES,Insulin,32388328,10.1016/j.dsx.2020.04.048,2020-05-11
Malaise,PROCESS_OF,Patients,32388326,10.1016/j.dsx.2020.04.038,2020-05-11
Crisis,PROCESS_OF,World,32388162,10.1016/j.scitotenv.2020.139178,2020-05-11
Coronavirus Infections,ISA,Disease,32388138,10.1016/j.mehy.2020.109750,2020-05-11
Disease,COEXISTS_WITH,brazilian,32388136,10.1016/j.scitotenv.2020.139088,2020-05-11
Coronavirus Infections,ISA,Disease,32388129,10.1016/j.scitotenv.2020.138916,2020-05-11
Pharmaceutical Preparations,TREATS,Disease,32388129,10.1016/j.scitotenv.2020.138916,2020-05-11
Vaccines,TREATS,Disease,32388129,10.1016/j.scitotenv.2020.138916,2020-05-11
Coronavirus Infections,ISA,Disease,32388083,10.1016/j.ijporl.2020.110075,2020-05-11
Coronavirus Infections,ISA,Disease,32388083,10.1016/j.ijporl.2020.110075,2020-05-11
Disease,PROCESS_OF,Patients,32387968,10.1016/j.jcv.2020.104393,2020-05-11
Health Services,TREATS,Patients,32387968,10.1016/j.jcv.2020.104393,2020-05-11
Health Services,TREATS(INFER),Disease,32387968,10.1016/j.jcv.2020.104393,2020-05-11
,PREVENTS,Anxiety,32387968,10.1016/j.jcv.2020.104393,2020-05-11
Larynx,LOCATION_OF,Bronchoscopy,32387968,10.1016/j.jcv.2020.104393,2020-05-11
Chest CT,METHOD_OF,Diagnosis,32387967,10.1016/j.jcv.2020.104385,2020-05-11
Hypersensitivity,PROCESS_OF,Patients,32387967,10.1016/j.jcv.2020.104385,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32387967,10.1016/j.jcv.2020.104385,2020-05-11
Chest CT,DIAGNOSES,Disease,32387967,10.1016/j.jcv.2020.104385,2020-05-11
Immunochromatographic Assay,DIAGNOSES,Disease,32387967,10.1016/j.jcv.2020.104385,2020-05-11
Pneumonia,PROCESS_OF,Child,32387924,10.1016/j.ejrad.2020.109017,2020-05-11
Pneumonia,PROCESS_OF,"Child, Hospitalized",32387924,10.1016/j.ejrad.2020.109017,2020-05-11
Interested,PROCESS_OF,"Child, Hospitalized",32387924,10.1016/j.ejrad.2020.109017,2020-05-11
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32387924,10.1016/j.ejrad.2020.109017,2020-05-11
Pulmonary artery structure,LOCATION_OF,Pathological Dilatation,32387864,10.1016/j.dsx.2020.04.033,2020-05-11
Pulmonary artery structure,LOCATION_OF,Pathological Dilatation,32387864,10.1016/j.dsx.2020.04.033,2020-05-11
Pulmonary artery structure,LOCATION_OF,Pathological Dilatation,32387864,10.1016/j.dsx.2020.04.033,2020-05-11
Diabetes,PROCESS_OF,Persons,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Heart Diseases,PROCESS_OF,Persons,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Disease,PROCESS_OF,Patients,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Inflammation,PROCESS_OF,Patients,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Obesity,AFFECTS,Severe Acute Respiratory Syndrome,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Obesity,COMPLICATES,Severe Acute Respiratory Syndrome,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Infection Problem,AFFECTS,Severe Acute Respiratory Syndrome,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Infection Problem,COMPLICATES,Severe Acute Respiratory Syndrome,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Obesity,32387855,10.1016/j.anndiagpath.2020.151530,2020-05-11
Syndrome,ASSOCIATED_WITH,Complement Activation,32387823,10.1016/j.scitotenv.2020.139089,2020-05-11
Coronavirus Infections,CAUSES,Disease,32387823,10.1016/j.scitotenv.2020.139089,2020-05-11
Structure of great blood vessel (organ),LOCATION_OF,Thrombus,32387823,10.1016/j.scitotenv.2020.139089,2020-05-11
Disasters,CAUSES,Coronavirus Infections,32387822,10.1016/j.scitotenv.2020.139179,2020-05-11
Possible,PROCESS_OF,Persons,32387795,10.1016/j.psychres.2020.113047,2020-05-11
Infected,PROCESS_OF,Persons,32387795,10.1016/j.psychres.2020.113047,2020-05-11
opioid use,ISA,Disease,32387794,10.1016/j.psychres.2020.113046,2020-05-11
opioid use,ISA,Disease,32387794,10.1016/j.psychres.2020.113046,2020-05-11
Disease,PROCESS_OF,Patients,32387794,10.1016/j.psychres.2020.113046,2020-05-11
opioid use,ISA,Disease,32387794,10.1016/j.psychres.2020.113046,2020-05-11
opioid use,PROCESS_OF(SPEC),Patients,32387794,10.1016/j.psychres.2020.113046,2020-05-11
Encephalitis,COEXISTS_WITH,Neurologic Deficits,32387778,10.1016/j.scitotenv.2020.138764,2020-05-11
Acclimatization,AFFECTS,Genus: Coronavirus,32387778,10.1016/j.scitotenv.2020.138764,2020-05-11
Triage,TREATS,Patients,32387778,10.1016/j.scitotenv.2020.138764,2020-05-11
Infection,OCCURS_IN,Population Group,32387756,10.1016/j.mehy.2020.109779,2020-05-11
Infected,PROCESS_OF,Persons,32387756,10.1016/j.mehy.2020.109779,2020-05-11
Infected,PROCESS_OF,Persons,32387756,10.1016/j.mehy.2020.109779,2020-05-11
Communicable Diseases,PROCESS_OF,Community,32387756,10.1016/j.mehy.2020.109779,2020-05-11
Vaccination,USES,EHD1 wt Allele,32387694,10.1016/j.tmaid.2020.101735,2020-05-11
Genus: Coronavirus,ISA,Virus,32387694,10.1016/j.tmaid.2020.101735,2020-05-11
Immunotherapy,TREATS,Malignant Neoplasms,32387694,10.1016/j.tmaid.2020.101735,2020-05-11
Vaccines,COEXISTS_WITH,Toxoids,32387694,10.1016/j.tmaid.2020.101735,2020-05-11
Infected,PROCESS_OF,Patients,32387694,10.1016/j.tmaid.2020.101735,2020-05-11
Coronavirus Infections,ISA,Disease,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
SARS coronavirus,CAUSES,Disease,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Antiviral Agents,ISA,Pharmaceutical Preparations,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Antiviral Agents,TREATS(SPEC),patient condition,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Pharmaceutical Preparations,TREATS,patient condition,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Chloroquine,TREATS,patient condition,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Hydroxychloroquine,TREATS,patient condition,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Prophylactic treatment,PREDISPOSES,Disease,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Prophylactic treatment,PREDISPOSES(SPEC),Coronavirus Infections,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Coronavirus Infections,ISA,Disease,32387682,10.1016/j.micinf.2020.04.011,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Lung,LOCATION_OF,Lesion,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32387671,10.1016/j.envpol.2020.114732,2020-05-11
Coronavirus Infections,PROCESS_OF,Animals,32387575,10.1016/j.jpainsymman.2020.04.153,2020-05-11
Virus,PROCESS_OF,human group,32387575,10.1016/j.jpainsymman.2020.04.153,2020-05-11
Hypnotics and Sedatives,TREATS,Pain,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Hypnotics and Sedatives,TREATS,Respiratory distress,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Anti-Anxiety Agents,TREATS,Pain,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Anti-Anxiety Agents,TREATS,Respiratory distress,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Anxiety,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Coughing,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Delirium,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Drowsiness,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Dyspnea,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Agitation,ISA,Symptoms,32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Fentanyl,ISA,"Analgesics, Opioid",32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Morphine,ISA,"Analgesics, Opioid",32387574,10.1016/j.jpainsymman.2020.05.002,2020-05-11
Bereavement Care,TREATS,Family,32387564,10.1016/j.meegid.2020.104351,2020-05-11
Virus,PROCESS_OF,Pholidota,32387502,10.1016/j.cjca.2020.04.038,2020-05-11
Choose (action),ISA,Event,32387502,10.1016/j.cjca.2020.04.038,2020-05-11
Congenital heart disease,PART_OF,Child,32387470,10.1016/j.autrev.2020.102573,2020-05-11
Exercise,TREATS,Child,32387470,10.1016/j.autrev.2020.102573,2020-05-11
Congenital heart disease,PART_OF,Child,32387470,10.1016/j.autrev.2020.102573,2020-05-11
Congenital heart disease,PART_OF,Child,32387470,10.1016/j.autrev.2020.102573,2020-05-11
Inflammation,COEXISTS_WITH,Syndrome,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
cytokine,AFFECTS,Inflammation,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
cytokine,AFFECTS,Increased ferritin,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
cytokine,CAUSES,Multiple Organ Failure,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
Increased ferritin,COEXISTS_WITH,Syndrome,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
Inflammation,PROCESS_OF,Patients,32387456,10.1016/j.annonc.2020.04.479,2020-05-11
TMPRSS2 gene,AFFECTS,Severe Acute Respiratory Syndrome,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
TMPRSS2 gene,AUGMENTS,Malignant neoplasm of prostate,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Malignant neoplasm of prostate,AFFECTS,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
neoplasm diagnosis,DIAGNOSES,Malignant neoplasm of prostate,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Antiandrogen therapy,ADMINISTERED_TO,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Antiandrogen therapy,NEG_ADMINISTERED_TO,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Malignant neoplasm of prostate,PROCESS_OF,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Antiandrogen therapy,ADMINISTERED_TO,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Malignant neoplasm of prostate,PROCESS_OF,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Severe Acute Respiratory Syndrome,PROCESS_OF,Cancer Patient,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Antiandrogen therapy,ADMINISTERED_TO,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Malignant neoplasm of prostate,PROCESS_OF,Patients,32387409,10.1016/j.tmaid.2020.101738,2020-05-11
Treatment Protocols,TREATS,Patients,32387389,10.1016/j.micpath.2020.104241,2020-05-11
Respiratory Failure,CAUSES,Cessation of life,32387389,10.1016/j.micpath.2020.104241,2020-05-11
Complication,PROCESS_OF,Patients,32387389,10.1016/j.micpath.2020.104241,2020-05-11
Blurred vision,PROCESS_OF,Transient Population Group,32387389,10.1016/j.micpath.2020.104241,2020-05-11
Epidemic,ISA,Disease Outbreaks,32387384,10.1016/j.mbs.2020.108370,2020-05-11
Household composition,PROCESS_OF,Persons,32387384,10.1016/j.mbs.2020.108370,2020-05-11
Disease,PROCESS_OF,Population Group,32387345,10.1016/j.bbi.2020.05.010,2020-05-11
Staff,DIAGNOSES,Anxiety,32387333,10.1016/j.micinf.2020.05.002,2020-05-11
Epithelial Cells,LOCATION_OF,Virus,32387332,10.1016/j.micinf.2020.05.001,2020-05-11
Nitric Oxide,PREVENTS,Respiratory Tract Infections,32387332,10.1016/j.micinf.2020.05.001,2020-05-11
Airway structure,LOCATION_OF,Mouth Breathing,32387332,10.1016/j.micinf.2020.05.001,2020-05-11
Inspiration function,COEXISTS_WITH,Sleep,32387332,10.1016/j.micinf.2020.05.001,2020-05-11
Hospitals,LOCATION_OF,Case-Control Studies,32387301,10.1016/j.phrs.2020.104866,2020-05-11
tocilizumab,TREATS,Patients,32387301,10.1016/j.phrs.2020.104866,2020-05-11
Lymphopenia,PROCESS_OF,Patients,32387301,10.1016/j.phrs.2020.104866,2020-05-11
Pneumonia,PROCESS_OF,Patients,32387301,10.1016/j.phrs.2020.104866,2020-05-11
tocilizumab,compared_with,tocilizumab,32387301,10.1016/j.phrs.2020.104866,2020-05-11
tocilizumab,TREATS,Patients,32387301,10.1016/j.phrs.2020.104866,2020-05-11
Hyperactive behavior,COEXISTS_WITH,Disease,32387247,10.1016/j.hrthm.2020.04.047,2020-05-11
Storm NOS,COEXISTS_WITH,Disease,32387247,10.1016/j.hrthm.2020.04.047,2020-05-11
ruxolitinib,ISA,Pharmaceutical Preparations,32387247,10.1016/j.hrthm.2020.04.047,2020-05-11
JAK1 Inhibitor,INTERACTS_WITH,cytokine,32387247,10.1016/j.hrthm.2020.04.047,2020-05-11
Antisense Oligonucleotides,PART_OF,Phosphotransferases,32387247,10.1016/j.hrthm.2020.04.047,2020-05-11
Electrocardiogram,PROCESS_OF,Patients,32387246,10.1016/j.hrthm.2020.05.001,2020-05-11
Electrocardiographic monitoring,DIAGNOSES,Prolonged QT interval,32387246,10.1016/j.hrthm.2020.05.001,2020-05-11
Electrolytes abnormal,PROCESS_OF,Patients,32387246,10.1016/j.hrthm.2020.05.001,2020-05-11
Prolonged QT interval,PROCESS_OF,Patients,32387246,10.1016/j.hrthm.2020.05.001,2020-05-11
Prolonged QT interval,PROCESS_OF,Patients,32387246,10.1016/j.hrthm.2020.05.001,2020-05-11
Myocarditis,COEXISTS_WITH,Direct trauma,32387238,10.1016/j.transci.2020.102804,2020-05-11
Signs and Symptoms,COEXISTS_WITH,Electrocardiogram,32387238,10.1016/j.transci.2020.102804,2020-05-11
Heart,LOCATION_OF,Magnetic Resonance Imaging,32387238,10.1016/j.transci.2020.102804,2020-05-11
Cardiovascular,LOCATION_OF,Comorbidity,32387238,10.1016/j.transci.2020.102804,2020-05-11
Biopsy,DIAGNOSES,cardiac infection,32387238,10.1016/j.transci.2020.102804,2020-05-11
Endomyocardium,LOCATION_OF,Biopsy,32387238,10.1016/j.transci.2020.102804,2020-05-11
Antibody Formation,AFFECTS,Disease Progression,32387230,10.1016/j.sapharm.2020.04.032,2020-05-11
Membrane Glycoproteins,PART_OF,Cells,32387230,10.1016/j.sapharm.2020.04.032,2020-05-11
angiotensin converting enzyme 2,AFFECTS,Renin-Angiotensin-Aldosterone System,32387230,10.1016/j.sapharm.2020.04.032,2020-05-11
Eye,LOCATION_OF,Shock,32387229,10.1016/j.sapharm.2020.04.033,2020-05-11
Pharmacist,ISA,Health Personnel,32387229,10.1016/j.sapharm.2020.04.033,2020-05-11
skill,PROCESS_OF,Health Personnel,32387229,10.1016/j.sapharm.2020.04.033,2020-05-11
skill,PROCESS_OF(SPEC),Pharmacist,32387229,10.1016/j.sapharm.2020.04.033,2020-05-11
Community Pharmacists,ISA,Health Personnel,32387156,10.1016/j.jhsa.2020.04.023,2020-05-11
Microsurgery,AFFECTS,Disease,32387155,10.1016/j.jhsa.2020.04.024,2020-05-11
Critical Illness,PROCESS_OF,Patients,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Limb structure,LOCATION_OF,Ischemia,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Ischemia,PROCESS_OF,Cohort,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Limb structure,LOCATION_OF,Ischemia,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Critical Illness,PROCESS_OF,Patients,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
intensive care unit,LOCATION_OF,Administration occupational activities,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Ischemia,PROCESS_OF,Patients,32387139,10.1016/j.jpainsymman.2020.04.031,2020-05-11
Disease,PROCESS_OF,member,32387138,10.1016/j.jpainsymman.2020.04.023,2020-05-11
Acute hospital,LOCATION_OF,Data Collection,32387138,10.1016/j.jpainsymman.2020.04.023,2020-05-11
Jordan,ISA,Country,32387102,10.1016/j.jiph.2020.04.013,2020-05-11
"CD69 protein, human",PREVENTS,Infection,32387102,10.1016/j.jiph.2020.04.013,2020-05-11
Infection,PROCESS_OF,Patients,32387102,10.1016/j.jiph.2020.04.013,2020-05-11
Abdominal Pain,ISA,Symptoms,32387072,10.1016/j.anorl.2020.04.013,2020-05-11
Ethics Committees,DIAGNOSES,Acute pancreatitis,32387072,10.1016/j.anorl.2020.04.013,2020-05-11
Complication,PROCESS_OF,Patients,32387072,10.1016/j.anorl.2020.04.013,2020-05-11
Malignant Neoplasms,PROCESS_OF,Child,32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
Malignant Neoplasms,PROCESS_OF,Adolescent (age group),32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
leukemia,PROCESS_OF,Child,32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
leukemia,PROCESS_OF,Adolescent (age group),32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
leukemia,PROCESS_OF,Committee,32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
Acute lymphocytic leukemia,PROCESS_OF,Child,32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
Acute lymphocytic leukemia,PROCESS_OF,Adolescent (age group),32387058,10.1016/j.jviscsurg.2020.04.013,2020-05-11
Peritoneum,LOCATION_OF,Pharmacotherapy,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Peritoneum,LOCATION_OF,Neoplasm Metastasis,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Peritoneum,LOCATION_OF(SPEC),Systemic Chemotherapy,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
ovarian,LOCATION_OF,Carcinomatosis,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Systemic Chemotherapy,ISA,Pharmacotherapy,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Systemic Chemotherapy,NEG_TREATS,Neoplasm Metastasis,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Peritoneum,LOCATION_OF,Pharmacotherapy,32387057,10.1016/j.jviscsurg.2020.04.007,2020-05-11
Appendix,LOCATION_OF,Syndrome,32387041,10.1016/j.arcmed.2020.04.017,2020-05-11
Emergency operation,TREATS,Appendicitis,32387041,10.1016/j.arcmed.2020.04.017,2020-05-11
Genus: Coronavirus,ISA,RNA Viruses,32387014,10.1016/j.encep.2020.04.010,2020-05-11
Polymerase,PART_OF,RNA Viruses,32387014,10.1016/j.encep.2020.04.010,2020-05-11
Polymerase,PART_OF(SPEC),Genus: Coronavirus,32387014,10.1016/j.encep.2020.04.010,2020-05-11
sofosbuvir,DISRUPTS,RNA-directed RNA polymerase activity,32387014,10.1016/j.encep.2020.04.010,2020-05-11
Coronavirus Infections,PROCESS_OF,Homo sapiens,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Infected,PROCESS_OF,Persons,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Infection,OCCURS_IN,Psychiatric inpatient,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Psychiatric Units,LOCATION_OF,Observation in research,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,ISA,Phenothiazine derivatives,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,ISA,Pharmaceutical Preparations,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,DISRUPTS,contagion,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,DISRUPTS,contagion,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,TREATS,Patients,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Lung,LOCATION_OF,Chlorpromazine,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,ISA,Pharmaceutical Preparations,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,TREATS(SPEC),Headache,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,TREATS(SPEC),Nausea,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Chlorpromazine,TREATS(SPEC),Vomiting of pregnancy,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Pharmaceutical Preparations,TREATS,Headache,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Pharmaceutical Preparations,TREATS,Nausea,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Pharmaceutical Preparations,TREATS,Vomiting of pregnancy,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Headache,ASSOCIATED_WITH,nervous system disorder,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Vomiting of pregnancy,COEXISTS_WITH,advanced cancer,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Anti-Anxiety Effect,AFFECTS,Blood - brain barrier anatomy,32386993,10.1016/j.ijoa.2020.04.003,2020-05-11
Community,LOCATION_OF,IMPACT gene,32386950,10.1016/j.acra.2020.04.028,2020-05-11
ambulatory care services,TREATS,Patients,32386911,10.1016/j.ygyno.2020.04.694,2020-05-11
Malignant Neoplasms,PROCESS_OF,Patients,32386898,10.1016/j.amjoto.2020.102514,2020-05-11
Malignant Neoplasms,PROCESS_OF,Patients,32386898,10.1016/j.amjoto.2020.102514,2020-05-11
Comorbidity,PROCESS_OF,Patients,32386898,10.1016/j.amjoto.2020.102514,2020-05-11
Lysosomal Storage Diseases,AFFECTS,Patients,32386804,10.1016/j.ajem.2020.04.075,2020-05-11
"Administration, Oral",ADMINISTERED_TO,Patients,32386804,10.1016/j.ajem.2020.04.075,2020-05-11
Enzyme Replacement Therapy,ADMINISTERED_TO,Patients,32386804,10.1016/j.ajem.2020.04.075,2020-05-11
Coughing,ISA,Symptoms,32386672,10.1016/j.bjoms.2020.04.030,2020-05-11
Fever,ISA,Symptoms,32386672,10.1016/j.bjoms.2020.04.030,2020-05-11
Asymptomatic,PROCESS_OF,Patients,32386672,10.1016/j.bjoms.2020.04.030,2020-05-11
Patient referral,TREATS,Dental abscess,32386671,10.1016/j.bjoms.2020.04.025,2020-05-11
Infected,PROCESS_OF,Patients,32386664,10.1016/j.maturitas.2020.04.004,2020-05-11
Experience,PROCESS_OF,Health Personnel,32386664,10.1016/j.maturitas.2020.04.004,2020-05-11
Bronchi,PART_OF,Homo sapiens,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
conjunctiva,PART_OF,Homo sapiens,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
macrophage,LOCATION_OF,angiotensin converting enzyme 2,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Alveolar Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Alveolar Epithelial Cells,PART_OF,Homo sapiens,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Mucous Membrane,PART_OF,conjunctiva,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Clara cell,PART_OF,Lung,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Clara cell,PART_OF,Mucous Membrane,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Clara cell,PART_OF,Epithelium of bronchus,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Epithelium,LOCATION_OF,SARS coronavirus,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Epithelium,LOCATION_OF,SARS coronavirus,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Epithelium,PART_OF,Alveolar,32386567,10.1016/S2213-8587(20)30157-1,2020-05-11
Pacific Northwest,ISA,Geographic Locations,32386514,10.1186/s13643-020-01371-0,2020-05-11
Placebos,NEG_ISA,Interventional procedure,32386473,10.1503/cjs.004720,2020-05-11
Interventional procedure,TREATS,Human Age Group,32386473,10.1503/cjs.004720,2020-05-11
Pinpoint,PROCESS_OF,Population at Risk,32386472,10.1503/cjs.006020,2020-05-11
Surgeon,ISA,Health Personnel,32386471,10.1503/cjs.006620,2020-05-11
Comorbidity,PROCESS_OF,Persons,32386460,10.1111/pde.14215,2020-05-10
Obesity,PROCESS_OF,Persons,32386460,10.1111/pde.14215,2020-05-10
Symptoms,PROCESS_OF,Persons,32386460,10.1111/pde.14215,2020-05-10
Chilblains,PROCESS_OF,Child,32386449,10.1111/hepr.13510,2020-05-10
Chilblains,PROCESS_OF,Adolescent (age group),32386449,10.1111/hepr.13510,2020-05-10
Fingers,LOCATION_OF,Lesion,32386449,10.1111/hepr.13510,2020-05-10
Foot,LOCATION_OF,Chilblains,32386449,10.1111/hepr.13510,2020-05-10
Foot,LOCATION_OF,Acral Lesion,32386449,10.1111/hepr.13510,2020-05-10
Hand,LOCATION_OF,Acral Lesion,32386449,10.1111/hepr.13510,2020-05-10
Toes,LOCATION_OF,Chilblains,32386449,10.1111/hepr.13510,2020-05-10
Lesion,PROCESS_OF,Patients,32386449,10.1111/hepr.13510,2020-05-10
Laboratory Procedures,USES,Coagulation procedure,32386449,10.1111/hepr.13510,2020-05-10
Patients,LOCATION_OF,Lupus Coagulation Inhibitor,32386449,10.1111/hepr.13510,2020-05-10
Complete blood count without differential,ISA,Laboratory Procedures,32386449,10.1111/hepr.13510,2020-05-10
Complete blood count without differential,USES(SPEC),Coagulation procedure,32386449,10.1111/hepr.13510,2020-05-10
Chilblains,PROCESS_OF,Child,32386449,10.1111/hepr.13510,2020-05-10
Chilblains,PROCESS_OF,Adolescent (age group),32386449,10.1111/hepr.13510,2020-05-10
Coronavirus Infections,PROCESS_OF,Patients,32386441,10.1111/aogs.13901,2020-05-10
Lung,LOCATION_OF,Ultrasonography,32386263,10.1111/1742-6723.13547,2020-05-10
Communicable Diseases,PROCESS_OF,Patients,32386263,10.1111/1742-6723.13547,2020-05-10
Lung,LOCATION_OF,Ultrasonography,32386263,10.1111/1742-6723.13547,2020-05-10
Physical Examination,TREATS,Patients,32386263,10.1111/1742-6723.13547,2020-05-10
Physical Examination,TREATS(INFER),Communicable Diseases,32386263,10.1111/1742-6723.13547,2020-05-10
Ultrasonography,ADMINISTERED_TO,Clinician,32386263,10.1111/1742-6723.13547,2020-05-10
Chest CT,ADMINISTERED_TO,Clinician,32386263,10.1111/1742-6723.13547,2020-05-10
Lung,LOCATION_OF,Ultrasonography,32386263,10.1111/1742-6723.13547,2020-05-10
Lung,LOCATION_OF,Ultrasonography,32386263,10.1111/1742-6723.13547,2020-05-10
Infected,PROCESS_OF,Patients,32386057,10.1093/labmed/lmaa031,2020-05-10
Chest CT,DIAGNOSES,Disease,32386057,10.1093/labmed/lmaa031,2020-05-10
Health care facility,LOCATION_OF,Nasal Swab (procedure),32386027,10.11817/j.issn.1672-7347.2020.200103,2020-05-10
Pneumonia,PROCESS_OF,Patients,32386019,10.11817/j.issn.1672-7347.2020.200099,2020-05-10
Symptoms,PROCESS_OF,Patients,32386018,10.11817/j.issn.1672-7347.2020.200132,2020-05-10
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32386018,10.11817/j.issn.1672-7347.2020.200132,2020-05-10
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32386018,10.11817/j.issn.1672-7347.2020.200132,2020-05-10
Diagnosis,AFFECTS,Screening procedure,32386017,10.11817/j.issn.1672-7347.2020.200136,2020-05-10
Multiple lesions,PROCESS_OF,Patients,32386016,10.11817/j.issn.1672-7347.2020.200141,2020-05-10
Lesion,PROCESS_OF,Patients,32386016,10.11817/j.issn.1672-7347.2020.200141,2020-05-10
Lesion,PROCESS_OF,Patients,32386016,10.11817/j.issn.1672-7347.2020.200141,2020-05-10
Nucleic Acids,NEG_PART_OF,Patients,32386015,10.11817/j.issn.1672-7347.2020.200144,2020-05-10
Chest CT,METHOD_OF,work up,32386015,10.11817/j.issn.1672-7347.2020.200144,2020-05-10
Lung,LOCATION_OF,Bands,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
Lung,LOCATION_OF,Lesion,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
Lung,LOCATION_OF,Diffuse Lesion,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
Lung,PART_OF,Caucasoid Race,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
Pleura,PART_OF,Lung,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
follow-up,TREATS,Symptoms,32386014,10.11817/j.issn.1672-7347.2020.200168,2020-05-10
Laboratory Procedures,DIAGNOSES,patient condition,32386013,10.11817/j.issn.1672-7347.2020.200206,2020-05-10
Chromosome 2q32-Q33 Deletion Syndrome,COEXISTS_WITH,Lesion,32386013,10.11817/j.issn.1672-7347.2020.200206,2020-05-10
Disease,COEXISTS_WITH,Lesion,32386013,10.11817/j.issn.1672-7347.2020.200206,2020-05-10
X-Ray Computed Tomography,ADMINISTERED_TO,Patients,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
Real-Time Polymerase Chain Reaction,METHOD_OF,X-Ray Computed Tomography,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
Coughing,PROCESS_OF,Patients,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
Fever,PROCESS_OF,Patients,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
Positive Finding,PROCESS_OF,Patients,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
Lesion,PROCESS_OF,Patients,32386012,10.11817/j.issn.1672-7347.2020.200152,2020-05-10
"Pneumonia, Viral",COEXISTS_WITH,Lesion,32386011,10.11817/j.issn.1672-7347.2020.200081,2020-05-10
screening examination,ADMINISTERED_TO,Patients,32386011,10.11817/j.issn.1672-7347.2020.200081,2020-05-10
Bronchi,LOCATION_OF,Physical findings,32386011,10.11817/j.issn.1672-7347.2020.200081,2020-05-10
Chromosome 2q32-Q33 Deletion Syndrome,ISA,Lesion,32386011,10.11817/j.issn.1672-7347.2020.200081,2020-05-10
Prophylactic treatment,AFFECTS,Cross Infection,32385990,10.3760/cma.j.cn121430-20200225-00200,2020-05-10
Physical Examination,PREVENTS,Cross Infection,32385990,10.3760/cma.j.cn121430-20200225-00200,2020-05-10
China,ISA,Country,32385985,10.3760/cma.j.cn121430-20200218-00188,2020-05-10
Netherlands,ISA,Country,32385985,10.3760/cma.j.cn121430-20200218-00188,2020-05-10
United States,ISA,Country,32385985,10.3760/cma.j.cn121430-20200218-00188,2020-05-10
Communicable Diseases,CAUSES,Coronavirus Infections,32385900,10.1002/eat.23293,2020-05-10
Lung,LOCATION_OF,Virus Diseases,32385900,10.1002/eat.23293,2020-05-10
Lung,LOCATION_OF,Lesion,32385900,10.1002/eat.23293,2020-05-10
tomography,AFFECTS,Virus Diseases,32385900,10.1002/eat.23293,2020-05-10
Lung,LOCATION_OF,Lesion,32385900,10.1002/eat.23293,2020-05-10
tomography,METHOD_OF,rapid diagnosis,32385900,10.1002/eat.23293,2020-05-10
Chest CT,AFFECTS,Patients,32385900,10.1002/eat.23293,2020-05-10
Eating Disorders,PROCESS_OF,Research Personnel,32385891,10.1111/dth.13537,2020-05-10
Therapeutic procedure,USES,Antineoplastic Agents,32385869,10.1111/dth.13544,2020-05-10
Therapeutic procedure,USES,Immunosuppressive Agents,32385869,10.1111/dth.13544,2020-05-10
Coronavirus Infections,ISA,Disease,32385869,10.1111/dth.13544,2020-05-10
Adverse reaction to drug,AFFECTS,Health Personnel,32385829,10.1007/s40199-020-00351-y,2020-05-10
Adverse reaction to drug,AFFECTS,Patients,32385829,10.1007/s40199-020-00351-y,2020-05-10
Infected,PROCESS_OF,Patients,32385799,10.1007/s11701-020-01090-7,2020-05-10
Human body,USES,regulatory,32385799,10.1007/s11701-020-01090-7,2020-05-10
responsibility,PROCESS_OF,Physicians,32385799,10.1007/s11701-020-01090-7,2020-05-10
Robotic assisted surgery,TREATS,patient condition,32385712,10.1007/s10555-020-09889-4,2020-05-10
Robotic assisted surgery,TREATS,Patients,32385712,10.1007/s10555-020-09889-4,2020-05-10
Insufflation,USES,cobaltous cation,32385712,10.1007/s10555-020-09889-4,2020-05-10
Pneumonia,COEXISTS_WITH,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Pneumonia,COEXISTS_WITH(SPEC),Coronavirus Infections,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Storm NOS,COEXISTS_WITH,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Storm NOS,COEXISTS_WITH(SPEC),Coronavirus Infections,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
inflammatory response,COEXISTS_WITH,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
inflammatory response,COEXISTS_WITH(SPEC),Coronavirus Infections,32385691,10.1007/s00403-020-02088-9,2020-05-10
Eicosanoids,CAUSES,Inflammation,32385691,10.1007/s00403-020-02088-9,2020-05-10
Resolvin,TREATS,Inflammation,32385691,10.1007/s00403-020-02088-9,2020-05-10
"Antibodies, Viral",PART_OF,B-Lymphocytes,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Arachidonic Acid,CONVERTS_TO,Epoxyeicosatrienoic Acid,32385691,10.1007/s00403-020-02088-9,2020-05-10
inhibitors,TREATS,Inflammation,32385691,10.1007/s00403-020-02088-9,2020-05-10
Extraction,USES,Clotrimazole,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Epoxyeicosatrienoic Acid,TREATS,Thrombosis,32385691,10.1007/s00403-020-02088-9,2020-05-10
Resolvin,TREATS,Thrombosis,32385691,10.1007/s00403-020-02088-9,2020-05-10
Inflammation,COEXISTS_WITH,Complication,32385691,10.1007/s00403-020-02088-9,2020-05-10
Inflammation,COEXISTS_WITH,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Inflammation,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32385691,10.1007/s00403-020-02088-9,2020-05-10
Inflammation,COEXISTS_WITH(SPEC),"Respiratory Distress Syndrome, Adult",32385691,10.1007/s00403-020-02088-9,2020-05-10
Inflammation,COEXISTS_WITH(SPEC),Coronavirus Infections,32385691,10.1007/s00403-020-02088-9,2020-05-10
"Respiratory Distress Syndrome, Adult",ISA,Complication,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
inhibitors,TREATS,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
inhibitors,TREATS(SPEC),Coronavirus Infections,32385691,10.1007/s00403-020-02088-9,2020-05-10
Coronavirus Infections,ISA,Disease,32385691,10.1007/s00403-020-02088-9,2020-05-10
Disease,COEXISTS_WITH,Co-morbid conditions,32385648,10.1007/s00330-020-06916-4,2020-05-10
Challenge,TREATS,Vulnerable Populations,32385648,10.1007/s00330-020-06916-4,2020-05-10
Infectious pneumonias,PROCESS_OF,Patients,32385628,10.1007/s11739-020-02355-7,2020-05-10
Symptoms,PROCESS_OF,Patients,32385628,10.1007/s11739-020-02355-7,2020-05-10
Multifocal Lesion,PROCESS_OF,Patients,32385628,10.1007/s11739-020-02355-7,2020-05-10
Ground Glass Opacity,PROCESS_OF,Patients,32385628,10.1007/s11739-020-02355-7,2020-05-10
Prognosis bad,COEXISTS_WITH,Symptoms,32385628,10.1007/s11739-020-02355-7,2020-05-10
Appendicitis,PROCESS_OF,Patients,32385568,10.1007/s00423-020-01888-x,2020-05-10
Laparoscopic appendectomy,TREATS,Patients,32385568,10.1007/s00423-020-01888-x,2020-05-10
Laparoscopic appendectomy,TREATS(INFER),Appendicitis,32385568,10.1007/s00423-020-01888-x,2020-05-10
Patients,LOCATION_OF,Peritoneal Fluid (body substance),32385568,10.1007/s00423-020-01888-x,2020-05-10
Neoplasms,PROCESS_OF,Patients,32385458,10.1038/s41415-020-1583-x,2020-05-10
Infected,PROCESS_OF,Patients,32385458,10.1038/s41415-020-1583-x,2020-05-10
Obstetric procedure,TREATS,Patients,32385187,10.1212/WNL.0000000000009675,2020-05-10
Disease,PROCESS_OF,Pregnant Women,32385187,10.1212/WNL.0000000000009675,2020-05-10
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32385187,10.1212/WNL.0000000000009675,2020-05-10
Physician service,TREATS,Enthesitis-Related Arthritis,32385186,10.1212/WNL.0000000000009713,2020-05-10
Residency,ISA,Training,32385186,10.1212/WNL.0000000000009713,2020-05-10
Structural modification,TREATS,inpatient,32385186,10.1212/WNL.0000000000009713,2020-05-10
Cerebrovascular Disorders,PROCESS_OF,Patients,32385146,10.1136/jitc-2020-000930,2020-05-10
Cerebrovascular accident,PROCESS_OF,Patients,32385146,10.1136/jitc-2020-000930,2020-05-10
Cerebrovascular accident,PROCESS_OF,Patients,32385146,10.1136/jitc-2020-000930,2020-05-10
IMPACT gene,ASSOCIATED_WITH,Cerebrovascular accident,32385146,10.1136/jitc-2020-000930,2020-05-10
Immune,COEXISTS_WITH,Acute respiratory distress,32385132,10.1136/svn-2020-000382,2020-05-10
Severe disorder,PROCESS_OF,Patients,32385132,10.1136/svn-2020-000382,2020-05-10
Recombinant Interferon-gamma,ISA,cytokine,32385132,10.1136/svn-2020-000382,2020-05-10
Serum,LOCATION_OF,cytokine,32385132,10.1136/svn-2020-000382,2020-05-10
Serum,LOCATION_OF(SPEC),Recombinant Interferon-gamma,32385132,10.1136/svn-2020-000382,2020-05-10
Critical Illness,PROCESS_OF,Patients,32385132,10.1136/svn-2020-000382,2020-05-10
Agent,AFFECTS,Inflammation,32385132,10.1136/svn-2020-000382,2020-05-10
Immunotherapy,TREATS,inflammatory response,32385132,10.1136/svn-2020-000382,2020-05-10
Experience,PROCESS_OF,Patients,32385132,10.1136/svn-2020-000382,2020-05-10
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32385130,10.1681/ASN.2020030354,2020-05-10
Cardiovascular Diseases,ISA,Illness (finding),32385126,10.1136/jech-2020-214297,2020-05-10
Comorbidity,PROCESS_OF,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Diabetes Mellitus,ISA,Illness (finding),32385126,10.1136/jech-2020-214297,2020-05-10
Hypertensive disease,ISA,Illness (finding),32385126,10.1136/jech-2020-214297,2020-05-10
Maintenance hemodialysis,TREATS,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Maintenance hemodialysis,TREATS(INFER),Comorbidity,32385126,10.1136/jech-2020-214297,2020-05-10
Maintenance hemodialysis,ADMINISTERED_TO,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Hemodialysis,TREATS,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Infected,PROCESS_OF,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Maintenance hemodialysis,ADMINISTERED_TO,Patients,32385126,10.1136/jech-2020-214297,2020-05-10
Severe disorder,PROCESS_OF,Patients,32385067,10.1503/cmaj.200920,2020-05-10
Climate,AFFECTS,Growth,32385055,10.1542/hpeds.2020-0135,2020-05-10
Reparative closure,NEG_AFFECTS,Growth,32385055,10.1542/hpeds.2020-0135,2020-05-10
Storm NOS,PROCESS_OF,Patients,32384917,10.1186/s13054-020-02925-3,2020-05-10
Extracorporeal Membrane Oxygenation,TREATS,Respiratory Failure,32384820,10.3390/v12050513,2020-05-10
Complication,PROCESS_OF,Patients,32384820,10.3390/v12050513,2020-05-10
Symptoms,PROCESS_OF,Patients,32384820,10.3390/v12050513,2020-05-10
Extracorporeal Membrane Oxygenation,TREATS,"Respiratory Distress Syndrome, Adult",32384820,10.3390/v12050513,2020-05-10
Cell Count,USES,"M Protein, multiple myeloma",32384798,10.3390/antiox9050389,2020-05-10
Virus Diseases,AFFECTS,Immunity,32384798,10.3390/antiox9050389,2020-05-10
Assay,MEASURES,Antibodies,32384798,10.3390/antiox9050389,2020-05-10
Serum,PART_OF,Homo sapiens,32384798,10.3390/antiox9050389,2020-05-10
Assay,USES,Luciferases,32384798,10.3390/antiox9050389,2020-05-10
systemic therapy,COEXISTS_WITH,Clinical Management,32384771,10.3390/healthcare8020126,2020-05-10
Inflammation,AFFECTS,Virus Diseases,32384771,10.3390/healthcare8020126,2020-05-10
Oxidative Stress,AFFECTS,Virus Diseases,32384771,10.3390/healthcare8020126,2020-05-10
Ozone,INTERACTS_WITH,Interleukin-1,32384771,10.3390/healthcare8020126,2020-05-10
Ozone,INTERACTS_WITH,GA-Binding Protein Transcription Factor,32384771,10.3390/healthcare8020126,2020-05-10
Antioxidants,AFFECTS,Equilibrium,32384771,10.3390/healthcare8020126,2020-05-10
Free Radicals,AFFECTS,Equilibrium,32384771,10.3390/healthcare8020126,2020-05-10
Present,COEXISTS_WITH,Inflammatory disorder,32384771,10.3390/healthcare8020126,2020-05-10
Chronic disease,PROCESS_OF,Population Group,32384707,10.3390/geriatrics5020030,2020-05-10
Chronic disease,PROCESS_OF(SPEC),Old age,32384707,10.3390/geriatrics5020030,2020-05-10
long-term care,TREATS,Old age,32384707,10.3390/geriatrics5020030,2020-05-10
Old age,ISA,Population Group,32384707,10.3390/geriatrics5020030,2020-05-10
Care of intensive care unit patient,TREATS,Adult,32384598,10.3390/ijerph17093215,2020-05-10
Virus,CAUSES,"Respiratory Distress Syndrome, Adult",32384412,10.1097/RTI.0000000000000529,2020-05-10
Virus,CAUSES,Bilateral pneumonia,32384412,10.1097/RTI.0000000000000529,2020-05-10
Basal segment of lung,LOCATION_OF,Diagnostic radiologic examination,32384412,10.1097/RTI.0000000000000529,2020-05-10
Chest,LOCATION_OF,X-Ray Computed Tomography,32384412,10.1097/RTI.0000000000000529,2020-05-10
NCKIPSD gene,PART_OF,Family,32384412,10.1097/RTI.0000000000000529,2020-05-10
Pharmaceutical Preparations,TREATS,Virus,32384412,10.1097/RTI.0000000000000529,2020-05-10
Treatment Protocols,TREATS,Coronavirus Infections,32384412,10.1097/RTI.0000000000000529,2020-05-10
Treatment Protocols,USES,Pharmaceutical Preparations,32384412,10.1097/RTI.0000000000000529,2020-05-10
Coronavirus Infections,NEG_ISA,Symptoms,32384412,10.1097/RTI.0000000000000529,2020-05-10
Fever,PROCESS_OF,Infant,32384397,10.1097/INF.0000000000002739,2020-05-10
Coronavirus Infections,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Disease,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,PROCESS_OF(SPEC),Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Pneumonia,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Disease,CAUSES,Pneumonia,32384387,10.1097/AOG.0000000000003950,2020-05-10
Dyspnea,CAUSES(SPEC),Pneumonia,32384387,10.1097/AOG.0000000000003950,2020-05-10
Dyspnea,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,ISA,Disease,32384387,10.1097/AOG.0000000000003950,2020-05-10
Child,LOCATION_OF,Interleukin-6,32384387,10.1097/AOG.0000000000003950,2020-05-10
Child,LOCATION_OF,Fibrin fragment D,32384387,10.1097/AOG.0000000000003950,2020-05-10
Child,LOCATION_OF,Interleukin-10,32384387,10.1097/AOG.0000000000003950,2020-05-10
Pneumonia,COEXISTS_WITH,risk factors,32384387,10.1097/AOG.0000000000003950,2020-05-10
Lesion,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Lesion,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Severe disorder,PROCESS_OF,Child,32384387,10.1097/AOG.0000000000003950,2020-05-10
Coronavirus Infections,PROCESS_OF,Pregnant Women,32384386,10.1097/AOG.0000000000003946,2020-05-10
Cesarean section,TREATS,Respiratory distress,32384386,10.1097/AOG.0000000000003946,2020-05-10
Coronavirus Infections,PROCESS_OF,Patients,32384386,10.1097/AOG.0000000000003946,2020-05-10
Gravidity,PROCESS_OF,Patients,32384386,10.1097/AOG.0000000000003946,2020-05-10
Rapid onset,PROCESS_OF,Patients,32384386,10.1097/AOG.0000000000003946,2020-05-10
Gravidity,PROCESS_OF,Patients,32384377,10.1097/MAO.0000000000002765,2020-05-10
Alveolar ventilation function,PROCESS_OF,Patients,32384377,10.1097/MAO.0000000000002765,2020-05-10
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32384377,10.1097/MAO.0000000000002765,2020-05-10
Gravidity,PROCESS_OF,Patients,32384377,10.1097/MAO.0000000000002765,2020-05-10
Evaluation,USES,Instrument - device,32384297,10.2106/JBJS.20.00715,2020-05-10
Drapes (device),USES,BARRIER,32384297,10.2106/JBJS.20.00715,2020-05-10
GRAP2 gene,compared_with,Microscopes,32384297,10.2106/JBJS.20.00715,2020-05-10
Drapes (device),USES,BARRIER,32384297,10.2106/JBJS.20.00715,2020-05-10
Coronavirus Infections,PREDISPOSES,Infection,32384251,10.1089/tmj.2020.0134,2020-05-10
Infection,PROCESS_OF,Population Group,32384251,10.1089/tmj.2020.0134,2020-05-10
Hospitalization,ADMINISTERED_TO,Community,32384227,10.1002/oby.22877,2020-05-10
risk factors,COEXISTS_WITH,Virus Diseases,32384183,10.1111/hae.14045,2020-05-10
Obesity,OCCURS_IN,Patients,32384183,10.1111/hae.14045,2020-05-10
Coronavirus Infections,CAUSES,Terminal illness,32384180,10.1111/ced.14277,2020-05-10
Pneumonia,PROCESS_OF,Patients,32384180,10.1111/ced.14277,2020-05-10
Respiratory Tract Infections,PROCESS_OF,Patients,32384180,10.1111/ced.14277,2020-05-10
Frail,PROCESS_OF,Patients,32384180,10.1111/ced.14277,2020-05-10
"Hemophilia, NOS",PROCESS_OF,Persons,32384180,10.1111/ced.14277,2020-05-10
"Hemophilia, NOS",PROCESS_OF,Persons,32384180,10.1111/ced.14277,2020-05-10
Therapeutic procedure,PREVENTS,Complication,32384180,10.1111/ced.14277,2020-05-10
"Hemophilia, NOS",PROCESS_OF,teams,32384180,10.1111/ced.14277,2020-05-10
Lesion,PROCESS_OF,Patients,32384164,10.1111/vox.12943,2020-05-10
Exanthema,PROCESS_OF,Patients,32384164,10.1111/vox.12943,2020-05-10
Virus Diseases,NEG_PROCESS_OF,Patients,32384164,10.1111/vox.12943,2020-05-10
Vesicular eruption,PROCESS_OF,Patients,32384164,10.1111/vox.12943,2020-05-10
Coronavirus Infections,CAUSES,Disease,32384159,10.1093/jtm/taaa068,2020-05-10
Infected,PROCESS_OF,traveler,32384153,10.1093/clinchem/hvaa116,2020-05-10
DNA Sequence,INTERACTS_WITH,SARS gene,32384078,10.1371/journal.pntd.0008280,2020-05-10
Oligonucleotide Primers,INTERACTS_WITH,Exonuclease,32384078,10.1371/journal.pntd.0008280,2020-05-10
Structure of right thigh,LOCATION_OF,Hypersensitivity,32384078,10.1371/journal.pntd.0008280,2020-05-10
Comorbidity,PROCESS_OF,Patients,32384045,10.3201/eid2608.201160,2020-05-10
Fever,ISA,Symptoms,32384045,10.3201/eid2608.201160,2020-05-10
Lymphopenia,PROCESS_OF,Patients,32384045,10.3201/eid2608.201160,2020-05-10
Radiology result abnormal,PROCESS_OF,Patients,32384045,10.3201/eid2608.201160,2020-05-10
risk factors,PROCESS_OF,Patients,32384045,10.3201/eid2608.201160,2020-05-10
Severe disorder,PROCESS_OF,Patients,32384019,10.1148/radiol.2020201874,2020-05-10
Routine procedure,TREATS,Population Group,32383989,10.1089/dia.2020.0187,2020-05-10
Isolation procedure,AFFECTS,Breast Feeding,32383989,10.1089/dia.2020.0187,2020-05-10
risk factors,PROCESS_OF,Patients,32383778,10.1111/jgs.16536,2020-05-10
Cessation of life,PROCESS_OF,Patients,32383778,10.1111/jgs.16536,2020-05-10
Cessation of life,AFFECTS,Male population group,32383778,10.1111/jgs.16536,2020-05-10
Cessation of life,PROCESS_OF,hospitalized patients,32383778,10.1111/jgs.16536,2020-05-10
early/brief intervention/therapy (treatment),TREATS,Patients,32383778,10.1111/jgs.16536,2020-05-10
Confusion,PROCESS_OF,Male population group,32383776,10.1002/jmv.25994,2020-05-10
Laboratory Procedures,USES,Buccal smear procedure,32383776,10.1002/jmv.25994,2020-05-10
Buccal smear procedure,ISA,Laboratory Procedures,32383776,10.1002/jmv.25994,2020-05-10
Health care facility,LOCATION_OF,Diagnosis,32383776,10.1002/jmv.25994,2020-05-10
Problem,PROCESS_OF,Patients,32383763,10.1093/eurheartj/ehaa388,2020-05-10
Pandemics,ISA,Disease Outbreaks,32383763,10.1093/eurheartj/ehaa388,2020-05-10
Heart,LOCATION_OF,concomitant disease,32383638,10.3201/eid2608.201097,2020-05-10
Pneumonia,PROCESS_OF,Patients,32383638,10.3201/eid2608.201097,2020-05-10
Atrial Fibrillation,PROCESS_OF,cardiac patient,32383638,10.3201/eid2608.201097,2020-05-10
Serum,LOCATION_OF,Creatinine,32383638,10.3201/eid2608.201097,2020-05-10
cardiac patient,LOCATION_OF,Troponin T,32383638,10.3201/eid2608.201097,2020-05-10
Embolism,PROCESS_OF,Patients,32383638,10.3201/eid2608.201097,2020-05-10
Heart Diseases,PROCESS_OF,Patients,32383638,10.3201/eid2608.201097,2020-05-10
Heart,LOCATION_OF,concomitant disease,32383638,10.3201/eid2608.201097,2020-05-10
Septic Shock,PROCESS_OF,cardiac patient,32383638,10.3201/eid2608.201097,2020-05-10
concomitant disease,PROCESS_OF,Patients,32383638,10.3201/eid2608.201097,2020-05-10
Italy,ISA,Country,32383576,10.23736/S1973-9087.20.06361-3,2020-05-10
Persons,LOCATION_OF,IMPACT gene,32383550,10.1002/hed.26252,2020-05-10
Disability,PROCESS_OF,Persons,32383550,10.1002/hed.26252,2020-05-10
Disability,PROCESS_OF,Persons,32383550,10.1002/hed.26252,2020-05-10
major surgery,ISA,Operative Surgical Procedures,32383532,10.1002/hed.26253,2020-05-10
Problem,PROCESS_OF,Clinician,32383520,10.1111/bju.15105,2020-05-10
Eating Disorders,PROCESS_OF,Persons,32383520,10.1111/bju.15105,2020-05-10
Telemedicine,ADMINISTERED_TO,World,32383520,10.1111/bju.15105,2020-05-10
Patient Discharge,COEXISTS_WITH,Minimally Invasive Surgical Procedures,32383432,10.4269/ajtmh.20-0391,2020-05-10
Patient Discharge,COEXISTS_WITH,"Surgical Procedures, Laparoscopic",32383432,10.4269/ajtmh.20-0391,2020-05-10
Minimally Invasive Surgical Procedures,TREATS,Staff,32383432,10.4269/ajtmh.20-0391,2020-05-10
Coronavirus Infections,ISA,Disease,32383431,10.4269/ajtmh.20-0394,2020-05-10
Coronavirus Infections,ISA,Disease,32383431,10.4269/ajtmh.20-0394,2020-05-10
Coronavirus Infections,ISA,Disease,32383430,10.4269/ajtmh.20-0376,2020-05-10
Coronavirus Infections,ISA,Disease,32383430,10.4269/ajtmh.20-0376,2020-05-10
Communicable Diseases,ISA,Disease,32383409,10.1177/0163278720923224,2020-05-10
Coronavirus Infections,ISA,Disease,32383409,10.1177/0163278720923224,2020-05-10
Coronavirus Infections,ISA,Disease,32383409,10.1177/0163278720923224,2020-05-10
Hydroxychloroquine,TREATS,Discontinued,32383409,10.1177/0163278720923224,2020-05-10
Obstruction,PROCESS_OF,Woman,32383409,10.1177/0163278720923224,2020-05-10
Measles,ISA,Virus Diseases,32383370,10.3346/jkms.2020.35.e174,2020-05-10
Coronavirus Infections,PROCESS_OF,Child,32383370,10.3346/jkms.2020.35.e174,2020-05-10
Asymptomatic,PROCESS_OF,Child,32383370,10.3346/jkms.2020.35.e174,2020-05-10
Monoclonal Antibodies,PART_OF,Homo sapiens,32383370,10.3346/jkms.2020.35.e174,2020-05-10
Ageusia,NEG_ISA,Symptoms,32383284,10.1002/ccd.28960,2020-05-10
Anosmia,PROCESS_OF,Patients,32383284,10.1002/ccd.28960,2020-05-10
Ageusia,PROCESS_OF,Patients,32383284,10.1002/ccd.28960,2020-05-10
Asymptomatic Diseases,PROCESS_OF,Patients,32383284,10.1002/ccd.28960,2020-05-10
Retrosternal pain,CAUSES,Hyperlipidemia,32383269,10.1002/jmv.25987,2020-05-10
Retrosternal pain,CAUSES,Migraine Disorders,32383269,10.1002/jmv.25987,2020-05-10
Medical History,PROCESS_OF,Woman,32383269,10.1002/jmv.25987,2020-05-10
tomography,DIAGNOSES,Left Cardiac Artery Dominance,32383269,10.1002/jmv.25987,2020-05-10
Coronary artery,LOCATION_OF,tomography,32383269,10.1002/jmv.25987,2020-05-10
Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32383269,10.1002/jmv.25987,2020-05-10
"Coronary Artery Dissection, Spontaneous",PROCESS_OF,Patients,32383269,10.1002/jmv.25987,2020-05-10
angiotensin converting enzyme 2,PART_OF,Animals,32383254,10.1002/jmv.25986,2020-05-10
angiotensin converting enzyme 2,PART_OF,Homo sapiens,32383254,10.1002/jmv.25986,2020-05-10
Toll-like receptors,PART_OF,Homo sapiens,32383254,10.1002/jmv.25986,2020-05-10
Chiroptera,LOCATION_OF,angiotensin converting enzyme 2,32383254,10.1002/jmv.25986,2020-05-10
Glycoproteins,INTERACTS_WITH,angiotensin converting enzyme 2,32383254,10.1002/jmv.25986,2020-05-10
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32383254,10.1002/jmv.25986,2020-05-10
Toll-like receptors,PART_OF,Cell surface,32383254,10.1002/jmv.25986,2020-05-10
TLR4 gene,CAUSES,inflammatory response,32383254,10.1002/jmv.25986,2020-05-10
Microneutralization Assay,ISA,Laboratory Procedures,32383239,10.1111/eci.13262,2020-05-10
Specimen Type - Serum,PART_OF,Homo sapiens,32383239,10.1111/eci.13262,2020-05-10
Test Method,METHOD_OF,Epidemiology,32383239,10.1111/eci.13262,2020-05-10
Endocrine System Diseases,PROCESS_OF,Patients,32383234,10.1111/dth.13528,2020-05-10
Diabetes type,PROCESS_OF,Patients,32383234,10.1111/dth.13528,2020-05-10
Exanthema,PROCESS_OF,Patients,32383183,10.1002/jmv.25989,2020-05-10
Vascular lesions,PROCESS_OF,Dermatologist,32383183,10.1002/jmv.25989,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Serum,PART_OF,Patients,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G,ISA,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Immunoglobulin G measurement,USES,Antibodies,32383182,10.1002/jmv.25996,2020-05-10
Disease,PROCESS_OF,Population Group,32383179,10.1002/jmv.25988,2020-05-10
Laboratory Procedures,METHOD_OF,Nasal Swab (procedure),32383171,10.1002/jmv.25990,2020-05-10
Nasal Swab (procedure),USES,Laboratory Procedures,32383171,10.1002/jmv.25990,2020-05-10
professional occupation status,LOCATION_OF,IMPACT gene,32383125,10.1007/s12630-020-01684-7,2020-05-10
Coronavirus Infections,ISA,Disease,32382932,10.1007/s00784-020-03291-8,2020-05-10
Coronavirus Infections,ISA,Disease,32382932,10.1007/s00784-020-03291-8,2020-05-10
Coronavirus Infections,ISA,Disease,32382932,10.1007/s00784-020-03291-8,2020-05-10
Post-Exposure Prophylaxis,USES,Hydroxychloroquine,32382932,10.1007/s00784-020-03291-8,2020-05-10
Symptoms,PROCESS_OF,Outpatients,32382932,10.1007/s00784-020-03291-8,2020-05-10
Coronavirus Infections,ISA,Disease,32382932,10.1007/s00784-020-03291-8,2020-05-10
Hydroxychloroquine,DISRUPTS,viral transmission,32382932,10.1007/s00784-020-03291-8,2020-05-10
Coronavirus Infections,ISA,Disease,32382932,10.1007/s00784-020-03291-8,2020-05-10
Participant,ISA,Persons,32382932,10.1007/s00784-020-03291-8,2020-05-10
perseverance,PROCESS_OF,Patients,32382877,10.1007/s00062-020-00911-4,2020-05-10
perseverance,PROCESS_OF,Patients,32382877,10.1007/s00062-020-00911-4,2020-05-10
Mild disorder,PROCESS_OF,Child,32382746,10.1093/infdis/jiaa244,2020-05-10
Hydranencephaly with Renal Aplasia-Dysplasia,OCCURS_IN,Households,32382737,10.1093/infdis/jiaa243,2020-05-10
county,ISA,Geographic Locations,32382737,10.1093/infdis/jiaa243,2020-05-10
High Level,PROCESS_OF,Households,32382737,10.1093/infdis/jiaa243,2020-05-10
Coronavirus Infections,CAUSES,Pneumonia,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Immunoglobulin G,INTERACTS_WITH,GSKIP gene,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Peptides,INTERACTS_WITH,GSKIP gene,32382727,10.1016/j.bbih.2020.100078,2020-05-10
CD40LG wt Allele,INTERACTS_WITH,GSKIP gene,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Patients,LOCATION_OF,Serum,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Serum,ASSOCIATED_WITH(INFER),Infected,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Serum,LOCATION_OF,,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Serum,PART_OF,Patients,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Infected,PROCESS_OF,Patients,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Confirmation,PROCESS_OF,Patients,32382727,10.1016/j.bbih.2020.100078,2020-05-10
Motivation,PROCESS_OF,Homo sapiens,32382684,10.1016/j.obmed.2020.100250,2020-05-10
Obesity,AUGMENTS,Enthesitis-Related Arthritis,32382516,10.1016/j.crwh.2020.e00217,2020-05-10
Obesity,PROCESS_OF,Patients,32382516,10.1016/j.crwh.2020.e00217,2020-05-10
Care of intensive care unit patient,TREATS,Patients,32382463,10.7759/cureus.7561,2020-05-10
Care of intensive care unit patient,TREATS(INFER),Shock,32382463,10.7759/cureus.7561,2020-05-10
Care of intensive care unit patient,TREATS(INFER),Gravidity,32382463,10.7759/cureus.7561,2020-05-10
Shock,PROCESS_OF,Patients,32382463,10.7759/cureus.7561,2020-05-10
Gravidity,PROCESS_OF,Patients,32382463,10.7759/cureus.7561,2020-05-10
Discharge to home,TREATS,Stable Disease,32382463,10.7759/cureus.7561,2020-05-10
Pneumonia,PROCESS_OF,Patients,32382463,10.7759/cureus.7561,2020-05-10
Gravidity,PROCESS_OF,Patients,32382463,10.7759/cureus.7561,2020-05-10
Coronavirus Infections,ISA,Disease,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Coronavirus Infections,ISA,Disease,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Symptoms,PROCESS_OF,Patients,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Coronavirus Infections,ISA,Disease,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Disease,COEXISTS_WITH,Disease Progression,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Rhabdomyolysis,COEXISTS_WITH(SPEC),Disease Progression,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Rhabdomyolysis,ISA,Disease,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Coronavirus Infections,COEXISTS_WITH(SPEC),Disease Progression,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Coronavirus Infections,ISA,Disease,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Rhabdomyolysis,PROCESS_OF,Patients,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Fluid Management,ADMINISTERED_TO,Patients,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Fluid Management,TREATS,patient condition,32382449,10.1016/j.eng.2020.04.008,2020-05-10
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32382358,10.1007/s13300-020-00830-0,2020-05-10
Study,MEASURES,CD40LG wt Allele,32382358,10.1007/s13300-020-00830-0,2020-05-10
Chemiluminescence immunoassay,MEASURES,Immunoglobulin level - finding,32382358,10.1007/s13300-020-00830-0,2020-05-10
Cessation of life,PROCESS_OF,Patients,32382358,10.1007/s13300-020-00830-0,2020-05-10
Detection,AFFECTS,Patients,32382358,10.1007/s13300-020-00830-0,2020-05-10
Detection,COEXISTS_WITH,disease detection,32382358,10.1007/s13300-020-00830-0,2020-05-10
Coronavirus Infections,ISA,Communicable Diseases,32382315,10.1016/j.nantod.2020.100883,2020-05-10
Metformin,TREATS,Virus Diseases,32382315,10.1016/j.nantod.2020.100883,2020-05-10
Virus Diseases,PROCESS_OF,Corona,32382315,10.1016/j.nantod.2020.100883,2020-05-10
pioglitazone,TREATS,Virus Diseases,32382315,10.1016/j.nantod.2020.100883,2020-05-10
Antidiabetics,TREATS,Virus Diseases,32382315,10.1016/j.nantod.2020.100883,2020-05-10
Stress,PROCESS_OF,Community,32382213,10.1016/j.ssci.2020.104806,2020-05-10
Laboratory,LOCATION_OF,Biosafety,32382212,10.1007/s10640-020-00426-z,2020-05-10
Facility,LOCATION_OF,Biosafety,32382212,10.1007/s10640-020-00426-z,2020-05-10
House mice,LOCATION_OF,Genes,32382072,10.1038/s41594-020-0440-6,2020-05-10
Pterygium,PROCESS_OF,Patients,32382072,10.1038/s41594-020-0440-6,2020-05-10
Serine Endopeptidases,PART_OF,integral to membrane,32382072,10.1038/s41594-020-0440-6,2020-05-10
Homo sapiens,LOCATION_OF,Genes,32382072,10.1038/s41594-020-0440-6,2020-05-10
conjunctiva,LOCATION_OF,angiotensin converting enzyme 2,32382072,10.1038/s41594-020-0440-6,2020-05-10
conjunctiva,LOCATION_OF,TMPRSS2 gene,32382072,10.1038/s41594-020-0440-6,2020-05-10
A549 Cells,PART_OF,Lung,32382072,10.1038/s41594-020-0440-6,2020-05-10
angiotensin converting enzyme 2,compared_with,TMPRSS2 gene,32382072,10.1038/s41594-020-0440-6,2020-05-10
Cornea,LOCATION_OF,TMPRSS2 gene,32382072,10.1038/s41594-020-0440-6,2020-05-10
Cornea,LOCATION_OF,ACE2 gene,32382072,10.1038/s41594-020-0440-6,2020-05-10
1-hexylcarbamoyl-5-fluorouracil,ISA,Antineoplastic Agents,32381643,10.1128/JCM.00890-20,2020-05-10
1-hexylcarbamoyl-5-fluorouracil,INHIBITS,"3C-like protease, SARS coronavirus",32381643,10.1128/JCM.00890-20,2020-05-10
Laboratory Procedures,ISA,Diagnostic tests,32381641,10.1128/JCM.00941-20,2020-05-10
Diagnostic tests,MEASURES,Infection,32381617,10.1128/MRA.00303-20,2020-05-10
Laboratory Procedures,METHOD_OF,Detection,32381617,10.1128/MRA.00303-20,2020-05-10
Hypersensitivity,PROCESS_OF,Cohort,32381617,10.1128/MRA.00303-20,2020-05-10
Patients,LOCATION_OF,Oropharyngeal swab,32381522,10.1136/neurintsurg-2020-016221,2020-05-10
Syndrome,PROCESS_OF,Patients,32381522,10.1136/neurintsurg-2020-016221,2020-05-10
Operative Surgical Procedures,ADMINISTERED_TO,Surgeon,32381430,10.1016/j.jdermsci.2020.04.011,2020-05-10
Patients,LOCATION_OF,IMPACT gene,32381430,10.1016/j.jdermsci.2020.04.011,2020-05-10
Skin Manifestations,PROCESS_OF,Patients,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Skin Manifestations,PROCESS_OF,Patients,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Livedo Reticularis,ISA,Lesion,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Foot,LOCATION_OF,Skin Manifestations,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Hand,LOCATION_OF,Skin Manifestations,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Skin Manifestations,PROCESS_OF,Patients,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32381426,10.1016/j.jviscsurg.2020.04.016,2020-05-10
Cross Infection,PROCESS_OF,Patients,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Department,LOCATION_OF,Interventional Study,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Cross Infection,PROCESS_OF,Patients,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Cross Infection,PROCESS_OF,Patients,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Comorbidity,PROCESS_OF,Patients,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Complication,COEXISTS_WITH,Malignant Neoplasms,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Operative Surgical Procedures,TREATS,Complication,32381385,10.1016/j.jadohealth.2020.03.037,2020-05-10
Eating Disorders,PROCESS_OF,Patients,32381375,10.1016/j.arcmed.2020.04.012,2020-05-10
Complication,OCCURS_IN,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Critical Illness,PROCESS_OF,Patients,32381148,10.1017/S0950268820000990,2020-05-10
"EMBOLISM, SYSTEMIC ARTERIAL",OCCURS_IN,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Complication,PROCESS_OF,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Complication,OCCURS_IN,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Critical Illness,PROCESS_OF,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Pneumonia,PROCESS_OF,Patients,32381148,10.1017/S0950268820000990,2020-05-10
Pandemics,ISA,Epidemic,32381147,10.1017/ice.2020.207,2020-05-10
Syndrome,PROCESS_OF,Patients,32381140,10.1017/ice.2020.211,2020-05-10
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32381140,10.1017/ice.2020.211,2020-05-10
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32381140,10.1017/ice.2020.211,2020-05-10
Alveolar rhabdomyosarcoma,PROCESS_OF,Racial group,32381073,10.1186/s12879-020-05056-w,2020-05-10
Asymptomatic,PROCESS_OF,Patients,32381073,10.1186/s12879-020-05056-w,2020-05-10
Alveolar rhabdomyosarcoma,PROCESS_OF,Racial group,32381073,10.1186/s12879-020-05056-w,2020-05-10
Coronavirus Infections,AFFECTS,Persons,32381057,10.1186/s12890-020-1170-6,2020-05-10
Chest CT,DIAGNOSES,Ground Glass Opacity,32381057,10.1186/s12890-020-1170-6,2020-05-10
lobe,LOCATION_OF,Ground Glass Opacity,32381057,10.1186/s12890-020-1170-6,2020-05-10
"Pneumonia, Viral",ISA,Respiration Disorders,32381022,10.1186/s12939-020-01178-4,2020-05-10
Health Services,TREATS,Ethnic group,32380958,10.1186/s10020-020-00172-4,2020-05-10
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Persons,32380908,10.1089/scd.2020.0080,2020-05-10
Coronavirus Infections,ISA,Disease,32380908,10.1089/scd.2020.0080,2020-05-10
Pathogenic,COEXISTS_WITH,Inflammation,32380908,10.1089/scd.2020.0080,2020-05-10
HMGB1 gene,INTERACTS_WITH,toll-like receptor 4,32380908,10.1089/scd.2020.0080,2020-05-10
DNA,PART_OF,Extracellular,32380908,10.1089/scd.2020.0080,2020-05-10
HMGB1 gene,PART_OF,Extracellular,32380908,10.1089/scd.2020.0080,2020-05-10
Lung,LOCATION_OF,High Level,32380908,10.1089/scd.2020.0080,2020-05-10
HMGB1 gene,DISRUPTS,endolysosome,32380908,10.1089/scd.2020.0080,2020-05-10
Cytoplasmic matrix,PART_OF,Cells,32380908,10.1089/scd.2020.0080,2020-05-10
HMGB1 gene,PART_OF,Extracellular,32380908,10.1089/scd.2020.0080,2020-05-10
Inflammasomes,CAUSES,Endocytosis,32380908,10.1089/scd.2020.0080,2020-05-10
Coronavirus Infections,ISA,Disease,32380908,10.1089/scd.2020.0080,2020-05-10
Endothelial Cells,LOCATION_OF,Apoptosis,32380908,10.1089/scd.2020.0080,2020-05-10
Endothelial Cells,PART_OF,Lung,32380908,10.1089/scd.2020.0080,2020-05-10
HMGB1 gene,PART_OF,Extracellular,32380908,10.1089/scd.2020.0080,2020-05-10
Oxygen,PART_OF,Arteries,32380903,10.1080/22221751.2020.1761267,2020-05-10
Serum,PART_OF,Patients,32380891,10.1177/0733464820924853,2020-05-10
victim,LOCATION_OF,IMPACT gene,32380879,10.1177/0020764020927051,2020-05-10
Societies,LOCATION_OF,Study,32380869,10.1177/1090198120927304,2020-05-10
Mental disorders,PROCESS_OF,Persons,32380869,10.1177/1090198120927304,2020-05-10
Coitus,AFFECTS,Anxiety,32380869,10.1177/1090198120927304,2020-05-10
Coitus,AFFECTS,Anxiety,32380869,10.1177/1090198120927304,2020-05-10
Coitus,AFFECTS,Depressive disorder,32380869,10.1177/1090198120927304,2020-05-10
Present,COEXISTS_WITH,Chronic disease,32380869,10.1177/1090198120927304,2020-05-10
Telemedicine,ADMINISTERED_TO,scholar,32380847,10.1089/acm.2020.0144,2020-05-10
Health Care,COEXISTS_WITH,Isolation procedure,32380847,10.1089/acm.2020.0144,2020-05-10
radiologist,TREATS,Patients,32380803,10.4081/monaldi.2020.1327,2020-05-10
Lung,LOCATION_OF,Ultrasonography,32380803,10.4081/monaldi.2020.1327,2020-05-10
Crisis,PROCESS_OF,Patients,32380803,10.4081/monaldi.2020.1327,2020-05-10
Chest,LOCATION_OF,tomography,32380803,10.4081/monaldi.2020.1327,2020-05-10
upper respiratory symptom,COEXISTS_WITH,Enthesitis-Related Arthritis,32380802,10.4081/monaldi.2020.1305,2020-05-10
Cardiac Arrhythmia,ISA,Complication,32380787,10.3390/ijms21093275,2020-05-10
Coronary Arteriosclerosis,COEXISTS_WITH,Cardiovascular morbidity,32380787,10.3390/ijms21093275,2020-05-10
Coronary Arteriosclerosis,PROCESS_OF,Patients,32380787,10.3390/ijms21093275,2020-05-10
IMPACT gene,CAUSES,Birth,32380787,10.3390/ijms21093275,2020-05-10
RNA Viruses,CAUSES,Respiratory Tract Infections,32380708,10.3390/jcm9051350,2020-05-10
China,ISA,Country,32380582,10.31616/asj.2020.0197,2020-05-10
Spinal Diseases,PROCESS_OF,Patients,32380565,10.1055/s-0040-1710512,2020-05-08
Vertebral column,LOCATION_OF,IMPACT gene,32380565,10.1055/s-0040-1710512,2020-05-08
Operative Surgical Procedures,TREATS,Patients,32380565,10.1055/s-0040-1710512,2020-05-08
Operative Surgical Procedures,TREATS(INFER),Spinal Diseases,32380565,10.1055/s-0040-1710512,2020-05-08
Health care facility,LOCATION_OF,Observational Study,32380565,10.1055/s-0040-1710512,2020-05-08
Severe disorder,NEG_PROCESS_OF,Child,32380564,10.1055/s-0040-1710539,2020-05-08
Severe disorder,NEG_PROCESS_OF,Infant,32380564,10.1055/s-0040-1710539,2020-05-08
Severe disorder,NEG_PROCESS_OF,"Infant, Newborn",32380564,10.1055/s-0040-1710539,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32380564,10.1055/s-0040-1710539,2020-05-08
Disease,PROCESS_OF,Child,32380564,10.1055/s-0040-1710539,2020-05-08
Disease,PROCESS_OF,Infant,32380564,10.1055/s-0040-1710539,2020-05-08
Disease,PROCESS_OF,"Infant, Newborn",32380564,10.1055/s-0040-1710539,2020-05-08
Coronavirus Infections,ISA,Disease,32380564,10.1055/s-0040-1710539,2020-05-08
Coronavirus Infections,PROCESS_OF(SPEC),Child,32380564,10.1055/s-0040-1710539,2020-05-08
Coronavirus Infections,PROCESS_OF(SPEC),Infant,32380564,10.1055/s-0040-1710539,2020-05-08
Coronavirus Infections,PROCESS_OF(SPEC),"Infant, Newborn",32380564,10.1055/s-0040-1710539,2020-05-08
Fetal Hemoglobin,ASSOCIATED_WITH,Coronavirus Infections,32380564,10.1055/s-0040-1710539,2020-05-08
Coronavirus Infections,PROCESS_OF,"Infant, Newborn",32380564,10.1055/s-0040-1710539,2020-05-08
Infected,PROCESS_OF,Pregnant Women,32380511,10.1038/s41586-020-2312-y,2020-05-08
Practice Experience,PROCESS_OF,inpatient,32380511,10.1038/s41586-020-2312-y,2020-05-08
Gravidity,PROCESS_OF,Patients,32380511,10.1038/s41586-020-2312-y,2020-05-08
Challenge,TREATS,Patients,32380511,10.1038/s41586-020-2312-y,2020-05-08
Challenge,TREATS(INFER),Gravidity,32380511,10.1038/s41586-020-2312-y,2020-05-08
Emergency medical service,TREATS,Patients,32380475,10.1530/EJE-20-0352,2020-05-08
Cushing Syndrome,PROCESS_OF,Patients,32380474,10.1530/EJE-20-0338,2020-05-08
Diabetes Insipidus,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Hyponatremia,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Complication,COEXISTS_WITH,Diabetes Insipidus,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
desmopressin,TREATS,Complication,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
desmopressin,TREATS(SPEC),Dilutional hyponatremia,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Dilutional hyponatremia,COEXISTS_WITH(SPEC),Diabetes Insipidus,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Dilutional hyponatremia,ISA,Complication,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Diabetes Insipidus,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Hyponatremia,OCCURS_IN,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Pneumonia,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Hypernatremia,PROCESS_OF,Patients,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Hypernatremic dehydration,PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Surgical Replantation,PREDISPOSES,Pulmonary Edema,32380453,10.1016/j.oraloncology.2020.104741,2020-05-08
Coronavirus Infections,ISA,Disease,32380430,10.1016/j.ejca.2020.04.017,2020-05-08
Malignant Neoplasms,PROCESS_OF,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Confirmation,PROCESS_OF,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Malignant Neoplasms,PROCESS_OF,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Hospitalization,ADMINISTERED_TO,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Immunotherapy,ADMINISTERED_TO,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Malignant Neoplasms,PROCESS_OF,Patients,32380382,10.1016/j.jcv.2020.104387,2020-05-08
Laboratory,LOCATION_OF,Assay,32380370,10.1016/j.scitotenv.2020.139087,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Modulus,32380370,10.1016/j.scitotenv.2020.139087,2020-05-08
Coronavirus Infections,ISA,Disease,32380315,10.1016/j.autrev.2020.102566,2020-05-08
hospitalized patients,LOCATION_OF,Plasma,32380315,10.1016/j.autrev.2020.102566,2020-05-08
Autoimmune Diseases,PROCESS_OF,Patients,32380210,10.1016/j.virusres.2020.197988,2020-05-08
Colchicine,TREATS,Negative,32380210,10.1016/j.virusres.2020.197988,2020-05-08
Hospitals,LOCATION_OF,Nasal Swab (procedure),32380209,10.1016/j.virusres.2020.198002,2020-05-08
MIA gene,COEXISTS_WITH,Proteins,32380200,10.1016/j.peptides.2020.170328,2020-05-08
Signs and Symptoms,CAUSES,Disease,32380200,10.1016/j.peptides.2020.170328,2020-05-08
Body tissue,LOCATION_OF,Virus,32380200,10.1016/j.peptides.2020.170328,2020-05-08
Toxic Epidermal Necrolysis,PROCESS_OF,World,32380154,10.1016/j.urology.2020.04.083,2020-05-08
Therapeutic procedure,TREATS,Patients,32380154,10.1016/j.urology.2020.04.083,2020-05-08
Therapeutic procedure,TREATS(INFER),Severe Acute Respiratory Syndrome,32380154,10.1016/j.urology.2020.04.083,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32380154,10.1016/j.urology.2020.04.083,2020-05-08
host cell membrane,PART_OF,viral membrane,32380154,10.1016/j.urology.2020.04.083,2020-05-08
Prophylactic treatment,USES,Peptides,32380154,10.1016/j.urology.2020.04.083,2020-05-08
Elective procedure,TREATS,"Ethics Committees, Research",32380051,10.1016/j.phrs.2020.104882,2020-05-08
Present,PROCESS_OF,Staff,32380051,10.1016/j.phrs.2020.104882,2020-05-08
Coronavirus Infections,CAUSES,Infectious pneumonias,32380026,10.1016/j.jpeds.2020.04.060,2020-05-08
Disease,PROCESS_OF,Persons,32380026,10.1016/j.jpeds.2020.04.060,2020-05-08
Disease,PROCESS_OF,Persons,32380026,10.1016/j.jpeds.2020.04.060,2020-05-08
Confirmation,PROCESS_OF,Persons,32380026,10.1016/j.jpeds.2020.04.060,2020-05-08
Infected,PROCESS_OF,Patients,32380026,10.1016/j.jpeds.2020.04.060,2020-05-08
Cessation of life,PROCESS_OF,Patients,32380010,10.1016/j.bjid.2020.04.007,2020-05-08
Patient in hospital,PROCESS_OF,Adult,32380010,10.1016/j.bjid.2020.04.007,2020-05-08
Country,ISA,Geographic Locations,32379999,10.1080/0167482X.2020.1759545,2020-05-08
Hydroxychloroquine,ADMINISTERED_TO,Patients,32379923,10.15252/emmm.202012661,2020-05-08
Hydroxychloroquine,ADMINISTERED_TO,Patients,32379923,10.15252/emmm.202012661,2020-05-08
Hydroxychloroquine,NEG_ADMINISTERED_TO,Patients,32379923,10.15252/emmm.202012661,2020-05-08
Oxygen,PART_OF,Arteries,32379923,10.15252/emmm.202012661,2020-05-08
Hydroxychloroquine,TREATS,Patients,32379923,10.15252/emmm.202012661,2020-05-08
Vaccination against tuberculosis,ADMINISTERED_TO,high-risk group,32379896,10.1002/1873-3468.13806,2020-05-08
Pharmaceutical Preparations,compared_with,Investigational New Drugs,32379887,10.1093/infdis/jiaa252,2020-05-08
sinefungin,ISA,Pharmaceutical Preparations,32379887,10.1093/infdis/jiaa252,2020-05-08
tecadenoson,ISA,Pharmaceutical Preparations,32379887,10.1093/infdis/jiaa252,2020-05-08
carfilzomib,ISA,Pharmaceutical Preparations,32379887,10.1093/infdis/jiaa252,2020-05-08
CD4/CD8 ratio procedure,DIAGNOSES,patient condition,32379882,10.1093/pm/pnaa176,2020-05-08
Pain,PROCESS_OF,Program Director,32379863,10.1093/clinchem/hvaa106,2020-05-08
Pain,PROCESS_OF,Program Director,32379863,10.1093/clinchem/hvaa106,2020-05-08
Betacoronavirus,PROCESS_OF,Homo sapiens,32379733,10.15585/mmwr.mm6918e2,2020-05-08
Reverse Transcriptase Polymerase Chain Reaction,NEG_DIAGNOSES,Rhinovirus A,32379733,10.15585/mmwr.mm6918e2,2020-05-08
Infection,PROCESS_OF,Persons,32379731,10.15585/mmwr.mm6918e3,2020-05-08
Contacts,TREATS,Community,32379731,10.15585/mmwr.mm6918e3,2020-05-08
BARRIER,USES,Facility,32379729,10.15585/mmwr.mm6918e1,2020-05-08
Disinfection,PREVENTS,SARS coronavirus,32379729,10.15585/mmwr.mm6918e1,2020-05-08
African race,ISA,Ethnic group,32379727,10.15585/mmwr.mm6918a2,2020-05-08
Disease,NEG_PROCESS_OF,Patients,32379727,10.15585/mmwr.mm6918a2,2020-05-08
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32379727,10.15585/mmwr.mm6918a2,2020-05-08
Assay,METHOD_OF,Detection,32379708,10.3855/jidc.12684,2020-05-08
Fluorescent Antibody Technique,METHOD_OF,Detection,32379708,10.3855/jidc.12684,2020-05-08
Detection,USES,"Antibodies, Anti-Idiotypic",32379708,10.3855/jidc.12684,2020-05-08
Detection,USES,"Antibodies, Anti-Idiotypic",32379708,10.3855/jidc.12684,2020-05-08
Coronavirus Infections,ISA,Disease,32379708,10.3855/jidc.12684,2020-05-08
Assay,DIAGNOSES,Animal Disease Models,32379708,10.3855/jidc.12684,2020-05-08
Pandemics,ISA,Disease Outbreaks,32379707,10.3855/jidc.12718,2020-05-08
Old age,ISA,Population Group,32379707,10.3855/jidc.12718,2020-05-08
Health Promotion,TREATS,Elderly (population group),32379707,10.3855/jidc.12718,2020-05-08
Incubation period,PROCESS_OF,Patients,32379699,10.1530/EJE-20-0361,2020-05-08
Addisonian crisis,COEXISTS_WITH,Crisis,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Adrenal gland hypofunction,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Adrenal gland hypofunction,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Severe course,PREDISPOSES,Disease,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Adrenal gland hypofunction,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Acute infectious disease,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Continuous fever,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Hydrocortisone,ADMINISTERED_TO,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
prednisolone,ADMINISTERED_TO,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Adrenal gland hypofunction,PROCESS_OF,Patients,32379692,10.1016/j.ctcp.2020.101165,2020-05-08
Coronavirus Infections,CAUSES,Pneumonia,32379667,10.1016/j.ctcp.2020.101132,2020-05-08
Isolation procedure,TREATS,Anxiety,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
High Level,PROCESS_OF,Patients,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Pharmaceutical Preparations,COMPLICATES,Disease,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Autogenic Training,AFFECTS,Anxiety,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Anxiety,PROCESS_OF,Patients,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Interventional procedure,PREVENTS,Anxiety,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Not significant,PROCESS_OF,Patients,32379639,10.1016/j.ctcp.2020.101174,2020-05-08
Psychological function,PROCESS_OF,Patients,32379592,10.2174/1570159X18666200507085335,2020-05-08
Psychological function,PROCESS_OF,geriatric patients,32379592,10.2174/1570159X18666200507085335,2020-05-08
Interventional procedure,AFFECTS,Respiration,32379592,10.2174/1570159X18666200507085335,2020-05-08
Psychological function,PROCESS_OF,geriatric patients,32379592,10.2174/1570159X18666200507085335,2020-05-08
Lung,LOCATION_OF,Transfer factor - respiratory measure,32379592,10.2174/1570159X18666200507085335,2020-05-08
Transfer factor - respiratory measure,PROCESS_OF,Intervention Group,32379592,10.2174/1570159X18666200507085335,2020-05-08
Anxiety,AFFECTS,Respiration,32379592,10.2174/1570159X18666200507085335,2020-05-08
Depressive disorder,PROCESS_OF,Old age,32379592,10.2174/1570159X18666200507085335,2020-05-08
Coronavirus Infections,ISA,Disease,32379502,10.1377/hlthaff.2020.00455,2020-05-08
Coronavirus Infections,ISA,Disease,32379502,10.1377/hlthaff.2020.00455,2020-05-08
Cerebral Hemorrhage,ISA,Acute cerebrovascular disease,32379502,10.1377/hlthaff.2020.00455,2020-05-08
Confirmation,PROCESS_OF,Patients,32379502,10.1377/hlthaff.2020.00455,2020-05-08
Coronavirus Infections,ISA,Disease,32379456,10.1021/acs.molpharmaceut.0c00371,2020-05-08
Infection,ISA,Disease,32379456,10.1021/acs.molpharmaceut.0c00371,2020-05-08
Coronavirus Infections,ISA,Disease,32379456,10.1021/acs.molpharmaceut.0c00371,2020-05-08
Infected,PROCESS_OF,Persons,32379417,10.1021/acschemneuro.0c00210,2020-05-08
Asymptomatic,PROCESS_OF,Persons,32379381,10.1002/art.41306,2020-05-08
Olfactory Epithelium,LOCATION_OF,Cell Count,32379381,10.1002/art.41306,2020-05-08
Phalangeal cell of cochlea,PART_OF,Olfactory Epithelium,32379381,10.1002/art.41306,2020-05-08
TMPRSS2 gene,INTERACTS_WITH,Phalangeal cell of cochlea,32379381,10.1002/art.41306,2020-05-08
ACE2 gene,INTERACTS_WITH,Phalangeal cell of cochlea,32379381,10.1002/art.41306,2020-05-08
Esthesia,PROCESS_OF,Patients,32379381,10.1002/art.41306,2020-05-08
Severe Acute Respiratory Syndrome,AFFECTS,Senility,32379381,10.1002/art.41306,2020-05-08
Infection,PROCESS_OF,Vulnerable Populations,32379348,10.1002/jmv.25993,2020-05-08
Disease,OCCURS_IN,Persons,32379348,10.1002/jmv.25993,2020-05-08
Disease,OCCURS_IN,Racial group,32379348,10.1002/jmv.25993,2020-05-08
Immunologic Adjuvants,AUGMENTS,Immune response,32379199,10.1097/INF.0000000000002720,2020-05-08
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32379199,10.1097/INF.0000000000002720,2020-05-08
Vaccines,AUGMENTS,Immune response,32379199,10.1097/INF.0000000000002720,2020-05-08
Vaccines,TREATS,Severe Acute Respiratory Syndrome,32379199,10.1097/INF.0000000000002720,2020-05-08
Critical Illness,PROCESS_OF,Infant,32379193,10.1097/INF.0000000000002721,2020-05-08
Nasopharynx,LOCATION_OF,Viral Shedding,32379193,10.1097/INF.0000000000002721,2020-05-08
Antibodies,NEG_PART_OF,CD8-Positive T-Lymphocytes,32379193,10.1097/INF.0000000000002721,2020-05-08
Critical Illness,PROCESS_OF,Infant,32379193,10.1097/INF.0000000000002721,2020-05-08
Serum,LOCATION_OF,Antibodies,32379193,10.1097/INF.0000000000002721,2020-05-08
Child,LOCATION_OF,"T-Cell Surface Glycoprotein CD4, human",32379193,10.1097/INF.0000000000002721,2020-05-08
Nasopharynx,LOCATION_OF,Viral Shedding,32379193,10.1097/INF.0000000000002721,2020-05-08
Mycoplasma pneumoniae Infection,COMPLICATES,Pleural effusion disorder,32379191,10.1097/INF.0000000000002729,2020-05-08
Lung,LOCATION_OF,Lesion,32379191,10.1097/INF.0000000000002729,2020-05-08
Dry cough,PROCESS_OF,Patients,32379191,10.1097/INF.0000000000002729,2020-05-08
Viral Shedding,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
"Hospitals, Pediatric",LOCATION_OF,Study,32379114,10.2106/JBJS.20.00390,2020-05-08
Viral Shedding,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
Asymptomatic,PROCESS_OF,Patients,32379114,10.2106/JBJS.20.00390,2020-05-08
Pneumonia,COEXISTS_WITH,chest findings,32379114,10.2106/JBJS.20.00390,2020-05-08
Pneumonia,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
Viral Shedding,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
Viral Shedding,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
Duration,AFFECTS,Fever,32379114,10.2106/JBJS.20.00390,2020-05-08
Viral Shedding,PROCESS_OF,Child,32379114,10.2106/JBJS.20.00390,2020-05-08
Disease,PROCESS_OF,general population,32379104,10.2106/JBJS.20.00686,2020-05-08
Coronavirus Infections,CAUSES,Disease,32379104,10.2106/JBJS.20.00686,2020-05-08
Fracture,PROCESS_OF,Patients,32379104,10.2106/JBJS.20.00686,2020-05-08
Present,PROCESS_OF,Cohort,32379104,10.2106/JBJS.20.00686,2020-05-08
Nose,LOCATION_OF,Congestion,32379104,10.2106/JBJS.20.00686,2020-05-08
High Level,PROCESS_OF,Patients,32379104,10.2106/JBJS.20.00686,2020-05-08
High Level,PROCESS_OF,Patients,32379104,10.2106/JBJS.20.00686,2020-05-08
Fracture,PROCESS_OF,Patients,32379104,10.2106/JBJS.20.00686,2020-05-08
Fracture,PROCESS_OF,Patients,32379104,10.2106/JBJS.20.00686,2020-05-08
Operative Surgical Procedures,TREATS,Affected Area,32379104,10.2106/JBJS.20.00686,2020-05-08
Infected,PROCESS_OF,Older people,32379077,10.1097/PAF.0000000000000567,2020-05-08
Hip Fractures,PROCESS_OF,Patients,32379077,10.1097/PAF.0000000000000567,2020-05-08
"CD69 protein, human",ASSOCIATED_WITH,Hip Fractures,32379077,10.1097/PAF.0000000000000567,2020-05-08
Femoral Fractures,PROCESS_OF,Cohort,32379077,10.1097/PAF.0000000000000567,2020-05-08
Hip Fractures,PROCESS_OF,Patients,32379077,10.1097/PAF.0000000000000567,2020-05-08
Operative Surgical Procedures,TREATS,Patients,32379077,10.1097/PAF.0000000000000567,2020-05-08
Hip Fractures,PROCESS_OF,Patients,32379077,10.1097/PAF.0000000000000567,2020-05-08
Coronavirus Infections,ISA,Disease,32379077,10.1097/PAF.0000000000000567,2020-05-08
Hip Fractures,PROCESS_OF,geriatric patients,32379056,10.18632/aging.103099,2020-05-08
Challenge,TREATS,geriatric patients,32379056,10.18632/aging.103099,2020-05-08
Cross Infection,PROCESS_OF,geriatric patients,32379056,10.18632/aging.103099,2020-05-08
Hip Fractures,PROCESS_OF,geriatric patients,32379056,10.18632/aging.103099,2020-05-08
Outpatient visits,PREVENTS,Protection,32379022,10.12788/jhm.3446,2020-05-08
Physician-Patient Relations,ISA,Communication,32379022,10.12788/jhm.3446,2020-05-08
Tertiary Care Centers,LOCATION_OF,Study,32379016,10.1017/dmp.2020.145,2020-05-08
Hospitals,LOCATION_OF,Observation in research,32379016,10.1017/dmp.2020.145,2020-05-08
Interventional procedure,TREATS,Physicians,32379016,10.1017/dmp.2020.145,2020-05-08
World,LOCATION_OF,IMPACT gene,32378963,10.1037/prj0000434,2020-05-08
Acute abdominal pain,PROCESS_OF,Woman,32378854,10.4045/tidsskr.20.0287,2020-05-08
Symptoms,PROCESS_OF,Patients,32378854,10.4045/tidsskr.20.0287,2020-05-08
Acute abdominal pain,PROCESS_OF,Patients,32378854,10.4045/tidsskr.20.0287,2020-05-08
Taste Disorders,PROCESS_OF,Patients,32378845,10.4045/tidsskr.20.0307,2020-05-08
Body tissue,PART_OF,Nose,32378845,10.4045/tidsskr.20.0307,2020-05-08
Host Cell,PART_OF,Body tissue,32378845,10.4045/tidsskr.20.0307,2020-05-08
Dysgeusia,PROCESS_OF,Male population group,32378845,10.4045/tidsskr.20.0307,2020-05-08
"Signs and Symptoms, Respiratory",PROCESS_OF,Male population group,32378845,10.4045/tidsskr.20.0307,2020-05-08
"Signs and Symptoms, Respiratory",PROCESS_OF,Daughter-in-law,32378845,10.4045/tidsskr.20.0307,2020-05-08
Anosmia,ISA,Symptoms,32378845,10.4045/tidsskr.20.0307,2020-05-08
Body tissue,PART_OF,Nose,32378845,10.4045/tidsskr.20.0307,2020-05-08
Ageusia,ISA,Symptoms,32378845,10.4045/tidsskr.20.0307,2020-05-08
Signs and Symptoms,PROCESS_OF,Patients,32378843,10.4045/tidsskr.20.0297,2020-05-08
Symptoms,ISA,Signs and Symptoms,32378843,10.4045/tidsskr.20.0297,2020-05-08
Coughing,ISA,Symptoms,32378843,10.4045/tidsskr.20.0297,2020-05-08
Fever,PROCESS_OF,Patients,32378843,10.4045/tidsskr.20.0297,2020-05-08
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32378843,10.4045/tidsskr.20.0297,2020-05-08
Malaise,PROCESS_OF,Patients,32378843,10.4045/tidsskr.20.0297,2020-05-08
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",32378843,10.4045/tidsskr.20.0297,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32378842,10.4045/tidsskr.20.0299,2020-05-08
Nasal Swab (procedure),NEG_DIAGNOSES,SARS coronavirus,32378842,10.4045/tidsskr.20.0299,2020-05-08
Viral Shedding,PROCESS_OF,Patients,32378842,10.4045/tidsskr.20.0299,2020-05-08
Upper respiratory tract,LOCATION_OF,Viral Shedding,32378842,10.4045/tidsskr.20.0299,2020-05-08
Disease,PROCESS_OF,Patients,32378805,10.1111/1742-6723.13537,2020-05-08
Respiratory Insufficiency,PROCESS_OF,Male population group,32378805,10.1111/1742-6723.13537,2020-05-08
Coronavirus Infections,ISA,Disease,32378801,10.1111/dth.13525,2020-05-08
Vaccines,ISA,Pharmaceutical Preparations,32378801,10.1111/dth.13525,2020-05-08
Therapeutic procedure,TREATS,Disease,32378801,10.1111/dth.13525,2020-05-08
Therapeutic procedure,TREATS(SPEC),Coronavirus Infections,32378801,10.1111/dth.13525,2020-05-08
Coronavirus Infections,ISA,Disease,32378801,10.1111/dth.13525,2020-05-08
Pneumonia,PROCESS_OF,Patients,32378797,10.1111/1742-6723.13540,2020-05-08
etiology unknown,PROCESS_OF,Patients,32378797,10.1111/1742-6723.13540,2020-05-08
Mechanical ventilation,ADMINISTERED_TO,Patients,32378743,10.1111/jdv.16592,2020-05-08
Urticaria,ISA,Lesion,32378737,10.1002/cpt.1889,2020-05-08
Immune response,PROCESS_OF,Homo sapiens,32378705,10.1042/BSR20201312,2020-05-08
Cells,LOCATION_OF,Virus,32378705,10.1042/BSR20201312,2020-05-08
Structural protein,INTERACTS_WITH,receptor,32378648,10.5582/ddt.2020.01015,2020-05-08
Structural protein,PART_OF,Virus,32378648,10.5582/ddt.2020.01015,2020-05-08
DNA Sequence,COEXISTS_WITH,Isolate - microorganism,32378648,10.5582/ddt.2020.01015,2020-05-08
Proteins,AFFECTS,receptor binding,32378648,10.5582/ddt.2020.01015,2020-05-08
Laboratory,LOCATION_OF,research study,32378647,10.5582/ddt.2020.03006,2020-05-08
Compassionate Use,TREATS,Homo sapiens,32378647,10.5582/ddt.2020.03006,2020-05-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32378503,10.1017/dmp.2020.141,2020-05-08
tocilizumab,ISA,Interleukin inhibitors,32378503,10.1017/dmp.2020.141,2020-05-08
tocilizumab,TREATS(SPEC),Patients,32378503,10.1017/dmp.2020.141,2020-05-08
Interleukin inhibitors,TREATS,Patients,32378503,10.1017/dmp.2020.141,2020-05-08
Interleukin inhibitors,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32378503,10.1017/dmp.2020.141,2020-05-08
Storm NOS,COEXISTS_WITH,Pneumonia,32378503,10.1017/dmp.2020.141,2020-05-08
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32378464,10.12968/bjcn.2020.25.5.247,2020-05-08
Sequela of disorder,AFFECTS,Hypertensive disease,32378460,10.12968/bjcn.2020.25.5.231,2020-05-08
Sequela of disorder,AFFECTS,Chronic Obstructive Airway Disease,32378460,10.12968/bjcn.2020.25.5.231,2020-05-08
Sequela of disorder,AFFECTS,Obesity,32378460,10.12968/bjcn.2020.25.5.231,2020-05-08
Virus,CAUSES,Disease,32378460,10.12968/bjcn.2020.25.5.231,2020-05-08
nursing therapy,TREATS,Persons,32378460,10.12968/bjcn.2020.25.5.231,2020-05-08
Advice,TREATS,Persons,32378459,10.2217/nnm-2020-0117,2020-05-08
SARS coronavirus,INTERACTS_WITH,Genus: Coronavirus,32378314,10.1111/ajt.15982,2020-05-08
SARS coronavirus,INTERACTS_WITH,Genus: Coronavirus,32378314,10.1111/ajt.15982,2020-05-08
Middle East Respiratory Syndrome Coronavirus,INTERACTS_WITH,Genus: Coronavirus,32378314,10.1111/ajt.15982,2020-05-08
Antibiotics,DISRUPTS,Decreased Immunologic Activity [PE],32378284,10.1111/dth.13516,2020-05-08
Hydroxychloroquine,DISRUPTS,Decreased Immunologic Activity [PE],32378284,10.1111/dth.13516,2020-05-08
"Immunoglobulins, Intravenous",DISRUPTS,Decreased Immunologic Activity [PE],32378284,10.1111/dth.13516,2020-05-08
lopinavir / Ritonavir,DISRUPTS,Decreased Immunologic Activity [PE],32378284,10.1111/dth.13516,2020-05-08
tocilizumab,DISRUPTS,Decreased Immunologic Activity [PE],32378284,10.1111/dth.13516,2020-05-08
Antimetabolites,compared_with,Hydroxychloroquine,32378284,10.1111/dth.13516,2020-05-08
Skin Manifestations,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32378252,10.1111/ijcp.13528,2020-05-08
Coronavirus Infections,ISA,Disease,32378252,10.1111/ijcp.13528,2020-05-08
Foot,LOCATION_OF,Lesion,32378252,10.1111/ijcp.13528,2020-05-08
Hand,LOCATION_OF,Lesion,32378252,10.1111/ijcp.13528,2020-05-08
Complication,COEXISTS_WITH,Lesion,32378252,10.1111/ijcp.13528,2020-05-08
Coronavirus Infections,COEXISTS_WITH,Lesion,32378252,10.1111/ijcp.13528,2020-05-08
Coronavirus Infections,ISA,Disease,32378252,10.1111/ijcp.13528,2020-05-08
Adult,ISA,Population Group,32378252,10.1111/ijcp.13528,2020-05-08
Infected,PROCESS_OF,Persons,32378180,10.1007/s40123-020-00254-w,2020-05-08
IMPACT gene,PART_OF,Persons,32378180,10.1007/s40123-020-00254-w,2020-05-08
England,ISA,Geographic Locations,32378180,10.1007/s40123-020-00254-w,2020-05-08
Disease,PROCESS_OF,Population Group,32378180,10.1007/s40123-020-00254-w,2020-05-08
Disease,PROCESS_OF,Homo sapiens,32378126,10.1007/s10597-020-00624-5,2020-05-08
Eye,LOCATION_OF,Sequela of disorder,32378126,10.1007/s10597-020-00624-5,2020-05-08
Septicemia,CAUSES,Blood Coagulation Disorders,32377965,10.1007/s40520-020-01570-8,2020-05-08
Septicemia,CAUSES(SPEC),Thrombophilia,32377965,10.1007/s40520-020-01570-8,2020-05-08
Thrombophilia,ISA,Blood Coagulation Disorders,32377965,10.1007/s40520-020-01570-8,2020-05-08
Brain,LOCATION_OF,Present,32377965,10.1007/s40520-020-01570-8,2020-05-08
Heparinoids,PREVENTS,Thrombosis,32377965,10.1007/s40520-020-01570-8,2020-05-08
alteplase,TREATS,Cerebrovascular accident,32377965,10.1007/s40520-020-01570-8,2020-05-08
Septicemia,CAUSES,Blood Coagulation Disorders,32377965,10.1007/s40520-020-01570-8,2020-05-08
Aging,PROCESS_OF,Population Group,32377932,10.1007/s00239-020-09947-z,2020-05-08
Virus,CAUSES,Infection,32377694,10.3892/ijmm.2020.4596,2020-05-08
Genus: Coronavirus,CAUSES(SPEC),Infection,32377694,10.3892/ijmm.2020.4596,2020-05-08
Genus: Coronavirus,ISA,Virus,32377694,10.3892/ijmm.2020.4596,2020-05-08
Virus,PROCESS_OF,Older people,32377694,10.3892/ijmm.2020.4596,2020-05-08
Symptoms,CAUSES,Cessation of life,32377694,10.3892/ijmm.2020.4596,2020-05-08
Obesity,PROCESS_OF,Patients,32377694,10.3892/ijmm.2020.4596,2020-05-08
Lipid Peroxidation,PROCESS_OF,Patients,32377694,10.3892/ijmm.2020.4596,2020-05-08
Metabolic Diseases,PROCESS_OF,Patients,32377694,10.3892/ijmm.2020.4596,2020-05-08
Elderly (population group),LOCATION_OF,"CD69 protein, human",32377666,10.1093/ageing/afaa097,2020-05-08
Persons,LOCATION_OF,Adrenal Cortex Hormones,32377666,10.1093/ageing/afaa097,2020-05-08
risk factors,PROCESS_OF,Patients,32377636,10.1093/crocol/otaa026,2020-05-08
Vaccines,NEG_CAUSES,risk factors,32377636,10.1093/crocol/otaa026,2020-05-08
Tissue damage,PROCESS_OF,Patients,32377636,10.1093/crocol/otaa026,2020-05-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32377636,10.1093/crocol/otaa026,2020-05-08
Supportive care,TREATS,Complication,32377636,10.1093/crocol/otaa026,2020-05-08
Health Services,TREATS,Patients,32377597,10.1016/j.adro.2020.04.015,2020-05-08
Prophylactic treatment,TREATS,Health Personnel,32377597,10.1016/j.adro.2020.04.015,2020-05-08
Prophylactic treatment,TREATS,Patients,32377597,10.1016/j.adro.2020.04.015,2020-05-08
Malignant Neoplasms,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Adrenal Cortex Hormones,TREATS,Radiation Pneumonitis,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Lung,LOCATION_OF,diseases and injuries,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Symptoms,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Symptoms,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Symptoms,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Fever,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Tapering - action,USES,Adrenal Cortex Hormones,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Chest CT,DIAGNOSES,Ground Glass Opacity,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Symptoms,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Exacerbation,PROCESS_OF,Patients,32377596,10.1016/j.adro.2020.04.014,2020-05-08
Hospitals,LOCATION_OF,Study,32377594,10.1016/j.ajoc.2020.100735,2020-05-08
Pneumonia,PROCESS_OF,Patients,32377576,10.1038/s41746-020-0280-0,2020-05-08
hemorrhagic conjunctivitis,COEXISTS_WITH,Pneumonia,32377576,10.1038/s41746-020-0280-0,2020-05-08
Breast scan,DIAGNOSES,"Pneumonia, Interstitial",32377576,10.1038/s41746-020-0280-0,2020-05-08
Tarsal,LOCATION_OF,Hemorrhage,32377576,10.1038/s41746-020-0280-0,2020-05-08
Eye Infections,ISA,Communicable Diseases,32377576,10.1038/s41746-020-0280-0,2020-05-08
Complication,PROCESS_OF,Patients,32377576,10.1038/s41746-020-0280-0,2020-05-08
Eye,LOCATION_OF,Complication,32377576,10.1038/s41746-020-0280-0,2020-05-08
Coronavirus Infections,ISA,Disease,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Cessation of life,PROCESS_OF,Persons,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Infected,PROCESS_OF,Patients,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Chloroquine,DISRUPTS,Virus Replication,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Chloroquine,ISA,Pharmaceutical Preparations,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Chloroquine,TREATS,Coronavirus Infections,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Nucleotides,DISRUPTS,Virus Replication,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Nucleotides,ISA,Pharmaceutical Preparations,32377508,10.1016/j.matpr.2020.04.723,2020-05-08
Pandemics,ISA,Disease Outbreaks,32377507,10.1016/j.idcr.2020.e00791,2020-05-08
Pandemics,ISA,Disease Outbreaks,32377507,10.1016/j.idcr.2020.e00791,2020-05-08
Vitality,PROCESS_OF,Consumer,32377507,10.1016/j.idcr.2020.e00791,2020-05-08
Sports,ISA,Activities,32377486,10.7759/cureus.7538,2020-05-08
Physical and emotional exhaustion state,PROCESS_OF,Physicians,32377469,10.7759/cureus.7521,2020-05-08
Pharmaceutical Preparations,AFFECTS,Household composition,32377468,10.7759/cureus.7520,2020-05-08
Diagnosis,DIAGNOSES,Enthesitis-Related Arthritis,32377468,10.7759/cureus.7520,2020-05-08
Fever,PROCESS_OF,Infant,32377462,10.7759/cureus.7514,2020-05-08
Severe diarrhea,PROCESS_OF,Infant,32377462,10.7759/cureus.7514,2020-05-08
Bronchial,LOCATION_OF,Infiltration,32377462,10.7759/cureus.7514,2020-05-08
Peripheral blood mononuclear cell (cell),LOCATION_OF,"Transcription, Genetic",32377315,10.1007/s40617-020-00435-w,2020-05-08
Self-care interventions,TREATS,Caregiver,32377058,10.1016/j.jceh.2020.04.020,2020-05-08
Virus,CAUSES,Disease,32377034,10.1016/j.ssci.2020.104791,2020-05-08
Traffic,PROCESS_OF,Passenger,32377030,10.1016/j.jeconom.2020.04.041,2020-05-08
Guanosine Diphosphate,PART_OF,World,32377030,10.1016/j.jeconom.2020.04.041,2020-05-08
IMPACT gene,INHIBITS,Guanosine Diphosphate,32377030,10.1016/j.jeconom.2020.04.041,2020-05-08
Intervention regimes,TREATS,Community,32377017,10.1038/s41575-020-0311-y,2020-05-08
"Promoter Regions, Genetic",PART_OF,TMPRSS2 gene,32376901,10.1038/s41577-020-0331-4,2020-05-08
"Transcription, Genetic",AFFECTS,physiological aspects,32376901,10.1038/s41577-020-0331-4,2020-05-08
Potassium Ion,COEXISTS_WITH,"Promoter Regions, Genetic",32376901,10.1038/s41577-020-0331-4,2020-05-08
G-Quadruplexes,COEXISTS_WITH,Potassium Ion,32376901,10.1038/s41577-020-0331-4,2020-05-08
Small Molecule,INHIBITS,G-Quadruplexes,32376901,10.1038/s41577-020-0331-4,2020-05-08
Cessation of life,PROCESS_OF,Patients,32376725,10.1542/peds.2020-0961,2020-05-08
Infected,PROCESS_OF,Patients,32376725,10.1542/peds.2020-0961,2020-05-08
SARS coronavirus,ISA,Virus,32376725,10.1542/peds.2020-0961,2020-05-08
Infection,CAUSES,Macrophage Activation Syndrome,32376725,10.1542/peds.2020-0961,2020-05-08
Macrophage Activation,PROCESS_OF,Patients,32376725,10.1542/peds.2020-0961,2020-05-08
Severe Acute Respiratory Syndrome,AFFECTS,Macrophage Activation,32376725,10.1542/peds.2020-0961,2020-05-08
Fever,ISA,Symptoms,32376717,10.1136/medethics-2020-106323,2020-05-08
Coinfection,PROCESS_OF,Child,32376717,10.1136/medethics-2020-106323,2020-05-08
Infected,PROCESS_OF,Child,32376717,10.1136/medethics-2020-106323,2020-05-08
Accidental Falls,PROCESS_OF,victim,32376714,10.1136/jclinpath-2020-206658,2020-05-08
Severe Acute Respiratory Syndrome,CAUSES,Fever,32376697,10.1128/mSphere.00160-20,2020-05-08
Host Cell,LOCATION_OF,Virus,32376697,10.1128/mSphere.00160-20,2020-05-08
Protein S,INTERACTS_WITH,angiotensin converting enzyme 2,32376697,10.1128/mSphere.00160-20,2020-05-08
angiotensin converting enzyme 2,ADMINISTERED_TO,Chiroptera,32376697,10.1128/mSphere.00160-20,2020-05-08
angiotensin converting enzyme 2,ADMINISTERED_TO,Pholidota,32376697,10.1128/mSphere.00160-20,2020-05-08
Peptide Hydrolases,PART_OF,Cells,32376697,10.1128/mSphere.00160-20,2020-05-08
"M Protein, multiple myeloma",INTERACTS_WITH,angiotensin converting enzyme 2,32376697,10.1128/mSphere.00160-20,2020-05-08
Peptide Hydrolases,PART_OF,Cells,32376697,10.1128/mSphere.00160-20,2020-05-08
Cessation of life,PROCESS_OF,Pholidota,32376634,10.1073/pnas.2003138117,2020-05-08
Lung,PART_OF,Pholidota,32376634,10.1073/pnas.2003138117,2020-05-08
Lung,LOCATION_OF,Present,32376634,10.1073/pnas.2003138117,2020-05-08
Lung,PART_OF,Pholidota,32376634,10.1073/pnas.2003138117,2020-05-08
Peptide Hydrolases,AUGMENTS,physiological aspects,32376627,10.1128/JVI.00635-20,2020-05-08
Peptide Hydrolases,PART_OF,Homo sapiens,32376627,10.1128/JVI.00635-20,2020-05-08
Peptide Hydrolases,PART_OF,Leptocyte,32376627,10.1128/JVI.00635-20,2020-05-08
paired basic amino acid cleaving enzyme,INHIBITS,Peptide Hydrolases,32376627,10.1128/JVI.00635-20,2020-05-08
paired basic amino acid cleaving enzyme,ISA,Proprotein Convertases,32376627,10.1128/JVI.00635-20,2020-05-08
Coronavirus Infections,ISA,Disease,32376613,10.1128/AAC.00876-20,2020-05-08
"Vitronectin, human",AFFECTS,Membrane Fusion Activity,32376613,10.1128/AAC.00876-20,2020-05-08
"S protein, severe acute respiratory syndrome coronavirus",AFFECTS,syncytium formation by plasma membrane fusion,32376613,10.1128/AAC.00876-20,2020-05-08
"S protein, severe acute respiratory syndrome coronavirus",AFFECTS,transduction,32376613,10.1128/AAC.00876-20,2020-05-08
Cyclosporine,INHIBITS,Peptidylprolyl Isomerase,32376612,10.4187/respcare.07919,2020-05-08
alisporivir,INHIBITS(SPEC),Peptidylprolyl Isomerase,32376612,10.4187/respcare.07919,2020-05-08
alisporivir,ISA,Cyclosporine,32376612,10.4187/respcare.07919,2020-05-08
Respiration,PROCESS_OF,Patients,32376603,10.1126/science.abc1932,2020-05-08
Pressure controlled ventilation,USES,Inspiratory limb,32376603,10.1126/science.abc1932,2020-05-08
GSKIP gene,CAUSES,Imbalance,32376603,10.1126/science.abc1932,2020-05-08
Inspiration function,PROCESS_OF,Persons,32376603,10.1126/science.abc1932,2020-05-08
Pressure controlled ventilation,TREATS,Non-Ossifying Fibroma,32376603,10.1126/science.abc1932,2020-05-08
Mus,LOCATION_OF,Antibodies,32376593,10.12122/j.issn.1673-4254.2020.03.08,2020-05-08
Rattus norvegicus,LOCATION_OF,Antibodies,32376593,10.12122/j.issn.1673-4254.2020.03.08,2020-05-08
Nonhuman primate,LOCATION_OF,Antibodies,32376593,10.12122/j.issn.1673-4254.2020.03.08,2020-05-08
Immunization,TREATS,Macaca,32376593,10.12122/j.issn.1673-4254.2020.03.08,2020-05-08
Patients,LOCATION_OF,Blood specimen,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
biomedical tube device,USES,Ethanol,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
Ethanol,INTERACTS_WITH,Matrix,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
acetonitrile,INTERACTS_WITH,Matrix,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
Specimen preparation,USES,Ethanol,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
peripheral blood,LOCATION_OF,voriconazole,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
whole blood specimen,LOCATION_OF,voriconazole,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
Therapeutic Drug Monitoring,USES,biomedical tube device,32376592,10.12122/j.issn.1673-4254.2020.03.07,2020-05-08
Critical Illness,PROCESS_OF,Patients,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
"Intubation, Intratracheal",TREATS,Patients,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
"Intubation, Intratracheal",TREATS(INFER),Critical Illness,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
"Intubation, Intratracheal",ADMINISTERED_TO,Anesthesiologist,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
Noninvasive Ventilation,ADMINISTERED_TO,Patients,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
Protection,PROCESS_OF,Medical Staff,32376589,10.12122/j.issn.1673-4254.2020.03.05,2020-05-08
Operative Surgical Procedures,ADMINISTERED_TO,member,32376587,10.12122/j.issn.1673-4254.2020.03.11,2020-05-08
Cerebral Infarction,PROCESS_OF,geriatric patients,32376581,10.12122/j.issn.1673-4254.2020.03.06,2020-05-08
Rapid disease progression,PROCESS_OF,Physicians,32376581,10.12122/j.issn.1673-4254.2020.03.06,2020-05-08
Rapid disease progression,PROCESS_OF,geriatric patients,32376581,10.12122/j.issn.1673-4254.2020.03.06,2020-05-08
Breast Feeding,PROCESS_OF,Intern,32376573,10.12122/j.issn.1673-4254.2020.03.04,2020-05-08
Breast Feeding,PROCESS_OF,Intern,32376573,10.12122/j.issn.1673-4254.2020.03.04,2020-05-08
Intern,DIAGNOSES,Anxiety,32376573,10.12122/j.issn.1673-4254.2020.03.04,2020-05-08
Intern,DIAGNOSES,Depressive disorder,32376573,10.12122/j.issn.1673-4254.2020.03.04,2020-05-08
Hospitals,LOCATION_OF,Radionuclide Imaging,32376571,10.12122/j.issn.1673-4254.2020.03.03,2020-05-08
Lesion,PROCESS_OF,Patients,32376571,10.12122/j.issn.1673-4254.2020.03.03,2020-05-08
Lesion,PROCESS_OF,Patients,32376571,10.12122/j.issn.1673-4254.2020.03.03,2020-05-08
Both lungs,LOCATION_OF,Lesion,32376571,10.12122/j.issn.1673-4254.2020.03.03,2020-05-08
Abnormality,PROCESS_OF,Patients,32376571,10.12122/j.issn.1673-4254.2020.03.03,2020-05-08
Disease,PROCESS_OF,Patients,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Patients,LOCATION_OF,Blood specimen,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Patients,LOCATION_OF,Plasma,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Patients,LOCATION_OF,peripheral blood,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Patients,LOCATION_OF,Serum,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Serum,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Total immunoglobulin measurement,USES,Immunochromatography,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Plasma specimen,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
IgG antibody,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Serum,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Serum,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Plasma specimen,LOCATION_OF,CD40LG wt Allele,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Immunoenzyme Procedure,METHOD_OF,Detection,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Immunochromatography,METHOD_OF,Detection,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
Immunochromatography,METHOD_OF,Procedure to identify antibody,32376546,10.12122/j.issn.1673-4254.2020.02.04,2020-05-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Communicable Diseases,32376543,10.12122/j.issn.1673-4254.2020.02.03,2020-05-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32376543,10.12122/j.issn.1673-4254.2020.02.03,2020-05-08
Respiratory complication,CAUSES,Cessation of life,32376543,10.12122/j.issn.1673-4254.2020.02.03,2020-05-08
"Hospitals, District",LOCATION_OF,Analysis,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Physical Examination,TREATS,Fever,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Physical Examination,USES,Chest CT,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Chest CT,METHOD_OF,Diagnosis,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Both lungs,LOCATION_OF,Multiple lesions,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Structure of pulmonary blood vessel,LOCATION_OF,Thickened,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Multiple lesions,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Physical findings,PROCESS_OF,Patients,32376535,10.12122/j.issn.1673-4254.2020.02.02,2020-05-08
Acute myocardial infarction,PROCESS_OF,Patients,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
Mobility aid,TREATS,Patients,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
Mobility aid,TREATS,Acute myocardial infarction,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
Acute myocardial infarction,PROCESS_OF,Patients,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
Physicians,TREATS,Patients,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
Acute myocardial infarction,PROCESS_OF,Patients,32376531,10.12122/j.issn.1673-4254.2020.02.05,2020-05-08
High Level,PROCESS_OF,College student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Anxiety,AFFECTS,Health behavior,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Anxiety,PROCESS_OF,student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Depressive disorder,AFFECTS,Health behavior,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Depressive disorder,PROCESS_OF,student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Anxiety,PROCESS_OF,student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Anxiety,PROCESS_OF,College student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Depressive disorder,PROCESS_OF,College student,32376402,10.1016/j.autrev.2020.102571,2020-05-08
Epithelium,PART_OF,Lung,32376398,10.1016/j.autrev.2020.102568,2020-05-08
Pharmaceutical Preparations,TREATS,Disease Progression,32376398,10.1016/j.autrev.2020.102568,2020-05-08
Proto-Oncogene Proteins c-akt,ISA,Protein-Serine-Threonine Kinases,32376398,10.1016/j.autrev.2020.102568,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376397,10.1016/j.autrev.2020.102570,2020-05-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32376397,10.1016/j.autrev.2020.102570,2020-05-08
Syndrome,CAUSES,"Respiratory Distress Syndrome, Adult",32376397,10.1016/j.autrev.2020.102570,2020-05-08
Monoclonal Antibodies,INTERACTS_WITH,Interleukin 6 Receptor,32376397,10.1016/j.autrev.2020.102570,2020-05-08
Lymphopenia,PROCESS_OF,Patients,32376397,10.1016/j.autrev.2020.102570,2020-05-08
High Level,PROCESS_OF,Patients,32376397,10.1016/j.autrev.2020.102570,2020-05-08
Septic Shock,PROCESS_OF,Patients,32376397,10.1016/j.autrev.2020.102570,2020-05-08
Syndrome,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32376397,10.1016/j.autrev.2020.102570,2020-05-08
Symptoms,PROCESS_OF,Patients,32376395,10.1016/j.autrev.2020.102575,2020-05-08
Adrenal Cortex Hormones,ADMINISTERED_TO,Patients,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Tertiary Care Centers,LOCATION_OF,Cross-Sectional Studies,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Autoimmune disease (systemic) NOS,PROCESS_OF,Outpatients,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,general population,32376394,10.1016/j.autrev.2020.102569,2020-05-08
Adrenal Cortex Hormones,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
heparin,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
Immunoglobulins,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
Calcineurin,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
Hydroxymethylglutaryl-CoA Reductase Inhibitors,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
Janus kinase inhibitor,STIMULATES,Peptidyl-Dipeptidase A,32376392,10.1016/j.autrev.2020.102567,2020-05-08
Disease,COEXISTS_WITH,Immunologic Deficiency Syndromes,32376368,10.1016/j.jep.2020.112932,2020-05-08
Vaccines,compared_with,Pharmaceutical Preparations,32376350,10.1016/j.athoracsur.2020.04.018,2020-05-08
Vaccines,higher_than,Pharmaceutical Preparations,32376350,10.1016/j.athoracsur.2020.04.018,2020-05-08
Epitopes,ISA,Antigens,32376350,10.1016/j.athoracsur.2020.04.018,2020-05-08
Acute Coronary Syndrome,PREDISPOSES,Severe Acute Respiratory Syndrome,32376317,10.1016/j.ajog.2020.04.039,2020-05-08
Acute Coronary Syndrome,PROCESS_OF,Patients,32376317,10.1016/j.ajog.2020.04.039,2020-05-08
Acute Coronary Syndrome,PROCESS_OF,Patients,32376317,10.1016/j.ajog.2020.04.039,2020-05-08
Acute Coronary Syndrome,PROCESS_OF,Patients,32376317,10.1016/j.ajog.2020.04.039,2020-05-08
Blood,PART_OF,"Infant, Newborn",32376309,10.1016/j.ijid.2020.04.083,2020-05-08
Maternal infection,PROCESS_OF,"Infant, Newborn",32376309,10.1016/j.ijid.2020.04.083,2020-05-08
SARS coronavirus,PROCESS_OF,"Infant, Newborn",32376309,10.1016/j.ijid.2020.04.083,2020-05-08
Blood,PART_OF,"Infant, Newborn",32376309,10.1016/j.ijid.2020.04.083,2020-05-08
Relative (related person),LOCATION_OF,Blood,32376309,10.1016/j.ijid.2020.04.083,2020-05-08
Immunoglobulin G measurement,USES,Antibodies,32376309,10.1016/j.ijid.2020.04.083,2020-05-08
Asymptomatic Infections,PROCESS_OF,Patients,32376308,10.1016/j.ijid.2020.04.086,2020-05-08
Asymptomatic Infections,PROCESS_OF,Patients,32376308,10.1016/j.ijid.2020.04.086,2020-05-08
Incubation period,PROCESS_OF,Patients,32376308,10.1016/j.ijid.2020.04.086,2020-05-08
Communicable Diseases,ISA,Symptoms,32376308,10.1016/j.ijid.2020.04.086,2020-05-08
Diagnosis,PRECEDES,Isolation procedure,32376308,10.1016/j.ijid.2020.04.086,2020-05-08
Cessation of life,AFFECTS,Prolonged grief disorder,32376208,10.1016/j.purol.2020.04.015,2020-05-08
Stress,PROCESS_OF,Relative (related person),32376208,10.1016/j.purol.2020.04.015,2020-05-08
Distress,PROCESS_OF,Staff,32376208,10.1016/j.purol.2020.04.015,2020-05-08
Poor outcome,PROCESS_OF,Relative (related person),32376208,10.1016/j.purol.2020.04.015,2020-05-08
Moral Injury,PROCESS_OF,Staff,32376208,10.1016/j.purol.2020.04.015,2020-05-08
Prolonged grief disorder,PROCESS_OF,Relative (related person),32376208,10.1016/j.purol.2020.04.015,2020-05-08
Advance Care Planning,AFFECTS,Possible,32376208,10.1016/j.purol.2020.04.015,2020-05-08
Physical and emotional exhaustion state,ISA,Disease,32376171,10.1016/j.arth.2020.04.040,2020-05-08
Physical and emotional exhaustion state,PROCESS_OF,Urologists,32376171,10.1016/j.arth.2020.04.040,2020-05-08
Urologists,LOCATION_OF,"CD69 protein, human",32376171,10.1016/j.arth.2020.04.040,2020-05-08
"CD69 protein, human",AFFECTS,Stress,32376171,10.1016/j.arth.2020.04.040,2020-05-08
"CD69 protein, human",AFFECTS,Negative,32376171,10.1016/j.arth.2020.04.040,2020-05-08
Respiration Disorders,PROCESS_OF,Patients,32376171,10.1016/j.arth.2020.04.040,2020-05-08
Urologists,LOCATION_OF,IMPACT gene,32376171,10.1016/j.arth.2020.04.040,2020-05-08
Coronavirus Infections,AFFECTS,Negative,32376170,10.1016/j.arth.2020.04.051,2020-05-08
Healthcare supplies,TREATS,Patients,32376169,10.1016/j.arth.2020.04.041,2020-05-08
Operative Surgical Procedures,TREATS,Patients,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Financial concerns,PROCESS_OF,Patients,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Bone structure of ischium,LOCATION_OF,Pain,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Knee,LOCATION_OF,Arthritis,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Knee,LOCATION_OF,Pain,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Pain,PROCESS_OF,Patients,32376137,10.1016/j.eururo.2020.04.056,2020-05-08
Urologists,ISA,Surgeon,32376133,10.1016/j.eururo.2020.04.042,2020-05-08
Herpes zoster disease,ISA,Disease,32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Herpes zoster disease,PROCESS_OF,Elderly (population group),32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Influenza,ISA,Disease,32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Influenza,PROCESS_OF,Elderly (population group),32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Pneumonia,ISA,Disease,32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Pneumonia,PROCESS_OF,Elderly (population group),32376101,10.1016/j.mayocp.2020.04.006,2020-05-08
Hospitals,LOCATION_OF,Retrospective Cohort Study,32376099,10.1016/j.mayocp.2020.03.026,2020-05-08
Death in hospital,PROCESS_OF,Patients,32376099,10.1016/j.mayocp.2020.03.026,2020-05-08
Pneumonia,PROCESS_OF,Patients,32376099,10.1016/j.mayocp.2020.03.026,2020-05-08
GSKIP gene,PART_OF,Patients,32376099,10.1016/j.mayocp.2020.03.026,2020-05-08
Angiotensin-Converting Enzyme Inhibitors,TREATS,Hypertensive disease,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Angiotensin II receptor antagonist,TREATS,Hypertensive disease,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Antihypertensive Agents,ADMINISTERED_TO,Patients,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Hypertensive disease,PROCESS_OF,Patients,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Agent,TREATS,Chronic Kidney Diseases,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Adverse event,PROCESS_OF,Patients,32376098,10.1016/j.jcf.2020.04.012,2020-05-08
Cystic Fibrosis,AFFECTS,Coronavirus Infections,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
"CD69 protein, human",ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
Cystic Fibrosis,PROCESS_OF,Cohort,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
Cessation of life,PROCESS_OF,Cohort,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
Cystic Fibrosis,PROCESS_OF,Persons,32376072,10.1016/j.rgmx.2020.04.001,2020-05-08
Persons,LOCATION_OF,IMPACT gene,32375922,10.1017/dmp.2020.147,2020-05-08
World,ISA,Population Group,32375922,10.1017/dmp.2020.147,2020-05-08
Mental disorders,PROCESS_OF,Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Patients,ISA,Persons,32375922,10.1017/dmp.2020.147,2020-05-08
risk factors,PROCESS_OF,Persons,32375922,10.1017/dmp.2020.147,2020-05-08
risk factors,PROCESS_OF(SPEC),Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Psychotropic Drugs,CAUSES,Confusion,32375922,10.1017/dmp.2020.147,2020-05-08
Therapeutic procedure,TREATS,Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Psychotropic Drugs,CAUSES,Symptoms,32375922,10.1017/dmp.2020.147,2020-05-08
Psychotropic Drugs,TREATS,Old age,32375922,10.1017/dmp.2020.147,2020-05-08
Infected,PROCESS_OF,Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Clozapine,ISA,Pharmaceutical Preparations,32375922,10.1017/dmp.2020.147,2020-05-08
Clozapine,ASSOCIATED_WITH,Bipolar Disorder,32375922,10.1017/dmp.2020.147,2020-05-08
Clozapine,ASSOCIATED_WITH,Schizophrenia,32375922,10.1017/dmp.2020.147,2020-05-08
Lithium,ASSOCIATED_WITH,Bipolar Disorder,32375922,10.1017/dmp.2020.147,2020-05-08
Lithium,ASSOCIATED_WITH,Schizophrenia,32375922,10.1017/dmp.2020.147,2020-05-08
Lithium,ISA,Pharmaceutical Preparations,32375922,10.1017/dmp.2020.147,2020-05-08
Coughing,ISA,"Signs and Symptoms, Respiratory",32375922,10.1017/dmp.2020.147,2020-05-08
Antidepressive Agents,ISA,Psychotropic Drugs,32375922,10.1017/dmp.2020.147,2020-05-08
Mental disorders,PROCESS_OF,Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Muscle Rigidity,PROCESS_OF,Patients,32375922,10.1017/dmp.2020.147,2020-05-08
Public school,LOCATION_OF,Convenience Sampling,32375914,10.1017/dmp.2020.142,2020-05-08
Cessation of life,PROCESS_OF,Persons,32375887,10.1186/s12954-020-00370-7,2020-05-08
Chronic disease,PROCESS_OF,Elderly man,32375887,10.1186/s12954-020-00370-7,2020-05-08
Disease Progression,PROCESS_OF,Elderly man,32375887,10.1186/s12954-020-00370-7,2020-05-08
Health Services,TREATS,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
Health Services,USES,Pharmaceutical Preparations,32375884,10.1186/s40463-020-00425-6,2020-05-08
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32375884,10.1186/s40463-020-00425-6,2020-05-08
Clinician,TREATS,Patients,32375884,10.1186/s40463-020-00425-6,2020-05-08
Naloxone,DISRUPTS,Overdose,32375884,10.1186/s40463-020-00425-6,2020-05-08
Infection,PROCESS_OF,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
"Analgesics, Opioid",ADMINISTERED_TO,user - individual,32375884,10.1186/s40463-020-00425-6,2020-05-08
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32375884,10.1186/s40463-020-00425-6,2020-05-08
Ablation,USES,Carbon Dioxide Lasers,32375845,10.1186/s13054-020-02911-9,2020-05-08
Carbon Dioxide Lasers,TREATS,Epistaxis,32375845,10.1186/s13054-020-02911-9,2020-05-08
Communicable Diseases,CAUSES,"Respiratory Distress Syndrome, Adult",32375787,10.1186/s12939-020-01181-9,2020-05-08
Lung Compliance,PROCESS_OF,Patients,32375787,10.1186/s12939-020-01181-9,2020-05-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32375787,10.1186/s12939-020-01181-9,2020-05-08
Adrenal Cortex Hormones,TREATS,Patients,32375787,10.1186/s12939-020-01181-9,2020-05-08
Adrenal Cortex Hormones,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32375787,10.1186/s12939-020-01181-9,2020-05-08
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32375787,10.1186/s12939-020-01181-9,2020-05-08
Disease,COEXISTS_WITH,Coronavirus Infections,32375487,10.1177/2048872620923639,2020-05-08
Oxygen,TREATS,Patients,32375487,10.1177/2048872620923639,2020-05-08
Therapeutic procedure,TREATS,Patients,32375487,10.1177/2048872620923639,2020-05-08
medical care,PROCESS_OF,Community,32375455,10.4178/epih.e2020026,2020-05-08
Infected,PROCESS_OF,Patients,32375446,10.3760/cma.j.cn112152-20200228-00146,2020-05-08
Malignant neoplasm of lung,PROCESS_OF,Patients,32375428,10.3760/cma.j.cn112141-20200302-00160,2020-05-08
Infected,PROCESS_OF,Cancer Patient,32375428,10.3760/cma.j.cn112141-20200302-00160,2020-05-08
Malignant neoplasm of lung,PROCESS_OF,Patients,32375428,10.3760/cma.j.cn112141-20200302-00160,2020-05-08
Malignant neoplasm of lung,PROCESS_OF,Patients,32375428,10.3760/cma.j.cn112141-20200302-00160,2020-05-08
Vaccines,PART_OF,Middle East Respiratory Syndrome Coronavirus,32375234,10.3390/biology9050094,2020-05-08
Virus,CAUSES,Disease,32375201,10.15252/emmm.202012634,2020-05-07
Virus,CAUSES(SPEC),Coronavirus Infections,32375201,10.15252/emmm.202012634,2020-05-07
Coronavirus Infections,ISA,Disease,32375201,10.15252/emmm.202012634,2020-05-07
SARS coronavirus,CAUSES,Disease,32375201,10.15252/emmm.202012634,2020-05-07
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32375201,10.15252/emmm.202012634,2020-05-07
Middle East Respiratory Syndrome Coronavirus,CAUSES,Disease,32375201,10.15252/emmm.202012634,2020-05-07
Middle East Respiratory Syndrome Coronavirus,CAUSES(SPEC),Coronavirus Infections,32375201,10.15252/emmm.202012634,2020-05-07
"Intubation, Intratracheal",TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32375197,10.1055/a-1164-9381,2020-05-07
Mediastinal Emphysema,PROCESS_OF,Patients,32375197,10.1055/a-1164-9381,2020-05-07
Pneumonia,PROCESS_OF,Patients,32375197,10.1055/a-1164-9381,2020-05-07
Disease,PREDISPOSES,Alveolar damage,32375197,10.1055/a-1164-9381,2020-05-07
Complication,PROCESS_OF,Cohort,32375197,10.1055/a-1164-9381,2020-05-07
Disease,COEXISTS_WITH,Acute illness,32375144,10.1159/000508254,2020-05-07
Symptoms,CAUSES,Cessation of life,32375144,10.1159/000508254,2020-05-07
"Kidney Failure, Acute",PROCESS_OF,Patients,32375144,10.1159/000508254,2020-05-07
Critical Illness,PROCESS_OF,Patients,32375144,10.1159/000508254,2020-05-07
Stress,PROCESS_OF,Patients,32375105,10.1016/j.scitotenv.2020.139086,2020-05-07
Congenital Abnormality,PART_OF,Patients,32375105,10.1016/j.scitotenv.2020.139086,2020-05-07
Fetal procedure,TREATS,Negative,32375105,10.1016/j.scitotenv.2020.139086,2020-05-07
Fetal procedure,TREATS,Severe Acute Respiratory Syndrome,32375105,10.1016/j.scitotenv.2020.139086,2020-05-07
Pregnant Women,LOCATION_OF,IMPACT gene,32375105,10.1016/j.scitotenv.2020.139086,2020-05-07
angiotensin converting enzyme 2,AFFECTS,Cardiovascular Physiological Phenomena,32375067,10.1016/j.scitotenv.2020.138959,2020-05-07
Cardiovascular injury,PROCESS_OF,Patients,32375067,10.1016/j.scitotenv.2020.138959,2020-05-07
Infected,PROCESS_OF,Persons,32375025,10.1016/j.cell.2020.04.031,2020-05-07
"Receptors, Cell Surface",AFFECTS,Membrane Fusion,32375011,10.1089/g4h.2020.0060,2020-05-07
Epitopes,DISRUPTS,receptor binding,32375011,10.1089/g4h.2020.0060,2020-05-07
mental health,PROCESS_OF,Persons,32375002,10.1021/acs.nanolett.0c01386,2020-05-07
Cholesterol derivative,PART_OF,NUSAP1 gene,32374942,10.1002/hed.26219,2020-05-07
Cholesterol,compared_with,Cholesterol,32374942,10.1002/hed.26219,2020-05-07
Tail,PART_OF,Vertebral column,32374942,10.1002/hed.26219,2020-05-07
Patient referral,USES,Metric,32374903,10.1111/ijcp.13525,2020-05-07
Triage,ADMINISTERED_TO,Patients,32374903,10.1111/ijcp.13525,2020-05-07
Viral Envelope Proteins,INTERACTS_WITH,Antibodies,32374901,10.1002/kjm2.12228,2020-05-07
Aspartate,LOCATION_OF,Mutation,32374901,10.1002/kjm2.12228,2020-05-07
Treatment Protocols,TREATS,Symptoms,32374886,10.4414/smw.2020.20277,2020-05-07
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32374884,10.1093/ehjqcco/qcaa036,2020-05-07
Decision,PROCESS_OF,Maker (occupation),32374884,10.1093/ehjqcco/qcaa036,2020-05-07
Cessation of life,PROCESS_OF,Physicians,32374823,10.1093/bioinformatics/btaa285,2020-05-07
Cessation of life,PROCESS_OF,Physicians,32374823,10.1093/bioinformatics/btaa285,2020-05-07
Prevotella,LOCATION_OF,sphingosine 1-phosphate,32374815,10.7326/M20-2003,2020-05-07
Infected,PROCESS_OF,Patients,32374815,10.7326/M20-2003,2020-05-07
Proteome,PART_OF,Homo sapiens,32374815,10.7326/M20-2003,2020-05-07
Proteome,PART_OF,Prevotella,32374815,10.7326/M20-2003,2020-05-07
Coronavirus Infections,CAUSES,Cessation of life,32374806,10.1590/0102-311X00054020,2020-05-07
Autopsy,DIAGNOSES,Confirmation,32374806,10.1590/0102-311X00054020,2020-05-07
Chronic disease,PROCESS_OF,Persons,32374718,10.2196/19601,2020-05-07
Intervention regimes,METHOD_OF,Prophylactic treatment,32374718,10.2196/19601,2020-05-07
spells (neurological symptom),PROCESS_OF,Patients,32374474,10.1111/jcmm.15360,2020-05-07
Communicable Diseases,PROCESS_OF,Patients,32374474,10.1111/jcmm.15360,2020-05-07
treatment options,CAUSES,Infection,32374466,10.1111/jgs.16539,2020-05-07
Pathogenic organism,LOCATION_OF,IMPACT gene,32374466,10.1111/jgs.16539,2020-05-07
IMPACT gene,AFFECTS,Immune system,32374466,10.1111/jgs.16539,2020-05-07
Interleukin-6,ISA,cytokine,32374466,10.1111/jgs.16539,2020-05-07
Interleukin-6,STIMULATES(SPEC),macrophage,32374466,10.1111/jgs.16539,2020-05-07
cytokine,STIMULATES,macrophage,32374466,10.1111/jgs.16539,2020-05-07
silvestrol,STIMULATES,MRC1 gene,32374466,10.1111/jgs.16539,2020-05-07
cytokine,COEXISTS_WITH,silvestrol,32374466,10.1111/jgs.16539,2020-05-07
silvestrol,DISRUPTS,Present,32374466,10.1111/jgs.16539,2020-05-07
silvestrol,AFFECTS,Immune Cell,32374466,10.1111/jgs.16539,2020-05-07
Focused attention,PROCESS_OF,Health Personnel,32374457,10.1002/jmv.25985,2020-05-07
Elderly (population group),LOCATION_OF,IMPACT gene,32374457,10.1002/jmv.25985,2020-05-07
Elderly (population group),LOCATION_OF,IMPACT gene,32374457,10.1002/jmv.25985,2020-05-07
Choice Behavior,PROCESS_OF,Persons,32374457,10.1002/jmv.25985,2020-05-07
Plasma membrane,PART_OF,Viral envelope,32374452,10.1002/jmv.25976,2020-05-07
Wall of endosome,PART_OF,Viral envelope,32374452,10.1002/jmv.25976,2020-05-07
Severe (severity modifier),PREDISPOSES,Virus Diseases,32374452,10.1002/jmv.25976,2020-05-07
Vero Cells,LOCATION_OF,Glycoproteins,32374452,10.1002/jmv.25976,2020-05-07
Cell surface,LOCATION_OF,Glycoproteins,32374452,10.1002/jmv.25976,2020-05-07
Structure of parenchyma of lung,PART_OF,Patients,32374452,10.1002/jmv.25976,2020-05-07
"Antibodies, Neutralizing",PART_OF,Extracellular,32374452,10.1002/jmv.25976,2020-05-07
Viracept,ISA,Nelfinavir Mesylate,32374452,10.1002/jmv.25976,2020-05-07
Nelfinavir,AFFECTS,Membrane Fusion,32374452,10.1002/jmv.25976,2020-05-07
Nelfinavir,DISRUPTS,Proteolytic Processing,32374452,10.1002/jmv.25976,2020-05-07
Chiroptera,LOCATION_OF,Glycoproteins,32374440,10.1111/jgs.16537,2020-05-07
Isolate - microorganism,PART_OF,Bat betacoronavirus,32374440,10.1111/jgs.16537,2020-05-07
Betacoronavirus,PROCESS_OF,Bos grunniens,32374440,10.1111/jgs.16537,2020-05-07
Betacoronavirus,PROCESS_OF,Bos grunniens,32374440,10.1111/jgs.16537,2020-05-07
Focused attention,PROCESS_OF,Health Personnel,32374427,10.1002/jmv.25981,2020-05-07
Decision,PROCESS_OF,Maker (occupation),32374427,10.1002/jmv.25981,2020-05-07
Conjunctival epithelial cell,PRODUCES,chemical cofactor,32374419,10.1111/his.14138,2020-05-07
Conjunctival epithelial cell,PRODUCES,angiotensin converting enzyme 2,32374419,10.1111/his.14138,2020-05-07
Patients,LOCATION_OF,Conjunctival specimen,32374419,10.1111/his.14138,2020-05-07
Study,USES,High-Throughput RNA Sequencing,32374419,10.1111/his.14138,2020-05-07
Conjunctival specimen,LOCATION_OF,angiotensin converting enzyme 2,32374419,10.1111/his.14138,2020-05-07
Infected,PROCESS_OF,Persons,32374416,10.1002/jmv.25978,2020-05-07
Pneumonia,PROCESS_OF,Patients,32374416,10.1002/jmv.25978,2020-05-07
Structure of parenchyma of lung,LOCATION_OF,Severe Acute Respiratory Syndrome,32374416,10.1002/jmv.25978,2020-05-07
Exudative inflammation,COEXISTS_WITH,Pneumonia,32374416,10.1002/jmv.25978,2020-05-07
Immune System Diseases,CAUSES,Pneumonia,32374416,10.1002/jmv.25978,2020-05-07
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,angiotensin converting enzyme 2,32374400,10.1001/jamanetworkopen.2020.8297,2020-05-07
Angiotensin II Type 1 Receptor Blockers,STIMULATES,angiotensin converting enzyme 2,32374400,10.1001/jamanetworkopen.2020.8297,2020-05-07
Critical Illness,PROCESS_OF,Patients,32374289,10.1515/jpm-2020-0174,2020-05-07
Disease Outbreaks,CAUSES,Infantile Neuroaxonal Dystrophy,32374289,10.1515/jpm-2020-0174,2020-05-07
Possible,PROCESS_OF,Population Group,32374264,10.2196/19199,2020-05-07
Coronavirus Infections,ISA,Disease,32374248,10.1017/S0950268820000977,2020-05-07
Disease,PROCESS_OF,Patients,32374248,10.1017/S0950268820000977,2020-05-07
Coronavirus Infections,ISA,Disease,32374248,10.1017/S0950268820000977,2020-05-07
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32374248,10.1017/S0950268820000977,2020-05-07
Hospitals,LOCATION_OF,Study,32374218,10.1080/03079457.2020.1761010,2020-05-07
Confirmation,PROCESS_OF,Patients,32374218,10.1080/03079457.2020.1761010,2020-05-07
Fatigue,ISA,Symptoms,32374218,10.1080/03079457.2020.1761010,2020-05-07
Antibiotics,TREATS,Patients,32374218,10.1080/03079457.2020.1761010,2020-05-07
Mechanical ventilation,TREATS,Patients,32374218,10.1080/03079457.2020.1761010,2020-05-07
Genus: Coronavirus,PROCESS_OF,Mammals,32374208,10.1089/vbz.2020.2650,2020-05-07
Infectious bronchitis virus,PROCESS_OF,Chickens,32374208,10.1089/vbz.2020.2650,2020-05-07
Disease,COEXISTS_WITH,Infectious bronchitis virus,32374208,10.1089/vbz.2020.2650,2020-05-07
Betacoronavirus,PROCESS_OF,Mammals,32374208,10.1089/vbz.2020.2650,2020-05-07
Cells,LOCATION_OF,Virus,32374208,10.1089/vbz.2020.2650,2020-05-07
Cells,PART_OF,Animals,32374208,10.1089/vbz.2020.2650,2020-05-07
Lesion,PROCESS_OF,Child,32374026,10.1111/bjh.16775,2020-05-07
Lesion,PROCESS_OF,Adolescent (age group),32374026,10.1111/bjh.16775,2020-05-07
Symptom mild,PROCESS_OF,Child,32374026,10.1111/bjh.16775,2020-05-07
Skin finding,PROCESS_OF,Child,32374026,10.1111/bjh.16775,2020-05-07
Thrombocytopenia,PROCESS_OF,Patients,32374024,10.5603/GP.2020.0045,2020-05-07
Interested,PROCESS_OF,Clinician,32374024,10.5603/GP.2020.0045,2020-05-07
Clinician,DIAGNOSES,Blood Coagulation Disorders,32374024,10.5603/GP.2020.0045,2020-05-07
Clinician,DIAGNOSES,Autoimmune thrombocytopenia,32374024,10.5603/GP.2020.0045,2020-05-07
Ultrasonic guidance procedure,DIAGNOSES,Pneumonia,32374001,10.26355/eurrev_202004_21047,2020-05-07
Lung,LOCATION_OF,Ultrasonography,32374001,10.26355/eurrev_202004_21047,2020-05-07
gene therapy,AFFECTS,Patients,32374000,10.26355/eurrev_202004_21046,2020-05-07
Infected,PROCESS_OF,Patients,32374000,10.26355/eurrev_202004_21046,2020-05-07
Diagnosis,AFFECTS,Virus Diseases,32374000,10.26355/eurrev_202004_21046,2020-05-07
Infected,PROCESS_OF,Patients,32374000,10.26355/eurrev_202004_21046,2020-05-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32373996,10.26355/eurrev_202004_21042,2020-05-07
Antiviral Administration,NEG_TREATS,Child,32373996,10.26355/eurrev_202004_21042,2020-05-07
Oseltamivir,TREATS,Coronavirus Infections,32373996,10.26355/eurrev_202004_21042,2020-05-07
Adult,LOCATION_OF,"CD69 protein, human",32373996,10.26355/eurrev_202004_21042,2020-05-07
Child,LOCATION_OF,"CD69 protein, human",32373996,10.26355/eurrev_202004_21042,2020-05-07
Coronavirus Infections,ISA,Disease,32373995,10.26355/eurrev_202004_21041,2020-05-07
Coronavirus Infections,ISA,Disease,32373995,10.26355/eurrev_202004_21041,2020-05-07
Pharmaceutical Preparations,AFFECTS,Life Threatening,32373993,10.26355/eurrev_202004_21038,2020-05-07
Pharmaceutical Preparations,INTERACTS_WITH,"Receptors, Cell Surface",32373993,10.26355/eurrev_202004_21038,2020-05-07
Chloroquine,TREATS,Malaria,32373992,10.26355/eurrev_202004_21037,2020-05-07
"CD69 protein, human",ASSOCIATED_WITH,Malaria,32373992,10.26355/eurrev_202004_21037,2020-05-07
Hydroxychloroquine,ISA,Chloroquine,32373992,10.26355/eurrev_202004_21037,2020-05-07
Chloroquine,TREATS,Infection,32373992,10.26355/eurrev_202004_21037,2020-05-07
Hydroxychloroquine,TREATS,Infection,32373992,10.26355/eurrev_202004_21037,2020-05-07
Malaria,ISA,Infection,32373992,10.26355/eurrev_202004_21037,2020-05-07
Infection,COEXISTS_WITH,Malaria,32373992,10.26355/eurrev_202004_21037,2020-05-07
Pharmaceutical Preparations,ADMINISTERED_TO,Persons,32373992,10.26355/eurrev_202004_21037,2020-05-07
Pharmaceutical Preparations,TREATS,Malaria,32373992,10.26355/eurrev_202004_21037,2020-05-07
Pharmaceutical Preparations,TREATS,Crisis,32373992,10.26355/eurrev_202004_21037,2020-05-07
Virus,INTERACTS_WITH,Animals,32373990,10.26355/eurrev_202004_21035,2020-05-07
China,ISA,Country,32373990,10.26355/eurrev_202004_21035,2020-05-07
Italy,ISA,Country,32373990,10.26355/eurrev_202004_21035,2020-05-07
Plants,LOCATION_OF,Phytochemicals,32373990,10.26355/eurrev_202004_21035,2020-05-07
tomography,ISA,Radiographic imaging procedure,32373989,10.26355/eurrev_202004_21034,2020-05-07
Chest CT,AFFECTS,Hypersensitivity,32373989,10.26355/eurrev_202004_21034,2020-05-07
"Hand, Foot and Mouth Disease",ISA,Disease,32373791,10.1016/j.jaccas.2020.04.027,2020-05-07
RISK-TAKING BEHAVIOR,PREDISPOSES,cardiovascular risk factor,32373789,10.1002/anr3.12041,2020-05-07
Awake intubation,TREATS,Patients,32373721,10.1016/j.ctro.2020.04.006,2020-05-07
Tracheostomy procedure,ISA,Operative Surgical Procedures,32373721,10.1016/j.ctro.2020.04.006,2020-05-07
Conscious Sedation,USES,remifentanil,32373721,10.1016/j.ctro.2020.04.006,2020-05-07
Respiration Disorders,PROCESS_OF,Patients,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
Malaise,PROCESS_OF,Patients,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
inflammatory response,PROCESS_OF,Patients,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
Low Dose Radiation Therapy,AFFECTS,Pneumonia,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
Disease,PREDISPOSES,Pneumonia,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
Disease,PROCESS_OF,Patients,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
Therapeutic procedure,NEG_ADMINISTERED_TO,Foundation for the Accreditation of Cellular Therapy,32373705,10.1016/j.onehlt.2020.100137,2020-05-07
patient care,PREVENTS,Cross Infection,32373652,10.1002/mdc3.12965,2020-05-07
Chronically Ill,PROCESS_OF,Patients,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Parkinson Disease,PROCESS_OF,Patients,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Fragility,PROCESS_OF,Patients,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Movement Disorders,PROCESS_OF,Neurologists,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Movement Disorders,PROCESS_OF,Neurologists,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Parkinson Disease,PROCESS_OF,Patients,32373467,10.1016/j.idcr.2020.e00774,2020-05-07
Fever,PROCESS_OF,Patients,32373461,10.1016/j.jece.2020.104006,2020-05-07
Nose,LOCATION_OF,Pharyngeal Swabs,32373461,10.1016/j.jece.2020.104006,2020-05-07
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32373461,10.1016/j.jece.2020.104006,2020-05-07
Malaise,PROCESS_OF,Patients,32373461,10.1016/j.jece.2020.104006,2020-05-07
Mucous Membrane,PART_OF,conjunctiva,32373461,10.1016/j.jece.2020.104006,2020-05-07
Health Personnel,NEG_DIAGNOSES,Symptoms,32373461,10.1016/j.jece.2020.104006,2020-05-07
Infected,PROCESS_OF,Persons,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Water,ISA,Chemicals,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Contact Dermatitis,PROCESS_OF,Persons,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Dry skin,PROCESS_OF,Persons,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Hand,LOCATION_OF,Eczema,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Hand,LOCATION_OF,sanitizers,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Adverse event,NEG_PROCESS_OF,Persons,32373394,10.1016/j.scib.2020.04.043,2020-05-07
Cessation of life,AFFECTS,Age,32373339,10.7189/jogh.10.011003,2020-05-07
Cessation of life,PROCESS_OF,Persons,32373339,10.7189/jogh.10.011003,2020-05-07
Cessation of life,AFFECTS,Elderly (population group),32373339,10.7189/jogh.10.011003,2020-05-07
Severe (severity modifier),PREDISPOSES,Disease Outcome,32373183,10.7573/dic.2020-4-5,2020-05-07
Chloroquine,TREATS,Malaria,32373061,10.3389/fneur.2020.00353,2020-05-07
Coronavirus Infections,ISA,Disease,32373061,10.3389/fneur.2020.00353,2020-05-07
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32372892,10.1007/s11469-020-00277-1,2020-05-07
Middle Cerebral Artery Syndrome,PROCESS_OF,Patients,32372892,10.1007/s11469-020-00277-1,2020-05-07
Breath,ASSOCIATED_WITH(INFER),Infected,32372857,10.1186/s41983-020-00177-0,2020-05-07
Breath,PART_OF,Persons,32372857,10.1186/s41983-020-00177-0,2020-05-07
Infected,PROCESS_OF,Persons,32372857,10.1186/s41983-020-00177-0,2020-05-07
Infected,PROCESS_OF,Persons,32372857,10.1186/s41983-020-00177-0,2020-05-07
Sodium Chloride,COMPLICATES,Filtration process,32372857,10.1186/s41983-020-00177-0,2020-05-07
Multiple Sclerosis,PROCESS_OF,Patients,32372852,10.1016/j.jor.2020.04.006,2020-05-07
Shock,COEXISTS_WITH,Affected Area,32372840,10.1016/S0262-4079(20)30858-7,2020-05-07
Minority Groups,ISA,Ethnic group,32372821,10.1016/S0262-4079(20)30788-0,2020-05-07
Coronavirus Infections,ISA,Disease,32372754,10.2807/1560-7917.ES.2020.25.17.2000556,2020-05-07
patient condition,COEXISTS_WITH,Communicable Diseases,32372753,10.2807/1560-7917.ES.2020.25.17.2000596,2020-05-07
patient condition,COEXISTS_WITH,Tropical Disease,32372753,10.2807/1560-7917.ES.2020.25.17.2000596,2020-05-07
Coronavirus Infections,ISA,Disease,32372695,10.1177/2048872620922784,2020-05-07
Disease,NEG_PROCESS_OF,Patients,32372695,10.1177/2048872620922784,2020-05-07
Coronavirus Infections,ISA,Disease,32372695,10.1177/2048872620922784,2020-05-07
Coronavirus Infections,NEG_PROCESS_OF(SPEC),Patients,32372695,10.1177/2048872620922784,2020-05-07
Coronavirus Infections,ISA,Disease,32372695,10.1177/2048872620922784,2020-05-07
Coronavirus Infections,ISA,Disease,32372664,10.1177/0840470420921542,2020-05-07
Coronavirus Infections,PROCESS_OF,Persons,32372664,10.1177/0840470420921542,2020-05-07
Heart,LOCATION_OF,Adverse effects,32372664,10.1177/0840470420921542,2020-05-07
Heart Injuries,PROCESS_OF,Patients,32372664,10.1177/0840470420921542,2020-05-07
Myocardium,LOCATION_OF,Toxic effect,32372664,10.1177/0840470420921542,2020-05-07
Agent,CAUSES,Toxic effect,32372664,10.1177/0840470420921542,2020-05-07
lopinavir / Ritonavir,AFFECTS,QT interval:Time:Point in time:Heart:Quantitative:EKG,32372664,10.1177/0840470420921542,2020-05-07
favipiravir,AFFECTS,QT interval:Time:Point in time:Heart:Quantitative:EKG,32372664,10.1177/0840470420921542,2020-05-07
Antibiotics,TREATS,Patients,32372664,10.1177/0840470420921542,2020-05-07
Azithromycin,AFFECTS,QT interval:Time:Point in time:Heart:Quantitative:EKG,32372664,10.1177/0840470420921542,2020-05-07
Heart,LOCATION_OF,Adverse effects,32372664,10.1177/0840470420921542,2020-05-07
contextual factors,PROCESS_OF,Outpatients,32372664,10.1177/0840470420921542,2020-05-07
Take,TREATS,inpatient,32372664,10.1177/0840470420921542,2020-05-07
Take,TREATS,Outpatients,32372664,10.1177/0840470420921542,2020-05-07
Diabetes,ISA,Disease,32372178,10.1007/s11060-020-03523-7,2020-05-07
Diabetes,PREDISPOSES(SPEC),Severe course,32372178,10.1007/s11060-020-03523-7,2020-05-07
Disease,PREDISPOSES,Severe course,32372178,10.1007/s11060-020-03523-7,2020-05-07
Hypertensive disease,ISA,Disease,32372178,10.1007/s11060-020-03523-7,2020-05-07
Hypertensive disease,PREDISPOSES(SPEC),Severe course,32372178,10.1007/s11060-020-03523-7,2020-05-07
Adrenal gland hypofunction,CAUSES,Diabetes Mellitus,32372178,10.1007/s11060-020-03523-7,2020-05-07
Diabetes Mellitus,ISA,Endocrine System Diseases,32372178,10.1007/s11060-020-03523-7,2020-05-07
Diabetes Mellitus,PROCESS_OF(SPEC),Patients,32372178,10.1007/s11060-020-03523-7,2020-05-07
Endocrine System Diseases,PROCESS_OF,Patients,32372178,10.1007/s11060-020-03523-7,2020-05-07
Hypopituitarism,CAUSES,Diabetes Mellitus,32372178,10.1007/s11060-020-03523-7,2020-05-07
Endocrine System Diseases,PROCESS_OF,Patients,32372178,10.1007/s11060-020-03523-7,2020-05-07
Challenge,TREATS,Patients,32372077,10.1093/occmed/kqaa074,2020-05-07
Day Care Centers for Children,LOCATION_OF,Cross-Sectional Studies,32372072,10.1093/ptj/pzaa089,2020-05-07
Sleep disturbances,PROCESS_OF,Participant,32372072,10.1093/ptj/pzaa089,2020-05-07
Sleep disturbances,PROCESS_OF,Health Personnel,32372072,10.1093/ptj/pzaa089,2020-05-07
Functional Limitation,PROCESS_OF,Elderly (population group),32372051,10.1038/s10038-020-0771-5,2020-05-07
Elderly (population group),LOCATION_OF,IMPACT gene,32372051,10.1038/s10038-020-0771-5,2020-05-07
AKR1A1 wt Allele,CONVERTS_TO,IMPACT gene,32372051,10.1038/s10038-020-0771-5,2020-05-07
Program,TREATS,Elderly (population group),32372051,10.1038/s10038-020-0771-5,2020-05-07
Program,TREATS,Elderly (population group),32372051,10.1038/s10038-020-0771-5,2020-05-07
DNA Sequence,CONVERTS_TO,Epitopes,32372026,10.1038/s41375-020-0848-3,2020-05-07
Screening procedure,TREATS,Population Group,32372026,10.1038/s41375-020-0848-3,2020-05-07
HLA class I,STIMULATES,CD8A wt Allele,32372026,10.1038/s41375-020-0848-3,2020-05-07
Duration,COEXISTS_WITH,Adrenal Cortex Hormones,32371988,10.1038/s41430-020-0646-z,2020-05-07
Infected,PROCESS_OF,Persons,32371934,10.1038/s41591-020-0843-2,2020-05-07
Vigorous physical activity,PREVENTS,"Arteriosclerotic cardiovascular disease, NOS",32371934,10.1038/s41591-020-0843-2,2020-05-07
Healthy Diet,PRECEDES,Quarantine,32371934,10.1038/s41591-020-0843-2,2020-05-07
Acute illness,PROCESS_OF,Adult,32371823,10.1213/XAA.0000000000001227,2020-05-07
Acute illness,PROCESS_OF,Child,32371823,10.1213/XAA.0000000000001227,2020-05-07
Complication,AFFECTS,Persons,32371611,10.1097/CCM.0000000000004411,2020-05-07
Telemedicine,METHOD_OF,Rehabilitation therapy,32371611,10.1097/CCM.0000000000004411,2020-05-07
contextual factors,PROCESS_OF,Outpatients,32371611,10.1097/CCM.0000000000004411,2020-05-07
Cardiac Arrest,PROCESS_OF,Patients,32371574,10.1136/bmjgh-2020-002553,2020-05-07
Symptoms,PROCESS_OF,Patients,32371574,10.1136/bmjgh-2020-002553,2020-05-07
Cessation of life,PROCESS_OF,Survivors,32371574,10.1136/bmjgh-2020-002553,2020-05-07
Face,LOCATION_OF,Protection,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Face,LOCATION_OF,Protection,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Face,LOCATION_OF,Protection,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Face,LOCATION_OF,Protection,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Face,LOCATION_OF,Protection,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Coronavirus Infections,ISA,Disease,32371564,10.3949/ccjm.87a.ccc013,2020-05-07
Cardiovascular Diseases,PREDISPOSES,Severe disorder,32371563,10.3949/ccjm.87a.ccc002,2020-05-07
Diabetes Mellitus,PREDISPOSES,Severe disorder,32371563,10.3949/ccjm.87a.ccc002,2020-05-07
Hypertensive disease,PREDISPOSES,Severe disorder,32371563,10.3949/ccjm.87a.ccc002,2020-05-07
Chronic Obstructive Airway Disease,PREDISPOSES,Severe disorder,32371563,10.3949/ccjm.87a.ccc002,2020-05-07
Severe asthma,PREDISPOSES,Severe disorder,32371562,10.3949/ccjm.87a.ccc005,2020-05-07
Asthma,PROCESS_OF,Patients,32371562,10.3949/ccjm.87a.ccc005,2020-05-07
Inhaler,USES,Controllers,32371562,10.3949/ccjm.87a.ccc005,2020-05-07
Therapeutic procedure,USES,Nebulizers,32371562,10.3949/ccjm.87a.ccc005,2020-05-07
Cystic Fibrosis,PROCESS_OF,Patients,32371561,10.3949/ccjm.87a.ccc006,2020-05-07
Cystic Fibrosis,PROCESS_OF,Patients,32371561,10.3949/ccjm.87a.ccc006,2020-05-07
Lung,LOCATION_OF,Exacerbation,32371561,10.3949/ccjm.87a.ccc006,2020-05-07
Telemedicine,TREATS,Outpatients,32371561,10.3949/ccjm.87a.ccc006,2020-05-07
ivacaftor,INHIBITS,Exacerbation,32371561,10.3949/ccjm.87a.ccc006,2020-05-07
Asymptomatic,PROCESS_OF,Patients,32371559,10.3949/ccjm.87a.ccc010,2020-05-07
Hydroxychloroquine,TREATS,Patients,32371557,10.3949/ccjm.87a.ccc001,2020-05-07
Hydroxychloroquine,TREATS,Patients,32371557,10.3949/ccjm.87a.ccc001,2020-05-07
treatment options,TREATS,myocardial injury,32371556,10.3949/ccjm.87a.ccc012,2020-05-07
myocardial injury,PROCESS_OF,Patients,32371556,10.3949/ccjm.87a.ccc012,2020-05-07
Critical Illness,PROCESS_OF,Patients,32371555,10.3949/ccjm.87a.ccc014,2020-05-07
Hyperglycemia,PROCESS_OF,Patients,32371555,10.3949/ccjm.87a.ccc014,2020-05-07
Critical Illness,PROCESS_OF,Patients,32371555,10.3949/ccjm.87a.ccc014,2020-05-07
Protection,PROCESS_OF,Caregiver,32371555,10.3949/ccjm.87a.ccc014,2020-05-07
Extracorporeal Membrane Oxygenation,TREATS,Patients,32371551,10.1158/1055-9965.EPI-20-0606,2020-05-07
Safety precautions,TREATS,Health Personnel,32371551,10.1158/1055-9965.EPI-20-0606,2020-05-07
Symptoms,PROCESS_OF,tracker,32371536,10.1681/ASN.2020040432,2020-05-07
Rheumatic Fever,PREDISPOSES,Prognosis bad,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Kidney,LOCATION_OF,Direct Contact Transmission Infection,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Kidney Failure,COMPLICATES,Dissection of aorta,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Respiratory Failure,COMPLICATES,Dissection of aorta,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Microscopy,DIAGNOSES,Vacuolation,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Kidney,LOCATION_OF,Direct Contact Transmission Infection,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Virus,PROCESS_OF,Persons,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Renal Tubule Epithelium,LOCATION_OF,Virus,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Kidney,LOCATION_OF,Direct Contact Transmission Infection,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
Vacuolation,PREDISPOSES,Severe Acute Respiratory Syndrome,32371479,10.1158/2159-8290.CD-ND2020-008,2020-05-07
tocilizumab,TREATS,Toxic effect,32371477,10.1126/science.abc0473,2020-05-07
Storm NOS,PROCESS_OF,Persons,32371477,10.1126/science.abc0473,2020-05-07
Symptoms,PROCESS_OF,tracker,32371472,10.1128/mSystems.00266-20,2020-05-07
SARS coronavirus,CAUSES,Disease,32371466,10.1136/bmj.m1642,2020-05-07
SARS coronavirus,LOCATION_OF,"Protein, Organized by Structure",32371466,10.1136/bmj.m1642,2020-05-07
Isolate - microorganism,ADMINISTERED_TO,Population Group,32371466,10.1136/bmj.m1642,2020-05-07
Infected,PROCESS_OF,Family member,32371463,10.1136/fmch-2020-000406,2020-05-07
Caring,PROCESS_OF,Staff,32371463,10.1136/fmch-2020-000406,2020-05-07
psychological distress,AFFECTS,Caring,32371463,10.1136/fmch-2020-000406,2020-05-07
Intervention regimes,AFFECTS,Protection,32371463,10.1136/fmch-2020-000406,2020-05-07
Fever,ISA,Symptoms,32371418,10.7861/clinmed.2020-0149,2020-05-07
Infected,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Infected,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Coughing,ISA,Symptoms,32371418,10.7861/clinmed.2020-0149,2020-05-07
Fever,ISA,Symptoms,32371418,10.7861/clinmed.2020-0149,2020-05-07
Anorexia,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Dyspnea,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Myalgia,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Chest tightness,PROCESS_OF,Patients,32371418,10.7861/clinmed.2020-0149,2020-05-07
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32371417,10.7861/clinmed.2020-0182,2020-05-07
Brain Stem,LOCATION_OF,Inflammation,32371416,10.1136/bcr-2020-235302,2020-05-07
Cervical segment of spinal cord,LOCATION_OF,Inflammation,32371416,10.1136/bcr-2020-235302,2020-05-07
Methylprednisolone,TREATS,Patients,32371403,10.1136/postgradmedj-2020-137828,2020-05-07
Oseltamivir,TREATS,Patients,32371403,10.1136/postgradmedj-2020-137828,2020-05-07
Current Therapy,TREATS,Pneumonia,32371403,10.1136/postgradmedj-2020-137828,2020-05-07
Zoonoses,ISA,Infection,32371362,10.1016/j.mehy.2020.109769,2020-05-07
Disease,PROCESS_OF,Patients,32371331,10.1016/j.jclinane.2020.109854,2020-05-07
General Anesthesia,TREATS,Patients,32371231,10.1016/j.scitotenv.2020.138875,2020-05-07
Infected,PROCESS_OF,Persons,32371230,10.1016/j.scitotenv.2020.138996,2020-05-07
Therapeutic procedure,PREVENTS,Coronavirus Infections,32371192,10.1016/j.ijid.2020.04.078,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Coitus,NEG_OCCURS_IN,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Fibrinogen,TREATS,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Fibrinogen,TREATS(INFER),Pneumonia,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Influenza,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Pneumonia,PROCESS_OF,Patients,32371150,10.1016/j.trim.2020.101304,2020-05-07
Organ,LOCATION_OF,Terminal illness,32371096,10.1016/j.ijantimicag.2020.106006,2020-05-07
Terminal illness,PROCESS_OF,Child,32371096,10.1016/j.ijantimicag.2020.106006,2020-05-07
Terminal illness,PROCESS_OF,Young Adult,32371096,10.1016/j.ijantimicag.2020.106006,2020-05-07
Single organ dysfunction,PROCESS_OF,Child,32371096,10.1016/j.ijantimicag.2020.106006,2020-05-07
Diarrhea,ISA,Symptoms,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Diarrhea,PROCESS_OF(SPEC),Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Hospitals,LOCATION_OF,Retrospective Studies,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Symptoms,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Diarrhea,ISA,Symptoms,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Diarrhea,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Diarrhea,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Diarrhea,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Gastrointestinal symptom,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Abdominal Pain,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
Nausea,PROCESS_OF,Patients,32370986,10.1016/j.ando.2020.04.005,2020-05-07
ACE2 gene,INHIBITS,angiotensin II,32370984,10.1016/j.encep.2020.04.008,2020-05-07
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,"Animals, Laboratory",32370984,10.1016/j.encep.2020.04.008,2020-05-07
ACE2 gene,PART_OF,soluble,32370984,10.1016/j.encep.2020.04.008,2020-05-07
Emotional Adjustment,ISA,mental health,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Cessation of life,PROCESS_OF,Health Personnel,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Uncertainty,PROCESS_OF,Health Personnel,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Infected,PROCESS_OF,Persons,32370983,10.1016/j.encep.2020.04.007,2020-05-07
disease characteristic,PREDISPOSES,psychological distress,32370983,10.1016/j.encep.2020.04.007,2020-05-07
disease characteristic,PREDISPOSES,Symptoms,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Critical Illness,PROCESS_OF,Patients,32370983,10.1016/j.encep.2020.04.007,2020-05-07
risk factors,PROCESS_OF,Health Personnel,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Stress,PREDISPOSES,High Level,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Physical and emotional exhaustion state,PREDISPOSES,High Level,32370983,10.1016/j.encep.2020.04.007,2020-05-07
mental health,PROCESS_OF,Health Personnel,32370983,10.1016/j.encep.2020.04.007,2020-05-07
Mental disorders,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Memory observations,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Mental disorders,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Mental disorders,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Comorbidity,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Initiative,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
acute psychosis,PROCESS_OF,Patients,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Possible,PREDISPOSES,Suicide,32370981,10.1016/j.encep.2020.04.004,2020-05-07
Airborne precautions,TREATS,patient condition,32370923,10.1016/j.arth.2020.04.057,2020-05-07
"CD69 protein, human",AFFECTS,Bone structure of ischium,32370766,10.1186/s40779-020-00251-x,2020-05-07
"CD69 protein, human",AFFECTS,Knee,32370766,10.1186/s40779-020-00251-x,2020-05-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32370766,10.1186/s40779-020-00251-x,2020-05-07
Infected,PROCESS_OF,Persons,32370758,10.1186/s12967-020-02355-3,2020-05-07
Investigational New Drugs,TREATS,Critical Illness,32370758,10.1186/s12967-020-02355-3,2020-05-07
"Therapies, Investigational",TREATS,patient condition,32370758,10.1186/s12967-020-02355-3,2020-05-07
"Hospitals, Pediatric",LOCATION_OF,Study,32370621,10.1177/1359105320925148,2020-05-07
Lymphopenia,PROCESS_OF,Patients,32370621,10.1177/1359105320925148,2020-05-07
Posterior segment,LOCATION_OF,Lesion,32370621,10.1177/1359105320925148,2020-05-07
Computed tomography result abnormal,PROCESS_OF,Patients,32370621,10.1177/1359105320925148,2020-05-07
lobe,LOCATION_OF,Lesion,32370621,10.1177/1359105320925148,2020-05-07
Chest CT,ADMINISTERED_TO,Patients,32370621,10.1177/1359105320925148,2020-05-07
Poor outcome,COEXISTS_WITH,Diabetes,32370577,10.1080/23744235.2020.1759817,2020-05-07
Poor outcome,PROCESS_OF,hospitalized patients,32370577,10.1080/23744235.2020.1759817,2020-05-07
Diabetes,PROCESS_OF,Patients,32370577,10.1080/23744235.2020.1759817,2020-05-07
Coronavirus Infections,PROCESS_OF,Patients,32370577,10.1080/23744235.2020.1759817,2020-05-07
Poor outcome,PROCESS_OF,Patients,32370577,10.1080/23744235.2020.1759817,2020-05-07
Screening procedure,AFFECTS,Uncertainty,32370558,10.1177/2324709620925571,2020-05-07
Patient identification,METHOD_OF,Point-of-Care Testing,32370558,10.1177/2324709620925571,2020-05-07
Communicable Diseases,AFFECTS,Patients,32370525,10.4102/phcfm.v12i1.2466,2020-05-07
Atrial Fibrillation,AFFECTS,Rhythm,32370525,10.4102/phcfm.v12i1.2466,2020-05-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
"Pneumonia, Viral",PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
Leukopenia,PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
Lymphopenia,PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
Eosinopenia,PROCESS_OF,Patients,32370275,10.3390/ijerph17093181,2020-05-07
Coronavirus Infections,ISA,Disease,32370269,10.3390/jcm9051321,2020-05-07
viral transmission,AFFECTS,Physicians,32370269,10.3390/jcm9051321,2020-05-07
Coronavirus Infections,ISA,Disease,32370204,10.3390/ijerph17093176,2020-05-07
Medical Examination,ADMINISTERED_TO,Patients,32370128,10.3390/tropicalmed5020068,2020-05-07
Enzyme-Linked Immunosorbent Assay,ISA,Laboratory Procedures,32370116,10.3390/ijerph17093165,2020-05-07
Laboratory Procedures,USES,Enzyme-Linked Immunosorbent Assay,32370116,10.3390/ijerph17093165,2020-05-07
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32370116,10.3390/ijerph17093165,2020-05-07
Dengue Fever,PROCESS_OF,Patients,32370116,10.3390/ijerph17093165,2020-05-07
Fever,PROCESS_OF,Patients,32370116,10.3390/ijerph17093165,2020-05-07
Dengue Fever,OCCURS_IN,Patients,32370116,10.3390/ijerph17093165,2020-05-07
Fever,PROCESS_OF,Patients,32370116,10.3390/ijerph17093165,2020-05-07
psychological distress,PROCESS_OF,general population,32370069,10.3390/ijerph17093161,2020-05-07
SARS coronavirus,CAUSES,Disease,32370065,10.3390/ijms21093216,2020-05-07
Coronavirus Infections,ISA,Disease,32369865,10.1002/pds.5029,2020-05-06
Cardiovascular Diseases,OCCURS_IN,Patients,32369865,10.1002/pds.5029,2020-05-06
research,USES,Interventional procedure,32369770,10.1530/EJE-20-0473,2020-05-06
Pituitary Neoplasms,PROCESS_OF,Patients,32369759,10.2196/19161,2020-05-06
Comorbidity,PROCESS_OF,Patients,32369759,10.2196/19161,2020-05-06
Pituitary Neoplasms,PROCESS_OF,Patients,32369759,10.2196/19161,2020-05-06
Diagnosis,DIAGNOSES,Enthesitis-Related Arthritis,32369759,10.2196/19161,2020-05-06
Coronavirus Infections,ISA,Disease,32369736,10.1016/j.cmet.2020.04.021,2020-05-06
Coronavirus Infections,ISA,Disease,32369736,10.1016/j.cmet.2020.04.021,2020-05-06
Coronavirus Infections,ISA,Disease,32369736,10.1016/j.cmet.2020.04.021,2020-05-06
Cross-Sectional Studies,USES,Masks,32369736,10.1016/j.cmet.2020.04.021,2020-05-06
Coronavirus Infections,ISA,Disease,32369736,10.1016/j.cmet.2020.04.021,2020-05-06
"Diabetes Mellitus, Non-Insulin-Dependent",COEXISTS_WITH,Severe (severity modifier),32369678,10.1111/andr.12811,2020-05-06
Medical procedure,TREATS,Patients,32369678,10.1111/andr.12811,2020-05-06
Organ,LOCATION_OF,Multiple Trauma,32369678,10.1111/andr.12811,2020-05-06
diabetic,NEG_PROCESS_OF,Persons,32369678,10.1111/andr.12811,2020-05-06
Blood Glucose,compared_with,Blood Glucose,32369678,10.1111/andr.12811,2020-05-06
Complication,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32369675,10.1111/odi.13383,2020-05-06
Complication,PROCESS_OF,Male population group,32369675,10.1111/odi.13383,2020-05-06
Venous Thromboembolism,PROCESS_OF,hospitalized patients,32369658,10.1111/liv.14506,2020-05-06
vinyltriethoxysilane,CAUSES,High Level,32369658,10.1111/liv.14506,2020-05-06
Communicable Diseases,CAUSES,"Signs and Symptoms, Respiratory",32369656,10.1111/1471-0528.16276,2020-05-06
Abdominal Pain,PROCESS_OF,Woman,32369656,10.1111/1471-0528.16276,2020-05-06
Diarrhea,PROCESS_OF,Woman,32369656,10.1111/1471-0528.16276,2020-05-06
Fever,PROCESS_OF,Woman,32369656,10.1111/1471-0528.16276,2020-05-06
Acute-On-Chronic Liver Failure,PROCESS_OF,Woman,32369656,10.1111/1471-0528.16276,2020-05-06
Antibiotics,TREATS,Patients,32369656,10.1111/1471-0528.16276,2020-05-06
Supportive care,TREATS,Patients,32369656,10.1111/1471-0528.16276,2020-05-06
Milk (body substance),PART_OF,Woman,32369646,10.1111/den.13712,2020-05-06
Pharyngeal structure,PART_OF,"Infant, Newborn",32369646,10.1111/den.13712,2020-05-06
Woman,LOCATION_OF,Milk (body substance),32369646,10.1111/den.13712,2020-05-06
Vaginal secretions,PART_OF,Woman,32369646,10.1111/den.13712,2020-05-06
Infected,PROCESS_OF,Pregnant Women,32369646,10.1111/den.13712,2020-05-06
Infected,PROCESS_OF,Woman,32369646,10.1111/den.13712,2020-05-06
Coronavirus Infections,NEG_PROCESS_OF,"Infant, Newborn",32369646,10.1111/den.13712,2020-05-06
Breast Feeding,PROCESS_OF,Pregnant Women,32369646,10.1111/den.13712,2020-05-06
Specimen from breast,LOCATION_OF,Breast Feeding,32369646,10.1111/den.13712,2020-05-06
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32369634,10.1111/dme.14317,2020-05-06
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32369634,10.1111/dme.14317,2020-05-06
Advice,TREATS,Patients,32369634,10.1111/dme.14317,2020-05-06
Advice,TREATS(INFER),Inflammatory Bowel Diseases,32369634,10.1111/dme.14317,2020-05-06
terminal patient care,TREATS,Hyperglycemia,32369632,10.1111/ced.14275,2020-05-06
Foot care,TREATS,Hyperglycemia,32369632,10.1111/ced.14275,2020-05-06
Consultation,TREATS,Chilblains,32369624,10.1002/hep.31307,2020-05-06
Alcohol Use Disorder,PROCESS_OF,Patients,32369611,10.1111/anae.15112,2020-05-06
Alcoholic Liver Diseases,PROCESS_OF,Patients,32369611,10.1111/anae.15112,2020-05-06
Liver,LOCATION_OF,Comorbidity,32369611,10.1111/anae.15112,2020-05-06
Coronavirus Infections,AFFECTS,Decompensation,32369611,10.1111/anae.15112,2020-05-06
Liver,LOCATION_OF,associated disease,32369611,10.1111/anae.15112,2020-05-06
Hospital admission,TREATS,Patients,32369611,10.1111/anae.15112,2020-05-06
Hospital admission,TREATS,associated disease,32369611,10.1111/anae.15112,2020-05-06
Liver diseases,PROCESS_OF,Patients,32369611,10.1111/anae.15112,2020-05-06
Airway Management,TREATS,Patients,32369601,10.1093/neuonc/noaa113,2020-05-06
Thoracic Injuries,PROCESS_OF,Patients,32369601,10.1093/neuonc/noaa113,2020-05-06
Malignant neoplasm of lung,PROCESS_OF,Patients,32369601,10.1093/neuonc/noaa113,2020-05-06
Thoracic Surgical Procedures,TREATS,Patients,32369601,10.1093/neuonc/noaa113,2020-05-06
Thoracic Surgical Procedures,TREATS(INFER),Thoracic Injuries,32369601,10.1093/neuonc/noaa113,2020-05-06
Thoracic Surgical Procedures,TREATS(INFER),Malignant neoplasm of lung,32369601,10.1093/neuonc/noaa113,2020-05-06
Airway Management,TREATS,surgical patients,32369601,10.1093/neuonc/noaa113,2020-05-06
Equilibrium,PROCESS_OF,Physicians,32369541,10.7326/M20-1632,2020-05-06
Neurosurgeon,TREATS,Patients,32369541,10.7326/M20-1632,2020-05-06
Malignant Glioma,PROCESS_OF,Patients,32369541,10.7326/M20-1632,2020-05-06
Malignant Glioma,PROCESS_OF,Patients,32369541,10.7326/M20-1632,2020-05-06
interdisciplinary collaboration,TREATS,Patients,32369541,10.7326/M20-1632,2020-05-06
Coronavirus Infections,COEXISTS_WITH,Disease,32369479,10.1371/journal.pmed.1003127,2020-05-06
Coronavirus Infections,ISA,Disease,32369479,10.1371/journal.pmed.1003127,2020-05-06
Coronavirus Infections,PROCESS_OF,Health Personnel,32369479,10.1371/journal.pmed.1003127,2020-05-06
Anxiety,PROCESS_OF,Health Personnel,32369479,10.1371/journal.pmed.1003127,2020-05-06
Depressive disorder,PROCESS_OF,Health Personnel,32369479,10.1371/journal.pmed.1003127,2020-05-06
psychological distress,PROCESS_OF,Health Personnel,32369479,10.1371/journal.pmed.1003127,2020-05-06
Rhinorrhea,ISA,Communicable Diseases,32369433,10.1080/23294515.2020.1759731,2020-05-06
Coronavirus Infections,PROCESS_OF,Animals,32369433,10.1080/23294515.2020.1759731,2020-05-06
Health Care Systems,LOCATION_OF,Training,32369430,10.1177/0194599820922986,2020-05-06
Smell Perception,PROCESS_OF,Patients,32369409,10.1200/OP.20.00241,2020-05-06
Smell Perception,PROCESS_OF,Patients,32369409,10.1200/OP.20.00241,2020-05-06
Coronavirus Infections,PROCESS_OF,Patients,32369409,10.1200/OP.20.00241,2020-05-06
Symptoms,OCCURS_IN,Patients,32369409,10.1200/OP.20.00241,2020-05-06
Symptoms,OCCURS_IN,Patients,32369409,10.1200/OP.20.00241,2020-05-06
Hospital specialist,TREATS,Patients,32369402,10.1177/0004563220928361,2020-05-06
Hematologic Neoplasms,PROCESS_OF,Patients,32369402,10.1177/0004563220928361,2020-05-06
Hematologic Neoplasms,PROCESS_OF,Patients,32369402,10.1177/0004563220928361,2020-05-06
Comorbidity,PROCESS_OF,Patients,32369320,10.1097/MPG.0000000000002768,2020-05-06
Skin Manifestations,PROCESS_OF,Woman,32369222,10.1002/jmv.25965,2020-05-06
Coronavirus Infections,CAUSES,Acute respiratory disease,32369217,10.1002/jmv.25975,2020-05-06
Nutritional Support,ISA,Interventional procedure,32369217,10.1002/jmv.25975,2020-05-06
Nutritional Support,TREATS,Patients,32369217,10.1002/jmv.25975,2020-05-06
Fever,ISA,Symptoms,32369208,10.1002/jmv.25966,2020-05-06
Chest,LOCATION_OF,Distress,32369208,10.1002/jmv.25966,2020-05-06
Comorbidity,PROCESS_OF,Patients,32369208,10.1002/jmv.25966,2020-05-06
Hypertensive disease,ISA,Symptoms,32369208,10.1002/jmv.25966,2020-05-06
Pneumonia,PROCESS_OF,Patients,32369208,10.1002/jmv.25966,2020-05-06
Patients,LOCATION_OF,C-reactive protein,32369208,10.1002/jmv.25966,2020-05-06
Patients,LOCATION_OF,Fibrin fragment D,32369208,10.1002/jmv.25966,2020-05-06
Patients,LOCATION_OF,procalcitonin,32369208,10.1002/jmv.25966,2020-05-06
Malignant Neoplasms,PROCESS_OF,Patients,32369208,10.1002/jmv.25966,2020-05-06
Malignant Neoplasms,PROCESS_OF,Patients,32369208,10.1002/jmv.25966,2020-05-06
Malignant Neoplasms,PROCESS_OF(SPEC),Cancer Patient,32369208,10.1002/jmv.25966,2020-05-06
Cancer Patient,ISA,Patients,32369208,10.1002/jmv.25966,2020-05-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
Symptom severe,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
exposure history,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
Comorbidity,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
Fever,ISA,Symptoms,32369205,10.1002/jmv.25969,2020-05-06
Abnormal Finding,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
Serum,LOCATION_OF,Ferritin,32369205,10.1002/jmv.25969,2020-05-06
Prognosis bad,PROCESS_OF,Patients,32369205,10.1002/jmv.25969,2020-05-06
Fever,ISA,Symptoms,32369204,10.1002/jmv.25973,2020-05-06
tocilizumab,ISA,Interleukin inhibitors,32369190,10.1111/all.14353,2020-05-06
tocilizumab,ADMINISTERED_TO,Patients,32369190,10.1111/all.14353,2020-05-06
Dyspnea,ISA,Symptoms,32369190,10.1111/all.14353,2020-05-06
Antiviral Agents,ADMINISTERED_TO,Patients,32369190,10.1111/all.14353,2020-05-06
Adverse event,PROCESS_OF,Patients,32369190,10.1111/all.14353,2020-05-06
Pharmaceutical Preparations,TREATS,Disease,32369030,10.2196/19462,2020-05-06
Pharmaceutical Preparations,TREATS(SPEC),Multiple Chronic Conditions,32369030,10.2196/19462,2020-05-06
Multiple Chronic Conditions,ISA,Disease,32369030,10.2196/19462,2020-05-06
Hospital admission,ISA,Hospitalization,32369030,10.2196/19462,2020-05-06
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Cohort,32369030,10.2196/19462,2020-05-06
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,hospitalized patients,32369030,10.2196/19462,2020-05-06
Angiotensin II receptor antagonist therapy,ADMINISTERED_TO,hospitalized patients,32369030,10.2196/19462,2020-05-06
Coronavirus Infections,ISA,Disease,32369029,10.2196/19097,2020-05-06
Sequela of disorder,ISA,Disease,32369029,10.2196/19097,2020-05-06
"Discharge, body substance",PART_OF,Patients,32369029,10.2196/19097,2020-05-06
Coronavirus Infections,ISA,Disease,32369029,10.2196/19097,2020-05-06
Coronavirus Infections,ISA,Disease,32369029,10.2196/19097,2020-05-06
Complication,AFFECTS,Virus,32369029,10.2196/19097,2020-05-06
Disease,PROCESS_OF,Survivors,32369029,10.2196/19097,2020-05-06
Coronavirus Infections,ISA,Disease,32369029,10.2196/19097,2020-05-06
Laboratory Procedures,DIAGNOSES,Present,32369026,10.2196/19556,2020-05-06
Infected,PROCESS_OF,Population Group,32369026,10.2196/19556,2020-05-06
Active Surveillance Methods,MEASURES,Mortality Vital Statistics,32369026,10.2196/19556,2020-05-06
Coronavirus Infections,ISA,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
Coronavirus Infections,ISA,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
Coronavirus Infections,ISA,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
mental health,PROCESS_OF,Persons,32368995,10.1192/bjp.2020.93,2020-05-06
IMPACT gene,AFFECTS,Negative,32368995,10.1192/bjp.2020.93,2020-05-06
Panic,COEXISTS_WITH,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
Panic,COEXISTS_WITH(SPEC),Coronavirus Infections,32368995,10.1192/bjp.2020.93,2020-05-06
Coronavirus Infections,ISA,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
Coronavirus Infections,ISA,Disease,32368995,10.1192/bjp.2020.93,2020-05-06
Panic,PROCESS_OF,Persons,32368995,10.1192/bjp.2020.93,2020-05-06
Mental disorders,PROCESS_OF,African race,32368994,10.1017/ipm.2020.29,2020-05-06
Ethanol,AFFECTS,Catabolism,32368884,10.4081/monaldi.2020.1342,2020-05-06
Households,LOCATION_OF,Bleach,32368884,10.4081/monaldi.2020.1342,2020-05-06
Steam,AFFECTS,Catabolism,32368884,10.4081/monaldi.2020.1342,2020-05-06
Bleach,AFFECTS,Catabolism,32368884,10.4081/monaldi.2020.1342,2020-05-06
Critical Illness,PROCESS_OF,Patients,32368875,10.4274/mirt.galenos.2020.33600,2020-05-06
Intubation,TREATS,"Respiratory Distress Syndrome, Adult",32368875,10.4274/mirt.galenos.2020.33600,2020-05-06
X-Ray Departments,LOCATION_OF,Diagnosis,32368850,10.1111/ajt.15969,2020-05-06
Negative,PROCESS_OF,Patients,32368799,10.1002/lary.28734,2020-05-06
Tracheostomy procedure,ADMINISTERED_TO,Clinician,32368792,10.1111/bph.15092,2020-05-06
Tracheostomy procedure,TREATS,Patients,32368792,10.1111/bph.15092,2020-05-06
Coronavirus Infections,CAUSES,Cessation of life,32368756,10.1016/j.jaccas.2020.04.026,2020-05-06
Echocardiography,AFFECTS,Coronavirus Infections,32368755,10.1016/j.jaccas.2020.04.025,2020-05-06
Critical Illness,PROCESS_OF,Patients,32368728,10.1016/j.eclinm.2020.100375,2020-05-06
Myocarditis,PROCESS_OF,Patients,32368728,10.1016/j.eclinm.2020.100375,2020-05-06
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32368728,10.1016/j.eclinm.2020.100375,2020-05-06
Aldose Reductase Inhibitor,CAUSES,Complete Recovery,32368728,10.1016/j.eclinm.2020.100375,2020-05-06
Coronavirus Infections,ISA,Disease,32368712,10.1089/heq.2020.0015,2020-05-06
Symptoms,PROCESS_OF,Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Coronavirus Infections,ISA,Disease,32368712,10.1089/heq.2020.0015,2020-05-06
Negative,PROCESS_OF,Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Coronavirus Infections,ISA,Disease,32368712,10.1089/heq.2020.0015,2020-05-06
Disease,PROCESS_OF,Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Respiration Disorders,ISA,Disease,32368712,10.1089/heq.2020.0015,2020-05-06
Respiration Disorders,PROCESS_OF,Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Respiration Disorders,PROCESS_OF(SPEC),Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Coronavirus Infections,ISA,Disease,32368712,10.1089/heq.2020.0015,2020-05-06
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32368712,10.1089/heq.2020.0015,2020-05-06
Practice Experience,PROCESS_OF,professional occupation status,32368570,10.1007/s13337-020-00587-x,2020-05-06
Mechanical Ventilator,USES,Masks,32368570,10.1007/s13337-020-00587-x,2020-05-06
World,ISA,Population Group,32368569,10.1007/s13337-020-00591-1,2020-05-06
Infected,PROCESS_OF,Persons,32368532,10.12998/wjcc.v8.i8.1391,2020-05-06
Contusions,PROCESS_OF,Woman,32368532,10.12998/wjcc.v8.i8.1391,2020-05-06
Lung,LOCATION_OF,Contusions,32368532,10.12998/wjcc.v8.i8.1391,2020-05-06
Lung,LOCATION_OF,Contusions,32368532,10.12998/wjcc.v8.i8.1391,2020-05-06
Symptoms,PROCESS_OF,Patients,32368528,10.12998/wjcc.v8.i8.1343,2020-05-06
Epithelium,LOCATION_OF,ACE2 gene,32368528,10.12998/wjcc.v8.i8.1343,2020-05-06
Biliary epithelial cell,PART_OF,Liver,32368528,10.12998/wjcc.v8.i8.1343,2020-05-06
Feces,PART_OF,Patients,32368528,10.12998/wjcc.v8.i8.1343,2020-05-06
Disease Outbreaks,CAUSES,Pneumonia,32368495,10.1016/j.idcr.2020.e00775,2020-05-06
Specimen Type - Stool = Fecal,LOCATION_OF,Nucleic Acids,32368495,10.1016/j.idcr.2020.e00775,2020-05-06
Coronavirus Infections,ISA,Disease,32368483,10.1016/j.rmcr.2020.101070,2020-05-06
Coinfection,CAUSES,Severe Acute Respiratory Syndrome,32368483,10.1016/j.rmcr.2020.101070,2020-05-06
Hydroxychloroquine,NEG_TREATS,Symptoms,32368429,10.7759/cureus.7873,2020-05-06
Azithromycin,NEG_TREATS,Symptoms,32368429,10.7759/cureus.7873,2020-05-06
United States,ISA,Country,32368424,10.7759/cureus.7492,2020-05-06
Experience,PROCESS_OF,Patients,32368424,10.7759/cureus.7492,2020-05-06
Virus,COEXISTS_WITH,Coronavirus Infections,32368252,10.3332/ecancer.2020.1027,2020-05-06
skill,PROCESS_OF,student,32368252,10.3332/ecancer.2020.1027,2020-05-06
Panic,PROCESS_OF,Community,32368252,10.3332/ecancer.2020.1027,2020-05-06
Health Care Systems,LOCATION_OF,Administration occupational activities,32367931,10.1055/s-0040-1710403,2020-05-06
Face,LOCATION_OF,Pressure Ulcer,32367899,10.1016/j.annals.2020.102942,2020-05-06
Severe Acute Respiratory Syndrome,PREDISPOSES,Pressure Ulcer,32367899,10.1016/j.annals.2020.102942,2020-05-06
Pressure Ulcer,PROCESS_OF,Health Personnel,32367899,10.1016/j.annals.2020.102942,2020-05-06
Pressure Ulcer,PROCESS_OF,Woman,32367899,10.1016/j.annals.2020.102942,2020-05-06
Face,LOCATION_OF,Pressure Ulcer,32367899,10.1016/j.annals.2020.102942,2020-05-06
"CD69 protein, human",ASSOCIATED_WITH(INFER),Pressure Ulcer,32367899,10.1016/j.annals.2020.102942,2020-05-06
"CD69 protein, human",PART_OF,Woman,32367899,10.1016/j.annals.2020.102942,2020-05-06
Heart,LOCATION_OF,Pneumonia,32367887,10.4103/njcp.njcp_163_20,2020-05-06
Lung,PART_OF,Patients,32367887,10.4103/njcp.njcp_163_20,2020-05-06
Gamma Irradiation,METHOD_OF,Sexual sterilization,32367847,10.4103/lungindia.lungindia_241_20,2020-05-06
Nose,LOCATION_OF,Virus,32367846,10.4103/lungindia.lungindia_189_20,2020-05-06
Pharyngeal mucous membrane,LOCATION_OF,Virus,32367846,10.4103/lungindia.lungindia_189_20,2020-05-06
Fever,PROCESS_OF,Patients,32367812,10.17992/lbl.2020.05.581,2020-05-06
Gastrointestinal symptom,PROCESS_OF,Patients,32367812,10.17992/lbl.2020.05.581,2020-05-06
Symptoms,PROCESS_OF,Patients,32367812,10.17992/lbl.2020.05.581,2020-05-06
Gastroenterologist,TREATS,Patients,32367812,10.17992/lbl.2020.05.581,2020-05-06
Lung,LOCATION_OF,Radionuclide Imaging,32367793,10.1017/dmp.2020.134,2020-05-06
Movement,PROCESS_OF,Population Group,32367767,10.1080/07391102.2020.1764868,2020-05-06
Fibrinogen,TREATS,Patients,32367764,10.1177/1129729820923935,2020-05-06
Medical Devices,USES,venous access,32367749,10.1080/09537104.2020.1760231,2020-05-06
Heparin-induced thrombocytopenia,PROCESS_OF,Patients,32367749,10.1080/09537104.2020.1760231,2020-05-06
teams,LOCATION_OF,HTATIP wt Allele,32367749,10.1080/09537104.2020.1760231,2020-05-06
Peripheral catheter,ISA,catheter device,32367749,10.1080/09537104.2020.1760231,2020-05-06
Edetic Acid,TREATS,Patients,32367746,10.1161/HYPERTENSIONAHA.120.15291,2020-05-06
Edetic Acid,TREATS(INFER),Pneumonia,32367746,10.1161/HYPERTENSIONAHA.120.15291,2020-05-06
Pneumonia,PROCESS_OF,Patients,32367746,10.1161/HYPERTENSIONAHA.120.15291,2020-05-06
Pharmaceutical Preparations,TREATS,Disease,32367739,10.1080/10255842.2020.1759560,2020-05-06
risk factors,PROCESS_OF,Adult,32367739,10.1080/10255842.2020.1759560,2020-05-06
risk factors,PROCESS_OF,Child,32367739,10.1080/10255842.2020.1759560,2020-05-06
Coronavirus Infections,AFFECTS,Child,32367739,10.1080/10255842.2020.1759560,2020-05-06
Myocardial Infarction,PROCESS_OF,Patients,32367648,10.1111/1462-2920.15053,2020-05-06
Myocardial Infarction,PROCESS_OF,Patients,32367648,10.1111/1462-2920.15053,2020-05-06
Communicable Diseases,AFFECTS,Patients,32367648,10.1111/1462-2920.15053,2020-05-06
Genome,COEXISTS_WITH,Cytosine,32367615,10.1002/cbic.202000250,2020-05-06
Assay,USES,molecular diagnostics (lab procedure),32367579,10.1096/fj.202000654R,2020-05-06
Fasting,PROCESS_OF,Racial group,32367576,10.1111/omi.12289,2020-05-06
,PART_OF,Transient Population Group,32367576,10.1111/omi.12289,2020-05-06
"CD69 protein, human",STIMULATES,,32367576,10.1111/omi.12289,2020-05-06
Experience,PROCESS_OF,Patients,32367558,10.1111/dth.13509,2020-05-06
Dermatologic disorders,PROCESS_OF,Patients,32367431,10.1007/s11684-020-0786-5,2020-05-06
Dermatologic disorders,PROCESS_OF,Patients,32367431,10.1007/s11684-020-0786-5,2020-05-06
Superficial mycosis,ISA,Dermatologic disorders,32367431,10.1007/s11684-020-0786-5,2020-05-06
Superficial mycosis,PROCESS_OF(SPEC),Patients,32367431,10.1007/s11684-020-0786-5,2020-05-06
Superficial mycosis,ISA,Dermatologic disorders,32367431,10.1007/s11684-020-0786-5,2020-05-06
Psoriasis,PROCESS_OF,Patients,32367431,10.1007/s11684-020-0786-5,2020-05-06
Superficial mycosis,PROCESS_OF,Patients,32367431,10.1007/s11684-020-0786-5,2020-05-06
Epithelium,PART_OF,Alveolus,32367422,10.1007/s00330-020-06915-5,2020-05-06
"Immunity, Innate",ASSOCIATED_WITH,Disease,32367422,10.1007/s00330-020-06915-5,2020-05-06
"Immunity, Innate",ASSOCIATED_WITH(SPEC),Hypoxia,32367422,10.1007/s00330-020-06915-5,2020-05-06
Hypoxia,ISA,Disease,32367422,10.1007/s00330-020-06915-5,2020-05-06
Lung Injury,CAUSES,Disease,32367422,10.1007/s00330-020-06915-5,2020-05-06
Lung Injury,CAUSES(SPEC),Hypoxia,32367422,10.1007/s00330-020-06915-5,2020-05-06
compromise,PROCESS_OF,Persons,32367422,10.1007/s00330-020-06915-5,2020-05-06
Blood Vessel,LOCATION_OF,Thickened,32367418,10.1007/s00330-020-06879-6,2020-05-06
Lung,LOCATION_OF,Unilateral disease,32367418,10.1007/s00330-020-06879-6,2020-05-06
Halo sign,ISA,Physical findings,32367418,10.1007/s00330-020-06879-6,2020-05-06
Pneumonia,PROCESS_OF,Patients,32367319,10.1007/s11547-020-01195-x,2020-05-06
Pneumonia,PROCESS_OF,Patients,32367319,10.1007/s11547-020-01195-x,2020-05-06
Congenital anomaly of lung,PART_OF,Patients,32367319,10.1007/s11547-020-01195-x,2020-05-06
Bronchi,LOCATION_OF,Abnormal shape,32367319,10.1007/s11547-020-01195-x,2020-05-06
Asymptomatic,PROCESS_OF,Patients,32367205,10.1007/s00701-020-04374-x,2020-05-06
Pneumonia,PROCESS_OF,Patients,32367205,10.1007/s00701-020-04374-x,2020-05-06
Parenchyma,PART_OF,Lung,32367205,10.1007/s00701-020-04374-x,2020-05-06
Anosmia,ISA,Symptoms,32367170,10.1007/s00134-020-06062-x,2020-05-06
Dysgeusia,ISA,Symptoms,32367170,10.1007/s00134-020-06062-x,2020-05-06
Headache,ISA,Symptoms,32367170,10.1007/s00134-020-06062-x,2020-05-06
Magnetic Resonance Imaging,DIAGNOSES,Lesion,32367170,10.1007/s00134-020-06062-x,2020-05-06
Virus,CAUSES,Systemic Inflammatory Response Syndrome,32367170,10.1007/s00134-020-06062-x,2020-05-06
invasive treatment,PREVENTS,Injury of central nervous system,32367170,10.1007/s00134-020-06062-x,2020-05-06
Thrombus,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Complication,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Continuous renal replacement therapy,ADMINISTERED_TO,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
thrombotic occlusion,OCCURS_IN,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
D-dimer above reference range,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Disseminated Intravascular Coagulation,NEG_PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
"von Willebrand factor, human",ISA,Antigens,32366817,10.1038/s41467-020-16256-y,2020-05-06
Complication,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Complication,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Critical Illness,PROCESS_OF,Patients,32366817,10.1038/s41467-020-16256-y,2020-05-06
Vaccines,TREATS,Disease,32366816,10.12659/MSM.924700,2020-05-06
Epitopes,PART_OF,communes,32366816,10.12659/MSM.924700,2020-05-06
Virus,LOCATION_OF,Epitopes,32366816,10.12659/MSM.924700,2020-05-06
"Antibodies, Blocking",INTERACTS_WITH,Epitopes,32366816,10.12659/MSM.924700,2020-05-06
Disease Progression,AFFECTS,Patients,32366765,10.2106/JBJS.20.00567,2020-05-06
Confirmation,PROCESS_OF,Patients,32366765,10.2106/JBJS.20.00567,2020-05-06
Drapes (device),USES,Personal protective equipment,32366759,10.1097/RTI.0000000000000528,2020-05-06
Intramedullary Nailing,ADMINISTERED_TO,Surgeon,32366759,10.1097/RTI.0000000000000528,2020-05-06
Intramedullary Nailing,TREATS,Patients,32366759,10.1097/RTI.0000000000000528,2020-05-06
Occupational Exposure,PROCESS_OF,Surgeon,32366759,10.1097/RTI.0000000000000528,2020-05-06
China,ISA,Country,32366746,10.1097/CM9.0000000000000899,2020-05-06
Experience,PROCESS_OF,World,32366746,10.1097/CM9.0000000000000899,2020-05-06
"Drugs, Non-Prescription",TREATS,Fever,32366720,10.1128/AAC.00819-20,2020-05-06
"Drugs, Non-Prescription",TREATS,Pain,32366720,10.1128/AAC.00819-20,2020-05-06
ACE2 gene,PREDISPOSES,Disease,32366720,10.1128/AAC.00819-20,2020-05-06
ACE2 gene,ASSOCIATED_WITH,Disease,32366720,10.1128/AAC.00819-20,2020-05-06
Protomers,AFFECTS,protein folding,32366669,10.1128/JCM.00926-20,2020-05-06
Protomers,AFFECTS,Immune Evasion,32366669,10.1128/JCM.00926-20,2020-05-06
Circulatory Process,PROCESS_OF,Community,32366633,10.18043/ncm.81.3.201,2020-05-06
Pandemics,ISA,Disease Outbreaks,32366633,10.18043/ncm.81.3.201,2020-05-06
Hand,LOCATION_OF,sanitizers,32366633,10.18043/ncm.81.3.201,2020-05-06
Coronavirus Infections,ISA,Symptoms,32366633,10.18043/ncm.81.3.201,2020-05-06
Pandemics,ISA,Disease Outbreaks,32366614,10.1136/svn-2020-000398,2020-05-06
Protection,PROCESS_OF,Medical Staff,32366614,10.1136/svn-2020-000398,2020-05-06
"Hospitals, Urban",ISA,Hospitals,32366614,10.1136/svn-2020-000398,2020-05-06
Symptoms,PROCESS_OF,Patients,32366612,10.1542/peds.2020-1121,2020-05-06
Neurologic Symptoms,PROCESS_OF,Patients,32366612,10.1542/peds.2020-1121,2020-05-06
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32366611,10.1542/peds.2020-1437,2020-05-06
Coughing,PROCESS_OF,Woman,32366610,10.1542/peds.2020-1243,2020-05-06
Fever,PROCESS_OF,Woman,32366610,10.1542/peds.2020-1243,2020-05-06
Vomiting,PROCESS_OF,Woman,32366610,10.1542/peds.2020-1243,2020-05-06
Medical History,NEG_PROCESS_OF,Woman,32366610,10.1542/peds.2020-1243,2020-05-06
"Immunoglobulins, Intravenous",TREATS,Thrombocytopenia,32366610,10.1542/peds.2020-1243,2020-05-06
Nitric Oxide,TREATS,Severe Acute Respiratory Syndrome,32366610,10.1542/peds.2020-1243,2020-05-06
Mechanical ventilation,TREATS,Severe Acute Respiratory Syndrome,32366610,10.1542/peds.2020-1243,2020-05-06
Airway Pressure Release Ventilation,TREATS,Severe Acute Respiratory Syndrome,32366610,10.1542/peds.2020-1243,2020-05-06
tocilizumab,ADMINISTERED_TO,Patients,32366610,10.1542/peds.2020-1243,2020-05-06
Child,LOCATION_OF,IMPACT gene,32366599,10.1136/jclinpath-2020-206635,2020-05-06
Hospitalization Required,PROCESS_OF,Child,32366599,10.1136/jclinpath-2020-206635,2020-05-06
Squamous cell carcinoma,PART_OF,Patients,32366584,10.1136/jech-2020-214209,2020-05-06
Tongue,LOCATION_OF,Squamous cell carcinoma,32366584,10.1136/jech-2020-214209,2020-05-06
post operative (finding),PROCESS_OF,Patients,32366584,10.1136/jech-2020-214209,2020-05-06
Epidemic,ISA,Disease Outbreaks,32366580,10.7861/clinmed.2020-0188,2020-05-06
SARS coronavirus,CAUSES,Disease,32366505,10.1136/bmj.m1672,2020-05-06
Disease,PROCESS_OF,Patients,32366505,10.1136/bmj.m1672,2020-05-06
Advice,TREATS,Pulmonologists,32366505,10.1136/bmj.m1672,2020-05-06
"Infections, Hospital",PROCESS_OF,Health Personnel,32366457,10.1136/postgradmedj-2020-137738,2020-05-06
Symptoms,PROCESS_OF,Persons,32366457,10.1136/postgradmedj-2020-137738,2020-05-06
Cardiovascular Diseases,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Diabetes,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366299,10.1186/s40463-020-00423-8,2020-05-06
Dysgeusia,ISA,Symptoms,32366290,10.1186/s13287-020-01678-8,2020-05-06
Anosmia,PROCESS_OF,Cohort,32366290,10.1186/s13287-020-01678-8,2020-05-06
Coronavirus Infections,ISA,Disease,32366279,10.1186/s13045-020-00883-5,2020-05-06
"Respiratory Distress Syndrome, Adult",ISA,Disease,32366279,10.1186/s13045-020-00883-5,2020-05-06
Coronavirus Infections,ISA,Disease,32366279,10.1186/s13045-020-00883-5,2020-05-06
Coronavirus Infections,ISA,Disease,32366279,10.1186/s13045-020-00883-5,2020-05-06
Coronavirus Infections,ISA,Disease,32366279,10.1186/s13045-020-00883-5,2020-05-06
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32366198,10.1177/0194599820925037,2020-05-06
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32366198,10.1177/0194599820925037,2020-05-06
Malignant Neoplasms,PROCESS_OF,Persons,32366198,10.1177/0194599820925037,2020-05-06
risk factors,PROCESS_OF,Persons,32366198,10.1177/0194599820925037,2020-05-06
receptor,ASSOCIATED_WITH,Neoplasms,32366198,10.1177/0194599820925037,2020-05-06
Malignant Neoplasms,PROCESS_OF,Homo sapiens,32366198,10.1177/0194599820925037,2020-05-06
Lung,LOCATION_OF,Adenocarcinoma,32366198,10.1177/0194599820925037,2020-05-06
Malignant Neoplasms,PROCESS_OF,Homo sapiens,32366198,10.1177/0194599820925037,2020-05-06
angiotensin converting enzyme 2,ASSOCIATED_WITH,Malignant Neoplasms,32366198,10.1177/0194599820925037,2020-05-06
Iran,ISA,Country,32366178,10.1177/0194599820925058,2020-05-06
Anosmia,PROCESS_OF,Patients,32366178,10.1177/0194599820925058,2020-05-06
Nose,LOCATION_OF,Congestion,32366178,10.1177/0194599820925058,2020-05-06
Neuropathy,INTERACTS_WITH,Virus,32366178,10.1177/0194599820925058,2020-05-06
Screening procedure,AFFECTS,Anosmia,32366178,10.1177/0194599820925058,2020-05-06
Infected,PROCESS_OF,Persons,32366178,10.1177/0194599820925058,2020-05-06
Anosmia,PROCESS_OF,Patients,32366178,10.1177/0194599820925058,2020-05-06
Epistaxis,PROCESS_OF,general population,32366172,10.1177/0194599820926463,2020-05-06
Asymptomatic,PROCESS_OF,Patients,32366172,10.1177/0194599820926463,2020-05-06
Anosmia,ISA,Symptoms,32366158,10.1177/0194599820925043,2020-05-06
Sense of smell impaired,ISA,Symptoms,32366158,10.1177/0194599820925043,2020-05-06
Anxiety,PROCESS_OF,Patients,32366131,10.1080/14787210.2020.1761333,2020-05-06
Chief complaint (finding),PROCESS_OF,Patients,32366025,10.3390/v12050498,2020-05-06
Family,INTERACTS_WITH,Dental Staff,32366025,10.3390/v12050498,2020-05-06
Food Poisoning,PROCESS_OF,Homo sapiens,32365891,10.3390/ijerph17093132,2020-05-06
"Food, Organic",ISA,Food,32365891,10.3390/ijerph17093132,2020-05-06
Insecurity,PROCESS_OF,Persons,32365851,10.3390/ijerph17093125,2020-05-06
Disease,CAUSES,Cessation of life,32365710,10.3390/ijerph17093114,2020-05-06
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32365710,10.3390/ijerph17093114,2020-05-06
ACE2 gene,PART_OF,Homo sapiens,32365710,10.3390/ijerph17093114,2020-05-06
ACE2 gene,compared_with,"M Protein, multiple myeloma",32365710,10.3390/ijerph17093114,2020-05-06
receptor binding,PROCESS_OF,Cells,32365710,10.3390/ijerph17093114,2020-05-06
Cell Count,DIAGNOSES,Disease,32365556,10.3390/molecules25092076,2020-05-06
Cells,PART_OF,Unmarried person,32365556,10.3390/molecules25092076,2020-05-06
Influenza,CAUSES,Lung diseases,32365466,10.3390/pathogens9050331,2020-05-06
TRANSCRIPTION FACTOR,PART_OF,Peroxisome Proliferator-Activated Receptors,32365466,10.3390/pathogens9050331,2020-05-06
Peroxisome Proliferator-Activated Receptors,ISA,TRANSCRIPTION FACTOR,32365466,10.3390/pathogens9050331,2020-05-06
Anti-Inflammatory Agents,AFFECTS,"Pneumonia, Viral",32365466,10.3390/pathogens9050331,2020-05-06
pioglitazone,ISA,Thiazolidinediones,32365466,10.3390/pathogens9050331,2020-05-06
Virus,PROCESS_OF,Chiroptera,32365415,10.1111/jocs.14602,2020-05-05
Aortic Valve Stenosis,PROCESS_OF,Patients,32365354,10.1038/s41586-020-2293-x,2020-05-05
Surgical Replantation,USES,Medical Valves,32365354,10.1038/s41586-020-2293-x,2020-05-05
Escherichia coli,LOCATION_OF,Genome,32365275,10.1002/oby.22867,2020-05-05
Genome,PART_OF,RNA Viruses,32365275,10.1002/oby.22867,2020-05-05
Genome,PART_OF(SPEC),Genus: Coronavirus,32365275,10.1002/oby.22867,2020-05-05
Genus: Coronavirus,ISA,RNA Viruses,32365275,10.1002/oby.22867,2020-05-05
Critical Illness,PROCESS_OF,Patients,32365259,10.1111/ggi.13939,2020-05-05
Obesity,PROCESS_OF,Patients,32365259,10.1111/ggi.13939,2020-05-05
Cardiac complication,PROCESS_OF,Patients,32365259,10.1111/ggi.13939,2020-05-05
Equilibrium,AFFECTS,Neoplasm Metastasis,32365233,10.1111/dme.14316,2020-05-05
Older people,LOCATION_OF,IMPACT gene,32365233,10.1111/dme.14316,2020-05-05
consideration,PROCESS_OF,Asians,32365233,10.1111/dme.14316,2020-05-05
Hospital specialist,TREATS,inpatient,32365221,10.1111/cei.13450,2020-05-05
Hospital specialist,TREATS,inpatient,32365221,10.1111/cei.13450,2020-05-05
Leptocyte,INTERACTS_WITH,angiotensin converting enzyme 2,32365178,10.1093/jtm/taaa066,2020-05-05
Ovary,LOCATION_OF,ACE2 gene,32365178,10.1093/jtm/taaa066,2020-05-05
Placenta,LOCATION_OF,ACE2 gene,32365178,10.1093/jtm/taaa066,2020-05-05
Uterus,LOCATION_OF,ACE2 gene,32365178,10.1093/jtm/taaa066,2020-05-05
Vagina,LOCATION_OF,ACE2 gene,32365178,10.1093/jtm/taaa066,2020-05-05
Ovulation,AFFECTS,Angiogenic Process,32365178,10.1093/jtm/taaa066,2020-05-05
Tracheostomy procedure,PREVENTS,Stenosis,32365046,10.2196/18821,2020-05-05
Coronavirus Infections,ISA,Disease,32365045,10.2196/19368,2020-05-05
Passenger,ISA,Persons,32365045,10.2196/19368,2020-05-05
Asymptomatic,PROCESS_OF,Patients,32365045,10.2196/19368,2020-05-05
Pulmonary opacity,PROCESS_OF,Patients,32365045,10.2196/19368,2020-05-05
Coronavirus Infections,ISA,Disease,32365044,10.2196/19009,2020-05-05
IMPACT gene,AFFECTS,disease transmission,32365044,10.2196/19009,2020-05-05
Coronavirus Infections,ISA,Disease,32365044,10.2196/19009,2020-05-05
Coronavirus Infections,ISA,Disease,32365044,10.2196/19009,2020-05-05
Anxiety,PROCESS_OF,Community,32365043,10.2196/19203,2020-05-05
Anxiety,PROCESS_OF,Health Personnel,32365043,10.2196/19203,2020-05-05
Depressive disorder,PROCESS_OF,Community,32365043,10.2196/19203,2020-05-05
Depressive disorder,PROCESS_OF,Health Personnel,32365043,10.2196/19203,2020-05-05
"CD69 protein, human",ADMINISTERED_TO,Community,32365043,10.2196/19203,2020-05-05
"CD69 protein, human",ADMINISTERED_TO,Health Personnel,32365043,10.2196/19203,2020-05-05
Anxiety,AFFECTS,Persons,32365043,10.2196/19203,2020-05-05
Anxiety,PROCESS_OF,Adult,32365043,10.2196/19203,2020-05-05
Depressive disorder,AFFECTS,Persons,32365043,10.2196/19203,2020-05-05
Depressive disorder,PROCESS_OF,Adult,32365043,10.2196/19203,2020-05-05
Disease,PROCESS_OF,Persons,32365043,10.2196/19203,2020-05-05
Coronavirus Infections,ISA,Disease,32365043,10.2196/19203,2020-05-05
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32365043,10.2196/19203,2020-05-05
Anxiety,PROCESS_OF,Community,32365043,10.2196/19203,2020-05-05
Anxiety,PROCESS_OF,Health Personnel,32365043,10.2196/19203,2020-05-05
Depressive disorder,PROCESS_OF,Community,32365043,10.2196/19203,2020-05-05
Depressive disorder,PROCESS_OF,Health Personnel,32365043,10.2196/19203,2020-05-05
Stress,PROCESS_OF,general population,32365022,10.1109/TMI.2020.2991954,2020-05-05
Mental health problem,PROCESS_OF,general population,32365022,10.1109/TMI.2020.2991954,2020-05-05
Persons,LOCATION_OF,IMPACT gene,32365022,10.1109/TMI.2020.2991954,2020-05-05
Serious mental illness,PREDISPOSES,Poor outcome,32365022,10.1109/TMI.2020.2991954,2020-05-05
Serious mental illness,PROCESS_OF,Persons,32365022,10.1109/TMI.2020.2991954,2020-05-05
Serious mental illness,PROCESS_OF,Persons,32365022,10.1109/TMI.2020.2991954,2020-05-05
research results,PROCESS_OF,Persons,32365022,10.1109/TMI.2020.2991954,2020-05-05
Serious mental illness,PROCESS_OF,Persons,32365022,10.1109/TMI.2020.2991954,2020-05-05
Epithelium,PART_OF,Lung,32364959,10.1016/j.rmed.2020.105980,2020-05-05
Coronavirus Infections,ISA,Disease,32364936,10.1016/j.bios.2020.112214,2020-05-05
Coronavirus Infections,ISA,Disease,32364936,10.1016/j.bios.2020.112214,2020-05-05
Coronavirus Infections,ISA,Disease,32364936,10.1016/j.bios.2020.112214,2020-05-05
Coronavirus Infections,ISA,Disease,32364936,10.1016/j.bios.2020.112214,2020-05-05
Chest CT,DIAGNOSES,patient condition,32364936,10.1016/j.bios.2020.112214,2020-05-05
Polymerase Chain Reaction,USES,Reverse Transcriptase Polymerase Chain Reaction,32364936,10.1016/j.bios.2020.112214,2020-05-05
Detection,USES,Biosensors,32364920,10.1532/hsf.3011,2020-05-05
Detection,USES,Biosensors,32364920,10.1532/hsf.3011,2020-05-05
Detection,USES,Biosensors,32364920,10.1532/hsf.3011,2020-05-05
Detection,USES,Biosensors,32364920,10.1532/hsf.3011,2020-05-05
Patient Problem,PROCESS_OF,Patients,32364890,10.3201/eid2607.201595,2020-05-05
"Angina, Unstable",PROCESS_OF,Patients,32364890,10.3201/eid2607.201595,2020-05-05
Coronary Arteriosclerosis,PROCESS_OF,Patients,32364890,10.3201/eid2607.201595,2020-05-05
Cardiac Surgery procedures,TREATS,Patients,32364890,10.3201/eid2607.201595,2020-05-05
Experience,PROCESS_OF,Patients,32364890,10.3201/eid2607.201595,2020-05-05
Infected,PROCESS_OF,Persons,32364809,10.1080/09546634.2020.1762843,2020-05-05
Operative Surgical Procedures,COEXISTS_WITH,Health Care,32364677,10.1111/tid.13306,2020-05-05
Medical pathologist,DIAGNOSES,Enthesitis-Related Arthritis,32364677,10.1111/tid.13306,2020-05-05
Medical pathologist,DIAGNOSES,Enthesitis-Related Arthritis,32364677,10.1111/tid.13306,2020-05-05
Pneumonia,PROCESS_OF,Patients,32364528,10.18632/aging.103170,2020-05-05
Fever,ISA,Symptoms,32364527,10.18632/aging.103101,2020-05-05
Co-morbid conditions,PROCESS_OF,Patients,32364527,10.18632/aging.103101,2020-05-05
Pleura,LOCATION_OF,Traction,32364527,10.18632/aging.103101,2020-05-05
lobe,LOCATION_OF,Ground Glass Opacity,32364527,10.18632/aging.103101,2020-05-05
Coughing,ISA,Symptoms,32364527,10.18632/aging.103101,2020-05-05
Fever,ISA,Symptoms,32364527,10.18632/aging.103101,2020-05-05
Chest CT,ISA,Evaluation,32364527,10.18632/aging.103101,2020-05-05
Disease Progression,PROCESS_OF,Judge,32364527,10.18632/aging.103101,2020-05-05
Fatigue,CAUSES,Cessation of life,32364358,10.1556/650.2020.31859,2020-05-05
Fever,CAUSES,Cessation of life,32364358,10.1556/650.2020.31859,2020-05-05
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32364358,10.1556/650.2020.31859,2020-05-05
Dry cough,CAUSES,Cessation of life,32364358,10.1556/650.2020.31859,2020-05-05
Interleukin-1,ISA,Interleukins,32364358,10.1556/650.2020.31859,2020-05-05
Interferons,TREATS,Middle East Respiratory Syndrome Coronavirus,32364358,10.1556/650.2020.31859,2020-05-05
Interleukin-6,ISA,Interleukins,32364358,10.1556/650.2020.31859,2020-05-05
Storm NOS,COEXISTS_WITH,INFECTIOUS PROCESS,32364358,10.1556/650.2020.31859,2020-05-05
Lymphocyte,PART_OF,Homo sapiens,32364358,10.1556/650.2020.31859,2020-05-05
Patients,LOCATION_OF,"T-Cell Surface Glycoprotein CD4, human",32364358,10.1556/650.2020.31859,2020-05-05
Blow -accident,CAUSES,Pneumonia,32364358,10.1556/650.2020.31859,2020-05-05
Quick Test for Liver Function,DIAGNOSES,Present,32364301,10.1111/jpc.14903,2020-05-05
Severe Acute Respiratory Syndrome,ISA,Disease,32364301,10.1111/jpc.14903,2020-05-05
Polymerase Chain Reaction,USES,Quick Test for Liver Function,32364301,10.1111/jpc.14903,2020-05-05
Quick Test for Liver Function,DIAGNOSES,Present,32364301,10.1111/jpc.14903,2020-05-05
Severe Acute Respiratory Syndrome,PROCESS_OF,general population,32364301,10.1111/jpc.14903,2020-05-05
Staff,LOCATION_OF,IMPACT gene,32364264,10.1111/his.14134,2020-05-05
basel,LOCATION_OF,Autopsy,32364242,10.1093/pubmed/fdaa058,2020-05-05
Blood capillaries,LOCATION_OF,Congestion,32364242,10.1093/pubmed/fdaa058,2020-05-05
Microthrombus,COEXISTS_WITH,Congestion,32364242,10.1093/pubmed/fdaa058,2020-05-05
Microthrombus,COEXISTS_WITH,Respiratory Failure,32364242,10.1093/pubmed/fdaa058,2020-05-05
Microthrombus,COEXISTS_WITH,diffuse alveolar damage,32364242,10.1093/pubmed/fdaa058,2020-05-05
Alveolar,LOCATION_OF,Hemorrhage,32364242,10.1093/pubmed/fdaa058,2020-05-05
Lung,LOCATION_OF,Thrombotic Microangiopathies,32364242,10.1093/pubmed/fdaa058,2020-05-05
Senile cardiac amyloidosis,PROCESS_OF,Patients,32364242,10.1093/pubmed/fdaa058,2020-05-05
Cardiovascular,LOCATION_OF,Comorbidity,32364242,10.1093/pubmed/fdaa058,2020-05-05
CODE protocol,PREVENTS,Severe Acute Respiratory Syndrome,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
Cerebrovascular accident,PROCESS_OF,Patients,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
hospital care,TREATS,Patients,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
hospital care,TREATS(INFER),Cerebrovascular accident,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Health Personnel,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
Decision,PROCESS_OF,Corona,32364126,10.1016/j.nrl.2020.04.006,2020-05-05
Neurologic Symptoms,MANIFESTATION_OF,Severe Acute Respiratory Syndrome,32364048,10.1080/20502877.2020.1762027,2020-05-05
Endopeptidases,ISA,Pharmaceutical Preparations,32364028,10.1177/0300891620923790,2020-05-05
Coronavirus Infections,ISA,Disease,32364011,10.1080/07391102.2020.1764393,2020-05-05
Coronavirus Infections,ISA,Disease,32364011,10.1080/07391102.2020.1764393,2020-05-05
Malignant Neoplasms,PROCESS_OF,Patients,32364011,10.1080/07391102.2020.1764393,2020-05-05
Pharyngeal structure,LOCATION_OF,Nasal Swabs,32364011,10.1080/07391102.2020.1764393,2020-05-05
tomography,DIAGNOSES,Infectious disease of lung,32364011,10.1080/07391102.2020.1764393,2020-05-05
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Radionuclide Imaging,32364011,10.1080/07391102.2020.1764393,2020-05-05
other medicated shampoos in ATC,TREATS,Patients,32364011,10.1080/07391102.2020.1764393,2020-05-05
other medicated shampoos in ATC,TREATS(INFER),Malignant Neoplasms,32364011,10.1080/07391102.2020.1764393,2020-05-05
Disease,COEXISTS_WITH,Crisis,32364011,10.1080/07391102.2020.1764393,2020-05-05
Coronavirus Infections,COEXISTS_WITH(SPEC),Crisis,32364011,10.1080/07391102.2020.1764393,2020-05-05
Coronavirus Infections,ISA,Disease,32364011,10.1080/07391102.2020.1764393,2020-05-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32363963,10.1080/09546634.2020.1764472,2020-05-05
"Immunoglobulins, Intravenous",TREATS,"Pemphigoid, Benign Mucous Membrane",32363880,10.1177/2048872620922790,2020-05-05
Pharmaceutical Preparations,NEG_TREATS,Infection,32363809,10.1002/alr.22602,2020-05-05
Breath,ASSOCIATED_WITH,Negative Test Result,32363750,10.1002/minf.202000080,2020-05-05
Altered Taste,COEXISTS_WITH,Symptoms,32363750,10.1002/minf.202000080,2020-05-05
Intestinal infectious disease (disorder),PROCESS_OF,Animals,32363596,10.1002/bjs.11679,2020-05-05
Intestinal infectious disease (disorder),PROCESS_OF,Homo sapiens,32363596,10.1002/bjs.11679,2020-05-05
Genus: Coronavirus,ISA,RNA Viruses,32363596,10.1002/bjs.11679,2020-05-05
Movement,PROCESS_OF,Patients,32363506,10.1007/s10072-020-04442-1,2020-05-05
Medical Devices,TREATS,Pneumoperitoneum,32363506,10.1007/s10072-020-04442-1,2020-05-05
Minimally Invasive Surgical Procedures,NEG_TREATS,Crisis,32363506,10.1007/s10072-020-04442-1,2020-05-05
Confusion,PROCESS_OF,Population Group,32363492,10.1007/s00787-020-01541-4,2020-05-05
Parkinson Disease,PROCESS_OF,Patients,32363492,10.1007/s00787-020-01541-4,2020-05-05
Frail,PROCESS_OF,Population Group,32363492,10.1007/s00787-020-01541-4,2020-05-05
Clinical Services,TREATS,Patients,32363492,10.1007/s00787-020-01541-4,2020-05-05
Clinical Services,TREATS(INFER),Parkinson Disease,32363492,10.1007/s00787-020-01541-4,2020-05-05
Emotional disorder,PROCESS_OF,Adolescent (age group),32363428,10.1007/s11357-020-00193-1,2020-05-05
Anxiety symptoms,PROCESS_OF,Adolescent (age group),32363428,10.1007/s11357-020-00193-1,2020-05-05
Anxiety symptoms,PROCESS_OF,high school students,32363428,10.1007/s11357-020-00193-1,2020-05-05
Mental problem,PROCESS_OF,Adolescent (age group),32363428,10.1007/s11357-020-00193-1,2020-05-05
mental health,PROCESS_OF,Adolescent (age group),32363428,10.1007/s11357-020-00193-1,2020-05-05
Airway structure,LOCATION_OF,Virus Diseases,32363391,10.1093/glycob/cwaa042,2020-05-05
"Vitronectin, human",AUGMENTS,Virus Attachment,32363351,10.1016/j.jaccas.2020.04.023,2020-05-05
Mass Spectrometry,USES,High resolution,32363351,10.1016/j.jaccas.2020.04.023,2020-05-05
Echocardiography,DIAGNOSES,ventricular hypokinesia,32363350,10.1007/s42843-020-00010-5,2020-05-05
Anxiety,PROCESS_OF,Psychologist,32363349,10.1007/s42843-020-00011-4,2020-05-05
IMPACT gene,AFFECTS,Anxiety,32363349,10.1007/s42843-020-00011-4,2020-05-05
Critical Illness,PROCESS_OF,Pregnant Women,32363336,10.1016/j.ajogmf.2020.100113,2020-05-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32363336,10.1016/j.ajogmf.2020.100113,2020-05-05
Coronavirus Infections,PROCESS_OF,Patients,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Gravidity,PROCESS_OF,Patients,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Cardiac dysfunction,PROCESS_OF,Patients,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Viral myocarditis,COEXISTS_WITH,patient condition,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Cardiomyopathies,COEXISTS_WITH,patient condition,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Cardiomyopathies,PROCESS_OF,Patients,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Pregnancy,PROCESS_OF,Pregnant Women,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Pneumonia,PROCESS_OF,Pregnant Women,32363334,10.1016/j.cjco.2020.04.003,2020-05-05
Extracorporeal Membrane Oxygenation,TREATS,Shock,32363326,10.1136/gpsych-2020-100216,2020-05-05
Cardiac complication,PROCESS_OF,Patients,32363326,10.1136/gpsych-2020-100216,2020-05-05
Pneumonia,ISA,Disease,32363255,10.1021/acsomega.0c00772,2020-05-05
Mental disorders,PROCESS_OF,Patients,32363255,10.1021/acsomega.0c00772,2020-05-05
Mental disorders,PROCESS_OF,hospitalized patients,32363255,10.1021/acsomega.0c00772,2020-05-05
Allium sativum,LOCATION_OF,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
Organic sulfur compound,COEXISTS_WITH,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
Human body,LOCATION_OF,receptor,32363254,10.20411/pai.v5i1.372,2020-05-05
Molecular Genetic Technique,USES,Boat dock,32363254,10.20411/pai.v5i1.372,2020-05-05
Amino Acids,INTERACTS_WITH,angiotensin converting enzyme 2,32363254,10.20411/pai.v5i1.372,2020-05-05
Allium sativum,LOCATION_OF,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
Allium sativum,LOCATION_OF,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
diallyl disulfide,COEXISTS_WITH,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
diallyl trisulfide,COEXISTS_WITH,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
Allium sativum,LOCATION_OF,"Oils, Volatile",32363254,10.20411/pai.v5i1.372,2020-05-05
"Oils, Volatile",ADMINISTERED_TO,Human body,32363254,10.20411/pai.v5i1.372,2020-05-05
Atypical pneumonia,PROCESS_OF,Patients,32363226,10.1016/j.jrid.2020.03.004,2020-05-05
MALL gene,DISRUPTS,Severe Acute Respiratory Syndrome,32363222,10.1016/j.gendis.2020.03.008,2020-05-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Biological Relative,32363222,10.1016/j.gendis.2020.03.008,2020-05-05
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32363222,10.1016/j.gendis.2020.03.008,2020-05-05
Fever,ISA,Symptoms,32363221,10.1016/j.cmrp.2020.04.001,2020-05-05
Diarrhea,COEXISTS_WITH,Disease,32363221,10.1016/j.cmrp.2020.04.001,2020-05-05
Diarrhea,PROCESS_OF,Patients,32363221,10.1016/j.cmrp.2020.04.001,2020-05-05
Influenza-like symptoms,MANIFESTATION_OF,Virus Diseases,32363219,10.1007/s13337-020-00585-z,2020-05-05
Influenza-like symptoms,PROCESS_OF,Persons,32363219,10.1007/s13337-020-00585-z,2020-05-05
Coughing,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Coughing,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Diarrhea,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Diarrhea,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Fatigue,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Fatigue,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Fever,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Fever,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Nausea,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Nausea,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Vomiting,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Vomiting,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Respiratory distress,ISA,Symptoms,32363219,10.1007/s13337-020-00585-z,2020-05-05
Respiratory distress,PROCESS_OF(SPEC),Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Symptoms,PROCESS_OF,Adult,32363219,10.1007/s13337-020-00585-z,2020-05-05
Anoxia,PROCESS_OF,Patients,32363219,10.1007/s13337-020-00585-z,2020-05-05
Nonadministration of necessary drug or medicine,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32363212,10.1093/ofid/ofaa130,2020-05-05
Protease Inhibitors,ISA,Pharmaceutical Preparations,32363212,10.1093/ofid/ofaa130,2020-05-05
Proteins,INTERACTS_WITH,Pharmaceutical Preparations,32363212,10.1093/ofid/ofaa130,2020-05-05
Proteins,INTERACTS_WITH(SPEC),Protease Inhibitors,32363212,10.1093/ofid/ofaa130,2020-05-05
Pharmaceutical Preparations,AFFECTS,Vitality,32363212,10.1093/ofid/ofaa130,2020-05-05
Protease Inhibitors,AFFECTS(SPEC),Vitality,32363212,10.1093/ofid/ofaa130,2020-05-05
Protease Inhibitors,ISA,Pharmaceutical Preparations,32363212,10.1093/ofid/ofaa130,2020-05-05
Disease,PROCESS_OF,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Disease,PROCESS_OF,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,PROCESS_OF,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Infected,PROCESS_OF,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Disease,PROCESS_OF,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Patient Isolation,TREATS,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Patient Isolation,TREATS(INFER),Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Patient Isolation,compared_with,Isolation procedure,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Patient Isolation,same_as,Isolation procedure,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Isolation procedure,TREATS,Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Isolation procedure,TREATS(INFER),Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,ISA,Disease,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32363157,10.4103/ijabmr.IJABMR_141_20,2020-05-05
Pharmaceutical Preparations,PART_OF,World,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
Vaccines,PART_OF,World,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
Chloroquine,ISA,Pharmaceutical Preparations,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
Hydroxychloroquine,ISA,Antimalarials,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
SARS coronavirus,PROCESS_OF,Persons,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32363146,10.1016/j.idcr.2020.e00782,2020-05-05
Fever,PROCESS_OF,Male population group,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Coronavirus Infections,ISA,Disease,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Nasal Swabs,TREATS,Disease,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Nasal Swabs,TREATS(SPEC),Coronavirus Infections,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Chloroquine,TREATS,Patients,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Azithromycin,TREATS,Patients,32363137,10.1016/j.apsb.2020.04.013,2020-05-05
Hypertensive disease,PROCESS_OF,Patients,32363136,10.1016/j.apsb.2020.04.009,2020-05-05
Coronavirus Infections,ISA,Disease,32363133,10.1007/s12553-020-00429-2,2020-05-05
SARS coronavirus,CAUSES,Disease,32363133,10.1007/s12553-020-00429-2,2020-05-05
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32363133,10.1007/s12553-020-00429-2,2020-05-05
Infection,PROCESS_OF,Homo sapiens,32363133,10.1007/s12553-020-00429-2,2020-05-05
Nucleocapsid Proteins,INTERACTS_WITH,Antiviral Agents,32363133,10.1007/s12553-020-00429-2,2020-05-05
Prophylactic treatment,TREATS,Disease,32363045,10.1016/j.cdtm.2020.02.003,2020-05-05
Pneumonia,PROCESS_OF,Transplant Recipients,32363011,10.1080/20008686.2020.1754538,2020-05-05
Virus,PROCESS_OF,special populations,32363011,10.1080/20008686.2020.1754538,2020-05-05
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32362969,10.14740/jocmr4142,2020-05-05
Awareness,PROCESS_OF,Health Personnel,32362799,10.1016/j.asoc.2020.106282,2020-05-05
"CD69 protein, human",AUGMENTS,Awareness,32362799,10.1016/j.asoc.2020.106282,2020-05-05
Decision,PROCESS_OF,Maker (occupation),32362735,10.1007/s11224-020-01536-6,2020-05-05
Pharmaceutical Preparations,TREATS,Homo sapiens,32362732,10.1016/j.jceh.2020.04.001,2020-05-05
Multiple Organ Failure,CAUSES,Cessation of life,32362721,10.1016/j.chb.2020.106357,2020-05-05
Challenge,TREATS,Crisis,32362711,10.1016/j.worlddev.2020.104953,2020-05-05
Male population group,ISA,Population Group,32362697,10.1016/j.physd.2020.132540,2020-05-05
Diet,AFFECTS,Blood Pressure,32362697,10.1016/j.physd.2020.132540,2020-05-05
Blood Pressure,AFFECTS,Homo sapiens,32362697,10.1016/j.physd.2020.132540,2020-05-05
IMPACT gene,PART_OF,Homo sapiens,32362697,10.1016/j.physd.2020.132540,2020-05-05
IMPACT gene,STIMULATES,SPEN gene,32362697,10.1016/j.physd.2020.132540,2020-05-05
Cell surface,LOCATION_OF,Dynamics,32362647,10.4103/ijmr.IJMR_1035_20,2020-05-05
Virion,PART_OF,Cells,32362647,10.4103/ijmr.IJMR_1035_20,2020-05-05
Patients,LOCATION_OF,sentinel,32362646,10.4103/ijmr.IJMR_1166_20,2020-05-05
Patients,LOCATION_OF,sentinel,32362646,10.4103/ijmr.IJMR_1166_20,2020-05-05
Introduction procedure,ADMINISTERED_TO,Community,32362644,10.4103/ijmr.IJMR_502_20,2020-05-05
Readiness,PROCESS_OF,Community,32362644,10.4103/ijmr.IJMR_502_20,2020-05-05
lopinavir / Ritonavir,ADMINISTERED_TO,hospitalized patients,32362643,10.4103/ijmr.IJMR_518_20,2020-05-05
SARS coronavirus,PROCESS_OF,hospitalized patients,32362643,10.4103/ijmr.IJMR_518_20,2020-05-05
Illness (finding),PROCESS_OF,Patients,32362642,10.4103/ijmr.IJMR_519_20,2020-05-05
Critical Illness,PROCESS_OF,Patients,32362642,10.4103/ijmr.IJMR_519_20,2020-05-05
Lacuna,INTERACTS_WITH,Pharmacist,32362571,10.1016/j.rbmo.2020.04.009,2020-05-05
Coronavirus Infections,ISA,Disease,32362564,10.1016/j.anorl.2020.04.012,2020-05-05
Infected,PROCESS_OF,Persons,32362564,10.1016/j.anorl.2020.04.012,2020-05-05
Pharmaceutical Preparations,TREATS,Patients,32362498,10.1016/j.eururo.2020.04.055,2020-05-05
Malignant neoplasm of prostate,PROCESS_OF,Male population group,32362440,10.1016/j.jiac.2020.04.007,2020-05-05
risk factors,PROCESS_OF,Patients,32362440,10.1016/j.jiac.2020.04.007,2020-05-05
Severe course,PROCESS_OF,Patients,32362440,10.1016/j.jiac.2020.04.007,2020-05-05
Steroids,TREATS,Inflammation,32362433,10.1016/j.acvd.2020.04.002,2020-05-05
Acute Disease,PROCESS_OF,Patients,32362424,10.1016/j.medin.2020.03.001,2020-05-05
Cardiovascular,LOCATION_OF,Acute Disease,32362424,10.1016/j.medin.2020.03.001,2020-05-05
Disease,PROCESS_OF,hospitalized patients,32362392,10.1016/j.healun.2020.03.008,2020-05-05
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",PROCESS_OF,Recipient,32362384,10.1016/j.arbres.2020.03.017,2020-05-05
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",PROCESS_OF,Recipient,32362384,10.1016/j.arbres.2020.03.017,2020-05-05
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",PROCESS_OF,Recipient,32362384,10.1016/j.arbres.2020.03.017,2020-05-05
Lymphopenia,PROCESS_OF,Recipient,32362384,10.1016/j.arbres.2020.03.017,2020-05-05
Respiratory endoscope,TREATS,Patients,32362368,10.1016/j.jviscsurg.2020.04.014,2020-05-05
Appendicitis,ISA,Disease,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
Appendectomy,ISA,Operative Surgical Procedures,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
Appendectomy,TREATS,Appendicitis,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
Recurrent appendicitis,ISA,Appendicitis,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
treatment options,TREATS,Appendicitis,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
treatment options,TREATS(SPEC),Recurrent appendicitis,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
Appendicitis,PROCESS_OF,Adult,32362345,10.1016/j.clinthera.2020.04.010,2020-05-05
Depressive disorder,PROCESS_OF,Patients,32362344,10.1016/j.clinthera.2020.04.009,2020-05-05
Pneumonia,COEXISTS_WITH,risk factors,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
Pneumonia,PROCESS_OF,Patients,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,risk factors,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
risk factors,PROCESS_OF,Patients,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
Interventional procedure,ADMINISTERED_TO,Patients,32362314,10.1016/j.molcel.2020.04.022,2020-05-05
Genus: Coronavirus,NEG_LOCATION_OF,Viral Proteins,32362299,10.1192/bjp.2020.92,2020-05-05
paired basic amino acid cleaving enzyme,ISA,Endopeptidases,32362299,10.1192/bjp.2020.92,2020-05-05
"Vitronectin, human",AFFECTS,syncytium formation by plasma membrane fusion,32362299,10.1192/bjp.2020.92,2020-05-05
Ambulatory Care Facilities,LOCATION_OF,Diagnosis,32362295,10.1192/bjp.2020.90,2020-05-05
Ambulatory Care Facilities,LOCATION_OF,Nucleic Acid Amplification Tests,32362295,10.1192/bjp.2020.90,2020-05-05
Triage,ISA,Interventional procedure,32362295,10.1192/bjp.2020.90,2020-05-05
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32362295,10.1192/bjp.2020.90,2020-05-05
United States,ISA,Country,32362245,10.1080/07391102.2020.1763201,2020-05-05
Pharmaceutical Preparations,TREATS,Virus,32362244,10.1177/1747493020923234,2020-05-05
Indinavir,ISA,Antiviral Agents,32362244,10.1177/1747493020923234,2020-05-05
Ischemic stroke,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Cerebrovascular accident,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Cerebrovascular accident,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
consideration,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Cerebrovascular accident,PROCESS_OF,Patients,32362243,10.1080/07391102.2020.1763202,2020-05-05
Pandemics,CAUSES,Coronavirus Infections,32362235,10.1080/07391102.2020.1752310,2020-05-05
Endopeptidases,COEXISTS_WITH,MAL gene,32362235,10.1080/07391102.2020.1752310,2020-05-05
Drug Discovery,USES,Drug Delivery Systems,32362235,10.1080/07391102.2020.1752310,2020-05-05
Antitussive Agents,TREATS,refractory cancer,32362217,10.1080/07391102.2020.1763199,2020-05-05
Noscapine,ISA,Antineoplastic Agents,32362217,10.1080/07391102.2020.1763199,2020-05-05
consideration,PROCESS_OF,World,32362106,10.31128/AJGP-COVID-18,2020-05-05
Elective Surgical Procedures,TREATS,Decreased tolerance,32362106,10.31128/AJGP-COVID-18,2020-05-05
Possible,PREDISPOSES,INFECTIOUS PROCESS,32362106,10.31128/AJGP-COVID-18,2020-05-05
Health Personnel,ISA,Persons,32362106,10.31128/AJGP-COVID-18,2020-05-05
Biological Factors,INHIBITS(SPEC),Interleukin-4,32362045,10.1111/jdv.16574,2020-05-04
Biological Factors,INHIBITS(SPEC),Interleukin-13,32362045,10.1111/jdv.16574,2020-05-04
Biological Factors,ISA,Pharmaceutical Preparations,32362045,10.1111/jdv.16574,2020-05-04
Pharmaceutical Preparations,INHIBITS,Interleukin-4,32362045,10.1111/jdv.16574,2020-05-04
Pharmaceutical Preparations,INHIBITS,Interleukin-13,32362045,10.1111/jdv.16574,2020-05-04
dupilumab,TREATS,Adult atopic dermatitis,32362045,10.1111/jdv.16574,2020-05-04
Interleukin-4,ISA,cytokine,32362045,10.1111/jdv.16574,2020-05-04
Interleukin-13,ISA,cytokine,32362045,10.1111/jdv.16574,2020-05-04
Virus Diseases,AFFECTS,Asthma,32362045,10.1111/jdv.16574,2020-05-04
Exacerbation,COMPLICATES,Asthma,32362045,10.1111/jdv.16574,2020-05-04
Patients,ISA,Persons,32362045,10.1111/jdv.16574,2020-05-04
Chronic disease,PROCESS_OF,Persons,32361996,10.1111/trf.15841,2020-05-04
Chronic disease,PROCESS_OF,Population Group,32361996,10.1111/trf.15841,2020-05-04
Chronic disease,PROCESS_OF(SPEC),Old age,32361996,10.1111/trf.15841,2020-05-04
Old age,ISA,Population Group,32361996,10.1111/trf.15841,2020-05-04
Infected,PROCESS_OF,Persons,32361996,10.1111/trf.15841,2020-05-04
Complete blood count without differential,NEG_DIAGNOSES,Symptom severe,32361996,10.1111/trf.15841,2020-05-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32361927,10.1007/s00167-020-06033-1,2020-05-04
Fever,PROCESS_OF,Patients,32361927,10.1007/s00167-020-06033-1,2020-05-04
Asymptomatic,PROCESS_OF,Patients,32361927,10.1007/s00167-020-06033-1,2020-05-04
Influenza-like symptoms,PROCESS_OF,Patients,32361927,10.1007/s00167-020-06033-1,2020-05-04
Symptoms,PROCESS_OF,Patients,32361927,10.1007/s00167-020-06033-1,2020-05-04
"CD69 protein, human",AFFECTS,Coronavirus Infections,32361911,10.1007/s11427-020-1705-0,2020-05-04
Arthroplasty,ISA,Operative Surgical Procedures,32361911,10.1007/s11427-020-1705-0,2020-05-04
Arthroplasty,ISA,Operative Surgical Procedures,32361911,10.1007/s11427-020-1705-0,2020-05-04
Repair of hip,TREATS,Femoral Neck Fractures,32361911,10.1007/s11427-020-1705-0,2020-05-04
Inferior Colliculus,LOCATION_OF,angiotensin converting enzyme 2,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,LOCATION_OF,Base Sequence,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,PART_OF,Testis,32361747,10.1093/cid/ciaa524,2020-05-04
Male gonocyte,LOCATION_OF,Base Sequence,32361747,10.1093/cid/ciaa524,2020-05-04
"Azoospermia, Nonobstructive",NEG_PROCESS_OF,Patients,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,PART_OF,Testis,32361747,10.1093/cid/ciaa524,2020-05-04
Male gonocyte,PART_OF,Homo sapiens,32361747,10.1093/cid/ciaa524,2020-05-04
angiotensin converting enzyme 2,INTERACTS_WITH,Male gonocyte,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,LOCATION_OF,Cathepsin L,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,LOCATION_OF,Cathepsins B,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,LOCATION_OF,TMPRSS2 gene,32361747,10.1093/cid/ciaa524,2020-05-04
Cells,LOCATION_OF,BSG gene,32361747,10.1093/cid/ciaa524,2020-05-04
Aspergillus,CAUSES,Pneumonia,32361744,10.1093/jac/dkaa152,2020-05-04
Bacteria,CAUSES,Pneumonia,32361744,10.1093/jac/dkaa152,2020-05-04
Superinfection,PROCESS_OF,Patients,32361744,10.1093/jac/dkaa152,2020-05-04
Antibiotics,TREATS,Superinfection,32361744,10.1093/jac/dkaa152,2020-05-04
Homo sapiens,ISA,Primates,32361738,10.1093/cid/ciaa539,2020-05-04
Donor person,LOCATION_OF,Plasma,32361738,10.1093/cid/ciaa539,2020-05-04
Laboratory Procedures,USES,"TNFRSF11A protein, human",32361723,10.1093/cid/ciaa538,2020-05-04
Leukocytosis,PREDISPOSES,Unfavorable Clinical Outcome,32361723,10.1093/cid/ciaa538,2020-05-04
risk factors,PREDISPOSES,Poor outcome,32361723,10.1093/cid/ciaa538,2020-05-04
Hospitals,LOCATION_OF,Study,32361715,10.1967/s002449912014,2020-05-04
Anosmia,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Coughing,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Fatigue,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Fever,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Ageusia,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Comorbidity,PROCESS_OF,Patients,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Comorbidity,PROCESS_OF,Old age,32361628,10.1016/j.ejca.2020.04.003,2020-05-04
Physicians,TREATS,Patients,32361598,10.1016/j.watres.2020.115899,2020-05-04
Genitourinary Cancer,PROCESS_OF,Patients,32361598,10.1016/j.watres.2020.115899,2020-05-04
Clinic Visits,TREATS,Patients,32361598,10.1016/j.watres.2020.115899,2020-05-04
Genus: Coronavirus,ISA,Virus,32361588,10.1016/j.mehy.2020.109765,2020-05-04
Feces,PART_OF,Patients,32361588,10.1016/j.mehy.2020.109765,2020-05-04
Anal swab,PART_OF,Patients,32361588,10.1016/j.mehy.2020.109765,2020-05-04
Pharmaceutical Preparations,TREATS,Disease,32361535,10.1016/j.clinimag.2020.04.023,2020-05-04
Niclosamide,ISA,Pharmaceutical Preparations,32361535,10.1016/j.clinimag.2020.04.023,2020-05-04
Pneumonia,PROCESS_OF,Patients,32361529,10.1016/j.mehy.2020.109786,2020-05-04
Assay,METHOD_OF,Detection,32361528,10.1016/j.mehy.2020.109781,2020-05-04
Assay,METHOD_OF,Diagnosis,32361528,10.1016/j.mehy.2020.109781,2020-05-04
China,ISA,Country,32361458,10.1016/j.scitotenv.2020.139016,2020-05-04
A 19,DISRUPTS,Cessation of life,32361458,10.1016/j.scitotenv.2020.139016,2020-05-04
Arima,compared_with,Arima,32361443,10.1016/j.scitotenv.2020.138862,2020-05-04
Arima,higher_than,Arima,32361443,10.1016/j.scitotenv.2020.138862,2020-05-04
Infected,PROCESS_OF,Persons,32361428,10.1016/j.scitotenv.2020.139085,2020-05-04
Asymptomatic,PROCESS_OF,Patients,32361409,10.1016/j.cellimm.2020.104114,2020-05-04
Symptom mild,PROCESS_OF,Persons,32361388,10.1016/j.ajp.2020.102111,2020-05-04
Infected,PROCESS_OF,Persons,32361388,10.1016/j.ajp.2020.102111,2020-05-04
Abnormality,PROCESS_OF,Health Personnel,32361387,10.1016/j.ajp.2020.102052,2020-05-04
Experience,PROCESS_OF,Health Personnel,32361387,10.1016/j.ajp.2020.102052,2020-05-04
Depressive Symptoms,ISA,Anxiety Disorders,32361327,10.1016/j.jcv.2020.104392,2020-05-04
Pandemics,ISA,Disease Outbreaks,32361327,10.1016/j.jcv.2020.104392,2020-05-04
Worse,PROCESS_OF,Patients,32361325,10.1016/j.jcv.2020.104379,2020-05-04
Serum,LOCATION_OF,C-reactive protein,32361325,10.1016/j.jcv.2020.104379,2020-05-04
Worse,PROCESS_OF,Patients,32361325,10.1016/j.jcv.2020.104379,2020-05-04
Elevated C-reactive protein,PREDISPOSES,Prognosis bad,32361325,10.1016/j.jcv.2020.104379,2020-05-04
Hospitals,LOCATION_OF,Retrospective Studies,32361323,10.1016/j.jcv.2020.104377,2020-05-04
Infected,PROCESS_OF,Patients,32361323,10.1016/j.jcv.2020.104377,2020-05-04
Hospitals,LOCATION_OF,Analysis,32361322,10.1016/j.jcv.2020.104374,2020-05-04
Asymptomatic,PROCESS_OF,Patients,32361322,10.1016/j.jcv.2020.104374,2020-05-04
Leukopenia,PROCESS_OF,Patients,32361322,10.1016/j.jcv.2020.104374,2020-05-04
Asymptomatic,PROCESS_OF,Child,32361322,10.1016/j.jcv.2020.104374,2020-05-04
Asymptomatic,PROCESS_OF,Child,32361322,10.1016/j.jcv.2020.104374,2020-05-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32361285,10.1016/j.jcv.2020.104384,2020-05-04
Laboratory,LOCATION_OF,Assay,32361250,10.1016/j.ebiom.2020.102763,2020-05-04
Assay,METHOD_OF,Detection,32361250,10.1016/j.ebiom.2020.102763,2020-05-04
Disease,PROCESS_OF,Patients,32361161,10.1016/j.biopha.2020.110195,2020-05-04
Coronavirus Infections,ISA,Disease,32361161,10.1016/j.biopha.2020.110195,2020-05-04
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32361161,10.1016/j.biopha.2020.110195,2020-05-04
Lymphopenia,PROCESS_OF,Patients,32361161,10.1016/j.biopha.2020.110195,2020-05-04
Severe disorder,PROCESS_OF,Patients,32361161,10.1016/j.biopha.2020.110195,2020-05-04
Storm NOS,PROCESS_OF,Patients,32361161,10.1016/j.biopha.2020.110195,2020-05-04
China,ISA,Country,32361152,10.1016/j.chest.2020.04.036,2020-05-04
Diagnosis,USES,Basis,32361152,10.1016/j.chest.2020.04.036,2020-05-04
Protection,COEXISTS_WITH,Coronavirus Infections,32361118,10.1016/j.scitotenv.2020.138811,2020-05-04
Evaluation,ADMINISTERED_TO,Health Personnel,32361118,10.1016/j.scitotenv.2020.138811,2020-05-04
Evaluation,ADMINISTERED_TO,Patients,32361118,10.1016/j.scitotenv.2020.138811,2020-05-04
Bronchoscopy,ADMINISTERED_TO,Patients,32361118,10.1016/j.scitotenv.2020.138811,2020-05-04
Asymptomatic,PROCESS_OF,Patients,32361118,10.1016/j.scitotenv.2020.138811,2020-05-04
SARS coronavirus,CAUSES,Disease,32361100,10.1016/j.mehy.2020.109755,2020-05-04
China,ISA,Country,32361082,10.1016/j.envres.2020.109605,2020-05-04
Epithelium,LOCATION_OF,angiotensin converting enzyme 2,32361082,10.1016/j.envres.2020.109605,2020-05-04
Epithelium,PART_OF,Salivary duct structure,32361082,10.1016/j.envres.2020.109605,2020-05-04
saliva,PART_OF,Patients,32361082,10.1016/j.envres.2020.109605,2020-05-04
Salivary Glands,LOCATION_OF,Inflammatory lesion,32361082,10.1016/j.envres.2020.109605,2020-05-04
Organ,LOCATION_OF,Inflammatory lesion,32361082,10.1016/j.envres.2020.109605,2020-05-04
Patients,NEG_ISA,Persons,32361028,10.1016/j.ijantimicag.2020.106004,2020-05-04
Peptide Hydrolases,PART_OF,Host Cell,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Cathepsin L,ISA,Peptide Hydrolases,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Cathepsin L,PART_OF(SPEC),Host Cell,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Cathepsins B,ISA,Peptide Hydrolases,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Cathepsins B,PART_OF(SPEC),Host Cell,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Lysosomes,LOCATION_OF,Enzymes,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Agent,TREATS,Influenza,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Amantadine,TREATS,Patients,32361001,10.1016/j.micinf.2020.04.009,2020-05-04
Training,ISA,Knowledge acquisition,32360943,10.1016/j.ijid.2020.04.066,2020-05-04
Intervention regimes,PREVENTS,Shock,32360939,10.1016/j.ijid.2020.04.068,2020-05-04
PER1 gene,PART_OF,Patients,32360909,10.1016/j.scitotenv.2020.139021,2020-05-04
Evaluation procedure,ADMINISTERED_TO,Patients,32360907,10.1016/j.scitotenv.2020.138817,2020-05-04
Evaluation procedure,METHOD_OF,Detection,32360907,10.1016/j.scitotenv.2020.138817,2020-05-04
Pneumonia,PROCESS_OF,Pregnant Women,32360862,10.1016/j.ajo.2020.04.029,2020-05-04
Printer/plotter,ISA,Physical object,32360862,10.1016/j.ajo.2020.04.029,2020-05-04
Dispenser,USES,sanitizers,32360862,10.1016/j.ajo.2020.04.029,2020-05-04
Delivery care,COEXISTS_WITH,Telemedicine,32360811,10.1016/j.cgh.2020.04.071,2020-05-04
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32360793,10.1016/j.cjca.2020.04.030,2020-05-04
Infected,PROCESS_OF,Patients,32360793,10.1016/j.cjca.2020.04.030,2020-05-04
Asymptomatic,PROCESS_OF,Patients,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Coughing,ISA,Symptoms,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Nose,LOCATION_OF,Congestion,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Hypogeusia,ISA,Symptoms,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Hypogeusia,PROCESS_OF(SPEC),Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Rhinorrhea,ISA,Symptoms,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Rhinorrhea,PROCESS_OF(SPEC),Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Symptoms,PROCESS_OF,Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Sense of smell impaired,PROCESS_OF,Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Asymptomatic,PROCESS_OF,Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Sense of smell impaired,PROCESS_OF,Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
Asymptomatic,PROCESS_OF,Persons,32360770,10.1016/j.mbs.2020.108364,2020-05-04
World,LOCATION_OF,IMPACT gene,32360733,10.1016/j.wneu.2020.04.181,2020-05-04
Quarantine,ISA,Isolation procedure,32360733,10.1016/j.wneu.2020.04.181,2020-05-04
Coronavirus Infections,ISA,Disease,32360729,10.1016/j.chest.2020.04.032,2020-05-04
Pathogenic organism,CAUSES,Disease,32360729,10.1016/j.chest.2020.04.032,2020-05-04
Pathogenic organism,CAUSES(SPEC),Coronavirus Infections,32360729,10.1016/j.chest.2020.04.032,2020-05-04
Asthma,PREDISPOSES,Severe disorder,32360710,10.1016/j.diabres.2020.108185,2020-05-04
Severe disorder,PROCESS_OF,Patients,32360710,10.1016/j.diabres.2020.108185,2020-05-04
Asthma,PROCESS_OF,Male population group,32360710,10.1016/j.diabres.2020.108185,2020-05-04
Asthma,CAUSES,Mucus cast,32360710,10.1016/j.diabres.2020.108185,2020-05-04
SARS coronavirus,COEXISTS_WITH,diffuse alveolar damage,32360710,10.1016/j.diabres.2020.108185,2020-05-04
Middle East Respiratory Syndrome Coronavirus,COEXISTS_WITH,diffuse alveolar damage,32360710,10.1016/j.diabres.2020.108185,2020-05-04
Diabetes,PROCESS_OF,Patients,32360703,10.1016/j.yjmcc.2020.04.031,2020-05-04
Severe (severity modifier),PREDISPOSES,Severe Acute Respiratory Syndrome,32360703,10.1016/j.yjmcc.2020.04.031,2020-05-04
Hyperglycemia,AFFECTS,Patients,32360703,10.1016/j.yjmcc.2020.04.031,2020-05-04
treatment options,TREATS,Cardiovascular Diseases,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
treatment options,TREATS,Immunocompromised Host,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
intensive care,PREVENTS,Sudden death,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
intensive care,PREVENTS,Multiple Organ Failure,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
angiotensin converting enzyme 2,INHIBITS,angiotensin II,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
inhibitors,TREATS,Cardiovascular Diseases,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
inhibitors,TREATS,Hypertensive disease,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
Patients,LOCATION_OF,angiotensin converting enzyme 2,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
Cardiovascular Diseases,AFFECTS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32360683,10.1016/j.jvs.2020.04.482,2020-05-04
Coronavirus Infections,PROCESS_OF,Patients,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Study,MEASURES,Incidence,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Limb ischemia,PROCESS_OF,Patients,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Limb ischemia,PROCESS_OF,Patients,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Limb ischemia,PROCESS_OF,Patients,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
heparin,ASSOCIATED_WITH,Limb ischemia,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Limb Salvage,ISA,Operative Surgical Procedures,32360608,10.1016/j.pbiomolbio.2020.04.002,2020-05-04
Coronavirus Infections,ISA,Disease,32360585,10.1016/j.phrs.2020.104854,2020-05-04
,AFFECTS,Membrane Fusion,32360585,10.1016/j.phrs.2020.104854,2020-05-04
Protein S,AFFECTS,Membrane Fusion,32360585,10.1016/j.phrs.2020.104854,2020-05-04
ACE2 gene,AFFECTS,Membrane Fusion,32360585,10.1016/j.phrs.2020.104854,2020-05-04
Fatigue,ISA,Symptoms,32360583,10.1016/j.phrs.2020.104872,2020-05-04
Fever,ISA,Symptoms,32360583,10.1016/j.phrs.2020.104872,2020-05-04
Dry cough,ISA,Symptoms,32360583,10.1016/j.phrs.2020.104872,2020-05-04
Prognosis good,PROCESS_OF,Patients,32360583,10.1016/j.phrs.2020.104872,2020-05-04
Evaluation,TREATS,Severe Acute Respiratory Syndrome,32360581,10.1016/j.phrs.2020.104874,2020-05-04
Infected,PROCESS_OF,Patients,32360581,10.1016/j.phrs.2020.104874,2020-05-04
Evaluation,TREATS,Cohort,32360581,10.1016/j.phrs.2020.104874,2020-05-04
Plain chest X-ray,CAUSES,Symptoms,32360581,10.1016/j.phrs.2020.104874,2020-05-04
Cell Count,USES,MIR7-3HG gene,32360578,10.1016/j.jtho.2020.04.016,2020-05-04
Assay,MEASURES,Cell Count,32360578,10.1016/j.jtho.2020.04.016,2020-05-04
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Comorbidity,PROCESS_OF,Patients,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Therapeutic procedure,TREATS,Non-Small Cell Lung Carcinoma,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Disease,PROCESS_OF,Patients,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Chemoimmunotherapy,ISA,Pharmacotherapy,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Chemoimmunotherapy,TREATS,Enthesitis-Related Arthritis,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Therapeutic procedure,AFFECTS,Patients,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
cancer therapy,TREATS,Negative Test Result,32360552,10.1016/j.ijid.2020.04.035,2020-05-04
Interleukin-6,AFFECTS,Lung Injury,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Interleukin-6,AFFECTS(SPEC),Lung Injury,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Interleukin-6,ASSOCIATED_WITH,Storm NOS,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Interleukin-6,ASSOCIATED_WITH(SPEC),Storm NOS,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Interleukin-6,ISA,cytokine,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
cytokine,AFFECTS,Lung Injury,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
cytokine,ASSOCIATED_WITH,Storm NOS,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Interventional procedure,AFFECTS,Patients,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Pneumonia,CAUSES,Severe Acute Respiratory Syndrome,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32360500,10.1016/j.jinf.2020.04.030,2020-05-04
Prophylactic treatment,TREATS,Child,32360497,10.1016/j.jinf.2020.04.031,2020-05-04
Pediculus (eukaryote),INTERACTS_WITH,Pediatrician (occupation),32360497,10.1016/j.jinf.2020.04.031,2020-05-04
Nucleic Acids,PART_OF,Virus,32360497,10.1016/j.jinf.2020.04.031,2020-05-04
Asymptomatic Infections,PROCESS_OF,Adult,32360497,10.1016/j.jinf.2020.04.031,2020-05-04
Experience,PROCESS_OF,Child,32360497,10.1016/j.jinf.2020.04.031,2020-05-04
Mass Spectrometry,USES,High resolution,32360482,10.1016/j.phrs.2020.104849,2020-05-04
Lipopolysaccharides,CAUSES,Pneumonia,32360482,10.1016/j.phrs.2020.104849,2020-05-04
Glycyrrhizic Acid,INHIBITS,agonists,32360482,10.1016/j.phrs.2020.104849,2020-05-04
agonists,AUGMENTS,interleukin-6 production,32360482,10.1016/j.phrs.2020.104849,2020-05-04
Fever,COEXISTS_WITH,Disease,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Fever,COEXISTS_WITH(SPEC),Disease,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Fever,ISA,Symptoms,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Ibuprofen,TREATS,Fever,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Ibuprofen,TREATS,Symptoms,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Ibuprofen,TREATS(SPEC),Fever,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Symptoms,COEXISTS_WITH,Disease,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Infection,AFFECTS,Patients,32360481,10.1016/j.phrs.2020.104821,2020-05-04
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32360481,10.1016/j.phrs.2020.104821,2020-05-04
"Anti-Inflammatory Agents, Non-Steroidal",TREATS(INFER),Infection,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Cyclooxygenase 2 Inhibitors,TREATS,Patients,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Cyclooxygenase 2 Inhibitors,TREATS(INFER),Infection,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Infection,PROCESS_OF,Patients,32360481,10.1016/j.phrs.2020.104821,2020-05-04
Hospitals,LOCATION_OF,Polymerase Chain Reaction,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Polymerase Chain Reaction,METHOD_OF,Epidemiology,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Symptoms,PROCESS_OF,Patients,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Fever,ISA,Symptoms,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Comorbidity,PROCESS_OF,Patients,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Lung,PART_OF,Patients,32360480,10.1016/j.phrs.2020.104859,2020-05-04
Vaccines,TREATS,Virus,32360479,10.1016/j.clinbiochem.2020.04.008,2020-05-04
angiotensin converting enzyme 2,INHIBITS,TMPRSS2 gene,32360479,10.1016/j.clinbiochem.2020.04.008,2020-05-04
lopinavir,ISA,HIV Protease Inhibitors,32360479,10.1016/j.clinbiochem.2020.04.008,2020-05-04
Hemodialysis,TREATS,Patients,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Hemodialysis,TREATS(INFER),"Kidney Failure, Chronic",32360444,10.1016/j.cmi.2020.04.031,2020-05-04
"Kidney Failure, Chronic",COMPLICATES,Pneumonia,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
"Kidney Failure, Chronic",PROCESS_OF,inpatient,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
"Kidney Failure, Chronic",PROCESS_OF,Patients,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Laboratory Procedures,DIAGNOSES,Lymphocyte count decreased,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Patients,LOCATION_OF,Multiple plaques,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Continuous venovenous hemodiafiltration,ADMINISTERED_TO,Patients,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Pneumonia,NEG_PROCESS_OF,Patients,32360444,10.1016/j.cmi.2020.04.031,2020-05-04
Italy,ISA,European country,32360439,10.1016/j.bbi.2020.04.077,2020-05-04
Anti-Inflammatory Agents,ADMINISTERED_TO,Patients,32360439,10.1016/j.bbi.2020.04.077,2020-05-04
Awareness,PROCESS_OF,Patients,32360439,10.1016/j.bbi.2020.04.077,2020-05-04
Worse,PROCESS_OF,Patients,32360439,10.1016/j.bbi.2020.04.077,2020-05-04
Present,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Disease,COMPLICATES,Acute Cerebrovascular Accidents,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Confirmation,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Cerebrovascular accident,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Cerebrovascular accident,PROCESS_OF,teams,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Wariness,PROCESS_OF,Patients,32360432,10.1016/j.avsg.2020.04.040,2020-05-04
Pneumonia,PROCESS_OF,Patients,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Thrombosis,PROCESS_OF,Patients,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Wound Healing,PROCESS_OF,Patients,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
interstitial,LOCATION_OF,Bilateral pneumonia,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Low molecular weight heparin therapy,USES,"Condoms, Male",32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
"Ultrasonography, Doppler, Duplex",DIAGNOSES,Thrombosis,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Aortic graft,LOCATION_OF,Thrombosis,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Radionuclide Imaging,DIAGNOSES,Thrombosis,32360420,10.1016/j.cytogfr.2020.04.002,2020-05-04
Interventional procedure,STIMULATES,cytokine production,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
Interventional procedure,TREATS,Patients,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
cytokine production,PROCESS_OF,Patients,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
Symptom mild,PROCESS_OF,Patients,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
Symptoms,PROCESS_OF,Patients,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
Storm NOS,CAUSES,Multiple Organ Failure,32360384,10.1016/j.athoracsur.2020.04.013,2020-05-04
immobilization prolonged,COEXISTS_WITH,Dehydration,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
immobilization prolonged,COEXISTS_WITH,Septicemia,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
immobilization prolonged,COEXISTS_WITH,Respiratory Failure,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
Lung,LOCATION_OF,Massive embolus,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
Embolectomy,ISA,Operative Surgical Procedures,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
Embolectomy,TREATS,Massive embolus,32360355,10.1016/j.jhin.2020.04.041,2020-05-04
Microorganism,ISA,Organism,32360302,10.1016/j.gie.2020.04.049,2020-05-04
Staphylococcus aureus,ISA,Organism,32360302,10.1016/j.gie.2020.04.049,2020-05-04
"Staphylococcus, coagulase negative (organism)",ISA,Organism,32360302,10.1016/j.gie.2020.04.049,2020-05-04
Health Care,AFFECTS,Possible,32360302,10.1016/j.gie.2020.04.049,2020-05-04
Severe Acute Respiratory Syndrome,ISA,Disease,32360286,10.1016/j.jaci.2020.04.027,2020-05-04
Antiviral Agents,TREATS,Coronavirus Infections,32360286,10.1016/j.jaci.2020.04.027,2020-05-04
Coronavirus Infections,PROCESS_OF,Homo sapiens,32360286,10.1016/j.jaci.2020.04.027,2020-05-04
silvestrol,DISRUPTS,Coronavirus Infections,32360286,10.1016/j.jaci.2020.04.027,2020-05-04
Patients,LOCATION_OF,cytokine,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Plasma specimen,LOCATION_OF,cytokine,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
,STIMULATES,Proteins,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Critical Illness,PROCESS_OF,Patients,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Monokines,STIMULATES,,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Monokines,STIMULATES,Hepatocyte Growth Factor,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Monokines,STIMULATES,Small Inducible Cytokine A3,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Monokines,STIMULATES,"CCL7 protein, human",32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
Disease Progression,PROCESS_OF,Patients,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
cytokine,ASSOCIATED_WITH,Disease,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
cytokine,ASSOCIATED_WITH,Fatal Outcome,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
,STIMULATES,Proteins,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
"CCL7 protein, human",COEXISTS_WITH,cytokine,32360238,10.1016/j.jpainsymman.2020.04.022,2020-05-04
arbidol,INTERACTS_WITH,Glycoproteins,32360230,10.1016/j.ijantimicag.2020.106001,2020-05-04
Digestive symptom,PROCESS_OF,Patients,32360182,10.1016/j.antiviral.2020.104811,2020-05-04
Lung,LOCATION_OF,Symptoms,32360182,10.1016/j.antiviral.2020.104811,2020-05-04
Viral Shedding,PROCESS_OF,Patients,32360182,10.1016/j.antiviral.2020.104811,2020-05-04
Recombinant Interferon,PART_OF,Homo sapiens,32360181,10.1016/j.sapharm.2020.04.020,2020-05-04
Vero Cells,LOCATION_OF,,32360181,10.1016/j.sapharm.2020.04.020,2020-05-04
Vero Cells,LOCATION_OF,,32360181,10.1016/j.sapharm.2020.04.020,2020-05-04
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32360126,10.1016/j.lfs.2020.117723,2020-05-04
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32360126,10.1016/j.lfs.2020.117723,2020-05-04
receptor,CAUSES,Heart failure,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
receptor,CAUSES,Cardiomyopathies,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
receptor,CAUSES,Cardiac dysfunction,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Cardiovascular Diseases,PROCESS_OF,Patients,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Symptom severe,PROCESS_OF,Patients,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Cardiac Arrhythmia,COEXISTS_WITH,Cardiovascular Diseases,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Coronary Arteriosclerosis,COEXISTS_WITH,Cardiovascular Diseases,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Hypertensive disease,COEXISTS_WITH,Cardiovascular Diseases,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Cardiomyopathies,COEXISTS_WITH,Cardiovascular Diseases,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Infected,PROCESS_OF,Patients,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Cardiac troponin I,PART_OF,Patients,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Inflammation,MANIFESTATION_OF,myocardial injury,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Interferons,AFFECTS,Immune response,32360119,10.1016/j.ajem.2020.04.080,2020-05-04
Acute respiratory distress,PROCESS_OF,Patients,32360111,10.1016/j.ajog.2020.04.020,2020-05-04
Coronary angiography,DIAGNOSES,Normal coronary arteries,32360111,10.1016/j.ajog.2020.04.020,2020-05-04
Lung,LOCATION_OF,Chest CT,32360111,10.1016/j.ajog.2020.04.020,2020-05-04
Lung,LOCATION_OF,Ultrasound examination,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Pleura,LOCATION_OF,Disease,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Pregnancy,PROCESS_OF,Patients,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Lung,LOCATION_OF,Ultrasound examination,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Pneumonia,PROCESS_OF,Pregnant Women,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Ultrasound examination,DIAGNOSES,Pneumonia,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Lung,PART_OF,Caucasoid Race,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Lung,LOCATION_OF,Ultrasound examination,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Imaging Device,TREATS,Pregnant Women,32360108,10.1016/j.ajog.2020.04.030,2020-05-04
Maternal Death,ASSOCIATED_WITH,Disease,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Respiration Disorders,PROCESS_OF,Pregnant Women,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Severe disorder,PROCESS_OF,Pregnant Women,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Severe disorder,PROCESS_OF,Pregnant Women,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Disease,CAUSES,Maternal Death,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Awareness,PROCESS_OF,Pregnant Women,32360083,10.1016/j.clnu.2020.04.036,2020-05-04
Liver diseases,COEXISTS_WITH,Disease,32360053,10.1016/j.joen.2020.04.001,2020-05-04
Liver diseases,COEXISTS_WITH(SPEC),Coronavirus Infections,32360053,10.1016/j.joen.2020.04.001,2020-05-04
Liver diseases,PROCESS_OF,Patients,32360053,10.1016/j.joen.2020.04.001,2020-05-04
Coronavirus Infections,ISA,Disease,32360053,10.1016/j.joen.2020.04.001,2020-05-04
Symptoms,PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
Fever,NEG_PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
disease history,PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
Periapical Periodontitis,PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
Acute apical abscess,PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
Symptomatic irreversible pulpitis,PROCESS_OF,Patients,32360037,10.1016/j.encep.2020.04.009,2020-05-04
Mental disorders,PROCESS_OF,Patients,32360034,10.1016/j.medin.2020.04.001,2020-05-04
Decision,PROCESS_OF,Patients,32360034,10.1016/j.medin.2020.04.001,2020-05-04
Coronaviridae,PROCESS_OF,Family,32359943,10.1016/j.jmii.2020.04.013,2020-05-04
Infected,PROCESS_OF,coworker,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Health Personnel,DIAGNOSES,Leukopenia,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Health Personnel,DIAGNOSES,Lymphopenia,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Infected,PROCESS_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Complement 3,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Infected,PROCESS_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Complement component C4,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Immunoglobulins,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Interleukin-2,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Interleukin-4,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Interleukin-10,PART_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Infected,PROCESS_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Pneumonia,OCCURS_IN,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Infected,PROCESS_OF,Health Personnel,32359937,10.1016/j.brachy.2020.04.005,2020-05-04
Brachytherapy,TREATS,Patients,32359869,10.1016/j.amjoto.2020.102484,2020-05-04
Breast,PART_OF,Patients,32359869,10.1016/j.amjoto.2020.102484,2020-05-04
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32359869,10.1016/j.amjoto.2020.102484,2020-05-04
Malignant neoplasm of prostate,PROCESS_OF,Patients,32359869,10.1016/j.amjoto.2020.102484,2020-05-04
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32359869,10.1016/j.amjoto.2020.102484,2020-05-04
Nance-Horan syndrome,PROCESS_OF,Staff,32359846,10.1016/j.clon.2020.04.006,2020-05-04
China,ISA,Country,32359819,10.1016/j.acra.2020.04.024,2020-05-04
Italy,ISA,Country,32359819,10.1016/j.acra.2020.04.024,2020-05-04
Severe Acute Respiratory Syndrome,ISA,Disease,32359819,10.1016/j.acra.2020.04.024,2020-05-04
Elective Surgical Procedures,ISA,Therapeutic procedure,32359819,10.1016/j.acra.2020.04.024,2020-05-04
Elective Surgical Procedures,TREATS,Virus,32359819,10.1016/j.acra.2020.04.024,2020-05-04
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32359765,10.1016/j.tins.2020.04.004,2020-05-04
Hydroxychloroquine,PREDISPOSES,Sudden Cardiac Death,32359765,10.1016/j.tins.2020.04.004,2020-05-04
lopinavir / Ritonavir,ISA,Pharmaceutical Preparations,32359765,10.1016/j.tins.2020.04.004,2020-05-04
lopinavir / Ritonavir,PREDISPOSES,Sudden Cardiac Death,32359765,10.1016/j.tins.2020.04.004,2020-05-04
Pharmacotherapy,ADMINISTERED_TO,Population Group,32359765,10.1016/j.tins.2020.04.004,2020-05-04
Heart Ventricle,LOCATION_OF,Drug induced arrhythmia,32359765,10.1016/j.tins.2020.04.004,2020-05-04
Possible,PREDISPOSES,exposure (to) disease,32359765,10.1016/j.tins.2020.04.004,2020-05-04
Post-Exposure Prophylaxis,TREATS,Drug induced arrhythmia,32359765,10.1016/j.tins.2020.04.004,2020-05-04
etiologic agent,CAUSES,neurological complication,32359479,10.1016/j.molmed.2020.02.008,2020-05-04
Genome,PART_OF,Persons,32359396,10.1016/j.chom.2020.03.021,2020-05-04
Infected,PROCESS_OF,Persons,32359396,10.1016/j.chom.2020.03.021,2020-05-04
Immune response,PROCESS_OF,Patients,32359227,10.1055/s-0040-1710541,2020-05-03
T-Cell Activation,AFFECTS,Disease,32359227,10.1055/s-0040-1710541,2020-05-03
Birth,NEG_PROCESS_OF,"Infant, Newborn",32359226,10.1055/s-0040-1710522,2020-05-03
Health care facility,LOCATION_OF,Study,32359226,10.1055/s-0040-1710522,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32359226,10.1055/s-0040-1710522,2020-05-03
Spontaneous abortion,PROCESS_OF,Woman,32359226,10.1055/s-0040-1710522,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32359223,10.1111/codi.15112,2020-05-03
Critical Illness,PROCESS_OF,Patients,32359223,10.1111/codi.15112,2020-05-03
Colorectal Carcinoma,OCCURS_IN,Community,32359210,10.1111/ajt.15985,2020-05-03
Coronavirus Infections,PROCESS_OF,Transplant Recipients,32359205,10.1111/apt.15804,2020-05-03
cytokine,ASSOCIATED_WITH,Influenza-like symptoms,32359205,10.1111/apt.15804,2020-05-03
tocilizumab,TREATS,Liver transplant recipient,32359205,10.1111/apt.15804,2020-05-03
Liver transplant recipient,COEXISTS_WITH,Pneumonia,32359205,10.1111/apt.15804,2020-05-03
Lung,LOCATION_OF,Ultrasonography,32359205,10.1111/apt.15804,2020-05-03
Coronavirus Infections,PROCESS_OF,Transplant Recipients,32359205,10.1111/apt.15804,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Coronavirus Infections,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Gastrointestinal symptom,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Crohn Disease,PROCESS_OF,Woman,32359203,10.1111/acem.14005,2020-05-03
Diarrhea,ISA,Symptoms,32359203,10.1111/acem.14005,2020-05-03
Diarrhea,ISA,Symptoms,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Diarrhea,ISA,Symptoms,32359203,10.1111/acem.14005,2020-05-03
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32359203,10.1111/acem.14005,2020-05-03
Chloroquine,ADMINISTERED_TO,Patients,32359201,10.1111/pai.13271,2020-05-03
Hydroxychloroquine,ADMINISTERED_TO,Patients,32359201,10.1111/pai.13271,2020-05-03
Asymptomatic,PROCESS_OF,Child,32359194,10.1111/ajt.15983,2020-05-03
Infection,NEG_CAUSES,Pneumonia,32359194,10.1111/ajt.15983,2020-05-03
Severe inflammation,CAUSES,Complication,32359194,10.1111/ajt.15983,2020-05-03
Adaptive Immune Response,PROCESS_OF,Patients,32359194,10.1111/ajt.15983,2020-05-03
Mucous Membrane,NEG_LOCATION_OF,IMPACT gene,32359194,10.1111/ajt.15983,2020-05-03
Airway structure,LOCATION_OF,Hyperventilation,32359194,10.1111/ajt.15983,2020-05-03
Alveolus,LOCATION_OF,Hyperventilation,32359194,10.1111/ajt.15983,2020-05-03
FATE1 gene,PART_OF,Patients,32359194,10.1111/ajt.15983,2020-05-03
Spain,ISA,Country,32359188,10.1111/ajt.15972,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32359188,10.1111/ajt.15972,2020-05-03
Cessation of life,PROCESS_OF,Donor person,32359177,10.1002/hep.31301,2020-05-03
Pneumonia,PROCESS_OF,Patients,32359101,10.1096/fj.202000967,2020-05-03
Injury of liver,COEXISTS_WITH,Disease,32359101,10.1096/fj.202000967,2020-05-03
Atypical Lipoma,PROCESS_OF,Patients,32359101,10.1096/fj.202000967,2020-05-03
Indicators,AFFECTS,diseases and injuries,32359101,10.1096/fj.202000967,2020-05-03
Liver,LOCATION_OF,diseases and injuries,32359101,10.1096/fj.202000967,2020-05-03
Bradykinin,CAUSES,Respiratory complication,32359098,10.1111/head.13830,2020-05-03
Bradykinin,CAUSES,Respiratory complication,32359098,10.1111/head.13830,2020-05-03
Migraine Disorders,PROCESS_OF,Patients,32358994,10.1111/all.14348,2020-05-03
Laboratory Procedures,DIAGNOSES,Present,32358956,10.1093/infdis/jiaa229,2020-05-03
Detection,TREATS,Community,32358956,10.1093/infdis/jiaa229,2020-05-03
Assay,USES,Antibodies,32358954,10.1093/cid/ciaa530,2020-05-03
Immunoglobulin G,ISA,Antibodies,32358954,10.1093/cid/ciaa530,2020-05-03
Antibodies,NEG_PART_OF,Patients,32358954,10.1093/cid/ciaa530,2020-05-03
Immunoglobulin G,ISA,Antibodies,32358954,10.1093/cid/ciaa530,2020-05-03
Immunoglobulin G,NEG_PART_OF(SPEC),Patients,32358954,10.1093/cid/ciaa530,2020-05-03
Immunoglobulin M,NEG_PART_OF,Patients,32358954,10.1093/cid/ciaa530,2020-05-03
Negative,PROCESS_OF,Patients,32358954,10.1093/cid/ciaa530,2020-05-03
Bacterial Infections,COEXISTS_WITH,Coronavirus Infections,32358952,10.4269/ajtmh.20-0234,2020-05-03
Bacterial Infections,PROCESS_OF,Patients,32358952,10.4269/ajtmh.20-0234,2020-05-03
Coronavirus Infections,PROCESS_OF,Patients,32358952,10.4269/ajtmh.20-0234,2020-05-03
Coronavirus Infections,PROCESS_OF,Patients,32358952,10.4269/ajtmh.20-0234,2020-05-03
Microbicides,TREATS,Patients,32358952,10.4269/ajtmh.20-0234,2020-05-03
Microbicides,TREATS(INFER),Coronavirus Infections,32358952,10.4269/ajtmh.20-0234,2020-05-03
Coronavirus Infections,ISA,Disease,32358890,10.1111/dth.13476,2020-05-03
Coronavirus Infections,ISA,Disease,32358890,10.1111/dth.13476,2020-05-03
Chloroquine,ISA,Pharmaceutical Preparations,32358884,10.1111/dar.13074,2020-05-03
Interferon-beta,ISA,Pharmaceutical Preparations,32358884,10.1111/dar.13074,2020-05-03
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32358884,10.1111/dar.13074,2020-05-03
Ritonavir,ISA,Pharmaceutical Preparations,32358884,10.1111/dar.13074,2020-05-03
lopinavir,ISA,Pharmaceutical Preparations,32358884,10.1111/dar.13074,2020-05-03
IMPACT gene,AFFECTS,Crisis,32358880,10.1002/hed.26235,2020-05-03
Coronavirus Infections,ISA,Disease,32358869,10.1111/dth.13477,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32358869,10.1111/dth.13477,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32358869,10.1111/dth.13477,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32358869,10.1111/dth.13477,2020-05-03
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32358869,10.1111/dth.13477,2020-05-03
Severe Acute Respiratory Syndrome,CAUSES,Communicable Diseases,32358855,10.1002/hed.26234,2020-05-03
Pruritus,ISA,Symptoms,32358855,10.1002/hed.26234,2020-05-03
Pruritus,PROCESS_OF,Patients,32358855,10.1002/hed.26234,2020-05-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Pruritus,32358855,10.1002/hed.26234,2020-05-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Virus Diseases,32358855,10.1002/hed.26234,2020-05-03
Pruritus,PROCESS_OF,Population Group,32358855,10.1002/hed.26234,2020-05-03
Pruritus,NEG_COEXISTS_WITH,Virus Diseases,32358855,10.1002/hed.26234,2020-05-03
Hand Sanitizers,ISA,Chemicals,32358855,10.1002/hed.26234,2020-05-03
Tracheostomy procedure,TREATS,Patients,32358853,10.1002/hed.26239,2020-05-03
Carcinoma,PROCESS_OF,Patients,32358853,10.1002/hed.26239,2020-05-03
Tonsil,LOCATION_OF,Carcinoma,32358853,10.1002/hed.26239,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32358689,10.1007/s11547-020-01200-3,2020-05-03
Lung,LOCATION_OF,Severe disorder,32358689,10.1007/s11547-020-01200-3,2020-05-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32358689,10.1007/s11547-020-01200-3,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,Italians,32358568,10.1038/s41375-020-0832-y,2020-05-03
Chest CT,DIAGNOSES,Congenital anomaly of lung,32358568,10.1038/s41375-020-0832-y,2020-05-03
Congenital anomaly of lung,PART_OF,Patients,32358568,10.1038/s41375-020-0832-y,2020-05-03
Infected,PROCESS_OF,Patients,32358568,10.1038/s41375-020-0832-y,2020-05-03
Pneumonia,PROCESS_OF,hospitalized patients,32358568,10.1038/s41375-020-0832-y,2020-05-03
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32358568,10.1038/s41375-020-0832-y,2020-05-03
malignant disease,PROCESS_OF,Patients,32358406,10.1097/MD.0000000000020175,2020-05-03
malignant disease,PROCESS_OF,Patients,32358406,10.1097/MD.0000000000020175,2020-05-03
malignant disease,PROCESS_OF,Patients,32358406,10.1097/MD.0000000000020175,2020-05-03
cancer care,AFFECTS,Patients,32358406,10.1097/MD.0000000000020175,2020-05-03
"CD69 protein, human",AFFECTS,Possible,32358406,10.1097/MD.0000000000020175,2020-05-03
tomography,DIAGNOSES,Multiple cysts,32358234,10.1097/RLU.0000000000003146,2020-05-03
Chest CT,DIAGNOSES,Pneumonia,32358234,10.1097/RLU.0000000000003146,2020-05-03
Chest CT,DIAGNOSES,Ground Glass Opacity,32358234,10.1097/RLU.0000000000003146,2020-05-03
Oxygen,ADMINISTERED_TO,Patients,32358234,10.1097/RLU.0000000000003146,2020-05-03
Lung,LOCATION_OF,Cyst Formation,32358234,10.1097/RLU.0000000000003146,2020-05-03
Infected,PROCESS_OF,Patients,32358232,10.1097/MAT.0000000000001180,2020-05-03
"Respiratory Distress Syndrome, Adult",COMPLICATES,Respiratory Failure,32358230,10.1097/SAP.0000000000002443,2020-05-03
Coronavirus Infections,ISA,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Disease,PROCESS_OF,Outpatients,32358218,10.1212/WNL.0000000000009700,2020-05-03
Coronavirus Infections,ISA,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Coronavirus Infections,ISA,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Coronavirus Infections,PROCESS_OF(SPEC),Outpatients,32358218,10.1212/WNL.0000000000009700,2020-05-03
Operative Surgical Procedures,AFFECTS,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Operative Surgical Procedures,AFFECTS(SPEC),Coronavirus Infections,32358218,10.1212/WNL.0000000000009700,2020-05-03
Coronavirus Infections,ISA,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Coronavirus Infections,ISA,Disease,32358218,10.1212/WNL.0000000000009700,2020-05-03
Health care facility,LOCATION_OF,Services,32358216,10.1212/WNL.0000000000009698,2020-05-03
Urgent Care,LOCATION_OF,Services,32358216,10.1212/WNL.0000000000009698,2020-05-03
Organoids,PART_OF,"Intestines, Small",32358134,10.1136/vr.m1772,2020-05-03
Organoids,PART_OF,"Intestines, Small",32358134,10.1136/vr.m1772,2020-05-03
Epithelium,PART_OF,Intestines,32358134,10.1136/vr.m1772,2020-05-03
Organoids,PART_OF,"Intestines, Small",32358134,10.1136/vr.m1772,2020-05-03
Labor (Childbirth),PROCESS_OF,Homo sapiens,32358044,10.2967/jnmt.120.244855,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
early identification,TREATS,Vulnerable Populations,32357977,10.7861/clinmed.2020-0160,2020-05-03
Malignant Neoplasms,PROCESS_OF,Patients,32357977,10.7861/clinmed.2020-0160,2020-05-03
early identification,TREATS,Vulnerable Populations,32357977,10.7861/clinmed.2020-0160,2020-05-03
Autoimmune disease (systemic) NOS,PROCESS_OF,Patients,32357976,10.7861/clinmed.2020-0143,2020-05-03
Pandemics,OCCURS_IN,Health Personnel,32357975,10.7861/clinmed.2020-0214,2020-05-03
Nance-Horan syndrome,PROCESS_OF,Health Personnel,32357975,10.7861/clinmed.2020-0214,2020-05-03
risk factors,COEXISTS_WITH,Disease Progression,32357808,10.1080/22221751.2020.1762515,2020-05-03
Wakefulness,PROCESS_OF,Community,32357808,10.1080/22221751.2020.1762515,2020-05-03
Antibody studies (procedure),METHOD_OF,Diagnosis,32357675,10.1063/5.0009454,2020-05-03
Patients,LOCATION_OF,Blood specimen,32357675,10.1063/5.0009454,2020-05-03
Infected,PROCESS_OF,Patients,32357675,10.1063/5.0009454,2020-05-03
CD40LG wt Allele,PART_OF,Patients,32357675,10.1063/5.0009454,2020-05-03
Detection,USES,CD40LG wt Allele,32357675,10.1063/5.0009454,2020-05-03
Infected,PROCESS_OF,Persons,32357655,10.1063/5.0007422,2020-05-03
Growth,PROCESS_OF,Social Networks,32357582,10.3390/geriatrics5020025,2020-05-03
Italy,ISA,Country,32357575,10.3390/geriatrics5020024,2020-05-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Elderly (population group),32357575,10.3390/geriatrics5020024,2020-05-03
multiple pathologies,PROCESS_OF,Patients,32357553,10.3390/v12050486,2020-05-03
Frailty,PREDISPOSES,Complication,32357553,10.3390/v12050486,2020-05-03
"CD69 protein, human",PART_OF,Community,32357553,10.3390/v12050486,2020-05-03
Disease Outbreaks,CAUSES,Severe Acute Respiratory Syndrome,32357545,10.3390/pathogens9050324,2020-05-03
Coronavirus Infections,PROCESS_OF,Family,32357545,10.3390/pathogens9050324,2020-05-03
Antiviral Agents,DISRUPTS,Virus Replication,32357545,10.3390/pathogens9050324,2020-05-03
Antiviral Agents,DISRUPTS,Biologic Development,32357545,10.3390/pathogens9050324,2020-05-03
Patients,LOCATION_OF,Plasma,32357503,10.3390/jcm9051259,2020-05-03
Mutation,AFFECTS,Genetic Drift,32357503,10.3390/jcm9051259,2020-05-03
France,ISA,European country,32357503,10.3390/jcm9051259,2020-05-03
Netherlands,ISA,European country,32357503,10.3390/jcm9051259,2020-05-03
Switzerland,ISA,European country,32357503,10.3390/jcm9051259,2020-05-03
Autopsy,DIAGNOSES,Present,32357471,10.3390/pathogens9050320,2020-05-03
Genus: Coronavirus,ISA,RNA Viruses,32357457,10.3390/ijerph17093010,2020-05-03
Human coronavirus 229E,CAUSES,Common Cold,32357457,10.3390/ijerph17093010,2020-05-03
Human coronavirus 229E,CAUSES,Pharyngitis,32357457,10.3390/ijerph17093010,2020-05-03
Human coronavirus 229E,CAUSES,Rhinitis,32357457,10.3390/ijerph17093010,2020-05-03
Human coronavirus 229E,ISA,Genus: Coronavirus,32357457,10.3390/ijerph17093010,2020-05-03
SARS coronavirus,ISA,Genus: Coronavirus,32357457,10.3390/ijerph17093010,2020-05-03
Pharmaceutical Preparations,TREATS,Human coronavirus,32357457,10.3390/ijerph17093010,2020-05-03
Vaccines,TREATS,Human coronavirus,32357457,10.3390/ijerph17093010,2020-05-03
Health behavior,PROCESS_OF,Persons,32357424,10.3390/ijerph17092997,2020-05-03
Healthy Lifestyle,ISA,Behavior,32357381,10.1002/hed.26232,2020-05-02
Detection of virus procedure,USES,Medical procedure on respiratory tract,32357380,10.1002/hed.26233,2020-05-02
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32357379,10.1002/hed.26228,2020-05-02
Primary operation,TREATS,Malignant neoplasm of mouth,32357379,10.1002/hed.26228,2020-05-02
Malignant neoplasm of tongue,PROCESS_OF,Patients,32357379,10.1002/hed.26228,2020-05-02
Malignant neoplasm of oropharynx,PROCESS_OF,Patients,32357379,10.1002/hed.26228,2020-05-02
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32357377,10.1002/hed.26230,2020-05-02
Low Grade Malignant Neoplasm,PROCESS_OF,Patients,32357377,10.1002/hed.26230,2020-05-02
Malignant Neoplasms,PROCESS_OF,Male population group,32357281,10.1002/hed.26227,2020-05-02
Pharmaceutical Preparations,TREATS,Systemic disease,32357281,10.1002/hed.26227,2020-05-02
Infertility,PROCESS_OF,Patients,32357281,10.1002/hed.26227,2020-05-02
Malignant neoplasm of mouth,ISA,Malignant Head and Neck Neoplasm,32357277,10.1002/hed.26226,2020-05-02
Malignant neoplasm of mouth,PROCESS_OF(SPEC),Male population group,32357277,10.1002/hed.26226,2020-05-02
Malignant Head and Neck Neoplasm,PROCESS_OF,Male population group,32357277,10.1002/hed.26226,2020-05-02
Coronavirus Infections,ISA,Disease,32357275,10.1111/tri.13634,2020-05-02
Disease,CAUSES,Health Services,32357275,10.1111/tri.13634,2020-05-02
Virus,PROCESS_OF,Patients,32357275,10.1111/tri.13634,2020-05-02
Coronavirus Infections,CAUSES(SPEC),Health Services,32357275,10.1111/tri.13634,2020-05-02
Coronavirus Infections,ISA,Disease,32357275,10.1111/tri.13634,2020-05-02
Coronavirus Infections,ISA,Disease,32357257,10.1111/iej.13313,2020-05-02
Dialysis procedure,TREATS,Patients,32357257,10.1111/iej.13313,2020-05-02
Kidney Transplantation,PRECEDES,Kidney operation,32357257,10.1111/iej.13313,2020-05-02
follow-up,TREATS,Patients,32357257,10.1111/iej.13313,2020-05-02
Coronavirus Infections,ISA,Communicable Diseases,32357210,10.1093/cid/ciaa525,2020-05-02
Mechanical Ventilator,USES,disposable,32357210,10.1093/cid/ciaa525,2020-05-02
Smell Perception,PROCESS_OF,Patients,32357209,10.1093/cid/ciaa523,2020-05-02
Patients,ISA,Persons,32357086,10.1089/tmj.2020.0089,2020-05-02
Asymptomatic,PROCESS_OF,Medical Staff,32357086,10.1089/tmj.2020.0089,2020-05-02
Confirmation,PROCESS_OF,Patients,32357086,10.1089/tmj.2020.0089,2020-05-02
"Respiratory Distress Syndrome, Adult",COMPLICATES,Respiratory Failure,32357072,10.4158/EP-2020-0108,2020-05-02
Cardiac care,TREATS,Myocardial Infarction,32356927,10.1111/risa.13500,2020-05-02
Academic Medical Centers,LOCATION_OF,Interdisciplinary Studies,32356927,10.1111/risa.13500,2020-05-02
Asymptomatic,PROCESS_OF,Persons,32356926,10.1002/ddr.21679,2020-05-02
Coronavirus Infections,CAUSES,pulmonary complications,32356910,10.1002/jmv.25961,2020-05-02
Type-II Pneumocytes,LOCATION_OF,ACE2 gene,32356910,10.1002/jmv.25961,2020-05-02
Alveolar Epithelial Cells,LOCATION_OF,Enzymes,32356910,10.1002/jmv.25961,2020-05-02
Protein complex,PART_OF,ACE2 gene,32356910,10.1002/jmv.25961,2020-05-02
cytokine,CAUSES,"Respiratory Distress Syndrome, Adult",32356910,10.1002/jmv.25961,2020-05-02
Pulmonary interstitium,LOCATION_OF,High Level,32356910,10.1002/jmv.25961,2020-05-02
Losartan,ISA,Agent,32356910,10.1002/jmv.25961,2020-05-02
telmisartan,ISA,Agent,32356910,10.1002/jmv.25961,2020-05-02
telmisartan,TREATS,Patients,32356910,10.1002/jmv.25961,2020-05-02
Persons,LOCATION_OF,Plasma,32356908,10.1002/jmv.25866,2020-05-02
Critical Illness,PROCESS_OF,Patients,32356908,10.1002/jmv.25866,2020-05-02
Patients,LOCATION_OF,Plasma,32356908,10.1002/jmv.25866,2020-05-02
SARS coronavirus,CAUSES,Infection,32356900,10.5694/mja2.50598,2020-05-02
Immune response,AFFECTS,Disease Progression,32356900,10.5694/mja2.50598,2020-05-02
Influenza,PROCESS_OF,Patients,32356900,10.5694/mja2.50598,2020-05-02
Influenza,PROCESS_OF,Patients,32356900,10.5694/mja2.50598,2020-05-02
patient condition,PROCESS_OF,Patients,32356900,10.5694/mja2.50598,2020-05-02
treatment options,TREATS,patient condition,32356900,10.5694/mja2.50598,2020-05-02
Oxygen,PART_OF,Nose,32356867,10.1001/jamainternmed.2020.2020,2020-05-02
Airway Management,TREATS,Patients,32356867,10.1001/jamainternmed.2020.2020,2020-05-02
Coughing,ISA,"Signs and Symptoms, Respiratory",32356863,10.1001/jamacardio.2020.1834,2020-05-02
Fever,ISA,Symptoms,32356863,10.1001/jamacardio.2020.1834,2020-05-02
Households,ISA,Family,32356863,10.1001/jamacardio.2020.1834,2020-05-02
Confirmation,PROCESS_OF,Patients,32356863,10.1001/jamacardio.2020.1834,2020-05-02
Hydroxychloroquine,ADMINISTERED_TO,Patients,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,ADMINISTERED_TO,Patients,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,ADMINISTERED_TO,Patients,32356777,10.2196/19007,2020-05-02
Azithromycin,COEXISTS_WITH,Hydroxychloroquine,32356777,10.2196/19007,2020-05-02
Azithromycin,TREATS,Pneumonia,32356777,10.2196/19007,2020-05-02
Prolonged QT interval,PROCESS_OF,Patients,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,compared_with,Hydroxychloroquine,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,AFFECTS,QT interval:Time:Point in time:Heart:Quantitative:EKG,32356777,10.2196/19007,2020-05-02
Azithromycin,compared_with,Hydroxychloroquine,32356777,10.2196/19007,2020-05-02
Azithromycin,AFFECTS,QT interval:Time:Point in time:Heart:Quantitative:EKG,32356777,10.2196/19007,2020-05-02
Prolonged QTc,PROCESS_OF,Patients,32356777,10.2196/19007,2020-05-02
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,ADMINISTERED_TO,Patients,32356777,10.2196/19007,2020-05-02
Azithromycin,TREATS,Patients,32356777,10.2196/19007,2020-05-02
Hydroxychloroquine,COEXISTS_WITH,Pharmaceutical Preparations,32356777,10.2196/19007,2020-05-02
Azithromycin,COEXISTS_WITH,Pharmaceutical Preparations,32356777,10.2196/19007,2020-05-02
Coronavirus Infections,ISA,Disease,32356761,10.1109/RBME.2020.2991444,2020-05-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Elderly (population group),32356761,10.1109/RBME.2020.2991444,2020-05-02
Coronavirus Infections,ISA,Disease,32356761,10.1109/RBME.2020.2991444,2020-05-02
Polymerase,PART_OF,Engineer,32356760,10.1109/RBME.2020.2990959,2020-05-02
tomography,ISA,Imaging Techniques,32356672,10.1024/1661-8157/a003512,2020-05-02
Lung,LOCATION_OF,Ultrasonography,32356672,10.1024/1661-8157/a003512,2020-05-02
PET/CT scan,ISA,tomography,32356672,10.1024/1661-8157/a003512,2020-05-02
IMPACT gene,PART_OF,SARS coronavirus,32356642,10.20452/pamw.15331,2020-05-02
High Level,PROCESS_OF,Patients,32356641,10.20452/pamw.15332,2020-05-02
Feces,PART_OF,Patients,32356628,10.1056/NEJMoa2008975,2020-05-02
gastrointestinal,LOCATION_OF,Epithelial Cells,32356628,10.1056/NEJMoa2008975,2020-05-02
Abdominal Pain,PROCESS_OF,Patients,32356628,10.1056/NEJMoa2008975,2020-05-02
Diarrhea,PROCESS_OF,Patients,32356628,10.1056/NEJMoa2008975,2020-05-02
Nausea,PROCESS_OF,Patients,32356628,10.1056/NEJMoa2008975,2020-05-02
Vomiting,PROCESS_OF,Patients,32356628,10.1056/NEJMoa2008975,2020-05-02
Adrenergic beta-Antagonists,TREATS,Relative (related person),32356627,10.1056/NEJMoa2006923,2020-05-02
Angiotensin-Converting Enzyme Inhibitors,TREATS,Relative (related person),32356627,10.1056/NEJMoa2006923,2020-05-02
Calcium Channel Blockers,TREATS,Relative (related person),32356627,10.1056/NEJMoa2006923,2020-05-02
Thiazide Diuretics,TREATS,Relative (related person),32356627,10.1056/NEJMoa2006923,2020-05-02
Pharmaceutical Preparations,TREATS,Patients,32356627,10.1056/NEJMoa2006923,2020-05-02
Angiotensin II receptor antagonist,TREATS,Relative (related person),32356627,10.1056/NEJMoa2006923,2020-05-02
Pharmaceutical Preparations,TREATS,Patients,32356627,10.1056/NEJMoa2006923,2020-05-02
Did not receive therapy or drug for,PROCESS_OF,Patients,32356627,10.1056/NEJMoa2006923,2020-05-02
Present,PROCESS_OF,Patients,32356627,10.1056/NEJMoa2006923,2020-05-02
Pharmaceutical Preparations,COEXISTS_WITH,Antihypertensive Agents,32356627,10.1056/NEJMoa2006923,2020-05-02
Angiotensin II receptor antagonist,compared_with,Antihypertensive Agents,32356626,10.1056/NEJMoa2007621,2020-05-02
Angiotensin II receptor antagonist,higher_than,Antihypertensive Agents,32356626,10.1056/NEJMoa2007621,2020-05-02
Disease,PROCESS_OF,Patients,32356626,10.1056/NEJMoa2007621,2020-05-02
Cardiovascular Diseases,PROCESS_OF,Persons,32356583,10.1002/ppul.24800,2020-05-02
Hospitals,LOCATION_OF,Analysis,32356583,10.1002/ppul.24800,2020-05-02
Death in hospital,PROCESS_OF,hospitalized patients,32356583,10.1002/ppul.24800,2020-05-02
Coronary Arteriosclerosis,PREDISPOSES,Death in hospital,32356583,10.1002/ppul.24800,2020-05-02
Cardiovascular Diseases,NEG_PREDISPOSES,Death in hospital,32356583,10.1002/ppul.24800,2020-05-02
Death in hospital,PROCESS_OF,Patients,32356583,10.1002/ppul.24800,2020-05-02
Disease,PROCESS_OF,Child,32356577,10.1111/dth.13475,2020-05-02
Coronavirus Infections,ISA,Disease,32356577,10.1111/dth.13475,2020-05-02
Coronavirus Infections,PROCESS_OF(SPEC),Child,32356577,10.1111/dth.13475,2020-05-02
Patients,LOCATION_OF,IMPACT gene,32356569,10.1002/cpt.1879,2020-05-02
Telemedicine,TREATS,At home,32356569,10.1002/cpt.1879,2020-05-02
responsibility,PROCESS_OF,Racial group,32356508,10.1097/JU.0000000000001089,2020-05-02
Prostate,LOCATION_OF,High-Risk Cancer,32356301,10.1055/a-1160-5770,2020-05-02
Prostate,LOCATION_OF,High-Risk Cancer,32356301,10.1055/a-1160-5770,2020-05-02
Radical prostatectomy,TREATS,High-Risk Cancer,32356301,10.1055/a-1160-5770,2020-05-02
Radical prostatectomy,TREATS,High-Risk Cancer,32356301,10.1055/a-1160-5770,2020-05-02
Radical prostatectomy,compared_with,Radical prostatectomy,32356301,10.1055/a-1160-5770,2020-05-02
Radical prostatectomy,TREATS,Male population group,32356301,10.1055/a-1160-5770,2020-05-02
Male population group,USES,Grade four rank,32356301,10.1055/a-1160-5770,2020-05-02
Persons,LOCATION_OF,"CD69 protein, human",32356298,10.1055/a-1160-5859,2020-05-02
"Stress, Psychological",AFFECTS,general population,32356298,10.1055/a-1160-5859,2020-05-02
"Stress, Psychological",AFFECTS,Sensitive Populations,32356298,10.1055/a-1160-5859,2020-05-02
World Health Organization,ISA,Organization administrative structures,32356298,10.1055/a-1160-5859,2020-05-02
mental health,PROCESS_OF,Population Group,32356298,10.1055/a-1160-5859,2020-05-02
Fear (Mental Process),PROCESS_OF,Population Group,32356298,10.1055/a-1160-5859,2020-05-02
Pharmaceutical Preparations,CAUSES,Ventricular arrhythmia,32356047,10.1007/s00167-020-06032-2,2020-05-02
Recombinant Proteins,CAUSES,Serum Sickness,32356047,10.1007/s00167-020-06032-2,2020-05-02
Recombinant Proteins,CAUSES,Immune complex deposition,32356047,10.1007/s00167-020-06032-2,2020-05-02
Societies,LOCATION_OF,Study,32356025,10.1007/s00428-020-02829-1,2020-05-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32355904,10.1016/j.idm.2020.04.001,2020-05-02
Blood Vessel,LOCATION_OF,Hemorrhage,32355904,10.1016/j.idm.2020.04.001,2020-05-02
Alveolar,LOCATION_OF,Hemorrhage,32355904,10.1016/j.idm.2020.04.001,2020-05-02
Asymptomatic,PROCESS_OF,Patients,32355904,10.1016/j.idm.2020.04.001,2020-05-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32355904,10.1016/j.idm.2020.04.001,2020-05-02
Asymptomatic,PROCESS_OF,general population,32355889,10.1055/a-1153-9014,2020-05-02
Masks,TREATS,Persons,32355889,10.1055/a-1153-9014,2020-05-02
Coronavirus Infections,ISA,Disease,32355837,10.21037/atm.2020.02.92,2020-05-02
Coronavirus Infections,ISA,Disease,32355658,10.1007/s12070-020-01865-2,2020-05-02
Disease,AFFECTS,Homo sapiens,32355658,10.1007/s12070-020-01865-2,2020-05-02
Coronavirus Infections,AFFECTS(SPEC),Homo sapiens,32355658,10.1007/s12070-020-01865-2,2020-05-02
Coronavirus Infections,ISA,Disease,32355658,10.1007/s12070-020-01865-2,2020-05-02
Health Personnel,USES,Face shield,32355607,10.1007/s40674-020-00145-y,2020-05-02
Autoimmune Diseases,PROCESS_OF,Patients,32355564,10.1016/j.nmni.2020.100689,2020-05-02
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32355564,10.1016/j.nmni.2020.100689,2020-05-02
Pharmaceutical Preparations,TREATS,Patients,32355564,10.1016/j.nmni.2020.100689,2020-05-02
Pharmaceutical Preparations,TREATS(INFER),Rheumatism,32355564,10.1016/j.nmni.2020.100689,2020-05-02
Rheumatism,PROCESS_OF,Patients,32355564,10.1016/j.nmni.2020.100689,2020-05-02
Rheumatism,PROCESS_OF,Patients,32355564,10.1016/j.nmni.2020.100689,2020-05-02
stop medication,CAUSES,Disease,32355564,10.1016/j.nmni.2020.100689,2020-05-02
Infection,NEG_PROCESS_OF,Patients,32355564,10.1016/j.nmni.2020.100689,2020-05-02
DNA,PART_OF,Extracellular,32355510,10.1016/j.jchirv.2020.04.015,2020-05-02
DNA,PART_OF,Extracellular,32355510,10.1016/j.jchirv.2020.04.015,2020-05-02
Dornase Alfa,INHIBITS,DNA,32355510,10.1016/j.jchirv.2020.04.015,2020-05-02
Accumulation,PROCESS_OF,Patients,32355510,10.1016/j.jchirv.2020.04.015,2020-05-02
Appendicitis,ISA,Disease,32355447,10.1186/s41182-020-00214-x,2020-05-02
Appendectomy,ISA,Operative Surgical Procedures,32355447,10.1186/s41182-020-00214-x,2020-05-02
Appendectomy,TREATS,Appendicitis,32355447,10.1186/s41182-020-00214-x,2020-05-02
Appendicitis,PROCESS_OF,Adult,32355447,10.1186/s41182-020-00214-x,2020-05-02
Recurrent appendicitis,ISA,Appendicitis,32355447,10.1186/s41182-020-00214-x,2020-05-02
treatment options,TREATS,Appendicitis,32355447,10.1186/s41182-020-00214-x,2020-05-02
treatment options,TREATS(SPEC),Recurrent appendicitis,32355447,10.1186/s41182-020-00214-x,2020-05-02
Coronavirus Infections,ISA,Disease,32355435,10.1016/j.cnsns.2020.105303,2020-05-02
Pandemics,ISA,Disease Outbreaks,32355415,10.1007/s00278-020-00424-y,2020-05-02
Communication,ISA,Behavior,32355132,10.1097/AOG.0000000000003931,2020-05-02
Educational circumstances,PROCESS_OF,"Students, Medical",32355131,10.1097/AOG.0000000000003933,2020-05-02
simulation,USES,Operative Surgical Procedures,32355131,10.1097/AOG.0000000000003933,2020-05-02
Structural modification,COEXISTS_WITH,Delivery of Health Care,32355114,10.1097/ICO.0000000000002397,2020-05-02
Disinfection,USES,ultraviolet lights,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Burning sensation,PROCESS_OF,Adult,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Photophobia,PROCESS_OF,Adult,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Eye pain,PROCESS_OF,Adult,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Excessive tearing,PROCESS_OF,Adult,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Blurred vision,PROCESS_OF,Adult,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Conjunctival hyperemia,PROCESS_OF,Patients,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Slit lamp biomicroscopy (procedure),DIAGNOSES,Punctate keratopathy,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Epidermis,LOCATION_OF,"Dermatitis, Phototoxic",32355107,10.1097/OLQ.0000000000001192,2020-05-02
Photokeratitis,PROCESS_OF,Patients,32355107,10.1097/OLQ.0000000000001192,2020-05-02
"Dermatitis, Phototoxic",PROCESS_OF,Patients,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Disinfection,USES,germicidal lamps,32355107,10.1097/OLQ.0000000000001192,2020-05-02
Coronavirus Infections,ISA,Disease,32355099,10.1097/BOT.0000000000001792,2020-05-02
Health Services,TREATS,Sexually Transmitted Diseases,32355099,10.1097/BOT.0000000000001792,2020-05-02
Medical service,TREATS,teams,32354990,10.1136/gutjnl-2020-321411,2020-05-02
Disease,PROCESS_OF,Patients,32354800,10.1136/heartjnl-2020-317056,2020-05-02
Therapeutic immunosuppression,ADMINISTERED_TO,Patients,32354800,10.1136/heartjnl-2020-317056,2020-05-02
Pneumonia,PROCESS_OF,Patients,32354800,10.1136/heartjnl-2020-317056,2020-05-02
Age,ASSOCIATED_WITH,Pneumonia,32354800,10.1136/heartjnl-2020-317056,2020-05-02
Flare,PROCESS_OF,Patients,32354800,10.1136/heartjnl-2020-317056,2020-05-02
Cardiac Arrhythmia,CAUSES,Cardiac complication,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Cardiac Arrest,CAUSES,Cardiac complication,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Myocarditis,CAUSES,Cardiac complication,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Acute Coronary Syndrome,CAUSES,Cardiac complication,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Takotsubo Cardiomyopathy,CAUSES,Cardiac complication,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Cardiovascular,LOCATION_OF,consideration,32354798,10.1136/heartjnl-2020-317007,2020-05-02
Pharmaceutical Preparations,TREATS,Cohort,32354770,10.1136/jnnp-2020-323522,2020-05-02
myocardial injury,OCCURS_IN,Cohort,32354770,10.1136/jnnp-2020-323522,2020-05-02
vasoactive agent,TREATS,Patients,32354770,10.1136/jnnp-2020-323522,2020-05-02
vasoactive agent,TREATS(INFER),myocardial injury,32354770,10.1136/jnnp-2020-323522,2020-05-02
myocardial injury,PROCESS_OF,Patients,32354770,10.1136/jnnp-2020-323522,2020-05-02
Cessation of life,OCCURS_IN,Patients,32354770,10.1136/jnnp-2020-323522,2020-05-02
Patients,LOCATION_OF,Troponin T,32354770,10.1136/jnnp-2020-323522,2020-05-02
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32354734,10.7861/clinmed.2020-0157,2020-05-02
Influenza-like symptoms,PROCESS_OF,Male population group,32354734,10.7861/clinmed.2020-0157,2020-05-02
headache severe,PROCESS_OF,Male population group,32354734,10.7861/clinmed.2020-0157,2020-05-02
Ischemic stroke,PROCESS_OF,Woman,32354734,10.7861/clinmed.2020-0157,2020-05-02
Heart Diseases,PROCESS_OF,Patients,32354732,10.7861/clinmed.2020-0159,2020-05-02
Cardiac complication,PROCESS_OF,Patients,32354732,10.7861/clinmed.2020-0159,2020-05-02
Experience,PROCESS_OF,Staff,32354706,10.3174/ajnr.A6565,2020-05-02
Emotional support,TREATS,Persons,32354706,10.3174/ajnr.A6565,2020-05-02
Chronic disease,PROCESS_OF,Population Group,32354706,10.3174/ajnr.A6565,2020-05-02
innovativeness,PROCESS_OF,Population Group,32354706,10.3174/ajnr.A6565,2020-05-02
Voluntary,PROCESS_OF,dyads,32354664,10.1016/j.rbmo.2020.04.002,2020-05-02
Infertility,PROCESS_OF,Homo sapiens,32354663,10.1016/j.rbmo.2020.04.003,2020-05-02
Infertility,PROCESS_OF,Patients,32354653,10.1016/j.clae.2020.04.006,2020-05-02
Neoplasms,PROCESS_OF,Patients,32354653,10.1016/j.clae.2020.04.006,2020-05-02
Oocyte Retrieval,TREATS,Patients,32354653,10.1016/j.clae.2020.04.006,2020-05-02
Oocyte Retrieval,TREATS,Woman,32354653,10.1016/j.clae.2020.04.006,2020-05-02
Oocyte Retrieval,TREATS(INFER),Neoplasms,32354653,10.1016/j.clae.2020.04.006,2020-05-02
Neuromuscular Diseases,PROCESS_OF,Social Networks,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Health Care,TREATS,Patients,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Health Care,TREATS,Social Networks,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Health Care,TREATS(INFER),Neuromuscular Diseases,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Therapeutic procedure,COEXISTS_WITH,Hospitalization,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Immunosuppressive Agents,TREATS,Patients,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Myasthenia Gravis,PROCESS_OF,Patients,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Neuromuscular Diseases,PREDISPOSES,Exacerbation,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Prolonged QT interval,PROCESS_OF,Patients,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Nonsense Mediated mRNA Decay,PROCESS_OF,Persons,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Possible,PROCESS_OF,ventilator dependent,32354637,10.1016/j.kint.2020.03.018,2020-05-02
Infection,CAUSES,Cessation of life,32354634,10.1016/j.kint.2020.04.002,2020-05-02
Severe disorder,PROCESS_OF,Patients,32354634,10.1016/j.kint.2020.04.002,2020-05-02
Fever,COEXISTS_WITH,Symptoms,32354634,10.1016/j.kint.2020.04.002,2020-05-02
Fever,ISA,Symptoms,32354634,10.1016/j.kint.2020.04.002,2020-05-02
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32354634,10.1016/j.kint.2020.04.002,2020-05-02
"Transplantation, Homologous",ADMINISTERED_TO,Patients,32354631,10.1016/j.diii.2020.04.004,2020-05-02
Diagnostic radiologic examination,AFFECTS,follow-up,32354631,10.1016/j.diii.2020.04.004,2020-05-02
"Kidney Failure, Acute",PROCESS_OF,Patients,32354631,10.1016/j.diii.2020.04.004,2020-05-02
tocilizumab,TREATS,Patients,32354631,10.1016/j.diii.2020.04.004,2020-05-02
Oxygen,TREATS,Transplant Recipients,32354631,10.1016/j.diii.2020.04.004,2020-05-02
Oxygen,TREATS(INFER),Pneumonia,32354631,10.1016/j.diii.2020.04.004,2020-05-02
Pneumonia,PROCESS_OF,Transplant Recipients,32354631,10.1016/j.diii.2020.04.004,2020-05-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Pneumonia,32354631,10.1016/j.diii.2020.04.004,2020-05-02
Elective Surgical Procedures,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32354536,10.1016/j.arth.2020.04.035,2020-05-02
terminal patient care,TREATS,Patients,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Interventional procedure,ADMINISTERED_TO,Health Personnel,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Interventional procedure,USES,Face shield,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Surgeon,USES,Headlights,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Surgeon,USES,Loupes,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Surgeon,USES,Surgical helmet system,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Helmets,ISA,Personal protective equipment,32354535,10.1016/j.arth.2020.04.030,2020-05-02
Fever,PROCESS_OF,Male population group,32354360,10.1186/s13054-020-02895-6,2020-05-02
Confirmation,PROCESS_OF,Patients,32354360,10.1186/s13054-020-02895-6,2020-05-02
Pharmaceutical Preparations,PREVENTS,Pulmonary Fibrosis,32354360,10.1186/s13054-020-02895-6,2020-05-02
Inflammation,AFFECTS,Microorganism,32354360,10.1186/s13054-020-02895-6,2020-05-02
Liver,LOCATION_OF,Protection,32354360,10.1186/s13054-020-02895-6,2020-05-02
Infected,PROCESS_OF,Patients,32354360,10.1186/s13054-020-02895-6,2020-05-02
Thrombocytopenia,ISA,Blood Coagulation Disorders,32354293,10.1080/14767058.2020.1759541,2020-05-02
Senility,PREDISPOSES,Poor outcome,32354293,10.1080/14767058.2020.1759541,2020-05-02
Poor outcome,COEXISTS_WITH,Disease Progression,32354293,10.1080/14767058.2020.1759541,2020-05-02
Disease,CAUSES,Cessation of life,32354081,10.3390/ijerph17093067,2020-05-02
Infected,PROCESS_OF,Persons,32354081,10.3390/ijerph17093067,2020-05-02
Vaccines,TREATS,SARS coronavirus,32354081,10.3390/ijerph17093067,2020-05-02
Pharmaceutical Preparations,TREATS,Possible,32354022,10.3390/v12050491,2020-05-02
Renin-Angiotensin-Aldosterone System,AFFECTS,Blood Pressure,32353991,10.3390/ijerph17093054,2020-05-02
Renin-Angiotensin-Aldosterone System,AFFECTS,Fluid Balance,32353991,10.3390/ijerph17093054,2020-05-02
ACE2 gene,AFFECTS,Defecation,32353991,10.3390/ijerph17093054,2020-05-02
Coronavirus Infections,ISA,Disease,32353982,10.3390/jcm9051269,2020-05-02
Uncertainty,PROCESS_OF,Persons,32353982,10.3390/jcm9051269,2020-05-02
Infected,PROCESS_OF,Persons,32353982,10.3390/jcm9051269,2020-05-02
conjunctiva,LOCATION_OF,Coronavirus Infections,32353978,10.3390/ijms21093099,2020-05-02
Virus,CAUSES,Infection,32353907,10.1111/jocs.14590,2020-05-01
Nurses,ISA,Health Personnel,32353898,10.1111/eci.13259,2020-05-01
Physicians,ISA,Health Personnel,32353898,10.1111/eci.13259,2020-05-01
Physician Assistant,ISA,Health Personnel,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS,Health Personnel,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS,Nurses,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS,Physicians,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS,Physician Assistant,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS(SPEC),Nurses,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS(SPEC),Physicians,32353898,10.1111/eci.13259,2020-05-01
Coronavirus Infections,AFFECTS(SPEC),Physician Assistant,32353898,10.1111/eci.13259,2020-05-01
Pharmaceutical Preparations,CAUSES,Problem,32353898,10.1111/eci.13259,2020-05-01
Fibrosis,PREDISPOSES,Pneumonia,32353870,10.1084/jem.20200678,2020-05-01
Inflammation,PREDISPOSES,Pneumonia,32353870,10.1084/jem.20200678,2020-05-01
Blood Vessel complications,PREDISPOSES,Pneumonia,32353870,10.1084/jem.20200678,2020-05-01
Epithelial Damage,PREDISPOSES,Pneumonia,32353870,10.1084/jem.20200678,2020-05-01
Diabetes Mellitus,PREDISPOSES,Disease,32353870,10.1084/jem.20200678,2020-05-01
Hypertensive disease,PREDISPOSES,Disease,32353870,10.1084/jem.20200678,2020-05-01
Obesity,PREDISPOSES,Disease,32353870,10.1084/jem.20200678,2020-05-01
Respiration Disorders,PREDISPOSES,Disease,32353870,10.1084/jem.20200678,2020-05-01
risk factors,COEXISTS_WITH,Pneumonia,32353870,10.1084/jem.20200678,2020-05-01
Senility,PREDISPOSES,Disease,32353870,10.1084/jem.20200678,2020-05-01
Toxic effect,COEXISTS_WITH,Infection,32353859,10.1038/s41586-020-2286-9,2020-05-01
Laboratory Procedures,USES,Detection,32353827,10.2196/19540,2020-05-01
Coronavirus Infections,ISA,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Pneumonia,CAUSES,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Pneumonia,CAUSES(SPEC),Coronavirus Infections,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Coronavirus Infections,ISA,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Pneumonia,COEXISTS_WITH,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Pneumonia,COEXISTS_WITH(SPEC),Coronavirus Infections,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Syndrome,COEXISTS_WITH,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Syndrome,COEXISTS_WITH(SPEC),Coronavirus Infections,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Coronavirus Infections,ISA,Disease,32353825,10.1016/j.biopha.2020.110176,2020-05-01
Burn injury,PROCESS_OF,Patients,32353790,10.1016/j.envres.2020.109586,2020-05-01
Hospitals,LOCATION_OF,Diagnosis,32353790,10.1016/j.envres.2020.109586,2020-05-01
Emergency treatment,ADMINISTERED_TO,Patients,32353790,10.1016/j.envres.2020.109586,2020-05-01
Burn injury,PROCESS_OF,Patients,32353790,10.1016/j.envres.2020.109586,2020-05-01
Emergency treatment,TREATS,Patients,32353790,10.1016/j.envres.2020.109586,2020-05-01
Emergency treatment,TREATS(INFER),Burn injury,32353790,10.1016/j.envres.2020.109586,2020-05-01
Protection,PREDISPOSES,exposure (to) disease,32353790,10.1016/j.envres.2020.109586,2020-05-01
"CD69 protein, human",COEXISTS_WITH,GSKIP gene,32353760,10.1016/j.jcv.2020.104383,2020-05-01
Cessation of life,PROCESS_OF,hospitalized patients,32353760,10.1016/j.jcv.2020.104383,2020-05-01
Cessation of life,ASSOCIATED_WITH,Disease,32353760,10.1016/j.jcv.2020.104383,2020-05-01
Cessation of life,PROCESS_OF,Patients,32353760,10.1016/j.jcv.2020.104383,2020-05-01
performance tests,DIAGNOSES,Severe Acute Respiratory Syndrome,32353746,10.1016/j.thromres.2020.04.024,2020-05-01
Complication,PROCESS_OF,hospitalized patients,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Lung,LOCATION_OF,Computed Tomography Angiography,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Lung,LOCATION_OF,Computed Tomography Angiography,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Computed Tomography Angiography,ADMINISTERED_TO,Patients,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Disseminated Intravascular Coagulation,PROCESS_OF,Patients,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Present,COEXISTS_WITH,Venous Thromboembolism,32353742,10.1016/j.mehy.2020.109767,2020-05-01
Immunosuppressive Agents,ISA,Pharmaceutical Preparations,32353740,10.1016/j.mehy.2020.109790,2020-05-01
tocilizumab,ISA,Pharmaceutical Preparations,32353740,10.1016/j.mehy.2020.109790,2020-05-01
Ergocalciferol,INTERACTS_WITH,Interleukins,32353740,10.1016/j.mehy.2020.109790,2020-05-01
Ergocalciferol,INTERACTS_WITH(SPEC),Interleukin-6,32353740,10.1016/j.mehy.2020.109790,2020-05-01
Interleukin-6,ISA,Interleukins,32353740,10.1016/j.mehy.2020.109790,2020-05-01
Symptoms,PROCESS_OF,Persons,32353724,10.1016/j.scitotenv.2020.138997,2020-05-01
Nose,LOCATION_OF,Congestion,32353724,10.1016/j.scitotenv.2020.138997,2020-05-01
Immunity,PROCESS_OF,Persons,32353724,10.1016/j.scitotenv.2020.138997,2020-05-01
Disease,PROCESS_OF,Animal Model,32353724,10.1016/j.scitotenv.2020.138997,2020-05-01
targeted prevention,PREDISPOSES,Coronavirus Infections,32353722,10.1016/j.scitotenv.2020.139022,2020-05-01
Infected,PROCESS_OF,Community,32353722,10.1016/j.scitotenv.2020.139022,2020-05-01
Infected,PROCESS_OF,Community,32353722,10.1016/j.scitotenv.2020.139022,2020-05-01
China,ISA,Country,32353720,10.1016/j.scitotenv.2020.138919,2020-05-01
Basis,AFFECTS,Movement,32353720,10.1016/j.scitotenv.2020.138919,2020-05-01
Immunity,NEG_PROCESS_OF,Homo sapiens,32353597,10.1016/j.jtho.2020.04.015,2020-05-01
inflammatory response,COEXISTS_WITH,Disease,32353597,10.1016/j.jtho.2020.04.015,2020-05-01
Malignant neoplasm of lung,PROCESS_OF,Patients,32353549,10.1016/j.ijid.2020.04.065,2020-05-01
Prognosis bad,PROCESS_OF,Patients,32353549,10.1016/j.ijid.2020.04.065,2020-05-01
Malignant neoplasm of lung,AFFECTS,Patients,32353549,10.1016/j.ijid.2020.04.065,2020-05-01
Infected,PROCESS_OF,Patients,32353545,10.1016/j.ijid.2020.04.063,2020-05-01
Pneumonia,PRECEDES,Severe Acute Respiratory Syndrome,32353526,10.1016/j.jgar.2020.04.024,2020-05-01
Experience,PROCESS_OF,Patients,32353518,10.1016/j.bbi.2020.04.069,2020-05-01
Stress,PROCESS_OF,Persons,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Coronavirus Infections,ISA,Disease,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Anxiety,PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Depressive disorder,PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Stress,PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Impulsive Behavior,PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Feeling suicidal (finding),PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Sleeplessness,PROCESS_OF,Psychiatric inpatient,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Anxiety,ISA,Mental disorders,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Anxiety,PROCESS_OF(SPEC),Respondents,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Mental disorders,PROCESS_OF,Respondents,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Depressive disorder,ISA,Mental disorders,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Depressive disorder,PROCESS_OF(SPEC),Respondents,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Stress,ISA,Mental disorders,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Stress,PROCESS_OF(SPEC),Respondents,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Coronavirus Infections,ISA,Disease,32353474,10.1016/j.ygeno.2020.04.016,2020-05-01
Eye,LOCATION_OF,Isolate - microorganism,32353457,10.1016/j.gie.2020.04.048,2020-05-01
Surgical face mask,compared_with,Mechanical Ventilator,32353441,10.1016/j.athoracsur.2020.04.011,2020-05-01
Equipment in use,PROCESS_OF,Health Personnel,32353441,10.1016/j.athoracsur.2020.04.011,2020-05-01
Respiratory System Agents,INTERACTS_WITH,Biological Factors,32353441,10.1016/j.athoracsur.2020.04.011,2020-05-01
removal technique,AFFECTS,Respiration,32353440,10.1016/j.athoracsur.2020.04.007,2020-05-01
removal technique,TREATS,Chronic pneumothorax,32353440,10.1016/j.athoracsur.2020.04.007,2020-05-01
Thoracoscopy,TREATS,Patients,32353440,10.1016/j.athoracsur.2020.04.007,2020-05-01
Pleurectomy,TREATS,Chronic pneumothorax,32353440,10.1016/j.athoracsur.2020.04.007,2020-05-01
Universities,ISA,School,32353398,10.1016/j.mad.2020.111255,2020-05-01
Disinfection,USES,Hydrogen Peroxide,32353398,10.1016/j.mad.2020.111255,2020-05-01
risk factors,PROCESS_OF,geriatric patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
risk factors,PROCESS_OF,geriatric patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
geriatric patients,ISA,Persons,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
Cessation of life,PROCESS_OF,Patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
Dyspnea,PROCESS_OF,Patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
Chest discomfort,PROCESS_OF,Patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
Comorbidity,PROCESS_OF,geriatric patients,32353371,10.1053/j.gastro.2020.04.052,2020-05-01
Virus,PROCESS_OF,Homo sapiens,32353347,10.1016/S1473-3099(20)30287-5,2020-05-01
Enterovirus,ISA,Virus,32353347,10.1016/S1473-3099(20)30287-5,2020-05-01
Communicable Diseases,PROCESS_OF,Community,32353252,10.1016/j.cell.2020.04.020,2020-05-01
Symptom severe,PROCESS_OF,general population,32353252,10.1016/j.cell.2020.04.020,2020-05-01
Vaccines,NEG_PART_OF,Virus,32353184,10.1111/epi.16544,2020-05-01
SARS coronavirus,INTERACTS_WITH,Virus,32353184,10.1111/epi.16544,2020-05-01
Pharmacologic Substance,NEG_PART_OF,Virus,32353184,10.1111/epi.16544,2020-05-01
Epilepsy,PROCESS_OF,Patients,32353107,10.7326/A19-0030,2020-05-01
psychological distress,PROCESS_OF,Patients,32353107,10.7326/A19-0030,2020-05-01
Epilepsy,PROCESS_OF,Patients,32353107,10.7326/A19-0030,2020-05-01
Epilepsy,PROCESS_OF,Patients,32353107,10.7326/A19-0030,2020-05-01
Negative Test Result,PROCESS_OF,Staff Member,32352933,10.1172/jci.insight.137662,2020-05-01
Laboratory Procedures,DIAGNOSES,Severe Acute Respiratory Syndrome,32352927,10.1556/2006.2020.00016,2020-05-01
Nucleic Acids,ADMINISTERED_TO,Persons,32352927,10.1556/2006.2020.00016,2020-05-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32352927,10.1556/2006.2020.00016,2020-05-01
Severe Acute Respiratory Syndrome,AFFECTS,Pneumonia,32352927,10.1556/2006.2020.00016,2020-05-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32352927,10.1556/2006.2020.00016,2020-05-01
Quarantine,AFFECTS,Coronavirus Infections,32352917,10.5152/dir.2020.20260,2020-05-01
Diagnostic radiologic examination,ADMINISTERED_TO,Patients,32352915,10.5152/dir.2020.20232,2020-05-01
Diagnostic radiologic examination,AFFECTS,Pneumonia,32352915,10.5152/dir.2020.20232,2020-05-01
Cesarean section,TREATS,Woman,32352911,10.1080/17441692.2020.1760915,2020-05-01
Surgical Delivery Procedure,ADMINISTERED_TO,teams,32352911,10.1080/17441692.2020.1760915,2020-05-01
Government,LOCATION_OF,Analysis,32352846,10.1377/hlthaff.2020.00505,2020-05-01
Coronavirus Infections,ISA,Disease,32352836,10.1308/rcsann.2020.0097,2020-05-01
Analysis,MEASURES,Degree or extent,32352836,10.1308/rcsann.2020.0097,2020-05-01
Communicable Diseases,COEXISTS_WITH,Virus,32352652,10.1002/oby.22861,2020-05-01
Virus,COEXISTS_WITH,Pneumoperitoneum,32352652,10.1002/oby.22861,2020-05-01
Life Style,ISA,Behavior,32352650,10.1002/oby.22860,2020-05-01
Child,LOCATION_OF,IMPACT gene,32352650,10.1002/oby.22860,2020-05-01
Obesity,PROCESS_OF,Adult,32352650,10.1002/oby.22860,2020-05-01
Exacerbation,PREDISPOSES,Obesity,32352637,10.1002/oby.22859,2020-05-01
Telemedicine,METHOD_OF,Weight maintenance regimen,32352637,10.1002/oby.22859,2020-05-01
Chronic disease,PROCESS_OF,Patients,32352633,10.1002/ccd.28948,2020-05-01
Obesity,PROCESS_OF,Patients,32352633,10.1002/ccd.28948,2020-05-01
"CD69 protein, human",ASSOCIATED_WITH,Chronic disease,32352633,10.1002/ccd.28948,2020-05-01
"CD69 protein, human",ASSOCIATED_WITH,Obesity,32352633,10.1002/ccd.28948,2020-05-01
Disease,AFFECTS,Negative,32352575,10.1002/jmv.25960,2020-05-01
"Angioplasty, Balloon, Coronary",TREATS,Population Group,32352575,10.1002/jmv.25960,2020-05-01
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32352575,10.1002/jmv.25960,2020-05-01
Coronavirus Infections,ISA,Disease,32352574,10.1002/jmv.25953,2020-05-01
Respiratory problem,COEXISTS_WITH,Disease,32352574,10.1002/jmv.25953,2020-05-01
Respiratory problem,COEXISTS_WITH(SPEC),Coronavirus Infections,32352574,10.1002/jmv.25953,2020-05-01
Infected,PROCESS_OF,Patients,32352537,10.3928/01484834-20200422-02,2020-05-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32352537,10.3928/01484834-20200422-02,2020-05-01
Respiratory viruses,PROCESS_OF,Patients,32352537,10.3928/01484834-20200422-02,2020-05-01
Viral respiratory infection,PROCESS_OF,Community,32352537,10.3928/01484834-20200422-02,2020-05-01
Virus Diseases,PROCESS_OF,Patients,32352537,10.3928/01484834-20200422-02,2020-05-01
Coronavirus Infections,ISA,Disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Disease,CAUSES,"Pneumonia, Interstitial",32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Disease,CAUSES,Severe Acute Respiratory Syndrome,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coronavirus Infections,CAUSES(SPEC),"Pneumonia, Interstitial",32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coronavirus Infections,CAUSES(SPEC),Severe Acute Respiratory Syndrome,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coronavirus Infections,ISA,Disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Serine Endopeptidases,INTERACTS_WITH,angiotensin converting enzyme 2,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Perivascular,LOCATION_OF,Pericytes,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
angiotensin converting enzyme 2,PART_OF,integral to membrane,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coronavirus Infections,ISA,Disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
inhibitors,TREATS,Disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
inhibitors,TREATS(SPEC),Coronavirus Infections,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coronavirus Infections,ISA,Disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Heart Injuries,PROCESS_OF,Patients,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Coagulation procedure,PREDISPOSES,complication of disease,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Cardiovascular,LOCATION_OF,consideration,32352480,10.1001/jamapsychiatry.2020.1276,2020-05-01
Nurses,TREATS,Patients,32352450,10.4193/Rhin20.159,2020-05-01
Physicians,TREATS,Patients,32352450,10.4193/Rhin20.159,2020-05-01
Ward (environment),ISA,Hospitals,32352450,10.4193/Rhin20.159,2020-05-01
"Mental Disorders, Severe",PROCESS_OF,Persons,32352450,10.4193/Rhin20.159,2020-05-01
Bereavement,PROCESS_OF,Health Personnel,32352450,10.4193/Rhin20.159,2020-05-01
Anosmia,ISA,Symptoms,32352421,10.23749/mdl.v111i2.9546,2020-05-01
Dysgeusia,ISA,Symptoms,32352421,10.23749/mdl.v111i2.9546,2020-05-01
Anosmia,PROCESS_OF,Adult,32352421,10.23749/mdl.v111i2.9546,2020-05-01
Anosmia,PROCESS_OF,Patients,32352421,10.23749/mdl.v111i2.9546,2020-05-01
Fever,ISA,Symptoms,32352397,10.1515/cclm-2020-0377,2020-05-01
"Kidney Failure, Acute",PROCESS_OF,hospitalized patients,32352397,10.1515/cclm-2020-0377,2020-05-01
Severe disorder,PROCESS_OF,Patients,32352383,10.2196/19458,2020-05-01
Neutrophil count (procedure),DIAGNOSES,patient condition,32352383,10.2196/19458,2020-05-01
Lymphopenia,PROCESS_OF,Patients,32352383,10.2196/19458,2020-05-01
Disease Progression,COEXISTS_WITH,patient condition,32352383,10.2196/19458,2020-05-01
Coronavirus Infections,ISA,Disease,32352359,10.5152/eurjrheum.2020.20055,2020-05-01
Coronavirus Infections,ISA,Disease,32352359,10.5152/eurjrheum.2020.20055,2020-05-01
Coronavirus Infections,ISA,Disease,32352359,10.5152/eurjrheum.2020.20055,2020-05-01
Coronavirus Infections,ISA,Disease,32352359,10.5152/eurjrheum.2020.20055,2020-05-01
"Lupus Erythematosus, Systemic",ISA,Autoimmune Diseases,32352314,10.1177/2048872620924922,2020-05-01
Severe course,PROCESS_OF,Patients,32352314,10.1177/2048872620924922,2020-05-01
Hydroxychloroquine,TREATS,Patients,32352314,10.1177/2048872620924922,2020-05-01
Headache,ISA,Symptoms,32352180,10.1002/hed.26212,2020-05-01
Nose,LOCATION_OF,Obstruction,32352180,10.1002/hed.26212,2020-05-01
Pharyngeal structure,LOCATION_OF,Chief complaint (finding),32352180,10.1002/hed.26212,2020-05-01
Nose,LOCATION_OF,Obstruction,32352180,10.1002/hed.26212,2020-05-01
Nose,LOCATION_OF,Obstruction,32352180,10.1002/hed.26212,2020-05-01
Obstruction,NEG_AFFECTS,Patients,32352180,10.1002/hed.26212,2020-05-01
Interventional procedure,COEXISTS_WITH,Screening procedure,32352081,10.1016/j.medidd.2020.100042,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Pneumonia,CAUSES,Cessation of life,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Acute respiratory failure,CAUSES,Cessation of life,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Single organ dysfunction,CAUSES,Cessation of life,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Infected,PROCESS_OF,Persons,32352076,10.1016/j.joule.2020.04.011,2020-05-01
IMPACT gene,PART_OF,Persons,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Apnea,PROCESS_OF,Homo sapiens,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Botulinum Toxins,CAUSES(SPEC),Paralysed,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Botulinum Toxins,ISA,Neurotoxins,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Neurotoxins,CAUSES,Paralysed,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Neurologic Deficits,ISA,Symptoms,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Brain,LOCATION_OF,IMPACT gene,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Heart,LOCATION_OF,IMPACT gene,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Lung,LOCATION_OF,IMPACT gene,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Coronavirus Infections,ISA,Disease,32352076,10.1016/j.joule.2020.04.011,2020-05-01
Persons,LOCATION_OF,IMPACT gene,32351873,10.1007/s10389-020-01293-0,2020-05-01
Coronavirus Infections,CAUSES,Disease,32351864,10.7759/cureus.7808,2020-05-01
Cessation of life,PROCESS_OF,Persons,32351864,10.7759/cureus.7808,2020-05-01
Large blood vessel structure,LOCATION_OF,Complete obstruction,32351860,10.7759/cureus.7482,2020-05-01
Complete obstruction,PART_OF,Patients,32351860,10.7759/cureus.7482,2020-05-01
Large blood vessel structure,LOCATION_OF,Complete obstruction,32351860,10.7759/cureus.7482,2020-05-01
Large blood vessel structure,LOCATION_OF,Complete obstruction,32351860,10.7759/cureus.7482,2020-05-01
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32351860,10.7759/cureus.7482,2020-05-01
Cerebrovascular accident,PROCESS_OF,Patients,32351860,10.7759/cureus.7482,2020-05-01
Coronavirus Infections,ISA,Disease,32351851,10.7759/cureus.7473,2020-05-01
Pandemics,ISA,Disease Outbreaks,32351851,10.7759/cureus.7473,2020-05-01
Coronavirus Infections,COEXISTS_WITH,Symptoms,32351851,10.7759/cureus.7473,2020-05-01
Coronavirus Infections,ISA,Disease,32351851,10.7759/cureus.7473,2020-05-01
Fever,PROCESS_OF,Patients,32351831,10.7759/cureus.7452,2020-05-01
Co-morbid conditions,PROCESS_OF,Patients,32351831,10.7759/cureus.7452,2020-05-01
Chest,LOCATION_OF,Radionuclide Imaging,32351831,10.7759/cureus.7452,2020-05-01
Brazil,ISA,Country,32351814,10.7759/cureus.7434,2020-05-01
Ecuador,ISA,Country,32351814,10.7759/cureus.7434,2020-05-01
Pandemics,ISA,Disease Outbreaks,32351814,10.7759/cureus.7434,2020-05-01
Chest CT,DIAGNOSES,Ground Glass Opacity,32351807,10.7759/cureus.7422,2020-05-01
Severe Acute Respiratory Syndrome,ISA,Virus Diseases,32351657,10.1016/j.radcr.2020.04.055,2020-05-01
Gastrointestinal symptom,PROCESS_OF,Patients,32351657,10.1016/j.radcr.2020.04.055,2020-05-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32351657,10.1016/j.radcr.2020.04.055,2020-05-01
Pneumonia,PROCESS_OF,Woman,32351243,10.4103/sjg.SJG_161_20,2020-05-01
Vascular structure of mesentery,LOCATION_OF,Venous Thrombosis,32351243,10.4103/sjg.SJG_161_20,2020-05-01
Health Personnel,TREATS,Patients,32351121,10.1177/1074248420921720,2020-05-01
Malaise,PROCESS_OF,Health Personnel,32351121,10.1177/1074248420921720,2020-05-01
Cessation of life,PROCESS_OF,Persons,32351103,10.3906/sag-2004-293,2020-05-01
Eye,LOCATION_OF,Infected,32351103,10.3906/sag-2004-293,2020-05-01
Comorbidity,PROCESS_OF,Patients,32351103,10.3906/sag-2004-293,2020-05-01
SARS coronavirus,CAUSES,Communicable Diseases,32351102,10.3906/sag-2004-272,2020-05-01
Symptoms,PROCESS_OF,Patients,32351102,10.3906/sag-2004-272,2020-05-01
Coughing,ISA,Symptoms,32351037,10.1111/tbed.13604,2020-05-01
Fever,ISA,Symptoms,32351037,10.1111/tbed.13604,2020-05-01
Abnormal Finding,PROCESS_OF,Patients,32351037,10.1111/tbed.13604,2020-05-01
Antimetabolites,ISA,Agent,32351037,10.1111/tbed.13604,2020-05-01
Hydroxychloroquine,ADMINISTERED_TO,hospitalized patients,32351037,10.1111/tbed.13604,2020-05-01
Azithromycin,ADMINISTERED_TO,hospitalized patients,32351037,10.1111/tbed.13604,2020-05-01
"Kidney Failure, Acute",PROCESS_OF,Patients,32351037,10.1111/tbed.13604,2020-05-01
Elevated C-reactive protein,PROCESS_OF,Adult,32350928,10.1096/fj.202000919,2020-05-01
Chloroquine,TREATS,Patients,32350871,10.1002/ijgo.13188,2020-05-01
Chloroquine,TREATS(INFER),Disease,32350871,10.1002/ijgo.13188,2020-05-01
Disease,PROCESS_OF,Patients,32350871,10.1002/ijgo.13188,2020-05-01
Hydroxychloroquine,TREATS,Patients,32350871,10.1002/ijgo.13188,2020-05-01
Agent,TREATS,Disease,32350871,10.1002/ijgo.13188,2020-05-01
Agent,TREATS,Immune System Diseases,32350871,10.1002/ijgo.13188,2020-05-01
Hydroxychloroquine,AFFECTS,cytokine production,32350871,10.1002/ijgo.13188,2020-05-01
Nucleoside Analogs,TREATS,Virus Diseases,32350871,10.1002/ijgo.13188,2020-05-01
Disease,PROCESS_OF,Foundation for the Accreditation of Cellular Therapy,32350871,10.1002/ijgo.13188,2020-05-01
Vaginal Diseases,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32350857,10.1002/bjs.11670,2020-05-01
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32350857,10.1002/bjs.11670,2020-05-01
Disease,PROCESS_OF,Patients,32350818,10.1007/s12471-020-01429-7,2020-05-01
Operative Surgical Procedures,TREATS,Population Group,32350818,10.1007/s12471-020-01429-7,2020-05-01
Chloroquine,TREATS,Patients,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS(INFER),Infected,32350796,10.1007/s11547-020-01203-0,2020-05-01
Infected,PROCESS_OF,Patients,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,CAUSES,Electrocardiogram,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,CAUSES,Electrocardiogram,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,CAUSES,Corrected Prolonged QT Interval by ECG Finding,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS,Electrocardiogram,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS,Electrocardiogram,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS,Patients,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS,Corrected Prolonged QT Interval by ECG Finding,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,NEG_TREATS,Torsades de Pointes,32350796,10.1007/s11547-020-01203-0,2020-05-01
Chloroquine,TREATS,Patients,32350796,10.1007/s11547-020-01203-0,2020-05-01
Symptom severe,PROCESS_OF,Patients,32350794,10.1007/s11547-020-01197-9,2020-05-01
Plain chest X-ray,ADMINISTERED_TO,Patients,32350794,10.1007/s11547-020-01197-9,2020-05-01
Lung,LOCATION_OF,Ultrasonography,32350773,10.1007/s10461-020-02894-2,2020-05-01
Coronavirus Infections,PROCESS_OF,Patients,32350773,10.1007/s10461-020-02894-2,2020-05-01
Coitus,PROCESS_OF,Male population group,32350745,10.1007/s10840-020-00747-5,2020-05-01
methylsulfonylmethane,compared_with,IMPACT gene,32350745,10.1007/s10840-020-00747-5,2020-05-01
HIV,COEXISTS_WITH,Enthesitis-Related Arthritis,32350745,10.1007/s10840-020-00747-5,2020-05-01
Disease,PROCESS_OF,Patients,32350686,10.1007/s12325-020-01351-9,2020-05-01
Health Personnel,TREATS,Patients,32350686,10.1007/s12325-020-01351-9,2020-05-01
Antiviral Agents,TREATS,Severe Acute Respiratory Syndrome,32350632,10.1007/s11886-020-01293-2,2020-05-01
Hydroxychloroquine,ISA,Chloroquine,32350632,10.1007/s11886-020-01293-2,2020-05-01
INVESTIGATIONAL AGENTS,TREATS,Patients,32350632,10.1007/s11886-020-01293-2,2020-05-01
Pharmaceutical Preparations,TREATS,Disease,32350632,10.1007/s11886-020-01293-2,2020-05-01
Cells,INTERACTS_WITH,ACE2 gene,32350584,10.1007/s00264-020-04575-0,2020-05-01
cardiovascular risk factor,COEXISTS_WITH,patient condition,32350584,10.1007/s00264-020-04575-0,2020-05-01
Cardiac complication,PROCESS_OF,Patients,32350584,10.1007/s00264-020-04575-0,2020-05-01
Fracture,PROCESS_OF,Patients,32350571,10.1007/s00011-020-01352-y,2020-05-01
Fracture,PROCESS_OF,Old age,32350571,10.1007/s00011-020-01352-y,2020-05-01
Fracture,PROCESS_OF,Patients,32350571,10.1007/s00011-020-01352-y,2020-05-01
Fracture,PROCESS_OF,Patients,32350571,10.1007/s00011-020-01352-y,2020-05-01
"Fracture Fixation, Internal",METHOD_OF,Operative Surgical Procedures,32350571,10.1007/s00011-020-01352-y,2020-05-01
Health Personnel,ISA,Persons,32350571,10.1007/s00011-020-01352-y,2020-05-01
Virus,PROCESS_OF,Population Group,32350543,10.1007/s00101-020-00780-z,2020-05-01
Resistance Process,PROCESS_OF,Persons,32350543,10.1007/s00101-020-00780-z,2020-05-01
Immunity,PROCESS_OF,Population Group,32350543,10.1007/s00101-020-00780-z,2020-05-01
Pharmaceutical Preparations,NEG_TREATS,Persons,32350543,10.1007/s00101-020-00780-z,2020-05-01
Immunity,AFFECTS,Virus,32350543,10.1007/s00101-020-00780-z,2020-05-01
Vaccines,NEG_TREATS,Persons,32350543,10.1007/s00101-020-00780-z,2020-05-01
Human coronavirus 229E,PROCESS_OF,human group,32350543,10.1007/s00101-020-00780-z,2020-05-01
"Coronavirus OC43, Human",PROCESS_OF,human group,32350543,10.1007/s00101-020-00780-z,2020-05-01
SARS coronavirus,PROCESS_OF,Homo sapiens,32350543,10.1007/s00101-020-00780-z,2020-05-01
SARS coronavirus,PROCESS_OF,human group,32350543,10.1007/s00101-020-00780-z,2020-05-01
Human coronavirus NL63,PROCESS_OF,human group,32350543,10.1007/s00101-020-00780-z,2020-05-01
Human coronavirus HKU1,PROCESS_OF,human group,32350543,10.1007/s00101-020-00780-z,2020-05-01
Mechanical ventilation,USES,Mechanical Ventilator,32350462,10.1038/s41591-020-0897-1,2020-05-01
Mechanical Ventilator,TREATS,Weaning,32350462,10.1038/s41591-020-0897-1,2020-05-01
Nurses,USES,Mechanical Ventilator,32350462,10.1038/s41591-020-0897-1,2020-05-01
therapist,USES,Mechanical Ventilator,32350462,10.1038/s41591-020-0897-1,2020-05-01
Antibody Formation,PROCESS_OF,Patients,32350235,10.1253/circj.CJ-20-0302,2020-05-01
Diagnosis,DIAGNOSES,Asymptomatic Infections,32350235,10.1253/circj.CJ-20-0302,2020-05-01
Cardiovascular Diseases,AFFECTS,Cardiologists,32350226,10.7883/yoken.JJID.2020.108,2020-05-01
Coronavirus Infections,AFFECTS,Cardiologists,32350226,10.7883/yoken.JJID.2020.108,2020-05-01
Infected,PROCESS_OF,Patients,32350226,10.7883/yoken.JJID.2020.108,2020-05-01
Assay,USES,Reagents,32350161,10.5582/bst.2020.03086,2020-05-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Modulus,32350161,10.5582/bst.2020.03086,2020-05-01
Coagulation procedure,TREATS,Patients,32350134,10.1073/pnas.2005615117,2020-05-01
Fibrinogen,STIMULATES,Fibrin fragment D,32350134,10.1073/pnas.2005615117,2020-05-01
Elevation procedure,USES,Fibrin fragment D,32350134,10.1073/pnas.2005615117,2020-05-01
Monoclonal Antibodies,INTERACTS_WITH,Interleukin-6,32350060,10.1126/science.abb8001,2020-05-01
tocilizumab,TREATS,Patients,32350060,10.1126/science.abb8001,2020-05-01
tocilizumab,ADMINISTERED_TO,Patients,32350060,10.1126/science.abb8001,2020-05-01
Pulmonary opacity,PROCESS_OF,Patients,32350060,10.1126/science.abb8001,2020-05-01
tocilizumab,ADMINISTERED_TO,Patients,32350060,10.1126/science.abb8001,2020-05-01
Laboratory,LOCATION_OF,Laboratory Procedures,32350047,10.1128/JCM.00797-20,2020-05-01
Centers for Disease Control and Prevention (U.S.),LOCATION_OF,Assay,32350047,10.1128/JCM.00797-20,2020-05-01
Centers for Disease Control and Prevention (U.S.),LOCATION_OF,Laboratory Procedures,32350047,10.1128/JCM.00797-20,2020-05-01
Assay,USES,Laboratory Procedures,32350047,10.1128/JCM.00797-20,2020-05-01
Assay,DIAGNOSES,Infection,32349982,10.1136/annrheumdis-2020-217407,2020-05-01
United States Food and Drug Administration,LOCATION_OF,Management procedure,32349982,10.1136/annrheumdis-2020-217407,2020-05-01
Systemic Scleroderma,PROCESS_OF,Patients,32349962,10.2196/19577,2020-05-01
Virus Diseases,COEXISTS_WITH,"Lung Diseases, Interstitial",32349962,10.2196/19577,2020-05-01
Systemic Scleroderma,PROCESS_OF,Patients,32349962,10.2196/19577,2020-05-01
Coronavirus Infections,ISA,Disease,32349928,10.1016/j.eururo.2020.04.039,2020-05-01
Adrenal Cortex Hormones,ASSOCIATED_WITH,Complication,32349382,10.3390/s20092479,2020-05-01
Duration,TREATS,Symptoms,32349382,10.3390/s20092479,2020-05-01
Patient Discharge,COEXISTS_WITH,Chinese herbal medicine,32349382,10.3390/s20092479,2020-05-01
Chinese herbs,INTERACTS_WITH,Pharmaceutical Preparations,32349382,10.3390/s20092479,2020-05-01
Chinese herbal medicine,TREATS,Coronavirus Infections,32349382,10.3390/s20092479,2020-05-01
Lung,PART_OF,Homo sapiens,32349259,10.3390/ijerph17093025,2020-05-01
Emotions,PROCESS_OF,Persons,32349198,10.11622/smedj.2020069,2020-04-30
Decision,PROCESS_OF,Maker (occupation),32349198,10.11622/smedj.2020069,2020-04-30
Chronic liver disease,PROCESS_OF,Patients,32349183,10.1002/art.41301,2020-04-30
Liver diseases,AFFECTS,Americas Ethnicity,32349183,10.1002/art.41301,2020-04-30
Pneumonia,COMPLICATES,Multiple Organ Failure,32349121,10.1038/s41586-020-2279-8,2020-04-30
Coronary Arteriosclerosis,PROCESS_OF,Patients,32349121,10.1038/s41586-020-2279-8,2020-04-30
Eye,LOCATION_OF,Disease,32349113,10.1097/APO.0000000000000280,2020-04-30
Disease,NEG_PROCESS_OF,Patients,32349113,10.1097/APO.0000000000000280,2020-04-30
Eye,LOCATION_OF,Disease,32349113,10.1097/APO.0000000000000280,2020-04-30
Lung,LOCATION_OF,Intravascular thrombosis,32349053,10.1097/AOG.0000000000003924,2020-04-30
Virus,INTERACTS_WITH,Coronavirus Infections,32349051,10.1097/AOG.0000000000003929,2020-04-30
Breast Feeding,PROCESS_OF,Woman,32349051,10.1097/AOG.0000000000003929,2020-04-30
Pregnant Women,NEG_ISA,Woman,32349051,10.1097/AOG.0000000000003929,2020-04-30
Gravidity,PROCESS_OF,Patients,32349045,10.1097/HPC.0000000000000226,2020-04-30
Disease,PROCESS_OF,Patients,32349045,10.1097/HPC.0000000000000226,2020-04-30
Gravidity,PROCESS_OF,Patients,32349045,10.1097/HPC.0000000000000226,2020-04-30
Gravidity,PROCESS_OF,Patients,32349045,10.1097/HPC.0000000000000226,2020-04-30
Health Services,PREVENTS,disease transmission,32349035,10.1097/JCMA.0000000000000335,2020-04-30
Pandemics,CAUSES,Respiration Disorders,32349032,10.1097/JCMA.0000000000000336,2020-04-30
Disease,PROCESS_OF,Patients,32349014,10.1097/ACM.0000000000003478,2020-04-30
Dipeptidyl-Peptidase IV,AFFECTS,Disease,32349014,10.1097/ACM.0000000000003478,2020-04-30
diabetic,PROCESS_OF,Patients,32349014,10.1097/ACM.0000000000003478,2020-04-30
IMPACT gene,ASSOCIATED_WITH,Communicable Diseases,32349014,10.1097/ACM.0000000000003478,2020-04-30
"Students, Medical",TREATS,Patients,32348946,10.1016/j.scitotenv.2020.138915,2020-04-30
Coronavirus Infections,ISA,Disease,32348943,10.1016/j.scitotenv.2020.138918,2020-04-30
Coronavirus Infections,ISA,Disease,32348943,10.1016/j.scitotenv.2020.138918,2020-04-30
Coronavirus Infections,ISA,Disease,32348943,10.1016/j.scitotenv.2020.138918,2020-04-30
Coronavirus Infections,ISA,Disease,32348943,10.1016/j.scitotenv.2020.138918,2020-04-30
Coronavirus Infections,ISA,Disease,32348943,10.1016/j.scitotenv.2020.138918,2020-04-30
India,ISA,Country,32348833,10.1016/j.jhin.2020.04.036,2020-04-30
Health Personnel,ISA,Persons,32348783,10.1016/j.cca.2020.04.027,2020-04-30
Respiratory equipment,TREATS,Health Personnel,32348783,10.1016/j.cca.2020.04.027,2020-04-30
Evaluation,TREATS,Unfavorable Clinical Outcome,32348728,10.1016/j.stem.2020.04.014,2020-04-30
Laboratory,LOCATION_OF,Work,32348711,10.1177/0269216320920780,2020-04-30
hospice environment,LOCATION_OF,telephone survey,32348692,10.1164/rccm.202003-0821OC,2020-04-30
Emotional support,TREATS,Symptoms,32348692,10.1164/rccm.202003-0821OC,2020-04-30
Child,ISA,Relative (related person),32348692,10.1164/rccm.202003-0821OC,2020-04-30
Eye,LOCATION_OF,Virus,32348594,10.1002/hed.26220,2020-04-30
Therapeutic procedure,PREDISPOSES,infection as a complication,32348594,10.1002/hed.26220,2020-04-30
Therapeutic procedure,PREDISPOSES,Infection,32348594,10.1002/hed.26220,2020-04-30
Severe Acute Respiratory Syndrome,NEG_AFFECTS,Patients,32348594,10.1002/hed.26220,2020-04-30
Pharmaceutical Preparations,TREATS,Patients,32348594,10.1002/hed.26220,2020-04-30
Intestines,LOCATION_OF,Inflammation,32348594,10.1002/hed.26220,2020-04-30
Operative procedure on head,COEXISTS_WITH,head and neck surgery,32348591,10.1002/hed.26224,2020-04-30
Coronavirus Infections,ISA,Disease,32348588,10.1111/joim.13091,2020-04-30
Complication,PROCESS_OF,Patients,32348588,10.1111/joim.13091,2020-04-30
Deglutition Disorders,ISA,Complication,32348588,10.1111/joim.13091,2020-04-30
Deglutition Disorders,PROCESS_OF(SPEC),Patients,32348588,10.1111/joim.13091,2020-04-30
Coronavirus Infections,ISA,Disease,32348588,10.1111/joim.13091,2020-04-30
Equilibrium,ASSOCIATED_WITH,Deglutition Disorders,32348588,10.1111/joim.13091,2020-04-30
Coronavirus Infections,ISA,Disease,32348588,10.1111/joim.13091,2020-04-30
Influenza-like symptoms,PROCESS_OF,Persons,32348582,10.1002/hed.26223,2020-04-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32348582,10.1002/hed.26223,2020-04-30
Conjunctivitis,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Coughing,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Dyspnea,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Fatigue,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Fever,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Headache,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Pharyngitis,ISA,Symptoms,32348582,10.1002/hed.26223,2020-04-30
Real-Time Polymerase Chain Reaction,USES,"Tool, device (physical object)",32348582,10.1002/hed.26223,2020-04-30
Therapeutic procedure,TREATS,Disease,32348582,10.1002/hed.26223,2020-04-30
Quarantine,ISA,Interventional procedure,32348582,10.1002/hed.26223,2020-04-30
Quarantine,TREATS(SPEC),Decreasing,32348582,10.1002/hed.26223,2020-04-30
Interventional procedure,TREATS,Decreasing,32348582,10.1002/hed.26223,2020-04-30
Skin Manifestations,ISA,Disease,32348495,10.1093/infdis/jiaa224,2020-04-30
Erythema,ISA,Lesion,32348495,10.1093/infdis/jiaa224,2020-04-30
Urticaria,ISA,Lesion,32348495,10.1093/infdis/jiaa224,2020-04-30
pustule,ISA,Lesion,32348495,10.1093/infdis/jiaa224,2020-04-30
Vesicle (morphologic abnormality),ISA,Lesion,32348495,10.1093/infdis/jiaa224,2020-04-30
Disease,PROCESS_OF,Patients,32348495,10.1093/infdis/jiaa224,2020-04-30
Symptoms,PROCESS_OF,Patients,32348495,10.1093/infdis/jiaa224,2020-04-30
Skin Manifestations,PROCESS_OF,Patients,32348495,10.1093/infdis/jiaa224,2020-04-30
Infected,PROCESS_OF,Persons,32348485,10.1093/infdis/jiaa228,2020-04-30
Severe disorder,PROCESS_OF,Minority Groups,32348485,10.1093/infdis/jiaa228,2020-04-30
Interferons,STIMULATES,Genes,32348485,10.1093/infdis/jiaa228,2020-04-30
B3GNT3 gene,CAUSES,Disease,32348485,10.1093/infdis/jiaa228,2020-04-30
early/brief intervention/therapy (treatment),TREATS,Persons,32348485,10.1093/infdis/jiaa228,2020-04-30
Viral Shedding,PRECEDES,Respiratory Failure,32348474,10.1042/BCJ20200223,2020-04-30
Critical Illness,PROCESS_OF,Patients,32348474,10.1042/BCJ20200223,2020-04-30
brazilian,PROCESS_OF,citizen,32348380,10.14218/ERHM.2020.00023,2020-04-30
Elevation procedure,TREATS,Patients,32348293,10.2196/19297,2020-04-30
Elevation procedure,TREATS,Patients,32348293,10.2196/19297,2020-04-30
"FABP3 protein, human",PART_OF,Patients,32348293,10.2196/19297,2020-04-30
Coronavirus Infections,ISA,Disease,32348233,10.3201/eid2608.201477,2020-04-30
Disease,PROCESS_OF,Patients,32348233,10.3201/eid2608.201477,2020-04-30
Coronavirus Infections,ISA,Disease,32348233,10.3201/eid2608.201477,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32348233,10.3201/eid2608.201477,2020-04-30
Disease,PROCESS_OF,Patients,32348232,10.2174/1871526520666200429115535,2020-04-30
Coronavirus Infections,ISA,Disease,32348232,10.2174/1871526520666200429115535,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32348232,10.2174/1871526520666200429115535,2020-04-30
Receptor Antagonist Therapy,USES,Interleukin-6,32348232,10.2174/1871526520666200429115535,2020-04-30
Diagnosis,ADMINISTERED_TO,Patients,32348232,10.2174/1871526520666200429115535,2020-04-30
Fever,PROCESS_OF,Patients,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
Chills,PROCESS_OF,Patients,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
Myalgia,PROCESS_OF,Patients,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
Laboratory,LOCATION_OF,Analysis,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
Laboratory Procedures,DIAGNOSES,Ground Glass Opacity,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
Oseltamivir 75 MG,TREATS,Patients,32348166,10.1161/HYPERTENSIONAHA.120.15143,2020-04-30
ACE2 gene,ASSOCIATED_WITH,Inflammation,32348165,10.1089/hs.2020.0043,2020-04-30
ACE2 gene,ASSOCIATED_WITH,Virus Diseases,32348165,10.1089/hs.2020.0043,2020-04-30
Hypertensive disease,PROCESS_OF,Patients,32348165,10.1089/hs.2020.0043,2020-04-30
Hypertensive disease,PROCESS_OF,Patients,32348165,10.1089/hs.2020.0043,2020-04-30
Blood Pressure,PROCESS_OF,Patients,32348165,10.1089/hs.2020.0043,2020-04-30
Challenge,AFFECTS,Engaged to be married,32348111,10.1021/acschemneuro.0c00217,2020-04-30
Medulla Oblongata,PART_OF,Brain,32348025,10.1002/alr.22596,2020-04-30
Respiratory Center,PART_OF,Brain,32348025,10.1002/alr.22596,2020-04-30
Brain Stem,LOCATION_OF,Shock,32348025,10.1002/alr.22596,2020-04-30
Respiratory Center,LOCATION_OF,Shock,32348025,10.1002/alr.22596,2020-04-30
Telephone consultation,ADMINISTERED_TO,Patients,32348015,10.1111/bjhp.12423,2020-04-30
Italy,ISA,European country,32348015,10.1111/bjhp.12423,2020-04-30
urgent Operation,ISA,Operative Surgical Procedures,32348015,10.1111/bjhp.12423,2020-04-30
Negative,PROCESS_OF,Patients,32348015,10.1111/bjhp.12423,2020-04-30
Negative attitude,PROCESS_OF,Respondents,32348003,10.1002/ccd.28951,2020-04-30
Coronavirus Infections,AFFECTS,Nance-Horan syndrome,32348003,10.1002/ccd.28951,2020-04-30
Screening procedure,TREATS,Acute myocardial infarction,32347997,10.1002/hed.26203,2020-04-30
Surgical drains,TREATS,Patients,32347991,10.1002/hed.26222,2020-04-30
Tracheostomy procedure,TREATS,Disease,32347972,10.1002/jmv.25957,2020-04-30
Tracheostomy procedure,TREATS(SPEC),Coronavirus Infections,32347972,10.1002/jmv.25957,2020-04-30
Coronavirus Infections,ISA,Disease,32347972,10.1002/jmv.25957,2020-04-30
Tracheostomy procedure,ADMINISTERED_TO,Caregiver,32347972,10.1002/jmv.25957,2020-04-30
Tracheostomy procedure,TREATS,Patients,32347972,10.1002/jmv.25957,2020-04-30
"WFDC2 protein, human",compared_with,Mucin-16,32347966,10.1002/jmv.25954,2020-04-30
China,ISA,Country,32347962,10.20882/adicciones.1546,2020-04-30
Vision,PROCESS_OF,Patients,32347747,10.1080/08830185.2020.1756284,2020-04-30
Pigmented lesions,PROCESS_OF,Patients,32347747,10.1080/08830185.2020.1756284,2020-04-30
Disease,PROCESS_OF,Persons,32347745,10.1177/2048872620922788,2020-04-30
Disease,PROCESS_OF,Old age,32347745,10.1177/2048872620922788,2020-04-30
High Level,PROCESS_OF,grandparent,32347745,10.1177/2048872620922788,2020-04-30
Chiroptera,ISA,Animals,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,ISA,Antioxidants,32347745,10.1177/2048872620922788,2020-04-30
Lung,LOCATION_OF,Inflammation,32347745,10.1177/2048872620922788,2020-04-30
Coronavirus Infections,CAUSES,Inflammation,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,INHIBITS,Inflammasomes,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,PREVENTS,Anxiety,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,PREVENTS,Fibrosis,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,PREVENTS,Oxidative Stress,32347745,10.1177/2048872620922788,2020-04-30
Melatonin,PREVENTS,Symptoms,32347745,10.1177/2048872620922788,2020-04-30
Coronavirus Infections,PROCESS_OF,Patients,32347745,10.1177/2048872620922788,2020-04-30
Symptom severe,PROCESS_OF,Patients,32347745,10.1177/2048872620922788,2020-04-30
QT interval:Time:Point in time:Heart:Quantitative:EKG,PREDISPOSES,Torsades de Pointes,32347685,10.23736/S0390-5616.20.04994-2,2020-04-30
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32347685,10.23736/S0390-5616.20.04994-2,2020-04-30
Torsades de Pointes,NEG_PROCESS_OF,Population Group,32347685,10.23736/S0390-5616.20.04994-2,2020-04-30
Hydroxychloroquine,TREATS,Patients,32347685,10.23736/S0390-5616.20.04994-2,2020-04-30
Pharmaceutical Preparations,CAUSES,Prolonged QT interval,32347685,10.23736/S0390-5616.20.04994-2,2020-04-30
Coronavirus Infections,ISA,Disease,32347612,10.1111/dth.13472,2020-04-30
Acne,ISA,Disease,32347612,10.1111/dth.13472,2020-04-30
Insight,PROCESS_OF,Tissue Donors,32347453,10.1007/s11605-020-04608-4,2020-04-30
Disease,PROCESS_OF,Patients,32347200,10.2807/1560-7917.ES.2020.25.16.2000508,2020-04-30
Coronavirus Infections,ISA,Disease,32347200,10.2807/1560-7917.ES.2020.25.16.2000508,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32347200,10.2807/1560-7917.ES.2020.25.16.2000508,2020-04-30
Severe disorder,PROCESS_OF,Patients,32347200,10.2807/1560-7917.ES.2020.25.16.2000508,2020-04-30
Assay,USES,Quantitative PCR analysis,32347055,10.13345/j.cjb.200049,2020-04-30
Organism,LOCATION_OF,Cyclophilin A,32347054,10.13345/j.cjb.200094,2020-04-30
SARS coronavirus,ISA,Genus: Coronavirus,32347054,10.13345/j.cjb.200094,2020-04-30
Basis,INTERACTS_WITH,Cyclophilin A,32347054,10.13345/j.cjb.200094,2020-04-30
Syndrome,PROCESS_OF,Homo sapiens,32347053,10.13345/j.cjb.200115,2020-04-30
Coronavirus Infections,CAUSES,Syndrome,32347053,10.13345/j.cjb.200115,2020-04-30
Diabetes,PROCESS_OF,Patients,32346873,10.1002/jmv.25944,2020-04-30
Diabetes,PROCESS_OF,Patients,32346873,10.1002/jmv.25944,2020-04-30
Diabetes,PROCESS_OF,Patients,32346873,10.1002/jmv.25944,2020-04-30
Coronavirus Infections,PROCESS_OF,Patients,32346873,10.1002/jmv.25944,2020-04-30
Crisis,PROCESS_OF,Patients,32346873,10.1002/jmv.25944,2020-04-30
Asymptomatic,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Infected,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Infected,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Infected,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Symptoms,NEG_PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Physical Examination,USES,Chest CT,32346843,10.1007/s12028-020-00978-4,2020-04-30
Anus,LOCATION_OF,Symptoms,32346843,10.1007/s12028-020-00978-4,2020-04-30
Pharyngeal structure,LOCATION_OF,Symptoms,32346843,10.1007/s12028-020-00978-4,2020-04-30
Asymptomatic,PROCESS_OF,Patients,32346843,10.1007/s12028-020-00978-4,2020-04-30
Pandemics,CAUSES,nervous system disorder,32346790,10.1007/s00330-020-06863-0,2020-04-30
Pharmaceutical Preparations,TREATS,Urinary hesitation,32346790,10.1007/s00330-020-06863-0,2020-04-30
Disease,PROCESS_OF,Patients,32346790,10.1007/s00330-020-06863-0,2020-04-30
Physical Examination,USES,tomography,32346785,10.1007/s00417-020-04694-9,2020-04-30
X-Ray Computed Tomography,DIAGNOSES,patient condition,32346785,10.1007/s00417-020-04694-9,2020-04-30
Osteoporosis,PROCESS_OF,Patients,32346676,10.1038/s43018-020-0065-z,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32346664,10.1016/j.idm.2020.03.003,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32346664,10.1016/j.idm.2020.03.003,2020-04-30
Infected,PROCESS_OF,Persons,32346663,10.1016/j.idm.2020.04.002,2020-04-30
Infected,PROCESS_OF,Persons,32346663,10.1016/j.idm.2020.04.002,2020-04-30
Infected,PROCESS_OF,Persons,32346663,10.1016/j.idm.2020.04.002,2020-04-30
Pneumonia,PROCESS_OF,hospitalized patients,32346593,10.1016/j.jrid.2020.04.003,2020-04-30
Coronavirus Infections,ISA,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Coronavirus Infections,ISA,Communicable Diseases,32346568,10.1016/j.dib.2020.105526,2020-04-30
Fatigue,ISA,Symptoms,32346568,10.1016/j.dib.2020.105526,2020-04-30
Fever,ISA,Symptoms,32346568,10.1016/j.dib.2020.105526,2020-04-30
Coronavirus Infections,ISA,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Dry cough,ISA,Symptoms,32346568,10.1016/j.dib.2020.105526,2020-04-30
Coronavirus Infections,ISA,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Basis,TREATS,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Basis,TREATS(SPEC),Coronavirus Infections,32346568,10.1016/j.dib.2020.105526,2020-04-30
Nucleic Acid Amplification Tests,DIAGNOSES,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Nucleic Acid Amplification Tests,DIAGNOSES(SPEC),Coronavirus Infections,32346568,10.1016/j.dib.2020.105526,2020-04-30
Coronavirus Infections,ISA,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Coronavirus Infections,ISA,Disease,32346568,10.1016/j.dib.2020.105526,2020-04-30
Early Diagnosis,USES,Basis,32346568,10.1016/j.dib.2020.105526,2020-04-30
Asymptomatic,PROCESS_OF,Persons,32346531,10.1007/s12070-020-01863-4,2020-04-30
Coronavirus Infections,ISA,Disease,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Coronavirus Infections,ISA,Disease,32346491,10.1016/j.eng.2020.03.007,2020-04-30
"Kidney Failure, Acute",ISA,Complication,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Severe disorder,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Severe disorder,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Disease,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Coronavirus Infections,ISA,Disease,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
blood treatment,TREATS,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
blood treatment,TREATS(INFER),Disease,32346491,10.1016/j.eng.2020.03.007,2020-04-30
Severe disorder,PROCESS_OF,Patients,32346491,10.1016/j.eng.2020.03.007,2020-04-30
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
favipiravir,compared_with,lopinavir / Ritonavir,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
,COEXISTS_WITH,AKR1A1 wt Allele,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
,COEXISTS_WITH,AKR1A1 wt Allele,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
lopinavir / Ritonavir,TREATS,Patients,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
AKR1A1 wt Allele,compared_with,AKR1A1 wt Allele,32346490,10.1016/j.jpha.2020.04.008,2020-04-30
Antiviral Agents,TREATS,Possible,32346470,10.1093/jscr/rjaa109,2020-04-30
Vaccines,TREATS,Possible,32346470,10.1093/jscr/rjaa109,2020-04-30
Cessation of life,PROCESS_OF,Patients,32346469,10.1093/jscr/rjaa095,2020-04-30
Malignant Neoplasms,PROCESS_OF,Palestinian race,32346393,10.3332/ecancer.2020.ed99,2020-04-30
skill,PROCESS_OF,Health Personnel,32346392,10.3332/ecancer.2020.1026,2020-04-30
NCI-Designated Cancer Center,LOCATION_OF,cancer diagnosis,32346373,10.3389/fpsyt.2020.00306,2020-04-30
Coronavirus Infections,ISA,Disease,32346359,10.1007/s11469-020-00281-5,2020-04-30
Psychological Factors,PROCESS_OF,Medical Staff,32346359,10.1007/s11469-020-00281-5,2020-04-30
Symptoms,PROCESS_OF,Participant,32346359,10.1007/s11469-020-00281-5,2020-04-30
Knowledge acquisition,AFFECTS,Symptoms,32346359,10.1007/s11469-020-00281-5,2020-04-30
High Schools,LOCATION_OF,Knowledge acquisition,32346359,10.1007/s11469-020-00281-5,2020-04-30
Sleeplessness,PROCESS_OF,Medical Staff,32346359,10.1007/s11469-020-00281-5,2020-04-30
Intervention regimes,TREATS,Sleeplessness,32346359,10.1007/s11469-020-00281-5,2020-04-30
Immune response,AFFECTS,Disease Progression,32345864,10.2106/JBJS.20.00617,2020-04-30
Human coronavirus,INTERACTS_WITH,SARS coronavirus,32345864,10.2106/JBJS.20.00617,2020-04-30
Therapeutic procedure,TREATS,Virus Diseases,32345864,10.2106/JBJS.20.00617,2020-04-30
Infected,PROCESS_OF,Patients,32345861,10.1213/ANE.0000000000004912,2020-04-30
Femoral Neck Fractures,PROCESS_OF,Patients,32345861,10.1213/ANE.0000000000004912,2020-04-30
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32345861,10.1213/ANE.0000000000004912,2020-04-30
Operative Surgical Procedures,TREATS,Patients,32345861,10.1213/ANE.0000000000004912,2020-04-30
Operative Surgical Procedures,TREATS,patient condition,32345861,10.1213/ANE.0000000000004912,2020-04-30
Respiratory Failure,COEXISTS_WITH,patient condition,32345861,10.1213/ANE.0000000000004912,2020-04-30
Femoral Fractures,PROCESS_OF,geriatric patients,32345861,10.1213/ANE.0000000000004912,2020-04-30
mental health,PROCESS_OF,Consultant,32345860,10.1213/ANE.0000000000004913,2020-04-30
Wounds and Injuries,PROCESS_OF,Patients,32345741,10.4187/respcare.07882,2020-04-30
Emergency operation,TREATS,Patients,32345741,10.4187/respcare.07882,2020-04-30
Emergency operation,TREATS(INFER),Wounds and Injuries,32345741,10.4187/respcare.07882,2020-04-30
Alveolar ventilation function,COEXISTS_WITH,Respiration,32345728,10.1212/WNL.0000000000009673,2020-04-30
neurological complication,COEXISTS_WITH,Coronavirus Infections,32345702,10.1681/ASN.2020030276,2020-04-30
neurological complication,PROCESS_OF,Patients,32345702,10.1681/ASN.2020030276,2020-04-30
Patients,USES,Preexisting Condition Coverage,32345702,10.1681/ASN.2020030276,2020-04-30
Neurological event,PROCESS_OF,Patients,32345702,10.1681/ASN.2020030276,2020-04-30
neurological complication,PROCESS_OF,hospitalized patients,32345702,10.1681/ASN.2020030276,2020-04-30
Pneumonia,PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Pneumonia,PROCESS_OF,hospitalized patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
"Kidney Failure, Acute",PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Complete Recovery,PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Pneumonia,PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Hematuria,PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Kidney,LOCATION_OF,Complication,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
"Kidney Failure, Acute",PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Proteinuria,PROCESS_OF,Patients,32345646,10.1158/1078-0432.CCR-20-1427,2020-04-30
Hematologic Neoplasms,PROCESS_OF,Patients,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
BTK Inhibitor,TREATS,Chronic Lymphocytic Leukemia,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
BTK Inhibitor,TREATS,Patients,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
BTK Inhibitor,TREATS,B-Cell Lymphomas,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
Discontinued,PREDISPOSES,Secondary Infections,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
B-Lymphocytes,LOCATION_OF,Malignant Neoplasms,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
Patients,LOCATION_OF,,32345594,10.1158/2159-8290.CD-20-0422,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
High risk of,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Neoplasm Metastasis,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Hematologic Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Severe disorder,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
High risk of,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Malignant Neoplasms,PROCESS_OF,Patients,32345579,10.1136/bmjdrc-2020-001343,2020-04-30
Diabetes,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Diabetes,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
GSKIP gene,ASSOCIATED_WITH,Diabetes,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Diabetes,NEG_PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Diabetes,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Diabetes,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Diabetes,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Mechanical ventilation,AFFECTS,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Fibrin fragment D,ISA,Fibrinogen,32345566,10.1016/j.arth.2020.04.038,2020-04-30
Neutrophil count (procedure),ISA,White Blood Cell Count procedure,32345566,10.1016/j.arth.2020.04.038,2020-04-30
High Level,PROCESS_OF,Patients,32345566,10.1016/j.arth.2020.04.038,2020-04-30
X-Ray Computed Tomography,DIAGNOSES,Ground Glass Opacity,32345515,10.1016/j.anl.2020.04.002,2020-04-30
lobe,LOCATION_OF,Ground Glass Opacity,32345515,10.1016/j.anl.2020.04.002,2020-04-30
Chest,LOCATION_OF,X-Ray Computed Tomography,32345515,10.1016/j.anl.2020.04.002,2020-04-30
Tracheostomy procedure,TREATS,Severely Abnormal Ventricular Ejection Fraction,32345485,10.1016/j.transci.2020.102790,2020-04-30
consideration,PROCESS_OF,Health Personnel,32345485,10.1016/j.transci.2020.102790,2020-04-30
Anesthesia procedures,ISA,Operative Surgical Procedures,32345485,10.1016/j.transci.2020.102790,2020-04-30
Experience,PROCESS_OF,Patients,32345485,10.1016/j.transci.2020.102790,2020-04-30
SARS coronavirus,PROCESS_OF,Patients,32345485,10.1016/j.transci.2020.102790,2020-04-30
Coronavirus Infections,ISA,Disease,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Virus,CAUSES,Disease,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Virus,CAUSES(SPEC),Coronavirus Infections,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Coronavirus Infections,ISA,Disease,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Coronavirus Infections,ISA,Disease,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Plasma,LOCATION_OF,Program,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Plasma,NEG_PART_OF,Recipient,32345478,10.1016/j.schres.2020.04.002,2020-04-30
Schizophrenia,PROCESS_OF,Research Personnel,32345446,10.1016/j.amjoto.2020.102508,2020-04-30
Coronavirus Infections,ISA,Disease,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Coronavirus Infections,ISA,Disease,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Nose,PART_OF,Patients,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
professional occupation status,TREATS,Patients,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Disease,PREDISPOSES,Cross Infection,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Coronavirus Infections,ISA,Disease,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Coronavirus Infections,PREDISPOSES(SPEC),Cross Infection,32345443,10.1016/j.ciresp.2020.04.009,2020-04-30
Human tissue,LOCATION_OF,angiotensin converting enzyme 2,32345343,10.1186/s13054-020-02882-x,2020-04-30
Human tissue,LOCATION_OF,angiotensin converting enzyme 2,32345343,10.1186/s13054-020-02882-x,2020-04-30
"Intestines, Small",LOCATION_OF,,32345343,10.1186/s13054-020-02882-x,2020-04-30
Body tissue,LOCATION_OF,angiotensin converting enzyme 2,32345343,10.1186/s13054-020-02882-x,2020-04-30
Lung,LOCATION_OF,angiotensin converting enzyme 2,32345343,10.1186/s13054-020-02882-x,2020-04-30
Severe Acute Respiratory Syndrome,INTERACTS_WITH,Virus,32345343,10.1186/s13054-020-02882-x,2020-04-30
Delirium,COEXISTS_WITH,Critical Illness,32345328,10.1186/s12943-020-01209-2,2020-04-30
Immobilization,AFFECTS,Neoplasm Metastasis,32345328,10.1186/s12943-020-01209-2,2020-04-30
Critical Illness,PROCESS_OF,Patients,32345328,10.1186/s12943-020-01209-2,2020-04-30
intensive care unit,LOCATION_OF,Administration occupational activities,32345328,10.1186/s12943-020-01209-2,2020-04-30
Intervention regimes,TREATS,Patients,32345328,10.1186/s12943-020-01209-2,2020-04-30
Intervention regimes,TREATS(INFER),Critical Illness,32345328,10.1186/s12943-020-01209-2,2020-04-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Lung,LOCATION_OF,Adenocarcinoma,32345226,10.1186/s12879-020-05010-w,2020-04-30
Lung,LOCATION_OF,Squamous cell carcinoma,32345226,10.1186/s12879-020-05010-w,2020-04-30
"PRSS2 protein, human",LOCATION_OF,Gene Expression,32345226,10.1186/s12879-020-05010-w,2020-04-30
ACE2 gene,LOCATION_OF,Gene Expression,32345226,10.1186/s12879-020-05010-w,2020-04-30
Lung,LOCATION_OF,Squamous cell carcinoma,32345226,10.1186/s12879-020-05010-w,2020-04-30
Malignant neoplasm of lung,PROCESS_OF,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Adenocarcinoma,PROCESS_OF,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Squamous cell carcinoma,PROCESS_OF,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32345226,10.1186/s12879-020-05010-w,2020-04-30
Coronavirus Infections,ISA,Disease,32345140,10.1080/07391102.2020.1762743,2020-04-30
Disease,COEXISTS_WITH,Non-Ossifying Fibroma,32345140,10.1080/07391102.2020.1762743,2020-04-30
Disease,PROCESS_OF,Patients,32345140,10.1080/07391102.2020.1762743,2020-04-30
Disease,PROCESS_OF,Patients,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,COEXISTS_WITH(SPEC),Non-Ossifying Fibroma,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,ISA,Disease,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,ISA,Disease,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32345140,10.1080/07391102.2020.1762743,2020-04-30
Critical Illness,PROCESS_OF,Patients,32345140,10.1080/07391102.2020.1762743,2020-04-30
Quantitative PCR analysis,DIAGNOSES,Disease,32345140,10.1080/07391102.2020.1762743,2020-04-30
Coronavirus Infections,ISA,Disease,32345124,10.1080/07391102.2020.1762741,2020-04-30
Pharmaceutical Preparations,TREATS,Disease,32345124,10.1080/07391102.2020.1762741,2020-04-30
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32345124,10.1080/07391102.2020.1762741,2020-04-30
Coronavirus Infections,ISA,Disease,32345124,10.1080/07391102.2020.1762741,2020-04-30
resveratrol,INHIBITS,"M Protein, multiple myeloma",32345124,10.1080/07391102.2020.1762741,2020-04-30
Cessation of life,PROCESS_OF,Homo sapiens,32345072,10.1080/17476348.2020.1761791,2020-04-30
"Plants, Medicinal",LOCATION_OF,oleanane,32345072,10.1080/17476348.2020.1761791,2020-04-30
Neurologists,ISA,Health Personnel,32344853,10.3390/ijerph17092986,2020-04-30
Comorbidity,COEXISTS_WITH,Parkinson Disease,32344853,10.3390/ijerph17092986,2020-04-30
Parkinson Disease,PROCESS_OF,Patients,32344853,10.3390/ijerph17092986,2020-04-30
Parkinson Disease,PROCESS_OF,Patients,32344853,10.3390/ijerph17092986,2020-04-30
Challenge,TREATS,Parkinson Disease,32344853,10.3390/ijerph17092986,2020-04-30
"CD69 protein, human",ASSOCIATED_WITH,Parkinson Disease,32344853,10.3390/ijerph17092986,2020-04-30
Parkinson Disease,PROCESS_OF,Patients,32344853,10.3390/ijerph17092986,2020-04-30
Immunization,USES,Recombinant Antibody,32344809,10.3390/ijerph17092977,2020-04-30
Recombinant Antibody,PART_OF,Homo sapiens,32344809,10.3390/ijerph17092977,2020-04-30
Quarantine,PREDISPOSES,Cachexia,32344809,10.3390/ijerph17092977,2020-04-30
Decision,PROCESS_OF,Maker (occupation),32344809,10.3390/ijerph17092977,2020-04-30
Epidemic,ISA,Disease Outbreaks,32344688,10.3390/ma13081997,2020-04-30
Epidemic,ISA,Disease Outbreaks,32344688,10.3390/ma13081997,2020-04-30
Face shield,USES,Printer/plotter,32344679,10.3390/jcm9041225,2020-04-30
Visual Analog Pain Scale,ADMINISTERED_TO,Clinician,32344679,10.3390/jcm9041225,2020-04-30
Disease Outbreaks,CAUSES,Disease,32344657,10.3390/sports8040056,2020-04-30
Chest Pain,ASSOCIATED_WITH,Disease,32344657,10.3390/sports8040056,2020-04-30
Fever,ASSOCIATED_WITH,Disease,32344657,10.3390/sports8040056,2020-04-30
Dry cough,ASSOCIATED_WITH,Disease,32344657,10.3390/sports8040056,2020-04-30
Infection,PROCESS_OF,Homo sapiens,32344657,10.3390/sports8040056,2020-04-30
sun light exposure,NEG_PROCESS_OF,Athletes,32344568,10.3390/ijms21083004,2020-04-30
sun light exposure,NEG_PROCESS_OF,Coach (occupation),32344568,10.3390/ijms21083004,2020-04-30
Renin-angiotensin system,AFFECTS,Blood Pressure,32344456,10.1111/anae.15105,2020-04-29
Angiotensin-Converting Enzyme Inhibitors,INTERACTS_WITH,Pharmaceutical Preparations,32344456,10.1111/anae.15105,2020-04-29
Pneumonia,PROCESS_OF,Patients,32344456,10.1111/anae.15105,2020-04-29
Coronavirus Infections,ISA,Disease,32344456,10.1111/anae.15105,2020-04-29
Medical Care Team,COEXISTS_WITH,"Intubation, Intratracheal",32344449,10.1002/cpt.1874,2020-04-29
"Anesthesia, Conduction",TREATS,Patients,32344449,10.1002/cpt.1874,2020-04-29
patient safety,PREVENTS,Possible,32344449,10.1002/cpt.1874,2020-04-29
Hydroxychloroquine,ISA,Antimalarials,32344444,10.1055/a-1163-9009,2020-04-29
Hydroxychloroquine,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32344444,10.1055/a-1163-9009,2020-04-29
Infected,PROCESS_OF,Patients,32344444,10.1055/a-1163-9009,2020-04-29
Dose Regimen,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32344444,10.1055/a-1163-9009,2020-04-29
Dose Regimen,USES,Hydroxychloroquine,32344444,10.1055/a-1163-9009,2020-04-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Elderly (population group),32344439,10.1055/a-1147-6244,2020-04-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32344439,10.1055/a-1147-6244,2020-04-29
Vaccination,PRECEDES,Quarantine,32344439,10.1055/a-1147-6244,2020-04-29
Vaccination,PRECEDES,Isolation procedure,32344439,10.1055/a-1147-6244,2020-04-29
intensive care unit,LOCATION_OF,Retrospective Cohort Study,32344438,10.1055/a-1163-3096,2020-04-29
Ward (environment),LOCATION_OF,Retrospective Cohort Study,32344438,10.1055/a-1163-3096,2020-04-29
inpatient,LOCATION_OF,IMPACT gene,32344425,10.1038/s41390-020-0927-1,2020-04-29
Therapeutic procedure,TREATS,Benign condition,32344425,10.1038/s41390-020-0927-1,2020-04-29
Therapeutic procedure,NEG_ISA,Interventional procedure,32344422,10.1159/000507898,2020-04-29
Negative Surgical Margin,PROCESS_OF,Child,32344422,10.1159/000507898,2020-04-29
Delivery of Health Care,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32344422,10.1159/000507898,2020-04-29
inflammatory response,COEXISTS_WITH,Septicemia,32344422,10.1159/000507898,2020-04-29
Bronchoscopy,ADMINISTERED_TO,Physicians,32344370,10.1016/j.dsx.2020.04.032,2020-04-29
Masks,TREATS,Patients,32344366,10.1016/j.seizure.2020.04.009,2020-04-29
Infected,PROCESS_OF,Patients,32344366,10.1016/j.seizure.2020.04.009,2020-04-29
Coronavirus Infections,CAUSES,Disease,32344321,10.1016/j.jcv.2020.104370,2020-04-29
C-reactive protein,PART_OF,Patients,32344320,10.1016/j.jcv.2020.104361,2020-04-29
Interleukin-6,PART_OF,Patients,32344320,10.1016/j.jcv.2020.104361,2020-04-29
procalcitonin,PART_OF,Patients,32344320,10.1016/j.jcv.2020.104361,2020-04-29
Interleukin-6,PART_OF,Patients,32344320,10.1016/j.jcv.2020.104361,2020-04-29
Patients,LOCATION_OF,C-reactive protein,32344320,10.1016/j.jcv.2020.104361,2020-04-29
Patients,LOCATION_OF,Interleukin-6,32344320,10.1016/j.jcv.2020.104361,2020-04-29
Immunity,PROCESS_OF,Patients,32344319,10.1016/j.jcv.2020.104381,2020-04-29
Pneumonia,PROCESS_OF,Patients,32344319,10.1016/j.jcv.2020.104381,2020-04-29
Nucleic Acid Amplification Tests,DIAGNOSES,Pneumonia,32344319,10.1016/j.jcv.2020.104381,2020-04-29
Disease,PROCESS_OF,Cancer Patient,32344314,10.1016/j.mehy.2020.109777,2020-04-29
Challenge,TREATS,Enthesitis-Related Arthritis,32344314,10.1016/j.mehy.2020.109777,2020-04-29
Disease,PROCESS_OF,Persons,32344313,10.1016/j.mehy.2020.109776,2020-04-29
Lymphocyte,PART_OF,Patients,32344313,10.1016/j.mehy.2020.109776,2020-04-29
neutrophil,PART_OF,Patients,32344313,10.1016/j.mehy.2020.109776,2020-04-29
Disease,CAUSES,Cessation of life,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Pharmaceutical Preparations,NEG_TREATS,Plague,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Comorbidity,PROCESS_OF,Patients,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Disease,COEXISTS_WITH,Cerebrovascular Disorders,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Inflammation,PROCESS_OF,Patients,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Serum,LOCATION_OF,Ferritin,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Comorbidity,PROCESS_OF,Patients,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Diabetes,PROCESS_OF,Patients,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Hypertensive disease,PROCESS_OF,Patients,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Inflammation,COEXISTS_WITH,Cardiovascular Diseases,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Insulin Resistance,COEXISTS_WITH,Cardiovascular Diseases,32344310,10.1016/j.mehy.2020.109760,2020-04-29
pioglitazone,ISA,Thiazolidinediones,32344310,10.1016/j.mehy.2020.109760,2020-04-29
rosiglitazone,ISA,Thiazolidinediones,32344310,10.1016/j.mehy.2020.109760,2020-04-29
agonists,INTERACTS_WITH,TRANSCRIPTION FACTOR,32344310,10.1016/j.mehy.2020.109760,2020-04-29
agonists,INTERACTS_WITH,"Receptors, Nuclear",32344310,10.1016/j.mehy.2020.109760,2020-04-29
Thiazolidinediones,STIMULATES,Peroxisome Proliferator-Activated Receptors,32344310,10.1016/j.mehy.2020.109760,2020-04-29
century,ASSOCIATED_WITH,Disease,32344310,10.1016/j.mehy.2020.109760,2020-04-29
Thiazolidinediones,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",32344310,10.1016/j.mehy.2020.109760,2020-04-29
Coronavirus Infections,CAUSES,Symptoms,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Respiration Disorders,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
"Respiratory Distress Syndrome, Adult",CAUSES,Single organ dysfunction,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Therapeutic procedure,TREATS,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Therapeutic procedure,TREATS(SPEC),Coronavirus Infections,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Disease,COEXISTS_WITH,Respiration Disorders,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,COEXISTS_WITH(SPEC),Respiration Disorders,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
novel AODU treatment method,TREATS,Respiration Disorders,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Body tissue,LOCATION_OF,Alveolar ventilation function,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Blood,LOCATION_OF,Carbon Dioxide,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Chloroquine,INTERACTS_WITH,Oxygen,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Chloroquine,PREVENTS,"Signs and Symptoms, Respiratory",32344309,10.1016/j.mehy.2020.109761,2020-04-29
Chloroquine,STIMULATES,Hemoglobin,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Chloroquine,STIMULATES,Hemoglobin,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Chloroquine,STIMULATES,Oxygen,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hydroxychloroquine,INTERACTS_WITH,Oxygen,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hydroxychloroquine,STIMULATES,Hemoglobin,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hydroxychloroquine,STIMULATES,Hemoglobin,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hydroxychloroquine,STIMULATES,Oxygen,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hydroxychloroquine,PREVENTS,"Signs and Symptoms, Respiratory",32344309,10.1016/j.mehy.2020.109761,2020-04-29
"Signs and Symptoms, Respiratory",ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Coronavirus Infections,ISA,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Hyperbaric oxygenation therapy,TREATS,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Therapeutic procedure,TREATS,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Therapeutic procedure,TREATS,patient condition,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Packed red blood cells,TREATS,Disease,32344309,10.1016/j.mehy.2020.109761,2020-04-29
Infected,PROCESS_OF,Patients,32344305,10.1016/j.mehy.2020.109759,2020-04-29
Abnormality,PROCESS_OF,Patients,32344305,10.1016/j.mehy.2020.109759,2020-04-29
SGTA gene,INTERACTS_WITH,Genome,32344304,10.1016/j.mehy.2020.109751,2020-04-29
SARS coronavirus,CAUSES,Diabetes,32344304,10.1016/j.mehy.2020.109751,2020-04-29
ACE2 gene,AUGMENTS,Uptake,32344304,10.1016/j.mehy.2020.109751,2020-04-29
Diabetes,PROCESS_OF,Patients,32344304,10.1016/j.mehy.2020.109751,2020-04-29
Hyperglycemia,PROCESS_OF,Patients,32344304,10.1016/j.mehy.2020.109751,2020-04-29
5-alpha Reductase Inhibitors,TREATS,Benign prostatic hypertrophy,32344294,10.1016/j.ejrad.2020.108996,2020-04-29
Infected,PROCESS_OF,Patients,32344276,10.1016/j.mehy.2020.109757,2020-04-29
High resolution,USES,TBATA gene,32344276,10.1016/j.mehy.2020.109757,2020-04-29
X-Ray Computed Tomography,ADMINISTERED_TO,radiologic technologist,32344276,10.1016/j.mehy.2020.109757,2020-04-29
Infected,PROCESS_OF,Patients,32344276,10.1016/j.mehy.2020.109757,2020-04-29
Acute Disease,PROCESS_OF,Patients,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
Sense of smell impaired,PROCESS_OF,Otolaryngologist,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
new onset,PROCESS_OF,Patients,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
Anosmia,PROCESS_OF,Author,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
Respiratory Tract Infections,CAUSES,Infection,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
Respiratory Tract Infections,ISA,Infection,32344226,10.1016/j.scitotenv.2020.138861,2020-04-29
United States,ISA,Country,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Antiviral Agents,AUGMENTS,patient condition,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Antiviral Agents,AUGMENTS,Symptoms,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Antiviral Agents,TREATS,Patients,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Chloroquine,TREATS,Patients,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Chloroquine,AUGMENTS,patient condition,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Chloroquine,AUGMENTS,Symptoms,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Azithromycin,TREATS,Patients,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Azithromycin,AUGMENTS,patient condition,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Azithromycin,AUGMENTS,Symptoms,32344202,10.1016/j.ebiom.2020.102768,2020-04-29
Vaccines,PREVENTS,SARS coronavirus,32344177,10.1016/j.micpath.2020.104228,2020-04-29
Globulins,AUGMENTS,immunoglobulin disease,32344177,10.1016/j.micpath.2020.104228,2020-04-29
Pharmaceutical Preparations,NEG_TREATS,Virus,32344167,10.1016/j.cmi.2020.04.026,2020-04-29
Infected,PROCESS_OF,Patients,32344167,10.1016/j.cmi.2020.04.026,2020-04-29
Lung,LOCATION_OF,Hydroxychloroquine,32344167,10.1016/j.cmi.2020.04.026,2020-04-29
Lung,LOCATION_OF,Azithromycin,32344167,10.1016/j.cmi.2020.04.026,2020-04-29
Lung,PART_OF,Homo sapiens,32344167,10.1016/j.cmi.2020.04.026,2020-04-29
Antiviral Agents,TREATS,Influenza,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Hospitals,LOCATION_OF,Retrospective Studies,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Confirmation,PROCESS_OF,Patients,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Negative,NEG_PROCESS_OF,Control Groups,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Negative,PROCESS_OF,Control Groups,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Negative,PROCESS_OF,Control Groups,32344166,10.1016/j.cmi.2020.04.023,2020-04-29
Challenge,USES,Diagnosis,32344143,10.1016/j.wneu.2020.04.155,2020-04-29
professional occupation status,TREATS,Patients,32344132,10.1016/j.wneu.2020.04.140,2020-04-29
Neurosurgical Procedures,ADMINISTERED_TO,teams,32344056,10.1016/j.jaci.2020.04.021,2020-04-29
"Aneurysm, Ruptured",PROCESS_OF,Patients,32344056,10.1016/j.jaci.2020.04.021,2020-04-29
Airborne precautions,ADMINISTERED_TO,Patients,32344056,10.1016/j.jaci.2020.04.021,2020-04-29
Eosinopenia,PROCESS_OF,Patients,32344011,10.1016/j.ijid.2020.04.061,2020-04-29
Pulmonary Pathology,AFFECTS,immunopotentiation,32344011,10.1016/j.ijid.2020.04.061,2020-04-29
Troponin,PART_OF,Heart,32343968,10.1016/j.chest.2020.04.024,2020-04-29
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32343968,10.1016/j.chest.2020.04.024,2020-04-29
Diagnosis,ADMINISTERED_TO,Patients,32343948,10.1016/j.cca.2020.04.026,2020-04-29
tocilizumab,TREATS,Cytokine release syndrome,32343948,10.1016/j.cca.2020.04.026,2020-04-29
Viral myocarditis,PROCESS_OF,Patients,32343948,10.1016/j.cca.2020.04.026,2020-04-29
tocilizumab,TREATS,Cytokine release syndrome,32343948,10.1016/j.cca.2020.04.026,2020-04-29
tocilizumab,TREATS,Secondary Hemophagocytic Lymphohistiocytosis,32343948,10.1016/j.cca.2020.04.026,2020-04-29
Serologic tests,USES,Antibodies,32343947,10.1016/j.amjmed.2020.04.003,2020-04-29
Confirmation,PROCESS_OF,Patients,32343947,10.1016/j.amjmed.2020.04.003,2020-04-29
"Immunoglobulin A, Human",TREATS,Patients,32343947,10.1016/j.amjmed.2020.04.003,2020-04-29
"Immunoglobulin A, Human",TREATS(INFER),Confirmation,32343947,10.1016/j.amjmed.2020.04.003,2020-04-29
Specific antibody,PART_OF,Virus,32343947,10.1016/j.amjmed.2020.04.003,2020-04-29
Poor outcome,COEXISTS_WITH,Coronavirus Infections,32343939,10.33321/cdi.2020.44.36,2020-04-29
Performance,PROCESS_OF,Patients,32343939,10.33321/cdi.2020.44.36,2020-04-29
poor health,COEXISTS_WITH,Obesity,32343939,10.33321/cdi.2020.44.36,2020-04-29
poor health,PROCESS_OF,Patients,32343939,10.33321/cdi.2020.44.36,2020-04-29
Dyspnea,ISA,Symptoms,32343939,10.33321/cdi.2020.44.36,2020-04-29
United States,ISA,Country,32343747,10.1371/journal.pone.0232452,2020-04-29
Disease,COEXISTS_WITH,Occupational Exposure,32343745,10.1371/journal.ppat.1008520,2020-04-29
Coitus,PROCESS_OF,Patients,32343686,10.1371/journal.pmed.1003123,2020-04-29
Hospitals,LOCATION_OF,Retrospective Studies,32343686,10.1371/journal.pmed.1003123,2020-04-29
Age,ASSOCIATED_WITH,Disease,32343686,10.1371/journal.pmed.1003123,2020-04-29
Coronavirus Infections,ISA,Disease,32343658,10.3238/arztebl.2020.0213,2020-04-29
Chloroquine,ISA,Antimalarials,32343650,10.20344/amp.13928,2020-04-29
Pharmaceutical Preparations,TREATS,Protozoan Infections,32343650,10.20344/amp.13928,2020-04-29
Clinical Trials,MEASURES,benefit,32343650,10.20344/amp.13928,2020-04-29
Cell Count,USES,Artificial Airways,32343514,10.1213/ANE.0000000000004849,2020-04-29
Virion,PART_OF,SARS coronavirus,32343514,10.1213/ANE.0000000000004849,2020-04-29
"Infections, Hospital",PROCESS_OF,Staff,32343458,10.1002/hed.26197,2020-04-29
Care of intensive care unit patient,ADMINISTERED_TO,Patients,32343454,10.1002/hed.26210,2020-04-29
Chief complaint (finding),PROCESS_OF,Patients,32343444,10.1002/hed.26216,2020-04-29
Malignant Head and Neck Neoplasm,PROCESS_OF,geriatric patients,32343428,10.1002/jmv.25949,2020-04-29
risk factors,PROCESS_OF,Patients,32343428,10.1002/jmv.25949,2020-04-29
Malignant Head and Neck Neoplasm,PROCESS_OF,geriatric patients,32343428,10.1002/jmv.25949,2020-04-29
Geriatric Assessment,TREATS,Population Group,32343428,10.1002/jmv.25949,2020-04-29
Palliative Care,TREATS,Patients,32343428,10.1002/jmv.25949,2020-04-29
Communicable Diseases,COEXISTS_WITH,Incubation period,32343419,10.1002/jmv.25947,2020-04-29
Operative Surgical Procedures,TREATS,Patients,32343415,10.1002/jmv.25946,2020-04-29
Cessation of life,PROCESS_OF,Patients,32343415,10.1002/jmv.25946,2020-04-29
Antibodies,AFFECTS,Humoral immune response,32343410,10.1002/jmv.25943,2020-04-29
Symptom severe,PROCESS_OF,Patients,32343410,10.1002/jmv.25943,2020-04-29
"Tuberculosis, Pulmonary",PROCESS_OF,Patients,32343366,10.1111/jgs.16519,2020-04-29
"Tuberculosis, Pulmonary",PROCESS_OF,Patients,32343366,10.1111/jgs.16519,2020-04-29
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Human body,32343363,10.1111/jgs.16513,2020-04-29
Disease,PROCESS_OF,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Persons,LOCATION_OF,IMPACT gene,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Schizophrenia,PROCESS_OF,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Birth,PROCESS_OF,inpatient,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Birth,PROCESS_OF,Outpatients,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Schizophrenia,AFFECTS,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Schizophrenia,PROCESS_OF,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
IMPACT gene,ASSOCIATED_WITH,Schizophrenia,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Poor outcome,PROCESS_OF,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Schizophrenia,PROCESS_OF,Persons,32343300,10.1001/jamaoto.2020.1191,2020-04-29
Bronchoscopy,DIAGNOSES,Enthesitis-Related Arthritis,32343244,10.1363/46e9020,2020-04-29
Microlaryngoscopy,DIAGNOSES,Enthesitis-Related Arthritis,32343244,10.1363/46e9020,2020-04-29
Department,LOCATION_OF,case series,32343244,10.1363/46e9020,2020-04-29
Urgent Procedure,USES,Artificial Airways,32343244,10.1363/46e9020,2020-04-29
Interventional procedure,ADMINISTERED_TO,Patients,32343244,10.1363/46e9020,2020-04-29
follow-up,TREATS,Patients,32343244,10.1363/46e9020,2020-04-29
Balloon Dilatation,TREATS,Subglottic stenosis,32343244,10.1363/46e9020,2020-04-29
Interventional procedure,ADMINISTERED_TO,Patients,32343244,10.1363/46e9020,2020-04-29
Sexual Health,ISA,Reproduction,32343223,10.3201/eid2607.201603,2020-04-29
Sexual Health,ISA,Reproduction,32343223,10.3201/eid2607.201603,2020-04-29
Complication,PROCESS_OF,Patients,32343222,10.3201/eid2608.201093,2020-04-29
Critical Illness,PROCESS_OF,Patients,32343222,10.3201/eid2608.201093,2020-04-29
Influenza,ISA,Pneumonia,32343222,10.3201/eid2608.201093,2020-04-29
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32343222,10.3201/eid2608.201093,2020-04-29
Pneumonia,PROCESS_OF,Patients,32343222,10.3201/eid2608.201093,2020-04-29
Invasive Pulmonary Aspergillosis,PROCESS_OF,Patients,32343222,10.3201/eid2608.201093,2020-04-29
Cessation of life,PROCESS_OF,Adult,32343162,10.1080/09546634.2020.1759770,2020-04-29
Coronavirus Infections,ISA,Disease,32343118,10.1503/cjs.005620,2020-04-29
Coronavirus Infections,ISA,Disease,32343118,10.1503/cjs.005620,2020-04-29
Pandemics,CAUSES,Disease,32343118,10.1503/cjs.005620,2020-04-29
Pandemics,CAUSES(SPEC),Coronavirus Infections,32343118,10.1503/cjs.005620,2020-04-29
disease transmission,MANIFESTATION_OF,end organ damage,32343118,10.1503/cjs.005620,2020-04-29
Coronavirus Infections,ISA,Disease,32343118,10.1503/cjs.005620,2020-04-29
Disease,NEG_AFFECTS,Patients,32343118,10.1503/cjs.005620,2020-04-29
Coronavirus Infections,ISA,Disease,32343118,10.1503/cjs.005620,2020-04-29
Coronavirus Infections,NEG_AFFECTS(SPEC),Patients,32343118,10.1503/cjs.005620,2020-04-29
Empowered,PROCESS_OF,Clinician,32343118,10.1503/cjs.005620,2020-04-29
Squamous Epithelial Cells,LOCATION_OF,Head and Neck Carcinoma,32342998,10.1111/jgs.16510,2020-04-29
pulmonary complications,AFFECTS,Patients,32342998,10.1111/jgs.16510,2020-04-29
Infection,AFFECTS,Patients,32342998,10.1111/jgs.16510,2020-04-29
Head and Neck Carcinoma,PROCESS_OF,Patients,32342998,10.1111/jgs.16510,2020-04-29
Lung,LOCATION_OF,Comorbidity,32342998,10.1111/jgs.16510,2020-04-29
Cardiopulmonary,LOCATION_OF,Comorbidity,32342998,10.1111/jgs.16510,2020-04-29
Head and Neck Carcinoma,PROCESS_OF,Patients,32342998,10.1111/jgs.16510,2020-04-29
Toxic effect,PROCESS_OF,Patients,32342998,10.1111/jgs.16510,2020-04-29
Head and Neck Carcinoma,PROCESS_OF,Patients,32342998,10.1111/jgs.16510,2020-04-29
Alcohol consumption,AFFECTS,Dental Hygiene,32342998,10.1111/jgs.16510,2020-04-29
Smoking,AFFECTS,Dental Hygiene,32342998,10.1111/jgs.16510,2020-04-29
Intervention regimes,TREATS,Comorbidity,32342998,10.1111/jgs.16510,2020-04-29
Centers for Medicare and Medicaid Services,ISA,United States Dept. of Health and Human Services,32342878,10.1016/j.radonc.2020.04.010,2020-04-29
SARS coronavirus,CAUSES,Disease,32342873,10.1016/j.radonc.2020.03.030,2020-04-29
Malignant neoplasm of gastrointestinal tract,PROCESS_OF,Patients,32342873,10.1016/j.radonc.2020.03.030,2020-04-29
Radiation Oncologists,TREATS,Patients,32342873,10.1016/j.radonc.2020.03.030,2020-04-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Cancer Patient,32342872,10.1016/j.radonc.2020.04.035,2020-04-29
Pharmacotherapy,ADMINISTERED_TO,Patients,32342870,10.1016/j.radonc.2020.03.029,2020-04-29
Prognosis bad,PROCESS_OF,Patients,32342870,10.1016/j.radonc.2020.03.029,2020-04-29
Radiation Oncologists,TREATS,Patients,32342870,10.1016/j.radonc.2020.03.029,2020-04-29
Prophylactic treatment,TREATS,Patients,32342864,10.1016/j.radonc.2020.03.045,2020-04-29
Prophylactic treatment,TREATS,Staff,32342864,10.1016/j.radonc.2020.03.045,2020-04-29
Malignant neoplasm of lung,PROCESS_OF,Patients,32342849,10.4269/ajtmh.20-0275,2020-04-29
Malignant neoplasm of lung,PROCESS_OF,Patients,32342849,10.4269/ajtmh.20-0275,2020-04-29
removal technique,PRECEDES,post surgery radiation therapy,32342849,10.4269/ajtmh.20-0275,2020-04-29
Malignant neoplasm of lung,PROCESS_OF,Patients,32342849,10.4269/ajtmh.20-0275,2020-04-29
stage I non-small cell lung cancer,ISA,Non-Small Cell Lung Carcinoma,32342849,10.4269/ajtmh.20-0275,2020-04-29
Prophylactic Cranial Irradiation,TREATS,limited stage small cell lung cancer,32342849,10.4269/ajtmh.20-0275,2020-04-29
Coronavirus Infections,ISA,Disease,32342724,10.1080/22221751.2020.1760144,2020-04-29
Viral Shedding,PROCESS_OF,Woman,32342724,10.1080/22221751.2020.1760144,2020-04-29
Pneumonia,PROCESS_OF,Homo sapiens,32342698,10.1177/2048872620922795,2020-04-29
Urine,PART_OF,Patients,32342698,10.1177/2048872620922795,2020-04-29
Serum,PART_OF,Patients,32342698,10.1177/2048872620922795,2020-04-29
consideration,PROCESS_OF,Persons,32342676,10.3947/ic.2020.52.2.281,2020-04-29
Fever,ISA,Symptoms,32342609,10.1111/ner.13172,2020-04-29
Septicemia,ISA,Disease,32342578,10.1111/1462-2920.15039,2020-04-29
cytokine,ASSOCIATED_WITH,Disease,32342578,10.1111/1462-2920.15039,2020-04-29
cytokine,ASSOCIATED_WITH,Septicemia,32342578,10.1111/1462-2920.15039,2020-04-29
cytokine,ASSOCIATED_WITH(SPEC),Septicemia,32342578,10.1111/1462-2920.15039,2020-04-29
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32342578,10.1111/1462-2920.15039,2020-04-29
Vagus Nerve Stimulation,TREATS,Patients,32342578,10.1111/1462-2920.15039,2020-04-29
Vagus Nerve Stimulation,TREATS(INFER),"Signs and Symptoms, Respiratory",32342578,10.1111/1462-2920.15039,2020-04-29
Antitussive Agents,AUGMENTS(SPEC),Nerve,32342578,10.1111/1462-2920.15039,2020-04-29
Antitussive Agents,ISA,Pharmaceutical Preparations,32342578,10.1111/1462-2920.15039,2020-04-29
Pharmaceutical Preparations,AUGMENTS,Nerve,32342578,10.1111/1462-2920.15039,2020-04-29
Opioids,AUGMENTS,Nerve,32342578,10.1111/1462-2920.15039,2020-04-29
Lung finding,PROCESS_OF,Patients,32342578,10.1111/1462-2920.15039,2020-04-29
developers,USES,Vaccines,32342570,10.1002/hed.26213,2020-04-29
Virus,LOCATION_OF,Vaccines,32342570,10.1002/hed.26213,2020-04-29
Negative,PROCESS_OF,Patients,32342566,10.1002/hed.26204,2020-04-29
Disease,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
Disease,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
"Hospitals, University",LOCATION_OF,case series,32342565,10.1002/hed.26214,2020-04-29
Taste Perception,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
Anosmia,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
Ageusia,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
Signs and Symptoms,PROCESS_OF,Patients,32342565,10.1002/hed.26214,2020-04-29
Symptoms,NEG_COEXISTS_WITH,Anosmia,32342565,10.1002/hed.26214,2020-04-29
Symptoms,NEG_COEXISTS_WITH,Ageusia,32342565,10.1002/hed.26214,2020-04-29
Respirator dependence,PROCESS_OF,Patients,32342543,10.1002/hed.26215,2020-04-29
Chronic respiratory failure,PROCESS_OF,Patients,32342543,10.1002/hed.26215,2020-04-29
Tracheotomy procedure,ADMINISTERED_TO,Surgeon,32342543,10.1002/hed.26215,2020-04-29
Tonsil,LOCATION_OF,Carcinoma,32342541,10.1002/hed.26206,2020-04-29
Mucous Membrane,PART_OF,Tract,32342516,10.1002/jdd.12163,2020-04-29
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32342516,10.1002/jdd.12163,2020-04-29
consideration,PROCESS_OF,Persons,32342516,10.1002/jdd.12163,2020-04-29
Health center,LOCATION_OF,Study,32342252,10.1007/s10096-020-03913-9,2020-04-29
Malaise,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Hypertensive disease,PRECEDES,Diabetes Mellitus,32342252,10.1007/s10096-020-03913-9,2020-04-29
Fever,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Malaise,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Comorbidity,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Comorbidity,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Malaise,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Severe disorder,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Severe disorder,PROCESS_OF,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Warburg Therapy,ADMINISTERED_TO,Patients,32342252,10.1007/s10096-020-03913-9,2020-04-29
Duration,COEXISTS_WITH,Hydroxychloroquine,32342242,10.1007/s10237-020-01332-5,2020-04-29
Duration,COEXISTS_WITH,Azithromycin,32342242,10.1007/s10237-020-01332-5,2020-04-29
Duration,TREATS,Patients,32342242,10.1007/s10237-020-01332-5,2020-04-29
Malignant Neoplasms,AFFECTS,Patients,32342184,10.1007/s00393-020-00799-y,2020-04-29
Malignant Neoplasms,NEG_COEXISTS_WITH,Secondary carcinoma,32342184,10.1007/s00393-020-00799-y,2020-04-29
"Diagnosis, clinical",DIAGNOSES,pulmonary involvement,32342184,10.1007/s00393-020-00799-y,2020-04-29
Coughing,NEG_PROCESS_OF,Patients,32342184,10.1007/s00393-020-00799-y,2020-04-29
Fever,NEG_PROCESS_OF,Patients,32342184,10.1007/s00393-020-00799-y,2020-04-29
FDG-Positron Emission Tomography and Computed Tomography Scan,DIAGNOSES,Disease,32342184,10.1007/s00393-020-00799-y,2020-04-29
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32342184,10.1007/s00393-020-00799-y,2020-04-29
Rheumatic Fever,PROCESS_OF,Patients,32342164,10.1007/s00270-020-02474-w,2020-04-29
Rheumatic Fever,PROCESS_OF,Patients,32342164,10.1007/s00270-020-02474-w,2020-04-29
Hospitals,LOCATION_OF,Administration occupational activities,32342154,10.1007/s00270-020-02483-9,2020-04-29
Depressive disorder,PROCESS_OF,Staff,32342154,10.1007/s00270-020-02483-9,2020-04-29
Interventional procedure,TREATS,Patients,32342140,10.1007/s00167-020-06031-3,2020-04-29
Experience,PROCESS_OF,Patients,32342138,10.1007/s00167-020-06022-4,2020-04-29
Surgeon,ISA,Health Personnel,32342126,10.1007/s00234-020-02437-5,2020-04-29
Austria,ISA,Country,32342126,10.1007/s00234-020-02437-5,2020-04-29
Face,LOCATION_OF,Protection,32342126,10.1007/s00234-020-02437-5,2020-04-29
Face,LOCATION_OF,Protection,32342126,10.1007/s00234-020-02437-5,2020-04-29
Masks,USES,Mechanical Ventilator,32342126,10.1007/s00234-020-02437-5,2020-04-29
"Respirators, Air-Purifying",ISA,Masks,32342126,10.1007/s00234-020-02437-5,2020-04-29
Electrocoagulation,ISA,Operative Surgical Procedures,32342126,10.1007/s00234-020-02437-5,2020-04-29
Neuroradiologist,DIAGNOSES,Neuropathogenesis,32342112,10.1007/s00192-020-04314-4,2020-04-29
Conservative Treatment,TREATS,patient is female,32342051,10.1016/j.jaccas.2020.04.018,2020-04-29
Telemedicine,METHOD_OF,Therapeutic procedure,32342051,10.1016/j.jaccas.2020.04.018,2020-04-29
Chest Pain,PROCESS_OF,Patients,32342049,10.1016/j.jaccas.2020.04.015,2020-04-29
Fever,PROCESS_OF,Patients,32342049,10.1016/j.jaccas.2020.04.015,2020-04-29
Respiratory Failure,PROCESS_OF,Patients,32342049,10.1016/j.jaccas.2020.04.015,2020-04-29
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Male population group,32342048,10.1016/j.asmr.2020.04.007,2020-04-29
Elective procedure,TREATS,disease transmission,32342041,10.1016/j.ajogmf.2020.100127,2020-04-29
Disease,OCCURS_IN,general population,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,OCCURS_IN(SPEC),general population,32342026,10.1177/2473974X20922528,2020-04-29
"CD69 protein, human",ASSOCIATED_WITH,Disease,32342026,10.1177/2473974X20922528,2020-04-29
"CD69 protein, human",ASSOCIATED_WITH(SPEC),Coronavirus Infections,32342026,10.1177/2473974X20922528,2020-04-29
Disease,PROCESS_OF,general population,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,PROCESS_OF(SPEC),general population,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,CAUSES,Cessation of life,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,PROCESS_OF,Pregnant Women,32342026,10.1177/2473974X20922528,2020-04-29
Coronavirus Infections,ISA,Disease,32342026,10.1177/2473974X20922528,2020-04-29
Disease,PROCESS_OF,Patients,32342019,10.1016/j.obmed.2020.100245,2020-04-29
Coronavirus Infections,ISA,Disease,32342019,10.1016/j.obmed.2020.100245,2020-04-29
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32342019,10.1016/j.obmed.2020.100245,2020-04-29
Source of information,PROCESS_OF,Patients,32342019,10.1016/j.obmed.2020.100245,2020-04-29
Obesity,PROCESS_OF,Persons,32341947,10.1016/j.gendis.2020.04.011,2020-04-29
Very Important,PROCESS_OF,Persons,32341947,10.1016/j.gendis.2020.04.011,2020-04-29
Coronavirus Infections,ISA,Disease,32341943,10.1016/j.anpede.2020.02.002,2020-04-29
Base Sequence,PART_OF,Virus,32341943,10.1016/j.anpede.2020.02.002,2020-04-29
Base Sequence,PART_OF,SARS coronavirus,32341943,10.1016/j.anpede.2020.02.002,2020-04-29
SARS coronavirus,ISA,Virus,32341943,10.1016/j.anpede.2020.02.002,2020-04-29
Coronavirus Infections,ISA,Communicable Diseases,32341913,10.1186/s40902-020-00256-5,2020-04-29
Coronavirus Infections,PROCESS_OF,Homo sapiens,32341910,10.1016/j.idcr.2020.e00778,2020-04-29
Coronavirus Infections,CAUSES,Disease,32341910,10.1016/j.idcr.2020.e00778,2020-04-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PREDISPOSES,Cross Infection,32341910,10.1016/j.idcr.2020.e00778,2020-04-29
Coronavirus Infections,PROCESS_OF,Patients,32341910,10.1016/j.idcr.2020.e00778,2020-04-29
Disease,PROCESS_OF,Persons,32341791,10.1136/lupus-2020-000396,2020-04-29
Autoimmune Diseases,PROCESS_OF,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Autoimmune Diseases,PROCESS_OF,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Chloroquine,ADMINISTERED_TO,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Pneumonia,PROCESS_OF,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
tocilizumab,ADMINISTERED_TO,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Immunomodulation,ADMINISTERED_TO,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Storm NOS,PROCESS_OF,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
baricitinib,ADMINISTERED_TO,Patients,32341785,10.1186/s40560-020-00445-4,2020-04-29
Anorexia,ISA,Symptoms,32341721,10.1016/j.jchirv.2020.04.012,2020-04-29
Digestive symptom,PROCESS_OF,Patients,32341721,10.1016/j.jchirv.2020.04.012,2020-04-29
Lung,LOCATION_OF,Symptoms,32341721,10.1016/j.jchirv.2020.04.012,2020-04-29
Viral Shedding,PROCESS_OF,Patients,32341721,10.1016/j.jchirv.2020.04.012,2020-04-29
Cross Infection,PROCESS_OF,Patients,32341719,10.1007/s13167-020-00207-0,2020-04-29
Department,LOCATION_OF,Interventional Study,32341719,10.1007/s13167-020-00207-0,2020-04-29
Cross Infection,PROCESS_OF,Patients,32341719,10.1007/s13167-020-00207-0,2020-04-29
Cross Infection,PROCESS_OF,Patients,32341719,10.1007/s13167-020-00207-0,2020-04-29
Comorbidity,PROCESS_OF,Patients,32341719,10.1007/s13167-020-00207-0,2020-04-29
Complication,COEXISTS_WITH,Malignant Neoplasms,32341719,10.1007/s13167-020-00207-0,2020-04-29
Operative Surgical Procedures,TREATS,Complication,32341719,10.1007/s13167-020-00207-0,2020-04-29
Infected,PROCESS_OF,Persons,32341718,10.1007/s11571-020-09588-4,2020-04-29
Country,ISA,Geographic Locations,32341718,10.1007/s11571-020-09588-4,2020-04-29
Common Cold,ISA,Disease,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Common Cold,PROCESS_OF(SPEC),Homo sapiens,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Disease,PROCESS_OF,Homo sapiens,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Genus: Coronavirus,CAUSES,Disease,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Genus: Coronavirus,CAUSES(SPEC),Common Cold,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Genus: Coronavirus,CAUSES(SPEC),Severe Acute Respiratory Syndrome,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Genus: Coronavirus,CAUSES(SPEC),Middle East Respiratory Syndrome,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Genus: Coronavirus,ISA,Virus,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Severe Acute Respiratory Syndrome,ISA,Disease,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Severe Acute Respiratory Syndrome,PROCESS_OF(SPEC),Homo sapiens,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Middle East Respiratory Syndrome,ISA,Disease,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Middle East Respiratory Syndrome,PROCESS_OF(SPEC),Homo sapiens,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Pneumonia,NEG_PROCESS_OF,Homo sapiens,32341628,10.1016/j.chaos.2020.109846,2020-04-29
Infected,PROCESS_OF,Persons,32341616,10.1016/j.matdes.2020.108749,2020-04-29
Coronavirus Infections,CAUSES,Terminal illness,32341519,10.1038/s41374-020-0431-6,2020-04-29
Virus,COEXISTS_WITH,Macrophage Activation Syndrome,32341519,10.1038/s41374-020-0431-6,2020-04-29
Hospitals,LOCATION_OF,Study,32341442,10.1038/s41440-020-0455-8,2020-04-29
Comorbidity,PROCESS_OF,Patients,32341442,10.1038/s41440-020-0455-8,2020-04-29
Coagulation procedure,TREATS,Patients,32341442,10.1038/s41440-020-0455-8,2020-04-29
Patients,LOCATION_OF,Interleukin-6,32341442,10.1038/s41440-020-0455-8,2020-04-29
Patients,LOCATION_OF,"Interleukin 2 receptor, soluble",32341442,10.1038/s41440-020-0455-8,2020-04-29
Heart Injuries,PROCESS_OF,Patients,32341442,10.1038/s41440-020-0455-8,2020-04-29
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,angiotensin converting enzyme 2,32341311,10.2106/JBJS.20.00609,2020-04-29
Angiotensin II receptor antagonist,STIMULATES,angiotensin converting enzyme 2,32341311,10.2106/JBJS.20.00609,2020-04-29
animal study,LOCATION_OF,angiotensin converting enzyme 2,32341311,10.2106/JBJS.20.00609,2020-04-29
Pneumonia,INTERACTS_WITH,SARS coronavirus,32341311,10.2106/JBJS.20.00609,2020-04-29
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Mus,32341311,10.2106/JBJS.20.00609,2020-04-29
Angiotensin-Converting Enzyme Inhibitors,ISA,Pharmaceutical Preparations,32341311,10.2106/JBJS.20.00609,2020-04-29
Angiotensin-Converting Enzyme Inhibitors,TREATS(SPEC),Patients,32341311,10.2106/JBJS.20.00609,2020-04-29
Cardiovascular Diseases,PROCESS_OF,Patients,32341311,10.2106/JBJS.20.00609,2020-04-29
Pharmaceutical Preparations,TREATS,Patients,32341311,10.2106/JBJS.20.00609,2020-04-29
Pharmaceutical Preparations,TREATS(INFER),Cardiovascular Diseases,32341311,10.2106/JBJS.20.00609,2020-04-29
Pharmaceutical Preparations,TREATS(INFER),Hypertensive disease,32341311,10.2106/JBJS.20.00609,2020-04-29
Hypertensive disease,PROCESS_OF,Patients,32341311,10.2106/JBJS.20.00609,2020-04-29
Injury assessment,COEXISTS_WITH,Triage,32341229,10.4103/sjg.SJG_131_20,2020-04-29
Respiratory Tract Infections,ISA,Symptoms,32341142,10.1128/JCM.00630-20,2020-04-29
Respiratory Tract Infections,PROCESS_OF,Population Group,32341142,10.1128/JCM.00630-20,2020-04-29
Symptom mild,PROCESS_OF,Persons,32341142,10.1128/JCM.00630-20,2020-04-29
Infected,PROCESS_OF,Persons,32341142,10.1128/JCM.00630-20,2020-04-29
Diagnosis,DIAGNOSES,patient condition,32341142,10.1128/JCM.00630-20,2020-04-29
Assay,USES,molecular diagnostics (lab procedure),32341142,10.1128/JCM.00630-20,2020-04-29
Assay,USES,Nasal Swab (procedure),32341142,10.1128/JCM.00630-20,2020-04-29
Infected,PROCESS_OF,Patients,32341141,10.1128/JCM.00708-20,2020-04-29
Assay,METHOD_OF,Detection,32341141,10.1128/JCM.00708-20,2020-04-29
inhibitors,TREATS,Lung Injury,32341078,10.7861/clinmed.2020-0150,2020-04-29
Lung,LOCATION_OF,Symptoms,32341077,10.7861/clinmed.2020-0187,2020-04-29
Acute abdominal pain,PROCESS_OF,Patients,32341077,10.7861/clinmed.2020-0187,2020-04-29
Symptoms,PROCESS_OF,Patients,32341077,10.7861/clinmed.2020-0187,2020-04-29
Elevated C-reactive protein level,PROCESS_OF,Patients,32341077,10.7861/clinmed.2020-0187,2020-04-29
Radionuclide Imaging,DIAGNOSES,Morphologically abnormal structure (morphologic abnormality),32341077,10.7861/clinmed.2020-0187,2020-04-29
"Hospitals, University",LOCATION_OF,Laboratory Procedures,32341077,10.7861/clinmed.2020-0187,2020-04-29
Acute abdominal pain,MANIFESTATION_OF,Infection,32341077,10.7861/clinmed.2020-0187,2020-04-29
Coronavirus Infections,ISA,Disease,32340900,10.1016/j.jviscsurg.2020.04.010,2020-04-29
Coronavirus Infections,ISA,Disease,32340864,10.1016/j.jvir.2020.03.022,2020-04-29
Septic Shock,PROCESS_OF,Patients,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Septic Shock,PROCESS_OF,Patients,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Septic Shock,PRODUCES,Interleukin-1,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Septic Shock,PRODUCES,Interleukin-6,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Septic Shock,PRODUCES,Tumor Necrosis Factors,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Anti-Inflammatory Agents,PREVENTS,Septic Shock,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Septic Shock,PROCESS_OF,Patients,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Antibiotic therapy,USES,Anti-Inflammatory Agents,32340751,10.1016/j.nefro.2020.04.001,2020-04-29
Hemodialysis,ISA,Therapeutic procedure,32340737,10.1016/j.jen.2020.03.006,2020-04-29
Hemodialysis,ISA,Therapeutic procedure,32340737,10.1016/j.jen.2020.03.006,2020-04-29
Communicable Diseases,PROCESS_OF,Patients,32340661,10.4140/TCP.n.2020.237,2020-04-29
Communicable Diseases,PROCESS_OF,Patients,32340661,10.4140/TCP.n.2020.237,2020-04-29
Communicable Diseases,PROCESS_OF,Patients,32340661,10.4140/TCP.n.2020.237,2020-04-29
Influenza,PROCESS_OF,Patients,32340661,10.4140/TCP.n.2020.237,2020-04-29
Measles,PROCESS_OF,Patients,32340661,10.4140/TCP.n.2020.237,2020-04-29
medicare/medicaid,LOCATION_OF,Services,32340654,10.4140/TCP.n.2020.190,2020-04-29
Therapeutic procedure,TREATS,Virus,32340645,10.1192/bjb.2020.44,2020-04-29
Care of intensive care unit patient,COEXISTS_WITH,Tracheotomy procedure,32340614,10.1186/s12968-020-00628-w,2020-04-29
Tracheotomy procedure,TREATS,Patients,32340614,10.1186/s12968-020-00628-w,2020-04-29
Malaise,PROCESS_OF,Patients,32340614,10.1186/s12968-020-00628-w,2020-04-29
"CD69 protein, human",ASSOCIATED_WITH,Enthesitis-Related Arthritis,32340588,10.1177/0194599820921393,2020-04-29
Confirmation,PROCESS_OF,Patients,32340588,10.1177/0194599820921393,2020-04-29
IMPACT gene,PREDISPOSES,Sequela of disorder,32340586,10.1177/1078390320919803,2020-04-29
Otolaryngologist,TREATS,Patients,32340586,10.1177/1078390320919803,2020-04-29
Hospitalization,TREATS,Family,32340583,10.1080/17843286.2020.1761162,2020-04-29
Hospitalization,TREATS,Patients,32340583,10.1080/17843286.2020.1761162,2020-04-29
Hospitalization,TREATS,Staff,32340583,10.1080/17843286.2020.1761162,2020-04-29
innovativeness,PROCESS_OF,Community,32340583,10.1080/17843286.2020.1761162,2020-04-29
Isolate - microorganism,PART_OF,Staff,32340562,10.1080/07391102.2020.1761883,2020-04-29
Endopeptidases,INTERACTS_WITH,Phytochemicals,32340555,10.1177/0194599820922992,2020-04-29
Anomia,ISA,Symptoms,32340553,10.1177/0194599820922990,2020-04-29
Otorhinolaryngologic Diseases,PROCESS_OF,Patients,32340551,10.1080/07391102.2020.1761881,2020-04-29
Patients,ISA,Persons,32340551,10.1080/07391102.2020.1761881,2020-04-29
Anti-Anxiety Agents,TREATS,Persons,32340549,10.1177/0194599820923623,2020-04-29
Anti-Anxiety Agents,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32340549,10.1177/0194599820923623,2020-04-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32340549,10.1177/0194599820923623,2020-04-29
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32340546,10.1177/0194599820922981,2020-04-29
Mucous Membrane,LOCATION_OF,Malignant Head and Neck Neoplasm,32340546,10.1177/0194599820922981,2020-04-29
Tracheotomy procedure,TREATS,Patients,32340542,10.1177/0194599820923622,2020-04-29
Malignant Head and Neck Neoplasm,PROCESS_OF,Surgeon,32340541,10.1177/0194599820922984,2020-04-29
Coronavirus Infections,ISA,Disease,32340539,10.1177/0194599820923621,2020-04-29
SARS coronavirus,CAUSES,Disease,32340539,10.1177/0194599820923621,2020-04-29
SARS coronavirus,CAUSES(SPEC),Coronavirus Infections,32340539,10.1177/0194599820923621,2020-04-29
Upper respiratory tract,LOCATION_OF,Surgical Endoscopy,32340539,10.1177/0194599820923621,2020-04-29
Larynx,LOCATION_OF,Ultrasonography,32340539,10.1177/0194599820923621,2020-04-29
higher education institution,LOCATION_OF,Knowledge acquisition,32340538,10.1177/0194599820923632,2020-04-29
Virus,PROCESS_OF,Health Personnel,32340531,10.1177/2150132720922957,2020-04-29
Asymptomatic,PROCESS_OF,Persons,32340531,10.1177/2150132720922957,2020-04-29
Present,PROCESS_OF,Patients,32340531,10.1177/2150132720922957,2020-04-29
Working Group,USES,Artificial Airways,32340531,10.1177/2150132720922957,2020-04-29
Coronavirus Infections,CAUSES,Disease,32340429,10.4081/monaldi.2020.1316,2020-04-29
Coronavirus Infections,ISA,Disease,32340429,10.4081/monaldi.2020.1316,2020-04-29
Virus,NEG_LOCATION_OF,concise,32340429,10.4081/monaldi.2020.1316,2020-04-29
Coronavirus Infections,ISA,Disease,32340389,10.3390/md18040225,2020-04-29
lopinavir,ISA,HIV Protease Inhibitors,32340349,10.3390/ijerph17082933,2020-04-29
Infected,PROCESS_OF,Persons,32340268,10.3390/s20082396,2020-04-29
"Hospitals, University",LOCATION_OF,Analysis,32340268,10.3390/s20082396,2020-04-29
Floods,ISA,Disasters,32340216,10.3390/nu12041181,2020-04-29
Vaccination,AFFECTS,Infection,32340120,10.3390/v12040476,2020-04-29
Virus,CAUSES,Disease,32340107,10.3390/ijerph17082906,2020-04-29
Therapeutic procedure,TREATS,Disease,32340107,10.3390/ijerph17082906,2020-04-29
Herpesviridae,ISA,Virus,32340107,10.3390/ijerph17082906,2020-04-29
Herpesviridae,CAUSES,Complication,32340107,10.3390/ijerph17082906,2020-04-29
Genus: Coronavirus,CAUSES,Complication,32340107,10.3390/ijerph17082906,2020-04-29
Infection,PRECEDES,Complication,32340107,10.3390/ijerph17082906,2020-04-29
Pathogenic organism,CAUSES,Respiratory Tract Infections,32340107,10.3390/ijerph17082906,2020-04-29
Herpesviridae,LOCATION_OF,Alkaloids,32340107,10.3390/ijerph17082906,2020-04-29
disorder control (procedure),TREATS,Epidemic disease,32340091,10.3760/cma.j.cn112338-20200321-00409,2020-04-29
Psychotic illness,PROCESS_OF,Persons,32340050,10.1055/a-1159-5575,2020-04-28
Psychiatrist,LOCATION_OF,IMPACT gene,32340048,10.1055/a-1159-5551,2020-04-28
Neurologists,LOCATION_OF,IMPACT gene,32340048,10.1055/a-1159-5551,2020-04-28
Health Personnel,LOCATION_OF,SSNA1 gene,32340047,10.1055/a-1159-5562,2020-04-28
Specialization,ISA,Occupations,32340047,10.1055/a-1159-5562,2020-04-28
Prophylactic treatment,COEXISTS_WITH,Intervention regimes,32340047,10.1055/a-1159-5562,2020-04-28
Psychiatric symptom,PROCESS_OF,Health Personnel,32340047,10.1055/a-1159-5562,2020-04-28
mental health,NEG_PROCESS_OF,Health Personnel,32340044,10.1055/a-1155-0501,2020-04-28
Peptidyl-Dipeptidase A,PART_OF,Dual,32340022,10.1038/s41586-020-2271-3,2020-04-28
Maintenance hemodialysis,TREATS,Males,32339998,10.2196/19106,2020-04-28
Respiratory Failure,PROCESS_OF,Patients,32339998,10.2196/19106,2020-04-28
Infectious disease prevention / control,TREATS,Patients,32339998,10.2196/19106,2020-04-28
Spain,ISA,Geographic Locations,32339971,10.1016/j.ijporl.2020.110059,2020-04-28
Coronavirus Infections,ISA,Disease,32339971,10.1016/j.ijporl.2020.110059,2020-04-28
Coronavirus Infections,PROCESS_OF,World,32339895,10.1016/j.ajp.2020.102119,2020-04-28
Disease,PROCESS_OF,Older people,32339895,10.1016/j.ajp.2020.102119,2020-04-28
Fatigue,ISA,Symptoms,32339895,10.1016/j.ajp.2020.102119,2020-04-28
Confirmation,PROCESS_OF,geriatric patients,32339895,10.1016/j.ajp.2020.102119,2020-04-28
Eye,LOCATION_OF,Coronavirus Infections,32339844,10.1016/j.scitotenv.2020.138890,2020-04-28
Mental health problem,PROCESS_OF,Medical Staff,32339844,10.1016/j.scitotenv.2020.138890,2020-04-28
mental health,PROCESS_OF,Health Personnel,32339844,10.1016/j.scitotenv.2020.138890,2020-04-28
Sleeplessness,PROCESS_OF,Health Personnel,32339844,10.1016/j.scitotenv.2020.138890,2020-04-28
Multi-disciplinary team,ADMINISTERED_TO,Patients,32339844,10.1016/j.scitotenv.2020.138890,2020-04-28
Climate,AFFECTS,Dynamics,32339832,10.1016/j.scitotenv.2020.138914,2020-04-28
Coronavirus Infections,ISA,Disease,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Coronavirus Infections,ISA,Disease,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
France,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Italy,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Spain,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
United States,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
India,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Coronavirus Infections,ISA,Disease,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Sterilizing Units,USES,Soap,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
United States,ISA,Country,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Coronavirus Infections,ISA,Disease,32339723,10.1016/j.ijid.2020.04.055,2020-04-28
Incubation period,PROCESS_OF,Patients,32339662,10.1016/j.bbmt.2020.04.018,2020-04-28
Health care facility,LOCATION_OF,Administration occupational activities,32339510,10.1016/j.chest.2020.04.026,2020-04-28
Infected,PROCESS_OF,Patients,32339510,10.1016/j.chest.2020.04.026,2020-04-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Population Group,32339510,10.1016/j.chest.2020.04.026,2020-04-28
Urologists,TREATS,Patients,32339510,10.1016/j.chest.2020.04.026,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339508,10.1016/j.athoracsur.2020.04.010,2020-04-28
Extracorporeal Membrane Oxygenation,TREATS,Respiratory Failure,32339508,10.1016/j.athoracsur.2020.04.010,2020-04-28
Trachea,LOCATION_OF,Endotracheal tube cuff,32339487,10.1016/j.cca.2020.04.024,2020-04-28
Percutaneous dilational tracheostomy,TREATS,Patients,32339487,10.1016/j.cca.2020.04.024,2020-04-28
Symptoms,PROCESS_OF,Health Personnel,32339487,10.1016/j.cca.2020.04.024,2020-04-28
Abnormal result,PROCESS_OF,Patients,32339477,10.1016/j.amjmed.2020.03.041,2020-04-28
Virus,CAUSES,Disease,32339391,10.1002/oby.22856,2020-04-28
Diabetes,PROCESS_OF,Patients,32339382,10.1111/1471-0528.16278,2020-04-28
Obesity,PROCESS_OF,Patients,32339382,10.1111/1471-0528.16278,2020-04-28
Adipocytes,PART_OF,Patients,32339382,10.1111/1471-0528.16278,2020-04-28
angiotensin converting enzyme 2,STIMULATES,Adipocytes,32339382,10.1111/1471-0528.16278,2020-04-28
Interstitium,PART_OF,Alveolar,32339382,10.1111/1471-0528.16278,2020-04-28
Thiazolidinediones,ISA,Antidiabetics,32339382,10.1111/1471-0528.16278,2020-04-28
Thiazolidinediones,STIMULATES,Peroxisome Proliferator-Activated Receptors,32339382,10.1111/1471-0528.16278,2020-04-28
Thiazolidinediones,TREATS,Resting state,32339382,10.1111/1471-0528.16278,2020-04-28
Birth,PROCESS_OF,Woman,32339350,10.1111/myc.13096,2020-04-28
Infected,PROCESS_OF,Pregnant Women,32339350,10.1111/myc.13096,2020-04-28
Breast Feeding,PROCESS_OF,Woman,32339350,10.1111/myc.13096,2020-04-28
American College of Cardiology/American Heart Association Lesion Complexity Score A,COEXISTS_WITH,Puerperal Infection,32339350,10.1111/myc.13096,2020-04-28
"Respiratory Distress Syndrome, Adult",ISA,Complication,32339344,10.1111/jdv.16544,2020-04-28
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32339344,10.1111/jdv.16544,2020-04-28
Virus Diseases,CAUSES,"Respiratory Distress Syndrome, Adult",32339344,10.1111/jdv.16544,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339344,10.1111/jdv.16544,2020-04-28
"Hospitals, University",LOCATION_OF,Study,32339344,10.1111/jdv.16544,2020-04-28
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32339344,10.1111/jdv.16544,2020-04-28
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32339344,10.1111/jdv.16544,2020-04-28
Kidney Transplantation,PRECEDES,disease prevention,32339260,10.1111/anae.15095,2020-04-28
Virus Diseases,COEXISTS_WITH,Decreased Immunologic Activity [PE],32339260,10.1111/anae.15095,2020-04-28
Virus Diseases,PROCESS_OF,Transplant Recipients,32339260,10.1111/anae.15095,2020-04-28
Decreased Immunologic Activity [PE],PROCESS_OF,Patients,32339260,10.1111/anae.15095,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339260,10.1111/anae.15095,2020-04-28
Hospitalization,TREATS,Transplant Recipients,32339260,10.1111/anae.15095,2020-04-28
Decreased Immunologic Activity [PE],PROCESS_OF,Population Group,32339260,10.1111/anae.15095,2020-04-28
Disease,COEXISTS_WITH,Crisis,32339250,10.14670/HH-18-223,2020-04-28
"SUPPLY, NOT OTHERWISE SPECIFIED",TREATS,Tissue Donors,32339250,10.14670/HH-18-223,2020-04-28
Anemia,PROCESS_OF,Patients,32339250,10.14670/HH-18-223,2020-04-28
Prophylactic treatment,TREATS,Anemia,32339250,10.14670/HH-18-223,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339250,10.14670/HH-18-223,2020-04-28
Coagulation procedure,AFFECTS,Patients,32339250,10.14670/HH-18-223,2020-04-28
Pharmaceutical Preparations,TREATS,Symptoms,32339248,10.1001/jamanetworkopen.2020.8857,2020-04-28
Organ,PART_OF,Homo sapiens,32339248,10.1001/jamanetworkopen.2020.8857,2020-04-28
chloroquine phosphate,TREATS,Patients,32339245,10.1093/cid/ciaa501,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339245,10.1093/cid/ciaa501,2020-04-28
Azithromycin,ADMINISTERED_TO,Patients,32339245,10.1093/cid/ciaa501,2020-04-28
Oseltamivir,ADMINISTERED_TO,Patients,32339245,10.1093/cid/ciaa501,2020-04-28
Day 4,NEG_PROCESS_OF,Patients,32339245,10.1093/cid/ciaa501,2020-04-28
Glioblastoma,PROCESS_OF,geriatric patients,32339231,10.1093/infdis/jiaa211,2020-04-28
Glioblastoma,PROCESS_OF,geriatric patients,32339231,10.1093/infdis/jiaa211,2020-04-28
O(6)-Methylguanine-DNA Methyltransferase,PART_OF,Patients,32339231,10.1093/infdis/jiaa211,2020-04-28
Glioblastoma,PROCESS_OF,geriatric patients,32339231,10.1093/infdis/jiaa211,2020-04-28
Infected,PROCESS_OF,Persons,32339228,10.1093/cid/ciaa500,2020-04-28
Middle Aged,ISA,Adult,32339228,10.1093/cid/ciaa500,2020-04-28
Blood Coagulation Disorders,COEXISTS_WITH,Coronavirus Infections,32339157,10.18632/aging.103100,2020-04-28
Disseminated coagulopathy,PROCESS_OF,Patients,32339157,10.18632/aging.103100,2020-04-28
Infected,PROCESS_OF,Patients,32339157,10.18632/aging.103100,2020-04-28
Acute Lung Injury,PROCESS_OF,Patients,32339157,10.18632/aging.103100,2020-04-28
Blood coagulation tests,ISA,Laboratory Procedures,32339157,10.18632/aging.103100,2020-04-28
Blood coagulation tests,USES,Laboratory Procedures,32339157,10.18632/aging.103100,2020-04-28
Critical Illness,PROCESS_OF,Patients,32339157,10.18632/aging.103100,2020-04-28
Critical Illness,PROCESS_OF,hospitalized patients,32339157,10.18632/aging.103100,2020-04-28
Septicemia,CAUSES,Blood Coagulation Disorders,32339157,10.18632/aging.103100,2020-04-28
Blood Coagulation Disorders,COEXISTS_WITH,Disseminated coagulopathy,32339157,10.18632/aging.103100,2020-04-28
angiotensin converting enzyme 2,INTERACTS_WITH,B-Lymphocytes,32339092,10.3201/eid2608.201229,2020-04-28
angiotensin converting enzyme 2,INTERACTS_WITH,macrophage,32339092,10.3201/eid2608.201229,2020-04-28
angiotensin converting enzyme 2,INTERACTS_WITH,neutrophil,32339092,10.3201/eid2608.201229,2020-04-28
Subgroup A Nepoviruses,LOCATION_OF,angiotensin converting enzyme 2,32339092,10.3201/eid2608.201229,2020-04-28
Immune Cell,LOCATION_OF,Subgroup A Nepoviruses,32339092,10.3201/eid2608.201229,2020-04-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32339092,10.3201/eid2608.201229,2020-04-28
Coronavirus Infections,ISA,Disease,32339091,10.3201/eid2608.201192,2020-04-28
Virus Diseases,ISA,Disease,32339091,10.3201/eid2608.201192,2020-04-28
Coronavirus Infections,ISA,Disease,32339091,10.3201/eid2608.201192,2020-04-28
Coronavirus Infections,ISA,Disease,32339082,10.1148/radiol.2020201473,2020-04-28
Department,LOCATION_OF,Diagnosis,32339082,10.1148/radiol.2020201473,2020-04-28
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32339081,10.1148/radiol.2020201491,2020-04-28
Performance,PROCESS_OF,Patients,32339081,10.1148/radiol.2020201491,2020-04-28
Performance,PROCESS_OF,radiologist,32339074,10.1089/lap.2020.0266,2020-04-28
Pneumonia,PROCESS_OF,Patients,32339074,10.1089/lap.2020.0266,2020-04-28
patient care,COEXISTS_WITH,Triage,32338807,10.1002/hed.26205,2020-04-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Surgeon,32338790,10.1002/hed.26207,2020-04-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Vulnerable Populations,32338708,10.1093/cid/ciaa478,2020-04-28
Nursing Homes,ISA,Health care facility,32338708,10.1093/cid/ciaa478,2020-04-28
Registered nurse,ISA,Occupational Groups,32338708,10.1093/cid/ciaa478,2020-04-28
Communicable Diseases,PROCESS_OF,Clinician,32338645,10.3390/diagnostics10040243,2020-04-28
Pharmacist,TREATS,Patients,32338645,10.3390/diagnostics10040243,2020-04-28
Pregnant Women,ISA,Population Group,32338613,10.2196/19374,2020-04-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32338613,10.2196/19374,2020-04-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),Pregnant Women,32338613,10.2196/19374,2020-04-28
Coronavirus Infections,ISA,Disease,32338605,10.7554/eLife.57555,2020-04-28
Coronavirus Infections,ISA,Disease,32338605,10.7554/eLife.57555,2020-04-28
Coronavirus Infections,ISA,Disease,32338605,10.7554/eLife.57555,2020-04-28
Vaccines,TREATS,Coronavirus Infections,32338605,10.7554/eLife.57555,2020-04-28
Coronavirus Infections,ISA,Disease,32338605,10.7554/eLife.57555,2020-04-28
Pulmonary Edema,COEXISTS_WITH,Disease,32338566,10.1080/00332747.2020.1750214,2020-04-28
Pulmonary Edema,PROCESS_OF,Patients,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,LOCATION_OF,Bradykinin Receptor,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,LOCATION_OF,BDKRB2 wt Allele,32338566,10.1080/00332747.2020.1750214,2020-04-28
Endothelial Cells,LOCATION_OF,Bradykinin Receptor,32338566,10.1080/00332747.2020.1750214,2020-04-28
Endothelial Cells,LOCATION_OF,BDKRB2 wt Allele,32338566,10.1080/00332747.2020.1750214,2020-04-28
Cells,INTERACTS_WITH,ACE2 gene,32338566,10.1080/00332747.2020.1750214,2020-04-28
Blood Vessel,LOCATION_OF,Extravasation,32338566,10.1080/00332747.2020.1750214,2020-04-28
Extravasation,AFFECTS,Angioedema,32338566,10.1080/00332747.2020.1750214,2020-04-28
ACE2 gene,INHIBITS,Bradykinin Receptor,32338566,10.1080/00332747.2020.1750214,2020-04-28
Kinins,AUGMENTS,Angioedema,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,LOCATION_OF,Body Fluids,32338566,10.1080/00332747.2020.1750214,2020-04-28
Oxygen,PART_OF,Body organ structure,32338566,10.1080/00332747.2020.1750214,2020-04-28
angiotensin II,AFFECTS,Blood Pressure,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,LOCATION_OF,Body Fluids,32338566,10.1080/00332747.2020.1750214,2020-04-28
ACE2 gene,INHIBITS,Kinins,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,LOCATION_OF,Body Fluids,32338566,10.1080/00332747.2020.1750214,2020-04-28
Patients,LOCATION_OF,Body Fluids,32338566,10.1080/00332747.2020.1750214,2020-04-28
Lung,PART_OF,Patients,32338566,10.1080/00332747.2020.1750214,2020-04-28
Severe Acute Respiratory Syndrome,AFFECTS,Pregnancy,32338400,10.1002/eat.23279,2020-04-28
Human Metapneumovirus,ISA,Metapneumovirus,32338400,10.1002/eat.23279,2020-04-28
Orthomyxoviridae,CAUSES,Infection,32338400,10.1002/eat.23279,2020-04-28
Respiratory syncytial virus,PROCESS_OF,Pregnant Women,32338400,10.1002/eat.23279,2020-04-28
Parainfluenza virus,NEG_CAUSES,intrauterine infection,32338400,10.1002/eat.23279,2020-04-28
Human Metapneumovirus,NEG_CAUSES,intrauterine infection,32338400,10.1002/eat.23279,2020-04-28
SARS coronavirus,ISA,Genus: Coronavirus,32338400,10.1002/eat.23279,2020-04-28
Eating Disorders,PROCESS_OF,Persons,32338353,10.26719/2020.26.4.370,2020-04-28
Eating Disorders,PROCESS_OF,Community,32338353,10.26719/2020.26.4.370,2020-04-28
Eating Disorders,PROCESS_OF,Persons,32338353,10.26719/2020.26.4.370,2020-04-28
Asymptomatic,PROCESS_OF,"Child, Hospitalized",32338298,10.1007/s00405-020-05995-9,2020-04-28
Acute illness,PROCESS_OF,"Child, Hospitalized",32338298,10.1007/s00405-020-05995-9,2020-04-28
Acute respiratory infections,ISA,Symptoms,32338298,10.1007/s00405-020-05995-9,2020-04-28
Disease,PROCESS_OF,Child,32338298,10.1007/s00405-020-05995-9,2020-04-28
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32338298,10.1007/s00405-020-05995-9,2020-04-28
Mild disorder,PROCESS_OF,Child,32338298,10.1007/s00405-020-05995-9,2020-04-28
Oxygen,TREATS,Health Personnel,32338298,10.1007/s00405-020-05995-9,2020-04-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32338254,10.4193/Rhin20.136,2020-04-28
Challenge,TREATS,Patients,32338254,10.4193/Rhin20.136,2020-04-28
Challenge,TREATS,Caregiver,32338254,10.4193/Rhin20.136,2020-04-28
Challenge,TREATS,Clinician,32338254,10.4193/Rhin20.136,2020-04-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32338254,10.4193/Rhin20.136,2020-04-28
Remote Consultation,AFFECTS,Coronavirus Infections,32338254,10.4193/Rhin20.136,2020-04-28
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32338254,10.4193/Rhin20.136,2020-04-28
Sense of smell impaired,NEG_PROCESS_OF,Patients,32338224,10.2174/1871530320666200427112902,2020-04-28
Present,PROCESS_OF,Patients,32338224,10.2174/1871530320666200427112902,2020-04-28
Epithelial Cells,PART_OF,Intestines,32338164,10.1080/07391102.2020.1761882,2020-04-28
"Vitronectin, human",STIMULATES,Leukocytes,32338164,10.1080/07391102.2020.1761882,2020-04-28
Leptocyte,LOCATION_OF,Virus,32338164,10.1080/07391102.2020.1761882,2020-04-28
Protein Subunits,INTERACTS_WITH,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,PART_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
SARS coronavirus,PROCESS_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
SARS coronavirus,PROCESS_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,PART_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
Infected,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,PART_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,PART_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,AFFECTS,Down-Regulation,32338164,10.1080/07391102.2020.1761882,2020-04-28
angiotensin II,STIMULATES,"Receptor, Angiotensin, Type 1a",32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,AFFECTS,Acute Lung Injury,32338164,10.1080/07391102.2020.1761882,2020-04-28
receptor,COEXISTS_WITH,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
Immune Cell,LOCATION_OF,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
Immune Cell,LOCATION_OF,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
,DISRUPTS,Severe Acute Respiratory Syndrome,32338164,10.1080/07391102.2020.1761882,2020-04-28
Mus,LOCATION_OF,Protein Subunits,32338164,10.1080/07391102.2020.1761882,2020-04-28
Middle East Respiratory Syndrome Coronavirus,LOCATION_OF,Protein Subunits,32338164,10.1080/07391102.2020.1761882,2020-04-28
Mus,LOCATION_OF,Monoclonal Antibodies,32338164,10.1080/07391102.2020.1761882,2020-04-28
"Antibodies, Neutralizing",PART_OF,Homo sapiens,32338164,10.1080/07391102.2020.1761882,2020-04-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Interleukin-1,ASSOCIATED_WITH,Syndrome,32338164,10.1080/07391102.2020.1761882,2020-04-28
Interleukin-6,ASSOCIATED_WITH,Syndrome,32338164,10.1080/07391102.2020.1761882,2020-04-28
Syndrome,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
cytokine,ASSOCIATED_WITH,Syndrome,32338164,10.1080/07391102.2020.1761882,2020-04-28
Infected,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Comorbidity,PROCESS_OF,Population Group,32338164,10.1080/07391102.2020.1761882,2020-04-28
Comorbidity,PROCESS_OF(SPEC),Frail Elderly,32338164,10.1080/07391102.2020.1761882,2020-04-28
Frail Elderly,ISA,Population Group,32338164,10.1080/07391102.2020.1761882,2020-04-28
Immunity,COEXISTS_WITH,Aging,32338164,10.1080/07391102.2020.1761882,2020-04-28
Lung,LOCATION_OF,Acute failure,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,PREVENTS,Acute failure,32338164,10.1080/07391102.2020.1761882,2020-04-28
angiotensin II,STIMULATES,AGTR1 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
angiotensin II,DISRUPTS,cell growth,32338164,10.1080/07391102.2020.1761882,2020-04-28
AGTR1 gene,DISRUPTS,cell growth,32338164,10.1080/07391102.2020.1761882,2020-04-28
Hypertensive disease,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Myocardial Infarction,PROCESS_OF,Rattus norvegicus,32338164,10.1080/07391102.2020.1761882,2020-04-28
Losartan,STIMULATES,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
olmesartan,TREATS,Hypertensive disease,32338164,10.1080/07391102.2020.1761882,2020-04-28
Infected,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Infected,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Symptoms,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Hypertensive disease,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Infected,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,AFFECTS,Renin-angiotensin system,32338164,10.1080/07391102.2020.1761882,2020-04-28
Epithelial Cells,LOCATION_OF,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
resveratrol,STIMULATES,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
polyphenols,INTERACTS_WITH,resveratrol,32338164,10.1080/07391102.2020.1761882,2020-04-28
SIRT1 gene,INHIBITS,AGTR1 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
resveratrol,AFFECTS,Cell Survival,32338164,10.1080/07391102.2020.1761882,2020-04-28
Ability,MANIFESTATION_OF,Negative Regulation of Apoptosis,32338164,10.1080/07391102.2020.1761882,2020-04-28
resveratrol,STIMULATES,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
resveratrol,TREATS,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Myocarditis,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
Syndrome,PROCESS_OF,Patients,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,AFFECTS,Myocarditis,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,AFFECTS,Syndrome,32338164,10.1080/07391102.2020.1761882,2020-04-28
Angiotensin-Converting Enzyme Inhibitors,INTERACTS_WITH,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
Angiotensin II Type 1 Receptor Blockers,INTERACTS_WITH,ACE2 gene,32338164,10.1080/07391102.2020.1761882,2020-04-28
ACE2 gene,NEG_PART_OF,Virus,32338164,10.1080/07391102.2020.1761882,2020-04-28
Chloroquine,ISA,Pharmaceutical Preparations,32338150,10.1080/22221751.2020.1760146,2020-04-28
Chloroquine,TREATS,patient condition,32338150,10.1080/22221751.2020.1760146,2020-04-28
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32338150,10.1080/22221751.2020.1760146,2020-04-28
long-term care,USES,Hydroxychloroquine,32338150,10.1080/22221751.2020.1760146,2020-04-28
Decontamination,AFFECTS,Cross Infection,32337859,10.1111/ajt.15947,2020-04-28
Decontamination,AFFECTS,Cross Infection,32337859,10.1111/ajt.15947,2020-04-28
Decontamination,USES,Ethanol,32337859,10.1111/ajt.15947,2020-04-28
Water,INHIBITS,Compliance,32337859,10.1111/ajt.15947,2020-04-28
Coronavirus Infections,PROCESS_OF,Transplant Recipients,32337795,10.1002/uog.22055,2020-04-28
Hydroxychloroquine,INHIBITS,Immunosuppressive Agents,32337795,10.1002/uog.22055,2020-04-28
lopinavir / Ritonavir,INHIBITS,Immunosuppressive Agents,32337795,10.1002/uog.22055,2020-04-28
Antiviral Agents,TREATS,Patients,32337795,10.1002/uog.22055,2020-04-28
Lung,LOCATION_OF,Ultrasonography,32337790,10.1111/ajt.15943,2020-04-28
Ultrasonography,DIAGNOSES,pulmonary involvement,32337790,10.1111/ajt.15943,2020-04-28
Lung,LOCATION_OF,Ultrasound examination,32337790,10.1111/ajt.15943,2020-04-28
Nasal Swab (procedure),METHOD_OF,Diagnosis,32337790,10.1111/ajt.15943,2020-04-28
Disease,PROCESS_OF,Health Personnel,32337790,10.1111/ajt.15943,2020-04-28
Lung,LOCATION_OF,Ultrasound examination,32337790,10.1111/ajt.15943,2020-04-28
Lung,PART_OF,Caucasoid Race,32337790,10.1111/ajt.15943,2020-04-28
Lung,LOCATION_OF,Ultrasonography,32337790,10.1111/ajt.15943,2020-04-28
Analysis,USES,Reverse Transcriptase Polymerase Chain Reaction,32337790,10.1111/ajt.15943,2020-04-28
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32337790,10.1111/ajt.15943,2020-04-28
Pneumonia,PROCESS_OF,Recipient,32337769,10.1002/ddr.21676,2020-04-28
Chloroquine,TREATS,over-exposure,32337769,10.1002/ddr.21676,2020-04-28
lopinavir / Ritonavir,TREATS,over-exposure,32337769,10.1002/ddr.21676,2020-04-28
Equilibrium,PROCESS_OF,Transplant Recipients,32337769,10.1002/ddr.21676,2020-04-28
Awareness,PROCESS_OF,Patients,32337769,10.1002/ddr.21676,2020-04-28
treatment options,AFFECTS,Drug Interactions,32337769,10.1002/ddr.21676,2020-04-28
Structure of parenchyma of lung,LOCATION_OF,ACE2 gene,32337664,10.1007/s40261-020-00917-3,2020-04-28
Pharmaceutical Preparations,TREATS,Coughing,32337664,10.1007/s40261-020-00917-3,2020-04-28
Noscapine,INHIBITS,Bradykinin,32337664,10.1007/s40261-020-00917-3,2020-04-28
Pneumonia,PROCESS_OF,Patients,32337662,10.1007/s10096-020-03901-z,2020-04-28
Storm NOS,PROCESS_OF,Patients,32337662,10.1007/s10096-020-03901-z,2020-04-28
Interleukin-6,ASSOCIATED_WITH(SPEC),Storm NOS,32337662,10.1007/s10096-020-03901-z,2020-04-28
Interleukin-6,ISA,cytokine,32337662,10.1007/s10096-020-03901-z,2020-04-28
cytokine,ASSOCIATED_WITH,Storm NOS,32337662,10.1007/s10096-020-03901-z,2020-04-28
tocilizumab,TREATS,Storm NOS,32337662,10.1007/s10096-020-03901-z,2020-04-28
Interleukin-6 Receptor Antagonist [EPC],TREATS,Cytokine release syndrome,32337662,10.1007/s10096-020-03901-z,2020-04-28
Coronavirus Infections,ISA,Disease,32337591,10.1093/cid/ciaa490,2020-04-28
Coronavirus Infections,ISA,Disease,32337591,10.1093/cid/ciaa490,2020-04-28
Coronavirus Infections,ISA,Disease,32337591,10.1093/cid/ciaa490,2020-04-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32337590,10.1093/cid/ciaa489,2020-04-28
Negative,PROCESS_OF,Patients,32337590,10.1093/cid/ciaa489,2020-04-28
Duration,PREVENTS,Disease,32337590,10.1093/cid/ciaa489,2020-04-28
Antibody Formation,PROCESS_OF,Patients,32337584,10.1093/cid/ciaa491,2020-04-28
Antibody Formation,PROCESS_OF,Patients,32337584,10.1093/cid/ciaa491,2020-04-28
ITSN2 gene,PART_OF,Nasopharynx,32337386,10.1016/j.adro.2020.04.010,2020-04-28
Heart,LOCATION_OF,Viral Shedding,32337386,10.1016/j.adro.2020.04.010,2020-04-28
Infected,PROCESS_OF,Health Personnel,32337386,10.1016/j.adro.2020.04.010,2020-04-28
Eye,LOCATION_OF,Malignant Neoplasms,32337328,10.1016/j.dib.2020.105551,2020-04-28
Eye,LOCATION_OF(SPEC),Uveal melanoma,32337328,10.1016/j.dib.2020.105551,2020-04-28
Uveal melanoma,ISA,Malignant Neoplasms,32337328,10.1016/j.dib.2020.105551,2020-04-28
Communicable Diseases,DISRUPTS,viral transmission,32337328,10.1016/j.dib.2020.105551,2020-04-28
Eyelash,LOCATION_OF,Communicable Diseases,32337328,10.1016/j.dib.2020.105551,2020-04-28
Uveal melanoma,PROCESS_OF,Patients,32337328,10.1016/j.dib.2020.105551,2020-04-28
Symptoms,PROCESS_OF,Patients,32337192,10.31661/jbpe.v0i0.2003-1085,2020-04-28
Gastrointestinal dysfunction,PROCESS_OF,Patients,32337192,10.31661/jbpe.v0i0.2003-1085,2020-04-28
Infected,PROCESS_OF,Persons,32337192,10.31661/jbpe.v0i0.2003-1085,2020-04-28
Radionuclide Imaging,DIAGNOSES,Nodule,32337192,10.31661/jbpe.v0i0.2003-1085,2020-04-28
patient condition,PROCESS_OF,Patients,32337192,10.31661/jbpe.v0i0.2003-1085,2020-04-28
Resistant virus,PROCESS_OF,Persons,32337151,10.1007/s10389-020-01279-y,2020-04-28
Therapeutic procedure,TREATS,Pneumonia,32337151,10.1007/s10389-020-01279-y,2020-04-28
Bacterial Infections,PROCESS_OF,Patients,32337151,10.1007/s10389-020-01279-y,2020-04-28
Coronavirus Infections,AFFECTS,Persons,32337148,10.7759/cureus.7782,2020-04-28
Administration occupational activities,ISA,Implementation,32337148,10.7759/cureus.7782,2020-04-28
Disease,PROCESS_OF,Patients,32337143,10.7759/cureus.7423,2020-04-28
Cardiac complication,PROCESS_OF,Patients,32337143,10.7759/cureus.7423,2020-04-28
Symptoms,PROCESS_OF,Patients,32337143,10.7759/cureus.7423,2020-04-28
Genus: Coronavirus,ISA,Virus,32337139,10.7759/cureus.7415,2020-04-28
RNA Viruses,NEG_PROCESS_OF,Homo sapiens,32337139,10.7759/cureus.7415,2020-04-28
Severe disorder,PROCESS_OF,Homo sapiens,32337139,10.7759/cureus.7415,2020-04-28
Illness (finding),PROCESS_OF,Homo sapiens,32337139,10.7759/cureus.7415,2020-04-28
Diarrhea,ISA,Symptoms,32337139,10.7759/cureus.7415,2020-04-28
Diarrhea,PROCESS_OF(SPEC),Persons,32337139,10.7759/cureus.7415,2020-04-28
Infected,PROCESS_OF,Persons,32337139,10.7759/cureus.7415,2020-04-28
Symptoms,PROCESS_OF,Persons,32337139,10.7759/cureus.7415,2020-04-28
Growth,COEXISTS_WITH,Movement,32337139,10.7759/cureus.7415,2020-04-28
Illness (finding),PROCESS_OF,Patients,32337139,10.7759/cureus.7415,2020-04-28
Infection,COEXISTS_WITH,Handling,32337139,10.7759/cureus.7415,2020-04-28
Hydroxychloroquine,TREATS,patient condition,32337131,10.7759/cureus.7405,2020-04-28
Azithromycin,TREATS,patient condition,32337131,10.7759/cureus.7405,2020-04-28
Disease,PROCESS_OF,Patients,32336957,10.1186/s12575-020-00121-9,2020-04-28
Lung,LOCATION_OF,Lesion,32336957,10.1186/s12575-020-00121-9,2020-04-28
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Disease,32336957,10.1186/s12575-020-00121-9,2020-04-28
Septicemia,COEXISTS_WITH,Disease,32336957,10.1186/s12575-020-00121-9,2020-04-28
Lesion,COEXISTS_WITH,Disease,32336957,10.1186/s12575-020-00121-9,2020-04-28
Respiratory Failure,COEXISTS_WITH,Disease,32336957,10.1186/s12575-020-00121-9,2020-04-28
Pandemics,ISA,Disease Outbreaks,32336927,10.1016/j.sjbs.2020.04.033,2020-04-28
Epidemiology,ISA,Biomedicine,32336927,10.1016/j.sjbs.2020.04.033,2020-04-28
Iran,ISA,Country,32336927,10.1016/j.sjbs.2020.04.033,2020-04-28
Synapsin I,COEXISTS_WITH,Proline,32336927,10.1016/j.sjbs.2020.04.033,2020-04-28
Coronavirus Infections,ISA,Disease,32336803,10.1007/s10273-020-2631-5,2020-04-28
Coronavirus Infections,ISA,Disease,32336803,10.1007/s10273-020-2631-5,2020-04-28
Shock,PROCESS_OF,Corona,32336725,10.5582/bst.2020.03098,2020-04-28
Hospitals,LOCATION_OF,Pharmacy Administration,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
Hospitals,LOCATION_OF,Study,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
Consultation,TREATS,Patients,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
Consultation,USES,Pharmaceutical Preparations,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
Pharmaceutical Preparations,PREVENTS,Drug usage,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
Bag Device Component,USES,Drug Packaging,32336612,10.1016/j.ejim.2020.04.037,2020-04-28
angiotensin converting enzyme 2,ADMINISTERED_TO,Cells,32336594,10.1016/j.resinv.2020.03.006,2020-04-28
Heart,LOCATION_OF,angiotensin converting enzyme 2,32336594,10.1016/j.resinv.2020.03.006,2020-04-28
angiotensin II,INHIBITS,angiotensin converting enzyme 2,32336594,10.1016/j.resinv.2020.03.006,2020-04-28
angiotensin converting enzyme 2,PART_OF,soluble,32336594,10.1016/j.resinv.2020.03.006,2020-04-28
Betacoronavirus,ISA,Virus,32336586,10.1016/j.ajem.2020.04.035,2020-04-28
Infected,PROCESS_OF,Patients,32336586,10.1016/j.ajem.2020.04.035,2020-04-28
Severe disorder,PROCESS_OF,Patients,32336586,10.1016/j.ajem.2020.04.035,2020-04-28
Point-of-Care Testing,USES,Diagnosis,32336586,10.1016/j.ajem.2020.04.035,2020-04-28
Chloroquine,ISA,Antimalarials,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Disease,PROCESS_OF,Patients,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Hydroxychloroquine,TREATS,Patients,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Hydroxychloroquine,TREATS(INFER),Disease,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Patients,LOCATION_OF,Plasma,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Respiratory Failure,PROCESS_OF,Patients,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Clinical Trials,USES,Prophylactic treatment,32336583,10.1016/j.ajem.2020.04.032,2020-04-28
Hospital Administration,METHOD_OF,Screening procedure,32336578,10.1016/j.clae.2020.04.002,2020-04-28
Intercostal Retractions,ISA,Dyspnea,32336564,10.1016/j.arbres.2020.03.019,2020-04-28
Respiratory distress,ISA,Dyspnea,32336564,10.1016/j.arbres.2020.03.019,2020-04-28
Lung,LOCATION_OF,Lesion,32336563,10.1016/j.arbres.2020.03.005,2020-04-28
Polymerase Chain Reaction,METHOD_OF,Diagnostic tests,32336563,10.1016/j.arbres.2020.03.005,2020-04-28
Evaluation,NEG_USES,Chest CT,32336563,10.1016/j.arbres.2020.03.005,2020-04-28
Chest,LOCATION_OF,Ultrasound examination,32336563,10.1016/j.arbres.2020.03.005,2020-04-28
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32336562,10.1016/j.scitotenv.2020.138858,2020-04-28
Severe disorder,PROCESS_OF,Persons,32336562,10.1016/j.scitotenv.2020.138858,2020-04-28
"Societies, Scientific",ISA,Societies,32336562,10.1016/j.scitotenv.2020.138858,2020-04-28
Warburg Therapy,USES,Nasal Cannula,32336562,10.1016/j.scitotenv.2020.138858,2020-04-28
Coronaviridae,PROCESS_OF,Family,32336528,10.1016/j.nrl.2020.04.001,2020-04-28
Severe Acute Respiratory Syndrome,OCCURS_IN,Patients,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
Emergency operation,TREATS,Patients,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
3/6,COEXISTS_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
Peritonitis,PROCESS_OF,Patients,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
Emergency operation,TREATS,Patients,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
Emergency operation,TREATS(INFER),Peritonitis,32336398,10.1016/j.bjoms.2020.03.001,2020-04-28
Surgical Manipulation,USES,Artificial Airways,32336225,10.1080/08959420.2020.1759758,2020-04-28
Critical Illness,PROCESS_OF,Patients,32336079,10.3906/sag-2004-199,2020-04-28
Extracorporeal Membrane Oxygenation,AFFECTS,Patients,32336079,10.3906/sag-2004-199,2020-04-28
Extracorporeal Membrane Oxygenation,TREATS,Patients,32336079,10.3906/sag-2004-199,2020-04-28
Critical Illness,PROCESS_OF,Patients,32336079,10.3906/sag-2004-199,2020-04-28
invasive treatment,AFFECTS,Patients,32336079,10.3906/sag-2004-199,2020-04-28
Early death,PROCESS_OF,Patients,32336079,10.3906/sag-2004-199,2020-04-28
Infected,PROCESS_OF,Persons,32336069,10.33963/KP.15302,2020-04-28
Masks,PREVENTS,Respiration Disorders,32336069,10.33963/KP.15302,2020-04-28
Mechanical Ventilator,USES,Masks,32336069,10.33963/KP.15302,2020-04-28
Fever,ISA,Symptoms,32336042,10.1111/aos.14445,2020-04-27
Comorbidity,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Cardiovascular Diseases,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Heart Injuries,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Heart Injuries,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Critical Illness,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Troponin,PART_OF,Heart,32336042,10.1111/aos.14445,2020-04-27
Cardiac Arrhythmia,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Comorbidity,PROCESS_OF,Patients,32336042,10.1111/aos.14445,2020-04-27
Cardiovascular,LOCATION_OF,Comorbidity,32336042,10.1111/aos.14445,2020-04-27
Infected,PROCESS_OF,Persons,32336007,10.1002/dmrr.3330,2020-04-27
Conjunctival specimen,ASSOCIATED_WITH(INFER),Infected,32336007,10.1002/dmrr.3330,2020-04-27
Conjunctival specimen,PART_OF,Persons,32336007,10.1002/dmrr.3330,2020-04-27
Eye,LOCATION_OF,Symptoms,32336007,10.1002/dmrr.3330,2020-04-27
Tropism,PROCESS_OF,Eye,32336007,10.1002/dmrr.3330,2020-04-27
Confirmation,PROCESS_OF,Patients,32336007,10.1002/dmrr.3330,2020-04-27
Confirmation,PROCESS_OF,Patients,32336007,10.1002/dmrr.3330,2020-04-27
Eye,LOCATION_OF,Symptoms,32336007,10.1002/dmrr.3330,2020-04-27
Eye,LOCATION_OF,Prodromal Symptoms,32336007,10.1002/dmrr.3330,2020-04-27
Symptoms,ASSOCIATED_WITH,Disease,32336007,10.1002/dmrr.3330,2020-04-27
Body tissue,LOCATION_OF,Exopeptidase,32335962,10.1111/den.13706,2020-04-27
Body tissue,LOCATION_OF(SPEC),Dipeptidyl-Peptidase IV,32335962,10.1111/den.13706,2020-04-27
Dipeptidyl-Peptidase IV,ISA,Exopeptidase,32335962,10.1111/den.13706,2020-04-27
Dipeptidyl-Peptidase IV,AFFECTS,Virulence,32335962,10.1111/den.13706,2020-04-27
Dipeptidyl-Peptidase IV,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32335962,10.1111/den.13706,2020-04-27
Dipeptidyl-Peptidase IV Inhibitors,INTERACTS_WITH,Dipeptidyl-Peptidase IV,32335962,10.1111/den.13706,2020-04-27
World,LOCATION_OF,IMPACT gene,32335946,10.1111/den.13703,2020-04-27
Endoscopy (procedure),ADMINISTERED_TO,Health Personnel,32335946,10.1111/den.13703,2020-04-27
Emergency procedure,TREATS,Patients,32335946,10.1111/den.13703,2020-04-27
"Respirators, Air-Purifying",compared_with,"Respirators, Air-Purifying",32335749,10.1007/s10441-020-09382-z,2020-04-27
Difficult intubation,PROCESS_OF,Drill baboon,32335749,10.1007/s10441-020-09382-z,2020-04-27
Coronaviridae,PROCESS_OF,Family,32335697,10.1007/s00167-020-06023-3,2020-04-27
Pandemics,ISA,Disease Outbreaks,32335697,10.1007/s00167-020-06023-3,2020-04-27
Kidney Failure,AFFECTS,Comorbidity,32335697,10.1007/s00167-020-06023-3,2020-04-27
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,Severe Acute Respiratory Syndrome,32335697,10.1007/s00167-020-06023-3,2020-04-27
hospital organization,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32335614,10.33314/jnhrc.v18i1.2593,2020-04-27
huperzine B,TREATS,Minor injury,32335614,10.33314/jnhrc.v18i1.2593,2020-04-27
huperzine B,TREATS,Minor injury,32335614,10.33314/jnhrc.v18i1.2593,2020-04-27
Wounds and Injuries,PROCESS_OF,Patients,32335614,10.33314/jnhrc.v18i1.2593,2020-04-27
Musculoskeletal Diseases,PROCESS_OF,Patients,32335614,10.33314/jnhrc.v18i1.2593,2020-04-27
Pneumonia,ISA,Symptoms,32335608,10.33314/jnhrc.v18i1.2608,2020-04-27
Coronavirus Infections,CAUSES,Symptoms,32335608,10.33314/jnhrc.v18i1.2608,2020-04-27
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32335608,10.33314/jnhrc.v18i1.2608,2020-04-27
Nepal,ISA,Country,32335607,10.33314/jnhrc.v18i1.2629,2020-04-27
Nepal,ISA,Country,32335607,10.33314/jnhrc.v18i1.2629,2020-04-27
Quarantine,TREATS,Persons,32335607,10.33314/jnhrc.v18i1.2629,2020-04-27
Laboratory,LOCATION_OF,Services,32335607,10.33314/jnhrc.v18i1.2629,2020-04-27
Laboratory Procedures,METHOD_OF,Diagnosis,32335584,10.33314/jnhrc.v18i1.2628,2020-04-27
Prophylactic treatment,TREATS,Complication,32335584,10.33314/jnhrc.v18i1.2628,2020-04-27
Quarantine,ISA,Isolation procedure,32335584,10.33314/jnhrc.v18i1.2628,2020-04-27
Quarantine,AFFECTS,Anxiety,32335559,10.1159/000507935,2020-04-27
Quarantine,AFFECTS,Depressive disorder,32335559,10.1159/000507935,2020-04-27
General mental state,PROCESS_OF,Population Group,32335559,10.1159/000507935,2020-04-27
Infected,PROCESS_OF,Pregnant Women,32335514,10.3899/jrheum.200492,2020-04-27
Biological Response Modifier Therapy,USES,"Antirheumatic Drugs, Disease-Modifying",32335513,10.3899/jrheum.200507,2020-04-27
Confirmation,PROCESS_OF,Patients,32335513,10.3899/jrheum.200507,2020-04-27
Infected,PROCESS_OF,Patients,32335512,10.3899/jrheum.200483,2020-04-27
Severe Acute Respiratory Syndrome,AFFECTS,Possible,32335456,10.1016/j.mehy.2020.109743,2020-04-27
Vaccines,PREVENTS,Disease,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Protein Subunits,INTERACTS_WITH,Peptide Hydrolases,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Cathepsins,AFFECTS,Viral Load result,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Factor Xa,AFFECTS,Viral Load result,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
heparin,INTERACTS_WITH,Anti-Inflammatory Agents,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
"Heparin, Low-Molecular-Weight",INTERACTS_WITH,Anti-Inflammatory Agents,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Peptide Hydrolases,PART_OF,Host Cell,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Dalteparin,INTERACTS_WITH,Anti-Inflammatory Agents,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
tinzaparin,INTERACTS_WITH,Anti-Inflammatory Agents,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
paired basic amino acid cleaving enzyme,ASSOCIATED_WITH,Virus Diseases,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Judgment,PROCESS_OF,hospitalized patients,32335426,10.1016/j.ejrad.2020.109008,2020-04-27
Lung,LOCATION_OF,Inflammatory lesion,32335410,10.1016/j.scitotenv.2020.138882,2020-04-27
Diagnosis,DIAGNOSES,Lesion,32335410,10.1016/j.scitotenv.2020.138882,2020-04-27
Lung,LOCATION_OF,Lesion,32335410,10.1016/j.scitotenv.2020.138882,2020-04-27
Hand,LOCATION_OF,sanitizers,32335407,10.1016/j.scitotenv.2020.138872,2020-04-27
Eye,PART_OF,World,32335407,10.1016/j.scitotenv.2020.138872,2020-04-27
3'-(1-butylphosphoryl)adenosine,INTERACTS_WITH,RNA,32335405,10.1016/j.scitotenv.2020.138778,2020-04-27
Negative,COEXISTS_WITH,Headache,32335405,10.1016/j.scitotenv.2020.138778,2020-04-27
Senility,PROCESS_OF,hospitalized patients,32335405,10.1016/j.scitotenv.2020.138778,2020-04-27
Chest tightness,PROCESS_OF,hospitalized patients,32335405,10.1016/j.scitotenv.2020.138778,2020-04-27
Viral Shedding,PROCESS_OF,Patients,32335405,10.1016/j.scitotenv.2020.138778,2020-04-27
Virus,CAUSES,Disease,32335366,10.1016/j.dsx.2020.04.024,2020-04-27
Prophylactic treatment,TREATS,Disease,32335366,10.1016/j.dsx.2020.04.024,2020-04-27
Cesarean section,TREATS,Patients,32335337,10.1016/j.ijid.2020.04.058,2020-04-27
Elective cesarian delivery procedure,TREATS,Patients,32335337,10.1016/j.ijid.2020.04.058,2020-04-27
Vaginal delivery procedure,TREATS,Patients,32335337,10.1016/j.ijid.2020.04.058,2020-04-27
Hypertensive disease,PROCESS_OF,Patients,32335336,10.1016/j.jcv.2020.104372,2020-04-27
Severe Acute Respiratory Syndrome,PROCESS_OF,prenatal,32335334,10.1016/j.meegid.2020.104330,2020-04-27
Reproduction,PROCESS_OF,Patients,32335334,10.1016/j.meegid.2020.104330,2020-04-27
Vaccines,TREATS,Woman,32335334,10.1016/j.meegid.2020.104330,2020-04-27
Gravidity,PROCESS_OF,Patients,32335334,10.1016/j.meegid.2020.104330,2020-04-27
dipeptidyl peptidase II,INHIBITS,cytokine,32335249,10.1016/j.avsg.2020.04.037,2020-04-27
Glycyrrhizic Acid,INHIBITS,Accumulation,32335249,10.1016/j.avsg.2020.04.037,2020-04-27
Reactive Oxygen Species,INHIBITS,Thrombin,32335249,10.1016/j.avsg.2020.04.037,2020-04-27
Reactive Oxygen Species,PART_OF,Protoplasm,32335249,10.1016/j.avsg.2020.04.037,2020-04-27
Continuous Positive Airway Pressure,USES,Hoods,32335244,10.1016/j.ijsu.2020.04.050,2020-04-27
Upper Extremity Deep Vein Thrombosis,PROCESS_OF,Patients,32335244,10.1016/j.ijsu.2020.04.050,2020-04-27
poor physical health,COEXISTS_WITH,physical symptom,32335197,10.1016/j.bbi.2020.04.053,2020-04-27
Problem,PROCESS_OF,Patients,32335173,10.1016/j.jinf.2020.04.026,2020-04-27
"Discharge, body substance",NEG_PART_OF,Pharyngeal structure,32335173,10.1016/j.jinf.2020.04.026,2020-04-27
Decreased Immunologic Activity [PE],PROCESS_OF,Adult,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Decreased Immunologic Activity [PE],PROCESS_OF,Child,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Immunocompromised Host,PROCESS_OF,Adult,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Disease Progression,PROCESS_OF,Adult,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Disease Progression,PROCESS_OF,Child,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Decreased Immunologic Activity [PE],PROCESS_OF,Adult,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Decreased Immunologic Activity [PE],PROCESS_OF,Child,32335171,10.1016/j.jinf.2020.04.018,2020-04-27
Upper respiratory tract,LOCATION_OF,Virus,32335169,10.1016/j.jinf.2020.04.021,2020-04-27
Upper respiratory tract,LOCATION_OF,Viral Shedding,32335169,10.1016/j.jinf.2020.04.021,2020-04-27
Isolation procedure,USES,Stop brand of fluoride,32335169,10.1016/j.jinf.2020.04.021,2020-04-27
risk factors,PREDISPOSES,Critical Illness,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Disease Progression,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Cardiovascular Diseases,ISA,Disease,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Cardiovascular Diseases,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Diabetes,ISA,Disease,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Diabetes,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Hypertensive disease,ISA,Disease,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Hypertensive disease,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Respiration Disorders,ISA,Disease,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Respiration Disorders,PROCESS_OF,Patients,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Dyspnea,ASSOCIATED_WITH,Disease,32335167,10.1016/j.jinf.2020.04.024,2020-04-27
Country,ISA,Geographic Locations,32335161,10.1016/j.jim.2020.112787,2020-04-27
Compliance,PROCESS_OF,Community,32335161,10.1016/j.jim.2020.112787,2020-04-27
Coronavirus Infections,CAUSES,Virus Diseases,32335097,10.1016/j.diabres.2020.108162,2020-04-27
risk factors,PROCESS_OF,Patients,32335089,10.1016/j.cca.2020.04.023,2020-04-27
"Diabetes Mellitus, Non-Insulin-Dependent",PREDISPOSES,Respiratory complication,32335089,10.1016/j.cca.2020.04.023,2020-04-27
Coronavirus Infections,PROCESS_OF,Family,32335089,10.1016/j.cca.2020.04.023,2020-04-27
DPP4 gene,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32335089,10.1016/j.cca.2020.04.023,2020-04-27
DPP4 gene,DISRUPTS,Tropism,32335089,10.1016/j.cca.2020.04.023,2020-04-27
Real-Time Polymerase Chain Reaction,METHOD_OF,Detection,32335068,10.1016/j.chest.2020.04.015,2020-04-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Male population group,32335067,10.1016/j.chest.2020.04.020,2020-04-27
Septic Shock,PROCESS_OF,Male population group,32335067,10.1016/j.chest.2020.04.020,2020-04-27
Hypersensitivity,PROCESS_OF,Patients,32335067,10.1016/j.chest.2020.04.020,2020-04-27
Hypersensitivity,AFFECTS,SARS coronavirus,32335067,10.1016/j.chest.2020.04.020,2020-04-27
small mass of the lung,PROCESS_OF,Patients,32335053,10.1016/j.ajog.2020.04.014,2020-04-27
Screening for malignant neoplasm of lung,AFFECTS,Evaluation,32335053,10.1016/j.ajog.2020.04.014,2020-04-27
Pneumonia,PROCESS_OF,Pregnant Women,32334979,10.1016/j.sapharm.2020.04.014,2020-04-27
Acute respiratory infections,NEG_PREDISPOSES,Spontaneous abortion,32334979,10.1016/j.sapharm.2020.04.014,2020-04-27
Acute respiratory infections,NEG_PREDISPOSES,Spontaneous Preterm Birth,32334979,10.1016/j.sapharm.2020.04.014,2020-04-27
Acute Cerebrovascular Accidents,PROCESS_OF,Patients,32334905,10.1016/j.canrad.2020.04.002,2020-04-27
Symptoms,PROCESS_OF,Patients,32334904,10.1016/j.ajic.2020.03.018,2020-04-27
Present,PROCESS_OF,Staff,32334904,10.1016/j.ajic.2020.03.018,2020-04-27
Detection,TREATS,Patients,32334904,10.1016/j.ajic.2020.03.018,2020-04-27
Fatigue,ISA,Malaise,32334884,10.1016/j.eururo.2020.04.018,2020-04-27
Epidemic,ISA,Disease Outbreaks,32334884,10.1016/j.eururo.2020.04.018,2020-04-27
Coughing,PROCESS_OF,Patients,32334646,10.1016/S2213-8587(20)30152-2,2020-04-27
Fever,PROCESS_OF,Patients,32334646,10.1016/S2213-8587(20)30152-2,2020-04-27
Headache,PROCESS_OF,Patients,32334646,10.1016/S2213-8587(20)30152-2,2020-04-27
severe Breathlessness,PROCESS_OF,Patients,32334646,10.1016/S2213-8587(20)30152-2,2020-04-27
Complication,PROCESS_OF,Patients,32334535,10.1186/s10194-020-01106-5,2020-04-27
Diabetes,PROCESS_OF,Patients,32334535,10.1186/s10194-020-01106-5,2020-04-27
Diabetes,PROCESS_OF,Patients,32334535,10.1186/s10194-020-01106-5,2020-04-27
Ibuprofen,ISA,Pharmaceutical Preparations,32334502,10.2174/1567202617666200425205122,2020-04-27
Ibuprofen,PREDISPOSES,Coronavirus Infections,32334502,10.2174/1567202617666200425205122,2020-04-27
inhibitors,ISA,Pharmaceutical Preparations,32334502,10.2174/1567202617666200425205122,2020-04-27
Infected,PROCESS_OF,Patients,32334502,10.2174/1567202617666200425205122,2020-04-27
Headache,PROCESS_OF,Patients,32334502,10.2174/1567202617666200425205122,2020-04-27
Ibuprofen,TREATS,Headache,32334502,10.2174/1567202617666200425205122,2020-04-27
inhibitors,TREATS,Headache,32334502,10.2174/1567202617666200425205122,2020-04-27
Virion,PART_OF,Family,32334422,10.1039/d0lc00304b,2020-04-26
Antiviral Therapy,USES,"FRAP1 protein, human",32334422,10.1039/d0lc00304b,2020-04-26
Reporting,TREATS,Patients,32334409,10.1016/j.ajp.2020.102076,2020-04-26
Disease,PROCESS_OF,Homo sapiens,32334409,10.1016/j.ajp.2020.102076,2020-04-26
Base Sequence,PART_OF,Pathogenic organism,32334409,10.1016/j.ajp.2020.102076,2020-04-26
Anxiety,PROCESS_OF,Woman,32334395,10.1016/j.dsx.2020.04.018,2020-04-26
Anxiety,PROCESS_OF,Persons,32334395,10.1016/j.dsx.2020.04.018,2020-04-26
Psychosocial procedure,PREVENTS,Anxiety,32334395,10.1016/j.dsx.2020.04.018,2020-04-26
Diabetes Mellitus,COEXISTS_WITH,Pneumonia,32334392,10.1016/j.dsx.2020.04.015,2020-04-26
Diabetes Mellitus,PROCESS_OF,Patients,32334392,10.1016/j.dsx.2020.04.015,2020-04-26
Poor outcome,PROCESS_OF,Patients,32334392,10.1016/j.dsx.2020.04.015,2020-04-26
Poor outcome,COEXISTS_WITH,Diabetes Mellitus,32334392,10.1016/j.dsx.2020.04.015,2020-04-26
Nutritional status,COEXISTS_WITH,Coronavirus Infections,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Selenium,AFFECTS,Viral Respiratory Tract Infection,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Trace Elements,AFFECTS,Viral Respiratory Tract Infection,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Zinc,AFFECTS,Viral Respiratory Tract Infection,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Nutraceuticals,AFFECTS,Immune System Processes,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Probiotics,ASSOCIATED_WITH,Virus Diseases,32334323,10.1016/j.breast.2020.04.006,2020-04-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32334207,10.1016/j.scitotenv.2020.138394,2020-04-26
diagnostic procedure,AFFECTS,Patients,32334207,10.1016/j.scitotenv.2020.138394,2020-04-26
Quantitative PCR analysis,METHOD_OF,Quick Test for Liver Function,32334164,10.1016/j.scitotenv.2020.138820,2020-04-26
Laboratory Procedures,USES,CD40LG wt Allele,32334164,10.1016/j.scitotenv.2020.138820,2020-04-26
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32334164,10.1016/j.scitotenv.2020.138820,2020-04-26
Coughing,ISA,Symptoms,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Fever,ISA,Symptoms,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Malaise,ISA,Symptoms,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Pharmaceutical Preparations,TREATS,Disease,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Vaccines,TREATS,Disease,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Pharmaceutical Preparations,TREATS,Protection,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Health Promotion,USES,Pharmaceutical Preparations,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Health Promotion,USES,Pharmaceutical Preparations,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
Pharmaceutical Preparations,TREATS,Infection,32334162,10.1016/j.scitotenv.2020.138835,2020-04-26
India,ISA,Country,32334159,10.1016/j.scitotenv.2020.138813,2020-04-26
China,ISA,Country,32334158,10.1016/j.scitotenv.2020.138810,2020-04-26
Italy,ISA,Country,32334158,10.1016/j.scitotenv.2020.138810,2020-04-26
Spain,ISA,Country,32334158,10.1016/j.scitotenv.2020.138810,2020-04-26
United States,ISA,Country,32334158,10.1016/j.scitotenv.2020.138810,2020-04-26
Decision,PROCESS_OF,Maker (occupation),32334157,10.1016/j.scitotenv.2020.138762,2020-04-26
Eye mask,USES,Filters,32334118,10.1016/j.ijid.2020.04.041,2020-04-26
Eye mask,USES,Filters,32334118,10.1016/j.ijid.2020.04.041,2020-04-26
Eye mask,USES,Filters,32334118,10.1016/j.ijid.2020.04.041,2020-04-26
Fog,AFFECTS,Coronavirus Infections,32334118,10.1016/j.ijid.2020.04.041,2020-04-26
IMPACT gene,PART_OF,Population Group,32334116,10.1016/j.ijid.2020.04.042,2020-04-26
psychological distress,PROCESS_OF,general population,32334062,10.1016/j.bbi.2020.04.046,2020-04-26
Distress,PREDISPOSES,Viral respiratory infection,32334062,10.1016/j.bbi.2020.04.046,2020-04-26
PDPN gene,CAUSES,Thrombosis,32333993,10.1016/j.resp.2020.103443,2020-04-26
DNA Repair,CAUSES,Premature Menopause,32333993,10.1016/j.resp.2020.103443,2020-04-26
Brain-Derived Neurotrophic Factor,ASSOCIATED_WITH,Mental disorders,32333993,10.1016/j.resp.2020.103443,2020-04-26
Aubergine,ASSOCIATED_WITH,Mercury Poisoning,32333993,10.1016/j.resp.2020.103443,2020-04-26
Inhibin A,TREATS,Premature Birth,32333993,10.1016/j.resp.2020.103443,2020-04-26
External Canal,LOCATION_OF,Adenoid Cystic Carcinoma,32333993,10.1016/j.resp.2020.103443,2020-04-26
Predisposition -- attribute,ASSOCIATED_WITH,Acute viral disease,32333961,10.1016/j.jpainsymman.2020.04.017,2020-04-26
High altitude (physical force),AFFECTS,Acute viral disease,32333961,10.1016/j.jpainsymman.2020.04.017,2020-04-26
Epithelium,LOCATION_OF,SARS coronavirus,32333961,10.1016/j.jpainsymman.2020.04.017,2020-04-26
Epithelium,PART_OF,Lung,32333961,10.1016/j.jpainsymman.2020.04.017,2020-04-26
Virus,INTERACTS_WITH,SARS coronavirus,32333961,10.1016/j.jpainsymman.2020.04.017,2020-04-26
Coronavirus Infections,ISA,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Disease,PROCESS_OF,Patients,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,ISA,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32333860,10.1016/j.cca.2020.04.020,2020-04-26
"Lung Diseases, Interstitial",PROCESS_OF,Patients,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Uncertainty,COEXISTS_WITH,Adverse reaction to drug,32333860,10.1016/j.cca.2020.04.020,2020-04-26
"Lung Diseases, Interstitial",PROCESS_OF,Patients,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,ISA,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,ISA,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
"Lung Diseases, Interstitial",COEXISTS_WITH,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
"Lung Diseases, Interstitial",COEXISTS_WITH(SPEC),Coronavirus Infections,32333860,10.1016/j.cca.2020.04.020,2020-04-26
"Lung Diseases, Interstitial",PROCESS_OF,Patients,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,ISA,Disease,32333860,10.1016/j.cca.2020.04.020,2020-04-26
Coronavirus Infections,AFFECTS,Immune response,32333850,10.1016/j.athoracsur.2020.04.009,2020-04-26
Immune response,PROCESS_OF,Patients,32333850,10.1016/j.athoracsur.2020.04.009,2020-04-26
Procalcitonin measurement,MEASURES,Daily,32333850,10.1016/j.athoracsur.2020.04.009,2020-04-26
Severe disorder,PROCESS_OF,Patients,32333850,10.1016/j.athoracsur.2020.04.009,2020-04-26
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32333849,10.1016/j.athoracsur.2020.04.008,2020-04-26
Conservative Treatment,TREATS,Mediastinal Emphysema,32333849,10.1016/j.athoracsur.2020.04.008,2020-04-26
Conservative Treatment,TREATS,Subcutaneous Emphysema,32333849,10.1016/j.athoracsur.2020.04.008,2020-04-26
Conservative Treatment,TREATS,patient condition,32333849,10.1016/j.athoracsur.2020.04.008,2020-04-26
Critical Illness,PROCESS_OF,Patients,32333836,10.1016/j.cell.2020.04.004,2020-04-26
Severe Acute Respiratory Syndrome,CAUSES,Cessation of life,32333818,10.15252/emmm.202012465,2020-04-26
"ACE2 protein, human",AFFECTS,Growth,32333818,10.15252/emmm.202012465,2020-04-26
"ACE2 protein, human",PART_OF,soluble,32333818,10.15252/emmm.202012465,2020-04-26
ACE2 gene,PART_OF,soluble,32333818,10.15252/emmm.202012465,2020-04-26
,PART_OF,House mice,32333818,10.15252/emmm.202012465,2020-04-26
Organoids,PART_OF,Blood Vessel,32333818,10.15252/emmm.202012465,2020-04-26
Organoids,PART_OF,Kidney,32333818,10.15252/emmm.202012465,2020-04-26
ACE2 gene,DISRUPTS,Organoids,32333818,10.15252/emmm.202012465,2020-04-26
ACE2 gene,DISRUPTS,Organoids,32333818,10.15252/emmm.202012465,2020-04-26
ACE2 gene,PART_OF,soluble,32333818,10.15252/emmm.202012465,2020-04-26
ACE2 gene,PART_OF,soluble,32333818,10.15252/emmm.202012465,2020-04-26
Therapeutic Intervention,USES,,32333757,10.1093/jamia/ocaa073,2020-04-26
Diabetes,PREDISPOSES,Dehydration,32333644,10.1111/1751-7915.13586,2020-04-26
Diabetes,PREDISPOSES,Hyperglycemia,32333644,10.1111/1751-7915.13586,2020-04-26
Diabetes,PREDISPOSES,Hypoglycemia,32333644,10.1111/1751-7915.13586,2020-04-26
Diabetes,PREDISPOSES,Severe disorder,32333644,10.1111/1751-7915.13586,2020-04-26
Dehydration,COEXISTS_WITH,Diabetes,32333644,10.1111/1751-7915.13586,2020-04-26
Diabetic Ketoacidosis,COEXISTS_WITH,Diabetes,32333644,10.1111/1751-7915.13586,2020-04-26
starvation acidosis,COEXISTS_WITH,Diabetes,32333644,10.1111/1751-7915.13586,2020-04-26
Hyperosmolar Hyperglycemic State,COEXISTS_WITH,Diabetes,32333644,10.1111/1751-7915.13586,2020-04-26
Diabetes,PROCESS_OF,Muslim population group,32333644,10.1111/1751-7915.13586,2020-04-26
Oligonucleotide Primers,INTERACTS_WITH,"RNA, Viral",32333619,10.1002/hed.26200,2020-04-26
Coughing,ISA,"Signs and Symptoms, Respiratory",32333601,10.1093/ibd/izaa085,2020-04-26
Symptoms,PROCESS_OF,Health Personnel,32333601,10.1093/ibd/izaa085,2020-04-26
Inflammation,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
Intestines,LOCATION_OF,Inflammation,32333581,10.3233/CH-209003,2020-04-26
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
Intestines,LOCATION_OF,"PRSS2 protein, human",32333581,10.3233/CH-209003,2020-04-26
Intestines,LOCATION_OF,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
Inflammation,PROCESS_OF,Animal Model,32333581,10.3233/CH-209003,2020-04-26
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
Epithelial Cells,LOCATION_OF,RNA Sequence,32333581,10.3233/CH-209003,2020-04-26
Epithelial Cells,PART_OF,Intestines,32333581,10.3233/CH-209003,2020-04-26
ileum,LOCATION_OF,TMPRSS2 gene,32333581,10.3233/CH-209003,2020-04-26
T-Lymphocyte,PART_OF,Lamina Propria,32333581,10.3233/CH-209003,2020-04-26
Mucous Membrane,LOCATION_OF,TMPRSS2 gene,32333581,10.3233/CH-209003,2020-04-26
Mucous Membrane,LOCATION_OF,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
Steroids,COEXISTS_WITH,TMPRSS2 gene,32333581,10.3233/CH-209003,2020-04-26
Steroids,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
Steroids,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
ustekinumab,COEXISTS_WITH,TMPRSS2 gene,32333581,10.3233/CH-209003,2020-04-26
ustekinumab,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
ustekinumab,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
vedolizumab,COEXISTS_WITH,TMPRSS2 gene,32333581,10.3233/CH-209003,2020-04-26
vedolizumab,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
vedolizumab,COEXISTS_WITH,ACE2 gene,32333581,10.3233/CH-209003,2020-04-26
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
ACE2 gene,ASSOCIATED_WITH,Inflammation,32333581,10.3233/CH-209003,2020-04-26
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32333581,10.3233/CH-209003,2020-04-26
Physical Examination,USES,Ultrasonography,32333552,10.3233/JPD-202072,2020-04-26
Mesentery,LOCATION_OF,Arteries,32333552,10.3233/JPD-202072,2020-04-26
Organ,LOCATION_OF,Infarction,32333552,10.3233/JPD-202072,2020-04-26
Deep Brain Stimulation,TREATS,Crisis,32333544,10.4269/ajtmh.20-0280,2020-04-26
Challenge,TREATS,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Epilepsy,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Obsessive-Compulsive Disorder,ISA,Disease,32333544,10.4269/ajtmh.20-0280,2020-04-26
Parkinson Disease,ISA,Movement Disorders,32333544,10.4269/ajtmh.20-0280,2020-04-26
Parkinson Disease,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Epilepsy,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Obsessive-Compulsive Disorder,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Worse,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Generalized dystonia,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Status dystonicus,PROCESS_OF,Patients,32333544,10.4269/ajtmh.20-0280,2020-04-26
Telephone consultation,METHOD_OF,Deep Brain Stimulation,32333544,10.4269/ajtmh.20-0280,2020-04-26
pulse generators,USES,Implants,32333544,10.4269/ajtmh.20-0280,2020-04-26
Disease,PROCESS_OF,Patients,32333518,10.1111/odi.13368,2020-04-26
Coronavirus Infections,ISA,Disease,32333518,10.1111/odi.13368,2020-04-26
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32333518,10.1111/odi.13368,2020-04-26
Coronavirus Infections,ISA,Disease,32333518,10.1111/odi.13368,2020-04-26
Lung finding,PROCESS_OF,Patients,32333518,10.1111/odi.13368,2020-04-26
Lung,PART_OF,Caucasoid Race,32333518,10.1111/odi.13368,2020-04-26
Lung,LOCATION_OF,Ultrasonography,32333518,10.1111/odi.13368,2020-04-26
Lung,LOCATION_OF,Ultrasonography,32333518,10.1111/odi.13368,2020-04-26
interstitial,LOCATION_OF,Syndrome,32333518,10.1111/odi.13368,2020-04-26
Chest radiograph,DIAGNOSES,Syndrome,32333518,10.1111/odi.13368,2020-04-26
Lung,LOCATION_OF,Ultrasonography,32333518,10.1111/odi.13368,2020-04-26
Lung,LOCATION_OF,Ultrasonography,32333518,10.1111/odi.13368,2020-04-26
Coronavirus Infections,ISA,Disease,32333518,10.1111/odi.13368,2020-04-26
SARS coronavirus,INTERACTS_WITH,Coronavirus Infections,32333437,10.1111/jocs.14580,2020-04-26
Severe Acute Respiratory Syndrome,AFFECTS,Neurological observations,32333437,10.1111/jocs.14580,2020-04-26
Middle East Respiratory Syndrome,AFFECTS,Neurological observations,32333437,10.1111/jocs.14580,2020-04-26
"Spike Glycoprotein, Coronavirus",INTERACTS_WITH,angiotensin converting enzyme 2,32333437,10.1111/jocs.14580,2020-04-26
Neurons,LOCATION_OF,receptor,32333437,10.1111/jocs.14580,2020-04-26
Endothelial Cells,LOCATION_OF,receptor,32333437,10.1111/jocs.14580,2020-04-26
Coronavirus Infections,ISA,Disease,32333437,10.1111/jocs.14580,2020-04-26
Critical Illness,PROCESS_OF,Patients,32333398,10.1111/bph.15082,2020-04-26
10 - 19,PROCESS_OF,Patients,32333398,10.1111/bph.15082,2020-04-26
Plain chest X-ray,DIAGNOSES,"Pneumonia, Interstitial",32333398,10.1111/bph.15082,2020-04-26
Critical Illness,PROCESS_OF,Patients,32333398,10.1111/bph.15082,2020-04-26
Binding Sites,PART_OF,Cell surface,32333293,10.1007/s10549-020-05644-z,2020-04-26
ACE2 gene,CONVERTS_TO,Peptides,32333293,10.1007/s10549-020-05644-z,2020-04-26
ACE2 gene,CONVERTS_TO,ACE gene,32333293,10.1007/s10549-020-05644-z,2020-04-26
angiotensin II,INTERACTS_WITH,Peptides,32333293,10.1007/s10549-020-05644-z,2020-04-26
Peptides,STIMULATES,receptor,32333293,10.1007/s10549-020-05644-z,2020-04-26
receptor,STIMULATES,MAS1 gene,32333293,10.1007/s10549-020-05644-z,2020-04-26
ACE2 gene,CONVERTS_TO,Peptides,32333293,10.1007/s10549-020-05644-z,2020-04-26
ACE2 gene,PART_OF,Homo sapiens,32333293,10.1007/s10549-020-05644-z,2020-04-26
Imbalance,PROCESS_OF,Patients,32333293,10.1007/s10549-020-05644-z,2020-04-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32333285,10.1007/s00467-020-04555-x,2020-04-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32333285,10.1007/s00467-020-04555-x,2020-04-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32333285,10.1007/s00467-020-04555-x,2020-04-26
Malignant neoplasm of breast,PROCESS_OF,Patients,32333285,10.1007/s00467-020-04555-x,2020-04-26
Kidney Failure,PROCESS_OF,Child,32333248,10.1007/s12519-020-00362-4,2020-04-26
Prophylactic treatment,TREATS,Child,32333243,10.1007/s11524-020-00438-6,2020-04-26
Experience,PROCESS_OF,Child,32333243,10.1007/s11524-020-00438-6,2020-04-26
Prophylactic treatment,TREATS,Child,32333243,10.1007/s11524-020-00438-6,2020-04-26
Seafood,AFFECTS,Communicable Diseases,32333196,10.1007/s12032-020-01376-8,2020-04-26
Epithelial Cells,PART_OF,Patients,32333196,10.1007/s12032-020-01376-8,2020-04-26
Family,INTERACTS_WITH,Homo sapiens,32333196,10.1007/s12032-020-01376-8,2020-04-26
Coronavirus Infections,PROCESS_OF,Family,32333196,10.1007/s12032-020-01376-8,2020-04-26
Infected,PROCESS_OF,Patients,32333196,10.1007/s12032-020-01376-8,2020-04-26
Infected,PROCESS_OF,Patients,32333196,10.1007/s12032-020-01376-8,2020-04-26
China,ISA,Country,32333196,10.1007/s12032-020-01376-8,2020-04-26
Antineoplastic Agents,CAUSES,Lymphopenia,32333185,10.1007/s10865-020-00157-y,2020-04-26
Antineoplastic Agents,CAUSES,Lymphopenia,32333185,10.1007/s10865-020-00157-y,2020-04-26
Antineoplastic Agents,TREATS,Cancer Patient,32333185,10.1007/s10865-020-00157-y,2020-04-26
Uncertainty,PROCESS_OF,Patients,32332856,10.1038/s41375-020-0836-7,2020-04-26
Mechanical Ventilator,TREATS,Patients,32332856,10.1038/s41375-020-0836-7,2020-04-26
Solid carcinoma,PROCESS_OF,Persons,32332765,10.1038/s41467-020-16048-4,2020-04-26
Hematologic Neoplasms,PROCESS_OF,Health Personnel,32332765,10.1038/s41467-020-16048-4,2020-04-26
Hematologic Neoplasms,PROCESS_OF,Persons,32332765,10.1038/s41467-020-16048-4,2020-04-26
Severe disorder,PROCESS_OF,Health Personnel,32332765,10.1038/s41467-020-16048-4,2020-04-26
risk factors,PROCESS_OF,Persons,32332765,10.1038/s41467-020-16048-4,2020-04-26
Hematologic Neoplasms,PROCESS_OF,Persons,32332765,10.1038/s41467-020-16048-4,2020-04-26
Immunoglobulin G Subclass 1 Measurement,USES,Immune Globulin (Human),32332516,10.1097/JCMA.0000000000000334,2020-04-26
SARS coronavirus,PROCESS_OF,Mus,32332516,10.1097/JCMA.0000000000000334,2020-04-26
SARS coronavirus,PROCESS_OF,Mus,32332516,10.1097/JCMA.0000000000000334,2020-04-26
Eye,LOCATION_OF,Present,32332481,10.1097/PHH.0000000000001189,2020-04-26
Coronavirus Infections,PROCESS_OF,Homo sapiens,32332481,10.1097/PHH.0000000000001189,2020-04-26
Viral Conjunctivitis,ISA,Conjunctivitis,32332481,10.1097/PHH.0000000000001189,2020-04-26
Eye,PART_OF,Ophthalmologist (occupation),32332481,10.1097/PHH.0000000000001189,2020-04-26
Nose,PART_OF,Ophthalmologist (occupation),32332481,10.1097/PHH.0000000000001189,2020-04-26
Infected,PROCESS_OF,Persons,32332347,10.1097/01.NAJ.0000662740.96299.0e,2020-04-26
Telemedicine,ISA,Intervention regimes,32332319,10.1097/RLU.0000000000003068,2020-04-26
Anxiety,PROCESS_OF,Patients,32332319,10.1097/RLU.0000000000003068,2020-04-26
Evaluation,TREATS,Hypertensive disease,32332319,10.1097/RLU.0000000000003068,2020-04-26
Blood pressure--Measurement,METHOD_OF,Evaluation,32332319,10.1097/RLU.0000000000003068,2020-04-26
Diarrhea,PROCESS_OF,Male population group,32332218,10.2106/JBJS.20.00577,2020-04-26
Fever,PROCESS_OF,Male population group,32332218,10.2106/JBJS.20.00577,2020-04-26
Vertigo,PROCESS_OF,Male population group,32332218,10.2106/JBJS.20.00577,2020-04-26
Lung,LOCATION_OF,Ground Glass Opacity,32332218,10.2106/JBJS.20.00577,2020-04-26
Lung,LOCATION_OF,Ground Glass Opacity,32332218,10.2106/JBJS.20.00577,2020-04-26
Uptake,PROCESS_OF,Lung,32332218,10.2106/JBJS.20.00577,2020-04-26
FDG-Positron Emission Tomography and Computed Tomography Scan,DIAGNOSES,Ground Glass Opacity,32332218,10.2106/JBJS.20.00577,2020-04-26
Lung,LOCATION_OF,Ground Glass Opacity,32332218,10.2106/JBJS.20.00577,2020-04-26
Study,MEASURES,geographic distribution,32332154,10.1136/medethics-2020-106250,2020-04-26
Medical Examination,USES,Videofluoroscopy swallow,32331982,10.1016/j.jmii.2020.03.032,2020-04-26
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32331919,10.1016/j.jvir.2020.03.021,2020-04-26
Coronavirus Infections,PROCESS_OF,Patients,32331919,10.1016/j.jvir.2020.03.021,2020-04-26
Disease,PROCESS_OF,Patients,32331919,10.1016/j.jvir.2020.03.021,2020-04-26
Practice Experience,PROCESS_OF,Persons,32331845,10.1016/j.jagp.2020.04.010,2020-04-26
Alzheimer's Disease,PROCESS_OF,Persons,32331805,10.1016/j.clinthera.2020.04.003,2020-04-26
Dementia,PROCESS_OF,Persons,32331805,10.1016/j.clinthera.2020.04.003,2020-04-26
Persons,LOCATION_OF,IMPACT gene,32331805,10.1016/j.clinthera.2020.04.003,2020-04-26
Care setting,LOCATION_OF,Diagnosis,32331805,10.1016/j.clinthera.2020.04.003,2020-04-26
Severe Acute Respiratory Syndrome,ISA,Disease,32331519,10.1186/s12941-020-00358-y,2020-04-26
Severe Acute Respiratory Syndrome,ISA,Infection,32331519,10.1186/s12941-020-00358-y,2020-04-26
Infection,PROCESS_OF,World,32331519,10.1186/s12941-020-00358-y,2020-04-26
Virus Diseases,PROCESS_OF,World,32331519,10.1186/s12941-020-00358-y,2020-04-26
Severe Acute Respiratory Syndrome,ISA,Infection,32331519,10.1186/s12941-020-00358-y,2020-04-26
Communicable Diseases,PROCESS_OF,Clinician,32331516,10.1186/s12889-020-08671-z,2020-04-26
Pneumonia,COEXISTS_WITH,Chief complaint (finding),32331516,10.1186/s12889-020-08671-z,2020-04-26
psychological distress,PROCESS_OF,Dental Staff,32331344,10.3390/ijerph17082893,2020-04-26
Pandemics,ISA,Disease Outbreaks,32331344,10.3390/ijerph17082893,2020-04-26
psychological distress,PROCESS_OF,Dental Staff,32331344,10.3390/ijerph17082893,2020-04-26
Hand Hygiene,PROCESS_OF,student,32331343,10.3390/ijms21082948,2020-04-26
Disease,COEXISTS_WITH,Comorbidity,32331291,10.3390/s20082376,2020-04-26
SARS coronavirus,PROCESS_OF,Male population group,32331291,10.3390/s20082376,2020-04-26
"M Protein, multiple myeloma",INHIBITS,angiotensin converting enzyme 2,32331291,10.3390/s20082376,2020-04-26
"M Protein, multiple myeloma",PART_OF,Virus,32331291,10.3390/s20082376,2020-04-26
Adipose tissue,LOCATION_OF,angiotensin converting enzyme 2,32331291,10.3390/s20082376,2020-04-26
Kidney,LOCATION_OF,angiotensin converting enzyme 2,32331291,10.3390/s20082376,2020-04-26
angiotensin converting enzyme 2,PART_OF,Myocardium,32331291,10.3390/s20082376,2020-04-26
Testosterone,TREATS,Venous Thromboembolism,32331291,10.3390/s20082376,2020-04-26
Venous Thromboembolism,PROCESS_OF,Male population group,32331291,10.3390/s20082376,2020-04-26
Venous Thromboembolism,PROCESS_OF,Patients,32331291,10.3390/s20082376,2020-04-26
Gonadal Steroid Hormones,INTERACTS_WITH,angiotensin converting enzyme 2,32331291,10.3390/s20082376,2020-04-26
Vitamin D Deficiency,PROCESS_OF,Elderly man,32331291,10.3390/s20082376,2020-04-26
Coronavirus Infections,ISA,Disease,32331255,10.3390/pathogens9040307,2020-04-26
ACE2 gene,INTERACTS_WITH,"M Protein, multiple myeloma",32331246,10.3390/jcm9041196,2020-04-26
ACE2 gene,PART_OF,Homo sapiens,32331246,10.3390/jcm9041196,2020-04-26
Antimalarials,TREATS,Disease,32331246,10.3390/jcm9041196,2020-04-26
Plasma,LOCATION_OF,Antibodies,32331246,10.3390/jcm9041196,2020-04-26
Disease,CAUSES,Health Care,32331217,10.3390/jcm9041191,2020-04-26
Perception,PROCESS_OF,Adult,32331217,10.3390/jcm9041191,2020-04-26
Coronavirus Infections,CAUSES,Disease,32331217,10.3390/jcm9041191,2020-04-26
Perception,PROCESS_OF,Population Group,32331217,10.3390/jcm9041191,2020-04-26
Perception,PROCESS_OF(SPEC),Hispanics,32331217,10.3390/jcm9041191,2020-04-26
Hispanics,ISA,Population Group,32331217,10.3390/jcm9041191,2020-04-26
Neoplasm Metastasis,CAUSES,"Respiratory Distress Syndrome, Adult",32330970,10.1055/s-0040-1709993,2020-04-25
Continuous Positive Airway Pressure,TREATS,Hypoxemia,32330970,10.1055/s-0040-1709993,2020-04-25
Continuous Positive Airway Pressure,TREATS,consideration,32330970,10.1055/s-0040-1709993,2020-04-25
Respiratory Failure,PROCESS_OF,Patients,32330970,10.1055/s-0040-1709993,2020-04-25
Coronavirus Infections,PREDISPOSES,Premature Birth,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Premature Obstetric Labor,COEXISTS_WITH,Coronavirus Infections,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Coronavirus Infections,PROCESS_OF,Patients,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Magnesium Sulfate,TREATS,Premature Obstetric Labor,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Magnesium Sulfate,TREATS,Streptococcus agalactiae,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Steroid therapy,TREATS,Premature Obstetric Labor,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Steroid therapy,TREATS,Streptococcus agalactiae,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Antibiotic Prophylaxis,TREATS,Premature Obstetric Labor,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Antibiotic Prophylaxis,TREATS,Streptococcus agalactiae,32330858,10.1016/j.oraloncology.2020.104684,2020-04-25
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32330817,10.1016/j.jcrc.2020.04.004,2020-04-25
Surgeon,ISA,Health Personnel,32330817,10.1016/j.jcrc.2020.04.004,2020-04-25
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32330817,10.1016/j.jcrc.2020.04.004,2020-04-25
Mucous Membrane,LOCATION_OF,Squamous cell carcinoma,32330817,10.1016/j.jcrc.2020.04.004,2020-04-25
Critical Illness,PROCESS_OF,Patients,32330703,10.1016/j.scitotenv.2020.138761,2020-04-25
Antibiotics,ADMINISTERED_TO,Patients,32330703,10.1016/j.scitotenv.2020.138761,2020-04-25
Antibiotics,TREATS,Pneumonia,32330703,10.1016/j.scitotenv.2020.138761,2020-04-25
Hypertensive disease,PROCESS_OF,Patients,32330703,10.1016/j.scitotenv.2020.138761,2020-04-25
Epidemic,ISA,Disease Outbreaks,32330593,10.1016/j.bbi.2020.04.049,2020-04-25
physical symptom,PROCESS_OF,general population,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Headache,ISA,Symptoms,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Comorbidity,PROCESS_OF,Participant,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Symptoms,PROCESS_OF,Participant,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Stress,COEXISTS_WITH,physical symptom,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Stress,COEXISTS_WITH,physical symptom,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
physical symptom,PROCESS_OF,Health Personnel,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Mean score,COEXISTS_WITH,physical symptom,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
physical symptom,PROCESS_OF,Health Personnel,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Intervention regimes,TREATS,Health Personnel,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Intervention regimes,TREATS(INFER),physical symptom,32330565,10.1016/j.cgh.2020.04.032,2020-04-25
Triage,TREATS,Fourth Stage of Labor,32330561,10.1016/j.tmaid.2020.101692,2020-04-25
Cardiovascular care,TREATS,Coronary Arteriosclerosis,32330531,10.1016/j.urology.2020.04.059,2020-04-25
Acute myocardial infarction,PROCESS_OF,Patients,32330531,10.1016/j.urology.2020.04.059,2020-04-25
acute care,TREATS,Enthesitis-Related Arthritis,32330531,10.1016/j.urology.2020.04.059,2020-04-25
Myocardium,LOCATION_OF,Traumatic injury,32330531,10.1016/j.urology.2020.04.059,2020-04-25
Acute myocardial infarction,PROCESS_OF,Patients,32330531,10.1016/j.urology.2020.04.059,2020-04-25
ST segment elevation myocardial infarction,PROCESS_OF,Patients,32330531,10.1016/j.urology.2020.04.059,2020-04-25
Telemedicine,METHOD_OF,Consultation,32330521,10.1016/j.jclinepi.2020.04.016,2020-04-25
In-person encounter,ADMINISTERED_TO,Persons,32330521,10.1016/j.jclinepi.2020.04.016,2020-04-25
Telemedicine,METHOD_OF,Consultation,32330521,10.1016/j.jclinepi.2020.04.016,2020-04-25
Consultation,TREATS,Patients,32330521,10.1016/j.jclinepi.2020.04.016,2020-04-25
Consultation,TREATS,Physicians,32330521,10.1016/j.jclinepi.2020.04.016,2020-04-25
Care setting,LOCATION_OF,research,32330458,10.1016/S2468-2667(20)30089-X,2020-04-25
Mild disorder,PROCESS_OF,Persons,32330437,10.1016/j.bjid.2020.04.003,2020-04-25
Oropharyngeal swab,PART_OF,Nose,32330414,10.1016/j.cell.2020.04.011,2020-04-25
Oropharyngeal,LOCATION_OF,Assay,32330414,10.1016/j.cell.2020.04.011,2020-04-25
brazilian,PROCESS_OF,Population Group,32330414,10.1016/j.cell.2020.04.011,2020-04-25
Genome,PRODUCES,Transcript,32330410,10.3201/eid2608.200219,2020-04-25
Coronavirus Infections,ISA,Disease,32330356,10.1111/ajt.15944,2020-04-25
Severe clinical course,PROCESS_OF,Recipient,32330351,10.1111/ajt.15948,2020-04-25
Diagnosis,DIAGNOSES,Symptoms,32330351,10.1111/ajt.15948,2020-04-25
Disease Progression,PROCESS_OF,Recipient,32330351,10.1111/ajt.15948,2020-04-25
contextual factors,PROCESS_OF,Outpatients,32330351,10.1111/ajt.15948,2020-04-25
Infected,PROCESS_OF,Patients,32330343,10.1111/ajt.15941,2020-04-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Recipient,32330340,10.1111/jdv.16530,2020-04-25
Fever,ISA,Symptoms,32330340,10.1111/jdv.16530,2020-04-25
Blood specimen,LOCATION_OF,Nucleic Acids,32330332,10.1111/pai.13267,2020-04-25
Respiratory sample,LOCATION_OF,Nucleic Acids,32330332,10.1111/pai.13267,2020-04-25
Pneumonia,PROCESS_OF,Patients,32330313,10.1002/jmv.25927,2020-04-25
Coronavirus Infections,CAUSES,Pneumonia,32330313,10.1002/jmv.25927,2020-04-25
Severe Acute Respiratory Syndrome,CAUSES,Disease,32330313,10.1002/jmv.25927,2020-04-25
Disease,COEXISTS_WITH,"Infant, Premature",32330313,10.1002/jmv.25927,2020-04-25
Disease,PROCESS_OF,Child,32330313,10.1002/jmv.25927,2020-04-25
Asymptomatic,PROCESS_OF,Child,32330313,10.1002/jmv.25927,2020-04-25
Infection,PROCESS_OF,Child,32330313,10.1002/jmv.25927,2020-04-25
Virus,PROCESS_OF,Child,32330313,10.1002/jmv.25927,2020-04-25
Asymptomatic,PROCESS_OF,Child,32330313,10.1002/jmv.25927,2020-04-25
Coronavirus Infections,ISA,Disease,32330305,10.1002/jmv.25936,2020-04-25
Coronavirus Infections,ISA,Disease,32330305,10.1002/jmv.25936,2020-04-25
Coronavirus Infections,PROCESS_OF,Pregnant Women,32330305,10.1002/jmv.25936,2020-04-25
Coronavirus Infections,ISA,Disease,32330305,10.1002/jmv.25936,2020-04-25
Anesthesia procedures,METHOD_OF,Cesarean section,32330305,10.1002/jmv.25936,2020-04-25
Antiviral Therapy,PRECEDES,Operative Surgical Procedures,32330305,10.1002/jmv.25936,2020-04-25
Coronavirus Infections,ISA,Disease,32330305,10.1002/jmv.25936,2020-04-25
Coronavirus Infections,PROCESS_OF,Pregnant Women,32330305,10.1002/jmv.25936,2020-04-25
Vertical Disease Transmission,NEG_CAUSES,intrauterine infection,32330305,10.1002/jmv.25936,2020-04-25
Asymptomatic Diseases,PROCESS_OF,Pregnant Women,32330305,10.1002/jmv.25936,2020-04-25
Patients,LOCATION_OF,Urine,32330303,10.1002/jmv.25930,2020-04-25
Patients,LOCATION_OF,Blood specimen,32330303,10.1002/jmv.25930,2020-04-25
Patients,LOCATION_OF,Oropharyngeal swab,32330303,10.1002/jmv.25930,2020-04-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32330303,10.1002/jmv.25930,2020-04-25
Coronavirus Infections,ISA,Disease,32330299,10.1002/jmv.25939,2020-04-25
Betacoronavirus,CAUSES,Disease,32330299,10.1002/jmv.25939,2020-04-25
Betacoronavirus,CAUSES(SPEC),Coronavirus Infections,32330299,10.1002/jmv.25939,2020-04-25
Nucleic Acid Amplification Tests,METHOD_OF,Diagnosis,32330299,10.1002/jmv.25939,2020-04-25
Coronavirus Infections,ISA,diseases/diagnoses,32330299,10.1002/jmv.25939,2020-04-25
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32330299,10.1002/jmv.25939,2020-04-25
diseases/diagnoses,PROCESS_OF,Patients,32330299,10.1002/jmv.25939,2020-04-25
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32330299,10.1002/jmv.25939,2020-04-25
Virus,PROCESS_OF,Patients,32330299,10.1002/jmv.25939,2020-04-25
Laboratory Procedures,ISA,diagnostic procedure,32330299,10.1002/jmv.25939,2020-04-25
Coronavirus Infections,ISA,Disease,32330299,10.1002/jmv.25939,2020-04-25
Asymptomatic,PROCESS_OF,Population Group,32330297,10.1002/jmv.25929,2020-04-25
Asymptomatic,PROCESS_OF,Patients,32330297,10.1002/jmv.25929,2020-04-25
Quarantine,TREATS,Asymptomatic,32330297,10.1002/jmv.25929,2020-04-25
Isolation procedure,TREATS,Asymptomatic,32330297,10.1002/jmv.25929,2020-04-25
Asymptomatic,PROCESS_OF,Patients,32330297,10.1002/jmv.25929,2020-04-25
Disease,PROCESS_OF,World,32330295,10.1002/jmv.25934,2020-04-25
Coronavirus Infections,ISA,Disease,32330295,10.1002/jmv.25934,2020-04-25
Coronavirus Infections,PROCESS_OF(SPEC),World,32330295,10.1002/jmv.25934,2020-04-25
anti-IgM,ISA,Antibodies,32330288,10.1111/bjh.16687,2020-04-25
"Analyzer, device",USES,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",32330288,10.1111/bjh.16687,2020-04-25
"Analyzers, Laboratory, Immunoassay, Chemiluminescent",ISA,"Analyzer, device",32330288,10.1111/bjh.16687,2020-04-25
anti-IgM,ISA,Antibodies,32330288,10.1111/bjh.16687,2020-04-25
"Analyzer, device",USES,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",32330288,10.1111/bjh.16687,2020-04-25
"Analyzers, Laboratory, Immunoassay, Chemiluminescent",ISA,"Analyzer, device",32330288,10.1111/bjh.16687,2020-04-25
hereditary anemia,PROCESS_OF,Patients,32330287,10.1002/ijgo.13182,2020-04-25
"Anemia, Sickle Cell",PROCESS_OF,Patients,32330287,10.1002/ijgo.13182,2020-04-25
Pyruvate Kinase,ISA,Red cell enzyme,32330287,10.1002/ijgo.13182,2020-04-25
Disease,CAUSES,Bacterial Infections,32330287,10.1002/ijgo.13182,2020-04-25
Antibiotic therapy,PREDISPOSES,Bacterial Infections,32330287,10.1002/ijgo.13182,2020-04-25
"Anemia, Sickle Cell",PROCESS_OF,Child,32330287,10.1002/ijgo.13182,2020-04-25
Bone Marrow Transplantation,TREATS,Disease,32330287,10.1002/ijgo.13182,2020-04-25
Complication,PROCESS_OF,Patients,32330287,10.1002/ijgo.13182,2020-04-25
Pregnancy,PROCESS_OF,Adult,32330285,10.4414/smw.2020.20261,2020-04-25
Gravidity,NEG_PROCESS_OF,Adult,32330285,10.4414/smw.2020.20261,2020-04-25
radiologist,TREATS,Patients,32330277,10.1001/jamanetworkopen.2020.8857,2020-04-25
chloroquine phosphate,TREATS,Patients,32330274,10.1093/jtm/taaa062,2020-04-25
Critical Illness,PROCESS_OF,Patients,32330274,10.1093/jtm/taaa062,2020-04-25
Azithromycin,ADMINISTERED_TO,Patients,32330274,10.1093/jtm/taaa062,2020-04-25
Oseltamivir,ADMINISTERED_TO,Patients,32330274,10.1093/jtm/taaa062,2020-04-25
Day 4,NEG_PROCESS_OF,Patients,32330274,10.1093/jtm/taaa062,2020-04-25
Pneumonia,PROCESS_OF,Patients,32330208,10.1371/journal.pone.0232391,2020-04-25
Asymptomatic,PROCESS_OF,Patients,32330208,10.1371/journal.pone.0232391,2020-04-25
DNA Sequence,PART_OF,Virus,32330124,10.1371/journal.pbio.3000730,2020-04-25
skill,PROCESS_OF,member,32330115,10.2196/19128,2020-04-25
Persons,LOCATION_OF,IMPACT gene,32330112,10.3201/eid2608.201016,2020-04-25
Family illness,PROCESS_OF,Persons,32330112,10.3201/eid2608.201016,2020-04-25
Disease,PROCESS_OF,Physicians,32330078,10.1177/2380084420924385,2020-04-25
Coronavirus Infections,ISA,Disease,32330078,10.1177/2380084420924385,2020-04-25
Coronavirus Infections,PROCESS_OF(SPEC),Physicians,32330078,10.1177/2380084420924385,2020-04-25
Asymptomatic,PROCESS_OF,Households,32330078,10.1177/2380084420924385,2020-04-25
Disease,PROCESS_OF,Health Personnel,32330078,10.1177/2380084420924385,2020-04-25
Coronavirus Infections,ISA,Disease,32330078,10.1177/2380084420924385,2020-04-25
Coronavirus Infections,PROCESS_OF(SPEC),Health Personnel,32330078,10.1177/2380084420924385,2020-04-25
Infected,PROCESS_OF,Households,32330078,10.1177/2380084420924385,2020-04-25
Oral health,TREATS,Protection,32330073,10.1513/AnnalsATS.202004-327FR,2020-04-25
Coughing,ISA,Symptoms,32330073,10.1513/AnnalsATS.202004-327FR,2020-04-25
Fever,ISA,Symptoms,32330073,10.1513/AnnalsATS.202004-327FR,2020-04-25
Lung Injury,PROCESS_OF,Patients,32329978,10.20452/pamw.15312,2020-04-25
Acetazolamide,TREATS,High altitude pulmonary edema,32329978,10.20452/pamw.15312,2020-04-25
Vasodilator Agents,TREATS,High altitude pulmonary edema,32329978,10.20452/pamw.15312,2020-04-25
Acetazolamide,TREATS,Acute mountain sickness,32329978,10.20452/pamw.15312,2020-04-25
Acetazolamide,TREATS,High altitude pulmonary edema,32329978,10.20452/pamw.15312,2020-04-25
Vasodilator Agents,TREATS,Acute mountain sickness,32329978,10.20452/pamw.15312,2020-04-25
Vasodilator Agents,TREATS,High altitude pulmonary edema,32329978,10.20452/pamw.15312,2020-04-25
Severe disorder,PROCESS_OF,Patients,32329971,10.1056/NEJMoa2008457,2020-04-25
Fever,ISA,Symptoms,32329958,10.1002/hed.26195,2020-04-25
Severe Acute Respiratory Syndrome,ISA,Symptoms,32329958,10.1002/hed.26195,2020-04-25
Eye,LOCATION_OF,Coronavirus Infections,32329948,10.1002/hed.26193,2020-04-25
Disease,PROCESS_OF,Patients,32329948,10.1002/hed.26193,2020-04-25
Malignant neoplasm of mouth,ISA,Disease,32329948,10.1002/hed.26193,2020-04-25
Malignant neoplasm of mouth,PROCESS_OF,Patients,32329948,10.1002/hed.26193,2020-04-25
Malignant neoplasm of mouth,PROCESS_OF,Patients,32329948,10.1002/hed.26193,2020-04-25
Malignant neoplasm of mouth,PROCESS_OF,Patients,32329948,10.1002/hed.26193,2020-04-25
hospital visit,TREATS,Patients,32329948,10.1002/hed.26193,2020-04-25
IMPACT gene,ASSOCIATED_WITH,Neoplasms,32329930,10.1111/all.14336,2020-04-25
Allergen Immunotherapy,AFFECTS,Immediate hypersensitivity,32329926,10.1002/hed.26191,2020-04-25
Postoperative Care,METHOD_OF,Tracheostomy procedure,32329924,10.1002/hed.26187,2020-04-25
Phasis,INTERACTS_WITH,Clinician,32329924,10.1002/hed.26187,2020-04-25
Malignant Neoplasms,AFFECTS,Birth,32329923,10.1002/hed.26189,2020-04-25
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32329923,10.1002/hed.26189,2020-04-25
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32329922,10.1002/hed.26192,2020-04-25
Elective Surgical Procedures,TREATS,Patients,32329921,10.1002/mus.26903,2020-04-25
Spinal Muscular Atrophy,PROCESS_OF,Patients,32329920,10.1002/mus.26902,2020-04-25
Spinal Muscular Atrophy,PROCESS_OF,Patients,32329920,10.1002/mus.26902,2020-04-25
Therapeutic procedure,TREATS,Spinal Muscular Atrophy,32329920,10.1002/mus.26902,2020-04-25
Spinal Muscular Atrophy,PROCESS_OF,Patients,32329920,10.1002/mus.26902,2020-04-25
Elective Surgical Procedures,NEG_ISA,Therapeutic procedure,32329920,10.1002/mus.26902,2020-04-25
consideration,PREDISPOSES,exposure (to) disease,32329920,10.1002/mus.26902,2020-04-25
Telemedicine,ADMINISTERED_TO,Patients,32329881,10.26355/eurrev_202004_20875,2020-04-25
Complementary therapies,USES,eculizumab,32329880,10.26355/eurrev_202004_20874,2020-04-25
eculizumab,TREATS,Patients,32329880,10.26355/eurrev_202004_20874,2020-04-25
Anticoagulant therapy,TREATS,Patients,32329880,10.26355/eurrev_202004_20874,2020-04-25
Antiviral Therapy,TREATS,Patients,32329880,10.26355/eurrev_202004_20874,2020-04-25
eculizumab,TREATS,Patients,32329880,10.26355/eurrev_202004_20874,2020-04-25
Coronavirus Infections,ISA,Disease,32329878,10.26355/eurrev_202004_20872,2020-04-25
Infected,PROCESS_OF,Persons,32329878,10.26355/eurrev_202004_20872,2020-04-25
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32329756,10.1172/jci.insight.138999,2020-04-25
neutrophil,PRODUCES,Chromatin,32329659,10.1089/tmj.2020.0105,2020-04-25
Lung,LOCATION_OF,Inflammation,32329659,10.1089/tmj.2020.0105,2020-04-25
Lung,LOCATION_OF,Thrombosis,32329659,10.1089/tmj.2020.0105,2020-04-25
Lung,PART_OF,Patients,32329659,10.1089/tmj.2020.0105,2020-04-25
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32329659,10.1089/tmj.2020.0105,2020-04-25
Patients,LOCATION_OF,Serum,32329659,10.1089/tmj.2020.0105,2020-04-25
Cell-Free DNA,COEXISTS_WITH,DNA,32329659,10.1089/tmj.2020.0105,2020-04-25
Mechanical ventilation,ADMINISTERED_TO,hospitalized patients,32329659,10.1089/tmj.2020.0105,2020-04-25
Persons,LOCATION_OF,Serum,32329659,10.1089/tmj.2020.0105,2020-04-25
Surgical face mask,USES,disposable,32329593,10.23736/S1973-9087.20.06331-5,2020-04-25
Sunlight,ISA,Light,32329593,10.23736/S1973-9087.20.06331-5,2020-04-25
Primary Respiratory Mechanism,PROCESS_OF,Physicians,32329589,10.23736/S1973-9087.20.06292-9,2020-04-25
Body tissue,LOCATION_OF,Disease,32329563,10.1111/liv.14465,2020-04-25
Organ,LOCATION_OF,Disease,32329563,10.1111/liv.14465,2020-04-25
Chronic liver disease,OCCURS_IN,Persons,32329548,10.1111/dar.13076,2020-04-25
Chronic liver disease,OCCURS_IN,Patients,32329548,10.1111/dar.13076,2020-04-25
"CD69 protein, human",ASSOCIATED_WITH,Liver damage,32329548,10.1111/dar.13076,2020-04-25
"CD69 protein, human",ASSOCIATED_WITH,Coronavirus Infections,32329548,10.1111/dar.13076,2020-04-25
Adult,ISA,Persons,32329548,10.1111/dar.13076,2020-04-25
Alcohol consumption,AFFECTS,Movement,32329522,10.1002/jmv.25885,2020-04-25
Alcohol consumption,AFFECTS,responsibility,32329522,10.1002/jmv.25885,2020-04-25
Disease,PROCESS_OF,victim,32329520,10.1111/bph.15072,2020-04-25
lopinavir / Ritonavir,ISA,Pharmaceutical Preparations,32329432,10.4269/ajtmh.20-0302,2020-04-25
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32329432,10.4269/ajtmh.20-0302,2020-04-25
Pharmaceutical Preparations,TREATS,Patients,32329432,10.4269/ajtmh.20-0302,2020-04-25
Coronavirus Infections,ISA,Disease,32329419,10.1080/07391102.2020.1760136,2020-04-25
Immune,PROCESS_OF,Persons,32329419,10.1080/07391102.2020.1760136,2020-04-25
Chloroquine,ISA,Antimalarials,32329408,10.1080/07391102.2020.1760137,2020-04-25
Diabetes,PROCESS_OF,Patients,32329408,10.1080/07391102.2020.1760137,2020-04-25
Disease,PROCESS_OF,Patients,32329408,10.1080/07391102.2020.1760137,2020-04-25
Hydroxychloroquine,ISA,Antimalarials,32329408,10.1080/07391102.2020.1760137,2020-04-25
Hypertensive disease,PROCESS_OF,Patients,32329408,10.1080/07391102.2020.1760137,2020-04-25
cardiac problem,PROCESS_OF,Patients,32329408,10.1080/07391102.2020.1760137,2020-04-25
Coronavirus Infections,ISA,Disease,32329337,10.1021/acsnano.0c03252,2020-04-25
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32329337,10.1021/acsnano.0c03252,2020-04-25
Gouge,TREATS,Disease,32329337,10.1021/acsnano.0c03252,2020-04-25
Gouge,TREATS(SPEC),Coronavirus Infections,32329337,10.1021/acsnano.0c03252,2020-04-25
Coronavirus Infections,ISA,Disease,32329337,10.1021/acsnano.0c03252,2020-04-25
Masks,USES,Textiles,32329276,10.7507/1001-5515.202002050,2020-04-25
Masks,USES,Textiles,32329276,10.7507/1001-5515.202002050,2020-04-25
Masks,USES,Textiles,32329276,10.7507/1001-5515.202002050,2020-04-25
China,ISA,Country,32329246,10.1111/jth.14872,2020-04-25
United Kingdom,ISA,Country,32329246,10.1111/jth.14872,2020-04-25
United States,ISA,Country,32329246,10.1111/jth.14872,2020-04-25
Critical Illness,PROCESS_OF,Patients,32329231,10.1111/jth.14871,2020-04-25
Respiration,PROCESS_OF,Patients,32329231,10.1111/jth.14871,2020-04-25
Lung,LOCATION_OF,cytokine,32329231,10.1111/jth.14871,2020-04-25
cytokine,INTERACTS_WITH,Leukocytes,32329231,10.1111/jth.14871,2020-04-25
Parenchyma,PART_OF,Lung,32329231,10.1111/jth.14871,2020-04-25
Lung,PART_OF,Patients,32329231,10.1111/jth.14871,2020-04-25
Epithelium,LOCATION_OF,Plasminogen Activator Inhibitor 1,32329231,10.1111/jth.14871,2020-04-25
Epithelium,PART_OF,Lung,32329231,10.1111/jth.14871,2020-04-25
Endothelial Cells,LOCATION_OF,Plasminogen Activator Inhibitor 1,32329231,10.1111/jth.14871,2020-04-25
Alveolar Epithelial Cells,LOCATION_OF,Thromboplastin,32329231,10.1111/jth.14871,2020-04-25
Alveolar Epithelial Cells,PART_OF,Endothelium,32329231,10.1111/jth.14871,2020-04-25
Fibrin,AUGMENTS,Fibrinolysis,32329231,10.1111/jth.14871,2020-04-25
Lung,LOCATION_OF,Fibrin,32329231,10.1111/jth.14871,2020-04-25
alteplase,ISA,Fibrinolytic Agents,32329231,10.1111/jth.14871,2020-04-25
alteplase,TREATS,"Respiratory Distress Syndrome, Adult",32329231,10.1111/jth.14871,2020-04-25
alteplase,ASSOCIATED_WITH,Croupous bronchitis,32329231,10.1111/jth.14871,2020-04-25
Critical Illness,PROCESS_OF,Patients,32329231,10.1111/jth.14871,2020-04-25
Plasminogen Activator,TREATS,patient condition,32329231,10.1111/jth.14871,2020-04-25
Alveolar ventilation function,PROCESS_OF,Patients,32329231,10.1111/jth.14871,2020-04-25
Antiviral Agents,TREATS,Patients,32329222,10.1002/alr.22592,2020-04-25
Antiviral Agents,TREATS(INFER),Syndrome,32329222,10.1002/alr.22592,2020-04-25
Syndrome,PROCESS_OF,Patients,32329222,10.1002/alr.22592,2020-04-25
Patients,LOCATION_OF,Plasma specimen,32329222,10.1002/alr.22592,2020-04-25
apixaban,COEXISTS_WITH,rivaroxaban,32329222,10.1002/alr.22592,2020-04-25
apixaban,COEXISTS_WITH,edoxaban,32329222,10.1002/alr.22592,2020-04-25
dabigatran,COEXISTS_WITH,rivaroxaban,32329222,10.1002/alr.22592,2020-04-25
dabigatran,COEXISTS_WITH,edoxaban,32329222,10.1002/alr.22592,2020-04-25
Antiviral Agents,TREATS,Patients,32329222,10.1002/alr.22592,2020-04-25
Hospitalization,TREATS,Patients,32329222,10.1002/alr.22592,2020-04-25
oral anticoagulants,compared_with,Antiviral Agents,32329222,10.1002/alr.22592,2020-04-25
oral anticoagulants,same_as,Antiviral Agents,32329222,10.1002/alr.22592,2020-04-25
Hospital admission,TREATS,Patients,32329159,10.1002/anie.202004721,2020-04-25
Hospital admission,TREATS,Disease Progression,32329159,10.1002/anie.202004721,2020-04-25
Respiratory Failure,COEXISTS_WITH,Diabetes,32329159,10.1002/anie.202004721,2020-04-25
ambulatory care services,AFFECTS,Anosmia,32329159,10.1002/anie.202004721,2020-04-25
Diagnosis,DIAGNOSES,Hypersensitivity,32329046,10.33588/rn.7009.2020155,2020-04-25
Complication,PREDISPOSES,Multiple Sclerosis,32329045,10.33588/rn.7009.2020173,2020-04-25
Therapeutic procedure,PREDISPOSES,Complication,32329045,10.33588/rn.7009.2020173,2020-04-25
"CD69 protein, human",ASSOCIATED_WITH,Multiple Sclerosis,32329045,10.33588/rn.7009.2020173,2020-04-25
"CD69 protein, human",ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32329045,10.33588/rn.7009.2020173,2020-04-25
Multiple Sclerosis,PROCESS_OF,Patients,32329045,10.33588/rn.7009.2020173,2020-04-25
Neurologists,TREATS,Patients,32329045,10.33588/rn.7009.2020173,2020-04-25
follow-up,TREATS,Patients,32329045,10.33588/rn.7009.2020173,2020-04-25
follow-up,TREATS(INFER),Multiple Sclerosis,32329045,10.33588/rn.7009.2020173,2020-04-25
Author,DIAGNOSES,Multiple Sclerosis,32329045,10.33588/rn.7009.2020173,2020-04-25
Epilepsy,PROCESS_OF,Persons,32329044,10.33588/rn.7009.2020179,2020-04-25
Epilepsy,PROCESS_OF,Patients,32329044,10.33588/rn.7009.2020179,2020-04-25
Coronavirus Infections,PROCESS_OF,Family,32329026,10.1007/s40618-020-01261-1,2020-04-25
Tropism,PROCESS_OF,Family,32329026,10.1007/s40618-020-01261-1,2020-04-25
Human coronavirus,COEXISTS_WITH,Genus: Coronavirus,32329026,10.1007/s40618-020-01261-1,2020-04-25
Encephalitis,ISA,Encephalopathies,32329026,10.1007/s40618-020-01261-1,2020-04-25
Neurologic Symptoms,PROCESS_OF,Patients,32329026,10.1007/s40618-020-01261-1,2020-04-25
Fever,COEXISTS_WITH,Possible,32329014,10.1007/s12630-020-01673-w,2020-04-25
Myalgia,COEXISTS_WITH,Possible,32329014,10.1007/s12630-020-01673-w,2020-04-25
Urine - SpecimenType,PART_OF,Voluntary Workers,32329014,10.1007/s12630-020-01673-w,2020-04-25
Ageusia,COEXISTS_WITH,Possible,32329014,10.1007/s12630-020-01673-w,2020-04-25
Urine - SpecimenType,ASSOCIATED_WITH,Present,32329014,10.1007/s12630-020-01673-w,2020-04-25
Coronavirus Infections,ISA,Disease,32328954,10.1007/s12016-020-08792-8,2020-04-25
Anesthesiologist,ISA,Health Personnel,32328954,10.1007/s12016-020-08792-8,2020-04-25
Malignant Neoplasms,PROCESS_OF,Patients,32328916,10.1007/s12250-020-00223-4,2020-04-25
Diabetes Mellitus,PROCESS_OF,Patients,32328916,10.1007/s12250-020-00223-4,2020-04-25
Heart Diseases,PROCESS_OF,Patients,32328916,10.1007/s12250-020-00223-4,2020-04-25
Hypertensive disease,PROCESS_OF,Patients,32328916,10.1007/s12250-020-00223-4,2020-04-25
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32328916,10.1007/s12250-020-00223-4,2020-04-25
Cessation of life,AFFECTS,Virus,32328916,10.1007/s12250-020-00223-4,2020-04-25
Immune,PROCESS_OF,Disabled Persons,32328850,10.1007/s10096-020-03897-6,2020-04-25
Challenge,TREATS,Disabled Persons,32328850,10.1007/s10096-020-03897-6,2020-04-25
Respiratory System,AFFECTS,Pregnancy,32328761,10.1007/s00330-020-06862-1,2020-04-25
Infection,AFFECTS,Pregnancy,32328761,10.1007/s00330-020-06862-1,2020-04-25
angiotensin converting enzyme 2,AUGMENTS,Pregnancy,32328761,10.1007/s00330-020-06862-1,2020-04-25
Pharmaceutical Preparations,TREATS,Pregnant Women,32328761,10.1007/s00330-020-06862-1,2020-04-25
Retinal Diseases,PROCESS_OF,Patients,32328595,10.3290/j.qi.a44392,2020-04-25
Retinal Diseases,PROCESS_OF,Patients,32328595,10.3290/j.qi.a44392,2020-04-25
Retinal Diseases,PROCESS_OF,Patients,32328595,10.3290/j.qi.a44392,2020-04-25
Treatment Protocols,ADMINISTERED_TO,Ophthalmologist (occupation),32328595,10.3290/j.qi.a44392,2020-04-25
consideration,PROCESS_OF,Healthy Volunteers,32328588,10.1016/j.jaccas.2020.04.009,2020-04-25
upper respiratory symptom,PROCESS_OF,Woman,32328533,10.1186/s41256-020-00146-3,2020-04-25
Adrenal Cortex Hormones,ASSOCIATED_WITH,Symptoms,32328533,10.1186/s41256-020-00146-3,2020-04-25
Colchicine,ASSOCIATED_WITH,Symptoms,32328533,10.1186/s41256-020-00146-3,2020-04-25
Hydroxychloroquine,ASSOCIATED_WITH,Symptoms,32328533,10.1186/s41256-020-00146-3,2020-04-25
Coronavirus Infections,ISA,Disease,32328510,10.1016/j.artd.2020.04.014,2020-04-25
Coronavirus Infections,ISA,Disease,32328510,10.1016/j.artd.2020.04.014,2020-04-25
Vaccines,TREATS,Lethal,32328378,10.7759/cureus.7366,2020-04-25
Coronavirus Infections,ISA,Disease,32328378,10.7759/cureus.7366,2020-04-25
Coronavirus Infections,CAUSES,Evaluation,32328369,10.7759/cureus.7357,2020-04-25
SARS coronavirus,ISA,Genus: Coronavirus,32328369,10.7759/cureus.7357,2020-04-25
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,32328369,10.7759/cureus.7357,2020-04-25
RNA Viruses,PROCESS_OF,Homo sapiens,32328364,10.7759/cureus.7352,2020-04-25
Disease,PROCESS_OF,Homo sapiens,32328364,10.7759/cureus.7352,2020-04-25
Evaluation,TREATS,Patients,32328364,10.7759/cureus.7352,2020-04-25
Neoplasm Metastasis,PROCESS_OF,Health Personnel,32328364,10.7759/cureus.7352,2020-04-25
Encephalopathies,NEG_ISA,Symptoms,32328363,10.7759/cureus.7351,2020-04-25
Encephalopathies,PROCESS_OF,Patients,32328363,10.7759/cureus.7351,2020-04-25
Coronavirus Infections,PROCESS_OF,Patients,32328363,10.7759/cureus.7351,2020-04-25
Throat swab sample,PART_OF,Woman,32328285,10.1186/s40545-020-00210-w,2020-04-25
Anal swab,PART_OF,Woman,32328285,10.1186/s40545-020-00210-w,2020-04-25
Health care facility,LOCATION_OF,Services,32328220,10.1007/s40617-020-00430-1,2020-04-25
Hospitals,ISA,Health care facility,32328220,10.1007/s40617-020-00430-1,2020-04-25
Hospitals,LOCATION_OF(SPEC),Services,32328220,10.1007/s40617-020-00430-1,2020-04-25
Suspensions,AFFECTS,Birth,32328219,10.1007/s40617-020-00431-0,2020-04-25
analysts,INTERACTS_WITH,parent,32328206,10.1016/j.jchirv.2020.04.011,2020-04-25
Peritoneum,LOCATION_OF,Pharmacotherapy,32328170,10.1186/s13037-020-00243-9,2020-04-25
Peritoneum,LOCATION_OF,Neoplasm Metastasis,32328170,10.1186/s13037-020-00243-9,2020-04-25
Peritoneum,LOCATION_OF(SPEC),Systemic Chemotherapy,32328170,10.1186/s13037-020-00243-9,2020-04-25
ovarian,LOCATION_OF,Carcinomatosis,32328170,10.1186/s13037-020-00243-9,2020-04-25
Systemic Chemotherapy,ISA,Pharmacotherapy,32328170,10.1186/s13037-020-00243-9,2020-04-25
Systemic Chemotherapy,NEG_TREATS,Neoplasm Metastasis,32328170,10.1186/s13037-020-00243-9,2020-04-25
Peritoneum,LOCATION_OF,Pharmacotherapy,32328170,10.1186/s13037-020-00243-9,2020-04-25
Aorta,LOCATION_OF,Syndrome,32327922,10.1177/1178646920910159,2020-04-25
Emergency operation,TREATS,Syndrome,32327922,10.1177/1178646920910159,2020-04-25
Critical Illness,PROCESS_OF,Patients,32327922,10.1177/1178646920910159,2020-04-25
Operative Surgical Procedures,TREATS,Patients,32327922,10.1177/1178646920910159,2020-04-25
Operative Surgical Procedures,TREATS(INFER),Critical Illness,32327922,10.1177/1178646920910159,2020-04-25
Hydrogen,NEG_INTERACTS_WITH,Genome,32327904,10.3748/wjg.v26.i14.1546,2020-04-25
"Balance, device",USES,Niacin,32327904,10.3748/wjg.v26.i14.1546,2020-04-25
Infected,PROCESS_OF,Patients,32327901,10.1016/j.chaos.2020.109828,2020-04-25
Gastrointestinal symptom,PROCESS_OF,Patients,32327901,10.1016/j.chaos.2020.109828,2020-04-25
Fecal occult blood test,ISA,Diagnostic tests,32327901,10.1016/j.chaos.2020.109828,2020-04-25
Communicable Diseases,PROCESS_OF,Social Networks,32327870,10.1016/j.recesp.2020.04.006,2020-04-25
Anticoagulant therapy,TREATS,Thrombus,32327866,10.1002/mma.6345,2020-04-25
Epithelial Cells,PART_OF,Intestines,32327757,10.1038/s41591-020-0877-5,2020-04-25
Epithelial Cells,LOCATION_OF,Genes,32327757,10.1038/s41591-020-0877-5,2020-04-25
Epithelial Cells,PART_OF,Nose,32327757,10.1038/s41591-020-0877-5,2020-04-25
Genes,PART_OF,Epithelial Cells,32327757,10.1038/s41591-020-0877-5,2020-04-25
"Immunity, Innate",ASSOCIATED_WITH,Virus Diseases,32327757,10.1038/s41591-020-0877-5,2020-04-25
Interleukin-6,AFFECTS,soluble,32327608,10.1073/pnas.2004978117,2020-04-25
T-Lymphocyte,PRODUCES,Interleukin-6,32327608,10.1073/pnas.2004978117,2020-04-25
Interleukin-6,AFFECTS,Immune,32327608,10.1073/pnas.2004978117,2020-04-25
Immune,COEXISTS_WITH,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Rheumatoid Arthritis,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Rheumatoid Arthritis,ISA,Rheumatism,32327608,10.1073/pnas.2004978117,2020-04-25
Angiolymphoid hyperplasia,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Takayasu Arteritis,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Giant Cell Arteritis,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Adult-Onset Still Disease,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Adult-Onset Still Disease,ISA,Rheumatism,32327608,10.1073/pnas.2004978117,2020-04-25
Cytokine release syndrome,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Juvenile arthritis,ISA,Disease,32327608,10.1073/pnas.2004978117,2020-04-25
Juvenile arthritis,ISA,Rheumatism,32327608,10.1073/pnas.2004978117,2020-04-25
Epilepsy,AFFECTS,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Hospitalization,COEXISTS_WITH,Transection (procedure),32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,COEXISTS_WITH,Crisis,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Advice,ADMINISTERED_TO,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PREDISPOSES,Exacerbation,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,COEXISTS_WITH,Coronavirus Infections,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
Epilepsy,PROCESS_OF,Persons,32327448,10.1128/JCM.00798-20,2020-04-25
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32327397,10.1016/j.sapharm.2020.04.016,2020-04-25
intensive care unit,LOCATION_OF,Diagnosis,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Lung,LOCATION_OF,Ultrasonography,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Chest,LOCATION_OF,tomography,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Lung,LOCATION_OF,multiple pathologies,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Ultrasonography,DIAGNOSES,multiple pathologies,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Lung,LOCATION_OF,Ultrasonography,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Ward (environment),LOCATION_OF,Ultrasonography,32327306,10.1016/j.biologicals.2020.04.003,2020-04-25
Decision,PROCESS_OF,Animals,32327293,10.1016/j.arcmed.2020.04.006,2020-04-25
Decision,PROCESS_OF,Homo sapiens,32327293,10.1016/j.arcmed.2020.04.006,2020-04-25
Anti-Inflammatory Agents,AFFECTS,Immune response,32327245,10.1016/j.ajem.2020.04.051,2020-04-25
Anti-Inflammatory Agents,AFFECTS,Antioxidant Effect,32327245,10.1016/j.ajem.2020.04.051,2020-04-25
Ground Glass Opacity,PROCESS_OF,Patients,32327229,10.1016/j.crad.2020.04.001,2020-04-25
lobe,LOCATION_OF,Coronavirus Infections,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Ground Glass Opacity,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Pleural effusion disorder,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Present,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Thickened,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Halo sign,COEXISTS_WITH,Ground Glass Opacity,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Thickening of pleura,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Physical findings,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Infection,PROCESS_OF,Patients,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Chest CT,AFFECTS,Lymphopenia,32327218,10.1016/j.amjoto.2020.102491,2020-04-25
Telemedicine,TREATS,Present,32327202,10.1016/j.kint.2020.04.003,2020-04-25
Critical Illness,PROCESS_OF,Patients,32327003,10.1017/cem.2020.379,2020-04-25
Kidney damage,PROCESS_OF,Patients,32327003,10.1017/cem.2020.379,2020-04-25
Light Microscopy,METHOD_OF,Autopsy,32327003,10.1017/cem.2020.379,2020-04-25
Multiple Organ Failure,COEXISTS_WITH,Respiratory Failure,32327003,10.1017/cem.2020.379,2020-04-25
Epithelium,LOCATION_OF,Coronavirus Infections,32327003,10.1017/cem.2020.379,2020-04-25
Patients,LOCATION_OF,ACE2 gene,32327003,10.1017/cem.2020.379,2020-04-25
Virulence,AFFECTS,"Kidney Failure, Acute",32327003,10.1017/cem.2020.379,2020-04-25
Coronavirus Infections,ISA,Disease,32326943,10.1186/s12978-020-0900-9,2020-04-25
Disease,PREDISPOSES,Post-Traumatic Stress Disorder,32326943,10.1186/s12978-020-0900-9,2020-04-25
Influenza,PROCESS_OF,Hispanics,32326943,10.1186/s12978-020-0900-9,2020-04-25
Post-Traumatic Stress Disorder,ISA,Disease,32326943,10.1186/s12978-020-0900-9,2020-04-25
Coronavirus Infections,ISA,Disease,32326943,10.1186/s12978-020-0900-9,2020-04-25
Coronavirus Infections,PREDISPOSES(SPEC),Post-Traumatic Stress Disorder,32326943,10.1186/s12978-020-0900-9,2020-04-25
Coronavirus Infections,ISA,Disease,32326943,10.1186/s12978-020-0900-9,2020-04-25
Severe Acute Respiratory Syndrome,PREDISPOSES,Post-Traumatic Stress Disorder,32326943,10.1186/s12978-020-0900-9,2020-04-25
Infected,PROCESS_OF,Patients,32326943,10.1186/s12978-020-0900-9,2020-04-25
Acute Disease,PROCESS_OF,Health Personnel,32326943,10.1186/s12978-020-0900-9,2020-04-25
psychological distress,PROCESS_OF,Population Group,32326943,10.1186/s12978-020-0900-9,2020-04-25
Post-Traumatic Stress Disorder,PROCESS_OF,Persons,32326943,10.1186/s12978-020-0900-9,2020-04-25
Post-Traumatic Stress Disorder,AFFECTS,Neoplasm Metastasis,32326943,10.1186/s12978-020-0900-9,2020-04-25
Sexual Health,ISA,Reproduction,32326853,10.1080/01634372.2020.1758271,2020-04-25
Decreased Immunologic Activity [PE],PROCESS_OF,Persons,32326853,10.1080/01634372.2020.1758271,2020-04-25
Sexual Health,ISA,Reproduction,32326853,10.1080/01634372.2020.1758271,2020-04-25
Sexual Health,ISA,Reproduction,32326853,10.1080/01634372.2020.1758271,2020-04-25
Gender,ASSOCIATED_WITH,Disease,32326853,10.1080/01634372.2020.1758271,2020-04-25
Gender,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32326853,10.1080/01634372.2020.1758271,2020-04-25
Coronavirus Infections,ISA,Disease,32326853,10.1080/01634372.2020.1758271,2020-04-25
Coronavirus Infections,ISA,Disease,32326853,10.1080/01634372.2020.1758271,2020-04-25
Sexual Health,ASSOCIATED_WITH,Disease,32326853,10.1080/01634372.2020.1758271,2020-04-25
Sexual Health,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32326853,10.1080/01634372.2020.1758271,2020-04-25
Sexual Health,ISA,Reproduction,32326853,10.1080/01634372.2020.1758271,2020-04-25
Procedure on spinal cord (procedure),PREVENTS,Cross Infection,32326618,10.3390/ijerph17082731,2020-04-25
Vertebral column,LOCATION_OF,traumatic fracture,32326618,10.3390/ijerph17082731,2020-04-25
camostate-mesilate,ISA,Protease Inhibitors,32326512,10.3390/healthcare8020099,2020-04-25
Endopeptidases,TREATS,Severe Acute Respiratory Syndrome,32326512,10.3390/healthcare8020099,2020-04-25
"M Protein, multiple myeloma",TREATS,Severe Acute Respiratory Syndrome,32326512,10.3390/healthcare8020099,2020-04-25
Endopeptidases,TREATS,Coronavirus Infections,32326512,10.3390/healthcare8020099,2020-04-25
angiotensin converting enzyme 2,INTERACTS_WITH,"M Protein, multiple myeloma",32326512,10.3390/healthcare8020099,2020-04-25
Disease,AFFECTS,Intestinal Microbiome,32326426,10.3390/jcm9041126,2020-04-25
Intestines,PART_OF,Patients,32326426,10.3390/jcm9041126,2020-04-25
Sputum,LOCATION_OF,Air,32326343,10.3390/nano10040802,2020-04-25
Flavonoids,ISA,Agent,32326343,10.3390/nano10040802,2020-04-25
Health Personnel,LOCATION_OF,IMPACT gene,32325980,10.3390/pathogens9040301,2020-04-25
Patients,LOCATION_OF,IMPACT gene,32325980,10.3390/pathogens9040301,2020-04-25
Disease,PROCESS_OF,Homo sapiens,32325888,10.3390/ijerph17082821,2020-04-25
Coronavirus Infections,CAUSES,Disease,32325888,10.3390/ijerph17082821,2020-04-25
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32325888,10.3390/ijerph17082821,2020-04-25
Orthomyxoviridae,ISA,Virus,32325888,10.3390/ijerph17082821,2020-04-25
Patient observation,PREVENTS,Possible,32325888,10.3390/ijerph17082821,2020-04-25
Coronavirus Infections,ISA,Disease,32325767,10.3390/ijms21082839,2020-04-25
Dentist,ISA,Health Personnel,32325767,10.3390/ijms21082839,2020-04-25
Infected,PROCESS_OF,Patients,32325767,10.3390/ijms21082839,2020-04-25
Anxiety,PROCESS_OF,Dentist,32325767,10.3390/ijms21082839,2020-04-25
Coronavirus Infections,ISA,Disease,32325767,10.3390/ijms21082839,2020-04-25
Coronavirus Infections,ISA,Disease,32325767,10.3390/ijms21082839,2020-04-25
Anxiety,AFFECTS,Disease,32325767,10.3390/ijms21082839,2020-04-25
Anxiety,AFFECTS(SPEC),Coronavirus Infections,32325767,10.3390/ijms21082839,2020-04-25
Coronavirus Infections,ISA,Disease,32325767,10.3390/ijms21082839,2020-04-25
IMPACT gene,CAUSES,Anxiety,32325767,10.3390/ijms21082839,2020-04-25
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32325763,10.3390/ijerph17082801,2020-04-25
"Psychotherapy, Multiple",TREATS,Symptoms,32325763,10.3390/ijerph17082801,2020-04-25
RNA Viruses,CAUSES,Infection,32325763,10.3390/ijerph17082801,2020-04-25
Perception,PROCESS_OF,Health Personnel,32325710,10.3390/ijerph17082800,2020-04-25
Hand,LOCATION_OF,sanitizers,32325710,10.3390/ijerph17082800,2020-04-25
Coronavirus Infections,ISA,Disease,32325425,10.2196/18808,2020-04-24
Coronavirus Infections,ISA,Disease,32325425,10.2196/18808,2020-04-24
Fasting,PROCESS_OF,Social Networks,32325425,10.2196/18808,2020-04-24
Coronavirus Infections,PROCESS_OF,Social Networks,32325425,10.2196/18808,2020-04-24
Abnormal behavior,PROCESS_OF,Population Group,32325425,10.2196/18808,2020-04-24
Coronavirus Infections,ISA,Disease,32325425,10.2196/18808,2020-04-24
T-Lymphocyte,AFFECTS,Antiviral Response,32325386,10.1016/j.psychres.2020.112998,2020-04-24
Blood specimen,LOCATION_OF,"T-Cell Surface Glycoprotein CD4, human",32325386,10.1016/j.psychres.2020.112998,2020-04-24
"T-Cell Surface Glycoprotein CD4, human",DISRUPTS,patient condition,32325386,10.1016/j.psychres.2020.112998,2020-04-24
"T-Cell Surface Glycoprotein CD4, human",AUGMENTS,patient condition,32325386,10.1016/j.psychres.2020.112998,2020-04-24
Generalized Anxiety Disorder,AFFECTS,Visual Accommodation,32325282,10.1016/j.ejrad.2020.109009,2020-04-24
Patients,LOCATION_OF,Congenital anomaly of lung,32325276,10.1016/j.ijid.2020.04.031,2020-04-24
Duration,TREATS,Patients,32325276,10.1016/j.ijid.2020.04.031,2020-04-24
lobe,PART_OF,Lung,32325276,10.1016/j.ijid.2020.04.031,2020-04-24
lobe,PART_OF,Lung,32325276,10.1016/j.ijid.2020.04.031,2020-04-24
Province,ISA,Geographic Locations,32325252,10.1016/j.clim.2020.108427,2020-04-24
Province,ISA,Geographic Locations,32325252,10.1016/j.clim.2020.108427,2020-04-24
Province,ISA,Geographic Locations,32325252,10.1016/j.clim.2020.108427,2020-04-24
Province,ISA,Geographic Locations,32325252,10.1016/j.clim.2020.108427,2020-04-24
Virus,CAUSES,Disease,32325167,10.1016/j.jpainsymman.2020.04.015,2020-04-24
Symptom mild,PROCESS_OF,Child,32325167,10.1016/j.jpainsymman.2020.04.015,2020-04-24
Dyspnea,ISA,Symptoms,32325129,10.1016/j.jinf.2020.04.001,2020-04-24
Morphine,ISA,"Analgesics, Opioid",32325129,10.1016/j.jinf.2020.04.001,2020-04-24
Child,LOCATION_OF,cytokine,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Coronavirus Infections,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Serum,LOCATION_OF,cytokine,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Serum,LOCATION_OF,cytokine,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Patients,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Child,LOCATION_OF,Interleukin-10,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Serum,LOCATION_OF,Interleukin-10,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Bacterial Infections,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Pneumonia,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Interleukin-10,AFFECTS,Symptom mild,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Symptom mild,PROCESS_OF,Child,32325124,10.1016/j.drudis.2020.04.010,2020-04-24
Chloroquine,TREATS,Virus Diseases,32325098,10.1016/j.bbi.2020.04.048,2020-04-24
Hydroxychloroquine,ISA,Chloroquine,32325098,10.1016/j.bbi.2020.04.048,2020-04-24
Hydroxychloroquine,TREATS(SPEC),Virus Diseases,32325098,10.1016/j.bbi.2020.04.048,2020-04-24
Malaise,PREDISPOSES,psychological distress,32325096,10.1016/j.resuscitation.2020.04.022,2020-04-24
psychological distress,PROCESS_OF,Persons,32325096,10.1016/j.resuscitation.2020.04.022,2020-04-24
Italians,ISA,Population Group,32325096,10.1016/j.resuscitation.2020.04.022,2020-04-24
Diazooxonorleucine,AFFECTS,Birth,32325025,10.1016/j.immuni.2020.04.003,2020-04-24
TMPRSS2 gene,STIMULATES,ACE2 gene,32324985,10.1556/650.2020.31818,2020-04-24
Familial Hemophagocytic Lymphocytosis,PROCESS_OF,Veterinarian,32324968,10.1002/oby.22849,2020-04-24
Comorbidity,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
Diabetes,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
Chronic inflammation,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
Insulin Resistance,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
Overweight,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
Storm Syndrome,PROCESS_OF,Persons,32324963,10.1111/dth.13449,2020-04-24
"M Protein, multiple myeloma",INTERACTS_WITH,"Receptors, Cell Surface",32324898,10.1002/cpt.1866,2020-04-24
Hospitals,LOCATION_OF,Pharmacovigilance,32324879,10.1093/jtm/taaa064,2020-04-24
Adverse reaction to drug,COEXISTS_WITH,risk factors,32324879,10.1093/jtm/taaa064,2020-04-24
Adverse reaction to drug,PROCESS_OF,Patients,32324879,10.1093/jtm/taaa064,2020-04-24
Adverse reaction to drug,PROCESS_OF,Patients,32324879,10.1093/jtm/taaa064,2020-04-24
Disease,PREDISPOSES,Adverse reaction to drug,32324879,10.1093/jtm/taaa064,2020-04-24
Hospitals,LOCATION_OF,Analysis,32324879,10.1093/jtm/taaa064,2020-04-24
Adverse reaction to drug,PROCESS_OF,Patients,32324879,10.1093/jtm/taaa064,2020-04-24
Active monitoring,TREATS,World,32324879,10.1093/jtm/taaa064,2020-04-24
Detected (finding),PROCESS_OF,Patients,32324640,10.1097/ACM.0000000000003449,2020-04-24
Health Personnel,TREATS,Patients,32324640,10.1097/ACM.0000000000003449,2020-04-24
Experience,PROCESS_OF,Social Networks,32324618,10.1097/PHM.0000000000001452,2020-04-24
Coronavirus Infections,NEG_PROCESS_OF,Patients,32324595,10.1172/jci.insight.137799,2020-04-24
Frail,PROCESS_OF,Patients,32324595,10.1172/jci.insight.137799,2020-04-24
Laboratory Procedures,DIAGNOSES,patient condition,32324533,10.18433/jpps31069,2020-04-24
"CD45RO, human",PRODUCES,"T-Cell Surface Glycoprotein CD4, human",32324533,10.18433/jpps31069,2020-04-24
CD8-Positive T-Lymphocytes,PRODUCES,,32324533,10.18433/jpps31069,2020-04-24
CD4 Positive T Lymphocytes,PRODUCES,,32324533,10.18433/jpps31069,2020-04-24
Patients,LOCATION_OF,Interleukin-6,32324533,10.18433/jpps31069,2020-04-24
Patients,LOCATION_OF,Interleukin 2 Receptor,32324533,10.18433/jpps31069,2020-04-24
Patients,LOCATION_OF,Interleukin-10,32324533,10.18433/jpps31069,2020-04-24
Estrogens,NEG_PREDISPOSES,Adverse reactions,32324530,10.3201/eid2608.201274,2020-04-24
Coronavirus Infections,ISA,Disease,32324468,10.12968/bjon.2020.29.8.491,2020-04-24
Disease,PROCESS_OF,Persons,32324468,10.12968/bjon.2020.29.8.491,2020-04-24
Coronavirus Infections,ISA,Disease,32324468,10.12968/bjon.2020.29.8.491,2020-04-24
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32324468,10.12968/bjon.2020.29.8.491,2020-04-24
Hospital admission,ISA,Hospitalization,32324367,10.1556/650.2020.31816,2020-04-24
Hospital admission,ISA,Hospitalization,32324367,10.1556/650.2020.31816,2020-04-24
Virulence,PROCESS_OF,Persons,32324366,10.1556/650.2020.31813,2020-04-24
Cardiopulmonary Resuscitation,ISA,Interventional procedure,32324366,10.1556/650.2020.31813,2020-04-24
Cardiopulmonary Resuscitation,TREATS,Patients,32324366,10.1556/650.2020.31813,2020-04-24
Hemoperfusion,TREATS,Septic Shock,32324364,10.1556/650.2020.31809,2020-04-24
Extracorporeal Membrane Oxygenation,TREATS,Hypoxemia,32324364,10.1556/650.2020.31809,2020-04-24
Nitric Oxide,TREATS,Hypoxemia,32324364,10.1556/650.2020.31809,2020-04-24
Epoprostenol,TREATS,Hypoxemia,32324364,10.1556/650.2020.31809,2020-04-24
Multiple Organ Failure,ISA,Kidney Failure,32324364,10.1556/650.2020.31809,2020-04-24
Operative Surgical Procedures,ISA,Interventional procedure,32324363,10.1556/650.2020.31817,2020-04-24
Perioperative Care,TREATS,Patients,32324363,10.1556/650.2020.31817,2020-04-24
Arthritis,ISA,Autoimmune Diseases,32324362,10.1556/650.2020.31810,2020-04-24
Pharmaceutical Preparations,TREATS,Autoimmune Diseases,32324362,10.1556/650.2020.31810,2020-04-24
Pharmaceutical Preparations,TREATS,Malaria,32324362,10.1556/650.2020.31810,2020-04-24
Pharmaceutical Preparations,TREATS(SPEC),Arthritis,32324362,10.1556/650.2020.31810,2020-04-24
Pharmaceutical Preparations,TREATS(SPEC),"Lupus Erythematosus, Systemic",32324362,10.1556/650.2020.31810,2020-04-24
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32324362,10.1556/650.2020.31810,2020-04-24
Hydroxychloroquine,TREATS(SPEC),Autoimmune Diseases,32324362,10.1556/650.2020.31810,2020-04-24
Hydroxychloroquine,TREATS(SPEC),Malaria,32324362,10.1556/650.2020.31810,2020-04-24
"Lupus Erythematosus, Systemic",ISA,Autoimmune Diseases,32324362,10.1556/650.2020.31810,2020-04-24
intensive care,TREATS,Patients,32324361,10.1556/650.2020.31812,2020-04-24
Pharmaceutical Preparations,TREATS,Disease,32324360,10.1556/650.2020.31814,2020-04-24
Respiratory Failure,PROCESS_OF,Patients,32324359,10.1556/650.2020.31815,2020-04-24
Critical Illness,PROCESS_OF,Patients,32324359,10.1556/650.2020.31815,2020-04-24
lobe,LOCATION_OF,Ground Glass Opacity,32324359,10.1556/650.2020.31815,2020-04-24
lobe,PART_OF,Lung,32324359,10.1556/650.2020.31815,2020-04-24
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32324358,10.1556/650.2020.31806,2020-04-24
Critical Illness,PROCESS_OF,Patients,32324358,10.1556/650.2020.31806,2020-04-24
Intervention regimes,USES,Instrument - device,32324357,10.1556/650.2020.31808,2020-04-24
Pneumonia,PROCESS_OF,Patients,32324284,10.1111/ejh.13432,2020-04-24
Comorbidity,PROCESS_OF,Recipient,32324284,10.1111/ejh.13432,2020-04-24
Pneumonia,PROCESS_OF,Patients,32324284,10.1111/ejh.13432,2020-04-24
tocilizumab,PREVENTS,Decreased Immunologic Activity [PE],32324284,10.1111/ejh.13432,2020-04-24
Pneumonia,PROCESS_OF,Recipient,32324284,10.1111/ejh.13432,2020-04-24
Hemolytic crisis,COEXISTS_WITH,Hereditary Diseases,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Hydroxychloroquine,CAUSES,Hemolytic crisis,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Hemolytic crisis,PROCESS_OF,Patients,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Hemolytic crisis,PROCESS_OF,Patients,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Glucose-6-phosphate deficiency,PROCESS_OF,Patients,32324209,10.1001/jamacardio.2020.1624,2020-04-24
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hospitalization,TREATS,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hospitalization,TREATS(INFER),Hypertensive disease,32324118,10.3201/eid2608.200679,2020-04-24
Hypertensive disease,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hypertensive disease,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Coronavirus Infections,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Coronavirus Infections,PROCESS_OF,hospitalized patients,32324118,10.3201/eid2608.200679,2020-04-24
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hypertensive disease,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hypertensive disease,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Hypertensive disease,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Coronavirus Infections,PROCESS_OF,Patients,32324118,10.3201/eid2608.200679,2020-04-24
Coronavirus Infections,ISA,Disease,32324109,10.1089/tmj.2020.0106,2020-04-24
Syndrome,PROCESS_OF,Patients,32323974,10.1021/acs.analchem.0c00784,2020-04-24
Coronavirus Infections,ISA,Disease,32323908,10.1002/ajmg.a.61595,2020-04-24
rapid technique,USES,Immunodiagnosis,32323908,10.1002/ajmg.a.61595,2020-04-24
Serum,LOCATION_OF,anti-IgG,32323908,10.1002/ajmg.a.61595,2020-04-24
Serum,PART_OF,Homo sapiens,32323908,10.1002/ajmg.a.61595,2020-04-24
Phosphoproteins,PART_OF,Nucleocapsid,32323908,10.1002/ajmg.a.61595,2020-04-24
Serum,LOCATION_OF,anti-IgG,32323908,10.1002/ajmg.a.61595,2020-04-24
Serum,PART_OF,Homo sapiens,32323908,10.1002/ajmg.a.61595,2020-04-24
Telemedicine,ISA,patient care,32323704,10.7417/CT.2020.2212,2020-04-24
Conjunctivitis,PROCESS_OF,Patients,32323646,10.4269/ajtmh.20-0290,2020-04-24
Pneumonia,PROCESS_OF,Patients,32323646,10.4269/ajtmh.20-0290,2020-04-24
Viral Conjunctivitis,PROCESS_OF,Patients,32323646,10.4269/ajtmh.20-0290,2020-04-24
Redness,COEXISTS_WITH,Viral Conjunctivitis,32323646,10.4269/ajtmh.20-0290,2020-04-24
Tarsal conjunctiva,LOCATION_OF,Fibrin,32323646,10.4269/ajtmh.20-0290,2020-04-24
Coronavirus Infections,ISA,Disease,32323644,10.4269/ajtmh.20-0281,2020-04-24
Pharmacotherapy,TREATS,Disease,32323644,10.4269/ajtmh.20-0281,2020-04-24
Pharmacotherapy,TREATS(SPEC),Coronavirus Infections,32323644,10.4269/ajtmh.20-0281,2020-04-24
Coronavirus Infections,ISA,Disease,32323644,10.4269/ajtmh.20-0281,2020-04-24
Chloroquine,ISA,Antimalarials,32323644,10.4269/ajtmh.20-0281,2020-04-24
Chloroquine,TREATS,75+ years,32323644,10.4269/ajtmh.20-0281,2020-04-24
"Drugs, Essential",TREATS,Malaria,32323644,10.4269/ajtmh.20-0281,2020-04-24
Hydroxychloroquine,TREATS,Autoimmune Diseases,32323644,10.4269/ajtmh.20-0281,2020-04-24
Hydroxychloroquine,TREATS,Disease,32323644,10.4269/ajtmh.20-0281,2020-04-24
Hydroxychloroquine,TREATS(SPEC),Coronavirus Infections,32323644,10.4269/ajtmh.20-0281,2020-04-24
Coronavirus Infections,ISA,Disease,32323644,10.4269/ajtmh.20-0281,2020-04-24
Coronavirus Infections,ISA,Disease,32323565,10.1089/ars.2020.8111,2020-04-24
Coronavirus Infections,ISA,Disease,32323565,10.1089/ars.2020.8111,2020-04-24
Type-II Pneumocytes,LOCATION_OF,Gene Expression,32323563,10.1302/0301-620X.102B6.BJJ-2020-0537,2020-04-24
Hospitals,LOCATION_OF,"Models, Organizational",32323499,10.3348/kjr.2020.0240,2020-04-24
Immunocompromised Host,PROCESS_OF,Recipient,32323287,10.1055/a-1157-9976,2020-04-24
Acute respiratory insufficiency,PROCESS_OF,Patients,32323279,10.1055/a-1152-3469,2020-04-24
Acute respiratory insufficiency,PROCESS_OF,Patients,32323279,10.1055/a-1152-3469,2020-04-24
Insufflation,USES,Oxygen,32323279,10.1055/a-1152-3469,2020-04-24
Instrument - device,TREATS,Acute respiratory insufficiency,32323279,10.1055/a-1152-3469,2020-04-24
Hypoxemia,PROCESS_OF,Patients,32323279,10.1055/a-1152-3469,2020-04-24
Respiratory Failure,PROCESS_OF,Patients,32323279,10.1055/a-1152-3469,2020-04-24
"Intubation, Intratracheal",NEG_TREATS,Acute respiratory insufficiency,32323279,10.1055/a-1152-3469,2020-04-24
Extracorporeal Membrane Oxygenation,ISA,Interventional procedure,32323279,10.1055/a-1152-3469,2020-04-24
angiotensin II,ISA,Peptides,32323102,10.1007/s12630-020-01674-9,2020-04-24
angiotensin II,PART_OF,Peptides,32323102,10.1007/s12630-020-01674-9,2020-04-24
Angiotensin-Converting Enzyme Inhibitors,ISA,Pharmaceutical Preparations,32323102,10.1007/s12630-020-01674-9,2020-04-24
Angiotensin II receptor antagonist,ISA,Pharmaceutical Preparations,32323102,10.1007/s12630-020-01674-9,2020-04-24
Extraction,USES,Trocar,32323011,10.1007/s00330-020-06880-z,2020-04-24
Surgical Endoscopy,ADMINISTERED_TO,Staff,32323011,10.1007/s00330-020-06880-z,2020-04-24
Disease,PROCESS_OF,Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Confirmation,PROCESS_OF,Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Influenza,ISA,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Influenza,PROCESS_OF(SPEC),Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Pneumonia,PROCESS_OF,Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Confirmation,PROCESS_OF,Patients,32322993,10.1007/s00705-020-04628-0,2020-04-24
Pleural effusion disorder,COEXISTS_WITH,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Pleural effusion disorder,COEXISTS_WITH,Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Pleural effusion disorder,COEXISTS_WITH(SPEC),Coronavirus Infections,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH,Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH,Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH(SPEC),Coronavirus Infections,32322993,10.1007/s00705-020-04628-0,2020-04-24
Thickened,COEXISTS_WITH(SPEC),Coronavirus Infections,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Physical findings,COEXISTS_WITH,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Physical findings,COEXISTS_WITH,Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Physical findings,COEXISTS_WITH(SPEC),Coronavirus Infections,32322993,10.1007/s00705-020-04628-0,2020-04-24
Bronchial wall thickening,AFFECTS,Ground Glass Opacity,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH(SPEC),Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Influenza,ISA,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,COEXISTS_WITH(SPEC),Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Influenza,ISA,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH(SPEC),Influenza,32322993,10.1007/s00705-020-04628-0,2020-04-24
Influenza,ISA,Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,COEXISTS_WITH(SPEC),Pneumonia,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Bronchial wall thickening,COEXISTS_WITH,Decreased translucency,32322993,10.1007/s00705-020-04628-0,2020-04-24
Bronchial wall thickening,COEXISTS_WITH,Ground Glass Opacity,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
CT of lungs,DIAGNOSES,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
CT of lungs,DIAGNOSES(SPEC),Coronavirus Infections,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH,Decreased translucency,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,COEXISTS_WITH,Ground Glass Opacity,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,COEXISTS_WITH(SPEC),Decreased translucency,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,COEXISTS_WITH(SPEC),Ground Glass Opacity,32322993,10.1007/s00705-020-04628-0,2020-04-24
Coronavirus Infections,ISA,Disease,32322993,10.1007/s00705-020-04628-0,2020-04-24
Disease,PROCESS_OF,Homo sapiens,32322988,10.1007/s00063-020-00693-0,2020-04-24
Coronavirus Infections,CAUSES,Disease,32322988,10.1007/s00063-020-00693-0,2020-04-24
Special observation,TREATS,Patients,32322959,10.1007/s00405-020-05982-0,2020-04-24
Special observation,TREATS,Staff,32322959,10.1007/s00405-020-05982-0,2020-04-24
Tracheostomy procedure,AFFECTS,"Respiratory Distress Syndrome, Adult",32322822,10.1016/j.bbih.2020.100076,2020-04-24
Experience,PROCESS_OF,Patients,32322822,10.1016/j.bbih.2020.100076,2020-04-24
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32322822,10.1016/j.bbih.2020.100076,2020-04-24
Tracheostomy procedure,ADMINISTERED_TO,Patients,32322822,10.1016/j.bbih.2020.100076,2020-04-24
Mood Disorders,AFFECTS,Respiratory viruses,32322766,10.1016/j.jvscit.2020.04.003,2020-04-24
"Kidney Failure, Acute",PROCESS_OF,Patients,32322758,10.1016/j.adro.2020.04.011,2020-04-24
Oliguria,PROCESS_OF,Patients,32322758,10.1016/j.adro.2020.04.011,2020-04-24
Fluid overload,PROCESS_OF,Patients,32322758,10.1016/j.adro.2020.04.011,2020-04-24
compromise,PROCESS_OF,Patients,32322758,10.1016/j.adro.2020.04.011,2020-04-24
Immunity,PROCESS_OF,Homo sapiens,32322641,10.1016/j.dib.2020.105530,2020-04-24
Wound Healing,AFFECTS,Community,32322478,10.1016/j.rmcr.2020.101063,2020-04-24
Storm Syndrome,CAUSES,Pneumonia,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Coughing,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Dyspnea,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Dyspnea,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Radiologic finding,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Patients,LOCATION_OF,Glutathione,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Pneumonia,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Respiratory distress,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Storm Syndrome,PROCESS_OF,Patients,32322475,10.1016/j.hlpt.2020.04.005,2020-04-24
Coronavirus Infections,PROCESS_OF,Family,32322401,10.1016/j.nmni.2020.100679,2020-04-24
Virus Diseases,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Infected,PROCESS_OF,Persons,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Virus,PROCESS_OF,Chiroptera,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Coronavirus Infections,ISA,Disease,32322400,10.1016/j.nmni.2020.100672,2020-04-24
Child,ISA,Population Group,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Comorbidity,PROCESS_OF,Persons,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Comorbidity,PROCESS_OF,Old age,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Cessation of life,PROCESS_OF,Persons,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Cessation of life,PROCESS_OF,Old age,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Disease,AFFECTS,Population Group,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Disease,AFFECTS(SPEC),Child,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Symptom mild,PROCESS_OF,Persons,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Infected,PROCESS_OF,Persons,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Coughing,ISA,Symptoms,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Fatigue,ISA,Symptoms,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Fever,ISA,Symptoms,32322398,10.1016/j.nmni.2020.100669,2020-04-24
Infected,PROCESS_OF,Persons,32322132,10.1007/s10745-020-00150-8,2020-04-24
Air Pollution,CAUSES,Chronic disease,32322132,10.1007/s10745-020-00150-8,2020-04-24
Gravidity,PROCESS_OF,Patients,32322102,10.1038/s41591-020-0883-7,2020-04-24
Infected,PROCESS_OF,Persons,32322046,10.1038/s41430-020-0642-3,2020-04-24
Malnutrition,PROCESS_OF,geriatric patients,32321905,10.5582/bst.2020.03082,2020-04-24
risk factors,PREDISPOSES,Malnutrition,32321905,10.5582/bst.2020.03082,2020-04-24
Albumins,ASSOCIATED_WITH,Diabetes Mellitus,32321905,10.5582/bst.2020.03082,2020-04-24
Malnutrition,OCCURS_IN,geriatric patients,32321905,10.5582/bst.2020.03082,2020-04-24
Nutritional Support,TREATS,Diabetes Mellitus,32321905,10.5582/bst.2020.03082,2020-04-24
Chloroquine,ISA,Antimalarials,32321904,10.5582/bst.2020.03069,2020-04-24
Chloroquine,ADMINISTERED_TO,Patients,32321904,10.5582/bst.2020.03069,2020-04-24
Symptoms,PROCESS_OF,Patients,32321904,10.5582/bst.2020.03069,2020-04-24
Chloroquine,STIMULATES,LINC-ROR gene,32321904,10.5582/bst.2020.03069,2020-04-24
Operating Room,LOCATION_OF,Work,32321878,10.5582/ddt.2020.03010,2020-04-24
Operative Surgical Procedures,TREATS,Patients,32321878,10.5582/ddt.2020.03010,2020-04-24
Emergency cesarean section,ISA,Operative Surgical Procedures,32321878,10.5582/ddt.2020.03010,2020-04-24
Anesthesia management,TREATS,Patients,32321878,10.5582/ddt.2020.03010,2020-04-24
Chloroquine,TREATS,Melioidosis,32321874,10.1620/tjem.250.271,2020-04-24
Burkholderia pseudomallei,CAUSES,Disease,32321874,10.1620/tjem.250.271,2020-04-24
Burkholderia pseudomallei,ISA,Bacteria,32321874,10.1620/tjem.250.271,2020-04-24
Coronavirus Infections,CAUSES,Communicable Diseases,32321856,10.1126/science.abb4489,2020-04-24
Common Cold,ISA,Illness (finding),32321856,10.1126/science.abb4489,2020-04-24
Singapore,ISA,Country,32321662,10.1016/j.bjoms.2020.04.008,2020-04-24
Coronavirus Infections,ISA,Disease,32321540,10.1186/s12969-020-00422-z,2020-04-24
Tracheotomy procedure,TREATS,patient condition,32321540,10.1186/s12969-020-00422-z,2020-04-24
Age,ASSOCIATED_WITH,Disease,32321530,10.1186/s12931-020-01363-7,2020-04-24
Collagen Diseases,AFFECTS,Patients,32321530,10.1186/s12931-020-01363-7,2020-04-24
Collagen Diseases,COEXISTS_WITH,Imbalance,32321530,10.1186/s12931-020-01363-7,2020-04-24
Pharmaceutical Preparations,ADMINISTERED_TO,Rheumatologist,32321530,10.1186/s12931-020-01363-7,2020-04-24
Infected,PROCESS_OF,Patients,32321530,10.1186/s12931-020-01363-7,2020-04-24
Infected,PROCESS_OF,Child,32321530,10.1186/s12931-020-01363-7,2020-04-24
Coronavirus Infections,ISA,Disease,32321524,10.1186/s12967-020-02344-6,2020-04-24
Nucleic acid assay,DIAGNOSES,Disease,32321524,10.1186/s12967-020-02344-6,2020-04-24
Nucleic acid assay,DIAGNOSES(SPEC),Coronavirus Infections,32321524,10.1186/s12967-020-02344-6,2020-04-24
Silent Mutation,ASSOCIATED_WITH,RNA-directed RNA polymerase activity,32321407,10.2174/1573409916666200422075440,2020-04-24
Pharmaceutical Preparations,TREATS,Severe Acute Respiratory Syndrome,32321407,10.2174/1573409916666200422075440,2020-04-24
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32321388,10.1176/appi.ps.202000166,2020-04-24
Vaccines,TREATS,Coronavirus Infections,32321388,10.1176/appi.ps.202000166,2020-04-24
Coronavirus Infections,PROCESS_OF,Animals,32321388,10.1176/appi.ps.202000166,2020-04-24
Hydrolase,COEXISTS_WITH,Multienzyme Complexes,32321388,10.1176/appi.ps.202000166,2020-04-24
Folic Acid,INTERACTS_WITH,Enzymes,32321388,10.1176/appi.ps.202000166,2020-04-24
Challenge,COEXISTS_WITH,Delivery care,32321369,10.1080/22221751.2020.1760143,2020-04-24
Fatal Outcome,PROCESS_OF,geriatric patients,32321209,10.31128/AJGP-COVID-15,2020-04-24
Penicillin G,TREATS,Pneumonia,32321209,10.31128/AJGP-COVID-15,2020-04-24
Chest CT,DIAGNOSES,Ground Glass Opacity,32321209,10.31128/AJGP-COVID-15,2020-04-24
Inflammatory Bowel Diseases,PROCESS_OF,Hospital specialist,32321116,10.6061/clinics/2020/e1894,2020-04-23
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32321116,10.6061/clinics/2020/e1894,2020-04-23
Disease,PROCESS_OF,Patients,32321075,10.1590/0102-311X00070120,2020-04-23
Hospitalization,TREATS,Acute illness,32321005,10.1590/1980-549720200033,2020-04-23
Hospitalization,TREATS,Acute illness,32321005,10.1590/1980-549720200033,2020-04-23
Hospitalization,TREATS,Acute illness,32321005,10.1590/1980-549720200033,2020-04-23
Preparation - action,NEG_TREATS,Latin American,32320852,10.1016/j.drudis.2020.03.019,2020-04-23
Coronavirus Infections,ISA,Disease,32320825,10.1016/j.meegid.2020.104327,2020-04-23
Coronavirus Infections,ISA,Disease,32320825,10.1016/j.meegid.2020.104327,2020-04-23
Genus: Coronavirus,ISA,Virus,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Virus,NEG_PROCESS_OF,Homo sapiens,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Pharmaceutical Preparations,NEG_TREATS,patient condition,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Antiviral Agents,TREATS,Influenza,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Pharmaceutical Preparations,TREATS,Arthritis,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Pharmaceutical Preparations,TREATS,Malaria,32320809,10.1016/j.ijid.2020.04.021,2020-04-23
Coronavirus Infections,ISA,Disease,32320740,10.1016/j.metabol.2020.154243,2020-04-23
GSKIP gene,COEXISTS_WITH,survive,32320687,10.1016/j.jmb.2020.04.009,2020-04-23
C-reactive protein measurement,USES,High sensitivity,32320687,10.1016/j.jmb.2020.04.009,2020-04-23
"Amino Acids, Basic",PART_OF,Genus: Coronavirus,32320677,10.1016/j.chom.2020.04.009,2020-04-23
"Amino Acids, Basic",PART_OF,SARS coronavirus,32320677,10.1016/j.chom.2020.04.009,2020-04-23
Respiratory Failure,PROCESS_OF,Patients,32320641,10.3201/eid2608.200536,2020-04-23
Respiratory Failure,PROCESS_OF,Patients,32320641,10.3201/eid2608.200536,2020-04-23
Plasma,PART_OF,Patients,32320641,10.3201/eid2608.200536,2020-04-23
tocilizumab,TREATS,Patients,32320641,10.3201/eid2608.200536,2020-04-23
Interleukin-6,INTERACTS_WITH,HLA-D Antigens,32320641,10.3201/eid2608.200536,2020-04-23
cytokine production,ASSOCIATED_WITH,Lymphopenia,32320641,10.3201/eid2608.200536,2020-04-23
Abnormality,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
intensive care unit,LOCATION_OF,Retrospective Studies,32320516,10.1111/jcmm.15364,2020-04-23
patient assessment,USES,"Ultrasonography, Doppler, Duplex",32320516,10.1111/jcmm.15364,2020-04-23
Neoplasm Metastasis,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
Pulmonary Embolism,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
Hypoxemia,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
Thromboembolism,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
Thromboembolism,PROCESS_OF,Patients,32320516,10.1111/jcmm.15364,2020-04-23
Chronic disease,PROCESS_OF,Persons,32320508,10.1111/ene.14273,2020-04-23
Chronic disease,PROCESS_OF,Sambucus,32320508,10.1111/ene.14273,2020-04-23
Sambucus,ISA,Population Group,32320508,10.1111/ene.14273,2020-04-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32320508,10.1111/ene.14273,2020-04-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF(SPEC),Sambucus,32320508,10.1111/ene.14273,2020-04-23
Infected,PROCESS_OF,Persons,32320508,10.1111/ene.14273,2020-04-23
hospitalized patients,ISA,Patients,32320506,10.1111/acem.13994,2020-04-23
Sexually Transmitted Diseases,PROCESS_OF,Control Groups,32320506,10.1111/acem.13994,2020-04-23
Sexually Transmitted Diseases,PROCESS_OF,Patients,32320506,10.1111/acem.13994,2020-04-23
Anosmia,ISA,Olfaction Disorders,32320506,10.1111/acem.13994,2020-04-23
Ageusia,ISA,Taste Disorders,32320506,10.1111/acem.13994,2020-04-23
Nose,LOCATION_OF,Obstruction,32320506,10.1111/acem.13994,2020-04-23
Influenza,PROCESS_OF,Patients,32320506,10.1111/acem.13994,2020-04-23
Poor outcome,PROCESS_OF,Patients,32320494,10.1111/pde.14202,2020-04-23
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32320494,10.1111/pde.14202,2020-04-23
Department,LOCATION_OF,Study,32320494,10.1111/pde.14202,2020-04-23
Therapeutic immunosuppression,TREATS,Child,32320478,10.1002/cpt.1863,2020-04-23
Asymptomatic,PROCESS_OF,Patients,32320478,10.1002/cpt.1863,2020-04-23
Biological Factors,ISA,Pharmaceutical Preparations,32320478,10.1002/cpt.1863,2020-04-23
Pharmaceutical Preparations,TREATS,Discontinued,32320478,10.1002/cpt.1863,2020-04-23
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32320477,10.1002/cpt.1864,2020-04-23
Pharmaceutical Preparations,STIMULATES,ACE2 gene,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin II receptor antagonist,TREATS,Patients,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin II receptor antagonist,STIMULATES,ACE2 gene,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Patients,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin II receptor antagonist,ADMINISTERED_TO,Patients,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32320477,10.1002/cpt.1864,2020-04-23
Angiotensin II receptor antagonist,TREATS,Patients,32320477,10.1002/cpt.1864,2020-04-23
Malaria,PROCESS_OF,Child,32320384,10.18632/aging.103102,2020-04-23
Chloroquine,TREATS,Adult,32320384,10.18632/aging.103102,2020-04-23
Chloroquine,TREATS,Child,32320384,10.18632/aging.103102,2020-04-23
Adult disease,PROCESS_OF,Adult,32320384,10.18632/aging.103102,2020-04-23
Adult disease,PROCESS_OF,Child,32320384,10.18632/aging.103102,2020-04-23
Enzyme-Linked Immunosorbent Assay,USES,CD40LG wt Allele,32320381,10.2196/19160,2020-04-23
Donor person,LOCATION_OF,Plasma,32320381,10.2196/19160,2020-04-23
Enzyme-Linked Immunosorbent Assay,MEASURES,,32320381,10.2196/19160,2020-04-23
Patients,LOCATION_OF,Plasma,32320381,10.2196/19160,2020-04-23
Plasma,LOCATION_OF,Antibodies,32320381,10.2196/19160,2020-04-23
Disease,PROCESS_OF,Health Personnel,32320375,10.1099/jmm.0.001191,2020-04-23
Perception,PROCESS_OF,Health Personnel,32320375,10.1099/jmm.0.001191,2020-04-23
Protection,PROCESS_OF,Health Personnel,32320211,10.1021/acschemneuro.0c00201,2020-04-23
Disease,AFFECTS,Protection,32320211,10.1021/acschemneuro.0c00201,2020-04-23
Confirmation,PROCESS_OF,Patients,32320211,10.1021/acschemneuro.0c00201,2020-04-23
SARS coronavirus,ISA,Virus,32320138,10.1002/ccd.28889,2020-04-23
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32320138,10.1002/ccd.28889,2020-04-23
Brain,PART_OF,Homo sapiens,32320138,10.1002/ccd.28889,2020-04-23
"Dermatitis, Atopic",ISA,Inflammatory disorder,32320084,10.1002/jmv.25924,2020-04-23
"Dermatitis, Atopic",PROCESS_OF(SPEC),Patients,32320084,10.1002/jmv.25924,2020-04-23
Psoriasis,ISA,Inflammatory disorder,32320084,10.1002/jmv.25924,2020-04-23
Psoriasis,PROCESS_OF(SPEC),Patients,32320084,10.1002/jmv.25924,2020-04-23
Coronavirus Infections,ISA,Disease,32320084,10.1002/jmv.25924,2020-04-23
Coronavirus Infections,PROCESS_OF,Patients,32320084,10.1002/jmv.25924,2020-04-23
Inflammatory disorder,PROCESS_OF,Patients,32320084,10.1002/jmv.25924,2020-04-23
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Skin lesion,32320084,10.1002/jmv.25924,2020-04-23
Exanthem due to chicken pox,PROCESS_OF,Transient Population Group,32320084,10.1002/jmv.25924,2020-04-23
Coronavirus Infections,PROCESS_OF,Homo sapiens,32320064,10.1002/jmv.25919,2020-04-23
SARS coronavirus,CAUSES,Pneumonia,32320064,10.1002/jmv.25919,2020-04-23
Severe Acute Respiratory Syndrome,PROCESS_OF,"Animals, Laboratory",32320064,10.1002/jmv.25919,2020-04-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32320064,10.1002/jmv.25919,2020-04-23
SARS coronavirus,PROCESS_OF,Patients,32320064,10.1002/jmv.25919,2020-04-23
SARS coronavirus,PROCESS_OF,Patients,32320064,10.1002/jmv.25919,2020-04-23
Infected,PROCESS_OF,Patients,32320064,10.1002/jmv.25919,2020-04-23
Assay,USES,Antibodies,32320062,10.1002/jmv.25853,2020-04-23
Assay,USES,Antibodies,32320062,10.1002/jmv.25853,2020-04-23
Assay,USES,Antibodies,32320062,10.1002/jmv.25853,2020-04-23
Assay,USES,Antibodies,32320062,10.1002/jmv.25853,2020-04-23
Procedure to identify antibody,USES,Indicators,32320062,10.1002/jmv.25853,2020-04-23
Coronavirus Infections,ISA,Disease,32320059,10.1002/jmv.25920,2020-04-23
Cessation of life,PROCESS_OF,Homo sapiens,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
Coronavirus Infections,CAUSES,Cessation of life,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",PART_OF,Pathogenic organism,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",TREATS,Acute respiratory disease,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",ADMINISTERED_TO,Foundation for the Accreditation of Cellular Therapy,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",PART_OF,Pathogenic organism,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",PART_OF,Pathogenic organism,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
"Vaccines, Attenuated",PART_OF,Pathogenic organism,32320004,10.1001/jamapediatrics.2020.1467,2020-04-23
Fatigue,PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Fever,PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Symptom mild,PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Dry cough,PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Bronchial,LOCATION_OF,Thickened,32320003,10.1001/jama.2020.6775,2020-04-23
Thickened,PROCESS_OF,Patients,32320003,10.1001/jama.2020.6775,2020-04-23
Asymptomatic,PROCESS_OF,Patients,32320003,10.1001/jama.2020.6775,2020-04-23
Ground Glass Opacity,PROCESS_OF,Patients,32320003,10.1001/jama.2020.6775,2020-04-23
Coronavirus Infections,OCCURS_IN,Infant,32320003,10.1001/jama.2020.6775,2020-04-23
Cessation of life,NEG_PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Therapeutic procedure,TREATS,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Therapeutic procedure,TREATS(INFER),Severe Acute Respiratory Syndrome,32320003,10.1001/jama.2020.6775,2020-04-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32320003,10.1001/jama.2020.6775,2020-04-23
Invasive mechanical ventilation NOS,ADMINISTERED_TO,Patients,32319971,10.4193/Rhin20.140,2020-04-23
New York City,ISA,Geographic Locations,32319971,10.4193/Rhin20.140,2020-04-23
Infected,PROCESS_OF,Patients,32319956,10.2196/18576,2020-04-23
Symptoms,PROCESS_OF,Patients,32319956,10.2196/18576,2020-04-23
Coronavirus Infections,ISA,Disease,32319792,10.2214/AJR.20.23240,2020-04-23
Coronavirus Infections,ISA,Disease,32319792,10.2214/AJR.20.23240,2020-04-23
China,ISA,Country,32319449,10.1701/3347.33190,2020-04-23
Infected,PROCESS_OF,Pregnant Women,32319448,10.1701/3347.33189,2020-04-23
Severe Acute Respiratory Syndrome,CAUSES,Disease,32319444,10.1701/3347.33185,2020-04-23
Respiratory Failure,COEXISTS_WITH,Disease,32319444,10.1701/3347.33185,2020-04-23
Lung,LOCATION_OF,American College of Cardiology/American Heart Association Lesion Complexity Score C,32319444,10.1701/3347.33185,2020-04-23
Infected,PROCESS_OF,Patients,32319444,10.1701/3347.33185,2020-04-23
Patients,ISA,Persons,32319444,10.1701/3347.33185,2020-04-23
Therapeutic Intervention,TREATS,Patients,32319444,10.1701/3347.33185,2020-04-23
Anxiety,PROCESS_OF,Patients,32319443,10.1701/3347.33184,2020-04-23
Ventilator - respiratory equipment,CAUSES,Anxiety,32319443,10.1701/3347.33184,2020-04-23
Ventilator - respiratory equipment,TREATS,Patients,32319443,10.1701/3347.33184,2020-04-23
Ventilator - respiratory equipment,TREATS(INFER),Respiratory Failure,32319443,10.1701/3347.33184,2020-04-23
Respiratory Failure,PROCESS_OF,Patients,32319443,10.1701/3347.33184,2020-04-23
Palliative Care,ADMINISTERED_TO,Patients,32319443,10.1701/3347.33184,2020-04-23
intensive care,TREATS,Disease,32319442,10.1701/3347.33183,2020-04-23
Imbalance,PROCESS_OF,World,32319442,10.1701/3347.33183,2020-04-23
Severe Acute Respiratory Syndrome,CAUSES,Disease,32319440,10.1701/3347.33181,2020-04-23
Italy,ISA,Country,32319440,10.1701/3347.33181,2020-04-23
"Resuscitation, anesthesia",AFFECTS,Patients,32319440,10.1701/3347.33181,2020-04-23
Chronic disease,PROCESS_OF,Patients,32319436,10.1701/3347.33177,2020-04-23
Pharmaceutical Preparations,TREATS,Respiration Disorders,32319436,10.1701/3347.33177,2020-04-23
Frail,PROCESS_OF,Patients,32319436,10.1701/3347.33177,2020-04-23
Therapeutic procedure,TREATS,Patients,32319434,10.1701/3347.33175,2020-04-23
Hypoxemia,PROCESS_OF,Patients,32319301,10.2144/btn-2020-0041,2020-04-23
Severe disorder,PROCESS_OF,Patients,32319301,10.2144/btn-2020-0041,2020-04-23
Fatigue,PROCESS_OF,Patients,32319301,10.2144/btn-2020-0041,2020-04-23
Respiratory distress,CAUSES,Exhaustion,32319301,10.2144/btn-2020-0041,2020-04-23
Pneumonia,COEXISTS_WITH,Disease,32319301,10.2144/btn-2020-0041,2020-04-23
Pneumonia,COEXISTS_WITH(SPEC),Coronavirus Infections,32319301,10.2144/btn-2020-0041,2020-04-23
Coronavirus Infections,ISA,Disease,32319301,10.2144/btn-2020-0041,2020-04-23
Comorbidity,PROCESS_OF,Patients,32319200,10.1111/dom.14062,2020-04-23
Severe Acute Respiratory Syndrome,AFFECTS,Patients,32319200,10.1111/dom.14062,2020-04-23
Therapeutic immunosuppression,ADMINISTERED_TO,Patients,32319200,10.1111/dom.14062,2020-04-23
tomography,DIAGNOSES,"Pneumonia, Interstitial",32319200,10.1111/dom.14062,2020-04-23
Antiviral Therapy,ADMINISTERED_TO,Patients,32319200,10.1111/dom.14062,2020-04-23
Antiviral Therapy,USES,Hydroxychloroquine,32319200,10.1111/dom.14062,2020-04-23
Virus,PROCESS_OF,Persons,32319131,10.1111/pai.13265,2020-04-23
Disease,AFFECTS,Patients,32319129,10.1111/pai.13262,2020-04-23
Birth,AFFECTS,Staff Member,32319129,10.1111/pai.13262,2020-04-23
Chronic disease,PROCESS_OF,Patients,32319118,10.1111/pai.13263,2020-04-23
Symptom severe,PROCESS_OF,Child,32319118,10.1111/pai.13263,2020-04-23
Adrenal Cortex Hormones,AUGMENTS,Severe disorder,32319118,10.1111/pai.13263,2020-04-23
Antihistamines,AUGMENTS,Severe disorder,32319118,10.1111/pai.13263,2020-04-23
Bronchodilator Agents,AUGMENTS,Severe disorder,32319118,10.1111/pai.13263,2020-04-23
Immunologic Deficiency Syndromes,PROCESS_OF,Child,32319118,10.1111/pai.13263,2020-04-23
Transection (procedure),TREATS,Hypersensitivity,32319118,10.1111/pai.13263,2020-04-23
Transection (procedure),TREATS,Immunologic Deficiency Syndromes,32319118,10.1111/pai.13263,2020-04-23
Immunity,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Immunoglobulins,ADMINISTERED_TO,B-Lymphocytes,32319041,10.1007/s11126-020-09744-3,2020-04-23
X-linked agammaglobulinemia,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Symptoms,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Nasal Swab (procedure),METHOD_OF,Detection,32319041,10.1007/s11126-020-09744-3,2020-04-23
Coughing,ASSOCIATED_WITH,"Pneumonia, Interstitial",32319041,10.1007/s11126-020-09744-3,2020-04-23
Fever,ASSOCIATED_WITH,"Pneumonia, Interstitial",32319041,10.1007/s11126-020-09744-3,2020-04-23
"Pneumonia, Interstitial",PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
X-linked agammaglobulinemia,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Severe Acute Respiratory Syndrome,PRECEDES,Pneumonia,32319041,10.1007/s11126-020-09744-3,2020-04-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Immune defect,PROCESS_OF,Patients,32319041,10.1007/s11126-020-09744-3,2020-04-23
Symptoms,PROCESS_OF,Employee,32318986,10.1007/s10900-020-00827-7,2020-04-23
Cessation of life,OCCURS_IN,24 hour time frame,32318916,10.1007/s11604-020-00973-x,2020-04-23
Virus,CAUSES,Disease,32318916,10.1007/s11604-020-00973-x,2020-04-23
Pneumonia,PROCESS_OF,Patients,32318915,10.1007/s10654-020-00634-3,2020-04-23
Pleural effusion disorder,PROCESS_OF,Patients,32318915,10.1007/s10654-020-00634-3,2020-04-23
Pneumonia,PROCESS_OF,Patients,32318915,10.1007/s10654-020-00634-3,2020-04-23
Lesion,PROCESS_OF,Patients,32318915,10.1007/s10654-020-00634-3,2020-04-23
Ground Glass Opacity,PROCESS_OF,Patients,32318915,10.1007/s10654-020-00634-3,2020-04-23
Posterior segment,LOCATION_OF,lobe,32318915,10.1007/s10654-020-00634-3,2020-04-23
Narration,ISA,Work,32318891,10.1186/s13089-020-00171-w,2020-04-23
Lung,LOCATION_OF,Ultrasonography,32318865,10.1007/s11886-020-01292-3,2020-04-23
Medical Examination,COEXISTS_WITH,Triage,32318865,10.1007/s11886-020-01292-3,2020-04-23
Cytokine release syndrome,MANIFESTATION_OF,Heart Injuries,32318729,10.1093/jpids/piaa044,2020-04-23
Therapeutic procedure,PREVENTS,Virus Diseases,32318729,10.1093/jpids/piaa044,2020-04-23
Fever,PROCESS_OF,Infant,32318706,10.1093/jpids/piaa045,2020-04-23
Basis,PREDISPOSES,Disease Progression,32318703,10.1093/infdis/jiaa205,2020-04-23
Asymptomatic,PROCESS_OF,Patients,32318665,10.1002/ame2.12108,2020-04-23
Decreased translucency,PROCESS_OF,Patients,32318665,10.1002/ame2.12108,2020-04-23
Chromosome 2q32-Q33 Deletion Syndrome,PROCESS_OF,Patients,32318665,10.1002/ame2.12108,2020-04-23
Asymptomatic,PROCESS_OF,Patients,32318665,10.1002/ame2.12108,2020-04-23
Asymptomatic,PROCESS_OF,Patients,32318665,10.1002/ame2.12108,2020-04-23
Virus Replication,PROCESS_OF,Monkeys,32318330,10.1016/j.lrr.2020.100201,2020-04-23
Hamman-Rich syndrome,PROCESS_OF,Monkeys,32318330,10.1016/j.lrr.2020.100201,2020-04-23
"Pneumonia, Interstitial",PROCESS_OF,Monkeys,32318330,10.1016/j.lrr.2020.100201,2020-04-23
"Antigens, Viral",CAUSES,"Pneumonia, Interstitial",32318330,10.1016/j.lrr.2020.100201,2020-04-23
"Pneumonia, Interstitial",PROCESS_OF,Monkeys,32318330,10.1016/j.lrr.2020.100201,2020-04-23
"Leukemia, Myelocytic, Acute",PROCESS_OF,Patients,32318328,10.1016/j.apsb.2020.04.006,2020-04-23
MYELODYSPLASTIC SYNDROME,PROCESS_OF,Patients,32318328,10.1016/j.apsb.2020.04.006,2020-04-23
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32318328,10.1016/j.apsb.2020.04.006,2020-04-23
Dipyridamole,ISA,Agent,32318325,10.1007/s10389-020-01291-2,2020-04-23
intensive care unit,ISA,Hospitals,32318324,10.1007/s40588-020-00140-w,2020-04-23
Disease,PROCESS_OF,Patients,32318324,10.1007/s40588-020-00140-w,2020-04-23
Critical Illness,PROCESS_OF,Patients,32318324,10.1007/s40588-020-00140-w,2020-04-23
Abnormal result,PROCESS_OF,Patients,32318324,10.1007/s40588-020-00140-w,2020-04-23
Abnormal result,PROCESS_OF,Survivors,32318324,10.1007/s40588-020-00140-w,2020-04-23
Coronavirus Infections,CAUSES,Pneumonia,32317823,10.1007/s10745-020-00147-3,2020-04-23
Prognosis bad,COEXISTS_WITH,Disease,32317823,10.1007/s10745-020-00147-3,2020-04-23
Immunologic Adjuvants,TREATS,Virus Diseases,32317823,10.1007/s10745-020-00147-3,2020-04-23
Iron Chelating Agents,INTERACTS_WITH,Iron,32317823,10.1007/s10745-020-00147-3,2020-04-23
Acquired Immunodeficiency Syndrome,PROCESS_OF,Patients,32317823,10.1007/s10745-020-00147-3,2020-04-23
HIV,LOCATION_OF,metal transporting protein 1,32317823,10.1007/s10745-020-00147-3,2020-04-23
metal transporting protein 1,PART_OF,Exporter,32317823,10.1007/s10745-020-00147-3,2020-04-23
Metals,INTERACTS_WITH,Iron,32317823,10.1007/s10745-020-00147-3,2020-04-23
Patients,LOCATION_OF,Metals,32317823,10.1007/s10745-020-00147-3,2020-04-23
SARS coronavirus,PROCESS_OF,Racial group,32317808,10.1007/s00112-020-00919-7,2020-04-23
Complication,PROCESS_OF,Child,32317558,10.1097/MRR.0000000000000418,2020-04-23
Complication,PROCESS_OF,Adolescent (age group),32317558,10.1097/MRR.0000000000000418,2020-04-23
Coughing,ISA,Symptoms,32317558,10.1097/MRR.0000000000000418,2020-04-23
Fever,ISA,Symptoms,32317558,10.1097/MRR.0000000000000418,2020-04-23
Disease,PROCESS_OF,Infant,32317558,10.1097/MRR.0000000000000418,2020-04-23
Infant,ISA,Child,32317558,10.1097/MRR.0000000000000418,2020-04-23
Charcot-Marie-Tooth Disease,PROCESS_OF,Male population group,32317557,10.1097/MAT.0000000000001185,2020-04-23
Extracorporeal Membrane Oxygenation,TREATS,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Extracorporeal Membrane Oxygenation,TREATS(INFER),Malaise,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Heart,LOCATION_OF,compromise,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Malaise,PROCESS_OF,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Experience,PROCESS_OF,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Hospitals,LOCATION_OF,Study,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Extraction,PRECEDES,Removal of tracheostomy tube,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Antiviral Agents,ADMINISTERED_TO,Survivors,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Hydroxychloroquine,ADMINISTERED_TO,Survivors,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Intravenous steroid injection,ADMINISTERED_TO,Survivors,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Adjuvant Analgesic,TREATS,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Critical Illness,PROCESS_OF,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Lung,LOCATION_OF,compromise,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Extracorporeal Membrane Oxygenation,AFFECTS,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Experience,PROCESS_OF,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Extracorporeal Membrane Oxygenation,TREATS,Patients,32317434,10.4103/ijo.IJO_797_20,2020-04-23
Vision,PROCESS_OF,Patients,32317433,10.4103/ijo.IJO_871_20,2020-04-23
Vision,PROCESS_OF,Patients,32317433,10.4103/ijo.IJO_871_20,2020-04-23
Human body,USES,regulatory,32317433,10.4103/ijo.IJO_871_20,2020-04-23
China,ISA,Country,32317431,10.4103/ijo.IJO_639_20,2020-04-23
Quarantine,TREATS,Disease,32317431,10.4103/ijo.IJO_639_20,2020-04-23
Host Cell,AFFECTS,Virus Replication,32317409,10.4103/ijmr.IJMR_795_20,2020-04-23
Nipah Virus,PROCESS_OF,Chiroptera,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Nipah Virus,PROCESS_OF(SPEC),Pteropus giganteus,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Pteropus giganteus,ISA,Chiroptera,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Rousettus,LOCATION_OF,sphingosine 1-phosphate,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Rousettus,ISA,Chiroptera,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Circulatory Process,PROCESS_OF,Chiroptera,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Detection,TREATS,Chiroptera,32317408,10.4103/ijmr.IJMR_585_20,2020-04-23
Pharmaceutical Preparations,TREATS,Disease,32317402,10.1681/ASN.2020030375,2020-04-23
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32317402,10.1681/ASN.2020030375,2020-04-23
Coronavirus Infections,ISA,Disease,32317402,10.1681/ASN.2020030375,2020-04-23
Antiviral Agents,INTERACTS_WITH,Nucleic Acids,32317402,10.1681/ASN.2020030375,2020-04-23
Antiviral Agents,INTERACTS_WITH,Proteins,32317402,10.1681/ASN.2020030375,2020-04-23
Nucleic Acids,PART_OF,Virus,32317402,10.1681/ASN.2020030375,2020-04-23
Proteins,PART_OF,Virus,32317402,10.1681/ASN.2020030375,2020-04-23
Fever,PROCESS_OF,Transplant Recipients,32317267,10.1136/bmj.m1443,2020-04-23
Immunocompromised Host,PROCESS_OF,Persons,32317267,10.1136/bmj.m1443,2020-04-23
Disease Progression,PROCESS_OF,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
RNA,ISA,Acids,32317257,10.1128/JCM.00776-20,2020-04-23
Patients,LOCATION_OF,Urine - SpecimenType,32317257,10.1128/JCM.00776-20,2020-04-23
Feces,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Virus,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Virus,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Respiratory sample,ASSOCIATED_WITH(INFER),Severe disorder,32317257,10.1128/JCM.00776-20,2020-04-23
Respiratory sample,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Respiratory sample,PART_OF,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Severe disorder,PROCESS_OF,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Duration,TREATS,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Duration,TREATS(INFER),Mild disorder,32317257,10.1128/JCM.00776-20,2020-04-23
Mild disorder,PROCESS_OF,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Virus,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Specimen Type - Stool = Fecal,LOCATION_OF,Duration,32317257,10.1128/JCM.00776-20,2020-04-23
Severe disorder,PROCESS_OF,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Duration,TREATS,Patients,32317257,10.1128/JCM.00776-20,2020-04-23
Pandemics,ISA,Disease Outbreaks,32317225,10.1016/j.jiac.2020.03.018,2020-04-23
tomography,AFFECTS,disease transmission,32317225,10.1016/j.jiac.2020.03.018,2020-04-23
Coronavirus Infections,ISA,Disease,32317220,10.1016/j.jaut.2020.102468,2020-04-23
Primary Health Care,TREATS,Male population group,32317220,10.1016/j.jaut.2020.102468,2020-04-23
acute care,TREATS,Male population group,32317220,10.1016/j.jaut.2020.102468,2020-04-23
Masks,USES,Mechanical Ventilator,32317220,10.1016/j.jaut.2020.102468,2020-04-23
Therapeutic procedure,USES,Masks,32317220,10.1016/j.jaut.2020.102468,2020-04-23
intensive care unit,LOCATION_OF,Task,32317220,10.1016/j.jaut.2020.102468,2020-04-23
Communicable Diseases,CAUSES,Pneumonia,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Communicable Diseases,CAUSES,Fatal Outcome,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Communicable Diseases,ISA,Disease,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Disease,PROCESS_OF,Animal Model,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
High Level,PROCESS_OF,Patients,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Antirheumatic Agents,TREATS,Severe viral infections,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Chloroquine,ISA,Agent,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Hydroxychloroquine,ISA,Agent,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Immunosuppressive Agents,TREATS,Severe Acute Respiratory Syndrome,32317205,10.1016/j.jfma.2020.04.008,2020-04-23
Pharmacotherapy,PREVENTS,Complication,32317203,10.1016/j.ajem.2020.04.048,2020-04-23
Coronavirus Infections,PROCESS_OF,World,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Physicians,ISA,Health Personnel,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Vaccines,TREATS,Virus,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Communicable Diseases,ISA,Disease,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Academia (organization),LOCATION_OF,research,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Academia (organization),LOCATION_OF,research,32317180,10.1016/j.eururo.2020.03.039,2020-04-23
Pneumonia,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,Family member,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,general population,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
"Kidney Failure, Acute",PROCESS_OF,Patients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Pneumonia,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Coronavirus Infections,PROCESS_OF,Transplant Recipients,32317154,10.1016/j.sapharm.2020.04.013,2020-04-23
Community Pharmacists,ISA,Health Personnel,32317153,10.1016/j.sapharm.2020.04.001,2020-04-23
Pharmaceutical Preparations,TREATS,patient condition,32317051,10.2807/1560-7917.ES.2020.25.15.2000448,2020-04-23
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32317051,10.2807/1560-7917.ES.2020.25.15.2000448,2020-04-23
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32317051,10.2807/1560-7917.ES.2020.25.15.2000448,2020-04-23
pharmacy management,COEXISTS_WITH,disease prevention,32317051,10.2807/1560-7917.ES.2020.25.15.2000448,2020-04-23
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Pharmaceutical Preparations,32317051,10.2807/1560-7917.ES.2020.25.15.2000448,2020-04-23
Coronavirus Infections,CAUSES,Pneumonia,32317044,10.1017/dmp.2020.115,2020-04-23
mental health,PROCESS_OF,therapist,32316979,10.1186/s13002-020-00366-4,2020-04-23
Quarantine,ISA,Isolation procedure,32316979,10.1186/s13002-020-00366-4,2020-04-23
follow-up,TREATS,Persons,32316857,10.1177/0049475520921616,2020-04-23
Critical Illness,PROCESS_OF,Patients,32316751,10.1080/09603123.2020.1747602,2020-04-23
Challenge,COEXISTS_WITH,Triage,32316751,10.1080/09603123.2020.1747602,2020-04-23
Coronavirus Infections,CAUSES,Acute respiratory disease,32316737,10.17235/reed.2020.7141/2020,2020-04-23
China,ISA,Country,32316737,10.17235/reed.2020.7141/2020,2020-04-23
Disability,PROCESS_OF,Persons,32316713,10.3779/j.issn.1009-3419.2020.102.15,2020-04-23
Exercise,PREVENTS,Frailty,32316713,10.3779/j.issn.1009-3419.2020.102.15,2020-04-23
Exercise,PREVENTS,Sarcopenia,32316713,10.3779/j.issn.1009-3419.2020.102.15,2020-04-23
Disability,PROCESS_OF,Survivors,32316713,10.3779/j.issn.1009-3419.2020.102.15,2020-04-23
Neoplasms,PROCESS_OF,Patients,32316647,10.3390/ijerph17082788,2020-04-23
Immune System Processes,CAUSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,32316647,10.3390/ijerph17082788,2020-04-23
Patient identification,TREATS,Patients,32316647,10.3390/ijerph17082788,2020-04-23
Disease,PROCESS_OF,Patients,32316647,10.3390/ijerph17082788,2020-04-23
Coronavirus Infections,ISA,Disease,32316647,10.3390/ijerph17082788,2020-04-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32316647,10.3390/ijerph17082788,2020-04-23
Family,INTERACTS_WITH,Homo sapiens,32316337,10.3390/ijerph17082763,2020-04-23
Coronavirus Infections,PROCESS_OF,Family,32316337,10.3390/ijerph17082763,2020-04-23
Infected,PROCESS_OF,Persons,32316337,10.3390/ijerph17082763,2020-04-23
Respiratory secretion,ASSOCIATED_WITH(INFER),Infected,32316337,10.3390/ijerph17082763,2020-04-23
Respiratory secretion,PART_OF,Persons,32316337,10.3390/ijerph17082763,2020-04-23
Antiviral Agents,PREVENTS,Respiratory complication,32316337,10.3390/ijerph17082763,2020-04-23
Virus,CAUSES,Disease,32316270,10.3390/molecules25081834,2020-04-23
Glucose-6-phosphate dehydrogenase Measurement,USES,Malnutrition screen,32316165,10.3390/ijerph17082750,2020-04-23
Antimalarials,ADMINISTERED_TO,Persons,32316165,10.3390/ijerph17082750,2020-04-23
Chloroquine,ADMINISTERED_TO(SPEC),Persons,32316165,10.3390/ijerph17082750,2020-04-23
Chloroquine,ISA,Antimalarials,32316165,10.3390/ijerph17082750,2020-04-23
Chloroquine,TREATS,Disease,32316165,10.3390/ijerph17082750,2020-04-23
Chloroquine,TREATS(SPEC),Coronavirus Infections,32316165,10.3390/ijerph17082750,2020-04-23
Pharmaceutical Preparations,TREATS,Disease,32316165,10.3390/ijerph17082750,2020-04-23
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32316165,10.3390/ijerph17082750,2020-04-23
Primaquine,ADMINISTERED_TO(SPEC),Persons,32316165,10.3390/ijerph17082750,2020-04-23
Primaquine,ISA,Antimalarials,32316165,10.3390/ijerph17082750,2020-04-23
Primaquine,TREATS,Disease,32316165,10.3390/ijerph17082750,2020-04-23
Primaquine,TREATS(SPEC),Coronavirus Infections,32316165,10.3390/ijerph17082750,2020-04-23
Quinine,ADMINISTERED_TO(SPEC),Persons,32316165,10.3390/ijerph17082750,2020-04-23
Quinine,ISA,Antimalarials,32316165,10.3390/ijerph17082750,2020-04-23
Quinine,TREATS,Disease,32316165,10.3390/ijerph17082750,2020-04-23
Quinine,TREATS(SPEC),Coronavirus Infections,32316165,10.3390/ijerph17082750,2020-04-23
Coronavirus Infections,ISA,Disease,32316165,10.3390/ijerph17082750,2020-04-23
Glucose-6-phosphate dehydrogenase Measurement,USES,Malnutrition screen,32316165,10.3390/ijerph17082750,2020-04-23
"Hospitals, Public",LOCATION_OF,Glucose-6-phosphate dehydrogenase Measurement,32316165,10.3390/ijerph17082750,2020-04-23
Glucose-6-phosphate dehydrogenase Measurement,USES,Malnutrition screen,32316165,10.3390/ijerph17082750,2020-04-23
Glucose-6-phosphate dehydrogenase Measurement,USES,Malnutrition screen,32316165,10.3390/ijerph17082750,2020-04-23
Chloroquine,TREATS,patient condition,32316165,10.3390/ijerph17082750,2020-04-23
Pyrimethamine / Sulfadoxine,ADMINISTERED_TO,Pregnant Women,32316165,10.3390/ijerph17082750,2020-04-23
Challenge,TREATS,Malaria,32316165,10.3390/ijerph17082750,2020-04-23
Infection,COEXISTS_WITH,Handling,32316118,10.3390/jcm9041138,2020-04-23
Malaria,AFFECTS,Variation (Genetics),32316113,10.3390/diagnostics10040224,2020-04-23
Coronavirus Infections,CAUSES,Pneumonia,32315980,10.1016/j.msard.2020.102120,2020-04-22
Comorbidity,PROCESS_OF,Patients,32315963,10.1016/j.ajp.2020.102092,2020-04-22
Immune response,CAUSES,High risk of,32315963,10.1016/j.ajp.2020.102092,2020-04-22
Infected,PROCESS_OF,Patients,32315963,10.1016/j.ajp.2020.102092,2020-04-22
ocrelizumab,TREATS,Patients,32315963,10.1016/j.ajp.2020.102092,2020-04-22
Chloroquine,TREATS,Patients,32315907,10.1016/j.scitotenv.2020.138647,2020-04-22
Chloroquine,TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",32315907,10.1016/j.scitotenv.2020.138647,2020-04-22
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Patients,32315907,10.1016/j.scitotenv.2020.138647,2020-04-22
Chloroquine,TREATS,"Diabetes Mellitus, Insulin-Dependent",32315907,10.1016/j.scitotenv.2020.138647,2020-04-22
"Diabetes Mellitus, Insulin-Dependent",PROCESS_OF,Patients,32315907,10.1016/j.scitotenv.2020.138647,2020-04-22
Challenge,AFFECTS,poor health,32315881,10.1016/j.psychres.2020.112980,2020-04-22
Challenge,TREATS,Crisis,32315881,10.1016/j.psychres.2020.112980,2020-04-22
Disease,PROCESS_OF,Psychiatric inpatient,32315874,10.1016/j.psychres.2020.113024,2020-04-22
Depressive disorder,PROCESS_OF,Survivors,32315817,10.1016/j.jcv.2020.104371,2020-04-22
Post-Traumatic Stress Disorder,PROCESS_OF,Survivors,32315817,10.1016/j.jcv.2020.104371,2020-04-22
MISUSE,PROCESS_OF,Survivors,32315817,10.1016/j.jcv.2020.104371,2020-04-22
Complication,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32315809,10.1016/j.ijid.2020.04.023,2020-04-22
Shock,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32315809,10.1016/j.ijid.2020.04.023,2020-04-22
Symptoms,PROCESS_OF,Patients,32315809,10.1016/j.ijid.2020.04.023,2020-04-22
Coronavirus Infections,ISA,Disease,32315808,10.1016/j.ijid.2020.04.034,2020-04-22
Respiratory sample,PART_OF,Tract,32315808,10.1016/j.ijid.2020.04.034,2020-04-22
Outpatients,ISA,Patients,32315808,10.1016/j.ijid.2020.04.034,2020-04-22
inpatient,LOCATION_OF,Oropharyngeal swab,32315808,10.1016/j.ijid.2020.04.034,2020-04-22
Troponin,PART_OF,Heart,32315732,10.1016/j.cardfail.2020.04.008,2020-04-22
High Level,PROCESS_OF,Patients,32315732,10.1016/j.cardfail.2020.04.008,2020-04-22
Heart failure,PROCESS_OF,Patients,32315725,10.1016/j.jinf.2020.04.012,2020-04-22
Provincial hospital,LOCATION_OF,Observational Study,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Logistic Regression,MEASURES,% of total,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Critical Illness,PROCESS_OF,Patients,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Patients,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Midline (qualifier value),LOCATION_OF,Lymphocyte,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Virus Diseases,PREDISPOSES,Possible,32315723,10.1016/j.jinf.2020.04.011,2020-04-22
Severe Acute Respiratory Syndrome,CAUSES,Cessation of life,32315614,10.1016/j.cca.2020.04.018,2020-04-22
Middle East Respiratory Syndrome,CAUSES,Cessation of life,32315614,10.1016/j.cca.2020.04.018,2020-04-22
Coronavirus Infections,ISA,Communicable Diseases,32315487,10.1111/cts.12805,2020-04-22
Feces,LOCATION_OF,Nucleic Acids,32315487,10.1111/cts.12805,2020-04-22
Patients,LOCATION_OF,Tears - SpecimenType,32315487,10.1111/cts.12805,2020-04-22
Eosinophil count procedure,DIAGNOSES,Elevated C-reactive protein,32315487,10.1111/cts.12805,2020-04-22
Blood,PART_OF,Patients,32315487,10.1111/cts.12805,2020-04-22
Negative,PROCESS_OF,Patients,32315487,10.1111/cts.12805,2020-04-22
Disease,PROCESS_OF,Patients,32315451,10.1002/14651858.CD013582,2020-04-22
Fever,ISA,Symptoms,32315451,10.1002/14651858.CD013582,2020-04-22
Respiratory Tract Infections,PROCESS_OF,Patients,32315386,10.1093/ageing/afaa068,2020-04-22
responsibility,PROCESS_OF,Health Personnel,32315386,10.1093/ageing/afaa068,2020-04-22
Nurses,ISA,Health Personnel,32315386,10.1093/ageing/afaa068,2020-04-22
Physicians,ISA,Health Personnel,32315386,10.1093/ageing/afaa068,2020-04-22
Infected,PROCESS_OF,Patients,32315386,10.1093/ageing/afaa068,2020-04-22
Health Personnel,USES,Masks,32315386,10.1093/ageing/afaa068,2020-04-22
Coronavirus Infections,ISA,Disease,32315380,10.7326/M20-1897,2020-04-22
Schizoaffective Disorder,PROCESS_OF,Male population group,32315380,10.7326/M20-1897,2020-04-22
Antibiotics,TREATS,Community acquired pneumonia,32315380,10.7326/M20-1897,2020-04-22
Pharyngitis,ISA,Disease,32315380,10.7326/M20-1897,2020-04-22
Frail,PROCESS_OF,Older people,32315380,10.7326/M20-1897,2020-04-22
Coronavirus Infections,ISA,Disease,32315281,10.3201/eid2607.200092,2020-04-22
Virus,PROCESS_OF,Pholidota,32315261,10.1177/0194599820922988,2020-04-22
Virus,PROCESS_OF,Homo sapiens,32315122,10.1111/ajt.15936,2020-04-22
Infected,PROCESS_OF,Persons,32315079,10.1111/pde.14201,2020-04-22
Severe course,NEG_PROCESS_OF,Population Group,32315079,10.1111/pde.14201,2020-04-22
Kidney,LOCATION_OF,Transplanted heart present,32315079,10.1111/pde.14201,2020-04-22
Present,PREDISPOSES,Poor outcome,32315079,10.1111/pde.14201,2020-04-22
Coronavirus Infections,ISA,Disease,32315076,10.1111/jgs.16500,2020-04-22
Symptom mild,PROCESS_OF,Woman,32315076,10.1111/jgs.16500,2020-04-22
Exanthem due to chicken pox,PROCESS_OF,Woman,32315076,10.1111/jgs.16500,2020-04-22
Panic,PROCESS_OF,general population,32315026,10.1093/cid/ciaa468,2020-04-22
Coronavirus Infections,CAUSES,Communicable Diseases,32314976,10.2196/18825,2020-04-22
Hospitals,LOCATION_OF,Cross-Sectional Studies,32314976,10.2196/18825,2020-04-22
Protection,PROCESS_OF,Staff,32314976,10.2196/18825,2020-04-22
Coronavirus Infections,ISA,Disease,32314976,10.2196/18825,2020-04-22
Protection,PROCESS_OF,Staff,32314976,10.2196/18825,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Discussion (procedure),AFFECTS,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Discussion (procedure),AFFECTS,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Discussion (procedure),AFFECTS(SPEC),Coronavirus Infections,32314954,10.1017/dmp.2020.109,2020-04-22
Discussion (procedure),AFFECTS(SPEC),Coronavirus Infections,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Coronavirus Infections,ISA,Disease,32314954,10.1017/dmp.2020.109,2020-04-22
Decision,PROCESS_OF,Maker (occupation),32314951,10.1080/08897077.2020.1752351,2020-04-22
Substance Use Disorders,PROCESS_OF,Persons,32314881,10.7518/hxkq.2020.02.001,2020-04-22
BARRIER,TREATS,Population Group,32314881,10.7518/hxkq.2020.02.001,2020-04-22
Disease,PROCESS_OF,Dentist,32314868,10.1002/oby.22843,2020-04-22
Coronavirus Infections,ISA,Disease,32314868,10.1002/oby.22843,2020-04-22
Coronavirus Infections,PROCESS_OF(SPEC),Dentist,32314868,10.1002/oby.22843,2020-04-22
Disease,PROCESS_OF,Patients,32314850,10.1002/rmv.2109,2020-04-22
Obesity,COEXISTS_WITH,Poor outcome,32314850,10.1002/rmv.2109,2020-04-22
hypoventilation syndrome,PROCESS_OF,Patients,32314850,10.1002/rmv.2109,2020-04-22
Obesity,PROCESS_OF,Persons,32314850,10.1002/rmv.2109,2020-04-22
Persons,LOCATION_OF,cytokine,32314850,10.1002/rmv.2109,2020-04-22
Obesity,PROCESS_OF,Persons,32314850,10.1002/rmv.2109,2020-04-22
Coronavirus Infections,PROCESS_OF,Persons,32314850,10.1002/rmv.2109,2020-04-22
Melatonin,PREDISPOSES,Storm NOS,32314811,10.1002/jmv.25909,2020-04-22
ARNTL gene,INHIBITS,Pyruvate Dehydrogenase Complex,32314811,10.1002/jmv.25909,2020-04-22
Pyruvate Dehydrogenase Complex,STIMULATES,Citric Acid Cycle,32314811,10.1002/jmv.25909,2020-04-22
Pyruvates,INTERACTS_WITH,Acetyl Coenzyme A,32314811,10.1002/jmv.25909,2020-04-22
Melatonin,PART_OF,Mitochondria,32314811,10.1002/jmv.25909,2020-04-22
Butyrates,AUGMENTS,Virus Replication,32314811,10.1002/jmv.25909,2020-04-22
Lipopolysaccharides,AUGMENTS,Virus Replication,32314811,10.1002/jmv.25909,2020-04-22
Infectious agent,CAUSES,Disease,32314810,10.1002/jmv.25915,2020-04-22
Nerve Tissue,LOCATION_OF,Virus,32314806,10.1002/jmv.25914,2020-04-22
"Stress, Psychological",PROCESS_OF,Medical Staff,32314805,10.1002/jmv.25910,2020-04-22
"Stress, Psychological",PROCESS_OF,College student,32314805,10.1002/jmv.25910,2020-04-22
Lesion,PROCESS_OF,Patients,32314804,10.1002/jmv.25908,2020-04-22
Thickening of pleura,PROCESS_OF,Patients,32314804,10.1002/jmv.25908,2020-04-22
Cessation of life,AFFECTS,Growth,32314790,10.1093/jpids/piaa037,2020-04-22
Respiration Disorders,COEXISTS_WITH,upper respiratory symptom,32314700,10.4269/ajtmh.20-0274,2020-04-22
Respiration Disorders,PROCESS_OF,Child,32314700,10.4269/ajtmh.20-0274,2020-04-22
Disease,COEXISTS_WITH,Virus,32314700,10.4269/ajtmh.20-0274,2020-04-22
Severe Acute Respiratory Syndrome,CAUSES,Disease,32314700,10.4269/ajtmh.20-0274,2020-04-22
Coronavirus Infections,ISA,Disease,32314699,10.4269/ajtmh.20-0266,2020-04-22
Coronavirus Infections,ISA,Disease,32314698,10.4269/ajtmh.20-0276,2020-04-22
Hydroxychloroquine,ADMINISTERED_TO,Patients,32314697,10.4269/ajtmh.20-0081,2020-04-22
Severe disorder,PROCESS_OF,Patients,32314697,10.4269/ajtmh.20-0081,2020-04-22
Coronavirus Infections,ISA,Disease,32314697,10.4269/ajtmh.20-0081,2020-04-22
Hepatotoxicity,COEXISTS_WITH,Disease,32314697,10.4269/ajtmh.20-0081,2020-04-22
Hepatotoxicity,COEXISTS_WITH(SPEC),Coronavirus Infections,32314697,10.4269/ajtmh.20-0081,2020-04-22
Health Personnel,LOCATION_OF,IMPACT gene,32314559,10.24272/j.issn.2095-8137.2020.031,2020-04-22
Hospitals,LOCATION_OF,Diagnosis,32314559,10.24272/j.issn.2095-8137.2020.031,2020-04-22
"Immunoglobulins, Intravenous",AFFECTS,Immune response,32314559,10.24272/j.issn.2095-8137.2020.031,2020-04-22
Pneumonia,PROCESS_OF,Homo sapiens,32314503,10.1002/dmrr.3325,2020-04-22
Genus: Coronavirus,CAUSES,Pneumonia,32314503,10.1002/dmrr.3325,2020-04-22
SARS coronavirus,CAUSES,Pneumonia,32314503,10.1002/dmrr.3325,2020-04-22
Middle East Respiratory Syndrome Coronavirus,CAUSES,Pneumonia,32314503,10.1002/dmrr.3325,2020-04-22
Obesity,PROCESS_OF,Patients,32314483,10.1111/dth.13434,2020-04-22
Chronic inflammation,COEXISTS_WITH,Comorbidity,32314483,10.1111/dth.13434,2020-04-22
Lung,LOCATION_OF,Diabetes,32314483,10.1111/dth.13434,2020-04-22
Lung,LOCATION_OF,Hypertensive disease,32314483,10.1111/dth.13434,2020-04-22
Lung,LOCATION_OF,Possible,32314483,10.1111/dth.13434,2020-04-22
Psoriasis,PROCESS_OF,Patients,32314460,10.1111/dth.13430,2020-04-22
Disease,CAUSES,Severe Acute Respiratory Syndrome,32314455,10.1111/dom.14057,2020-04-22
Communicable Diseases,PROCESS_OF,Patients,32314455,10.1111/dom.14057,2020-04-22
Ketosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Ketosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Acidosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Acidosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Diabetic Ketoacidosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Ketosis,CAUSES,Diabetic Ketoacidosis,32314436,10.1111/jdv.16519,2020-04-22
Ketosis,CAUSES,Diabetic Ketoacidosis,32314436,10.1111/jdv.16519,2020-04-22
Ketosis,PROCESS_OF,Patients,32314436,10.1111/jdv.16519,2020-04-22
Fever,PROCESS_OF,Patients,32314274,10.1007/s12250-020-00227-0,2020-04-22
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32314274,10.1007/s12250-020-00227-0,2020-04-22
China,ISA,Country,32314249,10.1007/s11695-020-04617-x,2020-04-22
Altered immunity,COEXISTS_WITH,Disease,32314249,10.1007/s11695-020-04617-x,2020-04-22
"Obesity, Morbid",PROCESS_OF,Patients,32314081,10.1007/s10900-020-00821-z,2020-04-22
Pharmaceutical Preparations,TREATS,Patients,32314059,10.1007/s00701-020-04342-5,2020-04-22
Infected,PROCESS_OF,Patients,32314058,10.1007/s00330-020-06865-y,2020-04-22
Neurosurgeon,LOCATION_OF,IMPACT gene,32314058,10.1007/s00330-020-06865-y,2020-04-22
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Respondents,32314058,10.1007/s00330-020-06865-y,2020-04-22
Early Diagnosis,DIAGNOSES,Disease,32314050,10.1007/s00405-020-05993-x,2020-04-22
"Intubation, Intratracheal",PRECEDES,Tracheostomy procedure,32314034,10.1007/s00417-020-04682-z,2020-04-22
Experience,PROCESS_OF,Patients,32314034,10.1007/s00417-020-04682-z,2020-04-22
Tracheostomy procedure,TREATS,Weaning,32314034,10.1007/s00417-020-04682-z,2020-04-22
Isolation procedure,TREATS,Patients,32314010,10.1007/s00296-020-04584-7,2020-04-22
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32314010,10.1007/s00296-020-04584-7,2020-04-22
Ophthalmology clinic,LOCATION_OF,Logistics,32314010,10.1007/s00296-020-04584-7,2020-04-22
Rheumatoid Arthritis,PROCESS_OF,Patients,32313886,10.1016/j.bbih.2020.100073,2020-04-22
Patients,LOCATION_OF,IMPACT gene,32313886,10.1016/j.bbih.2020.100073,2020-04-22
Pneumonia,PROCESS_OF,Patients,32313886,10.1016/j.bbih.2020.100073,2020-04-22
"Antirheumatic Drugs, Disease-Modifying",ADMINISTERED_TO,Patients,32313886,10.1016/j.bbih.2020.100073,2020-04-22
Antiviral Agents,TREATS,Patients,32313886,10.1016/j.bbih.2020.100073,2020-04-22
lopinavir / Ritonavir,ISA,Antiviral Agents,32313886,10.1016/j.bbih.2020.100073,2020-04-22
lopinavir / Ritonavir,TREATS(SPEC),Patients,32313886,10.1016/j.bbih.2020.100073,2020-04-22
Coronavirus Infections,CAUSES,Disease,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Coronavirus Infections,ISA,Disease,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Coronavirus Infections,ISA,Disease,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Coronavirus Infections,ISA,Disease,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Disease,AFFECTS,Possible,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Coronavirus Infections,AFFECTS(SPEC),Possible,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Coronavirus Infections,ISA,Disease,32313885,10.1016/j.jaccao.2020.04.002,2020-04-22
Neoplasms,PROCESS_OF,Community,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Severe Acute Respiratory Syndrome,AFFECTS,Severe (severity modifier),32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Pharmaceutical Preparations,TREATS,Influenza,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Neoplasms,PROCESS_OF,Community,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Therapeutic procedure,NEG_TREATS,Patients,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Therapeutic procedure,TREATS,Malaria,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Neoplasms,PROCESS_OF,Physicians,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Physicians,TREATS,Patients,32313884,10.1016/j.jaccas.2020.04.008,2020-04-22
Lung,LOCATION_OF,Massive embolus,32313883,10.3892/wasj.2020.42,2020-04-22
"Heart Failure, Right-Sided",COMPLICATES,Massive embolus,32313883,10.3892/wasj.2020.42,2020-04-22
Hormones,AFFECTS,Protein Biosynthesis,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Mitogens,AFFECTS,Protein Biosynthesis,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Bacterial product,INHIBITS,FKBP12-rapamycin associated protein,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Influenza,AFFECTS,Antibody Formation,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Steroids,TREATS,Pneumonia,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Sirolimus,TREATS,Pneumonia,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,INHIBITS,FKBP12-rapamycin associated protein,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,ISA,Pharmaceutical Preparations,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,ISA,Pharmaceutical Preparations,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Antidiabetics,TREATS,Neoplasms,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,TREATS,Patients,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,TREATS(INFER),diabetic,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Buformin,TREATS,Patients,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Insulin,TREATS,diabetic,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Phenformin,TREATS,Patients,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Sulfonylurea Compounds,TREATS,diabetic,32313880,10.1016/j.medidd.2020.100039,2020-04-22
diabetic,PROCESS_OF,Patients,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Influenza,PROCESS_OF,Mus,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Phenformin,compared_with,Buformin,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Phenformin,lower_than,Buformin,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,COEXISTS_WITH,Buformin,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,COEXISTS_WITH,Phenformin,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Buformin,TREATS,Influenza,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Phenformin,TREATS,Influenza,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Virus,COEXISTS_WITH,SARS coronavirus,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Infected,PROCESS_OF,Persons,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Therapeutic procedure,USES,Drug Delivery Systems,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,AFFECTS,Influenza,32313880,10.1016/j.medidd.2020.100039,2020-04-22
Biguanides,AFFECTS,Coronavirus Infections,32313880,10.1016/j.medidd.2020.100039,2020-04-22
,STIMULATES,Phosphotransferases,32313879,10.1016/j.eclinm.2020.100354,2020-04-22
"PKN1 protein, human",AUGMENTS,Abnormal,32313879,10.1016/j.eclinm.2020.100354,2020-04-22
"PKN1 protein, human",ISA,Phosphotransferases,32313879,10.1016/j.eclinm.2020.100354,2020-04-22
Antibiotics,TREATS,Virus Diseases,32313879,10.1016/j.eclinm.2020.100354,2020-04-22
Vaccines,TREATS,Virus Diseases,32313879,10.1016/j.eclinm.2020.100354,2020-04-22
Middle Aged,ISA,Persons,32313873,10.1016/j.htct.2020.04.002,2020-04-22
Households,ISA,Persons,32313873,10.1016/j.htct.2020.04.002,2020-04-22
Contacts,TREATS,Community,32313873,10.1016/j.htct.2020.04.002,2020-04-22
Contacts,TREATS,Households,32313873,10.1016/j.htct.2020.04.002,2020-04-22
Coronavirus Infections,AFFECTS,Persons,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
Pandemics,ISA,Disease Outbreaks,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
Hospital admission,TREATS,Patients,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
hospital visit,TREATS,Patients,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
lymphatic cancer,PROCESS_OF,Patients,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
lymphatic cancer,PROCESS_OF,Patients,32313828,10.1016/j.onehlt.2020.100135,2020-04-22
Genus: Coronavirus,PROCESS_OF,Chiroptera,32313807,10.1016/j.idcr.2020.e00771,2020-04-22
Coronavirus Infections,CAUSES,Syndrome,32313807,10.1016/j.idcr.2020.e00771,2020-04-22
Coronavirus Infections,PROCESS_OF,Patients,32313807,10.1016/j.idcr.2020.e00771,2020-04-22
Syndrome,PROCESS_OF,Patients,32313806,10.1007/s10389-020-01258-3,2020-04-22
Isolation procedure,TREATS,Patients,32313806,10.1007/s10389-020-01258-3,2020-04-22
Mutation,PROCESS_OF,Genome,32313804,10.1007/s40475-020-00205-2,2020-04-22
Oral cavity,LOCATION_OF,Protection,32313784,10.7759/cureus.7668,2020-04-22
Antimicrobial Effect,COEXISTS_WITH,Digestion,32313784,10.7759/cureus.7668,2020-04-22
Disease,PROCESS_OF,Community,32313784,10.7759/cureus.7668,2020-04-22
Hospitals,LOCATION_OF,Diagnosis,32313784,10.7759/cureus.7668,2020-04-22
Coronavirus Infections,ISA,Disease,32313784,10.7759/cureus.7668,2020-04-22
Coronavirus Infections,PROCESS_OF(SPEC),Community,32313784,10.7759/cureus.7668,2020-04-22
Disease,PROCESS_OF,Patients,32313784,10.7759/cureus.7668,2020-04-22
Health Personnel,TREATS,Patients,32313784,10.7759/cureus.7668,2020-04-22
Thrombocytopenia,ISA,Disease,32313784,10.7759/cureus.7668,2020-04-22
Thrombocytopenia,PROCESS_OF(SPEC),Patients,32313784,10.7759/cureus.7668,2020-04-22
Virus,CAUSES,Hemorrhage,32313784,10.7759/cureus.7668,2020-04-22
Coronavirus Infections,ISA,Disease,32313784,10.7759/cureus.7668,2020-04-22
Respiratory viruses,PROCESS_OF,hospitalized patients,32313784,10.7759/cureus.7668,2020-04-22
Diagnosis,DIAGNOSES,Disease,32313784,10.7759/cureus.7668,2020-04-22
Dentist,DIAGNOSES,Disease,32313784,10.7759/cureus.7668,2020-04-22
Dentist,DIAGNOSES(SPEC),Coronavirus Infections,32313784,10.7759/cureus.7668,2020-04-22
Health Personnel,DIAGNOSES,Disease,32313784,10.7759/cureus.7668,2020-04-22
Health Personnel,DIAGNOSES(SPEC),Coronavirus Infections,32313784,10.7759/cureus.7668,2020-04-22
Coronavirus Infections,ISA,Disease,32313784,10.7759/cureus.7668,2020-04-22
Coronavirus Infections,ISA,Disease,32313784,10.7759/cureus.7668,2020-04-22
Ward (environment),LOCATION_OF,Study,32313662,10.1002/ams2.509,2020-04-22
Extracorporeal Membrane Oxygenation,ISA,Therapeutic procedure,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Extracorporeal Membrane Oxygenation,TREATS,Acute respiratory failure,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Disease,PROCESS_OF,Patients,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Extracorporeal Membrane Oxygenation,TREATS,Patients,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Extracorporeal Membrane Oxygenation,TREATS(INFER),Disease,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Coronavirus Infections,ISA,Disease,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Extracorporeal Membrane Oxygenation,ISA,Introduction procedure,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Pneumonia,COEXISTS_WITH,Disease,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Pneumonia,COEXISTS_WITH(SPEC),Coronavirus Infections,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Coronavirus Infections,ISA,Disease,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Coronavirus Infections,ISA,Disease,32313660,10.1016/j.nmni.2020.100682,2020-04-22
Hydroxychloroquine,ISA,Antimalarials,32313613,10.5704/MOJ.2007.001,2020-04-22
Critical Illness,PROCESS_OF,Patients,32313613,10.5704/MOJ.2007.001,2020-04-22
Pharmaceutical Preparations,TREATS,Disease,32313613,10.5704/MOJ.2007.001,2020-04-22
Extracorporeal Membrane Oxygenation,TREATS,Patients,32313613,10.5704/MOJ.2007.001,2020-04-22
Extracorporeal Membrane Oxygenation,TREATS(INFER),Critical Illness,32313613,10.5704/MOJ.2007.001,2020-04-22
Coughing,PROCESS_OF,Male population group,32313587,10.1016/j.jchirv.2020.04.009,2020-04-22
Dyspnea,PROCESS_OF,Male population group,32313587,10.1016/j.jchirv.2020.04.009,2020-04-22
Fever,PROCESS_OF,Male population group,32313587,10.1016/j.jchirv.2020.04.009,2020-04-22
Coughing,ISA,Symptoms,32313405,10.1016/j.chaos.2020.109829,2020-04-22
Dyspnea,ISA,Symptoms,32313405,10.1016/j.chaos.2020.109829,2020-04-22
Fever,ISA,Symptoms,32313405,10.1016/j.chaos.2020.109829,2020-04-22
Myalgia,ISA,Symptoms,32313405,10.1016/j.chaos.2020.109829,2020-04-22
Infected,PROCESS_OF,Persons,32313360,10.1016/j.telpol.2020.101976,2020-04-22
Emotions,PROCESS_OF,citizen,32313296,10.1016/j.cplett.2020.137489,2020-04-22
Decision,PROCESS_OF,citizen,32313296,10.1016/j.cplett.2020.137489,2020-04-22
Malignant Neoplasms,PROCESS_OF,Patients,32313181,10.1038/s41409-020-0895-4,2020-04-22
IMPACT gene,PART_OF,Cancer Patient,32313181,10.1038/s41409-020-0895-4,2020-04-22
China,ISA,Geographic Locations,32312919,10.5604/01.3001.0014.1039,2020-04-22
Italy,ISA,Country,32312919,10.5604/01.3001.0014.1039,2020-04-22
Neoplasms,PROCESS_OF,Patients,32312919,10.5604/01.3001.0014.1039,2020-04-22
Neoplasms,PROCESS_OF,Patients,32312919,10.5604/01.3001.0014.1039,2020-04-22
Infected,PROCESS_OF,Persons,32312892,10.1158/1078-0432.CCR-20-1364,2020-04-22
Infected,PROCESS_OF,Population Group,32312892,10.1158/1078-0432.CCR-20-1364,2020-04-22
Surgical Endoscopy,ISA,Intervention regimes,32312892,10.1158/1078-0432.CCR-20-1364,2020-04-22
Human body,USES,regulatory,32312717,10.1136/jclinpath-2020-206614,2020-04-22
Malignant Neoplasms,PROCESS_OF,Persons,32312676,10.1016/j.anorl.2020.04.010,2020-04-22
Severe disorder,PROCESS_OF,general population,32312676,10.1016/j.anorl.2020.04.010,2020-04-22
head and neck surgery,TREATS,Patients,32312646,10.1016/j.jphys.2020.03.011,2020-04-22
Confirmation,PROCESS_OF,Patients,32312628,10.1016/j.jocn.2020.04.062,2020-04-22
Genus: Coronavirus,CAUSES,Sepsis,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Sepsis,ISA,Symptoms,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Guillain-Barre Syndrome,PROCESS_OF,Patients,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Infected,PROCESS_OF,Patients,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Chief complaint (finding),PROCESS_OF,Patients,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Coughing,PROCESS_OF,Patients,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Guillain-Barre Syndrome,ISA,Immune System Diseases,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Guillain-Barre Syndrome,MANIFESTATION_OF(SPEC),Autoimmune Diseases,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Immune System Diseases,MANIFESTATION_OF,Autoimmune Diseases,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Guillain-Barre Syndrome,PROCESS_OF,Patients,32312600,10.1016/j.medin.2020.03.005,2020-04-22
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32312585,10.1016/j.bjoms.2020.04.003,2020-04-22
Severe disorder,PROCESS_OF,Persons,32312585,10.1016/j.bjoms.2020.04.003,2020-04-22
"Societies, Scientific",ISA,Societies,32312585,10.1016/j.bjoms.2020.04.003,2020-04-22
Warburg Therapy,USES,Nasal Cannula,32312585,10.1016/j.bjoms.2020.04.003,2020-04-22
Symptoms,ASSOCIATED_WITH,Pulmonary Embolism,32312571,10.1016/j.bja.2020.03.026,2020-04-22
Symptoms,PROCESS_OF,Patients,32312571,10.1016/j.bja.2020.03.026,2020-04-22
Heart,LOCATION_OF,Present,32312571,10.1016/j.bja.2020.03.026,2020-04-22
"Intubation, Intratracheal",TREATS,patient condition,32312568,10.1016/j.burns.2020.03.014,2020-04-22
Airway Management,TREATS,Patients,32312568,10.1016/j.burns.2020.03.014,2020-04-22
"Intubation, Intratracheal",TREATS,patient condition,32312568,10.1016/j.burns.2020.03.014,2020-04-22
"Endotracheal intubation, emergency procedure",TREATS,patient condition,32312568,10.1016/j.burns.2020.03.014,2020-04-22
Mental disorders,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
Mental disorders,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
Mental disorders,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
Comorbidity,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
Initiative,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
acute psychosis,PROCESS_OF,Patients,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
Possible,PREDISPOSES,Suicide,32312544,10.1016/j.eururo.2020.03.026,2020-04-22
alteplase,ADMINISTERED_TO,Patients,32312166,10.1177/0194599820921395,2020-04-22
Standard of Care,ADMINISTERED_TO,Patients,32312166,10.1177/0194599820921395,2020-04-22
Standard of Care,TREATS,"Respiratory Distress Syndrome, Adult",32312166,10.1177/0194599820921395,2020-04-22
alteplase,TREATS,Patients,32312166,10.1177/0194599820921395,2020-04-22
alteplase,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32312166,10.1177/0194599820921395,2020-04-22
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32312166,10.1177/0194599820921395,2020-04-22
Disinfection,USES,Endoscopes,32312163,10.1177/0194599820921413,2020-04-22
Symptom mild,PROCESS_OF,Patients,32312158,10.1177/0194599820922502,2020-04-22
aggressive cancer,PROCESS_OF,Patients,32312158,10.1177/0194599820922502,2020-04-22
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32312158,10.1177/0194599820922502,2020-04-22
Lung,LOCATION_OF,Lesion,32312025,10.11622/smedj.2020066,2020-04-22
Physical Examination,TREATS,Patients,32312025,10.11622/smedj.2020066,2020-04-22
Physical Examination,USES,Chest CT,32312025,10.11622/smedj.2020066,2020-04-22
Upper respiratory tract,LOCATION_OF,Nucleic Acids,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
Assay,NEG_DIAGNOSES,Infection,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
tomography,METHOD_OF,Diagnosis,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
Congenital anomaly of lung,COEXISTS_WITH,Pneumonia,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
Parenchyma,LOCATION_OF,Congenital anomaly of lung,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
Duration,TREATS,Patients,32312021,10.3760/cma.j.cn112338-20200404-00516,2020-04-22
Infected,PROCESS_OF,Unmarried person,32311836,10.1002/acr2.11148,2020-04-21
Rheumatoid Arthritis,ISA,Rheumatism,32311826,10.1111/ijlh.13229,2020-04-21
Rheumatoid Arthritis,PROCESS_OF(SPEC),Patients,32311826,10.1111/ijlh.13229,2020-04-21
Pharmaceutical Preparations,TREATS,Rheumatoid Arthritis,32311826,10.1111/ijlh.13229,2020-04-21
Rheumatism,PROCESS_OF,Patients,32311826,10.1111/ijlh.13229,2020-04-21
Rheumatism,PROCESS_OF,Participant,32311826,10.1111/ijlh.13229,2020-04-21
Therapeutic procedure,TREATS,Rheumatism,32311826,10.1111/ijlh.13229,2020-04-21
Cardiovascular care,TREATS,Coronary Arteriosclerosis,32311790,10.1111/acem.13992,2020-04-21
Acute myocardial infarction,PROCESS_OF,Patients,32311790,10.1111/acem.13992,2020-04-21
acute care,TREATS,Enthesitis-Related Arthritis,32311790,10.1111/acem.13992,2020-04-21
Myocardium,LOCATION_OF,Traumatic injury,32311790,10.1111/acem.13992,2020-04-21
Acute myocardial infarction,PROCESS_OF,Patients,32311790,10.1111/acem.13992,2020-04-21
Critical Illness,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Disease,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,ISA,Disease,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32311771,10.1111/anae.15093,2020-04-21
Critical Illness,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Disease,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,ISA,Disease,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32311771,10.1111/anae.15093,2020-04-21
Critical Illness,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Disease,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,ISA,Disease,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32311771,10.1111/anae.15093,2020-04-21
Critical Illness,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Disease,PROCESS_OF,Patients,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,ISA,Disease,32311771,10.1111/anae.15093,2020-04-21
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32311771,10.1111/anae.15093,2020-04-21
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32311760,10.1111/vox.12937,2020-04-21
Infected,PROCESS_OF,Patients,32311760,10.1111/vox.12937,2020-04-21
Coughing,PROCESS_OF,Patients,32311760,10.1111/vox.12937,2020-04-21
Coronavirus Infections,PROCESS_OF,Family,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Coronavirus Infections,ISA,Illness (finding),32311668,10.1016/j.intimp.2020.106519,2020-04-21
Coronavirus Infections,PROCESS_OF,Homo sapiens,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Illness (finding),ASSOCIATED_WITH,Coronavirus Infections,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Serum,ASSOCIATED_WITH(INFER),Infected,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Serum,PART_OF,Patients,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Infected,PROCESS_OF,Patients,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Plasma,LOCATION_OF,Riboflavin,32311668,10.1016/j.intimp.2020.106519,2020-04-21
plaque assay,MEASURES,Titer,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Platelets Product,COEXISTS_WITH,GSKIP gene,32311668,10.1016/j.intimp.2020.106519,2020-04-21
Pandemics,ISA,Disease Outbreaks,32311652,10.1016/j.dsx.2020.04.013,2020-04-21
diabetes education,ISA,Self-Management,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
Diabetes Mellitus,PROCESS_OF,Persons,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
diabetes education,ISA,Self-Management,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
diabetes mellitus management,TREATS,Persons,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
diabetes mellitus management,TREATS(INFER),Diabetes Mellitus,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
diabetes mellitus management,TREATS,Diabetes,32311651,10.1016/j.dsx.2020.04.019,2020-04-21
Diabetes,PROCESS_OF,Patients,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Diabetes,PROCESS_OF,Patients,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Obesity,COEXISTS_WITH,Diabetes Mellitus,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Obesity,COEXISTS_WITH,Co-morbid conditions,32311650,10.1016/j.jcv.2020.104364,2020-04-21
ACE2 gene,CAUSES,Low pH,32311650,10.1016/j.jcv.2020.104364,2020-04-21
ACE2 gene,CAUSES,Cardiac Arrhythmia,32311650,10.1016/j.jcv.2020.104364,2020-04-21
ACE2 gene,CAUSES,Myocarditis,32311650,10.1016/j.jcv.2020.104364,2020-04-21
ACE2 gene,PART_OF,Heart,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Brain Stem,LOCATION_OF,ACE2 gene,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Medulla,LOCATION_OF,ACE2 gene,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Brain Stem,LOCATION_OF,angiotensin I (1-7),32311650,10.1016/j.jcv.2020.104364,2020-04-21
Diabetes,PROCESS_OF,Patients,32311650,10.1016/j.jcv.2020.104364,2020-04-21
Diabetes,PROCESS_OF,Patients,32311650,10.1016/j.jcv.2020.104364,2020-04-21
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32311650,10.1016/j.jcv.2020.104364,2020-04-21
"Hospitals, University",LOCATION_OF,Retrospective Studies,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Comorbidity,PROCESS_OF,Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Anorexia,ISA,Symptoms,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Anorexia,PROCESS_OF(SPEC),Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Dyspnea,ISA,Symptoms,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Dyspnea,PROCESS_OF(SPEC),Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Fever,ISA,Symptoms,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Fever,PROCESS_OF(SPEC),Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Symptoms,PROCESS_OF,Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Coinfection,PROCESS_OF,Patients,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Coinfection,PREDISPOSES,Poor outcome,32311646,10.1016/j.earlhumdev.2020.105043,2020-04-21
Malta,ISA,Country,32311643,10.1016/j.ejca.2020.03.024,2020-04-21
Hospital admission,TREATS,Population Group,32311643,10.1016/j.ejca.2020.03.024,2020-04-21
Coronavirus Infections,ISA,Disease,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Malignant Neoplasms,PROCESS_OF,Patients,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Coronavirus Infections,ISA,Disease,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Physicians,DIAGNOSES,Neoplasms,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Coronavirus Infections,ISA,Disease,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Coronavirus Infections,ISA,Disease,32311512,10.1016/j.cgh.2020.04.030,2020-04-21
Hospitals,LOCATION_OF,Diagnostic radiologic examination,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Pneumonia,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Pneumonia,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Dyspnea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Fever,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Pneumonia,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Diarrhea,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
RNA Viruses,PROCESS_OF,Patients,32311498,10.1016/j.bbi.2020.04.040,2020-04-21
Adaptive Immunity,AFFECTS,Chronic inflammation,32311451,10.1016/j.ijid.2020.04.027,2020-04-21
Inflammation,CAUSES,Chronic disease,32311451,10.1016/j.ijid.2020.04.027,2020-04-21
Fever,PROCESS_OF,Patients,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Infected,PROCESS_OF,Patients,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Associated symptom,PROCESS_OF,Patients,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Unknown Significance,PROCESS_OF,Patients,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
"Intestines, Small",LOCATION_OF,ACE2 gene,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Organ,LOCATION_OF,ACE2 gene,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Organ,PART_OF,Homo sapiens,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
ACE2 gene,ASSOCIATED_WITH,Symptoms,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Proteins,INTERACTS_WITH,Enterocytes,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Enterocytes,PART_OF,"Intestines, Small",32311449,10.1016/j.ijid.2020.04.024,2020-04-21
ACE2 gene,INTERACTS_WITH,Enterocytes,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
ACE2 gene,CAUSES,Inflammation,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
ACE2 gene,CAUSES,Gastrointestinal symptom,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Digestive symptom,COEXISTS_WITH,patient condition,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Digestive symptom,COEXISTS_WITH,patient condition,32311449,10.1016/j.ijid.2020.04.024,2020-04-21
Disinfectants,ISA,Physical object,32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Respiratory sample,PART_OF,Staff,32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Ward (environment),LOCATION_OF,Viral culture procedure,32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Respiratory sample,PART_OF,Staff,32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Disinfection,PREVENTS,"Infections, Hospital",32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Ward (environment),LOCATION_OF,Study,32311448,10.1016/j.jacc.2020.04.031,2020-04-21
Arteries,LOCATION_OF,Thrombosis,32311437,10.1016/j.tmaid.2020.101673,2020-04-21
Blood Circulation,PROCESS_OF,Arteries,32311437,10.1016/j.tmaid.2020.101673,2020-04-21
Inflammation,CAUSES,Virus Diseases,32311437,10.1016/j.tmaid.2020.101673,2020-04-21
Veins,LOCATION_OF,Thrombosis,32311437,10.1016/j.tmaid.2020.101673,2020-04-21
Thrombosis,PROCESS_OF,Patients,32311437,10.1016/j.tmaid.2020.101673,2020-04-21
Blood,LOCATION_OF,Nucleic Acids,32311431,10.1016/j.micpath.2020.104209,2020-04-21
Sputum,LOCATION_OF,Nucleic Acids,32311431,10.1016/j.micpath.2020.104209,2020-04-21
Sputum,PART_OF,Patients,32311431,10.1016/j.micpath.2020.104209,2020-04-21
"Coronavirus, Canine",PROCESS_OF,Population Group,32311380,10.1016/j.ajic.2020.04.011,2020-04-21
prescribed,PREVENTS,Infection,32311350,10.1016/j.ajog.2020.04.013,2020-04-21
prescribed,PREVENTS,Colonization,32311350,10.1016/j.ajog.2020.04.013,2020-04-21
Water,DISRUPTS,Circulatory Process,32311350,10.1016/j.ajog.2020.04.013,2020-04-21
Gravidity,PROCESS_OF,Patients,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Birth,AFFECTS,Pregnant Women,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Diagnosis,ADMINISTERED_TO,Pregnant Women,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Diagnosis,USES,Laboratory Procedures,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Cesarean section,TREATS,Patients,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Cesarean section,TREATS(INFER),Gravidity,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Gravidity,PROCESS_OF,Patients,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Pulmonary Valve Insufficiency,COEXISTS_WITH,late pregnancy,32311320,10.1016/S2468-2667(20)30090-6,2020-04-21
Orthomyxoviridae Infections,PROCESS_OF,Outpatients,32311318,10.1016/S0140-6736(20)30920-X,2020-04-21
Abnormal behavior,PROCESS_OF,Child,32311318,10.1016/S0140-6736(20)30920-X,2020-04-21
SARS coronavirus,PROCESS_OF,Research Personnel,32311303,10.1089/lap.2020.0239,2020-04-21
SARS coronavirus,PROCESS_OF,Medical pathologist,32311303,10.1089/lap.2020.0239,2020-04-21
SARS coronavirus,PROCESS_OF,Clinician,32311303,10.1089/lap.2020.0239,2020-04-21
Viremia,ISA,Disease,32311303,10.1089/lap.2020.0239,2020-04-21
Viremia,MANIFESTATION_OF,Disease,32311303,10.1089/lap.2020.0239,2020-04-21
dumping,PROCESS_OF,Patients,32311132,10.1002/hast.1093,2020-04-21
Neuropathy,PROCESS_OF,Patients,32311109,10.1002/jmv.25905,2020-04-21
Immunoglobulin Therapy,ADMINISTERED_TO,Outpatients,32311109,10.1002/jmv.25905,2020-04-21
Plasma Exchange,ADMINISTERED_TO,Outpatients,32311109,10.1002/jmv.25905,2020-04-21
Sputum specimen,PART_OF,Patients,32311047,10.1093/jamia/ocaa063,2020-04-21
Feces,LOCATION_OF,Nucleic Acids,32311047,10.1093/jamia/ocaa063,2020-04-21
Feces,PART_OF,Patients,32311047,10.1093/jamia/ocaa063,2020-04-21
Respiratory sample,LOCATION_OF,Nucleic Acids,32311047,10.1093/jamia/ocaa063,2020-04-21
Respiratory sample,PART_OF,Patients,32311047,10.1093/jamia/ocaa063,2020-04-21
Nucleic Acids,PART_OF,Virus,32311047,10.1093/jamia/ocaa063,2020-04-21
Intra-Aortic Balloon Pumping,ADMINISTERED_TO,Patients,32310921,10.1714/3343.33133,2020-04-21
Cardiovascular,LOCATION_OF,American College of Cardiology/American Heart Association Lesion Complexity Score C,32310920,10.1714/3343.33132,2020-04-21
Congestive heart failure,PROCESS_OF,Patients,32310920,10.1714/3343.33132,2020-04-21
Diagnosis,DIAGNOSES,Pneumonia,32310916,10.1714/3343.33128,2020-04-21
Evaluation,TREATS,Patients,32310916,10.1714/3343.33128,2020-04-21
Lung,LOCATION_OF,Ultrasonography,32310916,10.1714/3343.33128,2020-04-21
Patients,ISA,Persons,32310916,10.1714/3343.33128,2020-04-21
Respiratory Care Units,LOCATION_OF,Ultrasonography,32310916,10.1714/3343.33128,2020-04-21
tomography,NEG_ADMINISTERED_TO,Patients,32310916,10.1714/3343.33128,2020-04-21
Hemodynamic instability,PROCESS_OF,Patients,32310916,10.1714/3343.33128,2020-04-21
Complication,PROCESS_OF,Patients,32310915,10.1714/3343.33127,2020-04-21
myocardial injury,PROCESS_OF,hospitalized patients,32310915,10.1714/3343.33127,2020-04-21
Troponin,PART_OF,Patients,32310915,10.1714/3343.33127,2020-04-21
Patients,LOCATION_OF,Troponin,32310915,10.1714/3343.33127,2020-04-21
Patients,LOCATION_OF,Troponin,32310915,10.1714/3343.33127,2020-04-21
Troponin,PART_OF,Patients,32310915,10.1714/3343.33127,2020-04-21
Critical Illness,PROCESS_OF,Patients,32310915,10.1714/3343.33127,2020-04-21
myocardial injury,PROCESS_OF,Patients,32310915,10.1714/3343.33127,2020-04-21
Detection,PREVENTS,myocardial injury,32310915,10.1714/3343.33127,2020-04-21
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32310817,10.2196/19139,2020-04-21
Homo sapiens,ISA,Organism,32310817,10.2196/19139,2020-04-21
Cell surface,LOCATION_OF,ACE2 gene,32310817,10.2196/19139,2020-04-21
Cell surface,PART_OF,Type-II Pneumocytes,32310817,10.2196/19139,2020-04-21
Cylinder (shape),LOCATION_OF,Alveolar Epithelial Cells,32310817,10.2196/19139,2020-04-21
"RNA, Messenger",COEXISTS_WITH,ACE2 gene,32310817,10.2196/19139,2020-04-21
"RNA, Messenger",INTERACTS_WITH,Angiotensin-Converting Enzyme Inhibitors,32310817,10.2196/19139,2020-04-21
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32310817,10.2196/19139,2020-04-21
Virus,INTERACTS_WITH,animal study,32310817,10.2196/19139,2020-04-21
Structure of pulmonic area,LOCATION_OF,ACE2 gene,32310817,10.2196/19139,2020-04-21
ACE2 gene,INHIBITS,angiotensin II,32310817,10.2196/19139,2020-04-21
"CD69 protein, human",ASSOCIATED_WITH(INFER),"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32310817,10.2196/19139,2020-04-21
"CD69 protein, human",PART_OF,Patients,32310817,10.2196/19139,2020-04-21
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32310817,10.2196/19139,2020-04-21
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32310817,10.2196/19139,2020-04-21
Coronavirus Infections,ISA,Disease,32310815,10.2196/19054,2020-04-21
Coronavirus Infections,ISA,Disease,32310815,10.2196/19054,2020-04-21
Coronavirus Infections,ISA,Disease,32310715,10.1089/sur.2020.101,2020-04-21
Specimen Collection,METHOD_OF,Detection,32310715,10.1089/sur.2020.101,2020-04-21
Coronavirus Infections,ISA,Disease,32310715,10.1089/sur.2020.101,2020-04-21
Genus: Coronavirus,ISA,RNA Viruses,32310190,10.3233/JRS-201017,2020-04-21
Genus: Coronavirus,PROCESS_OF,Homo sapiens,32310190,10.3233/JRS-201017,2020-04-21
SARS coronavirus,ISA,Genus: Coronavirus,32310190,10.3233/JRS-201017,2020-04-21
Symptoms,PROCESS_OF,Human Age Group,32310190,10.3233/JRS-201017,2020-04-21
Severe disorder,PROCESS_OF,Human Age Group,32310190,10.3233/JRS-201017,2020-04-21
Symptom severe,PROCESS_OF,Adult,32310190,10.3233/JRS-201017,2020-04-21
Gastrointestinal symptom,PROCESS_OF,Child,32310190,10.3233/JRS-201017,2020-04-21
Present,PROCESS_OF,Child,32310190,10.3233/JRS-201017,2020-04-21
Coronavirus Infections,PROCESS_OF,Homo sapiens,32310190,10.3233/JRS-201017,2020-04-21
Infection,PROCESS_OF,Child,32310190,10.3233/JRS-201017,2020-04-21
Cessation of life,PROCESS_OF,Persons,32310028,10.1080/09273948.2020.1755442,2020-04-21
"Antibodies, Neutralizing",INTERACTS_WITH,Specific antigen,32310028,10.1080/09273948.2020.1755442,2020-04-21
Infected,PROCESS_OF,Persons,32310017,10.1177/1747493020923472,2020-04-21
Cerebrovascular accident,PROCESS_OF,Patients,32310015,10.1177/1747493020921664,2020-04-21
Telemedicine,TREATS,Cerebrovascular accident,32310015,10.1177/1747493020921664,2020-04-21
Coronavirus Infections,ISA,Disease,32309854,10.1093/pubmed/fdaa049,2020-04-21
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Disease,32309854,10.1093/pubmed/fdaa049,2020-04-21
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH(SPEC),Coronavirus Infections,32309854,10.1093/pubmed/fdaa049,2020-04-21
Cerebrovascular accident,PROCESS_OF,Patients,32309854,10.1093/pubmed/fdaa049,2020-04-21
Cerebrovascular accident,PROCESS_OF,Patients,32309854,10.1093/pubmed/fdaa049,2020-04-21
Coronavirus Infections,ISA,Disease,32309854,10.1093/pubmed/fdaa049,2020-04-21
Patients,ISA,Persons,32309794,10.1016/j.trechm.2020.03.003,2020-04-21
Infection,PROCESS_OF,Child,32309794,10.1016/j.trechm.2020.03.003,2020-04-21
Neoplasms,PROCESS_OF,Community,32309622,10.15190/d.2020.2,2020-04-21
Severe Acute Respiratory Syndrome,AFFECTS,Severe (severity modifier),32309622,10.15190/d.2020.2,2020-04-21
Pharmaceutical Preparations,TREATS,Influenza,32309622,10.15190/d.2020.2,2020-04-21
Neoplasms,PROCESS_OF,Community,32309622,10.15190/d.2020.2,2020-04-21
Therapeutic procedure,NEG_TREATS,Patients,32309622,10.15190/d.2020.2,2020-04-21
Therapeutic procedure,TREATS,Malaria,32309622,10.15190/d.2020.2,2020-04-21
Neoplasms,PROCESS_OF,Physicians,32309622,10.15190/d.2020.2,2020-04-21
Physicians,TREATS,Patients,32309622,10.15190/d.2020.2,2020-04-21
Coronavirus Infections,ISA,Disease,32309388,10.21037/atm.2020.03.22,2020-04-21
Coronavirus Infections,ISA,Disease,32309388,10.21037/atm.2020.03.22,2020-04-21
Interventional procedure,TREATS,Outpatients,32309267,10.12890/2020_001641,2020-04-21
Symptoms,PROCESS_OF,Patients,32309266,10.12890/2020_001632,2020-04-21
Infection,CAUSES,Pneumonia,32309108,10.1140/epjp/s13360-020-00383-y,2020-04-21
Seizures,COEXISTS_WITH,Physical findings,32308988,10.1186/s41077-020-00121-5,2020-04-21
Pneumonia,PROCESS_OF,Patients,32308536,10.21315/mjms2020.27.2.1,2020-04-21
Eye,LOCATION_OF,SARS coronavirus,32308532,10.1186/s41182-020-00203-0,2020-04-21
Symptoms,PROCESS_OF,Woman,32308494,10.2147/CLEP.S249903,2020-04-21
Medical History,NEG_PROCESS_OF,Young Adult,32308494,10.2147/CLEP.S249903,2020-04-21
Physical findings,PROCESS_OF,Patients,32308266,10.6026/97320630016236,2020-04-21
Physical findings,PROCESS_OF,Patients,32308266,10.6026/97320630016236,2020-04-21
Symptoms,PROCESS_OF,Patients,32308266,10.6026/97320630016236,2020-04-21
Symptoms,PROCESS_OF,Patients,32308266,10.6026/97320630016236,2020-04-21
Bronchitis,PROCESS_OF,Patients,32308266,10.6026/97320630016236,2020-04-21
Therapeutic procedure,ADMINISTERED_TO,Patients,32308266,10.6026/97320630016236,2020-04-21
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32308263,10.6026/97320630016219,2020-04-21
azelastine,AFFECTS,Hydrophobic Interactions,32308263,10.6026/97320630016219,2020-04-21
conivaptan,AFFECTS,Hydrophobic Interactions,32308263,10.6026/97320630016219,2020-04-21
Intervention regimes,METHOD_OF,Prophylactic treatment,32308258,10.1016/j.chaos.2020.109761,2020-04-21
Immunotherapy,TREATS,Patients,32308258,10.1016/j.chaos.2020.109761,2020-04-21
Attitude,PROCESS_OF,Dentist,32307905,10.1111/1742-6723.13525,2020-04-21
Eye,LOCATION_OF,"CD69 protein, human",32307905,10.1111/1742-6723.13525,2020-04-21
Asia,ISA,Geographical continent,32307905,10.1111/1742-6723.13525,2020-04-21
Physicians,TREATS,Patients,32307810,10.1111/dth.13438,2020-04-21
Spinal Cord Injuries,PROCESS_OF,Patients,32307810,10.1111/dth.13438,2020-04-21
Challenge,TREATS,Physicians,32307810,10.1111/dth.13438,2020-04-21
Coronavirus Infections,ISA,Disease,32307653,10.1007/s12015-020-09976-7,2020-04-21
,PART_OF,Persons,32307653,10.1007/s12015-020-09976-7,2020-04-21
Host Cell,LOCATION_OF,receptor,32307593,10.1186/s13613-020-00661-z,2020-04-21
Stem cells,PART_OF,bony process,32307593,10.1186/s13613-020-00661-z,2020-04-21
protein protein interaction,PROCESS_OF,Stem cells,32307593,10.1186/s13613-020-00661-z,2020-04-21
Azithromycin,INHIBITS,,32307593,10.1186/s13613-020-00661-z,2020-04-21
Patient Discharge,AFFECTS,Possible,32307593,10.1186/s13613-020-00661-z,2020-04-21
Azithromycin,INHIBITS,Metalloproteases,32307593,10.1186/s13613-020-00661-z,2020-04-21
Antiviral Response,AFFECTS,Virus Replication,32307593,10.1186/s13613-020-00661-z,2020-04-21
Complication,PROCESS_OF,Patients,32307593,10.1186/s13613-020-00661-z,2020-04-21
Stem cells,INTERACTS_WITH,,32307593,10.1186/s13613-020-00661-z,2020-04-21
Stem cells,INTERACTS_WITH,ACE2 gene,32307593,10.1186/s13613-020-00661-z,2020-04-21
Stem cells,PART_OF,bony process,32307593,10.1186/s13613-020-00661-z,2020-04-21
Critical Illness,PROCESS_OF,Patients,32307550,10.1093/cid/ciaa462,2020-04-21
Pharmaceutical Preparations,ISA,Agent,32307550,10.1093/cid/ciaa462,2020-04-21
Pharmaceutical Preparations,TREATS(SPEC),Disease,32307550,10.1093/cid/ciaa462,2020-04-21
Coronavirus Infections,ISA,Disease,32307550,10.1093/cid/ciaa462,2020-04-21
Agent,TREATS,Disease,32307550,10.1093/cid/ciaa462,2020-04-21
Agent,TREATS(SPEC),Coronavirus Infections,32307550,10.1093/cid/ciaa462,2020-04-21
Coronavirus Infections,ISA,Disease,32307550,10.1093/cid/ciaa462,2020-04-21
Coronavirus Infections,ISA,Disease,32307519,10.1093/pubmed/fdaa054,2020-04-21
Coronavirus Infections,ISA,Disease,32307519,10.1093/pubmed/fdaa054,2020-04-21
Plasma,LOCATION_OF,cytokine,32307519,10.1093/pubmed/fdaa054,2020-04-21
Coughing,ISA,Symptoms,32307519,10.1093/pubmed/fdaa054,2020-04-21
Fever,ISA,Symptoms,32307519,10.1093/pubmed/fdaa054,2020-04-21
Gene Expression,COEXISTS_WITH,T-Cell Activation,32307519,10.1093/pubmed/fdaa054,2020-04-21
Coronavirus Infections,ISA,Disease,32307519,10.1093/pubmed/fdaa054,2020-04-21
mental health,PROCESS_OF,Persons,32307322,10.1016/j.jfma.2020.04.007,2020-04-21
treatment options,TREATS,Virus,32307322,10.1016/j.jfma.2020.04.007,2020-04-21
intensive care,ADMINISTERED_TO,Is an only child,32307320,10.1016/j.jfma.2020.04.006,2020-04-21
SARS coronavirus,ISA,Virus,32307320,10.1016/j.jfma.2020.04.006,2020-04-21
SARS coronavirus,PROCESS_OF,Child,32307320,10.1016/j.jfma.2020.04.006,2020-04-21
Lung,LOCATION_OF,Normal tissue morphology,32307319,10.1016/j.sapharm.2020.04.007,2020-04-21
Chronic disease,PREDISPOSES,Adherence To Medication Regime,32307313,10.1016/j.canrad.2020.04.001,2020-04-21
Chronic disease,PROCESS_OF,Patients,32307313,10.1016/j.canrad.2020.04.001,2020-04-21
Community Pharmacists,TREATS,Patients,32307313,10.1016/j.canrad.2020.04.001,2020-04-21
Health Care Systems,LOCATION_OF,Services,32307313,10.1016/j.canrad.2020.04.001,2020-04-21
Disseminated Intravascular Coagulation,CAUSES,Hemorrhagic Disorders,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Disseminated Intravascular Coagulation,CAUSES,Acute necrotizing encephalopathy,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",AFFECTS,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",AFFECTS,Adult,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",PROCESS_OF,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Systemic Inflammatory Response Syndrome,PROCESS_OF,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Brain Injuries,OCCURS_IN,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Storm Syndrome,PROCESS_OF,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",COEXISTS_WITH,Cytopenia,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",COEXISTS_WITH,Exanthema,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",COEXISTS_WITH,Fever,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",COEXISTS_WITH,Hypertriglyceridemia,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",COEXISTS_WITH,Organomegaly,32307269,10.1016/j.acra.2020.04.001,2020-04-21
"Lymphohistiocytosis, Hemophagocytic",PROCESS_OF,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Abnormality of coagulation,PROCESS_OF,Patients,32307269,10.1016/j.acra.2020.04.001,2020-04-21
Validation,USES,Injection of therapeutic agent,32307265,10.1016/j.anorl.2020.04.006,2020-04-21
Injection of therapeutic agent,TREATS,Social Networks,32307265,10.1016/j.anorl.2020.04.006,2020-04-21
huperzine B,TREATS,Social Networks,32307265,10.1016/j.anorl.2020.04.006,2020-04-21
Coronavirus Infections,PROCESS_OF,Health Personnel,32307245,10.1016/j.jmii.2020.03.034,2020-04-21
X-Ray Computed Tomography,ISA,Diagnostic radiologic examination,32307245,10.1016/j.jmii.2020.03.034,2020-04-21
Pharmaceutical Preparations,PREVENTS,Coughing,32307245,10.1016/j.jmii.2020.03.034,2020-04-21
Implantation procedure,USES,Tracheostomy tube,32307245,10.1016/j.jmii.2020.03.034,2020-04-21
favipiravir,TREATS,patient condition,32307215,10.1016/j.eururo.2020.03.054,2020-04-21
Cytoplasm,LOCATION_OF,Viral Genome,32307215,10.1016/j.eururo.2020.03.054,2020-04-21
Italy,ISA,Country,32307192,10.1016/j.amjoto.2020.102490,2020-04-21
major surgery,ADMINISTERED_TO,Patients,32307192,10.1016/j.amjoto.2020.102490,2020-04-21
Tract,LOCATION_OF,"Carcinoma, Transitional Cell",32307192,10.1016/j.amjoto.2020.102490,2020-04-21
Malignant Neoplasms,PROCESS_OF,Patients,32307192,10.1016/j.amjoto.2020.102490,2020-04-21
contextual factors,PROCESS_OF,Outpatients,32307189,10.1016/j.amjoto.2020.102483,2020-04-21
Symptoms,PROCESS_OF,Patients,32307151,10.1016/j.redar.2020.03.006,2020-04-21
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32307115,10.1016/j.bja.2020.03.025,2020-04-21
Severe disorder,PROCESS_OF,Persons,32307115,10.1016/j.bja.2020.03.025,2020-04-21
"Societies, Scientific",ISA,Societies,32307115,10.1016/j.bja.2020.03.025,2020-04-21
Warburg Therapy,USES,Nasal Cannula,32307115,10.1016/j.bja.2020.03.025,2020-04-21
Critical Illness,PROCESS_OF,Minority Groups,32307085,10.1016/j.jormas.2020.03.011,2020-04-21
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Minority Groups,32307085,10.1016/j.jormas.2020.03.011,2020-04-21
Bilateral pneumonia,PROCESS_OF,Minority Groups,32307085,10.1016/j.jormas.2020.03.011,2020-04-21
Administration occupational activities,ISA,Management procedure,32307085,10.1016/j.jormas.2020.03.011,2020-04-21
Coronavirus Infections,ISA,Disease,32306864,10.1080/22221751.2020.1756699,2020-04-21
Cessation of life,PROCESS_OF,Patients,32306864,10.1080/22221751.2020.1756699,2020-04-21
Severe disorder,PROCESS_OF,Patients,32306864,10.1080/22221751.2020.1756699,2020-04-21
Coronavirus Infections,COEXISTS_WITH,Thrombosis,32306864,10.1080/22221751.2020.1756699,2020-04-21
Coronavirus Infections,ISA,Disease,32306864,10.1080/22221751.2020.1756699,2020-04-21
Virus Replication,PROCESS_OF,Patients,32306862,10.1080/07391102.2020.1758791,2020-04-21
triazulenone,ISA,Pharmaceutical Preparations,32306860,10.1080/07391102.2020.1758790,2020-04-21
Diabetes,ISA,Disease,32306859,10.1080/10810730.2020.1749193,2020-04-21
Diabetes,PROCESS_OF(SPEC),Persons,32306859,10.1080/10810730.2020.1749193,2020-04-21
Disease,PROCESS_OF,Persons,32306859,10.1080/10810730.2020.1749193,2020-04-21
Oligonucleotide Primers,INTERACTS_WITH,Nucleocapsid,32306836,10.1080/07391102.2020.1758788,2020-04-21
Coronavirus Infections,PROCESS_OF,Family,32306822,10.1080/07391102.2020.1757510,2020-04-21
Infected,PROCESS_OF,Persons,32306822,10.1080/07391102.2020.1757510,2020-04-21
experimental method,MEASURES,Time,32306822,10.1080/07391102.2020.1757510,2020-04-21
Coronavirus Infections,ISA,Disease,32306755,10.1177/0846537120918834,2020-04-21
Coughing,ISA,Symptoms,32306751,10.1177/1535370220920540,2020-04-21
Dyspnea,ISA,Symptoms,32306751,10.1177/1535370220920540,2020-04-21
Fatigue,ISA,Symptoms,32306751,10.1177/1535370220920540,2020-04-21
Fever,ISA,Symptoms,32306751,10.1177/1535370220920540,2020-04-21
Myalgia,ISA,Symptoms,32306751,10.1177/1535370220920540,2020-04-21
Blood Vessel,LOCATION_OF,Thickened,32306751,10.1177/1535370220920540,2020-04-21
Chest CT,DIAGNOSES,Ground Glass Opacity,32306751,10.1177/1535370220920540,2020-04-21
Infected,PROCESS_OF,Patients,32306626,10.3760/cma.j.cn115330-20200205-00237,2020-04-21
Eye,LOCATION_OF,Communicable Diseases,32306597,10.3760/cma.j.issn.1671-0274.2020-0316-00147,2020-04-21
Eye,LOCATION_OF,Symptoms,32306597,10.3760/cma.j.issn.1671-0274.2020-0316-00147,2020-04-21
"Abdomen, Acute",ISA,Disease,32306555,10.1002/ase.1968,2020-04-20
Gastrointestinal Hemorrhage,ISA,Disease,32306555,10.1002/ase.1968,2020-04-20
Gastrointestinal Neoplasms,ISA,Disease,32306555,10.1002/ase.1968,2020-04-20
trauma to the abdomen,ISA,Disease,32306555,10.1002/ase.1968,2020-04-20
Protection,PROCESS_OF,Medical Staff,32306555,10.1002/ase.1968,2020-04-20
Eye,LOCATION_OF,Fasting,32306513,10.1111/dth.13433,2020-04-20
Cornelia De Lange Syndrome,AFFECTS,Woman,32306500,10.1111/tbed.13588,2020-04-20
Coronavirus Infections,ISA,Disease,32306492,10.1111/jth.14859,2020-04-20
D-dimer above reference range,PROCESS_OF,Patients,32306491,10.1111/jocs.14538,2020-04-20
Fibrin fragment D,PART_OF,Patients,32306491,10.1111/jocs.14538,2020-04-20
Fibrin fragment D,PART_OF,Patients,32306491,10.1111/jocs.14538,2020-04-20
Patients,LOCATION_OF,Fibrin fragment D,32306491,10.1111/jocs.14538,2020-04-20
Patients,USES,Preexisting Condition Coverage,32306452,10.1096/fj.202000782,2020-04-20
Respiratory complication,COEXISTS_WITH,Disease,32306452,10.1096/fj.202000782,2020-04-20
Respiratory complication,COEXISTS_WITH(SPEC),Coronavirus Infections,32306452,10.1096/fj.202000782,2020-04-20
Respiratory complication,ISA,Disease,32306452,10.1096/fj.202000782,2020-04-20
Coronavirus Infections,ISA,Disease,32306452,10.1096/fj.202000782,2020-04-20
Cardiac Surgery procedures,TREATS,Patients,32306452,10.1096/fj.202000782,2020-04-20
Cardiac dysfunction,PROCESS_OF,Patients,32306452,10.1096/fj.202000782,2020-04-20
Cardiovascular,LOCATION_OF,Homeostasis,32306440,10.1111/pan.13889,2020-04-20
angiotensin converting enzyme 2,AFFECTS,Renin-angiotensin system,32306440,10.1111/pan.13889,2020-04-20
Anesthetist,TREATS,Patients,32306408,10.5694/mja2.50596,2020-04-20
Ventilator - respiratory equipment,TREATS,Nursing Staff,32306369,10.1007/s40615-020-00756-0,2020-04-20
Ventilator - respiratory equipment,TREATS,Clinician,32306369,10.1007/s40615-020-00756-0,2020-04-20
Immunity,PROCESS_OF,African race,32306290,10.1007/s11239-020-02084-w,2020-04-20
Immunity,PROCESS_OF,African race,32306290,10.1007/s11239-020-02084-w,2020-04-20
Coronavirus Infections,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Disease,PROCESS_OF,Patients,32306288,10.1007/s40262-020-00891-1,2020-04-20
Thrombosis,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Thrombosis,PROCESS_OF(SPEC),Patients,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32306288,10.1007/s40262-020-00891-1,2020-04-20
Disease,COMPLICATES,Arteriosclerosis Obliterans,32306288,10.1007/s40262-020-00891-1,2020-04-20
Disease,COMPLICATES,Venous Thrombosis,32306288,10.1007/s40262-020-00891-1,2020-04-20
Lower Extremity,LOCATION_OF,Arteriosclerosis Obliterans,32306288,10.1007/s40262-020-00891-1,2020-04-20
Lower Extremity,LOCATION_OF,Venous Thrombosis,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,COMPLICATES(SPEC),Arteriosclerosis Obliterans,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,COMPLICATES(SPEC),Venous Thrombosis,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Peripheral Vascular Diseases,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Deep Vein Thrombosis,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Coronavirus Infections,ISA,Disease,32306288,10.1007/s40262-020-00891-1,2020-04-20
Chloroquine,COEXISTS_WITH,Antimalarials,32306166,10.1007/s11604-020-00974-w,2020-04-20
Chloroquine,TREATS,Pneumonia,32306166,10.1007/s11604-020-00974-w,2020-04-20
Chloroquine,TREATS,Severe Acute Respiratory Syndrome,32306166,10.1007/s11604-020-00974-w,2020-04-20
Malaria,PROCESS_OF,Adult,32306166,10.1007/s11604-020-00974-w,2020-04-20
Critical Illness,PROCESS_OF,Patients,32306166,10.1007/s11604-020-00974-w,2020-04-20
Critical Illness,PROCESS_OF,Patients,32306166,10.1007/s11604-020-00974-w,2020-04-20
Obesity,PROCESS_OF,Patients,32306166,10.1007/s11604-020-00974-w,2020-04-20
Renal Insufficiency,PROCESS_OF,Patients,32306166,10.1007/s11604-020-00974-w,2020-04-20
Chloroquine,TREATS,Acute viral disease,32306166,10.1007/s11604-020-00974-w,2020-04-20
Acute viral disease,PROCESS_OF,Child,32306166,10.1007/s11604-020-00974-w,2020-04-20
Nose,LOCATION_OF,Congestion,32306047,10.1093/cid/ciaa461,2020-04-20
Upper respiratory tract,LOCATION_OF,Symptoms,32306047,10.1093/cid/ciaa461,2020-04-20
Symptoms,PROCESS_OF,Patients,32306047,10.1093/cid/ciaa461,2020-04-20
"Ear, nose and throat surgeon",TREATS,Patients,32306047,10.1093/cid/ciaa461,2020-04-20
Coughing,PROCESS_OF,Patients,32306047,10.1093/cid/ciaa461,2020-04-20
urgent Operation,USES,NT5E wt Allele,32306047,10.1093/cid/ciaa461,2020-04-20
ENT symptoms,PROCESS_OF,Patients,32306047,10.1093/cid/ciaa461,2020-04-20
Enzyme-Linked Immunosorbent Assay,METHOD_OF,Serologic tests,32306042,10.1093/cid/ciaa459,2020-04-20
Patients,LOCATION_OF,Recombinant Proteins,32306042,10.1093/cid/ciaa459,2020-04-20
Confirmation,PROCESS_OF,Patients,32306042,10.1093/cid/ciaa459,2020-04-20
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32306042,10.1093/cid/ciaa459,2020-04-20
Confirmation,PROCESS_OF,Patients,32306042,10.1093/cid/ciaa459,2020-04-20
Multiple Myeloma,PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
Smoldering myeloma,PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
Screening procedure,TREATS,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
Disease,PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
"Leukemia, Plasma Cell",PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32305937,10.1109/RBME.2020.2987975,2020-04-20
Artificial Intelligence,ISA,Technology,32305884,10.1016/j.jcv.2020.104357,2020-04-20
radiologist,DIAGNOSES,Disease,32305884,10.1016/j.jcv.2020.104357,2020-04-20
Hospitals,LOCATION_OF,tomography,32305884,10.1016/j.jcv.2020.104357,2020-04-20
Falls,PREDISPOSES,Venous Thromboembolism,32305882,10.1016/j.jcv.2020.104354,2020-04-20
Problem,PROCESS_OF,Patients,32305882,10.1016/j.jcv.2020.104354,2020-04-20
Blood Coagulation Disorders,COEXISTS_WITH,patient condition,32305882,10.1016/j.jcv.2020.104354,2020-04-20
Diabetes Mellitus,PROCESS_OF,Patients,32305831,10.1016/j.ejca.2020.03.021,2020-04-20
Disease,PROCESS_OF,Patients,32305831,10.1016/j.ejca.2020.03.021,2020-04-20
diabetic,PROCESS_OF,Patients,32305831,10.1016/j.ejca.2020.03.021,2020-04-20
diabetic,PROCESS_OF,Patients,32305831,10.1016/j.ejca.2020.03.021,2020-04-20
Disease,OCCURS_IN,Old age,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Severe course,PROCESS_OF,Child,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Severe course,PROCESS_OF,Young Adult,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Age,ASSOCIATED_WITH,Diabetes,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Age,ASSOCIATED_WITH,Hypertensive disease,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Severe course,PROCESS_OF,Child,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Pharmacotherapy,ADMINISTERED_TO,Child,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
treatment options,TREATS,Child,32305589,10.1016/j.ijantimicag.2020.105984,2020-04-20
Eye,LOCATION_OF,Virus Diseases,32305587,10.1016/j.ijantimicag.2020.105988,2020-04-20
Pharmaceutical Preparations,TREATS,Disease,32305587,10.1016/j.ijantimicag.2020.105988,2020-04-20
Pharmaceutical Preparations,TREATS,Patients,32305587,10.1016/j.ijantimicag.2020.105988,2020-04-20
Drug Repositioning,AFFECTS,Adverse effects,32305587,10.1016/j.ijantimicag.2020.105988,2020-04-20
Hydroxychloroquine,ADMINISTERED_TO,Persons,32305585,10.1016/j.jvsv.2020.04.009,2020-04-20
Coronavirus Infections,ISA,Disease,32305585,10.1016/j.jvsv.2020.04.009,2020-04-20
Malaise,PROCESS_OF,Patients,32305563,10.1016/j.medmal.2020.04.006,2020-04-20
D-dimer above reference range,PROCESS_OF,Patients,32305563,10.1016/j.medmal.2020.04.006,2020-04-20
Empirical therapy,TREATS,Patients,32305563,10.1016/j.medmal.2020.04.006,2020-04-20
Dysgeusia,PROCESS_OF,Patients,32305557,10.1016/j.pcad.2020.04.008,2020-04-20
Infected,PROCESS_OF,Patients,32305533,10.1016/j.ijsu.2020.04.018,2020-04-20
Myocarditis,PROCESS_OF,Patients,32305533,10.1016/j.ijsu.2020.04.018,2020-04-20
Infected,PROCESS_OF,Patients,32305506,10.1016/j.biochi.2020.04.008,2020-04-20
Pandemics,ISA,Disease Outbreaks,32305506,10.1016/j.biochi.2020.04.008,2020-04-20
Alveolar Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32305501,10.1016/j.micinf.2020.04.005,2020-04-20
Alveolar Epithelial Cells,PART_OF,Lung,32305501,10.1016/j.micinf.2020.04.005,2020-04-20
Chloroquine,INTERACTS_WITH,angiotensin converting enzyme 2,32305501,10.1016/j.micinf.2020.04.005,2020-04-20
INVESTIGATIONAL VACCINES,CAUSES,Additional concerns,32305500,10.1016/j.micinf.2020.04.004,2020-04-20
Coronavirus vaccination,USES,viral vector,32305500,10.1016/j.micinf.2020.04.004,2020-04-20
Chloroquine,ISA,Antimalarials,32305459,10.1016/j.jiph.2020.04.004,2020-04-20
Anti-Inflammatory Agents,TREATS,Rheumatoid Arthritis,32305459,10.1016/j.jiph.2020.04.004,2020-04-20
Hydroxychloroquine,TREATS,SARS coronavirus,32305459,10.1016/j.jiph.2020.04.004,2020-04-20
Chloroquine,AUGMENTS,Disease,32305459,10.1016/j.jiph.2020.04.004,2020-04-20
Coronavirus Infections,ISA,Disease,32305402,10.1016/j.jacc.2020.04.029,2020-04-20
Coronavirus Infections,ISA,Disease,32305402,10.1016/j.jacc.2020.04.029,2020-04-20
Prematurity of fetus,PROCESS_OF,Woman,32305402,10.1016/j.jacc.2020.04.029,2020-04-20
Critical Illness,PROCESS_OF,Patients,32305401,10.1016/j.jacc.2020.04.028,2020-04-20
angiotensin converting enzyme 2,AFFECTS,Protection,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Angiotensin-Converting Enzyme Inhibitors,AUGMENTS,receptor expression,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Cardiovascular Diseases,PROCESS_OF,Patients,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Virus Diseases,NEG_PROCESS_OF,Patients,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Angiotensin II receptor antagonist,AUGMENTS,receptor expression,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
receptor expression,PROCESS_OF,angiotensin converting enzyme 2,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Mineralocorticoid Receptor Antagonists,AUGMENTS,receptor expression,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Up-Regulation (Physiology),COEXISTS_WITH,Severe Acute Respiratory Syndrome,32305384,10.1016/j.jvs.2020.04.019,2020-04-20
Infected,PROCESS_OF,Patients,32305359,10.1016/j.bbmt.2020.04.005,2020-04-20
Blood Vessel,LOCATION_OF,huperzine B,32305359,10.1016/j.bbmt.2020.04.005,2020-04-20
Pathology procedure,DIAGNOSES,Obstruction,32305359,10.1016/j.bbmt.2020.04.005,2020-04-20
Pathology procedure,USES,Operative Surgical Procedures,32305359,10.1016/j.bbmt.2020.04.005,2020-04-20
Cell Therapy,TREATS,Patients,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Hemopoietic stem cell transplant,TREATS,Patients,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Pharmaceutical Services,TREATS,inpatient,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Pharmaceutical Services,TREATS,Outpatients,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Transplantation,TREATS,Hematopoietic Cell Transplantation Recipient,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Cell Therapy,TREATS,Population Group,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Cell Therapy,TREATS,Hematopoietic Cell Transplantation Recipient,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Hemopoietic stem cell transplant,TREATS,Population Group,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Pharmacy Service Providers,TREATS,Hematopoietic Cell Transplantation Recipient,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Cell Therapy,TREATS,Patients,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Hemopoietic stem cell transplant,TREATS,Patients,32305323,10.1016/j.idh.2020.04.001,2020-04-20
Acute pulmonary embolism,PROCESS_OF,Patients,32305286,10.1016/j.athoracsur.2020.04.003,2020-04-20
Clotrimazole,TREATS,"Foramen Ovale, Patent",32305286,10.1016/j.athoracsur.2020.04.003,2020-04-20
Embolectomy,ISA,Operative Surgical Procedures,32305286,10.1016/j.athoracsur.2020.04.003,2020-04-20
Evaluation,AFFECTS,Possible,32305269,10.1016/j.jmii.2020.04.002,2020-04-20
Italians,ISA,Population Group,32305269,10.1016/j.jmii.2020.04.002,2020-04-20
Infected,PROCESS_OF,Patients,32305269,10.1016/j.jmii.2020.04.002,2020-04-20
Zimbabwe,ISA,Country,32305249,10.1016/j.clinre.2020.03.013,2020-04-20
Diarrhea,PROCESS_OF,Patients,32305181,10.1016/j.clnu.2020.03.022,2020-04-20
Pharyngeal structure,LOCATION_OF,laboratory examination,32305181,10.1016/j.clnu.2020.03.022,2020-04-20
Diarrhea,ISA,Symptoms,32305181,10.1016/j.clnu.2020.03.022,2020-04-20
Gastrointestinal symptom,PROCESS_OF,Patients,32305181,10.1016/j.clnu.2020.03.022,2020-04-20
intensive care unit,LOCATION_OF,Administration occupational activities,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Respiratory complication,PROCESS_OF,Patients,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Malnutrition,PROCESS_OF,Persons,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Skeletal muscle structure,LOCATION_OF,Macrophage Activation Syndrome,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Stabilization,CAUSES,Macrophage Activation Syndrome,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Prophylactic treatment,TREATS,Malnutrition,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Malnutrition,COEXISTS_WITH,Senility,32305134,10.1067/j.cpradiol.2020.04.001,2020-04-20
Infected,PROCESS_OF,Patients,32305075,10.1016/S2468-1253(20)30119-9,2020-04-20
tomography,DIAGNOSES,Infection,32305075,10.1016/S2468-1253(20)30119-9,2020-04-20
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32305046,10.1055/s-0040-1710050,2020-04-19
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32305046,10.1055/s-0040-1710050,2020-04-19
Respiratory Failure,PROCESS_OF,Patients,32305025,10.1016/j.jcv.2020.104360,2020-04-19
Cesarean section,TREATS,Patients,32305025,10.1016/j.jcv.2020.104360,2020-04-19
Isolation procedure,TREATS,Patients,32305025,10.1016/j.jcv.2020.104360,2020-04-19
Real-Time Polymerase Chain Reaction,METHOD_OF,History,32305024,10.1016/j.dsx.2020.04.012,2020-04-19
Dry cough,ISA,Symptoms,32305024,10.1016/j.dsx.2020.04.012,2020-04-19
Intelligence,PROCESS_OF,Homo sapiens,32304994,10.1016/j.intimp.2020.106504,2020-04-19
C-reactive protein,PART_OF,Patients,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Inflammation,COEXISTS_WITH,Disease,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Inflammation,COEXISTS_WITH(SPEC),Coronavirus Infections,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Coronavirus Infections,ISA,Disease,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Coronavirus Infections,ISA,Disease,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Coughing,ISA,Symptoms,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Coronavirus Infections,ISA,Disease,32304973,10.1016/j.scitotenv.2020.138539,2020-04-19
Coronavirus Infections,CAUSES,Illness (finding),32304942,10.1016/j.scitotenv.2020.138513,2020-04-19
Pain,PROCESS_OF,Homeless persons,32304834,10.1016/j.jaip.2020.04.012,2020-04-19
psychological distress,PROCESS_OF,Homeless persons,32304834,10.1016/j.jaip.2020.04.012,2020-04-19
Hypersensitivity,PROCESS_OF,Community,32304822,10.1016/j.ijid.2020.03.049,2020-04-19
Hypersensitivity,PROCESS_OF,Community,32304822,10.1016/j.ijid.2020.03.049,2020-04-19
Influenza-like illness,PROCESS_OF,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Symptoms,PROCESS_OF,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Infected,PROCESS_OF,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Infected,PROCESS_OF,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Nasal Swabs,TREATS,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Quarantine,TREATS,Child,32304772,10.1016/j.chest.2020.04.010,2020-04-19
Fatal Outcome,COEXISTS_WITH,risk factors,32304747,10.1016/j.phrs.2020.104832,2020-04-19
GSKIP gene,PART_OF,Patients,32304747,10.1016/j.phrs.2020.104832,2020-04-19
procalcitonin,ASSOCIATED_WITH,Fatal Outcome,32304747,10.1016/j.phrs.2020.104832,2020-04-19
early identification,TREATS,Patients,32304747,10.1016/j.phrs.2020.104832,2020-04-19
Antihypertensive Agents,PREVENTS,Inflammation,32304745,10.1016/j.cmi.2020.04.012,2020-04-19
Virus Diseases,CAUSES,Severe Acute Respiratory Syndrome,32304745,10.1016/j.cmi.2020.04.012,2020-04-19
Diabetes,AFFECTS,Patients,32304745,10.1016/j.cmi.2020.04.012,2020-04-19
Hypertensive disease,AFFECTS,Patients,32304745,10.1016/j.cmi.2020.04.012,2020-04-19
Kidney Diseases,AFFECTS,Patients,32304745,10.1016/j.cmi.2020.04.012,2020-04-19
Coronavirus Infections,ISA,Disease,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Disease,PROCESS_OF,Patients,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Coronavirus Infections,ISA,Disease,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Mild disorder,PROCESS_OF,Patients,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Myalgia,ASSOCIATED_WITH,organic sexual dysfunction,32304737,10.1016/j.cgh.2020.04.028,2020-04-19
Experience,PROCESS_OF,Persons,32304643,10.1016/j.jacr.2020.03.025,2020-04-19
Experience,PROCESS_OF,Persons,32304643,10.1016/j.jacr.2020.03.025,2020-04-19
Infantile Neuroaxonal Dystrophy,AFFECTS,viral transmission,32304577,10.1111/bjh.16727,2020-04-19
Disseminated Intravascular Coagulation,ISA,Blood Coagulation Disorders,32304512,10.1097/AOG.0000000000003919,2020-04-19
Disease,PROCESS_OF,Patients,32304512,10.1097/AOG.0000000000003919,2020-04-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32304512,10.1097/AOG.0000000000003919,2020-04-19
Septicemia,CAUSES,Blood Coagulation Disorders,32304512,10.1097/AOG.0000000000003919,2020-04-19
Anxiety,PROCESS_OF,Obstetrician,32304508,10.1097/JCMA.0000000000000325,2020-04-19
Confusion,PROCESS_OF,Obstetrician,32304508,10.1097/JCMA.0000000000000325,2020-04-19
Malaise,PROCESS_OF,Patients,32304508,10.1097/JCMA.0000000000000325,2020-04-19
Malaise,PROCESS_OF,Pregnant Women,32304508,10.1097/JCMA.0000000000000325,2020-04-19
Face,LOCATION_OF,Protection,32304508,10.1097/JCMA.0000000000000325,2020-04-19
Pharmaceutical Preparations,TREATS,Transplant Recipients,32304466,10.1097/INF.0000000000002704,2020-04-19
Intervention regimes,TREATS,Patients,32304466,10.1097/INF.0000000000002704,2020-04-19
Transplantation,ADMINISTERED_TO,Clinician,32304466,10.1097/INF.0000000000002704,2020-04-19
"Therapies, Investigational",USES,Pharmaceutical Preparations,32304466,10.1097/INF.0000000000002704,2020-04-19
Nasopharynx,LOCATION_OF,Confirmation,32304435,10.1097/COC.0000000000000712,2020-04-19
Cancer Patient,LOCATION_OF,IMPACT gene,32304402,10.1097/RLI.0000000000000689,2020-04-19
Pneumonia,PROCESS_OF,Patients,32304401,10.5435/JAAOS-D-20-00360,2020-04-19
Lung,LOCATION_OF,Normal density,32304401,10.5435/JAAOS-D-20-00360,2020-04-19
Lung,LOCATION_OF,Normal density,32304401,10.5435/JAAOS-D-20-00360,2020-04-19
Pneumonia,PROCESS_OF,Patients,32304401,10.5435/JAAOS-D-20-00360,2020-04-19
Disease,PROCESS_OF,Patients,32304393,10.1097/MAT.0000000000001176,2020-04-19
Multiple Organ Failure,PROCESS_OF,Patients,32304393,10.1097/MAT.0000000000001176,2020-04-19
Elevation procedure,USES,cytokine,32304393,10.1097/MAT.0000000000001176,2020-04-19
Physical Examination,USES,fdg pet,32304387,10.1097/ACM.0000000000003441,2020-04-19
Syndrome,PROCESS_OF,Recipient,32304387,10.1097/ACM.0000000000003441,2020-04-19
Recipient,USES,Left ventricular assist device,32304387,10.1097/ACM.0000000000003441,2020-04-19
Left ventricular assist device,TREATS,Patients,32304387,10.1097/ACM.0000000000003441,2020-04-19
Training,ISA,patient care,32304386,10.1097/ACM.0000000000003440,2020-04-19
Medical center,LOCATION_OF,Personnel Management,32304371,10.21149/11408,2020-04-19
Virus,CAUSES,Disease,32304276,10.1111/odi.13359,2020-04-19
Quarantine,USES,Masks,32304276,10.1111/odi.13359,2020-04-19
Disease,COMPLICATES,Mouth Diseases,32304265,10.1111/1754-9485.13047,2020-04-19
Satisfaction,PROCESS_OF,Participant,32304208,10.1093/ajcp/aqaa064,2020-04-19
Assay,USES,PCR test for SARS,32304192,10.3906/sag-2004-187,2020-04-19
Readiness,COEXISTS_WITH,Influenza A,32304191,10.3906/sag-2004-174,2020-04-19
Coronavirus Infections,ISA,Disease,32304191,10.3906/sag-2004-174,2020-04-19
Chronic disease,PROCESS_OF,Persons,32304191,10.3906/sag-2004-174,2020-04-19
School,LOCATION_OF,Knowledge acquisition,32304191,10.3906/sag-2004-174,2020-04-19
Coronavirus Infections,ISA,Disease,32304119,10.1002/hed.26166,2020-04-19
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32304119,10.1002/hed.26166,2020-04-19
Coronavirus Infections,ISA,Disease,32304119,10.1002/hed.26166,2020-04-19
Disease,PROCESS_OF,Patients,32304119,10.1002/hed.26166,2020-04-19
Coronavirus Infections,ISA,Disease,32304119,10.1002/hed.26166,2020-04-19
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32304119,10.1002/hed.26166,2020-04-19
Disease,PROCESS_OF,Patients,32304119,10.1002/hed.26166,2020-04-19
Coronavirus Infections,ISA,Disease,32304119,10.1002/hed.26166,2020-04-19
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32304119,10.1002/hed.26166,2020-04-19
Lung,LOCATION_OF,Severe inflammation,32304108,10.1002/pro.3873,2020-04-19
Pharmaceutical Preparations,PREVENTS,Infection,32304092,10.1111/epi.16524,2020-04-19
Vaccines,PREVENTS,Infection,32304092,10.1111/epi.16524,2020-04-19
SARS coronavirus,ISA,Virus,32304092,10.1111/epi.16524,2020-04-19
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32304092,10.1111/epi.16524,2020-04-19
"CD69 protein, human",PREDISPOSES,Symptomatic seizures,32303925,10.1007/s10461-020-02871-9,2020-04-19
Symptomatic seizures,PROCESS_OF,Persons,32303925,10.1007/s10461-020-02871-9,2020-04-19
Severe disorder,PROCESS_OF,Persons,32303925,10.1007/s10461-020-02871-9,2020-04-19
Hypocalcemia,COEXISTS_WITH,Disease Progression,32303925,10.1007/s10461-020-02871-9,2020-04-19
"Stress Disorders, Traumatic, Acute",COEXISTS_WITH,Disease Progression,32303925,10.1007/s10461-020-02871-9,2020-04-19
Symptoms,PROCESS_OF,Persons,32303925,10.1007/s10461-020-02871-9,2020-04-19
Symptomatic seizures,PROCESS_OF,Persons,32303925,10.1007/s10461-020-02871-9,2020-04-19
Coronavirus Infections,ISA,Disease,32303920,10.1007/s10900-020-00825-9,2020-04-19
Multiple Chronic Conditions,PREDISPOSES,physical illness,32303920,10.1007/s10900-020-00825-9,2020-04-19
Critical Illness,PROCESS_OF,Patients,32303856,10.1007/s10072-020-04391-9,2020-04-19
Pneumonia,PROCESS_OF,Patients,32303856,10.1007/s10072-020-04391-9,2020-04-19
Immunosuppressive Agents,ISA,Pharmaceutical Preparations,32303821,10.1007/s00393-020-00800-8,2020-04-19
Multiple Sclerosis,PROCESS_OF,Persons,32303821,10.1007/s00393-020-00800-8,2020-04-19
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32303821,10.1007/s00393-020-00800-8,2020-04-19
Rheumatic Fever,PROCESS_OF,Patients,32303798,10.1007/s00068-020-01364-7,2020-04-19
Complication,PROCESS_OF,Cohort,32303672,10.1038/s41394-020-0274-9,2020-04-19
Antibiotics,TREATS,Fever,32303650,10.1212/WNL.0000000000009619,2020-04-19
Hydroxychloroquine,COEXISTS_WITH,lopinavir / Ritonavir,32303650,10.1212/WNL.0000000000009619,2020-04-19
Antiviral Therapy,USES,lopinavir / Ritonavir,32303650,10.1212/WNL.0000000000009619,2020-04-19
chest findings,PROCESS_OF,Patients,32303650,10.1212/WNL.0000000000009619,2020-04-19
Outpatients,ISA,Clients,32303650,10.1212/WNL.0000000000009619,2020-04-19
Suspicion,PROCESS_OF,Clients,32303650,10.1212/WNL.0000000000009619,2020-04-19
Suspicion,PROCESS_OF,inpatient,32303650,10.1212/WNL.0000000000009619,2020-04-19
Suspicion,PROCESS_OF(SPEC),Outpatients,32303650,10.1212/WNL.0000000000009619,2020-04-19
Anosmia,PROCESS_OF,Male population group,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Polyneuritis,PROCESS_OF,Patients,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Miller Fisher Syndrome,PROCESS_OF,Patients,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Ageusia,PROCESS_OF,Male population group,32303609,10.1136/gutjnl-2020-321269,2020-04-19
"Immunoglobulins, Intravenous",TREATS,Patients,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Immune response,CAUSES,Neurologic Manifestations,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Neurologic Symptoms,PROCESS_OF,Patients,32303609,10.1136/gutjnl-2020-321269,2020-04-19
Disease,CAUSES,Complication,32303607,10.1136/gutjnl-2020-321244,2020-04-19
Fatal Outcome,COEXISTS_WITH,Cytokine release syndrome,32303607,10.1136/gutjnl-2020-321244,2020-04-19
Lung Injury,COEXISTS_WITH,Cytokine release syndrome,32303607,10.1136/gutjnl-2020-321244,2020-04-19
ACE2 gene,PART_OF,Intestines,32303607,10.1136/gutjnl-2020-321244,2020-04-19
Immunoregulation,PROCESS_OF,Patients,32303607,10.1136/gutjnl-2020-321244,2020-04-19
Inflammatory Bowel Diseases,PROCESS_OF,Persons,32303592,10.1128/JVI.00510-20,2020-04-19
Inflammatory Bowel Diseases,PROCESS_OF,Working Group,32303592,10.1128/JVI.00510-20,2020-04-19
Operative Surgical Procedures,TREATS,consideration,32303592,10.1128/JVI.00510-20,2020-04-19
HLA-A Antigens,ISA,Histocompatibility Antigens Class I,32303590,10.1126/science.abb7314,2020-04-19
Syndrome,PROCESS_OF,Patients,32303589,10.1128/mBio.00850-20,2020-04-19
Focal,LOCATION_OF,Alveolar Epithelial Cells,32303589,10.1128/mBio.00850-20,2020-04-19
Ciliated epithelial cell,LOCATION_OF,Virus,32303589,10.1128/mBio.00850-20,2020-04-19
Ciliated epithelial cell,PART_OF,Bronchial,32303589,10.1128/mBio.00850-20,2020-04-19
Ciliated epithelial cell,PART_OF,Mucous membrane of bronchiole,32303589,10.1128/mBio.00850-20,2020-04-19
Lung,LOCATION_OF,Lesion,32303589,10.1128/mBio.00850-20,2020-04-19
Type-II Pneumocytes,LOCATION_OF,Virus,32303589,10.1128/mBio.00850-20,2020-04-19
Disease,PROCESS_OF,Macaca,32303589,10.1128/mBio.00850-20,2020-04-19
School,LOCATION_OF,case series,32303565,10.1128/JCM.00772-20,2020-04-19
Infected,PROCESS_OF,Patients,32303565,10.1128/JCM.00772-20,2020-04-19
Asymptomatic,PROCESS_OF,Patients,32303565,10.1128/JCM.00772-20,2020-04-19
Quarantine,TREATS,Patients,32303565,10.1128/JCM.00772-20,2020-04-19
Isolation procedure,TREATS,Patients,32303565,10.1128/JCM.00772-20,2020-04-19
Coughing,ASSOCIATED_WITH,Syndrome,32303564,10.1128/JCM.00760-20,2020-04-19
Disease Outbreaks,CAUSES,Syndrome,32303564,10.1128/JCM.00760-20,2020-04-19
Dyspnea,ASSOCIATED_WITH,Syndrome,32303564,10.1128/JCM.00760-20,2020-04-19
Fever,ASSOCIATED_WITH,Syndrome,32303564,10.1128/JCM.00760-20,2020-04-19
Physicians,DIAGNOSES,Nance-Horan syndrome,32303497,10.7861/clinmed.2020-0129,2020-04-19
Head and Neck Carcinoma,PROCESS_OF,Patients,32303480,10.1016/j.jmii.2020.04.003,2020-04-19
Hospitals,LOCATION_OF,research,32303424,10.1016/j.jaut.2020.102463,2020-04-19
Household composition,PROCESS_OF,Vulnerable Populations,32303424,10.1016/j.jaut.2020.102463,2020-04-19
SARS coronavirus,LOCATION_OF,ACE2 gene,32303420,10.1016/j.jcms.2020.03.011,2020-04-19
ACE2 gene,ASSOCIATED_WITH,Disease,32303420,10.1016/j.jcms.2020.03.011,2020-04-19
"CD69 protein, human",ADMINISTERED_TO,Patients,32303395,10.1053/j.jvca.2020.03.050,2020-04-19
Infected,PROCESS_OF,Patients,32303395,10.1053/j.jvca.2020.03.050,2020-04-19
Cross Infection,PROCESS_OF,Patients,32303395,10.1053/j.jvca.2020.03.050,2020-04-19
Infected,PROCESS_OF,Patients,32303395,10.1053/j.jvca.2020.03.050,2020-04-19
Coronavirus Infections,CAUSES,Pneumonia,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
Intubation,CAUSES,Shock,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
Syndrome,COEXISTS_WITH,Coronavirus Infections,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
adjuvant therapy,TREATS,Coronavirus Infections,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
Inflammation,COEXISTS_WITH,Lung Injury,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
Lung,LOCATION_OF,Inflammation,32303363,10.1016/j.ancard.2020.04.001,2020-04-19
Angiotensin Receptor,CAUSES,Pneumonia,32303336,10.1016/j.otorri.2020.03.001,2020-04-19
Angiotensin Receptor,PART_OF,Host Cell,32303336,10.1016/j.otorri.2020.03.001,2020-04-19
IMPACT gene,CAUSES,Grade 4 Lesion,32303336,10.1016/j.otorri.2020.03.001,2020-04-19
Cardiovascular,LOCATION_OF,Grade 4 Lesion,32303336,10.1016/j.otorri.2020.03.001,2020-04-19
Cardiovascular,LOCATION_OF,Protection,32303336,10.1016/j.otorri.2020.03.001,2020-04-19
Severe Acute Respiratory Syndrome,CAUSES,head and neck surgery,32303151,10.1177/0734242X20918312,2020-04-19
Study,USES,Detection,32303090,10.1055/a-1155-6229,2020-04-18
Disease,PROCESS_OF,High Risk Populations,32303027,10.24869/psyd.2020.32,2020-04-18
Gravidity,PROCESS_OF,Population Group,32303027,10.24869/psyd.2020.32,2020-04-18
Diastasis,PROCESS_OF,Infant,32303027,10.24869/psyd.2020.32,2020-04-18
Anxiety,PROCESS_OF,Persons,32303026,10.24869/psyd.2020.25,2020-04-18
Eye,LOCATION_OF,Virus,32303026,10.24869/psyd.2020.25,2020-04-18
Panic,PROCESS_OF,Persons,32303026,10.24869/psyd.2020.25,2020-04-18
Distress,PROCESS_OF,Persons,32303026,10.24869/psyd.2020.25,2020-04-18
Anxiety,PROCESS_OF,Phasis,32303026,10.24869/psyd.2020.25,2020-04-18
Obsessive-Compulsive Disorder,PROCESS_OF,Phasis,32303026,10.24869/psyd.2020.25,2020-04-18
Post-Traumatic Stress Disorder,PROCESS_OF,Phasis,32303026,10.24869/psyd.2020.25,2020-04-18
War,ISA,Conflict (Psychology),32303025,10.24869/psyd.2020.22,2020-04-18
Coronavirus Infections,COEXISTS_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,32303023,10.24869/psyd.2020.6,2020-04-18
Panic,ISA,Anxiety,32302966,10.2196/19118,2020-04-18
Coronavirus Infections,ISA,Disease,32302962,10.1016/j.ajp.2020.102053,2020-04-18
Coronavirus Infections,ISA,Disease,32302962,10.1016/j.ajp.2020.102053,2020-04-18
"CD69 protein, human",AFFECTS,Crisis,32302962,10.1016/j.ajp.2020.102053,2020-04-18
Prophylactic treatment,COEXISTS_WITH,Health Communication,32302962,10.1016/j.ajp.2020.102053,2020-04-18
Coronavirus Infections,ISA,Disease,32302962,10.1016/j.ajp.2020.102053,2020-04-18
Coronavirus Infections,ISA,Disease,32302956,10.1016/j.jcv.2020.104359,2020-04-18
Virus Diseases,AFFECTS,Negative,32302956,10.1016/j.jcv.2020.104359,2020-04-18
Communicable Diseases,CAUSES,Challenge,32302955,10.1016/j.jcv.2020.104356,2020-04-18
Negative,PROCESS_OF,Patients,32302955,10.1016/j.jcv.2020.104356,2020-04-18
CT of lungs,AFFECTS,Patients,32302955,10.1016/j.jcv.2020.104356,2020-04-18
Lung,LOCATION_OF,Hypersensitivity,32302955,10.1016/j.jcv.2020.104356,2020-04-18
Infected,PROCESS_OF,Pregnant Women,32302954,10.1016/j.jcv.2020.104366,2020-04-18
"Infant, Newborn",LOCATION_OF,Amniotic Fluid,32302954,10.1016/j.jcv.2020.104366,2020-04-18
"Infant, Newborn",LOCATION_OF,Umbilical Cord Blood,32302954,10.1016/j.jcv.2020.104366,2020-04-18
Pregnant Women,LOCATION_OF,Amniotic Fluid,32302954,10.1016/j.jcv.2020.104366,2020-04-18
Pregnant Women,LOCATION_OF,Umbilical Cord Blood,32302954,10.1016/j.jcv.2020.104366,2020-04-18
Critical Illness,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Health center,LOCATION_OF,Early Diagnosis,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Critical Illness,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Disease,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Pneumonia,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Fibrin fragment D,ISA,Fibrin split products,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Malaise,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Malaise,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Chronic disease,PROCESS_OF,geriatric patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Critical Illness,PROCESS_OF,Patients,32302953,10.1016/j.jcv.2020.104353,2020-04-18
Pharyngeal structure,LOCATION_OF,Nucleic Acids,32302935,10.1016/j.ajp.2020.102066,2020-04-18
Virus,PROCESS_OF,Child,32302935,10.1016/j.ajp.2020.102066,2020-04-18
Fecal occult blood test,USES,Buccal smear procedure,32302935,10.1016/j.ajp.2020.102066,2020-04-18
Sleep,ASSOCIATED_WITH,Symptoms,32302927,10.1016/j.clinimag.2020.04.001,2020-04-18
Patient Transport,COEXISTS_WITH,Decontamination,32302818,10.1016/j.psychres.2020.112977,2020-04-18
patient condition,PREDISPOSES,Cross Infection,32302818,10.1016/j.psychres.2020.112977,2020-04-18
student,ISA,Population Group,32302817,10.1016/j.psychres.2020.112972,2020-04-18
Cessation of life,PROCESS_OF,Health Personnel,32302816,10.1016/j.psychres.2020.112992,2020-04-18
Physicians,NEG_ISA,Persons,32302816,10.1016/j.psychres.2020.112992,2020-04-18
Symptoms,PROCESS_OF,Farmers,32302815,10.1016/j.psychres.2020.112955,2020-04-18
Attention,PROCESS_OF,high-risk group,32302815,10.1016/j.psychres.2020.112955,2020-04-18
Immunity,PROCESS_OF,Child,32302813,10.1016/j.psychres.2020.112945,2020-04-18
Infection,PROCESS_OF,Child,32302813,10.1016/j.psychres.2020.112945,2020-04-18
Light,AFFECTS,Mental disorders,32302812,10.1016/j.scitotenv.2020.138605,2020-04-18
Noise,ISA,Pollution,32302812,10.1016/j.scitotenv.2020.138605,2020-04-18
Addictive Behavior,PROCESS_OF,Persons,32302812,10.1016/j.scitotenv.2020.138605,2020-04-18
Homelessness,PROCESS_OF,Persons,32302812,10.1016/j.scitotenv.2020.138605,2020-04-18
Homelessness,PROCESS_OF,Persons,32302812,10.1016/j.scitotenv.2020.138605,2020-04-18
Lung,LOCATION_OF,Computed Tomography Angiography,32302722,10.1016/j.jhin.2020.04.019,2020-04-18
Fever,ISA,Symptoms,32302706,10.1016/j.phrs.2020.104833,2020-04-18
angiotensin converting enzyme 2,AFFECTS,Negative,32302681,10.1016/j.ijrobp.2020.04.016,2020-04-18
Homo sapiens,LOCATION_OF,angiotensin converting enzyme 2,32302681,10.1016/j.ijrobp.2020.04.016,2020-04-18
Severe Acute Respiratory Syndrome,AFFECTS,Pathologic Processes,32302681,10.1016/j.ijrobp.2020.04.016,2020-04-18
Coronavirus Infections,PROCESS_OF,Animals,32302499,10.1089/dia.2020.0161,2020-04-18
Coronavirus Infections,PROCESS_OF,Homo sapiens,32302499,10.1089/dia.2020.0161,2020-04-18
Epitopes,PART_OF,Genus: Coronavirus,32302499,10.1089/dia.2020.0161,2020-04-18
Epitopes,compared_with,Homologous Gene,32302499,10.1089/dia.2020.0161,2020-04-18
Homologous Gene,PART_OF,Genus: Coronavirus,32302499,10.1089/dia.2020.0161,2020-04-18
Homology Modeling,METHOD_OF,Epitope Mapping,32302499,10.1089/dia.2020.0161,2020-04-18
Critical Illness,PROCESS_OF,Patients,32302448,10.1111/jth.14854,2020-04-18
Cessation of life,PROCESS_OF,Population Group,32302448,10.1111/jth.14854,2020-04-18
Gravidity,NEG_PROCESS_OF,Population Group,32302448,10.1111/jth.14854,2020-04-18
Respiratory Failure,CAUSES,Cessation of life,32302448,10.1111/jth.14854,2020-04-18
Immune System Processes,AFFECTS,"Adaptation, Physiological",32302448,10.1111/jth.14854,2020-04-18
Patients,LOCATION_OF,Fibrin fragment D,32302448,10.1111/jth.14854,2020-04-18
Evaluation procedure,TREATS,Pregnant Women,32302448,10.1111/jth.14854,2020-04-18
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32302444,10.1111/jdv.16492,2020-04-18
intensive care unit,LOCATION_OF,Blood coagulation tests,32302444,10.1111/jdv.16492,2020-04-18
Laboratory Procedures,USES,Coagulation procedure,32302444,10.1111/jdv.16492,2020-04-18
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32302444,10.1111/jdv.16492,2020-04-18
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32302444,10.1111/jdv.16492,2020-04-18
Antithrombins,STIMULATES,Blood Platelets,32302444,10.1111/jdv.16492,2020-04-18
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32302444,10.1111/jdv.16492,2020-04-18
"Heparin, Low-Molecular-Weight",STIMULATES,Blood Platelets,32302444,10.1111/jdv.16492,2020-04-18
clopidogrel,STIMULATES,Blood Platelets,32302444,10.1111/jdv.16492,2020-04-18
Pulmonary Embolism,ISA,Complication,32302444,10.1111/jdv.16492,2020-04-18
Masks,USES,Mechanical Ventilator,32302442,10.1111/jth.14853,2020-04-18
Protective gloves,ISA,Personal protective equipment,32302442,10.1111/jth.14853,2020-04-18
Patients,LOCATION_OF,Blood,32302437,10.1111/jdv.16491,2020-04-18
Disease Outbreaks,CAUSES,Disease,32302435,10.1111/jth.14848,2020-04-18
Thrombocytopenia,PROCESS_OF,Patients,32302419,10.1111/bjd.19145,2020-04-18
Thrombocytopenia,PROCESS_OF,Patients,32302419,10.1111/bjd.19145,2020-04-18
Thrombocytopenia,PROCESS_OF,Patients,32302419,10.1111/bjd.19145,2020-04-18
Thrombocytopenia,PROCESS_OF,Survivors,32302419,10.1111/bjd.19145,2020-04-18
Azithromycin,ISA,Macrolide Antibiotics,32302401,10.1084/jem.20200652,2020-04-18
Genitourinary,LOCATION_OF,Bacterial Infections,32302401,10.1084/jem.20200652,2020-04-18
Azithromycin,NEG_TREATS,Virus Diseases,32302401,10.1084/jem.20200652,2020-04-18
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32302399,10.1093/neuros/nyaa147,2020-04-18
Airway structure,LOCATION_OF,mucus layer,32302399,10.1093/neuros/nyaa147,2020-04-18
Pituitary Adenoma,PROCESS_OF,Patients,32302395,10.1093/jamia/ocaa065,2020-04-18
"Thinking, function",PROCESS_OF,Medical Staff,32302395,10.1093/jamia/ocaa065,2020-04-18
Internal nose structure,LOCATION_OF,Surgical Endoscopy,32302395,10.1093/jamia/ocaa065,2020-04-18
post operative (finding),PROCESS_OF,Patients,32302395,10.1093/jamia/ocaa065,2020-04-18
Surgical Endoscopy,DIAGNOSES,Severe Acute Respiratory Syndrome,32302395,10.1093/jamia/ocaa065,2020-04-18
Elective Surgical Procedures,TREATS,Disease,32302395,10.1093/jamia/ocaa065,2020-04-18
Enrollment,METHOD_OF,Telemedicine,32302377,10.1093/cid/ciaa422,2020-04-18
Movement,PROCESS_OF,Population Group,32302370,10.1371/journal.pone.0231808,2020-04-18
Movement,PROCESS_OF,Population Group,32302370,10.1371/journal.pone.0231808,2020-04-18
Retirement,PROCESS_OF,Health Personnel,32302285,10.5811/westjem.2020.4.47552,2020-04-18
Does move,PROCESS_OF,Community,32302284,10.5811/westjem.2020.4.47549,2020-04-18
Nurses,TREATS,Patients,32302281,10.5811/westjem.2020.3.47444,2020-04-18
Coronavirus Infections,ISA,Disease,32302277,10.5811/westjem.2020.4.47385,2020-04-18
Laboratory Procedures,USES,Nasal Swab (procedure),32302277,10.5811/westjem.2020.4.47385,2020-04-18
Coronavirus Infections,ISA,Disease,32302277,10.5811/westjem.2020.4.47385,2020-04-18
Self-Assessment,PROCESS_OF,Participant,32302265,10.1161/CIRCRESAHA.120.317134,2020-04-18
Hypertensive disease,PROCESS_OF,Patients,32302257,10.1177/0022034520920580,2020-04-18
Hypertensive disease,PROCESS_OF,Patients,32302257,10.1177/0022034520920580,2020-04-18
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32302257,10.1177/0022034520920580,2020-04-18
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",PROCESS_OF,Patients,32302257,10.1177/0022034520920580,2020-04-18
American College of Cardiology/American Heart Association Lesion Complexity Score A,COEXISTS_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32302257,10.1177/0022034520920580,2020-04-18
Coronavirus Infections,ISA,Disease,32302216,10.1089/fpsam.2020.0185,2020-04-18
Coronavirus Infections,ISA,Disease,32302216,10.1089/fpsam.2020.0185,2020-04-18
Experience,PROCESS_OF,Italians,32302216,10.1089/fpsam.2020.0185,2020-04-18
Coronavirus Infections,ISA,Disease,32302216,10.1089/fpsam.2020.0185,2020-04-18
Oropharyngeal,LOCATION_OF,Oral mucous membrane structure,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
facial fractures,PROCESS_OF,Patients,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Virion,PART_OF,Oral mucous membrane structure,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Oropharyngeal,LOCATION_OF,Oral mucous membrane structure,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Operative Surgical Procedures,TREATS,Patients,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Operative Surgical Procedures,TREATS,facial fractures,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Protection,PROCESS_OF,Health Personnel,32302212,10.5858/arpa.2020-0186-SA,2020-04-18
Hepatitis,PROCESS_OF,Recipient,32302069,10.1002/cpmc.100,2020-04-18
Biliary Atresia,PART_OF,Infant,32302069,10.1002/cpmc.100,2020-04-18
Fever,PROCESS_OF,Patients,32302069,10.1002/cpmc.100,2020-04-18
Respiratory distress,PROCESS_OF,Patients,32302069,10.1002/cpmc.100,2020-04-18
Biopsy,DIAGNOSES,Acute hepatitis,32302069,10.1002/cpmc.100,2020-04-18
Liver,LOCATION_OF,Biopsy,32302069,10.1002/cpmc.100,2020-04-18
Virus,COEXISTS_WITH,Acute infectious disease,32302058,10.1002/rmv.2106,2020-04-18
"M Protein, multiple myeloma",CONVERTS_TO,Antigens,32302058,10.1002/rmv.2106,2020-04-18
Antibodies,INTERACTS_WITH,"M Protein, multiple myeloma",32302058,10.1002/rmv.2106,2020-04-18
Enzyme-Linked Immunosorbent Assay,METHOD_OF,high throughput screening,32302058,10.1002/rmv.2106,2020-04-18
Specimen Type - Serum,PART_OF,Homo sapiens,32302058,10.1002/rmv.2106,2020-04-18
Respiratory sample,PART_OF,Tract,32302000,10.1093/cid/ciaa451,2020-04-18
Coronavirus Infections,ISA,Disease,32301997,10.1093/cid/ciaa449,2020-04-18
Severe disorder,PROCESS_OF,Patients,32301997,10.1093/cid/ciaa449,2020-04-18
Critical Illness,PROCESS_OF,Patients,32301967,10.1093/cid/ciaa452,2020-04-18
Detection,TREATS,patient condition,32301967,10.1093/cid/ciaa452,2020-04-18
Critical Illness,PROCESS_OF,Patients,32301967,10.1093/cid/ciaa452,2020-04-18
inflammatory response,PROCESS_OF,Patients,32301967,10.1093/cid/ciaa452,2020-04-18
Fever,PROCESS_OF,Infant,32301964,10.1093/cid/ciaa450,2020-04-18
Hospitalization,METHOD_OF,Evaluation,32301964,10.1093/cid/ciaa450,2020-04-18
Severe Acute Respiratory Syndrome,PROCESS_OF,Infant,32301964,10.1093/cid/ciaa450,2020-04-18
Fever,PROCESS_OF,Infant,32301964,10.1093/cid/ciaa450,2020-04-18
Index case,PROCESS_OF,Households,32301928,10.1188/20.ONF.253-254,2020-04-18
Quarantine,ISA,Isolation procedure,32301818,10.5435/JAAOS-D-20-00380,2020-04-18
Equilibrium,AFFECTS,Patients,32301767,10.1097/BOT.0000000000001782,2020-04-18
Biologic Development,PROCESS_OF,Patients,32301767,10.1097/BOT.0000000000001782,2020-04-18
angiotensin converting enzyme 2,AFFECTS,Cardiovascular Physiological Phenomena,32301764,10.1097/ANA.0000000000000691,2020-04-18
Advice,COEXISTS_WITH,Neurosurgical Procedures,32301761,10.14309/ajg.0000000000000664,2020-04-18
Digestive symptom,OCCURS_IN,Patients,32301749,10.1515/cclm-2020-0443,2020-04-18
Severe disorder,PROCESS_OF,Outpatients,32301749,10.1515/cclm-2020-0443,2020-04-18
Diarrhea,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32301749,10.1515/cclm-2020-0443,2020-04-18
Nausea,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32301749,10.1515/cclm-2020-0443,2020-04-18
Vomiting,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32301749,10.1515/cclm-2020-0443,2020-04-18
Digestive symptom,COEXISTS_WITH,"Signs and Symptoms, Respiratory",32301749,10.1515/cclm-2020-0443,2020-04-18
Respiratory sample,PART_OF,Tract,32301749,10.1515/cclm-2020-0443,2020-04-18
Digestive symptom,COEXISTS_WITH,Diarrhea,32301749,10.1515/cclm-2020-0443,2020-04-18
Digestive symptom,PROCESS_OF,Patients,32301749,10.1515/cclm-2020-0443,2020-04-18
Digestive symptom,PROCESS_OF,Patients,32301749,10.1515/cclm-2020-0443,2020-04-18
Digestive symptom,PROCESS_OF,Patients,32301749,10.1515/cclm-2020-0443,2020-04-18
patient condition,COEXISTS_WITH,Digestive symptom,32301749,10.1515/cclm-2020-0443,2020-04-18
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32301749,10.1515/cclm-2020-0443,2020-04-18
Respiratory sample,PART_OF,Tract,32301746,10.1515/cclm-2020-0398,2020-04-18
Antibodies,STIMULATES,CD40LG wt Allele,32301746,10.1515/cclm-2020-0398,2020-04-18
Serum,LOCATION_OF,CD40LG wt Allele,32301746,10.1515/cclm-2020-0398,2020-04-18
Serum,PART_OF,Patients,32301746,10.1515/cclm-2020-0398,2020-04-18
Assay,USES,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",32301746,10.1515/cclm-2020-0398,2020-04-18
Infected,PROCESS_OF,Persons,32301745,10.1515/cclm-2020-0187,2020-04-18
"Signs and Symptoms, Respiratory",PROCESS_OF,Persons,32301745,10.1515/cclm-2020-0187,2020-04-18
Alkaline Phosphatase,PART_OF,Patients,32301745,10.1515/cclm-2020-0187,2020-04-18
Lactate Dehydrogenase,PART_OF,Patients,32301745,10.1515/cclm-2020-0187,2020-04-18
Lactate Dehydrogenase,NEG_PART_OF,Patients,32301745,10.1515/cclm-2020-0187,2020-04-18
Negative,PROCESS_OF,Patients,32301745,10.1515/cclm-2020-0187,2020-04-18
GOT1 gene,NEG_PART_OF,Patients,32301745,10.1515/cclm-2020-0187,2020-04-18
Hematologic Tests,ISA,Laboratory Procedures,32301745,10.1515/cclm-2020-0187,2020-04-18
Hematologic Tests,USES,Laboratory Procedures,32301745,10.1515/cclm-2020-0187,2020-04-18
Detection,TREATS,Patients,32301734,10.2196/19218,2020-04-18
Coronavirus Infections,ISA,Disease,32301692,10.5152/tud.2020.20119,2020-04-18
Coronavirus Infections,ISA,Disease,32301692,10.5152/tud.2020.20119,2020-04-18
Coronavirus Infections,ISA,Disease,32301692,10.5152/tud.2020.20119,2020-04-18
Coronavirus Infections,ISA,Disease,32301692,10.5152/tud.2020.20119,2020-04-18
Coronavirus Infections,ISA,Disease,32301692,10.5152/tud.2020.20119,2020-04-18
Hospitals,LOCATION_OF,Services,32301647,10.1148/radiol.2020201433,2020-04-18
Coughing,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Diarrhea,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Dyspnea,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Fatigue,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Fever,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Nausea,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Myalgia,CAUSES,Pneumonia,32301647,10.1148/radiol.2020201433,2020-04-18
Disease,AFFECTS,Patients,32301647,10.1148/radiol.2020201433,2020-04-18
unwellness,PROCESS_OF,Patients,32301647,10.1148/radiol.2020201433,2020-04-18
tomography,DIAGNOSES,Pneumonia,32301646,10.1148/radiol.2020201343,2020-04-18
Patients,LOCATION_OF,"CD69 protein, human",32301646,10.1148/radiol.2020201343,2020-04-18
Pneumonia,PROCESS_OF,Patients,32301646,10.1148/radiol.2020201343,2020-04-18
Chest CT,ADMINISTERED_TO,Patients,32301646,10.1148/radiol.2020201343,2020-04-18
Confirmation,PROCESS_OF,Patients,32301631,10.2214/AJR.20.23232,2020-04-18
Coronavirus Infections,ISA,Disease,32301508,10.1002/jmv.25901,2020-04-18
Coronavirus Infections,ISA,Disease,32301508,10.1002/jmv.25901,2020-04-18
Pregnant Women,ISA,Persons,32301508,10.1002/jmv.25901,2020-04-18
Symptoms,PROCESS_OF,Pregnant Women,32301508,10.1002/jmv.25901,2020-04-18
Respiratory secretion precautions,TREATS,Health Personnel,32301390,10.1080/22221751.2020.1756700,2020-04-18
Airborne precautions,TREATS,Patients,32301390,10.1080/22221751.2020.1756700,2020-04-18
Transitional Region,LOCATION_OF,Present,32301300,10.3346/jkms.2020.35.e154,2020-04-18
Amino Acids,PART_OF,Hamsters,32301300,10.3346/jkms.2020.35.e154,2020-04-18
Lung,LOCATION_OF,Weight Loss Adverse Event,32301300,10.3346/jkms.2020.35.e154,2020-04-18
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32301300,10.3346/jkms.2020.35.e154,2020-04-18
Consultation,TREATS,Patients,32301298,10.3346/jkms.2020.35.e152,2020-04-18
Consultation,TREATS(INFER),Fever,32301298,10.3346/jkms.2020.35.e152,2020-04-18
Consultation,TREATS(INFER),"Signs and Symptoms, Respiratory",32301298,10.3346/jkms.2020.35.e152,2020-04-18
Fever,PROCESS_OF,Patients,32301298,10.3346/jkms.2020.35.e152,2020-04-18
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32301298,10.3346/jkms.2020.35.e152,2020-04-18
Disinfection,TREATS,Adverse reactions,32301298,10.3346/jkms.2020.35.e152,2020-04-18
Infected,PROCESS_OF,Patients,32301284,10.1002/alr.22587,2020-04-18
Coronavirus Infections,ISA,Disease,32301284,10.1002/alr.22587,2020-04-18
Coughing,ISA,Symptoms,32301279,10.15252/emmm.202012488,2020-04-18
Dyspnea,ISA,Symptoms,32301279,10.15252/emmm.202012488,2020-04-18
Fatigue,ISA,Symptoms,32301279,10.15252/emmm.202012488,2020-04-18
Fever,ISA,Symptoms,32301279,10.15252/emmm.202012488,2020-04-18
Ageusia,ASSOCIATED_WITH,Coronavirus Infections,32301279,10.15252/emmm.202012488,2020-04-18
Anosmia,NEG_PREDISPOSES,Severe (severity modifier),32301279,10.15252/emmm.202012488,2020-04-18
Coronavirus Infections,CAUSES,Severe Acute Respiratory Syndrome,32301221,10.1111/jocd.13443,2020-04-18
Androgenetic Alopecia,PROCESS_OF,Patients,32301206,10.1111/ijcp.13516,2020-04-18
Disease,PROCESS_OF,Homo sapiens,32301198,10.1111/tid.13296,2020-04-18
Coronavirus Infections,PROCESS_OF,Family,32301198,10.1111/tid.13296,2020-04-18
Disease,PROCESS_OF,Population Group,32301155,10.1111/ajt.15929,2020-04-18
Virus Diseases,COEXISTS_WITH,Immunocompromised Host,32301155,10.1111/ajt.15929,2020-04-18
Respiratory Insufficiency,PROCESS_OF,Survivors,32301099,10.1007/s15010-020-01427-2,2020-04-18
Severe course,PROCESS_OF,Recipient,32301099,10.1007/s15010-020-01427-2,2020-04-18
Dry cough,ISA,Symptoms,32301047,10.1007/s12311-020-01131-9,2020-04-18
Dry cough,PROCESS_OF(SPEC),Child,32301047,10.1007/s12311-020-01131-9,2020-04-18
Symptoms,PROCESS_OF,Child,32301047,10.1007/s12311-020-01131-9,2020-04-18
Disease,PROCESS_OF,Child,32301047,10.1007/s12311-020-01131-9,2020-04-18
Complete Response with Incomplete Platelet Recovery,PROCESS_OF,Child,32301047,10.1007/s12311-020-01131-9,2020-04-18
Asymptomatic,PROCESS_OF,Patients,32301047,10.1007/s12311-020-01131-9,2020-04-18
Asymptomatic,PROCESS_OF,Patients,32301047,10.1007/s12311-020-01131-9,2020-04-18
Lung Injury,PROCESS_OF,Child,32301047,10.1007/s12311-020-01131-9,2020-04-18
Lung Injury,PROCESS_OF,Patients,32301047,10.1007/s12311-020-01131-9,2020-04-18
Brain,LOCATION_OF,IMPACT gene,32300971,10.1007/s00330-020-06829-2,2020-04-18
Brain,PART_OF,Homo sapiens,32300971,10.1007/s00330-020-06829-2,2020-04-18
Cerebellum,LOCATION_OF,IMPACT gene,32300971,10.1007/s00330-020-06829-2,2020-04-18
Dizziness,ISA,Disturbance of consciousness,32300971,10.1007/s00330-020-06829-2,2020-04-18
ataxic,PROCESS_OF,Patients,32300971,10.1007/s00330-020-06829-2,2020-04-18
Pneumonia,PROCESS_OF,Patients,32300968,10.1007/s00330-020-06850-5,2020-04-18
Pneumonia,PROCESS_OF,Patients,32300968,10.1007/s00330-020-06850-5,2020-04-18
Pneumonia,PROCESS_OF,Patients,32300968,10.1007/s00330-020-06850-5,2020-04-18
Physical Examination,ADMINISTERED_TO,radiologist,32300823,10.1007/s00106-020-00864-7,2020-04-18
Physical Examination,ADMINISTERED_TO,radiologic technologist,32300823,10.1007/s00106-020-00864-7,2020-04-18
Virus,CAUSES,Disease,32300673,10.1016/j.genrep.2020.100682,2020-04-18
Cessation of life,PROCESS_OF,Child,32300673,10.1016/j.genrep.2020.100682,2020-04-18
Hospitalization,TREATS,Older people,32300673,10.1016/j.genrep.2020.100682,2020-04-18
Illness (finding),PROCESS_OF,Homo sapiens,32300537,10.1016/j.exis.2020.04.003,2020-04-18
Prophylactic treatment,TREATS,Communicable Diseases,32300537,10.1016/j.exis.2020.04.003,2020-04-18
Academia (organization),LOCATION_OF,research,32300516,10.1007/s13555-020-00377-9,2020-04-18
Influenza,ISA,Upper Respiratory Infections,32300496,10.7759/cureus.7276,2020-04-18
Coronavirus Infections,ISA,Disease,32300496,10.7759/cureus.7276,2020-04-18
Biological Factors,compared_with,Placebos,32300496,10.7759/cureus.7276,2020-04-18
Symptoms,PROCESS_OF,Patients,32300370,10.1186/s12979-020-00180-2,2020-04-18
Vaccines,TREATS,Virus,32300370,10.1186/s12979-020-00180-2,2020-04-18
Disease,PROCESS_OF,Elderly (population group),32300261,10.1016/j.resconrec.2020.104814,2020-04-18
Discussion (procedure),PREVENTS,Disease,32300261,10.1016/j.resconrec.2020.104814,2020-04-18
Discussion (procedure),TREATS,Predisposition -- attribute,32300261,10.1016/j.resconrec.2020.104814,2020-04-18
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32300101,10.1038/s41368-020-0080-z,2020-04-18
Viral Respiratory Tract Infection,PROCESS_OF,Patients,32300101,10.1038/s41368-020-0080-z,2020-04-18
Oral cavity,LOCATION_OF,saliva,32300018,10.1073/pnas.2004911117,2020-04-18
China,ISA,Country,32299781,10.1016/j.cjca.2020.03.027,2020-04-18
disease detection,PREVENTS,Crisis,32299781,10.1016/j.cjca.2020.03.027,2020-04-18
Cardiac Catheterization Laboratory,LOCATION_OF,Administration occupational activities,32299776,10.1016/j.trsl.2020.04.007,2020-04-18
Mannose-Binding Protein-Associated Serine Proteases,STIMULATES,complement pathway,32299753,10.1016/j.cjca.2020.04.003,2020-04-18
Alveolar Septum,LOCATION_OF,Complement Membrane Attack Complex,32299753,10.1016/j.cjca.2020.04.003,2020-04-18
Microbicides,AUGMENTS,Prolonged QT interval,32299752,10.1016/j.cjca.2020.04.001,2020-04-18
"Tachycardia, Ventricular",COEXISTS_WITH,Complete atrioventricular block,32299750,10.1016/j.cjca.2020.04.006,2020-04-18
Patients,USES,Preexisting Condition Coverage,32299636,10.1016/j.nrl.2020.03.001,2020-04-18
Severe course,PROCESS_OF,Patients,32299636,10.1016/j.nrl.2020.03.001,2020-04-18
Cardiovascular,LOCATION_OF,Co-morbid conditions,32299636,10.1016/j.nrl.2020.03.001,2020-04-18
Coronavirus Infections,COEXISTS_WITH,SARS coronavirus,32299485,10.1186/s40249-020-00654-x,2020-04-18
Coronavirus Infections,COEXISTS_WITH,Middle East Respiratory Syndrome Coronavirus,32299485,10.1186/s40249-020-00654-x,2020-04-18
Neurologic Symptoms,ASSOCIATED_WITH,Coronavirus Infections,32299485,10.1186/s40249-020-00654-x,2020-04-18
Multiple Sclerosis,COEXISTS_WITH,Coronavirus Infections,32299485,10.1186/s40249-020-00654-x,2020-04-18
Coronavirus Infections,PROCESS_OF,Patients,32299485,10.1186/s40249-020-00654-x,2020-04-18
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32299485,10.1186/s40249-020-00654-x,2020-04-18
Coitus,PROCESS_OF,Persons,32299330,10.33321/cdi.2020.44.34,2020-04-18
Coitus,PROCESS_OF(SPEC),Woman,32299330,10.33321/cdi.2020.44.34,2020-04-18
Woman,ISA,Persons,32299330,10.33321/cdi.2020.44.34,2020-04-18
Anxiety,PROCESS_OF,Adult,32299208,10.3906/sag-2004-180,2020-04-18
Coronavirus Infections,ISA,Disease,32299205,10.3906/sag-2004-132,2020-04-18
Coronavirus Infections,ISA,Disease,32299205,10.3906/sag-2004-132,2020-04-18
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32299204,10.3906/sag-2004-133,2020-04-18
Influenza,PROCESS_OF,Asians,32299202,10.3906/sag-2004-168,2020-04-18
Influenza,PROCESS_OF,Hispanics,32299202,10.3906/sag-2004-168,2020-04-18
Structural protein,AFFECTS,envelope,32299201,10.3906/sag-2004-167,2020-04-18
Storm NOS,CAUSES,"Respiratory Distress Syndrome, Adult",32299201,10.3906/sag-2004-167,2020-04-18
Hydroxychloroquine,INHIBITS,Interleukin-1,32299201,10.3906/sag-2004-167,2020-04-18
Therapeutic immunosuppression,ISA,Therapeutic procedure,32299201,10.3906/sag-2004-167,2020-04-18
Interleukin-6,INHIBITS,Interleukin-1,32299201,10.3906/sag-2004-167,2020-04-18
Scientific Study,DIAGNOSES,Severe disorder,32299201,10.3906/sag-2004-167,2020-04-18
Influenza,PROCESS_OF,Asians,32299200,10.3906/sag-2004-160,2020-04-18
Influenza,PROCESS_OF,Hispanics,32299200,10.3906/sag-2004-160,2020-04-18
Pneumonia,PROCESS_OF,Patients,32299196,10.31128/AJGP-COVID-11,2020-04-18
Chest CT,ISA,Diagnostic tests,32299196,10.31128/AJGP-COVID-11,2020-04-18
Symptoms,PROCESS_OF,Patients,32299196,10.31128/AJGP-COVID-11,2020-04-18
Obesity,PROCESS_OF,Persons,32299017,10.1016/j.jns.2020.116832,2020-04-17
Coronavirus Infections,ISA,Disease,32299017,10.1016/j.jns.2020.116832,2020-04-17
Viral Pathogenesis,PROCESS_OF,Population Group,32299017,10.1016/j.jns.2020.116832,2020-04-17
Immune System Processes,AFFECTS,Viral Pathogenesis,32299017,10.1016/j.jns.2020.116832,2020-04-17
Obesity,AFFECTS,Vitamin D Deficiency,32299017,10.1016/j.jns.2020.116832,2020-04-17
Neurologic Manifestations,PROCESS_OF,Patients,32298988,10.1016/j.jcv.2020.104363,2020-04-17
Central Nervous System Involvement,PROCESS_OF,Patients,32298988,10.1016/j.jcv.2020.104363,2020-04-17
Neurologic Manifestations,PROCESS_OF,Patients,32298988,10.1016/j.jcv.2020.104363,2020-04-17
Central Nervous System Involvement,PROCESS_OF,Patients,32298988,10.1016/j.jcv.2020.104363,2020-04-17
Coronavirus Infections,CAUSES,Disease,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Coronavirus Infections,ISA,Disease,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Disease,PROCESS_OF,Patients,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Coronavirus Infections,ISA,Disease,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Coronavirus Infections,ISA,Disease,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Fever,ISA,Symptoms,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Lung,LOCATION_OF,sodium polymetaphosphate,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Severe disorder,PROCESS_OF,Patients,32298982,10.1016/j.dsx.2020.03.017,2020-04-17
Comorbidity,PROCESS_OF,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Diabetes,PROCESS_OF,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Disease,COEXISTS_WITH,Diabetes,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Antidiabetics,TREATS,scholar,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Diabetes,PROCESS_OF,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Blood Glucose control,AFFECTS,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Diabetes,PROCESS_OF,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Telemedicine,TREATS,Patients,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Telemedicine,TREATS(INFER),Diabetes,32298883,10.1016/j.scitotenv.2020.138436,2020-04-17
Burkitt Lymphoma,PROCESS_OF,Patients,32298803,10.1016/j.bbi.2020.04.027,2020-04-17
B-Cell Lymphomas,PROCESS_OF,Patients,32298803,10.1016/j.bbi.2020.04.027,2020-04-17
Chimeric Antigen Receptor T-Cell Therapy,TREATS,Patients,32298803,10.1016/j.bbi.2020.04.027,2020-04-17
Structure of articular surface of bone,LOCATION_OF,psychological stressor,32298802,10.1016/j.bbi.2020.04.028,2020-04-17
Psychotic Disorders,COEXISTS_WITH,Acute viral disease,32298802,10.1016/j.bbi.2020.04.028,2020-04-17
Encephalopathies,ISA,Symptoms,32298802,10.1016/j.bbi.2020.04.028,2020-04-17
Mood swings,PROCESS_OF,Patients,32298802,10.1016/j.bbi.2020.04.028,2020-04-17
Confidence,PROCESS_OF,Physicians,32298769,10.1016/j.jhep.2020.04.005,2020-04-17
Cirrhosis,PROCESS_OF,Patients,32298767,10.1016/j.jhep.2020.04.006,2020-04-17
Cirrhosis,PROCESS_OF,Patients,32298767,10.1016/j.jhep.2020.04.006,2020-04-17
Cirrhosis,PROCESS_OF,Patients,32298767,10.1016/j.jhep.2020.04.006,2020-04-17
Liver,LOCATION_OF,Disease,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
liver test abnormal,PROCESS_OF,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
Liver,LOCATION_OF,Abnormal test result,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
liver test abnormal,PROCESS_OF,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
Abnormal test result,PROCESS_OF,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
liver test abnormal,PROCESS_OF,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
Hospitalization,TREATS,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
liver test abnormal,PROCESS_OF,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
Evaluation,TREATS,Patients,32298748,10.1016/j.jpainsymman.2020.04.012,2020-04-17
Shock,PROCESS_OF,Patients,32298686,10.1016/j.urology.2020.04.004,2020-04-17
Infected,PROCESS_OF,Patients,32298686,10.1016/j.urology.2020.04.004,2020-04-17
diarrhea persistent,COEXISTS_WITH,Shock,32298686,10.1016/j.urology.2020.04.004,2020-04-17
diarrhea persistent,COEXISTS_WITH,Respiratory Failure,32298686,10.1016/j.urology.2020.04.004,2020-04-17
Respiratory Failure,PROCESS_OF,Patients,32298686,10.1016/j.urology.2020.04.004,2020-04-17
Critical Illness,PROCESS_OF,Patients,32298686,10.1016/j.urology.2020.04.004,2020-04-17
"Immunoglobulins, Intravenous",PREVENTS,Disease,32298686,10.1016/j.urology.2020.04.004,2020-04-17
"Immunoglobulins, Intravenous",TREATS,Patients,32298686,10.1016/j.urology.2020.04.004,2020-04-17
"Immunoglobulins, Intravenous",TREATS(INFER),Critical Illness,32298686,10.1016/j.urology.2020.04.004,2020-04-17
Diagnosis,NEG_DIAGNOSES,Virus,32298643,10.1016/j.jacr.2020.03.027,2020-04-17
Coronavirus Infections,PREDISPOSES,disease transmission,32298514,10.1111/jocd.13444,2020-04-17
patient care,TREATS,Ambulatory Visit,32298473,10.1002/hep.31281,2020-04-17
Propranolol,TREATS,Caregiver,32298473,10.1002/hep.31281,2020-04-17
Critical Illness,PROCESS_OF,Patients,32298415,10.1093/annweh/wxaa044,2020-04-17
Health Personnel,TREATS,Patients,32298415,10.1093/annweh/wxaa044,2020-04-17
Health Personnel,LOCATION_OF,IMPACT gene,32298415,10.1093/annweh/wxaa044,2020-04-17
Patients,LOCATION_OF,IMPACT gene,32298415,10.1093/annweh/wxaa044,2020-04-17
Coronavirus Infections,ISA,Virus Diseases,32298385,10.1371/journal.pone.0231924,2020-04-17
Italy,ISA,Country,32298385,10.1371/journal.pone.0231924,2020-04-17
Coronavirus Infections,ISA,Disease,32298385,10.1371/journal.pone.0231924,2020-04-17
Coronavirus Infections,ISA,Disease,32298385,10.1371/journal.pone.0231924,2020-04-17
Coronavirus Infections,ISA,Disease,32298273,10.1371/journal.pone.0230295,2020-04-17
Anxiety,COEXISTS_WITH,Disease,32298273,10.1371/journal.pone.0230295,2020-04-17
Anxiety,COEXISTS_WITH(SPEC),Coronavirus Infections,32298273,10.1371/journal.pone.0230295,2020-04-17
Coronavirus Infections,ISA,Disease,32298273,10.1371/journal.pone.0230295,2020-04-17
Anxiety,PROCESS_OF,general population,32298273,10.1371/journal.pone.0230295,2020-04-17
Depressive disorder,PROCESS_OF,general population,32298273,10.1371/journal.pone.0230295,2020-04-17
Mental health problem,PROCESS_OF,general population,32298273,10.1371/journal.pone.0230295,2020-04-17
Infection,PROCESS_OF,Homo sapiens,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Fetal organ,LOCATION_OF,angiotensin converting enzyme 2,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Placenta,LOCATION_OF,angiotensin converting enzyme 2,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Stromal Cells,PART_OF,Decidua,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Pericytes,PART_OF,Decidua,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Fetal Heart,PART_OF,Homo sapiens,32298251,10.15585/mmwr.mm6915e3,2020-04-17
angiotensin converting enzyme 2,INTERACTS_WITH,Cells,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Mus,LOCATION_OF,angiotensin converting enzyme 2,32298251,10.15585/mmwr.mm6915e3,2020-04-17
Hypertensive disease,ISA,Disease,32298250,10.15585/mmwr.mm6915e4,2020-04-17
Disease,PROCESS_OF,Persons,32298250,10.15585/mmwr.mm6915e4,2020-04-17
Therapeutic procedure,USES,Nebulizers,32298247,10.15585/mmwr.mm6915e6,2020-04-17
Standard precautions,TREATS,Patients,32298247,10.15585/mmwr.mm6915e6,2020-04-17
Symptoms,PROCESS_OF,Patients,32298247,10.15585/mmwr.mm6915e6,2020-04-17
Injury due to exposure to external cause,PROCESS_OF,"Personnel, Hospital",32298247,10.15585/mmwr.mm6915e6,2020-04-17
Nebulizers,TREATS,Patients,32298247,10.15585/mmwr.mm6915e6,2020-04-17
Therapeutic procedure,USES,Nebulizers,32298247,10.15585/mmwr.mm6915e6,2020-04-17
Injury due to exposure to external cause,PROCESS_OF,"Personnel, Hospital",32298247,10.15585/mmwr.mm6915e6,2020-04-17
Symptoms,PROCESS_OF,Patients,32298246,10.15585/mmwr.mm6915e1,2020-04-17
Cessation of life,OCCURS_IN,Health Personnel,32298246,10.15585/mmwr.mm6915e1,2020-04-17
Influenza,PROCESS_OF,Patients,32298227,10.3201/eid2607.200500,2020-04-17
Staphylococcus aureus,CAUSES,"Pneumonia, Necrotizing",32298227,10.3201/eid2607.200500,2020-04-17
Disease,PROCESS_OF,Young Adult,32298227,10.3201/eid2607.200500,2020-04-17
Superinfection,PROCESS_OF,Young Adult,32298227,10.3201/eid2607.200500,2020-04-17
Coronavirus Infections,ISA,Disease,32298227,10.3201/eid2607.200500,2020-04-17
Coronavirus Infections,PROCESS_OF(SPEC),Young Adult,32298227,10.3201/eid2607.200500,2020-04-17
Coronavirus Infections,ISA,Disease,32298218,10.1080/21645515.2020.1740560,2020-04-17
Immunity,PROCESS_OF,Mus,32298208,10.1089/tmj.2020.0084,2020-04-17
Alhydrogel,STIMULATES,"Antibodies, Neutralizing",32298208,10.1089/tmj.2020.0084,2020-04-17
SARS coronavirus,PROCESS_OF,Patients,32298208,10.1089/tmj.2020.0084,2020-04-17
Critical Illness,PROCESS_OF,Patients,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Coronavirus Infections,ISA,Disease,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Communicable Diseases,PROCESS_OF,Consultant,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Coronavirus Infections,ISA,Disease,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Engaged to be married,PROCESS_OF,Family,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Disease,AFFECTS,Staff,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Coronavirus Infections,AFFECTS(SPEC),Staff,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Coronavirus Infections,ISA,Disease,32298139,10.5858/arpa.2020-0172-RA,2020-04-17
Judgment,PROCESS_OF,Surgeon,32298035,10.1002/hed.26171,2020-04-17
Neoplasms,PROCESS_OF,Patients,32298035,10.1002/hed.26171,2020-04-17
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32298029,10.1634/theoncologist.2020-0267,2020-04-17
Tracheostomy tube,USES,Cuffs device,32298029,10.1634/theoncologist.2020-0267,2020-04-17
Screening procedure,TREATS,Outpatients,32298028,10.1002/hed.26168,2020-04-17
cancer therapy,PREVENTS,Severe Acute Respiratory Syndrome,32298028,10.1002/hed.26168,2020-04-17
Malignant Neoplasms,PROCESS_OF,Patients,32298028,10.1002/hed.26168,2020-04-17
Physical Examination,ADMINISTERED_TO,Physicians,32298018,10.1002/hed.26174,2020-04-17
Structure of upper respiratory tract cavity,LOCATION_OF,Enthesitis-Related Arthritis,32298018,10.1002/hed.26174,2020-04-17
SARS coronavirus,CAUSES,Enthesitis-Related Arthritis,32298018,10.1002/hed.26174,2020-04-17
Endoscopy of stomach,USES,Artificial Airways,32298018,10.1002/hed.26174,2020-04-17
Coronavirus Infections,ISA,Disease,32298017,10.1002/hed.26175,2020-04-17
Malignant Head and Neck Neoplasm,PROCESS_OF,Physicians,32298017,10.1002/hed.26175,2020-04-17
Dyspnea,PROCESS_OF,Patients,32298016,10.1002/hed.26183,2020-04-17
removal technique,TREATS,Squamous cell carcinoma,32298016,10.1002/hed.26183,2020-04-17
Stridor,PROCESS_OF,Patients,32298016,10.1002/hed.26183,2020-04-17
Tracheostomy procedure,TREATS,Squamous cell carcinoma,32298016,10.1002/hed.26183,2020-04-17
Free flap,LOCATION_OF,Reconstructive Surgical Procedures,32298016,10.1002/hed.26183,2020-04-17
Reconstructive Surgical Procedures,TREATS,Squamous cell carcinoma,32298016,10.1002/hed.26183,2020-04-17
Lung,LOCATION_OF,Nodule,32298016,10.1002/hed.26183,2020-04-17
Trachea,LOCATION_OF,Lesion,32298016,10.1002/hed.26183,2020-04-17
Tracheostomy procedure,TREATS,Malignant Head and Neck Neoplasm,32298016,10.1002/hed.26183,2020-04-17
Tracheostomy procedure,TREATS,Has difficulty doing (qualifier value),32298016,10.1002/hed.26183,2020-04-17
Total laryngectomy,TREATS,Patients,32298006,10.1002/hed.26165,2020-04-17
Artificial Airways,TREATS,Otolaryngologist,32298006,10.1002/hed.26165,2020-04-17
Malignant Head and Neck Neoplasm,PROCESS_OF,Patients,32297988,10.1002/jmv.25898,2020-04-17
Worse,COEXISTS_WITH,Disease,32297985,10.1002/jmv.25893,2020-04-17
Coughing,ISA,Symptoms,32297983,10.1002/jmv.25894,2020-04-17
Coughing,PROCESS_OF,Patients,32297983,10.1002/jmv.25894,2020-04-17
Coughing,PROCESS_OF(SPEC),Patients,32297983,10.1002/jmv.25894,2020-04-17
Liver Dysfunction,PROCESS_OF,Patients,32297983,10.1002/jmv.25894,2020-04-17
White blood cell count increased (lab result),PROCESS_OF,Patients,32297983,10.1002/jmv.25894,2020-04-17
Symptoms,PROCESS_OF,Patients,32297983,10.1002/jmv.25894,2020-04-17
Therapeutic regimen,TREATS,patient condition,32297983,10.1002/jmv.25894,2020-04-17
European country,ISA,Geographic Locations,32297980,10.1002/jmv.25883,2020-04-17
Coughing,PROCESS_OF,"Infant, Newborn",32297868,10.2196/18980,2020-04-17
Fever,PROCESS_OF,"Infant, Newborn",32297868,10.2196/18980,2020-04-17
Vomiting,PROCESS_OF,"Infant, Newborn",32297868,10.2196/18980,2020-04-17
Coronavirus Infections,ISA,Disease,32297843,10.1089/nat.2020.0868,2020-04-17
Pharmaceutical Preparations,TREATS,Crisis,32297828,10.1089/vim.2020.0062,2020-04-17
Conventional Treatment,METHOD_OF,Drug Design,32297828,10.1089/vim.2020.0062,2020-04-17
Syndrome,PROCESS_OF,Patients,32297723,10.4081/monaldi.2020.1292,2020-04-17
Cardiovascular,LOCATION_OF,Syndrome,32297723,10.4081/monaldi.2020.1292,2020-04-17
Uncertainty,COEXISTS_WITH,Myocarditis,32297723,10.4081/monaldi.2020.1292,2020-04-17
cytokine,CAUSES,myocardial injury,32297723,10.4081/monaldi.2020.1292,2020-04-17
Cardiovascular,LOCATION_OF,Syndrome,32297723,10.4081/monaldi.2020.1292,2020-04-17
Cardiovascular,LOCATION_OF,Syndrome,32297723,10.4081/monaldi.2020.1292,2020-04-17
Coronavirus Infections,ISA,Disease,32297671,10.1111/bjh.16659,2020-04-17
Binding Sites,INTERACTS_WITH,receptor,32297671,10.1111/bjh.16659,2020-04-17
Disease,PROCESS_OF,Patients,32297593,10.2196/19145,2020-04-17
Coronavirus Infections,ISA,Disease,32297571,10.2174/0929867327666200416131117,2020-04-17
Coronavirus Infections,ISA,Disease,32297571,10.2174/0929867327666200416131117,2020-04-17
Coronavirus Infections,ISA,Disease,32297571,10.2174/0929867327666200416131117,2020-04-17
Therapeutic Mobilization,TREATS,Community,32297571,10.2174/0929867327666200416131117,2020-04-17
SARS coronavirus,CAUSES,Disease,32297540,10.1080/09537104.2020.1754383,2020-04-17
Oseltamivir,ISA,Pharmaceutical Preparations,32297540,10.1080/09537104.2020.1754383,2020-04-17
lopinavir / Ritonavir,TREATS,Patients,32297540,10.1080/09537104.2020.1754383,2020-04-17
Chloroquine,ISA,Antimalarials,32297540,10.1080/09537104.2020.1754383,2020-04-17
Ebola virus,PROCESS_OF,Patients,32297540,10.1080/09537104.2020.1754383,2020-04-17
arbidol,ADMINISTERED_TO,Patients,32297540,10.1080/09537104.2020.1754383,2020-04-17
darunavir,ADMINISTERED_TO,Patients,32297540,10.1080/09537104.2020.1754383,2020-04-17
Thrombocytopenia,AFFECTS,Patients,32297490,10.4081/monaldi.2020.1315,2020-04-17
Disease,PROCESS_OF,Patients,32297490,10.4081/monaldi.2020.1315,2020-04-17
Coronavirus Infections,ISA,Disease,32297490,10.4081/monaldi.2020.1315,2020-04-17
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32297490,10.4081/monaldi.2020.1315,2020-04-17
Ultrasonography,DIAGNOSES,pulmonary involvement,32297089,10.1007/s11739-020-02331-1,2020-04-17
Lung,PART_OF,Caucasoid Race,32297089,10.1007/s11739-020-02331-1,2020-04-17
Syndrome,PROCESS_OF,Patients,32296940,10.1007/s00330-020-06827-4,2020-04-17
Acute viral disease,COEXISTS_WITH,Syndrome,32296940,10.1007/s00330-020-06827-4,2020-04-17
Therapeutic procedure,TREATS,Acute Disease,32296940,10.1007/s00330-020-06827-4,2020-04-17
Therapeutic procedure,TREATS,Possible,32296940,10.1007/s00330-020-06827-4,2020-04-17
Therapeutic procedure,USES,oral anticoagulants,32296940,10.1007/s00330-020-06827-4,2020-04-17
Pneumonia,ISA,Respiration Disorders,32296910,10.1007/s00277-020-04019-0,2020-04-17
Coronavirus Infections,CAUSES,Respiration Disorders,32296910,10.1007/s00277-020-04019-0,2020-04-17
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32296910,10.1007/s00277-020-04019-0,2020-04-17
Viral culture procedure,DIAGNOSES,Coronavirus Infections,32296910,10.1007/s00277-020-04019-0,2020-04-17
Viral nucleic acid assay,DIAGNOSES,Coronavirus Infections,32296910,10.1007/s00277-020-04019-0,2020-04-17
Coronavirus Infections,ISA,Disease,32296910,10.1007/s00277-020-04019-0,2020-04-17
Coronavirus Infections,CAUSES,Pneumonia,32296910,10.1007/s00277-020-04019-0,2020-04-17
Infected,PROCESS_OF,Patients,32296910,10.1007/s00277-020-04019-0,2020-04-17
Virus,CAUSES,Thrombocytopenia,32296888,10.1007/s00120-020-01200-1,2020-04-17
Health Care,TREATS,Patients,32296884,10.1007/s00259-020-04799-7,2020-04-17
early identification,COEXISTS_WITH,Hospitalization,32296817,10.1093/cid/ciaa444,2020-04-17
Serum,LOCATION_OF,Lactate Dehydrogenase,32296817,10.1093/cid/ciaa444,2020-04-17
Clinician,TREATS,Patients,32296817,10.1093/cid/ciaa444,2020-04-17
Breast Feeding,PROCESS_OF,Woman,32296777,10.1016/j.medidd.2020.100019,2020-04-17
Experience,PROCESS_OF,Pregnant Women,32296777,10.1016/j.medidd.2020.100019,2020-04-17
Iran,ISA,Country,32296735,10.1016/j.synbio.2020.03.002,2020-04-17
Italy,ISA,Country,32296735,10.1016/j.synbio.2020.03.002,2020-04-17
Japan,ISA,Country,32296735,10.1016/j.synbio.2020.03.002,2020-04-17
South Korea,ISA,Country,32296735,10.1016/j.synbio.2020.03.002,2020-04-17
Appendix,LOCATION_OF,Syndrome,32296266,10.1016/j.ssci.2020.104773,2020-04-17
Emergency operation,TREATS,Appendicitis,32296266,10.1016/j.ssci.2020.104773,2020-04-17
Pharmacotherapy,COEXISTS_WITH,Compassionate Use,32296181,10.1038/s41586-020-2202-3,2020-04-17
Viral Shedding,PROCESS_OF,Patients,32296046,10.1038/s41394-020-0275-8,2020-04-17
Symptoms,PROCESS_OF,Persons,32295814,10.1136/postgradmedj-2020-137785,2020-04-17
Chloroquine,ISA,Pharmaceutical Preparations,32295811,10.1136/dtb.2020.000026,2020-04-17
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32295811,10.1136/dtb.2020.000026,2020-04-17
Anti-Inflammatory Agents,TREATS,Multiple Chronic Conditions,32295811,10.1136/dtb.2020.000026,2020-04-17
Italy,ISA,Country,32295659,10.1017/dmp.2020.104,2020-04-17
Italy,ISA,Country,32295659,10.1017/dmp.2020.104,2020-04-17
Symptom severe,PROCESS_OF,Patients,32295659,10.1017/dmp.2020.104,2020-04-17
Coronavirus Infections,ISA,Disease,32295652,10.1017/dmp.2020.102,2020-04-17
Coronavirus Infections,ISA,Disease,32295652,10.1017/dmp.2020.102,2020-04-17
Coronavirus Infections,ISA,Disease,32295652,10.1017/dmp.2020.102,2020-04-17
Coronavirus Infections,ISA,Disease,32295322,10.3760/cma.j.cn112147-20200224-00168,2020-04-17
Positive pressure therapy,USES,Artificial Airways,32295322,10.3760/cma.j.cn112147-20200224-00168,2020-04-17
Medical Devices,TREATS,"Infections, Hospital",32295322,10.3760/cma.j.cn112147-20200224-00168,2020-04-17
Polysomnography,USES,Transducers,32295322,10.3760/cma.j.cn112147-20200224-00168,2020-04-17
South Korea,ISA,Country,32295237,10.3390/v12040445,2020-04-17
Virus,CAUSES,Severe Acute Respiratory Syndrome,32295153,10.3390/vaccines8020183,2020-04-17
Vaccines,ISA,Biological Factors,32294864,10.3760/cma.j.cn112137-20200221-00388,2020-04-17
Clinical Deterioration,ASSOCIATED_WITH,Coronavirus Infections,32294816,10.3760/cma.j.cn112147-20200224-00167,2020-04-17
Clinical Deterioration,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32294816,10.3760/cma.j.cn112147-20200224-00167,2020-04-17
Bronchoalveolar Lavage Fluid,LOCATION_OF,Nucleic Acids,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Symptoms,NEG_PROCESS_OF,Patients,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Lung,LOCATION_OF,Lesion,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Pneumonia,PROCESS_OF,Patients,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Bronchial Lavage,METHOD_OF,Detection,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Throat swab sample,LOCATION_OF,Nucleic Acids,32294815,10.3760/cma.j.cn112147-20200212-00076,2020-04-17
Communicable Diseases,AFFECTS,Patients,32294813,10.3760/cma.j.cn112147-20200304-00239,2020-04-17
Respiratory Tract Infections,AFFECTS(SPEC),Patients,32294813,10.3760/cma.j.cn112147-20200304-00239,2020-04-17
Respiratory Tract Infections,ISA,Communicable Diseases,32294813,10.3760/cma.j.cn112147-20200304-00239,2020-04-17
Experience,PROCESS_OF,Adult,32294813,10.3760/cma.j.cn112147-20200304-00239,2020-04-17
Critical Illness,PROCESS_OF,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Therapeutic procedure,TREATS,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Therapeutic procedure,TREATS(INFER),Critical Illness,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Pneumonia,PROCESS_OF,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Therapeutic procedure,TREATS,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Therapeutic procedure,TREATS(INFER),Pneumonia,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Masks,TREATS,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Masks,USES,Harbor,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Spontaneous respiration,PROCESS_OF,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Ventilator outlet,USES,Heat Exchangers,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Noninvasive Ventilation,ADMINISTERED_TO,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Noninvasive Ventilation,USES,Masks,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Spontaneous respiration,PROCESS_OF,Patients,32294812,10.3760/cma.j.cn112147-20200224-00172,2020-04-17
Critical Illness,PROCESS_OF,Patients,32294808,10.31128/AJGP-COVID-09,2020-04-16
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32294808,10.31128/AJGP-COVID-09,2020-04-16
Pulmonary Thromboembolisms,PROCESS_OF,Patients,32294808,10.31128/AJGP-COVID-09,2020-04-16
Quick Test for Liver Function,USES,CD40LG wt Allele,32294807,10.31128/AJGP-COVID-08,2020-04-16
Lung,LOCATION_OF,Diagnosis,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Ultrasonography,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Lesion,32294763,10.1055/a-1153-9710,2020-04-16
Lesion,PROCESS_OF,Patients,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Lesion,32294763,10.1055/a-1153-9710,2020-04-16
Lesion,PROCESS_OF,Patients,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Lesion,32294763,10.1055/a-1153-9710,2020-04-16
Evaluation procedure,TREATS,Patients,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Lesion,32294763,10.1055/a-1153-9710,2020-04-16
Lung,LOCATION_OF,Observation - diagnostic procedure,32294763,10.1055/a-1153-9710,2020-04-16
Ultrasonography,AFFECTS,Evaluation procedure,32294763,10.1055/a-1153-9710,2020-04-16
Respiratory distress,PROCESS_OF,Patients,32294718,10.36416/1806-3756/e20200121,2020-04-16
Pandemics,ISA,Disease Outbreaks,32294718,10.36416/1806-3756/e20200121,2020-04-16
"Respiratory Distress Syndrome, Newborn",PROCESS_OF,Patients,32294718,10.36416/1806-3756/e20200121,2020-04-16
acute care,TREATS,Patients,32294718,10.36416/1806-3756/e20200121,2020-04-16
Coronavirus Infections,CAUSES,Disease,32294713,10.1590/2237-6089-2020-0029,2020-04-16
brazilian,PROCESS_OF,Adult,32294667,10.11606/s1518-8787.2020054002471,2020-04-16
Engaged to be married,PROCESS_OF,Persons,32294667,10.11606/s1518-8787.2020054002471,2020-04-16
Coronavirus Infections,ISA,Disease,32294617,10.6004/jnccn.2020.7572,2020-04-16
Malignant Neoplasms,PROCESS_OF,Patients,32294583,10.1016/j.ajp.2020.102074,2020-04-16
Malignant Neoplasms,PROCESS_OF,Patients,32294583,10.1016/j.ajp.2020.102074,2020-04-16
Infected,PROCESS_OF,Persons,32294562,10.1016/j.tmaid.2020.101646,2020-04-16
Betacoronavirus,CAUSES,Atypical pneumonia,32294504,10.1016/j.jinf.2020.04.004,2020-04-16
Hospitals,LOCATION_OF,Nucleic Acid Amplification Tests,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Nucleic Acid Amplification Tests,DIAGNOSES,Pneumonia,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Symptoms,PROCESS_OF,Patients,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Lesion,PROCESS_OF,Patients,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Asymptomatic,PROCESS_OF,Patients,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Pneumonia,PROCESS_OF,Patients,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Detected (finding),PROCESS_OF,Patients,32294503,10.1016/j.jinf.2020.04.003,2020-04-16
Coronavirus Infections,ISA,Disease,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Disease,PROCESS_OF,Pregnant Women,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Fever,PROCESS_OF,Patients,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Fever,PROCESS_OF,Patients,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Laboratory Procedures,DIAGNOSES,Coronaviridae,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Laboratory Procedures,USES,Buccal smear procedure,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Pneumonia,ISA,Disease,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Buccal smear procedure,DIAGNOSES(SPEC),Coronaviridae,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Buccal smear procedure,ISA,Laboratory Procedures,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Fever,PROCESS_OF,Patients,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Puerperal pyrexia,PROCESS_OF,Patients,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Radioisotope scan of lung,DIAGNOSES,Ground Glass Opacity,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Asymptomatic,NEG_ISA,Symptoms,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Mild disorder,PROCESS_OF,Pregnant Women,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Disease,PROCESS_OF,Pregnant Women,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Coronavirus Infections,ISA,Disease,32294485,10.1016/j.jaci.2020.04.006,2020-04-16
Adult,ISA,Population Group,32294453,10.1016/j.jogn.2020.04.001,2020-04-16
Asthma,OCCURS_IN,Patients,32294453,10.1016/j.jogn.2020.04.001,2020-04-16
Cessation of life,ASSOCIATED_WITH,Hyperglycemia,32294453,10.1016/j.jogn.2020.04.001,2020-04-16
Cessation of life,PROCESS_OF,Patients,32294453,10.1016/j.jogn.2020.04.001,2020-04-16
Wound Healing,PRECEDES,Birth,32294297,10.1002/oby.22836,2020-04-16
Wound Healing,PROCESS_OF,Infant,32294297,10.1002/oby.22836,2020-04-16
ano-rectal,LOCATION_OF,Sexually Transmitted Diseases,32294297,10.1002/oby.22836,2020-04-16
Coronavirus Infections,ISA,Disease,32294285,10.1111/liv.14481,2020-04-16
Obesity,PROCESS_OF,Persons,32294285,10.1111/liv.14481,2020-04-16
Bariatric Surgery,TREATS,Persons,32294285,10.1111/liv.14481,2020-04-16
Bariatric Surgery,PRECEDES,Psychosocial assessment (procedure),32294285,10.1111/liv.14481,2020-04-16
Diabetes,PROCESS_OF,Persons,32294078,10.12659/MSM.923767,2020-04-16
"Diabetes Mellitus, Non-Insulin-Dependent",PROCESS_OF,Persons,32294078,10.12659/MSM.923767,2020-04-16
Reporting,TREATS,Persons,32294078,10.12659/MSM.923767,2020-04-16
Reporting,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",32294078,10.12659/MSM.923767,2020-04-16
Proteins,AFFECTS,Inflammation,32294078,10.12659/MSM.923767,2020-04-16
Proteins,PART_OF,coronavirus receptor,32294078,10.12659/MSM.923767,2020-04-16
Dipeptidyl-Peptidase IV,AFFECTS,Inflammation,32294078,10.12659/MSM.923767,2020-04-16
coronavirus receptor,AFFECTS(SPEC),Inflammation,32294078,10.12659/MSM.923767,2020-04-16
coronavirus receptor,ISA,Proteins,32294078,10.12659/MSM.923767,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Inflammation,32294078,10.12659/MSM.923767,2020-04-16
Dipeptidyl-Peptidase IV Inhibitors,ISA,Agent,32294078,10.12659/MSM.923767,2020-04-16
Male population group,ISA,Persons,32294077,10.1097/PRA.0000000000000473,2020-04-16
Psychological counseling,TREATS,Persons,32294077,10.1097/PRA.0000000000000473,2020-04-16
Coronavirus Infections,ISA,Disease,32294051,10.3201/eid2607.201285,2020-04-16
Viral Shedding,COEXISTS_WITH,Asymptomatic,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Down-Regulation,AFFECTS,angiotensin II,32293875,10.1021/acs.biochem.0c00160,2020-04-16
physiological aspects,ASSOCIATED_WITH,Anti-Inflammatory Agents,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Syndrome,CAUSES,Multiple Organ Failure,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Old age,ISA,Adult,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Interleukin-6,ISA,cytokine,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Inflammation,CAUSES,Disease of capillaries,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Inflammation,CAUSES,Myocarditis,32293875,10.1021/acs.biochem.0c00160,2020-04-16
Severe course,PROCESS_OF,Patients,32293833,10.3906/sag-2004-126,2020-04-16
Evaluation,TREATS,Couples (persons),32293833,10.3906/sag-2004-126,2020-04-16
Hydroxychloroquine,ISA,Chloroquine,32293833,10.3906/sag-2004-126,2020-04-16
Infection,PROCESS_OF,Homo sapiens,32293833,10.3906/sag-2004-126,2020-04-16
"Immunity, Herd",PROCESS_OF,Persons,32293832,10.3906/sag-2004-127,2020-04-16
Common Cold,PROCESS_OF,Homo sapiens,32293831,10.3906/sag-2004-122,2020-04-16
Pneumonia,PROCESS_OF,Homo sapiens,32293831,10.3906/sag-2004-122,2020-04-16
Systemic disease,CAUSES,Common Cold,32293831,10.3906/sag-2004-122,2020-04-16
Systemic disease,CAUSES,Pneumonia,32293831,10.3906/sag-2004-122,2020-04-16
cold symptoms,PROCESS_OF,Persons,32293831,10.3906/sag-2004-122,2020-04-16
Human coronavirus 229E,CAUSES,cold symptoms,32293831,10.3906/sag-2004-122,2020-04-16
"Coronavirus OC43, Human",CAUSES,cold symptoms,32293831,10.3906/sag-2004-122,2020-04-16
Human coronavirus NL63,CAUSES,cold symptoms,32293831,10.3906/sag-2004-122,2020-04-16
Human coronavirus HKU1,CAUSES,cold symptoms,32293831,10.3906/sag-2004-122,2020-04-16
Pneumonia,PROCESS_OF,Patients,32293831,10.3906/sag-2004-122,2020-04-16
Coronaviridae,ISA,Virus,32293831,10.3906/sag-2004-122,2020-04-16
century,AFFECTS,Does stand,32293817,10.23736/S1973-9087.20.06305-4,2020-04-16
intensive care,TREATS,patient condition,32293817,10.23736/S1973-9087.20.06305-4,2020-04-16
Mental disorders,PROCESS_OF,Patients,32293807,10.1002/jia2.25489,2020-04-16
Coronavirus Infections,CAUSES,Disease,32293753,10.1002/jmv.25889,2020-04-16
Prophylactic treatment,USES,Pharmaceutical Preparations,32293753,10.1002/jmv.25889,2020-04-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32293753,10.1002/jmv.25889,2020-04-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32293753,10.1002/jmv.25889,2020-04-16
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32293753,10.1002/jmv.25889,2020-04-16
Uncertainty,PROCESS_OF,Patients,32293753,10.1002/jmv.25889,2020-04-16
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32293741,10.1002/jmv.25891,2020-04-16
Smoking History,PROCESS_OF,Patients,32293741,10.1002/jmv.25891,2020-04-16
Chronic Obstructive Airway Disease,OCCURS_IN,Patients,32293741,10.1002/jmv.25891,2020-04-16
Hospitals,LOCATION_OF,Analysis,32293717,10.1002/14651858.CD011621.pub4,2020-04-16
Complication,PROCESS_OF,Patients,32293717,10.1002/14651858.CD011621.pub4,2020-04-16
Cessation of life,PROCESS_OF,Patients,32293717,10.1002/14651858.CD011621.pub4,2020-04-16
Recurrent gastrointestinal bleeding,NEG_COEXISTS_WITH,complication of disease,32293717,10.1002/14651858.CD011621.pub4,2020-04-16
Diazooxonorleucine,AUGMENTS,Compliance,32293716,10.1002/jmv.25884,2020-04-16
Diazooxonorleucine,ADMINISTERED_TO,Health Personnel,32293716,10.1002/jmv.25884,2020-04-16
"Respirators, Air-Purifying",compared_with,Masks,32293716,10.1002/jmv.25884,2020-04-16
"Respirators, Air-Purifying",higher_than,Masks,32293716,10.1002/jmv.25884,2020-04-16
Persons,USES,Gown,32293716,10.1002/jmv.25884,2020-04-16
Gown,compared_with,Apron,32293716,10.1002/jmv.25884,2020-04-16
Gown,higher_than,Apron,32293716,10.1002/jmv.25884,2020-04-16
Covers (device),compared_with,RAB3IL1 gene,32293716,10.1002/jmv.25884,2020-04-16
Hand,LOCATION_OF,Isopropyl Alcohol,32293716,10.1002/jmv.25884,2020-04-16
Extraction,USES,Gown,32293716,10.1002/jmv.25884,2020-04-16
Elevated C-reactive protein level,PROCESS_OF,Patients,32293715,10.1002/bjs.11646,2020-04-16
Leukopenia,PROCESS_OF,Patients,32293715,10.1002/bjs.11646,2020-04-16
Lesion,PROCESS_OF,Patients,32293715,10.1002/bjs.11646,2020-04-16
Lesion,PROCESS_OF,Patients,32293715,10.1002/bjs.11646,2020-04-16
Fever,ISA,Symptoms,32293715,10.1002/bjs.11646,2020-04-16
"CD69 protein, human",ADMINISTERED_TO,surgical patients,32293713,10.1002/jmv.25882,2020-04-16
Experience,PROCESS_OF,Anesthetist,32293713,10.1002/jmv.25882,2020-04-16
Experience,PROCESS_OF,Surgeon,32293713,10.1002/jmv.25882,2020-04-16
Elective Surgical Procedures,TREATS,Patients,32293713,10.1002/jmv.25882,2020-04-16
Epithelium,LOCATION_OF,Coronavirus Infections,32293709,10.1002/jmv.25881,2020-04-16
Epithelium,LOCATION_OF,angiotensin converting enzyme 2,32293709,10.1002/jmv.25881,2020-04-16
Epithelium,PART_OF,Lung,32293709,10.1002/jmv.25881,2020-04-16
Epithelium,PART_OF,Lung,32293709,10.1002/jmv.25881,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Immune response,32293709,10.1002/jmv.25881,2020-04-16
Diabetes Mellitus,CAUSES,Disease,32293709,10.1002/jmv.25881,2020-04-16
Diabetes Mellitus,ISA,Disease,32293709,10.1002/jmv.25881,2020-04-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32293709,10.1002/jmv.25881,2020-04-16
"Antibodies, Neutralizing",CAUSES,"Respiratory Distress Syndrome, Adult",32293709,10.1002/jmv.25881,2020-04-16
Equilibrium,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32293709,10.1002/jmv.25881,2020-04-16
Hydroxychloroquine,DISRUPTS,inflammatory response,32293709,10.1002/jmv.25881,2020-04-16
Hydroxychloroquine,ISA,Agent,32293709,10.1002/jmv.25881,2020-04-16
Coronavirus Infections,ISA,Disease,32293580,10.2196/19076,2020-04-16
Coronavirus Infections,ISA,Disease,32293580,10.2196/19076,2020-04-16
Coronavirus Infections,ISA,Disease,32293580,10.2196/19076,2020-04-16
Country,ISA,Geographic Locations,32293555,10.1192/bjp.2020.86,2020-04-16
Chile,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Ecuador,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
India,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Mexico,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Peru,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Spain,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
United Kingdom,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
United States,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Colombia,ISA,Country,32293555,10.1192/bjp.2020.86,2020-04-16
Virus,CAUSES,Disease,32293449,10.1186/s12931-020-01352-w,2020-04-16
Virus,CAUSES(SPEC),Coronavirus Infections,32293449,10.1186/s12931-020-01352-w,2020-04-16
Coronavirus Infections,ISA,Disease,32293449,10.1186/s12931-020-01352-w,2020-04-16
Challenge,TREATS,Patients,32293449,10.1186/s12931-020-01352-w,2020-04-16
Disease,PROCESS_OF,hospitalized patients,32293225,10.1148/radiol.2020201495,2020-04-16
Heart Injuries,ISA,Disease,32293225,10.1148/radiol.2020201495,2020-04-16
Heart Injuries,PROCESS_OF(SPEC),hospitalized patients,32293225,10.1148/radiol.2020201495,2020-04-16
Amino-terminal pro-brain natriuretic peptide,ISA,pro-brain natriuretic peptide (1-76),32293225,10.1148/radiol.2020201495,2020-04-16
Cessation of life,PROCESS_OF,Patients,32293225,10.1148/radiol.2020201495,2020-04-16
risk factors,PREDISPOSES,Death in hospital,32293225,10.1148/radiol.2020201495,2020-04-16
Death in hospital,PROCESS_OF,Patients,32293225,10.1148/radiol.2020201495,2020-04-16
Communicable Diseases,PROCESS_OF,Homo sapiens,32293098,10.1002/art.41285,2020-04-16
Medical Devices,USES,Transistors,32293098,10.1002/art.41285,2020-04-16
Medical Devices,USES,Transistors,32293098,10.1002/art.41285,2020-04-16
Hypertensive disease,PREDISPOSES,Severe (severity modifier),32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Infection,PROCESS_OF,Patients,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Hypertensive disease,PROCESS_OF,Patients,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Angiotensin-Converting Enzyme Inhibitors,TREATS(INFER),Lower respiratory tract infection,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Lower respiratory tract infection,PROCESS_OF,Patients,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Angiotensin II receptor antagonist,TREATS,Patients,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Angiotensin II receptor antagonist,TREATS(INFER),Lower respiratory tract infection,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Patients,LOCATION_OF,IMPACT gene,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Cardiovascular system,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Kidney,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Lung,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
angiotensin converting enzyme 2,AFFECTS,Body tissue,32292917,10.1016/j.jaccas.2020.03.006,2020-04-16
Percutaneous Administration,TREATS,Patients,32292915,10.1016/j.jaccas.2020.04.001,2020-04-16
Disease,COEXISTS_WITH,Acute respiratory distress,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Lung,LOCATION_OF,advanced disease,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Respiratory distress,ASSOCIATED_WITH,Virus Diseases,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Lung,LOCATION_OF,Disease,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Efferent,LOCATION_OF,Afferent neuron,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
TRPV1 gene,PRODUCES,neuronal,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Malignant Neoplasms,PROCESS_OF,Patients,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Pain,PROCESS_OF,Patients,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
resiniferatoxin,STIMULATES,TRPV1 gene,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
advanced disease,PROCESS_OF,Patients,32292904,10.1016/j.xkme.2020.03.001,2020-04-16
Virus,CAUSES,Communicable Diseases,32292903,10.1016/j.ajogmf.2020.100118,2020-04-16
Pneumonia,PROCESS_OF,Patients,32292903,10.1016/j.ajogmf.2020.100118,2020-04-16
Pneumonia,PROCESS_OF,Patients,32292903,10.1016/j.ajogmf.2020.100118,2020-04-16
Infectious disease prevention / control,TREATS,Patients,32292903,10.1016/j.ajogmf.2020.100118,2020-04-16
Gravidity,NEG_PROCESS_OF,Adult,32292902,10.1016/j.ajogmf.2020.100107,2020-04-16
Severe disorder,PROCESS_OF,Woman,32292902,10.1016/j.ajogmf.2020.100107,2020-04-16
Infection,PROCESS_OF,Adult,32292902,10.1016/j.ajogmf.2020.100107,2020-04-16
Severe Acute Respiratory Syndrome,CAUSES,Disease,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Severe Acute Respiratory Syndrome,CAUSES,Coronavirus Infections,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Coronavirus Infections,PROCESS_OF,Pregnant Women,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Tissue membrane,LOCATION_OF,Rupture,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Fever,ISA,Symptoms,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Tissue membrane,LOCATION_OF,Rupture,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Premature Birth,ISA,Pregnancy Outcome,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Pneumonia,PROCESS_OF,Mother (person),32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Perinatal death,PROCESS_OF,general population,32292901,10.1016/j.jtauto.2020.100051,2020-04-16
Vaccines,CAUSES,Autoimmune Diseases,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Vaccines,ASSOCIATED_WITH,Autoimmune Diseases,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Structure of parenchyma of lung,LOCATION_OF,Autoimmune Diseases,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Bacteria,LOCATION_OF,Peptides,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Virus,LOCATION_OF,Peptides,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Epitopes,compared_with,"NR4A2 protein, human",32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Symptoms,ASSOCIATED_WITH,Disease,32292899,10.1016/j.eclinm.2020.100331,2020-04-16
Coronavirus Infections,ISA,Disease,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Coronavirus Infections,ISA,Disease,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Elective Surgical Procedures,TREATS,Patients,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Coronavirus Infections,ISA,Disease,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Pneumonia,ISA,Disease,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Pneumonia,PROCESS_OF,Patients,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Comorbidity,PROCESS_OF,Patients,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Operative Surgical Procedures,TREATS,Comorbidity,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Complication,PROCESS_OF,Survivors,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Disease,PROCESS_OF,Patients,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
"Respiratory Distress Syndrome, Adult",ISA,Shock,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Coronavirus Infections,ISA,Disease,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32292898,10.1016/j.eclinm.2020.100329,2020-04-16
Coronavirus Infections,ISA,Disease,32292884,10.1007/s42399-020-00271-7,2020-04-16
Pharmaceutical Preparations,COEXISTS_WITH,ACE2 gene,32292881,10.15698/cst2020.04.216,2020-04-16
Disease,PROCESS_OF,Patients,32292881,10.15698/cst2020.04.216,2020-04-16
Specific antibody,PART_OF,Homo sapiens,32292881,10.15698/cst2020.04.216,2020-04-16
Genus: Coronavirus,ISA,RNA Viruses,32292880,10.1007/s42058-020-00031-5,2020-04-16
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Frail,32292880,10.1007/s42058-020-00031-5,2020-04-16
Infection,COEXISTS_WITH,Index case,32292880,10.1007/s42058-020-00031-5,2020-04-16
Coronavirus Infections,ISA,Disease,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
cytokine,ISA,Pharmaceutical Preparations,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Disease,PROCESS_OF,Patients,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Kidney Diseases,PROCESS_OF,Patients,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Disease,PROCESS_OF,Patients,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Coronavirus Infections,ISA,Disease,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32292848,10.1016/j.jacbts.2020.04.002,2020-04-16
Troponin,PREDISPOSES,Heart Injuries,32292842,10.1016/j.adro.2020.03.013,2020-04-16
Oxygen,PART_OF,Patients,32292842,10.1016/j.adro.2020.03.013,2020-04-16
Direct Contact Transmission Infection,CAUSES,Myocarditis,32292842,10.1016/j.adro.2020.03.013,2020-04-16
cytokine,AUGMENTS,Thrombus,32292842,10.1016/j.adro.2020.03.013,2020-04-16
cytokine,CAUSES,myocardial injury,32292842,10.1016/j.adro.2020.03.013,2020-04-16
Malaise,PROCESS_OF,Patients,32292842,10.1016/j.adro.2020.03.013,2020-04-16
Communicable Diseases,PROCESS_OF,Patients,32292839,10.1016/j.adro.2020.03.010,2020-04-16
Malignant neoplasm of breast,PROCESS_OF,Patients,32292839,10.1016/j.adro.2020.03.010,2020-04-16
Oncologists,TREATS,Patients,32292837,10.1016/j.adro.2020.03.003,2020-04-16
Malignant neoplasm of prostate,PROCESS_OF,Patients,32292837,10.1016/j.adro.2020.03.003,2020-04-16
professional occupation status,TREATS,Cancer Patient,32292826,10.12688/wellcomeopenres.15821.1,2020-04-16
Interventional procedure,NEG_METHOD_OF,Prophylactic treatment,32292817,10.1016/j.onehlt.2020.100131,2020-04-16
Registration,TREATS,Research Personnel,32292817,10.1016/j.onehlt.2020.100131,2020-04-16
Animal Health,PROCESS_OF,Community,32292815,10.1016/j.onehlt.2020.100129,2020-04-16
Eye,LOCATION_OF,Virus,32292805,10.1016/j.dib.2020.105552,2020-04-16
Crisis,PROCESS_OF,World,32292802,10.1007/s13337-020-00575-1,2020-04-16
Pharmaceutical Preparations,TREATS,Patients,32292802,10.1007/s13337-020-00575-1,2020-04-16
Nasogastric tube,NEG_USES,Pharmaceutical Preparations,32292802,10.1007/s13337-020-00575-1,2020-04-16
Virus,PROCESS_OF,Homo sapiens,32292707,10.1016/j.jbef.2020.100326,2020-04-16
Virus,CAUSES,Disease,32292707,10.1016/j.jbef.2020.100326,2020-04-16
Communicable Diseases,INTERACTS_WITH,Virus,32292697,10.1016/j.jot.2020.03.014,2020-04-16
Complication,PROCESS_OF,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Steroid therapy,ADMINISTERED_TO,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Avascular Necrosis of Femur Head,PROCESS_OF,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Head of femur,LOCATION_OF,Diagnosis,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Head of femur,LOCATION_OF,Shock,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Hip structure,LOCATION_OF,Degenerative polyarthritis,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Total Hip Replacement (procedure),TREATS,Patients,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Head of femur,LOCATION_OF,Shock,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Phytotherapy,PREVENTS,Shock,32292693,10.1016/j.jbo.2020.100291,2020-04-16
Fragility,PREDISPOSES,Respiratory complication,32292691,10.1016/j.spasta.2020.100443,2020-04-16
Secondary malignant neoplasm of vertebral column,ISA,Secondary malignant neoplasm of bone,32292691,10.1016/j.spasta.2020.100443,2020-04-16
Registration,NEG_TREATS,Coronavirus Infections,32292686,10.1007/s40121-020-00295-5,2020-04-16
Genus: Coronavirus,LOCATION_OF,Proteins,32292686,10.1007/s40121-020-00295-5,2020-04-16
Genus: Coronavirus,LOCATION_OF,SARS gene,32292686,10.1007/s40121-020-00295-5,2020-04-16
SARS gene,compared_with,Proteins,32292686,10.1007/s40121-020-00295-5,2020-04-16
"Pneumonia, Viral",COEXISTS_WITH,Coronavirus Infections,32292669,10.7759/cureus.7255,2020-04-16
Virus,CAUSES,Infection,32292669,10.7759/cureus.7255,2020-04-16
"Infections, Hospital",NEG_PROCESS_OF,Staff,32292636,10.1016/j.ijnss.2020.04.001,2020-04-16
Experience,PROCESS_OF,Patients,32292636,10.1016/j.ijnss.2020.04.001,2020-04-16
Experience,PROCESS_OF,Physicians,32292636,10.1016/j.ijnss.2020.04.001,2020-04-16
Experience,PROCESS_OF,teams,32292636,10.1016/j.ijnss.2020.04.001,2020-04-16
Disinfection,USES,medical supplies,32292636,10.1016/j.ijnss.2020.04.001,2020-04-16
intensive care unit,LOCATION_OF,Work,32292635,10.1016/j.ijnss.2020.03.012,2020-04-16
Hospital clinic,LOCATION_OF,Work,32292635,10.1016/j.ijnss.2020.03.012,2020-04-16
Contingency Management,TREATS,Patients,32292635,10.1016/j.ijnss.2020.03.012,2020-04-16
Ward (environment),LOCATION_OF,Work,32292635,10.1016/j.ijnss.2020.03.012,2020-04-16
Tertiary Care Centers,LOCATION_OF,Specimen Collection,32292634,10.1016/j.ijnss.2020.03.010,2020-04-16
Specimen Collection,USES,Buccal smear procedure,32292634,10.1016/j.ijnss.2020.03.010,2020-04-16
"Nursing, Team",COEXISTS_WITH,Prophylactic treatment,32292630,10.1016/j.wjorl.2020.03.002,2020-04-16
Influenza in Birds,PROCESS_OF,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Lung diseases,PROCESS_OF,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Pneumonia,ISA,Lung diseases,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Pneumonia,PROCESS_OF(SPEC),Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
"Respiratory Distress Syndrome, Adult",ISA,Lung diseases,32292626,10.1016/j.eng.2020.03.002,2020-04-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF(SPEC),Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,TREATS,Influenza in Birds,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,TREATS,Viral-induced pneumonia,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,PROCESS_OF,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,ADMINISTERED_TO,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,PROCESS_OF,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,PROCESS_OF,Patients,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,TREATS,Control Groups,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,USES,,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,TREATS,Human body,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Transplantation,USES,,32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Influenza in Birds,CAUSES,"Respiratory Distress Syndrome, Adult",32292626,10.1016/j.eng.2020.03.002,2020-04-16
Basis,TREATS,Influenza in Birds,32292626,10.1016/j.eng.2020.03.002,2020-04-16
lobe,PART_OF,Lung,32292623,10.1016/j.jpha.2020.02.010,2020-04-16
Household composition,PROCESS_OF,Persons,32292622,10.1016/j.shaw.2020.03.001,2020-04-16
Quick Test for Liver Function,DIAGNOSES,Communicable Diseases,32292622,10.1016/j.shaw.2020.03.001,2020-04-16
Laboratory Procedures,METHOD_OF,Molecular Diagnosis,32292622,10.1016/j.shaw.2020.03.001,2020-04-16
Task,ISA,Work,32292588,10.1016/j.nmni.2020.100674,2020-04-16
Coronavirus Infections,ISA,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
Coronavirus Infections,ISA,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
Coronavirus Infections,ISA,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
Therapeutic procedure,TREATS,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
Therapeutic procedure,TREATS(SPEC),Coronavirus Infections,32292527,10.1007/s12561-020-09277-0,2020-04-16
Coronavirus Infections,ISA,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
Coronavirus Infections,ISA,Disease,32292527,10.1007/s12561-020-09277-0,2020-04-16
professional occupation status,TREATS,Patients,32292527,10.1007/s12561-020-09277-0,2020-04-16
Disease,CAUSES,Coronavirus Infections,32292517,10.7150/thno.45016,2020-04-16
Severe disorder,PROCESS_OF,Homo sapiens,32292297,10.1016/j.mnl.2020.03.021,2020-04-16
Anxiety,COEXISTS_WITH,Disease,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Uncertainty,COEXISTS_WITH,Disease,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Engaged to be married,PROCESS_OF,citizen,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Engaged to be married,PROCESS_OF,citizen,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Engaged to be married,PROCESS_OF,citizen,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Engaged to be married,PROCESS_OF,citizen,32292232,10.1016/j.mjafi.2020.03.022,2020-04-16
Cessation of life,PROCESS_OF,Old age,32292217,10.1016/j.polymdegradstab.2020.109162,2020-04-16
Cardiovascular Diseases,AFFECTS,Immune response,32292217,10.1016/j.polymdegradstab.2020.109162,2020-04-16
Coronavirus Infections,ISA,Disease,32291858,10.1111/jpc.14891,2020-04-16
Malignant Neoplasms,PROCESS_OF,Patients,32291858,10.1111/jpc.14891,2020-04-16
Coronavirus Infections,ISA,Disease,32291858,10.1111/jpc.14891,2020-04-16
malignant disease,CAUSES,Disease,32291858,10.1111/jpc.14891,2020-04-16
malignant disease,CAUSES(SPEC),Coronavirus Infections,32291858,10.1111/jpc.14891,2020-04-16
Malignant neoplasm of lung,ISA,Lung diseases,32291858,10.1111/jpc.14891,2020-04-16
Malignant neoplasm of lung,PROCESS_OF,Patients,32291858,10.1111/jpc.14891,2020-04-16
Malignant neoplasm of lung,PROCESS_OF,Patients,32291858,10.1111/jpc.14891,2020-04-16
Coronavirus Infections,ISA,Disease,32291858,10.1111/jpc.14891,2020-04-16
Malignant neoplasm of lung,PROCESS_OF,Patients,32291858,10.1111/jpc.14891,2020-04-16
Coronavirus Infections,ISA,Disease,32291858,10.1111/jpc.14891,2020-04-16
Malignant neoplasm of lung,PROCESS_OF,Patients,32291858,10.1111/jpc.14891,2020-04-16
Coronavirus Infections,ISA,Disease,32291505,10.1007/s00063-020-00689-w,2020-04-16
Angiotensin-Converting Enzyme Inhibitors,ADMINISTERED_TO,Research Personnel,32291505,10.1007/s00063-020-00689-w,2020-04-16
Coronavirus Infections,ISA,Disease,32291505,10.1007/s00063-020-00689-w,2020-04-16
Critical Illness,PROCESS_OF,Patients,32291505,10.1007/s00063-020-00689-w,2020-04-16
Diabetes Mellitus,PROCESS_OF,Patients,32291505,10.1007/s00063-020-00689-w,2020-04-16
Hypertensive disease,PROCESS_OF,Patients,32291505,10.1007/s00063-020-00689-w,2020-04-16
Alveolar Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32291505,10.1007/s00063-020-00689-w,2020-04-16
angiotensin converting enzyme 2,ADMINISTERED_TO,Research Personnel,32291505,10.1007/s00063-020-00689-w,2020-04-16
Coronavirus Infections,ISA,Disease,32291505,10.1007/s00063-020-00689-w,2020-04-16
"SLC6A2 protein, human",AFFECTS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32291505,10.1007/s00063-020-00689-w,2020-04-16
angiotensin converting enzyme 2,ASSOCIATED_WITH,Inflammation,32291505,10.1007/s00063-020-00689-w,2020-04-16
Disease,NEG_CAUSES,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32291505,10.1007/s00063-020-00689-w,2020-04-16
Coronavirus Infections,CAUSES,Acute illness,32291502,10.1007/s00330-020-06823-8,2020-04-16
Symptom mild,PROCESS_OF,Patients,32291502,10.1007/s00330-020-06823-8,2020-04-16
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32291502,10.1007/s00330-020-06823-8,2020-04-16
Intubation,TREATS,patient condition,32291502,10.1007/s00330-020-06823-8,2020-04-16
Pneumonia,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Non-Ossifying Fibroma,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Infected,PROCESS_OF,Persons,32291501,10.1007/s00330-020-06860-3,2020-04-16
Fever,ISA,Symptoms,32291501,10.1007/s00330-020-06860-3,2020-04-16
Lung,LOCATION_OF,Lesion,32291501,10.1007/s00330-020-06860-3,2020-04-16
Decreased translucency,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Ground Glass Opacity,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Ground Glass Opacity,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Ground Glass Opacity,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
lobe,LOCATION_OF,Abnormal Finding,32291501,10.1007/s00330-020-06860-3,2020-04-16
Abnormal Finding,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Ground Glass Opacity,PROCESS_OF,Patients,32291501,10.1007/s00330-020-06860-3,2020-04-16
Chest deformity,PROCESS_OF,Patients,32291399,10.1038/s41379-020-0536-x,2020-04-16
Prophylactic treatment,TREATS,Patients,32291399,10.1038/s41379-020-0536-x,2020-04-16
Coronavirus Infections,ISA,Disease,32291351,10.1128/mSystems.00297-20,2020-04-16
Heart,LOCATION_OF,Core biopsy needle,32291351,10.1128/mSystems.00297-20,2020-04-16
Liver,LOCATION_OF,Core biopsy needle,32291351,10.1128/mSystems.00297-20,2020-04-16
Lung,LOCATION_OF,Core biopsy needle,32291351,10.1128/mSystems.00297-20,2020-04-16
Pneumonia,ISA,Disease,32291351,10.1128/mSystems.00297-20,2020-04-16
Disease Progression,PROCESS_OF,Patients,32291351,10.1128/mSystems.00297-20,2020-04-16
Disease,PROCESS_OF,Patients,32291351,10.1128/mSystems.00297-20,2020-04-16
leukemia,PROCESS_OF,Patients,32291351,10.1128/mSystems.00297-20,2020-04-16
White blood cell count increased (lab result),PROCESS_OF,Patients,32291351,10.1128/mSystems.00297-20,2020-04-16
Alveolar,LOCATION_OF,Acute inflammation,32291351,10.1128/mSystems.00297-20,2020-04-16
Focal fibrosis,COEXISTS_WITH,Disease,32291351,10.1128/mSystems.00297-20,2020-04-16
Autopsy,DIAGNOSES,diffuse alveolar damage,32291351,10.1128/mSystems.00297-20,2020-04-16
"Pneumonia, Bacterial",PROCESS_OF,Patients,32291351,10.1128/mSystems.00297-20,2020-04-16
Neoplasm Metastasis,COEXISTS_WITH,Disease,32291351,10.1128/mSystems.00297-20,2020-04-16
Amines,ISA,Pharmaceutical Preparations,32291278,10.1126/science.abb5793,2020-04-16
Camptothecin,ISA,Pharmaceutical Preparations,32291278,10.1126/science.abb5793,2020-04-16
Didanosine,ISA,Pharmaceutical Preparations,32291278,10.1126/science.abb5793,2020-04-16
"(2'-(4-aminophenyl)-(2,5'-bi-1H-benzimidazol)-5-amine)",ISA,Pharmaceutical Preparations,32291278,10.1126/science.abb5793,2020-04-16
health advice,NEG_PROCESS_OF,student,32291208,10.1016/j.jpurol.2020.04.007,2020-04-16
Health Promotion,TREATS,student,32291208,10.1016/j.jpurol.2020.04.007,2020-04-16
Coronavirus Infections,ISA,Disease,32291197,10.1016/j.diii.2020.03.014,2020-04-16
Myocarditis,CAUSES,Cessation of life,32291197,10.1016/j.diii.2020.03.014,2020-04-16
Heart,LOCATION_OF,Disease,32291197,10.1016/j.diii.2020.03.014,2020-04-16
Coronavirus Infections,ISA,Disease,32291197,10.1016/j.diii.2020.03.014,2020-04-16
tomography,DIAGNOSES,Pneumonia,32291137,10.1016/j.jaut.2020.102452,2020-04-16
Critical Illness,PROCESS_OF,Patients,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Cessation of life,PROCESS_OF,Patients,32291112,10.1016/j.tips.2020.03.006,2020-04-16
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Cytokine release syndrome,AFFECTS,Severe (severity modifier),32291112,10.1016/j.tips.2020.03.006,2020-04-16
Anti-Inflammatory Agents,TREATS,Cytokine release syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
novel AODU treatment method,TREATS,Cytokine release syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Therapeutic procedure,TREATS,Cytokine release syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Cytokine release syndrome,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Cytokine release syndrome,COEXISTS_WITH,Middle East Respiratory Syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Severe Acute Respiratory Syndrome,CAUSES,Cytokine release syndrome,32291112,10.1016/j.tips.2020.03.006,2020-04-16
Arteries,LOCATION_OF,Thromboembolism,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Myocardial Infarction,OCCURS_IN,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Pneumonia,PROCESS_OF,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Deep Vein Thrombosis,OCCURS_IN,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
"EMBOLISM, SYSTEMIC ARTERIAL",OCCURS_IN,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Ischemic stroke,OCCURS_IN,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Acute pulmonary embolism,OCCURS_IN,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Infection,PROCESS_OF,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Anticoagulant prophylaxis,TREATS,Patients,32291080,10.1016/j.crad.2020.03.028,2020-04-16
Plain chest X-ray,ISA,Imaging Techniques,32291076,10.1016/j.bbrc.2020.04.010,2020-04-16
tomography,ISA,Imaging Techniques,32291076,10.1016/j.bbrc.2020.04.010,2020-04-16
Severe Acute Respiratory Syndrome,AFFECTS,Problem,32290904,10.2807/1560-7917.ES.2020.25.14.2000433,2020-04-16
ACE2 gene,NEG_AUGMENTS,Line 2,32290904,10.2807/1560-7917.ES.2020.25.14.2000433,2020-04-16
Mammalian Cell,LOCATION_OF,ACE2 gene,32290904,10.2807/1560-7917.ES.2020.25.14.2000433,2020-04-16
Targeted Therapy,USES,Pharmaceutical Preparations,32290904,10.2807/1560-7917.ES.2020.25.14.2000433,2020-04-16
Coronavirus Infections,ISA,Disease,32290902,10.2807/1560-7917.ES.2020.25.14.2000398,2020-04-16
Coronavirus Infections,ISA,Disease,32290839,10.1186/s12967-020-02339-3,2020-04-16
Coronavirus Infections,CAUSES,Syndrome,32290754,10.2217/imt-2020-0077,2020-04-16
Complication,PROCESS_OF,Patients,32290754,10.2217/imt-2020-0077,2020-04-16
Exudate,PART_OF,Alveolar,32290754,10.2217/imt-2020-0077,2020-04-16
Monoclonal Antibodies,INTERACTS_WITH,Interleukin-6,32290754,10.2217/imt-2020-0077,2020-04-16
tocilizumab,TREATS,Patients,32290754,10.2217/imt-2020-0077,2020-04-16
cancer therapy,AFFECTS,Cancer Patient,32290644,10.4081/monaldi.2020.1294,2020-04-16
Infected,PROCESS_OF,Patients,32290643,10.23736/S0031-0808.20.03908-7,2020-04-16
Coughing,ISA,Symptoms,32290643,10.23736/S0031-0808.20.03908-7,2020-04-16
Fever,ISA,Symptoms,32290643,10.23736/S0031-0808.20.03908-7,2020-04-16
Upper Respiratory Infections,AFFECTS,Male population group,32290643,10.23736/S0031-0808.20.03908-7,2020-04-16
Medical Staff,TREATS,Patients,32290445,10.3390/ijerph17082630,2020-04-16
Agent,CAUSES,inflammatory response,32290077,10.3390/v12040428,2020-04-16
"M Protein, multiple myeloma",INTERACTS_WITH,ACE2 gene,32289878,10.1111/den.13694,2020-04-15
Genus: Coronavirus,PROCESS_OF,Chiroptera,32289878,10.1111/den.13694,2020-04-15
Disease,PROCESS_OF,Male population group,32289832,10.1055/a-1154-1814,2020-04-15
Bleeding esophageal varices,PROCESS_OF,Male population group,32289832,10.1055/a-1154-1814,2020-04-15
Ligation,TREATS,Hemorrhage,32289832,10.1055/a-1154-1814,2020-04-15
Ligation,USES,Bands,32289832,10.1055/a-1154-1814,2020-04-15
Emergency procedure,TREATS,Patients,32289832,10.1055/a-1154-1814,2020-04-15
Bronchoscopy,CAUSES,Coughing,32289821,10.1093/molbev/msaa094,2020-04-15
RNA modification,PROCESS_OF,Viral Genome,32289791,10.1159/000507638,2020-04-15
ZC3HAV1 gene,INTERACTS_WITH,cytidylyl-3'-5'-guanosine,32289791,10.1159/000507638,2020-04-15
RNA Viruses,PROCESS_OF,Mammals,32289791,10.1159/000507638,2020-04-15
cytidylyl-3'-5'-guanosine,AFFECTS,Virus Replication,32289791,10.1159/000507638,2020-04-15
cytidylyl-3'-5'-guanosine,COEXISTS_WITH,Viral Genome,32289791,10.1159/000507638,2020-04-15
cytidylyl-3'-5'-guanosine,COEXISTS_WITH,ZC3HAV1 gene,32289791,10.1159/000507638,2020-04-15
Betacoronavirus,LOCATION_OF,cytidylyl-3'-5'-guanosine,32289791,10.1159/000507638,2020-04-15
cytidylyl-3'-5'-guanosine,COEXISTS_WITH,Viral Genome,32289791,10.1159/000507638,2020-04-15
"Coronavirus, Canine",ISA,Alphacoronavirus,32289791,10.1159/000507638,2020-04-15
Clozapine,TREATS,Schizophrenia,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Schizophrenia,AFFECTS,Drug Kinetics,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Pneumonia,AFFECTS,Asians,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Clozapine,AUGMENTS,Pneumonia,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Pneumonia,PROCESS_OF,Patients,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Infected,PROCESS_OF,Patients,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Fever,PROCESS_OF,Patients,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Influenza-like symptoms,PROCESS_OF,Patients,32289565,10.1016/j.ijid.2020.03.070,2020-04-15
Hospitals,LOCATION_OF,Real-Time Polymerase Chain Reaction,32289548,10.1016/j.tmaid.2020.101663,2020-04-15
Real-Time Polymerase Chain Reaction,METHOD_OF,Epidemiology,32289548,10.1016/j.tmaid.2020.101663,2020-04-15
Antiviral Therapy,ADMINISTERED_TO,Patients,32289548,10.1016/j.tmaid.2020.101663,2020-04-15
Fever,ISA,Symptoms,32289548,10.1016/j.tmaid.2020.101663,2020-04-15
Hydroxychloroquine,TREATS,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Hydroxychloroquine,TREATS,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Azithromycin,TREATS,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Azithromycin,TREATS,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Infected,PROCESS_OF,inpatient,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Virus,NEG_PROCESS_OF,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Respiratory sample,PART_OF,Patients,32289516,10.1016/j.jtho.2020.04.003,2020-04-15
Lung excision,PRECEDES,tomography,32289472,10.1016/j.ijsu.2020.04.001,2020-04-15
Pneumonia,PROCESS_OF,Patients,32289472,10.1016/j.ijsu.2020.04.001,2020-04-15
Supportive care,TREATS,Severe (severity modifier),32289466,10.1016/j.jtos.2020.03.010,2020-04-15
Diagnosis,ADMINISTERED_TO,Patients,32289376,10.1016/j.jamcollsurg.2020.04.012,2020-04-15
Hospitals,LOCATION_OF,Cross-Sectional Studies,32289376,10.1016/j.jamcollsurg.2020.04.012,2020-04-15
Laboratory Diagnosis,USES,Assay,32289376,10.1016/j.jamcollsurg.2020.04.012,2020-04-15
Assay,USES,PCR test for SARS,32289376,10.1016/j.jamcollsurg.2020.04.012,2020-04-15
Conjunctival discharge,PROCESS_OF,Patients,32289376,10.1016/j.jamcollsurg.2020.04.012,2020-04-15
"DNA, Complementary",ISA,DNA,32289214,10.1056/NEJMoa2006100,2020-04-15
Infected,PROCESS_OF,Persons,32289152,10.1084/jem.20200653,2020-04-15
Infected,PROCESS_OF,Participant,32289152,10.1084/jem.20200653,2020-04-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32289152,10.1084/jem.20200653,2020-04-15
Infected,PROCESS_OF,Persons,32289152,10.1084/jem.20200653,2020-04-15
mental health center,LOCATION_OF,Study,32289117,10.1016/j.medidd.2020.100026,2020-04-15
Hospitals,LOCATION_OF,Training,32289117,10.1016/j.medidd.2020.100026,2020-04-15
Virus Diseases,PROCESS_OF,Psychiatric inpatient,32289117,10.1016/j.medidd.2020.100026,2020-04-15
Psychiatric hospital,LOCATION_OF,Study,32289117,10.1016/j.medidd.2020.100026,2020-04-15
Cell Count,USES,Therapeutic radiology procedure,32289115,10.1016/j.jhepr.2020.100113,2020-04-15
Vaccines,PREVENTS,Disease,32289115,10.1016/j.jhepr.2020.100113,2020-04-15
Liver,LOCATION_OF,advanced disease,32289100,10.1016/j.idm.2020.03.001,2020-04-15
advanced disease,PROCESS_OF,Patients,32289100,10.1016/j.idm.2020.03.001,2020-04-15
Chronic liver disease,PROCESS_OF,Patients,32289100,10.1016/j.idm.2020.03.001,2020-04-15
contextual factors,PROCESS_OF,Outpatients,32289100,10.1016/j.idm.2020.03.001,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Coronavirus Infections,ISA,Disease,32289051,10.1016/j.ejro.2020.100231,2020-04-15
Hospitals,LOCATION_OF,Retrospective Studies,32289038,10.1186/s40662-020-00187-2,2020-04-15
Physical Examination,USES,tomography,32289038,10.1186/s40662-020-00187-2,2020-04-15
Blood Vessel,LOCATION_OF,Thickened,32289038,10.1186/s40662-020-00187-2,2020-04-15
Coronavirus Infections,ISA,Disease,32289016,10.1016/j.imr.2020.100407,2020-04-15
Coronavirus Infections,ISA,Disease,32289016,10.1016/j.imr.2020.100407,2020-04-15
Insight,PROCESS_OF,manager,32288543,10.1186/s41182-020-00206-x,2020-04-15
Decision,PROCESS_OF,Maker (occupation),32288543,10.1186/s41182-020-00206-x,2020-04-15
research study,MEASURES,IMPACT gene,32288543,10.1186/s41182-020-00206-x,2020-04-15
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Maker (occupation),32288543,10.1186/s41182-020-00206-x,2020-04-15
Decision,PROCESS_OF,Maker (occupation),32288543,10.1186/s41182-020-00206-x,2020-04-15
Awareness,PROCESS_OF,Persons,32288416,10.1007/s12204-020-2168-1,2020-04-15
Coronavirus Infections,ISA,Disease,32288414,10.1007/s12204-020-2166-3,2020-04-15
BARRIER,TREATS,Communicable Diseases,32287808,10.1016/S0262-4079(20)30474-7,2020-04-15
Communicable Diseases,PROCESS_OF,Patients,32287140,10.14309/ajg.0000000000000620,2020-04-15
Airway Management,COEXISTS_WITH,Pediatric anesthesia,32287140,10.14309/ajg.0000000000000620,2020-04-15
Asymptomatic,PROCESS_OF,Patients,32287140,10.14309/ajg.0000000000000620,2020-04-15
"Intubation, Intratracheal",USES,Laryngoscopes,32287140,10.14309/ajg.0000000000000620,2020-04-15
"Intubation, Intratracheal",USES,Tracheal tube,32287140,10.14309/ajg.0000000000000620,2020-04-15
Tranquilizing Agents,STIMULATES,"Anesthetics, Intravenous",32287140,10.14309/ajg.0000000000000620,2020-04-15
Laryngoscopes,USES,videocassette,32287140,10.14309/ajg.0000000000000620,2020-04-15
Induction procedure,USES,"Anesthetics, Intravenous",32287140,10.14309/ajg.0000000000000620,2020-04-15
Tracheal tube,USES,Cuffs device,32287140,10.14309/ajg.0000000000000620,2020-04-15
Medical procedure,TREATS,Child,32287140,10.14309/ajg.0000000000000620,2020-04-15
Medical procedure,TREATS(INFER),Asymptomatic,32287140,10.14309/ajg.0000000000000620,2020-04-15
Asymptomatic,PROCESS_OF,Child,32287140,10.14309/ajg.0000000000000620,2020-04-15
Digestive symptom,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Confirmation,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Desire for food,NEG_PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Desire for food,NEG_PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Gastrointestinal symptom,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Digestive symptom,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Antibiotics,TREATS,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Antibiotics,TREATS(INFER),Digestive symptom,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Digestive symptom,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Digestive symptom,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Diarrhea,ISA,Digestive symptom,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Suspicion,PROCESS_OF,Patients,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Digestive symptom,PROCESS_OF,Clinician,32287086,10.5435/JAAOS-D-20-00379,2020-04-15
Anxiety,PROCESS_OF,Patients,32287083,10.1097/ACM.0000000000003419,2020-04-15
Confusion,PROCESS_OF,Patients,32287083,10.1097/ACM.0000000000003419,2020-04-15
Demand (clinical),COEXISTS_WITH,Health Care,32287082,10.1097/ACM.0000000000003418,2020-04-15
Coronavirus Infections,AFFECTS,Household composition,32287040,10.2196/18948,2020-04-15
World,ISA,Population Group,32287040,10.2196/18948,2020-04-15
Coronavirus Infections,ISA,Disease,32287039,10.2196/19016,2020-04-15
Coronavirus Infections,ISA,Disease,32287039,10.2196/19016,2020-04-15
follow-up,TREATS,Patients,32287039,10.2196/19016,2020-04-15
Coronavirus Infections,ISA,Disease,32287039,10.2196/19016,2020-04-15
Problem,COEXISTS_WITH,Disease,32287038,10.2196/18795,2020-04-15
Problem,COEXISTS_WITH(SPEC),Coronavirus Infections,32287038,10.2196/18795,2020-04-15
Coronavirus Infections,ISA,Disease,32287038,10.2196/18795,2020-04-15
Coronavirus Infections,ISA,Disease,32287038,10.2196/18795,2020-04-15
Coronavirus Infections,ISA,Disease,32287038,10.2196/18795,2020-04-15
Persons,LOCATION_OF,IMPACT gene,32287038,10.2196/18795,2020-04-15
Disease,CAUSES,Cessation of life,32287038,10.2196/18795,2020-04-15
Coronavirus Infections,CAUSES(SPEC),Cessation of life,32287038,10.2196/18795,2020-04-15
Coronavirus Infections,ISA,Disease,32287038,10.2196/18795,2020-04-15
Disease,PROCESS_OF,Community,32286947,10.2174/1568009620666200414151419,2020-04-15
Prophylactic treatment,TREATS,Disease,32286916,10.1177/0194599820919741,2020-04-15
Gown,USES,disposable,32286913,10.1177/0194599820920649,2020-04-15
Asymptomatic,PROCESS_OF,Patients,32286910,10.1177/0194599820919748,2020-04-15
China,ISA,Country,32286910,10.1177/0194599820919748,2020-04-15
Adult,ISA,Population Group,32286909,10.1177/0194599820919751,2020-04-15
Coronavirus Infections,PROCESS_OF,Population Group,32286909,10.1177/0194599820919751,2020-04-15
Coronavirus Infections,PROCESS_OF(SPEC),Adult,32286909,10.1177/0194599820919751,2020-04-15
Peptides,PART_OF,Helice,32286679,10.5603/CJ.a2020.0055,2020-04-15
Disease,PROCESS_OF,Animals,32286678,10.5603/CJ.a2020.0056,2020-04-15
Disease,PROCESS_OF,Persons,32286678,10.5603/CJ.a2020.0056,2020-04-15
Genus: Coronavirus,CAUSES,Disease,32286678,10.5603/CJ.a2020.0056,2020-04-15
Human coronavirus,CAUSES,Infection,32286678,10.5603/CJ.a2020.0056,2020-04-15
Coughing,ISA,Symptoms,32286678,10.5603/CJ.a2020.0056,2020-04-15
Fever,ISA,Symptoms,32286678,10.5603/CJ.a2020.0056,2020-04-15
Pneumonia,PROCESS_OF,Patients,32286678,10.5603/CJ.a2020.0056,2020-04-15
One chronic disease,PROCESS_OF,Old age,32286675,10.2340/16501977-2677,2020-04-15
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",ISA,Cardiovascular Diseases,32286675,10.2340/16501977-2677,2020-04-15
"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",AFFECTS,Patients,32286675,10.2340/16501977-2677,2020-04-15
Disease,PROCESS_OF,Persons,32286245,10.1515/cclm-2020-0369,2020-04-15
Coronavirus Infections,AFFECTS,Persons,32286245,10.1515/cclm-2020-0369,2020-04-15
Renal function,PROCESS_OF,Patients,32286242,10.1515/cclm-2020-0220,2020-04-15
Serum,LOCATION_OF,Ferritin,32286242,10.1515/cclm-2020-0220,2020-04-15
Serum,LOCATION_OF,Ferritin,32286242,10.1515/cclm-2020-0220,2020-04-15
Respiratory distress,PROCESS_OF,hospitalized patients,32286242,10.1515/cclm-2020-0220,2020-04-15
Diagnosis,USES,Viral studies,32286155,10.1080/22221751.2020.1752610,2020-04-15
urine occult blood,DIAGNOSES,patient condition,32286155,10.1080/22221751.2020.1752610,2020-04-15
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32286155,10.1080/22221751.2020.1752610,2020-04-15
Difficulty sleeping,PROCESS_OF,Health Personnel,32285930,10.1002/cpt.1856,2020-04-15
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32285930,10.1002/cpt.1856,2020-04-15
Hydroxychloroquine,ADMINISTERED_TO,Patients,32285862,10.24875/GMM.M20000346,2020-04-15
Coronavirus Infections,ISA,Disease,32285380,10.1007/s11684-020-0772-y,2020-04-15
Coronavirus Infections,ISA,Disease,32285380,10.1007/s11684-020-0772-y,2020-04-15
Infected,PROCESS_OF,Mother (person),32285338,10.1007/s11605-020-04592-9,2020-04-15
"CD69 protein, human",PART_OF,Mother (person),32285338,10.1007/s11605-020-04592-9,2020-04-15
Feces,PART_OF,"Infant, Newborn",32285338,10.1007/s11605-020-04592-9,2020-04-15
Urine,PART_OF,"Infant, Newborn",32285338,10.1007/s11605-020-04592-9,2020-04-15
Infected,PROCESS_OF,Mother (person),32285338,10.1007/s11605-020-04592-9,2020-04-15
Coronavirus Infections,PROCESS_OF,Family,32285222,10.1007/s10140-020-01775-4,2020-04-15
ACE2 gene,DISRUPTS,Inflammation,32285222,10.1007/s10140-020-01775-4,2020-04-15
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32284951,10.1093/ofid/ofaa105,2020-04-15
Parenchyma,LOCATION_OF,Ground Glass Opacity,32284951,10.1093/ofid/ofaa105,2020-04-15
Cessation of life,AFFECTS,Patients,32284616,10.1038/s41591-020-0822-7,2020-04-15
Communicable Diseases,PROCESS_OF,Pharmacist,32284616,10.1038/s41591-020-0822-7,2020-04-15
Communicable Diseases,PROCESS_OF,Pharmacist,32284616,10.1038/s41591-020-0822-7,2020-04-15
Assay,METHOD_OF,Epidemiology,32284362,10.1212/WNL.0000000000009566,2020-04-15
Neuromuscular Diseases,PROCESS_OF,Patients,32284326,10.1074/jbc.RA120.013679,2020-04-15
Patients,USES,Preexisting Condition Coverage,32284326,10.1074/jbc.RA120.013679,2020-04-15
Neuromuscular Diseases,PROCESS_OF,Patients,32284326,10.1074/jbc.RA120.013679,2020-04-15
Communicable Diseases,PROCESS_OF,Patients,32284182,10.1016/j.enfi.2020.03.002,2020-04-15
Disease,COEXISTS_WITH,Virus,32284182,10.1016/j.enfi.2020.03.002,2020-04-15
Redness of eye,ISA,Symptoms,32284092,10.3201/eid2607.200915,2020-04-15
Acute conjunctivitis,PROCESS_OF,Patients,32284092,10.3201/eid2607.200915,2020-04-15
Nose,LOCATION_OF,Congestion,32283904,10.3906/sag-2004-6,2020-04-15
Structure of upper respiratory tract cavity,LOCATION_OF,Symptoms,32283904,10.3906/sag-2004-6,2020-04-15
Nose,LOCATION_OF,Congestion,32283904,10.3906/sag-2004-6,2020-04-15
Fever,ISA,Symptoms,32283904,10.3906/sag-2004-6,2020-04-15
Complication,COEXISTS_WITH,3/4,32283904,10.3906/sag-2004-6,2020-04-15
Nose,LOCATION_OF,Congestion,32283904,10.3906/sag-2004-6,2020-04-15
Germany,ISA,Country,32283894,10.3906/sag-2003-260,2020-04-15
Italy,ISA,Country,32283894,10.3906/sag-2003-260,2020-04-15
Spain,ISA,Country,32283894,10.3906/sag-2003-260,2020-04-15
United States,ISA,Country,32283894,10.3906/sag-2003-260,2020-04-15
Conjunctival congestion,ISA,Symptoms,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Coronavirus Infections,PROCESS_OF,Patients,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Conjunctival congestion,PROCESS_OF,Patients,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Symptoms,PROCESS_OF,Patients,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Conjunctival congestion,ISA,Sign or Symptom,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Conjunctivitis,PROCESS_OF,Patients,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
conjunctiva,LOCATION_OF,Symptoms,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
Symptoms,NEG_ASSOCIATED_WITH,Coronavirus Infections,32283877,10.3760/cma.j.cn112148-20200313-00202,2020-04-15
World,ISA,Population Group,32283711,10.3390/cells9040920,2020-04-15
Coronavirus Infections,AFFECTS,Patients,32283711,10.3390/cells9040920,2020-04-15
Coronavirus Infections,PROCESS_OF,Patients,32283510,10.1016/j.ajp.2020.102083,2020-04-14
Inferior Colliculus,LOCATION_OF,angiotensin converting enzyme 2,32283510,10.1016/j.ajp.2020.102083,2020-04-14
Inferior Colliculus,PART_OF,Adult,32283510,10.1016/j.ajp.2020.102083,2020-04-14
Transcriptome,PART_OF,Cells,32283510,10.1016/j.ajp.2020.102083,2020-04-14
angiotensin converting enzyme 2,AUGMENTS,Spermatogonia,32283510,10.1016/j.ajp.2020.102083,2020-04-14
Testis,PART_OF,Homo sapiens,32283510,10.1016/j.ajp.2020.102083,2020-04-14
Attitude,PROCESS_OF,Population Group,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Perception,PROCESS_OF,Population Group,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Experience,PROCESS_OF,Population Group,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Coronavirus Infections,ISA,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Mental health problem,COEXISTS_WITH,Disease,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Mental health problem,COEXISTS_WITH(SPEC),Coronavirus Infections,32283499,10.1016/j.dsx.2020.03.016,2020-04-14
Comorbidity,PROCESS_OF,Patients,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Hypertensive disease,PRECEDES,Diabetes,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Cardiovascular Diseases,PROCESS_OF,Patients,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Diabetes,PROCESS_OF,Patients,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Hypertensive disease,PROCESS_OF,Patients,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Attention,PROCESS_OF,Patients,32283498,10.1016/j.dsx.2020.04.011,2020-04-14
Very high,PROCESS_OF,Patients,32283497,10.1016/j.dsx.2020.04.001,2020-04-14
Diabetes,AFFECTS,Patients,32283450,10.1016/j.psychres.2020.112958,2020-04-14
Physically active,PROCESS_OF,Persons,32283325,10.1016/j.cgh.2020.04.002,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Health center,LOCATION_OF,Study,32283324,10.1016/j.clim.2020.108420,2020-04-14
Fever,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Normal liver function,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
High Level,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Normal liver function,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Normal liver function,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Liver Dysfunction,PROCESS_OF,Patients,32283324,10.1016/j.clim.2020.108420,2020-04-14
Complication,PROCESS_OF,Patients,32283308,10.1016/j.scitotenv.2020.138401,2020-04-14
Severe disorder,NEG_PROCESS_OF,Child,32283308,10.1016/j.scitotenv.2020.138401,2020-04-14
Complication,PROCESS_OF,Adult,32283308,10.1016/j.scitotenv.2020.138401,2020-04-14
Therapeutic procedure,TREATS,Storm NOS,32283308,10.1016/j.scitotenv.2020.138401,2020-04-14
Hand Hygiene,ISA,Event,32283283,10.1016/j.ijid.2020.04.009,2020-04-14
Virus,COEXISTS_WITH,Coinfection,32283282,10.1016/j.ijid.2020.04.016,2020-04-14
Ward (environment),LOCATION_OF,Work,32283220,10.1016/j.jpainsymman.2020.04.006,2020-04-14
Ward (environment),LOCATION_OF,Study,32283220,10.1016/j.jpainsymman.2020.04.006,2020-04-14
"CD69 protein, human",ADMINISTERED_TO,member,32283220,10.1016/j.jpainsymman.2020.04.006,2020-04-14
Marital Status,NEG_PROCESS_OF,Patients,32283220,10.1016/j.jpainsymman.2020.04.006,2020-04-14
Physical and emotional exhaustion state,PROCESS_OF,Health Personnel,32283220,10.1016/j.jpainsymman.2020.04.006,2020-04-14
Malaise,PROCESS_OF,Population Group,32283219,10.1016/j.jpainsymman.2020.04.001,2020-04-14
patient care,METHOD_OF,Hospitalization,32283185,10.1016/j.bbmt.2020.04.001,2020-04-14
Pharmaceutical Preparations,TREATS,Outpatients,32283185,10.1016/j.bbmt.2020.04.001,2020-04-14
contextual factors,PROCESS_OF,inpatient,32283185,10.1016/j.bbmt.2020.04.001,2020-04-14
contextual factors,PROCESS_OF,inpatient,32283185,10.1016/j.bbmt.2020.04.001,2020-04-14
Medical consultation,METHOD_OF,Palliative care.team,32283185,10.1016/j.bbmt.2020.04.001,2020-04-14
Allogeneic Hematopoietic Stem Cell Transplantation,USES,Cyclophosphamide,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Hematocrit procedure,USES,Cryopreservation,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Hematologic Neoplasms,PROCESS_OF,Patients,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Allogeneic Hematopoietic Stem Cell Transplantation,TREATS,Hematologic Neoplasms,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Bone Marrow Transplantation,ADMINISTERED_TO,Patients,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Peripheral Stem Cell Transplantation,ADMINISTERED_TO,Patients,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Allogeneic Hematopoietic Stem Cell Transplantation,TREATS,Patients,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Chronic graft-versus-host disease,ISA,Graft-vs-Host Disease,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Cyclophosphamide,PREDISPOSES,Acute GVH disease,32283165,10.1016/j.jinf.2020.03.042,2020-04-14
Coronavirus Infections,PROCESS_OF,Patients,32283156,10.1016/j.jinf.2020.03.006,2020-04-14
Death in hospital,PROCESS_OF,Patients,32283156,10.1016/j.jinf.2020.03.006,2020-04-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32283156,10.1016/j.jinf.2020.03.006,2020-04-14
Fever,ISA,Symptoms,32283155,10.1016/j.jinf.2020.03.041,2020-04-14
Itching of eye,ISA,Symptoms,32283155,10.1016/j.jinf.2020.03.041,2020-04-14
Nose,LOCATION_OF,Congestion,32283155,10.1016/j.jinf.2020.03.041,2020-04-14
Mild disorder,PROCESS_OF,Patients,32283155,10.1016/j.jinf.2020.03.041,2020-04-14
Pneumonia,PROCESS_OF,Patients,32283155,10.1016/j.jinf.2020.03.041,2020-04-14
Symptom severe,PROCESS_OF,Patients,32283152,10.1016/j.jinf.2020.03.037,2020-04-14
Storm NOS,PROCESS_OF,Human body,32283146,10.1016/j.jinf.2020.03.058,2020-04-14
Genome,LOCATION_OF,Mutation,32283144,10.1016/j.jinf.2020.03.062,2020-04-14
Mutation,AFFECTS,virus pathogenesis,32283144,10.1016/j.jinf.2020.03.062,2020-04-14
Patients,LOCATION_OF,Adrenal Cortex Hormones,32283143,10.1016/j.jinf.2020.03.060,2020-04-14
Pneumonia,PROCESS_OF,Patients,32283143,10.1016/j.jinf.2020.03.060,2020-04-14
corticosteroid use,PROCESS_OF,Patients,32283143,10.1016/j.jinf.2020.03.060,2020-04-14
Disease,PROCESS_OF,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
arbidol,TREATS,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
arbidol,TREATS(INFER),Disease,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
lopinavir / Ritonavir,TREATS,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
lopinavir / Ritonavir,TREATS(INFER),Disease,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
Pneumonia,PROCESS_OF,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
lopinavir / Ritonavir,TREATS,Patients,32283141,10.1016/j.jinf.2020.03.051,2020-04-14
Ambulatory Care Facilities,LOCATION_OF,Diagnosis,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Gold Colloid,INTERACTS_WITH,CD40LG wt Allele,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Immunochromatography,USES,Gold Colloid,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Immunochromatographic Assay,USES,Detection,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Immunochromatographic Assay,USES,CD40LG wt Allele,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Immunochromatographic Assay,DIAGNOSES,Severe Acute Respiratory Syndrome,32283139,10.1016/j.jinf.2020.03.040,2020-04-14
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32283117,10.1016/j.resuscitation.2020.04.005,2020-04-14
Pneumonia,PROCESS_OF,Patients,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
Cardiac Arrest,MANIFESTATION_OF,Circulatory Process,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
Electromechanical dissociation,COEXISTS_WITH,5 - 9,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
Cardiopulmonary Resuscitation,ADMINISTERED_TO,Patients,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
Pneumonia,PROCESS_OF,Patients,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
In-Hospital Cardiac Arrest,PROCESS_OF,Patients,32283108,10.1016/j.antiviral.2020.104793,2020-04-14
RNA-Directed RNA Polymerase,INTERACTS_WITH,"RNA, Viral",32283100,10.1053/j.gastro.2020.04.012,2020-04-14
Nucleoside Analogs,TREATS,Virus Diseases,32283100,10.1053/j.gastro.2020.04.012,2020-04-14
Proteins,INTERACTS_WITH,Nucleotides,32283100,10.1053/j.gastro.2020.04.012,2020-04-14
removal technique,CAUSES,effect increased,32283100,10.1053/j.gastro.2020.04.012,2020-04-14
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32283073,10.1016/j.ajog.2020.04.005,2020-04-14
Peer Review,TREATS,Governing Board,32283073,10.1016/j.ajog.2020.04.005,2020-04-14
Peer Review,TREATS,Committee,32283073,10.1016/j.ajog.2020.04.005,2020-04-14
Chest,LOCATION_OF,Radionuclide Imaging,32283052,10.1016/j.jacr.2020.03.006,2020-04-14
Chest CT,USES,Microtomy,32283050,10.1016/j.nwh.2020.04.004,2020-04-14
Contrast bronchogram,USES,Air,32283050,10.1016/j.nwh.2020.04.004,2020-04-14
Chest CT,ADMINISTERED_TO,Persons,32283050,10.1016/j.nwh.2020.04.004,2020-04-14
Chest CT,USES,Microtomy,32283050,10.1016/j.nwh.2020.04.004,2020-04-14
Very high,PROCESS_OF,Persons,32283050,10.1016/j.nwh.2020.04.004,2020-04-14
Asymptomatic,PROCESS_OF,Persons,32282992,10.1111/ajt.15914,2020-04-14
Symptoms,PROCESS_OF,Persons,32282992,10.1111/ajt.15914,2020-04-14
Nasal Swab (procedure),DIAGNOSES,SARS coronavirus,32282992,10.1111/ajt.15914,2020-04-14
Olfactory Pathways,LOCATION_OF,Neurological observations,32282992,10.1111/ajt.15914,2020-04-14
Inflammation,PROCESS_OF,Patients,32282986,10.1111/ajt.15928,2020-04-14
Infected,PROCESS_OF,Patients,32282986,10.1111/ajt.15928,2020-04-14
Pneumonia,PROCESS_OF,Transplant Recipients,32282986,10.1111/ajt.15928,2020-04-14
Transplantation,ADMINISTERED_TO,Patients,32282982,10.1111/ajt.15915,2020-04-14
Acute Rejection,PROCESS_OF,Patients,32282982,10.1111/ajt.15915,2020-04-14
Kidney Transplantation,TREATS,Patients,32282982,10.1111/ajt.15915,2020-04-14
Immunosuppressive Agents,TREATS,Recipient,32282982,10.1111/ajt.15915,2020-04-14
Liver,PART_OF,Living Donors,32282974,10.1111/dewb.12262,2020-04-14
Liver,PART_OF,Tissue Donors,32282974,10.1111/dewb.12262,2020-04-14
Donor renal transplantation,ISA,Transplantation,32282974,10.1111/dewb.12262,2020-04-14
Serum,LOCATION_OF,procalcitonin,32282920,10.1093/geronb/gbaa048,2020-04-14
Thrombophilia,PROCESS_OF,hospitalized patients,32282920,10.1093/geronb/gbaa048,2020-04-14
D-dimer above reference range,COEXISTS_WITH,Disease Progression,32282920,10.1093/geronb/gbaa048,2020-04-14
Thrombocytopenia,CAUSES,Disseminated Intravascular Coagulation,32282920,10.1093/geronb/gbaa048,2020-04-14
Infected,PROCESS_OF,Patients,32282920,10.1093/geronb/gbaa048,2020-04-14
Actual Negative Self Image,PROCESS_OF,Woman,32282894,10.7326/M20-1301,2020-04-14
Actual Negative Self Image,PROCESS_OF,Woman,32282894,10.7326/M20-1301,2020-04-14
Respiratory sample,LOCATION_OF,RNA-Directed DNA Polymerase,32282863,10.1016/j.jpha.2020.03.001,2020-04-14
Laboratory,LOCATION_OF,Diagnosis,32282863,10.1016/j.jpha.2020.03.001,2020-04-14
Viral Shedding,COEXISTS_WITH,Convalescence,32282863,10.1016/j.jpha.2020.03.001,2020-04-14
Asymptomatic,PROCESS_OF,Persons,32282863,10.1016/j.jpha.2020.03.001,2020-04-14
Introduction procedure,ADMINISTERED_TO,human group,32282789,10.12659/MSM.924730,2020-04-14
Quarantine,TREATS,citizen,32282658,10.1097/INF.0000000000002690,2020-04-14
Care of intensive care unit patient,TREATS,Acute Cerebrovascular Accidents,32282502,10.1097/FJC.0000000000000836,2020-04-14
Eye,LOCATION_OF,Betacoronavirus,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Influenza,AFFECTS,Elderly (population group),32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Heart failure,PROCESS_OF,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Myocarditis,PROCESS_OF,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Acute myocardial infarction,PROCESS_OF,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Cardiovascular Diseases,PROCESS_OF,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Therapeutic procedure,TREATS,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Therapeutic procedure,TREATS(INFER),Cardiovascular Diseases,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Clinician,TREATS,Patients,32282442,10.5435/JAAOS-D-20-00371,2020-04-14
Patients,ISA,Persons,32282441,10.5435/JAAOS-D-20-00227,2020-04-14
Wounds and Injuries,PROCESS_OF,Patients,32282440,10.1097/PHH.0000000000001190,2020-04-14
Malaise,PROCESS_OF,Child,32282439,10.5435/JAAOS-D-20-00292,2020-04-14
Hospitalization,TREATS,Adult,32282439,10.5435/JAAOS-D-20-00292,2020-04-14
Hospitalization,TREATS,Child,32282439,10.5435/JAAOS-D-20-00292,2020-04-14
Hospitalization,TREATS,Pneumonia,32282439,10.5435/JAAOS-D-20-00292,2020-04-14
responsibility,PROCESS_OF,Surgeon,32282373,10.1097/ACM.0000000000003401,2020-04-14
Interested,PROCESS_OF,peer,32282372,10.1097/ACM.0000000000003402,2020-04-14
Symptoms,PROCESS_OF,Staff,32282359,10.1097/PHM.0000000000001443,2020-04-14
intensive care unit,LOCATION_OF,Administration occupational activities,32282344,10.1097/ACM.0000000000003414,2020-04-14
Moving,PROCESS_OF,Patients,32282344,10.1097/ACM.0000000000003414,2020-04-14
Cessation of life,PROCESS_OF,Clinician,32282312,10.5811/cpcem.2020.3.47349,2020-04-14
Exanthema,COEXISTS_WITH,patient condition,32282268,10.1080/1040841X.2020.1739001,2020-04-14
Influenza in Birds,ISA,Influenza,32282022,10.1001/jama.2020.6019,2020-04-14
Immunity,PROCESS_OF,human group,32282022,10.1001/jama.2020.6019,2020-04-14
Immunity,PROCESS_OF,Persons,32282022,10.1001/jama.2020.6019,2020-04-14
Infected,PROCESS_OF,Persons,32282022,10.1001/jama.2020.6019,2020-04-14
Prophylactic treatment,USES,Pharmaceutical Preparations,32281785,10.1021/acsnano.0c02439,2020-04-14
medical treatment method,TREATS,Virus,32281785,10.1021/acsnano.0c02439,2020-04-14
Angiotensin-Converting Enzyme Inhibitors,TREATS,Patients,32281785,10.1021/acsnano.0c02439,2020-04-14
Angiotensin II receptor antagonist,TREATS,Patients,32281785,10.1021/acsnano.0c02439,2020-04-14
Coronavirus Infections,ISA,Disease,32281695,10.1096/fj.202000502,2020-04-14
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Diagnosis,32281695,10.1096/fj.202000502,2020-04-14
Pharmaceutical Preparations,TREATS,Disease,32281689,10.1111/den.13693,2020-04-14
Bacteria,CAUSES,Communicable Diseases,32281689,10.1111/den.13693,2020-04-14
Virus,CAUSES,Communicable Diseases,32281689,10.1111/den.13693,2020-04-14
TAS2R10 gene,AFFECTS,Communicable Diseases,32281689,10.1111/den.13693,2020-04-14
Chloroquine,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
Chloroquine,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
Chlorpheniramine,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
Chlorpheniramine,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
Dextromethorphan,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
Dextromethorphan,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
Quinine,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
Quinine,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
artemisinine,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
artemisinine,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
diphenidol,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
diphenidol,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
yohimbine,ISA,Pharmaceutical Preparations,32281689,10.1111/den.13693,2020-04-14
yohimbine,TREATS,Symptoms,32281689,10.1111/den.13693,2020-04-14
Coffee,ISA,Substance,32281689,10.1111/den.13693,2020-04-14
Pharmaceutical Preparations,TREATS,Disease,32281689,10.1111/den.13693,2020-04-14
Tea,ISA,Substance,32281689,10.1111/den.13693,2020-04-14
Vegetables,ISA,Substance,32281689,10.1111/den.13693,2020-04-14
Influenza,PROCESS_OF,Patients,32281583,10.5582/bst.2020.03072,2020-04-14
Patients,LOCATION_OF,C-reactive protein,32281583,10.5582/bst.2020.03072,2020-04-14
C-reactive protein,ASSOCIATED_WITH,Disease,32281583,10.5582/bst.2020.03072,2020-04-14
Pneumonia,PROCESS_OF,Patients,32281481,10.1080/10937404.2020.1752340,2020-04-14
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32281481,10.1080/10937404.2020.1752340,2020-04-14
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32281481,10.1080/10937404.2020.1752340,2020-04-14
Coronavirus Infections,ISA,Disease,32281391,10.1177/0846537120916852,2020-04-14
Prescription procedure,TREATS,Communicable Diseases,32281391,10.1177/0846537120916852,2020-04-14
X-Ray Departments,LOCATION_OF,Analysis,32281335,10.19540/j.cnki.cjcmm.20200219.501,2020-04-14
Prophylactic treatment,NEG_COEXISTS_WITH,Infectious disease prevention / control,32281335,10.19540/j.cnki.cjcmm.20200219.501,2020-04-14
Handling,PROCESS_OF,Patients,32281335,10.19540/j.cnki.cjcmm.20200219.501,2020-04-14
Hormone Therapy,CAUSES,Complication,32281334,10.19540/j.cnki.cjcmm.20200211.501,2020-04-14
Severe Acute Respiratory Syndrome,AFFECTS,Disease,32281334,10.19540/j.cnki.cjcmm.20200211.501,2020-04-14
Middle East Respiratory Syndrome,AFFECTS,Disease,32281334,10.19540/j.cnki.cjcmm.20200211.501,2020-04-14
Infantile Neuroaxonal Dystrophy,PREDISPOSES,Drug usage,32281333,10.19540/j.cnki.cjcmm.20200225.501,2020-04-14
Pharmaceutical Preparations,TREATS,Syndrome,32281332,10.19540/j.cnki.cjcmm.20200220.502,2020-04-14
Pharmaceutical Preparations,TREATS,Syndrome,32281332,10.19540/j.cnki.cjcmm.20200220.502,2020-04-14
Lung,LOCATION_OF,Toxin,32281330,10.19540/j.cnki.cjcmm.20200220.501,2020-04-14
Decision,PROCESS_OF,Maker (occupation),32281330,10.19540/j.cnki.cjcmm.20200220.501,2020-04-14
cytokine,AUGMENTS,Body tissue,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
cytokine,AUGMENTS,Organ,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
"CCL2 protein, human",ISA,Monocyte Chemoattractant Protein-1,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
Injection,INTERACTS_WITH,cytokine,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
Injection,INTERACTS_WITH,cytokine,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
Injection,INTERACTS_WITH,cytokine,32281328,10.19540/j.cnki.cjcmm.20200216.401,2020-04-14
Ginkgo biloba,ISA,Plant seeds,32281327,10.19540/j.cnki.cjcmm.20200206.501,2020-04-14
Lung,LOCATION_OF,Syndrome,32281327,10.19540/j.cnki.cjcmm.20200206.501,2020-04-14
Lung,LOCATION_OF,Syndrome,32281327,10.19540/j.cnki.cjcmm.20200206.501,2020-04-14
Acupuncture and Oriental Medicine,TREATS,Communicable Diseases,32281317,10.3346/jkms.2020.35.e149,2020-04-14
Syndrome,PROCESS_OF,Patients,32281214,10.1111/jce.14493,2020-04-14
Department,LOCATION_OF,Early Diagnosis,32281214,10.1111/jce.14493,2020-04-14
Syndrome,PROCESS_OF,Health Personnel,32281214,10.1111/jce.14493,2020-04-14
Syndrome,PROCESS_OF,Patients,32281214,10.1111/jce.14493,2020-04-14
Influenza,PRECEDES,Coronavirus Infections,32281213,10.1111/1756-185X.13842,2020-04-14
Myocarditis,CAUSES,Sequela of disorder,32281213,10.1111/1756-185X.13842,2020-04-14
Problem,PROCESS_OF,Community,32281213,10.1111/1756-185X.13842,2020-04-14
Chloroquine,PREVENTS,Disease,32281114,10.1002/phar.2403,2020-04-14
Hydroxychloroquine,PREVENTS,Disease,32281114,10.1002/phar.2403,2020-04-14
Cardiovascular Diseases,PROCESS_OF,Patients,32281052,10.1007/s12015-020-09973-w,2020-04-14
Transplantation,PREVENTS,Pulmonary Fibrosis,32280993,10.1093/ptj/pzaa059,2020-04-14
Prophylactic treatment,NEG_USES,,32280993,10.1093/ptj/pzaa059,2020-04-14
Syndrome,PROCESS_OF,Physical Therapist,32280433,10.1016/j.csbj.2020.03.025,2020-04-14
Syndrome,PROCESS_OF,Persons,32280433,10.1016/j.csbj.2020.03.025,2020-04-14
Pharmaceutical Preparations,PREVENTS,HIV,32280076,10.3233/XST-200670,2020-04-14
Pneumonia,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Chest,LOCATION_OF,tomography,32280058,10.1016/j.nut.2020.110835,2020-04-14
exposure history,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Fever,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Lesion,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Lesion,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
lobe,LOCATION_OF,Lesion,32280058,10.1016/j.nut.2020.110835,2020-04-14
Pleural effusion disorder,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Ground Glass Opacity,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Coronavirus Infections,PROCESS_OF,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
radiologist,TREATS,Patients,32280058,10.1016/j.nut.2020.110835,2020-04-14
Disease,CAUSES,Pneumonia,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,ISA,Disease,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Italy,ISA,Country,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Disease,PROCESS_OF,Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Malnutrition,AFFECTS,Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,ISA,Disease,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Respiratory Failure,PROCESS_OF,Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Disease,PROCESS_OF,Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Malnutrition,PROCESS_OF,Population Group,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,ISA,Disease,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Nutritional Support,TREATS,Patients,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
Nutritional Support,TREATS(INFER),Disease,32279934,10.1053/j.jvca.2020.03.035,2020-04-14
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Anesthesiologist,32279908,10.1016/j.arcmed.2020.03.011,2020-04-14
Comorbidity,PROCESS_OF,Older people,32279903,10.1016/j.eururo.2020.03.027,2020-04-14
Severe disorder,PROCESS_OF,Patients,32279903,10.1016/j.eururo.2020.03.027,2020-04-14
Pharmaceutical Preparations,STIMULATES,angiotensin converting enzyme 2,32279903,10.1016/j.eururo.2020.03.027,2020-04-14
Homo sapiens,ISA,Animals,32279554,10.12968/bjon.2020.29.7.449,2020-04-14
No incoordination,PROCESS_OF,Population Group,32279554,10.12968/bjon.2020.29.7.449,2020-04-14
Decision,PROCESS_OF,Maker (occupation),32279554,10.12968/bjon.2020.29.7.449,2020-04-14
Today,ISA,Pharmaceutical Preparations,32279554,10.12968/bjon.2020.29.7.449,2020-04-14
Influenza-like symptoms,PROCESS_OF,Patients,32279437,10.1002/alr.22580,2020-04-13
Negative,COEXISTS_WITH,Pharyngitis,32279437,10.1002/alr.22580,2020-04-13
Coronavirus Infections,COEXISTS_WITH,Anosmia,32279437,10.1002/alr.22580,2020-04-13
Coronavirus Infections,ISA,Disease,32279437,10.1002/alr.22580,2020-04-13
Influenza-like symptoms,PROCESS_OF,Persons,32279437,10.1002/alr.22580,2020-04-13
Anosmia,COEXISTS_WITH,Coughing,32279418,10.1111/tid.13286,2020-04-13
Anosmia,COEXISTS_WITH,Dyspnea,32279418,10.1111/tid.13286,2020-04-13
Anosmia,COEXISTS_WITH,Fever,32279418,10.1111/tid.13286,2020-04-13
Renal dysplasia and retinal aplasia (disorder),AFFECTS,Woman,32279318,10.1002/hast.1107,2020-04-13
Common Cold,ISA,Symptoms,32279318,10.1002/hast.1107,2020-04-13
Fatigue,ISA,Symptoms,32279318,10.1002/hast.1107,2020-04-13
Dry cough,ISA,Symptoms,32279318,10.1002/hast.1107,2020-04-13
Stress,PROCESS_OF,Transplant Recipients,32279318,10.1002/hast.1107,2020-04-13
"Schools, Medical",ISA,School,32279219,10.1007/s11684-020-0768-7,2020-04-13
Universities,ISA,School,32279219,10.1007/s11684-020-0768-7,2020-04-13
Infected,PROCESS_OF,Persons,32279219,10.1007/s11684-020-0768-7,2020-04-13
Pneumonia,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Asymptomatic,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Comorbidity,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Elevated lactate dehydrogenase,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Fever,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Pneumonia,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Asymptomatic,PROCESS_OF,Patients,32279081,10.1093/gerona/glaa089,2020-04-13
Hospitals,LOCATION_OF,Study,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
hospitalized patients,ISA,Patients,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Fever,PROCESS_OF,Patients,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Chest,LOCATION_OF,Distress,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Comorbidity,PROCESS_OF,Patients,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Cessation of life,PROCESS_OF,Patients,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Abnormal renal function,ASSOCIATED_WITH,GSKIP gene,32278932,10.1016/j.hansur.2020.04.001,2020-04-13
Patients,LOCATION_OF,IMPACT gene,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Immunoglobulin deficiency,AFFECTS,Patients,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Immunoglobulin deficiency,PREDISPOSES,Mixed anxiety and depressive disorder,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Immunoglobulin deficiency,PROCESS_OF,Patients,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Immunoglobulin deficiency,PROCESS_OF,Patients,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Common Variable Immunodeficiency,COEXISTS_WITH,Disease,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Immunoglobulin deficiency,PREDISPOSES,Mixed anxiety and depressive disorder,32278811,10.1016/j.ijantimicag.2020.105969,2020-04-13
Pharmaceutical Preparations,TREATS,Disease,32278766,10.1016/j.sapharm.2020.04.003,2020-04-13
Disease,AFFECTS,Clinical Pharmacists,32278764,10.1016/j.diabres.2020.108142,2020-04-13
Diabetes,PROCESS_OF,Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Disease,PROCESS_OF,Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
"Respiratory Distress Syndrome, Adult",ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Diabetes,PROCESS_OF,Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Disease,PROCESS_OF,Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Coronavirus Infections,ISA,Disease,32278758,10.1016/j.tmaid.2020.101664,2020-04-13
Diarrhea,PROCESS_OF,Patients,32278755,10.1016/j.athoracsur.2020.03.005,2020-04-13
Vomiting,PROCESS_OF,Patients,32278755,10.1016/j.athoracsur.2020.03.005,2020-04-13
RNA,DISRUPTS,Virulence,32278755,10.1016/j.athoracsur.2020.03.005,2020-04-13
Malignant neoplasm of thorax,PROCESS_OF,Patients,32278727,10.1016/j.jamcollsurg.2020.03.031,2020-04-13
Malignant neoplasm of thorax,PROCESS_OF,Patients,32278727,10.1016/j.jamcollsurg.2020.03.031,2020-04-13
Patients,ISA,Persons,32278716,10.1016/j.jacc.2020.04.009,2020-04-13
Structural disorder of heart,PROCESS_OF,Patients,32278701,10.1016/j.jhin.2020.04.012,2020-04-13
Structural disorder of heart,PROCESS_OF,Patients,32278701,10.1016/j.jhin.2020.04.012,2020-04-13
Clinic,LOCATION_OF,Study,32278670,10.1016/j.accpm.2020.04.001,2020-04-13
Methisazone,STIMULATES,"Angiotensin II Receptor, Type 2",32278670,10.1016/j.accpm.2020.04.001,2020-04-13
Coronavirus Infections,ISA,Disease,32278670,10.1016/j.accpm.2020.04.001,2020-04-13
Non-invasive mechanical ventilation,ADMINISTERED_TO,Patients,32278616,10.1016/j.nefro.2020.03.002,2020-04-13
Mechanical ventilation,TREATS,Patients,32278616,10.1016/j.nefro.2020.03.002,2020-04-13
Comorbidity,PROCESS_OF,Patients,32278546,10.1016/j.jsurg.2020.03.020,2020-04-13
Uncertainty,PROCESS_OF,Population Group,32278546,10.1016/j.jsurg.2020.03.020,2020-04-13
Physical and emotional exhaustion state,PROCESS_OF,Caregiver,32278175,10.1016/j.scitotenv.2020.138277,2020-04-12
Globalization,CAUSES,Severe Acute Respiratory Syndrome,32278168,10.1016/j.ijporl.2020.110030,2020-04-12
Globalization,CAUSES,Middle East Respiratory Syndrome,32278168,10.1016/j.ijporl.2020.110030,2020-04-12
Artificial Airways,TREATS,Possible,32278147,10.1016/j.meegid.2020.104306,2020-04-12
Inflammation,PROCESS_OF,Patients,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Intestines,LOCATION_OF,Inflammation,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Lung,NEG_LOCATION_OF,angiotensin converting enzyme 2,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Lung,NEG_LOCATION_OF,TMPRSS2 gene,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Esophagus,LOCATION_OF,angiotensin converting enzyme 2,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Diarrhea,PROCESS_OF,Patients,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Diarrhea,PROCESS_OF,Patients,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Infected,PROCESS_OF,Patients,32277967,10.1016/j.jinf.2020.03.035,2020-04-12
Blood,LOCATION_OF,Serum amyloid A protein,32277878,10.1016/S0140-6736(20)30746-7,2020-04-12
Laboratory,LOCATION_OF,Data Collection,32277878,10.1016/S0140-6736(20)30746-7,2020-04-12
Serum amyloid A protein,PART_OF,Patients,32277878,10.1016/S0140-6736(20)30746-7,2020-04-12
Critical Illness,PROCESS_OF,Patients,32277878,10.1016/S0140-6736(20)30746-7,2020-04-12
High Level,PROCESS_OF,Patients,32277878,10.1016/S0140-6736(20)30746-7,2020-04-12
Respiratory Failure,INTERACTS_WITH,Virus,32277763,10.1002/mus.26891,2020-04-12
"Marriage, life event",PROCESS_OF,Couples (persons),32277763,10.1002/mus.26891,2020-04-12
Pharmacotherapy,USES,fulvestrant,32277763,10.1002/mus.26891,2020-04-12
Hydroxychloroquine,TREATS,Patients,32277763,10.1002/mus.26891,2020-04-12
cobicistat / darunavir,TREATS,Patients,32277763,10.1002/mus.26891,2020-04-12
Judgment,PROCESS_OF,Physicians,32277759,10.1093/cid/ciaa424,2020-04-12
SARS coronavirus,COEXISTS_WITH,Autoimmune Lymphoproliferative Syndrome,32277751,10.4193/Rhin20.116,2020-04-12
Index case,PROCESS_OF,Persons,32277751,10.4193/Rhin20.116,2020-04-12
Specimen from endotracheal tube,PART_OF,Patients,32277751,10.4193/Rhin20.116,2020-04-12
Asymptomatic,PROCESS_OF,Persons,32277751,10.4193/Rhin20.116,2020-04-12
Disease,PROCESS_OF,Child,32277751,10.4193/Rhin20.116,2020-04-12
Infected,PROCESS_OF,Child,32277751,10.4193/Rhin20.116,2020-04-12
Anosmia,PROCESS_OF,Patients,32277694,10.4269/ajtmh.20-0240,2020-04-12
Coronavirus Infections,PROCESS_OF,Patients,32277694,10.4269/ajtmh.20-0240,2020-04-12
Disease,PROCESS_OF,Brothers,32277591,10.1111/ajt.15909,2020-04-12
Coronavirus Infections,ISA,Disease,32277591,10.1111/ajt.15909,2020-04-12
Coronavirus Infections,PROCESS_OF(SPEC),Brothers,32277591,10.1111/ajt.15909,2020-04-12
Cessation of life,PROCESS_OF,Brothers,32277591,10.1111/ajt.15909,2020-04-12
Disease,PROCESS_OF,Persons,32277591,10.1111/ajt.15909,2020-04-12
Coronavirus Infections,ISA,Disease,32277591,10.1111/ajt.15909,2020-04-12
Coronavirus Infections,ISA,Disease,32277591,10.1111/ajt.15909,2020-04-12
Coronavirus Infections,PROCESS_OF(SPEC),Persons,32277591,10.1111/ajt.15909,2020-04-12
Multiple Organ Failure,COMPLICATES,Critical Illness,32277555,10.1111/ajt.15897,2020-04-12
"Infections, Hospital",COMPLICATES,Critical Illness,32277555,10.1111/ajt.15897,2020-04-12
Severe acute respiratory infection,PROCESS_OF,Recipient,32277490,10.1002/pd.5702,2020-04-12
Cyclosporine,TREATS,Patients,32277490,10.1002/pd.5702,2020-04-12
lopinavir / Ritonavir,TREATS,Patients,32277490,10.1002/pd.5702,2020-04-12
Severe acute respiratory infection,PROCESS_OF,Recipient,32277490,10.1002/pd.5702,2020-04-12
Severe acute respiratory infection,PROCESS_OF,Recipient,32277490,10.1002/pd.5702,2020-04-12
Myocardium,LOCATION_OF,Dyskinetic syndrome,32277387,10.1007/s12072-020-10043-z,2020-04-12
Plain chest X-ray,DIAGNOSES,Chromosome 2q32-Q33 Deletion Syndrome,32277387,10.1007/s12072-020-10043-z,2020-04-12
Virus,CAUSES,Myocarditis,32277387,10.1007/s12072-020-10043-z,2020-04-12
Cardiac complication,PROCESS_OF,Patients,32277387,10.1007/s12072-020-10043-z,2020-04-12
Study,METHOD_OF,Pathology,32277387,10.1007/s12072-020-10043-z,2020-04-12
Coronavirus Infections,CAUSES,Pneumonia,32277367,10.1007/s10067-020-05073-9,2020-04-12
Lung,LOCATION_OF,Severe disorder,32277367,10.1007/s10067-020-05073-9,2020-04-12
Prophylactic treatment,TREATS,Liver transplant recipient,32277367,10.1007/s10067-020-05073-9,2020-04-12
Thrombocytopenia,COEXISTS_WITH,Rheumatism,32277351,10.1007/s40257-020-00514-2,2020-04-12
Secondary Hemophagocytic Lymphohistiocytosis,COEXISTS_WITH,Adult-Onset Still Disease,32277351,10.1007/s40257-020-00514-2,2020-04-12
Secondary Hemophagocytic Lymphohistiocytosis,COEXISTS_WITH,Systemic onset juvenile chronic arthritis,32277351,10.1007/s40257-020-00514-2,2020-04-12
angiotensin converting enzyme 2,AFFECTS,Virus Internalization,32277351,10.1007/s40257-020-00514-2,2020-04-12
Rheumatism,COEXISTS_WITH,Coronavirus Infections,32277351,10.1007/s40257-020-00514-2,2020-04-12
Rheumatism,PROCESS_OF,Patients,32277351,10.1007/s40257-020-00514-2,2020-04-12
Glucocorticoids,TREATS,Patients,32277351,10.1007/s40257-020-00514-2,2020-04-12
Therapeutic procedure,ADMINISTERED_TO,Patients,32277351,10.1007/s40257-020-00514-2,2020-04-12
"Antirheumatic Drugs, Disease-Modifying",TREATS,Patients,32277351,10.1007/s40257-020-00514-2,2020-04-12
Discontinued,COEXISTS_WITH,Infection,32277351,10.1007/s40257-020-00514-2,2020-04-12
Severe Acute Respiratory Syndrome,AFFECTS,Immune response,32277299,10.1007/s00395-020-0792-4,2020-04-12
"Respiratory Distress Syndrome, Adult",ISA,Respiratory Failure,32277299,10.1007/s00395-020-0792-4,2020-04-12
Chronic disease,AFFECTS,Disease,32277299,10.1007/s00395-020-0792-4,2020-04-12
Glioma,PROCESS_OF,Patients,32277203,10.1038/s41415-020-1482-1,2020-04-12
Terminal illness,PROCESS_OF,Patients,32277203,10.1038/s41415-020-1482-1,2020-04-12
Glioma,PROCESS_OF,Adult,32277203,10.1038/s41415-020-1482-1,2020-04-12
Glioma,PROCESS_OF,Adult,32277203,10.1038/s41415-020-1482-1,2020-04-12
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Patients,32277203,10.1038/s41415-020-1482-1,2020-04-12
Severe disorder,PROCESS_OF,Woman,32277040,10.1126/science.abb7498,2020-04-12
Pandemics,CAUSES,Toxic Epidermal Necrolysis,32277023,10.1128/JCM.00375-20,2020-04-12
Immunochromatographic Assay,USES,Gold,32277022,10.1128/JCM.00599-20,2020-04-12
Specimen Type - Serum,LOCATION_OF,CD40LG wt Allele,32277022,10.1128/JCM.00599-20,2020-04-12
Immunochromatographic Assay,USES,Gold,32277022,10.1128/JCM.00599-20,2020-04-12
Real-Time Polymerase Chain Reaction,METHOD_OF,Ribonucleic acid extraction technique,32277021,10.1136/medethics-2020-106242,2020-04-12
Child,LOCATION_OF,Specimen Type - Stool = Fecal,32276778,10.1016/j.wombi.2020.03.011,2020-04-12
Feces,PART_OF,Patients,32276778,10.1016/j.wombi.2020.03.011,2020-04-12
Feces,ASSOCIATED_WITH(INFER),Infected,32276778,10.1016/j.wombi.2020.03.011,2020-04-12
Feces,PART_OF,Child,32276778,10.1016/j.wombi.2020.03.011,2020-04-12
Infected,PROCESS_OF,Child,32276778,10.1016/j.wombi.2020.03.011,2020-04-12
Interleukin-6,ASSOCIATED_WITH,inflammatory response,32276333,10.3390/ijms21072574,2020-04-12
Orthomyxoviridae,ISA,RNA Viruses,32276333,10.3390/ijms21072574,2020-04-12
Program,compared_with,Nucleotides,32276282,10.1055/s-0040-1709689,2020-04-11
Program,higher_than,Nucleotides,32276282,10.1055/s-0040-1709689,2020-04-11
Assay,USES,BCAR3 gene,32276282,10.1055/s-0040-1709689,2020-04-11
disease prevention,USES,Mechanical Ventilator,32276196,10.1016/j.psychres.2020.112936,2020-04-11
Coughing,CAUSES,Medical Care Team,32276196,10.1016/j.psychres.2020.112936,2020-04-11
Sneezing,CAUSES,Medical Care Team,32276196,10.1016/j.psychres.2020.112936,2020-04-11
Coronavirus Infections,ISA,Disease,32276140,10.1016/j.clim.2020.108410,2020-04-11
Anxiety,PROCESS_OF,Patients,32276140,10.1016/j.clim.2020.108410,2020-04-11
Depressive disorder,PROCESS_OF,Patients,32276140,10.1016/j.clim.2020.108410,2020-04-11
Infected,PROCESS_OF,Patients,32276140,10.1016/j.clim.2020.108410,2020-04-11
Mental disorders,AFFECTS,Medical Staff,32276140,10.1016/j.clim.2020.108410,2020-04-11
ACE2 gene,PART_OF,X Chromosome,32276139,10.1016/j.clim.2020.108413,2020-04-11
Hypomethylation,PROCESS_OF,ACE2 gene,32276139,10.1016/j.clim.2020.108413,2020-04-11
Demethylation,PROCESS_OF,Patients,32276139,10.1016/j.clim.2020.108413,2020-04-11
Disease remission,PROCESS_OF,Patients,32276139,10.1016/j.clim.2020.108413,2020-04-11
Symptoms,NEG_PROCESS_OF,Woman,32276137,10.1016/j.clim.2020.108409,2020-04-11
Glucocorticoids,CAUSES,Infection,32276137,10.1016/j.clim.2020.108409,2020-04-11
World,ISA,Population Group,32276116,10.1016/j.cmi.2020.04.001,2020-04-11
Detection,compared_with,Oligonucleotide Primers,32276102,10.1016/j.jpainsymman.2020.03.028,2020-04-11
Assay,METHOD_OF,Detection,32276102,10.1016/j.jpainsymman.2020.03.028,2020-04-11
Has difficulty doing (qualifier value),PROCESS_OF,Patients,32276101,10.1016/j.jpainsymman.2020.03.030,2020-04-11
Mechanical ventilation,AFFECTS,Patients,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Symptoms,PROCESS_OF,Population Group,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Acute hospital,LOCATION_OF,management planning,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Pharmaceutical Preparations,TREATS,Symptoms,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Pharmaceutical Preparations,TREATS(SPEC),Dyspnea,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Pharmaceutical Preparations,TREATS(SPEC),Fever,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Pharmaceutical Preparations,TREATS(SPEC),Malaise,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Dyspnea,ISA,Symptoms,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Fever,ISA,Symptoms,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
Malaise,ISA,Symptoms,32276099,10.1016/j.jpainsymman.2020.03.040,2020-04-11
No incoordination,PROCESS_OF,Community,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
No incoordination,PROCESS_OF,Outpatients,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
contextual factors,PROCESS_OF,Community,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
contextual factors,PROCESS_OF,Outpatients,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
Screening procedure,TREATS,Symptoms,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
contextual factors,PROCESS_OF,Community,32276097,10.1016/j.jpainsymman.2020.03.041,2020-04-11
Aging,PROCESS_OF,Adult,32276095,10.1016/j.jpainsymman.2020.03.039,2020-04-11
Aging,PROCESS_OF,Adult,32276095,10.1016/j.jpainsymman.2020.03.039,2020-04-11
Imbrication (procedure),TREATS,Pneumonia,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Symptoms,PROCESS_OF,Population Group,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Feces,LOCATION_OF,PLA2G2D gene,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Sputum,LOCATION_OF,PLA2G2D gene,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Feces,LOCATION_OF,PLA2G2D gene,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Feces,LOCATION_OF,PLA2G2D gene,32276051,10.1016/j.jmoldx.2020.03.006,2020-04-11
Malaise,PROCESS_OF,Health Personnel,32275914,10.1016/j.antiviral.2020.104791,2020-04-11
Respiration Disorders,PREDISPOSES,Disease Progression,32275914,10.1016/j.antiviral.2020.104791,2020-04-11
Plain chest X-ray,DIAGNOSES,Lung diseases,32275914,10.1016/j.antiviral.2020.104791,2020-04-11
Disease,PROCESS_OF,Community,32275914,10.1016/j.antiviral.2020.104791,2020-04-11
Interferon Type I,TREATS,Middle East Respiratory Syndrome Coronavirus,32275855,10.1016/j.cell.2020.03.045,2020-04-11
ACE2 gene,PART_OF,Homo sapiens,32275812,10.1056/NEJMoa2007016,2020-04-11
Monoclonal Antibodies,PART_OF,Mus,32275812,10.1056/NEJMoa2007016,2020-04-11
Oxygen,ADMINISTERED_TO,Patients,32275805,10.1111/1742-6723.13514,2020-04-11
Mechanical ventilation,ADMINISTERED_TO,Patients,32275805,10.1111/1742-6723.13514,2020-04-11
Mechanical ventilation,ADMINISTERED_TO,Patients,32275805,10.1111/1742-6723.13514,2020-04-11
Esthesia,PROCESS_OF,Clinician,32275804,10.15252/emmm.202012481,2020-04-11
Hospitalization,TREATS,Complication,32275766,10.1111/anae.15082,2020-04-11
Telemedicine,TREATS,medical care,32275766,10.1111/anae.15082,2020-04-11
Ultrasonography,ADMINISTERED_TO,Patients,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung Injury,PROCESS_OF,Patients,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung,LOCATION_OF,Ultrasonography,32275753,10.1093/qjmed/hcaa121,2020-04-11
Ultrasonography,AFFECTS,Infectious disease prevention / control,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung,LOCATION_OF,Ultrasonography,32275753,10.1093/qjmed/hcaa121,2020-04-11
Respiratory Failure,PROCESS_OF,Patients,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung,LOCATION_OF,Ultrasonography,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung,LOCATION_OF,Ultrasonography,32275753,10.1093/qjmed/hcaa121,2020-04-11
Lung,LOCATION_OF,Ultrasonography,32275753,10.1093/qjmed/hcaa121,2020-04-11
Inspiration function,PROCESS_OF,Patients,32275742,10.1093/ajcp/aqaa062,2020-04-11
Fibrin,INHIBITS,patient condition,32275742,10.1093/ajcp/aqaa062,2020-04-11
Lung,LOCATION_OF,Lesion,32275742,10.1093/ajcp/aqaa062,2020-04-11
Lung,LOCATION_OF,Lesion,32275742,10.1093/ajcp/aqaa062,2020-04-11
Plasminogen,TREATS,Lesion,32275742,10.1093/ajcp/aqaa062,2020-04-11
Plasminogen,TREATS,Hypoxemia,32275742,10.1093/ajcp/aqaa062,2020-04-11
5 - Moderate,PROCESS_OF,Patients,32275742,10.1093/ajcp/aqaa062,2020-04-11
Disease,PROCESS_OF,Patients,32275742,10.1093/ajcp/aqaa062,2020-04-11
5 - Moderate,PROCESS_OF,Patients,32275742,10.1093/ajcp/aqaa062,2020-04-11
Lung,LOCATION_OF,Lesion,32275742,10.1093/ajcp/aqaa062,2020-04-11
Plasminogen,TREATS,Chest tightness,32275742,10.1093/ajcp/aqaa062,2020-04-11
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Adult,32275742,10.1093/ajcp/aqaa062,2020-04-11
Lesion,COEXISTS_WITH,Coronavirus Infections,32275742,10.1093/ajcp/aqaa062,2020-04-11
Hypoxemia,COEXISTS_WITH,Coronavirus Infections,32275742,10.1093/ajcp/aqaa062,2020-04-11
Autopsy,DIAGNOSES,Edema,32275740,10.1182/blood.2020006028,2020-04-11
Autopsy,DIAGNOSES,Chronic inflammation,32275740,10.1182/blood.2020006028,2020-04-11
Autopsy,DIAGNOSES,diffuse alveolar damage,32275740,10.1182/blood.2020006028,2020-04-11
Mucous membrane of bronchus,LOCATION_OF,Edema,32275740,10.1182/blood.2020006028,2020-04-11
Mucous membrane of bronchus,LOCATION_OF,Chronic inflammation,32275740,10.1182/blood.2020006028,2020-04-11
Mucous membrane of bronchus,LOCATION_OF,diffuse alveolar damage,32275740,10.1182/blood.2020006028,2020-04-11
Abdominal Pain,PROCESS_OF,Male population group,32275740,10.1182/blood.2020006028,2020-04-11
Fever,PROCESS_OF,Male population group,32275740,10.1182/blood.2020006028,2020-04-11
Autopsy,DIAGNOSES,Acute bronchopneumonia,32275740,10.1182/blood.2020006028,2020-04-11
Airway structure,LOCATION_OF,Mucus cast,32275740,10.1182/blood.2020006028,2020-04-11
Serum,LOCATION_OF,CST3 gene,32275498,10.3201/eid2607.200994,2020-04-11
Heart Injuries,PROCESS_OF,Patients,32275295,10.1001/jama.2020.6130,2020-04-11
Influenza-like symptoms,PROCESS_OF,Patients,32275295,10.1001/jama.2020.6130,2020-04-11
Extracorporeal Membrane Oxygenation,TREATS,Patients,32275295,10.1001/jama.2020.6130,2020-04-11
Mechanical ventilation,TREATS,Patients,32275295,10.1001/jama.2020.6130,2020-04-11
Biopsy,DIAGNOSES,Myocarditis,32275295,10.1001/jama.2020.6130,2020-04-11
Endomyocardium,LOCATION_OF,Biopsy,32275295,10.1001/jama.2020.6130,2020-04-11
Movement,PROCESS_OF,Homo sapiens,32275288,10.1001/jamaneurol.2020.1127,2020-04-11
Quarantine,COEXISTS_WITH,Intervention regimes,32275288,10.1001/jamaneurol.2020.1127,2020-04-11
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Persons,32275288,10.1001/jamaneurol.2020.1127,2020-04-11
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Elderly (population group),32275288,10.1001/jamaneurol.2020.1127,2020-04-11
Intervention regimes,TREATS,Improved,32275288,10.1001/jamaneurol.2020.1127,2020-04-11
Neurologic Manifestations,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Disease,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Hypertensive disease,ISA,Disease,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Hypertensive disease,PROCESS_OF(SPEC),Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Muscle,LOCATION_OF,skeletal injury,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Neurologic Manifestations,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Neurologic Manifestations,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Neurologic Manifestations,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Vision,PROCESS_OF,Patients,32275287,10.23750/abm.v91i3-S.9511,2020-04-11
Attitude,PROCESS_OF,Cohort,32275261,10.23750/abm.v91i3-S.9507,2020-04-11
Laboratory,LOCATION_OF,Work,32275090,10.1002/jmv.25864,2020-04-11
Infected,PROCESS_OF,Patients,32275090,10.1002/jmv.25864,2020-04-11
Laboratory,LOCATION_OF,Work,32275090,10.1002/jmv.25864,2020-04-11
Sorting (Cognition),PROCESS_OF,Homo sapiens,32275090,10.1002/jmv.25864,2020-04-11
Laboratory,LOCATION_OF,Study,32275079,10.1002/jmv.25856,2020-04-11
Serum,LOCATION_OF,"Antibodies, Neutralizing",32275079,10.1002/jmv.25856,2020-04-11
Serum,LOCATION_OF,"Antibodies, Neutralizing",32275079,10.1002/jmv.25856,2020-04-11
Coronavirus Infections,ISA,Disease,32274964,10.1080/07391102.2020.1754293,2020-04-11
Pneumonia,PROCESS_OF,Pregnant Women,32274964,10.1080/07391102.2020.1754293,2020-04-11
Pneumonia,COEXISTS_WITH,late pregnancy,32274964,10.1080/07391102.2020.1754293,2020-04-11
Pneumonia,PROCESS_OF,Woman,32274964,10.1080/07391102.2020.1754293,2020-04-11
Plasma membrane,LOCATION_OF,angiotensin converting enzyme 2,32274917,10.3760/cma.j.cn112338-20200406-00517,2020-04-11
Plasma membrane,PART_OF,Host Cell,32274917,10.3760/cma.j.cn112338-20200406-00517,2020-04-11
Asymptomatic Infections,ISA,Asymptomatic Diseases,32274787,10.1055/a-1147-2889,2020-04-11
Alcohol consumption,PROCESS_OF,victim,32274774,10.1055/a-1144-5562,2020-04-11
Alcohol consumption,PROCESS_OF,Offenders,32274774,10.1055/a-1144-5562,2020-04-11
Pharmaceutical Preparations,AFFECTS,Domestic Violence,32274774,10.1055/a-1144-5562,2020-04-11
Serious mental illness,PROCESS_OF,Patients,32274774,10.1055/a-1144-5562,2020-04-11
Human virus,CAUSES,Common Cold,32274773,10.1055/a-1146-8674,2020-04-11
Virus,CAUSES,Acute Disease,32274773,10.1055/a-1146-8674,2020-04-11
Intervention regimes,USES,Anesthetics,32274773,10.1055/a-1146-8674,2020-04-11
Central Nervous System,LOCATION_OF,Analgesia in labor,32274773,10.1055/a-1146-8674,2020-04-11
Pregnancy,PROCESS_OF,Patients,32274773,10.1055/a-1146-8674,2020-04-11
intensive care,TREATS,Patients,32274773,10.1055/a-1146-8674,2020-04-11
Gravidity,PROCESS_OF,Patients,32274773,10.1055/a-1146-8674,2020-04-11
intensive care,TREATS,Patients,32274772,10.1055/s-0040-1709684,2020-04-11
Acute Lung Injury,PROCESS_OF,Patients,32274772,10.1055/s-0040-1709684,2020-04-11
Assisted breathing,TREATS,Single organ dysfunction,32274772,10.1055/s-0040-1709684,2020-04-11
Confirmation,PROCESS_OF,Patients,32274630,10.1007/s11060-020-03488-7,2020-04-11
Readiness,PROCESS_OF,Staff,32274630,10.1007/s11060-020-03488-7,2020-04-11
Cesarean section,TREATS,patient condition,32274630,10.1007/s11060-020-03488-7,2020-04-11
Cesarean section,TREATS,Confirmation,32274630,10.1007/s11060-020-03488-7,2020-04-11
Neoplastic disease,PROCESS_OF,Patients,32274617,10.1007/s11357-020-00186-0,2020-04-11
China,ISA,Country,32274570,10.1007/s00395-020-0791-5,2020-04-11
Taiwan,ISA,Asian country,32274570,10.1007/s00395-020-0791-5,2020-04-11
Immune,PROCESS_OF,Elderly (population group),32274570,10.1007/s00395-020-0791-5,2020-04-11
Clinical Response,PROCESS_OF,Elderly (population group),32274570,10.1007/s00395-020-0791-5,2020-04-11
Coronavirus Infections,ISA,Disease,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Cardiac Arrest,COEXISTS_WITH,patient condition,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Heart Diseases,COEXISTS_WITH,Cardiac Arrest,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Heart Diseases,COEXISTS_WITH,Myocarditis,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Heart Diseases,COEXISTS_WITH,Acute heart failure,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Myocarditis,COEXISTS_WITH,patient condition,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Acute heart failure,COEXISTS_WITH,patient condition,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Cardiac Arrest,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Myocarditis,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Acute heart failure,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Cardiovascular Physiological Phenomena,AFFECTS,Biological Processes,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Biological Processes,AFFECTS,Virus Diseases,32274425,10.1016/j.ctro.2020.03.009,2020-04-11
Discussion (procedure),TREATS,Present,32274342,10.14218/JCTH.2020.00018,2020-04-11
Liver damage,PROCESS_OF,Patients,32274341,10.14218/JCTH.2020.00019,2020-04-11
"Respiratory Distress Syndrome, Newborn",CAUSES,Anoxia,32274341,10.14218/JCTH.2020.00019,2020-04-11
"Respiratory Distress Syndrome, Newborn",CAUSES,Single organ dysfunction,32274341,10.14218/JCTH.2020.00019,2020-04-11
"Respiratory Distress Syndrome, Newborn",CAUSES,inflammatory response,32274341,10.14218/JCTH.2020.00019,2020-04-11
Coronavirus Infections,ISA,Disease,32274081,10.21037/jtd.2020.02.64,2020-04-11
Intrahepatic Cholestasis,PROCESS_OF,Patients,32274081,10.21037/jtd.2020.02.64,2020-04-11
Liver,LOCATION_OF,advanced disease,32274081,10.21037/jtd.2020.02.64,2020-04-11
Liver Failure,PROCESS_OF,Patients,32274081,10.21037/jtd.2020.02.64,2020-04-11
Serum,LOCATION_OF,Transaminases,32274081,10.21037/jtd.2020.02.64,2020-04-11
Problem,PROCESS_OF,Patients,32274081,10.21037/jtd.2020.02.64,2020-04-11
Quarantine,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,32273253,10.1016/j.sapharm.2020.03.027,2020-04-11
Disease,PROCESS_OF,Patients,32273245,10.1016/j.clae.2020.03.012,2020-04-11
Disease,PROCESS_OF,special populations,32273245,10.1016/j.clae.2020.03.012,2020-04-11
consideration,PROCESS_OF,hospitalized patients,32273245,10.1016/j.clae.2020.03.012,2020-04-11
"Lens, Crystalline",LOCATION_OF,Wears glasses,32273156,10.1016/j.joen.2020.03.008,2020-04-11
Coronavirus Infections,PROCESS_OF,Chiroptera,32273141,10.1016/j.ajem.2020.03.052,2020-04-11
Coronavirus Infections,PROCESS_OF,Pholidota,32273141,10.1016/j.ajem.2020.03.052,2020-04-11
Nasopharynx,LOCATION_OF,Coronavirus Infections,32273141,10.1016/j.ajem.2020.03.052,2020-04-11
Infectious disease prevention / control,TREATS,Patients,32273141,10.1016/j.ajem.2020.03.052,2020-04-11
Coronavirus Infections,ISA,Disease,32272957,10.1186/s13017-020-00304-5,2020-04-11
Coronavirus Infections,ISA,Disease,32272957,10.1186/s13017-020-00304-5,2020-04-11
"Signs and Symptoms, Respiratory",NEG_PROCESS_OF,Health Personnel,32272957,10.1186/s13017-020-00304-5,2020-04-11
"Signs and Symptoms, Respiratory",NEG_PROCESS_OF,Patients,32272957,10.1186/s13017-020-00304-5,2020-04-11
Infantile Neuroaxonal Dystrophy,AFFECTS,Readiness,32272857,10.1089/ten.TEA.2020.0094,2020-04-11
X-Ray Computed Tomography,DIAGNOSES,Lesion,32272550,10.3390/v12040406,2020-04-11
Lung field,LOCATION_OF,Lesion,32272550,10.3390/v12040406,2020-04-11
Disease,COEXISTS_WITH,Stable Disease,32272550,10.3390/v12040406,2020-04-11
Psychosocial problem,PROCESS_OF,Health Personnel,32272396,10.1016/j.intimp.2020.106455,2020-04-10
organic disease,PROCESS_OF,Health Personnel,32272396,10.1016/j.intimp.2020.106455,2020-04-10
risk factors,PROCESS_OF,Health Personnel,32272396,10.1016/j.intimp.2020.106455,2020-04-10
Psychosocial problem,PROCESS_OF,Health Personnel,32272396,10.1016/j.intimp.2020.106455,2020-04-10
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32272262,10.1016/j.ijid.2020.04.003,2020-04-10
Pathogenic organism,CAUSES,Respiratory Tract Infections,32272262,10.1016/j.ijid.2020.04.003,2020-04-10
Immunotherapy,TREATS,Virus,32272262,10.1016/j.ijid.2020.04.003,2020-04-10
Coughing,ISA,Symptoms,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
Fever,ISA,Symptoms,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
lobe,LOCATION_OF,Chest CT,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
lobe,PART_OF,Both lungs,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
Bronchi,LOCATION_OF,Physical findings,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
Lung,LOCATION_OF,Lesion,32272173,10.1016/j.antiviral.2020.104792,2020-04-10
Genus: Coronavirus,PROCESS_OF,Family,32272089,10.1016/S2352-4642(20)30095-X,2020-04-10
Genus: Coronavirus,PROCESS_OF,Family,32272089,10.1016/S2352-4642(20)30095-X,2020-04-10
SARS coronavirus,LOCATION_OF,"Spike Glycoprotein, Coronavirus",32272089,10.1016/S2352-4642(20)30095-X,2020-04-10
Finding of body mass index,PROCESS_OF,Patients,32271988,10.1111/jth.14830,2020-04-10
Obesity,PROCESS_OF,Patients,32271988,10.1111/jth.14830,2020-04-10
Attention,PROCESS_OF,Persons,32271988,10.1111/jth.14830,2020-04-10
Blood Coagulation Disorders,PROCESS_OF,Patients,32271978,10.1002/bmb.21351,2020-04-10
intensive care unit,LOCATION_OF,Study,32271978,10.1002/bmb.21351,2020-04-10
Pneumonia,PROCESS_OF,Patients,32271978,10.1002/bmb.21351,2020-04-10
Pneumonia,PROCESS_OF,Patients,32271978,10.1002/bmb.21351,2020-04-10
GSKIP gene,PART_OF,Patients,32271978,10.1002/bmb.21351,2020-04-10
Venous Thromboembolism,OCCURS_IN,Patients,32271978,10.1002/bmb.21351,2020-04-10
Structure of vein of lower extremity,LOCATION_OF,Ultrasonography,32271978,10.1002/bmb.21351,2020-04-10
Hypersensitivity,COEXISTS_WITH,Prognosis bad,32271978,10.1002/bmb.21351,2020-04-10
Pneumonia,OCCURS_IN,Patients,32271978,10.1002/bmb.21351,2020-04-10
Patients,LOCATION_OF,Fibrin fragment D,32271978,10.1002/bmb.21351,2020-04-10
Pneumonia,PROCESS_OF,Patients,32271978,10.1002/bmb.21351,2020-04-10
Laboratory,LOCATION_OF,research study,32271947,10.1002/ijgo.13166,2020-04-10
Vertical Disease Transmission,PROCESS_OF,Pregnant Women,32271942,10.1111/anae.15078,2020-04-10
Age,ASSOCIATED_WITH,Fourth disease,32271768,10.1371/journal.pone.0230802,2020-04-10
Attitude,PROCESS_OF,Adult,32271768,10.1371/journal.pone.0230802,2020-04-10
Low health literacy,PROCESS_OF,African race,32271768,10.1371/journal.pone.0230802,2020-04-10
Co-morbid conditions,PROCESS_OF,Adult,32271768,10.1371/journal.pone.0230802,2020-04-10
Detection of virus procedure,DIAGNOSES,Virus,32271728,10.15585/mmwr.mm6914e4,2020-04-10
"ORAL,SWAB",DIAGNOSES,Genus: Coronavirus,32271728,10.15585/mmwr.mm6914e4,2020-04-10
Alphacoronavirus,PROCESS_OF,Chiroptera,32271728,10.15585/mmwr.mm6914e4,2020-04-10
Alphacoronavirus,PROCESS_OF,Chiroptera,32271728,10.15585/mmwr.mm6914e4,2020-04-10
Betacoronavirus,PROCESS_OF,Chiroptera,32271728,10.15585/mmwr.mm6914e4,2020-04-10
Child,ISA,Population Group,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Infant,ISA,Population Group,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Adolescent (age group),ISA,Population Group,32271726,10.15585/mmwr.mm6914e2,2020-04-10
disease characteristic,PROCESS_OF,Patients,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Symptoms,PROCESS_OF,Adult,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Symptoms,PROCESS_OF,Child,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Coughing,PROCESS_OF,Adult,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Symptoms,PROCESS_OF,Patients,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Coughing,NEG_PROCESS_OF,Child,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Fever,NEG_PROCESS_OF,Child,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Hospitalization,TREATS,Human Age Group,32271726,10.15585/mmwr.mm6914e2,2020-04-10
Disease,PROCESS_OF,Elderly (population group),32271724,10.15585/mmwr.mm6914e3,2020-04-10
Signs and Symptoms,PROCESS_OF,Persons,32271722,10.15585/mmwr.mm6914e1,2020-04-10
Influenza,NEG_PROCESS_OF,Patients,32271722,10.15585/mmwr.mm6914e1,2020-04-10
Detection,TREATS,Community,32271722,10.15585/mmwr.mm6914e1,2020-04-10
Challenge,METHOD_OF,disorder control (procedure),32271650,10.1089/tmj.2020.0079,2020-04-10
Neoplasm Metastasis,PROCESS_OF,Patients,32271650,10.1089/tmj.2020.0079,2020-04-10
Neoplasm Metastasis,PROCESS_OF,Patients,32271650,10.1089/tmj.2020.0079,2020-04-10
Patients,ISA,Persons,32271650,10.1089/tmj.2020.0079,2020-04-10
Infected,PROCESS_OF,Persons,32271650,10.1089/tmj.2020.0079,2020-04-10
Infected,PROCESS_OF(SPEC),Patients,32271650,10.1089/tmj.2020.0079,2020-04-10
Adult,ISA,Population Group,32271609,10.2105/AJPH.2020.305699,2020-04-10
Coronavirus Infections,CAUSES,Pneumonia,32271602,10.34172/aim.2020.10,2020-04-10
X-Ray Computed Tomography,DIAGNOSES,patient condition,32271602,10.34172/aim.2020.10,2020-04-10
Coronavirus Infections,ISA,Disease,32271601,10.34172/aim.2020.09,2020-04-10
Infected,PROCESS_OF,Persons,32271601,10.34172/aim.2020.09,2020-04-10
Confirmation,PROCESS_OF,Patients,32271601,10.34172/aim.2020.09,2020-04-10
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32271601,10.34172/aim.2020.09,2020-04-10
Confirmation,PROCESS_OF,Patients,32271601,10.34172/aim.2020.09,2020-04-10
Ground Glass Opacity,COEXISTS_WITH,Bronchiectasis,32271601,10.34172/aim.2020.09,2020-04-10
Communicable Diseases,PROCESS_OF,Homo sapiens,32271600,10.34172/aim.2020.08,2020-04-10
Coronavirus Infections,CAUSES,Communicable Diseases,32271600,10.34172/aim.2020.08,2020-04-10
Suppressor,TREATS,Cancer Patient,32271598,10.34172/aim.2020.06,2020-04-10
American College of Cardiology/American Heart Association Lesion Complexity Score C,PREDISPOSES,Communicable Diseases,32271598,10.34172/aim.2020.06,2020-04-10
Coronavirus Infections,ISA,Disease,32271597,10.34172/aim.2020.05,2020-04-10
Disease,PROCESS_OF,"Students, Medical",32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,ISA,Disease,32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,PROCESS_OF(SPEC),"Students, Medical",32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,ISA,Disease,32271597,10.34172/aim.2020.05,2020-04-10
Disease,PREDISPOSES,Coronavirus Infections,32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,ISA,Disease,32271597,10.34172/aim.2020.05,2020-04-10
Disease,PROCESS_OF,"Students, Medical",32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,ISA,Disease,32271597,10.34172/aim.2020.05,2020-04-10
Coronavirus Infections,PROCESS_OF(SPEC),"Students, Medical",32271597,10.34172/aim.2020.05,2020-04-10
"Pneumonia, Viral",PROCESS_OF,World,32271595,10.34172/aim.2020.03,2020-04-10
Symptoms,PROCESS_OF,Patients,32271595,10.34172/aim.2020.03,2020-04-10
Assay,USES,PCR test for SARS,32271595,10.34172/aim.2020.03,2020-04-10
Infected,PROCESS_OF,Patients,32271594,10.34172/aim.2020.02,2020-04-10
Infected,PROCESS_OF,Patients,32271594,10.34172/aim.2020.02,2020-04-10
Coronavirus Infections,ISA,Disease,32271512,10.1590/S1677-5538.IBJU.2020.04.03,2020-04-10
Coronavirus Infections,ISA,Disease,32271512,10.1590/S1677-5538.IBJU.2020.04.03,2020-04-10
Challenge,TREATS,Disease,32271512,10.1590/S1677-5538.IBJU.2020.04.03,2020-04-10
Challenge,TREATS(SPEC),Coronavirus Infections,32271512,10.1590/S1677-5538.IBJU.2020.04.03,2020-04-10
Anosmia,ISA,Symptoms,32271462,10.26355/eurrev_202003_20715,2020-04-10
Anosmia,PROCESS_OF,Patients,32271462,10.26355/eurrev_202003_20715,2020-04-10
Pandemics,OCCURS_IN,Population Group,32271462,10.26355/eurrev_202003_20715,2020-04-10
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32271461,10.26355/eurrev_202003_20713,2020-04-10
Respiratory Failure,ISA,Disease,32271461,10.26355/eurrev_202003_20713,2020-04-10
Monoclonal Antibodies,INHIBITS,Interleukin-6,32271461,10.26355/eurrev_202003_20713,2020-04-10
Inositol,INHIBITS,Interleukin-6,32271461,10.26355/eurrev_202003_20713,2020-04-10
Inositol,AFFECTS,Severe Acute Respiratory Syndrome,32271461,10.26355/eurrev_202003_20713,2020-04-10
Nose,LOCATION_OF,saliva,32271460,10.26355/eurrev_202003_20712,2020-04-10
Nose,LOCATION_OF,"Discharge, body substance",32271460,10.26355/eurrev_202003_20712,2020-04-10
anatomical layer,LOCATION_OF,Masks,32271460,10.26355/eurrev_202003_20712,2020-04-10
Aspartate Transaminase,STIMULATES,C-reactive protein,32271458,10.26355/eurrev_202003_20709,2020-04-10
Lactate Dehydrogenase,compared_with,Creatine Kinase,32271458,10.26355/eurrev_202003_20709,2020-04-10
Lung,LOCATION_OF,Plaque (lesion),32271458,10.26355/eurrev_202003_20709,2020-04-10
Masks,TREATS,Influenza,32271456,10.26355/eurrev_202003_20706,2020-04-10
lopinavir / Ritonavir,TREATS,Control Groups,32271455,10.26355/eurrev_202003_20705,2020-04-10
Immunologic Adjuvants,ISA,Pharmaceutical Preparations,32271455,10.26355/eurrev_202003_20705,2020-04-10
Immunologic Adjuvants,ISA,Pharmaceutical Preparations,32271455,10.26355/eurrev_202003_20705,2020-04-10
Immunologic Adjuvants,TREATS(SPEC),Control Groups,32271455,10.26355/eurrev_202003_20705,2020-04-10
Pharmaceutical Preparations,TREATS,Control Groups,32271455,10.26355/eurrev_202003_20705,2020-04-10
lopinavir / Ritonavir,COEXISTS_WITH,Pharmaceutical Preparations,32271455,10.26355/eurrev_202003_20705,2020-04-10
lopinavir / Ritonavir,COEXISTS_WITH(SPEC),Immunologic Adjuvants,32271455,10.26355/eurrev_202003_20705,2020-04-10
lopinavir / Ritonavir,TREATS,Patients,32271455,10.26355/eurrev_202003_20705,2020-04-10
Alanine Transaminase,PART_OF,Patients,32271455,10.26355/eurrev_202003_20705,2020-04-10
Aspartate Transaminase,PART_OF,Patients,32271455,10.26355/eurrev_202003_20705,2020-04-10
lopinavir / Ritonavir,TREATS,Negative,32271455,10.26355/eurrev_202003_20705,2020-04-10
Adjuvant Analgesic,TREATS,Negative,32271455,10.26355/eurrev_202003_20705,2020-04-10
lopinavir / Ritonavir,COEXISTS_WITH,Adjuvant Analgesic,32271455,10.26355/eurrev_202003_20705,2020-04-10
Clinical Treatment,TREATS,Patients,32271455,10.26355/eurrev_202003_20705,2020-04-10
"Respiratory Distress Syndrome, Adult",CAUSES,Multiple Organ Failure,32271454,10.26355/eurrev_202003_20704,2020-04-10
Hospitals,LOCATION_OF,Study,32271454,10.26355/eurrev_202003_20704,2020-04-10
T cell differentiation,AFFECTS,Immune response,32271393,10.2340/16501977-2676,2020-04-10
T cell differentiation,AFFECTS,immunoglobulin secretion,32271393,10.2340/16501977-2676,2020-04-10
T cell differentiation,AFFECTS,extracellular matrix disassembly,32271393,10.2340/16501977-2676,2020-04-10
Pulmonary Edema,AFFECTS,Immune response,32271393,10.2340/16501977-2676,2020-04-10
Pulmonary capillary,LOCATION_OF,BARRIER,32271393,10.2340/16501977-2676,2020-04-10
BARRIER,TREATS,Pulmonary Edema,32271393,10.2340/16501977-2676,2020-04-10
risk factors,PROCESS_OF,Cohort,32271374,10.1093/cid/ciaa416,2020-04-10
Duration,COEXISTS_WITH,GSKIP gene,32271374,10.1093/cid/ciaa416,2020-04-10
Adrenal Cortex Hormones,TREATS,Hypertensive disease,32271374,10.1093/cid/ciaa416,2020-04-10
Hospital admission,TREATS,patient condition,32271374,10.1093/cid/ciaa416,2020-04-10
General treatment,TREATS,patient condition,32271374,10.1093/cid/ciaa416,2020-04-10
Coronavirus Infections,ISA,Disease,32271070,10.1037/tra0000592,2020-04-10
Intervention regimes,TREATS,Distress,32270980,10.37765/ajmc.2020.42784,2020-04-10
Laboratory Procedures,METHOD_OF,Nucleic acid assay,32270760,10.1192/bjp.2020.84,2020-04-10
Antiviral Agents,TREATS,Psychiatric inpatient,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
Psychiatric symptom,PROCESS_OF,Patients,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
Antidepressive Agents,INTERACTS_WITH,,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
Citalopram,INTERACTS_WITH(SPEC),,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
Citalopram,ISA,Antidepressive Agents,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
olanzapine,ISA,Antipsychotic Agents,32270660,10.3760/cma.j.cn501113-20200229-00076,2020-04-10
Family illness,PROCESS_OF,member,32270581,10.1002/hed.26164,2020-04-10
Complication,NEG_PROCESS_OF,Patients,32270581,10.1002/hed.26164,2020-04-10
Zoonoses,ISA,Disease,32270568,10.1002/hed.26161,2020-04-10
Coronavirus Infections,ISA,Disease,32270568,10.1002/hed.26161,2020-04-10
Comorbidity,PROCESS_OF,Persons,32270568,10.1002/hed.26161,2020-04-10
Comorbidity,PROCESS_OF,Old age,32270568,10.1002/hed.26161,2020-04-10
Infected,PROCESS_OF,Population Group,32270568,10.1002/hed.26161,2020-04-10
Infected,PROCESS_OF,Patients,32270568,10.1002/hed.26161,2020-04-10
Malignant Neoplasms,PROCESS_OF,Patients,32270568,10.1002/hed.26161,2020-04-10
Basis,TREATS,Patients,32270568,10.1002/hed.26161,2020-04-10
Basis,TREATS(INFER),Malignant Neoplasms,32270568,10.1002/hed.26161,2020-04-10
Anosmia,PROCESS_OF,Minority Groups,32270568,10.1002/hed.26161,2020-04-10
Dysgeusia,PROCESS_OF,Minority Groups,32270568,10.1002/hed.26161,2020-04-10
Chief complaint (finding),PROCESS_OF,Minority Groups,32270568,10.1002/hed.26161,2020-04-10
Symptoms,PROCESS_OF,Minority Groups,32270568,10.1002/hed.26161,2020-04-10
contextual factors,PROCESS_OF,Outpatients,32270568,10.1002/hed.26161,2020-04-10
Coronavirus Infections,ISA,Disease,32270568,10.1002/hed.26161,2020-04-10
Pneumonia,PROCESS_OF,Patients,32270565,10.1002/hed.26162,2020-04-10
China,ISA,Country,32270565,10.1002/hed.26162,2020-04-10
Pneumonia,PROCESS_OF,World,32270565,10.1002/hed.26162,2020-04-10
Head and Neck Neoplasms,PROCESS_OF,Patients,32270565,10.1002/hed.26162,2020-04-10
Neoplasms,PROCESS_OF,Patients,32270565,10.1002/hed.26162,2020-04-10
Heart,LOCATION_OF,Respiratory complication,32270521,10.1002/jmv.25850,2020-04-10
Disease,PROCESS_OF,Patients,32270521,10.1002/jmv.25850,2020-04-10
Coronavirus Infections,ISA,Disease,32270521,10.1002/jmv.25850,2020-04-10
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32270521,10.1002/jmv.25850,2020-04-10
Pharmaceutical Preparations,TREATS,Disease,32270521,10.1002/jmv.25850,2020-04-10
Pharmaceutical Preparations,TREATS(SPEC),Coronavirus Infections,32270521,10.1002/jmv.25850,2020-04-10
Coronavirus Infections,ISA,Disease,32270521,10.1002/jmv.25850,2020-04-10
Coronavirus Infections,ISA,Disease,32270521,10.1002/jmv.25850,2020-04-10
Comorbidity,PROCESS_OF,Male population group,32270479,10.1002/ijgo.13165,2020-04-10
Pneumonia,PROCESS_OF,Patients,32270477,10.1002/ijgo.13158,2020-04-10
Gravidity,PROCESS_OF,Patients,32270477,10.1002/ijgo.13158,2020-04-10
Gravidity,PROCESS_OF,hospitalized patients,32270477,10.1002/ijgo.13158,2020-04-10
Hospitalization,TREATS,Patients,32270477,10.1002/ijgo.13158,2020-04-10
Hospitalization,TREATS,Pregnant Women,32270477,10.1002/ijgo.13158,2020-04-10
Hospitalization,TREATS,Patients,32270477,10.1002/ijgo.13158,2020-04-10
Hospitalization,TREATS,Patients,32270477,10.1002/ijgo.13158,2020-04-10
Hospitalization,TREATS(INFER),Asymptomatic,32270477,10.1002/ijgo.13158,2020-04-10
Asymptomatic,PROCESS_OF,Patients,32270477,10.1002/ijgo.13158,2020-04-10
removal technique,PRECEDES,Biopsy,32270413,10.1007/s10096-020-03880-1,2020-04-10
removal technique,PRECEDES,Biopsy,32270413,10.1007/s10096-020-03880-1,2020-04-10
Vagina,LOCATION_OF,Biopsy,32270413,10.1007/s10096-020-03880-1,2020-04-10
Vaginectomy,PRECEDES,Biopsy,32270413,10.1007/s10096-020-03880-1,2020-04-10
Colposcopes,USES,videocassette,32270413,10.1007/s10096-020-03880-1,2020-04-10
Coronavirus Infections,ISA,Disease,32270388,10.1007/s12072-020-10041-1,2020-04-10
Chest CT,DIAGNOSES,Ground Glass Opacity,32270388,10.1007/s12072-020-10041-1,2020-04-10
Infected,PROCESS_OF,Patients,32270388,10.1007/s12072-020-10041-1,2020-04-10
Cessation of life,PROCESS_OF,Tissue Donors,32270376,10.1007/s11538-020-00726-x,2020-04-10
Transient Ischemic Attack,PROCESS_OF,Patients,32270184,10.1093/cid/ciaa410,2020-04-10
Cerebrovascular accident,PROCESS_OF,Patients,32270184,10.1093/cid/ciaa410,2020-04-10
SARS coronavirus,CAUSES,Asymptomatic Infections,32270178,10.1093/cid/ciaa408,2020-04-10
Asymptomatic Infections,AUGMENTS,Severe Acute Respiratory Syndrome,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,LOCATION_OF,Severe Acute Respiratory Syndrome,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,LOCATION_OF,SARS coronavirus,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,PART_OF,Lung,32270178,10.1093/cid/ciaa408,2020-04-10
Virion,PART_OF,Structure of parenchyma of lung,32270178,10.1093/cid/ciaa408,2020-04-10
Interferons,PART_OF,Human tissue,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,PART_OF,Lung,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,LOCATION_OF,Severe Acute Respiratory Syndrome,32270178,10.1093/cid/ciaa408,2020-04-10
Human tissue,PART_OF,Lung,32270178,10.1093/cid/ciaa408,2020-04-10
Hepatitis C Virus Infection,AFFECTS,SARS coronavirus,32269893,10.7759/cureus.7560,2020-04-10
HIV-1,CAUSES,Immune System Diseases,32269893,10.7759/cureus.7560,2020-04-10
Ascorbic Acid,ISA,Micronutrients,32269598,10.3332/ecancer.2020.ed98,2020-04-10
Vitamins,ISA,Micronutrients,32269598,10.3332/ecancer.2020.ed98,2020-04-10
Ibuprofen,ISA,"Anti-Inflammatory Agents, Non-Steroidal",32269598,10.3332/ecancer.2020.ed98,2020-04-10
cancer therapy,ADMINISTERED_TO,Patients,32269597,10.3332/ecancer.2020.ed97,2020-04-10
Neoplasms,PROCESS_OF,Patients,32269597,10.3332/ecancer.2020.ed97,2020-04-10
Neoplasms,PROCESS_OF,Patients,32269597,10.3332/ecancer.2020.ed97,2020-04-10
Chronic disease,PROCESS_OF,Persons,32269100,10.1128/JCM.00557-20,2020-04-10
Pharmacotherapy,ADMINISTERED_TO,Cancer Patient,32269100,10.1128/JCM.00557-20,2020-04-10
cancer care,PREDISPOSES,disease transmission,32269100,10.1128/JCM.00557-20,2020-04-10
Assay,USES,Gene probe,32269088,10.1183/13993003.00524-2020,2020-04-10
Pneumonia,PROCESS_OF,Patients,32269086,10.1183/13993003.00562-2020,2020-04-10
Pneumonia,PROCESS_OF,Patients,32269086,10.1183/13993003.00562-2020,2020-04-10
Pneumonia,PROCESS_OF,Patients,32269086,10.1183/13993003.00562-2020,2020-04-10
Pneumonia,PROCESS_OF,Patients,32269086,10.1183/13993003.00562-2020,2020-04-10
Infected,PROCESS_OF,Persons,32269020,10.1503/cmaj.200457,2020-04-10
Malaise,PROCESS_OF,Persons,32269018,10.1503/cmaj.200476,2020-04-10
Malaise,PROCESS_OF,Persons,32269018,10.1503/cmaj.200476,2020-04-10
disease characteristic,COEXISTS_WITH,First half,32269018,10.1503/cmaj.200476,2020-04-10
Isolation procedure,compared_with,Isolation procedure,32269018,10.1503/cmaj.200476,2020-04-10
disease transmission,PROCESS_OF,Population Group,32268984,10.1053/j.jvca.2020.03.026,2020-04-10
Isolation procedure,compared_with,Quarantine,32268984,10.1053/j.jvca.2020.03.026,2020-04-10
intensive care unit,ISA,Hospitals,32268984,10.1053/j.jvca.2020.03.026,2020-04-10
Cardiovascular Surgical Procedures,TREATS,Patients,32268945,10.1016/j.envpol.2020.114465,2020-04-10
High Level,PROCESS_OF,World,32268930,10.1017/cem.2020.364,2020-04-10
Chronic disease of respiratory system,PROCESS_OF,Persons,32268930,10.1017/cem.2020.364,2020-04-10
Ultrasonography,ADMINISTERED_TO,Patients,32268923,10.1186/s13643-020-01343-4,2020-04-10
Virus Diseases,AFFECTS,Pneumonia,32268855,10.33321/cdi.2020.44.30,2020-04-10
Terminal illness,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32268713,10.3760/cma.j.cn112141-20200218-00112,2020-04-10
Severe Acute Respiratory Syndrome,ISA,Illness (finding),32268713,10.3760/cma.j.cn112141-20200218-00112,2020-04-10
Infection,ISA,Wounds and Injuries,32268713,10.3760/cma.j.cn112141-20200218-00112,2020-04-10
Obtaining consent,METHOD_OF,Intubation,32268713,10.3760/cma.j.cn112141-20200218-00112,2020-04-10
Protection,PREDISPOSES,personal health,32268641,10.3760/cma.j.cn112150-20200217-00121,2020-04-10
Symptom mild,PROCESS_OF,Patients,32268640,10.3760/cma.j.cn112150-20200217-00125,2020-04-10
Severe viral infections,ISA,Communicable Diseases,32268640,10.3760/cma.j.cn112150-20200217-00125,2020-04-10
Contacts,PREVENTS,personal health,32268638,10.3760/cma.j.cn112150-20200217-00123,2020-04-10
Coronavirus Infections,CAUSES,Respiration Disorders,32268515,10.3390/v12040404,2020-04-10
Cross Infection,PROCESS_OF,Health Personnel,32268515,10.3390/v12040404,2020-04-10
Cross Infection,PROCESS_OF,Patients,32268515,10.3390/v12040404,2020-04-10
Cells,PART_OF,SARS coronavirus,32268456,10.3760/cma.j.cn501120-20200312-00153,2020-04-09
Cells,PART_OF,SARS coronavirus,32268456,10.3760/cma.j.cn501120-20200312-00153,2020-04-09
Pharmaceutical Preparations,TREATS,Patients,32268381,10.1055/s-0040-1709688,2020-04-09
Fetus,LOCATION_OF,Virus,32268195,10.1016/j.tmaid.2020.101654,2020-04-09
IMPACT gene,PART_OF,Virus,32268195,10.1016/j.tmaid.2020.101654,2020-04-09
Birth,PROCESS_OF,Infant,32268195,10.1016/j.tmaid.2020.101654,2020-04-09
Fetus,LOCATION_OF,IMPACT gene,32268195,10.1016/j.tmaid.2020.101654,2020-04-09
Possible,PREDISPOSES,Vertical Disease Transmission,32268195,10.1016/j.tmaid.2020.101654,2020-04-09
Blood Coagulation Disorders,PROCESS_OF,Patients,32267987,10.1002/rmv.2107,2020-04-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32267987,10.1002/rmv.2107,2020-04-09
Autopsy,CAUSES,Vascular occlusion,32267987,10.1002/rmv.2107,2020-04-09
Lung,LOCATION_OF,Microthrombus,32267987,10.1002/rmv.2107,2020-04-09
Compliance,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32267987,10.1002/rmv.2107,2020-04-09
alteplase,TREATS,Respiratory Failure,32267987,10.1002/rmv.2107,2020-04-09
Respiratory Failure,PROCESS_OF,Patients,32267987,10.1002/rmv.2107,2020-04-09
Respiratory Status,PROCESS_OF,Patients,32267987,10.1002/rmv.2107,2020-04-09
Coronavirus Infections,AFFECTS,Homo sapiens,32267963,10.1111/anae.15074,2020-04-09
China,ISA,Country,32267963,10.1111/anae.15074,2020-04-09
Coughing,ISA,Symptoms,32267963,10.1111/anae.15074,2020-04-09
Fatigue,ISA,Symptoms,32267963,10.1111/anae.15074,2020-04-09
Fever,ISA,Symptoms,32267963,10.1111/anae.15074,2020-04-09
Lung,PART_OF,Persons,32267963,10.1111/anae.15074,2020-04-09
Infected,PROCESS_OF,Persons,32267963,10.1111/anae.15074,2020-04-09
Adaptive Immune Response,PROCESS_OF,Patients,32267963,10.1111/anae.15074,2020-04-09
Academic Medical Centers,LOCATION_OF,Administration occupational activities,32267928,10.1093/jamia/ocaa051,2020-04-09
Asymptomatic,PROCESS_OF,Patients,32267833,10.18632/aging.103000,2020-04-09
Asymptomatic,PROCESS_OF,Patients,32267833,10.18632/aging.103000,2020-04-09
Triage,ADMINISTERED_TO,Patients,32267833,10.18632/aging.103000,2020-04-09
"CD69 protein, human",AUGMENTS,At risk of disease,32267826,10.3201/eid2607.200598,2020-04-09
patient condition,COEXISTS_WITH,Cerebrovascular Disorders,32267826,10.3201/eid2607.200598,2020-04-09
Cardiovascular Diseases,PREDISPOSES,Severe (severity modifier),32267826,10.3201/eid2607.200598,2020-04-09
Cerebrovascular Disorders,PREDISPOSES,Severe (severity modifier),32267826,10.3201/eid2607.200598,2020-04-09
Diabetes,PREDISPOSES,Severe (severity modifier),32267826,10.3201/eid2607.200598,2020-04-09
Hypertensive disease,PREDISPOSES,Severe (severity modifier),32267826,10.3201/eid2607.200598,2020-04-09
Chronic Obstructive Airway Disease,PREDISPOSES,Severe (severity modifier),32267826,10.3201/eid2607.200598,2020-04-09
Clinician,TREATS,Patients,32267826,10.3201/eid2607.200598,2020-04-09
RNA Viruses,PROCESS_OF,Persons,32267678,10.1021/acsnano.0c02618,2020-04-09
Asymptomatic,PROCESS_OF,Persons,32267678,10.1021/acsnano.0c02618,2020-04-09
Virus Diseases,COEXISTS_WITH,Crisis,32267607,10.1111/dewb.12261,2020-04-09
Decision,PROCESS_OF,Maker (occupation),32267538,10.1111/jgs.16477,2020-04-09
Triage,AFFECTS,Patients,32267243,10.1515/dx-2020-0041,2020-04-09
"Pneumonia, Interstitial",PROCESS_OF,Woman,32267243,10.1515/dx-2020-0041,2020-04-09
Addictive Behavior,ISA,Behavior Disorders,32267220,10.3201/eid2607.200841,2020-04-09
Assay,METHOD_OF,Detection,32267209,10.1148/radiol.2020201326,2020-04-09
Patients,LOCATION_OF,Specimen Type - Serum,32267209,10.1148/radiol.2020201326,2020-04-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32267209,10.1148/radiol.2020201326,2020-04-09
Infected,PROCESS_OF,Persons,32267209,10.1148/radiol.2020201326,2020-04-09
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32267209,10.1148/radiol.2020201326,2020-04-09
Enzyme-Linked Immunosorbent Assay,USES,"Immunoglobulin A, Human",32267209,10.1148/radiol.2020201326,2020-04-09
Triage,TREATS,Patients,32267163,10.1089/cyber.2020.0201,2020-04-09
Screening procedure,USES,Diagnosis,32267163,10.1089/cyber.2020.0201,2020-04-09
Hospitals,LOCATION_OF,Study,32267047,10.1111/pan.13863,2020-04-09
Infusion procedures,TREATS,Patients,32267047,10.1111/pan.13863,2020-04-09
Infusion procedures,TREATS(INFER),Macrophage Activation Syndrome,32267047,10.1111/pan.13863,2020-04-09
Infusion procedures,TREATS(INFER),Secondary Hemophagocytic Lymphohistiocytosis,32267047,10.1111/pan.13863,2020-04-09
Macrophage Activation Syndrome,PROCESS_OF,Patients,32267047,10.1111/pan.13863,2020-04-09
IL1RN gene,PART_OF,Homo sapiens,32267047,10.1111/pan.13863,2020-04-09
Secondary Hemophagocytic Lymphohistiocytosis,PROCESS_OF,Patients,32267047,10.1111/pan.13863,2020-04-09
Intravenous infusion procedures,USES,anakinra,32267047,10.1111/pan.13863,2020-04-09
Malaise,PROCESS_OF,Patients,32267047,10.1111/pan.13863,2020-04-09
anakinra,TREATS,Patients,32267047,10.1111/pan.13863,2020-04-09
anakinra,TREATS(INFER),Macrophage Activation Syndrome,32267047,10.1111/pan.13863,2020-04-09
Macrophage Activation Syndrome,PROCESS_OF,Patients,32267047,10.1111/pan.13863,2020-04-09
Severe disorder,PROCESS_OF,Patients,32267047,10.1111/pan.13863,2020-04-09
Disease,AFFECTS,Population Group,32266990,10.1002/jmv.25840,2020-04-09
Symptom mild,PROCESS_OF,Child,32266990,10.1002/jmv.25840,2020-04-09
Pediatric Death,PROCESS_OF,Child,32266990,10.1002/jmv.25840,2020-04-09
Adrenal Cortex Hormones,TREATS,Patients,32266873,10.1080/07391102.2020.1753577,2020-04-09
Hospitals,LOCATION_OF,Study,32266873,10.1080/07391102.2020.1753577,2020-04-09
Duration,TREATS,Patients,32266873,10.1080/07391102.2020.1753577,2020-04-09
Virus,PROCESS_OF,Patients,32266873,10.1080/07391102.2020.1753577,2020-04-09
"Hepatitis B, Chronic",ISA,Infection,32266873,10.1080/07391102.2020.1753577,2020-04-09
"Hepatitis B, Chronic",PROCESS_OF(SPEC),Patients,32266873,10.1080/07391102.2020.1753577,2020-04-09
Infection,PROCESS_OF,Patients,32266873,10.1080/07391102.2020.1753577,2020-04-09
Coronaviridae,PROCESS_OF,Family,32266867,10.1080/07391102.2020.1753580,2020-04-09
Infected,PROCESS_OF,Persons,32266867,10.1080/07391102.2020.1753580,2020-04-09
Polyproteins,CAUSES,Anabolism,32266867,10.1080/07391102.2020.1753580,2020-04-09
Polyproteins,PART_OF,replicase,32266867,10.1080/07391102.2020.1753580,2020-04-09
Screening procedure,USES,Bronchodilator Agents,32266828,10.1177/0004563220922255,2020-04-09
Electrolytes abnormal,PROCESS_OF,Patients,32266708,10.1007/s40292-020-00380-3,2020-04-09
Chlorides,compared_with,Calcium,32266708,10.1007/s40292-020-00380-3,2020-04-09
Electrolyte imbalance,COEXISTS_WITH,patient condition,32266708,10.1007/s40292-020-00380-3,2020-04-09
Patients,LOCATION_OF,Sodium,32266708,10.1007/s40292-020-00380-3,2020-04-09
Potassium,TREATS,patient condition,32266708,10.1007/s40292-020-00380-3,2020-04-09
Cardiovascular Diseases,COEXISTS_WITH,Hypertensive disease,32266524,10.1007/s11604-020-00967-9,2020-04-09
Cardiovascular Diseases,MANIFESTATION_OF,Severe Acute Respiratory Syndrome,32266524,10.1007/s11604-020-00967-9,2020-04-09
Epidemic,CAUSES,Cardiovascular Diseases,32266524,10.1007/s11604-020-00967-9,2020-04-09
Epidemic,CAUSES(SPEC),Hypertensive disease,32266524,10.1007/s11604-020-00967-9,2020-04-09
Hypertensive disease,ISA,Cardiovascular Diseases,32266524,10.1007/s11604-020-00967-9,2020-04-09
Hypertensive disease,MANIFESTATION_OF(SPEC),Severe Acute Respiratory Syndrome,32266524,10.1007/s11604-020-00967-9,2020-04-09
inhibitors,TREATS,Cardiovascular Diseases,32266524,10.1007/s11604-020-00967-9,2020-04-09
inhibitors,TREATS(SPEC),Hypertensive disease,32266524,10.1007/s11604-020-00967-9,2020-04-09
Therapeutic procedure,USES,Antihypertensive Agents,32266524,10.1007/s11604-020-00967-9,2020-04-09
Disease,PROCESS_OF,Homo sapiens,32266524,10.1007/s11604-020-00967-9,2020-04-09
Problem,COEXISTS_WITH,Disease,32266524,10.1007/s11604-020-00967-9,2020-04-09
Chest CT,DIAGNOSES,Ground Glass Opacity,32266381,10.1093/cid/ciaa398,2020-04-09
Coughing,ISA,Symptoms,32265848,10.3389/fmicb.2020.00298,2020-04-09
Coughing,PROCESS_OF(SPEC),Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Diarrhea,ISA,Symptoms,32265848,10.3389/fmicb.2020.00298,2020-04-09
Diarrhea,PROCESS_OF(SPEC),Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Fever,ISA,Symptoms,32265848,10.3389/fmicb.2020.00298,2020-04-09
Fever,PROCESS_OF(SPEC),Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Symptoms,PROCESS_OF,Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Exanthema,PROCESS_OF,Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Tachypnea,PROCESS_OF,Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Coronavirus Infections,PROCESS_OF,Pregnant Women,32265848,10.3389/fmicb.2020.00298,2020-04-09
Live Birth,PROCESS_OF,Infant,32265848,10.3389/fmicb.2020.00298,2020-04-09
Middle East Respiratory Syndrome Coronavirus,CAUSES,Infection,32265517,10.1038/s41564-020-0713-1,2020-04-09
Infection,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
Virus,CAUSES,Infection,32265517,10.1038/s41564-020-0713-1,2020-04-09
SARS coronavirus,CAUSES(SPEC),Infection,32265517,10.1038/s41564-020-0713-1,2020-04-09
SARS coronavirus,ISA,Virus,32265517,10.1038/s41564-020-0713-1,2020-04-09
Middle East Respiratory Syndrome Coronavirus,CAUSES(SPEC),Infection,32265517,10.1038/s41564-020-0713-1,2020-04-09
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32265517,10.1038/s41564-020-0713-1,2020-04-09
Infection,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
SARS coronavirus,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32265517,10.1038/s41564-020-0713-1,2020-04-09
physiological aspects,ASSOCIATED_WITH,"Vaccines, Subunit",32265517,10.1038/s41564-020-0713-1,2020-04-09
Structural protein,INTERACTS_WITH,"Vaccines, Subunit",32265517,10.1038/s41564-020-0713-1,2020-04-09
Coronavirus Infections,PROCESS_OF,Obstetric Patient,32265331,10.1128/mBio.00554-20,2020-04-09
Acute respiratory disease,PROCESS_OF,Homo sapiens,32265315,10.1128/mSystems.00245-20,2020-04-09
Parainfluenza Virus 5,LOCATION_OF,Vaccines,32265315,10.1128/mSystems.00245-20,2020-04-09
"M Protein, multiple myeloma",PART_OF,envelope,32265315,10.1128/mSystems.00245-20,2020-04-09
Middle East Respiratory Syndrome,PROCESS_OF,Mus,32265315,10.1128/mSystems.00245-20,2020-04-09
Prisons,ISA,Health care facility,32265310,10.1183/13993003.00858-2020,2020-04-09
Decision,PROCESS_OF,Maker (occupation),32265310,10.1183/13993003.00858-2020,2020-04-09
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32265235,10.1542/hpeds.2020-0123,2020-04-09
Possible,PROCESS_OF,Patients,32265235,10.1542/hpeds.2020-0123,2020-04-09
Respiratory viruses,CAUSES,"Respiratory Distress Syndrome, Adult",32265235,10.1542/hpeds.2020-0123,2020-04-09
Mesenchymal Stromal Cells,PART_OF,bony process,32265235,10.1542/hpeds.2020-0123,2020-04-09
systemic administration,PREVENTS,Respiratory viruses,32265235,10.1542/hpeds.2020-0123,2020-04-09
systemic administration,USES,,32265235,10.1542/hpeds.2020-0123,2020-04-09
,AFFECTS,Lung Injury,32265235,10.1542/hpeds.2020-0123,2020-04-09
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Infant,32265220,10.1136/bmj.m1328,2020-04-09
Aspirin,TREATS,Symptoms,32265220,10.1136/bmj.m1328,2020-04-09
"Immunoglobulins, Intravenous",TREATS,Symptoms,32265220,10.1136/bmj.m1328,2020-04-09
treatment guideline,TREATS,Symptoms,32265220,10.1136/bmj.m1328,2020-04-09
Intravenous infusion procedures,USES,Immunoglobulins,32265220,10.1136/bmj.m1328,2020-04-09
Fever,PROCESS_OF,Infant,32265220,10.1136/bmj.m1328,2020-04-09
Mucocutaneous Lymph Node Syndrome,PROCESS_OF,Infant,32265220,10.1136/bmj.m1328,2020-04-09
Detected (finding),PROCESS_OF,Persons,32265202,10.1136/bjophthalmol-2020-316304,2020-04-09
Pneumonia,PROCESS_OF,general population,32265202,10.1136/bjophthalmol-2020-316304,2020-04-09
Disease,PROCESS_OF,Male population group,32265182,10.3399/bjgpopen20X101069,2020-04-09
Present,PROCESS_OF,Patients,32265182,10.3399/bjgpopen20X101069,2020-04-09
Coronavirus Infections,ISA,Disease,32265182,10.3399/bjgpopen20X101069,2020-04-09
Coronavirus Infections,PROCESS_OF(SPEC),Male population group,32265182,10.3399/bjgpopen20X101069,2020-04-09
Bilateral conjunctivitis,PROCESS_OF,Male population group,32265182,10.3399/bjgpopen20X101069,2020-04-09
Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32265182,10.3399/bjgpopen20X101069,2020-04-09
Assay,DIAGNOSES,Present,32265182,10.3399/bjgpopen20X101069,2020-04-09
Viral Conjunctivitis,ISA,Complication,32265182,10.3399/bjgpopen20X101069,2020-04-09
Eye,LOCATION_OF,Complication,32265182,10.3399/bjgpopen20X101069,2020-04-09
Eye,LOCATION_OF(SPEC),Viral Conjunctivitis,32265182,10.3399/bjgpopen20X101069,2020-04-09
Infected,PROCESS_OF,Patients,32265182,10.3399/bjgpopen20X101069,2020-04-09
conjunctiva,NEG_LOCATION_OF,Virus,32265182,10.3399/bjgpopen20X101069,2020-04-09
Chloroquine,ISA,Pharmaceutical Preparations,32265180,10.1016/j.jmii.2020.03.022,2020-04-09
Hydroxychloroquine,ISA,Pharmaceutical Preparations,32265180,10.1016/j.jmii.2020.03.022,2020-04-09
Betacoronavirus,PROCESS_OF,Homo sapiens,32265115,10.1016/j.sapharm.2020.03.013,2020-04-09
Capsid,LOCATION_OF,Nucleoproteins,32265115,10.1016/j.sapharm.2020.03.013,2020-04-09
Open Reading Frames,COEXISTS_WITH,Genome,32265115,10.1016/j.sapharm.2020.03.013,2020-04-09
Italy,ISA,Country,32265088,10.1016/j.ijom.2020.03.015,2020-04-09
Spain,ISA,Country,32265088,10.1016/j.ijom.2020.03.015,2020-04-09
Possible,PROCESS_OF,mediterranean,32265088,10.1016/j.ijom.2020.03.015,2020-04-09
Masks,TREATS,Health Personnel,32265065,10.1016/j.ajem.2020.03.036,2020-04-09
Face,LOCATION_OF,Radionuclide Imaging,32265065,10.1016/j.ajem.2020.03.036,2020-04-09
Disease,CAUSES,Evaluation,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
LIN7B gene,PART_OF,Patients,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
Virus Diseases,ISA,Symptoms,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
"Respiratory Distress Syndrome, Adult",COMPLICATES,Pneumonia,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
"Respiratory Distress Syndrome, Adult",COMPLICATES,Pneumonia,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
Patient identification,PREVENTS,"Infections, Hospital",32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
Caring,PROCESS_OF,Health Personnel,32265008,10.2807/1560-7917.ES.2020.25.13.2000317,2020-04-09
Trees (plant),LOCATION_OF,DNA Sequence,32265005,10.2807/1560-7917.ES.2020.25.13.2000280,2020-04-09
small size,PROCESS_OF,Households,32265003,10.2807/1560-7917.ES.2020.25.13.2000323,2020-04-09
Coronavirus Infections,ISA,Disease,32264957,10.1186/s40249-020-00650-1,2020-04-09
Intervention regimes,ADMINISTERED_TO,Community,32264908,10.1186/s13014-020-01527-1,2020-04-09
Radiotherapy department,LOCATION_OF,Knowledge acquisition,32264898,10.1186/s13017-020-00307-2,2020-04-09
ACE2 gene,AFFECTS,Renin-angiotensin system,32264667,10.23736/S1973-9087.20.06303-0,2020-04-09
IMPACT gene,ASSOCIATED_WITH,Heparin-induced thrombocytopenia,32264666,10.4274/balkanmedj.galenos.2020.2020.4.43,2020-04-09
Imagery,PROCESS_OF,Persons,32264666,10.4274/balkanmedj.galenos.2020.2020.4.43,2020-04-09
Virus,CAUSES,Disease,32260471,10.3390/diagnostics10040202,2020-04-09
Fatigue,ISA,Symptoms,32260471,10.3390/diagnostics10040202,2020-04-09
Fever,ISA,Symptoms,32260471,10.3390/diagnostics10040202,2020-04-09
Dry cough,ISA,Symptoms,32260471,10.3390/diagnostics10040202,2020-04-09
Collagen Diseases,NEG_PREDISPOSES,Severe course,32260471,10.3390/diagnostics10040202,2020-04-09
Rheumatism,AFFECTS,Patients,32260471,10.3390/diagnostics10040202,2020-04-09
Antirheumatic Agents,PREVENTS,Disease Progression,32260471,10.3390/diagnostics10040202,2020-04-09
Rheumatism,PROCESS_OF,Patients,32260471,10.3390/diagnostics10040202,2020-04-09
Virus Diseases,PROCESS_OF,Patients,32260471,10.3390/diagnostics10040202,2020-04-09
Assay,USES,IVD gene,32260436,10.3390/s20072033,2020-04-09
Assay,METHOD_OF,Diagnosis,32260436,10.3390/s20072033,2020-04-09
Immunoglobulin G,TREATS,Persons,32260436,10.3390/s20072033,2020-04-09
Immunoglobulin M,TREATS,Persons,32260436,10.3390/s20072033,2020-04-09
Assay,USES,IVD gene,32260436,10.3390/s20072033,2020-04-09
Assay,USES,IVD gene,32260436,10.3390/s20072033,2020-04-09
Cardiovascular Diseases,CAUSES,Cessation of life,32260155,10.3390/ma13071668,2020-04-09
Sleep Apnea Syndromes,CAUSES(SPEC),Cessation of life,32260155,10.3390/ma13071668,2020-04-09
Sleep Apnea Syndromes,ISA,Cardiovascular Diseases,32260155,10.3390/ma13071668,2020-04-09
Illness (finding),CAUSES,Cessation of life,32260155,10.3390/ma13071668,2020-04-09
Symptoms,NEG_PROCESS_OF,Persons,32259853,10.1055/a-1152-2341,2020-04-08
"Respiratory Distress Syndrome, Adult",CAUSES,Cessation of life,32259853,10.1055/a-1152-2341,2020-04-08
Syndrome,PROCESS_OF,Persons,32259853,10.1055/a-1152-2341,2020-04-08
Coronaviridae,PROCESS_OF,Family,32259628,10.1016/j.jaip.2020.04.001,2020-04-08
baricitinib,DISRUPTS,Virus Assembly,32259546,10.1016/j.jhin.2020.03.036,2020-04-08
Vaccines,INTERACTS_WITH,WASF1 gene,32259477,10.1016/j.chom.2020.03.023,2020-04-08
Virus,PROCESS_OF,Population Group,32259477,10.1016/j.chom.2020.03.023,2020-04-08
Disease,PROCESS_OF,Homo sapiens,32259403,10.1002/ppul.24762,2020-04-08
Intestines,PART_OF,Lung,32259403,10.1002/ppul.24762,2020-04-08
Trachea,PART_OF,Lung,32259403,10.1002/ppul.24762,2020-04-08
Fever,ISA,Symptoms,32259394,10.15252/emmm.202012463,2020-04-08
Symptoms,PROCESS_OF,Child,32259394,10.15252/emmm.202012463,2020-04-08
Coronavirus Infections,PROCESS_OF,Child,32259394,10.15252/emmm.202012463,2020-04-08
Hand,LOCATION_OF,FATE1 gene,32259373,10.1002/cncy.22281,2020-04-08
Disease,PROCESS_OF,Woman,32259313,10.1002/phar.2398,2020-04-08
Coronavirus Infections,ISA,Disease,32259313,10.1002/phar.2398,2020-04-08
Coronavirus Infections,ISA,Disease,32259313,10.1002/phar.2398,2020-04-08
Coronavirus Infections,PROCESS_OF(SPEC),Woman,32259313,10.1002/phar.2398,2020-04-08
Coronavirus Infections,ISA,Disease,32259313,10.1002/phar.2398,2020-04-08
Operative Surgical Procedures,TREATS,Patients,32259313,10.1002/phar.2398,2020-04-08
Coronavirus Infections,ISA,Disease,32259313,10.1002/phar.2398,2020-04-08
Critical Illness,PROCESS_OF,Patients,32259288,10.1111/anae.15076,2020-04-08
consideration,PROCESS_OF,Patients,32259288,10.1111/anae.15076,2020-04-08
consideration,PROCESS_OF,Patients,32259288,10.1111/anae.15076,2020-04-08
Severe Acute Respiratory Syndrome,CAUSES,Complication,32259279,10.1111/aogs.13867,2020-04-08
Pandemics,CAUSES,Severe Acute Respiratory Syndrome,32259279,10.1111/aogs.13867,2020-04-08
Chronic pain,PROCESS_OF,Patients,32259279,10.1111/aogs.13867,2020-04-08
Comorbidity,PROCESS_OF,Old age,32259279,10.1111/aogs.13867,2020-04-08
Chronic pain,PROCESS_OF,Patients,32259279,10.1111/aogs.13867,2020-04-08
Pain,PROCESS_OF,Patients,32259279,10.1111/aogs.13867,2020-04-08
Pain,PROCESS_OF,Physicians,32259279,10.1111/aogs.13867,2020-04-08
Comorbidity,COEXISTS_WITH,Chronic pain,32259197,10.7326/M20-1260,2020-04-08
Chronic pain,ISA,Disability,32259197,10.7326/M20-1260,2020-04-08
Chronic pain,PROCESS_OF(SPEC),World,32259197,10.7326/M20-1260,2020-04-08
Disability,PROCESS_OF,World,32259197,10.7326/M20-1260,2020-04-08
Physicians,TREATS,Patients,32259197,10.7326/M20-1260,2020-04-08
Pain,PROCESS_OF,Practitioner,32259197,10.7326/M20-1260,2020-04-08
Telemedicine,PREVENTS,Sequela of disorder,32259197,10.7326/M20-1260,2020-04-08
Infantile Neuroaxonal Dystrophy,PROCESS_OF,Staff,32259197,10.7326/M20-1260,2020-04-08
Sequela of disorder,PROCESS_OF,Health Personnel,32259197,10.7326/M20-1260,2020-04-08
Decision,PROCESS_OF,Persons,32259197,10.7326/M20-1260,2020-04-08
Decision,PROCESS_OF,Persons,32259011,10.1055/a-1044-7237,2020-04-08
Italy,ISA,European country,32258351,10.1016/j.onehlt.2020.100128,2020-04-08
"Immunoglobulins, Intravenous",ADMINISTERED_TO,Patients,32257774,10.24171/j.phrp.2020.11.2.05,2020-04-08
Risk Assessment,COEXISTS_WITH,disease prevention,32257730,10.7759/cureus.7504,2020-04-08
Coronavirus Infections,ISA,Disease,32257554,10.14336/AD.2020.0301,2020-04-08
Disease,PROCESS_OF,Population Group,32257554,10.14336/AD.2020.0301,2020-04-08
Coronavirus Infections,ISA,Disease,32257554,10.14336/AD.2020.0301,2020-04-08
Coronavirus Infections,PROCESS_OF(SPEC),Population Group,32257554,10.14336/AD.2020.0301,2020-04-08
Disease,PROCESS_OF,Population Group,32257554,10.14336/AD.2020.0301,2020-04-08
Coronavirus Infections,ISA,Disease,32257554,10.14336/AD.2020.0301,2020-04-08
Coronavirus Infections,PROCESS_OF(SPEC),Population Group,32257554,10.14336/AD.2020.0301,2020-04-08
Metric,TREATS,Disease,32257554,10.14336/AD.2020.0301,2020-04-08
Metric,TREATS(SPEC),Coronavirus Infections,32257554,10.14336/AD.2020.0301,2020-04-08
Pneumonia,PROCESS_OF,Patients,32257431,10.1016/j.jare.2020.03.005,2020-04-08
Pneumonia,ISA,Disease,32257431,10.1016/j.jare.2020.03.005,2020-04-08
Pneumonia,PROCESS_OF,Patients,32257431,10.1016/j.jare.2020.03.005,2020-04-08
Transplantation,USES,,32257431,10.1016/j.jare.2020.03.005,2020-04-08
Transplantation,USES,,32257431,10.1016/j.jare.2020.03.005,2020-04-08
Virus,PROCESS_OF,Chiroptera,32257174,10.7189/jogh.10.011002,2020-04-08
SARS coronavirus,ISA,Genus: Coronavirus,32257174,10.7189/jogh.10.011002,2020-04-08
Adrenal Cortex Hormones,AFFECTS,Symptoms,32256705,10.3332/ecancer.2020.1022,2020-04-08
"Anti-Inflammatory Agents, Non-Steroidal",AFFECTS,Symptoms,32256705,10.3332/ecancer.2020.1022,2020-04-08
Symptoms,PROCESS_OF,Patients,32256705,10.3332/ecancer.2020.1022,2020-04-08
Clinician,TREATS,Patients,32256705,10.3332/ecancer.2020.1022,2020-04-08
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32256705,10.3332/ecancer.2020.1022,2020-04-08
Adrenal Cortex Hormones,TREATS,Patients,32256705,10.3332/ecancer.2020.1022,2020-04-08
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32256705,10.3332/ecancer.2020.1022,2020-04-08
Pharmaceutical Preparations,TREATS,Respiration Disorders,32256547,10.26633/RPSP.2020.40,2020-04-08
Therapeutic immunosuppression,TREATS,Respiration Disorders,32256547,10.26633/RPSP.2020.40,2020-04-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
Steroids,INTERACTS_WITH,Pharmaceutical Preparations,32256547,10.26633/RPSP.2020.40,2020-04-08
Tacrolimus,INHIBITS,Interleukin-1,32256547,10.26633/RPSP.2020.40,2020-04-08
MYCOPHENOLATE,INHIBITS,Interleukin-1,32256547,10.26633/RPSP.2020.40,2020-04-08
CTLA-4-Ig,INHIBITS,Interleukin-1,32256547,10.26633/RPSP.2020.40,2020-04-08
"Human B-Lymphocyte Antigen CD20, human",INHIBITS,Interleukin-1,32256547,10.26633/RPSP.2020.40,2020-04-08
"Anti-Inflammatory Agents, Non-Steroidal",NEG_INHIBITS,Tumor Necrosis Factors,32256547,10.26633/RPSP.2020.40,2020-04-08
"Anti-Inflammatory Agents, Non-Steroidal",TREATS,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
Pharmaceutical Preparations,TREATS,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
Pharmaceutical Preparations,TREATS(INFER),unwellness,32256547,10.26633/RPSP.2020.40,2020-04-08
Genus: Coronavirus,PROCESS_OF,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
Coronavirus Infections,PROCESS_OF,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
unwellness,PROCESS_OF,Patients,32256547,10.26633/RPSP.2020.40,2020-04-08
Methotrexate,TREATS,Autoimmune Diseases,32256547,10.26633/RPSP.2020.40,2020-04-08
Coronavirus Infections,ISA,Disease,32255735,10.1177/0194599820917914,2020-04-08
Infected,PROCESS_OF,Persons,32255735,10.1177/0194599820917914,2020-04-08
inhibitors,TREATS,Dermatologic disorders,32255507,10.1111/jgs.16472,2020-04-08
Immunologic Adjuvants,PREDISPOSES,Disease,32255507,10.1111/jgs.16472,2020-04-08
Severe disorder,PROCESS_OF,Patients,32255507,10.1111/jgs.16472,2020-04-08
Immunologic Adjuvants,TREATS,Dermatologic disorders,32255507,10.1111/jgs.16472,2020-04-08
Symptoms,PROCESS_OF,Patients,32255507,10.1111/jgs.16472,2020-04-08
Virus,PROCESS_OF,Elderly (population group),32255491,10.1042/CS20200363,2020-04-08
Disease,PROCESS_OF,Elderly (population group),32255491,10.1042/CS20200363,2020-04-08
Diabetes,PROCESS_OF,Adult,32255491,10.1042/CS20200363,2020-04-08
Hypertensive disease,PROCESS_OF,Adult,32255491,10.1042/CS20200363,2020-04-08
Chronic Kidney Diseases,PROCESS_OF,Adult,32255491,10.1042/CS20200363,2020-04-08
Pharmaceutical Preparations,STIMULATES,angiotensin converting enzyme 2,32255491,10.1042/CS20200363,2020-04-08
Pharmaceutical Preparations,AFFECTS,Infection,32255491,10.1042/CS20200363,2020-04-08
angiotensin converting enzyme 2,INTERACTS_WITH,angiotensin I (1-7),32255489,10.1093/cid/ciaa394,2020-04-08
Clinical Trials,USES,Dose Regimen,32255438,10.5867/medwave.2020.03.7867,2020-04-08
Decision,PROCESS_OF,Maker (occupation),32255413,10.1148/radiol.2020201365,2020-04-08
Malaise,PROCESS_OF,Health Personnel,32255382,10.1513/AnnalsATS.202003-225OC,2020-04-08
Respiration Disorders,PREDISPOSES,Disease Progression,32255382,10.1513/AnnalsATS.202003-225OC,2020-04-08
Plain chest X-ray,DIAGNOSES,Lung diseases,32255382,10.1513/AnnalsATS.202003-225OC,2020-04-08
Disease,PROCESS_OF,Community,32255382,10.1513/AnnalsATS.202003-225OC,2020-04-08
Cardiovascular,LOCATION_OF,Co-morbid conditions,32255222,10.1111/jonm.13014,2020-04-08
Troponin,PART_OF,Heart,32255222,10.1111/jonm.13014,2020-04-08
Acute infectious disease,COEXISTS_WITH,Myocardial Infarction,32255222,10.1111/jonm.13014,2020-04-08
Patient Discharge,USES,CTN,32255222,10.1111/jonm.13014,2020-04-08
Occupational Stress,PROCESS_OF,Nurses,32255183,10.1093/cid/ciaa390,2020-04-08
Occupational Stress,PROCESS_OF,Nurses,32255183,10.1093/cid/ciaa390,2020-04-08
mental health,PROCESS_OF,Nurses,32255183,10.1093/cid/ciaa390,2020-04-08
Stress,PROCESS_OF,Nurses,32255183,10.1093/cid/ciaa390,2020-04-08
Coronavirus Infections,ISA,Disease,32254064,10.1172/JCI138745,2020-04-08
Coronavirus Infections,ISA,Disease,32254064,10.1172/JCI138745,2020-04-08
Asymptomatic Infections,PROCESS_OF,Adult,32254064,10.1172/JCI138745,2020-04-08
Asymptomatic Infections,PROCESS_OF,Child,32254064,10.1172/JCI138745,2020-04-08
Coronavirus Infections,ISA,Disease,32254064,10.1172/JCI138745,2020-04-08
Passive Method,USES,Antibodies,32253942,10.1080/02713683.2020.1752737,2020-04-08
Conscious,PROCESS_OF,teams,32253890,10.3760/cma.j.cn112150-20200328-00461,2020-04-08
Communicable Diseases,PROCESS_OF,Surgeon,32253890,10.3760/cma.j.cn112150-20200328-00461,2020-04-08
Challenge,TREATS,Diastasis,32253888,10.23812/Editorial-Conti-3,2020-04-08
"Education, Continuing",METHOD_OF,preventive medicine specialty,32253888,10.23812/Editorial-Conti-3,2020-04-08
Preventive Health Programs,TREATS,Health Personnel,32253888,10.23812/Editorial-Conti-3,2020-04-08
Virus,CAUSES,"Respiratory Distress Syndrome, Adult",32253799,10.1111/dth.13380,2020-04-08
Virus Diseases,AFFECTS,Male population group,32253799,10.1111/dth.13380,2020-04-08
Steroid hormone,AFFECTS,Sex Chromosomes,32253799,10.1111/dth.13380,2020-04-08
Present,PROCESS_OF,Woman,32253799,10.1111/dth.13380,2020-04-08
Inflammation,PROCESS_OF,Male population group,32253799,10.1111/dth.13380,2020-04-08
Immune Cell,PRODUCES,,32253799,10.1111/dth.13380,2020-04-08
Virus Diseases,NEG_AFFECTS,Immune response,32253799,10.1111/dth.13380,2020-04-08
Woman,LOCATION_OF,,32253799,10.1111/dth.13380,2020-04-08
,INTERACTS_WITH,Immune Cell,32253799,10.1111/dth.13380,2020-04-08
Genes,INTERACTS_WITH,Immune Cell,32253799,10.1111/dth.13380,2020-04-08
TRANSCRIPTION FACTOR,ASSOCIATED_WITH,virus pathogenesis,32253799,10.1111/dth.13380,2020-04-08
FOXP3 gene,ASSOCIATED_WITH,virus pathogenesis,32253799,10.1111/dth.13380,2020-04-08
Woman,LOCATION_OF,,32253799,10.1111/dth.13380,2020-04-08
Woman,LOCATION_OF,CXCR3 gene,32253799,10.1111/dth.13380,2020-04-08
Woman,LOCATION_OF,"CD40 Ligand, human",32253799,10.1111/dth.13380,2020-04-08
Vaccines,TREATS,Virus,32253799,10.1111/dth.13380,2020-04-08
Pivot,ISA,Entity,32253771,10.1002/ca.23601,2020-04-08
Medical procedure,TREATS,student,32253759,10.1002/jmv.25801,2020-04-08
Surgical department,LOCATION_OF,Teaching Methods,32253759,10.1002/jmv.25801,2020-04-08
tocilizumab,TREATS,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Infected,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Tocilizumab therapy,TREATS,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Tocilizumab therapy,TREATS(INFER),Infected,32253535,10.1007/s00405-020-05965-1,2020-04-08
15-19,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Tocilizumab therapy,TREATS,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Tocilizumab therapy,TREATS(INFER),15-19,32253535,10.1007/s00405-020-05965-1,2020-04-08
Methylprednisolone,TREATS,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Critical Illness,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Cessation of life,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Elevated C-reactive protein,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
tocilizumab,ADMINISTERED_TO,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Serum,LOCATION_OF,Interleukin-6,32253535,10.1007/s00405-020-05965-1,2020-04-08
Tocilizumab therapy,TREATS,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
tocilizumab,STIMULATES,Interleukin-6,32253535,10.1007/s00405-020-05965-1,2020-04-08
Critical Illness,PROCESS_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Interleukin-6,ASSOCIATED_WITH(INFER),Critical Illness,32253535,10.1007/s00405-020-05965-1,2020-04-08
Interleukin-6,PART_OF,Patients,32253535,10.1007/s00405-020-05965-1,2020-04-08
Smell Perception,PROCESS_OF,Patients,32253449,10.1007/s00134-020-06028-z,2020-04-08
Facial Pain,ISA,Symptoms,32253449,10.1007/s00134-020-06028-z,2020-04-08
Nose,LOCATION_OF,Obstruction,32253449,10.1007/s00134-020-06028-z,2020-04-08
Anosmia,PROCESS_OF,Patients,32253449,10.1007/s00134-020-06028-z,2020-04-08
Nose,LOCATION_OF,Obstruction,32253449,10.1007/s00134-020-06028-z,2020-04-08
Smell Perception,AFFECTS,Females,32253449,10.1007/s00134-020-06028-z,2020-04-08
Taste Disorders,ISA,Symptoms,32253449,10.1007/s00134-020-06028-z,2020-04-08
Taste Disorders,PROCESS_OF(SPEC),Patients,32253449,10.1007/s00134-020-06028-z,2020-04-08
Symptoms,PROCESS_OF,Patients,32253449,10.1007/s00134-020-06028-z,2020-04-08
Residency,ISA,Training,32253318,10.1073/pnas.2004168117,2020-04-08
10 - severe,PROCESS_OF,Patients,32253226,10.1126/scitranslmed.abb5883,2020-04-08
Fever,PROCESS_OF,Patients,32253143,10.1016/j.jmii.2020.03.024,2020-04-08
Bat coronavirus,CAUSES,associated disease,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
"Signs and Symptoms, Respiratory",CAUSES,"Respiratory Distress Syndrome, Adult",32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Complication,PROCESS_OF,Patients,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Storm NOS,PROCESS_OF,Patients,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Antimalarials,INTERACTS_WITH,Peptide Hydrolases,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Peptide Hydrolases,AFFECTS,Virus Internalization,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Peptide Hydrolases,PART_OF,lysosomal,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Storm NOS,PROCESS_OF,Cohort,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Collagen Diseases,PROCESS_OF,Patients,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Pharmaceutical Preparations,ADMINISTERED_TO,Patients,32252979,10.1016/j.ciresp.2020.03.001,2020-04-08
Confirmation,PROCESS_OF,Patients,32252845,10.1017/dmp.2020.82,2020-04-08
SARS coronavirus,CAUSES,Respiration Disorders,32252845,10.1017/dmp.2020.82,2020-04-08
Suspected coronavirus infection,PROCESS_OF,Patients,32252845,10.1017/dmp.2020.82,2020-04-08
Coronavirus Infections,PROCESS_OF,hospitalized patients,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
"CD69 protein, human",COEXISTS_WITH,GSKIP gene,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Lung,LOCATION_OF,Lesion,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Both lungs,LOCATION_OF,Multiple lesions,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Ground Glass Opacity,PROCESS_OF,Patients,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Mediastinum,LOCATION_OF,Lymphadenopathy,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Physical Examination,USES,Chest CT,32252591,10.1161/CIRCRESAHA.120.317055,2020-04-08
Coronavirus Infections,ISA,Disease,32252338,10.3390/nu12040988,2020-04-08
Coronavirus Infections,ISA,Disease,32252338,10.3390/nu12040988,2020-04-08
Vitamin supplementation,PREDISPOSES,Respiratory Tract Infections,32252141,10.3345/cep.2020.00493,2020-04-07
Ergocalciferol,PREVENTS,Infection,32252141,10.3345/cep.2020.00493,2020-04-07
Defensins,PREVENTS,Inflammation,32252141,10.3345/cep.2020.00493,2020-04-07
Cathelicidins,PREVENTS,Inflammation,32252141,10.3345/cep.2020.00493,2020-04-07
Vitamin supplementation,PREVENTS,Influenza,32252141,10.3345/cep.2020.00493,2020-04-07
Vitamin D Deficiency,PREDISPOSES,"Respiratory Distress Syndrome, Adult",32252141,10.3345/cep.2020.00493,2020-04-07
Respiratory sample,PART_OF,Tract,32252139,10.3345/cep.2020.00535,2020-04-07
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32252139,10.3345/cep.2020.00535,2020-04-07
Disease,PROCESS_OF,Community,32252092,10.7326/G20-0021,2020-04-07
Cessation of life,ASSOCIATED_WITH,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Cessation of life,ASSOCIATED_WITH(SPEC),Coronavirus Infections,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
"CD69 protein, human",ASSOCIATED_WITH,Symptoms,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Coronavirus Infections,ISA,Disease,32251842,10.1016/j.cmi.2020.03.032,2020-04-07
Critical Illness,PROCESS_OF,Persons,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Laboratory Procedures,USES,PCR test for SARS,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Laboratory Procedures,USES,PCR test for SARS,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
PCR test for SARS,ISA,Laboratory Procedures,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
PCR test for SARS,ISA,Laboratory Procedures,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Asymptomatic,PROCESS_OF,Persons,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Symptoms,PROCESS_OF,Persons,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
follow-up,USES,Duration,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Critical Illness,PROCESS_OF,Persons,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Diarrhea,PROCESS_OF,Patients,32251805,10.1016/j.ijid.2020.03.053,2020-04-07
Critical Illness,PROCESS_OF,Patients,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Hospitals,LOCATION_OF,tomography,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Disease,AFFECTS,Cessation of life,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Hypertensive disease,AFFECTS(SPEC),Cessation of life,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Hypertensive disease,ISA,Disease,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Critical Illness,PROCESS_OF,Patients,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
D-lactate measurement,USES,Indicators,32251798,10.1016/j.ijid.2020.03.065,2020-04-07
Laboratory Infection,PROCESS_OF,Patients,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
Serum,LOCATION_OF,Antibodies,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
Serum,LOCATION_OF,CD40LG wt Allele,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
Detection,TREATS,Coronaviridae,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
CD40LG wt Allele,compared_with,CD40LG wt Allele,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
CD40LG wt Allele,higher_than,CD40LG wt Allele,32251796,10.1016/j.ijid.2020.03.041,2020-04-07
Asymptomatic,PROCESS_OF,Population Group,32251794,10.1016/j.ijid.2020.03.058,2020-04-07
China,ISA,Country,32251791,10.1016/j.ijid.2020.03.062,2020-04-07
Extracorporeal Membrane Oxygenation,TREATS,"Respiratory Distress Syndrome, Adult",32251791,10.1016/j.ijid.2020.03.062,2020-04-07
Extracorporeal Membrane Oxygenation,TREATS,Respiratory Failure,32251791,10.1016/j.ijid.2020.03.062,2020-04-07
Extracorporeal Membrane Oxygenation,TREATS,Patients,32251791,10.1016/j.ijid.2020.03.062,2020-04-07
Extracorporeal Membrane Oxygenation,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32251791,10.1016/j.ijid.2020.03.062,2020-04-07
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32251791,10.1016/j.ijid.2020.03.062,2020-04-07
Seizures,CAUSES,Meningitis,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Unconscious State,COEXISTS_WITH,Seizures,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Unconscious State,COEXISTS_WITH,Vomiting,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Generalized seizures,PROCESS_OF,Transient Population Group,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Specimen Type - Serum,NEG_LOCATION_OF,varicella-zoster immune globulin,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Temporal Lobe,LOCATION_OF,MRI brain procedure,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
CNS symptom,PROCESS_OF,Patients,32251790,10.1016/j.ijid.2020.03.059,2020-04-07
Therapeutic procedure,compared_with,Prophylactic treatment,32251789,10.1016/j.ijid.2020.03.076,2020-04-07
TBATA gene,ASSOCIATED_WITH,Infection,32251768,10.1016/j.antiviral.2020.104787,2020-04-07
TBATA gene,ASSOCIATED_WITH,Communicable Diseases,32251768,10.1016/j.antiviral.2020.104787,2020-04-07
TBATA gene,ASSOCIATED_WITH,Infection,32251768,10.1016/j.antiviral.2020.104787,2020-04-07
Ivermectin,INTERACTS_WITH,"RNA, Viral",32251767,10.1016/j.antiviral.2020.104786,2020-04-07
Ivermectin,TREATS,Homo sapiens,32251767,10.1016/j.antiviral.2020.104786,2020-04-07
Vero Cells,LOCATION_OF,SARS coronavirus,32251731,10.1016/j.ijantimicag.2020.105960,2020-04-07
Infected,PROCESS_OF,Patients,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Drug Repositioning,TREATS,Patients,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Drug Repositioning,TREATS(INFER),Infected,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
host cell surface,LOCATION_OF,Gangliosides,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Pharmaceutical Preparations,INTERACTS_WITH,Gangliosides,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Pharmaceutical Preparations,INTERACTS_WITH,Sialic Acids,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Viral Proteins,COEXISTS_WITH,Chloroquine,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Pharmaceutical Preparations,TREATS,Patients,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Repositioning (procedure),USES,Chloroquine,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Repositioning (procedure),USES,Chloroquine,32251729,10.1016/j.hjc.2020.03.002,2020-04-07
Inflammasomes,PART_OF,NLRP3 gene,32251717,10.1016/j.autrev.2020.102537,2020-04-07
Colchicine,AFFECTS,Complication,32251717,10.1016/j.autrev.2020.102537,2020-04-07
Pneumonia,PROCESS_OF,Patients,32251668,10.1053/j.gastro.2020.03.065,2020-04-07
Immunologic Deficiency Syndromes,COEXISTS_WITH,"Lymphohistiocytosis, Hemophagocytic",32251668,10.1053/j.gastro.2020.03.065,2020-04-07
Elevation procedure,USES,Interleukin-1,32251668,10.1053/j.gastro.2020.03.065,2020-04-07
Macrophage Activation Syndrome,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32251668,10.1053/j.gastro.2020.03.065,2020-04-07
Macrophage Activation Syndrome,COEXISTS_WITH,Pneumonia,32251668,10.1053/j.gastro.2020.03.065,2020-04-07
Gastrointestinal symptom,PROCESS_OF,Persons,32251649,10.1016/j.ajog.2020.03.038,2020-04-07
Gastrointestinal symptom,PROCESS_OF,Patients,32251649,10.1016/j.ajog.2020.03.038,2020-04-07
Gastrointestinal symptom,PROCESS_OF,Patients,32251649,10.1016/j.ajog.2020.03.038,2020-04-07
Patients,LOCATION_OF,Specimen Type - Stool = Fecal,32251649,10.1016/j.ajog.2020.03.038,2020-04-07
Collecting Sample,TREATS,Patients,32251649,10.1016/j.ajog.2020.03.038,2020-04-07
acute care,TREATS,Infected,32251634,10.1016/j.lfs.2020.117627,2020-04-07
acute care,TREATS,Sick person,32251634,10.1016/j.lfs.2020.117627,2020-04-07
Absenteeism,PROCESS_OF,Health Personnel,32251618,10.18433/jpps31002,2020-04-07
Pharmaceutical Preparations,TREATS,Virus,32251546,10.1002/ccd.28910,2020-04-07
Vaccines,TREATS,Virus,32251546,10.1002/ccd.28910,2020-04-07
Pharmaceutical Preparations,TREATS,Patients,32251546,10.1002/ccd.28910,2020-04-07
Malaria,ISA,Disease,32251546,10.1002/ccd.28910,2020-04-07
anatomic valve,PART_OF,Patients,32251543,10.1111/hir.12307,2020-04-07
Structural disorder of heart,PREDISPOSES,Cardiac complication,32251543,10.1111/hir.12307,2020-04-07
Librarians,DIAGNOSES,Coronavirus Infections,32251003,10.1097/CM9.0000000000000839,2020-04-07
Negative,PROCESS_OF,Patients,32251002,10.1097/CM9.0000000000000848,2020-04-07
Lung Transplantation,TREATS,Pulmonary Fibrosis,32251002,10.1097/CM9.0000000000000848,2020-04-07
Pulmonary Fibrosis,COEXISTS_WITH,"Respiratory Distress Syndrome, Adult",32251002,10.1097/CM9.0000000000000848,2020-04-07
Lung Transplantation,ADMINISTERED_TO,Patients,32251002,10.1097/CM9.0000000000000848,2020-04-07
Lung Transplantation,TREATS,patient condition,32251002,10.1097/CM9.0000000000000848,2020-04-07
Ethical Review,COEXISTS_WITH,Rehabilitation therapy,32251002,10.1097/CM9.0000000000000848,2020-04-07
Pulmonary Fibrosis,CAUSES,Respiratory Failure,32251002,10.1097/CM9.0000000000000848,2020-04-07
Respiratory Failure,PROCESS_OF,Patients,32251002,10.1097/CM9.0000000000000848,2020-04-07
Mental disorders,PROCESS_OF,Patients,32250963,10.2196/18961,2020-04-07
Experience,PROCESS_OF,Adult,32250963,10.2196/18961,2020-04-07
Basis,TREATS,patient condition,32250963,10.2196/18961,2020-04-07
Coronavirus Infections,ISA,Disease,32250962,10.2196/18908,2020-04-07
Interested,PROCESS_OF,Population Group,32250962,10.2196/18908,2020-04-07
Interested,PROCESS_OF,Population Group,32250962,10.2196/18908,2020-04-07
Interested,PROCESS_OF,Population Group,32250962,10.2196/18908,2020-04-07
Interested,PROCESS_OF,Population Group,32250962,10.2196/18908,2020-04-07
Prophylactic treatment,COEXISTS_WITH,Consultation,32250961,10.2196/18932,2020-04-07
Coronavirus Infections,ISA,Disease,32250961,10.2196/18932,2020-04-07
Coronavirus Infections,ISA,Disease,32250961,10.2196/18932,2020-04-07
Coronavirus Infections,ISA,Disease,32250961,10.2196/18932,2020-04-07
Coronavirus Infections,ISA,Disease,32250961,10.2196/18932,2020-04-07
Symptoms,PROCESS_OF,Counselee,32250961,10.2196/18932,2020-04-07
Suspicion,PROCESS_OF,Counselee,32250961,10.2196/18932,2020-04-07
Illness (finding),PROCESS_OF,Counselee,32250961,10.2196/18932,2020-04-07
Coronavirus Infections,ISA,Disease,32250961,10.2196/18932,2020-04-07
health information,TREATS,user - individual,32250959,10.2196/18798,2020-04-07
Coronavirus Infections,ISA,Disease,32250959,10.2196/18798,2020-04-07
Study,USES,Instrument - device,32250959,10.2196/18798,2020-04-07
Coronavirus Infections,ISA,Disease,32250959,10.2196/18798,2020-04-07
Disease,PROCESS_OF,Population Group,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,PROCESS_OF(SPEC),Population Group,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Disease,PROCESS_OF,Dentist,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,PROCESS_OF(SPEC),Dentist,32250958,10.2196/18668,2020-04-07
Comprehension,PROCESS_OF,Dentist,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250958,10.2196/18668,2020-04-07
Coronavirus Infections,ISA,Disease,32250751,10.1016/j.jcin.2020.04.001,2020-04-07
Coronavirus Infections,ISA,Disease,32250751,10.1016/j.jcin.2020.04.001,2020-04-07
anatomic valve,PART_OF,Patients,32250505,10.1111/ipd.12653,2020-04-07
Structural disorder of heart,PREDISPOSES,Cardiac complication,32250505,10.1111/ipd.12653,2020-04-07
Coronavirus Infections,ISA,Disease,32250385,10.1001/jama.2020.5394,2020-04-07
Coronavirus Infections,ISA,Disease,32250385,10.1001/jama.2020.5394,2020-04-07
Symptoms,PROCESS_OF,Child,32250385,10.1001/jama.2020.5394,2020-04-07
Comorbidity,PROCESS_OF,Child,32250385,10.1001/jama.2020.5394,2020-04-07
Disease,AFFECTS,Child,32250385,10.1001/jama.2020.5394,2020-04-07
Disease,PROCESS_OF,Child,32250385,10.1001/jama.2020.5394,2020-04-07
Coronavirus Infections,AFFECTS(SPEC),Child,32250385,10.1001/jama.2020.5394,2020-04-07
Coronavirus Infections,ISA,Disease,32250385,10.1001/jama.2020.5394,2020-04-07
Coronavirus Infections,ISA,Disease,32250385,10.1001/jama.2020.5394,2020-04-07
responsibility,PROCESS_OF,teams,32250385,10.1001/jama.2020.5394,2020-04-07
intensive care,TREATS,Social Networks,32250347,10.5543/tkda.2020.97198,2020-04-07
Infected,PROCESS_OF,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Comorbidity,PROCESS_OF,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Mechanical ventilation,ADMINISTERED_TO,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Noninvasive Ventilation,ADMINISTERED_TO,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Inspired fraction of oxygen,PROCESS_OF,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Hypertensive disease,PROCESS_OF,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Critical Illness,PROCESS_OF,Patients,32250347,10.5543/tkda.2020.97198,2020-04-07
Virus,PROCESS_OF,Patients,32250283,10.2196/18844,2020-04-07
Communicable Diseases,PROCESS_OF,Patients,32250283,10.2196/18844,2020-04-07
Cardiovascular Diseases,PROCESS_OF,geriatric patients,32250283,10.2196/18844,2020-04-07
"CD69 protein, human",ADMINISTERED_TO,Patients,32250283,10.2196/18844,2020-04-07
Study,MEASURES,Distance,32250281,10.2196/18887,2020-04-07
Human body,USES,regulatory,32250244,10.7554/eLife.57278,2020-04-07
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32250235,10.1192/bjo.2020.25,2020-04-07
receptor,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32250235,10.1192/bjo.2020.25,2020-04-07
receptor,ASSOCIATED_WITH,Respiratory Failure,32250235,10.1192/bjo.2020.25,2020-04-07
Respiratory Failure,PROCESS_OF,Patients,32250235,10.1192/bjo.2020.25,2020-04-07
Mental disorders,PROCESS_OF,Persons,32250170,10.1080/14712598.2020.1752177,2020-04-07
Upper airway infection,PROCESS_OF,Boys,32249956,10.1002/jmv.25832,2020-04-07
Symptoms,PROCESS_OF,Child,32249956,10.1002/jmv.25832,2020-04-07
ACE2 gene,PART_OF,Homo sapiens,32249952,10.1002/jmv.25834,2020-04-07
ACE2 gene,PART_OF,Homo sapiens,32249952,10.1002/jmv.25834,2020-04-07
ACE2 gene,compared_with,Wild Type,32249952,10.1002/jmv.25834,2020-04-07
ACE2 gene,STIMULATES,Basis,32249952,10.1002/jmv.25834,2020-04-07
Coronavirus Infections,CAUSES,Acute respiratory disease,32249918,10.1093/cid/ciaa352,2020-04-07
Vomiting,PROCESS_OF,Child,32249918,10.1093/cid/ciaa352,2020-04-07
Pneumonia,PROCESS_OF,Child,32249918,10.1093/cid/ciaa352,2020-04-07
Leukocytosis,PROCESS_OF,Child,32249918,10.1093/cid/ciaa352,2020-04-07
Leukopenia,PROCESS_OF,Adult,32249918,10.1093/cid/ciaa352,2020-04-07
Elevated creatine kinase,PROCESS_OF,Child,32249918,10.1093/cid/ciaa352,2020-04-07
Antiviral Therapy,ADMINISTERED_TO,Patients,32249918,10.1093/cid/ciaa352,2020-04-07
Pneumonia,PROCESS_OF,Pregnant Women,32249538,10.1111/bju.15071,2020-04-07
C-reactive protein,compared_with,Alanine Transaminase,32249538,10.1111/bju.15071,2020-04-07
Pneumonia,PROCESS_OF,Patients,32249538,10.1111/bju.15071,2020-04-07
Pneumonia,PROCESS_OF,Mother (person),32249538,10.1111/bju.15071,2020-04-07
Premature Birth,PROCESS_OF,Mother (person),32249538,10.1111/bju.15071,2020-04-07
Confirmation,PROCESS_OF,Mother (person),32249538,10.1111/bju.15071,2020-04-07
Pneumonia,PROCESS_OF,Pregnant Women,32249538,10.1111/bju.15071,2020-04-07
Coronavirus Infections,NEG_PROCESS_OF,"Infant, Newborn",32249538,10.1111/bju.15071,2020-04-07
Pneumonia,PROCESS_OF,Pregnant Women,32249538,10.1111/bju.15071,2020-04-07
IMPACT gene,COEXISTS_WITH,GSKIP gene,32249471,10.1002/uog.22034,2020-04-07
Positive Finding,PROCESS_OF,Patients,32249357,10.1007/s00592-020-01522-8,2020-04-07
Positive Finding,PROCESS_OF,Woman,32249357,10.1007/s00592-020-01522-8,2020-04-07
Placenta,NEG_PART_OF,Pregnant Women,32249357,10.1007/s00592-020-01522-8,2020-04-07
Umbilical Cord Blood,NEG_PART_OF,Pregnant Women,32249357,10.1007/s00592-020-01522-8,2020-04-07
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32249357,10.1007/s00592-020-01522-8,2020-04-07
Obesity,PREDISPOSES,Severe (severity modifier),32249257,10.5582/bst.2020.03058,2020-04-07
Obesity,PROCESS_OF,Patients,32249257,10.5582/bst.2020.03058,2020-04-07
Orthomyxoviridae,PROCESS_OF,Patients,32249257,10.5582/bst.2020.03058,2020-04-07
Complication,AFFECTS,Viral Shedding,32249257,10.5582/bst.2020.03058,2020-04-07
Obesity,PROCESS_OF,Persons,32249257,10.5582/bst.2020.03058,2020-04-07
Obesity,PROCESS_OF,Unmarried person,32249257,10.5582/bst.2020.03058,2020-04-07
Diabetes,COEXISTS_WITH,Obesity,32249257,10.5582/bst.2020.03058,2020-04-07
Medication Management,TREATS,Obesity,32249257,10.5582/bst.2020.03058,2020-04-07
Viral Shedding,COEXISTS_WITH,Obesity,32249257,10.5582/bst.2020.03058,2020-04-07
Normal weight,PROCESS_OF,Persons,32249257,10.5582/bst.2020.03058,2020-04-07
Macrolide Antibiotics,ISA,Pharmaceutical Preparations,32249203,10.1016/j.ebiom.2020.102743,2020-04-07
Macrolide Antibiotics,TREATS,Virus Diseases,32249203,10.1016/j.ebiom.2020.102743,2020-04-07
Prophylactic treatment,USES,Vaccines,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
TLR4 gene,STIMULATES,,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
Enzyme-Linked Immunosorbent Assay,USES,Assay,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
Vaccines,TREATS,Mus,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
Serum,LOCATION_OF,"Antibodies, Viral",32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
Birth,PRODUCES,"Vaccines, Subunit",32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
"Vaccines, Subunit",AUGMENTS,Antibody Formation,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
vaccine delivery,USES,N-nitroso-N-methyl-4-nitroaniline,32249102,10.1016/j.sapharm.2020.03.012,2020-04-07
medication use,COEXISTS_WITH,Coronavirus Infections,32249098,10.1016/j.jviscsurg.2020.03.008,2020-04-07
medication use,PROCESS_OF,Community,32249098,10.1016/j.jviscsurg.2020.03.008,2020-04-07
Emotional support,TREATS,Chronic disease,32249098,10.1016/j.jviscsurg.2020.03.008,2020-04-07
Dispense,USES,Pharmaceutical Preparations,32249098,10.1016/j.jviscsurg.2020.03.008,2020-04-07
"SUPPLY, NOT OTHERWISE SPECIFIED",USES,Equipment,32249098,10.1016/j.jviscsurg.2020.03.008,2020-04-07
Chemoradiotherapy,PREVENTS,Infection,32249089,10.1016/j.eururo.2020.03.030,2020-04-07
Fever,ISA,Symptoms,32249063,10.1016/j.it.2020.03.007,2020-04-07
Serum,LOCATION_OF,Creatinine,32249063,10.1016/j.it.2020.03.007,2020-04-07
Maintenance therapy,ADMINISTERED_TO,Patients,32249063,10.1016/j.it.2020.03.007,2020-04-07
Maintenance therapy,COEXISTS_WITH,Hospitalization,32249063,10.1016/j.it.2020.03.007,2020-04-07
Negative,PROCESS_OF,Patients,32249063,10.1016/j.it.2020.03.007,2020-04-07
Prophylactic treatment,USES,"Antibodies, Neutralizing",32248966,10.1016/j.ijcard.2020.03.063,2020-04-07
Symptoms,PROCESS_OF,Patients,32248387,10.1007/s40291-020-00460-z,2020-04-06
Infected,PROCESS_OF,Patients,32248387,10.1007/s40291-020-00460-z,2020-04-06
Cardiovascular Diseases,AFFECTS,Patients,32248387,10.1007/s40291-020-00460-z,2020-04-06
Cardiovascular Diseases,AFFECTS,Patients,32248387,10.1007/s40291-020-00460-z,2020-04-06
Therapeutic procedure,TREATS,Inflammatory disorder,32248146,10.1183/16000617.0068-2020,2020-04-06
Wound Healing,PRODUCES,Alarmins,32248146,10.1183/16000617.0068-2020,2020-04-06
4-(4-sulfophenylazo)-2-mercuriphenol,INHIBITS,Alarmins,32248146,10.1183/16000617.0068-2020,2020-04-06
4-(4-sulfophenylazo)-2-mercuriphenol,STIMULATES,Alarmins,32248146,10.1183/16000617.0068-2020,2020-04-06
Alarmins,ASSOCIATED_WITH,Chronic inflammatory disorder,32248146,10.1183/16000617.0068-2020,2020-04-06
Pandemics,ISA,Disease Outbreaks,32247931,10.1016/j.tmaid.2020.101660,2020-04-06
Polymerase Chain Reaction,METHOD_OF,Detection,32247898,10.1016/j.earlhumdev.2020.105026,2020-04-06
Hypertensive disease,PROCESS_OF,Woman,32247898,10.1016/j.earlhumdev.2020.105026,2020-04-06
Isolation procedure,TREATS,Patients,32247898,10.1016/j.earlhumdev.2020.105026,2020-04-06
Readiness,PROCESS_OF,Population Group,32247898,10.1016/j.earlhumdev.2020.105026,2020-04-06
Lung,LOCATION_OF,Ground Glass Opacity,32247680,10.1016/j.sapharm.2020.03.017,2020-04-06
Health belief model,TREATS,Uncertainty,32247631,10.1016/j.kint.2020.03.005,2020-04-06
Kidney Diseases,PROCESS_OF,Patients,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
"Kidney Failure, Acute",OCCURS_IN,Patients,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
Cessation of life,PROCESS_OF,Patients,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
Hospitals,LOCATION_OF,Prospective Cohort Study,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
Tertiary Care Centers,LOCATION_OF,Prospective Cohort Study,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
Proteinuria,PROCESS_OF,Patients,32247326,10.1016/S1473-3099(20)30230-9,2020-04-06
Communicable Diseases,PROCESS_OF,Persons,32247320,10.1016/S0140-6736(20)30744-3,2020-04-06
Angiotensin-Converting Enzyme Inhibitors,TREATS,Coronavirus Infections,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Chloroquine,TREATS,Coronavirus Infections,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Comorbidity,PROCESS_OF,Patients,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Hydroxychloroquine,TREATS,Coronavirus Infections,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Ibuprofen,TREATS,Patients,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Ibuprofen,TREATS,Coronavirus Infections,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Ibuprofen,TREATS(INFER),Comorbidity,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Angiotensin II receptor antagonist,TREATS,Coronavirus Infections,32247212,10.1016/j.dsx.2020.03.013,2020-04-05
Cardiovascular Diseases,PROCESS_OF,Patients,32247211,10.1016/j.dsx.2020.03.011,2020-04-05
Cardiovascular finding,PROCESS_OF,Patients,32247211,10.1016/j.dsx.2020.03.011,2020-04-05
IMPACT gene,AFFECTS,Heart,32247211,10.1016/j.dsx.2020.03.011,2020-04-05
Chloroquine,COEXISTS_WITH,Pharmaceutical Preparations,32247200,10.1016/j.nepr.2020.102775,2020-04-05
Pharmaceutical Preparations,TREATS,Patients,32247200,10.1016/j.nepr.2020.102775,2020-04-05
Pharmaceutical Preparations,TREATS(INFER),At risk of disease,32247200,10.1016/j.nepr.2020.102775,2020-04-05
Hydroxychloroquine,COEXISTS_WITH,Pharmaceutical Preparations,32247200,10.1016/j.nepr.2020.102775,2020-04-05
At risk of disease,COEXISTS_WITH,Disease,32247200,10.1016/j.nepr.2020.102775,2020-04-05
At risk of disease,PROCESS_OF,Patients,32247200,10.1016/j.nepr.2020.102775,2020-04-05
Hydroxychloroquine,TREATS,Diabetes,32247200,10.1016/j.nepr.2020.102775,2020-04-05
Malignant Female Reproductive System Neoplasm,PROCESS_OF,Patients,32247056,10.1016/j.jpainsymman.2020.03.026,2020-04-05
Surgical Management,TREATS,Patients,32247056,10.1016/j.jpainsymman.2020.03.026,2020-04-05
ovarian,LOCATION_OF,advanced cancer,32247056,10.1016/j.jpainsymman.2020.03.026,2020-04-05
Malignant Neoplasms,PROCESS_OF,Patients,32247056,10.1016/j.jpainsymman.2020.03.026,2020-04-05
Palliative Care,TREATS,Uncertainty,32247050,10.1016/j.ijid.2020.03.071,2020-04-05
Comorbidity,PROCESS_OF,Patients,32247013,10.1016/j.hrthm.2020.03.028,2020-04-05
Vaccinia Vaccine,TREATS,Disease Progression,32247013,10.1016/j.hrthm.2020.03.028,2020-04-05
Vaccinia Vaccine,TREATS,Infantile Neuroaxonal Dystrophy,32247013,10.1016/j.hrthm.2020.03.028,2020-04-05
Comorbidity,PROCESS_OF,Patients,32246905,10.1016/S1473-3099(20)30229-2,2020-04-05
Masks,PREVENTS,Laboratory Infection,32246849,10.1111/anae.15071,2020-04-05
Masks,compared_with,Mechanical Ventilator,32246849,10.1111/anae.15071,2020-04-05
Mechanical Ventilator,PREVENTS,Laboratory Infection,32246849,10.1111/anae.15071,2020-04-05
Coronavirus Infections,ISA,Disease,32246849,10.1111/anae.15071,2020-04-05
Coronavirus Infections,ISA,Disease,32246849,10.1111/anae.15071,2020-04-05
Masks,compared_with,Mechanical Ventilator,32246849,10.1111/anae.15071,2020-04-05
Masks,compared_with,Mechanical Ventilator,32246849,10.1111/anae.15071,2020-04-05
Coronavirus Infections,PROCESS_OF,Health Personnel,32246849,10.1111/anae.15071,2020-04-05
Artificial Airways,TREATS,Patients,32246845,10.15252/embj.20105114,2020-04-05
Artificial Airways,TREATS(INFER),Infected,32246845,10.15252/embj.20105114,2020-04-05
Infected,PROCESS_OF,Patients,32246845,10.15252/embj.20105114,2020-04-05
Hoods,USES,Equipment,32246845,10.15252/embj.20105114,2020-04-05
Cells,LOCATION_OF,TMPRSS2 gene,32246838,10.1111/anae.15072,2020-04-05
Cells,LOCATION_OF,ACE2 gene,32246838,10.1111/anae.15072,2020-04-05
Body tissue,LOCATION_OF,TMPRSS2 gene,32246838,10.1111/anae.15072,2020-04-05
Biochemical Pathway,AFFECTS,Guanosine Triphosphate Phosphohydrolases,32246838,10.1111/anae.15072,2020-04-05
Health Services,TREATS,Readiness,32246834,10.1002/cpt.1844,2020-04-05
Hospitals,LOCATION_OF,Training,32246834,10.1002/cpt.1844,2020-04-05
intensive care unit,LOCATION_OF,Training,32246834,10.1002/cpt.1844,2020-04-05
Interferons,ISA,Antiviral Agents,32246822,10.1093/clinchem/hvaa091,2020-04-05
Ribavirin,ISA,Antiviral Agents,32246822,10.1093/clinchem/hvaa091,2020-04-05
RNA-Directed RNA Polymerase,PART_OF,Virus,32246822,10.1093/clinchem/hvaa091,2020-04-05
lopinavir / Ritonavir,ISA,Antiviral Agents,32246822,10.1093/clinchem/hvaa091,2020-04-05
favipiravir,TREATS,Influenza,32246822,10.1093/clinchem/hvaa091,2020-04-05
Reverse Transcriptase Polymerase Chain Reaction,METHOD_OF,Detection,32246819,10.12659/MSM.923885,2020-04-05
Early Diagnosis,USES,Basis,32246787,10.1111/jsr.13052,2020-04-05
High Resolution Computed Tomography,ADMINISTERED_TO,Patients,32246787,10.1111/jsr.13052,2020-04-05
Confirmation,PROCESS_OF,Patients,32246787,10.1111/jsr.13052,2020-04-05
pulmonary involvement,PROCESS_OF,Patients,32246787,10.1111/jsr.13052,2020-04-05
Anticoagulants,TREATS,Patients,32246280,10.1007/s00784-020-03267-8,2020-04-05
Anticoagulants,TREATS(INFER),D-dimer above reference range,32246280,10.1007/s00784-020-03267-8,2020-04-05
D-dimer above reference range,PROCESS_OF,Patients,32246280,10.1007/s00784-020-03267-8,2020-04-05
Critical Illness,PROCESS_OF,Patients,32245885,10.1126/sciimmunol.abb8618,2020-04-05
intensive care unit,LOCATION_OF,Administration occupational activities,32245885,10.1126/sciimmunol.abb8618,2020-04-05
Malignant neoplasm of lung,PROCESS_OF,Patients,32245885,10.1126/sciimmunol.abb8618,2020-04-05
Malignant neoplasm of lung,PROCESS_OF,Patients,32245885,10.1126/sciimmunol.abb8618,2020-04-05
Respiratory sample,PART_OF,Tract,32245814,10.1073/pnas.2004064117,2020-04-05
Laboratory Procedures,DIAGNOSES,Severe Acute Respiratory Syndrome,32245814,10.1073/pnas.2004064117,2020-04-05
Assay,DIAGNOSES(SPEC),Severe Acute Respiratory Syndrome,32245814,10.1073/pnas.2004064117,2020-04-05
Assay,ISA,Laboratory Procedures,32245814,10.1073/pnas.2004064117,2020-04-05
Ventilator - respiratory equipment,TREATS,Patients,32245784,10.1126/science.abb7269,2020-04-05
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32245754,10.1136/postgradmedj-2020-137781,2020-04-05
Program,TREATS,Pneumonia,32245396,10.1186/s40779-020-00245-9,2020-04-05
Pharmaceutical Preparations,TREATS,Patients,32245396,10.1186/s40779-020-00245-9,2020-04-05
Department,LOCATION_OF,Hematologic Tests,32245346,10.1080/08959420.2020.1750543,2020-04-05
skilled nursing facility,LOCATION_OF,Management procedure,32245264,10.3390/ph13030051,2020-04-05
Pharmaceutical Preparations,TREATS,Amebiasis,32245157,10.3390/healthcare8010064,2020-04-05
Emetine,TREATS,Amebiasis,32245157,10.3390/healthcare8010064,2020-04-05
Analog,TREATS,Amebiasis,32245157,10.3390/healthcare8010064,2020-04-05
IPECAC ALKALOIDS,TREATS,Amebiasis,32245157,10.3390/healthcare8010064,2020-04-05
Virus,CAUSES,Disease,32244852,10.3390/jcm9030841,2020-04-05
Smoking,PROCESS_OF,Woman,32244841,10.3390/diagnostics10040198,2020-04-05
Evaluation,PREVENTS,Infection,32244841,10.3390/diagnostics10040198,2020-04-05
Epidemic,ISA,Disease Outbreaks,32244776,10.3390/brainsci10040207,2020-04-05
Analysis,USES,Regulators (device),32244776,10.3390/brainsci10040207,2020-04-05
other medicated shampoos in ATC,INHIBITS,receptor,32244776,10.3390/brainsci10040207,2020-04-05
High Level,PROCESS_OF,Participant,32244425,10.3390/ijerph17072365,2020-04-05
Mean score,PROCESS_OF,Participant,32244425,10.3390/ijerph17072365,2020-04-05
Chest,LOCATION_OF,Distress,32244415,10.3390/jcm9040965,2020-04-05
Eye,LOCATION_OF,Coronavirus Infections,32244261,10.3760/cma.j.cn112338-20200303-00242,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Virus Diseases,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Upper Respiratory Infections,COEXISTS_WITH,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Upper Respiratory Infections,COEXISTS_WITH(SPEC),Coronavirus Infections,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Lower respiratory tract infection,AFFECTS,Pneumonia,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Lower respiratory tract infection,AFFECTS,Pneumonia,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Disease,AFFECTS,Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,AFFECTS(SPEC),Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Disease,PROCESS_OF,Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,PROCESS_OF(SPEC),Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Vertical Disease Transmission,NEG_ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Vertical Disease Transmission,NEG_PROCESS_OF(SPEC),Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Disease,AFFECTS,Immune response,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,AFFECTS(SPEC),Immune response,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Disease,AFFECTS,Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,AFFECTS(SPEC),Pregnant Women,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Coronavirus Infections,ISA,Disease,32244059,10.1016/j.hrthm.2020.03.024,2020-04-04
Long QT Syndrome,ISA,Syndrome,32244041,10.1016/j.micpath.2020.104177,2020-04-04
Long QT Syndrome,PROCESS_OF(SPEC),Patients,32244041,10.1016/j.micpath.2020.104177,2020-04-04
Syndrome,PROCESS_OF,Patients,32244041,10.1016/j.micpath.2020.104177,2020-04-04
Syndrome,PROCESS_OF,Patients,32244041,10.1016/j.micpath.2020.104177,2020-04-04
Coronavirus Infections,PROCESS_OF,Family,32243945,10.1016/j.chest.2020.03.039,2020-04-04
SARS coronavirus,COEXISTS_WITH,Virus,32243945,10.1016/j.chest.2020.03.039,2020-04-04
Antibiotics,NEG_AFFECTS,Virion,32243945,10.1016/j.chest.2020.03.039,2020-04-04
Critical Illness,PROCESS_OF,Patients,32243911,10.1016/j.medmal.2020.03.007,2020-04-04
Supportive care,ADMINISTERED_TO,Patients,32243911,10.1016/j.medmal.2020.03.007,2020-04-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32243911,10.1016/j.medmal.2020.03.007,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,High Grade Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Lung,LOCATION_OF,Lesion,32243729,10.1002/ppul.24763,2020-04-04
Movement,PROCESS_OF,Population Group,32243697,10.1111/ajt.15896,2020-04-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Child,32243697,10.1111/ajt.15896,2020-04-04
Throat swab sample,PART_OF,Child,32243697,10.1111/ajt.15896,2020-04-04
Symptoms,PROCESS_OF,Patients,32243678,10.1002/alr.22577,2020-04-04
Sneezing,COEXISTS_WITH,Present,32243677,10.1111/ajt.15904,2020-04-04
Sneezing,PROCESS_OF,Outpatients,32243677,10.1111/ajt.15904,2020-04-04
BARRIER,USES,Surgical face mask,32243677,10.1111/ajt.15904,2020-04-04
Disease,PROCESS_OF,Outpatients,32243677,10.1111/ajt.15904,2020-04-04
"Surgical drill, device (physical object)",TREATS,Disease,32243677,10.1111/ajt.15904,2020-04-04
contextual factors,PROCESS_OF,Outpatients,32243677,10.1111/ajt.15904,2020-04-04
Instrument - device,compared_with,"Surgical drill, device (physical object)",32243677,10.1111/ajt.15904,2020-04-04
Instrument - device,lower_than,"Surgical drill, device (physical object)",32243677,10.1111/ajt.15904,2020-04-04
Italy,ISA,Country,32243673,10.1111/ajt.15901,2020-04-04
Infected,PROCESS_OF,Patients,32243673,10.1111/ajt.15901,2020-04-04
Infected,PROCESS_OF,Patients,32243673,10.1111/ajt.15901,2020-04-04
Cessation of life,PROCESS_OF,Donor person,32243673,10.1111/ajt.15901,2020-04-04
Transplantation,TREATS,Donor person,32243673,10.1111/ajt.15901,2020-04-04
Coronavirus Infections,PROCESS_OF,Population Group,32243672,10.1111/ajt.15902,2020-04-04
Adrenal Cortex Hormones,TREATS,Patients,32243672,10.1111/ajt.15902,2020-04-04
risk factors,PROCESS_OF,Cancer Patient,32243607,10.1002/jmv.25825,2020-04-04
Cancer Patient,LOCATION_OF,IMPACT gene,32243607,10.1002/jmv.25825,2020-04-04
Malignant Neoplasms,PROCESS_OF,Population Group,32243607,10.1002/jmv.25825,2020-04-04
consideration,PROCESS_OF,Population Group,32243607,10.1002/jmv.25825,2020-04-04
"Chemotherapy, Adjuvant",TREATS,Cancer Patient,32243607,10.1002/jmv.25825,2020-04-04
"Chemotherapy, Adjuvant",TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score A,32243607,10.1002/jmv.25825,2020-04-04
Elective Surgical Procedures,TREATS,Cancer Patient,32243607,10.1002/jmv.25825,2020-04-04
Elective Surgical Procedures,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score A,32243607,10.1002/jmv.25825,2020-04-04
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Cancer Patient,32243607,10.1002/jmv.25825,2020-04-04
Gastrointestinal symptom,PROCESS_OF,Patients,32243599,10.1002/jmv.25827,2020-04-04
Patients,LOCATION_OF,Urine - SpecimenType,32243599,10.1002/jmv.25827,2020-04-04
Quarantine,ISA,Interventional procedure,32243317,10.1097/MEJ.0000000000000701,2020-04-04
Infected,PROCESS_OF,Persons,32243317,10.1097/MEJ.0000000000000701,2020-04-04
Infection,ISA,Disease,32243317,10.1097/MEJ.0000000000000701,2020-04-04
Coronavirus Infections,CAUSES,Pneumonia,32243296,10.1213/ANE.0000000000004844,2020-04-04
Elective Surgical Procedures,TREATS,inpatient,32243287,10.1213/ANE.0000000000004846,2020-04-04
Elective Surgical Procedures,TREATS,Outpatients,32243287,10.1213/ANE.0000000000004846,2020-04-04
African swine fever,COEXISTS_WITH,Crisis,32243287,10.1213/ANE.0000000000004846,2020-04-04
"CD69 protein, human",PREDISPOSES,African swine fever,32243287,10.1213/ANE.0000000000004846,2020-04-04
Vaccines,PREVENTS,Human coronavirus,32243269,10.1097/JCMA.0000000000000319,2020-04-04
Diarrhea,PROCESS_OF,Patients,32243266,10.1097/MAT.0000000000001172,2020-04-04
Nausea,COEXISTS_WITH,Digestive symptom,32243266,10.1097/MAT.0000000000001172,2020-04-04
Feces,ASSOCIATED_WITH(INFER),Infected,32243266,10.1097/MAT.0000000000001172,2020-04-04
Feces,PART_OF,Patients,32243266,10.1097/MAT.0000000000001172,2020-04-04
Infected,PROCESS_OF,Patients,32243266,10.1097/MAT.0000000000001172,2020-04-04
Liver function,PROCESS_OF,Patients,32243266,10.1097/MAT.0000000000001172,2020-04-04
Coronavirus Infections,ISA,Disease,32243238,10.1148/radiol.2020201237,2020-04-04
Asymptomatic,PROCESS_OF,Donor person,32243238,10.1148/radiol.2020201237,2020-04-04
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,SARS coronavirus,32243068,10.1111/mcn.13010,2020-04-04
Chest CT,USES,Contrast Media,32243068,10.1111/mcn.13010,2020-04-04
scholar,DIAGNOSES,Pneumonia,32242878,10.4103/ijmr.IJMR_763_20,2020-04-04
Chest,LOCATION_OF,Distress,32242878,10.4103/ijmr.IJMR_763_20,2020-04-04
Communicable Diseases,CAUSES,Bilateral pneumonia,32242878,10.4103/ijmr.IJMR_763_20,2020-04-04
"Epitopes, T-Lymphocyte",COEXISTS_WITH,DNA Sequence,32242830,10.1515/cclm-2020-0332,2020-04-04
Province,ISA,Geographic Locations,32242790,10.1017/S0950268820000783,2020-04-04
Fever,ISA,Symptoms,32242349,10.3346/jkms.2020.35.e143,2020-04-04
Cardiopulmonary,LOCATION_OF,Comorbidity,32242349,10.3346/jkms.2020.35.e143,2020-04-04
Laboratory Procedures,METHOD_OF,Diagnosis,32242349,10.3346/jkms.2020.35.e143,2020-04-04
Child,ISA,Human Age Group,32242348,10.3346/jkms.2020.35.e142,2020-04-04
Possible,PROCESS_OF,Human Age Group,32242348,10.3346/jkms.2020.35.e142,2020-04-04
Possible,PROCESS_OF(SPEC),Child,32242348,10.3346/jkms.2020.35.e142,2020-04-04
Coughing,ISA,Symptoms,32242347,10.3346/jkms.2020.35.e140,2020-04-04
Symptoms,PROCESS_OF,Patients,32242347,10.3346/jkms.2020.35.e140,2020-04-04
Upper respiratory tract,LOCATION_OF,Viral Shedding,32242347,10.3346/jkms.2020.35.e140,2020-04-04
Easy,PROCESS_OF,Community,32242347,10.3346/jkms.2020.35.e140,2020-04-04
Confirmation,PROCESS_OF,Patients,32242340,10.3802/jgo.2020.31.e59,2020-04-04
Out-of-Hospital,PROCESS_OF,Patients,32242340,10.3802/jgo.2020.31.e59,2020-04-04
Surgical precautions,PREVENTS,"Leakage, gas",32241899,10.1136/gutjnl-2020-321013,2020-04-04
Symptoms,PROCESS_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Nausea,ISA,Symptoms,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Diarrhea,PROCESS_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Feces,PART_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Ulcer,PROCESS_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Esophageal bleeding,PROCESS_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Symptoms,PROCESS_OF,Patients,32241897,10.1136/gutjnl-2020-321185,2020-04-04
Coitus,PROCESS_OF,student,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,COEXISTS_WITH,Enthesitis-Related Arthritis,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,PROCESS_OF,Participant,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,OCCURS_IN,Child,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,OCCURS_IN,Adolescent (age group),32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Disease,COEXISTS_WITH,Malaria,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Tuberculosis,ISA,Bacterial Infections,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Disease Control,TREATS,Enthesitis-Related Arthritis,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,CAUSES,Cessation of life,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,PROCESS_OF,Child,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Communicable Diseases,PROCESS_OF,Adolescent (age group),32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
SARS coronavirus,CAUSES,Disease,32241695,10.1016/j.sapharm.2020.03.018,2020-04-04
Virus,CAUSES,Disease,32241328,10.1017/dmp.2020.68,2020-04-04
Genus: Coronavirus,CAUSES(SPEC),Disease,32241328,10.1017/dmp.2020.68,2020-04-04
Genus: Coronavirus,ISA,Virus,32241328,10.1017/dmp.2020.68,2020-04-04
Complication,PROCESS_OF,Patients,32241328,10.1017/dmp.2020.68,2020-04-04
South Korea,ISA,Country,32241316,10.1017/dmp.2020.66,2020-04-04
Disease Progression,PROCESS_OF,Patients,32241097,10.33963/KP.15265,2020-04-04
Diagnosis,AFFECTS,Screening procedure,32241097,10.33963/KP.15265,2020-04-04
Coronavirus Infections,PROCESS_OF,Patients,32241097,10.33963/KP.15265,2020-04-04
Coughing,ISA,Symptoms,32241071,10.11622/smedj.2020046,2020-04-04
Diarrhea,PROCESS_OF,Patients,32241071,10.11622/smedj.2020046,2020-04-04
Fever,ISA,Symptoms,32241071,10.11622/smedj.2020046,2020-04-04
Myalgia,PROCESS_OF,Patients,32241071,10.11622/smedj.2020046,2020-04-04
Coronavirus Infections,PROCESS_OF,Survivors,32241071,10.11622/smedj.2020046,2020-04-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Survivors,32241071,10.11622/smedj.2020046,2020-04-04
diffuse alveolar damage,PROCESS_OF,Survivors,32241071,10.11622/smedj.2020046,2020-04-04
Epithelial Cells,PART_OF,Bronchioles,32241071,10.11622/smedj.2020046,2020-04-04
lymph nodes,LOCATION_OF,Hemorrhagic necrosis,32241071,10.11622/smedj.2020046,2020-04-04
Spleen,LOCATION_OF,Hemorrhagic necrosis,32241071,10.11622/smedj.2020046,2020-04-04
Structure of small blood vessel (organ),LOCATION_OF,Thrombosis,32241071,10.11622/smedj.2020046,2020-04-04
Organ,LOCATION_OF,Microthrombosis,32241071,10.11622/smedj.2020046,2020-04-04
Organ,LOCATION_OF,Tissue damage,32241071,10.11622/smedj.2020046,2020-04-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32241071,10.11622/smedj.2020046,2020-04-04
Alveolar damage,PROCESS_OF,Patients,32241071,10.11622/smedj.2020046,2020-04-04
Pandemics,ISA,Disease Outbreaks,32241067,10.11622/smedj.2020045,2020-04-04
Fever,PROCESS_OF,Male population group,32241065,10.11622/smedj.2020050,2020-04-04
Dry cough,PROCESS_OF,Male population group,32241065,10.11622/smedj.2020050,2020-04-04
Infected,PROCESS_OF,Patients,32241056,10.3760/cma.j.cn112139-20200219-00100,2020-04-04
Alveolar Epithelial Cells,PART_OF,Homo sapiens,32241022,10.1093/cid/ciaa375,2020-04-03
Coronavirus Infections,ISA,Disease,32241022,10.1093/cid/ciaa375,2020-04-03
Coronavirus Infections,ISA,Disease,32241022,10.1093/cid/ciaa375,2020-04-03
Genitalia,LOCATION_OF,Communicable Diseases,32240973,10.2196/18936,2020-04-03
Pneumonia,PROCESS_OF,Woman,32240973,10.2196/18936,2020-04-03
Vaginal secretions,PART_OF,Woman,32240973,10.2196/18936,2020-04-03
Toxic Epidermal Necrolysis,PROCESS_OF,Woman,32240973,10.2196/18936,2020-04-03
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32240973,10.2196/18936,2020-04-03
IMPACT gene,INTERACTS_WITH,EHD1 wt Allele,32240972,10.2196/19043,2020-04-03
Pandemics,ISA,Disease Outbreaks,32240972,10.2196/19043,2020-04-03
Infected,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Infection,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Ground Glass Opacity,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
lobe,PART_OF,Lung,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Thickened,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Physical findings,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Ground Glass Opacity,PROCESS_OF,Patients,32240896,10.1016/j.psychres.2020.112921,2020-04-03
Mental Health Services,TREATS,Affected Area,32240770,10.1016/j.jamcollsurg.2020.03.019,2020-04-03
Hospitals,LOCATION_OF,Training,32240764,10.1016/j.bbi.2020.03.028,2020-04-03
Coronavirus Infections,ISA,Disease,32240762,10.1016/j.bbi.2020.03.031,2020-04-03
psychological care,ADMINISTERED_TO,Nursing Staff,32240762,10.1016/j.bbi.2020.03.031,2020-04-03
Infected,PROCESS_OF,Persons,32240762,10.1016/j.bbi.2020.03.031,2020-04-03
Virus Diseases,AFFECTS,Nervous System Physiological Phenomena,32240756,10.1016/j.jpainsymman.2020.03.019,2020-04-03
Genus: Coronavirus,CAUSES,nervous system disorder,32240756,10.1016/j.jpainsymman.2020.03.019,2020-04-03
Brain,LOCATION_OF,Genus: Coronavirus,32240756,10.1016/j.jpainsymman.2020.03.019,2020-04-03
Virus,INTERACTS_WITH,Coronavirus Infections,32240756,10.1016/j.jpainsymman.2020.03.019,2020-04-03
medical care,PROCESS_OF,Family,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
medical care,PROCESS_OF,Patients,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
medical care,PROCESS_OF,Clinician,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
consideration,PROCESS_OF,Patients,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
consideration,PROCESS_OF,Clinician,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
Telemedicine,ISA,Evaluation,32240755,10.1016/j.jpainsymman.2020.03.021,2020-04-03
Malignant Neoplasms,PROCESS_OF,Patients,32240754,10.1016/j.jpainsymman.2020.03.025,2020-04-03
Frail,PROCESS_OF,Population Group,32240754,10.1016/j.jpainsymman.2020.03.025,2020-04-03
advanced cancer,PROCESS_OF,Patients,32240754,10.1016/j.jpainsymman.2020.03.025,2020-04-03
hospital care,TREATS,Patients,32240752,10.1016/j.jpainsymman.2020.03.018,2020-04-03
"CD69 protein, human",PART_OF,Patients,32240751,10.1016/j.jpainsymman.2020.03.020,2020-04-03
Coronavirus Infections,PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Coronavirus Infections,PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Infected,PROCESS_OF,Persons,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Fatigue,ISA,Symptoms,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Lymphopenia,OCCURS_IN,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Lung,LOCATION_OF,Ground Glass Opacity,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Lung,PART_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
tomography,DIAGNOSES,Ground Glass Opacity,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Chest,LOCATION_OF,tomography,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Complication,PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Shock,PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
Single organ dysfunction,PROCESS_OF,Patients,32240670,10.1016/j.jinf.2020.03.019,2020-04-03
High Level,PROCESS_OF,geriatric patients,32240634,10.1016/S1473-3099(20)30243-7,2020-04-03
Cardiovascular Diseases,PREDISPOSES,Poor outcome,32240634,10.1016/S1473-3099(20)30243-7,2020-04-03
Chronic Obstructive Airway Disease,PREDISPOSES,Poor outcome,32240634,10.1016/S1473-3099(20)30243-7,2020-04-03
"Respiratory Distress Syndrome, Adult",PREDISPOSES,Poor outcome,32240634,10.1016/S1473-3099(20)30243-7,2020-04-03
Infected,PROCESS_OF,Persons,32240567,10.1002/pbc.28318,2020-04-03
Infected,PROCESS_OF,Persons,32240567,10.1002/pbc.28318,2020-04-03
Panic,PROCESS_OF,Population Group,32240545,10.1111/vox.12926,2020-04-03
Malignant Neoplasms,PROCESS_OF,Patients,32240545,10.1111/vox.12926,2020-04-03
Patients,LOCATION_OF,Plasma,32240484,10.1007/s11096-020-01020-5,2020-04-03
Disease,PROCESS_OF,Patients,32240484,10.1007/s11096-020-01020-5,2020-04-03
Coronavirus Infections,PROCESS_OF,Patients,32240462,10.1007/s11684-020-0767-8,2020-04-03
Complication,PROCESS_OF,Patients,32240303,10.1093/jamia/ocaa048,2020-04-03
Critical Illness,PROCESS_OF,Patients,32240303,10.1093/jamia/ocaa048,2020-04-03
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32240285,10.1093/cid/ciaa374,2020-04-03
Asymptomatic Infections,PROCESS_OF,Persons,32240279,10.4193/Rhin20.114,2020-04-03
Coughing,COEXISTS_WITH,Fever,32240123,10.15585/mmwr.mm6913e2,2020-04-03
Cardiovascular Diseases,ISA,Disease,32240096,10.2196/18807,2020-04-03
Diabetes Mellitus,ISA,Disease,32240096,10.2196/18807,2020-04-03
Chronic lung disease,ISA,Disease,32240096,10.2196/18807,2020-04-03
Influenza,ISA,Communicable Diseases,32240094,10.2196/18790,2020-04-03
Lower respiratory tract infection,PROCESS_OF,Persons,32240094,10.2196/18790,2020-04-03
Influenza-like symptoms,PROCESS_OF,Persons,32240094,10.2196/18790,2020-04-03
Lower respiratory tract infection,PROCESS_OF,Patients,32240094,10.2196/18790,2020-04-03
American College of Cardiology/American Heart Association Lesion Complexity Score A,PROCESS_OF,Patients,32240094,10.2196/18790,2020-04-03
Perception,PROCESS_OF,general population,32240079,10.3201/eid2607.200591,2020-04-03
Perception,PROCESS_OF,general population,32240079,10.3201/eid2607.200591,2020-04-03
Household income,PROCESS_OF,Participant,32240079,10.3201/eid2607.200591,2020-04-03
Household income,PROCESS_OF,Participant,32240079,10.3201/eid2607.200591,2020-04-03
care seeking,ISA,Behavior,32240079,10.3201/eid2607.200591,2020-04-03
Asymptomatic,PROCESS_OF,Patients,32240078,10.3201/eid2607.200764,2020-04-03
Coronavirus Infections,ISA,Disease,32239796,10.1111/liv.14455,2020-04-03
Hospitals,LOCATION_OF,Study,32239761,10.1111/all.14309,2020-04-03
Community acquired pneumonia,PROCESS_OF,Patients,32239761,10.1111/all.14309,2020-04-03
Atypical Lipoma,PROCESS_OF,Patients,32239761,10.1111/all.14309,2020-04-03
Complete Response with Incomplete Platelet Recovery,PREDISPOSES,Inflammation,32239761,10.1111/all.14309,2020-04-03
risk factors,PROCESS_OF,Patients,32239761,10.1111/all.14309,2020-04-03
Coronavirus Infections,ISA,Disease,32239591,10.1111/liv.14449,2020-04-03
Hospitals,LOCATION_OF,Retrospective Studies,32239532,10.1111/echo.14664,2020-04-03
intensive care unit,LOCATION_OF,logistic regression analysis,32239532,10.1111/echo.14664,2020-04-03
Lung,LOCATION_OF,Lesion,32239532,10.1111/echo.14664,2020-04-03
Liver function,PROCESS_OF,Patients,32239532,10.1111/echo.14664,2020-04-03
High Grade Lesion,PROCESS_OF,Patients,32239532,10.1111/echo.14664,2020-04-03
Lung,LOCATION_OF,Ultrasonography,32239525,10.1111/echo.14662,2020-04-03
pulmonary involvement,PROCESS_OF,Patients,32239525,10.1111/echo.14662,2020-04-03
Lung,LOCATION_OF,Ultrasonography,32239525,10.1111/echo.14662,2020-04-03
Mammals,LOCATION_OF,angiotensin converting enzyme 2,32239472,10.1007/s11547-020-01179-x,2020-04-03
"Vitronectin, human",COEXISTS_WITH,angiotensin converting enzyme 2,32239472,10.1007/s11547-020-01179-x,2020-04-03
Primates,LOCATION_OF,angiotensin converting enzyme 2,32239472,10.1007/s11547-020-01179-x,2020-04-03
angiotensin converting enzyme 2,PART_OF,Snakes,32239472,10.1007/s11547-020-01179-x,2020-04-03
Parenchyma,PART_OF,Lung,32239446,10.1007/s12250-020-00219-0,2020-04-03
SARS coronavirus,CAUSES,Pneumonia,32239142,10.1093/bioinformatics/btaa224,2020-04-03
Crisis,CAUSES,Infection,32239127,10.1093/cid/ciaa243,2020-04-03
Pharmaceutical Preparations,INTERACTS_WITH,Endopeptidases,32239127,10.1093/cid/ciaa243,2020-04-03
Comorbidity,PROCESS_OF,Health Personnel,32239125,10.37201/req/098.2020,2020-04-03
Cessation of life,PROCESS_OF,Patients,32239125,10.37201/req/098.2020,2020-04-03
Ground Glass Opacity,PROCESS_OF,Patients,32239125,10.37201/req/098.2020,2020-04-03
Pharmaceutical Preparations,COEXISTS_WITH,human plasma,32238978,10.4081/gh.2020.880,2020-04-03
SARS coronavirus,ISA,Genus: Coronavirus,32238673,10.5582/bst.2020.01110,2020-04-03
Prophylactic treatment,USES,Vaccines,32238673,10.5582/bst.2020.01110,2020-04-03
Choose (action),ISA,Event,32238429,10.2967/jnumed.120.246256,2020-04-03
Measles Virus Nucleoprotein,COEXISTS_WITH,"SH2D3A protein, human",32238429,10.2967/jnumed.120.246256,2020-04-03
Virus,PROCESS_OF,Pholidota,32238429,10.2967/jnumed.120.246256,2020-04-03
Coronavirus Infections,ISA,Disease,32238358,10.1158/2159-8290.CD-NB2020-021,2020-04-03
Coronavirus Infections,ISA,Disease,32238358,10.1158/2159-8290.CD-NB2020-021,2020-04-03
Malignant Neoplasms,PROCESS_OF,Community,32238336,10.2196/18810,2020-04-03
lifesaving,TREATS,Community,32238336,10.2196/18810,2020-04-03
lifesaving,TREATS(INFER),Malignant Neoplasms,32238336,10.2196/18810,2020-04-03
Societies,ISA,Organization administrative structures,32238260,10.31053/1853.0605.v77.n1.28031,2020-04-03
Coronavirus Infections,ISA,Disease,32238250,10.31053/1853.0605.v77.n1.27935,2020-04-03
IMPACT gene,PART_OF,World,32238250,10.31053/1853.0605.v77.n1.27935,2020-04-03
Coronavirus Infections,ISA,Disease,32238250,10.31053/1853.0605.v77.n1.27935,2020-04-03
Coronavirus Infections,ISA,Disease,32238250,10.31053/1853.0605.v77.n1.27935,2020-04-03
Communicable Diseases,COEXISTS_WITH,Atypical pneumonia,32238223,10.4269/ajtmh.20-0203,2020-04-03
Disease,PROCESS_OF,Patients,32238223,10.4269/ajtmh.20-0203,2020-04-03
Immunologic Deficiency Syndromes,AFFECTS,Immune response,32238223,10.4269/ajtmh.20-0203,2020-04-03
Immunologic Deficiency Syndromes,PRODUCES,cytokine,32238223,10.4269/ajtmh.20-0203,2020-04-03
Lung,LOCATION_OF,Severe inflammation,32238223,10.4269/ajtmh.20-0203,2020-04-03
Therapeutic procedure,TREATS,Patients,32238223,10.4269/ajtmh.20-0203,2020-04-03
Life support procedure,ISA,Therapeutic procedure,32238223,10.4269/ajtmh.20-0203,2020-04-03
Life support procedure,TREATS,Communicable Diseases,32238223,10.4269/ajtmh.20-0203,2020-04-03
Life support procedure,TREATS(SPEC),Patients,32238223,10.4269/ajtmh.20-0203,2020-04-03
Atypical pneumonia,COEXISTS_WITH,patient condition,32238221,10.1017/S1049023X20000424,2020-04-03
Disease,PROCESS_OF,Family member,32238221,10.1017/S1049023X20000424,2020-04-03
Coronavirus Infections,ISA,Disease,32238221,10.1017/S1049023X20000424,2020-04-03
Coronavirus Infections,PROCESS_OF(SPEC),Family member,32238221,10.1017/S1049023X20000424,2020-04-03
Nasopharynx,NEG_PART_OF,SARS coronavirus,32238221,10.1017/S1049023X20000424,2020-04-03
Pharyngeal structure,NEG_PART_OF,SARS coronavirus,32238221,10.1017/S1049023X20000424,2020-04-03
Pneumonia,ISA,Disease,32238221,10.1017/S1049023X20000424,2020-04-03
IMPACT gene,AFFECTS,Negative,32238216,10.1017/ice.2020.101,2020-04-03
Population Group,LOCATION_OF,IMPACT gene,32238216,10.1017/ice.2020.101,2020-04-03
Coronavirus Infections,ISA,Disease,32238177,10.1186/s12978-020-0899-y,2020-04-03
Coronavirus Infections,ISA,Disease,32238177,10.1186/s12978-020-0899-y,2020-04-03
Household composition,PROCESS_OF,Homo sapiens,32238177,10.1186/s12978-020-0899-y,2020-04-03
Sexual Health,ISA,Reproduction,32238094,10.1080/07391102.2020.1751298,2020-04-03
Coronavirus Infections,ISA,Disease,32238024,10.1080/23744235.2020.1744711,2020-04-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32238024,10.1080/23744235.2020.1744711,2020-04-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH(SPEC),Coronavirus Infections,32238024,10.1080/23744235.2020.1744711,2020-04-03
Disease,PROCESS_OF,Homo sapiens,32238024,10.1080/23744235.2020.1744711,2020-04-03
Proteins,AFFECTS,ion channel activity,32238024,10.1080/23744235.2020.1744711,2020-04-03
Homo sapiens,ISA,Vertebrates,32238024,10.1080/23744235.2020.1744711,2020-04-03
vibsanol B,INHIBITS,e protein,32238024,10.1080/23744235.2020.1744711,2020-04-03
Amino Acids,INTERACTS_WITH,Phytochemicals,32238024,10.1080/23744235.2020.1744711,2020-04-03
Disease,CAUSES,Severe Acute Respiratory Syndrome,32238024,10.1080/23744235.2020.1744711,2020-04-03
Diarrhea,PROCESS_OF,Woman,32237998,10.1080/09546634.2020.1750556,2020-04-03
Fever,PROCESS_OF,Woman,32237998,10.1080/09546634.2020.1750556,2020-04-03
Respiratory sample,PART_OF,Tract,32237998,10.1080/09546634.2020.1750556,2020-04-03
Personality Character,PROCESS_OF,Population Group,32237566,10.21149/11276,2020-04-03
Personality Character,PROCESS_OF(SPEC),Old age,32237566,10.21149/11276,2020-04-03
Causative_agents,PROCESS_OF,Relative (related person),32237566,10.21149/11276,2020-04-03
Old age,ISA,Population Group,32237566,10.21149/11276,2020-04-03
China,ISA,Country,32237288,10.3343/alm.2020.40.5.351,2020-04-03
disease prevention,COEXISTS_WITH,Clinical Laboratory Services,32237278,10.5694/mja2.50569,2020-04-03
Electron Microscopy,DIAGNOSES,Present,32237238,10.1002/lary.28692,2020-04-03
Critical Illness,PROCESS_OF,Patients,32237148,10.1002/jmv.25810,2020-04-03
Negative,PROCESS_OF,Patients,32236913,10.1055/a-1146-1160,2020-04-03
Negative,PROCESS_OF,Patients,32236913,10.1055/a-1146-1160,2020-04-03
Pneumonia,PROCESS_OF,Patients,32236694,10.1007/s00391-020-01725-2,2020-04-03
Chest CT,ADMINISTERED_TO,Patients,32236694,10.1007/s00391-020-01725-2,2020-04-03
Chest,LOCATION_OF,High Resolution Computed Tomography,32236694,10.1007/s00391-020-01725-2,2020-04-03
Lung,LOCATION_OF,Chest CT,32236694,10.1007/s00391-020-01725-2,2020-04-03
Lung,LOCATION_OF,Lesion,32236694,10.1007/s00391-020-01725-2,2020-04-03
Fever,PROCESS_OF,member,32236295,10.1590/0100-6991e-20202536,2020-04-03
Respiration Disorders,PROCESS_OF,member,32236295,10.1590/0100-6991e-20202536,2020-04-03
Disease,PROCESS_OF,Old age,32236089,10.4081/monaldi.2020.1285,2020-04-03
Adequate Knowledge,NEG_PROCESS_OF,Health Personnel,32236089,10.4081/monaldi.2020.1285,2020-04-03
Physiotherapy of chest,TREATS,Patients,32235945,10.1038/s41586-020-2196-x,2020-04-03
World,USES,Not prepared,32235486,10.3390/jcm9040941,2020-04-03
Incubation period,PROCESS_OF,Homo sapiens,32235486,10.3390/jcm9040941,2020-04-03
Infected,PROCESS_OF,Patients,32235486,10.3390/jcm9040941,2020-04-03
Infected,PROCESS_OF,Patients,32235486,10.3390/jcm9040941,2020-04-03
medical treatment method,TREATS,Patients,32235486,10.3390/jcm9040941,2020-04-03
medical treatment method,TREATS(INFER),Infected,32235486,10.3390/jcm9040941,2020-04-03
Fever,ISA,Symptoms,32235480,10.3390/jcm9040944,2020-04-03
Coronavirus Infections,CAUSES,Pneumonia,32235433,10.3390/ijerph17072309,2020-04-03
Communicable Diseases,PROCESS_OF,Patients,32235433,10.3390/ijerph17072309,2020-04-03
Wakefulness,PROCESS_OF,Community,32235413,10.3390/ijerph17072304,2020-04-03
Coronavirus Infections,ISA,Disease,32235387,10.3390/vaccines8020153,2020-04-03
Coronavirus Infections,ISA,Disease,32235387,10.3390/vaccines8020153,2020-04-03
China,ISA,Country,32235187,10.1097/RTI.0000000000000513,2020-04-03
Coronavirus Infections,CAUSES,Pneumonia,32235187,10.1097/RTI.0000000000000513,2020-04-03
Vaccines,TREATS,Communicable Diseases,32235187,10.1097/RTI.0000000000000513,2020-04-03
Disease,PROCESS_OF,Patients,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,CAUSES,Pneumonia,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,ISA,Disease,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,PROCESS_OF,Patients,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32235119,10.1159/000507537,2020-04-03
lobe,PART_OF,Both lungs,32235119,10.1159/000507537,2020-04-03
Disease,PROCESS_OF,Patients,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,ISA,Disease,32235119,10.1159/000507537,2020-04-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32235119,10.1159/000507537,2020-04-03
pulmonary involvement,PROCESS_OF,Patients,32235119,10.1159/000507537,2020-04-03
lobe,LOCATION_OF,pulmonary involvement,32235119,10.1159/000507537,2020-04-03
lobe,PART_OF,Lung,32235119,10.1159/000507537,2020-04-03
Therapeutic procedure,COEXISTS_WITH,intensive care,32235086,10.3855/jidc.12734,2020-04-03
Isolation procedure,TREATS,Patients,32235086,10.3855/jidc.12734,2020-04-03
Swab specimen,ISA,Materials,32235085,10.3855/jidc.12671,2020-04-03
Medical Devices,TREATS,Immune,32235085,10.3855/jidc.12671,2020-04-03
Coronavirus Infections,CAUSES,Middle East Respiratory Syndrome,32235084,10.3855/jidc.12585,2020-04-03
Coronavirus Infections,ISA,Disease,32235084,10.3855/jidc.12585,2020-04-03
Coronavirus Infections,ISA,Disease,32235084,10.3855/jidc.12585,2020-04-03
Contacts,ADMINISTERED_TO,Persons,32234804,10.1126/science.abb6105,2020-04-03
Movement,PROCESS_OF,Homo sapiens,32234728,10.1136/dtb.2020.000021,2020-04-03
Malignant Neoplasms,PROCESS_OF,Research Personnel,32234709,10.2196/18828,2020-04-03
Coronavirus Infections,ISA,Disease,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Iran,ISA,Country,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Coronavirus Infections,ISA,Disease,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Crisis,PREDISPOSES,Disease,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Crisis,PREDISPOSES(SPEC),Coronavirus Infections,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Hand,LOCATION_OF,sanitizers,32234468,10.1016/j.ijantimicag.2020.105955,2020-04-03
Coronavirus Infections,ISA,Disease,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
Quarantine,TREATS,Patients,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
Therapeutic procedure,TREATS,Patients,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
Coronavirus Infections,ISA,Disease,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
Coronavirus Infections,ISA,Disease,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
treatment options,TREATS,Coronavirus Infections,32234467,10.1016/j.ijantimicag.2020.105954,2020-04-03
Storm NOS,PROCESS_OF,Patients,32234466,10.1016/j.ijantimicag.2020.105951,2020-04-03
Interleukin-6,AFFECTS,Cytokine release syndrome,32234466,10.1016/j.ijantimicag.2020.105951,2020-04-03
Pharmaceutical Preparations,TREATS,Patients,32234466,10.1016/j.ijantimicag.2020.105951,2020-04-03
Interleukin 6 Receptor,AFFECTS,Signal Transduction Pathways,32234466,10.1016/j.ijantimicag.2020.105951,2020-04-03
Severe Acute Respiratory Syndrome,ISA,Virus Diseases,32234464,10.1016/j.ijantimicag.2020.105961,2020-04-03
treatment options,TREATS,Disease,32234464,10.1016/j.ijantimicag.2020.105961,2020-04-03
China,ISA,Asian country,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Disease,CAUSES,Pneumonia,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Disease,CAUSES,"Respiratory Distress Syndrome, Adult",32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,CAUSES(SPEC),Pneumonia,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,CAUSES(SPEC),"Respiratory Distress Syndrome, Adult",32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Severe Acute Respiratory Syndrome,COEXISTS_WITH(SPEC),Coronavirus Infections,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Middle East Respiratory Syndrome,COEXISTS_WITH,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Middle East Respiratory Syndrome,COEXISTS_WITH(SPEC),Coronavirus Infections,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Disease,PROCESS_OF,Community,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,PROCESS_OF(SPEC),Community,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Coronavirus Infections,ISA,Disease,32234343,10.1016/j.ijid.2020.03.050,2020-04-03
Anxiety,PROCESS_OF,Persons,32234250,10.1016/j.bja.2020.03.007,2020-04-03
Panic,PROCESS_OF,Persons,32234250,10.1016/j.bja.2020.03.007,2020-04-03
Spinal Anesthesia,TREATS,Patients,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Spinal Anesthesia,TREATS,Present,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Spinal Anesthesia,TREATS,Anesthetist,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Spinal Anesthesia,TREATS,Patients,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Pneumonia,NEG_PROCESS_OF,Patients,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Coronavirus Infections,PROCESS_OF,Patients,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Protection,PROCESS_OF,Patients,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Protection,PROCESS_OF,Anesthetist,32234175,10.3760/cma.j.cn112148-20200210-00066,2020-04-03
Coronavirus Infections,PROCESS_OF,Family,32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
Vaccines,PART_OF,Middle East Respiratory Syndrome Coronavirus,32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
"Vaccines, Inactivated",PART_OF,Virus,32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
RNA,INTERACTS_WITH,"M Protein, multiple myeloma",32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
Vaccines,AFFECTS,Antigenic Variation,32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
Old age,ISA,Population Group,32234129,10.3760/cma.j.cn112150-20200330-00473,2020-04-03
Coronavirus Infections,ISA,Disease,32234117,10.2807/1560-7917.ES.2020.25.12.2000293,2020-04-03
Hospital admission,METHOD_OF,Isolation procedure,32234115,10.2807/1560-7917.ES.2020.25.12.2000334,2020-04-03
Empowered,PROCESS_OF,Persons,32234115,10.2807/1560-7917.ES.2020.25.12.2000334,2020-04-03
Hospitals,LOCATION_OF,Services,32234115,10.2807/1560-7917.ES.2020.25.12.2000334,2020-04-03
Chief complaint (finding),PROCESS_OF,Health Personnel,32234108,10.1017/dmp.2020.64,2020-04-03
Influenza,PROCESS_OF,Hispanics,32234107,10.1017/dmp.2020.63,2020-04-03
Prophylactic treatment,USES,Basis,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,CAUSES,Disease,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,ISA,Disease,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,ISA,Disease,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Disease,AFFECTS,Persons,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,AFFECTS(SPEC),Persons,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,ISA,Disease,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Coronavirus Infections,ISA,Disease,32233980,10.1161/STROKEAHA.120.029838,2020-04-03
Cerebrovascular accident,PROCESS_OF,Patients,32233973,10.1089/tmj.2020.0066,2020-04-03
Ability,PREDISPOSES,Communicable Diseases,32233973,10.1089/tmj.2020.0066,2020-04-03
Recovery of Function,COEXISTS_WITH,Neurologic Symptoms,32233973,10.1089/tmj.2020.0066,2020-04-03
consideration,COEXISTS_WITH,Cerebrovascular accident,32233973,10.1089/tmj.2020.0066,2020-04-03
Performance,PROCESS_OF,Homo sapiens,32233973,10.1089/tmj.2020.0066,2020-04-03
Malaise,PROCESS_OF,Patients,32233816,10.1080/23744235.2020.1747634,2020-04-03
Coronavirus Infections,ISA,Disease,32233816,10.1080/23744235.2020.1747634,2020-04-03
Coronavirus Infections,PROCESS_OF,Homo sapiens,32233642,10.21037/apm.2020.03.26,2020-04-03
Disease Progression,COEXISTS_WITH,risk factors,32233641,10.21037/apm.2020.03.27,2020-04-03
reported History,PROCESS_OF,Patients,32233641,10.21037/apm.2020.03.27,2020-04-03
Coughing,ISA,Symptoms,32233641,10.21037/apm.2020.03.27,2020-04-03
Diarrhea,NEG_PROCESS_OF,Patients,32233641,10.21037/apm.2020.03.27,2020-04-03
Mechanical ventilation,NEG_ADMINISTERED_TO,Patients,32233641,10.21037/apm.2020.03.27,2020-04-03
Aggravated Disease,PROCESS_OF,Patients,32233641,10.21037/apm.2020.03.27,2020-04-03
Lung,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
Thoracic mammary region,LOCATION_OF,CAT scan normal,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Chest CT,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
Thoracic mammary region,LOCATION_OF,CAT scan normal,32233641,10.21037/apm.2020.03.27,2020-04-03
Thoracic mammary region,LOCATION_OF,CAT scan normal,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
lobe,LOCATION_OF,Invasive Lesion,32233641,10.21037/apm.2020.03.27,2020-04-03
CD4 Count determination procedure,ISA,Lymphocyte Count measurement,32233641,10.21037/apm.2020.03.27,2020-04-03
Disease Progression,COEXISTS_WITH,risk factors,32233641,10.21037/apm.2020.03.27,2020-04-03
Disease Progression,PROCESS_OF,Patients,32233641,10.21037/apm.2020.03.27,2020-04-03
Chinese herbal medicine,TREATS,Virus Diseases,32233563,10.3934/mbe.2020149,2020-04-03
Genes,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32233563,10.3934/mbe.2020149,2020-04-03
Genes,ASSOCIATED_WITH,Middle East Respiratory Syndrome,32233563,10.3934/mbe.2020149,2020-04-03
Quarantine,TREATS,Patients,32233562,10.3934/mbe.2020148,2020-04-03
Confirmation,PROCESS_OF,Patients,32233562,10.3934/mbe.2020148,2020-04-03
China,ISA,Country,32233560,10.3934/mbe.2020146,2020-04-03
Disease,PROCESS_OF,World,32233560,10.3934/mbe.2020146,2020-04-03
Coronavirus Infections,ISA,Disease,32233560,10.3934/mbe.2020146,2020-04-03
Coronavirus Infections,PROCESS_OF(SPEC),World,32233560,10.3934/mbe.2020146,2020-04-03
Coronavirus Infections,ISA,Disease,32233560,10.3934/mbe.2020146,2020-04-03
Coronavirus Infections,ISA,Disease,32233560,10.3934/mbe.2020146,2020-04-03
Korea,ISA,Country,32233064,10.1111/codi.15056,2020-04-02
Colon and Rectal Surgery (procedure),TREATS,Crisis,32233055,10.1111/ajt.15888,2020-04-02
Severe disorder,PROCESS_OF,Patients,32233034,10.1111/jgh.15053,2020-04-02
Diabetes,PROCESS_OF,Patients,32233013,10.1002/dmrr.3319,2020-04-02
Diabetes,PROCESS_OF,Patients,32233013,10.1002/dmrr.3319,2020-04-02
Chronic inflammation,AFFECTS,Coronavirus Infections,32233013,10.1002/dmrr.3319,2020-04-02
Interleukin-6,AUGMENTS,Disease,32233013,10.1002/dmrr.3319,2020-04-02
Patients,LOCATION_OF,cytokine,32233013,10.1002/dmrr.3319,2020-04-02
Monoclonal Antibodies,INTERACTS_WITH,Interleukin-6,32233013,10.1002/dmrr.3319,2020-04-02
Interleukin 6 Receptor,ASSOCIATED_WITH,Diabetes,32233013,10.1002/dmrr.3319,2020-04-02
Janus kinase inhibitor,TREATS,Pneumonia,32233013,10.1002/dmrr.3319,2020-04-02
Coronavirus Infections,ISA,Disease,32232986,10.1002/jmv.25805,2020-04-02
Diabetes,PREDISPOSES,Rapidly progressive,32232986,10.1002/jmv.25805,2020-04-02
Diabetes,PROCESS_OF,Patients,32232986,10.1002/jmv.25805,2020-04-02
Coronavirus Infections,ISA,Disease,32232986,10.1002/jmv.25805,2020-04-02
Serum,LOCATION_OF,Ferritin,32232986,10.1002/jmv.25805,2020-04-02
diabetic,PROCESS_OF,Patients,32232986,10.1002/jmv.25805,2020-04-02
Coagulation index,PROCESS_OF,Patients,32232986,10.1002/jmv.25805,2020-04-02
Diabetes,PROCESS_OF,Patients,32232986,10.1002/jmv.25805,2020-04-02
Hand,LOCATION_OF,Towelettes,32232980,10.1002/jmv.25807,2020-04-02
Hand,LOCATION_OF,Virus,32232980,10.1002/jmv.25807,2020-04-02
Hand,LOCATION_OF,Towelettes,32232980,10.1002/jmv.25807,2020-04-02
Towelettes,USES,Towel,32232980,10.1002/jmv.25807,2020-04-02
Heart Injuries,PROCESS_OF,Patients,32232976,10.1002/jmv.25804,2020-04-02
Cardiac troponin I,ISA,Troponin I,32232976,10.1002/jmv.25804,2020-04-02
Complication,PROCESS_OF,Patients,32232976,10.1002/jmv.25804,2020-04-02
SARS coronavirus,ISA,Genus: Coronavirus,32232837,10.1111/head.13811,2020-04-02
Membrane,LOCATION_OF,receptor,32232837,10.1111/head.13811,2020-04-02
receptor,PART_OF,integral to membrane,32232837,10.1111/head.13811,2020-04-02
"M Protein, multiple myeloma",PRODUCES,RNA,32232837,10.1111/head.13811,2020-04-02
"M Protein, multiple myeloma",PRODUCES,angiotensin converting enzyme 2,32232837,10.1111/head.13811,2020-04-02
Health care facility,LOCATION_OF,Cross-Sectional Studies,32232773,10.1007/s40620-020-00729-w,2020-04-02
Ward (environment),LOCATION_OF,Work,32232773,10.1007/s40620-020-00729-w,2020-04-02
Headache,PROCESS_OF,Respondents,32232773,10.1007/s40620-020-00729-w,2020-04-02
Headache,PROCESS_OF,Health Personnel,32232773,10.1007/s40620-020-00729-w,2020-04-02
Exacerbation,PROCESS_OF,Health Personnel,32232773,10.1007/s40620-020-00729-w,2020-04-02
Critical Illness,PROCESS_OF,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Warburg Therapy,ADMINISTERED_TO,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Experience,PROCESS_OF,Population Group,32232652,10.1007/s11596-020-2176-2,2020-04-02
Confirmation,PROCESS_OF,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Nasal Cannula,TREATS,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Acute respiratory failure,PROCESS_OF,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Noninvasive Ventilation,TREATS,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Peak gastric acid output,PROCESS_OF,Patients,32232652,10.1007/s11596-020-2176-2,2020-04-02
Operative Surgical Procedures,TREATS,Patients,32232648,10.1007/s11604-020-00958-w,2020-04-02
Cessation of life,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,32232648,10.1007/s11604-020-00958-w,2020-04-02
Operative Surgical Procedures,TREATS,Patients,32232648,10.1007/s11604-020-00958-w,2020-04-02
Chest CT,DIAGNOSES,Pneumonia,32232520,10.1007/s00259-020-04790-2,2020-04-02
Real-Time Polymerase Chain Reaction,METHOD_OF,Chest CT,32232520,10.1007/s00259-020-04790-2,2020-04-02
Respiration Disorders,COEXISTS_WITH,Symptoms,32232520,10.1007/s00259-020-04790-2,2020-04-02
Virus,PROCESS_OF,Voluntary Workers,32232433,10.1001/jamaophthalmol.2020.1291,2020-04-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Participant,32232433,10.1001/jamaophthalmol.2020.1291,2020-04-02
Infected,PROCESS_OF,Persons,32232432,10.1093/jamia/ocaa039,2020-04-02
conjunctiva,LOCATION_OF,Diagnosis,32232432,10.1093/jamia/ocaa039,2020-04-02
conjunctiva,PART_OF,Patients,32232432,10.1093/jamia/ocaa039,2020-04-02
GSKIP gene,PART_OF,Patients,32232432,10.1093/jamia/ocaa039,2020-04-02
conjunctiva,LOCATION_OF,Positive Finding,32232432,10.1093/jamia/ocaa039,2020-04-02
Positive Finding,PROCESS_OF,Patients,32232432,10.1093/jamia/ocaa039,2020-04-02
Eye,LOCATION_OF,Symptoms,32232432,10.1093/jamia/ocaa039,2020-04-02
Eye,LOCATION_OF,Symptoms,32232432,10.1093/jamia/ocaa039,2020-04-02
Symptoms,PROCESS_OF,Patients,32232432,10.1093/jamia/ocaa039,2020-04-02
Patients,LOCATION_OF,GSKIP gene,32232432,10.1093/jamia/ocaa039,2020-04-02
Pneumonia,PROCESS_OF,Patients,32232423,10.1001/jamaoto.2020.0780,2020-04-02
Real-Time Polymerase Chain Reaction,METHOD_OF,X-Ray Computed Tomography,32232423,10.1001/jamaoto.2020.0780,2020-04-02
Upper aerodigestive tract,LOCATION_OF,Disease,32232339,10.1084/jem.20200537,2020-04-02
Tracheostomy procedure,TREATS,Patients,32232339,10.1084/jem.20200537,2020-04-02
skill,PROCESS_OF,Health Personnel,32232339,10.1084/jem.20200537,2020-04-02
Respiration Disorders,ISA,Disease,32231392,10.1371/journal.pone.0231236,2020-04-02
Coronavirus Infections,CAUSES,Respiration Disorders,32231392,10.1371/journal.pone.0231236,2020-04-02
Coronavirus Infections,ISA,Disease,32231392,10.1371/journal.pone.0231236,2020-04-02
Universities,ISA,School,32231392,10.1371/journal.pone.0231236,2020-04-02
Protection,PROCESS_OF,Health Personnel,32231392,10.1371/journal.pone.0231236,2020-04-02
Psychological Factors,PROCESS_OF,Persons,32231374,10.1371/journal.pone.0230405,2020-04-02
Infected,PROCESS_OF,Persons,32231349,10.4081/monaldi.2020.1290,2020-04-02
Infected,PROCESS_OF,Persons,32231349,10.4081/monaldi.2020.1290,2020-04-02
Infected,PROCESS_OF,Population Group,32231349,10.4081/monaldi.2020.1290,2020-04-02
Vaccines,TREATS,Coronavirus Infections,32231345,10.1038/s41422-020-0305-x,2020-04-02
Therapeutic procedure,TREATS,Coronavirus Infections,32231345,10.1038/s41422-020-0305-x,2020-04-02
Coronavirus Infections,ISA,Disease,32231171,10.20452/pamw.15272,2020-04-02
Severe Acute Respiratory Syndrome,CAUSES,Disease,32231171,10.20452/pamw.15272,2020-04-02
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32231171,10.20452/pamw.15272,2020-04-02
"Vitronectin, human",AFFECTS,syncytium formation by plasma membrane fusion,32231171,10.20452/pamw.15272,2020-04-02
Fusion inhibitor,compared_with,Peptides,32231171,10.20452/pamw.15272,2020-04-02
Fusion inhibitor,higher_than,Peptides,32231171,10.20452/pamw.15272,2020-04-02
"S protein, severe acute respiratory syndrome coronavirus",AFFECTS,Membrane Fusion,32231171,10.20452/pamw.15272,2020-04-02
Prophylactic treatment,ADMINISTERED_TO,Mus,32231171,10.20452/pamw.15272,2020-04-02
Hypertensive disease,PROCESS_OF,Survivors,32230995,10.3390/ijerph17072275,2020-04-02
Hypertensive disease,PROCESS_OF,Population Group,32230995,10.3390/ijerph17072275,2020-04-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Older people,32230995,10.3390/ijerph17072275,2020-04-02
Epidemic,ISA,Disease Outbreaks,32230900,10.3390/v12040372,2020-04-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32230900,10.3390/v12040372,2020-04-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32230900,10.3390/v12040372,2020-04-02
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32230900,10.3390/v12040372,2020-04-02
Therapeutic procedure,TREATS,Virus Diseases,32229802,10.4097/kja.20116,2020-04-02
Confirmation,PROCESS_OF,hospitalized patients,32229706,10.18632/aging.103001,2020-04-02
Severe Acute Respiratory Syndrome,AFFECTS,Renal function,32229706,10.18632/aging.103001,2020-04-02
Department,LOCATION_OF,Study,32229706,10.18632/aging.103001,2020-04-02
Chronic Kidney Diseases,PROCESS_OF,Patients,32229706,10.18632/aging.103001,2020-04-02
Continuous renal replacement therapy,TREATS,Chronic Kidney Diseases,32229706,10.18632/aging.103001,2020-04-02
Hospitalization,TREATS,Patients,32229706,10.18632/aging.103001,2020-04-02
Hospitalization,TREATS(INFER),Chronic Kidney Diseases,32229706,10.18632/aging.103001,2020-04-02
Chronic Kidney Diseases,PROCESS_OF,Patients,32229706,10.18632/aging.103001,2020-04-02
Continuous renal replacement therapy,COEXISTS_WITH,Hospitalization,32229706,10.18632/aging.103001,2020-04-02
Indicators,NEG_AFFECTS,Pneumonia,32229706,10.18632/aging.103001,2020-04-02
Indicators,NEG_AFFECTS,Chronic Kidney Diseases,32229706,10.18632/aging.103001,2020-04-02
Chronic Kidney Diseases,PROCESS_OF,Patients,32229706,10.18632/aging.103001,2020-04-02
Chronic Kidney Diseases,PROCESS_OF,Patients,32229706,10.18632/aging.103001,2020-04-02
Patients,LOCATION_OF,Urine,32229706,10.18632/aging.103001,2020-04-02
Severe Acute Respiratory Syndrome,NEG_CAUSES,"Kidney Failure, Acute",32229706,10.18632/aging.103001,2020-04-02
Chronic Kidney Diseases,COEXISTS_WITH,patient condition,32229706,10.18632/aging.103001,2020-04-02
Doxycycline,INHIBITS,"TXN protein, human",32229705,10.18632/aging.102988,2020-04-02
Sirolimus,INHIBITS,"TXN protein, human",32229705,10.18632/aging.102988,2020-04-02
Antibiotics,DISRUPTS,Virus Replication,32229705,10.18632/aging.102988,2020-04-02
Antibiotics,DISRUPTS,interleukin-6 production,32229705,10.18632/aging.102988,2020-04-02
Antibiotics,PREVENTS,Disease,32229705,10.18632/aging.102988,2020-04-02
Doxycycline,DISRUPTS(SPEC),Virus Replication,32229705,10.18632/aging.102988,2020-04-02
Doxycycline,DISRUPTS(SPEC),interleukin-6 production,32229705,10.18632/aging.102988,2020-04-02
Doxycycline,ISA,Antibiotics,32229705,10.18632/aging.102988,2020-04-02
Azithromycin,DISRUPTS(SPEC),Virus Replication,32229705,10.18632/aging.102988,2020-04-02
Azithromycin,DISRUPTS(SPEC),interleukin-6 production,32229705,10.18632/aging.102988,2020-04-02
Azithromycin,ISA,Antibiotics,32229705,10.18632/aging.102988,2020-04-02
Aging,COEXISTS_WITH,physiological aspects,32229605,10.1128/JCM.00461-20,2020-04-02
Immunosenescence,AFFECTS,Immune System Processes,32229605,10.1128/JCM.00461-20,2020-04-02
Immune System Processes,PROCESS_OF,Old age,32229605,10.1128/JCM.00461-20,2020-04-02
Immune system,LOCATION_OF,Booster Immunization - ActSubstanceAdministrationCode,32229605,10.1128/JCM.00461-20,2020-04-02
Communicable Diseases,PROCESS_OF,Patients,32229501,10.1136/esmoopen-2020-000759,2020-04-02
Detection,USES,CD40LG wt Allele,32229501,10.1136/esmoopen-2020-000759,2020-04-02
Patients,LOCATION_OF,Specimen Type - Serum,32229501,10.1136/esmoopen-2020-000759,2020-04-02
High sensitivity,METHOD_OF,communicable disease diagnosis (procedure),32229501,10.1136/esmoopen-2020-000759,2020-04-02
High sensitivity,METHOD_OF,Detection,32229501,10.1136/esmoopen-2020-000759,2020-04-02
Anxiety,PROCESS_OF,Respondents,32229322,10.1016/j.ejrad.2020.108961,2020-04-02
Mild anxiety,PROCESS_OF,Respondents,32229322,10.1016/j.ejrad.2020.108961,2020-04-02
Moderate anxiety,PROCESS_OF,Respondents,32229322,10.1016/j.ejrad.2020.108961,2020-04-02
Academia (organization),LOCATION_OF,Correlation Study,32229322,10.1016/j.ejrad.2020.108961,2020-04-02
Suspicion,PROCESS_OF,Patients,32229257,10.1016/j.ijid.2020.03.047,2020-04-02
X-Ray Computed Tomography,DIAGNOSES,Pneumonia,32229257,10.1016/j.ijid.2020.03.047,2020-04-02
CAT scan normal,PROCESS_OF,Patients,32229257,10.1016/j.ijid.2020.03.047,2020-04-02
Abnormal Finding,PROCESS_OF,Patients,32229257,10.1016/j.ijid.2020.03.047,2020-04-02
Coronavirus Infections,ISA,Disease,32229157,10.1016/j.arcmed.2020.03.005,2020-04-02
Severe disorder,PROCESS_OF,Patients,32229157,10.1016/j.arcmed.2020.03.005,2020-04-02
Urgent Procedure,COEXISTS_WITH,Health Care,32229155,10.1016/j.arcmed.2020.03.004,2020-04-02
Virus,CAUSES,Syndrome,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Microorganism,ISA,Organism,32229107,10.1016/j.cca.2020.03.032,2020-04-02
,CONVERTS_TO,Protectin,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Arachidonic Acid,CONVERTS_TO,Protectin,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Leukotrienes,CAUSES,Inflammation,32229107,10.1016/j.cca.2020.03.032,2020-04-02
macrophage,LOCATION_OF,Phagocytosis,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Prostaglandins,CAUSES,Inflammation,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Thromboxanes,CAUSES,Inflammation,32229107,10.1016/j.cca.2020.03.032,2020-04-02
sodium dehydroacetate,CONVERTS_TO,Protectin,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Immunologic cell,LOCATION_OF,Phagocytosis,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Lipoxins,AUGMENTS,Phagocytosis,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Resolvin,NEG_DISRUPTS,Inflammation,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Severe Acute Respiratory Syndrome,ISA,Virus Diseases,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Middle East Respiratory Syndrome,ISA,Virus Diseases,32229107,10.1016/j.cca.2020.03.032,2020-04-02
Arachidonic Acid,ISA,"Fatty Acids, Unsaturated",32229107,10.1016/j.cca.2020.03.032,2020-04-02
Middle East Respiratory Syndrome,ISA,Infection,32229107,10.1016/j.cca.2020.03.032,2020-04-02
RNA Viruses,CAUSES,Acute respiratory disease,32228809,10.3201/eid2607.200718,2020-04-02
Influenza,AFFECTS,Male population group,32228809,10.3201/eid2607.200718,2020-04-02
Inflammation,CAUSES,Cessation of life,32228809,10.3201/eid2607.200718,2020-04-02
Pulmonary Fibrosis,CAUSES,Cessation of life,32228809,10.3201/eid2607.200718,2020-04-02
Virus,CAUSES,Influenza,32228809,10.3201/eid2607.200718,2020-04-02
Hydrogen,ISA,Gases,32228809,10.3201/eid2607.200718,2020-04-02
Therapeutic procedure,AFFECTS,Inspiration function,32228809,10.3201/eid2607.200718,2020-04-02
Antiviral Therapy,USES,New medications,32228809,10.3201/eid2607.200718,2020-04-02
Interleukin-1,ISA,cytokine,32228809,10.3201/eid2607.200718,2020-04-02
Toll-Like Receptor Family Gene,STIMULATES,Interleukin-1,32228809,10.3201/eid2607.200718,2020-04-02
Pharmaceutical Preparations,INHIBITS,Interleukin-1,32228809,10.3201/eid2607.200718,2020-04-02
Pharmaceutical Preparations,TREATS,Rheumatoid Arthritis,32228809,10.3201/eid2607.200718,2020-04-02
Disease,PROCESS_OF,Patients,32228808,10.3201/eid2607.200574,2020-04-02
Coronavirus Infections,ISA,Disease,32228808,10.3201/eid2607.200574,2020-04-02
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32228808,10.3201/eid2607.200574,2020-04-02
Asymptomatic,PROCESS_OF,Family,32228808,10.3201/eid2607.200574,2020-04-02
Coronavirus Infections,ISA,Disease,32228780,10.4269/ajtmh.20-0205,2020-04-02
Challenge,PREVENTS,Disease,32228780,10.4269/ajtmh.20-0205,2020-04-02
Challenge,PREVENTS(SPEC),Coronavirus Infections,32228780,10.4269/ajtmh.20-0205,2020-04-02
Coronavirus Infections,ISA,Disease,32228738,10.1017/dmp.2020.60,2020-04-02
Coronavirus Infections,CAUSES,Disease,32228737,10.1017/S2045796020000372,2020-04-02
Decision,PROCESS_OF,Maker (occupation),32228732,10.1017/dmp.2020.59,2020-04-02
Coronavirus Infections,ISA,Disease,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Diabetes Mellitus,COEXISTS_WITH,patient condition,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Hypertensive disease,COEXISTS_WITH,patient condition,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Obesity,COEXISTS_WITH,patient condition,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Diabetes,AFFECTS,Immune response,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Diabetes,AFFECTS,modulation by virus of host morphology or physiology,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Diabetes,PROCESS_OF,Patients,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Disease,PROCESS_OF,Patients,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Coronavirus Infections,ISA,Disease,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32228309,10.1161/CIRCULATIONAHA.120.047063,2020-04-02
Comorbidity,PROCESS_OF,Patients,32228252,10.1152/ajpheart.00217.2020,2020-04-02
Severe Acute Respiratory Syndrome,INTERACTS_WITH,Virus,32228226,10.1080/22221751.2020.1747363,2020-04-02
Body tissue,LOCATION_OF,Severe Acute Respiratory Syndrome,32228226,10.1080/22221751.2020.1747363,2020-04-02
Body tissue,PRODUCES,angiotensin converting enzyme 2,32228226,10.1080/22221751.2020.1747363,2020-04-02
angiotensin converting enzyme 2,INHIBITS,Enzymes,32228226,10.1080/22221751.2020.1747363,2020-04-02
Peptides,PREDISPOSES,Cardiovascular Diseases,32228226,10.1080/22221751.2020.1747363,2020-04-02
Peptides,PRODUCES,angiotensin I (1-7),32228226,10.1080/22221751.2020.1747363,2020-04-02
Hydroxymethylglutaryl-CoA Reductase Inhibitors,STIMULATES,angiotensin converting enzyme 2,32228226,10.1080/22221751.2020.1747363,2020-04-02
Cardiovascular Diseases,PROCESS_OF,Patients,32228226,10.1080/22221751.2020.1747363,2020-04-02
Chronic disease,PREDISPOSES,Severe Acute Respiratory Syndrome,32228226,10.1080/22221751.2020.1747363,2020-04-02
Hypertensive disease,ISA,Cardiovascular Diseases,32228226,10.1080/22221751.2020.1747363,2020-04-02
Hypertensive disease,PROCESS_OF,Patients,32228226,10.1080/22221751.2020.1747363,2020-04-02
Hypertensive disease,PROCESS_OF(SPEC),Patients,32228226,10.1080/22221751.2020.1747363,2020-04-02
Hydroxymethylglutaryl-CoA Reductase Inhibitors,INHIBITS,angiotensin converting enzyme 2,32228226,10.1080/22221751.2020.1747363,2020-04-02
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32228222,10.1080/22221751.2020.1746200,2020-04-02
p53 signaling pathway,PROCESS_OF,Lymphocyte,32228222,10.1080/22221751.2020.1746200,2020-04-02
Renin-angiotensin system,ASSOCIATED_WITH,patient condition,32227799,10.4414/smw.2020.20212,2020-04-01
peripheral blood,LOCATION_OF,Interleukin-6,32227799,10.4414/smw.2020.20212,2020-04-01
Severe disorder,PROCESS_OF,Patients,32227799,10.4414/smw.2020.20212,2020-04-01
Coughing,ISA,Symptoms,32227642,10.1002/bies.202000063,2020-04-01
Fever,PROCESS_OF,Patients,32227642,10.1002/bies.202000063,2020-04-01
Hypotension,PROCESS_OF,Patients,32227642,10.1002/bies.202000063,2020-04-01
intensive care unit,ISA,Hospitals,32227642,10.1002/bies.202000063,2020-04-01
Vasoconstrictor Agents,TREATS,Respiratory failure without hypercapnia,32227642,10.1002/bies.202000063,2020-04-01
Mechanical ventilation,ADMINISTERED_TO,Patients,32227642,10.1002/bies.202000063,2020-04-01
Critical Illness,PROCESS_OF,Patients,32227642,10.1002/bies.202000063,2020-04-01
Systemic disease,PROCESS_OF,Social Networks,32227596,10.1111/head.13810,2020-04-01
BARRIER,TREATS,Migraine Disorders,32227494,10.1002/jmv.25796,2020-04-01
Therapeutic procedure,AFFECTS,Patients,32227494,10.1002/jmv.25796,2020-04-01
Migraine Disorders,PROCESS_OF,Patients,32227494,10.1002/jmv.25796,2020-04-01
Severe disorder,PROCESS_OF,Old age,32227493,10.1002/jmv.25798,2020-04-01
Reverse Transcriptase Polymerase Chain Reaction,DIAGNOSES,Virus,32227493,10.1002/jmv.25798,2020-04-01
Respiratory secretion,PART_OF,Tract,32227493,10.1002/jmv.25798,2020-04-01
Therapeutic procedure,TREATS,Genus: Coronavirus,32227492,10.1002/jum.15285,2020-04-01
Ribavirin,ISA,Antiviral Agents,32227492,10.1002/jum.15285,2020-04-01
Ribavirin,TREATS,Muscle Rigidity,32227492,10.1002/jum.15285,2020-04-01
Disease,PROCESS_OF,Patients,32227357,10.1002/ddr.21666,2020-04-01
Lung,LOCATION_OF,Ultrasonography,32227357,10.1002/ddr.21666,2020-04-01
Coronavirus Infections,ISA,Disease,32227357,10.1002/ddr.21666,2020-04-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32227357,10.1002/ddr.21666,2020-04-01
Disease,PROCESS_OF,Patients,32227357,10.1002/ddr.21666,2020-04-01
Lung,LOCATION_OF,Ultrasonography,32227357,10.1002/ddr.21666,2020-04-01
Coronavirus Infections,ISA,Disease,32227357,10.1002/ddr.21666,2020-04-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32227357,10.1002/ddr.21666,2020-04-01
Experience,PROCESS_OF,Patients,32227357,10.1002/ddr.21666,2020-04-01
Disease,PROCESS_OF,World,32227274,10.1007/s00011-020-01342-0,2020-04-01
Coronavirus Infections,ISA,Disease,32227274,10.1007/s00011-020-01342-0,2020-04-01
Coronavirus Infections,PROCESS_OF(SPEC),World,32227274,10.1007/s00011-020-01342-0,2020-04-01
SARS coronavirus,CAUSES,Virus Diseases,32227274,10.1007/s00011-020-01342-0,2020-04-01
Angiotensin Receptor,INHIBITS,"Angiotensin II Receptor, Type 2",32227274,10.1007/s00011-020-01342-0,2020-04-01
Anti-Inflammatory Agents,PREVENTS,Acute Lung Injury,32227274,10.1007/s00011-020-01342-0,2020-04-01
Coronavirus Infections,ISA,Disease,32227274,10.1007/s00011-020-01342-0,2020-04-01
Acute Lung Injury,COEXISTS_WITH,Coronavirus Infections,32227274,10.1007/s00011-020-01342-0,2020-04-01
Hydroxymethylglutaryl-CoA Reductase Inhibitors,ISA,Hypolipidemic Agents,32227274,10.1007/s00011-020-01342-0,2020-04-01
Hospitals,LOCATION_OF,Study,32227123,10.1093/infdis/jiaa150,2020-04-01
lopinavir / Ritonavir,TREATS,Patients,32227123,10.1093/infdis/jiaa150,2020-04-01
Serum,LOCATION_OF,Lactate Dehydrogenase,32227123,10.1093/infdis/jiaa150,2020-04-01
Peripheral vascular alteration,PROCESS_OF,hospitalized patients,32227091,10.1093/cid/ciaa271,2020-04-01
Clinical Significance,PROCESS_OF,Patients,32227091,10.1093/cid/ciaa271,2020-04-01
X-Ray Computed Tomography,USES,Microtomy,32227090,10.1093/cvr/cvaa078,2020-04-01
SARS coronavirus,INTERACTS_WITH,Disease,32226823,10.1186/s41256-020-00135-6,2020-04-01
Severe disorder,PROCESS_OF,Patients,32226823,10.1186/s41256-020-00135-6,2020-04-01
Middle East Respiratory Syndrome Coronavirus,INTERACTS_WITH,Disease,32226823,10.1186/s41256-020-00135-6,2020-04-01
Complication,COEXISTS_WITH,patient condition,32226823,10.1186/s41256-020-00135-6,2020-04-01
Heart,PART_OF,Homo sapiens,32226823,10.1186/s41256-020-00135-6,2020-04-01
Organ,LOCATION_OF,angiotensin converting enzyme 2,32226823,10.1186/s41256-020-00135-6,2020-04-01
Heart,PART_OF,Adult,32226823,10.1186/s41256-020-00135-6,2020-04-01
Leptocyte,PART_OF,Heart,32226823,10.1186/s41256-020-00135-6,2020-04-01
Disease,PROCESS_OF,Patients,32226823,10.1186/s41256-020-00135-6,2020-04-01
Heart failure,ISA,Disease,32226823,10.1186/s41256-020-00135-6,2020-04-01
Heart failure,PROCESS_OF(SPEC),Patients,32226823,10.1186/s41256-020-00135-6,2020-04-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32226823,10.1186/s41256-020-00135-6,2020-04-01
Heart Injuries,PROCESS_OF,Patients,32226823,10.1186/s41256-020-00135-6,2020-04-01
Lung,LOCATION_OF,Increased markings,32226353,10.1007/s11469-020-00270-8,2020-04-01
Infiltration,PROCESS_OF,Patients,32226353,10.1007/s11469-020-00270-8,2020-04-01
High altitude pulmonary edema,PROCESS_OF,Patients,32226353,10.1007/s11469-020-00270-8,2020-04-01
Anxiety,PROCESS_OF,Persons,32226295,10.7150/ijbs.45134,2020-04-01
Worried,PROCESS_OF,Persons,32226295,10.7150/ijbs.45134,2020-04-01
Fear (Mental Process),PROCESS_OF,Persons,32226295,10.7150/ijbs.45134,2020-04-01
Severe Acute Respiratory Syndrome,CAUSES,Symptoms,32226294,10.7150/ijbs.45221,2020-04-01
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32226294,10.7150/ijbs.45221,2020-04-01
SARS coronavirus,ISA,Virus,32226294,10.7150/ijbs.45221,2020-04-01
Severe Acute Respiratory Syndrome,AFFECTS,Elderly (population group),32226294,10.7150/ijbs.45221,2020-04-01
Prophylactic treatment,TREATS,Disease,32226294,10.7150/ijbs.45221,2020-04-01
Confidence,PROCESS_OF,Respondents,32226293,10.7150/ijbs.45072,2020-04-01
Practice Experience,PROCESS_OF,Woman,32226293,10.7150/ijbs.45072,2020-04-01
Mental disorders,PROCESS_OF,Patients,32226292,10.7150/ijbs.45135,2020-04-01
Disease,PROCESS_OF,Patients,32226292,10.7150/ijbs.45135,2020-04-01
Coronavirus Infections,ISA,Disease,32226292,10.7150/ijbs.45135,2020-04-01
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32226292,10.7150/ijbs.45135,2020-04-01
Mental disorders,PROCESS_OF,Patients,32226292,10.7150/ijbs.45135,2020-04-01
Challenge,TREATS,Patients,32226292,10.7150/ijbs.45135,2020-04-01
Coronavirus Infections,ISA,Disease,32226290,10.7150/ijbs.45498,2020-04-01
Coronavirus Infections,ISA,Disease,32226290,10.7150/ijbs.45498,2020-04-01
Mental disorders,PROCESS_OF,Patients,32226290,10.7150/ijbs.45498,2020-04-01
Coronavirus Infections,ISA,Disease,32226290,10.7150/ijbs.45498,2020-04-01
Genus: Coronavirus,ISA,Virus,32226289,10.7150/ijbs.45123,2020-04-01
Severe disorder,PROCESS_OF,Homo sapiens,32226289,10.7150/ijbs.45123,2020-04-01
Genus: Coronavirus,CAUSES,Combat Disorders,32226289,10.7150/ijbs.45123,2020-04-01
Coronavirus Infections,CAUSES,Syndrome,32226288,10.7150/ijbs.45538,2020-04-01
Supportive care,TREATS,Symptoms,32226287,10.7150/ijbs.45357,2020-04-01
Infected,PROCESS_OF,Patients,32226287,10.7150/ijbs.45357,2020-04-01
SARS coronavirus,PROCESS_OF,Patients,32226287,10.7150/ijbs.45357,2020-04-01
Fever,ISA,Symptoms,32226286,10.7150/ijbs.45472,2020-04-01
Feces,LOCATION_OF,STMN1 gene,32226286,10.7150/ijbs.45472,2020-04-01
Nasopharyngeal swab (specimen),LOCATION_OF,STMN1 gene,32226286,10.7150/ijbs.45472,2020-04-01
SARS coronavirus,PROCESS_OF,Sister,32226285,10.7150/ijbs.45053,2020-04-01
Disease,PROCESS_OF,Homo sapiens,32226285,10.7150/ijbs.45053,2020-04-01
Insight,PROCESS_OF,Homo sapiens,32226285,10.7150/ijbs.45053,2020-04-01
Coronavirus Infections,CAUSES,Pneumonia,32226003,10.24875/BMHIM.20000039,2020-04-01
Infected,PROCESS_OF,Patients,32226003,10.24875/BMHIM.20000039,2020-04-01
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32225176,10.1038/s41586-020-2180-5,2020-04-01
Coronavirus Infections,COEXISTS_WITH,Respiratory Tract Infections,32225176,10.1038/s41586-020-2180-5,2020-04-01
Coronavirus Infections,PROCESS_OF,Homo sapiens,32225135,10.23736/S0393-2249.20.03861-8,2020-04-01
Postoperative Care,TREATS,Patients,32225133,10.5867/medwave.2020.02.7861,2020-04-01
"Oncologic procedure, NOS",TREATS,Patients,32225133,10.5867/medwave.2020.02.7861,2020-04-01
Urgent Procedure,TREATS,Patients,32225133,10.5867/medwave.2020.02.7861,2020-04-01
Triage,TREATS,Symptoms,32225133,10.5867/medwave.2020.02.7861,2020-04-01
Foundations,LOCATION_OF,Analysis,32224986,10.3390/ijerph17072225,2020-04-01
Analysis,MEASURES,Statistical Significance,32224986,10.3390/ijerph17072225,2020-04-01
Epidemic,CAUSES,Pneumonia,32224769,10.1097/CCM.0000000000004363,2020-04-01
Epidemic,CAUSES,Kidney Failure,32224769,10.1097/CCM.0000000000004363,2020-04-01
Fever,PROCESS_OF,Patients,32224769,10.1097/CCM.0000000000004363,2020-04-01
saliva,PART_OF,Homo sapiens,32224769,10.1097/CCM.0000000000004363,2020-04-01
intensive care unit,LOCATION_OF,Administration occupational activities,32224310,10.1016/S1473-3099(20)30200-0,2020-04-01
Critical Illness,PROCESS_OF,Patients,32224310,10.1016/S1473-3099(20)30200-0,2020-04-01
intensive care unit,LOCATION_OF,Administration occupational activities,32224310,10.1016/S1473-3099(20)30200-0,2020-04-01
Pneumonia,PROCESS_OF,Persons,32224294,10.1016/j.purol.2020.03.009,2020-04-01
Disease,PROCESS_OF,Patients,32224294,10.1016/j.purol.2020.03.009,2020-04-01
Coronavirus Infections,PROCESS_OF,Patients,32224232,10.1016/j.jaip.2020.03.012,2020-04-01
Malignant Neoplasms,PROCESS_OF,Patients,32224232,10.1016/j.jaip.2020.03.012,2020-04-01
Comorbidity,PROCESS_OF,Patients,32224232,10.1016/j.jaip.2020.03.012,2020-04-01
Surgical Management,TREATS,Patients,32224232,10.1016/j.jaip.2020.03.012,2020-04-01
Tract,PART_OF,Genitalia,32224232,10.1016/j.jaip.2020.03.012,2020-04-01
Asthma,PROCESS_OF,Patients,32224151,10.1016/j.annonc.2020.03.296,2020-04-01
Primary immune deficiency disorder,PROCESS_OF,Patients,32224151,10.1016/j.annonc.2020.03.296,2020-04-01
Chest CT,DIAGNOSES,Disease,32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
Chest CT,DIAGNOSES,Poor outcome,32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
Therapeutic procedure,ADMINISTERED_TO,Cancer Patient,32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
Therapeutic procedure,CAUSES,Decreased Immunologic Activity [PE],32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
Screening procedure,PREVENTS,Coinfection,32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
Screening procedure,TREATS,Coronavirus Infections,32224133,10.1016/j.sapharm.2020.03.007,2020-04-01
responsibility,PROCESS_OF,Community Pharmacists,32224116,10.1016/j.jmii.2020.03.010,2020-04-01
Feces,ASSOCIATED_WITH,Fourth Stage of Labor,32224074,10.1016/j.chest.2020.03.032,2020-04-01
Feces,PART_OF,Patients,32224074,10.1016/j.chest.2020.03.032,2020-04-01
Pneumonia,PROCESS_OF,Patients,32223871,10.5811/westjem.2020.3.47348,2020-04-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32223871,10.5811/westjem.2020.3.47348,2020-04-01
Sequential Organ Failure Assessment Scores,PROCESS_OF,Patients,32223871,10.5811/westjem.2020.3.47348,2020-04-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32223871,10.5811/westjem.2020.3.47348,2020-04-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32223871,10.5811/westjem.2020.3.47348,2020-04-01
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Patients,32223840,10.3760/cma.j.cn112338-20200314-00345,2020-04-01
Fever,NEG_PROCESS_OF,Caucasoid Race,32223840,10.3760/cma.j.cn112338-20200314-00345,2020-04-01
Patients,LOCATION_OF,GSKIP gene,32223840,10.3760/cma.j.cn112338-20200314-00345,2020-04-01
Evaluation,ADMINISTERED_TO,Physicians,32223774,10.1017/dmp.2020.55,2020-04-01
Epidemic,ISA,Disease Outbreaks,32223063,10.1002/ccd.28888,2020-03-31
Acute disease of cardiovascular system,PROCESS_OF,Patients,32223012,10.1111/irv.12739,2020-03-31
Laboratory,LOCATION_OF,Administration occupational activities,32223012,10.1111/irv.12739,2020-03-31
Fever,PROCESS_OF,Patients,32222995,10.1002/jmv.25797,2020-03-31
unwellness,PROCESS_OF,Patients,32222995,10.1002/jmv.25797,2020-03-31
Isolate - microorganism,COEXISTS_WITH,century,32222993,10.1002/jmv.25794,2020-03-31
Coronavirus Infections,ISA,Disease,32222993,10.1002/jmv.25794,2020-03-31
Isolate - microorganism,COEXISTS_WITH,Genome,32222993,10.1002/jmv.25794,2020-03-31
Coronavirus Infections,CAUSES,Communicable Diseases,32222988,10.1111/apt.15731,2020-03-31
Infected,PROCESS_OF,Child,32222988,10.1111/apt.15731,2020-03-31
Throat swab sample,LOCATION_OF,Nucleic Acids,32222988,10.1111/apt.15731,2020-03-31
Gastrointestinal symptom,PROCESS_OF,Adult,32222986,10.1002/jmv.25793,2020-03-31
Gastrointestinal symptom,PROCESS_OF,Child,32222986,10.1002/jmv.25793,2020-03-31
Vomiting,PROCESS_OF,Child,32222986,10.1002/jmv.25793,2020-03-31
Digestive symptom,PROCESS_OF,Adult,32222986,10.1002/jmv.25793,2020-03-31
Digestive symptom,PROCESS_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
Gastrointestinal symptom,PROCESS_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
Gastrointestinal symptom,PROCESS_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
Epithelial Cells,LOCATION_OF,Nucleocapsid Proteins,32222986,10.1002/jmv.25793,2020-03-31
Epithelial Cells,LOCATION_OF,angiotensin converting enzyme 2,32222986,10.1002/jmv.25793,2020-03-31
Virion,LOCATION_OF,Nucleocapsid Proteins,32222986,10.1002/jmv.25793,2020-03-31
Virion,LOCATION_OF,angiotensin converting enzyme 2,32222986,10.1002/jmv.25793,2020-03-31
gastrointestinal,LOCATION_OF,Epithelial Cells,32222986,10.1002/jmv.25793,2020-03-31
Symptoms,PROCESS_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
Epithelial Cells,PART_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
Feces,PART_OF,Patients,32222986,10.1002/jmv.25793,2020-03-31
gastrointestinal,LOCATION_OF,Epithelial Cells,32222986,10.1002/jmv.25793,2020-03-31
Infected,PROCESS_OF,Medical Staff,32222911,10.1007/s11096-020-01017-0,2020-03-31
Lesion,PROCESS_OF,Medical Staff,32222911,10.1007/s11096-020-01017-0,2020-03-31
lobe,LOCATION_OF,Lesion,32222911,10.1007/s11096-020-01017-0,2020-03-31
Pharmaceutical Services,PREVENTS,Infection,32222812,10.1007/s00134-020-06022-5,2020-03-31
intensive care unit,LOCATION_OF,Administration occupational activities,32222720,10.31616/asj.2020.0122,2020-03-31
Critical Illness,PROCESS_OF,Patients,32222720,10.31616/asj.2020.0122,2020-03-31
intensive care unit,LOCATION_OF,Administration occupational activities,32222720,10.31616/asj.2020.0122,2020-03-31
Experience,PROCESS_OF,Outpatients,32222713,10.1159/000507417,2020-03-31
"Kidney Failure, Chronic",PROCESS_OF,Patients,32222703,10.1159/000507261,2020-03-31
Chronic Kidney Diseases,PROCESS_OF,Patients,32222703,10.1159/000507261,2020-03-31
IGA Glomerulonephritis,CAUSES,"Kidney Failure, Chronic",32222703,10.1159/000507261,2020-03-31
Maintenance hemodialysis,TREATS,IGA Glomerulonephritis,32222703,10.1159/000507261,2020-03-31
interstitial,LOCATION_OF,Bilateral pneumonia,32222703,10.1159/000507261,2020-03-31
Hydroxychloroquine,TREATS,Disease,32222703,10.1159/000507261,2020-03-31
tocilizumab,TREATS,Disease,32222703,10.1159/000507261,2020-03-31
"Kidney Failure, Chronic",PROCESS_OF,Male population group,32222466,10.1016/j.clim.2020.108393,2020-03-31
"Kidney Failure, Chronic",PROCESS_OF,Patients,32222466,10.1016/j.clim.2020.108393,2020-03-31
Pandemics,ISA,Disease Outbreaks,32222463,10.1016/j.lfs.2020.117592,2020-03-31
Severe disorder,PROCESS_OF,Patients,32222463,10.1016/j.lfs.2020.117592,2020-03-31
Clinical immunologist,TREATS,Patients,32222463,10.1016/j.lfs.2020.117592,2020-03-31
Interleukin-6 Antagonist [EPC],TREATS,Inflammation,32222463,10.1016/j.lfs.2020.117592,2020-03-31
Middle East Respiratory Syndrome,CAUSES,Cessation of life,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Pharmaceutical Preparations,INTERACTS_WITH,RNA-Directed RNA Polymerase,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Polymerase,INTERACTS_WITH(SPEC),RNA-Directed RNA Polymerase,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Polymerase,ISA,Pharmaceutical Preparations,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Infection,ASSOCIATED_WITH,GSKIP gene,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Pharmaceutical Preparations,TREATS,Patients,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Pharmaceutical Preparations,TREATS,Disease,32222433,10.1016/j.gofs.2020.03.017,2020-03-31
Malignant Neoplasms,PROCESS_OF,Patients,32222119,10.1002/jmv.25789,2020-03-30
Surgical Management,TREATS,Patients,32222119,10.1002/jmv.25789,2020-03-30
ovarian,LOCATION_OF,advanced cancer,32222119,10.1002/jmv.25789,2020-03-30
Malignant Neoplasms,PROCESS_OF,Patients,32222119,10.1002/jmv.25789,2020-03-30
Fever,NEG_PROCESS_OF,Pregnant Women,32221983,10.1002/jmv.25785,2020-03-30
Liver normal,PROCESS_OF,Patients,32221983,10.1002/jmv.25785,2020-03-30
Fever,PROCESS_OF,Pregnant Women,32221983,10.1002/jmv.25785,2020-03-30
Fever,PROCESS_OF,Patients,32221983,10.1002/jmv.25785,2020-03-30
Homeostasis,PROCESS_OF,Homo sapiens,32221973,10.1111/anae.15049,2020-03-30
Heart,LOCATION_OF,angiotensin converting enzyme 2,32221973,10.1111/anae.15049,2020-03-30
Inferior Colliculus,LOCATION_OF,angiotensin converting enzyme 2,32221973,10.1111/anae.15049,2020-03-30
Kidney,LOCATION_OF,angiotensin converting enzyme 2,32221973,10.1111/anae.15049,2020-03-30
Lung,LOCATION_OF,angiotensin converting enzyme 2,32221973,10.1111/anae.15049,2020-03-30
Alveolar Epithelial Cells,PART_OF,Homo sapiens,32221973,10.1111/anae.15049,2020-03-30
"Respiratory Distress Syndrome, Adult",ISA,Disease,32221973,10.1111/anae.15049,2020-03-30
Pharmaceutical Preparations,AUGMENTS,angiotensin converting enzyme activity,32221973,10.1111/anae.15049,2020-03-30
Pharmaceutical Preparations,PREVENTS,Chronic disease,32221973,10.1111/anae.15049,2020-03-30
Pharmaceutical Preparations,PREVENTS,"Respiratory Distress Syndrome, Adult",32221973,10.1111/anae.15049,2020-03-30
"M Protein, multiple myeloma",AUGMENTS,angiotensin converting enzyme activity,32221973,10.1111/anae.15049,2020-03-30
"M Protein, multiple myeloma",PREVENTS,Chronic disease,32221973,10.1111/anae.15049,2020-03-30
"M Protein, multiple myeloma",PREVENTS,"Respiratory Distress Syndrome, Adult",32221973,10.1111/anae.15049,2020-03-30
Airway Management,TREATS,Patients,32221964,10.1111/anae.15048,2020-03-30
Trachea,LOCATION_OF,Unexpected difficult intubation,32221964,10.1111/anae.15048,2020-03-30
Staff,TREATS,Patients,32221635,10.1007/s00115-020-00905-0,2020-03-30
intensive care unit,LOCATION_OF,simulation,32221635,10.1007/s00115-020-00905-0,2020-03-30
Stress,PROCESS_OF,Health Personnel,32221523,10.1093/cid/ciaa345,2020-03-30
Stress,PROCESS_OF,Health Personnel,32221523,10.1093/cid/ciaa345,2020-03-30
psychological distress,AFFECTS,Health Personnel,32221523,10.1093/cid/ciaa345,2020-03-30
psychological distress,AFFECTS,teams,32221523,10.1093/cid/ciaa345,2020-03-30
psychological distress,PROCESS_OF,Health Personnel,32221523,10.1093/cid/ciaa345,2020-03-30
Digital Array,METHOD_OF,"Diagnosis, clinical",32221519,10.1093/cid/ciaa344,2020-03-30
Respiratory sample,PART_OF,Tract,32221519,10.1093/cid/ciaa344,2020-03-30
Antibody Formation,PROCESS_OF,Patients,32221306,10.1038/s41467-020-15562-9,2020-03-30
Infected,PROCESS_OF,Patients,32221306,10.1038/s41467-020-15562-9,2020-03-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32221306,10.1038/s41467-020-15562-9,2020-03-30
Negative Finding,PROCESS_OF,Patients,32221306,10.1038/s41467-020-15562-9,2020-03-30
Present,PROCESS_OF,Patients,32221306,10.1038/s41467-020-15562-9,2020-03-30
RNA,AFFECTS,Hypersensitivity,32221306,10.1038/s41467-020-15562-9,2020-03-30
Cell Count,USES,"ACE2 protein, human",32221172,10.1213/ANE.0000000000004830,2020-03-30
Care of intensive care unit patient,TREATS,patient condition,32221117,10.1097/SLA.0000000000003925,2020-03-30
Chicago,ISA,Cities,32221117,10.1097/SLA.0000000000003925,2020-03-30
New York City,ISA,Cities,32221117,10.1097/SLA.0000000000003925,2020-03-30
Experience,PROCESS_OF,Community,32221117,10.1097/SLA.0000000000003925,2020-03-30
Perioperative complication,PROCESS_OF,surgical patients,32221059,10.1097/JNN.0000000000000525,2020-03-30
Elective Surgical Procedures,TREATS,Community,32221059,10.1097/JNN.0000000000000525,2020-03-30
Elective Surgical Procedures,TREATS,Patients,32221059,10.1097/JNN.0000000000000525,2020-03-30
Eye,LOCATION_OF,"CD69 protein, human",32220989,10.1136/vr.m1234,2020-03-30
Foot,LOCATION_OF,Traffic,32220989,10.1136/vr.m1234,2020-03-30
"CD69 protein, human",PART_OF,Neoplasm Metastasis,32220989,10.1136/vr.m1234,2020-03-30
Rest,TREATS,Present,32220650,10.1016/S1473-3099(20)30198-5,2020-03-30
Present,PROCESS_OF,Community,32220650,10.1016/S1473-3099(20)30198-5,2020-03-30
Injury due to exposure to external cause,PROCESS_OF,Patients,32220574,10.1016/j.jmii.2020.03.008,2020-03-30
upper respiratory symptom,PROCESS_OF,Patients,32220574,10.1016/j.jmii.2020.03.008,2020-03-30
Fever,ISA,Symptoms,32220574,10.1016/j.jmii.2020.03.008,2020-03-30
Interferon-alpha,ADMINISTERED_TO,Child,32220574,10.1016/j.jmii.2020.03.008,2020-03-30
Asymptomatic,PROCESS_OF,Child,32220574,10.1016/j.jmii.2020.03.008,2020-03-30
Comorbidity,PROCESS_OF,Patients,32220557,10.1053/j.jvca.2020.03.021,2020-03-30
Anesthetics,TREATS,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
Wound Healing,PROCESS_OF,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
SARS coronavirus,PROCESS_OF,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
Dissection of aorta,PROCESS_OF,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
SARS coronavirus,PROCESS_OF,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
Critical Illness,PROCESS_OF,Patients,32220310,10.1016/j.cell.2020.03.035,2020-03-30
Gravidity,PROCESS_OF,Patients,32220276,10.3760/cma.j.issn.0253-2727.2020.0006,2020-03-30
GSKIP gene,PART_OF,Patients,32220276,10.3760/cma.j.issn.0253-2727.2020.0006,2020-03-30
Fetus,PART_OF,"Infant, Newborn",32220276,10.3760/cma.j.issn.0253-2727.2020.0006,2020-03-30
Gravidity,NEG_PROCESS_OF,Adult,32220276,10.3760/cma.j.issn.0253-2727.2020.0006,2020-03-30
Coronavirus Infections,ISA,Communicable Diseases,32220243,10.1186/s13054-020-2841-7,2020-03-30
Infection,PROCESS_OF,Medical Staff,32220208,10.1056/NEJMoa2005412,2020-03-29
Infection,PROCESS_OF,Homo sapiens,32220208,10.1056/NEJMoa2005412,2020-03-29
Communicable Diseases,PROCESS_OF,Nurses,32220208,10.1056/NEJMoa2005412,2020-03-29
Quarantine,TREATS,Persons,32220181,10.12182/20200360107,2020-03-29
Infected,PROCESS_OF,Patients,32220181,10.12182/20200360107,2020-03-29
Infected,PROCESS_OF,Staff,32220181,10.12182/20200360107,2020-03-29
GSKIP gene,PART_OF,Staff,32220181,10.12182/20200360107,2020-03-29
Family member,ISA,Persons,32220180,10.12182/20200360101,2020-03-29
Coughing,ISA,Symptoms,32220180,10.12182/20200360101,2020-03-29
Fever,ISA,Symptoms,32220180,10.12182/20200360101,2020-03-29
Weakness,ISA,Symptoms,32220180,10.12182/20200360101,2020-03-29
Thickened,PROCESS_OF,Patients,32220180,10.12182/20200360101,2020-03-29
Fibrinogen,STIMULATES,Lactate Dehydrogenase,32220180,10.12182/20200360101,2020-03-29
Coronavirus Infections,ISA,Disease,32220179,10.12182/20200360606,2020-03-29
Critical Illness,PROCESS_OF,Adult,32220178,10.12182/20200360506,2020-03-29
Diabetes,PROCESS_OF,inpatient,32220178,10.12182/20200360506,2020-03-29
Critical Illness,PROCESS_OF,Patients,32220178,10.12182/20200360506,2020-03-29
Disease,PREDISPOSES,Diabetic Ketoacidosis,32220178,10.12182/20200360506,2020-03-29
Interferons,ISA,Biological Factors,32220177,10.12182/20200360505,2020-03-29
Coughing,COEXISTS_WITH,Leukopenia,32220112,10.1111/jth.14817,2020-03-29
Coughing,COEXISTS_WITH,Lymphopenia,32220112,10.1111/jth.14817,2020-03-29
Coughing,ISA,Symptoms,32220112,10.1111/jth.14817,2020-03-29
Fever,COEXISTS_WITH,Leukopenia,32220112,10.1111/jth.14817,2020-03-29
Fever,COEXISTS_WITH,Lymphopenia,32220112,10.1111/jth.14817,2020-03-29
Fever,ISA,Symptoms,32220112,10.1111/jth.14817,2020-03-29
Infected,PROCESS_OF,Patients,32220112,10.1111/jth.14817,2020-03-29
Virus,PROCESS_OF,general population,32220112,10.1111/jth.14817,2020-03-29
Prophylactic treatment,TREATS,Panic,32220112,10.1111/jth.14817,2020-03-29
heparin,PREDISPOSES,Disseminated Intravascular Coagulation,32220033,10.1111/joim.13063,2020-03-29
heparin,PREDISPOSES,Venous Thromboembolism,32220033,10.1111/joim.13063,2020-03-29
heparin,PREDISPOSES,Blood Coagulation Disorders,32220033,10.1111/joim.13063,2020-03-29
heparin,compared_with,"Heparin, Low-Molecular-Weight",32220033,10.1111/joim.13063,2020-03-29
"Heparin, Low-Molecular-Weight",PREDISPOSES,Blood Coagulation Disorders,32220033,10.1111/joim.13063,2020-03-29
"Heparin, Low-Molecular-Weight",TREATS,Patients,32220033,10.1111/joim.13063,2020-03-29
Coronavirus Infections,ISA,Disease,32220017,10.1002/hep.31257,2020-03-29
Cardiovascular Diseases,PROCESS_OF,Patients,32220017,10.1002/hep.31257,2020-03-29
Diabetes,PROCESS_OF,Patients,32220017,10.1002/hep.31257,2020-03-29
Coronavirus Infections,ISA,Disease,32220017,10.1002/hep.31257,2020-03-29
Severe course,COEXISTS_WITH,Disease,32220017,10.1002/hep.31257,2020-03-29
Severe course,COEXISTS_WITH(SPEC),Coronavirus Infections,32220017,10.1002/hep.31257,2020-03-29
Diagnosis,USES,Indicators,32219882,10.1002/jmv.25788,2020-03-29
Screening procedure,TREATS,Severe Acute Respiratory Syndrome,32219882,10.1002/jmv.25788,2020-03-29
Infection,ISA,Respiration Disorders,32219882,10.1002/jmv.25788,2020-03-29
Virus Diseases,AFFECTS,Pregnant Women,32219846,10.1002/lary.28672,2020-03-29
Fever,PROCESS_OF,Pregnant Women,32219846,10.1002/lary.28672,2020-03-29
Mucous Membrane,PART_OF,Upper respiratory tract,32219845,10.1002/hast.1090,2020-03-29
China,ISA,Country,32219845,10.1002/hast.1090,2020-03-29
Central Nervous System Involvement,PROCESS_OF,Patients,32219674,10.1007/s11845-020-02215-5,2020-03-29
Prophylactic treatment,TREATS,Patients,32219674,10.1007/s11845-020-02215-5,2020-03-29
Household composition,PROCESS_OF,Persons,32219626,10.1007/s11596-020-2174-4,2020-03-29
Hospitals,LOCATION_OF,Administration occupational activities,32219625,10.1007/s11596-020-2173-5,2020-03-29
Advice,TREATS,Severe Acute Respiratory Syndrome,32219625,10.1007/s11596-020-2173-5,2020-03-29
Severe Acute Respiratory Syndrome,PROCESS_OF,"Infant, Newborn",32219625,10.1007/s11596-020-2173-5,2020-03-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Pregnant Women,32219625,10.1007/s11596-020-2173-5,2020-03-29
Communicable Diseases,PROCESS_OF,Persons,32219428,10.1001/jama.2020.4783,2020-03-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32219428,10.1001/jama.2020.4783,2020-03-29
Critical Illness,PROCESS_OF,Patients,32219398,10.1093/pubmed/fdaa046,2020-03-29
Critical Illness,PROCESS_OF,Patients,32219398,10.1093/pubmed/fdaa046,2020-03-29
Infectious diseases department,LOCATION_OF,Study,32219398,10.1093/pubmed/fdaa046,2020-03-29
Mechanical ventilation,ADMINISTERED_TO,Patients,32219398,10.1093/pubmed/fdaa046,2020-03-29
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32219398,10.1093/pubmed/fdaa046,2020-03-29
Critical Illness,PROCESS_OF,Patients,32219398,10.1093/pubmed/fdaa046,2020-03-29
Genus: Coronavirus,CAUSES,"Pneumonia, Viral",32219357,10.1001/jamacardio.2020.1096,2020-03-29
Cardiovascular Diseases,PROCESS_OF,Patients,32219357,10.1001/jamacardio.2020.1096,2020-03-29
Heart,LOCATION_OF,risk factors,32219357,10.1001/jamacardio.2020.1096,2020-03-29
Cardiovascular Diseases,COEXISTS_WITH,Comorbidity,32219357,10.1001/jamacardio.2020.1096,2020-03-29
Cerebrovascular Disorders,COEXISTS_WITH,Comorbidity,32219357,10.1001/jamacardio.2020.1096,2020-03-29
Diabetes Mellitus,COEXISTS_WITH,Comorbidity,32219357,10.1001/jamacardio.2020.1096,2020-03-29
Hypertensive disease,COEXISTS_WITH,Comorbidity,32219357,10.1001/jamacardio.2020.1096,2020-03-29
"Respiratory Distress Syndrome, Adult",CAUSES,Myocarditis,32219357,10.1001/jamacardio.2020.1096,2020-03-29
"Respiratory Distress Syndrome, Adult",CAUSES,vascular inflammations,32219357,10.1001/jamacardio.2020.1096,2020-03-29
B Virus Infection,CAUSES,Myocarditis,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Heart,LOCATION_OF,Magnetic Resonance Imaging,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Acute myocarditis,PROCESS_OF,Patients,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Troponin T,STIMULATES,Gadolinium,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Heart,LOCATION_OF,obstructive disease,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Heart,LOCATION_OF,Magnetic Resonance Imaging,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Magnetic Resonance Imaging,DIAGNOSES,Thickened,32219356,10.1001/jamacardio.2020.1017,2020-03-29
DNA Sequence,STIMULATES,Gadolinium,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Chloroquine,TREATS,Heart failure,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Steroids,AFFECTS,Heart,32219356,10.1001/jamacardio.2020.1017,2020-03-29
lopinavir / Ritonavir,ISA,Antiviral Agents,32219356,10.1001/jamacardio.2020.1017,2020-03-29
Cardiac complication,AFFECTS,Fatal Outcome,32219057,10.1007/s40475-020-00201-6,2020-03-29
Fatal Outcome,PROCESS_OF,Patients,32219057,10.1007/s40475-020-00201-6,2020-03-29
IMPACT gene,ASSOCIATED_WITH,Cardiovascular Diseases,32219057,10.1007/s40475-020-00201-6,2020-03-29
IMPACT gene,ASSOCIATED_WITH,myocardial injury,32219057,10.1007/s40475-020-00201-6,2020-03-29
Comorbidity,PROCESS_OF,Patients,32219057,10.1007/s40475-020-00201-6,2020-03-29
Plasma C-reactive protein measurement,USES,High sensitivity,32219057,10.1007/s40475-020-00201-6,2020-03-29
Cessation of life,PROCESS_OF,Patients,32219057,10.1007/s40475-020-00201-6,2020-03-29
Hospitalization,TREATS,Survivors,32219057,10.1007/s40475-020-00201-6,2020-03-29
Plasma,LOCATION_OF,Troponin T,32219057,10.1007/s40475-020-00201-6,2020-03-29
Troponin T,compared_with,pro-brain natriuretic peptide (1-76),32219057,10.1007/s40475-020-00201-6,2020-03-29
Fatal Outcome,AFFECTS,Patients,32219057,10.1007/s40475-020-00201-6,2020-03-29
Coronavirus Infections,ISA,Disease,32219006,10.1007/s40484-020-0199-0,2020-03-29
ACE2 gene,PART_OF,Host Cell,32219006,10.1007/s40484-020-0199-0,2020-03-29
Vaccines,PART_OF,SARS coronavirus,32219006,10.1007/s40484-020-0199-0,2020-03-29
Italy,ISA,Country,32218558,10.34172/ijoem.2020.1977,2020-03-29
Coronavirus Infections,COEXISTS_WITH,"Pneumonia, Viral",32218340,10.3390/ijms21072272,2020-03-29
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32218151,10.3390/v12040360,2020-03-29
Coronavirus Infections,CAUSES,Respiratory Tract Infections,32218151,10.3390/v12040360,2020-03-29
Genus: Coronavirus,INTERACTS_WITH,Animals,32218151,10.3390/v12040360,2020-03-29
Epithelial Cells,PART_OF,Intestines,32218151,10.3390/v12040360,2020-03-29
Operating Room,LOCATION_OF,Administration occupational activities,32217900,10.1097/RCT.0000000000001023,2020-03-29
Nose,LOCATION_OF,Povidone-Iodine,32217900,10.1097/RCT.0000000000001023,2020-03-29
Patients,USES,Towelettes,32217900,10.1097/RCT.0000000000001023,2020-03-29
Towelettes,USES,Chlorhexidine,32217900,10.1097/RCT.0000000000001023,2020-03-29
Disinfection,USES,huperzine B,32217900,10.1097/RCT.0000000000001023,2020-03-29
Enterobacter,LOCATION_OF,sphingosine 1-phosphate,32217900,10.1097/RCT.0000000000001023,2020-03-29
Coronavirus Infections,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Fever,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Dry cough,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Thoracic mammary region,LOCATION_OF,High Resolution Computed Tomography,32217835,10.1172/JCI137244,2020-03-29
Ground Glass Opacity,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Lung,LOCATION_OF,Lesion,32217835,10.1172/JCI137244,2020-03-29
Lesion,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Asymptomatic,PROCESS_OF,Child,32217835,10.1172/JCI137244,2020-03-29
Asymptomatic,PROCESS_OF,Patients,32217835,10.1172/JCI137244,2020-03-29
Ferritin,compared_with,Fibrin fragment D,32217834,10.1172/JCI137647,2020-03-29
CD4 Positive T Lymphocytes,INTERACTS_WITH,T-Lymphocyte,32217834,10.1172/JCI137647,2020-03-29
Eye,LOCATION_OF,Communicable Diseases,32217650,10.1183/13993003.00547-2020,2020-03-29
Eye,LOCATION_OF(SPEC),Coronavirus Infections,32217650,10.1183/13993003.00547-2020,2020-03-29
Coronavirus Infections,ISA,Communicable Diseases,32217650,10.1183/13993003.00547-2020,2020-03-29
CD4 Positive T Lymphocytes,LOCATION_OF,,32217650,10.1183/13993003.00547-2020,2020-03-29
Severe disorder,COEXISTS_WITH,Lymphopenia,32217650,10.1183/13993003.00547-2020,2020-03-29
Hypertensive disease,PRECEDES,Diabetes,32217556,10.1136/bmj.m1091,2020-03-29
Comorbidity,PROCESS_OF,Patients,32217556,10.1136/bmj.m1091,2020-03-29
Comorbidity,PROCESS_OF,Patients,32217556,10.1136/bmj.m1091,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Comorbidity,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
hypertension chronic,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cardiovascular,LOCATION_OF,Comorbidity,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Disease,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Dyspnea,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Chest tightness,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Conscious,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Patients,LOCATION_OF,Fibrin fragment D,32217507,10.2196/18717,2020-03-29
Patients,LOCATION_OF,Cardiac troponin I,32217507,10.2196/18717,2020-03-29
Complication,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cessation of life,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Comorbidity,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cardiac complication,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Cardiovascular,LOCATION_OF,Comorbidity,32217507,10.2196/18717,2020-03-29
Cardiovascular Diseases,COEXISTS_WITH,Acute respiratory infections,32217507,10.2196/18717,2020-03-29
Heart failure,COEXISTS_WITH,Acute respiratory infections,32217507,10.2196/18717,2020-03-29
Heart Injuries,COEXISTS_WITH,Acute respiratory infections,32217507,10.2196/18717,2020-03-29
Single organ dysfunction,PROCESS_OF,Patients,32217507,10.2196/18717,2020-03-29
Complication,COEXISTS_WITH,Exacerbation,32217507,10.2196/18717,2020-03-29
Protection,PROCESS_OF,Community,32217117,10.1016/j.lfs.2020.117583,2020-03-29
Infected,PROCESS_OF,Patients,32217113,10.1016/j.ajog.2020.03.021,2020-03-29
Anti-Inflammatory Agents,PREVENTS,"Respiratory Distress Syndrome, Adult",32217113,10.1016/j.ajog.2020.03.021,2020-03-29
Melatonin,TREATS,Patients,32217113,10.1016/j.ajog.2020.03.021,2020-03-29
Virus Diseases,PROCESS_OF,Patients,32217113,10.1016/j.ajog.2020.03.021,2020-03-29
Asymptomatic,PROCESS_OF,Persons,32216961,10.1016/j.crad.2020.03.004,2020-03-29
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32216961,10.1016/j.crad.2020.03.004,2020-03-29
Respiratory Failure,AFFECTS,Rapidly progressive,32216961,10.1016/j.crad.2020.03.004,2020-03-29
Respiratory Failure,COEXISTS_WITH,Gravidity,32216961,10.1016/j.crad.2020.03.004,2020-03-29
Challenge,USES,Diagnosis,32216961,10.1016/j.crad.2020.03.004,2020-03-29
Present,PROCESS_OF,Patients,32216872,10.7554/eLife.57032,2020-03-29
Patients,LOCATION_OF,GSKIP gene,32216717,10.1148/radiol.2020201160,2020-03-29
3-Hydroxybutyrate Dehydrogenase,ASSOCIATED_WITH,Pneumonia,32216717,10.1148/radiol.2020201160,2020-03-29
Neutrophil count (procedure),ISA,White Blood Cell Count procedure,32216717,10.1148/radiol.2020201160,2020-03-29
Age,ASSOCIATED_WITH,Pneumonia,32216717,10.1148/radiol.2020201160,2020-03-29
Males,ASSOCIATED_WITH,Pneumonia,32216717,10.1148/radiol.2020201160,2020-03-29
Hospitals,LOCATION_OF,Retrospective Studies,32216698,10.1152/physrev.00013.2020,2020-03-29
Confirmation,PROCESS_OF,Patients,32216698,10.1152/physrev.00013.2020,2020-03-29
Hypertensive disease,PROCESS_OF,Patients,32216653,10.1200/GO.20.00063,2020-03-29
Plasmin,TREATS,Patients,32216653,10.1200/GO.20.00063,2020-03-29
Plasmin,TREATS(INFER),Co-morbid conditions,32216653,10.1200/GO.20.00063,2020-03-29
Co-morbid conditions,PROCESS_OF,Patients,32216653,10.1200/GO.20.00063,2020-03-29
Plasmin,ISA,Peptide Hydrolases,32216653,10.1200/GO.20.00063,2020-03-29
DNA Sequence - Cloning Site,COEXISTS_WITH,Proteins,32216653,10.1200/GO.20.00063,2020-03-29
Plasmin,ASSOCIATED_WITH,Hyperfibrinolysis,32216653,10.1200/GO.20.00063,2020-03-29
D-dimer above reference range,PROCESS_OF,Patients,32216653,10.1200/GO.20.00063,2020-03-29
Malignant Neoplasms,PROCESS_OF,Patients,32216640,10.1161/CIRCULATIONAHA.120.047011,2020-03-29
Malignant Neoplasms,PROCESS_OF,Patients,32216640,10.1161/CIRCULATIONAHA.120.047011,2020-03-29
medical care,PROCESS_OF,Patients,32216640,10.1161/CIRCULATIONAHA.120.047011,2020-03-29
Malignant Neoplasms,PROCESS_OF,Patients,32216640,10.1161/CIRCULATIONAHA.120.047011,2020-03-29
Cardiovascular,LOCATION_OF,Problem,32216550,10.1080/01634372.2020.1746723,2020-03-29
Comorbidity,COEXISTS_WITH,Cardiovascular Diseases,32216114,10.1002/pro.3857,2020-03-28
Coronavirus Infections,AFFECTS,Severe disorder,32215956,10.1111/jgh.15047,2020-03-28
Peptide Hydrolases,PART_OF,Genus: Coronavirus,32215956,10.1111/jgh.15047,2020-03-28
Genus: Coronavirus,LOCATION_OF,Pyridoxal Phosphate,32215956,10.1111/jgh.15047,2020-03-28
Genus: Coronavirus,LOCATION_OF,Pyridoxal Phosphate,32215956,10.1111/jgh.15047,2020-03-28
Coronavirus Infections,ISA,Disease,32215896,10.1055/a-1095-2344,2020-03-28
Fever,PROCESS_OF,Patients,32215896,10.1055/a-1095-2344,2020-03-28
Infected,PROCESS_OF,Patients,32215896,10.1055/a-1095-2344,2020-03-28
gastrointestinal,LOCATION_OF,Epithelial Cells,32215896,10.1055/a-1095-2344,2020-03-28
angiotensin converting enzyme 2,INTERACTS_WITH,Epithelial Cells,32215896,10.1055/a-1095-2344,2020-03-28
Symptoms,PROCESS_OF,Patients,32215622,10.1093/cid/ciaa325,2020-03-28
Negative Finding,PROCESS_OF,Patients,32215622,10.1093/cid/ciaa325,2020-03-28
Positive Finding,PROCESS_OF,Patients,32215622,10.1093/cid/ciaa325,2020-03-28
CAT scan normal,PROCESS_OF,Patients,32215622,10.1093/cid/ciaa325,2020-03-28
Chest,LOCATION_OF,CAT scan normal,32215622,10.1093/cid/ciaa325,2020-03-28
angiotensin converting enzyme 2,PART_OF,Mammals,32215613,10.1093/cid/ciaa329,2020-03-28
Body tissue,PART_OF,Organ,32215613,10.1093/cid/ciaa329,2020-03-28
Nucleocapsid Proteins,AFFECTS,Intestines,32215613,10.1093/cid/ciaa329,2020-03-28
Cytokine Signaling Process,COEXISTS_WITH,Wound Healing,32215613,10.1093/cid/ciaa329,2020-03-28
Immunization,NEG_TREATS,Pulmonary Pathology,32215613,10.1093/cid/ciaa329,2020-03-28
angiotensin converting enzyme 2,ASSOCIATED_WITH,Cardiovascular Diseases,32215548,10.1093/ecco-jcc/jjaa061,2020-03-28
Heart,LOCATION_OF,Virulence,32215548,10.1093/ecco-jcc/jjaa061,2020-03-28
Lung,LOCATION_OF,Virulence,32215548,10.1093/ecco-jcc/jjaa061,2020-03-28
angiotensin II,CAUSES,Myocarditis,32215548,10.1093/ecco-jcc/jjaa061,2020-03-28
angiotensin II,CAUSES,"Respiratory Distress Syndrome, Adult",32215548,10.1093/ecco-jcc/jjaa061,2020-03-28
Ulcerative Colitis,ISA,Chronic inflammatory disorder,32215365,10.1136/gpsych-2020-100213,2020-03-28
Complication,ISA,Disease,32215365,10.1136/gpsych-2020-100213,2020-03-28
Coronavirus Infections,ISA,Disease,32215365,10.1136/gpsych-2020-100213,2020-03-28
Intestines,LOCATION_OF,Inflammation,32215365,10.1136/gpsych-2020-100213,2020-03-28
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32215365,10.1136/gpsych-2020-100213,2020-03-28
Inflammatory Bowel Diseases,PROCESS_OF,Population Group,32215365,10.1136/gpsych-2020-100213,2020-03-28
Household composition,PROCESS_OF,Persons,32214086,10.15585/mmwr.mm6912e3,2020-03-28
psychological distress,PROCESS_OF,general population,32214086,10.15585/mmwr.mm6912e3,2020-03-28
Virus,CAUSES,Disease,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Virus,CAUSES(SPEC),Coronavirus Infections,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Coronavirus Infections,ISA,Disease,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Disease,PROCESS_OF,Vulnerable Populations,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Coronavirus Infections,ISA,Disease,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Coronavirus Infections,ISA,Disease,32214083,10.15585/mmwr.mm6912e1,2020-03-28
Coronavirus Infections,ISA,Disease,32214079,10.15585/mmwr.mm6912e2,2020-03-28
Coronavirus Infections,ISA,Disease,32214079,10.15585/mmwr.mm6912e2,2020-03-28
Coronavirus Infections,ISA,Disease,32214079,10.15585/mmwr.mm6912e2,2020-03-28
Infected,PROCESS_OF,Patients,32214079,10.15585/mmwr.mm6912e2,2020-03-28
Infected,PROCESS_OF,Staff Member,32214079,10.15585/mmwr.mm6912e2,2020-03-28
Cessation of life,OCCURS_IN,Adult,32213786,10.1097/AOG.0000000000003873,2020-03-28
Cessation of life,OCCURS_IN,Persons,32213786,10.1097/AOG.0000000000003873,2020-03-28
Cessation of life,PROCESS_OF,Adult,32213786,10.1097/AOG.0000000000003873,2020-03-28
Cessation of life,PROCESS_OF,Persons,32213786,10.1097/AOG.0000000000003873,2020-03-28
Cessation of life,PROCESS_OF,Older Population,32213786,10.1097/AOG.0000000000003873,2020-03-28
Asymptomatic,PROCESS_OF,Persons,32213760,10.5582/ddt.2020.01017,2020-03-28
Infected,PROCESS_OF,Mother (person),32213760,10.5582/ddt.2020.01017,2020-03-28
Infected,PROCESS_OF,Woman,32213760,10.5582/ddt.2020.01017,2020-03-28
Gravidity,PROCESS_OF,Health Personnel,32213760,10.5582/ddt.2020.01017,2020-03-28
Malaise,PROCESS_OF,Persons,32213760,10.5582/ddt.2020.01017,2020-03-28
Pharmaceutical Preparations,TREATS,Patients,32213647,10.1126/science.abb4218,2020-03-28
Virus,PROCESS_OF,human group,32213556,10.1136/gutjnl-2020-320926,2020-03-28
Symptoms,PROCESS_OF,Patients,32213476,10.2196/18848,2020-03-28
Nausea,ISA,Symptoms,32213476,10.2196/18848,2020-03-28
Nausea,PROCESS_OF(SPEC),Patients,32213476,10.2196/18848,2020-03-28
Symptoms,PROCESS_OF,Patients,32213476,10.2196/18848,2020-03-28
Fever,PROCESS_OF,Patients,32213476,10.2196/18848,2020-03-28
Respiratory Tract Infections,CAUSES,Malaise,32213332,10.1016/S1473-3099(20)30162-6,2020-03-28
Patients,LOCATION_OF,saliva,32213332,10.1016/S1473-3099(20)30162-6,2020-03-28
Infectious disease prevention / control,USES,Antiviral Agents,32213332,10.1016/S1473-3099(20)30162-6,2020-03-28
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32213332,10.1016/S1473-3099(20)30162-6,2020-03-28
early/brief intervention/therapy (treatment),TREATS,Population Group,32213270,10.3760/cma.j.cn112338-20200301-00223,2020-03-28
Infected,PROCESS_OF,Persons,32213270,10.3760/cma.j.cn112338-20200301-00223,2020-03-28
Malignant Neoplasms,CAUSES,Coronavirus Infections,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Coronavirus Infections,AFFECTS,Cancer Patient,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Cancer Patient,ISA,Persons,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Oncologists,DIAGNOSES,Coronavirus Infections,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Neoplasms,PROCESS_OF,Community,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
time out,PROCESS_OF,Community,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Oncologists,ISA,Health Personnel,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Cancer Patient,LOCATION_OF,IMPACT gene,32212513,10.12116/j.issn.1004-5619.2020.02.001,2020-03-27
Prescription Drugs,TREATS,Connective Tissue Diseases,32212409,10.1002/ccd.28887,2020-03-27
Prescription Drugs,TREATS,Malaria,32212409,10.1002/ccd.28887,2020-03-27
chloroquine phosphate,ISA,Antimalarials,32212409,10.1002/ccd.28887,2020-03-27
chloroquine phosphate,CAUSES,Poisoning,32212409,10.1002/ccd.28887,2020-03-27
Clinical Treatment,TREATS,Malaria,32212409,10.1002/ccd.28887,2020-03-27
Chloroquine,ISA,Pharmaceutical Preparations,32212409,10.1002/ccd.28887,2020-03-27
patient care,TREATS,Persons,32212386,10.1111/jgs.16445,2020-03-27
patient care,TREATS(INFER),Infected,32212386,10.1111/jgs.16445,2020-03-27
Infected,PROCESS_OF,Persons,32212386,10.1111/jgs.16445,2020-03-27
Coronavirus Infections,ISA,Disease,32212059,10.1007/s11684-020-0766-9,2020-03-27
Patients,ISA,Persons,32212059,10.1007/s11684-020-0766-9,2020-03-27
Manipulation procedure,USES,Artificial Airways,32212059,10.1007/s11684-020-0766-9,2020-03-27
Infectious disease prevention / control,COEXISTS_WITH,Anesthesia procedures,32212059,10.1007/s11684-020-0766-9,2020-03-27
"Anesthesia, Conduction",TREATS,Patients,32212059,10.1007/s11684-020-0766-9,2020-03-27
Coronavirus Infections,ISA,Disease,32211963,10.1007/s00330-020-06816-7,2020-03-27
Parenchyma,LOCATION_OF,Congenital anomaly of lung,32211920,10.1007/s00101-020-00760-3,2020-03-27
Parenchyma,LOCATION_OF,Congenital anomaly of lung,32211920,10.1007/s00101-020-00760-3,2020-03-27
Study,MEASURES,Score,32211920,10.1007/s00101-020-00760-3,2020-03-27
Halo sign,PROCESS_OF,Patients,32211920,10.1007/s00101-020-00760-3,2020-03-27
Coronavirus Infections,ISA,Disease,32211911,10.11622/smedj.2020036,2020-03-27
Diabetes,COEXISTS_WITH,multiple pathologies,32211816,10.1001/jamacardio.2020.0950,2020-03-27
Heart Diseases,COEXISTS_WITH,multiple pathologies,32211816,10.1001/jamacardio.2020.0950,2020-03-27
Hypertensive disease,COEXISTS_WITH,multiple pathologies,32211816,10.1001/jamacardio.2020.0950,2020-03-27
Chronic Obstructive Airway Disease,COEXISTS_WITH,multiple pathologies,32211816,10.1001/jamacardio.2020.0950,2020-03-27
Fever,PROCESS_OF,Patients,32211816,10.1001/jamacardio.2020.0950,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Aspartate Transaminase,compared_with,Creatinine,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Complication,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Heart Injuries,PROCESS_OF,Patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Disease,PROCESS_OF,hospitalized patients,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
American College of Cardiology/American Heart Association Lesion Complexity Score C,COEXISTS_WITH,Disease,32211765,10.1093/ecco-jcc/jjaa058,2020-03-27
Confusion,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Diarrhea,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Drowsiness,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Dyspnea,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Malaise,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Myalgia,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
interstitial,LOCATION_OF,Bilateral pneumonia,32211755,10.1093/cid/ciaa322,2020-03-27
Bilateral pneumonia,ISA,Symptoms,32211755,10.1093/cid/ciaa322,2020-03-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32211755,10.1093/cid/ciaa322,2020-03-27
Inflammatory Bowel Diseases,PROCESS_OF,Patients,32211755,10.1093/cid/ciaa322,2020-03-27
olympics,ISA,sporting event,32210742,10.17179/excli2020-1167,2020-03-27
World Cup,ISA,sporting event,32210742,10.17179/excli2020-1167,2020-03-27
Disease,PROCESS_OF,Homo sapiens,32210741,10.17179/excli2020-1189,2020-03-27
Study,MEASURES,Mutation,32210741,10.17179/excli2020-1189,2020-03-27
DIRECT ACTING ANTIVIRALS,TREATS,Virus Diseases,32210421,10.4081/monaldi.2020.1284,2020-03-27
HIV Protease Inhibitors,INHIBITS,"3C-like protease, SARS coronavirus",32210421,10.4081/monaldi.2020.1284,2020-03-27
Health Care,TREATS,Population Group,32210236,10.1038/s41597-020-0448-0,2020-03-27
Coronavirus Infections,ISA,Disease,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Disease,PROCESS_OF,Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Symptoms,PROCESS_OF,Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Complication,PROCESS_OF,Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Disseminated Intravascular Coagulation,COEXISTS_WITH,Death characteristics,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Respiratory Distress Syndrome, Adult",ISA,Complication,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF(SPEC),Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Complication,PROCESS_OF,Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Kidney Failure, Acute",ISA,Complication,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Kidney Failure, Acute",PROCESS_OF(SPEC),Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Respiratory Distress Syndrome, Adult",ISA,Complication,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF(SPEC),Patients,32209598,10.1158/2159-8290.CD-NB2020-018,2020-03-27
Malignant Neoplasms,PROCESS_OF,Scientist,32209231,10.1016/j.compbiomed.2020.103670,2020-03-27
Genus: Coronavirus,LOCATION_OF,Amino Acids,32209226,10.7554/eLife.57162,2020-03-27
Community,LOCATION_OF,IMPACT gene,32209164,10.2807/1560-7917.ES.2020.25.11.2000230,2020-03-27
SARS coronavirus,PROCESS_OF,Patients,32209163,10.2807/1560-7917.ES.2020.25.11.2000266,2020-03-27
Lung,LOCATION_OF,SARS coronavirus,32209163,10.2807/1560-7917.ES.2020.25.11.2000266,2020-03-27
Coronavirus Infections,ISA,Disease,32209118,10.1186/s40249-020-00649-8,2020-03-27
CD40LG wt Allele,INTERACTS_WITH,Nucleocapsid,32209118,10.1186/s40249-020-00649-8,2020-03-27
CD40LG wt Allele,INTERACTS_WITH,"M Protein, multiple myeloma",32209118,10.1186/s40249-020-00649-8,2020-03-27
Syndrome,PROCESS_OF,Homo sapiens,32208987,10.1161/HYPERTENSIONAHA.120.15082,2020-03-27
Hypertensive disease,PROCESS_OF,Patients,32208983,10.7547/20-051,2020-03-27
receptor,ISA,Proteins,32208983,10.7547/20-051,2020-03-27
Blood,LOCATION_OF,ACE2 gene,32208983,10.7547/20-051,2020-03-27
ACE2 gene,AFFECTS,Catabolism,32208983,10.7547/20-051,2020-03-27
Angiotensin-Converting Enzyme Inhibitors,NEG_INHIBITS,ACE2 gene,32208983,10.7547/20-051,2020-03-27
"Animals, Laboratory",LOCATION_OF,ACE2 gene,32208983,10.7547/20-051,2020-03-27
Angiotensin II Type 1 Receptor Blockers,STIMULATES,ACE2 gene,32208983,10.7547/20-051,2020-03-27
Angiotensin-Converting Enzyme Inhibitors,STIMULATES,ACE2 gene,32208983,10.7547/20-051,2020-03-27
Animals,LOCATION_OF,ACE2 gene,32208983,10.7547/20-051,2020-03-27
Homo sapiens,LOCATION_OF,ACE2 gene,32208983,10.7547/20-051,2020-03-27
"Receptor, Angiotensin, Type 1",STIMULATES,ACE2 gene,32208983,10.7547/20-051,2020-03-27
Amputation,PREDISPOSES,Infection,32208977,10.1556/2060.2020.00015,2020-03-27
Diabetes,PROCESS_OF,Patients,32208977,10.1556/2060.2020.00015,2020-03-27
Foot Ulcer,PROCESS_OF,Patients,32208977,10.1556/2060.2020.00015,2020-03-27
Podiatrist,TREATS,Patients,32208977,10.1556/2060.2020.00015,2020-03-27
Virus,COEXISTS_WITH,Enthesitis-Related Arthritis,32208917,10.1080/22221751.2020.1744483,2020-03-27
Fever,PROCESS_OF,Child,32208840,10.1080/22221751.2020.1741327,2020-03-27
Symptoms,PROCESS_OF,Child,32208840,10.1080/22221751.2020.1741327,2020-03-27
Lymphopenia,PROCESS_OF,Patients,32208840,10.1080/22221751.2020.1741327,2020-03-27
Critical Illness,PROCESS_OF,Patients,32208494,10.4414/smw.2020.20233,2020-03-26
Health Personnel,TREATS,inpatient,32208481,10.1093/jamia/ocaa037,2020-03-26
Health Personnel,TREATS,Outpatients,32208481,10.1093/jamia/ocaa037,2020-03-26
Health Personnel,TREATS,Patients,32208481,10.1093/jamia/ocaa037,2020-03-26
Physical Examination,TREATS,Patients,32207679,10.3201/eid2607.200250,2020-03-25
Physical Examination,TREATS,Persons,32207679,10.3201/eid2607.200250,2020-03-25
Infectious disease prevention / control,COEXISTS_WITH,Quarantine,32207542,10.1111/jgs.16443,2020-03-25
Telemedicine,ISA,Evaluation procedure,32207377,10.1080/22221751.2020.1743767,2020-03-25
Patients,LOCATION_OF,IMPACT gene,32207377,10.1080/22221751.2020.1743767,2020-03-25
Assay,USES,Detection,32207255,10.3348/kjr.2020.0180,2020-03-25
Parenchyma,LOCATION_OF,Pulmonary opacity,32207208,10.1002/uog.22028,2020-03-25
Lung,LOCATION_OF,Lesion,32207208,10.1002/uog.22028,2020-03-25
Chest CT,DIAGNOSES,Lesion,32207208,10.1002/uog.22028,2020-03-25
Bulla,ISA,Disease,32207208,10.1002/uog.22028,2020-03-25
Mediastinal Emphysema,ISA,Disease,32207208,10.1002/uog.22028,2020-03-25
Pneumothorax,ISA,Disease,32207208,10.1002/uog.22028,2020-03-25
Lung,LOCATION_OF,Ultrasound examination,32207068,10.1007/s40620-020-00727-y,2020-03-25
Ultrasound examination,ADMINISTERED_TO,Obstetrician and gynecologist,32207068,10.1007/s40620-020-00727-y,2020-03-25
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32207068,10.1007/s40620-020-00727-y,2020-03-25
Point-of-Care Testing,USES,Diagnosis,32207032,10.1007/s11596-020-2172-6,2020-03-25
Experience,PROCESS_OF,Italians,32207032,10.1007/s11596-020-2172-6,2020-03-25
Hospitals,LOCATION_OF,Cross-Sectional Studies,32206694,10.1007/s13337-020-00571-5,2020-03-25
Fever,ISA,Symptoms,32206694,10.1007/s13337-020-00571-5,2020-03-25
Hospitalization,TREATS,Human Age Group,32206694,10.1007/s13337-020-00571-5,2020-03-25
Study,MEASURES,Variation (Genetics),32205937,10.5005/jp-journals-10071-23365,2020-03-25
Coronavirus Infections,COEXISTS_WITH,SARS coronavirus,32205937,10.5005/jp-journals-10071-23365,2020-03-25
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32205937,10.5005/jp-journals-10071-23365,2020-03-25
Prophylactic treatment,USES,Vaccines,32205937,10.5005/jp-journals-10071-23365,2020-03-25
lobe,PART_OF,Lung,32205269,10.1016/j.tmaid.2020.101632,2020-03-25
Headache,PROCESS_OF,Patients,32205269,10.1016/j.tmaid.2020.101632,2020-03-25
Pneumonia,PROCESS_OF,Patients,32205269,10.1016/j.tmaid.2020.101632,2020-03-25
Hospitals,LOCATION_OF,Diagnosis,32205267,10.1016/j.tmaid.2020.101636,2020-03-25
Isolation procedure,TREATS,Patients,32205267,10.1016/j.tmaid.2020.101636,2020-03-25
Vero Cells,LOCATION_OF,SARS coronavirus,32205204,10.1016/j.ijantimicag.2020.105949,2020-03-25
carboxypeptidase H,ADMINISTERED_TO,Vero Cells,32205204,10.1016/j.ijantimicag.2020.105949,2020-03-25
Cell Count,USES,MIR7-3HG gene,32205204,10.1016/j.ijantimicag.2020.105949,2020-03-25
Chloroquine,TREATS,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Hydroxychloroquine,TREATS,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Symptoms,PROCESS_OF,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Symptoms,PROCESS_OF,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Hydranencephaly with Renal Aplasia-Dysplasia,ISA,Symptoms,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Hydranencephaly with Renal Aplasia-Dysplasia,PROCESS_OF(SPEC),Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Did not receive therapy or drug for,PROCESS_OF,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Hydroxychloroquine,TREATS,Virus,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Azithromycin,TREATS,Patients,32205186,10.1016/j.autrev.2020.102523,2020-03-25
Antiviral Therapy,TREATS,SARS coronavirus,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Adrenal Cortex Hormones,compared_with,Pharmaceutical Preparations,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Adrenal Cortex Hormones,TREATS,Disease,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Rheumatoid Arthritis,PREDISPOSES,Communicable Diseases,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Autoimmune Diseases,COEXISTS_WITH,iatrogenic effects,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Pharmaceutical Preparations,TREATS,Disease,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Rheumatoid Arthritis,PROCESS_OF,Patients,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Pharmaceutical Preparations,TREATS,Rheumatoid Arthritis,32205138,10.1016/j.jinf.2020.03.022,2020-03-25
Fedratinib,ISA,JAK2 Inhibitor,32205091,10.1016/j.jmii.2020.03.013,2020-03-25
Hand Disinfection,TREATS,Traffic,32204990,10.1016/j.acra.2020.03.002,2020-03-25
chest findings,PROCESS_OF,Patients,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Coronavirus Infections,PROCESS_OF,Patients,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Coronavirus Infections,PROCESS_OF,radiologist,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Contrast bronchogram,USES,Air,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Mediastinum,LOCATION_OF,Lymphadenopathy,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Lung,LOCATION_OF,Lesion,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Lesion,PROCESS_OF,Patients,32204987,10.1016/j.acra.2020.03.003,2020-03-25
Coronavirus Infections,CAUSES,Disease,32204922,10.1016/j.rce.2020.03.001,2020-03-25
Coronavirus Infections,ISA,Disease,32204922,10.1016/j.rce.2020.03.001,2020-03-25
Coronavirus Infections,ISA,Disease,32204922,10.1016/j.rce.2020.03.001,2020-03-25
Lung,LOCATION_OF,Lesion,32204922,10.1016/j.rce.2020.03.001,2020-03-25
High Resolution Computed Tomography,CAUSES,Disease,32204922,10.1016/j.rce.2020.03.001,2020-03-25
Physical Examination,USES,tomography,32204922,10.1016/j.rce.2020.03.001,2020-03-25
mental health,PROCESS_OF,Persons,32203970,10.1159/000507305,2020-03-24
"Kidney Failure, Acute",AFFECTS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",32203711,10.1016/S2213-2600(20)30121-1,2020-03-24
Severe Acute Respiratory Syndrome,AFFECTS,Kidney Diseases,32203711,10.1016/S2213-2600(20)30121-1,2020-03-24
Clinical Management,COEXISTS_WITH,Dialysis procedure,32203711,10.1016/S2213-2600(20)30121-1,2020-03-24
Clinical Management,COEXISTS_WITH,Kidney Transplantation,32203711,10.1016/S2213-2600(20)30121-1,2020-03-24
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Coronavirus Infections,PROCESS_OF,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Conventional Treatment,NEG_TREATS,Severe Acute Respiratory Syndrome,32203189,10.1038/s41423-020-0400-4,2020-03-24
Extracorporeal Membrane Oxygenation,ISA,Therapeutic procedure,32203189,10.1038/s41423-020-0400-4,2020-03-24
Extracorporeal Membrane Oxygenation,ADMINISTERED_TO,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Critical Illness,PROCESS_OF,Patients,32203189,10.1038/s41423-020-0400-4,2020-03-24
Antibodies,AFFECTS,Virus Attachment,32202993,10.3201/eid2607.200407,2020-03-24
Vaccines,AFFECTS,Virus Attachment,32202993,10.3201/eid2607.200407,2020-03-24
angiotensin converting enzyme 2,PART_OF,Chiroptera,32202993,10.3201/eid2607.200407,2020-03-24
angiotensin converting enzyme 2,DISRUPTS,Host Cell,32202993,10.3201/eid2607.200407,2020-03-24
Coronavirus Infections,ISA,Disease,32202911,10.17235/reed.2020.7052/2020,2020-03-24
Disease,PROCESS_OF,Patients,32202824,10.1037/hea0000875,2020-03-24
Disease,PROCESS_OF,professional occupation status,32202824,10.1037/hea0000875,2020-03-24
Esophagogastroduodenoscopy,ISA,"Endoscopy, Gastrointestinal",32202824,10.1037/hea0000875,2020-03-24
Feces,PART_OF,Patients,32202824,10.1037/hea0000875,2020-03-24
Colonic biopsy sample,LOCATION_OF,Virus,32202824,10.1037/hea0000875,2020-03-24
Respiratory secretion,PART_OF,Tract,32202824,10.1037/hea0000875,2020-03-24
Asymptomatic,PROCESS_OF,Persons,32202824,10.1037/hea0000875,2020-03-24
viral transmission,PROCESS_OF,Persons,32202824,10.1037/hea0000875,2020-03-24
Coronavirus Infections,AFFECTS,Reaching,32202659,10.1111/eci.13223,2020-03-24
Crisis,PROCESS_OF,Community,32202659,10.1111/eci.13223,2020-03-24
Research Personnel,ISA,Persons,32202659,10.1111/eci.13223,2020-03-24
Health Personnel,TREATS,Patients,32202513,10.1172/JCI138305,2020-03-24
Symptoms,PROCESS_OF,Participant,32202513,10.1172/JCI138305,2020-03-24
Hospitals,LOCATION_OF,Diagnosis,32202513,10.1172/JCI138305,2020-03-24
Infected,PROCESS_OF,Patients,32202343,10.1111/apa.15270,2020-03-24
Symptoms,PROCESS_OF,Child,32202064,10.1111/ajt.15876,2020-03-24
Mild disorder,PROCESS_OF,Child,32202064,10.1111/ajt.15876,2020-03-24
Fever,PROCESS_OF,Adult,32202064,10.1111/ajt.15876,2020-03-24
Pneumonia,PROCESS_OF,Child,32202064,10.1111/ajt.15876,2020-03-24
"Signs and Symptoms, Respiratory",PROCESS_OF,Adult,32202064,10.1111/ajt.15876,2020-03-24
Elevated inflammatory markers,PROCESS_OF,Child,32202064,10.1111/ajt.15876,2020-03-24
Disease,PROCESS_OF,"Infant, Newborn",32202064,10.1111/ajt.15876,2020-03-24
Inspiration function,OCCURS_IN,Child,32202064,10.1111/ajt.15876,2020-03-24
Pneumonia,PROCESS_OF,Adult,32201449,10.4103/ijp.IJP_115_20,2020-03-24
Communicable Diseases,ISA,Disease,32201335,10.1016/j.jacc.2020.03.031,2020-03-24
SARS coronavirus,LOCATION_OF,"Vitronectin, human",32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
SARS coronavirus,LOCATION_OF,"Vitronectin, human",32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
ACE2 gene,PART_OF,Chinese Hamster,32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
"S protein, severe acute respiratory syndrome coronavirus",INTERACTS_WITH,ACE2 gene,32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
ACE2 gene,PART_OF,Homo sapiens,32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
"S protein, severe acute respiratory syndrome coronavirus",COEXISTS_WITH,ACE2 gene,32200663,10.1161/CIRCULATIONAHA.120.046941,2020-03-24
Critical Illness,PROCESS_OF,Patients,32200634,10.1021/acs.jproteome.0c00129,2020-03-24
myocardial injury,PROCESS_OF,Patients,32200634,10.1021/acs.jproteome.0c00129,2020-03-24
Analysis,METHOD_OF,Bio-Informatics,32200613,10.5114/ait.2020.93867,2020-03-24
Virus,PROCESS_OF,Family,32200109,10.1016/j.ijid.2020.03.007,2020-03-23
Infection,CAUSES,Severe Acute Respiratory Syndrome,32200109,10.1016/j.ijid.2020.03.007,2020-03-23
China,ISA,Country,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
Coronavirus Infections,ISA,Disease,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
Disease,PROCESS_OF,Patients,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
Coronavirus Infections,ISA,Disease,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
Coronavirus Infections,ISA,Disease,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32199996,10.1016/j.gofs.2020.03.014,2020-03-23
China,ISA,Geographical continent,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Syndrome,CAUSES,Pulmonary Pathology,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Symptoms,PROCESS_OF,Pregnant Women,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Infected,PROCESS_OF,Mother (person),32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Respiratory distress,PROCESS_OF,"Infant, Newborn",32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Influenza,CAUSES(SPEC),Pregnancy,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Influenza,COEXISTS_WITH,Symptoms,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Influenza,ISA,Respiratory Tract Infections,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Respiratory Tract Infections,CAUSES,Pregnancy,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Possible,PROCESS_OF,Pregnant Women,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Basis,TREATS,Pregnant Women,32199943,10.1016/j.micinf.2020.03.003,2020-03-23
Human coronavirus,CAUSES,Pneumonia,32199877,10.1016/j.ijantimicag.2020.105946,2020-03-23
,PART_OF,Mammals,32199877,10.1016/j.ijantimicag.2020.105946,2020-03-23
,PART_OF,Muridae,32199877,10.1016/j.ijantimicag.2020.105946,2020-03-23
Columbidae,ISA,Aves,32199877,10.1016/j.ijantimicag.2020.105946,2020-03-23
Japan,ISA,Country,32199792,10.1016/j.jiph.2020.02.033,2020-03-23
South Korea,ISA,Country,32199792,10.1016/j.jiph.2020.02.033,2020-03-23
Taiwan,ISA,Country,32199792,10.1016/j.jiph.2020.02.033,2020-03-23
Disease Outbreaks,CAUSES,Pneumonia,32199619,10.1016/j.crad.2020.03.002,2020-03-23
Lung,LOCATION_OF,Bilateral Disease,32199615,10.1016/j.bbrc.2020.03.044,2020-03-23
Lung,LOCATION_OF,Unilateral disease,32199615,10.1016/j.bbrc.2020.03.044,2020-03-23
Pneumonia,PROCESS_OF,Patients,32199615,10.1016/j.bbrc.2020.03.044,2020-03-23
Bilateral Disease,PROCESS_OF,Patients,32199615,10.1016/j.bbrc.2020.03.044,2020-03-23
Unilateral disease,PROCESS_OF,Patients,32199615,10.1016/j.bbrc.2020.03.044,2020-03-23
Lung,LOCATION_OF,ACE2 gene,32199182,10.1016/j.psychres.2020.112915,2020-03-22
receptor,AUGMENTS,Virus Internalization,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Cells,PART_OF,Unmarried person,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Cells,PART_OF,Unmarried person,32199182,10.1016/j.psychres.2020.112915,2020-03-22
keratinocyte,PART_OF,Esophagus,32199182,10.1016/j.psychres.2020.112915,2020-03-22
ACE2 gene,PRODUCES,PGR-AS1 gene,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Biliary epithelial cell,PART_OF,Liver,32199182,10.1016/j.psychres.2020.112915,2020-03-22
PGR-AS1 gene,PART_OF,Lung,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Human tissue,LOCATION_OF,ACE2 gene,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Cross Reactions,PROCESS_OF,Cells,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Body tissue,LOCATION_OF,Cell Count,32199182,10.1016/j.psychres.2020.112915,2020-03-22
macrophage,INTERACTS_WITH,chemokine,32199182,10.1016/j.psychres.2020.112915,2020-03-22
Mental disorders,PROCESS_OF,Elderly (population group),32199075,10.1016/S0140-6736(20)30553-5,2020-03-22
Distress,PROCESS_OF,Elderly (population group),32199075,10.1016/S0140-6736(20)30553-5,2020-03-22
Coronavirus Infections,ISA,Disease,32198989,10.12116/j.issn.1004-5619.2020.01.007,2020-03-22
Coronavirus Infections,ISA,Disease,32198989,10.12116/j.issn.1004-5619.2020.01.007,2020-03-22
Coronavirus Infections,ISA,Disease,32198989,10.12116/j.issn.1004-5619.2020.01.007,2020-03-22
Awareness,PROCESS_OF,Health Personnel,32198985,10.12116/j.issn.1004-5619.2020.01.003,2020-03-22
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32198985,10.12116/j.issn.1004-5619.2020.01.003,2020-03-22
Genus: Coronavirus,CAUSES,Middle East Respiratory Syndrome,32198985,10.12116/j.issn.1004-5619.2020.01.003,2020-03-22
Pathogenesis,CAUSES,Cessation of life,32198984,10.12116/j.issn.1004-5619.2020.01.002,2020-03-22
Autopsy,ISA,Physical Examination,32198984,10.12116/j.issn.1004-5619.2020.01.002,2020-03-22
"Lung Diseases, Interstitial",AFFECTS,exacerbation acute,32198834,10.1111/ajt.15874,2020-03-22
Fever,ISA,Symptoms,32198776,10.1002/jmv.25783,2020-03-22
Gastrointestinal Diseases,ISA,Symptoms,32198776,10.1002/jmv.25783,2020-03-22
Disease,PROCESS_OF,Patients,32198754,10.1111/trf.15789,2020-03-22
Lung,LOCATION_OF,Ground Glass Opacity,32198754,10.1111/trf.15789,2020-03-22
Antiviral Therapy,ADMINISTERED_TO,Patients,32198754,10.1111/trf.15789,2020-03-22
Kaletra,ADMINISTERED_TO,Patients,32198754,10.1111/trf.15789,2020-03-22
C-reactive protein,compared_with,Aspartate Transaminase,32198754,10.1111/trf.15789,2020-03-22
Kaletra,TREATS,"Pneumonia, Viral",32198754,10.1111/trf.15789,2020-03-22
daily activities,TREATS,Community,32198708,10.1007/s11684-020-0753-1,2020-03-22
Infected,PROCESS_OF,Patients,32198291,10.1126/science.abb3405,2020-03-22
Antibodies,CAUSES,Coronavirus Infections,32198291,10.1126/science.abb3405,2020-03-22
Antibody studies (procedure),USES,Enzyme-Linked Immunosorbent Assay,32198291,10.1126/science.abb3405,2020-03-22
CD40LG wt Allele,COEXISTS_WITH,Duration,32198291,10.1126/science.abb3405,2020-03-22
Enzyme-Linked Immunosorbent Assay,USES,CD40LG wt Allele,32198291,10.1126/science.abb3405,2020-03-22
Enzyme-Linked Immunosorbent Assay,USES,CD40LG wt Allele,32198291,10.1126/science.abb3405,2020-03-22
Pandemics,CAUSES,"Respiratory Distress Syndrome, Adult",32198163,10.1128/mBio.00398-20,2020-03-22
consideration,PROCESS_OF,Cohort,32198163,10.1128/mBio.00398-20,2020-03-22
Hydroxymethylglutaryl-CoA Reductase Inhibitors,STIMULATES,ACE2 gene,32198088,10.1016/j.ijid.2020.03.031,2020-03-22
Angiotensin II receptor antagonist,STIMULATES,ACE2 gene,32198088,10.1016/j.ijid.2020.03.031,2020-03-22
Drug Combinations,TREATS,Patients,32198088,10.1016/j.ijid.2020.03.031,2020-03-22
Infection,PROCESS_OF,Homo sapiens,32197339,10.3390/diagnostics10030165,2020-03-22
Coronavirus Infections,ISA,Disease,32197238,10.6004/jnccn.2020.7560,2020-03-21
Malignant Neoplasms,PROCESS_OF,Patients,32197085,10.1016/j.cub.2020.03.022,2020-03-21
Lung,PART_OF,Pholidota,32197060,10.3201/eid2607.200445,2020-03-21
Cessation of life,PROCESS_OF,Subgenus Paramanis,32197060,10.3201/eid2607.200445,2020-03-21
Subgenus Paramanis,LOCATION_OF,Genome,32197060,10.3201/eid2607.200445,2020-03-21
ACE2 gene,PART_OF,Homo sapiens,32197060,10.3201/eid2607.200445,2020-03-21
Lower Extremity,LOCATION_OF,Pain,32197059,10.3201/eid2607.200359,2020-03-21
Lung,LOCATION_OF,Lesion,32197059,10.3201/eid2607.200359,2020-03-21
Rhabdomyolysis,PROCESS_OF,Patients,32197059,10.3201/eid2607.200359,2020-03-21
Lesion,PROCESS_OF,Patients,32197059,10.3201/eid2607.200359,2020-03-21
SARS coronavirus,PROCESS_OF,Patients,32197059,10.3201/eid2607.200359,2020-03-21
Symptoms,PROCESS_OF,Patients,32197059,10.3201/eid2607.200359,2020-03-21
Infection,PROCESS_OF,traveler,32196707,10.1002/jmv.25781,2020-03-21
Pneumonia,ISA,Disease,32196678,10.1111/all.14289,2020-03-21
Pathogenic organism,CAUSES,Pneumonia,32196678,10.1111/all.14289,2020-03-21
Orthomyxoviridae,PROCESS_OF,Patients,32196678,10.1111/all.14289,2020-03-21
Alanine Transaminase,compared_with,Aspartate Transaminase,32196678,10.1111/all.14289,2020-03-21
"Respiratory Distress Syndrome, Adult",ISA,Complication,32196678,10.1111/all.14289,2020-03-21
Antiviral Therapy,ADMINISTERED_TO,Patients,32196678,10.1111/all.14289,2020-03-21
Glucocorticoids,TREATS,Patients,32196678,10.1111/all.14289,2020-03-21
Pharmaceutical Preparations,TREATS,Hemoptysis,32196678,10.1111/all.14289,2020-03-21
Coinfection,PROCESS_OF,Patients,32196678,10.1111/all.14289,2020-03-21
Hypersensitivity,PROCESS_OF,Patients,32196655,10.1002/ijgo.13146,2020-03-21
Symptoms,NEG_PROCESS_OF,Patients,32196655,10.1002/ijgo.13146,2020-03-21
Severe course,NEG_PROCESS_OF,Patients,32196655,10.1002/ijgo.13146,2020-03-21
Chronic Obstructive Airway Disease,COMPLICATES,Secondary bacterial pneumonia,32196655,10.1002/ijgo.13146,2020-03-21
Cesarean section,TREATS,Infection,32196627,10.26355/eurrev_202003_20549,2020-03-21
Coronavirus Infections,COEXISTS_WITH,Pregnancy 5,32196627,10.26355/eurrev_202003_20549,2020-03-21
Lung,LOCATION_OF,Ultrasonography,32196430,10.1080/22221751.2020.1745095,2020-03-21
Lung,LOCATION_OF,Ultrasonography,32196430,10.1080/22221751.2020.1745095,2020-03-21
Lung,LOCATION_OF,Ultrasonography,32196430,10.1080/22221751.2020.1745095,2020-03-21
Lung,LOCATION_OF,Ultrasonography,32196430,10.1080/22221751.2020.1745095,2020-03-21
Infected,PROCESS_OF,Patients,32196430,10.1080/22221751.2020.1745095,2020-03-21
Hospitals,LOCATION_OF,Assay,32196426,10.1146/annurev-virology-012420-022445,2020-03-21
Clinic,LOCATION_OF,Assay,32196426,10.1146/annurev-virology-012420-022445,2020-03-21
Influenza,ISA,Disease,32196410,10.1080/22221751.2020.1746199,2020-03-21
SARS coronavirus,ISA,Virus,32196410,10.1080/22221751.2020.1746199,2020-03-21
Organ,LOCATION_OF,Complication,32196406,10.1089/lrb.2020.29084.cov,2020-03-21
Prognosis good,PROCESS_OF,Patients,32196406,10.1089/lrb.2020.29084.cov,2020-03-21
Symptom mild,PROCESS_OF,Patients,32196406,10.1089/lrb.2020.29084.cov,2020-03-21
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32196406,10.1089/lrb.2020.29084.cov,2020-03-21
Low molecular weight heparin therapy,USES,Anticoagulants,32196406,10.1089/lrb.2020.29084.cov,2020-03-21
Critical Illness,PROCESS_OF,Patients,32196116,10.1093/ndt/gfaa069,2020-03-21
Ventilator - respiratory equipment,TREATS,Vulnerable Populations,32196116,10.1093/ndt/gfaa069,2020-03-21
Evaluation procedure,USES,Ventilator - respiratory equipment,32196116,10.1093/ndt/gfaa069,2020-03-21
Coronavirus Infections,CAUSES,Disease,32196083,10.1093/jac/dkaa114,2020-03-21
Coronavirus Infections,PROCESS_OF,Old age,32196083,10.1093/jac/dkaa114,2020-03-21
Take,TREATS,Patients,32196083,10.1093/jac/dkaa114,2020-03-21
Coronavirus Infections,ISA,Disease,32195887,10.1097/RTI.0000000000000508,2020-03-21
Hydroxychloroquine,TREATS,Severe course,32195887,10.1097/RTI.0000000000000508,2020-03-21
Coronavirus Infections,ISA,Disease,32195887,10.1097/RTI.0000000000000508,2020-03-21
Storm NOS,DISRUPTS,T-Cell Activation,32195887,10.1097/RTI.0000000000000508,2020-03-21
Pneumonia,PROCESS_OF,Patients,32195705,10.1097/ALN.0000000000003296,2020-03-21
Intubation,TREATS,Disease Progression,32195704,10.1097/ALN.0000000000003300,2020-03-21
Intubation,PREDISPOSES,Cross Infection,32195704,10.1097/ALN.0000000000003300,2020-03-21
Critical Illness,PROCESS_OF,Patients,32195704,10.1097/ALN.0000000000003300,2020-03-21
Intubation,USES,Videolaryngoscope,32195704,10.1097/ALN.0000000000003300,2020-03-21
Rapid sequence induction,USES,Videolaryngoscope,32195704,10.1097/ALN.0000000000003300,2020-03-21
Infected,PROCESS_OF,Patients,32195699,10.1097/ALN.0000000000003301,2020-03-21
Care of intensive care unit patient,TREATS,Patients,32195699,10.1097/ALN.0000000000003301,2020-03-21
Coronavirus Infections,ISA,Disease,32195698,10.1097/ALN.0000000000003303,2020-03-21
Anesthesiologist,ISA,Health Personnel,32195698,10.1097/ALN.0000000000003303,2020-03-21
Infected,PROCESS_OF,Patients,32195698,10.1097/ALN.0000000000003303,2020-03-21
Health Personnel,TREATS,Patients,32195698,10.1097/ALN.0000000000003303,2020-03-21
Anesthesiologist,ISA,Health Personnel,32195698,10.1097/ALN.0000000000003303,2020-03-21
Health Personnel,TREATS,Patients,32195311,10.1016/j.onehlt.2020.100124,2020-03-21
Anesthesiologist,TREATS,Patients,32195311,10.1016/j.onehlt.2020.100124,2020-03-21
Coronavirus Infections,ISA,Disease,32195311,10.1016/j.onehlt.2020.100124,2020-03-21
Critical Illness,PROCESS_OF,Patients,32195311,10.1016/j.onehlt.2020.100124,2020-03-21
Introduction procedure,ADMINISTERED_TO,human group,32194995,10.1038/s41541-020-0170-0,2020-03-21
Coronavirus Infections,AFFECTS,Homo sapiens,32194995,10.1038/s41541-020-0170-0,2020-03-21
Coronavirus Infections,ISA,Disease,32194980,10.1038/s41421-020-0153-3,2020-03-21
Alleviating anxiety,METHOD_OF,Isolation procedure,32194253,10.1016/j.micinf.2020.03.002,2020-03-21
Epitopes,PART_OF,Homo sapiens,32194239,10.1016/j.ijid.2020.03.027,2020-03-21
Epitopes,PART_OF,Genus: Coronavirus,32194239,10.1016/j.ijid.2020.03.027,2020-03-21
Disease,COEXISTS_WITH,Incubation period,32194034,10.1016/j.apmr.2020.03.003,2020-03-21
Coronavirus Infections,COEXISTS_WITH(SPEC),Incubation period,32194034,10.1016/j.apmr.2020.03.003,2020-03-21
Coronavirus Infections,ISA,Disease,32194034,10.1016/j.apmr.2020.03.003,2020-03-21
Confirmation,PROCESS_OF,Patients,32194034,10.1016/j.apmr.2020.03.003,2020-03-21
Immunity,NEG_PROCESS_OF,Population Group,32193905,10.3346/jkms.2020.35.e124,2020-03-21
Immunity,NEG_PROCESS_OF(SPEC),World,32193905,10.3346/jkms.2020.35.e124,2020-03-21
World,ISA,Population Group,32193905,10.3346/jkms.2020.35.e124,2020-03-21
Problem,PROCESS_OF,Community,32193904,10.3346/jkms.2020.35.e123,2020-03-21
Specimen,CAUSES,Pneumonia,32193904,10.3346/jkms.2020.35.e123,2020-03-21
Severe Acute Respiratory Syndrome,AFFECTS,Persons,32193638,10.1007/s00330-020-06801-0,2020-03-21
Critical Illness,PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Hyperpnea,ISA,Symptoms,32193638,10.1007/s00330-020-06801-0,2020-03-21
Plaque (lesion),PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Critical Illness,PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Invasive mechanical ventilation NOS,TREATS,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Invasive mechanical ventilation NOS,TREATS(INFER),Critical Illness,32193638,10.1007/s00330-020-06801-0,2020-03-21
Hyperpnea,ISA,Symptoms,32193638,10.1007/s00330-020-06801-0,2020-03-21
Critical Illness,PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Storm NOS,PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Storm NOS,PROCESS_OF,Patients,32193638,10.1007/s00330-020-06801-0,2020-03-21
Fibrosis,COEXISTS_WITH,patient condition,32193037,10.1016/j.ejrad.2020.108941,2020-03-21
Diagnosis,DIAGNOSES,Pneumonia,32192580,10.1016/S0140-6736(20)30528-6,2020-03-21
Abnormal Finding,PROCESS_OF,Patients,32192580,10.1016/S0140-6736(20)30528-6,2020-03-21
Atelectasis,PROCESS_OF,Patients,32192580,10.1016/S0140-6736(20)30528-6,2020-03-21
Lung,PART_OF,Caucasoid Race,32192580,10.1016/S0140-6736(20)30528-6,2020-03-21
Pleural effusion disorder,PROCESS_OF,Patients,32192580,10.1016/S0140-6736(20)30528-6,2020-03-21
Coronavirus Infections,AFFECTS,World,32192424,10.33321/cdi.2020.44.23,2020-03-21
metastatic colorectal cancer,PROCESS_OF,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Tumor Progression,PROCESS_OF,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Differential Diagnosis,ADMINISTERED_TO,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Fever,PROCESS_OF,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Screening procedure,ADMINISTERED_TO,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Disease,PROCESS_OF,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Stable Disease,PROCESS_OF,Patients,32192296,10.3760/cma.j.cn.441530-20200217-00057,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Colorectal Neoplasms,PROCESS_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Medical Staff,DIAGNOSES,Colorectal Neoplasms,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Prophylactic treatment,TREATS,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Prophylactic treatment,TREATS(INFER),Colorectal Neoplasms,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Physician service,TREATS,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Heart,LOCATION_OF,Pneumonia,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Prophylactic treatment,TREATS,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Life Threatening,PROCESS_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Emergency operation,ADMINISTERED_TO,Surgeon,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Decompression of intestine,ADMINISTERED_TO,Surgeon,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Body Fluids,PART_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Feces,PART_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Medical observation,ADMINISTERED_TO,Health Personnel,32192295,10.3760/cma.j.cn.441530-20200224-00074,2020-03-21
Elective Surgical Procedures,ISA,Operative Surgical Procedures,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Colorectal Carcinoma,PROCESS_OF,Patients,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Total mesorectal excision,PREVENTS,Cross Infection,32192294,10.3760/cma.j.cn.441530-20200217-00058,2020-03-21
Medical Staff,TREATS,Patients,32192285,10.3760/cma.j.cn112137-20200205-00196,2020-03-21
Emergency operation,TREATS,Patients,32192285,10.3760/cma.j.cn112137-20200205-00196,2020-03-21
China,ISA,Country,32191830,10.5114/ait.2020.93756,2020-03-20
"Respiratory Distress Syndrome, Adult",ISA,Complication,32191813,10.4414/smw.2020.20225,2020-03-20
"Respiratory Distress Syndrome, Adult",OCCURS_IN,Elderly (population group),32191813,10.4414/smw.2020.20225,2020-03-20
Switzerland,ISA,Country,32191764,10.1371/journal.pone.0230548,2020-03-20
Infected,PROCESS_OF,Persons,32191764,10.1371/journal.pone.0230548,2020-03-20
Severe Acute Respiratory Syndrome,PROCESS_OF,Persons,32191764,10.1371/journal.pone.0230548,2020-03-20
Isolation procedure,COEXISTS_WITH,Contacts,32191764,10.1371/journal.pone.0230548,2020-03-20
Comorbidity,PROCESS_OF,Elderly (population group),32191691,10.15585/mmwr.mm6911e1,2020-03-20
Pneumonia,PROCESS_OF,Patients,32191689,10.15585/mmwr.mm6911e2,2020-03-20
Influenza-like symptoms,PROCESS_OF,Patients,32191689,10.15585/mmwr.mm6911e2,2020-03-20
Differential panel,DIAGNOSES,patient condition,32191689,10.15585/mmwr.mm6911e2,2020-03-20
Endocytosis,AFFECTS,Cholesterol,32191675,10.23750/abm.v91i1.9397,2020-03-20
Coronavirus Infections,PROCESS_OF,Family,32191675,10.23750/abm.v91i1.9397,2020-03-20
Infected,PROCESS_OF,Patients,32191588,10.1148/radiol.2020200905,2020-03-20
Coronavirus Infections,ISA,Disease,32191587,10.1148/radiol.2020200843,2020-03-20
Medical Examination,METHOD_OF,Detection,32191587,10.1148/radiol.2020200843,2020-03-20
Medical Examination,USES,"Tomography, Spiral Computed",32191587,10.1148/radiol.2020200843,2020-03-20
Medical Examination,USES,CT of lungs,32191587,10.1148/radiol.2020200843,2020-03-20
Medical Examination,USES,Chest CT,32191587,10.1148/radiol.2020200843,2020-03-20
Community acquired pneumonia,ISA,Lung diseases,32191587,10.1148/radiol.2020200843,2020-03-20
Pneumonia,PROCESS_OF,Patients,32191174,10.5811/westjem.2020.1.46760,2020-03-20
Residual Tumor,PROCESS_OF,Patients,32191174,10.5811/westjem.2020.1.46760,2020-03-20
Communicable Diseases,COEXISTS_WITH,SARS coronavirus,32191173,10.3201/eid2606.200357,2020-03-20
Communicable Diseases,COEXISTS_WITH,Middle East Respiratory Syndrome Coronavirus,32191173,10.3201/eid2606.200357,2020-03-20
Coronavirus Infections,COEXISTS_WITH(SPEC),SARS coronavirus,32191173,10.3201/eid2606.200357,2020-03-20
Coronavirus Infections,COEXISTS_WITH(SPEC),Middle East Respiratory Syndrome Coronavirus,32191173,10.3201/eid2606.200357,2020-03-20
Coronavirus Infections,ISA,Communicable Diseases,32191173,10.3201/eid2606.200357,2020-03-20
Infected,PROCESS_OF,Persons,32191173,10.3201/eid2606.200357,2020-03-20
Coronavirus Infections,ISA,Disease,32190908,10.1002/jmv.25773,2020-03-20
Screening procedure,AFFECTS,patient condition,32190785,10.1016/j.idm.2020.02.003,2020-03-20
Infected,PROCESS_OF,Persons,32189175,10.1007/s11604-020-00945-1,2020-03-20
Symptoms,PROCESS_OF,Persons,32189175,10.1007/s11604-020-00945-1,2020-03-20
Epithelial Cells,LOCATION_OF,Virus,32189175,10.1007/s11604-020-00945-1,2020-03-20
Epithelial Cells,PART_OF,Lung,32189175,10.1007/s11604-020-00945-1,2020-03-20
Both lungs,LOCATION_OF,Ground Glass Opacity,32189081,10.1007/s10916-020-01562-1,2020-03-20
Pneumonia,COEXISTS_WITH,Ground Glass Opacity,32189081,10.1007/s10916-020-01562-1,2020-03-20
Both lungs,LOCATION_OF,Ground Glass Opacity,32189081,10.1007/s10916-020-01562-1,2020-03-20
Epidemic,CAUSES,Coronavirus Infections,32189015,10.1007/s00101-020-00758-x,2020-03-20
Coronavirus Infections,ISA,Disease,32189010,10.1007/s00134-020-06009-2,2020-03-20
Infection,AFFECTS,Persons,32188753,10.1128/mSphere.00203-20,2020-03-20
Coronavirus Infections,CAUSES,Pneumonia,32187921,10.3760/cma.j.issn.0529-5815.2020.03.004,2020-03-20
Genus: Coronavirus,COEXISTS_WITH,SARS coronavirus,32187921,10.3760/cma.j.issn.0529-5815.2020.03.004,2020-03-20
Genus: Coronavirus,COEXISTS_WITH,Middle East Respiratory Syndrome Coronavirus,32187921,10.3760/cma.j.issn.0529-5815.2020.03.004,2020-03-20
Peptidyl-Dipeptidase A,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32187921,10.3760/cma.j.issn.0529-5815.2020.03.004,2020-03-20
Coronavirus Infections,ISA,Disease,32187920,10.3760/cma.j.issn.0529-5815.2020.03.003,2020-03-20
Aorta,LOCATION_OF,Syndrome,32187920,10.3760/cma.j.issn.0529-5815.2020.03.003,2020-03-20
Syndrome,PROCESS_OF,Patients,32187920,10.3760/cma.j.issn.0529-5815.2020.03.003,2020-03-20
Communicable Diseases,ISA,Disease,32187887,10.1002/ppul.24734,2020-03-19
Coronavirus Infections,ISA,Disease,32187887,10.1002/ppul.24734,2020-03-19
Pneumonia,PROCESS_OF,Patients,32187837,10.1002/cbic.202000081,2020-03-19
Coronavirus Infections,ISA,Disease,32187837,10.1002/cbic.202000081,2020-03-19
Present,PROCESS_OF,World,32187837,10.1002/cbic.202000081,2020-03-19
Oligonucleotides,ISA,DNA,32187818,10.1002/cyto.a.23999,2020-03-19
Therapeutic procedure,AFFECTS,hospitalized patients,32187007,10.3201/eid2606.200495,2020-03-19
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32187007,10.3201/eid2606.200495,2020-03-19
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32187007,10.3201/eid2606.200495,2020-03-19
Serious Adverse Event,ISA,Adverse event,32187007,10.3201/eid2606.200495,2020-03-19
lopinavir / Ritonavir,NEG_TREATS,Patients,32187007,10.3201/eid2606.200495,2020-03-19
Growth,AFFECTS,Virus,32186952,10.1080/21645515.2020.1735227,2020-03-19
Pharmaceutical Preparations,INTERACTS_WITH,"M Protein, multiple myeloma",32186894,10.2214/AJR.20.23072,2020-03-19
Coronavirus Infections,ISA,Disease,32186277,10.2807/1560-7917.ES.2020.25.11.2000285,2020-03-19
Pneumonia,PROCESS_OF,Patients,32186277,10.2807/1560-7917.ES.2020.25.11.2000285,2020-03-19
Comorbidity,PROCESS_OF,Cohort,32186277,10.2807/1560-7917.ES.2020.25.11.2000285,2020-03-19
Country,ISA,Geographic Locations,32186172,10.3760/cma.j.cn112147-20200312-00320,2020-03-19
Disease,PROCESS_OF,Patients,32186172,10.3760/cma.j.cn112147-20200312-00320,2020-03-19
Italy,ISA,Country,32186172,10.3760/cma.j.cn112147-20200312-00320,2020-03-19
Coronavirus Infections,ISA,Disease,32186172,10.3760/cma.j.cn112147-20200312-00320,2020-03-19
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32186172,10.3760/cma.j.cn112147-20200312-00320,2020-03-19
Comorbidity,PROCESS_OF,Patients,32186171,10.3760/cma.j.cn115330-20200225-00128,2020-03-19
10 - severe,PROCESS_OF,Patients,32186171,10.3760/cma.j.cn115330-20200225-00128,2020-03-19
Evaluation,TREATS,Malaria,32185669,10.1007/s11604-020-00948-y,2020-03-19
Virus Diseases,PROCESS_OF,Health Personnel,32185669,10.1007/s11604-020-00948-y,2020-03-19
care seeking,ISA,Behavior,32185669,10.1007/s11604-020-00948-y,2020-03-19
Challenge,TREATS,Malaria,32185669,10.1007/s11604-020-00948-y,2020-03-19
Quarantine,TREATS,Persons,32183920,10.1017/ice.2020.81,2020-03-19
Incubation period,PROCESS_OF,traveler,32183901,10.1186/s40249-020-00646-x,2020-03-19
Coronavirus Infections,ISA,Disease,32183357,10.3390/mi11030306,2020-03-19
Coronavirus Infections,ISA,Disease,32183357,10.3390/mi11030306,2020-03-19
Infected,PROCESS_OF,Persons,32183357,10.3390/mi11030306,2020-03-19
Diagnosis,AFFECTS,Coronavirus Infections,32183357,10.3390/mi11030306,2020-03-19
Detection,USES,Medical Devices,32183172,10.3390/jcm9030789,2020-03-19
Epidemic disease,AFFECTS,Crisis,32182724,10.3390/biology9030050,2020-03-19
Transplant Recipients,LOCATION_OF,IMPACT gene,32181911,10.1002/jmv.25770,2020-03-18
Pneumonia,PROCESS_OF,Recipient,32181911,10.1002/jmv.25770,2020-03-18
Pneumonia,PROCESS_OF,Patients,32181911,10.1002/jmv.25770,2020-03-18
Pneumonia,PROCESS_OF,Patients,32181911,10.1002/jmv.25770,2020-03-18
Patients,LOCATION_OF,"CD69 protein, human",32181903,10.1002/jmv.25767,2020-03-18
Fibrinogen,compared_with,C-reactive protein,32181903,10.1002/jmv.25767,2020-03-18
Interleukin-6,COEXISTS_WITH,Fibrin fragment D,32181903,10.1002/jmv.25767,2020-03-18
Patients,LOCATION_OF,Interleukin-6,32181903,10.1002/jmv.25767,2020-03-18
Patients,LOCATION_OF,Fibrin fragment D,32181903,10.1002/jmv.25767,2020-03-18
Blood Platelets,PART_OF,Patients,32181901,10.1002/jmv.25768,2020-03-18
Blood Platelets,PART_OF,Patients,32181901,10.1002/jmv.25768,2020-03-18
Storm NOS,PROCESS_OF,Patients,32181901,10.1002/jmv.25768,2020-03-18
Coronavirus Infections,PROCESS_OF,Patients,32181874,10.5055/jem.2020.0464,2020-03-18
Genus: Coronavirus,PROCESS_OF,Chiroptera,32181874,10.5055/jem.2020.0464,2020-03-18
SARS coronavirus,LOCATION_OF,Proteins,32181874,10.5055/jem.2020.0464,2020-03-18
Decision,PROCESS_OF,Maker (occupation),32181807,10.1093/qjmed/hcaa089,2020-03-18
Decision,PROCESS_OF,Maker (occupation),32181807,10.1093/qjmed/hcaa089,2020-03-18
Temporal region,LOCATION_OF,Back,32181672,10.2214/AJR.20.22961,2020-03-18
Fever,ISA,Symptoms,32181672,10.2214/AJR.20.22961,2020-03-18
Eye,LOCATION_OF,Respiration Disorders,32180292,10.1002/uog.22014,2020-03-18
SARS coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32180292,10.1002/uog.22014,2020-03-18
Coronavirus Infections,NEG_CAUSES,Maternal Death,32180292,10.1002/uog.22014,2020-03-18
Severe Acute Respiratory Syndrome,CAUSES,Coronavirus Infections,32180292,10.1002/uog.22014,2020-03-18
Middle East Respiratory Syndrome,CAUSES,Coronavirus Infections,32180292,10.1002/uog.22014,2020-03-18
Infected,PROCESS_OF,Pregnant Women,32180292,10.1002/uog.22014,2020-03-18
Woman,LOCATION_OF,IMPACT gene,32180175,10.1007/s12630-020-01630-7,2020-03-18
Coronavirus Infections,AFFECTS,Woman,32180175,10.1007/s12630-020-01630-7,2020-03-18
Severe Acute Respiratory Syndrome,AFFECTS,Woman,32180175,10.1007/s12630-020-01630-7,2020-03-18
Middle East Respiratory Syndrome,AFFECTS,Pregnancy,32180175,10.1007/s12630-020-01630-7,2020-03-18
Coronavirus Infections,AFFECTS,Woman,32180175,10.1007/s12630-020-01630-7,2020-03-18
Vaginal delivery procedure,METHOD_OF,Cesarean section,32180175,10.1007/s12630-020-01630-7,2020-03-18
Spontaneous abortion,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32180175,10.1007/s12630-020-01630-7,2020-03-18
Fetal Death,COEXISTS_WITH,Severe Acute Respiratory Syndrome,32180175,10.1007/s12630-020-01630-7,2020-03-18
Severe Acute Respiratory Syndrome,AFFECTS,Pregnancy,32180175,10.1007/s12630-020-01630-7,2020-03-18
Severe Acute Respiratory Syndrome,OCCURS_IN,Woman,32180175,10.1007/s12630-020-01630-7,2020-03-18
Lethal,COEXISTS_WITH,Disease,32180175,10.1007/s12630-020-01630-7,2020-03-18
Birth,COEXISTS_WITH,Pregnancy,32180175,10.1007/s12630-020-01630-7,2020-03-18
Long-Term Synaptic Depression,PROCESS_OF,Son (person),32180175,10.1007/s12630-020-01630-7,2020-03-18
General Anesthesia,METHOD_OF,Cesarean section,32180140,10.1007/s12519-020-00356-2,2020-03-18
Communicable Diseases,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Coronavirus Infections,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Coronavirus Infections,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
SARS coronavirus,PROCESS_OF,"Infant, Newborn",32180140,10.1007/s12519-020-00356-2,2020-03-18
Cesarean section,TREATS,Patients,32180140,10.1007/s12519-020-00356-2,2020-03-18
Epidural Anesthesia,TREATS,Patients,32180140,10.1007/s12519-020-00356-2,2020-03-18
General Anesthesia,ADMINISTERED_TO,Patients,32180140,10.1007/s12519-020-00356-2,2020-03-18
Cesarean section,TREATS,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Cesarean section,TREATS(SPEC),Coronavirus Infections,32180140,10.1007/s12519-020-00356-2,2020-03-18
Coronavirus Infections,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Cesarean section,ADMINISTERED_TO,Medical Staff,32180140,10.1007/s12519-020-00356-2,2020-03-18
Coronavirus Infections,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Coronavirus Infections,ISA,Disease,32180140,10.1007/s12519-020-00356-2,2020-03-18
Confirmation,PROCESS_OF,Child,32179910,10.1093/infdis/jiaa119,2020-03-18
Symptom mild,PROCESS_OF,Child,32179910,10.1093/infdis/jiaa119,2020-03-18
Infected,PROCESS_OF,Adult,32179910,10.1093/infdis/jiaa119,2020-03-18
Infected,PROCESS_OF,Child,32179910,10.1093/infdis/jiaa119,2020-03-18
Infected,PROCESS_OF,Child,32179910,10.1093/infdis/jiaa119,2020-03-18
Infected,PROCESS_OF,Patients,32179908,10.1093/infdis/jiaa113,2020-03-18
Infected,PROCESS_OF,Family member,32179908,10.1093/infdis/jiaa113,2020-03-18
Coronavirus Infections,ISA,Disease,32179908,10.1093/infdis/jiaa113,2020-03-18
Coronavirus Infections,ISA,Disease,32179890,10.1093/cid/ciaa287,2020-03-18
Disease,PROCESS_OF,Child,32179890,10.1093/cid/ciaa287,2020-03-18
Disease,PROCESS_OF,Child,32179890,10.1093/cid/ciaa287,2020-03-18
Disease,PROCESS_OF,Patients,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,ISA,Disease,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,ISA,Disease,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,ISA,Disease,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,ISA,Disease,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,PROCESS_OF(SPEC),Child,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,PROCESS_OF(SPEC),Child,32179890,10.1093/cid/ciaa287,2020-03-18
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32179890,10.1093/cid/ciaa287,2020-03-18
Disease,PROCESS_OF,Patients,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Disease,PROCESS_OF,Patients,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,ISA,Disease,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,ISA,Disease,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Disease,AFFECTS,Child,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,AFFECTS(SPEC),Child,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Coronavirus Infections,ISA,Disease,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Infant,ISA,Child,32179150,10.1016/j.ijantimicag.2020.105944,2020-03-18
Pneumonia,CAUSES,Coronavirus Infections,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Ribavirin,DISRUPTS,Coronavirus Infections,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Ritonavir,DISRUPTS,Coronavirus Infections,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
lopinavir,DISRUPTS,Coronavirus Infections,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Antibiotics,TREATS,Staphylococcal Infections,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Virus,PROCESS_OF,Patients,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Teicoplanin,TREATS,Patients,32179140,10.1016/j.ijid.2020.03.022,2020-03-18
Fever,ISA,Symptoms,32179125,10.1016/j.tmaid.2020.101624,2020-03-18
Bilateral pneumonia,PROCESS_OF,Patients,32179125,10.1016/j.tmaid.2020.101624,2020-03-18
Day 7,PROCESS_OF,Patients,32179125,10.1016/j.tmaid.2020.101624,2020-03-18
Pneumonia,AFFECTS,Patients,32179125,10.1016/j.tmaid.2020.101624,2020-03-18
Coronavirus Infections,CAUSES,Respiration Disorders,32179124,10.1016/j.tmaid.2020.101623,2020-03-18
Anxiety,PROCESS_OF,Population Group,32179124,10.1016/j.tmaid.2020.101623,2020-03-18
Decision,PROCESS_OF,Maker (occupation),32179124,10.1016/j.tmaid.2020.101623,2020-03-18
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32179106,10.1016/j.gie.2020.03.019,2020-03-18
Comorbidity,PROCESS_OF,Patients,32179106,10.1016/j.gie.2020.03.019,2020-03-18
Fatal Outcome,PROCESS_OF,hospitalized patients,32179106,10.1016/j.gie.2020.03.019,2020-03-18
"corticotropin-releasing factor, human",AFFECTS,patient condition,32179106,10.1016/j.gie.2020.03.019,2020-03-18
Coronavirus Infections,CAUSES,Acute illness,32178975,10.1016/j.cca.2020.03.022,2020-03-18
Patients,ISA,Persons,32178975,10.1016/j.cca.2020.03.022,2020-03-18
Infected,PROCESS_OF,Persons,32178975,10.1016/j.cca.2020.03.022,2020-03-18
Infected,PROCESS_OF(SPEC),Patients,32178975,10.1016/j.cca.2020.03.022,2020-03-18
Acute respiratory insufficiency,PROCESS_OF,Patients,32178975,10.1016/j.cca.2020.03.022,2020-03-18
Thrombocytopenia,COEXISTS_WITH,patient condition,32178970,10.1016/j.jmii.2020.03.002,2020-03-18
Platelet Count measurement,DIAGNOSES,patient condition,32178970,10.1016/j.jmii.2020.03.002,2020-03-18
Severe disorder,PROCESS_OF,Patients,32178970,10.1016/j.jmii.2020.03.002,2020-03-18
Codon (nucleotide sequence),COEXISTS_WITH,Open Reading Frames,32178954,10.1053/j.jvca.2020.02.039,2020-03-18
Codon (nucleotide sequence),COEXISTS_WITH,Open Reading Frames,32178954,10.1053/j.jvca.2020.02.039,2020-03-18
Genome,PART_OF,Genus: Coronavirus,32178954,10.1053/j.jvca.2020.02.039,2020-03-18
SARS coronavirus,ISA,Genus: Coronavirus,32178954,10.1053/j.jvca.2020.02.039,2020-03-18
Hospitals,LOCATION_OF,Administration occupational activities,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
"Hospitals, Pediatric",ISA,Hospitals,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Confirmation,PROCESS_OF,Health Personnel,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Confirmation,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,TREATS,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,TREATS,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,TREATS(INFER),Confirmation,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
"CD69 protein, human",PREVENTS,Cross Infection,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Chronic disease,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Lymphopenia,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Operating Room,LOCATION_OF,Study,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Mottling,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Confirmation,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,PREVENTS,Cross Infection,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,TREATS,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Emergency procedure,TREATS(INFER),Confirmation,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Ground Glass Opacity,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Fever,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Confirmation,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
Dry cough,PROCESS_OF,Patients,32178769,10.1016/S0140-6736(20)30627-9,2020-03-18
intensive care,TREATS,Pneumonia,32178768,10.1016/S0140-6736(20)30607-3,2020-03-18
Infected,PROCESS_OF,Patients,32178768,10.1016/S0140-6736(20)30607-3,2020-03-18
Infected,PROCESS_OF,Patients,32178768,10.1016/S0140-6736(20)30607-3,2020-03-18
Asymptomatic,PROCESS_OF,Health Personnel,32178593,10.1080/22221751.2020.1739565,2020-03-18
Glycoproteins,ASSOCIATED_WITH,Tissue Adhesions,32176808,10.4414/smw.2020.20224,2020-03-17
Glycoproteins,INTERACTS_WITH,"DPP4 protein, human",32176808,10.4414/smw.2020.20224,2020-03-17
"DPP4 protein, human",PART_OF,Homo sapiens,32176808,10.4414/smw.2020.20224,2020-03-17
Coronavirus Infections,CAUSES,Infection,32176772,10.1093/cid/ciaa272,2020-03-17
Fever,ISA,Symptoms,32175797,10.1080/09273948.2020.1738501,2020-03-17
Antiviral Therapy,ADMINISTERED_TO,Patients,32175797,10.1080/09273948.2020.1738501,2020-03-17
Lactate Dehydrogenase,compared_with,C-reactive protein,32175797,10.1080/09273948.2020.1738501,2020-03-17
Eye Infections,PROCESS_OF,Animals,32175703,10.2991/jegh.k.200218.003,2020-03-17
Conjunctivitis,PROCESS_OF,Felis catus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Conjunctivitis,PROCESS_OF,Mus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Optic Neuritis,PROCESS_OF,Felis catus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Optic Neuritis,PROCESS_OF,Mus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Retinitis,PROCESS_OF,Felis catus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Retinitis,PROCESS_OF,Mus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Anterior uveitis,PROCESS_OF,Felis catus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Anterior uveitis,PROCESS_OF,Mus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Ocular Tissue,LOCATION_OF,Human coronavirus,32175703,10.2991/jegh.k.200218.003,2020-03-17
Cessation of life,PROCESS_OF,Patients,32175421,10.21037/atm.2020.02.66,2020-03-17
Hypertensive disease,PROCESS_OF,Population Group,32175421,10.21037/atm.2020.02.66,2020-03-17
Coronavirus Infections,CAUSES,Pneumonia,32174267,10.1080/22221751.2020.1738905,2020-03-17
Pneumonia,PROCESS_OF,Patients,32174129,10.2214/AJR.20.23034,2020-03-17
Diagnosis,DIAGNOSES,Pneumonia,32174129,10.2214/AJR.20.23034,2020-03-17
Diagnosis,DIAGNOSES,Pneumonia,32174129,10.2214/AJR.20.23034,2020-03-17
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Homologous Gene,PART_OF,Genus: Coronavirus,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Lung diseases,AFFECTS,Pulmonary Dysfunction,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Lung diseases,PROCESS_OF,Survivors,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Pulmonary Fibrosis,AFFECTS(SPEC),Pulmonary Dysfunction,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Pulmonary Fibrosis,ISA,Lung diseases,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Pulmonary Fibrosis,PROCESS_OF(SPEC),Survivors,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Survivors,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Complication,COEXISTS_WITH,patient condition,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Pulmonary Fibrosis,PREDISPOSES,Possible,32174069,10.3346/jkms.2020.35.e112,2020-03-17
Infected,PROCESS_OF,Patients,32174053,10.3348/kjr.2020.0146,2020-03-17
Hospitals,LOCATION_OF,Retrospective Studies,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
GSKIP gene,PART_OF,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Albumins,ASSOCIATED_WITH,Pleural effusion disorder,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Albumins,ASSOCIATED_WITH,Bilateral pneumonia,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Aspartate Transaminase,ASSOCIATED_WITH,Fever,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Lactate Dehydrogenase,compared_with,C-reactive protein,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Senility,PROCESS_OF,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Expectorants,ADMINISTERED_TO,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Oxygen,ADMINISTERED_TO,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Mechanical ventilation,ADMINISTERED_TO,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
adjunctive treatment,ADMINISTERED_TO,Patients,32173576,10.1016/j.ijid.2020.03.013,2020-03-17
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
Hospitals,LOCATION_OF,Data Collection,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
Coughing,ISA,Symptoms,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
Fever,ISA,Symptoms,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
lopinavir,compared_with,other medicated shampoos in ATC,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
lopinavir,higher_than,other medicated shampoos in ATC,32173574,10.1016/j.ijid.2020.03.017,2020-03-17
Disease,OCCURS_IN,Patients,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Infected,PROCESS_OF,Patients,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Infected,PROCESS_OF,Patients,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Fever,ISA,Symptoms,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Diabetes,PRECEDES,Cardiovascular Diseases,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Cardiovascular Diseases,COEXISTS_WITH,patient condition,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Hypertensive disease,COEXISTS_WITH,patient condition,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Respiration Disorders,COEXISTS_WITH,patient condition,32173572,10.1016/j.ijid.2020.03.021,2020-03-17
Agitation,ASSOCIATED_WITH,Coronavirus Infections,32173241,10.1016/j.jmii.2020.02.012,2020-03-17
Pneumonia,PROCESS_OF,Patients,32173188,10.1016/j.anpedi.2020.02.001,2020-03-17
Coronaviridae,PROCESS_OF,Family,32173110,10.1016/j.jcrc.2020.03.005,2020-03-17
Chloroquine,TREATS,Patients,32172672,10.1080/22221751.2020.1736644,2020-03-17
Chloroquine,TREATS,Patients,32172672,10.1080/22221751.2020.1736644,2020-03-17
Coronavirus Infections,PROCESS_OF,Animals,32172669,10.1080/22221751.2020.1735265,2020-03-17
Human coronavirus,ISA,Virus,32172669,10.1080/22221751.2020.1735265,2020-03-17
SARS coronavirus,ISA,Virus,32172669,10.1080/22221751.2020.1735265,2020-03-17
Middle East Respiratory Syndrome Coronavirus,ISA,Virus,32172669,10.1080/22221751.2020.1735265,2020-03-17
Lung,LOCATION_OF,Leucocytic infiltrate,32172546,10.3760/cma.j.cn112151-20200312-00193,2020-03-17
Respiratory sample,PART_OF,Tract,32172226,10.1515/cclm-2020-0188,2020-03-17
Antiretroviral therapy,ADMINISTERED_TO,Patients,32172226,10.1515/cclm-2020-0188,2020-03-17
Mental Recall,PROCESS_OF,Patients,32172226,10.1515/cclm-2020-0188,2020-03-17
Negative Test Result,PROCESS_OF,Patients,32172226,10.1515/cclm-2020-0188,2020-03-17
Coronavirus Infections,AFFECTS,Pneumonia,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Hospitals,LOCATION_OF,Study,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Patients,LOCATION_OF,Fibrin fragment D,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Patients,LOCATION_OF,Fibrin split products,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Coagulation procedure,TREATS,Patients,32171952,10.1016/j.ijid.2020.03.004,2020-03-17
Iran,ISA,Country,32171948,10.1016/j.ijid.2020.03.018,2020-03-17
Quarantine,STIMULATES,Cessation of life,32171872,10.1016/j.jinf.2020.03.002,2020-03-17
lopinavir / Ritonavir,compared_with,GSKIP gene,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
arbidol,ADMINISTERED_TO,Patients,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
lopinavir,ADMINISTERED_TO,Patients,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
Chest CT,METHOD_OF,Diagnosis,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
arbidol,ADMINISTERED_TO,Patients,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
lopinavir,ADMINISTERED_TO,Patients,32171869,10.1016/j.jinf.2020.03.004,2020-03-17
Coronavirus Infections,ISA,Disease,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Coronavirus Infections,ISA,Disease,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
GSKIP gene,PART_OF,Patients,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Symptoms,PROCESS_OF,Patients,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Fever,PROCESS_OF,Patients,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Fever,PROCESS_OF,Patients,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Upper respiratory sample,PART_OF,Tract,32171867,10.1016/j.jinf.2020.03.001,2020-03-17
Coronavirus Infections,ISA,Disease,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
Pneumonia,ISA,Disease,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
Pneumonia,PROCESS_OF,Patients,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
Coronavirus Infections,ISA,Disease,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
SARS coronavirus,PROCESS_OF,Patients,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
"Lymphopenia, progressive",PROCESS_OF,Patients,32171866,10.1016/j.jinf.2020.03.005,2020-03-17
Pneumonia,PROCESS_OF,Patients,32171865,10.1016/j.jinf.2020.03.007,2020-03-17
Pneumonia,PROCESS_OF,geriatric patients,32171865,10.1016/j.jinf.2020.03.007,2020-03-17
Provincial hospital,LOCATION_OF,Retrospective Studies,32171865,10.1016/j.jinf.2020.03.007,2020-03-17
Coughing,ISA,Symptoms,32171865,10.1016/j.jinf.2020.03.007,2020-03-17
Fever,ISA,Symptoms,32171865,10.1016/j.jinf.2020.03.007,2020-03-17
Disease,PROCESS_OF,Child,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Disease,PROCESS_OF,Pregnant Women,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Lymphopenia,COEXISTS_WITH,Confirmation,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Gravidity,NEG_PROCESS_OF,Adult,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Gravidity,NEG_PROCESS_OF,Adult,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Confirmation,PROCESS_OF,Adult,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Gravidity,NEG_PROCESS_OF,Adult,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
pulmonary involvement,PROCESS_OF,Child,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Symptoms,PROCESS_OF,Child,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
exposure history,PROCESS_OF,Child,32171740,10.1016/j.ijantimicag.2020.105938,2020-03-17
Infectious disease of lung,PROCESS_OF,Homo sapiens,32171622,10.1016/j.ajic.2020.01.023,2020-03-17
Coronavirus Infections,ISA,Disease,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Nose,LOCATION_OF,Virus,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Nose,PART_OF,Patients,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Pharyngeal structure,LOCATION_OF,Virus,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Pharyngeal structure,PART_OF,Patients,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Fibrosis,PRODUCES,Interleukin-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Interleukin-1,STIMULATES,Caspase-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Interleukin-1,STIMULATES,Inflammasomes,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Pneumonia,PRODUCES,Interleukin-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Interleukin-1,ASSOCIATED_WITH,Inflammatory disorder,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Interleukin-6,ASSOCIATED_WITH,Inflammatory disorder,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
IL37 gene,DISRUPTS,Inflammation,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
IL37 gene,INTERACTS_WITH,"FRAP1 protein, human",32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
cytokine,ASSOCIATED_WITH,Inflammatory disorder,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
IL37 gene,INHIBITS,Interleukin-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Interleukin-1,ISA,cytokine,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Immune Cell,PRODUCES,Interleukin-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
cytokine,INHIBITS,Interleukin-1,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
cytokine,INHIBITS,Interleukins,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
IL1F10 gene,ASSOCIATED_WITH,Virus Diseases,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
IL1F10 gene,DISRUPTS,Inflammation,32171191,10.3760/cma.j.cn112150-20200217-00128,2020-03-17
Hospitals,LOCATION_OF,Study,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Comorbidity,PROCESS_OF,Patients,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Hypertensive disease,PRECEDES,Diabetes,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Cessation of life,PROCESS_OF,Survivors,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Viral Shedding,PROCESS_OF,Survivors,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Viral Shedding,PROCESS_OF,Survivors,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Prognosis bad,PROCESS_OF,Patients,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Infected,PROCESS_OF,Patients,32171059,10.1016/S1473-3099(20)30144-4,2020-03-15
Infected,PROCESS_OF,Passenger,32170865,10.1002/jmv.25766,2020-03-15
Coronavirus Infections,ISA,Disease,32170800,10.1111/dth.13310,2020-03-15
Lung,LOCATION_OF,Lesion,32170800,10.1111/dth.13310,2020-03-15
Liver damage,PROCESS_OF,Patients,32170800,10.1111/dth.13310,2020-03-15
Coronavirus Infections,ISA,Disease,32170800,10.1111/dth.13310,2020-03-15
Chronic dermatitis,COMPLICATES,Dermatologic disorders,32170560,10.1007/s11684-020-0754-0,2020-03-15
Hair,LOCATION_OF,Protection,32170560,10.1007/s11684-020-0754-0,2020-03-15
Oral mucous membrane structure,LOCATION_OF,Protection,32170560,10.1007/s11684-020-0754-0,2020-03-15
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32170559,10.1007/s11684-020-0757-x,2020-03-15
RNA Sequence,ISA,Base Sequence,32170559,10.1007/s11684-020-0757-x,2020-03-15
RNA Sequence,PART_OF,Cells,32170559,10.1007/s11684-020-0757-x,2020-03-15
Organ,PART_OF,Homo sapiens,32170559,10.1007/s11684-020-0757-x,2020-03-15
Epithelial Cells,PART_OF,Esophagus,32170559,10.1007/s11684-020-0757-x,2020-03-15
Confirmation,PROCESS_OF,Patients,32170017,10.1073/pnas.2002616117,2020-03-15
China,ISA,Country,32169673,10.1016/j.meegid.2020.104285,2020-03-15
Coronavirus Infections,COEXISTS_WITH,Genus: Coronavirus,32169498,10.1016/j.bbi.2020.03.007,2020-03-15
Compassion Fatigue,PROCESS_OF,Medical Staff,32169481,10.1016/j.jinf.2020.02.026,2020-03-15
Compassion Fatigue,PROCESS_OF,general population,32169481,10.1016/j.jinf.2020.02.026,2020-03-15
"M Protein, multiple myeloma",PART_OF,Genus: Coronavirus,32169119,10.1186/s40779-020-00240-0,2020-03-15
Coronavirus Infections,CAUSES,Acute respiratory disease,32168465,10.3201/eid2606.200251,2020-03-14
Introduction procedure,ADMINISTERED_TO,human group,32168465,10.3201/eid2606.200251,2020-03-14
Current Therapy,TREATS,Coronavirus Infections,32168465,10.3201/eid2606.200251,2020-03-14
Coronavirus Infections,ISA,Disease,32168464,10.3201/eid2606.200233,2020-03-14
Coronavirus Infections,ISA,Disease,32168464,10.3201/eid2606.200233,2020-03-14
Coronavirus Infections,ISA,Disease,32168463,10.3201/eid2606.200320,2020-03-14
Coronavirus Infections,ISA,Disease,32168463,10.3201/eid2606.200320,2020-03-14
Coronavirus Infections,ISA,Disease,32168463,10.3201/eid2606.200320,2020-03-14
Lung,LOCATION_OF,Ground Glass Opacity,32167823,10.12968/bjon.2020.29.5.322,2020-03-14
Lung,LOCATION_OF,Lesion,32167823,10.12968/bjon.2020.29.5.322,2020-03-14
apprehension,PROCESS_OF,World,32167524,10.1001/jamainternmed.2020.0994,2020-03-14
Pneumonia,PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Pneumonia,PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Pneumonia,PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Dyspnea,NEG_PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Methylprednisolone,AFFECTS,Cessation of life,32167245,10.1111/jebm.12381,2020-03-14
Methylprednisolone,TREATS,Patients,32167245,10.1111/jebm.12381,2020-03-14
Methylprednisolone,TREATS(INFER),"Respiratory Distress Syndrome, Adult",32167245,10.1111/jebm.12381,2020-03-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Immune response,CAUSES,Cessation of life,32167245,10.1111/jebm.12381,2020-03-14
Fever,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",32167245,10.1111/jebm.12381,2020-03-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32167245,10.1111/jebm.12381,2020-03-14
Methylprednisolone,TREATS,"Respiratory Distress Syndrome, Adult",32167245,10.1111/jebm.12381,2020-03-14
Mechanical Ventilator,PREVENTS,Influenza,32167181,10.1002/jmv.25763,2020-03-14
Mechanical Ventilator,compared_with,Surgical face mask,32167181,10.1002/jmv.25763,2020-03-14
Surgical face mask,PREVENTS,Influenza,32167181,10.1002/jmv.25763,2020-03-14
Mechanical Ventilator,compared_with,Surgical face mask,32167181,10.1002/jmv.25763,2020-03-14
Influenza,PROCESS_OF,Patients,32167181,10.1002/jmv.25763,2020-03-14
Infected,NEG_PROCESS_OF,Patients,32167180,10.1002/jmv.25762,2020-03-14
Radionuclide Imaging,DIAGNOSES,Present,32167180,10.1002/jmv.25762,2020-03-14
Radionuclide Imaging,DIAGNOSES,Present,32167180,10.1002/jmv.25762,2020-03-14
Hypersensitivity,AFFECTS,Variation (Genetics),32167173,10.1002/jmv.25761,2020-03-14
RNA-Directed RNA Polymerase,ISA,Polymerase,32167166,10.1002/jmv.25758,2020-03-14
Virus,LOCATION_OF,Synapsin I,32167153,10.1042/CS20200163,2020-03-14
"M Protein, multiple myeloma",PART_OF,SARS coronavirus,32166939,10.3760/cma.j.cn115330-20200223-00116,2020-03-14
Host Cell,LOCATION_OF,Virus,32166939,10.3760/cma.j.cn115330-20200223-00116,2020-03-14
angiotensin converting enzyme 2,PART_OF,soluble,32166939,10.3760/cma.j.cn115330-20200223-00116,2020-03-14
Upper respiratory sample,PART_OF,Tract,32166607,10.1007/s12098-020-03263-6,2020-03-14
Virus,PROCESS_OF,Chiroptera,32166600,10.1007/s11684-020-0755-z,2020-03-14
Fever,ISA,Symptoms,32166600,10.1007/s11684-020-0755-z,2020-03-14
Disease,PROCESS_OF,Persons,32166600,10.1007/s11684-020-0755-z,2020-03-14
Laboratory Procedures,METHOD_OF,Diagnosis,32166600,10.1007/s11684-020-0755-z,2020-03-14
X-Ray Computed Tomography,DIAGNOSES,Abnormal,32166600,10.1007/s11684-020-0755-z,2020-03-14
X-Ray Computed Tomography,DIAGNOSES,Symptoms,32166600,10.1007/s11684-020-0755-z,2020-03-14
X-Ray Computed Tomography,DIAGNOSES,Mild disorder,32166600,10.1007/s11684-020-0755-z,2020-03-14
Chest,LOCATION_OF,X-Ray Computed Tomography,32166600,10.1007/s11684-020-0755-z,2020-03-14
Severe Acute Respiratory Syndrome,AFFECTS,Traffic,32166310,10.1093/cid/ciaa256,2020-03-14
China,ISA,Country,32165386,10.1128/MRA.00169-20,2020-03-14
TMPRSS2 gene,INTERACTS_WITH,Cells,32165386,10.1128/MRA.00169-20,2020-03-14
TMPRSS2 gene,AUGMENTS,Severe Acute Respiratory Syndrome,32165386,10.1128/MRA.00169-20,2020-03-14
Treatment Protocols,TREATS,Patients,32164401,10.3760/cma.j.cn112338-20200301-00222,2020-03-14
Infected,PROCESS_OF,Patients,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
ACE2 gene,CAUSES,Pneumonia,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
ACE2 gene,PART_OF,Homo sapiens,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
ACE2 gene,INTERACTS_WITH,rasagiline,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
Ras Inhibitor,TREATS,Symptoms,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
ACE2 gene,CAUSES,Exhaustion,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
Equilibrium,AFFECTS,acute pneumonia,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
rasagiline,CAUSES,Exacerbation,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
Lung,LOCATION_OF,inflammatory response,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164091,10.3760/cma.j.issn.1001-0939.2020.03.015,2020-03-14
Interventional procedure,TREATS,Health Personnel,32164087,10.3760/cma.j.issn.1001-0939.2020.03.011,2020-03-14
SPEN gene,AUGMENTS,Coronavirus Infections,32164086,10.3760/cma.j.issn.1001-0939.2020.03.010,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164086,10.3760/cma.j.issn.1001-0939.2020.03.010,2020-03-14
Severe acute respiratory infection,ISA,Disease,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Coronavirus Infections,AFFECTS,Patients,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Respiratory Failure,PROCESS_OF,Patients,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Severe acute respiratory infection,PROCESS_OF,Patients,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Complication,PROCESS_OF,Health Personnel,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Complication,PROCESS_OF,Medical Staff,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Cross Infection,PROCESS_OF,Health Personnel,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
Cross Infection,PROCESS_OF,Medical Staff,32164085,10.3760/cma.j.issn.1001-0939.2020.03.009,2020-03-14
chloroquine phosphate,ISA,Chloroquine,32164083,10.3760/cma.j.issn.1001-0939.2020.03.007,2020-03-14
Chloroquine,TREATS,Patients,32164083,10.3760/cma.j.issn.1001-0939.2020.03.007,2020-03-14
Chloroquine,TREATS,Pneumonia,32164083,10.3760/cma.j.issn.1001-0939.2020.03.007,2020-03-14
Chloroquine,TREATS(INFER),Pneumonia,32164083,10.3760/cma.j.issn.1001-0939.2020.03.007,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164083,10.3760/cma.j.issn.1001-0939.2020.03.007,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164082,10.3760/cma.j.issn.1001-0939.2020.03.006,2020-03-14
Coronavirus Infections,CAUSES,Pneumonia,32164082,10.3760/cma.j.issn.1001-0939.2020.03.006,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164081,10.3760/cma.j.issn.1001-0939.2020.03.005,2020-03-14
Respiratory Failure,AFFECTS,Alveolar ventilation function,32164081,10.3760/cma.j.issn.1001-0939.2020.03.005,2020-03-14
Respiratory Failure,PROCESS_OF,Patients,32164081,10.3760/cma.j.issn.1001-0939.2020.03.005,2020-03-14
Coronavirus Infections,CAUSES,Communicable Diseases,32164080,10.3760/cma.j.issn.1001-0939.2020.03.004,2020-03-14
Treatment Protocols,AFFECTS,Middle East Respiratory Syndrome,32164080,10.3760/cma.j.issn.1001-0939.2020.03.004,2020-03-14
Antibiotics,TREATS,Pneumonia,32164080,10.3760/cma.j.issn.1001-0939.2020.03.004,2020-03-14
Oseltamivir,ISA,"Neuraminidase inhibitors, direct acting antivirals",32164079,10.3760/cma.j.issn.1001-0939.2020.03.003,2020-03-14
lopinavir / Ritonavir,COEXISTS_WITH,Interferons,32164079,10.3760/cma.j.issn.1001-0939.2020.03.003,2020-03-14
Pharmaceutical Preparations,TREATS,Patients,32164079,10.3760/cma.j.issn.1001-0939.2020.03.003,2020-03-14
Pharmaceutical Preparations,TREATS(INFER),Pneumonia,32164079,10.3760/cma.j.issn.1001-0939.2020.03.003,2020-03-14
Pneumonia,PROCESS_OF,Patients,32164079,10.3760/cma.j.issn.1001-0939.2020.03.003,2020-03-14
Infected,PROCESS_OF,Persons,32162995,10.1177/0022034520914246,2020-03-13
Disease,AFFECTS,Persons,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Disease,AFFECTS,Persons,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Virus,CAUSES,Pneumonia,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Animals,LOCATION_OF,Glucans,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Vaccines,PREVENTS,Disease,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Human coronavirus,CAUSES,Disease,32162858,10.3760/cma.j.cn112338-20200219-00121,2020-03-13
Fever,ISA,Symptoms,32162699,10.1002/jmv.25755,2020-03-13
C-reactive protein,STIMULATES,Oxidoreductase,32162699,10.1002/jmv.25755,2020-03-13
"Discharge, body substance",PART_OF,Patients,32162699,10.1002/jmv.25755,2020-03-13
Problem,PROCESS_OF,World,32162604,10.4269/ajtmh.20-0135,2020-03-13
Coronavirus Infections,ISA,Disease,32162456,10.1002/minf.202000028,2020-03-13
"Hospitals, General",ISA,Hospitals,32162081,10.1007/s00247-020-04656-7,2020-03-13
chest findings,PROCESS_OF,Child,32161990,10.1007/s00392-020-01626-9,2020-03-13
Chest CT,ADMINISTERED_TO,Child,32161990,10.1007/s00392-020-01626-9,2020-03-13
Cohort,LOCATION_OF,Congenital anomaly of lung,32161990,10.1007/s00392-020-01626-9,2020-03-13
Coronavirus Infections,PROCESS_OF,Patients,32161968,10.1093/cid/ciaa247,2020-03-13
Diabetes,PROCESS_OF,Patients,32161968,10.1093/cid/ciaa247,2020-03-13
Heart Injuries,PROCESS_OF,Patients,32161968,10.1093/cid/ciaa247,2020-03-13
Comorbidity,PROCESS_OF,Patients,32161968,10.1093/cid/ciaa247,2020-03-13
Severe disorder,PROCESS_OF,Patients,32161968,10.1093/cid/ciaa247,2020-03-13
Pneumonia,PROCESS_OF,Patients,32161941,10.1093/cid/ciaa225,2020-03-13
Coughing,ISA,Symptoms,32161941,10.1093/cid/ciaa225,2020-03-13
Fever,ISA,Symptoms,32161941,10.1093/cid/ciaa225,2020-03-13
Coronavirus Infections,ISA,Disease,32161940,10.1093/cid/ciaa248,2020-03-13
Complication,PROCESS_OF,Population Group,32161940,10.1093/cid/ciaa248,2020-03-13
Complication,PROCESS_OF(SPEC),Pregnant Women,32161940,10.1093/cid/ciaa248,2020-03-13
Pregnant Women,ISA,Population Group,32161940,10.1093/cid/ciaa248,2020-03-13
Coronavirus Infections,ISA,Disease,32161940,10.1093/cid/ciaa248,2020-03-13
Coronavirus Infections,ISA,Disease,32161940,10.1093/cid/ciaa248,2020-03-13
Fever,ISA,Symptoms,32161107,10.1126/scitranslmed.abb1469,2020-03-13
Regulatory T-Lymphocytes,INTERACTS_WITH,Lymphocyte,32161107,10.1126/scitranslmed.abb1469,2020-03-13
China,ISA,Country,32160149,10.3201/eid2606.200516,2020-03-12
user - individual,ISA,Persons,32160149,10.3201/eid2606.200516,2020-03-12
Diagnosis,ADMINISTERED_TO,Patients,32160148,10.3201/eid2606.200299,2020-03-12
Nasopharynx,LOCATION_OF,Virus,32160148,10.3201/eid2606.200299,2020-03-12
Vero Cells,LOCATION_OF,Virus,32160148,10.3201/eid2606.200299,2020-03-12
Vero Cells,LOCATION_OF,Virus,32160148,10.3201/eid2606.200299,2020-03-12
Influenza A virus,PROCESS_OF,Patients,32159317,10.3760/cma.j.cn112338-20200228-00209,2020-03-12
Pneumonia,PROCESS_OF,Patients,32159317,10.3760/cma.j.cn112338-20200228-00209,2020-03-12
Codon (nucleotide sequence),COEXISTS_WITH,Structural gene,32159234,10.1002/jmv.25751,2020-03-12
Endopeptidases,compared_with,Purines,32159234,10.1002/jmv.25751,2020-03-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32159234,10.1002/jmv.25751,2020-03-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32159234,10.1002/jmv.25751,2020-03-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32159234,10.1002/jmv.25751,2020-03-12
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32159234,10.1002/jmv.25751,2020-03-12
Goldfish,ISA,"Carp, fish",32158961,10.1186/s41256-020-00137-4,2020-03-12
Grass Carp (fish),ISA,"Carp, fish",32158961,10.1186/s41256-020-00137-4,2020-03-12
GSKIP gene,ASSOCIATED_WITH,Coronavirus Infections,32157862,10.4274/balkanmedj.galenos.2020.2020.2.15,2020-03-12
Intervention regimes,AFFECTS,research results,32157862,10.4274/balkanmedj.galenos.2020.2020.2.15,2020-03-12
Decision,PROCESS_OF,Maker (occupation),32157862,10.4274/balkanmedj.galenos.2020.2020.2.15,2020-03-12
Coronavirus Infections,AFFECTS,Persons,32157849,10.3760/cma.j.cn112137-20200228-00499,2020-03-12
Pneumonia,COEXISTS_WITH,Coronavirus Infections,32157849,10.3760/cma.j.cn112137-20200228-00499,2020-03-12
Chief complaint (finding),PROCESS_OF,Patients,32157849,10.3760/cma.j.cn112137-20200228-00499,2020-03-12
Pneumonia,PROCESS_OF,Patients,32157849,10.3760/cma.j.cn112137-20200228-00499,2020-03-12
Antibodies,INTERACTS_WITH,"Tumor cells, malignant",32156648,10.1016/j.jgar.2020.02.021,2020-03-12
Fc Receptor,ASSOCIATED_WITH,Adverse effects,32156648,10.1016/j.jgar.2020.02.021,2020-03-12
Fc Receptor,PART_OF,Persons,32156648,10.1016/j.jgar.2020.02.021,2020-03-12
Polysaccharides,INTERACTS_WITH,Fc Receptor,32156648,10.1016/j.jgar.2020.02.021,2020-03-12
Polysaccharides,INTERACTS_WITH,"FCGR2B protein, human",32156648,10.1016/j.jgar.2020.02.021,2020-03-12
Asthma,ISA,Chronic Obstructive Airway Disease,32156607,10.1016/j.cca.2020.03.009,2020-03-12
Coronavirus Infections,COEXISTS_WITH,Country 2,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Isolation procedure,PREVENTS,Secondary Infections,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Hospitals,LOCATION_OF,Laboratory Diagnostic Method,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Hospitals,LOCATION_OF(SPEC),Viral studies,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Viral studies,DIAGNOSES,Severe Acute Respiratory Syndrome,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Viral studies,ISA,Laboratory Diagnostic Method,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Age,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Gender,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32156332,10.2807/1560-7917.ES.2020.25.9.2000202,2020-03-12
Assay,METHOD_OF,Detection,32156327,10.2807/1560-7917.ES.2020.25.9.2000178,2020-03-12
Laboratory,LOCATION_OF,Early Diagnosis,32155789,10.3390/ijerph17051729,2020-03-12
Glycoproteins,INTERACTS_WITH,Antibodies,32155431,10.1016/j.tim.2020.02.001,2020-03-11
ACE2 gene,PART_OF,Homo sapiens,32155431,10.1016/j.tim.2020.02.001,2020-03-11
Infection,PROCESS_OF,Homo sapiens,32155105,10.1148/radiol.2020200823,2020-03-11
Insight,PROCESS_OF,Homo sapiens,32155105,10.1148/radiol.2020200823,2020-03-11
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32154287,10.21037/atm.2020.02.20,2020-03-11
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32154287,10.21037/atm.2020.02.20,2020-03-11
Blood Vessel,LOCATION_OF,Thickened,32154287,10.21037/atm.2020.02.20,2020-03-11
Pneumonia,PROCESS_OF,Mother (person),32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Coughing,ISA,Symptoms,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Diarrhea,PROCESS_OF,Patients,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Fever,ISA,Symptoms,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Fever,ISA,Symptoms,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Liver Dysfunction,COEXISTS_WITH,Thrombocytopenia,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Symptoms,PROCESS_OF,"Infant, Newborn",32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Liver Dysfunction,COEXISTS_WITH,Thrombocytopenia,32153171,10.3760/cma.j.cn112147-20200227-00201,2020-03-11
Chronic disease,PROCESS_OF,Patients,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Chronic Obstructive Airway Disease,PROCESS_OF,Patients,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Chronic Obstructive Airway Disease,COEXISTS_WITH,Menstruation Disturbances,32153170,10.3760/cma.j.cn501113-20200226-00070,2020-03-11
Fever,PROCESS_OF,Patients,32153166,10.3760/cma.j.cn112151-20200309-00184,2020-03-11
Pneumonia,PROCESS_OF,Patients,32153166,10.3760/cma.j.cn112151-20200309-00184,2020-03-11
"Signs and Symptoms, Respiratory",PROCESS_OF,Patients,32153166,10.3760/cma.j.cn112151-20200309-00184,2020-03-11
Disease,PROCESS_OF,Patients,32153166,10.3760/cma.j.cn112151-20200309-00184,2020-03-11
Lung,LOCATION_OF,Noncommunicable Diseases,32153166,10.3760/cma.j.cn112151-20200309-00184,2020-03-11
SARS coronavirus,ISA,Human coronavirus,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Interferon-beta,TREATS,Patients,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
lopinavir / Ritonavir,TREATS,Patients,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Ritonavir,TREATS,Callithrix,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Ritonavir,TREATS,Mus,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Ritonavir,TREATS,Mouse Model,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Therapeutic procedure,TREATS,Coronavirus Infections,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Therapeutic procedure,TREATS,Infection,32151335,10.1016/S0140-6736(20)30360-3,2020-03-11
Coronavirus Infections,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Pregnant Women,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Pregnant Women,32150748,10.7326/M20-0504,2020-03-10
Coronavirus Infections,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Throat swab sample,PART_OF,"Infant, Newborn",32150748,10.7326/M20-0504,2020-03-10
Fever,PROCESS_OF,Patients,32150748,10.7326/M20-0504,2020-03-10
Lymphopenia,PROCESS_OF,Patients,32150748,10.7326/M20-0504,2020-03-10
Transaminases increased,PROCESS_OF,Patients,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Patients,32150748,10.7326/M20-0504,2020-03-10
Asphyxia Neonatorum,NEG_PROCESS_OF,"Infant, Newborn",32150748,10.7326/M20-0504,2020-03-10
Patients,LOCATION_OF,Milk (body substance),32150748,10.7326/M20-0504,2020-03-10
Pneumonia,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Pregnant Women,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Pregnant Women,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,ISA,Disease,32150748,10.7326/M20-0504,2020-03-10
Pneumonia,PROCESS_OF,Woman,32150748,10.7326/M20-0504,2020-03-10
Vertical Disease Transmission,CAUSES,intrauterine infection,32150748,10.7326/M20-0504,2020-03-10
Vertical Disease Transmission,PROCESS_OF,Woman,32150748,10.7326/M20-0504,2020-03-10
Pharmaceutical Preparations,TREATS,Autoimmune Diseases,32150576,10.1371/journal.ppat.1008392,2020-03-10
Pharmaceutical Preparations,TREATS,Malaria,32150576,10.1371/journal.ppat.1008392,2020-03-10
Hydroxychloroquine,compared_with,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
Hydroxychloroquine,same_as,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
cytokine,INTERACTS_WITH,Hydroxychloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
Infected,PROCESS_OF,Patients,32150576,10.1371/journal.ppat.1008392,2020-03-10
Body Fluids,LOCATION_OF,Hydroxychloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
Body Fluids,PART_OF,Lung,32150576,10.1371/journal.ppat.1008392,2020-03-10
Treatment Protocols,compared_with,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
Treatment Protocols,higher_than,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
chloroquine phosphate,compared_with,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
chloroquine phosphate,higher_than,Chloroquine,32150576,10.1371/journal.ppat.1008392,2020-03-10
Murine hepatitis,ISA,Coronavirus Infections,32150527,10.3201/eid2606.200301,2020-03-10
receptor binding,CAUSES,Macromolecular alteration,32150527,10.3201/eid2606.200301,2020-03-10
Asymptomatic,PROCESS_OF,Child,32149773,10.1097/CM9.0000000000000791,2020-03-10
Respiratory sample,PART_OF,Tract,32149773,10.1097/CM9.0000000000000791,2020-03-10
Lower respiratory tract infection,PROCESS_OF,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
adjuvant therapy,TREATS,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
adjuvant therapy,TREATS(INFER),Lower respiratory tract infection,32149769,10.1097/CM9.0000000000000797,2020-03-10
Glucocorticoids,COEXISTS_WITH,EHD1 wt Allele,32149769,10.1097/CM9.0000000000000797,2020-03-10
Symptom severe,PROCESS_OF,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
Malaise,PROCESS_OF,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
Severe disorder,PROCESS_OF,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
"Glucocorticoids, Systemic",TREATS,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
Glucocorticoids,TREATS,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
RAB3D gene,INTERACTS_WITH(INFER),Glucocorticoids,32149769,10.1097/CM9.0000000000000797,2020-03-10
RAB3D gene,PART_OF,Patients,32149769,10.1097/CM9.0000000000000797,2020-03-10
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
"RNA, Small Interfering",ADMINISTERED_TO,Cells,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
"RNA, Small Interfering",AFFECTS,silence,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
plaque assay,USES,angiotensin converting enzyme 2,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
cepharanthine,ISA,Pharmaceutical Preparations,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
Mefloquine Hydrochloride,ISA,Pharmaceutical Preparations,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
selamectin,ISA,Pharmaceutical Preparations,32149484,10.3760/cma.j.cn112338-20200223-00152,2020-03-10
Reporting,ADMINISTERED_TO,Patients,32149036,10.24171/j.phrp.2020.11.1.02,2020-03-10
Fever,ISA,Symptoms,32149036,10.24171/j.phrp.2020.11.1.02,2020-03-10
Pneumonia,PROCESS_OF,Patients,32149036,10.24171/j.phrp.2020.11.1.02,2020-03-10
Secondary Infections,PROCESS_OF,Patients,32149036,10.24171/j.phrp.2020.11.1.02,2020-03-10
Communicable Diseases,ISA,Disease,32149036,10.24171/j.phrp.2020.11.1.02,2020-03-10
Pneumonia,PROCESS_OF,Patients,32147731,10.1093/cid/ciaa227,2020-03-10
Coronavirus Infections,ISA,Disease,32147731,10.1093/cid/ciaa227,2020-03-10
Coughing,PROCESS_OF,Patients,32147731,10.1093/cid/ciaa227,2020-03-10
Fever,PROCESS_OF,Patients,32147731,10.1093/cid/ciaa227,2020-03-10
Pneumonia,PROCESS_OF,Patients,32147731,10.1093/cid/ciaa227,2020-03-10
Chloroquine,ISA,Pharmaceutical Preparations,32147538,10.1016/j.ijid.2020.03.003,2020-03-10
Laboratory Procedures,DIAGNOSES,Convalescence,32147496,10.1016/j.antiviral.2020.104762,2020-03-10
Antimalarials,TREATS,Patients,32146694,10.1007/s11427-020-1661-4,2020-03-09
Disease,PROCESS_OF,Patients,32146554,10.1007/s10729-020-09504-6,2020-03-09
Coronavirus Infections,ISA,Disease,32146554,10.1007/s10729-020-09504-6,2020-03-09
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32146554,10.1007/s10729-020-09504-6,2020-03-09
patient condition,PROCESS_OF,Community,32146554,10.1007/s10729-020-09504-6,2020-03-09
Throat swab sample,LOCATION_OF,Nucleic Acids,32146554,10.1007/s10729-020-09504-6,2020-03-09
Fever,ISA,Symptoms,32146554,10.1007/s10729-020-09504-6,2020-03-09
Does communicate,PROCESS_OF,Patients,32146554,10.1007/s10729-020-09504-6,2020-03-09
Comorbidity,PROCESS_OF,Old age,32145768,10.1016/S1473-3099(20)30129-8,2020-03-09
Coronavirus Infections,AFFECTS,Persons,32145714,10.3760/cma.j.cn112141-20200218-00111,2020-03-09
Infected,PROCESS_OF,traveler,32143990,10.1016/j.jaut.2020.102434,2020-03-08
Decrease in height,PROCESS_OF,Community,32143990,10.1016/j.jaut.2020.102434,2020-03-08
Nucleic Acids,PART_OF,Patients,32143519,10.3390/ijerph17051679,2020-03-08
Nucleic Acids,PART_OF,Virus,32143519,10.3390/ijerph17051679,2020-03-08
Infected,PROCESS_OF,Patients,32143519,10.3390/ijerph17051679,2020-03-08
Influenza,PROCESS_OF,Hispanics,32143519,10.3390/ijerph17051679,2020-03-08
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32143502,10.3390/pathogens9030186,2020-03-08
nuclear migration,PROCESS_OF,Family,32143502,10.3390/pathogens9030186,2020-03-08
Genus: Coronavirus,ISA,RNA Viruses,32142938,10.1016/j.meegid.2020.104272,2020-03-07
"Pneumonia, Viral",PROCESS_OF,Patients,32142938,10.1016/j.meegid.2020.104272,2020-03-07
Betacoronavirus,CAUSES,Pneumonia,32142651,10.1016/j.cell.2020.02.052,2020-03-07
NOONAN SYNDROME 8,AFFECTS,Immune response,32142651,10.1016/j.cell.2020.02.052,2020-03-07
Peptide Hydrolases,PART_OF,Host Cell,32141624,10.1002/jmv.25750,2020-03-07
Patients,LOCATION_OF,Serum,32141624,10.1002/jmv.25750,2020-03-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32141624,10.1002/jmv.25750,2020-03-07
Infected,PROCESS_OF,Population Group,32141619,10.1002/jmv.25749,2020-03-07
Attention,PROCESS_OF,World,32141588,10.26719/2020.26.2.136,2020-03-07
Coronavirus Infections,ISA,Disease,32141588,10.26719/2020.26.2.136,2020-03-07
Asymptomatic,PROCESS_OF,Patients,32141588,10.26719/2020.26.2.136,2020-03-07
Coronavirus Infections,ISA,Disease,32141588,10.26719/2020.26.2.136,2020-03-07
Virus,CAUSES,Severe Acute Respiratory Syndrome,32141570,10.26355/eurrev_202002_20379,2020-03-07
Coronavirus Infections,PROCESS_OF,Family,32141570,10.26355/eurrev_202002_20379,2020-03-07
Virus,PROCESS_OF,Homo sapiens,32141570,10.26355/eurrev_202002_20379,2020-03-07
Infection,PROCESS_OF,Homo sapiens,32141569,10.26355/eurrev_202002_20378,2020-03-07
Antibodies,PART_OF,SARS coronavirus,32141280,10.3760/cma.j.cn112148-20200225-00123,2020-03-07
Contacts,TREATS,general population,32139372,10.7861/clinmed.2019-coron,2020-03-07
Heart,LOCATION_OF,Causative_agents,32138266,10.3390/ijerph17051633,2020-03-07
Genus: Coronavirus,CAUSES,Severe Acute Respiratory Syndrome,32135587,10.3760/cma.j.issn.0578-1310.2020.03.004,2020-03-07
Infection,PROCESS_OF,Homo sapiens,32135587,10.3760/cma.j.issn.0578-1310.2020.03.004,2020-03-07
Symptoms,PROCESS_OF,Patients,32134800,10.1097/RLI.0000000000000674,2020-03-07
Coronavirus Infections,CAUSES,Disease,32134681,10.2214/AJR.20.22975,2020-03-07
Coronavirus Infections,ISA,Disease,32134681,10.2214/AJR.20.22975,2020-03-07
Coronavirus Infections,ISA,Disease,32134681,10.2214/AJR.20.22975,2020-03-07
Coronavirus Infections,ISA,Disease,32134681,10.2214/AJR.20.22975,2020-03-07
Chest,LOCATION_OF,High Resolution Computed Tomography,32134681,10.2214/AJR.20.22975,2020-03-07
Chest,LOCATION_OF,High Resolution Computed Tomography,32134681,10.2214/AJR.20.22975,2020-03-07
Contrast bronchogram,USES,Air,32134681,10.2214/AJR.20.22975,2020-03-07
Blood Sedimentation,DIAGNOSES,Pneumonia,32134681,10.2214/AJR.20.22975,2020-03-07
Chest CT,MEASURES,Pneumonia,32134681,10.2214/AJR.20.22975,2020-03-07
Coronavirus Infections,COEXISTS_WITH,Ground Glass Opacity,32134681,10.2214/AJR.20.22975,2020-03-07
Coronavirus Infections,ISA,Disease,32134681,10.2214/AJR.20.22975,2020-03-07
Disease,PROCESS_OF,Woman,32134278,10.12932/AP-200220-0773,2020-03-07
Coronavirus Infections,ISA,Disease,32134278,10.12932/AP-200220-0773,2020-03-07
Coronavirus Infections,PROCESS_OF(SPEC),Woman,32134278,10.12932/AP-200220-0773,2020-03-07
Coronavirus Infections,COEXISTS_WITH,Disease,32134205,10.1002/ppul.24718,2020-03-07
Coronavirus Infections,ISA,Disease,32134205,10.1002/ppul.24718,2020-03-07
Vaccines,TREATS,Coronavirus Infections,32134205,10.1002/ppul.24718,2020-03-07
Coronavirus Infections,ISA,Disease,32134205,10.1002/ppul.24718,2020-03-07
Coronavirus Infections,ISA,Disease,32134205,10.1002/ppul.24718,2020-03-07
Therapeutic Intervention,TREATS,Disease,32134205,10.1002/ppul.24718,2020-03-07
Therapeutic Intervention,TREATS(SPEC),Coronavirus Infections,32134205,10.1002/ppul.24718,2020-03-07
SARS coronavirus,ISA,Genus: Coronavirus,32134205,10.1002/ppul.24718,2020-03-07
Coronavirus Infections,ISA,Disease,32134205,10.1002/ppul.24718,2020-03-07
Laboratory Procedures,DIAGNOSES,Laboratory Infection,32134116,10.1002/jmv.25748,2020-03-07
Coronavirus Infections,PROCESS_OF,Adult,32134116,10.1002/jmv.25748,2020-03-07
Chest CT,ADMINISTERED_TO,Patients,32134116,10.1002/jmv.25748,2020-03-07
Coughing,ISA,Symptoms,32134116,10.1002/jmv.25748,2020-03-07
Attention,PROCESS_OF,Adult,32134116,10.1002/jmv.25748,2020-03-07
Elevation procedure,USES,procalcitonin,32134116,10.1002/jmv.25748,2020-03-07
Coinfection,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
Lung,LOCATION_OF,Lesion,32134116,10.1002/jmv.25748,2020-03-07
Lesion,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
Halo sign,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
Halo sign,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
Ground Glass Opacity,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
Halo sign,ISA,Physical findings,32134116,10.1002/jmv.25748,2020-03-07
Halo sign,PROCESS_OF(SPEC),Patients,32134116,10.1002/jmv.25748,2020-03-07
Physical findings,PROCESS_OF,Patients,32134116,10.1002/jmv.25748,2020-03-07
"Intubation, Intratracheal",PREDISPOSES,Communicable Diseases,32133578,10.1007/s11606-020-05762-w,2020-03-07
intensive care unit,LOCATION_OF,Retrospective Studies,32133578,10.1007/s11606-020-05762-w,2020-03-07
Treatment Protocols,USES,Anesthetics,32133578,10.1007/s11606-020-05762-w,2020-03-07
Fentanyl,TREATS,Sedated state,32133578,10.1007/s11606-020-05762-w,2020-03-07
Morphine,TREATS,Sedated state,32133578,10.1007/s11606-020-05762-w,2020-03-07
Nucleic Acids,NEG_PART_OF,Health Personnel,32133578,10.1007/s11606-020-05762-w,2020-03-07
Nucleic Acids,PART_OF,Virus,32133578,10.1007/s11606-020-05762-w,2020-03-07
"Intubation, Intratracheal",TREATS,Patients,32133578,10.1007/s11606-020-05762-w,2020-03-07
Therapeutic procedure,COEXISTS_WITH,Clinical Management,32133152,10.1038/s41421-020-0148-0,2020-03-07
Coronavirus Infections,CAUSES,"Pneumonia, Viral",32132521,10.12659/MSM.923549,2020-03-07
Medical Staff,TREATS,Patients,32132196,10.1128/JCM.00310-20,2020-03-07
Medical Staff,TREATS,Patients,32132196,10.1128/JCM.00310-20,2020-03-07
Coronavirus Infections,PROCESS_OF,Patients,32132196,10.1128/JCM.00310-20,2020-03-07
Anxiety,PROCESS_OF,Patients,32132196,10.1128/JCM.00310-20,2020-03-07
Coronavirus Infections,PROCESS_OF,Patients,32132196,10.1128/JCM.00310-20,2020-03-07
DNA Helicases,compared_with,Nucleocapsid,32132184,10.1126/science.abb2762,2020-03-07
Assay,USES,DNA Helicases,32132184,10.1126/science.abb2762,2020-03-07
"ACE2 protein, human",COEXISTS_WITH,SLC1A4 gene,32131908,10.1017/ice.2020.58,2020-03-07
Hospitals,LOCATION_OF,Molecular Diagnostic Testing,32131537,10.3390/jcm9030674,2020-03-07
Coronavirus Infections,ISA,Disease,32131537,10.3390/jcm9030674,2020-03-07
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32131537,10.3390/jcm9030674,2020-03-07
Bronchoalveolar Lavage Fluid,ASSOCIATED_WITH(INFER),Infected,32129670,10.1177/0846537120913033,2020-03-05
Bronchoalveolar Lavage Fluid,PART_OF,Patients,32129670,10.1177/0846537120913033,2020-03-05
Bronchoalveolar Lavage Fluid,PART_OF,Patients,32129670,10.1177/0846537120913033,2020-03-05
Virus,INTERACTS_WITH,Microorganism,32129670,10.1177/0846537120913033,2020-03-05
Virus,ISA,Microorganism,32129670,10.1177/0846537120913033,2020-03-05
Infected,PROCESS_OF,Patients,32129670,10.1177/0846537120913033,2020-03-05
Community acquired pneumonia,PROCESS_OF,Patients,32129670,10.1177/0846537120913033,2020-03-05
Infected,PROCESS_OF,Patients,32129670,10.1177/0846537120913033,2020-03-05
Community acquired pneumonia,AFFECTS,Virulence,32129670,10.1177/0846537120913033,2020-03-05
Health care facility,LOCATION_OF,Study,32129583,10.3760/cma.j.cn112148-20200218-00093,2020-03-05
Festivals,ISA,Holidays,32129580,10.3760/cma.j.cn112147-20200225-00175,2020-03-05
Movement,PROCESS_OF,Population Group,32129580,10.3760/cma.j.cn112147-20200225-00175,2020-03-05
disease transmission,PROCESS_OF,Medical Staff,32129518,10.1002/ddr.21656,2020-03-05
disease transmission,PROCESS_OF,Patients,32129518,10.1002/ddr.21656,2020-03-05
SARS coronavirus,INTERACTS_WITH,Severe Acute Respiratory Syndrome,32127517,10.1038/s41368-020-0075-9,2020-03-05
Angiotensin II receptor antagonist,TREATS,Severe Acute Respiratory Syndrome,32127517,10.1038/s41368-020-0075-9,2020-03-05
China,ISA,Country,32127124,10.2807/1560-7917.ES.2020.25.8.2000097,2020-03-05
Rhinolophus affinis,ISA,Chiroptera,32127124,10.2807/1560-7917.ES.2020.25.8.2000097,2020-03-05
Mucous Membrane,PART_OF,Eye,32127124,10.2807/1560-7917.ES.2020.25.8.2000097,2020-03-05
Influenza,ISA,Respiratory Tract Diseases,32126197,10.33321/cdi.2020.44.20,2020-03-04
Influenza,ISA,Infection,32126197,10.33321/cdi.2020.44.20,2020-03-04
Respiratory Tract Infections,ISA,Symptoms,32126197,10.33321/cdi.2020.44.20,2020-03-04
Antiviral Therapy,NEG_TREATS,Severe Acute Respiratory Syndrome,32125362,10.1001/jama.2020.3204,2020-03-04
Severe Acute Respiratory Syndrome,CAUSES,inflammatory response,32125362,10.1001/jama.2020.3204,2020-03-04
"Immunoglobulins, Intravenous",TREATS,Pneumonia,32125362,10.1001/jama.2020.3204,2020-03-04
Hospitals,LOCATION_OF,case series,32125269,10.3201/eid2606.200239,2020-03-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32125269,10.3201/eid2606.200239,2020-03-04
Nasopharynx,LOCATION_OF,Viral Shedding,32125269,10.3201/eid2606.200239,2020-03-04
Severe Acute Respiratory Syndrome,PROCESS_OF,hospitalized patients,32125269,10.3201/eid2606.200239,2020-03-04
lopinavir / Ritonavir,TREATS,Supplemental oxygen,32125269,10.3201/eid2606.200239,2020-03-04
Nausea,PROCESS_OF,Patients,32125269,10.3201/eid2606.200239,2020-03-04
Severe Acute Respiratory Syndrome,ISA,Respiratory Tract Infections,32125269,10.3201/eid2606.200239,2020-03-04
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32125269,10.3201/eid2606.200239,2020-03-04
Anti-Retroviral Agents,TREATS,Supplemental oxygen,32125269,10.3201/eid2606.200239,2020-03-04
Niclosamide,ISA,Anthelmintics,32125133,10.3760/cma.j.cn112150-20200222-00163,2020-03-04
Lung,LOCATION_OF,advanced cancer,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
advanced cancer,PROCESS_OF,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Lung,LOCATION_OF,advanced cancer,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
advanced cancer,PROCESS_OF,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Malignant Neoplasms,CAUSES,Coronavirus Infections,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Non-Small Cell Lung Carcinoma,PROCESS_OF(SPEC),Outpatients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Outpatients,ISA,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Non-Small Cell Lung Carcinoma,PROCESS_OF,Patients,32125131,10.3760/cma.j.cn112147-20200217-00106,2020-03-04
Movement,PROCESS_OF,Population Group,32125128,10.3760/cma.j.cn112338-20200210-00086,2020-03-04
Infected,PROCESS_OF,Patients,32124995,10.1002/jmv.25742,2020-03-04
Gastrointestinal symptom,NEG_PROCESS_OF,Patients,32124990,10.1002/jmv.25743,2020-03-04
Infected,PROCESS_OF,Persons,32124000,10.1007/s00417-020-04641-8,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Fever,PROCESS_OF,Patients,32122430,10.1017/ice.2020.61,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Endoscopy of nose,CAUSES,Sneezing,32122430,10.1017/ice.2020.61,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Coronavirus Infections,ISA,Disease,32122430,10.1017/ice.2020.61,2020-03-04
Country,ISA,Geographic Locations,32120458,10.3760/cma.j.cn112148-20200220-00105,2020-03-04
SARS coronavirus,PROCESS_OF,Homo sapiens,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
Middle East Respiratory Syndrome Coronavirus,PROCESS_OF,Homo sapiens,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
Hepatitis C Antibodies,ISA,Pharmaceutical Preparations,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
Polymerase,ISA,Pharmaceutical Preparations,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
Polymerase,ISA,Pharmaceutical Preparations,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
sofosbuvir,ISA,Pharmaceutical Preparations,32119825,10.1016/S2214-109X(20)30074-7,2020-03-03
Coronavirus Infections,ISA,Disease,32118639,10.1097/CM9.0000000000000774,2020-03-03
Pneumonia,COEXISTS_WITH,patient condition,32118639,10.1097/CM9.0000000000000774,2020-03-03
Coronavirus Infections,ISA,Disease,32118639,10.1097/CM9.0000000000000774,2020-03-03
Disease,CAUSES,Pneumonia,32118639,10.1097/CM9.0000000000000774,2020-03-03
Fever,ISA,Symptoms,32118639,10.1097/CM9.0000000000000774,2020-03-03
Respiratory Failure,PROCESS_OF,Patients,32118639,10.1097/CM9.0000000000000774,2020-03-03
Pneumonia,ISA,Disease,32118639,10.1097/CM9.0000000000000774,2020-03-03
Pneumonia,ISA,Disease,32118639,10.1097/CM9.0000000000000774,2020-03-03
Disease,PROCESS_OF,Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,ISA,Disease,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Disease,PROCESS_OF,Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Disease,PROCESS_OF,Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,ISA,Disease,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,ISA,Disease,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
GSKIP gene,INTERACTS_WITH,T-Lymphocyte,32118615,10.1097/RLI.0000000000000672,2020-03-03
Symptoms,PROCESS_OF,Patients,32118615,10.1097/RLI.0000000000000672,2020-03-03
Swab specimen,ISA,Specimen,32118615,10.1097/RLI.0000000000000672,2020-03-03
Urine - SpecimenType,LOCATION_OF,Nucleic Acids,32118615,10.1097/RLI.0000000000000672,2020-03-03
Feces,LOCATION_OF,Duration,32118615,10.1097/RLI.0000000000000672,2020-03-03
Feces,LOCATION_OF,Duration,32118615,10.1097/RLI.0000000000000672,2020-03-03
Feces,LOCATION_OF,GSKIP gene,32118615,10.1097/RLI.0000000000000672,2020-03-03
Glucocorticoids,NEG_TREATS,Disease,32118615,10.1097/RLI.0000000000000672,2020-03-03
Glucocorticoids,NEG_TREATS(SPEC),Coronavirus Infections,32118615,10.1097/RLI.0000000000000672,2020-03-03
Coronavirus Infections,ISA,Disease,32118615,10.1097/RLI.0000000000000672,2020-03-03
Sputum,ASSOCIATED_WITH,Comorbidity,32118533,10.3201/eid2606.200452,2020-03-03
Senility,PROCESS_OF,Patients,32118533,10.3201/eid2606.200452,2020-03-03
Bronchial wall thickening,OCCURS_IN,Patients,32118533,10.3201/eid2606.200452,2020-03-03
Lymphopenia,PREDISPOSES,Pneumonia,32118533,10.3201/eid2606.200452,2020-03-03
tomography,DIAGNOSES,Symptoms,32118533,10.3201/eid2606.200452,2020-03-03
Disease,PROCESS_OF,Patients,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
Coronavirus Infections,ISA,Disease,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
upper respiratory symptom,PROCESS_OF,Patients,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
Upper respiratory tract,LOCATION_OF,Symptoms,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
Symptoms,PROCESS_OF,Patients,32118394,10.3760/cma.j.cn112152-20200229-00152,2020-03-03
Communicable Diseases,ISA,Disease,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Coronavirus Infections,ISA,Disease,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Disease,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Coronavirus Infections,ISA,Disease,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
Malignant neoplasm of lung,PROCESS_OF,Patients,32118393,10.3760/cma.j.issn.cn112148-20200220-00106,2020-03-03
World,ISA,Population Group,32116147,10.1080/01478885.2020.1734718,2020-03-03
Infected,PROCESS_OF,Persons,32116147,10.1080/01478885.2020.1734718,2020-03-03
Today,ISA,Pharmaceutical Preparations,32116147,10.1080/01478885.2020.1734718,2020-03-03
Today,TREATS,Patients,32116147,10.1080/01478885.2020.1734718,2020-03-03
Infected,PROCESS_OF,Patients,32116147,10.1080/01478885.2020.1734718,2020-03-03
Coronavirus Infections,PROCESS_OF,Persons,32115733,10.1002/jmv.25740,2020-03-03
Disease,PROCESS_OF,Child,32114755,10.3961/jpmph.20.048,2020-03-03
Coronavirus Infections,ISA,Disease,32114755,10.3961/jpmph.20.048,2020-03-03
Coronavirus Infections,PROCESS_OF(SPEC),Child,32114755,10.3961/jpmph.20.048,2020-03-03
Experience,PROCESS_OF,Adult,32114755,10.3961/jpmph.20.048,2020-03-03
Cessation of life,NEG_PROCESS_OF,Human Age Group,32114755,10.3961/jpmph.20.048,2020-03-03
Coronavirus Infections,ISA,Disease,32114755,10.3961/jpmph.20.048,2020-03-03
Coronavirus Infections,PROCESS_OF,Child,32114755,10.3961/jpmph.20.048,2020-03-03
Coronavirus Infections,PROCESS_OF,"Infant, Newborn",32114755,10.3961/jpmph.20.048,2020-03-03
Confirmation,PROCESS_OF,Patients,32114748,10.3760/cma.j.cn112142-20200224-00102,2020-03-03
Eye,LOCATION_OF,Protection,32114747,10.3760/cma.j.cn501120-20200224-00088,2020-03-03
Eye,LOCATION_OF,Coronavirus Infections,32114747,10.3760/cma.j.cn501120-20200224-00088,2020-03-03
stem cell therapy,DISRUPTS,Storm NOS,32114746,10.3760/cma.j.cn112138-20200219-00097,2020-03-03
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
"Pneumonia, Viral",PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
Leukopenia,PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
Lymphopenia,PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
Eosinopenia,PROCESS_OF,Patients,32114744,10.3760/cma.j.cn112151-20200225-00138,2020-03-03
Nucleic Acids,PART_OF,Virus,32114094,10.1016/j.jtho.2020.02.010,2020-03-03
Infected,PROCESS_OF,Patients,32114094,10.1016/j.jtho.2020.02.010,2020-03-03
Lobectomy,TREATS,Adenocarcinoma,32113880,10.1016/j.acra.2020.02.003,2020-03-03
Lobectomy,TREATS,Patients,32113880,10.1016/j.acra.2020.02.003,2020-03-03
Edema,PROCESS_OF,Patients,32113880,10.1016/j.acra.2020.02.003,2020-03-03
Lung,PART_OF,Patients,32113880,10.1016/j.acra.2020.02.003,2020-03-03
Symptoms,NEG_PROCESS_OF,Patients,32113880,10.1016/j.acra.2020.02.003,2020-03-03
Chinese herbs,TREATS,Viral Respiratory Tract Infection,32113824,10.1016/j.jfma.2020.02.007,2020-03-03
Coronavirus Infections,ISA,Disease,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Severe Acute Respiratory Syndrome,CAUSES,Disease,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Coronavirus Infections,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Coronavirus Infections,ISA,Disease,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Infected,PROCESS_OF,Persons,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Coronavirus Infections,ISA,Disease,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Coronavirus Infections,ISA,Disease,32113198,10.3760/cma.j.cn112338-20200216-00106,2020-03-03
Pneumonia,PROCESS_OF,Homo sapiens,32112966,10.1016/j.ijid.2020.02.043,2020-03-01
Betacoronavirus,CAUSES,Middle East Respiratory Syndrome,32112966,10.1016/j.ijid.2020.02.043,2020-03-01
Coronavirus Infections,CAUSES,Pulmonary Pathology,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Severe Acute Respiratory Syndrome,CAUSES(SPEC),Pulmonary Pathology,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Chest imaging,DIAGNOSES,SARS coronavirus,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Chest imaging,DIAGNOSES,Middle East Respiratory Syndrome Coronavirus,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Lung,LOCATION_OF,Lesion,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Tract,LOCATION_OF,Pleural effusion disorder,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Hypertrophy,COEXISTS_WITH,Pulmonary Infiltrate,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Pulmonary vessels,LOCATION_OF,Hypertrophy,32112886,10.1016/j.jinf.2020.02.018,2020-03-01
Fever,ISA,Symptoms,32112884,10.1016/j.jinf.2020.02.016,2020-03-01
Contacts,TREATS,Community,32112884,10.1016/j.jinf.2020.02.016,2020-03-01
Contacts,TREATS,Family,32112884,10.1016/j.jinf.2020.02.016,2020-03-01
Tertiary Care Centers,LOCATION_OF,Reverse Transcriptase Polymerase Chain Reaction,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
exposure history,PROCESS_OF,Persons,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Fever,ISA,Symptoms,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Leukopenia,PROCESS_OF,Patients,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Lung,LOCATION_OF,Lesion,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
CAT scan normal,PROCESS_OF,Patients,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Chest,LOCATION_OF,CAT scan normal,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Lung,LOCATION_OF,Decreased translucency,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Lung,LOCATION_OF,Chromosome 2q32-Q33 Deletion Syndrome,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Breast normal,PROCESS_OF,Patients,32112714,10.1016/S0140-6736(20)30460-8,2020-03-01
Confusion,ISA,Symptoms,32112549,10.3760/cma.j.cn112152-20200227-00141,2020-03-01
Quarantine,NEG_higher_than,Quarantine,32112549,10.3760/cma.j.cn112152-20200227-00141,2020-03-01
Quarantine,compared_with,Quarantine,32112549,10.3760/cma.j.cn112152-20200227-00141,2020-03-01
Malignant Neoplasms,PROCESS_OF,Patients,32112336,10.1007/s12519-020-00347-3,2020-03-01
Challenge,TREATS,Patients,32112336,10.1007/s12519-020-00347-3,2020-03-01
Malignant Neoplasms,PROCESS_OF,Patients,32112336,10.1007/s12519-020-00347-3,2020-03-01
Family,TREATS,Patients,32112336,10.1007/s12519-020-00347-3,2020-03-01
Medical Staff,TREATS,Patients,32112336,10.1007/s12519-020-00347-3,2020-03-01
Asymptomatic,PROCESS_OF,Persons,32112072,10.1093/cid/ciaa198,2020-03-01
Coronavirus Infections,PROCESS_OF,Child,32111449,10.1016/j.jmii.2020.02.009,2020-03-01
Disease,PROCESS_OF,Child,32111449,10.1016/j.jmii.2020.02.009,2020-03-01
Coronavirus Infections,ISA,Disease,32111449,10.1016/j.jmii.2020.02.009,2020-03-01
Coronavirus Infections,PROCESS_OF(SPEC),Child,32111449,10.1016/j.jmii.2020.02.009,2020-03-01
Coronavirus Infections,ISA,Disease,32111262,10.1186/s40249-020-00640-3,2020-03-01
Coronavirus Infections,CAUSES,Pneumonia,32111114,10.3760/cma.j.cn501120-20200224-00083,2020-03-01
Practice Experience,PROCESS_OF,Outpatients,32110875,10.3390/jcm9030623,2020-03-01
Intervention regimes,TREATS,Coronavirus Infections,32110742,10.1016/j.idm.2020.02.002,2020-02-29
Pharmaceutical Preparations,TREATS,Human coronavirus,32109443,10.1016/j.jinf.2020.02.017,2020-02-29
Vaccines,TREATS,Human coronavirus,32109443,10.1016/j.jinf.2020.02.017,2020-02-29
tomography,DIAGNOSES,Pneumonia,32109279,10.1093/cid/ciaa199,2020-02-29
tomography,DIAGNOSES,Pneumonia,32109279,10.1093/cid/ciaa199,2020-02-29
Elevated C-reactive protein,PROCESS_OF,Patients,32109279,10.1093/cid/ciaa199,2020-02-29
lobe,LOCATION_OF,Lesion,32109279,10.1093/cid/ciaa199,2020-02-29
Coronavirus Infections,COEXISTS_WITH,Non-Ossifying Fibroma,32109273,10.1093/jtm/taaa030,2020-02-29
3 - severe,PROCESS_OF,Patients,32109273,10.1093/jtm/taaa030,2020-02-29
Parenchyma,PART_OF,Lung,32109273,10.1093/jtm/taaa030,2020-02-29
Liver Dysfunction,PROCESS_OF,Patients,32109273,10.1093/jtm/taaa030,2020-02-29
Abnormal,PROCESS_OF,Patients,32109273,10.1093/jtm/taaa030,2020-02-29
Infected,PROCESS_OF,Patients,32109273,10.1093/jtm/taaa030,2020-02-29
Malaise,NEG_PROCESS_OF,Passenger,32109013,10.1056/NEJMoa2002032,2020-02-29
Malaise,PROCESS_OF,Passenger,32109013,10.1056/NEJMoa2002032,2020-02-29
Infected,PROCESS_OF,Persons,32109013,10.1056/NEJMoa2002032,2020-02-29
Invasive mechanical ventilation NOS,TREATS,Patients,32108862,10.1093/bioinformatics/btaa145,2020-02-29
Fever,ISA,Symptoms,32108862,10.1093/bioinformatics/btaa145,2020-02-29
Ground Glass Opacity,ISA,Radiologic finding,32108862,10.1093/bioinformatics/btaa145,2020-02-29
Radiology result abnormal,NEG_PROCESS_OF,Patients,32108862,10.1093/bioinformatics/btaa145,2020-02-29
Coronavirus Infections,ISA,Disease,32108458,10.3760/cma.j.cn112137-20200221-00387,2020-02-29
Medical counseling,TREATS,Disease,32108458,10.3760/cma.j.cn112137-20200221-00387,2020-02-29
Hepatic Vein Thrombosis,ISA,Disease,32108458,10.3760/cma.j.cn112137-20200221-00387,2020-02-29
Hepatic Vein Thrombosis,PROCESS_OF,Patients,32108458,10.3760/cma.j.cn112137-20200221-00387,2020-02-29
Coronavirus Infections,ISA,Disease,32108458,10.3760/cma.j.cn112137-20200221-00387,2020-02-29
Pharmaceutical Preparations,TREATS,Pneumonia,32108351,10.1002/jmv.25735,2020-02-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Coughing,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Coughing,OCCURS_IN(SPEC),Patients,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Symptoms,OCCURS_IN,Patients,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Fatigue,PROCESS_OF,Persons,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Myalgia,PROCESS_OF,Persons,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Diarrhea,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Headache,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Hemoptysis,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Pharyngitis,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Shock,ISA,Symptoms,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32107911,10.3760/cma.j.cn112150-20200220-00149,2020-02-29
Coronavirus Infections,CAUSES,Pneumonia,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Hospitals,LOCATION_OF,Real-Time Polymerase Chain Reaction,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Infected,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
ct scan contrast,ADMINISTERED_TO,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Chest,LOCATION_OF,ct scan contrast,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Lung,LOCATION_OF,Lesion,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Coughing,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Fever,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Infected,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Infected,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Ground Glass Opacity,PROCESS_OF,Patients,32107119,10.1016/j.tmrv.2020.02.003,2020-02-29
Syndrome,PROCESS_OF,Homo sapiens,32106567,10.3390/v12030254,2020-02-29
Genus: Coronavirus,CAUSES,Communicable Diseases,32106567,10.3390/v12030254,2020-02-29
"Epitopes, T-Lymphocyte",COEXISTS_WITH,Structural protein,32106462,10.3390/mi11030238,2020-02-29
Structural protein,PART_OF,SARS coronavirus,32106462,10.3390/mi11030238,2020-02-29
Epitopes,PREVENTS,Virus,32106462,10.3390/mi11030238,2020-02-29
Infected,PROCESS_OF,Persons,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
"Respiratory Distress Syndrome, Adult",COEXISTS_WITH,29+,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Septicemia,PROCESS_OF,Patients,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Infection,COEXISTS_WITH,Spontaneous abortion,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Woman,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Middle East Respiratory Syndrome,PROCESS_OF,Pregnant Women,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Health care facility,LOCATION_OF,Administration occupational activities,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Bacterial Infections,CAUSES,Fluid overload,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Mechanical ventilation,TREATS,Respiratory Insufficiency,32105637,10.1016/S1473-3099(20)30086-4,2020-02-28
Pneumonia,PROCESS_OF,Patients,32105632,10.1016/S2213-2600(20)30079-5,2020-02-28
Pneumonia,PROCESS_OF,Patients,32105632,10.1016/S2213-2600(20)30079-5,2020-02-28
Asymptomatic,PROCESS_OF,Patients,32105632,10.1016/S2213-2600(20)30079-5,2020-02-28
Critical Illness,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
Severe acute respiratory infection,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
Critical Illness,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
acute pneumonia,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
GSKIP gene,ASSOCIATED_WITH(INFER),Critical Illness,32105090,10.12932/AP-200220-0772,2020-02-28
GSKIP gene,PART_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
acute pneumonia,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
Chronic disease,PROCESS_OF,Male population group,32105090,10.12932/AP-200220-0772,2020-02-28
Fever,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Survivors,32105090,10.12932/AP-200220-0772,2020-02-28
Mechanical ventilation,ADMINISTERED_TO,Survivors,32105090,10.12932/AP-200220-0772,2020-02-28
Critical Illness,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
acute pneumonia,PROCESS_OF,Patients,32105090,10.12932/AP-200220-0772,2020-02-28
Coronavirus Infections,CAUSES,Disease,32105052,10.3760/cma.j.cn112152-20200226-00128,2020-02-28
Malignant Neoplasms,PROCESS_OF,Patients,32105048,10.3760/cma.j.cn112140-20200217-00097,2020-02-28
Challenge,TREATS,Patients,32105048,10.3760/cma.j.cn112140-20200217-00097,2020-02-28
Esophageal Neoplasms,ISA,Malignant Neoplasms,32105048,10.3760/cma.j.cn112140-20200217-00097,2020-02-28
Coronavirus Infections,ISA,Disease,32104915,10.1002/jmv.25728,2020-02-28
Laboratory Procedures,METHOD_OF,Diagnosis,32104915,10.1002/jmv.25728,2020-02-28
Laboratory Procedures,USES,Nucleic acid probe with target amplification,32104915,10.1002/jmv.25728,2020-02-28
SARS coronavirus,ISA,Virus,32104915,10.1002/jmv.25728,2020-02-28
Infected,PROCESS_OF,Patients,32104915,10.1002/jmv.25728,2020-02-28
Blood,LOCATION_OF,Immunoglobulin M,32104915,10.1002/jmv.25728,2020-02-28
Blood,PART_OF,Homo sapiens,32104915,10.1002/jmv.25728,2020-02-28
Laboratory Procedures,DIAGNOSES,patient condition,32104915,10.1002/jmv.25728,2020-02-28
Negative,PROCESS_OF,Patients,32104915,10.1002/jmv.25728,2020-02-28
Blood,PART_OF,Venous blood substance,32104915,10.1002/jmv.25728,2020-02-28
Plasma,PART_OF,Venous blood substance,32104915,10.1002/jmv.25728,2020-02-28
Serum,PART_OF,Venous blood substance,32104915,10.1002/jmv.25728,2020-02-28
Respiratory distress,ISA,Symptoms,32104911,10.1002/jmv.25731,2020-02-28
Genus: Coronavirus,CAUSES,nervous system disorder,32104911,10.1002/jmv.25731,2020-02-28
Brain,LOCATION_OF,SARS coronavirus,32104911,10.1002/jmv.25731,2020-02-28
Lung,LOCATION_OF,Genus: Coronavirus,32104911,10.1002/jmv.25731,2020-02-28
Genome,PART_OF,Virus,32104907,10.1002/jmv.25729,2020-02-28
Attention,PROCESS_OF,Chiroptera,32104907,10.1002/jmv.25729,2020-02-28
lopinavir,DISRUPTS,peptidase activity,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
lopinavir,ISA,Agent,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
lopinavir,TREATS,Patients,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
lopinavir,TREATS,Patients,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
lopinavir,TREATS(INFER),Severe Acute Respiratory Syndrome,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
lopinavir,TREATS(INFER),Middle East Respiratory Syndrome,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
Middle East Respiratory Syndrome,PROCESS_OF,Patients,32103652,10.3760/cma.j.cn112338-20200225-00166,2020-02-28
Coronavirus Infections,AFFECTS,Persons,32102726,10.24920/003724,2020-02-28
Infected,PROCESS_OF,Persons,32102726,10.24920/003724,2020-02-28
Virus,CAUSES,Pneumonia,32102726,10.24920/003724,2020-02-28
Coronavirus Infections,ISA,Communicable Diseases,32102625,10.1080/22221751.2020.1732837,2020-02-28
Symptom mild,PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
Infected,PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
Blood Coagulation Disorders,PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
Septic Shock,PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
Metabolic acidosis,PROCESS_OF,Patients,32102625,10.1080/22221751.2020.1732837,2020-02-28
"Intubation, Intratracheal",TREATS,patient condition,32102625,10.1080/22221751.2020.1732837,2020-02-28
Evaluation procedure,USES,Artificial Airways,32102625,10.1080/22221751.2020.1732837,2020-02-28
Patients,USES,Artificial Airways,32102625,10.1080/22221751.2020.1732837,2020-02-28
Patients,USES,Artificial Airways,32102625,10.1080/22221751.2020.1732837,2020-02-28
Laboratory,LOCATION_OF,Real-Time Polymerase Chain Reaction,32102279,10.3390/jcm9020601,2020-02-28
Coronavirus Infections,CAUSES,Pneumonia,32102279,10.3390/jcm9020601,2020-02-28
Chest CT,DIAGNOSES,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Chest CT,DIAGNOSES(SPEC),Coronavirus Infections,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Assay,DIAGNOSES,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Assay,DIAGNOSES(SPEC),Coronavirus Infections,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Chest CT,ADMINISTERED_TO,Patients,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Chest CT,DIAGNOSES,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Chest CT,DIAGNOSES(SPEC),Coronavirus Infections,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Positive Finding,PROCESS_OF,Patients,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
High sensitivity,DIAGNOSES,Disease,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
High sensitivity,DIAGNOSES(SPEC),Coronavirus Infections,32100979,10.3760/cma.j.cn112152-20200221-00110,2020-02-27
Coronavirus Infections,ISA,Disease,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
Malignant neoplasm of breast,PROCESS_OF,Patients,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
Malignant neoplasm of breast,PROCESS_OF,Patients,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
Malignant neoplasm of breast,PROCESS_OF,Patients,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
Malignant neoplasm of breast,PROCESS_OF,Patients,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
Psychological counseling,TREATS,Patients,32100978,10.3760/cma.j.cn112150-20200221-00151,2020-02-27
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32100877,10.1002/jmv.25726,2020-02-27
Invasive positive pressure ventilation,AFFECTS,Patients,32100877,10.1002/jmv.25726,2020-02-27
Airway Management,PREVENTS,Complication,32100877,10.1002/jmv.25726,2020-02-27
Hospitals,LOCATION_OF,Prospective Studies,32100667,10.1017/S0950268820000424,2020-02-27
Pneumonia,PROCESS_OF,Patients,32100667,10.1017/S0950268820000424,2020-02-27
Conjunctivitis,PROCESS_OF,Patients,32100667,10.1017/S0950268820000424,2020-02-27
Conjunctivitis,PROCESS_OF,Patients,32100667,10.1017/S0950268820000424,2020-02-27
Pneumonia,PROCESS_OF,Patients,32100667,10.1017/S0950268820000424,2020-02-27
Coronavirus Infections,PROCESS_OF,Homo sapiens,32100486,10.3348/kjr.2020.0112,2020-02-27
Cambodia,ISA,Country,32100486,10.3348/kjr.2020.0112,2020-02-27
Canada,ISA,Country,32100486,10.3348/kjr.2020.0112,2020-02-27
Malaysia,ISA,Country,32100486,10.3348/kjr.2020.0112,2020-02-27
Thailand,ISA,Country,32100486,10.3348/kjr.2020.0112,2020-02-27
United States,ISA,Country,32100486,10.3348/kjr.2020.0112,2020-02-27
Pneumonia,PROCESS_OF,Patients,32100485,10.3348/kjr.2020.0132,2020-02-27
Symptoms,PROCESS_OF,Patients,32100485,10.3348/kjr.2020.0132,2020-02-27
Lung,LOCATION_OF,Ground Glass Opacity,32100485,10.3348/kjr.2020.0132,2020-02-27
Fibrosis,ISA,Lesion,32100485,10.3348/kjr.2020.0132,2020-02-27
Pneumonia,ISA,Disease,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Coronavirus Infections,ISA,Disease,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Coronavirus Infections,PROCESS_OF,Patients,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Pneumonia,ISA,Disease,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Plain chest X-ray,METHOD_OF,tomography,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Lung,LOCATION_OF,Lesion,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Both lungs,LOCATION_OF,Ground Glass Opacity,32099934,10.1016/j.idm.2020.02.001,2020-02-27
lobe,LOCATION_OF,Lesion,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Pneumonia,ISA,Disease,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Pneumonia,PROCESS_OF,Patients,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Standard chest X-ray normal,PROCESS_OF,Patients,32099934,10.1016/j.idm.2020.02.001,2020-02-27
Pathogenic organism,ASSOCIATED_WITH,Respiratory Tract Infections,32098302,10.3390/pathogens9020148,2020-02-27
Severe Acute Respiratory Syndrome,PROCESS_OF,World,32098302,10.3390/pathogens9020148,2020-02-27
Epithelium,PART_OF,Patients,32098302,10.3390/pathogens9020148,2020-02-27
Pneumonia,PROCESS_OF,Patients,32098302,10.3390/pathogens9020148,2020-02-27
Symptoms,CAUSES,Disease,32098302,10.3390/pathogens9020148,2020-02-27
Virus,CAUSES,Disease,32098302,10.3390/pathogens9020148,2020-02-27
SARS coronavirus,INTERACTS_WITH,Virus,32098302,10.3390/pathogens9020148,2020-02-27
SARS coronavirus,INTERACTS_WITH,Virus,32098302,10.3390/pathogens9020148,2020-02-27
Pneumonia,PROCESS_OF,Homo sapiens,32098289,10.3390/jcm9020596,2020-02-27
Pharmaceutical Preparations,NEG_TREATS,Genus: Coronavirus,32098019,10.3390/jcm9020580,2020-02-27
Infected,PROCESS_OF,Persons,32097725,10.1016/j.ijid.2020.02.033,2020-02-26
Infected,PROCESS_OF,Persons,32097725,10.1016/j.ijid.2020.02.033,2020-02-26
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Persons,32097725,10.1016/j.ijid.2020.02.033,2020-02-26
Cessation of life,PROCESS_OF,Young Adult,32097725,10.1016/j.ijid.2020.02.033,2020-02-26
Coronavirus Infections,ISA,Disease,32096566,10.1002/jmv.25723,2020-02-26
Coronavirus Infections,ISA,Disease,32096566,10.1002/jmv.25723,2020-02-26
Coronavirus Infections,ISA,Disease,32096566,10.1002/jmv.25723,2020-02-26
Coronavirus Infections,ISA,Disease,32096566,10.1002/jmv.25723,2020-02-26
Malignant neoplasm of gastrointestinal tract,ISA,Malignant Neoplasms,32096395,10.3760/cma.j.cn112139-20200221-00116,2020-02-26
Cancer of Digestive System,PROCESS_OF,Patients,32096395,10.3760/cma.j.cn112139-20200221-00116,2020-02-26
Coronavirus Infections,ISA,Disease,32094589,10.1038/s41564-020-0688-y,2020-02-26
Prophylactic treatment,TREATS,Breast Diseases,32094589,10.1038/s41564-020-0688-y,2020-02-26
Coronavirus Infections,ISA,Disease,32094589,10.1038/s41564-020-0688-y,2020-02-26
Coronavirus Infections,ISA,Disease,32094589,10.1038/s41564-020-0688-y,2020-02-26
Coronavirus Infections,ISA,Disease,32094589,10.1038/s41564-020-0688-y,2020-02-26
Breast Diseases,PROCESS_OF,Patients,32094589,10.1038/s41564-020-0688-y,2020-02-26
Coronavirus Infections,ISA,Disease,32094589,10.1038/s41564-020-0688-y,2020-02-26
Coronavirus Infections,PROCESS_OF,Animals,32094336,10.1038/s41368-020-0074-x,2020-02-26
SARS coronavirus,ISA,Betacoronavirus,32094336,10.1038/s41368-020-0074-x,2020-02-26
ACE2 gene,PART_OF,Homo sapiens,32094336,10.1038/s41368-020-0074-x,2020-02-26
ACE2 gene,ADMINISTERED_TO,Cells,32094225,10.1074/jbc.AC120.013056,2020-02-26
Mucous Membrane,LOCATION_OF,ACE2 gene,32094225,10.1074/jbc.AC120.013056,2020-02-26
ACE2 gene,INTERACTS_WITH,Cells,32094225,10.1074/jbc.AC120.013056,2020-02-26
Transcriptome,PART_OF,Cells,32094225,10.1074/jbc.AC120.013056,2020-02-26
Mucous Membrane,LOCATION_OF,ACE2 gene,32094225,10.1074/jbc.AC120.013056,2020-02-26
Epithelial Cells,PART_OF,Tongue,32094225,10.1074/jbc.AC120.013056,2020-02-26
receptor,AUGMENTS,Epithelial Cells,32094225,10.1074/jbc.AC120.013056,2020-02-26
Communicable Diseases,AFFECTS,American College of Cardiology/American Heart Association Lesion Complexity Score C,32094225,10.1074/jbc.AC120.013056,2020-02-26
Cytospin-B,ISA,Proteins,32093211,10.3390/jcm9020575,2020-02-26
Cerebral Infarction,COEXISTS_WITH,Severe (severity modifier),32093043,10.3390/jcm9020571,2020-02-26
"Bronchitis, Chronic",COEXISTS_WITH,Severe (severity modifier),32093043,10.3390/jcm9020571,2020-02-26
Coronary Arteriosclerosis,COEXISTS_WITH,Severe (severity modifier),32093043,10.3390/jcm9020571,2020-02-26
Diabetes,COEXISTS_WITH,Severe (severity modifier),32093043,10.3390/jcm9020571,2020-02-26
Hypertensive disease,COEXISTS_WITH,Severe (severity modifier),32093043,10.3390/jcm9020571,2020-02-26
World,ISA,Population Group,32092748,10.5582/bst.2020.01056,2020-02-25
Coronavirus Infections,CAUSES,Middle East Respiratory Syndrome,32092748,10.5582/bst.2020.01056,2020-02-25
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32092748,10.5582/bst.2020.01056,2020-02-25
Clinician,TREATS,Patients,32092539,10.1016/j.micinf.2020.02.006,2020-02-25
chloroquine phosphate,TREATS,Pneumonia,32092539,10.1016/j.micinf.2020.02.006,2020-02-25
Discrepancy,PROCESS_OF,World,32092483,10.1016/j.meegid.2020.104260,2020-02-25
Antibody-Dependent Enhancement,AFFECTS,Immune response,32092483,10.1016/j.meegid.2020.104260,2020-02-25
Epitopes,ISA,Antigens,32092483,10.1016/j.meegid.2020.104260,2020-02-25
Virus,LOCATION_OF,Epitopes,32092483,10.1016/j.meegid.2020.104260,2020-02-25
Coronavirus Infections,CAUSES,Virus Diseases,32092296,10.1016/j.jacr.2020.02.008,2020-02-25
Dyspnea,ASSOCIATED_WITH,Pneumonia,32091414,10.1097/RLI.0000000000000670,2020-02-25
Fatigue,ASSOCIATED_WITH,Pneumonia,32091414,10.1097/RLI.0000000000000670,2020-02-25
Fever,ASSOCIATED_WITH,Pneumonia,32091414,10.1097/RLI.0000000000000670,2020-02-25
Dry cough,ASSOCIATED_WITH,Pneumonia,32091414,10.1097/RLI.0000000000000670,2020-02-25
Author,TREATS,Patients,32091414,10.1097/RLI.0000000000000670,2020-02-25
Patients,LOCATION_OF,"CD69 protein, human",32091395,10.7554/eLife.55570,2020-02-25
Coughing,PROCESS_OF,Patients,32091395,10.7554/eLife.55570,2020-02-25
High Level,PROCESS_OF,Patients,32091395,10.7554/eLife.55570,2020-02-25
Lung,LOCATION_OF,Thickened,32091395,10.7554/eLife.55570,2020-02-25
Infected,PROCESS_OF,Persons,32091386,10.3201/eid2605.200198,2020-02-25
Ground Glass Opacity,PROCESS_OF,Patients,32088679,10.3855/jidc.12425,2020-02-24
Lung,LOCATION_OF,Lesion,32088679,10.3855/jidc.12425,2020-02-24
Symptoms,PROCESS_OF,Patients,32088598,10.1016/j.ijheh.2020.113490,2020-02-24
Infection,PROCESS_OF,Child,32088598,10.1016/j.ijheh.2020.113490,2020-02-24
Rodent,ISA,Animals,32088333,10.1016/j.micinf.2020.02.004,2020-02-24
China,ISA,Country,32087820,10.1016/S0140-6736(20)30411-6,2020-02-24
Disease,PROCESS_OF,Human Age Group,32087621,10.3760/cma.j.cn112147-20200222-00151,2020-02-24
Diabetes Mellitus,ISA,Disease,32087621,10.3760/cma.j.cn112147-20200222-00151,2020-02-24
Injury wounds,PROCESS_OF,Patients,32087621,10.3760/cma.j.cn112147-20200222-00151,2020-02-24
Physicians,TREATS,Patients,32087621,10.3760/cma.j.cn112147-20200222-00151,2020-02-24
Transcriptional Activation,AFFECTS,Patients,32087334,10.1016/j.micinf.2020.02.002,2020-02-23
disease prevention,TREATS,Infantile Neuroaxonal Dystrophy,32086886,10.3760/cma.j.cn112144-20200213-00053,2020-02-23
Severe Acute Respiratory Syndrome,PREDISPOSES,Middle East Respiratory Syndrome,32086886,10.3760/cma.j.cn112144-20200213-00053,2020-02-23
Globalization,CAUSES,Severe Acute Respiratory Syndrome,32086886,10.3760/cma.j.cn112144-20200213-00053,2020-02-23
Globalization,CAUSES,Middle East Respiratory Syndrome,32086886,10.3760/cma.j.cn112144-20200213-00053,2020-02-23
Mouth Diseases,PROCESS_OF,Patients,32084675,10.3760/cma.j.cn441530-20200217-00058,2020-02-23
Experience,ISA,Cognition,32084675,10.3760/cma.j.cn441530-20200217-00058,2020-02-23
Mouth Diseases,COEXISTS_WITH,patient mental state,32084675,10.3760/cma.j.cn441530-20200217-00058,2020-02-23
Disease,PROCESS_OF,Patients,32084675,10.3760/cma.j.cn441530-20200217-00058,2020-02-23
Mouth Diseases,PROCESS_OF,Patients,32084675,10.3760/cma.j.cn441530-20200217-00058,2020-02-23
Medical Staff,TREATS,Patients,32084674,10.3760/cma.j.cn112151.20200219.00001,2020-02-23
Emergency operation,TREATS,Patients,32084674,10.3760/cma.j.cn112151.20200219.00001,2020-02-23
Coronavirus Infections,CAUSES,Disease,32083728,10.1111/inr.12578,2020-02-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32081636,10.1016/j.ijantimicag.2020.105924,2020-02-23
Pneumonia,ISA,Symptoms,32081569,10.1016/j.sapharm.2020.02.003,2020-02-23
Pneumonia,ISA,Symptoms,32081569,10.1016/j.sapharm.2020.02.003,2020-02-23
Pneumonia,PROCESS_OF,Patients,32081569,10.1016/j.sapharm.2020.02.003,2020-02-23
Virus,LOCATION_OF,RNA Recognition Motif,32080994,10.3760/cma.j.cn112144-20200205-00037,2020-02-23
Animals,LOCATION_OF,angiotensin converting enzyme 2,32080994,10.3760/cma.j.cn112144-20200205-00037,2020-02-23
Intestines,LOCATION_OF,angiotensin converting enzyme 2,32080994,10.3760/cma.j.cn112144-20200205-00037,2020-02-23
Kidney,LOCATION_OF,angiotensin converting enzyme 2,32080994,10.3760/cma.j.cn112144-20200205-00037,2020-02-23
Testis,LOCATION_OF,angiotensin converting enzyme 2,32080994,10.3760/cma.j.cn112144-20200205-00037,2020-02-23
comply,TREATS,Mouth Diseases,32080991,10.3346/jkms.2020.35.e86,2020-02-23
Hospitals,LOCATION_OF,Training Programs,32080991,10.3346/jkms.2020.35.e86,2020-02-23
China,ISA,Country,32080990,10.3346/jkms.2020.35.e84,2020-02-23
Illness (finding),PROCESS_OF,Patients,32080990,10.3346/jkms.2020.35.e84,2020-02-23
Confirmation,PROCESS_OF,Patients,32080990,10.3346/jkms.2020.35.e84,2020-02-23
Severe Acute Respiratory Syndrome,PROCESS_OF,Patients,32079150,10.3390/jcm9020538,2020-02-23
Chest,LOCATION_OF,Carpal Tunnel Syndrome,32077662,10.3760/cma.j.cn112137-20200213-00280,2020-02-23
CAT scan normal,PROCESS_OF,Patients,32077662,10.3760/cma.j.cn112137-20200213-00280,2020-02-23
Critical Illness,PROCESS_OF,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Therapeutic procedure,TREATS,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Therapeutic procedure,TREATS(INFER),Critical Illness,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Pneumonia,PROCESS_OF,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Therapeutic procedure,TREATS,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Therapeutic procedure,TREATS(INFER),Pneumonia,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Masks,TREATS,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Masks,USES,Harbor,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Spontaneous respiration,PROCESS_OF,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Ventilator outlet,USES,Heat Exchangers,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Noninvasive Ventilation,ADMINISTERED_TO,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Noninvasive Ventilation,USES,Masks,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Spontaneous respiration,PROCESS_OF,Patients,32077660,10.3760/cma.j.issn.1007-3418.2020.02.003,2020-02-23
Coronavirus Infections,ISA,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Coronavirus Infections,ISA,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Patients,ISA,Persons,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant Neoplasms,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Prognosis bad,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Coronavirus Infections,ISA,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Fever,PREDISPOSES,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Fever,PREDISPOSES(SPEC),Coronavirus Infections,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
"Signs and Symptoms, Respiratory",PREDISPOSES,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
"Signs and Symptoms, Respiratory",PREDISPOSES(SPEC),Coronavirus Infections,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Coronavirus Infections,ISA,Disease,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Malignant neoplasm of lung,PROCESS_OF,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Clinical Management,TREATS,Patients,32077440,10.3779/j.issn.1009-3419.2020.03.01,2020-02-23
Disease,PROCESS_OF,Patients,32077115,10.1111/all.14238,2020-02-23
Coronavirus Infections,ISA,Disease,32077115,10.1111/all.14238,2020-02-23
Coronavirus Infections,PROCESS_OF(SPEC),Patients,32077115,10.1111/all.14238,2020-02-23
Lesion,PROCESS_OF,Patients,32077115,10.1111/all.14238,2020-02-23
Operative Surgical Procedures,ISA,Interventional procedure,32077115,10.1111/all.14238,2020-02-23
Coronavirus Infections,ISA,Disease,32077115,10.1111/all.14238,2020-02-23
Asthma,ISA,Hypersensitivity,32075877,10.1126/science.abb2507,2020-02-23
Eosinopenia,PROCESS_OF,Patients,32075877,10.1126/science.abb2507,2020-02-23
Diagnosis,USES,Indicators,32075877,10.1126/science.abb2507,2020-02-23
Asthma,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32075877,10.1126/science.abb2507,2020-02-23
Hypersensitivity,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32075877,10.1126/science.abb2507,2020-02-23
Chronic Obstructive Airway Disease,NEG_PREDISPOSES,Severe Acute Respiratory Syndrome,32075877,10.1126/science.abb2507,2020-02-23
Glycoproteins,INTERACTS_WITH,Vaccines,32075786,10.1136/bmj.m606,2020-02-23
"Vitronectin, human",INTERACTS_WITH,angiotensin converting enzyme 2,32075786,10.1136/bmj.m606,2020-02-23
Infected,PROCESS_OF,Patients,32075365,10.3760/cma.j.issn.1001-0939.2020.0019,2020-02-23
Fever,ISA,Symptoms,32075365,10.3760/cma.j.issn.1001-0939.2020.0019,2020-02-23
chloroquine phosphate,ISA,Chloroquine,32075364,10.3760/cma.j.issn.1007-3418.2020.02.001,2020-02-23
Chloroquine,TREATS,Patients,32075364,10.3760/cma.j.issn.1007-3418.2020.02.001,2020-02-23
Chloroquine,TREATS,Pneumonia,32075364,10.3760/cma.j.issn.1007-3418.2020.02.001,2020-02-23
Chloroquine,TREATS(INFER),Pneumonia,32075364,10.3760/cma.j.issn.1007-3418.2020.02.001,2020-02-23
Pneumonia,PROCESS_OF,Patients,32075364,10.3760/cma.j.issn.1007-3418.2020.02.001,2020-02-23
Coronavirus Infections,CAUSES,Pneumonia,32075152,10.3390/jcm9020523,2020-02-23
Prophylactic treatment,TREATS,Pneumonia,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Gastrointestinal Neoplasms,PROCESS_OF,Patients,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Fever,PROCESS_OF,Patients,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Operative Surgical Procedures,PREVENTS,Cross Infection,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Interventional procedure,TREATS,Benign Neoplasm,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Operative Surgical Procedures,ISA,Interventional procedure,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Operative Surgical Procedures,TREATS(SPEC),Benign Neoplasm,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Transarterial embolization,TREATS,Gastrointestinal Neoplasms,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Acute hemorrhage,PROCESS_OF,Patients,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Anesthetist,USES,Masks,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Enterostomy procedure,ISA,Operation on gastrointestinal tract,32074719,10.3760/cma.j.issn.1671-0274.2020.03.002,2020-02-23
Severe Acute Respiratory Syndrome,CAUSES,Pneumonia,32074550,10.5582/bst.2020.01047,2020-02-20
Colorectal Carcinoma,PROCESS_OF,Patients,32074550,10.5582/bst.2020.01047,2020-02-20
Operative Surgical Procedures,ADMINISTERED_TO,Patients,32074550,10.5582/bst.2020.01047,2020-02-20
Colorectal Carcinoma,PROCESS_OF,Patients,32074550,10.5582/bst.2020.01047,2020-02-20
Colorectal Carcinoma,PROCESS_OF,Patients,32074550,10.5582/bst.2020.01047,2020-02-20
"Surgical Procedures, Laparoscopic",TREATS,Patients,32074550,10.5582/bst.2020.01047,2020-02-20
"Surgical Procedures, Laparoscopic",TREATS(INFER),Colorectal Carcinoma,32074550,10.5582/bst.2020.01047,2020-02-20
Pharmaceutical Preparations,TREATS,Malaria,32074516,10.7883/yoken.JJID.2020.061,2020-02-20
Pharmaceutical Preparations,TREATS,Coronavirus Infections,32074516,10.7883/yoken.JJID.2020.061,2020-02-20
Prophylactic treatment,TREATS,Pneumonia,32074516,10.7883/yoken.JJID.2020.061,2020-02-20
Pneumonia,PROCESS_OF,Patients,32072569,10.1007/s15010-020-01401-y,2020-02-20
Coagulation procedure,CAUSES,Coronavirus Infections,32072569,10.1007/s15010-020-01401-y,2020-02-20
Bacterial Infections,AFFECTS,hospitalized patients,32070465,10.2807/1560-7917.ES.2020.25.6.2000094,2020-02-20
"Respiratory Distress Syndrome, Adult",AFFECTS,hospitalized patients,32070465,10.2807/1560-7917.ES.2020.25.6.2000094,2020-02-20
Asymptomatic,PROCESS_OF,Family member,32066206,10.3760/cma.j.issn.0529-5815.2020.0002,2020-02-19
Reduced mobility,PROCESS_OF,Male population group,32066206,10.3760/cma.j.issn.0529-5815.2020.0002,2020-02-19
Coronavirus Infections,COEXISTS_WITH,Incubation period,32066206,10.3760/cma.j.issn.0529-5815.2020.0002,2020-02-19
Aorta,LOCATION_OF,Syndrome,32065520,10.3760/cma.j.issn.0578-1310.2020.0009,2020-02-18
Syndrome,PROCESS_OF,Patients,32065520,10.3760/cma.j.issn.0578-1310.2020.0009,2020-02-18
Prophylactic treatment,PREVENTS,Severe Acute Respiratory Syndrome,32065221,10.1093/femspd/ftaa006,2020-02-18
Prophylactic treatment,TREATS,Population Group,32065221,10.1093/femspd/ftaa006,2020-02-18
Prophylactic treatment,TREATS(INFER),American College of Cardiology/American Heart Association Lesion Complexity Score C,32065221,10.1093/femspd/ftaa006,2020-02-18
American College of Cardiology/American Heart Association Lesion Complexity Score C,PROCESS_OF,Population Group,32065221,10.1093/femspd/ftaa006,2020-02-18
lonicerae flos,PREVENTS,Influenza,32065221,10.1093/femspd/ftaa006,2020-02-18
lonicerae flos,PREVENTS,Severe Acute Respiratory Syndrome,32065221,10.1093/femspd/ftaa006,2020-02-18
Infected,PROCESS_OF,Homo sapiens,32065057,10.1080/22221751.2020.1729071,2020-02-18
Molecular Diagnosis,DIAGNOSES,Disease,32065055,10.1080/22221751.2020.1729069,2020-02-18
"ORAL,SWAB",TREATS,Confirmation,32065055,10.1080/22221751.2020.1729069,2020-02-18
Organ,LOCATION_OF,Virus,32065055,10.1080/22221751.2020.1729069,2020-02-18
Infected,PROCESS_OF,Patients,32065055,10.1080/22221751.2020.1729069,2020-02-18
Laboratory Infection,PROCESS_OF,Homo sapiens,32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
Coronavirus Infections,CAUSES,Laboratory Infection,32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
Anti-Antibodies,PART_OF,SARS coronavirus,32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
Prophylactic treatment,USES,"Antibodies, Neutralizing",32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
Binding Sites,PART_OF,SARS coronavirus,32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
"Antibodies, Neutralizing",INTERACTS_WITH,Binding Sites,32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
"Antibodies, Neutralizing",NEG_INTERACTS_WITH,"M Protein, multiple myeloma",32064856,10.3760/cma.j.issn.0253-9624.2020.03.003,2020-02-18
Contacts,TREATS,Traffic,32064855,10.3760/cma.j.issn.0253-9624.2020.0005,2020-02-18
Asymptomatic,PROCESS_OF,Patients,32064853,10.3760/cma.j.issn.0254-6450.2020.02.003,2020-02-18
Lung,LOCATION_OF,Lesion,32064853,10.3760/cma.j.issn.0254-6450.2020.02.003,2020-02-18
Screening procedure,AFFECTS,Lesion,32064853,10.3760/cma.j.issn.0254-6450.2020.02.003,2020-02-18
Screening procedure,TREATS,Patients,32064853,10.3760/cma.j.issn.0254-6450.2020.02.003,2020-02-18
Infected,PROCESS_OF,Patients,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
ACE2 gene,CAUSES,Pneumonia,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
ACE2 gene,PART_OF,Homo sapiens,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
ACE2 gene,INTERACTS_WITH,rasagiline,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
Ras Inhibitor,TREATS,Symptoms,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
ACE2 gene,CAUSES,Exhaustion,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
Equilibrium,AFFECTS,acute pneumonia,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
rasagiline,CAUSES,Exacerbation,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
Lung,LOCATION_OF,inflammatory response,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
Pneumonia,PROCESS_OF,Patients,32061066,10.3760/cma.j.issn.1001-0939.2020.0013,2020-02-16
China,ISA,Country,32057769,10.1016/j.antiviral.2020.104742,2020-02-15
Fusion inhibitor,COEXISTS_WITH,"M Protein, multiple myeloma",32057769,10.1016/j.antiviral.2020.104742,2020-02-15
Infected,PROCESS_OF,Homo sapiens,32057212,10.3760/cma.j.issn.0529-5815.2020.0001,2020-02-15
paired basic amino acid cleaving enzyme,COEXISTS_WITH,"M Protein, multiple myeloma",32057212,10.3760/cma.j.issn.0529-5815.2020.0001,2020-02-15
Pneumonia,ISA,Communicable Diseases,32057211,10.3760/cma.j.issn.0254-6450.2020.02.002,2020-02-15
Pneumonia,PROCESS_OF,Patients,32057210,10.3760/cma.j.issn.1002-0098.2020.0001,2020-02-15
Pneumonia,PROCESS_OF,Patients,32057210,10.3760/cma.j.issn.1002-0098.2020.0001,2020-02-15
Coronavirus Infections,CAUSES,Pneumonia,32057209,10.3760/cma.j.issn.1001-0939.2020.0012,2020-02-15
Cross Infection,PROCESS_OF,Patients,32057209,10.3760/cma.j.issn.1001-0939.2020.0012,2020-02-15
Cross Infection,PROCESS_OF,Practitioner,32057209,10.3760/cma.j.issn.1001-0939.2020.0012,2020-02-15
Coronavirus Infections,CAUSES,Communicable Diseases,32056407,10.3346/jkms.2020.35.e79,2020-02-15
Treatment Protocols,AFFECTS,Middle East Respiratory Syndrome,32056407,10.3346/jkms.2020.35.e79,2020-02-15
Infection,PROCESS_OF,Community,32056397,10.3348/kjr.2020.0078,2020-02-15
Coronavirus Infections,PROCESS_OF,Patients,32056397,10.3348/kjr.2020.0078,2020-02-15
Lung,LOCATION_OF,Ground Glass Opacity,32056249,10.1002/jmv.25709,2020-02-15
Confirmation,PROCESS_OF,Patients,32054787,10.1073/pnas.1922083117,2020-02-15
Confirmation,PROCESS_OF,Patients,32054787,10.1073/pnas.1922083117,2020-02-15
Ground Glass Opacity,PROCESS_OF,Patients,32054787,10.1073/pnas.1922083117,2020-02-15
Ground Glass Opacity,PROCESS_OF,Patients,32054787,10.1073/pnas.1922083117,2020-02-15
Nodule,COEXISTS_WITH,"Pneumonia, Viral",32054787,10.1073/pnas.1922083117,2020-02-15
Pneumonia,PROCESS_OF,Patients,32054787,10.1073/pnas.1922083117,2020-02-15
Lung,LOCATION_OF,Lesion,32054124,10.3390/jcm9020498,2020-02-15
Body tissue,LOCATION_OF,Prophylactic treatment,32054124,10.3390/jcm9020498,2020-02-15
Vaccination,PREVENTS,Disease,32054124,10.3390/jcm9020498,2020-02-15
Lung,LOCATION_OF,Lesion,32054124,10.3390/jcm9020498,2020-02-15
Lung,LOCATION_OF,Sign or Symptom,32054124,10.3390/jcm9020498,2020-02-15
Hospitalization,TREATS,Patients,32054045,10.3390/jcm9020488,2020-02-15
Pneumonia,PROCESS_OF,Patients,32053479,10.3201/eid2605.200146,2020-02-14
Nucleic acid sequencing,DIAGNOSES,Coronavirus Infections,32053479,10.3201/eid2605.200146,2020-02-14
Malaise,PROCESS_OF,traveler,32053479,10.3201/eid2605.200146,2020-02-14
Patients,ISA,Persons,32053479,10.3201/eid2605.200146,2020-02-14
Malaise,PROCESS_OF,Persons,32053479,10.3201/eid2605.200146,2020-02-14
Malaise,PROCESS_OF,traveler,32053479,10.3201/eid2605.200146,2020-02-14
Malaise,PROCESS_OF(SPEC),Patients,32053479,10.3201/eid2605.200146,2020-02-14
Coronavirus Infections,ISA,Disease,32053470,10.1148/radiol.2020200370,2020-02-14
Coronavirus Infections,ISA,Disease,32053470,10.1148/radiol.2020200370,2020-02-14
Respiratory distress,PROCESS_OF,Patients,32052466,10.1002/jmv.25707,2020-02-14
lobe,PART_OF,Lung,32052466,10.1002/jmv.25707,2020-02-14
treatment options,AFFECTS,Coronavirus Infections,32052373,10.1007/s12630-020-01591-x,2020-02-14
Nutritional status,NEG_PROCESS_OF,Health Personnel,32052373,10.1007/s12630-020-01591-x,2020-02-14
Nutritional status,NEG_PROCESS_OF,Persons,32052373,10.1007/s12630-020-01591-x,2020-02-14
Infected,PROCESS_OF,Patients,32052373,10.1007/s12630-020-01591-x,2020-02-14
Confirmation,PROCESS_OF,Patients,32050635,10.3390/v12020194,2020-02-14
Cessation of life,OCCURS_IN,special populations,32050080,10.33321/cdi.2020.44.14,2020-02-13
Coronavirus Infections,AFFECTS,Infant,32050080,10.33321/cdi.2020.44.14,2020-02-13
Coronavirus Infections,AFFECTS,Pregnant Women,32050080,10.33321/cdi.2020.44.14,2020-02-13
Severe Acute Respiratory Syndrome,AFFECTS,Infant,32050080,10.33321/cdi.2020.44.14,2020-02-13
Severe Acute Respiratory Syndrome,AFFECTS,Pregnant Women,32050080,10.33321/cdi.2020.44.14,2020-02-13
Severe Acute Respiratory Syndrome,AFFECTS(SPEC),Infant,32050080,10.33321/cdi.2020.44.14,2020-02-13
Severe Acute Respiratory Syndrome,AFFECTS(SPEC),Pregnant Women,32050080,10.33321/cdi.2020.44.14,2020-02-13
Severe Acute Respiratory Syndrome,ISA,Coronavirus Infections,32050080,10.33321/cdi.2020.44.14,2020-02-13
Middle East Respiratory Syndrome,AFFECTS,Infant,32050080,10.33321/cdi.2020.44.14,2020-02-13
Middle East Respiratory Syndrome,AFFECTS,Pregnant Women,32050080,10.33321/cdi.2020.44.14,2020-02-13
Middle East Respiratory Syndrome,AFFECTS(SPEC),Infant,32050080,10.33321/cdi.2020.44.14,2020-02-13
Middle East Respiratory Syndrome,AFFECTS(SPEC),Pregnant Women,32050080,10.33321/cdi.2020.44.14,2020-02-13
Middle East Respiratory Syndrome,ISA,Coronavirus Infections,32050080,10.33321/cdi.2020.44.14,2020-02-13
Coronavirus Infections,ISA,Disease,32049601,10.1148/radiol.2020200343,2020-02-13
Coronavirus Infections,ISA,Disease,32049601,10.1148/radiol.2020200343,2020-02-13
Coronavirus Infections,NEG_PROCESS_OF,Patients,32048815,10.1111/jebm.12376,2020-02-13
Positive Finding,PROCESS_OF,Patients,32048815,10.1111/jebm.12376,2020-02-13
Laboratory Procedures,METHOD_OF,Isolation procedure,32048815,10.1111/jebm.12376,2020-02-13
Laboratory Procedures,USES,Buccal smear procedure,32048815,10.1111/jebm.12376,2020-02-13
Isolation procedure,TREATS,Pneumonia,32048815,10.1111/jebm.12376,2020-02-13
Buccal smear procedure,ISA,Laboratory Procedures,32048815,10.1111/jebm.12376,2020-02-13
Buccal smear procedure,METHOD_OF(SPEC),Isolation procedure,32048815,10.1111/jebm.12376,2020-02-13
Laboratory Procedures,USES,Buccal smear procedure,32048815,10.1111/jebm.12376,2020-02-13
X-Ray Computed Tomography,AFFECTS,Screening procedure,32048815,10.1111/jebm.12376,2020-02-13
Suspicion,PROCESS_OF,Persons,32048815,10.1111/jebm.12376,2020-02-13
Buccal smear procedure,ISA,Laboratory Procedures,32048815,10.1111/jebm.12376,2020-02-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32048501,10.3760/cma.j.issn.1001-0939.2020.0010,2020-02-13
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32048501,10.3760/cma.j.issn.1001-0939.2020.0010,2020-02-13
Pneumonia,PROCESS_OF,Patients,32048163,10.1007/s11427-020-1643-8,2020-02-13
Respiratory Failure,AFFECTS,Alveolar ventilation function,32048163,10.1007/s11427-020-1643-8,2020-02-13
Respiratory Failure,PROCESS_OF,Patients,32048163,10.1007/s11427-020-1643-8,2020-02-13
China,ISA,Country,32047895,10.1093/cid/ciaa149,2020-02-13
Pneumonia,PROCESS_OF,Patients,32047895,10.1093/cid/ciaa149,2020-02-13
Lactate Dehydrogenase,INHIBITS,CD8A wt Allele,32047895,10.1093/cid/ciaa149,2020-02-13
Respiratory tract structure,PART_OF,Patients,32047895,10.1093/cid/ciaa149,2020-02-13
C-reactive protein,ISA,Albumins,32047895,10.1093/cid/ciaa149,2020-02-13
angiotensin II,PART_OF,Patients,32047895,10.1093/cid/ciaa149,2020-02-13
Infected,PROCESS_OF,Patients,32047895,10.1093/cid/ciaa149,2020-02-13
Plasma specimen,LOCATION_OF,angiotensin II,32047895,10.1093/cid/ciaa149,2020-02-13
Infectious disease prevention / control,TREATS,Patients,32046819,10.2807/1560-7917.ES.2020.25.5.2000062,2020-02-13
Country,ISA,Geographic Locations,32046137,10.3390/jcm9020462,2020-02-13
European country,ISA,Geographic Locations,32046137,10.3390/jcm9020462,2020-02-13
European country,ISA,Geographic Locations,32046137,10.3390/jcm9020462,2020-02-13
Infected,PROCESS_OF,Persons,32045966,10.3760/cma.j.issn.0578-1310.2020.0005,2020-02-13
Lymphopenia,PROCESS_OF,Patients,32040667,10.1007/s00134-020-05943-5,2020-02-11
lobe,LOCATION_OF,Radionuclide Imaging,32040667,10.1007/s00134-020-05943-5,2020-02-11
lobe,PART_OF,Lung,32040667,10.1007/s00134-020-05943-5,2020-02-11
Critical Illness,PROCESS_OF,Patients,32040667,10.1007/s00134-020-05943-5,2020-02-11
Immunoglobulin G,ADMINISTERED_TO,Patients,32040667,10.1007/s00134-020-05943-5,2020-02-11
systemic administration,USES,Adrenal Cortex Hormones,32040667,10.1007/s00134-020-05943-5,2020-02-11
Present,PROCESS_OF,Patients,32040667,10.1007/s00134-020-05943-5,2020-02-11
Chest,LOCATION_OF,"Pneumonia, Viral",32040667,10.1007/s00134-020-05943-5,2020-02-11
Prognosis bad,PROCESS_OF,Middle Aged,32040667,10.1007/s00134-020-05943-5,2020-02-11
Prognosis bad,PROCESS_OF,geriatric patients,32040667,10.1007/s00134-020-05943-5,2020-02-11
Respiratory Failure,AFFECTS,Comorbidity,32040667,10.1007/s00134-020-05943-5,2020-02-11
Respiratory viruses,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Viral Pathogenesis,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Agent,CAUSES,Severe Acute Respiratory Syndrome,32040190,10.1093/inthealth/ihaa001,2020-02-11
Respiratory failure without hypercapnia,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Severe viral infections,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Critical Illness,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Influenza,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Oseltamivir,ISA,Neuraminidase inhibitor,32040190,10.1093/inthealth/ihaa001,2020-02-11
Oseltamivir,TREATS(SPEC),Influenza,32040190,10.1093/inthealth/ihaa001,2020-02-11
Oseltamivir,TREATS(SPEC),Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Neuraminidase inhibitor,TREATS,Influenza,32040190,10.1093/inthealth/ihaa001,2020-02-11
Neuraminidase inhibitor,TREATS,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Neuraminidase inhibitor,TREATS(INFER),Critical Illness,32040190,10.1093/inthealth/ihaa001,2020-02-11
Neuraminidase inhibitor,TREATS(INFER),Influenza,32040190,10.1093/inthealth/ihaa001,2020-02-11
Ascorbic Acid,ASSOCIATED_WITH,Severe viral infections,32040190,10.1093/inthealth/ihaa001,2020-02-11
Noninvasive Ventilation,CAUSES,Pneumonia,32040190,10.1093/inthealth/ihaa001,2020-02-11
Noninvasive Ventilation,CAUSES,Acute hypoxemic respiratory failure,32040190,10.1093/inthealth/ihaa001,2020-02-11
Noninvasive Ventilation,TREATS,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
Critical Illness,PROCESS_OF,Patients,32040190,10.1093/inthealth/ihaa001,2020-02-11
risk factors,PROCESS_OF,Rural Communities,32038538,10.3389/fmicb.2019.03085,2020-02-11
Human behavior,PROCESS_OF,Rural Communities,32038538,10.3389/fmicb.2019.03085,2020-02-11
Intestines,LOCATION_OF,Coronavirus Infections,32037389,10.5582/bst.2020.01030,2020-02-11
"Fc receptor, neonatal",AUGMENTS,"Immunity, Mucosal",32037389,10.5582/bst.2020.01030,2020-02-11
"RNA, Small Interfering",STIMULATES,,32037389,10.5582/bst.2020.01030,2020-02-11
"RNA, Small Interfering",STIMULATES,Fc Receptor,32037389,10.5582/bst.2020.01030,2020-02-11
"RNA, Small Interfering",STIMULATES,"DDX58 protein, human",32037389,10.5582/bst.2020.01030,2020-02-11
"RNA, Small Interfering",STIMULATES,TLR9 gene,32037389,10.5582/bst.2020.01030,2020-02-11
Cell Count,USES,IGKJ2 gene,32037389,10.5582/bst.2020.01030,2020-02-11
Transforming Growth Factors,STIMULATES,IGKJ2 gene,32037389,10.5582/bst.2020.01030,2020-02-11
Nucleocapsid,PART_OF,Transmissible gastroenteritis virus,32037389,10.5582/bst.2020.01030,2020-02-11
Measles Virus Nucleoprotein,AFFECTS,Receptor Up-Regulation,32037389,10.5582/bst.2020.01030,2020-02-11
Fc Receptor,LOCATION_OF,Transcriptional Activation,32037389,10.5582/bst.2020.01030,2020-02-11
Transforming Growth Factors,STIMULATES,Fc Receptor,32037389,10.5582/bst.2020.01030,2020-02-11
Measles Virus Nucleoprotein,PART_OF,Transmissible gastroenteritis virus,32037389,10.5582/bst.2020.01030,2020-02-11
Measles Virus Nucleoprotein,STIMULATES,Fc Receptor,32037389,10.5582/bst.2020.01030,2020-02-11
Therapeutic procedure,TREATS,Patients,32036774,10.1080/01652176.2020.1727993,2020-02-11
Respiratory Tract Infections,PROCESS_OF,Homo sapiens,32035431,10.4178/epih.e2020007,2020-02-10
Human coronavirus,CAUSES,Respiratory Tract Infections,32035431,10.4178/epih.e2020007,2020-02-10
Disinfection,ADMINISTERED_TO,Homo sapiens,32035431,10.4178/epih.e2020007,2020-02-10
Benzalkonium Chloride,ISA,Agent,32035431,10.4178/epih.e2020007,2020-02-10
chlorhexidine gluconate,ISA,Agent,32035431,10.4178/epih.e2020007,2020-02-10
Confirmation,PROCESS_OF,Patients,32035428,10.3760/cma.j.issn.0412-4081.2020.0001,2020-02-10
Eye,LOCATION_OF,medical care,32035028,10.1016/j.chom.2020.02.001,2020-02-09
Instrument - device,PREVENTS,Cross Infection,32035028,10.1016/j.chom.2020.02.001,2020-02-09
Infection,PROCESS_OF,Child,32033514,10.3760/cma.j.issn.1001-0939.2020.0006,2020-02-09
Prophylactic treatment,TREATS,Child,32033514,10.3760/cma.j.issn.1001-0939.2020.0006,2020-02-09
Interventional procedure,TREATS,Health Personnel,32033513,10.3760/cma.j.issn.0376-2491.2020.0001,2020-02-09
Coronavirus Infections,COEXISTS_WITH,Virus,32032682,10.1016/j.micinf.2020.01.004,2020-02-08
Infected,PROCESS_OF,Persons,32032682,10.1016/j.micinf.2020.01.004,2020-02-08
Cessation of life,PROCESS_OF,Persons,32032682,10.1016/j.micinf.2020.01.004,2020-02-08
Influenza,PROCESS_OF,Asians,32032682,10.1016/j.micinf.2020.01.004,2020-02-08
Infected,PROCESS_OF,Persons,32032682,10.1016/j.micinf.2020.01.004,2020-02-08
Virus,INTERACTS_WITH,Disease,32031583,10.1093/clinchem/hvaa029,2020-02-08
Coronavirus Infections,PROCESS_OF,Patients,32031570,10.1001/jama.2020.1585,2020-02-08
Acute respiratory disease,PROCESS_OF,Patients,32031570,10.1001/jama.2020.1585,2020-02-08
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,32031570,10.1001/jama.2020.1585,2020-02-08
SARS coronavirus,ISA,Virus,32031570,10.1001/jama.2020.1585,2020-02-08
Assay,DIAGNOSES,Virus,32031570,10.1001/jama.2020.1585,2020-02-08
SARS coronavirus,ISA,Virus,32031570,10.1001/jama.2020.1585,2020-02-08
Patients,LOCATION_OF,Respiratory sample,32031570,10.1001/jama.2020.1585,2020-02-08
Plasmids,ISA,DNA,32031570,10.1001/jama.2020.1585,2020-02-08
Detection,TREATS,Homo sapiens,32031570,10.1001/jama.2020.1585,2020-02-08
Critical Illness,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Malaise,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Lymphopenia,OCCURS_IN,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Elevated lactate dehydrogenase,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Prothrombin time increased,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Lung,LOCATION_OF,Ground Glass Opacity,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Lung,PART_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Antiviral Therapy,ADMINISTERED_TO,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Comorbidity,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Dyspnea,PROCESS_OF,Patients,32030925,10.3346/jkms.2020.35.e61,2020-02-08
Pneumonia,PROCESS_OF,Patients,32029004,10.1186/s40779-020-0233-6,2020-02-08
Pneumonia,PROCESS_OF,Patients,32029004,10.1186/s40779-020-0233-6,2020-02-08
Acute respiratory infections,ISA,Disease,32027631,10.15585/mmwr.mm6905e1,2020-02-07
Seafood,AFFECTS,Acute illness,32027573,10.1148/radiol.2020200274,2020-02-07
Acute illness,PROCESS_OF,Persons,32027573,10.1148/radiol.2020200274,2020-02-07
Pneumonia,PROCESS_OF,Homo sapiens,32027036,10.1002/jmv.25700,2020-02-07
Coronavirus Infections,PROCESS_OF,Patients,32027036,10.1002/jmv.25700,2020-02-07
White blood cell count normal,PROCESS_OF,Patients,32027036,10.1002/jmv.25700,2020-02-07
Leucine,COEXISTS_WITH,Viral Proteins,32027035,10.1002/jmv.25701,2020-02-07
Genome,PART_OF,Virus,32026671,10.3760/cma.j.issn.1001-0939.2020.0005,2020-02-07
Toxic Epidermal Necrolysis,PROCESS_OF,Patients,32024089,10.3390/jcm9020388,2020-02-07
Child health care,TREATS,Respiratory Tract Infections,32024089,10.3390/jcm9020388,2020-02-07
Respiratory Tract Infections,PROCESS_OF,Child,32024089,10.3390/jcm9020388,2020-02-07
Universities,ISA,School,32024089,10.3390/jcm9020388,2020-02-07
Maximum Likelihood Estimation,MEASURES,Numbers,32023775,10.4178/epih.e2020006,2020-02-07
Pneumonia,PROCESS_OF,Patients,32023686,10.3760/cma.j.issn.1001-0939.2020.0003,2020-02-06
Coronavirus Infections,CAUSES,Pneumonia,32023686,10.3760/cma.j.issn.1001-0939.2020.0003,2020-02-06
Oseltamivir,ISA,"Neuraminidase inhibitors, direct acting antivirals",32023684,10.3760/cma.j.issn.1001-0939.2020.0001,2020-02-06
lopinavir / Ritonavir,COEXISTS_WITH,Interferons,32023684,10.3760/cma.j.issn.1001-0939.2020.0001,2020-02-06
Pharmaceutical Preparations,TREATS,Patients,32023684,10.3760/cma.j.issn.1001-0939.2020.0001,2020-02-06
Pharmaceutical Preparations,TREATS(INFER),Pneumonia,32023684,10.3760/cma.j.issn.1001-0939.2020.0001,2020-02-06
Pneumonia,PROCESS_OF,Patients,32023684,10.3760/cma.j.issn.1001-0939.2020.0001,2020-02-06
Genus: Coronavirus,COEXISTS_WITH,SARS coronavirus,32023681,10.3760/cma.j.issn.0578-1426.2020.03.003,2020-02-06
Genus: Coronavirus,COEXISTS_WITH,Middle East Respiratory Syndrome Coronavirus,32023681,10.3760/cma.j.issn.0578-1426.2020.03.003,2020-02-06
Peptidyl-Dipeptidase A,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,32023681,10.3760/cma.j.issn.0578-1426.2020.03.003,2020-02-06
Coronavirus Infections,CAUSES,Communicable Diseases,32023680,10.3760/cma.j.issn.1673-0860.2020.0001,2020-02-06
Lung,LOCATION_OF,Leucocytic infiltrate,32023680,10.3760/cma.j.issn.1673-0860.2020.0001,2020-02-06
"Epitopes, B-Lymphocyte",COEXISTS_WITH,Membrane Glycoproteins,32022275,10.1002/jmv.25699,2020-02-06
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32022275,10.1002/jmv.25699,2020-02-06
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32022275,10.1002/jmv.25699,2020-02-06
Epitopes,PART_OF,Cytotoxic T-Lymphocytes,32022275,10.1002/jmv.25699,2020-02-06
Visual Accommodation,PROCESS_OF,Couples (persons),32020915,10.15171/ijoem.2020.1921,2020-02-06
Syndrome,PROCESS_OF,Patients,32019669,10.2807/1560-7917.ES.2020.25.4.2000058,2020-02-06
Genus: Coronavirus,PROCESS_OF,Rhinolophus,32019669,10.2807/1560-7917.ES.2020.25.4.2000058,2020-02-06
Coronavirus Infections,CAUSES,Pneumonia,32019667,10.2807/1560-7917.ES.2020.25.4.2000057,2020-02-06
Coronavirus Infections,CAUSES,Respiration Disorders,32019667,10.2807/1560-7917.ES.2020.25.4.2000057,2020-02-06
China,ISA,Country,32017661,10.1148/radiol.2020200230,2020-02-06
Lung,LOCATION_OF,Nodule,32015508,10.1038/s41586-020-2008-3,2020-02-06
Lung,LOCATION_OF,Cavitation,32015508,10.1038/s41586-020-2008-3,2020-02-06
Severe Acute Respiratory Syndrome,ISA,Communicable Diseases,32015507,10.1038/s41586-020-2012-7,2020-02-06
Coronavirus Infections,CAUSES,Atypical pneumonia,32007643,10.1016/j.ijid.2020.01.050,2020-02-03
China,ISA,Country,32007627,10.1016/j.meegid.2020.104211,2020-02-03
"Pneumonia, Viral",PROCESS_OF,Patients,32007143,10.1016/S0140-6736(20)30211-7,2020-02-03
Microbial agent,CAUSES,"Pneumonia, Viral",32007143,10.1016/S0140-6736(20)30211-7,2020-02-03
Virus,PROCESS_OF,Homo sapiens,32007143,10.1016/S0140-6736(20)30211-7,2020-02-03
Structural analysis,TREATS,Homo sapiens,32007143,10.1016/S0140-6736(20)30211-7,2020-02-03
Hospitals,LOCATION_OF,Study,32004758,10.1016/j.meegid.2020.104212,2020-02-01
Pneumonia,PROCESS_OF,Patients,32004758,10.1016/j.meegid.2020.104212,2020-02-01
Chronic disease,PROCESS_OF,Patients,32004758,10.1016/j.meegid.2020.104212,2020-02-01
Pneumothorax,PROCESS_OF,Patients,32004758,10.1016/j.meegid.2020.104212,2020-02-01
"Respiratory Distress Syndrome, Adult",ISA,Respiration Disorders,32004758,10.1016/j.meegid.2020.104212,2020-02-01
"Respiratory Distress Syndrome, Adult",PROCESS_OF,Patients,32004758,10.1016/j.meegid.2020.104212,2020-02-01
Severe Acute Respiratory Syndrome,PROCESS_OF,Homo sapiens,32004427,10.1056/NEJMoa2001191,2020-02-01
Betacoronavirus,LOCATION_OF,Genome,32004427,10.1056/NEJMoa2001191,2020-02-01
Virulence,PROCESS_OF,Homo sapiens,32004427,10.1056/NEJMoa2001191,2020-02-01
Infection,PROCESS_OF,Homo sapiens,31997390,10.1002/jmv.25693,2020-01-31
Pneumonia,PROCESS_OF,Patients,31997390,10.1002/jmv.25693,2020-01-31
Coughing,PROCESS_OF,Patients,31997390,10.1002/jmv.25693,2020-01-31
Dyspnea,PROCESS_OF,Patients,31997390,10.1002/jmv.25693,2020-01-31
Fever,PROCESS_OF,Patients,31997390,10.1002/jmv.25693,2020-01-31
Plain chest X-ray,DIAGNOSES,Decreased translucency,31997390,10.1002/jmv.25693,2020-01-31
Present,PROCESS_OF,Patients,31997390,10.1002/jmv.25693,2020-01-31
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,31997390,10.1002/jmv.25693,2020-01-31
Respiration Disorders,PROCESS_OF,Homo sapiens,31997390,10.1002/jmv.25693,2020-01-31
Cities,ISA,Geographic Locations,31996494,10.5582/bst.2020.01020,2020-01-31
Medication Management,TREATS,Homo sapiens,31996437,10.1128/JVI.00127-20,2020-01-31
Coronavirus Infections,PROCESS_OF,Animals,31996437,10.1128/JVI.00127-20,2020-01-31
Genus: Coronavirus,PROCESS_OF,Persons,31996437,10.1128/JVI.00127-20,2020-01-31
New medications,TREATS,Human coronavirus,31996437,10.1128/JVI.00127-20,2020-01-31
Coronavirus Infections,CAUSES,Symptoms,31996413,10.1128/mSphere.00807-19,2020-01-31
Symptoms,PROCESS_OF,Homo sapiens,31996413,10.1128/mSphere.00807-19,2020-01-31
Virus,PROCESS_OF,Homo sapiens,31995857,10.1056/NEJMoa2001316,2020-01-30
Coughing,ISA,Symptoms,31994738,10.1002/jmv.25688,2020-01-30
Cessation of life,PROCESS_OF,Persons,31994738,10.1002/jmv.25688,2020-01-30
Cessation of life,OCCURS_IN,Elderly (population group),31994738,10.1002/jmv.25688,2020-01-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,31992388,10.2807/1560-7917.ES.2020.25.3.2000044,2020-01-30
Mutation,PROCESS_OF,Glycoproteins,31992388,10.2807/1560-7917.ES.2020.25.3.2000044,2020-01-30
Mutation,PROCESS_OF,Measles Virus Nucleoprotein,31992388,10.2807/1560-7917.ES.2020.25.3.2000044,2020-01-30
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,31992388,10.2807/1560-7917.ES.2020.25.3.2000044,2020-01-30
Coronavirus Infections,CAUSES,Acute respiratory disease,31992387,10.2807/1560-7917.ES.2020.25.3.2000045,2020-01-30
Patients,LOCATION_OF,Viral Genome,31986264,10.1016/S0140-6736(20)30183-5,2020-01-28
Severe Acute Respiratory Syndrome,PROCESS_OF,Chiroptera,31986264,10.1016/S0140-6736(20)30183-5,2020-01-28
SARS coronavirus,PROCESS_OF,Homo sapiens,31986264,10.1016/S0140-6736(20)30183-5,2020-01-28
Virus,INTERACTS_WITH,Severe Acute Respiratory Syndrome,31986264,10.1016/S0140-6736(20)30183-5,2020-01-28
Disease,PROCESS_OF,Male population group,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
Infected,PROCESS_OF,Patients,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
Fever,ISA,Symptoms,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
Lymphopenia,PROCESS_OF,Patients,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
Pneumonia,PROCESS_OF,Patients,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
High Level,PROCESS_OF,Patients,31986261,10.1016/S0140-6736(20)30154-9,2020-01-28
Pneumonia,PROCESS_OF,Patients,31981224,10.1002/jmv.25685,2020-01-26
Patients,LOCATION_OF,DNA Sequence,31981224,10.1002/jmv.25685,2020-01-26
Fever,PROCESS_OF,Family member,31981224,10.1002/jmv.25685,2020-01-26
Tract,LOCATION_OF,"Signs and Symptoms, Respiratory",31981224,10.1002/jmv.25685,2020-01-26
Lung,LOCATION_OF,Ground Glass Opacity,31981224,10.1002/jmv.25685,2020-01-26
Asymptomatic,PROCESS_OF,Child,31981224,10.1002/jmv.25685,2020-01-26
Ground Glass Opacity,PROCESS_OF,Child,31981224,10.1002/jmv.25685,2020-01-26
Symptoms,PROCESS_OF,Patients,31981224,10.1002/jmv.25685,2020-01-26
Nasopharynx,NEG_PART_OF,Microorganism,31981224,10.1002/jmv.25685,2020-01-26
Pharyngeal structure,NEG_PART_OF,Microorganism,31981224,10.1002/jmv.25685,2020-01-26
Hospitals,LOCATION_OF,Massively-Parallel Sequencing,31981224,10.1002/jmv.25685,2020-01-26
Genus: Coronavirus,ISA,RNA Viruses,31979013,10.3390/v12020130,2020-01-26
Lung,LOCATION_OF,Impaired gas exchange,31979013,10.3390/v12020130,2020-01-26
Inflammation,PREDISPOSES,Pneumonia,31979013,10.3390/v12020130,2020-01-26
Lung,LOCATION_OF,Inflammation,31979013,10.3390/v12020130,2020-01-26
Genus: Coronavirus,CAUSES,Pneumonia,31979013,10.3390/v12020130,2020-01-26
Pneumonia,PROCESS_OF,Patients,31967327,10.1002/jmv.25681,2020-01-23
Pneumonia,PROCESS_OF,Patients,31967327,10.1002/jmv.25681,2020-01-23
Family,INTERACTS_WITH,Homo sapiens,31967327,10.1002/jmv.25681,2020-01-23
SARS coronavirus,ISA,Genus: Coronavirus,31967327,10.1002/jmv.25681,2020-01-23
Middle East Respiratory Syndrome Coronavirus,ISA,Genus: Coronavirus,31967327,10.1002/jmv.25681,2020-01-23
"Pneumonia, Viral",PROCESS_OF,Patients,31967321,10.1002/jmv.25682,2020-01-23
Disease,PROCESS_OF,Animals,31967321,10.1002/jmv.25682,2020-01-23
Disease,PROCESS_OF,Homo sapiens,31967321,10.1002/jmv.25682,2020-01-23
Coronavirus Infections,CAUSES,"Pneumonia, Viral",31944312,10.1002/jmv.25674,2020-01-17
"Animals, Wild",ISA,Animals,31944312,10.1002/jmv.25674,2020-01-17
Bacteria,CAUSES,Viral Respiratory Tract Infection,31943059,10.1093/jtm/taaa008,2020-01-17
Disease,PROCESS_OF,Homo sapiens,31943059,10.1093/jtm/taaa008,2020-01-17
Virus,CAUSES,Disease,31943059,10.1093/jtm/taaa008,2020-01-17
Virus,CAUSES,Viral Respiratory Tract Infection,31943059,10.1093/jtm/taaa008,2020-01-17
Household composition,PROCESS_OF,Persons,31943059,10.1093/jtm/taaa008,2020-01-17
Assay,ISA,Diagnostic tests,31943059,10.1093/jtm/taaa008,2020-01-17
Assay,METHOD_OF,Detection,31943059,10.1093/jtm/taaa008,2020-01-17
Detection,COEXISTS_WITH,Clinical Laboratory Services,31943059,10.1093/jtm/taaa008,2020-01-17
diagnostic procedure,DIAGNOSES,Respiratory viruses,31943059,10.1093/jtm/taaa008,2020-01-17
Assay,DIAGNOSES,Respiratory viruses,31943059,10.1093/jtm/taaa008,2020-01-17
Coronavirus Infections,CAUSES,Watery diarrhea,31896597,10.1128/JVI.01674-19,2020-01-04
"Intestines, Small",LOCATION_OF,Lesion,31896597,10.1128/JVI.01674-19,2020-01-04
Polymeric Immunoglobulin Receptors,ISA,immunoglobulin receptor,31896597,10.1128/JVI.01674-19,2020-01-04
"Fc receptor, neonatal",ISA,immunoglobulin receptor,31896597,10.1128/JVI.01674-19,2020-01-04
Intestinal Mucosa,LOCATION_OF,Fc Receptor,31896597,10.1128/JVI.01674-19,2020-01-04
Intestinal Mucosa,LOCATION_OF,Polymeric Immunoglobulin Receptors,31896597,10.1128/JVI.01674-19,2020-01-04
Intestinal Mucosa,LOCATION_OF,NF-kappa B,31896597,10.1128/JVI.01674-19,2020-01-04
Intestinal Mucosa,LOCATION_OF,Fc Receptor,31896597,10.1128/JVI.01674-19,2020-01-04
Cell physiology,PROCESS_OF,Eukaryota,31859605,10.1080/22221751.2019.1701391,2019-12-21
Virion,PART_OF,Baculoviridae,31859605,10.1080/22221751.2019.1701391,2019-12-21
Coronavirus Infections,CAUSES,Severe diarrhea,31850725,10.23736/S0026-4725.19.05048-5,2019-12-19
Coronavirus Infections,PROCESS_OF,Family suidae,31850725,10.23736/S0026-4725.19.05048-5,2019-12-19
Clone,PRODUCES,"Gene Products, Protein",31850725,10.23736/S0026-4725.19.05048-5,2019-12-19
Pycnogenol,TREATS,Stented artery,31826992,10.1128/JVI.02015-19,2019-12-13
antibody therapy,USES,Pharmaceutical Preparations,31741497,10.4314/gmj.v53i3.9,2019-11-20
host cell surface,LOCATION_OF,receptor,31741497,10.4314/gmj.v53i3.9,2019-11-20
"Spike Glycoprotein, Coronavirus",AFFECTS,Virus Internalization,31741497,10.4314/gmj.v53i3.9,2019-11-20
"Antibodies, Blocking",AFFECTS,Virus Internalization,31741497,10.4314/gmj.v53i3.9,2019-11-20
Monoclonal Antibodies,STIMULATES,Proteolysis,31741497,10.4314/gmj.v53i3.9,2019-11-20
Monoclonal Antibodies,INTERACTS_WITH,Fc Receptor,31741497,10.4314/gmj.v53i3.9,2019-11-20
Fc Receptor,PART_OF,surface IgG,31741497,10.4314/gmj.v53i3.9,2019-11-20
"Receptors, Virus",AFFECTS,Virus Internalization,31741497,10.4314/gmj.v53i3.9,2019-11-20
Monoclonal Antibodies,AUGMENTS,Virus Internalization,31741497,10.4314/gmj.v53i3.9,2019-11-20
receptor,AUGMENTS,Virus Internalization,31741497,10.4314/gmj.v53i3.9,2019-11-20
Lung,LOCATION_OF,Uncommon disorder,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
Accumulation,COEXISTS_WITH,Pulmonary Alveolar Proteinosis,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
Bronchoscopic irrigation,DIAGNOSES,Pulmonary artery pressure,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
transbronchial lung biopsy,DIAGNOSES,Pulmonary artery pressure,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
One-Lung Ventilation,USES,Positive End-Expiratory Pressure,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
Anesthetics,TREATS,Patients,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
Interventional procedure,TREATS,Patients,31712093,10.1016/j.jviromet.2019.113772,2019-11-13
Clone,PART_OF,Porcine epidemic diarrhea virus,31690127,10.1096/fj.201901624RR,2019-11-07
Peripheral Arterial Diseases,AFFECTS,Persons,31343640,10.23938/ASSN.0715,2019-07-26
Disease,PROCESS_OF,Persons,31343640,10.23938/ASSN.0715,2019-07-26
Aspirin,DISRUPTS,Heart,31343640,10.23938/ASSN.0715,2019-07-26
Peripheral Arterial Diseases,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Peripheral Arterial Diseases,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Treatment Protocols,TREATS,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Treatment Protocols,TREATS(INFER),Peripheral Arterial Diseases,31343640,10.23938/ASSN.0715,2019-07-26
Peripheral Arterial Diseases,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
American College of Cardiology/American Heart Association Lesion Complexity Score C,NEG_PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Treatment Protocols,TREATS,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Treatment Protocols,TREATS(INFER),Peripheral Arterial Diseases,31343640,10.23938/ASSN.0715,2019-07-26
Vascular Diseases,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Risk Reduction,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Peripheral Arterial Diseases,PROCESS_OF,Patients,31343640,10.23938/ASSN.0715,2019-07-26
Prognosis bad,PROCESS_OF,Patients,31295016,10.5858/arpa.2019-0058-RA,2019-07-12
Neoplasm Metastasis,COEXISTS_WITH,Head and Neck Carcinoma,31295016,10.5858/arpa.2019-0058-RA,2019-07-12
primary tumor,COEXISTS_WITH,Head and Neck Carcinoma,31295016,10.5858/arpa.2019-0058-RA,2019-07-12
Poziotinib,ISA,HM781-36B,30918070,10.1128/JVI.00291-19,2019-03-29
Paclitaxel,TREATS,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Phase 2 Clinical Trials,MEASURES,Maximum Tolerated Dose,30918070,10.1128/JVI.00291-19,2019-03-29
trastuzumab,TREATS,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Poziotinib,ADMINISTERED_TO,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Poziotinib,COEXISTS_WITH,Paclitaxel,30918070,10.1128/JVI.00291-19,2019-03-29
Poziotinib,COEXISTS_WITH,trastuzumab,30918070,10.1128/JVI.00291-19,2019-03-29
Exanthema,ISA,Adverse event,30918070,10.1128/JVI.00291-19,2019-03-29
In complete remission,PROCESS_OF,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Poziotinib,COEXISTS_WITH,Paclitaxel,30918070,10.1128/JVI.00291-19,2019-03-29
Poziotinib,COEXISTS_WITH,trastuzumab,30918070,10.1128/JVI.00291-19,2019-03-29
Malignant neoplasm of stomach,PROCESS_OF,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Toxic effect,PROCESS_OF,Patients,30918070,10.1128/JVI.00291-19,2019-03-29
Ions,STIMULATES,Glutamate-ammonia-ligase adenylyltransferase,30867314,10.1128/JVI.00015-19,2019-03-15
"RNA, Double-Stranded",PART_OF,acceptors,30867314,10.1128/JVI.00015-19,2019-03-15
Mucous Membrane,PART_OF,Upper respiratory tract,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Pharyngitis,OCCURS_IN,Child,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Mucous Membrane,LOCATION_OF,"CD69 protein, human",30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Protein Component,PART_OF,"CD69 protein, human",30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Standard of Care,TREATS,Child,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Sore Throat,PROCESS_OF,School child,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Medical Devices,TREATS,Disease,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Immunologic Adjuvants,TREATS,Easy,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Pharyngitis,PROCESS_OF,Child,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
Easy,PROCESS_OF,Child,30693878,10.4103/jpgm.JPGM_431_18,2019-01-30
